Citrus Sinensis ID: 002010

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620-------630-------640-------650-------660-------670-------680-------690-------700-------710-------720-------730-------740-------750-------760-------770-------780-------790-------800-------810-------820-------830-------840-------850-------860-------870-------880-------890-------900-------910-------920-------930-------940-------950-------960-------970-------980--
Protein Sequence
MRATASFNPHLYISLFLLLFSLSCAYSDMDVLLKLKSSMIGPKGSGLKNWEPSSSPSAHCSFSGVTCDQDSRVVSLNVSFMPLFGSIPPEIGLLTKLVNLTISNVNLTGRLPSEMALLTSLKVFNISGNVFQGNFAGQIVRGMTELQVLDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLNGIGLNGTVPAFLSRLKNLREMYIGYFNTYTGGIPPGFGALTQLQVLDMASCNISGEIPTSLSRLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLSGELPEKMSGASLNQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYGKIPPGISKLIDLSILNLSRNGITGSIPNEMRNMMSLTTLDLSYNNLIGNIPSGGQFLAFNETSFIGNPNLCLLRNGTCQSLINSAKHSGDGYGSSFGASKIVITVIALLTFMLLVILTIYQLRKRRLQKSKAWKLTAFQRLDFKAEDVLESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQSAPSLITL
Secondary Structure (PSIPRED)
ccccccHHHHHHHHHHHHHHHHcccHHHHHHHHHHHHcccccccccccccccccccccccccEEEEccccccEEEEEEcccccEEEccccccccccccEEEcccccccccccHHHcccccccEEEcccccccccccHHHHHccccccEEEcccccccccccccccccccccEEEcccccccccccccccccccccEEEcccccccccccHHHHccccccccccccccccccccccccccccccccccccccccEEcccccccccccccEEEccccccEEcccHHHcccccccEEcccccEEEEcccHHHHccccccEEEcccccccccccHHccccccccEEEcccccccccccHHHHccccccEEEEEcccccccccHHHHccccccEEEccccEEEEcccccccccccccEEEcccccccccccccccccccccEEEcccccccccccccccccccccEEcccccccccccccccccccccEEEcccccccccccHHHHcccccccEEcccccccccccHHHHccccccEEEcccccccccccHHHHccccccccccccccccccccHHHHccccccEEccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccHHHHHHccccccEEEcccccEEEEEEcccccEEEEEEEcccccccccHHHHHHHHHHccccccccccEEEEEEcccccEEEEcccccccHHccccccccccccHHHHHHHHHHHHHHHcccccccccccEEcccccccccccccccEEEccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHcccccccccccccHHHHHHHHccccccccccccHHHHcccccccccHHHHHHHHHHHHccccccccccccHHHHHHHHccccccccccccc
Secondary Structure Prediction (SSPRO)
ccHHHHHHHHHHHHHHHHHHHHHcccHHHHHHHHHHHHccccccccccccccccccccccccEEEEEcccccEEEEEEccccccccccHHHcccccccEEEcccccccccccHHHHccccccEEEcccccccccccHHHHHHHccccEEEEccccccccccHHHccccccEEEEEccccccccccHHHcccHccEEEEcccccccccccHHHHHcccccEEEEEEEccEEccccHHHHHcccccEEEEEEEccEEEccHHHHHcccccEEEccccEEEccccHHHHHcccccEEEccccccEEEccHHHHccccccEEEccccccEEEccHHHHccccccEEEEEcccccccccHHHccccccEEEEEccccEEccccHHHHHcccccEEEEEEEccEEEccHHHHHcccccEEEccccEEEccccHHHHHcccccEEEccccccEEEccHHHHcccccEEEEccccccccccHHccccccccEEEccccccEEcccHHHHHcccccEEEccccEEEEEccHHHHHcccccEEEcccccEEccccHHHHHcccccEEEEEEEccEEEccHHHHHcccccEEEccccEEEccccccccHccccHHHccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccccccEEEccccccccHHHHHHHccHccEEEcccccEEEEEEcccccEEEEEEEcccccccccccHHHHHHHHHHcHHHHHHHHHHHccccccEEEEEEEcccccHHHHHcccccccccHHHHHHHHHHHHHHHHHHHccccccEEEEccccccEEccccccHHHHHHHHHHHHHcccccccccHHccccccEccccEEEEEEcccHHHHHHHHHHHHHHccccccccccccccHHHHHHHHHHHcccccccccHHHHHcHHcccccHHHHHHHHHHHHHHccccccccccHHHHHHHHHHccccccccccc
Coil and Loop (DISEMBL)
mratasfnpHLYISLFLLLFSLSCAYSDMDVLLKLKssmigpkgsglknwepssspsahcsfsgvtcdqdsrvvslnvsfmplfgsippeiGLLTKLVNLTISnvnltgrlpSEMALLTSLKVfnisgnvfqgnfaGQIVRGMTELQVLDAynnnftgplPVEIASLKslrhlsfggnyftgkipqsysEIQSLEYIglngiglngtVPAFLSRLKNLREMYIGYFntytggippgfgaltQLQVLDmascnisgeiptSLSRLKLLHSLFLQMnkltghippqlsglislksldlslnyltgeipESFAALKNLTLLQLFKnnlrgpipsflgdfpnlEVLQVWGnnftfelpenlgrngKLLILDVtsnhltgtiprdlckggklkSLILMQNFfigpipeelgqcksltkirfsknylngtipaglfnlpllnmmelddnllsgelpekmsgaslNQLKVAnnnitgkipaaignlpslnilslqnnrlegeipvesfNLKMITsinisdnnisgeipysisqchsltsvdlsrnslygkippgiskLIDLSIlnlsrngitgsipneMRNMMSLTTLDLSYnnlignipsggqflafnetsfignpnlcllrngTCQSLINSakhsgdgygssfgaSKIVITVIALLTFMLLVILTIYQLRKRRLQKSKAWKLTAFQRLDFKAEDVLESlkdeniigkggagivyrgsmpdgIDVAIKRLvgrgtggndhgFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYeympngslgemlhgakgghlkwETRYRIALEAAKGLcylhhdcspliihrdvksnnilldsdfeaHVADFGLAKFlqdagasecmssvagsygyiapeyaytlkvdeksdvYSFGVVLLELIagkkpvgefgdgvDIVRWVRKttsevsqpsdaaSVLAVvdprlsgypltgVIHLFKVAMMCVedessarptMREVVHMlanppqsapslitl
Flexible Loop (DISEMBL)
mratasfnpHLYISLFLLLFSLSCAYSDMDVLLKLKSSMIGPKGSGLKNWEPSSSPSAHCSFSGVTCDQDSRVVSLNVSFMPLFGSIPPEIGLLTKLVNLTISNVNLTGRLPSEMALLTSLKVFNISGNVFQGNFAGQIVRGMTELQVLDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLNGIGLNGTVPAFLSRLKNLREMYIGYFNTYTGGIPPGFGALTQLQVLDMASCNISGEIPTSLSRLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLSGELPEKMSGASLNQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYGKIPPGISKLIDLSILNLSRNGITGSIPNEMRNMMSLTTLDLSYNNLIGNIPSGGQFLAFNETSFIGNPNLCLLRNGTCQSLINSAKHSGDGYGSSFGASKIVITVIALLTFMLLVILTIYQLRKRRLQKSkawkltafqrldFKAEDVLeslkdeniigkggagivyrgsMPDGIDVAIKRLVGRGTGGNDHGFLAEIqtlgrirhRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELiagkkpvgefgdgVDIVRWVRKttsevsqpsdaasvLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMlanppqsapslitl
Low Complexity Region (SEG)
MRATASFNPHLYIslflllfslsCAYSDMDVLLKLKSSMIGPKGSGLKNWEPssspsahcsfsGVTCDQDSRVVSLNVSFMPLFGSIPPEIGLLTKLVNLTISNVNLTGRLPSEMALLTSLKVFNISGNVFQGNFAGQIVRGMTELQVLDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLNGIGLNGTVPAFLSRLKNLREMYIGYFNTYTGGIPPGFGALTQLQVLDMASCNISGEIPTslsrlkllhslflQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGTIPAGLFnlpllnmmelddnllSGELPEKMSGASLNQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESFNLKMITsinisdnnisGEIPYSISQCHSLTSVDLSRNSLYGKIPPGISKLIDLSILNLSRNGITGSIPNEMRNMMSLTTLDLSYNNLIGNIPSGGQFLAFNETSFIGNPNLCLLRNGTCQSLINSAKHSGDGYGSSFGASKIVITVIALLTFMLLVILTIYQLRKRRLQKSKAWKLTAFQRLDFKAEDVLESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQSAPSLITL
Disordered region (IsUnstruct)
******FNPHLYISLFLLLFSLSCAYSDMDVLLKLK**************************SGVTCDQDSRVVSLNVSFMPLFGSIPPEIGLLTKLVNLTISNVNLTGRLPSEMALLTSLKVFNISGNVFQGNFAGQIVRGMTELQVLDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLNGIGLNGTVPAFLSRLKNLREMYIGYFNTYTGGIPPGFGALTQLQVLDMASCNISGEIPTSLSRLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLL**************QLKVANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYGKIPPGISKLIDLSILNLSRNGITGSIPNEMRNMMSLTTLDLSYNNLIGNIPSGGQFLAFNETSFIGNPNLCLLRNGTCQSLINSAKHSGDGYGSSFGASKIVITVIALLTFMLLVILTIYQLRKRRLQKSKAWKLTAFQRLDFKAEDVLESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTT********AASVLAVVDPRLSGYPLTGVIHLFKVAMMCVE*****************************
Disordered Region (DISOPRED)
****ASFNPHLYISLFLLLFSLSCAYSDMDVLLKLKSSMIG*KGSGLKNWEPSSSPSAHCSFSGVTCDQDSRVVSLNVSFMPLFGSIPPEIGLLTKLVNLTISNVNLTGRLPSEMALLTSLKVFNISGNVFQGNFAGQIVRGMTELQVLDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLNGIGLNGTVPAFLSRLKNLREMYIGYFNTYTGGIPPGFGALTQLQVLDMASCNISGEIPTSLSRLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLSGELPEKMSGASLNQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYGKIPPGISKLIDLSILNLSRNGITGSIPNEMRNMMSLTTLDLSYNNLIGNIPSGGQFLAFNETSFIGNPNLCLLRN***********************SKIVITVIALLTFMLLVILTIY********************LDFKAEDVLESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGT****HGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTS*****SDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQSAPSLI*L
Disordered Region (DISEMBL)
MRATASFNPHLYISLFLLLFSLSCAYSDMDVLLKLKSSMIGPKG******************SGVTCDQDSRVVSLNVSFMPLFGSIPPEIGLLTKLVNLTISNVNLTGRLPSEMALLTSLKVFNISGNVFQGNFAGQIVRGMTELQVLDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLNGIGLNGTVPAFLSRLKNLREMYIGYFNTYTGGIPPGFGALTQLQVLDMASCNISGEIPTSLSRLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLSGELPEKMSGASLNQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYGKIPPGISKLIDLSILNLSRNGITGSIPNEMRNMMSLTTLDLSYNNLIGNIPSGGQFLAFNETSFIGNPNLCLLRNGTCQSLINSAKHSGDGYGSSFGASKIVITVIALLTFMLLVILTIYQLRKRRLQKSKAWKLTAFQRLDFKAEDVLESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKT*********AASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQSAPSLITL
Disordered Region (DISPRO)
*RATASFNPHLYISLFLLLFSLSCAYSDMDVLLKLKSSMIGPKGSGLKNWEPSSSPSAHCSFSGVTCDQDSRVVSLNVSFMPLFGSIPPEIGLLTKLVNLTISNVNLTGRLPSEMALLTSLKVFNISGNVFQGNFAGQIVRGMTELQVLDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLNGIGLNGTVPAFLSRLKNLREMYIGYFNTYTGGIPPGFGALTQLQVLDMASCNISGEIPTSLSRLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLSGELPEKMSGASLNQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYGKIPPGISKLIDLSILNLSRNGITGSIPNEMRNMMSLTTLDLSYNNLIGNIPSGGQFLAFNETSFIGNPNLCLLRNGTCQ************YGSSFGASKIVITVIALLTFMLLVILTIYQLRKRRLQKSKAWKLTAFQRLDFKAEDVLESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPP*********
Transmembrane Helix (TMHMM)
iiiiiiHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (MEMSAT)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSiiiHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
SSSSSSSSSSSSSSSSSSSSSSSSSSSoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
SSSSSSSSSSSSSSSSSSSSSSSSSSSSoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MRATASFNPHLYISLFLLLFSLSCAYSDMDVLLKLKSSMIGPKGSGLKNWEPSSSPSAHCSFSGVTCDQDSRVVSLNVSFMPLFGSIPPEIGLLTKLVNLTISNVNLTGRLPSEMALLTSLKVFNISGNVFQGNFAGQIVRGMTELQVLDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLNGIGLNGTVPAFLSRLKNLREMYIGYFNTYTGGIPPGFGALTQLQVLDMASCNISGEIPTSLSRLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLSGELPEKMSGASLNQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYGKIPPGISKLIDLSILNLSRNGITGSIPNEMRNMMSLTTLDLSYNNLIGNIPSGGQFLAFNETSFIGNPNLCLLRNGTCQSLINSAKHSGDGYGSSFGASKIVITVIALLTFMLLVILTIYQLRKRRLQKSKAWKLTAFQRLDFKAEDVLESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQSAPSLITL
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	982	2.2.26 [Sep-21-2011]
Q9SYQ8	980	Receptor protein kinase C	yes	no	0.973	0.975	0.697	0.0
O49545	1003	Leucine-rich repeat recep	no	no	0.967	0.947	0.549	0.0
Q9M2Z1	1002	Leucine-rich repeat recep	no	no	0.958	0.939	0.540	0.0
O65440	992	Leucine-rich repeat recep	no	no	0.955	0.945	0.498	0.0
Q9FII5	1041	Leucine-rich repeat recep	no	no	0.931	0.878	0.421	0.0
Q9FRS6	1029	Leucine-rich repeat recep	no	no	0.939	0.896	0.381	0.0
Q9SGP2	996	Receptor-like protein kin	no	no	0.915	0.902	0.388	1e-179
Q9M0G7	1013	Leucine-rich repeat recep	no	no	0.948	0.919	0.386	1e-178
Q9SHI2	1101	Leucine-rich repeat recep	no	no	0.957	0.853	0.361	1e-167
P47735	999	Receptor-like protein kin	no	no	0.915	0.899	0.382	1e-162

>sp|Q9SYQ8|CLV1_ARATH Receptor protein kinase CLAVATA1 OS=Arabidopsis thaliana GN=CLV1 PE=1 SV=3

 Score = 1382 bits (3576), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 669/959 (69%), Positives = 793/959 (82%), Gaps = 3/959 (0%)

Query: 25  AYSDMDVLLKLKSSMIGPKGSGLKNWEPSSSPSAHCSFSGVTCDQDSRVVSLNVSFMPLF 84
           AY+DM+VLL LKSSMIGPKG GL +W  SSSP AHCSFSGV+CD D+RV+SLNVSF PLF
Sbjct: 24  AYTDMEVLLNLKSSMIGPKGHGLHDWIHSSSPDAHCSFSGVSCDDDARVISLNVSFTPLF 83

Query: 85  GSIPPEIGLLTKLVNLTISNVNLTGRLPSEMALLTSLKVFNISGN-VFQGNFAGQIVRGM 143
           G+I PEIG+LT LVNLT++  N TG LP EM  LTSLKV NIS N    G F G+I++ M
Sbjct: 84  GTISPEIGMLTHLVNLTLAANNFTGELPLEMKSLTSLKVLNISNNGNLTGTFPGEILKAM 143

Query: 144 TELQVLDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLNGIG 203
            +L+VLD YNNNF G LP E++ LK L++LSFGGN+F+G+IP+SY +IQSLEY+GLNG G
Sbjct: 144 VDLEVLDTYNNNFNGKLPPEMSELKKLKYLSFGGNFFSGEIPESYGDIQSLEYLGLNGAG 203

Query: 204 LNGTVPAFLSRLKNLREMYIGYFNTYTGGIPPGFGALTQLQVLDMASCNISGEIPTSLSR 263
           L+G  PAFLSRLKNLREMYIGY+N+YTGG+PP FG LT+L++LDMASC ++GEIPTSLS 
Sbjct: 204 LSGKSPAFLSRLKNLREMYIGYYNSYTGGVPPEFGGLTKLEILDMASCTLTGEIPTSLSN 263

Query: 264 LKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQLFKN 323
           LK LH+LFL +N LTGHIPP+LSGL+SLKSLDLS+N LTGEIP+SF  L N+TL+ LF+N
Sbjct: 264 LKHLHTLFLHINNLTGHIPPELSGLVSLKSLDLSINQLTGEIPQSFINLGNITLINLFRN 323

Query: 324 NLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDLCK 383
           NL G IP  +G+ P LEV +VW NNFT +LP NLGRNG L+ LDV+ NHLTG IP+DLC+
Sbjct: 324 NLYGQIPEAIGELPKLEVFEVWENNFTLQLPANLGRNGNLIKLDVSDNHLTGLIPKDLCR 383

Query: 384 GGKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDN 443
           G KL+ LIL  NFF GPIPEELG+CKSLTKIR  KN LNGT+PAGLFNLPL+ ++EL DN
Sbjct: 384 GEKLEMLILSNNFFFGPIPEELGKCKSLTKIRIVKNLLNGTVPAGLFNLPLVTIIELTDN 443

Query: 444 LLSGELPEKMSGASLNQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESFNL 503
             SGELP  MSG  L+Q+ ++NN  +G+IP AIGN P+L  L L  NR  G IP E F L
Sbjct: 444 FFSGELPVTMSGDVLDQIYLSNNWFSGEIPPAIGNFPNLQTLFLDRNRFRGNIPREIFEL 503

Query: 504 KMITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYGKIPPGISKLIDLSILNLSRNG 563
           K ++ IN S NNI+G IP SIS+C +L SVDLSRN + G+IP GI+ + +L  LN+S N 
Sbjct: 504 KHLSRINTSANNITGGIPDSISRCSTLISVDLSRNRINGEIPKGINNVKNLGTLNISGNQ 563

Query: 564 ITGSIPNEMRNMMSLTTLDLSYNNLIGNIPSGGQFLAFNETSFIGNPNLCLLRNGTCQSL 623
           +TGSIP  + NM SLTTLDLS+N+L G +P GGQFL FNETSF GN  LCL    +C + 
Sbjct: 564 LTGSIPTGIGNMTSLTTLDLSFNDLSGRVPLGGQFLVFNETSFAGNTYLCLPHRVSCPT- 622

Query: 624 INSAKHSGDGYGSSFGASKIVITVIALLTFMLLVILTIYQLRKRRLQKSKAWKLTAFQRL 683
               + S   + + F  S+IVITVIA +T ++L+ + I Q+ K++ QKS AWKLTAFQ+L
Sbjct: 623 -RPGQTSDHNHTALFSPSRIVITVIAAITGLILISVAIRQMNKKKNQKSLAWKLTAFQKL 681

Query: 684 DFKAEDVLESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTL 743
           DFK+EDVLE LK+ENIIGKGGAGIVYRGSMP+ +DVAIKRLVGRGTG +DHGF AEIQTL
Sbjct: 682 DFKSEDVLECLKEENIIGKGGAGIVYRGSMPNNVDVAIKRLVGRGTGRSDHGFTAEIQTL 741

Query: 744 GRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKG 803
           GRIRHR+IVRLLGYV+N+DTNLLLYEYMPNGSLGE+LHG+KGGHL+WETR+R+A+EAAKG
Sbjct: 742 GRIRHRHIVRLLGYVANKDTNLLLYEYMPNGSLGELLHGSKGGHLQWETRHRVAVEAAKG 801

Query: 804 LCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYI 863
           LCYLHHDCSPLI+HRDVKSNNILLDSDFEAHVADFGLAKFL D  ASECMSS+AGSYGYI
Sbjct: 802 LCYLHHDCSPLILHRDVKSNNILLDSDFEAHVADFGLAKFLVDGAASECMSSIAGSYGYI 861

Query: 864 APEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAA 923
           APEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFG+GVDIVRWVR T  E++QPSDAA
Sbjct: 862 APEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGEGVDIVRWVRNTEEEITQPSDAA 921

Query: 924 SVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQSAPSLITL 982
            V+A+VDPRL+GYPLT VIH+FK+AMMCVE+E++ARPTMREVVHML NPP+S  +LI  
Sbjct: 922 IVVAIVDPRLTGYPLTSVIHVFKIAMMCVEEEAAARPTMREVVHMLTNPPKSVANLIAF 980

Involved in the detection of CLV3 and CLV3-like peptides, that act as extracellular signals regulating meristem maintenance. Acts with CLV3 as a ligand-receptor pair in a signal transduction pathway coordinating growth between adjacent meristematic regions and controlling the balance between meristem cell proliferation and differentiation.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|O49545|BAME1_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase BAM1 OS=Arabidopsis thaliana GN=BAM1 PE=1 SV=1

 Score = 1032 bits (2668), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 531/967 (54%), Positives = 687/967 (71%), Gaps = 17/967 (1%)

Query: 20  FSLSCAYSDMDVLLKLKSSMIGP---KGSGLKNWEPSSSPSAHCSFSGVTCDQDSR-VVS 75
           F+ S   S+   LL LK+S+ G    K S L +W+ S+S    C++ GVTCD   R V S
Sbjct: 17  FTASRPISEFRALLSLKTSLTGAGDDKNSPLSSWKVSTS---FCTWIGVTCDVSRRHVTS 73

Query: 76  LNVSFMPLFGSIPPEIGLLTKLVNLTISNVNLTGRLPSEMALLTSLKVFNISGNVFQGNF 135
           L++S + L G++ P++  L  L NL+++   ++G +P E++ L+ L+  N+S NVF G+F
Sbjct: 74  LDLSGLNLSGTLSPDVSHLRLLQNLSLAENLISGPIPPEISSLSGLRHLNLSNNVFNGSF 133

Query: 136 AGQIVRGMTELQVLDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQSLE 195
             +I  G+  L+VLD YNNN TG LPV + +L  LRHL  GGNYF GKIP SY     +E
Sbjct: 134 PDEISSGLVNLRVLDVYNNNLTGDLPVSVTNLTQLRHLHLGGNYFAGKIPPSYGSWPVIE 193

Query: 196 YIGLNGIGLNGTVPAFLSRLKNLREMYIGYFNTYTGGIPPGFGALTQLQVLDMASCNISG 255
           Y+ ++G  L G +P  +  L  LRE+YIGY+N +  G+PP  G L++L   D A+C ++G
Sbjct: 194 YLAVSGNELVGKIPPEIGNLTTLRELYIGYYNAFEDGLPPEIGNLSELVRFDGANCGLTG 253

Query: 256 EIPTSLSRLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNL 315
           EIP  + +L+ L +LFLQ+N  +G +  +L  L SLKS+DLS N  TGEIP SFA LKNL
Sbjct: 254 EIPPEIGKLQKLDTLFLQVNVFSGPLTWELGTLSSLKSMDLSNNMFTGEIPASFAELKNL 313

Query: 316 TLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTG 375
           TLL LF+N L G IP F+GD P LEVLQ+W NNFT  +P+ LG NGKL ++D++SN LTG
Sbjct: 314 TLLNLFRNKLHGEIPEFIGDLPELEVLQLWENNFTGSIPQKLGENGKLNLVDLSSNKLTG 373

Query: 376 TIPRDLCKGGKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGTIPAGLFNLPLL 435
           T+P ++C G KL++LI + NF  G IP+ LG+C+SLT+IR  +N+LNG+IP GLF LP L
Sbjct: 374 TLPPNMCSGNKLETLITLGNFLFGSIPDSLGKCESLTRIRMGENFLNGSIPKGLFGLPKL 433

Query: 436 NMMELDDNLLSGELPEKMSGASLN--QLKVANNNITGKIPAAIGNLPSLNILSLQNNRLE 493
             +EL DN LSGELP    G S+N  Q+ ++NN ++G +P AIGN   +  L L  N+ +
Sbjct: 434 TQVELQDNYLSGELP-VAGGVSVNLGQISLSNNQLSGPLPPAIGNFTGVQKLLLDGNKFQ 492

Query: 494 GEIPVESFNLKMITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYGKIPPGISKLID 553
           G IP E   L+ ++ I+ S N  SG I   IS+C  LT VDLSRN L G+IP  I+ +  
Sbjct: 493 GPIPSEVGKLQQLSKIDFSHNLFSGRIAPEISRCKLLTFVDLSRNELSGEIPNEITAMKI 552

Query: 554 LSILNLSRNGITGSIPNEMRNMMSLTTLDLSYNNLIGNIPSGGQFLAFNETSFIGNPNLC 613
           L+ LNLSRN + GSIP  + +M SLT+LD SYNNL G +P  GQF  FN TSF+GNP+LC
Sbjct: 553 LNYLNLSRNHLVGSIPGSISSMQSLTSLDFSYNNLSGLVPGTGQFSYFNYTSFLGNPDLC 612

Query: 614 LLRNGTCQSLINSAKHSGDGYGSSFGASKIVITVIALLTFMLLVILTIYQLRK-RRLQKS 672
               G C+  +    H     G    + K+++ +  L+  +   ++ I + R  ++  +S
Sbjct: 613 GPYLGPCKDGVAKGGHQSHSKGPLSASMKLLLVLGLLVCSIAFAVVAIIKARSLKKASES 672

Query: 673 KAWKLTAFQRLDFKAEDVLESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTG-G 731
           +AW+LTAFQRLDF  +DVL+SLK++NIIGKGGAGIVY+G MP+G  VA+KRL     G  
Sbjct: 673 RAWRLTAFQRLDFTCDDVLDSLKEDNIIGKGGAGIVYKGVMPNGDLVAVKRLAAMSRGSS 732

Query: 732 NDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWE 791
           +DHGF AEIQTLGRIRHR+IVRLLG+ SN +TNLL+YEYMPNGSLGE+LHG KGGHL W+
Sbjct: 733 HDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWD 792

Query: 792 TRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASE 851
           TRY+IALEAAKGLCYLHHDCSPLI+HRDVKSNNILLDS+FEAHVADFGLAKFLQD+G SE
Sbjct: 793 TRYKIALEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSNFEAHVADFGLAKFLQDSGTSE 852

Query: 852 CMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRK 911
           CMS++AGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLEL+ G+KPVGEFGDGVDIV+WVRK
Sbjct: 853 CMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELVTGRKPVGEFGDGVDIVQWVRK 912

Query: 912 TTSEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLAN 971
            T      S+  SVL V+DPRLS  P+  V H+F VAM+CVE+++  RPTMREVV +L  
Sbjct: 913 MTD-----SNKDSVLKVLDPRLSSIPIHEVTHVFYVAMLCVEEQAVERPTMREVVQILTE 967

Query: 972 PPQSAPS 978
            P+  PS
Sbjct: 968 IPKLPPS 974

Necessary for male gametophyte development, as well as ovule specification and function. Involved in cell-cell communication process required during early anther development, and regulating cell division and differentiation to organize cell layers. Required for the development of high-ordered vascular strands within the leaf and a correlated control of leaf shape, size and symmetry. May regulate the CLV1-dependent CLV3-mediated signaling in meristems maintenance.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9M2Z1|BAME2_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase BAM2 OS=Arabidopsis thaliana GN=BAM2 PE=1 SV=1

 Score = 1001 bits (2588), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 520/962 (54%), Positives = 677/962 (70%), Gaps = 21/962 (2%)

Query: 20  FSLSCAYSDMDVLLKLKSSM-IGPKGSGLKNWEPSSSPSAHCSFSGVTCDQDSR-VVSLN 77
           F+++   +++  LL LKSS  I      L +W  S++    CS++GVTCD   R V SL+
Sbjct: 19  FTVAKPITELHALLSLKSSFTIDEHSPLLTSWNLSTT---FCSWTGVTCDVSLRHVTSLD 75

Query: 78  VSFMPLFGSIPPEIGLLTKLVNLTISNVNLTGRLPSEMALLTSLKVFNISGNVFQGNFAG 137
           +S + L G++  ++  L  L NL+++   ++G +P +++ L  L+  N+S NVF G+F  
Sbjct: 76  LSGLNLSGTLSSDVAHLPLLQNLSLAANQISGPIPPQISNLYELRHLNLSNNVFNGSFPD 135

Query: 138 QIVRGMTELQVLDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYI 197
           ++  G+  L+VLD YNNN TG LPV + +L  LRHL  GGNYF+GKIP +Y     LEY+
Sbjct: 136 ELSSGLVNLRVLDLYNNNLTGDLPVSLTNLTQLRHLHLGGNYFSGKIPATYGTWPVLEYL 195

Query: 198 GLNGIGLNGTVPAFLSRLKNLREMYIGYFNTYTGGIPPGFGALTQLQVLDMASCNISGEI 257
            ++G  L G +P  +  L  LRE+YIGY+N +  G+PP  G L++L   D A+C ++GEI
Sbjct: 196 AVSGNELTGKIPPEIGNLTTLRELYIGYYNAFENGLPPEIGNLSELVRFDAANCGLTGEI 255

Query: 258 PTSLSRLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTL 317
           P  + +L+ L +LFLQ+N  TG I  +L  + SLKS+DLS N  TGEIP SF+ LKNLTL
Sbjct: 256 PPEIGKLQKLDTLFLQVNAFTGTITQELGLISSLKSMDLSNNMFTGEIPTSFSQLKNLTL 315

Query: 318 LQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTI 377
           L LF+N L G IP F+G+ P LEVLQ+W NNFT  +P+ LG NG+L+ILD++SN LTGT+
Sbjct: 316 LNLFRNKLYGAIPEFIGEMPELEVLQLWENNFTGSIPQKLGENGRLVILDLSSNKLTGTL 375

Query: 378 PRDLCKGGKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNM 437
           P ++C G +L +LI + NF  G IP+ LG+C+SLT+IR  +N+LNG+IP  LF LP L+ 
Sbjct: 376 PPNMCSGNRLMTLITLGNFLFGSIPDSLGKCESLTRIRMGENFLNGSIPKELFGLPKLSQ 435

Query: 438 MELDDNLLSGELPEKMSGAS--LNQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLEGE 495
           +EL DN L+GELP    G S  L Q+ ++NN ++G +PAAIGNL  +  L L  N+  G 
Sbjct: 436 VELQDNYLTGELPISGGGVSGDLGQISLSNNQLSGSLPAAIGNLSGVQKLLLDGNKFSGS 495

Query: 496 IPVESFNLKMITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYGKIPPGISKLIDLS 555
           IP E   L+ ++ ++ S N  SG I   IS+C  LT VDLSRN L G IP  ++ +  L+
Sbjct: 496 IPPEIGRLQQLSKLDFSHNLFSGRIAPEISRCKLLTFVDLSRNELSGDIPNELTGMKILN 555

Query: 556 ILNLSRNGITGSIPNEMRNMMSLTTLDLSYNNLIGNIPSGGQFLAFNETSFIGNPNLCLL 615
            LNLSRN + GSIP  + +M SLT++D SYNNL G +PS GQF  FN TSF+GN +LC  
Sbjct: 556 YLNLSRNHLVGSIPVTIASMQSLTSVDFSYNNLSGLVPSTGQFSYFNYTSFVGNSHLCGP 615

Query: 616 RNGTCQSLINSAKHSGDGYGSSFGA-SKIVITVIALLTFMLLVILTIYQLRK-RRLQKSK 673
             G C       K +   +     A +K+++ +  L   M+  I+ I + R  R   ++K
Sbjct: 616 YLGPC------GKGTHQSHVKPLSATTKLLLVLGLLFCSMVFAIVAIIKARSLRNASEAK 669

Query: 674 AWKLTAFQRLDFKAEDVLESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTG-GN 732
           AW+LTAFQRLDF  +DVL+SLK++NIIGKGGAGIVY+G+MP G  VA+KRL     G  +
Sbjct: 670 AWRLTAFQRLDFTCDDVLDSLKEDNIIGKGGAGIVYKGTMPKGDLVAVKRLATMSHGSSH 729

Query: 733 DHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWET 792
           DHGF AEIQTLGRIRHR+IVRLLG+ SN +TNLL+YEYMPNGSLGE+LHG KGGHL W T
Sbjct: 730 DHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWNT 789

Query: 793 RYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASEC 852
           RY+IALEAAKGLCYLHHDCSPLI+HRDVKSNNILLDS+FEAHVADFGLAKFLQD+G SEC
Sbjct: 790 RYKIALEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSNFEAHVADFGLAKFLQDSGTSEC 849

Query: 853 MSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKT 912
           MS++AGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELI GKKPVGEFGDGVDIV+WVR  
Sbjct: 850 MSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGKKPVGEFGDGVDIVQWVRSM 909

Query: 913 TSEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANP 972
           T      S+   VL V+D RLS  P+  V H+F VA++CVE+++  RPTMREVV +L   
Sbjct: 910 TD-----SNKDCVLKVIDLRLSSVPVHEVTHVFYVALLCVEEQAVERPTMREVVQILTEI 964

Query: 973 PQ 974
           P+
Sbjct: 965 PK 966

Necessary for male gametophyte development, as well as ovule specification and function. Involved in cell-cell communication process required during early anther development, and regulating cell division and differentiation to organize cell layers. Required for the development of high-ordered vascular strands within the leaf and a correlated control of leaf shape, size and symmetry. May regulate the CLV1-dependent CLV3-mediated signaling in meristems maintenance.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O65440|BAME3_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase BAM3 OS=Arabidopsis thaliana GN=BAM3 PE=2 SV=3

 Score =  902 bits (2332), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 479/960 (49%), Positives = 648/960 (67%), Gaps = 22/960 (2%)

Query: 30  DVLLKLKSSMIGPKGSGLKNWEPSSSPSAHCSFSGVTCDQ-DSRVVSLNVSFMPLFGSIP 88
           +VL+ LK S      S L +W   +  S  CS++GV+CD  +  +  L++S + + G+I 
Sbjct: 36  NVLISLKQSFDSYDPS-LDSWNIPNFNSL-CSWTGVSCDNLNQSITRLDLSNLNISGTIS 93

Query: 89  PEIGLLT-KLVNLTISNVNLTGRLPSEMALLTSLKVFNISGNVFQGNFAGQIVRGMTELQ 147
           PEI  L+  LV L IS+ + +G LP E+  L+ L+V NIS NVF+G    +    MT+L 
Sbjct: 94  PEISRLSPSLVFLDISSNSFSGELPKEIYELSGLEVLNISSNVFEGELETRGFSQMTQLV 153

Query: 148 VLDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLNGIGLNGT 207
            LDAY+N+F G LP+ + +L  L HL  GGNYF G+IP+SY    SL+++ L+G  L G 
Sbjct: 154 TLDAYDNSFNGSLPLSLTTLTRLEHLDLGGNYFDGEIPRSYGSFLSLKFLSLSGNDLRGR 213

Query: 208 VPAFLSRLKNLREMYIGYFNTYTGGIPPGFGALTQLQVLDMASCNISGEIPTSLSRLKLL 267
           +P  L+ +  L ++Y+GY+N Y GGIP  FG L  L  LD+A+C++ G IP  L  LK L
Sbjct: 214 IPNELANITTLVQLYLGYYNDYRGGIPADFGRLINLVHLDLANCSLKGSIPAELGNLKNL 273

Query: 268 HSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQLFKNNLRG 327
             LFLQ N+LTG +P +L  + SLK+LDLS N+L GEIP   + L+ L L  LF N L G
Sbjct: 274 EVLFLQTNELTGSVPRELGNMTSLKTLDLSNNFLEGEIPLELSGLQKLQLFNLFFNRLHG 333

Query: 328 PIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDLCKGGKL 387
            IP F+ + P+L++L++W NNFT ++P  LG NG L+ +D+++N LTG IP  LC G +L
Sbjct: 334 EIPEFVSELPDLQILKLWHNNFTGKIPSKLGSNGNLIEIDLSTNKLTGLIPESLCFGRRL 393

Query: 388 KSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLSG 447
           K LIL  NF  GP+PE+LGQC+ L + R  +N+L   +P GL  LP L+++EL +N L+G
Sbjct: 394 KILILFNNFLFGPLPEDLGQCEPLWRFRLGQNFLTSKLPKGLIYLPNLSLLELQNNFLTG 453

Query: 448 ELPEKMSG----ASLNQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESFNL 503
           E+PE+ +G    +SL Q+ ++NN ++G IP +I NL SL IL L  NRL G+IP E  +L
Sbjct: 454 EIPEEEAGNAQFSSLTQINLSNNRLSGPIPGSIRNLRSLQILLLGANRLSGQIPGEIGSL 513

Query: 504 KMITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYGKIPPGISKLIDLSILNLSRNG 563
           K +  I++S NN SG+ P     C SLT +DLS N + G+IP  IS++  L+ LN+S N 
Sbjct: 514 KSLLKIDMSRNNFSGKFPPEFGDCMSLTYLDLSHNQISGQIPVQISQIRILNYLNVSWNS 573

Query: 564 ITGSIPNEMRNMMSLTTLDLSYNNLIGNIPSGGQFLAFNETSFIGNPNLCLLRNGTCQSL 623
              S+PNE+  M SLT+ D S+NN  G++P+ GQF  FN TSF+GNP LC   +  C   
Sbjct: 574 FNQSLPNELGYMKSLTSADFSHNNFSGSVPTSGQFSYFNNTSFLGNPFLCGFSSNPCNGS 633

Query: 624 INSAK----HSGDGYGSSFGASKIVITVIALLTFMLLVILTIYQLRKRRLQKSKA--WKL 677
            N ++    +  +       ++K  +     L    LV + +  ++ RR++K+    WKL
Sbjct: 634 QNQSQSQLLNQNNARSRGEISAKFKLFFGLGLLGFFLVFVVLAVVKNRRMRKNNPNLWKL 693

Query: 678 TAFQRLDFKAEDVLESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTG-GNDHGF 736
             FQ+L F++E +LE +K+ ++IGKGG GIVY+G MP+G +VA+K+L+    G  +D+G 
Sbjct: 694 IGFQKLGFRSEHILECVKENHVIGKGGRGIVYKGVMPNGEEVAVKKLLTITKGSSHDNGL 753

Query: 737 LAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRI 796
            AEIQTLGRIRHRNIVRLL + SN+D NLL+YEYMPNGSLGE+LHG  G  LKWETR +I
Sbjct: 754 AAEIQTLGRIRHRNIVRLLAFCSNKDVNLLVYEYMPNGSLGEVLHGKAGVFLKWETRLQI 813

Query: 797 ALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKF-LQDAGASECMSS 855
           ALEAAKGLCYLHHDCSPLIIHRDVKSNNILL  +FEAHVADFGLAKF +QD GASECMSS
Sbjct: 814 ALEAAKGLCYLHHDCSPLIIHRDVKSNNILLGPEFEAHVADFGLAKFMMQDNGASECMSS 873

Query: 856 VAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFG-DGVDIVRWVRKTTS 914
           +AGSYGYIAPEYAYTL++DEKSDVYSFGVVLLELI G+KPV  FG +G+DIV+W     S
Sbjct: 874 IAGSYGYIAPEYAYTLRIDEKSDVYSFGVVLLELITGRKPVDNFGEEGIDIVQW-----S 928

Query: 915 EVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQ 974
           ++    +   V+ ++D RLS  PL   + LF VAM+CV++ S  RPTMREVV M++   Q
Sbjct: 929 KIQTNCNRQGVVKIIDQRLSNIPLAEAMELFFVAMLCVQEHSVERPTMREVVQMISQAKQ 988

Necessary for male gametophyte development, as well as ovule specification and function. Required for the development of high-ordered vascular strands within the leaf and a correlated control of leaf shape, size and symmetry.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FII5|TDR_ARATH Leucine-rich repeat receptor-like protein kinase TDR OS=Arabidopsis thaliana GN=TDR PE=1 SV=1

 Score =  682 bits (1760), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 403/957 (42%), Positives = 558/957 (58%), Gaps = 42/957 (4%)

Query: 45  SGLKNWE---PSSSPSAHCSFSGVTCDQ-DSRVVSLNVSFMPLFGSIPPEIGLLTKLVNL 100
           S  ++W+      + +  CS+SGV CD   ++V+SL++S   L G IP +I  L+ L+ L
Sbjct: 51  SAFQDWKVPVNGQNDAVWCSWSGVVCDNVTAQVISLDLSHRNLSGRIPIQIRYLSSLLYL 110

Query: 101 TISNVNLTGRLPSEMALLTSLKVFNISGNVFQGNFAGQIVRGMTELQVLDAYNNNFTGPL 160
            +S  +L G  P+ +  LT L   +IS N F  +F   I + +  L+V +A++NNF G L
Sbjct: 111 NLSGNSLEGSFPTSIFDLTKLTTLDISRNSFDSSFPPGISK-LKFLKVFNAFSNNFEGLL 169

Query: 161 PVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLNGIGLNGTVPAFLSRLKNLRE 220
           P +++ L+ L  L+FGG+YF G+IP +Y  +Q L++I L G  L G +P  L  L  L+ 
Sbjct: 170 PSDVSRLRFLEELNFGGSYFEGEIPAAYGGLQRLKFIHLAGNVLGGKLPPRLGLLTELQH 229

Query: 221 MYIGYFNTYTGGIPPGFGALTQLQVLDMASCNISGEIPTSLSRLKLLHSLFLQMNKLTGH 280
           M IGY N + G IP  F  L+ L+  D+++C++SG +P  L  L  L +LFL  N  TG 
Sbjct: 230 MEIGY-NHFNGNIPSEFALLSNLKYFDVSNCSLSGSLPQELGNLSNLETLFLFQNGFTGE 288

Query: 281 IPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQLFKNNLRGPIPSFLGDFPNLE 340
           IP   S L SLK LD S N L+G IP  F+ LKNLT L L  NNL G +P  +G+ P L 
Sbjct: 289 IPESYSNLKSLKLLDFSSNQLSGSIPSGFSTLKNLTWLSLISNNLSGEVPEGIGELPELT 348

Query: 341 VLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFIGP 400
            L +W NNFT  LP  LG NGKL  +DV++N  TGTIP  LC G KL  LIL  N F G 
Sbjct: 349 TLFLWNNNFTGVLPHKLGSNGKLETMDVSNNSFTGTIPSSLCHGNKLYKLILFSNMFEGE 408

Query: 401 IPEELGQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLSGELPEKMSGASLNQ 460
           +P+ L +C+SL + R   N LNGTIP G  +L  L  ++L +N  + ++P   + A + Q
Sbjct: 409 LPKSLTRCESLWRFRSQNNRLNGTIPIGFGSLRNLTFVDLSNNRFTDQIPADFATAPVLQ 468

Query: 461 -LKVANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNISGE 519
            L ++ N    K+P  I   P+L I S   + L GEIP      K    I +  N+++G 
Sbjct: 469 YLNLSTNFFHRKLPENIWKAPNLQIFSASFSNLIGEIP-NYVGCKSFYRIELQGNSLNGT 527

Query: 520 IPYSISQCHSLTSVDLSRNSLYGKIPPGISKLIDLSILNLSRNGITGSIPNEMRNMMSLT 579
           IP+ I  C  L  ++LS+N L G IP  IS L  ++ ++LS N +TG+IP++  +  ++T
Sbjct: 528 IPWDIGHCEKLLCLNLSQNHLNGIIPWEISTLPSIADVDLSHNLLTGTIPSDFGSSKTIT 587

Query: 580 TLDLSYNNLIGNIPSGGQFLAFNETSFIGNPNLC-LLRNGTCQS-LINSAKHSGDGYGSS 637
           T ++SYN LIG IPS G F   N + F  N  LC  L    C S   N+     DG+   
Sbjct: 588 TFNVSYNQLIGPIPS-GSFAHLNPSFFSSNEGLCGDLVGKPCNSDRFNAGNADIDGHHKE 646

Query: 638 FGASKIVITVIALLTFMLLVILTIYQLRKRRLQKSKA---------------WKLTAFQR 682
               K    ++ +L   + V   +     R  QKS                 WKLTAFQR
Sbjct: 647 ERPKKTAGAIVWILAAAIGVGFFVLVAATRCFQKSYGNRVDGGGRNGGDIGPWKLTAFQR 706

Query: 683 LDFKAEDVLESL-KDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGG-----NDHGF 736
           L+F A+DV+E L K +NI+G G  G VY+  MP+G  +A+K+L G+            G 
Sbjct: 707 LNFTADDVVECLSKTDNILGMGSTGTVYKAEMPNGEIIAVKKLWGKNKENGKIRRRKSGV 766

Query: 737 LAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKG---GHLKWETR 793
           LAE+  LG +RHRNIVRLLG  +NRD  +LLYEYMPNGSL ++LHG         +W   
Sbjct: 767 LAEVDVLGNVRHRNIVRLLGCCTNRDCTMLLYEYMPNGSLDDLLHGGDKTMTAAAEWTAL 826

Query: 794 YRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECM 853
           Y+IA+  A+G+CYLHHDC P+I+HRD+K +NILLD+DFEA VADFG+AK +Q     E M
Sbjct: 827 YQIAIGVAQGICYLHHDCDPVIVHRDLKPSNILLDADFEARVADFGVAKLIQ---TDESM 883

Query: 854 SSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVG-EFGDGVDIVRWVRKT 912
           S VAGSYGYIAPEYAYTL+VD+KSD+YS+GV+LLE+I GK+ V  EFG+G  IV WVR  
Sbjct: 884 SVVAGSYGYIAPEYAYTLQVDKKSDIYSYGVILLEIITGKRSVEPEFGEGNSIVDWVR-- 941

Query: 913 TSEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHML 969
            S++    D   VL     R        +  + ++A++C     + RP MR+V+ +L
Sbjct: 942 -SKLKTKEDVEEVLDKSMGRSCSLIREEMKQMLRIALLCTSRSPTDRPPMRDVLLIL 997

Acts with CLE41p and CLE44p peptides as a ligand-receptor pair in a signal transduction pathway involved in the regulation of procambium maintenance and polarity during vascular-tissue development. Mediates repression of tracheary element differentiation and the promotion of procambial cells formation and polar division adjacent to phloem cells in the veins.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FRS6|PXL1_ARATH Leucine-rich repeat receptor-like protein kinase PXL1 OS=Arabidopsis thaliana GN=PXL1 PE=2 SV=1

 Score =  635 bits (1637), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 392/1028 (38%), Positives = 572/1028 (55%), Gaps = 105/1028 (10%)

Query: 10   HLYISLFLLLFSLSCAYSDMDVLLKLKSSMIGPKGSGLKNWE-PSSSPS----AHCSFSG 64
            ++  +LF  + S +   S+ ++LL  KS +  P  + L++W+ P ++ +     HC ++G
Sbjct: 12   YIGFALFPFVSSETFQNSEQEILLAFKSDLFDPSNN-LQDWKRPENATTFSELVHCHWTG 70

Query: 65   VTCDQDSRVVSLNVSFMPLFGSIPPEIGLLTKLVNLTISNVNLTGRLPSEMALLTSLKVF 124
            V CD +  V  L +S M L G++  +I     L  L +SN      LP  ++ LTSLKV 
Sbjct: 71   VHCDANGYVAKLLLSNMNLSGNVSDQIQSFPSLQALDLSNNAFESSLPKSLSNLTSLKVI 130

Query: 125  NISGNVFQGNFAGQIVRGM-TELQVLDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGK 183
            ++S N F G F   +  GM T L  ++A +NNF+G LP ++ +  +L  L F G YF G 
Sbjct: 131  DVSVNSFFGTFPYGL--GMATGLTHVNASSNNFSGFLPEDLGNATTLEVLDFRGGYFEGS 188

Query: 184  IPQSYSEIQSLEYIGLNGIGLNGTVPAFLSRLKNLREMYIGYFNTYTGGIPPGFGALTQL 243
            +P S+  +++L+++GL+G    G VP  +  L +L  + +GY N + G IP  FG LT+L
Sbjct: 189  VPSSFKNLKNLKFLGLSGNNFGGKVPKVIGELSSLETIILGY-NGFMGEIPEEFGKLTRL 247

Query: 244  QVLDMASCNISGEIPTSLSRLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTG 303
            Q LD+A  N++G+IP+SL +LK L +++L  N+LTG +P +L G+ SL  LDLS N +TG
Sbjct: 248  QYLDLAVGNLTGQIPSSLGQLKQLTTVYLYQNRLTGKLPRELGGMTSLVFLDLSDNQITG 307

Query: 304  EIPESFAALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKL 363
            EIP     LKNL LL L +N L G IPS + + PNLEVL++W N+    LP +LG+N  L
Sbjct: 308  EIPMEVGELKNLQLLNLMRNQLTGIIPSKIAELPNLEVLELWQNSLMGSLPVHLGKNSPL 367

Query: 364  LILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNG 423
              LDV+SN L+G IP  LC    L  LIL  N F G IPEE+  C +L ++R  KN+++G
Sbjct: 368  KWLDVSSNKLSGDIPSGLCYSRNLTKLILFNNSFSGQIPEEIFSCPTLVRVRIQKNHISG 427

Query: 424  TIPAGLFNLPLLNMMELDDNLLSGELPEKMSGAS------------------------LN 459
            +IPAG  +LP+L  +EL  N L+G++P+ ++ ++                        L 
Sbjct: 428  SIPAGSGDLPMLQHLELAKNNLTGKIPDDIALSTSLSFIDISFNHLSSLSSSIFSSPNLQ 487

Query: 460  QLKVANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNISGE 519
                ++NN  GKIP  I + PSL++L L  N   G IP    + + + S+N+  N + GE
Sbjct: 488  TFIASHNNFAGKIPNQIQDRPSLSVLDLSFNHFSGGIPERIASFEKLVSLNLKSNQLVGE 547

Query: 520  IPYSISQCHSLTSVDLSRNSLYGKIPPGISKLIDLSILNLSRNGITGSIPNEMRNMMSLT 579
            IP +++  H L  +DLS NSL G IP  +     L +LN                     
Sbjct: 548  IPKALAGMHMLAVLDLSNNSLTGNIPADLGASPTLEMLN--------------------- 586

Query: 580  TLDLSYNNLIGNIPSGGQFLAFNETSFIGNPNLCLLRNGTC-QSLINSAKHSGDG----- 633
               +S+N L G IPS   F A +    +GN  LC      C +SL  SAK    G     
Sbjct: 587  ---VSFNKLDGPIPSNMLFAAIDPKDLVGNNGLCGGVLPPCSKSLALSAKGRNPGRIHVN 643

Query: 634  ---YGSSFGASKIVITVIALLTFMLLVILTIYQLRK---------RRLQKSKAWKLTAFQ 681
               +G   G S  VI  + ++      I T + L           ++ ++   W+L AFQ
Sbjct: 644  HAVFGFIVGTS--VIVAMGMMFLAGRWIYTRWDLYSNFAREYIFCKKPREEWPWRLVAFQ 701

Query: 682  RLDFKAEDVLESLKDENIIGKGGAGIVYRGSMPDG--IDVAIKRLVGRGTGGND------ 733
            RL F A D+L  +K+ NIIG G  GIVY+  +     + VA+K+L    +  ND      
Sbjct: 702  RLCFTAGDILSHIKESNIIGMGAIGIVYKAEVMRRPLLTVAVKKLWRSPSPQNDIEDHHQ 761

Query: 734  -----HGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHL 788
                    L E+  LG +RHRNIV++LGYV N    +++YEYMPNG+LG  LH      L
Sbjct: 762  EEDEEDDILREVNLLGGLRHRNIVKILGYVHNEREVMMVYEYMPNGNLGTALHSKDEKFL 821

Query: 789  --KWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQD 846
               W +RY +A+   +GL YLH+DC P IIHRD+KSNNILLDS+ EA +ADFGLAK +  
Sbjct: 822  LRDWLSRYNVAVGVVQGLNYLHNDCYPPIIHRDIKSNNILLDSNLEARIADFGLAKMMLH 881

Query: 847  AGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVG-EFGDGVDI 905
               +E +S VAGSYGYIAPEY YTLK+DEKSD+YS GVVLLEL+ GK P+   F D +D+
Sbjct: 882  --KNETVSMVAGSYGYIAPEYGYTLKIDEKSDIYSLGVVLLELVTGKMPIDPSFEDSIDV 939

Query: 906  VRWVRKTTSEVSQPSDAASVLAVVDPRLSG---YPLTGVIHLFKVAMMCVEDESSARPTM 962
            V W+R+   +        S+  V+D  ++G   + +  ++   ++A++C       RP++
Sbjct: 940  VEWIRRKVKK------NESLEEVIDASIAGDCKHVIEEMLLALRIALLCTAKLPKDRPSI 993

Query: 963  REVVHMLA 970
            R+V+ MLA
Sbjct: 994  RDVITMLA 1001

Involved in the regulation of procambium maintenance and polarity during vascular-tissue development.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SGP2|HSL1_ARATH Receptor-like protein kinase HSL1 OS=Arabidopsis thaliana GN=HSL1 PE=2 SV=1

 Score =  630 bits (1625), Expect = e-179,   Method: Compositional matrix adjust.
 Identities = 388/999 (38%), Positives = 566/999 (56%), Gaps = 100/999 (10%)

Query: 19  LFSLSCAYSDMDVLLKLKSSMIGPKGSGLKNWEPSSSPSAHCSFSGVTCDQD-SRVVSLN 77
           +FSL+    D  +L ++K S+  P  S L +W  +S+ ++ C +SGV+C  D S V S++
Sbjct: 13  VFSLN---QDGFILQQVKLSLDDPD-SYLSSW--NSNDASPCRWSGVSCAGDFSSVTSVD 66

Query: 78  VSFMPLFGSIPPEIGLLTKLVNLTISNVNLTGRLPSEMALLTSLKVFNISGNVFQGNFAG 137
           +S   L G  P  I  L+ L +L++ N ++   LP  +A   SL                
Sbjct: 67  LSSANLAGPFPSVICRLSNLAHLSLYNNSINSTLPLNIAACKSL---------------- 110

Query: 138 QIVRGMTELQVLDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYI 197
                    Q LD   N  TG LP  +A + +L HL   GN F+G IP S+ + ++LE +
Sbjct: 111 ---------QTLDLSQNLLTGELPQTLADIPTLVHLDLTGNNFSGDIPASFGKFENLEVL 161

Query: 198 GLNGIGLNGTVPAFLSRLKNLREMYIGYFNTYTGGIPPGFGALTQLQVLDMASCNISGEI 257
            L    L+GT+P FL  +  L+ + + Y       IPP FG LT L+V+ +  C++ G+I
Sbjct: 162 SLVYNLLDGTIPPFLGNISTLKMLNLSYNPFSPSRIPPEFGNLTNLEVMWLTECHLVGQI 221

Query: 258 PTSLSRLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTL 317
           P SL +L  L  L L +N L GHIPP L GL ++  ++L  N LTGEIP     LK+L L
Sbjct: 222 PDSLGQLSKLVDLDLALNDLVGHIPPSLGGLTNVVQIELYNNSLTGEIPPELGNLKSLRL 281

Query: 318 LQ-----------------------LFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELP 354
           L                        L++NNL G +P+ +   PNL  ++++GN  T  LP
Sbjct: 282 LDASMNQLTGKIPDELCRVPLESLNLYENNLEGELPASIALSPNLYEIRIFGNRLTGGLP 341

Query: 355 ENLGRNGKLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFIGPIPEELGQCKSLTKI 414
           ++LG N  L  LDV+ N  +G +P DLC  G+L+ L+++ N F G IPE L  C+SLT+I
Sbjct: 342 KDLGLNSPLRWLDVSENEFSGDLPADLCAKGELEELLIIHNSFSGVIPESLADCRSLTRI 401

Query: 415 RFSKNYLNGTIPAGLFNLPLLNMMELDDNLLSGELPEKMSGAS-LNQLKVANNNITGKIP 473
           R + N  +G++P G + LP +N++EL +N  SGE+ + + GAS L+ L ++NN  TG +P
Sbjct: 402 RLAYNRFSGSVPTGFWGLPHVNLLELVNNSFSGEISKSIGGASNLSLLILSNNEFTGSLP 461

Query: 474 AAIGNLPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIPYSISQCHSLTSV 533
             IG+L +LN LS   N+  G +P    +L  + ++++  N  SGE+   I     L  +
Sbjct: 462 EEIGSLDNLNQLSASGNKFSGSLPDSLMSLGELGTLDLHGNQFSGELTSGIKSWKKLNEL 521

Query: 534 DLSRNSLYGKIPPGISKLIDLSILNLSRNGITGSIPNEMRNMMSLTTLDLSYNNLIGNIP 593
           +L+ N   GKIP  I  L  L+ L+LS N  +G IP  ++++  L  L+LSYN L G++P
Sbjct: 522 NLADNEFTGKIPDEIGSLSVLNYLDLSGNMFSGKIPVSLQSL-KLNQLNLSYNRLSGDLP 580

Query: 594 SGGQFLAFN--ETSFIGNPNLCLLRNGTCQSLINSAKHSGDGYGSSFGASKIVITVIALL 651
                LA +  + SFIGNP LC    G C S  N AK  G  +        ++ ++  L 
Sbjct: 581 PS---LAKDMYKNSFIGNPGLCGDIKGLCGSE-NEAKKRGYVW--------LLRSIFVLA 628

Query: 652 TFMLLVILTIYQLRKRRLQKSKA-----WKLTAFQRLDFKAEDVLESLKDENIIGKGGAG 706
             +LL  +  +  + R  +K++A     W L +F +L F   ++LESL ++N+IG G +G
Sbjct: 629 AMVLLAGVAWFYFKYRTFKKARAMERSKWTLMSFHKLGFSEHEILESLDEDNVIGAGASG 688

Query: 707 IVYRGSMPDGIDVAIKRLV--------------GRGTGGNDHGFLAEIQTLGRIRHRNIV 752
            VY+  + +G  VA+KRL               G   G  D  F AE++TLG+IRH+NIV
Sbjct: 689 KVYKVVLTNGETVAVKRLWTGSVKETGDCDPEKGYKPGVQDEAFEAEVETLGKIRHKNIV 748

Query: 753 RLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCS 812
           +L    S RD  LL+YEYMPNGSLG++LH +KGG L W+TR++I L+AA+GL YLHHD  
Sbjct: 749 KLWCCCSTRDCKLLVYEYMPNGSLGDLLHSSKGGMLGWQTRFKIILDAAEGLSYLHHDSV 808

Query: 813 PLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAG-ASECMSSVAGSYGYIAPEYAYTL 871
           P I+HRD+KSNNIL+D D+ A VADFG+AK +   G A + MS +AGS GYIAPEYAYTL
Sbjct: 809 PPIVHRDIKSNNILIDGDYGARVADFGVAKAVDLTGKAPKSMSVIAGSCGYIAPEYAYTL 868

Query: 872 KVDEKSDVYSFGVVLLELIAGKKPVG-EFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVD 930
           +V+EKSD+YSFGVV+LE++  K+PV  E G+  D+V+WV  T        D   +  V+D
Sbjct: 869 RVNEKSDIYSFGVVILEIVTRKRPVDPELGEK-DLVKWVCSTL-------DQKGIEHVID 920

Query: 931 PRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHML 969
           P+L       +  +  V ++C       RP+MR VV ML
Sbjct: 921 PKLDSCFKEEISKILNVGLLCTSPLPINRPSMRRVVKML 959

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9M0G7|PXL2_ARATH Leucine-rich repeat receptor-like protein kinase PXL2 OS=Arabidopsis thaliana GN=PXL2 PE=2 SV=1

 Score =  626 bits (1615), Expect = e-178,   Method: Compositional matrix adjust.
 Identities = 379/980 (38%), Positives = 562/980 (57%), Gaps = 49/980 (5%)

Query: 27  SDMDVLLKLKSSMIGPKGSGLKNWEPSSSPSAHCSFSGVTCDQDSRVVSLNVSFMPLFGS 86
           +++ VLL +KS+++ P  + LK+W+ S + S HC+++GV C+ +  V  L+++ M L G 
Sbjct: 29  NELSVLLSVKSTLVDPL-NFLKDWKLSDT-SDHCNWTGVRCNSNGNVEKLDLAGMNLTGK 86

Query: 87  IPPEIGLLTKLVNLTISNVNLTGRLPSEMALLTSLKVFNISGNVFQGN---FAGQIVRGM 143
           I   I  L+ LV+  IS       LP  +     LK  +IS N F G+   F+ + + G+
Sbjct: 87  ISDSISQLSSLVSFNISCNGFESLLPKSIP---PLKSIDISQNSFSGSLFLFSNESL-GL 142

Query: 144 TELQVLDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLNGIG 203
             L   +A  NN +G L  ++ +L SL  L   GN+F G +P S+  +Q L ++GL+G  
Sbjct: 143 VHL---NASGNNLSGNLTEDLGNLVSLEVLDLRGNFFQGSLPSSFKNLQKLRFLGLSGNN 199

Query: 204 LNGTVPAFLSRLKNLREMYIGYFNTYTGGIPPGFGALTQLQVLDMASCNISGEIPTSLSR 263
           L G +P+ L +L +L    +GY N + G IPP FG +  L+ LD+A   +SGEIP+ L +
Sbjct: 200 LTGELPSVLGQLPSLETAILGY-NEFKGPIPPEFGNINSLKYLDLAIGKLSGEIPSELGK 258

Query: 264 LKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQLFKN 323
           LK L +L L  N  TG IP ++  + +LK LD S N LTGEIP     LKNL LL L +N
Sbjct: 259 LKSLETLLLYENNFTGTIPREIGSITTLKVLDFSDNALTGEIPMEITKLKNLQLLNLMRN 318

Query: 324 NLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDLCK 383
            L G IP  +     L+VL++W N  + ELP +LG+N  L  LDV+SN  +G IP  LC 
Sbjct: 319 KLSGSIPPAISSLAQLQVLELWNNTLSGELPSDLGKNSPLQWLDVSSNSFSGEIPSTLCN 378

Query: 384 GGKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDN 443
            G L  LIL  N F G IP  L  C+SL ++R   N LNG+IP G   L  L  +EL  N
Sbjct: 379 KGNLTKLILFNNTFTGQIPATLSTCQSLVRVRMQNNLLNGSIPIGFGKLEKLQRLELAGN 438

Query: 444 LLSGELPEKMSGA-SLNQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESFN 502
            LSG +P  +S + SL+ +  + N I   +P+ I ++ +L    + +N + GE+P +  +
Sbjct: 439 RLSGGIPGDISDSVSLSFIDFSRNQIRSSLPSTILSIHNLQAFLVADNFISGEVPDQFQD 498

Query: 503 LKMITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYGKIPPGISKLIDLSILNLSRN 562
              ++++++S N ++G IP SI+ C  L S++L  N+L G+IP  I+ +  L++L+LS N
Sbjct: 499 CPSLSNLDLSSNTLTGTIPSSIASCEKLVSLNLRNNNLTGEIPRQITTMSALAVLDLSNN 558

Query: 563 GITGSIPNEMRNMMSLTTLDLSYNNLIGNIPSGGQFLAFNETSFIGNPNLCLLRNGTCQS 622
            +TG +P  +    +L  L++SYN L G +P  G     N     GN  LC      C  
Sbjct: 559 SLTGVLPESIGTSPALELLNVSYNKLTGPVPINGFLKTINPDDLRGNSGLCGGVLPPCSK 618

Query: 623 LINSAKHSGDGYGSSFGASKIV-ITVIALLTFMLLVILTIYQL--------RKRRLQKSK 673
              +       +G    A  ++ I  +  L  + +V  T+Y+          +   +   
Sbjct: 619 FQRATSSHSSLHGKRIVAGWLIGIASVLALGILTIVTRTLYKKWYSNGFCGDETASKGEW 678

Query: 674 AWKLTAFQRLDFKAEDVLESLKDENIIGKGGAGIVYRGSMPDGIDV-AIKRL------VG 726
            W+L AF RL F A D+L  +K+ N+IG G  GIVY+  M     V A+K+L      + 
Sbjct: 679 PWRLMAFHRLGFTASDILACIKESNMIGMGATGIVYKAEMSRSSTVLAVKKLWRSAADIE 738

Query: 727 RGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGG 786
            GT G+   F+ E+  LG++RHRNIVRLLG++ N    +++YE+M NG+LG+ +HG    
Sbjct: 739 DGTTGD---FVGEVNLLGKLRHRNIVRLLGFLYNDKNMMIVYEFMLNGNLGDAIHGKNAA 795

Query: 787 H---LKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKF 843
               + W +RY IAL  A GL YLHHDC P +IHRD+KSNNILLD++ +A +ADFGLA+ 
Sbjct: 796 GRLLVDWVSRYNIALGVAHGLAYLHHDCHPPVIHRDIKSNNILLDANLDARIADFGLARM 855

Query: 844 LQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVG-EFGDG 902
           +  A   E +S VAGSYGYIAPEY YTLKVDEK D+YS+GVVLLEL+ G++P+  EFG+ 
Sbjct: 856 M--ARKKETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSYGVVLLELLTGRRPLEPEFGES 913

Query: 903 VDIVRWVRKTTSEVSQPSDAASVLAVVDPRLSG--YPLTGVIHLFKVAMMCVEDESSARP 960
           VDIV WVR+      +  D  S+   +DP +    Y    ++ + ++A++C       RP
Sbjct: 914 VDIVEWVRR------KIRDNISLEEALDPNVGNCRYVQEEMLLVLQIALLCTTKLPKDRP 967

Query: 961 TMREVVHML--ANPPQSAPS 978
           +MR+V+ ML  A P + + S
Sbjct: 968 SMRDVISMLGEAKPRRKSNS 987

Involved in the regulation of procambium maintenance and polarity during vascular-tissue development.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SHI2|Y1723_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase At1g17230 OS=Arabidopsis thaliana GN=At1g17230 PE=2 SV=2

 Score =  590 bits (1521), Expect = e-167,   Method: Compositional matrix adjust.
 Identities = 387/1071 (36%), Positives = 561/1071 (52%), Gaps = 131/1071 (12%)

Query: 16   FLLLFSLSCAYSDMDVLLKLKSSMIGPKGSGLKNW-EPSSSPSAHCSFSGVTCDQDSRVV 74
            F+L+ SL+    +  VLL+ K+ +    G  L +W +  S+P   C+++G+ C     V 
Sbjct: 18   FILVRSLN---EEGRVLLEFKAFLNDSNGY-LASWNQLDSNP---CNWTGIACTHLRTVT 70

Query: 75   SLNVSFMPLFGSIPPEIGLLTKLVNLTISNVNLTGRLPSEMALLTSLKVFNISGNVFQGN 134
            S++++ M L G++ P I  L  L  L +S   ++G +P +++L  SL+V ++  N F G 
Sbjct: 71   SVDLNGMNLSGTLSPLICKLHGLRKLNVSTNFISGPIPQDLSLCRSLEVLDLCTNRFHGV 130

Query: 135  FAGQI-----------------------VRGMTELQVLDAYNNNFTGPLPVEIASLKSLR 171
               Q+                       +  ++ LQ L  Y+NN TG +P  +A L+ LR
Sbjct: 131  IPIQLTMIITLKKLYLCENYLFGSIPRQIGNLSSLQELVIYSNNLTGVIPPSMAKLRQLR 190

Query: 172  HLSFGGNYFTGKIPQSYSEIQSLEYIGLNGIGLNGTVPAFLSRLKNLREMYIGYFNTYTG 231
             +  G N F+G IP   S  +SL+ +GL    L G++P  L +L+NL ++ I + N  +G
Sbjct: 191  IIRAGRNGFSGVIPSEISGCESLKVLGLAENLLEGSLPKQLEKLQNLTDL-ILWQNRLSG 249

Query: 232  GIPPGFGALTQLQVLDMASCNISGEIPTSLSRLKLLHSLFLQMNKLTGHIPPQLSGLISL 291
             IPP  G +++L+VL +     +G IP  + +L  +  L+L  N+LTG IP ++  LI  
Sbjct: 250  EIPPSVGNISRLEVLALHENYFTGSIPREIGKLTKMKRLYLYTNQLTGEIPREIGNLIDA 309

Query: 292  KSLDLSLNYLTGEIPESFAALKNLTLLQLFKNNLRGPIPSFLGD---------------- 335
              +D S N LTG IP+ F  + NL LL LF+N L GPIP  LG+                
Sbjct: 310  AEIDFSENQLTGFIPKEFGHILNLKLLHLFENILLGPIPRELGELTLLEKLDLSINRLNG 369

Query: 336  --------FPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDLCKGGKL 387
                     P L  LQ++ N    ++P  +G      +LD+++N L+G IP   C+   L
Sbjct: 370  TIPQELQFLPYLVDLQLFDNQLEGKIPPLIGFYSNFSVLDMSANSLSGPIPAHFCRFQTL 429

Query: 388  KSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLSG 447
              L L  N   G IP +L  CKSLTK+    N L G++P  LFNL  L  +EL  N LSG
Sbjct: 430  ILLSLGSNKLSGNIPRDLKTCKSLTKLMLGDNQLTGSLPIELFNLQNLTALELHQNWLSG 489

Query: 448  ELPEKMSG-ASLNQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESFNLKMI 506
             +   +    +L +L++ANNN TG+IP  IGNL  +   ++ +N+L G IP E  +   I
Sbjct: 490  NISADLGKLKNLERLRLANNNFTGEIPPEIGNLTKIVGFNISSNQLTGHIPKELGSCVTI 549

Query: 507  TSIN------------------------ISDNNISGEIPYSISQCHSL------------ 530
              ++                        +SDN ++GEIP+S      L            
Sbjct: 550  QRLDLSGNKFSGYIAQELGQLVYLEILRLSDNRLTGEIPHSFGDLTRLMELQLGGNLLSE 609

Query: 531  -------------TSVDLSRNSLYGKIPPGISKLIDLSILNLSRNGITGSIPNEMRNMMS 577
                          S+++S N+L G IP  +  L  L IL L+ N ++G IP  + N+MS
Sbjct: 610  NIPVELGKLTSLQISLNISHNNLSGTIPDSLGNLQMLEILYLNDNKLSGEIPASIGNLMS 669

Query: 578  LTTLDLSYNNLIGNIPSGGQFLAFNETSFIGNPNLCLLRNGTCQSLINSAKHSGDGYGSS 637
            L   ++S NNL+G +P    F   + ++F GN  LC  +   CQ L+  +    +   + 
Sbjct: 670  LLICNISNNNLVGTVPDTAVFQRMDSSNFAGNHGLCNSQRSHCQPLVPHSDSKLNWLING 729

Query: 638  FGASKIV-ITVIALLTFMLLVILTIYQLRKRR---------LQKSKAWKLTAFQRLDFKA 687
                KI+ IT I + +  L+  L +    KRR           K        F +  F  
Sbjct: 730  SQRQKILTITCIVIGSVFLITFLGLCWTIKRREPAFVALEDQTKPDVMDSYYFPKKGFTY 789

Query: 688  E---DVLESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGG-NDHGFLAEIQTL 743
            +   D   +  ++ ++G+G  G VY+  M  G  +A+K+L  RG G  +D+ F AEI TL
Sbjct: 790  QGLVDATRNFSEDVVLGRGACGTVYKAEMSGGEVIAVKKLNSRGEGASSDNSFRAEISTL 849

Query: 744  GRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLH-GAKGGHLKWETRYRIALEAAK 802
            G+IRHRNIV+L G+  ++++NLLLYEYM  GSLGE L  G K   L W  RYRIAL AA+
Sbjct: 850  GKIRHRNIVKLYGFCYHQNSNLLLYEYMSKGSLGEQLQRGEKNCLLDWNARYRIALGAAE 909

Query: 803  GLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGY 862
            GLCYLHHDC P I+HRD+KSNNILLD  F+AHV DFGLAK + D   S+ MS+VAGSYGY
Sbjct: 910  GLCYLHHDCRPQIVHRDIKSNNILLDERFQAHVGDFGLAKLI-DLSYSKSMSAVAGSYGY 968

Query: 863  IAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDA 922
            IAPEYAYT+KV EK D+YSFGVVLLELI GK PV     G D+V WVR++        + 
Sbjct: 969  IAPEYAYTMKVTEKCDIYSFGVVLLELITGKPPVQPLEQGGDLVNWVRRSI------RNM 1022

Query: 923  ASVLAVVDPRLSGYPLTGVIHL---FKVAMMCVEDESSARPTMREVVHMLA 970
               + + D RL       V  +    K+A+ C  +  ++RPTMREVV M+ 
Sbjct: 1023 IPTIEMFDARLDTNDKRTVHEMSLVLKIALFCTSNSPASRPTMREVVAMIT 1073

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P47735|RLK5_ARATH Receptor-like protein kinase 5 OS=Arabidopsis thaliana GN=RLK5 PE=1 SV=1

 Score =  574 bits (1479), Expect = e-162,   Method: Compositional matrix adjust.
 Identities = 382/1000 (38%), Positives = 552/1000 (55%), Gaps = 101/1000 (10%)

Query: 28  DMDVLLKLKSSMIGPKGSGLKNWEPSSSPSAHCSFSGVTCDQDSRVVSLNVS-FMPLFGS 86
           D  +L + K  +  P  S L +W  ++  +  C + GV+CD  S VVS+++S FM     
Sbjct: 24  DATILRQAKLGLSDPAQS-LSSWSDNNDVTP-CKWLGVSCDATSNVVSVDLSSFM----- 76

Query: 87  IPPEIGLLTKLVNLTISNVNLTGRLPSEMALLTSLKVFNISGNVFQGNFAGQIVRGMTEL 146
                               L G  PS +  L SL   ++  N   G+ +         L
Sbjct: 77  --------------------LVGPFPSILCHLPSLHSLSLYNNSINGSLSADDFDTCHNL 116

Query: 147 QVLDAYNNNFTGPLPVEIA-SLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLNGIGLN 205
             LD   N   G +P  +  +L +L+ L   GN  +  IP S+ E + LE + L G  L+
Sbjct: 117 ISLDLSENLLVGSIPKSLPFNLPNLKFLEISGNNLSDTIPSSFGEFRKLESLNLAGNFLS 176

Query: 206 GTVPAFLSRLKNLREMYIGYFNTYTGGIPPGFGALTQLQVLDMASCNISGEIPTSLSRLK 265
           GT+PA L  +  L+E+ + Y       IP   G LT+LQVL +A CN+ G IP SLSRL 
Sbjct: 177 GTIPASLGNVTTLKELKLAYNLFSPSQIPSQLGNLTELQVLWLAGCNLVGPIPPSLSRLT 236

Query: 266 LLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESF----------AALKNL 315
            L +L L  N+LTG IP  ++ L +++ ++L  N  +GE+PES           A++  L
Sbjct: 237 SLVNLDLTFNQLTGSIPSWITQLKTVEQIELFNNSFSGELPESMGNMTTLKRFDASMNKL 296

Query: 316 T-------------LLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGK 362
           T              L LF+N L GP+P  +     L  L+++ N  T  LP  LG N  
Sbjct: 297 TGKIPDNLNLLNLESLNLFENMLEGPLPESITRSKTLSELKLFNNRLTGVLPSQLGANSP 356

Query: 363 LLILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLN 422
           L  +D++ N  +G IP ++C  GKL+ LIL+ N F G I   LG+CKSLT++R S N L+
Sbjct: 357 LQYVDLSYNRFSGEIPANVCGEGKLEYLILIDNSFSGEISNNLGKCKSLTRVRLSNNKLS 416

Query: 423 GTIPAGLFNLPLLNMMELDDNLLSGELPEKMSGA-SLNQLKVANNNITGKIPAAIGNLPS 481
           G IP G + LP L+++EL DN  +G +P+ + GA +L+ L+++ N  +G IP  IG+L  
Sbjct: 417 GQIPHGFWGLPRLSLLELSDNSFTGSIPKTIIGAKNLSNLRISKNRFSGSIPNEIGSLNG 476

Query: 482 LNILSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLY 541
           +  +S   N   GEIP     LK ++ +++S N +SGEIP  +    +L  ++L+ N L 
Sbjct: 477 IIEISGAENDFSGEIPESLVKLKQLSRLDLSKNQLSGEIPRELRGWKNLNELNLANNHLS 536

Query: 542 GKIPPGISKLIDLSILNLSRNGITGSIPNEMRNMMSLTTLDLSYNNLIGNIPS--GGQFL 599
           G+IP  +  L  L+ L+LS N  +G IP E++N + L  L+LSYN+L G IP     +  
Sbjct: 537 GEIPKEVGILPVLNYLDLSSNQFSGEIPLELQN-LKLNVLNLSYNHLSGKIPPLYANKIY 595

Query: 600 AFNETSFIGNPNLCLLRNGTCQSLINSAKHSGDGYGSSFGASKIVITVIAL--LTFMLLV 657
           A +   FIGNP LC+  +G C+ +  S          + G   I++T+  L  L F++ +
Sbjct: 596 AHD---FIGNPGLCVDLDGLCRKITRSK---------NIGYVWILLTIFLLAGLVFVVGI 643

Query: 658 ILTIYQLRKRRLQKSK---AWKLTAFQRLDFKAEDVLESLKDENIIGKGGAGIVYRGSMP 714
           ++ I + RK R  KS    A K  +F +L F   ++ + L ++N+IG G +G VY+  + 
Sbjct: 644 VMFIAKCRKLRALKSSTLAASKWRSFHKLHFSEHEIADCLDEKNVIGFGSSGKVYKVELR 703

Query: 715 DGIDVAIKRLVGRGTGGNDHG---------FLAEIQTLGRIRHRNIVRLLGYVSNRDTNL 765
            G  VA+K+L     GG+D           F AE++TLG IRH++IVRL    S+ D  L
Sbjct: 704 GGEVVAVKKLNKSVKGGDDEYSSDSLNRDVFAAEVETLGTIRHKSIVRLWCCCSSGDCKL 763

Query: 766 LLYEYMPNGSLGEMLHGAKGGH--LKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSN 823
           L+YEYMPNGSL ++LHG + G   L W  R RIAL+AA+GL YLHHDC P I+HRDVKS+
Sbjct: 764 LVYEYMPNGSLADVLHGDRKGGVVLGWPERLRIALDAAEGLSYLHHDCVPPIVHRDVKSS 823

Query: 824 NILLDSDFEAHVADFGLAKFLQDAGAS--ECMSSVAGSYGYIAPEYAYTLKVDEKSDVYS 881
           NILLDSD+ A VADFG+AK  Q +G+   E MS +AGS GYIAPEY YTL+V+EKSD+YS
Sbjct: 824 NILLDSDYGAKVADFGIAKVGQMSGSKTPEAMSGIAGSCGYIAPEYVYTLRVNEKSDIYS 883

Query: 882 FGVVLLELIAGKKPV-GEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDPRLS---GYP 937
           FGVVLLEL+ GK+P   E GD  D+ +WV           D   +  V+DP+L       
Sbjct: 884 FGVVLLELVTGKQPTDSELGDK-DMAKWVCTAL-------DKCGLEPVIDPKLDLKFKEE 935

Query: 938 LTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQSAP 977
           ++ VIH   + ++C       RP+MR+VV ML     + P
Sbjct: 936 ISKVIH---IGLLCTSPLPLNRPSMRKVVIMLQEVSGAVP 972

Receptor with a dual specificity kinase activity acting on both serine/threonine- and tyrosine-containing substrates that controls floral organ abscission. May interact with the 'INFLORESCENCE DEFICIENT IN ABSCISSION' (IDA) ligands family.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	982
225457925	984	PREDICTED: receptor protein kinase CLAVA	0.996	0.994	0.729	0.0
255538984	985	Receptor protein kinase CLAVATA1 precurs	0.966	0.963	0.734	0.0
224085908	973	predicted protein [Populus trichocarpa]	0.969	0.978	0.743	0.0
224061985	939	predicted protein [Populus trichocarpa]	0.954	0.997	0.742	0.0
15222877	980	receptor protein kinase CLAVATA1 [Arabid	0.973	0.975	0.697	0.0
25287710	978	protein T4O12.5 [imported] - Arabidopsis	0.973	0.977	0.697	0.0
297842329	980	hypothetical protein ARALYDRAFT_476729 [	0.973	0.975	0.695	0.0
290796119	987	CLAVATA1 [Brassica napus]	0.988	0.983	0.694	0.0
2160756	980	CLV1 receptor kinase [Arabidopsis thalia	0.973	0.975	0.696	0.0
31540632	978	CLV1-like receptor kinase [Brassica napu	0.979	0.983	0.697	0.0

>gi|225457925|ref|XP_002279563.1| PREDICTED: receptor protein kinase CLAVATA1-like [Vitis vinifera]

 Score = 1456 bits (3770), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 717/983 (72%), Positives = 828/983 (84%), Gaps = 4/983 (0%)

Query: 1   MRATASFNPHLYISLFLLLFSLSCAYSDMDVLLKLKSSMIGPKGSGLKNW-EPSSSPSAH 59
           MRA+  +    +I L  ++FS   AY D+ VLLKL+S MIGPKGSGL++W + SSS   H
Sbjct: 5   MRASLKYALPFFICL--MMFSRGFAYGDLQVLLKLRSFMIGPKGSGLEDWVDDSSSLFPH 62

Query: 60  CSFSGVTCDQDSRVVSLNVSFMPLFGSIPPEIGLLTKLVNLTISNVNLTGRLPSEMALLT 119
           CSFSGV+CD+DSRVVSLN+SF+ LFGSIPPEIG+L KLVNLT++  NLTG+LP EMA LT
Sbjct: 63  CSFSGVSCDEDSRVVSLNLSFVTLFGSIPPEIGMLNKLVNLTLACDNLTGKLPMEMAKLT 122

Query: 120 SLKVFNISGNVFQGNFAGQIVRGMTELQVLDAYNNNFTGPLPVEIASLKSLRHLSFGGNY 179
           SLK+ N+S N F G F G+I+ GM EL+VLD YNNNFTGPLP E+  LK L+H+  GGNY
Sbjct: 123 SLKLVNLSNNNFNGQFPGRILVGMKELEVLDMYNNNFTGPLPTEVGKLKKLKHMHLGGNY 182

Query: 180 FTGKIPQSYSEIQSLEYIGLNGIGLNGTVPAFLSRLKNLREMYIGYFNTYTGGIPPGFGA 239
           F+G IP  +S+I SLE +GLNG  L+G +P  L RL NL+ +++GYFN Y GGIPP  G 
Sbjct: 183 FSGDIPDVFSDIHSLELLGLNGNNLSGRIPTSLVRLSNLQGLFLGYFNIYEGGIPPELGL 242

Query: 240 LTQLQVLDMASCNISGEIPTSLSRLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLN 299
           L+ L+VLD+ SCN++GEIP SL RLK+LHSLFLQ+N+L+GH+P +LSGL++LKSLDLS N
Sbjct: 243 LSSLRVLDLGSCNLTGEIPPSLGRLKMLHSLFLQLNQLSGHLPQELSGLVNLKSLDLSNN 302

Query: 300 YLTGEIPESFAALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGR 359
            LTGEIPESF+ L+ LTL+ LF N LRG IP F+GD PNLEVLQVW NNFTFELPE LGR
Sbjct: 303 VLTGEIPESFSQLRELTLINLFGNQLRGRIPEFIGDLPNLEVLQVWENNFTFELPERLGR 362

Query: 360 NGKLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKN 419
           NGKL  LDV +NHLTGTIPRDLCKGGKL +LILM+N+F GPIPE+LG+CKSLT+IR  KN
Sbjct: 363 NGKLKNLDVATNHLTGTIPRDLCKGGKLLTLILMENYFFGPIPEQLGECKSLTRIRIMKN 422

Query: 420 YLNGTIPAGLFNLPLLNMMELDDNLLSGELPEKMSGASLNQLKVANNNITGKIPAAIGNL 479
           + NGTIPAGLFNLPL+NM+ELDDNL +GELP  +SG  L    V+NN ITGKIP AIGNL
Sbjct: 423 FFNGTIPAGLFNLPLVNMLELDDNLFTGELPAHISGDVLGIFTVSNNLITGKIPPAIGNL 482

Query: 480 PSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIPYSISQCHSLTSVDLSRNS 539
            SL  L+LQ NR  GEIP E FNLKM++ +NIS NN+SGEIP  I  C SLTS+D S+NS
Sbjct: 483 SSLQTLALQINRFSGEIPGEIFNLKMLSKVNISANNLSGEIPACIVSCTSLTSIDFSQNS 542

Query: 540 LYGKIPPGISKLIDLSILNLSRNGITGSIPNEMRNMMSLTTLDLSYNNLIGNIPSGGQFL 599
           L G+IP GI+KL  L ILNLS N + G IP+E+++M SLTTLDLSYN+  G IP+GGQF 
Sbjct: 543 LNGEIPKGIAKLGILGILNLSTNHLNGQIPSEIKSMASLTTLDLSYNDFSGVIPTGGQFP 602

Query: 600 AFNETSFIGNPNLCLLRNGTCQSLINSAKHSGDGYGSSFGASKIVITVIALLTFMLLVIL 659
            FN +SF GNPNLCL R   C SL N  +  G    SSF +SK+VIT+IAL+ F L++ L
Sbjct: 603 VFNSSSFAGNPNLCLPRV-PCSSLQNITQIHGRRQTSSFTSSKLVITIIALVAFALVLTL 661

Query: 660 TIYQLRKRRLQKSKAWKLTAFQRLDFKAEDVLESLKDENIIGKGGAGIVYRGSMPDGIDV 719
            + ++R+++ QKSKAWKLTAFQRLDFKAEDVLE LK+ENIIGKGGAGIVYRGSMPDG+DV
Sbjct: 662 AVLRIRRKKHQKSKAWKLTAFQRLDFKAEDVLECLKEENIIGKGGAGIVYRGSMPDGVDV 721

Query: 720 AIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEM 779
           AIKRLVGRG+G +DHGF AEIQTLGRIRHRNIVRLLGYVSN+DTNLLLYEYMPNGSLGE+
Sbjct: 722 AIKRLVGRGSGRSDHGFSAEIQTLGRIRHRNIVRLLGYVSNKDTNLLLYEYMPNGSLGEI 781

Query: 780 LHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFG 839
           LHG+KG HL+WETRYRIA+EAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFG
Sbjct: 782 LHGSKGAHLQWETRYRIAVEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFG 841

Query: 840 LAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEF 899
           LAKFLQDAGASECMSS+AGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAG+KPVGEF
Sbjct: 842 LAKFLQDAGASECMSSIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGRKPVGEF 901

Query: 900 GDGVDIVRWVRKTTSEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSAR 959
           GDGVDIVRWVRKTTSE+SQPSD ASVLAVVDPRLSGYPLTGVI+LFK+AMMCVEDESSAR
Sbjct: 902 GDGVDIVRWVRKTTSEISQPSDRASVLAVVDPRLSGYPLTGVINLFKIAMMCVEDESSAR 961

Query: 960 PTMREVVHMLANPPQSAPSLITL 982
           PTMREVVHML NPPQ+APSLITL
Sbjct: 962 PTMREVVHMLTNPPQNAPSLITL 984

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255538984|ref|XP_002510557.1| Receptor protein kinase CLAVATA1 precursor, putative [Ricinus communis] gi|223551258|gb|EEF52744.1| Receptor protein kinase CLAVATA1 precursor, putative [Ricinus communis]

 Score = 1443 bits (3735), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 701/954 (73%), Positives = 822/954 (86%), Gaps = 5/954 (0%)

Query: 25  AYSDMDVLLKLKSSMIGPKGSGLKNWEPSSSPSAHCSFSGVTCDQDSRVVSLNV-SFMPL 83
            YSD ++LLKLKSSMI   GSGL++WEPS SPSAHCSFSGVTCD+DSRVVSLN+ S    
Sbjct: 25  GYSDAELLLKLKSSMIARNGSGLQDWEPSPSPSAHCSFSGVTCDKDSRVVSLNLTSRHGF 84

Query: 84  FGSIPPEIGLLTKLVNLTISNVNLTGRLPSEMALLTSLKVFNISGNVFQGNFAGQIVRGM 143
           FG IPPEIGLL KLVNL+I+++NLTGRLP E+A LTSL++FNIS N F GNF G+I   M
Sbjct: 85  FGFIPPEIGLLNKLVNLSIASLNLTGRLPLELAQLTSLRIFNISNNAFIGNFPGEITLVM 144

Query: 144 TELQVLDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLNGIG 203
           T+LQ+LD YNNNF+G LP+E+  LK+L+HL  GGNYF+G IP+SYS I+SLEY+GLNG  
Sbjct: 145 TQLQILDIYNNNFSGLLPLELIKLKNLKHLHLGGNYFSGTIPESYSAIESLEYLGLNGNS 204

Query: 204 LNGTVPAFLSRLKNLREMYIGYFNTYTGGIPPGFGALTQLQVLDMASCNISGEIPTSLSR 263
           L+G VPA L++LKNLR++Y+GYFN++ GGIPP FG+L+ L++LDMA  N+SGEIP SL +
Sbjct: 205 LSGKVPASLAKLKNLRKLYLGYFNSWEGGIPPEFGSLSSLEILDMAQSNLSGEIPPSLGQ 264

Query: 264 LKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQLFKN 323
           LK L+SLFLQMN+L+GHIPP+LS LISL+SLDLS+N L GEIP SF+ LKN+TL+ LF+N
Sbjct: 265 LKNLNSLFLQMNRLSGHIPPELSDLISLQSLDLSINSLKGEIPASFSKLKNITLIHLFQN 324

Query: 324 NLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDLCK 383
           NL G IP F+GDFPNLEVL VW NNFT ELP+NLG +GKL +LDV+ NHLTG IP+DLCK
Sbjct: 325 NLGGEIPEFIGDFPNLEVLHVWENNFTLELPKNLGSSGKLKMLDVSYNHLTGLIPKDLCK 384

Query: 384 GGKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDN 443
           GG+LK L+LM+NFF+GP+P+ELGQCKSL KIR + N L+GTIP+G+FNLP + ++EL+DN
Sbjct: 385 GGRLKELVLMKNFFLGPLPDELGQCKSLYKIRVANNMLSGTIPSGIFNLPSMAILELNDN 444

Query: 444 LLSGELPEKMSGASLNQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESFNL 503
             SGELP +MSG +L  LK++NN I+G IP  +GNL +L I+ L+ NRL GEIP E FNL
Sbjct: 445 YFSGELPSEMSGIALGLLKISNNLISGSIPETLGNLRNLQIIKLEINRLSGEIPNEIFNL 504

Query: 504 KMITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYGKIPPGISKLIDLSILNLSRNG 563
           K +T+IN S NN+SG+IP SIS C SLTSVD SRN+L+G+IP  I+ L DLSILN+S+N 
Sbjct: 505 KYLTAINFSANNLSGDIPPSISHCTSLTSVDFSRNNLHGQIPVEIANLKDLSILNVSQNH 564

Query: 564 ITGSIPNEMRNMMSLTTLDLSYNNLIGNIPSGGQFLAFNETSFIGNPNLCLLRNGTCQSL 623
           +TG IP ++R M SLTTLDLSYNNL+G +P+GGQFL F ++SFIGNPNLC     +C SL
Sbjct: 565 LTGQIPGDIRIMTSLTTLDLSYNNLLGRVPTGGQFLVFKDSSFIGNPNLCAPHQVSCPSL 624

Query: 624 INSAKHSGDGYGSSFGASKIVITVIALLTFMLLVILTIYQLRKRRLQKSKAWKLTAFQRL 683
                 SG G+ +SFG  K++ITVIAL+T ++L+++T Y+LRK+RL+KS+AWKLTAFQRL
Sbjct: 625 ----HGSGHGHTASFGTPKLIITVIALVTALMLIVVTAYRLRKKRLEKSRAWKLTAFQRL 680

Query: 684 DFKAEDVLESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTL 743
           DFKAEDVLE LK+ENIIGKGGAGIVYRGSMPDG DVAIKRLVGRG+G NDHGF AEIQTL
Sbjct: 681 DFKAEDVLECLKEENIIGKGGAGIVYRGSMPDGADVAIKRLVGRGSGRNDHGFSAEIQTL 740

Query: 744 GRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKG 803
           GRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGE+LHG+KGGHLKWE+RYRIA+EAAKG
Sbjct: 741 GRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGELLHGSKGGHLKWESRYRIAVEAAKG 800

Query: 804 LCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYI 863
           LCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAG SECMSSVAGSYGYI
Sbjct: 801 LCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGESECMSSVAGSYGYI 860

Query: 864 APEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAA 923
           APEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFG+GVDIVRWVRKT SE+SQPSDAA
Sbjct: 861 APEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGEGVDIVRWVRKTASELSQPSDAA 920

Query: 924 SVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQSAP 977
           SVLAVVD RL+GYPL GVIHLFK+AMMCVEDES ARPTMREVVHML NPP   P
Sbjct: 921 SVLAVVDHRLTGYPLAGVIHLFKIAMMCVEDESGARPTMREVVHMLTNPPPICP 974

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224085908|ref|XP_002307734.1| predicted protein [Populus trichocarpa] gi|224144099|ref|XP_002336108.1| predicted protein [Populus trichocarpa] gi|222857183|gb|EEE94730.1| predicted protein [Populus trichocarpa] gi|222872880|gb|EEF10011.1| predicted protein [Populus trichocarpa]

 Score = 1441 bits (3731), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 714/960 (74%), Positives = 820/960 (85%), Gaps = 8/960 (0%)

Query: 25  AYSDMDVLLKLKSSMIGPKGSGLKNWEPS-SSPSAHCSFSGVTCDQDSRVVSLNVSFMPL 83
            YSD++VLLKLK+SM G  G+GL++W  S +SP+AHC FSGVTCD+DSRVVSLNVSF  L
Sbjct: 20  GYSDLEVLLKLKTSMYGHNGTGLQDWVASPASPTAHCYFSGVTCDEDSRVVSLNVSFRHL 79

Query: 84  FGSIPPEIGLLTKLVNLTISNVNLTGRLPSEMALLTSLKVFNISGNVFQGNFAGQIVRGM 143
            GSIPPEIGLL KLVNLT+S  NLTG  P E+A+LTSL++ NIS NV  GNF G+I  GM
Sbjct: 80  PGSIPPEIGLLNKLVNLTLSGNNLTGGFPVEIAMLTSLRILNISNNVIAGNFPGKITLGM 139

Query: 144 TELQVLDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLNGIG 203
             L+VLD YNNNFTG LP EI  LK+L+H+  GGN+F+G IP+ YSEI SLEY+GLNG  
Sbjct: 140 ALLEVLDVYNNNFTGALPTEIVKLKNLKHVHLGGNFFSGTIPEEYSEILSLEYLGLNGNA 199

Query: 204 LNGTVPAFLSRLKNLREMYIGYFNTYTGGIPPGFGALTQLQVLDMASCNISGEIPTSLSR 263
           L+G VP+ LSRLKNL+ + +GYFN Y G IPP FG+L+ L++LDMASCN+ GEIP++LS+
Sbjct: 200 LSGKVPSSLSRLKNLKSLCVGYFNRYEGSIPPEFGSLSNLELLDMASCNLDGEIPSALSQ 259

Query: 264 LKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQLFKN 323
           L  LHSLFLQ+N LTGHIPP+LSGLISLKSLDLS+N LTGEIPESF+ LKN+ L+ LF+N
Sbjct: 260 LTHLHSLFLQVNNLTGHIPPELSGLISLKSLDLSINNLTGEIPESFSDLKNIELINLFQN 319

Query: 324 NLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDLCK 383
            L GPIP F GDFPNLEVLQVWGNNFTFELP+NLGRNGKL++LDV+ NHLTG +PRDLCK
Sbjct: 320 KLHGPIPEFFGDFPNLEVLQVWGNNFTFELPQNLGRNGKLMMLDVSINHLTGLVPRDLCK 379

Query: 384 GGKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDN 443
           GGKL +LILM NFF+G +P+E+GQCKSL KIR   N  +GTIPAG+FNLPL  ++EL +N
Sbjct: 380 GGKLTTLILMNNFFLGSLPDEIGQCKSLLKIRIMNNMFSGTIPAGIFNLPLATLVELSNN 439

Query: 444 LLSGELPEKMSGASLNQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESFNL 503
           L SGELP ++SG +L  L V+NN ITGKIP AIGNL +L  LSL  NRL GEIP E + L
Sbjct: 440 LFSGELPPEISGDALGLLSVSNNRITGKIPPAIGNLKNLQTLSLDTNRLSGEIPEEIWGL 499

Query: 504 KMITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYGKIPPGISKLIDLSILNLSRNG 563
           K +T INI  NNI GEIP SIS C SLTSVD S+NSL G+IP  I+KL DLS L+LSRN 
Sbjct: 500 KSLTKINIRANNIRGEIPASISHCTSLTSVDFSQNSLSGEIPKKIAKLNDLSFLDLSRNQ 559

Query: 564 ITGSIPNEMRNMMSLTTLDLSYNNLIGNIPSGGQFLAFNETSFIGNPNLCLLRNGTCQSL 623
           +TG +P E+  M SLT+L+LSYNNL G IPS GQFLAFN++SF+GNPNLC  RN TC   
Sbjct: 560 LTGQLPGEIGYMRSLTSLNLSYNNLFGRIPSAGQFLAFNDSSFLGNPNLCAARNNTCS-- 617

Query: 624 INSAKHSGDGYGSSFGASKIVITVIALLTFMLLVILTIYQLRKRRLQKSKAWKLTAFQRL 683
                H     G SF  SK++ITVIAL+T +LL+++T+Y+LRK+RLQKS+AWKLTAFQRL
Sbjct: 618 FGDHGHR----GGSFSTSKLIITVIALVTVLLLIVVTVYRLRKKRLQKSRAWKLTAFQRL 673

Query: 684 DFKAEDVLESLKDENIIGKGGAGIVYRGSMPDGID-VAIKRLVGRGTGGNDHGFLAEIQT 742
           DFKAEDVLE LK+ENIIGKGGAGIVYRGSMP+G+D VAIKRLVGRG+G +DHGF AEIQT
Sbjct: 674 DFKAEDVLECLKEENIIGKGGAGIVYRGSMPEGVDHVAIKRLVGRGSGRSDHGFSAEIQT 733

Query: 743 LGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAK 802
           LGRIRHRNIVRLLGYVSN+DTNLLLYEYMPNGSLGE+LHG+KGGHL+WETRYRIA+EAAK
Sbjct: 734 LGRIRHRNIVRLLGYVSNKDTNLLLYEYMPNGSLGELLHGSKGGHLQWETRYRIAVEAAK 793

Query: 803 GLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGY 862
           GLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAG+SECMSSVAGSYGY
Sbjct: 794 GLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGSSECMSSVAGSYGY 853

Query: 863 IAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDA 922
           IAPEYAYTLKVDEKSDVYSFGVVLLELIAG+KPVGEFGDGVDIVRWVRKTTSE+SQPSDA
Sbjct: 854 IAPEYAYTLKVDEKSDVYSFGVVLLELIAGRKPVGEFGDGVDIVRWVRKTTSELSQPSDA 913

Query: 923 ASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQSAPSLITL 982
           A+VLAVVDPRLSGYPL GVIHLFK+AM+CV+DESSARPTMREVVHML NPPQSAPSL+ L
Sbjct: 914 ATVLAVVDPRLSGYPLAGVIHLFKIAMLCVKDESSARPTMREVVHMLTNPPQSAPSLLAL 973

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224061985|ref|XP_002300697.1| predicted protein [Populus trichocarpa] gi|222842423|gb|EEE79970.1| predicted protein [Populus trichocarpa]

 Score = 1431 bits (3704), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 702/946 (74%), Positives = 813/946 (85%), Gaps = 9/946 (0%)

Query: 39  MIGPKGSGLKNWEPS-SSPSAHCSFSGVTCDQDSRVVSLNVSFMPLFGSIPPEIGLLTKL 97
           M G  G+GL++W  S +SPSAHC FSGVTCD+ SRVVSLN+SF  L GSIPPEIGLL KL
Sbjct: 1   MYGHNGTGLEDWVASPTSPSAHCFFSGVTCDESSRVVSLNLSFRHLPGSIPPEIGLLNKL 60

Query: 98  VNLTISNVNLTGRLPSEMALLTSLKVFNISGNVFQGNFAGQIVRGMTELQVLDAYNNNFT 157
           VNLT++N NLTG LP+E+A+L SL++ NISGN   GNF+G+I  GMT+L+VLD YNNN +
Sbjct: 61  VNLTLANDNLTGELPAEIAMLKSLRILNISGNAIGGNFSGKITPGMTQLEVLDIYNNNCS 120

Query: 158 GPLPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLNGIGLNGTVPAFLSRLKN 217
           GPLP+EIA+LK L+HL  GGN+F+GKIP+ YSEI  LE++GLNG  L+G VP+ LS+LKN
Sbjct: 121 GPLPIEIANLKKLKHLHLGGNFFSGKIPEEYSEIMILEFLGLNGNDLSGKVPSSLSKLKN 180

Query: 218 LREMYIGYFNTYTGGIPPGFGALTQLQVLDMASCNISGEIPTSLSRLKLLHSLFLQMNKL 277
           L+ + IGY+N Y GGIPP FG+L+ L++LDM SCN++GEIP++L +L  LHSLFLQ N L
Sbjct: 181 LKSLCIGYYNHYEGGIPPEFGSLSNLELLDMGSCNLNGEIPSTLGQLTHLHSLFLQFNNL 240

Query: 278 TGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQLFKNNLRGPIPSFLGDFP 337
           TG+IP +LSGLISLKSLDLS+N LTGEIPESF+ALKNLTLL LF+N L GPIP F+GDFP
Sbjct: 241 TGYIPSELSGLISLKSLDLSINNLTGEIPESFSALKNLTLLNLFQNKLHGPIPDFVGDFP 300

Query: 338 NLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFF 397
           NLEVLQVWGNNFTFELP+ LGRNGKL+ LDV+ NHLTG +PRDLCKGGKLK+LILM NFF
Sbjct: 301 NLEVLQVWGNNFTFELPKQLGRNGKLMYLDVSYNHLTGLVPRDLCKGGKLKTLILMNNFF 360

Query: 398 IGPIPEELGQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLSGELPEKMSGAS 457
           IG +PEE+GQCKSL KIR   N   GTIPAG+FNLPL+  +EL  N  SGELP ++SG +
Sbjct: 361 IGSLPEEIGQCKSLLKIRIICNLFTGTIPAGIFNLPLVTQIELSHNYFSGELPPEISGDA 420

Query: 458 LNQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNIS 517
           L  L V++N ITG+IP AIGNL SL  LSL+ NRL GEIP E F+L++++ I+I  NNIS
Sbjct: 421 LGSLSVSDNRITGRIPRAIGNLKSLQFLSLEMNRLSGEIPDEIFSLEILSKISIRANNIS 480

Query: 518 GEIPYSISQCHSLTSVDLSRNSLYGKIPPGISKLIDLSILNLSRNGITGSIPNEMRNMMS 577
           GEIP S+  C SLTSVD S+NS+ G+IP  I+KL DLSIL+LSRN +TG +P+E+R M S
Sbjct: 481 GEIPASMFHCTSLTSVDFSQNSISGEIPKEITKLKDLSILDLSRNQLTGQLPSEIRYMTS 540

Query: 578 LTTLDLSYNNLIGNIPSGGQFLAFNETSFIGNPNLCLLRNGTCQSLINSAKHSGDGYGSS 637
           LTTL+LSYNNL G IPS GQFLAFN++SF+GNPNLC+ RN +C          G G+  S
Sbjct: 541 LTTLNLSYNNLFGRIPSVGQFLAFNDSSFLGNPNLCVARNDSCS-------FGGHGHRRS 593

Query: 638 FGASKIVITVIALLTFMLLVILTIYQLRKRRLQKSKAWKLTAFQRLDFKAEDVLESLKDE 697
           F  SK++ITVIAL+T +LL+ +T+Y+LRK+ LQKS+AWKLTAFQRLDFKAEDVLE LK+E
Sbjct: 594 FNTSKLMITVIALVTALLLIAVTVYRLRKKNLQKSRAWKLTAFQRLDFKAEDVLECLKEE 653

Query: 698 NIIGKGGAGIVYRGSMPDGID-VAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLG 756
           NIIGKGGAGIVYRGSM +GID VAIKRLVGRGTG NDHGF AEIQTLGRIRHRNIVRLLG
Sbjct: 654 NIIGKGGAGIVYRGSMTEGIDHVAIKRLVGRGTGRNDHGFSAEIQTLGRIRHRNIVRLLG 713

Query: 757 YVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLII 816
           YVSN+DTNLLLYEYMPNGSLGE+LHG+KGGHL+WETRYRIA+EAAKGLCYLHHDCSPLII
Sbjct: 714 YVSNKDTNLLLYEYMPNGSLGELLHGSKGGHLQWETRYRIAVEAAKGLCYLHHDCSPLII 773

Query: 817 HRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEK 876
           HRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSS+AGSYGYIAPEYAYTLKVDEK
Sbjct: 774 HRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSIAGSYGYIAPEYAYTLKVDEK 833

Query: 877 SDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDPRLSGY 936
           SDVYS GVVLLELIAG+KPVGEFGDGVDIVRWVRKTTSE+SQPSDAASVLAVVDPRLSGY
Sbjct: 834 SDVYSCGVVLLELIAGRKPVGEFGDGVDIVRWVRKTTSELSQPSDAASVLAVVDPRLSGY 893

Query: 937 PLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQSAPSLITL 982
           PLTG IHLFK+AM+CV+DESS RPTMREVVHML NPPQSA SL+TL
Sbjct: 894 PLTGAIHLFKIAMLCVKDESSNRPTMREVVHMLTNPPQSASSLLTL 939

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|15222877|ref|NP_177710.1| receptor protein kinase CLAVATA1 [Arabidopsis thaliana] gi|51338834|sp|Q9SYQ8.3|CLV1_ARATH RecName: Full=Receptor protein kinase CLAVATA1; Flags: Precursor gi|224589487|gb|ACN59277.1| leucine-rich repeat receptor-like protein kinase [Arabidopsis thaliana] gi|332197641|gb|AEE35762.1| receptor protein kinase CLAVATA1 [Arabidopsis thaliana]

 Score = 1382 bits (3576), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 669/959 (69%), Positives = 793/959 (82%), Gaps = 3/959 (0%)

Query: 25  AYSDMDVLLKLKSSMIGPKGSGLKNWEPSSSPSAHCSFSGVTCDQDSRVVSLNVSFMPLF 84
           AY+DM+VLL LKSSMIGPKG GL +W  SSSP AHCSFSGV+CD D+RV+SLNVSF PLF
Sbjct: 24  AYTDMEVLLNLKSSMIGPKGHGLHDWIHSSSPDAHCSFSGVSCDDDARVISLNVSFTPLF 83

Query: 85  GSIPPEIGLLTKLVNLTISNVNLTGRLPSEMALLTSLKVFNISGN-VFQGNFAGQIVRGM 143
           G+I PEIG+LT LVNLT++  N TG LP EM  LTSLKV NIS N    G F G+I++ M
Sbjct: 84  GTISPEIGMLTHLVNLTLAANNFTGELPLEMKSLTSLKVLNISNNGNLTGTFPGEILKAM 143

Query: 144 TELQVLDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLNGIG 203
            +L+VLD YNNNF G LP E++ LK L++LSFGGN+F+G+IP+SY +IQSLEY+GLNG G
Sbjct: 144 VDLEVLDTYNNNFNGKLPPEMSELKKLKYLSFGGNFFSGEIPESYGDIQSLEYLGLNGAG 203

Query: 204 LNGTVPAFLSRLKNLREMYIGYFNTYTGGIPPGFGALTQLQVLDMASCNISGEIPTSLSR 263
           L+G  PAFLSRLKNLREMYIGY+N+YTGG+PP FG LT+L++LDMASC ++GEIPTSLS 
Sbjct: 204 LSGKSPAFLSRLKNLREMYIGYYNSYTGGVPPEFGGLTKLEILDMASCTLTGEIPTSLSN 263

Query: 264 LKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQLFKN 323
           LK LH+LFL +N LTGHIPP+LSGL+SLKSLDLS+N LTGEIP+SF  L N+TL+ LF+N
Sbjct: 264 LKHLHTLFLHINNLTGHIPPELSGLVSLKSLDLSINQLTGEIPQSFINLGNITLINLFRN 323

Query: 324 NLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDLCK 383
           NL G IP  +G+ P LEV +VW NNFT +LP NLGRNG L+ LDV+ NHLTG IP+DLC+
Sbjct: 324 NLYGQIPEAIGELPKLEVFEVWENNFTLQLPANLGRNGNLIKLDVSDNHLTGLIPKDLCR 383

Query: 384 GGKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDN 443
           G KL+ LIL  NFF GPIPEELG+CKSLTKIR  KN LNGT+PAGLFNLPL+ ++EL DN
Sbjct: 384 GEKLEMLILSNNFFFGPIPEELGKCKSLTKIRIVKNLLNGTVPAGLFNLPLVTIIELTDN 443

Query: 444 LLSGELPEKMSGASLNQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESFNL 503
             SGELP  MSG  L+Q+ ++NN  +G+IP AIGN P+L  L L  NR  G IP E F L
Sbjct: 444 FFSGELPVTMSGDVLDQIYLSNNWFSGEIPPAIGNFPNLQTLFLDRNRFRGNIPREIFEL 503

Query: 504 KMITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYGKIPPGISKLIDLSILNLSRNG 563
           K ++ IN S NNI+G IP SIS+C +L SVDLSRN + G+IP GI+ + +L  LN+S N 
Sbjct: 504 KHLSRINTSANNITGGIPDSISRCSTLISVDLSRNRINGEIPKGINNVKNLGTLNISGNQ 563

Query: 564 ITGSIPNEMRNMMSLTTLDLSYNNLIGNIPSGGQFLAFNETSFIGNPNLCLLRNGTCQSL 623
           +TGSIP  + NM SLTTLDLS+N+L G +P GGQFL FNETSF GN  LCL    +C + 
Sbjct: 564 LTGSIPTGIGNMTSLTTLDLSFNDLSGRVPLGGQFLVFNETSFAGNTYLCLPHRVSCPT- 622

Query: 624 INSAKHSGDGYGSSFGASKIVITVIALLTFMLLVILTIYQLRKRRLQKSKAWKLTAFQRL 683
               + S   + + F  S+IVITVIA +T ++L+ + I Q+ K++ QKS AWKLTAFQ+L
Sbjct: 623 -RPGQTSDHNHTALFSPSRIVITVIAAITGLILISVAIRQMNKKKNQKSLAWKLTAFQKL 681

Query: 684 DFKAEDVLESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTL 743
           DFK+EDVLE LK+ENIIGKGGAGIVYRGSMP+ +DVAIKRLVGRGTG +DHGF AEIQTL
Sbjct: 682 DFKSEDVLECLKEENIIGKGGAGIVYRGSMPNNVDVAIKRLVGRGTGRSDHGFTAEIQTL 741

Query: 744 GRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKG 803
           GRIRHR+IVRLLGYV+N+DTNLLLYEYMPNGSLGE+LHG+KGGHL+WETR+R+A+EAAKG
Sbjct: 742 GRIRHRHIVRLLGYVANKDTNLLLYEYMPNGSLGELLHGSKGGHLQWETRHRVAVEAAKG 801

Query: 804 LCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYI 863
           LCYLHHDCSPLI+HRDVKSNNILLDSDFEAHVADFGLAKFL D  ASECMSS+AGSYGYI
Sbjct: 802 LCYLHHDCSPLILHRDVKSNNILLDSDFEAHVADFGLAKFLVDGAASECMSSIAGSYGYI 861

Query: 864 APEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAA 923
           APEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFG+GVDIVRWVR T  E++QPSDAA
Sbjct: 862 APEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGEGVDIVRWVRNTEEEITQPSDAA 921

Query: 924 SVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQSAPSLITL 982
            V+A+VDPRL+GYPLT VIH+FK+AMMCVE+E++ARPTMREVVHML NPP+S  +LI  
Sbjct: 922 IVVAIVDPRLTGYPLTSVIHVFKIAMMCVEEEAAARPTMREVVHMLTNPPKSVANLIAF 980

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|25287710|pir||E96787 protein T4O12.5 [imported] - Arabidopsis thaliana gi|6721118|gb|AAF26772.1|AC007396_21 T4O12.5 [Arabidopsis thaliana]

 Score = 1381 bits (3574), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 669/959 (69%), Positives = 793/959 (82%), Gaps = 3/959 (0%)

Query: 25  AYSDMDVLLKLKSSMIGPKGSGLKNWEPSSSPSAHCSFSGVTCDQDSRVVSLNVSFMPLF 84
           AY+DM+VLL LKSSMIGPKG GL +W  SSSP AHCSFSGV+CD D+RV+SLNVSF PLF
Sbjct: 22  AYTDMEVLLNLKSSMIGPKGHGLHDWIHSSSPDAHCSFSGVSCDDDARVISLNVSFTPLF 81

Query: 85  GSIPPEIGLLTKLVNLTISNVNLTGRLPSEMALLTSLKVFNISGN-VFQGNFAGQIVRGM 143
           G+I PEIG+LT LVNLT++  N TG LP EM  LTSLKV NIS N    G F G+I++ M
Sbjct: 82  GTISPEIGMLTHLVNLTLAANNFTGELPLEMKSLTSLKVLNISNNGNLTGTFPGEILKAM 141

Query: 144 TELQVLDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLNGIG 203
            +L+VLD YNNNF G LP E++ LK L++LSFGGN+F+G+IP+SY +IQSLEY+GLNG G
Sbjct: 142 VDLEVLDTYNNNFNGKLPPEMSELKKLKYLSFGGNFFSGEIPESYGDIQSLEYLGLNGAG 201

Query: 204 LNGTVPAFLSRLKNLREMYIGYFNTYTGGIPPGFGALTQLQVLDMASCNISGEIPTSLSR 263
           L+G  PAFLSRLKNLREMYIGY+N+YTGG+PP FG LT+L++LDMASC ++GEIPTSLS 
Sbjct: 202 LSGKSPAFLSRLKNLREMYIGYYNSYTGGVPPEFGGLTKLEILDMASCTLTGEIPTSLSN 261

Query: 264 LKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQLFKN 323
           LK LH+LFL +N LTGHIPP+LSGL+SLKSLDLS+N LTGEIP+SF  L N+TL+ LF+N
Sbjct: 262 LKHLHTLFLHINNLTGHIPPELSGLVSLKSLDLSINQLTGEIPQSFINLGNITLINLFRN 321

Query: 324 NLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDLCK 383
           NL G IP  +G+ P LEV +VW NNFT +LP NLGRNG L+ LDV+ NHLTG IP+DLC+
Sbjct: 322 NLYGQIPEAIGELPKLEVFEVWENNFTLQLPANLGRNGNLIKLDVSDNHLTGLIPKDLCR 381

Query: 384 GGKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDN 443
           G KL+ LIL  NFF GPIPEELG+CKSLTKIR  KN LNGT+PAGLFNLPL+ ++EL DN
Sbjct: 382 GEKLEMLILSNNFFFGPIPEELGKCKSLTKIRIVKNLLNGTVPAGLFNLPLVTIIELTDN 441

Query: 444 LLSGELPEKMSGASLNQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESFNL 503
             SGELP  MSG  L+Q+ ++NN  +G+IP AIGN P+L  L L  NR  G IP E F L
Sbjct: 442 FFSGELPVTMSGDVLDQIYLSNNWFSGEIPPAIGNFPNLQTLFLDRNRFRGNIPREIFEL 501

Query: 504 KMITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYGKIPPGISKLIDLSILNLSRNG 563
           K ++ IN S NNI+G IP SIS+C +L SVDLSRN + G+IP GI+ + +L  LN+S N 
Sbjct: 502 KHLSRINTSANNITGGIPDSISRCSTLISVDLSRNRINGEIPKGINNVKNLGTLNISGNQ 561

Query: 564 ITGSIPNEMRNMMSLTTLDLSYNNLIGNIPSGGQFLAFNETSFIGNPNLCLLRNGTCQSL 623
           +TGSIP  + NM SLTTLDLS+N+L G +P GGQFL FNETSF GN  LCL    +C + 
Sbjct: 562 LTGSIPTGIGNMTSLTTLDLSFNDLSGRVPLGGQFLVFNETSFAGNTYLCLPHRVSCPT- 620

Query: 624 INSAKHSGDGYGSSFGASKIVITVIALLTFMLLVILTIYQLRKRRLQKSKAWKLTAFQRL 683
               + S   + + F  S+IVITVIA +T ++L+ + I Q+ K++ QKS AWKLTAFQ+L
Sbjct: 621 -RPGQTSDHNHTALFSPSRIVITVIAAITGLILISVAIRQMNKKKNQKSLAWKLTAFQKL 679

Query: 684 DFKAEDVLESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTL 743
           DFK+EDVLE LK+ENIIGKGGAGIVYRGSMP+ +DVAIKRLVGRGTG +DHGF AEIQTL
Sbjct: 680 DFKSEDVLECLKEENIIGKGGAGIVYRGSMPNNVDVAIKRLVGRGTGRSDHGFTAEIQTL 739

Query: 744 GRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKG 803
           GRIRHR+IVRLLGYV+N+DTNLLLYEYMPNGSLGE+LHG+KGGHL+WETR+R+A+EAAKG
Sbjct: 740 GRIRHRHIVRLLGYVANKDTNLLLYEYMPNGSLGELLHGSKGGHLQWETRHRVAVEAAKG 799

Query: 804 LCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYI 863
           LCYLHHDCSPLI+HRDVKSNNILLDSDFEAHVADFGLAKFL D  ASECMSS+AGSYGYI
Sbjct: 800 LCYLHHDCSPLILHRDVKSNNILLDSDFEAHVADFGLAKFLVDGAASECMSSIAGSYGYI 859

Query: 864 APEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAA 923
           APEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFG+GVDIVRWVR T  E++QPSDAA
Sbjct: 860 APEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGEGVDIVRWVRNTEEEITQPSDAA 919

Query: 924 SVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQSAPSLITL 982
            V+A+VDPRL+GYPLT VIH+FK+AMMCVE+E++ARPTMREVVHML NPP+S  +LI  
Sbjct: 920 IVVAIVDPRLTGYPLTSVIHVFKIAMMCVEEEAAARPTMREVVHMLTNPPKSVANLIAF 978

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Class: N/A

Phylum: Streptophyta

>gi|297842329|ref|XP_002889046.1| hypothetical protein ARALYDRAFT_476729 [Arabidopsis lyrata subsp. lyrata] gi|297334887|gb|EFH65305.1| hypothetical protein ARALYDRAFT_476729 [Arabidopsis lyrata subsp. lyrata]

 Score = 1381 bits (3574), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 667/959 (69%), Positives = 792/959 (82%), Gaps = 3/959 (0%)

Query: 25  AYSDMDVLLKLKSSMIGPKGSGLKNWEPSSSPSAHCSFSGVTCDQDSRVVSLNVSFMPLF 84
           A +DM+VLL LKSSMIGP G+GL +W PSSSP+AHCSFSGV+CD D+RV+SLNVSF PLF
Sbjct: 24  ANTDMEVLLNLKSSMIGPNGTGLHDWIPSSSPAAHCSFSGVSCDGDARVISLNVSFTPLF 83

Query: 85  GSIPPEIGLLTKLVNLTISNVNLTGRLPSEMALLTSLKVFNISGN-VFQGNFAGQIVRGM 143
           G+I PEIG+L +LVNLT++  N +G LP EM  LTSLKV NIS N    G+F G+IV+ M
Sbjct: 84  GTISPEIGMLNRLVNLTLAANNFSGALPLEMKSLTSLKVLNISNNGNLNGSFPGEIVKAM 143

Query: 144 TELQVLDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLNGIG 203
            +L+VLDAYNN FTG LP EI  LK L+HLS GGN+F G+IP+SY +IQSLEY+GLNG G
Sbjct: 144 VDLEVLDAYNNGFTGTLPPEIPELKKLKHLSLGGNFFNGEIPESYGDIQSLEYLGLNGAG 203

Query: 204 LNGTVPAFLSRLKNLREMYIGYFNTYTGGIPPGFGALTQLQVLDMASCNISGEIPTSLSR 263
           ++G  PAFLSRLKNL+EMYIGY+N+YTGGIPP FG LT+L++LDMASC ++GEIPTSLS 
Sbjct: 204 ISGKSPAFLSRLKNLKEMYIGYYNSYTGGIPPEFGGLTKLEILDMASCTLTGEIPTSLSN 263

Query: 264 LKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQLFKN 323
           LK LH+LFL +N LTGHIPP+LSGL+SLKSLDLS+N LTGEIP+SF  L N+TL+ LF+N
Sbjct: 264 LKHLHTLFLHVNNLTGHIPPELSGLVSLKSLDLSINQLTGEIPQSFIDLGNITLINLFRN 323

Query: 324 NLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDLCK 383
           NL G IP  +G+ P LEV +VW NNFT +LP NLGRNG L+ LDV+ NHLTG IP DLC+
Sbjct: 324 NLYGQIPDCIGELPKLEVFEVWENNFTLQLPANLGRNGNLIKLDVSHNHLTGLIPMDLCR 383

Query: 384 GGKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDN 443
           G KL+ LIL  NFF GPIPEELG+CKSL KIR  KN LNGT+PAGLFNLPL+ M+EL DN
Sbjct: 384 GEKLEMLILTNNFFFGPIPEELGKCKSLNKIRIVKNLLNGTVPAGLFNLPLVTMIELTDN 443

Query: 444 LLSGELPEKMSGASLNQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESFNL 503
             SGELP  MSG  L+Q+ ++NN  +G+IP AIGN P+L  L L  NR  G +P E F L
Sbjct: 444 FFSGELPATMSGDVLDQIYLSNNWFSGEIPPAIGNFPNLQTLFLDRNRFRGNLPREIFEL 503

Query: 504 KMITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYGKIPPGISKLIDLSILNLSRNG 563
           K ++ IN S NNI+G IP SIS+C +L SVDLSRN + G+IP  I+ +I+L  LNLS N 
Sbjct: 504 KHLSKINTSANNITGVIPDSISRCTTLISVDLSRNRITGEIPEDINNVINLGTLNLSGNQ 563

Query: 564 ITGSIPNEMRNMMSLTTLDLSYNNLIGNIPSGGQFLAFNETSFIGNPNLCLLRNGTCQSL 623
           +TGSIP  + NM SLTTLDLS+N+L G +P GGQF+ FNETSF GN  LCL    +C + 
Sbjct: 564 LTGSIPTRIGNMTSLTTLDLSFNDLSGRVPLGGQFMVFNETSFAGNTYLCLPHRVSCPT- 622

Query: 624 INSAKHSGDGYGSSFGASKIVITVIALLTFMLLVILTIYQLRKRRLQKSKAWKLTAFQRL 683
               + S   + + F  S+IV+TVIA +T ++L+ + I Q++K++ QKS AWKLTAFQ+L
Sbjct: 623 -RPGQTSDHNHTALFSPSRIVLTVIAAITALILISVAIRQMKKKKNQKSLAWKLTAFQKL 681

Query: 684 DFKAEDVLESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTL 743
           DFK+EDVLE LK+ENIIGKGGAGIVYRGSMP+ +DVAIKRLVGRGTG +DHGF AEIQTL
Sbjct: 682 DFKSEDVLECLKEENIIGKGGAGIVYRGSMPNNVDVAIKRLVGRGTGRSDHGFTAEIQTL 741

Query: 744 GRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKG 803
           GRIRHR+IVRLLGYV+N+DTNLLLYEYMPNGSLGE+LHG+KGGHL+WETR+R+A+EAAKG
Sbjct: 742 GRIRHRHIVRLLGYVANKDTNLLLYEYMPNGSLGELLHGSKGGHLQWETRHRVAVEAAKG 801

Query: 804 LCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYI 863
           LCYLHHDCSPLI+HRDVKSNNILLDSDFEAHVADFGLAKFL D  ASECMSS+AGSYGYI
Sbjct: 802 LCYLHHDCSPLILHRDVKSNNILLDSDFEAHVADFGLAKFLVDGAASECMSSIAGSYGYI 861

Query: 864 APEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAA 923
           APEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFG+GVDIVRWVR T  E++QPSDAA
Sbjct: 862 APEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGEGVDIVRWVRNTEEEITQPSDAA 921

Query: 924 SVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQSAPSLITL 982
            V+A+VDPRL+GYPLT VIH+FK+AMMCVEDE++ARPTMREVVHML NPP+S  +LI  
Sbjct: 922 IVVAIVDPRLTGYPLTSVIHVFKIAMMCVEDEAAARPTMREVVHMLTNPPKSVANLIAF 980

Source: Arabidopsis lyrata subsp. lyrata

Species: Arabidopsis lyrata

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|290796119|gb|ADD64789.1| CLAVATA1 [Brassica napus]

 Score = 1380 bits (3573), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 676/974 (69%), Positives = 795/974 (81%), Gaps = 3/974 (0%)

Query: 10  HLYISLFLLLFSLSCAYSDMDVLLKLKSSMIGPKGSGLKNWEPSSSPSAHCSFSGVTCDQ 69
           H  IS+ LL FS   A +DMD LL LKSSM+GP G GL +W  S SPSAHCSFSGV+CD 
Sbjct: 16  HYVISILLLSFSPCFASTDMDHLLTLKSSMVGPNGHGLHDWVRSPSPSAHCSFSGVSCDG 75

Query: 70  DSRVVSLNVSFMPLFGSIPPEIGLLTKLVNLTISNVNLTGRLPSEMALLTSLKVFNISGN 129
           D+RV+SLNVSF PLFG+I PEIG+L +LVNLT++  N +G LP EM  LTSLKV NIS N
Sbjct: 76  DARVISLNVSFTPLFGTISPEIGMLDRLVNLTLAANNFSGMLPLEMKSLTSLKVLNISNN 135

Query: 130 V-FQGNFAGQIVRGMTELQVLDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSY 188
           V   G F G+I+  M +L+VLDAYNNNFTGPLP EI  LK LRHLS GGN+ TG+IP+SY
Sbjct: 136 VNLNGTFPGEILTPMVDLEVLDAYNNNFTGPLPPEIPGLKKLRHLSLGGNFLTGEIPESY 195

Query: 189 SEIQSLEYIGLNGIGLNGTVPAFLSRLKNLREMYIGYFNTYTGGIPPGFGALTQLQVLDM 248
            +IQSLEY+GLNG GL+G  PAFLSRLKNL+EMY+GYFN+YTGG+PP FG LT L+VLDM
Sbjct: 196 GDIQSLEYLGLNGAGLSGESPAFLSRLKNLKEMYVGYFNSYTGGVPPEFGELTNLEVLDM 255

Query: 249 ASCNISGEIPTSLSRLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPES 308
           ASC ++GEIPT+LS LK LH+LFL +N LTG+IPP+LSGLISLKSLDLS+N LTGEIP+S
Sbjct: 256 ASCTLTGEIPTTLSNLKHLHTLFLHINNLTGNIPPELSGLISLKSLDLSINQLTGEIPQS 315

Query: 309 FAALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDV 368
           F +L N+TL+ LF+NNL GPIP F+GD PNL+VLQVW NNFT ELP NLGRNG L  LDV
Sbjct: 316 FISLWNITLVNLFRNNLHGPIPEFIGDMPNLQVLQVWENNFTLELPANLGRNGNLKKLDV 375

Query: 369 TSNHLTGTIPRDLCKGGKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGTIPAG 428
           + NHLTG IP DLC+GGKL++L+L  NFF G IPE+LG+CKSL KIR  KN LNGT+PAG
Sbjct: 376 SDNHLTGLIPMDLCRGGKLETLVLSDNFFFGSIPEKLGRCKSLNKIRIVKNLLNGTVPAG 435

Query: 429 LFNLPLLNMMELDDNLLSGELPEKMSGASLNQLKVANNNITGKIPAAIGNLPSLNILSLQ 488
           LF LPL+ ++EL DN  SGELP +MSG  L+ + ++NN  TG IP AIGN  +L  L L 
Sbjct: 436 LFTLPLVTIIELTDNFFSGELPGEMSGDLLDHIYLSNNWFTGLIPPAIGNFKNLQDLFLD 495

Query: 489 NNRLEGEIPVESFNLKMITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYGKIPPGI 548
            NR  G IP E F LK +T IN S NN++G+IP SIS+C SL SVDLSRN + G IP  I
Sbjct: 496 RNRFSGNIPREVFELKHLTKINTSANNLTGDIPDSISRCTSLISVDLSRNRIGGDIPKDI 555

Query: 549 SKLIDLSILNLSRNGITGSIPNEMRNMMSLTTLDLSYNNLIGNIPSGGQFLAFNETSFIG 608
             +I+L  LNLS N +TGSIP  +  M SLTTLDLS+N+L G +P GGQFL FN+TSF G
Sbjct: 556 HDVINLGTLNLSGNQLTGSIPIGIGKMTSLTTLDLSFNDLSGRVPLGGQFLVFNDTSFAG 615

Query: 609 NPNLCLLRNGTCQSLINSAKHSGDGYGSSFGASKIVITVIALLTFMLLVILTIYQLRKRR 668
           NP LCL R+ +C  L    + S   + + F  S+I IT+IA +T ++L+ + I Q+ K++
Sbjct: 616 NPYLCLPRHVSC--LTRPGQTSDRIHTALFSPSRIAITIIAAVTALILISVAIRQMNKKK 673

Query: 669 LQKSKAWKLTAFQRLDFKAEDVLESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRG 728
            ++S +WKLTAFQRLDFKAEDVLE L++ENIIGKGGAGIVYRGSMP+ +DVAIKRLVGRG
Sbjct: 674 HERSLSWKLTAFQRLDFKAEDVLECLQEENIIGKGGAGIVYRGSMPNNVDVAIKRLVGRG 733

Query: 729 TGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHL 788
           TG +DHGF AEIQTLGRIRHR+IVRLLGYV+NRDTNLLLYEYMPNGSLGE+LHG+KGGHL
Sbjct: 734 TGRSDHGFTAEIQTLGRIRHRHIVRLLGYVANRDTNLLLYEYMPNGSLGELLHGSKGGHL 793

Query: 789 KWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAG 848
           +WETR+R+A+EAAKGLCYLHHDCSPLI+HRDVKSNNILLDSDFEAHVADFGLAKFL D  
Sbjct: 794 QWETRHRVAVEAAKGLCYLHHDCSPLILHRDVKSNNILLDSDFEAHVADFGLAKFLLDGA 853

Query: 849 ASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRW 908
           ASECMSS+AGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFG+GVDIVRW
Sbjct: 854 ASECMSSIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGEGVDIVRW 913

Query: 909 VRKTTSEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHM 968
           VR T  E+ QPSDAA+V+A+VD RL+GYPLT VIH+FK+AMMCVEDE++ RPTMREVVHM
Sbjct: 914 VRNTEGEIPQPSDAATVVAIVDQRLTGYPLTSVIHVFKIAMMCVEDEATTRPTMREVVHM 973

Query: 969 LANPPQSAPSLITL 982
           L NPP+S  +LI  
Sbjct: 974 LTNPPKSVTNLIAF 987

Source: Brassica napus

Species: Brassica napus

Genus: Brassica

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|2160756|gb|AAB58929.1| CLV1 receptor kinase [Arabidopsis thaliana]

 Score = 1378 bits (3566), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 668/959 (69%), Positives = 792/959 (82%), Gaps = 3/959 (0%)

Query: 25  AYSDMDVLLKLKSSMIGPKGSGLKNWEPSSSPSAHCSFSGVTCDQDSRVVSLNVSFMPLF 84
           AY+DM+VLL LKSSMIGPKG GL +W  SSSP AHCSFSGV+CD D+RV+SLNVSF PLF
Sbjct: 24  AYTDMEVLLNLKSSMIGPKGHGLHDWIHSSSPDAHCSFSGVSCDDDARVISLNVSFTPLF 83

Query: 85  GSIPPEIGLLTKLVNLTISNVNLTGRLPSEMALLTSLKVFNISGN-VFQGNFAGQIVRGM 143
           G+I PEIG+LT LVNLT++  N TG LP EM  LTSLKV NIS N    G F G+I++ M
Sbjct: 84  GTISPEIGMLTHLVNLTLAANNFTGELPLEMKSLTSLKVLNISNNGNLTGTFPGEILKAM 143

Query: 144 TELQVLDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLNGIG 203
            +L+VLD YNNNF G LP E++ LK L++LSFGGN+F+G+IP+SY +IQSLEY+GLNG G
Sbjct: 144 VDLEVLDTYNNNFNGKLPPEMSELKKLKYLSFGGNFFSGEIPESYGDIQSLEYLGLNGAG 203

Query: 204 LNGTVPAFLSRLKNLREMYIGYFNTYTGGIPPGFGALTQLQVLDMASCNISGEIPTSLSR 263
           L+G  PAFLSRLKNLREMYIGY+N+YTGG+P  FG LT+L++LDMASC ++GEIPTSLS 
Sbjct: 204 LSGKSPAFLSRLKNLREMYIGYYNSYTGGVPREFGGLTKLEILDMASCTLTGEIPTSLSN 263

Query: 264 LKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQLFKN 323
           LK LH+LFL +N LTGHIPP+LSGL+SLKSLDLS+N LTGEIP+SF  L N+TL+ LF+N
Sbjct: 264 LKHLHTLFLHINNLTGHIPPELSGLVSLKSLDLSINQLTGEIPQSFINLGNITLINLFRN 323

Query: 324 NLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDLCK 383
           NL G IP  +G+ P LEV +VW NNFT +LP NLGRNG L+ LDV+ NHLTG IP+DLC+
Sbjct: 324 NLYGQIPEAIGELPKLEVFEVWENNFTLQLPANLGRNGNLIKLDVSDNHLTGLIPKDLCR 383

Query: 384 GGKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDN 443
           G KL+ LIL  NFF GPIPEELG+CKSLTKIR  KN LNGT+PAGLFNLPL+ ++EL DN
Sbjct: 384 GEKLEMLILSNNFFFGPIPEELGKCKSLTKIRIVKNLLNGTVPAGLFNLPLVTIIELTDN 443

Query: 444 LLSGELPEKMSGASLNQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESFNL 503
             SGELP  MSG  L+Q+ ++NN  +G+IP AIGN P+L  L L  NR  G IP E F L
Sbjct: 444 FFSGELPVTMSGDVLDQIYLSNNWFSGEIPPAIGNFPNLQTLFLDRNRFRGNIPREIFEL 503

Query: 504 KMITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYGKIPPGISKLIDLSILNLSRNG 563
           K ++ IN S NNI+G IP SIS+C +L SVDLSRN + G+IP GI+ + +L  LN+S N 
Sbjct: 504 KHLSRINTSANNITGGIPDSISRCSTLISVDLSRNRINGEIPKGINNVKNLGTLNISGNQ 563

Query: 564 ITGSIPNEMRNMMSLTTLDLSYNNLIGNIPSGGQFLAFNETSFIGNPNLCLLRNGTCQSL 623
           +TGSIP  + NM SLTTLDLS+N+L G +P GGQFL FNETSF GN  LCL    +C + 
Sbjct: 564 LTGSIPTGIGNMTSLTTLDLSFNDLSGRVPLGGQFLVFNETSFAGNTYLCLPHRVSCPT- 622

Query: 624 INSAKHSGDGYGSSFGASKIVITVIALLTFMLLVILTIYQLRKRRLQKSKAWKLTAFQRL 683
               + S   + + F  S+IVITVIA +T ++L+ + I Q+ K++ QKS AWKLTAFQ+L
Sbjct: 623 -RPGQTSDHNHTALFSPSRIVITVIAAITGLILISVAIRQMNKKKNQKSLAWKLTAFQKL 681

Query: 684 DFKAEDVLESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTL 743
           DFK+EDVLE LK+ENIIGKGGAGIVYRGSMP+ +DVAIKRLVGRGTG +DHGF AEIQTL
Sbjct: 682 DFKSEDVLECLKEENIIGKGGAGIVYRGSMPNNVDVAIKRLVGRGTGRSDHGFTAEIQTL 741

Query: 744 GRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKG 803
           GRIRHR+IVRLLGYV+N+DTNLLLYEYMPNGSLGE+LHG+KGGHL+WETR+R+A+EAAKG
Sbjct: 742 GRIRHRHIVRLLGYVANKDTNLLLYEYMPNGSLGELLHGSKGGHLQWETRHRVAVEAAKG 801

Query: 804 LCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYI 863
           LCYLHHDCSPLI+HRDVKSNNILLDSDFEAHVADFGLAKFL D  ASECMSS+AGSYGYI
Sbjct: 802 LCYLHHDCSPLILHRDVKSNNILLDSDFEAHVADFGLAKFLVDGAASECMSSIAGSYGYI 861

Query: 864 APEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAA 923
           APEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFG+GVDIVRWVR T  E++QPSDAA
Sbjct: 862 APEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGEGVDIVRWVRNTEEEITQPSDAA 921

Query: 924 SVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQSAPSLITL 982
            V+A+VDPRL+GYPLT VIH+FK+AMMCVE+E++ARPTMREVVHML NPP+S  +LI  
Sbjct: 922 IVVAIVDPRLTGYPLTSVIHVFKIAMMCVEEEAAARPTMREVVHMLTNPPKSVANLIAF 980

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|31540632|gb|AAP49010.1| CLV1-like receptor kinase [Brassica napus]

 Score = 1375 bits (3560), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 673/965 (69%), Positives = 790/965 (81%), Gaps = 3/965 (0%)

Query: 10  HLYISLFLLLFSLSCAYSDMDVLLKLKSSMIGPKGSGLKNWEPSSSPSAHCSFSGVTCDQ 69
           H  IS+ LL FS   A +DMD LL LKSSM+GP G GL +W  S SPSAHCSFSGV+CD 
Sbjct: 16  HYVISILLLSFSPCFASTDMDHLLTLKSSMVGPNGHGLHDWVRSPSPSAHCSFSGVSCDG 75

Query: 70  DSRVVSLNVSFMPLFGSIPPEIGLLTKLVNLTISNVNLTGRLPSEMALLTSLKVFNISGN 129
           D+RV+SLNVSF PLFG+I PEIG+L +LVNLT++  N +G LP EM  LTSLKV NIS N
Sbjct: 76  DARVISLNVSFTPLFGTISPEIGMLDRLVNLTLAANNFSGMLPLEMKSLTSLKVLNISNN 135

Query: 130 V-FQGNFAGQIVRGMTELQVLDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSY 188
           V   G F G+I+  M +L+VLDAYNNNFTGPLP EI  LK LRHLS GGN+ TG+IP+SY
Sbjct: 136 VNLNGTFPGEILTPMVDLEVLDAYNNNFTGPLPPEIPGLKKLRHLSLGGNFLTGEIPESY 195

Query: 189 SEIQSLEYIGLNGIGLNGTVPAFLSRLKNLREMYIGYFNTYTGGIPPGFGALTQLQVLDM 248
            +IQSLEY+GLNG GL+G  PAFLSRLKNL+EMY+GYFN+YTGG+PP FG LT L+VLDM
Sbjct: 196 GDIQSLEYLGLNGAGLSGESPAFLSRLKNLKEMYVGYFNSYTGGVPPEFGELTNLEVLDM 255

Query: 249 ASCNISGEIPTSLSRLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPES 308
           ASC ++GEIPT+LS LK LH+LFL +N LTG+IPP+LSGLISLKSLDLS+N LTGEIP+S
Sbjct: 256 ASCTLTGEIPTTLSNLKHLHTLFLHINNLTGNIPPELSGLISLKSLDLSINQLTGEIPQS 315

Query: 309 FAALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDV 368
           F +L N+TL+ LF+NNL GPIP F+GD PNL+VLQVW NNFT ELP NLGRNG L  LDV
Sbjct: 316 FISLWNITLVNLFRNNLHGPIPEFIGDMPNLQVLQVWENNFTLELPANLGRNGNLKKLDV 375

Query: 369 TSNHLTGTIPRDLCKGGKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGTIPAG 428
           + NHLTG IP DLC+GGKL++L+L  NFF G IPE+LG+CKSL KIR  KN LNGT+PAG
Sbjct: 376 SDNHLTGLIPMDLCRGGKLETLVLSDNFFFGSIPEKLGRCKSLNKIRIVKNLLNGTVPAG 435

Query: 429 LFNLPLLNMMELDDNLLSGELPEKMSGASLNQLKVANNNITGKIPAAIGNLPSLNILSLQ 488
           LF LPL+ ++EL DN  SGELP +MSG  L+ + ++NN  TG IP AIGN  +L  L L 
Sbjct: 436 LFTLPLVTIIELTDNFFSGELPGEMSGDLLDHIYLSNNWFTGLIPPAIGNFKNLQDLFLD 495

Query: 489 NNRLEGEIPVESFNLKMITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYGKIPPGI 548
            NR  G IP E F LK +T IN S NN++G+IP SIS+C SL SVDLSRN + G IP  I
Sbjct: 496 RNRFSGNIPREVFELKHLTKINTSANNLTGDIPDSISRCTSLISVDLSRNRIGGDIPKDI 555

Query: 549 SKLIDLSILNLSRNGITGSIPNEMRNMMSLTTLDLSYNNLIGNIPSGGQFLAFNETSFIG 608
             +I+L  LNLS N +TGSIP  +  M SLTTLDLS+N+L G +P GGQFL FN+TSF G
Sbjct: 556 HDVINLGTLNLSGNQLTGSIPIGIGKMTSLTTLDLSFNDLSGRVPLGGQFLVFNDTSFAG 615

Query: 609 NPNLCLLRNGTCQSLINSAKHSGDGYGSSFGASKIVITVIALLTFMLLVILTIYQLRKRR 668
           NP LCL R+ +C  L    + S   + + F  S+I IT+IA +T ++L+ + I Q+ K++
Sbjct: 616 NPYLCLPRHVSC--LTRPGQTSDRIHTALFSPSRIAITIIAAVTALILISVAIRQMNKKK 673

Query: 669 LQKSKAWKLTAFQRLDFKAEDVLESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRG 728
            ++S +WKLTAFQRLDFKAEDVLE L++ENIIGKGGAGIVYRGSMP+ +DVAIKRLVGRG
Sbjct: 674 HERSLSWKLTAFQRLDFKAEDVLECLQEENIIGKGGAGIVYRGSMPNNVDVAIKRLVGRG 733

Query: 729 TGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHL 788
           TG +DHGF AEIQTLGRIRHR+IVRLLGYV+NRDTNLLLYEYMPNGSLGE+LHG+KGGHL
Sbjct: 734 TGRSDHGFTAEIQTLGRIRHRHIVRLLGYVANRDTNLLLYEYMPNGSLGELLHGSKGGHL 793

Query: 789 KWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAG 848
           +WETR+R+A+EAAKGLCYLHHDCSPLI+HRDVKSNNILLDSDFEAHVADFGLAKFL D  
Sbjct: 794 QWETRHRVAVEAAKGLCYLHHDCSPLILHRDVKSNNILLDSDFEAHVADFGLAKFLLDGA 853

Query: 849 ASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRW 908
           ASECMSS+AGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFG+GVDIVRW
Sbjct: 854 ASECMSSIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGEGVDIVRW 913

Query: 909 VRKTTSEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHM 968
           VR T  E+ QPSDAA+V+A+VD RL+GYPLT VIH+FK+AMMCVEDE++ RPTMREVVHM
Sbjct: 914 VRNTEGEIPQPSDAATVVAIVDQRLTGYPLTSVIHVFKIAMMCVEDEATTRPTMREVVHM 973

Query: 969 LANPP 973
           L NPP
Sbjct: 974 LTNPP 978

Source: Brassica napus

Species: Brassica napus

Genus: Brassica

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	982
TAIR|locus:2204350	980	CLV1 "AT1G75820" [Arabidopsis	0.971	0.973	0.663	0.0
UNIPROTKB|Q5Z9N5	994	P0481E08.42 "Os06g0717200 prot	0.964	0.952	0.544	1.8e-270
TAIR|locus:2169965	1003	BAM1 "BARELY ANY MERISTEM 1" [	0.960	0.940	0.530	6.5e-264
TAIR|locus:2097310	1002	BAM2 "BARELY ANY MERISTEM 2" [	0.951	0.932	0.524	1.1e-254
TAIR|locus:2120412	992	BAM3 "BARELY ANY MERISTEM 3" [	0.955	0.945	0.480	8.4e-232
TAIR|locus:2161158	1041	PXY "PHLOEM INTERCALATED WITH	0.670	0.632	0.372	1.1e-181
TAIR|locus:2169975	993	HSL2 "HAESA-like 2" [Arabidops	0.905	0.895	0.366	1.4e-161
TAIR|locus:2032553	996	HSL1 "HAESA-like 1" [Arabidops	0.933	0.920	0.378	4e-154
TAIR|locus:2005540	999	HAE "HAESA" [Arabidopsis thali	0.938	0.922	0.364	2.2e-146
TAIR|locus:2024432	977	LRR XI-23 [Arabidopsis thalian	0.920	0.925	0.363	1.2e-143

TAIR|locus:2204350 CLV1 "AT1G75820" [Arabidopsis thaliana (taxid:3702)]

 Score = 3310 (1170.2 bits), Expect = 0., P = 0.
 Identities = 635/957 (66%), Positives = 754/957 (78%)

Query:    25 AYSDMDVLLKLKSSMIGPKGSGLKNWEPXXXXXXXXXXXGVTCDQDSRVVSLNVSFMPLF 84
             AY+DM+VLL LKSSMIGPKG GL +W             GV+CD D+RV+SLNVSF PLF
Sbjct:    24 AYTDMEVLLNLKSSMIGPKGHGLHDWIHSSSPDAHCSFSGVSCDDDARVISLNVSFTPLF 83

Query:    85 GSIPPEIGLLTKLVNLTISNVNLTGRLPSEMALLTSLKVFNISGNV-FQGNFAGQIVRGM 143
             G+I PEIG+LT LVNLT++  N TG LP EM  LTSLKV NIS N    G F G+I++ M
Sbjct:    84 GTISPEIGMLTHLVNLTLAANNFTGELPLEMKSLTSLKVLNISNNGNLTGTFPGEILKAM 143

Query:   144 TELQVLDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLNGIG 203
              +L+VLD YNNNF G LP E++ LK L++LSFGGN+F+G+IP+SY +IQSLEY+GLNG G
Sbjct:   144 VDLEVLDTYNNNFNGKLPPEMSELKKLKYLSFGGNFFSGEIPESYGDIQSLEYLGLNGAG 203

Query:   204 LNGTVPAFLSRLKNLREMYIGYFNTYTGGIPPGFGALTQLQVLDMASCNISGEIPTXXXX 263
             L+G  PAFLSRLKNLREMYIGY+N+YTGG+PP FG LT+L++LDMASC ++GEIPT    
Sbjct:   204 LSGKSPAFLSRLKNLREMYIGYYNSYTGGVPPEFGGLTKLEILDMASCTLTGEIPTSLSN 263

Query:   264 XXXXXXXXXQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQLFKN 323
                       +N LTGHIPP+LSGL+SLKSLDLS+N LTGEIP+SF  L N+TL+ LF+N
Sbjct:   264 LKHLHTLFLHINNLTGHIPPELSGLVSLKSLDLSINQLTGEIPQSFINLGNITLINLFRN 323

Query:   324 NLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDLCK 383
             NL G IP  +G+ P LEV +VW NNFT +LP NLGRNG L+ LDV+ NHLTG IP+DLC+
Sbjct:   324 NLYGQIPEAIGELPKLEVFEVWENNFTLQLPANLGRNGNLIKLDVSDNHLTGLIPKDLCR 383

Query:   384 GGKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGTIPAGLFXXXXXXXXXXXXX 443
             G KL+ LIL  NFF GPIPEELG+CKSLTKIR  KN LNGT+PAGLF             
Sbjct:   384 GEKLEMLILSNNFFFGPIPEELGKCKSLTKIRIVKNLLNGTVPAGLFNLPLVTIIELTDN 443

Query:   444 XXSGELPEKMSGASLNQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESFNL 503
               SGELP  MSG  L+Q+ ++NN  +G+IP AIGN P+L  L L  NR  G IP E F L
Sbjct:   444 FFSGELPVTMSGDVLDQIYLSNNWFSGEIPPAIGNFPNLQTLFLDRNRFRGNIPREIFEL 503

Query:   504 KMITXXXXXXXXXXGEIPYSISQCHSLTSVDLSRNSLYGKIPPGISKLIDLSILNLSRNG 563
             K ++          G IP SIS+C +L SVDLSRN + G+IP GI+ + +L  LN+S N 
Sbjct:   504 KHLSRINTSANNITGGIPDSISRCSTLISVDLSRNRINGEIPKGINNVKNLGTLNISGNQ 563

Query:   564 ITGSIPNEMRNMMSLTTLDLSYNNLIGNIPSGGQFLAFNETSFIGNPNLCLLRNGTCQSL 623
             +TGSIP  + NM SLTTLDLS+N+L G +P GGQFL FNETSF GN  LCL    +C + 
Sbjct:   564 LTGSIPTGIGNMTSLTTLDLSFNDLSGRVPLGGQFLVFNETSFAGNTYLCLPHRVSCPT- 622

Query:   624 INSAKHSGDGYGSSFGASKIVITVIALLTFMLLVILTIYQLRKRRLQKSKAWKLTAFQRL 683
                 + S   + + F  S+IVITVIA +T ++L+ + I Q+ K++ QKS AWKLTAFQ+L
Sbjct:   623 -RPGQTSDHNHTALFSPSRIVITVIAAITGLILISVAIRQMNKKKNQKSLAWKLTAFQKL 681

Query:   684 DFKAEDVLESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTL 743
             DFK+EDVLE LK+ENIIGKGGAGIVYRGSMP+ +DVAIKRLVGRGTG +DHGF AEIQTL
Sbjct:   682 DFKSEDVLECLKEENIIGKGGAGIVYRGSMPNNVDVAIKRLVGRGTGRSDHGFTAEIQTL 741

Query:   744 GRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKG 803
             GRIRHR+IVRLLGYV+N+DTNLLLYEYMPNGSLGE+LHG+KGGHL+WETR+R+A+EAAKG
Sbjct:   742 GRIRHRHIVRLLGYVANKDTNLLLYEYMPNGSLGELLHGSKGGHLQWETRHRVAVEAAKG 801

Query:   804 LCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYI 863
             LCYLHHDCSPLI+HRDVKSNNILLDSDFEAHVADFGLAKFL D  ASECMSS+AGSYGYI
Sbjct:   802 LCYLHHDCSPLILHRDVKSNNILLDSDFEAHVADFGLAKFLVDGAASECMSSIAGSYGYI 861

Query:   864 APEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAA 923
             APEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFG+GVDIVRWVR T  E++QPSDAA
Sbjct:   862 APEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGEGVDIVRWVRNTEEEITQPSDAA 921

Query:   924 SVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQSAPSLI 980
              V+A+VDPRL+GYPLT VIH+FK+AMMCVE+E++ARPTMREVVHML NPP+S  +LI
Sbjct:   922 IVVAIVDPRLTGYPLTSVIHVFKIAMMCVEEEAAARPTMREVVHMLTNPPKSVANLI 978

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0005524 "ATP binding" evidence=ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0007172 "signal complex assembly" evidence=IDA

GO:0016021 "integral to membrane" evidence=TAS

GO:0030154 "cell differentiation" evidence=IMP

GO:0005515 "protein binding" evidence=IPI

GO:0033612 "receptor serine/threonine kinase binding" evidence=IPI

GO:0043621 "protein self-association" evidence=IDA

GO:0004702 "receptor signaling protein serine/threonine kinase activity" evidence=ISS

GO:0009934 "regulation of meristem structural organization" evidence=IMP

GO:0016020 "membrane" evidence=ISS

GO:0042802 "identical protein binding" evidence=IPI

UNIPROTKB|Q5Z9N5 P0481E08.42 "Os06g0717200 protein" [Oryza sativa Japonica Group (taxid:39947)]

 Score = 2601 (920.7 bits), Expect = 1.8e-270, P = 1.8e-270
 Identities = 528/969 (54%), Positives = 660/969 (68%)

Query:    28 DMDVLLKLKSSMI-GPKGSG---LKNWEPXXXXXXXXXXXGVTCDQDSRVVSLNVSFMPL 83
             D+  L KLK++++  P  +    L +W+P           GVTCD  SRVV++N++ +PL
Sbjct:    22 DIYALAKLKAALVPSPSATAPPPLADWDPAATSPAHCTFSGVTCDGRSRVVAINLTALPL 81

Query:    84 F-GSIPPEIGLLTKLVNLTISNVNLTGRLPSEMALLTSLKVFNISGNVFQGNF-----AG 137
               G +PPEI LL  L NLTI+   L G +P E+  L SL+  N+S N   G+F      G
Sbjct:    82 HSGYLPPEIALLDSLANLTIAACCLPGHVPLELPTLPSLRHLNLSNNNLSGHFPVPDSGG 141

Query:   138 QIVRGMTELQVLDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYI 197
                     L+++DAYNNN +G LP   AS   LR+L  GGNYFTG IP SY ++ +LEY+
Sbjct:   142 GASPYFPSLELIDAYNNNLSGLLPPFSASHARLRYLHLGGNYFTGAIPDSYGDLAALEYL 201

Query:   198 GLNGIGLNGTVPAFLSRLKNLREMYIGYFNTYTGGIPPGFGALTQLQVLDMASCNISGEI 257
             GLNG  L+G VP  LSRL  LREMYIGY+N Y GG+PP FG L  L  LDM+SCN++G +
Sbjct:   202 GLNGNTLSGHVPVSLSRLTRLREMYIGYYNQYDGGVPPEFGDLGALLRLDMSSCNLTGPV 261

Query:   258 PTXXXXXXXXXXXXXQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTL 317
             P              Q N+L+G IPPQL  L SL SLDLS+N L GEIP S A L NL L
Sbjct:   262 PPELGRLQRLDTLFLQWNRLSGEIPPQLGDLSSLASLDLSVNDLAGEIPPSLANLSNLKL 321

Query:   318 LQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTI 377
             L LF+N+LRG IP F+  F  LEVLQ+W NN T  +P  LG+NG+L  LD+ +NHLTG I
Sbjct:   322 LNLFRNHLRGSIPDFVAGFAQLEVLQLWDNNLTGNIPAGLGKNGRLKTLDLATNHLTGPI 381

Query:   378 PRDLCKGGKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGTIPAGLFXXXXXXX 437
             P DLC G +L+ L+LM+N   GPIP+ LG CK+LT++R +KN+L G +PAGLF       
Sbjct:   382 PADLCAGRRLEMLVLMENGLFGPIPDSLGDCKTLTRVRLAKNFLTGPVPAGLFNLPQANM 441

Query:   438 XXXXXXXXSGELPEKMSGASLNQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIP 497
                     +GELP+ + G  +  L + NN I G+IP AIGNLP+L  LSL++N   G +P
Sbjct:   442 VELTDNLLTGELPDVIGGDKIGMLLLGNNGIGGRIPPAIGNLPALQTLSLESNNFSGALP 501

Query:   498 VESFNLKMITXXXXXXXXXXGEIPYSISQCHSLTSVDLSRNSLYGKIPPGISKLIDLSIL 557
              E  NLK ++          G IP  + +C SL +VDLSRN   G+IP  I+ L  L  L
Sbjct:   502 PEIGNLKNLSRLNVSGNALTGAIPDELIRCASLAAVDLSRNGFSGEIPESITSLKILCTL 561

Query:   558 NLSRNGITGSIPNEMRNMMSLTTLDLSYNNLIGNIPSGGQFLAFNETSFIGNPNLCLLRN 617
             N+SRN +TG +P EM NM SLTTLD+SYN+L G +P  GQFL FNE+SF+GNP LC    
Sbjct:   562 NVSRNRLTGELPPEMSNMTSLTTLDVSYNSLSGPVPMQGQFLVFNESSFVGNPGLC--GG 619

Query:   618 GTCQSLINSAKHSGDGYGSS----FGASKIVITVIALLTFMLLVILTIYQ----LRKRRL 669
                 +   S    G G GS     + + K+++ ++A    + +  L   +     R    
Sbjct:   620 PVADACPPSMAGGGGGAGSQLRLRWDSKKMLVALVAAFAAVAVAFLGARKGCSAWRSAAR 679

Query:   670 QKSKAWKLTAFQRLDFKAEDVLESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGT 729
             ++S AWK+TAFQ+L+F AEDV+E +K++NIIGKGGAGIVY G +  G ++AIKRLVGRG 
Sbjct:   680 RRSGAWKMTAFQKLEFSAEDVVECVKEDNIIGKGGAGIVYHG-VTRGAELAIKRLVGRGG 738

Query:   730 GGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLK 789
             G +D GF AE+ TLGRIRHRNIVRLLG+VSNR+TNLLLYEYMPNGSLGEMLHG KGGHL 
Sbjct:   739 GEHDRGFSAEVTTLGRIRHRNIVRLLGFVSNRETNLLLYEYMPNGSLGEMLHGGKGGHLG 798

Query:   790 WETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGA 849
             WE R R+A EAA GLCYLHHDC+P IIHRDVKSNNILLDS FEAHVADFGLAKFL  A  
Sbjct:   799 WEARARVAAEAACGLCYLHHDCAPRIIHRDVKSNNILLDSAFEAHVADFGLAKFLGGA-T 857

Query:   850 SECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWV 909
             SECMS++AGSYGYIAPEYAYTL+VDEKSDVYSFGVVLLELI G++PVG FGDGVDIV WV
Sbjct:   858 SECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELITGRRPVGGFGDGVDIVHWV 917

Query:   910 RKTTSEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHML 969
             RK T+E+   SD A+VLAV D RL+  P+  +++L+KVAM CVE+ S+ARPTMREVVHML
Sbjct:   918 RKVTAELPDNSDTAAVLAVADRRLTPEPVALMVNLYKVAMACVEEASTARPTMREVVHML 977

Query:   970 ANPPQSAPS 978
             +NP  + P+
Sbjct:   978 SNPNSAQPN 986

GO:0010080 "regulation of floral meristem growth" evidence=IMP

GO:0048833 "specification of floral organ number" evidence=IMP

TAIR|locus:2169965 BAM1 "BARELY ANY MERISTEM 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 2539 (898.8 bits), Expect = 6.5e-264, P = 6.5e-264
 Identities = 509/960 (53%), Positives = 655/960 (68%)

Query:    27 SDMDVLLKLKSSMIGP---KGSGLKNWEPXXXXXXXXXXXGVTCDQDSR-VVSLNVSFMP 82
             S+   LL LK+S+ G    K S L +W+            GVTCD   R V SL++S + 
Sbjct:    24 SEFRALLSLKTSLTGAGDDKNSPLSSWK---VSTSFCTWIGVTCDVSRRHVTSLDLSGLN 80

Query:    83 LFGSIPPEIGLLTKLVNLTISNVNLTGRLPSEMALLTSLKVFNISGNVFQGNFAGQIVRG 142
             L G++ P++  L  L NL+++   ++G +P E++ L+ L+  N+S NVF G+F  +I  G
Sbjct:    81 LSGTLSPDVSHLRLLQNLSLAENLISGPIPPEISSLSGLRHLNLSNNVFNGSFPDEISSG 140

Query:   143 MTELQVLDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLNGI 202
             +  L+VLD YNNN TG LPV + +L  LRHL  GGNYF GKIP SY     +EY+ ++G 
Sbjct:   141 LVNLRVLDVYNNNLTGDLPVSVTNLTQLRHLHLGGNYFAGKIPPSYGSWPVIEYLAVSGN 200

Query:   203 GLNGTVPAFLSRLKNLREMYIGYFNTYTGGIPPGFGALTQLQVLDMASCNISGEIPTXXX 262
              L G +P  +  L  LRE+YIGY+N +  G+PP  G L++L   D A+C ++GEIP    
Sbjct:   201 ELVGKIPPEIGNLTTLRELYIGYYNAFEDGLPPEIGNLSELVRFDGANCGLTGEIPPEIG 260

Query:   263 XXXXXXXXXXQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQLFK 322
                       Q+N  +G +  +L  L SLKS+DLS N  TGEIP SFA LKNLTLL LF+
Sbjct:   261 KLQKLDTLFLQVNVFSGPLTWELGTLSSLKSMDLSNNMFTGEIPASFAELKNLTLLNLFR 320

Query:   323 NNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDLC 382
             N L G IP F+GD P LEVLQ+W NNFT  +P+ LG NGKL ++D++SN LTGT+P ++C
Sbjct:   321 NKLHGEIPEFIGDLPELEVLQLWENNFTGSIPQKLGENGKLNLVDLSSNKLTGTLPPNMC 380

Query:   383 KGGKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGTIPAGLFXXXXXXXXXXXX 442
              G KL++LI + NF  G IP+ LG+C+SLT+IR  +N+LNG+IP GLF            
Sbjct:   381 SGNKLETLITLGNFLFGSIPDSLGKCESLTRIRMGENFLNGSIPKGLFGLPKLTQVELQD 440

Query:   443 XXXSGELPEKMSGASLN--QLKVANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVES 500
                SGELP    G S+N  Q+ ++NN ++G +P AIGN   +  L L  N+ +G IP E 
Sbjct:   441 NYLSGELPVA-GGVSVNLGQISLSNNQLSGPLPPAIGNFTGVQKLLLDGNKFQGPIPSEV 499

Query:   501 FNLKMITXXXXXXXXXXGEIPYSISQCHSLTSVDLSRNSLYGKIPPGISKLIDLSILNLS 560
               L+ ++          G I   IS+C  LT VDLSRN L G+IP  I+ +  L+ LNLS
Sbjct:   500 GKLQQLSKIDFSHNLFSGRIAPEISRCKLLTFVDLSRNELSGEIPNEITAMKILNYLNLS 559

Query:   561 RNGITGSIPNEMRNMMSLTTLDLSYNNLIGNIPSGGQFLAFNETSFIGNPNLCLLRNGTC 620
             RN + GSIP  + +M SLT+LD SYNNL G +P  GQF  FN TSF+GNP+LC    G C
Sbjct:   560 RNHLVGSIPGSISSMQSLTSLDFSYNNLSGLVPGTGQFSYFNYTSFLGNPDLCGPYLGPC 619

Query:   621 QSLINSAKHSGDGYGSSFGASKIVITVIALLTFMLLVILTIYQLRK-RRLQKSKAWKLTA 679
             +  +    H     G    + K+++ +  L+  +   ++ I + R  ++  +S+AW+LTA
Sbjct:   620 KDGVAKGGHQSHSKGPLSASMKLLLVLGLLVCSIAFAVVAIIKARSLKKASESRAWRLTA 679

Query:   680 FQRLDFKAEDVLESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGN-DHGFLA 738
             FQRLDF  +DVL+SLK++NIIGKGGAGIVY+G MP+G  VA+KRL     G + DHGF A
Sbjct:   680 FQRLDFTCDDVLDSLKEDNIIGKGGAGIVYKGVMPNGDLVAVKRLAAMSRGSSHDHGFNA 739

Query:   739 EIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIAL 798
             EIQTLGRIRHR+IVRLLG+ SN +TNLL+YEYMPNGSLGE+LHG KGGHL W+TRY+IAL
Sbjct:   740 EIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAL 799

Query:   799 EAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAG 858
             EAAKGLCYLHHDCSPLI+HRDVKSNNILLDS+FEAHVADFGLAKFLQD+G SECMS++AG
Sbjct:   800 EAAKGLCYLHHDCSPLIVHRDVKSNNILLDSNFEAHVADFGLAKFLQDSGTSECMSAIAG 859

Query:   859 SYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQ 918
             SYGYIAPEYAYTLKVDEKSDVYSFGVVLLEL+ G+KPVGEFGDGVDIV+WVRK T     
Sbjct:   860 SYGYIAPEYAYTLKVDEKSDVYSFGVVLLELVTGRKPVGEFGDGVDIVQWVRKMTD---- 915

Query:   919 PSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQSAPS 978
              S+  SVL V+DPRLS  P+  V H+F VAM+CVE+++  RPTMREVV +L   P+  PS
Sbjct:   916 -SNKDSVLKVLDPRLSSIPIHEVTHVFYVAMLCVEEQAVERPTMREVVQILTEIPKLPPS 974

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010075 "regulation of meristem growth" evidence=IGI;RCA

GO:0048229 "gametophyte development" evidence=IGI

GO:0048437 "floral organ development" evidence=IGI

GO:0010480 "microsporocyte differentiation" evidence=IGI

GO:0048653 "anther development" evidence=IGI;RCA

GO:0009934 "regulation of meristem structural organization" evidence=IGI

GO:0005515 "protein binding" evidence=IPI

GO:0033612 "receptor serine/threonine kinase binding" evidence=IPI

GO:0043621 "protein self-association" evidence=IDA

GO:0000271 "polysaccharide biosynthetic process" evidence=RCA

GO:0007020 "microtubule nucleation" evidence=RCA

GO:0009825 "multidimensional cell growth" evidence=RCA

GO:0009932 "cell tip growth" evidence=RCA

GO:0010817 "regulation of hormone levels" evidence=RCA

GO:0043481 "anthocyanin accumulation in tissues in response to UV light" evidence=RCA

GO:0048767 "root hair elongation" evidence=RCA

GO:0071555 "cell wall organization" evidence=RCA

TAIR|locus:2097310 BAM2 "BARELY ANY MERISTEM 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 2452 (868.2 bits), Expect = 1.1e-254, P = 1.1e-254
 Identities = 501/955 (52%), Positives = 642/955 (67%)

Query:    27 SDMDVLLKLKSSM-IGPKGSGLKNWEPXXXXXXXXXXXGVTCDQDSR-VVSLNVSFMPLF 84
             +++  LL LKSS  I      L +W             GVTCD   R V SL++S + L 
Sbjct:    26 TELHALLSLKSSFTIDEHSPLLTSWN---LSTTFCSWTGVTCDVSLRHVTSLDLSGLNLS 82

Query:    85 GSIPPEIGLLTKLVNLTISNVNLTGRLPSEMALLTSLKVFNISGNVFQGNFAGQIVRGMT 144
             G++  ++  L  L NL+++   ++G +P +++ L  L+  N+S NVF G+F  ++  G+ 
Sbjct:    83 GTLSSDVAHLPLLQNLSLAANQISGPIPPQISNLYELRHLNLSNNVFNGSFPDELSSGLV 142

Query:   145 ELQVLDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLNGIGL 204
              L+VLD YNNN TG LPV + +L  LRHL  GGNYF+GKIP +Y     LEY+ ++G  L
Sbjct:   143 NLRVLDLYNNNLTGDLPVSLTNLTQLRHLHLGGNYFSGKIPATYGTWPVLEYLAVSGNEL 202

Query:   205 NGTVPAFLSRLKNLREMYIGYFNTYTGGIPPGFGALTQLQVLDMASCNISGEIPTXXXXX 264
              G +P  +  L  LRE+YIGY+N +  G+PP  G L++L   D A+C ++GEIP      
Sbjct:   203 TGKIPPEIGNLTTLRELYIGYYNAFENGLPPEIGNLSELVRFDAANCGLTGEIPPEIGKL 262

Query:   265 XXXXXXXXQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQLFKNN 324
                     Q+N  TG I  +L  + SLKS+DLS N  TGEIP SF+ LKNLTLL LF+N 
Sbjct:   263 QKLDTLFLQVNAFTGTITQELGLISSLKSMDLSNNMFTGEIPTSFSQLKNLTLLNLFRNK 322

Query:   325 LRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDLCKG 384
             L G IP F+G+ P LEVLQ+W NNFT  +P+ LG NG+L+ILD++SN LTGT+P ++C G
Sbjct:   323 LYGAIPEFIGEMPELEVLQLWENNFTGSIPQKLGENGRLVILDLSSNKLTGTLPPNMCSG 382

Query:   385 GKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGTIPAGLFXXXXXXXXXXXXXX 444
              +L +LI + NF  G IP+ LG+C+SLT+IR  +N+LNG+IP  LF              
Sbjct:   383 NRLMTLITLGNFLFGSIPDSLGKCESLTRIRMGENFLNGSIPKELFGLPKLSQVELQDNY 442

Query:   445 XSGELPEKMSGAS--LNQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESFN 502
              +GELP    G S  L Q+ ++NN ++G +PAAIGNL  +  L L  N+  G IP E   
Sbjct:   443 LTGELPISGGGVSGDLGQISLSNNQLSGSLPAAIGNLSGVQKLLLDGNKFSGSIPPEIGR 502

Query:   503 LKMITXXXXXXXXXXGEIPYSISQCHSLTSVDLSRNSLYGKIPPGISKLIDLSILNLSRN 562
             L+ ++          G I   IS+C  LT VDLSRN L G IP  ++ +  L+ LNLSRN
Sbjct:   503 LQQLSKLDFSHNLFSGRIAPEISRCKLLTFVDLSRNELSGDIPNELTGMKILNYLNLSRN 562

Query:   563 GITGSIPNEMRNMMSLTTLDLSYNNLIGNIPSGGQFLAFNETSFIGNPNLCLLRNGTCQS 622
              + GSIP  + +M SLT++D SYNNL G +PS GQF  FN TSF+GN +LC    G C  
Sbjct:   563 HLVGSIPVTIASMQSLTSVDFSYNNLSGLVPSTGQFSYFNYTSFVGNSHLCGPYLGPC-- 620

Query:   623 LINSAKHSGDGYGSSFGASKIVITVIALL-TFMLLVILTIYQLRK-RRLQKSKAWKLTAF 680
                  K +   +     A+  ++ V+ LL   M+  I+ I + R  R   ++KAW+LTAF
Sbjct:   621 ----GKGTHQSHVKPLSATTKLLLVLGLLFCSMVFAIVAIIKARSLRNASEAKAWRLTAF 676

Query:   681 QRLDFKAEDVLESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGN-DHGFLAE 739
             QRLDF  +DVL+SLK++NIIGKGGAGIVY+G+MP G  VA+KRL     G + DHGF AE
Sbjct:   677 QRLDFTCDDVLDSLKEDNIIGKGGAGIVYKGTMPKGDLVAVKRLATMSHGSSHDHGFNAE 736

Query:   740 IQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALE 799
             IQTLGRIRHR+IVRLLG+ SN +TNLL+YEYMPNGSLGE+LHG KGGHL W TRY+IALE
Sbjct:   737 IQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWNTRYKIALE 796

Query:   800 AAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGS 859
             AAKGLCYLHHDCSPLI+HRDVKSNNILLDS+FEAHVADFGLAKFLQD+G SECMS++AGS
Sbjct:   797 AAKGLCYLHHDCSPLIVHRDVKSNNILLDSNFEAHVADFGLAKFLQDSGTSECMSAIAGS 856

Query:   860 YGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQP 919
             YGYIAPEYAYTLKVDEKSDVYSFGVVLLELI GKKPVGEFGDGVDIV+WVR  T      
Sbjct:   857 YGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGKKPVGEFGDGVDIVQWVRSMTD----- 911

Query:   920 SDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQ 974
             S+   VL V+D RLS  P+  V H+F VA++CVE+++  RPTMREVV +L   P+
Sbjct:   912 SNKDCVLKVIDLRLSSVPVHEVTHVFYVALLCVEEQAVERPTMREVVQILTEIPK 966

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010075 "regulation of meristem growth" evidence=IGI;RCA

GO:0048229 "gametophyte development" evidence=IGI

GO:0048437 "floral organ development" evidence=IGI

GO:0010480 "microsporocyte differentiation" evidence=IGI

GO:0048653 "anther development" evidence=IGI;RCA

GO:0009934 "regulation of meristem structural organization" evidence=IGI

GO:0005515 "protein binding" evidence=IPI

GO:0033612 "receptor serine/threonine kinase binding" evidence=IPI

GO:0000271 "polysaccharide biosynthetic process" evidence=RCA

GO:0007389 "pattern specification process" evidence=RCA

GO:0008361 "regulation of cell size" evidence=RCA

GO:0009664 "plant-type cell wall organization" evidence=RCA

GO:0009740 "gibberellic acid mediated signaling pathway" evidence=RCA

GO:0009825 "multidimensional cell growth" evidence=RCA

GO:0009832 "plant-type cell wall biogenesis" evidence=RCA

GO:0009926 "auxin polar transport" evidence=RCA

GO:0009932 "cell tip growth" evidence=RCA

GO:0010015 "root morphogenesis" evidence=RCA

GO:0010162 "seed dormancy process" evidence=RCA

GO:0010817 "regulation of hormone levels" evidence=RCA

GO:0040007 "growth" evidence=RCA

GO:0043481 "anthocyanin accumulation in tissues in response to UV light" evidence=RCA

GO:0048767 "root hair elongation" evidence=RCA

GO:0071555 "cell wall organization" evidence=RCA

TAIR|locus:2120412 BAM3 "BARELY ANY MERISTEM 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 2236 (792.2 bits), Expect = 8.4e-232, P = 8.4e-232
 Identities = 461/960 (48%), Positives = 618/960 (64%)

Query:    30 DVLLKLKSSMIGPKGSGLKNWEPXXXXXXXXXXXGVTCDQ-DSRVVSLNVSFMPLFGSIP 88
             +VL+ LK S      S L +W             GV+CD  +  +  L++S + + G+I 
Sbjct:    36 NVLISLKQSFDSYDPS-LDSWN-IPNFNSLCSWTGVSCDNLNQSITRLDLSNLNISGTIS 93

Query:    89 PEIGLLT-KLVNLTISNVNLTGRLPSEMALLTSLKVFNISGNVFQGNFAGQIVRGMTELQ 147
             PEI  L+  LV L IS+ + +G LP E+  L+ L+V NIS NVF+G    +    MT+L 
Sbjct:    94 PEISRLSPSLVFLDISSNSFSGELPKEIYELSGLEVLNISSNVFEGELETRGFSQMTQLV 153

Query:   148 VLDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLNGIGLNGT 207
              LDAY+N+F G LP+ + +L  L HL  GGNYF G+IP+SY    SL+++ L+G  L G 
Sbjct:   154 TLDAYDNSFNGSLPLSLTTLTRLEHLDLGGNYFDGEIPRSYGSFLSLKFLSLSGNDLRGR 213

Query:   208 VPAFLSRLKNLREMYIGYFNTYTGGIPPGFGALTQLQVLDMASCNISGEIPTXXXXXXXX 267
             +P  L+ +  L ++Y+GY+N Y GGIP  FG L  L  LD+A+C++ G IP         
Sbjct:   214 IPNELANITTLVQLYLGYYNDYRGGIPADFGRLINLVHLDLANCSLKGSIPAELGNLKNL 273

Query:   268 XXXXXQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQLFKNNLRG 327
                  Q N+LTG +P +L  + SLK+LDLS N+L GEIP   + L+ L L  LF N L G
Sbjct:   274 EVLFLQTNELTGSVPRELGNMTSLKTLDLSNNFLEGEIPLELSGLQKLQLFNLFFNRLHG 333

Query:   328 PIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDLCKGGKL 387
              IP F+ + P+L++L++W NNFT ++P  LG NG L+ +D+++N LTG IP  LC G +L
Sbjct:   334 EIPEFVSELPDLQILKLWHNNFTGKIPSKLGSNGNLIEIDLSTNKLTGLIPESLCFGRRL 393

Query:   388 KSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGTIPAGLFXXXXXXXXXXXXXXXSG 447
             K LIL  NF  GP+PE+LGQC+ L + R  +N+L   +P GL                +G
Sbjct:   394 KILILFNNFLFGPLPEDLGQCEPLWRFRLGQNFLTSKLPKGLIYLPNLSLLELQNNFLTG 453

Query:   448 ELPEKMSG----ASLNQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESFNL 503
             E+PE+ +G    +SL Q+ ++NN ++G IP +I NL SL IL L  NRL G+IP E  +L
Sbjct:   454 EIPEEEAGNAQFSSLTQINLSNNRLSGPIPGSIRNLRSLQILLLGANRLSGQIPGEIGSL 513

Query:   504 KMITXXXXXXXXXXGEIPYSISQCHSLTSVDLSRNSLYGKIPPGISKLIDLSILNLSRNG 563
             K +           G+ P     C SLT +DLS N + G+IP  IS++  L+ LN+S N 
Sbjct:   514 KSLLKIDMSRNNFSGKFPPEFGDCMSLTYLDLSHNQISGQIPVQISQIRILNYLNVSWNS 573

Query:   564 ITGSIPNEMRNMMSLTTLDLSYNNLIGNIPSGGQFLAFNETSFIGNPNLCLLRNGTCQSL 623
                S+PNE+  M SLT+ D S+NN  G++P+ GQF  FN TSF+GNP LC   +  C   
Sbjct:   574 FNQSLPNELGYMKSLTSADFSHNNFSGSVPTSGQFSYFNNTSFLGNPFLCGFSSNPCNGS 633

Query:   624 INSAKHS--GDGYGSSFG--ASKIVITV-IALLTFMLL-VILTIYQLRKRRLQKSKAWKL 677
              N ++          S G  ++K  +   + LL F L+ V+L + + R+ R      WKL
Sbjct:   634 QNQSQSQLLNQNNARSRGEISAKFKLFFGLGLLGFFLVFVVLAVVKNRRMRKNNPNLWKL 693

Query:   678 TAFQRLDFKAEDVLESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGN-DHGF 736
               FQ+L F++E +LE +K+ ++IGKGG GIVY+G MP+G +VA+K+L+    G + D+G 
Sbjct:   694 IGFQKLGFRSEHILECVKENHVIGKGGRGIVYKGVMPNGEEVAVKKLLTITKGSSHDNGL 753

Query:   737 LAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRI 796
              AEIQTLGRIRHRNIVRLL + SN+D NLL+YEYMPNGSLGE+LHG  G  LKWETR +I
Sbjct:   754 AAEIQTLGRIRHRNIVRLLAFCSNKDVNLLVYEYMPNGSLGEVLHGKAGVFLKWETRLQI 813

Query:   797 ALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFL-QDAGASECMSS 855
             ALEAAKGLCYLHHDCSPLIIHRDVKSNNILL  +FEAHVADFGLAKF+ QD GASECMSS
Sbjct:   814 ALEAAKGLCYLHHDCSPLIIHRDVKSNNILLGPEFEAHVADFGLAKFMMQDNGASECMSS 873

Query:   856 VAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGD-GVDIVRWVRKTTS 914
             +AGSYGYIAPEYAYTL++DEKSDVYSFGVVLLELI G+KPV  FG+ G+DIV+W     S
Sbjct:   874 IAGSYGYIAPEYAYTLRIDEKSDVYSFGVVLLELITGRKPVDNFGEEGIDIVQW-----S 928

Query:   915 EVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQ 974
             ++    +   V+ ++D RLS  PL   + LF VAM+CV++ S  RPTMREVV M++   Q
Sbjct:   929 KIQTNCNRQGVVKIIDQRLSNIPLAEAMELFFVAMLCVQEHSVERPTMREVVQMISQAKQ 988

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010075 "regulation of meristem growth" evidence=IGI;RCA

GO:0048437 "floral organ development" evidence=IGI

GO:0000271 "polysaccharide biosynthetic process" evidence=RCA

GO:0009825 "multidimensional cell growth" evidence=RCA

GO:0009855 "determination of bilateral symmetry" evidence=RCA

GO:0009932 "cell tip growth" evidence=RCA

GO:0010014 "meristem initiation" evidence=RCA

GO:0010073 "meristem maintenance" evidence=RCA

GO:0010817 "regulation of hormone levels" evidence=RCA

GO:0043481 "anthocyanin accumulation in tissues in response to UV light" evidence=RCA

GO:0048653 "anther development" evidence=RCA

GO:0048767 "root hair elongation" evidence=RCA

GO:0071555 "cell wall organization" evidence=RCA

TAIR|locus:2161158 PXY "PHLOEM INTERCALATED WITH XYLEM" [Arabidopsis thaliana (taxid:3702)]

 Score = 1023 (365.2 bits), Expect = 1.1e-181, Sum P(2) = 1.1e-181
 Identities = 255/685 (37%), Positives = 354/685 (51%)

Query:    32 LLKLKSSMIGPKGSGLKNWE-PXXXXXXXX--XXXGVTCDQ-DSRVVSLNVSFMPLFGSI 87
             LL LK+S+ GP  S  ++W+ P             GV CD   ++V+SL++S   L G I
Sbjct:    39 LLSLKTSLSGPP-SAFQDWKVPVNGQNDAVWCSWSGVVCDNVTAQVISLDLSHRNLSGRI 97

Query:    88 PPEIGLLTKLVNLTISNVNLTGRLPSEMALLTSLKVFNISGNVFQGNFAGQIVRGMTELQ 147
             P +I  L+ L+ L +S  +L G  P+ +  LT L   +IS N F  +F   I + +  L+
Sbjct:    98 PIQIRYLSSLLYLNLSGNSLEGSFPTSIFDLTKLTTLDISRNSFDSSFPPGISK-LKFLK 156

Query:   148 VLDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLNGIGLNGT 207
             V +A++NNF G LP +++ L+ L  L+FGG+YF G+IP +Y  +Q L++I L G  L G 
Sbjct:   157 VFNAFSNNFEGLLPSDVSRLRFLEELNFGGSYFEGEIPAAYGGLQRLKFIHLAGNVLGGK 216

Query:   208 VPAFLSRLKNLREMYIGYFNTYTGGIPPGFGALTQLQVLDMASCNISGEIPTXXXXXXXX 267
             +P  L  L  L+ M IGY N + G IP  F  L+ L+  D+++C++SG +P         
Sbjct:   217 LPPRLGLLTELQHMEIGY-NHFNGNIPSEFALLSNLKYFDVSNCSLSGSLPQELGNLSNL 275

Query:   268 XXXXXQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQLFKNNLRG 327
                    N  TG IP   S L SLK LD S N L+G IP  F+ LKNLT L L  NNL G
Sbjct:   276 ETLFLFQNGFTGEIPESYSNLKSLKLLDFSSNQLSGSIPSGFSTLKNLTWLSLISNNLSG 335

Query:   328 PIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDLCKGGKL 387
              +P  +G+ P L  L +W NNFT  LP  LG NGKL  +DV++N  TGTIP  LC G KL
Sbjct:   336 EVPEGIGELPELTTLFLWNNNFTGVLPHKLGSNGKLETMDVSNNSFTGTIPSSLCHGNKL 395

Query:   388 KSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGTIPAGLFXXXXXXXXXXXXXXXSG 447
               LIL  N F G +P+ L +C+SL + R   N LNGTIP G                 + 
Sbjct:   396 YKLILFSNMFEGELPKSLTRCESLWRFRSQNNRLNGTIPIGFGSLRNLTFVDLSNNRFTD 455

Query:   448 ELPEKMSGASLNQ-LKVANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESFNLKMI 506
             ++P   + A + Q L ++ N    K+P  I   P+L I S   + L GEIP      K  
Sbjct:   456 QIPADFATAPVLQYLNLSTNFFHRKLPENIWKAPNLQIFSASFSNLIGEIP-NYVGCKSF 514

Query:   507 TXXXXXXXXXXGEIPYSISQCHSLTSVDLSRNSLYGKIPPGISKLIDLSILNLSRNGITG 566
                        G IP+ I  C  L  ++LS+N L G IP  IS L  ++ ++LS N +TG
Sbjct:   515 YRIELQGNSLNGTIPWDIGHCEKLLCLNLSQNHLNGIIPWEISTLPSIADVDLSHNLLTG 574

Query:   567 SIPNEMRNMMSLTTLDLSYNNLIGNIPSGGQFLAFNETSFIGNPNLCL-LRNGTCQS-LI 624
             +IP++  +  ++TT ++SYN LIG IPSG  F   N + F  N  LC  L    C S   
Sbjct:   575 TIPSDFGSSKTITTFNVSYNQLIGPIPSGS-FAHLNPSFFSSNEGLCGDLVGKPCNSDRF 633

Query:   625 NSAKHSGDGYGSSFGASKIVITVIALLTFMLLVILTIYQLRKRRLQKSKA---------- 674
             N+     DG+       K    ++ +L   + V   +     R  QKS            
Sbjct:   634 NAGNADIDGHHKEERPKKTAGAIVWILAAAIGVGFFVLVAATRCFQKSYGNRVDGGGRNG 693

Query:   675 -----WKLTAFQRLDFKAEDVLESL 694
                  WKLTAFQRL+F A+DV+E L
Sbjct:   694 GDIGPWKLTAFQRLNFTADDVVECL 718

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010067 "procambium histogenesis" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0010089 "xylem development" evidence=IMP

GO:0010223 "secondary shoot formation" evidence=IMP

GO:0009855 "determination of bilateral symmetry" evidence=RCA

GO:0009887 "organ morphogenesis" evidence=RCA

GO:0009944 "polarity specification of adaxial/abaxial axis" evidence=RCA

GO:0010014 "meristem initiation" evidence=RCA

GO:0010051 "xylem and phloem pattern formation" evidence=RCA

GO:0010073 "meristem maintenance" evidence=RCA

GO:0010075 "regulation of meristem growth" evidence=RCA

GO:0048439 "flower morphogenesis" evidence=RCA

GO:0048519 "negative regulation of biological process" evidence=RCA

TAIR|locus:2169975 HSL2 "HAESA-like 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 1352 (481.0 bits), Expect = 1.4e-161, Sum P(2) = 1.4e-161
 Identities = 341/931 (36%), Positives = 498/931 (53%)

Query:    28 DMDVLLKLKSS-MIGPKGSGLKNWEPXXXXXXXXXXXGVTCD----QDSRVVSLNVSFMP 82
             D ++L ++K + +  P G+ L++W             G+TC         V ++++S   
Sbjct:    27 DAEILSRVKKTRLFDPDGN-LQDWVITGDNRSPCNWTGITCHIRKGSSLAVTTIDLSGYN 85

Query:    83 LFGSIPPEIGLLTKLVNLTISNVNLTGRLPSEMALLTSLKVFNISGNVFQGNFAGQIVRG 142
             + G  P     +  L+N+T+S  NL G + S    L S K+ N+  N  Q NF+G++   
Sbjct:    86 ISGGFPYGFCRIRTLINITLSQNNLNGTIDSAPLSLCS-KLQNLILN--QNNFSGKLPEF 142

Query:   143 MTE---LQVLDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGL 199
               E   L+VL+  +N FTG +P     L +L+ L+  GN  +G +P     +  L  + L
Sbjct:   143 SPEFRKLRVLELESNLFTGEIPQSYGRLTALQVLNLNGNPLSGIVPAFLGYLTELTRLDL 202

Query:   200 NGIGLNGT-VPAFLSRLKNLREMYIGYFNTYTGGIPPGFGALTQLQVLDMASCNISGEIP 258
               I  + + +P+ L  L NL ++ + + N   G IP     L  L+ LD+A  +++GEIP
Sbjct:   203 AYISFDPSPIPSTLGNLSNLTDLRLTHSNL-VGEIPDSIMNLVLLENLDLAMNSLTGEIP 261

Query:   259 TXXXXXXXXXXXXXQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLL 318
                             N+L+G +P  +  L  L++ D+S N LTGE+PE  AAL+ L   
Sbjct:   262 ESIGRLESVYQIELYDNRLSGKLPESIGNLTELRNFDVSQNNLTGELPEKIAALQ-LISF 320

Query:   319 QLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTIP 378
              L  N   G +P  +   PNL   +++ N+FT  LP NLG+  ++   DV++N  +G +P
Sbjct:   321 NLNDNFFTGGLPDVVALNPNLVEFKIFNNSFTGTLPRNLGKFSEISEFDVSTNRFSGELP 380

Query:   379 RDLCKGGKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGTIPAGLFXXXXXXXX 438
               LC   KL+ +I   N   G IPE  G C SL  IR + N L+G +PA  +        
Sbjct:   381 PYLCYRRKLQKIITFSNQLSGEIPESYGDCHSLNYIRMADNKLSGEVPARFWELPLTRLE 440

Query:   439 XXXXXXXSGELPEKMSGAS-LNQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIP 497
                     G +P  +S A  L+QL+++ NN +G IP  + +L  L ++ L  N   G IP
Sbjct:   441 LANNNQLQGSIPPSISKARHLSQLEISANNFSGVIPVKLCDLRDLRVIDLSRNSFLGSIP 500

Query:   498 VESFNLKMITXXXXXXXXXXGEIPYSISQCHSLTSVDLSRNSLYGKIPPGISKLIDLSIL 557
                  LK +           GEIP S+S C  LT ++LS N L G IPP +  L  L+ L
Sbjct:   501 SCINKLKNLERVEMQENMLDGEIPSSVSSCTELTELNLSNNRLRGGIPPELGDLPVLNYL 560

Query:   558 NLSRNGITGSIPNEMRNMMSLTTLDLSYNNLIGNIPSGGQFLAFNETSFIGNPNLCLLRN 617
             +LS N +TG IP E+  +  L   ++S N L G IPSG Q   F   SF+GNPNLC    
Sbjct:   561 DLSNNQLTGEIPAELLRL-KLNQFNVSDNKLYGKIPSGFQQDIFRP-SFLGNPNLCAPNL 618

Query:   618 GTCQSLINSAKHSGDGYGSSFGASKIVITVIALLTFMLLVILTIYQLRKRRLQKSKAWKL 677
                   I   +   +   + +     ++ ++AL   ++ + +    L KR+ +++   K+
Sbjct:   619 DP----IRPCRSKRE---TRYILPISILCIVALTGALVWLFIKTKPLFKRKPKRTN--KI 669

Query:   678 TAFQRLDFKAEDVLESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHG-- 735
             T FQR+ F  ED+   L ++NIIG GG+G+VYR  +  G  +A+K+L G  TG       
Sbjct:   670 TIFQRVGFTEEDIYPQLTEDNIIGSGGSGLVYRVKLKSGQTLAVKKLWGE-TGQKTESES 728

Query:   736 -FLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGH----LKW 790
              F +E++TLGR+RH NIV+LL   +  +   L+YE+M NGSLG++LH  K       L W
Sbjct:   729 VFRSEVETLGRVRHGNIVKLLMCCNGEEFRFLVYEFMENGSLGDVLHSEKEHRAVSPLDW 788

Query:   791 ETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQ---DA 847
              TR+ IA+ AA+GL YLHHD  P I+HRDVKSNNILLD + +  VADFGLAK L+   + 
Sbjct:   789 TTRFSIAVGAAQGLSYLHHDSVPPIVHRDVKSNNILLDHEMKPRVADFGLAKPLKREDND 848

Query:   848 GASEC-MSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPV-GEFGDGVDI 905
             G S+  MS VAGSYGYIAPEY YT KV+EKSDVYSFGVVLLELI GK+P    FG+  DI
Sbjct:   849 GVSDVSMSCVAGSYGYIAPEYGYTSKVNEKSDVYSFGVVLLELITGKRPNDSSFGENKDI 908

Query:   906 VRWVRKTTSEVSQPSDAASVLAVVDPRLSGY 936
             V++  +    +  PS +A   A+    L  Y
Sbjct:   909 VKFAMEAA--LCYPSPSAEDGAMNQDSLGNY 937

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2032553 HSL1 "HAESA-like 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1503 (534.1 bits), Expect = 4.0e-154, P = 4.0e-154
 Identities = 363/960 (37%), Positives = 524/960 (54%)

Query:    31 VLLKLKSSMIGPKGSGLKNWEPXXXXXXXXXXXGVTCDQD-SRVVSLNVSFMPLFGSIPP 89
             +L ++K S+  P  S L +W             GV+C  D S V S+++S   L G  P 
Sbjct:    22 ILQQVKLSLDDPD-SYLSSWN--SNDASPCRWSGVSCAGDFSSVTSVDLSSANLAGPFPS 78

Query:    90 EIGLLTKLVNLTISNVNLTGRLPSEMALLTSLKVFNISGNVFQGNFAGQIVRGMTELQVL 149
              I  L+ L +L++ N ++   LP  +A   SL+  ++S N+  G    Q +  +  L  L
Sbjct:    79 VICRLSNLAHLSLYNNSINSTLPLNIAACKSLQTLDLSQNLLTGELP-QTLADIPTLVHL 137

Query:   150 DAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLNGIGLNGT-V 208
             D   NNF+G +P      ++L  LS   N   G IP     I +L+ + L+    + + +
Sbjct:   138 DLTGNNFSGDIPASFGKFENLEVLSLVYNLLDGTIPPFLGNISTLKMLNLSYNPFSPSRI 197

Query:   209 PAFLSRLKNLREMYIGYFNTYTGGIPPGFGALTQLQVLDMASCNISGEIPTXXXXXXXXX 268
             P     L NL  M++   +   G IP   G L++L  LD+A  ++ G IP          
Sbjct:   198 PPEFGNLTNLEVMWLTECHL-VGQIPDSLGQLSKLVDLDLALNDLVGHIPPSLGGLTNVV 256

Query:   269 XXXXQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQLFKNNLRGP 328
                   N LTG IPP+L  L SL+ LD S+N LTG+IP+    +  L  L L++NNL G 
Sbjct:   257 QIELYNNSLTGEIPPELGNLKSLRLLDASMNQLTGKIPDELCRVP-LESLNLYENNLEGE 315

Query:   329 IPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDLCKGGKLK 388
             +P+ +   PNL  ++++GN  T  LP++LG N  L  LDV+ N  +G +P DLC  G+L+
Sbjct:   316 LPASIALSPNLYEIRIFGNRLTGGLPKDLGLNSPLRWLDVSENEFSGDLPADLCAKGELE 375

Query:   389 SLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGTIPAGLFXXXXXXXXXXXXXXXSGE 448
              L+++ N F G IPE L  C+SLT+IR + N  +G++P G +               SGE
Sbjct:   376 ELLIIHNSFSGVIPESLADCRSLTRIRLAYNRFSGSVPTGFWGLPHVNLLELVNNSFSGE 435

Query:   449 LPEKMSGAS-LNQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESFNLKMIT 507
             + + + GAS L+ L ++NN  TG +P  IG+L +LN LS   N+  G +P    +L  + 
Sbjct:   436 ISKSIGGASNLSLLILSNNEFTGSLPEEIGSLDNLNQLSASGNKFSGSLPDSLMSLGELG 495

Query:   508 XXXXXXXXXXGEIPYSISQCHSLTSVDLSRNSLYGKIPPGISKLIDLSILNLSRNGITGS 567
                       GE+   I     L  ++L+ N   GKIP  I  L  L+ L+LS N  +G 
Sbjct:   496 TLDLHGNQFSGELTSGIKSWKKLNELNLADNEFTGKIPDEIGSLSVLNYLDLSGNMFSGK 555

Query:   568 IPNEMRNMMSLTTLDLSYNNLIGNIPSGGQFLAFN--ETSFIGNPNLCLLRNGTCQSLIN 625
             IP  ++++  L  L+LSYN L G++P     LA +  + SFIGNP LC    G C S  N
Sbjct:   556 IPVSLQSL-KLNQLNLSYNRLSGDLPPS---LAKDMYKNSFIGNPGLCGDIKGLCGSE-N 610

Query:   626 SAKHSGDGYGSSFGASKIVITVIALLTFMLLVILTIYQLRKRRLQKSKAWKLTAFQRLDF 685
              AK  G  +      S  V+  + LL  +          +K R  +   W L +F +L F
Sbjct:   611 EAKKRGYVW---LLRSIFVLAAMVLLAGVAWFYFKYRTFKKARAMERSKWTLMSFHKLGF 667

Query:   686 KAEDVLESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRL-VG--RGTGG----------- 731
                ++LESL ++N+IG G +G VY+  + +G  VA+KRL  G  + TG            
Sbjct:   668 SEHEILESLDEDNVIGAGASGKVYKVVLTNGETVAVKRLWTGSVKETGDCDPEKGYKPGV 727

Query:   732 NDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWE 791
              D  F AE++TLG+IRH+NIV+L    S RD  LL+YEYMPNGSLG++LH +KGG L W+
Sbjct:   728 QDEAFEAEVETLGKIRHKNIVKLWCCCSTRDCKLLVYEYMPNGSLGDLLHSSKGGMLGWQ 787

Query:   792 TRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAG-AS 850
             TR++I L+AA+GL YLHHD  P I+HRD+KSNNIL+D D+ A VADFG+AK +   G A 
Sbjct:   788 TRFKIILDAAEGLSYLHHDSVPPIVHRDIKSNNILIDGDYGARVADFGVAKAVDLTGKAP 847

Query:   851 ECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVG-EFGDGVDIVRWV 909
             + MS +AGS GYIAPEYAYTL+V+EKSD+YSFGVV+LE++  K+PV  E G+  D+V+WV
Sbjct:   848 KSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILEIVTRKRPVDPELGEK-DLVKWV 906

Query:   910 RKTTSEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHML 969
               T        D   +  V+DP+L       +  +  V ++C       RP+MR VV ML
Sbjct:   907 CSTL-------DQKGIEHVIDPKLDSCFKEEISKILNVGLLCTSPLPINRPSMRRVVKML 959

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0000271 "polysaccharide biosynthetic process" evidence=RCA

GO:0007020 "microtubule nucleation" evidence=RCA

GO:0007389 "pattern specification process" evidence=RCA

GO:0008361 "regulation of cell size" evidence=RCA

GO:0009664 "plant-type cell wall organization" evidence=RCA

GO:0009825 "multidimensional cell growth" evidence=RCA

GO:0009832 "plant-type cell wall biogenesis" evidence=RCA

GO:0009926 "auxin polar transport" evidence=RCA

GO:0009932 "cell tip growth" evidence=RCA

GO:0010015 "root morphogenesis" evidence=RCA

GO:0010075 "regulation of meristem growth" evidence=RCA

GO:0010817 "regulation of hormone levels" evidence=RCA

GO:0040007 "growth" evidence=RCA

GO:0043481 "anthocyanin accumulation in tissues in response to UV light" evidence=RCA

GO:0048653 "anther development" evidence=RCA

GO:0048767 "root hair elongation" evidence=RCA

GO:0071555 "cell wall organization" evidence=RCA

TAIR|locus:2005540 HAE "HAESA" [Arabidopsis thaliana (taxid:3702)]

 Score = 1430 (508.4 bits), Expect = 2.2e-146, P = 2.2e-146
 Identities = 356/977 (36%), Positives = 526/977 (53%)

Query:    28 DMDVLLKLKSSMIGPKGSGLKNWEPXXXXXXXXXXXGVTCDQDSRVVSLNVSFMPLFGSI 87
             D  +L + K  +  P  S L +W             GV+CD  S VVS+++S   L G  
Sbjct:    24 DATILRQAKLGLSDPAQS-LSSWSDNNDVTPCKWL-GVSCDATSNVVSVDLSSFMLVGPF 81

Query:    88 PPEIGLLTKLVNLTISNVNLTGRLPSE-MALLTSLKVFNISGNVFQGNFAGQIVRGMTEL 146
             P  +  L  L +L++ N ++ G L ++      +L   ++S N+  G+    +   +  L
Sbjct:    82 PSILCHLPSLHSLSLYNNSINGSLSADDFDTCHNLISLDLSENLLVGSIPKSLPFNLPNL 141

Query:   147 QVLDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLN-GIGLN 205
             + L+   NN +  +P      + L  L+  GN+ +G IP S   + +L+ + L   +   
Sbjct:   142 KFLEISGNNLSDTIPSSFGEFRKLESLNLAGNFLSGTIPASLGNVTTLKELKLAYNLFSP 201

Query:   206 GTVPAFLSRLKNLREMYIGYFNTYTGGIPPGFGALTQLQVLDMASCNISGEIPTXXXXXX 265
               +P+ L  L  L+ +++   N   G IPP    LT L  LD+    ++G IP+      
Sbjct:   202 SQIPSQLGNLTELQVLWLAGCNL-VGPIPPSLSRLTSLVNLDLTFNQLTGSIPSWITQLK 260

Query:   266 XXXXXXXQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQLFKNNL 325
                      N  +G +P  +  + +LK  D S+N LTG+IP++   L NL  L LF+N L
Sbjct:   261 TVEQIELFNNSFSGELPESMGNMTTLKRFDASMNKLTGKIPDNLNLL-NLESLNLFENML 319

Query:   326 RGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDLCKGG 385
              GP+P  +     L  L+++ N  T  LP  LG N  L  +D++ N  +G IP ++C  G
Sbjct:   320 EGPLPESITRSKTLSELKLFNNRLTGVLPSQLGANSPLQYVDLSYNRFSGEIPANVCGEG 379

Query:   386 KLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGTIPAGLFXXXXXXXXXXXXXXX 445
             KL+ LIL+ N F G I   LG+CKSLT++R S N L+G IP G +               
Sbjct:   380 KLEYLILIDNSFSGEISNNLGKCKSLTRVRLSNNKLSGQIPHGFWGLPRLSLLELSDNSF 439

Query:   446 SGELPEKMSGA-SLNQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESFNLK 504
             +G +P+ + GA +L+ L+++ N  +G IP  IG+L  +  +S   N   GEIP     LK
Sbjct:   440 TGSIPKTIIGAKNLSNLRISKNRFSGSIPNEIGSLNGIIEISGAENDFSGEIPESLVKLK 499

Query:   505 MITXXXXXXXXXXGEIPYSISQCHSLTSVDLSRNSLYGKIPPGISKLIDLSILNLSRNGI 564
              ++          GEIP  +    +L  ++L+ N L G+IP  +  L  L+ L+LS N  
Sbjct:   500 QLSRLDLSKNQLSGEIPRELRGWKNLNELNLANNHLSGEIPKEVGILPVLNYLDLSSNQF 559

Query:   565 TGSIPNEMRNMMSLTTLDLSYNNLIGNIPS--GGQFLAFNETSFIGNPNLCLLRNGTCQS 622
             +G IP E++N+  L  L+LSYN+L G IP     +  A +   FIGNP LC+  +G C+ 
Sbjct:   560 SGEIPLELQNL-KLNVLNLSYNHLSGKIPPLYANKIYAHD---FIGNPGLCVDLDGLCRK 615

Query:   623 LINSAKHSGDGYGSSFGASKIVITVIAL--LTFMLLVILTIYQLRKRRLQKSK---AWKL 677
             +  S          + G   I++T+  L  L F++ +++ I + RK R  KS    A K 
Sbjct:   616 ITRS---------KNIGYVWILLTIFLLAGLVFVVGIVMFIAKCRKLRALKSSTLAASKW 666

Query:   678 TAFQRLDFKAEDVLESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHG-- 735
              +F +L F   ++ + L ++N+IG G +G VY+  +  G  VA+K+L     GG+D    
Sbjct:   667 RSFHKLHFSEHEIADCLDEKNVIGFGSSGKVYKVELRGGEVVAVKKLNKSVKGGDDEYSS 726

Query:   736 -------FLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHG-AKGGH 787
                    F AE++TLG IRH++IVRL    S+ D  LL+YEYMPNGSL ++LHG  KGG 
Sbjct:   727 DSLNRDVFAAEVETLGTIRHKSIVRLWCCCSSGDCKLLVYEYMPNGSLADVLHGDRKGGV 786

Query:   788 -LKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQD 846
              L W  R RIAL+AA+GL YLHHDC P I+HRDVKS+NILLDSD+ A VADFG+AK  Q 
Sbjct:   787 VLGWPERLRIALDAAEGLSYLHHDCVPPIVHRDVKSSNILLDSDYGAKVADFGIAKVGQM 846

Query:   847 AGAS--ECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPV-GEFGDGV 903
             +G+   E MS +AGS GYIAPEY YTL+V+EKSD+YSFGVVLLEL+ GK+P   E GD  
Sbjct:   847 SGSKTPEAMSGIAGSCGYIAPEYVYTLRVNEKSDIYSFGVVLLELVTGKQPTDSELGDK- 905

Query:   904 DIVRWVRKTTSEVSQPSDAASVLAVVDPRLS---GYPLTGVIHLFKVAMMCVEDESSARP 960
             D+ +WV   T+      D   +  V+DP+L       ++ VIH   + ++C       RP
Sbjct:   906 DMAKWV--CTA-----LDKCGLEPVIDPKLDLKFKEEISKVIH---IGLLCTSPLPLNRP 955

Query:   961 TMREVVHMLANPPQSAP 977
             +MR+VV ML     + P
Sbjct:   956 SMRKVVIMLQEVSGAVP 972

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0009617 "response to bacterium" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0045087 "innate immune response" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

TAIR|locus:2024432 LRR XI-23 [Arabidopsis thaliana (taxid:3702)]

 Score = 1404 (499.3 bits), Expect = 1.2e-143, P = 1.2e-143
 Identities = 349/961 (36%), Positives = 505/961 (52%)

Query:    28 DMDVLLKLKSSMIGPKGSGLKNWEPXXXXXXXXXXXGVTCDQDSRVVSLNVSFMPLFGSI 87
             D+ VLLKLKSS      +   +W+            GVTC+    V  +++S   L G+ 
Sbjct:    30 DLQVLLKLKSSFADSNLAVFDSWK-LNSGIGPCSFIGVTCNSRGNVTEIDLSRRGLSGNF 88

Query:    88 P-PEIGLLTKLVNLTISNVNLTGRLPSEMALLTSLKVFNISGNVFQGNFAGQIVRGMTEL 146
             P   +  +  L  L++   +L+G +PS++   TSLK  ++  N+F G F       + +L
Sbjct:    89 PFDSVCEIQSLEKLSLGFNSLSGIIPSDLKNCTSLKYLDLGNNLFSGAFPE--FSSLNQL 146

Query:   147 QVLDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLNGIGLNG 206
             Q L   N+ F+G  P      KSLR+        T  +  S         +G N      
Sbjct:   147 QFLYLNNSAFSGVFP-----WKSLRNA-------TSLVVLS---------LGDNPFDATA 185

Query:   207 TVPAFLSRLKNLREMYIGYFNTYTGGIPPGFGALTQLQVLDMASCNISGEIPTXXXXXXX 266
               P  +  LK L  +Y+   +   G IPP  G LT+L+ L+++   ++GEIP+       
Sbjct:   186 DFPVEVVSLKKLSWLYLSNCSI-AGKIPPAIGDLTELRNLEISDSGLTGEIPSEISKLTN 244

Query:   267 XXXXXXQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQLFKNNLR 326
                     N LTG +P     L +L  LD S N L G++ E   +L NL  LQ+F+N   
Sbjct:   245 LWQLELYNNSLTGKLPTGFGNLKNLTYLDASTNLLQGDLSE-LRSLTNLVSLQMFENEFS 303

Query:   327 GPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDLCKGGK 386
             G IP   G+F +L  L ++ N  T  LP+ LG       +D + N LTG IP D+CK GK
Sbjct:   304 GEIPLEFGEFKDLVNLSLYTNKLTGSLPQGLGSLADFDFIDASENLLTGPIPPDMCKNGK 363

Query:   387 LKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGTIPAGLFXXXXXXXXXXXXXXXS 446
             +K+L+L+QN   G IPE    C +L + R S+N LNGT+PAGL+                
Sbjct:   364 MKALLLLQNNLTGSIPESYANCLTLQRFRVSENNLNGTVPAGLWGLPKLEIIDIEMNNFE 423

Query:   447 GELPEKM-SGASLNQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESFNLKM 505
             G +   + +G  L  L +  N ++ ++P  IG+  SL  + L NNR  G+IP     LK 
Sbjct:   424 GPITADIKNGKMLGALYLGFNKLSDELPEEIGDTESLTKVELNNNRFTGKIPSSIGKLKG 483

Query:   506 ITXXXXXXXXXXGEIPYSISQCHSLTSVDLSRNSLYGKIPPGISKLIDLSILNLSRNGIT 565
             ++          GEIP SI  C  L+ V++++NS+ G+IP  +  L  L+ LNLS N ++
Sbjct:   484 LSSLKMQSNGFSGEIPDSIGSCSMLSDVNMAQNSISGEIPHTLGSLPTLNALNLSDNKLS 543

Query:   566 GSIPNEMRNMMSLTTLDLSYNNLIGNIPSGGQFLAFNETSFIGNPNLCLLRNGTCQSLIN 625
             G IP  + ++  L+ LDLS N L G IP     L+    SF GNP LC     +    IN
Sbjct:   544 GRIPESLSSLR-LSLLDLSNNRLSGRIPLS---LSSYNGSFNGNPGLCSTTIKSFNRCIN 599

Query:   626 SAKHSGDGYGSSFGASKIVITVIALLTFMLLVILTIYQLRKRRLQKSKAWKLTAFQRLDF 685
              ++  GD           ++ ++A L F L +  T  + ++ R  K ++W + +F+++ F
Sbjct:   600 PSRSHGDTRVFVLCIVFGLLILLASLVFFLYLKKT--EKKEGRSLKHESWSIKSFRKMSF 657

Query:   686 KAEDVLESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTG--------------G 731
               +D+++S+K+EN+IG+GG G VYR  + DG +VA+K +    T               G
Sbjct:   658 TEDDIIDSIKEENLIGRGGCGDVYRVVLGDGKEVAVKHIRCSSTQKNFSSAMPILTEREG 717

Query:   732 NDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWE 791
                 F  E+QTL  IRH N+V+L   +++ D++LL+YEY+PNGSL +MLH  K  +L WE
Sbjct:   718 RSKEFETEVQTLSSIRHLNVVKLYCSITSDDSSLLVYEYLPNGSLWDMLHSCKKSNLGWE 777

Query:   792 TRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDA-GAS 850
             TRY IAL AAKGL YLHH     +IHRDVKS+NILLD   +  +ADFGLAK LQ + G  
Sbjct:   778 TRYDIALGAAKGLEYLHHGYERPVIHRDVKSSNILLDEFLKPRIADFGLAKILQASNGGP 837

Query:   851 ECMSSVAGSYGYIAP-EYAYTLKVDEKSDVYSFGVVLLELIAGKKPV-GEFGDGVDIVRW 908
             E    VAG+YGYIAP EY Y  KV EK DVYSFGVVL+EL+ GKKP+  EFG+  DIV W
Sbjct:   838 ESTHVVAGTYGYIAPAEYGYASKVTEKCDVYSFGVVLMELVTGKKPIEAEFGESKDIVNW 897

Query:   909 VRKTTSEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHM 968
             V              SV+ +VD ++        + + ++A++C       RPTMR VV M
Sbjct:   898 VSNNLKSKE------SVMEIVDKKIGEMYREDAVKMLRIAIICTARLPGLRPTMRSVVQM 951

Query:   969 L 969
             +
Sbjct:   952 I 952

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0046777 "protein autophosphorylation" evidence=RCA;IDA

GO:0006979 "response to oxidative stress" evidence=IMP

GO:0009845 "seed germination" evidence=IMP

GO:0070825 "micropyle" evidence=IDA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0006499 "N-terminal protein myristoylation" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0006944 "cellular membrane fusion" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0009627 "systemic acquired resistance" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0031347 "regulation of defense response" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q9SYQ8	CLV1_ARATH	2, ., 7, ., 1, 1, ., 1	0.6976	0.9735	0.9755	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.991
3rd Layer	2.7.11	0.976

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	982
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-174
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	2e-45
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	2e-43
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	3e-42
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	1e-41
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	2e-41
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	5e-41
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	3e-40
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	9e-39
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	2e-35
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	2e-30
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	1e-29
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	3e-29
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	1e-26
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	5e-26
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	6e-26
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	8e-26
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	2e-25
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	5e-25
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	9e-25
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	2e-24
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	3e-24
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	1e-23
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	2e-23
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	3e-23
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	3e-23
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	3e-23
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	4e-23
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	5e-23
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	7e-23
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	8e-23
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	1e-22
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	2e-22
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	3e-22
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	3e-22
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	3e-22
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	3e-22
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	6e-22
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	3e-21
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	3e-21
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	4e-21
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	4e-21
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	8e-21
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	8e-21
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	1e-20
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	2e-20
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	3e-20
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	1e-19
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	2e-19
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	2e-19
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	4e-19
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	6e-19
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	6e-19
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	7e-19
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	7e-19
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	8e-19
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	8e-19
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	1e-18
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	2e-18
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	3e-18
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	4e-18
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	5e-18
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	6e-18
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	7e-18
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	1e-17
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	2e-17
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	4e-17
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	5e-17
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	5e-17
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	8e-17
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	8e-17
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	9e-17
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	9e-17
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	1e-16
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	1e-16
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	2e-16
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	2e-16
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	3e-16
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	3e-16
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	3e-16
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	3e-16
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	4e-16
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	4e-16
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	6e-16
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	6e-16
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	1e-15
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	1e-15
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	1e-15
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	2e-15
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	2e-15
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	2e-15
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	2e-15
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	2e-15
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	2e-15
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	3e-15
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	3e-15
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	5e-15
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	5e-15
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	1e-14
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	1e-14
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	1e-14
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	1e-14
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	1e-14
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	1e-14
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	1e-14
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	1e-14
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	2e-14
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	2e-14
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	2e-14
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	2e-14
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	2e-14
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	2e-14
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	3e-14
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	3e-14
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	4e-14
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	5e-14
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	5e-14
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	5e-14
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	5e-14
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	8e-14
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	1e-13
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	1e-13
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	2e-13
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	2e-13
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	2e-13
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	2e-13
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	2e-13
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	3e-13
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	3e-13
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	3e-13
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	3e-13
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	3e-13
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	4e-13
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	5e-13
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	5e-13
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	6e-13
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	6e-13
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	6e-13
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	6e-13
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	7e-13
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	9e-13
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	1e-12
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	1e-12
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	1e-12
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	1e-12
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	2e-12
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	2e-12
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	2e-12
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	2e-12
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	3e-12
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	3e-12
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	3e-12
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	3e-12
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	4e-12
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	4e-12
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	5e-12
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	5e-12
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	5e-12
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	5e-12
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	6e-12
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	6e-12
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	6e-12
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	7e-12
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	8e-12
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	8e-12
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	9e-12
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	9e-12
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	1e-11
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	1e-11
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	1e-11
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	1e-11
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	2e-11
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	2e-11
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	2e-11
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	2e-11
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	2e-11
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	3e-11
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	3e-11
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	3e-11
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	3e-11
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	3e-11
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	3e-11
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	4e-11
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	4e-11
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	4e-11
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	4e-11
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	5e-11
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	5e-11
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	5e-11
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	5e-11
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	5e-11
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	6e-11
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	6e-11
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	6e-11
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	6e-11
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	7e-11
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	7e-11
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	8e-11
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	8e-11
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	9e-11
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	9e-11
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	9e-11
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	1e-10
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	1e-10
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	2e-10
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	2e-10
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	2e-10
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	3e-10
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	3e-10
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	3e-10
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	4e-10
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	5e-10
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	5e-10
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	6e-10
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	6e-10
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	6e-10
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	9e-10
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-09
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	1e-09
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	1e-09
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	1e-09
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	1e-09
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	2e-09
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	2e-09
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	2e-09
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	2e-09
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	2e-09
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	2e-09
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	2e-09
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	2e-09
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	3e-09
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	3e-09
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	3e-09
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	4e-09
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	4e-09
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	5e-09
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	5e-09
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	5e-09
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	6e-09
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	6e-09
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	7e-09
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	7e-09
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	9e-09
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	1e-08
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	1e-08
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	1e-08
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	2e-08
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	2e-08
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	2e-08
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	2e-08
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	2e-08
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	2e-08
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	2e-08
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	2e-08
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	2e-08
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	2e-08
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	2e-08
pfam08263	42	pfam08263, LRRNT_2, Leucine rich repeat N-terminal	2e-08
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	3e-08
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	3e-08
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	3e-08
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	3e-08
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	4e-08
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	4e-08
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	4e-08
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	5e-08
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	5e-08
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	5e-08
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	6e-08
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	8e-08
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	8e-08
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	1e-07
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	1e-07
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	1e-07
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	2e-07
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	2e-07
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	2e-07
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	3e-07
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	3e-07
cd00116	319	cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo	5e-07
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	5e-07
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	7e-07
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	8e-07
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	8e-07
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	8e-07
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	9e-07
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	9e-07
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-06
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	1e-06
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	2e-06
cd00116	319	cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo	3e-06
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	3e-06
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	3e-06
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	4e-06
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	5e-06
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	5e-06
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	5e-06
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	5e-06
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	7e-06
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	8e-06
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	8e-06
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	9e-06
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-05
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	1e-05
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	1e-05
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	1e-05
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	2e-05
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	2e-05
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	2e-05
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	2e-05
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	2e-05
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	2e-05
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	3e-05
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	4e-05
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	6e-05
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	7e-05
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	9e-05
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	9e-05
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	1e-04
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	1e-04
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	1e-04
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	2e-04
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	4e-04
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	0.001
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	0.002
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	0.002
smart00750	176	smart00750, KIND, kinase non-catalytic C-lobe doma	0.002
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	0.002
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	0.003
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	0.004

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  531 bits (1370), Expect = e-174
 Identities = 348/1017 (34%), Positives = 521/1017 (51%), Gaps = 110/1017 (10%)

Query: 9   PHLYISLFLLLFSLSCAYSD-MDVLLKLKSSMIGPKGSGLKNWEPSSSPSAHCSFSGVTC 67
           P+L   LF L  + S  +++ +++LL  KSS+  P    L NW  S+     C + G+TC
Sbjct: 10  PYLIFMLFFLFLNFSMLHAEELELLLSFKSSINDPLKY-LSNWNSSAD---VCLWQGITC 65

Query: 68  DQDSRVVSLNVSFMPLFGSIPPEIGLLTKLVNLTISNVNLTGRLPSEMALLT-SLKVFNI 126
           +  SRVVS+++S   + G I   I  L  +  + +SN  L+G +P ++   + SL+  N+
Sbjct: 66  NNSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNL 125

Query: 127 SGNVFQGNFAGQIVRG-MTELQVLDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIP 185
           S N    NF G I RG +  L+ LD  NN  +G +P +I S  SL+ L  GGN   GKIP
Sbjct: 126 SNN----NFTGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIP 181

Query: 186 QSYSEIQSLEYIGLNGIGLNGTVPAFLSRLKNLREMYIGYFNTYTGGIPPGFGALTQLQV 245
            S + + SLE++ L    L G +P  L ++K+L+ +Y+GY N  +G IP   G LT L  
Sbjct: 182 NSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGY-NNLSGEIPYEIGGLTSLNH 240

Query: 246 LDMASCNISGEIPTSLSRLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEI 305
           LD+   N++G IP+SL  LK L  LFL  NKL+G IPP +  L  L SLDLS N L+GEI
Sbjct: 241 LDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEI 300

Query: 306 PESFAALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLI 365
           PE    L+NL +L LF NN  G IP  L   P L+VLQ+W N F+ E+P+NLG++  L +
Sbjct: 301 PELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTV 360

Query: 366 LDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGTI 425
           LD+++N+LTG IP  LC  G L  LIL  N   G IP+ LG C+SL ++R   N  +G +
Sbjct: 361 LDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGEL 420

Query: 426 PAGLFNLPL------------------------LNMMELDDNLLSGELPEKMSGASLNQL 461
           P+    LPL                        L M+ L  N   G LP+      L  L
Sbjct: 421 PSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENL 480

Query: 462 KVANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIP 521
            ++ N  +G +P  +G+L  L  L L  N+L GEIP E  + K + S+++S N +SG+IP
Sbjct: 481 DLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIP 540

Query: 522 YSISQCHSLTSVDLSRNSLYGKIPPGISKLIDLSILNLSRNGITGSIPNEMRNMMSLTTL 581
            S S+   L+ +DLS+N L G+IP            NL              N+ SL  +
Sbjct: 541 ASFSEMPVLSQLDLSQNQLSGEIPK-----------NLG-------------NVESLVQV 576

Query: 582 DLSYNNLIGNIPSGGQFLAFNETSFIGNPNLCLLRNGTCQSLINSAKHSGDGYGSSFGAS 641
           ++S+N+L G++PS G FLA N ++  GN +LC    G   S +   K         F   
Sbjct: 577 NISHNHLHGSLPSTGAFLAINASAVAGNIDLC---GGDTTSGLPPCKRVRKTPSWWF--- 630

Query: 642 KIVITVIALLTFMLLVILTIYQLRKRRLQKSKA------WKLTAFQR---LDFKAEDVLE 692
            I  T+ A L   L+    ++   +  L+  +       W+L  F           D+L 
Sbjct: 631 YITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITINDILS 690

Query: 693 SLKDENIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHGFL--AEIQTLGRIRHR 749
           SLK+EN+I +G  G  Y+G S+ +G+   +K +       ND   +  +EI  +G+++H 
Sbjct: 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEI-------NDVNSIPSSEIADMGKLQHP 743

Query: 750 NIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHH 809
           NIV+L+G   +     L++EY+   +L E+L       L WE R +IA+  AK L +LH 
Sbjct: 744 NIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN-----LSWERRRKIAIGIAKALRFLHC 798

Query: 810 DCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAG-SYGYIAPEYA 868
            CSP ++  ++    I++D   E H+    L   L       C  +    S  Y+APE  
Sbjct: 799 RCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLL-------CTDTKCFISSAYVAPETR 850

Query: 869 YTLKVDEKSDVYSFGVVLLELIAGKKPV-GEFGDGVDIVRWVRKTTSEVSQPSDAASVLA 927
            T  + EKSD+Y FG++L+EL+ GK P   EFG    IV W R   S+         +  
Sbjct: 851 ETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSD-------CHLDM 903

Query: 928 VVDPRLSGYPLTG---VIHLFKVAMMCVEDESSARPTMREVVHMLANPPQSAPSLIT 981
            +DP + G        ++ +  +A+ C   + +ARP   +V+  L +  +S+ S +T
Sbjct: 904 WIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSSSSCVT 960

Length = 968

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  162 bits (413), Expect = 2e-45
 Identities = 74/193 (38%), Positives = 102/193 (52%), Gaps = 9/193 (4%)

Query: 700 IGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYV 758
           +G+GG G VY       G  VAIK +    +       L EI+ L ++ H NIV+L G  
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 759 SNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHR 818
            + +   L+ EY   GSL ++L     G L  +   RI L+  +GL YLH   S  IIHR
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLK-ENEGKLSEDEILRILLQILEGLEYLH---SNGIIHR 116

Query: 819 DVKSNNILLDSD-FEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPE-YAYTLKVDEK 876
           D+K  NILLDSD  +  +ADFGL+K L        + ++ G+  Y+APE         EK
Sbjct: 117 DLKPENILLDSDNGKVKLADFGLSKLLTS--DKSLLKTIVGTPAYMAPEVLLGKGYYSEK 174

Query: 877 SDVYSFGVVLLEL 889
           SD++S GV+L EL
Sbjct: 175 SDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  158 bits (401), Expect = 2e-43
 Identities = 79/252 (31%), Positives = 115/252 (45%), Gaps = 21/252 (8%)

Query: 695 KDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVR 753
           +    +G+G  G VY       G  VAIK +  +    +    L EI+ L +++H NIVR
Sbjct: 2   EILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVR 61

Query: 754 LLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLK-WETRYRIALEAAKGLCYLHHDCS 812
           L     + D   L+ EY   G L ++L   K G L   E R+    +    L YLH    
Sbjct: 62  LYDVFEDEDKLYLVMEYCEGGDLFDLLK--KRGRLSEDEARF-YLRQILSALEYLHSKG- 117

Query: 813 PLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLK 872
             I+HRD+K  NILLD D    +ADFGLA+ L      E +++  G+  Y+APE      
Sbjct: 118 --IVHRDLKPENILLDEDGHVKLADFGLARQLDP---GEKLTTFVGTPEYMAPEVLLGKG 172

Query: 873 VDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLA----- 927
             +  D++S GV+L EL+ GK P       +++ + + K       P    S  A     
Sbjct: 173 YGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIR 232

Query: 928 ---VVDP--RLS 934
              V DP  RL+
Sbjct: 233 KLLVKDPEKRLT 244

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  155 bits (393), Expect = 3e-42
 Identities = 77/200 (38%), Positives = 105/200 (52%), Gaps = 10/200 (5%)

Query: 699 IIGKGGAGIVYRGS-MPDGIDVAIKRLVGRGTG-GNDHGFLAEIQTLGRIRHRNIVRLLG 756
            +G G  G VY+      G  VA+K L  R      D     EI+ L R+ H NIVRL+ 
Sbjct: 6   KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65

Query: 757 YVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLII 816
              ++D   L+ EY   G L + L   +GG L  +   +IAL+  +GL YLH +    II
Sbjct: 66  AFEDKDHLYLVMEYCEGGDLFDYLS--RGGPLSEDEAKKIALQILRGLEYLHSNG---II 120

Query: 817 HRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPE-YAYTLKVDE 875
           HRD+K  NILLD +    +ADFGLAK L    +S  +++  G+  Y+APE          
Sbjct: 121 HRDLKPENILLDENGVVKIADFGLAKKL--LKSSSSLTTFVGTPWYMAPEVLLGGNGYGP 178

Query: 876 KSDVYSFGVVLLELIAGKKP 895
           K DV+S GV+L EL+ GK P
Sbjct: 179 KVDVWSLGVILYELLTGKPP 198

Length = 260

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  153 bits (388), Expect = 1e-41
 Identities = 72/289 (24%), Positives = 121/289 (41%), Gaps = 45/289 (15%)

Query: 694 LKDENIIGKGGAGIVYRG-----SMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRH 748
           L     +G+G  G VY+G          ++VA+K L    +      FL E + + ++ H
Sbjct: 1   LTLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDH 60

Query: 749 RNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLH 808
            N+V+LLG  +  +   ++ EYM  G L   L       L        AL+ A+G+ YL 
Sbjct: 61  PNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLR-KNRPKLSLSDLLSFALQIARGMEYLE 119

Query: 809 HDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAG---ASECMSSVAGSYGYIAP 865
                  IHRD+ + N L+  +    ++DFGL++ L D            +     ++AP
Sbjct: 120 SKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIR----WMAP 172

Query: 866 EYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAAS 924
           E     K   KSDV+SFGV+L E+   G++P        +++ +++              
Sbjct: 173 ESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGM-SNEEVLEYLKN------------- 218

Query: 925 VLAVVDPRLSGY----PLTGVIHLFKVAMMCVEDESSARPTMREVVHML 969
                     GY    P      L+ + + C  ++   RPT  E+V +L
Sbjct: 219 ----------GYRLPQPPNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  152 bits (387), Expect = 2e-41
 Identities = 74/285 (25%), Positives = 127/285 (44%), Gaps = 36/285 (12%)

Query: 694 LKDENIIGKGGAGIVYRG-----SMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRH 748
           L     +G+G  G VY+G          ++VA+K L    +      FL E + + ++ H
Sbjct: 1   LTLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDH 60

Query: 749 RNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLH 808
            NIV+LLG  +  +  +++ EYMP G L + L   +   L        AL+ A+G+ YL 
Sbjct: 61  PNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE 120

Query: 809 HDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAG---ASECMSSVAGSYGYIAP 865
                  IHRD+ + N L+  +    ++DFGL++ L D            +     ++AP
Sbjct: 121 SKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIR----WMAP 173

Query: 866 EYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAAS 924
           E     K   KSDV+SFGV+L E+   G++P        +++ ++ K    + +P +   
Sbjct: 174 ESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGM-SNAEVLEYL-KKGYRLPKPPNCPP 231

Query: 925 VLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHML 969
                              L+K+ + C  ++   RPT  E+V +L
Sbjct: 232 ------------------ELYKLMLQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  151 bits (383), Expect = 5e-41
 Identities = 73/281 (25%), Positives = 121/281 (43%), Gaps = 40/281 (14%)

Query: 700 IGKGGAGIVYRG-----SMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRL 754
           +G+G  G VY+G            VA+K L    +      FL E   + ++ H NIVRL
Sbjct: 7   LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66

Query: 755 LGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLH-HDCSP 813
           LG  +  +   ++ EYMP G L + L    G  L  +   ++AL+ AKG+ YL   +   
Sbjct: 67  LGVCTQGEPLYIVTEYMPGGDLLDFLR-KHGEKLTLKDLLQMALQIAKGMEYLESKNF-- 123

Query: 814 LIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAG----ASECMSSVAGSYGYIAPEYAY 869
             +HRD+ + N L+  +    ++DFGL++ + +             +     ++APE   
Sbjct: 124 --VHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIK----WMAPESLK 177

Query: 870 TLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAV 928
             K   KSDV+SFGV+L E+   G++P        +++  +                   
Sbjct: 178 DGKFTSKSDVWSFGVLLWEIFTLGEQPYPGM-SNEEVLELLED----------------- 219

Query: 929 VDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHML 969
              RL   P      L+++ + C   +   RPT  E+V  L
Sbjct: 220 -GYRLP-RPENCPDELYELMLQCWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  149 bits (378), Expect = 3e-40
 Identities = 71/289 (24%), Positives = 122/289 (42%), Gaps = 43/289 (14%)

Query: 698 NIIGKGGAGIVYRGSMPDG----IDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVR 753
             +G+G  G VY+G +        +VA+K L    +      FL E + + ++ H N+VR
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 754 LLGYVSNRDTNLLLYEYMPNGSL-------GEMLHGAKGGHLKWETRYRIALEAAKGLCY 806
           LLG  +  +   L+ EYM  G L         +    +   L  +     A++ AKG+ Y
Sbjct: 61  LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120

Query: 807 LHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAG----ASECMSSVAGSYGY 862
           L    S   +HRD+ + N L+  D    ++DFGL++ + D       +     +     +
Sbjct: 121 LA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR----W 173

Query: 863 IAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSD 921
           +APE         KSDV+SFGV+L E+   G  P        +++ ++RK    + +P  
Sbjct: 174 MAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGL-SNEEVLEYLRK-GYRLPKPEY 231

Query: 922 AASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLA 970
                                 L+++ + C + +   RPT  E+V  L 
Sbjct: 232 CPD------------------ELYELMLSCWQLDPEDRPTFSELVERLE 262

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  145 bits (367), Expect = 9e-39
 Identities = 70/214 (32%), Positives = 104/214 (48%), Gaps = 11/214 (5%)

Query: 698 NIIGKGGAGIVYRG-SMPDGIDVAIKRL-VGRGTGGNDHGFLAEIQTLGRIRHRNIVRLL 755
            ++G+G  G VY       G  +A+K + +   +         EI+ L  ++H NIVR  
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65

Query: 756 G-YVSNRDTNLLLY-EYMPNGSLGEMLHGAKGGHLKWETRYRI-ALEAAKGLCYLHHDCS 812
           G         L ++ EY+  GSL  +L   K G L  E   R    +  +GL YLH   S
Sbjct: 66  GSERDEEKNTLNIFLEYVSGGSLSSLLK--KFGKLP-EPVIRKYTRQILEGLAYLH---S 119

Query: 813 PLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLK 872
             I+HRD+K  NIL+DSD    +ADFG AK L D    E   SV G+  ++APE     +
Sbjct: 120 NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEE 179

Query: 873 VDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIV 906
               +D++S G  ++E+  GK P  E G+ +  +
Sbjct: 180 YGRAADIWSLGCTVIEMATGKPPWSELGNPMAAL 213

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  134 bits (340), Expect = 2e-35
 Identities = 72/202 (35%), Positives = 104/202 (51%), Gaps = 9/202 (4%)

Query: 700 IGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYV 758
           IGKGG G VY+      G +VAIK +    +       + EIQ L + +H NIV+  G  
Sbjct: 8   IGKGGFGEVYKARHKRTGKEVAIKVIKLE-SKEKKEKIINEIQILKKCKHPNIVKYYGSY 66

Query: 759 SNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHR 818
             +D   ++ E+   GSL ++L        + +  Y +  E  KGL YLH   S  IIHR
Sbjct: 67  LKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAY-VCKELLKGLEYLH---SNGIIHR 122

Query: 819 DVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSD 878
           D+K+ NILL SD E  + DFGL+  L D  A    +++ G+  ++APE       D K+D
Sbjct: 123 DIKAANILLTSDGEVKLIDFGLSAQLSDTKAR---NTMVGTPYWMAPEVINGKPYDYKAD 179

Query: 879 VYSFGVVLLELIAGKKPVGEFG 900
           ++S G+  +EL  GK P  E  
Sbjct: 180 IWSLGITAIELAEGKPPYSELP 201

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  120 bits (303), Expect = 2e-30
 Identities = 85/288 (29%), Positives = 123/288 (42%), Gaps = 42/288 (14%)

Query: 691 LESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRN 750
            + LK    IGKG  G V  G    G  VA+K L  +        FLAE   +  +RH N
Sbjct: 5   SKELKLGATIGKGEFGDVMLGDY-RGQKVAVKCL--KDDSTAAQAFLAEASVMTTLRHPN 61

Query: 751 IVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHD 810
           +V+LLG V   +   ++ EYM  GSL + L       +    +   AL+  +G+ YL   
Sbjct: 62  LVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE-- 119

Query: 811 CSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSY--GYIAPEYA 868
                +HRD+ + N+L+  D  A V+DFGLAK              +G     + APE  
Sbjct: 120 -EKNFVHRDLAARNVLVSEDLVAKVSDFGLAK-------EASQGQDSGKLPVKWTAPEAL 171

Query: 869 YTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAV 928
              K   KSDV+SFG++L E+ +       FG     V + R    +V        V  V
Sbjct: 172 REKKFSTKSDVWSFGILLWEIYS-------FGR----VPYPRIPLKDV--------VPHV 212

Query: 929 VDPRLSGY----PLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANP 972
                 GY    P      ++KV   C E + + RPT +++   LA  
Sbjct: 213 E----KGYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  118 bits (298), Expect = 1e-29
 Identities = 68/207 (32%), Positives = 103/207 (49%), Gaps = 9/207 (4%)

Query: 697 ENIIGKGGAGIVYRGSM----PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIV 752
           E +IG G  G V RG +       IDVAIK L    +      FL E   +G+  H NI+
Sbjct: 9   EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68

Query: 753 RLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCS 812
           RL G V+     +++ EYM NGSL + L     G         +    A G+ YL     
Sbjct: 69  RLEGVVTKSRPVMIITEYMENGSLDKFLR-ENDGKFTVGQLVGMLRGIASGMKYLSEMNY 127

Query: 813 PLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLK 872
              +HRD+ + NIL++S+    V+DFGL++ L+D+ A+           + APE     K
Sbjct: 128 ---VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRK 184

Query: 873 VDEKSDVYSFGVVLLELIA-GKKPVGE 898
               SDV+SFG+V+ E+++ G++P  +
Sbjct: 185 FTSASDVWSFGIVMWEVMSYGERPYWD 211

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  117 bits (295), Expect = 3e-29
 Identities = 68/212 (32%), Positives = 111/212 (52%), Gaps = 21/212 (9%)

Query: 692 ESLKDENIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRN 750
             L+   ++G+G +G+VY+    P G   A+K++   G        L E++TL       
Sbjct: 1   SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPY 60

Query: 751 IVRLLG-YVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHH 809
           +V+  G +    + +++L EYM  GSL ++L   K G +       IA +  KGL YLH 
Sbjct: 61  VVKCYGAFYKEGEISIVL-EYMDGGSLADLL--KKVGKIPEPVLAYIARQILKGLDYLHT 117

Query: 810 DCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPE--- 866
                IIHRD+K +N+L++S  E  +ADFG++K L++    +C + V G+  Y++PE   
Sbjct: 118 KRH--IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD-QCNTFV-GTVTYMSPERIQ 173

Query: 867 ---YAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
              Y+Y       +D++S G+ LLE   GK P
Sbjct: 174 GESYSY------AADIWSLGLTLLECALGKFP 199

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  109 bits (275), Expect = 1e-26
 Identities = 64/200 (32%), Positives = 98/200 (49%), Gaps = 7/200 (3%)

Query: 697 ENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLG 756
           E  +G G  G V+ G   + + VAIK ++          F  E+Q L R+RH++++ L  
Sbjct: 11  ERKLGSGYFGEVWEGLWKNRVRVAIK-ILKSDDLLKQQDFQKEVQALKRLRHKHLISLFA 69

Query: 757 YVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLII 816
             S  +   ++ E M  GSL   L   +G  L   +   +A + A+G+ YL        I
Sbjct: 70  VCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQNSI 126

Query: 817 HRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEK 876
           HRD+ + NIL+  D    VADFGLA+ +++       S     Y + APE A       K
Sbjct: 127 HRDLAARNILVGEDLVCKVADFGLARLIKEDVYLS--SDKKIPYKWTAPEAASHGTFSTK 184

Query: 877 SDVYSFGVVLLELIA-GKKP 895
           SDV+SFG++L E+   G+ P
Sbjct: 185 SDVWSFGILLYEMFTYGQVP 204

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  107 bits (270), Expect = 5e-26
 Identities = 64/200 (32%), Positives = 102/200 (51%), Gaps = 9/200 (4%)

Query: 698 NIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDH-GFLAEIQTLGRIRHRNIVRLL 755
           ++IG+G  G+VY+G ++  G  VAIK++             + EI  L  ++H NIV+ +
Sbjct: 6   DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65

Query: 756 GYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLI 815
           G +   D+  ++ EY  NGSL +++   K G            +  +GL YLH      +
Sbjct: 66  GSIETSDSLYIILEYAENGSLRQIIK--KFGPFPESLVAVYVYQVLQGLAYLHEQG---V 120

Query: 816 IHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDE 875
           IHRD+K+ NIL   D    +ADFG+A  L D    +  +SV G+  ++APE         
Sbjct: 121 IHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDD--ASVVGTPYWMAPEVIEMSGAST 178

Query: 876 KSDVYSFGVVLLELIAGKKP 895
            SD++S G  ++EL+ G  P
Sbjct: 179 ASDIWSLGCTVIELLTGNPP 198

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  110 bits (276), Expect = 6e-26
 Identities = 80/292 (27%), Positives = 116/292 (39%), Gaps = 26/292 (8%)

Query: 700 IGKGGAGIVYRGSMPDGIDVAIKRL--VGRGTGGNDHGFLAEIQTLGRIRH-RNIVRLLG 756
           +G+G  G VY     D   VA+K L             FL EIQ L  + H  NIV+L  
Sbjct: 8   LGEGSFGEVYLA--RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYD 65

Query: 757 YVSNRDTNLLLYEYMPNGSLGEML-HGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLI 815
           +  +  +  L+ EY+  GSL ++L    + G L       I  +    L YLH   S  I
Sbjct: 66  FFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKGI 122

Query: 816 IHRDVKSNNILLDSD-FEAHVADFGLAKFLQDAGAS----ECMSSVAGSYGYIAPEYAYT 870
           IHRD+K  NILLD D     + DFGLAK L D G++       S+  G+ GY+APE    
Sbjct: 123 IHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLG 182

Query: 871 L---KVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLA 927
           L        SD++S G+ L EL+ G  P     +     + ++      +          
Sbjct: 183 LSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLA------ 236

Query: 928 VVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVV-HMLANPPQSAPS 978
              P     P         +    +  +   R +    + H L    +   S
Sbjct: 237 --SPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKES 286

Length = 384

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  107 bits (269), Expect = 8e-26
 Identities = 70/207 (33%), Positives = 108/207 (52%), Gaps = 11/207 (5%)

Query: 692 ESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNI 751
           ESLK E  +G G  G V+ G+      VA+K L   GT   +  FL E Q + ++RH  +
Sbjct: 6   ESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTL-KPGTMSPE-AFLQEAQIMKKLRHDKL 63

Query: 752 VRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDC 811
           V+L    S  +   ++ EYM  GSL + L   +G  L+      +A + A+G+ YL    
Sbjct: 64  VQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE--- 120

Query: 812 SPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSY--GYIAPEYAY 869
           S   IHRD+ + NIL+  +    +ADFGLA+ ++D    E  +     +   + APE A 
Sbjct: 121 SRNYIHRDLAARNILVGENLVCKIADFGLARLIED---DEYTAREGAKFPIKWTAPEAAN 177

Query: 870 TLKVDEKSDVYSFGVVLLELIA-GKKP 895
             +   KSDV+SFG++L E++  G+ P
Sbjct: 178 YGRFTIKSDVWSFGILLTEIVTYGRVP 204

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  106 bits (268), Expect = 2e-25
 Identities = 66/214 (30%), Positives = 100/214 (46%), Gaps = 17/214 (7%)

Query: 687 AEDVLESLKDENIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGR 745
             D  E  K+   IG+G +G VY+      G +VAIK++  R    N    + EI  +  
Sbjct: 14  EGDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKM--RLRKQNKELIINEILIMKD 71

Query: 746 IRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKG----GHLKWETRYRIALEAA 801
            +H NIV         D   ++ EYM  GSL +++           +       +  E  
Sbjct: 72  CKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIA-----YVCREVL 126

Query: 802 KGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYG 861
           +GL YLH   S  +IHRD+KS+NILL  D    +ADFG A  L    +    +SV G+  
Sbjct: 127 QGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKR--NSVVGTPY 181

Query: 862 YIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
           ++APE         K D++S G++ +E+  G+ P
Sbjct: 182 WMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  104 bits (263), Expect = 5e-25
 Identities = 60/207 (28%), Positives = 91/207 (43%), Gaps = 23/207 (11%)

Query: 700 IGKGGAGIVYRG-SMPDGIDVAIKRL-VGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGY 757
           IGKG  G VY      DG    +K + +   +       L E++ L ++ H NI++   Y
Sbjct: 8   IGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIK---Y 64

Query: 758 VSNRDTNLLLY---EYMPNGSLGEMLH--GAKGGHLKWETRYRIALEAAKGLCYLHHDCS 812
             + +    L    EY   G L + +     +G     E      ++    L YLH   S
Sbjct: 65  YESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH---S 121

Query: 813 PLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPE----YA 868
             I+HRD+K  NI L S+    + DFG++K L      +   +V G+  Y++PE      
Sbjct: 122 RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSS--TVDLAKTVVGTPYYLSPELCQNKP 179

Query: 869 YTLKVDEKSDVYSFGVVLLELIAGKKP 895
           Y    + KSD++S G VL EL   K P
Sbjct: 180 Y----NYKSDIWSLGCVLYELCTLKHP 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  104 bits (261), Expect = 9e-25
 Identities = 62/199 (31%), Positives = 99/199 (49%), Gaps = 11/199 (5%)

Query: 700 IGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVS 759
           +G G  G V+ G   +   VA+K L        D  FLAE Q + ++RH  +++L    +
Sbjct: 14  LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKD--FLAEAQIMKKLRHPKLIQLYAVCT 71

Query: 760 NRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRD 819
             +   ++ E M  GSL E L G  G  LK      +A + A G+ YL    +   IHRD
Sbjct: 72  LEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE---AQNYIHRD 128

Query: 820 VKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSY--GYIAPEYAYTLKVDEKS 877
           + + N+L+  +    VADFGLA+ +++       +     +   + APE A   +   KS
Sbjct: 129 LAARNVLVGENNICKVADFGLARVIKE---DIYEAREGAKFPIKWTAPEAALYNRFSIKS 185

Query: 878 DVYSFGVVLLELIA-GKKP 895
           DV+SFG++L E++  G+ P
Sbjct: 186 DVWSFGILLTEIVTYGRMP 204

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score =  103 bits (259), Expect = 2e-24
 Identities = 79/279 (28%), Positives = 114/279 (40%), Gaps = 33/279 (11%)

Query: 700 IGKGGAGIVYRG--SMPDG--IDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLL 755
           +G G  G+V RG  S   G  I VA+K L           FL E   +  + H N++RL 
Sbjct: 3   LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62

Query: 756 GYVSNRDTNLLL-YEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPL 814
           G V      L++  E  P GSL + L     GH    T    A++ A G+ YL    S  
Sbjct: 63  GVV--LTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE---SKR 117

Query: 815 IIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMS-SVAGSYGYIAPEYAYTLKV 873
            IHRD+ + NILL SD +  + DFGL + L        M   +   + + APE   T   
Sbjct: 118 FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTF 177

Query: 874 DEKSDVYSFGVVLLELIA-GKKP-VGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDP 931
              SDV+ FGV L E+   G++P  G    G  I++ + K    + +P            
Sbjct: 178 SHASDVWMFGVTLWEMFTYGEEPWAGL--SGSQILKKIDKEGERLERPEACPQ------- 228

Query: 932 RLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLA 970
                       ++ V + C     + RPT   +   L 
Sbjct: 229 -----------DIYNVMLQCWAHNPADRPTFAALREFLP 256

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score =  102 bits (256), Expect = 3e-24
 Identities = 76/274 (27%), Positives = 132/274 (48%), Gaps = 32/274 (11%)

Query: 700 IGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVS 759
           IG G  G+V+ G   +   VAIK +  R    ++  F+ E Q + ++ H  +V+L G  +
Sbjct: 12  IGSGQFGLVWLGYWLEKRKVAIKTI--REGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCT 69

Query: 760 NRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRD 819
            R    L++E+M +G L + L  A+ G    ET   + L+  +G+ YL       +IHRD
Sbjct: 70  ERSPICLVFEFMEHGCLSDYLR-AQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRD 125

Query: 820 VKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSY--GYIAPEYAYTLKVDEKS 877
           + + N L+  +    V+DFG+ +F+ D    +  SS    +   + +PE     K   KS
Sbjct: 126 LAARNCLVGENQVVKVSDFGMTRFVLD---DQYTSSTGTKFPVKWSSPEVFSFSKYSSKS 182

Query: 878 DVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDPRLSGY 936
           DV+SFGV++ E+ + GK P            +  ++ SEV +  +A   L    PRL+  
Sbjct: 183 DVWSFGVLMWEVFSEGKTP------------YENRSNSEVVETINAGFRL--YKPRLASQ 228

Query: 937 PLTGVIHLFKVAMMCVEDESSARPTMREVVHMLA 970
                  ++++   C ++    RP+   ++H LA
Sbjct: 229 ------SVYELMQHCWKERPEDRPSFSLLLHQLA 256

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score =  100 bits (252), Expect = 1e-23
 Identities = 75/278 (26%), Positives = 124/278 (44%), Gaps = 40/278 (14%)

Query: 700 IGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVS 759
           +G G  G+V+ G     IDVAIK ++  G    D  F+ E + + ++ H N+V+L G  +
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIK-MIREGAMSEDD-FIEEAKVMMKLSHPNLVQLYGVCT 69

Query: 760 NRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRD 819
            +    ++ EYM NG L   L   KG  L  E    +  +  + + YL  +     IHRD
Sbjct: 70  KQRPIFIVTEYMANGCLLNYLRERKG-KLGTEWLLDMCSDVCEAMEYLESNG---FIHRD 125

Query: 820 VKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSY--GYIAPEYAYTLKVDEKS 877
           + + N L+  D    V+DFGLA+++ D    +  SS    +   +  PE     +   KS
Sbjct: 126 LAARNCLVGEDNVVKVSDFGLARYVLD---DQYTSSQGTKFPVKWAPPEVFDYSRFSSKS 182

Query: 878 DVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDPRLSGY 936
           DV+SFGV++ E+ + GK P              R + SE            VV+   +GY
Sbjct: 183 DVWSFGVLMWEVFSEGKMPYE------------RFSNSE------------VVESVSAGY 218

Query: 937 ----PLTGVIHLFKVAMMCVEDESSARPTMREVVHMLA 970
               P      ++ +   C  ++   RP  ++++  L 
Sbjct: 219 RLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT 256

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  100 bits (251), Expect = 2e-23
 Identities = 66/205 (32%), Positives = 96/205 (46%), Gaps = 12/205 (5%)

Query: 698 NIIGKGGAGIVYRG-SMPDGIDVAIKR--LVGRGTGGNDHGFLAEIQTLGRIRHRNIVRL 754
            +IG G   +VY    +P+   VAIKR  L    T  ++     E+Q + +  H N+V+ 
Sbjct: 7   EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDE--LRKEVQAMSQCNHPNVVKY 64

Query: 755 LGYVSNRDTNLLLYEYMPNGSLGE-MLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSP 813
                  D   L+  Y+  GSL + M      G L       +  E  KGL YLH   S 
Sbjct: 65  YTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH---SN 121

Query: 814 LIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMS--SVAGSYGYIAPEYAYTL 871
             IHRD+K+ NILL  D    +ADFG++  L D G        +  G+  ++APE    +
Sbjct: 122 GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQV 181

Query: 872 K-VDEKSDVYSFGVVLLELIAGKKP 895
              D K+D++SFG+  +EL  G  P
Sbjct: 182 HGYDFKADIWSFGITAIELATGAAP 206

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  100 bits (250), Expect = 3e-23
 Identities = 67/213 (31%), Positives = 112/213 (52%), Gaps = 25/213 (11%)

Query: 699 IIGKGGAGIVYRG-SMPDGIDVAIKRL-VGRGTGGNDH--------GFLAEIQTLGRIRH 748
           +IGKG  G VY   ++  G  +A+K++ +     G              +EI+TL  + H
Sbjct: 8   LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67

Query: 749 RNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLH 808
            NIV+ LG+ +  +   +  EY+P GS+G  L     G  + +       +  +GL YLH
Sbjct: 68  LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLR--TYGRFEEQLVRFFTEQVLEGLAYLH 125

Query: 809 HDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPE-- 866
              S  I+HRD+K++N+L+D+D    ++DFG++K   D   ++   S+ GS  ++APE  
Sbjct: 126 ---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVI 182

Query: 867 ----YAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
                 Y+ KV    D++S G V+LE+ AG++P
Sbjct: 183 HSYSQGYSAKV----DIWSLGCVVLEMFAGRRP 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  100 bits (251), Expect = 3e-23
 Identities = 85/292 (29%), Positives = 123/292 (42%), Gaps = 35/292 (11%)

Query: 692 ESLKDENIIGKGGAGIVYRGSMP-----DGIDVAIKRLVGRGTGGNDH--GFLAEIQTLG 744
             LK    +G+G  G V            G  VA+K L    +G   H   F  EI+ L 
Sbjct: 4   RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSL--NHSGEEQHRSDFEREIEILR 61

Query: 745 RIRHRNIVRLLG--YVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAK 802
            + H NIV+  G        +  L+ EY+P+GSL + L   +   +  +     + +  K
Sbjct: 62  TLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRD-QINLKRLLLFSSQICK 120

Query: 803 GLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFL-QDAG---ASECMSSVAG 858
           G+ YL    S   IHRD+ + NIL++S+    ++DFGLAK L +D       E   S   
Sbjct: 121 GMDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIF 177

Query: 859 SYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA----GKKPVGEFGDGVDIVRWVRKTTS 914
            Y   APE   T K    SDV+SFGV L EL       + P  EF   + I +     T 
Sbjct: 178 WY---APECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTR 234

Query: 915 EVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVV 966
            +    +   +     PR    P   V  L K   +C E E   RP+  +++
Sbjct: 235 LLELLKEGERL-----PRPPSCP-DEVYDLMK---LCWEAEPQDRPSFADLI 277

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score =  100 bits (249), Expect = 3e-23
 Identities = 71/207 (34%), Positives = 109/207 (52%), Gaps = 12/207 (5%)

Query: 692 ESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNI 751
           ESL+ E  +G+G  G V+ G+      VAIK L   GT   +  FL E Q + ++RH  +
Sbjct: 6   ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPE-AFLQEAQVMKKLRHEKL 63

Query: 752 VRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDC 811
           V+L   VS      ++ EYM  GSL + L G  G +L+      +A + A G+ Y+    
Sbjct: 64  VQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN 122

Query: 812 SPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSY--GYIAPEYAY 869
               +HRD+++ NIL+  +    VADFGLA+ ++D   +E  +     +   + APE A 
Sbjct: 123 ---YVHRDLRAANILVGENLVCKVADFGLARLIED---NEYTARQGAKFPIKWTAPEAAL 176

Query: 870 TLKVDEKSDVYSFGVVLLELIA-GKKP 895
             +   KSDV+SFG++L EL   G+ P
Sbjct: 177 YGRFTIKSDVWSFGILLTELTTKGRVP 203

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 99.7 bits (249), Expect = 4e-23
 Identities = 76/282 (26%), Positives = 125/282 (44%), Gaps = 34/282 (12%)

Query: 700 IGKGGAGIVYRG--SMPDG--IDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLL 755
           +G G  G V +G   M  G  ++VA+K L           FL E   + ++ H  IVRL+
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62

Query: 756 GYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLI 815
           G V   +  +L+ E  P G L + L   K   +       +A + A G+ YL    S   
Sbjct: 63  G-VCKGEPLMLVMELAPLGPLLKYLK--KRREIPVSDLKELAHQVAMGMAYLE---SKHF 116

Query: 816 IHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSY--GYIAPEYAYTLKV 873
           +HRD+ + N+LL +  +A ++DFG+++ L  AG+    ++ AG +   + APE     K 
Sbjct: 117 VHRDLAARNVLLVNRHQAKISDFGMSRALG-AGSDYYRATTAGRWPLKWYAPECINYGKF 175

Query: 874 DEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDPR 932
             KSDV+S+GV L E  + G KP GE   G +++  +      + +P             
Sbjct: 176 SSKSDVWSYGVTLWEAFSYGAKPYGEM-KGAEVIAMLESG-ERLPRPE------------ 221

Query: 933 LSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQ 974
               P      ++ + + C +     RPT  E+       P+
Sbjct: 222 --ECP----QEIYSIMLSCWKYRPEDRPTFSELESTFRRDPE 257

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 99.7 bits (248), Expect = 5e-23
 Identities = 79/288 (27%), Positives = 138/288 (47%), Gaps = 40/288 (13%)

Query: 693 SLKDENIIGKGGAGIVYRGSMP----DGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRH 748
            +  + +IG G  G V+RG +       + VAIK L    T      FL+E   +G+  H
Sbjct: 6   HITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSH 65

Query: 749 RNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLH 808
            NI+RL G V+     +++ EYM NG+L + L    G    ++    +   AA G+ YL 
Sbjct: 66  HNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAA-GMKYL- 123

Query: 809 HDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGS---YGYIAP 865
            D +   +HRD+ + NIL++S+ E  V+DFGL++ L+D    E   + +G      + AP
Sbjct: 124 SDMN--YVHRDLAARNILVNSNLECKVSDFGLSRVLED--DPEGTYTTSGGKIPIRWTAP 179

Query: 866 EYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSE---VSQPSD 921
           E     K    SDV+SFG+V+ E+++ G++P  +  +       V K  ++   +  P D
Sbjct: 180 EAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN-----HEVMKAINDGFRLPAPMD 234

Query: 922 AASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHML 969
             S                   ++++ + C + + + RP   ++V++L
Sbjct: 235 CPSA------------------VYQLMLQCWQQDRARRPRFVDIVNLL 264

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 98.9 bits (247), Expect = 7e-23
 Identities = 60/202 (29%), Positives = 97/202 (48%), Gaps = 10/202 (4%)

Query: 699 IIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGY 757
            +G+G  G VY+      G  VAIK +       +    + EI  L +     IV+  G 
Sbjct: 10  KLGEGSYGSVYKAIHKETGQVVAIKVV---PVEEDLQEIIKEISILKQCDSPYIVKYYGS 66

Query: 758 VSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIH 817
                   ++ EY   GS+ +++       L  E    I  +  KGL YLH   S   IH
Sbjct: 67  YFKNTDLWIVMEYCGAGSVSDIMK-ITNKTLTEEEIAAILYQTLKGLEYLH---SNKKIH 122

Query: 818 RDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKS 877
           RD+K+ NILL+ + +A +ADFG++  L D  A    ++V G+  ++APE    +  + K+
Sbjct: 123 RDIKAGNILLNEEGQAKLADFGVSGQLTDTMAK--RNTVIGTPFWMAPEVIQEIGYNNKA 180

Query: 878 DVYSFGVVLLELIAGKKPVGEF 899
           D++S G+  +E+  GK P  + 
Sbjct: 181 DIWSLGITAIEMAEGKPPYSDI 202

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 98.9 bits (246), Expect = 8e-23
 Identities = 70/207 (33%), Positives = 106/207 (51%), Gaps = 12/207 (5%)

Query: 692 ESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNI 751
           ESL+    +G G  G V+ G+      VA+K L   GT   +  FL E Q + ++RH  +
Sbjct: 6   ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTL-KPGTMSPE-SFLEEAQIMKKLRHDKL 63

Query: 752 VRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDC 811
           V+L   VS      ++ EYM  GSL + L   +G  LK      +A + A G+ Y+    
Sbjct: 64  VQLYAVVSEEPI-YIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN 122

Query: 812 SPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSY--GYIAPEYAY 869
               IHRD++S NIL+       +ADFGLA+ ++D   +E  +     +   + APE A 
Sbjct: 123 ---YIHRDLRSANILVGDGLVCKIADFGLARLIED---NEYTARQGAKFPIKWTAPEAAL 176

Query: 870 TLKVDEKSDVYSFGVVLLELIA-GKKP 895
             +   KSDV+SFG++L EL+  G+ P
Sbjct: 177 YGRFTIKSDVWSFGILLTELVTKGRVP 203

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 98.0 bits (244), Expect = 1e-22
 Identities = 70/230 (30%), Positives = 110/230 (47%), Gaps = 11/230 (4%)

Query: 698 NIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHG-FLAEIQTLGRIRHRNIVRLL 755
           N IGKG  G+V++     D    A+K++        +    + E + L ++    I+R  
Sbjct: 6   NKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRY- 64

Query: 756 GYVSNRDTNLL--LYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSP 813
            Y S  D   L  + EY  NG L ++L   +G  L  +  +R  ++   GL +LH   S 
Sbjct: 65  -YESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH---SK 120

Query: 814 LIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKV 873
            I+HRD+KS N+ LD+     + D G+AK L D   +   +++ G+  Y++PE       
Sbjct: 121 KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSD--NTNFANTIVGTPYYLSPELCEDKPY 178

Query: 874 DEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAA 923
           +EKSDV++ GVVL E   GK P      G  I++ +R     VSQ     
Sbjct: 179 NEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQ 228

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 98.1 bits (245), Expect = 2e-22
 Identities = 62/197 (31%), Positives = 97/197 (49%), Gaps = 11/197 (5%)

Query: 700 IGKGGAGIVYR-GSMPDGIDVAIKRL-VGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGY 757
           IG+G  GIV++      G  VA+K++ + R  GG  +  L EI+ L   +H  +V+LL  
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD- 66

Query: 758 VSNRDTNL-LLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLII 816
           V    +   L+ EYMP   L E+L   +    + + +        KG+ Y+H   +  I+
Sbjct: 67  VFPHGSGFVLVMEYMP-SDLSEVLRDEERPLPEAQVK-SYMRMLLKGVAYMH---ANGIM 121

Query: 817 HRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAY-TLKVDE 875
           HRD+K  N+L+ +D    +ADFGLA+ L         S    +  Y APE  Y   K D 
Sbjct: 122 HRDLKPANLLISADGVLKIADFGLAR-LFSEEEPRLYSHQVATRWYRAPELLYGARKYDP 180

Query: 876 KSDVYSFGVVLLELIAG 892
             D+++ G +  EL+ G
Sbjct: 181 GVDLWAVGCIFAELLNG 197

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 97.2 bits (242), Expect = 3e-22
 Identities = 68/210 (32%), Positives = 107/210 (50%), Gaps = 12/210 (5%)

Query: 694 LKDENIIGKGGAGIVYRGSM-PDG---IDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHR 749
           +K E +IG G  G V RG +   G   I VAIK L    T      FL+E   +G+  H 
Sbjct: 6   VKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHP 65

Query: 750 NIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHH 809
           NI+ L G V+     +++ E+M NG+L   L     G         +    A G+ YL  
Sbjct: 66  NIIHLEGVVTKSRPVMIITEFMENGALDSFLR-QNDGQFTVIQLVGMLRGIAAGMKYL-S 123

Query: 810 DCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGS---YGYIAPE 866
           + +   +HRD+ + NIL++S+    V+DFGL++FL+D  +    +S  G      + APE
Sbjct: 124 EMN--YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPE 181

Query: 867 YAYTLKVDEKSDVYSFGVVLLELIA-GKKP 895
                K    SDV+S+G+V+ E+++ G++P
Sbjct: 182 AIAYRKFTSASDVWSYGIVMWEVMSYGERP 211

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 97.1 bits (242), Expect = 3e-22
 Identities = 64/210 (30%), Positives = 95/210 (45%), Gaps = 22/210 (10%)

Query: 700 IGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHGFLA----EIQTLGRIRHRNIVRL 754
           +G G  G VY G ++ DG   A+K +     G      +     EI  L +++H NIV+ 
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67

Query: 755 LGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPL 814
           LG     D   +  E +P GSL ++L   K G            +   GL YLH      
Sbjct: 68  LGTEREEDNLYIFLELVPGGSLAKLL--KKYGSFPEPVIRLYTRQILLGLEYLH---DRN 122

Query: 815 IIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEY-----AY 869
            +HRD+K  NIL+D++    +ADFG+AK + +        S  GS  ++APE       Y
Sbjct: 123 TVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSF---AKSFKGSPYWMAPEVIAQQGGY 179

Query: 870 TLKVDEKSDVYSFGVVLLELIAGKKPVGEF 899
            L      D++S G  +LE+  GK P  + 
Sbjct: 180 GLAA----DIWSLGCTVLEMATGKPPWSQL 205

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 96.8 bits (241), Expect = 3e-22
 Identities = 57/198 (28%), Positives = 96/198 (48%), Gaps = 14/198 (7%)

Query: 700 IGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVS 759
           IGKG  G VY+G +    +VA+K             FL E + L +  H NIV+L+G   
Sbjct: 3   IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCV 62

Query: 760 NRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRD 819
            +    ++ E +P GSL   L   K   L  +   +++L+AA G+ YL        IHRD
Sbjct: 63  QKQPIYIVMELVPGGSLLTFLRKKKNR-LTVKKLLQMSLDAAAGMEYLESKNC---IHRD 118

Query: 820 VKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYI-----APEYAYTLKVD 874
           + + N L+  +    ++DFG+++  ++ G    + +V+     I     APE     +  
Sbjct: 119 LAARNCLVGENNVLKISDFGMSR--EEEGG---IYTVSDGLKQIPIKWTAPEALNYGRYT 173

Query: 875 EKSDVYSFGVVLLELIAG 892
            +SDV+S+G++L E  + 
Sbjct: 174 SESDVWSYGILLWETFSL 191

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 97.0 bits (242), Expect = 3e-22
 Identities = 64/209 (30%), Positives = 101/209 (48%), Gaps = 12/209 (5%)

Query: 698 NIIGKGGAGIVYRG-SMPDGIDVAIKRL-VGRGTGGNDHGFLAEIQTLGRIRHRNIVRLL 755
           N IG G  G VY   ++  G  +A+K + +             E++ L  ++H N+V+  
Sbjct: 6   NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65

Query: 756 GYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLI 815
           G   +R+   +  EY   G+L E+L   +         Y + L   +GL YLH   S  I
Sbjct: 66  GVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQL--LEGLAYLH---SHGI 120

Query: 816 IHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS--ECMSSVAGSYGYIAPEYAYTLKV 873
           +HRD+K  NI LD +    + DFG A  L++   +  E + S+AG+  Y+APE     K 
Sbjct: 121 VHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKG 180

Query: 874 DEK---SDVYSFGVVLLELIAGKKPVGEF 899
                 +D++S G V+LE+  GK+P  E 
Sbjct: 181 KGHGRAADIWSLGCVVLEMATGKRPWSEL 209

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 96.7 bits (241), Expect = 6e-22
 Identities = 80/300 (26%), Positives = 130/300 (43%), Gaps = 53/300 (17%)

Query: 694 LKDENIIGKGGAGIVYRGS-MPDG----IDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRH 748
           L+   ++G G  G VY+G  +P+G    I VAIK L    +   +   L E   +  + H
Sbjct: 9   LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDH 68

Query: 749 RNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGG-----HLKWETRYRIALEAAKG 803
            ++VRLLG +       L+ + MP G L + +   K        L W       ++ AKG
Sbjct: 69  PHVVRLLG-ICLSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNW------CVQIAKG 121

Query: 804 LCYL--HHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSY- 860
           + YL         ++HRD+ + N+L+ +     + DFGLAK L D    E  +   G   
Sbjct: 122 MSYLEEKR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLL-DVDEKEYHAE-GGKVP 174

Query: 861 -GYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQ 918
             ++A E         KSDV+S+GV + EL+  G KP     +G+           E+  
Sbjct: 175 IKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPY----EGIP--------AVEIPD 222

Query: 919 PSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH----MLANPPQ 974
                  L     RL   P    I ++ V + C   ++ +RPT +E+++    M  +P +
Sbjct: 223 -------LLEKGERLP-QPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARDPQR 274

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 94.7 bits (236), Expect = 3e-21
 Identities = 73/294 (24%), Positives = 113/294 (38%), Gaps = 52/294 (17%)

Query: 700 IGKGGAGIVYRG---SMPDG---IDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVR 753
           +G+G  G+VY G    +  G     VAIK +    +      FL E   +      ++VR
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 754 LLGYVSNRDTNLLLYEYMPNGSLG--------EMLHGAKGGHLKWETRYRIALEAAKGLC 805
           LLG VS     L++ E M  G L         E  +    G    +   ++A E A G+ 
Sbjct: 74  LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133

Query: 806 YLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAK--FLQD--AGASECMSSVAGSYG 861
           YL    +   +HRD+ + N ++  D    + DFG+ +  +  D      + +  V     
Sbjct: 134 YLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVR---- 186

Query: 862 YIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSD 921
           ++APE         KSDV+SFGVVL E+                        +   QP  
Sbjct: 187 WMAPESLKDGVFTTKSDVWSFGVVLWEM-----------------------ATLAEQPYQ 223

Query: 922 AASVLAVVDPRLSG----YPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLAN 971
             S   V+   + G     P      L ++  MC +     RPT  E+V  L +
Sbjct: 224 GLSNEEVLKFVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 94.5 bits (236), Expect = 3e-21
 Identities = 63/211 (29%), Positives = 103/211 (48%), Gaps = 31/211 (14%)

Query: 698 NIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHGF----LAEIQTLGRIRHRNIV 752
             IG+G  G VY+  +   G  VA+K++  R     + GF    + EI+ L ++RH NIV
Sbjct: 5   AQIGEGTYGQVYKARNKKTGELVALKKI--RMENEKE-GFPITAIREIKLLQKLRHPNIV 61

Query: 753 RLLGYVSNRDTN--LLLYEYMPNGSLGEMLHGAKG---GHLKWETRYRIALEAAKGLCYL 807
           RL   V+++      +++EYM +   G +           +K         +  +GL YL
Sbjct: 62  RLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIK-----CYMKQLLEGLQYL 116

Query: 808 HHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEY 867
           H +    I+HRD+K +NIL+++D    +ADFGLA+      +++  + V   + Y  PE 
Sbjct: 117 HSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLW-YRPPEL 172

Query: 868 -----AYTLKVDEKSDVYSFGVVLLELIAGK 893
                 Y  +V    D++S G +L EL  GK
Sbjct: 173 LLGATRYGPEV----DMWSVGCILAELFLGK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 93.9 bits (234), Expect = 4e-21
 Identities = 66/215 (30%), Positives = 105/215 (48%), Gaps = 10/215 (4%)

Query: 692 ESLKDENIIGKGGAGIVYRGS-MPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRN 750
           + L+    +G G +G+V +    P G  +A+K +            L E+  L +     
Sbjct: 1   DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPY 60

Query: 751 IVRLLG-YVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHH 809
           IV   G + +N D ++ + EYM  GSL ++L   +G  +      +IA+   KGL YLH 
Sbjct: 61  IVGFYGAFYNNGDISICM-EYMDGGSLDKILKEVQGR-IPERILGKIAVAVLKGLTYLHE 118

Query: 810 DCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAY 869
                IIHRDVK +NIL++S  +  + DFG++  L ++ A     +  G+  Y+APE   
Sbjct: 119 KHK--IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA----KTFVGTSSYMAPERIQ 172

Query: 870 TLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVD 904
                 KSD++S G+ L+EL  G+ P     D  D
Sbjct: 173 GNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPD 207

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 93.6 bits (232), Expect = 4e-21
 Identities = 69/207 (33%), Positives = 108/207 (52%), Gaps = 12/207 (5%)

Query: 692 ESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNI 751
           ESL+ +  +G+G  G V+ G+      VAIK L   GT   +  FL E Q + ++RH  +
Sbjct: 6   ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTL-KPGTMMPE-AFLQEAQIMKKLRHDKL 63

Query: 752 VRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDC 811
           V L   VS      ++ E+M  GSL + L    G +LK      +A + A G+ Y+    
Sbjct: 64  VPLYAVVSEEPI-YIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN 122

Query: 812 SPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSY--GYIAPEYAY 869
               IHRD+++ NIL+  +    +ADFGLA+ ++D   +E  +     +   + APE A 
Sbjct: 123 ---YIHRDLRAANILVGDNLVCKIADFGLARLIED---NEYTARQGAKFPIKWTAPEAAL 176

Query: 870 TLKVDEKSDVYSFGVVLLELIA-GKKP 895
             +   KSDV+SFG++L EL+  G+ P
Sbjct: 177 YGRFTIKSDVWSFGILLTELVTKGRVP 203

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 92.9 bits (231), Expect = 8e-21
 Identities = 68/212 (32%), Positives = 108/212 (50%), Gaps = 21/212 (9%)

Query: 699 IIGKGGAGIVYRGSMPD-GIDVAIKRLVGRGTGGND-------HGFLAEIQTLGRIRHRN 750
           ++G+G  G VY     D G ++A+K++       +        +    EIQ L  ++H  
Sbjct: 9   LLGQGAFGRVYLCYDVDTGRELAVKQV---PFDPDSPETKKEVNALECEIQLLKNLQHER 65

Query: 751 IVRLLGYVSNRDTNLLLYEYMPNGSLGEML--HGAKGGHLKWETRYRIALEAAKGLCYLH 808
           IV+  G + + +T  +  EYMP GS+ + L  +GA    +  +   +I LE   G+ YLH
Sbjct: 66  IVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQI-LE---GVEYLH 121

Query: 809 HDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASEC-MSSVAGSYGYIAPEY 867
              S +I+HRD+K  NIL DS     + DFG +K LQ   +S   M SV G+  +++PE 
Sbjct: 122 ---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEV 178

Query: 868 AYTLKVDEKSDVYSFGVVLLELIAGKKPVGEF 899
                   K+DV+S G  ++E++  K P  EF
Sbjct: 179 ISGEGYGRKADVWSVGCTVVEMLTEKPPWAEF 210

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 93.0 bits (231), Expect = 8e-21
 Identities = 79/288 (27%), Positives = 129/288 (44%), Gaps = 42/288 (14%)

Query: 694 LKDENIIGKGGAGIVYRGSMP----DGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHR 749
           +K E +IG G  G V  G +       I VAIK L    T      FL+E   +G+  H 
Sbjct: 6   IKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHP 65

Query: 750 NIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHH 809
           NI+ L G V+     +++ EYM NGSL   L     G         +    A G+ YL  
Sbjct: 66  NIIHLEGVVTKSKPVMIVTEYMENGSLDAFLR-KHDGQFTVIQLVGMLRGIASGMKYL-S 123

Query: 810 DCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGS---YGYIAPE 866
           D     +HRD+ + NIL++S+    V+DFGL++ L+D    E   +  G      + APE
Sbjct: 124 DMG--YVHRDLAARNILVNSNLVCKVSDFGLSRVLED--DPEAAYTTRGGKIPIRWTAPE 179

Query: 867 YAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASV 925
                K    SDV+S+G+V+ E+++ G++P  E  +  D+++ + +              
Sbjct: 180 AIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ-DVIKAIEE-------------- 224

Query: 926 LAVVDPRLSGY----PLTGVIHLFKVAMMCVEDESSARPTMREVVHML 969
                    GY    P+     L ++ + C + + + RP   ++V +L
Sbjct: 225 ---------GYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSIL 263

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 92.4 bits (229), Expect = 1e-20
 Identities = 67/207 (32%), Positives = 101/207 (48%), Gaps = 14/207 (6%)

Query: 691 LESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRN 750
           ++ LK    IGKG  G V  G    G  VA+K +    T      FLAE   + ++RH N
Sbjct: 5   MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA---QAFLAEASVMTQLRHSN 60

Query: 751 IVRLLGYVSNRDTNL-LLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHH 809
           +V+LLG +      L ++ EYM  GSL + L       L  +   + +L+  + + YL  
Sbjct: 61  LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEA 120

Query: 810 DCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAY 869
           +     +HRD+ + N+L+  D  A V+DFGL K      AS    +      + APE   
Sbjct: 121 NN---FVHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALR 172

Query: 870 TLKVDEKSDVYSFGVVLLELIA-GKKP 895
             K   KSDV+SFG++L E+ + G+ P
Sbjct: 173 EKKFSTKSDVWSFGILLWEIYSFGRVP 199

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 91.8 bits (228), Expect = 2e-20
 Identities = 67/218 (30%), Positives = 109/218 (50%), Gaps = 23/218 (10%)

Query: 695 KDENIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVR 753
            +  ++GKG  GIVY    +   + +AIK +  R +         EI     ++HRNIV+
Sbjct: 11  GERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSR-YVQPLHEEIALHSYLKHRNIVQ 69

Query: 754 LLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKW--ETRYRIALEAAKGLCYLHHDC 811
            LG  S      +  E +P GSL  +L  +K G LK   +T      +  +GL YLH + 
Sbjct: 70  YLGSDSENGFFKIFMEQVPGGSLSALLR-SKWGPLKDNEQTIIFYTKQILEGLKYLHDN- 127

Query: 812 SPLIIHRDVKSNNILLDS-DFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYT 870
              I+HRD+K +N+L+++      ++DFG +K L  AG + C  +  G+  Y+APE    
Sbjct: 128 --QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL--AGINPCTETFTGTLQYMAPEV--- 180

Query: 871 LKVDE-------KSDVYSFGVVLLELIAGKKPVGEFGD 901
             +D+        +D++S G  ++E+  GK P  E G+
Sbjct: 181 --IDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGE 216

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 91.1 bits (226), Expect = 3e-20
 Identities = 65/207 (31%), Positives = 107/207 (51%), Gaps = 12/207 (5%)

Query: 692 ESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNI 751
           E+LK    +G G  G V+ G       VAIK L  +G+   +  FLAE   + +++H  +
Sbjct: 6   ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSL-KQGSMSPE-AFLAEANLMKQLQHPRL 63

Query: 752 VRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDC 811
           VRL   V+ ++   ++ EYM NGSL + L   +G  L       +A + A+G+ ++    
Sbjct: 64  VRLYAVVT-QEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN 122

Query: 812 SPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSY--GYIAPEYAY 869
               IHRD+++ NIL+       +ADFGLA+ ++D   +E  +     +   + APE   
Sbjct: 123 Y---IHRDLRAANILVSETLCCKIADFGLARLIED---NEYTAREGAKFPIKWTAPEAIN 176

Query: 870 TLKVDEKSDVYSFGVVLLELIA-GKKP 895
                 KSDV+SFG++L E++  G+ P
Sbjct: 177 YGTFTIKSDVWSFGILLTEIVTYGRIP 203

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 89.2 bits (221), Expect = 1e-19
 Identities = 60/207 (28%), Positives = 103/207 (49%), Gaps = 14/207 (6%)

Query: 698 NIIGKGGAGIVYRGSMPDGIDVAIKRLV----GRGTGGNDHGFL-AEIQTLGRIRHRNIV 752
            ++GKG  G VY G    G  +A+K++            ++  L  E+  L  ++H NIV
Sbjct: 6   EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65

Query: 753 RLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCS 812
           + LG   + +T  +  E++P GS+  +L+  + G L      +   +   G+ YLH++C 
Sbjct: 66  QYLGTCLDDNTISIFMEFVPGGSISSILN--RFGPLPEPVFCKYTKQILDGVAYLHNNC- 122

Query: 813 PLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGA----SECMSSVAGSYGYIAPEYA 868
             ++HRD+K NN++L  +    + DFG A+ L   G     S  + S+ G+  ++APE  
Sbjct: 123 --VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVI 180

Query: 869 YTLKVDEKSDVYSFGVVLLELIAGKKP 895
                  KSD++S G  + E+  GK P
Sbjct: 181 NESGYGRKSDIWSIGCTVFEMATGKPP 207

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 88.8 bits (220), Expect = 2e-19
 Identities = 76/278 (27%), Positives = 125/278 (44%), Gaps = 48/278 (17%)

Query: 700 IGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVS 759
           +G G  G+V  G      DVAIK ++  G+   D  F+ E + + ++ H  +V+L G  +
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIK-MIKEGSMSEDE-FIEEAKVMMKLSHEKLVQLYGVCT 69

Query: 760 NRDTNLLLYEYMPNGSL----GEMLHGAKGGHLKWETRYRIALEAAKGLC----YLHHDC 811
            +    ++ EYM NG L     E     +   L         LE  K +C    YL    
Sbjct: 70  KQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQL---------LEMCKDVCEGMAYLE--- 117

Query: 812 SPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSY--GYIAPEYAY 869
           S   IHRD+ + N L+D      V+DFGL++++ D    E  SSV   +   +  PE   
Sbjct: 118 SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLD---DEYTSSVGSKFPVRWSPPEVLL 174

Query: 870 TLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAV 928
             K   KSDV++FGV++ E+ + GK P   F +         +T  +VSQ       L +
Sbjct: 175 YSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN--------SETVEKVSQG------LRL 220

Query: 929 VDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVV 966
             P L+         ++ +   C  +++  RPT ++++
Sbjct: 221 YRPHLASE------KVYAIMYSCWHEKAEERPTFQQLL 252

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 88.5 bits (219), Expect = 2e-19
 Identities = 71/273 (26%), Positives = 123/273 (45%), Gaps = 31/273 (11%)

Query: 692 ESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNI 751
           ES+K    +G G  G V+ G   +   VA+K L  +    +   FL E   +  ++H  +
Sbjct: 6   ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTL--KPGTMSVQAFLEEANLMKTLQHDKL 63

Query: 752 VRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDC 811
           VRL   V+  +   ++ EYM  GSL + L   +GG +        + + A+G+ Y+    
Sbjct: 64  VRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN 123

Query: 812 SPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSY--GYIAPEYAY 869
               IHRD+++ N+L+       +ADFGLA+ ++D   +E  +     +   + APE   
Sbjct: 124 ---YIHRDLRAANVLVSESLMCKIADFGLARVIED---NEYTAREGAKFPIKWTAPEAIN 177

Query: 870 TLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAV 928
                 KSDV+SFG++L E++  GK P            +   + S+V         +  
Sbjct: 178 FGSFTIKSDVWSFGILLYEIVTYGKIP------------YPGMSNSDVMSALQRGYRM-- 223

Query: 929 VDPRLSGYPLTGVIHLFKVAMMCVEDESSARPT 961
             PR+   P      L+ +   C ++++  RPT
Sbjct: 224 --PRMENCP----DELYDIMKTCWKEKAEERPT 250

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 88.0 bits (218), Expect = 4e-19
 Identities = 54/160 (33%), Positives = 80/160 (50%), Gaps = 8/160 (5%)

Query: 739 EIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIAL 798
           EI+ + R+ H +I+R+LG         L  E+M  GS+  +L   K G  K         
Sbjct: 53  EIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLS--KYGAFKEAVIINYTE 110

Query: 799 EAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFE-AHVADFGLAKFL--QDAGASECMSS 855
           +  +GL YLH +    IIHRDVK  N+L+DS  +   +ADFG A  L  +  GA E    
Sbjct: 111 QLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQ 167

Query: 856 VAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
           + G+  ++APE     +     DV+S G V++E+   K P
Sbjct: 168 LLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPP 207

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 87.2 bits (216), Expect = 6e-19
 Identities = 67/273 (24%), Positives = 121/273 (44%), Gaps = 32/273 (11%)

Query: 700 IGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVS 759
           +G G  G+V+ G     I VAIK +       ++  F+ E + + ++ H  +V+L G  +
Sbjct: 12  LGSGQFGVVHLGKWRAQIKVAIKAI--NEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCT 69

Query: 760 NRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRD 819
            +    ++ E+M NG L   L   + G L  +    +  +  +G+ YL  +     IHRD
Sbjct: 70  QQKPLYIVTEFMENGCLLNYLR-QRQGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRD 125

Query: 820 VKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSY--GYIAPEYAYTLKVDEKS 877
           + + N L+ S     V+DFG+ +++ D    E  SS    +   +  PE     K   KS
Sbjct: 126 LAARNCLVSSTGVVKVSDFGMTRYVLD---DEYTSSSGAKFPVKWSPPEVFNFSKYSSKS 182

Query: 878 DVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDPRLSGY 936
           DV+SFGV++ E+   GK P  E     ++V  + +    + +P  A+             
Sbjct: 183 DVWSFGVLMWEVFTEGKMPF-EKKSNYEVVEMISR-GFRLYRPKLASMT----------- 229

Query: 937 PLTGVIHLFKVAMMCVEDESSARPTMREVVHML 969
                  +++V   C  ++   RPT  E++  +
Sbjct: 230 -------VYEVMYSCWHEKPEGRPTFAELLRAI 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 87.3 bits (217), Expect = 6e-19
 Identities = 67/209 (32%), Positives = 98/209 (46%), Gaps = 16/209 (7%)

Query: 698 NIIGKGGAGIVY---RGSMPDGIDVAIKRL-VGRGTGGNDHGFLAEIQTLGRIRHRNIVR 753
             IGKG  G V    R S  DG  +  K +  G  T       ++E+  L  ++H NIVR
Sbjct: 6   ETIGKGSFGTVRKVRRKS--DGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVR 63

Query: 754 LLGYVSNRDTNLLLY---EYMPNGSLGEMLHGAKGGHLKWETRY--RIALEAAKGLCYLH 808
               + +R +N  LY   EY   G L +++   K      E  +  RI  +    L   H
Sbjct: 64  YYDRIIDR-SNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECH 122

Query: 809 H--DCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPE 866
           +  D    ++HRD+K  NI LD++    + DFGLAK L    +S   + V   Y Y++PE
Sbjct: 123 NRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGH-DSSFAKTYVGTPY-YMSPE 180

Query: 867 YAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
               +  DEKSD++S G ++ EL A   P
Sbjct: 181 QLNHMSYDEKSDIWSLGCLIYELCALSPP 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 87.9 bits (218), Expect = 7e-19
 Identities = 63/219 (28%), Positives = 99/219 (45%), Gaps = 30/219 (13%)

Query: 700 IGKGGAGIVYRGSMPDGID------VAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVR 753
           +G+G  G V+ G             VA+K L    +      F  E + L   +H NIV+
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72

Query: 754 LLGYVSNRDTNLLLYEYMPNGSLGEML--HG----------AKGGHLKWETRYRIALEAA 801
             G  +  D  ++++EYM +G L + L  HG          +  G L      +IA++ A
Sbjct: 73  FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132

Query: 802 KGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGS-- 859
            G+ YL    S   +HRD+ + N L+  D    + DFG+++   D   ++    V G   
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR---DVYTTD-YYRVGGHTM 185

Query: 860 --YGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKP 895
               ++ PE     K   +SDV+SFGVVL E+   GK+P
Sbjct: 186 LPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 87.9 bits (218), Expect = 7e-19
 Identities = 61/224 (27%), Positives = 98/224 (43%), Gaps = 27/224 (12%)

Query: 688 EDVLESLKDENIIGKGGAGIVYRGSM--PDGID----VAIKRLVGRGTGGNDHGFLAEIQ 741
           E  L +++    +G+G  G VY+G +  P+       VAIK L           F  E +
Sbjct: 1   EIPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAE 60

Query: 742 TLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEML-------------HGAKGGHL 788
            +  ++H NIV LLG  +      +L+EY+ +G L E L                     
Sbjct: 61  LMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSS 120

Query: 789 KWETRY-RIALEAAKGLCYL--HHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQ 845
              + +  IA++ A G+ YL  HH      +HRD+ + N L+       ++DFGL++ + 
Sbjct: 121 LDCSDFLHIAIQIAAGMEYLSSHH-----FVHRDLAARNCLVGEGLTVKISDFGLSRDIY 175

Query: 846 DAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLEL 889
            A      S       ++ PE     K   +SD++SFGVVL E+
Sbjct: 176 SADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 86.8 bits (216), Expect = 8e-19
 Identities = 58/161 (36%), Positives = 76/161 (47%), Gaps = 11/161 (6%)

Query: 737 LAEIQTLGRIRHRNIVRLLGYVSNRDTNL-LLYEYMPNGSLGEMLHGAKGGHLKWETRYR 795
           L E   L RI H  IV+L  Y    +  L L+ EY P G L   L   K G    E    
Sbjct: 41  LTERNILSRINHPFIVKLH-YAFQTEEKLYLVLEYAPGGELFSHLS--KEGRFSEERARF 97

Query: 796 IALEAAKGLCYLH-HDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMS 854
            A E    L YLH       II+RD+K  NILLD+D    + DFGLAK  + +      +
Sbjct: 98  YAAEIVLALEYLHSLG----IIYRDLKPENILLDADGHIKLTDFGLAK--ELSSEGSRTN 151

Query: 855 SVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
           +  G+  Y+APE        +  D +S GV+L E++ GK P
Sbjct: 152 TFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPP 192

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 86.9 bits (215), Expect = 8e-19
 Identities = 66/206 (32%), Positives = 103/206 (50%), Gaps = 14/206 (6%)

Query: 691 LESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRN 750
           L+ L    IIG+G  G V +G    G  VA+K +    T      FL E   + ++ H+N
Sbjct: 5   LQKLTLGEIIGEGEFGAVLQGEYT-GQKVAVKNIKCDVTA---QAFLEETAVMTKLHHKN 60

Query: 751 IVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHD 810
           +VRLLG + +    +++ E M  G+L   L       +      + +L+ A+G+ YL   
Sbjct: 61  LVRLLGVILHNGLYIVM-ELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE-- 117

Query: 811 CSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYT 870
            S  ++HRD+ + NIL+  D  A V+DFGLA+ +   G       V     + APE    
Sbjct: 118 -SKKLVHRDLAARNILVSEDGVAKVSDFGLAR-VGSMGVDNSKLPVK----WTAPEALKH 171

Query: 871 LKVDEKSDVYSFGVVLLELIA-GKKP 895
            K   KSDV+S+GV+L E+ + G+ P
Sbjct: 172 KKFSSKSDVWSYGVLLWEVFSYGRAP 197

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 86.9 bits (215), Expect = 1e-18
 Identities = 75/296 (25%), Positives = 127/296 (42%), Gaps = 45/296 (15%)

Query: 694 LKDENIIGKGGAGIVYRGS-MPDG----IDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRH 748
           L+   ++G G  G V++G  +P+G    I VAIK +  R            +  +G + H
Sbjct: 9   LRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDH 68

Query: 749 RNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGG-----HLKWETRYRIALEAAKG 803
             IVRLLG        L+  +  P GSL + +   +        L W       ++ AKG
Sbjct: 69  AYIVRLLGICPGASLQLVT-QLSPLGSLLDHVRQHRDSLDPQRLLNW------CVQIAKG 121

Query: 804 LCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYI 863
           + YL       ++HR++ + NILL SD    +ADFG+A  L         S       ++
Sbjct: 122 MYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWM 178

Query: 864 APEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDA 922
           A E     +   +SDV+S+GV + E+++ G +P                      +P + 
Sbjct: 179 ALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGM------------------RPHEV 220

Query: 923 ASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH----MLANPPQ 974
             +L   + RL+  P    I ++ V + C   + + RPT +E+ +    M  +PP+
Sbjct: 221 PDLLEKGE-RLA-QPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARDPPR 274

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 86.3 bits (213), Expect = 2e-18
 Identities = 59/168 (35%), Positives = 89/168 (52%), Gaps = 16/168 (9%)

Query: 739 EIQTLGRIRHRNIVRLLGYVSNR--DTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRI 796
           EIQ L  ++H  IV+  G + +R   T  +  EYMP GS+ + L  A G   +  TR + 
Sbjct: 54  EIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLK-AYGALTESVTR-KY 111

Query: 797 ALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMS-- 854
             +  +G+ YLH   S +I+HRD+K  NIL DS     + DFG +K LQ    + CMS  
Sbjct: 112 TRQILEGMSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQ----TICMSGT 164

Query: 855 ---SVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEF 899
              SV G+  +++PE         K+DV+S G  ++E++  K P  E+
Sbjct: 165 GIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEY 212

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 86.0 bits (213), Expect = 3e-18
 Identities = 69/220 (31%), Positives = 106/220 (48%), Gaps = 27/220 (12%)

Query: 684 DFKAEDVLESLKDENIIGKGGAGIVYR-GSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQT 742
           D + ED LE++ D   +G G  G V +   +P G  +A K +            L E+Q 
Sbjct: 1   DLRNED-LETISD---LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQI 56

Query: 743 LGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAK 802
           +   R   IV   G   N +   +  E+M  GSL  +    KGG +  E   +IA+   +
Sbjct: 57  MHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYK--KGGPIPVEILGKIAVAVVE 114

Query: 803 GLCYL---HHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVA-- 857
           GL YL   H      I+HRD+K +NIL++S  +  + DFG++         E ++S+A  
Sbjct: 115 GLTYLYNVHR-----IMHRDIKPSNILVNSRGQIKLCDFGVS--------GELINSIADT 161

Query: 858 --GSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
             G+  Y++PE     K   KSDV+S G+ ++EL  GK P
Sbjct: 162 FVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFP 201

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 84.9 bits (210), Expect = 4e-18
 Identities = 55/197 (27%), Positives = 92/197 (46%), Gaps = 13/197 (6%)

Query: 697 ENIIGKGGAGIVYRGSMPD-GIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLL 755
           ++ +G G  G VY G      + VA+K L  +        FL E   +  I+H N+V+LL
Sbjct: 11  KHKLGGGQYGEVYEGVWKKYSLTVAVKTL--KEDTMEVEEFLKEAAVMKEIKHPNLVQLL 68

Query: 756 GYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLI 815
           G  +      ++ E+M  G+L + L       +       +A + +  + YL        
Sbjct: 69  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNF 125

Query: 816 IHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGS---YGYIAPEYAYTLK 872
           IHRD+ + N L+  +    VADFGL++ +      +  ++ AG+     + APE     K
Sbjct: 126 IHRDLAARNCLVGENHLVKVADFGLSRLMTG----DTYTAHAGAKFPIKWTAPESLAYNK 181

Query: 873 VDEKSDVYSFGVVLLEL 889
              KSDV++FGV+L E+
Sbjct: 182 FSIKSDVWAFGVLLWEI 198

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 84.7 bits (209), Expect = 5e-18
 Identities = 66/213 (30%), Positives = 104/213 (48%), Gaps = 21/213 (9%)

Query: 699 IIGKGGAGIVYRGSMPD-GIDVAIKRLV----GRGTGGNDHGFLAEIQTLGRIRHRNIVR 753
           ++G+G  G VY     D G ++A+K++      + T    +    EIQ L  +RH  IV+
Sbjct: 9   LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68

Query: 754 LLGYVSNRDTNLL--LYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDC 811
             G + + +   L    EYMP GS+ + L     G L      R   +  +G+ YLH   
Sbjct: 69  YYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAY--GALTENVTRRYTRQILQGVSYLH--- 123

Query: 812 SPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMS-----SVAGSYGYIAPE 866
           S +I+HRD+K  NIL DS     + DFG +K +Q    + CMS     SV G+  +++PE
Sbjct: 124 SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQ----TICMSGTGIKSVTGTPYWMSPE 179

Query: 867 YAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEF 899
                    K+DV+S    ++E++  K P  E+
Sbjct: 180 VISGEGYGRKADVWSVACTVVEMLTEKPPWAEY 212

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 84.6 bits (210), Expect = 6e-18
 Identities = 63/215 (29%), Positives = 94/215 (43%), Gaps = 22/215 (10%)

Query: 699 IIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRI-RHRNIVRLLG 756
           +IG+G  G VY+      G  VAIK  +       +     E   L +   H NI    G
Sbjct: 13  VIGEGTYGKVYKARHKKTGQLVAIK--IMDIIEDEEEEIKEEYNILRKYSNHPNIATFYG 70

Query: 757 -YVSNRDTNL-----LLYEYMPNGSLGEMLHG--AKGGHLKWETRYRIALEAAKGLCYLH 808
            ++            L+ E    GS+ +++ G   KG  LK E    I  E  +GL YLH
Sbjct: 71  AFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH 130

Query: 809 HDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPE-- 866
                 +IHRD+K  NILL  + E  + DFG++  L         ++  G+  ++APE  
Sbjct: 131 ---ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDS--TLGRRNTFIGTPYWMAPEVI 185

Query: 867 ---YAYTLKVDEKSDVYSFGVVLLELIAGKKPVGE 898
                     D +SDV+S G+  +EL  GK P+ +
Sbjct: 186 ACDEQPDASYDARSDVWSLGITAIELADGKPPLCD 220

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 84.3 bits (209), Expect = 7e-18
 Identities = 47/159 (29%), Positives = 69/159 (43%), Gaps = 8/159 (5%)

Query: 737 LAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRI 796
           L E + L  + H  +V L     + +   L+ + +  G L    H ++      E     
Sbjct: 48  LNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDL--RYHLSQKVKFSEEQVKFW 105

Query: 797 ALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSV 856
             E    L YLH   S  IIHRD+K +NILLD     H+ DF +A  +         +S 
Sbjct: 106 ICEIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTP---DTLTTST 159

Query: 857 AGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
           +G+ GY+APE           D +S GV   E + GK+P
Sbjct: 160 SGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRP 198

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 83.5 bits (207), Expect = 1e-17
 Identities = 69/207 (33%), Positives = 98/207 (47%), Gaps = 25/207 (12%)

Query: 700 IGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHGFLA-EIQTLGRIRHRNIVRLLGY 757
           IG G  G VY+   +  G  VAIK  V +   G+D   +  EI  L   RH NIV   G 
Sbjct: 11  IGSGTYGDVYKARDIATGELVAIK--VIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGS 68

Query: 758 VSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIAL---EAAKGLCYLHHDCSPL 814
              RD   ++ EY   GSL ++      G L   +  +IA    E  KGL YLH      
Sbjct: 69  YLRRDKLWIVMEYCGGGSLQDIYQ-VTRGPL---SELQIAYVCRETLKGLAYLHETG--- 121

Query: 815 IIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMS---SVAGSYGYIAPEYAYTL 871
            IHRD+K  NILL  D +  +ADFG++     A  +  ++   S  G+  ++APE A   
Sbjct: 122 KIHRDIKGANILLTEDGDVKLADFGVS-----AQLTATIAKRKSFIGTPYWMAPEVAAVE 176

Query: 872 KV---DEKSDVYSFGVVLLELIAGKKP 895
           +    D K D+++ G+  +EL   + P
Sbjct: 177 RKGGYDGKCDIWALGITAIELAELQPP 203

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 83.0 bits (206), Expect = 2e-17
 Identities = 65/213 (30%), Positives = 101/213 (47%), Gaps = 25/213 (11%)

Query: 692 ESLKDENIIGKGGAGIVYRGSMPDGID------VAIKRLVGRGTGGNDHGFLA-EIQTLG 744
           E       IGKG  G VY+      ID      VAIK ++      ++   +  EIQ L 
Sbjct: 1   ELFTLLECIGKGSFGEVYKA-----IDKRTNQVVAIK-VIDLEEAEDEIEDIQQEIQFLS 54

Query: 745 RIRHRNIVRLLG-YVSNRDTNL-LLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAK 802
           + R   I +  G ++  + + L ++ EY   GS  ++L   K G L       I  E   
Sbjct: 55  QCRSPYITKYYGSFL--KGSKLWIIMEYCGGGSCLDLL---KPGKLDETYIAFILREVLL 109

Query: 803 GLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGY 862
           GL YLH +     IHRD+K+ NILL  + +  +ADFG++  L    +    ++  G+  +
Sbjct: 110 GLEYLHEEGK---IHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSK--RNTFVGTPFW 164

Query: 863 IAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
           +APE       DEK+D++S G+  +EL  G+ P
Sbjct: 165 MAPEVIKQSGYDEKADIWSLGITAIELAKGEPP 197

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 82.1 bits (203), Expect = 4e-17
 Identities = 85/283 (30%), Positives = 118/283 (41%), Gaps = 44/283 (15%)

Query: 698 NIIGKGGAGIVYRGSMPDG----IDVAIKRLVGRGTGGND-HGFLAEIQTLGRIRHRNIV 752
            +IGKG  G VY G++ D     I  A+K L  R T   +   FL E   +    H N++
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSL-NRITDLEEVEQFLKEGIIMKDFSHPNVL 59

Query: 753 RLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETR-------YRIALEAAKGLC 805
            LLG         L  E  P   L  M HG     ++ ET            L+ AKG+ 
Sbjct: 60  SLLGI-------CLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGME 112

Query: 806 YLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSY--GYI 863
           YL    S   +HRD+ + N +LD  F   VADFGLA+ + D       +         ++
Sbjct: 113 YL---ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWM 169

Query: 864 APEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAA 923
           A E   T K   KSDV+SFGV+L EL+    P     D  DI  ++ +    + QP    
Sbjct: 170 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQ-GRRLLQPEYCP 228

Query: 924 SVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVV 966
                 DP            L++V + C   +   RPT  E+V
Sbjct: 229 ------DP------------LYEVMLSCWHPKPEMRPTFSELV 253

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 83.7 bits (207), Expect = 5e-17
 Identities = 69/222 (31%), Positives = 106/222 (47%), Gaps = 25/222 (11%)

Query: 691 LESLKDENIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHR 749
           L  L+  N IG G  G VY+    P G   A+K + G            EI+ L  + H 
Sbjct: 73  LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHP 132

Query: 750 NIVRLLG-YVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRY--RIALEAAKGLCY 806
           N+V+    +  N +  +LL E+M  GSL       +G H+  + ++   +A +   G+ Y
Sbjct: 133 NVVKCHDMFDHNGEIQVLL-EFMDGGSL-------EGTHI-ADEQFLADVARQILSGIAY 183

Query: 807 LHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPE 866
           LH      I+HRD+K +N+L++S     +ADFG+++ L       C SSV G+  Y++PE
Sbjct: 184 LH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQT-MDPCNSSV-GTIAYMSPE 238

Query: 867 YAYTLKVDEK-----SDVYSFGVVLLELIAGKKP--VGEFGD 901
              T            D++S GV +LE   G+ P  VG  GD
Sbjct: 239 RINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD 280

Length = 353

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 81.6 bits (201), Expect = 5e-17
 Identities = 68/229 (29%), Positives = 108/229 (47%), Gaps = 13/229 (5%)

Query: 699 IIGKGGAGIVYRGSMPD-GIDVAIKRLV----GRGTGGNDHGFLAEIQTLGRIRHRNIVR 753
           ++G+G  G VY     D G ++A+K++        T    +    EIQ L  + H  IV+
Sbjct: 9   LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68

Query: 754 LLGYVSN--RDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDC 811
             G + +    T  +  E+MP GS+ + L     G L      +   +  +G+ YLH   
Sbjct: 69  YYGCLRDPMERTLSIFMEHMPGGSIKDQLKSY--GALTENVTRKYTRQILEGVSYLH--- 123

Query: 812 SPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASEC-MSSVAGSYGYIAPEYAYT 870
           S +I+HRD+K  NIL DS     + DFG +K LQ    S   M SV G+  +++PE    
Sbjct: 124 SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISG 183

Query: 871 LKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQP 919
                K+D++S G  ++E++  K P  EF     I +   + T+ V  P
Sbjct: 184 EGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPP 232

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 80.8 bits (199), Expect = 8e-17
 Identities = 57/190 (30%), Positives = 94/190 (49%), Gaps = 5/190 (2%)

Query: 699 IIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYV 758
           ++GKG  G V++G++ D   VA+K             FL+E + L +  H NIV+L+G  
Sbjct: 2   LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61

Query: 759 SNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHR 818
           + R    ++ E +P G     L   K   LK +   + AL+AA G+ YL    S   IHR
Sbjct: 62  TQRQPIYIVMELVPGGDFLSFLR-KKKDELKTKQLVKFALDAAAGMAYLE---SKNCIHR 117

Query: 819 DVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSD 878
           D+ + N L+  +    ++DFG+++  +D G             + APE     +   +SD
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSR-QEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESD 176

Query: 879 VYSFGVVLLE 888
           V+S+G++L E
Sbjct: 177 VWSYGILLWE 186

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 82.0 bits (203), Expect = 8e-17
 Identities = 64/201 (31%), Positives = 94/201 (46%), Gaps = 12/201 (5%)

Query: 698 NIIGKGGAGIVYRG-SMPDGIDVAIKRL-VGRGTGGNDHGFLAEIQTLGRIRHRNIVRLL 755
           N IG+G  GIVYR      G  VA+K++ +     G     L EI  L  +RH NIV L 
Sbjct: 13  NRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELK 72

Query: 756 GYVSNR--DTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSP 813
             V  +  D+  L+ EY     L  +L        + + +  + L+  +GL YLH +   
Sbjct: 73  EVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKC-LMLQLLRGLQYLHENF-- 128

Query: 814 LIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKV 873
            IIHRD+K +N+LL       +ADFGLA+          M+    +  Y APE       
Sbjct: 129 -IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKP--MTPKVVTLWYRAPELLLGCTT 185

Query: 874 DEKS-DVYSFGVVLLELIAGK 893
              + D+++ G +L EL+A K
Sbjct: 186 YTTAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 82.0 bits (202), Expect = 9e-17
 Identities = 83/293 (28%), Positives = 139/293 (47%), Gaps = 40/293 (13%)

Query: 694 LKDENIIGKGGAGIVYRGS-MPDG----IDVAIKRLVGRGTGGNDH-GFLAEIQTLGRIR 747
           LK   ++G G  G VY+G  +P+G    I VAIK ++   TG   +  F+ E   +  + 
Sbjct: 9   LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIK-ILNETTGPKANVEFMDEALIMASMD 67

Query: 748 HRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYL 807
           H ++VRLLG V    T  L+ + MP+G L + +H  K  ++  +      ++ AKG+ YL
Sbjct: 68  HPHLVRLLG-VCLSPTIQLVTQLMPHGCLLDYVHEHKD-NIGSQLLLNWCVQIAKGMMYL 125

Query: 808 HHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSY--GYIAP 865
                  ++HRD+ + N+L+ S     + DFGLA+ L+  G  +  ++  G     ++A 
Sbjct: 126 EER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLE--GDEKEYNADGGKMPIKWMAL 180

Query: 866 EYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAAS 924
           E  +  K   +SDV+S+GV + EL+  G KP     DG+               P+    
Sbjct: 181 ECIHYRKFTHQSDVWSYGVTIWELMTFGGKPY----DGI---------------PTREIP 221

Query: 925 VLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVV---HMLANPPQ 974
            L     RL   P+   I ++ V + C   ++ +RP  +E+      +A  PQ
Sbjct: 222 DLLEKGERLPQPPIC-TIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDPQ 273

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 81.6 bits (202), Expect = 9e-17
 Identities = 60/203 (29%), Positives = 98/203 (48%), Gaps = 23/203 (11%)

Query: 700 IGKGGAGIVYRGSMPD-GIDVAIKRLVGRGTGGNDH---GFLAEIQTLGRIRHRNIVRLL 755
           +G+G  G+V +      G  VAIK+   + +  ++      L E++ L ++RH NIV L 
Sbjct: 9   VGEGAYGVVLKCRNKATGEIVAIKKF--KESEDDEDVKKTALREVKVLRQLRHENIVNLK 66

Query: 756 GYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLH-HDCSPL 814
                +    L++EY+   +L E+L  + GG L  +       +  + + Y H H+    
Sbjct: 67  EAFRRKGRLYLVFEYVER-TLLELLEASPGG-LPPDAVRSYIWQLLQAIAYCHSHN---- 120

Query: 815 IIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVD 874
           IIHRD+K  NIL+       + DFG A+ L+   AS     VA  + Y APE    L V 
Sbjct: 121 IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRW-YRAPE----LLVG 175

Query: 875 EKS-----DVYSFGVVLLELIAG 892
           + +     DV++ G ++ EL+ G
Sbjct: 176 DTNYGKPVDVWAIGCIMAELLDG 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 81.0 bits (200), Expect = 1e-16
 Identities = 63/176 (35%), Positives = 87/176 (49%), Gaps = 12/176 (6%)

Query: 719 VAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLG--YVSNRDTNLLLYEYMPNGSL 776
           VA+K+L    T  +   F  EI+ L  ++H NIV+  G  Y + R    L+ EY+P GSL
Sbjct: 36  VAVKKL-QHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSL 94

Query: 777 GEML--HGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAH 834
            + L  H  +  H K       A +  KG+ YL    S   +HRD+ + NIL++S+    
Sbjct: 95  RDYLQKHRERLDHRKL---LLYASQICKGMEYLG---SKRYVHRDLATRNILVESENRVK 148

Query: 835 VADFGLAKFL-QDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLEL 889
           + DFGL K L QD    +          + APE     K    SDV+SFGVVL EL
Sbjct: 149 IGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 204

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 81.0 bits (201), Expect = 1e-16
 Identities = 62/209 (29%), Positives = 93/209 (44%), Gaps = 32/209 (15%)

Query: 699 IIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHGF----LAEIQTLGRIRHRNIVR 753
            +G+G  G+VY+      G  VA+K++  R     + G     L EI  L  ++H NIV+
Sbjct: 6   KLGEGTYGVVYKARDKKTGEIVALKKI--RLDNEEE-GIPSTALREISLLKELKHPNIVK 62

Query: 754 LLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGG----HLKWETRYRIALEAAKGLCYLHH 809
           LL  +       L++EY     L + L    G      +K      I  +  +GL Y H 
Sbjct: 63  LLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIK-----SIMYQLLRGLAYCH- 115

Query: 810 DCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPE--- 866
             S  I+HRD+K  NIL++ D    +ADFGLA+           +    +  Y APE   
Sbjct: 116 --SHRILHRDLKPQNILINRDGVLKLADFGLARAFGI--PLRTYTHEVVTLWYRAPEILL 171

Query: 867 --YAYTLKVDEKSDVYSFGVVLLELIAGK 893
               Y+  V    D++S G +  E+I GK
Sbjct: 172 GSKHYSTAV----DIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 80.8 bits (200), Expect = 2e-16
 Identities = 53/200 (26%), Positives = 92/200 (46%), Gaps = 16/200 (8%)

Query: 700 IGKGGAGIVYRG-SMPDGIDVAIKRL-VGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGY 757
           IG+G  G+VY+      G  VAIK++ +   + G     L EI+ L  + H NI++LL  
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66

Query: 758 VSNRDTNLLLYEYMPNGSLGEMLHGAKG---GHLKWETRYRIALEAAKGLCYLHHDCSPL 814
             ++    L++E+M       +    +G     +K         +  +GL + H   S  
Sbjct: 67  FRHKGDLYLVFEFMDTDLYKLIKDRQRGLPESLIKS-----YLYQLLQGLAFCH---SHG 118

Query: 815 IIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKV- 873
           I+HRD+K  N+L++++    +ADFGLA+           +    +  Y APE     K  
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGLARSF--GSPVRPYTHYVVTRWYRAPELLLGDKGY 176

Query: 874 DEKSDVYSFGVVLLELIAGK 893
               D++S G +  EL++ +
Sbjct: 177 STPVDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 80.2 bits (198), Expect = 2e-16
 Identities = 49/169 (28%), Positives = 81/169 (47%), Gaps = 19/169 (11%)

Query: 736 FLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLG----EMLHGAKGGHLKWE 791
           F+ EI  L   +H NIV L       +   +L E+   G+L     E+  G     +++ 
Sbjct: 49  FMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYV 108

Query: 792 TRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASE 851
            R  +     + L +LH   S  +IHRD+K+ NILL  D +  +ADFG++   +     +
Sbjct: 109 CRQML-----EALNFLH---SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKS--TLQ 158

Query: 852 CMSSVAGSYGYIAPEYAY--TLK---VDEKSDVYSFGVVLLELIAGKKP 895
              +  G+  ++APE     T K    D K+D++S G+ L+EL   + P
Sbjct: 159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPP 207

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 80.2 bits (198), Expect = 3e-16
 Identities = 56/213 (26%), Positives = 100/213 (46%), Gaps = 32/213 (15%)

Query: 698 NIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHG-FLAEIQTLGRIRHRNIVRLLG 756
           + +G+G  G V +  + +   +   + +      +     L E++     +   IV+  G
Sbjct: 7   SRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYG 66

Query: 757 -YVSNRDTNL-LLYEYMPNGSL----GEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHD 810
            ++    +++ +  EY   GSL     ++    +GG +  +   +IA    KGL YLH  
Sbjct: 67  AFLDESSSSIGIAMEYCEGGSLDSIYKKVK--KRGGRIGEKVLGKIAESVLKGLSYLH-- 122

Query: 811 CSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYG----YIAPE 866
            S  IIHRD+K +NILL    +  + DFG+        + E ++S+AG++     Y+APE
Sbjct: 123 -SRKIIHRDIKPSNILLTRKGQVKLCDFGV--------SGELVNSLAGTFTGTSFYMAPE 173

Query: 867 Y----AYTLKVDEKSDVYSFGVVLLELIAGKKP 895
                 Y++     SDV+S G+ LLE+   + P
Sbjct: 174 RIQGKPYSI----TSDVWSLGLTLLEVAQNRFP 202

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 79.9 bits (198), Expect = 3e-16
 Identities = 54/177 (30%), Positives = 82/177 (46%), Gaps = 26/177 (14%)

Query: 739 EIQTLGRI-RHRNIVRLLGYVSNRDTNL-LLYEYMPNGSLGEMLHGAKGGHLKWETRYRI 796
           E + L R+  H  I++L     + + NL  + EY PNG L + +        K  TR+  
Sbjct: 51  EKEVLTRLNGHPGIIKLYYTFQD-EENLYFVLEYAPNGELLQYIRKYGSLDEKC-TRF-Y 107

Query: 797 ALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFL-------QDAGA 849
           A E    L YLH   S  IIHRD+K  NILLD D    + DFG AK L        + G 
Sbjct: 108 AAEILLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGD 164

Query: 850 SECM-----------SSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
           +  +           +S  G+  Y++PE        + SD+++ G ++ +++ GK P
Sbjct: 165 ATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 79.5 bits (196), Expect = 3e-16
 Identities = 52/161 (32%), Positives = 84/161 (52%), Gaps = 9/161 (5%)

Query: 739 EIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIAL 798
           EI  L  ++H NIV+ LG   + D   +  EY+P GS+  +L+    G  +         
Sbjct: 56  EIALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNY--GAFEETLVRNFVR 113

Query: 799 EAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQ----DAGASECMS 854
           +  KGL YLH   +  IIHRD+K  NIL+D+     ++DFG++K L+        +    
Sbjct: 114 QILKGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARP 170

Query: 855 SVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
           S+ GS  ++APE         K+D++S G +++E++ GK P
Sbjct: 171 SLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 79.0 bits (195), Expect = 3e-16
 Identities = 58/203 (28%), Positives = 99/203 (48%), Gaps = 17/203 (8%)

Query: 699 IIGKG--GAGIVYRGSMPDGI----DVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIV 752
           ++GKG  G   +YR +  D +    +V + RL  +         L EI  L  ++H NI+
Sbjct: 7   VLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKER----RDALNEIVILSLLQHPNII 62

Query: 753 RLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCS 812
               +  + +T L+  EY   G+L + +   KG   + E       +    + Y+H    
Sbjct: 63  AYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH---K 119

Query: 813 PLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMS-SVAGSYGYIAPEYAYTL 871
             I+HRD+K+ NI L       + DFG++K L   G+   M+ +V G+  Y++PE    +
Sbjct: 120 AGILHRDIKTLNIFLTKAGLIKLGDFGISKIL---GSEYSMAETVVGTPYYMSPELCQGV 176

Query: 872 KVDEKSDVYSFGVVLLELIAGKK 894
           K + KSD+++ G VL EL+  K+
Sbjct: 177 KYNFKSDIWALGCVLYELLTLKR 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 78.9 bits (194), Expect = 4e-16
 Identities = 58/207 (28%), Positives = 104/207 (50%), Gaps = 12/207 (5%)

Query: 692 ESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNI 751
           ESLK E  +G G  G V+  +      VA+K +  +    +   FLAE   +  ++H  +
Sbjct: 6   ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTM--KPGSMSVEAFLAEANVMKTLQHDKL 63

Query: 752 VRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDC 811
           V+L   V+ ++   ++ E+M  GSL + L   +G           + + A+G+ ++    
Sbjct: 64  VKLHAVVT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN 122

Query: 812 SPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSY--GYIAPEYAY 869
               IHRD+++ NIL+ +     +ADFGLA+ ++D   +E  +     +   + APE   
Sbjct: 123 ---YIHRDLRAANILVSASLVCKIADFGLARVIED---NEYTAREGAKFPIKWTAPEAIN 176

Query: 870 TLKVDEKSDVYSFGVVLLELIA-GKKP 895
                 KSDV+SFG++L+E++  G+ P
Sbjct: 177 FGSFTIKSDVWSFGILLMEIVTYGRIP 203

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 79.0 bits (195), Expect = 4e-16
 Identities = 65/234 (27%), Positives = 116/234 (49%), Gaps = 22/234 (9%)

Query: 691 LESLKDENIIGKGGAGIVYRG-SMPDGIDVAIKRL----VGRGTGGNDHGFLAEIQTLGR 745
           L + K E  IGKG   +VY+   + DG  VA+K++    +       D   L EI  L +
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQD--CLKEIDLLKQ 58

Query: 746 IRHRNIVRLL-GYVSNRDTNLLLYEYMPNGSLGEML-HGAKGGHLKWE-TRYRIALEAAK 802
           + H N+++ L  ++ N + N++L E    G L  M+ H  K   L  E T ++  ++   
Sbjct: 59  LDHPNVIKYLASFIENNELNIVL-ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCS 117

Query: 803 GLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMS--SVAGSY 860
            L ++H   S  I+HRD+K  N+ + +     + D GL +F     +S+  +  S+ G+ 
Sbjct: 118 ALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFF----SSKTTAAHSLVGTP 170

Query: 861 GYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTS 914
            Y++PE  +    + KSD++S G +L E+ A + P   +GD +++    +K   
Sbjct: 171 YYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF--YGDKMNLYSLCKKIEK 222

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 79.4 bits (196), Expect = 6e-16
 Identities = 49/161 (30%), Positives = 86/161 (53%), Gaps = 10/161 (6%)

Query: 737 LAEIQTLGRIRHRNIVRLLG-YVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYR 795
           + E++ L       IV   G + S+ + ++ + E+M  GSL ++L   K G +      +
Sbjct: 47  IRELKVLHECNSPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVLK--KAGRIPENILGK 103

Query: 796 IALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSS 855
           I++   +GL YL       I+HRDVK +NIL++S  E  + DFG++  L D+ A    +S
Sbjct: 104 ISIAVLRGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA----NS 157

Query: 856 VAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPV 896
             G+  Y++PE         +SD++S G+ L+E+  G+ P+
Sbjct: 158 FVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPI 198

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 79.2 bits (195), Expect = 6e-16
 Identities = 61/192 (31%), Positives = 95/192 (49%), Gaps = 13/192 (6%)

Query: 716 GIDVAIKRLVGRGTGGNDHGFL-AEIQTLGRIRHRNIVRLLGYVSNRDTN--LLLYEYMP 772
           G  VA+K L    +GGN    L  EI+ L  + H NIV+  G  +    N   L+ E++P
Sbjct: 33  GEQVAVKSL-KPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLP 91

Query: 773 NGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFE 832
           +GSL E L   K   +  + + + A++  KG+ YL    S   +HRD+ + N+L++S+ +
Sbjct: 92  SGSLKEYLPRNKN-KINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQ 147

Query: 833 AHVADFGLAKFLQ-DAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELI- 890
             + DFGL K ++ D         +     + APE     K    SDV+SFGV L EL+ 
Sbjct: 148 VKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT 207

Query: 891 ---AGKKPVGEF 899
              +   P+  F
Sbjct: 208 YCDSESSPMTLF 219

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 77.6 bits (191), Expect = 1e-15
 Identities = 66/203 (32%), Positives = 99/203 (48%), Gaps = 17/203 (8%)

Query: 699 IIGKGGAGIVY--RGSMPDGIDVAIKRL-VGRGTGGNDHGFLAEIQTLGRIRHRNIVRLL 755
           ++G+G  GIV+  R    D   V IK++ V + T         E Q L  + H NI+   
Sbjct: 7   VVGRGAFGIVHLCRR-KADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNII--- 62

Query: 756 GYVSN--RDTNLLL-YEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCS 812
            Y  N   D  L++  EY P G+L E +       L  +T   I     + L  LHH  +
Sbjct: 63  EYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDT---ILHFFVQILLALHHVHT 119

Query: 813 PLIIHRDVKSNNILLDS-DFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTL 871
            LI+HRD+K+ NILLD       + DFG++K L     +    +V G+  YI+PE     
Sbjct: 120 KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKA---YTVVGTPCYISPELCEGK 176

Query: 872 KVDEKSDVYSFGVVLLELIAGKK 894
             ++KSD+++ G VL EL + K+
Sbjct: 177 PYNQKSDIWALGCVLYELASLKR 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 77.9 bits (192), Expect = 1e-15
 Identities = 46/153 (30%), Positives = 72/153 (47%), Gaps = 7/153 (4%)

Query: 745 RIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHG--AKGGHLKWETRYRIALEAAK 802
           ++RH NIVR        D   ++ + +    LGE  +    K      E  + I ++   
Sbjct: 65  QLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVL 124

Query: 803 GLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGY 862
            L YLH +    I+HRD+  NNI+L  D +  + DFGLAK          ++SV G+  Y
Sbjct: 125 ALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAK---QKQPESKLTSVVGTILY 179

Query: 863 IAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
             PE        EK+DV++FG +L ++   + P
Sbjct: 180 SCPEIVKNEPYGEKADVWAFGCILYQMCTLQPP 212

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 77.8 bits (192), Expect = 1e-15
 Identities = 57/202 (28%), Positives = 93/202 (46%), Gaps = 11/202 (5%)

Query: 699 IIGKGGAGIVYRGSM----PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRL 754
            IG+G  G VY+G       + I VA+K      +      FL E   + +  H +IV+L
Sbjct: 13  CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72

Query: 755 LGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPL 814
           +G ++     +++ E  P G L   L   K   L   +    + + +  L YL    S  
Sbjct: 73  IGVITENPVWIVM-ELAPLGELRSYLQVNKY-SLDLASLILYSYQLSTALAYLE---SKR 127

Query: 815 IIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVD 874
            +HRD+ + N+L+ S     + DFGL+++L+D    +  S       ++APE     +  
Sbjct: 128 FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKA-SKGKLPIKWMAPESINFRRFT 186

Query: 875 EKSDVYSFGVVLLE-LIAGKKP 895
             SDV+ FGV + E L+ G KP
Sbjct: 187 SASDVWMFGVCMWEILMLGVKP 208

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 77.3 bits (190), Expect = 2e-15
 Identities = 67/224 (29%), Positives = 113/224 (50%), Gaps = 15/224 (6%)

Query: 693 SLKDENIIGKGGAGIVYRG--SMPDG--IDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRH 748
           S+K E I+G G  G + RG   +P    + VAI  L    +     GFLAE  TLG+  H
Sbjct: 6   SIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDH 65

Query: 749 RNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLH 808
            NIVRL G ++  +T +++ EYM NG+L   L   + G L       +    A G+ YL 
Sbjct: 66  SNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHE-GQLVAGQLMGMLPGLASGMKYL- 123

Query: 809 HDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYG--YIAPE 866
                  +H+ + ++ +L++SD    ++ F     LQ+  +    ++++G     + APE
Sbjct: 124 --SEMGYVHKGLAAHKVLVNSDLVCKISGFRR---LQEDKSEAIYTTMSGKSPVLWAAPE 178

Query: 867 YAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWV 909
                     SDV+SFG+V+ E+++ G++P  +   G D+++ V
Sbjct: 179 AIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMS-GQDVIKAV 221

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 78.1 bits (192), Expect = 2e-15
 Identities = 61/216 (28%), Positives = 106/216 (49%), Gaps = 24/216 (11%)

Query: 694 LKDENIIGKGGAGIVYRGSM-PDGI--DVAIKRLVGRGTGGNDHGFLAEIQTLGRI-RHR 749
           +K +++IG+G  G V +  +  DG+  D AIKR+    +  +   F  E++ L ++  H 
Sbjct: 9   IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHP 68

Query: 750 NIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAK--------------GGHLKWETRYR 795
           NI+ LLG   +R    L  EY P+G+L + L  ++                 L  +    
Sbjct: 69  NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 128

Query: 796 IALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSS 855
            A + A+G+ YL        IHRD+ + NIL+  ++ A +ADFGL++  Q+    + M  
Sbjct: 129 FAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRG-QEVYVKKTMGR 184

Query: 856 VAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA 891
           +     ++A E          SDV+S+GV+L E+++
Sbjct: 185 L--PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 77.1 bits (190), Expect = 2e-15
 Identities = 58/202 (28%), Positives = 93/202 (46%), Gaps = 15/202 (7%)

Query: 700 IGKGGAGIVYRGS-MPDGIDVAIKRL-VGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGY 757
           +GKG  G VY+   + D    A+K + +G  +       + EI+ L  + H NI+     
Sbjct: 8   LGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISY--K 65

Query: 758 VSNRDTNLL--LYEYMPNGSLGEML--HGAKGGHLKWETRYRIALEAAKGLCYLHHDCSP 813
            +  D N L  + EY P G L + +     K   +  +  +RI ++  +GL  LH     
Sbjct: 66  EAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH---EQ 122

Query: 814 LIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKV 873
            I+HRD+KS NILL ++    + D G++K L          +  G+  Y+APE       
Sbjct: 123 KILHRDLKSANILLVANDLVKIGDLGISKVL----KKNMAKTQIGTPHYMAPEVWKGRPY 178

Query: 874 DEKSDVYSFGVVLLELIAGKKP 895
             KSD++S G +L E+     P
Sbjct: 179 SYKSDIWSLGCLLYEMATFAPP 200

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 77.6 bits (191), Expect = 2e-15
 Identities = 80/303 (26%), Positives = 121/303 (39%), Gaps = 57/303 (18%)

Query: 694 LKDENIIGKGGAG--IVYR--------GSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTL 743
           LK   ++G+G  G   +Y         G M     VA+K L       N  G+  EI  L
Sbjct: 6   LKKIRVLGEGHFGKVSLYCYDPANDGTGEM-----VAVKTLKRECGQQNTSGWKKEINIL 60

Query: 744 GRIRHRNIVRLLGYVSNRDTN--LLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAA 801
             + H NIV+  G  S +      L+ EY+P GSL + L   K   L        A +  
Sbjct: 61  KTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK---LNLAQLLLFAQQIC 117

Query: 802 KGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGS-Y 860
           +G+ YLH   S   IHRD+ + N+LLD+D    + DFGLAK + +      +     S  
Sbjct: 118 EGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPV 174

Query: 861 GYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPS 920
            + A E     K    SDV+SFGV L EL+                       S+ S P 
Sbjct: 175 FWYAVECLKENKFSYASDVWSFGVTLYELLT-------------------HCDSKQSPPK 215

Query: 921 DAASVLAVVDPRLSGYPLTGVI--------------HLFKVAMMCVEDESSARPTMREVV 966
               ++     +++   L  ++               ++ +   C E E+  RPT R ++
Sbjct: 216 KFEEMIGPKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLI 275

Query: 967 HML 969
            +L
Sbjct: 276 PIL 278

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 77.2 bits (190), Expect = 2e-15
 Identities = 66/218 (30%), Positives = 95/218 (43%), Gaps = 25/218 (11%)

Query: 698 NIIGKGGAGIVYRGSMPD-------GIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRN 750
           N +G G  G VY G+  D        I VA+K L    T      FL E   +    H N
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60

Query: 751 IVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAK-----GGHLKWETRYRIALEAAKGLC 805
           IV+LLG     +   ++ E M  G L   L  A+        L  +    I L+ AKG  
Sbjct: 61  IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120

Query: 806 YLH--HDCSPLIIHRDVKSNNILL-----DSDFEAHVADFGLAKFLQDAGASECMSSVAG 858
           YL   H      IHRD+ + N L+     D+D    + DFGLA+ +  +           
Sbjct: 121 YLEQMH-----FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLL 175

Query: 859 SYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKP 895
              ++APE     K   +SDV+SFGV++ E++  G++P
Sbjct: 176 PVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 77.4 bits (190), Expect = 2e-15
 Identities = 64/219 (29%), Positives = 105/219 (47%), Gaps = 26/219 (11%)

Query: 692 ESLKDENIIGKGGAGIVYRGSMP-DG--IDVAIKRLVGRGTGGNDHGFLAEIQTLGRI-R 747
           E +K E++IG+G  G V R  +  DG  ++ AIK L    +  +   F  E++ L ++  
Sbjct: 2   EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGH 61

Query: 748 HRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEML---------------HGAKGGHLKWET 792
           H NI+ LLG   NR    +  EY P G+L + L               HG     L  + 
Sbjct: 62  HPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGT-ASTLTSQQ 120

Query: 793 RYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASEC 852
             + A + A G+ YL        IHRD+ + N+L+  +  + +ADFGL++  ++    + 
Sbjct: 121 LLQFASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSRG-EEVYVKKT 176

Query: 853 MSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA 891
           M  +     ++A E         KSDV+SFGV+L E+++
Sbjct: 177 MGRL--PVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 79.9 bits (197), Expect = 3e-15
 Identities = 59/198 (29%), Positives = 84/198 (42%), Gaps = 41/198 (20%)

Query: 485 LSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYGKI 544
           L L N  L G IP +   L+ + SIN+S N+I G IP S+    SL  +DLS NS  G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 545 PPGISKLIDLSILNLSRNGITGSIPNEMRNMMSLTTLDLSYNNLIGNIPSGGQFLAFNET 604
           P  + +L  L ILNL+ N ++G +P  +                      GG+ L     
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAAL----------------------GGRLLHRASF 520

Query: 605 SFIGNPNLC---LLRNGTCQSLINSAKHSGDGYGSSFGASKIVITVIALLTFMLLVILTI 661
           +F  N  LC    LR   C   ++               +KI I     + F+ LVI  +
Sbjct: 521 NFTDNAGLCGIPGLR--ACGPHLSV-------------GAKIGIAFGVSVAFLFLVICAM 565

Query: 662 YQLRKRRLQKSKAWKLTA 679
               KRR    +A ++ A
Sbjct: 566 CWW-KRRQNILRAQRIAA 582

Length = 623

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 77.2 bits (190), Expect = 3e-15
 Identities = 71/220 (32%), Positives = 102/220 (46%), Gaps = 24/220 (10%)

Query: 685 FKAEDVLESLKDENIIGKGGAGIVY--RGSMPDGIDVAIKRLVGRGTGGND--HGFLAEI 740
           F  +D  +   D   IG G  G VY  R    + + VAIK++   G   N+     + E+
Sbjct: 8   FSKDDPEKLFTDLREIGHGSFGAVYFARDVRTNEV-VAIKKMSYSGKQSNEKWQDIIKEV 66

Query: 741 QTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEA 800
           + L ++RH N +   G      T  L+ EY   GS  ++L   K    + E    I   A
Sbjct: 67  RFLQQLRHPNTIEYKGCYLREHTAWLVMEYCL-GSASDILEVHKKPLQEVEIA-AICHGA 124

Query: 801 AKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSY 860
            +GL YLH       IHRD+K+ NILL       +ADFG A  +  A      +S  G+ 
Sbjct: 125 LQGLAYLHSHER---IHRDIKAGNILLTEPGTVKLADFGSASLVSPA------NSFVGTP 175

Query: 861 GYIAPEYAYTLKVDE-----KSDVYSFGVVLLELIAGKKP 895
            ++APE    L +DE     K DV+S G+  +EL A +KP
Sbjct: 176 YWMAPE--VILAMDEGQYDGKVDVWSLGITCIEL-AERKP 212

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 76.3 bits (188), Expect = 5e-15
 Identities = 60/203 (29%), Positives = 96/203 (47%), Gaps = 15/203 (7%)

Query: 699 IIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGND-HGFLAEIQTLGRIRH---RNIVR 753
           +IG+G  G VYRG  +P G  VA+K ++   T  +D      E+  L ++R     NI +
Sbjct: 8   LIGRGAYGAVYRGKHVPTGRVVALK-IINLDTPDDDVSDIQREVALLSQLRQSQPPNITK 66

Query: 754 LLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSP 813
             G         ++ EY   GS+  ++   K G +  +    I  E    L Y+H     
Sbjct: 67  YYGSYLKGPRLWIIMEYAEGGSVRTLM---KAGPIAEKYISVIIREVLVALKYIHKVG-- 121

Query: 814 LIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKV 873
            +IHRD+K+ NIL+ +     + DFG+A  L     S   S+  G+  ++APE     K 
Sbjct: 122 -VIHRDIKAANILVTNTGNVKLCDFGVAALLNQ--NSSKRSTFVGTPYWMAPEVITEGKY 178

Query: 874 -DEKSDVYSFGVVLLELIAGKKP 895
            D K+D++S G+ + E+  G  P
Sbjct: 179 YDTKADIWSLGITIYEMATGNPP 201

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 76.1 bits (187), Expect = 5e-15
 Identities = 76/287 (26%), Positives = 117/287 (40%), Gaps = 40/287 (13%)

Query: 700 IGKGGAGIVYRGSMPDGIDVA---IKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLG 756
           IG G  G V  G    G+  A   +K L    T      FL E+Q    + H N+++ LG
Sbjct: 3   IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62

Query: 757 YVSNRDTNLLLYEYMPNGSLGEML---HGAKGGHLKWETRYRIALEAAKGLCYLHHDCSP 813
                   LL+ E+ P G L   L    G      + +   R+A E A GL +LH     
Sbjct: 63  QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD-- 120

Query: 814 LIIHRDVKSNNILLDSDFEAHVADFGLA--KFLQDAGAS-ECMSSVAGSYGYIAPEYA-- 868
             IH D+   N  L +D    + D+GLA  ++ +D   + +C    A    ++APE    
Sbjct: 121 -FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCH---AVPLRWLAPELVEI 176

Query: 869 -----YTLKVDEKSDVYSFGVVLLELI-AGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDA 922
                      +KS+++S GV + EL  A  +P  +  D   + + VR+   ++ +P   
Sbjct: 177 RGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQ-- 234

Query: 923 ASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHML 969
                 +D + S          ++V   C  D    RPT  E VH L
Sbjct: 235 ------LDLKYSD-------RWYEVMQFCWLD-PETRPTAEE-VHEL 266

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 75.4 bits (185), Expect = 1e-14
 Identities = 67/234 (28%), Positives = 105/234 (44%), Gaps = 27/234 (11%)

Query: 700 IGKGGAGIVYRGSM--PDGID----VAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVR 753
           +G+   G +Y+G +  P G+D    VAIK L           F  E   +  + H NIV 
Sbjct: 13  LGECAFGKIYKGHLYLP-GMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVC 71

Query: 754 LLGYVSNRDTNLLLYEYMPNGSLGEML-----HGAKG------GHLKWETRY----RIAL 798
           LLG V+      +L+EY+  G L E L     H   G      G +K    +     IA+
Sbjct: 72  LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131

Query: 799 EAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAG 858
           + A G+ YL    S   +H+D+ + NIL+       ++D GL++ +  A           
Sbjct: 132 QIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLL 188

Query: 859 SYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRK 911
              ++ PE     K    SD++SFGVVL E+ + G +P   F +  +++  VRK
Sbjct: 189 PIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ-EVIEMVRK 241

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 74.7 bits (183), Expect = 1e-14
 Identities = 57/194 (29%), Positives = 92/194 (47%), Gaps = 13/194 (6%)

Query: 700 IGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGND--HGFLAEIQTLGRIRHRNIVRLLG 756
           IG+G  G V+ G +  D   VA+K    R T   D    FL E + L +  H NIVRL+G
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSC--RETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60

Query: 757 YVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLII 816
             + +    ++ E +  G     L   +G  LK +   ++   AA G+ YL        I
Sbjct: 61  VCTQKQPIYIVMELVQGGDFLTFLR-TEGPRLKVKELIQMVENAAAGMEYLESKHC---I 116

Query: 817 HRDVKSNNILLDSDFEAHVADFGLAKFLQDA--GASECMSSVAGSYGYIAPEYAYTLKVD 874
           HRD+ + N L+       ++DFG+++  +D    ++  M  +     + APE     +  
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQI--PVKWTAPEALNYGRYS 174

Query: 875 EKSDVYSFGVVLLE 888
            +SDV+SFG++L E
Sbjct: 175 SESDVWSFGILLWE 188

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 75.5 bits (185), Expect = 1e-14
 Identities = 75/307 (24%), Positives = 129/307 (42%), Gaps = 47/307 (15%)

Query: 694 LKDENII-----GKGGAGIVYRGSM------PDGIDVAIKRLVGRGTGGNDHGFLAEIQT 742
           +K  NI+     G+G  G V+           D I VA+K L    +      F  E + 
Sbjct: 2   IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTL-KDASDNARKDFHREAEL 60

Query: 743 LGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEML--HG------AKGG---HLKWE 791
           L  ++H +IV+  G     D  ++++EYM +G L + L  HG      A+G     L   
Sbjct: 61  LTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQS 120

Query: 792 TRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASE 851
               IA + A G+ YL    S   +HRD+ + N L+  +    + DFG+++ +       
Sbjct: 121 QMLHIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYR 177

Query: 852 CMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVR 910
                     ++ PE     K   +SDV+S GVVL E+   GK+P            W +
Sbjct: 178 VGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP------------WYQ 225

Query: 911 KTTSEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLA 970
            + +EV        +  +   R+   P T    ++ + + C + E   R  ++E+  +L 
Sbjct: 226 LSNNEV--------IECITQGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQ 277

Query: 971 NPPQSAP 977
           N  +++P
Sbjct: 278 NLAKASP 284

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 75.3 bits (186), Expect = 1e-14
 Identities = 65/211 (30%), Positives = 97/211 (45%), Gaps = 35/211 (16%)

Query: 700 IGKGGAGIVYRG-SMPDGIDVAIKRL-VGRGTGGNDHGF----LAEIQTLGRIRHRNIVR 753
           +G+G   +VY+      G  VAIK++ +G      D G     L EI+ L  ++H NI+ 
Sbjct: 8   LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKD-GINFTALREIKLLQELKHPNIIG 66

Query: 754 LLGYVSNRDTNL-LLYEYMPNGSLGEMLHGAKG-----GHLKWETRYRIALEAAKGLCYL 807
           LL  V    +N+ L++E+M    L E +   K        +K        L   +GL YL
Sbjct: 67  LLD-VFGHKSNINLVFEFME-TDL-EKVIKDKSIVLTPADIK-----SYMLMTLRGLEYL 118

Query: 808 HHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEY 867
           H   S  I+HRD+K NN+L+ SD    +ADFGLA+          M+    +  Y APE 
Sbjct: 119 H---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN--RKMTHQVVTRWYRAPEL 173

Query: 868 -----AYTLKVDEKSDVYSFGVVLLELIAGK 893
                 Y + V    D++S G +  EL+   
Sbjct: 174 LFGARHYGVGV----DMWSVGCIFAELLLRV 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 75.0 bits (185), Expect = 1e-14
 Identities = 66/211 (31%), Positives = 101/211 (47%), Gaps = 35/211 (16%)

Query: 698 NIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHGF----LAEIQTLGRIR---HR 749
             IG+G  G VY+   +  G  VA+K++       ++ G     L EI  L ++    H 
Sbjct: 5   AEIGEGAYGTVYKARDLNTGRFVALKKVRVPL---SEEGIPLSTLREIALLKQLESFEHP 61

Query: 750 NIVRLL----GYVSNRDTNLLL-YEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGL 804
           NIVRLL    G  ++R+  L L +E++       +    K G L  ET   +  +  +G+
Sbjct: 62  NIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPG-LPPETIKDLMRQLLRGV 120

Query: 805 CYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIA 864
            +LH   S  I+HRD+K  NIL+ SD +  +ADFGLA+      A   ++SV  +  Y A
Sbjct: 121 DFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMA---LTSVVVTLWYRA 174

Query: 865 PE------YAYTLKVDEKSDVYSFGVVLLEL 889
           PE      YA  +      D++S G +  EL
Sbjct: 175 PEVLLQSSYATPV------DMWSVGCIFAEL 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 75.1 bits (185), Expect = 1e-14
 Identities = 69/267 (25%), Positives = 113/267 (42%), Gaps = 33/267 (12%)

Query: 719 VAIKRLVGRGTGGNDHG---FLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGS 775
           VA+K L       +D+    FL E++ L R+   NI RLLG  +      ++ EYM NG 
Sbjct: 49  VAVKVL---RPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGD 105

Query: 776 LGEML--HGAKGGHLK-------WETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNIL 826
           L + L  H A+   L        + T   +A + A G+ YL    S   +HRD+ + N L
Sbjct: 106 LNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRNCL 162

Query: 827 LDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVL 886
           +  ++   +ADFG+++ L  +              ++A E     K   KSDV++FGV L
Sbjct: 163 VGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTL 222

Query: 887 LEL--IAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDPRLSGYPLTGVIHL 944
            E+  +  ++P     D     + V +      +       L    PR    P      +
Sbjct: 223 WEILTLCREQPYEHLTD-----QQVIENAGHFFRDDGRQIYL----PRPPNCPKD----I 269

Query: 945 FKVAMMCVEDESSARPTMREVVHMLAN 971
           +++ + C   +   RPT RE+   L  
Sbjct: 270 YELMLECWRRDEEDRPTFREIHLFLQR 296

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 75.4 bits (185), Expect = 1e-14
 Identities = 68/263 (25%), Positives = 113/263 (42%), Gaps = 28/263 (10%)

Query: 719 VAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGE 778
           VA+K L    T    + FL EI+ + R+++ NI+RLLG   + D   ++ EYM NG L +
Sbjct: 47  VAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQ 106

Query: 779 ML----------HGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLD 828
            L          H      +       +A++ A G+ YL    S   +HRD+ + N L+ 
Sbjct: 107 FLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVG 163

Query: 829 SDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLE 888
           + +   +ADFG+++ L                 ++A E     K    SDV++FGV L E
Sbjct: 164 NHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWE 223

Query: 889 L--IAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFK 946
           +  +  ++P     D       V + T E  +  +    + +    L   P      +FK
Sbjct: 224 MFTLCKEQPYSLLSD-----EQVIENTGEFFR--NQGRQIYLSQTPLCPSP------VFK 270

Query: 947 VAMMCVEDESSARPTMREVVHML 969
           + M C   +   RPT  ++ H L
Sbjct: 271 LMMRCWSRDIKDRPTFNKIHHFL 293

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 75.1 bits (185), Expect = 1e-14
 Identities = 69/225 (30%), Positives = 102/225 (45%), Gaps = 22/225 (9%)

Query: 685 FKAEDVLESLKDENIIGKGGAGIVYRGSM---PDGIDVAIKRLVGRGTGGNDHGFLAEIQ 741
           F AED    LKD   IG+G  G V +  M   P G  +A+KR+            L ++ 
Sbjct: 1   FTAED----LKDLGEIGRGAFGTVNK--MLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLD 54

Query: 742 TLGRIRH-RNIVRLLGYVSNRDTNLLLYEYMPNGSLGEM---LHGAKGGHLKWETRYRIA 797
            + R      IV+  G +       +  E M + SL +    ++      +  E   +IA
Sbjct: 55  VVMRSSDCPYIVKFYGALFREGDCWICMELM-DISLDKFYKYVYEVLKSVIPEEILGKIA 113

Query: 798 LEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVA 857
           +   K L YL  +    IIHRDVK +NILLD +    + DFG++  L D+ A    +  A
Sbjct: 114 VATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAK---TRDA 168

Query: 858 GSYGYIAPEYAYTL---KVDEKSDVYSFGVVLLELIAGKKPVGEF 899
           G   Y+APE          D +SDV+S G+ L E+  GK P  ++
Sbjct: 169 GCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKW 213

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 75.5 bits (185), Expect = 2e-14
 Identities = 71/219 (32%), Positives = 102/219 (46%), Gaps = 19/219 (8%)

Query: 685 FKAEDVLESLKDENIIGKGGAGIVY--RGSMPDGIDVAIKRLVGRGTGGND--HGFLAEI 740
           F  ED  +   D   IG G  G VY  R    + + VAIK++   G   N+     + E+
Sbjct: 18  FFKEDPEKLFTDLREIGHGSFGAVYFARDVRTNEV-VAIKKMSYSGKQSNEKWQDIIKEV 76

Query: 741 QTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEA 800
           + L RI+H N +   G      T  L+ EY   GS  ++L   K    + E    I   A
Sbjct: 77  KFLQRIKHPNSIEYKGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIA-AITHGA 134

Query: 801 AKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSY 860
            +GL YLH   S  +IHRD+K+ NILL    +  +ADFG A     A      +S  G+ 
Sbjct: 135 LQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA------NSFVGTP 185

Query: 861 GYIAPEYAYTL---KVDEKSDVYSFGVVLLELIAGKKPV 896
            ++APE    +   + D K DV+S G+  +EL   K P+
Sbjct: 186 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 224

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 75.4 bits (185), Expect = 2e-14
 Identities = 79/287 (27%), Positives = 129/287 (44%), Gaps = 47/287 (16%)

Query: 694 LKDENIIGKGGAGIVYRGS-MPDG----IDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRH 748
            K   ++G G  G VY+G  +P+G    I VAIK L    +   +   L E   +  + +
Sbjct: 9   FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68

Query: 749 RNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAK---GGH--LKWETRYRIALEAAKG 803
            ++ RLLG +    T  L+ + MP G L + +   K   G    L W       ++ AKG
Sbjct: 69  PHVCRLLG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 121

Query: 804 LCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGS---Y 860
           + YL       ++HRD+ + N+L+ +     + DFGLAK L   GA E      G     
Sbjct: 122 MNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL---GADEKEYHAEGGKVPI 175

Query: 861 GYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQP 919
            ++A E         +SDV+S+GV + EL+  G KP     DG+                
Sbjct: 176 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY----DGI--------------PA 217

Query: 920 SDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVV 966
           S+ +S+L   + RL   P+   I ++ + + C   ++ +RP  RE++
Sbjct: 218 SEISSILEKGE-RLPQPPIC-TIDVYMIMVKCWMIDADSRPKFRELI 262

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 74.4 bits (182), Expect = 2e-14
 Identities = 64/214 (29%), Positives = 98/214 (45%), Gaps = 26/214 (12%)

Query: 699 IIGKGGAGIVYRGS-MPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRI-RHRNIVRLLG 756
           ++G G  G VY+G  +  G   AIK  V   TG  +     EI  L +   HRNI    G
Sbjct: 13  LVGNGTYGQVYKGRHVKTGQLAAIK--VMDVTGDEEEEIKQEINMLKKYSHHRNIATYYG 70

Query: 757 YVSNR------DTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHD 810
               +      D   L+ E+   GS+ +++   KG  LK E    I  E  +GL +LH  
Sbjct: 71  AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH 130

Query: 811 CSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYT 870
               +IHRD+K  N+LL  + E  + DFG++  L         ++  G+  ++APE    
Sbjct: 131 ---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRR--NTFIGTPYWMAPE---V 182

Query: 871 LKVDE--------KSDVYSFGVVLLELIAGKKPV 896
           +  DE        KSD++S G+  +E+  G  P+
Sbjct: 183 IACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 216

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 75.1 bits (184), Expect = 2e-14
 Identities = 61/209 (29%), Positives = 102/209 (48%), Gaps = 14/209 (6%)

Query: 694 LKDENI-----IGKGGAGIVYR-GSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIR 747
           LKD++      +G G  G+V +    P G+ +A K +         +  + E+Q L    
Sbjct: 2   LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECN 61

Query: 748 HRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYL 807
              IV   G   +     +  E+M  GSL ++L  AK   +  E   ++++   +GL YL
Sbjct: 62  SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAK--RIPEEILGKVSIAVLRGLAYL 119

Query: 808 HHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEY 867
                  I+HRDVK +NIL++S  E  + DFG++  L D+ A    +S  G+  Y++PE 
Sbjct: 120 REKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA----NSFVGTRSYMSPER 173

Query: 868 AYTLKVDEKSDVYSFGVVLLELIAGKKPV 896
                   +SD++S G+ L+EL  G+ P+
Sbjct: 174 LQGTHYSVQSDIWSMGLSLVELAIGRYPI 202

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 77.6 bits (191), Expect = 2e-14
 Identities = 61/216 (28%), Positives = 97/216 (44%), Gaps = 27/216 (12%)

Query: 736 FLAEIQTLGRIRHRNIVRLLGYVSNRDTNLL-LYEYMPNGSLGEMLHGAKGGHLKWETRY 794
           F  E     R+ H NIV LL         L  ++EY+P  +L E+L  A  G L      
Sbjct: 25  FRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRTLREVL--AADGALPAGETG 82

Query: 795 RIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLD-SDFEAH--VADFGLAKFLQDAGASE 851
           R+ L+    L   H+     I+HRD+K  NI++  +    H  V DFG+   L     ++
Sbjct: 83  RLMLQVLDALACAHNQG---IVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDAD 139

Query: 852 CMS-----SVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIV 906
             +      V G+  Y APE      V   SD+Y++G++ LE + G++ V   G  V  +
Sbjct: 140 VATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQRVVQ--GASVAEI 197

Query: 907 RWVRKTTSEVSQPSDAASVLAVVDPRLSGYPLTGVI 942
            + + +  +VS P           P ++G+PL  V+
Sbjct: 198 LYQQLSPVDVSLP-----------PWIAGHPLGQVL 222

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 73.8 bits (182), Expect = 2e-14
 Identities = 67/212 (31%), Positives = 97/212 (45%), Gaps = 31/212 (14%)

Query: 700 IGKGGAGIVYR-GSMPDGIDVAIKRLVGR---GTGGNDHGFLAEIQTLGRIRHRNIVRLL 755
           +G GG G V            A+K +  R    TG  +H F  E + L    H  IV+L 
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFS-EKEILEECNHPFIVKL- 58

Query: 756 GYVSNRDTNLL--LYEYMPNGSLGEMLHGAKGGHL-KWETRYRIA--LEAAKGLCYLHHD 810
            Y + +D   +  L EY   G L  +L     G   ++  R+ IA  + A     YLH+ 
Sbjct: 59  -YRTFKDKKYIYMLMEYCLGGELWTILR--DRGLFDEYTARFYIACVVLA---FEYLHNR 112

Query: 811 CSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEY--- 867
               II+RD+K  N+LLDS+    + DFG AK L+    +    +  G+  Y+APE    
Sbjct: 113 G---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTW---TFCGTPEYVAPEIILN 166

Query: 868 -AYTLKVDEKSDVYSFGVVLLELIAGKKPVGE 898
             Y   V    D +S G++L EL+ G+ P GE
Sbjct: 167 KGYDFSV----DYWSLGILLYELLTGRPPFGE 194

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 74.7 bits (183), Expect = 3e-14
 Identities = 65/218 (29%), Positives = 100/218 (45%), Gaps = 17/218 (7%)

Query: 685 FKAEDVLESLKDENIIGKGGAGIVYRGSMPDGID-VAIKRLVGRGTGGND--HGFLAEIQ 741
           F  +D  E     + IG G  G VY  +     + VA+K++   G   N+     + E++
Sbjct: 14  FYKDDPEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVK 73

Query: 742 TLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAA 801
            L +++H N +   G      T  L+ EY   GS  ++L   K    + E    I   A 
Sbjct: 74  FLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIA-AITHGAL 131

Query: 802 KGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYG 861
           +GL YLH      +IHRD+K+ NILL    +  +ADFG A     A      +S  G+  
Sbjct: 132 QGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSPA------NSFVGTPY 182

Query: 862 YIAPEYAYTL---KVDEKSDVYSFGVVLLELIAGKKPV 896
           ++APE    +   + D K DV+S G+  +EL   K P+
Sbjct: 183 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 220

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 73.7 bits (181), Expect = 3e-14
 Identities = 61/236 (25%), Positives = 98/236 (41%), Gaps = 42/236 (17%)

Query: 692 ESLKDENIIGKGGAGIVYRGSMPDGID-------VAIKRLVGRGTGGNDHGFLAEIQTLG 744
            +L++   +G+G  G V+      GI+       V +K L           F  E+    
Sbjct: 5   SNLQEITTLGRGEFGEVFLAKAK-GIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFR 63

Query: 745 RIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWE-----TRYRIAL- 798
           ++ H+N+VRLLG     + + ++ EY   G L + L   K    K +     T+ ++AL 
Sbjct: 64  KLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALC 123

Query: 799 -EAAKGLCYL--HHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSS 855
            + A G+ +L          +HRD+ + N L+ S  E  V+   L+K   D   SE    
Sbjct: 124 TQIALGMDHLSNAR-----FVHRDLAARNCLVSSQREVKVSLLSLSK---DVYNSE---- 171

Query: 856 VAGSYGY---------IAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGD 901
               Y           +APE         KSDV+SFGV++ E+   G+ P     D
Sbjct: 172 ---YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD 224

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 73.2 bits (179), Expect = 4e-14
 Identities = 60/212 (28%), Positives = 103/212 (48%), Gaps = 24/212 (11%)

Query: 698 NIIGKGGAGIVYRGSMP-DGI--DVAIKRLVGRGTGGNDHGFLAEIQTLGRI-RHRNIVR 753
           ++IG+G  G V +  +  DG+  D AIKR+    +  +   F  E++ L ++  H NI+ 
Sbjct: 1   DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60

Query: 754 LLGYVSNRDTNLLLYEYMPNGSLGEMLHGAK--------------GGHLKWETRYRIALE 799
           LLG   +R    L  EY P+G+L + L  ++                 L  +     A +
Sbjct: 61  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120

Query: 800 AAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGS 859
            A+G+ YL        IHRD+ + NIL+  ++ A +ADFGL++  Q+    + M  +   
Sbjct: 121 VARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRG-QEVYVKKTMGRL--P 174

Query: 860 YGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA 891
             ++A E          SDV+S+GV+L E+++
Sbjct: 175 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 73.2 bits (179), Expect = 5e-14
 Identities = 60/197 (30%), Positives = 91/197 (46%), Gaps = 9/197 (4%)

Query: 700 IGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGND-HGFLAEIQTLGRIRHRNIVRLLGYV 758
           IGKG  G VY+G      +V   +++      ++      EI  L +     I R  G  
Sbjct: 12  IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY 71

Query: 759 SNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHR 818
                  ++ EY+  GS  ++L   K G L+      I  E  KGL YLH   S   IHR
Sbjct: 72  LKGTKLWIIMEYLGGGSALDLL---KPGPLEETYIATILREILKGLDYLH---SERKIHR 125

Query: 819 DVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSD 878
           D+K+ N+LL    +  +ADFG+A  L D       ++  G+  ++APE       D K+D
Sbjct: 126 DIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR--NTFVGTPFWMAPEVIKQSAYDFKAD 183

Query: 879 VYSFGVVLLELIAGKKP 895
           ++S G+  +EL  G+ P
Sbjct: 184 IWSLGITAIELAKGEPP 200

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 73.1 bits (179), Expect = 5e-14
 Identities = 59/216 (27%), Positives = 94/216 (43%), Gaps = 24/216 (11%)

Query: 700 IGKGGAGIVYRGS----MP--DGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVR 753
           +G+G  G V+       +P  D + VA+K L    +      F  E + L  ++H++IVR
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKAL-KEASESARQDFQREAELLTVLQHQHIVR 71

Query: 754 LLGYVSNRDTNLLLYEYMPNGSLGEML--HG-----------AKGGHLKWETRYRIALEA 800
             G  +     L+++EYM +G L   L  HG              G L       IA + 
Sbjct: 72  FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131

Query: 801 AKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSY 860
           A G+ YL    S   +HRD+ + N L+       + DFG+++ +                
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 188

Query: 861 GYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKP 895
            ++ PE     K   +SD++SFGVVL E+   GK+P
Sbjct: 189 RWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 73.1 bits (179), Expect = 5e-14
 Identities = 77/286 (26%), Positives = 125/286 (43%), Gaps = 37/286 (12%)

Query: 694 LKDENIIGKGGAGIVYRGS-MPDG----IDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRH 748
           LK   ++G G  G VY+G  +PDG    I VAIK L    +   +   L E   +  +  
Sbjct: 9   LKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGS 68

Query: 749 RNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIA--LEAAKGLCY 806
             + RLLG +    T  L+ + MP G L + +   K    +  ++  +   ++ AKG+ Y
Sbjct: 69  PYVCRLLG-ICLTSTVQLVTQLMPYGCLLDYVRENKD---RIGSQDLLNWCVQIAKGMSY 124

Query: 807 LHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAG-SYGYIAP 865
           L       ++HRD+ + N+L+ S     + DFGLA+ L D   +E  +        ++A 
Sbjct: 125 LE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLL-DIDETEYHADGGKVPIKWMAL 180

Query: 866 EYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAAS 924
           E     +   +SDV+S+GV + EL+  G KP     DG+               P+    
Sbjct: 181 ESILHRRFTHQSDVWSYGVTVWELMTFGAKPY----DGI---------------PAREIP 221

Query: 925 VLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLA 970
            L     RL   P    I ++ + + C   +S  RP  RE+V   +
Sbjct: 222 DLLEKGERLP-QPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFS 266

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 73.9 bits (181), Expect = 5e-14
 Identities = 61/209 (29%), Positives = 104/209 (49%), Gaps = 14/209 (6%)

Query: 694 LKDENI-----IGKGGAGIVYRGS-MPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIR 747
           LKD++      +G G  G+V++ S  P G+ +A K +         +  + E+Q L    
Sbjct: 2   LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECN 61

Query: 748 HRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYL 807
              IV   G   +     +  E+M  GSL ++L   K G +  +   ++++   KGL YL
Sbjct: 62  SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK--KAGRIPEQILGKVSIAVIKGLTYL 119

Query: 808 HHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEY 867
                  I+HRDVK +NIL++S  E  + DFG++  L D+ A    +S  G+  Y++PE 
Sbjct: 120 REKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA----NSFVGTRSYMSPER 173

Query: 868 AYTLKVDEKSDVYSFGVVLLELIAGKKPV 896
                   +SD++S G+ L+E+  G+ P+
Sbjct: 174 LQGTHYSVQSDIWSMGLSLVEMAIGRYPI 202

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 72.8 bits (178), Expect = 8e-14
 Identities = 66/245 (26%), Positives = 115/245 (46%), Gaps = 16/245 (6%)

Query: 682 RLDFKAEDVLESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQ 741
           R D    +V E + +   +G G  G VY+    +   +A  +++   +      ++ EI+
Sbjct: 5   RRDLDPNEVWEIIGE---LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIE 61

Query: 742 TLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSL-GEMLHGAKGGHLKWETRYRIALEA 800
            L    H  IV+LLG         ++ E+ P G++   ML   +G  L       I  + 
Sbjct: 62  ILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRG--LTEPQIQVICRQM 119

Query: 801 AKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSY 860
            + L YLH   S  IIHRD+K+ N+LL  D +  +ADFG++   ++    +   S  G+ 
Sbjct: 120 LEALQYLH---SMKIIHRDLKAGNVLLTLDGDIKLADFGVSA--KNVKTLQRRDSFIGTP 174

Query: 861 GYIAPEYAY--TLK---VDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSE 915
            ++APE     T+K    D K+D++S G+ L+E+   + P  E      +++  +     
Sbjct: 175 YWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPT 234

Query: 916 VSQPS 920
           +SQPS
Sbjct: 235 LSQPS 239

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 72.4 bits (177), Expect = 1e-13
 Identities = 66/218 (30%), Positives = 100/218 (45%), Gaps = 17/218 (7%)

Query: 685 FKAEDVLESLKDENIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGND--HGFLAEIQ 741
           F  +D  +   D   IG G  G VY    + +   VAIK++   G   N+     + E++
Sbjct: 8   FFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVR 67

Query: 742 TLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAA 801
            L ++RH N ++  G      T  L+ EY   GS  ++L   K    + E    +   A 
Sbjct: 68  FLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIA-AVTHGAL 125

Query: 802 KGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYG 861
           +GL YLH   S  +IHRDVK+ NILL       + DFG A  +  A      +   G+  
Sbjct: 126 QGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA------NXFVGTPY 176

Query: 862 YIAPEYAYTL---KVDEKSDVYSFGVVLLELIAGKKPV 896
           ++APE    +   + D K DV+S G+  +EL   K P+
Sbjct: 177 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 72.0 bits (176), Expect = 1e-13
 Identities = 59/257 (22%), Positives = 108/257 (42%), Gaps = 38/257 (14%)

Query: 736 FLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEML--HGAKG-------- 785
           F  E + L  ++H +IV+  G   + D  ++++EYM +G L + L  HG           
Sbjct: 54  FQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQP 113

Query: 786 ----GHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLA 841
               G L       IA + A G+ YL    S   +HRD+ + N L+ ++    + DFG++
Sbjct: 114 RQAKGELGLSQMLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMS 170

Query: 842 KFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFG 900
           + +                 ++ PE     K   +SDV+SFGV+L E+   GK+P     
Sbjct: 171 RDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP----- 225

Query: 901 DGVDIVRWVRKTTSEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARP 960
                  W + + +EV        +  +   R+   P      ++ + + C + E   R 
Sbjct: 226 -------WFQLSNTEV--------IECITQGRVLERPRVCPKEVYDIMLGCWQREPQQRL 270

Query: 961 TMREVVHMLANPPQSAP 977
            ++E+  +L    ++ P
Sbjct: 271 NIKEIYKILHALGKATP 287

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 71.4 bits (176), Expect = 2e-13
 Identities = 53/166 (31%), Positives = 82/166 (49%), Gaps = 24/166 (14%)

Query: 737 LAEIQTLGRIRHRNIVRLLGYVSNRDTNL-LLYEYMPNGSLGEMLHGAKGGHLKWETRYR 795
           L E + L  IRH  +V L G   + D+NL L+ EY+P G   E+       HL+   R+ 
Sbjct: 49  LNEKRILQSIRHPFLVNLYGSFQD-DSNLYLVMEYVPGG---ELFS-----HLRKSGRFP 99

Query: 796 I------ALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGA 849
                  A +    L YLH      I++RD+K  N+LLDSD    + DFG AK ++    
Sbjct: 100 EPVARFYAAQVVLALEYLHS-LD--IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTY 156

Query: 850 SECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
           + C     G+  Y+APE   +    +  D ++ G+++ E++AG  P
Sbjct: 157 TLC-----GTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 71.9 bits (176), Expect = 2e-13
 Identities = 59/213 (27%), Positives = 100/213 (46%), Gaps = 26/213 (12%)

Query: 700 IGKGGAGIVYRG-------SMPD-GIDVAIKRLVGRGTGGNDHGFLAEIQTLGRI-RHRN 750
           +G+G  G V R        S PD  + VA+K L    T  +    ++E++ +  I +H+N
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79

Query: 751 IVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAK--------------GGHLKWETRYRI 796
           I+ LLG  +      ++ EY   G+L E L   +                 L ++     
Sbjct: 80  IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139

Query: 797 ALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSV 856
           A + A+G+ YL    S   IHRD+ + N+L+  D    +ADFGLA+ + D    +  S+ 
Sbjct: 140 AYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNG 196

Query: 857 AGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLEL 889
                ++APE  +      +SDV+SFG+++ E+
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGILMWEI 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 72.1 bits (177), Expect = 2e-13
 Identities = 50/130 (38%), Positives = 67/130 (51%), Gaps = 13/130 (10%)

Query: 769 EYMPNGSLGEMLHGAKGGHLKWETRYRI-ALEAAKGLCYLHHDCSPLIIHRDVKSNNILL 827
           EY+  G L  M H    G    E R R  A E   GL +LH      II+RD+K +N+LL
Sbjct: 76  EYLNGGDL--MFHIQSSGRFD-EARARFYAAEIICGLQFLH---KKGIIYRDLKLDNVLL 129

Query: 828 DSDFEAHVADFGLAK--FLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVV 885
           D D    +ADFG+ K     +  A    S+  G+  YIAPE     K +E  D +SFGV+
Sbjct: 130 DKDGHIKIADFGMCKENMNGEGKA----STFCGTPDYIAPEILKGQKYNESVDWWSFGVL 185

Query: 886 LLELIAGKKP 895
           L E++ G+ P
Sbjct: 186 LYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 71.7 bits (176), Expect = 2e-13
 Identities = 53/165 (32%), Positives = 79/165 (47%), Gaps = 16/165 (9%)

Query: 739 EIQTLGRIRHRNIVRLLGYVSNRDTNLL--LYEYMPNGSLGEMLHGAKGGHLKWETRYRI 796
           E + L  + H  I+RL  + +  D   L  L EY+P G L   L  +  G     T    
Sbjct: 51  EKRVLKEVSHPFIIRL--FWTEHDQRFLYMLMEYVPGGELFSYLRNS--GRFSNSTGLFY 106

Query: 797 ALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSV 856
           A E    L YLH   S  I++RD+K  NILLD +    + DFG AK L+D   + C    
Sbjct: 107 ASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTLC---- 159

Query: 857 AGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGD 901
            G+  Y+APE   +   ++  D ++ G+++ E++ G  P   F D
Sbjct: 160 -GTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPF--FDD 201

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 71.5 bits (175), Expect = 2e-13
 Identities = 55/202 (27%), Positives = 89/202 (44%), Gaps = 22/202 (10%)

Query: 719 VAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGE 778
           VA+K L         + FL E++ L R++  NI+RLLG   + D   ++ EYM NG L +
Sbjct: 49  VAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQ 108

Query: 779 ML-----------------HGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVK 821
            L                        + + +   +AL+ A G+ YL    S   +HRD+ 
Sbjct: 109 FLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLA 165

Query: 822 SNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYS 881
           + N L+  +    +ADFG+++ L                 ++A E     K    SDV++
Sbjct: 166 TRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWA 225

Query: 882 FGVVLLEL--IAGKKPVGEFGD 901
           FGV L E+  +  ++P GE  D
Sbjct: 226 FGVTLWEILMLCKEQPYGELTD 247

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 71.7 bits (176), Expect = 3e-13
 Identities = 48/136 (35%), Positives = 70/136 (51%), Gaps = 11/136 (8%)

Query: 769 EYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLD 828
           EY+  G L  M H  + G  K       A E A GL +LH   S  II+RD+K +N++LD
Sbjct: 81  EYVNGGDL--MYHIQQVGKFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLD 135

Query: 829 SDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLE 888
           ++    +ADFG+ K     G +    +  G+  YIAPE        +  D ++FGV+L E
Sbjct: 136 AEGHIKIADFGMCKENIFGGKTTR--TFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYE 193

Query: 889 LIAGKKPVGEFGDGVD 904
           ++AG+ P     DG D
Sbjct: 194 MLAGQPPF----DGED 205

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 72.0 bits (176), Expect = 3e-13
 Identities = 70/255 (27%), Positives = 115/255 (45%), Gaps = 25/255 (9%)

Query: 690 VLESLKDENIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHGFLA--EIQTLGRI 746
           VL+  +    IG G  GIV        GI+VA+K+L  R      H   A  E+  L  +
Sbjct: 19  VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKL-SRPFQNQTHAKRAYRELVLLKCV 77

Query: 747 RHRNIVRLLGYVSNRDT-----NLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAA 801
            H+NI+ LL   + + +     ++ L   + + +L +++H      L  E   R++    
Sbjct: 78  NHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHM----ELDHE---RMSYLLY 130

Query: 802 KGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYG 861
           + LC + H  S  IIHRD+K +NI++ SD    + DFGLA+    A  +  M+    +  
Sbjct: 131 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TACTNFMMTPYVVTRY 187

Query: 862 YIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSD 921
           Y APE    +   E  D++S G ++ EL+ G         G D +    K   ++  PS 
Sbjct: 188 YRAPEVILGMGYKENVDIWSVGCIMGELVKGSV----IFQGTDHIDQWNKVIEQLGTPS- 242

Query: 922 AASVLAVVDPRLSGY 936
            A  +  + P +  Y
Sbjct: 243 -AEFMNRLQPTVRNY 256

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 71.3 bits (175), Expect = 3e-13
 Identities = 46/129 (35%), Positives = 65/129 (50%), Gaps = 11/129 (8%)

Query: 769 EYMPNGSLGEMLHGAKGGHLKWETRYRI-ALEAAKGLCYLH-HDCSPLIIHRDVKSNNIL 826
           EY+  G L  M H  + G    E R R  A E   GL +LH       II+RD+K +N+L
Sbjct: 76  EYVNGGDL--MFHIQRSGRFD-EPRARFYAAEIVLGLQFLHERG----IIYRDLKLDNVL 128

Query: 827 LDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVL 886
           LDS+    +ADFG+ K  +        S+  G+  YIAPE           D ++ GV+L
Sbjct: 129 LDSEGHIKIADFGMCK--EGILGGVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLL 186

Query: 887 LELIAGKKP 895
            E++AG+ P
Sbjct: 187 YEMLAGQSP 195

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 71.6 bits (176), Expect = 3e-13
 Identities = 69/240 (28%), Positives = 94/240 (39%), Gaps = 61/240 (25%)

Query: 699 IIGKGGAGIVYRGSMPDGIDV-AIKRL-----VGRGTGGNDHGFLAEIQTLGRIRHRNIV 752
           +IG+G  G V+     D   V A+K L     + R    +     AE   L       IV
Sbjct: 8   VIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAH---VRAERDILADADSPWIV 64

Query: 753 RLLGYVSNRDTNLLLY--EYMPNGSLGEMLHGAKGGHLKWET-RYRI-----ALEAAKGL 804
           +L  Y S +D   L    EYMP G L  M    +      ET R+ I     AL++   L
Sbjct: 65  KL--YYSFQDEEHLYLVMEYMPGGDL--MNLLIRKDVFPEETARFYIAELVLALDSVHKL 120

Query: 805 CYLHHDCSPLIIHRDVKSNNILLDSDFEAHV--ADFGLAKFLQDAGASECMS-------- 854
            +         IHRD+K +NIL+D+D   H+  ADFGL K +  A   E           
Sbjct: 121 GF---------IHRDIKPDNILIDAD--GHIKLADFGLCKKMNKAKDREYYLNDSHNLLF 169

Query: 855 -------------------SVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
                              S  G+  YIAPE         + D +S GV+L E++ G  P
Sbjct: 170 RDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPP 229

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 70.9 bits (174), Expect = 3e-13
 Identities = 71/283 (25%), Positives = 117/283 (41%), Gaps = 44/283 (15%)

Query: 700 IGKGGAGIVYRGSM---PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRH-RNIVRLL 755
           +G+G  G+V +  M   P G  +A+KR+            L ++    R       V   
Sbjct: 9   LGRGAYGVVDK--MRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFY 66

Query: 756 GYVSNRDTNLLLYEYMPNGSLGEMLHGA--KGGHLKWETRYRIALEAAKGLCYLHHDCSP 813
           G +       +  E M + SL +       KG  +  +   +IA+   K L YLH   S 
Sbjct: 67  GALFREGDVWICMEVM-DTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS- 124

Query: 814 LIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPE------- 866
            +IHRDVK +N+L++ + +  + DFG++ +L D+ A    +  AG   Y+APE       
Sbjct: 125 -VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAK---TIDAGCKPYMAPERINPELN 180

Query: 867 -YAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASV 925
              Y    D KSDV+S G+ ++EL  G+ P   +      ++ V      V +PS     
Sbjct: 181 QKGY----DVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQV------VEEPS----- 225

Query: 926 LAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHM 968
                P+L     +     F     C++     RP   E++  
Sbjct: 226 -----PQLPAEKFSPEFQDF--VNKCLKKNYKERPNYPELLQH 261

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 70.5 bits (172), Expect = 4e-13
 Identities = 67/208 (32%), Positives = 97/208 (46%), Gaps = 23/208 (11%)

Query: 700 IGKGGAGIVYRGSMPDGID------VAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVR 753
           IGKG  G V++G     ID      VAIK +              EI  L +     + +
Sbjct: 12  IGKGSFGEVFKG-----IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTK 66

Query: 754 LLG-YVSNRDTNL-LLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDC 811
             G Y+  +DT L ++ EY+  GS  ++L   + G L       I  E  KGL YLH   
Sbjct: 67  YYGSYL--KDTKLWIIMEYLGGGSALDLL---EPGPLDETQIATILREILKGLDYLH--- 118

Query: 812 SPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTL 871
           S   IHRD+K+ N+LL    E  +ADFG+A  L D       ++  G+  ++APE     
Sbjct: 119 SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR--NTFVGTPFWMAPEVIKQS 176

Query: 872 KVDEKSDVYSFGVVLLELIAGKKPVGEF 899
             D K+D++S G+  +EL  G+ P  E 
Sbjct: 177 AYDSKADIWSLGITAIELAKGEPPHSEL 204

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 71.0 bits (175), Expect = 5e-13
 Identities = 64/232 (27%), Positives = 96/232 (41%), Gaps = 63/232 (27%)

Query: 695 KDENIIGKGGAGIVYRGSMPD-GIDVAIKRLVGRGTGGN--DHGFLA-----EIQTLGRI 746
           +    IG G  G+V        G  VAIK++       N  D    A     EI+ L  +
Sbjct: 3   ELLKPIGSGAYGVVCSAVDKRTGRKVAIKKI------SNVFDDLIDAKRILREIKLLRHL 56

Query: 747 RHRNIVRLL------GYVSNRDTNLLLY---EYMP---------NGSLGEMLHGAKGGHL 788
           RH NI+ LL            D    +Y   E M             L +        H+
Sbjct: 57  RHENIIGLLDILRPPSPEDFND----VYIVTELMETDLHKVIKSPQPLTD-------DHI 105

Query: 789 KWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQ-DA 847
           ++   Y+I     +GL YLH   S  +IHRD+K +NIL++S+ +  + DFGLA+ +  D 
Sbjct: 106 QYFL-YQIL----RGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDE 157

Query: 848 GASECMSS-VAGSYGYIAPE-----YAYTLKVDEKSDVYSFGVVLLELIAGK 893
                ++  V   + Y APE       YT  +    D++S G +  EL+  K
Sbjct: 158 DEKGFLTEYVVTRW-YRAPELLLSSSRYTKAI----DIWSVGCIFAELLTRK 204

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 70.1 bits (171), Expect = 5e-13
 Identities = 59/202 (29%), Positives = 89/202 (44%), Gaps = 19/202 (9%)

Query: 700 IGKGGAGIVYRGSMPDGID------VAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVR 753
           IGKG  G V++G     ID      VAIK +              EI  L +     + +
Sbjct: 12  IGKGSFGEVFKG-----IDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTK 66

Query: 754 LLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSP 813
             G         ++ EY+  GS  ++L        +  T  +   E  KGL YLH   S 
Sbjct: 67  YYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLK---EILKGLDYLH---SE 120

Query: 814 LIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKV 873
             IHRD+K+ N+LL    +  +ADFG+A  L D       ++  G+  ++APE       
Sbjct: 121 KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR--NTFVGTPFWMAPEVIQQSAY 178

Query: 874 DEKSDVYSFGVVLLELIAGKKP 895
           D K+D++S G+  +EL  G+ P
Sbjct: 179 DSKADIWSLGITAIELAKGEPP 200

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 69.8 bits (171), Expect = 6e-13
 Identities = 49/191 (25%), Positives = 77/191 (40%), Gaps = 19/191 (9%)

Query: 750 NIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHH 809
            + +L     ++D   L+ EY+  G    ++    G    W  +Y    E   G+  LH 
Sbjct: 58  YVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQY--IAEVVLGVEDLHQ 115

Query: 810 DCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAY 869
                IIHRD+K  N+L+D      + DFGL++               G+  Y+APE   
Sbjct: 116 RG---IIHRDIKPENLLIDQTGHLKLTDFGLSR------NGLENKKFVGTPDYLAPETIL 166

Query: 870 TLKVDEKSDVYSFGVVLLELIAGKKPV-GEFGDGV--DIVR----WV-RKTTSEVSQPSD 921
            +  D+ SD +S G V+ E + G  P   E  D V  +I+     W          +  D
Sbjct: 167 GVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVD 226

Query: 922 AASVLAVVDPR 932
             + L  +DP 
Sbjct: 227 LINRLLCMDPA 237

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 70.9 bits (174), Expect = 6e-13
 Identities = 63/203 (31%), Positives = 89/203 (43%), Gaps = 21/203 (10%)

Query: 700 IGKGGAGIVYRGSMPDGID-VAIKRLVGRGTGGND---HGFLAEIQTLGRIRHRNIVRLL 755
           +G+GG G V+     D  + VA+KR+        +   H  L E   L   +   +V+LL
Sbjct: 9   VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRH-VLTERDILTTTKSEWLVKLL 67

Query: 756 GYVSNRDTNLLL-YEYMPNGSLGEMLHGAKGGHLKWETRYRIA--LEAAKGLCYLHHDCS 812
            Y    D  L L  EY+P G    +L+   G   +   R+ +A   EA   L  L     
Sbjct: 68  -YAFQDDEYLYLAMEYVPGGDFRTLLN-NLGVLSEDHARFYMAEMFEAVDALHELG---- 121

Query: 813 PLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLK 872
              IHRD+K  N L+D+     + DFGL+K     G     +SV GS  Y+APE      
Sbjct: 122 --YIHRDLKPENFLIDASGHIKLTDFGLSK-----GIVTYANSVVGSPDYMAPEVLRGKG 174

Query: 873 VDEKSDVYSFGVVLLELIAGKKP 895
            D   D +S G +L E + G  P
Sbjct: 175 YDFTVDYWSLGCMLYEFLCGFPP 197

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 69.8 bits (171), Expect = 6e-13
 Identities = 58/215 (26%), Positives = 98/215 (45%), Gaps = 23/215 (10%)

Query: 699 IIGKGGAGIVYRG--SMPDG--IDVAIKRLVGRGTGGND-HGFLAEIQTLGRIRHRNIVR 753
           I+G+G  G V  G  S  DG  + VA+K +       ++   FL+E   +    H N+++
Sbjct: 6   ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65

Query: 754 LLGY-VSNRDTN-----LLLYEYMPNGSLGEMLHGAKGG----HLKWETRYRIALEAAKG 803
           L+G              +++  +M +G L   L  ++ G     L  +T  +  ++ A G
Sbjct: 66  LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125

Query: 804 LCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAK--FLQDAGASECMSSVAGSYG 861
           + YL    +   IHRD+ + N +L  D    VADFGL+K  +  D      ++ +     
Sbjct: 126 MEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKM--PVK 180

Query: 862 YIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKP 895
           +IA E         KSDV++FGV + E+   G+ P
Sbjct: 181 WIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTP 215

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 70.0 bits (171), Expect = 6e-13
 Identities = 61/214 (28%), Positives = 98/214 (45%), Gaps = 26/214 (12%)

Query: 699 IIGKGGAGIVYRGS-MPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRI-RHRNIVRLLG 756
           ++G G  G VY+G  +  G   AIK  V   T   +     EI  L +   HRNI    G
Sbjct: 23  VVGNGTYGQVYKGRHVKTGQLAAIK--VMDVTEDEEEEIKLEINMLKKYSHHRNIATYYG 80

Query: 757 YV------SNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHD 810
                    + D   L+ E+   GS+ +++   KG  LK +    I  E  +GL +LH  
Sbjct: 81  AFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLH-- 138

Query: 811 CSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYT 870
            +  +IHRD+K  N+LL  + E  + DFG++  L         ++  G+  ++APE    
Sbjct: 139 -AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRR--NTFIGTPYWMAPE---V 192

Query: 871 LKVDE--------KSDVYSFGVVLLELIAGKKPV 896
           +  DE        +SD++S G+  +E+  G  P+
Sbjct: 193 IACDENPDATYDYRSDIWSLGITAIEMAEGAPPL 226

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 70.4 bits (172), Expect = 7e-13
 Identities = 51/168 (30%), Positives = 79/168 (47%), Gaps = 21/168 (12%)

Query: 761 RDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDV 820
           ++    + E++  G L  M H    G       YR    AA+ +C L    S  II+RD+
Sbjct: 68  KEHLFFVMEFLNGGDL--MFHIQDKGRFDL---YRATFYAAEIVCGLQFLHSKGIIYRDL 122

Query: 821 KSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVY 880
           K +N++LD D    +ADFG+ K  ++       S+  G+  YIAPE    LK     D +
Sbjct: 123 KLDNVMLDRDGHIKIADFGMCK--ENVFGDNRASTFCGTPDYIAPEILQGLKYTFSVDWW 180

Query: 881 SFGVVLLELIAGKKPVGEFGDGVDIV------------RWVRKTTSEV 916
           SFGV+L E++ G+ P    GD  D +            RW+ K + ++
Sbjct: 181 SFGVLLYEMLIGQSPF--HGDDEDELFESIRVDTPHYPRWITKESKDI 226

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 70.4 bits (172), Expect = 9e-13
 Identities = 54/195 (27%), Positives = 92/195 (47%), Gaps = 19/195 (9%)

Query: 717 IDVAIKRLVGRGTGGNDHGFLAEIQTLGRI-RHRNIVRLLGYVSNRDTNLLLYEYMPNGS 775
           + VA+K L    T  +    ++E++ +  I +H+NI+ LLG  +      +L EY   G+
Sbjct: 45  VTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGN 104

Query: 776 LGEMLHGAK--------------GGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVK 821
           L E L   +                 L ++     A + A+G+ YL    S   IHRD+ 
Sbjct: 105 LREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYL---ASQKCIHRDLA 161

Query: 822 SNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYS 881
           + N+L+  D    +ADFGLA+ + +    +  ++      ++APE  +      +SDV+S
Sbjct: 162 ARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWS 221

Query: 882 FGVVLLELIA-GKKP 895
           FGV+L E+   G  P
Sbjct: 222 FGVLLWEIFTLGGSP 236

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 68.9 bits (168), Expect = 1e-12
 Identities = 68/286 (23%), Positives = 128/286 (44%), Gaps = 33/286 (11%)

Query: 691 LESLKDENIIGKGGAGIVYRGS-MPDGIDVAIKR--LVGRGTGGNDHGFLAEIQTLGRIR 747
           L + + E  IG+G    VYR + + DG+ VA+K+  +            + EI  L ++ 
Sbjct: 1   LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN 60

Query: 748 HRNIVRLLG-YVSNRDTNLLLYEYMPNGSLGEML-HGAKGGHLKWE-TRYRIALEAAKGL 804
           H N+++    ++ + + N++L E    G L  M+ H  K   L  E T ++  ++    L
Sbjct: 61  HPNVIKYYASFIEDNELNIVL-ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSAL 119

Query: 805 CYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIA 864
            ++H   S  ++HRD+K  N+ + +     + D GL +F   +  +    S+ G+  Y++
Sbjct: 120 EHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLVGTPYYMS 174

Query: 865 PEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTS--EVSQPSDA 922
           PE  +    + KSD++S G +L E+ A + P   +GD +++    +K         PSD 
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEMAALQSPF--YGDKMNLYSLCKKIEQCDYPPLPSDH 232

Query: 923 ASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHM 968
            S                   L ++  MC+  +   RP +  V  +
Sbjct: 233 YSE-----------------ELRQLVNMCINPDPEKRPDITYVYDV 261

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 69.4 bits (170), Expect = 1e-12
 Identities = 57/229 (24%), Positives = 101/229 (44%), Gaps = 24/229 (10%)

Query: 683 LDFKAEDVLESLKDENIIGKGGAGIVYRGS------MPDGIDVAIKRLVGRGTGGNDHGF 736
           LD + E   + L     +G+G  G V +          +   VA+K L    T  +    
Sbjct: 3   LDPEWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDL 62

Query: 737 LAEIQTLGRI-RHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAK----------- 784
           ++E++ +  I +H+NI+ LLG  +      ++ EY  +G+L + L   +           
Sbjct: 63  VSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDP 122

Query: 785 ---GGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLA 841
                 L  +     A + A+G+ +L    S   IHRD+ + N+L+  D    +ADFGLA
Sbjct: 123 RPPEETLTQKDLVSFAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLA 179

Query: 842 KFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELI 890
           + +         ++      ++APE  +      +SDV+SFGV+L E+ 
Sbjct: 180 RDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIF 228

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 70.4 bits (172), Expect = 1e-12
 Identities = 65/253 (25%), Positives = 111/253 (43%), Gaps = 29/253 (11%)

Query: 401 IPEELGQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLSGELP--EKMSGASL 458
             E L     L  +  + N L   I   L  L  L  ++LD+N ++ ++P    +  ++L
Sbjct: 85  GSENLLNLLPLPSLDLNLNRLRSNISE-LLELTNLTSLDLDNNNIT-DIPPLIGLLKSNL 142

Query: 459 NQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNISG 518
            +L +++N I   +P+ + NLP+L  L L  N L  ++P    NL  + ++++S N IS 
Sbjct: 143 KELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS- 199

Query: 519 EIPYSISQCHSLTSVDLSRNSLYGKIPPGISKLIDLSILNLSRNGIT------------- 565
           ++P  I    +L  +DLS NS+  ++   +S L +LS L LS N +              
Sbjct: 200 DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLEDLPESIGNLSNLE 258

Query: 566 --------GSIPNEMRNMMSLTTLDLSYNNLIGNIPSGGQFLAFNETSFIGNPNLCLLRN 617
                    S  + + ++ +L  LDLS N+L   +P     L   E        L  L  
Sbjct: 259 TLDLSNNQISSISSLGSLTNLRELDLSGNSLSNALPLIALLLLLLELLLNLLLTLKALEL 318

Query: 618 GTCQSLINSAKHS 630
                L+N+   S
Sbjct: 319 KLNSILLNNNILS 331

Length = 394

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 68.9 bits (169), Expect = 1e-12
 Identities = 63/205 (30%), Positives = 95/205 (46%), Gaps = 28/205 (13%)

Query: 700 IGKGGAGIVYRGSMPD-GIDVAIKRLVGRGTGGNDHGF-LAEIQTLGRIRHRNIVRLLGY 757
           IG+G  G+V++    + G  VAIK+ V            L EI+ L +++H N+V L+  
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLI-E 67

Query: 758 VSNRDTNL-LLYEYMPNGSLGEM---LHGAKGGHLKWETRYRIALEAAKGLCYLH-HDCS 812
           V  R   L L++EY  +  L E+     G     +K     +I  +  + + + H H+C 
Sbjct: 68  VFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIK-----KIIWQTLQAVNFCHKHNC- 121

Query: 813 PLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEY----- 867
              IHRDVK  NIL+    +  + DFG A+ L   G  +    VA  + Y APE      
Sbjct: 122 ---IHRDVKPENILITKQGQIKLCDFGFARILTGPGD-DYTDYVATRW-YRAPELLVGDT 176

Query: 868 AYTLKVDEKSDVYSFGVVLLELIAG 892
            Y   V    DV++ G V  EL+ G
Sbjct: 177 QYGPPV----DVWAIGCVFAELLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 68.9 bits (169), Expect = 2e-12
 Identities = 38/105 (36%), Positives = 56/105 (53%), Gaps = 9/105 (8%)

Query: 795 RIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMS 854
           ++ +   K L YL       +IHRDVK +NILLD+     + DFG++  L D+ A    +
Sbjct: 118 KMTVAIVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK---T 172

Query: 855 SVAGSYGYIAPEY----AYTLKVDEKSDVYSFGVVLLELIAGKKP 895
             AG   Y+APE         K D ++DV+S G+ L+EL  G+ P
Sbjct: 173 RSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 68.1 bits (166), Expect = 2e-12
 Identities = 45/158 (28%), Positives = 76/158 (48%), Gaps = 6/158 (3%)

Query: 739 EIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIAL 798
           E+  L +++H NIV             ++ EY   G L + ++  +G     +      +
Sbjct: 49  EVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFV 108

Query: 799 EAAKGLCYLHHDCSPLIIHRDVKSNNILLDSD-FEAHVADFGLAKFLQDAGASECMSSVA 857
           + + GL ++H      I+HRD+KS NI L  +   A + DFG+A+ L D+   E   +  
Sbjct: 109 QISLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS--MELAYTCV 163

Query: 858 GSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
           G+  Y++PE       + K+D++S G VL EL   K P
Sbjct: 164 GTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHP 201

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 68.4 bits (167), Expect = 2e-12
 Identities = 52/194 (26%), Positives = 87/194 (44%), Gaps = 14/194 (7%)

Query: 719 VAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGE 778
           VA+K L         + FL EI+ + R++  NI+RLL      D   ++ EYM NG L +
Sbjct: 49  VAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQ 108

Query: 779 ML--HGAKGGHLKWETRY-------RIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDS 829
            L  H  +    K +           +A + A G+ YL    S   +HRD+ + N L+  
Sbjct: 109 FLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGK 165

Query: 830 DFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLEL 889
           ++   +ADFG+++ L                 +++ E     K    SDV++FGV L E+
Sbjct: 166 NYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEI 225

Query: 890 IA--GKKPVGEFGD 901
           +    ++P  +  D
Sbjct: 226 LTLCKEQPYSQLSD 239

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 68.5 bits (167), Expect = 2e-12
 Identities = 54/197 (27%), Positives = 97/197 (49%), Gaps = 10/197 (5%)

Query: 700 IGKGGAGIVYRGSMP-DGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYV 758
           IG+G  GIV   +    G  VA+K++  R     +  F  E+  +    H N+V +    
Sbjct: 30  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLF-NEVVIMRDYHHENVVDMYNSY 88

Query: 759 SNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHR 818
              D   ++ E++  G+L +++   +   +  E    + L   + L YLH+     +IHR
Sbjct: 89  LVGDELWVVMEFLEGGALTDIVTHTR---MNEEQIATVCLSVLRALSYLHNQG---VIHR 142

Query: 819 DVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSD 878
           D+KS++ILL SD    ++DFG     Q +       S+ G+  ++APE    L    + D
Sbjct: 143 DIKSDSILLTSDGRIKLSDFGFCA--QVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVD 200

Query: 879 VYSFGVVLLELIAGKKP 895
           ++S G++++E+I G+ P
Sbjct: 201 IWSLGIMVIEMIDGEPP 217

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 70.2 bits (172), Expect = 3e-12
 Identities = 36/83 (43%), Positives = 49/83 (59%)

Query: 255 GEIPTSLSRLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKN 314
           G IP  +S+L+ L S+ L  N + G+IPP L  + SL+ LDLS N   G IPES   L +
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTS 491

Query: 315 LTLLQLFKNNLRGPIPSFLGDFP 337
           L +L L  N+L G +P+ LG   
Sbjct: 492 LRILNLNGNSLSGRVPAALGGRL 514

Length = 623

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 67.9 bits (166), Expect = 3e-12
 Identities = 61/211 (28%), Positives = 92/211 (43%), Gaps = 15/211 (7%)

Query: 700 IGKGGAGIVYRGSMPD-GIDVAIKRLVGR--GTGGNDHGFLAEIQTLGRIRHRNIVRLLG 756
           +GKGG G V    +   G   A K+L  +       +   L E + L ++  R IV L  
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60

Query: 757 YVSNRDTNLLLYEYMPNGSLGEML--HGAKGGHLKWETRYRI-ALEAAKGLCYLHHDCSP 813
               +D   L+   M  G L   +   G  G     E R    A +   GL +LH     
Sbjct: 61  AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFP---EARAIFYAAQIICGLEHLHQR--- 114

Query: 814 LIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKV 873
            I++RD+K  N+LLD      ++D GLA  L+     + +   AG+ GY+APE       
Sbjct: 115 RIVYRDLKPENVLLDDHGNVRISDLGLAVELKG---GKKIKGRAGTPGYMAPEVLQGEVY 171

Query: 874 DEKSDVYSFGVVLLELIAGKKPVGEFGDGVD 904
           D   D ++ G  L E+IAG+ P  +  + V+
Sbjct: 172 DFSVDWFALGCTLYEMIAGRSPFRQRKEKVE 202

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 67.7 bits (165), Expect = 3e-12
 Identities = 57/202 (28%), Positives = 94/202 (46%), Gaps = 12/202 (5%)

Query: 700 IGKGGAGIVYRGSM---PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLG 756
           +G G  G V +G        IDVAIK L            + E + + ++ +  IVR++G
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62

Query: 757 YVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLII 816
            V   +  +L+ E    G L + L   K   +       +  + + G+ YL        +
Sbjct: 63  -VCEAEALMLVMEMASGGPLNKFL-SGKKDEITVSNVVELMHQVSMGMKYLEGKN---FV 117

Query: 817 HRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSY--GYIAPEYAYTLKVD 874
           HRD+ + N+LL +   A ++DFGL+K L  A  S   +  AG +   + APE     K  
Sbjct: 118 HRDLAARNVLLVNQHYAKISDFGLSKAL-GADDSYYKARSAGKWPLKWYAPECINFRKFS 176

Query: 875 EKSDVYSFGVVLLELIA-GKKP 895
            +SDV+S+G+ + E  + G+KP
Sbjct: 177 SRSDVWSYGITMWEAFSYGQKP 198

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 68.0 bits (166), Expect = 3e-12
 Identities = 58/214 (27%), Positives = 102/214 (47%), Gaps = 24/214 (11%)

Query: 692 ESLKDENIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRN 750
           + ++ + I+G G  G VY+   +     +A+K +    T       ++E++ L +     
Sbjct: 1   QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPY 60

Query: 751 IVRLLG--YVSNRDTNLLLYEYMPNGSL---GEMLHGAKGGHLKWETRYRIALEAAKGLC 805
           I+   G  +V NR +  +  E+M  GSL    ++     G         RIA+   KGL 
Sbjct: 61  IIGFYGAFFVENRIS--ICTEFMDGGSLDVYRKIPEHVLG---------RIAVAVVKGLT 109

Query: 806 YLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAP 865
           YL    S  I+HRDVK +N+L+++  +  + DFG++  L ++ A     +  G+  Y+AP
Sbjct: 110 YL---WSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIA----KTYVGTNAYMAP 162

Query: 866 EYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEF 899
           E     +    SDV+S G+  +EL  G+ P  + 
Sbjct: 163 ERISGEQYGIHSDVWSLGISFMELALGRFPYPQI 196

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 67.7 bits (165), Expect = 4e-12
 Identities = 74/290 (25%), Positives = 115/290 (39%), Gaps = 48/290 (16%)

Query: 700 IGKGGAGIVYRGSMPDGID------VAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVR 753
           +G+G  G+VY G+  D I       VA+K +    +      FL E   +      ++VR
Sbjct: 14  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73

Query: 754 LLGYVSNRDTNLLLYEYMPNGSLGEMLH----------GAKGGHLKWETRYRIALEAAKG 803
           LLG VS     L++ E M +G L   L           G     L+     ++A E A G
Sbjct: 74  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQ--EMIQMAAEIADG 131

Query: 804 LCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYI 863
           + YL+   +   +HRD+ + N ++  DF   + DFG+ + + +               ++
Sbjct: 132 MAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 188

Query: 864 APEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAA 923
           APE          SD++SFGVVL E+                       TS   QP    
Sbjct: 189 APESLKDGVFTTSSDMWSFGVVLWEI-----------------------TSLAEQPYQGL 225

Query: 924 S---VLA-VVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHML 969
           S   VL  V+D      P      +  +  MC +     RPT  E+V++L
Sbjct: 226 SNEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLL 275

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 69.5 bits (170), Expect = 4e-12
 Identities = 45/143 (31%), Positives = 70/143 (48%), Gaps = 15/143 (10%)

Query: 783 AKGGHLKWETRYRIA-----LEAAKGLCYL------HHDCSPLIIHRDVKSNNILLDSDF 831
           A  G L+ E + R        E   GL ++      HH  S  +IHRD+KS NILL S+ 
Sbjct: 121 ANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNG 180

Query: 832 EAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA 891
              + DFG +K      + +   +  G+  Y+APE        +K+D++S GV+L EL+ 
Sbjct: 181 LVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLT 240

Query: 892 GKKPVGEFGDGVDIVRWVRKTTS 914
            K+P     DG ++   + KT +
Sbjct: 241 LKRPF----DGENMEEVMHKTLA 259

Length = 496

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 67.7 bits (165), Expect = 5e-12
 Identities = 71/229 (31%), Positives = 99/229 (43%), Gaps = 28/229 (12%)

Query: 691 LESLKDEN-------IIGKGGAGIVYR-GSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQT 742
           LESL D          IGKG  G VY+  +  DG   A+K L        D    AE   
Sbjct: 14  LESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKIL--DPISDVDEEIEAEYNI 71

Query: 743 LGRI-RHRNIVRLLGYVSNRDTNL-----LLYEYMPNGSLGEMLHG--AKGGHLKWETRY 794
           L  +  H N+V+  G     D  +     L+ E    GS+ E++ G    G  L      
Sbjct: 72  LQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMIS 131

Query: 795 RIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMS 854
            I   A  GL +LH++    IIHRDVK NNILL ++    + DFG++  L         S
Sbjct: 132 YILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS 188

Query: 855 SVAGSYGYIAPEY-----AYTLKVDEKSDVYSFGVVLLELIAGKKPVGE 898
              G+  ++APE       Y    D + DV+S G+  +EL  G  P+ +
Sbjct: 189 --VGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFD 235

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 67.4 bits (164), Expect = 5e-12
 Identities = 62/235 (26%), Positives = 100/235 (42%), Gaps = 18/235 (7%)

Query: 693 SLKDENIIGKGGAGIV------YRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRI 746
           + +   ++GKGG G V        G M     +  KR+  R     +   L E Q L ++
Sbjct: 1   TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRK---GESMALNEKQILEKV 57

Query: 747 RHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCY 806
             R +V L      +D   L+   M  G L    H    G   +E   R    AA+  C 
Sbjct: 58  NSRFVVSLAYAYETKDALCLVLTLMNGGDL--KFHIYHMGEAGFEEG-RAVFYAAEICCG 114

Query: 807 LHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPE 866
           L       I++RD+K  NILLD      ++D GLA  + +    + +    G+ GY+APE
Sbjct: 115 LEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG---QTIKGRVGTVGYMAPE 171

Query: 867 YAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGV---DIVRWVRKTTSEVSQ 918
                +     D ++ G +L E+IAG+ P  +    +   ++ R V++   E S+
Sbjct: 172 VVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSE 226

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 68.1 bits (166), Expect = 5e-12
 Identities = 46/136 (33%), Positives = 68/136 (50%), Gaps = 11/136 (8%)

Query: 769 EYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLD 828
           EY+  G L  M H  + G  K       A E + GL +LH      II+RD+K +N++LD
Sbjct: 81  EYVNGGDL--MYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLD 135

Query: 829 SDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLE 888
           S+    +ADFG+ K     G      +  G+  YIAPE        +  D +++GV+L E
Sbjct: 136 SEGHIKIADFGMCKEHMVDGV--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYE 193

Query: 889 LIAGKKPVGEFGDGVD 904
           ++AG+ P     DG D
Sbjct: 194 MLAGQPPF----DGED 205

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 68.0 bits (167), Expect = 5e-12
 Identities = 70/226 (30%), Positives = 103/226 (45%), Gaps = 62/226 (27%)

Query: 700 IGKGGAGIVYRGSMPDGID------VAIKRLVGRGTGGNDHGFLA------------EIQ 741
           +GKG  GIV++      ID      VA+K++           F A            EI 
Sbjct: 15  LGKGAYGIVWKA-----IDRRTKEVVALKKI-----------FDAFRNATDAQRTFREIM 58

Query: 742 TLGRIR-HRNIVRLLGYV---SNRDTNLLLYEYMPNGSLGEMLHGA-KGGHLKWETRYRI 796
            L  +  H NIV+LL  +   +++D   L++EYM        LH   +   L+   +  I
Sbjct: 59  FLQELGDHPNIVKLLNVIKAENDKDI-YLVFEYMETD-----LHAVIRANILEDVHKRYI 112

Query: 797 ALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSS- 855
             +  K L Y+H   S  +IHRD+K +NILL+SD    +ADFGLA+ L +   +      
Sbjct: 113 MYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVL 169

Query: 856 ---VAGSYGYIAPE-----YAYTLKVDEKSDVYSFGVVLLELIAGK 893
              VA  + Y APE       YT  V    D++S G +L E++ GK
Sbjct: 170 TDYVATRW-YRAPEILLGSTRYTKGV----DMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 67.2 bits (164), Expect = 6e-12
 Identities = 58/223 (26%), Positives = 92/223 (41%), Gaps = 30/223 (13%)

Query: 700 IGKGGAGIVYRGSMP------DGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVR 753
           IG+G  G V++   P          VA+K L    +      F  E   +    H NIV+
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72

Query: 754 LLGYVSNRDTNLLLYEYMPNGSLGEML--------HGAKGGHLKWET------------R 793
           LLG  +      LL+EYM  G L E L                                +
Sbjct: 73  LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132

Query: 794 YRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECM 853
             IA + A G+ YL        +HRD+ + N L+  +    +ADFGL++ +  A   +  
Sbjct: 133 LCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189

Query: 854 SSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKP 895
            + A    ++ PE  +  +   +SDV+++GVVL E+ + G +P
Sbjct: 190 ENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQP 232

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 67.2 bits (164), Expect = 6e-12
 Identities = 58/197 (29%), Positives = 93/197 (47%), Gaps = 10/197 (5%)

Query: 700 IGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYV 758
           IG+G +G VY    +  G +VAIK++            + EI  +   +H NIV  L   
Sbjct: 27  IGQGASGTVYTAIDVATGQEVAIKQM-NLQQQPKKELIINEILVMRENKHPNIVNYLDSY 85

Query: 759 SNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHR 818
              D   ++ EY+  GSL +++        +     R  L+A   L +LH   S  +IHR
Sbjct: 86  LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQA---LEFLH---SNQVIHR 139

Query: 819 DVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSD 878
           D+KS+NILL  D    + DFG     Q        S++ G+  ++APE         K D
Sbjct: 140 DIKSDNILLGMDGSVKLTDFGFCA--QITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVD 197

Query: 879 VYSFGVVLLELIAGKKP 895
           ++S G++ +E++ G+ P
Sbjct: 198 IWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 67.0 bits (163), Expect = 6e-12
 Identities = 57/229 (24%), Positives = 109/229 (47%), Gaps = 18/229 (7%)

Query: 691 LESLKDENIIGKGGAGIVYRGS-MPDGIDVAIKR--LVGRGTGGNDHGFLAEIQTLGRIR 747
           L + + E  IG+G    VYR + + D   VA+K+  +            + EI  L ++ 
Sbjct: 1   LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLN 60

Query: 748 HRNIVRLL-GYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRY---RIALEAAKG 803
           H N+++ L  ++ + + N++L E    G L +M+      + K + R    R   +    
Sbjct: 61  HPNVIKYLDSFIEDNELNIVL-ELADAGDLSQMIK-----YFKKQKRLIPERTVWKYFVQ 114

Query: 804 LCY-LHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGY 862
           LC  + H  S  ++HRD+K  N+ + +     + D GL +F   +  +    S+ G+  Y
Sbjct: 115 LCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLVGTPYY 172

Query: 863 IAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRK 911
           ++PE  +    + KSD++S G +L E+ A + P   +GD +++    +K
Sbjct: 173 MSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF--YGDKMNLFSLCQK 219

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 67.4 bits (164), Expect = 7e-12
 Identities = 51/192 (26%), Positives = 91/192 (47%), Gaps = 22/192 (11%)

Query: 715 DGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRI-RHRNIVRLLGYVSNRDTNLLLYEYMPN 773
           + + VA+K L    T  +    ++E++ +  I +H+NI+ LLG  +      ++ EY   
Sbjct: 46  EAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASK 105

Query: 774 GSLGEMLHGAKGGHLKWETRYRIA----------------LEAAKGLCYLHHDCSPLIIH 817
           G+L E L   +      E  Y IA                 + A+G+ YL    S   IH
Sbjct: 106 GNLREYLRARRP--PGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYL---ASQKCIH 160

Query: 818 RDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKS 877
           RD+ + N+L+  +    +ADFGLA+ + +    +  ++      ++APE  +      +S
Sbjct: 161 RDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQS 220

Query: 878 DVYSFGVVLLEL 889
           DV+SFGV++ E+
Sbjct: 221 DVWSFGVLMWEI 232

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 66.7 bits (163), Expect = 8e-12
 Identities = 61/216 (28%), Positives = 90/216 (41%), Gaps = 25/216 (11%)

Query: 692 ESLKDENIIGKGGAGIVYRGSM------PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGR 745
           +S+     +G G  G VY G           + VA+K L    +  ++  FL E   + +
Sbjct: 6   DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSK 65

Query: 746 IRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEML-----HGAKGGHLKWETRYRIALEA 800
             H+NIVRL+G    R    +L E M  G L   L        +   L  +     A + 
Sbjct: 66  FNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDV 125

Query: 801 AKGLCYLHHDCSPLIIHRDVKSNNILLDS---DFEAHVADFGLAKFLQDAG----ASECM 853
           AKG  YL        IHRD+ + N LL        A +ADFG+A+ +  A         M
Sbjct: 126 AKGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAM 182

Query: 854 SSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLEL 889
             +     ++ PE         K+DV+SFGV+L E+
Sbjct: 183 LPIK----WMPPEAFLDGIFTSKTDVWSFGVLLWEI 214

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 67.3 bits (164), Expect = 8e-12
 Identities = 48/129 (37%), Positives = 66/129 (51%), Gaps = 11/129 (8%)

Query: 769 EYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLD 828
           EY+  G L   +       L   T Y  A E   GL +LH   S  I++RD+K +NILLD
Sbjct: 76  EYLNGGDLMFHIQSCHKFDLPRATFY--AAEIICGLQFLH---SKGIVYRDLKLDNILLD 130

Query: 829 SDFEAHVADFGLAK--FLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVL 886
           +D    +ADFG+ K   L DA       +  G+  YIAPE     K +   D +SFGV+L
Sbjct: 131 TDGHIKIADFGMCKENMLGDAKT----CTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLL 186

Query: 887 LELIAGKKP 895
            E++ G+ P
Sbjct: 187 YEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 67.0 bits (164), Expect = 9e-12
 Identities = 47/159 (29%), Positives = 74/159 (46%), Gaps = 18/159 (11%)

Query: 742 TLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAA 801
           T    RH  +V L       D    + EY   G L  M+H       +    +  A    
Sbjct: 55  TANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDL--MMHIHTDVFSEPRAVFYAA-CVV 111

Query: 802 KGLCYLH-HDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSY 860
            GL YLH +     I++RD+K +N+LLD++    +ADFGL K  +  G  +  S+  G+ 
Sbjct: 112 LGLQYLHENK----IVYRDLKLDNLLLDTEGFVKIADFGLCK--EGMGFGDRTSTFCGTP 165

Query: 861 GYIAPEY----AYTLKVDEKSDVYSFGVVLLELIAGKKP 895
            ++APE     +YT  V    D +  GV++ E++ G+ P
Sbjct: 166 EFLAPEVLTETSYTRAV----DWWGLGVLIYEMLVGESP 200

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 66.6 bits (162), Expect = 9e-12
 Identities = 58/230 (25%), Positives = 108/230 (46%), Gaps = 11/230 (4%)

Query: 700 IGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVS 759
           +G G  G VY+    +   +A  +++   +      ++ EI  L    H NIV+LL    
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72

Query: 760 NRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRD 819
             +   +L E+   G++  ++   +    + + R  +  +  + L YLH +    IIHRD
Sbjct: 73  YENNLWILIEFCAGGAVDAVMLELERPLTEPQIRV-VCKQTLEALNYLHEN---KIIHRD 128

Query: 820 VKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAY--TLK---VD 874
           +K+ NIL   D +  +ADFG++   ++    +   S  G+  ++APE     T K    D
Sbjct: 129 LKAGNILFTLDGDIKLADFGVSA--KNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYD 186

Query: 875 EKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAAS 924
            K+DV+S G+ L+E+   + P  E      +++  +     ++QPS  +S
Sbjct: 187 YKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSS 236

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 66.3 bits (162), Expect = 1e-11
 Identities = 57/211 (27%), Positives = 102/211 (48%), Gaps = 16/211 (7%)

Query: 689 DVLESLKDENIIGKGGAGIVYRGS-MPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIR 747
           D    L +   IG+G  GIV   +    G  VA+K++  R     +  F  E+  +   +
Sbjct: 16  DPRSYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLF-NEVVIMRDYQ 74

Query: 748 HRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYL 807
           H NIV +       D   ++ E++  G+L +++       +  E    + L   K L +L
Sbjct: 75  HPNIVEMYSSYLVGDELWVVMEFLEGGALTDIV---THTRMNEEQIATVCLAVLKALSFL 131

Query: 808 HHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECM---SSVAGSYGYIA 864
           H   +  +IHRD+KS++ILL SD    ++DFG       A  S+ +    S+ G+  ++A
Sbjct: 132 H---AQGVIHRDIKSDSILLTSDGRVKLSDFGFC-----AQVSKEVPRRKSLVGTPYWMA 183

Query: 865 PEYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
           PE    L    + D++S G++++E++ G+ P
Sbjct: 184 PEVISRLPYGTEVDIWSLGIMVIEMVDGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 65.7 bits (161), Expect = 1e-11
 Identities = 68/217 (31%), Positives = 95/217 (43%), Gaps = 38/217 (17%)

Query: 700 IGKGGAGIVY---RGSMPDGIDVAIKRLVGRGTGGND--HGFLAEIQTLGRIRHRNIVRL 754
           I KG  G V+   + S  D    AIK +        +     L E   L + +   +V+L
Sbjct: 1   ISKGAYGRVFLAKKKSTGD--IYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL 58

Query: 755 LGYVSNRDT-NL-LLYEYMPNGSLGEMLHGAKGGHL-KWETRYRIALEAAKGLCYLHHDC 811
             Y S +   NL L+ EY+P G L  +L     G L +   R  IA E    L YLH   
Sbjct: 59  --YYSFQGKKNLYLVMEYLPGGDLASLLE--NVGSLDEDVARIYIA-EIVLALEYLH--- 110

Query: 812 SPLIIHRDVKSNNILLDSDFEAHVADFGLAKF-------LQDAGASECMSSVAGSYGYIA 864
           S  IIHRD+K +NIL+DS+    + DFGL+K          +    E    + G+  YIA
Sbjct: 111 SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKED-KRIVGTPDYIA 169

Query: 865 PE------YAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
           PE      ++ T       D +S G +L E + G  P
Sbjct: 170 PEVILGQGHSKT------VDWWSLGCILYEFLVGIPP 200

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 66.0 bits (161), Expect = 1e-11
 Identities = 63/222 (28%), Positives = 93/222 (41%), Gaps = 34/222 (15%)

Query: 700 IGKGGAGIVY------RGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVR 753
           +GKGG G V        G +     +  KRL  R       G + E + L ++  R IV 
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRK---GYEGAMVEKRILAKVHSRFIVS 57

Query: 754 LLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWE-----------TRYRIALEAAK 802
           L  Y     T+L L   + NG           G L++               R     A+
Sbjct: 58  L-AYAFQTKTDLCLVMTIMNG-----------GDLRYHIYNVDEENPGFPEPRACFYTAQ 105

Query: 803 GLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGY 862
            +  L H     II+RD+K  N+LLD+D    ++D GLA  L+D          AG+ G+
Sbjct: 106 IISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKD--GQSKTKGYAGTPGF 163

Query: 863 IAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVD 904
           +APE     + D   D ++ GV L E+IA + P    G+ V+
Sbjct: 164 MAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE 205

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 66.3 bits (161), Expect = 1e-11
 Identities = 57/199 (28%), Positives = 95/199 (47%), Gaps = 14/199 (7%)

Query: 700 IGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYV 758
           IG+G +G VY    +  G +VAIK++  +     +   + EI  +   ++ NIV  L   
Sbjct: 27  IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKEL-IINEILVMRENKNPNIVNYLDSY 85

Query: 759 SNRDTNLLLYEYMPNGSLGEMLHGA--KGGHLKWETRYRIALEAAKGLCYLHHDCSPLII 816
              D   ++ EY+  GSL +++       G +    R     E  + L +LH   S  +I
Sbjct: 86  LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR-----ECLQALDFLH---SNQVI 137

Query: 817 HRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEK 876
           HRD+KS+NILL  D    + DFG     Q        S++ G+  ++APE         K
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCA--QITPEQSKRSTMVGTPYWMAPEVVTRKAYGPK 195

Query: 877 SDVYSFGVVLLELIAGKKP 895
            D++S G++ +E++ G+ P
Sbjct: 196 VDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 66.4 bits (162), Expect = 2e-11
 Identities = 58/211 (27%), Positives = 100/211 (47%), Gaps = 20/211 (9%)

Query: 689 DVLESLKDENIIGKGGAGIVYRGSMPD---GIDVAIKRLVGR-GTGGNDHGFLAEIQTLG 744
           ++     D   +G G  G+V   S  D   G +VAIK+++    T         E++ L 
Sbjct: 7   EITNRYVDLQPVGMGAFGLVC--SARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLK 64

Query: 745 RIRHRNIVRLLG-YVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKG 803
            +RH NI+ L   ++S  +    + E +    L  +L       L+ +       +  +G
Sbjct: 65  HLRHENIISLSDIFISPLEDIYFVTELLGT-DLHRLL---TSRPLEKQFIQYFLYQILRG 120

Query: 804 LCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYI 863
           L Y+H   S  ++HRD+K +NIL++ + +  + DFGLA+ +QD      M+    +  Y 
Sbjct: 121 LKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLAR-IQDPQ----MTGYVSTRYYR 172

Query: 864 APEYAYTL-KVDEKSDVYSFGVVLLELIAGK 893
           APE   T  K D + D++S G +  E++ GK
Sbjct: 173 APEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 65.8 bits (160), Expect = 2e-11
 Identities = 50/186 (26%), Positives = 89/186 (47%), Gaps = 18/186 (9%)

Query: 719 VAIKRLVGRGTGGNDHGFLAEIQTLGRI-RHRNIVRLLGYVSNRDTNLLLYEYMPNGSLG 777
           VA+K L    T  +    ++E++ +  I +H+NI+ LLG  +      ++ EY   G+L 
Sbjct: 53  VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 112

Query: 778 EMLHGAKGGHLKW--------------ETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSN 823
           E L   +   +++              +     A + A+G+ YL    S   IHRD+ + 
Sbjct: 113 EYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYL---ASKKCIHRDLAAR 169

Query: 824 NILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFG 883
           N+L+  D    +ADFGLA+ +      +  ++      ++APE  +      +SDV+SFG
Sbjct: 170 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFG 229

Query: 884 VVLLEL 889
           V+L E+
Sbjct: 230 VLLWEI 235

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 65.4 bits (159), Expect = 2e-11
 Identities = 52/197 (26%), Positives = 97/197 (49%), Gaps = 10/197 (5%)

Query: 700 IGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYV 758
           IG+G  GIV   ++   G  VA+K++  R     +  F  E+  +   +H N+V +    
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLF-NEVVIMRDYQHENVVEMYNSY 86

Query: 759 SNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHR 818
              D   ++ E++  G+L +++   +   +  E    + L   K L  LH   +  +IHR
Sbjct: 87  LVGDELWVVMEFLEGGALTDIVTHTR---MNEEQIAAVCLAVLKALSVLH---AQGVIHR 140

Query: 819 DVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSD 878
           D+KS++ILL  D    ++DFG     Q +       S+ G+  ++APE    L    + D
Sbjct: 141 DIKSDSILLTHDGRVKLSDFGFCA--QVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVD 198

Query: 879 VYSFGVVLLELIAGKKP 895
           ++S G++++E++ G+ P
Sbjct: 199 IWSLGIMVIEMVDGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 66.2 bits (161), Expect = 2e-11
 Identities = 63/210 (30%), Positives = 102/210 (48%), Gaps = 15/210 (7%)

Query: 690 VLESLKDENIIGKGGAGIVYRGSMPDGI---DVAIKRLVGRGTGGNDHGFLA--EIQTLG 744
           VL+  ++   IG G  GIV   +  D I   +VAIK+L  R      H   A  E+  + 
Sbjct: 22  VLKRYQNLKPIGSGAQGIVC--AAYDAILERNVAIKKL-SRPFQNQTHAKRAYRELVLMK 78

Query: 745 RIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRY-RIALEAAKG 803
            + H+NI+ LL   + + +   L E+     + E++       ++ E  + R++    + 
Sbjct: 79  CVNHKNIIGLLNVFTPQKS---LEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQM 135

Query: 804 LCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYI 863
           LC + H  S  IIHRD+K +NI++ SD    + DFGLA+    AG S  M+    +  Y 
Sbjct: 136 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYR 192

Query: 864 APEYAYTLKVDEKSDVYSFGVVLLELIAGK 893
           APE    +   E  D++S G ++ E+I G 
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKGG 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 66.3 bits (161), Expect = 2e-11
 Identities = 61/210 (29%), Positives = 102/210 (48%), Gaps = 15/210 (7%)

Query: 690 VLESLKDENIIGKGGAGIVYRGSMPDGI---DVAIKRLVGRGTGGNDHGFLA--EIQTLG 744
           VL+  ++   IG G  GIV   +  D +   +VAIK+L  R      H   A  E+  + 
Sbjct: 15  VLKRYQNLKPIGSGAQGIVC--AAYDAVLDRNVAIKKL-SRPFQNQTHAKRAYRELVLMK 71

Query: 745 RIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRY-RIALEAAKG 803
            + H+NI+ LL   + + +   L E+     + E++       ++ E  + R++    + 
Sbjct: 72  CVNHKNIISLLNVFTPQKS---LEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQM 128

Query: 804 LCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYI 863
           LC + H  S  IIHRD+K +NI++ SD    + DFGLA+    AG S  M+    +  Y 
Sbjct: 129 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYR 185

Query: 864 APEYAYTLKVDEKSDVYSFGVVLLELIAGK 893
           APE    +   E  D++S G ++ E++  K
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMVRHK 215

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 65.0 bits (158), Expect = 3e-11
 Identities = 56/209 (26%), Positives = 88/209 (42%), Gaps = 15/209 (7%)

Query: 693 SLKDENIIGKGGAGIV------YRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRI 746
           + +   ++GKGG G V        G M     +  KR+  R     +   L E Q L ++
Sbjct: 1   TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRK---GESMALNEKQILEKV 57

Query: 747 RHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCY 806
             + +V L      +D   L+   M  G L    H    G+  +E   R    AA+ LC 
Sbjct: 58  NSQFVVNLAYAYETKDALCLVLTIMNGGDL--KFHIYNMGNPGFEEE-RALFYAAEILCG 114

Query: 807 LHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPE 866
           L        ++RD+K  NILLD      ++D GLA  + +    E +    G+ GY+APE
Sbjct: 115 LEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG---ESIRGRVGTVGYMAPE 171

Query: 867 YAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
                +     D +  G ++ E+I G+ P
Sbjct: 172 VLNNQRYTLSPDYWGLGCLIYEMIEGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 65.1 bits (158), Expect = 3e-11
 Identities = 54/197 (27%), Positives = 94/197 (47%), Gaps = 10/197 (5%)

Query: 700 IGKGGAGIVYRGS-MPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYV 758
           IG+G +G V+    +  G +VAIK+ +           + EI  +  +++ NIV  L   
Sbjct: 27  IGQGASGTVFTAIDVATGQEVAIKQ-INLQKQPKKELIINEILVMKELKNPNIVNFLDSF 85

Query: 759 SNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHR 818
              D   ++ EY+  GSL +++        +     R  L+A   L +LH +    +IHR
Sbjct: 86  LVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQA---LEFLHAN---QVIHR 139

Query: 819 DVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSD 878
           D+KS+N+LL  D    + DFG     Q        S++ G+  ++APE         K D
Sbjct: 140 DIKSDNVLLGMDGSVKLTDFGFCA--QITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVD 197

Query: 879 VYSFGVVLLELIAGKKP 895
           ++S G++ +E++ G+ P
Sbjct: 198 IWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 66.6 bits (162), Expect = 3e-11
 Identities = 47/158 (29%), Positives = 77/158 (48%), Gaps = 1/158 (0%)

Query: 738 AEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIA 797
           +E+  L    H  IV+      + D  LL+ EY   G L + +      HL ++  Y + 
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQ-EYEVG 172

Query: 798 LEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVA 857
           L   + +  L    S  ++HRD+KS NI L       + DFG +K   D+ + +  SS  
Sbjct: 173 LLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFC 232

Query: 858 GSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
           G+  Y+APE     +  +K+D++S GV+L EL+   +P
Sbjct: 233 GTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRP 270

Length = 478

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 65.1 bits (158), Expect = 3e-11
 Identities = 57/199 (28%), Positives = 95/199 (47%), Gaps = 14/199 (7%)

Query: 700 IGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYV 758
           IG+G +G VY    +  G +VAI+++  +     +   + EI  +   ++ NIV  L   
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL-IINEILVMRENKNPNIVNYLDSY 86

Query: 759 SNRDTNLLLYEYMPNGSLGEMLHGA--KGGHLKWETRYRIALEAAKGLCYLHHDCSPLII 816
              D   ++ EY+  GSL +++       G +    R     E  + L +LH   S  +I
Sbjct: 87  LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR-----ECLQALEFLH---SNQVI 138

Query: 817 HRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEK 876
           HRD+KS+NILL  D    + DFG     Q        S++ G+  ++APE         K
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCA--QITPEQSKRSTMVGTPYWMAPEVVTRKAYGPK 196

Query: 877 SDVYSFGVVLLELIAGKKP 895
            D++S G++ +E+I G+ P
Sbjct: 197 VDIWSLGIMAIEMIEGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 65.4 bits (160), Expect = 3e-11
 Identities = 58/220 (26%), Positives = 109/220 (49%), Gaps = 27/220 (12%)

Query: 688 EDVLESLKDENIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHGF----LAEIQT 742
            DV    ++ + IG+G  G+V      P G+ VAIK++    +      F    L EI+ 
Sbjct: 1   FDVGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKI----SPFEHQTFCQRTLREIKI 56

Query: 743 LGRIRHRNIVRLLGYV--SNRDTNLLLY---EYMPNGSLGEMLHGAK--GGHLKWETRYR 795
           L R +H NI+ +L  +   + ++   +Y   E M    L +++        H+++   Y+
Sbjct: 57  LRRFKHENIIGILDIIRPPSFESFNDVYIVQELMET-DLYKLIKTQHLSNDHIQYFL-YQ 114

Query: 796 IALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKF-LQDAGASECMS 854
           I     +GL Y+H   S  ++HRD+K +N+LL+++ +  + DFGLA+    +   +  ++
Sbjct: 115 IL----RGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLT 167

Query: 855 SVAGSYGYIAPEYAYTLKVDEKS-DVYSFGVVLLELIAGK 893
               +  Y APE     K   K+ D++S G +L E+++ +
Sbjct: 168 EYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 65.4 bits (159), Expect = 3e-11
 Identities = 44/127 (34%), Positives = 66/127 (51%), Gaps = 7/127 (5%)

Query: 769 EYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLD 828
           EY+  G L  M    + G  K       A E A GL +LH   S  II+RD+K +N++LD
Sbjct: 81  EYVNGGDL--MYQIQQVGRFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLD 135

Query: 829 SDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLE 888
           S+    +ADFG+ K  ++        +  G+  YIAPE        +  D ++FGV+L E
Sbjct: 136 SEGHIKIADFGMCK--ENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYE 193

Query: 889 LIAGKKP 895
           ++AG+ P
Sbjct: 194 MLAGQAP 200

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 64.6 bits (157), Expect = 4e-11
 Identities = 64/205 (31%), Positives = 97/205 (47%), Gaps = 22/205 (10%)

Query: 739 EIQTLGRIRHRNIVRLLGYVSNRDTNL-LLYEYMPNGSLGEMLHGAKGGHLKWETRYR-- 795
           E Q L  IR    +  L Y    DT L L+ +Y+ NG  GE+       HL    R++  
Sbjct: 54  ERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYI-NG--GELF-----THLSQRERFKEQ 105

Query: 796 -IALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAK-FLQDAGASECM 853
            + + + + +  L H     II+RD+K  NILLDS+    + DFGL+K F +D    E  
Sbjct: 106 EVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHED--EVERA 163

Query: 854 SSVAGSYGYIAPEYAYTLKV--DEKSDVYSFGVVLLELIAGKKPV---GEFGDGVDIVRW 908
            S  G+  Y+AP+         D+  D +S GV++ EL+ G  P    GE     +I R 
Sbjct: 164 YSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRR 223

Query: 909 VRKTTSEVSQPSDAASVLAVVDPRL 933
           + K  SE   P + +++   +  RL
Sbjct: 224 ILK--SEPPYPQEMSALAKDIIQRL 246

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 64.3 bits (156), Expect = 4e-11
 Identities = 56/200 (28%), Positives = 94/200 (47%), Gaps = 10/200 (5%)

Query: 700 IGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVS 759
           +G G  G VY+       ++A  +++    G +      EI  +   +H NIV   G   
Sbjct: 17  VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76

Query: 760 NRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRD 819
           +R+   +  EY   GSL ++ H   G   + +  Y +  E  +GL YLH   S   +HRD
Sbjct: 77  SREKLWICMEYCGGGSLQDIYH-VTGPLSELQIAY-VCRETLQGLAYLH---SKGKMHRD 131

Query: 820 VKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLK---VDEK 876
           +K  NILL  + +  +ADFG+A  +    A     S  G+  ++APE A   K    ++ 
Sbjct: 132 IKGANILLTDNGDVKLADFGVAAKITATIAKR--KSFIGTPYWMAPEVAAVEKNGGYNQL 189

Query: 877 SDVYSFGVVLLELIAGKKPV 896
            D+++ G+  +EL   + P+
Sbjct: 190 CDIWAVGITAIELAELQPPM 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 65.4 bits (159), Expect = 4e-11
 Identities = 70/249 (28%), Positives = 113/249 (45%), Gaps = 26/249 (10%)

Query: 681 QRLDFKAEDVLESLKDENIIGKGGAGIV-YRGSMPDGIDVAIKRLVGRGTGGNDHGFLA- 738
           Q ++    +V +  +D   +G G  G V        G  VAIK+L  R          A 
Sbjct: 4   QEVNKTIWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLY-RPFQSELFAKRAY 62

Query: 739 -EIQTLGRIRHRNIVRLLGYVSNRDTNLL----LYEYMP--NGSLGEMLHGAKGGHLKWE 791
            E++ L  ++H N++ LL  V   D +L      Y  MP     LG+++   K      E
Sbjct: 63  RELRLLKHMKHENVIGLLD-VFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLS----E 117

Query: 792 TRYR-IALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS 850
            R + +  +  KGL Y+H   +  IIHRD+K  N+ ++ D E  + DFGLA+       S
Sbjct: 118 DRIQFLVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR----QTDS 170

Query: 851 ECMSSVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWV 909
           E    V   + Y APE     +   +  D++S G ++ E++ G KP+ +  D +D +  +
Sbjct: 171 EMTGYVVTRW-YRAPEVILNWMHYTQTVDIWSVGCIMAEMLTG-KPLFKGHDHLDQLMEI 228

Query: 910 RKTTSEVSQ 918
            K T   S+
Sbjct: 229 MKVTGTPSK 237

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 64.5 bits (157), Expect = 4e-11
 Identities = 62/232 (26%), Positives = 96/232 (41%), Gaps = 24/232 (10%)

Query: 699 IIGKGGAGIV------YRGSMPDGIDVAIKRLVGRGTGGNDHG---FLAEIQTLGRIRHR 749
           ++GKGG G V        G M     +  KR+  R       G    L E Q L ++  R
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKR------KGEAMALNEKQILEKVNSR 60

Query: 750 NIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHH 809
            +V L      +D   L+   M  G L   ++         E   R    AA+  C L  
Sbjct: 61  FVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEE---RAVFYAAEITCGLED 117

Query: 810 DCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAY 869
                I++RD+K  NILLD      ++D GLA  + +    E +    G+ GY+APE   
Sbjct: 118 LHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPE---GETIRGRVGTVGYMAPEVVK 174

Query: 870 TLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGV---DIVRWVRKTTSEVSQ 918
             +     D +  G ++ E+I GK P  +  + V   ++ R V++   E S+
Sbjct: 175 NERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSE 226

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 63.8 bits (155), Expect = 5e-11
 Identities = 43/153 (28%), Positives = 73/153 (47%), Gaps = 5/153 (3%)

Query: 743 LGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAK 802
           L +++H NIV             ++ EY   G L + +   +G     +T  +  ++   
Sbjct: 52  LAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCL 111

Query: 803 GLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGY 862
           G+ ++H      ++HRD+KS NI L  + +  + DFG A+ L   GA  C  +  G+  Y
Sbjct: 112 GVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYAC--TYVGTPYY 166

Query: 863 IAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
           + PE    +  + KSD++S G +L EL   K P
Sbjct: 167 VPPEIWENMPYNNKSDIWSLGCILYELCTLKHP 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 64.4 bits (157), Expect = 5e-11
 Identities = 40/145 (27%), Positives = 75/145 (51%), Gaps = 6/145 (4%)

Query: 700 IGKGGAGIVYRG-SMPDGIDVAIKRL-VGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGY 757
           IG+G  G+VY+  +   G  VA+K++ +   T G     + EI  L  + H NIV+LL  
Sbjct: 8   IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 67

Query: 758 VSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIH 817
           +   +   L++E++ +  L + +  +    +          +  +GL + H   S  ++H
Sbjct: 68  IHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH---SHRVLH 123

Query: 818 RDVKSNNILLDSDFEAHVADFGLAK 842
           RD+K  N+L++++    +ADFGLA+
Sbjct: 124 RDLKPQNLLINTEGAIKLADFGLAR 148

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 64.2 bits (156), Expect = 5e-11
 Identities = 68/236 (28%), Positives = 104/236 (44%), Gaps = 21/236 (8%)

Query: 700 IGKGGAGIVYRGSMPDGID---VAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLG 756
           IG G  G V  G +  G     V +K L    +      FL E Q    ++H N+++ LG
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62

Query: 757 YVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHL---KWETRYRIALEAAKGLCYLHHDCSP 813
             +     LL+ E+ P G L   L   +   L      T  R+A E A GL +LH +   
Sbjct: 63  QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN-- 120

Query: 814 LIIHRDVKSNNILLDSDFEAHVADFGLA--KFLQDAGASECMSSVAGSYGYIAPE----- 866
             IH D+   N LL +D    + D+GL+  K+ +D   +     V     +IAPE     
Sbjct: 121 -FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWV--PLRWIAPELVDEV 177

Query: 867 YAYTLKVDE--KSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQP 919
           +   L VD+  +S+V+S GV + EL   G +P     D   +   VR+   ++ +P
Sbjct: 178 HGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKP 233

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 64.4 bits (157), Expect = 5e-11
 Identities = 55/197 (27%), Positives = 93/197 (47%), Gaps = 9/197 (4%)

Query: 700 IGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYV 758
           +G+G    VY+G +   G  VA+K +      G     + EI  +  ++H NIVRL   +
Sbjct: 8   LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVI 67

Query: 759 SNRDTNLLLYEYMPNGSLGEM-LHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIH 817
              +  +L++EYM       M  HG +G  L   T      +  KG+ + H +    ++H
Sbjct: 68  HTENKLMLVFEYMDKDLKKYMDTHGVRGA-LDPNTVKSFTYQLLKGIAFCHEN---RVLH 123

Query: 818 RDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKS 877
           RD+K  N+L++   E  +ADFGLA+           S+   +  Y AP+     +    S
Sbjct: 124 RDLKPQNLLINKRGELKLADFGLARAF--GIPVNTFSNEVVTLWYRAPDVLLGSRTYSTS 181

Query: 878 -DVYSFGVVLLELIAGK 893
            D++S G ++ E+I G+
Sbjct: 182 IDIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 64.9 bits (158), Expect = 5e-11
 Identities = 45/163 (27%), Positives = 73/163 (44%), Gaps = 24/163 (14%)

Query: 737 LAEIQTLGRIRHRNIVRLLGYVSNRDTNLL--------LYEYMPNGSLGEMLHGAKGGHL 788
           L E   L  + H +++R+   + +     +        LY Y+   S            L
Sbjct: 105 LIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSSDLYTYLTKRS----------RPL 154

Query: 789 KWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAG 848
             +    I  +  +GL YLH   +  IIHRDVK+ NI ++   +  + D G A+F   A 
Sbjct: 155 PIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP 211

Query: 849 ASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA 891
           A      +AG+    APE     K + K+D++S G+VL E++A
Sbjct: 212 A---FLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLA 251

Length = 357

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 64.3 bits (156), Expect = 6e-11
 Identities = 54/209 (25%), Positives = 93/209 (44%), Gaps = 23/209 (11%)

Query: 719 VAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGE 778
           VAIK L  +  G     F  E     R++H NIV LLG V+      +++ Y  +  L E
Sbjct: 38  VAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHE 97

Query: 779 ML-----HGAKGG---------HLKWETRYRIALEAAKGLCYL--HHDCSPLIIHRDVKS 822
            L     H   G           L+      I  + A G+ +L  HH     ++H+D+ +
Sbjct: 98  FLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH-----VVHKDLAT 152

Query: 823 NNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSF 882
            N+L+       ++D GL + +  A   + M +      +++PE     K    SD++S+
Sbjct: 153 RNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSY 212

Query: 883 GVVLLELIA-GKKPVGEFGDGVDIVRWVR 910
           GVVL E+ + G +P   + +  D++  +R
Sbjct: 213 GVVLWEVFSYGLQPYCGYSNQ-DVIEMIR 240

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 64.3 bits (156), Expect = 6e-11
 Identities = 55/198 (27%), Positives = 99/198 (50%), Gaps = 12/198 (6%)

Query: 700 IGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYV 758
           IG+G  GIV        G  VA+K +  R     +  F  E+  +   +H+N+V +    
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLF-NEVVIMRDYQHQNVVEMYKSY 87

Query: 759 SNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHR 818
              +   +L E++  G+L +++   +    +  T     L+A   LCYLH   S  +IHR
Sbjct: 88  LVGEELWVLMEFLQGGALTDIVSQTRLNEEQIATVCESVLQA---LCYLH---SQGVIHR 141

Query: 819 DVKSNNILLDSDFEAHVADFGL-AKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKS 877
           D+KS++ILL  D    ++DFG  A+  +D    +   S+ G+  ++APE         + 
Sbjct: 142 DIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRK---SLVGTPYWMAPEVISRTPYGTEV 198

Query: 878 DVYSFGVVLLELIAGKKP 895
           D++S G++++E++ G+ P
Sbjct: 199 DIWSLGIMVIEMVDGEPP 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 64.1 bits (156), Expect = 6e-11
 Identities = 60/208 (28%), Positives = 95/208 (45%), Gaps = 22/208 (10%)

Query: 700 IGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYV 758
           +GKG  G VY+    P G+ +A+K +         +  + E+  L +     IV   G  
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68

Query: 759 SNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRY-RIALEAAKGLCYLHHDCSPLIIH 817
                  +  EYM  GSL ++  G        E    RI     KGL +L  + +  IIH
Sbjct: 69  FIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--IIH 126

Query: 818 RDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEY---------- 867
           RDVK  N+L++ + +  + DFG++  L    AS   +++ G   Y+APE           
Sbjct: 127 RDVKPTNVLVNGNGQVKLCDFGVSGNLV---ASLAKTNI-GCQSYMAPERIKSGGPNQNP 182

Query: 868 AYTLKVDEKSDVYSFGVVLLELIAGKKP 895
            YT+    +SDV+S G+ +LE+  G+ P
Sbjct: 183 TYTV----QSDVWSLGLSILEMALGRYP 206

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 64.4 bits (157), Expect = 6e-11
 Identities = 66/218 (30%), Positives = 104/218 (47%), Gaps = 32/218 (14%)

Query: 698 NIIGKGGAGIVYRGSMPD-GIDVAIKRLVGRGTGGNDHGF----LAEIQTLGRIRHRNIV 752
             IG+G  G VY+    D G  VA+K++          GF    + EI+ L ++ HRNIV
Sbjct: 13  GQIGEGTYGQVYKARDKDTGELVALKKV---RLDNEKEGFPITAIREIKILRQLNHRNIV 69

Query: 753 RLLGYVSNRDTNL----------LLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAK 802
            L   V+++   L          L++EYM +  +G +  G    H   +       +  +
Sbjct: 70  NLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLV--HFSEDHIKSFMKQLLE 127

Query: 803 GLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGY 862
           GL Y H       +HRD+K +NILL++  +  +ADFGLA+ L ++  S   ++   +  Y
Sbjct: 128 GLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFGLAR-LYNSEESRPYTNKVITLWY 183

Query: 863 IAPEYAYTLKVDEKS----DVYSFGVVLLELIAGKKPV 896
             PE    L  +E+     DV+S G +L EL   KKP+
Sbjct: 184 RPPEL---LLGEERYGPAIDVWSCGCILGELFT-KKPI 217

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 64.4 bits (157), Expect = 7e-11
 Identities = 42/106 (39%), Positives = 53/106 (50%), Gaps = 6/106 (5%)

Query: 791 ETRYRI-ALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGA 849
           E R R  A E A  L YLH   S  II+RD+K  NILLDS     + DFGL K  +    
Sbjct: 95  EPRARFYAAEIASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCK--EGIEH 149

Query: 850 SECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
           S+  S+  G+  Y+APE       D   D +  G VL E++ G  P
Sbjct: 150 SKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 64.3 bits (156), Expect = 7e-11
 Identities = 44/141 (31%), Positives = 69/141 (48%), Gaps = 7/141 (4%)

Query: 765 LLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNN 824
            L+ EY+  G L  M H  +   L  E     A E    L +LH      II+RD+K +N
Sbjct: 72  FLVIEYVNGGDL--MFHMQRQRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDN 126

Query: 825 ILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGV 884
           +LLD+D    + D+G+ K  +  G  +  S+  G+  YIAPE     +     D ++ GV
Sbjct: 127 VLLDADGHIKLTDYGMCK--EGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGV 184

Query: 885 VLLELIAGKKPVGEFGDGVDI 905
           ++ E++AG+ P     D  D+
Sbjct: 185 LMFEMMAGRSPFDIITDNPDM 205

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 63.6 bits (155), Expect = 8e-11
 Identities = 57/236 (24%), Positives = 103/236 (43%), Gaps = 32/236 (13%)

Query: 739 EIQTLGRIRHRNIVRLLGYVSNRDTNL----LLYEYMPNGSLGEMLHGAKGGHLKWETRY 794
           EI+ L RI   NI+++ G++ +   +L    L+ EY   G L E+L   K   L ++T+ 
Sbjct: 68  EIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEK--DLSFKTKL 125

Query: 795 RIALEAAKGLCYLH-HDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECM 853
            +A++  KGL  L+ +   P   ++++ S + L+  +++  +   GL K L         
Sbjct: 126 DMAIDCCKGLYNLYKYTNKP---YKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVN 182

Query: 854 SSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTT 913
             V  SY  +   ++   +   K D+YS GVVL E+  GK P  E     +I   +    
Sbjct: 183 FMVYFSYKMLNDIFS---EYTIKDDIYSLGVVLWEIFTGKIPF-ENLTTKEIYDLIINKN 238

Query: 914 SEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHML 969
           + +  P D    +  +           V         C   +S  RP ++E+++ L
Sbjct: 239 NSLKLPLDCPLEIKCI-----------VEA-------CTSHDSIKRPNIKEILYNL 276

Length = 283

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 63.5 bits (154), Expect = 8e-11
 Identities = 54/200 (27%), Positives = 91/200 (45%), Gaps = 10/200 (5%)

Query: 700 IGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVS 759
           IG G  G VY+    +  ++A  +++    G +      EI  +   +H NIV   G   
Sbjct: 17  IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76

Query: 760 NRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRD 819
            RD   +  E+   GSL ++ H    G L       ++ E  +GL YLH       +HRD
Sbjct: 77  RRDKLWICMEFCGGGSLQDIYHVT--GPLSESQIAYVSRETLQGLYYLHSKGK---MHRD 131

Query: 820 VKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLK---VDEK 876
           +K  NILL  +    +ADFG++  +    A     S  G+  ++APE A   +    ++ 
Sbjct: 132 IKGANILLTDNGHVKLADFGVSAQITATIAKR--KSFIGTPYWMAPEVAAVERKGGYNQL 189

Query: 877 SDVYSFGVVLLELIAGKKPV 896
            D+++ G+  +EL   + P+
Sbjct: 190 CDIWAVGITAIELAELQPPM 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 65.6 bits (160), Expect = 9e-11
 Identities = 35/93 (37%), Positives = 47/93 (50%)

Query: 366 LDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGTI 425
           L + +  L G IP D+ K   L+S+ L  N   G IP  LG   SL  +  S N  NG+I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 426 PAGLFNLPLLNMMELDDNLLSGELPEKMSGASL 458
           P  L  L  L ++ L+ N LSG +P  + G  L
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRLL 515

Length = 623

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 64.0 bits (156), Expect = 9e-11
 Identities = 47/174 (27%), Positives = 80/174 (45%), Gaps = 4/174 (2%)

Query: 717 IDVAIKRLVGRGTGGNDHGFLAEIQTLGRI-RHRNIVRLLGYVSNRDTNLLLYEYMPNGS 775
           + VA+K L            ++E++ +  +  H NIV LLG  +     L++ EY   G 
Sbjct: 66  MKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGD 125

Query: 776 LGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHV 835
           L   L   +   L  E     + + AKG+ +L    S   IHRD+ + N+LL       +
Sbjct: 126 LLNFLRRKRESFLTLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNVLLTHGKIVKI 182

Query: 836 ADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLEL 889
            DFGLA+ + +        +      ++APE  +      +SDV+S+G++L E+
Sbjct: 183 CDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEI 236

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 64.1 bits (156), Expect = 9e-11
 Identities = 50/164 (30%), Positives = 70/164 (42%), Gaps = 13/164 (7%)

Query: 733 DHGFLAEIQTLGRIRHRNIVRLL-GYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWE 791
            H    E   L  + H  IV ++  +        LL E++  G L    H  K G    +
Sbjct: 63  QH-VAQEKSILMELSHPFIVNMMCSFQDENRVYFLL-EFVVGGEL--FTHLRKAGRFPND 118

Query: 792 TRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASE 851
                  E      YLH   S  II+RD+K  N+LLD+     V DFG AK + D   + 
Sbjct: 119 VAKFYHAELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFTL 175

Query: 852 CMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
           C     G+  Y+APE   +    +  D ++ GV+L E IAG  P
Sbjct: 176 C-----GTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPP 214

Length = 329

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 63.8 bits (155), Expect = 1e-10
 Identities = 46/171 (26%), Positives = 76/171 (44%), Gaps = 5/171 (2%)

Query: 446 SGELPEKMSGASLNQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESFNLKM 505
           S +  E +           N N      + +  L +L  L L NN +  +IP     LK 
Sbjct: 82  SLDGSENLLNLLPLPSLDLNLNRLRSNISELLELTNLTSLDLDNNNIT-DIPPLIGLLKS 140

Query: 506 -ITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYGKIPPGISKLIDLSILNLSRNGI 564
            +  +++SDN I   +P  +    +L ++DLS N L   +P  +S L +L+ L+LS N I
Sbjct: 141 NLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDL-SDLPKLLSNLSNLNNLDLSGNKI 198

Query: 565 TGSIPNEMRNMMSLTTLDLSYNNLIGNIPSGGQFLAFNETSFIGNPNLCLL 615
           +  +P E+  + +L  LDLS N++I  + S       +      N    L 
Sbjct: 199 S-DLPPEIELLSALEELDLSNNSIIELLSSLSNLKNLSGLELSNNKLEDLP 248

Length = 394

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 63.7 bits (155), Expect = 1e-10
 Identities = 37/107 (34%), Positives = 58/107 (54%), Gaps = 8/107 (7%)

Query: 791 ETRYRI-ALEAAKGLCYLH-HDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAG 848
           E R R  A E    L +LH H     +I+RD+K +NILLD++    +ADFG+ K  +   
Sbjct: 95  EPRSRFYAAEVTLALMFLHRHG----VIYRDLKLDNILLDAEGHCKLADFGMCK--EGIL 148

Query: 849 ASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
                ++  G+  YIAPE    L+     D ++ GV++ E++AG+ P
Sbjct: 149 NGVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 62.7 bits (152), Expect = 2e-10
 Identities = 63/207 (30%), Positives = 99/207 (47%), Gaps = 18/207 (8%)

Query: 700 IGKGGAGIVYRGSMPD-GIDVAIKRL-VGRGTGGNDHGFLAEIQTLGRIR---HRNIVRL 754
           IG G  G VY+   P  G  VA+K + V     G     + E+  L R+    H NIVRL
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67

Query: 755 LGYV----SNRDTNL-LLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHH 809
           +       ++R+T + L++E++ +  L   L       L  ET   +  +  +GL +LH 
Sbjct: 68  MDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHA 126

Query: 810 DCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAY 869
           +C   I+HRD+K  NIL+ S  +  +ADFGLA+      A   ++ V  +  Y APE   
Sbjct: 127 NC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMA---LTPVVVTLWYRAPEVLL 180

Query: 870 TLKVDEKSDVYSFGVVLLELIAGKKPV 896
                   D++S G +  E+   +KP+
Sbjct: 181 QSTYATPVDMWSVGCIFAEMFR-RKPL 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 62.5 bits (152), Expect = 2e-10
 Identities = 65/193 (33%), Positives = 89/193 (46%), Gaps = 20/193 (10%)

Query: 738 AEIQTLGRIRHRNIVRLLGYVSNRDTNL-LLYEYMPNGSLGEML-HGAKGGHLKWETRYR 795
            E Q L  +R    +  L Y    DT L L+ +Y+ NG  GE+  H  +  H   E+  R
Sbjct: 53  TERQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYV-NG--GELFTHLYQREHFT-ESEVR 108

Query: 796 IAL-EAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAK-FLQDAGASECM 853
           + + E    L +LH      II+RD+K  NILLDS+    + DFGL+K FL  A   E  
Sbjct: 109 VYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEFL--AEEEERA 163

Query: 854 SSVAGSYGYIAPEYAYTLKV--DEKSDVYSFGVVLLELIAGKKPV---GEFGDGVDIVRW 908
            S  G+  Y+APE         D+  D +S GV+  EL+ G  P    GE     +I R 
Sbjct: 164 YSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISR- 222

Query: 909 VRKTTSEVSQPSD 921
            R   S+   P  
Sbjct: 223 -RILKSKPPFPKT 234

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 63.2 bits (154), Expect = 2e-10
 Identities = 66/214 (30%), Positives = 101/214 (47%), Gaps = 23/214 (10%)

Query: 690 VLESLKDENIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHGFLA--EIQTLGRI 746
           VL+  ++   IG G  GIV        G +VAIK+L  R      H   A  E+  +  +
Sbjct: 14  VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKL-SRPFQNVTHAKRAYRELVLMKLV 72

Query: 747 RHRNIVRLLGYVSNRDTNL-------LLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALE 799
            H+NI+ LL  V     +L       L+ E M + +L +++       L  E   R++  
Sbjct: 73  NHKNIIGLLN-VFTPQKSLEEFQDVYLVMELM-DANLCQVIQM----DLDHE---RMSYL 123

Query: 800 AAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGS 859
             + LC + H  S  IIHRD+K +NI++ SD    + DFGLA+    AG S  M+    +
Sbjct: 124 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVT 180

Query: 860 YGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGK 893
             Y APE    +   E  D++S G ++ E+I G 
Sbjct: 181 RYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 62.0 bits (150), Expect = 3e-10
 Identities = 54/205 (26%), Positives = 88/205 (42%), Gaps = 19/205 (9%)

Query: 700 IGKGGAGIVYRGSMPDGI-------DVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIV 752
           +G+G  G+VY G +  G+        VAIK +    +      FL E   +      ++V
Sbjct: 14  LGQGSFGMVYEG-IAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 72

Query: 753 RLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKG--------GHLKWETRYRIALEAAKGL 804
           RLLG VS     L++ E M  G L   L   +              +   ++A E A G+
Sbjct: 73  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGM 132

Query: 805 CYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIA 864
            YL+ +     +HRD+ + N ++  DF   + DFG+ + + +               +++
Sbjct: 133 AYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 189

Query: 865 PEYAYTLKVDEKSDVYSFGVVLLEL 889
           PE          SDV+SFGVVL E+
Sbjct: 190 PESLKDGVFTTYSDVWSFGVVLWEI 214

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 61.9 bits (151), Expect = 3e-10
 Identities = 59/212 (27%), Positives = 91/212 (42%), Gaps = 39/212 (18%)

Query: 699 IIGKGGAGI---VYRG-SMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIR-HRNIVR 753
           I+GK G G    V +  S   G   AIK +            L EIQ L R+  H NI+R
Sbjct: 3   ILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILR 62

Query: 754 LLGYVSNRDTN--LLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDC 811
           L+  + +R T    L++E M + +L E++ G K   L  +       +  K L ++H + 
Sbjct: 63  LIEVLFDRKTGRLALVFELM-DMNLYELIKGRKR-PLPEKRVKSYMYQLLKSLDHMHRNG 120

Query: 812 SPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAG------------ASECMSSVAGS 859
              I HRD+K  NIL+  D    +ADFG  + +                A EC+ +  G 
Sbjct: 121 ---IFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLT-DGY 175

Query: 860 YGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA 891
           YG              K D+++ G V  E+++
Sbjct: 176 YGP-------------KMDIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 61.5 bits (149), Expect = 3e-10
 Identities = 58/205 (28%), Positives = 95/205 (46%), Gaps = 18/205 (8%)

Query: 700 IGKGGAGIVYRG--SMPDGID-VAIKRLVGRGTGGNDHG----FLAEIQTLGRIRHRNIV 752
           +G G  G V +G   M      VA+K L       ND       L E   + ++ +  IV
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKIL---KNDNNDPALKDELLREANVMQQLDNPYIV 59

Query: 753 RLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCS 812
           R++G +   ++ +L+ E    G L + L   K  H+  +    +  + + G+ YL     
Sbjct: 60  RMIG-ICEAESWMLVMELAELGPLNKFL--QKNKHVTEKNITELVHQVSMGMKYLEETN- 115

Query: 813 PLIIHRDVKSNNILLDSDFEAHVADFGLAKFL-QDAGASECMSSVAGSYGYIAPEYAYTL 871
              +HRD+ + N+LL +   A ++DFGL+K L  D    +  +       + APE     
Sbjct: 116 --FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYY 173

Query: 872 KVDEKSDVYSFGVVLLELIA-GKKP 895
           K   KSDV+SFGV++ E  + G+KP
Sbjct: 174 KFSSKSDVWSFGVLMWEAFSYGQKP 198

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 61.6 bits (150), Expect = 4e-10
 Identities = 56/210 (26%), Positives = 96/210 (45%), Gaps = 26/210 (12%)

Query: 695 KDENI--IGKGGAGIVYRGSMPD-GIDVAIKRLVGRGTGGNDHGF-----LAEIQTLGRI 746
           K EN+  +G+G  G+V +    + G  VAIK+ +       D        + EI+ L ++
Sbjct: 2   KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLES----EDDKMVKKIAMREIRMLKQL 57

Query: 747 RHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCY 806
           RH N+V L+     +    L++E++ +  L ++     G  L      +   +  +G+ +
Sbjct: 58  RHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNG--LDESRVRKYLFQILRGIEF 115

Query: 807 LHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPE 866
            H   S  IIHRD+K  NIL+       + DFG A+ L  A   E  +    +  Y APE
Sbjct: 116 CH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTL--AAPGEVYTDYVATRWYRAPE 170

Query: 867 YAYTLKVDEKS----DVYSFGVVLLELIAG 892
               L  D K     D+++ G ++ E++ G
Sbjct: 171 L---LVGDTKYGRAVDIWAVGCLVTEMLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 62.9 bits (153), Expect = 5e-10
 Identities = 36/98 (36%), Positives = 54/98 (55%), Gaps = 5/98 (5%)

Query: 277 LTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQLFKNNLRGPIPSFLGDF 336
           L G IP  +S L  L+S++LS N + G IP S  ++ +L +L L  N+  G IP  LG  
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQL 489

Query: 337 PNLEVLQVWGNNFTFELPENLGRNGKLL---ILDVTSN 371
            +L +L + GN+ +  +P  LG  G+LL     + T N
Sbjct: 490 TSLRILNLNGNSLSGRVPAALG--GRLLHRASFNFTDN 525

Length = 623

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 61.8 bits (150), Expect = 5e-10
 Identities = 37/127 (29%), Positives = 63/127 (49%), Gaps = 7/127 (5%)

Query: 769 EYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLD 828
           E++  G L  M H  +   L  E     + E +  L +LH      II+RD+K +N+LLD
Sbjct: 76  EFVSGGDL--MFHMQRQRKLPEEHARFYSAEISLALNFLH---ERGIIYRDLKLDNVLLD 130

Query: 829 SDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLE 888
           ++    + D+G+ K  +     +  S+  G+  YIAPE           D ++ GV++ E
Sbjct: 131 AEGHIKLTDYGMCK--EGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFE 188

Query: 889 LIAGKKP 895
           ++AG+ P
Sbjct: 189 MMAGRSP 195

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 61.2 bits (148), Expect = 6e-10
 Identities = 66/234 (28%), Positives = 102/234 (43%), Gaps = 21/234 (8%)

Query: 700 IGKGGAGIVYR-GSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIR-HRNIVRLLGY 757
           IGKG  G V++  +  +G   A+K L        D    AE   L  +  H N+V+  G 
Sbjct: 26  IGKGTYGKVFKVLNKKNGSKAAVKIL--DPIHDIDEEIEAEYNILKALSDHPNVVKFYGM 83

Query: 758 -----VSNRDTNLLLYEYMPNGSLGEMLHG--AKGGHLKWETRYRIALEAAKGLCYLHHD 810
                V N D   L+ E    GS+ +++ G   +G  ++      I  EA  GL +LH +
Sbjct: 84  YYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN 143

Query: 811 CSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEY--- 867
            +   IHRDVK NNILL ++    + DFG++  L         S   G+  ++APE    
Sbjct: 144 KT---IHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS--VGTPFWMAPEVIAC 198

Query: 868 --AYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQP 919
                   D + DV+S G+  +EL  G  P+ +      + +  R     + QP
Sbjct: 199 EQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTLHQP 252

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 61.2 bits (148), Expect = 6e-10
 Identities = 69/250 (27%), Positives = 108/250 (43%), Gaps = 28/250 (11%)

Query: 700 IGKGGAGIVY--RGSMPDGIDVAIKRL-VGRGTGGNDHGFLAEIQTLGRIR---HRNIVR 753
           IG+G  G V+  R     G  VA+KR+ V  G  G     + E+  L  +    H N+VR
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68

Query: 754 LLGYVS----NRDTNL-LLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLH 808
           L    +    +R+T L L++E++ +  L   L       +  ET   +  +  +GL +LH
Sbjct: 69  LFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 127

Query: 809 HDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYA 868
              S  ++HRD+K  NIL+ S  +  +ADFGLA+      A   ++SV  +  Y APE  
Sbjct: 128 ---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA---LTSVVVTLWYRAPEVL 181

Query: 869 YTLKVDEKSDVYSFGVVLLE------LIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDA 922
                    D++S G +  E      L  G   V + G  +D++        E   P D 
Sbjct: 182 LQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVI----GLPGEEDWPRDV 237

Query: 923 ASVLAVVDPR 932
           A        +
Sbjct: 238 ALPRQAFHSK 247

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 61.1 bits (148), Expect = 6e-10
 Identities = 49/220 (22%), Positives = 91/220 (41%), Gaps = 31/220 (14%)

Query: 699 IIGKGGAGIVYRGS------MPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIV 752
            +G+G  G V + +            VA+K L    +       L+E   L ++ H +++
Sbjct: 7   TLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVI 66

Query: 753 RLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAK----GGHLKWETRYRIALEA-------- 800
           +L G  S     LL+ EY   GSL   L  ++            R    L+         
Sbjct: 67  KLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTM 126

Query: 801 ----------AKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS 850
                     ++G+ YL       ++HRD+ + N+L+    +  ++DFGL++ + +  + 
Sbjct: 127 GDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSY 183

Query: 851 ECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELI 890
              S       ++A E  +      +SDV+SFGV+L E++
Sbjct: 184 VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIV 223

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 60.8 bits (147), Expect = 9e-10
 Identities = 55/202 (27%), Positives = 95/202 (47%), Gaps = 21/202 (10%)

Query: 700 IGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYV 758
           +G+G    VY+G S  +G  VA+K +  +   G     + E   L  ++H NIV L   +
Sbjct: 13  LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDII 72

Query: 759 SNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHR 818
             ++T   ++EYM +  L + +    GG   +  R     +  +GL Y+H      I+HR
Sbjct: 73  HTKETLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRL-FMFQLLRGLAYIHGQ---HILHR 127

Query: 819 DVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAP-------EYAYTL 871
           D+K  N+L+    E  +ADFGLA+    +  S+  SS   +  Y  P       +Y+  L
Sbjct: 128 DLKPQNLLISYLGELKLADFGLAR--AKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSAL 185

Query: 872 KVDEKSDVYSFGVVLLELIAGK 893
                 D++  G + +E++ G+
Sbjct: 186 ------DIWGAGCIFIEMLQGQ 201

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 62.1 bits (151), Expect = 1e-09
 Identities = 27/86 (31%), Positives = 48/86 (55%), Gaps = 1/86 (1%)

Query: 440 LDDNLLSGELPEKMSG-ASLNQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPV 498
           LD+  L G +P  +S    L  + ++ N+I G IP ++G++ SL +L L  N   G IP 
Sbjct: 425 LDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPE 484

Query: 499 ESFNLKMITSINISDNNISGEIPYSI 524
               L  +  +N++ N++SG +P ++
Sbjct: 485 SLGQLTSLRILNLNGNSLSGRVPAAL 510

Length = 623

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 59.8 bits (145), Expect = 1e-09
 Identities = 48/164 (29%), Positives = 76/164 (46%), Gaps = 23/164 (14%)

Query: 739 EIQTLGRIRHRNIVRLLGYVSNRDTNLLLY---EYMPNGSLGEMLHGAKG------GHLK 789
           E+  L  ++H NIV+   Y  + + N  LY   +Y   G L + ++  +G        L 
Sbjct: 49  EVAVLSNMKHPNIVQ---YQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILD 105

Query: 790 WETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGA 849
           W  +  +AL+         HD    I+HRD+KS NI L  D    + DFG+A+ L     
Sbjct: 106 WFVQICLALKHV-------HDRK--ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNS--T 154

Query: 850 SECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGK 893
            E   +  G+  Y++PE       + KSD+++ G VL E+   K
Sbjct: 155 VELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLK 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 60.4 bits (146), Expect = 1e-09
 Identities = 43/128 (33%), Positives = 58/128 (45%), Gaps = 16/128 (12%)

Query: 787 HLKWETRYR------IALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGL 840
           HL+ E  +        A E A  + YLH   S  II+RD+K  NILLDS     + DFGL
Sbjct: 86  HLQRERCFLEPRARFYAAEVASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGL 142

Query: 841 AKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKP----- 895
            K  +     E  S+  G+  Y+APE       D   D +  G VL E++ G  P     
Sbjct: 143 CK--EGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD 200

Query: 896 VGEFGDGV 903
           V +  D +
Sbjct: 201 VSQMYDNI 208

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 60.3 bits (147), Expect = 1e-09
 Identities = 62/211 (29%), Positives = 102/211 (48%), Gaps = 27/211 (12%)

Query: 698 NIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHGF----LAEIQTLGRIRHRNIV 752
           N I +G  G+VYR      G  VA+K+L          GF    L EI  L +++H NIV
Sbjct: 11  NRIEEGTYGVVYRARDKKTGEIVALKKLKMEK---EKEGFPITSLREINILLKLQHPNIV 67

Query: 753 RLLGYV--SNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHD 810
            +   V  SN D   ++ EY+ +  L  ++   K   L+ E +  + L+   G+ +LH +
Sbjct: 68  TVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKC-LMLQLLSGVAHLHDN 125

Query: 811 CSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEY--- 867
               I+HRD+K++N+LL++     + DFGLA+           + +  +  Y APE    
Sbjct: 126 ---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKP--YTQLVVTLWYRAPELLLG 180

Query: 868 --AYTLKVDEKSDVYSFGVVLLELIAGKKPV 896
              Y+  +    D++S G +  EL+  KKP+
Sbjct: 181 AKEYSTAI----DMWSVGCIFAELLT-KKPL 206

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 60.5 bits (146), Expect = 1e-09
 Identities = 61/216 (28%), Positives = 99/216 (45%), Gaps = 24/216 (11%)

Query: 685 FKAEDVLESLKDENIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTL 743
           F   D  E L+    +G+G    VY+G S  +G  VA+K +  +   G     + E   L
Sbjct: 1   FGKADSYEKLEK---LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLL 57

Query: 744 GRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKG 803
             ++H NIV L   +  ++T  L++EY+ +  L + +    GG L  E       +  +G
Sbjct: 58  KGLKHANIVLLHDIIHTKETLTLVFEYV-HTDLCQYMDKHPGG-LHPENVKLFLFQLLRG 115

Query: 804 LCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYI 863
           L Y+H      I+HRD+K  N+L+    E  +ADFGLA+    +  S   S+   +  Y 
Sbjct: 116 LSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLAR--AKSVPSHTYSNEVVTLWYR 170

Query: 864 AP-------EYAYTLKVDEKSDVYSFGVVLLELIAG 892
            P       EY+  L      D++  G + +E+I G
Sbjct: 171 PPDVLLGSTEYSTCL------DMWGVGCIFVEMIQG 200

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 61.0 bits (148), Expect = 2e-09
 Identities = 34/111 (30%), Positives = 58/111 (52%), Gaps = 5/111 (4%)

Query: 461 LKVANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNISGEI 520
           L + N  + G IP  I  L  L  ++L  N + G IP    ++  +  +++S N+ +G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 521 PYSISQCHSLTSVDLSRNSLYGKIPPGI-SKLIDLSILNLSRN----GITG 566
           P S+ Q  SL  ++L+ NSL G++P  +  +L+  +  N + N    GI G
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPG 533

Length = 623

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 60.4 bits (146), Expect = 2e-09
 Identities = 44/134 (32%), Positives = 64/134 (47%), Gaps = 11/134 (8%)

Query: 766 LLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNI 825
           ++ EYMP G L  ++        KW   Y    E    L  +H   S  +IHRDVK +N+
Sbjct: 120 MVMEYMPGGDLVNLMSNYDVPE-KWAKFY--TAEVVLALDAIH---SMGLIHRDVKPDNM 173

Query: 826 LLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVD----EKSDVYS 881
           LLD      +ADFG    + + G   C ++V G+  YI+PE   +   D     + D +S
Sbjct: 174 LLDKHGHLKLADFGTCMKMDETGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWS 232

Query: 882 FGVVLLELIAGKKP 895
            GV L E++ G  P
Sbjct: 233 VGVFLFEMLVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 59.9 bits (146), Expect = 2e-09
 Identities = 42/145 (28%), Positives = 69/145 (47%), Gaps = 6/145 (4%)

Query: 700 IGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRI-RHRNIVRLLGY 757
           +G G  G VY   +   G  VAIK++  +     +   L E+++L ++  H NIV+L   
Sbjct: 7   LGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEV 66

Query: 758 VSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIH 817
               D    ++EYM  G+L +++   KG          I  +  +GL ++H        H
Sbjct: 67  FRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG---FFH 122

Query: 818 RDVKSNNILLDSDFEAHVADFGLAK 842
           RD+K  N+L+       +ADFGLA+
Sbjct: 123 RDLKPENLLVSGPEVVKIADFGLAR 147

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 60.1 bits (145), Expect = 2e-09
 Identities = 50/161 (31%), Positives = 72/161 (44%), Gaps = 11/161 (6%)

Query: 737 LAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRI 796
           L E + L   RH  +  L      +D    + EY+ NG  GE+        +  E R R 
Sbjct: 43  LTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYV-NG--GELFFHLSRERVFSEDRTRF 99

Query: 797 -ALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAK-FLQDAGASECMS 854
              E    L YLH   S  I++RD+K  N++LD D    + DFGL K  + DA     M 
Sbjct: 100 YGAEIVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAAT---MK 153

Query: 855 SVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
           +  G+  Y+APE           D +  GVV+ E++ G+ P
Sbjct: 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 59.2 bits (143), Expect = 2e-09
 Identities = 57/202 (28%), Positives = 88/202 (43%), Gaps = 24/202 (11%)

Query: 745 RIRHR-------NIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWET----- 792
           RI+ R       N  R+L  V++R    L Y Y    +L  +L    GG LK+       
Sbjct: 37  RIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGN 96

Query: 793 ----RYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAG 848
                 R    AA+  C L       I++RD+K  NILLD      ++D GLA  + +  
Sbjct: 97  PGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG- 155

Query: 849 ASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGV---DI 905
             E +    G+ GY+APE     K     D +  G ++ E+I G+ P  +  + V   ++
Sbjct: 156 --ETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEV 213

Query: 906 VRWVRKTTSEVSQ--PSDAASV 925
            R V++   E S+    DA S+
Sbjct: 214 DRRVKEDQEEYSEKFSEDAKSI 235

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 60.5 bits (146), Expect = 2e-09
 Identities = 46/180 (25%), Positives = 78/180 (43%), Gaps = 39/180 (21%)

Query: 739 EIQTLGRIRHRNIVRL--------LGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKW 790
           EI  LGR+ H NI+++          Y+  +  +  LY +M + +        K   L  
Sbjct: 213 EILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFD-----WKDRPLLK 267

Query: 791 ETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS 850
           +TR  I  +    + Y+H      +IHRD+K  NI L+ D +  + DFG A   +     
Sbjct: 268 QTR-AIMKQLLCAVEYIH---DKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEK---- 319

Query: 851 ECMSSVAGSYGYI------APEYAYTLKVDEKSDVYSFGVVLLELIA---------GKKP 895
                 A  YG++      +PE        E +D++S G++LL++++         G KP
Sbjct: 320 ---EREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKP 376

Length = 501

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 59.8 bits (145), Expect = 2e-09
 Identities = 41/140 (29%), Positives = 62/140 (44%), Gaps = 15/140 (10%)

Query: 766 LLYEYMPNGSLGEMLHGAKGGHLKW---------ETRYRI-ALEAAKGLCYLHHDCSPLI 815
           L Y +  +  L  ++  A GG L +         E R R    E    L YLH   S  +
Sbjct: 60  LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLH---SCDV 116

Query: 816 IHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDE 875
           ++RD+K  N++LD D    + DFGL K  +       M +  G+  Y+APE         
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLEDNDYGR 174

Query: 876 KSDVYSFGVVLLELIAGKKP 895
             D +  GVV+ E++ G+ P
Sbjct: 175 AVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 59.2 bits (143), Expect = 2e-09
 Identities = 62/222 (27%), Positives = 100/222 (45%), Gaps = 21/222 (9%)

Query: 700 IGKGGAGIV------YRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVR 753
           +GKGG G V        G M     +  KRL  +   G     L E + L ++    IV 
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRL--KKKSGEKMALL-EKEILEKVNSPFIVN 57

Query: 754 LLGYVSNRDTNL-LLYEYMPNGSLGEMLH--GAKGGHLKWETRYRIALEAAKGLCYLHHD 810
           L  Y     T+L L+   M  G L   ++  G +G  ++     R+   +A+  C + H 
Sbjct: 58  L-AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEME-----RVIHYSAQITCGILHL 111

Query: 811 CSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYT 870
            S  I++RD+K  N+LLD      ++D GLA  L+D    + ++  AG+ GY+APE    
Sbjct: 112 HSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG---KTITQRAGTNGYMAPEILKE 168

Query: 871 LKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKT 912
                  D ++ G  + E++AG+ P  +  + V      R+T
Sbjct: 169 EPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRT 210

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 59.3 bits (143), Expect = 3e-09
 Identities = 50/154 (32%), Positives = 73/154 (47%), Gaps = 9/154 (5%)

Query: 743 LGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRI-ALEAA 801
           L  ++H  +V L       D    + +Y+ NG  GE+ +  +      E R R  A E A
Sbjct: 50  LKNVKHPFLVGLHFSFQTADKLYFVLDYI-NG--GELFYHLQRERCFLEPRARFYAAEIA 106

Query: 802 KGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYG 861
             L YLH   S  I++RD+K  NILLDS     + DFGL K  ++   +   S+  G+  
Sbjct: 107 SALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNGTTSTFCGTPE 161

Query: 862 YIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
           Y+APE  +    D   D +  G VL E++ G  P
Sbjct: 162 YLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 58.5 bits (141), Expect = 3e-09
 Identities = 55/211 (26%), Positives = 93/211 (44%), Gaps = 18/211 (8%)

Query: 700 IGKGGAGIVYRGSMPDG---IDVAIKRL-VGRGTGGNDHGFLAEIQTLGRIRHRNIVRLL 755
           +G+G  G V  G +      + VA+K + +   T      FL+E   +    H N++RL+
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 756 GYVSNRDTN------LLLYEYMPNGSLGEMLHGAKGG----HLKWETRYRIALEAAKGLC 805
           G       +      +++  +M +G L   L  ++ G    +L  +   +   + A G+ 
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126

Query: 806 YLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAP 865
           YL    S   IHRD+ + N +L+ +    VADFGL+K + +               +IA 
Sbjct: 127 YL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183

Query: 866 EYAYTLKVDEKSDVYSFGVVLLELIA-GKKP 895
           E         KSDV+SFGV + E+   G+ P
Sbjct: 184 ESLADRVYTTKSDVWSFGVTMWEIATRGQTP 214

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 59.9 bits (145), Expect = 3e-09
 Identities = 57/185 (30%), Positives = 79/185 (42%), Gaps = 16/185 (8%)

Query: 722 KRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLH 781
           K +V   TGG   G   EI  L  I HR I+ L+     + T  ++   MP        +
Sbjct: 121 KVIVKAVTGGKTPG--REIDILKTISHRAIINLIHAYRWKSTVCMV---MPKYKCDLFTY 175

Query: 782 GAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLA 841
             + G L  E    I     + L YLH      IIHRDVK+ NI LD    A + DFG A
Sbjct: 176 VDRSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAA 232

Query: 842 KFLQDAGASECMSSVAGSYGYIAPEYAYTLKVD---EKSDVYSFGVVLLELIAGKKPVGE 898
             L     +      +G+    +PE    L +D    K+D++S G+VL E+      +  
Sbjct: 233 CKLDAHPDTPQCYGWSGTLETNSPEL---LALDPYCAKTDIWSAGLVLFEMSVKNVTL-- 287

Query: 899 FGDGV 903
           FG  V
Sbjct: 288 FGKQV 292

Length = 392

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 59.8 bits (145), Expect = 4e-09
 Identities = 29/82 (35%), Positives = 41/82 (50%)

Query: 231 GGIPPGFGALTQLQVLDMASCNISGEIPTSLSRLKLLHSLFLQMNKLTGHIPPQLSGLIS 290
           G IP     L  LQ ++++  +I G IP SL  +  L  L L  N   G IP  L  L S
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTS 491

Query: 291 LKSLDLSLNYLTGEIPESFAAL 312
           L+ L+L+ N L+G +P +    
Sbjct: 492 LRILNLNGNSLSGRVPAALGGR 513

Length = 623

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 58.6 bits (142), Expect = 4e-09
 Identities = 67/257 (26%), Positives = 114/257 (44%), Gaps = 32/257 (12%)

Query: 700 IGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHGF----LAEIQTLGRIRHRNIVRL 754
           IG+G  G V++  +      VA+KR+       +D G     L EI  L  ++H+NIVRL
Sbjct: 8   IGEGTYGTVFKAKNRETHEIVALKRV---RLDDDDEGVPSSALREICLLKELKHKNIVRL 64

Query: 755 LGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPL 814
              + +     L++EY  +  L +    +  G +  E       +  KGL + H   S  
Sbjct: 65  YDVLHSDKKLTLVFEYC-DQDLKKYFD-SCNGDIDPEIVKSFMFQLLKGLAFCH---SHN 119

Query: 815 IIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVD 874
           ++HRD+K  N+L++ + E  +ADFGLA+         C S+   +  Y  P+  +  K+ 
Sbjct: 120 VLHRDLKPQNLLINKNGELKLADFGLARAF--GIPVRCYSAEVVTLWYRPPDVLFGAKLY 177

Query: 875 EKS-DVYSFGVVLLELIAGKKPV---GEFGDGVDIVRWVRKTTSEVSQPS---------- 920
             S D++S G +  EL    +P+    +  D +  +  +  T +E S P           
Sbjct: 178 STSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPY 237

Query: 921 ---DAASVLAVVDPRLS 934
               A + L  V P+L+
Sbjct: 238 PMYPATTSLVNVVPKLN 254

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 59.0 bits (143), Expect = 5e-09
 Identities = 45/134 (33%), Positives = 64/134 (47%), Gaps = 11/134 (8%)

Query: 766 LLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNI 825
           ++ EYMP G L  ++        KW  R+  A E    L  +H   S   IHRDVK +N+
Sbjct: 120 MVMEYMPGGDLVNLMSNYDIPE-KW-ARFYTA-EVVLALDAIH---SMGFIHRDVKPDNM 173

Query: 826 LLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVD----EKSDVYS 881
           LLD      +ADFG    +   G   C ++V G+  YI+PE   +   D     + D +S
Sbjct: 174 LLDKSGHLKLADFGTCMKMDANGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWS 232

Query: 882 FGVVLLELIAGKKP 895
            GV L E++ G  P
Sbjct: 233 VGVFLYEMLVGDTP 246

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 58.8 bits (143), Expect = 5e-09
 Identities = 55/188 (29%), Positives = 87/188 (46%), Gaps = 24/188 (12%)

Query: 716 GIDVAIKRLVGRGTGGNDHGFLA--EIQTLGRIRHRNIVRLLGYVSNRDTNLLLYE--YM 771
           G  VAIK+L  R      H      E++ L  + H N++ LL  V    ++L  ++  Y+
Sbjct: 40  GRKVAIKKLS-RPFQSAIHAKRTYRELRLLKHMDHENVIGLLD-VFTPASSLEDFQDVYL 97

Query: 772 PNGSLGEMLHG-AKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSD 830
               +G  L+   K   L  +    +  +  +GL Y+H   S  IIHRD+K +NI ++ D
Sbjct: 98  VTHLMGADLNNIVKCQKLSDDHIQFLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNED 154

Query: 831 FEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPE-----YAYTLKVDEKSDVYSFGVV 885
            E  + DFGLA+        + M+    +  Y APE       Y   V    D++S G +
Sbjct: 155 CELKILDFGLARH-----TDDEMTGYVATRWYRAPEIMLNWMHYNQTV----DIWSVGCI 205

Query: 886 LLELIAGK 893
           + EL+ GK
Sbjct: 206 MAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 58.1 bits (141), Expect = 5e-09
 Identities = 50/162 (30%), Positives = 75/162 (46%), Gaps = 40/162 (24%)

Query: 700 IGKGGAGIVYRG-SMPDGIDVAIK--RLVGRGTGGNDHGF----LAEIQTLGRIRHRNIV 752
           IG+G  G+VY+      G  VA+K  RL        D G     + EI  L  + H NIV
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKIRL-----ETEDEGVPSTAIREISLLKELNHPNIV 61

Query: 753 RLLGYVSNRDTNL-LLYEYM-----------PNGSLGEMLHGAKGGHLKWETRYRIALEA 800
           RLL  V + +  L L++E++           P   L   L       +K    Y++    
Sbjct: 62  RLLD-VVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPL-------IKSYL-YQLL--- 109

Query: 801 AKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAK 842
            +G+ Y H   S  ++HRD+K  N+L+D +    +ADFGLA+
Sbjct: 110 -QGIAYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLAR 147

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 59.4 bits (144), Expect = 6e-09
 Identities = 37/94 (39%), Positives = 54/94 (57%), Gaps = 2/94 (2%)

Query: 294 LDLSLNYLTGEIPESFAALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFEL 353
           L L    L G IP   + L++L  + L  N++RG IP  LG   +LEVL +  N+F   +
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 354 PENLGRNGKLLILDVTSNHLTGTIPRDLCKGGKL 387
           PE+LG+   L IL++  N L+G +P  L  GG+L
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAAL--GGRL 514

Length = 623

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 58.4 bits (142), Expect = 6e-09
 Identities = 54/216 (25%), Positives = 95/216 (43%), Gaps = 36/216 (16%)

Query: 700 IGKGGAGIVY---RGSMPDGIDVAIKRLVGRGTGGNDHGF----LAEIQTLGRIRHRNIV 752
           IG+G  G VY   R +  DG + AIK+  G        G       EI  L  ++H N+V
Sbjct: 8   IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYT--GISQSACREIALLRELKHENVV 65

Query: 753 RLLG-YVSNRDTNL-LLYEYMPNGSLGEMLH---GAKGGHLKWETRYRIALEAAKGLCYL 807
            L+  ++ + D ++ LL++Y  +  L +++     AK   +       +  +   G+ YL
Sbjct: 66  SLVEVFLEHADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYL 124

Query: 808 HHDCSPLIIHRDVKSNNILLDSDFEAH----VADFGLAKFLQDAGASECMSSVAG---SY 860
           H   S  ++HRD+K  NIL+  +        + D GLA+        + ++ +     + 
Sbjct: 125 H---SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNA--PLKPLADLDPVVVTI 179

Query: 861 GYIAPEYA-----YTLKVDEKSDVYSFGVVLLELIA 891
            Y APE       YT  +    D+++ G +  EL+ 
Sbjct: 180 WYRAPELLLGARHYTKAI----DIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 58.0 bits (140), Expect = 7e-09
 Identities = 50/164 (30%), Positives = 79/164 (48%), Gaps = 17/164 (10%)

Query: 737 LAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETR--- 793
           LAE   L ++    IV L     + +   L+  ++ NG  GE+ H     HL+ E R   
Sbjct: 41  LAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFI-NG--GELFH-----HLQREGRFDL 92

Query: 794 YRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVA--DFGLAKFLQDAGASE 851
            R     A+ LC L +     +I+RD+K  NILL  D++ H+A  DFGL K   +    +
Sbjct: 93  SRARFYTAELLCALENLHKFNVIYRDLKPENILL--DYQGHIALCDFGLCKL--NMKDDD 148

Query: 852 CMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
             ++  G+  Y+APE        +  D ++ GV+L E++ G  P
Sbjct: 149 KTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPP 192

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 58.1 bits (140), Expect = 7e-09
 Identities = 40/131 (30%), Positives = 64/131 (48%), Gaps = 7/131 (5%)

Query: 765 LLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNN 824
             + EY+  G L  M H  +   L  E     + E +  L YLH      II+RD+K +N
Sbjct: 72  FFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDN 126

Query: 825 ILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGV 884
           +LLDS+    + D+G+ K  +     +  S+  G+  YIAPE           D ++ GV
Sbjct: 127 VLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGV 184

Query: 885 VLLELIAGKKP 895
           ++ E++AG+ P
Sbjct: 185 LMFEMMAGRSP 195

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 58.1 bits (140), Expect = 9e-09
 Identities = 66/220 (30%), Positives = 94/220 (42%), Gaps = 18/220 (8%)

Query: 683 LDFKAEDVLESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGR--GTGGNDHGFLAEI 740
           L  KAED  E +K   +IG+G  G V          V   +L+ +      +D  F  E 
Sbjct: 38  LRMKAED-YEVVK---VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEE 93

Query: 741 QTLGRIRHRNIVRLLGYVSNRDTNL-LLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALE 799
           + +    +   V  L Y    D  L ++ EYMP G L  ++        KW   Y    E
Sbjct: 94  RDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPE-KWARFY--TAE 150

Query: 800 AAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGS 859
               L  +H   S   IHRDVK +N+LLD      +ADFG    +   G   C ++V G+
Sbjct: 151 VVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GT 206

Query: 860 YGYIAPEYAYTLKVD----EKSDVYSFGVVLLELIAGKKP 895
             YI+PE   +   D     + D +S GV L E++ G  P
Sbjct: 207 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 57.7 bits (139), Expect = 1e-08
 Identities = 48/160 (30%), Positives = 70/160 (43%), Gaps = 9/160 (5%)

Query: 737 LAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRI 796
           + E + L   RH  +  L       D    + EY  NG  GE+        +  E R R 
Sbjct: 43  VTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEY-ANG--GELFFHLSRERVFTEERARF 99

Query: 797 -ALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSS 855
              E    L YLH   S  +++RD+K  N++LD D    + DFGL K     GA+  M +
Sbjct: 100 YGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKT 154

Query: 856 VAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
             G+  Y+APE           D +  GVV+ E++ G+ P
Sbjct: 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 57.7 bits (139), Expect = 1e-08
 Identities = 58/185 (31%), Positives = 84/185 (45%), Gaps = 22/185 (11%)

Query: 739 EIQTLGRIRHRNIVRLLGYVSNRDTNL-LLYEYMPNGSLGEML-HGAKGGHLKWETRYRI 796
           E   L  +R    +  L Y    +  L L+ +Y+   S GEM  H  +  +   E   R 
Sbjct: 54  ERNVLEHVRQSPFLVTLHYAFQTEAKLHLILDYV---SGGEMFTHLYQRDNFS-EDEVRF 109

Query: 797 AL-EAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAK-FLQDAGASECMS 854
              E    L +LH      I++RD+K  NILLDS+    + DFGL+K FL +    E   
Sbjct: 110 YSGEIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSE--EKERTY 164

Query: 855 SVAGSYGYIAPEYAYTLKVDEKS-DVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTT 913
           S  G+  Y+APE         K+ D +S G+++ EL+ G  P    G+        R T 
Sbjct: 165 SFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGE--------RNTQ 216

Query: 914 SEVSQ 918
           SEVS+
Sbjct: 217 SEVSR 221

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 57.1 bits (138), Expect = 1e-08
 Identities = 36/97 (37%), Positives = 51/97 (52%), Gaps = 5/97 (5%)

Query: 799 EAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAG 858
           E A  L +LH   S  II+RD+K  NILLD +    + DFGL+K   D        S  G
Sbjct: 106 ELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK--AYSFCG 160

Query: 859 SYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
           +  Y+APE        + +D +SFGV++ E++ G  P
Sbjct: 161 TVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLP 197

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 57.3 bits (138), Expect = 2e-08
 Identities = 68/231 (29%), Positives = 106/231 (45%), Gaps = 12/231 (5%)

Query: 216 KNLREMYIGYFNTYTGGIPPGFGALTQLQVLDMASCNISGEIPTSLSRLKLLHSLFLQMN 275
            NL+E+ +   N     +P     L  L+ LD++  ++S ++P  LS L  L++L L  N
Sbjct: 140 SNLKELDLS-DNKIES-LPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGN 196

Query: 276 KLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQLFKNNLRGPIPSFLGD 335
           K++  +PP++  L +L+ LDLS N +  E+  S + LKNL+ L+L  NN    +P  +G+
Sbjct: 197 KIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLEL-SNNKLEDLPESIGN 253

Query: 336 FPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQN 395
             NLE L +  NN    +         L  LD++ N L+  +P        L  L L+ N
Sbjct: 254 LSNLETLDL-SNNQISSISSLGSLT-NLRELDLSGNSLSNALPLIA---LLLLLLELLLN 308

Query: 396 FFIGPIPEELGQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLS 446
             +     EL     L       N    + P  L  L  LN +   DN L 
Sbjct: 309 LLLTLKALELKLNSILLNNNILSNGE-TSSPEALSILESLNNLWTLDNALD 358

Length = 394

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 57.4 bits (139), Expect = 2e-08
 Identities = 68/231 (29%), Positives = 106/231 (45%), Gaps = 47/231 (20%)

Query: 700 IGKGGAGIV----YRGSMPDGIDVAIKR---------LVGRGTGGNDHGFLAEIQTLGRI 746
           +G+G  GIV       +  +   VAIK+         L  R         L E++ L   
Sbjct: 8   LGQGAYGIVCSARNAET-SEEETVAIKKITNVFSKKILAKRA--------LRELKLLRHF 58

Query: 747 R-HRNIVRL--LGYVSNRDTN-LLLYEYMPNGSLGEMLHGAK---GGHLKWETRYRIALE 799
           R H+NI  L  +  V   + N L LYE +    L +++   +     H +    Y+I   
Sbjct: 59  RGHKNITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFI-YQILC- 116

Query: 800 AAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAK-----FLQDAGASECMS 854
              GL Y+H   S  ++HRD+K  N+L+++D E  + DFGLA+       ++AG    M+
Sbjct: 117 ---GLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGF---MT 167

Query: 855 SVAGSYGYIAPEYAYTLKVDEKS-DVYSFGVVLLELIAGKKPVGEFGDGVD 904
               +  Y APE   + +   K+ DV+S G +L EL+   KPV +  D VD
Sbjct: 168 EYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGR-KPVFKGKDYVD 217

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 56.8 bits (137), Expect = 2e-08
 Identities = 48/157 (30%), Positives = 72/157 (45%), Gaps = 10/157 (6%)

Query: 740 IQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRI-AL 798
           I +L R  H  + +L       D    + E++  G L  M H  K      E R R  A 
Sbjct: 48  ILSLAR-NHPFLTQLYCCFQTPDRLFFVMEFVNGGDL--MFHIQKSRRFD-EARARFYAA 103

Query: 799 EAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAG 858
           E    L +LH      II+RD+K +N+LLD +    +ADFG+ K  +     +  S+  G
Sbjct: 104 EITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCK--EGIFNGKTTSTFCG 158

Query: 859 SYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
           +  YIAPE    +      D ++ GV+L E++ G  P
Sbjct: 159 TPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 56.9 bits (137), Expect = 2e-08
 Identities = 40/106 (37%), Positives = 53/106 (50%), Gaps = 6/106 (5%)

Query: 791 ETRYRI-ALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGA 849
           E R R  A E A  L YLH   S  I++RD+K  NILLDS     + DFGL K  +    
Sbjct: 95  EPRARFYAAEIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCK--EGIAQ 149

Query: 850 SECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
           S+  ++  G+  Y+APE       D   D +  G VL E++ G  P
Sbjct: 150 SDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 57.4 bits (139), Expect = 2e-08
 Identities = 59/217 (27%), Positives = 96/217 (44%), Gaps = 45/217 (20%)

Query: 700 IGKGGAGIVYRGSMP-DGIDVAIKRLVGRGTGGNDHGF---------LAEIQTLGRIRHR 749
           IG G  G+V+  + P DG  VA+K++         + F           E++ L   +H 
Sbjct: 8   IGYGAFGVVWSVTDPRDGKRVALKKMP--------NVFQNLVSCKRVFRELKMLCFFKHD 59

Query: 750 NIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGA-------KGGHLKWETRYRIALEAAK 802
           N++  L  +     +     Y+    +   LH            H+K    Y+I     +
Sbjct: 60  NVLSALDILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFL-YQIL----R 114

Query: 803 GLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSS-VAGSYG 861
           GL YLH   S  I+HRD+K  N+L++S+    + DFGLA+ +++   S+ M+  V   Y 
Sbjct: 115 GLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLAR-VEEPDESKHMTQEVVTQY- 169

Query: 862 YIAPEYA-----YTLKVDEKSDVYSFGVVLLELIAGK 893
           Y APE       YT  V    D++S G +  EL+  +
Sbjct: 170 YRAPEILMGSRHYTSAV----DIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 56.5 bits (136), Expect = 2e-08
 Identities = 59/215 (27%), Positives = 95/215 (44%), Gaps = 23/215 (10%)

Query: 699 IIGKGGAGIVYRG--SMPDG--IDVAIKRLVGRGTGGND-HGFLAEIQTLGRIRHRNIVR 753
           ++GKG  G V        DG    VA+K L       +D   FL E   +    H N+++
Sbjct: 6   MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIK 65

Query: 754 LLGYVSNRDTN------LLLYEYMPNGSLGEMLHGAKGGH----LKWETRYRIALEAAKG 803
           L+G              +++  +M +G L   L  ++ G     L  +T  R  ++ A G
Sbjct: 66  LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASG 125

Query: 804 LCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAK--FLQDAGASECMSSVAGSYG 861
           + YL    S   IHRD+ + N +L+ +    VADFGL+K  +  D     C S +     
Sbjct: 126 MEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL--PVK 180

Query: 862 YIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKP 895
           ++A E          SDV++FGV + E++  G+ P
Sbjct: 181 WLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTP 215

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 56.5 bits (136), Expect = 2e-08
 Identities = 52/199 (26%), Positives = 92/199 (46%), Gaps = 12/199 (6%)

Query: 699 IIGKGGAGIVYRGSMPDGID-VAIKRLVGRGTGGNDH---GFLAEIQTLGRIRHRNIVRL 754
           ++G+G  G+V +    +  + VAIK+   + +  N+      L E++ L  ++  NIV L
Sbjct: 8   VVGEGAYGVVLKCRHKETKEIVAIKKF--KDSEENEEVKETTLRELKMLRTLKQENIVEL 65

Query: 755 LGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPL 814
                 R    L++EY+    L E+L     G    + R  I  +  K + + H +    
Sbjct: 66  KEAFRRRGKLYLVFEYVEKNML-ELLEEMPNGVPPEKVRSYI-YQLIKAIHWCHKN---D 120

Query: 815 IIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVD 874
           I+HRD+K  N+L+  +    + DFG A+ L +   +     VA  + Y +PE        
Sbjct: 121 IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRW-YRSPELLLGAPYG 179

Query: 875 EKSDVYSFGVVLLELIAGK 893
           +  D++S G +L EL  G+
Sbjct: 180 KAVDMWSVGCILGELSDGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 56.6 bits (137), Expect = 2e-08
 Identities = 51/202 (25%), Positives = 84/202 (41%), Gaps = 25/202 (12%)

Query: 681 QRLDFKAEDVLESLKDENIIGKGGAGIVY--RGSMPDGIDVAIKR-LVGRGTGGNDHGFL 737
            + +F   D +   +    IG+G  G V+  R      I VA+K+ L+     G     L
Sbjct: 1   DQYEFPFCDEVSKYEKLAKIGQGTFGEVFKARHKKTKQI-VALKKVLMENEKEGFPITAL 59

Query: 738 AEIQTLGRIRHRNIVRLL--------GYVSNRDTNLLLYEYMPN---GSLGEMLHGAKGG 786
            EI+ L  ++H N+V L+         Y   + +  L++E+  +   G L          
Sbjct: 60  REIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLS 119

Query: 787 HLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAK--FL 844
            +K     ++      GL Y+H      I+HRD+K+ NIL+  D    +ADFGLA+   L
Sbjct: 120 EIK-----KVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSL 171

Query: 845 QDAGASECMSSVAGSYGYIAPE 866
                    ++   +  Y  PE
Sbjct: 172 SKNSKPNRYTNRVVTLWYRPPE 193

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 55.9 bits (135), Expect = 2e-08
 Identities = 67/289 (23%), Positives = 115/289 (39%), Gaps = 52/289 (17%)

Query: 700 IGKGGAGIVYRGSM---PD------GIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRN 750
           +G+G    +Y+G +    D      G +V++   V      +   F      + ++ H++
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62

Query: 751 IVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGG-HLKWETRYRIALEAAKGLCY-LH 808
           +V+L G V  RD N+++ EY+  G L   LH  K    L W+      L+ AK L   LH
Sbjct: 63  LVKLYG-VCVRDENIMVEEYVKFGPLDVFLHREKNNVSLHWK------LDVAKQLASALH 115

Query: 809 HDCSPLIIHRDVKSNNILL--DSDFEAHVADFGLAKFLQDAGASECMSSVA---GSYGYI 863
           +     ++H +V   NIL+      E +V      K L D G    + S         +I
Sbjct: 116 YLEDKKLVHGNVCGKNILVARYGLNEGYVPF---IK-LSDPGIPITVLSREERVERIPWI 171

Query: 864 APEYAYTL--KVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPS 920
           APE        +   +D +SFG  LLE+ + G++P+               ++SE  +  
Sbjct: 172 APECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLST------------LSSSEKERFY 219

Query: 921 DAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHML 969
                L + D             L  +   C   + + RP+ R ++  L
Sbjct: 220 QDQHRLPMPD----------CAELANLINQCWTYDPTKRPSFRAILRDL 258

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 56.5 bits (136), Expect = 2e-08
 Identities = 46/142 (32%), Positives = 74/142 (52%), Gaps = 21/142 (14%)

Query: 762 DTNL-LLYEYMPNGSLGEMLHGAKGGHLKWE-TRYRIALEAAKGLCYLH-HDCSPLIIHR 818
           D++L L+ +YM  G L    H  K G    +  ++ IA E    L +LH +D    I++R
Sbjct: 68  DSDLYLVTDYMSGGEL--FWHLQKEGRFSEDRAKFYIA-ELVLALEHLHKYD----IVYR 120

Query: 819 DVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKS- 877
           D+K  NILLD+     + DFGL+K   +   ++  ++  G+  Y+APE    + +DEK  
Sbjct: 121 DLKPENILLDATGHIALCDFGLSK--ANLTDNKTTNTFCGTTEYLAPE----VLLDEKGY 174

Query: 878 ----DVYSFGVVLLELIAGKKP 895
               D +S GV++ E+  G  P
Sbjct: 175 TKHVDFWSLGVLVFEMCCGWSP 196

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 56.8 bits (137), Expect = 2e-08
 Identities = 44/159 (27%), Positives = 73/159 (45%), Gaps = 14/159 (8%)

Query: 739 EIQTLGRIRHRNIVRLLG-YVSNRDTNLL--LYEYMPNGSLGEMLHGAKGGHLKWETRYR 795
           E+  L  ++H N++ LL  + S    +     Y  MP   +   L    G  L  +    
Sbjct: 64  ELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMP--YMQTDLQKIMGHPLSEDKVQY 121

Query: 796 IALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSS 855
           +  +   GL Y+H   S  IIHRD+K  N+ ++ D E  + DFGLA+      A   M+ 
Sbjct: 122 LVYQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLAR-----HADAEMTG 173

Query: 856 VAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELIAGK 893
              +  Y APE     +  ++  D++S G ++ E++ GK
Sbjct: 174 YVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain

 Score = 50.4 bits (121), Expect = 2e-08
 Identities = 19/42 (45%), Positives = 24/42 (57%), Gaps = 2/42 (4%)

Query: 27 SDMDVLLKLKSSMIGPKGSGLKNWEPSSSPSAHCSFSGVTCD 68
           D D LL  KSS+ G     L +W  + S S  CS++GVTCD
Sbjct: 3  DDRDALLAFKSSLNGDPSGALSSW--NPSSSDPCSWTGVTCD 42

Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 56.9 bits (137), Expect = 3e-08
 Identities = 78/331 (23%), Positives = 136/331 (41%), Gaps = 16/331 (4%)

Query: 241 TQLQVLDMASCNISGEIPTSLSRLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNY 300
                L   S   S +   +L  L  L SL L +N+L  +I   L  L +L SLDL  N 
Sbjct: 69  LLSLDLLSPSGISSLDGSENLLNLLPLPSLDLNLNRLRSNISE-LLELTNLTSLDLDNNN 127

Query: 301 LTGEIPESFAALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRN 360
           +T   P       NL  L L  N +   +PS L + PNL+ L +   N   +LP+ L   
Sbjct: 128 ITDIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDL-SFNDLSDLPKLLSNL 185

Query: 361 GKLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNY 420
             L  LD++ N ++  +P ++     L+ L L  N  I  +   L   K+L+ +  S N 
Sbjct: 186 SNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNK 243

Query: 421 LNGTIPAGLFNLPLLNMMELDDNLLSGELPEKMSGASLNQLKVANNNITGKIPAAIG--N 478
           L   +P  + NL  L  ++L +N +S  +    S  +L +L ++ N+++  +P       
Sbjct: 244 LE-DLPESIGNLSNLETLDLSNNQIS-SISSLGSLTNLRELDLSGNSLSNALPLIALLLL 301

Query: 479 LPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIPYSISQCHSLTSVDLSRN 538
           L  L +  L          +E     ++ + NI  N      P ++S   SL ++    N
Sbjct: 302 LLELLLNLLLTL-----KALELKLNSILLNNNILSNGE-TSSPEALSILESLNNLWTLDN 355

Query: 539 SLYGKIPPGISKLIDLSILNLSRNGITGSIP 569
               +       + + + +    + +   + 
Sbjct: 356 -ALDESNLNRYIVKNPNAIGSLLDLVKKHVN 385

Length = 394

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 56.2 bits (136), Expect = 3e-08
 Identities = 60/240 (25%), Positives = 97/240 (40%), Gaps = 60/240 (25%)

Query: 693 SLKDENIIGK---GGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHGF----LAEIQTLG 744
            L+D  I+GK   G  G VY+   +  G  VA+K+++       D GF    L EI+ L 
Sbjct: 6   KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNE--KD-GFPITALREIKILK 62

Query: 745 RIRHRNIVRLLGYVSNR-----DTNLLLYEYMP--NGSLGEMLHGAKGGHLKWETRYRIA 797
           +++H N+V L+     R          +Y   P  +  L  +L               + 
Sbjct: 63  KLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENP-----------SVK 111

Query: 798 LEAAK----------GLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQD- 846
           L  ++          G+ YLH      I+HRD+K+ NIL+D+     +ADFGLA+     
Sbjct: 112 LTESQIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLARPYDGP 168

Query: 847 --------AGASECMSSVAGSYGYIAPEYA-----YTLKVDEKSDVYSFGVVLLELIAGK 893
                    G +   +++  +  Y  PE       YT  V    D++  G V  E+   +
Sbjct: 169 PPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAV----DIWGIGCVFAEMFTRR 224

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 56.6 bits (136), Expect = 3e-08
 Identities = 48/160 (30%), Positives = 71/160 (44%), Gaps = 8/160 (5%)

Query: 737 LAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRI 796
           L E + L   RH  +  L       D    + EY  NG  GE+        +  E R R 
Sbjct: 43  LTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEY-ANG--GELFFHLSRERVFSEDRARF 99

Query: 797 -ALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSS 855
              E    L YLH + +  +++RD+K  N++LD D    + DFGL K     GA+  M +
Sbjct: 100 YGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MKT 155

Query: 856 VAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
             G+  Y+APE           D +  GVV+ E++ G+ P
Sbjct: 156 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 55.9 bits (135), Expect = 3e-08
 Identities = 69/294 (23%), Positives = 120/294 (40%), Gaps = 54/294 (18%)

Query: 698 NIIGKGGAGIVYRGSMPDGI-----DVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIV 752
           +++ +G  G ++ G + D       +V +K +    +       L E   L  + H+NI+
Sbjct: 12  DLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNIL 71

Query: 753 RLLGYVS-NRDTNLLLYEYMPNGSLGEML----HGAKGGHLKWETR--YRIALEAAKGLC 805
            +L     + +   +LY YM  G+L   L     G         T+    +A++ A G+ 
Sbjct: 72  PILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMS 131

Query: 806 YLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAK--FLQDAGASECMSSVAGSY--- 860
           YLH      +IH+D+ + N ++D + +  + D  L++  F  D     C+          
Sbjct: 132 YLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMD---YHCLGD--NENRPV 183

Query: 861 GYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQP 919
            ++A E     +    SDV+SFGV+L EL+  G+ P  E    +D              P
Sbjct: 184 KWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVE----ID--------------P 225

Query: 920 SDAASVLAVVDPRLSGYPLTGVIH----LFKVAMMCVEDESSARPTMREVVHML 969
            + A+ L        GY L   I+    LF V   C   +   RP+  ++V  L
Sbjct: 226 FEMAAYLK------DGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCL 273

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 56.2 bits (136), Expect = 4e-08
 Identities = 32/106 (30%), Positives = 54/106 (50%), Gaps = 12/106 (11%)

Query: 802 KGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASEC--MSSVAGS 859
           +GL Y+H   S  +IHRD+K +N+L++ D E  + DFG+A+ L  +       M+    +
Sbjct: 118 RGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVAT 174

Query: 860 YGYIAPEYAYTL-KVDEKSDVYSFGVVLLELIA------GKKPVGE 898
             Y APE   +L +     D++S G +  E++       GK  V +
Sbjct: 175 RWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQ 220

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 56.2 bits (135), Expect = 4e-08
 Identities = 41/163 (25%), Positives = 80/163 (49%), Gaps = 21/163 (12%)

Query: 739 EIQTLGRIRHRNIVRLLGYVSNRDT-----NLLLYEYMPNGSLGEMLHGAK--GGHLKWE 791
           E++ L  ++H N++ LL   +   +     ++ L  ++    L  ++   K    H+++ 
Sbjct: 66  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF- 124

Query: 792 TRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASE 851
               +  +  +GL Y+H   S  IIHRD+K +N+ ++ D E  + DFGLA+   D     
Sbjct: 125 ----LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---- 173

Query: 852 CMSSVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELIAGK 893
            M+    +  Y APE     +  ++  D++S G ++ EL+ G+
Sbjct: 174 -MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 56.2 bits (135), Expect = 4e-08
 Identities = 62/217 (28%), Positives = 95/217 (43%), Gaps = 31/217 (14%)

Query: 692 ESLKDENIIGKGGAGIVYRGSMPDGID-VAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRN 750
           +S K  NIIG G  G+VY     D  + VAIK+++      N      E+  +  + H N
Sbjct: 66  KSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKN-----RELLIMKNLNHIN 120

Query: 751 IVRLLGY-----VSNRDTNLLL---YEYMPNGSLGEMLHGAKGGH-LKWETRYRIALEAA 801
           I+ L  Y         + N+ L    E++P      M H A+  H L        + +  
Sbjct: 121 IIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLC 180

Query: 802 KGLCYLHHDCSPLIIHRDVKSNNILLDSDFEA-HVADFGLAKFLQDAGASECMSSVAGSY 860
           + L Y+H   S  I HRD+K  N+L+D +     + DFG AK L        +S +   +
Sbjct: 181 RALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNL--LAGQRSVSYICSRF 235

Query: 861 GYIAPEYA-----YTLKVDEKSDVYSFGVVLLELIAG 892
            Y APE       YT  +    D++S G ++ E+I G
Sbjct: 236 -YRAPELMLGATNYTTHI----DLWSLGCIIAEMILG 267

Length = 440

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 55.8 bits (134), Expect = 5e-08
 Identities = 45/158 (28%), Positives = 78/158 (49%), Gaps = 11/158 (6%)

Query: 739 EIQTLGRIRHRNIVRLLGYVSNRDTNLLLYE-YMPNGSLGEMLHG-AKGGHLKWETRYRI 796
           E++ L  ++H N++ LL   +   +     E Y+    +G  L+   K   L  E    +
Sbjct: 64  ELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFL 123

Query: 797 ALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSV 856
             +  +GL Y+H   S  IIHRD+K +N+ ++ D E  + DFGLA+      A + M+  
Sbjct: 124 IYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLAR-----QADDEMTGY 175

Query: 857 AGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELIAGK 893
             +  Y APE     +  ++  D++S G ++ EL+ GK
Sbjct: 176 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 54.9 bits (132), Expect = 5e-08
 Identities = 40/148 (27%), Positives = 67/148 (45%), Gaps = 18/148 (12%)

Query: 750 NIVRLLGYVSNRDTNLLLYEYMPNGSL----GEMLHGAKGGHLKWETRYRIALEAAKGLC 805
           N+V L  Y+ + D+  L+ ++   G L     + L+  +    +W     +AL+A     
Sbjct: 46  NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDA----- 100

Query: 806 YLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAP 865
            LH +    I+ RD+  NNILLD      +  F     ++D+   E + ++     Y AP
Sbjct: 101 -LHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM-----YCAP 151

Query: 866 EYAYTLKVDEKSDVYSFGVVLLELIAGK 893
           E     +  E  D +S G +L EL+ GK
Sbjct: 152 EVGGISEETEACDWWSLGAILFELLTGK 179

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 55.1 bits (133), Expect = 5e-08
 Identities = 43/146 (29%), Positives = 71/146 (48%), Gaps = 7/146 (4%)

Query: 700 IGKGGAGIVYRG-SMPDGIDVAIK--RLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLG 756
           IG+G  G+VY+G +   G  VA+K  RL     G      + EI  L  ++H NIV L  
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTA-IREISLLKELQHPNIVCLQD 66

Query: 757 YVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLII 816
            +       L++E++       +    KG ++  E       +  +G+ + H   S  ++
Sbjct: 67  VLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH---SRRVL 123

Query: 817 HRDVKSNNILLDSDFEAHVADFGLAK 842
           HRD+K  N+L+D+     +ADFGLA+
Sbjct: 124 HRDLKPQNLLIDNKGVIKLADFGLAR 149

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 55.2 bits (133), Expect = 6e-08
 Identities = 61/212 (28%), Positives = 96/212 (45%), Gaps = 26/212 (12%)

Query: 697 ENIIGKGGAGIVYRGSMPD---GIDVAIKRLVGRGTGGND-HGFLAEIQTLGRIRHRNIV 752
           + +IGKG  G+V   S  D   G  VAIK++       +D    L EI+ L  +RH +IV
Sbjct: 5   QEVIGKGSYGVV--CSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIV 62

Query: 753 RLLGYV---SNRDTN--LLLYEYMPNGSLGEMLHGAKGGH--LKWETRYRIALEAAKGLC 805
            +   +   S R+     +++E M        LH     +  L  E       +  + L 
Sbjct: 63  EIKHIMLPPSRREFKDIYVVFELM-----ESDLHQVIKANDDLTPEHHQFFLYQLLRALK 117

Query: 806 YLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAK--FLQDAGASECMSSVAGSYGYI 863
           Y+H   +  + HRD+K  NIL ++D +  + DFGLA+  F     A      VA  + Y 
Sbjct: 118 YIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRW-YR 173

Query: 864 APEY--AYTLKVDEKSDVYSFGVVLLELIAGK 893
           APE   ++  K     D++S G +  E++ GK
Sbjct: 174 APELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 56.0 bits (135), Expect = 8e-08
 Identities = 26/83 (31%), Positives = 46/83 (55%), Gaps = 1/83 (1%)

Query: 399 GPIPEELGQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLSGELPEKMSG-AS 457
           G IP ++ + + L  I  S N + G IP  L ++  L +++L  N  +G +PE +    S
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTS 491

Query: 458 LNQLKVANNNITGKIPAAIGNLP 480
           L  L +  N+++G++PAA+G   
Sbjct: 492 LRILNLNGNSLSGRVPAALGGRL 514

Length = 623

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 54.2 bits (130), Expect = 8e-08
 Identities = 46/154 (29%), Positives = 70/154 (45%), Gaps = 10/154 (6%)

Query: 739 EIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYM---PNGSLGEMLHGAKGGHLKWETRYR 795
           E Q L +++H NIV         D   LLY  M     G L   L   KG  L       
Sbjct: 49  EAQLLSQLKHPNIVAYRESWEGEDG--LLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVE 106

Query: 796 IALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSS 855
             ++ A  L YLH      I+HRD+K+ N+ L       V D G+A+ L++    +  S+
Sbjct: 107 WFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN--QCDMAST 161

Query: 856 VAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLEL 889
           + G+  Y++PE       + KSDV++ G  + E+
Sbjct: 162 LIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEM 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 54.2 bits (130), Expect = 1e-07
 Identities = 34/100 (34%), Positives = 54/100 (54%), Gaps = 8/100 (8%)

Query: 797 ALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSV 856
           A E   GL ++H+     +++RD+K  NILLD      ++D GLA    D    +  +SV
Sbjct: 103 AAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLA---CDFSKKKPHASV 156

Query: 857 AGSYGYIAPE-YAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
            G++GY+APE     +  D  +D +S G +L +L+ G  P
Sbjct: 157 -GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 54.1 bits (131), Expect = 1e-07
 Identities = 43/156 (27%), Positives = 73/156 (46%), Gaps = 26/156 (16%)

Query: 748 HRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHL-KWETRYRIALEAAKGLCY 806
           + N ++L   V+    ++L+ +Y+ +G L ++L   K G L + E + +I  +  + L  
Sbjct: 68  NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLK--KEGKLSEAEVK-KIIRQLVEALND 124

Query: 807 LHHDCSPLIIHRDVKSNNILLD-SDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAP 865
           LH      IIH D+K  N+L D +    ++ D+GL K     G   C     G+  Y +P
Sbjct: 125 LH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKI---IGTPSCYD---GTLDYFSP 175

Query: 866 E------YAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
           E      Y  +       D ++ GV+  EL+ GK P
Sbjct: 176 EKIKGHNYDVSF------DWWAVGVLTYELLTGKHP 205

Length = 267

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 53.8 bits (129), Expect = 1e-07
 Identities = 41/153 (26%), Positives = 70/153 (45%), Gaps = 8/153 (5%)

Query: 739 EIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIA- 797
           E Q L ++ H  IV+       RD   ++ EY     L   L   K              
Sbjct: 52  EAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEW 111

Query: 798 -LEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSV 856
            ++   G+ Y+H      I+HRD+K+ NI L ++    + DFG+++ L   G+ +  ++ 
Sbjct: 112 FIQLLLGVHYMHQR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLLM--GSCDLATTF 165

Query: 857 AGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLEL 889
            G+  Y++PE       D KSD++S G +L E+
Sbjct: 166 TGTPYYMSPEALKHQGYDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 53.6 bits (129), Expect = 2e-07
 Identities = 58/206 (28%), Positives = 88/206 (42%), Gaps = 18/206 (8%)

Query: 699 IIGKGGAGIVYRGSMPDGID--------VAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRN 750
           ++GKGG G V++     G D        V  K  + R      H   AE   L  ++H  
Sbjct: 3   VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHT-KAERNILEAVKHPF 61

Query: 751 IVRLLGYVSNRDTNL-LLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHH 809
           IV L+ Y       L L+ EY+  G L   +H  + G    +T      E +  L +LH 
Sbjct: 62  IVDLI-YAFQTGGKLYLILEYLSGGEL--FMHLEREGIFMEDTACFYLSEISLALEHLHQ 118

Query: 810 DCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAY 869
                II+RD+K  NILLD+     + DFGL K  +         +  G+  Y+APE   
Sbjct: 119 QG---IIYRDLKPENILLDAQGHVKLTDFGLCK--ESIHEGTVTHTFCGTIEYMAPEILM 173

Query: 870 TLKVDEKSDVYSFGVVLLELIAGKKP 895
                +  D +S G ++ +++ G  P
Sbjct: 174 RSGHGKAVDWWSLGALMYDMLTGAPP 199

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 54.8 bits (132), Expect = 2e-07
 Identities = 57/230 (24%), Positives = 90/230 (39%), Gaps = 51/230 (22%)

Query: 699 IIGKGGAGIVYRGSMPD-GIDVAIKRLVGRGTGGND---HGFLAEIQTLGRIRHRNIVRL 754
           +IGKGG G VY    P     VA+K+ +      N      FL E +    + H  IV +
Sbjct: 9   LIGKGGMGEVYLAYDPVCSRRVALKK-IREDLSENPLLKKRFLREAKIAADLIHPGIVPV 67

Query: 755 LGYVSNRDTNLLLYEYMP---NGSLGEMLHGAKGGHLKWE---------------TRYRI 796
               S+ D    +Y  MP     +L  +L         W+                   I
Sbjct: 68  YSICSDGD---PVYYTMPYIEGYTLKSLLKSV------WQKESLSKELAEKTSVGAFLSI 118

Query: 797 ALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQ---------DA 847
             +    + Y+H   S  ++HRD+K +NILL    E  + D+G A F +         D 
Sbjct: 119 FHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDV 175

Query: 848 GASECMSS-------VAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELI 890
                  S       + G+  Y+APE    +   E +D+Y+ GV+L +++
Sbjct: 176 DERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQML 225

Length = 932

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 53.8 bits (129), Expect = 2e-07
 Identities = 55/214 (25%), Positives = 90/214 (42%), Gaps = 35/214 (16%)

Query: 731 GNDHGFLAEIQTLGRIRHRNIVRLLG-YVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLK 789
           G   G   E   L  I H +I++L G +  N+ T L+L  Y  +             +  
Sbjct: 125 GQRGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTDL------------YCY 172

Query: 790 WETRYRIAL--------EAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLA 841
              +  IA+           + + YLH +    IIHRD+K+ NI ++   +  + DFG A
Sbjct: 173 LAAKRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAA 229

Query: 842 KFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGD 901
            F  D  A++     AG+    APE           D++S G+VL E+      + E  D
Sbjct: 230 CFPVDINANK-YYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFE-KD 287

Query: 902 GVD--------IVRWVRKTTSEVSQ-PSDAASVL 926
           G+D        I   +R++ +  ++ P DA + L
Sbjct: 288 GLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANL 321

Length = 391

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 52.7 bits (126), Expect = 3e-07
 Identities = 36/104 (34%), Positives = 55/104 (52%), Gaps = 16/104 (15%)

Query: 797 ALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSV 856
           A E   GL ++H+     +++RD+K  NILLD      ++D GLA    D    +  +SV
Sbjct: 103 ATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLA---CDFSKKKPHASV 156

Query: 857 AGSYGYIAPEY-----AYTLKVDEKSDVYSFGVVLLELIAGKKP 895
            G++GY+APE      AY    D  +D +S G +L +L+ G  P
Sbjct: 157 -GTHGYMAPEVLQKGTAY----DSSADWFSLGCMLFKLLRGHSP 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 54.4 bits (130), Expect = 3e-07
 Identities = 47/184 (25%), Positives = 76/184 (41%), Gaps = 30/184 (16%)

Query: 739 EIQTLGRIRHRNIVRLLGYVSNRDTNLL--LYEYMPNGSLGEMLHGAKG--GHLKWETRY 794
           E+  +  ++H+NIVR +    N+    L  L E+   G L   +       G ++     
Sbjct: 62  EVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIV 121

Query: 795 RIALEAAKGLCYLHH----DCSPLIIHRDVKSNNILLDSDFE-----------------A 833
            I  +    L Y H+         ++HRD+K  NI L +                    A
Sbjct: 122 DITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIA 181

Query: 834 HVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAY--TLKVDEKSDVYSFGVVLLELIA 891
            + DFGL+K   + G      S  G+  Y +PE     T   D+KSD+++ G ++ EL +
Sbjct: 182 KIGDFGLSK---NIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCS 238

Query: 892 GKKP 895
           GK P
Sbjct: 239 GKTP 242

Length = 1021

>gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

 Score = 52.4 bits (126), Expect = 5e-07
 Identities = 74/288 (25%), Positives = 102/288 (35%), Gaps = 54/288 (18%)

Query: 240 LTQLQVLDMASCNISGE----IPTSLSRLKLLHSLFLQMNKLTGHIPPQL----SGLIS- 290
           L  LQVL +    +  E    + ++L     L  L L +N+ TG IP  L     GL   
Sbjct: 22  LLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNE-TGRIPRGLQSLLQGLTKG 80

Query: 291 --LKSLDLSLNYLTGEIPESFAALKNLTLLQLFK--NNLRGPIP------SFLGDFPNLE 340
             L+ LDLS N L  +      +L   + LQ  K  NN  G               P LE
Sbjct: 81  CGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALE 140

Query: 341 VLQVWGNNFT----FELPENLGRNGKLLILDVTSNHLTGTIPRDLCKGGK----LKSLIL 392
            L +  N         L + L  N  L  L++ +N +     R L +G K    L+ L L
Sbjct: 141 KLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDL 200

Query: 393 MQNFF----IGPIPEELGQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLSGE 448
             N         + E L   KSL  +    N           NL       L   LLS  
Sbjct: 201 NNNGLTDEGASALAETLASLKSLEVLNLGDN-----------NLTDAGAAALASALLSP- 248

Query: 449 LPEKMSGASLNQLKVANNNIT----GKIPAAIGNLPSLNILSLQNNRL 492
                   SL  L ++ N+IT      +   +    SL  L L+ N+ 
Sbjct: 249 ------NISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKF 290

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 52.4 bits (126), Expect = 5e-07
 Identities = 41/126 (32%), Positives = 68/126 (53%), Gaps = 18/126 (14%)

Query: 802 KGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYG 861
           +GL Y+H   S  ++HRD+K +N+LL+++ +  + DFGLA+   + G  + M+    +  
Sbjct: 119 RGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG--DFMTEYVVTRW 173

Query: 862 YIAPEY-----AYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEV 916
           Y APE       YT  +    DV+S G +  EL+ G+KP+  F  G D V  ++  T  +
Sbjct: 174 YRAPELLLNCSEYTTAI----DVWSVGCIFAELL-GRKPL--F-PGKDYVHQLKLITELL 225

Query: 917 SQPSDA 922
             PS+ 
Sbjct: 226 GSPSEE 231

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 52.9 bits (127), Expect = 7e-07
 Identities = 28/82 (34%), Positives = 42/82 (51%)

Query: 353 LPENLGRNGKLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFIGPIPEELGQCKSLT 412
           +P ++ +   L  ++++ N + G IP  L     L+ L L  N F G IPE LGQ  SL 
Sbjct: 434 IPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLR 493

Query: 413 KIRFSKNYLNGTIPAGLFNLPL 434
            +  + N L+G +PA L    L
Sbjct: 494 ILNLNGNSLSGRVPAALGGRLL 515

Length = 623

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 52.0 bits (125), Expect = 8e-07
 Identities = 66/259 (25%), Positives = 106/259 (40%), Gaps = 79/259 (30%)

Query: 692 ESLKDENIIGKGGAGIVYRGSMPDGIDV-AIKRL-----VGRGTGGNDHGFLAEIQTLGR 745
           ES+K   +IG+G  G V      D   + A+K+L     + +    +     AE   L  
Sbjct: 4   ESIK---VIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAH---VRAERDILAE 57

Query: 746 IRHRNIVRLLGYVSNRDTN--LLLYEYMPNGSLGEMLHGAKGGHLKW------ETRYRI- 796
             +  +V+L  Y S +D N   L+ EY+P G +  +L       +K       ETR+ I 
Sbjct: 58  ADNPWVVKL--YYSFQDENYLYLIMEYLPGGDMMTLL-------MKKDTFTEEETRFYIA 108

Query: 797 ----ALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASE- 851
               A+++   L Y         IHRD+K +N+LLD+     ++DFGL   L+ +  +E 
Sbjct: 109 ETILAIDSIHKLGY---------IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEF 159

Query: 852 ------------------CMS-----------------SVAGSYGYIAPEYAYTLKVDEK 876
                              MS                 S  G+  YIAPE       +++
Sbjct: 160 YRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKE 219

Query: 877 SDVYSFGVVLLELIAGKKP 895
            D +S GV++ E++ G  P
Sbjct: 220 CDWWSLGVIMYEMLVGYPP 238

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 51.7 bits (124), Expect = 8e-07
 Identities = 47/151 (31%), Positives = 74/151 (49%), Gaps = 17/151 (11%)

Query: 700 IGKGGAGIVYRGSMPDGID---VAIKRL-VGRGTGGNDHGFLAEIQTLGRIRHRNIVRLL 755
           IG+G  G+VY+    D +    +A+K++ + +   G     + EI  L  ++H NIVRL 
Sbjct: 10  IGEGTYGVVYKAR--DRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQ 67

Query: 756 GYVSNRDTNLLLYEYMPNGSLGEMLHG---AKGGHLKWETRYRIALEAAKGLCYLHHDCS 812
             V +     L++EY+       M      AK   L     Y+I     +G+ Y H   S
Sbjct: 68  DVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQI----LRGIAYCH---S 120

Query: 813 PLIIHRDVKSNNILLDSDFEA-HVADFGLAK 842
             ++HRD+K  N+L+D    A  +ADFGLA+
Sbjct: 121 HRVLHRDLKPQNLLIDRRTNALKLADFGLAR 151

Length = 294

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 51.7 bits (124), Expect = 8e-07
 Identities = 42/139 (30%), Positives = 63/139 (45%), Gaps = 11/139 (7%)

Query: 766 LLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNI 825
           L+ EY P G L  +L+  +    +   ++ +A E    +  +H       +HRD+K  N+
Sbjct: 78  LVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLA-ELVLAIHSVHQMG---YVHRDIKPENV 133

Query: 826 LLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKS------DV 879
           L+D      +ADFG A  L           V G+  YIAPE   T+  D K       D 
Sbjct: 134 LIDRTGHIKLADFGSAARLTANKMVNSKLPV-GTPDYIAPEVLTTMNGDGKGTYGVECDW 192

Query: 880 YSFGVVLLELIAGKKPVGE 898
           +S GV+  E+I G+ P  E
Sbjct: 193 WSLGVIAYEMIYGRSPFHE 211

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 52.5 bits (126), Expect = 9e-07
 Identities = 35/113 (30%), Positives = 52/113 (46%), Gaps = 25/113 (22%)

Query: 100 LTISNVNLTGRLPSEMALLTSLKVFNISGNVFQGNFAGQIVRGMTELQVLDAYNNNFTGP 159
           L + N  L G +P++++ L  L+  N+SGN  +GN                         
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGN------------------------- 457

Query: 160 LPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLNGIGLNGTVPAFL 212
           +P  + S+ SL  L    N F G IP+S  ++ SL  + LNG  L+G VPA L
Sbjct: 458 IPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAAL 510

Length = 623

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 51.5 bits (123), Expect = 9e-07
 Identities = 30/86 (34%), Positives = 47/86 (54%), Gaps = 8/86 (9%)

Query: 816 IHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVA-GSYGYIAPEYAYTL--- 871
           +HRD+K +N+LLD +    +ADFG    +   G  +  SSVA G+  YI+PE    +   
Sbjct: 124 VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQ--SSVAVGTPDYISPEILQAMEDG 181

Query: 872 --KVDEKSDVYSFGVVLLELIAGKKP 895
             K   + D +S GV + E++ G+ P
Sbjct: 182 MGKYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 51.7 bits (124), Expect = 1e-06
 Identities = 45/161 (27%), Positives = 70/161 (43%), Gaps = 33/161 (20%)

Query: 32  LLKLKSSMIGPKGSGLKNWEPSSSPSAHCSFSGVTCDQDSR-----VVSLNVSFMPLFGS 86
           L  LKSS+  P   G  N +P   P  H  +SG  C  DS      +  L +    L G 
Sbjct: 377 LQTLKSSLGLPLRFGW-NGDPCV-PQQH-PWSGADCQFDSTKGKWFIDGLGLDNQGLRGF 433

Query: 87  IPPEIGLLTKLVNLTISNVNLTGRLPSEMALLTSLKVFNISGNVFQGNFAGQIVRGMTEL 146
           IP +I  L  L ++ +S  ++ G +P  +  +TSL+V ++S                   
Sbjct: 434 IPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLS------------------- 474

Query: 147 QVLDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQS 187
                  N+F G +P  +  L SLR L+  GN  +G++P +
Sbjct: 475 ------YNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAA 509

Length = 623

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 51.6 bits (123), Expect = 1e-06
 Identities = 61/248 (24%), Positives = 100/248 (40%), Gaps = 58/248 (23%)

Query: 691 LESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIR-HR 749
            ESLK   +IG+G  G V      D   V   +++ +         + E + +G IR  R
Sbjct: 3   FESLK---VIGRGAFGEVRLVQKKDTGHVYAMKILRKAD-------MLEKEQVGHIRAER 52

Query: 750 NI---------VRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEA 800
           +I         V++     ++    L+ E++P G +  +L   K    + ET++ IA E 
Sbjct: 53  DILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLM-KKDTLTEEETQFYIA-ET 110

Query: 801 AKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMS------ 854
              +  +H       IHRD+K +N+LLDS     ++DFGL   L+ A  +E         
Sbjct: 111 VLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSL 167

Query: 855 ---------------------------SVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLL 887
                                      S  G+  YIAPE       ++  D +S GV++ 
Sbjct: 168 PSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMY 227

Query: 888 ELIAGKKP 895
           E++ G  P
Sbjct: 228 EMLIGYPP 235

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 50.8 bits (121), Expect = 2e-06
 Identities = 45/153 (29%), Positives = 74/153 (48%), Gaps = 17/153 (11%)

Query: 752 VRLLGYVSNRDTNL-LLYEYMPNGSLGEMLHGAKGGHLKWETRYRIA--LEAAKGLCYLH 808
           +  L Y    + NL L+ +Y   G L  +L   +    +   R+ +A  + A   +  LH
Sbjct: 63  ITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH 122

Query: 809 HDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVA-GSYGYIAPEY 867
           +      +HRD+K +NIL+D +    +ADFG    L + G  +  SSVA G+  YI+PE 
Sbjct: 123 Y------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQ--SSVAVGTPDYISPEI 174

Query: 868 AYTL-----KVDEKSDVYSFGVVLLELIAGKKP 895
              +     K   + D +S GV + E++ G+ P
Sbjct: 175 LQAMEDGKGKYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

 Score = 50.0 bits (120), Expect = 3e-06
 Identities = 67/290 (23%), Positives = 108/290 (37%), Gaps = 60/290 (20%)

Query: 337 PNLEVLQVWGNNFTFE----LPENLGRNGKLLILDVTSNHLTGTIPRDLCKGGKLKSLIL 392
             L+VL++ GN    E    L   L     L  L ++ N  TG IPR L          L
Sbjct: 23  LCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNE-TGRIPRGL--------QSL 73

Query: 393 MQNFFIGPIPEELGQCKSLTKIRFSKNYLNGTIPAGLFNL---PLLNMMELDDNLLSGEL 449
           +Q          L +   L ++  S N L       L +L     L  ++L++N L G+ 
Sbjct: 74  LQG---------LTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGL-GDR 123

Query: 450 PEKMSGASLNQLKVA-------NNNITGKIPAAIGNL----PSLNILSLQNNRLEGE-IP 497
             ++    L  L  A        N + G    A+         L  L+L NN +    I 
Sbjct: 124 GLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIR 183

Query: 498 VESFNLKMITS---INISDNNISGE----IPYSISQCHSLTSVDLSRNSLYGKIPPGISK 550
             +  LK   +   +++++N ++ E    +  +++   SL  ++L  N+L      G + 
Sbjct: 184 ALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDA---GAAA 240

Query: 551 LID--------LSILNLSRNGIT----GSIPNEMRNMMSLTTLDLSYNNL 588
           L          L  L+LS N IT      +   +    SL  LDL  N  
Sbjct: 241 LASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKF 290

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 50.4 bits (120), Expect = 3e-06
 Identities = 45/163 (27%), Positives = 71/163 (43%), Gaps = 11/163 (6%)

Query: 733 DHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWET 792
           DH F +E + L  I H   V L G   +     L+ E++  G     L   K        
Sbjct: 76  DHVF-SERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGC 134

Query: 793 RYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASEC 852
            Y     AA+ +    +  S  I++RD+K  N+LLD D    + DFG AK +     + C
Sbjct: 135 FY-----AAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYTLC 189

Query: 853 MSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
                G+  YIAPE    +   + +D ++ G+ + E++ G  P
Sbjct: 190 -----GTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPP 227

Length = 340

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 49.6 bits (118), Expect = 3e-06
 Identities = 42/154 (27%), Positives = 73/154 (47%), Gaps = 8/154 (5%)

Query: 691 LESLKDENIIGKGGAGIVYRG--SMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRH 748
           LE+    + +G+G    VY+G   + D + VA+K +      G     + E+  L  ++H
Sbjct: 5   LETYIKLDKLGEGTYATVYKGRSKLTDNL-VALKEIRLEHEEGAPCTAIREVSLLKDLKH 63

Query: 749 RNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLH 808
            NIV L   +    +  L++EY+ +  L + L    G  +          +  +GL Y H
Sbjct: 64  ANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDC-GNSINMHNVKLFLFQLLRGLNYCH 121

Query: 809 HDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAK 842
                 ++HRD+K  N+L++   E  +ADFGLA+
Sbjct: 122 RR---KVLHRDLKPQNLLINERGELKLADFGLAR 152

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 49.6 bits (118), Expect = 4e-06
 Identities = 61/257 (23%), Positives = 100/257 (38%), Gaps = 72/257 (28%)

Query: 689 DVLESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGF-------LAEIQ 741
           D  ESLK   +IG+G  G V              RLV +   G+ +         + E +
Sbjct: 1   DDFESLK---VIGRGAFGEV--------------RLVQKKDTGHIYAMKILRKADMLEKE 43

Query: 742 TLGRIR-HRNI---------VRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWE 791
            +  IR  R+I         V++     ++    L+ E++P G +  +L   K    +  
Sbjct: 44  QVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLM-KKDTLSEEA 102

Query: 792 TRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASE 851
           T++ IA E    +  +H       IHRD+K +N+LLD+     ++DFGL   L+ A  +E
Sbjct: 103 TQFYIA-ETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTE 158

Query: 852 ---------------------------------CMSSVAGSYGYIAPEYAYTLKVDEKSD 878
                                               S  G+  YIAPE       ++  D
Sbjct: 159 FYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCD 218

Query: 879 VYSFGVVLLELIAGKKP 895
            +S GV++ E++ G  P
Sbjct: 219 WWSLGVIMYEMLIGYPP 235

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 50.2 bits (120), Expect = 5e-06
 Identities = 29/87 (33%), Positives = 50/87 (57%), Gaps = 2/87 (2%)

Query: 182 GKIPQSYSEIQSLEYIGLNGIGLNGTVPAFLSRLKNLREMYIGYFNTYTGGIPPGFGALT 241
           G IP   S+++ L+ I L+G  + G +P  L  + +L  + + Y N++ G IP   G LT
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSY-NSFNGSIPESLGQLT 490

Query: 242 QLQVLDMASCNISGEIPTSLSRLKLLH 268
            L++L++   ++SG +P +L    LLH
Sbjct: 491 SLRILNLNGNSLSGRVPAALGGR-LLH 516

Length = 623

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 49.6 bits (118), Expect = 5e-06
 Identities = 41/176 (23%), Positives = 76/176 (43%), Gaps = 23/176 (13%)

Query: 797 ALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSV 856
           + + A+G+ +L    S   IHRD+ + NILL  +    + DFGLA+ +          S 
Sbjct: 180 SFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSA 236

Query: 857 AGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSE 915
                ++APE  +      +SDV+SFGV+L E+ + G  P        +  + ++  T  
Sbjct: 237 RLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGT-R 295

Query: 916 VSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLAN 971
           +  P +A                     ++++ + C + +   RPT   +V +L +
Sbjct: 296 MRAPENATP------------------EIYRIMLACWQGDPKERPTFSALVEILGD 333

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 49.2 bits (117), Expect = 5e-06
 Identities = 44/154 (28%), Positives = 74/154 (48%), Gaps = 8/154 (5%)

Query: 691 LESLKDENIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHR 749
           LE+    + +G+G    V++G S      VA+K +      G     + E+  L  ++H 
Sbjct: 4   LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHA 63

Query: 750 NIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIAL-EAAKGLCYLH 808
           NIV L   +       L++EY+ +  L + L     G+L      +I + +  +GL Y H
Sbjct: 64  NIVTLHDIIHTERCLTLVFEYLDS-DLKQYLDNC--GNLMSMHNVKIFMFQLLRGLSYCH 120

Query: 809 HDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAK 842
                 I+HRD+K  N+L++   E  +ADFGLA+
Sbjct: 121 KR---KILHRDLKPQNLLINEKGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 49.4 bits (118), Expect = 5e-06
 Identities = 47/183 (25%), Positives = 76/183 (41%), Gaps = 45/183 (24%)

Query: 737 LAEIQTLGRIRHRNIVRLLG-YVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYR 795
           L E++ +  I+H NI+ L+  YV     NL++ + M    L +++          + + R
Sbjct: 68  LRELKIMNEIKHENIMGLVDVYVEGDFINLVM-DIM-ASDLKKVV----------DRKIR 115

Query: 796 --------IALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLA-KFLQD 846
                   I L+   GL  LH       +HRD+   NI ++S     +ADFGLA ++   
Sbjct: 116 LTESQVKCILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYP 172

Query: 847 AGASEC-----------MSSVAGSYGYIAPEY-----AYTLKVDEKSDVYSFGVVLLELI 890
             +              M+S   +  Y APE       Y   V    D++S G +  EL+
Sbjct: 173 PYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAV----DMWSVGCIFAELL 228

Query: 891 AGK 893
            GK
Sbjct: 229 TGK 231

Length = 335

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 48.9 bits (116), Expect = 7e-06
 Identities = 46/180 (25%), Positives = 75/180 (41%), Gaps = 23/180 (12%)

Query: 797 ALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSV 856
           + + AKG+ +L    S   IHRD+ + NILL  +    + DFGLA+ +            
Sbjct: 185 SFQVAKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 241

Query: 857 AGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSE 915
                ++APE  +      +SDV+SFGV+L E+ + G  P        +  R +++ T  
Sbjct: 242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT-R 300

Query: 916 VSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQS 975
           +  P                        +++  + C   E S RPT  E+V  L N  Q+
Sbjct: 301 MRAPDYTTP------------------EMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 342

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 48.6 bits (116), Expect = 8e-06
 Identities = 29/86 (33%), Positives = 46/86 (53%), Gaps = 8/86 (9%)

Query: 816 IHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVA-GSYGYIAPEYAYTL--- 871
           +HRD+K +N+LLD +    +ADFG    L   G     S+VA G+  YI+PE    +   
Sbjct: 124 VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT--VQSNVAVGTPDYISPEILQAMEDG 181

Query: 872 --KVDEKSDVYSFGVVLLELIAGKKP 895
             +   + D +S GV + E++ G+ P
Sbjct: 182 KGRYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 48.7 bits (116), Expect = 8e-06
 Identities = 32/102 (31%), Positives = 54/102 (52%), Gaps = 4/102 (3%)

Query: 795 RIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMS 854
           R + + A+G+ +L    S   IHRDV + N+LL     A + DFGLA+ + +        
Sbjct: 216 RFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKG 272

Query: 855 SVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKP 895
           +      ++APE  +      +SDV+S+G++L E+ + GK P
Sbjct: 273 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSP 314

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 48.6 bits (116), Expect = 9e-06
 Identities = 56/216 (25%), Positives = 95/216 (43%), Gaps = 34/216 (15%)

Query: 700 IGKGGAGIVYRGSMPD-GIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRL---L 755
           +G G  G+V+     D    VA+K++V        H  L EI+ + R+ H NIV++   L
Sbjct: 13  LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHA-LREIKIIRRLDHDNIVKVYEVL 71

Query: 756 GYVSNRDTNLL--------LY---EYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGL 804
           G   +  T  +        +Y   EYM    L  +L   + G L  E       +  +GL
Sbjct: 72  GPSGSDLTEDVGSLTELNSVYIVQEYM-ETDLANVL---EQGPLSEEHARLFMYQLLRGL 127

Query: 805 CYLHHDCSPLIIHRDVKSNNILLDS-DFEAHVADFGLAKFL-QDAGASECMSSVAGSYGY 862
            Y+H   S  ++HRD+K  N+ +++ D    + DFGLA+ +         +S    +  Y
Sbjct: 128 KYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWY 184

Query: 863 IAPEYA-----YTLKVDEKSDVYSFGVVLLELIAGK 893
            +P        YT    +  D+++ G +  E++ GK
Sbjct: 185 RSPRLLLSPNNYT----KAIDMWAAGCIFAEMLTGK 216

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 49.0 bits (117), Expect = 1e-05
 Identities = 34/112 (30%), Positives = 52/112 (46%), Gaps = 6/112 (5%)

Query: 149 LDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLNGIGLNGTV 208
           L   N    G +P +I+ L+ L+ ++  GN   G IP S   I SLE + L+    NG++
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 209 PAFLSRLKNLREMYIGYFNTYTGGIPPGFGAL----TQLQVLDMAS-CNISG 255
           P  L +L +LR + +   N+ +G +P   G            D A  C I G
Sbjct: 483 PESLGQLTSLRILNLNG-NSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPG 533

Length = 623

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 48.3 bits (115), Expect = 1e-05
 Identities = 30/98 (30%), Positives = 47/98 (47%), Gaps = 29/98 (29%)

Query: 757 YVSNRDTNLL--LYEYMPNGSLGEMLHGAKGGHLKWE------TRYRIA-----LEAAKG 803
           Y S +D   L  + E++P G L  ML       +K++      TR+ +A     +EA   
Sbjct: 67  YYSFQDAQYLYLIMEFLPGGDLMTML-------IKYDTFSEDVTRFYMAECVLAIEAVHK 119

Query: 804 LCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLA 841
           L +         IHRD+K +NIL+D      ++DFGL+
Sbjct: 120 LGF---------IHRDIKPDNILIDRGGHIKLSDFGLS 148

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 47.8 bits (114), Expect = 1e-05
 Identities = 46/154 (29%), Positives = 72/154 (46%), Gaps = 8/154 (5%)

Query: 691 LESLKDENIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHR 749
           LE+ K  + +G+G    VY+G S   G  VA+K +      G     + E   L  ++H 
Sbjct: 4   LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHA 63

Query: 750 NIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIAL-EAAKGLCYLH 808
           NIV L   +  + T  L++EY+       M     G  +      R+ L +  +GL Y H
Sbjct: 64  NIVTLHDIIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMH---NVRLFLFQLLRGLAYCH 120

Query: 809 HDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAK 842
                 ++HRD+K  N+L+    E  +ADFGLA+
Sbjct: 121 QR---RVLHRDLKPQNLLISERGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 48.1 bits (114), Expect = 1e-05
 Identities = 49/204 (24%), Positives = 77/204 (37%), Gaps = 52/204 (25%)

Query: 738 AEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWE-TRYRI 796
           AE   L    +  +VRL     ++D    + +Y+P G +  +L   + G    +  R+ I
Sbjct: 50  AERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLL--IRMGIFPEDLARFYI 107

Query: 797 ALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGL---------AKFLQ-- 845
           A    +  C +        IHRD+K +NIL+D D    + DFGL         +K+ Q  
Sbjct: 108 A----ELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSG 163

Query: 846 ---------------DAGASEC-------------------MSSVAGSYGYIAPEYAYTL 871
                          D     C                     S+ G+  YIAPE     
Sbjct: 164 DHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRT 223

Query: 872 KVDEKSDVYSFGVVLLELIAGKKP 895
              +  D +S GV+L E++ G+ P
Sbjct: 224 GYTQLCDWWSVGVILYEMLVGQPP 247

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 42.9 bits (102), Expect = 2e-05
 Identities = 24/61 (39%), Positives = 35/61 (57%), Gaps = 2/61 (3%)

Query: 481 SLNILSLQNNRLEGEIPVESF-NLKMITSINISDNNISGEIPYSISQCHSLTSVDLSRNS 539
           +L  L L NNRL   IP  +F  L  +  +++S NN++   P + S   SL S+DLS N+
Sbjct: 1   NLKSLDLSNNRLT-VIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59

Query: 540 L 540
           L
Sbjct: 60  L 60

Length = 60

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 42.9 bits (102), Expect = 2e-05
 Identities = 27/61 (44%), Positives = 35/61 (57%), Gaps = 2/61 (3%)

Query: 529 SLTSVDLSRNSLYGKIPPGI-SKLIDLSILNLSRNGITGSIPNEMRNMMSLTTLDLSYNN 587
           +L S+DLS N L   IP G    L +L +L+LS N +T   P     + SL +LDLS NN
Sbjct: 1   NLKSLDLSNNRL-TVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59

Query: 588 L 588
           L
Sbjct: 60  L 60

Length = 60

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 47.9 bits (114), Expect = 2e-05
 Identities = 49/189 (25%), Positives = 78/189 (41%), Gaps = 52/189 (27%)

Query: 751 IVRLLGYVSNRDTNLLLY--EYMPNGSLGEMLHGAKGGHLKWE-TRYRIALEAAKGLCYL 807
           +V+L  Y S +D + L +  +Y+P G +  +L   + G  + +  R+ IA E    +  +
Sbjct: 63  VVKL--YYSFQDKDNLYFVMDYIPGGDMMSLL--IRLGIFEEDLARFYIA-ELTCAIESV 117

Query: 808 HHDCSPLIIHRDVKSNNILLDSDFEAHVADFGL---------AKFLQDAG---------- 848
           H       IHRD+K +NIL+D D    + DFGL         +K+ Q             
Sbjct: 118 HKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPS 174

Query: 849 --ASECMS--------------------SVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVL 886
              SE                       S+ G+  YIAPE        +  D +S GV+L
Sbjct: 175 EEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 234

Query: 887 LELIAGKKP 895
            E++ G+ P
Sbjct: 235 YEMLVGQPP 243

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 47.7 bits (113), Expect = 2e-05
 Identities = 46/207 (22%), Positives = 76/207 (36%), Gaps = 58/207 (28%)

Query: 738 AEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEML--HGAKGGHLK--WETR 793
           AE   L    +  +V+L     ++D    + +Y+P G +  +L         L   +   
Sbjct: 50  AERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAE 109

Query: 794 YRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGL---------AKFL 844
             +A+E+   + +         IHRD+K +NIL+D D    + DFGL         +K+ 
Sbjct: 110 LTLAIESVHKMGF---------IHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYY 160

Query: 845 Q-----------------DAGASEC-------------------MSSVAGSYGYIAPEYA 868
           Q                 D     C                     S+ G+  YIAPE  
Sbjct: 161 QKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVL 220

Query: 869 YTLKVDEKSDVYSFGVVLLELIAGKKP 895
                 +  D +S GV+L E++ G+ P
Sbjct: 221 LRKGYTQLCDWWSVGVILFEMLVGQPP 247

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 46.8 bits (111), Expect = 2e-05
 Identities = 53/218 (24%), Positives = 88/218 (40%), Gaps = 22/218 (10%)

Query: 700 IGKGGAGIVYRGSM---PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLG 756
           IG G  G V    +        V +K L    +    + FL +      ++H NI++ LG
Sbjct: 3   IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62

Query: 757 YVSNRDTNLLLYEYMPNGSLGEML--HGAKGGHLKWETRYRIALEAAKGLCYLH-HDCSP 813
                   LL++EY   G L   L        + +     R+A E A G+ ++H H+   
Sbjct: 63  QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN--- 119

Query: 814 LIIHRDVKSNNILLDSDFEAHVADFGL--AKFLQDAGASECMSSVAGSYGYIAPEYA--- 868
             +H D+   N  L SD    V D+G+  +++ +D   +E          ++APE     
Sbjct: 120 -FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE--DDKCVPLRWLAPELVGEF 176

Query: 869 ----YTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGD 901
                T +  + S+V++ GV L EL     +P     D
Sbjct: 177 HGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD 214

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 47.1 bits (112), Expect = 2e-05
 Identities = 41/149 (27%), Positives = 63/149 (42%), Gaps = 20/149 (13%)

Query: 766 LLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNI 825
           ++ EY+  G    +L     G L  +       E    L YLH   +  I+HRD+K +N+
Sbjct: 78  MVMEYVEGGDCATLLKNI--GALPVDMARMYFAETVLALEYLH---NYGIVHRDLKPDNL 132

Query: 826 LLDSDFEAHVADFGLAKF------------LQDAGASECM-SSVAGSYGYIAPEYAYTLK 872
           L+ S     + DFGL+K               +    E +   V G+  YIAPE      
Sbjct: 133 LITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQG 192

Query: 873 VDEKSDVYSFGVVLLELIAGKKPVGEFGD 901
             +  D ++ G++L E + G  P   FGD
Sbjct: 193 YGKPVDWWAMGIILYEFLVGCVPF--FGD 219

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 46.9 bits (111), Expect = 3e-05
 Identities = 47/198 (23%), Positives = 95/198 (47%), Gaps = 13/198 (6%)

Query: 700 IGKGGAGIVYRG--SMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGY 757
           +G+G    V++G   + + + VA+K +      G     + E+  L  ++H NIV L   
Sbjct: 14  LGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72

Query: 758 VSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIAL-EAAKGLCYLHHDCSPLII 816
           V    +  L++EY+ +  L + +     G++      +I L +  +GL Y H      ++
Sbjct: 73  VHTDKSLTLVFEYL-DKDLKQYMDDC--GNIMSMHNVKIFLYQILRGLAYCHRR---KVL 126

Query: 817 HRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAY-TLKVDE 875
           HRD+K  N+L++   E  +ADFGLA+    +  ++  S+   +  Y  P+    + +   
Sbjct: 127 HRDLKPQNLLINERGELKLADFGLAR--AKSVPTKTYSNEVVTLWYRPPDVLLGSSEYST 184

Query: 876 KSDVYSFGVVLLELIAGK 893
           + D++  G +  E+ +G+
Sbjct: 185 QIDMWGVGCIFFEMASGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 46.8 bits (111), Expect = 4e-05
 Identities = 26/78 (33%), Positives = 43/78 (55%), Gaps = 8/78 (10%)

Query: 815 IIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEY----AYT 870
           IIHRD+K+ N+L++   +  + DFG A F + + ++     +AG+    APE      YT
Sbjct: 281 IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYT 340

Query: 871 LKVDEKSDVYSFGVVLLE 888
             V    D++S G+V+ E
Sbjct: 341 PSV----DIWSAGLVIFE 354

Length = 461

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 41.4 bits (98), Expect = 6e-05
 Identities = 30/60 (50%), Positives = 35/60 (58%), Gaps = 2/60 (3%)

Query: 267 LHSLFLQMNKLTGHIPPQ-LSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQLFKNNL 325
           L SL L  N+LT  IP     GL +LK LDLS N LT   PE+F+ L +L  L L  NNL
Sbjct: 2   LKSLDLSNNRLT-VIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 46.0 bits (109), Expect = 7e-05
 Identities = 30/98 (30%), Positives = 51/98 (52%), Gaps = 4/98 (4%)

Query: 799 EAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAG 858
           + AKG+ +L    S   IHRD+ + NILL       + DFGLA+ +++        +   
Sbjct: 222 QVAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARL 278

Query: 859 SYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKP 895
              ++APE  +      +SDV+S+G++L E+ + G  P
Sbjct: 279 PVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSP 316

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 45.4 bits (107), Expect = 9e-05
 Identities = 53/212 (25%), Positives = 96/212 (45%), Gaps = 25/212 (11%)

Query: 700 IGKGGAGIVYRGSMPDGID---VAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLG 756
           +G+G  G VY+    DG D    A+K++ G G   +      EI  L  ++H N++ L  
Sbjct: 9   VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSA---CREIALLRELKHPNVISLQK 65

Query: 757 -YVSNRDTNL-LLYEYMPNGSLGEML--HGAKGGHLKWETRYR-----IALEAAKGLCYL 807
            ++S+ D  + LL++Y  +  L  ++  H A   + K     R     +  +   G+ YL
Sbjct: 66  VFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL 124

Query: 808 HHDCSPLIIHRDVKSNNILLDSD----FEAHVADFGLAKFLQDAGASEC-MSSVAGSYGY 862
           H +    ++HRD+K  NIL+  +        +AD G A+           +  V  ++ Y
Sbjct: 125 HAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY 181

Query: 863 IAPEYAYTLKVDEKS-DVYSFGVVLLELIAGK 893
            APE     +   K+ D+++ G +  EL+  +
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 46.0 bits (109), Expect = 9e-05
 Identities = 27/77 (35%), Positives = 41/77 (53%), Gaps = 5/77 (6%)

Query: 766 LLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNI 825
           L+ EY+  G +  +LH    G+   E   +   E A  L YLH      IIHRD+K +N+
Sbjct: 81  LVMEYLIGGDVKSLLHIY--GYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNM 135

Query: 826 LLDSDFEAHVADFGLAK 842
           L+ ++    + DFGL+K
Sbjct: 136 LISNEGHIKLTDFGLSK 152

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 40.6 bits (96), Expect = 1e-04
 Identities = 24/61 (39%), Positives = 33/61 (54%), Gaps = 2/61 (3%)

Query: 242 QLQVLDMASCNISGEIPTSLSRLKLLHSLFLQMNKLTGHIPPQ-LSGLISLKSLDLSLNY 300
            L+ LD+++  ++     +   L  L  L L  N LT  I P+  SGL SL+SLDLS N 
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLT-SISPEAFSGLPSLRSLDLSGNN 59

Query: 301 L 301
           L
Sbjct: 60  L 60

Length = 60

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 45.2 bits (107), Expect = 1e-04
 Identities = 31/100 (31%), Positives = 50/100 (50%), Gaps = 4/100 (4%)

Query: 797 ALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSV 856
           + + A+G+ +L    S   IHRD+ + NILL  +    + DFGLA+ +            
Sbjct: 179 SFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 235

Query: 857 AGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKP 895
                ++APE  +      +SDV+SFGV+L E+ + G  P
Sbjct: 236 RLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASP 275

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 45.1 bits (106), Expect = 1e-04
 Identities = 53/212 (25%), Positives = 96/212 (45%), Gaps = 25/212 (11%)

Query: 700 IGKGGAGIVYRGSMPDGID---VAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLG 756
           +G+G  G VY+    DG D    A+K++ G G   +      EI  L  ++H N++ L  
Sbjct: 9   VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSA---CREIALLRELKHPNVIALQK 65

Query: 757 -YVSNRDTNL-LLYEYMPNGSLGEML--HGAKGGHLKWETRYR-----IALEAAKGLCYL 807
            ++S+ D  + LL++Y  +  L  ++  H A   + K     R     +  +   G+ YL
Sbjct: 66  VFLSHSDRKVWLLFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYL 124

Query: 808 HHDCSPLIIHRDVKSNNILLDSD----FEAHVADFGLAKFLQDAGASEC-MSSVAGSYGY 862
           H +    ++HRD+K  NIL+  +        +AD G A+           +  V  ++ Y
Sbjct: 125 HAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY 181

Query: 863 IAPEYAYTLKVDEKS-DVYSFGVVLLELIAGK 893
            APE     +   K+ D+++ G +  EL+  +
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 44.2 bits (105), Expect = 2e-04
 Identities = 50/193 (25%), Positives = 72/193 (37%), Gaps = 44/193 (22%)

Query: 737 LAEIQTLGRIRHRNIVRLLGYVSNRDTNL-LLYEYMPNGSLGEMLHGAKGGHLKWETRYR 795
           L E + L  + H  +  L       +T L L+ +Y P G L  +L    G  L  E    
Sbjct: 49  LTEQEILATLDHPFLPTLYA-SFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARF 107

Query: 796 IALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHV--ADFGLAKFLQDAG----- 848
            A E    L YLH      I++RD+K  NILL      H+  +DF L+K           
Sbjct: 108 YAAEVLLALEYLHLLG---IVYRDLKPENILLHES--GHIMLSDFDLSKQSDVEPPPVSK 162

Query: 849 ----------------------ASECMSSVAGSYGYIAPE----YAYTLKVDEKSDVYSF 882
                                  S   +S  G+  YIAPE      +   V    D ++ 
Sbjct: 163 ALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAV----DWWTL 218

Query: 883 GVVLLELIAGKKP 895
           G++L E++ G  P
Sbjct: 219 GILLYEMLYGTTP 231

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 39.1 bits (92), Expect = 4e-04
 Identities = 21/61 (34%), Positives = 33/61 (54%), Gaps = 2/61 (3%)

Query: 457 SLNQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESF-NLKMITSINISDNN 515
           +L  L ++NN +T     A   LP+L +L L  N L   I  E+F  L  + S+++S NN
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLT-SISPEAFSGLPSLRSLDLSGNN 59

Query: 516 I 516
           +
Sbjct: 60  L 60

Length = 60

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 42.1 bits (99), Expect = 0.001
 Identities = 43/155 (27%), Positives = 66/155 (42%), Gaps = 14/155 (9%)

Query: 699 IIGKGGAGIVYRG-SMPDGIDVAIKR-LVGRGTGGNDHGFLAEIQTLGRIRHRN-IVRLL 755
            IG+G  G VY+      G  VA+K+  +     G     L EI  L  +     IVRLL
Sbjct: 8   KIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLL 67

Query: 756 GYVSNRDTN-----LLLYEYMPNGSLGEM-LHGAKGGH-LKWETRYRIALEAAKGLCYLH 808
                 + N      L++EY+ +     M  +G   G  L  +T      +  KG+ + H
Sbjct: 68  DVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH 127

Query: 809 HDCSPLIIHRDVKSNNILLDSDFEA-HVADFGLAK 842
                 ++HRD+K  N+L+D       +AD GL +
Sbjct: 128 ---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR 159

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 37.1 bits (87), Expect = 0.002
 Identities = 26/60 (43%), Positives = 31/60 (51%)

Query: 290 SLKSLDLSLNYLTGEIPESFAALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNF 349
           +LKSLDLS N LT     +F  L NL +L L  NNL    P      P+L  L + GNN 
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 41.2 bits (97), Expect = 0.002
 Identities = 44/195 (22%), Positives = 68/195 (34%), Gaps = 70/195 (35%)

Query: 738 AEIQTLGRIRHRNIV----------------RLLGYVSNRDTNLLLYEYMPNGSLGEMLH 781
            EI T  +++H NI+                 L+ Y S  D   LL  + P G L E+  
Sbjct: 48  QEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCED---LLKTHFPEG-LPELA- 102

Query: 782 GAKGGHLKWETRYRIAL---EAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADF 838
                         IA    +    L Y+H       IHR VK+++ILL  D +  ++  
Sbjct: 103 --------------IAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGL 145

Query: 839 GLAKFLQDAGASECMSSVAGS------YGY----------IAPEYAYT--LKVDEKSDVY 880
                         +S +         + +          ++PE         +EKSD+Y
Sbjct: 146 -----------RYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIY 194

Query: 881 SFGVVLLELIAGKKP 895
           S G+   EL  G  P
Sbjct: 195 SVGITACELANGHVP 209

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain

 Score = 40.1 bits (94), Expect = 0.002
 Identities = 26/100 (26%), Positives = 37/100 (37%), Gaps = 18/100 (18%)

Query: 796 IALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSS 855
           + L+    L  LH         R  KS NILL   ++  +   G   F          S 
Sbjct: 22  VCLQCLGALRELH---------RQAKSGNILLT--WDGLLKLDGSVAFKTPE-----QSR 65

Query: 856 VAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
               +   APE        EK+D+YS G+ L E +  + P
Sbjct: 66  PDPYFM--APEVIQGQSYTEKADIYSLGITLYEALDYELP 103

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 41.2 bits (96), Expect = 0.002
 Identities = 26/93 (27%), Positives = 46/93 (49%), Gaps = 3/93 (3%)

Query: 799 EAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAG 858
           + A+G+ +L    S   +HRD+ + N+LL       + DFGLA+ +          S   
Sbjct: 245 QVARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFL 301

Query: 859 SYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA 891
              ++APE  +       SDV+S+G++L E+ +
Sbjct: 302 PVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 40.8 bits (95), Expect = 0.003
 Identities = 37/176 (21%), Positives = 75/176 (42%), Gaps = 23/176 (13%)

Query: 797 ALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSV 856
           + + A G+ +L    S   +HRD+ + N+L+       + DFGLA+ +          S 
Sbjct: 245 SYQVANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGST 301

Query: 857 AGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSE 915
                ++APE  +       SDV+SFG++L E+   G  P  E          +++    
Sbjct: 302 FLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGY-R 360

Query: 916 VSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLAN 971
           +++P+ A+                    ++++   C E++   RP   ++VH++ +
Sbjct: 361 MAKPAHASD------------------EIYEIMQKCWEEKFEIRPDFSQLVHLVGD 398

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 38.5 bits (90), Expect = 0.004
 Identities = 28/147 (19%), Positives = 56/147 (38%), Gaps = 15/147 (10%)

Query: 699 IIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIV--RLLG 756
           ++  G    VY   +    +  + ++      G D      I  L  +  + +   ++L 
Sbjct: 5   LLKGGLTNRVYL--LGTKDEDYVLKINPSREKGADREREVAILQL--LARKGLPVPKVLA 60

Query: 757 YVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLII 816
              +   + LL E++   +L E+           E +  IA + A+ L  LH     ++ 
Sbjct: 61  SGESDGWSYLLMEWIEGETLDEVSE---------EEKEDIAEQLAELLAKLHQLPLLVLC 111

Query: 817 HRDVKSNNILLDSDFEAHVADFGLAKF 843
           H D+   NIL+D      + D+  A +
Sbjct: 112 HGDLHPGNILVDDGKILGIIDWEYAGY 138

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	982
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0472	565	consensus Leucine-rich repeat protein [Function un	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0472	565	consensus Leucine-rich repeat protein [Function un	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.98
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.98
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	99.98
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	99.98
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.98
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.98
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.98
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.98
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.98
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.98
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.98
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.97
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.97
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.97
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.97
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.97
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.97
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.97
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.97
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.97
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.97
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.97
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.97
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.97
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.97
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.97
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.97
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.97
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.97
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.97
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.97
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.96
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.96
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.96
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.96
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.96
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.96
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.96
KOG1152	772	consensus Signal transduction serine/threonine kin	99.95
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.95
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.94
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.94
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.94
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.94
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.93
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.93
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.93
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.93
KOG4237	498	consensus Extracellular matrix protein slit, conta	99.92
KOG4237	498	consensus Extracellular matrix protein slit, conta	99.92
PLN03210	1153	Resistant to P. syringae 6; Provisional	99.91
PLN03210	1153	Resistant to P. syringae 6; Provisional	99.91
PLN00181	793	protein SPA1-RELATED; Provisional	99.9
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.9
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	99.89
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	99.89
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.88
PRK09188	365	serine/threonine protein kinase; Provisional	99.87
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.85
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.85
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	99.84
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.84
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.84
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	99.84
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.82
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.8
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.8
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.79
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.78
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.78
PRK12274	218	serine/threonine protein kinase; Provisional	99.78
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.77
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.77
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	99.76
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	99.76
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.75
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.74
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.73
PRK10345	210	hypothetical protein; Provisional	99.71
smart00090	237	RIO RIO-like kinase.	99.66
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.65
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.65
PRK14879	211	serine/threonine protein kinase; Provisional	99.65
PLN03150	623	hypothetical protein; Provisional	99.63
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.63
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.63
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.6
PLN03150	623	hypothetical protein; Provisional	99.54
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.53
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.53
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.53
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.5
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	99.47
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	99.41
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.39
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	99.32
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	99.31
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.3
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.27
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.26
KOG1909	382	consensus Ran GTPase-activating protein [RNA proce	99.22
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.21
KOG3207	505	consensus Beta-tubulin folding cofactor E [Posttra	99.17
KOG1243	690	consensus Protein kinase [General function predict	99.17
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	99.14
KOG3207	505	consensus Beta-tubulin folding cofactor E [Posttra	99.13
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.12
KOG4658	889	consensus Apoptotic ATPase [Signal transduction me	99.11
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.1
KOG3087	229	consensus Serine/threonine protein kinase [General	99.1
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	99.08
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.07
KOG1909	382	consensus Ran GTPase-activating protein [RNA proce	99.07
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	99.07
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.06
COG4248	637	Uncharacterized protein with protein kinase and he	99.05
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	99.02
KOG0531	414	consensus Protein phosphatase 1, regulatory subuni	98.97
PF08263	43	LRRNT_2: Leucine rich repeat N-terminal domain; In	98.97
KOG0531	414	consensus Protein phosphatase 1, regulatory subuni	98.97
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.95
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.88
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.81
KOG4658	889	consensus Apoptotic ATPase [Signal transduction me	98.81
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.79
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.76
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.74
KOG1859	1096	consensus Leucine-rich repeat proteins [General fu	98.69
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.67
KOG4579	177	consensus Leucine-rich repeat (LRR) protein associ	98.64
PRK09902	216	hypothetical protein; Provisional	98.62
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.59
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.52
KOG2982	418	consensus Uncharacterized conserved protein [Funct	98.45
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.38

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=1.5e-117  Score=1129.23  Aligned_cols=916  Identities=36%  Similarity=0.635  Sum_probs=788.7

Q ss_pred             hhcC-chhHHHHHHHHHhcccCCCCCCCCCCCCCCCCCCCCccceeeeCCCCCEEEEEeccCCccccCCcCccccccccE
Q 002010           21 SLSC-AYSDMDVLLKLKSSMIGPKGSGLKNWEPSSSPSAHCSFSGVTCDQDSRVVSLNVSFMPLFGSIPPEIGLLTKLVN   99 (982)
Q Consensus        21 ~~~~-~~~~~~~ll~~k~~~~~~~~~~~~~w~~~~~~~~~C~w~gv~C~~~~~v~~l~l~~~~l~g~~~~~i~~l~~L~~   99 (982)
                      ..+| .++|++||++||+++.+|. ..+++|..   ..+||.|.||+|++.++|+.++++++.+.|.+|+.+..+++|+.
T Consensus        22 ~~~~~~~~~~~~l~~~~~~~~~~~-~~~~~w~~---~~~~c~w~gv~c~~~~~v~~L~L~~~~i~~~~~~~~~~l~~L~~   97 (968)
T PLN00113         22 NFSMLHAEELELLLSFKSSINDPL-KYLSNWNS---SADVCLWQGITCNNSSRVVSIDLSGKNISGKISSAIFRLPYIQT   97 (968)
T ss_pred             HccCCCHHHHHHHHHHHHhCCCCc-ccCCCCCC---CCCCCcCcceecCCCCcEEEEEecCCCccccCChHHhCCCCCCE
Confidence            3344 6789999999999997554 46899964   35799999999998889999999999999999999999999999


Q ss_pred             EEeccCCCCCCCChhhh-hhcccceeeccCCccccccchhhhhcCCCccEEeccCccccCCCchhccccccccEEeecCc
Q 002010          100 LTISNVNLTGRLPSEMA-LLTSLKVFNISGNVFQGNFAGQIVRGMTELQVLDAYNNNFTGPLPVEIASLKSLRHLSFGGN  178 (982)
Q Consensus       100 L~l~~n~l~~~~p~~l~-~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N  178 (982)
                      |+|++|+++|.+|..+. .+++|++|+|++|.+.+.+|.   ..+++|++|+|++|.+++.+|..++++++|++|+|++|
T Consensus        98 L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~---~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n  174 (968)
T PLN00113         98 INLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR---GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGN  174 (968)
T ss_pred             EECCCCccCCcCChHHhccCCCCCEEECcCCccccccCc---cccCCCCEEECcCCcccccCChHHhcCCCCCEEECccC
Confidence            99999999999998866 999999999999999988775   46899999999999999999999999999999999999


Q ss_pred             ccccccCCCccccCcceEeeccCcccccchhhHHhhhhhHHHHhhcccccccccCCCCCCCCCCCCEEecccCcCcccCc
Q 002010          179 YFTGKIPQSYSEIQSLEYIGLNGIGLNGTVPAFLSRLKNLREMYIGYFNTYTGGIPPGFGALTQLQVLDMASCNISGEIP  258 (982)
Q Consensus       179 ~l~~~~p~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~l~~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~  258 (982)
                      .+++.+|..++++++|++|++++|.+.+.+|..++++++|++|+++. |.+.+.+|..++++++|++|++++|++++.+|
T Consensus       175 ~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~-n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p  253 (968)
T PLN00113        175 VLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGY-NNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIP  253 (968)
T ss_pred             cccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcC-CccCCcCChhHhcCCCCCEEECcCceeccccC
Confidence            99999999999999999999999999999999999999999999986 66788999999999999999999999999999


Q ss_pred             hhhcCCCccceeecccccCCCCCCccccCCCCCCEEEeeCCcccCcCchhhhcccchhhhhhccCCCCCCCCCcCCCCCC
Q 002010          259 TSLSRLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQLFKNNLRGPIPSFLGDFPN  338 (982)
Q Consensus       259 ~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~  338 (982)
                      ..++++++|++|++++|++++.+|..+.++++|++|+|++|.+++.+|..+..+++|+.|++++|.+.+.+|..++.+++
T Consensus       254 ~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~  333 (968)
T PLN00113        254 SSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPR  333 (968)
T ss_pred             hhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCChhHhcCCC
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ccEEEccCCCcccccCccccCCCcccEEEeccccccccCCccccCccccceeecccccccccCCccccCCCCCCEEEccC
Q 002010          339 LEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSK  418 (982)
Q Consensus       339 L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~l~~N~~~~~~~~~l~~l~~L~~L~Ls~  418 (982)
                      |+.|++++|.+++.+|..++.+.+|+.|++++|++++.+|..++.+++|+.|++++|.+.+.+|..++.+++|+.|++++
T Consensus       334 L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~  413 (968)
T PLN00113        334 LQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQD  413 (968)
T ss_pred             CCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcC
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CccCCCCCccccCCCccccccCCCccccccCCccccc-CCccEEEeeccccCCCCchhccCCCCcceeeeccccccCCCc
Q 002010          419 NYLNGTIPAGLFNLPLLNMMELDDNLLSGELPEKMSG-ASLNQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIP  497 (982)
Q Consensus       419 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~-~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p  497 (982)
                      |++++.+|..+..++.|+.|++++|.+++.++..+.. ++|+.|++++|++.+.+|..+ ..++|+.|++++|++++.+|
T Consensus       414 n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~-~~~~L~~L~ls~n~l~~~~~  492 (968)
T PLN00113        414 NSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSF-GSKRLENLDLSRNQFSGAVP  492 (968)
T ss_pred             CEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCccc-ccccceEEECcCCccCCccC
Confidence            9999999999999999999999999999988876544 789999999999999988876 46899999999999999999


Q ss_pred             cccccccccceeeeeccccCCCCCcccccccCCCeeeCCCCcccCCCCcccccccccceEEcccccccccCccccccccc
Q 002010          498 VESFNLKMITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYGKIPPGISKLIDLSILNLSRNGITGSIPNEMRNMMS  577 (982)
Q Consensus       498 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~  577 (982)
                      ..+..+++|++|+|++|++++.+|..+..+++|++|+|++|.++|.+|..|.++++|+.|+|++|+++|.+|..+..+++
T Consensus       493 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~  572 (968)
T PLN00113        493 RKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVES  572 (968)
T ss_pred             hhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cceecccCCccccCCCCCccccccccccccCCcCcccCCC----CCCccCCCCCCCCCCCCCCCCCCceeehhhHHHHHH
Q 002010          578 LTTLDLSYNNLIGNIPSGGQFLAFNETSFIGNPNLCLLRN----GTCQSLINSAKHSGDGYGSSFGASKIVITVIALLTF  653 (982)
Q Consensus       578 L~~L~Ls~N~l~~~ip~~~~~~~~~~~~~~~n~~~c~~~~----~~c~~~~~~~~~s~~~~~~~~~~~~ii~~~~~~~~~  653 (982)
                      |+.|++++|+++|.+|..++|.++.+.+|.|||.+|+.+.    ++|...           .++.....+++++++++++
T Consensus       573 L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~-----------~~~~~~~~~~~~~~~~~~~  641 (968)
T PLN00113        573 LVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRV-----------RKTPSWWFYITCTLGAFLV  641 (968)
T ss_pred             cCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCccc-----------cccceeeeehhHHHHHHHH
Confidence            9999999999999999999999999999999999998652    244211           0111122223333333333


Q ss_pred             HHHHHHHhhhhhhhhhccchh-------hhhccccc---ccccHHHHHhhcccccccccccceEEEEEEe-CCCcEEEEE
Q 002010          654 MLLVILTIYQLRKRRLQKSKA-------WKLTAFQR---LDFKAEDVLESLKDENIIGKGGAGIVYRGSM-PDGIDVAIK  722 (982)
Q Consensus       654 ~~l~~l~~~~~r~~~~~~~~~-------~~~~~~~~---~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK  722 (982)
                      ++++++.++.+|+++..+.+.       |....+..   ..+..++....++..+.||+|+||.||+|.. .+++.||||
T Consensus       642 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK  721 (968)
T PLN00113        642 LALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVK  721 (968)
T ss_pred             HHHHHHHHHHHHhhhcccccccccccccccccccccccchhhhHHHHHhhCCcccEEccCCCeeEEEEEECCCCcEEEEE
Confidence            333333334333332211111       11111111   1234556667788889999999999999975 578999999


Q ss_pred             EeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHH
Q 002010          723 RLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAK  802 (982)
Q Consensus       723 ~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~  802 (982)
                      ++.....     ...+|++++++++|||||+++|++.+++..++||||+++|+|.++++     .++|.++.+++.|+++
T Consensus       722 ~~~~~~~-----~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~-----~l~~~~~~~i~~~ia~  791 (968)
T PLN00113        722 EINDVNS-----IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR-----NLSWERRRKIAIGIAK  791 (968)
T ss_pred             EccCCcc-----ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHh-----cCCHHHHHHHHHHHHH
Confidence            8843221     12356889999999999999999999999999999999999999995     3889999999999999


Q ss_pred             HHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCcccccccccccccccccccccCCCCcchhhHHH
Q 002010          803 GLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSF  882 (982)
Q Consensus       803 ~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvwsl  882 (982)
                      |++|||...+++|+||||||+||+++.++..++. ||.+.....      .....+++.|+|||++.+..++.++|||||
T Consensus       792 ~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~  864 (968)
T PLN00113        792 ALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT------DTKCFISSAYVAPETRETKDITEKSDIYGF  864 (968)
T ss_pred             HHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc------CCCccccccccCcccccCCCCCcccchhhH
Confidence            9999996544559999999999999999888875 665443221      122367899999999999999999999999


Q ss_pred             HHHHHHHHhCCCCCCCC-CCCchHHHHHHHhccCCCCCCcccccceeecCCCC---CCChHhHHHHHHHHhhccCCCCCC
Q 002010          883 GVVLLELIAGKKPVGEF-GDGVDIVRWVRKTTSEVSQPSDAASVLAVVDPRLS---GYPLTGVIHLFKVAMMCVEDESSA  958 (982)
Q Consensus       883 G~il~elltg~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~  958 (982)
                      ||++|||+||+.||... .......+|.+.....       ......+|+...   ..+.....++.+++.+||+.||++
T Consensus       865 Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~  937 (968)
T PLN00113        865 GLILIELLTGKSPADAEFGVHGSIVEWARYCYSD-------CHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTA  937 (968)
T ss_pred             HHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCc-------cchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchh
Confidence            99999999999999642 2234455555443221       112234455443   234566678899999999999999


Q ss_pred             CCCHHHHHHHhcCCCCCCCCCC
Q 002010          959 RPTMREVVHMLANPPQSAPSLI  980 (982)
Q Consensus       959 Rpt~~ell~~L~~~~~~~~~~~  980 (982)
                      ||||+|+++.|+++.+..++..
T Consensus       938 RPt~~evl~~L~~~~~~~~~~~  959 (968)
T PLN00113        938 RPCANDVLKTLESASRSSSSCV  959 (968)
T ss_pred             CcCHHHHHHHHHHhhccccccc
Confidence            9999999999999887665543

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=1.9e-62  Score=624.02  Aligned_cols=518  Identities=34%  Similarity=0.528  Sum_probs=492.7

Q ss_pred             ccccEEEeccCCCCCCCChhhhhhcccceeeccCCccccccchhhhhcCCCccEEeccCccccCCCchhccccccccEEe
Q 002010           95 TKLVNLTISNVNLTGRLPSEMALLTSLKVFNISGNVFQGNFAGQIVRGMTELQVLDAYNNNFTGPLPVEIASLKSLRHLS  174 (982)
Q Consensus        95 ~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~  174 (982)
                      .+++.|+|++|+++|.+|..+..+++|++|+|++|.+.+.+|..++.++++|++|+|++|++++.+|.  +.+++|++|+
T Consensus        69 ~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~  146 (968)
T PLN00113         69 SRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLD  146 (968)
T ss_pred             CcEEEEEecCCCccccCChHHhCCCCCCEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEE
Confidence            46899999999999999999999999999999999999999999988999999999999999998885  5789999999


Q ss_pred             ecCcccccccCCCccccCcceEeeccCcccccchhhHHhhhhhHHHHhhcccccccccCCCCCCCCCCCCEEecccCcCc
Q 002010          175 FGGNYFTGKIPQSYSEIQSLEYIGLNGIGLNGTVPAFLSRLKNLREMYIGYFNTYTGGIPPGFGALTQLQVLDMASCNIS  254 (982)
Q Consensus       175 L~~N~l~~~~p~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~l~~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~  254 (982)
                      |++|.+++.+|..++++++|++|++++|.+.+.+|..+.++++|++|++++ |.+.+.+|..++++++|++|+|++|+++
T Consensus       147 Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~-n~l~~~~p~~l~~l~~L~~L~L~~n~l~  225 (968)
T PLN00113        147 LSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLAS-NQLVGQIPRELGQMKSLKWIYLGYNNLS  225 (968)
T ss_pred             CcCCcccccCChHHhcCCCCCEEECccCcccccCChhhhhCcCCCeeeccC-CCCcCcCChHHcCcCCccEEECcCCccC
Confidence            999999999999999999999999999999999999999999999999986 5678889999999999999999999999


Q ss_pred             ccCchhhcCCCccceeecccccCCCCCCccccCCCCCCEEEeeCCcccCcCchhhhcccchhhhhhccCCCCCCCCCcCC
Q 002010          255 GEIPTSLSRLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQLFKNNLRGPIPSFLG  334 (982)
Q Consensus       255 ~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~  334 (982)
                      +.+|..++++++|++|++++|++++.+|..++++++|++|+|++|.+++.+|..+..+++|+.|++++|.+.+.+|..+.
T Consensus       226 ~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~  305 (968)
T PLN00113        226 GEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVI  305 (968)
T ss_pred             CcCChhHhcCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCccEEEccCCCcccccCccccCCCcccEEEeccccccccCCccccCccccceeecccccccccCCccccCCCCCCEE
Q 002010          335 DFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFIGPIPEELGQCKSLTKI  414 (982)
Q Consensus       335 ~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~l~~N~~~~~~~~~l~~l~~L~~L  414 (982)
                      .+++|+.|++++|.+++..|..+..+++|+.|++++|.+++.+|..+..+.+|+.|++++|.+.+.+|..+..+++|+.|
T Consensus       306 ~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L  385 (968)
T PLN00113        306 QLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKL  385 (968)
T ss_pred             CCCCCcEEECCCCccCCcCChhHhcCCCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEE
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             EccCCccCCCCCccccCCCccccccCCCccccccCCccccc-CCccEEEeeccccCCCCchhccCCCCcceeeecccccc
Q 002010          415 RFSKNYLNGTIPAGLFNLPLLNMMELDDNLLSGELPEKMSG-ASLNQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLE  493 (982)
Q Consensus       415 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~-~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~  493 (982)
                      ++++|++.+.+|..+..+++|+.|++++|++++.+|..+.. +.|+.|++++|++++.+|..+..+++|+.|++++|++.
T Consensus       386 ~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~  465 (968)
T PLN00113        386 ILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFF  465 (968)
T ss_pred             ECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceee
Confidence            99999999999999999999999999999999998887765 78999999999999999999999999999999999999


Q ss_pred             CCCccccccccccceeeeeccccCCCCCcccccccCCCeeeCCCCcccCCCCcccccccccceEEcccccccccCccccc
Q 002010          494 GEIPVESFNLKMITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYGKIPPGISKLIDLSILNLSRNGITGSIPNEMR  573 (982)
Q Consensus       494 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~  573 (982)
                      +.+|..+ ..++|+.|++++|++++.+|..+..+++|+.|+|++|++++.+|..+.++++|++|+|++|++++.+|..+.
T Consensus       466 ~~~p~~~-~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~  544 (968)
T PLN00113        466 GGLPDSF-GSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFS  544 (968)
T ss_pred             eecCccc-ccccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHh
Confidence            8888765 568999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cccccceecccCCccccCCCCC-ccccccccccccCCcCcccCC
Q 002010          574 NMMSLTTLDLSYNNLIGNIPSG-GQFLAFNETSFIGNPNLCLLR  616 (982)
Q Consensus       574 ~l~~L~~L~Ls~N~l~~~ip~~-~~~~~~~~~~~~~n~~~c~~~  616 (982)
                      .+++|+.|||++|+++|.+|.. ..+..+....+.+|+..+..|
T Consensus       545 ~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p  588 (968)
T PLN00113        545 EMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLP  588 (968)
T ss_pred             CcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCC
Confidence            9999999999999999999974 335567777888998776444

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-46  Score=386.66  Aligned_cols=251  Identities=27%  Similarity=0.429  Sum_probs=215.0

Q ss_pred             hhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCc-cEEEEe
Q 002010          692 ESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDT-NLLLYE  769 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~lv~e  769 (982)
                      .+++..+.||+|..|+|||+++ ++++.+|+|++.........+++.+|++++++++||+||++||+|..+.. ..++||
T Consensus        79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mE  158 (364)
T KOG0581|consen   79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICME  158 (364)
T ss_pred             HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehh
Confidence            4566778899999999999965 56889999999666666677889999999999999999999999999884 999999


Q ss_pred             ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccC
Q 002010          770 YMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHH-DCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAG  848 (982)
Q Consensus       770 ~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  848 (982)
                      ||++|+|++++.  +.+++++....+++.++++||.|||+ ++   ||||||||+|||++..|+|||||||.+..+.+. 
T Consensus       159 YMDgGSLd~~~k--~~g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS-  232 (364)
T KOG0581|consen  159 YMDGGSLDDILK--RVGRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS-  232 (364)
T ss_pred             hcCCCCHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHhhhh-
Confidence            999999999997  34789999999999999999999996 66   999999999999999999999999999987643 


Q ss_pred             CcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCC-CCCchHHHHHHHhccCCCCCCcccccce
Q 002010          849 ASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEF-GDGVDIVRWVRKTTSEVSQPSDAASVLA  927 (982)
Q Consensus       849 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~  927 (982)
                         ...+.+||..|||||.+.+..|+.++||||||+.++|+.+|+.||... .........+...               
T Consensus       233 ---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~I---------------  294 (364)
T KOG0581|consen  233 ---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAI---------------  294 (364)
T ss_pred             ---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHH---------------
Confidence               456789999999999999999999999999999999999999999764 2223333333322               


Q ss_pred             eecCCCCCCChH-hHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          928 VVDPRLSGYPLT-GVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       928 ~~~~~~~~~~~~-~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                       .+..-+..|.+ ...++.+|+..|+++||.+|||+.|+++
T Consensus       295 -v~~ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~  334 (364)
T KOG0581|consen  295 -VDEPPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQ  334 (364)
T ss_pred             -hcCCCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence             22222334443 6678999999999999999999999986

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-44  Score=398.00  Aligned_cols=279  Identities=48%  Similarity=0.840  Sum_probs=237.8

Q ss_pred             HHHHHhhcccccccccccceEEEEEEeCCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCC-ccE
Q 002010          687 AEDVLESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRD-TNL  765 (982)
Q Consensus       687 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~  765 (982)
                      ....++.|...+.||+|+||.||+|...+|..||||++....... ..+|.+|+.++.+++|||+|+++|||.+.+ ..+
T Consensus        70 l~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~-~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~  148 (361)
T KOG1187|consen   70 LRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG-EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRL  148 (361)
T ss_pred             HHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc-hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEE
Confidence            556678999999999999999999999899999999885544433 566999999999999999999999999988 499


Q ss_pred             EEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhcc
Q 002010          766 LLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQ  845 (982)
Q Consensus       766 lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~  845 (982)
                      +|||||++|+|.++++......++|..|.+|+.++|+||+|||+...++||||||||+|||+|+++++||+|||+|+...
T Consensus       149 LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~  228 (361)
T KOG1187|consen  149 LVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGP  228 (361)
T ss_pred             EEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCC
Confidence            99999999999999986544389999999999999999999999888899999999999999999999999999996544


Q ss_pred             ccCCccccccc-ccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCC--CCCchHHHHHHHhccCCCCCCcc
Q 002010          846 DAGASECMSSV-AGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEF--GDGVDIVRWVRKTTSEVSQPSDA  922 (982)
Q Consensus       846 ~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~--~~~~~~~~~~~~~~~~~~~~~~~  922 (982)
                      ..  ....... .||.+|+|||+...+..+.|+|||||||++.|++||+.|.+..  ........|......       .
T Consensus       229 ~~--~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~-------~  299 (361)
T KOG1187|consen  229 EG--DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLE-------E  299 (361)
T ss_pred             cc--ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHH-------C
Confidence            21  1112222 8999999999999999999999999999999999999988753  234447777755544       2


Q ss_pred             cccceeecCCCC--CCCh-HhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCCC
Q 002010          923 ASVLAVVDPRLS--GYPL-TGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQS  975 (982)
Q Consensus       923 ~~~~~~~~~~~~--~~~~-~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~~~  975 (982)
                      ..+.+++||++.  .++. .....+.++..+|++.+|.+||+|.||++.|+.+...
T Consensus       300 ~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~  355 (361)
T KOG1187|consen  300 GKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL  355 (361)
T ss_pred             cchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence            267789999985  4454 5778899999999999999999999999999766543

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=9.2e-45  Score=395.72  Aligned_cols=259  Identities=36%  Similarity=0.529  Sum_probs=216.4

Q ss_pred             hcccccccccccceEEEEEEeCCCcEEEEEEeccCCC-CCchhhHHHHHHHHhcCCCCcccceEeEEEcCC-ccEEEEec
Q 002010          693 SLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGT-GGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRD-TNLLLYEY  770 (982)
Q Consensus       693 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e~  770 (982)
                      .+...+.+|+|+||+||+|.+.....||||++..... ....+.|.+|+.++.+++|||||+++|++.+.. ..++||||
T Consensus        42 ~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy  121 (362)
T KOG0192|consen   42 ELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEY  121 (362)
T ss_pred             HhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEe
Confidence            4455566999999999999994444499999854432 222668999999999999999999999999887 79999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCC-CEEEeccccchhccccCC
Q 002010          771 MPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDF-EAHVADFGLAKFLQDAGA  849 (982)
Q Consensus       771 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~-~~kl~DfG~a~~~~~~~~  849 (982)
                      +++|+|.++++..+...+++..+.+++.|||+||.|||+++.  ||||||||+|||++.++ ++||+|||+++...... 
T Consensus       122 ~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~-  198 (362)
T KOG0192|consen  122 MPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK-  198 (362)
T ss_pred             CCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc-
Confidence            999999999986557899999999999999999999998753  99999999999999997 99999999998765321 


Q ss_pred             cccccccccccccccccccc--cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccce
Q 002010          850 SECMSSVAGSYGYIAPEYAY--TLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLA  927 (982)
Q Consensus       850 ~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  927 (982)
                       ..++...||+.|||||++.  ...|+.|+||||||+++|||+||+.||..... ......+.....             
T Consensus       199 -~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-~~~~~~v~~~~~-------------  263 (362)
T KOG0192|consen  199 -TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-VQVASAVVVGGL-------------  263 (362)
T ss_pred             -ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-HHHHHHHHhcCC-------------
Confidence             3445578999999999999  66999999999999999999999999998765 333333332222             


Q ss_pred             eecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCC
Q 002010          928 VVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQ  974 (982)
Q Consensus       928 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~~  974 (982)
                           .+..+..++..+..+|.+||+.||++||++.|++..|+.+..
T Consensus       264 -----Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~  305 (362)
T KOG0192|consen  264 -----RPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMS  305 (362)
T ss_pred             -----CCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHH
Confidence                 223344466789999999999999999999999999986544

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-44  Score=390.77  Aligned_cols=258  Identities=29%  Similarity=0.473  Sum_probs=220.8

Q ss_pred             hhcccccccccccceEEEEEEeCCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEecc
Q 002010          692 ESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYM  771 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  771 (982)
                      +.++..+.||+|.||.||.|.+....+||+|.++..  ......|.+|+.+|++++|++||+++++|..++..+||||||
T Consensus       206 ~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~--~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m  283 (468)
T KOG0197|consen  206 EELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG--SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYM  283 (468)
T ss_pred             HHHHHHHHhcCCccceEEEEEEcCCCcccceEEecc--ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEec
Confidence            456667789999999999999977779999998554  344567899999999999999999999999988999999999


Q ss_pred             CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCcc
Q 002010          772 PNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASE  851 (982)
Q Consensus       772 ~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~  851 (982)
                      +.|+|.++++......+...+.+.++.|||+||+||++++   +|||||.++||||+++..+||+|||+|+...++ .+.
T Consensus       284 ~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~-~Y~  359 (468)
T KOG0197|consen  284 PKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDD-EYT  359 (468)
T ss_pred             ccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCC-cee
Confidence            9999999999767788999999999999999999999998   999999999999999999999999999955433 344


Q ss_pred             cccccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceeec
Q 002010          852 CMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVD  930 (982)
Q Consensus       852 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  930 (982)
                      ......-+..|.|||++....++.|||||||||+||||+| |+.||......+ ..+.+....+ .              
T Consensus       360 ~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~e-v~~~le~GyR-l--------------  423 (468)
T KOG0197|consen  360 ASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEE-VLELLERGYR-L--------------  423 (468)
T ss_pred             ecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHH-HHHHHhccCc-C--------------
Confidence            4444556789999999999999999999999999999999 999998765433 2333322221 1              


Q ss_pred             CCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCCC
Q 002010          931 PRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQS  975 (982)
Q Consensus       931 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~~~  975 (982)
                          ..|..||..++++|..||+.+|++|||++.+...|+.+...
T Consensus       424 ----p~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~  464 (468)
T KOG0197|consen  424 ----PRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS  464 (468)
T ss_pred             ----CCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence                24556778999999999999999999999999999887653

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8.6e-45  Score=374.98  Aligned_cols=254  Identities=26%  Similarity=0.354  Sum_probs=210.3

Q ss_pred             HHhhcccccccccccceEEEEE-EeCCCcEEEEEEeccCCCCC------chhhHHHHHHHHhcCCCCcccceEeEEEcCC
Q 002010          690 VLESLKDENIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGG------NDHGFLAEIQTLGRIRHRNIVRLLGYVSNRD  762 (982)
Q Consensus       690 ~~~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  762 (982)
                      +.+.|.+.+.+|+|+||.|-+| ..++|+.||||.+.+.....      ....+.+|+++|++++|||||+++++|..++
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d  249 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD  249 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence            5567889999999999999999 55789999999996654332      2334679999999999999999999999999


Q ss_pred             ccEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCC---CCEEEeccc
Q 002010          763 TNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSD---FEAHVADFG  839 (982)
Q Consensus       763 ~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~---~~~kl~DfG  839 (982)
                      ..|+||||++||+|.+.+-  .++.+.+.....+++|++.|+.|||++|   |+||||||+|||++.+   ..+||+|||
T Consensus       250 s~YmVlE~v~GGeLfd~vv--~nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDFG  324 (475)
T KOG0615|consen  250 SSYMVLEYVEGGELFDKVV--ANKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDFG  324 (475)
T ss_pred             ceEEEEEEecCccHHHHHH--hccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecccc
Confidence            9999999999999999997  5567888888999999999999999999   9999999999999766   779999999


Q ss_pred             cchhccccCCcccccccccccccccccccccCCC---CcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCC
Q 002010          840 LAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKV---DEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEV  916 (982)
Q Consensus       840 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  916 (982)
                      +|+...   ....+...+||+.|.|||++.+..+   ..++|+||+||++|-+++|.+||.+...+....+.+.......
T Consensus       325 lAK~~g---~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f  401 (475)
T KOG0615|consen  325 LAKVSG---EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAF  401 (475)
T ss_pred             hhhccc---cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccc
Confidence            999865   3456788999999999999987653   3478999999999999999999987544443333333222211


Q ss_pred             CCCCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          917 SQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       917 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                      -.                ........+..++|.+||..||++|||++|+++
T Consensus       402 ~p----------------~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~  436 (475)
T KOG0615|consen  402 GP----------------LQWDRISEEALDLINWMLVVDPENRPSADEALN  436 (475)
T ss_pred             cC----------------hhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence            11                112234567889999999999999999999886

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.8e-44  Score=389.86  Aligned_cols=248  Identities=26%  Similarity=0.370  Sum_probs=214.7

Q ss_pred             hhcccccccccccceEEEEEEe-CCCcEEEEEEeccCC--CCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEE
Q 002010          692 ESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRG--TGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLY  768 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  768 (982)
                      ..|+.+++||+|||+.||+++. .+|+.||+|++.+..  .....+.+.+|+++.++++|||||+++++|++.+..|+|.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            4699999999999999999976 789999999996542  3455667889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccC
Q 002010          769 EYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAG  848 (982)
Q Consensus       769 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  848 (982)
                      |.|+.++|.++++  +.+.+++.+++.+++||+.|+.|||+.+   |+|||||..|++++++.+|||+|||+|..+..+ 
T Consensus        98 ELC~~~sL~el~K--rrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~-  171 (592)
T KOG0575|consen   98 ELCHRGSLMELLK--RRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD-  171 (592)
T ss_pred             EecCCccHHHHHH--hcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCc-
Confidence            9999999999998  6679999999999999999999999998   999999999999999999999999999988743 


Q ss_pred             CcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCccccccee
Q 002010          849 ASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAV  928 (982)
Q Consensus       849 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  928 (982)
                       .....+.+|||.|.|||++.+..++..+||||+||++|.|+.|++||+...-.+.+.++......              
T Consensus       172 -~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~--------------  236 (592)
T KOG0575|consen  172 -GERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYS--------------  236 (592)
T ss_pred             -ccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcc--------------
Confidence             24456789999999999999999999999999999999999999999764333332222221111              


Q ss_pred             ecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          929 VDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       929 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                             +|..-..+..+||.++|++||.+|||+++|+.
T Consensus       237 -------~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~  268 (592)
T KOG0575|consen  237 -------MPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD  268 (592)
T ss_pred             -------cccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                   22233346789999999999999999999987

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-44  Score=370.08  Aligned_cols=205  Identities=33%  Similarity=0.529  Sum_probs=182.4

Q ss_pred             HhhcccccccccccceEEEEEEe-CCCcEEEEEEeccCC-CCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEE
Q 002010          691 LESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRG-TGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLY  768 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  768 (982)
                      ..+|...+.||+|+||+||+|++ +++.+||||.+.... ..+..+....|+.+++.++|||||++++++..++..|+||
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM   88 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM   88 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence            45688888899999999999965 568999999996554 3445556789999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCC------CCEEEeccccch
Q 002010          769 EYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSD------FEAHVADFGLAK  842 (982)
Q Consensus       769 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~------~~~kl~DfG~a~  842 (982)
                      |||.||+|.+|++  +.+.+++..+..++.|||.|+++||+++   ||||||||+|||++..      ..+||+|||+|+
T Consensus        89 EyC~gGDLs~yi~--~~~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR  163 (429)
T KOG0595|consen   89 EYCNGGDLSDYIR--RRGRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR  163 (429)
T ss_pred             EeCCCCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence            9999999999998  4568999999999999999999999998   9999999999999765      568999999999


Q ss_pred             hccccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCc
Q 002010          843 FLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGV  903 (982)
Q Consensus       843 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~  903 (982)
                      .+...   ......+|++.|||||++...+|+.|+|+||+|+|+|||++|++||......+
T Consensus       164 ~L~~~---~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~e  221 (429)
T KOG0595|consen  164 FLQPG---SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKE  221 (429)
T ss_pred             hCCch---hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHH
Confidence            98743   33456899999999999999999999999999999999999999998754433

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=1.8e-43  Score=399.73  Aligned_cols=265  Identities=27%  Similarity=0.425  Sum_probs=229.2

Q ss_pred             hcccccccccccceEEEEEEeC------CCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEE
Q 002010          693 SLKDENIIGKGGAGIVYRGSMP------DGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLL  766 (982)
Q Consensus       693 ~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  766 (982)
                      +.+..+.||+|+||+||+|+..      +...||||.+++..+....++|.+|++.+..++|||||+++|.|.+++.+++
T Consensus       487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~M  566 (774)
T KOG1026|consen  487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCM  566 (774)
T ss_pred             heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEE
Confidence            4555678999999999999653      3456999999887777788999999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHhhcCC--------C----CCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEE
Q 002010          767 LYEYMPNGSLGEMLHGAK--------G----GHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAH  834 (982)
Q Consensus       767 v~e~~~~~sL~~~l~~~~--------~----~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~k  834 (982)
                      |+|||..|+|.++|....        .    .+++..+.+.|+.|||.||+||.+++   +|||||..+|+||.++..||
T Consensus       567 vFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~VK  643 (774)
T KOG1026|consen  567 VFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLVVK  643 (774)
T ss_pred             EEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceEEE
Confidence            999999999999996422        1    23888999999999999999999888   99999999999999999999


Q ss_pred             EeccccchhccccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHhc
Q 002010          835 VADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTT  913 (982)
Q Consensus       835 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~  913 (982)
                      |+|||+++.+...++++......-+.+|||||.+..++|+.+||||||||++||+++ |+.||.+..+.+.+..+...  
T Consensus       644 IsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g--  721 (774)
T KOG1026|consen  644 ISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAG--  721 (774)
T ss_pred             ecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcC--
Confidence            999999998877766665545556789999999999999999999999999999999 99999998776544333221  


Q ss_pred             cCCCCCCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCCCCCCCC
Q 002010          914 SEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQSAPSLI  980 (982)
Q Consensus       914 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~~~~~~~~  980 (982)
                                        .+-+.|.++|.++++||.+||+..|.+||+++||-..|...-+.+|-+.
T Consensus       722 ------------------~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~~~~  770 (774)
T KOG1026|consen  722 ------------------QLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQASPKYS  770 (774)
T ss_pred             ------------------CcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCcccc
Confidence                              2234677888899999999999999999999999999988777766543

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.5e-44  Score=348.82  Aligned_cols=257  Identities=24%  Similarity=0.357  Sum_probs=209.3

Q ss_pred             HhhcccccccccccceEEEEE-EeCCCcEEEEEEeccCC-CCCchhhHHHHHHHHhcCCCCcccceEe-EEEcCCc-cEE
Q 002010          691 LESLKDENIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRG-TGGNDHGFLAEIQTLGRIRHRNIVRLLG-YVSNRDT-NLL  766 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~-~~~~~~~-~~l  766 (982)
                      ...|++.++||+|.||+|||+ ...+|..||.|.+.-.. +....+....|+.++++++|||||++++ .+.++.. .++
T Consensus        18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlni   97 (375)
T KOG0591|consen   18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNI   97 (375)
T ss_pred             HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHH
Confidence            356888999999999999999 46789999999885332 3344567889999999999999999998 4544444 899


Q ss_pred             EEeccCCCCHHHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHHhhcC-CCcEEecCCCCCcEEEcCCCCEEEeccccchh
Q 002010          767 LYEYMPNGSLGEMLHG--AKGGHLKWETRYRIALEAAKGLCYLHHDC-SPLIIHRDVKSNNILLDSDFEAHVADFGLAKF  843 (982)
Q Consensus       767 v~e~~~~~sL~~~l~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~  843 (982)
                      |||+|.+|+|..+++.  .+.+.+++..+|+++.|++.|+.++|..- ...|+||||||.||+++.+|.||++|||++++
T Consensus        98 vmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~  177 (375)
T KOG0591|consen   98 VMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF  177 (375)
T ss_pred             HHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhH
Confidence            9999999999999974  34567999999999999999999999832 12389999999999999999999999999999


Q ss_pred             ccccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCccc
Q 002010          844 LQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAA  923 (982)
Q Consensus       844 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  923 (982)
                      +...  .....+.+|||.||+||.+.+.+|+.+|||||+||++|||+.-++||.+.    .+....++....        
T Consensus       178 l~s~--~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~----n~~~L~~KI~qg--------  243 (375)
T KOG0591|consen  178 LSSK--TTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD----NLLSLCKKIEQG--------  243 (375)
T ss_pred             hcch--hHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc----cHHHHHHHHHcC--------
Confidence            8753  34456789999999999999999999999999999999999999999864    334444333321        


Q ss_pred             ccceeecCCCCCCC-hHhHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 002010          924 SVLAVVDPRLSGYP-LTGVIHLFKVAMMCVEDESSARPTMREVVHML  969 (982)
Q Consensus       924 ~~~~~~~~~~~~~~-~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L  969 (982)
                              ..+..| .-....+.+++..|+..||+.||+...++..+
T Consensus       244 --------d~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di  282 (375)
T KOG0591|consen  244 --------DYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDI  282 (375)
T ss_pred             --------CCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHH
Confidence                    112233 33456789999999999999999865555544

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-42  Score=356.88  Aligned_cols=243  Identities=26%  Similarity=0.307  Sum_probs=204.6

Q ss_pred             HhhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCC--CCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEE
Q 002010          691 LESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGT--GGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLL  767 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  767 (982)
                      .+.|+..++||+|+||.||.++. .+++.||+|++.+...  ....+...+|..++.+++||+||+++..|++.+..|+|
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV  103 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV  103 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence            46789999999999999999965 4588999999966543  23467788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhcccc
Q 002010          768 YEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDA  847 (982)
Q Consensus       768 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  847 (982)
                      +||+.||.|.-.+.  +++.+++..+..++..|+.||.|||++|   |||||+||+|||+|++|+++|+|||+++.--..
T Consensus       104 ld~~~GGeLf~hL~--~eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~  178 (357)
T KOG0598|consen  104 LDYLNGGELFYHLQ--REGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD  178 (357)
T ss_pred             EeccCCccHHHHHH--hcCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhcccC
Confidence            99999999999997  6789999999999999999999999998   999999999999999999999999999854322


Q ss_pred             CCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccce
Q 002010          848 GASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLA  927 (982)
Q Consensus       848 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  927 (982)
                        .......+||+.|||||++.+..|+.++|+||+|+++|||++|.+||....-.    .+.++.....           
T Consensus       179 --~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~----~~~~~I~~~k-----------  241 (357)
T KOG0598|consen  179 --GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVK----KMYDKILKGK-----------  241 (357)
T ss_pred             --CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHH----HHHHHHhcCc-----------
Confidence              23445689999999999999999999999999999999999999999864332    2322222211           


Q ss_pred             eecCCCCCCChHhHHHHHHHHhhccCCCCCCCC
Q 002010          928 VVDPRLSGYPLTGVIHLFKVAMMCVEDESSARP  960 (982)
Q Consensus       928 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp  960 (982)
                           +...+.--..+..+++.+.+.+||++|.
T Consensus       242 -----~~~~p~~ls~~ardll~~LL~rdp~~RL  269 (357)
T KOG0598|consen  242 -----LPLPPGYLSEEARDLLKKLLKRDPRQRL  269 (357)
T ss_pred             -----CCCCCccCCHHHHHHHHHHhccCHHHhc
Confidence                 1111122234678999999999999996

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=1.8e-42  Score=343.30  Aligned_cols=269  Identities=21%  Similarity=0.294  Sum_probs=211.9

Q ss_pred             hhcccccccccccceEEEEEEeC-CCcEEEEEEeccCCCCCc-hhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEe
Q 002010          692 ESLKDENIIGKGGAGIVYRGSMP-DGIDVAIKRLVGRGTGGN-DHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYE  769 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  769 (982)
                      ++|+....+|+|+||+|||++.+ +|+.||||++.+...+.. .+-.++|++++++++|||+|.++++|......++|+|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            46788889999999999999764 599999999977655433 3456899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCC
Q 002010          770 YMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGA  849 (982)
Q Consensus       770 ~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  849 (982)
                      ||+. ++.+-+.. -...++.+.+.+++.|++.|+.|+|+++   ||||||||+||+++.+|.+|+||||.|+.+..  .
T Consensus        82 ~~dh-TvL~eLe~-~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~--p  154 (396)
T KOG0593|consen   82 YCDH-TVLHELER-YPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSA--P  154 (396)
T ss_pred             ecch-HHHHHHHh-ccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcC--C
Confidence            9965 55555543 3356888999999999999999999998   99999999999999999999999999998874  3


Q ss_pred             ccccccccccccccccccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCc----ccc
Q 002010          850 SECMSSVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSD----AAS  924 (982)
Q Consensus       850 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~  924 (982)
                      ....+.++.|..|+|||.+.+ .+|+..+||||+||++.||++|.+-|.+..+-+.+..+.+..+.-.+.-..    ...
T Consensus       155 gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~  234 (396)
T KOG0593|consen  155 GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPF  234 (396)
T ss_pred             cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCc
Confidence            445677889999999999887 689999999999999999999999998877766555555544432221100    001


Q ss_pred             cceeecCCCC---CCC---hHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          925 VLAVVDPRLS---GYP---LTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       925 ~~~~~~~~~~---~~~---~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                      +..+.=|...   ..+   +....-+.++++.|++.||.+|++-+|++.
T Consensus       235 F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  235 FHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             eeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence            1111111111   000   111225789999999999999999999875

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-42  Score=362.71  Aligned_cols=272  Identities=19%  Similarity=0.255  Sum_probs=223.2

Q ss_pred             HHHHhhcccccccccccceEEEEEE-eCCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCC-CCcccceEeEEEcCC-cc
Q 002010          688 EDVLESLKDENIIGKGGAGIVYRGS-MPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIR-HRNIVRLLGYVSNRD-TN  764 (982)
Q Consensus       688 ~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~-~~  764 (982)
                      ..+.++|...+.||.|.||.||+|+ ..+|..||||+++.+...-....-.||++.+++++ ||||+++.+.+.+.+ ..
T Consensus         6 ~~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L   85 (538)
T KOG0661|consen    6 VIFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRIL   85 (538)
T ss_pred             hhHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceE
Confidence            3456789999999999999999995 45689999999976654444445679999999998 999999999998877 89


Q ss_pred             EEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhc
Q 002010          765 LLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFL  844 (982)
Q Consensus       765 ~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~  844 (982)
                      |+||||| ..+|+++++++ +..++++.+..|+.||++||+|+|++|   +.|||+||+|||+.....+||+|||+|+.+
T Consensus        86 ~fVfE~M-d~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev  160 (538)
T KOG0661|consen   86 YFVFEFM-DCNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREV  160 (538)
T ss_pred             eeeHHhh-hhhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEeccccccccc
Confidence            9999999 67999999876 789999999999999999999999999   999999999999998999999999999988


Q ss_pred             cccCCcccccccccccccccccccc-cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcc-
Q 002010          845 QDAGASECMSSVAGSYGYIAPEYAY-TLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDA-  922 (982)
Q Consensus       845 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-  922 (982)
                      .....   .+.++.|..|+|||++. ..-|+.+.||||+|||++|+.+-++-|.+..+.+.+.++..-.+.+....+.. 
T Consensus       161 ~SkpP---YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg  237 (538)
T KOG0661|consen  161 RSKPP---YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEG  237 (538)
T ss_pred             ccCCC---cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhH
Confidence            75433   46788899999999875 56699999999999999999999999988777666666655555433222221 


Q ss_pred             cccceeecCCCC---CC-----ChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          923 ASVLAVVDPRLS---GY-----PLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       923 ~~~~~~~~~~~~---~~-----~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                      ..+...++-+++   +.     -.....+..+++.+|+.+||.+||||+|.++
T Consensus       238 ~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~  290 (538)
T KOG0661|consen  238 YNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQ  290 (538)
T ss_pred             HHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhc
Confidence            122222332222   21     1236678899999999999999999999987

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=100.00  E-value=2.2e-45  Score=376.43  Aligned_cols=486  Identities=25%  Similarity=0.396  Sum_probs=384.3

Q ss_pred             EEEEeccCCccccCCcCccccccccEEEeccCCCCCCCChhhhhhcccceeeccCCccccccchhhhhcCCCccEEeccC
Q 002010           74 VSLNVSFMPLFGSIPPEIGLLTKLVNLTISNVNLTGRLPSEMALLTSLKVFNISGNVFQGNFAGQIVRGMTELQVLDAYN  153 (982)
Q Consensus        74 ~~l~l~~~~l~g~~~~~i~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~  153 (982)
                      ..+.++++.+. .+.+.+.++..|+.|++++|++. .+|++++.+..++.|++|+|+++ .+|.+ ...+.+|+.|+.++
T Consensus        48 ~~lils~N~l~-~l~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~-i~s~~~l~~l~~s~  123 (565)
T KOG0472|consen   48 QKLILSHNDLE-VLREDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQ-IGSLISLVKLDCSS  123 (565)
T ss_pred             hhhhhccCchh-hccHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHH-Hhhhhhhhhhhccc
Confidence            45666766654 45667889999999999999999 79999999999999999999997 34443 45788999999999


Q ss_pred             ccccCCCchhccccccccEEeecCcccccccCCCccccCcceEeeccCcccccchhhHHhhhhhHHHHhhcccccccccC
Q 002010          154 NNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLNGIGLNGTVPAFLSRLKNLREMYIGYFNTYTGGI  233 (982)
Q Consensus       154 n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~l~~~n~~~~~~  233 (982)
                      |.+. .+|..++.+..|+.|+..+|+++ ..|+.+..+.+|..|++.+|.+....|..+. ++.|++|+..  .+.-+.+
T Consensus       124 n~~~-el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~-m~~L~~ld~~--~N~L~tl  198 (565)
T KOG0472|consen  124 NELK-ELPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHIA-MKRLKHLDCN--SNLLETL  198 (565)
T ss_pred             ccee-ecCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchhhCCHHHHH-HHHHHhcccc--hhhhhcC
Confidence            9999 78999999999999999999999 7888999999999999999999977777776 9999999986  4667789


Q ss_pred             CCCCCCCCCCCEEecccCcCcccCchhhcCCCccceeecccccCCCCCCcc-ccCCCCCCEEEeeCCcccCcCchhhhcc
Q 002010          234 PPGFGALTQLQVLDMASCNISGEIPTSLSRLKLLHSLFLQMNKLTGHIPPQ-LSGLISLKSLDLSLNYLTGEIPESFAAL  312 (982)
Q Consensus       234 p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~-l~~l~~L~~L~Ls~N~l~~~~~~~l~~l  312 (982)
                      |+.++.+.+|..|+|.+|+|. ..| +|..+..|++|+++.|+|+ .+|.. ...++++..|||.+|+++ ..|+.+.-+
T Consensus       199 P~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clL  274 (565)
T KOG0472|consen  199 PPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLL  274 (565)
T ss_pred             ChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccc-cCchHHHHh
Confidence            999999999999999999998 666 8999999999999999999 55554 558999999999999999 789999999


Q ss_pred             cchhhhhhccCCCCCCCCCcCCCCCCccEEEccCCCcccccCccccCCC--cccEEEeccccccccCCccccCcccccee
Q 002010          313 KNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNG--KLLILDVTSNHLTGTIPRDLCKGGKLKSL  390 (982)
Q Consensus       313 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~--~L~~L~L~~N~l~~~~p~~~~~~~~L~~L  390 (982)
                      ++|++||+|+|.|+ ..|..++++ .|+.|-+.+|++...-.+.+..-+  -|++|.=   .+....+..- .-.+-..-
T Consensus       275 rsL~rLDlSNN~is-~Lp~sLgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs---~~~~dglS~s-e~~~e~~~  348 (565)
T KOG0472|consen  275 RSLERLDLSNNDIS-SLPYSLGNL-HLKFLALEGNPLRTIRREIISKGTQEVLKYLRS---KIKDDGLSQS-EGGTETAM  348 (565)
T ss_pred             hhhhhhcccCCccc-cCCcccccc-eeeehhhcCCchHHHHHHHHcccHHHHHHHHHH---hhccCCCCCC-cccccccC
Confidence            99999999999999 578889999 999999999999743222222111  1222210   1110000000 00000000


Q ss_pred             ecccccccccCCccccCCCCCCEEEccCCccCCCCCccccCCCc---cccccCCCccccccCCccccc-CC-ccEEEeec
Q 002010          391 ILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGTIPAGLFNLPL---LNMMELDDNLLSGELPEKMSG-AS-LNQLKVAN  465 (982)
Q Consensus       391 ~l~~N~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~---L~~L~L~~N~l~~~~~~~~~~-~~-L~~L~L~~  465 (982)
                      ++    ..+.. .....+.+.+.|++++-+++ .+|+..+....   ....+++.|++. ++|..+.. .. ++.+.+++
T Consensus       349 t~----~~~~~-~~~~~~i~tkiL~~s~~qlt-~VPdEVfea~~~~~Vt~VnfskNqL~-elPk~L~~lkelvT~l~lsn  421 (565)
T KOG0472|consen  349 TL----PSESF-PDIYAIITTKILDVSDKQLT-LVPDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVELKELVTDLVLSN  421 (565)
T ss_pred             CC----CCCcc-cchhhhhhhhhhcccccccc-cCCHHHHHHhhhcceEEEecccchHh-hhhhhhHHHHHHHHHHHhhc
Confidence            00    00011 11223455666677777766 55655554443   566677777776 33433332 23 44556666


Q ss_pred             cccCCCCchhccCCCCcceeeeccccccCCCccccccccccceeeeeccccCCCCCcccccccCCCeeeCCCCcccCCCC
Q 002010          466 NNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYGKIP  545 (982)
Q Consensus       466 N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p  545 (982)
                      |.++ .+|..++.+++|..|+|++|.+. .+|.+++.+..|+.||+|.|+|. .+|..+..+..|+.+-.++|++....|
T Consensus       422 n~is-fv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~  498 (565)
T KOG0472|consen  422 NKIS-FVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGSVDP  498 (565)
T ss_pred             Cccc-cchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhccccccccCh
Confidence            6665 89999999999999999999998 79999999999999999999999 899999888999999999999986666


Q ss_pred             cccccccccceEEcccccccccCccccccccccceecccCCccc
Q 002010          546 PGISKLIDLSILNLSRNGITGSIPNEMRNMMSLTTLDLSYNNLI  589 (982)
Q Consensus       546 ~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~  589 (982)
                      ..+.+|.+|..|||.+|.|. ++|+.+++|++|++|+++||++.
T Consensus       499 ~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr  541 (565)
T KOG0472|consen  499 SGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR  541 (565)
T ss_pred             HHhhhhhhcceeccCCCchh-hCChhhccccceeEEEecCCccC
Confidence            66999999999999999999 88999999999999999999998

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-41  Score=363.42  Aligned_cols=250  Identities=27%  Similarity=0.359  Sum_probs=214.0

Q ss_pred             hhcccccccccccceEEEEEE-eCCCcEEEEEEeccCC--CCCchhhHHHHHHHHhcC-CCCcccceEeEEEcCCccEEE
Q 002010          692 ESLKDENIIGKGGAGIVYRGS-MPDGIDVAIKRLVGRG--TGGNDHGFLAEIQTLGRI-RHRNIVRLLGYVSNRDTNLLL  767 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv  767 (982)
                      .+|..++.||+|+|++|++|+ ..++++||||++.+..  .+...+.+.+|-.+|.++ .||.|++++.-|+++...|+|
T Consensus        73 ~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFv  152 (604)
T KOG0592|consen   73 NDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFV  152 (604)
T ss_pred             hhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEE
Confidence            568889999999999999995 4679999999985543  233455678899999999 899999999999999999999


Q ss_pred             EeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhcccc
Q 002010          768 YEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDA  847 (982)
Q Consensus       768 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  847 (982)
                      +||+++|+|.++|+  +.+.+++..++.++.+|+.|++|||++|   ||||||||+|||+|+|+++||+|||.|..+.+.
T Consensus       153 Le~A~nGdll~~i~--K~Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l~~~  227 (604)
T KOG0592|consen  153 LEYAPNGDLLDLIK--KYGSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKILSPS  227 (604)
T ss_pred             EEecCCCcHHHHHH--HhCcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccCChh
Confidence            99999999999998  5589999999999999999999999998   999999999999999999999999999988654


Q ss_pred             CCc---------cc--ccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCC
Q 002010          848 GAS---------EC--MSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEV  916 (982)
Q Consensus       848 ~~~---------~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  916 (982)
                      ...         ..  ....+||..|.+||++.....++++|+|+||||+|+|+.|.+||....+...+.+++.....  
T Consensus       228 ~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~--  305 (604)
T KOG0592|consen  228 QKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYE--  305 (604)
T ss_pred             hccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhccc--
Confidence            221         11  24588999999999999999999999999999999999999999987665444444433222  


Q ss_pred             CCCCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          917 SQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       917 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                                         +++..+....+|+++.|..||.+|+|++||.+
T Consensus       306 -------------------fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~  337 (604)
T KOG0592|consen  306 -------------------FPEGFPEDARDLIKKLLVRDPSDRLTSQQIKA  337 (604)
T ss_pred             -------------------CCCCCCHHHHHHHHHHHccCccccccHHHHhh
Confidence                               23334457889999999999999999999876

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.6e-41  Score=355.46  Aligned_cols=271  Identities=24%  Similarity=0.327  Sum_probs=217.3

Q ss_pred             HhhcccccccccccceEEEEEE-eCCCcEEEEEEeccCC-CCCchhhHHHHHHHHhcCCCCcccceEeEEEcC--CccEE
Q 002010          691 LESLKDENIIGKGGAGIVYRGS-MPDGIDVAIKRLVGRG-TGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNR--DTNLL  766 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~l  766 (982)
                      .+.|+..+.||+|.||.||+|+ ..+|+.||+|++.-.. .+....-..+||.++++++||||+++.+...+.  ...|+
T Consensus       116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl  195 (560)
T KOG0600|consen  116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL  195 (560)
T ss_pred             hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence            3567888899999999999995 5679999999996654 344556678999999999999999999988776  68899


Q ss_pred             EEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccc
Q 002010          767 LYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQD  846 (982)
Q Consensus       767 v~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  846 (982)
                      |+|||+. +|..++. ...-++++.++..+++|++.|++|+|.+|   |+|||||.+|||+|.+|.+||+|||+|+++..
T Consensus       196 VFeYMdh-DL~GLl~-~p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~  270 (560)
T KOG0600|consen  196 VFEYMDH-DLSGLLS-SPGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYTP  270 (560)
T ss_pred             EEecccc-hhhhhhc-CCCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeeccC
Confidence            9999965 8888875 34568999999999999999999999998   99999999999999999999999999998875


Q ss_pred             cCCcccccccccccccccccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcc--c
Q 002010          847 AGASECMSSVAGSYGYIAPEYAYTL-KVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDA--A  923 (982)
Q Consensus       847 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--~  923 (982)
                      .. ....+..+-|..|+|||.+.+. .|+.++|+||.|||+.||++|++.|.+..+-+.+..+++..+.+...-+..  -
T Consensus       271 ~~-~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kL  349 (560)
T KOG0600|consen  271 SG-SAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKL  349 (560)
T ss_pred             CC-CcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccC
Confidence            43 3346778889999999998865 599999999999999999999999988766666666666655532222110  0


Q ss_pred             ccceeecCCCC------CCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          924 SVLAVVDPRLS------GYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       924 ~~~~~~~~~~~------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                      .....+.+..+      +.-...+....+|+..+|..||++|.||.++++
T Consensus       350 P~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~  399 (560)
T KOG0600|consen  350 PHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ  399 (560)
T ss_pred             CcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence            00111111111      112233456789999999999999999999886

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-42  Score=380.66  Aligned_cols=259  Identities=29%  Similarity=0.485  Sum_probs=222.3

Q ss_pred             HhhcccccccccccceEEEEEEeC----CCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEE
Q 002010          691 LESLKDENIIGKGGAGIVYRGSMP----DGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLL  766 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  766 (982)
                      ....+++++||.|.||.||+|+.+    ....||||.++...+++...+|+.|+.||.+++||||+++.|........++
T Consensus       628 ~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMI  707 (996)
T KOG0196|consen  628 PSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMI  707 (996)
T ss_pred             hhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEE
Confidence            345677899999999999999763    2456999999888888889999999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccc
Q 002010          767 LYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQD  846 (982)
Q Consensus       767 v~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  846 (982)
                      |+|||++|+|+.+|+.. ++++.+.+...+.+.|+.||+||.+++   +|||||.++||||+.+..+|++|||+++.+.+
T Consensus       708 iTEyMENGsLDsFLR~~-DGqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvled  783 (996)
T KOG0196|consen  708 ITEYMENGSLDSFLRQN-DGQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED  783 (996)
T ss_pred             EhhhhhCCcHHHHHhhc-CCceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeeccc
Confidence            99999999999999854 467999999999999999999999999   99999999999999999999999999998875


Q ss_pred             cCCccccccccc--ccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHhccCCCCCCccc
Q 002010          847 AGASECMSSVAG--SYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAA  923 (982)
Q Consensus       847 ~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  923 (982)
                      +. ....+...|  +.+|.|||.+..++++.+|||||||+++||.++ |+.||.+....+.+..+ ..... .       
T Consensus       784 d~-~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaI-e~gyR-L-------  853 (996)
T KOG0196|consen  784 DP-EAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAI-EQGYR-L-------  853 (996)
T ss_pred             CC-CccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHH-HhccC-C-------
Confidence            53 222333333  469999999999999999999999999999998 99999987665443332 22111 1       


Q ss_pred             ccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCC
Q 002010          924 SVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQ  974 (982)
Q Consensus       924 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~~  974 (982)
                                 .-|.+||..+.+||..||++|-.+||++++|+..|.++..
T Consensus       854 -----------PpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIr  893 (996)
T KOG0196|consen  854 -----------PPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIR  893 (996)
T ss_pred             -----------CCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhc
Confidence                       2355778899999999999999999999999999976443

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=1.4e-40  Score=324.93  Aligned_cols=274  Identities=23%  Similarity=0.345  Sum_probs=219.5

Q ss_pred             hhcccccccccccceEEEEEE-eCCCcEEEEEEeccCC-CCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEe
Q 002010          692 ESLKDENIIGKGGAGIVYRGS-MPDGIDVAIKRLVGRG-TGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYE  769 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  769 (982)
                      ++|...+.+|+|.||.||+|+ ..+|+.||||+++... .+.......+|++.++.++||||+.++++|...+...+|+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            467788899999999999995 5679999999996543 33445678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCC
Q 002010          770 YMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGA  849 (982)
Q Consensus       770 ~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  849 (982)
                      ||+ .+|+..+++ +...++..++..++.++++|++|+|++.   |+||||||.|++++++|.+||+|||+|+.+.... 
T Consensus        82 fm~-tdLe~vIkd-~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~-  155 (318)
T KOG0659|consen   82 FMP-TDLEVVIKD-KNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN-  155 (318)
T ss_pred             ecc-ccHHHHhcc-cccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCC-
Confidence            995 599999974 5578999999999999999999999888   9999999999999999999999999999887543 


Q ss_pred             cccccccccccccccccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccc----
Q 002010          850 SECMSSVAGSYGYIAPEYAYTL-KVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAAS----  924 (982)
Q Consensus       850 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----  924 (982)
                       ......+-|..|+|||.+.+. .|+..+||||.|||+.||+-|.+-|.+..|-+.+..+++..+.+.+..+....    
T Consensus       156 -~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpd  234 (318)
T KOG0659|consen  156 -RIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPD  234 (318)
T ss_pred             -cccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccccccc
Confidence             333444788999999988865 59999999999999999999988887777766666666665543332221111    


Q ss_pred             ---cceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH--HhcCC
Q 002010          925 ---VLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH--MLANP  972 (982)
Q Consensus       925 ---~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~--~L~~~  972 (982)
                         +.....+.....-..+.....+++..|+..||.+|+|+.|+++  .+...
T Consensus       235 Y~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~  287 (318)
T KOG0659|consen  235 YVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSL  287 (318)
T ss_pred             HHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcC
Confidence               1111112222233344455699999999999999999999987  44443

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-40  Score=347.93  Aligned_cols=263  Identities=26%  Similarity=0.369  Sum_probs=217.0

Q ss_pred             HhhcccccccccccceEEEEEE-eCCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEe
Q 002010          691 LESLKDENIIGKGGAGIVYRGS-MPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYE  769 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  769 (982)
                      .+.|+..+.||.|..++||+|+ .+.++.||||++.-.........+.+|+..|+.++||||++++..|..+...|+||.
T Consensus        25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp  104 (516)
T KOG0582|consen   25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP  104 (516)
T ss_pred             ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence            3578889999999999999995 577899999999665555557889999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCC
Q 002010          770 YMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGA  849 (982)
Q Consensus       770 ~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  849 (982)
                      ||.+|++.++++..-...+++..+..+.+++++||.|||++|   .||||||+.|||++++|.|||+|||.+-.+.+.+.
T Consensus       105 fMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~  181 (516)
T KOG0582|consen  105 FMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGD  181 (516)
T ss_pred             hhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecccCc
Confidence            999999999998766677999999999999999999999999   99999999999999999999999998877765542


Q ss_pred             ccc-c-cccccccccccccccc--cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCccccc
Q 002010          850 SEC-M-SSVAGSYGYIAPEYAY--TLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASV  925 (982)
Q Consensus       850 ~~~-~-~~~~gt~~y~aPE~~~--~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  925 (982)
                      ... . ...+||+.|||||+++  ...|+.|+||||||++..|+.+|+.||...+.-..+...+....+.+.        
T Consensus       182 R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~--------  253 (516)
T KOG0582|consen  182 RQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLL--------  253 (516)
T ss_pred             eeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcc--------
Confidence            111 1 4568999999999954  346999999999999999999999999987665544444433322111        


Q ss_pred             ceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          926 LAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       926 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                      ....+.   +........+.+++..|+++||.+|||++++++
T Consensus       254 t~~~~~---d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk  292 (516)
T KOG0582|consen  254 TSGLDK---DEDKKFSKSFREMIALCLVKDPSKRPTASKLLK  292 (516)
T ss_pred             cccCCh---HHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence            001110   111222347889999999999999999999987

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.6e-41  Score=352.50  Aligned_cols=254  Identities=30%  Similarity=0.454  Sum_probs=204.1

Q ss_pred             hhcccccccccccceEEEEEEeC-CCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCC--ccEEEE
Q 002010          692 ESLKDENIIGKGGAGIVYRGSMP-DGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRD--TNLLLY  768 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~lv~  768 (982)
                      .++..++.||+|+||+||++... +|...|||.+....... .+...+|+.++.+++|||||+++|.....+  .+++.|
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~-~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m   95 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT-SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM   95 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh-HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence            45777889999999999999654 48999999885442222 566889999999999999999999755544  589999


Q ss_pred             eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcC-CCCEEEeccccchhccc-
Q 002010          769 EYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDS-DFEAHVADFGLAKFLQD-  846 (982)
Q Consensus       769 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~-~~~~kl~DfG~a~~~~~-  846 (982)
                      ||+++|+|.+++..... ++++..+.++++||++|++|||++|   ||||||||+|||++. ++.+||+|||++..... 
T Consensus        96 Ey~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~  171 (313)
T KOG0198|consen   96 EYAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLESK  171 (313)
T ss_pred             eccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence            99999999999986555 8999999999999999999999888   999999999999999 79999999999987663 


Q ss_pred             cCCcccccccccccccccccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCccccc
Q 002010          847 AGASECMSSVAGSYGYIAPEYAYTL-KVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASV  925 (982)
Q Consensus       847 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  925 (982)
                      ...........||+.|||||++..+ ...+++||||+||++.||+||++||....+.   ..++-....           
T Consensus       172 ~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~---~~~~~~ig~-----------  237 (313)
T KOG0198|consen  172 GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEE---AEALLLIGR-----------  237 (313)
T ss_pred             cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcch---HHHHHHHhc-----------
Confidence            1122334567899999999999953 3345999999999999999999999874111   111111111           


Q ss_pred             ceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002010          926 LAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHM  968 (982)
Q Consensus       926 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~  968 (982)
                          +...+.+|...+....+|+.+|+.+||++||||+|+++-
T Consensus       238 ----~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~h  276 (313)
T KOG0198|consen  238 ----EDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEH  276 (313)
T ss_pred             ----cCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhC
Confidence                011123444555678899999999999999999999873

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.4e-41  Score=392.75  Aligned_cols=261  Identities=28%  Similarity=0.449  Sum_probs=224.3

Q ss_pred             hhcccccccccccceEEEEEEeCC--C----cEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccE
Q 002010          692 ESLKDENIIGKGGAGIVYRGSMPD--G----IDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNL  765 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~~~--~----~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  765 (982)
                      +..+..+.||+|+||.||+|...+  |    ..||||.+.+..+.+...+|.+|..+|+.++|||||+++|.+.+....+
T Consensus       692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~  771 (1025)
T KOG1095|consen  692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL  771 (1025)
T ss_pred             hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence            345667789999999999996533  3    3499999988778888889999999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHhhcCC-----CCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEecccc
Q 002010          766 LLYEYMPNGSLGEMLHGAK-----GGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGL  840 (982)
Q Consensus       766 lv~e~~~~~sL~~~l~~~~-----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~  840 (982)
                      +++|||++|+|..+|++.+     ...++..+...++.|||+|+.||++++   +|||||..+|+|+++...|||+|||+
T Consensus       772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFGl  848 (1025)
T KOG1095|consen  772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFGL  848 (1025)
T ss_pred             EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccch
Confidence            9999999999999998642     356889999999999999999999988   99999999999999999999999999


Q ss_pred             chhccccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHhccCCCCC
Q 002010          841 AKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQP  919 (982)
Q Consensus       841 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  919 (982)
                      |+.+.+..+++......-+.+|||||.+..+.++.|+|||||||++||++| |..||.+....+.+..+....  +.++ 
T Consensus       849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg--RL~~-  925 (1025)
T KOG1095|consen  849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG--RLDP-  925 (1025)
T ss_pred             hHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC--ccCC-
Confidence            997776666555544445679999999999999999999999999999999 999999876655544444333  3333 


Q ss_pred             CcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCCC
Q 002010          920 SDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQS  975 (982)
Q Consensus       920 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~~~  975 (982)
                                       |..|+..++++|..||+.+|++||++..+++.+..+.+.
T Consensus       926 -----------------P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~  964 (1025)
T KOG1095|consen  926 -----------------PSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNA  964 (1025)
T ss_pred             -----------------CCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhh
Confidence                             344566899999999999999999999999988776653

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-41  Score=365.59  Aligned_cols=266  Identities=29%  Similarity=0.399  Sum_probs=217.3

Q ss_pred             HHHHHhhcccccccccccceEEEEEEeCCCcEEEEEEeccCC-CCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccE
Q 002010          687 AEDVLESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRG-TGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNL  765 (982)
Q Consensus       687 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  765 (982)
                      ++...+.+...+.||+|.||+||+|++..  .||||++.... +++..+.|+.|+.++++-+|.||+-+.||+..+.. .
T Consensus       387 WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-A  463 (678)
T KOG0193|consen  387 WEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-A  463 (678)
T ss_pred             cccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-e
Confidence            34445667788899999999999998843  69999985443 33456789999999999999999999999998777 9


Q ss_pred             EEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhcc
Q 002010          766 LLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQ  845 (982)
Q Consensus       766 lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~  845 (982)
                      +|+.||+|.+|+.++|..+ .+++....+.|++||++||.|||.++   |||||+|..||++.+++.|||+|||++..-.
T Consensus       464 IiTqwCeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~  539 (678)
T KOG0193|consen  464 IITQWCEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLATVKT  539 (678)
T ss_pred             eeehhccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccceeeee
Confidence            9999999999999999644 78999999999999999999999988   9999999999999999999999999997544


Q ss_pred             ccCCccccccccccccccccccccc---CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcc
Q 002010          846 DAGASECMSSVAGSYGYIAPEYAYT---LKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDA  922 (982)
Q Consensus       846 ~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  922 (982)
                      .-..........|...|||||++..   ..|++++||||||+++|||+||..||.. ...+. .-|....          
T Consensus       540 ~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi-~~~dq-IifmVGr----------  607 (678)
T KOG0193|consen  540 RWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSI-QNRDQ-IIFMVGR----------  607 (678)
T ss_pred             eeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCC-CChhh-eEEEecc----------
Confidence            3333333445678889999999864   4589999999999999999999999983 22221 1111111          


Q ss_pred             cccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCCC
Q 002010          923 ASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQS  975 (982)
Q Consensus       923 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~~~  975 (982)
                          ....|+......+++.++.+|+..||..++++||.+.+|+..|+.+...
T Consensus       608 ----G~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~  656 (678)
T KOG0193|consen  608 ----GYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS  656 (678)
T ss_pred             ----cccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence                1122344455678888999999999999999999999999988776653

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-40  Score=359.74  Aligned_cols=251  Identities=27%  Similarity=0.387  Sum_probs=209.7

Q ss_pred             HHhhcccccccccccceEEEEEE-eCCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEE
Q 002010          690 VLESLKDENIIGKGGAGIVYRGS-MPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLY  768 (982)
Q Consensus       690 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  768 (982)
                      ....|+.-+.||+|+.|.||.|. ..+++.||||++... .+...+-+.+|+.+|+..+|+|||.+++.|..++..|+||
T Consensus       271 P~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~-~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVM  349 (550)
T KOG0578|consen  271 PRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLR-KQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVM  349 (550)
T ss_pred             hhhhhcchhhhccccccceeeeeeccCCceEEEEEEEec-cCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEE
Confidence            34567777889999999999994 567899999998443 3334456789999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccC
Q 002010          769 EYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAG  848 (982)
Q Consensus       769 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  848 (982)
                      ||++||+|.+.+.   ...+++.++..|.+.++.||+|||.++   |+|||||.+||+++.+|.+||+|||++..+....
T Consensus       350 Eym~ggsLTDvVt---~~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~  423 (550)
T KOG0578|consen  350 EYMEGGSLTDVVT---KTRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQ  423 (550)
T ss_pred             eecCCCchhhhhh---cccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeecccccc
Confidence            9999999999995   345999999999999999999999998   9999999999999999999999999998876543


Q ss_pred             CcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCccccccee
Q 002010          849 ASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAV  928 (982)
Q Consensus       849 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  928 (982)
                      .  .....+|||.|||||++....|+++.||||+|++++||+.|++||-.... -.....+...+.  +           
T Consensus       424 ~--KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~P-lrAlyLIa~ng~--P-----------  487 (550)
T KOG0578|consen  424 S--KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENP-LRALYLIATNGT--P-----------  487 (550)
T ss_pred             C--ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCCh-HHHHHHHhhcCC--C-----------
Confidence            2  44668999999999999999999999999999999999999999975322 222222222221  0           


Q ss_pred             ecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          929 VDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       929 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                         .+ ..+......+.+|+.+||+.||++||+|.|+++
T Consensus       488 ---~l-k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~  522 (550)
T KOG0578|consen  488 ---KL-KNPEKLSPELKDFLDRCLVVDVEQRASAKELLE  522 (550)
T ss_pred             ---Cc-CCccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence               01 122334457899999999999999999999997

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=7.2e-40  Score=350.21  Aligned_cols=264  Identities=27%  Similarity=0.399  Sum_probs=223.4

Q ss_pred             hcccccccccccceEEEEEEeCCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEeccC
Q 002010          693 SLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMP  772 (982)
Q Consensus       693 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  772 (982)
                      ...+++.||+|-||.|..+....+..||||.++.........+|.+|+++|.+++|||||+++|+|..++.+++|+|||+
T Consensus       539 ~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmE  618 (807)
T KOG1094|consen  539 RLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYME  618 (807)
T ss_pred             heehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHh
Confidence            45667899999999999999877899999999888777778999999999999999999999999999999999999999


Q ss_pred             CCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCccc
Q 002010          773 NGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASEC  852 (982)
Q Consensus       773 ~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~  852 (982)
                      +|+|.+++..+.......+...+++.||+.||+||.+-+   +||||+.++|+|++.++++||+|||+++-+....+.+.
T Consensus       619 nGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~v  695 (807)
T KOG1094|consen  619 NGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRV  695 (807)
T ss_pred             cCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCCceee
Confidence            999999998765555667778889999999999999988   99999999999999999999999999997776666666


Q ss_pred             ccccccccccccccccccCCCCcchhhHHHHHHHHHHHh--CCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceeec
Q 002010          853 MSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA--GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVD  930 (982)
Q Consensus       853 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  930 (982)
                      ....+-+.+|||||.+.-++++.++|||+||+++||+++  .+.||....++...    ...........         .
T Consensus       696 qgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vv----en~~~~~~~~~---------~  762 (807)
T KOG1094|consen  696 QGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVV----ENAGEFFRDQG---------R  762 (807)
T ss_pred             ecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHH----HhhhhhcCCCC---------c
Confidence            666677889999999999999999999999999999877  88999876554322    11111110000         0


Q ss_pred             CCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 002010          931 PRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANP  972 (982)
Q Consensus       931 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~  972 (982)
                      .-....|..++..++++|.+||..|-++||+++++...|.+.
T Consensus       763 ~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  763 QVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             ceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence            011245667788999999999999999999999999887543

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=2.2e-40  Score=352.85  Aligned_cols=247  Identities=28%  Similarity=0.407  Sum_probs=211.0

Q ss_pred             hhcccccccccccceEEEEEEe-CCCcEEEEEEeccCC-CCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEe
Q 002010          692 ESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRG-TGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYE  769 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  769 (982)
                      ++|.+.+.||+|.||.||||+. .+.+.||+|.+.+.. .+++.+.+.+|++++++++|||||.++++|+...+.++|+|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            4677778999999999999954 468899999985543 34456678999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCC
Q 002010          770 YMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGA  849 (982)
Q Consensus       770 ~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  849 (982)
                      |+.| +|..++.  .++.++++.+..++.|++.|+.|||+.+   |.|||+||+||+++..+++|+||||+|+.+..  .
T Consensus        82 ~a~g-~L~~il~--~d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~--~  153 (808)
T KOG0597|consen   82 YAVG-DLFTILE--QDGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMST--N  153 (808)
T ss_pred             hhhh-hHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhccc--C
Confidence            9976 9999997  6789999999999999999999999988   99999999999999999999999999998764  3


Q ss_pred             cccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceee
Q 002010          850 SECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVV  929 (982)
Q Consensus       850 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  929 (982)
                      ....+...|||.|||||+..+..|+..+|+||+|||+||+++|++||..    ..+...++.....+..           
T Consensus       154 t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a----~si~~Lv~~I~~d~v~-----------  218 (808)
T KOG0597|consen  154 TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYA----RSITQLVKSILKDPVK-----------  218 (808)
T ss_pred             ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchH----HHHHHHHHHHhcCCCC-----------
Confidence            3445678899999999999999999999999999999999999999965    3344444444332111           


Q ss_pred             cCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          930 DPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       930 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                            .|......+..+++..+.+||.+|.|..+++.
T Consensus       219 ------~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~  250 (808)
T KOG0597|consen  219 ------PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG  250 (808)
T ss_pred             ------CcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence                  12233446889999999999999999998875

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=1.8e-39  Score=363.34  Aligned_cols=261  Identities=25%  Similarity=0.427  Sum_probs=208.0

Q ss_pred             hhcccccccccccceEEEEEEe------CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcC-CCCcccceEeEEEcCC-c
Q 002010          692 ESLKDENIIGKGGAGIVYRGSM------PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRI-RHRNIVRLLGYVSNRD-T  763 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~-~  763 (982)
                      ++|++.+.||+|+||.||+|..      .+++.||+|++...........+.+|+.++.++ +||||+++++++.... .
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~   86 (338)
T cd05102           7 DRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGP   86 (338)
T ss_pred             hHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCc
Confidence            5788899999999999999953      235689999986544444456789999999999 8999999999887644 5


Q ss_pred             cEEEEeccCCCCHHHHhhcCC-----------------------------------------------------------
Q 002010          764 NLLLYEYMPNGSLGEMLHGAK-----------------------------------------------------------  784 (982)
Q Consensus       764 ~~lv~e~~~~~sL~~~l~~~~-----------------------------------------------------------  784 (982)
                      .++||||+++|+|.+++...+                                                           
T Consensus        87 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (338)
T cd05102          87 LMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDL  166 (338)
T ss_pred             eEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcccc
Confidence            789999999999999986422                                                           


Q ss_pred             -CCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCcccccccccccccc
Q 002010          785 -GGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYI  863 (982)
Q Consensus       785 -~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~  863 (982)
                       ...+++.++..++.||++|++|||+.+   |+||||||+||+++.++.+||+|||+++...............+++.|+
T Consensus       167 ~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~  243 (338)
T cd05102         167 WKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWM  243 (338)
T ss_pred             ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcccc
Confidence             134778889999999999999999988   9999999999999999999999999998654332222223345677899


Q ss_pred             cccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceeecCCCCCCChHhHH
Q 002010          864 APEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDPRLSGYPLTGVI  942 (982)
Q Consensus       864 aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  942 (982)
                      |||++.+..++.++|||||||++|||++ |..||............+.....                   ...+...+.
T Consensus       244 aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~  304 (338)
T cd05102         244 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTR-------------------MRAPENATP  304 (338)
T ss_pred             CcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCC-------------------CCCCCCCCH
Confidence            9999999999999999999999999997 99999765433333322221110                   011223345


Q ss_pred             HHHHHHhhccCCCCCCCCCHHHHHHHhcCCCC
Q 002010          943 HLFKVAMMCVEDESSARPTMREVVHMLANPPQ  974 (982)
Q Consensus       943 ~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~~  974 (982)
                      .+.+++.+||+.||++|||+.|+++.|+++.+
T Consensus       305 ~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~  336 (338)
T cd05102         305 EIYRIMLACWQGDPKERPTFSALVEILGDLLQ  336 (338)
T ss_pred             HHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            78999999999999999999999999987655

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=100.00  E-value=3.3e-43  Score=360.43  Aligned_cols=453  Identities=27%  Similarity=0.400  Sum_probs=301.7

Q ss_pred             hcccceeeccCCccccccchhhhhcCCCccEEeccCccccCCCchhccccccccEEeecCcccccccCCCccccCcceEe
Q 002010          118 LTSLKVFNISGNVFQGNFAGQIVRGMTELQVLDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYI  197 (982)
Q Consensus       118 l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L  197 (982)
                      -..|..|++++|.+.-.-+  -..++..|.+|++++|+++ ..|.+++.+.+++.|+.++|+++ ++|+.++.+.+|..|
T Consensus        44 qv~l~~lils~N~l~~l~~--dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l  119 (565)
T KOG0472|consen   44 QVDLQKLILSHNDLEVLRE--DLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKL  119 (565)
T ss_pred             hcchhhhhhccCchhhccH--hhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhh
Confidence            3556667777776653222  2346667777777777776 56777777777777777777766 555555555555555


Q ss_pred             eccCcccccchhhHHhhhhhHHHHhhcccccccccCCCCCCCCCCCCEEecccCcCcccCchhhcCCCccceeecccccC
Q 002010          198 GLNGIGLNGTVPAFLSRLKNLREMYIGYFNTYTGGIPPGFGALTQLQVLDMASCNISGEIPTSLSRLKLLHSLFLQMNKL  277 (982)
Q Consensus       198 ~L~~n~i~~~~~~~l~~l~~L~~L~l~~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l  277 (982)
                      +.+.|.+. .                         +|++++.+-.|+.|+..+|+++ ..|..+..+.+|..|++.+|++
T Consensus       120 ~~s~n~~~-e-------------------------l~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l  172 (565)
T KOG0472|consen  120 DCSSNELK-E-------------------------LPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKL  172 (565)
T ss_pred             hcccccee-e-------------------------cCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccch
Confidence            55555544 3                         4444555555555555555555 4444455555555555555555


Q ss_pred             CCCCCccccCCCCCCEEEeeCCcccCcCchhhhcccchhhhhhccCCCCCCCCCcCCCCCCccEEEccCCCcccccCccc
Q 002010          278 TGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENL  357 (982)
Q Consensus       278 ~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l  357 (982)
                      +...|..+. ++.|++||...|-++ .+|..++.+.+|..|+|..|+|. ..| .|.++..|++|+++.|+|.....+..
T Consensus       173 ~~l~~~~i~-m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~~lpae~~  248 (565)
T KOG0472|consen  173 KALPENHIA-MKRLKHLDCNSNLLE-TLPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIEMLPAEHL  248 (565)
T ss_pred             hhCCHHHHH-HHHHHhcccchhhhh-cCChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHHhhHHHHh
Confidence            533333333 555555555555555 44455555555555555555555 344 45555555555555555553333333


Q ss_pred             cCCCcccEEEeccccccccCCccccCccccceeecccccccccCCccccCCCCCCEEEccCCccCC--------------
Q 002010          358 GRNGKLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNG--------------  423 (982)
Q Consensus       358 ~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~l~~N~~~~~~~~~l~~l~~L~~L~Ls~N~l~~--------------  423 (982)
                      .++.++.+|||.+|+++ ..|..+|.+.+|++||+++|.++ ..|.+++++ .|++|-+.+|.+..              
T Consensus       249 ~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is-~Lp~sLgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vL  325 (565)
T KOG0472|consen  249 KHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDIS-SLPYSLGNL-HLKFLALEGNPLRTIRREIISKGTQEVL  325 (565)
T ss_pred             cccccceeeeccccccc-cCchHHHHhhhhhhhcccCCccc-cCCcccccc-eeeehhhcCCchHHHHHHHHcccHHHHH
Confidence            35555555555555555 45555555555555555555554 344455555 55555555554420              


Q ss_pred             -----------------------CCCcc----ccCCCccccccCCCccccccCCcccccCC---ccEEEeeccccCCCCc
Q 002010          424 -----------------------TIPAG----LFNLPLLNMMELDDNLLSGELPEKMSGAS---LNQLKVANNNITGKIP  473 (982)
Q Consensus       424 -----------------------~~p~~----~~~l~~L~~L~L~~N~l~~~~~~~~~~~~---L~~L~L~~N~i~~~~p  473 (982)
                                             ..|.+    ...+.+.+.|++++-+++..+.+.|....   ....+++.|++. .+|
T Consensus       326 KyLrs~~~~dglS~se~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt~VPdEVfea~~~~~Vt~VnfskNqL~-elP  404 (565)
T KOG0472|consen  326 KYLRSKIKDDGLSQSEGGTETAMTLPSESFPDIYAIITTKILDVSDKQLTLVPDEVFEAAKSEIVTSVNFSKNQLC-ELP  404 (565)
T ss_pred             HHHHHhhccCCCCCCcccccccCCCCCCcccchhhhhhhhhhcccccccccCCHHHHHHhhhcceEEEecccchHh-hhh
Confidence                                   11111    22355678899999999877666666544   889999999999 788


Q ss_pred             hhccCCCCcce-eeeccccccCCCccccccccccceeeeeccccCCCCCcccccccCCCeeeCCCCcccCCCCccccccc
Q 002010          474 AAIGNLPSLNI-LSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYGKIPPGISKLI  552 (982)
Q Consensus       474 ~~~~~l~~L~~-L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~  552 (982)
                      ..+..+..+.+ +.+++|.++ .+|..+..+++|+.|+|++|-+. .+|.+++.+..|+.||+|+|+|. .+|..+-.+.
T Consensus       405 k~L~~lkelvT~l~lsnn~is-fv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq  481 (565)
T KOG0472|consen  405 KRLVELKELVTDLVLSNNKIS-FVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQ  481 (565)
T ss_pred             hhhHHHHHHHHHHHhhcCccc-cchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHH
Confidence            88777776654 566666665 89999999999999999999998 79999999999999999999997 8999988888


Q ss_pred             ccceEEcccccccccCccccccccccceecccCCccccCCCCCccccccccccccCCcCc
Q 002010          553 DLSILNLSRNGITGSIPNEMRNMMSLTTLDLSYNNLIGNIPSGGQFLAFNETSFIGNPNL  612 (982)
Q Consensus       553 ~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~~~~~~~~~~~~~~n~~~  612 (982)
                      .|+.+-.++|++....|..+.+|.+|.+|||.+|.+...+|..+.+.++......|||..
T Consensus       482 ~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq~IPp~LgnmtnL~hLeL~gNpfr  541 (565)
T KOG0472|consen  482 TLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQQIPPILGNMTNLRHLELDGNPFR  541 (565)
T ss_pred             HHHHHHhccccccccChHHhhhhhhcceeccCCCchhhCChhhccccceeEEEecCCccC
Confidence            899988899999866666699999999999999999988888888999999999999865

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=6.8e-40  Score=324.78  Aligned_cols=238  Identities=24%  Similarity=0.299  Sum_probs=203.4

Q ss_pred             HhhcccccccccccceEEEEEEe-CCCcEEEEEEeccCC--CCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEE
Q 002010          691 LESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRG--TGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLL  767 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  767 (982)
                      .++|+..+.||.|+||.|..++. .+|..+|+|++.+..  .....+...+|..+++.+.||+++++++.+.+.+..|+|
T Consensus        43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv  122 (355)
T KOG0616|consen   43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV  122 (355)
T ss_pred             hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence            45688889999999999999965 458899999984432  223345678899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhcccc
Q 002010          768 YEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDA  847 (982)
Q Consensus       768 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  847 (982)
                      |||++||.|..+++  +.+++++..++.++.||+.|++|||+.+   |++||+||+|||+|.+|.+||+|||.|+.+.+.
T Consensus       123 meyv~GGElFS~Lr--k~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r  197 (355)
T KOG0616|consen  123 MEYVPGGELFSYLR--KSGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR  197 (355)
T ss_pred             EeccCCccHHHHHH--hcCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecCc
Confidence            99999999999997  6679999999999999999999999988   999999999999999999999999999877532


Q ss_pred             CCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccce
Q 002010          848 GASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLA  927 (982)
Q Consensus       848 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  927 (982)
                           .-..+|||.|+|||.+....|+.++|+|||||++|||+.|.+||.+......+..++.....             
T Consensus       198 -----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~-------------  259 (355)
T KOG0616|consen  198 -----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVK-------------  259 (355)
T ss_pred             -----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCccc-------------
Confidence                 45689999999999999999999999999999999999999999876553333333333222             


Q ss_pred             eecCCCCCCChHhHHHHHHHHhhccCCCCCCC
Q 002010          928 VVDPRLSGYPLTGVIHLFKVAMMCVEDESSAR  959 (982)
Q Consensus       928 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R  959 (982)
                              +|.-....+.+|++..+++|-.+|
T Consensus       260 --------fP~~fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  260 --------FPSYFSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             --------CCcccCHHHHHHHHHHHhhhhHhh
Confidence                    222333468899999999999988

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-40  Score=350.97  Aligned_cols=246  Identities=28%  Similarity=0.444  Sum_probs=209.7

Q ss_pred             HhhcccccccccccceEEEEEEeCCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEec
Q 002010          691 LESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEY  770 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  770 (982)
                      ++.+...+.+|.|+-|.||.|+. .++.||||+++.-        -..+|+-+++++||||+.|.|+|.....++|||||
T Consensus       123 Fe~IsELeWlGSGaQGAVF~Grl-~netVAVKKV~el--------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEf  193 (904)
T KOG4721|consen  123 FEEISELEWLGSGAQGAVFLGRL-HNETVAVKKVREL--------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEF  193 (904)
T ss_pred             HHHhhhhhhhccCcccceeeeec-cCceehhHHHhhh--------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeec
Confidence            45566678999999999999998 7889999987332        23678899999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCc
Q 002010          771 MPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS  850 (982)
Q Consensus       771 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  850 (982)
                      |..|-|+..++  ....+.......|.++||.||.|||.+.   |||||||.-||||+.+..|||+|||-++...+.   
T Consensus       194 Ca~GqL~~VLk--a~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---  265 (904)
T KOG4721|consen  194 CAQGQLYEVLK--AGRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDK---  265 (904)
T ss_pred             cccccHHHHHh--ccCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhh---
Confidence            99999999997  5568888999999999999999999887   999999999999999999999999999987643   


Q ss_pred             ccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceeec
Q 002010          851 ECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVD  930 (982)
Q Consensus       851 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  930 (982)
                      ..+..++||..|||||++.+...++|+|||||||++|||+||..||.+.+..    .++...+.                
T Consensus       266 STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss----AIIwGVGs----------------  325 (904)
T KOG4721|consen  266 STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS----AIIWGVGS----------------  325 (904)
T ss_pred             hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchh----eeEEeccC----------------
Confidence            3345689999999999999999999999999999999999999999764321    11111111                


Q ss_pred             CCCC-CCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 002010          931 PRLS-GYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPP  973 (982)
Q Consensus       931 ~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~  973 (982)
                      ..+. ..|..++..+.-|++.||+..|..||++.+++.-|+-+.
T Consensus       326 NsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~  369 (904)
T KOG4721|consen  326 NSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIAS  369 (904)
T ss_pred             CcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcC
Confidence            1122 456778888999999999999999999999998776543

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-39  Score=355.05  Aligned_cols=250  Identities=26%  Similarity=0.349  Sum_probs=208.4

Q ss_pred             HHhhcccccccccccceEEEEEE-eCCCcEEEEEEeccCCC----CCchhhHHHHHHHHhcCC-CCcccceEeEEEcCCc
Q 002010          690 VLESLKDENIIGKGGAGIVYRGS-MPDGIDVAIKRLVGRGT----GGNDHGFLAEIQTLGRIR-HRNIVRLLGYVSNRDT  763 (982)
Q Consensus       690 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~  763 (982)
                      ....|+.++.||+|+||.|+.|. ..+++.||+|.+.....    ....+.+.+|+.++++++ ||||+++++++.....
T Consensus        15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~   94 (370)
T KOG0583|consen   15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK   94 (370)
T ss_pred             ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence            34679999999999999999994 45789999996644311    133456678999999998 9999999999999999


Q ss_pred             cEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCC-CCEEEeccccch
Q 002010          764 NLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSD-FEAHVADFGLAK  842 (982)
Q Consensus       764 ~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~-~~~kl~DfG~a~  842 (982)
                      .++||||+.||+|.+++..  .+++.+.++.++++|++.|++|+|+.|   |+||||||+||+++.+ +.+||+|||++.
T Consensus        95 ~~ivmEy~~gGdL~~~i~~--~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~s~  169 (370)
T KOG0583|consen   95 IYIVMEYCSGGDLFDYIVN--KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGLSA  169 (370)
T ss_pred             EEEEEEecCCccHHHHHHH--cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEecccccc
Confidence            9999999999999999984  678999999999999999999999998   9999999999999999 999999999998


Q ss_pred             hccccCCcccccccccccccccccccccCC-CC-cchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCC
Q 002010          843 FLQDAGASECMSSVAGSYGYIAPEYAYTLK-VD-EKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPS  920 (982)
Q Consensus       843 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  920 (982)
                      ...  .........+||+.|+|||++.+.. |+ .++||||+||++|-|++|+.||.+.........+....   .    
T Consensus       170 ~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~---~----  240 (370)
T KOG0583|consen  170 ISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGE---F----  240 (370)
T ss_pred             ccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCC---c----
Confidence            774  2334567789999999999999887 86 78999999999999999999998733322222211111   1    


Q ss_pred             cccccceeecCCCCCCChHh-HHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          921 DAASVLAVVDPRLSGYPLTG-VIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       921 ~~~~~~~~~~~~~~~~~~~~-~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                                    .+|... ..++.+++.+|+..||.+|+|+.|+++
T Consensus       241 --------------~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~  274 (370)
T KOG0583|consen  241 --------------KIPSYLLSPEARSLIEKMLVPDPSTRITLLEILE  274 (370)
T ss_pred             --------------cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence                          122222 457899999999999999999999993

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.5e-40  Score=341.98  Aligned_cols=248  Identities=25%  Similarity=0.330  Sum_probs=209.7

Q ss_pred             hcccccccccccceEEEEEE-eCCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEecc
Q 002010          693 SLKDENIIGKGGAGIVYRGS-MPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYM  771 (982)
Q Consensus       693 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  771 (982)
                      .|+..+.||+|.||.||+|. ...++.||+|++.-........++.+|+.++.+++++||.++|+.|..+...+++||||
T Consensus        14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~   93 (467)
T KOG0201|consen   14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYC   93 (467)
T ss_pred             ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHh
Confidence            46666899999999999995 46789999999977777777788999999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCcc
Q 002010          772 PNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASE  851 (982)
Q Consensus       772 ~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~  851 (982)
                      .||++.+.++  ....+++..+..+++++..|+.|+|.++   .+|||||+.||++..+|.+|++|||.+-.+.....  
T Consensus        94 ~gGsv~~lL~--~~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~--  166 (467)
T KOG0201|consen   94 GGGSVLDLLK--SGNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK--  166 (467)
T ss_pred             cCcchhhhhc--cCCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhh--
Confidence            9999999996  3445588888999999999999999988   99999999999999999999999999988764422  


Q ss_pred             cccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceeecC
Q 002010          852 CMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDP  931 (982)
Q Consensus       852 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  931 (982)
                      .....+||+.|||||++....|+.|+||||+|++.+||.+|.+|+.+..+.... -.                   +...
T Consensus       167 rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvl-fl-------------------Ipk~  226 (467)
T KOG0201|consen  167 RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVL-FL-------------------IPKS  226 (467)
T ss_pred             ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEE-Ee-------------------ccCC
Confidence            226789999999999999999999999999999999999999999876442111 00                   0000


Q ss_pred             CCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          932 RLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       932 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                      .-+.+.......+.+|+..|+++||+.||+|.++++
T Consensus       227 ~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK  262 (467)
T KOG0201|consen  227 APPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLK  262 (467)
T ss_pred             CCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence            111122244557899999999999999999999987

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.6e-39  Score=313.01  Aligned_cols=249  Identities=27%  Similarity=0.366  Sum_probs=216.0

Q ss_pred             HhhcccccccccccceEEEEEEe-CCCcEEEEEEeccCC--CCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEE
Q 002010          691 LESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRG--TGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLL  767 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  767 (982)
                      .++|++++.||+|.||.||.|+. +++..||+|++.+.+  .......+.+|+++-..++||||+++|++|.++...|++
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi  100 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI  100 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence            46789999999999999999965 567889999985543  233456788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhcccc
Q 002010          768 YEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDA  847 (982)
Q Consensus       768 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  847 (982)
                      +||..+|+++..+...+..++++...+.++.|+|.|+.|+|..+   |+||||||+|+|++.++.+|++|||.+..-.  
T Consensus       101 lEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p--  175 (281)
T KOG0580|consen  101 LEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP--  175 (281)
T ss_pred             EEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC--
Confidence            99999999999999888889999999999999999999999888   9999999999999999999999999987543  


Q ss_pred             CCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccce
Q 002010          848 GASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLA  927 (982)
Q Consensus       848 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  927 (982)
                        .......+||..|.|||+..+..++..+|+|++|++.||++.|.+||......+.+.++.+-...             
T Consensus       176 --~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~-------------  240 (281)
T KOG0580|consen  176 --SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLK-------------  240 (281)
T ss_pred             --CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHcccc-------------
Confidence              33446689999999999999999999999999999999999999999886655554444433222             


Q ss_pred             eecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          928 VVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       928 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                              +|........++|.+|+.++|.+|.+..|+++
T Consensus       241 --------~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~  272 (281)
T KOG0580|consen  241 --------FPSTISGGAADLISRLLVKNPIERLALTEVMD  272 (281)
T ss_pred             --------CCcccChhHHHHHHHHhccCccccccHHHHhh
Confidence                    22334447889999999999999999999876

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.6e-39  Score=351.25  Aligned_cols=247  Identities=29%  Similarity=0.390  Sum_probs=211.8

Q ss_pred             hhcccccccccccceEEEEEE-eCCCcEEEEEEeccCC--CCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEE
Q 002010          692 ESLKDENIIGKGGAGIVYRGS-MPDGIDVAIKRLVGRG--TGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLY  768 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  768 (982)
                      .-|+.++.||.|+.|.|-.|+ ..+|+.+|||.+.+..  +......+.+|+-+|+-+.||||+++|+.+++..++|+|.
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl   91 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL   91 (786)
T ss_pred             cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence            457888999999999999995 4679999999996552  3445667889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccC
Q 002010          769 EYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAG  848 (982)
Q Consensus       769 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  848 (982)
                      ||+++|.|++++-  +.+++++.++++++.||+.|+.|+|..+   |+|||+||+|+++|..+.+||+|||+|..-..  
T Consensus        92 Eyv~gGELFdylv--~kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~--  164 (786)
T KOG0588|consen   92 EYVPGGELFDYLV--RKGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVP--  164 (786)
T ss_pred             EecCCchhHHHHH--hhCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccC--
Confidence            9999999999997  6689999999999999999999999998   99999999999999999999999999986432  


Q ss_pred             CcccccccccccccccccccccCCCC-cchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccce
Q 002010          849 ASECMSSVAGSYGYIAPEYAYTLKVD-EKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLA  927 (982)
Q Consensus       849 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  927 (982)
                       .......+|++.|.|||++.+..|. .++||||+|||+|.|+||+.||++.    .+...+.+....            
T Consensus       165 -gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDd----Nir~LLlKV~~G------------  227 (786)
T KOG0588|consen  165 -GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDD----NIRVLLLKVQRG------------  227 (786)
T ss_pred             -CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCc----cHHHHHHHHHcC------------
Confidence             3455678999999999999999985 7999999999999999999999742    233333332221            


Q ss_pred             eecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          928 VVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       928 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                           .-++|...+.+.++|+.+|+..||++|.|++||++
T Consensus       228 -----~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~k  262 (786)
T KOG0588|consen  228 -----VFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILK  262 (786)
T ss_pred             -----cccCCCcCCHHHHHHHHHHhccCccccccHHHHhh
Confidence                 01234455568899999999999999999999987

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=1.1e-38  Score=341.64  Aligned_cols=254  Identities=22%  Similarity=0.276  Sum_probs=206.1

Q ss_pred             HhhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCC--CCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEE
Q 002010          691 LESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGT--GGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLL  767 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  767 (982)
                      .++|+..+.||+|+||.||.|+. .+|+.+|+|++++...  ......+..|..+|...++|+||++|.+|++.+..|+|
T Consensus       140 ~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLi  219 (550)
T KOG0605|consen  140 LDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLI  219 (550)
T ss_pred             cccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEE
Confidence            46788999999999999999965 4699999999966543  34456788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhcccc
Q 002010          768 YEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDA  847 (982)
Q Consensus       768 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  847 (982)
                      |||++||++..+|.  +.+.+++..+..++.+++.|+..+|+.|   ||||||||+|+|||..|++||+|||++..+...
T Consensus       220 MEylPGGD~mTLL~--~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~  294 (550)
T KOG0605|consen  220 MEYLPGGDMMTLLM--RKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKK  294 (550)
T ss_pred             EEecCCccHHHHHH--hcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhhhh
Confidence            99999999999997  6679999999999999999999999999   999999999999999999999999998643210


Q ss_pred             ----------------------CCc-----cc------------------ccccccccccccccccccCCCCcchhhHHH
Q 002010          848 ----------------------GAS-----EC------------------MSSVAGSYGYIAPEYAYTLKVDEKSDVYSF  882 (982)
Q Consensus       848 ----------------------~~~-----~~------------------~~~~~gt~~y~aPE~~~~~~~~~~~Dvwsl  882 (982)
                                            ...     ..                  ..+.+|||.|||||++.+..|+..+|+||+
T Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSL  374 (550)
T KOG0605|consen  295 HRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSL  374 (550)
T ss_pred             hhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHH
Confidence                                  000     00                  113479999999999999999999999999


Q ss_pred             HHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCC-
Q 002010          883 GVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPT-  961 (982)
Q Consensus       883 G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt-  961 (982)
                      |||+|||+.|.+||......+....++ ........|..                .....+..++|.+|+. ||++|.- 
T Consensus       375 G~ImyEmLvGyPPF~s~tp~~T~rkI~-nwr~~l~fP~~----------------~~~s~eA~DLI~rll~-d~~~RLG~  436 (550)
T KOG0605|consen  375 GCIMYEMLVGYPPFCSETPQETYRKIV-NWRETLKFPEE----------------VDLSDEAKDLITRLLC-DPENRLGS  436 (550)
T ss_pred             HHHHHHHHhCCCCCCCCCHHHHHHHHH-HHhhhccCCCc----------------CcccHHHHHHHHHHhc-CHHHhcCc
Confidence            999999999999998754443333332 22221111111                1112578899999999 9999985 


Q ss_pred             --HHHHHH
Q 002010          962 --MREVVH  967 (982)
Q Consensus       962 --~~ell~  967 (982)
                        ++||.+
T Consensus       437 ~G~~EIK~  444 (550)
T KOG0605|consen  437 KGAEEIKK  444 (550)
T ss_pred             ccHHHHhc
Confidence              666654

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=2.3e-38  Score=318.51  Aligned_cols=273  Identities=24%  Similarity=0.253  Sum_probs=218.6

Q ss_pred             HHHHhhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCC-CCchhhHHHHHHHHhcCCCCcccceEeEEEc--CCc
Q 002010          688 EDVLESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGT-GGNDHGFLAEIQTLGRIRHRNIVRLLGYVSN--RDT  763 (982)
Q Consensus       688 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~  763 (982)
                      ..-++.|+..+.|++|+||.||+|+. ++++.||+|+++.... ..-.....+|+.++.+++|||||.+-++...  -+.
T Consensus        72 Crsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~  151 (419)
T KOG0663|consen   72 CRSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDK  151 (419)
T ss_pred             cccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccce
Confidence            34467789999999999999999964 5689999999965432 2234457899999999999999999987654  456


Q ss_pred             cEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchh
Q 002010          764 NLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKF  843 (982)
Q Consensus       764 ~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~  843 (982)
                      .|+|||||+. +|...++..+ +++...++..++.|+++|++|||++.   |+|||+|++|+|++..|.+||+|||+|+.
T Consensus       152 iy~VMe~~Eh-DLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~  226 (419)
T KOG0663|consen  152 IYIVMEYVEH-DLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLARE  226 (419)
T ss_pred             eeeeHHHHHh-hHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhh
Confidence            8999999965 8999887543 78999999999999999999999888   99999999999999999999999999999


Q ss_pred             ccccCCcccccccccccccccccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcc
Q 002010          844 LQDAGASECMSSVAGSYGYIAPEYAYTL-KVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDA  922 (982)
Q Consensus       844 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  922 (982)
                      +..+  ...++..+-|..|+|||.+.+. .|+.+.|+||+|||+.||+++++-|.+..+.+.+..+++..+.+....+..
T Consensus       227 ygsp--~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg  304 (419)
T KOG0663|consen  227 YGSP--LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPG  304 (419)
T ss_pred             hcCC--cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCC
Confidence            8754  3446677889999999998865 599999999999999999999999998777766777776666544443333


Q ss_pred             cccceeec-CCCCCC---------ChH-hHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          923 ASVLAVVD-PRLSGY---------PLT-GVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       923 ~~~~~~~~-~~~~~~---------~~~-~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                      -.....+. -.++..         +.. ....-++++..++..||.+|.||+|.++
T Consensus       305 ~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~  360 (419)
T KOG0663|consen  305 YSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK  360 (419)
T ss_pred             ccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence            22222221 111111         111 2345678999999999999999999886

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3e-39  Score=355.59  Aligned_cols=259  Identities=27%  Similarity=0.408  Sum_probs=210.6

Q ss_pred             hhcccccccccccceEEEEEEeC--CC---cEEEEEEecc--CCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCcc
Q 002010          692 ESLKDENIIGKGGAGIVYRGSMP--DG---IDVAIKRLVG--RGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTN  764 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~~--~~---~~vavK~~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  764 (982)
                      ++....+.||+|+||.||+|+..  ++   ..||||..+.  ........++++|+++|++++|||||++||++..+...
T Consensus       157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl  236 (474)
T KOG0194|consen  157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPL  236 (474)
T ss_pred             cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCcc
Confidence            34455689999999999999653  22   2389998864  23455667899999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhc
Q 002010          765 LLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFL  844 (982)
Q Consensus       765 ~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~  844 (982)
                      ++|||+|.||+|.+++++.. ..++..++..++.+.|+||+|||+++   ++||||.++|+|++.++.+||+|||+++.-
T Consensus       237 ~ivmEl~~gGsL~~~L~k~~-~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs~~~  312 (474)
T KOG0194|consen  237 MLVMELCNGGSLDDYLKKNK-KSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLSRAG  312 (474)
T ss_pred             EEEEEecCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCccccccCC
Confidence            99999999999999998543 36999999999999999999999988   999999999999999999999999998754


Q ss_pred             cccCCccccc-ccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHhccCCCCCCcc
Q 002010          845 QDAGASECMS-SVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDA  922 (982)
Q Consensus       845 ~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  922 (982)
                      ..   ..... ...-+.+|+|||.+....|++++|||||||++||+++ |..||.+.... +...++.....+.      
T Consensus       313 ~~---~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~-~v~~kI~~~~~r~------  382 (474)
T KOG0194|consen  313 SQ---YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY-EVKAKIVKNGYRM------  382 (474)
T ss_pred             cc---eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH-HHHHHHHhcCccC------
Confidence            31   11111 2234679999999999999999999999999999999 89999876543 3333332222111      


Q ss_pred             cccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCCCC
Q 002010          923 ASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQSA  976 (982)
Q Consensus       923 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~~~~  976 (982)
                                  ..+...+..+..++.+||..||++||||.++.+.++.+....
T Consensus       383 ------------~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~  424 (474)
T KOG0194|consen  383 ------------PIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKK  424 (474)
T ss_pred             ------------CCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcc
Confidence                        223355668889999999999999999999999997766543

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=100.00  E-value=8.6e-40  Score=349.45  Aligned_cols=364  Identities=23%  Similarity=0.199  Sum_probs=268.0

Q ss_pred             ccEEeccCccccCCCchhccccccccEEeecCcccccccCCCccccCcceEeeccCcccccchhhHHhhhhhHHHHhhcc
Q 002010          146 LQVLDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLNGIGLNGTVPAFLSRLKNLREMYIGY  225 (982)
Q Consensus       146 L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~l~~  225 (982)
                      -++||+++|+++..-+..|.++++|+++++.+|.++ .+|.-.....+|+.|+|.+|.|...-...++            
T Consensus        80 t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~sv~se~L~------------  146 (873)
T KOG4194|consen   80 TQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLISSVTSEELS------------  146 (873)
T ss_pred             eeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeeeccccccccHHHHH------------
Confidence            356777888777777777778888888888888777 6676555556678888877777654444433            


Q ss_pred             cccccccCCCCCCCCCCCCEEecccCcCcccCchhhcCCCccceeecccccCCCCCCccccCCCCCCEEEeeCCcccCcC
Q 002010          226 FNTYTGGIPPGFGALTQLQVLDMASCNISGEIPTSLSRLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEI  305 (982)
Q Consensus       226 ~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~  305 (982)
                                   .++.|+.|||+.|.|+.....+|..-.++++|+|++|+|+......|.++.+|..|.|+.|+|+...
T Consensus       147 -------------~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp  213 (873)
T KOG4194|consen  147 -------------ALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLP  213 (873)
T ss_pred             -------------hHhhhhhhhhhhchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccccC
Confidence                         3455666777777787555567777788888899999988888888888889999999999999777


Q ss_pred             chhhhcccchhhhhhccCCCCCCCCCcCCCCCCccEEEccCCCcccccCccccCCCcccEEEeccccccccCCccccCcc
Q 002010          306 PESFAALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDLCKGG  385 (982)
Q Consensus       306 ~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~  385 (982)
                      +.+|+.+++|+.|+|..|+|.-.---.|.++++|+.|.|..|.+.......|..+.+++.|+|+.|+++..-..++.+++
T Consensus       214 ~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt  293 (873)
T KOG4194|consen  214 QRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLT  293 (873)
T ss_pred             HHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccc
Confidence            78888899999999999998844467788899999999999998877777888888899999999998877777888888


Q ss_pred             ccceeecccccccccCCccccCCCCCCEEEccCCccCCCCCccccCCCccccccCCCccccccCCcccccCCccEEEeec
Q 002010          386 KLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLSGELPEKMSGASLNQLKVAN  465 (982)
Q Consensus       386 ~L~~L~l~~N~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~L~~  465 (982)
                      +|+.|++++|.|....++.+.-+++|++|+|++|+|+...+..|..+..|++|.|++|.                     
T Consensus       294 ~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Ns---------------------  352 (873)
T KOG4194|consen  294 SLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNS---------------------  352 (873)
T ss_pred             hhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccc---------------------
Confidence            88888888888888888888888888888888888886666666655555444444444                     


Q ss_pred             cccCCCCchhccCCCCcceeeeccccccCCCcc---ccccccccceeeeeccccCCCCCcccccccCCCeeeCCCCcccC
Q 002010          466 NNITGKIPAAIGNLPSLNILSLQNNRLEGEIPV---ESFNLKMITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYG  542 (982)
Q Consensus       466 N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~---~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~  542 (982)
                        ++..-...|..+.+|+.|||++|.|+..+..   .|..|+.|+.|+|.+|+|..+....|.++..|+.|||.+|.|..
T Consensus       353 --i~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaS  430 (873)
T KOG4194|consen  353 --IDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIAS  430 (873)
T ss_pred             --hHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCccee
Confidence              4434445666777777788888777755443   24456666666666666664444556666666666666666665


Q ss_pred             CCCcccccccccceEEc
Q 002010          543 KIPPGISKLIDLSILNL  559 (982)
Q Consensus       543 ~~p~~~~~l~~L~~L~L  559 (982)
                      +-|.+|..+ .|++|.+
T Consensus       431 Iq~nAFe~m-~Lk~Lv~  446 (873)
T KOG4194|consen  431 IQPNAFEPM-ELKELVM  446 (873)
T ss_pred             ecccccccc-hhhhhhh
Confidence            556666665 5555544

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=8e-38  Score=344.66  Aligned_cols=264  Identities=25%  Similarity=0.398  Sum_probs=206.4

Q ss_pred             hhcccccccccccceEEEEEEeCC-----------------CcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccce
Q 002010          692 ESLKDENIIGKGGAGIVYRGSMPD-----------------GIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRL  754 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~  754 (982)
                      ++|+..+.||+|+||.||+|.+.+                 +..||+|.+...........+.+|+.++.+++||||+++
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~   84 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL   84 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence            468888999999999999996432                 346999988654444445678999999999999999999


Q ss_pred             EeEEEcCCccEEEEeccCCCCHHHHhhcCC-----------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEe
Q 002010          755 LGYVSNRDTNLLLYEYMPNGSLGEMLHGAK-----------------GGHLKWETRYRIALEAAKGLCYLHHDCSPLIIH  817 (982)
Q Consensus       755 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-----------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH  817 (982)
                      ++++.+.+..++||||+++++|.+++....                 ...+++..+.+++.||+.|++|||+.+   |+|
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---ivH  161 (304)
T cd05096          85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVH  161 (304)
T ss_pred             EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccc
Confidence            999999999999999999999999986421                 124678889999999999999999988   999


Q ss_pred             cCCCCCcEEEcCCCCEEEeccccchhccccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHh--CCCC
Q 002010          818 RDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA--GKKP  895 (982)
Q Consensus       818 rDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt--g~~p  895 (982)
                      |||||+||+++.++.+||+|||+++.+.............++..|+|||++.+..++.++||||+|+++|||++  +..|
T Consensus       162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p  241 (304)
T cd05096         162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP  241 (304)
T ss_pred             cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence            99999999999999999999999986654332222334456789999999988889999999999999999987  5678


Q ss_pred             CCCCCCCchHHHHHHHhccCCCCCCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 002010          896 VGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLAN  971 (982)
Q Consensus       896 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~  971 (982)
                      |....... ....+.........            ......+..++..+.+++.+||+.||++|||++||.+.|++
T Consensus       242 ~~~~~~~~-~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~  304 (304)
T cd05096         242 YGELTDEQ-VIENAGEFFRDQGR------------QVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE  304 (304)
T ss_pred             CCcCCHHH-HHHHHHHHhhhccc------------cccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence            87654332 22222211110000            00011223445678999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=6.7e-38  Score=354.23  Aligned_cols=260  Identities=23%  Similarity=0.387  Sum_probs=209.6

Q ss_pred             HhhcccccccccccceEEEEEEe------CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcC-CCCcccceEeEEEcCCc
Q 002010          691 LESLKDENIIGKGGAGIVYRGSM------PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRI-RHRNIVRLLGYVSNRDT  763 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~  763 (982)
                      .++|+..+.||+|+||.||+|..      .++..||||++.........+.+.+|+.++..+ +||||+++++++.+.+.
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~  113 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP  113 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence            45788999999999999999953      235689999986554444556788999999999 89999999999999999


Q ss_pred             cEEEEeccCCCCHHHHhhcCC-----------------------------------------------------------
Q 002010          764 NLLLYEYMPNGSLGEMLHGAK-----------------------------------------------------------  784 (982)
Q Consensus       764 ~~lv~e~~~~~sL~~~l~~~~-----------------------------------------------------------  784 (982)
                      .++||||+++|+|.+++....                                                           
T Consensus       114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (375)
T cd05104         114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS  193 (375)
T ss_pred             ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence            999999999999999986422                                                           


Q ss_pred             --------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCc
Q 002010          785 --------------GGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS  850 (982)
Q Consensus       785 --------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  850 (982)
                                    ...++++.+..++.||+.|++|||+.+   |+||||||+||+++.++.+||+|||+++........
T Consensus       194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  270 (375)
T cd05104         194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY  270 (375)
T ss_pred             ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence                          124788899999999999999999988   999999999999999999999999999866533222


Q ss_pred             ccccccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceee
Q 002010          851 ECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVV  929 (982)
Q Consensus       851 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  929 (982)
                      .......++..|+|||++.+..++.++|||||||++|||++ |..||............+......              
T Consensus       271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~--------------  336 (375)
T cd05104         271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRM--------------  336 (375)
T ss_pred             cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccC--------------
Confidence            22223345678999999999999999999999999999998 899997654444444433322110              


Q ss_pred             cCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 002010          930 DPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANP  972 (982)
Q Consensus       930 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~  972 (982)
                           ..+...+.++.+++.+||+.||++|||++||++.|++.
T Consensus       337 -----~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         337 -----LSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             -----CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence                 01112235789999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.2e-38  Score=326.42  Aligned_cols=247  Identities=23%  Similarity=0.353  Sum_probs=209.1

Q ss_pred             HhhcccccccccccceEEEEEE-eCCCcEEEEEEeccCCCCC--chhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEE
Q 002010          691 LESLKDENIIGKGGAGIVYRGS-MPDGIDVAIKRLVGRGTGG--NDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLL  767 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  767 (982)
                      ..+|++.+.||+|.||.|-+|. .+.|+.||||.+++.....  ..-.+.+|++||..++||||+.+|++|+..+...+|
T Consensus        52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv  131 (668)
T KOG0611|consen   52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV  131 (668)
T ss_pred             hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence            3568888899999999999994 4789999999996664433  334678999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhcccc
Q 002010          768 YEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDA  847 (982)
Q Consensus       768 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  847 (982)
                      |||..+|.|++|+.  +.+.+++.++..+++||..|+.|+|+++   ++|||+|.+||++|+++++||+|||++..+.+.
T Consensus       132 MEYaS~GeLYDYiS--er~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~~  206 (668)
T KOG0611|consen  132 MEYASGGELYDYIS--ERGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYADK  206 (668)
T ss_pred             EEecCCccHHHHHH--HhccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhccc
Confidence            99999999999997  5678999999999999999999999998   999999999999999999999999999988753


Q ss_pred             CCcccccccccccccccccccccCCCC-cchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccc
Q 002010          848 GASECMSSVAGSYGYIAPEYAYTLKVD-EKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVL  926 (982)
Q Consensus       848 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  926 (982)
                         ......+|++-|.+||.+.+..|. +.+|.||+||++|.++.|..||++.+......++-......+..|       
T Consensus       207 ---kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~~P-------  276 (668)
T KOG0611|consen  207 ---KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPETP-------  276 (668)
T ss_pred             ---cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCCCC-------
Confidence               445778999999999999999884 789999999999999999999976533222222222222222222       


Q ss_pred             eeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          927 AVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       927 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                                     ....-+|++|+..+|++|.|+++|..
T Consensus       277 ---------------SdA~gLIRwmLmVNP~RRATieDiAs  302 (668)
T KOG0611|consen  277 ---------------SDASGLIRWMLMVNPERRATIEDIAS  302 (668)
T ss_pred             ---------------chHHHHHHHHHhcCcccchhHHHHhh
Confidence                           24567899999999999999999875

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-39  Score=348.33  Aligned_cols=374  Identities=23%  Similarity=0.204  Sum_probs=309.1

Q ss_pred             CCCEEecccCcCcccCchhhcCCCccceeecccccCCCCCCccccCCCCCCEEEeeCCcccCcCchhhhcccchhhhhhc
Q 002010          242 QLQVLDMASCNISGEIPTSLSRLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQLF  321 (982)
Q Consensus       242 ~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~  321 (982)
                      .-+.|++++|.++..-+..|.++++|+++++..|.++ .+|........|+.|+|.+|.|+..-.+.++.++.|+.||||
T Consensus        79 ~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLS  157 (873)
T KOG4194|consen   79 QTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLS  157 (873)
T ss_pred             ceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeeeccccccccHHHHHhHhhhhhhhhh
Confidence            3467899999998888888889999999999999998 677655556669999999999988778888888999999999


Q ss_pred             cCCCCCCCCCcCCCCCCccEEEccCCCcccccCccccCCCcccEEEeccccccccCCccccCccccceeecccccccccC
Q 002010          322 KNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFIGPI  401 (982)
Q Consensus       322 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~l~~N~~~~~~  401 (982)
                      .|.|+.+.-..|..-.++++|+|++|.|+..-...|..+.+|..|.|++|+++...+..|.++++|+.|+|..|+|.-..
T Consensus       158 rN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive  237 (873)
T KOG4194|consen  158 RNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVE  237 (873)
T ss_pred             hchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccccCHHHhhhcchhhhhhccccceeeeh
Confidence            99998665566777778999999999998877888888889999999999998666677777999999999999887666


Q ss_pred             CccccCCCCCCEEEccCCccCCCCCccccCCCccccccCCCccccccCCccccc-CCccEEEeeccccCCCCchhccCCC
Q 002010          402 PEELGQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLSGELPEKMSG-ASLNQLKVANNNITGKIPAAIGNLP  480 (982)
Q Consensus       402 ~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~-~~L~~L~L~~N~i~~~~p~~~~~l~  480 (982)
                      --.|.++++|+.|.|..|.+.......|..+.++++|+|+.|++...-..++.+ ++|++|+||+|.|..+.++.+.-.+
T Consensus       238 ~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~Wsftq  317 (873)
T KOG4194|consen  238 GLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQ  317 (873)
T ss_pred             hhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcc
Confidence            778888999999999999988777778888999999999999988776665554 7899999999999888888888888


Q ss_pred             CcceeeeccccccCCCccccccccccceeeeeccccCCCCCcccccccCCCeeeCCCCcccCCCCc---ccccccccceE
Q 002010          481 SLNILSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYGKIPP---GISKLIDLSIL  557 (982)
Q Consensus       481 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~---~~~~l~~L~~L  557 (982)
                      +|++|+|++|+|+...+..|..+..|++|+|++|+|+..-...|..+++|+.|||++|.|+..|.+   .|.+|++|+.|
T Consensus       318 kL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL  397 (873)
T KOG4194|consen  318 KLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKL  397 (873)
T ss_pred             cceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhhe
Confidence            999999999999877777888899999999999999877777888899999999999998877653   47888999999


Q ss_pred             EcccccccccCccccccccccceecccCCccccCCCCCccccccccccccCCcCcccCC
Q 002010          558 NLSRNGITGSIPNEMRNMMSLTTLDLSYNNLIGNIPSGGQFLAFNETSFIGNPNLCLLR  616 (982)
Q Consensus       558 ~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~~~~~~~~~~~~~~n~~~c~~~  616 (982)
                      +|.+|+|..+...+|.++..|+.|||.+|.+...-|....-..+.+.-+..-..+|++.
T Consensus       398 ~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m~Lk~Lv~nSssflCDCq  456 (873)
T KOG4194|consen  398 RLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPMELKELVMNSSSFLCDCQ  456 (873)
T ss_pred             eecCceeeecchhhhccCcccceecCCCCcceeecccccccchhhhhhhcccceEEecc
Confidence            99999998666678999999999999999888665544322344555555566777764

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-38  Score=347.78  Aligned_cols=242  Identities=22%  Similarity=0.316  Sum_probs=206.5

Q ss_pred             hhcccccccccccceEEEEEEe-CCCcEEEEEEeccCC--CCCchhhHHHHHHHHhcC-CCCcccceEeEEEcCCccEEE
Q 002010          692 ESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRG--TGGNDHGFLAEIQTLGRI-RHRNIVRLLGYVSNRDTNLLL  767 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv  767 (982)
                      ++|+..++||+|+||.|+.|.. .+++.||||++++..  ..++.+..+.|.+++... +||+++.++..|+..++.|+|
T Consensus       368 ~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fv  447 (694)
T KOG0694|consen  368 DDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFV  447 (694)
T ss_pred             cceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEE
Confidence            5788899999999999999975 458899999997664  345566788899888877 599999999999999999999


Q ss_pred             EeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhcccc
Q 002010          768 YEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDA  847 (982)
Q Consensus       768 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  847 (982)
                      |||+.||++..+.   ....+++..+..++..|+.||+|||+++   ||+||||.+|||+|.+|++||+|||+++.-.. 
T Consensus       448 mey~~Ggdm~~~~---~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~-  520 (694)
T KOG0694|consen  448 MEYVAGGDLMHHI---HTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKEGMG-  520 (694)
T ss_pred             EEecCCCcEEEEE---ecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccccccccCC-
Confidence            9999999944443   4578999999999999999999999999   99999999999999999999999999986432 


Q ss_pred             CCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccce
Q 002010          848 GASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLA  927 (982)
Q Consensus       848 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  927 (982)
                       ......+.+|||.|||||++.+..|+.++|+|||||++|||+.|+.||.+.++++.+..++.....             
T Consensus       521 -~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~-------------  586 (694)
T KOG0694|consen  521 -QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVR-------------  586 (694)
T ss_pred             -CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCC-------------
Confidence             234567899999999999999999999999999999999999999999876555554444433222             


Q ss_pred             eecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCH
Q 002010          928 VVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTM  962 (982)
Q Consensus       928 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~  962 (982)
                              +|...+.+..++|++++.++|++|.-+
T Consensus       587 --------yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  587 --------YPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             --------CCCcccHHHHHHHHHHhccCcccccCC
Confidence                    344455688999999999999999965

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=1.1e-37  Score=338.98  Aligned_cols=247  Identities=23%  Similarity=0.360  Sum_probs=200.8

Q ss_pred             cccccccceEEEEEEeCCCcEEEEEEeccCCCCC--chhhHHHHHHHHhcCCCCcccceEeEEEc----CCccEEEEecc
Q 002010          698 NIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGG--NDHGFLAEIQTLGRIRHRNIVRLLGYVSN----RDTNLLLYEYM  771 (982)
Q Consensus       698 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~lv~e~~  771 (982)
                      ..||+|++|.||+|.. +|+.||||++.......  ..+.+.+|+.++++++||||++++|++.+    ....++||||+
T Consensus        26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~  104 (283)
T PHA02988         26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC  104 (283)
T ss_pred             eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence            5799999999999988 78999999985442222  13567899999999999999999999876    34678999999


Q ss_pred             CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhc-CCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCc
Q 002010          772 PNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHD-CSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS  850 (982)
Q Consensus       772 ~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  850 (982)
                      ++|+|.+++..  ...+++.....++.|++.|++|+|+. +   ++||||||+||++++++.+||+|||+++.+....  
T Consensus       105 ~~g~L~~~l~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~--  177 (283)
T PHA02988        105 TRGYLREVLDK--EKDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP--  177 (283)
T ss_pred             CCCcHHHHHhh--CCCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhcccc--
Confidence            99999999973  45789999999999999999999974 6   8899999999999999999999999998654321  


Q ss_pred             cccccccccccccccccccc--CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCccccccee
Q 002010          851 ECMSSVAGSYGYIAPEYAYT--LKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAV  928 (982)
Q Consensus       851 ~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  928 (982)
                         ....++..|+|||++.+  ..++.++|||||||++|||++|+.||...... +....+.......            
T Consensus       178 ---~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~-~~~~~i~~~~~~~------------  241 (283)
T PHA02988        178 ---FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK-EIYDLIINKNNSL------------  241 (283)
T ss_pred             ---ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH-HHHHHHHhcCCCC------------
Confidence               23467889999999876  67999999999999999999999999865332 2222221111111            


Q ss_pred             ecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCC
Q 002010          929 VDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQ  974 (982)
Q Consensus       929 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~~  974 (982)
                            ..+..++..+.+++.+||+.||++|||++|+++.|+.+.+
T Consensus       242 ------~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~  281 (283)
T PHA02988        242 ------KLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF  281 (283)
T ss_pred             ------CCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence                  1222345679999999999999999999999999987643

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=7.9e-38  Score=353.23  Aligned_cols=261  Identities=25%  Similarity=0.412  Sum_probs=208.0

Q ss_pred             HhhcccccccccccceEEEEEEe------CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcC-CCCcccceEeEEEcCCc
Q 002010          691 LESLKDENIIGKGGAGIVYRGSM------PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRI-RHRNIVRLLGYVSNRDT  763 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~  763 (982)
                      .++|+..+.||+|+||.||+|..      .++..||+|++...........+.+|+.+++.+ +||||+++++++...+.
T Consensus        37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~  116 (374)
T cd05106          37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP  116 (374)
T ss_pred             HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence            35788999999999999999863      224579999986554444456788999999999 89999999999999999


Q ss_pred             cEEEEeccCCCCHHHHhhcCC-----------------------------------------------------------
Q 002010          764 NLLLYEYMPNGSLGEMLHGAK-----------------------------------------------------------  784 (982)
Q Consensus       764 ~~lv~e~~~~~sL~~~l~~~~-----------------------------------------------------------  784 (982)
                      .++||||+++|+|.+++....                                                           
T Consensus       117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (374)
T cd05106         117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD  196 (374)
T ss_pred             eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence            999999999999999985321                                                           


Q ss_pred             ---------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCcccccc
Q 002010          785 ---------GGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSS  855 (982)
Q Consensus       785 ---------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~  855 (982)
                               ..++++..+.+++.||+.|++|||+.+   |+||||||+||++++++.+||+|||+++.............
T Consensus       197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~  273 (374)
T cd05106         197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN  273 (374)
T ss_pred             ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence                     124788899999999999999999988   99999999999999999999999999986543322222223


Q ss_pred             cccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceeecCCCC
Q 002010          856 VAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDPRLS  934 (982)
Q Consensus       856 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  934 (982)
                      ..++..|+|||++.+..++.++||||+||++|||++ |+.||.................. .                  
T Consensus       274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~-~------------------  334 (374)
T cd05106         274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQ-M------------------  334 (374)
T ss_pred             CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccC-c------------------
Confidence            345678999999998899999999999999999998 99999765443332222221111 0                  


Q ss_pred             CCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 002010          935 GYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPP  973 (982)
Q Consensus       935 ~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~  973 (982)
                      ..+...+.++.+++.+||+.||++|||+.++++.|+++.
T Consensus       335 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~  373 (374)
T cd05106         335 SRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL  373 (374)
T ss_pred             cCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence            011122357899999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.6e-38  Score=326.49  Aligned_cols=263  Identities=25%  Similarity=0.329  Sum_probs=204.5

Q ss_pred             hcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCC-----ccEE
Q 002010          693 SLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRD-----TNLL  766 (982)
Q Consensus       693 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~~l  766 (982)
                      +|+..+++|.|+||.||+|.. .+++.||||++......     -.+|+.+|++++|||||++..+|....     ...+
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~-----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl   99 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY-----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL   99 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc-----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence            577788999999999999965 45789999998544332     237999999999999999998875432     2358


Q ss_pred             EEeccCCCCHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCC-CCEEEeccccchh
Q 002010          767 LYEYMPNGSLGEMLHGA--KGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSD-FEAHVADFGLAKF  843 (982)
Q Consensus       767 v~e~~~~~sL~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~-~~~kl~DfG~a~~  843 (982)
                      |||||+. +|.++++..  .+.+++...+.-++.||++|++|||+.+   |+||||||.|+|||.+ |.+||||||.|+.
T Consensus       100 VleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~  175 (364)
T KOG0658|consen  100 VLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKV  175 (364)
T ss_pred             HHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCccee
Confidence            9999965 999988742  3567888889999999999999999988   9999999999999977 9999999999998


Q ss_pred             ccccCCcccccccccccccccccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCc-
Q 002010          844 LQDAGASECMSSVAGSYGYIAPEYAYTL-KVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSD-  921 (982)
Q Consensus       844 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-  921 (982)
                      +.....   ..++..|..|+|||.+.+. .|+.+.||||.||++.||+-|++-|.+......+..+++-.+.+...... 
T Consensus       176 L~~~ep---niSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~  252 (364)
T KOG0658|consen  176 LVKGEP---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKS  252 (364)
T ss_pred             eccCCC---ceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhh
Confidence            875433   3567889999999998875 59999999999999999999999998865555555555544433221111 


Q ss_pred             -ccccceeecCCCCC------CChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          922 -AASVLAVVDPRLSG------YPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       922 -~~~~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                       .........|.+..      .....+.+..+++.++++.+|.+|.++.|++.
T Consensus       253 mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~  305 (364)
T KOG0658|consen  253 MNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA  305 (364)
T ss_pred             cCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence             11111122222221      33445667899999999999999999999886

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=6.8e-38  Score=336.29  Aligned_cols=251  Identities=32%  Similarity=0.547  Sum_probs=200.3

Q ss_pred             cccccccccceEEEEEEeC-----CCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEec
Q 002010          696 DENIIGKGGAGIVYRGSMP-----DGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEY  770 (982)
Q Consensus       696 ~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  770 (982)
                      ..+.||.|+||.||+|.+.     .+..|+||.+...........+.+|++.+++++||||++++|++...+..++||||
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~   82 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY   82 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence            4568999999999999765     36789999985544444567899999999999999999999999988889999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCc
Q 002010          771 MPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS  850 (982)
Q Consensus       771 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  850 (982)
                      +++|+|.+++.......+++..+..++.||++|++|||+.+   ++||||+++||++++++.+||+|||++.........
T Consensus        83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~  159 (259)
T PF07714_consen   83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY  159 (259)
T ss_dssp             -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred             ccccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccc
Confidence            99999999998766688999999999999999999999988   999999999999999999999999999876322222


Q ss_pred             ccccccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceee
Q 002010          851 ECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVV  929 (982)
Q Consensus       851 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  929 (982)
                      ...........|+|||.+....++.++||||||+++||+++ |+.||... ....+...+..... .             
T Consensus       160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~-~~~~~~~~~~~~~~-~-------------  224 (259)
T PF07714_consen  160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY-DNEEIIEKLKQGQR-L-------------  224 (259)
T ss_dssp             EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS-CHHHHHHHHHTTEE-T-------------
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccc-cccccccccccccc-c-------------
Confidence            33344557789999999999889999999999999999999 78998776 33333333322221 1             


Q ss_pred             cCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 002010          930 DPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHML  969 (982)
Q Consensus       930 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L  969 (982)
                           ..+...+..+.+++.+||+.||++|||+.++++.|
T Consensus       225 -----~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  225 -----PIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             -----TSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             -----eeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence                 11223445789999999999999999999999876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=3.1e-37  Score=318.52  Aligned_cols=278  Identities=20%  Similarity=0.275  Sum_probs=219.4

Q ss_pred             HhhcccccccccccceEEEEEE-eCCCcEEEEEEeccCCC-CCchhhHHHHHHHHhcCCCCc-ccceEeEEEcCC-----
Q 002010          691 LESLKDENIIGKGGAGIVYRGS-MPDGIDVAIKRLVGRGT-GGNDHGFLAEIQTLGRIRHRN-IVRLLGYVSNRD-----  762 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~-----  762 (982)
                      ...|+..+.||+|+||+||+|+ ..+|+.||+|++.-... +.......+|+.++++++|+| ||++++++....     
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~   89 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI   89 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence            4567777889999999999995 45789999999965544 455667789999999999999 999999998877     


Q ss_pred             -ccEEEEeccCCCCHHHHhhcCCC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccc
Q 002010          763 -TNLLLYEYMPNGSLGEMLHGAKG--GHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFG  839 (982)
Q Consensus       763 -~~~lv~e~~~~~sL~~~l~~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG  839 (982)
                       ..++||||+ .-+|..++.....  ..++...+..++.||++|++|+|+++   |+||||||+||+++++|.+||+|||
T Consensus        90 ~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFG  165 (323)
T KOG0594|consen   90 GKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFG  165 (323)
T ss_pred             ceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccc
Confidence             788999999 5699999986443  46777899999999999999999998   9999999999999999999999999


Q ss_pred             cchhccccCCcccccccccccccccccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCC
Q 002010          840 LAKFLQDAGASECMSSVAGSYGYIAPEYAYTL-KVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQ  918 (982)
Q Consensus       840 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  918 (982)
                      +|+.+.-  .....+..++|..|+|||++.+. .|+...||||+|||++||+++++-|.+..+.+.+.++.+..+.+...
T Consensus       166 lAra~~i--p~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~  243 (323)
T KOG0594|consen  166 LARAFSI--PMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEK  243 (323)
T ss_pred             hHHHhcC--CcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCcc
Confidence            9996542  23335667889999999999877 69999999999999999999999998877766666666655554333


Q ss_pred             CCcccccceeecCCCCC------CC---hHhHHHHHHHHhhccCCCCCCCCCHHHHHHH--hcCCCC
Q 002010          919 PSDAASVLAVVDPRLSG------YP---LTGVIHLFKVAMMCVEDESSARPTMREVVHM--LANPPQ  974 (982)
Q Consensus       919 ~~~~~~~~~~~~~~~~~------~~---~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~--L~~~~~  974 (982)
                      .+.......-.++.++.      ..   +.......+++.+|++.+|.+|.|++.+++.  +.....
T Consensus       244 ~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~  310 (323)
T KOG0594|consen  244 DWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPE  310 (323)
T ss_pred             CCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccccc
Confidence            22222212212211111      11   1112468899999999999999999999884  554433

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.9e-38  Score=340.83  Aligned_cols=252  Identities=24%  Similarity=0.332  Sum_probs=217.2

Q ss_pred             hhcccccccccccceEEEEEEe-CCCcEEEEEEeccCC-CCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCc-cEEEE
Q 002010          692 ESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRG-TGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDT-NLLLY  768 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~lv~  768 (982)
                      +.|...+.+|+|+||.++.++. .++..||+|.+.-.. +....+....|+.++++++|||||.+++.|.+++. .+|||
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm   83 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM   83 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence            5788889999999999999954 467899999885443 33444577899999999999999999999999888 89999


Q ss_pred             eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccC
Q 002010          769 EYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAG  848 (982)
Q Consensus       769 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  848 (982)
                      +|++||++.+.+.+.+...++++.+..|+.|++.|+.|||+++   |+|||||+.||+++.++.|||+|||+|+.+....
T Consensus        84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~  160 (426)
T KOG0589|consen   84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED  160 (426)
T ss_pred             eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence            9999999999999888889999999999999999999999888   9999999999999999999999999999887542


Q ss_pred             CcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCccccccee
Q 002010          849 ASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAV  928 (982)
Q Consensus       849 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  928 (982)
                        ......+||+.||.||.+.+..|+.|+||||+||++|||++-+++|...+......++.....               
T Consensus       161 --~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~---------------  223 (426)
T KOG0589|consen  161 --SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLY---------------  223 (426)
T ss_pred             --hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccC---------------
Confidence              244678999999999999999999999999999999999999999987655444444433321               


Q ss_pred             ecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002010          929 VDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHM  968 (982)
Q Consensus       929 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~  968 (982)
                           ...|.....++..++..|++++|+.||++.+++..
T Consensus       224 -----~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  224 -----SPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             -----CCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence                 12334455689999999999999999999999985

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-38  Score=337.14  Aligned_cols=256  Identities=27%  Similarity=0.405  Sum_probs=217.7

Q ss_pred             hcccccccccccceEEEEEEeC---CCc--EEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEE
Q 002010          693 SLKDENIIGKGGAGIVYRGSMP---DGI--DVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLL  767 (982)
Q Consensus       693 ~~~~~~~lg~G~~g~Vy~~~~~---~~~--~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  767 (982)
                      .++..++||+|-||.||+|.+.   .|+  .||||.-+.....+..+.|+.|..+|+.++||||++++|.|.+ ...++|
T Consensus       390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~Wiv  468 (974)
T KOG4257|consen  390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIV  468 (974)
T ss_pred             hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeEE
Confidence            3556678999999999999542   233  4899988777777788899999999999999999999999875 567999


Q ss_pred             EeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhcccc
Q 002010          768 YEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDA  847 (982)
Q Consensus       768 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  847 (982)
                      ||.++.|.|.+|++. +...++......++.||+.|++|||+..   +|||||..+||+|....-||++|||+++++.++
T Consensus       469 mEL~~~GELr~yLq~-nk~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~  544 (974)
T KOG4257|consen  469 MELAPLGELREYLQQ-NKDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRYLEDD  544 (974)
T ss_pred             EecccchhHHHHHHh-ccccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhhcccc
Confidence            999999999999984 4467888999999999999999999887   999999999999999999999999999999987


Q ss_pred             CCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHhccCCCCCCcccccc
Q 002010          848 GASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVL  926 (982)
Q Consensus       848 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  926 (982)
                      .++... ...-+..|||||.+.-++++.++|||.|||.+||++. |..||......+.+.                    
T Consensus       545 ~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~--------------------  603 (974)
T KOG4257|consen  545 AYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIG--------------------  603 (974)
T ss_pred             chhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEE--------------------
Confidence            665544 3344679999999999999999999999999999998 999998744332211                    


Q ss_pred             eeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCC
Q 002010          927 AVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQ  974 (982)
Q Consensus       927 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~~  974 (982)
                      .+-+......|+.||..++.+|.+||..||.+||++.|+...|.++.+
T Consensus       604 ~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q  651 (974)
T KOG4257|consen  604 HIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ  651 (974)
T ss_pred             EecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence            111233346788899999999999999999999999999999877665

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=3.1e-37  Score=336.45  Aligned_cols=258  Identities=26%  Similarity=0.457  Sum_probs=210.5

Q ss_pred             hhcccccccccccceEEEEEEeCC------CcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccE
Q 002010          692 ESLKDENIIGKGGAGIVYRGSMPD------GIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNL  765 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  765 (982)
                      ++|+..+.||+|+||.||+|....      ...||+|.+...........+.+|+.++.+++||||+++++++......+
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC   84 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence            468888999999999999996532      25799998865544444567899999999999999999999999989999


Q ss_pred             EEEeccCCCCHHHHhhcCCC--------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCC
Q 002010          766 LLYEYMPNGSLGEMLHGAKG--------------GHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDF  831 (982)
Q Consensus       766 lv~e~~~~~sL~~~l~~~~~--------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~  831 (982)
                      ++|||+++++|.+++.....              ..+++..+..++.|++.|++|||+.+   ++||||||+||++++++
T Consensus        85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~  161 (283)
T cd05048          85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL  161 (283)
T ss_pred             EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence            99999999999999974321              45788999999999999999999988   99999999999999999


Q ss_pred             CEEEeccccchhccccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHH
Q 002010          832 EAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVR  910 (982)
Q Consensus       832 ~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~  910 (982)
                      .+||+|||++................+++.|+|||.+.+..++.++||||+||++|||++ |..||...... +....+.
T Consensus       162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~-~~~~~i~  240 (283)
T cd05048         162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ-EVIEMIR  240 (283)
T ss_pred             cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH-HHHHHHH
Confidence            999999999986543332233334556788999999988899999999999999999998 99999764332 2223222


Q ss_pred             HhccCCCCCCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 002010          911 KTTSEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANP  972 (982)
Q Consensus       911 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~  972 (982)
                      ...                   ....+...+.++.+++.+||+.||++||++.||++.|+.+
T Consensus       241 ~~~-------------------~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~  283 (283)
T cd05048         241 SRQ-------------------LLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW  283 (283)
T ss_pred             cCC-------------------cCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence            111                   1122344567899999999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-38  Score=324.54  Aligned_cols=275  Identities=24%  Similarity=0.352  Sum_probs=212.2

Q ss_pred             hhcccccccccccceEEEEEE-eCCCcEEEEEEeccC-CCCCchhhHHHHHHHHhcCCCCcccceEeEEEc-----CCcc
Q 002010          692 ESLKDENIIGKGGAGIVYRGS-MPDGIDVAIKRLVGR-GTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSN-----RDTN  764 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~~~~  764 (982)
                      ..|...+.||+|+||.|++|. ..+|+.||||++... ......++..+|++.++.++|+||+.+++.+..     -...
T Consensus        22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~Dv  101 (359)
T KOG0660|consen   22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDV  101 (359)
T ss_pred             ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccccee
Confidence            456667899999999999995 467999999998533 344456788999999999999999999998865     3467


Q ss_pred             EEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhc
Q 002010          765 LLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFL  844 (982)
Q Consensus       765 ~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~  844 (982)
                      |+|+|+| +.+|...++  .+..++.+.+..++.|+++|+.|+|+.+   |+|||+||+|++++.+..+||+|||+|+..
T Consensus       102 YiV~elM-etDL~~iik--~~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLAR~~  175 (359)
T KOG0660|consen  102 YLVFELM-ETDLHQIIK--SQQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLARYL  175 (359)
T ss_pred             EEehhHH-hhHHHHHHH--cCccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccceeec
Confidence            9999999 679999997  4456999999999999999999999988   999999999999999999999999999987


Q ss_pred             cccCCcccccccccccccccccccc-cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCccc
Q 002010          845 QDAGASECMSSVAGSYGYIAPEYAY-TLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAA  923 (982)
Q Consensus       845 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  923 (982)
                      ........++.++.|..|.|||.+. ...|+.+.||||.|||+.||++|++-|.+.+ ..+....+......+.. ....
T Consensus       176 ~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d-~v~Ql~lI~~~lGtP~~-e~l~  253 (359)
T KOG0660|consen  176 DKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKD-YVHQLQLILELLGTPSE-EDLQ  253 (359)
T ss_pred             cccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCc-hHHHHHHHHHhcCCCCH-HHHH
Confidence            6543445568889999999999875 5679999999999999999999999997653 33333333333322211 0000


Q ss_pred             cc-----ceee-----cCCCC---CCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH--HhcCCCCC
Q 002010          924 SV-----LAVV-----DPRLS---GYPLTGVIHLFKVAMMCVEDESSARPTMREVVH--MLANPPQS  975 (982)
Q Consensus       924 ~~-----~~~~-----~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~--~L~~~~~~  975 (982)
                      .+     ...+     .|+.+   .+| .......+++.+||..||.+|+|++|.++  .|+....+
T Consensus       254 ~i~s~~ar~yi~slp~~p~~~f~~~fp-~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp  319 (359)
T KOG0660|consen  254 KIRSEKARPYIKSLPQIPKQPFSSIFP-NANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDP  319 (359)
T ss_pred             HhccHHHHHHHHhCCCCCCCCHHHHcC-CCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCC
Confidence            00     0000     01111   122 33456789999999999999999999987  55554443

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=3.9e-37  Score=332.20  Aligned_cols=256  Identities=27%  Similarity=0.421  Sum_probs=206.9

Q ss_pred             hhcccccccccccceEEEEEEe----CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEE
Q 002010          692 ESLKDENIIGKGGAGIVYRGSM----PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLL  767 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  767 (982)
                      ++|++.+.||+|+||.||+|..    ..+..||+|.+...........+.+|+.++.+++||||+++++++...+..++|
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   84 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV   84 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence            5688889999999999999964    236789999986554444556789999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhcccc
Q 002010          768 YEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDA  847 (982)
Q Consensus       768 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  847 (982)
                      |||+++++|.+++... ...+++..+..++.|++.|++|||+.+   ++||||||+||+++.++.+|++|||.+......
T Consensus        85 ~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~  160 (266)
T cd05064          85 TEYMSNGALDSFLRKH-EGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE  160 (266)
T ss_pred             EEeCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence            9999999999999743 357899999999999999999999988   999999999999999999999999987654322


Q ss_pred             CCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHhccCCCCCCcccccc
Q 002010          848 GASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVL  926 (982)
Q Consensus       848 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  926 (982)
                      .. .......++..|+|||.+.+..++.++||||+||++||+++ |..||....... ....+.....            
T Consensus       161 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~-~~~~~~~~~~------------  226 (266)
T cd05064         161 AI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD-VIKAVEDGFR------------  226 (266)
T ss_pred             ch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH-HHHHHHCCCC------------
Confidence            11 11112334678999999999999999999999999999876 999997653322 2222211100            


Q ss_pred             eeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 002010          927 AVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANP  972 (982)
Q Consensus       927 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~  972 (982)
                             ...+..++..+.+++.+||+.+|++||+++|+.+.|++.
T Consensus       227 -------~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         227 -------LPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             -------CCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence                   012234456789999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=3.7e-37  Score=335.71  Aligned_cols=251  Identities=24%  Similarity=0.295  Sum_probs=203.1

Q ss_pred             cccccccccccceEEEEEEe-CCCcEEEEEEeccCCC--CCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEec
Q 002010          694 LKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGT--GGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEY  770 (982)
Q Consensus       694 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  770 (982)
                      |+..+.||+|+||.||+|.. .+++.||+|.+.....  ......+.+|+.++.+++|++|+++++++.+++..++||||
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~   81 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence            66778999999999999965 5799999998854322  22334578899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCc
Q 002010          771 MPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS  850 (982)
Q Consensus       771 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  850 (982)
                      +++|+|.+++.......+++..+..++.|++.|++|||+.+   |+||||||+||++++++.+||+|||++......   
T Consensus        82 ~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~---  155 (285)
T cd05631          82 MNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEG---  155 (285)
T ss_pred             cCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC---
Confidence            99999998886555567899999999999999999999988   999999999999999999999999999865432   


Q ss_pred             ccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceeec
Q 002010          851 ECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVD  930 (982)
Q Consensus       851 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  930 (982)
                      .......|+..|+|||++.+..++.++||||+||++|||++|+.||..................                
T Consensus       156 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~----------------  219 (285)
T cd05631         156 ETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKE----------------  219 (285)
T ss_pred             CeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhc----------------
Confidence            1223457899999999999999999999999999999999999999864432221111111110                


Q ss_pred             CCCCCCChHhHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 002010          931 PRLSGYPLTGVIHLFKVAMMCVEDESSARPT-----MREVVH  967 (982)
Q Consensus       931 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt-----~~ell~  967 (982)
                       ....++...+..+.+++.+||+.||++||+     ++|+++
T Consensus       220 -~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~  260 (285)
T cd05631         220 -DQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ  260 (285)
T ss_pred             -ccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence             001122233457889999999999999997     788876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-37  Score=325.59  Aligned_cols=256  Identities=24%  Similarity=0.273  Sum_probs=199.9

Q ss_pred             HHHhhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCC-------------CCchhhHHHHHHHHhcCCCCcccce
Q 002010          689 DVLESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGT-------------GGNDHGFLAEIQTLGRIRHRNIVRL  754 (982)
Q Consensus       689 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-------------~~~~~~~~~E~~~l~~l~h~niv~~  754 (982)
                      ...++|++.+.||+|.||.|-+|+. .+++.||||++.+...             ....+...+|+.+|+++.|||||++
T Consensus        94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L  173 (576)
T KOG0585|consen   94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL  173 (576)
T ss_pred             eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence            3467899999999999999999964 5689999999954321             1123478999999999999999999


Q ss_pred             EeEEEc--CCccEEEEeccCCCCHHHHhhcCCCCC-CCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCC
Q 002010          755 LGYVSN--RDTNLLLYEYMPNGSLGEMLHGAKGGH-LKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDF  831 (982)
Q Consensus       755 ~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~~~~~-l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~  831 (982)
                      +++..+  .+..|+|+|||..|.+...=   ..+. +++.++++++++++.||+|||.+|   ||||||||+|+|++++|
T Consensus       174 iEvLDDP~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g  247 (576)
T KOG0585|consen  174 IEVLDDPESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDG  247 (576)
T ss_pred             EEeecCcccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCC
Confidence            998866  45789999999988765432   3344 899999999999999999999988   99999999999999999


Q ss_pred             CEEEeccccchhcccc---CCcccccccccccccccccccccCC----CCcchhhHHHHHHHHHHHhCCCCCCCCCCCch
Q 002010          832 EAHVADFGLAKFLQDA---GASECMSSVAGSYGYIAPEYAYTLK----VDEKSDVYSFGVVLLELIAGKKPVGEFGDGVD  904 (982)
Q Consensus       832 ~~kl~DfG~a~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslG~il~elltg~~p~~~~~~~~~  904 (982)
                      +|||+|||.+......   +........+|||.|+|||...++.    .+.+.||||+||++|.|+.|+.||-+....+.
T Consensus       248 ~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l  327 (576)
T KOG0585|consen  248 TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELEL  327 (576)
T ss_pred             cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHH
Confidence            9999999999876321   2223344578999999999887632    35788999999999999999999975332222


Q ss_pred             HHHHHHHhccCCCCCCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 002010          905 IVRWVRKTTSEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHML  969 (982)
Q Consensus       905 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L  969 (982)
                      +..++......+..                   .+....+.+++++||.+||++|.+..+|..-.
T Consensus       328 ~~KIvn~pL~fP~~-------------------pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp  373 (576)
T KOG0585|consen  328 FDKIVNDPLEFPEN-------------------PEINEDLKDLIKRLLEKDPEQRITLPDIKLHP  373 (576)
T ss_pred             HHHHhcCcccCCCc-------------------ccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence            22222211111111                   12345788999999999999999999987644

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-37  Score=353.95  Aligned_cols=258  Identities=25%  Similarity=0.310  Sum_probs=209.9

Q ss_pred             hhcccccccccccceEEEEEEeCCC-cEEEEEEeccCCCCCchhhHHHHHHHHhcCC-CCcccceEeE-EEc------CC
Q 002010          692 ESLKDENIIGKGGAGIVYRGSMPDG-IDVAIKRLVGRGTGGNDHGFLAEIQTLGRIR-HRNIVRLLGY-VSN------RD  762 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~-~~~------~~  762 (982)
                      .++++.++|.+|||+.||.|+...+ .+||+|++... .+.....+.+|+.+|++++ |+|||.++|. ...      ..
T Consensus        37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~-de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~  115 (738)
T KOG1989|consen   37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN-DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW  115 (738)
T ss_pred             EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC-CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence            3567788999999999999976555 99999998665 6667788999999999996 9999999993 221      13


Q ss_pred             ccEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccch
Q 002010          763 TNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAK  842 (982)
Q Consensus       763 ~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~  842 (982)
                      ++++.||||.||.|-+++..+....+++.++++|+.|+++|+++||.. .+||||||||-+|||++.++..||||||.|.
T Consensus       116 EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSat  194 (738)
T KOG1989|consen  116 EVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSAT  194 (738)
T ss_pred             EEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcccccc
Confidence            568999999999999999876667799999999999999999999988 5889999999999999999999999999987


Q ss_pred             hccccCCccc-------ccccccccccccccccc---cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHh
Q 002010          843 FLQDAGASEC-------MSSVAGSYGYIAPEYAY---TLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKT  912 (982)
Q Consensus       843 ~~~~~~~~~~-------~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~  912 (982)
                      ..........       .-....|+.|+|||++.   +...++|+||||+||+||-|+....||++.+.           
T Consensus       195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~-----------  263 (738)
T KOG1989|consen  195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK-----------  263 (738)
T ss_pred             cccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc-----------
Confidence            5432211000       11235789999999875   66799999999999999999999999976322           


Q ss_pred             ccCCCCCCcccccceeecCCCC-CCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCCC
Q 002010          913 TSEVSQPSDAASVLAVVDPRLS-GYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQS  975 (982)
Q Consensus       913 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~~~  975 (982)
                                   .++++..+. .-.+.....+.+||+.||+.||++||++-+|++.+-++...
T Consensus       264 -------------laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~  314 (738)
T KOG1989|consen  264 -------------LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANK  314 (738)
T ss_pred             -------------eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcC
Confidence                         223333332 11245667899999999999999999999999988766553

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=5.5e-37  Score=347.31  Aligned_cols=262  Identities=22%  Similarity=0.356  Sum_probs=209.8

Q ss_pred             HhhcccccccccccceEEEEEEeC------CCcEEEEEEeccCCCCCchhhHHHHHHHHhcCC-CCcccceEeEEEcCCc
Q 002010          691 LESLKDENIIGKGGAGIVYRGSMP------DGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIR-HRNIVRLLGYVSNRDT  763 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~  763 (982)
                      .++|++++.||+|+||.||+|...      .+..||||++.........+.+.+|+.++.++. ||||+++++++.+.+.
T Consensus        36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~  115 (400)
T cd05105          36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP  115 (400)
T ss_pred             ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence            357888899999999999999642      234799999865555455567899999999996 9999999999999999


Q ss_pred             cEEEEeccCCCCHHHHhhcCC-----------------------------------------------------------
Q 002010          764 NLLLYEYMPNGSLGEMLHGAK-----------------------------------------------------------  784 (982)
Q Consensus       764 ~~lv~e~~~~~sL~~~l~~~~-----------------------------------------------------------  784 (982)
                      .++||||+++|+|.++++...                                                           
T Consensus       116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (400)
T cd05105         116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK  195 (400)
T ss_pred             eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence            999999999999999886421                                                           


Q ss_pred             -----------------------------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcC
Q 002010          785 -----------------------------------GGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDS  829 (982)
Q Consensus       785 -----------------------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~  829 (982)
                                                         ...+++..+..++.|+++|++|||+.+   |+||||||+||+++.
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~~  272 (400)
T cd05105         196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLAQ  272 (400)
T ss_pred             hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEeC
Confidence                                               124778888999999999999999988   999999999999999


Q ss_pred             CCCEEEeccccchhccccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHHH
Q 002010          830 DFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRW  908 (982)
Q Consensus       830 ~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~  908 (982)
                      ++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||............
T Consensus       273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~  352 (400)
T cd05105         273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNK  352 (400)
T ss_pred             CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHH
Confidence            99999999999986543322222333456788999999998889999999999999999997 99999764333222222


Q ss_pred             HHHhccCCCCCCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCC
Q 002010          909 VRKTTSEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQ  974 (982)
Q Consensus       909 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~~  974 (982)
                      +.....                   ...+...+..+.+++.+||+.||++|||+.+|.+.|+++..
T Consensus       353 ~~~~~~-------------------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~  399 (400)
T cd05105         353 IKSGYR-------------------MAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP  399 (400)
T ss_pred             HhcCCC-------------------CCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence            221111                   01122344578999999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=6.6e-37  Score=334.32  Aligned_cols=269  Identities=19%  Similarity=0.270  Sum_probs=205.1

Q ss_pred             hhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEec
Q 002010          692 ESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEY  770 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  770 (982)
                      ++|+..+.||+|+||.||+|.. .+++.||+|.+...........+.+|+.++++++||||+++++++.+++..++||||
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY   84 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence            4688889999999999999965 468899999986554444556778999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCc
Q 002010          771 MPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS  850 (982)
Q Consensus       771 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  850 (982)
                      ++ ++|.+++... ...+++..+..++.||+.|++|||+.+   |+||||||+||++++++.+||+|||+++.....  .
T Consensus        85 ~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~--~  157 (288)
T cd07871          85 LD-SDLKQYLDNC-GNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVP--T  157 (288)
T ss_pred             CC-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCC--C
Confidence            96 4999988632 345789999999999999999999988   999999999999999999999999999754322  1


Q ss_pred             cccccccccccccccccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCC----ccccc
Q 002010          851 ECMSSVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPS----DAASV  925 (982)
Q Consensus       851 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~  925 (982)
                      .......+++.|+|||++.+ ..++.++||||+||++|||++|++||......+.................    .....
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (288)
T cd07871         158 KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEF  237 (288)
T ss_pred             ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhh
Confidence            22234567899999998865 56899999999999999999999999765443333333332222111100    00011


Q ss_pred             ceeecCCCC-----CCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          926 LAVVDPRLS-----GYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       926 ~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                      .....+...     ........+..+++.+|++.||.+|||++|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         238 RSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             hccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            111111111     011123456789999999999999999999974

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-37  Score=338.79  Aligned_cols=244  Identities=24%  Similarity=0.281  Sum_probs=201.0

Q ss_pred             hcccccccccccceEEEEEEe-CCCcEEEEEEeccCC--CCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEe
Q 002010          693 SLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRG--TGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYE  769 (982)
Q Consensus       693 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  769 (982)
                      +|+..+.||+|+||.||+|.. .+++.||+|++....  .......+.+|+.++++++||||+++++++.++...++|||
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   81 (291)
T cd05612           2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLME   81 (291)
T ss_pred             CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEe
Confidence            578889999999999999965 468999999985432  12234567899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCC
Q 002010          770 YMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGA  849 (982)
Q Consensus       770 ~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  849 (982)
                      |+++++|.+++.  +...+++..+..++.|++.|++|||+.+   |+||||||+||+++.++.+||+|||++......  
T Consensus        82 ~~~~~~L~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~--  154 (291)
T cd05612          82 YVPGGELFSYLR--NSGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR--  154 (291)
T ss_pred             CCCCCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCC--
Confidence            999999999997  3457899999999999999999999988   999999999999999999999999999866432  


Q ss_pred             cccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceee
Q 002010          850 SECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVV  929 (982)
Q Consensus       850 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  929 (982)
                         .....|++.|+|||++.+..++.++||||+||++|||++|+.||....... ....+.....               
T Consensus       155 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~-~~~~i~~~~~---------------  215 (291)
T cd05612         155 ---TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG-IYEKILAGKL---------------  215 (291)
T ss_pred             ---cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhCCc---------------
Confidence               223568999999999999899999999999999999999999997643222 1121111100               


Q ss_pred             cCCCCCCChHhHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 002010          930 DPRLSGYPLTGVIHLFKVAMMCVEDESSARPT-----MREVVH  967 (982)
Q Consensus       930 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt-----~~ell~  967 (982)
                           ..+......+.+++++||+.||.+||+     ++|+++
T Consensus       216 -----~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  253 (291)
T cd05612         216 -----EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN  253 (291)
T ss_pred             -----CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence                 112223446889999999999999995     888776

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=7e-37  Score=317.20  Aligned_cols=255  Identities=21%  Similarity=0.240  Sum_probs=216.6

Q ss_pred             HhhcccccccccccceEEEEEEeCC-CcEEEEEEeccCCC--CCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEE
Q 002010          691 LESLKDENIIGKGGAGIVYRGSMPD-GIDVAIKRLVGRGT--GGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLL  767 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  767 (982)
                      .+.|+..+.||+|.-|+||.++..+ +..+|+|++.+...  .....+...|.+|+..++||.+..+|+.|+.++..++|
T Consensus        76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~  155 (459)
T KOG0610|consen   76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLV  155 (459)
T ss_pred             HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEE
Confidence            3568888899999999999998754 58899999955432  33445677899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhcccc
Q 002010          768 YEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDA  847 (982)
Q Consensus       768 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  847 (982)
                      ||||+||+|..+.+++....++++.++.++..++-||+|||..|   ||.|||||+||||.++|++.|+||.++......
T Consensus       156 meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~~  232 (459)
T KOG0610|consen  156 MEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPVS  232 (459)
T ss_pred             EecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence            99999999999999999999999999999999999999999999   999999999999999999999999997643210


Q ss_pred             --------------------------------C-C---------------------cccccccccccccccccccccCCC
Q 002010          848 --------------------------------G-A---------------------SECMSSVAGSYGYIAPEYAYTLKV  873 (982)
Q Consensus       848 --------------------------------~-~---------------------~~~~~~~~gt~~y~aPE~~~~~~~  873 (982)
                                                      . .                     ..+..+.+||-.|.|||++.+...
T Consensus       233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH  312 (459)
T KOG0610|consen  233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH  312 (459)
T ss_pred             CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence                                            0 0                     011224579999999999999999


Q ss_pred             CcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceeecCCCCCCChHhHHHHHHHHhhccC
Q 002010          874 DEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVE  953 (982)
Q Consensus       874 ~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~  953 (982)
                      +.++|+|+|||++|||+.|..||.+....+.+..++.+....+..                  + .....+.+||++.|.
T Consensus       313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~------------------~-~vs~~akDLIr~LLv  373 (459)
T KOG0610|consen  313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEE------------------P-EVSSAAKDLIRKLLV  373 (459)
T ss_pred             CchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCC------------------C-cchhHHHHHHHHHhc
Confidence            999999999999999999999999988888777777655443222                  2 344578999999999


Q ss_pred             CCCCCCCC----HHHHHH
Q 002010          954 DESSARPT----MREVVH  967 (982)
Q Consensus       954 ~dP~~Rpt----~~ell~  967 (982)
                      +||.+|.-    |+||-+
T Consensus       374 KdP~kRlg~~rGA~eIK~  391 (459)
T KOG0610|consen  374 KDPSKRLGSKRGAAEIKR  391 (459)
T ss_pred             cChhhhhccccchHHhhc
Confidence            99999997    777765

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=2.4e-37  Score=343.23  Aligned_cols=242  Identities=23%  Similarity=0.276  Sum_probs=197.9

Q ss_pred             cccccccceEEEEEEe-CCCcEEEEEEeccCC--CCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEeccCCC
Q 002010          698 NIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRG--TGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNG  774 (982)
Q Consensus       698 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~  774 (982)
                      +.||+|+||.||+|.. .+|+.||+|++....  .......+.+|+.++++++||||+++++++...+..++||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            3689999999999965 568999999985432  2233456788999999999999999999999999999999999999


Q ss_pred             CHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCccccc
Q 002010          775 SLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMS  854 (982)
Q Consensus       775 sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~  854 (982)
                      +|.+++.  +...+++..+..++.||+.||+|||+.+   |+||||||+||+++.++.+||+|||+++.....  .....
T Consensus        81 ~L~~~l~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~--~~~~~  153 (323)
T cd05571          81 ELFFHLS--RERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISD--GATMK  153 (323)
T ss_pred             cHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccC--CCccc
Confidence            9999987  4467899999999999999999999988   999999999999999999999999998754322  12234


Q ss_pred             ccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceeecCCCC
Q 002010          855 SVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDPRLS  934 (982)
Q Consensus       855 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  934 (982)
                      ...||+.|+|||++.+..++.++||||+||++|||++|+.||...... .....+....                    .
T Consensus       154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~-~~~~~~~~~~--------------------~  212 (323)
T cd05571         154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-KLFELILMEE--------------------I  212 (323)
T ss_pred             ceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH-HHHHHHHcCC--------------------C
Confidence            467999999999999999999999999999999999999999754322 1111111100                    0


Q ss_pred             CCChHhHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 002010          935 GYPLTGVIHLFKVAMMCVEDESSARP-----TMREVVH  967 (982)
Q Consensus       935 ~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~ell~  967 (982)
                      .++......+.+++.+||+.||++||     ++.|+++
T Consensus       213 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  250 (323)
T cd05571         213 RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME  250 (323)
T ss_pred             CCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence            12223345788999999999999999     7998875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=7.2e-37  Score=340.78  Aligned_cols=261  Identities=26%  Similarity=0.415  Sum_probs=207.8

Q ss_pred             hhcccccccccccceEEEEEEe------CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcC-CCCcccceEeEEEcC-Cc
Q 002010          692 ESLKDENIIGKGGAGIVYRGSM------PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRI-RHRNIVRLLGYVSNR-DT  763 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~-~~  763 (982)
                      ++|++.+.||+|+||.||+|..      .+++.||+|++...........+.+|+.++.++ +||||+++++++... ..
T Consensus         7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~   86 (337)
T cd05054           7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP   86 (337)
T ss_pred             HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence            5788999999999999999953      235789999885443333445678899999999 899999999987654 56


Q ss_pred             cEEEEeccCCCCHHHHhhcCCC----------------------------------------------------------
Q 002010          764 NLLLYEYMPNGSLGEMLHGAKG----------------------------------------------------------  785 (982)
Q Consensus       764 ~~lv~e~~~~~sL~~~l~~~~~----------------------------------------------------------  785 (982)
                      .+++|||+++++|.+++.....                                                          
T Consensus        87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (337)
T cd05054          87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY  166 (337)
T ss_pred             EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence            7899999999999999863221                                                          


Q ss_pred             -CCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCccccccccccccccc
Q 002010          786 -GHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIA  864 (982)
Q Consensus       786 -~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~a  864 (982)
                       .++++..+..++.||+.|++|||+.+   |+||||||+||++++++.+||+|||+++.+.............++..|+|
T Consensus       167 ~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a  243 (337)
T cd05054         167 KEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA  243 (337)
T ss_pred             hcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence             26889999999999999999999988   99999999999999999999999999987653322222334456778999


Q ss_pred             ccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceeecCCCCCCChHhHHH
Q 002010          865 PEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDPRLSGYPLTGVIH  943 (982)
Q Consensus       865 PE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  943 (982)
                      ||++.+..++.++||||+||++|||++ |..||......+...........                   ...+.....+
T Consensus       244 PE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~  304 (337)
T cd05054         244 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTR-------------------MRAPEYATPE  304 (337)
T ss_pred             cHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCC-------------------CCCCccCCHH
Confidence            999999999999999999999999998 99999764433333332221111                   0112233457


Q ss_pred             HHHHHhhccCCCCCCCCCHHHHHHHhcCCCC
Q 002010          944 LFKVAMMCVEDESSARPTMREVVHMLANPPQ  974 (982)
Q Consensus       944 l~~li~~cl~~dP~~Rpt~~ell~~L~~~~~  974 (982)
                      +.+++.+||+.+|++||+++|+++.|+++.+
T Consensus       305 ~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~  335 (337)
T cd05054         305 IYSIMLDCWHNNPEDRPTFSELVEILGDLLQ  335 (337)
T ss_pred             HHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            8999999999999999999999999988765

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=1.1e-36  Score=331.57  Aligned_cols=257  Identities=25%  Similarity=0.445  Sum_probs=207.8

Q ss_pred             hhcccccccccccceEEEEEEeC------CCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccE
Q 002010          692 ESLKDENIIGKGGAGIVYRGSMP------DGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNL  765 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  765 (982)
                      ++|...+.||+|+||.||+|...      +++.||+|.+...........+.+|++++++++||||+++++++......+
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   84 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI   84 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence            45777889999999999999653      347899999865444435578999999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHhhcCC------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCE
Q 002010          766 LLYEYMPNGSLGEMLHGAK------------GGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEA  833 (982)
Q Consensus       766 lv~e~~~~~sL~~~l~~~~------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~  833 (982)
                      +||||+++++|.+++....            ...+++..+..++.|++.|++|+|+.+   ++||||||+||+++.++.+
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~  161 (280)
T cd05049          85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVV  161 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeE
Confidence            9999999999999997432            245788999999999999999999988   9999999999999999999


Q ss_pred             EEeccccchhccccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHh
Q 002010          834 HVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKT  912 (982)
Q Consensus       834 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~  912 (982)
                      ||+|||.+................+++.|+|||++.+..++.++||||+||++|||++ |..||....... ....+...
T Consensus       162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~-~~~~~~~~  240 (280)
T cd05049         162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE-VIECITQG  240 (280)
T ss_pred             EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH-HHHHHHcC
Confidence            9999999976543222222233445788999999999999999999999999999999 999997653322 22222111


Q ss_pred             ccCCCCCCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 002010          913 TSEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLAN  971 (982)
Q Consensus       913 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~  971 (982)
                      .                   ....+...+..+.+++.+||+.||++|||++||++.|++
T Consensus       241 ~-------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~  280 (280)
T cd05049         241 R-------------------LLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK  280 (280)
T ss_pred             C-------------------cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence            0                   111122344578999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=1.8e-36  Score=325.11  Aligned_cols=252  Identities=25%  Similarity=0.436  Sum_probs=204.7

Q ss_pred             hhcccccccccccceEEEEEEeCCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEecc
Q 002010          692 ESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYM  771 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  771 (982)
                      +.|+..+.||+|+||.||+|+.+++..+|+|.+...  ......+.+|+.++++++||||+++++++..++..++||||+
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~   81 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG--AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFM   81 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC--CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcC
Confidence            457888899999999999998888889999987432  334567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCcc
Q 002010          772 PNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASE  851 (982)
Q Consensus       772 ~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~  851 (982)
                      ++++|.++++... ..+++..+..++.|++.|++|||+.+   |+||||||+||++++++.+|++|||.++...... ..
T Consensus        82 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~-~~  156 (256)
T cd05114          82 ENGCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE-YT  156 (256)
T ss_pred             CCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCc-ee
Confidence            9999999987433 46899999999999999999999988   9999999999999999999999999998654321 11


Q ss_pred             cccccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceeec
Q 002010          852 CMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVD  930 (982)
Q Consensus       852 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  930 (982)
                      ......++..|+|||++.+..++.++||||+|+++|||++ |+.||...... .....+......               
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~-~~~~~i~~~~~~---------------  220 (256)
T cd05114         157 SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY-EVVEMISRGFRL---------------  220 (256)
T ss_pred             ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH-HHHHHHHCCCCC---------------
Confidence            1223345668999999988889999999999999999999 89999764332 222222221110               


Q ss_pred             CCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 002010          931 PRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLA  970 (982)
Q Consensus       931 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~  970 (982)
                          ..+...+..+.+++.+||+.||++||+++|+++.|.
T Consensus       221 ----~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~  256 (256)
T cd05114         221 ----YRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT  256 (256)
T ss_pred             ----CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence                011122346899999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=1.5e-36  Score=326.76  Aligned_cols=256  Identities=26%  Similarity=0.427  Sum_probs=210.1

Q ss_pred             HhhcccccccccccceEEEEEEeCCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEec
Q 002010          691 LESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEY  770 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  770 (982)
                      .++|+..+.||+|+||.||+|...++..||+|.+...  ....+.+.+|+.++++++|+||+++++++...+..+++|||
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   82 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPG--TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEY   82 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCC--chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEec
Confidence            3678889999999999999998878889999987432  23356788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCc
Q 002010          771 MPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS  850 (982)
Q Consensus       771 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  850 (982)
                      +++++|.++++......+++..+..++.|++.|++|||+.+   ++||||||+||+++.++.+||+|||.+....... .
T Consensus        83 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~-~  158 (261)
T cd05072          83 MAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNE-Y  158 (261)
T ss_pred             CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCc-e
Confidence            99999999997656677899999999999999999999988   9999999999999999999999999998765321 1


Q ss_pred             ccccccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceee
Q 002010          851 ECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVV  929 (982)
Q Consensus       851 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  929 (982)
                      .......++..|+|||+..+..++.++||||+||++|+|++ |+.||....... ....+.....   .           
T Consensus       159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~-~~~~~~~~~~---~-----------  223 (261)
T cd05072         159 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD-VMSALQRGYR---M-----------  223 (261)
T ss_pred             eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH-HHHHHHcCCC---C-----------
Confidence            12223345678999999988889999999999999999998 999997543222 2222211110   0           


Q ss_pred             cCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 002010          930 DPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANP  972 (982)
Q Consensus       930 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~  972 (982)
                           ......+..+.+++.+||+.+|++||+++++.+.|+++
T Consensus       224 -----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  261 (261)
T cd05072         224 -----PRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF  261 (261)
T ss_pred             -----CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence                 01112345788999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-38  Score=306.29  Aligned_cols=252  Identities=23%  Similarity=0.298  Sum_probs=205.4

Q ss_pred             HhhcccccccccccceEEEEE-EeCCCcEEEEEEeccC-CCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEE
Q 002010          691 LESLKDENIIGKGGAGIVYRG-SMPDGIDVAIKRLVGR-GTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLY  768 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  768 (982)
                      .+.|+..+.||+|.|+.||++ ..++|+.+|+|.+.-. -+....+++.+|+.+-+.++|||||++.+.+.+....|+|+
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF   89 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   89 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence            356888889999999999998 5578999999987433 23446678899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCC---CCEEEeccccchhcc
Q 002010          769 EYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSD---FEAHVADFGLAKFLQ  845 (982)
Q Consensus       769 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~---~~~kl~DfG~a~~~~  845 (982)
                      |+|+|++|..-+-.  ..-+++..+...++||++|++|+|.++   |||||+||+|+++...   .-+|++|||+|..+.
T Consensus        90 e~m~G~dl~~eIV~--R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~  164 (355)
T KOG0033|consen   90 DLVTGGELFEDIVA--REFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN  164 (355)
T ss_pred             ecccchHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence            99999999876642  256788888999999999999999998   9999999999999543   459999999999887


Q ss_pred             ccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCccccc
Q 002010          846 DAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASV  925 (982)
Q Consensus       846 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  925 (982)
                      +   .......+|||.|||||++...+|+..+|||+.||++|-++.|.+||.+......+.++...... .+.+.     
T Consensus       165 ~---g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd-~~~~~-----  235 (355)
T KOG0033|consen  165 D---GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYD-YPSPE-----  235 (355)
T ss_pred             C---ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccC-CCCcc-----
Confidence            3   33445688999999999999999999999999999999999999999875444333333322221 11111     


Q ss_pred             ceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          926 LAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       926 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                                 -....++..+++++|+..||.+|.|+.|.+.
T Consensus       236 -----------w~~is~~Ak~LvrrML~~dP~kRIta~EAL~  266 (355)
T KOG0033|consen  236 -----------WDTVTPEAKSLIRRMLTVNPKKRITADEALK  266 (355)
T ss_pred             -----------cCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence                       1122346789999999999999999999874

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=3.6e-37  Score=342.67  Aligned_cols=246  Identities=25%  Similarity=0.285  Sum_probs=201.6

Q ss_pred             HhhcccccccccccceEEEEEEe-CCCcEEEEEEeccCC--CCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEE
Q 002010          691 LESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRG--TGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLL  767 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  767 (982)
                      .++|+..+.||+|+||.||+|+. .+++.||+|++....  .......+.+|+.++++++||||+++++++.+++..++|
T Consensus        17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   96 (329)
T PTZ00263         17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL   96 (329)
T ss_pred             chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence            35788899999999999999976 468899999985432  223345688999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhcccc
Q 002010          768 YEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDA  847 (982)
Q Consensus       768 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  847 (982)
                      |||+++++|.+++.  +...+++..+..++.||+.|++|||+.+   |+||||||+||+++.++.+||+|||++......
T Consensus        97 ~e~~~~~~L~~~l~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  171 (329)
T PTZ00263         97 LEFVVGGELFTHLR--KAGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR  171 (329)
T ss_pred             EcCCCCChHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence            99999999999997  3457889999999999999999999988   999999999999999999999999999865432


Q ss_pred             CCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccce
Q 002010          848 GASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLA  927 (982)
Q Consensus       848 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  927 (982)
                           .....|++.|+|||++.+..++.++||||+||++|||++|+.||....... ....+....  .           
T Consensus       172 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-~~~~i~~~~--~-----------  232 (329)
T PTZ00263        172 -----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFR-IYEKILAGR--L-----------  232 (329)
T ss_pred             -----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHH-HHHHHhcCC--c-----------
Confidence                 123578999999999999999999999999999999999999997543211 111111100  0           


Q ss_pred             eecCCCCCCChHhHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 002010          928 VVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPT-----MREVVH  967 (982)
Q Consensus       928 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt-----~~ell~  967 (982)
                             ..+...+..+.+++.+||+.||.+||+     +++++.
T Consensus       233 -------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  270 (329)
T PTZ00263        233 -------KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN  270 (329)
T ss_pred             -------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence                   111223346889999999999999997     677764

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=2e-36  Score=326.86  Aligned_cols=257  Identities=30%  Similarity=0.489  Sum_probs=209.1

Q ss_pred             hhcccccccccccceEEEEEEeC----CCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEE
Q 002010          692 ESLKDENIIGKGGAGIVYRGSMP----DGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLL  767 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  767 (982)
                      ++|+..+.||+|+||.||+|..+    +...||+|.+...........+.+|+.++++++||||+++++++...+..++|
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   83 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII   83 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence            56888999999999999999763    24579999886555555566789999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhcccc
Q 002010          768 YEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDA  847 (982)
Q Consensus       768 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  847 (982)
                      |||+++++|.+++... ...+++..+..++.|++.|++|||+.+   |+||||||+||++++++.++++|||+++.....
T Consensus        84 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~  159 (266)
T cd05033          84 TEYMENGSLDKFLREN-DGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS  159 (266)
T ss_pred             EEcCCCCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence            9999999999999743 347899999999999999999999988   999999999999999999999999999877522


Q ss_pred             CCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHhccCCCCCCcccccc
Q 002010          848 GASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVL  926 (982)
Q Consensus       848 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  926 (982)
                      ..........++..|+|||.+.+..++.++||||+|+++|||++ |..||....... ....+......           
T Consensus       160 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~-~~~~~~~~~~~-----------  227 (266)
T cd05033         160 EATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD-VIKAVEDGYRL-----------  227 (266)
T ss_pred             ccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH-HHHHHHcCCCC-----------
Confidence            22212223345678999999998899999999999999999998 999997643322 22222211110           


Q ss_pred             eeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 002010          927 AVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANP  972 (982)
Q Consensus       927 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~  972 (982)
                              ..+...+..+.+++.+||+.+|++||+++||++.|+++
T Consensus       228 --------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         228 --------PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             --------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                    01123345789999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.3e-37  Score=321.59  Aligned_cols=275  Identities=26%  Similarity=0.387  Sum_probs=201.0

Q ss_pred             hhcccccccccccceEEEEEEeCCCcEEEEEEeccCCCCCchhhHHHHHHHHh--cCCCCcccceEeEEEcCC----ccE
Q 002010          692 ESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLG--RIRHRNIVRLLGYVSNRD----TNL  765 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~--~l~h~niv~~~~~~~~~~----~~~  765 (982)
                      ...+..+.||+|+||.||||.. +++.||||++..    ...+.|..|-++..  .++|+||++++++-....    .++
T Consensus       210 ~pl~l~eli~~Grfg~V~KaqL-~~~~VAVKifp~----~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eyw  284 (534)
T KOG3653|consen  210 DPLQLLELIGRGRFGCVWKAQL-DNRLVAVKIFPE----QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYW  284 (534)
T ss_pred             CchhhHHHhhcCccceeehhhc-cCceeEEEecCH----HHHHHHHhHHHHHhccCccchhHHHhhchhccCCcccccee
Confidence            3455667899999999999998 669999999833    34556777766655  458999999999865544    789


Q ss_pred             EEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC------CCcEEecCCCCCcEEEcCCCCEEEeccc
Q 002010          766 LLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDC------SPLIIHRDVKSNNILLDSDFEAHVADFG  839 (982)
Q Consensus       766 lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~------~~~ivHrDlkp~Nill~~~~~~kl~DfG  839 (982)
                      +|+||.+.|+|.+|++   ...++|....+++..+++||+|||+..      +++|+|||||++||||.+|+++.|+|||
T Consensus       285 LVt~fh~kGsL~dyL~---~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFG  361 (534)
T KOG3653|consen  285 LVTEFHPKGSLCDYLK---ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFG  361 (534)
T ss_pred             EEeeeccCCcHHHHHH---hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccc
Confidence            9999999999999996   457999999999999999999999754      5679999999999999999999999999


Q ss_pred             cchhccccCCcccccccccccccccccccccCC-CC-----cchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhc
Q 002010          840 LAKFLQDAGASECMSSVAGSYGYIAPEYAYTLK-VD-----EKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTT  913 (982)
Q Consensus       840 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-----~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~  913 (982)
                      +|..+............+||.+|||||++.+.. +.     .+.||||+|.++|||+++...++....++-....-.+.+
T Consensus       362 LAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG  441 (534)
T KOG3653|consen  362 LALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVG  441 (534)
T ss_pred             eeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhc
Confidence            999988665555556689999999999998653 22     478999999999999997655431101100001111111


Q ss_pred             cCCCCCCc-ccccceeecCCCCCC--ChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCC
Q 002010          914 SEVSQPSD-AASVLAVVDPRLSGY--PLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQ  974 (982)
Q Consensus       914 ~~~~~~~~-~~~~~~~~~~~~~~~--~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~~  974 (982)
                      ..+..... ..-++....|.++..  ....+.-+.+.+..||+.||+.|.|+.=+-+.+.++.-
T Consensus       442 ~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~  505 (534)
T KOG3653|consen  442 NHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMM  505 (534)
T ss_pred             CCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhc
Confidence            11110000 000111122333211  12455668999999999999999999877776655433

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=1.8e-36  Score=326.17  Aligned_cols=255  Identities=29%  Similarity=0.453  Sum_probs=211.4

Q ss_pred             hhcccccccccccceEEEEEEeCCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEecc
Q 002010          692 ESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYM  771 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  771 (982)
                      .+|+..+.||+|+||.||+|...+++.+|+|.+... .......+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus         6 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   84 (261)
T cd05148           6 EEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSD-DLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM   84 (261)
T ss_pred             HHHHHhhhhccCCCccEEEeEecCCCcEEEEecccc-chhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence            568888999999999999998878999999988443 3334557889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCcc
Q 002010          772 PNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASE  851 (982)
Q Consensus       772 ~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~  851 (982)
                      ++++|.+++.......+++..+..++.|++.|++|||+.+   |+||||+|+||++++++.+||+|||.+........  
T Consensus        85 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~--  159 (261)
T cd05148          85 EKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY--  159 (261)
T ss_pred             ccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCccc--
Confidence            9999999998766677899999999999999999999988   99999999999999999999999999987653321  


Q ss_pred             cccccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceeec
Q 002010          852 CMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVD  930 (982)
Q Consensus       852 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  930 (982)
                      ......++..|+|||+..+..++.++||||+|+++|+|++ |+.||....... ....+.....                
T Consensus       160 ~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~-~~~~~~~~~~----------------  222 (261)
T cd05148         160 LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE-VYDQITAGYR----------------  222 (261)
T ss_pred             cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHH-HHHHHHhCCc----------------
Confidence            1223446778999999988889999999999999999998 899997644322 2222221111                


Q ss_pred             CCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 002010          931 PRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANP  972 (982)
Q Consensus       931 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~  972 (982)
                         ...+...+..+.+++.+||+.||++|||++++++.|+.+
T Consensus       223 ---~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~  261 (261)
T cd05148         223 ---MPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI  261 (261)
T ss_pred             ---CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence               011223345788999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-37  Score=333.69  Aligned_cols=256  Identities=24%  Similarity=0.365  Sum_probs=218.1

Q ss_pred             hcccccccccccceEEEEEEeCC-CcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEecc
Q 002010          693 SLKDENIIGKGGAGIVYRGSMPD-GIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYM  771 (982)
Q Consensus       693 ~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  771 (982)
                      +++....||.|-||.||.|.|+. .-.||||.++..  .....+|+.|+.+|+.++|||+|+++|+|..+...|||+|||
T Consensus       268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED--tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM  345 (1157)
T KOG4278|consen  268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED--TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFM  345 (1157)
T ss_pred             heeeeeccCCCcccceeeeeeeccceeeehhhhhhc--chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecc
Confidence            45667789999999999998754 678999988544  445788999999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCcc
Q 002010          772 PNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASE  851 (982)
Q Consensus       772 ~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~  851 (982)
                      .+|+|.+|+++-....++.-..++++.||..||.||..++   +|||||..+|+||.++-.||++|||+++.+..+ .++
T Consensus       346 ~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlMtgD-TYT  421 (1157)
T KOG4278|consen  346 CYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLMTGD-TYT  421 (1157)
T ss_pred             cCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhhcCC-cee
Confidence            9999999998777777888888999999999999999998   999999999999999999999999999998754 344


Q ss_pred             cccccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceeec
Q 002010          852 CMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVD  930 (982)
Q Consensus       852 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  930 (982)
                      ......-++.|.|||.+....++.|+|||+|||++||+.| |-.||.+.+-. .....                    ++
T Consensus       422 AHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlS-qVY~L--------------------LE  480 (1157)
T KOG4278|consen  422 AHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-QVYGL--------------------LE  480 (1157)
T ss_pred             cccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHH-HHHHH--------------------Hh
Confidence            4455566789999999999999999999999999999999 88898764221 11112                    12


Q ss_pred             CCCC-CCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCCC
Q 002010          931 PRLS-GYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQS  975 (982)
Q Consensus       931 ~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~~~  975 (982)
                      ..++ +-|+.|+..++++|+.||++.|.+||+++|+-+.++.+.+.
T Consensus       481 kgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~  526 (1157)
T KOG4278|consen  481 KGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSS  526 (1157)
T ss_pred             ccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcc
Confidence            2222 34667788999999999999999999999999999876553

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=4.3e-37  Score=342.49  Aligned_cols=246  Identities=21%  Similarity=0.256  Sum_probs=201.5

Q ss_pred             HhhcccccccccccceEEEEEEeCC--CcEEEEEEeccCC--CCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEE
Q 002010          691 LESLKDENIIGKGGAGIVYRGSMPD--GIDVAIKRLVGRG--TGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLL  766 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  766 (982)
                      .+.|+..+.||+|+||.||+|....  +..||+|++....  .......+.+|+.+++.++||||+++++++.+.+..++
T Consensus        29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l  108 (340)
T PTZ00426         29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL  108 (340)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence            4678999999999999999996433  3689999885432  23345568899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccc
Q 002010          767 LYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQD  846 (982)
Q Consensus       767 v~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  846 (982)
                      ||||+++|+|.+++.  +...+++..+..++.|++.|++|||+.+   |+||||||+||+++.++.+||+|||++.....
T Consensus       109 v~Ey~~~g~L~~~i~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~  183 (340)
T PTZ00426        109 VLEFVIGGEFFTFLR--RNKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT  183 (340)
T ss_pred             EEeCCCCCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence            999999999999997  3457899999999999999999999988   99999999999999999999999999976542


Q ss_pred             cCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccc
Q 002010          847 AGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVL  926 (982)
Q Consensus       847 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  926 (982)
                      .     .....||+.|+|||++.+..++.++||||+||++|||++|..||............... ..            
T Consensus       184 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~-~~------------  245 (340)
T PTZ00426        184 R-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEG-II------------  245 (340)
T ss_pred             C-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcC-CC------------
Confidence            1     23457899999999999888999999999999999999999999764332211111111 00            


Q ss_pred             eeecCCCCCCChHhHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 002010          927 AVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARP-----TMREVVH  967 (982)
Q Consensus       927 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~ell~  967 (982)
                              ..+...+..+.+++++|++.||++|+     +++|+++
T Consensus       246 --------~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~  283 (340)
T PTZ00426        246 --------YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKE  283 (340)
T ss_pred             --------CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHc
Confidence                    11222234678999999999999995     8888876

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.5e-36  Score=323.98  Aligned_cols=255  Identities=28%  Similarity=0.439  Sum_probs=208.3

Q ss_pred             hhcccccccccccceEEEEEEeCCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEecc
Q 002010          692 ESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYM  771 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  771 (982)
                      ++|+..+.||+|++|.||+|...+++.||+|.+...  ....+.+.+|+.++++++||||+++++++...+..++||||+
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05068           6 TSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPG--TMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM   83 (261)
T ss_pred             hheeeEEEecccCCccEEEEEecCCeEEEEEeeCCC--cccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence            568888999999999999998777888999988543  234567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCcc
Q 002010          772 PNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASE  851 (982)
Q Consensus       772 ~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~  851 (982)
                      ++++|.+++.......+++..+..++.|++.|++|||+.+   |+||||||+||++++++.+||+|||++........ .
T Consensus        84 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-~  159 (261)
T cd05068          84 KYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIY-E  159 (261)
T ss_pred             cCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCcc-c
Confidence            9999999997655567899999999999999999999988   99999999999999999999999999987653211 1


Q ss_pred             cccccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceeec
Q 002010          852 CMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVD  930 (982)
Q Consensus       852 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  930 (982)
                      .......+..|+|||++.+..++.++||||+|+++|||++ |+.||....... ....+..... .              
T Consensus       160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-~~~~~~~~~~-~--------------  223 (261)
T cd05068         160 AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE-VLQQVDQGYR-M--------------  223 (261)
T ss_pred             ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH-HHHHHHcCCC-C--------------
Confidence            1112223458999999998899999999999999999999 999997643322 2222211110 0              


Q ss_pred             CCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 002010          931 PRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANP  972 (982)
Q Consensus       931 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~  972 (982)
                          ..+...+..+.+++.+|++.||++||+++++++.|+.+
T Consensus       224 ----~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~  261 (261)
T cd05068         224 ----PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF  261 (261)
T ss_pred             ----CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence                11223345789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=3.1e-36  Score=335.56  Aligned_cols=267  Identities=22%  Similarity=0.329  Sum_probs=205.0

Q ss_pred             hhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEec
Q 002010          692 ESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEY  770 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  770 (982)
                      ++|+..+.||+|+||.||+|+. .++..||+|.+...........+.+|++++++++||||+++++++..++..++||||
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   84 (331)
T cd06649           5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH   84 (331)
T ss_pred             ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeec
Confidence            5788899999999999999965 468889999885543334456789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCc
Q 002010          771 MPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS  850 (982)
Q Consensus       771 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  850 (982)
                      +++++|.+++..  ...+++..+..++.|++.|++|||+.+  .|+||||||+||+++.++.+||+|||++......   
T Consensus        85 ~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---  157 (331)
T cd06649          85 MDGGSLDQVLKE--AKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---  157 (331)
T ss_pred             CCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc---
Confidence            999999999973  456899999999999999999999742  2999999999999999999999999999765432   


Q ss_pred             ccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCc--c------
Q 002010          851 ECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSD--A------  922 (982)
Q Consensus       851 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~------  922 (982)
                       ......|++.|+|||++.+..++.++||||+||++|||++|+.||..... ..+...+............  .      
T Consensus       158 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (331)
T cd06649         158 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDA-KELEAIFGRPVVDGEEGEPHSISPRPRP  235 (331)
T ss_pred             -ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHhcccccccccCCccccCccccc
Confidence             12345689999999999998999999999999999999999999965432 2222222111000000000  0      


Q ss_pred             ---------------ccc----ceeecCCCCCC-ChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          923 ---------------ASV----LAVVDPRLSGY-PLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       923 ---------------~~~----~~~~~~~~~~~-~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                                     ...    ..+.....+.. ......++.+++.+||+.||++|||++|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~  300 (331)
T cd06649         236 PGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMN  300 (331)
T ss_pred             ccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhc
Confidence                           000    00000000111 1123457899999999999999999999987

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=2e-36  Score=331.28  Aligned_cols=268  Identities=22%  Similarity=0.261  Sum_probs=202.2

Q ss_pred             hcccccccccccceEEEEEEe-C-CCcEEEEEEeccCCCC-CchhhHHHHHHHHhcC---CCCcccceEeEEEc-----C
Q 002010          693 SLKDENIIGKGGAGIVYRGSM-P-DGIDVAIKRLVGRGTG-GNDHGFLAEIQTLGRI---RHRNIVRLLGYVSN-----R  761 (982)
Q Consensus       693 ~~~~~~~lg~G~~g~Vy~~~~-~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~-----~  761 (982)
                      +|+..+.||+|+||.||+|+. . +++.||+|++...... .....+.+|+.+++.+   +||||+++++++..     .
T Consensus         2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~   81 (290)
T cd07862           2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE   81 (290)
T ss_pred             CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence            588889999999999999965 2 4688999988544322 2334566787777665   69999999998853     3


Q ss_pred             CccEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccc
Q 002010          762 DTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLA  841 (982)
Q Consensus       762 ~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a  841 (982)
                      ...++||||++ ++|.+++.......+++..+..++.|++.|++|||+.+   |+||||||+||+++.++.+||+|||++
T Consensus        82 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg~~  157 (290)
T cd07862          82 TKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLA  157 (290)
T ss_pred             CcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEccccce
Confidence            45789999995 69999997655667899999999999999999999988   999999999999999999999999999


Q ss_pred             hhccccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCC-
Q 002010          842 KFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPS-  920 (982)
Q Consensus       842 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-  920 (982)
                      +.....   .......|++.|+|||++.+..++.++||||+||++|||++|++||....+.+.+...+.......+... 
T Consensus       158 ~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~  234 (290)
T cd07862         158 RIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP  234 (290)
T ss_pred             EeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhch
Confidence            765432   2234556899999999998888999999999999999999999999876554444444433221111000 


Q ss_pred             -cccccceeecCCCC----CCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          921 -DAASVLAVVDPRLS----GYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       921 -~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                       ........+.+...    ......+..+.+++.+|++.||++|||+.|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         235 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             hhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence             00000000111000    111234456789999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=1.6e-36  Score=331.54  Aligned_cols=269  Identities=18%  Similarity=0.230  Sum_probs=203.6

Q ss_pred             hcccccccccccceEEEEEEeC-CCcEEEEEEeccCCC-CCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEec
Q 002010          693 SLKDENIIGKGGAGIVYRGSMP-DGIDVAIKRLVGRGT-GGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEY  770 (982)
Q Consensus       693 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  770 (982)
                      +|++.+.||+|+||.||+|+.. +++.||+|++..... ......+.+|+.++++++||||+++++++..++..++||||
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (287)
T cd07848           2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEY   81 (287)
T ss_pred             CceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEec
Confidence            5888899999999999999764 588999999855432 23345678999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCc
Q 002010          771 MPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS  850 (982)
Q Consensus       771 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  850 (982)
                      ++++.+..+..  ....+++..+..++.|++.|++|||+.+   |+||||||+||+++.++.+||+|||++....... .
T Consensus        82 ~~~~~l~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~  155 (287)
T cd07848          82 VEKNMLELLEE--MPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS-N  155 (287)
T ss_pred             CCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccccc-c
Confidence            99877765543  3357899999999999999999999988   9999999999999999999999999998764321 2


Q ss_pred             ccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCC----CCcccccc
Q 002010          851 ECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQ----PSDAASVL  926 (982)
Q Consensus       851 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~  926 (982)
                      .......|++.|+|||++.+..++.++||||+||++|||++|++||...................+..    ........
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (287)
T cd07848         156 ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFH  235 (287)
T ss_pred             ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhc
Confidence            22334578999999999998889999999999999999999999998654333222222111110000    00000000


Q ss_pred             eeecCCCC-------CCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          927 AVVDPRLS-------GYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       927 ~~~~~~~~-------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                      ....+...       ......+..+.+++.+||+.||++|||++|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         236 GLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             ccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            00000000       011123456899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=1.9e-36  Score=331.48  Aligned_cols=264  Identities=24%  Similarity=0.435  Sum_probs=212.3

Q ss_pred             hhcccccccccccceEEEEEEe------CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccE
Q 002010          692 ESLKDENIIGKGGAGIVYRGSM------PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNL  765 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  765 (982)
                      .+|...+.||+|+||.||+|..      .++..+++|.+.. ......+.+.+|+.++++++||||+++++++...+..+
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKD-PTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLI   83 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCC-ccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceE
Confidence            4577788999999999999963      2355688888732 22333457889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCC
Q 002010          766 LLYEYMPNGSLGEMLHGAK--------------GGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDF  831 (982)
Q Consensus       766 lv~e~~~~~sL~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~  831 (982)
                      +||||+++++|.+++....              ...+++..++.++.||+.|++|||+++   |+||||||+||+++.++
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~  160 (291)
T cd05094          84 MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANL  160 (291)
T ss_pred             EEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCC
Confidence            9999999999999996432              245889999999999999999999988   99999999999999999


Q ss_pred             CEEEeccccchhccccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHH
Q 002010          832 EAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVR  910 (982)
Q Consensus       832 ~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~  910 (982)
                      .+||+|||++................++..|+|||++.+..++.++||||+|+++|||++ |..||....... ......
T Consensus       161 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-~~~~~~  239 (291)
T cd05094         161 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE-VIECIT  239 (291)
T ss_pred             cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHHh
Confidence            999999999976543322222334556788999999999999999999999999999999 999987643322 222111


Q ss_pred             HhccCCCCCCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCCCCCCC
Q 002010          911 KTTSEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQSAPSL  979 (982)
Q Consensus       911 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~~~~~~~  979 (982)
                      ..                   .....+...+..+.+++.+||+.||++|||+++|++.|+++....|.+
T Consensus       240 ~~-------------------~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~~~~~  289 (291)
T cd05094         240 QG-------------------RVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKATPIY  289 (291)
T ss_pred             CC-------------------CCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhhcCcc
Confidence            10                   011112233457899999999999999999999999999998888876

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=3.5e-36  Score=331.32  Aligned_cols=269  Identities=23%  Similarity=0.333  Sum_probs=202.9

Q ss_pred             hhcccccccccccceEEEEEEeC-CCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEec
Q 002010          692 ESLKDENIIGKGGAGIVYRGSMP-DGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEY  770 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  770 (982)
                      ++|+..+.||+|+||.||+|+.. +++.||+|++...........+.+|+.++++++||||+++++++.+++..++||||
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (303)
T cd07869           5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEY   84 (303)
T ss_pred             ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEEC
Confidence            57888999999999999999764 68899999986554444455678999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCc
Q 002010          771 MPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS  850 (982)
Q Consensus       771 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  850 (982)
                      ++ ++|.+++.. ....++++.+..++.|++.|++|||+.+   |+||||||+||++++++.+||+|||++......  .
T Consensus        85 ~~-~~l~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~--~  157 (303)
T cd07869          85 VH-TDLCQYMDK-HPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVP--S  157 (303)
T ss_pred             CC-cCHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCC--C
Confidence            95 688888763 3356889999999999999999999988   999999999999999999999999998754322  1


Q ss_pred             cccccccccccccccccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCccc-cccee
Q 002010          851 ECMSSVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAA-SVLAV  928 (982)
Q Consensus       851 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~  928 (982)
                      .......+++.|+|||++.+ ..++.++||||+||++|||++|..||....+.......+......+....... .....
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (303)
T cd07869         158 HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPH  237 (303)
T ss_pred             ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccc
Confidence            22334568899999998865 45889999999999999999999999875443333322222111111000000 00000


Q ss_pred             ecCC-CC-CCC---------hHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          929 VDPR-LS-GYP---------LTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       929 ~~~~-~~-~~~---------~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                      .++. .. ..+         ......+.+++.+|++.||++|||++|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         238 FKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             cccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence            0000 00 000         012245789999999999999999999986

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.2e-37  Score=321.87  Aligned_cols=264  Identities=21%  Similarity=0.307  Sum_probs=222.6

Q ss_pred             HhhcccccccccccceEEEEEE-eCCCcEEEEEEeccCCCC-CchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEE
Q 002010          691 LESLKDENIIGKGGAGIVYRGS-MPDGIDVAIKRLVGRGTG-GNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLY  768 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  768 (982)
                      ..-|...+.||+|.|+.|-.|+ .-+|.+||||++.+...+ .....+.+|++.|+.++|||||++|++.......|+|.
T Consensus        17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL   96 (864)
T KOG4717|consen   17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL   96 (864)
T ss_pred             eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence            3457788899999999999994 568999999999555433 34557889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEE-cCCCCEEEeccccchhcccc
Q 002010          769 EYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILL-DSDFEAHVADFGLAKFLQDA  847 (982)
Q Consensus       769 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill-~~~~~~kl~DfG~a~~~~~~  847 (982)
                      |.-.+|+|++|+.++. ..+.++.+.+++.||+.|+.|+|+.+   |||||+||+||++ ..-|-||+.|||++..+.++
T Consensus        97 ELGD~GDl~DyImKHe-~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG  172 (864)
T KOG4717|consen   97 ELGDGGDLFDYIMKHE-EGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG  172 (864)
T ss_pred             EecCCchHHHHHHhhh-ccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence            9999999999998643 67899999999999999999999998   9999999999876 45589999999999877643


Q ss_pred             CCcccccccccccccccccccccCCCC-cchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccc
Q 002010          848 GASECMSSVAGSYGYIAPEYAYTLKVD-EKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVL  926 (982)
Q Consensus       848 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  926 (982)
                         ......+|+..|.|||++.+..|+ +++||||+|||+|-+++|++||....+.+.+-.++....             
T Consensus       173 ---~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKY-------------  236 (864)
T KOG4717|consen  173 ---KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKY-------------  236 (864)
T ss_pred             ---chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccc-------------
Confidence               456778999999999999999987 688999999999999999999998877655443332111             


Q ss_pred             eeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH--HhcCCCCCCCCCCCC
Q 002010          927 AVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH--MLANPPQSAPSLITL  982 (982)
Q Consensus       927 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~--~L~~~~~~~~~~~~~  982 (982)
                              ..|.-...++.++|..|+.+||.+|.+.+||+.  -|...-.+.+++|+|
T Consensus       237 --------tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~~~sT~iPL  286 (864)
T KOG4717|consen  237 --------TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDRGLSTAIPL  286 (864)
T ss_pred             --------cCchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCCCCccccCce
Confidence                    245556678999999999999999999999987  456666666666765

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-37  Score=297.92  Aligned_cols=262  Identities=23%  Similarity=0.306  Sum_probs=208.0

Q ss_pred             hhcccccccccccceEEEEEE-eCCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcC-----CccE
Q 002010          692 ESLKDENIIGKGGAGIVYRGS-MPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNR-----DTNL  765 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~  765 (982)
                      ++|++.+.+|+|||+-||.++ ..+++.||+|++.... .+..+..++|++..++++||||++++++...+     ...|
T Consensus        21 ~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~-~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y   99 (302)
T KOG2345|consen   21 KRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS-QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY   99 (302)
T ss_pred             ceEEEeeeecCCCceeeeeecccCcccchhhheeeccc-hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence            578899999999999999995 5778999999995543 56677789999999999999999999876443     3489


Q ss_pred             EEEeccCCCCHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchh
Q 002010          766 LLYEYMPNGSLGEMLHGA--KGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKF  843 (982)
Q Consensus       766 lv~e~~~~~sL~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~  843 (982)
                      ++++|...|+|.+.+...  ++..+++.++..|+.+|++|+++||+.. ++++||||||.||++++.+.+++.|||.++.
T Consensus       100 ll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~~  178 (302)
T KOG2345|consen  100 LLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSATQ  178 (302)
T ss_pred             EEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCccc
Confidence            999999999999998753  3457999999999999999999999874 6799999999999999999999999999986


Q ss_pred             ccccCCc-------ccccccccccccccccccc---cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhc
Q 002010          844 LQDAGAS-------ECMSSVAGSYGYIAPEYAY---TLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTT  913 (982)
Q Consensus       844 ~~~~~~~-------~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~  913 (982)
                      ..-.-..       +.......|..|+|||.+.   +...++++||||+||++|+|+.|..||+..-..           
T Consensus       179 a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~-----------  247 (302)
T KOG2345|consen  179 APIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQ-----------  247 (302)
T ss_pred             cceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhc-----------
Confidence            5322111       1122345789999999886   445789999999999999999999999642110           


Q ss_pred             cCCCCCCcccccceeecCCCC-CCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 002010          914 SEVSQPSDAASVLAVVDPRLS-GYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPP  973 (982)
Q Consensus       914 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~  973 (982)
                             +..-..++..+... .-....+..+.+++++|++.||.+||++.|++..+..+.
T Consensus       248 -------GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li  301 (302)
T KOG2345|consen  248 -------GGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI  301 (302)
T ss_pred             -------CCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence                   01111223332222 111125678999999999999999999999999887653

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=1.8e-36  Score=329.18  Aligned_cols=258  Identities=26%  Similarity=0.414  Sum_probs=205.3

Q ss_pred             HhhcccccccccccceEEEEEEeC------CCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCcc
Q 002010          691 LESLKDENIIGKGGAGIVYRGSMP------DGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTN  764 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  764 (982)
                      .++|+..+.||+|+||.||+|...      .+..||+|++..........++.+|+.+++.++||||+++++++.+....
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~   84 (277)
T cd05062           5 REKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT   84 (277)
T ss_pred             HHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCe
Confidence            467899999999999999998642      35679999875443333455688999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHhhcCC--------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEe
Q 002010          765 LLLYEYMPNGSLGEMLHGAK--------GGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVA  836 (982)
Q Consensus       765 ~lv~e~~~~~sL~~~l~~~~--------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~  836 (982)
                      ++||||+++++|.+++....        ...+++..+..++.|++.|++|||+.+   ++||||||+||++++++.+|++
T Consensus        85 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l~  161 (277)
T cd05062          85 LVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIG  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEEC
Confidence            99999999999999986432        134678889999999999999999988   9999999999999999999999


Q ss_pred             ccccchhccccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHhccC
Q 002010          837 DFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSE  915 (982)
Q Consensus       837 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  915 (982)
                      |||+++...............+++.|+|||++.+..++.++||||+||++|||++ |..||..... ......+....  
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~-~~~~~~~~~~~--  238 (277)
T cd05062         162 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN-EQVLRFVMEGG--  238 (277)
T ss_pred             CCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH-HHHHHHHHcCC--
Confidence            9999976543322222222345778999999998889999999999999999999 7889875433 22222221111  


Q ss_pred             CCCCCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 002010          916 VSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLAN  971 (982)
Q Consensus       916 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~  971 (982)
                                       ....+...+..+.+++.+||+.||++|||+.|+++.|++
T Consensus       239 -----------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~  277 (277)
T cd05062         239 -----------------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE  277 (277)
T ss_pred             -----------------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence                             011122344578999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=2e-36  Score=330.79  Aligned_cols=264  Identities=24%  Similarity=0.426  Sum_probs=210.8

Q ss_pred             hhcccccccccccceEEEEEEe------CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccE
Q 002010          692 ESLKDENIIGKGGAGIVYRGSM------PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNL  765 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  765 (982)
                      ++|.+.+.||+|+||.||++..      .++..+|+|.+... .......+.+|+.++++++||||+++++++...+..+
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA-SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI   83 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence            4688889999999999999964      23456899987432 3334557889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHhhcCC-----------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEE
Q 002010          766 LLYEYMPNGSLGEMLHGAK-----------GGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAH  834 (982)
Q Consensus       766 lv~e~~~~~sL~~~l~~~~-----------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~k  834 (982)
                      +||||+++++|.+++....           ...+++..+..++.|++.|++|||+.+   ++||||||+||++++++.+|
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~k  160 (288)
T cd05093          84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVK  160 (288)
T ss_pred             EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEE
Confidence            9999999999999986432           235899999999999999999999988   99999999999999999999


Q ss_pred             EeccccchhccccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHhc
Q 002010          835 VADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTT  913 (982)
Q Consensus       835 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~  913 (982)
                      ++|||++................++..|+|||++.+..++.++||||+||++|||++ |..||....... ....+....
T Consensus       161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~-~~~~i~~~~  239 (288)
T cd05093         161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE-VIECITQGR  239 (288)
T ss_pred             eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHHHcCC
Confidence            999999986543322222233445778999999998899999999999999999999 999987653322 222221111


Q ss_pred             cCCCCCCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCCCCCCC
Q 002010          914 SEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQSAPSL  979 (982)
Q Consensus       914 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~~~~~~~  979 (982)
                      .                   ...+...+..+.+++.+||+.||.+|||+.|+.+.|+.+.+..+.+
T Consensus       240 ~-------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~~~~~  286 (288)
T cd05093         240 V-------------------LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKASPVY  286 (288)
T ss_pred             c-------------------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHhcccc
Confidence            0                   0011123346899999999999999999999999999888776554

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.9e-37  Score=302.57  Aligned_cols=256  Identities=25%  Similarity=0.373  Sum_probs=211.5

Q ss_pred             HHHHHhhcccccccccccceEEEEE-EeCCCcEEEEEEeccCCCCC---c----hhhHHHHHHHHhcC-CCCcccceEeE
Q 002010          687 AEDVLESLKDENIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGG---N----DHGFLAEIQTLGRI-RHRNIVRLLGY  757 (982)
Q Consensus       687 ~~~~~~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~---~----~~~~~~E~~~l~~l-~h~niv~~~~~  757 (982)
                      .+++..+|+..+.+|.|..++|-++ ..++|.++|+|++.......   .    .+...+|+.+++++ .||+|+++.++
T Consensus        12 a~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~   91 (411)
T KOG0599|consen   12 AKGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDV   91 (411)
T ss_pred             HhhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeee
Confidence            4567788999999999999999988 45678999999884433221   1    23456799999998 69999999999


Q ss_pred             EEcCCccEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEec
Q 002010          758 VSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVAD  837 (982)
Q Consensus       758 ~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~D  837 (982)
                      |+.+...++|+|.|+.|.|.+++.  ..-.+++++..++++|+.+|++|||..+   |||||+||+||+++++.++||+|
T Consensus        92 yes~sF~FlVFdl~prGELFDyLt--s~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isD  166 (411)
T KOG0599|consen   92 YESDAFVFLVFDLMPRGELFDYLT--SKVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISD  166 (411)
T ss_pred             ccCcchhhhhhhhcccchHHHHhh--hheeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEec
Confidence            999999999999999999999997  5568999999999999999999999998   99999999999999999999999


Q ss_pred             cccchhccccCCcccccccccccccccccccc------cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHH
Q 002010          838 FGLAKFLQDAGASECMSSVAGSYGYIAPEYAY------TLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRK  911 (982)
Q Consensus       838 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~  911 (982)
                      ||.|+.+.++   ......+|||+|.|||.+.      ...|+..+|+||+|||+|.++.|.+||....+ ....+.+..
T Consensus       167 FGFa~~l~~G---ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ-mlMLR~Ime  242 (411)
T KOG0599|consen  167 FGFACQLEPG---EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ-MLMLRMIME  242 (411)
T ss_pred             cceeeccCCc---hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH-HHHHHHHHh
Confidence            9999988753   4567789999999999875      34688999999999999999999999986533 233344433


Q ss_pred             hccCCCCCCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          912 TTSEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       912 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                      .......|.+                .+......+++.+|++.||.+|.|++|+++
T Consensus       243 GkyqF~speW----------------adis~~~KdLIsrlLqVdp~~Ritake~La  282 (411)
T KOG0599|consen  243 GKYQFRSPEW----------------ADISATVKDLISRLLQVDPTKRITAKEALA  282 (411)
T ss_pred             cccccCCcch----------------hhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence            3333332222                123346789999999999999999999886

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.3e-37  Score=337.82  Aligned_cols=240  Identities=23%  Similarity=0.263  Sum_probs=194.6

Q ss_pred             cccccceEEEEEEe-CCCcEEEEEEeccCC--CCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEeccCCCCH
Q 002010          700 IGKGGAGIVYRGSM-PDGIDVAIKRLVGRG--TGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSL  776 (982)
Q Consensus       700 lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL  776 (982)
                      ||+|+||.||+|.. .+++.||+|++....  .......+.+|+.++.+++||||+++++++..++..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            69999999999965 458899999985432  233445678899999999999999999999999999999999999999


Q ss_pred             HHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCccccccc
Q 002010          777 GEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSV  856 (982)
Q Consensus       777 ~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~  856 (982)
                      .+++.  +...+++..+..++.|++.|++|||+.+   |+||||||+||+++.++.+||+|||+++.....  .......
T Consensus        81 ~~~l~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~--~~~~~~~  153 (312)
T cd05585          81 FHHLQ--REGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKD--DDKTNTF  153 (312)
T ss_pred             HHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccC--CCccccc
Confidence            99997  3457899999999999999999999988   999999999999999999999999999754322  1223446


Q ss_pred             ccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceeecCCCCCC
Q 002010          857 AGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDPRLSGY  936 (982)
Q Consensus       857 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  936 (982)
                      .||+.|+|||++.+..++.++||||+||++|||++|+.||.......    .........                 ...
T Consensus       154 ~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~----~~~~~~~~~-----------------~~~  212 (312)
T cd05585         154 CGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNE----MYRKILQEP-----------------LRF  212 (312)
T ss_pred             cCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHH----HHHHHHcCC-----------------CCC
Confidence            78999999999999999999999999999999999999997643222    111111100                 012


Q ss_pred             ChHhHHHHHHHHhhccCCCCCCCCC---HHHHHH
Q 002010          937 PLTGVIHLFKVAMMCVEDESSARPT---MREVVH  967 (982)
Q Consensus       937 ~~~~~~~l~~li~~cl~~dP~~Rpt---~~ell~  967 (982)
                      +...+..+.+++.+||+.||++||+   +.|++.
T Consensus       213 ~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~  246 (312)
T cd05585         213 PDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKN  246 (312)
T ss_pred             CCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence            2233457889999999999999985   555543

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.2e-37  Score=330.37  Aligned_cols=251  Identities=25%  Similarity=0.390  Sum_probs=204.5

Q ss_pred             hhcccccccccccceEEEEEEeCCCcEEEEEEeccC-CCCCchhhHHHHHHHHhcCC-CCcccceEeEEEcCCccEEEEe
Q 002010          692 ESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGR-GTGGNDHGFLAEIQTLGRIR-HRNIVRLLGYVSNRDTNLLLYE  769 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e  769 (982)
                      ..|++.+.||+||.+.||++...+.+.||+|++... ........|..|+..+.+++ |.+||++|+|-..++..|+|||
T Consensus       361 ~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE  440 (677)
T KOG0596|consen  361 REYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVME  440 (677)
T ss_pred             chhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEee
Confidence            357888899999999999998877788888877443 34455678999999999994 8999999999999999999999


Q ss_pred             ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCC
Q 002010          770 YMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGA  849 (982)
Q Consensus       770 ~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  849 (982)
                      |- ..+|.+++.+.......| .+..+.+|++.|+.++|++|   |||.||||.|+++- .|.+||+|||+|..+..+..
T Consensus       441 ~G-d~DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DTT  514 (677)
T KOG0596|consen  441 CG-DIDLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDTT  514 (677)
T ss_pred             cc-cccHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEE-eeeEEeeeechhcccCcccc
Confidence            97 679999998655545555 77889999999999999999   99999999999994 67999999999999887766


Q ss_pred             cccccccccccccccccccccC-----------CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCC
Q 002010          850 SECMSSVAGSYGYIAPEYAYTL-----------KVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQ  918 (982)
Q Consensus       850 ~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  918 (982)
                      .-...+.+||+.||+||++...           +.++++||||+|||+|+|+.|+.||..+..      .+         
T Consensus       515 sI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n------~~---------  579 (677)
T KOG0596|consen  515 SIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN------QI---------  579 (677)
T ss_pred             ceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH------HH---------
Confidence            6667789999999999988632           256899999999999999999999976421      11         


Q ss_pred             CCcccccceeecCCCC-CCCh-HhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          919 PSDAASVLAVVDPRLS-GYPL-TGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       919 ~~~~~~~~~~~~~~~~-~~~~-~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                          ..+.++.||... ++|. ....++.++|+.||.+||.+|||+.|+++
T Consensus       580 ----aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq  626 (677)
T KOG0596|consen  580 ----AKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ  626 (677)
T ss_pred             ----HHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence                122334444221 2221 11223899999999999999999999987

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=1.3e-36  Score=337.25  Aligned_cols=242  Identities=23%  Similarity=0.263  Sum_probs=197.1

Q ss_pred             cccccccceEEEEEEe-CCCcEEEEEEeccCC--CCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEeccCCC
Q 002010          698 NIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRG--TGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNG  774 (982)
Q Consensus       698 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~  774 (982)
                      +.||+|+||.||+|.. .+|..||+|++....  .......+.+|+.++++++||||+++++++...+..++||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            3689999999999965 568999999985432  2233456778999999999999999999999999999999999999


Q ss_pred             CHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCccccc
Q 002010          775 SLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMS  854 (982)
Q Consensus       775 sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~  854 (982)
                      +|..++.  +...+++..+..++.||+.|++|||+.+   |+||||||+||+++.++.+||+|||++......  .....
T Consensus        81 ~L~~~l~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~--~~~~~  153 (323)
T cd05595          81 ELFFHLS--RERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMK  153 (323)
T ss_pred             cHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCC--CCccc
Confidence            9999886  3457899999999999999999999988   999999999999999999999999998753221  12233


Q ss_pred             ccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceeecCCCC
Q 002010          855 SVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDPRLS  934 (982)
Q Consensus       855 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  934 (982)
                      ...|++.|+|||++.+..++.++||||+||++|||++|+.||.................                     
T Consensus       154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~---------------------  212 (323)
T cd05595         154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI---------------------  212 (323)
T ss_pred             cccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC---------------------
Confidence            46789999999999999999999999999999999999999976433222222111100                     


Q ss_pred             CCChHhHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 002010          935 GYPLTGVIHLFKVAMMCVEDESSARP-----TMREVVH  967 (982)
Q Consensus       935 ~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~ell~  967 (982)
                      ..+...+..+.+++.+||+.||++||     ++.++++
T Consensus       213 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~  250 (323)
T cd05595         213 RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  250 (323)
T ss_pred             CCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence            11223345788999999999999998     8888765

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-37  Score=334.77  Aligned_cols=254  Identities=26%  Similarity=0.432  Sum_probs=213.2

Q ss_pred             hhcccccccccccceEEEEEEeC--CC--cEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEE
Q 002010          692 ESLKDENIIGKGGAGIVYRGSMP--DG--IDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLL  767 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~~--~~--~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  767 (982)
                      ++++..+.||+|.||.|++|.|.  +|  ..||||.+..........+|.+|+.+|.+++|||++++||.+.+ ...++|
T Consensus       110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV  188 (1039)
T KOG0199|consen  110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMV  188 (1039)
T ss_pred             HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHH
Confidence            45666778999999999999763  34  45899999766655577899999999999999999999998887 778899


Q ss_pred             EeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhcccc
Q 002010          768 YEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDA  847 (982)
Q Consensus       768 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  847 (982)
                      ||.++.|+|.+.+++.....+-......++.|||.||.||..++   .||||+..+|+++-..-.|||+|||+.+-+...
T Consensus       189 ~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~n  265 (1039)
T KOG0199|consen  189 FELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGEN  265 (1039)
T ss_pred             hhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCC
Confidence            99999999999999867788889999999999999999999888   999999999999998889999999999988655


Q ss_pred             CCcccccc-cccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHhccCCCCCCccccc
Q 002010          848 GASECMSS-VAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASV  925 (982)
Q Consensus       848 ~~~~~~~~-~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  925 (982)
                      .....+.. ..-...|+|||.+....++.++|||+|||++|||+| |+.||.+.... .+...+. .             
T Consensus       266 ed~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~-qIL~~iD-~-------------  330 (1039)
T KOG0199|consen  266 EDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGI-QILKNID-A-------------  330 (1039)
T ss_pred             CcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHH-HHHHhcc-c-------------
Confidence            43333333 334568999999999999999999999999999999 89999876442 2222222 1             


Q ss_pred             ceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 002010          926 LAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHML  969 (982)
Q Consensus       926 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L  969 (982)
                           ..+-.-|+.|+.+++++|+.||..+|++|||+..|.+.+
T Consensus       331 -----~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~  369 (1039)
T KOG0199|consen  331 -----GERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL  369 (1039)
T ss_pred             -----cccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence                 111245677888999999999999999999999998543

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=5.1e-36  Score=323.00  Aligned_cols=255  Identities=24%  Similarity=0.370  Sum_probs=207.7

Q ss_pred             hhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEec
Q 002010          692 ESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEY  770 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  770 (982)
                      ..|+..+.||+|+||.||+|.. ..++.||+|.+...  .....++.+|+.++++++||||+++++++..++..++||||
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED--TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF   83 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC--chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEe
Confidence            4577788999999999999965 45889999987432  33456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCc
Q 002010          771 MPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS  850 (982)
Q Consensus       771 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  850 (982)
                      +++++|.+++.......+++..+..++.|++.|++|||+.+   ++||||||+||++++++.+||+|||.+....... .
T Consensus        84 ~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~-~  159 (263)
T cd05052          84 MTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT-Y  159 (263)
T ss_pred             CCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccce-e
Confidence            99999999997655567899999999999999999999988   9999999999999999999999999998765321 1


Q ss_pred             ccccccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceee
Q 002010          851 ECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVV  929 (982)
Q Consensus       851 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  929 (982)
                      .......++..|+|||.+.+..++.++||||+||++|||++ |..||..... ............               
T Consensus       160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~-~~~~~~~~~~~~---------------  223 (263)
T cd05052         160 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-SQVYELLEKGYR---------------  223 (263)
T ss_pred             eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH-HHHHHHHHCCCC---------------
Confidence            11122334668999999998899999999999999999998 9999875422 222222211100               


Q ss_pred             cCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 002010          930 DPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANP  972 (982)
Q Consensus       930 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~  972 (982)
                          ...+...+..+.+++.+||+.||++|||+.|+++.|+.+
T Consensus       224 ----~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         224 ----MERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             ----CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence                012233456799999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=3.8e-36  Score=327.82  Aligned_cols=257  Identities=25%  Similarity=0.418  Sum_probs=207.4

Q ss_pred             hhcccccccccccceEEEEEEe-----CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEE
Q 002010          692 ESLKDENIIGKGGAGIVYRGSM-----PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLL  766 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  766 (982)
                      +.|+..+.||+|+||.||+|..     .++..||+|.+...........+.+|+.++++++||||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            4677888999999999999963     34678999998654443444678899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHhhcCC---------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCC
Q 002010          767 LYEYMPNGSLGEMLHGAK---------------GGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDF  831 (982)
Q Consensus       767 v~e~~~~~sL~~~l~~~~---------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~  831 (982)
                      ||||+++++|.+++....               ...+++.++..++.|++.|++|||+.+   |+||||||+||++++++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~  161 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL  161 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence            999999999999985321               234788899999999999999999988   99999999999999999


Q ss_pred             CEEEeccccchhccccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHH
Q 002010          832 EAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVR  910 (982)
Q Consensus       832 ~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~  910 (982)
                      .+|++|||+++...............++..|+|||++.+..++.++||||+|+++|||++ |..||..... ......+.
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~-~~~~~~~~  240 (283)
T cd05090         162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN-QEVIEMVR  240 (283)
T ss_pred             cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH-HHHHHHHH
Confidence            999999999987654332223334456778999999988889999999999999999999 9999876432 22333332


Q ss_pred             HhccCCCCCCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 002010          911 KTTSEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLAN  971 (982)
Q Consensus       911 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~  971 (982)
                      ....                   ...+...+..+.+++.+||+.||++||++.++.+.|..
T Consensus       241 ~~~~-------------------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         241 KRQL-------------------LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             cCCc-------------------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence            2111                   01222344578899999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-39  Score=366.06  Aligned_cols=473  Identities=25%  Similarity=0.300  Sum_probs=282.5

Q ss_pred             cCCcCccccccccEEEeccCCCCCCCChhhhhhcccceeeccCCccccccchhhhhcCCCccEEeccCccccCCCchhcc
Q 002010           86 SIPPEIGLLTKLVNLTISNVNLTGRLPSEMALLTSLKVFNISGNVFQGNFAGQIVRGMTELQVLDAYNNNFTGPLPVEIA  165 (982)
Q Consensus        86 ~~~~~i~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~l~  165 (982)
                      .||..|-.-..++.|+++.|-+....-+.+...-+|+.||||+|.+. .+|.. +..+.+|+.|+++.|.+. ..|.++.
T Consensus        12 ~ip~~i~~~~~~~~ln~~~N~~l~~pl~~~~~~v~L~~l~lsnn~~~-~fp~~-it~l~~L~~ln~s~n~i~-~vp~s~~   88 (1081)
T KOG0618|consen   12 LIPEQILNNEALQILNLRRNSLLSRPLEFVEKRVKLKSLDLSNNQIS-SFPIQ-ITLLSHLRQLNLSRNYIR-SVPSSCS   88 (1081)
T ss_pred             ccchhhccHHHHHhhhccccccccCchHHhhheeeeEEeeccccccc-cCCch-hhhHHHHhhcccchhhHh-hCchhhh
Confidence            45555555555666666666555322233334444667777766664 33322 244566666677766666 5666666


Q ss_pred             ccccccEEeecCcccccccCCCccccCcceEeeccCcccccchhhHHhhhhhHHHHhhcccccccccCCCCCCCCCCCCE
Q 002010          166 SLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLNGIGLNGTVPAFLSRLKNLREMYIGYFNTYTGGIPPGFGALTQLQV  245 (982)
Q Consensus       166 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~l~~~n~~~~~~p~~~~~l~~L~~  245 (982)
                      ++.+|++|.|.+|++. ..|.++..+.+|++|+++.|.+. .+|..+..+..+..+..++| .....    ++... ++.
T Consensus        89 ~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS~N~f~-~~Pl~i~~lt~~~~~~~s~N-~~~~~----lg~~~-ik~  160 (1081)
T KOG0618|consen   89 NMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLSFNHFG-PIPLVIEVLTAEEELAASNN-EKIQR----LGQTS-IKK  160 (1081)
T ss_pred             hhhcchhheeccchhh-cCchhHHhhhcccccccchhccC-CCchhHHhhhHHHHHhhhcc-hhhhh----hcccc-chh
Confidence            6667777777666665 66666666666777776666665 55666666666666666643 11111    12212 666


Q ss_pred             EecccCcCcccCchhhcCCCccceeecccccCCCCCCccccCCCCCCEEEeeCCcccCcCchhhhcccchhhhhhccCCC
Q 002010          246 LDMASCNISGEIPTSLSRLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQLFKNNL  325 (982)
Q Consensus       246 L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l  325 (982)
                      +++..|.+.+.++..+..++.  .|+|++|.+. .  ..+.++.+|+.|....|++....    -..++|+.|+.++|.+
T Consensus       161 ~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~-~--~dls~~~~l~~l~c~rn~ls~l~----~~g~~l~~L~a~~n~l  231 (1081)
T KOG0618|consen  161 LDLRLNVLGGSFLIDIYNLTH--QLDLRYNEME-V--LDLSNLANLEVLHCERNQLSELE----ISGPSLTALYADHNPL  231 (1081)
T ss_pred             hhhhhhhcccchhcchhhhhe--eeecccchhh-h--hhhhhccchhhhhhhhcccceEE----ecCcchheeeeccCcc
Confidence            666666666666666655555  5666666665 1  23555666666666666665221    1235666666666666


Q ss_pred             CCCCCCcCCCCCCccEEEccCCCcccccCccccCCCcccEEEeccccccccCCccccCccccceeecccccccccCCccc
Q 002010          326 RGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFIGPIPEEL  405 (982)
Q Consensus       326 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~l~~N~~~~~~~~~l  405 (982)
                      ....+..  .-.+|++++++.|+++. +|++++.+.+|+.|+..+|+++ .+|..+...++|++|.+..|.+. -+|...
T Consensus       232 ~~~~~~p--~p~nl~~~dis~n~l~~-lp~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~-yip~~l  306 (1081)
T KOG0618|consen  232 TTLDVHP--VPLNLQYLDISHNNLSN-LPEWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELE-YIPPFL  306 (1081)
T ss_pred             eeecccc--ccccceeeecchhhhhc-chHHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhh-hCCCcc
Confidence            6322211  22356777777777763 4466777777777777777774 66666666677777777777655 455556


Q ss_pred             cCCCCCCEEEccCCccCCCCCcccc-CCCc-cccccCCCccccccCCc-ccccCCccEEEeeccccCCCCchhccCCCCc
Q 002010          406 GQCKSLTKIRFSKNYLNGTIPAGLF-NLPL-LNMMELDDNLLSGELPE-KMSGASLNQLKVANNNITGKIPAAIGNLPSL  482 (982)
Q Consensus       406 ~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~-L~~L~L~~N~l~~~~~~-~~~~~~L~~L~L~~N~i~~~~p~~~~~l~~L  482 (982)
                      ..++.|+.|+|..|+|. ..|+.+. .+.. |+.|+.+.|++...... ......|+.|++.+|.++...-+.+.+++.|
T Consensus       307 e~~~sL~tLdL~~N~L~-~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hL  385 (1081)
T KOG0618|consen  307 EGLKSLRTLDLQSNNLP-SLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHL  385 (1081)
T ss_pred             cccceeeeeeehhcccc-ccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccce
Confidence            66677777777777776 4444332 2222 56666666666543311 1112456667777777776666666666777


Q ss_pred             ceeeeccccccCCCccccccccccceeeeeccccCCCCCcccccccCCCeeeCCCCcccCCCCcccccccccceEEcccc
Q 002010          483 NILSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYGKIPPGISKLIDLSILNLSRN  562 (982)
Q Consensus       483 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N  562 (982)
                      +.|+|++|+|.......+.++..|+.|+||+|+++ .+|..+..+..|+.|...+|++. ..| .+..++.|+.+|+|.|
T Consensus       386 KVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N  462 (1081)
T KOG0618|consen  386 KVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCN  462 (1081)
T ss_pred             eeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccc
Confidence            77777777776333334556666777777777776 56666677777777777777765 555 5667777777777777


Q ss_pred             cccccCccccccccccceecccCCc
Q 002010          563 GITGSIPNEMRNMMSLTTLDLSYNN  587 (982)
Q Consensus       563 ~l~~~~p~~l~~l~~L~~L~Ls~N~  587 (982)
                      +|+...-..-...++|++|||+||.
T Consensus       463 ~L~~~~l~~~~p~p~LkyLdlSGN~  487 (1081)
T KOG0618|consen  463 NLSEVTLPEALPSPNLKYLDLSGNT  487 (1081)
T ss_pred             hhhhhhhhhhCCCcccceeeccCCc
Confidence            7664333222333667777777765

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=5.6e-36  Score=321.13  Aligned_cols=252  Identities=25%  Similarity=0.415  Sum_probs=204.6

Q ss_pred             hhcccccccccccceEEEEEEeCCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEecc
Q 002010          692 ESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYM  771 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  771 (982)
                      ++|+..+.||+|+||.||+|+..++..||+|.+...  ......+.+|+.++++++||||+++++++...+..++||||+
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   81 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG--SMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYM   81 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCC--cccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcC
Confidence            467888899999999999998877778999987533  233567899999999999999999999999888999999999


Q ss_pred             CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCcc
Q 002010          772 PNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASE  851 (982)
Q Consensus       772 ~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~  851 (982)
                      ++++|.+++.... ..+++..+..++.||+.|++|||+.+   ++||||||+||++++++.+||+|||.++...+... .
T Consensus        82 ~~~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~-~  156 (256)
T cd05113          82 SNGCLLNYLREHG-KRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY-T  156 (256)
T ss_pred             CCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCce-e
Confidence            9999999997433 37899999999999999999999988   99999999999999999999999999876543321 1


Q ss_pred             cccccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceeec
Q 002010          852 CMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVD  930 (982)
Q Consensus       852 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  930 (982)
                      ......++..|+|||+..+..++.++||||+|+++|||++ |..||....... ....+.....                
T Consensus       157 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~-~~~~~~~~~~----------------  219 (256)
T cd05113         157 SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE-TVEKVSQGLR----------------  219 (256)
T ss_pred             ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH-HHHHHhcCCC----------------
Confidence            1222345678999999988889999999999999999999 999997654322 2222211111                


Q ss_pred             CCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 002010          931 PRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLA  970 (982)
Q Consensus       931 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~  970 (982)
                         ...+...+..+.+++.+||+.||.+|||+.++++.|+
T Consensus       220 ---~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         220 ---LYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             ---CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence               0011123457899999999999999999999998774

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-36  Score=338.84  Aligned_cols=252  Identities=23%  Similarity=0.294  Sum_probs=204.3

Q ss_pred             hcccccccccccceEEEEEEeC-CCcEEEEEEeccCCC--CCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEe
Q 002010          693 SLKDENIIGKGGAGIVYRGSMP-DGIDVAIKRLVGRGT--GGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYE  769 (982)
Q Consensus       693 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  769 (982)
                      +|++.+.||+|+||.||+|... +++.||+|++.....  ......+.+|+.++..++||||+++++++.+.+..++|||
T Consensus         2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e   81 (333)
T cd05600           2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAME   81 (333)
T ss_pred             CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEe
Confidence            5788899999999999999764 588999999854322  2334568899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCC
Q 002010          770 YMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGA  849 (982)
Q Consensus       770 ~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  849 (982)
                      |+++++|.+++.  +...+++..+..++.|++.|++|||+.+   |+||||||+||+++.++.+||+|||++.....   
T Consensus        82 ~~~g~~L~~~l~--~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~---  153 (333)
T cd05600          82 YVPGGDFRTLLN--NLGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT---  153 (333)
T ss_pred             CCCCCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc---
Confidence            999999999996  3457899999999999999999999988   99999999999999999999999999976543   


Q ss_pred             cccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceee
Q 002010          850 SECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVV  929 (982)
Q Consensus       850 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  929 (982)
                        ......|++.|+|||++.+..++.++||||+||++|||++|..||......+ ....+.........+.         
T Consensus       154 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~---------  221 (333)
T cd05600         154 --YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE-TWENLKYWKETLQRPV---------  221 (333)
T ss_pred             --ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHH-HHHHHHhccccccCCC---------
Confidence              2345678999999999999999999999999999999999999997643322 2222221111111110         


Q ss_pred             cCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          930 DPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       930 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                         ........+..+.+++.+||..+|++||+++|+++
T Consensus       222 ---~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~  256 (333)
T cd05600         222 ---YDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKN  256 (333)
T ss_pred             ---CCccccccCHHHHHHHHHHhhChhhhcCCHHHHHh
Confidence               00001123457889999999999999999999986

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.6e-36  Score=312.00  Aligned_cols=267  Identities=27%  Similarity=0.388  Sum_probs=202.8

Q ss_pred             HHHhhcccccccccccceEEEEEEeCCCcEEEEEEeccCCCCCchhhHHHHHHHHhc--CCCCcccceEeEEEcCC----
Q 002010          689 DVLESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGR--IRHRNIVRLLGYVSNRD----  762 (982)
Q Consensus       689 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~~~~----  762 (982)
                      .+..+....+.||+|.||+||+|++ .|+.||||++...    +++...+|.++.+.  ++|+||+.++++-..+.    
T Consensus       208 TiarqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~sr----dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~T  282 (513)
T KOG2052|consen  208 TIARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSR----DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWT  282 (513)
T ss_pred             hhhheeEEEEEecCccccceeeccc-cCCceEEEEeccc----chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceE
Confidence            4556788889999999999999999 8999999999432    34445566666554  59999999998754443    


Q ss_pred             ccEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhh-----cCCCcEEecCCCCCcEEEcCCCCEEEec
Q 002010          763 TNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHH-----DCSPLIIHRDVKSNNILLDSDFEAHVAD  837 (982)
Q Consensus       763 ~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-----~~~~~ivHrDlkp~Nill~~~~~~kl~D  837 (982)
                      ..++|++|.|.|+|+||+.   ...++.+...+++..+|.||+|||.     +|++.|.|||||+.||+|..++.+.|+|
T Consensus       283 QLwLvTdYHe~GSL~DyL~---r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IAD  359 (513)
T KOG2052|consen  283 QLWLVTDYHEHGSLYDYLN---RNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD  359 (513)
T ss_pred             EEEEeeecccCCcHHHHHh---hccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEee
Confidence            4689999999999999996   3689999999999999999999995     3567799999999999999999999999


Q ss_pred             cccchhccccC--CcccccccccccccccccccccCC------CCcchhhHHHHHHHHHHHhC----------CCCCCCC
Q 002010          838 FGLAKFLQDAG--ASECMSSVAGSYGYIAPEYAYTLK------VDEKSDVYSFGVVLLELIAG----------KKPVGEF  899 (982)
Q Consensus       838 fG~a~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwslG~il~elltg----------~~p~~~~  899 (982)
                      +|+|.......  ........+||.+|||||++...-      .-..+||||||.++||+.-+          ++||.+.
T Consensus       360 LGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~  439 (513)
T KOG2052|consen  360 LGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDV  439 (513)
T ss_pred             ceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccC
Confidence            99998765431  122235678999999999987532      12478999999999999753          5677764


Q ss_pred             CCCchHHHHHHHhccCCCCCCcccccceeecCCCCC--CChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCC
Q 002010          900 GDGVDIVRWVRKTTSEVSQPSDAASVLAVVDPRLSG--YPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQ  974 (982)
Q Consensus       900 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~~  974 (982)
                      .+.+...+-.++..-           .+...|.++.  ...+....+.++|+.||..+|..|-|+=.+-+.|.++.+
T Consensus       440 Vp~DPs~eeMrkVVC-----------v~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~  505 (513)
T KOG2052|consen  440 VPSDPSFEEMRKVVC-----------VQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN  505 (513)
T ss_pred             CCCCCCHHHHhccee-----------ecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence            332221111111111           0111122221  234566779999999999999999999999998877764

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=5.3e-36  Score=331.88  Aligned_cols=259  Identities=25%  Similarity=0.408  Sum_probs=205.8

Q ss_pred             hhcccccccccccceEEEEEEeC-CCc----EEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEE
Q 002010          692 ESLKDENIIGKGGAGIVYRGSMP-DGI----DVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLL  766 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  766 (982)
                      .+|+..+.||+|+||.||+|.+. ++.    .||+|.+.........+++.+|+.+++.++||||++++|++... ..++
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~   85 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   85 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence            45888899999999999999653 333    48999886544445567788999999999999999999988764 5789


Q ss_pred             EEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccc
Q 002010          767 LYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQD  846 (982)
Q Consensus       767 v~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  846 (982)
                      |+||+++|+|.+++... ...+++..+..++.||+.||+|||+.+   |+||||||+||++++++.+||+|||+++.+..
T Consensus        86 v~e~~~~g~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~  161 (316)
T cd05108          86 ITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  161 (316)
T ss_pred             eeecCCCCCHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEccccccccccC
Confidence            99999999999999743 356889999999999999999999988   99999999999999999999999999987654


Q ss_pred             cCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHhccCCCCCCccccc
Q 002010          847 AGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASV  925 (982)
Q Consensus       847 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  925 (982)
                      ...........++..|+|||++.+..++.++||||||+++|||++ |..||..... ..+..+...... .         
T Consensus       162 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~-~~~~~~~~~~~~-~---------  230 (316)
T cd05108         162 DEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-SEISSILEKGER-L---------  230 (316)
T ss_pred             CCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH-HHHHHHHhCCCC-C---------
Confidence            322222223344678999999999999999999999999999998 9999975432 222222221111 0         


Q ss_pred             ceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCCC
Q 002010          926 LAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQS  975 (982)
Q Consensus       926 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~~~  975 (982)
                               ..+..++..+.+++.+||+.||++||++.+++..+..+.+.
T Consensus       231 ---------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~  271 (316)
T cd05108         231 ---------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD  271 (316)
T ss_pred             ---------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcC
Confidence                     11122345788999999999999999999999998766543

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=2.9e-36  Score=328.81  Aligned_cols=257  Identities=24%  Similarity=0.399  Sum_probs=206.0

Q ss_pred             hhcccccccccccceEEEEEEeC------CCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccE
Q 002010          692 ESLKDENIIGKGGAGIVYRGSMP------DGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNL  765 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  765 (982)
                      ..|+..+.||+|+||.||+|...      .+..||+|++...........+.+|+.++.+++||||+++++++...+..+
T Consensus         5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~   84 (283)
T cd05091           5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS   84 (283)
T ss_pred             HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence            45777889999999999999653      257899999864433333456889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHhhcC--------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCC
Q 002010          766 LLYEYMPNGSLGEMLHGA--------------KGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDF  831 (982)
Q Consensus       766 lv~e~~~~~sL~~~l~~~--------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~  831 (982)
                      +++||+++++|.+++...              ....+++..+..++.|++.|++|+|+.+   |+||||||+||++++++
T Consensus        85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~  161 (283)
T cd05091          85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKL  161 (283)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCC
Confidence            999999999999998521              1235788899999999999999999988   99999999999999999


Q ss_pred             CEEEeccccchhccccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHH
Q 002010          832 EAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVR  910 (982)
Q Consensus       832 ~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~  910 (982)
                      .+||+|||+++...............+++.|+|||++.+..++.++||||+||++|||++ |..||...... .....+.
T Consensus       162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-~~~~~i~  240 (283)
T cd05091         162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ-DVIEMIR  240 (283)
T ss_pred             ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH-HHHHHHH
Confidence            999999999886654332222334456789999999988889999999999999999998 88888764332 2222222


Q ss_pred             HhccCCCCCCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 002010          911 KTTSEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLAN  971 (982)
Q Consensus       911 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~  971 (982)
                      ...                   ....+.+.+..+.+++.+||+.||++||+++||+..|+.
T Consensus       241 ~~~-------------------~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         241 NRQ-------------------VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             cCC-------------------cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence            111                   111233455678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=1.8e-36  Score=336.70  Aligned_cols=242  Identities=24%  Similarity=0.287  Sum_probs=197.4

Q ss_pred             cccccccceEEEEEEe-CCCcEEEEEEeccCC--CCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEeccCCC
Q 002010          698 NIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRG--TGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNG  774 (982)
Q Consensus       698 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~  774 (982)
                      +.||+|+||.||+|+. .+++.||+|++....  .......+.+|+.+++.++||||+++++++..++..++||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            3689999999999965 468999999985432  2234456788999999999999999999999999999999999999


Q ss_pred             CHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCccccc
Q 002010          775 SLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMS  854 (982)
Q Consensus       775 sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~  854 (982)
                      +|.+++.  ....+++..+..++.||+.|++|||+.+   |+||||||+||+++.++.+||+|||+++.....  .....
T Consensus        81 ~L~~~l~--~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~--~~~~~  153 (328)
T cd05593          81 ELFFHLS--RERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITD--AATMK  153 (328)
T ss_pred             CHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCc--ccccc
Confidence            9999886  3457899999999999999999999988   999999999999999999999999998754321  12233


Q ss_pred             ccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceeecCCCC
Q 002010          855 SVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDPRLS  934 (982)
Q Consensus       855 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  934 (982)
                      ...||+.|+|||++.+..++.++||||+||++|||++|+.||...... .....+   ...                 ..
T Consensus       154 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~-~~~~~~---~~~-----------------~~  212 (328)
T cd05593         154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-KLFELI---LME-----------------DI  212 (328)
T ss_pred             cccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH-HHHHHh---ccC-----------------Cc
Confidence            457899999999999989999999999999999999999999754322 111111   110                 00


Q ss_pred             CCChHhHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 002010          935 GYPLTGVIHLFKVAMMCVEDESSARP-----TMREVVH  967 (982)
Q Consensus       935 ~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~ell~  967 (982)
                      .++...+..+.+++.+||++||++||     +++|+++
T Consensus       213 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~  250 (328)
T cd05593         213 KFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMR  250 (328)
T ss_pred             cCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhc
Confidence            12223345788999999999999997     8999875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=6.3e-36  Score=328.72  Aligned_cols=260  Identities=23%  Similarity=0.409  Sum_probs=210.2

Q ss_pred             HhhcccccccccccceEEEEEEe------CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcC-CCCcccceEeEEEcCCc
Q 002010          691 LESLKDENIIGKGGAGIVYRGSM------PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRI-RHRNIVRLLGYVSNRDT  763 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~  763 (982)
                      .++|+..+.||+|+||.||+|..      ..+..||+|.+.........+.+.+|+.+++++ +||||+++++++...+.
T Consensus        34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  113 (302)
T cd05055          34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP  113 (302)
T ss_pred             HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence            35788899999999999999953      235579999885544444456788999999999 79999999999999999


Q ss_pred             cEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchh
Q 002010          764 NLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKF  843 (982)
Q Consensus       764 ~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~  843 (982)
                      .++||||+++++|.++++......+++.++..++.|++.|++|||+.+   |+|+||||+||+++.++.+|++|||++..
T Consensus       114 ~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~~~  190 (302)
T cd05055         114 ILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLARD  190 (302)
T ss_pred             eEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCccccc
Confidence            999999999999999997554455899999999999999999999988   99999999999999999999999999986


Q ss_pred             ccccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHhccCCCCCCcc
Q 002010          844 LQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDA  922 (982)
Q Consensus       844 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  922 (982)
                      ..............++..|+|||++.+..++.++||||+||++|||++ |..||........+.........        
T Consensus       191 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~--------  262 (302)
T cd05055         191 IMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYR--------  262 (302)
T ss_pred             ccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCc--------
Confidence            543322112223345778999999998889999999999999999998 99999765444333333221111        


Q ss_pred             cccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 002010          923 ASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANP  972 (982)
Q Consensus       923 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~  972 (982)
                                 ...+...+..+.+++.+||+.+|++|||+.|+++.|++.
T Consensus       263 -----------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         263 -----------MAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             -----------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence                       001112234789999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=4.9e-36  Score=320.98  Aligned_cols=250  Identities=25%  Similarity=0.377  Sum_probs=199.6

Q ss_pred             cccccccceEEEEEEe-CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEeccCCCCH
Q 002010          698 NIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSL  776 (982)
Q Consensus       698 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL  776 (982)
                      +.||+|+||.||+|.. .+++.||+|.+...........+.+|++++++++||||+++++++......++||||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            3689999999999965 468899999875544444456789999999999999999999999999999999999999999


Q ss_pred             HHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCccccccc
Q 002010          777 GEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSV  856 (982)
Q Consensus       777 ~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~  856 (982)
                      .+++.. ....+++..+..++.|++.|++|||+.+   |+||||||+||+++.++.+|++|||++...............
T Consensus        81 ~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  156 (252)
T cd05084          81 LTFLRT-EGPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMK  156 (252)
T ss_pred             HHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCCC
Confidence            999963 2346899999999999999999999888   999999999999999999999999998765432111111122


Q ss_pred             ccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceeecCCCCC
Q 002010          857 AGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDPRLSG  935 (982)
Q Consensus       857 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  935 (982)
                      ..+..|+|||.+.+..++.++||||+|+++|||++ |..||...... .....+.....                   ..
T Consensus       157 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~-~~~~~~~~~~~-------------------~~  216 (252)
T cd05084         157 QIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ-QTREAIEQGVR-------------------LP  216 (252)
T ss_pred             CCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH-HHHHHHHcCCC-------------------CC
Confidence            33457999999998889999999999999999998 88888654322 11111111000                   01


Q ss_pred             CChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 002010          936 YPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLAN  971 (982)
Q Consensus       936 ~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~  971 (982)
                      .+...+..+.+++.+||+.||++|||+.|+.+.|..
T Consensus       217 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~  252 (252)
T cd05084         217 CPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQS  252 (252)
T ss_pred             CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhC
Confidence            222345578999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=3.3e-36  Score=350.71  Aligned_cols=252  Identities=21%  Similarity=0.274  Sum_probs=202.6

Q ss_pred             hhcccccccccccceEEEEEEe-CC-CcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEe
Q 002010          692 ESLKDENIIGKGGAGIVYRGSM-PD-GIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYE  769 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~-~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  769 (982)
                      ..|...+.||+|++|.||+|.. .+ ++.||+|.+... .......+.+|+.+++.++||||+++++++..++..++|||
T Consensus        67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~-~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E  145 (478)
T PTZ00267         67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN-DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIME  145 (478)
T ss_pred             eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEE
Confidence            4588899999999999999954 34 677888876322 23334567789999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhcccc
Q 002010          770 YMPNGSLGEMLHGA--KGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDA  847 (982)
Q Consensus       770 ~~~~~sL~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  847 (982)
                      |+++|+|.++++..  ...++++..+..++.||+.||+|+|+.+   |+||||||+||+++.++.+||+|||+++.+...
T Consensus       146 ~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~  222 (478)
T PTZ00267        146 YGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS  222 (478)
T ss_pred             CCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCc
Confidence            99999999988642  3456889999999999999999999988   999999999999999999999999999876543


Q ss_pred             CCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccce
Q 002010          848 GASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLA  927 (982)
Q Consensus       848 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  927 (982)
                      ..........||+.|+|||++.+..++.++||||+||++|||++|+.||...... .....+.....             
T Consensus       223 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~-~~~~~~~~~~~-------------  288 (478)
T PTZ00267        223 VSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR-EIMQQVLYGKY-------------  288 (478)
T ss_pred             cccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhCCC-------------
Confidence            2222334567999999999999999999999999999999999999999754322 11111111100             


Q ss_pred             eecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          928 VVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       928 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                            ...+...+..+.+++.+||+.||++||++++++.
T Consensus       289 ------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        289 ------DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             ------CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence                  0112223357899999999999999999999864

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=1e-35  Score=323.49  Aligned_cols=263  Identities=26%  Similarity=0.420  Sum_probs=206.2

Q ss_pred             hhcccccccccccceEEEEEEe-CCCc----EEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEE
Q 002010          692 ESLKDENIIGKGGAGIVYRGSM-PDGI----DVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLL  766 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  766 (982)
                      ++|+..+.||+|+||+||+|.+ .+++    .|++|.+..........++..|+.++++++||||+++++++. ....++
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~   85 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL   85 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence            4678888999999999999975 3444    477777643333333456778888999999999999999875 456788


Q ss_pred             EEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccc
Q 002010          767 LYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQD  846 (982)
Q Consensus       767 v~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  846 (982)
                      ++||+++|+|.+++... ...+++..+..++.||+.|++|||+.+   ++||||||+||++++++.+||+|||+++....
T Consensus        86 i~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~  161 (279)
T cd05111          86 VTQLSPLGSLLDHVRQH-RDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYP  161 (279)
T ss_pred             EEEeCCCCcHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence            99999999999999742 357899999999999999999999988   99999999999999999999999999986643


Q ss_pred             cCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHhccCCCCCCccccc
Q 002010          847 AGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASV  925 (982)
Q Consensus       847 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  925 (982)
                      ...........++..|+|||.+.+..++.++||||||+++||+++ |..||..... .....++..... ..        
T Consensus       162 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~-~~~~~~~~~~~~-~~--------  231 (279)
T cd05111         162 DDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP-HEVPDLLEKGER-LA--------  231 (279)
T ss_pred             CCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH-HHHHHHHHCCCc-CC--------
Confidence            322222334556778999999998889999999999999999998 9999976422 222233221111 11        


Q ss_pred             ceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCCCCCCC
Q 002010          926 LAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQSAPSL  979 (982)
Q Consensus       926 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~~~~~~~  979 (982)
                                .+..++..+.+++.+||..||++|||+.|+++.|..+.+..|.+
T Consensus       232 ----------~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~~~~~  275 (279)
T cd05111         232 ----------QPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARDPPRY  275 (279)
T ss_pred             ----------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhCCcce
Confidence                      11123346788999999999999999999999998877665544

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=2.7e-36  Score=330.85  Aligned_cols=260  Identities=25%  Similarity=0.396  Sum_probs=209.3

Q ss_pred             HhhcccccccccccceEEEEEEeC------CCcEEEEEEeccCCCCCchhhHHHHHHHHhcC-CCCcccceEeEEEcCCc
Q 002010          691 LESLKDENIIGKGGAGIVYRGSMP------DGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRI-RHRNIVRLLGYVSNRDT  763 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~  763 (982)
                      .++|+..+.||+|+||.||+|...      ....+|+|.+...........+.+|+.++.++ +||||+++++++..++.
T Consensus        11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~   90 (293)
T cd05053          11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGP   90 (293)
T ss_pred             HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCC
Confidence            356888899999999999999653      23679999886544444455688999999999 89999999999999999


Q ss_pred             cEEEEeccCCCCHHHHhhcC--------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcC
Q 002010          764 NLLLYEYMPNGSLGEMLHGA--------------KGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDS  829 (982)
Q Consensus       764 ~~lv~e~~~~~sL~~~l~~~--------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~  829 (982)
                      .+++|||+++++|.++++..              ....+++..+..++.|++.|++|||+.+   |+||||||+||+++.
T Consensus        91 ~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~~~  167 (293)
T cd05053          91 LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLVTE  167 (293)
T ss_pred             eEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEEcC
Confidence            99999999999999999642              2356889999999999999999999888   999999999999999


Q ss_pred             CCCEEEeccccchhccccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHHH
Q 002010          830 DFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRW  908 (982)
Q Consensus       830 ~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~  908 (982)
                      ++.+|++|||.++.+.............++..|+|||+..+..++.++|||||||++|||++ |..||....... ....
T Consensus       168 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-~~~~  246 (293)
T cd05053         168 DHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE-LFKL  246 (293)
T ss_pred             CCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH-HHHH
Confidence            99999999999987654322222233345678999999998899999999999999999998 999987643322 2222


Q ss_pred             HHHhccCCCCCCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 002010          909 VRKTTSEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPP  973 (982)
Q Consensus       909 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~  973 (982)
                      ......                   ...+...+..+.+++.+||+.||++|||+.|+++.|+.+.
T Consensus       247 ~~~~~~-------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         247 LKEGYR-------------------MEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             HHcCCc-------------------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence            211110                   0122234457889999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=6.6e-36  Score=332.89  Aligned_cols=266  Identities=23%  Similarity=0.349  Sum_probs=203.2

Q ss_pred             hhcccccccccccceEEEEEEeC-CCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEec
Q 002010          692 ESLKDENIIGKGGAGIVYRGSMP-DGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEY  770 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  770 (982)
                      ++|+..+.||+|+||.||+|... ++..+|+|.+...........+.+|++++++++||||+++++++.+++..++||||
T Consensus         5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   84 (333)
T cd06650           5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH   84 (333)
T ss_pred             hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEec
Confidence            57888999999999999999654 68889999885544434456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhc-CCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCC
Q 002010          771 MPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHD-CSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGA  849 (982)
Q Consensus       771 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  849 (982)
                      +++++|.+++..  ...+++..+..++.|++.|++|||+. +   |+||||||+||+++.++.+||+|||++..+...  
T Consensus        85 ~~~~~L~~~l~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--  157 (333)
T cd06650          85 MDGGSLDQVLKK--AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--  157 (333)
T ss_pred             CCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChhhEEEcCCCCEEEeeCCcchhhhhh--
Confidence            999999999973  45688999999999999999999974 5   999999999999999999999999999765432  


Q ss_pred             cccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCC-------cc
Q 002010          850 SECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPS-------DA  922 (982)
Q Consensus       850 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-------~~  922 (982)
                        ......|+..|+|||++.+..++.++||||+||++|||++|+.||..... ......+...........       ..
T Consensus       158 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (333)
T cd06650         158 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDA-KELELMFGCPVEGDPAESETSPRPRPP  234 (333)
T ss_pred             --ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcch-hHHHHHhcCcccCCccccccCcccCCc
Confidence              12335688999999999988899999999999999999999999975432 111111111000000000       00


Q ss_pred             cc--------------cc----eeecCCCCCCCh-HhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          923 AS--------------VL----AVVDPRLSGYPL-TGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       923 ~~--------------~~----~~~~~~~~~~~~-~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                      ..              ..    .+.....+..+. ....++.+++.+||+.||++|||++|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~  298 (333)
T cd06650         235 GRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMV  298 (333)
T ss_pred             cchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhh
Confidence            00              00    000000001111 13456889999999999999999999976

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=4.8e-36  Score=337.26  Aligned_cols=248  Identities=26%  Similarity=0.408  Sum_probs=196.3

Q ss_pred             hhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEec
Q 002010          692 ESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEY  770 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  770 (982)
                      ++|+..+.||+|+||.||+|.. .+++.||||++...........+.+|+++++.++|+||+++++++...+..++||||
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  153 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF  153 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence            4567778999999999999965 468999999986554444456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCc
Q 002010          771 MPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS  850 (982)
Q Consensus       771 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  850 (982)
                      +++++|.+..      ...+..+..++.||+.||+|||+.+   |+||||||+||++++++.+||+|||+++.+...  .
T Consensus       154 ~~~~~L~~~~------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~--~  222 (353)
T PLN00034        154 MDGGSLEGTH------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQT--M  222 (353)
T ss_pred             CCCCcccccc------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceecccc--c
Confidence            9999986542      3467788899999999999999988   999999999999999999999999999865432  1


Q ss_pred             cccccccccccccccccccc-----CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCccccc
Q 002010          851 ECMSSVAGSYGYIAPEYAYT-----LKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASV  925 (982)
Q Consensus       851 ~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  925 (982)
                      .......|+..|+|||++..     ...+.++|||||||++|||++|+.||...... +...........          
T Consensus       223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~-~~~~~~~~~~~~----------  291 (353)
T PLN00034        223 DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG-DWASLMCAICMS----------  291 (353)
T ss_pred             ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc-cHHHHHHHHhcc----------
Confidence            12234578999999998743     23456899999999999999999999743221 111111111110          


Q ss_pred             ceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          926 LAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       926 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                            .....+...+.++.+++.+||+.||++|||++|+++
T Consensus       292 ------~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~  327 (353)
T PLN00034        292 ------QPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQ  327 (353)
T ss_pred             ------CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                  001122334457899999999999999999999998

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=7.1e-36  Score=328.98  Aligned_cols=254  Identities=26%  Similarity=0.320  Sum_probs=215.9

Q ss_pred             HHHHhhcccccccccccceEEEEEEeC-CCcEEEEEEeccCCCCC--chhhHHHHHHHHhcCC-CCcccceEeEEEcCCc
Q 002010          688 EDVLESLKDENIIGKGGAGIVYRGSMP-DGIDVAIKRLVGRGTGG--NDHGFLAEIQTLGRIR-HRNIVRLLGYVSNRDT  763 (982)
Q Consensus       688 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~  763 (982)
                      +.+.+.|+..+.||+|.||.||++..+ +|+.+|+|.+.+.....  ....+.+|+.+|++++ |||||.++++|++...
T Consensus        31 ~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~  110 (382)
T KOG0032|consen   31 EDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDS  110 (382)
T ss_pred             ccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCe
Confidence            345567889999999999999999664 49999999996654433  3467899999999998 9999999999999999


Q ss_pred             cEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCC----CCEEEeccc
Q 002010          764 NLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSD----FEAHVADFG  839 (982)
Q Consensus       764 ~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~----~~~kl~DfG  839 (982)
                      .++|||+++||.|.+.+...   .+++.++..++.|++.|++|+|+.|   |+|||+||+|+++...    +.+|++|||
T Consensus       111 ~~lvmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFG  184 (382)
T KOG0032|consen  111 VYLVMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFG  184 (382)
T ss_pred             EEEEEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence            99999999999999999754   4999999999999999999999988   9999999999999643    579999999


Q ss_pred             cchhccccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCC
Q 002010          840 LAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQP  919 (982)
Q Consensus       840 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  919 (982)
                      +|.....   .......+||+.|+|||++....|+..+||||+||++|.|++|.+||...........+.........  
T Consensus       185 la~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~--  259 (382)
T KOG0032|consen  185 LAKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTS--  259 (382)
T ss_pred             CceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCC--
Confidence            9998764   44567889999999999999999999999999999999999999999987665555544433321111  


Q ss_pred             CcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          920 SDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       920 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                                     +........+.++++.|+..||.+|+|+.++++
T Consensus       260 ---------------~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~  292 (382)
T KOG0032|consen  260 ---------------EPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ  292 (382)
T ss_pred             ---------------CCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence                           112233457889999999999999999999998

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=7.8e-36  Score=324.18  Aligned_cols=256  Identities=26%  Similarity=0.400  Sum_probs=204.4

Q ss_pred             hhcccccccccccceEEEEEEeC------CCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccE
Q 002010          692 ESLKDENIIGKGGAGIVYRGSMP------DGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNL  765 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  765 (982)
                      ++|+..+.||+|++|.||+|...      .+..||+|.+...........+.+|+.++++++|+||+++++++.+....+
T Consensus         6 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   85 (277)
T cd05036           6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRF   85 (277)
T ss_pred             HHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcE
Confidence            56888899999999999999664      356799998754444444567899999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHhhcCCC-----CCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCC---CEEEec
Q 002010          766 LLYEYMPNGSLGEMLHGAKG-----GHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDF---EAHVAD  837 (982)
Q Consensus       766 lv~e~~~~~sL~~~l~~~~~-----~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~---~~kl~D  837 (982)
                      +||||+++++|.+++.....     ..+++..+.+++.||+.|++|||+.+   ++||||||+||+++.++   .+|++|
T Consensus        86 lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl~d  162 (277)
T cd05036          86 ILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIAD  162 (277)
T ss_pred             EEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEecc
Confidence            99999999999999975432     35899999999999999999999988   99999999999998764   599999


Q ss_pred             cccchhccccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHhccCC
Q 002010          838 FGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEV  916 (982)
Q Consensus       838 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  916 (982)
                      ||+++.+..............+..|+|||++.+..++.++||||+||++|||++ |..||...... .....+.....  
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~-~~~~~~~~~~~--  239 (277)
T cd05036         163 FGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ-EVMEFVTGGGR--  239 (277)
T ss_pred             CccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-HHHHHHHcCCc--
Confidence            999987643222221222334568999999998899999999999999999997 99999764332 22222211110  


Q ss_pred             CCCCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 002010          917 SQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLA  970 (982)
Q Consensus       917 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~  970 (982)
                                       ...+...+..+.+++.+||+.+|++||++.+|++.|.
T Consensus       240 -----------------~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         240 -----------------LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             -----------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence                             0112233457899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=1.2e-35  Score=319.85  Aligned_cols=254  Identities=30%  Similarity=0.448  Sum_probs=205.2

Q ss_pred             hhcccccccccccceEEEEEEeCCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEecc
Q 002010          692 ESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYM  771 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  771 (982)
                      ++|++.+.||+|+||.||+|...+...||+|.+...  ......+.+|+.++++++||||+++++++. +...++||||+
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~   82 (262)
T cd05071           6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG--TMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM   82 (262)
T ss_pred             HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccC--ccCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcC
Confidence            568899999999999999998767778999988532  223457899999999999999999999875 45689999999


Q ss_pred             CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCcc
Q 002010          772 PNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASE  851 (982)
Q Consensus       772 ~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~  851 (982)
                      ++++|.+++.......+++..+..++.|++.|++|+|+.+   ++||||||+||++++++.+||+|||.++.+..... .
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~-~  158 (262)
T cd05071          83 SKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-T  158 (262)
T ss_pred             CCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeecccccc-c
Confidence            9999999997655567899999999999999999999988   99999999999999999999999999976653321 1


Q ss_pred             cccccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceeec
Q 002010          852 CMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVD  930 (982)
Q Consensus       852 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  930 (982)
                      ......++..|+|||+..+..++.++||||+|+++|||++ |..||......... ........                
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~-~~~~~~~~----------------  221 (262)
T cd05071         159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL-DQVERGYR----------------  221 (262)
T ss_pred             cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHH-HHHhcCCC----------------
Confidence            1223446678999999988889999999999999999999 88888754332211 11111000                


Q ss_pred             CCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 002010          931 PRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANP  972 (982)
Q Consensus       931 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~  972 (982)
                         ...+...+..+.+++.+|++.||++||+++++++.|+..
T Consensus       222 ---~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~  260 (262)
T cd05071         222 ---MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  260 (262)
T ss_pred             ---CCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence               011223456789999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-36  Score=334.51  Aligned_cols=256  Identities=28%  Similarity=0.448  Sum_probs=217.0

Q ss_pred             cccccccccccceEEEEEEe-CCC----cEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEE
Q 002010          694 LKDENIIGKGGAGIVYRGSM-PDG----IDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLY  768 (982)
Q Consensus       694 ~~~~~~lg~G~~g~Vy~~~~-~~~----~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  768 (982)
                      .+..++||+|+||+||+|.+ ++|    .+||+|++......+...++.+|+.+|.+++|||++|++|++..+. ..+|+
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt  776 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT  776 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence            55677999999999999964 554    4689999988778888899999999999999999999999998765 88999


Q ss_pred             eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccC
Q 002010          769 EYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAG  848 (982)
Q Consensus       769 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  848 (982)
                      +|++.|+|.+|++.. ...+-.+..+.|..|||+||.|||++.   +|||||..+||||.+-..+||.|||+|+.....+
T Consensus       777 q~mP~G~LlDyvr~h-r~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~  852 (1177)
T KOG1025|consen  777 QLMPLGCLLDYVREH-RDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE  852 (1177)
T ss_pred             HhcccchHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence            999999999999864 467888899999999999999999888   9999999999999999999999999999887665


Q ss_pred             CcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHhccCCCCCCcccccce
Q 002010          849 ASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLA  927 (982)
Q Consensus       849 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  927 (982)
                      .........-.+.|||-|.+....|++++|||||||++||++| |..||..... +++.+.++...+             
T Consensus       853 ~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~-~eI~dlle~geR-------------  918 (1177)
T KOG1025|consen  853 KEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPA-EEIPDLLEKGER-------------  918 (1177)
T ss_pred             ccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCH-HHhhHHHhcccc-------------
Confidence            4444444555779999999999999999999999999999999 9999987543 333444333222             


Q ss_pred             eecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCC
Q 002010          928 VVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQ  974 (982)
Q Consensus       928 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~~  974 (982)
                            -..|+.+..+++.+|.+||..|+..||+++++...+.+...
T Consensus       919 ------LsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar  959 (1177)
T KOG1025|consen  919 ------LSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR  959 (1177)
T ss_pred             ------CCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence                  13456677799999999999999999999999998866443

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=1.2e-35  Score=319.53  Aligned_cols=254  Identities=30%  Similarity=0.484  Sum_probs=206.3

Q ss_pred             HhhcccccccccccceEEEEEEeCCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEec
Q 002010          691 LESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEY  770 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  770 (982)
                      .++|+..+.||+|+||.||+|...++..||+|.+....  .....+.+|+.++++++||+++++++++. ....+++|||
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~   81 (260)
T cd05070           5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGT--MSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEY   81 (260)
T ss_pred             hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCC--CCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEe
Confidence            35688889999999999999988788899999885432  23467899999999999999999999875 4568999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCc
Q 002010          771 MPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS  850 (982)
Q Consensus       771 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  850 (982)
                      +++++|.++++......+++..+..++.|++.|++|||+.+   |+||||||+||++++++.++|+|||.+..+.... .
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~-~  157 (260)
T cd05070          82 MSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNE-Y  157 (260)
T ss_pred             cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCcc-c
Confidence            99999999998655567899999999999999999999988   9999999999999999999999999997654322 1


Q ss_pred             ccccccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceee
Q 002010          851 ECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVV  929 (982)
Q Consensus       851 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  929 (982)
                      .......++..|+|||+..+..++.++||||+|+++|||++ |..||...... +..........               
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~-~~~~~~~~~~~---------------  221 (260)
T cd05070         158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR-EVLEQVERGYR---------------  221 (260)
T ss_pred             ccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH-HHHHHHHcCCC---------------
Confidence            11222345668999999988889999999999999999999 89999764322 22222211100               


Q ss_pred             cCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 002010          930 DPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLAN  971 (982)
Q Consensus       930 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~  971 (982)
                          ...+...+..+.+++.+|++.||++|||++++.+.|+.
T Consensus       222 ----~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         222 ----MPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             ----CCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence                01223345579999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=3.9e-36  Score=333.59  Aligned_cols=242  Identities=25%  Similarity=0.317  Sum_probs=195.8

Q ss_pred             cccccccceEEEEEEe----CCCcEEEEEEeccCC---CCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEec
Q 002010          698 NIIGKGGAGIVYRGSM----PDGIDVAIKRLVGRG---TGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEY  770 (982)
Q Consensus       698 ~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  770 (982)
                      +.||+|+||.||++..    .+++.||+|++....   .......+.+|+.++++++||||+++++++..++..++||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            5799999999999964    357899999985432   223345677899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCc
Q 002010          771 MPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS  850 (982)
Q Consensus       771 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  850 (982)
                      +++++|.+++.  +...+.+..+..++.|++.|++|||+.+   |+||||||+||+++.++.+||+|||+++......  
T Consensus        82 ~~~~~L~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--  154 (323)
T cd05584          82 LSGGELFMHLE--REGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG--  154 (323)
T ss_pred             CCCchHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCC--
Confidence            99999999996  3457888999999999999999999988   9999999999999999999999999987543221  


Q ss_pred             ccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceeec
Q 002010          851 ECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVD  930 (982)
Q Consensus       851 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  930 (982)
                      .......|++.|+|||++.+..++.++||||+||++|||++|+.||............... .                 
T Consensus       155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~-~-----------------  216 (323)
T cd05584         155 TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKG-K-----------------  216 (323)
T ss_pred             CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-C-----------------
Confidence            2223457899999999999888999999999999999999999999764332211111110 0                 


Q ss_pred             CCCCCCChHhHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 002010          931 PRLSGYPLTGVIHLFKVAMMCVEDESSARP-----TMREVVH  967 (982)
Q Consensus       931 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~ell~  967 (982)
                         ...+...+..+.+++.+||+.||++||     +++++++
T Consensus       217 ---~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~  255 (323)
T cd05584         217 ---LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS  255 (323)
T ss_pred             ---CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence               011223345788999999999999999     7888766

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.3e-36  Score=324.59  Aligned_cols=258  Identities=26%  Similarity=0.409  Sum_probs=208.3

Q ss_pred             HhhcccccccccccceEEEEEEeC------CCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCcc
Q 002010          691 LESLKDENIIGKGGAGIVYRGSMP------DGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTN  764 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  764 (982)
                      .++|+..+.||+|+||.||+|...      .+..||+|.+...........+.+|+.+++.++||||+++++++......
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   84 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT   84 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence            357888899999999999999653      24689999875444334456788999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHhhcCC--------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEe
Q 002010          765 LLLYEYMPNGSLGEMLHGAK--------GGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVA  836 (982)
Q Consensus       765 ~lv~e~~~~~sL~~~l~~~~--------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~  836 (982)
                      ++||||+++++|.+++....        ...+++..+..++.|++.|++|||+.+   |+||||||+||++++++.+||+
T Consensus        85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~  161 (277)
T cd05032          85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence            99999999999999996432        234788899999999999999999888   9999999999999999999999


Q ss_pred             ccccchhccccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHhccC
Q 002010          837 DFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSE  915 (982)
Q Consensus       837 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  915 (982)
                      |||+++.+.............++..|+|||.+.+..++.++||||+||++||+++ |..||..... ...........  
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~-~~~~~~~~~~~--  238 (277)
T cd05032         162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN-EEVLKFVIDGG--  238 (277)
T ss_pred             CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCH-HHHHHHHhcCC--
Confidence            9999986654332222333456789999999988889999999999999999998 9999975432 22333322111  


Q ss_pred             CCCCCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 002010          916 VSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLAN  971 (982)
Q Consensus       916 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~  971 (982)
                                       ....+...+..+.+++.+||+.+|++|||+.|+++.|++
T Consensus       239 -----------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  277 (277)
T cd05032         239 -----------------HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD  277 (277)
T ss_pred             -----------------CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence                             111222335678999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1e-35  Score=326.42  Aligned_cols=264  Identities=25%  Similarity=0.356  Sum_probs=205.2

Q ss_pred             hhcccccccccccceEEEEEEeCC---------------CcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEe
Q 002010          692 ESLKDENIIGKGGAGIVYRGSMPD---------------GIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLG  756 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~~~---------------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~  756 (982)
                      ++|+..+.||+|+||.||+|...+               ...||+|.+...........+.+|++++++++|||++++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   84 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG   84 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            468888999999999999986432               23589998865444444567889999999999999999999


Q ss_pred             EEEcCCccEEEEeccCCCCHHHHhhcCC----------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEE
Q 002010          757 YVSNRDTNLLLYEYMPNGSLGEMLHGAK----------GGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNIL  826 (982)
Q Consensus       757 ~~~~~~~~~lv~e~~~~~sL~~~l~~~~----------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nil  826 (982)
                      ++......++||||+++++|.+++....          ...+++..+..++.|++.|++|||+.+   ++||||||+||+
T Consensus        85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil  161 (295)
T cd05097          85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCL  161 (295)
T ss_pred             EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhEE
Confidence            9999999999999999999999986432          124688899999999999999999988   999999999999


Q ss_pred             EcCCCCEEEeccccchhccccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHh--CCCCCCCCCCCch
Q 002010          827 LDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA--GKKPVGEFGDGVD  904 (982)
Q Consensus       827 l~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt--g~~p~~~~~~~~~  904 (982)
                      +++++.+|++|||++................++..|+|||+..+..++.++||||||+++|+|++  |..||........
T Consensus       162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~  241 (295)
T cd05097         162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQV  241 (295)
T ss_pred             EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHH
Confidence            99999999999999986543322222233455778999999988889999999999999999998  6678876443322


Q ss_pred             HHHHHHHhccCCCCCCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 002010          905 IVRWVRKTTSEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLAN  971 (982)
Q Consensus       905 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~  971 (982)
                      ............             .......+...+..+.+++.+||+.||++||++++|++.|++
T Consensus       242 ~~~~~~~~~~~~-------------~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~  295 (295)
T cd05097         242 IENTGEFFRNQG-------------RQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE  295 (295)
T ss_pred             HHHHHHhhhhcc-------------ccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence            222111110000             000011122344589999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=9e-36  Score=337.10  Aligned_cols=261  Identities=23%  Similarity=0.394  Sum_probs=208.1

Q ss_pred             HhhcccccccccccceEEEEEEeC------CCcEEEEEEeccCCCCCchhhHHHHHHHHhcCC-CCcccceEeEEEcCCc
Q 002010          691 LESLKDENIIGKGGAGIVYRGSMP------DGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIR-HRNIVRLLGYVSNRDT  763 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~  763 (982)
                      .++|.+.+.||+|+||.||+|.+.      .+..||+|++.........+.+.+|+.++.++. ||||+++++++...+.
T Consensus        36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~  115 (401)
T cd05107          36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGP  115 (401)
T ss_pred             HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCC
Confidence            457888899999999999999752      346899999965544444557889999999997 9999999999999999


Q ss_pred             cEEEEeccCCCCHHHHhhcCCC----------------------------------------------------------
Q 002010          764 NLLLYEYMPNGSLGEMLHGAKG----------------------------------------------------------  785 (982)
Q Consensus       764 ~~lv~e~~~~~sL~~~l~~~~~----------------------------------------------------------  785 (982)
                      .++||||+++|+|.++++..+.                                                          
T Consensus       116 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (401)
T cd05107         116 IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDM  195 (401)
T ss_pred             cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcc
Confidence            9999999999999999964321                                                          


Q ss_pred             --------------------------------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEE
Q 002010          786 --------------------------------------GHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILL  827 (982)
Q Consensus       786 --------------------------------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill  827 (982)
                                                            ..+++..+..++.|++.|++|||+.+   |+||||||+||++
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiLl  272 (401)
T cd05107         196 KGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVLI  272 (401)
T ss_pred             hhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEEE
Confidence                                                  23677788999999999999999887   9999999999999


Q ss_pred             cCCCCEEEeccccchhccccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHH
Q 002010          828 DSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIV  906 (982)
Q Consensus       828 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~  906 (982)
                      ++++.+|++|||+++...............++..|+|||.+.+..++.++||||+|+++|||++ |..||..........
T Consensus       273 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~  352 (401)
T cd05107         273 CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFY  352 (401)
T ss_pred             eCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHH
Confidence            9999999999999986543221112223456788999999998889999999999999999998 899987654333222


Q ss_pred             HHHHHhccCCCCCCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 002010          907 RWVRKTTSEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPP  973 (982)
Q Consensus       907 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~  973 (982)
                      ..+..... .                  ..+...+..+.+++.+||+.+|++||+++||++.|+.+.
T Consensus       353 ~~~~~~~~-~------------------~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~  400 (401)
T cd05107         353 NAIKRGYR-M------------------AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL  400 (401)
T ss_pred             HHHHcCCC-C------------------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence            22221110 0                  112233457899999999999999999999999998653

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-35  Score=318.41  Aligned_cols=252  Identities=27%  Similarity=0.441  Sum_probs=203.8

Q ss_pred             hhcccccccccccceEEEEEEeCCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEecc
Q 002010          692 ESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYM  771 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  771 (982)
                      .+|+..+.||+|+||.||+|..+++..+|+|.+...  ......+.+|+.++++++||||+++++++...+..++||||+
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   81 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREG--AMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYM   81 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEecCCccEEEEEeccC--CCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecC
Confidence            357788899999999999998877788999987432  233456889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCcc
Q 002010          772 PNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASE  851 (982)
Q Consensus       772 ~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~  851 (982)
                      ++++|.+++.... ..+++..+..++.|++.|++|||+.+   |+||||||+||++++++.+||+|||.++...+... .
T Consensus        82 ~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~-~  156 (256)
T cd05059          82 ANGCLLNYLRERK-GKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY-T  156 (256)
T ss_pred             CCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceecccccc-c
Confidence            9999999997433 47899999999999999999999988   99999999999999999999999999976543211 1


Q ss_pred             cccccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceeec
Q 002010          852 CMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVD  930 (982)
Q Consensus       852 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  930 (982)
                      ......++..|+|||.+.+..++.++||||+|+++|||++ |+.||....+.+ ....+.....                
T Consensus       157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-~~~~~~~~~~----------------  219 (256)
T cd05059         157 SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE-VVESVSAGYR----------------  219 (256)
T ss_pred             ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH-HHHHHHcCCc----------------
Confidence            1112234457999999998899999999999999999999 899997643322 2222211100                


Q ss_pred             CCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 002010          931 PRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLA  970 (982)
Q Consensus       931 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~  970 (982)
                         ...+...+.++.+++.+||+.+|++|||+.|+++.|.
T Consensus       220 ---~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~  256 (256)
T cd05059         220 ---LYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT  256 (256)
T ss_pred             ---CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence               0112234557999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=9.3e-36  Score=325.47  Aligned_cols=265  Identities=24%  Similarity=0.386  Sum_probs=209.1

Q ss_pred             HhhcccccccccccceEEEEEEeC------CCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCcc
Q 002010          691 LESLKDENIIGKGGAGIVYRGSMP------DGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTN  764 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  764 (982)
                      .++|++.+.||+|+||.||+|..+      .+..||+|.+...........+.+|+.++++++||||+++++++.+....
T Consensus         5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   84 (288)
T cd05061           5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPT   84 (288)
T ss_pred             HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCc
Confidence            467899999999999999998542      25579999875444333445688899999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHhhcCC--------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEe
Q 002010          765 LLLYEYMPNGSLGEMLHGAK--------GGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVA  836 (982)
Q Consensus       765 ~lv~e~~~~~sL~~~l~~~~--------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~  836 (982)
                      ++||||+++|+|.+++....        ....++..+..++.|++.|++|||+.+   |+||||||+||++++++.+|++
T Consensus        85 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L~  161 (288)
T cd05061          85 LVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKIG  161 (288)
T ss_pred             EEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEEC
Confidence            99999999999999997422        234567788999999999999999988   9999999999999999999999


Q ss_pred             ccccchhccccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHhccC
Q 002010          837 DFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSE  915 (982)
Q Consensus       837 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  915 (982)
                      |||+++...............++..|+|||.+.+..++.++||||+||++|||++ |..||..... .+....+...   
T Consensus       162 Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~-~~~~~~~~~~---  237 (288)
T cd05061         162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN-EQVLKFVMDG---  237 (288)
T ss_pred             cCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHHHcC---
Confidence            9999986543322222223345678999999998889999999999999999999 7889875432 2222222111   


Q ss_pred             CCCCCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCCCCCC
Q 002010          916 VSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQSAPS  978 (982)
Q Consensus       916 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~~~~~~  978 (982)
                                      .....+...+..+.+++.+|++.||++|||+.|+++.|+...-+...
T Consensus       238 ----------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~  284 (288)
T cd05061         238 ----------------GYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFP  284 (288)
T ss_pred             ----------------CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCC
Confidence                            01112223346799999999999999999999999999876554433

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=1.8e-35  Score=318.18  Aligned_cols=254  Identities=28%  Similarity=0.450  Sum_probs=207.3

Q ss_pred             HhhcccccccccccceEEEEEEeCCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEec
Q 002010          691 LESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEY  770 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  770 (982)
                      .+.|+..+.||+|+||.||+|..++++.||+|.+...  ......+.+|+.++++++||||+++++++. ++..+++|||
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~   81 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQG--SMSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEY   81 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecCCCceEEEEEecCC--CCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEc
Confidence            3578888999999999999998888999999988533  234567889999999999999999999874 5678999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCc
Q 002010          771 MPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS  850 (982)
Q Consensus       771 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  850 (982)
                      +++++|.+++.......+++.++..++.|++.|++|||+.+   ++||||||+||++++++.++++|||.+....... .
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-~  157 (260)
T cd05067          82 MENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNE-Y  157 (260)
T ss_pred             CCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCC-c
Confidence            99999999997666678899999999999999999999888   9999999999999999999999999997655221 1


Q ss_pred             ccccccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceee
Q 002010          851 ECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVV  929 (982)
Q Consensus       851 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  929 (982)
                      .......++..|+|||++.+..++.++||||+|+++||+++ |+.||....... ..........               
T Consensus       158 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-~~~~~~~~~~---------------  221 (260)
T cd05067         158 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE-VIQNLERGYR---------------  221 (260)
T ss_pred             ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHH-HHHHHHcCCC---------------
Confidence            11223445678999999988889999999999999999999 999997643322 2222211110               


Q ss_pred             cCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 002010          930 DPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLAN  971 (982)
Q Consensus       930 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~  971 (982)
                          ...+...+.++.+++.+||+.+|++|||+++++..|+.
T Consensus       222 ----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         222 ----MPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             ----CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence                01122234579999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=8.8e-36  Score=328.38  Aligned_cols=261  Identities=24%  Similarity=0.397  Sum_probs=209.0

Q ss_pred             HhhcccccccccccceEEEEEEe--------CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcC-CCCcccceEeEEEcC
Q 002010          691 LESLKDENIIGKGGAGIVYRGSM--------PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRI-RHRNIVRLLGYVSNR  761 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~--------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~  761 (982)
                      .++|++.+.||+|+||.||+|+.        .++..||+|.+...........+.+|+.+++.+ +||||+++++++...
T Consensus        14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   93 (304)
T cd05101          14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD   93 (304)
T ss_pred             HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence            46788899999999999999963        134579999885444444556788999999999 899999999999999


Q ss_pred             CccEEEEeccCCCCHHHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEE
Q 002010          762 DTNLLLYEYMPNGSLGEMLHGAK--------------GGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILL  827 (982)
Q Consensus       762 ~~~~lv~e~~~~~sL~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill  827 (982)
                      ...++||||+++++|.+++...+              ...+++..+..++.||+.|++|||+.+   |+||||||+||++
T Consensus        94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nili  170 (304)
T cd05101          94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVLV  170 (304)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEEE
Confidence            99999999999999999997532              235788899999999999999999988   9999999999999


Q ss_pred             cCCCCEEEeccccchhccccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHH
Q 002010          828 DSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIV  906 (982)
Q Consensus       828 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~  906 (982)
                      ++++.+||+|||.++.+.............+++.|+|||++.+..++.++||||+|+++|||++ |..||..... ....
T Consensus       171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-~~~~  249 (304)
T cd05101         171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV-EELF  249 (304)
T ss_pred             cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH-HHHH
Confidence            9999999999999987653322222233445678999999998889999999999999999998 7888865422 2222


Q ss_pred             HHHHHhccCCCCCCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCC
Q 002010          907 RWVRKTTSEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQ  974 (982)
Q Consensus       907 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~~  974 (982)
                      ..+.....                   ...+..++..+.+++.+||+.+|++|||+.|+++.|+++..
T Consensus       250 ~~~~~~~~-------------------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~  298 (304)
T cd05101         250 KLLKEGHR-------------------MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT  298 (304)
T ss_pred             HHHHcCCc-------------------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHH
Confidence            22211110                   01123345678999999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-38  Score=310.63  Aligned_cols=248  Identities=25%  Similarity=0.363  Sum_probs=207.2

Q ss_pred             hcccccccccccceEEEEEE-eCCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEecc
Q 002010          693 SLKDENIIGKGGAGIVYRGS-MPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYM  771 (982)
Q Consensus       693 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  771 (982)
                      -|.+.+.+|+|+||.||+|. ..+|+.+|||.+.   -+...+++..|+.+|++++.|+||++||.|......++|||||
T Consensus        34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VP---V~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYC  110 (502)
T KOG0574|consen   34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVP---VDTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYC  110 (502)
T ss_pred             HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecC---ccchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhc
Confidence            46667789999999999994 4579999999873   2455788999999999999999999999998889999999999


Q ss_pred             CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCcc
Q 002010          772 PNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASE  851 (982)
Q Consensus       772 ~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~  851 (982)
                      ..|++.+.++ .+++++++.++..+.++.++|++|||...   =+|||||..||+++.+|.+|++|||.|-.+.+.  -.
T Consensus       111 GAGSiSDI~R-~R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT--MA  184 (502)
T KOG0574|consen  111 GAGSISDIMR-ARRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT--MA  184 (502)
T ss_pred             CCCcHHHHHH-HhcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhh--HH
Confidence            9999999997 45689999999999999999999999887   799999999999999999999999999877643  22


Q ss_pred             cccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceeecC
Q 002010          852 CMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDP  931 (982)
Q Consensus       852 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  931 (982)
                      ......||+.|||||++..-.|+.++||||+|+...||..|++||.+...-..   ++.....++              |
T Consensus       185 KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRA---IFMIPT~PP--------------P  247 (502)
T KOG0574|consen  185 KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRA---IFMIPTKPP--------------P  247 (502)
T ss_pred             hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccce---eEeccCCCC--------------C
Confidence            23567899999999999999999999999999999999999999987543211   110000000              0


Q ss_pred             CCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          932 RLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       932 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                      .+ .-|..-..++-+++++|+-+.|++|.|+-++++
T Consensus       248 TF-~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~  282 (502)
T KOG0574|consen  248 TF-KKPEEWSSEFNDFIRSCLIKKPEERKTALRLCE  282 (502)
T ss_pred             CC-CChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence            00 124445567899999999999999999998876

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=6.5e-36  Score=332.13  Aligned_cols=245  Identities=23%  Similarity=0.301  Sum_probs=194.7

Q ss_pred             cccccccccccceEEEEEEe-CCCcEEEEEEeccCC--CCCchhhHHHHHHHH---hcCCCCcccceEeEEEcCCccEEE
Q 002010          694 LKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRG--TGGNDHGFLAEIQTL---GRIRHRNIVRLLGYVSNRDTNLLL  767 (982)
Q Consensus       694 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l---~~l~h~niv~~~~~~~~~~~~~lv  767 (982)
                      |++.+.||+|+||.||+|.. .+++.||||++....  .....+.+.+|+.++   +.++||||+++++++...+..++|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            56678899999999999965 468999999985432  222334566666654   566899999999999999999999


Q ss_pred             EeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhcccc
Q 002010          768 YEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDA  847 (982)
Q Consensus       768 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  847 (982)
                      |||+++++|..+++   ...+++..+..++.||+.|++|||+.+   |+||||||+||+++.++.+||+|||++......
T Consensus        81 ~E~~~~~~L~~~~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~  154 (324)
T cd05589          81 MEYAAGGDLMMHIH---TDVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF  154 (324)
T ss_pred             EcCCCCCcHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCCC
Confidence            99999999998885   347999999999999999999999988   999999999999999999999999998753322


Q ss_pred             CCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccce
Q 002010          848 GASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLA  927 (982)
Q Consensus       848 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  927 (982)
                        ........|++.|+|||++.+..++.++||||+||++|||++|+.||...........+. ....             
T Consensus       155 --~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~-~~~~-------------  218 (324)
T cd05589         155 --GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIV-NDEV-------------  218 (324)
T ss_pred             --CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHH-hCCC-------------
Confidence              222345678999999999999999999999999999999999999997643222211111 1100             


Q ss_pred             eecCCCCCCChHhHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 002010          928 VVDPRLSGYPLTGVIHLFKVAMMCVEDESSARP-----TMREVVH  967 (982)
Q Consensus       928 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~ell~  967 (982)
                             ..+...+..+.+++.+||+.||.+||     ++.++++
T Consensus       219 -------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~  256 (324)
T cd05589         219 -------RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK  256 (324)
T ss_pred             -------CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence                   11222345688999999999999999     5666655

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=6e-36  Score=330.84  Aligned_cols=240  Identities=25%  Similarity=0.323  Sum_probs=191.5

Q ss_pred             cccccccceEEEEEEe-CCCcEEEEEEeccCC--CCCchhhHHHHHHHHhcC-CCCcccceEeEEEcCCccEEEEeccCC
Q 002010          698 NIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRG--TGGNDHGFLAEIQTLGRI-RHRNIVRLLGYVSNRDTNLLLYEYMPN  773 (982)
Q Consensus       698 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  773 (982)
                      +.||+|+||.||+|.. .+++.||+|++....  .......+..|..++... +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            3689999999999975 457889999985432  223344556677776654 899999999999999999999999999


Q ss_pred             CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCcccc
Q 002010          774 GSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECM  853 (982)
Q Consensus       774 ~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~  853 (982)
                      |+|.+++.  ....+++..+..++.|++.|++|||+.+   |+||||||+||+++.++.+||+|||++.......  ...
T Consensus        81 g~L~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~~  153 (316)
T cd05592          81 GDLMFHIQ--SSGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GKA  153 (316)
T ss_pred             CcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Ccc
Confidence            99999986  3457899999999999999999999988   9999999999999999999999999997543221  223


Q ss_pred             cccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceeecCCC
Q 002010          854 SSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDPRL  933 (982)
Q Consensus       854 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  933 (982)
                      ....||+.|+|||++.+..++.++||||+||++|||++|+.||....... ....+....                    
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~-~~~~i~~~~--------------------  212 (316)
T cd05592         154 STFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDE-LFDSILNDR--------------------  212 (316)
T ss_pred             ccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHH-HHHHHHcCC--------------------
Confidence            45678999999999999899999999999999999999999997643322 111111100                    


Q ss_pred             CCCChHhHHHHHHHHhhccCCCCCCCCCHHHH
Q 002010          934 SGYPLTGVIHLFKVAMMCVEDESSARPTMREV  965 (982)
Q Consensus       934 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~el  965 (982)
                      +..+...+..+.+++.+||+.||++||++.+.
T Consensus       213 ~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~  244 (316)
T cd05592         213 PHFPRWISKEAKDCLSKLFERDPTKRLGVDGD  244 (316)
T ss_pred             CCCCCCCCHHHHHHHHHHccCCHHHcCCChHH
Confidence            11222334567899999999999999987643

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=2.9e-35  Score=316.48  Aligned_cols=253  Identities=29%  Similarity=0.456  Sum_probs=205.0

Q ss_pred             hhcccccccccccceEEEEEEeCCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEecc
Q 002010          692 ESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYM  771 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  771 (982)
                      ++|+..+.||+|++|.||+|...++..+|+|.+...  ....+.+.+|+.++++++|||++++++++. .+..++||||+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~   82 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPG--TMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFM   82 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccC--CccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcC
Confidence            568888899999999999998877778999987432  233467889999999999999999999875 45688999999


Q ss_pred             CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCcc
Q 002010          772 PNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASE  851 (982)
Q Consensus       772 ~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~  851 (982)
                      ++++|.++++......+++..+..++.|++.|++|||+.+   ++||||||+||++++++.++|+|||.+....... ..
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~-~~  158 (260)
T cd05069          83 GKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNE-YT  158 (260)
T ss_pred             CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCc-cc
Confidence            9999999997655566899999999999999999999988   9999999999999999999999999997664321 11


Q ss_pred             cccccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceeec
Q 002010          852 CMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVD  930 (982)
Q Consensus       852 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  930 (982)
                      ......++..|+|||...+..++.++||||+|+++|||++ |..||....+.. ..........                
T Consensus       159 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-~~~~~~~~~~----------------  221 (260)
T cd05069         159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE-VLEQVERGYR----------------  221 (260)
T ss_pred             ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHHHcCCC----------------
Confidence            1223345678999999988889999999999999999999 899997643322 2222211110                


Q ss_pred             CCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 002010          931 PRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLAN  971 (982)
Q Consensus       931 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~  971 (982)
                         ...+...+..+.+++.+||++||++||+++++++.|+.
T Consensus       222 ---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         222 ---MPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             ---CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence               01122344578999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=8.4e-36  Score=332.74  Aligned_cols=252  Identities=22%  Similarity=0.255  Sum_probs=199.3

Q ss_pred             hcccccccccccceEEEEEEe----CCCcEEEEEEeccCC---CCCchhhHHHHHHHHhcC-CCCcccceEeEEEcCCcc
Q 002010          693 SLKDENIIGKGGAGIVYRGSM----PDGIDVAIKRLVGRG---TGGNDHGFLAEIQTLGRI-RHRNIVRLLGYVSNRDTN  764 (982)
Q Consensus       693 ~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~  764 (982)
                      +|+..+.||+|+||.||+|+.    .+++.||+|++....   .......+..|+.+++++ +||+|+++++++..++..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            367888999999999999864    358899999985432   223345678899999999 589999999999999999


Q ss_pred             EEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhc
Q 002010          765 LLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFL  844 (982)
Q Consensus       765 ~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~  844 (982)
                      ++||||+++|+|.+++.  +...+++..+..++.||+.||+|||+.+   |+||||||+||+++.++.+||+|||+++.+
T Consensus        81 ~lv~e~~~~g~L~~~l~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~~  155 (332)
T cd05614          81 HLILDYVSGGEMFTHLY--QRDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEF  155 (332)
T ss_pred             EEEEeCCCCCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCccc
Confidence            99999999999999996  3457899999999999999999999988   999999999999999999999999999865


Q ss_pred             cccCCcccccccccccccccccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCccc
Q 002010          845 QDAGASECMSSVAGSYGYIAPEYAYTL-KVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAA  923 (982)
Q Consensus       845 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  923 (982)
                      ..... .......||+.|+|||++.+. .++.++||||+||++|||++|+.||..................         
T Consensus       156 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~---------  225 (332)
T cd05614         156 LSEEK-ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILK---------  225 (332)
T ss_pred             cccCC-CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhc---------
Confidence            43221 222345789999999998865 4789999999999999999999999754332222222111111         


Q ss_pred             ccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 002010          924 SVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARP-----TMREVVH  967 (982)
Q Consensus       924 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~ell~  967 (982)
                           .++   ..+...+..+.+++.+||+.||++||     +++++++
T Consensus       226 -----~~~---~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  266 (332)
T cd05614         226 -----CDP---PFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE  266 (332)
T ss_pred             -----CCC---CCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence                 001   12223345688999999999999999     6777765

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=7.3e-36  Score=329.45  Aligned_cols=263  Identities=25%  Similarity=0.381  Sum_probs=208.6

Q ss_pred             HhhcccccccccccceEEEEEEeC--------CCcEEEEEEeccCCCCCchhhHHHHHHHHhcC-CCCcccceEeEEEcC
Q 002010          691 LESLKDENIIGKGGAGIVYRGSMP--------DGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRI-RHRNIVRLLGYVSNR  761 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~  761 (982)
                      .++|.+.+.||+|+||.||+|...        ++..||+|.+...........+.+|+.+++.+ +||||+++++++...
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   96 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   96 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence            467999999999999999999642        23579999886544444456788899999999 799999999999999


Q ss_pred             CccEEEEeccCCCCHHHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEE
Q 002010          762 DTNLLLYEYMPNGSLGEMLHGAK--------------GGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILL  827 (982)
Q Consensus       762 ~~~~lv~e~~~~~sL~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill  827 (982)
                      +..++||||+++++|.+++...+              ...+++.++..++.|++.|++|||+.+   ++||||||+||++
T Consensus        97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill  173 (307)
T cd05098          97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV  173 (307)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEE
Confidence            99999999999999999997532              135889999999999999999999988   9999999999999


Q ss_pred             cCCCCEEEeccccchhccccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHH
Q 002010          828 DSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIV  906 (982)
Q Consensus       828 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~  906 (982)
                      +.++.+||+|||.++...............+++.|+|||++.+..++.++||||+||++|||++ |..||.... .....
T Consensus       174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~-~~~~~  252 (307)
T cd05098         174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-VEELF  252 (307)
T ss_pred             cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC-HHHHH
Confidence            9999999999999976543211111222234568999999998889999999999999999998 888886532 22222


Q ss_pred             HHHHHhccCCCCCCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCCCC
Q 002010          907 RWVRKTTSEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQSA  976 (982)
Q Consensus       907 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~~~~  976 (982)
                      ..+.....                   ...+...+..+.+++.+||+.+|++|||+.|+++.|+++.+..
T Consensus       253 ~~~~~~~~-------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~  303 (307)
T cd05098         253 KLLKEGHR-------------------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALT  303 (307)
T ss_pred             HHHHcCCC-------------------CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHh
Confidence            22211110                   1122334457889999999999999999999999998876543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-35  Score=324.29  Aligned_cols=251  Identities=24%  Similarity=0.297  Sum_probs=202.3

Q ss_pred             cccccccccccceEEEEEEe-CCCcEEEEEEeccCCC--CCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEec
Q 002010          694 LKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGT--GGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEY  770 (982)
Q Consensus       694 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  770 (982)
                      |+..+.||+|+||+||++.. .+++.||+|++.....  ......+.+|+.++++++||||+++++++..++..++||||
T Consensus         2 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (285)
T cd05605           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEec
Confidence            67778999999999999965 4689999998854322  12234577899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCc
Q 002010          771 MPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS  850 (982)
Q Consensus       771 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  850 (982)
                      +++++|.+++.......+++..+..++.|++.|++|||+.+   |+||||||+||++++++.++|+|||++.......  
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~--  156 (285)
T cd05605          82 MNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE--  156 (285)
T ss_pred             cCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC--
Confidence            99999999887555567999999999999999999999988   9999999999999999999999999997654221  


Q ss_pred             ccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceeec
Q 002010          851 ECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVD  930 (982)
Q Consensus       851 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  930 (982)
                       ......|++.|+|||++.+..++.++||||+||++|||++|+.||..................                
T Consensus       157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~----------------  219 (285)
T cd05605         157 -TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKE----------------  219 (285)
T ss_pred             -ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhh----------------
Confidence             123457899999999999888999999999999999999999999764332221111111110                


Q ss_pred             CCCCCCChHhHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 002010          931 PRLSGYPLTGVIHLFKVAMMCVEDESSARP-----TMREVVH  967 (982)
Q Consensus       931 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~ell~  967 (982)
                       .....+...+..+.+++.+||+.||++||     +++++++
T Consensus       220 -~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05605         220 -DQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA  260 (285)
T ss_pred             -cccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence             00112233445788999999999999999     8888865

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=6.9e-36  Score=334.79  Aligned_cols=268  Identities=22%  Similarity=0.294  Sum_probs=198.0

Q ss_pred             hcccccccccccceEEEEEEe-CCCcEEEEEEeccCC-CCCchhhHHHHHHHHhcCCCCcccceEeEEEcCC-----ccE
Q 002010          693 SLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRG-TGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRD-----TNL  765 (982)
Q Consensus       693 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~~  765 (982)
                      +|+..+.||+|+||.||+|.. .++..||+|++.... .......+.+|+.++++++||||+++++++....     ..+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            477888999999999999965 468999999885432 2233456889999999999999999999875432     479


Q ss_pred             EEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhcc
Q 002010          766 LLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQ  845 (982)
Q Consensus       766 lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~  845 (982)
                      +||||+ +++|.+++.  +...+++..+..++.||++|++|||+.+   |+||||||+||+++.++.+||+|||+++...
T Consensus        81 lv~e~~-~~~L~~~l~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~  154 (338)
T cd07859          81 VVFELM-ESDLHQVIK--ANDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAF  154 (338)
T ss_pred             EEEecC-CCCHHHHHH--hcccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCccccccc
Confidence            999999 468999886  4457899999999999999999999988   9999999999999999999999999998653


Q ss_pred             ccCC-ccccccccccccccccccccc--CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCC--
Q 002010          846 DAGA-SECMSSVAGSYGYIAPEYAYT--LKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPS--  920 (982)
Q Consensus       846 ~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--  920 (982)
                      .... ........|++.|+|||++.+  ..++.++||||+||++|||++|++||....... ....+......+....  
T Consensus       155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~  233 (338)
T cd07859         155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVH-QLDLITDLLGTPSPETIS  233 (338)
T ss_pred             cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHH-HHHHHHHHhCCCCHHHHH
Confidence            2211 122244678999999999875  678999999999999999999999997643221 1111111111000000  


Q ss_pred             -----cccccceeecCCCC----CCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          921 -----DAASVLAVVDPRLS----GYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       921 -----~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                           ........+.+..+    ......+..+.+++.+||+.||++|||++|+++
T Consensus       234 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~  289 (338)
T cd07859         234 RVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA  289 (338)
T ss_pred             HhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence                 00000000000000    001123456789999999999999999999986

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=5.4e-36  Score=331.82  Aligned_cols=237  Identities=23%  Similarity=0.303  Sum_probs=192.0

Q ss_pred             cccccccceEEEEEEe-CCCcEEEEEEeccCC--CCCchhhHHHHHHHHhcC-CCCcccceEeEEEcCCccEEEEeccCC
Q 002010          698 NIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRG--TGGNDHGFLAEIQTLGRI-RHRNIVRLLGYVSNRDTNLLLYEYMPN  773 (982)
Q Consensus       698 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  773 (982)
                      +.||+|+||.||+|.. .+++.||+|++....  .......+..|..++... +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            3689999999999975 458899999985432  233445677888888776 699999999999999999999999999


Q ss_pred             CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCcccc
Q 002010          774 GSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECM  853 (982)
Q Consensus       774 ~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~  853 (982)
                      |+|.+++.  +...+++..+..++.|++.|++|||+.+   |+||||||+||+++.++.+||+|||++......  ....
T Consensus        81 g~L~~~i~--~~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~--~~~~  153 (320)
T cd05590          81 GDLMFHIQ--KSRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN--GKTT  153 (320)
T ss_pred             chHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC--CCcc
Confidence            99999987  3457899999999999999999999988   999999999999999999999999998754321  1223


Q ss_pred             cccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceeecCCC
Q 002010          854 SSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDPRL  933 (982)
Q Consensus       854 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  933 (982)
                      ....||+.|+|||++.+..++.++||||+||++|||++|+.||....... ....+.....                   
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~-~~~~i~~~~~-------------------  213 (320)
T cd05590         154 STFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDD-LFEAILNDEV-------------------  213 (320)
T ss_pred             cccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH-HHHHHhcCCC-------------------
Confidence            44578999999999999899999999999999999999999997643322 2222111100                   


Q ss_pred             CCCChHhHHHHHHHHhhccCCCCCCCCCH
Q 002010          934 SGYPLTGVIHLFKVAMMCVEDESSARPTM  962 (982)
Q Consensus       934 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~  962 (982)
                       ..+...+..+.+++.+|++.||++||++
T Consensus       214 -~~~~~~~~~~~~li~~~L~~dP~~R~~~  241 (320)
T cd05590         214 -VYPTWLSQDAVDILKAFMTKNPTMRLGS  241 (320)
T ss_pred             -CCCCCCCHHHHHHHHHHcccCHHHCCCC
Confidence             1112233468899999999999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=1.2e-35  Score=323.26  Aligned_cols=261  Identities=23%  Similarity=0.367  Sum_probs=209.7

Q ss_pred             HhhcccccccccccceEEEEEEeCC-----CcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEc-CCcc
Q 002010          691 LESLKDENIIGKGGAGIVYRGSMPD-----GIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSN-RDTN  764 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~  764 (982)
                      .++|+..+.||+|+||.||+|...+     +..|++|++...........+.+|+.++++++||||+++++++.. ....
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~   84 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP   84 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence            3578888999999999999997654     788999988654444556678899999999999999999998765 5678


Q ss_pred             EEEEeccCCCCHHHHhhcCCC------CCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEecc
Q 002010          765 LLLYEYMPNGSLGEMLHGAKG------GHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADF  838 (982)
Q Consensus       765 ~lv~e~~~~~sL~~~l~~~~~------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Df  838 (982)
                      ++++||+++++|.+++.....      ..+++..+..++.|++.|++|||+.+   ++||||||+||++++++.+|++||
T Consensus        85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d~  161 (280)
T cd05043          85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDN  161 (280)
T ss_pred             EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECCC
Confidence            999999999999999975432      46899999999999999999999988   999999999999999999999999


Q ss_pred             ccchhccccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHhccCCC
Q 002010          839 GLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVS  917 (982)
Q Consensus       839 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  917 (982)
                      |+++.+.............++..|+|||++.+..++.++||||+|+++||+++ |+.||.... ......++..... . 
T Consensus       162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~-~~~~~~~~~~~~~-~-  238 (280)
T cd05043         162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEID-PFEMAAYLKDGYR-L-  238 (280)
T ss_pred             CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCC-HHHHHHHHHcCCC-C-
Confidence            99986643322112223445678999999998889999999999999999999 999997642 2333333222111 0 


Q ss_pred             CCCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCC
Q 002010          918 QPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQ  974 (982)
Q Consensus       918 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~~  974 (982)
                                       ..+...+..+.+++.+||+.||++|||+.|+++.|+.+..
T Consensus       239 -----------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~  278 (280)
T cd05043         239 -----------------AQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA  278 (280)
T ss_pred             -----------------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence                             0112234578999999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=2.7e-35  Score=318.56  Aligned_cols=253  Identities=27%  Similarity=0.381  Sum_probs=194.0

Q ss_pred             ccccccceEEEEEEeCC---CcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEeccCCCC
Q 002010          699 IIGKGGAGIVYRGSMPD---GIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGS  775 (982)
Q Consensus       699 ~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~s  775 (982)
                      .||+|+||.||+|...+   +..+|+|.+...........+.+|+.++++++||||+++++++.+....++||||+++|+
T Consensus         2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~   81 (269)
T cd05087           2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD   81 (269)
T ss_pred             cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence            58999999999996533   467999987554444444578899999999999999999999999999999999999999


Q ss_pred             HHHHhhcCC---CCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCccc
Q 002010          776 LGEMLHGAK---GGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASEC  852 (982)
Q Consensus       776 L~~~l~~~~---~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~  852 (982)
                      |.+++...+   ....++..+..++.|++.|++|||+.+   ++||||||+||+++.++.+|++|||.+...........
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~  158 (269)
T cd05087          82 LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT  158 (269)
T ss_pred             HHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence            999997432   235677888899999999999999988   99999999999999999999999999975443322222


Q ss_pred             ccccccccccccccccccC-------CCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHhccCCCCCCcccc
Q 002010          853 MSSVAGSYGYIAPEYAYTL-------KVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAAS  924 (982)
Q Consensus       853 ~~~~~gt~~y~aPE~~~~~-------~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  924 (982)
                      .....++..|+|||++.+.       .++.++||||+|+++|||++ |..||......+.....+.......        
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~--------  230 (269)
T cd05087         159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKL--------  230 (269)
T ss_pred             CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCC--------
Confidence            2334567889999988642       35789999999999999997 9999976543322211111111100        


Q ss_pred             cceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 002010          925 VLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLA  970 (982)
Q Consensus       925 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~  970 (982)
                          .++.   ........+.+++..|| .+|++|||++||++.|+
T Consensus       231 ----~~~~---~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         231 ----PKPR---LKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             ----CCCc---cCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence                0111   11123345788999999 58999999999999875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=1.5e-35  Score=322.35  Aligned_cols=256  Identities=24%  Similarity=0.405  Sum_probs=203.7

Q ss_pred             hhcccccccccccceEEEEEEe------CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccE
Q 002010          692 ESLKDENIIGKGGAGIVYRGSM------PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNL  765 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  765 (982)
                      ++|...+.||+|+||.||+|..      .++..+|+|.+.. ........+.+|+.++++++||||+++++++...+..+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE-ASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL   83 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCc-CCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence            4567778999999999999953      2356789998743 33344567899999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHhhcCCC-------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCC
Q 002010          766 LLYEYMPNGSLGEMLHGAKG-------------GHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFE  832 (982)
Q Consensus       766 lv~e~~~~~sL~~~l~~~~~-------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~  832 (982)
                      ++|||+++++|.+++.....             ..+++..+..++.|++.|++|||+.+   ++||||||+||++++++.
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~  160 (280)
T cd05092          84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLV  160 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCC
Confidence            99999999999999975321             35889999999999999999999988   999999999999999999


Q ss_pred             EEEeccccchhccccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHH
Q 002010          833 AHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRK  911 (982)
Q Consensus       833 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~  911 (982)
                      +||+|||++..+.............+++.|+|||++.+..++.++|||||||++|||++ |.+||........ ......
T Consensus       161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~-~~~~~~  239 (280)
T cd05092         161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA-IECITQ  239 (280)
T ss_pred             EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHH-HHHHHc
Confidence            99999999976543222222223345678999999998899999999999999999998 9999876433222 111111


Q ss_pred             hccCCCCCCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 002010          912 TTSEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLAN  971 (982)
Q Consensus       912 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~  971 (982)
                      ...                   ...+...+..+.+++.+||+.||.+||+++||++.|++
T Consensus       240 ~~~-------------------~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~  280 (280)
T cd05092         240 GRE-------------------LERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA  280 (280)
T ss_pred             Ccc-------------------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence            100                   01122334578899999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=8.9e-36  Score=346.78  Aligned_cols=254  Identities=22%  Similarity=0.315  Sum_probs=204.2

Q ss_pred             HhhcccccccccccceEEEEEEe-CCCcEEEEEEeccCC-CCCchhhHHHHHHHHhcCCCCcccceEeEEEcCC------
Q 002010          691 LESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRG-TGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRD------  762 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------  762 (982)
                      .++|++.+.||+|+||+||+|.. .+++.||||++.... .......+.+|+..+..++|+||+++++.+...+      
T Consensus        31 ~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~  110 (496)
T PTZ00283         31 AKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPEN  110 (496)
T ss_pred             CCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCccc
Confidence            46899999999999999999964 579999999985443 2333456788999999999999999988765432      


Q ss_pred             --ccEEEEeccCCCCHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEecc
Q 002010          763 --TNLLLYEYMPNGSLGEMLHGA--KGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADF  838 (982)
Q Consensus       763 --~~~lv~e~~~~~sL~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Df  838 (982)
                        ..++||||+++|+|.++++..  ....+++..+..++.|++.||+|+|+.+   |+||||||+||+++.++.+||+||
T Consensus       111 ~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL~DF  187 (496)
T PTZ00283        111 VLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKLGDF  187 (496)
T ss_pred             ceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEEEec
Confidence              257999999999999998642  2357899999999999999999999888   999999999999999999999999


Q ss_pred             ccchhccccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCC
Q 002010          839 GLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQ  918 (982)
Q Consensus       839 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  918 (982)
                      |+++.+.............||+.|+|||++.+..++.++||||+||++|||++|+.||.....    ...+.....    
T Consensus       188 Gls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~----~~~~~~~~~----  259 (496)
T PTZ00283        188 GFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM----EEVMHKTLA----  259 (496)
T ss_pred             ccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH----HHHHHHHhc----
Confidence            999876543223333456799999999999999999999999999999999999999975322    122221111    


Q ss_pred             CCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          919 PSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       919 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                                  ......+...+..+.+++.+||+.||++||++.++++
T Consensus       260 ------------~~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~  296 (496)
T PTZ00283        260 ------------GRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLN  296 (496)
T ss_pred             ------------CCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHh
Confidence                        0011123344567899999999999999999999876

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=1.9e-35  Score=320.81  Aligned_cols=246  Identities=24%  Similarity=0.296  Sum_probs=196.3

Q ss_pred             cccccceEEEEEEe-CCCcEEEEEEeccCCCC--CchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEeccCCCCH
Q 002010          700 IGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTG--GNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSL  776 (982)
Q Consensus       700 lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL  776 (982)
                      ||+|+||.||+++. .+|+.||+|++......  .....+..|++++++++||||+++++++..+...++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            69999999999965 46899999998543221  2234456799999999999999999999999999999999999999


Q ss_pred             HHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCccccccc
Q 002010          777 GEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSV  856 (982)
Q Consensus       777 ~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~  856 (982)
                      .+++.......+++..+..++.|++.|++|||+.+   |+||||||+||+++.++.++|+|||++......   ......
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~---~~~~~~  154 (277)
T cd05607          81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG---KTITQR  154 (277)
T ss_pred             HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCC---ceeecc
Confidence            99887555567899999999999999999999988   999999999999999999999999999766432   122345


Q ss_pred             ccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceeecCCCCCC
Q 002010          857 AGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDPRLSGY  936 (982)
Q Consensus       857 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  936 (982)
                      .|+..|+|||++.+..++.++||||+||++|||++|+.||...................                .....
T Consensus       155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~----------------~~~~~  218 (277)
T cd05607         155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLED----------------EVKFE  218 (277)
T ss_pred             CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhcc----------------ccccc
Confidence            68899999999998889999999999999999999999997643322222222221110                00000


Q ss_pred             ChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          937 PLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       937 ~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                      ....+.++.+++.+||+.||++||+++|+++
T Consensus       219 ~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~  249 (277)
T cd05607         219 HQNFTEESKDICRLFLAKKPEDRLGSREKND  249 (277)
T ss_pred             cccCCHHHHHHHHHHhccCHhhCCCCccchh
Confidence            1123346889999999999999999977664

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=1.7e-35  Score=321.94  Aligned_cols=258  Identities=27%  Similarity=0.431  Sum_probs=206.0

Q ss_pred             hhcccccccccccceEEEEEEe-CCCc----EEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEE
Q 002010          692 ESLKDENIIGKGGAGIVYRGSM-PDGI----DVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLL  766 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  766 (982)
                      ++|+..+.||+|+||+||+|.+ .+++    .||+|.+...........+.+|+.+++.++||||+++++++.. ...++
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l   85 (279)
T cd05109           7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQL   85 (279)
T ss_pred             hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEE
Confidence            4678888999999999999964 3444    4899988655554556678899999999999999999998875 45789


Q ss_pred             EEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccc
Q 002010          767 LYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQD  846 (982)
Q Consensus       767 v~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  846 (982)
                      +|||+++|+|.++++.. ...+++..+..++.|++.|++|||+.+   |+||||||+||++++++.+||+|||+++.+..
T Consensus        86 ~~~~~~~g~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~  161 (279)
T cd05109          86 VTQLMPYGCLLDYVREN-KDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLDI  161 (279)
T ss_pred             EEEcCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeeccc
Confidence            99999999999999742 356899999999999999999999988   99999999999999999999999999987653


Q ss_pred             cCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHhccCCCCCCccccc
Q 002010          847 AGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASV  925 (982)
Q Consensus       847 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  925 (982)
                      ...........+++.|+|||...+..++.++||||+||++|||++ |..||..... .....++..... .         
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-~~~~~~~~~~~~-~---------  230 (279)
T cd05109         162 DETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA-REIPDLLEKGER-L---------  230 (279)
T ss_pred             ccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH-HHHHHHHHCCCc-C---------
Confidence            322222223345678999999998899999999999999999998 8999875432 223333322111 0         


Q ss_pred             ceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCC
Q 002010          926 LAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQ  974 (982)
Q Consensus       926 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~~  974 (982)
                               ..+...+..+.+++.+||+.||++||++.|+++.|+.+.+
T Consensus       231 ---------~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05109         231 ---------PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMAR  270 (279)
T ss_pred             ---------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence                     1112234578899999999999999999999999887654

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=1e-35  Score=337.98  Aligned_cols=253  Identities=20%  Similarity=0.254  Sum_probs=197.4

Q ss_pred             hcccccccccccceEEEEEEe-CCCcEEEEEEeccCC--CCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEe
Q 002010          693 SLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRG--TGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYE  769 (982)
Q Consensus       693 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  769 (982)
                      .|+..+.||+|+||+||+|.. .+++.||+|++....  .......+.+|+.++++++||||+++++++.+.+..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            477788999999999999954 568899999985432  22334568899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCC
Q 002010          770 YMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGA  849 (982)
Q Consensus       770 ~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  849 (982)
                      |+++|+|.+++.  +...+++..+..++.||+.|++|||+.+   |+||||||+||+++.++++||+|||++..+.....
T Consensus        82 ~~~gg~L~~~l~--~~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~  156 (381)
T cd05626          82 YIPGGDMMSLLI--RMEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHN  156 (381)
T ss_pred             cCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCcccccccc
Confidence            999999999997  3457899999999999999999999988   99999999999999999999999999764321000


Q ss_pred             ---------------------------------------------cccccccccccccccccccccCCCCcchhhHHHHH
Q 002010          850 ---------------------------------------------SECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGV  884 (982)
Q Consensus       850 ---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~  884 (982)
                                                                   ........||+.|+|||++.+..++.++||||+||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~  236 (381)
T cd05626         157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV  236 (381)
T ss_pred             cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhh
Confidence                                                         00012346999999999999889999999999999


Q ss_pred             HHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceeecCCCCCCChHhHHHHHHHHhh--ccCCCCCCCCCH
Q 002010          885 VLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMM--CVEDESSARPTM  962 (982)
Q Consensus       885 il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~--cl~~dP~~Rpt~  962 (982)
                      ++|||++|+.||.................. ..               .+ .......++.+++.+  |+..+|..||++
T Consensus       237 il~elltG~~Pf~~~~~~~~~~~i~~~~~~-~~---------------~~-~~~~~s~~~~dli~~ll~~~~~~~~R~~~  299 (381)
T cd05626         237 ILFEMLVGQPPFLAPTPTETQLKVINWENT-LH---------------IP-PQVKLSPEAVDLITKLCCSAEERLGRNGA  299 (381)
T ss_pred             HHHHHHhCCCCCcCCCHHHHHHHHHccccc-cC---------------CC-CCCCCCHHHHHHHHHHccCcccccCCCCH
Confidence            999999999999765433322222111000 00               00 001123467788877  556666679999


Q ss_pred             HHHHH
Q 002010          963 REVVH  967 (982)
Q Consensus       963 ~ell~  967 (982)
                      +|+++
T Consensus       300 ~~~l~  304 (381)
T cd05626         300 DDIKA  304 (381)
T ss_pred             HHHhc
Confidence            99987

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=1.7e-35  Score=331.23  Aligned_cols=262  Identities=27%  Similarity=0.401  Sum_probs=205.3

Q ss_pred             hhcccccccccccceEEEEEEe------CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcC-CCCcccceEeEEEcC-Cc
Q 002010          692 ESLKDENIIGKGGAGIVYRGSM------PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRI-RHRNIVRLLGYVSNR-DT  763 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~-~~  763 (982)
                      ++|+..+.||+|+||.||+|..      .+++.||||++...........+.+|+.++.++ +||||+++++++... ..
T Consensus         7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~   86 (343)
T cd05103           7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP   86 (343)
T ss_pred             hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence            5789999999999999999953      357889999986544444456788999999999 689999999987654 45


Q ss_pred             cEEEEeccCCCCHHHHhhcCC-----------------------------------------------------------
Q 002010          764 NLLLYEYMPNGSLGEMLHGAK-----------------------------------------------------------  784 (982)
Q Consensus       764 ~~lv~e~~~~~sL~~~l~~~~-----------------------------------------------------------  784 (982)
                      .++||||+++|+|.+++....                                                           
T Consensus        87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (343)
T cd05103          87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA  166 (343)
T ss_pred             eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence            789999999999999986421                                                           


Q ss_pred             ------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCccccccccc
Q 002010          785 ------GGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAG  858 (982)
Q Consensus       785 ------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~g  858 (982)
                            ...+++..+..++.||++|++|||+.+   |+||||||+||++++++.+||+|||++................+
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~  243 (343)
T cd05103         167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL  243 (343)
T ss_pred             hhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence                  123678888999999999999999988   99999999999999999999999999986543322222223345


Q ss_pred             ccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceeecCCCCCCC
Q 002010          859 SYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDPRLSGYP  937 (982)
Q Consensus       859 t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  937 (982)
                      +..|+|||.+.+..++.++||||+|+++|||++ |..||............+..... .                  ..+
T Consensus       244 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~-~------------------~~~  304 (343)
T cd05103         244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR-M------------------RAP  304 (343)
T ss_pred             CcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCC-C------------------CCC
Confidence            678999999988899999999999999999997 99999764333222222211111 0                  011


Q ss_pred             hHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCCC
Q 002010          938 LTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQS  975 (982)
Q Consensus       938 ~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~~~  975 (982)
                      ...+..+.+++.+||+.||++|||+.|+++.|+.+.+.
T Consensus       305 ~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~  342 (343)
T cd05103         305 DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  342 (343)
T ss_pred             CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            11234688999999999999999999999999877653

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.9e-35  Score=316.87  Aligned_cols=255  Identities=29%  Similarity=0.475  Sum_probs=208.7

Q ss_pred             HhhcccccccccccceEEEEEEeCCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEec
Q 002010          691 LESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEY  770 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  770 (982)
                      .++|++.+.||+|+||.||+|...+++.||+|.+...  .....++.+|+.++++++||||+++++++..+...++||||
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   82 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPG--TMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY   82 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCC--ccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence            3578889999999999999998878889999988533  23456789999999999999999999999988999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCc
Q 002010          771 MPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS  850 (982)
Q Consensus       771 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  850 (982)
                      +++++|.+++.......+++..+..++.|++.|++|||+.+   ++||||||+||++++++.+|++|||.+..+.... .
T Consensus        83 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~-~  158 (261)
T cd05034          83 MSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDE-Y  158 (261)
T ss_pred             cCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchh-h
Confidence            99999999998655567999999999999999999999988   9999999999999999999999999987664321 1


Q ss_pred             ccccccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceee
Q 002010          851 ECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVV  929 (982)
Q Consensus       851 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  929 (982)
                      ........+..|+|||.+.+..++.++||||+|+++|++++ |+.||....... ..........               
T Consensus       159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~-~~~~~~~~~~---------------  222 (261)
T cd05034         159 TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE-VLEQVERGYR---------------  222 (261)
T ss_pred             hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHHHcCCC---------------
Confidence            11122234568999999998889999999999999999999 999996543222 2222211100               


Q ss_pred             cCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 002010          930 DPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLAN  971 (982)
Q Consensus       930 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~  971 (982)
                          ...+...+..+.+++.+|++.+|++||+++++++.|+.
T Consensus       223 ----~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         223 ----MPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             ----CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence                01112234578999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=3.5e-36  Score=334.40  Aligned_cols=242  Identities=23%  Similarity=0.278  Sum_probs=196.1

Q ss_pred             cccccccceEEEEEEe-CCCcEEEEEEeccCC--CCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEeccCCC
Q 002010          698 NIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRG--TGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNG  774 (982)
Q Consensus       698 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~  774 (982)
                      +.||+|+||.||+|.. .+++.||+|.+....  .......+.+|+.++..++||||+++++++...+..++||||++++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            3689999999999964 568999999985432  2233456778999999999999999999999999999999999999


Q ss_pred             CHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCcccc
Q 002010          775 SLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHH-DCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECM  853 (982)
Q Consensus       775 sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~  853 (982)
                      +|..++.  +...+++..+..++.||+.|++|||+ .+   |+||||||+||+++.++.+||+|||+++.....  ....
T Consensus        81 ~L~~~l~--~~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~--~~~~  153 (325)
T cd05594          81 ELFFHLS--RERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD--GATM  153 (325)
T ss_pred             cHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCC--Cccc
Confidence            9999886  34578999999999999999999997 67   999999999999999999999999998753322  1223


Q ss_pred             cccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceeecCCC
Q 002010          854 SSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDPRL  933 (982)
Q Consensus       854 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  933 (982)
                      ....||+.|+|||++.+..++.++||||+||++|||++|+.||...... .....+.....                   
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~-~~~~~i~~~~~-------------------  213 (325)
T cd05594         154 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-KLFELILMEEI-------------------  213 (325)
T ss_pred             ccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH-HHHHHHhcCCC-------------------
Confidence            3457899999999999999999999999999999999999999754322 11121111000                   


Q ss_pred             CCCChHhHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 002010          934 SGYPLTGVIHLFKVAMMCVEDESSARP-----TMREVVH  967 (982)
Q Consensus       934 ~~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~ell~  967 (982)
                       .++...+..+.+++.+||+.||++|+     +++++++
T Consensus       214 -~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~  251 (325)
T cd05594         214 -RFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ  251 (325)
T ss_pred             -CCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence             11222345788999999999999996     8999875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=1.7e-35  Score=323.50  Aligned_cols=257  Identities=26%  Similarity=0.448  Sum_probs=205.7

Q ss_pred             hhcccccccccccceEEEEEEeC------CCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccE
Q 002010          692 ESLKDENIIGKGGAGIVYRGSMP------DGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNL  765 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  765 (982)
                      ++|+..+.||+|+||.||+|..+      ++..||+|.+...........+.+|+.++++++||||+++++++.+++..+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~   84 (288)
T cd05050           5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMC   84 (288)
T ss_pred             HhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccE
Confidence            56888899999999999999753      467899998865444444567889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHhhcCC--------------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcE
Q 002010          766 LLYEYMPNGSLGEMLHGAK--------------------GGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNI  825 (982)
Q Consensus       766 lv~e~~~~~sL~~~l~~~~--------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Ni  825 (982)
                      +||||+++++|.+++....                    ...+++..+..++.|++.|++|||+.+   ++||||||+||
T Consensus        85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~ni  161 (288)
T cd05050          85 LLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRNC  161 (288)
T ss_pred             EEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhhe
Confidence            9999999999999996422                    134788899999999999999999988   99999999999


Q ss_pred             EEcCCCCEEEeccccchhccccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCch
Q 002010          826 LLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVD  904 (982)
Q Consensus       826 ll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~  904 (982)
                      ++++++.+|++|||.+..+..............+..|+|||.+.+..++.++||||+||++|||++ |..||...... +
T Consensus       162 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~-~  240 (288)
T cd05050         162 LVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE-E  240 (288)
T ss_pred             EecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-H
Confidence            999999999999999876543322222223345678999999998899999999999999999998 88888654322 2


Q ss_pred             HHHHHHHhccCCCCCCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 002010          905 IVRWVRKTTSEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLAN  971 (982)
Q Consensus       905 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~  971 (982)
                      ....+....                   ....+...+..+.+++.+||+.||++|||+.|+++.|++
T Consensus       241 ~~~~~~~~~-------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         241 VIYYVRDGN-------------------VLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             HHHHHhcCC-------------------CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence            222221110                   011122344678999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=3.1e-35  Score=322.71  Aligned_cols=264  Identities=24%  Similarity=0.366  Sum_probs=204.7

Q ss_pred             hhcccccccccccceEEEEEEeC-----------------CCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccce
Q 002010          692 ESLKDENIIGKGGAGIVYRGSMP-----------------DGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRL  754 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~  754 (982)
                      ++|+..+.||+|+||.||+++..                 ++..||+|.+...........+.+|+.+++.++||||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            46888999999999999998532                 2346899988654444445678999999999999999999


Q ss_pred             EeEEEcCCccEEEEeccCCCCHHHHhhcCCC---------CCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcE
Q 002010          755 LGYVSNRDTNLLLYEYMPNGSLGEMLHGAKG---------GHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNI  825 (982)
Q Consensus       755 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~---------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Ni  825 (982)
                      ++++..++..++||||+++++|.+++.....         ..+++..+..++.|++.|++|||+.+   ++||||||+||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Ni  161 (296)
T cd05095          85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNC  161 (296)
T ss_pred             EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChheE
Confidence            9999999999999999999999999875321         24778899999999999999999988   99999999999


Q ss_pred             EEcCCCCEEEeccccchhccccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHh--CCCCCCCCCCCc
Q 002010          826 LLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA--GKKPVGEFGDGV  903 (982)
Q Consensus       826 ll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt--g~~p~~~~~~~~  903 (982)
                      ++++++.++++|||++..+.............++..|+|||...+..++.++||||+||++|||++  |..||.......
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~  241 (296)
T cd05095         162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ  241 (296)
T ss_pred             EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence            999999999999999986643322222223344678999999888889999999999999999998  778887643322


Q ss_pred             hHHHHHHHhccCCCCCCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 002010          904 DIVRWVRKTTSEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLAN  971 (982)
Q Consensus       904 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~  971 (982)
                      .. ...........        .    ......+..++..+.+++.+||+.||++||++.||++.|++
T Consensus       242 ~~-~~~~~~~~~~~--------~----~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  296 (296)
T cd05095         242 VI-ENTGEFFRDQG--------R----QVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE  296 (296)
T ss_pred             HH-HHHHHHHhhcc--------c----cccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            21 11111100000        0    00001122344678999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=1.4e-35  Score=324.39  Aligned_cols=258  Identities=23%  Similarity=0.371  Sum_probs=205.3

Q ss_pred             hcccccccccccceEEEEEEeC------CCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEE
Q 002010          693 SLKDENIIGKGGAGIVYRGSMP------DGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLL  766 (982)
Q Consensus       693 ~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  766 (982)
                      +|+..+.||+|+||.||+|...      ....+++|.+...........+.+|+.+++.++||||+++++.+..++..++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            3667789999999999999642      2356888887544443445678899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHhhcCC----------------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCc
Q 002010          767 LYEYMPNGSLGEMLHGAK----------------------GGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNN  824 (982)
Q Consensus       767 v~e~~~~~sL~~~l~~~~----------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~N  824 (982)
                      +|||+++++|.+++....                      ...+++..+..++.|++.|++|||+.+   |+||||||+|
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n  157 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN  157 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence            999999999999986421                      135788999999999999999999888   9999999999


Q ss_pred             EEEcCCCCEEEeccccchhccccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCc
Q 002010          825 ILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGV  903 (982)
Q Consensus       825 ill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~  903 (982)
                      |++++++.+||+|||+++...............++..|+|||+..+..++.++||||+|+++|||++ |..||.... ..
T Consensus       158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~-~~  236 (290)
T cd05045         158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA-PE  236 (290)
T ss_pred             EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC-HH
Confidence            9999999999999999986543322222223345678999999988889999999999999999999 999996543 22


Q ss_pred             hHHHHHHHhccCCCCCCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 002010          904 DIVRWVRKTTSEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPP  973 (982)
Q Consensus       904 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~  973 (982)
                      .....+.....                   ...+...+.++.+++.+||+.+|++||+++|+++.|+++.
T Consensus       237 ~~~~~~~~~~~-------------------~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~  287 (290)
T cd05045         237 RLFNLLKTGYR-------------------MERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM  287 (290)
T ss_pred             HHHHHHhCCCC-------------------CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence            22332221111                   0112234457899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=3e-35  Score=317.92  Aligned_cols=260  Identities=21%  Similarity=0.299  Sum_probs=207.6

Q ss_pred             hhcccccccccccceEEEEEEe-CCCcEEEEEEeccCC--CCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEE
Q 002010          692 ESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRG--TGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLY  768 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  768 (982)
                      ++|++.+.||+|+||.||+|.. .+++.||+|.+....  .......+.+|+.++++++||||+++++++.+.+..++||
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            4688889999999999999965 478999999875432  2233456889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccc
Q 002010          769 EYMPNGSLGEMLHGA--KGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQD  846 (982)
Q Consensus       769 e~~~~~sL~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  846 (982)
                      ||+++++|.+++...  +...+++..+..++.|++.|++|||+.+   ++||||||+||+++.++.++++|||.+.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~  158 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence            999999999988532  2355889999999999999999999988   99999999999999999999999999886643


Q ss_pred             cCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccc
Q 002010          847 AGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVL  926 (982)
Q Consensus       847 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  926 (982)
                      ..  .......+++.|+|||.+.+..++.++|+||+|+++|||++|+.||......  ...+..........+       
T Consensus       159 ~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~--~~~~~~~~~~~~~~~-------  227 (267)
T cd08228         159 KT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN--LFSLCQKIEQCDYPP-------  227 (267)
T ss_pred             hh--HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc--HHHHHHHHhcCCCCC-------
Confidence            21  1123356888999999998888999999999999999999999998653221  112221111100000       


Q ss_pred             eeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 002010          927 AVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPP  973 (982)
Q Consensus       927 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~  973 (982)
                              ..+...+..+.+++.+||+.+|++||+++|+++.++++.
T Consensus       228 --------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~  266 (267)
T cd08228         228 --------LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH  266 (267)
T ss_pred             --------CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence                    011233457899999999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=1.4e-35  Score=318.04  Aligned_cols=251  Identities=21%  Similarity=0.304  Sum_probs=205.4

Q ss_pred             hcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEecc
Q 002010          693 SLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYM  771 (982)
Q Consensus       693 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  771 (982)
                      +|+..+.||+|+||.||++.. .++..||+|.+.........+.+.+|+.++++++||||+++++++.+++..++||||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            367788999999999999965 4688999998855444445667889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCcc
Q 002010          772 PNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASE  851 (982)
Q Consensus       772 ~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~  851 (982)
                      ++++|.+++.......+++..+..++.|++.|++|||+.+   |+|+||||+||++++++.++++|||.+.......  .
T Consensus        81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~--~  155 (255)
T cd08219          81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG--A  155 (255)
T ss_pred             CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeecccc--c
Confidence            9999999987655667899999999999999999999988   9999999999999999999999999997664322  2


Q ss_pred             cccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceeecC
Q 002010          852 CMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDP  931 (982)
Q Consensus       852 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  931 (982)
                      ......+++.|+|||+..+..++.++|+||+|+++|+|++|..||...... .....+... .                 
T Consensus       156 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~-~~~~~~~~~-~-----------------  216 (255)
T cd08219         156 YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWK-NLILKVCQG-S-----------------  216 (255)
T ss_pred             ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHH-HHHHHHhcC-C-----------------
Confidence            223456888999999999888999999999999999999999999753221 111111110 0                 


Q ss_pred             CCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002010          932 RLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHM  968 (982)
Q Consensus       932 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~  968 (982)
                       ....+...+..+.+++.+||+.||++|||++|++..
T Consensus       217 -~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         217 -YKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             -CCCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence             011122233468899999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=7.4e-36  Score=331.22  Aligned_cols=242  Identities=22%  Similarity=0.294  Sum_probs=195.1

Q ss_pred             cccccccceEEEEEEe-CCCcEEEEEEeccCC--CCCchhhHHHHHHHHhcC-CCCcccceEeEEEcCCccEEEEeccCC
Q 002010          698 NIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRG--TGGNDHGFLAEIQTLGRI-RHRNIVRLLGYVSNRDTNLLLYEYMPN  773 (982)
Q Consensus       698 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  773 (982)
                      +.||+|+||.||+|+. .+++.||+|++....  .......+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            3689999999999965 457899999985432  233345677888888866 799999999999999999999999999


Q ss_pred             CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCcccc
Q 002010          774 GSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECM  853 (982)
Q Consensus       774 ~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~  853 (982)
                      ++|..++.  +...+++..+..++.||+.|++|||+.+   |+||||||+||+++.++.+||+|||++......  ....
T Consensus        81 ~~L~~~l~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~--~~~~  153 (321)
T cd05591          81 GDLMFQIQ--RSRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILN--GVTT  153 (321)
T ss_pred             CcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccC--Cccc
Confidence            99999986  4457899999999999999999999988   999999999999999999999999998754322  1223


Q ss_pred             cccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceeecCCC
Q 002010          854 SSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDPRL  933 (982)
Q Consensus       854 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  933 (982)
                      ....|++.|+|||++.+..++.++||||+||++|||++|+.||......... ..+.....                   
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~-~~i~~~~~-------------------  213 (321)
T cd05591         154 TTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLF-ESILHDDV-------------------  213 (321)
T ss_pred             cccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHH-HHHHcCCC-------------------
Confidence            3457899999999999989999999999999999999999999765432222 21111100                   


Q ss_pred             CCCChHhHHHHHHHHhhccCCCCCCCC-------CHHHHHH
Q 002010          934 SGYPLTGVIHLFKVAMMCVEDESSARP-------TMREVVH  967 (982)
Q Consensus       934 ~~~~~~~~~~l~~li~~cl~~dP~~Rp-------t~~ell~  967 (982)
                       ..+...+..+.+++.+||+.||++||       +++++++
T Consensus       214 -~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~  253 (321)
T cd05591         214 -LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ  253 (321)
T ss_pred             -CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence             01112334688999999999999999       7787764

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=3e-35  Score=319.03  Aligned_cols=256  Identities=25%  Similarity=0.392  Sum_probs=202.6

Q ss_pred             cccccccccccceEEEEEEeCC----CcEEEEEEeccCCC-CCchhhHHHHHHHHhcCCCCcccceEeEEEcCCc-----
Q 002010          694 LKDENIIGKGGAGIVYRGSMPD----GIDVAIKRLVGRGT-GGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDT-----  763 (982)
Q Consensus       694 ~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-----  763 (982)
                      |++.+.||+|+||.||+|....    +..||+|++..... ......+.+|+..++.++||||+++++++...+.     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            4567889999999999996532    46799998854322 2234578899999999999999999998866554     


Q ss_pred             -cEEEEeccCCCCHHHHhhcC----CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEecc
Q 002010          764 -NLLLYEYMPNGSLGEMLHGA----KGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADF  838 (982)
Q Consensus       764 -~~lv~e~~~~~sL~~~l~~~----~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Df  838 (982)
                       .+++|||+++++|..++...    ....+++..+..++.|++.|++|+|+.+   |+||||||+||++++++.+||+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence             78999999999999998543    2346899999999999999999999988   999999999999999999999999


Q ss_pred             ccchhccccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHhccCCC
Q 002010          839 GLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVS  917 (982)
Q Consensus       839 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  917 (982)
                      |+++.+..............+..|+|||.+.+..++.++||||+||++|||++ |..||.+.... .....+....    
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~-~~~~~~~~~~----  232 (273)
T cd05035         158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH-EIYDYLRHGN----  232 (273)
T ss_pred             cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHHHcCC----
Confidence            99987654332222222345678999999988889999999999999999999 88998764332 2222222111    


Q ss_pred             CCCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 002010          918 QPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANP  972 (982)
Q Consensus       918 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~  972 (982)
                                     ....+...+..+.+++.+||+.||++|||+.|+++.|+++
T Consensus       233 ---------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         233 ---------------RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             ---------------CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                           1112233455789999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=2.4e-35  Score=323.78  Aligned_cols=264  Identities=25%  Similarity=0.386  Sum_probs=207.6

Q ss_pred             hhcccccccccccceEEEEEEeCC-----------------CcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccce
Q 002010          692 ESLKDENIIGKGGAGIVYRGSMPD-----------------GIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRL  754 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~  754 (982)
                      .+|+..+.||+|+||.||+|...+                 +..||+|.+...........+.+|+.++++++||||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~   84 (296)
T cd05051           5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL   84 (296)
T ss_pred             hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence            468888999999999999986532                 246899988655444456678899999999999999999


Q ss_pred             EeEEEcCCccEEEEeccCCCCHHHHhhcCC---------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcE
Q 002010          755 LGYVSNRDTNLLLYEYMPNGSLGEMLHGAK---------GGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNI  825 (982)
Q Consensus       755 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~---------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Ni  825 (982)
                      ++++..++..++||||+++++|.+++....         ...+++..+..++.|++.|++|||+.+   |+||||||+||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~Ni  161 (296)
T cd05051          85 LGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRNC  161 (296)
T ss_pred             EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhce
Confidence            999999999999999999999999997433         126899999999999999999999988   99999999999


Q ss_pred             EEcCCCCEEEeccccchhccccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHh--CCCCCCCCCCCc
Q 002010          826 LLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA--GKKPVGEFGDGV  903 (982)
Q Consensus       826 ll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt--g~~p~~~~~~~~  903 (982)
                      +++.++.++++|||+++...............+++.|+|||++.+..++.++||||+||++|||++  +..||.......
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~  241 (296)
T cd05051         162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQ  241 (296)
T ss_pred             eecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHH
Confidence            999999999999999986543332223334456788999999988889999999999999999998  778886543322


Q ss_pred             hHHHHHHHhccCCCCCCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 002010          904 DIVRWVRKTTSEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLAN  971 (982)
Q Consensus       904 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~  971 (982)
                       .............            .+.....+...+.++.+++.+||+.||++|||+.||++.|+.
T Consensus       242 -~~~~~~~~~~~~~------------~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~  296 (296)
T cd05051         242 -VIENAGHFFRDDG------------RQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR  296 (296)
T ss_pred             -HHHHHHhcccccc------------ccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence             2222211110000            000001122344679999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=4e-35  Score=313.58  Aligned_cols=248  Identities=27%  Similarity=0.407  Sum_probs=200.5

Q ss_pred             cccccccceEEEEEEeCCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEeccCCCCHH
Q 002010          698 NIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLG  777 (982)
Q Consensus       698 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~  777 (982)
                      +.||+|+||.||+|...++..||+|.+...........+.+|+.++++++||||+++++++...+..++||||+++++|.
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            36899999999999887889999998855444344456889999999999999999999999999999999999999999


Q ss_pred             HHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCcccccccc
Q 002010          778 EMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVA  857 (982)
Q Consensus       778 ~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~  857 (982)
                      +++... ...+++..+..++.|++.|+.|+|+.+   ++||||||+||++++++.+|++|||++....... ........
T Consensus        81 ~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~  155 (250)
T cd05085          81 SFLRKK-KDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGI-YSSSGLKQ  155 (250)
T ss_pred             HHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccc-cccCCCCC
Confidence            998643 356889999999999999999999988   9999999999999999999999999987543221 11112233


Q ss_pred             cccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceeecCCCCCC
Q 002010          858 GSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDPRLSGY  936 (982)
Q Consensus       858 gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  936 (982)
                      ++..|+|||++.+..++.++||||+|+++|++++ |..||........ ...+.....                   ...
T Consensus       156 ~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~-~~~~~~~~~-------------------~~~  215 (250)
T cd05085         156 IPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQA-REQVEKGYR-------------------MSC  215 (250)
T ss_pred             CcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHH-HHHHHcCCC-------------------CCC
Confidence            4568999999998889999999999999999999 9999976433221 111111100                   011


Q ss_pred             ChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 002010          937 PLTGVIHLFKVAMMCVEDESSARPTMREVVHMLA  970 (982)
Q Consensus       937 ~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~  970 (982)
                      +...+..+.+++.+||+.+|++||++.|+++.|.
T Consensus       216 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         216 PQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            2234457899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=100.00  E-value=6.3e-38  Score=336.42  Aligned_cols=363  Identities=28%  Similarity=0.374  Sum_probs=241.7

Q ss_pred             cceeeccCCccccccchhhhhcCCCccEEeccCccccCCCchhccccccccEEeecCcccccccCCCccccCcceEeecc
Q 002010          121 LKVFNISGNVFQGNFAGQIVRGMTELQVLDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLN  200 (982)
Q Consensus       121 L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~  200 (982)
                      .+-.|+|+|.|+|.-.+.-...|++++.|.|...++. .+|..++.|.+|++|.+++|++.                   
T Consensus         9 VrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-------------------   68 (1255)
T KOG0444|consen    9 VRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-------------------   68 (1255)
T ss_pred             eecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-------------------
Confidence            3445566666664322223356677777777777776 68888888888888888888876                   


Q ss_pred             CcccccchhhHHhhhhhHHHHhhcccccccccCCCCCCCCCCCCEEecccCcCcccCchhhcCCCccceeecccccCCCC
Q 002010          201 GIGLNGTVPAFLSRLKNLREMYIGYFNTYTGGIPPGFGALTQLQVLDMASCNISGEIPTSLSRLKLLHSLFLQMNKLTGH  280 (982)
Q Consensus       201 ~n~i~~~~~~~l~~l~~L~~L~l~~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~  280 (982)
                            .+-..++.|+.||.+.+.+|+.-...||+.+..|..|++|||++|++. +.|..+.+-+++-.|+||+|+|..+
T Consensus        69 ------~vhGELs~Lp~LRsv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetI  141 (1255)
T KOG0444|consen   69 ------SVHGELSDLPRLRSVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETI  141 (1255)
T ss_pred             ------hhhhhhccchhhHHHhhhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccC
Confidence                  233345566677777777777777789999999999999999999998 7888888889999999999999855


Q ss_pred             CCccccCCCCCCEEEeeCCcccCcCchhhhcccchhhhhhccCCCCCCCCCcCCCCCCccEEEccCCCcc-cccCccccC
Q 002010          281 IPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFT-FELPENLGR  359 (982)
Q Consensus       281 ~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~-~~~~~~l~~  359 (982)
                      ..+.|-+|+.|-+||||+|++. .+|..+..+.+|+.|+|++|.+...--..+..+.+|++|.+++.+=+ ..+|..+..
T Consensus       142 Pn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~  220 (1255)
T KOG0444|consen  142 PNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDD  220 (1255)
T ss_pred             CchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhh
Confidence            5556778888889999999988 56667788888888888888876443344455666777777765443 235555555


Q ss_pred             CCcccEEEeccccccccCCccccCccccceeecccccccccCCccccCCCCCCEEEccCCccCCCCCccccCCCcccccc
Q 002010          360 NGKLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMME  439 (982)
Q Consensus       360 l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~l~~N~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~  439 (982)
                      +.+|..+|+|.|.+.                         .+|+++-++++|+.|+||+|+|+ .+......+       
T Consensus       221 l~NL~dvDlS~N~Lp-------------------------~vPecly~l~~LrrLNLS~N~it-eL~~~~~~W-------  267 (1255)
T KOG0444|consen  221 LHNLRDVDLSENNLP-------------------------IVPECLYKLRNLRRLNLSGNKIT-ELNMTEGEW-------  267 (1255)
T ss_pred             hhhhhhccccccCCC-------------------------cchHHHhhhhhhheeccCcCcee-eeeccHHHH-------
Confidence            555555555555554                         34444445555555555555554 222222222       


Q ss_pred             CCCccccccCCcccccCCccEEEeeccccCCCCchhccCCCCcceeeecccccc-CCCccccccccccceeeeeccccCC
Q 002010          440 LDDNLLSGELPEKMSGASLNQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLE-GEIPVESFNLKMITSINISDNNISG  518 (982)
Q Consensus       440 L~~N~l~~~~~~~~~~~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~  518 (982)
                                      ..|++|+||+|+++ .+|.+++.++.|+.|++.+|+++ .-+|..++.+.+|+.+..++|++. 
T Consensus       268 ----------------~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-  329 (1255)
T KOG0444|consen  268 ----------------ENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-  329 (1255)
T ss_pred             ----------------hhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhccccc-
Confidence                            23444555555555 66677777777777777777665 235555666666666666666665 


Q ss_pred             CCCcccccccCCCeeeCCCCcccCCCCcccccccccceEEccccc
Q 002010          519 EIPYSISQCHSLTSVDLSRNSLYGKIPPGISKLIDLSILNLSRNG  563 (982)
Q Consensus       519 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~  563 (982)
                      .+|+.++.|.+|+.|.|++|++. .+|+.|.-|+.|+.|||.+|.
T Consensus       330 lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNp  373 (1255)
T KOG0444|consen  330 LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENP  373 (1255)
T ss_pred             cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCCc
Confidence            56666666666666666666665 566666666666666666663

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.5e-35  Score=332.57  Aligned_cols=272  Identities=22%  Similarity=0.263  Sum_probs=203.7

Q ss_pred             hhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEec
Q 002010          692 ESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEY  770 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  770 (982)
                      ..|+..+.||+|+||.||+|.. .+++.||+|...       ...+.+|+.++++++||||+++++++......++|+|+
T Consensus        92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~-------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~  164 (391)
T PHA03212         92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ-------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR  164 (391)
T ss_pred             CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh-------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence            4688999999999999999964 568899999642       23467899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCc
Q 002010          771 MPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS  850 (982)
Q Consensus       771 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  850 (982)
                      + +++|..++..  ...+++.++..++.||+.||+|||+.+   |+||||||+||+++.++.+||+|||+|+...... .
T Consensus       165 ~-~~~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~-~  237 (391)
T PHA03212        165 Y-KTDLYCYLAA--KRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN-A  237 (391)
T ss_pred             C-CCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCccccccccc-c
Confidence            9 4789888863  357899999999999999999999988   9999999999999999999999999997543221 1


Q ss_pred             ccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCC-------CchHHHHHHHhccCCC-CCCcc
Q 002010          851 ECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGD-------GVDIVRWVRKTTSEVS-QPSDA  922 (982)
Q Consensus       851 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~-------~~~~~~~~~~~~~~~~-~~~~~  922 (982)
                      .......||+.|+|||++.+..++.++||||+||++|||++|+.||.....       ...+...+......+. .+...
T Consensus       238 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~  317 (391)
T PHA03212        238 NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDA  317 (391)
T ss_pred             cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcch
Confidence            223346799999999999998999999999999999999999988754211       1122222222221110 00000


Q ss_pred             -cccceee---------cCCCCC---CChHhHHHHHHHHhhccCCCCCCCCCHHHHHH--HhcCCCCCCC
Q 002010          923 -ASVLAVV---------DPRLSG---YPLTGVIHLFKVAMMCVEDESSARPTMREVVH--MLANPPQSAP  977 (982)
Q Consensus       923 -~~~~~~~---------~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~--~L~~~~~~~~  977 (982)
                       ......+         .+....   .....+.++.+++.+||+.||++|||++|+++  .+..+..+-|
T Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~~~  387 (391)
T PHA03212        318 QANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIPDPYP  387 (391)
T ss_pred             hHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCCCCCC
Confidence             0000000         000000   01123557889999999999999999999986  5555554443

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=2.4e-35  Score=320.53  Aligned_cols=246  Identities=25%  Similarity=0.304  Sum_probs=196.5

Q ss_pred             cccccceEEEEEEe-CCCcEEEEEEeccCCCC--CchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEeccCCCCH
Q 002010          700 IGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTG--GNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSL  776 (982)
Q Consensus       700 lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL  776 (982)
                      ||+|+||+||++.. .+++.||+|.+......  .....+..|+.++++++||||+++++++..+...++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            69999999999965 46889999998543222  2234577899999999999999999999999999999999999999


Q ss_pred             HHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCccccc
Q 002010          777 GEMLHG--AKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMS  854 (982)
Q Consensus       777 ~~~l~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~  854 (982)
                      ..++..  .....+++..+..++.||+.|++|||+.+   |+||||||+||+++.++.+||+|||.+..+....  ....
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~--~~~~  155 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ--SKTK  155 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCC--cccc
Confidence            988753  23457899999999999999999999988   9999999999999999999999999997654321  1223


Q ss_pred             ccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceeecCCCC
Q 002010          855 SVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDPRLS  934 (982)
Q Consensus       855 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  934 (982)
                      ...|++.|+|||++.+..++.++||||+||++|||++|+.||..................                . ..
T Consensus       156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~----------------~-~~  218 (280)
T cd05608         156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILN----------------D-SV  218 (280)
T ss_pred             ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcc----------------c-CC
Confidence            457899999999999999999999999999999999999999764332221111111111                0 00


Q ss_pred             CCChHhHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 002010          935 GYPLTGVIHLFKVAMMCVEDESSARP-----TMREVVH  967 (982)
Q Consensus       935 ~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~ell~  967 (982)
                      ..+...+..+.+++.+||+.||++||     |++|+++
T Consensus       219 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~  256 (280)
T cd05608         219 TYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT  256 (280)
T ss_pred             CCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence            12233455788999999999999999     7777775

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-36  Score=293.52  Aligned_cols=252  Identities=24%  Similarity=0.399  Sum_probs=207.4

Q ss_pred             hhcccccccccccceEEEEEEeC-CCcEEEEEEeccCCCCCchhhHHHHHHHHhcC-CCCcccceEeEEEcCCccEEEEe
Q 002010          692 ESLKDENIIGKGGAGIVYRGSMP-DGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRI-RHRNIVRLLGYVSNRDTNLLLYE  769 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e  769 (982)
                      +.++....+|.|..|+||++++. +|...|||.+......++.+++...+.++... ++|+||+++|||..+...++.||
T Consensus        92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe  171 (391)
T KOG0983|consen   92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME  171 (391)
T ss_pred             HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence            45566678999999999999764 58999999998888888888899999887776 48999999999999999999999


Q ss_pred             ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCC
Q 002010          770 YMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGA  849 (982)
Q Consensus       770 ~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  849 (982)
                      .| ....+.+++ +-..++++.-+-++...+++||.||.+++  +|+|||+||+|||+|+.|++|+||||++-++.+.  
T Consensus       172 lM-s~C~ekLlk-rik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS--  245 (391)
T KOG0983|consen  172 LM-STCAEKLLK-RIKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS--  245 (391)
T ss_pred             HH-HHHHHHHHH-HhcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecc--
Confidence            98 435555554 34467899889999999999999998855  3999999999999999999999999999887754  


Q ss_pred             cccccccccccccccccccc---cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccc
Q 002010          850 SECMSSVAGSYGYIAPEYAY---TLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVL  926 (982)
Q Consensus       850 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  926 (982)
                       ...+...|.+.|||||.+.   ...|+-++||||+|+.++|+.||+.||.....+.+....+....+  +         
T Consensus       246 -kAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~eP--P---------  313 (391)
T KOG0983|consen  246 -KAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEP--P---------  313 (391)
T ss_pred             -cccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCC--C---------
Confidence             3345567899999999986   446899999999999999999999999987777666666655322  1         


Q ss_pred             eeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          927 AVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       927 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                           .+++ .......+.+++..|+++|+.+||...++++
T Consensus       314 -----~L~~-~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~  348 (391)
T KOG0983|consen  314 -----LLPG-HMGFSPDFQSFVKDCLTKDHRKRPKYNKLLE  348 (391)
T ss_pred             -----CCCc-ccCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence                 1110 0112346889999999999999999999886

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=3.4e-35  Score=318.38  Aligned_cols=255  Identities=24%  Similarity=0.358  Sum_probs=198.2

Q ss_pred             ccccccccccceEEEEEEeCC-C--cEEEEEEeccCC-CCCchhhHHHHHHHHhcCCCCcccceEeEEEcC------Ccc
Q 002010          695 KDENIIGKGGAGIVYRGSMPD-G--IDVAIKRLVGRG-TGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNR------DTN  764 (982)
Q Consensus       695 ~~~~~lg~G~~g~Vy~~~~~~-~--~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~~  764 (982)
                      .+++.||+|+||.||+|...+ +  ..||+|.+.... .......+.+|+.++++++||||+++++++...      ...
T Consensus         2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   81 (272)
T cd05075           2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP   81 (272)
T ss_pred             ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence            456789999999999997644 3  268999875432 223355788899999999999999999976432      246


Q ss_pred             EEEEeccCCCCHHHHhhcC----CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEecccc
Q 002010          765 LLLYEYMPNGSLGEMLHGA----KGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGL  840 (982)
Q Consensus       765 ~lv~e~~~~~sL~~~l~~~----~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~  840 (982)
                      +++|||+++++|.+++...    ....+++..+..++.|++.|++|||+.+   |+||||||+||++++++.+||+|||+
T Consensus        82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~  158 (272)
T cd05075          82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGL  158 (272)
T ss_pred             EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCCc
Confidence            8999999999999987422    2345889999999999999999999988   99999999999999999999999999


Q ss_pred             chhccccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHhccCCCCC
Q 002010          841 AKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQP  919 (982)
Q Consensus       841 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  919 (982)
                      +..+.............+++.|+|||...+..++.++||||+|+++|||++ |+.||..... ......+.....     
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-~~~~~~~~~~~~-----  232 (272)
T cd05075         159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN-SEIYDYLRQGNR-----  232 (272)
T ss_pred             ccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH-HHHHHHHHcCCC-----
Confidence            987654322222223345678999999999999999999999999999999 8899875432 222222221111     


Q ss_pred             CcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 002010          920 SDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANP  972 (982)
Q Consensus       920 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~  972 (982)
                                    ...+...+..+.+++.+||+.||++|||++|+++.|+++
T Consensus       233 --------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         233 --------------LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             --------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                          011123345689999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=1.1e-35  Score=330.24  Aligned_cols=242  Identities=24%  Similarity=0.296  Sum_probs=194.7

Q ss_pred             hcccccccccccceEEEEEEeC-CCcEEEEEEeccCC--CCCchhhHHHHHHHHhcCCC-CcccceEeEEEcCCccEEEE
Q 002010          693 SLKDENIIGKGGAGIVYRGSMP-DGIDVAIKRLVGRG--TGGNDHGFLAEIQTLGRIRH-RNIVRLLGYVSNRDTNLLLY  768 (982)
Q Consensus       693 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~lv~  768 (982)
                      +|+..+.||+|+||.||+|... +++.||+|++....  .......+..|..++..++| ++|+++++++.+.+..|+||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            3677889999999999999654 57899999985432  23345567889999999976 56888999999999999999


Q ss_pred             eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccC
Q 002010          769 EYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAG  848 (982)
Q Consensus       769 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  848 (982)
                      ||+++|+|.+++.  +...+++..+..++.||+.|++|||+.+   |+||||||+||+++.++.+||+|||++...... 
T Consensus        81 E~~~~g~L~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~-  154 (324)
T cd05587          81 EYVNGGDLMYHIQ--QVGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG-  154 (324)
T ss_pred             cCCCCCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCC-
Confidence            9999999999986  3457899999999999999999999988   999999999999999999999999998743211 


Q ss_pred             CcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCccccccee
Q 002010          849 ASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAV  928 (982)
Q Consensus       849 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  928 (982)
                       ........||+.|+|||++.+..++.++||||+||++|||++|+.||....... ....+....               
T Consensus       155 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~-~~~~i~~~~---------------  217 (324)
T cd05587         155 -GKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE-LFQSIMEHN---------------  217 (324)
T ss_pred             -CCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH-HHHHHHcCC---------------
Confidence             122334678999999999999999999999999999999999999997643322 222211110               


Q ss_pred             ecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCH
Q 002010          929 VDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTM  962 (982)
Q Consensus       929 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~  962 (982)
                           ..++...+..+.+++.+||+.||.+|++.
T Consensus       218 -----~~~~~~~~~~~~~li~~~l~~~P~~R~~~  246 (324)
T cd05587         218 -----VSYPKSLSKEAVSICKGLLTKHPAKRLGC  246 (324)
T ss_pred             -----CCCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence                 01122234568899999999999999976

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=2.4e-35  Score=326.35  Aligned_cols=261  Identities=26%  Similarity=0.420  Sum_probs=207.1

Q ss_pred             HhhcccccccccccceEEEEEEeC--------CCcEEEEEEeccCCCCCchhhHHHHHHHHhcC-CCCcccceEeEEEcC
Q 002010          691 LESLKDENIIGKGGAGIVYRGSMP--------DGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRI-RHRNIVRLLGYVSNR  761 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~  761 (982)
                      .++|++.+.||+|+||.||+|+..        ....||+|.+...........+..|+.+++++ +||||+++++++...
T Consensus        11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~   90 (314)
T cd05099          11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE   90 (314)
T ss_pred             HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence            367889999999999999999631        24578999886544444456788999999999 699999999999998


Q ss_pred             CccEEEEeccCCCCHHHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEE
Q 002010          762 DTNLLLYEYMPNGSLGEMLHGAK--------------GGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILL  827 (982)
Q Consensus       762 ~~~~lv~e~~~~~sL~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill  827 (982)
                      ...++||||+++++|.+++....              ...+++.++..++.|++.|++|||+.+   |+||||||+||++
T Consensus        91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill  167 (314)
T cd05099          91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLV  167 (314)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEE
Confidence            89999999999999999996532              245889999999999999999999988   9999999999999


Q ss_pred             cCCCCEEEeccccchhccccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHH
Q 002010          828 DSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIV  906 (982)
Q Consensus       828 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~  906 (982)
                      ++++.+||+|||.++...............++..|+|||++.+..++.++||||+|+++|||++ |..||..... ....
T Consensus       168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~-~~~~  246 (314)
T cd05099         168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV-EELF  246 (314)
T ss_pred             cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH-HHHH
Confidence            9999999999999986643222221222234567999999998889999999999999999999 8899865432 2222


Q ss_pred             HHHHHhccCCCCCCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCC
Q 002010          907 RWVRKTTSEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQ  974 (982)
Q Consensus       907 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~~  974 (982)
                      ........                   ...+...+.++.+++.+||+.||++|||+.|+++.|+++..
T Consensus       247 ~~~~~~~~-------------------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~  295 (314)
T cd05099         247 KLLREGHR-------------------MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA  295 (314)
T ss_pred             HHHHcCCC-------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence            22221100                   01122344578899999999999999999999999877653

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=2e-35  Score=333.38  Aligned_cols=204  Identities=26%  Similarity=0.339  Sum_probs=174.9

Q ss_pred             hhcccccccccccceEEEEEEe-CCCcEEEEEEeccCC--CCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEE
Q 002010          692 ESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRG--TGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLY  768 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  768 (982)
                      ++|+..+.||+|+||+||+|.. .+++.||+|++....  .......+.+|+.++.+++||+|+++++.+.+....++||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            3578889999999999999965 468999999985432  1223456788999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccC
Q 002010          769 EYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAG  848 (982)
Q Consensus       769 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  848 (982)
                      ||+++|+|.+++.  +...+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++.+....
T Consensus        81 E~~~gg~L~~~l~--~~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~  155 (363)
T cd05628          81 EFLPGGDMMTLLM--KKDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAH  155 (363)
T ss_pred             cCCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCcccccccc
Confidence            9999999999997  3467999999999999999999999988   9999999999999999999999999987653211


Q ss_pred             Cc---------------------------------ccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCC
Q 002010          849 AS---------------------------------ECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKP  895 (982)
Q Consensus       849 ~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p  895 (982)
                      ..                                 ......+||+.|+|||++.+..++.++||||+||++|||++|+.|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~P  235 (363)
T cd05628         156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP  235 (363)
T ss_pred             cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCC
Confidence            00                                 001235799999999999999999999999999999999999999


Q ss_pred             CCCCC
Q 002010          896 VGEFG  900 (982)
Q Consensus       896 ~~~~~  900 (982)
                      |....
T Consensus       236 f~~~~  240 (363)
T cd05628         236 FCSET  240 (363)
T ss_pred             CCCCC
Confidence            97643

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=1.8e-35  Score=324.69  Aligned_cols=259  Identities=27%  Similarity=0.410  Sum_probs=202.8

Q ss_pred             hhcccccccccccceEEEEEEeCC-C--cEEEEEEeccCCCCCchhhHHHHHHHHhcC-CCCcccceEeEEEcCCccEEE
Q 002010          692 ESLKDENIIGKGGAGIVYRGSMPD-G--IDVAIKRLVGRGTGGNDHGFLAEIQTLGRI-RHRNIVRLLGYVSNRDTNLLL  767 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~~~-~--~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv  767 (982)
                      ++|++.+.||+|+||.||+|..++ +  ..+++|.++........+.+.+|+.++.++ +||||+++++++......++|
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            468888999999999999996543 3  347888775433334456788999999999 799999999999999999999


Q ss_pred             EeccCCCCHHHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCE
Q 002010          768 YEYMPNGSLGEMLHGAK--------------GGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEA  833 (982)
Q Consensus       768 ~e~~~~~sL~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~  833 (982)
                      |||+++++|.+++....              ...+++..+..++.|++.|++|||+.+   |+||||||+||++++++.+
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~  158 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS  158 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence            99999999999996432              135888999999999999999999988   9999999999999999999


Q ss_pred             EEeccccchhccccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHh
Q 002010          834 HVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKT  912 (982)
Q Consensus       834 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~  912 (982)
                      ||+|||++......   ........+..|+|||+..+..++.++||||+||++|||++ |..||....... ...   ..
T Consensus       159 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~-~~~---~~  231 (297)
T cd05089         159 KIADFGLSRGEEVY---VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE-LYE---KL  231 (297)
T ss_pred             EECCcCCCccccce---eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH-HHH---HH
Confidence            99999998643211   11111223557999999988889999999999999999998 999997643221 111   11


Q ss_pred             ccCCCCCCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCCCC
Q 002010          913 TSEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQSA  976 (982)
Q Consensus       913 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~~~~  976 (982)
                      ....                ....+...+..+.+++.+||+.+|.+|||++++++.|+.+.+..
T Consensus       232 ~~~~----------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~  279 (297)
T cd05089         232 PQGY----------------RMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR  279 (297)
T ss_pred             hcCC----------------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence            1100                00112234457889999999999999999999999987766543

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=4e-35  Score=314.59  Aligned_cols=249  Identities=24%  Similarity=0.404  Sum_probs=198.4

Q ss_pred             ccccccceEEEEEEeC---CCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEeccCCCC
Q 002010          699 IIGKGGAGIVYRGSMP---DGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGS  775 (982)
Q Consensus       699 ~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~s  775 (982)
                      .||+|+||.||+|.+.   ++..||+|...........+.+.+|+.++++++||||+++++++. .+..++||||+++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence            3899999999999652   356799998855444444567889999999999999999999875 457899999999999


Q ss_pred             HHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCc-cccc
Q 002010          776 LGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS-ECMS  854 (982)
Q Consensus       776 L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~-~~~~  854 (982)
                      |.+++.. ....+++..+.+++.|++.|++|||+.+   ++||||||+||+++.++.+|++|||++......... ....
T Consensus        81 L~~~l~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  156 (257)
T cd05115          81 LNKFLSG-KKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARS  156 (257)
T ss_pred             HHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceeccC
Confidence            9999863 2357899999999999999999999988   999999999999999999999999999865432211 1112


Q ss_pred             ccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceeecCCC
Q 002010          855 SVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDPRL  933 (982)
Q Consensus       855 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  933 (982)
                      ...++..|+|||++....++.++||||||+++||+++ |..||...... .....+.....                   
T Consensus       157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-~~~~~~~~~~~-------------------  216 (257)
T cd05115         157 AGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP-EVMSFIEQGKR-------------------  216 (257)
T ss_pred             CCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH-HHHHHHHCCCC-------------------
Confidence            2233578999999988889999999999999999997 99999765432 22222221111                   


Q ss_pred             CCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 002010          934 SGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANP  972 (982)
Q Consensus       934 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~  972 (982)
                      ...+..++.++.+++.+||+.||++||++.+|.+.|+.+
T Consensus       217 ~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         217 LDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence            112334456889999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=3.6e-35  Score=317.12  Aligned_cols=257  Identities=29%  Similarity=0.485  Sum_probs=205.9

Q ss_pred             hhcccccccccccceEEEEEEeC----CCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEE
Q 002010          692 ESLKDENIIGKGGAGIVYRGSMP----DGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLL  767 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  767 (982)
                      .+|++.+.||+|+||.||+|...    .+..+|+|.+...........+.+|+.++++++||||+++++++..++..++|
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV   83 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence            56888899999999999999653    23479999885544444456789999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhcccc
Q 002010          768 YEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDA  847 (982)
Q Consensus       768 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  847 (982)
                      |||+++++|.+++... ...+++.++..++.|++.|++|||+.+   ++||||||+||+++.++.++++|||++..+...
T Consensus        84 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd05066          84 TEYMENGSLDAFLRKH-DGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  159 (267)
T ss_pred             EEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence            9999999999999743 356899999999999999999999988   999999999999999999999999999876533


Q ss_pred             CCcc-cccccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHhccCCCCCCccccc
Q 002010          848 GASE-CMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASV  925 (982)
Q Consensus       848 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  925 (982)
                      .... ......++..|+|||++.+..++.++|+||+|+++||+++ |..||...... +....+..... .         
T Consensus       160 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~-~~~~~~~~~~~-~---------  228 (267)
T cd05066         160 PEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ-DVIKAIEEGYR-L---------  228 (267)
T ss_pred             cceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH-HHHHHHhCCCc-C---------
Confidence            2111 1112233568999999998889999999999999999887 99999764332 22222221111 0         


Q ss_pred             ceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 002010          926 LAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANP  972 (982)
Q Consensus       926 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~  972 (982)
                               ..+...+..+.+++.+||+.+|++||++.++++.|+++
T Consensus       229 ---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         229 ---------PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             ---------CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence                     01122345788999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=4.3e-35  Score=317.00  Aligned_cols=253  Identities=27%  Similarity=0.390  Sum_probs=192.8

Q ss_pred             ccccccceEEEEEEeCC---CcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEeccCCCC
Q 002010          699 IIGKGGAGIVYRGSMPD---GIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGS  775 (982)
Q Consensus       699 ~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~s  775 (982)
                      .||+|+||.||+|...+   ...+|+|.+...........+.+|+..++.++||||+++++++......++||||+++|+
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~   81 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD   81 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence            58999999999996433   456888877544333445578899999999999999999999999999999999999999


Q ss_pred             HHHHhhcCCC---CCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCccc
Q 002010          776 LGEMLHGAKG---GHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASEC  852 (982)
Q Consensus       776 L~~~l~~~~~---~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~  852 (982)
                      |.+++...+.   ...++..+..++.||+.|++|||+.+   |+||||||+||++++++.+||+|||++...........
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~  158 (269)
T cd05042          82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT  158 (269)
T ss_pred             HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchheec
Confidence            9999975432   33567888999999999999999988   99999999999999999999999999875433222222


Q ss_pred             cccccccccccccccccc-------CCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHhccCCCCCCcccc
Q 002010          853 MSSVAGSYGYIAPEYAYT-------LKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAAS  924 (982)
Q Consensus       853 ~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  924 (982)
                      .....++..|+|||+...       ..++.++||||+||++|||++ |..||....+.+.....+.......+.      
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~------  232 (269)
T cd05042         159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPK------  232 (269)
T ss_pred             cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCC------
Confidence            233445678999998643       356789999999999999999 788887654333222222221111111      


Q ss_pred             cceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 002010          925 VLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLA  970 (982)
Q Consensus       925 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~  970 (982)
                               +..+...+..+.+++..|| .||++|||++||++.|.
T Consensus       233 ---------~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         233 ---------PQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             ---------CcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence                     1122234456778889998 59999999999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=3.4e-36  Score=333.59  Aligned_cols=239  Identities=25%  Similarity=0.263  Sum_probs=193.9

Q ss_pred             cccccccceEEEEEEe----CCCcEEEEEEeccCCC-CCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEeccC
Q 002010          698 NIIGKGGAGIVYRGSM----PDGIDVAIKRLVGRGT-GGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMP  772 (982)
Q Consensus       698 ~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  772 (982)
                      +.||+|+||.||+++.    .+|+.||+|++..... ......+.+|++++++++||||+++++++.+++..|+||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            5799999999999854    3588999999854322 2233456789999999999999999999999999999999999


Q ss_pred             CCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCccc
Q 002010          773 NGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASEC  852 (982)
Q Consensus       773 ~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~  852 (982)
                      +++|.+++.  +...+++..+..++.||+.|++|||+.+   |+||||||+||++++++.+||+|||++.......  ..
T Consensus        82 ~~~L~~~l~--~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~~  154 (318)
T cd05582          82 GGDLFTRLS--KEVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--KK  154 (318)
T ss_pred             CCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCC--Cc
Confidence            999999996  4457899999999999999999999988   9999999999999999999999999997654321  22


Q ss_pred             ccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceeecCC
Q 002010          853 MSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDPR  932 (982)
Q Consensus       853 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  932 (982)
                      .....|++.|+|||++.+..++.++||||+||++|||++|+.||....... ....+....                   
T Consensus       155 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~-~~~~i~~~~-------------------  214 (318)
T cd05582         155 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKE-TMTMILKAK-------------------  214 (318)
T ss_pred             eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHH-HHHHHHcCC-------------------
Confidence            334678999999999998889999999999999999999999997543221 111111100                   


Q ss_pred             CCCCChHhHHHHHHHHhhccCCCCCCCCCHHH
Q 002010          933 LSGYPLTGVIHLFKVAMMCVEDESSARPTMRE  964 (982)
Q Consensus       933 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~e  964 (982)
                       ...+...+..+.+++.+||+.||++||++.+
T Consensus       215 -~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         215 -LGMPQFLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             -CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence             0122233457889999999999999999554

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-38  Score=356.18  Aligned_cols=492  Identities=25%  Similarity=0.288  Sum_probs=404.7

Q ss_pred             CEEEEEeccCCccccCCcCccccccccEEEeccCCCCCCCChhhhhhcccceeeccCCccccccchhhhhcCCCccEEec
Q 002010           72 RVVSLNVSFMPLFGSIPPEIGLLTKLVNLTISNVNLTGRLPSEMALLTSLKVFNISGNVFQGNFAGQIVRGMTELQVLDA  151 (982)
Q Consensus        72 ~v~~l~l~~~~l~g~~~~~i~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L  151 (982)
                      +++.+++..+-+...--+.+..--+|+.|++++|++. ..|..+..+.+|+.|+++.|.+... | .....+.+|++|.|
T Consensus        22 ~~~~ln~~~N~~l~~pl~~~~~~v~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~~v-p-~s~~~~~~l~~lnL   98 (1081)
T KOG0618|consen   22 ALQILNLRRNSLLSRPLEFVEKRVKLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYIRSV-P-SSCSNMRNLQYLNL   98 (1081)
T ss_pred             HHHhhhccccccccCchHHhhheeeeEEeeccccccc-cCCchhhhHHHHhhcccchhhHhhC-c-hhhhhhhcchhhee
Confidence            3667777766554322244555556999999999887 7899999999999999999998743 3 45678999999999


Q ss_pred             cCccccCCCchhccccccccEEeecCcccccccCCCccccCcceEeeccCcccccchhhHHhhhhhHHHHhhcccccccc
Q 002010          152 YNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLNGIGLNGTVPAFLSRLKNLREMYIGYFNTYTG  231 (982)
Q Consensus       152 s~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~l~~~n~~~~  231 (982)
                      ..|.+. ..|..+..+++|++|++|+|+|. .+|..+..++.++.+..++|......+.    .. .+++++.. +.+.+
T Consensus        99 ~~n~l~-~lP~~~~~lknl~~LdlS~N~f~-~~Pl~i~~lt~~~~~~~s~N~~~~~lg~----~~-ik~~~l~~-n~l~~  170 (1081)
T KOG0618|consen   99 KNNRLQ-SLPASISELKNLQYLDLSFNHFG-PIPLVIEVLTAEEELAASNNEKIQRLGQ----TS-IKKLDLRL-NVLGG  170 (1081)
T ss_pred             ccchhh-cCchhHHhhhcccccccchhccC-CCchhHHhhhHHHHHhhhcchhhhhhcc----cc-chhhhhhh-hhccc
Confidence            999998 89999999999999999999998 8999999999999999999822222222    11 55666654 55667


Q ss_pred             cCCCCCCCCCCCCEEecccCcCcccCchhhcCCCccceeecccccCCCCCCccccCCCCCCEEEeeCCcccCcCchhhhc
Q 002010          232 GIPPGFGALTQLQVLDMASCNISGEIPTSLSRLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAA  311 (982)
Q Consensus       232 ~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~  311 (982)
                      .++.++..++.  .|+|++|.+. .  ..+..+.+|+.|....|+++...    -..++|+.|+.++|.++...+. + .
T Consensus       171 ~~~~~i~~l~~--~ldLr~N~~~-~--~dls~~~~l~~l~c~rn~ls~l~----~~g~~l~~L~a~~n~l~~~~~~-p-~  239 (1081)
T KOG0618|consen  171 SFLIDIYNLTH--QLDLRYNEME-V--LDLSNLANLEVLHCERNQLSELE----ISGPSLTALYADHNPLTTLDVH-P-V  239 (1081)
T ss_pred             chhcchhhhhe--eeecccchhh-h--hhhhhccchhhhhhhhcccceEE----ecCcchheeeeccCcceeeccc-c-c
Confidence            77777887777  7999999997 2  35788899999999999998432    2347899999999999843332 2 2


Q ss_pred             ccchhhhhhccCCCCCCCCCcCCCCCCccEEEccCCCcccccCccccCCCcccEEEeccccccccCCccccCccccceee
Q 002010          312 LKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDLCKGGKLKSLI  391 (982)
Q Consensus       312 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~  391 (982)
                      -.+|+++++++|+++ .+|++++.+.+|+.++..+|+++ .+|..+...++|+.|++..|.++ .+|....+++.|+.|+
T Consensus       240 p~nl~~~dis~n~l~-~lp~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLd  316 (1081)
T KOG0618|consen  240 PLNLQYLDISHNNLS-NLPEWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLD  316 (1081)
T ss_pred             cccceeeecchhhhh-cchHHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeeee
Confidence            358999999999999 46699999999999999999996 78999999999999999999998 8888899999999999


Q ss_pred             cccccccccCCccccCCCC-CCEEEccCCccCCCCC-ccccCCCccccccCCCccccccCCccccc-CCccEEEeecccc
Q 002010          392 LMQNFFIGPIPEELGQCKS-LTKIRFSKNYLNGTIP-AGLFNLPLLNMMELDDNLLSGELPEKMSG-ASLNQLKVANNNI  468 (982)
Q Consensus       392 l~~N~~~~~~~~~l~~l~~-L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~-~~L~~L~L~~N~i  468 (982)
                      |..|++....+..+..... |..|..+.|++. ..| .+-...+.|+.|.+.+|.++....+.+.+ ..|+.|+|++|++
T Consensus       317 L~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~-~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL  395 (1081)
T KOG0618|consen  317 LQSNNLPSLPDNFLAVLNASLNTLNVSSNKLS-TLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRL  395 (1081)
T ss_pred             ehhccccccchHHHhhhhHHHHHHhhhhcccc-ccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeeccccc
Confidence            9999988666666666554 889999999998 444 23345778999999999999877666655 8899999999999


Q ss_pred             CCCCchhccCCCCcceeeeccccccCCCccccccccccceeeeeccccCCCCCcccccccCCCeeeCCCCcccCCCCccc
Q 002010          469 TGKIPAAIGNLPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYGKIPPGI  548 (982)
Q Consensus       469 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~  548 (982)
                      .......+.++..|++|+||+|+|+ .+|..+.+++.|++|...+|+|. ..| .+.+++.|+.+|+|.|+|+...-..-
T Consensus       396 ~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~  472 (1081)
T KOG0618|consen  396 NSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEA  472 (1081)
T ss_pred             ccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhh
Confidence            9777788999999999999999999 89999999999999999999999 778 89999999999999999985543333


Q ss_pred             ccccccceEEcccccccccCccccccccccceecccCCccccCCCCCc
Q 002010          549 SKLIDLSILNLSRNGITGSIPNEMRNMMSLTTLDLSYNNLIGNIPSGG  596 (982)
Q Consensus       549 ~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~~  596 (982)
                      ..-++|++|||++|.=.-.....|..+.++..++++-|    .+|.+.
T Consensus       473 ~p~p~LkyLdlSGN~~l~~d~~~l~~l~~l~~~~i~~~----~~~d~~  516 (1081)
T KOG0618|consen  473 LPSPNLKYLDLSGNTRLVFDHKTLKVLKSLSQMDITLN----NTPDGN  516 (1081)
T ss_pred             CCCcccceeeccCCcccccchhhhHHhhhhhheecccC----CCCccc
Confidence            33389999999999743355667888888888888877    455543

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.8e-35  Score=314.12  Aligned_cols=250  Identities=33%  Similarity=0.471  Sum_probs=206.9

Q ss_pred             hhcccccccccccceEEEEEEeCCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEecc
Q 002010          692 ESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYM  771 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  771 (982)
                      +.|+..+.||+|+||.||+|.. .|+.||+|.+.....  ..+.+.+|+.++++++|+||+++++++.+.+..++||||+
T Consensus         6 ~~~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   82 (256)
T cd05039           6 KELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDST--AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM   82 (256)
T ss_pred             hhccceeeeecCCCceEEEEEe-cCcEEEEEEeccchh--HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence            4678889999999999999986 588999999854432  4567899999999999999999999999889999999999


Q ss_pred             CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCcc
Q 002010          772 PNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASE  851 (982)
Q Consensus       772 ~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~  851 (982)
                      ++++|.+++.......+++..+..++.|++.|++|||+.+   ++||||||+||+++.++.+||+|||.++......   
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~---  156 (256)
T cd05039          83 AKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ---  156 (256)
T ss_pred             CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEccccccccccccc---
Confidence            9999999997655557999999999999999999999988   9999999999999999999999999998663221   


Q ss_pred             cccccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceeec
Q 002010          852 CMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVD  930 (982)
Q Consensus       852 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  930 (982)
                        .....+..|+|||++....++.++||||+|+++|||++ |..||..... ......+.....                
T Consensus       157 --~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-~~~~~~~~~~~~----------------  217 (256)
T cd05039         157 --DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-KDVVPHVEKGYR----------------  217 (256)
T ss_pred             --ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH-HHHHHHHhcCCC----------------
Confidence              12334568999999988889999999999999999998 9999976432 222222211100                


Q ss_pred             CCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 002010          931 PRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANP  972 (982)
Q Consensus       931 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~  972 (982)
                         ...+...+..+.+++.+||+.+|++|||++|++++|+.+
T Consensus       218 ---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  256 (256)
T cd05039         218 ---MEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI  256 (256)
T ss_pred             ---CCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence               011223346789999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=1.8e-35  Score=326.94  Aligned_cols=241  Identities=25%  Similarity=0.338  Sum_probs=192.8

Q ss_pred             cccccccceEEEEEEeC-CCcEEEEEEeccCCC--CCchhhHHHHHHHHhcC-CCCcccceEeEEEcCCccEEEEeccCC
Q 002010          698 NIIGKGGAGIVYRGSMP-DGIDVAIKRLVGRGT--GGNDHGFLAEIQTLGRI-RHRNIVRLLGYVSNRDTNLLLYEYMPN  773 (982)
Q Consensus       698 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  773 (982)
                      +.||+|+||.||+|..+ +|+.||+|.+.....  .........|..++... +||+|+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            46999999999999764 688999999854321  23344566788787654 899999999999999999999999999


Q ss_pred             CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCcccc
Q 002010          774 GSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECM  853 (982)
Q Consensus       774 ~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~  853 (982)
                      ++|..++.  +...+++..+..++.|++.|++|||+.+   |+||||||+||+++.++.+||+|||+++.....  ....
T Consensus        81 g~L~~~i~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~  153 (316)
T cd05620          81 GDLMFHIQ--DKGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG--DNRA  153 (316)
T ss_pred             CcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccC--CCce
Confidence            99999986  3457899999999999999999999988   999999999999999999999999998743211  1223


Q ss_pred             cccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceeecCCC
Q 002010          854 SSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDPRL  933 (982)
Q Consensus       854 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  933 (982)
                      ....||+.|+|||++.+..++.++||||+||++|||++|+.||...... .....+....                    
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~-~~~~~~~~~~--------------------  212 (316)
T cd05620         154 STFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED-ELFESIRVDT--------------------  212 (316)
T ss_pred             eccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH-HHHHHHHhCC--------------------
Confidence            4567899999999999999999999999999999999999999754322 2222221111                    


Q ss_pred             CCCChHhHHHHHHHHhhccCCCCCCCCCHH-HHH
Q 002010          934 SGYPLTGVIHLFKVAMMCVEDESSARPTMR-EVV  966 (982)
Q Consensus       934 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~-ell  966 (982)
                      ...+.....++.+++.+||+.||++||++. ++.
T Consensus       213 ~~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         213 PHYPRWITKESKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             CCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence            011222344688999999999999999985 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=1.7e-35  Score=327.63  Aligned_cols=242  Identities=24%  Similarity=0.319  Sum_probs=195.3

Q ss_pred             cccccccceEEEEEEeC-CCcEEEEEEeccCC--CCCchhhHHHHHHHHhcC-CCCcccceEeEEEcCCccEEEEeccCC
Q 002010          698 NIIGKGGAGIVYRGSMP-DGIDVAIKRLVGRG--TGGNDHGFLAEIQTLGRI-RHRNIVRLLGYVSNRDTNLLLYEYMPN  773 (982)
Q Consensus       698 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  773 (982)
                      +.||+|+||.||+|... +++.||+|++....  .......+.+|..+++.+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            36899999999999654 57899999986432  223345677888888887 699999999999999999999999999


Q ss_pred             CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCcccc
Q 002010          774 GSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECM  853 (982)
Q Consensus       774 ~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~  853 (982)
                      ++|..++.  +...+++..+..++.|++.|++|||+.+   |+||||||+||++++++.+||+|||+++.....  ....
T Consensus        81 ~~L~~~~~--~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~--~~~~  153 (318)
T cd05570          81 GDLMFHIQ--RSGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILG--GVTT  153 (318)
T ss_pred             CCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcC--CCcc
Confidence            99999886  3457999999999999999999999988   999999999999999999999999998753221  1122


Q ss_pred             cccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceeecCCC
Q 002010          854 SSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDPRL  933 (982)
Q Consensus       854 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  933 (982)
                      ....|++.|+|||++.+..++.++||||+||++|+|++|+.||...... .....+.....                   
T Consensus       154 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~-~~~~~i~~~~~-------------------  213 (318)
T cd05570         154 STFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED-ELFQSILEDEV-------------------  213 (318)
T ss_pred             cceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH-HHHHHHHcCCC-------------------
Confidence            3456899999999999999999999999999999999999999754322 22111111000                   


Q ss_pred             CCCChHhHHHHHHHHhhccCCCCCCCCCH-----HHHHH
Q 002010          934 SGYPLTGVIHLFKVAMMCVEDESSARPTM-----REVVH  967 (982)
Q Consensus       934 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~-----~ell~  967 (982)
                       ..+...+..+.+++.+||+.||.+||++     .++++
T Consensus       214 -~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~  251 (318)
T cd05570         214 -RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG  251 (318)
T ss_pred             -CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence             1122334578899999999999999999     77765

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6e-36  Score=336.88  Aligned_cols=252  Identities=25%  Similarity=0.264  Sum_probs=203.9

Q ss_pred             hcccccccccccceEEEEEEeC-CCcEEEEEEeccCC--CCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEe
Q 002010          693 SLKDENIIGKGGAGIVYRGSMP-DGIDVAIKRLVGRG--TGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYE  769 (982)
Q Consensus       693 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  769 (982)
                      +|+..+.||+|+||+||+|... +++.||+|++....  .......+.+|+.++..++||||+++++++.+++..++|||
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (350)
T cd05573           2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVME   81 (350)
T ss_pred             CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEc
Confidence            5788899999999999999754 68999999985432  22345568899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccC-
Q 002010          770 YMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAG-  848 (982)
Q Consensus       770 ~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-  848 (982)
                      |+++++|.+++...  ..+++..+..++.||+.||+|||+.+   |+||||||+||+++.++.+||+|||++....... 
T Consensus        82 ~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~  156 (350)
T cd05573          82 YMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKD  156 (350)
T ss_pred             CCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCcccCc
Confidence            99999999999743  67899999999999999999999988   9999999999999999999999999998765332 


Q ss_pred             --------------------------CcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCC
Q 002010          849 --------------------------ASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDG  902 (982)
Q Consensus       849 --------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~  902 (982)
                                                .........||+.|+|||++.+..++.++||||+||++|||++|+.||......
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~  236 (350)
T cd05573         157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQ  236 (350)
T ss_pred             ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHH
Confidence                                      011223457899999999999999999999999999999999999999765432


Q ss_pred             chHHHHHHHhccCCCCCCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCC-HHHHHH
Q 002010          903 VDIVRWVRKTTSEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPT-MREVVH  967 (982)
Q Consensus       903 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt-~~ell~  967 (982)
                      ........ ......               ++. ....+..+.+++.+|+. ||.+||+ ++|+++
T Consensus       237 ~~~~~i~~-~~~~~~---------------~p~-~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~  284 (350)
T cd05573         237 ETYNKIIN-WKESLR---------------FPP-DPPVSPEAIDLICRLLC-DPEDRLGSFEEIKS  284 (350)
T ss_pred             HHHHHHhc-cCCccc---------------CCC-CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhc
Confidence            22222111 001000               000 01134578899999997 9999999 999987

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=4.4e-35  Score=314.54  Aligned_cols=248  Identities=25%  Similarity=0.387  Sum_probs=197.8

Q ss_pred             ccccccceEEEEEEe---CCCcEEEEEEeccCCC-CCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEeccCCC
Q 002010          699 IIGKGGAGIVYRGSM---PDGIDVAIKRLVGRGT-GGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNG  774 (982)
Q Consensus       699 ~lg~G~~g~Vy~~~~---~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~  774 (982)
                      .||+|+||.||+|.+   .++..||+|++..... ....+++.+|+.+++.++||||+++++++. .+..++||||++++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence            589999999999954   3578899998753322 223457889999999999999999999875 45678999999999


Q ss_pred             CHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCc-ccc
Q 002010          775 SLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS-ECM  853 (982)
Q Consensus       775 sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~-~~~  853 (982)
                      +|.+++.  +...+++..+..++.|++.|++|+|+.+   |+||||||+||++++++.+||+|||++..+...... ...
T Consensus        81 ~L~~~l~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  155 (257)
T cd05116          81 PLNKFLQ--KNKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAK  155 (257)
T ss_pred             cHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeec
Confidence            9999996  3357899999999999999999999988   999999999999999999999999999876433211 111


Q ss_pred             cccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceeecCC
Q 002010          854 SSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDPR  932 (982)
Q Consensus       854 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  932 (982)
                      ....++..|+|||.+....++.++||||+||++|||++ |..||..... ......+.....                  
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-~~~~~~i~~~~~------------------  216 (257)
T cd05116         156 THGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG-NEVTQMIESGER------------------  216 (257)
T ss_pred             CCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHHHCCCC------------------
Confidence            22334578999999988889999999999999999998 9999976433 223333222111                  


Q ss_pred             CCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 002010          933 LSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANP  972 (982)
Q Consensus       933 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~  972 (982)
                       ...+...+..+.+++.+||+.||++||++++|++.|+..
T Consensus       217 -~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~  255 (257)
T cd05116         217 -MECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY  255 (257)
T ss_pred             -CCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence             012223445789999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=2.3e-35  Score=325.94  Aligned_cols=241  Identities=24%  Similarity=0.346  Sum_probs=192.5

Q ss_pred             cccccccceEEEEEEeC-CCcEEEEEEeccCC--CCCchhhHHHHHHHHhcC-CCCcccceEeEEEcCCccEEEEeccCC
Q 002010          698 NIIGKGGAGIVYRGSMP-DGIDVAIKRLVGRG--TGGNDHGFLAEIQTLGRI-RHRNIVRLLGYVSNRDTNLLLYEYMPN  773 (982)
Q Consensus       698 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  773 (982)
                      +.||+|+||.||+|+.. +++.||+|++....  .......+..|..++... +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            36899999999999764 57899999985542  223345566788887764 899999999999999999999999999


Q ss_pred             CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCcccc
Q 002010          774 GSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECM  853 (982)
Q Consensus       774 ~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~  853 (982)
                      |+|.+++.  +...+++.++..++.|++.|++|||+.+   |+||||||+||+++.++.+||+|||++......  ....
T Consensus        81 g~L~~~l~--~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~  153 (316)
T cd05619          81 GDLMFHIQ--SCHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLG--DAKT  153 (316)
T ss_pred             CcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCC--CCce
Confidence            99999996  3457899999999999999999999988   999999999999999999999999998753211  1122


Q ss_pred             cccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceeecCCC
Q 002010          854 SSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDPRL  933 (982)
Q Consensus       854 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  933 (982)
                      ....||+.|+|||++.+..++.++||||+||++|||++|+.||..... ......+.....                   
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~-~~~~~~i~~~~~-------------------  213 (316)
T cd05619         154 CTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE-EELFQSIRMDNP-------------------  213 (316)
T ss_pred             eeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhCCC-------------------
Confidence            345789999999999998999999999999999999999999976432 222222211110                   


Q ss_pred             CCCChHhHHHHHHHHhhccCCCCCCCCCHH-HHH
Q 002010          934 SGYPLTGVIHLFKVAMMCVEDESSARPTMR-EVV  966 (982)
Q Consensus       934 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~-ell  966 (982)
                       ..+......+.+++.+||+.||++||++. ++.
T Consensus       214 -~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05619         214 -CYPRWLTREAKDILVKLFVREPERRLGVKGDIR  246 (316)
T ss_pred             -CCCccCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence             01122334678999999999999999997 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=2.7e-35  Score=332.37  Aligned_cols=253  Identities=22%  Similarity=0.248  Sum_probs=201.0

Q ss_pred             HhhcccccccccccceEEEEEEe-CCCcEEEEEEeccCC--CCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEE
Q 002010          691 LESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRG--TGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLL  767 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  767 (982)
                      .++|+..+.||+|+||.||+|.. .+++.||+|++....  .......+.+|+.+++.++||||+++++++.++...++|
T Consensus        42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv  121 (370)
T cd05596          42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMV  121 (370)
T ss_pred             HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence            45788999999999999999965 468899999985422  223344577899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhcccc
Q 002010          768 YEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDA  847 (982)
Q Consensus       768 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  847 (982)
                      |||+++|+|.+++..   ..+++..+..++.||+.|++|||+.+   |+||||||+||+++.++.+||+|||++......
T Consensus       122 ~Ey~~gg~L~~~l~~---~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~  195 (370)
T cd05596         122 MEYMPGGDLVNLMSN---YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN  195 (370)
T ss_pred             EcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeeccCC
Confidence            999999999999863   35788899999999999999999988   999999999999999999999999999865432


Q ss_pred             CCcccccccccccccccccccccC----CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCccc
Q 002010          848 GASECMSSVAGSYGYIAPEYAYTL----KVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAA  923 (982)
Q Consensus       848 ~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  923 (982)
                      . ........||+.|+|||++.+.    .++.++||||+||++|||++|+.||...........+... ......+    
T Consensus       196 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~-~~~~~~~----  269 (370)
T cd05596         196 G-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDH-KNSLTFP----  269 (370)
T ss_pred             C-cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcC-CCcCCCC----
Confidence            2 1122346799999999988653    3789999999999999999999999764432222222111 0000000    


Q ss_pred             ccceeecCCCCCCChHhHHHHHHHHhhccCCCCCC--CCCHHHHHH
Q 002010          924 SVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSA--RPTMREVVH  967 (982)
Q Consensus       924 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--Rpt~~ell~  967 (982)
                                  .....+..+.+++.+|++.+|.+  |||++|+++
T Consensus       270 ------------~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~  303 (370)
T cd05596         270 ------------DDIEISKQAKDLICAFLTDREVRLGRNGVDEIKS  303 (370)
T ss_pred             ------------CcCCCCHHHHHHHHHHccChhhccCCCCHHHHhc
Confidence                        01123457889999999999998  999999975

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=3.5e-35  Score=320.23  Aligned_cols=268  Identities=27%  Similarity=0.368  Sum_probs=204.5

Q ss_pred             cccccccccccceEEEEEEe-----CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcC--CccEE
Q 002010          694 LKDENIIGKGGAGIVYRGSM-----PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNR--DTNLL  766 (982)
Q Consensus       694 ~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~l  766 (982)
                      |+..+.||+|+||+||++..     .++..||+|.+...........+.+|+.++++++||||+++++++...  ...++
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL   85 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence            37788999999999988642     357889999986554444556788999999999999999999987653  35789


Q ss_pred             EEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccc
Q 002010          767 LYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQD  846 (982)
Q Consensus       767 v~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  846 (982)
                      ||||+++++|.+++..   ..+++..+..++.|++.|++|||+.+   |+||||||+||++++++.+||+|||++..+..
T Consensus        86 v~e~~~~~~l~~~~~~---~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~  159 (283)
T cd05080          86 IMEYVPLGSLRDYLPK---HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE  159 (283)
T ss_pred             EecCCCCCCHHHHHHH---cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccCC
Confidence            9999999999999963   35899999999999999999999988   99999999999999999999999999987653


Q ss_pred             cCCccc-ccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCccccc
Q 002010          847 AGASEC-MSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASV  925 (982)
Q Consensus       847 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  925 (982)
                      ...... .....++..|+|||...+..++.++||||+|+++|||++|..||......  +.........    .......
T Consensus       160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~--~~~~~~~~~~----~~~~~~~  233 (283)
T cd05080         160 GHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKK--FEEMIGPKQG----QMTVVRL  233 (283)
T ss_pred             cchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcch--hhhhhccccc----ccchhhh
Confidence            221111 12234566799999998888999999999999999999999998653321  1111110000    0000111


Q ss_pred             ceeecCCC-CCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 002010          926 LAVVDPRL-SGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPP  973 (982)
Q Consensus       926 ~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~  973 (982)
                      ....+... ...+...+..+.+++.+||+.||++|||++++++.|+++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         234 IELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             hhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            11111111 1234455678999999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-35  Score=335.52  Aligned_cols=252  Identities=23%  Similarity=0.285  Sum_probs=199.1

Q ss_pred             hcccccccccccceEEEEEEe-CCCcEEEEEEeccCC--CCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEe
Q 002010          693 SLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRG--TGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYE  769 (982)
Q Consensus       693 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  769 (982)
                      +|+..+.||+|+||.||+|+. .+++.||||++....  .......+.+|+.+++.++||||+++++++.+++..++|||
T Consensus         2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E   81 (364)
T cd05599           2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIME   81 (364)
T ss_pred             CceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEEC
Confidence            578889999999999999965 468999999985432  12334567889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCC
Q 002010          770 YMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGA  849 (982)
Q Consensus       770 ~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  849 (982)
                      |+++|+|.+++.  +...+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++..+.....
T Consensus        82 ~~~~g~L~~~l~--~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~  156 (364)
T cd05599          82 YLPGGDMMTLLM--KKDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHR  156 (364)
T ss_pred             CCCCcHHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecccccc
Confidence            999999999997  3457999999999999999999999988   99999999999999999999999999875432110


Q ss_pred             cc------------------------------------cccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCC
Q 002010          850 SE------------------------------------CMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGK  893 (982)
Q Consensus       850 ~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~  893 (982)
                      ..                                    ......||+.|+|||++.+..++.++||||+||++|||++|.
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~  236 (364)
T cd05599         157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGY  236 (364)
T ss_pred             ccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCC
Confidence            00                                    011246899999999999999999999999999999999999


Q ss_pred             CCCCCCCCCchHHHHHHHhccCCCCCCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCC---HHHHHH
Q 002010          894 KPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPT---MREVVH  967 (982)
Q Consensus       894 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt---~~ell~  967 (982)
                      .||......... ..+.........+.                ....+..+.+++.+|+. +|.+|++   ++|+++
T Consensus       237 ~Pf~~~~~~~~~-~~i~~~~~~~~~~~----------------~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~  295 (364)
T cd05599         237 PPFCSDNPQETY-RKIINWKETLQFPD----------------EVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS  295 (364)
T ss_pred             CCCCCCCHHHHH-HHHHcCCCccCCCC----------------CCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence            999764332221 11111111000000                01123467889999996 9999998   888876

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=4.4e-35  Score=323.57  Aligned_cols=269  Identities=19%  Similarity=0.270  Sum_probs=203.8

Q ss_pred             hhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEec
Q 002010          692 ESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEY  770 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  770 (982)
                      +.|+..+.||+|+||.||+|.. .+++.||+|++...........+.+|+.++++++||||+++++++..++..++||||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   85 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY   85 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence            4688889999999999999965 467889999986554444555678999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCc
Q 002010          771 MPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS  850 (982)
Q Consensus       771 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  850 (982)
                      +++ +|.+++... ...+++..+..++.|++.|++|||+.+   |+||||||+||+++.++.+||+|||++......  .
T Consensus        86 ~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~--~  158 (309)
T cd07872          86 LDK-DLKQYMDDC-GNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVP--T  158 (309)
T ss_pred             CCC-CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCC--c
Confidence            964 888887643 345889999999999999999999988   999999999999999999999999999754322  1


Q ss_pred             cccccccccccccccccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCc----cccc
Q 002010          851 ECMSSVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSD----AASV  925 (982)
Q Consensus       851 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~  925 (982)
                      .......+++.|+|||++.+ ..++.++||||+||++|||++|++||......+......+...........    ....
T Consensus       159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (309)
T cd07872         159 KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEF  238 (309)
T ss_pred             cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhh
Confidence            22234567889999998865 458899999999999999999999997654433333333222211110000    0000


Q ss_pred             ceeecCCCC-----CCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          926 LAVVDPRLS-----GYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       926 ~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                      ...-.+...     ......+.++.+++.+|++.||++|||++|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         239 KNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK  285 (309)
T ss_pred             hhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence            000000000     011223456789999999999999999999887

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=4.3e-35  Score=314.49  Aligned_cols=250  Identities=26%  Similarity=0.397  Sum_probs=205.4

Q ss_pred             cccccccccccceEEEEEEe-CCCcEEEEEEeccC-CCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEecc
Q 002010          694 LKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGR-GTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYM  771 (982)
Q Consensus       694 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  771 (982)
                      |+..+.||+|++|.||+|.. .+++.|++|.+... ........+.+|+.++++++||||+++++++.+++..++||||+
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   81 (256)
T cd08529           2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYA   81 (256)
T ss_pred             ceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeC
Confidence            66778899999999999965 46899999988543 23345567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCcc
Q 002010          772 PNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASE  851 (982)
Q Consensus       772 ~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~  851 (982)
                      ++++|.+++.......+++..+..++.|++.|+.|||+.+   ++||||+|+||++++++.++++|||++..+....  .
T Consensus        82 ~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~--~  156 (256)
T cd08529          82 ENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT--N  156 (256)
T ss_pred             CCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCcc--c
Confidence            9999999998655678999999999999999999999988   9999999999999999999999999988665332  1


Q ss_pred             cccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceeecC
Q 002010          852 CMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDP  931 (982)
Q Consensus       852 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  931 (982)
                      ......+++.|+|||+..+..++.++|+||+|+++|||++|+.||...... .........                   
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~-------------------  216 (256)
T cd08529         157 FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG-ALILKIIRG-------------------  216 (256)
T ss_pred             hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHcC-------------------
Confidence            223456788999999999988999999999999999999999999764322 111111110                   


Q ss_pred             CCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002010          932 RLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHM  968 (982)
Q Consensus       932 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~  968 (982)
                      ..+..+...+..+.+++.+||+.+|++||++.|+++.
T Consensus       217 ~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         217 VFPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             CCCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence            0111222344578999999999999999999999863

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=3.3e-35  Score=348.74  Aligned_cols=265  Identities=23%  Similarity=0.271  Sum_probs=204.8

Q ss_pred             hhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCC--CchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEE
Q 002010          692 ESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTG--GNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLY  768 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  768 (982)
                      ++|+..+.||+|+||.||+|.. .+++.||+|++......  ...+++.+|+.++++++||||+++++++.+.+..++||
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            4688899999999999999965 45899999998543322  23457889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhcCC---------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccc
Q 002010          769 EYMPNGSLGEMLHGAK---------GGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFG  839 (982)
Q Consensus       769 e~~~~~sL~~~l~~~~---------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG  839 (982)
                      ||++|++|.+++....         ....++..+.+++.||++|++|||+.+   |+||||||+||+++.++.+||+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence            9999999999986321         234567788999999999999999988   9999999999999999999999999


Q ss_pred             cchhccccCC----------------cccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCc
Q 002010          840 LAKFLQDAGA----------------SECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGV  903 (982)
Q Consensus       840 ~a~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~  903 (982)
                      ++........                ........||+.|+|||++.+..++.++||||+||++|||+||+.||.......
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k  238 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK  238 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence            9986621100                011123468999999999999999999999999999999999999997632211


Q ss_pred             hHHHHHHHhccCCCCCCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCC-CHHHHHHHhcCCCCCCC
Q 002010          904 DIVRWVRKTTSEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARP-TMREVVHMLANPPQSAP  977 (982)
Q Consensus       904 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-t~~ell~~L~~~~~~~~  977 (982)
                      ...   .....   .+.            ........+..+.+++.+|++.||++|| +++++++.|+...+..|
T Consensus       239 i~~---~~~i~---~P~------------~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~~p  295 (932)
T PRK13184        239 ISY---RDVIL---SPI------------EVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQGSP  295 (932)
T ss_pred             hhh---hhhcc---Chh------------hccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcCc
Confidence            100   00000   000            0000112345688999999999999996 66778887776655443

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.3e-35  Score=314.61  Aligned_cols=253  Identities=27%  Similarity=0.401  Sum_probs=203.4

Q ss_pred             hhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCCC----chhhHHHHHHHHhcCCCCcccceEeEEEcCCccEE
Q 002010          692 ESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGG----NDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLL  766 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  766 (982)
                      +.|+..+.||+|++|.||+|.. .++++||+|.+.......    ....+.+|+.++++++||||+++++++.+++..++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            4688889999999999999964 568999999885433221    23467889999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccc
Q 002010          767 LYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQD  846 (982)
Q Consensus       767 v~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  846 (982)
                      ||||+++++|.+++..  ...+++..+..++.|++.|++|||+.+   |+||||+|+||++++++.++|+|||++.....
T Consensus        82 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~  156 (263)
T cd06625          82 FMEYMPGGSVKDQLKA--YGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQT  156 (263)
T ss_pred             EEEECCCCcHHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceeccc
Confidence            9999999999999873  356889999999999999999999988   99999999999999999999999999876543


Q ss_pred             cCCccc-ccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCccccc
Q 002010          847 AGASEC-MSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASV  925 (982)
Q Consensus       847 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  925 (982)
                      ...... .....++..|+|||++.+..++.++||||+|+++|||++|+.||............. ...            
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~-~~~------------  223 (263)
T cd06625         157 ICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIA-TQP------------  223 (263)
T ss_pred             cccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHh-ccC------------
Confidence            211111 123457889999999999889999999999999999999999997643322211111 100            


Q ss_pred             ceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002010          926 LAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHM  968 (982)
Q Consensus       926 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~  968 (982)
                            .....+...+..+.+++.+||+.+|++|||+.|+++.
T Consensus       224 ------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         224 ------TNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             ------CCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence                  0112233445578899999999999999999999863

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=6.7e-35  Score=314.03  Aligned_cols=250  Identities=28%  Similarity=0.482  Sum_probs=206.6

Q ss_pred             cccccccceEEEEEEeCC----CcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEeccCC
Q 002010          698 NIIGKGGAGIVYRGSMPD----GIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPN  773 (982)
Q Consensus       698 ~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  773 (982)
                      +.||+|+||.||+|....    +..|++|.+...........+.+|++.+..++|+||+++++++......++||||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            468999999999996643    8889999986554444467889999999999999999999999999999999999999


Q ss_pred             CCHHHHhhcCC-------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccc
Q 002010          774 GSLGEMLHGAK-------GGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQD  846 (982)
Q Consensus       774 ~sL~~~l~~~~-------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  846 (982)
                      ++|.+++....       ...+++..+..++.|++.|++|||+.+   |+||||+|+||++++++.+||+|||.+.....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence            99999997542       367999999999999999999999988   99999999999999999999999999987764


Q ss_pred             cCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHhccCCCCCCccccc
Q 002010          847 AGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASV  925 (982)
Q Consensus       847 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  925 (982)
                      ...........++..|+|||.+....++.++||||+|+++|||++ |..||..... ......+...             
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-~~~~~~~~~~-------------  223 (262)
T cd00192         158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN-EEVLEYLRKG-------------  223 (262)
T ss_pred             ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH-HHHHHHHHcC-------------
Confidence            432233344567889999999988889999999999999999999 6999976532 2222222211             


Q ss_pred             ceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 002010          926 LAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLA  970 (982)
Q Consensus       926 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~  970 (982)
                            .....+...+..+.+++.+||+.||++|||++|+++.|+
T Consensus       224 ------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         224 ------YRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             ------CCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence                  011122333567899999999999999999999999874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=6e-35  Score=313.52  Aligned_cols=250  Identities=26%  Similarity=0.441  Sum_probs=200.0

Q ss_pred             cccccccceEEEEEEeC--C--CcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEeccCC
Q 002010          698 NIIGKGGAGIVYRGSMP--D--GIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPN  773 (982)
Q Consensus       698 ~~lg~G~~g~Vy~~~~~--~--~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  773 (982)
                      +.||+|+||.||+|.+.  +  +..||+|.+.........+++.+|+.++++++||||+++++++. .+..++||||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            46999999999999542  2  36899998865544445567899999999999999999999876 4567999999999


Q ss_pred             CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCcc-c
Q 002010          774 GSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASE-C  852 (982)
Q Consensus       774 ~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~-~  852 (982)
                      ++|.+++..  ...+++..+..++.|++.|++|||+.+   ++||||||+||+++.++.+||+|||.++.+....... .
T Consensus        80 ~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~  154 (257)
T cd05060          80 GPLLKYLKK--RREIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRA  154 (257)
T ss_pred             CcHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCccccc
Confidence            999999974  347899999999999999999999988   9999999999999999999999999998765332111 1


Q ss_pred             ccccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceeecC
Q 002010          853 MSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDP  931 (982)
Q Consensus       853 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  931 (982)
                      .....++..|+|||...+..++.++||||+|+++|||++ |..||..... ......+.....                 
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~-~~~~~~~~~~~~-----------------  216 (257)
T cd05060         155 TTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG-AEVIAMLESGER-----------------  216 (257)
T ss_pred             ccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH-HHHHHHHHcCCc-----------------
Confidence            112223568999999998899999999999999999998 9999976533 233333322111                 


Q ss_pred             CCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 002010          932 RLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPP  973 (982)
Q Consensus       932 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~  973 (982)
                        ...+...+..+.+++.+||+.+|++||++.++++.|+++.
T Consensus       217 --~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~  256 (257)
T cd05060         217 --LPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP  256 (257)
T ss_pred             --CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence              0112233457889999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=6e-35  Score=315.72  Aligned_cols=257  Identities=28%  Similarity=0.515  Sum_probs=205.4

Q ss_pred             hhcccccccccccceEEEEEEeC-CC---cEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEE
Q 002010          692 ESLKDENIIGKGGAGIVYRGSMP-DG---IDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLL  767 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  767 (982)
                      +.|+..+.||+|+||.||+|..+ ++   ..+|+|.+.........+.+..|+.++++++||||+++++++...+..++|
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (268)
T cd05063           5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII   84 (268)
T ss_pred             HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence            46778889999999999999754 23   379999885544444456788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhcccc
Q 002010          768 YEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDA  847 (982)
Q Consensus       768 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  847 (982)
                      |||+++++|.+++... ...+++..+..++.|++.|++|||+.+   ++||||||+||++++++.+|++|||++......
T Consensus        85 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~  160 (268)
T cd05063          85 TEYMENGALDKYLRDH-DGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLEDD  160 (268)
T ss_pred             EEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceecccc
Confidence            9999999999999742 357899999999999999999999988   999999999999999999999999999766432


Q ss_pred             CCccc-ccccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHhccCCCCCCccccc
Q 002010          848 GASEC-MSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASV  925 (982)
Q Consensus       848 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  925 (982)
                      ..... ......+..|+|||++.+..++.++||||+||++|||++ |+.||...... .....+..... .         
T Consensus       161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~-~~~~~i~~~~~-~---------  229 (268)
T cd05063         161 PEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH-EVMKAINDGFR-L---------  229 (268)
T ss_pred             cccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH-HHHHHHhcCCC-C---------
Confidence            21111 111223457999999998889999999999999999998 99999764332 22222221110 0         


Q ss_pred             ceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 002010          926 LAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANP  972 (982)
Q Consensus       926 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~  972 (982)
                               ..+...+..+.+++.+||+.+|++||++.+|++.|+++
T Consensus       230 ---------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         230 ---------PAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             ---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                     01122345789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=3.2e-35  Score=327.04  Aligned_cols=247  Identities=20%  Similarity=0.272  Sum_probs=195.2

Q ss_pred             cccccccceEEEEEEe-CCCcEEEEEEeccCCC--CCchhhHHHHHHHHhcC-CCCcccceEeEEEcCCccEEEEeccCC
Q 002010          698 NIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGT--GGNDHGFLAEIQTLGRI-RHRNIVRLLGYVSNRDTNLLLYEYMPN  773 (982)
Q Consensus       698 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  773 (982)
                      +.||+|+||.||+|.. .+++.||+|++.....  ......+.+|..++.++ +||||+++++++.++...++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            3689999999999965 4688999999865322  22345578899999888 799999999999999999999999999


Q ss_pred             CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCcccc
Q 002010          774 GSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECM  853 (982)
Q Consensus       774 ~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~  853 (982)
                      |+|.+++.  +...+++..+..++.|++.|++|||+.+   |+||||||+||+++.++.+||+|||++......  ....
T Consensus        81 g~L~~~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--~~~~  153 (329)
T cd05588          81 GDLMFHMQ--RQRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP--GDTT  153 (329)
T ss_pred             CCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccC--CCcc
Confidence            99999886  3467999999999999999999999988   999999999999999999999999998743211  1223


Q ss_pred             cccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCc----hHHHHHHHhccCCCCCCcccccceee
Q 002010          854 SSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGV----DIVRWVRKTTSEVSQPSDAASVLAVV  929 (982)
Q Consensus       854 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~  929 (982)
                      ....||+.|+|||++.+..++.++||||+||++|||++|+.||.......    ....+......               
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~---------------  218 (329)
T cd05588         154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVIL---------------  218 (329)
T ss_pred             ccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHH---------------
Confidence            44678999999999999999999999999999999999999996422111    11111111110               


Q ss_pred             cCCCCCCChHhHHHHHHHHhhccCCCCCCCCC------HHHHHH
Q 002010          930 DPRLSGYPLTGVIHLFKVAMMCVEDESSARPT------MREVVH  967 (982)
Q Consensus       930 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt------~~ell~  967 (982)
                       ......|...+..+.+++.+||+.||.+||+      ++++++
T Consensus       219 -~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~  261 (329)
T cd05588         219 -EKQIRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS  261 (329)
T ss_pred             -cCCCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence             0001122334457889999999999999997      567764

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=4.3e-35  Score=316.94  Aligned_cols=257  Identities=30%  Similarity=0.491  Sum_probs=205.3

Q ss_pred             hhcccccccccccceEEEEEEeCC-C---cEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEE
Q 002010          692 ESLKDENIIGKGGAGIVYRGSMPD-G---IDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLL  767 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~~~-~---~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  767 (982)
                      ..|+..+.||+|+||.||+|.... +   ..||+|.+..........++..|+.++++++||||+++++++.++...++|
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv   83 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII   83 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence            457888999999999999997532 3   369999885544444556899999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhcccc
Q 002010          768 YEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDA  847 (982)
Q Consensus       768 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  847 (982)
                      |||+++++|.+++... ...+++.++..++.|++.|++|||+.+   ++||||||+||+++.++.+|++|||.+......
T Consensus        84 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~  159 (269)
T cd05065          84 TEFMENGALDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD  159 (269)
T ss_pred             EecCCCCcHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccccccC
Confidence            9999999999998743 356899999999999999999999988   999999999999999999999999998766432


Q ss_pred             CCcccccccc---cccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHhccCCCCCCccc
Q 002010          848 GASECMSSVA---GSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAA  923 (982)
Q Consensus       848 ~~~~~~~~~~---gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  923 (982)
                      ..........   .+..|+|||.+.+..++.++||||+||++|||++ |..||..... .....++.....   .     
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~-~~~~~~i~~~~~---~-----  230 (269)
T cd05065         160 TSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN-QDVINAIEQDYR---L-----  230 (269)
T ss_pred             ccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH-HHHHHHHHcCCc---C-----
Confidence            2111111111   2457999999998899999999999999999987 9999976432 223333321111   0     


Q ss_pred             ccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 002010          924 SVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANP  972 (982)
Q Consensus       924 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~  972 (982)
                                 ..+.+.+..+.+++.+||+.+|++||++++++..|+++
T Consensus       231 -----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         231 -----------PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             -----------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                       01123345788999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=7.5e-35  Score=312.57  Aligned_cols=249  Identities=29%  Similarity=0.439  Sum_probs=202.1

Q ss_pred             hhcccccccccccceEEEEEEeCCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEE-cCCccEEEEec
Q 002010          692 ESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVS-NRDTNLLLYEY  770 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-~~~~~~lv~e~  770 (982)
                      ++|+..+.||+|+||.||+|.. .|..||+|....   ....+.+.+|+.++++++|++++++++++. .+...++||||
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~   81 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKN---DATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   81 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCC---CchHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence            4678889999999999999976 578899998743   233557889999999999999999999754 45678999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCc
Q 002010          771 MPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS  850 (982)
Q Consensus       771 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  850 (982)
                      +++++|.+++.......+++..+..++.|++.|++|||+.+   |+||||||+||++++++.+|++|||.+......   
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~---  155 (256)
T cd05082          82 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---  155 (256)
T ss_pred             CCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceecccc---
Confidence            99999999998655556899999999999999999999988   999999999999999999999999998754322   


Q ss_pred             ccccccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceee
Q 002010          851 ECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVV  929 (982)
Q Consensus       851 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  929 (982)
                        .....++..|+|||++.+..++.++||||+||++|||++ |+.||..... ......+.....               
T Consensus       156 --~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~-~~~~~~~~~~~~---------------  217 (256)
T cd05082         156 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-KDVVPRVEKGYK---------------  217 (256)
T ss_pred             --CCCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHHhcCCC---------------
Confidence              122334568999999998889999999999999999998 9999865322 222222211100               


Q ss_pred             cCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 002010          930 DPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANP  972 (982)
Q Consensus       930 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~  972 (982)
                          ...+...+..+.+++.+||+.||++|||++++++.|+++
T Consensus       218 ----~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         218 ----MDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             ----CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence                011223455788999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=3.8e-35  Score=327.63  Aligned_cols=262  Identities=26%  Similarity=0.401  Sum_probs=208.0

Q ss_pred             hhcccccccccccceEEEEEEeC--------CCcEEEEEEeccCCCCCchhhHHHHHHHHhcC-CCCcccceEeEEEcCC
Q 002010          692 ESLKDENIIGKGGAGIVYRGSMP--------DGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRI-RHRNIVRLLGYVSNRD  762 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~  762 (982)
                      .+|++.+.||+|+||.||+|+..        ++..||+|.+..........++.+|+.+++++ +||||+++++++..++
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG   91 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence            46888999999999999999642        12468999875544444556789999999999 7999999999999999


Q ss_pred             ccEEEEeccCCCCHHHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEc
Q 002010          763 TNLLLYEYMPNGSLGEMLHGAK--------------GGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLD  828 (982)
Q Consensus       763 ~~~lv~e~~~~~sL~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~  828 (982)
                      ..+++|||+++++|.+++....              ...+++.++..++.|++.|++|||+.+   |+||||||+||+++
T Consensus        92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill~  168 (334)
T cd05100          92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLVT  168 (334)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEc
Confidence            9999999999999999997432              235788999999999999999999988   99999999999999


Q ss_pred             CCCCEEEeccccchhccccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHH
Q 002010          829 SDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVR  907 (982)
Q Consensus       829 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~  907 (982)
                      +++.+||+|||+++...............++..|+|||++.+..++.++||||+|+++|||++ |..||..... .+...
T Consensus       169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-~~~~~  247 (334)
T cd05100         169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV-EELFK  247 (334)
T ss_pred             CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH-HHHHH
Confidence            999999999999986543322222222334568999999999999999999999999999999 8888865432 22222


Q ss_pred             HHHHhccCCCCCCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCCCC
Q 002010          908 WVRKTTSEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQSA  976 (982)
Q Consensus       908 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~~~~  976 (982)
                      .+....                   ....+...+..+.+++.+||+.+|++|||+.|+++.|+.+....
T Consensus       248 ~~~~~~-------------------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~  297 (334)
T cd05100         248 LLKEGH-------------------RMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT  297 (334)
T ss_pred             HHHcCC-------------------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence            221110                   01112233457889999999999999999999999998777543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=1.3e-34  Score=312.80  Aligned_cols=259  Identities=22%  Similarity=0.343  Sum_probs=209.6

Q ss_pred             hhcccccccccccceEEEEEEeC-CCcEEEEEEeccCC--CCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEE
Q 002010          692 ESLKDENIIGKGGAGIVYRGSMP-DGIDVAIKRLVGRG--TGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLY  768 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  768 (982)
                      ++|+..+.||+|+||.||+|... +|+.||+|.+....  .....+.+.+|++++++++|++++++++++..++..++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            46888899999999999999764 78999999885332  2233567889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccc
Q 002010          769 EYMPNGSLGEMLHGA--KGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQD  846 (982)
Q Consensus       769 e~~~~~sL~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  846 (982)
                      ||+++++|.+++...  ....+++..+..++.|++.|++|||+.+   |+||||+|+||+++.++.++++|||.+.....
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~  158 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence            999999999998642  3456899999999999999999999988   99999999999999999999999999876543


Q ss_pred             cCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccc
Q 002010          847 AGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVL  926 (982)
Q Consensus       847 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  926 (982)
                      ..  .......+++.|+|||.+.+..++.++||||+|+++|+|++|+.||....  ....+........           
T Consensus       159 ~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--~~~~~~~~~~~~~-----------  223 (267)
T cd08224         159 KT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK--MNLYSLCKKIEKC-----------  223 (267)
T ss_pred             CC--cccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC--ccHHHHHhhhhcC-----------
Confidence            21  11233567889999999998889999999999999999999999986532  1122222111110           


Q ss_pred             eeecCCCCCCCh-HhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 002010          927 AVVDPRLSGYPL-TGVIHLFKVAMMCVEDESSARPTMREVVHMLANPP  973 (982)
Q Consensus       927 ~~~~~~~~~~~~-~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~  973 (982)
                           .....+. ..+..+.+++.+||+.+|++|||+.+|++.|+++.
T Consensus       224 -----~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         224 -----DYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             -----CCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence                 0111122 34457889999999999999999999999998765

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=2.1e-35  Score=327.84  Aligned_cols=242  Identities=24%  Similarity=0.296  Sum_probs=194.4

Q ss_pred             hcccccccccccceEEEEEEeC-CCcEEEEEEeccCCC--CCchhhHHHHHHHHhcC-CCCcccceEeEEEcCCccEEEE
Q 002010          693 SLKDENIIGKGGAGIVYRGSMP-DGIDVAIKRLVGRGT--GGNDHGFLAEIQTLGRI-RHRNIVRLLGYVSNRDTNLLLY  768 (982)
Q Consensus       693 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~  768 (982)
                      +|+..+.||+|+||.||+|... +++.||+|.+.....  ......+..|..++..+ .|++|+++++++...+..++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            3677889999999999999654 578999999864322  22334567788888777 5899999999999999999999


Q ss_pred             eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccC
Q 002010          769 EYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAG  848 (982)
Q Consensus       769 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  848 (982)
                      ||+++|+|.+++.  +...+++..+..++.||+.|++|||+.+   |+||||||+||++++++.+||+|||++...... 
T Consensus        81 E~~~~g~L~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~-  154 (323)
T cd05616          81 EYVNGGDLMYQIQ--QVGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD-  154 (323)
T ss_pred             cCCCCCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCC-
Confidence            9999999999986  3457899999999999999999999988   999999999999999999999999998754321 


Q ss_pred             CcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCccccccee
Q 002010          849 ASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAV  928 (982)
Q Consensus       849 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  928 (982)
                       ........||+.|+|||++.+..++.++||||+||++|||++|+.||....... ....+.....              
T Consensus       155 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~-~~~~i~~~~~--------------  218 (323)
T cd05616         155 -GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE-LFQSIMEHNV--------------  218 (323)
T ss_pred             -CCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHH-HHHHHHhCCC--------------
Confidence             112334678999999999999999999999999999999999999997643322 2222211110              


Q ss_pred             ecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCH
Q 002010          929 VDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTM  962 (982)
Q Consensus       929 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~  962 (982)
                            .++...+.++.+++.+|++.||++|++.
T Consensus       219 ------~~p~~~s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         219 ------AYPKSMSKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             ------CCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence                  1222334578899999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=1.7e-35  Score=328.74  Aligned_cols=238  Identities=26%  Similarity=0.293  Sum_probs=189.5

Q ss_pred             cccccccceEEEEEEe-CCCcEEEEEEeccCC--CCCchhhHHHHHH-HHhcCCCCcccceEeEEEcCCccEEEEeccCC
Q 002010          698 NIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRG--TGGNDHGFLAEIQ-TLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPN  773 (982)
Q Consensus       698 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  773 (982)
                      +.||+|+||+||+|.. .+|+.||+|++....  .......+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            3689999999999965 468999999985432  1222334555555 46778999999999999999999999999999


Q ss_pred             CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCcccc
Q 002010          774 GSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECM  853 (982)
Q Consensus       774 ~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~  853 (982)
                      ++|.+++.  +...+++..+..++.||+.|++|||+.+   |+||||||+||+++.++.+||+|||++......  ....
T Consensus        81 g~L~~~l~--~~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~~  153 (323)
T cd05575          81 GELFFHLQ--RERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH--SKTT  153 (323)
T ss_pred             CCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccC--CCcc
Confidence            99999987  4457899999999999999999999988   999999999999999999999999998754322  2223


Q ss_pred             cccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceeecCCC
Q 002010          854 SSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDPRL  933 (982)
Q Consensus       854 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  933 (982)
                      ....||+.|+|||++.+..++.++||||+||++|||++|+.||.......    .........                 
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~----~~~~i~~~~-----------------  212 (323)
T cd05575         154 STFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAE----MYDNILNKP-----------------  212 (323)
T ss_pred             ccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHH----HHHHHHcCC-----------------
Confidence            44678999999999999999999999999999999999999997643221    111111100                 


Q ss_pred             CCCChHhHHHHHHHHhhccCCCCCCCCCHH
Q 002010          934 SGYPLTGVIHLFKVAMMCVEDESSARPTMR  963 (982)
Q Consensus       934 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~  963 (982)
                      ...+...+..+.+++.+|++.||.+||++.
T Consensus       213 ~~~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         213 LRLKPNISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             CCCCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence            011122345788999999999999999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=6.9e-35  Score=328.83  Aligned_cols=268  Identities=24%  Similarity=0.286  Sum_probs=200.3

Q ss_pred             HHHhhcccccccccccceEEEEEEe-CCCcEEEEEEeccCC-CCCchhhHHHHHHHHhcCCCCcccceEeEEEcCC----
Q 002010          689 DVLESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRG-TGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRD----  762 (982)
Q Consensus       689 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----  762 (982)
                      .+.++|+..+.||+|+||.||+|.. .+|..||+|++.... .......+.+|+.+++.++||||+++++++....    
T Consensus        18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   97 (359)
T cd07876          18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE   97 (359)
T ss_pred             hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence            3567899999999999999999965 468999999985432 2334556789999999999999999999886543    


Q ss_pred             --ccEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEecccc
Q 002010          763 --TNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGL  840 (982)
Q Consensus       763 --~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~  840 (982)
                        ..++||||+++ ++.+.+.    ..+++..+..++.|++.|++|||+.+   |+||||||+||+++.++.+||+|||+
T Consensus        98 ~~~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~  169 (359)
T cd07876          98 FQDVYLVMELMDA-NLCQVIH----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL  169 (359)
T ss_pred             cceeEEEEeCCCc-CHHHHHh----ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCC
Confidence              46899999965 6766664    34788999999999999999999988   99999999999999999999999999


Q ss_pred             chhccccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCC---
Q 002010          841 AKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVS---  917 (982)
Q Consensus       841 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---  917 (982)
                      ++.....   .......+|+.|+|||++.+..++.++||||+||++|+|++|+.||.....................   
T Consensus       170 a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  246 (359)
T cd07876         170 ARTACTN---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFM  246 (359)
T ss_pred             ccccccC---ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHH
Confidence            9754321   2234457899999999999999999999999999999999999999865332222111111110000   


Q ss_pred             -------------CCCc-ccccce----eecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          918 -------------QPSD-AASVLA----VVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       918 -------------~~~~-~~~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                                   .+.. .....+    ...+............+.+++.+||+.||++|||++|+++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  314 (359)
T cd07876         247 NRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR  314 (359)
T ss_pred             HHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhc
Confidence                         0000 000000    0001111111223456889999999999999999999987

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=3.6e-35  Score=337.86  Aligned_cols=264  Identities=23%  Similarity=0.281  Sum_probs=196.5

Q ss_pred             hhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcC--------C
Q 002010          692 ESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNR--------D  762 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--------~  762 (982)
                      ++|+..+.||+|+||.||+|.. .+++.||||++...     .....+|+.+++.++||||+++++++...        .
T Consensus        66 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~-----~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~  140 (440)
T PTZ00036         66 KSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD-----PQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI  140 (440)
T ss_pred             CeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecC-----cchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence            4688999999999999999965 46889999988432     22345799999999999999999986432        1


Q ss_pred             ccEEEEeccCCCCHHHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCC-CEEEeccc
Q 002010          763 TNLLLYEYMPNGSLGEMLHG--AKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDF-EAHVADFG  839 (982)
Q Consensus       763 ~~~lv~e~~~~~sL~~~l~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~-~~kl~DfG  839 (982)
                      ..++||||++ +++.+++..  .....+++..+..++.||+.||+|||+.+   |+||||||+||+++.++ .+||+|||
T Consensus       141 ~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DFG  216 (440)
T PTZ00036        141 FLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFG  216 (440)
T ss_pred             EEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeeccc
Confidence            3568999996 477777653  23467899999999999999999999988   99999999999998664 79999999


Q ss_pred             cchhccccCCcccccccccccccccccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCC
Q 002010          840 LAKFLQDAGASECMSSVAGSYGYIAPEYAYTL-KVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQ  918 (982)
Q Consensus       840 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  918 (982)
                      +|+.+...   .......||+.|+|||++.+. .++.++||||+||++|||++|.+||........+...+.........
T Consensus       217 la~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~  293 (440)
T PTZ00036        217 SAKNLLAG---QRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTED  293 (440)
T ss_pred             cchhccCC---CCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence            99876532   122345789999999988754 68999999999999999999999998755444444443332211100


Q ss_pred             CC--cccccceeecCC-----CC-CCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          919 PS--DAASVLAVVDPR-----LS-GYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       919 ~~--~~~~~~~~~~~~-----~~-~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                      ..  .........-+.     +. .+|...+.++.+++.+||+.||.+|||+.|+++
T Consensus       294 ~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~  350 (440)
T PTZ00036        294 QLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA  350 (440)
T ss_pred             HHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence            00  000000000000     00 123334567899999999999999999999885

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=4.1e-35  Score=325.93  Aligned_cols=242  Identities=21%  Similarity=0.281  Sum_probs=191.4

Q ss_pred             cccccccceEEEEEEe-CCCcEEEEEEeccCC--CCCchhhHHHHHHHHhcC-CCCcccceEeEEEcCCccEEEEeccCC
Q 002010          698 NIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRG--TGGNDHGFLAEIQTLGRI-RHRNIVRLLGYVSNRDTNLLLYEYMPN  773 (982)
Q Consensus       698 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  773 (982)
                      +.||+|+||.||+|.. .+++.||+|++....  .......+.+|+.++.++ +||||+++++++..++..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            3689999999999965 468899999986542  222344577888888776 799999999999999999999999999


Q ss_pred             CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCcccc
Q 002010          774 GSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECM  853 (982)
Q Consensus       774 ~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~  853 (982)
                      ++|..++.  +...+++..+..++.|++.|++|||+.+   |+||||||+||+++.++.+||+|||+++.....  ....
T Consensus        81 ~~L~~~~~--~~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~--~~~~  153 (329)
T cd05618          81 GDLMFHMQ--RQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP--GDTT  153 (329)
T ss_pred             CCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCC--CCcc
Confidence            99999886  3457999999999999999999999988   999999999999999999999999998753321  1223


Q ss_pred             cccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCC----chHHHHHHHhccCCCCCCcccccceee
Q 002010          854 SSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDG----VDIVRWVRKTTSEVSQPSDAASVLAVV  929 (982)
Q Consensus       854 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~  929 (982)
                      ....||+.|+|||++.+..++.++||||+||++|||++|+.||......    .....++.....               
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~---------------  218 (329)
T cd05618         154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL---------------  218 (329)
T ss_pred             ccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHh---------------
Confidence            3467899999999999999999999999999999999999999642111    111111111110               


Q ss_pred             cCCCCCCChHhHHHHHHHHhhccCCCCCCCCCH
Q 002010          930 DPRLSGYPLTGVIHLFKVAMMCVEDESSARPTM  962 (982)
Q Consensus       930 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~  962 (982)
                       ......|......+.+++.+||+.||++||++
T Consensus       219 -~~~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~  250 (329)
T cd05618         219 -EKQIRIPRSLSVKAASVLKSFLNKDPKERLGC  250 (329)
T ss_pred             -cCCCCCCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence             00011233444578899999999999999984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-35  Score=335.50  Aligned_cols=252  Identities=22%  Similarity=0.262  Sum_probs=196.8

Q ss_pred             hcccccccccccceEEEEEEe-CCCcEEEEEEeccCC--CCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEe
Q 002010          693 SLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRG--TGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYE  769 (982)
Q Consensus       693 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  769 (982)
                      +|+..+.||+|+||.||+|.. .+++.||||++....  .......+.+|+.++++++||||+++++++.+....|+|||
T Consensus         2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E   81 (377)
T cd05629           2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIME   81 (377)
T ss_pred             CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEe
Confidence            578889999999999999964 578999999885432  22334567889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCC
Q 002010          770 YMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGA  849 (982)
Q Consensus       770 ~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  849 (982)
                      |+++|+|.+++.  +...+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++.+.....
T Consensus        82 ~~~gg~L~~~l~--~~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~  156 (377)
T cd05629          82 FLPGGDLMTMLI--KYDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHD  156 (377)
T ss_pred             CCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccccccc
Confidence            999999999997  3467899999999999999999999988   99999999999999999999999999964321100


Q ss_pred             c------------c---------------------------------cccccccccccccccccccCCCCcchhhHHHHH
Q 002010          850 S------------E---------------------------------CMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGV  884 (982)
Q Consensus       850 ~------------~---------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~  884 (982)
                      .            .                                 ......||+.|+|||++.+..++.++||||+||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv  236 (377)
T cd05629         157 SAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGA  236 (377)
T ss_pred             cccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecch
Confidence            0            0                                 001246899999999999999999999999999


Q ss_pred             HHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCC---CC
Q 002010          885 VLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSAR---PT  961 (982)
Q Consensus       885 il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R---pt  961 (982)
                      ++|||++|..||...........+. ........+.                .......+.+++.+|+. +|.+|   +|
T Consensus       237 il~elltG~~Pf~~~~~~~~~~~i~-~~~~~~~~p~----------------~~~~s~~~~dli~~lL~-~~~~r~~r~~  298 (377)
T cd05629         237 IMFECLIGWPPFCSENSHETYRKII-NWRETLYFPD----------------DIHLSVEAEDLIRRLIT-NAENRLGRGG  298 (377)
T ss_pred             hhhhhhcCCCCCCCCCHHHHHHHHH-ccCCccCCCC----------------CCCCCHHHHHHHHHHhc-CHhhcCCCCC
Confidence            9999999999997643322221111 1111000000                00123467899999997 66665   59


Q ss_pred             HHHHHH
Q 002010          962 MREVVH  967 (982)
Q Consensus       962 ~~ell~  967 (982)
                      +.|++.
T Consensus       299 ~~~~l~  304 (377)
T cd05629         299 AHEIKS  304 (377)
T ss_pred             HHHHhc
Confidence            999877

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=2.5e-35  Score=324.34  Aligned_cols=259  Identities=26%  Similarity=0.433  Sum_probs=202.7

Q ss_pred             hhcccccccccccceEEEEEEeC-CCc--EEEEEEeccCCCCCchhhHHHHHHHHhcC-CCCcccceEeEEEcCCccEEE
Q 002010          692 ESLKDENIIGKGGAGIVYRGSMP-DGI--DVAIKRLVGRGTGGNDHGFLAEIQTLGRI-RHRNIVRLLGYVSNRDTNLLL  767 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv  767 (982)
                      ++|+..+.||+|+||.||+|... ++.  .+|+|.+...........+.+|+.++.++ +||||+++++++..++..++|
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv   86 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   86 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence            56788899999999999999753 444  46777765433444456788999999999 899999999999999999999


Q ss_pred             EeccCCCCHHHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCE
Q 002010          768 YEYMPNGSLGEMLHGAK--------------GGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEA  833 (982)
Q Consensus       768 ~e~~~~~sL~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~  833 (982)
                      |||+++++|.++++...              ...+++..+..++.|++.|++|||+.+   |+||||||+||++++++.+
T Consensus        87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~  163 (303)
T cd05088          87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA  163 (303)
T ss_pred             EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcE
Confidence            99999999999997432              235789999999999999999999988   9999999999999999999


Q ss_pred             EEeccccchhccccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHh
Q 002010          834 HVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKT  912 (982)
Q Consensus       834 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~  912 (982)
                      ||+|||++......   .......++..|+|||++.+..++.++||||+||++|||+| |..||...... +.....   
T Consensus       164 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-~~~~~~---  236 (303)
T cd05088         164 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-ELYEKL---  236 (303)
T ss_pred             EeCccccCcccchh---hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH-HHHHHH---
Confidence            99999998643211   11112234568999999988889999999999999999998 99999654322 111111   


Q ss_pred             ccCCCCCCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCCCC
Q 002010          913 TSEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQSA  976 (982)
Q Consensus       913 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~~~~  976 (982)
                      ....                ....+...+..+.+++.+||+.+|++||++++++..|+++....
T Consensus       237 ~~~~----------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~  284 (303)
T cd05088         237 PQGY----------------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER  284 (303)
T ss_pred             hcCC----------------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence            1100                00111223446889999999999999999999999887755443

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-36  Score=323.91  Aligned_cols=246  Identities=29%  Similarity=0.378  Sum_probs=201.1

Q ss_pred             hhcccccccccccceEEEEEEe-CCCcEEEEEEeccCC--CCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEE
Q 002010          692 ESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRG--TGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLY  768 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  768 (982)
                      ..|...+.||.|+||.||.|+. .+.+.||||++....  +.+.+.++..|+..+++++|||++.+.|+|..+...|+||
T Consensus        26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM  105 (948)
T KOG0577|consen   26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM  105 (948)
T ss_pred             HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence            4466677899999999999964 568899999985443  3445678999999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccC
Q 002010          769 EYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAG  848 (982)
Q Consensus       769 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  848 (982)
                      ||| -|+-.+++.-. .+++.+.++..|..+.+.|++|||+.+   .||||||..||++++.|.||++|||.|..+.+. 
T Consensus       106 EYC-lGSAsDlleVh-kKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA-  179 (948)
T KOG0577|consen  106 EYC-LGSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAPA-  179 (948)
T ss_pred             HHH-hccHHHHHHHH-hccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCch-
Confidence            999 45777776533 367889999999999999999999988   999999999999999999999999999877643 


Q ss_pred             Ccccccccccccccccccccc---cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCccccc
Q 002010          849 ASECMSSVAGSYGYIAPEYAY---TLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASV  925 (982)
Q Consensus       849 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  925 (982)
                           .+++|||.|||||++.   .+.|+-++||||+|++..|+...++|+-....-..+.-+ .....  +.       
T Consensus       180 -----nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHI-AQNes--Pt-------  244 (948)
T KOG0577|consen  180 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI-AQNES--PT-------  244 (948)
T ss_pred             -----hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHH-HhcCC--CC-------
Confidence                 5689999999999874   678999999999999999999999998665332222221 11111  11       


Q ss_pred             ceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          926 LAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       926 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                             ++  ..+....+..|+..|+++-|.+|||.+++++
T Consensus       245 -------Lq--s~eWS~~F~~Fvd~CLqKipqeRptse~ll~  277 (948)
T KOG0577|consen  245 -------LQ--SNEWSDYFRNFVDSCLQKIPQERPTSEELLK  277 (948)
T ss_pred             -------CC--CchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence                   11  1233446889999999999999999999987

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=6.5e-35  Score=319.03  Aligned_cols=268  Identities=23%  Similarity=0.272  Sum_probs=199.8

Q ss_pred             hcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCC-CchhhHHHHHHHHhcC---CCCcccceEeEEEcC-----C
Q 002010          693 SLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTG-GNDHGFLAEIQTLGRI---RHRNIVRLLGYVSNR-----D  762 (982)
Q Consensus       693 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~-----~  762 (982)
                      +|+..+.||+|+||+||+|.. .+++.||+|.+...... .....+.+|+.+++++   +||||+++++++...     .
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            477888999999999999965 46889999988544322 2234566777777665   699999999987642     3


Q ss_pred             ccEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccch
Q 002010          763 TNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAK  842 (982)
Q Consensus       763 ~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~  842 (982)
                      ..++||||++ ++|.+++.......+++..+..++.|++.|++|+|+.+   |+||||||+||+++.++.+||+|||++.
T Consensus        81 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~~  156 (288)
T cd07863          81 KVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLAR  156 (288)
T ss_pred             eEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCccc
Confidence            4689999996 58999987655567899999999999999999999988   9999999999999999999999999998


Q ss_pred             hccccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCC--C
Q 002010          843 FLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQP--S  920 (982)
Q Consensus       843 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--~  920 (982)
                      .....   .......++..|+|||++.+..++.++||||+||++|||++|++||.......................  .
T Consensus       157 ~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (288)
T cd07863         157 IYSCQ---MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPR  233 (288)
T ss_pred             cccCc---ccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcc
Confidence            66432   122345678999999999988999999999999999999999999976544433333333221111000  0


Q ss_pred             cccccceeecCCC----CCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          921 DAASVLAVVDPRL----SGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       921 ~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                      ........+.+..    .......+..+.+++.+|++.||++|||+.|++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         234 DVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             cccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            0000000001000    1122234556889999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=8.4e-35  Score=314.39  Aligned_cols=260  Identities=21%  Similarity=0.318  Sum_probs=208.1

Q ss_pred             hhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCC--CCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEE
Q 002010          692 ESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGT--GGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLY  768 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  768 (982)
                      ++|+..+.||+|++|.||+|.. .+++.||||.+.....  .....++.+|+.+++.++||||+++++++.+++..+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            4677888999999999999964 5789999998754322  223457889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccc
Q 002010          769 EYMPNGSLGEMLHG--AKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQD  846 (982)
Q Consensus       769 e~~~~~sL~~~l~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  846 (982)
                      ||+++++|.+++..  .....+++..+..++.||+.|++|||+.+   ++|+||||+||+++.++.++++|||++..+..
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence            99999999998863  23456899999999999999999999988   99999999999999999999999999886643


Q ss_pred             cCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccc
Q 002010          847 AGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVL  926 (982)
Q Consensus       847 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  926 (982)
                      ..  .......++..|+|||+..+..++.++||||+|+++|+|++|..||......  ............          
T Consensus       159 ~~--~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~~----------  224 (267)
T cd08229         159 KT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN--LYSLCKKIEQCD----------  224 (267)
T ss_pred             CC--cccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch--HHHHhhhhhcCC----------
Confidence            22  1123356888999999998888999999999999999999999999653221  111111111100          


Q ss_pred             eeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 002010          927 AVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPP  973 (982)
Q Consensus       927 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~  973 (982)
                         .+.  ..+...+..+.+++.+||+.||++|||+.+|++.++++.
T Consensus       225 ---~~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~  266 (267)
T cd08229         225 ---YPP--LPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH  266 (267)
T ss_pred             ---CCC--CCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence               000  011234557899999999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=1.7e-35  Score=328.85  Aligned_cols=241  Identities=23%  Similarity=0.256  Sum_probs=189.9

Q ss_pred             cccccccceEEEEEEeC-CCcEEEEEEeccCCC--CCchhhHHHHHH-HHhcCCCCcccceEeEEEcCCccEEEEeccCC
Q 002010          698 NIIGKGGAGIVYRGSMP-DGIDVAIKRLVGRGT--GGNDHGFLAEIQ-TLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPN  773 (982)
Q Consensus       698 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  773 (982)
                      +.||+|+||+||+|... +++.||+|++.....  ......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            36999999999999654 578899999854321  122334444544 46778999999999999999999999999999


Q ss_pred             CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCcccc
Q 002010          774 GSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECM  853 (982)
Q Consensus       774 ~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~  853 (982)
                      ++|.+++.  +...+.+..+..++.||++||+|||+.+   |+||||||+||+++.++.+||+|||++......  ....
T Consensus        81 ~~L~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~--~~~~  153 (325)
T cd05602          81 GELFYHLQ--RERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEH--NGTT  153 (325)
T ss_pred             CcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccC--CCCc
Confidence            99999997  3456888899999999999999999988   999999999999999999999999999754322  1223


Q ss_pred             cccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceeecCCC
Q 002010          854 SSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDPRL  933 (982)
Q Consensus       854 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  933 (982)
                      ....||+.|+|||++.+..++.++||||+||++|||++|+.||......... ..+.....                   
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~-~~i~~~~~-------------------  213 (325)
T cd05602         154 STFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMY-DNILNKPL-------------------  213 (325)
T ss_pred             ccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHH-HHHHhCCc-------------------
Confidence            4567999999999999999999999999999999999999999764332221 11111100                   


Q ss_pred             CCCChHhHHHHHHHHhhccCCCCCCCCCHHHHH
Q 002010          934 SGYPLTGVIHLFKVAMMCVEDESSARPTMREVV  966 (982)
Q Consensus       934 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell  966 (982)
                       ..+...+..+.+++.+|++.||.+||++.+.+
T Consensus       214 -~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~  245 (325)
T cd05602         214 -QLKPNITNSARHLLEGLLQKDRTKRLGAKDDF  245 (325)
T ss_pred             -CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence             01122334688999999999999999987543

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=5.4e-35  Score=315.86  Aligned_cols=254  Identities=24%  Similarity=0.323  Sum_probs=201.0

Q ss_pred             hhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEec
Q 002010          692 ESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEY  770 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  770 (982)
                      ++|+..+.||+|+||.||+|.. .+++.||+|++... .......+.+|+.++++++||||+++++++..++..++||||
T Consensus         9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~-~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~   87 (267)
T cd06646           9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLE-PGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY   87 (267)
T ss_pred             hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecC-ccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence            5688899999999999999965 56889999988433 223345678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCc
Q 002010          771 MPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS  850 (982)
Q Consensus       771 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  850 (982)
                      +++++|.++++  +...+++..+..++.|++.|++|||+.+   |+|||++|+||+++.++.+||+|||++..+....  
T Consensus        88 ~~~~~L~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~--  160 (267)
T cd06646          88 CGGGSLQDIYH--VTGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATI--  160 (267)
T ss_pred             CCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeecccc--
Confidence            99999999986  3457899999999999999999999988   9999999999999999999999999998664321  


Q ss_pred             ccccccccccccccccccc---cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccce
Q 002010          851 ECMSSVAGSYGYIAPEYAY---TLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLA  927 (982)
Q Consensus       851 ~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  927 (982)
                      .......++..|+|||.+.   ...++.++||||+||++|||++|+.||...........+.....   .          
T Consensus       161 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~---~----------  227 (267)
T cd06646         161 AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNF---Q----------  227 (267)
T ss_pred             cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCC---C----------
Confidence            1223456888999999874   34578899999999999999999999865432211111100000   0          


Q ss_pred             eecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 002010          928 VVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHML  969 (982)
Q Consensus       928 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L  969 (982)
                        .+... .....+..+.+++.+||+.||++|||++++++.+
T Consensus       228 --~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         228 --PPKLK-DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             --CCCCc-cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence              00010 1122345788999999999999999999998743

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=1.1e-34  Score=311.49  Aligned_cols=251  Identities=29%  Similarity=0.466  Sum_probs=201.2

Q ss_pred             cccccccceEEEEEEeCC--C--cEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEeccCC
Q 002010          698 NIIGKGGAGIVYRGSMPD--G--IDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPN  773 (982)
Q Consensus       698 ~~lg~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  773 (982)
                      +.||+|++|.||+|.+.+  +  ..||+|.+.........+.+.+|+.++++++||||+++++++.. ...++||||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            368999999999997533  3  36899988554443456678999999999999999999999888 888999999999


Q ss_pred             CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCc-cc
Q 002010          774 GSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS-EC  852 (982)
Q Consensus       774 ~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~-~~  852 (982)
                      ++|.+++.......+++..++.++.|++.|++|||+.+   ++||||||+||+++.++.+||+|||++..+...... ..
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  156 (257)
T cd05040          80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM  156 (257)
T ss_pred             CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence            99999997544357899999999999999999999988   999999999999999999999999999876542211 11


Q ss_pred             ccccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceeecC
Q 002010          853 MSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDP  931 (982)
Q Consensus       853 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  931 (982)
                      .....++..|+|||++.+..++.++||||+||++|||++ |+.||......+ ....+.......               
T Consensus       157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-~~~~~~~~~~~~---------------  220 (257)
T cd05040         157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ-ILKKIDKEGERL---------------  220 (257)
T ss_pred             ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHHHhcCCcC---------------
Confidence            223456788999999998899999999999999999999 999997543322 222222111100               


Q ss_pred             CCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 002010          932 RLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLAN  971 (982)
Q Consensus       932 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~  971 (982)
                         ..+...+..+.+++.+||+.+|++||++.|+++.|.+
T Consensus       221 ---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~  257 (257)
T cd05040         221 ---ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLPE  257 (257)
T ss_pred             ---CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhcC
Confidence               1122334578999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=8.8e-35  Score=312.79  Aligned_cols=254  Identities=26%  Similarity=0.454  Sum_probs=206.5

Q ss_pred             HhhcccccccccccceEEEEEEeCCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEec
Q 002010          691 LESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEY  770 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  770 (982)
                      .++|+..+.||+|+||.||+|...++..+|+|.+...  ......+.+|+.++++++|+||+++++.+.. ...+++|||
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~   81 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG--SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEF   81 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEecCCccEEEEecCCC--hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEe
Confidence            3578889999999999999998777888999987432  2235678899999999999999999999887 778999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCc
Q 002010          771 MPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS  850 (982)
Q Consensus       771 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  850 (982)
                      +++++|.+++.......+++..+..++.|++.|++|||+.+   ++||||+|+||+++.++.+|++|||.+....... .
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~-~  157 (260)
T cd05073          82 MAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNE-Y  157 (260)
T ss_pred             CCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCC-c
Confidence            99999999998666667899999999999999999999988   9999999999999999999999999997654321 1


Q ss_pred             ccccccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceee
Q 002010          851 ECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVV  929 (982)
Q Consensus       851 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  929 (982)
                      .......++..|+|||++....++.++|+||+||++|++++ |+.||...... ...........               
T Consensus       158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~-~~~~~~~~~~~---------------  221 (260)
T cd05073         158 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP-EVIRALERGYR---------------  221 (260)
T ss_pred             ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH-HHHHHHhCCCC---------------
Confidence            12223345678999999998889999999999999999999 99999754322 22222211110               


Q ss_pred             cCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 002010          930 DPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLAN  971 (982)
Q Consensus       930 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~  971 (982)
                          ...+...+..+.+++.+||+.+|++||++.++.+.|+.
T Consensus       222 ----~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         222 ----MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             ----CCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence                01112334578899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=1.5e-35  Score=330.38  Aligned_cols=252  Identities=20%  Similarity=0.197  Sum_probs=201.0

Q ss_pred             hcccccccccccceEEEEEEe-CCCcEEEEEEeccCCC--CCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEe
Q 002010          693 SLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGT--GGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYE  769 (982)
Q Consensus       693 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  769 (982)
                      +|+..+.||+|+||+||+|.. .+++.||+|++.....  ......+.+|+.+++.++||||+++++++.+++..++|||
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (330)
T cd05601           2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVME   81 (330)
T ss_pred             CceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEEC
Confidence            578889999999999999965 4689999999864322  2344567889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCC
Q 002010          770 YMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGA  849 (982)
Q Consensus       770 ~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  849 (982)
                      |+++++|.+++... ...+++..+..++.|++.|++|||+.+   |+||||||+||+++.++.+||+|||++..+.....
T Consensus        82 ~~~~~~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~  157 (330)
T cd05601          82 YQPGGDLLSLLNRY-EDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM  157 (330)
T ss_pred             CCCCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCCCc
Confidence            99999999999743 357899999999999999999999988   99999999999999999999999999987653322


Q ss_pred             cccccccccccccccccccc------cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCccc
Q 002010          850 SECMSSVAGSYGYIAPEYAY------TLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAA  923 (982)
Q Consensus       850 ~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  923 (982)
                       .......||+.|+|||++.      ...++.++||||+||++|||++|+.||........+...... .....      
T Consensus       158 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~-~~~~~------  229 (330)
T cd05601         158 -VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNF-QRFLK------  229 (330)
T ss_pred             -eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcC-CCccC------
Confidence             1223457899999999986      456789999999999999999999999764332222222111 00000      


Q ss_pred             ccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          924 SVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       924 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                               ++ .....+..+.+++..|++ +|.+|||++++++
T Consensus       230 ---------~~-~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~  262 (330)
T cd05601         230 ---------FP-EDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC  262 (330)
T ss_pred             ---------CC-CCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence                     00 011234568899999998 9999999999885

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=2.1e-34  Score=311.29  Aligned_cols=253  Identities=24%  Similarity=0.353  Sum_probs=191.4

Q ss_pred             ccccccceEEEEEEeCCC---cEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEeccCCCC
Q 002010          699 IIGKGGAGIVYRGSMPDG---IDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGS  775 (982)
Q Consensus       699 ~lg~G~~g~Vy~~~~~~~---~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~s  775 (982)
                      .||+|+||.||+|...++   ..+++|.+...........+.+|+.+++.++||||+++++++......++||||+++|+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   81 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD   81 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence            589999999999965333   34667766444444456789999999999999999999999999999999999999999


Q ss_pred             HHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCcccc
Q 002010          776 LGEMLHGAK--GGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECM  853 (982)
Q Consensus       776 L~~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~  853 (982)
                      |.+++....  ....++..+..++.||+.|++|||+.+   ++||||||+||+++.++.+||+|||++............
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~  158 (268)
T cd05086          82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE  158 (268)
T ss_pred             HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence            999997532  234667778899999999999999988   999999999999999999999999998643222111222


Q ss_pred             ccccccccccccccccc-------CCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHhccCCCCCCccccc
Q 002010          854 SSVAGSYGYIAPEYAYT-------LKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASV  925 (982)
Q Consensus       854 ~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  925 (982)
                      ....++..|+|||+...       ..++.++||||+|+++|||++ |..||....+..............          
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~----------  228 (268)
T cd05086         159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVK----------  228 (268)
T ss_pred             cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccc----------
Confidence            34567889999998753       245789999999999999997 577886544333222222221111          


Q ss_pred             ceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 002010          926 LAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLA  970 (982)
Q Consensus       926 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~  970 (982)
                        ..++..   +......+.+++..|| .+|++||+++||++.|.
T Consensus       229 --~~~~~~---~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         229 --LFKPQL---ELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             --cCCCcc---CCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence              111111   1223356788999999 67999999999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=3.4e-35  Score=334.18  Aligned_cols=252  Identities=22%  Similarity=0.246  Sum_probs=195.0

Q ss_pred             hcccccccccccceEEEEEEe-CCCcEEEEEEeccCCC--CCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEe
Q 002010          693 SLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGT--GGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYE  769 (982)
Q Consensus       693 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  769 (982)
                      .|+..+.||+|+||+||+|+. .+++.||+|++.....  ......+.+|+.++++++||||+++++++.+++..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            477888999999999999965 5688999999854321  2234568889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCC
Q 002010          770 YMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGA  849 (982)
Q Consensus       770 ~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  849 (982)
                      |+++|+|.+++..  ...+++..+..++.||+.|++|||+.+   |+||||||+||+++.++.+||+|||++..+.....
T Consensus        82 ~~~gg~L~~~l~~--~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~  156 (382)
T cd05625          82 YIPGGDMMSLLIR--MGIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD  156 (382)
T ss_pred             CCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCcccccccc
Confidence            9999999999973  357889999999999999999999988   99999999999999999999999999753321000


Q ss_pred             ---------------------------------------------cccccccccccccccccccccCCCCcchhhHHHHH
Q 002010          850 ---------------------------------------------SECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGV  884 (982)
Q Consensus       850 ---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~  884 (982)
                                                                   ........||+.|+|||++.+..++.++||||+||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGv  236 (382)
T cd05625         157 SKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV  236 (382)
T ss_pred             ccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechH
Confidence                                                         00012346899999999999999999999999999


Q ss_pred             HHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCC---
Q 002010          885 VLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPT---  961 (982)
Q Consensus       885 il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt---  961 (982)
                      ++|||++|++||.................. ...+            .    .........+++.+|+ .+|++|++   
T Consensus       237 il~elltG~~Pf~~~~~~~~~~~i~~~~~~-~~~p------------~----~~~~s~~~~~li~~l~-~~p~~R~~~~~  298 (382)
T cd05625         237 ILYEMLVGQPPFLAQTPLETQMKVINWQTS-LHIP------------P----QAKLSPEASDLIIKLC-RGPEDRLGKNG  298 (382)
T ss_pred             HHHHHHhCCCCCCCCCHHHHHHHHHccCCC-cCCC------------C----cccCCHHHHHHHHHHc-cCHhHcCCCCC
Confidence            999999999999764332222222111000 0000            0    0112235667777765 59999997   


Q ss_pred             HHHHHH
Q 002010          962 MREVVH  967 (982)
Q Consensus       962 ~~ell~  967 (982)
                      ++|+++
T Consensus       299 ~~ei~~  304 (382)
T cd05625         299 ADEIKA  304 (382)
T ss_pred             HHHHhc
Confidence            887765

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=6.8e-35  Score=318.00  Aligned_cols=271  Identities=24%  Similarity=0.342  Sum_probs=204.1

Q ss_pred             hcccccccccccceEEEEEEe-----CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcC--CccE
Q 002010          693 SLKDENIIGKGGAGIVYRGSM-----PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNR--DTNL  765 (982)
Q Consensus       693 ~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~  765 (982)
                      -|++.+.||+|+||.||.|..     .++..||+|.+...........+.+|+.++++++||||+++++++...  ...+
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK   84 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence            467788999999999999963     357889999986554444556789999999999999999999998775  5678


Q ss_pred             EEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhcc
Q 002010          766 LLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQ  845 (982)
Q Consensus       766 lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~  845 (982)
                      +||||+++++|.+++... ...+++..+..++.|++.|++|+|+.+   |+||||||+||+++.++.+||+|||+++.+.
T Consensus        85 lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~  160 (284)
T cd05079          85 LIMEFLPSGSLKEYLPRN-KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIE  160 (284)
T ss_pred             EEEEccCCCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccccc
Confidence            999999999999998643 246899999999999999999999988   9999999999999999999999999998765


Q ss_pred             ccCCc-ccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccc
Q 002010          846 DAGAS-ECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAAS  924 (982)
Q Consensus       846 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  924 (982)
                      ..... .......++..|+|||+..+..++.++||||+|+++|||+++..|+.....  ......   ............
T Consensus       161 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~--~~~~~~---~~~~~~~~~~~~  235 (284)
T cd05079         161 TDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMT--LFLKMI---GPTHGQMTVTRL  235 (284)
T ss_pred             cCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccc--hhhhhc---ccccccccHHHH
Confidence            33211 112234567789999999888899999999999999999998776533110  000000   000000000000


Q ss_pred             cceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 002010          925 VLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANP  972 (982)
Q Consensus       925 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~  972 (982)
                      .....+......+...+..+.+++.+||+.||++|||++++++.++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         236 VRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             HHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            000001111122334556899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-34  Score=309.77  Aligned_cols=250  Identities=24%  Similarity=0.388  Sum_probs=201.0

Q ss_pred             cccccccceEEEEEEeCCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEeccCCCCHH
Q 002010          698 NIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLG  777 (982)
Q Consensus       698 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~  777 (982)
                      +.||+|+||.||+|...+++.||+|.+...........+.+|+.++++++||||+++++++.+....++||||+++++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            36899999999999876699999998855444334567899999999999999999999999999999999999999999


Q ss_pred             HHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCcccccccc
Q 002010          778 EMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVA  857 (982)
Q Consensus       778 ~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~  857 (982)
                      +++... ...+++..+..++.+++.|++|||+.+   ++||||+|+||+++.++.+||+|||.+................
T Consensus        81 ~~l~~~-~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~  156 (251)
T cd05041          81 TFLRKK-KNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQ  156 (251)
T ss_pred             HHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCc
Confidence            999643 346889999999999999999999988   9999999999999999999999999997654221111111223


Q ss_pred             cccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceeecCCCCCC
Q 002010          858 GSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDPRLSGY  936 (982)
Q Consensus       858 gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  936 (982)
                      .+..|+|||.+.+..++.++|+||+|+++|||++ |..||....... ....+..... .                  ..
T Consensus       157 ~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~-~~~~~~~~~~-~------------------~~  216 (251)
T cd05041         157 IPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ-TRERIESGYR-M------------------PA  216 (251)
T ss_pred             ceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH-HHHHHhcCCC-C------------------CC
Confidence            4567999999988889999999999999999999 888887653322 2222211100 0                  11


Q ss_pred             ChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 002010          937 PLTGVIHLFKVAMMCVEDESSARPTMREVVHMLAN  971 (982)
Q Consensus       937 ~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~  971 (982)
                      +...+..+.+++.+||+.+|++|||++|+++.|.+
T Consensus       217 ~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~  251 (251)
T cd05041         217 PQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQI  251 (251)
T ss_pred             CccCCHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence            22344579999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=5.7e-35  Score=329.20  Aligned_cols=254  Identities=22%  Similarity=0.260  Sum_probs=199.3

Q ss_pred             HhhcccccccccccceEEEEEEe-CCCcEEEEEEeccCC--CCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEE
Q 002010          691 LESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRG--TGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLL  767 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  767 (982)
                      .++|+..+.||+|+||.||+|+. .+++.||+|.+....  .......+.+|+.+++.++||||+++++++.++...++|
T Consensus        42 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv  121 (370)
T cd05621          42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMV  121 (370)
T ss_pred             HHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence            36789999999999999999976 458899999885322  223345678899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhcccc
Q 002010          768 YEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDA  847 (982)
Q Consensus       768 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  847 (982)
                      |||+++|+|.+++..   ..+++..+..++.||+.|++|||+.+   |+||||||+||++++++.+||+|||+|......
T Consensus       122 ~Ey~~gg~L~~~l~~---~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~  195 (370)
T cd05621         122 MEYMPGGDLVNLMSN---YDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDET  195 (370)
T ss_pred             EcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceecccC
Confidence            999999999999963   35889999999999999999999988   999999999999999999999999999876432


Q ss_pred             CCcccccccccccccccccccccCC----CCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCccc
Q 002010          848 GASECMSSVAGSYGYIAPEYAYTLK----VDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAA  923 (982)
Q Consensus       848 ~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  923 (982)
                      . ........||+.|+|||++.+..    ++.++||||+||++|||++|+.||...........+.... .....+    
T Consensus       196 ~-~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~-~~~~~p----  269 (370)
T cd05621         196 G-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHK-NSLNFP----  269 (370)
T ss_pred             C-ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-cccCCC----
Confidence            2 12224567999999999987543    7889999999999999999999997643322222222111 100000    


Q ss_pred             ccceeecCCCCCCChHhHHHHHHHHhhccCCCCCC--CCCHHHHHHH
Q 002010          924 SVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSA--RPTMREVVHM  968 (982)
Q Consensus       924 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--Rpt~~ell~~  968 (982)
                                  ........+.+++..|+..+|.+  |+|++|+++-
T Consensus       270 ------------~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         270 ------------EDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             ------------CcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence                        00122346778899999866654  8899998873

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.5e-36  Score=324.01  Aligned_cols=244  Identities=28%  Similarity=0.467  Sum_probs=204.3

Q ss_pred             ccccccceEEEEEEe-CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEeccCCCCHH
Q 002010          699 IIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLG  777 (982)
Q Consensus       699 ~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~  777 (982)
                      ++|+|.||+||.|++ .+...+|||-+..+.+ ...+-..+|+..-++++|.|||+++|.+.+.+..-+.||-++||+|.
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekds-r~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS  660 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDS-REVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS  660 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccc-hhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence            799999999999975 4577899999855443 44556789999999999999999999999999888999999999999


Q ss_pred             HHhhcCCCCCC--CHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcC-CCCEEEeccccchhccccCCccccc
Q 002010          778 EMLHGAKGGHL--KWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDS-DFEAHVADFGLAKFLQDAGASECMS  854 (982)
Q Consensus       778 ~~l~~~~~~~l--~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~-~~~~kl~DfG~a~~~~~~~~~~~~~  854 (982)
                      ++++. +=+++  .+..+..+.+||++|+.|||+..   |||||||-+||+|+. .|.+||+|||-++++..  -.....
T Consensus       661 sLLrs-kWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg--inP~TE  734 (1226)
T KOG4279|consen  661 SLLRS-KWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG--INPCTE  734 (1226)
T ss_pred             HHHHh-ccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhcc--CCcccc
Confidence            99973 33555  67888899999999999999988   999999999999964 58999999999998764  334456


Q ss_pred             ccccccccccccccccC--CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceeecCC
Q 002010          855 SVAGSYGYIAPEYAYTL--KVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDPR  932 (982)
Q Consensus       855 ~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  932 (982)
                      ...||..|||||++..+  .|+.++|||||||++.||.||++||.....+....-.+.-.                  +.
T Consensus       735 TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmy------------------Kv  796 (1226)
T KOG4279|consen  735 TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMY------------------KV  796 (1226)
T ss_pred             ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcce------------------ec
Confidence            68899999999999864  59999999999999999999999998876554322222111                  11


Q ss_pred             CCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          933 LSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       933 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                      -+.+|.+...+...++.+|+..||.+||++.+++.
T Consensus       797 HP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  797 HPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             CCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence            23566777788999999999999999999999987

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=1.3e-34  Score=317.37  Aligned_cols=251  Identities=23%  Similarity=0.338  Sum_probs=203.3

Q ss_pred             HHhhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEE
Q 002010          690 VLESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLY  768 (982)
Q Consensus       690 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  768 (982)
                      ...+|+..+.||+|+||.||+|.. .+++.||+|.+.... ......+.+|+.+++.++||||+++++++..+...++||
T Consensus        18 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~   96 (296)
T cd06654          18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ-QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM   96 (296)
T ss_pred             cccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCC-cchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEee
Confidence            346788889999999999999964 568899999885433 334567889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccC
Q 002010          769 EYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAG  848 (982)
Q Consensus       769 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  848 (982)
                      ||+++++|.+++..   ..+++.++..++.|++.|++|||+.+   |+||||||+||+++.++.+||+|||.+.......
T Consensus        97 e~~~~~~L~~~~~~---~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~  170 (296)
T cd06654          97 EYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  170 (296)
T ss_pred             cccCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhccccc
Confidence            99999999999853   45789999999999999999999988   9999999999999999999999999987654321


Q ss_pred             CcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCccccccee
Q 002010          849 ASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAV  928 (982)
Q Consensus       849 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  928 (982)
                        .......+++.|+|||.+.+..++.++|||||||++|+|++|+.||...........+... ..  +           
T Consensus       171 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~-~~--~-----------  234 (296)
T cd06654         171 --SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN-GT--P-----------  234 (296)
T ss_pred             --cccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcC-CC--C-----------
Confidence              1123456888999999999888999999999999999999999999754322211111100 00  0           


Q ss_pred             ecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          929 VDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       929 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                         .. ..+...+..+.+++.+||..||++|||++|+++
T Consensus       235 ---~~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~  269 (296)
T cd06654         235 ---EL-QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (296)
T ss_pred             ---CC-CCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence               00 112233456889999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=3.1e-35  Score=333.95  Aligned_cols=252  Identities=21%  Similarity=0.244  Sum_probs=196.7

Q ss_pred             hcccccccccccceEEEEEEe-CCCcEEEEEEeccCC--CCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEe
Q 002010          693 SLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRG--TGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYE  769 (982)
Q Consensus       693 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  769 (982)
                      +|++.+.||+|+||.||+|+. .+++.||+|.+....  .......+.+|+.++++++||||+++++.+.+++..++|||
T Consensus         2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E   81 (376)
T cd05598           2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (376)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence            578889999999999999965 468999999985332  12234567899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccC-
Q 002010          770 YMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAG-  848 (982)
Q Consensus       770 ~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-  848 (982)
                      |+++|+|.+++.  +...+++..+..++.||+.|++|||+.+   |+||||||+||+++.++.+||+|||+|..+.... 
T Consensus        82 ~~~~g~L~~~i~--~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~  156 (376)
T cd05598          82 YIPGGDMMSLLI--RLGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD  156 (376)
T ss_pred             CCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCcccccccc
Confidence            999999999997  3457889999999999999999999988   9999999999999999999999999975331000 


Q ss_pred             ----------------------------------------CcccccccccccccccccccccCCCCcchhhHHHHHHHHH
Q 002010          849 ----------------------------------------ASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLE  888 (982)
Q Consensus       849 ----------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~e  888 (982)
                                                              .........||+.|+|||++.+..++.++||||+||++||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilye  236 (376)
T cd05598         157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE  236 (376)
T ss_pred             ccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeee
Confidence                                                    0000123469999999999999999999999999999999


Q ss_pred             HHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCC---CHHHH
Q 002010          889 LIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARP---TMREV  965 (982)
Q Consensus       889 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp---t~~el  965 (982)
                      |++|+.||............. ........            +    ........+.+++.+|+ .+|.+|+   |+.|+
T Consensus       237 ll~G~~Pf~~~~~~~~~~~i~-~~~~~~~~------------~----~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~el  298 (376)
T cd05598         237 MLVGQPPFLADTPAETQLKVI-NWETTLHI------------P----SQAKLSREASDLILRLC-CGAEDRLGKNGADEI  298 (376)
T ss_pred             hhhCCCCCCCCCHHHHHHHHh-ccCccccC------------C----CCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHH
Confidence            999999997654322222111 10000000            0    01112345677888876 5999999   88998


Q ss_pred             HH
Q 002010          966 VH  967 (982)
Q Consensus       966 l~  967 (982)
                      ++
T Consensus       299 l~  300 (376)
T cd05598         299 KA  300 (376)
T ss_pred             hC
Confidence            86

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=7.8e-35  Score=315.01  Aligned_cols=250  Identities=28%  Similarity=0.452  Sum_probs=199.8

Q ss_pred             ccccccceEEEEEEeCC-------CcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEecc
Q 002010          699 IIGKGGAGIVYRGSMPD-------GIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYM  771 (982)
Q Consensus       699 ~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  771 (982)
                      .||+|+||.||+|...+       +..||+|.+...........+.+|+.++++++||||+++++++...+..++||||+
T Consensus         2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   81 (269)
T cd05044           2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM   81 (269)
T ss_pred             ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence            68999999999996532       25799998755444455667899999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcCC-----CCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCC-----CEEEeccccc
Q 002010          772 PNGSLGEMLHGAK-----GGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDF-----EAHVADFGLA  841 (982)
Q Consensus       772 ~~~sL~~~l~~~~-----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~-----~~kl~DfG~a  841 (982)
                      ++++|.+++....     ...+++.++..++.|++.|++|||+.+   ++|+||||+||+++.++     .++++|||++
T Consensus        82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~  158 (269)
T cd05044          82 EGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLA  158 (269)
T ss_pred             CCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCcccc
Confidence            9999999997432     234788999999999999999999888   99999999999999887     8999999999


Q ss_pred             hhccccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHhccCCCCCC
Q 002010          842 KFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPS  920 (982)
Q Consensus       842 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  920 (982)
                      ................++..|+|||++.+..++.++||||||+++|||++ |+.||...... .....+....       
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~-~~~~~~~~~~-------  230 (269)
T cd05044         159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ-EVLQHVTAGG-------  230 (269)
T ss_pred             cccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH-HHHHHHhcCC-------
Confidence            76643322222223345678999999998899999999999999999998 99999754322 2222211100       


Q ss_pred             cccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 002010          921 DAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLAN  971 (982)
Q Consensus       921 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~  971 (982)
                                  ....+...+..+.+++.+||+.+|.+||+++++++.|.+
T Consensus       231 ------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  269 (269)
T cd05044         231 ------------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN  269 (269)
T ss_pred             ------------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence                        001122345678899999999999999999999998863

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4e-36  Score=322.78  Aligned_cols=251  Identities=24%  Similarity=0.353  Sum_probs=206.5

Q ss_pred             hhcccccccccccceEEEEEEeCCC-cEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEec
Q 002010          692 ESLKDENIIGKGGAGIVYRGSMPDG-IDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEY  770 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  770 (982)
                      +.|++...||.|+||.||+|..++. ...|.|++ ...+.....+|+-|++|+..++||+||+++++|..+...+++.||
T Consensus        32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvI-etkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEF  110 (1187)
T KOG0579|consen   32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVI-ETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEF  110 (1187)
T ss_pred             HHHHHHhhhcCccchhhhhhhcccchhhhhhhhh-cccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEee
Confidence            3466777899999999999966553 34455655 566777788899999999999999999999999989999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCc
Q 002010          771 MPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS  850 (982)
Q Consensus       771 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  850 (982)
                      |.||.++..+-. -+..+.+.++..+.+|++.||.|||+++   |||||+|..||+++-+|.++++|||.+-....  ..
T Consensus       111 C~GGAVDaimlE-L~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~--t~  184 (1187)
T KOG0579|consen  111 CGGGAVDAIMLE-LGRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKS--TR  184 (1187)
T ss_pred             cCCchHhHHHHH-hccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchh--HH
Confidence            999999887753 3468999999999999999999999988   99999999999999999999999998854322  12


Q ss_pred             ccccccccccccccccccc-----cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCccccc
Q 002010          851 ECMSSVAGSYGYIAPEYAY-----TLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASV  925 (982)
Q Consensus       851 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  925 (982)
                      .......|||+|||||+.+     ...|++++||||||+.+.||..+.+|-.....-..+..+.+...+...+|+.    
T Consensus       185 qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~----  260 (1187)
T KOG0579|consen  185 QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSH----  260 (1187)
T ss_pred             hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcch----
Confidence            2345688999999999864     5679999999999999999999999987765555555554444443333332    


Q ss_pred             ceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          926 LAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       926 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                                    ....+.+++.+|+.+||+.||+++++++
T Consensus       261 --------------Ws~~F~DfLk~cL~Knp~~Rp~aaqll~  288 (1187)
T KOG0579|consen  261 --------------WSRSFSDFLKRCLVKNPRNRPPAAQLLK  288 (1187)
T ss_pred             --------------hhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence                          2236889999999999999999999986

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-34  Score=315.31  Aligned_cols=260  Identities=26%  Similarity=0.425  Sum_probs=207.1

Q ss_pred             hhcccccccccccceEEEEEEeC-CCc----EEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEE
Q 002010          692 ESLKDENIIGKGGAGIVYRGSMP-DGI----DVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLL  766 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  766 (982)
                      .+|+..+.||+|+||.||+|... +|.    .||+|............++.+|+.++.+++||||+++++++.. ...++
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~   85 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL   85 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence            56788899999999999999653 233    5899987554444445678899999999999999999999887 78899


Q ss_pred             EEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccc
Q 002010          767 LYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQD  846 (982)
Q Consensus       767 v~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  846 (982)
                      ||||+++|+|.+++... ...+++..+..++.|++.|++|||+.+   ++||||||+||++++++.+||+|||.++....
T Consensus        86 v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~  161 (279)
T cd05057          86 ITQLMPLGCLLDYVRNH-KDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLDV  161 (279)
T ss_pred             EEecCCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCcccccccC
Confidence            99999999999999743 345899999999999999999999988   99999999999999999999999999987653


Q ss_pred             cCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHhccCCCCCCccccc
Q 002010          847 AGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASV  925 (982)
Q Consensus       847 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  925 (982)
                      ...........++..|+|||......++.++|+||+|+++||+++ |+.||..... .+....+.....           
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-~~~~~~~~~~~~-----------  229 (279)
T cd05057         162 DEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA-VEIPDLLEKGER-----------  229 (279)
T ss_pred             cccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH-HHHHHHHhCCCC-----------
Confidence            322221222234568999999988889999999999999999999 9999976532 223333222111           


Q ss_pred             ceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCCCC
Q 002010          926 LAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQSA  976 (982)
Q Consensus       926 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~~~~  976 (982)
                              ...+..++..+.+++.+||..||.+|||+.++++.|+++.+.-
T Consensus       230 --------~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~  272 (279)
T cd05057         230 --------LPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARDP  272 (279)
T ss_pred             --------CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhCC
Confidence                    0112223356889999999999999999999999998875543

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=1.2e-34  Score=315.90  Aligned_cols=251  Identities=25%  Similarity=0.312  Sum_probs=200.7

Q ss_pred             cccccccccccceEEEEEEe-CCCcEEEEEEeccCCCCC--chhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEec
Q 002010          694 LKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGG--NDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEY  770 (982)
Q Consensus       694 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  770 (982)
                      |+..+.||+|+||.||+|.. .+++.||+|.+.......  ....+..|+.++++++|++|+++++.+.+++..++||||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence            56677899999999999965 468899999885443222  234567899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCc
Q 002010          771 MPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS  850 (982)
Q Consensus       771 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  850 (982)
                      +++++|.+++.......+++..+..++.|++.|++|||+.+   |+||||||+||++++++.++|+|||++.......  
T Consensus        82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~--  156 (285)
T cd05630          82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ--  156 (285)
T ss_pred             cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCc--
Confidence            99999999987555567999999999999999999999888   9999999999999999999999999987654221  


Q ss_pred             ccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceeec
Q 002010          851 ECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVD  930 (982)
Q Consensus       851 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  930 (982)
                       ......|+..|+|||++.+..++.++||||+|+++|+|++|+.||............ ......               
T Consensus       157 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~-~~~~~~---------------  219 (285)
T cd05630         157 -TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEV-ERLVKE---------------  219 (285)
T ss_pred             -cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHH-Hhhhhh---------------
Confidence             123457899999999999989999999999999999999999999764332111111 110000               


Q ss_pred             CCCCCCChHhHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 002010          931 PRLSGYPLTGVIHLFKVAMMCVEDESSARPT-----MREVVH  967 (982)
Q Consensus       931 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt-----~~ell~  967 (982)
                       .....+...+..+.+++.+||+.||++|||     ++|+++
T Consensus       220 -~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~  260 (285)
T cd05630         220 -VQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE  260 (285)
T ss_pred             -hhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence             000112233456889999999999999999     888887

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=2.5e-34  Score=310.34  Aligned_cols=252  Identities=25%  Similarity=0.431  Sum_probs=202.4

Q ss_pred             hcccccccccccceEEEEEEeCCCcEEEEEEeccCCCC-----CchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEE
Q 002010          693 SLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTG-----GNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLL  767 (982)
Q Consensus       693 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  767 (982)
                      +|+..+.||+|+||.||+|...+++.+|+|.+......     .....+.+|+.++++++|+||+++++++.+.+..++|
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            36778899999999999998778999999988543221     1224578899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhcccc
Q 002010          768 YEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDA  847 (982)
Q Consensus       768 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  847 (982)
                      |||+++++|.+++..  ..++++..+..++.|++.|++|||+.+   |+|+||+|+||++++++.+||+|||.+......
T Consensus        81 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  155 (265)
T cd06631          81 MEFVPGGSISSILNR--FGPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWV  155 (265)
T ss_pred             EecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhhc
Confidence            999999999999963  356889999999999999999999988   999999999999999999999999999865321


Q ss_pred             C----CcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCccc
Q 002010          848 G----ASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAA  923 (982)
Q Consensus       848 ~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  923 (982)
                      .    .........++..|+|||++.+..++.++||||+|+++|+|++|+.||..................         
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~---------  226 (265)
T cd06631         156 GLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGL---------  226 (265)
T ss_pred             cccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCC---------
Confidence            1    111123456888999999999888999999999999999999999999754322221111111000         


Q ss_pred             ccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          924 SVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       924 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                               .+..+...+..+.+++.+||+.+|++|||+.|++.
T Consensus       227 ---------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         227 ---------MPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             ---------CCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                     11122334557899999999999999999999875

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=1.7e-34  Score=314.51  Aligned_cols=250  Identities=24%  Similarity=0.342  Sum_probs=199.4

Q ss_pred             hcccccccccccceEEEEEEeC-CCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEecc
Q 002010          693 SLKDENIIGKGGAGIVYRGSMP-DGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYM  771 (982)
Q Consensus       693 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  771 (982)
                      .|+..+.||+|+||.||+|... ++..+++|.+... .......+.+|+.+++.++||||+++++++..++..++||||+
T Consensus         6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~   84 (282)
T cd06643           6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK-SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   84 (282)
T ss_pred             HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC-CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEec
Confidence            3677788999999999999764 5778899887332 3334557889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCcc
Q 002010          772 PNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASE  851 (982)
Q Consensus       772 ~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~  851 (982)
                      ++++|..++.. ...++++..+..++.|++.|++|||+.+   |+||||||+||+++.++.+|++|||++......  ..
T Consensus        85 ~~~~l~~~~~~-~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~--~~  158 (282)
T cd06643          85 AGGAVDAVMLE-LERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--IQ  158 (282)
T ss_pred             CCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEcccccccccccc--cc
Confidence            99999998763 3457899999999999999999999988   999999999999999999999999998765422  12


Q ss_pred             cccccccccccccccccc-----cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccc
Q 002010          852 CMSSVAGSYGYIAPEYAY-----TLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVL  926 (982)
Q Consensus       852 ~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  926 (982)
                      ......++..|+|||++.     +..++.++||||+||++|||++|++||....................          
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~----------  228 (282)
T cd06643         159 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTL----------  228 (282)
T ss_pred             ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCC----------
Confidence            233456889999999874     34578899999999999999999999976543222222211111000          


Q ss_pred             eeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          927 AVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       927 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                              ..+...+..+.+++.+||+.||.+||+++++++
T Consensus       229 --------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  261 (282)
T cd06643         229 --------AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ  261 (282)
T ss_pred             --------CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                    112223457899999999999999999999886

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=2.4e-35  Score=327.79  Aligned_cols=239  Identities=25%  Similarity=0.288  Sum_probs=190.1

Q ss_pred             cccccccceEEEEEEe-CCCcEEEEEEeccCC--CCCchhhHHHHHHH-HhcCCCCcccceEeEEEcCCccEEEEeccCC
Q 002010          698 NIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRG--TGGNDHGFLAEIQT-LGRIRHRNIVRLLGYVSNRDTNLLLYEYMPN  773 (982)
Q Consensus       698 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~-l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  773 (982)
                      +.||+|+||+||+|.. .+|+.||+|++....  .......+..|..+ ++.++||||+++++++..++..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            3689999999999965 568999999985432  22233455566554 6778999999999999999999999999999


Q ss_pred             CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCcccc
Q 002010          774 GSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECM  853 (982)
Q Consensus       774 ~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~  853 (982)
                      ++|..++.  +...+++..+..++.||+.|++|||+.+   |+||||||+||+++.++.+||+|||++......  ....
T Consensus        81 ~~L~~~l~--~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~--~~~~  153 (325)
T cd05604          81 GELFFHLQ--RERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ--SDTT  153 (325)
T ss_pred             CCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCC--CCCc
Confidence            99999886  4567899999999999999999999988   999999999999999999999999998753221  1223


Q ss_pred             cccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceeecCCC
Q 002010          854 SSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDPRL  933 (982)
Q Consensus       854 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  933 (982)
                      ....|++.|+|||++.+..++.++||||+||++|||++|+.||............... ..                   
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~-~~-------------------  213 (325)
T cd05604         154 TTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHK-PL-------------------  213 (325)
T ss_pred             ccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcC-Cc-------------------
Confidence            4567899999999999999999999999999999999999999764322211111110 00                   


Q ss_pred             CCCChHhHHHHHHHHhhccCCCCCCCCCHHH
Q 002010          934 SGYPLTGVIHLFKVAMMCVEDESSARPTMRE  964 (982)
Q Consensus       934 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~e  964 (982)
                       ..+......+.+++.+|++.||.+||++.+
T Consensus       214 -~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~  243 (325)
T cd05604         214 -VLRPGASLTAWSILEELLEKDRQRRLGAKE  243 (325)
T ss_pred             -cCCCCCCHHHHHHHHHHhccCHHhcCCCCC
Confidence             011123346789999999999999998864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=2.1e-34  Score=317.73  Aligned_cols=266  Identities=23%  Similarity=0.347  Sum_probs=203.5

Q ss_pred             hcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEecc
Q 002010          693 SLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYM  771 (982)
Q Consensus       693 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  771 (982)
                      +|+..+.||+|+||.||+|.. .++..||+|.+...........+.+|++++++++||||+++++++.+++..++||||+
T Consensus         2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~   81 (308)
T cd06615           2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHM   81 (308)
T ss_pred             CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeecc
Confidence            578889999999999999965 4688899998754433334456889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCc
Q 002010          772 PNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHH-DCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS  850 (982)
Q Consensus       772 ~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  850 (982)
                      ++++|.++++.  ...+++..+..++.|++.|++|||+ .+   ++||||||+||+++.++.+||+|||++......   
T Consensus        82 ~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~---  153 (308)
T cd06615          82 DGGSLDQVLKK--AGRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---  153 (308)
T ss_pred             CCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCccccccc---
Confidence            99999999973  3678999999999999999999997 46   999999999999999999999999998765432   


Q ss_pred             ccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCccc-------
Q 002010          851 ECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAA-------  923 (982)
Q Consensus       851 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------  923 (982)
                       ......++..|+|||+..+..++.++||||+|+++|+|++|+.||.... ......+..........+....       
T Consensus       154 -~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (308)
T cd06615         154 -MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPD-AKELEAMFGRPVSEGEAKESHRPVSGHPP  231 (308)
T ss_pred             -ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcc-hhhHHHhhcCccccccccCCcccccCCCC
Confidence             1234568899999999988889999999999999999999999996532 2222222221111110000000       


Q ss_pred             ---c-------cceeecCCCCCCCh-HhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002010          924 ---S-------VLAVVDPRLSGYPL-TGVIHLFKVAMMCVEDESSARPTMREVVHM  968 (982)
Q Consensus       924 ---~-------~~~~~~~~~~~~~~-~~~~~l~~li~~cl~~dP~~Rpt~~ell~~  968 (982)
                         .       ....+....+..+. ..+.++.+++.+||+.||++|||++|+++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  287 (308)
T cd06615         232 DSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH  287 (308)
T ss_pred             CccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence               0       00000000011111 134568899999999999999999999874

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=1.4e-34  Score=315.37  Aligned_cols=251  Identities=24%  Similarity=0.306  Sum_probs=200.6

Q ss_pred             cccccccccccceEEEEEEe-CCCcEEEEEEeccCCCC--CchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEec
Q 002010          694 LKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTG--GNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEY  770 (982)
Q Consensus       694 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  770 (982)
                      |+..+.||+|+||+||+|.. .+++.||+|.+......  .....+.+|+.++++++|++|+++++++..++..++||||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            56667899999999999965 56889999988543221  2234577899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCc
Q 002010          771 MPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS  850 (982)
Q Consensus       771 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  850 (982)
                      +++++|.+++.......+++..+..++.|++.|+.|||+.+   |+||||||+||++++++.+||+|||++......   
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~---  155 (285)
T cd05632          82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEG---  155 (285)
T ss_pred             ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCC---
Confidence            99999999887555567999999999999999999999988   999999999999999999999999998754322   


Q ss_pred             ccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceeec
Q 002010          851 ECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVD  930 (982)
Q Consensus       851 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  930 (982)
                      .......|+..|+|||++.+..++.++|+||+|+++|||++|..||....+......+....... .             
T Consensus       156 ~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~-~-------------  221 (285)
T cd05632         156 ESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLET-E-------------  221 (285)
T ss_pred             CcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhcc-c-------------
Confidence            12234578999999999998899999999999999999999999997643322222221111110 0             


Q ss_pred             CCCCCCChHhHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 002010          931 PRLSGYPLTGVIHLFKVAMMCVEDESSARPT-----MREVVH  967 (982)
Q Consensus       931 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt-----~~ell~  967 (982)
                         ...+...+..+.+++.+||+.||++||+     +++++.
T Consensus       222 ---~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05632         222 ---EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR  260 (285)
T ss_pred             ---cccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence               0112223446789999999999999999     666665

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-34  Score=312.91  Aligned_cols=250  Identities=26%  Similarity=0.435  Sum_probs=196.2

Q ss_pred             cccccccceEEEEEEeCC-Cc--EEEEEEeccCCCCCchhhHHHHHHHHhcC-CCCcccceEeEEEcCCccEEEEeccCC
Q 002010          698 NIIGKGGAGIVYRGSMPD-GI--DVAIKRLVGRGTGGNDHGFLAEIQTLGRI-RHRNIVRLLGYVSNRDTNLLLYEYMPN  773 (982)
Q Consensus       698 ~~lg~G~~g~Vy~~~~~~-~~--~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  773 (982)
                      +.||+|+||.||+|..++ +.  .+++|.+...........+.+|+.++.++ +||||+++++++......++||||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            368999999999997643 43  46888875444444556788999999999 799999999999999999999999999


Q ss_pred             CCHHHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccc
Q 002010          774 GSLGEMLHGAK--------------GGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFG  839 (982)
Q Consensus       774 ~sL~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG  839 (982)
                      ++|.+++....              ...+++..+..++.|++.|++|||+.+   ++||||||+||++++++.+|++|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence            99999997432              135789999999999999999999988   9999999999999999999999999


Q ss_pred             cchhccccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHhccCCCC
Q 002010          840 LAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQ  918 (982)
Q Consensus       840 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  918 (982)
                      ++......   ........+..|+|||++....++.++||||||+++|||++ |..||...... .....+   ....  
T Consensus       158 l~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~-~~~~~~---~~~~--  228 (270)
T cd05047         158 LSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-ELYEKL---PQGY--  228 (270)
T ss_pred             Cccccchh---hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH-HHHHHH---hCCC--
Confidence            98632211   11112233567999999988889999999999999999997 99999653322 111111   1100  


Q ss_pred             CCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 002010          919 PSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPP  973 (982)
Q Consensus       919 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~  973 (982)
                                    ....+...+..+.+++.+||+.||.+|||++|++..|+++.
T Consensus       229 --------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         229 --------------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             --------------CCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence                          00112223456889999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=6.8e-35  Score=323.46  Aligned_cols=241  Identities=24%  Similarity=0.309  Sum_probs=193.8

Q ss_pred             cccccccccccceEEEEEEe-CCCcEEEEEEeccCC--CCCchhhHHHHHHHHhcCC-CCcccceEeEEEcCCccEEEEe
Q 002010          694 LKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRG--TGGNDHGFLAEIQTLGRIR-HRNIVRLLGYVSNRDTNLLLYE  769 (982)
Q Consensus       694 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e  769 (982)
                      |+..+.||+|+||.||+|.. .+++.||+|++....  .......+..|..++..+. |++|+++++++.+.+..++|||
T Consensus         2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E   81 (323)
T cd05615           2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVME   81 (323)
T ss_pred             ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEc
Confidence            56678899999999999965 468899999985432  2233456778888888885 5788889999999999999999


Q ss_pred             ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCC
Q 002010          770 YMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGA  849 (982)
Q Consensus       770 ~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  849 (982)
                      |+++|+|.+++.  +...+++.++..++.|++.|++|||+.+   |+||||||+||+++.++.+||+|||++....... 
T Consensus        82 y~~~g~L~~~i~--~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~-  155 (323)
T cd05615          82 YVNGGDLMYHIQ--QVGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG-  155 (323)
T ss_pred             CCCCCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCCC-
Confidence            999999999986  4457999999999999999999999988   9999999999999999999999999987543221 


Q ss_pred             cccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceee
Q 002010          850 SECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVV  929 (982)
Q Consensus       850 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  929 (982)
                       .......||+.|+|||++.+..++.++||||+||++|||++|+.||...... .....+.....               
T Consensus       156 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~-~~~~~i~~~~~---------------  218 (323)
T cd05615         156 -VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED-ELFQSIMEHNV---------------  218 (323)
T ss_pred             -ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH-HHHHHHHhCCC---------------
Confidence             1223456899999999999888999999999999999999999999764332 22222111110               


Q ss_pred             cCCCCCCChHhHHHHHHHHhhccCCCCCCCCCH
Q 002010          930 DPRLSGYPLTGVIHLFKVAMMCVEDESSARPTM  962 (982)
Q Consensus       930 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~  962 (982)
                           ..+...+..+.+++.+|++.||.+|++.
T Consensus       219 -----~~p~~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         219 -----SYPKSLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             -----CCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence                 1122233467899999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=2.2e-34  Score=313.03  Aligned_cols=248  Identities=23%  Similarity=0.347  Sum_probs=198.3

Q ss_pred             hcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEecc
Q 002010          693 SLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYM  771 (982)
Q Consensus       693 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  771 (982)
                      +|+..+.||+|+||.||+|.. .+++.||+|.+...........+.+|+.++.+++||||+++++++..++..++||||+
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   81 (279)
T cd06619           2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM   81 (279)
T ss_pred             cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence            467778999999999999964 5788999998855434444567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCcc
Q 002010          772 PNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASE  851 (982)
Q Consensus       772 ~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~  851 (982)
                      ++++|..+.      .+++..+..++.|++.|++|||+.+   |+|+||||+||+++.++.+||+|||++......    
T Consensus        82 ~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~----  148 (279)
T cd06619          82 DGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS----  148 (279)
T ss_pred             CCCChHHhh------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccc----
Confidence            999997653      4678889999999999999999988   999999999999999999999999999765422    


Q ss_pred             cccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchH---HHHHHHhccCCCCCCccccccee
Q 002010          852 CMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDI---VRWVRKTTSEVSQPSDAASVLAV  928 (982)
Q Consensus       852 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~  928 (982)
                      ......++..|+|||++.+..++.++||||+|+++|+|++|+.||.........   ...........            
T Consensus       149 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~------------  216 (279)
T cd06619         149 IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED------------  216 (279)
T ss_pred             cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC------------
Confidence            223457889999999999889999999999999999999999999753322111   11111111000            


Q ss_pred             ecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002010          929 VDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHM  968 (982)
Q Consensus       929 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~  968 (982)
                       .+...  ....+.++.+++.+||+.||++||+++|+++.
T Consensus       217 -~~~~~--~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         217 -PPVLP--VGQFSEKFVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             -CCCCC--CCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence             00000  11223468899999999999999999999863

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=3.5e-35  Score=325.99  Aligned_cols=238  Identities=25%  Similarity=0.303  Sum_probs=188.6

Q ss_pred             cccccccceEEEEEEe-CCCcEEEEEEeccCC--CCCchhhHHHHHH-HHhcCCCCcccceEeEEEcCCccEEEEeccCC
Q 002010          698 NIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRG--TGGNDHGFLAEIQ-TLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPN  773 (982)
Q Consensus       698 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  773 (982)
                      +.||+|+||.||+|+. .+++.||+|++....  .......+.+|.. +++.++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            3699999999999976 468899999985432  1222334555554 57788999999999999999999999999999


Q ss_pred             CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCcccc
Q 002010          774 GSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECM  853 (982)
Q Consensus       774 ~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~  853 (982)
                      ++|..++.  +...+++..+..++.||+.|++|||+.+   |+||||||+||+++.++.+||+|||+++.....  ....
T Consensus        81 ~~L~~~l~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~~  153 (321)
T cd05603          81 GELFFHLQ--RERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP--EETT  153 (321)
T ss_pred             CCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCC--CCcc
Confidence            99998886  3457889999999999999999999988   999999999999999999999999998753221  1223


Q ss_pred             cccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceeecCCC
Q 002010          854 SSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDPRL  933 (982)
Q Consensus       854 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  933 (982)
                      ....|++.|+|||++.+..++.++||||+||++|||++|+.||...... .....+   ....                 
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~i---~~~~-----------------  212 (321)
T cd05603         154 STFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS-QMYDNI---LHKP-----------------  212 (321)
T ss_pred             ccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHH-HHHHHH---hcCC-----------------
Confidence            4457899999999999889999999999999999999999999764321 111111   1100                 


Q ss_pred             CCCChHhHHHHHHHHhhccCCCCCCCCCHH
Q 002010          934 SGYPLTGVIHLFKVAMMCVEDESSARPTMR  963 (982)
Q Consensus       934 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~  963 (982)
                      ...+......+.+++.+|++.||.+||++.
T Consensus       213 ~~~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         213 LQLPGGKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             CCCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence            012223345688999999999999999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.3e-34  Score=315.72  Aligned_cols=258  Identities=27%  Similarity=0.375  Sum_probs=207.5

Q ss_pred             hhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEec
Q 002010          692 ESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEY  770 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  770 (982)
                      +.|+..+.||+|+||+||+|.. ++++.||+|++...........+.+|+++++.++||||+++++++......++||||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF   84 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence            5678888999999999999965 468899999886554455567889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCC
Q 002010          771 MPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHH-DCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGA  849 (982)
Q Consensus       771 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  849 (982)
                      +++++|.+++..  .+.+++..+..++.+++.|+.|||+ .+   ++||||+|+||++++++.++|+|||++......  
T Consensus        85 ~~~~~L~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~--  157 (284)
T cd06620          85 MDCGSLDRIYKK--GGPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELINS--  157 (284)
T ss_pred             CCCCCHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchhhh--
Confidence            999999999863  4578999999999999999999997 46   999999999999999999999999998754322  


Q ss_pred             cccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCc-------hHHHHHHHhccCCCCCCcc
Q 002010          850 SECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGV-------DIVRWVRKTTSEVSQPSDA  922 (982)
Q Consensus       850 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~-------~~~~~~~~~~~~~~~~~~~  922 (982)
                        ......|+..|+|||++.+..++.++||||+||++|++++|..||.......       ....++......       
T Consensus       158 --~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-------  228 (284)
T cd06620         158 --IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQE-------  228 (284)
T ss_pred             --ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhc-------
Confidence              1223568899999999988889999999999999999999999998643321       111222211110       


Q ss_pred             cccceeecCCCCCCC-hHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCC
Q 002010          923 ASVLAVVDPRLSGYP-LTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQ  974 (982)
Q Consensus       923 ~~~~~~~~~~~~~~~-~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~~  974 (982)
                               ..+..+ ...+..+.+++.+||+.||++|||++|+++...-+..
T Consensus       229 ---------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~  272 (284)
T cd06620         229 ---------PPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA  272 (284)
T ss_pred             ---------cCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence                     000111 1244578899999999999999999999986543333

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.6e-34  Score=315.17  Aligned_cols=271  Identities=27%  Similarity=0.348  Sum_probs=201.7

Q ss_pred             hhcccccccccccceEEEEEEe-----CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEc--CCcc
Q 002010          692 ESLKDENIIGKGGAGIVYRGSM-----PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSN--RDTN  764 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~  764 (982)
                      ..|+..+.||+|+||.||+|..     .+++.||+|.+... .....+.+.+|+.++++++||||+++++++..  ....
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   82 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS-TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   82 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence            3577888999999999999964     35789999987433 33344578899999999999999999998654  3467


Q ss_pred             EEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhc
Q 002010          765 LLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFL  844 (982)
Q Consensus       765 ~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~  844 (982)
                      ++||||+++++|.+++... ...+++..+..++.|++.|++|||+.+   |+||||||+||++++++.+||+|||++...
T Consensus        83 ~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~  158 (284)
T cd05081          83 RLVMEYLPYGSLRDYLQKH-RERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVL  158 (284)
T ss_pred             EEEEEecCCCCHHHHHHhc-CcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccc
Confidence            8999999999999999643 346899999999999999999999988   999999999999999999999999999876


Q ss_pred             cccCCccc-ccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCccc
Q 002010          845 QDAGASEC-MSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAA  923 (982)
Q Consensus       845 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  923 (982)
                      ........ .....++..|+|||+..+..++.++||||+|+++|||++|..|+.....  ...........   ......
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~--~~~~~~~~~~~---~~~~~~  233 (284)
T cd05081         159 PQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPA--EFMRMMGNDKQ---GQMIVY  233 (284)
T ss_pred             cCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcch--hhhhhcccccc---cccchH
Confidence            53322111 1122334569999999988899999999999999999998877643211  11111110000   000000


Q ss_pred             ccceeec-CCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 002010          924 SVLAVVD-PRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANP  972 (982)
Q Consensus       924 ~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~  972 (982)
                      ....... ......+...+..+.+++.+||+.+|++|||+.||++.|+.+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         234 HLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             HHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            0000011 011122334456799999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=2.4e-34  Score=310.83  Aligned_cols=258  Identities=27%  Similarity=0.417  Sum_probs=208.1

Q ss_pred             hhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEec
Q 002010          692 ESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEY  770 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  770 (982)
                      ++|+..+.||.|+||+||+|.. .++..+|+|++...........+.+|+.+++.++|+||+++++.+..++..++|||+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            3578889999999999999975 468899999986544444667889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCC
Q 002010          771 MPNGSLGEMLHGAKG-GHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGA  849 (982)
Q Consensus       771 ~~~~sL~~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  849 (982)
                      +++++|.+++..... ..+++..+..++.|++.|++|||+.+   |+||||+|+||++++++.++++|||++..+.....
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~  157 (267)
T cd06610          81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD  157 (267)
T ss_pred             cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence            999999999975333 57899999999999999999999888   99999999999999999999999999987764322


Q ss_pred             cc--cccccccccccccccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccc
Q 002010          850 SE--CMSSVAGSYGYIAPEYAYTL-KVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVL  926 (982)
Q Consensus       850 ~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  926 (982)
                      ..  ......++..|+|||++... .++.++|+||+|+++|||++|+.||.......................       
T Consensus       158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-------  230 (267)
T cd06610         158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETG-------  230 (267)
T ss_pred             ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCc-------
Confidence            21  22334688899999998776 789999999999999999999999976544333333322211100000       


Q ss_pred             eeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          927 AVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       927 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                              ......+..+.+++.+||+.||++|||++|+++
T Consensus       231 --------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         231 --------ADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             --------cccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence                    001233457889999999999999999999975

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=8.2e-36  Score=325.35  Aligned_cols=246  Identities=26%  Similarity=0.432  Sum_probs=201.9

Q ss_pred             ccccccccccceEEEEEE-eCCCcEEEEEEecc---CCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCc--cEEEE
Q 002010          695 KDENIIGKGGAGIVYRGS-MPDGIDVAIKRLVG---RGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDT--NLLLY  768 (982)
Q Consensus       695 ~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~---~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~--~~lv~  768 (982)
                      +..++||+|+|-+||||- ..+|.+||--.++.   ..+....++|..|+.+++.++||||+++|+++.+...  ..+|+
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT  122 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT  122 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence            344579999999999994 44688887543322   2334445789999999999999999999999887665  67899


Q ss_pred             eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCC-CCEEEeccccchhcccc
Q 002010          769 EYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSD-FEAHVADFGLAKFLQDA  847 (982)
Q Consensus       769 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~-~~~kl~DfG~a~~~~~~  847 (982)
                      |.+..|+|..|.+  +.++.+.+.+..|++||++||.|||++ .+||+|||||.+||+|+.+ |.|||+|.|+|..+...
T Consensus       123 EL~TSGtLr~Y~k--k~~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s  199 (632)
T KOG0584|consen  123 ELFTSGTLREYRK--KHRRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS  199 (632)
T ss_pred             ecccCCcHHHHHH--HhccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence            9999999999998  456888999999999999999999998 5899999999999999876 89999999999987643


Q ss_pred             CCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccce
Q 002010          848 GASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLA  927 (982)
Q Consensus       848 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  927 (982)
                          ...+.+|||.|||||+.. ..|++.+||||||+.+.||+|+..||..+..+..+.+.+.....       ...+. 
T Consensus       200 ----~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiK-------P~sl~-  266 (632)
T KOG0584|consen  200 ----HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIK-------PAALS-  266 (632)
T ss_pred             ----ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCC-------HHHhh-
Confidence                224478999999999888 78999999999999999999999999998776555555444332       11111 


Q ss_pred             eecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          928 VVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       928 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                                .....++.+||.+|+.. ..+|||+.|+++
T Consensus       267 ----------kV~dPevr~fIekCl~~-~~~R~sa~eLL~  295 (632)
T KOG0584|consen  267 ----------KVKDPEVREFIEKCLAT-KSERLSAKELLK  295 (632)
T ss_pred             ----------ccCCHHHHHHHHHHhcC-chhccCHHHHhh
Confidence                      12234688999999999 999999999987

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=6.1e-35  Score=330.81  Aligned_cols=267  Identities=19%  Similarity=0.250  Sum_probs=199.2

Q ss_pred             cccccccccccceEEEEEEe-CCCcEEEEEEeccCC-CCCchhhHHHHHHHHhcCCCCcccceEeEEEcCC-----ccEE
Q 002010          694 LKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRG-TGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRD-----TNLL  766 (982)
Q Consensus       694 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~~l  766 (982)
                      |+..+.||+|+||.||+|.. .+++.||+|++.... .....+.+.+|+.+++.++||||+++++++...+     ..++
T Consensus         2 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l   81 (372)
T cd07853           2 VEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYV   81 (372)
T ss_pred             CcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEE
Confidence            67788999999999999965 578999999885432 2223456889999999999999999999998766     6799


Q ss_pred             EEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccc
Q 002010          767 LYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQD  846 (982)
Q Consensus       767 v~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  846 (982)
                      ||||+. ++|.+++.  ....+++..+..++.||+.|++|||+.+   |+||||||+||+++.++.+||+|||+++....
T Consensus        82 v~e~~~-~~l~~~~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~  155 (372)
T cd07853          82 VTELMQ-SDLHKIIV--SPQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEP  155 (372)
T ss_pred             Eeeccc-cCHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeeccc
Confidence            999995 68888875  4467999999999999999999999988   99999999999999999999999999986543


Q ss_pred             cCCcccccccccccccccccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCC--ccc
Q 002010          847 AGASECMSSVAGSYGYIAPEYAYTL-KVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPS--DAA  923 (982)
Q Consensus       847 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~  923 (982)
                      . .........+++.|+|||++.+. .++.++||||+||++|||++|+.||...........+............  ...
T Consensus       156 ~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~  234 (372)
T cd07853         156 D-ESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACE  234 (372)
T ss_pred             C-ccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhH
Confidence            2 12223345678899999998764 4789999999999999999999999765433222222111111000000  000


Q ss_pred             cccee-----ec-CC---CCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          924 SVLAV-----VD-PR---LSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       924 ~~~~~-----~~-~~---~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                      .....     .. +.   ...........+.+++.+||+.||++|||++|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  287 (372)
T cd07853         235 GARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA  287 (372)
T ss_pred             HHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence            00000     00 00   00112223557889999999999999999999986

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=3.8e-35  Score=323.87  Aligned_cols=265  Identities=25%  Similarity=0.309  Sum_probs=207.6

Q ss_pred             hhcccccccccccceEEEEE-EeCCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCC-C-----CcccceEeEEEcCCcc
Q 002010          692 ESLKDENIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIR-H-----RNIVRLLGYVSNRDTN  764 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~~~~~~~~~~~~  764 (982)
                      .+|++.++||+|+||.|.+| +.++++.||||+++...  .-..+...|+.++..++ |     -|+|+++++|....+.
T Consensus       186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k--~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hl  263 (586)
T KOG0667|consen  186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK--RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHL  263 (586)
T ss_pred             EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh--HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccce
Confidence            37899999999999999999 45679999999984432  22344567999999996 3     5899999999999999


Q ss_pred             EEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCC--CCEEEeccccch
Q 002010          765 LLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSD--FEAHVADFGLAK  842 (982)
Q Consensus       765 ~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~--~~~kl~DfG~a~  842 (982)
                      |+|+|.+ ..+|+++++..+-..++...++.++.||+.||.+||+.+   |||.||||+|||+.+-  ..+||+|||.|+
T Consensus       264 ciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc  339 (586)
T KOG0667|consen  264 CIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSC  339 (586)
T ss_pred             eeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEeccccc
Confidence            9999999 669999999888889999999999999999999999988   9999999999999754  479999999999


Q ss_pred             hccccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCC----
Q 002010          843 FLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQ----  918 (982)
Q Consensus       843 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~----  918 (982)
                      +....    . ..+.-+..|+|||++.+.+|+.+.||||||||++||++|.+-|.+..+.+.+..++.-.+.++..    
T Consensus       340 ~~~q~----v-ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~  414 (586)
T KOG0667|consen  340 FESQR----V-YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDT  414 (586)
T ss_pred             ccCCc----c-eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            76532    1 25667889999999999999999999999999999999988887765544444444433322110    


Q ss_pred             ---------C-Cccccccee--------------------ec---C-CCC----CCChHhHHHHHHHHhhccCCCCCCCC
Q 002010          919 ---------P-SDAASVLAV--------------------VD---P-RLS----GYPLTGVIHLFKVAMMCVEDESSARP  960 (982)
Q Consensus       919 ---------~-~~~~~~~~~--------------------~~---~-~~~----~~~~~~~~~l~~li~~cl~~dP~~Rp  960 (982)
                               . .+.......                    .+   | ..+    ..+......+.+++++|++.||.+|+
T Consensus       415 ~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~  494 (586)
T KOG0667|consen  415 AKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERI  494 (586)
T ss_pred             ccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcC
Confidence                     0 000000000                    00   1 000    11224456689999999999999999


Q ss_pred             CHHHHHH
Q 002010          961 TMREVVH  967 (982)
Q Consensus       961 t~~ell~  967 (982)
                      |+.|.++
T Consensus       495 tp~qal~  501 (586)
T KOG0667|consen  495 TPAQALN  501 (586)
T ss_pred             CHHHHhc
Confidence            9999987

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=1.9e-34  Score=317.22  Aligned_cols=268  Identities=19%  Similarity=0.261  Sum_probs=202.9

Q ss_pred             hhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEec
Q 002010          692 ESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEY  770 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  770 (982)
                      ++|+..+.||+|+||.||+|.. .+++.||+|.+...........+.+|+.++++++||||+++++++..+...++||||
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~   85 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   85 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence            5688889999999999999965 468899999986554444556778999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCc
Q 002010          771 MPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS  850 (982)
Q Consensus       771 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  850 (982)
                      ++ ++|.+++... ...+++..+..++.|++.|++|||+.+   |+||||||+||++++++.+||+|||++.......  
T Consensus        86 ~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~--  158 (301)
T cd07873          86 LD-KDLKQYLDDC-GNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT--  158 (301)
T ss_pred             cc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCC--
Confidence            96 5899988643 356889999999999999999999988   9999999999999999999999999997643221  


Q ss_pred             ccccccccccccccccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCccccc--ce
Q 002010          851 ECMSSVAGSYGYIAPEYAYTL-KVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASV--LA  927 (982)
Q Consensus       851 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~  927 (982)
                      .......+++.|+|||++.+. .++.++||||+||++|||++|++||........ ...+......+.........  ..
T Consensus       159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  237 (301)
T cd07873         159 KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQ-LHFIFRILGTPTEETWPGILSNEE  237 (301)
T ss_pred             CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHcCCCChhhchhhhcccc
Confidence            122334578899999987654 578899999999999999999999976433222 22222211111110000000  00


Q ss_pred             eecCCCC--------CCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          928 VVDPRLS--------GYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       928 ~~~~~~~--------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                      ......+        ......+..+.+++.+|++.||.+|||++|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~  285 (301)
T cd07873         238 FKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK  285 (301)
T ss_pred             ccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            0000011        111233456889999999999999999999986

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=1.6e-34  Score=312.73  Aligned_cols=258  Identities=25%  Similarity=0.376  Sum_probs=204.7

Q ss_pred             hhcccccccccccceEEEEEEeCC----CcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEE
Q 002010          692 ESLKDENIIGKGGAGIVYRGSMPD----GIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLL  767 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  767 (982)
                      ++|...+.||+|+||.||+|...+    ...||+|...........+.+.+|+.++++++||||+++++++.+ +..++|
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv   84 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV   84 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence            457788899999999999996533    346899987544434455678999999999999999999998875 557899


Q ss_pred             EeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhcccc
Q 002010          768 YEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDA  847 (982)
Q Consensus       768 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  847 (982)
                      |||+++++|.+++... ...+++..+..++.|++.|++|||+.+   ++||||||+||+++.++.+|++|||.++.....
T Consensus        85 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~  160 (270)
T cd05056          85 MELAPLGELRSYLQVN-KYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE  160 (270)
T ss_pred             EEcCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeecccc
Confidence            9999999999999743 346899999999999999999999888   999999999999999999999999999866533


Q ss_pred             CCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHhccCCCCCCcccccc
Q 002010          848 GASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVL  926 (982)
Q Consensus       848 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  926 (982)
                      ... ......++..|+|||.+....++.++||||+|+++||+++ |..||........ ...+.....            
T Consensus       161 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~-~~~~~~~~~------------  226 (270)
T cd05056         161 SYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDV-IGRIENGER------------  226 (270)
T ss_pred             cce-ecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHH-HHHHHcCCc------------
Confidence            211 1122334568999999988889999999999999999997 9999976543222 222211110            


Q ss_pred             eeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCCC
Q 002010          927 AVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQS  975 (982)
Q Consensus       927 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~~~  975 (982)
                             ...+...+..+.+++.+|+..+|++|||+.++++.|+.+...
T Consensus       227 -------~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~  268 (270)
T cd05056         227 -------LPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE  268 (270)
T ss_pred             -------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence                   011223445789999999999999999999999999877654

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=1.4e-34  Score=325.95  Aligned_cols=268  Identities=22%  Similarity=0.267  Sum_probs=200.6

Q ss_pred             HHHhhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCC-CCchhhHHHHHHHHhcCCCCcccceEeEEEcCC----
Q 002010          689 DVLESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGT-GGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRD----  762 (982)
Q Consensus       689 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----  762 (982)
                      .+.++|+..+.||+|+||.||+|.. ..++.||+|++..... ......+.+|+.+++.++||||+++++++....    
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   93 (355)
T cd07874          14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE   93 (355)
T ss_pred             hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence            3567899999999999999999964 4688999998854332 233456788999999999999999999886433    


Q ss_pred             --ccEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEecccc
Q 002010          763 --TNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGL  840 (982)
Q Consensus       763 --~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~  840 (982)
                        ..++||||+++ ++.+.+.    ..+++..+..++.|++.|++|||+.+   |+||||||+||+++.++.+||+|||+
T Consensus        94 ~~~~~lv~e~~~~-~l~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~  165 (355)
T cd07874          94 FQDVYLVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL  165 (355)
T ss_pred             cceeEEEhhhhcc-cHHHHHh----hcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcc
Confidence              46899999965 6777664    25788999999999999999999988   99999999999999999999999999


Q ss_pred             chhccccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCC---
Q 002010          841 AKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVS---  917 (982)
Q Consensus       841 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---  917 (982)
                      ++.....   .......+|+.|+|||++.+..++.++||||+||++|||++|+.||............+.......+   
T Consensus       166 ~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  242 (355)
T cd07874         166 ARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM  242 (355)
T ss_pred             cccCCCc---cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            9865422   2234457899999999999999999999999999999999999999764332222222221111000   


Q ss_pred             -------------CCCccc-ccceee-cCCC---CCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          918 -------------QPSDAA-SVLAVV-DPRL---SGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       918 -------------~~~~~~-~~~~~~-~~~~---~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                                   .+.... .....+ +...   ...+......+.+++.+|++.||++|||++|+++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~  310 (355)
T cd07874         243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQ  310 (355)
T ss_pred             HhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhc
Confidence                         000000 000000 0000   1112223456889999999999999999999998

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=1.9e-34  Score=314.89  Aligned_cols=269  Identities=20%  Similarity=0.261  Sum_probs=202.1

Q ss_pred             hcccccccccccceEEEEEEe-CCCcEEEEEEeccCCC-CCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEec
Q 002010          693 SLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGT-GGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEY  770 (982)
Q Consensus       693 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  770 (982)
                      +|+..+.||+|++|.||+|.. .++..||+|.+..... ......+.+|+.++++++||||+++++++.++...++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            367788999999999999965 4689999998854332 23345678999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCC
Q 002010          771 MPNGSLGEMLHGAK-GGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGA  849 (982)
Q Consensus       771 ~~~~sL~~~l~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  849 (982)
                      ++ ++|.+++.... ...+++..+..++.|++.||+|||+.+   |+||||+|+||+++.++.+||+|||++......  
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--  154 (285)
T cd07861          81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP--  154 (285)
T ss_pred             CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCC--
Confidence            97 68988886433 367899999999999999999999988   999999999999999999999999999755422  


Q ss_pred             cccccccccccccccccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcc----cc
Q 002010          850 SECMSSVAGSYGYIAPEYAYTL-KVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDA----AS  924 (982)
Q Consensus       850 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~  924 (982)
                      ........+++.|+|||++.+. .++.++||||+|+++|||+||++||..........................    ..
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (285)
T cd07861         155 VRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPD  234 (285)
T ss_pred             cccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHH
Confidence            1222334568899999987654 478999999999999999999999976543333333322222111100000    00


Q ss_pred             ccee----ecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          925 VLAV----VDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       925 ~~~~----~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                      ....    ............+.++.+++.+||+.||++|||+.++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         235 YKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             HHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence            0000    000111112224557789999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=2.9e-34  Score=310.16  Aligned_cols=250  Identities=28%  Similarity=0.414  Sum_probs=201.3

Q ss_pred             hcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCCCc--------hhhHHHHHHHHhcCCCCcccceEeEEEcCCc
Q 002010          693 SLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGN--------DHGFLAEIQTLGRIRHRNIVRLLGYVSNRDT  763 (982)
Q Consensus       693 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~--------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  763 (982)
                      +|..++.||+|++|.||+|.. .+++.||+|.+........        .+.+.+|+.++++++||||+++++++...+.
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            366778999999999999965 4688999998854432211        2457889999999999999999999999999


Q ss_pred             cEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchh
Q 002010          764 NLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKF  843 (982)
Q Consensus       764 ~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~  843 (982)
                      .++||||+++++|.+++..  ...+++..+..++.|++.|++|||+.+   ++||||+|+||++++++.+||+|||.++.
T Consensus        81 ~~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~~  155 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNN--YGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKK  155 (267)
T ss_pred             cEEEEEecCCCCHHHHHHh--ccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCcc
Confidence            9999999999999999973  357889999999999999999999988   99999999999999999999999999987


Q ss_pred             ccccCC----cccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCC
Q 002010          844 LQDAGA----SECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQP  919 (982)
Q Consensus       844 ~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  919 (982)
                      ......    ........++..|+|||.+.+..++.++||||+|+++|+|++|+.||..............         
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---------  226 (267)
T cd06628         156 LEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGE---------  226 (267)
T ss_pred             cccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhc---------
Confidence            653211    1111234578899999999988899999999999999999999999976433221111100         


Q ss_pred             CcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          920 SDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       920 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                                 ...+..+...+..+.+++.+||+.||.+||++.|+++
T Consensus       227 -----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         227 -----------NASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             -----------cCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence                       0111223344567889999999999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=1.9e-34  Score=311.58  Aligned_cols=253  Identities=25%  Similarity=0.343  Sum_probs=200.3

Q ss_pred             HhhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEe
Q 002010          691 LESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYE  769 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  769 (982)
                      .++|+..+.||+|+||.||+|.. .+++.||+|.+... .......+.+|+.+++.++||||+++++++..++..++|||
T Consensus         8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e   86 (267)
T cd06645           8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLE-PGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICME   86 (267)
T ss_pred             HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecC-chhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEe
Confidence            35788888999999999999964 56889999988543 22334567889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCC
Q 002010          770 YMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGA  849 (982)
Q Consensus       770 ~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  849 (982)
                      |+++++|.+++.  ..+.+++.++..++.|++.|++|||+.+   ++||||||+||+++.++.+||+|||++......  
T Consensus        87 ~~~~~~L~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~--  159 (267)
T cd06645          87 FCGGGSLQDIYH--VTGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITAT--  159 (267)
T ss_pred             ccCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCc--
Confidence            999999999986  3457899999999999999999999988   999999999999999999999999998765432  


Q ss_pred             cccccccccccccccccccc---cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccc
Q 002010          850 SECMSSVAGSYGYIAPEYAY---TLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVL  926 (982)
Q Consensus       850 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  926 (982)
                      ........|+..|+|||++.   ...++.++||||+||++|+|++|..||..................   .+       
T Consensus       160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~---~~-------  229 (267)
T cd06645         160 IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQ---PP-------  229 (267)
T ss_pred             ccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCC---CC-------
Confidence            12223457899999999874   455889999999999999999999998654332221111111000   00       


Q ss_pred             eeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          927 AVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       927 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                           ... .....+..+.+++.+||+.||++|||++++++
T Consensus       230 -----~~~-~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         230 -----KLK-DKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             -----ccc-ccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence                 000 00112346789999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=2.4e-34  Score=320.15  Aligned_cols=268  Identities=19%  Similarity=0.243  Sum_probs=197.6

Q ss_pred             ccccccc--cceEEEEEEe-CCCcEEEEEEeccCCCC-CchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEeccC
Q 002010          697 ENIIGKG--GAGIVYRGSM-PDGIDVAIKRLVGRGTG-GNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMP  772 (982)
Q Consensus       697 ~~~lg~G--~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  772 (982)
                      .++||+|  +|++||++.. .+|+.||+|++...... .....+.+|+.+++.++||||+++++++..++..++||||++
T Consensus         3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~   82 (327)
T cd08227           3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA   82 (327)
T ss_pred             hhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccC
Confidence            4679999  6889999954 57899999998544332 233457789999999999999999999999999999999999


Q ss_pred             CCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCcc-
Q 002010          773 NGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASE-  851 (982)
Q Consensus       773 ~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~-  851 (982)
                      +++|.+++.......+++..+..++.|++.|++|||+.+   |+||||||+||+++.++.++++||+.+......+... 
T Consensus        83 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~  159 (327)
T cd08227          83 YGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLR  159 (327)
T ss_pred             CCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcccccccccc
Confidence            999999997554566899999999999999999999988   9999999999999999999999998765433221110 


Q ss_pred             ----ccccccccccccccccccc--CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCC-----CC
Q 002010          852 ----CMSSVAGSYGYIAPEYAYT--LKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQ-----PS  920 (982)
Q Consensus       852 ----~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-----~~  920 (982)
                          ......++..|+|||++.+  ..++.++||||+||++|||++|+.||......................     +.
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (327)
T cd08227         160 VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAE  239 (327)
T ss_pred             ccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhh
Confidence                1122346778999999876  458999999999999999999999997654433222222111110000     00


Q ss_pred             c----------ccccce--e---ecC-----CCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          921 D----------AASVLA--V---VDP-----RLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       921 ~----------~~~~~~--~---~~~-----~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                      .          ......  .   ..+     ............+.+++.+||+.||++|||++|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~  306 (327)
T cd08227         240 ELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN  306 (327)
T ss_pred             hcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence            0          000000  0   000     000112233457899999999999999999999987

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=3.2e-34  Score=314.22  Aligned_cols=249  Identities=23%  Similarity=0.356  Sum_probs=203.1

Q ss_pred             hhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEec
Q 002010          692 ESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEY  770 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  770 (982)
                      ..|+..+.||.|++|.||+|.. .+++.||+|.+... .......+.+|+.+++.++||||+++++++...+..++|+||
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   97 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQ-KQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEY   97 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecc-cCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEe
Confidence            4688889999999999999964 57899999988543 333456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCc
Q 002010          771 MPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS  850 (982)
Q Consensus       771 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  850 (982)
                      +++++|.+++..   ..+++.++..++.|++.|++|||+.+   ++||||||+||+++.++.+||+|||++........ 
T Consensus        98 ~~~~~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~-  170 (296)
T cd06655          98 LAGGSLTDVVTE---TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS-  170 (296)
T ss_pred             cCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcccccc-
Confidence            999999999853   46899999999999999999999988   99999999999999999999999999876543221 


Q ss_pred             ccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceeec
Q 002010          851 ECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVD  930 (982)
Q Consensus       851 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  930 (982)
                       ......++..|+|||.+.+..++.++||||+||++|+|++|+.||...................               
T Consensus       171 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~---------------  234 (296)
T cd06655         171 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPE---------------  234 (296)
T ss_pred             -cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcc---------------
Confidence             1233568889999999998889999999999999999999999997643322222111110000               


Q ss_pred             CCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          931 PRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       931 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                         ...+...+..+.+++.+||..||++|||+++++.
T Consensus       235 ---~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~  268 (296)
T cd06655         235 ---LQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ  268 (296)
T ss_pred             ---cCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence               0112223446889999999999999999999886

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=2.8e-34  Score=309.37  Aligned_cols=252  Identities=29%  Similarity=0.425  Sum_probs=193.8

Q ss_pred             cccccccceEEEEEEeC----CCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEE-cCCccEEEEeccC
Q 002010          698 NIIGKGGAGIVYRGSMP----DGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVS-NRDTNLLLYEYMP  772 (982)
Q Consensus       698 ~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-~~~~~~lv~e~~~  772 (982)
                      +.||+|+||.||+|...    ++..||+|++...........+.+|+.+++.++||||+++++++. .+...++||||+.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            36899999999999642    245799998744333334567889999999999999999999765 4556799999999


Q ss_pred             CCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCc--
Q 002010          773 NGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS--  850 (982)
Q Consensus       773 ~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~--  850 (982)
                      +++|.+++... ....++..+..++.|++.|++|||+.+   ++||||||+||++++++.+||+|||+++.+.+....  
T Consensus        81 ~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~  156 (262)
T cd05058          81 HGDLRNFIRSE-THNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSV  156 (262)
T ss_pred             CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCcceee
Confidence            99999999743 345678888999999999999999988   999999999999999999999999999765432111  


Q ss_pred             ccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhC-CCCCCCCCCCchHHHHHHHhccCCCCCCcccccceee
Q 002010          851 ECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAG-KKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVV  929 (982)
Q Consensus       851 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  929 (982)
                      .......++..|+|||.+.+..++.++||||||+++|||++| .+||... ........+.....               
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~-~~~~~~~~~~~~~~---------------  220 (262)
T cd05058         157 HNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-DSFDITVYLLQGRR---------------  220 (262)
T ss_pred             cccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCC-CHHHHHHHHhcCCC---------------
Confidence            111233456789999999888899999999999999999995 5566543 22222222211100               


Q ss_pred             cCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 002010          930 DPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPP  973 (982)
Q Consensus       930 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~  973 (982)
                          ...+...+..+.+++.+||+.+|++||++.|+++.|+++.
T Consensus       221 ----~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~  260 (262)
T cd05058         221 ----LLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF  260 (262)
T ss_pred             ----CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence                0111123457889999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=2.4e-34  Score=325.17  Aligned_cols=267  Identities=23%  Similarity=0.266  Sum_probs=200.5

Q ss_pred             HHhhcccccccccccceEEEEEEe-CCCcEEEEEEeccCC-CCCchhhHHHHHHHHhcCCCCcccceEeEEEcC------
Q 002010          690 VLESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRG-TGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNR------  761 (982)
Q Consensus       690 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------  761 (982)
                      +.++|+..+.||+|+||.||+|.. ..++.||||++.... .......+.+|+.+++.++||||+++++++...      
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            457899999999999999999964 468899999985432 233445678999999999999999999987543      


Q ss_pred             CccEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccc
Q 002010          762 DTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLA  841 (982)
Q Consensus       762 ~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a  841 (982)
                      ...++||||++ +++.+++.    ..+++..+..++.|++.|++|||+++   |+||||||+||+++.++.+||+|||++
T Consensus       102 ~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a  173 (364)
T cd07875         102 QDVYIVMELMD-ANLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA  173 (364)
T ss_pred             CeEEEEEeCCC-CCHHHHHH----hcCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCCc
Confidence            34699999995 47777774    24788999999999999999999988   999999999999999999999999999


Q ss_pred             hhccccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCC----
Q 002010          842 KFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVS----  917 (982)
Q Consensus       842 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----  917 (982)
                      +.....   .......+|+.|+|||++.+..++.++||||+||++|||++|+.||............+.......+    
T Consensus       174 ~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  250 (364)
T cd07875         174 RTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMK  250 (364)
T ss_pred             cccCCC---CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence            865422   2223457899999999999999999999999999999999999999765433332222221111000    


Q ss_pred             ------------CCCc-ccccceee----cCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          918 ------------QPSD-AASVLAVV----DPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       918 ------------~~~~-~~~~~~~~----~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                                  .+.. .......+    .+............+.+++.+|++.||++|||++|+++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~  317 (364)
T cd07875         251 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ  317 (364)
T ss_pred             hhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence                        0000 00000000    00001111223356889999999999999999999987

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=3e-34  Score=308.02  Aligned_cols=251  Identities=24%  Similarity=0.319  Sum_probs=205.8

Q ss_pred             hcccccccccccceEEEEEEe-CCCcEEEEEEeccCC-CCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEec
Q 002010          693 SLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRG-TGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEY  770 (982)
Q Consensus       693 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  770 (982)
                      +|+..+.||+|+||.||.++. .+++.+++|.+.... .......+.+|+.++++++|+||+++++++.+.+..+++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            477888999999999999854 568899999875432 334456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCc
Q 002010          771 MPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS  850 (982)
Q Consensus       771 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  850 (982)
                      +++++|.+++.......+++..+..++.|++.|++|||+.+   ++||||+|+||++++++.+||+|||.+........ 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~-  156 (256)
T cd08221          81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS-  156 (256)
T ss_pred             cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence            99999999998655567899999999999999999999988   99999999999999999999999999986643321 


Q ss_pred             ccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceeec
Q 002010          851 ECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVD  930 (982)
Q Consensus       851 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  930 (982)
                       ......+++.|+|||...+..++.++||||+|+++|||++|..||......+........                   
T Consensus       157 -~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~-------------------  216 (256)
T cd08221         157 -MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQG-------------------  216 (256)
T ss_pred             -cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC-------------------
Confidence             233456889999999998888999999999999999999999999754322222222110                   


Q ss_pred             CCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002010          931 PRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHM  968 (982)
Q Consensus       931 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~  968 (982)
                       .....+...+..+.+++.+||+.+|++||+++|+++.
T Consensus       217 -~~~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~  253 (256)
T cd08221         217 -NYTPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ  253 (256)
T ss_pred             -CCCCCccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence             0111112334578899999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=3.6e-34  Score=307.32  Aligned_cols=252  Identities=27%  Similarity=0.464  Sum_probs=202.4

Q ss_pred             hhcccccccccccceEEEEEEeCCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEecc
Q 002010          692 ESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYM  771 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  771 (982)
                      .+|+..+.||+|+||.||+|...++..+|+|.+...  ......+.+|++++++++||+++++++++......++||||+
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   81 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREG--AMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFM   81 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCC--CCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcC
Confidence            467778899999999999998767889999987432  233457889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCcc
Q 002010          772 PNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASE  851 (982)
Q Consensus       772 ~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~  851 (982)
                      ++++|.+++... ...++++.+..++.|++.|++|||+.+   ++||||||+||+++.++.+||+|||.+....... ..
T Consensus        82 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~  156 (256)
T cd05112          82 EHGCLSDYLRAQ-RGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ-YT  156 (256)
T ss_pred             CCCcHHHHHHhC-ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCc-cc
Confidence            999999998643 346889999999999999999999988   9999999999999999999999999987654321 11


Q ss_pred             cccccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceeec
Q 002010          852 CMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVD  930 (982)
Q Consensus       852 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  930 (982)
                      ......++..|+|||.+.+..++.++||||+|+++|||++ |..||..... ............                
T Consensus       157 ~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-~~~~~~~~~~~~----------------  219 (256)
T cd05112         157 SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN-SEVVETINAGFR----------------  219 (256)
T ss_pred             ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH-HHHHHHHhCCCC----------------
Confidence            1223345678999999998889999999999999999998 9999975332 122222111100                


Q ss_pred             CCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 002010          931 PRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLA  970 (982)
Q Consensus       931 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~  970 (982)
                      +   ..+...+..+.+++.+||+.+|++|||+.|+++.|.
T Consensus       220 ~---~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~  256 (256)
T cd05112         220 L---YKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQLA  256 (256)
T ss_pred             C---CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence            0   011112357899999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.3e-34  Score=327.75  Aligned_cols=264  Identities=22%  Similarity=0.242  Sum_probs=201.1

Q ss_pred             hhcccccccccccceEEEEEEe---CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEE
Q 002010          692 ESLKDENIIGKGGAGIVYRGSM---PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLY  768 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~---~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  768 (982)
                      .+|++.+.||+|+||.||+|..   ..+..||+|.+...      ....+|+.++++++||||+++++++......++||
T Consensus        92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~  165 (392)
T PHA03207         92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG------KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM  165 (392)
T ss_pred             CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc------ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence            4688999999999999999954   23678999987432      23568999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccC
Q 002010          769 EYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAG  848 (982)
Q Consensus       769 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  848 (982)
                      |++. ++|.+++.  ....+++..+..++.||+.||+|||+.+   |+||||||+||+++.++.+||+|||++.......
T Consensus       166 e~~~-~~l~~~l~--~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~  239 (392)
T PHA03207        166 PKYK-CDLFTYVD--RSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP  239 (392)
T ss_pred             hhcC-CCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence            9994 68888884  4567999999999999999999999988   9999999999999999999999999998765433


Q ss_pred             CcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCC---chHHHHHHHhccCC-CCCCcc-c
Q 002010          849 ASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDG---VDIVRWVRKTTSEV-SQPSDA-A  923 (982)
Q Consensus       849 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~---~~~~~~~~~~~~~~-~~~~~~-~  923 (982)
                      .........||+.|+|||++.+..++.++||||+||++|||++|+.||......   ..+...++...... ..+... .
T Consensus       240 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~  319 (392)
T PHA03207        240 DTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGST  319 (392)
T ss_pred             ccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccch
Confidence            333334567999999999999999999999999999999999999999764332   12222222211110 001000 0


Q ss_pred             c-------cceeecCCCC--C--CChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          924 S-------VLAVVDPRLS--G--YPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       924 ~-------~~~~~~~~~~--~--~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                      .       ......+...  .  .....+.++.+++.+|+..||++|||+.|++.
T Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~  374 (392)
T PHA03207        320 NLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILS  374 (392)
T ss_pred             hHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhh
Confidence            0       0000001000  0  01123456889999999999999999999987

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=2.4e-34  Score=311.70  Aligned_cols=252  Identities=27%  Similarity=0.396  Sum_probs=199.4

Q ss_pred             HHhhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcC-CCCcccceEeEEEcC------
Q 002010          690 VLESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRI-RHRNIVRLLGYVSNR------  761 (982)
Q Consensus       690 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~------  761 (982)
                      ..+.|+..+.||+|+||.||+|.. .+++.||+|++...  ......+.+|+.++.++ +||||+++++++...      
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~--~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (272)
T cd06637           4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT--GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD   81 (272)
T ss_pred             hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcC--CccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence            346688888999999999999965 46889999988433  33456788999999998 699999999998653      


Q ss_pred             CccEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccc
Q 002010          762 DTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLA  841 (982)
Q Consensus       762 ~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a  841 (982)
                      ...++||||+++++|.+++.......+++..+..++.|++.|++|||+.+   |+||||||+||++++++.+||+|||++
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~~  158 (272)
T cd06637          82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVS  158 (272)
T ss_pred             cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCCc
Confidence            35789999999999999998655667899999999999999999999988   999999999999999999999999999


Q ss_pred             hhccccCCcccccccccccccccccccc-----cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCC
Q 002010          842 KFLQDAGASECMSSVAGSYGYIAPEYAY-----TLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEV  916 (982)
Q Consensus       842 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  916 (982)
                      ......  ........|++.|+|||++.     +..++.++||||+||++|||++|+.||............   ...  
T Consensus       159 ~~~~~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~---~~~--  231 (272)
T cd06637         159 AQLDRT--VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI---PRN--  231 (272)
T ss_pred             eecccc--cccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHH---hcC--
Confidence            765422  12234466889999999886     345888999999999999999999999754322111111   000  


Q ss_pred             CCCCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          917 SQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       917 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                                    +.....+...+..+.+++.+||+.||.+|||++|+++
T Consensus       232 --------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         232 --------------PAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             --------------CCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence                          0000111123456889999999999999999999875

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=4e-34  Score=313.33  Aligned_cols=251  Identities=24%  Similarity=0.349  Sum_probs=199.8

Q ss_pred             hhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEec
Q 002010          692 ESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEY  770 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  770 (982)
                      +.|++.+.||+|+||.||+|+. .++..||+|.+.. ........+.+|+.+++.++||||+++++++..+...++||||
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   90 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIET-KSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF   90 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEecc-CCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence            5688889999999999999976 4588999998843 2333456788899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCc
Q 002010          771 MPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS  850 (982)
Q Consensus       771 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  850 (982)
                      +++++|..++... ...+++..+..++.|++.|++|||+.+   ++||||||+||+++.++.+||+|||.+......  .
T Consensus        91 ~~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~--~  164 (292)
T cd06644          91 CPGGAVDAIMLEL-DRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT--L  164 (292)
T ss_pred             CCCCcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceecccc--c
Confidence            9999998887532 356899999999999999999999888   999999999999999999999999998754321  1


Q ss_pred             ccccccccccccccccccc-----cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCccccc
Q 002010          851 ECMSSVAGSYGYIAPEYAY-----TLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASV  925 (982)
Q Consensus       851 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  925 (982)
                      .......+++.|+|||++.     ...++.++||||+||++|||++|..||.............    ....        
T Consensus       165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~----~~~~--------  232 (292)
T cd06644         165 QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIA----KSEP--------  232 (292)
T ss_pred             cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHh----cCCC--------
Confidence            2223456788999999884     3447889999999999999999999997643322221111    1000        


Q ss_pred             ceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          926 LAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       926 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                           +.. ..+...+..+.+++.+||+.||++||+++|+++
T Consensus       233 -----~~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         233 -----PTL-SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             -----ccC-CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence                 000 112233446889999999999999999999987

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=3.4e-34  Score=315.41  Aligned_cols=258  Identities=27%  Similarity=0.443  Sum_probs=202.9

Q ss_pred             hhcccccccccccceEEEEEEe-CCCc----EEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEE
Q 002010          692 ESLKDENIIGKGGAGIVYRGSM-PDGI----DVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLL  766 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  766 (982)
                      ++|+..+.||+|+||.||+|.. .++.    .||+|.+..........++.+|+.++++++||||+++++++... ..++
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~   85 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL   85 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence            4577788999999999999965 3443    57888875443333445788999999999999999999988654 5678


Q ss_pred             EEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccc
Q 002010          767 LYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQD  846 (982)
Q Consensus       767 v~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  846 (982)
                      ++||+++|+|.+++... ...+++..+..++.|++.|++|||+.+   |+||||||+||+++.++.+||+|||+++.+..
T Consensus        86 v~e~~~~g~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~  161 (303)
T cd05110          86 VTQLMPHGCLLDYVHEH-KDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLEG  161 (303)
T ss_pred             eehhcCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccccccC
Confidence            99999999999998742 346889999999999999999999988   99999999999999999999999999987653


Q ss_pred             cCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHhccCCCCCCccccc
Q 002010          847 AGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASV  925 (982)
Q Consensus       847 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  925 (982)
                      ...........++..|+|||++.+..++.++||||+|+++|||++ |+.||.... ......++..... .         
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~-~~~~~~~~~~~~~-~---------  230 (303)
T cd05110         162 DEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIP-TREIPDLLEKGER-L---------  230 (303)
T ss_pred             cccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCC-HHHHHHHHHCCCC-C---------
Confidence            322222233445678999999998899999999999999999998 999997542 2223333222111 0         


Q ss_pred             ceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCC
Q 002010          926 LAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQ  974 (982)
Q Consensus       926 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~~  974 (982)
                               ..+..++..+.+++.+||..+|++||+++|+++.|+++..
T Consensus       231 ---------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~  270 (303)
T cd05110         231 ---------PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMAR  270 (303)
T ss_pred             ---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence                     0111233578899999999999999999999999987543

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=3e-34  Score=307.98  Aligned_cols=249  Identities=26%  Similarity=0.378  Sum_probs=203.2

Q ss_pred             hhcccccccccccceEEEEEEeCC-CcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEec
Q 002010          692 ESLKDENIIGKGGAGIVYRGSMPD-GIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEY  770 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  770 (982)
                      ++|+..+.||+|+||.||+|...+ ++.|++|.+.....   ...+.+|++++++++||||+++++++.++...++++||
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~   79 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED---LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY   79 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH---HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence            468888999999999999997654 78999998843322   67899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCc
Q 002010          771 MPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS  850 (982)
Q Consensus       771 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  850 (982)
                      +++++|.+++.. ....+++..+..++.|++.|++|||+.+   ++||||+|+||+++.++.+||+|||.+.......  
T Consensus        80 ~~~~~L~~~l~~-~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~--  153 (256)
T cd06612          80 CGAGSVSDIMKI-TNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM--  153 (256)
T ss_pred             CCCCcHHHHHHh-CccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCc--
Confidence            999999999863 2357899999999999999999999988   9999999999999999999999999998765332  


Q ss_pred             ccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceeec
Q 002010          851 ECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVD  930 (982)
Q Consensus       851 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  930 (982)
                      .......++..|+|||++.+..++.++||||+|+++|+|++|+.||..............   .               .
T Consensus       154 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~---~---------------~  215 (256)
T cd06612         154 AKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPN---K---------------P  215 (256)
T ss_pred             cccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhcc---C---------------C
Confidence            122345578899999999988999999999999999999999999975433221111000   0               0


Q ss_pred             CCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          931 PRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       931 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                      +.....+......+.+++.+||+.||++|||+.|+++
T Consensus       216 ~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         216 PPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             CCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence            0000112233457899999999999999999999985

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=1.9e-34  Score=325.36  Aligned_cols=254  Identities=21%  Similarity=0.236  Sum_probs=198.2

Q ss_pred             HhhcccccccccccceEEEEEEe-CCCcEEEEEEeccCC--CCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEE
Q 002010          691 LESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRG--TGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLL  767 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  767 (982)
                      .++|+..+.||+|+||.||+|+. .+++.||+|++....  .......+.+|+.+++.++||||+++++++.++...++|
T Consensus        42 ~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv  121 (371)
T cd05622          42 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMV  121 (371)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence            36899999999999999999965 468899999985322  222344577899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhcccc
Q 002010          768 YEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDA  847 (982)
Q Consensus       768 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  847 (982)
                      |||+++|+|.+++..   ..+++..+..++.||+.|++|||+.+   |+||||||+||+++.++.+||+|||++......
T Consensus       122 ~Ey~~gg~L~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~  195 (371)
T cd05622         122 MEYMPGGDLVNLMSN---YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE  195 (371)
T ss_pred             EcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCceeEcCcC
Confidence            999999999999863   35888999999999999999999988   999999999999999999999999999866432


Q ss_pred             CCcccccccccccccccccccccCC----CCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCccc
Q 002010          848 GASECMSSVAGSYGYIAPEYAYTLK----VDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAA  923 (982)
Q Consensus       848 ~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  923 (982)
                      . ........||+.|+|||++.+..    ++.++||||+||++|||++|+.||...........+... ......+    
T Consensus       196 ~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~-~~~~~~~----  269 (371)
T cd05622         196 G-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNH-KNSLTFP----  269 (371)
T ss_pred             C-cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcC-CCcccCC----
Confidence            2 12234567999999999987543    789999999999999999999999764332222222111 1100000    


Q ss_pred             ccceeecCCCCCCChHhHHHHHHHHhhccCCCCCC--CCCHHHHHHH
Q 002010          924 SVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSA--RPTMREVVHM  968 (982)
Q Consensus       924 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--Rpt~~ell~~  968 (982)
                                  .....+..+.+++.+|+..++.+  |++++|+++-
T Consensus       270 ------------~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h  304 (371)
T cd05622         270 ------------DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH  304 (371)
T ss_pred             ------------CcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence                        01123446788999999844443  7899998873

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=6.1e-35  Score=314.12  Aligned_cols=253  Identities=30%  Similarity=0.464  Sum_probs=200.5

Q ss_pred             cccccccccccceEEEEEEeC-CCcEEEEEEeccCCCCCch-hhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEecc
Q 002010          694 LKDENIIGKGGAGIVYRGSMP-DGIDVAIKRLVGRGTGGND-HGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYM  771 (982)
Q Consensus       694 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~-~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  771 (982)
                      |+..+.||+|+||+||+|... +++.||+|.+......... ....+|+.++++++||||+++++++.+....++||||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            677889999999999999764 4678999998554332222 23356999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCcc
Q 002010          772 PNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASE  851 (982)
Q Consensus       772 ~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~  851 (982)
                      ++++|.+++.  +...+++..+..++.|+++|+++||+.+   |+||||||+||++++++.++|+|||.+..+..  ...
T Consensus        81 ~~~~L~~~l~--~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~--~~~  153 (260)
T PF00069_consen   81 PGGSLQDYLQ--KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLSE--NNE  153 (260)
T ss_dssp             TTEBHHHHHH--HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEESTS--TTS
T ss_pred             cccccccccc--cccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccc--ccc
Confidence            9999999997  4567899999999999999999999998   99999999999999999999999999875421  223


Q ss_pred             cccccccccccccccccc-cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceeec
Q 002010          852 CMSSVAGSYGYIAPEYAY-TLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVD  930 (982)
Q Consensus       852 ~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  930 (982)
                      ......++..|+|||++. +..++.++||||+|+++|+|++|..||........................          
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~----------  223 (260)
T PF00069_consen  154 NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSS----------  223 (260)
T ss_dssp             EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHT----------
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccc----------
Confidence            345567899999999998 888999999999999999999999999865211111111111111000000          


Q ss_pred             CCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          931 PRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       931 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                          .........+.+++.+||+.||++|||+.++++
T Consensus       224 ----~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  224 ----QQSREKSEELRDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             ----TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             ----cccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                000111258999999999999999999999975

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=2.3e-34  Score=315.59  Aligned_cols=253  Identities=24%  Similarity=0.337  Sum_probs=204.3

Q ss_pred             HHHHhhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEE
Q 002010          688 EDVLESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLL  766 (982)
Q Consensus       688 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  766 (982)
                      .+...+|+..+.||+|+||.||+|.. .+++.||+|.+.... ......+.+|+.+++.++||||+++++++..++..++
T Consensus        15 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l   93 (297)
T cd06656          15 GDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQ-QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWV   93 (297)
T ss_pred             CChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCc-cchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEE
Confidence            34457899999999999999999964 579999999885432 3344667899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccc
Q 002010          767 LYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQD  846 (982)
Q Consensus       767 v~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  846 (982)
                      ||||+++++|.+++..   ..+++..+..++.|++.|+.|||+.+   |+||||||+||+++.++.++|+|||.+.....
T Consensus        94 v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~  167 (297)
T cd06656          94 VMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP  167 (297)
T ss_pred             eecccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccC
Confidence            9999999999999853   45789999999999999999999988   99999999999999999999999999876543


Q ss_pred             cCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccc
Q 002010          847 AGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVL  926 (982)
Q Consensus       847 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  926 (982)
                      ..  .......+++.|+|||...+..++.++|+||+||++|+|++|..||............... ..            
T Consensus       168 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~-~~------------  232 (297)
T cd06656         168 EQ--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GT------------  232 (297)
T ss_pred             Cc--cCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccC-CC------------
Confidence            21  1123456788999999999888999999999999999999999999653321111100000 00            


Q ss_pred             eeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          927 AVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       927 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                          + ....+...+..+.+++.+||+.||++||+++++++
T Consensus       233 ----~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (297)
T cd06656         233 ----P-ELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ  268 (297)
T ss_pred             ----C-CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                0 00112233456789999999999999999999998

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=1.8e-34  Score=320.59  Aligned_cols=242  Identities=22%  Similarity=0.273  Sum_probs=191.5

Q ss_pred             cccccccceEEEEEEe-CCCcEEEEEEeccCCC--CCchhhHHHHHHHHhcC-CCCcccceEeEEEcCCccEEEEeccCC
Q 002010          698 NIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGT--GGNDHGFLAEIQTLGRI-RHRNIVRLLGYVSNRDTNLLLYEYMPN  773 (982)
Q Consensus       698 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  773 (982)
                      +.||+|+||.||+|.. .+++.||+|++.....  ......+.+|+.++.++ +||+|+++++++.+....++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            3699999999999965 4678999999865422  23345678899998888 699999999999999999999999999


Q ss_pred             CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCcccc
Q 002010          774 GSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECM  853 (982)
Q Consensus       774 ~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~  853 (982)
                      ++|..++.  +...+++..+..++.||+.|++|||+.+   |+||||||+||+++.++.+||+|||++......  ....
T Consensus        81 ~~L~~~~~--~~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~--~~~~  153 (327)
T cd05617          81 GDLMFHMQ--RQRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP--GDTT  153 (327)
T ss_pred             CcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCC--CCce
Confidence            99999886  3457999999999999999999999988   999999999999999999999999998753221  1223


Q ss_pred             cccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCc--hHHHHHHHhccCCCCCCcccccceeecC
Q 002010          854 SSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGV--DIVRWVRKTTSEVSQPSDAASVLAVVDP  931 (982)
Q Consensus       854 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~  931 (982)
                      ....||+.|+|||++.+..++.++||||+||++|||++|..||.......  ............                
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~----------------  217 (327)
T cd05617         154 STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILE----------------  217 (327)
T ss_pred             ecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHh----------------
Confidence            44678999999999999999999999999999999999999996432211  111111111100                


Q ss_pred             CCCCCChHhHHHHHHHHhhccCCCCCCCCCH
Q 002010          932 RLSGYPLTGVIHLFKVAMMCVEDESSARPTM  962 (982)
Q Consensus       932 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~  962 (982)
                      .....|...+..+.+++.+||+.||++|+++
T Consensus       218 ~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~  248 (327)
T cd05617         218 KPIRIPRFLSVKASHVLKGFLNKDPKERLGC  248 (327)
T ss_pred             CCCCCCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence            0001222334568899999999999999985

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-34  Score=320.77  Aligned_cols=256  Identities=20%  Similarity=0.209  Sum_probs=196.9

Q ss_pred             hhcccccccccccceEEEEEEe-CCCcEEEEEEeccCC--CCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEE
Q 002010          692 ESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRG--TGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLY  768 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  768 (982)
                      ++|++.+.||+|+||.||++.. .+++.||+|++....  .......+.+|+.++..++|+||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            3688889999999999999965 468999999985421  2233456788999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccC
Q 002010          769 EYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAG  848 (982)
Q Consensus       769 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  848 (982)
                      ||+++++|.+++.. ....+++..+..++.||+.|++|||+++   |+||||||+||+++.++.+||+|||++.......
T Consensus        81 e~~~g~~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  156 (331)
T cd05597          81 DYYVGGDLLTLLSK-FEDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG  156 (331)
T ss_pred             ecCCCCcHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCCC
Confidence            99999999999963 2457899999999999999999999988   9999999999999999999999999987654322


Q ss_pred             Cccccccccccccccccccccc-----CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCccc
Q 002010          849 ASECMSSVAGSYGYIAPEYAYT-----LKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAA  923 (982)
Q Consensus       849 ~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  923 (982)
                      . .......||+.|+|||++..     ..++.++||||+||++|||++|+.||......+....+... ....       
T Consensus       157 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~-~~~~-------  227 (331)
T cd05597         157 T-VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH-KEHF-------  227 (331)
T ss_pred             C-ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcC-CCcc-------
Confidence            1 12233568999999999863     45788999999999999999999999754322222221111 0000       


Q ss_pred             ccceeecCCCCCCChHhHHHHHHHHhhccCCCCCC--CCCHHHHHHH
Q 002010          924 SVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSA--RPTMREVVHM  968 (982)
Q Consensus       924 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--Rpt~~ell~~  968 (982)
                              .++......+..+.+++.+|+..++++  ||+++++++-
T Consensus       228 --------~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         228 --------QFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             --------cCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence                    011111123456788888877654443  7899888873

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=4.6e-34  Score=306.71  Aligned_cols=250  Identities=24%  Similarity=0.321  Sum_probs=201.4

Q ss_pred             hcccccccccccceEEEEEEe-CCCcEEEEEEeccCC-CCCchhhHHHHHHHHhcCCCCcccceEeEEEcC-CccEEEEe
Q 002010          693 SLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRG-TGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNR-DTNLLLYE  769 (982)
Q Consensus       693 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~lv~e  769 (982)
                      .|+..+.||+|++|.||++.. .+++.||+|++.... .....+.+.+|+.++++++|||++++++.+... ...+++||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            377888999999999999965 457899999985432 233445688899999999999999999987644 45789999


Q ss_pred             ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCC
Q 002010          770 YMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGA  849 (982)
Q Consensus       770 ~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  849 (982)
                      |+++++|.+++.......+++.++..++.|++.|++++|+.+   |+||||||+||+++.++.++|+|||++..+.... 
T Consensus        81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~-  156 (257)
T cd08223          81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC-  156 (257)
T ss_pred             ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccC-
Confidence            999999999998655567899999999999999999999988   9999999999999999999999999998664321 


Q ss_pred             cccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceee
Q 002010          850 SECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVV  929 (982)
Q Consensus       850 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  929 (982)
                       .......+++.|+|||+..+..++.++||||+|+++|+|++|+.||...............                  
T Consensus       157 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~------------------  217 (257)
T cd08223         157 -DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEG------------------  217 (257)
T ss_pred             -CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc------------------
Confidence             2233456788999999999999999999999999999999999999753321111111110                  


Q ss_pred             cCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          930 DPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       930 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                        ..+..+...+..+.+++.+||+.||++|||+.|+++
T Consensus       218 --~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  253 (257)
T cd08223         218 --KLPPMPKDYSPELGELIATMLSKRPEKRPSVKSILR  253 (257)
T ss_pred             --CCCCCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence              011122334457889999999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.7e-34  Score=305.90  Aligned_cols=253  Identities=28%  Similarity=0.354  Sum_probs=204.3

Q ss_pred             hhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEec
Q 002010          692 ESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEY  770 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  770 (982)
                      ++|+..+.||+|+||.||+|.. .+++.+++|.+.... ....+.+.+|+.++++++||||+++++++.+....+++|||
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~   81 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP-GDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY   81 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCc-hhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence            4688889999999999999965 457889999885433 23557788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCc
Q 002010          771 MPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS  850 (982)
Q Consensus       771 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  850 (982)
                      +++++|.+++... ...+++..+..++.|++.|++|||+.+   |+||||+|+||++++++.+||+|||.+......  .
T Consensus        82 ~~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~--~  155 (262)
T cd06613          82 CGGGSLQDIYQVT-RGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTAT--I  155 (262)
T ss_pred             CCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhh--h
Confidence            9999999998742 257899999999999999999999988   999999999999999999999999999865432  1


Q ss_pred             ccccccccccccccccccccC---CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccce
Q 002010          851 ECMSSVAGSYGYIAPEYAYTL---KVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLA  927 (982)
Q Consensus       851 ~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  927 (982)
                      .......++..|+|||.+.+.   .++.++||||+|+++|||++|+.||..................             
T Consensus       156 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~-------------  222 (262)
T cd06613         156 AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFP-------------  222 (262)
T ss_pred             hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC-------------
Confidence            122345678899999998776   7899999999999999999999999765432222211111000             


Q ss_pred             eecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          928 VVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       928 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                         +.....+...+..+.+++.+||..||.+|||+++++.
T Consensus       223 ---~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         223 ---PPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             ---CccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence               0000112334567899999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=4.4e-34  Score=306.95  Aligned_cols=251  Identities=28%  Similarity=0.501  Sum_probs=202.7

Q ss_pred             ccccccccccceEEEEEEeCC-----CcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEe
Q 002010          695 KDENIIGKGGAGIVYRGSMPD-----GIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYE  769 (982)
Q Consensus       695 ~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  769 (982)
                      +..+.||+|+||.||+|...+     +..||+|.+...........+..|+.++.+++|+||+++++++.+.+..+++||
T Consensus         2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e   81 (258)
T smart00219        2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVME   81 (258)
T ss_pred             cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEe
Confidence            456789999999999997643     488999998555444456788999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCC
Q 002010          770 YMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGA  849 (982)
Q Consensus       770 ~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  849 (982)
                      |+++++|.+++.......+++..+..++.|++.|++|||+.+   ++||||+|+||++++++.++++|||.+........
T Consensus        82 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~  158 (258)
T smart00219       82 YMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY  158 (258)
T ss_pred             ccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccccc
Confidence            999999999997544333899999999999999999999988   99999999999999999999999999987654322


Q ss_pred             cccccccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHhccCCCCCCccccccee
Q 002010          850 SECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAV  928 (982)
Q Consensus       850 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  928 (982)
                      ... ....+++.|+|||.+.+..++.++||||+|+++|+|++ |.+||..... ......+.....              
T Consensus       159 ~~~-~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~-~~~~~~~~~~~~--------------  222 (258)
T smart00219      159 YKK-KGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN-EEVLEYLKKGYR--------------  222 (258)
T ss_pred             ccc-ccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHHhcCCC--------------
Confidence            211 12336789999999988889999999999999999999 8888865322 222222211111              


Q ss_pred             ecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 002010          929 VDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHML  969 (982)
Q Consensus       929 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L  969 (982)
                           ...+...+.++.+++.+|++.||++|||+.|+++.|
T Consensus       223 -----~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      223 -----LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             -----CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence                 111222455789999999999999999999999865

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=9.6e-35  Score=327.66  Aligned_cols=252  Identities=22%  Similarity=0.279  Sum_probs=196.2

Q ss_pred             hcccccccccccceEEEEEEe-CCCcEEEEEEeccCC--CCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEe
Q 002010          693 SLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRG--TGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYE  769 (982)
Q Consensus       693 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  769 (982)
                      .|+..+.||+|+||.||+|.. .+++.||+|++....  .......+.+|+.++.+++||+|+++++++.+++..++|||
T Consensus         2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E   81 (360)
T cd05627           2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIME   81 (360)
T ss_pred             CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence            577888999999999999965 468999999985432  23344567889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCC
Q 002010          770 YMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGA  849 (982)
Q Consensus       770 ~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  849 (982)
                      |+++|+|.+++.  +...+++..+..++.|++.|++|||+.+   |+||||||+||+++.++.+||+|||++........
T Consensus        82 ~~~gg~L~~~l~--~~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~  156 (360)
T cd05627          82 FLPGGDMMTLLM--KKDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHR  156 (360)
T ss_pred             CCCCccHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccccc
Confidence            999999999997  4467899999999999999999999988   99999999999999999999999999875432110


Q ss_pred             c---------------------------------ccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCC
Q 002010          850 S---------------------------------ECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPV  896 (982)
Q Consensus       850 ~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~  896 (982)
                      .                                 .......||+.|+|||++.+..++.++||||+||++|||++|+.||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf  236 (360)
T cd05627         157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF  236 (360)
T ss_pred             cccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCC
Confidence            0                                 0012357999999999999999999999999999999999999999


Q ss_pred             CCCCCCchHHHHHHHhccCCCCCCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCC---HHHHHH
Q 002010          897 GEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPT---MREVVH  967 (982)
Q Consensus       897 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt---~~ell~  967 (982)
                      ............. ........           .+.     ......+.+++.+|+ .||.+|++   ++|+++
T Consensus       237 ~~~~~~~~~~~i~-~~~~~~~~-----------p~~-----~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~  292 (360)
T cd05627         237 CSETPQETYRKVM-NWKETLVF-----------PPE-----VPISEKAKDLILRFC-TDSENRIGSNGVEEIKS  292 (360)
T ss_pred             CCCCHHHHHHHHH-cCCCceec-----------CCC-----CCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhc
Confidence            7643322222111 10000000           000     012345778888876 49999995   566554

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-34  Score=310.44  Aligned_cols=247  Identities=27%  Similarity=0.374  Sum_probs=203.1

Q ss_pred             hcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEecc
Q 002010          693 SLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYM  771 (982)
Q Consensus       693 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  771 (982)
                      +|+..+.||.|++|.||+|.. .+++.||+|.+...........+.+|+.++++++||||+++++++.++...++|+||+
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   81 (274)
T cd06609           2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYC   81 (274)
T ss_pred             hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEee
Confidence            577788999999999999965 4688999999865544455567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCcc
Q 002010          772 PNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASE  851 (982)
Q Consensus       772 ~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~  851 (982)
                      ++++|.+++..   .++++..+..++.|++.|+.|||+.+   ++||||+|+||++++++.++++|||.+..+....  .
T Consensus        82 ~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~  153 (274)
T cd06609          82 GGGSCLDLLKP---GKLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM--S  153 (274)
T ss_pred             CCCcHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeecccc--c
Confidence            99999999963   27899999999999999999999988   9999999999999999999999999998765331  2


Q ss_pred             cccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceeecC
Q 002010          852 CMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDP  931 (982)
Q Consensus       852 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  931 (982)
                      ......+++.|+|||.+.+..++.++||||+|+++|+|++|+.||...... .....+.....                +
T Consensus       154 ~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~-~~~~~~~~~~~----------------~  216 (274)
T cd06609         154 KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM-RVLFLIPKNNP----------------P  216 (274)
T ss_pred             ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH-HHHHHhhhcCC----------------C
Confidence            233456788999999999888999999999999999999999999754321 11111111000                0


Q ss_pred             CCCCCChH-hHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          932 RLSGYPLT-GVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       932 ~~~~~~~~-~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                      .   .+.. .+..+.+++.+||..||++|||++++++
T Consensus       217 ~---~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~  250 (274)
T cd06609         217 S---LEGNKFSKPFKDFVSLCLNKDPKERPSAKELLK  250 (274)
T ss_pred             C---CcccccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence            0   1111 3446889999999999999999999987

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=5e-34  Score=305.80  Aligned_cols=247  Identities=28%  Similarity=0.451  Sum_probs=200.6

Q ss_pred             hhcccccccccccceEEEEEEeCCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEecc
Q 002010          692 ESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYM  771 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  771 (982)
                      ++|+..+.||+|+||.||++.. +++.||+|.+...   .....+.+|+.++++++|||++++++++..+ ..++||||+
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~---~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~   80 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCD---VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELM   80 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-CCCceEEEeecCc---chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECC
Confidence            5688899999999999999975 7888999987432   2345788999999999999999999988654 579999999


Q ss_pred             CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCcc
Q 002010          772 PNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASE  851 (982)
Q Consensus       772 ~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~  851 (982)
                      ++++|.+++.......+++..+..++.|++.|++|+|+.+   ++||||||+||+++.++.+||+|||.+......    
T Consensus        81 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~----  153 (254)
T cd05083          81 SKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMG----  153 (254)
T ss_pred             CCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceecccc----
Confidence            9999999997655567899999999999999999999988   999999999999999999999999998754321    


Q ss_pred             cccccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceeec
Q 002010          852 CMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVD  930 (982)
Q Consensus       852 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  930 (982)
                       ......+..|+|||.+.+..++.++|+||+|+++|||++ |+.||...... ...........                
T Consensus       154 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-~~~~~~~~~~~----------------  215 (254)
T cd05083         154 -VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK-EVKECVEKGYR----------------  215 (254)
T ss_pred             -CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH-HHHHHHhCCCC----------------
Confidence             122334568999999988889999999999999999998 99999754322 22222111100                


Q ss_pred             CCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 002010          931 PRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLAN  971 (982)
Q Consensus       931 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~  971 (982)
                         ...+...+..+.+++.+||+.+|++||+++++++.|+.
T Consensus       216 ---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         216 ---MEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             ---CCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence               01122334678899999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=7.8e-34  Score=308.27  Aligned_cols=257  Identities=24%  Similarity=0.385  Sum_probs=204.8

Q ss_pred             hhcccccccccccceEEEEEEeC------CCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccE
Q 002010          692 ESLKDENIIGKGGAGIVYRGSMP------DGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNL  765 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  765 (982)
                      ++|+..+.||+|+||.||+|+.+      +...|++|.+...........+.+|++++++++||||+++++++.+.+..+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            56788889999999999999753      246789998744333224567899999999999999999999999989999


Q ss_pred             EEEeccCCCCHHHHhhcCCC-------CCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEecc
Q 002010          766 LLYEYMPNGSLGEMLHGAKG-------GHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADF  838 (982)
Q Consensus       766 lv~e~~~~~sL~~~l~~~~~-------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Df  838 (982)
                      +||||+++++|.+++.....       ..+++..+..++.|++.|++|||+.+   |+||||||+||+++.++.++++||
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence            99999999999999975431       26899999999999999999999988   999999999999999999999999


Q ss_pred             ccchhccccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHhccCCC
Q 002010          839 GLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVS  917 (982)
Q Consensus       839 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  917 (982)
                      |++....... ........++..|+|||.+.+..++.++||||+|+++|+|++ |..||....+.. ............ 
T Consensus       162 ~~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~-~~~~~~~~~~~~-  238 (275)
T cd05046         162 SLSKDVYNSE-YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE-VLNRLQAGKLEL-  238 (275)
T ss_pred             ccccccCccc-ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH-HHHHHHcCCcCC-
Confidence            9987543221 122233456778999999988888999999999999999999 888987644322 222221111000 


Q ss_pred             CCCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 002010          918 QPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLAN  971 (982)
Q Consensus       918 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~  971 (982)
                                       ..+...+..+.+++.+||+.||++|||+.|+++.|.+
T Consensus       239 -----------------~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~  275 (275)
T cd05046         239 -----------------PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE  275 (275)
T ss_pred             -----------------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence                             1122344578999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=2.5e-34  Score=312.41  Aligned_cols=248  Identities=27%  Similarity=0.349  Sum_probs=202.1

Q ss_pred             hhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEec
Q 002010          692 ESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEY  770 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  770 (982)
                      +.|+..+.||+|+||.||+|.. .+++.||+|.+...........+.+|+.++++++||||+++++++..+...++||||
T Consensus         4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06642           4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence            4567778899999999999964 457889999885444444556788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCc
Q 002010          771 MPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS  850 (982)
Q Consensus       771 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  850 (982)
                      +++++|.+++.   ...+++..+..++.|+++|++|||+.+   ++|+||+|+||++++++.++++|||++..+....  
T Consensus        84 ~~~~~L~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~--  155 (277)
T cd06642          84 LGGGSALDLLK---PGPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--  155 (277)
T ss_pred             cCCCcHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcc--
Confidence            99999999985   346899999999999999999999888   9999999999999999999999999997665321  


Q ss_pred             ccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceeec
Q 002010          851 ECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVD  930 (982)
Q Consensus       851 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  930 (982)
                      .......++..|+|||++.+..++.++||||+|+++|||++|+.||........ ...+...                  
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~-~~~~~~~------------------  216 (277)
T cd06642         156 IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV-LFLIPKN------------------  216 (277)
T ss_pred             hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH-HhhhhcC------------------
Confidence            122234678899999999988899999999999999999999999875432211 1111000                  


Q ss_pred             CCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          931 PRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       931 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                       ..+..+...+..+.+++.+||+.+|++|||+.|+++
T Consensus       217 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  252 (277)
T cd06642         217 -SPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLK  252 (277)
T ss_pred             -CCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence             001112234457889999999999999999999987

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=7.5e-34  Score=310.32  Aligned_cols=269  Identities=22%  Similarity=0.286  Sum_probs=203.0

Q ss_pred             hhcccccccccccceEEEEEEeC-CCcEEEEEEeccCCC-CCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEe
Q 002010          692 ESLKDENIIGKGGAGIVYRGSMP-DGIDVAIKRLVGRGT-GGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYE  769 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  769 (982)
                      ++|+..+.||+|++|.||+|..+ +++.||+|++..... ....+.+.+|+.++++++|||++++++++..+...++|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            35788889999999999999764 589999998854432 2234567899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCC
Q 002010          770 YMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGA  849 (982)
Q Consensus       770 ~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  849 (982)
                      |++++++..+..  ....+++..+..++.|++.|++|||+.+   ++||||||+||+++.++.+||+|||++........
T Consensus        81 ~~~~~~l~~~~~--~~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~  155 (286)
T cd07847          81 YCDHTVLNELEK--NPRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPGD  155 (286)
T ss_pred             ccCccHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCcc
Confidence            999998888775  3456899999999999999999999988   99999999999999999999999999987653321


Q ss_pred             ccccccccccccccccccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCC---CC-cccc
Q 002010          850 SECMSSVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQ---PS-DAAS  924 (982)
Q Consensus       850 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~-~~~~  924 (982)
                        ......++..|+|||++.+ ..++.++||||+|+++|||++|+.||......+....+..........   .. ....
T Consensus       156 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (286)
T cd07847         156 --DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQF  233 (286)
T ss_pred             --cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccc
Confidence              2233457889999999875 457899999999999999999999998654433322222211110000   00 0000


Q ss_pred             cceeecCCCC------CCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          925 VLAVVDPRLS------GYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       925 ~~~~~~~~~~------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                      ......+...      ......+..+.+++.+||+.||++|||+.|++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         234 FKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             cccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence            0000000000      001123467889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=5.6e-34  Score=311.29  Aligned_cols=251  Identities=24%  Similarity=0.337  Sum_probs=201.1

Q ss_pred             hcccccccccccceEEEEEEeC-CCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEecc
Q 002010          693 SLKDENIIGKGGAGIVYRGSMP-DGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYM  771 (982)
Q Consensus       693 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  771 (982)
                      +|+..+.||+|+||.||+|... ++..||+|.+...........+.+|+.++++++||||+++++++..+...++||||+
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   81 (286)
T cd06622           2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM   81 (286)
T ss_pred             hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence            5778889999999999999764 689999998854433344567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHhh-cCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCC
Q 002010          772 PNGSLGEMLHGAK-GGHLKWETRYRIALEAAKGLCYLHH-DCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGA  849 (982)
Q Consensus       772 ~~~sL~~~l~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  849 (982)
                      ++++|.+++.... ...+++..+..++.|++.|+.|||+ .+   |+||||||+||+++.++.+||+|||.+..+...  
T Consensus        82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--  156 (286)
T cd06622          82 DAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS--  156 (286)
T ss_pred             CCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccCC--
Confidence            9999999987432 3478999999999999999999996 46   999999999999999999999999998765322  


Q ss_pred             cccccccccccccccccccccC------CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCccc
Q 002010          850 SECMSSVAGSYGYIAPEYAYTL------KVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAA  923 (982)
Q Consensus       850 ~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  923 (982)
                        ......+++.|+|||.+.+.      .++.++||||+||++|+|++|+.||......... .......          
T Consensus       157 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~-~~~~~~~----------  223 (286)
T cd06622         157 --LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIF-AQLSAIV----------  223 (286)
T ss_pred             --ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHH-HHHHHHh----------
Confidence              12334578899999988544      3578999999999999999999999754322211 1111111          


Q ss_pred             ccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          924 SVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       924 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                            +......+...+.++.+++.+||+.+|++||++++++.
T Consensus       224 ------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  261 (286)
T cd06622         224 ------DGDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE  261 (286)
T ss_pred             ------hcCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence                  11111233345567889999999999999999999987

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=5.2e-34  Score=316.40  Aligned_cols=196  Identities=24%  Similarity=0.380  Sum_probs=160.2

Q ss_pred             ccccccccceEEEEEEeC---CCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEc--CCccEEEEecc
Q 002010          697 ENIIGKGGAGIVYRGSMP---DGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSN--RDTNLLLYEYM  771 (982)
Q Consensus       697 ~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~  771 (982)
                      ++.||+|+||+||+|...   +++.||+|.+...   .....+.+|+.++++++||||+++++++..  +...++||||+
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~   82 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGT---GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA   82 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCC---CCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEecc
Confidence            457999999999999753   4678999988432   223457789999999999999999998854  45578999999


Q ss_pred             CCCCHHHHhhcC-------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEE----cCCCCEEEecccc
Q 002010          772 PNGSLGEMLHGA-------KGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILL----DSDFEAHVADFGL  840 (982)
Q Consensus       772 ~~~sL~~~l~~~-------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill----~~~~~~kl~DfG~  840 (982)
                      + ++|.+++...       +...+++..+..++.||+.|++|||+.+   |+||||||+||++    +.++.+||+|||+
T Consensus        83 ~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~  158 (317)
T cd07868          83 E-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGF  158 (317)
T ss_pred             C-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence            5 5888887532       1235889999999999999999999988   9999999999999    4567899999999


Q ss_pred             chhccccCC-ccccccccccccccccccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCC
Q 002010          841 AKFLQDAGA-SECMSSVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELIAGKKPVGEF  899 (982)
Q Consensus       841 a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~  899 (982)
                      ++.+..... ........+|+.|+|||++.+ ..++.++||||+||++|||++|++||...
T Consensus       159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~  219 (317)
T cd07868         159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             eeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence            987653321 122345678999999999876 45899999999999999999999999653

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.1e-34  Score=311.32  Aligned_cols=252  Identities=24%  Similarity=0.340  Sum_probs=201.5

Q ss_pred             HhhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEe
Q 002010          691 LESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYE  769 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  769 (982)
                      .++|++.+.||+|+||.||+|.. .++..||+|.+... .......+.+|+.++++++||||+++++++..+...++|||
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE-SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIE   82 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEee
Confidence            35688889999999999999975 46889999988432 33344578899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCC
Q 002010          770 YMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGA  849 (982)
Q Consensus       770 ~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  849 (982)
                      |+++++|.+++... ...+++..+..++.|++.|++|||+.+   |+||||+|+||+++.++.++|+|||.+......  
T Consensus        83 ~~~~~~L~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~--  156 (280)
T cd06611          83 FCDGGALDSIMLEL-ERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKST--  156 (280)
T ss_pred             ccCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhccc--
Confidence            99999999998642 356899999999999999999999988   999999999999999999999999998765422  


Q ss_pred             cccccccccccccccccccc-----cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccc
Q 002010          850 SECMSSVAGSYGYIAPEYAY-----TLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAAS  924 (982)
Q Consensus       850 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  924 (982)
                      ........+++.|+|||.+.     ...++.++||||+|+++|||++|+.||...........+......          
T Consensus       157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~----------  226 (280)
T cd06611         157 LQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPP----------  226 (280)
T ss_pred             ccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCC----------
Confidence            11223456888999999874     344678999999999999999999999765332222222111000          


Q ss_pred             cceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          925 VLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       925 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                             .+ ..+...+..+.+++.+||+.||++||+++++++
T Consensus       227 -------~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (280)
T cd06611         227 -------TL-DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLK  261 (280)
T ss_pred             -------Cc-CCcccCCHHHHHHHHHHhccChhhCcCHHHHhc
Confidence                   00 112223446889999999999999999999987

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=8.9e-34  Score=305.04  Aligned_cols=240  Identities=22%  Similarity=0.357  Sum_probs=187.8

Q ss_pred             cccccccceEEEEEEeCC-------------CcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCcc
Q 002010          698 NIIGKGGAGIVYRGSMPD-------------GIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTN  764 (982)
Q Consensus       698 ~~lg~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  764 (982)
                      +.||+|+||.||+|....             ...|++|.+... .......+.+|+.+++.++||||+++++++..+...
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~-~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~   79 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS-HRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVEN   79 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh-hhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence            368999999999996421             235888876432 233445788899999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCC-------EEEec
Q 002010          765 LLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFE-------AHVAD  837 (982)
Q Consensus       765 ~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~-------~kl~D  837 (982)
                      ++||||+++++|..++.. +...+++..+.+++.||++|++|||+.+   |+||||||+||+++.++.       ++++|
T Consensus        80 ~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d  155 (262)
T cd05077          80 IMVEEFVEFGPLDLFMHR-KSDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSD  155 (262)
T ss_pred             EEEEecccCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCC
Confidence            999999999999998863 3356899999999999999999999988   999999999999987654       89999


Q ss_pred             cccchhccccCCcccccccccccccccccccc-cCCCCcchhhHHHHHHHHHHH-hCCCCCCCCCCCchHHHHHHHhccC
Q 002010          838 FGLAKFLQDAGASECMSSVAGSYGYIAPEYAY-TLKVDEKSDVYSFGVVLLELI-AGKKPVGEFGDGVDIVRWVRKTTSE  915 (982)
Q Consensus       838 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~ell-tg~~p~~~~~~~~~~~~~~~~~~~~  915 (982)
                      ||.+.....      .....++..|+|||.+. +..++.++||||+||++|||+ +|..||...... ........ .. 
T Consensus       156 ~g~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~-~~~~~~~~-~~-  226 (262)
T cd05077         156 PGIPITVLS------RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLA-EKERFYEG-QC-  226 (262)
T ss_pred             CCCCccccC------cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchh-HHHHHHhc-Cc-
Confidence            999875432      12345778899999886 566899999999999999998 488888653221 11111100 00 


Q ss_pred             CCCCCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 002010          916 VSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLA  970 (982)
Q Consensus       916 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~  970 (982)
                                        . ........+.+++.+||+.||++||++.++++.++
T Consensus       227 ------------------~-~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~  262 (262)
T cd05077         227 ------------------M-LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN  262 (262)
T ss_pred             ------------------c-CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence                              0 01112346889999999999999999999998774

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=2.2e-34  Score=309.19  Aligned_cols=240  Identities=20%  Similarity=0.358  Sum_probs=188.0

Q ss_pred             cccccccceEEEEEEeCC--------CcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEe
Q 002010          698 NIIGKGGAGIVYRGSMPD--------GIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYE  769 (982)
Q Consensus       698 ~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  769 (982)
                      +.||+|+||.||+|....        ..+||+|.+.. ......+.+.+|+.+++.++||||+++++++..++..++|||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~-~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e   79 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDK-SHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQE   79 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcc-hhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEe
Confidence            368999999999996422        23488887632 223334568889999999999999999999999899999999


Q ss_pred             ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCC--------EEEeccccc
Q 002010          770 YMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFE--------AHVADFGLA  841 (982)
Q Consensus       770 ~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~--------~kl~DfG~a  841 (982)
                      |+++|+|.++++.. ...+++..+..++.||+.|++|||+.+   |+||||||+||+++.++.        ++++|||.+
T Consensus        80 ~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~  155 (258)
T cd05078          80 YVKFGSLDTYLKKN-KNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS  155 (258)
T ss_pred             cCCCCcHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccc
Confidence            99999999999743 346899999999999999999999988   999999999999987765        699999988


Q ss_pred             hhccccCCccccccccccccccccccccc-CCCCcchhhHHHHHHHHHHHhCC-CCCCCCCCCchHHHHHHHhccCCCCC
Q 002010          842 KFLQDAGASECMSSVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELIAGK-KPVGEFGDGVDIVRWVRKTTSEVSQP  919 (982)
Q Consensus       842 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~  919 (982)
                      ......      ....++..|+|||++.+ ..++.++||||+|+++|||++|. .|+..... ...........      
T Consensus       156 ~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~-~~~~~~~~~~~------  222 (258)
T cd05078         156 ITVLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDS-QKKLQFYEDRH------  222 (258)
T ss_pred             cccCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccH-HHHHHHHHccc------
Confidence            654321      23457788999999886 45789999999999999999985 56544322 11111111100      


Q ss_pred             CcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 002010          920 SDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLA  970 (982)
Q Consensus       920 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~  970 (982)
                                     ..+.....++.+++.+||+.||++|||++++++.|+
T Consensus       223 ---------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         223 ---------------QLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             ---------------cCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence                           112222346889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=8.5e-34  Score=324.49  Aligned_cols=264  Identities=20%  Similarity=0.258  Sum_probs=197.6

Q ss_pred             hhcccccccccccceEEEEEEeC-CCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEec
Q 002010          692 ESLKDENIIGKGGAGIVYRGSMP-DGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEY  770 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  770 (982)
                      ..|.+.+.||+|+||.||+|... .++.||||...       ...+.+|+.++++++|||||++++++...+..++|||+
T Consensus       169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~-------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~  241 (461)
T PHA03211        169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW-------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK  241 (461)
T ss_pred             CCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc-------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            36888899999999999999664 57889999531       23467899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCc
Q 002010          771 MPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS  850 (982)
Q Consensus       771 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  850 (982)
                      + .++|.+++.. ....+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++........
T Consensus       242 ~-~~~L~~~l~~-~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~  316 (461)
T PHA03211        242 Y-RSDLYTYLGA-RLRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWST  316 (461)
T ss_pred             c-CCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceeccccccc
Confidence            9 4789888863 2347999999999999999999999988   999999999999999999999999999876433222


Q ss_pred             ccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCC-------CchHHHHHHHhccCCC-CCCc-
Q 002010          851 ECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGD-------GVDIVRWVRKTTSEVS-QPSD-  921 (982)
Q Consensus       851 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~-------~~~~~~~~~~~~~~~~-~~~~-  921 (982)
                      .......||+.|+|||++.+..++.++|||||||++|||++|..|+.....       ...+.+.+........ .+.. 
T Consensus       317 ~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~  396 (461)
T PHA03211        317 PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHA  396 (461)
T ss_pred             ccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCc
Confidence            222345799999999999999999999999999999999998776533211       1223333333221110 0000 


Q ss_pred             ccccce--------eecCCCCCC--C--hHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          922 AASVLA--------VVDPRLSGY--P--LTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       922 ~~~~~~--------~~~~~~~~~--~--~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                      ...+..        ...+.....  .  ......+.+++.+||+.||.+|||+.|+++
T Consensus       397 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~  454 (461)
T PHA03211        397 GSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLR  454 (461)
T ss_pred             chHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhh
Confidence            000000        000000000  0  012236789999999999999999999987

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.2e-34  Score=322.89  Aligned_cols=266  Identities=22%  Similarity=0.283  Sum_probs=198.4

Q ss_pred             HHHhhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCC-CCchhhHHHHHHHHhcCCCCcccceEeEEEcC-----
Q 002010          689 DVLESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGT-GGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNR-----  761 (982)
Q Consensus       689 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----  761 (982)
                      .+.++|+..+.||+|+||.||+|.. .+++.||+|++..... ......+.+|+.++++++||||+++++++...     
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07878          12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN   91 (343)
T ss_pred             hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence            3457899999999999999999964 5688999998854322 22345677899999999999999999987543     


Q ss_pred             -CccEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEecccc
Q 002010          762 -DTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGL  840 (982)
Q Consensus       762 -~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~  840 (982)
                       ...++++|++ +++|.+++.   ...+++..+..++.||+.|++|||+.+   |+||||||+||++++++.+||+|||+
T Consensus        92 ~~~~~~~~~~~-~~~l~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~  164 (343)
T cd07878          92 FNEVYLVTNLM-GADLNNIVK---CQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGL  164 (343)
T ss_pred             cCcEEEEeecC-CCCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCcc
Confidence             3468999988 789988874   356999999999999999999999988   99999999999999999999999999


Q ss_pred             chhccccCCccccccccccccccccccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCC
Q 002010          841 AKFLQDAGASECMSSVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQP  919 (982)
Q Consensus       841 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  919 (982)
                      ++.....     .....|++.|+|||++.+ ..++.++||||+||++|+|++|+.||...........+...........
T Consensus       165 ~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  239 (343)
T cd07878         165 ARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEV  239 (343)
T ss_pred             ceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            9865422     234578999999999876 5689999999999999999999999976433322222222211110000


Q ss_pred             C---cccccceeecCCCCCCC--------hHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          920 S---DAASVLAVVDPRLSGYP--------LTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       920 ~---~~~~~~~~~~~~~~~~~--------~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                      .   ....... ....++..+        ......+.+++.+|++.||++|||++|+++
T Consensus       240 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~  297 (343)
T cd07878         240 LKKISSEHARK-YIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA  297 (343)
T ss_pred             HHhcchhhHHH-HhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            0   0000000 000001011        112335789999999999999999999986

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=3.8e-34  Score=340.82  Aligned_cols=256  Identities=22%  Similarity=0.330  Sum_probs=199.0

Q ss_pred             HHHhhcccccccccccceEEEEEEe-CCCcEEEEEEeccCC-CCCchhhHHHHHHHHhcCCCCcccceEeEEEc--CCcc
Q 002010          689 DVLESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRG-TGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSN--RDTN  764 (982)
Q Consensus       689 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~  764 (982)
                      ...+.|++.+.||+|+||+||+|.. .++..||+|.+.... .......+..|+.++++++|||||+++++|..  ....
T Consensus        10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l   89 (1021)
T PTZ00266         10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL   89 (1021)
T ss_pred             cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence            3456899999999999999999965 457789999885432 22334578899999999999999999998854  3568


Q ss_pred             EEEEeccCCCCHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHhhcCC----CcEEecCCCCCcEEEcC---------
Q 002010          765 LLLYEYMPNGSLGEMLHGA--KGGHLKWETRYRIALEAAKGLCYLHHDCS----PLIIHRDVKSNNILLDS---------  829 (982)
Q Consensus       765 ~lv~e~~~~~sL~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~----~~ivHrDlkp~Nill~~---------  829 (982)
                      |+||||+++++|.+++...  ....+++..++.|+.||+.||+|||+.+.    .+||||||||+||+++.         
T Consensus        90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~  169 (1021)
T PTZ00266         90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT  169 (1021)
T ss_pred             EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence            9999999999999999742  23579999999999999999999998431    34999999999999964         


Q ss_pred             --------CCCEEEeccccchhccccCCccccccccccccccccccccc--CCCCcchhhHHHHHHHHHHHhCCCCCCCC
Q 002010          830 --------DFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYT--LKVDEKSDVYSFGVVLLELIAGKKPVGEF  899 (982)
Q Consensus       830 --------~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~elltg~~p~~~~  899 (982)
                              .+.+||+|||++..+...   .......||+.|+|||++.+  ..++.++|||||||++|||++|+.||...
T Consensus       170 ~~~~n~ng~~iVKLsDFGlAr~l~~~---s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~  246 (1021)
T PTZ00266        170 AQANNLNGRPIAKIGDFGLSKNIGIE---SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA  246 (1021)
T ss_pred             ccccccCCCCceEEccCCcccccccc---ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence                    245899999999865432   12234578999999999854  45889999999999999999999999764


Q ss_pred             CCCchHHHHHHHhccCCCCCCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          900 GDGVDIVRWVRKTTSEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       900 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                      .........+...   +..+             .    ...+..+.+||..||+.+|.+||++.|++.
T Consensus       247 ~~~~qli~~lk~~---p~lp-------------i----~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~  294 (1021)
T PTZ00266        247 NNFSQLISELKRG---PDLP-------------I----KGKSKELNILIKNLLNLSAKERPSALQCLG  294 (1021)
T ss_pred             CcHHHHHHHHhcC---CCCC-------------c----CCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence            3322222222111   1000             0    112346889999999999999999999984

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=8.7e-34  Score=308.09  Aligned_cols=248  Identities=25%  Similarity=0.331  Sum_probs=203.5

Q ss_pred             hhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEec
Q 002010          692 ESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEY  770 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  770 (982)
                      ..|+..+.||+|+||.||+|.. .++..||+|.+...........+.+|+.++++++||||+++++++.++...++||||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence            4567778899999999999965 458899999886544444556788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCc
Q 002010          771 MPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS  850 (982)
Q Consensus       771 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  850 (982)
                      +++++|.+++..   .++++..+..++.|++.|++|+|+.+   ++|+||+|+||+++.++.++++|||++.......  
T Consensus        84 ~~~~~L~~~i~~---~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~--  155 (277)
T cd06640          84 LGGGSALDLLRA---GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--  155 (277)
T ss_pred             CCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCc--
Confidence            999999999853   46889999999999999999999888   9999999999999999999999999997654322  


Q ss_pred             ccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceeec
Q 002010          851 ECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVD  930 (982)
Q Consensus       851 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  930 (982)
                      .......++..|+|||++.+..++.++|+||+|+++|||++|..||........    ......                
T Consensus       156 ~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~----~~~~~~----------------  215 (277)
T cd06640         156 IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRV----LFLIPK----------------  215 (277)
T ss_pred             cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhH----hhhhhc----------------
Confidence            122334678899999999888899999999999999999999999975432111    100000                


Q ss_pred             CCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          931 PRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       931 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                      ...+..+...+..+.+++.+||+.+|++||++++++.
T Consensus       216 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  252 (277)
T cd06640         216 NNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLK  252 (277)
T ss_pred             CCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHh
Confidence            0011233455677899999999999999999999976

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=6.5e-34  Score=310.45  Aligned_cols=267  Identities=23%  Similarity=0.308  Sum_probs=199.1

Q ss_pred             hcccccccccccceEEEEEEe-CCCcEEEEEEeccCC-CCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEec
Q 002010          693 SLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRG-TGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEY  770 (982)
Q Consensus       693 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  770 (982)
                      +|+..+.||+|+||.||+|.. .+|+.||+|++.... .......+.+|+.++++++||||+++++++.+....++|+||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            367788999999999999965 468999999985432 223345678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCc
Q 002010          771 MPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS  850 (982)
Q Consensus       771 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  850 (982)
                      ++ ++|.+++... ...+++..+..++.||++|++|||+.+   |+||||||+||+++.++.+||+|||+++.....  .
T Consensus        81 ~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~--~  153 (284)
T cd07839          81 CD-QDLKKYFDSC-NGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIP--V  153 (284)
T ss_pred             CC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCC--C
Confidence            96 5888887632 356899999999999999999999988   999999999999999999999999999865422  1


Q ss_pred             ccccccccccccccccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceee
Q 002010          851 ECMSSVAGSYGYIAPEYAYTL-KVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVV  929 (982)
Q Consensus       851 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  929 (982)
                      .......++..|+|||++.+. .++.++||||+||++|||++|+.|+....+.....+.+........... ........
T Consensus       154 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~  232 (284)
T cd07839         154 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEES-WPGVSKLP  232 (284)
T ss_pred             CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHH-hHHhhhcc
Confidence            222345678899999988764 4789999999999999999999887543333332222222111110000 00000000


Q ss_pred             c----CCCC------CCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          930 D----PRLS------GYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       930 ~----~~~~------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                      +    +...      .........+.+++.+||+.||.+|||++|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         233 DYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             cccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence            0    0000      111223457889999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=6.2e-34  Score=305.53  Aligned_cols=250  Identities=21%  Similarity=0.293  Sum_probs=203.8

Q ss_pred             hcccccccccccceEEEEEEe-CCCcEEEEEEeccCC-CCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEec
Q 002010          693 SLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRG-TGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEY  770 (982)
Q Consensus       693 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  770 (982)
                      +|+..+.||+|+||.||++.. .+++.||+|.+.... ......++.+|+.++++++||||+++++++...+..++||||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            477888999999999999954 468899999885432 233445788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCc
Q 002010          771 MPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS  850 (982)
Q Consensus       771 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  850 (982)
                      +++++|.+++.......+++..+..++.|++.|++|||+.+   ++|+||+|+||+++.++.++++|||.+.......  
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~--  155 (256)
T cd08218          81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV--  155 (256)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcch--
Confidence            99999999997555557899999999999999999999988   9999999999999999999999999997654321  


Q ss_pred             ccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceeec
Q 002010          851 ECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVD  930 (982)
Q Consensus       851 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  930 (982)
                      .......+++.|+|||+..+..++.++|+||+|+++|+|++|+.||...........+...                   
T Consensus       156 ~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~-------------------  216 (256)
T cd08218         156 ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRG-------------------  216 (256)
T ss_pred             hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcC-------------------
Confidence            1123345788999999999888999999999999999999999999753222211111111                   


Q ss_pred             CCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          931 PRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       931 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                       .....+...+..+.+++.+||+.+|++||++.||++
T Consensus       217 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~  252 (256)
T cd08218         217 -SYPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE  252 (256)
T ss_pred             -CCCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence             011122334457899999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1e-33  Score=306.88  Aligned_cols=255  Identities=28%  Similarity=0.429  Sum_probs=199.0

Q ss_pred             hcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCCC---------chhhHHHHHHHHhcCCCCcccceEeEEEcCC
Q 002010          693 SLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGG---------NDHGFLAEIQTLGRIRHRNIVRLLGYVSNRD  762 (982)
Q Consensus       693 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~---------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  762 (982)
                      +|...+.||+|+||.||+|.. .+++.||+|.+.......         ..+.+.+|+.++++++|||++++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            467788999999999999954 468999999874321111         1235778999999999999999999999999


Q ss_pred             ccEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccch
Q 002010          763 TNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAK  842 (982)
Q Consensus       763 ~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~  842 (982)
                      ..++||||+++++|.+++..  ...+++..+..++.||+.|+.|||+.+   ++||||+|+||+++.++.++++|||.+.
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~~  156 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRT--YGRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISK  156 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeeccccc
Confidence            99999999999999999974  367899999999999999999999988   9999999999999999999999999997


Q ss_pred             hccccCCcccccccccccccccccccccCC--CCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCC
Q 002010          843 FLQDAGASECMSSVAGSYGYIAPEYAYTLK--VDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPS  920 (982)
Q Consensus       843 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  920 (982)
                      ...............++..|+|||......  ++.++|+||+|+++||+++|..||.......   ........... + 
T Consensus       157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~---~~~~~~~~~~~-~-  231 (272)
T cd06629         157 KSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIA---AMFKLGNKRSA-P-  231 (272)
T ss_pred             cccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHH---HHHHhhccccC-C-
Confidence            654322222233456788999999987654  8899999999999999999999996432221   11111111000 0 


Q ss_pred             cccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          921 DAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       921 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                             .+.   .......+..+.+++.+||+.||++|||++++++
T Consensus       232 -------~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (272)
T cd06629         232 -------PIP---PDVSMNLSPVALDFLNACFTINPDNRPTARELLQ  268 (272)
T ss_pred             -------cCC---ccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence                   000   0112234567899999999999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.1e-33  Score=304.14  Aligned_cols=238  Identities=23%  Similarity=0.409  Sum_probs=189.2

Q ss_pred             cccccccceEEEEEEeCCC-----------cEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEE
Q 002010          698 NIIGKGGAGIVYRGSMPDG-----------IDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLL  766 (982)
Q Consensus       698 ~~lg~G~~g~Vy~~~~~~~-----------~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  766 (982)
                      +.||+|+||.||+|...+.           ..|++|.+......  ...+.+|+.++++++||||+++++++.. ...++
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~l   77 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD--SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIM   77 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh--HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEE
Confidence            3689999999999976442           24777766433222  6788999999999999999999999887 77899


Q ss_pred             EEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCC-------CEEEeccc
Q 002010          767 LYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDF-------EAHVADFG  839 (982)
Q Consensus       767 v~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~-------~~kl~DfG  839 (982)
                      ||||+++++|.+++.... ..+++..+..++.||+.|++|||+.+   |+||||||+||+++.++       .+|++|||
T Consensus        78 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg  153 (259)
T cd05037          78 VEEYVKFGPLDVFLHREK-NNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPG  153 (259)
T ss_pred             EEEcCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCC
Confidence            999999999999997432 37899999999999999999999888   99999999999999887       79999999


Q ss_pred             cchhccccCCcccccccccccccccccccccC--CCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHhccCC
Q 002010          840 LAKFLQDAGASECMSSVAGSYGYIAPEYAYTL--KVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEV  916 (982)
Q Consensus       840 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  916 (982)
                      ++.....      .....++..|+|||++.+.  .++.++||||+|+++|||++ |..||..... .....+......  
T Consensus       154 ~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~-~~~~~~~~~~~~--  224 (259)
T cd05037         154 IPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSS-SEKERFYQDQHR--  224 (259)
T ss_pred             ccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCc-hhHHHHHhcCCC--
Confidence            9986542      1234466789999998876  78999999999999999999 5777766432 222222111000  


Q ss_pred             CCCCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 002010          917 SQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLA  970 (982)
Q Consensus       917 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~  970 (982)
                                         .+......+.+++.+||+.+|.+|||+.|+++.|+
T Consensus       225 -------------------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         225 -------------------LPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             -------------------CCCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence                               00011157889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=1.1e-33  Score=303.48  Aligned_cols=249  Identities=24%  Similarity=0.350  Sum_probs=202.3

Q ss_pred             hcccccccccccceEEEEEEe-CCCcEEEEEEeccCC-CCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEec
Q 002010          693 SLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRG-TGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEY  770 (982)
Q Consensus       693 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  770 (982)
                      +|+..+.||+|+||.||+|.. .+++.+|+|++.... .......+.+|+.++++++||||+++++.+..++..++||||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            477788999999999999965 468899999985432 233456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCC-CCEEEeccccchhccccCC
Q 002010          771 MPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSD-FEAHVADFGLAKFLQDAGA  849 (982)
Q Consensus       771 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~-~~~kl~DfG~a~~~~~~~~  849 (982)
                      +++++|.+++.......+++..+..++.|++.|++|||+.+   |+||||+|+||+++++ +.+|++|||.+....... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~-  156 (256)
T cd08220          81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS-  156 (256)
T ss_pred             CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc-
Confidence            99999999998655567899999999999999999999988   9999999999999865 468999999998664321 


Q ss_pred             cccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceee
Q 002010          850 SECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVV  929 (982)
Q Consensus       850 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  929 (982)
                        ......++..|+|||.+.+..++.++||||+|+++|+|++|+.||.................                
T Consensus       157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~----------------  218 (256)
T cd08220         157 --KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTF----------------  218 (256)
T ss_pred             --cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCC----------------
Confidence              12235678899999999988899999999999999999999999976433222222111100                


Q ss_pred             cCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          930 DPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       930 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                          ...+...+..+.+++.+||+.||++|||++|+++
T Consensus       219 ----~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~  252 (256)
T cd08220         219 ----APISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA  252 (256)
T ss_pred             ----CCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence                0112223457889999999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=8.1e-34  Score=309.70  Aligned_cols=271  Identities=27%  Similarity=0.379  Sum_probs=204.9

Q ss_pred             hhcccccccccccceEEEEEEeC-----CCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEc--CCcc
Q 002010          692 ESLKDENIIGKGGAGIVYRGSMP-----DGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSN--RDTN  764 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~  764 (982)
                      +.|+..+.||+|+||.||+|...     ++..||+|.+...........+.+|+.++++++||||+++++++..  ....
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            35677789999999999999642     3788999998544333345678999999999999999999999877  5578


Q ss_pred             EEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhc
Q 002010          765 LLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFL  844 (982)
Q Consensus       765 ~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~  844 (982)
                      ++||||+++++|.+++... ...+++..+..++.|++.|++|||+.+   ++||||||+||+++.++.++++|||.+...
T Consensus        84 ~lv~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  159 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQRH-RDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKVL  159 (284)
T ss_pred             EEEEecCCCCCHHHHHHhC-ccccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEccccccccc
Confidence            9999999999999999743 236899999999999999999999988   999999999999999999999999999876


Q ss_pred             cccCCc-ccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCccc
Q 002010          845 QDAGAS-ECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAA  923 (982)
Q Consensus       845 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  923 (982)
                      ...... .......++..|+|||...+..++.++||||+|+++|||++|+.|+.......  ..+......    .....
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~--~~~~~~~~~----~~~~~  233 (284)
T cd05038         160 PEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEF--LRMIGIAQG----QMIVT  233 (284)
T ss_pred             ccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchh--ccccccccc----cccHH
Confidence            532211 11122345567999999988889999999999999999999999986532211  000000000    00000


Q ss_pred             ccceeecCCC-CCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 002010          924 SVLAVVDPRL-SGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANP  972 (982)
Q Consensus       924 ~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~  972 (982)
                      .....+.... ...+..++.++.+++.+||+.+|++|||+.||+++|+.+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         234 RLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             HHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            0000000000 112233456799999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=8e-34  Score=306.35  Aligned_cols=251  Identities=28%  Similarity=0.403  Sum_probs=204.5

Q ss_pred             hcccccccccccceEEEEEEeC-CCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEecc
Q 002010          693 SLKDENIIGKGGAGIVYRGSMP-DGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYM  771 (982)
Q Consensus       693 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  771 (982)
                      +|+..+.||+|++|.||+|... +++.||+|++...........+.+|+.++++++||||+++++++..+...++++||+
T Consensus         2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   81 (265)
T cd06605           2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM   81 (265)
T ss_pred             cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence            4677788999999999999664 689999999865544455667889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCc
Q 002010          772 PNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHH-DCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS  850 (982)
Q Consensus       772 ~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  850 (982)
                      ++++|.+++.... ..+++..+..++.|++.|++|+|+ .+   ++||||||+||++++++.++|+|||.+........ 
T Consensus        82 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-  156 (265)
T cd06605          82 DGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA-  156 (265)
T ss_pred             CCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHHh-
Confidence            9999999997433 678999999999999999999998 77   99999999999999999999999999876643211 


Q ss_pred             ccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCC-CchHHHHHHHhccCCCCCCcccccceee
Q 002010          851 ECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGD-GVDIVRWVRKTTSEVSQPSDAASVLAVV  929 (982)
Q Consensus       851 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~  929 (982)
                         ....++..|+|||.+.+..++.++||||+|+++|+|++|+.||..... ..............              
T Consensus       157 ---~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--------------  219 (265)
T cd06605         157 ---KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNE--------------  219 (265)
T ss_pred             ---hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcC--------------
Confidence               126678899999999988999999999999999999999999976422 12222222221110              


Q ss_pred             cCCCCCCChH-hHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          930 DPRLSGYPLT-GVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       930 ~~~~~~~~~~-~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                        ..+..+.. .+..+.+++.+||..||++|||+.|+++
T Consensus       220 --~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  256 (265)
T cd06605         220 --PPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLE  256 (265)
T ss_pred             --CCCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence              01111222 4456889999999999999999999985

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=8.8e-34  Score=307.13  Aligned_cols=239  Identities=22%  Similarity=0.347  Sum_probs=186.6

Q ss_pred             ccccccceEEEEEEeC-------------------------CCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccc
Q 002010          699 IIGKGGAGIVYRGSMP-------------------------DGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVR  753 (982)
Q Consensus       699 ~lg~G~~g~Vy~~~~~-------------------------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~  753 (982)
                      .||+|+||.||+|...                         ....||+|.+... ......++.+|+.++++++||||++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~-~~~~~~~~~~~~~~~~~l~h~niv~   80 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS-HRDIALAFFETASLMSQVSHIHLAF   80 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH-HHHHHHHHHHHHHHHhcCCCCCeee
Confidence            5899999999998531                         1235888887432 2223456888999999999999999


Q ss_pred             eEeEEEcCCccEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCC--
Q 002010          754 LLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDF--  831 (982)
Q Consensus       754 ~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~--  831 (982)
                      +++++......++||||+++++|..++.. ....+++..+..++.||++|++|||+.+   |+||||||+||+++..+  
T Consensus        81 ~~~~~~~~~~~~lv~ey~~~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~  156 (274)
T cd05076          81 VHGVCVRGSENIMVEEFVEHGPLDVCLRK-EKGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLA  156 (274)
T ss_pred             EEEEEEeCCceEEEEecCCCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcc
Confidence            99999999999999999999999999863 3457899999999999999999999888   99999999999997643  


Q ss_pred             -----CEEEeccccchhccccCCccccccccccccccccccccc-CCCCcchhhHHHHHHHHHHH-hCCCCCCCCCCCch
Q 002010          832 -----EAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELI-AGKKPVGEFGDGVD  904 (982)
Q Consensus       832 -----~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell-tg~~p~~~~~~~~~  904 (982)
                           .+|++|||.+......      ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.||....... 
T Consensus       157 ~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-  229 (274)
T cd05076         157 EGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE-  229 (274)
T ss_pred             cCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH-
Confidence                 4899999988643321      22356788999998865 56899999999999999995 6999997643322 


Q ss_pred             HHHHHHHhccCCCCCCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 002010          905 IVRWVRKTTSEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLA  970 (982)
Q Consensus       905 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~  970 (982)
                      ..........                     .+......+.+++.+||+.+|++|||++++++.|+
T Consensus       230 ~~~~~~~~~~---------------------~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         230 KERFYEKKHR---------------------LPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             HHHHHHhccC---------------------CCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence            1222111110                     01111236889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-33  Score=308.85  Aligned_cols=268  Identities=22%  Similarity=0.328  Sum_probs=199.8

Q ss_pred             hhcccccccccccceEEEEEEeC-CCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEec
Q 002010          692 ESLKDENIIGKGGAGIVYRGSMP-DGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEY  770 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  770 (982)
                      +.|+..+.||+|++|.||+|..+ +++.||+|.+...........+.+|+.++++++||||+++++++.+++..++||||
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY   84 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence            56888899999999999999654 68999999986544444445677899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCc
Q 002010          771 MPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS  850 (982)
Q Consensus       771 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  850 (982)
                      ++ ++|.+++.... ..+++..+..++.|++.|++|||+.+   |+||||||+||+++.++.+||+|||.++......  
T Consensus        85 ~~-~~L~~~~~~~~-~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~--  157 (291)
T cd07844          85 LD-TDLKQYMDDCG-GGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPS--  157 (291)
T ss_pred             CC-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCC--
Confidence            97 49999887433 47899999999999999999999988   9999999999999999999999999987543211  


Q ss_pred             cccccccccccccccccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccc---
Q 002010          851 ECMSSVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVL---  926 (982)
Q Consensus       851 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---  926 (982)
                      .......++..|+|||++.+ ..++.++||||+|+++|||++|+.||.......+................ .....   
T Consensus       158 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~  236 (291)
T cd07844         158 KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEET-WPGVSSNP  236 (291)
T ss_pred             ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhh-hhhhhhcc
Confidence            11223346789999998875 45889999999999999999999999764422222221111111100000 00000   


Q ss_pred             -------eeec-CCCCC-C-ChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          927 -------AVVD-PRLSG-Y-PLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       927 -------~~~~-~~~~~-~-~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                             .... ..+.. . .......+.+++.+|++.||++|||+.|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         237 EFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             ccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence                   0000 00000 0 0111256789999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=6.8e-34  Score=310.98  Aligned_cols=250  Identities=26%  Similarity=0.380  Sum_probs=199.3

Q ss_pred             hhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEec
Q 002010          692 ESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEY  770 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  770 (982)
                      +.|.....||+|+||.||++.. .++..||+|.+... .......+.+|+.+++.++||||+++++.+...+..++||||
T Consensus        22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~  100 (292)
T cd06658          22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR-KQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEF  100 (292)
T ss_pred             HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecc-hHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeC
Confidence            4445456799999999999965 46889999987432 333455688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCc
Q 002010          771 MPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS  850 (982)
Q Consensus       771 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  850 (982)
                      +++++|.+++..   ..+++.++..++.||+.|++|||+.+   |+||||||+||++++++.+||+|||++.......  
T Consensus       101 ~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~--  172 (292)
T cd06658         101 LEGGALTDIVTH---TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV--  172 (292)
T ss_pred             CCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhccccc--
Confidence            999999998852   46889999999999999999999988   9999999999999999999999999987654321  


Q ss_pred             ccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceeec
Q 002010          851 ECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVD  930 (982)
Q Consensus       851 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  930 (982)
                      .......++..|+|||...+..++.++||||+|+++|||++|+.||......... ..+.....                
T Consensus       173 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~-~~~~~~~~----------------  235 (292)
T cd06658         173 PKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAM-RRIRDNLP----------------  235 (292)
T ss_pred             ccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHhcCC----------------
Confidence            1223456889999999998888999999999999999999999999754322211 11111100                


Q ss_pred             CCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002010          931 PRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHM  968 (982)
Q Consensus       931 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~  968 (982)
                      +... .....+..+.+++.+||..||.+|||++|+++.
T Consensus       236 ~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         236 PRVK-DSHKVSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             Cccc-cccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            0011 011223468899999999999999999999973

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=1.3e-33  Score=308.57  Aligned_cols=269  Identities=25%  Similarity=0.332  Sum_probs=204.6

Q ss_pred             hcccccccccccceEEEEEEe-CCCcEEEEEEeccCCC-CCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEec
Q 002010          693 SLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGT-GGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEY  770 (982)
Q Consensus       693 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  770 (982)
                      +|+..+.||+|++|.||+|.. .+|+.||+|++..... ......+.+|+.++++++||||+++++++..+...++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            477888999999999999975 4689999999865432 33456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCc
Q 002010          771 MPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS  850 (982)
Q Consensus       771 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  850 (982)
                      + +++|.+++.... ..+++.++..++.||++|++|||+.+   ++|+||||+||+++.++.++++|||.+........ 
T Consensus        81 ~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-  154 (286)
T cd07832          81 M-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP-  154 (286)
T ss_pred             c-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-
Confidence            9 999999987433 67899999999999999999999988   99999999999999999999999999987654321 


Q ss_pred             ccccccccccccccccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCC----ccccc
Q 002010          851 ECMSSVAGSYGYIAPEYAYTL-KVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPS----DAASV  925 (982)
Q Consensus       851 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~  925 (982)
                      .......++..|+|||++.+. .++.++||||+|+++|||++|.+||....+...................    .....
T Consensus       155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (286)
T cd07832         155 RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDY  234 (286)
T ss_pred             CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchh
Confidence            223345688899999988654 4689999999999999999998888654433322222222111100000    00000


Q ss_pred             ceeecCCC-----CCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          926 LAVVDPRL-----SGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       926 ~~~~~~~~-----~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                      .....+..     .....+.+..+.+++.+|++.||++|||++++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~  281 (286)
T cd07832         235 NKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR  281 (286)
T ss_pred             hcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            00000000     0111233478899999999999999999999986

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=4e-34  Score=318.79  Aligned_cols=256  Identities=20%  Similarity=0.202  Sum_probs=197.3

Q ss_pred             hhcccccccccccceEEEEEEeC-CCcEEEEEEeccCC--CCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEE
Q 002010          692 ESLKDENIIGKGGAGIVYRGSMP-DGIDVAIKRLVGRG--TGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLY  768 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  768 (982)
                      ++|+..+.||+|+||.||++..+ +++.||+|.+.+..  .......+.+|+.++..++|++|+++++++.+++..++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            35788899999999999999764 57889999884321  2223345788999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccC
Q 002010          769 EYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAG  848 (982)
Q Consensus       769 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  848 (982)
                      ||+++|+|.+++... ...+++..+..++.||+.|++|||+.+   |+||||||+||+++.++.+||+|||++.......
T Consensus        81 ey~~~g~L~~~l~~~-~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~  156 (332)
T cd05623          81 DYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG  156 (332)
T ss_pred             eccCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccCC
Confidence            999999999999742 356899999999999999999999988   9999999999999999999999999987654221


Q ss_pred             Ccccccccccccccccccccc-----cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCccc
Q 002010          849 ASECMSSVAGSYGYIAPEYAY-----TLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAA  923 (982)
Q Consensus       849 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  923 (982)
                       ........||+.|+|||++.     ...++.++||||+||++|||++|+.||.............. .....       
T Consensus       157 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~-~~~~~-------  227 (332)
T cd05623         157 -TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN-HKERF-------  227 (332)
T ss_pred             -cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhC-CCccc-------
Confidence             12223457899999999886     34588999999999999999999999976432222222111 10000       


Q ss_pred             ccceeecCCCCCCChHhHHHHHHHHhhccCCCCCC--CCCHHHHHHH
Q 002010          924 SVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSA--RPTMREVVHM  968 (982)
Q Consensus       924 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--Rpt~~ell~~  968 (982)
                              .++......+..+.+++.+|+..+|++  |++++|+++-
T Consensus       228 --------~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         228 --------QFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             --------cCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence                    011111233456888999988665554  7899988763

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=8.1e-34  Score=309.71  Aligned_cols=268  Identities=19%  Similarity=0.270  Sum_probs=203.6

Q ss_pred             cccccccccccceEEEEEEe-CCCcEEEEEEeccCCC-CCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEecc
Q 002010          694 LKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGT-GGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYM  771 (982)
Q Consensus       694 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  771 (982)
                      |+..+.||+|++|.||+|.. .+++.||||.+..... ......+.+|++++++++||||+++++++.+.+..++||||+
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   81 (284)
T cd07860           2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL   81 (284)
T ss_pred             ceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeecc
Confidence            67788999999999999965 4689999998854332 233456889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCcc
Q 002010          772 PNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASE  851 (982)
Q Consensus       772 ~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~  851 (982)
                      . ++|.+++.......+++..+..++.|++.|++|||+.+   ++||||+|+||+++.++.+|++|||++......  ..
T Consensus        82 ~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~--~~  155 (284)
T cd07860          82 H-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP--VR  155 (284)
T ss_pred             c-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccC--cc
Confidence            5 68999987666678999999999999999999999988   999999999999999999999999998765422  11


Q ss_pred             cccccccccccccccccccCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCc--------c
Q 002010          852 CMSSVAGSYGYIAPEYAYTLK-VDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSD--------A  922 (982)
Q Consensus       852 ~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--------~  922 (982)
                      ......++..|+|||++.+.. ++.++||||+|+++|||+||+.||....+.....+..............        .
T Consensus       156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (284)
T cd07860         156 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYK  235 (284)
T ss_pred             ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHH
Confidence            223345678999999887644 6889999999999999999999997654444444443332221110000        0


Q ss_pred             cccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          923 ASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       923 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                      .....................+.+++.+||+.||++|||++|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         236 PSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             hhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence            000000000000111223456789999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=1.9e-33  Score=303.56  Aligned_cols=250  Identities=28%  Similarity=0.427  Sum_probs=195.4

Q ss_pred             hcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCC----CchhhHHHHHHHHhcCCCCcccceEeEEEcC--CccE
Q 002010          693 SLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTG----GNDHGFLAEIQTLGRIRHRNIVRLLGYVSNR--DTNL  765 (982)
Q Consensus       693 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~  765 (982)
                      .|+..+.||+|+||.||+|.. .++..||+|++......    .....+.+|+.++++++||||+++++++.+.  ...+
T Consensus         3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   82 (266)
T cd06651           3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT   82 (266)
T ss_pred             CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence            578889999999999999965 46899999987543221    1234578899999999999999999988653  5678


Q ss_pred             EEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhcc
Q 002010          766 LLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQ  845 (982)
Q Consensus       766 lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~  845 (982)
                      ++|||+++++|.+++..  ...+++.....++.|++.|++|||+.+   |+||||+|+||+++.++.+||+|||++....
T Consensus        83 l~~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~  157 (266)
T cd06651          83 IFMEYMPGGSVKDQLKA--YGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ  157 (266)
T ss_pred             EEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccccc
Confidence            99999999999999973  346889999999999999999999888   9999999999999999999999999987654


Q ss_pred             ccC-CcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccc
Q 002010          846 DAG-ASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAAS  924 (982)
Q Consensus       846 ~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  924 (982)
                      ... .........++..|+|||.+.+..++.++||||+||++|||++|+.||...........    .....        
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~----~~~~~--------  225 (266)
T cd06651         158 TICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFK----IATQP--------  225 (266)
T ss_pred             cccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHH----HhcCC--------
Confidence            211 11112234578899999999988899999999999999999999999976433222111    11100        


Q ss_pred             cceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          925 VLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       925 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                             ..+..+......+.+++ +||..+|++||+++|+++
T Consensus       226 -------~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         226 -------TNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             -------CCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence                   01122333344566777 688899999999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=1.1e-33  Score=309.11  Aligned_cols=255  Identities=27%  Similarity=0.381  Sum_probs=198.2

Q ss_pred             HHHhhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcC-CCCcccceEeEEE-----cC
Q 002010          689 DVLESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRI-RHRNIVRLLGYVS-----NR  761 (982)
Q Consensus       689 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~-----~~  761 (982)
                      +..++|+..+.||+|+||.||+|.. .+++.||+|.+...  ......+.+|+.+++++ +||||+++++++.     .+
T Consensus        15 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~--~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   92 (286)
T cd06638          15 DPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI--HDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNG   92 (286)
T ss_pred             CcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc--cchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCC
Confidence            3457889999999999999999965 46889999987432  22345678899999999 6999999999874     34


Q ss_pred             CccEEEEeccCCCCHHHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccc
Q 002010          762 DTNLLLYEYMPNGSLGEMLHG--AKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFG  839 (982)
Q Consensus       762 ~~~~lv~e~~~~~sL~~~l~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG  839 (982)
                      +..++||||+++++|.+++..  .....+++..+..++.|++.|+.|||+.+   |+||||||+||++++++.+|++|||
T Consensus        93 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl~dfg  169 (286)
T cd06638          93 DQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKLVDFG  169 (286)
T ss_pred             CeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEEccCC
Confidence            568999999999999998753  23456889999999999999999999888   9999999999999999999999999


Q ss_pred             cchhccccCCccccccccccccccccccccc-----CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhcc
Q 002010          840 LAKFLQDAGASECMSSVAGSYGYIAPEYAYT-----LKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTS  914 (982)
Q Consensus       840 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  914 (982)
                      .+..+....  .......|++.|+|||++..     ..++.++||||+||++|||++|+.||..............   .
T Consensus       170 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~---~  244 (286)
T cd06638         170 VSAQLTSTR--LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPR---N  244 (286)
T ss_pred             ceeecccCC--CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccc---c
Confidence            987654321  12234568899999998753     4478899999999999999999999976433222111100   0


Q ss_pred             CCCCCCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002010          915 EVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHM  968 (982)
Q Consensus       915 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~  968 (982)
                      ..              +.. ..+......+.+++.+||+.||++|||+.|+++.
T Consensus       245 ~~--------------~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  283 (286)
T cd06638         245 PP--------------PTL-HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH  283 (286)
T ss_pred             CC--------------Ccc-cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence            00              000 0111223468899999999999999999999874

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=3.6e-34  Score=318.87  Aligned_cols=255  Identities=19%  Similarity=0.193  Sum_probs=197.2

Q ss_pred             hhcccccccccccceEEEEEEe-CCCcEEEEEEeccCC--CCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEE
Q 002010          692 ESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRG--TGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLY  768 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  768 (982)
                      ++|+..+.||+|+||.||+++. .+++.||+|.+....  .......+.+|+.++..++|++|+++++++.+++..|+||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            3688889999999999999975 467889999885421  2223445778999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccC
Q 002010          769 EYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAG  848 (982)
Q Consensus       769 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  848 (982)
                      ||+++|+|.+++... ...+++..+..++.|++.|++|+|+.+   |+||||||+||+++.++.+||+|||++..+....
T Consensus        81 Ey~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  156 (331)
T cd05624          81 DYYVGGDLLTLLSKF-EDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG  156 (331)
T ss_pred             eCCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCCC
Confidence            999999999999742 357899999999999999999999988   9999999999999999999999999997664322


Q ss_pred             Cccccccccccccccccccccc-----CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCccc
Q 002010          849 ASECMSSVAGSYGYIAPEYAYT-----LKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAA  923 (982)
Q Consensus       849 ~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  923 (982)
                      . .......|++.|+|||++.+     ..++.++||||+||++|||++|+.||.............. ......      
T Consensus       157 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~-~~~~~~------  228 (331)
T cd05624         157 T-VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN-HEERFQ------  228 (331)
T ss_pred             c-eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHc-CCCccc------
Confidence            1 12233568999999998875     4678899999999999999999999975433222221111 111000      


Q ss_pred             ccceeecCCCCCCChHhHHHHHHHHhhccCCCCCC--CCCHHHHHH
Q 002010          924 SVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSA--RPTMREVVH  967 (982)
Q Consensus       924 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--Rpt~~ell~  967 (982)
                               ++......+..+.+++.+|+..++++  |++++++++
T Consensus       229 ---------~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~  265 (331)
T cd05624         229 ---------FPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKK  265 (331)
T ss_pred             ---------CCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence                     11111123457888999999876654  568888765

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.3e-33  Score=301.46  Aligned_cols=248  Identities=27%  Similarity=0.408  Sum_probs=201.4

Q ss_pred             hcccccccccccceEEEEEEeC-CCcEEEEEEeccCCC----CCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEE
Q 002010          693 SLKDENIIGKGGAGIVYRGSMP-DGIDVAIKRLVGRGT----GGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLL  767 (982)
Q Consensus       693 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  767 (982)
                      +|+..+.||+|++|.||+|... +++.|++|.+.....    .+..+.+.+|+.++++++||||+++++++.++...+++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            3667789999999999999765 789999998854332    22345688999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhcccc
Q 002010          768 YEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDA  847 (982)
Q Consensus       768 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  847 (982)
                      |||+++++|.+++..  ...+++..+..++.|++.|++|||+.+   |+|+||+|+||+++.++.+||+|||.+......
T Consensus        81 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~  155 (258)
T cd06632          81 LELVPGGSLAKLLKK--YGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVEF  155 (258)
T ss_pred             EEecCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceecccc
Confidence            999999999999973  356889999999999999999999988   999999999999999999999999998765432


Q ss_pred             CCcccccccccccccccccccccCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccc
Q 002010          848 GASECMSSVAGSYGYIAPEYAYTLK-VDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVL  926 (982)
Q Consensus       848 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  926 (982)
                      .   ......++..|+|||.+.... ++.++|+||+|+++|+|++|+.||...........+. ...             
T Consensus       156 ~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~-~~~-------------  218 (258)
T cd06632         156 S---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIG-RSK-------------  218 (258)
T ss_pred             c---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHH-hcc-------------
Confidence            2   233456888999999987766 8999999999999999999999997654222111111 100             


Q ss_pred             eeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          927 AVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       927 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                           ..+..+......+.+++.+||+.+|++||+++++++
T Consensus       219 -----~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         219 -----ELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             -----cCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence                 011122234457889999999999999999999875

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=8.6e-34  Score=330.56  Aligned_cols=263  Identities=17%  Similarity=0.208  Sum_probs=191.1

Q ss_pred             HhhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCC------CcccceEeEEEcC-C
Q 002010          691 LESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRH------RNIVRLLGYVSNR-D  762 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h------~niv~~~~~~~~~-~  762 (982)
                      .++|++.+.||+|+||+||+|.. ..++.||||++...  ......+..|+.+++.++|      ++++++++++..+ .
T Consensus       128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~  205 (467)
T PTZ00284        128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNV--PKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETG  205 (467)
T ss_pred             CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecc--hhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCc
Confidence            46799999999999999999965 45888999998432  1223345567777766644      5688999988765 4


Q ss_pred             ccEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCcEEecCCCCCcEEEcCCC----------
Q 002010          763 TNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHH-DCSPLIIHRDVKSNNILLDSDF----------  831 (982)
Q Consensus       763 ~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivHrDlkp~Nill~~~~----------  831 (982)
                      .+++|||++ +++|.+++.  +...+++..+..++.||+.||+|||+ .+   ||||||||+||+++.++          
T Consensus       206 ~~~iv~~~~-g~~l~~~l~--~~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~~~~~~  279 (467)
T PTZ00284        206 HMCIVMPKY-GPCLLDWIM--KHGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDPVTNRA  279 (467)
T ss_pred             eEEEEEecc-CCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCcccccccccc
Confidence            678899988 778999886  34679999999999999999999997 47   99999999999998765          


Q ss_pred             ------CEEEeccccchhccccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchH
Q 002010          832 ------EAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDI  905 (982)
Q Consensus       832 ------~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~  905 (982)
                            .+||+|||.+....     .......||+.|+|||++.+..|+.++||||+||++|||++|++||......+..
T Consensus       280 ~~~~~~~vkl~DfG~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~  354 (467)
T PTZ00284        280 LPPDPCRVRICDLGGCCDER-----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHL  354 (467)
T ss_pred             cCCCCceEEECCCCccccCc-----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence                  49999999876432     1234567899999999999999999999999999999999999999765433222


Q ss_pred             HHHHHHhccCCCCCCc----ccccceee------cCCCC------------CCChHhHHHHHHHHhhccCCCCCCCCCHH
Q 002010          906 VRWVRKTTSEVSQPSD----AASVLAVV------DPRLS------------GYPLTGVIHLFKVAMMCVEDESSARPTMR  963 (982)
Q Consensus       906 ~~~~~~~~~~~~~~~~----~~~~~~~~------~~~~~------------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~  963 (982)
                      .. +.......+....    .......+      ++...            .........+.+|+.+||+.||++|||++
T Consensus       355 ~~-i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~  433 (467)
T PTZ00284        355 HL-MEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNAR  433 (467)
T ss_pred             HH-HHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHH
Confidence            22 2221111110000    00000000      00000            00011234578999999999999999999


Q ss_pred             HHHH
Q 002010          964 EVVH  967 (982)
Q Consensus       964 ell~  967 (982)
                      |+++
T Consensus       434 e~L~  437 (467)
T PTZ00284        434 QMTT  437 (467)
T ss_pred             HHhc
Confidence            9987

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=1.2e-33  Score=306.31  Aligned_cols=256  Identities=23%  Similarity=0.361  Sum_probs=198.8

Q ss_pred             cccccccccccceEEEEEEeC----CCcEEEEEEeccCCC-CCchhhHHHHHHHHhcCCCCcccceEeEEEcCC------
Q 002010          694 LKDENIIGKGGAGIVYRGSMP----DGIDVAIKRLVGRGT-GGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRD------  762 (982)
Q Consensus       694 ~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------  762 (982)
                      |+..+.||+|+||.||+|...    +++.||+|++..... ....+++.+|+.++++++||||+++++++...+      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            456778999999999999642    468899998854332 234556889999999999999999999886532      


Q ss_pred             ccEEEEeccCCCCHHHHhhcC----CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEecc
Q 002010          763 TNLLLYEYMPNGSLGEMLHGA----KGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADF  838 (982)
Q Consensus       763 ~~~lv~e~~~~~sL~~~l~~~----~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Df  838 (982)
                      ..++++||+++++|.+++...    +...+++..+..++.|++.|++|||+.+   |+||||||+||+++.++.+|++||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence            237889999999999887532    1235788999999999999999999988   999999999999999999999999


Q ss_pred             ccchhccccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHhccCCC
Q 002010          839 GLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVS  917 (982)
Q Consensus       839 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  917 (982)
                      |.++...............+++.|++||...+..++.++||||+|+++|||++ |++||..... ......+.....   
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~-~~~~~~~~~~~~---  233 (273)
T cd05074         158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN-SEIYNYLIKGNR---  233 (273)
T ss_pred             cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH-HHHHHHHHcCCc---
Confidence            99986643222222223345678999999998889999999999999999999 8899875432 222222211110   


Q ss_pred             CCCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 002010          918 QPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANP  972 (982)
Q Consensus       918 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~  972 (982)
                                      ...+...+..+.+++.+||+.+|++||++.|+++.|+++
T Consensus       234 ----------------~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         234 ----------------LKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             ----------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                            001122345789999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-35  Score=343.39  Aligned_cols=252  Identities=27%  Similarity=0.378  Sum_probs=208.9

Q ss_pred             hcccccccccccceEEEEE-EeCCCcEEEEEEeccCCC-CCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEec
Q 002010          693 SLKDENIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGT-GGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEY  770 (982)
Q Consensus       693 ~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  770 (982)
                      ++..+..||.|.||.||.| ...+|+-.|+|-++.... ......+.+|+.++..++|||+|++||+-...+..+|.|||
T Consensus      1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEy 1315 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEY 1315 (1509)
T ss_pred             eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHH
Confidence            5667789999999999999 456799999998854433 33455688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccC--
Q 002010          771 MPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAG--  848 (982)
Q Consensus       771 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~--  848 (982)
                      |++|+|.+.+.  .....++.....+..|++.|++|||++|   ||||||||.||+++.+|.+|++|||.|..+....  
T Consensus      1316 C~~GsLa~ll~--~gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~ 1390 (1509)
T KOG4645|consen 1316 CEGGSLASLLE--HGRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQT 1390 (1509)
T ss_pred             hccCcHHHHHH--hcchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecCchhc
Confidence            99999999996  3345666777788999999999999998   9999999999999999999999999999876541  


Q ss_pred             CcccccccccccccccccccccC---CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCccccc
Q 002010          849 ASECMSSVAGSYGYIAPEYAYTL---KVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASV  925 (982)
Q Consensus       849 ~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  925 (982)
                      .........||+.|||||++.+.   ....++||||+||++.||+||+.||...+....+.-.|.....           
T Consensus      1391 ~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~----------- 1459 (1509)
T KOG4645|consen 1391 MPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHK----------- 1459 (1509)
T ss_pred             CCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCC-----------
Confidence            22334567899999999999754   4668999999999999999999999988776665555543332           


Q ss_pred             ceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002010          926 LAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHM  968 (982)
Q Consensus       926 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~  968 (982)
                              +..|.....+-.+++..|++.||.+|+++.|+++.
T Consensus      1460 --------Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1460 --------PQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred             --------CCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence                    12233344467799999999999999999998873

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=2.1e-33  Score=303.57  Aligned_cols=250  Identities=27%  Similarity=0.427  Sum_probs=195.4

Q ss_pred             hcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEecc
Q 002010          693 SLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYM  771 (982)
Q Consensus       693 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  771 (982)
                      .+.....||+|+||.||+|.. .++..||+|.+... .....+.+.+|+.++++++|+||+++++++..++..++|+||+
T Consensus         9 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   87 (268)
T cd06624           9 ENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPER-DSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQV   87 (268)
T ss_pred             cCCceEEEecCCceEEEEeEecCCCcEEEEEEecCC-CHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecC
Confidence            344455899999999999964 46788999987433 2234557889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcCCCCCC--CHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcC-CCCEEEeccccchhccccC
Q 002010          772 PNGSLGEMLHGAKGGHL--KWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDS-DFEAHVADFGLAKFLQDAG  848 (982)
Q Consensus       772 ~~~sL~~~l~~~~~~~l--~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~-~~~~kl~DfG~a~~~~~~~  848 (982)
                      ++++|.+++.... ..+  ++..+..++.||+.|++|||+.+   |+||||||+||+++. ++.++|+|||.+.......
T Consensus        88 ~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~  163 (268)
T cd06624          88 PGGSLSALLRSKW-GPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGIN  163 (268)
T ss_pred             CCCCHHHHHHHhc-ccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheecccCC
Confidence            9999999997432 334  78888999999999999999888   999999999999976 6799999999987654221


Q ss_pred             CcccccccccccccccccccccC--CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccc
Q 002010          849 ASECMSSVAGSYGYIAPEYAYTL--KVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVL  926 (982)
Q Consensus       849 ~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  926 (982)
                        .......+++.|+|||++.+.  .++.++||||+|+++|+|++|..||............. ...             
T Consensus       164 --~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~-~~~-------------  227 (268)
T cd06624         164 --PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKV-GMF-------------  227 (268)
T ss_pred             --CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhh-hhh-------------
Confidence              122334678899999998654  37899999999999999999999997543221111100 000             


Q ss_pred             eeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          927 AVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       927 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                          ...+..+......+.+++.+||+.+|++|||+.|+++
T Consensus       228 ----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  264 (268)
T cd06624         228 ----KIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ  264 (268)
T ss_pred             ----ccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence                0011223344557889999999999999999999875

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=2e-33  Score=306.48  Aligned_cols=250  Identities=26%  Similarity=0.414  Sum_probs=194.7

Q ss_pred             hcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCCCchhhHHHHHHH-HhcCCCCcccceEeEEEcCCccEEEEec
Q 002010          693 SLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQT-LGRIRHRNIVRLLGYVSNRDTNLLLYEY  770 (982)
Q Consensus       693 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~-l~~l~h~niv~~~~~~~~~~~~~lv~e~  770 (982)
                      +|+..+.||+|+||.||+|.. .+|+.||+|++...........+..|+.. ++..+||||+++++++..+...++||||
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~   81 (283)
T cd06617           2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEV   81 (283)
T ss_pred             CceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhh
Confidence            577888999999999999965 46999999998654433344556667665 5556899999999999999999999999


Q ss_pred             cCCCCHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHhhc-CCCcEEecCCCCCcEEEcCCCCEEEeccccchhcccc
Q 002010          771 MPNGSLGEMLHGA--KGGHLKWETRYRIALEAAKGLCYLHHD-CSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDA  847 (982)
Q Consensus       771 ~~~~sL~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  847 (982)
                      ++ ++|.+++...  ....+++..+..++.|++.|++|||++ +   ++||||||+||+++.++.+||+|||.+..+...
T Consensus        82 ~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~  157 (283)
T cd06617          82 MD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS  157 (283)
T ss_pred             hc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence            96 6888887542  335789999999999999999999986 6   999999999999999999999999999865432


Q ss_pred             CCccccccccccccccccccccc----CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCccc
Q 002010          848 GASECMSSVAGSYGYIAPEYAYT----LKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAA  923 (982)
Q Consensus       848 ~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  923 (982)
                         .......++..|+|||++.+    ..++.++|+||+|+++|||++|+.||..................         
T Consensus       158 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~---------  225 (283)
T cd06617         158 ---VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPS---------  225 (283)
T ss_pred             ---cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCC---------
Confidence               11233467889999998864    45688999999999999999999999754332222111111100         


Q ss_pred             ccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          924 SVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       924 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                             +..+  ....+..+.+++.+||+.||++||+++++++
T Consensus       226 -------~~~~--~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         226 -------PQLP--AEKFSPEFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             -------CCCC--ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                   0000  0123457889999999999999999999987

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-33  Score=311.71  Aligned_cols=253  Identities=23%  Similarity=0.267  Sum_probs=203.7

Q ss_pred             hcccccccccccceEEEEEEeC-CCcEEEEEEeccCCCC--CchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEe
Q 002010          693 SLKDENIIGKGGAGIVYRGSMP-DGIDVAIKRLVGRGTG--GNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYE  769 (982)
Q Consensus       693 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  769 (982)
                      +|+..+.||+|++|.||+|... +++.||+|.+......  ...+.+.+|+.+++.++||||+++++.+......++|||
T Consensus         2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   81 (316)
T cd05574           2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMD   81 (316)
T ss_pred             ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEE
Confidence            5778889999999999999654 5899999998654332  244568899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCC
Q 002010          770 YMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGA  849 (982)
Q Consensus       770 ~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  849 (982)
                      |+++++|.+++.......+++..+..++.|++.|++|||+.+   ++||||||+||+++.++.++|+|||++........
T Consensus        82 ~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~  158 (316)
T cd05574          82 YCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPP  158 (316)
T ss_pred             ecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccccccc
Confidence            999999999998655678999999999999999999999988   99999999999999999999999999875432111


Q ss_pred             c---------------------------ccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCC
Q 002010          850 S---------------------------ECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDG  902 (982)
Q Consensus       850 ~---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~  902 (982)
                      .                           .......|+..|+|||++.+..++.++||||+|+++|+|++|+.||......
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~  238 (316)
T cd05574         159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRD  238 (316)
T ss_pred             ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchH
Confidence            0                           0111346788999999999888999999999999999999999999765433


Q ss_pred             chHHHHHHHhccCCCCCCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCC----HHHHHH
Q 002010          903 VDIVRWVRKTTSEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPT----MREVVH  967 (982)
Q Consensus       903 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt----~~ell~  967 (982)
                      ...........   .               .+ .....+..+.+++.+||+.||++|||    ++|++.
T Consensus       239 ~~~~~~~~~~~---~---------------~~-~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~  288 (316)
T cd05574         239 ETFSNILKKEV---T---------------FP-GSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ  288 (316)
T ss_pred             HHHHHHhcCCc---c---------------CC-CccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence            22222211100   0               00 00113457899999999999999999    777766

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=7.4e-34  Score=310.38  Aligned_cols=268  Identities=21%  Similarity=0.337  Sum_probs=202.3

Q ss_pred             hcccccccccccceEEEEEEeC-CCcEEEEEEeccCCCC-CchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEec
Q 002010          693 SLKDENIIGKGGAGIVYRGSMP-DGIDVAIKRLVGRGTG-GNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEY  770 (982)
Q Consensus       693 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  770 (982)
                      +|+..+.||+|+||.||+|..+ +++.||+|++...... ...+.+.+|+++++.++||||+++++++..++..++||||
T Consensus         2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   81 (286)
T cd07846           2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEF   81 (286)
T ss_pred             ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEec
Confidence            5778899999999999999764 5899999987554332 2345688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCc
Q 002010          771 MPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS  850 (982)
Q Consensus       771 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  850 (982)
                      ++++++.++..  ....+++..+..++.|++.|++|||+.+   ++||||+|+||++++++.++++|||++.......  
T Consensus        82 ~~~~~l~~~~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~--  154 (286)
T cd07846          82 VDHTVLDDLEK--YPNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG--  154 (286)
T ss_pred             CCccHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc--
Confidence            99999988775  3345899999999999999999999988   9999999999999999999999999998654322  


Q ss_pred             cccccccccccccccccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCC---c-cccc
Q 002010          851 ECMSSVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPS---D-AASV  925 (982)
Q Consensus       851 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~-~~~~  925 (982)
                      .......++..|+|||++.+ ..++.++||||+|+++|||++|++||........................   . ....
T Consensus       155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (286)
T cd07846         155 EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLF  234 (286)
T ss_pred             cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHh
Confidence            22334567889999998875 44788999999999999999999999754332222222211111000000   0 0000


Q ss_pred             ceeecCCCC------CCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          926 LAVVDPRLS------GYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       926 ~~~~~~~~~------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                      .....+...      ...+..+..+.+++.+||+.+|++|||++++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         235 AGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             hccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence            000000000      112234567899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.9e-33  Score=302.59  Aligned_cols=254  Identities=26%  Similarity=0.403  Sum_probs=201.7

Q ss_pred             hcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCCC-----chhhHHHHHHHHhcCCCCcccceEeEEEcCCccEE
Q 002010          693 SLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGG-----NDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLL  766 (982)
Q Consensus       693 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  766 (982)
                      .|+.++.||+|++|.||+|.. .+++.||+|.+.......     ....+.+|+.++++++||||+++++++.+.+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            367788999999999999964 678999999885433211     24568899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCC-CEEEeccccchhcc
Q 002010          767 LYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDF-EAHVADFGLAKFLQ  845 (982)
Q Consensus       767 v~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~-~~kl~DfG~a~~~~  845 (982)
                      ||||+++++|.+++..  ..++++..+..++.|++.|++|||+.+   ++||||+|+||+++.++ .+||+|||.+..+.
T Consensus        81 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~  155 (268)
T cd06630          81 FVEWMAGGSVSHLLSK--YGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARLA  155 (268)
T ss_pred             EEeccCCCcHHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEcccccccccc
Confidence            9999999999999973  457889999999999999999999988   99999999999998776 59999999998765


Q ss_pred             ccCC--cccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCccc
Q 002010          846 DAGA--SECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAA  923 (982)
Q Consensus       846 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  923 (982)
                      ....  ........++..|+|||.+.+..++.++||||+|+++|+|++|..||...........+......         
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~---------  226 (268)
T cd06630         156 AKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASA---------  226 (268)
T ss_pred             cccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhcc---------
Confidence            3311  11122346788999999998888999999999999999999999999653322111111111000         


Q ss_pred             ccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          924 SVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       924 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                             ......+...+..+.+++.+|++.+|++|||+.|+++
T Consensus       227 -------~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         227 -------TTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             -------CCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence                   0011233344567889999999999999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-34  Score=320.15  Aligned_cols=241  Identities=24%  Similarity=0.223  Sum_probs=187.0

Q ss_pred             cccccceEEEEEEe-CCCcEEEEEEeccCCC--CCchhhHHHHHHHHhcC---CCCcccceEeEEEcCCccEEEEeccCC
Q 002010          700 IGKGGAGIVYRGSM-PDGIDVAIKRLVGRGT--GGNDHGFLAEIQTLGRI---RHRNIVRLLGYVSNRDTNLLLYEYMPN  773 (982)
Q Consensus       700 lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~~~lv~e~~~~  773 (982)
                      ||+|+||+||+|+. .+++.||+|++.....  ......+..|..++.+.   +||+|+++++++.++...++||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            69999999999965 4689999999843321  12233455666776655   699999999999999999999999999


Q ss_pred             CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCcccc
Q 002010          774 GSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECM  853 (982)
Q Consensus       774 ~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~  853 (982)
                      ++|.+++.  +...+++..+..++.||++|++|||+.+   |+||||||+||+++.++.+||+|||++......  ....
T Consensus        81 g~L~~~l~--~~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~--~~~~  153 (330)
T cd05586          81 GELFWHLQ--KEGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTD--NKTT  153 (330)
T ss_pred             ChHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCC--CCCc
Confidence            99999986  4567899999999999999999999988   999999999999999999999999998754322  1223


Q ss_pred             cccccccccccccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceeecCC
Q 002010          854 SSVAGSYGYIAPEYAYTL-KVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDPR  932 (982)
Q Consensus       854 ~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  932 (982)
                      ....||+.|+|||++.+. .++.++||||+||++|||++|+.||....... ....+.....  .               
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~-~~~~i~~~~~--~---------------  215 (330)
T cd05586         154 NTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQ-MYRNIAFGKV--R---------------  215 (330)
T ss_pred             cCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHH-HHHHHHcCCC--C---------------
Confidence            456789999999998754 48999999999999999999999997543221 1111111000  0               


Q ss_pred             CCCCChHhHHHHHHHHhhccCCCCCCCC----CHHHHHH
Q 002010          933 LSGYPLTGVIHLFKVAMMCVEDESSARP----TMREVVH  967 (982)
Q Consensus       933 ~~~~~~~~~~~l~~li~~cl~~dP~~Rp----t~~ell~  967 (982)
                      ++  ....+..+.+++.+||+.||.+||    +++|+++
T Consensus       216 ~~--~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~  252 (330)
T cd05586         216 FP--KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE  252 (330)
T ss_pred             CC--CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence            00  011234678999999999999998    5666655

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=2e-33  Score=308.87  Aligned_cols=277  Identities=23%  Similarity=0.303  Sum_probs=206.0

Q ss_pred             hcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCC----CchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEE
Q 002010          693 SLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTG----GNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLL  767 (982)
Q Consensus       693 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  767 (982)
                      +|+..+.||+|++|.||+|.. .+++.||+|.+......    .....+..|+.++++++|+||+++++++.+....++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            367778899999999999965 46899999998654332    2234567899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhcccc
Q 002010          768 YEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDA  847 (982)
Q Consensus       768 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  847 (982)
                      |||+ +++|.+++.... ..+++..+..++.||++||+|||+++   |+||||+|+||+++.++.+||+|||++......
T Consensus        81 ~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~  155 (298)
T cd07841          81 FEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSP  155 (298)
T ss_pred             Eccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccCC
Confidence            9999 899999997432 47999999999999999999999988   999999999999999999999999999876532


Q ss_pred             CCccccccccccccccccccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCC-ccccc
Q 002010          848 GASECMSSVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPS-DAASV  925 (982)
Q Consensus       848 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~  925 (982)
                      .  .......+++.|+|||.+.+ ..++.++||||+||++|||++|.+||....+................... .....
T Consensus       156 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (298)
T cd07841         156 N--RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSL  233 (298)
T ss_pred             C--ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccc
Confidence            1  22233456788999998864 45789999999999999999998888764443332222222111000000 00000


Q ss_pred             ceee------cCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHH--hcCCCCCC
Q 002010          926 LAVV------DPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHM--LANPPQSA  976 (982)
Q Consensus       926 ~~~~------~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~--L~~~~~~~  976 (982)
                      ....      ..............+.+++.+||+.||++|||++|+++.  +++-.++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~~  292 (298)
T cd07841         234 PDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPT  292 (298)
T ss_pred             cccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCCC
Confidence            0000      000011123345678999999999999999999999984  55544443

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=1.6e-33  Score=308.81  Aligned_cols=247  Identities=23%  Similarity=0.355  Sum_probs=198.7

Q ss_pred             cccccccccccceEEEEEEe-CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEeccC
Q 002010          694 LKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMP  772 (982)
Q Consensus       694 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  772 (982)
                      |+....||+|+||.||+|.. .+++.||+|.+... .......+.+|+.+++.++||||+++++++..++..++||||++
T Consensus        23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~  101 (297)
T cd06659          23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLR-KQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQ  101 (297)
T ss_pred             HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEec-ccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCC
Confidence            33445799999999999965 46899999998443 33345668899999999999999999999999999999999999


Q ss_pred             CCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCccc
Q 002010          773 NGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASEC  852 (982)
Q Consensus       773 ~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~  852 (982)
                      +++|.+++..   ..+++..+..++.|++.|++|||+.+   ++||||+|+||+++.++.+||+|||++..+....  ..
T Consensus       102 ~~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~--~~  173 (297)
T cd06659         102 GGALTDIVSQ---TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV--PK  173 (297)
T ss_pred             CCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhccccc--cc
Confidence            9999998752   46899999999999999999999988   9999999999999999999999999987654321  12


Q ss_pred             ccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceeecCC
Q 002010          853 MSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDPR  932 (982)
Q Consensus       853 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  932 (982)
                      .....++..|+|||++.+..++.++||||+||++|||++|+.||....... ....+.....    +             
T Consensus       174 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-~~~~~~~~~~----~-------------  235 (297)
T cd06659         174 RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQ-AMKRLRDSPP----P-------------  235 (297)
T ss_pred             ccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHhccCC----C-------------
Confidence            234568899999999998889999999999999999999999997543222 2222111100    0             


Q ss_pred             CCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          933 LSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       933 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                      ........+..+.+++.+||+.+|++||+++|+++
T Consensus       236 ~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~  270 (297)
T cd06659         236 KLKNAHKISPVLRDFLERMLTREPQERATAQELLD  270 (297)
T ss_pred             CccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence            00011122346889999999999999999999998

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=1.4e-33  Score=308.48  Aligned_cols=244  Identities=25%  Similarity=0.310  Sum_probs=200.3

Q ss_pred             hcccccccccccceEEEEEEe-CCCcEEEEEEeccCCC--CCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEe
Q 002010          693 SLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGT--GGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYE  769 (982)
Q Consensus       693 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  769 (982)
                      +|+..+.||+|+||.||+|.. .+++.||+|++.....  ......+.+|++++++++||||+++++++.+....++|||
T Consensus         2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   81 (290)
T cd05580           2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVME   81 (290)
T ss_pred             ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEe
Confidence            578888999999999999965 4689999998854322  2334568899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCC
Q 002010          770 YMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGA  849 (982)
Q Consensus       770 ~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  849 (982)
                      |+++++|.+++..  ...+++..+..++.|++.|++|||+.+   |+||||+|+||+++.++.+||+|||++......  
T Consensus        82 ~~~~~~L~~~~~~--~~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~--  154 (290)
T cd05580          82 YVPGGELFSHLRK--SGRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--  154 (290)
T ss_pred             cCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC--
Confidence            9999999999973  467899999999999999999999988   999999999999999999999999999866432  


Q ss_pred             cccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceee
Q 002010          850 SECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVV  929 (982)
Q Consensus       850 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  929 (982)
                         .....+++.|+|||.+.+..++.++||||+|+++|+|++|+.||...... ........  ...             
T Consensus       155 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~--~~~-------------  215 (290)
T cd05580         155 ---TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI-QIYEKILE--GKV-------------  215 (290)
T ss_pred             ---CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHhc--CCc-------------
Confidence               23456889999999998888899999999999999999999999764321 11111111  000             


Q ss_pred             cCCCCCCChHhHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 002010          930 DPRLSGYPLTGVIHLFKVAMMCVEDESSARP-----TMREVVH  967 (982)
Q Consensus       930 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~ell~  967 (982)
                           ..+...+..+.+++.+||+.||.+|+     +++|+++
T Consensus       216 -----~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~  253 (290)
T cd05580         216 -----RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN  253 (290)
T ss_pred             -----cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence                 11222345788999999999999999     7777764

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=1.9e-33  Score=309.81  Aligned_cols=256  Identities=19%  Similarity=0.215  Sum_probs=199.2

Q ss_pred             hcccccccccccceEEEEEEe-CCCcEEEEEEeccCCC--CCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEe
Q 002010          693 SLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGT--GGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYE  769 (982)
Q Consensus       693 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  769 (982)
                      .|+..+.||+|+||.||++.. .+++.||+|.+.....  ......+.+|+.+++.++||||+++++.+..++..++|||
T Consensus         2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (305)
T cd05609           2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVME   81 (305)
T ss_pred             CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEe
Confidence            577788999999999999965 4578999998854422  2234567889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccC-
Q 002010          770 YMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAG-  848 (982)
Q Consensus       770 ~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-  848 (982)
                      |+++++|.+++..  ...+++..+..++.|++.|++|+|+.+   ++||||||+||+++.++.+|++|||+++...... 
T Consensus        82 ~~~g~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~  156 (305)
T cd05609          82 YVEGGDCATLLKN--IGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLT  156 (305)
T ss_pred             cCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcCcc
Confidence            9999999999963  357899999999999999999999988   9999999999999999999999999986421100 


Q ss_pred             ------------CcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCC
Q 002010          849 ------------ASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEV  916 (982)
Q Consensus       849 ------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  916 (982)
                                  .........++..|+|||.+.+..++.++|+||+|+++|||++|..||..................  
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~--  234 (305)
T cd05609         157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIE--  234 (305)
T ss_pred             ccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC--
Confidence                        000111245788999999998888999999999999999999999999754322111111111000  


Q ss_pred             CCCCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 002010          917 SQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLAN  971 (982)
Q Consensus       917 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~  971 (982)
                       .+               ..+...+..+.+++.+||+.||++||++.++.+.|+.
T Consensus       235 -~~---------------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~  273 (305)
T cd05609         235 -WP---------------EGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH  273 (305)
T ss_pred             -CC---------------CccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence             00               0011234568899999999999999997666666554

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-34  Score=317.94  Aligned_cols=272  Identities=25%  Similarity=0.322  Sum_probs=205.6

Q ss_pred             cccccccccccceEEEEEE-eCCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcC------CccEE
Q 002010          694 LKDENIIGKGGAGIVYRGS-MPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNR------DTNLL  766 (982)
Q Consensus       694 ~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~~~l  766 (982)
                      |...+.||+|+||.||+|+ ..+|+.||||.+.........+...+|++++++++|||||++++.-.+.      +...+
T Consensus        15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl   94 (732)
T KOG4250|consen   15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL   94 (732)
T ss_pred             eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence            4556789999999999997 5679999999997777777788889999999999999999999875443      35689


Q ss_pred             EEeccCCCCHHHHhhcCCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEc--CCC--CEEEeccccc
Q 002010          767 LYEYMPNGSLGEMLHGAKG-GHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLD--SDF--EAHVADFGLA  841 (982)
Q Consensus       767 v~e~~~~~sL~~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~--~~~--~~kl~DfG~a  841 (982)
                      |||||.+|+|+..+.+.++ ..+++.+.+.+..+++.||.|||+++   ||||||||.||++-  ++|  ..||+|||.|
T Consensus        95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A  171 (732)
T KOG4250|consen   95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA  171 (732)
T ss_pred             EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence            9999999999999986543 67999999999999999999999998   99999999999983  333  4799999999


Q ss_pred             hhccccCCccccccccccccccccccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCC
Q 002010          842 KFLQDAGASECMSSVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPS  920 (982)
Q Consensus       842 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  920 (982)
                      +.+++..   ...+..||..|.+||+... +.|+..+|.|||||++|++.||..||.....+..............+...
T Consensus       172 rel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v  248 (732)
T KOG4250|consen  172 RELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGV  248 (732)
T ss_pred             ccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCce
Confidence            9887643   5678899999999999994 88999999999999999999999999886655321111111111111100


Q ss_pred             cccccce-----eecCCCC---CCChHhHHHHHHHHhhccCCCCCCCC--CHHHHHHHhcC
Q 002010          921 DAASVLA-----VVDPRLS---GYPLTGVIHLFKVAMMCVEDESSARP--TMREVVHMLAN  971 (982)
Q Consensus       921 ~~~~~~~-----~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rp--t~~ell~~L~~  971 (982)
                      .......     .+...++   .........+...+..++..+|++|.  .+.+..+.+..
T Consensus       249 ~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~d  309 (732)
T KOG4250|consen  249 AIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDD  309 (732)
T ss_pred             eEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHH
Confidence            0000000     0001111   12223334566788889999999999  55555544433

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=2e-33  Score=311.82  Aligned_cols=264  Identities=19%  Similarity=0.292  Sum_probs=187.8

Q ss_pred             ccccccccceEEEEEEeC---CCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEc--CCccEEEEecc
Q 002010          697 ENIIGKGGAGIVYRGSMP---DGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSN--RDTNLLLYEYM  771 (982)
Q Consensus       697 ~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~  771 (982)
                      +..||+|+||.||+|...   ++..||+|.+...   .....+.+|+.++++++||||+++++++..  +...++||||+
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~   82 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGT---GISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYA   82 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCC---CCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeee
Confidence            357999999999999754   4578999987432   223457899999999999999999998854  45678999998


Q ss_pred             CCCCHHHHhhcC-------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEE----cCCCCEEEecccc
Q 002010          772 PNGSLGEMLHGA-------KGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILL----DSDFEAHVADFGL  840 (982)
Q Consensus       772 ~~~sL~~~l~~~-------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill----~~~~~~kl~DfG~  840 (982)
                      + ++|.+++...       ....+++..+..++.||+.|++|||+.+   |+||||||+||++    +.++.+||+|||+
T Consensus        83 ~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~  158 (317)
T cd07867          83 E-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGF  158 (317)
T ss_pred             C-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccc
Confidence            5 5787777421       1235889999999999999999999988   9999999999999    5667999999999


Q ss_pred             chhccccCC-ccccccccccccccccccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCc---------hHHHHH
Q 002010          841 AKFLQDAGA-SECMSSVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGV---------DIVRWV  909 (982)
Q Consensus       841 a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~---------~~~~~~  909 (982)
                      ++....... ........+|+.|+|||++.+ ..++.++||||+||++|||+||++||....+..         ....+.
T Consensus       159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~  238 (317)
T cd07867         159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIF  238 (317)
T ss_pred             eeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHH
Confidence            987653321 112234578999999999876 458999999999999999999999997532211         111111


Q ss_pred             HHhccCCCCCCcc-------cccceee-cC---------CCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          910 RKTTSEVSQPSDA-------ASVLAVV-DP---------RLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       910 ~~~~~~~~~~~~~-------~~~~~~~-~~---------~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                      .............       ......+ ..         ............+.+++.+|++.||.+|||++|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~  313 (317)
T cd07867         239 SVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQ  313 (317)
T ss_pred             HhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhc
Confidence            1111000000000       0000000 00         000111122345889999999999999999999985

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.2e-33  Score=317.74  Aligned_cols=261  Identities=21%  Similarity=0.281  Sum_probs=191.7

Q ss_pred             hhcccccccccccceEEEEEEeC-CCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEec
Q 002010          692 ESLKDENIIGKGGAGIVYRGSMP-DGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEY  770 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  770 (982)
                      ..|++.+.||+|+||.||+|... +++.||+|....       .....|+.++++++||||+++++++......++|||+
T Consensus        66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  138 (357)
T PHA03209         66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK-------GTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPH  138 (357)
T ss_pred             cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc-------cccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEc
Confidence            35888899999999999999664 577899996422       1235799999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCc
Q 002010          771 MPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS  850 (982)
Q Consensus       771 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  850 (982)
                      + .++|.+++.. ....+++..+..++.||+.|++|||+.+   |+||||||+||+++.++.+||+|||.++.....   
T Consensus       139 ~-~~~l~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~---  210 (357)
T PHA03209        139 Y-SSDLYTYLTK-RSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA---  210 (357)
T ss_pred             c-CCcHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccC---
Confidence            9 5688888863 3467899999999999999999999988   999999999999999999999999999753321   


Q ss_pred             ccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCC-CCCCCC---------chHHHHHHHhccCC-CCC
Q 002010          851 ECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPV-GEFGDG---------VDIVRWVRKTTSEV-SQP  919 (982)
Q Consensus       851 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~-~~~~~~---------~~~~~~~~~~~~~~-~~~  919 (982)
                      .......||+.|+|||++.+..++.++||||+||++|||+++..|+ ......         ..+...+......+ ..+
T Consensus       211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  290 (357)
T PHA03209        211 PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFP  290 (357)
T ss_pred             cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcC
Confidence            1223456899999999999999999999999999999999955544 432211         11111111111100 000


Q ss_pred             Cc-cccc-ceeec------CCCCC----CChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          920 SD-AASV-LAVVD------PRLSG----YPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       920 ~~-~~~~-~~~~~------~~~~~----~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                      .. .... ...++      .....    .....+....+++.+||+.||.+|||+.|+++
T Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~  350 (357)
T PHA03209        291 RDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILN  350 (357)
T ss_pred             CCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhc
Confidence            00 0000 00000      00000    01122345667999999999999999999885

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=3.6e-33  Score=301.20  Aligned_cols=251  Identities=27%  Similarity=0.391  Sum_probs=197.1

Q ss_pred             hhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCC----CchhhHHHHHHHHhcCCCCcccceEeEEEcC--Ccc
Q 002010          692 ESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTG----GNDHGFLAEIQTLGRIRHRNIVRLLGYVSNR--DTN  764 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~  764 (982)
                      .+|+..+.||+|+||.||+|.. .+++.||+|.+......    .....+.+|+.++++++||||+++++++.+.  ...
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            4678889999999999999965 45899999987533211    1234678899999999999999999988764  457


Q ss_pred             EEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhc
Q 002010          765 LLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFL  844 (982)
Q Consensus       765 ~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~  844 (982)
                      +++|||+++++|.+++..  ...+++..+..++.|++.|++|||+.+   |+|+||||+||+++.++.++|+|||++...
T Consensus        82 ~~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~  156 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKS--YGALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRL  156 (265)
T ss_pred             EEEEEecCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCcccccc
Confidence            799999999999999873  346888999999999999999999988   999999999999999999999999999865


Q ss_pred             cccCC-cccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCccc
Q 002010          845 QDAGA-SECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAA  923 (982)
Q Consensus       845 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  923 (982)
                      ..... ........++..|+|||++.+..++.++||||+|+++|||++|+.||...........    ....        
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~----~~~~--------  224 (265)
T cd06652         157 QTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFK----IATQ--------  224 (265)
T ss_pred             ccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHH----HhcC--------
Confidence            42211 1112335688899999999888899999999999999999999999975432222111    1110        


Q ss_pred             ccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          924 SVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       924 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                             +..+..+......+.+++.+|+. +|++||+++|+++
T Consensus       225 -------~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~  260 (265)
T cd06652         225 -------PTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR  260 (265)
T ss_pred             -------CCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence                   01112233444568889999995 9999999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=3.7e-33  Score=301.86  Aligned_cols=253  Identities=25%  Similarity=0.360  Sum_probs=200.0

Q ss_pred             cccccccccccceEEEEEEeCC--CcEEEEEEeccCC---------CCCchhhHHHHHHHHhc-CCCCcccceEeEEEcC
Q 002010          694 LKDENIIGKGGAGIVYRGSMPD--GIDVAIKRLVGRG---------TGGNDHGFLAEIQTLGR-IRHRNIVRLLGYVSNR  761 (982)
Q Consensus       694 ~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~---------~~~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~~  761 (982)
                      |+..+.||+|+||.||+|....  ++.+|+|.+....         ......++.+|+.++.+ ++||||+++++++..+
T Consensus         2 y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~   81 (269)
T cd08528           2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEN   81 (269)
T ss_pred             chhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccC
Confidence            6677889999999999997644  7889999874322         11223456778888765 6999999999999999


Q ss_pred             CccEEEEeccCCCCHHHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCcEEecCCCCCcEEEcCCCCEEEecc
Q 002010          762 DTNLLLYEYMPNGSLGEMLHG--AKGGHLKWETRYRIALEAAKGLCYLHH-DCSPLIIHRDVKSNNILLDSDFEAHVADF  838 (982)
Q Consensus       762 ~~~~lv~e~~~~~sL~~~l~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivHrDlkp~Nill~~~~~~kl~Df  838 (982)
                      +..++||||+++++|.+++..  .....+++..++.++.|++.|+.|||+ .+   ++||||+|+||+++.++.+||+||
T Consensus        82 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~df  158 (269)
T cd08528          82 DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITDF  158 (269)
T ss_pred             CeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEecc
Confidence            999999999999999998853  234578999999999999999999996 56   999999999999999999999999


Q ss_pred             ccchhccccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCC
Q 002010          839 GLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQ  918 (982)
Q Consensus       839 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  918 (982)
                      |.+.......   ......++..|+|||++.+..++.++||||+|+++|+|++|+.||........ ...+.....   .
T Consensus       159 g~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~-~~~~~~~~~---~  231 (269)
T cd08528         159 GLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSL-ATKIVEAVY---E  231 (269)
T ss_pred             cceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHH-HHHHhhccC---C
Confidence            9998655332   33455688899999999988899999999999999999999999965422211 111111100   0


Q ss_pred             CCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 002010          919 PSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLAN  971 (982)
Q Consensus       919 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~  971 (982)
                      +.               .....+..+.+++.+||+.||++||++.|+.++++.
T Consensus       232 ~~---------------~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~  269 (269)
T cd08528         232 PL---------------PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD  269 (269)
T ss_pred             cC---------------CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence            00               011223578899999999999999999999998863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-33  Score=304.48  Aligned_cols=252  Identities=28%  Similarity=0.422  Sum_probs=199.9

Q ss_pred             HhhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcC-CCCcccceEeEEEcCC------
Q 002010          691 LESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRI-RHRNIVRLLGYVSNRD------  762 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~------  762 (982)
                      .++|+..+.||+|++|.||+|.. .+++.|++|++....  .....+.+|+.+++++ +||||+++++++....      
T Consensus         5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   82 (275)
T cd06608           5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE--DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD   82 (275)
T ss_pred             hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc--hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence            47899999999999999999976 457899999874332  2446788999999999 7999999999987644      


Q ss_pred             ccEEEEeccCCCCHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEecccc
Q 002010          763 TNLLLYEYMPNGSLGEMLHGAK--GGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGL  840 (982)
Q Consensus       763 ~~~lv~e~~~~~sL~~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~  840 (982)
                      ..++||||+++++|.+++....  ...+++..+..++.|++.|++|||+.+   ++||||+|+||++++++.+|++|||.
T Consensus        83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~~  159 (275)
T cd06608          83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGV  159 (275)
T ss_pred             EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCcc
Confidence            4799999999999999987533  567899999999999999999999988   99999999999999999999999999


Q ss_pred             chhccccCCccccccccccccccccccccc-----CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccC
Q 002010          841 AKFLQDAGASECMSSVAGSYGYIAPEYAYT-----LKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSE  915 (982)
Q Consensus       841 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  915 (982)
                      +......  ........++..|+|||++..     ..++.++||||+|+++|+|++|+.||.................  
T Consensus       160 ~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--  235 (275)
T cd06608         160 SAQLDST--LGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPP--  235 (275)
T ss_pred             ceecccc--hhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCC--
Confidence            8765432  122334568889999998753     3477899999999999999999999975433222222111000  


Q ss_pred             CCCCCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          916 VSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       916 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                                     +.. ..+...+..+.+++.+||..||++|||++|+++
T Consensus       236 ---------------~~~-~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         236 ---------------PTL-KSPENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             ---------------CCC-CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence                           000 111223457889999999999999999999985

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-33  Score=333.32  Aligned_cols=259  Identities=25%  Similarity=0.427  Sum_probs=214.4

Q ss_pred             hhcccccccccccceEEEEEEeC----C----CcEEEEEEeccCCCCCchhhHHHHHHHHhcC-CCCcccceEeEEEcCC
Q 002010          692 ESLKDENIIGKGGAGIVYRGSMP----D----GIDVAIKRLVGRGTGGNDHGFLAEIQTLGRI-RHRNIVRLLGYVSNRD  762 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~~----~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~  762 (982)
                      ++.+..+.+|+|+||.|++|...    .    ...||||..+........+.+..|+++|+.+ +||||+.++|++..+.
T Consensus       296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~  375 (609)
T KOG0200|consen  296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDG  375 (609)
T ss_pred             hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCC
Confidence            34455669999999999999532    1    4579999998777777788999999999999 6999999999999999


Q ss_pred             ccEEEEeccCCCCHHHHhhcCC------------C--CCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEc
Q 002010          763 TNLLLYEYMPNGSLGEMLHGAK------------G--GHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLD  828 (982)
Q Consensus       763 ~~~lv~e~~~~~sL~~~l~~~~------------~--~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~  828 (982)
                      ..++|+||++.|+|.++++..+            .  ..++..+...++.|||.|++||++..   +||||+..+||+++
T Consensus       376 ~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaRNVLi~  452 (609)
T KOG0200|consen  376 PLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAARNVLIT  452 (609)
T ss_pred             ceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhhhEEec
Confidence            9999999999999999998654            0  13889999999999999999999887   99999999999999


Q ss_pred             CCCCEEEeccccchhccccCCccccccc-ccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHH
Q 002010          829 SDFEAHVADFGLAKFLQDAGASECMSSV-AGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIV  906 (982)
Q Consensus       829 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~  906 (982)
                      ++..+||+|||+|+...+...+...... .-+..|||||.+....|+.++|||||||++||++| |..||.+.....++.
T Consensus       453 ~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~  532 (609)
T KOG0200|consen  453 KNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELL  532 (609)
T ss_pred             CCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHH
Confidence            9999999999999976654444322221 13557999999999999999999999999999999 999998755445555


Q ss_pred             HHHHHhccCCCCCCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 002010          907 RWVRKTTSEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANP  972 (982)
Q Consensus       907 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~  972 (982)
                      ++++... +..                  .|..+..+++++|+.||+.+|++||++.|+++.++..
T Consensus       533 ~~l~~G~-r~~------------------~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~  579 (609)
T KOG0200|consen  533 EFLKEGN-RME------------------QPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH  579 (609)
T ss_pred             HHHhcCC-CCC------------------CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence            5443322 222                  3444556899999999999999999999999998773

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-33  Score=306.02  Aligned_cols=268  Identities=21%  Similarity=0.263  Sum_probs=202.2

Q ss_pred             cccccccccccceEEEEEEe-CCCcEEEEEEeccCCC-CCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEecc
Q 002010          694 LKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGT-GGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYM  771 (982)
Q Consensus       694 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  771 (982)
                      |+..+.||.|++|.||+|.. .+|..||+|++..... ......+.+|+.++++++|||++++++++.+++..+++|||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            45677899999999999965 4799999998854432 223456888999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCcc
Q 002010          772 PNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASE  851 (982)
Q Consensus       772 ~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~  851 (982)
                      + ++|.+++.......+++..+..++.|+++|++|||+.+   ++||||+|+||+++.++.++|+|||.+......  ..
T Consensus        81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~--~~  154 (283)
T cd07835          81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVP--VR  154 (283)
T ss_pred             C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCC--cc
Confidence            4 69999997555457899999999999999999999988   999999999999999999999999999765322  11


Q ss_pred             cccccccccccccccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcc----cccc
Q 002010          852 CMSSVAGSYGYIAPEYAYTL-KVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDA----ASVL  926 (982)
Q Consensus       852 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~  926 (982)
                      ......++..|+|||++.+. .++.++||||+|+++|+|++|++||....+........+............    ....
T Consensus       155 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (283)
T cd07835         155 TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYK  234 (283)
T ss_pred             ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhh
Confidence            22334568899999987654 578999999999999999999999976544333333332221111100000    0000


Q ss_pred             ----eeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          927 ----AVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       927 ----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                          ....+.........+..+.+++.+||+.||++|||++|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         235 PTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             hhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence                00001111122233457889999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=5.6e-33  Score=299.55  Aligned_cols=253  Identities=29%  Similarity=0.442  Sum_probs=202.0

Q ss_pred             hcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCC-CchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEec
Q 002010          693 SLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTG-GNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEY  770 (982)
Q Consensus       693 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  770 (982)
                      +|+..+.||+|+||.||+|.. .+++.||+|.+...... .....+.+|+.++++++|+||+++++++...+..++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            467788999999999999965 46899999998544332 3556789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCc
Q 002010          771 MPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS  850 (982)
Q Consensus       771 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  850 (982)
                      +++++|.+++..  ...+++..+..++.|++.|++|||+.+   |+||||+|+||++++++.+||+|||.+.........
T Consensus        81 ~~~~~L~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~  155 (264)
T cd06626          81 CSGGTLEELLEH--GRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT  155 (264)
T ss_pred             CCCCcHHHHHhh--cCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCCc
Confidence            999999999973  346889999999999999999999988   999999999999999999999999999876543221


Q ss_pred             cc--ccccccccccccccccccCC---CCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCccccc
Q 002010          851 EC--MSSVAGSYGYIAPEYAYTLK---VDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASV  925 (982)
Q Consensus       851 ~~--~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  925 (982)
                      ..  .....++..|+|||++.+..   ++.++||||+|+++|++++|+.||............+.. ...          
T Consensus       156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~----------  224 (264)
T cd06626         156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA-GHK----------  224 (264)
T ss_pred             ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc-CCC----------
Confidence            11  12356788999999988766   889999999999999999999999765332222221111 110          


Q ss_pred             ceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          926 LAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       926 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                           +.++. ....+..+.+++.+||+.+|++|||++|++.
T Consensus       225 -----~~~~~-~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         225 -----PPIPD-SLQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             -----CCCCc-ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence                 00110 1112456789999999999999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=2.5e-33  Score=306.80  Aligned_cols=251  Identities=24%  Similarity=0.355  Sum_probs=202.3

Q ss_pred             HhhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEe
Q 002010          691 LESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYE  769 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  769 (982)
                      .++|+..+.||+|+||.||+|.. .+++.||+|.+... .....+.+.+|+.++++++||||+++++++..++..++|+|
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e   96 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQ-QQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVME   96 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccc-cchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEe
Confidence            46788899999999999999964 46889999987432 33345678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCC
Q 002010          770 YMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGA  849 (982)
Q Consensus       770 ~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  849 (982)
                      |+++++|.+++..   ..+++.++..++.|++.|++|||+.+   ++||||+|+||+++.++.+||+|||++....... 
T Consensus        97 ~~~~~~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~-  169 (293)
T cd06647          97 YLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-  169 (293)
T ss_pred             cCCCCcHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceecccccc-
Confidence            9999999999863   35789999999999999999999988   9999999999999999999999999887654332 


Q ss_pred             cccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceee
Q 002010          850 SECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVV  929 (982)
Q Consensus       850 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  929 (982)
                       .......+++.|+|||.+.+..++.++||||+|+++|++++|+.||.............. ...               
T Consensus       170 -~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~-~~~---------------  232 (293)
T cd06647         170 -SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGT---------------  232 (293)
T ss_pred             -cccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhc-CCC---------------
Confidence             122334688899999999888899999999999999999999999975432211111100 000               


Q ss_pred             cCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002010          930 DPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHM  968 (982)
Q Consensus       930 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~  968 (982)
                       +.. ..+...+..+.+++.+||+.+|++||++++++..
T Consensus       233 -~~~-~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         233 -PEL-QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             -CCC-CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence             000 1122234568899999999999999999999873

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=3.6e-33  Score=303.28  Aligned_cols=248  Identities=28%  Similarity=0.372  Sum_probs=201.9

Q ss_pred             hhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEec
Q 002010          692 ESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEY  770 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  770 (982)
                      +-|+..+.||+|+||.||+|.. .+++.||+|.............+.+|+.++++++||||+++++++..++..++||||
T Consensus         4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   83 (277)
T cd06641           4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY   83 (277)
T ss_pred             HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence            3467778899999999999965 468899999875444344456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCc
Q 002010          771 MPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS  850 (982)
Q Consensus       771 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  850 (982)
                      +++++|.+++.   ...+++..+..++.|++.|+.|||+.+   ++|+||+|+||+++.++.++++|||++..+....  
T Consensus        84 ~~~~~l~~~i~---~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~--  155 (277)
T cd06641          84 LGGGSALDLLE---PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--  155 (277)
T ss_pred             CCCCcHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccch--
Confidence            99999999985   346899999999999999999999988   9999999999999999999999999987654321  


Q ss_pred             ccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceeec
Q 002010          851 ECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVD  930 (982)
Q Consensus       851 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  930 (982)
                      .......++..|+|||...+..++.++|+||+||++|+|++|..||...... .....+... .                
T Consensus       156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~-~----------------  217 (277)
T cd06641         156 IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM-KVLFLIPKN-N----------------  217 (277)
T ss_pred             hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH-HHHHHHhcC-C----------------
Confidence            1123346788999999998888899999999999999999999999753321 111111100 0                


Q ss_pred             CCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          931 PRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       931 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                        .+..+...+..+.+++.+||+.+|++||+++++++
T Consensus       218 --~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  252 (277)
T cd06641         218 --PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLK  252 (277)
T ss_pred             --CCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence              01122234457889999999999999999999998

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=6.3e-33  Score=302.67  Aligned_cols=269  Identities=22%  Similarity=0.332  Sum_probs=203.9

Q ss_pred             hcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEecc
Q 002010          693 SLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYM  771 (982)
Q Consensus       693 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  771 (982)
                      +|+..+.||+|++|.||+|.. .+|..||+|++...........+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            377888999999999999976 4688999999865555555567788999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCc
Q 002010          772 PNGSLGEMLHGAK-GGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS  850 (982)
Q Consensus       772 ~~~sL~~~l~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  850 (982)
                      ++ +|.+++.... ...+++..+..++.|++.|++|||+.+   ++||||+|+||++++++.++++|||++......  .
T Consensus        81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~--~  154 (284)
T cd07836          81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIP--V  154 (284)
T ss_pred             Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCC--c
Confidence            75 8888876432 356899999999999999999999988   999999999999999999999999999765432  1


Q ss_pred             ccccccccccccccccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceee
Q 002010          851 ECMSSVAGSYGYIAPEYAYTL-KVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVV  929 (982)
Q Consensus       851 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  929 (982)
                      .......++..|+|||++.+. .++.++||||+|+++|+|++|+.||......+..........................
T Consensus       155 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T cd07836         155 NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEY  234 (284)
T ss_pred             cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchh
Confidence            122344578899999987654 5789999999999999999999999875444333333222211111000000000000


Q ss_pred             cCCCC--------CCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          930 DPRLS--------GYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       930 ~~~~~--------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                      ....+        ......+..+.+++.+|++.||.+||+++|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         235 KPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             cccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            01111        111223456889999999999999999999875

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=100.00  E-value=4.7e-36  Score=322.11  Aligned_cols=370  Identities=25%  Similarity=0.390  Sum_probs=274.6

Q ss_pred             ccEEeecCcccc-cccCCCccccCcceEeeccCcccccchhhHHhhhhhHHHHhhcccccccccCCCCCCCCCCCCEEec
Q 002010          170 LRHLSFGGNYFT-GKIPQSYSEIQSLEYIGLNGIGLNGTVPAFLSRLKNLREMYIGYFNTYTGGIPPGFGALTQLQVLDM  248 (982)
Q Consensus       170 L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~l~~~n~~~~~~p~~~~~l~~L~~L~L  248 (982)
                      .+-.|+++|.|+ +..|.....+++++.|.|...++. .+|..++.|.+|++|.+++|+..+  +...++.|+.|+.+++
T Consensus         9 VrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~~--vhGELs~Lp~LRsv~~   85 (1255)
T KOG0444|consen    9 VRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLIS--VHGELSDLPRLRSVIV   85 (1255)
T ss_pred             eecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhHh--hhhhhccchhhHHHhh
Confidence            334445555554 344555555555555555544443 677888888888888887654332  4455677778888888


Q ss_pred             ccCcCcc-cCchhhcCCCccceeecccccCCCCCCccccCCCCCCEEEeeCCcccCcCchhhhcccchhhhhhccCCCCC
Q 002010          249 ASCNISG-EIPTSLSRLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQLFKNNLRG  327 (982)
Q Consensus       249 ~~n~l~~-~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~  327 (982)
                      ..|++.. -+|..+.++..|+.||||+|+++ ..|..+..-.++-.|+||+|+|..+....|.++..|-+||||+|++. 
T Consensus        86 R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe-  163 (1255)
T KOG0444|consen   86 RDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLE-  163 (1255)
T ss_pred             hccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchhh-
Confidence            8887753 35666777888888888888887 66777777777788888888887544455677777777888888877 


Q ss_pred             CCCCcCCCCCCccEEEccCCCcccccCccccCCCcccEEEeccccccccCCccccCccccceeecccccccccCCccccC
Q 002010          328 PIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFIGPIPEELGQ  407 (982)
Q Consensus       328 ~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~l~~N~~~~~~~~~l~~  407 (982)
                      .+|..+..+..|+.|.|++|++...--..+..+++|.+|.+++.+=+                       ...+|.++..
T Consensus       164 ~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRT-----------------------l~N~Ptsld~  220 (1255)
T KOG0444|consen  164 MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRT-----------------------LDNIPTSLDD  220 (1255)
T ss_pred             hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccch-----------------------hhcCCCchhh
Confidence            56666777777777777777765333333334444444444443332                       2356778888


Q ss_pred             CCCCCEEEccCCccCCCCCccccCCCccccccCCCccccccCCcccccCCccEEEeeccccCCCCchhccCCCCcceeee
Q 002010          408 CKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLSGELPEKMSGASLNQLKVANNNITGKIPAAIGNLPSLNILSL  487 (982)
Q Consensus       408 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L  487 (982)
                      +.+|..+|+|.|.+. .+|+.+.++++|+.|+|++|.|+                        .+.-..+...+|++|+|
T Consensus       221 l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~it------------------------eL~~~~~~W~~lEtLNl  275 (1255)
T KOG0444|consen  221 LHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKIT------------------------ELNMTEGEWENLETLNL  275 (1255)
T ss_pred             hhhhhhccccccCCC-cchHHHhhhhhhheeccCcCcee------------------------eeeccHHHHhhhhhhcc
Confidence            888888888888888 77888887776666666655554                        33345566779999999


Q ss_pred             ccccccCCCccccccccccceeeeeccccCC-CCCcccccccCCCeeeCCCCcccCCCCcccccccccceEEcccccccc
Q 002010          488 QNNRLEGEIPVESFNLKMITSINISDNNISG-EIPYSISQCHSLTSVDLSRNSLYGKIPPGISKLIDLSILNLSRNGITG  566 (982)
Q Consensus       488 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~  566 (982)
                      |.|+++ .+|..+..++.|+.|.+.+|+++- -+|..++++.+|+.+..++|.+. ..|+.++.+..|+.|.|++|++- 
T Consensus       276 SrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-  352 (1255)
T KOG0444|consen  276 SRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-  352 (1255)
T ss_pred             ccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhccccccee-
Confidence            999999 899999999999999999999973 48999999999999999999997 99999999999999999999998 


Q ss_pred             cCccccccccccceecccCCccccCCCCC
Q 002010          567 SIPNEMRNMMSLTTLDLSYNNLIGNIPSG  595 (982)
Q Consensus       567 ~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~  595 (982)
                      ++|+++.-++.|+.|||..|+=--.+|..
T Consensus       353 TLPeaIHlL~~l~vLDlreNpnLVMPPKP  381 (1255)
T KOG0444|consen  353 TLPEAIHLLPDLKVLDLRENPNLVMPPKP  381 (1255)
T ss_pred             echhhhhhcCCcceeeccCCcCccCCCCc
Confidence            89999999999999999999866566643

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=5.9e-33  Score=303.16  Aligned_cols=255  Identities=24%  Similarity=0.396  Sum_probs=200.7

Q ss_pred             hcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcC--CccEEEEe
Q 002010          693 SLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNR--DTNLLLYE  769 (982)
Q Consensus       693 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e  769 (982)
                      +|+..+.||.|++|.||+|.. .+++.||+|.+...........+.+|++++++++||||+++++++.+.  ...++|||
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e   81 (287)
T cd06621           2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAME   81 (287)
T ss_pred             ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEE
Confidence            577788999999999999976 468899999886544444566789999999999999999999988654  36799999


Q ss_pred             ccCCCCHHHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhcccc
Q 002010          770 YMPNGSLGEMLHG--AKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDA  847 (982)
Q Consensus       770 ~~~~~sL~~~l~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  847 (982)
                      |+++++|.+++..  .....+++..+..++.|++.|++|||+.+   ++|+||+|+||++++++.++|+|||++......
T Consensus        82 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~  158 (287)
T cd06621          82 YCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS  158 (287)
T ss_pred             ecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeecccccccccc
Confidence            9999999988753  23456889999999999999999999988   999999999999999999999999998755422


Q ss_pred             CCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCC----CchHHHHHHHhccCCCCCCccc
Q 002010          848 GASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGD----GVDIVRWVRKTTSEVSQPSDAA  923 (982)
Q Consensus       848 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~~~  923 (982)
                      .    .....++..|+|||.+.+..++.++||||+|+++|+|++|+.||.....    ..+...+......  +.     
T Consensus       159 ~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~-----  227 (287)
T cd06621         159 L----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPN--PE-----  227 (287)
T ss_pred             c----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCc--hh-----
Confidence            1    1234567899999999988999999999999999999999999976421    1222222211100  00     


Q ss_pred             ccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          924 SVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       924 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                           +.. ........+..+.+++.+||+.+|++|||+.|+++
T Consensus       228 -----~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~  265 (287)
T cd06621         228 -----LKD-EPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE  265 (287)
T ss_pred             -----hcc-CCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence                 000 00001123457899999999999999999999998

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=2.4e-33  Score=305.53  Aligned_cols=252  Identities=25%  Similarity=0.382  Sum_probs=198.7

Q ss_pred             HHhhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcC-CCCcccceEeEEEc------C
Q 002010          690 VLESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRI-RHRNIVRLLGYVSN------R  761 (982)
Q Consensus       690 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~------~  761 (982)
                      ..+.|+..+.||+|+||.||+|.. .+++.||+|.+...  ......+..|+.++.++ +||||+++++++..      .
T Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~--~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   91 (282)
T cd06636          14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT--EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHD   91 (282)
T ss_pred             hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC--hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCC
Confidence            346788889999999999999965 56889999987432  23345678899999998 69999999998853      4


Q ss_pred             CccEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccc
Q 002010          762 DTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLA  841 (982)
Q Consensus       762 ~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a  841 (982)
                      ...+++|||+++++|.+++...+...+++..+..++.|++.|++|||+.+   |+||||+|+||++++++.++|+|||++
T Consensus        92 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~l~dfg~~  168 (282)
T cd06636          92 DQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKLVDFGVS  168 (282)
T ss_pred             CEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCcch
Confidence            56799999999999999998666667889999999999999999999988   999999999999999999999999998


Q ss_pred             hhccccCCcccccccccccccccccccc-----cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCC
Q 002010          842 KFLQDAGASECMSSVAGSYGYIAPEYAY-----TLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEV  916 (982)
Q Consensus       842 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  916 (982)
                      ......  ........+++.|+|||++.     ...++.++||||+||++|||++|..||..............   .  
T Consensus       169 ~~~~~~--~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~---~--  241 (282)
T cd06636         169 AQLDRT--VGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPR---N--  241 (282)
T ss_pred             hhhhcc--ccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhh---C--
Confidence            765422  11223456889999999875     34578899999999999999999999975432221111100   0  


Q ss_pred             CCCCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          917 SQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       917 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                      .            .+  .......+..+.+++.+||+.||.+|||+.|+++
T Consensus       242 ~------------~~--~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         242 P------------PP--KLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             C------------CC--CCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence            0            00  0011234457899999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=5.4e-33  Score=299.70  Aligned_cols=251  Identities=27%  Similarity=0.428  Sum_probs=206.0

Q ss_pred             hcccccccccccceEEEEEEeC-CCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEecc
Q 002010          693 SLKDENIIGKGGAGIVYRGSMP-DGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYM  771 (982)
Q Consensus       693 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  771 (982)
                      +|+..+.||+|++|.||+|... +++.||+|++...........+.+|+.++.+++|||++++++++..+...++||||+
T Consensus         2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   81 (264)
T cd06623           2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYM   81 (264)
T ss_pred             cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEec
Confidence            5777889999999999999764 599999999865544345678899999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCc
Q 002010          772 PNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHH-DCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS  850 (982)
Q Consensus       772 ~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  850 (982)
                      ++++|.+++..  ...+++..+..++.|+++|++|+|+ .+   ++||||+|+||+++.++.++|+|||.+........ 
T Consensus        82 ~~~~L~~~l~~--~~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~-  155 (264)
T cd06623          82 DGGSLADLLKK--VGKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD-  155 (264)
T ss_pred             CCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCCC-
Confidence            99999999973  3678999999999999999999998 88   99999999999999999999999999986643221 


Q ss_pred             ccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceeec
Q 002010          851 ECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVD  930 (982)
Q Consensus       851 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  930 (982)
                       ......++..|+|||...+..++.++|+||+|+++|+|++|+.||...... ............               
T Consensus       156 -~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~-~~~~~~~~~~~~---------------  218 (264)
T cd06623         156 -QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQP-SFFELMQAICDG---------------  218 (264)
T ss_pred             -cccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccccc-CHHHHHHHHhcC---------------
Confidence             122456788999999999888999999999999999999999999775421 111111111110               


Q ss_pred             CCCCCCChH-hHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          931 PRLSGYPLT-GVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       931 ~~~~~~~~~-~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                       .....+.. .+..+.+++.+||+.+|++||++.|+++
T Consensus       219 -~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~  255 (264)
T cd06623         219 -PPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQ  255 (264)
T ss_pred             -CCCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence             01112222 4568999999999999999999999987

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=5.6e-33  Score=304.16  Aligned_cols=253  Identities=28%  Similarity=0.363  Sum_probs=198.3

Q ss_pred             HHhhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcC-CCCcccceEeEEEcC-----C
Q 002010          690 VLESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRI-RHRNIVRLLGYVSNR-----D  762 (982)
Q Consensus       690 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~-----~  762 (982)
                      ..++|+..+.||+|+||.||+|.. .+++.+|+|++...  ......+.+|+.+++++ +|||++++++++...     .
T Consensus        20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~--~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~   97 (291)
T cd06639          20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI--SDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGG   97 (291)
T ss_pred             CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccc--ccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCC
Confidence            356789999999999999999965 56889999987432  23345677899999998 899999999998653     3


Q ss_pred             ccEEEEeccCCCCHHHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEecccc
Q 002010          763 TNLLLYEYMPNGSLGEMLHG--AKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGL  840 (982)
Q Consensus       763 ~~~lv~e~~~~~sL~~~l~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~  840 (982)
                      ..++||||+++++|.++++.  .....+++..+..++.|++.|++|||+.+   ++||||||+||++++++.+||+|||.
T Consensus        98 ~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~kl~dfg~  174 (291)
T cd06639          98 QLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVKLVDFGV  174 (291)
T ss_pred             eeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEeeccc
Confidence            57999999999999998863  23457899999999999999999999888   99999999999999999999999999


Q ss_pred             chhccccCCcccccccccccccccccccccC-----CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccC
Q 002010          841 AKFLQDAGASECMSSVAGSYGYIAPEYAYTL-----KVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSE  915 (982)
Q Consensus       841 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  915 (982)
                      +.......  .......++..|+|||++...     .++.++||||+||++|||++|+.||...........+...... 
T Consensus       175 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~-  251 (291)
T cd06639         175 SAQLTSTR--LRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPP-  251 (291)
T ss_pred             chhccccc--ccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCC-
Confidence            88654321  112335678899999987543     3688999999999999999999999765433222222111000 


Q ss_pred             CCCCCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          916 VSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       916 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                                      .. ..+......+.+++.+||+.||++||++.|+++
T Consensus       252 ----------------~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  286 (291)
T cd06639         252 ----------------TL-LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE  286 (291)
T ss_pred             ----------------CC-CcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence                            00 011223346889999999999999999999875

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-33  Score=303.70  Aligned_cols=247  Identities=25%  Similarity=0.383  Sum_probs=199.9

Q ss_pred             hcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCC---CCcccceEeEEEcCCccEEEE
Q 002010          693 SLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIR---HRNIVRLLGYVSNRDTNLLLY  768 (982)
Q Consensus       693 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~lv~  768 (982)
                      .|+..+.||+|+||.||+|.. .+++.||+|.+..........++.+|+.++++++   |||++++++++..+...++||
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            366778899999999999965 5789999998865544555667889999999986   999999999999999999999


Q ss_pred             eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccC
Q 002010          769 EYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAG  848 (982)
Q Consensus       769 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  848 (982)
                      ||+++++|.+++..   ..+++..+..++.|++.|++|||+.+   |+||||+|+||++++++.++++|||.+..+....
T Consensus        82 e~~~~~~L~~~~~~---~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~  155 (277)
T cd06917          82 EYAEGGSVRTLMKA---GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS  155 (277)
T ss_pred             ecCCCCcHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCCc
Confidence            99999999999853   37899999999999999999999988   9999999999999999999999999998765432


Q ss_pred             Cccccccccccccccccccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccce
Q 002010          849 ASECMSSVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLA  927 (982)
Q Consensus       849 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  927 (982)
                        .......|+..|+|||.+.+ ..++.++||||+|+++|+|++|..||......    .........            
T Consensus       156 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~----~~~~~~~~~------------  217 (277)
T cd06917         156 --SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAF----RAMMLIPKS------------  217 (277)
T ss_pred             --cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChh----hhhhccccC------------
Confidence              22234568889999998865 44789999999999999999999999753221    111110000            


Q ss_pred             eecCCCCCCCh-HhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          928 VVDPRLSGYPL-TGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       928 ~~~~~~~~~~~-~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                          ..+..+. ..+..+.+++.+||+.||++||++.|+++
T Consensus       218 ----~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~  254 (277)
T cd06917         218 ----KPPRLEDNGYSKLLREFVAACLDEEPKERLSAEELLK  254 (277)
T ss_pred             ----CCCCCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence                0001111 13457889999999999999999999987

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-34  Score=300.46  Aligned_cols=246  Identities=25%  Similarity=0.288  Sum_probs=202.6

Q ss_pred             hhcccccccccccceEEEEEEe-CCCcEEEEEEeccCC--CCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEE
Q 002010          692 ESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRG--TGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLY  768 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  768 (982)
                      +.|+.-++||+|+||.||-++. .+|+.||.|++.++.  ........+.|-.++.+++.++||.+-.+|+.++..++|+
T Consensus       185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL  264 (591)
T KOG0986|consen  185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL  264 (591)
T ss_pred             cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence            3466667899999999999965 469999999884332  2334455678999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccC
Q 002010          769 EYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAG  848 (982)
Q Consensus       769 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  848 (982)
                      ..|.||+|.=+|....+..++++.+..++.+|+.||++||+.+   ||.||+||+|||+|+.|+++|+|.|+|..+... 
T Consensus       265 tlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g-  340 (591)
T KOG0986|consen  265 TLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPEG-  340 (591)
T ss_pred             EeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCCC-
Confidence            9999999998887666779999999999999999999999998   999999999999999999999999999988754 


Q ss_pred             CcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCccccccee
Q 002010          849 ASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAV  928 (982)
Q Consensus       849 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  928 (982)
                        ......+||.+|||||++.+..|+...|+||+||++|||+.|+.||......+.....-+....              
T Consensus       341 --~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~--------------  404 (591)
T KOG0986|consen  341 --KPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLE--------------  404 (591)
T ss_pred             --CccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhc--------------
Confidence              3345569999999999999999999999999999999999999999865332221111111110              


Q ss_pred             ecCCCCCCChHhHHHHHHHHhhccCCCCCCCC
Q 002010          929 VDPRLSGYPLTGVIHLFKVAMMCVEDESSARP  960 (982)
Q Consensus       929 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp  960 (982)
                         .-.+++.....+..++.+..+++||++|.
T Consensus       405 ---~~~ey~~kFS~eakslc~~LL~Kdp~~RL  433 (591)
T KOG0986|consen  405 ---DPEEYSDKFSEEAKSLCEGLLTKDPEKRL  433 (591)
T ss_pred             ---chhhcccccCHHHHHHHHHHHccCHHHhc
Confidence               00123444556788999999999999987

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=8.1e-33  Score=302.87  Aligned_cols=269  Identities=22%  Similarity=0.290  Sum_probs=199.2

Q ss_pred             hhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEec
Q 002010          692 ESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEY  770 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  770 (982)
                      +.|+..+.||+|+||.||+|.. .+++.||+|++...........+.+|+.+++.++|+||+++++++..++..++||||
T Consensus         5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07870           5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEY   84 (291)
T ss_pred             ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEec
Confidence            5688889999999999999965 468899999986554444455678999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCc
Q 002010          771 MPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS  850 (982)
Q Consensus       771 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  850 (982)
                      +. +++.+++... ...+++..+..++.|++.|++|||+.+   |+||||||+||+++.++.+||+|||+++.....  .
T Consensus        85 ~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~--~  157 (291)
T cd07870          85 MH-TDLAQYMIQH-PGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIP--S  157 (291)
T ss_pred             cc-CCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCC--C
Confidence            95 6777776532 346788889999999999999999988   999999999999999999999999998754322  1


Q ss_pred             ccccccccccccccccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCC---------CC
Q 002010          851 ECMSSVAGSYGYIAPEYAYTL-KVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQ---------PS  920 (982)
Q Consensus       851 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---------~~  920 (982)
                      .......+++.|+|||++.+. .++.++||||+|+++|||++|..||....+..............+..         +.
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (291)
T cd07870         158 QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPN  237 (291)
T ss_pred             CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhccc
Confidence            122334578899999998754 57889999999999999999999997654322211111111110000         00


Q ss_pred             cccccceee-cCCCCC--CChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          921 DAASVLAVV-DPRLSG--YPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       921 ~~~~~~~~~-~~~~~~--~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                      ......... .+....  .....+..+.+++.+|++.||.+|||++|++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         238 YKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             ccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence            000000000 000000  01112457889999999999999999999874

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=2.3e-33  Score=306.70  Aligned_cols=253  Identities=28%  Similarity=0.395  Sum_probs=196.2

Q ss_pred             hhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCC-CCcccceEeEEEcCCccEEEEe
Q 002010          692 ESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIR-HRNIVRLLGYVSNRDTNLLLYE  769 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e  769 (982)
                      +.|+..+.||+|+||.||++.. .+++.||+|.+...........+.+|+.++.++. ||||+++++++..+...+++||
T Consensus         4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e   83 (288)
T cd06616           4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME   83 (288)
T ss_pred             HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence            3456667899999999999965 4689999999865444445567889999999996 9999999999998889999999


Q ss_pred             ccCCCCHHHH---hhcCCCCCCCHHHHHHHHHHHHHHHHHHhhc-CCCcEEecCCCCCcEEEcCCCCEEEeccccchhcc
Q 002010          770 YMPNGSLGEM---LHGAKGGHLKWETRYRIALEAAKGLCYLHHD-CSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQ  845 (982)
Q Consensus       770 ~~~~~sL~~~---l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~  845 (982)
                      |++ +++.++   +.......+++..+..++.|++.|++|||+. +   |+||||||+||+++.++.+||+|||++..+.
T Consensus        84 ~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  159 (288)
T cd06616          84 LMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLV  159 (288)
T ss_pred             ccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence            985 455543   3323446799999999999999999999974 6   9999999999999999999999999998654


Q ss_pred             ccCCcccccccccccccccccccccC---CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcc
Q 002010          846 DAGASECMSSVAGSYGYIAPEYAYTL---KVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDA  922 (982)
Q Consensus       846 ~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  922 (982)
                      ...   ......++..|+|||++.+.   .++.++||||+||++|||++|+.||.....   ....+.......      
T Consensus       160 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~---~~~~~~~~~~~~------  227 (288)
T cd06616         160 DSI---AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS---VFDQLTQVVKGD------  227 (288)
T ss_pred             cCC---ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch---HHHHHhhhcCCC------
Confidence            321   12334678899999998766   689999999999999999999999975431   111111111100      


Q ss_pred             cccceeecCCCC-CCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          923 ASVLAVVDPRLS-GYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       923 ~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                             .+.+. ..+...+..+.+++.+||+.||++|||++||++
T Consensus       228 -------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~  266 (288)
T cd06616         228 -------PPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLE  266 (288)
T ss_pred             -------CCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                   01111 112234557899999999999999999999987

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=7.9e-33  Score=301.65  Aligned_cols=248  Identities=24%  Similarity=0.358  Sum_probs=199.0

Q ss_pred             hcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEecc
Q 002010          693 SLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYM  771 (982)
Q Consensus       693 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  771 (982)
                      .|+..+.||+|++|.||+|.. .+++.|++|++... .......+.+|+.++++++||||+++++++...+..++|+||+
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~-~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~   98 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR-KQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFL   98 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc-chhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEecc
Confidence            344556899999999999964 56889999987432 2334456889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCcc
Q 002010          772 PNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASE  851 (982)
Q Consensus       772 ~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~  851 (982)
                      ++++|.+++..   .++++..+..++.|++.|++|||+.+   ++||||+|+||+++.++.++++|||.+.......  .
T Consensus        99 ~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~--~  170 (285)
T cd06648          99 EGGALTDIVTH---TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV--P  170 (285)
T ss_pred             CCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCC--c
Confidence            99999999864   56899999999999999999999988   9999999999999999999999999887654321  1


Q ss_pred             cccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceeecC
Q 002010          852 CMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDP  931 (982)
Q Consensus       852 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  931 (982)
                      ......|++.|+|||...+..++.++||||+|+++|||++|+.||...... ...........  +              
T Consensus       171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~-~~~~~~~~~~~--~--------------  233 (285)
T cd06648         171 RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL-QAMKRIRDNLP--P--------------  233 (285)
T ss_pred             ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH-HHHHHHHhcCC--C--------------
Confidence            123356889999999998888999999999999999999999999653221 11111111100  0              


Q ss_pred             CCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          932 RLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       932 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                      .. ..+...+..+.+++.+||+.+|++|||+.++++
T Consensus       234 ~~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         234 KL-KNLHKVSPRLRSFLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             CC-cccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence            00 011123457899999999999999999999996

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-33  Score=306.03  Aligned_cols=269  Identities=22%  Similarity=0.304  Sum_probs=204.0

Q ss_pred             hcccccccccccceEEEEEEeC-CCcEEEEEEeccCCC-CCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEec
Q 002010          693 SLKDENIIGKGGAGIVYRGSMP-DGIDVAIKRLVGRGT-GGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEY  770 (982)
Q Consensus       693 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  770 (982)
                      +|+..+.||+|++|.||+|... +++.||+|.+..... ......+.+|++++++++|+||+++++++..++..++||||
T Consensus         2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   81 (288)
T cd07833           2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY   81 (288)
T ss_pred             ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence            5788889999999999999764 588999998854332 33456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCc
Q 002010          771 MPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS  850 (982)
Q Consensus       771 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  850 (982)
                      ++++.+..+..  +...+++..+..++.||+.|++|||+.+   ++|||++|+||++++++.+||+|||.+........ 
T Consensus        82 ~~~~~l~~~~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~-  155 (288)
T cd07833          82 VERTLLELLEA--SPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARPA-  155 (288)
T ss_pred             CCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCcc-
Confidence            98877766654  3456899999999999999999999988   99999999999999999999999999987654321 


Q ss_pred             ccccccccccccccccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCC---CCcc-ccc
Q 002010          851 ECMSSVAGSYGYIAPEYAYTL-KVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQ---PSDA-ASV  925 (982)
Q Consensus       851 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~-~~~  925 (982)
                      .......++..|+|||++.+. .++.++||||+|+++|+|++|++||....................+.   .... ...
T Consensus       156 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (288)
T cd07833         156 SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRF  235 (288)
T ss_pred             ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccc
Confidence            123345678899999999887 78999999999999999999999997654332222221111110000   0000 000


Q ss_pred             --ceeecCCCC-----CCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          926 --LAVVDPRLS-----GYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       926 --~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                        ....+....     .++...+..+.+++++||+.+|++|||++++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         236 AGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             cccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence              000000000     122233677999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=5.5e-34  Score=330.25  Aligned_cols=254  Identities=28%  Similarity=0.428  Sum_probs=193.1

Q ss_pred             HhhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcC--------
Q 002010          691 LESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNR--------  761 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--------  761 (982)
                      ..+|+..++||+||||.||+++. -||+.||||++.-..+......+.+|+..+++++|||||+++.++.+.        
T Consensus       478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e  557 (1351)
T KOG1035|consen  478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE  557 (1351)
T ss_pred             hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence            45677788999999999999965 489999999997776666677899999999999999999998431100        


Q ss_pred             --------------------------------------------------------------------------------
Q 002010          762 --------------------------------------------------------------------------------  761 (982)
Q Consensus       762 --------------------------------------------------------------------------------  761 (982)
                                                                                                      
T Consensus       558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e  637 (1351)
T KOG1035|consen  558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE  637 (1351)
T ss_pred             ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence                                                                                            


Q ss_pred             -------------------------------CccEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhc
Q 002010          762 -------------------------------DTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHD  810 (982)
Q Consensus       762 -------------------------------~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~  810 (982)
                                                     ...||-||||+..++.+++++..... .....++++++|++|++|+|++
T Consensus       638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~-~~d~~wrLFreIlEGLaYIH~~  716 (1351)
T KOG1035|consen  638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS-QRDEAWRLFREILEGLAYIHDQ  716 (1351)
T ss_pred             CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch-hhHHHHHHHHHHHHHHHHHHhC
Confidence                                           01278999999988888886432111 4778899999999999999999


Q ss_pred             CCCcEEecCCCCCcEEEcCCCCEEEeccccchhcc------c----------cCCcccccccccccccccccccccCC--
Q 002010          811 CSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQ------D----------AGASECMSSVAGSYGYIAPEYAYTLK--  872 (982)
Q Consensus       811 ~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~------~----------~~~~~~~~~~~gt~~y~aPE~~~~~~--  872 (982)
                      |   ||||||||.||+++++..|||+|||+|....      +          .......+..+||.-|+|||++.+..  
T Consensus       717 g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~  793 (1351)
T KOG1035|consen  717 G---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSN  793 (1351)
T ss_pred             c---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccc
Confidence            8   9999999999999999999999999998721      0          11122456788999999999987654  


Q ss_pred             -CCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceeecCCCCCCChHhHHHHHHHHhhc
Q 002010          873 -VDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMC  951 (982)
Q Consensus       873 -~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c  951 (982)
                       |+.|+|+||+||+++||+.   ||.-   .++.+..+..... ...|..            +++..+....=..+|++|
T Consensus       794 ~Yn~KiDmYSLGIVlFEM~y---PF~T---sMERa~iL~~LR~-g~iP~~------------~~f~~~~~~~e~slI~~L  854 (1351)
T KOG1035|consen  794 KYNSKIDMYSLGIVLFEMLY---PFGT---SMERASILTNLRK-GSIPEP------------ADFFDPEHPEEASLIRWL  854 (1351)
T ss_pred             cccchhhhHHHHHHHHHHhc---cCCc---hHHHHHHHHhccc-CCCCCC------------cccccccchHHHHHHHHH
Confidence             9999999999999999984   4542   2333333322221 111110            122223333456899999


Q ss_pred             cCCCCCCCCCHHHHHH
Q 002010          952 VEDESSARPTMREVVH  967 (982)
Q Consensus       952 l~~dP~~Rpt~~ell~  967 (982)
                      +++||.+||||.|++.
T Consensus       855 l~hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  855 LSHDPSKRPTATELLN  870 (1351)
T ss_pred             hcCCCccCCCHHHHhh
Confidence            9999999999999986

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=6.4e-33  Score=302.89  Aligned_cols=252  Identities=28%  Similarity=0.383  Sum_probs=204.2

Q ss_pred             HHhhcccccccccccceEEEEEEeC-CCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEE
Q 002010          690 VLESLKDENIIGKGGAGIVYRGSMP-DGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLY  768 (982)
Q Consensus       690 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  768 (982)
                      ..+.|+..+.+|+|++|.||+|..+ ++..|++|++.....  ....+.+|++++++++|+|++++++++...+..++|+
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   94 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ--NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM   94 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch--hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence            4456788889999999999999764 688999999854332  4567889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccC
Q 002010          769 EYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAG  848 (982)
Q Consensus       769 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  848 (982)
                      ||+++++|.+++.... ..+++..+..++.|++.|++|||+.+   |+|+||+|+||+++.++.++|+|||.+.......
T Consensus        95 e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  170 (286)
T cd06614          95 EYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK  170 (286)
T ss_pred             eccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence            9999999999997433 47999999999999999999999988   9999999999999999999999999987654321


Q ss_pred             CcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCccccccee
Q 002010          849 ASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAV  928 (982)
Q Consensus       849 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  928 (982)
                        .......++..|+|||.+.+..++.++||||+|+++|+|++|+.||...........+......              
T Consensus       171 --~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~--------------  234 (286)
T cd06614         171 --SKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIP--------------  234 (286)
T ss_pred             --hhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC--------------
Confidence              1223345788999999998888999999999999999999999999754332222221111000              


Q ss_pred             ecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          929 VDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       929 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                         .. ..+...+..+.+++.+||+.+|.+|||+.++++
T Consensus       235 ---~~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  269 (286)
T cd06614         235 ---PL-KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ  269 (286)
T ss_pred             ---CC-cchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence               00 011123457889999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=4.2e-33  Score=299.27  Aligned_cols=250  Identities=23%  Similarity=0.320  Sum_probs=201.6

Q ss_pred             hcccccccccccceEEEEEEe-CCCcEEEEEEeccCC-CCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEec
Q 002010          693 SLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRG-TGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEY  770 (982)
Q Consensus       693 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  770 (982)
                      +|+..+.||+|+||.||+|.. .+|..||+|.+.... .......+.+|+.++++++|+||+++++++......++|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            367788999999999999965 458899999885432 223445678999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCC-CEEEeccccchhccccCC
Q 002010          771 MPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDF-EAHVADFGLAKFLQDAGA  849 (982)
Q Consensus       771 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~-~~kl~DfG~a~~~~~~~~  849 (982)
                      +++++|.+++.......+++..+..++.|++.|++|||+.+   ++|+||+|+||++++++ .+|++|||.+....... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~-  156 (257)
T cd08225          81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM-  156 (257)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCc-
Confidence            99999999997655556899999999999999999999988   99999999999999886 46999999998765321 


Q ss_pred             cccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceee
Q 002010          850 SECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVV  929 (982)
Q Consensus       850 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  929 (982)
                       .......|++.|+|||+..+..++.++|+||+|+++|||++|+.||.......    .+.......             
T Consensus       157 -~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~----~~~~~~~~~-------------  218 (257)
T cd08225         157 -ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQ----LVLKICQGY-------------  218 (257)
T ss_pred             -ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH----HHHHHhccc-------------
Confidence             12233468889999999988889999999999999999999999997543222    222211110             


Q ss_pred             cCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          930 DPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       930 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                         ....+...+..+.+++.+||+.+|++|||+.|+++
T Consensus       219 ---~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  253 (257)
T cd08225         219 ---FAPISPNFSRDLRSLISQLFKVSPRDRPSITSILK  253 (257)
T ss_pred             ---CCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence               11111223357889999999999999999999976

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-34  Score=291.65  Aligned_cols=259  Identities=22%  Similarity=0.314  Sum_probs=216.5

Q ss_pred             hcccccccccccceEEEEEEe------CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEc-CCccE
Q 002010          693 SLKDENIIGKGGAGIVYRGSM------PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSN-RDTNL  765 (982)
Q Consensus       693 ~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~  765 (982)
                      +++....+.+|.||.||.|.+      .+.+.|.+|.++...++.....+..|.-.+..+.|||+.++.+.+.+ .+..+
T Consensus       285 Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~  364 (563)
T KOG1024|consen  285 RVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPF  364 (563)
T ss_pred             heechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcce
Confidence            455666889999999999943      34567889999888888888889999999999999999999997654 56778


Q ss_pred             EEEeccCCCCHHHHhh-----cCC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccc
Q 002010          766 LLYEYMPNGSLGEMLH-----GAK-GGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFG  839 (982)
Q Consensus       766 lv~e~~~~~sL~~~l~-----~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG  839 (982)
                      +++.++.-|+|..++.     +.+ .+.++..+...++.|++.|++|||+++   |||.||..+|+++++..++||+|-.
T Consensus       365 V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~LqVkltDsa  441 (563)
T KOG1024|consen  365 VLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQLQVKLTDSA  441 (563)
T ss_pred             EEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhheeEEeccch
Confidence            9999998899999997     222 245777888999999999999999998   9999999999999999999999999


Q ss_pred             cchhccccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHhccCCCC
Q 002010          840 LAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQ  918 (982)
Q Consensus       840 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  918 (982)
                      +++.+.+.++..-....-.+..||+||.+....|+.++|||||||++|||+| |+.||.+.+ +.+...+++.. .+.. 
T Consensus       442 LSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeID-PfEm~~ylkdG-yRla-  518 (563)
T KOG1024|consen  442 LSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEID-PFEMEHYLKDG-YRLA-  518 (563)
T ss_pred             hccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccC-HHHHHHHHhcc-ceec-
Confidence            9998876655544445567789999999999999999999999999999999 999998764 34444444332 2222 


Q ss_pred             CCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCC
Q 002010          919 PSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQ  974 (982)
Q Consensus       919 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~~  974 (982)
                                       .|-+||.+++.+|.-||..+|++||+++|++.-|.++..
T Consensus       519 -----------------QP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~  557 (563)
T KOG1024|consen  519 -----------------QPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHT  557 (563)
T ss_pred             -----------------CCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHH
Confidence                             345677799999999999999999999999998877644

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=1.2e-32  Score=304.71  Aligned_cols=278  Identities=21%  Similarity=0.300  Sum_probs=201.5

Q ss_pred             cccHHHHHhhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCC-CCchhhHHHHHHHHhcCCCCcccceEeEEEcC
Q 002010          684 DFKAEDVLESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGT-GGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNR  761 (982)
Q Consensus       684 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  761 (982)
                      ++...+..++|+..+.||+|+||.||+|.. .+++.||+|.+..... ......+.+|+.++++++||||+++++++...
T Consensus         4 ~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~   83 (310)
T cd07865           4 EFPFCDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTK   83 (310)
T ss_pred             cCcccchhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecc
Confidence            445556678899999999999999999965 4689999998854332 22234567899999999999999999988765


Q ss_pred             Cc--------cEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCE
Q 002010          762 DT--------NLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEA  833 (982)
Q Consensus       762 ~~--------~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~  833 (982)
                      +.        .++||||+. +++.+++.. ....+++.++..++.||+.|++|||+.+   ++||||||+||+++.++.+
T Consensus        84 ~~~~~~~~~~~~lv~e~~~-~~l~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~  158 (310)
T cd07865          84 ATPYNRYKGSFYLVFEFCE-HDLAGLLSN-KNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGIL  158 (310)
T ss_pred             cccccCCCceEEEEEcCCC-cCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcE
Confidence            43        499999995 588888763 3347899999999999999999999988   9999999999999999999


Q ss_pred             EEeccccchhccccCCc--ccccccccccccccccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHH
Q 002010          834 HVADFGLAKFLQDAGAS--ECMSSVAGSYGYIAPEYAYTL-KVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVR  910 (982)
Q Consensus       834 kl~DfG~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~  910 (982)
                      ||+|||.+..+......  .......++..|+|||.+.+. .++.++||||+|+++|||++|.+||...... .....+.
T Consensus       159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~-~~~~~~~  237 (310)
T cd07865         159 KLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQ-HQLTLIS  237 (310)
T ss_pred             EECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHH
Confidence            99999999866432211  122334577889999987664 4788999999999999999999999764332 2222222


Q ss_pred             HhccCCCCCC-cccccceeecC-CCC-C----C-----ChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          911 KTTSEVSQPS-DAASVLAVVDP-RLS-G----Y-----PLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       911 ~~~~~~~~~~-~~~~~~~~~~~-~~~-~----~-----~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                      ......+... ........++. ..+ .    .     +......+.+++.+||+.||++|||++|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~  306 (310)
T cd07865         238 QLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN  306 (310)
T ss_pred             HHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence            2211111000 00000000000 000 0    0     0012345679999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=6.6e-33  Score=303.89  Aligned_cols=270  Identities=21%  Similarity=0.272  Sum_probs=202.2

Q ss_pred             HhhcccccccccccceEEEEEEeC-CCcEEEEEEeccCCC-CCchhhHHHHHHHHhcCCCCcccceEeEEEcC--CccEE
Q 002010          691 LESLKDENIIGKGGAGIVYRGSMP-DGIDVAIKRLVGRGT-GGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNR--DTNLL  766 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~l  766 (982)
                      .+.|+..+.||+|+||.||+|... +++.||+|.+..... ......+.+|+.++++++||||+++++++..+  ...++
T Consensus         4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l   83 (293)
T cd07843           4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM   83 (293)
T ss_pred             hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence            356888899999999999999764 588999999854332 22334567899999999999999999998877  88999


Q ss_pred             EEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccc
Q 002010          767 LYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQD  846 (982)
Q Consensus       767 v~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  846 (982)
                      ||||++ ++|.+++.... ..+++..+..++.|++.|++|||+.+   ++||||||+||+++.++.+||+|||++..+..
T Consensus        84 v~e~~~-~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~  158 (293)
T cd07843          84 VMEYVE-HDLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS  158 (293)
T ss_pred             EehhcC-cCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence            999996 59999886432 46899999999999999999999988   99999999999999999999999999987653


Q ss_pred             cCCcccccccccccccccccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCC-----
Q 002010          847 AGASECMSSVAGSYGYIAPEYAYTL-KVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPS-----  920 (982)
Q Consensus       847 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-----  920 (982)
                      ..  .......+++.|+|||.+.+. .++.++|+||+|+++|+|++|++||........................     
T Consensus       159 ~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (293)
T cd07843         159 PL--KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSE  236 (293)
T ss_pred             Cc--cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhc
Confidence            31  222345578899999988754 4689999999999999999999999865443333332222211100000     


Q ss_pred             ---cc-cccceeecCCC-CCCChH-hHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          921 ---DA-ASVLAVVDPRL-SGYPLT-GVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       921 ---~~-~~~~~~~~~~~-~~~~~~-~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                         .. ..........+ ..++.. ....+.+++.+||+.||++|||++|++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         237 LPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             cchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence               00 00000000000 112222 3567889999999999999999999975

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=9e-33  Score=300.12  Aligned_cols=245  Identities=26%  Similarity=0.313  Sum_probs=196.2

Q ss_pred             cccccceEEEEEEe-CCCcEEEEEEeccCC--CCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEeccCCCCH
Q 002010          700 IGKGGAGIVYRGSM-PDGIDVAIKRLVGRG--TGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSL  776 (982)
Q Consensus       700 lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL  776 (982)
                      ||+|+||+||+|.. .+|+.||+|.+....  .......+..|+.++++++||||+++++++...+..++||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            69999999999964 468999999885432  122344567899999999999999999999999999999999999999


Q ss_pred             HHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCccccccc
Q 002010          777 GEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSV  856 (982)
Q Consensus       777 ~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~  856 (982)
                      .+++.......+++..+..++.|++.|+.|||+.+   ++||||+|+||++++++.+||+|||.+......   ......
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~---~~~~~~  154 (277)
T cd05577          81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGG---KKIKGR  154 (277)
T ss_pred             HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccC---Cccccc
Confidence            99997655557999999999999999999999988   999999999999999999999999999865432   222345


Q ss_pred             ccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceeecCCCCCC
Q 002010          857 AGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDPRLSGY  936 (982)
Q Consensus       857 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  936 (982)
                      .++..|+|||+..+..++.++||||+|+++|+|++|+.||..................                 .....
T Consensus       155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-----------------~~~~~  217 (277)
T cd05577         155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLE-----------------MAVEY  217 (277)
T ss_pred             cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcccc-----------------ccccC
Confidence            6788999999998888999999999999999999999999764332221111111100                 01112


Q ss_pred             ChHhHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 002010          937 PLTGVIHLFKVAMMCVEDESSARP-----TMREVVH  967 (982)
Q Consensus       937 ~~~~~~~l~~li~~cl~~dP~~Rp-----t~~ell~  967 (982)
                      +...+..+.+++.+||+.||++||     ++.+++.
T Consensus       218 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  253 (277)
T cd05577         218 PDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE  253 (277)
T ss_pred             CccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence            233355789999999999999999     6776764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=6.5e-33  Score=299.16  Aligned_cols=250  Identities=25%  Similarity=0.403  Sum_probs=200.9

Q ss_pred             hcccccccccccceEEEEEEe-CCCcEEEEEEeccCC-CCCchhhHHHHHHHHhcCCCCcccceEeEEEc--CCccEEEE
Q 002010          693 SLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRG-TGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSN--RDTNLLLY  768 (982)
Q Consensus       693 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~  768 (982)
                      +|+..+.||.|+||.||+|.. .++..||+|.+.... .....+.+..|+.++++++||||+++++++..  ....+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            367778999999999999954 568899999885433 23334568889999999999999999998764  34578999


Q ss_pred             eccCCCCHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHh-----hcCCCcEEecCCCCCcEEEcCCCCEEEeccccc
Q 002010          769 EYMPNGSLGEMLHGA--KGGHLKWETRYRIALEAAKGLCYLH-----HDCSPLIIHRDVKSNNILLDSDFEAHVADFGLA  841 (982)
Q Consensus       769 e~~~~~sL~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~LH-----~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a  841 (982)
                      ||+++++|.+++...  ....+++..++.++.|++.|++|||     +.+   ++||||+|+||++++++.+|++|||++
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~d~g~~  157 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLGDFGLA  157 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEeccccc
Confidence            999999999998643  2467899999999999999999999     666   999999999999999999999999999


Q ss_pred             hhccccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCc
Q 002010          842 KFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSD  921 (982)
Q Consensus       842 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  921 (982)
                      .......  .......+++.|+|||++.+..++.++|+||+|+++|+|++|+.||.... .......+...         
T Consensus       158 ~~~~~~~--~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-~~~~~~~~~~~---------  225 (265)
T cd08217         158 KILGHDS--SFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN-QLQLASKIKEG---------  225 (265)
T ss_pred             ccccCCc--ccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC-HHHHHHHHhcC---------
Confidence            8765332  11234568899999999998889999999999999999999999997643 22222222111         


Q ss_pred             ccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          922 AASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       922 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                                ..+..+...+..+.+++.+|++.+|++|||+++|++
T Consensus       226 ----------~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~  261 (265)
T cd08217         226 ----------KFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ  261 (265)
T ss_pred             ----------CCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence                      111223334457899999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=3.1e-33  Score=300.42  Aligned_cols=248  Identities=25%  Similarity=0.280  Sum_probs=202.2

Q ss_pred             hcccccccccccceEEEEEEeC-CCcEEEEEEeccCCC--CCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEe
Q 002010          693 SLKDENIIGKGGAGIVYRGSMP-DGIDVAIKRLVGRGT--GGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYE  769 (982)
Q Consensus       693 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  769 (982)
                      .|+..+.||.|+||.||+|... +++.||+|.+.....  ....+.+.+|+.++++++||||+++++++.++...++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            3677889999999999999764 589999999854332  2345678999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCC
Q 002010          770 YMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGA  849 (982)
Q Consensus       770 ~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  849 (982)
                      |+++++|.+++..  ...+++..+..++.|+++|++|||+.+   ++|+||+|+||++++++.++|+|||.+....... 
T Consensus        81 ~~~~~~L~~~l~~--~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-  154 (258)
T cd05578          81 LLLGGDLRYHLSQ--KVKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT-  154 (258)
T ss_pred             CCCCCCHHHHHHh--cCCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc-
Confidence            9999999999963  368899999999999999999999988   9999999999999999999999999988654321 


Q ss_pred             cccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceee
Q 002010          850 SECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVV  929 (982)
Q Consensus       850 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  929 (982)
                        ......++..|+|||.+.+..++.++|+||+|+++|+|++|..||...... ...........               
T Consensus       155 --~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~---------------  216 (258)
T cd05578         155 --LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT-IRDQIRAKQET---------------  216 (258)
T ss_pred             --cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc-HHHHHHHHhcc---------------
Confidence              223456788999999998888999999999999999999999999865432 11111111110               


Q ss_pred             cCCCCCCChHhHHHHHHHHhhccCCCCCCCCCH--HHHH
Q 002010          930 DPRLSGYPLTGVIHLFKVAMMCVEDESSARPTM--REVV  966 (982)
Q Consensus       930 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~--~ell  966 (982)
                        .....+...+..+.+++.+||+.||.+||++  +|++
T Consensus       217 --~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         217 --ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             --ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence              0111223344678899999999999999999  6654

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=1.3e-32  Score=301.68  Aligned_cols=270  Identities=20%  Similarity=0.262  Sum_probs=200.9

Q ss_pred             hhcccccccccccceEEEEEEeC-CCcEEEEEEeccCCC-CCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEe
Q 002010          692 ESLKDENIIGKGGAGIVYRGSMP-DGIDVAIKRLVGRGT-GGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYE  769 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  769 (982)
                      ++|+..+.||+|++|.||+|... +++.||+|.+..... ......+.+|+.++++++||||+++++++.++...++|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            46888899999999999999754 688999998854332 2334568899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcC-CCCEEEeccccchhccccC
Q 002010          770 YMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDS-DFEAHVADFGLAKFLQDAG  848 (982)
Q Consensus       770 ~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~-~~~~kl~DfG~a~~~~~~~  848 (982)
                      |++ +++.+++........++..+..++.||+.|++|||+.+   ++||||+|+||+++. ++.+|++|||++...... 
T Consensus        82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~-  156 (294)
T PLN00009         82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP-  156 (294)
T ss_pred             ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCC-
Confidence            995 58888876544455788899999999999999999988   999999999999985 567999999999765322 


Q ss_pred             Cccccccccccccccccccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcc----c
Q 002010          849 ASECMSSVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDA----A  923 (982)
Q Consensus       849 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~----~  923 (982)
                       ........+++.|+|||++.+ ..++.++||||+|+++|+|+||++||....+.....................    .
T Consensus       157 -~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (294)
T PLN00009        157 -VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLP  235 (294)
T ss_pred             -ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccch
Confidence             112233467889999998865 4578999999999999999999999976544333333322222111110000    0


Q ss_pred             ccceee----cCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          924 SVLAVV----DPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       924 ~~~~~~----~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                      ......    ...........+.++.+++.+|++.||++||++.++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~  283 (294)
T PLN00009        236 DYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE  283 (294)
T ss_pred             hhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence            000000    00000112233456889999999999999999999986

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=1.4e-32  Score=304.58  Aligned_cols=268  Identities=20%  Similarity=0.231  Sum_probs=198.6

Q ss_pred             cccccccccceEEEEEEeCCCcEEEEEEeccC-CCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEeccCCC
Q 002010          696 DENIIGKGGAGIVYRGSMPDGIDVAIKRLVGR-GTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNG  774 (982)
Q Consensus       696 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~  774 (982)
                      +++.+|.|+++.||++.. +++.||+|++... ........+.+|+.++++++||||+++++++.+++..+++|||++++
T Consensus         6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~   84 (314)
T cd08216           6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG   84 (314)
T ss_pred             hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence            344455566666666554 7999999998654 23445567899999999999999999999999999999999999999


Q ss_pred             CHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCC-----
Q 002010          775 SLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGA-----  849 (982)
Q Consensus       775 sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~-----  849 (982)
                      +|.+++.......+++..+..++.|++.|++|||+++   |+||||||+||+++.++.+|++|||.+..+.....     
T Consensus        85 ~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~  161 (314)
T cd08216          85 SCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV  161 (314)
T ss_pred             CHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeecccccccccc
Confidence            9999998655567899999999999999999999988   99999999999999999999999998876543211     


Q ss_pred             ccccccccccccccccccccc--CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCC----CCCCccc
Q 002010          850 SECMSSVAGSYGYIAPEYAYT--LKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEV----SQPSDAA  923 (982)
Q Consensus       850 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~~  923 (982)
                      ........++..|+|||++..  ..++.++||||+||++|||++|+.||....................    ..+....
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (314)
T cd08216         162 HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYED  241 (314)
T ss_pred             ccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcC
Confidence            111223456778999999875  3588999999999999999999999987544333322222111100    0000000


Q ss_pred             ccce----eecCCC-----CCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          924 SVLA----VVDPRL-----SGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       924 ~~~~----~~~~~~-----~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                      ....    ..++..     ..........+.+++.+||+.||++|||++|+++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~  294 (314)
T cd08216         242 SMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN  294 (314)
T ss_pred             CcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence            0000    000000     0123334567889999999999999999999987

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=1.6e-32  Score=295.58  Aligned_cols=243  Identities=25%  Similarity=0.320  Sum_probs=196.6

Q ss_pred             cccccceEEEEEEeC-CCcEEEEEEeccCCC--CCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEeccCCCCH
Q 002010          700 IGKGGAGIVYRGSMP-DGIDVAIKRLVGRGT--GGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSL  776 (982)
Q Consensus       700 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL  776 (982)
                      ||.|++|.||+|... +++.||+|++.....  ....+.+.+|+.++++++||||+++++++.++...++||||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            699999999999764 488999999854432  23456788999999999999999999999999999999999999999


Q ss_pred             HHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCccccccc
Q 002010          777 GEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSV  856 (982)
Q Consensus       777 ~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~  856 (982)
                      .+++..  ...+++..+..++.|++.|++|+|+.+   ++|+||+|+||+++.++.++|+|||.+.......   .....
T Consensus        81 ~~~l~~--~~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~  152 (262)
T cd05572          81 WTILRD--RGLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTF  152 (262)
T ss_pred             HHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---ccccc
Confidence            999973  356899999999999999999999988   9999999999999999999999999998765321   22335


Q ss_pred             ccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceeecCCCCCC
Q 002010          857 AGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDPRLSGY  936 (982)
Q Consensus       857 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  936 (982)
                      .++..|+|||.+.+..++.++|+||+|+++|+|++|..||......  ...........               ......
T Consensus       153 ~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~---------------~~~~~~  215 (262)
T cd05572         153 CGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED--PMEIYNDILKG---------------NGKLEF  215 (262)
T ss_pred             cCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC--HHHHHHHHhcc---------------CCCCCC
Confidence            6788999999998888999999999999999999999999765421  11222111100               000112


Q ss_pred             ChHhHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 002010          937 PLTGVIHLFKVAMMCVEDESSARPT-----MREVVH  967 (982)
Q Consensus       937 ~~~~~~~l~~li~~cl~~dP~~Rpt-----~~ell~  967 (982)
                      +...+..+.+++.+||+.||++||+     ++|+++
T Consensus       216 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         216 PNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             CcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence            2223457899999999999999999     777765

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=2e-32  Score=292.94  Aligned_cols=248  Identities=31%  Similarity=0.464  Sum_probs=202.1

Q ss_pred             cccccccccccceEEEEEEeC-CCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEeccC
Q 002010          694 LKDENIIGKGGAGIVYRGSMP-DGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMP  772 (982)
Q Consensus       694 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  772 (982)
                      |+..+.||+|++|.||+|... ++..|++|++..... .....+.+|+.++++++||+++++++++..+...++++||++
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   80 (253)
T cd05122           2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK-EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS   80 (253)
T ss_pred             ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch-hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence            667789999999999999764 688999999854433 455678899999999999999999999999999999999999


Q ss_pred             CCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCccc
Q 002010          773 NGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASEC  852 (982)
Q Consensus       773 ~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~  852 (982)
                      +++|.+++.... ..+++..+..++.|++.|+++||+.+   ++||||+|+||++++++.++|+|||.+........   
T Consensus        81 ~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---  153 (253)
T cd05122          81 GGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---  153 (253)
T ss_pred             CCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc---
Confidence            999999987432 57899999999999999999999988   99999999999999999999999999987654321   


Q ss_pred             ccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceeecCC
Q 002010          853 MSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDPR  932 (982)
Q Consensus       853 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  932 (982)
                      .....++..|+|||.+.+..++.++||||+|+++|+|++|+.||............ .. .....               
T Consensus       154 ~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~-~~-~~~~~---------------  216 (253)
T cd05122         154 RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKI-AT-NGPPG---------------  216 (253)
T ss_pred             ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHH-Hh-cCCCC---------------
Confidence            33456788999999998888999999999999999999999999764322211111 11 00000               


Q ss_pred             CCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          933 LSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       933 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                      . ..+...+..+.+++.+||+.||++|||++|+++
T Consensus       217 ~-~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~  250 (253)
T cd05122         217 L-RNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK  250 (253)
T ss_pred             c-CcccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            0 001112457899999999999999999999875

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=7.6e-34  Score=281.52  Aligned_cols=250  Identities=23%  Similarity=0.280  Sum_probs=198.5

Q ss_pred             HHhhcccc-cccccccceEEEEEE-eCCCcEEEEEEeccCCCCCchhhHHHHHHHHhcC-CCCcccceEeEEEc----CC
Q 002010          690 VLESLKDE-NIIGKGGAGIVYRGS-MPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRI-RHRNIVRLLGYVSN----RD  762 (982)
Q Consensus       690 ~~~~~~~~-~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~----~~  762 (982)
                      ++++|.+. ++||-|-.|.|-.+. ..+|+++|+|++...      ....+|++.--+. .|||||.+++.|..    ..
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rk  132 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS------PKARREVELHWMASGHPHIVSIIDVYENSYQGRK  132 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCce
Confidence            44555543 579999999999984 457999999988432      2345777775444 69999999998754    34


Q ss_pred             ccEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcC---CCCEEEeccc
Q 002010          763 TNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDS---DFEAHVADFG  839 (982)
Q Consensus       763 ~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~---~~~~kl~DfG  839 (982)
                      ...+|||.|+||.|.+.++++....+++.++..|++||+.|+.|||+.+   |.||||||+|+|.+.   |..+|++|||
T Consensus       133 cLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfG  209 (400)
T KOG0604|consen  133 CLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFG  209 (400)
T ss_pred             eeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccc
Confidence            5678999999999999999888889999999999999999999999998   999999999999964   5679999999


Q ss_pred             cchhccccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCC---CchHHHHHHHhccCC
Q 002010          840 LAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGD---GVDIVRWVRKTTSEV  916 (982)
Q Consensus       840 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~---~~~~~~~~~~~~~~~  916 (982)
                      .|+.-..   .......+.|+.|.|||++...+|+...|+||+||++|-|++|.+||+....   .....+.++.....+
T Consensus       210 FAK~t~~---~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~F  286 (400)
T KOG0604|consen  210 FAKETQE---PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEF  286 (400)
T ss_pred             cccccCC---CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccC
Confidence            9986542   3445678899999999999999999999999999999999999999987432   111222222222211


Q ss_pred             CCCCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          917 SQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       917 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                      +.+.                .....+...++|+.++..+|.+|.|+.|++.
T Consensus       287 P~pE----------------Ws~VSe~aKdlIR~LLkt~PteRlTI~~~m~  321 (400)
T KOG0604|consen  287 PEPE----------------WSCVSEAAKDLIRKLLKTEPTERLTIEEVMD  321 (400)
T ss_pred             CChh----------------HhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence            1111                1234567889999999999999999999886

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=1.4e-32  Score=303.73  Aligned_cols=270  Identities=25%  Similarity=0.287  Sum_probs=199.8

Q ss_pred             HhhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCC-CchhhHHHHHHHHhcCCCCcccceEeEEEcC--CccEE
Q 002010          691 LESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTG-GNDHGFLAEIQTLGRIRHRNIVRLLGYVSNR--DTNLL  766 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~l  766 (982)
                      .++|+..+.||+|+||.||+|.. .+|+.||+|.+...... .....+.+|+.++++++|+||+++++++...  +..++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            46788999999999999999965 46899999998544322 2234567899999999999999999998765  45799


Q ss_pred             EEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccc
Q 002010          767 LYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQD  846 (982)
Q Consensus       767 v~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  846 (982)
                      ||||++ ++|.+++... ...+++.++..++.|++.|++|||+.+   ++||||||+||++++++.+||+|||.+.....
T Consensus        86 v~e~~~-~~l~~~l~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~  160 (309)
T cd07845          86 VMEYCE-QDLASLLDNM-PTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGL  160 (309)
T ss_pred             EEecCC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecCC
Confidence            999996 5888888643 367899999999999999999999988   99999999999999999999999999987653


Q ss_pred             cCCccccccccccccccccccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcc---
Q 002010          847 AGASECMSSVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDA---  922 (982)
Q Consensus       847 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---  922 (982)
                      ..  .......++..|+|||.+.+ ..++.++||||+|+++|||++|++||....+.....................   
T Consensus       161 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (309)
T cd07845         161 PA--KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSD  238 (309)
T ss_pred             cc--CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhc
Confidence            22  12233345778999998865 4578999999999999999999999976544333322222211111000000   


Q ss_pred             cccceeec---CCCCCC---ChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          923 ASVLAVVD---PRLSGY---PLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       923 ~~~~~~~~---~~~~~~---~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                      ......+.   ......   .......+.+++.+|++.||++|||++|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~  289 (309)
T cd07845         239 LPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE  289 (309)
T ss_pred             ccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            00000000   000000   0112456789999999999999999999987

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=1.5e-32  Score=299.49  Aligned_cols=264  Identities=21%  Similarity=0.225  Sum_probs=196.0

Q ss_pred             cccccccccccceEEEEEEe-CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCC-CCcccceEeEEEcC--CccEEEEe
Q 002010          694 LKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIR-HRNIVRLLGYVSNR--DTNLLLYE  769 (982)
Q Consensus       694 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~--~~~~lv~e  769 (982)
                      |+..+.||+|+||.||+|.. .+++.||+|++.............+|+.++.++. |||++++++++.++  +..++|||
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            45677899999999999964 4688999999865444444445568999999885 99999999999887  88999999


Q ss_pred             ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCC
Q 002010          770 YMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGA  849 (982)
Q Consensus       770 ~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  849 (982)
                      |++ +++.+++... ...+++.++..++.|++.|++|||+.+   ++||||+|+||+++. +.+||+|||.+........
T Consensus        81 ~~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~  154 (282)
T cd07831          81 LMD-MNLYELIKGR-KRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP  154 (282)
T ss_pred             cCC-ccHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCCC
Confidence            996 5888887642 357899999999999999999999988   999999999999999 9999999999987643321


Q ss_pred             cccccccccccccccccccc-cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCC----cccc
Q 002010          850 SECMSSVAGSYGYIAPEYAY-TLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPS----DAAS  924 (982)
Q Consensus       850 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~  924 (982)
                         .....++..|+|||++. +..++.++||||+||++|||++|..||......+. ...............    ....
T Consensus       155 ---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  230 (282)
T cd07831         155 ---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQ-IAKIHDVLGTPDAEVLKKFRKSR  230 (282)
T ss_pred             ---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHH-HHHHHHHcCCCCHHHHHhhcccc
Confidence               12345788999999764 45578999999999999999999999976433222 222221111100000    0000


Q ss_pred             cceeecC-----CCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          925 VLAVVDP-----RLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       925 ~~~~~~~-----~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                      ......+     .+.......+..+.+++.+||+.+|++|||++|+++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         231 HMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             cccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence            0000000     001112244678999999999999999999999985

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.1e-34  Score=283.89  Aligned_cols=248  Identities=23%  Similarity=0.243  Sum_probs=205.8

Q ss_pred             hhcccccccccccceEEEEEE-eCCCcEEEEEEeccCCC--CCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEE
Q 002010          692 ESLKDENIIGKGGAGIVYRGS-MPDGIDVAIKRLVGRGT--GGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLY  768 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  768 (982)
                      +.|+..+++|+|.||.|-.++ ..+++.||+|++++...  .+.......|-++++..+||++..+...|+..+..++||
T Consensus       168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVM  247 (516)
T KOG0690|consen  168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVM  247 (516)
T ss_pred             chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEE
Confidence            567778899999999999995 45799999999866543  233455678999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccC
Q 002010          769 EYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAG  848 (982)
Q Consensus       769 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  848 (982)
                      ||..||.|.-.+.  +...+++.....+-..|+.|+.|||+++   ||.||+|.+|.++|.+|++||.|||+++.-.  .
T Consensus       248 eyanGGeLf~HLs--rer~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I--~  320 (516)
T KOG0690|consen  248 EYANGGELFFHLS--RERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEI--K  320 (516)
T ss_pred             EEccCceEeeehh--hhhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhcc--c
Confidence            9999999988776  5678999999999999999999999988   9999999999999999999999999998533  2


Q ss_pred             CcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCccccccee
Q 002010          849 ASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAV  928 (982)
Q Consensus       849 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  928 (982)
                      ....+...+|||.|.|||++....|+.++|+|.+||++|||++|+.||...+....+--+.......             
T Consensus       321 ~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kF-------------  387 (516)
T KOG0690|consen  321 YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKF-------------  387 (516)
T ss_pred             ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccC-------------
Confidence            3455678999999999999999999999999999999999999999998754443333333333221             


Q ss_pred             ecCCCCCCChHhHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 002010          929 VDPRLSGYPLTGVIHLFKVAMMCVEDESSARP-----TMREVVH  967 (982)
Q Consensus       929 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~ell~  967 (982)
                              |..-..+...++...+.+||.+|.     .+.||.+
T Consensus       388 --------Pr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~  423 (516)
T KOG0690|consen  388 --------PRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMR  423 (516)
T ss_pred             --------CccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHh
Confidence                    222223567888899999999997     5566654

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=5e-33  Score=310.78  Aligned_cols=273  Identities=21%  Similarity=0.314  Sum_probs=201.9

Q ss_pred             HhhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCC-----cc
Q 002010          691 LESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRD-----TN  764 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~  764 (982)
                      .++|++.+.||+|+||.||+|.. .+|+.||+|++...........+.+|+.++++++||||+++++++....     ..
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            36789999999999999999964 5689999999854333444566888999999999999999999876543     46


Q ss_pred             EEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhc
Q 002010          765 LLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFL  844 (982)
Q Consensus       765 ~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~  844 (982)
                      ++|+||++ +++.+++.   ...+++..+..++.|++.|++|||+.+   |+||||||+||+++.++.+||+|||++...
T Consensus        84 ~lv~e~~~-~~l~~~~~---~~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~  156 (336)
T cd07849          84 YIVQELME-TDLYKLIK---TQHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIA  156 (336)
T ss_pred             EEEehhcc-cCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceeec
Confidence            89999995 58888774   357999999999999999999999988   999999999999999999999999999765


Q ss_pred             cccCC-ccccccccccccccccccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcc
Q 002010          845 QDAGA-SECMSSVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDA  922 (982)
Q Consensus       845 ~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  922 (982)
                      ..... ........++..|+|||.+.+ ..++.++||||+||++|+|++|+.||...........+ ......+..    
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~-~~~~~~~~~----  231 (336)
T cd07849         157 DPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLI-LGVLGTPSQ----  231 (336)
T ss_pred             cccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-HHHcCCCCH----
Confidence            43221 112234568899999998654 56889999999999999999999999654322111111 111111000    


Q ss_pred             cccceeec-------------CCCC--CCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHH--hcCCCCC
Q 002010          923 ASVLAVVD-------------PRLS--GYPLTGVIHLFKVAMMCVEDESSARPTMREVVHM--LANPPQS  975 (982)
Q Consensus       923 ~~~~~~~~-------------~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~--L~~~~~~  975 (982)
                      .......+             +..+  .........+.+++.+||+.||++|||++|+++.  ++...+.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~  301 (336)
T cd07849         232 EDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDP  301 (336)
T ss_pred             HHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCC
Confidence            00000000             0000  0011234568899999999999999999999984  6555543

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=1.9e-32  Score=308.32  Aligned_cols=267  Identities=23%  Similarity=0.287  Sum_probs=199.6

Q ss_pred             HHhhcccccccccccceEEEEEEe-CCCcEEEEEEeccCC-CCCchhhHHHHHHHHhcCCCCcccceEeEEEcC------
Q 002010          690 VLESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRG-TGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNR------  761 (982)
Q Consensus       690 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------  761 (982)
                      +.++|+..+.||+|+||.||+|.. .+++.||+|.+.... .......+.+|+.++++++||||+++++++...      
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            457899999999999999999965 578999999885432 223345677899999999999999999988643      


Q ss_pred             CccEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccc
Q 002010          762 DTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLA  841 (982)
Q Consensus       762 ~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a  841 (982)
                      ...++||||+. ++|.+.+..    .+++..+..++.|++.|++|||+.+   |+||||||+||+++.++.+||+|||++
T Consensus        94 ~~~~lv~e~~~-~~l~~~~~~----~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~~  165 (353)
T cd07850          94 QDVYLVMELMD-ANLCQVIQM----DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA  165 (353)
T ss_pred             CcEEEEEeccC-CCHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCccc
Confidence            34699999995 588888752    2889999999999999999999988   999999999999999999999999999


Q ss_pred             hhccccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCC----
Q 002010          842 KFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVS----  917 (982)
Q Consensus       842 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----  917 (982)
                      +.....   .......++..|+|||++.+..++.++||||+||++|+|++|+.||...+.................    
T Consensus       166 ~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  242 (353)
T cd07850         166 RTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMS  242 (353)
T ss_pred             eeCCCC---CCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence            865432   1223456788999999999999999999999999999999999999754322222221111111000    


Q ss_pred             ------------CCC-cccccceeec----CCCC-CCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          918 ------------QPS-DAASVLAVVD----PRLS-GYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       918 ------------~~~-~~~~~~~~~~----~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                                  .+. ........+.    +... ..+...+..+.+++.+||+.||++|||+.|+++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~  310 (353)
T cd07850         243 RLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ  310 (353)
T ss_pred             HhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence                        000 0000000000    0000 112234567889999999999999999999986

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=2.7e-32  Score=298.69  Aligned_cols=259  Identities=18%  Similarity=0.220  Sum_probs=186.2

Q ss_pred             hhcccccccccccceEEEEEEeCC----CcEEEEEEeccCCCCCch----------hhHHHHHHHHhcCCCCcccceEeE
Q 002010          692 ESLKDENIIGKGGAGIVYRGSMPD----GIDVAIKRLVGRGTGGND----------HGFLAEIQTLGRIRHRNIVRLLGY  757 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~----------~~~~~E~~~l~~l~h~niv~~~~~  757 (982)
                      ++|++.+.||+|+||.||+|...+    +..+|+|...........          .....+...+..++|+++++++++
T Consensus        12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~   91 (294)
T PHA02882         12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC   91 (294)
T ss_pred             CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence            578999999999999999997644    345666653222111100          112233445666789999999997


Q ss_pred             EEcCC----ccEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCE
Q 002010          758 VSNRD----TNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEA  833 (982)
Q Consensus       758 ~~~~~----~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~  833 (982)
                      +....    ..++++|++ ..++.+.+..  ....++..+..++.|++.|++|||+.+   |+||||||+||+++.++.+
T Consensus        92 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~~~  165 (294)
T PHA02882         92 GSFKRCRMYYRFILLEKL-VENTKEIFKR--IKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNNRG  165 (294)
T ss_pred             eeEecCCceEEEEEEehh-ccCHHHHHHh--hccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCcE
Confidence            65543    336788877 3466666652  234578889999999999999999988   9999999999999999999


Q ss_pred             EEeccccchhccccCCc-----ccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHH
Q 002010          834 HVADFGLAKFLQDAGAS-----ECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRW  908 (982)
Q Consensus       834 kl~DfG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~  908 (982)
                      +|+|||+|+.+......     .......||+.|+|||+..+..++.++||||+||++|||++|+.||............
T Consensus       166 ~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~  245 (294)
T PHA02882        166 YIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHA  245 (294)
T ss_pred             EEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHH
Confidence            99999999876432111     1122346999999999999999999999999999999999999999876433332222


Q ss_pred             HHHhc-cCCCCCCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 002010          909 VRKTT-SEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLA  970 (982)
Q Consensus       909 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~  970 (982)
                      ..... .....            +..  .....+..+.+++..|++.+|++||+++++++.++
T Consensus       246 ~~~~~~~~~~~------------~~~--~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~  294 (294)
T PHA02882        246 AKCDFIKRLHE------------GKI--KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD  294 (294)
T ss_pred             hHHHHHHHhhh------------hhh--ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence            11111 10000            000  01123467899999999999999999999998764

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=2.6e-32  Score=293.33  Aligned_cols=252  Identities=30%  Similarity=0.440  Sum_probs=204.9

Q ss_pred             hcccccccccccceEEEEEEeC-CCcEEEEEEeccCCC-CCchhhHHHHHHHHhcCCCCcccceEeEEEcC--CccEEEE
Q 002010          693 SLKDENIIGKGGAGIVYRGSMP-DGIDVAIKRLVGRGT-GGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNR--DTNLLLY  768 (982)
Q Consensus       693 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~  768 (982)
                      +|+..+.||+|++|.||+|... +++.|++|++..... ....+.+.+|+.++++++||||+++++.+...  ...++|+
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            3667789999999999999764 689999998854432 23456788999999999999999999999888  8899999


Q ss_pred             eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccC
Q 002010          769 EYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAG  848 (982)
Q Consensus       769 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  848 (982)
                      ||+++++|.+++...  ..+++..+..++.|++.|++|||+.+   ++|+||+|+||+++.++.++|+|||.+.......
T Consensus        81 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  155 (260)
T cd06606          81 EYVSGGSLSSLLKKF--GKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIE  155 (260)
T ss_pred             EecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEeccccc
Confidence            999999999999743  38999999999999999999999988   9999999999999999999999999998765432


Q ss_pred             CcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCccccccee
Q 002010          849 ASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAV  928 (982)
Q Consensus       849 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  928 (982)
                      .........++..|+|||...+..++.++||||+|+++|+|++|..||....+......   ....              
T Consensus       156 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~---~~~~--------------  218 (260)
T cd06606         156 TGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALY---KIGS--------------  218 (260)
T ss_pred             ccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHH---hccc--------------
Confidence            21123445688899999999888899999999999999999999999976542211111   1110              


Q ss_pred             ecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          929 VDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       929 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                       .......+...+..+.+++.+|++.||++||++.|++.
T Consensus       219 -~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         219 -SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             -cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence             01111233334568999999999999999999999975

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=1.8e-32  Score=294.29  Aligned_cols=250  Identities=25%  Similarity=0.353  Sum_probs=205.1

Q ss_pred             hcccccccccccceEEEEEEe-CCCcEEEEEEeccCCC-CCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEec
Q 002010          693 SLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGT-GGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEY  770 (982)
Q Consensus       693 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  770 (982)
                      +|+..+.||+|+||.||++.. .++..||+|++..... ......+.+|++++++++|||++++++.+...+..++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            367778999999999999965 3688999999854433 24456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccC
Q 002010          771 MPNGSLGEMLHGAK--GGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAG  848 (982)
Q Consensus       771 ~~~~sL~~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  848 (982)
                      +++++|.+++....  ...+++..+..++.+++.|++|||+.+   ++|+||+|+||++++++.++|+|||.+.......
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  157 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV  157 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence            99999999997543  478999999999999999999999988   9999999999999999999999999998665332


Q ss_pred             CcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCccccccee
Q 002010          849 ASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAV  928 (982)
Q Consensus       849 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  928 (982)
                        .......+++.|+|||...+..++.++|+||+|+++|+|++|+.||......    .........             
T Consensus       158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~----~~~~~~~~~-------------  218 (258)
T cd08215         158 --DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL----ELALKILKG-------------  218 (258)
T ss_pred             --ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH----HHHHHHhcC-------------
Confidence              2233456888999999998888999999999999999999999999654322    222111110             


Q ss_pred             ecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          929 VDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       929 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                         .....+...+..+.+++.+||+.+|++|||+.|+++
T Consensus       219 ---~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  254 (258)
T cd08215         219 ---QYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ  254 (258)
T ss_pred             ---CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence               011122234457899999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=1.5e-32  Score=301.58  Aligned_cols=269  Identities=20%  Similarity=0.225  Sum_probs=198.7

Q ss_pred             hcccccccccccceEEEEEEe-CCCcEEEEEEeccCCC-CCchhhHHHHHHHHhcCC-CCcccceEeEEEcCCc-----c
Q 002010          693 SLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGT-GGNDHGFLAEIQTLGRIR-HRNIVRLLGYVSNRDT-----N  764 (982)
Q Consensus       693 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~-----~  764 (982)
                      +|+..+.||+|+||.||+|.. .+++.||+|.+..... ......+.+|+.+++++. ||||+++++++...+.     .
T Consensus         2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~   81 (295)
T cd07837           2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSL   81 (295)
T ss_pred             CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceE
Confidence            578888999999999999975 4689999998754432 223456888999999995 6999999999877665     7


Q ss_pred             EEEEeccCCCCHHHHhhcCC---CCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcC-CCCEEEecccc
Q 002010          765 LLLYEYMPNGSLGEMLHGAK---GGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDS-DFEAHVADFGL  840 (982)
Q Consensus       765 ~lv~e~~~~~sL~~~l~~~~---~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~-~~~~kl~DfG~  840 (982)
                      |+||||+++ +|.+++....   ...+++..+..++.||+.|++|||+.+   |+||||+|+||+++. ++.+||+|||.
T Consensus        82 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg~  157 (295)
T cd07837          82 YLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGL  157 (295)
T ss_pred             EEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeeccc
Confidence            999999975 8988886432   246899999999999999999999988   999999999999998 89999999999


Q ss_pred             chhccccCCccccccccccccccccccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCC
Q 002010          841 AKFLQDAGASECMSSVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQP  919 (982)
Q Consensus       841 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  919 (982)
                      +..+...  ........+++.|+|||.+.+ ..++.++||||+|+++|+|++|..||....+..................
T Consensus       158 ~~~~~~~--~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (295)
T cd07837         158 GRAFSIP--VKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQV  235 (295)
T ss_pred             ceecCCC--ccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence            8765322  111223456788999998765 4578999999999999999999999976544443333332221111000


Q ss_pred             Ccc-cccceee-cCCC-----CCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          920 SDA-ASVLAVV-DPRL-----SGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       920 ~~~-~~~~~~~-~~~~-----~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                      ... ....... -+..     ....+..+..+.+++.+||+.||.+||+++|++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         236 WPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             CcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            000 0000000 0000     0111234556889999999999999999999875

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=2e-32  Score=304.79  Aligned_cols=266  Identities=19%  Similarity=0.252  Sum_probs=195.4

Q ss_pred             ccccc--cceEEEEEEe-CCCcEEEEEEeccCCC-CCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEeccCCC
Q 002010          699 IIGKG--GAGIVYRGSM-PDGIDVAIKRLVGRGT-GGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNG  774 (982)
Q Consensus       699 ~lg~G--~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~  774 (982)
                      .||+|  +||+||+|.. .+|+.||+|.+..... ....+.+.+|+.+++.++||||+++++++..++..++||||+.++
T Consensus         5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~   84 (328)
T cd08226           5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG   84 (328)
T ss_pred             HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCC
Confidence            46666  9999999965 5799999999854332 223456788999999999999999999999999999999999999


Q ss_pred             CHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCccc--
Q 002010          775 SLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASEC--  852 (982)
Q Consensus       775 sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~--  852 (982)
                      ++.+++.......+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.++++||+.+...........  
T Consensus        85 ~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (328)
T cd08226          85 SANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVV  161 (328)
T ss_pred             CHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccc
Confidence            9999997655567899999999999999999999888   99999999999999999999999986644322111110  


Q ss_pred             ---cccccccccccccccccc--CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCccc----
Q 002010          853 ---MSSVAGSYGYIAPEYAYT--LKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAA----  923 (982)
Q Consensus       853 ---~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~----  923 (982)
                         .....++..|+|||++.+  ..++.++||||+||++|||++|+.||...................+.......    
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (328)
T cd08226         162 YDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEES  241 (328)
T ss_pred             ccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhh
Confidence               111234567999999876  34789999999999999999999999765433333222221111000000000    


Q ss_pred             c-----------cc----------eeecCCCC-CCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          924 S-----------VL----------AVVDPRLS-GYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       924 ~-----------~~----------~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                      .           ..          ...+.... ..+......+.+++++||+.||++|||++|+++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~  307 (328)
T cd08226         242 RMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS  307 (328)
T ss_pred             hhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence            0           00          00000111 123345667899999999999999999999985

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=2.8e-32  Score=296.22  Aligned_cols=242  Identities=26%  Similarity=0.286  Sum_probs=187.9

Q ss_pred             ccccccceEEEEEEe-CCCcEEEEEEeccCCCCC--chhhHHHHHHHHhc---CCCCcccceEeEEEcCCccEEEEeccC
Q 002010          699 IIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGG--NDHGFLAEIQTLGR---IRHRNIVRLLGYVSNRDTNLLLYEYMP  772 (982)
Q Consensus       699 ~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~---l~h~niv~~~~~~~~~~~~~lv~e~~~  772 (982)
                      .||+|+||.||+|.. .+++.||+|.+.......  ....+.+|..+++.   .+||+|+++++++..++..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            489999999999965 468899999885543221  22334445444333   479999999999999999999999999


Q ss_pred             CCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCccc
Q 002010          773 NGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASEC  852 (982)
Q Consensus       773 ~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~  852 (982)
                      +++|.+++.  ....+++..+..++.|++.|++|||+.+   |+||||||+||++++++.++++|||++.......    
T Consensus        81 ~~~L~~~i~--~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~----  151 (279)
T cd05633          81 GGDLHYHLS--QHGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----  151 (279)
T ss_pred             CCCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC----
Confidence            999999986  3457999999999999999999999988   9999999999999999999999999987554221    


Q ss_pred             ccccccccccccccccc-cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceeecC
Q 002010          853 MSSVAGSYGYIAPEYAY-TLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDP  931 (982)
Q Consensus       853 ~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  931 (982)
                      .....|+..|+|||... +..++.++||||+||++|||++|..||........ .. .......             .+ 
T Consensus       152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-~~-~~~~~~~-------------~~-  215 (279)
T cd05633         152 PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HE-IDRMTLT-------------VN-  215 (279)
T ss_pred             ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCH-HH-HHHHhhc-------------CC-
Confidence            22346899999999886 45689999999999999999999999976433221 11 1111100             00 


Q ss_pred             CCCCCChHhHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 002010          932 RLSGYPLTGVIHLFKVAMMCVEDESSARP-----TMREVVH  967 (982)
Q Consensus       932 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~ell~  967 (982)
                        ...+...+..+.+++.+||+.||++||     |++|+++
T Consensus       216 --~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~  254 (279)
T cd05633         216 --VELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKE  254 (279)
T ss_pred             --cCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHh
Confidence              112333455788999999999999999     5999887

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=1.6e-32  Score=302.75  Aligned_cols=248  Identities=28%  Similarity=0.357  Sum_probs=196.4

Q ss_pred             HhhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCC--CchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEE
Q 002010          691 LESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTG--GNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLL  767 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  767 (982)
                      .+.|+..+.||+|+||.||+|.. .+++.||+|.+......  ....++.+|+.+++.++||||+++++++.+++..++|
T Consensus        14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv   93 (307)
T cd06607          14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV   93 (307)
T ss_pred             chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence            35688888999999999999965 46899999988543222  2335688999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhcccc
Q 002010          768 YEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDA  847 (982)
Q Consensus       768 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  847 (982)
                      |||++ |++.+++... ...+++..+..++.|++.|+.|||+.+   |+||||+|+||+++.++.+||+|||++......
T Consensus        94 ~e~~~-g~l~~~~~~~-~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~  168 (307)
T cd06607          94 MEYCL-GSASDILEVH-KKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPA  168 (307)
T ss_pred             HHhhC-CCHHHHHHHc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCCC
Confidence            99996 5777776532 346899999999999999999999988   999999999999999999999999998754322


Q ss_pred             CCcccccccccccccccccccc---cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccc
Q 002010          848 GASECMSSVAGSYGYIAPEYAY---TLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAAS  924 (982)
Q Consensus       848 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  924 (982)
                            ....+++.|+|||++.   ...++.++||||+|+++|||++|..||............ .....          
T Consensus       169 ------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~-~~~~~----------  231 (307)
T cd06607         169 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI-AQNDS----------  231 (307)
T ss_pred             ------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHH-hcCCC----------
Confidence                  2346788999999874   456889999999999999999999999654322111111 00000          


Q ss_pred             cceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002010          925 VLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHM  968 (982)
Q Consensus       925 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~  968 (982)
                            +.  ..+...+..+.+++.+||+.||++||++.+++..
T Consensus       232 ------~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  267 (307)
T cd06607         232 ------PT--LSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH  267 (307)
T ss_pred             ------CC--CCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence                  00  0112234578999999999999999999999874

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-32  Score=297.45  Aligned_cols=267  Identities=23%  Similarity=0.254  Sum_probs=200.3

Q ss_pred             cccccccccccceEEEEEEeC-CCcEEEEEEeccCCCCC-chhhHHHHHHHHhcC---CCCcccceEeEEEcCCc-----
Q 002010          694 LKDENIIGKGGAGIVYRGSMP-DGIDVAIKRLVGRGTGG-NDHGFLAEIQTLGRI---RHRNIVRLLGYVSNRDT-----  763 (982)
Q Consensus       694 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~-----  763 (982)
                      |++.+.||+|+||.||+|..+ +++.||+|++....... ....+.+|+.+++++   +|||++++++++...+.     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            566788999999999999765 48999999986443322 234566787776665   69999999999988776     


Q ss_pred             cEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchh
Q 002010          764 NLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKF  843 (982)
Q Consensus       764 ~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~  843 (982)
                      .+++|||+. ++|.+++.......+++..+..++.|++.|++|||+.+   ++|+||+|+||++++++.+||+|||.+..
T Consensus        81 ~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~~  156 (287)
T cd07838          81 LTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARI  156 (287)
T ss_pred             eEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCccee
Confidence            899999996 58999887544457999999999999999999999988   99999999999999999999999999976


Q ss_pred             ccccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCccc
Q 002010          844 LQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAA  923 (982)
Q Consensus       844 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  923 (982)
                      +....   ......++..|+|||++.+..++.++||||+||++|||++|++||......+...++...............
T Consensus       157 ~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (287)
T cd07838         157 YSFEM---ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRN  233 (287)
T ss_pred             ccCCc---ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCC
Confidence            64321   122345788999999999888999999999999999999999999875544444444332211100000000


Q ss_pred             c--cceeecC----CCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          924 S--VLAVVDP----RLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       924 ~--~~~~~~~----~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                      .  ....+..    ............+.+++.+||+.||++||+++|++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         234 VSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             cccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence            0  0000000    111112234567789999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=2.4e-32  Score=298.56  Aligned_cols=244  Identities=23%  Similarity=0.348  Sum_probs=196.5

Q ss_pred             ccccccccceEEEEEEe-CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEeccCCCC
Q 002010          697 ENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGS  775 (982)
Q Consensus       697 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~s  775 (982)
                      ...||+|+||.||+|.. .+++.||+|++.. ........+.+|+.+++.++|+||+++++++...+..++||||+++++
T Consensus        25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~  103 (292)
T cd06657          25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDL-RKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGA  103 (292)
T ss_pred             HHHcCCCCCeEEEEEEEcCCCeEEEEEEecc-cchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCc
Confidence            35799999999999965 5789999998743 233345568899999999999999999999999999999999999999


Q ss_pred             HHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCcccccc
Q 002010          776 LGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSS  855 (982)
Q Consensus       776 L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~  855 (982)
                      |.+++.   ...+++..+..++.|++.|++|+|+.+   ++||||+|+||++++++.++++|||.+.......  .....
T Consensus       104 L~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~--~~~~~  175 (292)
T cd06657         104 LTDIVT---HTRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PRRKS  175 (292)
T ss_pred             HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceeccccc--ccccc
Confidence            999875   246899999999999999999999988   9999999999999999999999999987654321  12234


Q ss_pred             cccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceeecCCCCC
Q 002010          856 VAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDPRLSG  935 (982)
Q Consensus       856 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  935 (982)
                      ..+++.|+|||...+..++.++|+||+|+++|+|++|..||...... ...........                +.+..
T Consensus       176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~-~~~~~~~~~~~----------------~~~~~  238 (292)
T cd06657         176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL-KAMKMIRDNLP----------------PKLKN  238 (292)
T ss_pred             cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhhCC----------------cccCC
Confidence            56788999999998888899999999999999999999999754322 22222221111                00110


Q ss_pred             CChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          936 YPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       936 ~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                       ....+..+.+++.+||+.||.+||++.++++
T Consensus       239 -~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~  269 (292)
T cd06657         239 -LHKVSPSLKGFLDRLLVRDPAQRATAAELLK  269 (292)
T ss_pred             -cccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence             1122346789999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=9.3e-35  Score=283.33  Aligned_cols=253  Identities=26%  Similarity=0.353  Sum_probs=202.0

Q ss_pred             cccccccccccceEEEEEE-eCCCcEEEEEEeccCCCCCchhhHHHHHHHHhcC-CCCcccceEeEEEcCCccEEEEecc
Q 002010          694 LKDENIIGKGGAGIVYRGS-MPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRI-RHRNIVRLLGYVSNRDTNLLLYEYM  771 (982)
Q Consensus       694 ~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~  771 (982)
                      .+....||.|+||+|+|-. .+.|+..|||+++......+.+++..|.+...+- ++||||++||+.-.++..|+.||.|
T Consensus        66 Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM  145 (361)
T KOG1006|consen   66 LQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM  145 (361)
T ss_pred             HHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH
Confidence            4455679999999999984 5679999999998887777788899998886655 7899999999999999999999999


Q ss_pred             CCCCHHHHh---hcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccC
Q 002010          772 PNGSLGEML---HGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAG  848 (982)
Q Consensus       772 ~~~sL~~~l---~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  848 (982)
                       +.+++.+.   ...+...+++.-.-.++...+.||.||.+..  .|||||+||+|||++..|.+|+||||++-.+.+. 
T Consensus       146 -d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S-  221 (361)
T KOG1006|consen  146 -DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS-  221 (361)
T ss_pred             -hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHHH-
Confidence             55665543   3445678999999999999999999998743  4999999999999999999999999999876643 


Q ss_pred             Ccccccccccccccccccccc--cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccC-CCCCCccccc
Q 002010          849 ASECMSSVAGSYGYIAPEYAY--TLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSE-VSQPSDAASV  925 (982)
Q Consensus       849 ~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  925 (982)
                        ...+.-.|...|||||.+.  +..|+-+|||||+|+++||+.||..||..+..-.+....+.....+ ...+      
T Consensus       222 --iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~------  293 (361)
T KOG1006|consen  222 --IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFD------  293 (361)
T ss_pred             --HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCc------
Confidence              2334567888999999886  3458999999999999999999999999876544433333222210 0000      


Q ss_pred             ceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          926 LAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       926 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                               .........+.+++..|+.+|-..||...++.+
T Consensus       294 ---------~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~  326 (361)
T KOG1006|consen  294 ---------KECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK  326 (361)
T ss_pred             ---------ccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence                     011224457899999999999999999999876

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=3.6e-32  Score=297.13  Aligned_cols=266  Identities=24%  Similarity=0.324  Sum_probs=201.1

Q ss_pred             cccccccccccceEEEEEEeC-CCcEEEEEEeccCC-CCCchhhHHHHHHHHhcCCCCcccceEeEEEcC--CccEEEEe
Q 002010          694 LKDENIIGKGGAGIVYRGSMP-DGIDVAIKRLVGRG-TGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNR--DTNLLLYE  769 (982)
Q Consensus       694 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e  769 (982)
                      |++.+.||+|++|.||+|... +++.||+|++.... .......+.+|+.++++++|||++++++++...  +..++|||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            556778999999999999764 58899999996553 233455688999999999999999999999887  78999999


Q ss_pred             ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCC
Q 002010          770 YMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGA  849 (982)
Q Consensus       770 ~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  849 (982)
                      |+++ +|.+++... ...+++..+..++.||+.|++|||+.+   ++|+||+|+||++++++.+|++|||.+........
T Consensus        81 ~~~~-~l~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~  155 (287)
T cd07840          81 YMDH-DLTGLLDSP-EVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS  155 (287)
T ss_pred             cccc-cHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCCc
Confidence            9964 898888633 257899999999999999999999988   99999999999999999999999999987654321


Q ss_pred             ccccccccccccccccccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccce-
Q 002010          850 SECMSSVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLA-  927 (982)
Q Consensus       850 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  927 (982)
                       .......++..|+|||.+.+ ..++.++||||+|+++|||++|+.||................... .. ........ 
T Consensus       156 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~-~~-~~~~~~~~~  232 (287)
T cd07840         156 -ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSP-TD-ENWPGVSKL  232 (287)
T ss_pred             -ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC-ch-hhccccccc
Confidence             12233456788999997764 457899999999999999999999997654433333322221111 10 00000000 


Q ss_pred             ----eecCC------CCC-CChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          928 ----VVDPR------LSG-YPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       928 ----~~~~~------~~~-~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                          ...+.      +.. .....+..+.+++.+||+.+|++||+++++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  283 (287)
T cd07840         233 PWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ  283 (287)
T ss_pred             hhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence                00000      000 11112567899999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=4e-32  Score=299.21  Aligned_cols=273  Identities=24%  Similarity=0.292  Sum_probs=201.9

Q ss_pred             HHHhhcccccccccccceEEEEEEeC-CCcEEEEEEeccCCC-CCchhhHHHHHHHHhcCCCCcccceEeEEEcCC----
Q 002010          689 DVLESLKDENIIGKGGAGIVYRGSMP-DGIDVAIKRLVGRGT-GGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRD----  762 (982)
Q Consensus       689 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----  762 (982)
                      ...++|++.+.||+|+||.||+|..+ +++.||+|++..... ......+.+|+.++++++||||+++++++.+..    
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            34678999999999999999999764 588999999854432 233456778999999999999999999987655    


Q ss_pred             ------ccEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEe
Q 002010          763 ------TNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVA  836 (982)
Q Consensus       763 ------~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~  836 (982)
                            ..++|+||+++ ++.+.+... ...+++..+..++.|++.|++|||+.+   |+||||||+||++++++.+||+
T Consensus        84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl~  158 (302)
T cd07864          84 FKKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLA  158 (302)
T ss_pred             ccccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEeC
Confidence                  68999999975 777777532 457899999999999999999999988   9999999999999999999999


Q ss_pred             ccccchhccccCCccccccccccccccccccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccC
Q 002010          837 DFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSE  915 (982)
Q Consensus       837 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  915 (982)
                      |||.+........ .......++..|+|||.+.+ ..++.++||||+||++|||++|++||...................
T Consensus       159 dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~  237 (302)
T cd07864         159 DFGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSP  237 (302)
T ss_pred             cccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence            9999987653321 11223346778999998765 457899999999999999999999997654433333332222111


Q ss_pred             CCCCCc---ccccceeecC------CCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          916 VSQPSD---AASVLAVVDP------RLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       916 ~~~~~~---~~~~~~~~~~------~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                      ......   ........++      .........+..+.+++.+||+.||.+|||++++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         238 CPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             ChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            110000   0000000000      000111123567899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-32  Score=293.27  Aligned_cols=251  Identities=27%  Similarity=0.383  Sum_probs=198.4

Q ss_pred             hhcccccccccccceEEEEEEe-CCCcEEEEEEeccCC----CCCchhhHHHHHHHHhcCCCCcccceEeEEEcC--Ccc
Q 002010          692 ESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRG----TGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNR--DTN  764 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~  764 (982)
                      ..|+..+.||+|+||.||+|.. .++..||+|.+....    .......+.+|+.++++++||||+++++++.+.  ...
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            4688889999999999999965 468999999874321    122345788999999999999999999998764  457


Q ss_pred             EEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhc
Q 002010          765 LLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFL  844 (982)
Q Consensus       765 ~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~  844 (982)
                      +++|||+++++|.+++..  ...+++..+..++.|++.|++|||+.+   ++||||||+||+++.++.++|+|||.++..
T Consensus        82 ~~v~e~~~~~~L~~~~~~--~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~  156 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKA--YGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRI  156 (264)
T ss_pred             EEEEEeCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcccccccc
Confidence            899999999999999863  346889999999999999999999888   999999999999999999999999999865


Q ss_pred             cccCC-cccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCccc
Q 002010          845 QDAGA-SECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAA  923 (982)
Q Consensus       845 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  923 (982)
                      ..... ........++..|+|||.+.+..++.++|+||+||++|+|++|+.||............   ...         
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~---~~~---------  224 (264)
T cd06653         157 QTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKI---ATQ---------  224 (264)
T ss_pred             ccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHH---HcC---------
Confidence            32111 11123356888999999999888999999999999999999999999764332222111   111         


Q ss_pred             ccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          924 SVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       924 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                             +..+..+......+.+++.+||+ +|.+|||+.+++.
T Consensus       225 -------~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         225 -------PTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             -------CCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence                   01112334445678999999999 5799999998765

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=4.1e-32  Score=297.99  Aligned_cols=253  Identities=26%  Similarity=0.419  Sum_probs=196.7

Q ss_pred             HhhcccccccccccceEEEEEEeCC-CcEEEEEEeccCCCCCchhhHHHHHHHHhcC-CCCcccceEeEEEcCCccEEEE
Q 002010          691 LESLKDENIIGKGGAGIVYRGSMPD-GIDVAIKRLVGRGTGGNDHGFLAEIQTLGRI-RHRNIVRLLGYVSNRDTNLLLY  768 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~  768 (982)
                      .++|+..+.||+|+||.||+|...+ ++.||||.+...........+.+|+.++.+. .||||+++++++.++...++||
T Consensus        14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   93 (296)
T cd06618          14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM   93 (296)
T ss_pred             cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence            3568888999999999999997754 8999999986554444455677788777666 4999999999999999999999


Q ss_pred             eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCcEEecCCCCCcEEEcCCCCEEEeccccchhcccc
Q 002010          769 EYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHH-DCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDA  847 (982)
Q Consensus       769 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  847 (982)
                      ||++ +++.+++.. ....+++..+..++.|++.|++|||+ .+   |+||||+|+||++++++.+||+|||++..+...
T Consensus        94 e~~~-~~l~~l~~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~  168 (296)
T cd06618          94 ELMS-TCLDKLLKR-IQGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLVDS  168 (296)
T ss_pred             eccC-cCHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence            9984 577777653 23478999999999999999999997 46   999999999999999999999999999766432


Q ss_pred             CCcccccccccccccccccccccCC----CCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCccc
Q 002010          848 GASECMSSVAGSYGYIAPEYAYTLK----VDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAA  923 (982)
Q Consensus       848 ~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  923 (982)
                      ..   .....++..|+|||.+.+..    ++.++||||+|+++|+|++|+.||.......+....+......        
T Consensus       169 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~--------  237 (296)
T cd06618         169 KA---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPP--------  237 (296)
T ss_pred             Cc---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCC--------
Confidence            11   22345778999999987553    7889999999999999999999997543322222221111100        


Q ss_pred             ccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002010          924 SVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHM  968 (982)
Q Consensus       924 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~  968 (982)
                              ..+ .....+.++.+++.+||+.||++||+++++++.
T Consensus       238 --------~~~-~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         238 --------SLP-PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             --------CCC-CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence                    000 011234578999999999999999999999863

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-33  Score=278.51  Aligned_cols=259  Identities=22%  Similarity=0.348  Sum_probs=197.4

Q ss_pred             ccccccccceEEEEE-EeCCCcEEEEEEeccCCCCCchhhHHHHHHHHhcC-CCCcccceEeEEEcCCccEEEEeccCCC
Q 002010          697 ENIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRI-RHRNIVRLLGYVSNRDTNLLLYEYMPNG  774 (982)
Q Consensus       697 ~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~  774 (982)
                      .+.||+|+|+.|-.+ ...+|.+||||++. +.......++.+|++++.++ .|+||++++++|+++...|+|||.|.||
T Consensus        83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiid-Kq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GG  161 (463)
T KOG0607|consen   83 SELLGEGAYASVQTCVSIQTGKEYAVKIID-KQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGG  161 (463)
T ss_pred             HHHhcCccceeeeeeeeeccchhhhhhhhh-cCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCc
Confidence            357999999999988 56789999999984 44666778899999999999 4999999999999999999999999999


Q ss_pred             CHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCC---CEEEeccccchhcccc----
Q 002010          775 SLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDF---EAHVADFGLAKFLQDA----  847 (982)
Q Consensus       775 sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~---~~kl~DfG~a~~~~~~----  847 (982)
                      +|...++  +...+++.++.+++++|+.||.+||++|   |.|||+||+||+.....   -+|||||.+...+.-.    
T Consensus       162 plLshI~--~~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~s  236 (463)
T KOG0607|consen  162 PLLSHIQ--KRKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCS  236 (463)
T ss_pred             hHHHHHH--HhhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccccccCCCCC
Confidence            9999998  5568999999999999999999999998   99999999999996543   4899999988654321    


Q ss_pred             -CCcccccccccccccccccccc-----cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCc
Q 002010          848 -GASECMSSVAGSYGYIAPEYAY-----TLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSD  921 (982)
Q Consensus       848 -~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  921 (982)
                       .......+.+|+..|||||+..     ...|+.+.|.||+|||+|-|++|.+||.+.-+.+  ..|-+....+    ..
T Consensus       237 pastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~d--CGWdrGe~Cr----~C  310 (463)
T KOG0607|consen  237 PASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGAD--CGWDRGEVCR----VC  310 (463)
T ss_pred             CCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCc--CCccCCCccH----HH
Confidence             1122234567899999999764     2358999999999999999999999997643311  1111111000    00


Q ss_pred             ccccceeecCCCCCCChH----hHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          922 AASVLAVVDPRLSGYPLT----GVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       922 ~~~~~~~~~~~~~~~~~~----~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                      ...+.+.+....-++|..    ...+..+++...+.+|+..|.++.+++.
T Consensus       311 Q~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  311 QNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             HHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence            000011111111123322    2335678899999999999999998876

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=2.8e-32  Score=304.99  Aligned_cols=273  Identities=24%  Similarity=0.331  Sum_probs=201.8

Q ss_pred             HHHhhcccccccccccceEEEEEEeC-CCcEEEEEEeccCC-CCCchhhHHHHHHHHhcC-CCCcccceEeEEEcCC--c
Q 002010          689 DVLESLKDENIIGKGGAGIVYRGSMP-DGIDVAIKRLVGRG-TGGNDHGFLAEIQTLGRI-RHRNIVRLLGYVSNRD--T  763 (982)
Q Consensus       689 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~--~  763 (982)
                      .+.++|+..+.||+|+||.||+|... +++.||+|++.... .......+.+|+.+++++ +||||+++++++...+  .
T Consensus         4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~   83 (337)
T cd07852           4 HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKD   83 (337)
T ss_pred             hhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCce
Confidence            35578899999999999999999754 68899999885432 223345677899999999 9999999999886543  5


Q ss_pred             cEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchh
Q 002010          764 NLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKF  843 (982)
Q Consensus       764 ~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~  843 (982)
                      .++||||++ ++|..++..   ..+++..+..++.||+.|++|||+.+   |+||||||+||+++.++.+||+|||++..
T Consensus        84 ~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~  156 (337)
T cd07852          84 IYLVFEYME-TDLHAVIRA---NILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARS  156 (337)
T ss_pred             EEEEecccc-cCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence            799999996 599998863   27889999999999999999999988   99999999999999999999999999987


Q ss_pred             ccccCCc---cccccccccccccccccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCC
Q 002010          844 LQDAGAS---ECMSSVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQP  919 (982)
Q Consensus       844 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  919 (982)
                      .......   .......++..|+|||.+.+ ..++.++||||+|+++|+|++|+.||..........+............
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~  236 (337)
T cd07852         157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAED  236 (337)
T ss_pred             cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence            6533211   22334568889999998764 4578999999999999999999999976443332222222211100000


Q ss_pred             ------Ccccccce-eecCC---CCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002010          920 ------SDAASVLA-VVDPR---LSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHM  968 (982)
Q Consensus       920 ------~~~~~~~~-~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~  968 (982)
                            ........ .....   ........+..+.+++.+||+.||++|||+.++++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         237 IESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             HHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence                  00000000 00000   011112245678999999999999999999999973

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=5.2e-32  Score=299.98  Aligned_cols=248  Identities=27%  Similarity=0.364  Sum_probs=196.9

Q ss_pred             hhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCC--CchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEE
Q 002010          692 ESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTG--GNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLY  768 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  768 (982)
                      +.|+..+.||+|+||.||+|.. .++..||+|.+......  .....+.+|+.++++++|||++++++++.+++..++||
T Consensus        25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  104 (317)
T cd06635          25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM  104 (317)
T ss_pred             hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence            3467778899999999999965 46889999988543222  23346888999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccC
Q 002010          769 EYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAG  848 (982)
Q Consensus       769 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  848 (982)
                      ||++ |++.+.+.. ...++++.++..++.|++.|+.|||+.+   |+||||+|+||+++.++.+||+|||++.....  
T Consensus       105 e~~~-g~l~~~~~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~--  177 (317)
T cd06635         105 EYCL-GSASDLLEV-HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASP--  177 (317)
T ss_pred             eCCC-CCHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCC--
Confidence            9996 477777753 2456899999999999999999999988   99999999999999999999999999875432  


Q ss_pred             Ccccccccccccccccccccc---cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCccccc
Q 002010          849 ASECMSSVAGSYGYIAPEYAY---TLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASV  925 (982)
Q Consensus       849 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  925 (982)
                          .....+++.|+|||++.   ...++.++||||+||++|||++|+.||...........+......           
T Consensus       178 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~-----------  242 (317)
T cd06635         178 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP-----------  242 (317)
T ss_pred             ----cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCC-----------
Confidence                12346788999999874   456889999999999999999999998764332222222221110           


Q ss_pred             ceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 002010          926 LAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHML  969 (982)
Q Consensus       926 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L  969 (982)
                              .......+..+.+++.+||+.+|.+||++.++++..
T Consensus       243 --------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~  278 (317)
T cd06635         243 --------TLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHM  278 (317)
T ss_pred             --------CCCCccccHHHHHHHHHHccCCcccCcCHHHHHhCh
Confidence                    001112334688999999999999999999999854

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-32  Score=297.58  Aligned_cols=267  Identities=21%  Similarity=0.289  Sum_probs=200.6

Q ss_pred             cccccccccccceEEEEEEeC-CCcEEEEEEeccCCCCCchhhHHHHHHHHhcCC-CCcccceEeEEEcCCccEEEEecc
Q 002010          694 LKDENIIGKGGAGIVYRGSMP-DGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIR-HRNIVRLLGYVSNRDTNLLLYEYM  771 (982)
Q Consensus       694 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~  771 (982)
                      |++.+.||+|++|+||+|... +++.||+|++.............+|+..+++++ ||||+++++++.+++..++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            566788999999999999764 578899999855443333445567999999998 999999999999999999999999


Q ss_pred             CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCcc
Q 002010          772 PNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASE  851 (982)
Q Consensus       772 ~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~  851 (982)
                       +++|.+++.......+++..+..++.|++.|++|||+.+   ++|+||+|+||++++++.++|+|||.+.......   
T Consensus        81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~---  153 (283)
T cd07830          81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP---  153 (283)
T ss_pred             -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCC---
Confidence             889999987554467899999999999999999999988   9999999999999999999999999998654321   


Q ss_pred             cccccccccccccccccc-cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCc-ccccceee
Q 002010          852 CMSSVAGSYGYIAPEYAY-TLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSD-AASVLAVV  929 (982)
Q Consensus       852 ~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~  929 (982)
                      ......++..|+|||++. ...++.++|+||||+++|||++|++||......................... .......+
T Consensus       154 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (283)
T cd07830         154 PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKL  233 (283)
T ss_pred             CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccc
Confidence            123356788999999875 4557899999999999999999999997654333222222111111000000 00000000


Q ss_pred             cCCC--------CCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          930 DPRL--------SGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       930 ~~~~--------~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                      +..+        .......+..+.+++.+||+.||++|||++|++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  279 (283)
T cd07830         234 GFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ  279 (283)
T ss_pred             cccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence            1011        1111122467889999999999999999999975

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.5e-32  Score=306.87  Aligned_cols=274  Identities=21%  Similarity=0.261  Sum_probs=201.9

Q ss_pred             HhhcccccccccccceEEEEEEe-CCCcEEEEEEeccCC-CCCchhhHHHHHHHHhcCCCCcccceEeEEEcCC-----c
Q 002010          691 LESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRG-TGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRD-----T  763 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~  763 (982)
                      .++|+..+.||+|+||+||+|.. .+++.||+|.+.... .......+.+|+.+++.++||||+++++++....     .
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            35688899999999999999964 568999999885432 2233456778999999999999999999876542     4


Q ss_pred             cEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchh
Q 002010          764 NLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKF  843 (982)
Q Consensus       764 ~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~  843 (982)
                      .++||||+. ++|.+++.  +..++++..+..++.|++.|+.|||+.+   ++||||||+||+++.++.+||+|||++..
T Consensus        84 ~~lv~e~~~-~~L~~~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~  157 (337)
T cd07858          84 VYIVYELMD-TDLHQIIR--SSQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLART  157 (337)
T ss_pred             EEEEEeCCC-CCHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCccccc
Confidence            799999995 78998886  3467999999999999999999999988   99999999999999999999999999986


Q ss_pred             ccccCCccccccccccccccccccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCC--
Q 002010          844 LQDAGASECMSSVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPS--  920 (982)
Q Consensus       844 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--  920 (982)
                      .....  .......++..|+|||.+.. ..++.++||||+||++|+|++|++||........................  
T Consensus       158 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (337)
T cd07858         158 TSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGF  235 (337)
T ss_pred             cCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhh
Confidence            64321  22334567889999998764 46889999999999999999999999754322111111111111000000  


Q ss_pred             -cccccce-------eecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHH--hcCC
Q 002010          921 -DAASVLA-------VVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHM--LANP  972 (982)
Q Consensus       921 -~~~~~~~-------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~--L~~~  972 (982)
                       .......       ..++.........+..+.+++.+||+.||++|||++|+++-  ++.+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~  297 (337)
T cd07858         236 IRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL  297 (337)
T ss_pred             cCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence             0000000       00011111122345678999999999999999999999874  5443

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=9.2e-33  Score=322.70  Aligned_cols=274  Identities=18%  Similarity=0.248  Sum_probs=190.1

Q ss_pred             HHHhhcccccccccccceEEEEEEeCC--CcEEEEEEe--------------ccC--CCCCchhhHHHHHHHHhcCCCCc
Q 002010          689 DVLESLKDENIIGKGGAGIVYRGSMPD--GIDVAIKRL--------------VGR--GTGGNDHGFLAEIQTLGRIRHRN  750 (982)
Q Consensus       689 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~--------------~~~--~~~~~~~~~~~E~~~l~~l~h~n  750 (982)
                      .+.++|++.+.||+|+||+||++..+.  +..++.|.+              .+.  ........+.+|+.++++++|||
T Consensus       145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hpn  224 (501)
T PHA03210        145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHEN  224 (501)
T ss_pred             hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCC
Confidence            356789999999999999999985422  222222211              000  11122345789999999999999


Q ss_pred             ccceEeEEEcCCccEEEEeccCCCCHHHHhhcCC---CCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEE
Q 002010          751 IVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAK---GGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILL  827 (982)
Q Consensus       751 iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~---~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill  827 (982)
                      |+++++++...+..|+|+|++ ++++.+++....   ........+..++.||+.||+|||+.+   ||||||||+||++
T Consensus       225 Iv~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl  300 (501)
T PHA03210        225 ILKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFL  300 (501)
T ss_pred             cCcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEE
Confidence            999999999999999999999 457777775321   123345677889999999999999988   9999999999999


Q ss_pred             cCCCCEEEeccccchhccccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCC-CCCCCC--Cch
Q 002010          828 DSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKP-VGEFGD--GVD  904 (982)
Q Consensus       828 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p-~~~~~~--~~~  904 (982)
                      +.++.+||+|||+++.+.... ........||+.|+|||++.+..++.++||||+||++|||++|..+ +.....  ...
T Consensus       301 ~~~~~vkL~DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~  379 (501)
T PHA03210        301 NCDGKIVLGDFGTAMPFEKER-EAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQ  379 (501)
T ss_pred             CCCCCEEEEeCCCceecCccc-ccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHH
Confidence            999999999999998765332 1222346789999999999999999999999999999999998754 433221  112


Q ss_pred             HHHHHHHhccC-CCCCCcccccceeecC-CCC----CC-----ChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          905 IVRWVRKTTSE-VSQPSDAASVLAVVDP-RLS----GY-----PLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       905 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~-~~~----~~-----~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                      +...+...... ...+.........++. ...    ..     ....+..+.+++.+|++.||.+|||+.|+++
T Consensus       380 ~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~  453 (501)
T PHA03210        380 LLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA  453 (501)
T ss_pred             HHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence            22222211100 0001100001111000 000    00     0112345778899999999999999999986

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=8.8e-32  Score=290.27  Aligned_cols=243  Identities=22%  Similarity=0.288  Sum_probs=188.8

Q ss_pred             HHhhccccccc--ccccceEEEEEEe-CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcC-CCCcccceEeEEEcCCccE
Q 002010          690 VLESLKDENII--GKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRI-RHRNIVRLLGYVSNRDTNL  765 (982)
Q Consensus       690 ~~~~~~~~~~l--g~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~  765 (982)
                      ..+.|++.+.+  |+|+||.||++.. .++..+|+|.+.......      .|+.....+ +||||+++++++...+..+
T Consensus        12 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~------~e~~~~~~~~~h~~iv~~~~~~~~~~~~~   85 (267)
T PHA03390         12 FLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA------IEPMVHQLMKDNPNFIKLYYSVTTLKGHV   85 (267)
T ss_pred             HHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch------hhHHHHHHhhcCCCEEEEEEEEecCCeeE
Confidence            34556666655  9999999999964 568889999874432111      122222222 7999999999999999999


Q ss_pred             EEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCC-CEEEeccccchhc
Q 002010          766 LLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDF-EAHVADFGLAKFL  844 (982)
Q Consensus       766 lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~-~~kl~DfG~a~~~  844 (982)
                      +||||+++++|.+++..  ...+++.++..++.|+++|++|||+.+   ++||||||+||+++.++ .++++|||.+...
T Consensus        86 iv~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~  160 (267)
T PHA03390         86 LIMDYIKDGDLFDLLKK--EGKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKII  160 (267)
T ss_pred             EEEEcCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccceec
Confidence            99999999999999973  348999999999999999999999988   99999999999999998 9999999998765


Q ss_pred             cccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCc-hHHHHHHHhccCCCCCCccc
Q 002010          845 QDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGV-DIVRWVRKTTSEVSQPSDAA  923 (982)
Q Consensus       845 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  923 (982)
                      ...      ....++..|+|||++.+..++.++||||+|+++|||++|+.||....+.. ....+.......        
T Consensus       161 ~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--------  226 (267)
T PHA03390        161 GTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKK--------  226 (267)
T ss_pred             CCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhccc--------
Confidence            422      23467889999999998899999999999999999999999997543322 112222111110        


Q ss_pred             ccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCC-HHHHHH
Q 002010          924 SVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPT-MREVVH  967 (982)
Q Consensus       924 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt-~~ell~  967 (982)
                                ...+...+..+.+++.+||+.||.+||+ ++|+++
T Consensus       227 ----------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        227 ----------LPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             ----------CCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence                      0111234457899999999999999996 588874

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=8e-33  Score=301.90  Aligned_cols=249  Identities=26%  Similarity=0.329  Sum_probs=207.5

Q ss_pred             HhhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCCC-chhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEE
Q 002010          691 LESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGG-NDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLY  768 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  768 (982)
                      +..|.+.+.||+|.|+.|..|.. .++..||||.+.+..-.. ..+.+.+|+++|..++|||||+++.+...+...|+||
T Consensus        55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~  134 (596)
T KOG0586|consen   55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM  134 (596)
T ss_pred             ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence            45688889999999999999954 569999999886654333 3356889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccC
Q 002010          769 EYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAG  848 (982)
Q Consensus       769 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  848 (982)
                      ||+.+|.+++|+.  +.++..+.++..++.|+.+|++|+|+++   |||||||++|++++.+.++||+|||++.++..  
T Consensus       135 eya~~ge~~~yl~--~~gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~--  207 (596)
T KOG0586|consen  135 EYASGGELFDYLV--KHGRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFDY--  207 (596)
T ss_pred             EeccCchhHHHHH--hcccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeecc--
Confidence            9999999999997  5567777999999999999999999998   99999999999999999999999999998873  


Q ss_pred             CcccccccccccccccccccccCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccce
Q 002010          849 ASECMSSVAGSYGYIAPEYAYTLKV-DEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLA  927 (982)
Q Consensus       849 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  927 (982)
                       .......+|++.|.|||++.+.+| ++++|+||+|+++|-|+.|..||++..-.....+.+....+             
T Consensus       208 -~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~r-------------  273 (596)
T KOG0586|consen  208 -GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYR-------------  273 (596)
T ss_pred             -cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeec-------------
Confidence             344567899999999999998886 58999999999999999999999863222111111111111             


Q ss_pred             eecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002010          928 VVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHM  968 (982)
Q Consensus       928 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~  968 (982)
                              .+-....++.+++++++..+|.+|++.+++.+.
T Consensus       274 --------Ip~~ms~dce~lLrk~lvl~Pskr~~~dqim~~  306 (596)
T KOG0586|consen  274 --------IPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD  306 (596)
T ss_pred             --------ccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence                    111222357789999999999999999999873

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=4.1e-32  Score=301.21  Aligned_cols=271  Identities=21%  Similarity=0.300  Sum_probs=197.0

Q ss_pred             hcccccccccccceEEEEEEeC---CCcEEEEEEeccCC--CCCchhhHHHHHHHHhcCCCCcccceEeEEEcC--CccE
Q 002010          693 SLKDENIIGKGGAGIVYRGSMP---DGIDVAIKRLVGRG--TGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNR--DTNL  765 (982)
Q Consensus       693 ~~~~~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~  765 (982)
                      +|+..+.||+|+||.||+|...   +++.||+|.+....  .......+.+|+.++++++||||+++++++.+.  ...+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            3677788999999999999653   47899999986532  123345678899999999999999999999888  7899


Q ss_pred             EEEeccCCCCHHHHhhcCC---CCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcC----CCCEEEecc
Q 002010          766 LLYEYMPNGSLGEMLHGAK---GGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDS----DFEAHVADF  838 (982)
Q Consensus       766 lv~e~~~~~sL~~~l~~~~---~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~----~~~~kl~Df  838 (982)
                      +||||+++ ++.+++....   ...+++..+..++.|++.|++|||+.+   |+||||||+||+++.    ++.+|++||
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            99999965 6777664322   236889999999999999999999988   999999999999999    899999999


Q ss_pred             ccchhccccCC-cccccccccccccccccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCc---------hHHH
Q 002010          839 GLAKFLQDAGA-SECMSSVAGSYGYIAPEYAYTL-KVDEKSDVYSFGVVLLELIAGKKPVGEFGDGV---------DIVR  907 (982)
Q Consensus       839 G~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~---------~~~~  907 (982)
                      |++........ ........++..|+|||++.+. .++.++||||+|+++|+|++|++||.......         ....
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
T cd07842         157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER  236 (316)
T ss_pred             ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence            99987643322 1122345678899999987764 57899999999999999999999997643322         1111


Q ss_pred             HHHHhccCCCC--------CCcccccceeecCCCC--C----CC--hHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          908 WVRKTTSEVSQ--------PSDAASVLAVVDPRLS--G----YP--LTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       908 ~~~~~~~~~~~--------~~~~~~~~~~~~~~~~--~----~~--~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                      ++.........        +...............  .    .+  .....++.+++.+|++.||++|||+.|+++
T Consensus       237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~  312 (316)
T cd07842         237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE  312 (316)
T ss_pred             HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            11111100000        0000000000000000  0    00  133456889999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=1.9e-32  Score=305.94  Aligned_cols=270  Identities=20%  Similarity=0.278  Sum_probs=200.4

Q ss_pred             hhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCC-CCchhhHHHHHHHHhcCCCCcccceEeEEEc----CCccE
Q 002010          692 ESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGT-GGNDHGFLAEIQTLGRIRHRNIVRLLGYVSN----RDTNL  765 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~  765 (982)
                      ++|+..+.||+|++|.||+|.. .+++.||+|++..... ......+.+|+.++++++||||+++++++..    ....+
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   84 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY   84 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence            6788889999999999999965 4699999999854432 2345567789999999999999999998753    34578


Q ss_pred             EEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhcc
Q 002010          766 LLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQ  845 (982)
Q Consensus       766 lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~  845 (982)
                      +||||+. ++|.+++.  ....+++..+..++.||+.|++|||+.+   |+||||||+||++++++.+||+|||++....
T Consensus        85 lv~e~~~-~~l~~~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~  158 (334)
T cd07855          85 VVMDLME-SDLHHIIH--SDQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLS  158 (334)
T ss_pred             EEEehhh-hhHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccceeec
Confidence            9999995 68999886  3456999999999999999999999988   9999999999999999999999999997654


Q ss_pred             ccCC--ccccccccccccccccccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCC--
Q 002010          846 DAGA--SECMSSVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPS--  920 (982)
Q Consensus       846 ~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--  920 (982)
                      ....  ........++..|+|||.+.+ ..++.++||||+|+++|||++|+.||...................+....  
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~  238 (334)
T cd07855         159 SSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNR  238 (334)
T ss_pred             ccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhh
Confidence            3221  111234578889999998765 45889999999999999999999999764332222222211111100000  


Q ss_pred             -cccccceeec--CCCCCC-----ChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          921 -DAASVLAVVD--PRLSGY-----PLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       921 -~~~~~~~~~~--~~~~~~-----~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                       ........++  +.....     ....+..+.+++.+||+.||++|||+++++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  293 (334)
T cd07855         239 IGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ  293 (334)
T ss_pred             hchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence             0000000000  000111     1234567999999999999999999999887

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=3.4e-33  Score=278.03  Aligned_cols=272  Identities=21%  Similarity=0.298  Sum_probs=199.9

Q ss_pred             HhhcccccccccccceEEEEEE-eC--C--CcEEEEEEeccCCCC-CchhhHHHHHHHHhcCCCCcccceEeEEEc-CCc
Q 002010          691 LESLKDENIIGKGGAGIVYRGS-MP--D--GIDVAIKRLVGRGTG-GNDHGFLAEIQTLGRIRHRNIVRLLGYVSN-RDT  763 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~-~~--~--~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~  763 (982)
                      ...|+..+.||+|.||.||+|. .+  +  ...+|+|+++..... .......+|+..++.++||||+.+..++.. +..
T Consensus        23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~  102 (438)
T KOG0666|consen   23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK  102 (438)
T ss_pred             HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence            4578889999999999999993 22  2  337999998554332 334567899999999999999999998876 788


Q ss_pred             cEEEEeccCCCCHHHHhhcC---CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCC----CCEEEe
Q 002010          764 NLLLYEYMPNGSLGEMLHGA---KGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSD----FEAHVA  836 (982)
Q Consensus       764 ~~lv~e~~~~~sL~~~l~~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~----~~~kl~  836 (982)
                      .++++||.+. +|.+.++-.   +...++...+..++.||+.|+.|||++-   |+|||+||.||+|..+    |.|||+
T Consensus       103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIa  178 (438)
T KOG0666|consen  103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIA  178 (438)
T ss_pred             EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEee
Confidence            9999999976 888888643   2356888999999999999999999887   9999999999999877    999999


Q ss_pred             ccccchhccccCC-cccccccccccccccccccccCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCCC--------chHH
Q 002010          837 DFGLAKFLQDAGA-SECMSSVAGSYGYIAPEYAYTLK-VDEKSDVYSFGVVLLELIAGKKPVGEFGDG--------VDIV  906 (982)
Q Consensus       837 DfG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~elltg~~p~~~~~~~--------~~~~  906 (982)
                      |||+++.+.+.-. .......+-|..|+|||.+.+.. ||.+.||||.|||+.||+|-++-|......        .+..
T Consensus       179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl  258 (438)
T KOG0666|consen  179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQL  258 (438)
T ss_pred             cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHH
Confidence            9999998875422 22334466789999999988764 999999999999999999999888653221        1122


Q ss_pred             HHHHHhccCCCCCCcccccceeec-------CCCC---C--CC------hHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          907 RWVRKTTSEVSQPSDAASVLAVVD-------PRLS---G--YP------LTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       907 ~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~---~--~~------~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                      ..+.+....+....+. .+....+       -+..   .  +.      ...+...++++.++++.||-+|.|+++.++
T Consensus       259 ~rIf~vLG~Pt~~~Wp-~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAle  336 (438)
T KOG0666|consen  259 DRIFEVLGTPTDKDWP-DLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALE  336 (438)
T ss_pred             HHHHHHcCCCccccch-hhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhc
Confidence            2222222222211110 0000000       0000   0  00      011223778999999999999999999987

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.6e-32  Score=289.86  Aligned_cols=248  Identities=29%  Similarity=0.454  Sum_probs=202.3

Q ss_pred             hcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCC-CchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEec
Q 002010          693 SLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTG-GNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEY  770 (982)
Q Consensus       693 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  770 (982)
                      +|+..+.||+|++|.||+|.. .+++.|++|.+...... .....+.+|++++++++|||++++++++.++...+++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            367788999999999999965 46789999998554321 3445788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCc
Q 002010          771 MPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS  850 (982)
Q Consensus       771 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  850 (982)
                      +++++|.+++..  ...+++..+..++.|++.|++|||+.+   |+||||+|+||+++.++.++|+|||.+........ 
T Consensus        81 ~~~~~L~~~~~~--~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-  154 (254)
T cd06627          81 AENGSLRQIIKK--FGPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK-  154 (254)
T ss_pred             CCCCcHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCcc-
Confidence            999999999973  367899999999999999999999888   99999999999999999999999999987654322 


Q ss_pred             ccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceeec
Q 002010          851 ECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVD  930 (982)
Q Consensus       851 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  930 (982)
                       ......++..|+|||...+..++.++||||+|+++|+|++|+.||...........   ....                
T Consensus       155 -~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~---~~~~----------------  214 (254)
T cd06627         155 -DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFR---IVQD----------------  214 (254)
T ss_pred             -cccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHH---Hhcc----------------
Confidence             12345678899999998888889999999999999999999999976432111111   1111                


Q ss_pred             CCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          931 PRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       931 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                       .....+...+..+.+++.+||+.+|++|||+.|++.
T Consensus       215 -~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         215 -DHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             -CCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence             001122233457889999999999999999999874

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=3.4e-32  Score=292.01  Aligned_cols=248  Identities=25%  Similarity=0.334  Sum_probs=202.8

Q ss_pred             hcccccccccccceEEEEEEe-CCCcEEEEEEeccCC-CCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEec
Q 002010          693 SLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRG-TGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEY  770 (982)
Q Consensus       693 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  770 (982)
                      +|+..+.||+|+||.||++.. .+++.+|+|.+.... .......+.+|+.++++++||||+++++++.+....++||||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            367788999999999999954 568899999985433 233455678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccC
Q 002010          771 MPNGSLGEMLHGA--KGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAG  848 (982)
Q Consensus       771 ~~~~sL~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  848 (982)
                      +++++|.+++...  ....+++..+..++.|++.|++|||+.+   ++||||+|+||++++++.+|++|||++...... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-  156 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN-  156 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence            9999999998642  2356899999999999999999999988   999999999999999999999999999876543 


Q ss_pred             CcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCccccccee
Q 002010          849 ASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAV  928 (982)
Q Consensus       849 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  928 (982)
                         ......+++.|+|||...+..++.++|+||+|+++|||++|+.||...... .....+..                 
T Consensus       157 ---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~-~~~~~~~~-----------------  215 (256)
T cd08530         157 ---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ-DLRYKVQR-----------------  215 (256)
T ss_pred             ---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHhc-----------------
Confidence               223355788999999999988999999999999999999999999764322 22121111                 


Q ss_pred             ecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          929 VDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       929 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                        ...+..+...+..+.+++.+|++.+|++|||+.|+++
T Consensus       216 --~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  252 (256)
T cd08530         216 --GKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA  252 (256)
T ss_pred             --CCCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence              1111222344567899999999999999999999975

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=1.2e-31  Score=291.09  Aligned_cols=242  Identities=25%  Similarity=0.266  Sum_probs=187.7

Q ss_pred             ccccccceEEEEEEe-CCCcEEEEEEeccCCCCCc--hhhHHHHHH---HHhcCCCCcccceEeEEEcCCccEEEEeccC
Q 002010          699 IIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGN--DHGFLAEIQ---TLGRIRHRNIVRLLGYVSNRDTNLLLYEYMP  772 (982)
Q Consensus       699 ~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~--~~~~~~E~~---~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  772 (982)
                      .||+|+||.||+|.. .+++.||+|.+........  ...+..|..   .++...||+|+++++++...+..++||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            489999999999965 4588999998855432211  222334433   3444579999999999999999999999999


Q ss_pred             CCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCccc
Q 002010          773 NGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASEC  852 (982)
Q Consensus       773 ~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~  852 (982)
                      +++|.+++.  +...+++..+..++.|+++|++|||+.+   |+||||||+||+++.++.+||+|||++..+....    
T Consensus        81 g~~L~~~l~--~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~----  151 (278)
T cd05606          81 GGDLHYHLS--QHGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----  151 (278)
T ss_pred             CCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccC----
Confidence            999999886  3457999999999999999999999988   9999999999999999999999999987654221    


Q ss_pred             ccccccccccccccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceeecC
Q 002010          853 MSSVAGSYGYIAPEYAYTL-KVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDP  931 (982)
Q Consensus       853 ~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  931 (982)
                      .....|+..|+|||++.+. .++.++||||+|+++|||++|+.||......... ........              .+ 
T Consensus       152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~-~~~~~~~~--------------~~-  215 (278)
T cd05606         152 PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMTLT--------------MA-  215 (278)
T ss_pred             CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchH-HHHHHhhc--------------cC-
Confidence            2234689999999998754 6899999999999999999999999764322111 11110000              00 


Q ss_pred             CCCCCChHhHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 002010          932 RLSGYPLTGVIHLFKVAMMCVEDESSARP-----TMREVVH  967 (982)
Q Consensus       932 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~ell~  967 (982)
                        ...+...+..+.+++.+|+..+|.+||     ++.|+++
T Consensus       216 --~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  254 (278)
T cd05606         216 --VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  254 (278)
T ss_pred             --CCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence              112223345789999999999999999     9999986

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=2.5e-32  Score=294.53  Aligned_cols=248  Identities=24%  Similarity=0.312  Sum_probs=196.4

Q ss_pred             cccccceEEEEEEeC-CCcEEEEEEeccCCC--CCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEeccCCCCH
Q 002010          700 IGKGGAGIVYRGSMP-DGIDVAIKRLVGRGT--GGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSL  776 (982)
Q Consensus       700 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL  776 (982)
                      ||+|+||.||+|... +|+.||+|.+.....  ......+.+|+.++++++||||+++++.+..+...++||||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            689999999999765 489999998854322  13455788899999999999999999999999999999999999999


Q ss_pred             HHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCC------c
Q 002010          777 GEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGA------S  850 (982)
Q Consensus       777 ~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~------~  850 (982)
                      .+++...  ..+++..+..++.|++.|++|||+.+   ++||||+|+||++++++.++|+|||++........      .
T Consensus        81 ~~~l~~~--~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~  155 (265)
T cd05579          81 ASLLENV--GSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE  155 (265)
T ss_pred             HHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccc
Confidence            9999743  47899999999999999999999988   99999999999999999999999999876432211      1


Q ss_pred             ccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceeec
Q 002010          851 ECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVD  930 (982)
Q Consensus       851 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  930 (982)
                      .......++..|+|||......++.++||||+|+++|++++|..||........ .........  ..+.          
T Consensus       156 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~-~~~~~~~~~--~~~~----------  222 (265)
T cd05579         156 KEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEI-FQNILNGKI--EWPE----------  222 (265)
T ss_pred             ccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHhcCCc--CCCc----------
Confidence            122345678899999999888899999999999999999999999976433221 111111000  0000          


Q ss_pred             CCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 002010          931 PRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLAN  971 (982)
Q Consensus       931 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~  971 (982)
                            ....+..+.+++.+||+.+|++|||+.++.+.|+.
T Consensus       223 ------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~  257 (265)
T cd05579         223 ------DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNH  257 (265)
T ss_pred             ------cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcC
Confidence                  00124578899999999999999999666665543

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-32  Score=296.05  Aligned_cols=265  Identities=21%  Similarity=0.277  Sum_probs=202.5

Q ss_pred             cccccccccccceEEEEEEe-CCCcEEEEEEeccCCCC-CchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEecc
Q 002010          694 LKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTG-GNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYM  771 (982)
Q Consensus       694 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  771 (982)
                      |+..+.||+|++|.||+|.. .+++.+++|++...... .....+.+|+.++++++||||+++++++..+...++||||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            45667899999999999965 46889999988554322 34567888999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCcc
Q 002010          772 PNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASE  851 (982)
Q Consensus       772 ~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~  851 (982)
                      ++ ++.+++... ...+++..+..++.|++.|++|||+.+   |+|+||+|+||+++.++.+||+|||.+.......  .
T Consensus        81 ~~-~l~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--~  153 (283)
T cd05118          81 DT-DLYKLIKDR-QRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--R  153 (283)
T ss_pred             CC-CHHHHHHhh-cccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--c
Confidence            65 888888643 367899999999999999999999988   9999999999999999999999999997765432  1


Q ss_pred             cccccccccccccccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccce---
Q 002010          852 CMSSVAGSYGYIAPEYAYTL-KVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLA---  927 (982)
Q Consensus       852 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---  927 (982)
                      ......++..|+|||.+.+. .++.++|+||+|+++|+|++|+.||......+..............  ........   
T Consensus       154 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~  231 (283)
T cd05118         154 PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDP--EVWPKFTSLAR  231 (283)
T ss_pred             cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCch--Hhcccchhhhh
Confidence            22345678899999998876 7899999999999999999999999765433332222222111100  00000000   


Q ss_pred             -----eecC---CCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          928 -----VVDP---RLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       928 -----~~~~---~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                           ..+.   .......+.+..+.+++.+||+.||.+||+++|++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         232 NYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             hhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence                 0000   001122345678999999999999999999999975

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=5.4e-32  Score=295.86  Aligned_cols=256  Identities=25%  Similarity=0.260  Sum_probs=200.8

Q ss_pred             cccccccccccceEEEEEEe----CCCcEEEEEEeccCC---CCCchhhHHHHHHHHhcC-CCCcccceEeEEEcCCccE
Q 002010          694 LKDENIIGKGGAGIVYRGSM----PDGIDVAIKRLVGRG---TGGNDHGFLAEIQTLGRI-RHRNIVRLLGYVSNRDTNL  765 (982)
Q Consensus       694 ~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~  765 (982)
                      |+..+.||+|++|.||+|..    .++..||+|++....   .......+.+|+.++.++ +||+|+++++.+..+...+
T Consensus         2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~   81 (288)
T cd05583           2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLH   81 (288)
T ss_pred             ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEE
Confidence            66778999999999999864    357889999885432   122345678899999999 5999999999999999999


Q ss_pred             EEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhcc
Q 002010          766 LLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQ  845 (982)
Q Consensus       766 lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~  845 (982)
                      +||||+++++|.+++.  +...+++..+..++.|+++|++|||+.+   ++||||+|+||+++.++.++++|||+++...
T Consensus        82 lv~e~~~~~~L~~~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  156 (288)
T cd05583          82 LILDYVNGGELFTHLY--QREHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEFL  156 (288)
T ss_pred             EEEecCCCCcHHHHHh--hcCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccccc
Confidence            9999999999999986  3457889999999999999999999888   9999999999999999999999999987654


Q ss_pred             ccCCcccccccccccccccccccccCC--CCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCccc
Q 002010          846 DAGASECMSSVAGSYGYIAPEYAYTLK--VDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAA  923 (982)
Q Consensus       846 ~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  923 (982)
                      ... ........++..|+|||...+..  .+.++||||+|+++|||++|..||...........+.......        
T Consensus       157 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~--------  227 (288)
T cd05583         157 AEE-EERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKS--------  227 (288)
T ss_pred             ccc-ccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHcc--------
Confidence            332 11222346788999999987655  7889999999999999999999996432221111221111110        


Q ss_pred             ccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 002010          924 SVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANP  972 (982)
Q Consensus       924 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~  972 (982)
                               ....+...+..+.+++.+||+.||++|||+.++.+.|+..
T Consensus       228 ---------~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~  267 (288)
T cd05583         228 ---------KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP  267 (288)
T ss_pred             ---------CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence                     0112223345688999999999999999999888877664

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-33  Score=321.14  Aligned_cols=267  Identities=22%  Similarity=0.234  Sum_probs=211.9

Q ss_pred             HhhcccccccccccceEEEEEEe-CCCcEEEEEEeccCC--CCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEE
Q 002010          691 LESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRG--TGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLL  767 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  767 (982)
                      .++|++.++||+|+||.|..++. .+++.||+|++.+..  ......-|..|..+|..-+.+.|+.++.+|+++.+.|+|
T Consensus        74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlV  153 (1317)
T KOG0612|consen   74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLV  153 (1317)
T ss_pred             HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEE
Confidence            35689999999999999999975 458899999985532  234456788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhcccc
Q 002010          768 YEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDA  847 (982)
Q Consensus       768 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  847 (982)
                      ||||+||+|-.++.+.  .+++++-+..++..|+-||..+|+.|   +|||||||+|||+|..|++||+|||.+-.+...
T Consensus       154 MdY~pGGDlltLlSk~--~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFGsClkm~~d  228 (1317)
T KOG0612|consen  154 MDYMPGGDLLTLLSKF--DRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFGSCLKMDAD  228 (1317)
T ss_pred             EecccCchHHHHHhhc--CCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccchhHHhcCCC
Confidence            9999999999999744  48999999999999999999999999   999999999999999999999999999888744


Q ss_pred             CCcccccccccccccccccccc----c-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcc
Q 002010          848 GASECMSSVAGSYGYIAPEYAY----T-LKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDA  922 (982)
Q Consensus       848 ~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  922 (982)
                      + .......+|||.|.+||++.    + +.|+..+|+||+||++|||+.|..||+...--+.+..++..... ...|   
T Consensus       229 G-~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~-l~FP---  303 (1317)
T KOG0612|consen  229 G-TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKES-LSFP---  303 (1317)
T ss_pred             C-cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhh-cCCC---
Confidence            3 44556789999999999875    3 56999999999999999999999999863322222222222111 1111   


Q ss_pred             cccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCC---HHHHHH--Hh-----cCCCCCCCCCCC
Q 002010          923 ASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPT---MREVVH--ML-----ANPPQSAPSLIT  981 (982)
Q Consensus       923 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt---~~ell~--~L-----~~~~~~~~~~~~  981 (982)
                                   ...+.+....+||.+.+. +|+.|..   ++++-.  .+     ..++...|++||
T Consensus       304 -------------~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~~iR~~~pP~vP  358 (1317)
T KOG0612|consen  304 -------------DETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWDNIRESVPPVVP  358 (1317)
T ss_pred             -------------cccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCChhhhhhcCCCCCC
Confidence                         012245567788887765 7888887   888765  22     445666666654

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.98  E-value=1e-31  Score=293.97  Aligned_cols=251  Identities=24%  Similarity=0.266  Sum_probs=196.9

Q ss_pred             cccccccccccceEEEEEEe----CCCcEEEEEEeccCCC---CCchhhHHHHHHHHhcC-CCCcccceEeEEEcCCccE
Q 002010          694 LKDENIIGKGGAGIVYRGSM----PDGIDVAIKRLVGRGT---GGNDHGFLAEIQTLGRI-RHRNIVRLLGYVSNRDTNL  765 (982)
Q Consensus       694 ~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~  765 (982)
                      |+..+.||+|+||.||+|..    .+|..||+|++.....   ....+.+.+|+.+++++ +|++|+++++++..+...+
T Consensus         2 y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~   81 (290)
T cd05613           2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLH   81 (290)
T ss_pred             ceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEE
Confidence            67778999999999999965    3688999999854321   22345678899999999 5899999999999988999


Q ss_pred             EEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhcc
Q 002010          766 LLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQ  845 (982)
Q Consensus       766 lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~  845 (982)
                      +||||+++++|.+++..  ...+++..+..++.|++.|++|||+.+   ++||||+|+||++++++.+||+|||++....
T Consensus        82 lv~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~  156 (290)
T cd05613          82 LILDYINGGELFTHLSQ--RERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFH  156 (290)
T ss_pred             EEEecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCccceecc
Confidence            99999999999999973  456889999999999999999999988   9999999999999999999999999997654


Q ss_pred             ccCCcccccccccccccccccccccC--CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCccc
Q 002010          846 DAGASECMSSVAGSYGYIAPEYAYTL--KVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAA  923 (982)
Q Consensus       846 ~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  923 (982)
                      .... .......|+..|+|||.+...  .++.++||||+|+++|+|++|+.||...........+.......        
T Consensus       157 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~--------  227 (290)
T cd05613         157 EDEV-ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKS--------  227 (290)
T ss_pred             cccc-cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhcc--------
Confidence            3221 122345688899999998753  46789999999999999999999997533322222222211110        


Q ss_pred             ccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 002010          924 SVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARP-----TMREVVH  967 (982)
Q Consensus       924 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~ell~  967 (982)
                               ....+...+..+.+++.+||+.||++||     ++++++.
T Consensus       228 ---------~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~  267 (290)
T cd05613         228 ---------EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK  267 (290)
T ss_pred             ---------CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence                     0112223445788999999999999997     6677765

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.98  E-value=1.3e-31  Score=299.36  Aligned_cols=270  Identities=22%  Similarity=0.217  Sum_probs=199.9

Q ss_pred             hhcc-cccccccccceEEEEEEe-CCCcEEEEEEeccCCCCC-------------chhhHHHHHHHHhcCCCCcccceEe
Q 002010          692 ESLK-DENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGG-------------NDHGFLAEIQTLGRIRHRNIVRLLG  756 (982)
Q Consensus       692 ~~~~-~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-------------~~~~~~~E~~~l~~l~h~niv~~~~  756 (982)
                      ++|. ..+.||+|+||+||+|.. .+++.||+|.+.......             ....+.+|+.++++++||||+++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            4454 456799999999999965 468999999885432221             1124678999999999999999999


Q ss_pred             EEEcCCccEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEe
Q 002010          757 YVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVA  836 (982)
Q Consensus       757 ~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~  836 (982)
                      ++..++..++||||++ ++|.+++.  ....+++..+..++.|++.|++|||+.+   |+||||+|+||+++.++.+|++
T Consensus        88 ~~~~~~~~~lv~e~~~-~~l~~~l~--~~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl~  161 (335)
T PTZ00024         88 VYVEGDFINLVMDIMA-SDLKKVVD--RKIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIA  161 (335)
T ss_pred             EEecCCcEEEEEeccc-cCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEEC
Confidence            9999999999999996 69999986  3456899999999999999999999988   9999999999999999999999


Q ss_pred             ccccchhccccC------------CcccccccccccccccccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCc
Q 002010          837 DFGLAKFLQDAG------------ASECMSSVAGSYGYIAPEYAYTL-KVDEKSDVYSFGVVLLELIAGKKPVGEFGDGV  903 (982)
Q Consensus       837 DfG~a~~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~  903 (982)
                      |||.+.......            .........++..|+|||.+.+. .++.++||||+||++|||++|++||....+..
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~  241 (335)
T PTZ00024        162 DFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEID  241 (335)
T ss_pred             CccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            999997654111            01112234567889999998764 46899999999999999999999998655433


Q ss_pred             hHHHHHHHhccCCCCCCcccc-------cceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          904 DIVRWVRKTTSEVSQPSDAAS-------VLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       904 ~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                      .....................       ......+............+.+++.+||+.||++|||++|++.
T Consensus       242 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  312 (335)
T PTZ00024        242 QLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK  312 (335)
T ss_pred             HHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence            333332222211110000000       0000011111122233557889999999999999999999987

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=99.98  E-value=8.1e-32  Score=289.82  Aligned_cols=245  Identities=22%  Similarity=0.255  Sum_probs=188.6

Q ss_pred             cccccccceEEEEEEe-CCCcEEEEEEeccCCC--CCchhhHHHHHHHH-hcCCCCcccceEeEEEcCCccEEEEeccCC
Q 002010          698 NIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGT--GGNDHGFLAEIQTL-GRIRHRNIVRLLGYVSNRDTNLLLYEYMPN  773 (982)
Q Consensus       698 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l-~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  773 (982)
                      +.||+|+||.||+|.. .+++.||+|.+.....  ......+..|..++ ...+|||++++++++..++..++||||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            4689999999999965 4688999998854321  11222344554443 445899999999999999999999999999


Q ss_pred             CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCcccc
Q 002010          774 GSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECM  853 (982)
Q Consensus       774 ~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~  853 (982)
                      ++|.+++.  +...+++..+..++.|++.|+.|||+.+   ++||||+|+||++++++.+||+|||.+.....      .
T Consensus        82 ~~L~~~l~--~~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~  150 (260)
T cd05611          82 GDCASLIK--TLGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------N  150 (260)
T ss_pred             CCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc------c
Confidence            99999996  3357899999999999999999999988   99999999999999999999999999875432      2


Q ss_pred             cccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceeecCCC
Q 002010          854 SSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDPRL  933 (982)
Q Consensus       854 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  933 (982)
                      ....++..|+|||...+..++.++||||+|+++|||++|..||..................   .+              
T Consensus       151 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~---~~--------------  213 (260)
T cd05611         151 KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRIN---WP--------------  213 (260)
T ss_pred             ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccC---CC--------------
Confidence            2345788999999998888999999999999999999999999754332211111110000   00              


Q ss_pred             CCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 002010          934 SGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLA  970 (982)
Q Consensus       934 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~  970 (982)
                      .......+..+.+++.+||+.||++||++.++.+.++
T Consensus       214 ~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~  250 (260)
T cd05611         214 EEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKS  250 (260)
T ss_pred             CcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence            0111233457899999999999999998765555443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=99.98  E-value=4e-32  Score=303.09  Aligned_cols=276  Identities=22%  Similarity=0.261  Sum_probs=207.4

Q ss_pred             hcccccccccccceEEEEEEeC-CCcEEEEEEeccCCC-CCchhhHHHHHHHHhcCCCCcccceEeEEEcCC-----ccE
Q 002010          693 SLKDENIIGKGGAGIVYRGSMP-DGIDVAIKRLVGRGT-GGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRD-----TNL  765 (982)
Q Consensus       693 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~~  765 (982)
                      +|+..+.||+|++|.||+|... +++.||+|++..... ....+.+.+|+.++++++||||+++++++....     ..+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            4778889999999999999764 589999998855432 344567889999999999999999999987765     789


Q ss_pred             EEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhcc
Q 002010          766 LLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQ  845 (982)
Q Consensus       766 lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~  845 (982)
                      +||||++ ++|.+++.  +...+++..+..++.|++.|++|||+.+   |+||||||+||+++.++.++|+|||.+....
T Consensus        81 lv~e~~~-~~l~~~l~--~~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~~  154 (330)
T cd07834          81 IVTELME-TDLHKVIK--SPQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVD  154 (330)
T ss_pred             EEecchh-hhHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEeec
Confidence            9999996 58999886  3348999999999999999999999988   9999999999999999999999999998765


Q ss_pred             ccCC-cccccccccccccccccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCC---
Q 002010          846 DAGA-SECMSSVAGSYGYIAPEYAYTL-KVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPS---  920 (982)
Q Consensus       846 ~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---  920 (982)
                      .... ........++..|+|||++.+. .++.++|+||+|+++|+|++|.+||........................   
T Consensus       155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  234 (330)
T cd07834         155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFI  234 (330)
T ss_pred             ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhc
Confidence            4321 0123345678899999999887 7899999999999999999999999875443322222222111110000   


Q ss_pred             cccccceeec---CC----CCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH--HhcCCCC
Q 002010          921 DAASVLAVVD---PR----LSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH--MLANPPQ  974 (982)
Q Consensus       921 ~~~~~~~~~~---~~----~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~--~L~~~~~  974 (982)
                      ........+.   ..    ........+..+.+++.+||+.||++|||+++++.  .+++..+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~  297 (330)
T cd07834         235 TSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD  297 (330)
T ss_pred             cccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence            0000000000   00    00112234567899999999999999999999998  3544444

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.98  E-value=3.4e-32  Score=296.20  Aligned_cols=249  Identities=26%  Similarity=0.362  Sum_probs=202.1

Q ss_pred             hcccccccccccceEEEEEEe-CCCcEEEEEEeccCC--CCCchhhHHHHHHHHhcCC-CCcccceEeEEEcCCccEEEE
Q 002010          693 SLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRG--TGGNDHGFLAEIQTLGRIR-HRNIVRLLGYVSNRDTNLLLY  768 (982)
Q Consensus       693 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~  768 (982)
                      +|+..+.||+|+||.||+|.. .++..||+|++....  .......+.+|+.++++++ ||||+++++++..++..++||
T Consensus         2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~   81 (280)
T cd05581           2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVL   81 (280)
T ss_pred             CceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEE
Confidence            578888999999999999965 468999999885432  2233456888999999998 999999999999999999999


Q ss_pred             eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccC
Q 002010          769 EYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAG  848 (982)
Q Consensus       769 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  848 (982)
                      ||+++++|.+++..  ...+++..+..++.|++.|++|||+.+   ++|+||+|+||+++.++.++++|||++.......
T Consensus        82 e~~~~~~L~~~l~~--~~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~  156 (280)
T cd05581          82 EYAPNGELLQYIRK--YGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNS  156 (280)
T ss_pred             cCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCCcc
Confidence            99999999999973  457999999999999999999999988   9999999999999999999999999998765332


Q ss_pred             Cc------------------ccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHH
Q 002010          849 AS------------------ECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVR  910 (982)
Q Consensus       849 ~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~  910 (982)
                      ..                  .......++..|+|||+.....++.++||||+|+++|++++|..||............. 
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~-  235 (280)
T cd05581         157 SPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKIL-  235 (280)
T ss_pred             ccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHH-
Confidence            11                  12233457889999999988889999999999999999999999998654322211111 


Q ss_pred             HhccCCCCCCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCH----HHHHH
Q 002010          911 KTTSEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTM----REVVH  967 (982)
Q Consensus       911 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~----~ell~  967 (982)
                      ...                    ...+...+..+.+++.+||+.||++|||+    +++++
T Consensus       236 ~~~--------------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         236 KLE--------------------YSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             hcC--------------------CCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence            100                    01222234578899999999999999999    77764

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.98  E-value=6.5e-32  Score=247.87  Aligned_cols=266  Identities=23%  Similarity=0.325  Sum_probs=204.3

Q ss_pred             hcccccccccccceEEEEEEe-CCCcEEEEEEeccCCC-CCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEec
Q 002010          693 SLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGT-GGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEY  770 (982)
Q Consensus       693 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  770 (982)
                      +|...+.||+|.||+||+|+. .+++.||+|+++-... +.......+|+-+++.++|.|||++++....+....+|+||
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            466677899999999999965 4588899999965543 44566789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCc
Q 002010          771 MPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS  850 (982)
Q Consensus       771 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  850 (982)
                      | +.+|..+... -++.++.+.+..++.|+++|+.+.|+++   +.|||+||.|.+++.+|++|++|||+++.+.-  +.
T Consensus        83 c-dqdlkkyfds-lng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgi--pv  155 (292)
T KOG0662|consen   83 C-DQDLKKYFDS-LNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGI--PV  155 (292)
T ss_pred             h-hHHHHHHHHh-cCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCC--ce
Confidence            9 5588888863 4578999999999999999999999998   99999999999999999999999999997653  23


Q ss_pred             ccccccccccccccccccccCC-CCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHhccCCCCCCccccccee
Q 002010          851 ECMSSVAGSYGYIAPEYAYTLK-VDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAV  928 (982)
Q Consensus       851 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  928 (982)
                      +..+..+-|..|.+|+++.+.+ |+...|+||.|||+.|+.. |++-|.+.+-.+...++.+..+..... . .+.+...
T Consensus       156 rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed-~-wps~t~l  233 (292)
T KOG0662|consen  156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTED-Q-WPSMTKL  233 (292)
T ss_pred             EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccc-c-CCccccC
Confidence            3445566788999999998765 8999999999999999998 666666544444444444443332111 1 1112222


Q ss_pred             ecCC-CCCCChHh---------HHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          929 VDPR-LSGYPLTG---------VIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       929 ~~~~-~~~~~~~~---------~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                      .|-. .+.+|...         ...=.+++++.+.-+|..|.++++.++
T Consensus       234 pdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq  282 (292)
T KOG0662|consen  234 PDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ  282 (292)
T ss_pred             CCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence            2211 11122111         112467888899999999999998875

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.98  E-value=9.5e-32  Score=297.58  Aligned_cols=272  Identities=21%  Similarity=0.263  Sum_probs=197.5

Q ss_pred             HhhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCC-CchhhHHHHHHHHhcCCCCcccceEeEEEcCC------
Q 002010          691 LESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTG-GNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRD------  762 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------  762 (982)
                      .++|+..+.||+|+||.||+|.. .+++.||+|++...... .....+.+|++++++++||||+++++++.+..      
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            46899999999999999999965 46899999988544322 23346778999999999999999999875433      


Q ss_pred             --ccEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEecccc
Q 002010          763 --TNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGL  840 (982)
Q Consensus       763 --~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~  840 (982)
                        ..++||||+++ ++...+.. ....+++..+..++.|+++|++|||+.+   |+||||||+||++++++.+|++|||+
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~  161 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLEN-PSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGL  161 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCcc
Confidence              35899999954 67777753 3457999999999999999999999988   99999999999999999999999999


Q ss_pred             chhccccCCc---------cccccccccccccccccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHH
Q 002010          841 AKFLQDAGAS---------ECMSSVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVR  910 (982)
Q Consensus       841 a~~~~~~~~~---------~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~  910 (982)
                      +.........         .......+++.|+|||.+.+ ..++.++||||+|+++|||++|++||..............
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~  241 (311)
T cd07866         162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFK  241 (311)
T ss_pred             chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            9865432211         11123456788999998765 4588999999999999999999999976544333333222


Q ss_pred             HhccCCCCCCcc-cccceee----cCCCC----CCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          911 KTTSEVSQPSDA-ASVLAVV----DPRLS----GYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       911 ~~~~~~~~~~~~-~~~~~~~----~~~~~----~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                      ......+..... .......    .+..+    .........+.+++.+|++.||++|||+.|++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         242 LCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             HhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence            221111100000 0000000    00000    000112256889999999999999999999875

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.98  E-value=1.6e-31  Score=294.80  Aligned_cols=253  Identities=25%  Similarity=0.332  Sum_probs=197.7

Q ss_pred             hhcccccccccccceEEEEEEe-CCCcEEEEEEeccCC--CCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEE
Q 002010          692 ESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRG--TGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLY  768 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  768 (982)
                      +.|+..+.||+|+||.||+|.. .++..||+|.+....  ......++.+|+.+++.++|+|++++++++..+...++||
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   94 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence            4466778899999999999975 467889999885322  2223456788999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccC
Q 002010          769 EYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAG  848 (982)
Q Consensus       769 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  848 (982)
                      ||+. +++.+++... ...+++..+..++.|++.|+.|||+.+   ++||||+|+||+++.++.+|++|||++.....  
T Consensus        95 e~~~-~~l~~~~~~~-~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~--  167 (308)
T cd06634          95 EYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP--  167 (308)
T ss_pred             EccC-CCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecC--
Confidence            9996 6888777532 356899999999999999999999888   99999999999999999999999999875432  


Q ss_pred             Ccccccccccccccccccccc---cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCccccc
Q 002010          849 ASECMSSVAGSYGYIAPEYAY---TLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASV  925 (982)
Q Consensus       849 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  925 (982)
                          .....+++.|+|||.+.   ...++.++||||+||++|+|++|..||...........+......           
T Consensus       168 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~-----------  232 (308)
T cd06634         168 ----ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP-----------  232 (308)
T ss_pred             ----cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCC-----------
Confidence                12346788999999874   356788999999999999999999998764322222211111000           


Q ss_pred             ceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCC
Q 002010          926 LAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQ  974 (982)
Q Consensus       926 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~~  974 (982)
                            .  ..+...+..+.+++.+||+.+|++||+++++++.-.-...
T Consensus       233 ------~--~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~  273 (308)
T cd06634         233 ------A--LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE  273 (308)
T ss_pred             ------C--cCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcccccc
Confidence                  0  0112234568899999999999999999999986544433

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.98  E-value=7.5e-32  Score=301.81  Aligned_cols=266  Identities=23%  Similarity=0.322  Sum_probs=198.5

Q ss_pred             HHhhcccccccccccceEEEEEE-eCCCcEEEEEEeccCCC-CCchhhHHHHHHHHhcCCCCcccceEeEEEcCC-----
Q 002010          690 VLESLKDENIIGKGGAGIVYRGS-MPDGIDVAIKRLVGRGT-GGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRD-----  762 (982)
Q Consensus       690 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----  762 (982)
                      +.++|+..+.||+|+||.||+|. ..++..||||++..... ......+.+|+.++++++||||+++++++..+.     
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07880          13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF   92 (343)
T ss_pred             cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence            45679999999999999999995 45789999998854322 223446789999999999999999999887654     


Q ss_pred             -ccEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccc
Q 002010          763 -TNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLA  841 (982)
Q Consensus       763 -~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a  841 (982)
                       .+++||||+ +++|.+++.   ...+++..+..++.|++.|++|||+.+   |+||||||+||+++.++.+|++|||++
T Consensus        93 ~~~~lv~e~~-~~~l~~~~~---~~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg~~  165 (343)
T cd07880          93 HDFYLVMPFM-GTDLGKLMK---HEKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA  165 (343)
T ss_pred             ceEEEEEecC-CCCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccc
Confidence             358999999 779998885   346899999999999999999999988   999999999999999999999999999


Q ss_pred             hhccccCCccccccccccccccccccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCC---
Q 002010          842 KFLQDAGASECMSSVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVS---  917 (982)
Q Consensus       842 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---  917 (982)
                      ......     .....+++.|+|||++.+ ..++.++|+||+|+++|++++|..||.....................   
T Consensus       166 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  240 (343)
T cd07880         166 RQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFV  240 (343)
T ss_pred             cccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence            865421     223467889999998876 45889999999999999999999999764332222222221111000   


Q ss_pred             ---CCCcccccc-e---eecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          918 ---QPSDAASVL-A---VVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       918 ---~~~~~~~~~-~---~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                         ......... .   ...+.+..........+.+++.+|++.||++|||+.++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~  297 (343)
T cd07880         241 QKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA  297 (343)
T ss_pred             HhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence               000000000 0   0000011112234456889999999999999999999984

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.98  E-value=1.4e-31  Score=291.80  Aligned_cols=267  Identities=23%  Similarity=0.304  Sum_probs=200.4

Q ss_pred             cccccccccccceEEEEEEeC-CCcEEEEEEeccCC-CCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEecc
Q 002010          694 LKDENIIGKGGAGIVYRGSMP-DGIDVAIKRLVGRG-TGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYM  771 (982)
Q Consensus       694 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  771 (982)
                      |+..+.||+|++|.||+|... +++.||+|.+.... .......+..|+.++++++|+|++++++++.+.+..++||||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            455678999999999999664 58999999986543 2334466788999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCcc
Q 002010          772 PNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASE  851 (982)
Q Consensus       772 ~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~  851 (982)
                      + ++|.+++.... ..+++..+..++.|++.|++|||+.+   |+||||+|+||++++++.+||+|||.+.......  .
T Consensus        81 ~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~--~  153 (282)
T cd07829          81 D-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPL--R  153 (282)
T ss_pred             C-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCc--c
Confidence            7 59999997432 57999999999999999999999988   9999999999999999999999999998654321  1


Q ss_pred             cccccccccccccccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceeec
Q 002010          852 CMSSVAGSYGYIAPEYAYTL-KVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVD  930 (982)
Q Consensus       852 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  930 (982)
                      ......++..|+|||.+.+. .++.++||||+|+++|||++|++||..........+.................-....+
T Consensus       154 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (282)
T cd07829         154 TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYK  233 (282)
T ss_pred             ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccc
Confidence            22334457789999998766 78999999999999999999999997644333222222221111000000000000001


Q ss_pred             CCCC--------CCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          931 PRLS--------GYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       931 ~~~~--------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                      ...+        ......+..+.+++.+||+.||++||++++++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         234 PTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             ccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence            1111        001122457899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.98  E-value=4e-31  Score=292.20  Aligned_cols=245  Identities=26%  Similarity=0.355  Sum_probs=193.0

Q ss_pred             hcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCC--CchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEe
Q 002010          693 SLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTG--GNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYE  769 (982)
Q Consensus       693 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  769 (982)
                      .|...+.||+|+||.||+|.. .+++.|++|++......  .....+.+|+.++++++|||++++++++.+.+..++|||
T Consensus        22 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  101 (313)
T cd06633          22 IFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVME  101 (313)
T ss_pred             HhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEe
Confidence            356667799999999999965 46889999988543222  223467889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCC
Q 002010          770 YMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGA  849 (982)
Q Consensus       770 ~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  849 (982)
                      |+. +++.+++.. ....+++.++..++.|++.|++|||+.+   |+||||+|+||+++.++.+||+|||.+....    
T Consensus       102 ~~~-~~l~~~l~~-~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~----  172 (313)
T cd06633         102 YCL-GSASDLLEV-HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSS----  172 (313)
T ss_pred             cCC-CCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccC----
Confidence            995 578777753 3356899999999999999999999988   9999999999999999999999999886432    


Q ss_pred             cccccccccccccccccccc---cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccc
Q 002010          850 SECMSSVAGSYGYIAPEYAY---TLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVL  926 (982)
Q Consensus       850 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  926 (982)
                        ......++..|+|||++.   ...++.++||||+|+++|||++|..||..................            
T Consensus       173 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~------------  238 (313)
T cd06633         173 --PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSP------------  238 (313)
T ss_pred             --CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC------------
Confidence              123456888999999874   456888999999999999999999999764332222211111000            


Q ss_pred             eeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          927 AVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       927 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                           ..  .....+..+.+++.+||+.+|.+||+++++++
T Consensus       239 -----~~--~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~  272 (313)
T cd06633         239 -----TL--QSNEWTDSFRGFVDYCLQKIPQERPASAELLR  272 (313)
T ss_pred             -----CC--CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                 00  01112246889999999999999999999986

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.97  E-value=1.4e-31  Score=299.81  Aligned_cols=267  Identities=21%  Similarity=0.302  Sum_probs=197.7

Q ss_pred             HHHhhcccccccccccceEEEEEEe-CCCcEEEEEEeccCC-CCCchhhHHHHHHHHhcCCCCcccceEeEEEcC-----
Q 002010          689 DVLESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRG-TGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNR-----  761 (982)
Q Consensus       689 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----  761 (982)
                      .+.++|+..+.||+|+||.||+|.. .+++.||+|++.... .......+.+|+.++++++||||+++++++...     
T Consensus        14 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~   93 (345)
T cd07877          14 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE   93 (345)
T ss_pred             hccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccc
Confidence            3457899999999999999999964 578999999885432 222345678899999999999999999987543     


Q ss_pred             -CccEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEecccc
Q 002010          762 -DTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGL  840 (982)
Q Consensus       762 -~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~  840 (982)
                       ...+++++++ +++|.+++..   ..+++..+..++.|+++|++|||+.+   |+||||||+||++++++.+||+|||+
T Consensus        94 ~~~~~lv~~~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~dfg~  166 (345)
T cd07877          94 FNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGL  166 (345)
T ss_pred             cccEEEEehhc-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEEEecccc
Confidence             2357788877 8899988752   46899999999999999999999988   99999999999999999999999999


Q ss_pred             chhccccCCccccccccccccccccccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCC
Q 002010          841 AKFLQDAGASECMSSVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQP  919 (982)
Q Consensus       841 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  919 (982)
                      +.....     ......++..|+|||.+.+ ..++.++||||+||++|||++|+.||.......................
T Consensus       167 ~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  241 (345)
T cd07877         167 ARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAEL  241 (345)
T ss_pred             cccccc-----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            875432     1234567889999998766 4688999999999999999999999975433332222222221110000


Q ss_pred             C-----c-ccccc----eeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          920 S-----D-AASVL----AVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       920 ~-----~-~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                      .     . .....    ......+..........+.+++.+|++.||.+||++.++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  299 (345)
T cd07877         242 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  299 (345)
T ss_pred             HhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhc
Confidence            0     0 00000    00000111111123456889999999999999999999886

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.97  E-value=1.3e-31  Score=299.97  Aligned_cols=272  Identities=22%  Similarity=0.270  Sum_probs=198.7

Q ss_pred             HhhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCC-CCchhhHHHHHHHHhcCCCCcccceEeEEEcCC------
Q 002010          691 LESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGT-GGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRD------  762 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------  762 (982)
                      ..+|...+.||+|+||.||+|.. .+++.||+|++..... ......+.+|+.++++++||||+++++++....      
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            35788889999999999999965 4689999998854332 233456789999999999999999999886543      


Q ss_pred             ccEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccch
Q 002010          763 TNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAK  842 (982)
Q Consensus       763 ~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~  842 (982)
                      .+++|+||+. .++.++..    ..++++.+..++.|++.|++|||+.+   |+||||||+||+++.++.+|++|||+++
T Consensus        94 ~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~~  165 (342)
T cd07879          94 DFYLVMPYMQ-TDLQKIMG----HPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLAR  165 (342)
T ss_pred             eEEEEecccc-cCHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCCc
Confidence            3589999995 47776652    36889999999999999999999988   9999999999999999999999999987


Q ss_pred             hccccCCccccccccccccccccccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCC---
Q 002010          843 FLQDAGASECMSSVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQ---  918 (982)
Q Consensus       843 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---  918 (982)
                      ....     ......++..|+|||++.+ ..++.++||||+||++|||++|+.||........+...........+.   
T Consensus       166 ~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  240 (342)
T cd07879         166 HADA-----EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQ  240 (342)
T ss_pred             CCCC-----CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence            5432     1234567889999999876 458899999999999999999999997643322222222111100000   


Q ss_pred             ---CCcccccce----eecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH--HhcCCCCC
Q 002010          919 ---PSDAASVLA----VVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH--MLANPPQS  975 (982)
Q Consensus       919 ---~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~--~L~~~~~~  975 (982)
                         .........    ...+.+..........+.+++.+||+.||++||+++|++.  .+++..+.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~  306 (342)
T cd07879         241 KLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDA  306 (342)
T ss_pred             HhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccc
Confidence               000000000    0000000111123456889999999999999999999995  46665553

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.97  E-value=2.1e-31  Score=296.09  Aligned_cols=274  Identities=22%  Similarity=0.274  Sum_probs=201.0

Q ss_pred             HHhhcccccccccccceEEEEEEe-CCCcEEEEEEeccCC-CCCchhhHHHHHHHHhcCCCCcccceEeEEEc-CCccEE
Q 002010          690 VLESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRG-TGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSN-RDTNLL  766 (982)
Q Consensus       690 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~l  766 (982)
                      +.++|+..+.||+|+||.||+|.. .+++.||+|++.... .....+.+.+|+.++++++||||+++++++.. ....++
T Consensus         8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~l   87 (328)
T cd07856           8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYF   87 (328)
T ss_pred             cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEE
Confidence            346789999999999999999964 479999999885433 23345678899999999999999999998865 457889


Q ss_pred             EEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccc
Q 002010          767 LYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQD  846 (982)
Q Consensus       767 v~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  846 (982)
                      ||||+ +++|.+++.   ...+++..+..++.|+++|++|||+.+   |+||||+|+||++++++.+|++|||.+.....
T Consensus        88 v~e~~-~~~L~~~~~---~~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~  160 (328)
T cd07856          88 VTELL-GTDLHRLLT---SRPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQDP  160 (328)
T ss_pred             Eeehh-ccCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccccccCC
Confidence            99998 678998885   346788889999999999999999988   99999999999999999999999999875432


Q ss_pred             cCCccccccccccccccccccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCC---cc
Q 002010          847 AGASECMSSVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPS---DA  922 (982)
Q Consensus       847 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~  922 (982)
                           ......++..|+|||.+.+ ..++.++||||+|+++|+|++|++||...........+.......+....   ..
T Consensus       161 -----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (328)
T cd07856         161 -----QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICS  235 (328)
T ss_pred             -----CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccc
Confidence                 1233456889999998765 56899999999999999999999999754321111111111111000000   00


Q ss_pred             cccceeec--C---CC--CCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHH--hcCCCCC
Q 002010          923 ASVLAVVD--P---RL--SGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHM--LANPPQS  975 (982)
Q Consensus       923 ~~~~~~~~--~---~~--~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~--L~~~~~~  975 (982)
                      ......+.  +   ..  .......+..+.+++.+||+.+|++|||++|++..  ++...++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~  297 (328)
T cd07856         236 ENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDP  297 (328)
T ss_pred             hhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCC
Confidence            00000000  0   00  01112234678999999999999999999999874  4444443

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.97  E-value=1.4e-31  Score=287.83  Aligned_cols=249  Identities=23%  Similarity=0.310  Sum_probs=195.1

Q ss_pred             hcccccccccccceEEEEEEeCC-CcEEEEEEeccCC----CCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEE
Q 002010          693 SLKDENIIGKGGAGIVYRGSMPD-GIDVAIKRLVGRG----TGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLL  767 (982)
Q Consensus       693 ~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  767 (982)
                      +|.+.+.||+|+||.||++.... +..+++|.++...    .......+.+|+.++++++||||+++++++.+.+..++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            47778899999999999996533 4456666553321    222334567899999999999999999999988999999


Q ss_pred             EeccCCCCHHHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhcc
Q 002010          768 YEYMPNGSLGEMLHG--AKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQ  845 (982)
Q Consensus       768 ~e~~~~~sL~~~l~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~  845 (982)
                      |||+++++|.+++..  .....+++..+..++.|++.|++|||+.+   ++|+||+|+||++++ +.+|++|||.+....
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence            999999999998864  23467899999999999999999999988   999999999999975 579999999987654


Q ss_pred             ccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCccccc
Q 002010          846 DAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASV  925 (982)
Q Consensus       846 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  925 (982)
                      ...  .......+++.|+|||...+..++.++|+||+|+++|+|++|..||.....    .........           
T Consensus       157 ~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~----~~~~~~~~~-----------  219 (260)
T cd08222         157 GSC--DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF----LSVVLRIVE-----------  219 (260)
T ss_pred             CCc--ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH----HHHHHHHHc-----------
Confidence            321  222345678899999999888889999999999999999999999964322    111111111           


Q ss_pred             ceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          926 LAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       926 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                           ...+..+...+..+.+++.+||+.||++||++.|+++
T Consensus       220 -----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         220 -----GPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             -----CCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence                 0111223344567899999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.97  E-value=1.4e-31  Score=299.75  Aligned_cols=266  Identities=20%  Similarity=0.287  Sum_probs=194.7

Q ss_pred             hhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcC---------
Q 002010          692 ESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNR---------  761 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~---------  761 (982)
                      .+|+..+.||+|+||.||+|.. .+++.||+|.+.... ....+.+.+|+.++++++||||+++++++...         
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~-~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTD-PQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG   83 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCC-CchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence            5788899999999999999965 568999999885443 34456688999999999999999999876543         


Q ss_pred             -----CccEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcC-CCCEEE
Q 002010          762 -----DTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDS-DFEAHV  835 (982)
Q Consensus       762 -----~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~-~~~~kl  835 (982)
                           ...++||||++ ++|.+++.   ...+++..+..++.||+.|++|||+.+   |+||||||+||+++. ++.+|+
T Consensus        84 ~~~~~~~~~lv~e~~~-~~L~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~kl  156 (342)
T cd07854          84 SLTELNSVYIVQEYME-TDLANVLE---QGPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKI  156 (342)
T ss_pred             cccccceEEEEeeccc-ccHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEEE
Confidence                 34689999996 58988885   346899999999999999999999988   999999999999974 567899


Q ss_pred             eccccchhccccCCc-cccccccccccccccccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhc
Q 002010          836 ADFGLAKFLQDAGAS-ECMSSVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTT  913 (982)
Q Consensus       836 ~DfG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~  913 (982)
                      +|||.+......... .......++..|+|||.+.+ ..++.++||||+||++|||++|+.||....+............
T Consensus       157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~  236 (342)
T cd07854         157 GDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVP  236 (342)
T ss_pred             CCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence            999999765422111 11122357889999997654 5688899999999999999999999976543333222222111


Q ss_pred             cCCCCCCccccc--------c-eeecCCCC--CCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          914 SEVSQPSDAASV--------L-AVVDPRLS--GYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       914 ~~~~~~~~~~~~--------~-~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                      ...  +......        . ....+..+  ........++.+++.+||+.||++|||++|+++
T Consensus       237 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  299 (342)
T cd07854         237 VVR--EEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM  299 (342)
T ss_pred             CCC--hHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence            000  0000000        0 00000000  111223456889999999999999999999985

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.97  E-value=4e-31  Score=294.96  Aligned_cols=269  Identities=20%  Similarity=0.251  Sum_probs=193.9

Q ss_pred             hcccccccccccceEEEEEEeC-C--CcEEEEEEeccCCCC-CchhhHHHHHHHHhcC-CCCcccceEeEEEcC----Cc
Q 002010          693 SLKDENIIGKGGAGIVYRGSMP-D--GIDVAIKRLVGRGTG-GNDHGFLAEIQTLGRI-RHRNIVRLLGYVSNR----DT  763 (982)
Q Consensus       693 ~~~~~~~lg~G~~g~Vy~~~~~-~--~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~----~~  763 (982)
                      +|+..+.||+|+||.||+|... +  +..||+|++...... ...+.+.+|+.+++++ +||||+++++.....    ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            3677789999999999999653 3  778999988543222 2345678899999999 599999999875332    45


Q ss_pred             cEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchh
Q 002010          764 NLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKF  843 (982)
Q Consensus       764 ~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~  843 (982)
                      .++++||++ ++|.+++.  ....+++..+..++.||+.|++|||+.+   |+||||||+||+++.++.+||+|||.+..
T Consensus        81 ~~~~~e~~~-~~L~~~l~--~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~~  154 (332)
T cd07857          81 LYLYEELME-ADLHQIIR--SGQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARG  154 (332)
T ss_pred             EEEEEeccc-CCHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCcee
Confidence            688889885 68999886  4467899999999999999999999988   99999999999999999999999999986


Q ss_pred             ccccCC--ccccccccccccccccccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCC--
Q 002010          844 LQDAGA--SECMSSVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQ--  918 (982)
Q Consensus       844 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--  918 (982)
                      ......  ........|+..|+|||+..+ ..++.++||||+|+++|+|++|++||............+.........  
T Consensus       155 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  234 (332)
T cd07857         155 FSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETL  234 (332)
T ss_pred             cccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            543211  111233568899999998765 568999999999999999999999997643322222111111110000  


Q ss_pred             -----CCcccccc---eeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          919 -----PSDAASVL---AVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       919 -----~~~~~~~~---~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                           +.......   ......+..........+.+++.+|++.||++|||++|++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~  291 (332)
T cd07857         235 SRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE  291 (332)
T ss_pred             HhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence                 00000000   00000111111123457889999999999999999999876

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.97  E-value=4.1e-31  Score=282.49  Aligned_cols=237  Identities=30%  Similarity=0.339  Sum_probs=193.1

Q ss_pred             cccccceEEEEEEeC-CCcEEEEEEeccCCCC--CchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEeccCCCCH
Q 002010          700 IGKGGAGIVYRGSMP-DGIDVAIKRLVGRGTG--GNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSL  776 (982)
Q Consensus       700 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL  776 (982)
                      ||+|+||.||++... +++.||+|.+......  .....+..|+.++++++||||+++++.+..+...++||||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            699999999999654 5899999988554332  2345788999999999999999999999999999999999999999


Q ss_pred             HHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCccccccc
Q 002010          777 GEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSV  856 (982)
Q Consensus       777 ~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~  856 (982)
                      .+++..  ...+++..+..++.|++.|+.|+|+.+   ++|+||+|+||+++.++.++++|||.+.......  ......
T Consensus        81 ~~~l~~--~~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~  153 (250)
T cd05123          81 FSHLSK--EGRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNTF  153 (250)
T ss_pred             HHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccCC
Confidence            999973  346899999999999999999999988   9999999999999999999999999997654321  223445


Q ss_pred             ccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceeecCCCCCC
Q 002010          857 AGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDPRLSGY  936 (982)
Q Consensus       857 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  936 (982)
                      .++..|+|||...+...+.++|+||+|+++|++++|..||..... ......+..  ...                  ..
T Consensus       154 ~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-~~~~~~~~~--~~~------------------~~  212 (250)
T cd05123         154 CGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR-KEIYEKILK--DPL------------------RF  212 (250)
T ss_pred             cCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-HHHHHHHhc--CCC------------------CC
Confidence            678899999999888889999999999999999999999965432 121222111  000                  11


Q ss_pred             ChHhHHHHHHHHhhccCCCCCCCCCHHH
Q 002010          937 PLTGVIHLFKVAMMCVEDESSARPTMRE  964 (982)
Q Consensus       937 ~~~~~~~l~~li~~cl~~dP~~Rpt~~e  964 (982)
                      +...+..+.+++.+||..||++||++++
T Consensus       213 ~~~~~~~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         213 PEFLSPEARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             CCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence            2222457889999999999999999944

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.97  E-value=1.2e-31  Score=300.42  Aligned_cols=266  Identities=22%  Similarity=0.301  Sum_probs=198.4

Q ss_pred             HHhhcccccccccccceEEEEEEe-CCCcEEEEEEeccCC-CCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCc----
Q 002010          690 VLESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRG-TGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDT----  763 (982)
Q Consensus       690 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~----  763 (982)
                      +.++|+..+.||+|++|.||+|.. .++..||+|++.... .......+.+|+.++++++|||++++++++...+.    
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF   92 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence            356788999999999999999976 458899999875432 22234567789999999999999999998766554    


Q ss_pred             --cEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccc
Q 002010          764 --NLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLA  841 (982)
Q Consensus       764 --~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a  841 (982)
                        .++|+||+ +++|.+++..   .++++..+..++.|+++|++|||+.+   |+||||+|+||++++++.+||+|||.+
T Consensus        93 ~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~~  165 (343)
T cd07851          93 QDVYLVTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLA  165 (343)
T ss_pred             ccEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEcccccc
Confidence              79999999 6799999863   57999999999999999999999988   999999999999999999999999999


Q ss_pred             hhccccCCccccccccccccccccccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCC-
Q 002010          842 KFLQDAGASECMSSVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQP-  919 (982)
Q Consensus       842 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-  919 (982)
                      ......     .....++..|+|||.+.+ ..++.++||||+|+++|||++|+.||...........+........... 
T Consensus       166 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~  240 (343)
T cd07851         166 RHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELL  240 (343)
T ss_pred             cccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHH
Confidence            865422     234567889999998765 3678999999999999999999999975433222222221111100000 


Q ss_pred             -----Ccccccceee----cCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          920 -----SDAASVLAVV----DPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       920 -----~~~~~~~~~~----~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                           ..........    .+.+.......+..+.+++.+|++.||++|||+.|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~  297 (343)
T cd07851         241 QKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA  297 (343)
T ss_pred             hhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence                 0000000000    00011111123567899999999999999999999976

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=4.7e-32  Score=278.69  Aligned_cols=240  Identities=25%  Similarity=0.287  Sum_probs=197.7

Q ss_pred             hcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCC--CchhhHHHHHHHHhcC-CCCcccceEeEEEcCCccEEEE
Q 002010          693 SLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTG--GNDHGFLAEIQTLGRI-RHRNIVRLLGYVSNRDTNLLLY  768 (982)
Q Consensus       693 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~  768 (982)
                      .|....+||+|+||.|-.|.. .+.+.||||++++....  +..+-.+.|-+++..- +-|.+++++..|+..+..|+||
T Consensus       350 DFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVM  429 (683)
T KOG0696|consen  350 DFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVM  429 (683)
T ss_pred             ccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeEE
Confidence            466677999999999999954 44677999998766432  2333345677777665 5799999999999999999999


Q ss_pred             eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccC
Q 002010          769 EYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAG  848 (982)
Q Consensus       769 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  848 (982)
                      ||+.||+|--.++  +-+++.+..+..++..||-||-+||++|   |+.||+|.+||+++.+|++||+|||++..---+ 
T Consensus       430 EyvnGGDLMyhiQ--Q~GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~-  503 (683)
T KOG0696|consen  430 EYVNGGDLMYHIQ--QVGKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIFD-  503 (683)
T ss_pred             EEecCchhhhHHH--HhcccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeecccccccccC-
Confidence            9999999987776  5678999999999999999999999998   999999999999999999999999999753222 


Q ss_pred             CcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCccccccee
Q 002010          849 ASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAV  928 (982)
Q Consensus       849 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  928 (982)
                       .......+|||.|+|||.+....|+.++|+||+||++|||+.|++||++.++++.+..+.....               
T Consensus       504 -~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnv---------------  567 (683)
T KOG0696|consen  504 -GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNV---------------  567 (683)
T ss_pred             -CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccC---------------
Confidence             2345678999999999999999999999999999999999999999988655544444433322               


Q ss_pred             ecCCCCCCChHhHHHHHHHHhhccCCCCCCCC
Q 002010          929 VDPRLSGYPLTGVIHLFKVAMMCVEDESSARP  960 (982)
Q Consensus       929 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp  960 (982)
                            .+|.....+..++.+..+.+.|.+|.
T Consensus       568 ------syPKslSkEAv~ickg~ltK~P~kRL  593 (683)
T KOG0696|consen  568 ------SYPKSLSKEAVAICKGLLTKHPGKRL  593 (683)
T ss_pred             ------cCcccccHHHHHHHHHHhhcCCcccc
Confidence                  24555566788888999999999886

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1e-31  Score=294.93  Aligned_cols=239  Identities=22%  Similarity=0.276  Sum_probs=194.1

Q ss_pred             HhhcccccccccccceEEEEEE-eCCCcEEEEEEeccCCCCCchhhHHHHHHHHhcC-CCCcccceEeEEEcCCccEEEE
Q 002010          691 LESLKDENIIGKGGAGIVYRGS-MPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRI-RHRNIVRLLGYVSNRDTNLLLY  768 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~  768 (982)
                      .+.|+....+|.|+|+.|-.+. .++++..++|++.+.     ..+..+|+.++... +||||++.++.+.+....|+||
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~-----~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~  395 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR-----ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM  395 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheecccc-----ccccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence            4567777789999999999884 567889999998544     12233567665555 7999999999999999999999


Q ss_pred             eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEE-cCCCCEEEeccccchhcccc
Q 002010          769 EYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILL-DSDFEAHVADFGLAKFLQDA  847 (982)
Q Consensus       769 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill-~~~~~~kl~DfG~a~~~~~~  847 (982)
                      |.+.|+-+.+.+...  .... .++..|+.+|+.|+.|||++|   |||||+||+|||+ ++.++++|+|||.++...+.
T Consensus       396 e~l~g~ell~ri~~~--~~~~-~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~  469 (612)
T KOG0603|consen  396 ELLDGGELLRRIRSK--PEFC-SEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS  469 (612)
T ss_pred             hhccccHHHHHHHhc--chhH-HHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence            999999887777532  2333 778889999999999999988   9999999999999 58899999999999877643


Q ss_pred             CCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccce
Q 002010          848 GASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLA  927 (982)
Q Consensus       848 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  927 (982)
                           ....+-|..|.|||+.....|++++||||+|+++|+|++|+.||...+.+.++...+...               
T Consensus       470 -----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~---------------  529 (612)
T KOG0603|consen  470 -----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMP---------------  529 (612)
T ss_pred             -----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCC---------------
Confidence                 334566889999999999999999999999999999999999998876653333322111               


Q ss_pred             eecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          928 VVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       928 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                             .+.........+|+.+||+.||.+||++.++..
T Consensus       530 -------~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~  562 (612)
T KOG0603|consen  530 -------KFSECVSDEAKDLLQQLLQVDPALRLGADEIGA  562 (612)
T ss_pred             -------ccccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence                   011334457889999999999999999999876

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=9.6e-33  Score=266.87  Aligned_cols=279  Identities=20%  Similarity=0.285  Sum_probs=205.6

Q ss_pred             cccHHHHHhhcccccccccccceEEEEEEe-CCCcEEEEEEecc-CCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcC
Q 002010          684 DFKAEDVLESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVG-RGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNR  761 (982)
Q Consensus       684 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  761 (982)
                      .+...+....|+....||+|.||.||+|+. .+|++||+|++.- .....-.....+|++++..++|+|++.+++.|...
T Consensus         9 ~~P~~~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk   88 (376)
T KOG0669|consen    9 YEPFCDEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTK   88 (376)
T ss_pred             cCCceecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhc
Confidence            334445567788888999999999999965 4578889886633 33344455678999999999999999999876432


Q ss_pred             --------CccEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCE
Q 002010          762 --------DTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEA  833 (982)
Q Consensus       762 --------~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~  833 (982)
                              ...|+||.+|+. +|..++.. ...+++..++.++++++..|+.|+|+..   |+|||+||.|++++.+|.+
T Consensus        89 ~Tp~~r~r~t~ylVf~~ceh-DLaGlLsn-~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgil  163 (376)
T KOG0669|consen   89 ATPTNRDRATFYLVFDFCEH-DLAGLLSN-RKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGIL  163 (376)
T ss_pred             cCCcccccceeeeeHHHhhh-hHHHHhcC-ccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceE
Confidence                    346899999965 88888863 3468999999999999999999999988   9999999999999999999


Q ss_pred             EEeccccchhcccc--CCcccccccccccccccccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHH
Q 002010          834 HVADFGLAKFLQDA--GASECMSSVAGSYGYIAPEYAYTL-KVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVR  910 (982)
Q Consensus       834 kl~DfG~a~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~  910 (982)
                      ||+|||+++.+...  ......+..+-|..|.+||.+.+. .|+++.|||+.|||+.||+||.+-+....+...+.-+..
T Consensus       164 klADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~  243 (376)
T KOG0669|consen  164 KLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQ  243 (376)
T ss_pred             EeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHH
Confidence            99999999866432  222334556779999999988764 699999999999999999999998877544333222222


Q ss_pred             Hh---ccCCCCCCcccccceeec-CCCC-C-C--------ChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          911 KT---TSEVSQPSDAASVLAVVD-PRLS-G-Y--------PLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       911 ~~---~~~~~~~~~~~~~~~~~~-~~~~-~-~--------~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                      -.   ....++..+...+...++ +.++ + .        |-.......+++..++..||.+|+++++++.
T Consensus       244 LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln  314 (376)
T KOG0669|consen  244 LCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN  314 (376)
T ss_pred             HhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence            22   222222222222222221 0011 0 0        1111235779999999999999999999886

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.97  E-value=1e-30  Score=314.78  Aligned_cols=147  Identities=29%  Similarity=0.380  Sum_probs=130.2

Q ss_pred             HhhcccccccccccceEEEEEEeC-CCcEEEEEEeccCCC--CCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEE
Q 002010          691 LESLKDENIIGKGGAGIVYRGSMP-DGIDVAIKRLVGRGT--GGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLL  767 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  767 (982)
                      .++|++.+.||+|+||.||+|... +++.||||++.....  ......+.+|+.++..++||||+++++++......|+|
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV   82 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV   82 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence            357888999999999999999764 689999999854322  12235688899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccch
Q 002010          768 YEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAK  842 (982)
Q Consensus       768 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~  842 (982)
                      |||+++++|.+++..  ...+++..++.++.||+.||+|||+.+   |+||||||+||+++.++.+||+|||+++
T Consensus        83 mEy~~g~~L~~li~~--~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          83 MEYLIGGDVKSLLHI--YGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             EeCCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            999999999999973  456889999999999999999999988   9999999999999999999999999986

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.97  E-value=9.5e-32  Score=284.06  Aligned_cols=245  Identities=23%  Similarity=0.340  Sum_probs=199.7

Q ss_pred             cccccccccceEEEEEE-eCCCcEEEEEEeccCC-CCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEeccCC
Q 002010          696 DENIIGKGGAGIVYRGS-MPDGIDVAIKRLVGRG-TGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPN  773 (982)
Q Consensus       696 ~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  773 (982)
                      ..++||+|-||+||-|. .++|+.||||++.+-. ..........|+.|++.+.||.||.+.-.|+..+..++|||.+ .
T Consensus       568 ~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~  646 (888)
T KOG4236|consen  568 ADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-H  646 (888)
T ss_pred             hHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-c
Confidence            35789999999999995 4679999999995433 3444567889999999999999999999999999999999999 5


Q ss_pred             CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCC---CCEEEeccccchhccccCCc
Q 002010          774 GSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSD---FEAHVADFGLAKFLQDAGAS  850 (982)
Q Consensus       774 ~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~---~~~kl~DfG~a~~~~~~~~~  850 (982)
                      |+..+++-..+.+++++.....++.||+.|+.|||.++   |+|.|+||+||++.+.   ..+||||||.|+.+...   
T Consensus       647 GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk---  720 (888)
T KOG4236|consen  647 GDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK---  720 (888)
T ss_pred             chHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchh---
Confidence            67777776677789999999999999999999999998   9999999999999654   57999999999987643   


Q ss_pred             ccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceeec
Q 002010          851 ECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVD  930 (982)
Q Consensus       851 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  930 (982)
                      ......+|||.|.|||++..+.|...-|+||.|||+|--++|..||.+..+..+..+-..  ...++.|+          
T Consensus       721 sFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAa--FMyPp~PW----------  788 (888)
T KOG4236|consen  721 SFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAA--FMYPPNPW----------  788 (888)
T ss_pred             hhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhccc--cccCCCch----------
Confidence            334678999999999999999999999999999999999999999986444332222111  11111111          


Q ss_pred             CCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHH
Q 002010          931 PRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVV  966 (982)
Q Consensus       931 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell  966 (982)
                             .+......++|...++..-++|.+++.-+
T Consensus       789 -------~eis~~AidlIn~LLqVkm~kRysvdk~l  817 (888)
T KOG4236|consen  789 -------SEISPEAIDLINNLLQVKMRKRYSVDKSL  817 (888)
T ss_pred             -------hhcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence                   12234678899999999999999887654

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=4.5e-31  Score=297.04  Aligned_cols=252  Identities=25%  Similarity=0.397  Sum_probs=205.4

Q ss_pred             HHhhcccccccccccceEEEEEE-eCCCcEEEEEEeccCCCCCchhhHHHHHHHHhcC-CCCcccceEeEEEc-----CC
Q 002010          690 VLESLKDENIIGKGGAGIVYRGS-MPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRI-RHRNIVRLLGYVSN-----RD  762 (982)
Q Consensus       690 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~-----~~  762 (982)
                      ..+.|++.+.||.|.+|.||+++ .++++.+|+|+.....  +...++..|..+++.. .|||++.++|+|..     ++
T Consensus        17 p~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~--d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~D   94 (953)
T KOG0587|consen   17 PADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE--DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGD   94 (953)
T ss_pred             CCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc--cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCC
Confidence            34678889999999999999995 4578899999874443  3445667888888887 69999999998853     56


Q ss_pred             ccEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccch
Q 002010          763 TNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAK  842 (982)
Q Consensus       763 ~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~  842 (982)
                      ..|+|||||.+|+..++++.....++.|+.+..|.+.++.|+.+||...   ++|||||-.||+++.++.||++|||.+.
T Consensus        95 qLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLvDFGvSa  171 (953)
T KOG0587|consen   95 QLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLVDFGVSA  171 (953)
T ss_pred             eEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEeeeeeee
Confidence            7899999999999999999888899999999999999999999999888   9999999999999999999999999998


Q ss_pred             hccccCCccccccccccccccccccccc-----CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCC
Q 002010          843 FLQDAGASECMSSVAGSYGYIAPEYAYT-----LKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVS  917 (982)
Q Consensus       843 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  917 (982)
                      .+...  -......+|||.|||||++.-     ..|+.++|+||+|++..||-.|.+|+.+...-    +.+-...+   
T Consensus       172 QldsT--~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPm----raLF~IpR---  242 (953)
T KOG0587|consen  172 QLDST--VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPM----RALFLIPR---  242 (953)
T ss_pred             eeecc--cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchh----hhhccCCC---
Confidence            77542  233456789999999999863     34788999999999999999999999764331    11111111   


Q ss_pred             CCCcccccceeecCCCC-CCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          918 QPSDAASVLAVVDPRLS-GYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       918 ~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                                  +|... ..+..-..++.++|..|+.+|-++||++.++++
T Consensus       243 ------------NPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~  281 (953)
T KOG0587|consen  243 ------------NPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK  281 (953)
T ss_pred             ------------CCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence                        01111 234455668999999999999999999999876

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.6e-31  Score=276.90  Aligned_cols=260  Identities=25%  Similarity=0.334  Sum_probs=200.1

Q ss_pred             HHhhcccccccccccceEEEEE-EeCCCcEEEEEEeccCCCCCch------hhHHHHHHHHhcCCCCcccceEeEEEc-C
Q 002010          690 VLESLKDENIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGND------HGFLAEIQTLGRIRHRNIVRLLGYVSN-R  761 (982)
Q Consensus       690 ~~~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~-~  761 (982)
                      +.++|-...+||+|+|+.||+| +....+.||+|+-.-...+...      +...+|.+|-+.++||.||++|+||.- .
T Consensus       461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt  540 (775)
T KOG1151|consen  461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT  540 (775)
T ss_pred             hHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc
Confidence            4567778889999999999999 5667889999976443333222      246789999999999999999999865 5


Q ss_pred             CccEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcC---CCCEEEecc
Q 002010          762 DTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDS---DFEAHVADF  838 (982)
Q Consensus       762 ~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~---~~~~kl~Df  838 (982)
                      +..+-|.|||+|-+|+-|++  +...++++++..|+.||+.||.||.+. ++||||=|+||.||++..   -|.+||.||
T Consensus       541 dsFCTVLEYceGNDLDFYLK--QhklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDF  617 (775)
T KOG1151|consen  541 DSFCTVLEYCEGNDLDFYLK--QHKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDF  617 (775)
T ss_pred             ccceeeeeecCCCchhHHHH--hhhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeec
Confidence            66788999999999999997  556899999999999999999999988 588999999999999954   478999999


Q ss_pred             ccchhccccCCccc-----ccccccccccccccccccC----CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHH
Q 002010          839 GLAKFLQDAGASEC-----MSSVAGSYGYIAPEYAYTL----KVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWV  909 (982)
Q Consensus       839 G~a~~~~~~~~~~~-----~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~  909 (982)
                      |+++.+.++.....     .+...||..|.+||.+.-+    +.+.|+||||+|||+|+++.|+.||+......++...-
T Consensus       618 GLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeN  697 (775)
T KOG1151|consen  618 GLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQEN  697 (775)
T ss_pred             chhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhh
Confidence            99999987644322     3346799999999987643    46789999999999999999999998744333333221


Q ss_pred             HHhccCCCCCCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          910 RKTTSEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       910 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                      .....           .++   .++ ..+....+...+|++|++.--++|....++..
T Consensus       698 TIlkA-----------tEV---qFP-~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~  740 (775)
T KOG1151|consen  698 TILKA-----------TEV---QFP-PKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC  740 (775)
T ss_pred             chhcc-----------eec---cCC-CCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence            11100           000   000 01122346778999999998888888777654

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.97  E-value=1.2e-31  Score=275.75  Aligned_cols=267  Identities=21%  Similarity=0.255  Sum_probs=205.9

Q ss_pred             HHhhcccccccccccceEEEEEE-eCCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCC-C-C----cccceEeEEEcCC
Q 002010          690 VLESLKDENIIGKGGAGIVYRGS-MPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIR-H-R----NIVRLLGYVSNRD  762 (982)
Q Consensus       690 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h-~----niv~~~~~~~~~~  762 (982)
                      +..+|++...+|+|.||.|-++- ...+..||||+++.-  ..-.+..+-|+.++.++. + |    -+|.+.+||....
T Consensus        87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V--~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrg  164 (415)
T KOG0671|consen   87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV--DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRG  164 (415)
T ss_pred             cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH--HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccC
Confidence            36789999999999999999993 345889999987432  122334567899999993 2 3    3678888899999


Q ss_pred             ccEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcC-------------
Q 002010          763 TNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDS-------------  829 (982)
Q Consensus       763 ~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~-------------  829 (982)
                      +.++|+|.+ |-++++++......+++...+..++.|+++++++||+.+   ++|.|+||+||++.+             
T Consensus       165 hiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~~  240 (415)
T KOG0671|consen  165 HICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKKV  240 (415)
T ss_pred             ceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCcc
Confidence            999999999 779999999888899999999999999999999999988   999999999999842             


Q ss_pred             -------CCCEEEeccccchhccccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCC
Q 002010          830 -------DFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDG  902 (982)
Q Consensus       830 -------~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~  902 (982)
                             ...++++|||.|++....     ....+.|..|.|||++.+-.++.++||||+|||++|+.||..-|...++.
T Consensus       241 ~~~r~~ks~~I~vIDFGsAtf~~e~-----hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~  315 (415)
T KOG0671|consen  241 CFIRPLKSTAIKVIDFGSATFDHEH-----HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENL  315 (415)
T ss_pred             ceeccCCCcceEEEecCCcceeccC-----cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcH
Confidence                   245899999999865432     25677899999999999999999999999999999999999999887665


Q ss_pred             chHHHHHHHhccCCCCCCccc--------------------ccceeecCCCC-----CCChHhHHHHHHHHhhccCCCCC
Q 002010          903 VDIVRWVRKTTSEVSQPSDAA--------------------SVLAVVDPRLS-----GYPLTGVIHLFKVAMMCVEDESS  957 (982)
Q Consensus       903 ~~~~~~~~~~~~~~~~~~~~~--------------------~~~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~dP~  957 (982)
                      +.+...-+..++.+.......                    ....+.++..+     .....+...+++|+++|+..||.
T Consensus       316 EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~  395 (415)
T KOG0671|consen  316 EHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPA  395 (415)
T ss_pred             HHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcc
Confidence            554322222222111111000                    01122222221     12234556799999999999999


Q ss_pred             CCCCHHHHHH
Q 002010          958 ARPTMREVVH  967 (982)
Q Consensus       958 ~Rpt~~ell~  967 (982)
                      +|+|+.|++.
T Consensus       396 ~RiTl~EAL~  405 (415)
T KOG0671|consen  396 RRITLREALS  405 (415)
T ss_pred             ccccHHHHhc
Confidence            9999999875

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.97  E-value=3.3e-31  Score=249.31  Aligned_cols=214  Identities=26%  Similarity=0.415  Sum_probs=179.4

Q ss_pred             hhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcC-CCCcccceEeEEEcCCccEEEEe
Q 002010          692 ESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRI-RHRNIVRLLGYVSNRDTNLLLYE  769 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e  769 (982)
                      +.......||+|++|.|-+.++ .+|...|+|+++.....+..++..+|+.+..+. .+|++|++||.+......++.||
T Consensus        46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME  125 (282)
T KOG0984|consen   46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICME  125 (282)
T ss_pred             hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHH
Confidence            3455566799999999998854 689999999998777777778888999986665 79999999999999999999999


Q ss_pred             ccCCCCHHHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhcccc
Q 002010          770 YMPNGSLGEMLHG--AKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDA  847 (982)
Q Consensus       770 ~~~~~sL~~~l~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  847 (982)
                      .| ..+|..+-.+  .++..+++..+-+++..+..|+.|||++-  .|+|||+||+|||++.+|+||+||||++-.+.+.
T Consensus       126 ~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dS  202 (282)
T KOG0984|consen  126 LM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYLVDS  202 (282)
T ss_pred             Hh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceeehhh
Confidence            99 5688776543  35678999999999999999999999865  3999999999999999999999999999877653


Q ss_pred             CCcccccccccccccccccccc----cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHH
Q 002010          848 GASECMSSVAGSYGYIAPEYAY----TLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRK  911 (982)
Q Consensus       848 ~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~  911 (982)
                         -..+...|...|||||.+.    ...|+-++||||+|+.+.||.+++.||..+.-+....+.+.+
T Consensus       203 ---iAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVe  267 (282)
T KOG0984|consen  203 ---IAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVE  267 (282)
T ss_pred             ---hHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhc
Confidence               2223356788999999875    346899999999999999999999999987766655554443

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.97  E-value=4.4e-30  Score=271.85  Aligned_cols=219  Identities=23%  Similarity=0.197  Sum_probs=175.5

Q ss_pred             ccceEEEEEEe-CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEeccCCCCHHHHhh
Q 002010          703 GGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLH  781 (982)
Q Consensus       703 G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~  781 (982)
                      |.+|.||++.. .+++.||+|++....      .+.+|...+....||||+++++++.+.+..++||||+++++|.+++.
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~   77 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHIS   77 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHH
Confidence            89999999965 568999999985432      23345555555679999999999999999999999999999999987


Q ss_pred             cCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCcccccccccccc
Q 002010          782 GAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYG  861 (982)
Q Consensus       782 ~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~  861 (982)
                      .  ...+++..+..++.|++.|++|+|+.+   |+||||||+||+++.++.++++|||.+......     .....++..
T Consensus        78 ~--~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~~  147 (237)
T cd05576          78 K--FLNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVENM  147 (237)
T ss_pred             H--hcCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCcc
Confidence            3  346899999999999999999999988   999999999999999999999999988765432     123445678


Q ss_pred             cccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceeecCCCCCCChHhH
Q 002010          862 YIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDPRLSGYPLTGV  941 (982)
Q Consensus       862 y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  941 (982)
                      |+|||...+..++.++||||+|+++|||++|..|+........      . ..               .   ...+...+
T Consensus       148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~------~-~~---------------~---~~~~~~~~  202 (237)
T cd05576         148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN------T-HT---------------T---LNIPEWVS  202 (237)
T ss_pred             ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc------c-cc---------------c---cCCcccCC
Confidence            9999999888899999999999999999999988753211100      0 00               0   01222334


Q ss_pred             HHHHHHHhhccCCCCCCCCCH
Q 002010          942 IHLFKVAMMCVEDESSARPTM  962 (982)
Q Consensus       942 ~~l~~li~~cl~~dP~~Rpt~  962 (982)
                      ..+.+++.+|++.||++||++
T Consensus       203 ~~~~~li~~~l~~dp~~R~~~  223 (237)
T cd05576         203 EEARSLLQQLLQFNPTERLGA  223 (237)
T ss_pred             HHHHHHHHHHccCCHHHhcCC
Confidence            578899999999999999997

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=3.4e-31  Score=279.48  Aligned_cols=244  Identities=23%  Similarity=0.292  Sum_probs=203.8

Q ss_pred             HhhcccccccccccceEEEEEEeCCCc-EEEEEEeccCC--CCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEE
Q 002010          691 LESLKDENIIGKGGAGIVYRGSMPDGI-DVAIKRLVGRG--TGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLL  767 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~-~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  767 (982)
                      ...++....||-|+||.|-.+...+.. .+|+|.+++..  .......+..|-.+|...+.|+||++|--|.++...|+.
T Consensus       419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmL  498 (732)
T KOG0614|consen  419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYML  498 (732)
T ss_pred             hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhh
Confidence            345667778999999999999774443 38999886553  334455678899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhcccc
Q 002010          768 YEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDA  847 (982)
Q Consensus       768 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  847 (982)
                      ||-|-||.+...+.  ..+.++...+..++..+.+|++|||++|   ||.||+||+|.+++.+|-+||.|||.|+.+...
T Consensus       499 mEaClGGElWTiLr--dRg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g  573 (732)
T KOG0614|consen  499 MEACLGGELWTILR--DRGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG  573 (732)
T ss_pred             HHhhcCchhhhhhh--hcCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence            99999999999997  5578999999999999999999999998   999999999999999999999999999988643


Q ss_pred             CCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccce
Q 002010          848 GASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLA  927 (982)
Q Consensus       848 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  927 (982)
                         ...-..+|||.|.|||++.++..+.++|.||+|+++||+++|.+||...++-.. ...+.+.....           
T Consensus       574 ---~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmkt-Yn~ILkGid~i-----------  638 (732)
T KOG0614|consen  574 ---RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKT-YNLILKGIDKI-----------  638 (732)
T ss_pred             ---CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHH-HHHHHhhhhhh-----------
Confidence               344568999999999999999999999999999999999999999987644333 33333322211           


Q ss_pred             eecCCCCCCChHhHHHHHHHHhhccCCCCCCCCC
Q 002010          928 VVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPT  961 (982)
Q Consensus       928 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt  961 (982)
                             .+|........++|++....+|.+|.-
T Consensus       639 -------~~Pr~I~k~a~~Lik~LCr~~P~ERLG  665 (732)
T KOG0614|consen  639 -------EFPRRITKTATDLIKKLCRDNPTERLG  665 (732)
T ss_pred             -------hcccccchhHHHHHHHHHhcCcHhhhc
Confidence                   223334456789999999999999984

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.97  E-value=2.8e-29  Score=266.73  Aligned_cols=239  Identities=30%  Similarity=0.412  Sum_probs=195.7

Q ss_pred             cceEEEEEEeC-CCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEeccCCCCHHHHhhc
Q 002010          704 GAGIVYRGSMP-DGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHG  782 (982)
Q Consensus       704 ~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~  782 (982)
                      +||.||+|... +++.+|+|++.........+.+.+|++.+++++|+|++++++++..+...+++|||+++++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            58999999765 48999999985544333367899999999999999999999999998999999999999999999974


Q ss_pred             CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCccccccccccccc
Q 002010          783 AKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGY  862 (982)
Q Consensus       783 ~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y  862 (982)
                      .  ..+++..+..++.+++.++++||+.+   ++|+||+|+||++++++.++++|||.+.......   ......++..|
T Consensus        81 ~--~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~  152 (244)
T smart00220       81 R--GRLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPEY  152 (244)
T ss_pred             c--cCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcCC
Confidence            3  23899999999999999999999988   9999999999999999999999999998765331   33455678899


Q ss_pred             ccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceeecCCCCCCChHhHH
Q 002010          863 IAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDPRLSGYPLTGVI  942 (982)
Q Consensus       863 ~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  942 (982)
                      +|||...+..++.++||||+|+++|++++|..||....+.................                 .....+.
T Consensus       153 ~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~  215 (244)
T smart00220      153 MAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPP-----------------PEWKISP  215 (244)
T ss_pred             CCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcc-----------------ccccCCH
Confidence            99999988889999999999999999999999997644444433333322111000                 0000345


Q ss_pred             HHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          943 HLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       943 ~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                      ++.+++.+|+..+|++||++.++++
T Consensus       216 ~~~~~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      216 EAKDLIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             HHHHHHHHHccCCchhccCHHHHhh
Confidence            7899999999999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=5.2e-30  Score=276.50  Aligned_cols=204  Identities=25%  Similarity=0.305  Sum_probs=173.4

Q ss_pred             hcccccccccccceEEEEEEe-CCCcEEEEEEeccCCC--CCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEe
Q 002010          693 SLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGT--GGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYE  769 (982)
Q Consensus       693 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  769 (982)
                      -|...+.||-|+||.|.+++. .+...||+|.+.+..-  ......++.|..|+..-+.+.||++|..|++++..|+||+
T Consensus       630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd  709 (1034)
T KOG0608|consen  630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD  709 (1034)
T ss_pred             ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence            366778999999999999954 4567799998855432  2234567889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhcccc--
Q 002010          770 YMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDA--  847 (982)
Q Consensus       770 ~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--  847 (982)
                      |++||++-.+|.  +-+-+.++.++.++..+..|+++.|+.|   +|||||||+|||||.+|++||.|||++.-+.-.  
T Consensus       710 YIPGGDmMSLLI--rmgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHd  784 (1034)
T KOG0608|consen  710 YIPGGDMMSLLI--RMGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD  784 (1034)
T ss_pred             ccCCccHHHHHH--HhccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccceeccc
Confidence            999999999987  5578999999999999999999999999   999999999999999999999999998754210  


Q ss_pred             -CCcc------c-------------------------------ccccccccccccccccccCCCCcchhhHHHHHHHHHH
Q 002010          848 -GASE------C-------------------------------MSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLEL  889 (982)
Q Consensus       848 -~~~~------~-------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el  889 (982)
                       .++.      .                               ....+||+.|+|||++....|+..+|+||.|||+|||
T Consensus       785 skYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em  864 (1034)
T KOG0608|consen  785 SKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEM  864 (1034)
T ss_pred             cccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHH
Confidence             0000      0                               0124699999999999999999999999999999999


Q ss_pred             HhCCCCCCCCCC
Q 002010          890 IAGKKPVGEFGD  901 (982)
Q Consensus       890 ltg~~p~~~~~~  901 (982)
                      +.|++||.....
T Consensus       865 ~~g~~pf~~~tp  876 (1034)
T KOG0608|consen  865 LVGQPPFLADTP  876 (1034)
T ss_pred             hhCCCCccCCCC
Confidence            999999976443

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.96  E-value=1.8e-30  Score=290.82  Aligned_cols=245  Identities=25%  Similarity=0.367  Sum_probs=188.4

Q ss_pred             cccccccccccceE-EEEEEeCCCcEEEEEEeccCCCCCchhhHHHHHHHHhcC-CCCcccceEeEEEcCCccEEEEecc
Q 002010          694 LKDENIIGKGGAGI-VYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRI-RHRNIVRLLGYVSNRDTNLLLYEYM  771 (982)
Q Consensus       694 ~~~~~~lg~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~  771 (982)
                      |...+++|.|+.|+ ||+|.+ +|+.||||++...    -.....+|+..++.- +|||||++|+.-.++...|+..|.|
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e----~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC  585 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEE----FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC  585 (903)
T ss_pred             eccHHHcccCCCCcEEEEEee-CCceehHHHHhhH----hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence            33456799999876 799988 8899999988432    233456899999988 6999999999989999999999999


Q ss_pred             CCCCHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcC---C--CCEEEeccccchhc
Q 002010          772 PNGSLGEMLHGA--KGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDS---D--FEAHVADFGLAKFL  844 (982)
Q Consensus       772 ~~~sL~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~---~--~~~kl~DfG~a~~~  844 (982)
                       ..+|.+++...  ..........+.+..|+++|+++||+-+   ||||||||.||||+.   +  .+++|+|||+++.+
T Consensus       586 -~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl  661 (903)
T KOG1027|consen  586 -ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL  661 (903)
T ss_pred             -hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence             67999999853  1111222455788999999999999988   999999999999976   3  57899999999988


Q ss_pred             cccC-CcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHhccCCCCCCcc
Q 002010          845 QDAG-ASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDA  922 (982)
Q Consensus       845 ~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  922 (982)
                      .... .........||-+|+|||++....-+.++||||+||++|+.++ |.+||++.-..  ...++.....        
T Consensus       662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R--~~NIl~~~~~--------  731 (903)
T KOG1027|consen  662 AGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER--QANILTGNYT--------  731 (903)
T ss_pred             CCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHh--hhhhhcCccc--------
Confidence            6542 2333456789999999999999888899999999999999999 59999863211  1112111110        


Q ss_pred             cccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          923 ASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       923 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                                +..+.........++|.+|++.||..||+|.+|+.
T Consensus       732 ----------L~~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~  766 (903)
T KOG1027|consen  732 ----------LVHLEPLPDCEAKDLISRMLNPDPQLRPSATDVLN  766 (903)
T ss_pred             ----------eeeeccCchHHHHHHHHHhcCCCcccCCCHHHHhC
Confidence                      00011111116789999999999999999999975

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=7.4e-30  Score=255.83  Aligned_cols=247  Identities=21%  Similarity=0.281  Sum_probs=194.6

Q ss_pred             HhhcccccccccccceEEEEEEe-CCCcEEEEEEeccCC--CCCchhhHHHHHHHHhcC-CCCcccceEeEEEcCCccEE
Q 002010          691 LESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRG--TGGNDHGFLAEIQTLGRI-RHRNIVRLLGYVSNRDTNLL  766 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~l  766 (982)
                      ...|+..++||+|+|+.|-.++. ++.+.||+|++++.-  .++...-+..|-.+..+. +||++|-++.+|+.+...++
T Consensus       249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff  328 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF  328 (593)
T ss_pred             cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence            45688889999999999999975 457889999986542  233344466777777666 79999999999999999999


Q ss_pred             EEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccc
Q 002010          767 LYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQD  846 (982)
Q Consensus       767 v~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  846 (982)
                      |.||++||+|--.++  +..+++++.+..+...|+-|+.|||+.|   |+.||+|..||+++..|++|+.|+|+++.-- 
T Consensus       329 vieyv~ggdlmfhmq--rqrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l-  402 (593)
T KOG0695|consen  329 VIEYVNGGDLMFHMQ--RQRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL-  402 (593)
T ss_pred             EEEEecCcceeeehh--hhhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCC-
Confidence            999999999866554  6678999999999999999999999999   9999999999999999999999999998533 


Q ss_pred             cCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCC---CchHHHHHHHhccCCCCCCccc
Q 002010          847 AGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGD---GVDIVRWVRKTTSEVSQPSDAA  923 (982)
Q Consensus       847 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~  923 (982)
                       +.....+..+|||.|.|||.+.+..|...+|+|++||+++||+.|+.||+--..   ++....++-...          
T Consensus       403 -~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvi----------  471 (593)
T KOG0695|consen  403 -GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVI----------  471 (593)
T ss_pred             -CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHH----------
Confidence             234456778999999999999999999999999999999999999999975221   111111111100          


Q ss_pred             ccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCC
Q 002010          924 SVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARP  960 (982)
Q Consensus       924 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp  960 (982)
                           .++ -.-.|.....+...+++.-+++||.+|.
T Consensus       472 -----lek-qiriprslsvkas~vlkgflnkdp~erl  502 (593)
T KOG0695|consen  472 -----LEK-QIRIPRSLSVKASHVLKGFLNKDPKERL  502 (593)
T ss_pred             -----hhh-cccccceeehhhHHHHHHhhcCCcHHhc
Confidence                 000 0012223334556788888999999886

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.96  E-value=6.9e-29  Score=291.10  Aligned_cols=260  Identities=17%  Similarity=0.212  Sum_probs=167.7

Q ss_pred             HhhcccccccccccceEEEEEEeC-C----CcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeE------EE
Q 002010          691 LESLKDENIIGKGGAGIVYRGSMP-D----GIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGY------VS  759 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~~-~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~------~~  759 (982)
                      .++|+..+.||+|+||.||+|... +    +..||+|++.....   ......|  .++...+.+++.++..      ..
T Consensus       131 ~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~---~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~  205 (566)
T PLN03225        131 KDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA---VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK  205 (566)
T ss_pred             cCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch---hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence            467899999999999999999653 4    68999998743211   1111111  1112222222222221      23


Q ss_pred             cCCccEEEEeccCCCCHHHHhhcCCCC------------------CCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCC
Q 002010          760 NRDTNLLLYEYMPNGSLGEMLHGAKGG------------------HLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVK  821 (982)
Q Consensus       760 ~~~~~~lv~e~~~~~sL~~~l~~~~~~------------------~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk  821 (982)
                      .+...++||||+++++|.+++......                  ......+..++.|++.||+|||+.+   |+|||||
T Consensus       206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK  282 (566)
T PLN03225        206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK  282 (566)
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence            456789999999999999998643210                  1123345679999999999999988   9999999


Q ss_pred             CCcEEEcC-CCCEEEeccccchhccccCCcccccccccccccccccccccC----------------------CCCcchh
Q 002010          822 SNNILLDS-DFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTL----------------------KVDEKSD  878 (982)
Q Consensus       822 p~Nill~~-~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~D  878 (982)
                      |+||++++ ++.+||+|||+|..+... .........+++.|+|||.+...                      .++.++|
T Consensus       283 P~NILl~~~~~~~KL~DFGlA~~l~~~-~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D  361 (566)
T PLN03225        283 PQNIIFSEGSGSFKIIDLGAAADLRVG-INYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD  361 (566)
T ss_pred             HHHEEEeCCCCcEEEEeCCCccccccc-cccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence            99999986 589999999999865432 22233456789999999965322                      2345679


Q ss_pred             hHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceeecCCC----C---CCChHhHHHHHHHHhhc
Q 002010          879 VYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDPRL----S---GYPLTGVIHLFKVAMMC  951 (982)
Q Consensus       879 vwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~---~~~~~~~~~l~~li~~c  951 (982)
                      |||+||++|||+++..|+..  +...+...+.....      +...+.....+..    .   ..........++|+.+|
T Consensus       362 VwSlGviL~el~~~~~~~~~--~~~~~~~~l~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~m  433 (566)
T PLN03225        362 IYSAGLIFLQMAFPNLRSDS--NLIQFNRQLKRNDY------DLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSM  433 (566)
T ss_pred             cHHHHHHHHHHHhCcCCCch--HHHHHHHHHHhcCC------cHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHH
Confidence            99999999999997766432  11111111111100      0000000001100    0   00011123456899999


Q ss_pred             cCCCCCCCCCHHHHHH
Q 002010          952 VEDESSARPTMREVVH  967 (982)
Q Consensus       952 l~~dP~~Rpt~~ell~  967 (982)
                      ++.||++|||++|+++
T Consensus       434 L~~dP~kR~ta~e~L~  449 (566)
T PLN03225        434 MRFKGRQRISAKAALA  449 (566)
T ss_pred             ccCCcccCCCHHHHhC
Confidence            9999999999999987

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.2e-30  Score=254.76  Aligned_cols=267  Identities=22%  Similarity=0.297  Sum_probs=198.1

Q ss_pred             cccccccccccceEEEEEEe-CCCcEEEEEEeccCC-CCCchhhHHHHHHHHhcCCCCcccceEeEEEcCC-----ccEE
Q 002010          694 LKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRG-TGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRD-----TNLL  766 (982)
Q Consensus       694 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~~l  766 (982)
                      .+..+.||.|+||.||.+.+ .+|+.||+|++.... .-...+.+.+|++++..++|.|++..++..+-..     ..|+
T Consensus        55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV  134 (449)
T KOG0664|consen   55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV  134 (449)
T ss_pred             CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence            45667899999999999965 569999999884322 2234567889999999999999999998765433     4578


Q ss_pred             EEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccc
Q 002010          767 LYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQD  846 (982)
Q Consensus       767 v~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  846 (982)
                      ++|.| ..+|..++-  ..+.++.+.+.-+.+||++|++|||+.+   |.||||||.|.+|+.+..+||||||+++.-+.
T Consensus       135 ~TELm-QSDLHKIIV--SPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~  208 (449)
T KOG0664|consen  135 LTELM-QSDLHKIIV--SPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQ  208 (449)
T ss_pred             HHHHH-Hhhhhheec--cCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccch
Confidence            88988 558888775  5578889999999999999999999988   99999999999999999999999999986553


Q ss_pred             cCCcccccccccccccccccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCccccc
Q 002010          847 AGASECMSSVAGSYGYIAPEYAYTL-KVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASV  925 (982)
Q Consensus       847 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  925 (982)
                      . ....++..+-|..|+|||.+++. .|+.+.||||.|||+.|++.++.-|...... ...+.+......+.........
T Consensus       209 d-~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~Pi-qQL~lItdLLGTPs~EaMr~AC  286 (449)
T KOG0664|consen  209 R-DRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPI-EQLQMIIDLLGTPSQEAMKYAC  286 (449)
T ss_pred             h-hhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChH-HHHHHHHHHhCCCcHHHHHHHh
Confidence            3 34456666778899999999875 5899999999999999999999888764433 2333333322221111000000


Q ss_pred             ----cee-----ecCCCC-----CCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002010          926 ----LAV-----VDPRLS-----GYPLTGVIHLFKVAMMCVEDESSARPTMREVVHM  968 (982)
Q Consensus       926 ----~~~-----~~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~  968 (982)
                          ..+     ..|.++     ..+...-.+-..+...++..||++|.+.++.+..
T Consensus       287 EGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~  343 (449)
T KOG0664|consen  287 EGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQH  343 (449)
T ss_pred             hhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccc
Confidence                001     112221     1122333446678889999999999999987763

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.96  E-value=1.2e-29  Score=242.28  Aligned_cols=262  Identities=23%  Similarity=0.279  Sum_probs=196.9

Q ss_pred             HhhcccccccccccceEEEEEE-eCCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCC-CCcccceEeEEEcC--CccEE
Q 002010          691 LESLKDENIIGKGGAGIVYRGS-MPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIR-HRNIVRLLGYVSNR--DTNLL  766 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~--~~~~l  766 (982)
                      .++|++.+.+|+|.|+.||.|. ..+.++++||.+++-    ..+.+.+|+.+++.+. ||||+++++...++  ....+
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV----kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL  112 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV----KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL  112 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH----HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence            4678899999999999999995 567889999988432    3567889999999996 99999999998764  46689


Q ss_pred             EEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCC-CCEEEeccccchhcc
Q 002010          767 LYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSD-FEAHVADFGLAKFLQ  845 (982)
Q Consensus       767 v~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~-~~~kl~DfG~a~~~~  845 (982)
                      |+||+.+.+...+.     +.++..++..++.+++.|+.|+|++|   |+|||+||+|+++|.. -.++++|+|+|.++-
T Consensus       113 iFE~v~n~Dfk~ly-----~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH  184 (338)
T KOG0668|consen  113 IFEYVNNTDFKQLY-----PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  184 (338)
T ss_pred             HhhhhccccHHHHh-----hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcC
Confidence            99999988777665     36788889999999999999999999   9999999999999865 569999999999886


Q ss_pred             ccCCcccccccccccccccccccccCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCC-------
Q 002010          846 DAGASECMSSVAGSYGYIAPEYAYTLK-VDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVS-------  917 (982)
Q Consensus       846 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-------  917 (982)
                      +.   ......+.+..|.-||.+...+ |+.+-|+||+||++..|+..+.||-...+-.+..-.+.+......       
T Consensus       185 p~---~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~K  261 (338)
T KOG0668|consen  185 PG---KEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNK  261 (338)
T ss_pred             CC---ceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHH
Confidence            54   3345566788899999987654 889999999999999999999998664443333222222221100       


Q ss_pred             -CCCcccccceeec----CCCC-----CCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          918 -QPSDAASVLAVVD----PRLS-----GYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       918 -~~~~~~~~~~~~~----~~~~-----~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                       ...-.+...+++.    ..+.     +-..-...+..+++.+.+..|-.+|+|+.|.++
T Consensus       262 Y~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~  321 (338)
T KOG0668|consen  262 YQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA  321 (338)
T ss_pred             HccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence             0000001111110    0000     011112356789999999999999999999875

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.96  E-value=3e-28  Score=277.67  Aligned_cols=257  Identities=20%  Similarity=0.284  Sum_probs=178.0

Q ss_pred             HhhcccccccccccceEEEEEEe-----------------CCCcEEEEEEeccCCCC-------------CchhhHHHHH
Q 002010          691 LESLKDENIIGKGGAGIVYRGSM-----------------PDGIDVAIKRLVGRGTG-------------GNDHGFLAEI  740 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~~-------------~~~~~~~~E~  740 (982)
                      .++|++.++||+|+||+||+|..                 .+++.||||++......             ...+....|+
T Consensus       144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~  223 (507)
T PLN03224        144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA  223 (507)
T ss_pred             ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence            46799999999999999999853                 23568999998432211             1122344577


Q ss_pred             HHHhcCCCCc-----ccceEeEEEc--------CCccEEEEeccCCCCHHHHhhcCC----------------------C
Q 002010          741 QTLGRIRHRN-----IVRLLGYVSN--------RDTNLLLYEYMPNGSLGEMLHGAK----------------------G  785 (982)
Q Consensus       741 ~~l~~l~h~n-----iv~~~~~~~~--------~~~~~lv~e~~~~~sL~~~l~~~~----------------------~  785 (982)
                      .++.+++|.+     +++++++|..        ++..++||||+++++|.++++...                      .
T Consensus       224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~  303 (507)
T PLN03224        224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ  303 (507)
T ss_pred             HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence            7777776654     4677777643        346799999999999999987421                      1


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCcccccccccccccccc
Q 002010          786 GHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAP  865 (982)
Q Consensus       786 ~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aP  865 (982)
                      ...++..+..++.|++.|++|+|+.+   |+||||||+||+++.++.+||+|||++..+.... ........+++.|+||
T Consensus       304 ~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~-~~~~~~g~~tp~Y~aP  379 (507)
T PLN03224        304 DKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGI-NFNPLYGMLDPRYSPP  379 (507)
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCC-ccCccccCCCcceeCh
Confidence            23467788999999999999999988   9999999999999999999999999997654321 1111223347899999


Q ss_pred             cccccCC--------------------C--CcchhhHHHHHHHHHHHhCCC-CCCCCCCC--------chHHHHHHHhcc
Q 002010          866 EYAYTLK--------------------V--DEKSDVYSFGVVLLELIAGKK-PVGEFGDG--------VDIVRWVRKTTS  914 (982)
Q Consensus       866 E~~~~~~--------------------~--~~~~DvwslG~il~elltg~~-p~~~~~~~--------~~~~~~~~~~~~  914 (982)
                      |.+....                    |  ..+.||||+||++|||++|.. |+......        .+...|......
T Consensus       380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~  459 (507)
T PLN03224        380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQ  459 (507)
T ss_pred             hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhccc
Confidence            9875322                    1  134799999999999999875 66532111        111111111000


Q ss_pred             CCCCCCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCC---CCCCCHHHHHH
Q 002010          915 EVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDES---SARPTMREVVH  967 (982)
Q Consensus       915 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP---~~Rpt~~ell~  967 (982)
                      .               ..+. ..........+++.+|+..+|   .+|+|++|+++
T Consensus       460 ~---------------~~~~-~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~  499 (507)
T PLN03224        460 K---------------YDFS-LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS  499 (507)
T ss_pred             C---------------CCcc-cccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence            0               0011 112234568899999999876   68999999875

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.95  E-value=3e-28  Score=261.39  Aligned_cols=198  Identities=23%  Similarity=0.343  Sum_probs=170.1

Q ss_pred             hhcccccccccccceEEEEEEeC-CCcEEEEEEeccCC-------CCCchhhHHHHHHHHhcCC---CCcccceEeEEEc
Q 002010          692 ESLKDENIIGKGGAGIVYRGSMP-DGIDVAIKRLVGRG-------TGGNDHGFLAEIQTLGRIR---HRNIVRLLGYVSN  760 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~  760 (982)
                      ..|...+.+|+|+||.|+.|.++ +...|+||.+.+..       .+...-.+-.|+.||..++   |+||+|++++|++
T Consensus       561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd  640 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED  640 (772)
T ss_pred             ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence            35888899999999999999654 46778999885432       1122224567999999997   9999999999999


Q ss_pred             CCccEEEEecc-CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccc
Q 002010          761 RDTNLLLYEYM-PNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFG  839 (982)
Q Consensus       761 ~~~~~lv~e~~-~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG  839 (982)
                      ++.+|++||.. ++.+|++++.  ....+++.++..|++||+.|+++||+.+   |||||||-+||.++.+|-+||+|||
T Consensus       641 dd~yyl~te~hg~gIDLFd~IE--~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidfg  715 (772)
T KOG1152|consen  641 DDYYYLETEVHGEGIDLFDFIE--FKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDFG  715 (772)
T ss_pred             CCeeEEEecCCCCCcchhhhhh--ccCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeecc
Confidence            99999999987 4669999997  5578999999999999999999999998   9999999999999999999999999


Q ss_pred             cchhccccCCcccccccccccccccccccccCCC-CcchhhHHHHHHHHHHHhCCCCCCC
Q 002010          840 LAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKV-DEKSDVYSFGVVLLELIAGKKPVGE  898 (982)
Q Consensus       840 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~p~~~  898 (982)
                      .|.....+    .....+||..|.|||++.+..| +..-|||++|+++|.++....||+.
T Consensus       716 saa~~ksg----pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  716 SAAYTKSG----PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             chhhhcCC----CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence            99876533    2346789999999999999887 4667999999999999999999864

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.95  E-value=5.3e-28  Score=236.83  Aligned_cols=260  Identities=17%  Similarity=0.267  Sum_probs=195.0

Q ss_pred             ccccccHHHHHhhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcC-CCCcccceEe-E
Q 002010          681 QRLDFKAEDVLESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRI-RHRNIVRLLG-Y  757 (982)
Q Consensus       681 ~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~-~  757 (982)
                      ..++.+.-++.+.|.+.+.+|+|.||.+-.+++ .+...+|+|.++..  ....++|.+|...--.+ .|.||+.-|+ +
T Consensus        13 ~~~el~kv~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p--~tt~~dF~rEfhY~~~Ls~H~hIi~tY~va   90 (378)
T KOG1345|consen   13 PMEELKKVDLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP--QTTQADFVREFHYSFFLSPHQHIIDTYEVA   90 (378)
T ss_pred             ccccccccchhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc--hhhHHHHHHHhccceeeccchhhhHHHHHH
Confidence            334444556778899999999999999999965 45788999987543  34567899998876666 5899999887 5


Q ss_pred             EEcCCccEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEc--CCCCEEE
Q 002010          758 VSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLD--SDFEAHV  835 (982)
Q Consensus       758 ~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~--~~~~~kl  835 (982)
                      |+..+.+++++||++.|+|.+.+.   ...+.+....+++.|+++|+.|||+++   +||||||.+||||-  +..++|+
T Consensus        91 Fqt~d~YvF~qE~aP~gdL~snv~---~~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKl  164 (378)
T KOG1345|consen   91 FQTSDAYVFVQEFAPRGDLRSNVE---AAGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKL  164 (378)
T ss_pred             hhcCceEEEeeccCccchhhhhcC---cccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEe
Confidence            788889999999999999999885   356888888999999999999999998   99999999999993  3458999


Q ss_pred             eccccchhccccCCccccccccccccccccccccc-----CCCCcchhhHHHHHHHHHHHhCCCCCCC-CCCCchHHHHH
Q 002010          836 ADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYT-----LKVDEKSDVYSFGVVLLELIAGKKPVGE-FGDGVDIVRWV  909 (982)
Q Consensus       836 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~elltg~~p~~~-~~~~~~~~~~~  909 (982)
                      ||||..+...     ........+..|.|||....     ....+.+|||.||+++|.++||.+||.. ..++..+.+|.
T Consensus       165 cDFG~t~k~g-----~tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~  239 (378)
T KOG1345|consen  165 CDFGLTRKVG-----TTVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWE  239 (378)
T ss_pred             eecccccccC-----ceehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHH
Confidence            9999987543     12223345668999997642     2357889999999999999999999985 22333444444


Q ss_pred             HHhccCCCCCCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          910 RKTTSEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       910 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                      .-...              ..++.+..-......+.+++++-+.++|++|-.+.++.+
T Consensus       240 ~w~~r--------------k~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk  283 (378)
T KOG1345|consen  240 QWLKR--------------KNPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKK  283 (378)
T ss_pred             HHhcc--------------cCccCchhhcccCHHHHHHHHHhcCCcccccchhHHHHH
Confidence            33222              111222111122346788999999999999954444433

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=5.2e-27  Score=247.88  Aligned_cols=273  Identities=20%  Similarity=0.234  Sum_probs=199.7

Q ss_pred             hhcccccccccccceEEEEE-EeCCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCC-----C---CcccceEeEEEc--
Q 002010          692 ESLKDENIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIR-----H---RNIVRLLGYVSN--  760 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~~~~~~~~--  760 (982)
                      .+|...++||.|.|++||.| +....+.||+|+++...  .=.+..+.||+++++++     |   .+||++++.|..  
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq--hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG  155 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ--HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG  155 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh--HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence            47889999999999999999 55678899999885432  22345678999999983     2   479999999865  


Q ss_pred             --CCccEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCC--------
Q 002010          761 --RDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSD--------  830 (982)
Q Consensus       761 --~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~--------  830 (982)
                        ..++++|+|+. |.+|..+|.....+.++...+.+|++||+.||.|||+..  +|||.||||+|||+..+        
T Consensus       156 pNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~~~e~~~~~~~  232 (590)
T KOG1290|consen  156 PNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLCSTEIDPAKDA  232 (590)
T ss_pred             CCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeeeccccchhhhh
Confidence              45779999999 889999999888899999999999999999999999966  49999999999998310        


Q ss_pred             ---C----------------------------------------------------------------------------
Q 002010          831 ---F----------------------------------------------------------------------------  831 (982)
Q Consensus       831 ---~----------------------------------------------------------------------------  831 (982)
                         +                                                                            
T Consensus       233 ~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~  312 (590)
T KOG1290|consen  233 REAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGN  312 (590)
T ss_pred             hhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCcc
Confidence               0                                                                            


Q ss_pred             -------------------------------------------------------------------------------C
Q 002010          832 -------------------------------------------------------------------------------E  832 (982)
Q Consensus       832 -------------------------------------------------------------------------------~  832 (982)
                                                                                                     .
T Consensus       313 ~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~  392 (590)
T KOG1290|consen  313 ESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIR  392 (590)
T ss_pred             ccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCcccee
Confidence                                                                                           0


Q ss_pred             EEEeccccchhccccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCC------CCCchHH
Q 002010          833 AHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEF------GDGVDIV  906 (982)
Q Consensus       833 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~------~~~~~~~  906 (982)
                      |||+|||-|+++..     ..+.-+-|..|+|||++.+..|+..+||||++|++|||.||..-|+..      .+++.++
T Consensus       393 vKIaDlGNACW~~k-----hFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA  467 (590)
T KOG1290|consen  393 VKIADLGNACWVHK-----HFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIA  467 (590)
T ss_pred             EEEeeccchhhhhh-----hhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHH
Confidence            23333333333221     122234567899999999999999999999999999999999998652      2334444


Q ss_pred             HHHHHhccCCCCCCc-ccccceeecCC----------C----------CCCChHhHHHHHHHHhhccCCCCCCCCCHHHH
Q 002010          907 RWVRKTTSEVSQPSD-AASVLAVVDPR----------L----------SGYPLTGVIHLFKVAMMCVEDESSARPTMREV  965 (982)
Q Consensus       907 ~~~~~~~~~~~~~~~-~~~~~~~~~~~----------~----------~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~el  965 (982)
                      .++.-.+.-++...- .....++++.+          .          -+.+.+....+.+|+.-||+.+|++||||.+.
T Consensus       468 ~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~c  547 (590)
T KOG1290|consen  468 LIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQC  547 (590)
T ss_pred             HHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHH
Confidence            444433332221110 01111222211          0          03567778889999999999999999999999


Q ss_pred             HH--HhcCCCC
Q 002010          966 VH--MLANPPQ  974 (982)
Q Consensus       966 l~--~L~~~~~  974 (982)
                      ++  -|.....
T Consensus       548 l~hPwLn~~~~  558 (590)
T KOG1290|consen  548 LKHPWLNPVAG  558 (590)
T ss_pred             hcCccccCCCC
Confidence            85  4444443

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.94  E-value=2.1e-27  Score=238.91  Aligned_cols=261  Identities=24%  Similarity=0.298  Sum_probs=196.0

Q ss_pred             hhcccccccccccceEEEEE-EeCCCcEEEEEEeccC-CCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCC------c
Q 002010          692 ESLKDENIIGKGGAGIVYRG-SMPDGIDVAIKRLVGR-GTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRD------T  763 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------~  763 (982)
                      .+|...+.+|.|+- .|..| +.-.+++||+|++... ......++..+|...+..++|+||++++.+|.-..      .
T Consensus        17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e   95 (369)
T KOG0665|consen   17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE   95 (369)
T ss_pred             eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence            45666778999988 55555 3346889999987433 33444567889999999999999999999986443      5


Q ss_pred             cEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchh
Q 002010          764 NLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKF  843 (982)
Q Consensus       764 ~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~  843 (982)
                      .|+|||+| ..+|...+.    -.++-+.+..+..|++.|++|+|+.+   |+||||||+||++..+..+||.|||+|+.
T Consensus        96 ~y~v~e~m-~~nl~~vi~----~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar~  167 (369)
T KOG0665|consen   96 VYLVMELM-DANLCQVIL----MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLART  167 (369)
T ss_pred             HHHHHHhh-hhHHHHHHH----HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhcc
Confidence            69999999 678988886    45778899999999999999999998   99999999999999999999999999985


Q ss_pred             ccccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhcc--CCC----
Q 002010          844 LQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTS--EVS----  917 (982)
Q Consensus       844 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~--~~~----  917 (982)
                      -.   ..-.++.++.|..|.|||++.+-.|.+.+||||.||++.||++|+.-|.+...   +-+|.+....  .+.    
T Consensus       168 e~---~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~---idQ~~ki~~~lgtpd~~F~  241 (369)
T KOG0665|consen  168 ED---TDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDH---IDQWNKIIEQLGTPDPSFM  241 (369)
T ss_pred             cC---cccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchH---HHHHHHHHHHhcCCCHHHH
Confidence            43   23466778899999999999988899999999999999999999998874322   2222221111  000    


Q ss_pred             -------------CCCcc-ccc-ceeecCCCC---CCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          918 -------------QPSDA-ASV-LAVVDPRLS---GYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       918 -------------~~~~~-~~~-~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                                   .+... ... .-+.|..++   +.++-...-..+++.+||..||++|-+++++++
T Consensus       242 ~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~  309 (369)
T KOG0665|consen  242 KQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR  309 (369)
T ss_pred             HHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence                         00000 000 011122222   122233345778999999999999999999987

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.94  E-value=4.8e-26  Score=235.94  Aligned_cols=211  Identities=36%  Similarity=0.589  Sum_probs=182.8

Q ss_pred             cccccceEEEEEEeCC-CcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEeccCCCCHHH
Q 002010          700 IGKGGAGIVYRGSMPD-GIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGE  778 (982)
Q Consensus       700 lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~  778 (982)
                      ||+|.+|.||++...+ ++++++|++...........+.+|+..++.++|++++++++++......+++|||+++++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            6899999999997744 899999998544332235678999999999999999999999999899999999999999999


Q ss_pred             HhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcC-CCCEEEeccccchhccccCCcccccccc
Q 002010          779 MLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDS-DFEAHVADFGLAKFLQDAGASECMSSVA  857 (982)
Q Consensus       779 ~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~-~~~~kl~DfG~a~~~~~~~~~~~~~~~~  857 (982)
                      ++.... ..+++..+..++.++++++++||+.+   ++|+||+|.||+++. ++.++++|||.+........  ......
T Consensus        81 ~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~  154 (215)
T cd00180          81 LLKENE-GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIV  154 (215)
T ss_pred             HHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhccc
Confidence            997432 46899999999999999999999988   999999999999999 89999999999986653321  233456


Q ss_pred             cccccccccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceeecCCCCCC
Q 002010          858 GSYGYIAPEYAYTL-KVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDPRLSGY  936 (982)
Q Consensus       858 gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  936 (982)
                      +...|++||..... .++.++|+|++|++++++                                               
T Consensus       155 ~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-----------------------------------------------  187 (215)
T cd00180         155 GTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-----------------------------------------------  187 (215)
T ss_pred             CCCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------------------------
Confidence            77899999998877 788999999999999999                                               


Q ss_pred             ChHhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002010          937 PLTGVIHLFKVAMMCVEDESSARPTMREVVHM  968 (982)
Q Consensus       937 ~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~  968 (982)
                           ..+.+++.+|++.||++||+++++++.
T Consensus       188 -----~~~~~~l~~~l~~~p~~R~~~~~l~~~  214 (215)
T cd00180         188 -----PELKDLIRKMLQKDPEKRPSAKEILEH  214 (215)
T ss_pred             -----HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence                 157899999999999999999999874

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.94  E-value=1.3e-27  Score=260.95  Aligned_cols=252  Identities=25%  Similarity=0.329  Sum_probs=201.4

Q ss_pred             hhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEec
Q 002010          692 ESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEY  770 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  770 (982)
                      ++|+....+|.|.||.||||+. .+++..|+|.++-. .........+|+-+++..+|||||.++|.+...+..++.|||
T Consensus        15 ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLe-p~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy   93 (829)
T KOG0576|consen   15 DDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLE-PGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY   93 (829)
T ss_pred             cchhheeeecCCcccchhhhcccccCchhhheeeecc-CCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence            5678888999999999999964 56889999988433 344455677899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCc
Q 002010          771 MPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS  850 (982)
Q Consensus       771 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  850 (982)
                      |.||+|.+..+  -.+++++.++..+.+...+|++|||+.+   =+|||||-.||++++.|.+|++|||.+-.+..  ..
T Consensus        94 cgggslQdiy~--~TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqita--ti  166 (829)
T KOG0576|consen   94 CGGGSLQDIYH--VTGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITA--TI  166 (829)
T ss_pred             cCCCcccceee--ecccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhh--hh
Confidence            99999999876  5578999999999999999999999888   79999999999999999999999999876643  23


Q ss_pred             ccccccccccccccccccc---cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccce
Q 002010          851 ECMSSVAGSYGYIAPEYAY---TLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLA  927 (982)
Q Consensus       851 ~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  927 (982)
                      .......||+.|||||+..   .+.|...+|||+.|+...|+-.-++|.-+... ........+....++..        
T Consensus       167 ~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhp-mr~l~LmTkS~~qpp~l--------  237 (829)
T KOG0576|consen  167 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHP-MRALFLMTKSGFQPPTL--------  237 (829)
T ss_pred             hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccch-HHHHHHhhccCCCCCcc--------
Confidence            3346789999999999763   56799999999999999999888887644322 12222222222111111        


Q ss_pred             eecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          928 VVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       928 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                             ..+..-...+-+|++.|+.++|.+|||++.++.
T Consensus       238 -------kDk~kws~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  238 -------KDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             -------cCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence                   112222335779999999999999999987654

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.93  E-value=2.7e-25  Score=233.21  Aligned_cols=211  Identities=32%  Similarity=0.423  Sum_probs=175.3

Q ss_pred             cccccccccccceEEEEEEeCC-CcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEeccC
Q 002010          694 LKDENIIGKGGAGIVYRGSMPD-GIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMP  772 (982)
Q Consensus       694 ~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  772 (982)
                      |+..+.||+|++|.||+|...+ ++.+|+|.+.........+.+.+|++.+++++|+|++++++++......++++||++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            4566789999999999997654 889999998544332246678899999999999999999999999999999999999


Q ss_pred             CCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCccc
Q 002010          773 NGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASEC  852 (982)
Q Consensus       773 ~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~  852 (982)
                      +++|.+++..... .+++..+..++.+++.++.++|+.+   ++|+|++|+||+++.++.++|+|||.+....... ...
T Consensus        81 ~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~-~~~  155 (225)
T smart00221       81 GGDLFDYLRKKGG-KLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDL-AAL  155 (225)
T ss_pred             CCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCcc-ccc
Confidence            9999999974321 1889999999999999999999988   9999999999999999999999999998765432 112


Q ss_pred             cccccccccccccccc-ccCCCCcchhhHHHHHHHHHHHhCCCCCCC-CCCCchHHHHH
Q 002010          853 MSSVAGSYGYIAPEYA-YTLKVDEKSDVYSFGVVLLELIAGKKPVGE-FGDGVDIVRWV  909 (982)
Q Consensus       853 ~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslG~il~elltg~~p~~~-~~~~~~~~~~~  909 (982)
                      .....++..|++||.. ....++.++|||++|+++++|++|+.||.. ..+...+.+.+
T Consensus       156 ~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~  214 (225)
T smart00221      156 LKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVW  214 (225)
T ss_pred             ccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHH
Confidence            3345677889999998 667788899999999999999999999976 33333444433

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.93  E-value=1.8e-26  Score=241.49  Aligned_cols=270  Identities=23%  Similarity=0.292  Sum_probs=199.3

Q ss_pred             HHHHHhhcccccccccccceEEEEEEeC----CCcEEEEEEeccCCCCCchhhHHHHHHHHhcC-CCCcccceEeEEEcC
Q 002010          687 AEDVLESLKDENIIGKGGAGIVYRGSMP----DGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRI-RHRNIVRLLGYVSNR  761 (982)
Q Consensus       687 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~  761 (982)
                      ...+.+.|..+++||+|.|++||+|...    ..+.||+|.+...   .....+..|++++..+ .+.||+++.+++...
T Consensus        31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t---s~p~ri~~El~~L~~~gG~~ni~~~~~~~rnn  107 (418)
T KOG1167|consen   31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT---SSPSRILNELEMLYRLGGSDNIIKLNGCFRNN  107 (418)
T ss_pred             hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccc---cCchHHHHHHHHHHHhccchhhhcchhhhccC
Confidence            3445567899999999999999999432    5788999988443   3345688999999999 589999999999999


Q ss_pred             CccEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCC-CCEEEecccc
Q 002010          762 DTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSD-FEAHVADFGL  840 (982)
Q Consensus       762 ~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~-~~~kl~DfG~  840 (982)
                      +...+|+||++...-.++..     .++..++..+++.+..||+++|..|   ||||||||+|++.+.. +.-.|.|||+
T Consensus       108 d~v~ivlp~~~H~~f~~l~~-----~l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgL  179 (418)
T KOG1167|consen  108 DQVAIVLPYFEHDRFRDLYR-----SLSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGL  179 (418)
T ss_pred             CeeEEEecccCccCHHHHHh-----cCCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechh
Confidence            99999999999999988885     4668899999999999999999998   9999999999999854 6789999999


Q ss_pred             chhccccC----------------------------------C--------cccccccccccccccccccccCC-CCcch
Q 002010          841 AKFLQDAG----------------------------------A--------SECMSSVAGSYGYIAPEYAYTLK-VDEKS  877 (982)
Q Consensus       841 a~~~~~~~----------------------------------~--------~~~~~~~~gt~~y~aPE~~~~~~-~~~~~  877 (982)
                      |...+...                                  .        ........||++|.|||++.... .+.++
T Consensus       180 A~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qttai  259 (418)
T KOG1167|consen  180 AQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAI  259 (418)
T ss_pred             HHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcc
Confidence            98432110                                  0        00011346999999999987654 68899


Q ss_pred             hhHHHHHHHHHHHhCCCCCCCCCCCchH-HHHHHHhcc-----------C--CCCCCcccc---cceeecCC--------
Q 002010          878 DVYSFGVVLLELIAGKKPVGEFGDGVDI-VRWVRKTTS-----------E--VSQPSDAAS---VLAVVDPR--------  932 (982)
Q Consensus       878 DvwslG~il~elltg~~p~~~~~~~~~~-~~~~~~~~~-----------~--~~~~~~~~~---~~~~~~~~--------  932 (982)
                      ||||.|||+..+++++.||-...++.+. ..++...+.           .  .+++.....   ....++..        
T Consensus       260 Diws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~  339 (418)
T KOG1167|consen  260 DIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKS  339 (418)
T ss_pred             ceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccc
Confidence            9999999999999999999765444322 222221111           1  111111000   00000000        


Q ss_pred             ----CC--CCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          933 ----LS--GYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       933 ----~~--~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                          ..  ......+..+++++++|++.||.+|-|++|.++
T Consensus       340 ~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk  380 (418)
T KOG1167|consen  340 RQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK  380 (418)
T ss_pred             cccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence                00  111222346899999999999999999999876

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.93  E-value=2.4e-26  Score=243.66  Aligned_cols=266  Identities=23%  Similarity=0.261  Sum_probs=199.4

Q ss_pred             HhhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCC------CCcccceEeEEEcCCc
Q 002010          691 LESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIR------HRNIVRLLGYVSNRDT  763 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~~~~~~~~~~~  763 (982)
                      -.+|.+....|+|-|++|.+|.. ..|..||||++...  +...+.=+.|++++++++      --|.++++-.|....+
T Consensus       431 D~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN--E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknH  508 (752)
T KOG0670|consen  431 DSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN--EVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNH  508 (752)
T ss_pred             cceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc--hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcce
Confidence            35788888999999999999954 45889999998443  222333467999999995      3578999999999999


Q ss_pred             cEEEEeccCCCCHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCC-CCEEEeccccc
Q 002010          764 NLLLYEYMPNGSLGEMLHGA-KGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSD-FEAHVADFGLA  841 (982)
Q Consensus       764 ~~lv~e~~~~~sL~~~l~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~-~~~kl~DfG~a  841 (982)
                      .|+|+|-. ..+|.+.+++. ++-.+....+..++.|+.-||..|...+   |+|.||||.||||++. ..+||||||.|
T Consensus       509 LClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCDfGSA  584 (752)
T KOG0670|consen  509 LCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCDFGSA  584 (752)
T ss_pred             eEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeeccCccc
Confidence            99999998 66999999753 4567888999999999999999999888   9999999999999875 67899999999


Q ss_pred             hhccccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCC---
Q 002010          842 KFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQ---  918 (982)
Q Consensus       842 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---  918 (982)
                      .+.....    .+.+.-+..|.|||++.+..|++..|+||+||.+||+.||+.-|.+...-. ..++........+.   
T Consensus       585 ~~~~ene----itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~-MLrl~me~KGk~p~Kml  659 (752)
T KOG0670|consen  585 SFASENE----ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQ-MLRLFMELKGKFPNKML  659 (752)
T ss_pred             ccccccc----ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHH-HHHHHHHhcCCCcHHHh
Confidence            8765432    233445668999999999999999999999999999999999998754432 22222222111110   


Q ss_pred             ----------CC---------------cccccceeecCC------C---CCCChH---hHHHHHHHHhhccCCCCCCCCC
Q 002010          919 ----------PS---------------DAASVLAVVDPR------L---SGYPLT---GVIHLFKVAMMCVEDESSARPT  961 (982)
Q Consensus       919 ----------~~---------------~~~~~~~~~~~~------~---~~~~~~---~~~~l~~li~~cl~~dP~~Rpt  961 (982)
                                ..               ....++..+.|.      +   +.++.+   ....+.+|+..|+..||++|.|
T Consensus       660 RKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit  739 (752)
T KOG0670|consen  660 RKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRIT  739 (752)
T ss_pred             hhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCC
Confidence                      00               001111122220      0   012333   3346889999999999999999


Q ss_pred             HHHHHH
Q 002010          962 MREVVH  967 (982)
Q Consensus       962 ~~ell~  967 (982)
                      ..+.++
T Consensus       740 ~nqAL~  745 (752)
T KOG0670|consen  740 VNQALK  745 (752)
T ss_pred             HHHHhc
Confidence            999875

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.93  E-value=2.7e-26  Score=224.43  Aligned_cols=252  Identities=23%  Similarity=0.323  Sum_probs=196.3

Q ss_pred             cccccccccccceEEEEEEeCCCcEEEEEEec-cCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEeccC
Q 002010          694 LKDENIIGKGGAGIVYRGSMPDGIDVAIKRLV-GRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMP  772 (982)
Q Consensus       694 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~-~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  772 (982)
                      .....+|.+...|..|+|++ .|..+++|++. ...+....++|..|.-.++.+.||||++++|+|..+....++..||+
T Consensus       192 lnl~tkl~e~hsgelwrgrw-qgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp  270 (448)
T KOG0195|consen  192 LNLITKLAESHSGELWRGRW-QGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMP  270 (448)
T ss_pred             hhhhhhhccCCCcccccccc-cCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeecc
Confidence            34455788999999999999 55666777663 23445566789999999999999999999999999999999999999


Q ss_pred             CCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCccc
Q 002010          773 NGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASEC  852 (982)
Q Consensus       773 ~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~  852 (982)
                      .|+|+..++....-..+..++.+++.++++|++|||+.. +-|.---+.++.|++|++.+.+|.- +-+      .....
T Consensus       271 ~gslynvlhe~t~vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarism-ad~------kfsfq  342 (448)
T KOG0195|consen  271 FGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISM-ADT------KFSFQ  342 (448)
T ss_pred             chHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheec-ccc------eeeee
Confidence            999999999877777888999999999999999999864 3233446889999999998888751 111      11122


Q ss_pred             ccccccccccccccccccCCCC---cchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceee
Q 002010          853 MSSVAGSYGYIAPEYAYTLKVD---EKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVV  929 (982)
Q Consensus       853 ~~~~~gt~~y~aPE~~~~~~~~---~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  929 (982)
                      .......|.||+||.+..++.+   .++|+|||++++||+.|...||.+...-+ ....+.-.+                
T Consensus       343 e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspme-cgmkialeg----------------  405 (448)
T KOG0195|consen  343 EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPME-CGMKIALEG----------------  405 (448)
T ss_pred             ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchh-hhhhhhhcc----------------
Confidence            2344567899999999876643   57899999999999999999998865422 222111111                


Q ss_pred             cCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 002010          930 DPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPP  973 (982)
Q Consensus       930 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~  973 (982)
                        -....|+.....+.++|.-|++.||.+||.++.++-.||+..
T Consensus       406 --lrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  406 --LRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             --ccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence              112345555668999999999999999999999999998753

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=99.92  E-value=6.6e-27  Score=240.96  Aligned_cols=277  Identities=18%  Similarity=0.187  Sum_probs=168.9

Q ss_pred             cccEEEeccCCCCCCCChhhhhhcccceeeccCCccccccchhhhhcCCCccEEeccC-ccccCCCchhccccccccEEe
Q 002010           96 KLVNLTISNVNLTGRLPSEMALLTSLKVFNISGNVFQGNFAGQIVRGMTELQVLDAYN-NNFTGPLPVEIASLKSLRHLS  174 (982)
Q Consensus        96 ~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~-n~l~~~~p~~l~~l~~L~~L~  174 (982)
                      ..++++|..|+|+...|.+|+.+++|+.||||+|.++ .+.+.+|.++.+|.+|-+.+ |+|+...-..|++|.+|+.|.
T Consensus        68 ~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is-~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLl  146 (498)
T KOG4237|consen   68 ETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNIS-FIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLL  146 (498)
T ss_pred             cceEEEeccCCcccCChhhccchhhhceecccccchh-hcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHh
Confidence            4577889999999777788889999999999998887 45667788888887776655 888855556678888888888


Q ss_pred             ecCcccccccCCCccccCcceEeeccCcccccchhhHHhhhhhHHHHhhcccccccc-----------cCCCCCCCCCCC
Q 002010          175 FGGNYFTGKIPQSYSEIQSLEYIGLNGIGLNGTVPAFLSRLKNLREMYIGYFNTYTG-----------GIPPGFGALTQL  243 (982)
Q Consensus       175 L~~N~l~~~~p~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~l~~~n~~~~-----------~~p~~~~~l~~L  243 (982)
                      +.-|++.-...+.|..+++|..|.+..|.+....-..+..+..++.+.+..+.....           ..|..+++..-.
T Consensus       147 lNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgarc~  226 (498)
T KOG4237|consen  147 LNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGARCV  226 (498)
T ss_pred             cChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccchhhhHHhhchhhcccceec
Confidence            888888877778888888888888888887765555777777777777765331111           122233333333


Q ss_pred             CEEecccCcCcccCchhhcCC-CccceeecccccCCCCCC-ccccCCCCCCEEEeeCCcccCcCchhhhcccchhhhhhc
Q 002010          244 QVLDMASCNISGEIPTSLSRL-KLLHSLFLQMNKLTGHIP-PQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQLF  321 (982)
Q Consensus       244 ~~L~L~~n~l~~~~~~~l~~l-~~L~~L~L~~N~l~~~~~-~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~  321 (982)
                      .-..+.++++..+.+..|..- ..+.+=..+.+...+..| ..|..|++|+.|+|++|+|+.+.+.+|..+..+++|.|.
T Consensus       227 ~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~  306 (498)
T KOG4237|consen  227 SPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLT  306 (498)
T ss_pred             chHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcC
Confidence            333444444443333322111 111111111111222222 235555555555555555555555555555555555555


Q ss_pred             cCCCCCCCCCcCCCCCCccEEEccCCCcccccCccccCCCcccEEEeccccc
Q 002010          322 KNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHL  373 (982)
Q Consensus       322 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l  373 (982)
                      .|+|...-...|.++..|+.|+|.+|+|+...|.+|..+..|.+|+|-.|.+
T Consensus       307 ~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~  358 (498)
T KOG4237|consen  307 RNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPF  358 (498)
T ss_pred             cchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcc
Confidence            5555544445555555555555555555555555555555555555555544

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=99.92  E-value=1.6e-26  Score=238.16  Aligned_cols=404  Identities=19%  Similarity=0.193  Sum_probs=251.0

Q ss_pred             cccEEeecCcccccccCCCccccCcceEeeccCcccccchhhHHhhhhhHHHHhhcccccccccCCCCCCCCCCCCEEec
Q 002010          169 SLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLNGIGLNGTVPAFLSRLKNLREMYIGYFNTYTGGIPPGFGALTQLQVLDM  248 (982)
Q Consensus       169 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~l~~~n~~~~~~p~~~~~l~~L~~L~L  248 (982)
                      .-++++|..|+|+...|.+|+.+++|+.|+|++|.|+.+.|.+|.++.+|..|.+-++|.++..-...|++|.+|+.|.+
T Consensus        68 ~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLll  147 (498)
T KOG4237|consen   68 ETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLL  147 (498)
T ss_pred             cceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhc
Confidence            34556666666665556666666666666666666666667777777777777666656665444445777777777778


Q ss_pred             ccCcCcccCchhhcCCCccceeecccccCCCCCCccccCCCCCCEEEeeCCcc------------cCcCchhhhcccchh
Q 002010          249 ASCNISGEIPTSLSRLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYL------------TGEIPESFAALKNLT  316 (982)
Q Consensus       249 ~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l------------~~~~~~~l~~l~~L~  316 (982)
                      .-|++.-.....|..+++|..|.+.+|.+..+--..|..+.+++.+.+..|.+            ....|..++......
T Consensus       148 Nan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgarc~~  227 (498)
T KOG4237|consen  148 NANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGARCVS  227 (498)
T ss_pred             ChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccchhhhHHhhchhhcccceecc
Confidence            78888767777788888888888888888744444777888888888877772            222334445555555


Q ss_pred             hhhhccCCCCCCCCCcCCCC-CCcc-EEEccCCCcccccCccccCCCcccEEEeccccccccCCccccCccccceeeccc
Q 002010          317 LLQLFKNNLRGPIPSFLGDF-PNLE-VLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQ  394 (982)
Q Consensus       317 ~L~L~~N~l~~~~p~~~~~l-~~L~-~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~l~~  394 (982)
                      -..+.++++..+.+..|... ..+. .+....+.........|..+++|+.|+|++|++++.-+.+|.++..+++|.|..
T Consensus       228 p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~  307 (498)
T KOG4237|consen  228 PYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTR  307 (498)
T ss_pred             hHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCc
Confidence            55666666654444433322 1111 122222222222334567777777777777777777777777777777777777


Q ss_pred             ccccccCCccccCCCCCCEEEccCCccCCCCCccccCCCccccccCCCccccccCCcccccCCccEEEeeccccCCCCch
Q 002010          395 NFFIGPIPEELGQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLSGELPEKMSGASLNQLKVANNNITGKIPA  474 (982)
Q Consensus       395 N~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~L~~N~i~~~~p~  474 (982)
                      |++...-...|.++..|+.|+|.+|+|+..-|..|..+..|..|.|-.|.+...-.-.|-...|     ..+.-.|. |.
T Consensus       308 N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~l~wl~~Wl-----r~~~~~~~-~~  381 (498)
T KOG4237|consen  308 NKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNCRLAWLGEWL-----RKKSVVGN-PR  381 (498)
T ss_pred             chHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCccchHHHHHHH-----hhCCCCCC-CC
Confidence            7777666677777777777888888877777777777777777777777665332111111111     11111111 11


Q ss_pred             hccCCCCcceeeecccccc---CCCccccc---------cccccc-eeeeeccccCCCCCcccccccCCCeeeCCCCccc
Q 002010          475 AIGNLPSLNILSLQNNRLE---GEIPVESF---------NLKMIT-SINISDNNISGEIPYSISQCHSLTSVDLSRNSLY  541 (982)
Q Consensus       475 ~~~~l~~L~~L~L~~N~l~---~~~p~~~~---------~l~~L~-~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  541 (982)
                      . +.-..++.+.++++.+.   ...|++..         ..+-+. ....|++.++ .+|..+-  ..-++|++.+|.++
T Consensus       382 C-q~p~~~~~~~~~dv~~~~~~c~~~ee~~~~~s~~cP~~c~c~~tVvRcSnk~lk-~lp~~iP--~d~telyl~gn~~~  457 (498)
T KOG4237|consen  382 C-QSPGFVRQIPISDVAFGDFRCGGPEELGCLTSSPCPPPCTCLDTVVRCSNKLLK-LLPRGIP--VDVTELYLDGNAIT  457 (498)
T ss_pred             C-CCCchhccccchhccccccccCCccccCCCCCCCCCCCcchhhhhHhhcccchh-hcCCCCC--chhHHHhcccchhc
Confidence            0 11123444444444332   11222211         122232 3445565555 5554443  35678899999998


Q ss_pred             CCCCcccccccccceEEcccccccccCccccccccccceecccCC
Q 002010          542 GKIPPGISKLIDLSILNLSRNGITGSIPNEMRNMMSLTTLDLSYN  586 (982)
Q Consensus       542 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N  586 (982)
                       .+|..  .+.+| .+||++|+++..-...|.++++|.+|-||+|
T Consensus       458 -~vp~~--~~~~l-~~dls~n~i~~Lsn~tf~n~tql~tlilsyn  498 (498)
T KOG4237|consen  458 -SVPDE--LLRSL-LLDLSNNRISSLSNYTFSNMTQLSTLILSYN  498 (498)
T ss_pred             -ccCHH--HHhhh-hcccccCceehhhcccccchhhhheeEEecC
Confidence             77776  67788 8899999998666678899999999998887

>PLN03210 Resistant to P

Probab=99.91  E-value=7.4e-24  Score=269.88  Aligned_cols=337  Identities=21%  Similarity=0.266  Sum_probs=255.7

Q ss_pred             CCCCCCCCCCEEecccCc------CcccCchhhcCCC-ccceeecccccCCCCCCccccCCCCCCEEEeeCCcccCcCch
Q 002010          235 PGFGALTQLQVLDMASCN------ISGEIPTSLSRLK-LLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPE  307 (982)
Q Consensus       235 ~~~~~l~~L~~L~L~~n~------l~~~~~~~l~~l~-~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~  307 (982)
                      ..|.++++|+.|.+..+.      +...+|..|..++ +|+.|++.+|.++ .+|..| ...+|+.|+|++|++. .++.
T Consensus       552 ~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~~  628 (1153)
T PLN03210        552 NAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLWD  628 (1153)
T ss_pred             HHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-cccc
Confidence            347788888888886653      3334666676664 5888899888887 667666 4678899999998887 5677


Q ss_pred             hhhcccchhhhhhccCCCCCCCCCcCCCCCCccEEEccCCCcccccCccccCCCcccEEEeccccccccCCccccCcccc
Q 002010          308 SFAALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDLCKGGKL  387 (982)
Q Consensus       308 ~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L  387 (982)
                      .+..+++|+.|+|+++.....+|. ++.+++|+.|++++|.....+|..++.+++|+.|++++|.....+|..+ ++++|
T Consensus       629 ~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~sL  706 (1153)
T PLN03210        629 GVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKSL  706 (1153)
T ss_pred             ccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCCCC
Confidence            778888899999988765446664 7788899999998887767788888888999999998876555777655 68889


Q ss_pred             ceeecccccccccCCccccCCCCCCEEEccCCccCCCCCccccCCCccccccCCCccccc-------cCCccc-ccCCcc
Q 002010          388 KSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLSG-------ELPEKM-SGASLN  459 (982)
Q Consensus       388 ~~L~l~~N~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-------~~~~~~-~~~~L~  459 (982)
                      +.|++++|...+.+|..   ..+|++|++++|.+. .+|..+ .+++|..|++.++....       ..+... ..++|+
T Consensus       707 ~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~-~lP~~~-~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~  781 (1153)
T PLN03210        707 YRLNLSGCSRLKSFPDI---STNISWLDLDETAIE-EFPSNL-RLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLT  781 (1153)
T ss_pred             CEEeCCCCCCccccccc---cCCcCeeecCCCccc-cccccc-cccccccccccccchhhccccccccchhhhhccccch
Confidence            99999888766666643   457888999999887 567655 57778888777643211       111111 125788


Q ss_pred             EEEeeccccCCCCchhccCCCCcceeeeccccccCCCccccccccccceeeeeccccCCCCCcccccccCCCeeeCCCCc
Q 002010          460 QLKVANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIPYSISQCHSLTSVDLSRNS  539 (982)
Q Consensus       460 ~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~  539 (982)
                      .|++++|...+.+|..++++++|+.|++++|..-+.+|..+ .+++|++|+|++|..-..+|..   .++|+.|+|++|.
T Consensus       782 ~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls~n~  857 (1153)
T PLN03210        782 RLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNISDLNLSRTG  857 (1153)
T ss_pred             heeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc---ccccCEeECCCCC
Confidence            99999988777888889999999999998875444677665 6888999999987655455543   3678899999999


Q ss_pred             ccCCCCcccccccccceEEccc-ccccccCccccccccccceecccCCc
Q 002010          540 LYGKIPPGISKLIDLSILNLSR-NGITGSIPNEMRNMMSLTTLDLSYNN  587 (982)
Q Consensus       540 l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~l~~l~~L~~L~Ls~N~  587 (982)
                      ++ .+|.++..+++|+.|+|++ |++. .+|..+..+++|+.+++++|.
T Consensus       858 i~-~iP~si~~l~~L~~L~L~~C~~L~-~l~~~~~~L~~L~~L~l~~C~  904 (1153)
T PLN03210        858 IE-EVPWWIEKFSNLSFLDMNGCNNLQ-RVSLNISKLKHLETVDFSDCG  904 (1153)
T ss_pred             Cc-cChHHHhcCCCCCEEECCCCCCcC-ccCcccccccCCCeeecCCCc
Confidence            87 6888889999999999988 4555 577778888899999988875

syringae 6; Provisional

>PLN03210 Resistant to P

Probab=99.91  E-value=2.7e-23  Score=264.76  Aligned_cols=285  Identities=25%  Similarity=0.296  Sum_probs=152.7

Q ss_pred             CCCCEEecccCcCcccCchhhcCCCccceeecccccCCCCCCccccCCCCCCEEEeeCCcccCcCchhhhcccchhhhhh
Q 002010          241 TQLQVLDMASCNISGEIPTSLSRLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQL  320 (982)
Q Consensus       241 ~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L  320 (982)
                      .+|+.|++.+|++. .++..+..+++|+.|+|+++.....+| .++.+++|++|+|++|.....+|..+..+++|+.|++
T Consensus       611 ~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip-~ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L  688 (1153)
T PLN03210        611 ENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIP-DLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDM  688 (1153)
T ss_pred             cCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCC-ccccCCcccEEEecCCCCccccchhhhccCCCCEEeC
Confidence            45555555555554 344445555555555555544333444 2455555666666555444455555555556666666


Q ss_pred             ccCCCCCCCCCcCCCCCCccEEEccCCCcccccCccccCCCcccEEEeccccccccCCccccCccccceeecccccc---
Q 002010          321 FKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFF---  397 (982)
Q Consensus       321 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~l~~N~~---  397 (982)
                      ++|..-+.+|..+ ++++|+.|++++|.....+|..   ..+|+.|++++|.+. .+|..+ .+.+|++|.+.++..   
T Consensus       689 ~~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~-~lP~~~-~l~~L~~L~l~~~~~~~l  762 (1153)
T PLN03210        689 SRCENLEILPTGI-NLKSLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIE-EFPSNL-RLENLDELILCEMKSEKL  762 (1153)
T ss_pred             CCCCCcCccCCcC-CCCCCCEEeCCCCCCccccccc---cCCcCeeecCCCccc-cccccc-cccccccccccccchhhc
Confidence            5543333444433 4556666666665443333332   235566666666654 344433 345555555554221   


Q ss_pred             ----cccCCccccCCCCCCEEEccCCccCCCCCccccCCCccccccCCCccccccCCcccccCCccEEEeeccccCCCCc
Q 002010          398 ----IGPIPEELGQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLSGELPEKMSGASLNQLKVANNNITGKIP  473 (982)
Q Consensus       398 ----~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~L~~N~i~~~~p  473 (982)
                          ....+......++|+.|+|++|...+.+|..+.++++|+.|++++|..-+.+|                       
T Consensus       763 ~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP-----------------------  819 (1153)
T PLN03210        763 WERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLP-----------------------  819 (1153)
T ss_pred             cccccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeC-----------------------
Confidence                11112222234567777777776666667666666666666665553322333                       


Q ss_pred             hhccCCCCcceeeeccccccCCCccccccccccceeeeeccccCCCCCcccccccCCCeeeCCC-CcccCCCCccccccc
Q 002010          474 AAIGNLPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIPYSISQCHSLTSVDLSR-NSLYGKIPPGISKLI  552 (982)
Q Consensus       474 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~  552 (982)
                      ..+ ++++|+.|++++|..-..+|..   ..+|++|+|++|.|+ .+|.++..+++|+.|+|++ |++. .+|..+..++
T Consensus       820 ~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~-~l~~~~~~L~  893 (1153)
T PLN03210        820 TGI-NLESLESLDLSGCSRLRTFPDI---STNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQ-RVSLNISKLK  893 (1153)
T ss_pred             CCC-CccccCEEECCCCCcccccccc---ccccCEeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcC-ccCccccccc
Confidence            322 3455555555554332233322   245666666666666 5666667777777777776 3444 4666677777


Q ss_pred             ccceEEcccc
Q 002010          553 DLSILNLSRN  562 (982)
Q Consensus       553 ~L~~L~Ls~N  562 (982)
                      +|+.|+++++
T Consensus       894 ~L~~L~l~~C  903 (1153)
T PLN03210        894 HLETVDFSDC  903 (1153)
T ss_pred             CCCeeecCCC
Confidence            7777777666

syringae 6; Provisional

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.90  E-value=3.7e-24  Score=264.96  Aligned_cols=196  Identities=18%  Similarity=0.213  Sum_probs=139.6

Q ss_pred             cCCC-CcccceEeEE-------EcCCccEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEE
Q 002010          745 RIRH-RNIVRLLGYV-------SNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLII  816 (982)
Q Consensus       745 ~l~h-~niv~~~~~~-------~~~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iv  816 (982)
                      .++| +||+++++++       ...+..+.++||+ +++|.+++... ...+++.++..++.||++||+|||+++   |+
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~g---Iv  102 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAHSQG---IV  102 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence            3455 6888888877       2334567788988 66999999732 456999999999999999999999988   99


Q ss_pred             ecCCCCCcEEEcC-------------------CCCEEEeccccchhccccCC--------------cccccccccccccc
Q 002010          817 HRDVKSNNILLDS-------------------DFEAHVADFGLAKFLQDAGA--------------SECMSSVAGSYGYI  863 (982)
Q Consensus       817 HrDlkp~Nill~~-------------------~~~~kl~DfG~a~~~~~~~~--------------~~~~~~~~gt~~y~  863 (982)
                      ||||||+|||++.                   ++.+|++|||+++.......              ........||+.||
T Consensus       103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~  182 (793)
T PLN00181        103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT  182 (793)
T ss_pred             eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence            9999999999964                   34566666666654211000              00011245788999


Q ss_pred             cccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceeecCCCCCCChHhHHH
Q 002010          864 APEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDPRLSGYPLTGVIH  943 (982)
Q Consensus       864 aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  943 (982)
                      |||++.+..|+.++|||||||++|||++|.+|+....  .....+... ..               .+..    ......
T Consensus       183 APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~-~~---------------~~~~----~~~~~~  240 (793)
T PLN00181        183 SPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHR-VL---------------PPQI----LLNWPK  240 (793)
T ss_pred             ChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHh-hc---------------Chhh----hhcCHH
Confidence            9999999999999999999999999999988865321  111111110 00               0000    011123


Q ss_pred             HHHHHhhccCCCCCCCCCHHHHHH
Q 002010          944 LFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       944 l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                      ..+++.+||+.||.+||+++|+++
T Consensus       241 ~~~~~~~~L~~~P~~Rps~~eil~  264 (793)
T PLN00181        241 EASFCLWLLHPEPSCRPSMSELLQ  264 (793)
T ss_pred             HHHHHHHhCCCChhhCcChHHHhh
Confidence            567889999999999999999986

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.90  E-value=3.6e-23  Score=208.04  Aligned_cols=167  Identities=22%  Similarity=0.234  Sum_probs=126.9

Q ss_pred             CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCcccc
Q 002010          774 GSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECM  853 (982)
Q Consensus       774 ~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~  853 (982)
                      |+|.++++. +...+++.+++.++.||+.|++|||+.+         ||+||+++.++.+|+  ||.+......      
T Consensus         1 GsL~~~l~~-~~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~------   62 (176)
T smart00750        1 VSLADILEV-RGRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPE------   62 (176)
T ss_pred             CcHHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeeccc------
Confidence            689999974 2457999999999999999999999764         999999999999999  9998765432      


Q ss_pred             cccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceeecCCC
Q 002010          854 SSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDPRL  933 (982)
Q Consensus       854 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  933 (982)
                       ...|++.|||||++.+..++.++||||+||++|||+||+.||............+........             +..
T Consensus        63 -~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-------------~~~  128 (176)
T smart00750       63 -QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADD-------------PRD  128 (176)
T ss_pred             -cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCC-------------ccc
Confidence             125789999999999999999999999999999999999999764332222222222111100             000


Q ss_pred             CCCChHhH--HHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 002010          934 SGYPLTGV--IHLFKVAMMCVEDESSARPTMREVVHMLANP  972 (982)
Q Consensus       934 ~~~~~~~~--~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~  972 (982)
                      ...+....  ..+.+++.+||+.||++|||+.|+++.+...
T Consensus       129 ~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~  169 (176)
T smart00750      129 RSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL  169 (176)
T ss_pred             cccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence            01111222  2689999999999999999999999876543

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=99.89  E-value=3.4e-23  Score=243.92  Aligned_cols=263  Identities=27%  Similarity=0.330  Sum_probs=172.1

Q ss_pred             CccceeecccccCCCCCCccccCCCCCCEEEeeCCcccCcCchhhhcccchhhhhhccCCCCCCCCCcCCCCCCccEEEc
Q 002010          265 KLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQV  344 (982)
Q Consensus       265 ~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L  344 (982)
                      ..-..|+|++|.|+ .+|..+.  ++|+.|++++|+|+. +|..   +++|++|++++|+|+. +|..   .++|+.|++
T Consensus       201 ~~~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt~-LP~l---p~~Lk~LdLs~N~Lts-LP~l---p~sL~~L~L  269 (788)
T PRK15387        201 NGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTS-LPAL---PPELRTLEVSGNQLTS-LPVL---PPGLLELSI  269 (788)
T ss_pred             CCCcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCCC-CCCC---CCCCcEEEecCCccCc-ccCc---ccccceeec
Confidence            34567888888888 5666664  368888888888873 4532   3566777777777763 3432   345666666


Q ss_pred             cCCCcccccCccccCCCcccEEEeccccccccCCccccCccccceeecccccccccCCccccCCCCCCEEEccCCccCCC
Q 002010          345 WGNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGT  424 (982)
Q Consensus       345 ~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~l~~N~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~  424 (982)
                      ++|.++. +|..   ..+|+.|++++|+++ .+|..                           .++|+.|++++|+|++ 
T Consensus       270 s~N~L~~-Lp~l---p~~L~~L~Ls~N~Lt-~LP~~---------------------------p~~L~~LdLS~N~L~~-  316 (788)
T PRK15387        270 FSNPLTH-LPAL---PSGLCKLWIFGNQLT-SLPVL---------------------------PPGLQELSVSDNQLAS-  316 (788)
T ss_pred             cCCchhh-hhhc---hhhcCEEECcCCccc-ccccc---------------------------ccccceeECCCCcccc-
Confidence            6666652 3322   134555556666555 22321                           2345566666666553 


Q ss_pred             CCccccCCCccccccCCCccccccCCcccccCCccEEEeeccccCCCCchhccCCCCcceeeeccccccCCCcccccccc
Q 002010          425 IPAGLFNLPLLNMMELDDNLLSGELPEKMSGASLNQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESFNLK  504 (982)
Q Consensus       425 ~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~  504 (982)
                      +|...   ..|+.|++++|.+++ +|..  ..+|+.|+|++|+|++ +|..   .++|+.|++++|+|+ .+|..   ..
T Consensus       317 Lp~lp---~~L~~L~Ls~N~L~~-LP~l--p~~Lq~LdLS~N~Ls~-LP~l---p~~L~~L~Ls~N~L~-~LP~l---~~  382 (788)
T PRK15387        317 LPALP---SELCKLWAYNNQLTS-LPTL--PSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLT-SLPAL---PS  382 (788)
T ss_pred             CCCCc---ccccccccccCcccc-cccc--ccccceEecCCCccCC-CCCC---Ccccceehhhccccc-cCccc---cc
Confidence            33211   235555666666654 2321  1467788888888874 4443   346777888888887 46643   35


Q ss_pred             ccceeeeeccccCCCCCcccccccCCCeeeCCCCcccCCCCcccccccccceEEcccccccccCccccccccccceeccc
Q 002010          505 MITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYGKIPPGISKLIDLSILNLSRNGITGSIPNEMRNMMSLTTLDLS  584 (982)
Q Consensus       505 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls  584 (982)
                      +|+.|+|++|+|++ +|..   .++|+.|++++|+|+ .+|..+   .+|+.|+|++|+|+ .+|..+.++++|+.|+|+
T Consensus       383 ~L~~LdLs~N~Lt~-LP~l---~s~L~~LdLS~N~Ls-sIP~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs  453 (788)
T PRK15387        383 GLKELIVSGNRLTS-LPVL---PSELKELMVSGNRLT-SLPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLE  453 (788)
T ss_pred             ccceEEecCCcccC-CCCc---ccCCCEEEccCCcCC-CCCcch---hhhhhhhhccCccc-ccChHHhhccCCCeEECC
Confidence            68888889888884 5543   357889999999998 467543   46788999999998 788889999999999999


Q ss_pred             CCccccCCCC
Q 002010          585 YNNLIGNIPS  594 (982)
Q Consensus       585 ~N~l~~~ip~  594 (982)
                      +|+|+|.+|.
T Consensus       454 ~N~Ls~~~~~  463 (788)
T PRK15387        454 GNPLSERTLQ  463 (788)
T ss_pred             CCCCCchHHH
Confidence            9999988774

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=99.89  E-value=3.2e-23  Score=244.10  Aligned_cols=268  Identities=27%  Similarity=0.399  Sum_probs=194.2

Q ss_pred             CCCCEEecccCcCcccCchhhcCCCccceeecccccCCCCCCccccCCCCCCEEEeeCCcccCcCchhhhcccchhhhhh
Q 002010          241 TQLQVLDMASCNISGEIPTSLSRLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQL  320 (982)
Q Consensus       241 ~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L  320 (982)
                      ..-..|+|+.|+++ .+|..+.  ++|+.|++++|+++. +|.   .+++|++|+|++|+|+. +|..   .++|+.|++
T Consensus       201 ~~~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt~-LP~---lp~~Lk~LdLs~N~Lts-LP~l---p~sL~~L~L  269 (788)
T PRK15387        201 NGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTS-LPA---LPPELRTLEVSGNQLTS-LPVL---PPGLLELSI  269 (788)
T ss_pred             CCCcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCCC-CCC---CCCCCcEEEecCCccCc-ccCc---ccccceeec
Confidence            34678999999999 6787775  489999999999994 554   25789999999999994 5643   468999999


Q ss_pred             ccCCCCCCCCCcCCCCCCccEEEccCCCcccccCccccCCCcccEEEeccccccccCCccccCccccceeeccccccccc
Q 002010          321 FKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFIGP  400 (982)
Q Consensus       321 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~l~~N~~~~~  400 (982)
                      ++|.++ .+|..+   .+|+.|++++|+++. +|..   .++|+.|++++|++++ +|..   ..+|+.|++++|.+++ 
T Consensus       270 s~N~L~-~Lp~lp---~~L~~L~Ls~N~Lt~-LP~~---p~~L~~LdLS~N~L~~-Lp~l---p~~L~~L~Ls~N~L~~-  336 (788)
T PRK15387        270 FSNPLT-HLPALP---SGLCKLWIFGNQLTS-LPVL---PPGLQELSVSDNQLAS-LPAL---PSELCKLWAYNNQLTS-  336 (788)
T ss_pred             cCCchh-hhhhch---hhcCEEECcCCcccc-cccc---ccccceeECCCCcccc-CCCC---cccccccccccCcccc-
Confidence            999998 455433   578899999999994 4542   4689999999999985 4442   2346667777777653 


Q ss_pred             CCccccCCCCCCEEEccCCccCCCCCccccCCCccccccCCCccccccCCcccccCCccEEEeeccccCCCCchhccCCC
Q 002010          401 IPEELGQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLSGELPEKMSGASLNQLKVANNNITGKIPAAIGNLP  480 (982)
Q Consensus       401 ~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~L~~N~i~~~~p~~~~~l~  480 (982)
                      +|..   ..+|+.|+|++|+|+ .+|...                          .+|+.|++++|+|+. +|..   ..
T Consensus       337 LP~l---p~~Lq~LdLS~N~Ls-~LP~lp--------------------------~~L~~L~Ls~N~L~~-LP~l---~~  382 (788)
T PRK15387        337 LPTL---PSGLQELSVSDNQLA-SLPTLP--------------------------SELYKLWAYNNRLTS-LPAL---PS  382 (788)
T ss_pred             cccc---ccccceEecCCCccC-CCCCCC--------------------------cccceehhhcccccc-Cccc---cc
Confidence            3321   135666677666666 233211                          245556666666663 4432   24


Q ss_pred             CcceeeeccccccCCCccccccccccceeeeeccccCCCCCcccccccCCCeeeCCCCcccCCCCcccccccccceEEcc
Q 002010          481 SLNILSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYGKIPPGISKLIDLSILNLS  560 (982)
Q Consensus       481 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls  560 (982)
                      +|+.|++++|+|+ .+|..   .++|+.|++++|+|++ +|..   ..+|+.|+|++|+|+ .+|..++++++|+.|+|+
T Consensus       383 ~L~~LdLs~N~Lt-~LP~l---~s~L~~LdLS~N~Lss-IP~l---~~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs  453 (788)
T PRK15387        383 GLKELIVSGNRLT-SLPVL---PSELKELMVSGNRLTS-LPML---PSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLE  453 (788)
T ss_pred             ccceEEecCCccc-CCCCc---ccCCCEEEccCCcCCC-CCcc---hhhhhhhhhccCccc-ccChHHhhccCCCeEECC
Confidence            6777888888877 35543   3568888888888884 5643   346788999999997 788889999999999999


Q ss_pred             cccccccCccccccc
Q 002010          561 RNGITGSIPNEMRNM  575 (982)
Q Consensus       561 ~N~l~~~~p~~l~~l  575 (982)
                      +|+|++.+|..+..+
T Consensus       454 ~N~Ls~~~~~~L~~l  468 (788)
T PRK15387        454 GNPLSERTLQALREI  468 (788)
T ss_pred             CCCCCchHHHHHHHH
Confidence            999998888766444

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.88  E-value=1.4e-21  Score=215.66  Aligned_cols=259  Identities=21%  Similarity=0.257  Sum_probs=196.0

Q ss_pred             hcccccccccccceEEEEEEeCC--CcEEEEEEeccCCCCCchhhHHHHHHHHhcCC----CCcccceEeEE-EcCCccE
Q 002010          693 SLKDENIIGKGGAGIVYRGSMPD--GIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIR----HRNIVRLLGYV-SNRDTNL  765 (982)
Q Consensus       693 ~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~----h~niv~~~~~~-~~~~~~~  765 (982)
                      +|++.+.||+|+||.||.|...+  ...+|+|........... .+..|..++..+.    .+++.++++.. ..+...+
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~-~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~   97 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS-VLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNF   97 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc-cchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeE
Confidence            78999999999999999997544  357888877544333333 6778888888886    26899999988 4777889


Q ss_pred             EEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCC-----CCEEEecccc
Q 002010          766 LLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSD-----FEAHVADFGL  840 (982)
Q Consensus       766 lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~-----~~~kl~DfG~  840 (982)
                      +||+.+ |.+|.++......+.++..++.+++.|++.+|+++|+.|   ++||||||.|+.+...     -.+++.|||+
T Consensus        98 iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl  173 (322)
T KOG1164|consen   98 IVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL  173 (322)
T ss_pred             EEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence            999998 889999886555689999999999999999999999998   9999999999999765     3599999999


Q ss_pred             chhcc--ccCC-----ccc-ccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHh
Q 002010          841 AKFLQ--DAGA-----SEC-MSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKT  912 (982)
Q Consensus       841 a~~~~--~~~~-----~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~  912 (982)
                      |+.+.  ....     .+. .....||.+|+++.+..+...+++.|+||++.++.|+..|..||................
T Consensus       174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~  253 (322)
T KOG1164|consen  174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDP  253 (322)
T ss_pred             CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHh
Confidence            98332  2211     111 123459999999999999999999999999999999999999997755443322222211


Q ss_pred             ccCCCCCCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 002010          913 TSEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANP  972 (982)
Q Consensus       913 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~  972 (982)
                      ......                ......+..+.+++..+-..+...+|....+...++..
T Consensus       254 ~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~  297 (322)
T KOG1164|consen  254 RKLLTD----------------RFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDV  297 (322)
T ss_pred             hhhccc----------------cccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHH
Confidence            110000                01122334556666666668999999999988876443

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.87  E-value=3.5e-22  Score=218.42  Aligned_cols=168  Identities=23%  Similarity=0.200  Sum_probs=129.9

Q ss_pred             HHHhhcccccccccccceEEEEEEeC--CCcEEEEEEeccCCC----CCchhhHHHHHHHHhcCCCCcccceEeEEEcCC
Q 002010          689 DVLESLKDENIIGKGGAGIVYRGSMP--DGIDVAIKRLVGRGT----GGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRD  762 (982)
Q Consensus       689 ~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  762 (982)
                      .+.+.|+..+.||+|+||+||+|...  +++.||||+......    ......+.+|++++++++|+|+++.+..   ..
T Consensus        15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~   91 (365)
T PRK09188         15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TG   91 (365)
T ss_pred             cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cC
Confidence            34567999999999999999999653  577789998743311    1234568999999999999999864322   24


Q ss_pred             ccEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCC-CCCcEEEcCCCCEEEeccccc
Q 002010          763 TNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDV-KSNNILLDSDFEAHVADFGLA  841 (982)
Q Consensus       763 ~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDl-kp~Nill~~~~~~kl~DfG~a  841 (982)
                      ..++||||++|++|... .  ..   .   ...++.|+++|++|+|+.+   |+|||| ||+||+++.++.+||+|||+|
T Consensus        92 ~~~LVmE~~~G~~L~~~-~--~~---~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFGlA  159 (365)
T PRK09188         92 KDGLVRGWTEGVPLHLA-R--PH---G---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQLA  159 (365)
T ss_pred             CcEEEEEccCCCCHHHh-C--cc---c---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECccc
Confidence            57999999999999732 1  11   1   1467899999999999988   999999 999999999999999999999


Q ss_pred             hhccccCCccc------ccccccccccccccccccC
Q 002010          842 KFLQDAGASEC------MSSVAGSYGYIAPEYAYTL  871 (982)
Q Consensus       842 ~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~  871 (982)
                      +.+...+....      .....+++.|+|||.+...
T Consensus       160 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~  195 (365)
T PRK09188        160 SVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR  195 (365)
T ss_pred             eecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence            97765432211      1356688899999988644

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.85  E-value=3.4e-22  Score=233.32  Aligned_cols=255  Identities=21%  Similarity=0.244  Sum_probs=186.4

Q ss_pred             ccccccccccceEEEEEEe-CCCcEEEEEEeccCC-CCCc----hhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEE
Q 002010          695 KDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRG-TGGN----DHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLY  768 (982)
Q Consensus       695 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  768 (982)
                      ...+++|.|++|.|+.+.. .....++.|.+.... ....    ...+..|+-+-..+.|||++..+..+.+.....-+|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            3456899999998887743 334444444332100 1111    112566777888889999988888777766666669


Q ss_pred             eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccC
Q 002010          769 EYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAG  848 (982)
Q Consensus       769 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  848 (982)
                      |||++ +|..++.  +...+...++..+++|+..|++|+|+.|   |.|||+|++|++++.+|.+||+|||.+..+.-+.
T Consensus       401 E~~~~-Dlf~~~~--~~~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~  474 (601)
T KOG0590|consen  401 EYCPY-DLFSLVM--SNGKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYPW  474 (601)
T ss_pred             hcccH-HHHHHHh--cccccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence            99999 9999997  3357888999999999999999999999   9999999999999999999999999998665332


Q ss_pred             Cc--ccccccccccccccccccccCCCCc-chhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCccccc
Q 002010          849 AS--ECMSSVAGSYGYIAPEYAYTLKVDE-KSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASV  925 (982)
Q Consensus       849 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~-~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  925 (982)
                      ..  ......+|+..|+|||++.+..|.+ ..||||.|+++..|.+|+.||......+....   ....       ... 
T Consensus       475 e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~---~~~~-------~~~-  543 (601)
T KOG0590|consen  475 EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFK---TNNY-------SDQ-  543 (601)
T ss_pred             chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchh---hhcc-------ccc-
Confidence            22  4456678999999999999999986 57999999999999999999976433322110   0000       000 


Q ss_pred             ceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          926 LAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       926 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                      ..+.. .........+.+...+|.+|++.||.+|.|+++|++
T Consensus       544 ~~~~~-~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  544 RNIFE-GPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             ccccc-ChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence            00000 000122334556788999999999999999999886

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.85  E-value=1.8e-20  Score=189.42  Aligned_cols=254  Identities=18%  Similarity=0.221  Sum_probs=191.4

Q ss_pred             hcccccccccccceEEEEEE-eCCCcEEEEEEeccCCCCCchhhHHHHHHHHhcC-CCCcccceEeEEEcCCccEEEEec
Q 002010          693 SLKDENIIGKGGAGIVYRGS-MPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRI-RHRNIVRLLGYVSNRDTNLLLYEY  770 (982)
Q Consensus       693 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~  770 (982)
                      .|++++.||+|.||.++.|. .-+++.||||.-.. .+  .......|.+..+.+ ..+.|..+|.+..+.....+|+|.
T Consensus        29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPr-kS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL  105 (449)
T KOG1165|consen   29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPR-KS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL  105 (449)
T ss_pred             cceeccccccCcceeeecccccccCceEEEEeccc-cC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence            58899999999999999994 46899999996522 22  233466788887777 469999999888888888999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCC-----CCEEEeccccchhcc
Q 002010          771 MPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSD-----FEAHVADFGLAKFLQ  845 (982)
Q Consensus       771 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~-----~~~kl~DfG~a~~~~  845 (982)
                      . |-+|++++. --+.+++.++++.+|.|++.-++|+|++.   .|.|||||+|+||...     ..+.++|||+|+.+.
T Consensus       106 L-GPSLEDLFD-~CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Yr  180 (449)
T KOG1165|consen  106 L-GPSLEDLFD-LCGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYR  180 (449)
T ss_pred             h-CcCHHHHHH-HhcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhhhc
Confidence            9 778888775 24568999999999999999999999988   9999999999999643     458999999999988


Q ss_pred             ccCC-----cccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCC
Q 002010          846 DAGA-----SECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPS  920 (982)
Q Consensus       846 ~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  920 (982)
                      +...     ++...+..||.+||+-....+++.+.+.|+-|+|-++++.+-|..||.+...+.. .....+.+..-..  
T Consensus       181 Dp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tn-K~kYeKIGe~Kr~--  257 (449)
T KOG1165|consen  181 DPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTN-KEKYEKIGETKRS--  257 (449)
T ss_pred             CccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcch-HHHHHHhcccccc--
Confidence            7643     3345567899999999999999999999999999999999999999988644332 2222222210000  


Q ss_pred             cccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          921 DAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       921 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                                ..+..+....|.++..-++..=..+-++-|..+-+..
T Consensus       258 ----------T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~  294 (449)
T KOG1165|consen  258 ----------TPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRK  294 (449)
T ss_pred             ----------CCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence                      0001122334455555555555566666666554443

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=99.84  E-value=1.9e-21  Score=230.99  Aligned_cols=265  Identities=25%  Similarity=0.440  Sum_probs=130.2

Q ss_pred             CCCEEecccCcCcccCchhhcCCCccceeecccccCCCCCCccccCCCCCCEEEeeCCcccCcCchhhhcccchhhhhhc
Q 002010          242 QLQVLDMASCNISGEIPTSLSRLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQLF  321 (982)
Q Consensus       242 ~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~  321 (982)
                      +...|++++++++ .+|..+.  +.|+.|+|++|+|+ .+|..+.  .+|++|++++|+++ .+|..+.  .+|+.|+|+
T Consensus       179 ~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls  249 (754)
T PRK15370        179 NKTELRLKILGLT-TIPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELS  249 (754)
T ss_pred             CceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECc
Confidence            4567788877777 4555443  46777777777777 3444433  46777777777776 3454332  245556666


Q ss_pred             cCCCCCCCCCcCCCCCCccEEEccCCCcccccCccccCCCcccEEEeccccccccCCccccCccccceeecccccccccC
Q 002010          322 KNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFIGPI  401 (982)
Q Consensus       322 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~l~~N~~~~~~  401 (982)
                      +|++. .+|..+.  .+|+.|++++|+++ .+|..+.  .+|+.|++++|+|++ +|..                     
T Consensus       250 ~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt~-LP~~---------------------  301 (754)
T PRK15370        250 INRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIRT-LPAH---------------------  301 (754)
T ss_pred             CCccC-cCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECCCCcccc-Cccc---------------------
Confidence            66555 3443332  24555555555544 2333221  234444444444431 2211                     


Q ss_pred             CccccCCCCCCEEEccCCccCCCCCccccCCCccccccCCCccccccCCcccccCCccEEEeeccccCCCCchhccCCCC
Q 002010          402 PEELGQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLSGELPEKMSGASLNQLKVANNNITGKIPAAIGNLPS  481 (982)
Q Consensus       402 ~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~L~~N~i~~~~p~~~~~l~~  481 (982)
                         +.  ++|+.|++++|+++ .+|..+.                         .+|+.|++++|.+++ +|..+.  ++
T Consensus       302 ---lp--~sL~~L~Ls~N~Lt-~LP~~l~-------------------------~sL~~L~Ls~N~Lt~-LP~~l~--~s  347 (754)
T PRK15370        302 ---LP--SGITHLNVQSNSLT-ALPETLP-------------------------PGLKTLEAGENALTS-LPASLP--PE  347 (754)
T ss_pred             ---ch--hhHHHHHhcCCccc-cCCcccc-------------------------ccceeccccCCcccc-CChhhc--Cc
Confidence               11  12333344444433 1222111                         234444444444442 333321  45


Q ss_pred             cceeeeccccccCCCccccccccccceeeeeccccCCCCCcccccccCCCeeeCCCCcccCCCCccc----ccccccceE
Q 002010          482 LNILSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYGKIPPGI----SKLIDLSIL  557 (982)
Q Consensus       482 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~----~~l~~L~~L  557 (982)
                      |+.|++++|+|+ .+|..+  .+.|++|+|++|+|+ .+|..+.  ..|+.|++++|+|+ .+|..+    ..++.+..|
T Consensus       348 L~~L~Ls~N~L~-~LP~~l--p~~L~~LdLs~N~Lt-~LP~~l~--~sL~~LdLs~N~L~-~LP~sl~~~~~~~~~l~~L  420 (754)
T PRK15370        348 LQVLDVSKNQIT-VLPETL--PPTITTLDVSRNALT-NLPENLP--AALQIMQASRNNLV-RLPESLPHFRGEGPQPTRI  420 (754)
T ss_pred             ccEEECCCCCCC-cCChhh--cCCcCEEECCCCcCC-CCCHhHH--HHHHHHhhccCCcc-cCchhHHHHhhcCCCccEE
Confidence            555555555554 344333  245556666666665 3444332  24666666666665 444433    233566667


Q ss_pred             EcccccccccCccccccccccceecccCCccccC
Q 002010          558 NLSRNGITGSIPNEMRNMMSLTTLDLSYNNLIGN  591 (982)
Q Consensus       558 ~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~  591 (982)
                      +|.+|.++      ...+++|+.| ++.+.+.|.
T Consensus       421 ~L~~Npls------~~tl~~L~~L-l~s~~~~gp  447 (754)
T PRK15370        421 IVEYNPFS------ERTIQNMQRL-MSSVGYQGP  447 (754)
T ss_pred             EeeCCCcc------HHHHHHHHHh-hhcccccCC
Confidence            77777665      2334444444 344555444

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.84  E-value=9.9e-21  Score=182.99  Aligned_cols=204  Identities=25%  Similarity=0.336  Sum_probs=169.6

Q ss_pred             HHhhcccccccccccceEEEEE-EeCCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCC-CcccceEeEEEcCCccEEE
Q 002010          690 VLESLKDENIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRH-RNIVRLLGYVSNRDTNLLL  767 (982)
Q Consensus       690 ~~~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~lv  767 (982)
                      +..+|+..+.||+|+||.+|.| ...+|++||||.-...+   .-.....|.++.+.+++ ..|..+..|..+.....+|
T Consensus        13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a---~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlV   89 (341)
T KOG1163|consen   13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA---KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLV   89 (341)
T ss_pred             eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC---CCcchhHHHHHHHHhccCCCCchhhhhccccccceee
Confidence            3468999999999999999999 46789999999753322   23346688888888875 6677777778888889999


Q ss_pred             EeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCC---CCEEEeccccchhc
Q 002010          768 YEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSD---FEAHVADFGLAKFL  844 (982)
Q Consensus       768 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~---~~~kl~DfG~a~~~  844 (982)
                      |+.. |-+|++++. .-...++.++++-++-|++.-++|+|.++   ++||||||+|+++.-+   ..+.++|||+|+.+
T Consensus        90 MdLL-GPsLEdLfn-fC~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky  164 (341)
T KOG1163|consen   90 MDLL-GPSLEDLFN-FCSRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY  164 (341)
T ss_pred             eecc-CccHHHHHH-HHhhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhh
Confidence            9999 889998875 23467899999999999999999999999   9999999999999644   46899999999987


Q ss_pred             cccC-----CcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCC
Q 002010          845 QDAG-----ASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGD  901 (982)
Q Consensus       845 ~~~~-----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~  901 (982)
                      .+..     +.+......||.+|.+-....+...+.+.|+-|+|.++.++--|..||.+...
T Consensus       165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka  226 (341)
T KOG1163|consen  165 RDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKA  226 (341)
T ss_pred             ccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccch
Confidence            6543     23334556799999998888888889999999999999999999999988543

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.84  E-value=1.5e-19  Score=202.09  Aligned_cols=258  Identities=29%  Similarity=0.410  Sum_probs=200.5

Q ss_pred             cccccccccccceEEEEEEeCCCcEEEEEEeccCCCCC--chhhHHHHHHHHhcCCCC-cccceEeEEEcCCccEEEEec
Q 002010          694 LKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGG--NDHGFLAEIQTLGRIRHR-NIVRLLGYVSNRDTNLLLYEY  770 (982)
Q Consensus       694 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~-niv~~~~~~~~~~~~~lv~e~  770 (982)
                      |+..+.+|.|+||.||++...  ..+++|.+.......  ....+.+|+.+++.+.|+ +++++++.+......++++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            566778999999999999765  789999986665544  377899999999999988 799999999777778999999


Q ss_pred             cCCCCHHHHhhcCCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCC-CEEEeccccchhccccC
Q 002010          771 MPNGSLGEMLHGAKG-GHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDF-EAHVADFGLAKFLQDAG  848 (982)
Q Consensus       771 ~~~~sL~~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~-~~kl~DfG~a~~~~~~~  848 (982)
                      +.++++.+++..... ..+.......++.|++.++.|+|+.+   ++|||+||+||+++..+ .++++|||.+..+....
T Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~  156 (384)
T COG0515          80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG  156 (384)
T ss_pred             CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence            999999977753221 27889999999999999999999988   99999999999999988 79999999998654332


Q ss_pred             Ccc----ccccccccccccccccccc---CCCCcchhhHHHHHHHHHHHhCCCCCCCCCC---CchHHHHHHHhccC-CC
Q 002010          849 ASE----CMSSVAGSYGYIAPEYAYT---LKVDEKSDVYSFGVVLLELIAGKKPVGEFGD---GVDIVRWVRKTTSE-VS  917 (982)
Q Consensus       849 ~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~elltg~~p~~~~~~---~~~~~~~~~~~~~~-~~  917 (982)
                      ...    ......|+..|+|||...+   ..+....|+|++|++++++++|..||.....   .......+...... ..
T Consensus       157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (384)
T COG0515         157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLA  236 (384)
T ss_pred             ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccc
Confidence            221    3466789999999999987   5788999999999999999999999766443   22333333322221 00


Q ss_pred             CCCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002010          918 QPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHM  968 (982)
Q Consensus       918 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~  968 (982)
                      ...         .   ...+......+.+++..|+..+|..|.+..+....
T Consensus       237 ~~~---------~---~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         237 SPL---------S---PSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             ccc---------C---ccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            000         0   00002223467899999999999999999887653

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=99.84  E-value=4.4e-21  Score=227.96  Aligned_cols=247  Identities=29%  Similarity=0.448  Sum_probs=162.9

Q ss_pred             ccceeecccccCCCCCCccccCCCCCCEEEeeCCcccCcCchhhhcccchhhhhhccCCCCCCCCCcCCCCCCccEEEcc
Q 002010          266 LLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVW  345 (982)
Q Consensus       266 ~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~  345 (982)
                      +.+.|++++++++ .+|..+.  ++|+.|+|++|+|+ .+|..+.  ++|+.|++++|+++ .+|..+.  ++|+.|+|+
T Consensus       179 ~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls  249 (754)
T PRK15370        179 NKTELRLKILGLT-TIPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELS  249 (754)
T ss_pred             CceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECc
Confidence            4567888888888 4565443  46888888888888 4554433  36666666666666 3343322  245555555


Q ss_pred             CCCcccccCccccCCCcccEEEeccccccccCCccccCccccceeecccccccccCCccccCCCCCCEEEccCCccCCCC
Q 002010          346 GNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGTI  425 (982)
Q Consensus       346 ~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~l~~N~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~  425 (982)
                      +|.+. .+|..+.  .                        +|+.|++++|++. .+|..+.  ++|+.|++++|+|+ .+
T Consensus       250 ~N~L~-~LP~~l~--s------------------------~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt-~L  298 (754)
T PRK15370        250 INRIT-ELPERLP--S------------------------ALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIR-TL  298 (754)
T ss_pred             CCccC-cCChhHh--C------------------------CCCEEECcCCccC-ccccccC--CCCcEEECCCCccc-cC
Confidence            55554 2333221  2                        3334444444333 2233222  35666777777666 23


Q ss_pred             CccccCCCccccccCCCccccccCCcccccCCccEEEeeccccCCCCchhccCCCCcceeeeccccccCCCccccccccc
Q 002010          426 PAGLFNLPLLNMMELDDNLLSGELPEKMSGASLNQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESFNLKM  505 (982)
Q Consensus       426 p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~  505 (982)
                      |..+.                         .+|+.|++++|+++. +|..+  .++|+.|++++|.++ .+|..+.  ++
T Consensus       299 P~~lp-------------------------~sL~~L~Ls~N~Lt~-LP~~l--~~sL~~L~Ls~N~Lt-~LP~~l~--~s  347 (754)
T PRK15370        299 PAHLP-------------------------SGITHLNVQSNSLTA-LPETL--PPGLKTLEAGENALT-SLPASLP--PE  347 (754)
T ss_pred             cccch-------------------------hhHHHHHhcCCcccc-CCccc--cccceeccccCCccc-cCChhhc--Cc
Confidence            32211                         246667777777763 44433  368999999999998 4776654  79


Q ss_pred             cceeeeeccccCCCCCcccccccCCCeeeCCCCcccCCCCcccccccccceEEcccccccccCcccc----cccccccee
Q 002010          506 ITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYGKIPPGISKLIDLSILNLSRNGITGSIPNEM----RNMMSLTTL  581 (982)
Q Consensus       506 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l----~~l~~L~~L  581 (982)
                      |+.|++++|+|+ .+|..+.  ++|+.|+|++|+|+ .+|..+.  ..|+.|++++|+|+ .+|..+    ..++++..|
T Consensus       348 L~~L~Ls~N~L~-~LP~~lp--~~L~~LdLs~N~Lt-~LP~~l~--~sL~~LdLs~N~L~-~LP~sl~~~~~~~~~l~~L  420 (754)
T PRK15370        348 LQVLDVSKNQIT-VLPETLP--PTITTLDVSRNALT-NLPENLP--AALQIMQASRNNLV-RLPESLPHFRGEGPQPTRI  420 (754)
T ss_pred             ccEEECCCCCCC-cCChhhc--CCcCEEECCCCcCC-CCCHhHH--HHHHHHhhccCCcc-cCchhHHHHhhcCCCccEE
Confidence            999999999998 5776663  68999999999998 5777665  37999999999998 566544    445889999


Q ss_pred             cccCCcccc
Q 002010          582 DLSYNNLIG  590 (982)
Q Consensus       582 ~Ls~N~l~~  590 (982)
                      +|.+|+++.
T Consensus       421 ~L~~Npls~  429 (754)
T PRK15370        421 IVEYNPFSE  429 (754)
T ss_pred             EeeCCCccH
Confidence            999999974

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.82  E-value=4e-20  Score=190.95  Aligned_cols=195  Identities=24%  Similarity=0.303  Sum_probs=142.5

Q ss_pred             CCCcccceEeEEEcC---------------------------CccEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHH
Q 002010          747 RHRNIVRLLGYVSNR---------------------------DTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALE  799 (982)
Q Consensus       747 ~h~niv~~~~~~~~~---------------------------~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~  799 (982)
                      +|||||++.++|.++                           ...|+||... ..+|.+|+..   ...+...+.-++.|
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~---~~~s~r~~~~~laQ  349 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWT---RHRSYRTGRVILAQ  349 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhc---CCCchHHHHHHHHH
Confidence            599999999876431                           2448899888 5699999963   34666777889999


Q ss_pred             HHHHHHHHhhcCCCcEEecCCCCCcEEEc--CC--CCEEEeccccchhccccC----CcccccccccccccccccccccC
Q 002010          800 AAKGLCYLHHDCSPLIIHRDVKSNNILLD--SD--FEAHVADFGLAKFLQDAG----ASECMSSVAGSYGYIAPEYAYTL  871 (982)
Q Consensus       800 i~~~l~~LH~~~~~~ivHrDlkp~Nill~--~~--~~~kl~DfG~a~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~  871 (982)
                      +++|+.|||++|   |.|||+|++||++.  +|  ..+.++|||++---+..+    +........|...-||||+....
T Consensus       350 lLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~  426 (598)
T KOG4158|consen  350 LLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAV  426 (598)
T ss_pred             HHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcC
Confidence            999999999998   99999999999993  33  457899999885433211    11122345678889999987643


Q ss_pred             C------CCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceeecCCCCCCChHhHHHHH
Q 002010          872 K------VDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDPRLSGYPLTGVIHLF  945 (982)
Q Consensus       872 ~------~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  945 (982)
                      .      --.|+|.|+.|.+.||+++...||+...+.  ..+...                 .-+..++.+|..++..+.
T Consensus       427 PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem--~L~~r~-----------------Yqe~qLPalp~~vpp~~r  487 (598)
T KOG4158|consen  427 PGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEM--LLDTRT-----------------YQESQLPALPSRVPPVAR  487 (598)
T ss_pred             CCCceeeccchhhhhhhhhhHHHHhccCCcccccchh--eechhh-----------------hhhhhCCCCcccCChHHH
Confidence            2      135899999999999999999999873221  111110                 011234456677778899


Q ss_pred             HHHhhccCCCCCCCCCHHHHHH
Q 002010          946 KVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       946 ~li~~cl~~dP~~Rpt~~ell~  967 (982)
                      +++...+++||.+|+++.-...
T Consensus       488 qlV~~lL~r~pskRvsp~iAAN  509 (598)
T KOG4158|consen  488 QLVFDLLKRDPSKRVSPNIAAN  509 (598)
T ss_pred             HHHHHHhcCCccccCCccHHHh
Confidence            9999999999999998654433

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.80  E-value=6.4e-20  Score=185.95  Aligned_cols=172  Identities=14%  Similarity=0.152  Sum_probs=133.7

Q ss_pred             HHhhcccccccccccceEEEEEEeCCCcEEEEEEeccCCCCCch--hh------HHHHHHHHhcCCCCcccceEeEEEcC
Q 002010          690 VLESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGND--HG------FLAEIQTLGRIRHRNIVRLLGYVSNR  761 (982)
Q Consensus       690 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~--~~------~~~E~~~l~~l~h~niv~~~~~~~~~  761 (982)
                      +..+|+..+++|.|+||.||.+.. ++..+|+|.+.+.......  ..      +.+|+..+.++.||+|..+.+++...
T Consensus        29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~  107 (232)
T PRK10359         29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA  107 (232)
T ss_pred             hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence            346799999999999999999866 6778999999655433221  12      57899999999999999999986643


Q ss_pred             --------CccEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCE
Q 002010          762 --------DTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEA  833 (982)
Q Consensus       762 --------~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~  833 (982)
                              ...++||||++|.+|.++..      .+.    ....+++.+++.+|+.|   ++|||+||+||+++.++ +
T Consensus       108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g-i  173 (232)
T PRK10359        108 ERKTLRYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG-L  173 (232)
T ss_pred             ccccccccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-E
Confidence                    35789999999999988742      222    24569999999999998   99999999999999988 9


Q ss_pred             EEeccccchhccccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHH
Q 002010          834 HVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELI  890 (982)
Q Consensus       834 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell  890 (982)
                      +++|||.+.........              ........|..++|+|++|+.+....
T Consensus       174 ~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        174 RIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             EEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHH
Confidence            99999988654321110              01334455778999999999887654

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.80  E-value=1.9e-19  Score=181.43  Aligned_cols=141  Identities=17%  Similarity=0.160  Sum_probs=109.5

Q ss_pred             ccccccccceEEEEEEeCCCcEEEEEEeccCCCCC-c-------hh-----------------hHHHHHHHHhcCCCCcc
Q 002010          697 ENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGG-N-------DH-----------------GFLAEIQTLGRIRHRNI  751 (982)
Q Consensus       697 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-~-------~~-----------------~~~~E~~~l~~l~h~ni  751 (982)
                      .+.||+|++|.||+|..++|+.||||+++...... .       ..                 ....|++.+.++.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            35799999999999987789999999986542211 1       01                 12349999999988877


Q ss_pred             cceEeEEEcCCccEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHH-hhcCCCcEEecCCCCCcEEEcCC
Q 002010          752 VRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYL-HHDCSPLIIHRDVKSNNILLDSD  830 (982)
Q Consensus       752 v~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~L-H~~~~~~ivHrDlkp~Nill~~~  830 (982)
                      .....+..  ...++||||++++++.....  +...++++++..++.|++.+++++ |+.+   |+||||||+||+++ +
T Consensus        82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~--~~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~-~  153 (190)
T cd05147          82 PCPEPILL--KSHVLVMEFIGDDGWAAPRL--KDAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH-D  153 (190)
T ss_pred             CCCcEEEe--cCCEEEEEEeCCCCCcchhh--hcCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-C
Confidence            54433322  23489999999877765432  335788999999999999999999 6888   99999999999998 4


Q ss_pred             CCEEEeccccchhcc
Q 002010          831 FEAHVADFGLAKFLQ  845 (982)
Q Consensus       831 ~~~kl~DfG~a~~~~  845 (982)
                      +.++++|||+|....
T Consensus       154 ~~v~LiDFG~a~~~~  168 (190)
T cd05147         154 GKLYIIDVSQSVEHD  168 (190)
T ss_pred             CcEEEEEccccccCC
Confidence            789999999997543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.79  E-value=5.8e-20  Score=211.90  Aligned_cols=255  Identities=18%  Similarity=0.210  Sum_probs=183.2

Q ss_pred             hcccccccccccceEEEEEEeCCCcEEEEEEeccCCCCCchhhHHHHHHH--HhcCCCCcccceEeEEEcCCccEEEEec
Q 002010          693 SLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQT--LGRIRHRNIVRLLGYVSNRDTNLLLYEY  770 (982)
Q Consensus       693 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~--l~~l~h~niv~~~~~~~~~~~~~lv~e~  770 (982)
                      .+...+.+|++.|=.|.+|++.+|. |+||++.+.........|.++++-  ...+++||.+++.-+...+...|+|-+|
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy  102 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY  102 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence            5667788999999999999987887 999999777666666655554443  4445899999998887778888899899


Q ss_pred             cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhcc--ccC
Q 002010          771 MPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQ--DAG  848 (982)
Q Consensus       771 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~--~~~  848 (982)
                      + .-+|+|.+.  -..-+...+...++.|++.|+..+|+.|   |+|||||.+|||++.=.=+.|+||..-+...  .+.
T Consensus       103 v-khnLyDRlS--TRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDN  176 (1431)
T KOG1240|consen  103 V-KHNLYDRLS--TRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDN  176 (1431)
T ss_pred             H-hhhhhhhhc--cchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCCC
Confidence            8 558999885  3344566777889999999999999998   9999999999999988889999997544321  111


Q ss_pred             C---cccccccccccccccccccccCC-----------CCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHhc
Q 002010          849 A---SECMSSVAGSYGYIAPEYAYTLK-----------VDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTT  913 (982)
Q Consensus       849 ~---~~~~~~~~gt~~y~aPE~~~~~~-----------~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~  913 (982)
                      +   .........-..|.|||.+....           .+++-||||+||+++|+++ |++||.-       .+......
T Consensus       177 Padf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L-------SQL~aYr~  249 (1431)
T KOG1240|consen  177 PADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL-------SQLLAYRS  249 (1431)
T ss_pred             cccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH-------HHHHhHhc
Confidence            1   11111122334799999875421           5678899999999999999 7888842       22222111


Q ss_pred             cCCCCCCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCC
Q 002010          914 SEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQ  974 (982)
Q Consensus       914 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~~  974 (982)
                      ..   ..+.....+.+          ....+..++..|++.||++|.++++.++.-++..-
T Consensus       250 ~~---~~~~e~~Le~I----------ed~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~~F  297 (1431)
T KOG1240|consen  250 GN---ADDPEQLLEKI----------EDVSLRNLILSMIQRDPSKRLSAEDYLQKYRGLVF  297 (1431)
T ss_pred             cC---ccCHHHHHHhC----------cCccHHHHHHHHHccCchhccCHHHHHHhhhcccc
Confidence            10   00001111111          11257899999999999999999999998766543

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.78  E-value=6.1e-20  Score=202.67  Aligned_cols=226  Identities=23%  Similarity=0.229  Sum_probs=181.8

Q ss_pred             ccccccceEEEEEEe----CCCcEEEEEEeccCCCC-CchhhHHHHHHHHhcCC-CCcccceEeEEEcCCccEEEEeccC
Q 002010          699 IIGKGGAGIVYRGSM----PDGIDVAIKRLVGRGTG-GNDHGFLAEIQTLGRIR-HRNIVRLLGYVSNRDTNLLLYEYMP  772 (982)
Q Consensus       699 ~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~  772 (982)
                      ++|+|.||.|+.++.    ..|.-+|+|+..+.... ........|..++..++ ||.+|++..+++.+...+++++|..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            379999999998743    34777899987544221 11225567888888886 9999999999999999999999999


Q ss_pred             CCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCccc
Q 002010          773 NGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASEC  852 (982)
Q Consensus       773 ~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~  852 (982)
                      +|.+...+.  +...+++.....+...++-|++++|+.+   |+|||+|++||+++.+|++++.|||.++..-+...   
T Consensus        81 gg~lft~l~--~~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~---  152 (612)
T KOG0603|consen   81 GGDLFTRLS--KEVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI---  152 (612)
T ss_pred             cchhhhccc--cCCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhh---
Confidence            999988876  5567788888889999999999999998   99999999999999999999999999987654321   


Q ss_pred             ccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceeecCC
Q 002010          853 MSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDPR  932 (982)
Q Consensus       853 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  932 (982)
                         .+||..|||||++.  .+..++|+||+|++.+||+||..||..    +...++.+...                   
T Consensus       153 ---~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~-------------------  204 (612)
T KOG0603|consen  153 ---ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAEL-------------------  204 (612)
T ss_pred             ---cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhcc-------------------
Confidence               28999999999988  577899999999999999999999976    22233322221                   


Q ss_pred             CCCCChHhHHHHHHHHhhccCCCCCCCCCH
Q 002010          933 LSGYPLTGVIHLFKVAMMCVEDESSARPTM  962 (982)
Q Consensus       933 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~  962 (982)
                        ..|........+++.++..++|..|.-.
T Consensus       205 --~~p~~l~~~a~~~~~~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  205 --EMPRELSAEARSLFRQLFKRNPENRLGA  232 (612)
T ss_pred             --CCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence              2344455567888899999999988854

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.78  E-value=4.6e-19  Score=185.17  Aligned_cols=233  Identities=19%  Similarity=0.259  Sum_probs=148.5

Q ss_pred             hcccccccccccceEEEEEEe-CCCcEEEEEEeccCCC--CCchhhHHHHHHHHhcCC----------CCcccceEeEEE
Q 002010          693 SLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGT--GGNDHGFLAEIQTLGRIR----------HRNIVRLLGYVS  759 (982)
Q Consensus       693 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~----------h~niv~~~~~~~  759 (982)
                      .+..++.||.|+++.||.+++ .+++++|+|++.....  ....+.+.+|.-....+.          |-.++..++...
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence            466778999999999999966 4589999999855442  223445666665554432          222333333221


Q ss_pred             c---------C---C-----ccEEEEeccCCCCHHHHhhc---CCC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEe
Q 002010          760 N---------R---D-----TNLLLYEYMPNGSLGEMLHG---AKG--GHLKWETRYRIALEAAKGLCYLHHDCSPLIIH  817 (982)
Q Consensus       760 ~---------~---~-----~~~lv~e~~~~~sL~~~l~~---~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH  817 (982)
                      .         .   .     ..+++|+-+ .++|.+++..   ...  .......+..+..|+++.+++||+.|   +||
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVH  168 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVH  168 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEE
T ss_pred             EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEe
Confidence            1         1   1     225678877 5688877542   111  12333455667799999999999999   999


Q ss_pred             cCCCCCcEEEcCCCCEEEeccccchhccccCCccccccccccccccccccccc--------CCCCcchhhHHHHHHHHHH
Q 002010          818 RDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYT--------LKVDEKSDVYSFGVVLLEL  889 (982)
Q Consensus       818 rDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwslG~il~el  889 (982)
                      +||+|+|++++++|.++|+||+........     ......+..|.|||....        ..++++.|.|++|+++|.|
T Consensus       169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~-----~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~l  243 (288)
T PF14531_consen  169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTR-----YRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSL  243 (288)
T ss_dssp             ST-SGGGEEE-TTS-EEE--GGGEEETTEE-----EEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHH
T ss_pred             cccceeeEEEcCCCCEEEcChHHHeecCce-----eeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHH
Confidence            999999999999999999999877654321     111344578999997643        2478999999999999999


Q ss_pred             HhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCC
Q 002010          890 IAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSAR  959 (982)
Q Consensus       890 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R  959 (982)
                      +++..||.........                        +..+..+. +.+..+.++|..+++++|++|
T Consensus       244 WC~~lPf~~~~~~~~~------------------------~~~f~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  244 WCGRLPFGLSSPEADP------------------------EWDFSRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HHSS-STCCCGGGSTS------------------------GGGGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             HHccCCCCCCCccccc------------------------cccchhcC-CcCHHHHHHHHHHccCCcccC
Confidence            9999999753221100                        00233455 777889999999999999988

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.78  E-value=1.7e-18  Score=171.24  Aligned_cols=186  Identities=16%  Similarity=0.042  Sum_probs=137.5

Q ss_pred             cccccccccceEEEEEEeCCCcEEEEEEeccCCCC---CchhhHHHHHHHHhcCC-CCcccceEeEEEcCCccEEEEecc
Q 002010          696 DENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTG---GNDHGFLAEIQTLGRIR-HRNIVRLLGYVSNRDTNLLLYEYM  771 (982)
Q Consensus       696 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~  771 (982)
                      ....|++|+||+||.+.. .+.+++.+.+....-.   .....+.+|+++++++. |+++.+++++    ...+++|||+
T Consensus         6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI   80 (218)
T PRK12274          6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL   80 (218)
T ss_pred             cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence            456899999999998866 7778887766322111   11225789999999995 5889999886    4569999999


Q ss_pred             CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCC-CCCcEEEcCCCCEEEeccccchhccccCCc
Q 002010          772 PNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDV-KSNNILLDSDFEAHVADFGLAKFLQDAGAS  850 (982)
Q Consensus       772 ~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDl-kp~Nill~~~~~~kl~DfG~a~~~~~~~~~  850 (982)
                      +|.+|.+....         ....++.|++.+++++|+.|   |+|||| ||.||+++.++.++|+|||+|.........
T Consensus        81 ~G~~L~~~~~~---------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~  148 (218)
T PRK12274         81 AGAAMYQRPPR---------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARW  148 (218)
T ss_pred             cCccHHhhhhh---------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcchH
Confidence            99998765421         11357789999999999998   999999 799999999999999999999855432210


Q ss_pred             ----c--c-----ccccccccccccccccccC-CCC-cchhhHHHHHHHHHHHhCCCCCCC
Q 002010          851 ----E--C-----MSSVAGSYGYIAPEYAYTL-KVD-EKSDVYSFGVVLLELIAGKKPVGE  898 (982)
Q Consensus       851 ----~--~-----~~~~~gt~~y~aPE~~~~~-~~~-~~~DvwslG~il~elltg~~p~~~  898 (982)
                          .  .     ......++.|++|+...-- ..+ .+.++++-|+-+|.++|+..|...
T Consensus       149 ~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~  209 (218)
T PRK12274        149 MRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE  209 (218)
T ss_pred             HHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence                0  0     0012357778888743321 233 577999999999999999988754

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.77  E-value=2.7e-18  Score=174.01  Aligned_cols=141  Identities=20%  Similarity=0.172  Sum_probs=111.0

Q ss_pred             ccccccccceEEEEEEeCCCcEEEEEEeccCCCCC--------------------c-----hhhHHHHHHHHhcCCCCcc
Q 002010          697 ENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGG--------------------N-----DHGFLAEIQTLGRIRHRNI  751 (982)
Q Consensus       697 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--------------------~-----~~~~~~E~~~l~~l~h~ni  751 (982)
                      .+.||+|++|.||+|...+|+.||||++.......                    .     ...+.+|...+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            45799999999999987689999999986542110                    0     1123578899999999987


Q ss_pred             cceEeEEEcCCccEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCcEEecCCCCCcEEEcCC
Q 002010          752 VRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHH-DCSPLIIHRDVKSNNILLDSD  830 (982)
Q Consensus       752 v~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivHrDlkp~Nill~~~  830 (982)
                      .....+...  ..++||||++|+++.....  ....++..++..++.|++.++.++|+ .|   |+||||||+||+++ +
T Consensus        82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l--~~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~-~  153 (190)
T cd05145          82 PVPEPILLK--KNVLVMEFIGDDGSPAPRL--KDVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH-D  153 (190)
T ss_pred             CCceEEEec--CCEEEEEEecCCCchhhhh--hhccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-C
Confidence            655544333  3589999998875544322  23467888999999999999999999 88   99999999999998 8


Q ss_pred             CCEEEeccccchhcc
Q 002010          831 FEAHVADFGLAKFLQ  845 (982)
Q Consensus       831 ~~~kl~DfG~a~~~~  845 (982)
                      +.++++|||++....
T Consensus       154 ~~~~liDFG~a~~~~  168 (190)
T cd05145         154 GKPYIIDVSQAVELD  168 (190)
T ss_pred             CCEEEEEcccceecC
Confidence            899999999998664

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.77  E-value=1.3e-18  Score=193.08  Aligned_cols=217  Identities=24%  Similarity=0.404  Sum_probs=166.6

Q ss_pred             HhcCCCCcccceEeEEEcCCccEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCC
Q 002010          743 LGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKS  822 (982)
Q Consensus       743 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp  822 (982)
                      |+.+.|.|+.+++|.+.++...+.|.+||..|+|.+.+.. ....+++.....++++|+.|++|+|...  -..|+.+++
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~-~~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~s   77 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN-EDIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALKS   77 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc-cccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeecc
Confidence            4577999999999999999999999999999999999974 5678999999999999999999999743  238999999


Q ss_pred             CcEEEcCCCCEEEeccccchhccccCCcccccccccccccccccccccCC-------CCcchhhHHHHHHHHHHHhCCCC
Q 002010          823 NNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLK-------VDEKSDVYSFGVVLLELIAGKKP  895 (982)
Q Consensus       823 ~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~DvwslG~il~elltg~~p  895 (982)
                      +|++++....+|+.|||+.....+..............-|.|||.+....       .+.+.||||+|++++|+++.+.|
T Consensus        78 ~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~  157 (484)
T KOG1023|consen   78 SNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP  157 (484)
T ss_pred             ccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence            99999999999999999988764311111112223445799999887642       46779999999999999999999


Q ss_pred             CCCCCCCch---HHHHHHHhccCCCCCCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 002010          896 VGEFGDGVD---IVRWVRKTTSEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANP  972 (982)
Q Consensus       896 ~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~  972 (982)
                      |.......+   +...+++....            .+.|.+.... +.+..+..++..||..+|++||+++++-..++.+
T Consensus       158 ~~~~~~~~~~~eii~~~~~~~~~------------~~rP~i~~~~-e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~  224 (484)
T KOG1023|consen  158 FDLRNLVEDPDEIILRVKKGGSN------------PFRPSIELLN-ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTI  224 (484)
T ss_pred             cccccccCChHHHHHHHHhcCCC------------CcCcchhhhh-hcchHHHHHHHHhcccChhhCccHHHHHhhhhhh
Confidence            987444333   33333331111            1122222111 2333688999999999999999999999988876


Q ss_pred             CCC
Q 002010          973 PQS  975 (982)
Q Consensus       973 ~~~  975 (982)
                      ...
T Consensus       225 ~~~  227 (484)
T KOG1023|consen  225 NKG  227 (484)
T ss_pred             ccc
Confidence            654

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=99.76  E-value=9.4e-20  Score=202.34  Aligned_cols=155  Identities=28%  Similarity=0.316  Sum_probs=70.8

Q ss_pred             CCCEEecccCcCccc----CchhhcCCCccceeecccccCCCC----CCccccCCCCCCEEEeeCCcccCcC----chhh
Q 002010          242 QLQVLDMASCNISGE----IPTSLSRLKLLHSLFLQMNKLTGH----IPPQLSGLISLKSLDLSLNYLTGEI----PESF  309 (982)
Q Consensus       242 ~L~~L~L~~n~l~~~----~~~~l~~l~~L~~L~L~~N~l~~~----~~~~l~~l~~L~~L~Ls~N~l~~~~----~~~l  309 (982)
                      +|+.|++++|.+++.    ++..+..+++|++|++++|.+++.    ++..+..+++|++|++++|.+++..    ...+
T Consensus       138 ~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~  217 (319)
T cd00116         138 ALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETL  217 (319)
T ss_pred             CceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHh
Confidence            444444444444421    122233344444444444444421    1112233344555555555443221    1223


Q ss_pred             hcccchhhhhhccCCCCCCCCCcCC-----CCCCccEEEccCCCccc----ccCccccCCCcccEEEecccccccc----
Q 002010          310 AALKNLTLLQLFKNNLRGPIPSFLG-----DFPNLEVLQVWGNNFTF----ELPENLGRNGKLLILDVTSNHLTGT----  376 (982)
Q Consensus       310 ~~l~~L~~L~L~~N~l~~~~p~~~~-----~l~~L~~L~L~~N~l~~----~~~~~l~~l~~L~~L~L~~N~l~~~----  376 (982)
                      ..+++|++|++++|.+++.....+.     ..+.|+.|++++|.++.    .+...+..+++|+++++++|.++..    
T Consensus       218 ~~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~  297 (319)
T cd00116         218 ASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQL  297 (319)
T ss_pred             cccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHH
Confidence            3344455555555554431111111     23566666666666651    2233444556677777777776644    


Q ss_pred             CCccccCc-cccceeeccccc
Q 002010          377 IPRDLCKG-GKLKSLILMQNF  396 (982)
Q Consensus       377 ~p~~~~~~-~~L~~L~l~~N~  396 (982)
                      ..+.+... +.|+++++.+|.
T Consensus       298 ~~~~~~~~~~~~~~~~~~~~~  318 (319)
T cd00116         298 LAESLLEPGNELESLWVKDDS  318 (319)
T ss_pred             HHHHHhhcCCchhhcccCCCC
Confidence            23333333 567777776664

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=99.76  E-value=8.4e-20  Score=202.70  Aligned_cols=266  Identities=24%  Similarity=0.245  Sum_probs=133.3

Q ss_pred             hhhcCCCccEEeccCccccCC----CchhccccccccEEeecCccccc------ccCCCccccCcceEeeccCcccccch
Q 002010          139 IVRGMTELQVLDAYNNNFTGP----LPVEIASLKSLRHLSFGGNYFTG------KIPQSYSEIQSLEYIGLNGIGLNGTV  208 (982)
Q Consensus       139 ~~~~l~~L~~L~Ls~n~l~~~----~p~~l~~l~~L~~L~L~~N~l~~------~~p~~~~~l~~L~~L~L~~n~i~~~~  208 (982)
                      .+..+.+|++|+++++.+++.    ++..+...++|++|+++++.+.+      .++..+..+++|+.|++++|.+.+..
T Consensus        18 ~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~~~   97 (319)
T cd00116          18 LLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDG   97 (319)
T ss_pred             HHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcCceeEEEccCCCCChhH
Confidence            333444444444444444321    33444445555555555555441      22233444555555555555554433


Q ss_pred             hhHHhhhhhHHHHhhcccccccccCCCCCCCCCCCCEEecccCcCcc----cCchhhcCC-CccceeecccccCCCC---
Q 002010          209 PAFLSRLKNLREMYIGYFNTYTGGIPPGFGALTQLQVLDMASCNISG----EIPTSLSRL-KLLHSLFLQMNKLTGH---  280 (982)
Q Consensus       209 ~~~l~~l~~L~~L~l~~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~----~~~~~l~~l-~~L~~L~L~~N~l~~~---  280 (982)
                      +..+..+.                     .. ++|++|++++|++++    .+...+..+ ++|++|++++|.+++.   
T Consensus        98 ~~~~~~l~---------------------~~-~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~  155 (319)
T cd00116          98 CGVLESLL---------------------RS-SSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCE  155 (319)
T ss_pred             HHHHHHHh---------------------cc-CcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHH
Confidence            33332221                     11 457777777777763    223345555 6777777777777742   


Q ss_pred             -CCccccCCCCCCEEEeeCCcccCc----CchhhhcccchhhhhhccCCCCCCC----CCcCCCCCCccEEEccCCCccc
Q 002010          281 -IPPQLSGLISLKSLDLSLNYLTGE----IPESFAALKNLTLLQLFKNNLRGPI----PSFLGDFPNLEVLQVWGNNFTF  351 (982)
Q Consensus       281 -~~~~l~~l~~L~~L~Ls~N~l~~~----~~~~l~~l~~L~~L~L~~N~l~~~~----p~~~~~l~~L~~L~L~~N~l~~  351 (982)
                       ++..+..+.+|++|++++|.+++.    ++..+..+++|+.|++++|.+++..    +..+..+++|++|++++|.+++
T Consensus       156 ~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~  235 (319)
T cd00116         156 ALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTD  235 (319)
T ss_pred             HHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCch
Confidence             223445556677777777776642    1222333445566666655554321    2233344455555555555443


Q ss_pred             ccCccccCCCcccEEEeccccccccCCccccCccccceeeccccccc----ccCCccccCCCCCCEEEccCCccCCC---
Q 002010          352 ELPENLGRNGKLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFI----GPIPEELGQCKSLTKIRFSKNYLNGT---  424 (982)
Q Consensus       352 ~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~l~~N~~~----~~~~~~l~~l~~L~~L~Ls~N~l~~~---  424 (982)
                      .....+...                   ......+|++|++++|.++    ..+...+..+++|+++++++|.++..   
T Consensus       236 ~~~~~l~~~-------------------~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~  296 (319)
T cd00116         236 AGAAALASA-------------------LLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQ  296 (319)
T ss_pred             HHHHHHHHH-------------------HhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHH
Confidence            211111100                   0001245555555555554    12234455567788888888877743   


Q ss_pred             -CCccccCC-CccccccCCCccc
Q 002010          425 -IPAGLFNL-PLLNMMELDDNLL  445 (982)
Q Consensus       425 -~p~~~~~l-~~L~~L~L~~N~l  445 (982)
                       +...+... +.|+++++.+|.+
T Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~  319 (319)
T cd00116         297 LLAESLLEPGNELESLWVKDDSF  319 (319)
T ss_pred             HHHHHHhhcCCchhhcccCCCCC
Confidence             23333334 5677777777653

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.75  E-value=3.7e-18  Score=202.37  Aligned_cols=195  Identities=20%  Similarity=0.203  Sum_probs=162.5

Q ss_pred             HhhcccccccccccceEEEEEEeCCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCC---CCcccceEeEEEcCCccEEE
Q 002010          691 LESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIR---HRNIVRLLGYVSNRDTNLLL  767 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~lv  767 (982)
                      -+.|.+.+.+|+|+||.||+|...+|+.||+|+-++....    +|.-=.+++.+++   -+.|..+..++.-.+.-++|
T Consensus       697 ~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W----EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv  772 (974)
T KOG1166|consen  697 GEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW----EFYICLQVMERLKPQMLPSIMHISSAHVFQNASVLV  772 (974)
T ss_pred             ceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce----eeeehHHHHHhhchhhhcchHHHHHHHccCCcceee
Confidence            3568888999999999999998778999999987554433    2333334455554   24566666666667788999


Q ss_pred             EeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcC-------CCCEEEecccc
Q 002010          768 YEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDS-------DFEAHVADFGL  840 (982)
Q Consensus       768 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~-------~~~~kl~DfG~  840 (982)
                      +||.+.|||.+++.  ..+.++|.-+..++.|+++.+++||..+   |||+||||+|+++..       ...++|+|||.
T Consensus       773 ~ey~~~Gtlld~~N--~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~  847 (974)
T KOG1166|consen  773 SEYSPYGTLLDLIN--TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLIDFGR  847 (974)
T ss_pred             eeccccccHHHhhc--cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEEeccc
Confidence            99999999999997  6678999999999999999999999998   999999999999942       35699999999


Q ss_pred             chhccccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCC
Q 002010          841 AKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKK  894 (982)
Q Consensus       841 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~  894 (982)
                      +..+.--.........++|-.+--+|+..++.+++++|.|.++.+++-|+.|+.
T Consensus       848 siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  848 SIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             ceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence            988765545566777889999999999999999999999999999999999975

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.74  E-value=8e-20  Score=167.54  Aligned_cols=179  Identities=25%  Similarity=0.428  Sum_probs=128.8

Q ss_pred             cCCCCCCEEEccCCccCCCCCccccCCCccccccCCCccccccCCcccccCCccEEEeeccccCCCCchhccCCCCccee
Q 002010          406 GQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLSGELPEKMSGASLNQLKVANNNITGKIPAAIGNLPSLNIL  485 (982)
Q Consensus       406 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L  485 (982)
                      -++.+.+.|.||+|+++ .+|..+..+.+|+.|++++|++                       . ..|..++.+++|+.|
T Consensus        30 f~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqi-----------------------e-~lp~~issl~klr~l   84 (264)
T KOG0617|consen   30 FNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQI-----------------------E-ELPTSISSLPKLRIL   84 (264)
T ss_pred             cchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchh-----------------------h-hcChhhhhchhhhhe
Confidence            34566667777777777 5666666666555555555554                       4 566777778888888


Q ss_pred             eeccccccCCCccccccccccceeeeeccccCC-CCCcccccccCCCeeeCCCCcccCCCCcccccccccceEEcccccc
Q 002010          486 SLQNNRLEGEIPVESFNLKMITSINISDNNISG-EIPYSISQCHSLTSVDLSRNSLYGKIPPGISKLIDLSILNLSRNGI  564 (982)
Q Consensus       486 ~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l  564 (982)
                      +++-|++. ..|..|+.++.|+.|||++|++.. .+|..|-.++.|+.|+|++|.+. .+|..++++++|+.|.+.+|.+
T Consensus        85 nvgmnrl~-~lprgfgs~p~levldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndl  162 (264)
T KOG0617|consen   85 NVGMNRLN-ILPRGFGSFPALEVLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDL  162 (264)
T ss_pred             ecchhhhh-cCccccCCCchhhhhhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCch
Confidence            88888776 777778888888888888887763 46777778888888888888886 7788888888888888888887


Q ss_pred             cccCccccccccccceecccCCccccCCCCCcccccccc---ccccCCcCc
Q 002010          565 TGSIPNEMRNMMSLTTLDLSYNNLIGNIPSGGQFLAFNE---TSFIGNPNL  612 (982)
Q Consensus       565 ~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~~~~~~~~~---~~~~~n~~~  612 (982)
                      - ..|.+++.++.|+.|.+.+|+++-.+|..++......   ...+.|||.
T Consensus       163 l-~lpkeig~lt~lrelhiqgnrl~vlppel~~l~l~~~k~v~r~E~NPwv  212 (264)
T KOG0617|consen  163 L-SLPKEIGDLTRLRELHIQGNRLTVLPPELANLDLVGNKQVMRMEENPWV  212 (264)
T ss_pred             h-hCcHHHHHHHHHHHHhcccceeeecChhhhhhhhhhhHHHHhhhhCCCC
Confidence            7 6788888888888888888888877776554433322   224566654

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.73  E-value=1.2e-19  Score=166.39  Aligned_cols=185  Identities=24%  Similarity=0.464  Sum_probs=161.1

Q ss_pred             cccCccccceeecccccccccCCccccCCCCCCEEEccCCccCCCCCccccCCCccccccCCCccccccCCcccccCCcc
Q 002010          380 DLCKGGKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLSGELPEKMSGASLN  459 (982)
Q Consensus       380 ~~~~~~~L~~L~l~~N~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~  459 (982)
                      .+..+..+..|.|++|+++ .+|..++.+.+|+.|++++|+|. .+|..+..+++|+.|+++-|++.             
T Consensus        28 gLf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-------------   92 (264)
T KOG0617|consen   28 GLFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-------------   92 (264)
T ss_pred             cccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-------------
Confidence            3556788999999999988 67778999999999999999998 88999999988777777766654             


Q ss_pred             EEEeeccccCCCCchhccCCCCcceeeecccccc-CCCccccccccccceeeeeccccCCCCCcccccccCCCeeeCCCC
Q 002010          460 QLKVANNNITGKIPAAIGNLPSLNILSLQNNRLE-GEIPVESFNLKMITSINISDNNISGEIPYSISQCHSLTSVDLSRN  538 (982)
Q Consensus       460 ~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N  538 (982)
                                 ..|..|+.++.|+.|||.+|++. ..+|..|+.++.|+.|+|++|.+. .+|..++++++|+.|.+..|
T Consensus        93 -----------~lprgfgs~p~levldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdn  160 (264)
T KOG0617|consen   93 -----------ILPRGFGSFPALEVLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDN  160 (264)
T ss_pred             -----------cCccccCCCchhhhhhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccC
Confidence                       77889999999999999999986 468999999999999999999998 89999999999999999999


Q ss_pred             cccCCCCcccccccccceEEcccccccccCcccccccc---ccceecccCCccccCCC
Q 002010          539 SLYGKIPPGISKLIDLSILNLSRNGITGSIPNEMRNMM---SLTTLDLSYNNLIGNIP  593 (982)
Q Consensus       539 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~---~L~~L~Ls~N~l~~~ip  593 (982)
                      .+- .+|..++.++.|++|++.+|+++ .+|.+++++.   +=+.+.+.+|++...|-
T Consensus       161 dll-~lpkeig~lt~lrelhiqgnrl~-vlppel~~l~l~~~k~v~r~E~NPwv~pIa  216 (264)
T KOG0617|consen  161 DLL-SLPKEIGDLTRLRELHIQGNRLT-VLPPELANLDLVGNKQVMRMEENPWVNPIA  216 (264)
T ss_pred             chh-hCcHHHHHHHHHHHHhcccceee-ecChhhhhhhhhhhHHHHhhhhCCCCChHH
Confidence            998 89999999999999999999999 7777777764   34567778888765554

>PRK10345 hypothetical protein; Provisional

Probab=99.71  E-value=7.2e-17  Score=163.85  Aligned_cols=137  Identities=22%  Similarity=0.295  Sum_probs=104.8

Q ss_pred             cccccccccccceEEEEEEeCCCcEEEEEEeccCCCCCchhhHHHHHHHHhcC-----CCCcccceEeEEEcCC---ccE
Q 002010          694 LKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRI-----RHRNIVRLLGYVSNRD---TNL  765 (982)
Q Consensus       694 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~~~~~~~~~~---~~~  765 (982)
                      +...+.||+|+||.||.  .++....+||++.... ....+.+.+|+.+++.+     +||||++++|++.++.   ..+
T Consensus         4 L~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~-~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~   80 (210)
T PRK10345          4 LSEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRG-DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY   80 (210)
T ss_pred             cCCcceecCCCceEEEE--CCCCcCeEEEEEeccc-cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence            34456899999999996  4333334799875432 33456789999999999     5799999999998874   223


Q ss_pred             -EEEec--cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHH-HHHhhcCCCcEEecCCCCCcEEEcC----CCCEEEec
Q 002010          766 -LLYEY--MPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGL-CYLHHDCSPLIIHRDVKSNNILLDS----DFEAHVAD  837 (982)
Q Consensus       766 -lv~e~--~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l-~~LH~~~~~~ivHrDlkp~Nill~~----~~~~kl~D  837 (982)
                       +|+||  +++++|.+++.+   ..+++.  ..++.+++.++ +|||+++   |+||||||+||+++.    ++.++|+|
T Consensus        81 ~~I~e~~G~~~~tL~~~l~~---~~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiD  152 (210)
T PRK10345         81 DVIADFDGKPSITLTEFAEQ---CRYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCD  152 (210)
T ss_pred             EEEecCCCCcchhHHHHHHc---ccccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEE
Confidence             78999  557999999963   235555  35677888777 9999998   999999999999974    34799999


Q ss_pred             cccc
Q 002010          838 FGLA  841 (982)
Q Consensus       838 fG~a  841 (982)
                      |+.+
T Consensus       153 g~G~  156 (210)
T PRK10345        153 NIGE  156 (210)
T ss_pred             CCCC
Confidence            5444

>smart00090 RIO RIO-like kinase

Probab=99.66  E-value=6.1e-16  Score=161.40  Aligned_cols=143  Identities=17%  Similarity=0.163  Sum_probs=109.4

Q ss_pred             cccccccccccceEEEEEE--eCCCcEEEEEEeccCCCCC-----------------------chhhHHHHHHHHhcCCC
Q 002010          694 LKDENIIGKGGAGIVYRGS--MPDGIDVAIKRLVGRGTGG-----------------------NDHGFLAEIQTLGRIRH  748 (982)
Q Consensus       694 ~~~~~~lg~G~~g~Vy~~~--~~~~~~vavK~~~~~~~~~-----------------------~~~~~~~E~~~l~~l~h  748 (982)
                      |++.+.||+|++|.||+|.  ..+|+.||+|++.......                       ....+.+|+..+.++.+
T Consensus        30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~  109 (237)
T smart00090       30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE  109 (237)
T ss_pred             HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence            5677899999999999997  5689999999986432110                       01235689999999975


Q ss_pred             Cc--ccceEeEEEcCCccEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEE
Q 002010          749 RN--IVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNIL  826 (982)
Q Consensus       749 ~n--iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nil  826 (982)
                      ..  +.+++++    ...++||||+++.++.....  ........++..++.|++.+++++|+.+  .|+||||||+||+
T Consensus       110 ~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dikp~NIl  181 (237)
T smart00090      110 AGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRL--KDVEPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLSEYNIL  181 (237)
T ss_pred             cCCCCCeeeEe----cCceEEEEEecCCccccccc--ccCCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCChhhEE
Confidence            32  3344432    34589999999988876543  2334566677899999999999999765  2999999999999


Q ss_pred             EcCCCCEEEeccccchhcc
Q 002010          827 LDSDFEAHVADFGLAKFLQ  845 (982)
Q Consensus       827 l~~~~~~kl~DfG~a~~~~  845 (982)
                      ++ ++.++++|||.+....
T Consensus       182 i~-~~~i~LiDFg~a~~~~  199 (237)
T smart00090      182 VH-DGKVVIIDVSQSVELD  199 (237)
T ss_pred             EE-CCCEEEEEChhhhccC
Confidence            99 8899999999987544

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.65  E-value=9.3e-16  Score=157.38  Aligned_cols=132  Identities=25%  Similarity=0.420  Sum_probs=107.6

Q ss_pred             ccccccceEEEEEEeCCCcEEEEEEeccCCCCCc-------hhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEecc
Q 002010          699 IIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGN-------DHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYM  771 (982)
Q Consensus       699 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  771 (982)
                      .||+|+||.||+|.. ++..|++|+.........       ..++.+|++++..++|+++.....++...+..++||||+
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            389999999999985 678899998644322111       245678999999999887666665666677789999999


Q ss_pred             CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhc
Q 002010          772 PNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFL  844 (982)
Q Consensus       772 ~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~  844 (982)
                      +|++|.+++....  .       .++.+++.+++++|+.+   ++|||++|.||+++ ++.++++|||.+...
T Consensus        80 ~g~~l~~~~~~~~--~-------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~~  139 (199)
T TIGR03724        80 EGKPLKDVIEEGN--D-------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKYS  139 (199)
T ss_pred             CCccHHHHHhhcH--H-------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence            9999999875321  0       78999999999999988   99999999999999 889999999998753

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.65  E-value=1.2e-16  Score=185.01  Aligned_cols=208  Identities=22%  Similarity=0.241  Sum_probs=145.3

Q ss_pred             hhcccccccccccceEEEEEEeCC-CcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEec
Q 002010          692 ESLKDENIIGKGGAGIVYRGSMPD-GIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEY  770 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  770 (982)
                      ..|+.++.|..|+||.||.++++. .+++|+| +.+...      +.+-  ++.....|.+|                  
T Consensus        83 ~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~l------ilRn--ilt~a~npfvv------------------  135 (1205)
T KOG0606|consen   83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNL------ILRN--ILTFAGNPFVV------------------  135 (1205)
T ss_pred             cccceeEeeccCCCCceeeeeccccccchhhc-ccccch------hhhc--cccccCCccee------------------
Confidence            467888899999999999997653 6678884 322110      1110  33333444443                  


Q ss_pred             cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhcccc---
Q 002010          771 MPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDA---  847 (982)
Q Consensus       771 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~---  847 (982)
                         |+-...++  ..++++.+.        +.+++|+|+.+   |+|||+||+|.+|+.-|++|+.|||+++..-..   
T Consensus       136 ---gDc~tllk--~~g~lPvdm--------vla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~at  199 (1205)
T KOG0606|consen  136 ---GDCATLLK--NIGPLPVDM--------VLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLAT  199 (1205)
T ss_pred             ---chhhhhcc--cCCCCcchh--------hHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhccc
Confidence               44445554  223333322        78999999888   999999999999999999999999998752110   


Q ss_pred             ----C------CcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCC
Q 002010          848 ----G------ASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVS  917 (982)
Q Consensus       848 ----~------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  917 (982)
                          +      ..-.....+||+.|.|||++....|+..+|+|++|+|+||.+-|+.||.+...++.+...+......+.
T Consensus       200 nl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE  279 (1205)
T KOG0606|consen  200 NLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPE  279 (1205)
T ss_pred             hhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccc
Confidence                0      011123458999999999999999999999999999999999999999876555545444443332111


Q ss_pred             CCCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCC
Q 002010          918 QPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARP  960 (982)
Q Consensus       918 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp  960 (982)
                                        -....+.+..+++.+.++.+|..|-
T Consensus       280 ------------------~dea~p~Ea~dli~~LL~qnp~~Rl  304 (1205)
T KOG0606|consen  280 ------------------EDEALPPEAQDLIEQLLRQNPLCRL  304 (1205)
T ss_pred             ------------------cCcCCCHHHHHHHHHHHHhChHhhc
Confidence                              1122234678899999999999997

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.65  E-value=1.3e-15  Score=157.95  Aligned_cols=135  Identities=22%  Similarity=0.380  Sum_probs=113.5

Q ss_pred             cccccccceEEEEEEeCCCcEEEEEEeccCCCCCc-------hhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEec
Q 002010          698 NIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGN-------DHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEY  770 (982)
Q Consensus       698 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  770 (982)
                      +.||+|++|.||+|.. .|..|++|+.........       ...+.+|+.++..+.|+++.....++...+..++||||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            4689999999999987 778899997644322111       23577899999999999988887777778889999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchh
Q 002010          771 MPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKF  843 (982)
Q Consensus       771 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~  843 (982)
                      ++|++|.+++....     + .+..++.+++.+++++|+.+   ++|||++|.||+++ ++.++++|||.+..
T Consensus        81 ~~G~~L~~~~~~~~-----~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         81 IEGEPLKDLINSNG-----M-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             eCCcCHHHHHHhcc-----H-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            99999999986321     2 78889999999999999988   99999999999999 78999999999875

>PLN03150 hypothetical protein; Provisional

Probab=99.63  E-value=1.1e-15  Score=182.00  Aligned_cols=157  Identities=24%  Similarity=0.387  Sum_probs=123.9

Q ss_pred             hcCchhHHHHHHHHHhcccCCCCCCCCCCCCCCCCCCCCccceeeeCCC-----CCEEEEEeccCCccccCCcCcccccc
Q 002010           22 LSCAYSDMDVLLKLKSSMIGPKGSGLKNWEPSSSPSAHCSFSGVTCDQD-----SRVVSLNVSFMPLFGSIPPEIGLLTK   96 (982)
Q Consensus        22 ~~~~~~~~~~ll~~k~~~~~~~~~~~~~w~~~~~~~~~C~w~gv~C~~~-----~~v~~l~l~~~~l~g~~~~~i~~l~~   96 (982)
                      ..+.+.|.+||++||+++.++.   ..+|.++.....+|.|.||.|+..     .+|+.|+|+++++.|.+|++++.+++
T Consensus       367 ~~t~~~~~~aL~~~k~~~~~~~---~~~W~g~~C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~~i~~L~~  443 (623)
T PLN03150        367 SKTLLEEVSALQTLKSSLGLPL---RFGWNGDPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRH  443 (623)
T ss_pred             cccCchHHHHHHHHHHhcCCcc---cCCCCCCCCCCcccccccceeeccCCCCceEEEEEECCCCCccccCCHHHhCCCC
Confidence            3467789999999999986543   248975311111248999999531     25889999999999999999999999


Q ss_pred             ccEEEeccCCCCCCCChhhhhhcccceeeccCCccccccchhhhhcCCCccEEeccCccccCCCchhcccc-ccccEEee
Q 002010           97 LVNLTISNVNLTGRLPSEMALLTSLKVFNISGNVFQGNFAGQIVRGMTELQVLDAYNNNFTGPLPVEIASL-KSLRHLSF  175 (982)
Q Consensus        97 L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l-~~L~~L~L  175 (982)
                      |+.|+|++|+++|.+|..++.+++|+.|||++|.++|.+|.. +.++++|++|+|++|+++|.+|..++.+ .++..+++
T Consensus       444 L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~-l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~l~~  522 (623)
T PLN03150        444 LQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPES-LGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNF  522 (623)
T ss_pred             CCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchH-HhcCCCCCEEECcCCcccccCChHHhhccccCceEEe
Confidence            999999999999999999999999999999999888877753 5678888888888888888888888764 46778888


Q ss_pred             cCccccc
Q 002010          176 GGNYFTG  182 (982)
Q Consensus       176 ~~N~l~~  182 (982)
                      ++|....
T Consensus       523 ~~N~~lc  529 (623)
T PLN03150        523 TDNAGLC  529 (623)
T ss_pred             cCCcccc
Confidence            8886543

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.63  E-value=1.3e-15  Score=155.96  Aligned_cols=137  Identities=22%  Similarity=0.173  Sum_probs=107.9

Q ss_pred             cccccccccccceEEEEEEeCCCcEEEEEEeccCCCC---------------------CchhhHHHHHHHHhcCCCC--c
Q 002010          694 LKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTG---------------------GNDHGFLAEIQTLGRIRHR--N  750 (982)
Q Consensus       694 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---------------------~~~~~~~~E~~~l~~l~h~--n  750 (982)
                      |...+.||+|+||.||+|..++|+.||||++......                     .....+.+|+.++..+.|+  .
T Consensus        17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~   96 (198)
T cd05144          17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP   96 (198)
T ss_pred             hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence            5667889999999999998878999999987543210                     0112356788888888776  4


Q ss_pred             ccceEeEEEcCCccEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCC
Q 002010          751 IVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSD  830 (982)
Q Consensus       751 iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~  830 (982)
                      +.+.++    ....++||||+++++|......        .....++.+++.++.++|+.+   |+||||||+||+++++
T Consensus        97 v~~~~~----~~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p~Nill~~~  161 (198)
T cd05144          97 VPKPID----WNRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYKHG---IIHGDLSEFNILVDDD  161 (198)
T ss_pred             CCceee----cCCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHHCC---CCcCCCCcccEEEcCC
Confidence            444444    2456899999999998776421        345678899999999999988   9999999999999999


Q ss_pred             CCEEEeccccchhcc
Q 002010          831 FEAHVADFGLAKFLQ  845 (982)
Q Consensus       831 ~~~kl~DfG~a~~~~  845 (982)
                      +.++|+|||++....
T Consensus       162 ~~~~liDfg~~~~~~  176 (198)
T cd05144         162 EKIYIIDWPQMVSTD  176 (198)
T ss_pred             CcEEEEECCccccCC
Confidence            999999999996554

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.63  E-value=7.9e-17  Score=174.88  Aligned_cols=172  Identities=22%  Similarity=0.379  Sum_probs=130.6

Q ss_pred             ccEEEEeccCCCCHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccc
Q 002010          763 TNLLLYEYMPNGSLGEMLHG-AKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLA  841 (982)
Q Consensus       763 ~~~lv~e~~~~~sL~~~l~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a  841 (982)
                      ..|+.|++|+-.+|.+|+.. ......++.....++.|++.|+.|   ++   .+|||+||.||+...+..+||.|||+.
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~  403 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLV  403 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhe
Confidence            56899999999999999973 334667888999999999999999   56   899999999999999999999999999


Q ss_pred             hhccccC----CcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHhccCC
Q 002010          842 KFLQDAG----ASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEV  916 (982)
Q Consensus       842 ~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  916 (982)
                      .......    ....++...||..||+||.+.+..|+.++||||+|++++|++. -..+++..    ....-++..    
T Consensus       404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~----~t~~d~r~g----  475 (516)
T KOG1033|consen  404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERI----ATLTDIRDG----  475 (516)
T ss_pred             eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHH----HhhhhhhcC----
Confidence            8766443    2345567889999999999999999999999999999999997 33333211    011111100    


Q ss_pred             CCCCcccccceeecCCC-CCCChHhHHHHHHHHhhccCCCCCCCCCHHH
Q 002010          917 SQPSDAASVLAVVDPRL-SGYPLTGVIHLFKVAMMCVEDESSARPTMRE  964 (982)
Q Consensus       917 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~e  964 (982)
                                 .++|.+ .++|     .=+.|+.+++...|.+||++.+
T Consensus       476 -----------~ip~~~~~d~p-----~e~~ll~~lls~~p~~RP~~~~  508 (516)
T KOG1033|consen  476 -----------IIPPEFLQDYP-----EEYTLLQQLLSPSPEERPSAIE  508 (516)
T ss_pred             -----------CCChHHhhcCc-----HHHHHHHHhcCCCcccCchHHH
Confidence                       011111 1122     2347899999999999995544

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.60  E-value=3.8e-15  Score=175.86  Aligned_cols=138  Identities=22%  Similarity=0.359  Sum_probs=111.7

Q ss_pred             hhcccccccccccceEEEEEEeCCCcEEEEEEeccCC-CCC------chhhHHHHHHHHhcCCCCcccceEeEEEcCCcc
Q 002010          692 ESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRG-TGG------NDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTN  764 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  764 (982)
                      ..|...+.||+|+||+||+|.+... .+++|+..... ...      ....+.+|++++++++|++++..+.++......
T Consensus       333 ~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~  411 (535)
T PRK09605        333 RRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK  411 (535)
T ss_pred             cccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence            3456678999999999999987443 44444432221 111      124578999999999999999888887777788


Q ss_pred             EEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhc
Q 002010          765 LLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFL  844 (982)
Q Consensus       765 ~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~  844 (982)
                      ++||||+++++|.+++.          ....++.+++.++++||+.+   ++|||+||+||++ +++.++++|||+++..
T Consensus       412 ~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~~~  477 (535)
T PRK09605        412 TIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGKYS  477 (535)
T ss_pred             EEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence            99999999999999884          35678999999999999988   9999999999999 6789999999999753

>PLN03150 hypothetical protein; Provisional

Probab=99.54  E-value=1.1e-14  Score=173.41  Aligned_cols=117  Identities=33%  Similarity=0.605  Sum_probs=96.7

Q ss_pred             ccceeeeeccccCCCCCcccccccCCCeeeCCCCcccCCCCcccccccccceEEcccccccccCccccccccccceeccc
Q 002010          505 MITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYGKIPPGISKLIDLSILNLSRNGITGSIPNEMRNMMSLTTLDLS  584 (982)
Q Consensus       505 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls  584 (982)
                      .++.|+|++|.++|.+|..++.+++|+.|+|++|.|+|.+|..++.+++|+.|+|++|+++|.+|..+..+++|+.|+|+
T Consensus       419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls  498 (623)
T PLN03150        419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN  498 (623)
T ss_pred             EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence            36778888888888888888888889999999998888888888888899999999999988888888889999999999


Q ss_pred             CCccccCCCCCc--cccccccccccCCcCcccCC-CCCCc
Q 002010          585 YNNLIGNIPSGG--QFLAFNETSFIGNPNLCLLR-NGTCQ  621 (982)
Q Consensus       585 ~N~l~~~ip~~~--~~~~~~~~~~~~n~~~c~~~-~~~c~  621 (982)
                      +|+++|.+|...  .+..+....+.+|+.+|+.+ ...|.
T Consensus       499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~l~~C~  538 (623)
T PLN03150        499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGLRACG  538 (623)
T ss_pred             CCcccccCChHHhhccccCceEEecCCccccCCCCCCCCc
Confidence            999998888632  12344566789999999876 45674

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.53  E-value=1.7e-15  Score=177.42  Aligned_cols=256  Identities=23%  Similarity=0.250  Sum_probs=190.9

Q ss_pred             hhcccccccccccceEEEEEEeCC--CcEEEEEEeccCC-CCCchhhHHHHHHHHhcCC-CCcccceEeEEEcCCccEEE
Q 002010          692 ESLKDENIIGKGGAGIVYRGSMPD--GIDVAIKRLVGRG-TGGNDHGFLAEIQTLGRIR-HRNIVRLLGYVSNRDTNLLL  767 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv  767 (982)
                      ..|...+.||+|+|+.|-.+....  ...+|+|.+.... ..........|..+-..+. |+|++++++.....+..+++
T Consensus        20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~   99 (601)
T KOG0590|consen   20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS   99 (601)
T ss_pred             ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence            356777789999999999885433  3445666553332 2222333445777777776 99999999999999999999


Q ss_pred             EeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHh-hcCCCcEEecCCCCCcEEEcCCC-CEEEeccccchhcc
Q 002010          768 YEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLH-HDCSPLIIHRDVKSNNILLDSDF-EAHVADFGLAKFLQ  845 (982)
Q Consensus       768 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH-~~~~~~ivHrDlkp~Nill~~~~-~~kl~DfG~a~~~~  845 (982)
                      .||..++++.+.+........+...+..++.|+..++.|+| ..+   ++|||+||+|.+++..+ ..++.|||+|..+.
T Consensus       100 ~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~  176 (601)
T KOG0590|consen  100 LSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATAYR  176 (601)
T ss_pred             cCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhcccc
Confidence            99999999999883222225667777889999999999999 887   99999999999999999 99999999999887


Q ss_pred             c-cCCccccccccc-ccccccccccccCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCCCc-hHHHHHHHhccCCCCCCc
Q 002010          846 D-AGASECMSSVAG-SYGYIAPEYAYTLK-VDEKSDVYSFGVVLLELIAGKKPVGEFGDGV-DIVRWVRKTTSEVSQPSD  921 (982)
Q Consensus       846 ~-~~~~~~~~~~~g-t~~y~aPE~~~~~~-~~~~~DvwslG~il~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~  921 (982)
                      . .+........+| ++.|+|||...+.. ..+..|+||.|+++.-+++|..|+....... ....|........     
T Consensus       177 ~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~-----  251 (601)
T KOG0590|consen  177 NKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFT-----  251 (601)
T ss_pred             ccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccc-----
Confidence            6 566666667788 99999999998854 4678999999999999999999997643322 1122222111000     


Q ss_pred             ccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          922 AASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       922 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                                  ............++..+++..+|+.|.+.+++..
T Consensus       252 ------------~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~  285 (601)
T KOG0590|consen  252 ------------QLPWNSISDQAHDLLHKILKENPSNRLSIEELKL  285 (601)
T ss_pred             ------------cCccccCChhhhhcccccccCCchhccccccccc
Confidence                        0011112234667888899999999999988754

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.53  E-value=3.6e-14  Score=138.62  Aligned_cols=134  Identities=22%  Similarity=0.233  Sum_probs=111.8

Q ss_pred             ccccccccceEEEEEEeCCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCC--CcccceEeEEEcCCccEEEEeccCCC
Q 002010          697 ENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRH--RNIVRLLGYVSNRDTNLLLYEYMPNG  774 (982)
Q Consensus       697 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~lv~e~~~~~  774 (982)
                      .+.+|+|.++.||++...+ ..+++|.......   ...+.+|+..++.+++  +.+.+++++....+..+++|||++++
T Consensus         3 ~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~---~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~   78 (155)
T cd05120           3 IKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK---GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE   78 (155)
T ss_pred             ceecccccccceEEEEecC-CeEEEEecCCCCc---hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence            4679999999999998744 7899998744322   4578899999999976  58999999888878899999999887


Q ss_pred             CHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchh
Q 002010          775 SLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKF  843 (982)
Q Consensus       775 sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~  843 (982)
                      .+..+         +......++.+++++++++|.....+++|+|++|+||++++.+.++++|||.+..
T Consensus        79 ~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          79 TLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             ecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            76543         4566778899999999999985334599999999999999989999999998864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.53  E-value=4.8e-14  Score=143.10  Aligned_cols=137  Identities=21%  Similarity=0.230  Sum_probs=97.3

Q ss_pred             ccccccccceEEEEEEeCCCcEEEEEEeccCCCCCc-hhh----------------------HHHHHHHHhcCCCC--cc
Q 002010          697 ENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGN-DHG----------------------FLAEIQTLGRIRHR--NI  751 (982)
Q Consensus       697 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~-~~~----------------------~~~E~~~l~~l~h~--ni  751 (982)
                      .+.||+|+||+||+|...+++.||||++........ ...                      ...|...+.++.+.  .+
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            457999999999999887899999998854322111 111                      13455556555433  24


Q ss_pred             cceEeEEEcCCccEEEEeccCCCCHHH-HhhcCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCcEEecCCCCCcEEEcC
Q 002010          752 VRLLGYVSNRDTNLLLYEYMPNGSLGE-MLHGAKGGHLKWETRYRIALEAAKGLCYLHH-DCSPLIIHRDVKSNNILLDS  829 (982)
Q Consensus       752 v~~~~~~~~~~~~~lv~e~~~~~sL~~-~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivHrDlkp~Nill~~  829 (982)
                      .+.++.    ...++||||++++++.. .+...   ... .++..++.+++.++.++|. .+   |+||||||+||+++ 
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~---~~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~-  149 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDV---RLL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD-  149 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhh---hhc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-
Confidence            444432    34689999999854321 11100   011 6678899999999999998 77   99999999999999 


Q ss_pred             CCCEEEeccccchhcc
Q 002010          830 DFEAHVADFGLAKFLQ  845 (982)
Q Consensus       830 ~~~~kl~DfG~a~~~~  845 (982)
                      ++.++++|||.+....
T Consensus       150 ~~~~~liDfg~a~~~~  165 (187)
T cd05119         150 DGKVYIIDVPQAVEID  165 (187)
T ss_pred             CCcEEEEECccccccc
Confidence            8999999999997654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.50  E-value=1.3e-13  Score=144.36  Aligned_cols=137  Identities=21%  Similarity=0.296  Sum_probs=105.8

Q ss_pred             ccccc-cccceEEEEEEeCCCcEEEEEEeccCC------------CCCchhhHHHHHHHHhcCCCCcc--cceEeEEEcC
Q 002010          697 ENIIG-KGGAGIVYRGSMPDGIDVAIKRLVGRG------------TGGNDHGFLAEIQTLGRIRHRNI--VRLLGYVSNR  761 (982)
Q Consensus       697 ~~~lg-~G~~g~Vy~~~~~~~~~vavK~~~~~~------------~~~~~~~~~~E~~~l~~l~h~ni--v~~~~~~~~~  761 (982)
                      ...|| .|+.|+||++.. .+..++||++....            .......+.+|+.++.+++|++|  ++.+++....
T Consensus        36 ~~~lg~~~g~gtv~~v~~-~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQT-PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             CceeecCCCCccEEEEEe-CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            45687 899999999977 57789999884321            01223467889999999988775  6677764432


Q ss_pred             Cc----cEEEEeccCC-CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEe
Q 002010          762 DT----NLLLYEYMPN-GSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVA  836 (982)
Q Consensus       762 ~~----~~lv~e~~~~-~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~  836 (982)
                      ..    .++|||+++| .+|.+++..   ..++..    .+.+++.+++++|+.|   |+||||||.||+++.++.++++
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~---~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LI  184 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQE---APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLI  184 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhc---CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEE
Confidence            22    2599999997 699998853   344443    3578999999999998   9999999999999999999999


Q ss_pred             ccccchhc
Q 002010          837 DFGLAKFL  844 (982)
Q Consensus       837 DfG~a~~~  844 (982)
                      |||.+...
T Consensus       185 Dfg~~~~~  192 (239)
T PRK01723        185 DFDRGELR  192 (239)
T ss_pred             ECCCcccC
Confidence            99988753

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=99.47  E-value=2.9e-15  Score=162.32  Aligned_cols=195  Identities=28%  Similarity=0.488  Sum_probs=154.5

Q ss_pred             CCcccEEEeccccccccCCccccCccccceeecccccccccCCccccCCCCCCEEEccCCccCCCCCccccCCCcccccc
Q 002010          360 NGKLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMME  439 (982)
Q Consensus       360 l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~l~~N~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~  439 (982)
                      +..-...||+.|++. .+|..++.+..|+.+.|..|.+. .+|..+.++..|++|||+.|+++ ..|..++.++      
T Consensus        74 ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp------  144 (722)
T KOG0532|consen   74 LTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP------  144 (722)
T ss_pred             ccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc------
Confidence            344556788888887 78888888888888888888766 67888888888888888888887 6666666554      


Q ss_pred             CCCccccccCCcccccCCccEEEeeccccCCCCchhccCCCCcceeeeccccccCCCccccccccccceeeeeccccCCC
Q 002010          440 LDDNLLSGELPEKMSGASLNQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNISGE  519 (982)
Q Consensus       440 L~~N~l~~~~~~~~~~~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~  519 (982)
                                        |+.|.+++|+++ .+|..++.+..|..||.+.|.+. .+|..++++..|+.|.+..|++. .
T Consensus       145 ------------------Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~  203 (722)
T KOG0532|consen  145 ------------------LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-D  203 (722)
T ss_pred             ------------------ceeEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-h
Confidence                              778888888888 78888888888999999999987 77888888888888888888888 5


Q ss_pred             CCcccccccCCCeeeCCCCcccCCCCcccccccccceEEcccccccccCcccccc---ccccceecccCCc
Q 002010          520 IPYSISQCHSLTSVDLSRNSLYGKIPPGISKLIDLSILNLSRNGITGSIPNEMRN---MMSLTTLDLSYNN  587 (982)
Q Consensus       520 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~---l~~L~~L~Ls~N~  587 (982)
                      +|.++. .-.|..||+|.|+++ .+|-.|.+|+.|++|-|.+|.|+ ..|..+..   ..=.++|+..-++
T Consensus       204 lp~El~-~LpLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLq-SPPAqIC~kGkVHIFKyL~~qA~q  271 (722)
T KOG0532|consen  204 LPEELC-SLPLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQ-SPPAQICEKGKVHIFKYLSTQACQ  271 (722)
T ss_pred             CCHHHh-CCceeeeecccCcee-ecchhhhhhhhheeeeeccCCCC-CChHHHHhccceeeeeeecchhcc
Confidence            677777 556888999999987 78888999999999999999998 66665533   3344666666654

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=99.41  E-value=1.1e-14  Score=157.92  Aligned_cols=178  Identities=25%  Similarity=0.382  Sum_probs=154.5

Q ss_pred             CCCCCCEEEccCCccCCCCCccccCCCccccccCCCccccccCCcccccCCccEEEeeccccCCCCchhccCCCCcceee
Q 002010          407 QCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLSGELPEKMSGASLNQLKVANNNITGKIPAAIGNLPSLNILS  486 (982)
Q Consensus       407 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~  486 (982)
                      .+..-...||+.|++. .+|..++.+..|..+.|..|.+...++.......|++|+|+.|+++ ..|..++.++ |+.|-
T Consensus        73 ~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli  149 (722)
T KOG0532|consen   73 DLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIRTIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLI  149 (722)
T ss_pred             cccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccceecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEE
Confidence            3455567788888887 7888888888888888888888866555555577888899999988 7788887776 89999


Q ss_pred             eccccccCCCccccccccccceeeeeccccCCCCCcccccccCCCeeeCCCCcccCCCCcccccccccceEEcccccccc
Q 002010          487 LQNNRLEGEIPVESFNLKMITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYGKIPPGISKLIDLSILNLSRNGITG  566 (982)
Q Consensus       487 L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~  566 (982)
                      +++|+++ .+|..++.+..|..||.|.|++. .+|..++++.+|+.|++..|++. .+|+.++.| .|..||+|.|+++ 
T Consensus       150 ~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~L-pLi~lDfScNkis-  224 (722)
T KOG0532|consen  150 VSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSL-PLIRLDFSCNKIS-  224 (722)
T ss_pred             EecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCC-ceeeeecccCcee-
Confidence            9999998 89999999999999999999999 78899999999999999999998 788888854 6889999999999 


Q ss_pred             cCccccccccccceecccCCccccCC
Q 002010          567 SIPNEMRNMMSLTTLDLSYNNLIGNI  592 (982)
Q Consensus       567 ~~p~~l~~l~~L~~L~Ls~N~l~~~i  592 (982)
                      .+|-.|..|+.|++|-|.+|+|..+.
T Consensus       225 ~iPv~fr~m~~Lq~l~LenNPLqSPP  250 (722)
T KOG0532|consen  225 YLPVDFRKMRHLQVLQLENNPLQSPP  250 (722)
T ss_pred             ecchhhhhhhhheeeeeccCCCCCCh
Confidence            89999999999999999999998653

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.39  E-value=8.6e-13  Score=150.21  Aligned_cols=152  Identities=19%  Similarity=0.218  Sum_probs=106.1

Q ss_pred             cHHHHHhhcccccccccccceEEEEEEeCCCcEEEEEEeccCCCCCc---------------------------------
Q 002010          686 KAEDVLESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGN---------------------------------  732 (982)
Q Consensus       686 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~---------------------------------  732 (982)
                      ..++.+..|+. +.||.|++|.||+|+.++|+.||||+.++......                                 
T Consensus       112 ~~~~~F~~fd~-~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~  190 (437)
T TIGR01982       112 PLEELFAEFEE-KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEF  190 (437)
T ss_pred             CHHHHHhhCCC-cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHH
Confidence            34455556663 68999999999999999999999999854321100                                 


Q ss_pred             ------hhhHHHHHHHHhcCC----CCcccceEeEE-EcCCccEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHH
Q 002010          733 ------DHGFLAEIQTLGRIR----HRNIVRLLGYV-SNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAA  801 (982)
Q Consensus       733 ------~~~~~~E~~~l~~l~----h~niv~~~~~~-~~~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~  801 (982)
                            .-+|.+|+..+.++.    |..-+.+-..+ ......++||||++|++|.++..... ...   .+..++.+++
T Consensus       191 ~~~l~~Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~-~~~---~~~~ia~~~~  266 (437)
T TIGR01982       191 EKTLRRELDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE-AGL---DRKALAENLA  266 (437)
T ss_pred             HHHHHHHHCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHh-cCC---CHHHHHHHHH
Confidence                  013555666666552    22223332322 22445799999999999988764221 112   2345666666


Q ss_pred             H-HHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhcc
Q 002010          802 K-GLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQ  845 (982)
Q Consensus       802 ~-~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~  845 (982)
                      . .+..+|..|   ++|+|+||.||+++.++.++++|||++..+.
T Consensus       267 ~~~l~ql~~~g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       267 RSFLNQVLRDG---FFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             HHHHHHHHhCC---ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence            5 467889888   9999999999999999999999999997765

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=99.32  E-value=2e-12  Score=147.74  Aligned_cols=200  Identities=30%  Similarity=0.404  Sum_probs=107.6

Q ss_pred             EEEccCCCcccccCccccCCCcccEEEeccccccccCCccccCcc-ccceeecccccccccCCccccCCCCCCEEEccCC
Q 002010          341 VLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDLCKGG-KLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKN  419 (982)
Q Consensus       341 ~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~-~L~~L~l~~N~~~~~~~~~l~~l~~L~~L~Ls~N  419 (982)
                      .+.++.|.+.. ....+...+.+..|++.+|.++ .+|....... +|+.|++++|.+. .+|..++.+++|+.|++++|
T Consensus        97 ~l~~~~~~~~~-~~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N  173 (394)
T COG4886          97 SLDLNLNRLRS-NISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFN  173 (394)
T ss_pred             eeecccccccc-CchhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCc
Confidence            45555555432 1222333355555666666655 4444444442 4555555555443 23344555555666666666


Q ss_pred             ccCCCCCccccCCCccccccCCCccccccCCcccccCCccEEEeeccccCCCCchhccCCCCcceeeeccccccCCCccc
Q 002010          420 YLNGTIPAGLFNLPLLNMMELDDNLLSGELPEKMSGASLNQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVE  499 (982)
Q Consensus       420 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~  499 (982)
                      +++ .+|...+..+                       .|+.|++++|++. .+|..+.....|++|.+++|++. .++..
T Consensus       174 ~l~-~l~~~~~~~~-----------------------~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~  227 (394)
T COG4886         174 DLS-DLPKLLSNLS-----------------------NLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSS  227 (394)
T ss_pred             hhh-hhhhhhhhhh-----------------------hhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchh
Confidence            555 3343333444                       4444444455544 34444444445666666666433 34555


Q ss_pred             cccccccceeeeeccccCCCCCcccccccCCCeeeCCCCcccCCCCcccccccccceEEcccccccccCcccc
Q 002010          500 SFNLKMITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYGKIPPGISKLIDLSILNLSRNGITGSIPNEM  572 (982)
Q Consensus       500 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l  572 (982)
                      +..++++..|.+++|++. .++..++.+++|+.|++++|+++ .++. ++.+.+|+.|++++|.++...|...
T Consensus       228 ~~~~~~l~~l~l~~n~~~-~~~~~~~~l~~l~~L~~s~n~i~-~i~~-~~~~~~l~~L~~s~n~~~~~~~~~~  297 (394)
T COG4886         228 LSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQIS-SISS-LGSLTNLRELDLSGNSLSNALPLIA  297 (394)
T ss_pred             hhhcccccccccCCceee-eccchhccccccceecccccccc-cccc-ccccCccCEEeccCccccccchhhh
Confidence            566666666666666665 33556666677777777777776 3333 6777777777777777765555433

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=99.31  E-value=2.2e-12  Score=147.42  Aligned_cols=198  Identities=32%  Similarity=0.452  Sum_probs=119.0

Q ss_pred             EEecccCcCcccCchhhcCCCccceeecccccCCCCCCccccCCC-CCCEEEeeCCcccCcCchhhhcccchhhhhhccC
Q 002010          245 VLDMASCNISGEIPTSLSRLKLLHSLFLQMNKLTGHIPPQLSGLI-SLKSLDLSLNYLTGEIPESFAALKNLTLLQLFKN  323 (982)
Q Consensus       245 ~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~-~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N  323 (982)
                      .|++..|.+... ...+..++.++.|++.+|.++ .++.....+. +|+.|++++|.+. .+|..+..+++|+.|++++|
T Consensus        97 ~l~~~~~~~~~~-~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N  173 (394)
T COG4886          97 SLDLNLNRLRSN-ISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFN  173 (394)
T ss_pred             eeeccccccccC-chhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCc
Confidence            566666666422 233455566777777777777 4555555553 7777777777776 45555667777777777777


Q ss_pred             CCCCCCCCcCCCCCCccEEEccCCCcccccCccccCCCcccEEEeccccccccCCccccCccccceeecccccccccCCc
Q 002010          324 NLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFIGPIPE  403 (982)
Q Consensus       324 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~l~~N~~~~~~~~  403 (982)
                      ++. .+|...+..++|+.|++++|+++ .+|........|++|++++|.+. ..+..+.++.++..+.+.+|++.. .+.
T Consensus       174 ~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~~-~~~  249 (394)
T COG4886         174 DLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLED-LPE  249 (394)
T ss_pred             hhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceeee-ccc
Confidence            777 44444446667777777777776 34544445555667777776433 344555555666666666665442 245


Q ss_pred             cccCCCCCCEEEccCCccCCCCCccccCCCccccccCCCccccccCCc
Q 002010          404 ELGQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLSGELPE  451 (982)
Q Consensus       404 ~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~  451 (982)
                      .++.++++++|++++|+++ .++. +..+.+++.|++++|.+....+.
T Consensus       250 ~~~~l~~l~~L~~s~n~i~-~i~~-~~~~~~l~~L~~s~n~~~~~~~~  295 (394)
T COG4886         250 SIGNLSNLETLDLSNNQIS-SISS-LGSLTNLRELDLSGNSLSNALPL  295 (394)
T ss_pred             hhccccccceecccccccc-cccc-ccccCccCEEeccCccccccchh
Confidence            5556666666666666665 3332 55555555555555555544443

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.30  E-value=6.3e-12  Score=128.03  Aligned_cols=204  Identities=21%  Similarity=0.311  Sum_probs=140.9

Q ss_pred             HHHHhcCCCCcccceEeEEEcC-----CccEEEEeccCCCCHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 002010          740 IQTLGRIRHRNIVRLLGYVSNR-----DTNLLLYEYMPNGSLGEMLHGAK--GGHLKWETRYRIALEAAKGLCYLHHDCS  812 (982)
Q Consensus       740 ~~~l~~l~h~niv~~~~~~~~~-----~~~~lv~e~~~~~sL~~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~~  812 (982)
                      +..+-++.|.|+|+++.|+.+.     ....+++|||+.|++..++++.+  ...+..+...+|..||..||.|||+- .
T Consensus       118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~  196 (458)
T KOG1266|consen  118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-D  196 (458)
T ss_pred             HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-C
Confidence            3445566799999999987653     34689999999999999998533  35577778889999999999999987 6


Q ss_pred             CcEEecCCCCCcEEEcCCCCEEEeccccchhccc--cCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHH
Q 002010          813 PLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQD--AGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELI  890 (982)
Q Consensus       813 ~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~--~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell  890 (982)
                      ++|+|+++..+-|++..+|-+|+.--.-......  ...........+-++|.|||.-.....+.++|||+||....||.
T Consensus       197 PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema  276 (458)
T KOG1266|consen  197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA  276 (458)
T ss_pred             CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence            8999999999999999998888853211111000  00111122334678999999888777888999999999999998


Q ss_pred             hCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          891 AGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       891 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                      .+..--.........-.-......            ..-++           .-.+++..|++..|..||+|.+++.
T Consensus       277 ilEiq~tnseS~~~~ee~ia~~i~------------~len~-----------lqr~~i~kcl~~eP~~rp~ar~llf  330 (458)
T KOG1266|consen  277 ILEIQSTNSESKVEVEENIANVII------------GLENG-----------LQRGSITKCLEGEPNGRPDARLLLF  330 (458)
T ss_pred             HheeccCCCcceeehhhhhhhhee------------eccCc-----------cccCcCcccccCCCCCCcchhhhhc
Confidence            876542221111100000000000            00000           1135688999999999999999765

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.27  E-value=3.4e-12  Score=146.43  Aligned_cols=151  Identities=15%  Similarity=0.172  Sum_probs=101.0

Q ss_pred             ccHHHHHhhcccccccccccceEEEEEEeCC-CcEEEEEEeccCCCCC-------------------------c------
Q 002010          685 FKAEDVLESLKDENIIGKGGAGIVYRGSMPD-GIDVAIKRLVGRGTGG-------------------------N------  732 (982)
Q Consensus       685 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~-------------------------~------  732 (982)
                      ...++.+..|+. +.+|+|++|.||+|+.++ |+.||||+.++.....                         .      
T Consensus       113 ~~~~~~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~  191 (537)
T PRK04750        113 GPVEEWFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVA  191 (537)
T ss_pred             CCHHHHHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHH
Confidence            345667778887 799999999999998877 9999999986542100                         0      


Q ss_pred             --h------hhHHHHHHHHhcCC----CCcccceEeEEEc-CCccEEEEeccCCCCHHHHhhcCCCC----CCCHHHHHH
Q 002010          733 --D------HGFLAEIQTLGRIR----HRNIVRLLGYVSN-RDTNLLLYEYMPNGSLGEMLHGAKGG----HLKWETRYR  795 (982)
Q Consensus       733 --~------~~~~~E~~~l~~l~----h~niv~~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~----~l~~~~~~~  795 (982)
                        .      -++.+|+..+.++.    +...+.+-..+.+ ....++||||++|+.+.++-.-...+    .+....+..
T Consensus       192 e~~~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~  271 (537)
T PRK04750        192 EFEKTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEV  271 (537)
T ss_pred             HHHHHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHH
Confidence              0      12445555555542    3333444444433 45678999999999998743211111    122222333


Q ss_pred             HHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCC----CEEEeccccchhccc
Q 002010          796 IALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDF----EAHVADFGLAKFLQD  846 (982)
Q Consensus       796 i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~----~~kl~DfG~a~~~~~  846 (982)
                      ++.|       +...|   ++|+|+||.||+++.++    .++++|||++..+.+
T Consensus       272 ~~~Q-------if~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        272 FFTQ-------VFRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             HHHH-------HHhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence            3334       34567   99999999999999888    999999999987653

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.26  E-value=8.8e-12  Score=138.93  Aligned_cols=247  Identities=21%  Similarity=0.213  Sum_probs=181.4

Q ss_pred             hhccccccccc--ccceEEEEEEe---CCCcEEEEEEeccCC-CCCchhhHHHHHHHHhcC-CCCcccceEeEEEcCCcc
Q 002010          692 ESLKDENIIGK--GGAGIVYRGSM---PDGIDVAIKRLVGRG-TGGNDHGFLAEIQTLGRI-RHRNIVRLLGYVSNRDTN  764 (982)
Q Consensus       692 ~~~~~~~~lg~--G~~g~Vy~~~~---~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~  764 (982)
                      ..+.+.+.+|.  |.+|.||.+..   .++..+|+|+-+... .......-++|+...+.+ .|++.++.+..+...+..
T Consensus       114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l  193 (524)
T KOG0601|consen  114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL  193 (524)
T ss_pred             hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence            34556678899  99999999965   458889999753332 223344556788887777 499999999999999999


Q ss_pred             EEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHH----HHHHHhhcCCCcEEecCCCCCcEEEcCC-CCEEEeccc
Q 002010          765 LLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAK----GLCYLHHDCSPLIIHRDVKSNNILLDSD-FEAHVADFG  839 (982)
Q Consensus       765 ~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~----~l~~LH~~~~~~ivHrDlkp~Nill~~~-~~~kl~DfG  839 (982)
                      ++-+|++ +.++.++.+. ....++....+....+..+    |+.++|..+   ++|-|+||.||+...+ ...+++|||
T Consensus       194 fiqtE~~-~~sl~~~~~~-~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df~  268 (524)
T KOG0601|consen  194 FIQTELC-GESLQSYCHT-PCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDFG  268 (524)
T ss_pred             eeeeccc-cchhHHhhhc-ccccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCcc
Confidence            9999999 5788888763 3345777888888888888    999999888   9999999999999999 899999999


Q ss_pred             cchhccccCCccc---ccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCC--CCCchHHHHHHHhcc
Q 002010          840 LAKFLQDAGASEC---MSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEF--GDGVDIVRWVRKTTS  914 (982)
Q Consensus       840 ~a~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~--~~~~~~~~~~~~~~~  914 (982)
                      +...+.+......   .....|...|++||...+ .++.++|+|++|.++.+..++..+....  .....+..+.     
T Consensus       269 ~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~-----  342 (524)
T KOG0601|consen  269 LVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY-----  342 (524)
T ss_pred             eeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc-----
Confidence            9988775532211   122256778999997654 5788999999999999999876654321  1111100000     


Q ss_pred             CCCCCCcccccceeecCCCC-CCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          915 EVSQPSDAASVLAVVDPRLS-GYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       915 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                                        ++ ++......++...+..|++.+|..|++++++..
T Consensus       343 ------------------ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~  378 (524)
T KOG0601|consen  343 ------------------IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA  378 (524)
T ss_pred             ------------------CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence                              00 111122234555889999999999999887764

>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms]

Probab=99.22  E-value=2.2e-12  Score=132.90  Aligned_cols=247  Identities=22%  Similarity=0.253  Sum_probs=156.1

Q ss_pred             hhhhcccceeeccCCccccc---cchhhhhcCCCccEEeccCc---cccCCCchh-------ccccccccEEeecCcccc
Q 002010          115 MALLTSLKVFNISGNVFQGN---FAGQIVRGMTELQVLDAYNN---NFTGPLPVE-------IASLKSLRHLSFGGNYFT  181 (982)
Q Consensus       115 l~~l~~L~~L~Ls~n~l~~~---~~~~~~~~l~~L~~L~Ls~n---~l~~~~p~~-------l~~l~~L~~L~L~~N~l~  181 (982)
                      +..+.+++.|+||+|.|...   .....+.+.++|+..++|+-   ++...+|..       +...++|++||||+|-|.
T Consensus        26 ~~~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~G  105 (382)
T KOG1909|consen   26 LEPMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNAFG  105 (382)
T ss_pred             hcccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccccC
Confidence            33445555555555555321   22233445556666666542   122234443       334467888888888877


Q ss_pred             cccCCCc----cccCcceEeeccCcccccchhhHHhhhhhHHHHhhcccccccccCCCCCCCCCCCCEEecccCcCcccC
Q 002010          182 GKIPQSY----SEIQSLEYIGLNGIGLNGTVPAFLSRLKNLREMYIGYFNTYTGGIPPGFGALTQLQVLDMASCNISGEI  257 (982)
Q Consensus       182 ~~~p~~~----~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~l~~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~  257 (982)
                      -..+..|    +.+.+|++|.|.+|+++......+++  .|.+|...          .-.+.-++|+++...+|++....
T Consensus       106 ~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~--al~~l~~~----------kk~~~~~~Lrv~i~~rNrlen~g  173 (382)
T KOG1909|consen  106 PKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGR--ALFELAVN----------KKAASKPKLRVFICGRNRLENGG  173 (382)
T ss_pred             ccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHH--HHHHHHHH----------hccCCCcceEEEEeecccccccc
Confidence            6555443    45788888888888887554444443  24444321          12344578999999999997543


Q ss_pred             ----chhhcCCCccceeecccccCCCCC----CccccCCCCCCEEEeeCCcccCcC----chhhhcccchhhhhhccCCC
Q 002010          258 ----PTSLSRLKLLHSLFLQMNKLTGHI----PPQLSGLISLKSLDLSLNYLTGEI----PESFAALKNLTLLQLFKNNL  325 (982)
Q Consensus       258 ----~~~l~~l~~L~~L~L~~N~l~~~~----~~~l~~l~~L~~L~Ls~N~l~~~~----~~~l~~l~~L~~L~L~~N~l  325 (982)
                          ...|...+.|+.+.++.|.|....    ...+..+++|+.|||.+|.++...    ...++.+++|+.|+++++.+
T Consensus       174 a~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll  253 (382)
T KOG1909|consen  174 ATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLL  253 (382)
T ss_pred             HHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeeccccccc
Confidence                335677789999999999887432    245677889999999999887543    34456677888888888888


Q ss_pred             CCCCCCcC-----CCCCCccEEEccCCCcccc----cCccccCCCcccEEEeccccc
Q 002010          326 RGPIPSFL-----GDFPNLEVLQVWGNNFTFE----LPENLGRNGKLLILDVTSNHL  373 (982)
Q Consensus       326 ~~~~p~~~-----~~l~~L~~L~L~~N~l~~~----~~~~l~~l~~L~~L~L~~N~l  373 (982)
                      +......|     ...|+|++|.+.+|.++..    +...+...+.|+.|+|+.|.+
T Consensus       254 ~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l  310 (382)
T KOG1909|consen  254 ENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRL  310 (382)
T ss_pred             ccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCcccc
Confidence            75433222     2367888888888888733    222334456677777777776

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.21  E-value=4.3e-11  Score=119.31  Aligned_cols=130  Identities=18%  Similarity=0.102  Sum_probs=95.9

Q ss_pred             cccccccceEEEEEEeCCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCccc-ceEeEEEcCCccEEEEeccCCCCH
Q 002010          698 NIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIV-RLLGYVSNRDTNLLLYEYMPNGSL  776 (982)
Q Consensus       698 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~~~~~~~~~~~~~lv~e~~~~~sL  776 (982)
                      +.++.|.++.||+++. .+..|++|.......  ....+.+|+.+++.+.+..++ +++++.  ....++||||++|.++
T Consensus         4 ~~l~~G~~~~vy~~~~-~~~~~~lK~~~~~~~--~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l   78 (170)
T cd05151           4 SPLKGGMTNKNYRVEV-ANKKYVVRIPGNGTE--LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL   78 (170)
T ss_pred             eecCCcccCceEEEEE-CCeEEEEEeCCCCcc--cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence            4689999999999987 477899998643321  233567899999988655544 444433  3346899999999887


Q ss_pred             HHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CCcEEecCCCCCcEEEcCCCCEEEeccccchh
Q 002010          777 GEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDC--SPLIIHRDVKSNNILLDSDFEAHVADFGLAKF  843 (982)
Q Consensus       777 ~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~  843 (982)
                      .+.-          ......+.+++++++.||+.+  ...++|+|++|.||+++ ++.++++|||.+..
T Consensus        79 ~~~~----------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          79 LTED----------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             cccc----------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            5430          111245679999999999876  12259999999999998 67899999998863

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]

Probab=99.17  E-value=1.5e-11  Score=130.23  Aligned_cols=186  Identities=20%  Similarity=0.192  Sum_probs=115.6

Q ss_pred             hhhcccceeeccCCccccccchhhhhcCCCccEEeccCccccC--CCchhccccccccEEeecCcccccccCCCc-cccC
Q 002010          116 ALLTSLKVFNISGNVFQGNFAGQIVRGMTELQVLDAYNNNFTG--PLPVEIASLKSLRHLSFGGNYFTGKIPQSY-SEIQ  192 (982)
Q Consensus       116 ~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~--~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~-~~l~  192 (982)
                      .++.+|+...|.+..............+++++.||||.|-|..  ++-.-...|++|+.|+|+.|++........ ..++
T Consensus       118 sn~kkL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~  197 (505)
T KOG3207|consen  118 SNLKKLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLS  197 (505)
T ss_pred             hhHHhhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhh
Confidence            4578888888888887654444567788999999999987763  234445678899999999998764333222 2467


Q ss_pred             cceEeeccCccccc-chhhHHhhhhhHHHHhhcccccccccCCCCCCCCCCCCEEecccCcCcccC-chhhcCCCcccee
Q 002010          193 SLEYIGLNGIGLNG-TVPAFLSRLKNLREMYIGYFNTYTGGIPPGFGALTQLQVLDMASCNISGEI-PTSLSRLKLLHSL  270 (982)
Q Consensus       193 ~L~~L~L~~n~i~~-~~~~~l~~l~~L~~L~l~~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~-~~~l~~l~~L~~L  270 (982)
                      +|+.|.|++|+++. .+...+..+++|+.|++..|+ ....-......+..|+.|||++|++-... -...+.++.|+.|
T Consensus       198 ~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~-~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~L  276 (505)
T KOG3207|consen  198 HLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANE-IILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQL  276 (505)
T ss_pred             hhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhccc-ccceecchhhhhhHHhhccccCCcccccccccccccccchhhh
Confidence            88899999999884 333344556777777777654 11112223344566677777776665221 1345566666666


Q ss_pred             ecccccCCCCC-Ccc-----ccCCCCCCEEEeeCCccc
Q 002010          271 FLQMNKLTGHI-PPQ-----LSGLISLKSLDLSLNYLT  302 (982)
Q Consensus       271 ~L~~N~l~~~~-~~~-----l~~l~~L~~L~Ls~N~l~  302 (982)
                      +++.+.++..- |+.     ...+++|++|+++.|+|.
T Consensus       277 nls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~  314 (505)
T KOG3207|consen  277 NLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIR  314 (505)
T ss_pred             hccccCcchhcCCCccchhhhcccccceeeecccCccc
Confidence            66666665321 111     123455566666665553

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.17  E-value=4.6e-10  Score=126.15  Aligned_cols=167  Identities=20%  Similarity=0.229  Sum_probs=126.4

Q ss_pred             EeCCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEeccCCCCHHHHhhcCCCCCCCHH
Q 002010          712 SMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWE  791 (982)
Q Consensus       712 ~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~  791 (982)
                      +..++.+|.|........ .......+.++.++.++||+|+++++.+..++..|+|+|.+  ..|..++..     +...
T Consensus        33 ~k~~~~~vsVF~~~~~~~-~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~-----l~~~  104 (690)
T KOG1243|consen   33 RKADGGPVSVFVYKRSNG-EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKE-----LGKE  104 (690)
T ss_pred             eeccCCceEEEEEeCCCc-hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHH-----hHHH
Confidence            455788888887743333 44455778899999999999999999999999999999998  367777763     2356


Q ss_pred             HHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCcccccccccccccccccccccC
Q 002010          792 TRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTL  871 (982)
Q Consensus       792 ~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  871 (982)
                      ....-+.||+.||.+||+.+.  ++|++|.-..|+|++.|+.||++|.++........  ......--..|..|+.+...
T Consensus       105 ~v~~Gl~qIl~AL~FL~~d~~--lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s  180 (690)
T KOG1243|consen  105 EVCLGLFQILAALSFLNDDCN--LVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPS  180 (690)
T ss_pred             HHHHHHHHHHHHHHHHhccCC--eeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCcc
Confidence            667789999999999986543  99999999999999999999999998865442221  11111122245666644432


Q ss_pred             CCCcchhhHHHHHHHHHHHhC
Q 002010          872 KVDEKSDVYSFGVVLLELIAG  892 (982)
Q Consensus       872 ~~~~~~DvwslG~il~elltg  892 (982)
                      .  -..|.|.||+++||++.|
T Consensus       181 ~--~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  181 E--WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             c--cchhhhhHHHHHHHHhCc
Confidence            2  346999999999999999

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=99.14  E-value=1.1e-11  Score=124.46  Aligned_cols=131  Identities=27%  Similarity=0.358  Sum_probs=105.1

Q ss_pred             CccEEEeeccccCCCCchhccCCCCcceeeeccccccCCCccccccccccceeeeeccccCCCCCcccccccCCCeeeCC
Q 002010          457 SLNQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIPYSISQCHSLTSVDLS  536 (982)
Q Consensus       457 ~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls  536 (982)
                      .|+++||++|.|+ .+.....-.|.++.|++|+|.+. .+- .+..+++|+.||||+|.++ .+..+-..+-+.+.|.|+
T Consensus       285 ~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~-~v~-nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~La  360 (490)
T KOG1259|consen  285 ELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIR-TVQ-NLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKLA  360 (490)
T ss_pred             hhhhccccccchh-hhhhhhhhccceeEEecccccee-eeh-hhhhcccceEeecccchhH-hhhhhHhhhcCEeeeehh
Confidence            5778888888887 66777778888999999999887 232 3777888999999999888 556666778889999999


Q ss_pred             CCcccCCCCcccccccccceEEcccccccccCc-cccccccccceecccCCccccCCC
Q 002010          537 RNSLYGKIPPGISKLIDLSILNLSRNGITGSIP-NEMRNMMSLTTLDLSYNNLIGNIP  593 (982)
Q Consensus       537 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~l~~l~~L~~L~Ls~N~l~~~ip  593 (982)
                      .|.|..  -..+++|-+|..||+++|+|..... ..+++++-|+.+.|.+|++.+.+-
T Consensus       361 ~N~iE~--LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~vd  416 (490)
T KOG1259|consen  361 QNKIET--LSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSVD  416 (490)
T ss_pred             hhhHhh--hhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccch
Confidence            999862  3458888999999999999974322 568899999999999999997654

>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]

Probab=99.13  E-value=1.8e-11  Score=129.63  Aligned_cols=212  Identities=21%  Similarity=0.226  Sum_probs=161.7

Q ss_pred             cccccccEEEeccCCCCCCCC-hhhhhhcccceeeccCCccccccc-hhhhhcCCCccEEeccCccccCCCchhc-cccc
Q 002010           92 GLLTKLVNLTISNVNLTGRLP-SEMALLTSLKVFNISGNVFQGNFA-GQIVRGMTELQVLDAYNNNFTGPLPVEI-ASLK  168 (982)
Q Consensus        92 ~~l~~L~~L~l~~n~l~~~~p-~~l~~l~~L~~L~Ls~n~l~~~~~-~~~~~~l~~L~~L~Ls~n~l~~~~p~~l-~~l~  168 (982)
                      .++++|+++.|.+..+....- .....|++++.||||+|-|..-.+ .++.+.|++|+.|+|+.|++.-...... ..++
T Consensus       118 sn~kkL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~  197 (505)
T KOG3207|consen  118 SNLKKLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLS  197 (505)
T ss_pred             hhHHhhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhh
Confidence            457889999999987764322 467889999999999999875433 4677899999999999999874333332 3688


Q ss_pred             cccEEeecCcccccccCC-CccccCcceEeeccCcccccchhhHHhhhhhHHHHhhcccccccccCCCCCCCCCCCCEEe
Q 002010          169 SLRHLSFGGNYFTGKIPQ-SYSEIQSLEYIGLNGIGLNGTVPAFLSRLKNLREMYIGYFNTYTGGIPPGFGALTQLQVLD  247 (982)
Q Consensus       169 ~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~l~~~n~~~~~~p~~~~~l~~L~~L~  247 (982)
                      +|+.|.|+.|.++...-. ....+++|+.|+|..|...........-++.|++|+|+.++..+-..-...+.++.|+.|+
T Consensus       198 ~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~Ln  277 (505)
T KOG3207|consen  198 HLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQLN  277 (505)
T ss_pred             hhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhhh
Confidence            999999999999854333 3456899999999999655555566677899999999998877766556789999999999


Q ss_pred             cccCcCccc-Cchh-----hcCCCccceeecccccCCCC-CCccccCCCCCCEEEeeCCcccC
Q 002010          248 MASCNISGE-IPTS-----LSRLKLLHSLFLQMNKLTGH-IPPQLSGLISLKSLDLSLNYLTG  303 (982)
Q Consensus       248 L~~n~l~~~-~~~~-----l~~l~~L~~L~L~~N~l~~~-~~~~l~~l~~L~~L~Ls~N~l~~  303 (982)
                      ++.|+++.. .|+.     ....++|++|+++.|++..- .-..+..+.+|+.|....|.++.
T Consensus       278 ls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~ln~  340 (505)
T KOG3207|consen  278 LSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRITLNYLNK  340 (505)
T ss_pred             ccccCcchhcCCCccchhhhcccccceeeecccCccccccccchhhccchhhhhhcccccccc
Confidence            999999853 2332     35678999999999999622 11234455667777777777763

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.12  E-value=6.7e-10  Score=105.94  Aligned_cols=132  Identities=24%  Similarity=0.392  Sum_probs=101.3

Q ss_pred             cccccccceEEEEEEeCCCcEEEEEEeccC-CCCCc------hhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEec
Q 002010          698 NIIGKGGAGIVYRGSMPDGIDVAIKRLVGR-GTGGN------DHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEY  770 (982)
Q Consensus       698 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~-~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  770 (982)
                      ..+++|+-+.+|.+.+ -|.++++|.=.++ .....      .....+|+.++.+++.-.|...+=+..+.+...++|||
T Consensus         2 ~~i~~GAEa~i~~~~~-~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~   80 (204)
T COG3642           2 DLIKQGAEAIIYLTDF-LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY   80 (204)
T ss_pred             chhhCCcceeEEeeec-cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence            3689999999999977 4445666643222 11111      23567899999998766666656667778888999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchh
Q 002010          771 MPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKF  843 (982)
Q Consensus       771 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~  843 (982)
                      ++|..|.+++...         ...++..+-.-+.-||..+   |+|+|+.++||.+..+. +.++|||++.+
T Consensus        81 I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          81 IEGELLKDALEEA---------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             eCChhHHHHHHhc---------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence            9999999998632         2457778888889999998   99999999999997664 99999999974

>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms]

Probab=99.11  E-value=6.2e-11  Score=144.04  Aligned_cols=294  Identities=18%  Similarity=0.205  Sum_probs=194.7

Q ss_pred             ccccccccEEEeccCCCCCCCChhhhhhcccceeeccCCcc-ccccchhhhhcCCCccEEeccCccccCCCchhcccccc
Q 002010           91 IGLLTKLVNLTISNVNLTGRLPSEMALLTSLKVFNISGNVF-QGNFAGQIVRGMTELQVLDAYNNNFTGPLPVEIASLKS  169 (982)
Q Consensus        91 i~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l-~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~  169 (982)
                      .......+...+.+|++. .++.... ++.|++|-+..|.. ...++..+|..|+.|++||||+|.=-+.+|..++.|-+
T Consensus       519 ~~~~~~~rr~s~~~~~~~-~~~~~~~-~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~  596 (889)
T KOG4658|consen  519 VKSWNSVRRMSLMNNKIE-HIAGSSE-NPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVH  596 (889)
T ss_pred             ccchhheeEEEEeccchh-hccCCCC-CCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhh
Confidence            334467788888888765 3333332 33788888888863 34677788899999999999998777789999999999


Q ss_pred             ccEEeecCcccccccCCCccccCcceEeeccCcccccchhhHHhhhhhHHHHhhcccc-cccccCCCCCCCCCCCCEEec
Q 002010          170 LRHLSFGGNYFTGKIPQSYSEIQSLEYIGLNGIGLNGTVPAFLSRLKNLREMYIGYFN-TYTGGIPPGFGALTQLQVLDM  248 (982)
Q Consensus       170 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~l~~~n-~~~~~~p~~~~~l~~L~~L~L  248 (982)
                      |++|+|++..++ .+|..+++|+.|.+|++..+.....+|.....|.+||+|.+-... ..+...-..+.++.+|+.+..
T Consensus       597 LryL~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ls~  675 (889)
T KOG4658|consen  597 LRYLDLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLENLSI  675 (889)
T ss_pred             hhcccccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeeccccccchhhHHhhhcccchhhhee
Confidence            999999999998 889999999999999999888777778888889999998876543 222333344566666666666


Q ss_pred             ccCcCcccCchhhcCCCccc----eeecccccCCCCCCccccCCCCCCEEEeeCCcccCcCchhhhc------ccchhhh
Q 002010          249 ASCNISGEIPTSLSRLKLLH----SLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAA------LKNLTLL  318 (982)
Q Consensus       249 ~~n~l~~~~~~~l~~l~~L~----~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~------l~~L~~L  318 (982)
                      .....  .+-..+..+..|.    .+.+.++... ..+..+..+.+|+.|.+.++.+..........      ++++..+
T Consensus       676 ~~~s~--~~~e~l~~~~~L~~~~~~l~~~~~~~~-~~~~~~~~l~~L~~L~i~~~~~~e~~~~~~~~~~~~~~f~~l~~~  752 (889)
T KOG4658|consen  676 TISSV--LLLEDLLGMTRLRSLLQSLSIEGCSKR-TLISSLGSLGNLEELSILDCGISEIVIEWEESLIVLLCFPNLSKV  752 (889)
T ss_pred             ecchh--HhHhhhhhhHHHHHHhHhhhhcccccc-eeecccccccCcceEEEEcCCCchhhcccccccchhhhHHHHHHH
Confidence            44443  1112233333333    3333333333 44556788899999999999886433322222      2233333


Q ss_pred             hhccCCCCCCCCCcCCCCCCccEEEccCCCcccccCccccCCCcccEEEecccccccc-CCccccCccccceee
Q 002010          319 QLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGT-IPRDLCKGGKLKSLI  391 (982)
Q Consensus       319 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~-~p~~~~~~~~L~~L~  391 (982)
                      .+.++..- ..+.+....++|+.|.+..+.....+.+....+..+..+-+..+.+.+. .-.....++++..+.
T Consensus       753 ~~~~~~~~-r~l~~~~f~~~L~~l~l~~~~~~e~~i~~~k~~~~l~~~i~~f~~~~~l~~~~~l~~l~~i~~~~  825 (889)
T KOG4658|consen  753 SILNCHML-RDLTWLLFAPHLTSLSLVSCRLLEDIIPKLKALLELKELILPFNKLEGLRMLCSLGGLPQLYWLP  825 (889)
T ss_pred             Hhhccccc-cccchhhccCcccEEEEecccccccCCCHHHHhhhcccEEecccccccceeeecCCCCceeEecc
Confidence            33333222 2334444568899999998888777777777777777777777777654 233334444444333

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.10  E-value=1.2e-09  Score=108.89  Aligned_cols=137  Identities=15%  Similarity=0.152  Sum_probs=98.0

Q ss_pred             cccccccceEEEEEEeCC-------CcEEEEEEeccCCC-----------C---------Cc-hhhH----HHHHHHHhc
Q 002010          698 NIIGKGGAGIVYRGSMPD-------GIDVAIKRLVGRGT-----------G---------GN-DHGF----LAEIQTLGR  745 (982)
Q Consensus       698 ~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~-----------~---------~~-~~~~----~~E~~~l~~  745 (982)
                      ..||.|--+.||.|...+       +..+|||..+....           +         .. ...+    .+|++.|++
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            478999999999996532       57999998843210           0         01 1122    379999998


Q ss_pred             CCC--CcccceEeEEEcCCccEEEEeccCCCCHHH-HhhcCCCCCCCHHHHHHHHHHHHHHHHHH-hhcCCCcEEecCCC
Q 002010          746 IRH--RNIVRLLGYVSNRDTNLLLYEYMPNGSLGE-MLHGAKGGHLKWETRYRIALEAAKGLCYL-HHDCSPLIIHRDVK  821 (982)
Q Consensus       746 l~h--~niv~~~~~~~~~~~~~lv~e~~~~~sL~~-~l~~~~~~~l~~~~~~~i~~~i~~~l~~L-H~~~~~~ivHrDlk  821 (982)
                      +..  -.+.+++++    ...++||||+.+..+.. .++   ...++.++...+..+++.++..+ |+.+   +||+|++
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk---d~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDLs  152 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK---DAKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADLS  152 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh---ccccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCCC
Confidence            843  455555553    56799999997643321 222   22345566777889999999999 8888   9999999


Q ss_pred             CCcEEEcCCCCEEEeccccchhcc
Q 002010          822 SNNILLDSDFEAHVADFGLAKFLQ  845 (982)
Q Consensus       822 p~Nill~~~~~~kl~DfG~a~~~~  845 (982)
                      +.||+++ ++.+.++|||.|....
T Consensus       153 ~~NIL~~-~~~v~iIDF~qav~~~  175 (197)
T cd05146         153 EYNMLWH-DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             HHHEEEE-CCcEEEEECCCceeCC
Confidence            9999997 4689999999887543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.10  E-value=9e-10  Score=104.18  Aligned_cols=144  Identities=22%  Similarity=0.248  Sum_probs=108.1

Q ss_pred             cccccccccceEEEEEEeCCCcEEEEEEeccCCCC-------CchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEE
Q 002010          696 DENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTG-------GNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLY  768 (982)
Q Consensus       696 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  768 (982)
                      ....+-+|+-+.|+++.+ .|+..+||.=..+.-.       -..++..+|++.+.++.--.|.-..=++.+.....++|
T Consensus        11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M   89 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM   89 (229)
T ss_pred             cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence            345789999999999988 7777777743222111       12346788999999886545544444677778889999


Q ss_pred             eccCC-CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCC---CEEEeccccchh
Q 002010          769 EYMPN-GSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDF---EAHVADFGLAKF  843 (982)
Q Consensus       769 e~~~~-~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~---~~kl~DfG~a~~  843 (982)
                      ||++| .++.+++...-......+....++++|-+.+.-||..+   |+|+|+..+||++..++   .+.++|||++..
T Consensus        90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence            99976 48888887544444444444789999999999999998   99999999999997654   358999999864

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=99.08  E-value=3.1e-11  Score=121.15  Aligned_cols=207  Identities=23%  Similarity=0.206  Sum_probs=130.5

Q ss_pred             CCCCCCCCCCCCEEecccCcCcccCchhhcCCCccceeecccccCCCCCCccccCCCCCCEEEeeC-CcccCcCchhhhc
Q 002010          233 IPPGFGALTQLQVLDMASCNISGEIPTSLSRLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSL-NYLTGEIPESFAA  311 (982)
Q Consensus       233 ~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~-N~l~~~~~~~l~~  311 (982)
                      +|-.+.-+++|..+.++.|.-..+. .--..-+.|.++.+.+..++. .|. +-....+..+.-+. .-.+|..-..+..
T Consensus       206 l~f~l~~f~~l~~~~~s~~~~~~i~-~~~~~kptl~t~~v~~s~~~~-~~~-l~pe~~~~D~~~~E~~t~~G~~~~~~dT  282 (490)
T KOG1259|consen  206 LSFNLNAFRNLKTLKFSALSTENIV-DIELLKPTLQTICVHNTTIQD-VPS-LLPETILADPSGSEPSTSNGSALVSADT  282 (490)
T ss_pred             cccchHHhhhhheeeeeccchhhee-ceeecCchhheeeeecccccc-ccc-ccchhhhcCccCCCCCccCCceEEecch
Confidence            3444555566666666666543221 111222456666665554442 111 11112222221111 1122222233344


Q ss_pred             ccchhhhhhccCCCCCCCCCcCCCCCCccEEEccCCCcccccCccccCCCcccEEEeccccccccCCccccCccccceee
Q 002010          312 LKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDLCKGGKLKSLI  391 (982)
Q Consensus       312 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~  391 (982)
                      .+.|+.+|||+|.|+ .+.....-.|.++.|++++|.+..  ...+..+.+|+.||||+|.++ .+..+-.++.+++.|.
T Consensus       283 Wq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~--v~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~  358 (490)
T KOG1259|consen  283 WQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRT--VQNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLK  358 (490)
T ss_pred             Hhhhhhccccccchh-hhhhhhhhccceeEEeccccceee--ehhhhhcccceEeecccchhH-hhhhhHhhhcCEeeee
Confidence            467888888888887 566677778888888888888873  234777888888888888887 5666667788888888


Q ss_pred             cccccccccCCccccCCCCCCEEEccCCccCCCC-CccccCCCccccccCCCcccccc
Q 002010          392 LMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGTI-PAGLFNLPLLNMMELDDNLLSGE  448 (982)
Q Consensus       392 l~~N~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~  448 (982)
                      |++|.+..  -..++.+-+|..||+++|+|.... -..++++|-|+.+.|.+|.+.+.
T Consensus       359 La~N~iE~--LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~  414 (490)
T KOG1259|consen  359 LAQNKIET--LSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGS  414 (490)
T ss_pred             hhhhhHhh--hhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCcccc
Confidence            88888742  234667788999999999987432 34688899899999999988754

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.07  E-value=1.1e-10  Score=130.34  Aligned_cols=248  Identities=19%  Similarity=0.141  Sum_probs=174.1

Q ss_pred             hhcccccccccccceEEEEEEe--CCCcEEEEEEeccCCCCCc-hhhHHHHHHHHhcC-CCCcccceEeEEEcCCccEEE
Q 002010          692 ESLKDENIIGKGGAGIVYRGSM--PDGIDVAIKRLVGRGTGGN-DHGFLAEIQTLGRI-RHRNIVRLLGYVSNRDTNLLL  767 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~-~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv  767 (982)
                      .+|..+..||.|.|+.|++...  .++..|++|.+........ ...-..|+.+...+ .|.++++.+..+...+..|+-
T Consensus       265 ~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip  344 (524)
T KOG0601|consen  265 TDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIP  344 (524)
T ss_pred             CCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCc
Confidence            3466677899999999999853  4678899998744432222 22234566666666 588888888777777777899


Q ss_pred             EeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCC-CCEEEeccccchhccc
Q 002010          768 YEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSD-FEAHVADFGLAKFLQD  846 (982)
Q Consensus       768 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~-~~~kl~DfG~a~~~~~  846 (982)
                      -|||++++......  -...+++..++++..|++.++.++|+..   ++|+|+||+||++..+ +..++.|||++..+.-
T Consensus       345 ~e~~~~~s~~l~~~--~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~  419 (524)
T KOG0601|consen  345 LEFCEGGSSSLRSV--TSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWTRLAF  419 (524)
T ss_pred             hhhhcCcchhhhhH--HHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhccccccccccce
Confidence            99999998776652  3345778888999999999999999887   9999999999999886 8889999999874321


Q ss_pred             cCCcccccccccccccc--cccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccc
Q 002010          847 AGASECMSSVAGSYGYI--APEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAAS  924 (982)
Q Consensus       847 ~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  924 (982)
                      .     .....+..+++  +|+......+..+.|++++|.-+.+..++.+--......   ..+                
T Consensus       420 ~-----~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~---~~i----------------  475 (524)
T KOG0601|consen  420 S-----SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQS---LTI----------------  475 (524)
T ss_pred             e-----cccccccccccccchhhccccccccccccccccccccccccCcccCcccccc---eee----------------
Confidence            1     11122233344  566667778899999999999999999886533221110   000                


Q ss_pred             cceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 002010          925 VLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPP  973 (982)
Q Consensus       925 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~  973 (982)
                          .....+-.+... ..+..+.+.+...|+..||.+.++....+-..
T Consensus       476 ----~~~~~p~~~~~~-~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~  519 (524)
T KOG0601|consen  476 ----RSGDTPNLPGLK-LQLQVLLKVMINPDRKRRPSAVELSLHSEFYR  519 (524)
T ss_pred             ----ecccccCCCchH-HhhhhhhhhhcCCccccchhhhhhcccchhhh
Confidence                001111111122 45677888899999999999998876554433

>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms]

Probab=99.07  E-value=2.3e-11  Score=125.60  Aligned_cols=186  Identities=23%  Similarity=0.238  Sum_probs=87.1

Q ss_pred             CCCCEEecccCcCcccCchh----hcCCCccceeecccccCCCCCCc-------------cccCCCCCCEEEeeCCcccC
Q 002010          241 TQLQVLDMASCNISGEIPTS----LSRLKLLHSLFLQMNKLTGHIPP-------------QLSGLISLKSLDLSLNYLTG  303 (982)
Q Consensus       241 ~~L~~L~L~~n~l~~~~~~~----l~~l~~L~~L~L~~N~l~~~~~~-------------~l~~l~~L~~L~Ls~N~l~~  303 (982)
                      ++|++|+||.|-+.-..+..    +..+..|++|+|.+|.+.-....             ..+.-+.|+.+...+|++..
T Consensus        92 ~~L~~ldLSDNA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rNrlen  171 (382)
T KOG1909|consen   92 PKLQKLDLSDNAFGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRNRLEN  171 (382)
T ss_pred             CceeEeeccccccCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeecccccc
Confidence            45555555555554333322    23345555555555554421111             12233456666666666653


Q ss_pred             cCc----hhhhcccchhhhhhccCCCCCCC----CCcCCCCCCccEEEccCCCcccc----cCccccCCCcccEEEeccc
Q 002010          304 EIP----ESFAALKNLTLLQLFKNNLRGPI----PSFLGDFPNLEVLQVWGNNFTFE----LPENLGRNGKLLILDVTSN  371 (982)
Q Consensus       304 ~~~----~~l~~l~~L~~L~L~~N~l~~~~----p~~~~~l~~L~~L~L~~N~l~~~----~~~~l~~l~~L~~L~L~~N  371 (982)
                      ...    ..|...+.|+.+.++.|.|....    ...|..+++|++|+|.+|-++..    +...+..++.|+.|+++++
T Consensus       172 ~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dc  251 (382)
T KOG1909|consen  172 GGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDC  251 (382)
T ss_pred             ccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeeccccc
Confidence            322    23444455556666666554211    12344555555555555555422    2233334444555555555


Q ss_pred             cccccCCccccCccccceeecccccccccCCccccCCCCCCEEEccCCccCC----CCCccccCCCccccccCCCccc
Q 002010          372 HLTGTIPRDLCKGGKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNG----TIPAGLFNLPLLNMMELDDNLL  445 (982)
Q Consensus       372 ~l~~~~p~~~~~~~~L~~L~l~~N~~~~~~~~~l~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~L~~N~l  445 (982)
                      .+.......+...                   .-...++|+.|.|.+|.++.    .+-..+...+.|..|+|++|.+
T Consensus       252 ll~~~Ga~a~~~a-------------------l~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l  310 (382)
T KOG1909|consen  252 LLENEGAIAFVDA-------------------LKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRL  310 (382)
T ss_pred             ccccccHHHHHHH-------------------HhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCcccc
Confidence            4443322222110                   00124566666666666652    1222334466666666666666

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=99.07  E-value=1.1e-10  Score=113.91  Aligned_cols=84  Identities=26%  Similarity=0.394  Sum_probs=23.2

Q ss_pred             ccccceeeeeccccCCCCCcccccccCCCeeeCCCCcccCCCCccc-ccccccceEEcccccccccCc-cccccccccce
Q 002010          503 LKMITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYGKIPPGI-SKLIDLSILNLSRNGITGSIP-NEMRNMMSLTT  580 (982)
Q Consensus       503 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~Ls~N~l~~~~p-~~l~~l~~L~~  580 (982)
                      +.+|+.||||+|.|+. ++ .+..++.|+.|++++|+|+ .+++.+ ..+++|++|+|++|+|...-. ..+..+++|+.
T Consensus        41 l~~L~~L~Ls~N~I~~-l~-~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~~L~L~~N~I~~l~~l~~L~~l~~L~~  117 (175)
T PF14580_consen   41 LDKLEVLDLSNNQITK-LE-GLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNLQELYLSNNKISDLNELEPLSSLPKLRV  117 (175)
T ss_dssp             -TT--EEE-TTS--S---T-T----TT--EEE--SS----S-CHHHHHH-TT--EEE-TTS---SCCCCGGGGG-TT--E
T ss_pred             hcCCCEEECCCCCCcc-cc-CccChhhhhhcccCCCCCC-ccccchHHhCCcCCEEECcCCcCCChHHhHHHHcCCCcce
Confidence            3444444444444442 11 2444455555555555554 232222 234555555555555543111 23445555555


Q ss_pred             ecccCCccc
Q 002010          581 LDLSYNNLI  589 (982)
Q Consensus       581 L~Ls~N~l~  589 (982)
                      |+|.+|+++
T Consensus       118 L~L~~NPv~  126 (175)
T PF14580_consen  118 LSLEGNPVC  126 (175)
T ss_dssp             EE-TT-GGG
T ss_pred             eeccCCccc
Confidence            555555554

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.06  E-value=1.3e-09  Score=113.87  Aligned_cols=143  Identities=20%  Similarity=0.243  Sum_probs=109.5

Q ss_pred             cccccccceEEEEEEeCCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCC--CcccceEeEEEcC---CccEEEEeccC
Q 002010          698 NIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRH--RNIVRLLGYVSNR---DTNLLLYEYMP  772 (982)
Q Consensus       698 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~---~~~~lv~e~~~  772 (982)
                      +.++.|.++.||++...+|..+++|.............+..|++++..+.+  ..+.+++.+....   +..++||||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            468999999999998766789999987443332245578899999999965  3456677766553   25689999999


Q ss_pred             CCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC-----------------------------------------
Q 002010          773 NGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDC-----------------------------------------  811 (982)
Q Consensus       773 ~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-----------------------------------------  811 (982)
                      |.++.+.+..   ..++.++...++.++++++++||+..                                         
T Consensus        84 G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (223)
T cd05154          84 GRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL  160 (223)
T ss_pred             CEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence            9888776531   35677777788888888888888531                                         


Q ss_pred             ------------CCcEEecCCCCCcEEEcC--CCCEEEeccccchh
Q 002010          812 ------------SPLIIHRDVKSNNILLDS--DFEAHVADFGLAKF  843 (982)
Q Consensus       812 ------------~~~ivHrDlkp~Nill~~--~~~~kl~DfG~a~~  843 (982)
                                  ...++|+|++|.||+++.  ++.+.++||+.+..
T Consensus       161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                        134799999999999998  66789999998753

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.05  E-value=2.3e-09  Score=113.28  Aligned_cols=264  Identities=16%  Similarity=0.187  Sum_probs=159.1

Q ss_pred             cccccccccccceEEEEEEeCCCcEEEEEEeccCCCCCchhhHHHHHHHHhcC-CCCcccceEeEE------E-cCCccE
Q 002010          694 LKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRI-RHRNIVRLLGYV------S-NRDTNL  765 (982)
Q Consensus       694 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~------~-~~~~~~  765 (982)
                      +..++.||+|+.+.+|..-.  -..-+.|+++..-.. ..   .+.+..|... .||-+-.=+.|=      . ......
T Consensus        13 i~~gr~LgqGgea~ly~l~e--~~d~VAKIYh~Pppa-~~---aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iG   86 (637)
T COG4248          13 IPPGRPLGQGGEADLYTLGE--VRDQVAKIYHAPPPA-AQ---AQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIG   86 (637)
T ss_pred             cCCCccccCCccceeeecch--hhchhheeecCCCch-HH---HHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeE
Confidence            34567899999999997521  122345655333211 11   1233344444 465544322221      1 122256


Q ss_pred             EEEeccCCCC-HHHHhh----cCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEecccc
Q 002010          766 LLYEYMPNGS-LGEMLH----GAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGL  840 (982)
Q Consensus       766 lv~e~~~~~s-L~~~l~----~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~  840 (982)
                      ++|..+.+.. ...+..    ++.....+|....++++.++.+.+.||+.|   .+-+|+.++|+||++++.|.+.|-..
T Consensus        87 flmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDs  163 (637)
T COG4248          87 FLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDS  163 (637)
T ss_pred             EecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccc
Confidence            7888887652 222221    123456889999999999999999999998   89999999999999999999988543


Q ss_pred             chhccccCCcccccccccccccccccccc-----cCCCCcchhhHHHHHHHHHHHhC-CCCCCCCCCCch----HH-HHH
Q 002010          841 AKFLQDAGASECMSSVAGSYGYIAPEYAY-----TLKVDEKSDVYSFGVVLLELIAG-KKPVGEFGDGVD----IV-RWV  909 (982)
Q Consensus       841 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg-~~p~~~~~~~~~----~~-~~~  909 (982)
                      -...   .........+|...|.+||...     +..-+..+|.|.+|+++++++.| ++||.+.....+    .. ++.
T Consensus       164 fqi~---~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia  240 (637)
T COG4248         164 FQIN---ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIA  240 (637)
T ss_pred             eeec---cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhh
Confidence            2211   1233345567889999999754     44567789999999999999995 999987422111    00 010


Q ss_pred             HHhccCCCCCCcccccceeecCCCCCCCh-HhHHHHHHHHhhccCCC--CCCCCCHHHHHHHhcCCCCC
Q 002010          910 RKTTSEVSQPSDAASVLAVVDPRLSGYPL-TGVIHLFKVAMMCVEDE--SSARPTMREVVHMLANPPQS  975 (982)
Q Consensus       910 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~~li~~cl~~d--P~~Rpt~~ell~~L~~~~~~  975 (982)
                      .....   +..+..  ... .|.-.+.|- --+..+..++.+|+...  |.-|||++.++..|.++.++
T Consensus       241 ~g~f~---ya~~~~--~g~-~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~  303 (637)
T COG4248         241 HGRFA---YASDQR--RGL-KPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQ  303 (637)
T ss_pred             cceee---echhcc--CCC-CCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHh
Confidence            00000   000000  000 000001111 12335667777888754  45799999999988776654

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=99.02  E-value=1.7e-10  Score=112.55  Aligned_cols=131  Identities=24%  Similarity=0.338  Sum_probs=52.2

Q ss_pred             CCcccccCCccEEEeeccccCCCCchhcc-CCCCcceeeeccccccCCCccccccccccceeeeeccccCCCCCccc-cc
Q 002010          449 LPEKMSGASLNQLKVANNNITGKIPAAIG-NLPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIPYSI-SQ  526 (982)
Q Consensus       449 ~~~~~~~~~L~~L~L~~N~i~~~~p~~~~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~  526 (982)
                      .+.......+++|+|.+|+|+. +. .++ .+.+|+.|+|++|.|+. ++ .+..++.|++|++++|+|+. ++..+ ..
T Consensus        12 ~~~~~n~~~~~~L~L~~n~I~~-Ie-~L~~~l~~L~~L~Ls~N~I~~-l~-~l~~L~~L~~L~L~~N~I~~-i~~~l~~~   86 (175)
T PF14580_consen   12 IAQYNNPVKLRELNLRGNQIST-IE-NLGATLDKLEVLDLSNNQITK-LE-GLPGLPRLKTLDLSNNRISS-ISEGLDKN   86 (175)
T ss_dssp             --------------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS---S--CHHHHHH
T ss_pred             cccccccccccccccccccccc-cc-chhhhhcCCCEEECCCCCCcc-cc-CccChhhhhhcccCCCCCCc-cccchHHh
Confidence            3444445678999999999984 43 455 68899999999999984 33 57778999999999999994 44444 46


Q ss_pred             ccCCCeeeCCCCcccCCCC-cccccccccceEEcccccccccCc---cccccccccceeccc
Q 002010          527 CHSLTSVDLSRNSLYGKIP-PGISKLIDLSILNLSRNGITGSIP---NEMRNMMSLTTLDLS  584 (982)
Q Consensus       527 l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p---~~l~~l~~L~~L~Ls  584 (982)
                      +++|+.|+|++|+|...-- ..+..+++|+.|+|.+|.++...-   ..+..+|+|+.||-.
T Consensus        87 lp~L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~~~YR~~vi~~lP~Lk~LD~~  148 (175)
T PF14580_consen   87 LPNLQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEKKNYRLFVIYKLPSLKVLDGQ  148 (175)
T ss_dssp             -TT--EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGSTTHHHHHHHH-TT-SEETTE
T ss_pred             CCcCCEEECcCCcCCChHHhHHHHcCCCcceeeccCCcccchhhHHHHHHHHcChhheeCCE
Confidence            8999999999999975332 457788999999999999984321   235778888888743

>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]

Probab=98.97  E-value=7.6e-11  Score=134.82  Aligned_cols=250  Identities=25%  Similarity=0.255  Sum_probs=126.5

Q ss_pred             CCccceeecccccCCCCCCccccCCCCCCEEEeeCCcccCcCchhhhcccchhhhhhccCCCCCCCCCcCCCCCCccEEE
Q 002010          264 LKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQ  343 (982)
Q Consensus       264 l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  343 (982)
                      +..++.+.+..|.+.. +-..+..+.+|+.|++.+|+|.. +...+..+++|++|++++|.|+...+  +..++.|+.|+
T Consensus        71 l~~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~~-i~~~l~~~~~L~~L~ls~N~I~~i~~--l~~l~~L~~L~  146 (414)
T KOG0531|consen   71 LTSLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIEK-IENLLSSLVNLQVLDLSFNKITKLEG--LSTLTLLKELN  146 (414)
T ss_pred             hHhHHhhccchhhhhh-hhcccccccceeeeeccccchhh-cccchhhhhcchheeccccccccccc--hhhccchhhhe
Confidence            3444444455555552 22334455555555555555552 22224455555555555555553322  33444455555


Q ss_pred             ccCCCcccccCccccCCCcccEEEeccccccccCC-ccccCccccceeecccccccccCCccccCCCCCCEEEccCCccC
Q 002010          344 VWGNNFTFELPENLGRNGKLLILDVTSNHLTGTIP-RDLCKGGKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLN  422 (982)
Q Consensus       344 L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p-~~~~~~~~L~~L~l~~N~~~~~~~~~l~~l~~L~~L~Ls~N~l~  422 (982)
                      +++|.|+.  ...+..+..|+.+++++|++...-+ . ...+.+++.+++.+|.+..  ...+..+..+..+++..|.++
T Consensus       147 l~~N~i~~--~~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~--i~~~~~~~~l~~~~l~~n~i~  221 (414)
T KOG0531|consen  147 LSGNLISD--ISGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIRE--IEGLDLLKKLVLLSLLDNKIS  221 (414)
T ss_pred             eccCcchh--ccCCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchhc--ccchHHHHHHHHhhcccccce
Confidence            55555552  2233334555555555555552222 1 2334444444444444331  112222233333344555444


Q ss_pred             CCCCccccCCCccccccCCCccccccCCcccccCCccEEEeeccccCCCCchhccCCCCcceeeeccccccCCCcccccc
Q 002010          423 GTIPAGLFNLPLLNMMELDDNLLSGELPEKMSGASLNQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESFN  502 (982)
Q Consensus       423 ~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~  502 (982)
                      ..-+  +..+..                     ..|+.+++++|++. ..+..+..+.++..|++.+|++...  ..+..
T Consensus       222 ~~~~--l~~~~~---------------------~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~~~~--~~~~~  275 (414)
T KOG0531|consen  222 KLEG--LNELVM---------------------LHLRELYLSGNRIS-RSPEGLENLKNLPVLDLSSNRISNL--EGLER  275 (414)
T ss_pred             eccC--cccchh---------------------HHHHHHhcccCccc-cccccccccccccccchhhcccccc--ccccc
Confidence            1111  111111                     02556666666665 3335566777788888888887632  23444


Q ss_pred             ccccceeeeeccccCCC---CCcc-cccccCCCeeeCCCCcccCCCCccc
Q 002010          503 LKMITSINISDNNISGE---IPYS-ISQCHSLTSVDLSRNSLYGKIPPGI  548 (982)
Q Consensus       503 l~~L~~L~Ls~N~l~~~---~p~~-~~~l~~L~~L~Ls~N~l~~~~p~~~  548 (982)
                      ...+..+.++.|.+...   .... ......++.+.+.+|.+....+...
T Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (414)
T KOG0531|consen  276 LPKLSELWLNDNKLALSEAISQEYITSAAPTLVTLTLELNPIRKISSLDL  325 (414)
T ss_pred             cchHHHhccCcchhcchhhhhccccccccccccccccccCcccccccccH
Confidence            56666777777776521   2222 5567888999999999886655433

>PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape []

Probab=98.97  E-value=5.4e-10  Score=81.80  Aligned_cols=42  Identities=45%  Similarity=0.753  Sum_probs=30.7

Q ss_pred             hhHHHHHHHHHhcccCCCCCCCCCCCCCCCCCCCCccceeeeC
Q 002010           26 YSDMDVLLKLKSSMIGPKGSGLKNWEPSSSPSAHCSFSGVTCD   68 (982)
Q Consensus        26 ~~~~~~ll~~k~~~~~~~~~~~~~w~~~~~~~~~C~w~gv~C~   68 (982)
                      ++|++||++||+++.+++...+.+|+.+. ..+||+|.||+||
T Consensus         2 ~~d~~aLl~~k~~l~~~~~~~l~~W~~~~-~~~~C~W~GV~Cd   43 (43)
T PF08263_consen    2 NQDRQALLAFKKSLNNDPSGVLSSWNPSS-DSDPCSWSGVTCD   43 (43)
T ss_dssp             HHHHHHHHHHHHCTT-SC-CCCTT--TT---S-CCCSTTEEE-
T ss_pred             cHHHHHHHHHHHhcccccCcccccCCCcC-CCCCeeeccEEeC
Confidence            57999999999999976667899998753 3689999999996

LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A.

>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]

Probab=98.97  E-value=8.2e-11  Score=134.54  Aligned_cols=130  Identities=32%  Similarity=0.355  Sum_probs=65.1

Q ss_pred             CCCCCCCCEEecccCcCcccCchhhcCCCccceeecccccCCCCCCccccCCCCCCEEEeeCCcccCcCchhhhcccchh
Q 002010          237 FGALTQLQVLDMASCNISGEIPTSLSRLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLT  316 (982)
Q Consensus       237 ~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~  316 (982)
                      ++.+++|..|++.+|+|.... ..+..+++|++|++++|.|+...  .+..++.|+.|++++|.|+..  ..+..+++|+
T Consensus        91 l~~~~~l~~l~l~~n~i~~i~-~~l~~~~~L~~L~ls~N~I~~i~--~l~~l~~L~~L~l~~N~i~~~--~~~~~l~~L~  165 (414)
T KOG0531|consen   91 LSKLKSLEALDLYDNKIEKIE-NLLSSLVNLQVLDLSFNKITKLE--GLSTLTLLKELNLSGNLISDI--SGLESLKSLK  165 (414)
T ss_pred             cccccceeeeeccccchhhcc-cchhhhhcchheecccccccccc--chhhccchhhheeccCcchhc--cCCccchhhh
Confidence            555566666666666665322 22455556666666666665332  244445555666666665522  2334455555


Q ss_pred             hhhhccCCCCCCCC-CcCCCCCCccEEEccCCCcccccCccccCCCcccEEEecccccc
Q 002010          317 LLQLFKNNLRGPIP-SFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLT  374 (982)
Q Consensus       317 ~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~  374 (982)
                      .+++++|++....+ . ...+.+++.+++.+|.+.  ....+..+..+..+++..|.++
T Consensus       166 ~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~--~i~~~~~~~~l~~~~l~~n~i~  221 (414)
T KOG0531|consen  166 LLDLSYNRIVDIENDE-LSELISLEELDLGGNSIR--EIEGLDLLKKLVLLSLLDNKIS  221 (414)
T ss_pred             cccCCcchhhhhhhhh-hhhccchHHHhccCCchh--cccchHHHHHHHHhhcccccce
Confidence            55666655553322 1 344555555555555554  1223333334444445555444

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.95  E-value=2.5e-10  Score=133.46  Aligned_cols=249  Identities=20%  Similarity=0.208  Sum_probs=170.6

Q ss_pred             hhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCC--CchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEE
Q 002010          692 ESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTG--GNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLY  768 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  768 (982)
                      +.+.+.+.+-+|.++.++.+.- ..|...++|+.......  ...+....+-.+.....+|.+++..-.+.-....++++
T Consensus       804 d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~  883 (1205)
T KOG0606|consen  804 DGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVG  883 (1205)
T ss_pred             ccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhh
Confidence            4456667888999999998743 23444444443211111  01122223333333345677776665555567789999


Q ss_pred             eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccc--
Q 002010          769 EYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQD--  846 (982)
Q Consensus       769 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~--  846 (982)
                      +|..+++|...++  ..+..+.+.+...+..+..+.+|||...   +.|||++|.|.+...++..++.|||.......  
T Consensus       884 ~~~~~~~~~Skl~--~~~~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~  958 (1205)
T KOG0606|consen  884 HYLNGGDLPSKLH--NSGCLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIP  958 (1205)
T ss_pred             HHhccCCchhhhh--cCCCcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCcccccccccccc
Confidence            9999999999997  3345666667778888899999999876   89999999999999999999999984332110  


Q ss_pred             ----c-----------------------CCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Q 002010          847 ----A-----------------------GASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEF  899 (982)
Q Consensus       847 ----~-----------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~  899 (982)
                          .                       +.........+|+.|.+||...+......+|+|+.|++++|.++|.+||...
T Consensus       959 p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~ 1038 (1205)
T KOG0606|consen  959 PTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAE 1038 (1205)
T ss_pred             CcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCc
Confidence                0                       0001123456899999999999999999999999999999999999999865


Q ss_pred             CCCchHHHHHHHhccCCCCCCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHH
Q 002010          900 GDGVDIVRWVRKTTSEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMR  963 (982)
Q Consensus       900 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~  963 (982)
                      .....+..+..                  .+...+..+.....+..+++...+..+|.+|-.+.
T Consensus      1039 tpq~~f~ni~~------------------~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1039 TPQQIFENILN------------------RDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             chhhhhhcccc------------------CCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence            43322211111                  11122233444555677888888899999998776

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.88  E-value=2e-08  Score=106.25  Aligned_cols=141  Identities=18%  Similarity=0.150  Sum_probs=100.7

Q ss_pred             ccccccceEEEEEEeCCCcEEEEEEeccCCCC----------CchhhHHHHHHHHhcCCCC--cccceEeEEEc-----C
Q 002010          699 IIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTG----------GNDHGFLAEIQTLGRIRHR--NIVRLLGYVSN-----R  761 (982)
Q Consensus       699 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----------~~~~~~~~E~~~l~~l~h~--niv~~~~~~~~-----~  761 (982)
                      .+-+-....|+++.. +|+.|.||+.......          .....+.+|...+.++...  .+.+.+++...     .
T Consensus        29 ~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~  107 (268)
T PRK15123         29 VFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT  107 (268)
T ss_pred             EEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence            344444455777766 7788999977332211          1122477899988888432  23344555533     2


Q ss_pred             CccEEEEeccCCC-CHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcC-------CCCE
Q 002010          762 DTNLLLYEYMPNG-SLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDS-------DFEA  833 (982)
Q Consensus       762 ~~~~lv~e~~~~~-sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~-------~~~~  833 (982)
                      ...++|||++++. +|.+++........+......++.+++..++.||+.|   |+|+|++++||+++.       ++.+
T Consensus       108 ~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~~  184 (268)
T PRK15123        108 RTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLKL  184 (268)
T ss_pred             ceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCceE
Confidence            3468999999886 8999885322345566778899999999999999999   999999999999975       4689


Q ss_pred             EEeccccchh
Q 002010          834 HVADFGLAKF  843 (982)
Q Consensus       834 kl~DfG~a~~  843 (982)
                      .++||+.+..
T Consensus       185 ~LIDl~r~~~  194 (268)
T PRK15123        185 SVIDLHRAQI  194 (268)
T ss_pred             EEEECCcccc
Confidence            9999998853

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.81  E-value=2.8e-09  Score=85.43  Aligned_cols=60  Identities=43%  Similarity=0.559  Sum_probs=34.3

Q ss_pred             CCCeeeCCCCcccCCCCcccccccccceEEcccccccccCccccccccccceecccCCcc
Q 002010          529 SLTSVDLSRNSLYGKIPPGISKLIDLSILNLSRNGITGSIPNEMRNMMSLTTLDLSYNNL  588 (982)
Q Consensus       529 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l  588 (982)
                      +|+.|++++|+|+...+..|.++++|++|++++|+|++..|..|.++++|++|++++|+|
T Consensus         2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l   61 (61)
T PF13855_consen    2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL   61 (61)
T ss_dssp             TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred             cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence            455555555555544445555556666666666666555555566666666666666553

...

>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms]

Probab=98.81  E-value=4.6e-09  Score=127.94  Aligned_cols=131  Identities=24%  Similarity=0.286  Sum_probs=89.9

Q ss_pred             hhcccceeeccCCccccccchhhhhcCCCccEEeccCcc--ccCCCchhccccccccEEeecCcccccccCCCccccCcc
Q 002010          117 LLTSLKVFNISGNVFQGNFAGQIVRGMTELQVLDAYNNN--FTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQSL  194 (982)
Q Consensus       117 ~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~--l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L  194 (982)
                      +....+...+-+|.+......   ...++|++|-+..|.  +....+..|..++.|++|||++|.=-+.+|.++++|-+|
T Consensus       521 ~~~~~rr~s~~~~~~~~~~~~---~~~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~L  597 (889)
T KOG4658|consen  521 SWNSVRRMSLMNNKIEHIAGS---SENPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHL  597 (889)
T ss_pred             chhheeEEEEeccchhhccCC---CCCCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhh
Confidence            336667777777766422111   234578888888886  553444457789999999999888777888888888888


Q ss_pred             eEeeccCcccccchhhHHhhhhhHHHHhhcccccccccCCCCCCCCCCCCEEecccCc
Q 002010          195 EYIGLNGIGLNGTVPAFLSRLKNLREMYIGYFNTYTGGIPPGFGALTQLQVLDMASCN  252 (982)
Q Consensus       195 ~~L~L~~n~i~~~~~~~l~~l~~L~~L~l~~~n~~~~~~p~~~~~l~~L~~L~L~~n~  252 (982)
                      ++|++++..+. .+|..+.+|++|.+|++.....+.. +|.....|++|++|.+....
T Consensus       598 ryL~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~-~~~i~~~L~~Lr~L~l~~s~  653 (889)
T KOG4658|consen  598 RYLDLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLES-IPGILLELQSLRVLRLPRSA  653 (889)
T ss_pred             hcccccCCCcc-ccchHHHHHHhhheecccccccccc-ccchhhhcccccEEEeeccc
Confidence            88888888887 7777777777777777765333322 24444446666666665544

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.79  E-value=3.5e-09  Score=84.87  Aligned_cols=61  Identities=33%  Similarity=0.465  Sum_probs=45.2

Q ss_pred             cccceeeeeccccCCCCCcccccccCCCeeeCCCCcccCCCCcccccccccceEEcccccc
Q 002010          504 KMITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYGKIPPGISKLIDLSILNLSRNGI  564 (982)
Q Consensus       504 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l  564 (982)
                      ++|++|++++|+|+...+..|.++++|++|++++|.++...|..|.++++|++|++++|+|
T Consensus         1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l   61 (61)
T PF13855_consen    1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL   61 (61)
T ss_dssp             TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred             CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence            3567777777777755566777777777888877777766677778888888888877765

...

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.76  E-value=5.1e-08  Score=96.97  Aligned_cols=126  Identities=26%  Similarity=0.320  Sum_probs=82.2

Q ss_pred             EEEEEEeCCCcEEEEEEeccCCC------------CC-------------chhhHHHHHHHHhcCCCC--cccceEeEEE
Q 002010          707 IVYRGSMPDGIDVAIKRLVGRGT------------GG-------------NDHGFLAEIQTLGRIRHR--NIVRLLGYVS  759 (982)
Q Consensus       707 ~Vy~~~~~~~~~vavK~~~~~~~------------~~-------------~~~~~~~E~~~l~~l~h~--niv~~~~~~~  759 (982)
                      .||.|...+|..+|+|..+....            ..             ......+|++.|.++...  ++.+++++  
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~--   78 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY--   78 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence            48999888999999998853211            00             012367799999999654  45555543  


Q ss_pred             cCCccEEEEeccC--CCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHH-HhhcCCCcEEecCCCCCcEEEcCCCCEEEe
Q 002010          760 NRDTNLLLYEYMP--NGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCY-LHHDCSPLIIHRDVKSNNILLDSDFEAHVA  836 (982)
Q Consensus       760 ~~~~~~lv~e~~~--~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~-LH~~~~~~ivHrDlkp~Nill~~~~~~kl~  836 (982)
                        ...++||||++  |..+..+.. .   .++.+....++.+++..+.. +|+.|   |+|+|+.+.||+++++ .+.++
T Consensus        79 --~~~~ivME~I~~~G~~~~~l~~-~---~~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~iI  148 (188)
T PF01163_consen   79 --NRNVIVMEYIGEDGVPLPRLKD-V---DLSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYII  148 (188)
T ss_dssp             --ETTEEEEE--EETTEEGGCHHH-C---GGGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE-
T ss_pred             --eCCEEEEEecCCCccchhhHHh-c---cccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEEE
Confidence              35689999998  555544332 1   11134456677788886555 57887   9999999999999887 99999


Q ss_pred             ccccchhc
Q 002010          837 DFGLAKFL  844 (982)
Q Consensus       837 DfG~a~~~  844 (982)
                      |||.+...
T Consensus       149 Df~qav~~  156 (188)
T PF01163_consen  149 DFGQAVDS  156 (188)
T ss_dssp             -GTTEEET
T ss_pred             ecCcceec
Confidence            99988643

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.74  E-value=2.9e-07  Score=100.52  Aligned_cols=169  Identities=18%  Similarity=0.293  Sum_probs=128.4

Q ss_pred             cceEEEEE-EeCCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEc----CCccEEEEeccCC-CCHH
Q 002010          704 GAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSN----RDTNLLLYEYMPN-GSLG  777 (982)
Q Consensus       704 ~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~lv~e~~~~-~sL~  777 (982)
                      -..+.||+ ...+|..|++|+++....... ..-..-+++++++.|+|||++.+++..    +...++||+|.++ ++|.
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~-nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~  366 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQST-NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLY  366 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccccCc-ccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHH
Confidence            44678999 446899999999954433322 223355788999999999999998863    4456899999986 4888


Q ss_pred             HHhhcC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhc
Q 002010          778 EMLHGA-------------KGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFL  844 (982)
Q Consensus       778 ~~l~~~-------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~  844 (982)
                      ++....             ++...++..+|.++.|+..||.++|+.|   ...+-+.+++|+++.+.+++|+..|....+
T Consensus       367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl  443 (655)
T KOG3741|consen  367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVL  443 (655)
T ss_pred             HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeee
Confidence            865432             2345778999999999999999999998   889999999999999999999888877655


Q ss_pred             cccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCC
Q 002010          845 QDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKP  895 (982)
Q Consensus       845 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p  895 (982)
                      ..+.              .  |.+.   --.+-|.-.+|.++..+.||..-
T Consensus       444 ~~d~--------------~--~~le---~~Qq~D~~~lG~ll~aLAt~~~n  475 (655)
T KOG3741|consen  444 QEDP--------------T--EPLE---SQQQNDLRDLGLLLLALATGTEN  475 (655)
T ss_pred             cCCC--------------C--cchh---HHhhhhHHHHHHHHHHHhhcccc
Confidence            4321              0  1111   12467999999999999999543

>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]

Probab=98.69  E-value=8.8e-10  Score=123.29  Aligned_cols=181  Identities=23%  Similarity=0.262  Sum_probs=131.1

Q ss_pred             CccccCCCCCCEEEccCCccCCCCCccccCCC-ccccccCCCccc----------cccCCcccccCCccEEEeeccccCC
Q 002010          402 PEELGQCKSLTKIRFSKNYLNGTIPAGLFNLP-LLNMMELDDNLL----------SGELPEKMSGASLNQLKVANNNITG  470 (982)
Q Consensus       402 ~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~L~~N~l----------~~~~~~~~~~~~L~~L~L~~N~i~~  470 (982)
                      |-.+...++|+.|.|.++.|..  -.++..+. .|+.|-.. |.+          .|.+...+....|...+.++|.+. 
T Consensus       102 pi~ifpF~sLr~LElrg~~L~~--~~GL~~lr~qLe~LIC~-~Sl~Al~~v~ascggd~~ns~~Wn~L~~a~fsyN~L~-  177 (1096)
T KOG1859|consen  102 PISIFPFRSLRVLELRGCDLST--AKGLQELRHQLEKLICH-NSLDALRHVFASCGGDISNSPVWNKLATASFSYNRLV-  177 (1096)
T ss_pred             CceeccccceeeEEecCcchhh--hhhhHHHHHhhhhhhhh-ccHHHHHHHHHHhccccccchhhhhHhhhhcchhhHH-
Confidence            5567778899999999998873  22222222 23333222 211          123333334457888899999998 


Q ss_pred             CCchhccCCCCcceeeeccccccCCCccccccccccceeeeeccccCCCCCcccccccCCCeeeCCCCcccCCCCccccc
Q 002010          471 KIPAAIGNLPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYGKIPPGISK  550 (982)
Q Consensus       471 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~  550 (982)
                      .....+.-++.|+.|+|++|+++..-  .+..++.|++|||++|++....-....++. |+.|.|++|.++.  -..+.+
T Consensus       178 ~mD~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~-L~~L~lrnN~l~t--L~gie~  252 (1096)
T KOG1859|consen  178 LMDESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLRHVPQLSMVGCK-LQLLNLRNNALTT--LRGIEN  252 (1096)
T ss_pred             hHHHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhccccccchhhhh-heeeeecccHHHh--hhhHHh
Confidence            77788888999999999999998432  677899999999999999844333445555 9999999999873  245889


Q ss_pred             ccccceEEcccccccccCc-cccccccccceecccCCccccC
Q 002010          551 LIDLSILNLSRNGITGSIP-NEMRNMMSLTTLDLSYNNLIGN  591 (982)
Q Consensus       551 l~~L~~L~Ls~N~l~~~~p-~~l~~l~~L~~L~Ls~N~l~~~  591 (982)
                      |++|+.|||++|-|.+.-. .-+..|..|+.|+|.||++...
T Consensus       253 LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~  294 (1096)
T KOG1859|consen  253 LKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCA  294 (1096)
T ss_pred             hhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccC
Confidence            9999999999999886433 2357788999999999998754

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.67  E-value=1.3e-07  Score=96.06  Aligned_cols=135  Identities=22%  Similarity=0.181  Sum_probs=98.9

Q ss_pred             ccccccccccceEEEEEEeCCCcEEEEEEeccCCC---------------------CCchhhHHHHHHHHhcCCCC--cc
Q 002010          695 KDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGT---------------------GGNDHGFLAEIQTLGRIRHR--NI  751 (982)
Q Consensus       695 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~---------------------~~~~~~~~~E~~~l~~l~h~--ni  751 (982)
                      .++..||-|.-+.||.|..++|.++|||.-+...+                     ........+|+++|.++...  .|
T Consensus        94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V  173 (304)
T COG0478          94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV  173 (304)
T ss_pred             hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence            34678999999999999999999999996532110                     00122467899999998544  56


Q ss_pred             cceEeEEEcCCccEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCC
Q 002010          752 VRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDF  831 (982)
Q Consensus       752 v~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~  831 (982)
                      .+.++    -+.+.+|||+++|..|...-       ++.+....+...|++-+..+-..|   |||+|+.+-||+++++|
T Consensus       174 P~P~~----~nRHaVvMe~ieG~eL~~~r-------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~dg  239 (304)
T COG0478         174 PKPIA----WNRHAVVMEYIEGVELYRLR-------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVTEDG  239 (304)
T ss_pred             CCccc----cccceeeeehcccceeeccc-------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEecCC
Confidence            66665    36779999999987665432       133444455566666666666677   99999999999999999


Q ss_pred             CEEEeccccchh
Q 002010          832 EAHVADFGLAKF  843 (982)
Q Consensus       832 ~~kl~DfG~a~~  843 (982)
                      .+.++||--+..
T Consensus       240 ~~~vIDwPQ~v~  251 (304)
T COG0478         240 DIVVIDWPQAVP  251 (304)
T ss_pred             CEEEEeCccccc
Confidence            999999976654

>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only]

Probab=98.64  E-value=1.8e-09  Score=96.55  Aligned_cols=136  Identities=22%  Similarity=0.251  Sum_probs=98.0

Q ss_pred             ccEEEeeccccCCCCchhcc---CCCCcceeeeccccccCCCccccccccccceeeeeccccCCCCCcccccccCCCeee
Q 002010          458 LNQLKVANNNITGKIPAAIG---NLPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIPYSISQCHSLTSVD  534 (982)
Q Consensus       458 L~~L~L~~N~i~~~~p~~~~---~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~  534 (982)
                      +..++|+++++- .+++...   ....|+..+|++|.+....+.....++.++.|+|++|+|+ .+|.++..++.|+.|+
T Consensus        29 ~h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lN  106 (177)
T KOG4579|consen   29 LHFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFKKFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLN  106 (177)
T ss_pred             hhhcccccchhh-HHHHHHHHHhCCceEEEEecccchhhhCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcc
Confidence            455666766665 3444433   4455666788888887433333345568888888888888 6788888999999999


Q ss_pred             CCCCcccCCCCcccccccccceEEcccccccccCccccccccccceecccCCccccCCCCCcc
Q 002010          535 LSRNSLYGKIPPGISKLIDLSILNLSRNGITGSIPNEMRNMMSLTTLDLSYNNLIGNIPSGGQ  597 (982)
Q Consensus       535 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~~~  597 (982)
                      ++.|.|. ..|..|..|.+|..|+..+|.+. .+|-.+-.-......++.++++.+..|...|
T Consensus       107 l~~N~l~-~~p~vi~~L~~l~~Lds~~na~~-eid~dl~~s~~~al~~lgnepl~~~~~~klq  167 (177)
T KOG4579|consen  107 LRFNPLN-AEPRVIAPLIKLDMLDSPENARA-EIDVDLFYSSLPALIKLGNEPLGDETKKKLQ  167 (177)
T ss_pred             cccCccc-cchHHHHHHHhHHHhcCCCCccc-cCcHHHhccccHHHHHhcCCcccccCccccc
Confidence            9999987 77888888899999999988887 5555555455556667788888887776543

>PRK09902 hypothetical protein; Provisional

Probab=98.62  E-value=6.2e-07  Score=89.43  Aligned_cols=139  Identities=14%  Similarity=0.091  Sum_probs=104.2

Q ss_pred             cccccceEEEEEEeCCCcEEEEEEeccCC--C---CCchhhHHHHHHHHhcCCC--CcccceEeEEE-c----CCccEEE
Q 002010          700 IGKGGAGIVYRGSMPDGIDVAIKRLVGRG--T---GGNDHGFLAEIQTLGRIRH--RNIVRLLGYVS-N----RDTNLLL  767 (982)
Q Consensus       700 lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~---~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~-~----~~~~~lv  767 (982)
                      -|+||.+-|++... +|..+-+|+.....  +   +-....|.+|+..+.++..  -.+.+++ ++. .    ....++|
T Consensus        26 ~~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV  103 (216)
T PRK09902         26 YRRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV  103 (216)
T ss_pred             cCCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence            37789999999877 55578899763111  1   2345679999999999842  2244444 332 1    1234799


Q ss_pred             EeccCC-CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCC--EEEeccccchh
Q 002010          768 YEYMPN-GSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFE--AHVADFGLAKF  843 (982)
Q Consensus       768 ~e~~~~-~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~--~kl~DfG~a~~  843 (982)
                      +|-++| .+|.+++....-.+.+......++.+++.+++-||+.|   +.|+|+.++||+++.++.  ++++||.-++.
T Consensus       104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            998854 59999986544456788888899999999999999999   999999999999986666  99999987764

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.59  E-value=1.6e-07  Score=107.49  Aligned_cols=153  Identities=18%  Similarity=0.219  Sum_probs=103.2

Q ss_pred             cHHHHHhhcccccccccccceEEEEEEeCCCcEEEEEEeccCCCCCc---------------------------------
Q 002010          686 KAEDVLESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGN---------------------------------  732 (982)
Q Consensus       686 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~---------------------------------  732 (982)
                      ..++.+.+|+. +.|+.++-|.||+|+.++|+.||||+.++...+..                                 
T Consensus       120 ~iee~F~eF~~-~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~  198 (517)
T COG0661         120 PIEELFSEFEP-EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEF  198 (517)
T ss_pred             CHHHHHHHcCC-CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHH
Confidence            35556666664 58999999999999999999999999865432110                                 


Q ss_pred             ------hhhHHHHHHHHhcCC-----CCcccceEeEE-EcCCccEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHH
Q 002010          733 ------DHGFLAEIQTLGRIR-----HRNIVRLLGYV-SNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEA  800 (982)
Q Consensus       733 ------~~~~~~E~~~l~~l~-----h~niv~~~~~~-~~~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i  800 (982)
                            +-++.+|+..+.+++     .|++ ++-..| +-.....++|||++|..+.+...... ...+.+.+.....++
T Consensus       199 ~~~l~~ElDy~~EA~n~~~~~~nf~~~~~v-~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~  276 (517)
T COG0661         199 EKRLREELDYRREAANAERFRENFKDDPDV-YVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRA  276 (517)
T ss_pred             HHHHHHHhCHHHHHHHHHHHHHHcCCCCCe-EeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHH
Confidence                  012455666666652     2332 222333 33566799999999988888743222 455544433332222


Q ss_pred             HHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccc
Q 002010          801 AKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQD  846 (982)
Q Consensus       801 ~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  846 (982)
                      .  +..+-..|   +.|.|.+|.||+++.+|++.+.|||+...+.+
T Consensus       277 f--~~q~~~dg---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         277 F--LRQLLRDG---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             H--HHHHHhcC---ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence            2  33333456   99999999999999999999999999987654

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.52  E-value=6.8e-07  Score=91.62  Aligned_cols=124  Identities=24%  Similarity=0.280  Sum_probs=90.7

Q ss_pred             CCcEEEEEEeccCCCC------CchhhHHHHHHHHhcCCC--CcccceEeEEEcCC----ccEEEEeccCCC-CHHHHhh
Q 002010          715 DGIDVAIKRLVGRGTG------GNDHGFLAEIQTLGRIRH--RNIVRLLGYVSNRD----TNLLLYEYMPNG-SLGEMLH  781 (982)
Q Consensus       715 ~~~~vavK~~~~~~~~------~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~----~~~lv~e~~~~~-sL~~~l~  781 (982)
                      .++.+.+|........      -......+|...+.++..  -.+.+.+++.....    ..++|+|++++. +|.+++.
T Consensus        31 ~~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~  110 (206)
T PF06293_consen   31 VGRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQ  110 (206)
T ss_pred             cceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHH
Confidence            3556666654222111      234457788888877743  33455666655432    348999999884 8999987


Q ss_pred             cCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCC---CEEEeccccchh
Q 002010          782 GAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDF---EAHVADFGLAKF  843 (982)
Q Consensus       782 ~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~---~~kl~DfG~a~~  843 (982)
                      ...  ..+......++.+++..++-||+.|   |+|+|+++.|||++.++   .+.++||+-++.
T Consensus       111 ~~~--~~~~~~~~~ll~~l~~~i~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  111 QWE--QLDPSQRRELLRALARLIAKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             hhc--ccchhhHHHHHHHHHHHHHHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            422  2666778899999999999999999   99999999999999887   899999998764

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>KOG2982 consensus Uncharacterized conserved protein [Function unknown]

Probab=98.45  E-value=1e-07  Score=96.43  Aligned_cols=236  Identities=22%  Similarity=0.244  Sum_probs=118.7

Q ss_pred             cCCcCccccccccEEEeccCCCCCCCCh-hh-hhhcccceeeccCCccccc-cchhhhhcCCCccEEeccCccccCCCch
Q 002010           86 SIPPEIGLLTKLVNLTISNVNLTGRLPS-EM-ALLTSLKVFNISGNVFQGN-FAGQIVRGMTELQVLDAYNNNFTGPLPV  162 (982)
Q Consensus        86 ~~~~~i~~l~~L~~L~l~~n~l~~~~p~-~l-~~l~~L~~L~Ls~n~l~~~-~~~~~~~~l~~L~~L~Ls~n~l~~~~p~  162 (982)
                      .-+-.+..+..++-|.+.++.+....-. .| ..++.++.|||.+|.++.= -...++.+|+.|++|+|+.|.+.     
T Consensus        36 ~s~~~v~s~ra~ellvln~~~id~~gd~~~~~~~~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~-----  110 (418)
T KOG2982|consen   36 LSYLGVSSLRALELLVLNGSIIDNEGDVMLFGSSVTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLS-----  110 (418)
T ss_pred             cceeeeccccchhhheecCCCCCcchhHHHHHHHhhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCC-----
Confidence            3333344444555566666555432221 12 2345566666666665531 11223344455555555555444     


Q ss_pred             hccccccccEEeecCcccccccCCCccccCcceEeeccCccccc-chhhHHhhhhhHHHHhhcccccccccCCCCCCCCC
Q 002010          163 EIASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLNGIGLNG-TVPAFLSRLKNLREMYIGYFNTYTGGIPPGFGALT  241 (982)
Q Consensus       163 ~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~i~~-~~~~~l~~l~~L~~L~l~~~n~~~~~~p~~~~~l~  241 (982)
                                         ..|-..-..+.+|+.|-|++..+.- .....+..++.+++|+++.|               
T Consensus       111 -------------------s~I~~lp~p~~nl~~lVLNgT~L~w~~~~s~l~~lP~vtelHmS~N---------------  156 (418)
T KOG2982|consen  111 -------------------SDIKSLPLPLKNLRVLVLNGTGLSWTQSTSSLDDLPKVTELHMSDN---------------  156 (418)
T ss_pred             -------------------CccccCcccccceEEEEEcCCCCChhhhhhhhhcchhhhhhhhccc---------------
Confidence                               2222111234455555555555542 23344556667777776653               


Q ss_pred             CCCEEecccCcCcccCch--hhcCCCccceeecccccCCCCCCccccCCCCCCEEEeeCCcccCcC-chhhhcccchhhh
Q 002010          242 QLQVLDMASCNISGEIPT--SLSRLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEI-PESFAALKNLTLL  318 (982)
Q Consensus       242 ~L~~L~L~~n~l~~~~~~--~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~-~~~l~~l~~L~~L  318 (982)
                      +++.+.+..|-+...-|.  .+..++.+..+.++-|++...       ++++..+-+..|.+...- ...+..++.+.-|
T Consensus       157 ~~rq~n~Dd~c~e~~s~~v~tlh~~~c~~~~w~~~~~l~r~-------Fpnv~sv~v~e~PlK~~s~ek~se~~p~~~~L  229 (418)
T KOG2982|consen  157 SLRQLNLDDNCIEDWSTEVLTLHQLPCLEQLWLNKNKLSRI-------FPNVNSVFVCEGPLKTESSEKGSEPFPSLSCL  229 (418)
T ss_pred             hhhhhccccccccccchhhhhhhcCCcHHHHHHHHHhHHhh-------cccchheeeecCcccchhhcccCCCCCcchhh
Confidence            244455555554432221  233344445555555555532       245666667777665332 1234455666677


Q ss_pred             hhccCCCCCC-CCCcCCCCCCccEEEccCCCcccccCc------cccCCCcccEEE
Q 002010          319 QLFKNNLRGP-IPSFLGDFPNLEVLQVWGNNFTFELPE------NLGRNGKLLILD  367 (982)
Q Consensus       319 ~L~~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~~~------~l~~l~~L~~L~  367 (982)
                      +|+.|+|..- .-+.+..+++|..|.+++|++...+..      -++++++++.|+
T Consensus       230 nL~~~~idswasvD~Ln~f~~l~dlRv~~~Pl~d~l~~~err~llIaRL~~v~vLN  285 (418)
T KOG2982|consen  230 NLGANNIDSWASVDALNGFPQLVDLRVSENPLSDPLRGGERRFLLIARLTKVQVLN  285 (418)
T ss_pred             hhcccccccHHHHHHHcCCchhheeeccCCcccccccCCcceEEEEeeccceEEec
Confidence            7777777642 124566777788888888777643221      234555555554

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.38  E-value=1.4e-07  Score=106.93  Aligned_cols=151  Identities=21%  Similarity=0.336  Sum_probs=103.2

Q ss_pred             HHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCccc-------cccccccccccccccccc
Q 002010          798 LEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASEC-------MSSVAGSYGYIAPEYAYT  870 (982)
Q Consensus       798 ~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~-------~~~~~gt~~y~aPE~~~~  870 (982)
                      .+++.|+.|+|.  +.++||+.|.|++|.++..+..||+.|+.+.-.........       ..-......|.|||++.+
T Consensus       106 ~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~  183 (700)
T KOG2137|consen  106 GNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG  183 (700)
T ss_pred             hcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence            344589999997  44699999999999999999999999998765443111000       001124457999999999


Q ss_pred             CCCCcchhhHHHHHHHHHHHhCCCC-CCCCCCCchHHHHHHHhccCCCCCCcccccceeecCCCCCCChHhHHHHHHHHh
Q 002010          871 LKVDEKSDVYSFGVVLLELIAGKKP-VGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAM  949 (982)
Q Consensus       871 ~~~~~~~DvwslG~il~elltg~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  949 (982)
                      ...+.++|+||+|+++|.+..|..+ +...... ........                ..+-....+....+.++.+=+.
T Consensus       184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~-~~~~~~~~----------------~~~~~~~~~s~~~p~el~~~l~  246 (700)
T KOG2137|consen  184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGL-LSYSFSRN----------------LLNAGAFGYSNNLPSELRESLK  246 (700)
T ss_pred             ccccccccceeeeeEEEEEecCCcchhhccCCc-chhhhhhc----------------ccccccccccccCcHHHHHHHH
Confidence            8889999999999999999965444 3332211 11111111                0111112334555667888889


Q ss_pred             hccCCCCCCCCCHHHHHH
Q 002010          950 MCVEDESSARPTMREVVH  967 (982)
Q Consensus       950 ~cl~~dP~~Rpt~~ell~  967 (982)
                      +++..++..||++.++..
T Consensus       247 k~l~~~~~~rp~~~~l~~  264 (700)
T KOG2137|consen  247 KLLNGDSAVRPTLDLLLS  264 (700)
T ss_pred             HHhcCCcccCcchhhhhc
Confidence            999999999997776654

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	982
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		3e-52
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		5e-51
3riz_A	772	Crystal Structure Of The Plant Steroid Receptor Bri		3e-46
3riz_A	772	Crystal Structure Of The Plant Steroid Receptor Bri		1e-27
3rgx_A	768	Structural Insight Into Brassinosteroid Perception		5e-46
3rgx_A	768	Structural Insight Into Brassinosteroid Perception		2e-27
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		7e-37
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		3e-36
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		5e-36
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		5e-36
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		3e-35
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		5e-34
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		4e-27
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		5e-27
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		6e-22
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		7e-22
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		1e-21
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		1e-21
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		6e-21
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		7e-21
4h58_A	275	Braf In Complex With Compound 3 Length = 275		9e-21
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		1e-20
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		1e-20
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		1e-20
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		1e-20
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		1e-20
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		2e-20
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		2e-20
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		2e-20
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		2e-20
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		3e-20
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		3e-20
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		3e-20
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		3e-20
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		3e-20
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		3e-20
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		3e-20
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		4e-20
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		4e-20
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		4e-20
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		4e-20
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		5e-20
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		5e-20
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		5e-20
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		5e-20
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		6e-20
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		7e-20
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		8e-20
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-19
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		1e-19
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		1e-19
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		1e-19
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		1e-19
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		1e-19
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		1e-19
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		2e-19
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		2e-19
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		2e-19
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		2e-19
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		5e-19
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		7e-19
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		2e-18
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		2e-18
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		3e-18
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		4e-18
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-18
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		5e-18
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		5e-18
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		5e-18
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		6e-18
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		6e-18
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		7e-18
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		7e-18
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		7e-18
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		8e-18
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		9e-18
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-17
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		1e-17
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		1e-17
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		1e-17
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		1e-17
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		1e-17
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		2e-17
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		2e-17
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		3e-17
3a4o_X	286	Lyn Kinase Domain Length = 286		4e-17
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		4e-17
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		4e-17
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		5e-17
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		5e-17
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		5e-17
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		5e-17
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		6e-17
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		6e-17
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		6e-17
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		6e-17
1ogq_A	313	The Crystal Structure Of Pgip (Polygalacturonase In		6e-17
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		6e-17
2pl0_A	289	Lck Bound To Imatinib Length = 289		6e-17
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		7e-17
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		7e-17
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		7e-17
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		8e-17
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		9e-17
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		9e-17
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		1e-16
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		1e-16
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		1e-16
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		1e-16
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		1e-16
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		1e-16
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		1e-16
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		2e-16
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		2e-16
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		2e-16
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		2e-16
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		2e-16
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		2e-16
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		2e-16
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		2e-16
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		2e-16
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		3e-16
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		3e-16
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		3e-16
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		3e-16
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		3e-16
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		3e-16
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		3e-16
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		3e-16
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		3e-16
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		3e-16
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		4e-16
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		4e-16
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		4e-16
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		4e-16
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		4e-16
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		4e-16
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		4e-16
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		4e-16
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		4e-16
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		4e-16
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		4e-16
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		4e-16
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		5e-16
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		5e-16
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		5e-16
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		5e-16
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		5e-16
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		5e-16
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		5e-16
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		7e-16
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		7e-16
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		7e-16
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		8e-16
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		8e-16
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		8e-16
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		9e-16
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		9e-16
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		9e-16
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		9e-16
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		9e-16
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		1e-15
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		1e-15
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		1e-15
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		1e-15
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		1e-15
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		1e-15
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		1e-15
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		2e-15
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		2e-15
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		2e-15
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		2e-15
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		2e-15
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		2e-15
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		2e-15
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		2e-15
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		2e-15
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		2e-15
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		3e-15
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		3e-15
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		3e-15
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		3e-15
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		3e-15
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		3e-15
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		3e-15
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		3e-15
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		6e-15
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		6e-15
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		6e-15
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		1e-14
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		1e-14
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		1e-14
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		1e-14
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		1e-14
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		1e-14
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		1e-14
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		2e-14
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		2e-14
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		2e-14
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		2e-14
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		2e-14
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-14
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		2e-14
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-14
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		2e-14
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		2e-14
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		2e-14
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		2e-14
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		2e-14
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		2e-14
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		2e-14
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		3e-14
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		4e-14
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		4e-14
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		4e-14
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		4e-14
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		5e-14
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		5e-14
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		6e-14
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		6e-14
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		6e-14
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		7e-14
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		7e-14
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		7e-14
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		8e-14
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		9e-14
1fvr_A	327	Tie2 Kinase Domain Length = 327		1e-13
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		1e-13
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		1e-13
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-13
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		1e-13
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-13
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		1e-13
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-13
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		1e-13
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-13
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		1e-13
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-13
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		1e-13
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		1e-13
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		1e-13
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		1e-13
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		1e-13
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		2e-13
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		2e-13
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		2e-13
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		2e-13
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		2e-13
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		2e-13
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		2e-13
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		2e-13
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		2e-13
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		2e-13
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		2e-13
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		2e-13
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		3e-13
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		4e-13
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		4e-13
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		4e-13
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		4e-13
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		4e-13
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		4e-13
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		4e-13
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		5e-13
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		5e-13
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		5e-13
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		5e-13
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		5e-13
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		5e-13
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		5e-13
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		5e-13
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		5e-13
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		6e-13
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		6e-13
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		6e-13
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		6e-13
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		6e-13
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		6e-13
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		6e-13
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		6e-13
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		7e-13
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		7e-13
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		8e-13
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		8e-13
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		8e-13
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		9e-13
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		9e-13
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		1e-12
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		1e-12
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		1e-12
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		1e-12
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		1e-12
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-12
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		1e-12
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-12
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		2e-12
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-12
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		2e-12
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		2e-12
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		2e-12
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		2e-12
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		2e-12
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		2e-12
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		3e-12
3a7f_A	303	Human Mst3 Kinase Length = 303		3e-12
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		3e-12
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		3e-12
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-12
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		3e-12
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		3e-12
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		3e-12
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		3e-12
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-12
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-12
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		4e-12
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		4e-12
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		4e-12
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		4e-12
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-12
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		5e-12
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		5e-12
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		5e-12
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		5e-12
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		5e-12
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		5e-12
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		6e-12
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		7e-12
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		7e-12
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		7e-12
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		7e-12
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		7e-12
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		7e-12
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		7e-12
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		7e-12
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		7e-12
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		7e-12
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		8e-12
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		8e-12
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		8e-12
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		8e-12
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		8e-12
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		8e-12
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		8e-12
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		8e-12
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		8e-12
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		9e-12
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		9e-12
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		9e-12
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		9e-12
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		9e-12
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		9e-12
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		9e-12
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		9e-12
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		1e-11
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		1e-11
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		1e-11
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		1e-11
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		1e-11
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-11
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		1e-11
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		1e-11
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		1e-11
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		1e-11
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		1e-11
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-11
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		1e-11
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		1e-11
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-11
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		1e-11
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		2e-11
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-11
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		2e-11
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		2e-11
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		2e-11
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		2e-11
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		2e-11
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		2e-11
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		2e-11
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		2e-11
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		2e-11
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		2e-11
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		2e-11
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-11
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-11
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		2e-11
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		2e-11
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		2e-11
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-11
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		2e-11
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		2e-11
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		2e-11
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		2e-11
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		2e-11
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		2e-11
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		2e-11
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		2e-11
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		2e-11
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		2e-11
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		2e-11
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		2e-11
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		2e-11
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		2e-11
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		3e-11
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		3e-11
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		3e-11
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		3e-11
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-11
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		3e-11
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		3e-11
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		3e-11
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		3e-11
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		3e-11
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		3e-11
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		3e-11
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		3e-11
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		3e-11
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		3e-11
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		3e-11
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		3e-11
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		3e-11
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		3e-11
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		3e-11
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		3e-11
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		3e-11
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		3e-11
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		3e-11
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		3e-11
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		3e-11
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		3e-11
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		3e-11
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		3e-11
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		3e-11
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		3e-11
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		3e-11
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		4e-11
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		4e-11
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		4e-11
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		4e-11
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		4e-11
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		4e-11
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-11
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		4e-11
3b2t_A	311	Structure Of Phosphotransferase Length = 311		4e-11
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		4e-11
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		4e-11
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		4e-11
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		4e-11
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		4e-11
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		4e-11
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		4e-11
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		4e-11
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		4e-11
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		4e-11
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		4e-11
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		4e-11
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		4e-11
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		5e-11
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-11
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		5e-11
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		5e-11
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		5e-11
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		5e-11
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		5e-11
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		5e-11
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		5e-11
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		5e-11
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		5e-11
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		5e-11
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		5e-11
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		5e-11
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		5e-11
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		5e-11
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		6e-11
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		6e-11
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		6e-11
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		6e-11
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		6e-11
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		6e-11
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		6e-11
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		6e-11
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		7e-11
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		7e-11
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		7e-11
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		8e-11
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		8e-11
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		8e-11
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		8e-11
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		8e-11
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		8e-11
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		8e-11
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		8e-11
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		8e-11
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		8e-11
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		8e-11
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		8e-11
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		9e-11
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		9e-11
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		9e-11
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		9e-11
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-10
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-10
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		1e-10
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-10
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		1e-10
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		1e-10
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		1e-10
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		1e-10
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-10
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-10
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-10
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		1e-10
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		1e-10
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		1e-10
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		1e-10
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-10
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		1e-10
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		1e-10
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-10
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		1e-10
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		1e-10
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		1e-10
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		1e-10
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		1e-10
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		1e-10
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		1e-10
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-10
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		1e-10
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		1e-10
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		1e-10
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-10
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		1e-10
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		1e-10
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		1e-10
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		1e-10
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		1e-10
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		2e-10
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		2e-10
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		2e-10
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		2e-10
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		2e-10
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		2e-10
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		2e-10
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		2e-10
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		2e-10
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-10
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		2e-10
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		2e-10
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		2e-10
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		2e-10
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-10
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-10
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		2e-10
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		2e-10
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-10
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		2e-10
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		2e-10
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		2e-10
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		2e-10
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		2e-10
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		2e-10
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		2e-10
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-10
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		3e-10
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		3e-10
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-10
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		3e-10
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		3e-10
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-10
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		3e-10
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		3e-10
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		3e-10
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-10
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		3e-10
4fie_A	423	Full-Length Human Pak4 Length = 423		3e-10
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		3e-10
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		3e-10
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-10
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		3e-10
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		3e-10
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		4e-10
4fl3_A	635	Structural And Biophysical Characterization Of The		4e-10
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-10
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-10
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		4e-10
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-10
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		4e-10
4fl2_A	636	Structural And Biophysical Characterization Of The		4e-10
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		4e-10
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		4e-10
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		4e-10
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		4e-10
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		4e-10
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		4e-10
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		5e-10
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		5e-10
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		5e-10
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		5e-10
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		5e-10
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-10
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		5e-10
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		5e-10
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		5e-10
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		5e-10
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		5e-10
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		5e-10
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		5e-10
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		5e-10
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		5e-10
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		6e-10
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		6e-10
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		6e-10
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		6e-10
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		7e-10
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		7e-10
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		7e-10
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		7e-10
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		7e-10
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		8e-10
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		8e-10
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		8e-10
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		8e-10
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		9e-10
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		9e-10
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		9e-10
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		1e-09
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		1e-09
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-09
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		1e-09
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		1e-09
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		1e-09
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-09
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-09
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		1e-09
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		1e-09
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		1e-09
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		2e-09
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-09
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		2e-09
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-09
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		2e-09
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		2e-09
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		2e-09
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		2e-09
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		2e-09
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		2e-09
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		2e-09
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		2e-09
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		2e-09
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		2e-09
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		2e-09
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-09
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-09
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		2e-09
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-09
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		3e-09
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		3e-09
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		3e-09
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		3e-09
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		3e-09
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		3e-09
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		3e-09
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-09
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		3e-09
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		3e-09
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		3e-09
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		3e-09
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		4e-09
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		4e-09
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		4e-09
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		4e-09
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		4e-09
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		4e-09
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		4e-09
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		4e-09
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		4e-09
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		4e-09
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-09
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		4e-09
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		4e-09
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		4e-09
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		4e-09
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		4e-09
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		4e-09
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		4e-09
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		4e-09
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		4e-09
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		4e-09
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		4e-09
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		4e-09
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		4e-09
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		4e-09
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		4e-09
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		4e-09
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		4e-09
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		4e-09
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		4e-09
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		4e-09
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		4e-09
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		4e-09
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		4e-09
3hec_A	348	P38 In Complex With Imatinib Length = 348		4e-09
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		4e-09
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		4e-09
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		5e-09
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		5e-09
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		5e-09
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		5e-09
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		5e-09
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		5e-09
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		5e-09
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		5e-09
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		5e-09
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		5e-09
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		5e-09
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		5e-09
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		5e-09
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		5e-09
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		5e-09
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		5e-09
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		5e-09
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		5e-09
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		5e-09
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		5e-09
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		5e-09
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		5e-09
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		5e-09
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		5e-09
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		5e-09
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		5e-09
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		5e-09
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		5e-09
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		5e-09
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		5e-09
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		5e-09
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		5e-09
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		5e-09
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		6e-09
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		6e-09
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		6e-09
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		6e-09
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		6e-09
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		6e-09
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		6e-09
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		6e-09
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		6e-09
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		6e-09
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		6e-09
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		6e-09
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		6e-09
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		6e-09
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		6e-09
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		7e-09
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		7e-09
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		7e-09
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		7e-09
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		7e-09
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		8e-09
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		8e-09
3kk9_A	282	Camkii Substrate Complex B Length = 282		8e-09
3kk8_A	284	Camkii Substrate Complex A Length = 284		8e-09
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		8e-09
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		8e-09
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		8e-09
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		8e-09
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		9e-09
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		9e-09
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		1e-08
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		1e-08
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		1e-08
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		1e-08
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		1e-08
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-08
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		1e-08
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		1e-08
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		1e-08
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-08
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		1e-08
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		1e-08
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		1e-08
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		1e-08
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		1e-08
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		1e-08
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		1e-08
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		2e-08
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		2e-08
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		2e-08
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		2e-08
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		2e-08
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		2e-08
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		2e-08
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		2e-08
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		2e-08
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		2e-08
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-08
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		2e-08
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		3e-08
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		3e-08
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		3e-08
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-08
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		3e-08
2oza_B	366	Structure Of P38alpha Complex Length = 366		3e-08
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		3e-08
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		3e-08
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		3e-08
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		3e-08
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		3e-08
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		4e-08
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		4e-08
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		4e-08
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		4e-08
3g51_A	325	Structural Diversity Of The Active Conformation Of		4e-08
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		4e-08
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		4e-08
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		5e-08
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		5e-08
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		5e-08
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		6e-08
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		6e-08
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		6e-08
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		6e-08
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		7e-08
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		7e-08
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		7e-08
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		8e-08
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		8e-08
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		8e-08
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		8e-08
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		8e-08
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		9e-08
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		9e-08
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		9e-08
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		9e-08
3soa_A	444	Full-Length Human Camkii Length = 444		1e-07
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		1e-07
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		1e-07
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-07
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		1e-07
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		1e-07
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-07
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		1e-07
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		2e-07
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		2e-07
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		2e-07
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		2e-07
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		2e-07
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		2e-07
4exu_A	371	Mapk13, Inactive Form Length = 371		2e-07
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		2e-07
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		3e-07
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		3e-07
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		3e-07
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		3e-07
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		3e-07
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		3e-07
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		3e-07
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		3e-07
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		3e-07
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		3e-07
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		3e-07
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		3e-07
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		3e-07
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		4e-07
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		4e-07
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		4e-07
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		4e-07
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		4e-07
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		4e-07
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		4e-07
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		5e-07
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		5e-07
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		5e-07
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		5e-07
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		5e-07
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		5e-07
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		5e-07
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		5e-07
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		5e-07
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		5e-07
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		6e-07
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		6e-07
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		6e-07
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		6e-07
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		6e-07
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		6e-07
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		6e-07
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		7e-07
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		7e-07
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		7e-07
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		8e-07
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		8e-07
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		8e-07
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		9e-07
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		9e-07
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		1e-06
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		1e-06
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		1e-06
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		1e-06
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		1e-06
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		1e-06
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		1e-06
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		1e-06
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		1e-06
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		1e-06
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		1e-06
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		1e-06
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-06
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		1e-06
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-06
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		1e-06
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		1e-06
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-06
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		1e-06
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		2e-06
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		2e-06
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		2e-06
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		3e-06
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		3e-06
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		4e-06
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		4e-06
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		5e-06
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		5e-06
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		6e-06
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		6e-06
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		6e-06
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		6e-06
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		6e-06
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		7e-06
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		8e-06
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		8e-06
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		8e-06
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		9e-06
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		9e-06
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		1e-05
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		1e-05
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		1e-05
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		1e-05
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		1e-05
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		1e-05
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		1e-05
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		1e-05
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		1e-05
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		2e-05
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		2e-05
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-05
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		2e-05
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		2e-05
4ae6_A	343	Structure And Function Of The Human Sperm-specific		2e-05
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		2e-05
4ae9_A	343	Structure And Function Of The Human Sperm-specific		2e-05
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-05
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-05
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		2e-05
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-05
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		2e-05
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-05
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		2e-05
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		2e-05
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		2e-05
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		3e-05
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		3e-05
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		3e-05
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		3e-05
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		3e-05
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		3e-05
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		3e-05
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		3e-05
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		3e-05
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		4e-05
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		4e-05
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		4e-05
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		4e-05
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		5e-05
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		5e-05
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		5e-05
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		5e-05
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		5e-05
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		5e-05
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		5e-05
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		5e-05
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		5e-05
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		5e-05
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		5e-05
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		5e-05
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		5e-05
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		5e-05
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		5e-05
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		5e-05
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		6e-05
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		6e-05
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		7e-05
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		7e-05
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		7e-05
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		7e-05
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		7e-05
4b8c_D	727	Nuclease Module Of The Yeast Ccr4-Not Complex Lengt		7e-05
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		7e-05
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		7e-05
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		7e-05
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		8e-05
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		9e-05
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		9e-05
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		1e-04

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  204 bits (518), Expect = 3e-52,   Method: Composition-based stats.
 Identities = 120/285 (42%), Positives = 159/285 (55%), Gaps = 15/285 (5%)
Query: 692 ESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNI 751
           ++  ++NI+G+GG G VY+G + DG  VA+KRL    T G +  F  E++ +    HRN+
Sbjct: 30  DNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNL 89
Query: 752 VRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGH--LKWETRYRIALEAAKGLCYLHH 809
           +RL G+       LL+Y YM NGS+   L         L W  R RIAL +A+GL YLH 
Sbjct: 90  LRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHD 149
Query: 810 DCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAY 869
            C P IIHRDVK+ NILLD +FEA V DFGLAK L D        +V G  G+IAPEY  
Sbjct: 150 HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK-LMDYKDXHVXXAVRGXIGHIAPEYLS 208
Query: 870 TLKVDEKSDVYSFGVVLLELIAGKKPVG----EFGDGVDIVRWVRKTTSEVSQPSDAASV 925
           T K  EK+DV+ +GV+LLELI G++          D V ++ WV+    E         +
Sbjct: 209 TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE-------KKL 261
Query: 926 LAVVDPRLSG-YPLTGVIHLFKVAMMCVEDESSARPTMREVVHML 969
            A+VD  L G Y    V  L +VA++C +     RP M EVV ML
Sbjct: 262 EALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  199 bits (507), Expect = 5e-51,   Method: Compositional matrix adjust.
 Identities = 119/285 (41%), Positives = 159/285 (55%), Gaps = 15/285 (5%)
Query: 692 ESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNI 751
           ++  ++NI+G+GG G VY+G + DG  VA+KRL      G +  F  E++ +    HRN+
Sbjct: 38  DNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQFQTEVEMISMAVHRNL 97
Query: 752 VRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGH--LKWETRYRIALEAAKGLCYLHH 809
           +RL G+       LL+Y YM NGS+   L         L W  R RIAL +A+GL YLH 
Sbjct: 98  LRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHD 157
Query: 810 DCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAY 869
            C P IIHRDVK+ NILLD +FEA V DFGLAK L D        +V G+ G+IAPEY  
Sbjct: 158 HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK-LMDYKDXHVXXAVRGTIGHIAPEYLS 216
Query: 870 TLKVDEKSDVYSFGVVLLELIAGKKPVG----EFGDGVDIVRWVRKTTSEVSQPSDAASV 925
           T K  EK+DV+ +GV+LLELI G++          D V ++ WV+    E         +
Sbjct: 217 TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE-------KKL 269
Query: 926 LAVVDPRLSG-YPLTGVIHLFKVAMMCVEDESSARPTMREVVHML 969
            A+VD  L G Y    V  L +VA++C +     RP M EVV ML
Sbjct: 270 EALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 314

>pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772

Iteration: 1
 Score =  184 bits (466), Expect = 3e-46,   Method: Compositional matrix adjust.
 Identities = 175/566 (30%), Positives = 249/566 (43%), Gaps = 81/566 (14%)
Query: 100 LTISNVNLTGRLPSEMALLTSLKVFNISGNVFQGNFAGQIVRGMTELQVLDAYNNNFTGP 159
           L +S+ N +  +P  +   ++L+  +ISGN   G+F+ + +   TEL++L+  +N F GP
Sbjct: 202 LDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFS-RAISTCTELKLLNISSNQFVGP 259
Query: 160 LPVEIASLKSLRHLSFGGNYFTGKIPQSYS-EIQSLEYIGLNGIGLNGTVPAF------- 211
           +P     LKSL++LS   N FTG+IP   S    +L  + L+G    G VP F       
Sbjct: 260 IPP--LPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLL 317
Query: 212 ------------------LSRLKNLREMYIGYFNTYTGGIPPGFGALT-QLQVLDMASCN 252
                             L +++ L+ + +  FN ++G +P     L+  L  LD++S N
Sbjct: 318 ESLALSSNNFSGELPMDTLLKMRGLKVLDLS-FNEFSGELPESLTNLSASLLTLDLSSNN 376
Query: 253 ISGEI-PTXXXX-XXXXXXXXXQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFA 310
            SG I P               Q N  TG IPP LS    L SL LS NYL+G IP S  
Sbjct: 377 FSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLG 436
Query: 311 ALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTS 370
           +L  L  L+L+ N L G IP  L     LE L +  N+ T E+P  L     L  + +++
Sbjct: 437 SLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSN 496
Query: 371 NHLTGTIPRDLCKGGKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGTIPAGLF 430
           N LTG IP+ + +   L  L L  N F G IP ELG C+SL  +  + N  NGTIPA +F
Sbjct: 497 NRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMF 556
Query: 431 XXXXXXXX---------------XXXXXXXSGELPE--KMSGASLNQLKVAN-NNITGKI 472
                                         +G L E   +    LN+L   N  NIT ++
Sbjct: 557 KQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRV 616
Query: 473 -----PAAIGNLPSLNILSLQNNRLEGEIPVESFNLKMITXXXXXXXXXXGEIPYSISQC 527
                     N  S+  L +  N L G IP E  ++  +           G IP  +   
Sbjct: 617 YGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDL 676
Query: 528 HSLTSVDLSRNSLYGKIPPGISKLIDLSILNLSRNGITGSIPNEMRNMMSLTTLDLSYNN 587
             L  +DLS N L G+IP  +S L  L+ ++LS N ++G IP EM               
Sbjct: 677 RGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIP-EM--------------- 720
Query: 588 LIGNIPSGGQFLAFNETSFIGNPNLC 613
                   GQF  F    F+ NP LC
Sbjct: 721 --------GQFETFPPAKFLNNPGLC 738

>pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772

Iteration: 1
 Score =  122 bits (306), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 130/475 (27%), Positives = 187/475 (39%), Gaps = 109/475 (22%)
Query: 227 NTYTGGIPPGFGALTQLQVLDMASCNISGEIPTXXXXXXXXXXXXXQMNKLTGHIPPQLS 286
           N++  G   GF     L  LD++  ++SG + T              ++  T   P ++S
Sbjct: 83  NSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVS 142
Query: 287 GLISLKS---LDLSLNYLTGE------IPESFAALK-------------------NLTLL 318
           G + L S   LDLS N ++G       + +    LK                   NL  L
Sbjct: 143 GGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVDVSRCVNLEFL 202
Query: 319 QLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTIP 378
            +  NN    IP FLGD   L+ L + GN  + +    +    +L +L+++SN   G IP
Sbjct: 203 DVSSNNFSTGIP-FLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIP 261
Query: 379 RDLCKGGKLKSLILMQNFFIGPIPEEL-GQCKSLTKIRFSKNYLNGTIPA---------- 427
               K   L+ L L +N F G IP+ L G C +LT +  S N+  G +P           
Sbjct: 262 PLPLK--SLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLES 319
Query: 428 ---------------GLFXXXXXXXXXXXXXXXSGELPEKMSGAS--------------- 457
                           L                SGELPE ++  S               
Sbjct: 320 LALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSG 379
Query: 458 -------------LNQLKVANNNITGK------------------------IPAAIGNLP 480
                        L +L + NN  TGK                        IP+++G+L 
Sbjct: 380 PILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLS 439
Query: 481 SLNILSLQNNRLEGEIPVESFNLKMITXXXXXXXXXXGEIPYSISQCHSLTSVDLSRNSL 540
            L  L L  N LEGEIP E   +K +           GEIP  +S C +L  + LS N L
Sbjct: 440 KLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRL 499
Query: 541 YGKIPPGISKLIDLSILNLSRNGITGSIPNEMRNMMSLTTLDLSYNNLIGNIPSG 595
            G+IP  I +L +L+IL LS N  +G+IP E+ +  SL  LDL+ N   G IP+ 
Sbjct: 500 TGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAA 554

>pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768

Iteration: 1
 Score =  183 bits (464), Expect = 5e-46,   Method: Compositional matrix adjust.
 Identities = 175/566 (30%), Positives = 249/566 (43%), Gaps = 81/566 (14%)
Query: 100 LTISNVNLTGRLPSEMALLTSLKVFNISGNVFQGNFAGQIVRGMTELQVLDAYNNNFTGP 159
           L +S+ N +  +P  +   ++L+  +ISGN   G+F+ + +   TEL++L+  +N F GP
Sbjct: 205 LDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFS-RAISTCTELKLLNISSNQFVGP 262
Query: 160 LPVEIASLKSLRHLSFGGNYFTGKIPQSYS-EIQSLEYIGLNGIGLNGTVPAF------- 211
           +P     LKSL++LS   N FTG+IP   S    +L  + L+G    G VP F       
Sbjct: 263 IPP--LPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLL 320
Query: 212 ------------------LSRLKNLREMYIGYFNTYTGGIPPGFGALT-QLQVLDMASCN 252
                             L +++ L+ + +  FN ++G +P     L+  L  LD++S N
Sbjct: 321 ESLALSSNNFSGELPMDTLLKMRGLKVLDLS-FNEFSGELPESLTNLSASLLTLDLSSNN 379
Query: 253 ISGEI-PTXXXX-XXXXXXXXXQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFA 310
            SG I P               Q N  TG IPP LS    L SL LS NYL+G IP S  
Sbjct: 380 FSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLG 439
Query: 311 ALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTS 370
           +L  L  L+L+ N L G IP  L     LE L +  N+ T E+P  L     L  + +++
Sbjct: 440 SLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSN 499
Query: 371 NHLTGTIPRDLCKGGKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGTIPAGLF 430
           N LTG IP+ + +   L  L L  N F G IP ELG C+SL  +  + N  NGTIPA +F
Sbjct: 500 NRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMF 559
Query: 431 XXXXXXXX---------------XXXXXXXSGELPE--KMSGASLNQLKVAN-NNITGKI 472
                                         +G L E   +    LN+L   N  NIT ++
Sbjct: 560 KQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRV 619
Query: 473 -----PAAIGNLPSLNILSLQNNRLEGEIPVESFNLKMITXXXXXXXXXXGEIPYSISQC 527
                     N  S+  L +  N L G IP E  ++  +           G IP  +   
Sbjct: 620 YGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDL 679
Query: 528 HSLTSVDLSRNSLYGKIPPGISKLIDLSILNLSRNGITGSIPNEMRNMMSLTTLDLSYNN 587
             L  +DLS N L G+IP  +S L  L+ ++LS N ++G IP EM               
Sbjct: 680 RGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIP-EM--------------- 723
Query: 588 LIGNIPSGGQFLAFNETSFIGNPNLC 613
                   GQF  F    F+ NP LC
Sbjct: 724 --------GQFETFPPAKFLNNPGLC 741

>pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768

Iteration: 1
 Score =  121 bits (303), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 130/475 (27%), Positives = 187/475 (39%), Gaps = 109/475 (22%)
Query: 227 NTYTGGIPPGFGALTQLQVLDMASCNISGEIPTXXXXXXXXXXXXXQMNKLTGHIPPQLS 286
           N++  G   GF     L  LD++  ++SG + T              ++  T   P ++S
Sbjct: 86  NSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVS 145
Query: 287 GLISLKS---LDLSLNYLTGE------IPESFAALK-------------------NLTLL 318
           G + L S   LDLS N ++G       + +    LK                   NL  L
Sbjct: 146 GGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVDVSRCVNLEFL 205
Query: 319 QLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTIP 378
            +  NN    IP FLGD   L+ L + GN  + +    +    +L +L+++SN   G IP
Sbjct: 206 DVSSNNFSTGIP-FLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIP 264
Query: 379 RDLCKGGKLKSLILMQNFFIGPIPEEL-GQCKSLTKIRFSKNYLNGTIPA---------- 427
               K   L+ L L +N F G IP+ L G C +LT +  S N+  G +P           
Sbjct: 265 PLPLK--SLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLES 322
Query: 428 ---------------GLFXXXXXXXXXXXXXXXSGELPEKMSGAS--------------- 457
                           L                SGELPE ++  S               
Sbjct: 323 LALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSG 382
Query: 458 -------------LNQLKVANNNITGK------------------------IPAAIGNLP 480
                        L +L + NN  TGK                        IP+++G+L 
Sbjct: 383 PILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLS 442
Query: 481 SLNILSLQNNRLEGEIPVESFNLKMITXXXXXXXXXXGEIPYSISQCHSLTSVDLSRNSL 540
            L  L L  N LEGEIP E   +K +           GEIP  +S C +L  + LS N L
Sbjct: 443 KLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRL 502
Query: 541 YGKIPPGISKLIDLSILNLSRNGITGSIPNEMRNMMSLTTLDLSYNNLIGNIPSG 595
            G+IP  I +L +L+IL LS N  +G+IP E+ +  SL  LDL+ N   G IP+ 
Sbjct: 503 TGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAA 557

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  152 bits (385), Expect = 7e-37,   Method: Compositional matrix adjust.
 Identities = 99/276 (35%), Positives = 151/276 (54%), Gaps = 15/276 (5%)
Query: 698 NIIGKGGAGIVYRGSMPDGIDVAIKRL---VGRGTGGNDHGFLAEIQTLGRIRHRNIVRL 754
           N +G+GG G+VY+G + +   VA+K+L   V   T      F  EI+ + + +H N+V L
Sbjct: 37  NKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVEL 95
Query: 755 LGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGH-LKWETRYRIALEAAKGLCYLHHDCSP 813
           LG+ S+ D   L+Y YMPNGSL + L    G   L W  R +IA  AA G+ +LH +   
Sbjct: 96  LGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHH- 154
Query: 814 LIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKV 873
             IHRD+KS NILLD  F A ++DFGLA+  +    +   S + G+  Y+APE A   ++
Sbjct: 155 --IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXSRIVGTTAYMAPE-ALRGEI 211
Query: 874 DEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDPRL 933
             KSD+YSFGVVLLE+I G   V E  +   ++    +   E     D       +D ++
Sbjct: 212 TPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIED------YIDKKM 265
Query: 934 SGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHML 969
           +    T V  ++ VA  C+ ++ + RP +++V  +L
Sbjct: 266 NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLL 301

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  150 bits (380), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 98/276 (35%), Positives = 150/276 (54%), Gaps = 15/276 (5%)
Query: 698 NIIGKGGAGIVYRGSMPDGIDVAIKRL---VGRGTGGNDHGFLAEIQTLGRIRHRNIVRL 754
           N +G+GG G+VY+G + +   VA+K+L   V   T      F  EI+ + + +H N+V L
Sbjct: 37  NKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVEL 95
Query: 755 LGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGH-LKWETRYRIALEAAKGLCYLHHDCSP 813
           LG+ S+ D   L+Y YMPNGSL + L    G   L W  R +IA  AA G+ +LH +   
Sbjct: 96  LGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHH- 154
Query: 814 LIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKV 873
             IHRD+KS NILLD  F A ++DFGLA+  +    +     + G+  Y+APE A   ++
Sbjct: 155 --IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXXRIVGTTAYMAPE-ALRGEI 211
Query: 874 DEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDPRL 933
             KSD+YSFGVVLLE+I G   V E  +   ++    +   E     D       +D ++
Sbjct: 212 TPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIED------YIDKKM 265
Query: 934 SGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHML 969
           +    T V  ++ VA  C+ ++ + RP +++V  +L
Sbjct: 266 NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLL 301

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  150 bits (378), Expect = 5e-36,   Method: Compositional matrix adjust.
 Identities = 103/298 (34%), Positives = 158/298 (53%), Gaps = 16/298 (5%)
Query: 688 EDVLESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIR 747
           E+   +   + +IG G  G VY+G + DG  VA+KR     + G +  F  EI+TL   R
Sbjct: 35  EEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIE-EFETEIETLSFCR 93
Query: 748 HRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAK--GGHLKWETRYRIALEAAKGLC 805
           H ++V L+G+   R+  +L+Y+YM NG+L   L+G+      + WE R  I + AA+GL 
Sbjct: 94  HPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLH 153
Query: 806 YLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAP 865
           YLH   +  IIHRDVKS NILLD +F   + DFG++K   + G +     V G+ GYI P
Sbjct: 154 YLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKGTLGYIDP 210
Query: 866 EYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEF--GDGVDIVRWVRKTTSEVSQPSDAA 923
           EY    ++ EKSDVYSFGVVL E++  +  + +    + V++  W         +  +  
Sbjct: 211 EYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEW-------AVESHNNG 263
Query: 924 SVLAVVDPRLSGYPLTGVIHLF-KVAMMCVEDESSARPTMREVVHMLANPPQSAPSLI 980
            +  +VDP L+       +  F   A+ C+   S  RP+M +V+  L    +   S+I
Sbjct: 264 QLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQESVI 321

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  150 bits (378), Expect = 5e-36,   Method: Compositional matrix adjust.
 Identities = 98/276 (35%), Positives = 149/276 (53%), Gaps = 15/276 (5%)
Query: 698 NIIGKGGAGIVYRGSMPDGIDVAIKRL---VGRGTGGNDHGFLAEIQTLGRIRHRNIVRL 754
           N +G+GG G+VY+G + +   VA+K+L   V   T      F  EI+ + + +H N+V L
Sbjct: 31  NKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVEL 89
Query: 755 LGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGH-LKWETRYRIALEAAKGLCYLHHDCSP 813
           LG+ S+ D   L+Y YMPNGSL + L    G   L W  R +IA  AA G+ +LH +   
Sbjct: 90  LGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHH- 148
Query: 814 LIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKV 873
             IHRD+KS NILLD  F A ++DFGLA+  +          + G+  Y+APE A   ++
Sbjct: 149 --IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVMXXRIVGTTAYMAPE-ALRGEI 205
Query: 874 DEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDPRL 933
             KSD+YSFGVVLLE+I G   V E  +   ++    +   E     D       +D ++
Sbjct: 206 TPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIED------YIDKKM 259
Query: 934 SGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHML 969
           +    T V  ++ VA  C+ ++ + RP +++V  +L
Sbjct: 260 NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLL 295

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  147 bits (371), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 102/298 (34%), Positives = 157/298 (52%), Gaps = 16/298 (5%)
Query: 688 EDVLESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIR 747
           E+   +   + +IG G  G VY+G + DG  VA+KR     + G +  F  EI+TL   R
Sbjct: 35  EEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIE-EFETEIETLSFCR 93
Query: 748 HRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAK--GGHLKWETRYRIALEAAKGLC 805
           H ++V L+G+   R+  +L+Y+YM NG+L   L+G+      + WE R  I + AA+GL 
Sbjct: 94  HPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLH 153
Query: 806 YLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAP 865
           YLH   +  IIHRDVKS NILLD +F   + DFG++K   +   +     V G+ GYI P
Sbjct: 154 YLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKGTLGYIDP 210
Query: 866 EYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEF--GDGVDIVRWVRKTTSEVSQPSDAA 923
           EY    ++ EKSDVYSFGVVL E++  +  + +    + V++  W         +  +  
Sbjct: 211 EYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEW-------AVESHNNG 263
Query: 924 SVLAVVDPRLSGYPLTGVIHLF-KVAMMCVEDESSARPTMREVVHMLANPPQSAPSLI 980
            +  +VDP L+       +  F   A+ C+   S  RP+M +V+  L    +   S+I
Sbjct: 264 QLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQESVI 321

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  143 bits (360), Expect = 5e-34,   Method: Compositional matrix adjust.
 Identities = 98/276 (35%), Positives = 144/276 (52%), Gaps = 15/276 (5%)
Query: 698 NIIGKGGAGIVYRGSMPDGIDVAIKRL---VGRGTGGNDHGFLAEIQTLGRIRHRNIVRL 754
           N  G+GG G+VY+G + +   VA+K+L   V   T      F  EI+   + +H N+V L
Sbjct: 28  NKXGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVXAKCQHENLVEL 86
Query: 755 LGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGH-LKWETRYRIALEAAKGLCYLHHDCSP 813
           LG+ S+ D   L+Y Y PNGSL + L    G   L W  R +IA  AA G+ +LH +   
Sbjct: 87  LGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWHXRCKIAQGAANGINFLHENHH- 145
Query: 814 LIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKV 873
             IHRD+KS NILLD  F A ++DFGLA+  +        S + G+  Y APE A   ++
Sbjct: 146 --IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVXXSRIVGTTAYXAPE-ALRGEI 202
Query: 874 DEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDPRL 933
             KSD+YSFGVVLLE+I G   V E  +   ++    +   E     D       +D + 
Sbjct: 203 TPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIED------YIDKKX 256
Query: 934 SGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHML 969
           +    T V   + VA  C+ ++ + RP +++V  +L
Sbjct: 257 NDADSTSVEAXYSVASQCLHEKKNKRPDIKKVQQLL 292

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  120 bits (300), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 78/203 (38%), Positives = 116/203 (57%), Gaps = 12/203 (5%)
Query: 700 IGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGND-HGFLAEIQTLGRIRHRNIVRLLGYV 758
           IG G  G V+R     G DVA+K L+ +       + FL E+  + R+RH NIV  +G V
Sbjct: 45  IGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 759 SNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRI--ALEAAKGLCYLHHDCSPLII 816
           +      ++ EY+  GSL  +LH + G   + + R R+  A + AKG+ YLH+  +P I+
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKS-GAREQLDERRRLSMAYDVAKGMNYLHNR-NPPIV 161
Query: 817 HRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSS--VAGSYGYIAPEYAYTLKVD 874
           HR++KS N+L+D  +   V DFGL++      AS  +SS   AG+  ++APE       +
Sbjct: 162 HRNLKSPNLLVDKKYTVKVCDFGLSRL----KASTFLSSKSAAGTPEWMAPEVLRDEPSN 217
Query: 875 EKSDVYSFGVVLLELIAGKKPVG 897
           EKSDVYSFGV+L EL   ++P G
Sbjct: 218 EKSDVYSFGVILWELATLQQPWG 240

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  120 bits (300), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 78/203 (38%), Positives = 115/203 (56%), Gaps = 12/203 (5%)
Query: 700 IGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGND-HGFLAEIQTLGRIRHRNIVRLLGYV 758
           IG G  G V+R     G DVA+K L+ +       + FL E+  + R+RH NIV  +G V
Sbjct: 45  IGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 759 SNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRI--ALEAAKGLCYLHHDCSPLII 816
           +      ++ EY+  GSL  +LH + G   + + R R+  A + AKG+ YLH+  +P I+
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKS-GAREQLDERRRLSMAYDVAKGMNYLHNR-NPPIV 161
Query: 817 HRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSS--VAGSYGYIAPEYAYTLKVD 874
           HRD+KS N+L+D  +   V DFGL++      AS  + S   AG+  ++APE       +
Sbjct: 162 HRDLKSPNLLVDKKYTVKVCDFGLSRL----KASXFLXSKXAAGTPEWMAPEVLRDEPSN 217
Query: 875 EKSDVYSFGVVLLELIAGKKPVG 897
           EKSDVYSFGV+L EL   ++P G
Sbjct: 218 EKSDVYSFGVILWELATLQQPWG 240

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score =  103 bits (256), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 83/301 (27%), Positives = 135/301 (44%), Gaps = 49/301 (16%)
Query: 679 AFQRLDFKAEDVLESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLA 738
           +   +D+K  +V      E ++G+G  G+V +       DVAIK++    +      F+ 
Sbjct: 2   SLHMIDYKEIEV------EEVVGRGAFGVVCKAKW-RAKDVAIKQI---ESESERKAFIV 51
Query: 739 EIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAK------GGH-LKWE 791
           E++ L R+ H NIV+L G   N     L+ EY   GSL  +LHGA+        H + W 
Sbjct: 52  ELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSW- 108
Query: 792 TRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEA-HVADFGLAKFLQDAGAS 850
                 L+ ++G+ YLH      +IHRD+K  N+LL +      + DFG A  +Q     
Sbjct: 109 -----CLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--- 160
Query: 851 ECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVR 910
             M++  GS  ++APE        EK DV+S+G++L E+I  +KP  E G     + W  
Sbjct: 161 --MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAV 218
Query: 911 KTTSEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLA 970
              +                P +   P      +  +   C   + S RP+M E+V ++ 
Sbjct: 219 HNGTR--------------PPLIKNLPKP----IESLMTRCWSKDPSQRPSMEEIVKIMT 260
Query: 971 N 971
           +
Sbjct: 261 H 261

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score =  103 bits (256), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 83/301 (27%), Positives = 135/301 (44%), Gaps = 49/301 (16%)
Query: 679 AFQRLDFKAEDVLESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLA 738
           +   +D+K  +V      E ++G+G  G+V +       DVAIK++    +      F+ 
Sbjct: 1   SLHMIDYKEIEV------EEVVGRGAFGVVCKAKW-RAKDVAIKQI---ESESERKAFIV 50
Query: 739 EIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAK------GGH-LKWE 791
           E++ L R+ H NIV+L G   N     L+ EY   GSL  +LHGA+        H + W 
Sbjct: 51  ELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSW- 107
Query: 792 TRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEA-HVADFGLAKFLQDAGAS 850
                 L+ ++G+ YLH      +IHRD+K  N+LL +      + DFG A  +Q     
Sbjct: 108 -----CLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--- 159
Query: 851 ECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVR 910
             M++  GS  ++APE        EK DV+S+G++L E+I  +KP  E G     + W  
Sbjct: 160 --MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAV 217
Query: 911 KTTSEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLA 970
              +                P +   P      +  +   C   + S RP+M E+V ++ 
Sbjct: 218 HNGTR--------------PPLIKNLPKP----IESLMTRCWSKDPSQRPSMEEIVKIMT 259
Query: 971 N 971
           +
Sbjct: 260 H 260

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score =  102 bits (254), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 86/307 (28%), Positives = 138/307 (44%), Gaps = 31/307 (10%)
Query: 683 LDFKAEDVLESLKDENIIGKGGAGIVYRGSMPDG-----IDVAIKRLVGRGTGGNDHGFL 737
           L F  E     +  + +IG G  G VY+G +        + VAIK L    T      FL
Sbjct: 35  LKFTTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFL 94
Query: 738 AEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIA 797
            E   +G+  H NI+RL G +S     +++ EYM NG+L + L   K G         + 
Sbjct: 95  GEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLR-EKDGEFSVLQLVGML 153
Query: 798 LEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQ-DAGASECMSSV 856
              A G+ YL    +   +HRD+ + NIL++S+    V+DFGL++ L+ D  A+   S  
Sbjct: 154 RGIAAGMKYL---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGG 210
Query: 857 AGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSE 915
                + APE     K    SDV+SFG+V+ E++  G++P  E                 
Sbjct: 211 KIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL---------------- 254
Query: 916 VSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQS 975
               S+   + A+ D      P+     ++++ M C + E + RP   ++V +L    ++
Sbjct: 255 ----SNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 310
Query: 976 APSLITL 982
             SL TL
Sbjct: 311 PDSLKTL 317

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score =  102 bits (253), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 86/290 (29%), Positives = 137/290 (47%), Gaps = 42/290 (14%)
Query: 697 ENIIGKGGAGIVYRGSM-PDGIDVAIKRLV-GRGTGGND-----HGFLAEIQTLGRIRHR 749
           E  IGKGG G+V++G +  D   VAIK L+ G   G  +       F  E+  +  + H 
Sbjct: 24  EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83
Query: 750 NIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHH 809
           NIV+L G + N     ++ E++P G L   L   K   +KW  + R+ L+ A G+ Y+ +
Sbjct: 84  NIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLD-KAHPIKWSVKLRLMLDIALGIEYMQN 140
Query: 810 DCSPLIIHRDVKSNNILLDSDFE-----AHVADFGLAKFLQDAGASECMSSVAGSYGYIA 864
             +P I+HRD++S NI L S  E     A VADFGL++      +   +S + G++ ++A
Sbjct: 141 Q-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVSGLLGNFQWMA 194
Query: 865 PEY--AYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDG-VDIVRWVRKTTSEVSQPSD 921
           PE   A      EK+D YSF ++L  ++ G+ P  E+  G +  +  +R+     + P D
Sbjct: 195 PETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPED 254
Query: 922 AASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLAN 971
                    PRL             V  +C   +   RP    +V  L+ 
Sbjct: 255 CP-------PRLRN-----------VIELCWSGDPKKRPHFSYIVKELSE 286

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 99.8 bits (247), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 85/290 (29%), Positives = 136/290 (46%), Gaps = 42/290 (14%)
Query: 697 ENIIGKGGAGIVYRGSM-PDGIDVAIKRLV-GRGTGGND-----HGFLAEIQTLGRIRHR 749
           E  IGKGG G+V++G +  D   VAIK L+ G   G  +       F  E+  +  + H 
Sbjct: 24  EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83
Query: 750 NIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHH 809
           NIV+L G + N     ++ E++P G L   L   K   +KW  + R+ L+ A G+ Y+ +
Sbjct: 84  NIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLD-KAHPIKWSVKLRLMLDIALGIEYMQN 140
Query: 810 DCSPLIIHRDVKSNNILLDSDFE-----AHVADFGLAKFLQDAGASECMSSVAGSYGYIA 864
             +P I+HRD++S NI L S  E     A VADFG ++      +   +S + G++ ++A
Sbjct: 141 Q-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQ-----QSVHSVSGLLGNFQWMA 194
Query: 865 PEY--AYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDG-VDIVRWVRKTTSEVSQPSD 921
           PE   A      EK+D YSF ++L  ++ G+ P  E+  G +  +  +R+     + P D
Sbjct: 195 PETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPED 254
Query: 922 AASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLAN 971
                    PRL             V  +C   +   RP    +V  L+ 
Sbjct: 255 CP-------PRLRN-----------VIELCWSGDPKKRPHFSYIVKELSE 286

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 99.8 bits (247), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 85/290 (29%), Positives = 136/290 (46%), Gaps = 42/290 (14%)
Query: 697 ENIIGKGGAGIVYRGSM-PDGIDVAIKRLV-GRGTGGND-----HGFLAEIQTLGRIRHR 749
           E  IGKGG G+V++G +  D   VAIK L+ G   G  +       F  E+  +  + H 
Sbjct: 24  EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83
Query: 750 NIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHH 809
           NIV+L G + N     ++ E++P G L   L   K   +KW  + R+ L+ A G+ Y+ +
Sbjct: 84  NIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLD-KAHPIKWSVKLRLMLDIALGIEYMQN 140
Query: 810 DCSPLIIHRDVKSNNILLDSDFE-----AHVADFGLAKFLQDAGASECMSSVAGSYGYIA 864
             +P I+HRD++S NI L S  E     A VADF L++      +   +S + G++ ++A
Sbjct: 141 Q-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ-----QSVHSVSGLLGNFQWMA 194
Query: 865 PEY--AYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDG-VDIVRWVRKTTSEVSQPSD 921
           PE   A      EK+D YSF ++L  ++ G+ P  E+  G +  +  +R+     + P D
Sbjct: 195 PETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPED 254
Query: 922 AASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLAN 971
                    PRL             V  +C   +   RP    +V  L+ 
Sbjct: 255 CP-------PRLRN-----------VIELCWSGDPKKRPHFSYIVKELSE 286

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 99.4 bits (246), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 74/220 (33%), Positives = 107/220 (48%), Gaps = 29/220 (13%)
Query: 700 IGKGGAGIVYRGSMPDGIDVAIKRL-VGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYV 758
           IG G  G VY+G      DVA+K L V   T      F  E+  L + RH NI+  +GY 
Sbjct: 16  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY- 72
Query: 759 SNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYR------IALEAAKGLCYLHHDCS 812
           S +    ++ ++    SL   LH         ET++       IA + A+G+ YLH   +
Sbjct: 73  STKPQLAIVTQWCEGSSLYHHLHII-------ETKFEMIKLIDIARQTAQGMDYLH---A 122
Query: 813 PLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLK 872
             IIHRD+KSNNI L  D    + DFGLA        S     ++GS  ++APE    ++
Sbjct: 123 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE---VIR 179
Query: 873 VDEK------SDVYSFGVVLLELIAGKKPVGEFGDGVDIV 906
           + +K      SDVY+FG+VL EL+ G+ P     +   I+
Sbjct: 180 MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQII 219

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 99.0 bits (245), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 84/302 (27%), Positives = 141/302 (46%), Gaps = 36/302 (11%)
Query: 683 LDFKAEDVLESLKDENIIGKGGAGIVYRGSM--PDGID--VAIKRLVGRGTGGNDHGFLA 738
           ++F  E  +  +K E +IG G  G V RG +  P   +  VAIK L G  T      FL+
Sbjct: 5   MEFAKEIDVSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLS 64
Query: 739 EIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIAL 798
           E   +G+  H NI+RL G V+N    ++L E+M NG+L   L     G         +  
Sbjct: 65  EASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLR-LNDGQFTVIQLVGMLR 123
Query: 799 EAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAG 858
             A G+ YL        +HRD+ + NIL++S+    V+DFGL++FL++  +    +S  G
Sbjct: 124 GIASGMRYLAEMS---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLG 180
Query: 859 S---YGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTS 914
                 + APE     K    SD +S+G+V+ E+++ G++P  +  +  D++  + +   
Sbjct: 181 GKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQ-DVINAIEQDY- 238
Query: 915 EVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVV----HMLA 970
            +  P D  +                   L ++ + C + + +ARP   +VV     M+ 
Sbjct: 239 RLPPPPDCPT------------------SLHQLMLDCWQKDRNARPRFPQVVSALDKMIR 280
Query: 971 NP 972
           NP
Sbjct: 281 NP 282

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 99.0 bits (245), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 74/220 (33%), Positives = 107/220 (48%), Gaps = 29/220 (13%)
Query: 700 IGKGGAGIVYRGSMPDGIDVAIKRL-VGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYV 758
           IG G  G VY+G      DVA+K L V   T      F  E+  L + RH NI+  +GY 
Sbjct: 18  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY- 74
Query: 759 SNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYR------IALEAAKGLCYLHHDCS 812
           S +    ++ ++    SL   LH         ET++       IA + A+G+ YLH   +
Sbjct: 75  STKPQLAIVTQWCEGSSLYHHLHII-------ETKFEMIKLIDIARQTAQGMDYLH---A 124
Query: 813 PLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLK 872
             IIHRD+KSNNI L  D    + DFGLA        S     ++GS  ++APE    ++
Sbjct: 125 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE---VIR 181
Query: 873 VDEK------SDVYSFGVVLLELIAGKKPVGEFGDGVDIV 906
           + +K      SDVY+FG+VL EL+ G+ P     +   I+
Sbjct: 182 MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQII 221

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 99.0 bits (245), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 74/216 (34%), Positives = 107/216 (49%), Gaps = 15/216 (6%)
Query: 700 IGKGGAGIVYRGSMPDGIDVAIKRL-VGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYV 758
           IG G  G VY+G      DVA+K L V   T      F  E+  L + RH NI+  +GY 
Sbjct: 20  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY- 76
Query: 759 SNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETR--YRIALEAAKGLCYLHHDCSPLII 816
           S +    ++ ++    SL   LH ++    K+E +    IA + A+G+ YLH   +  II
Sbjct: 77  STKPQLAIVTQWCEGSSLYHHLHASE---TKFEMKKLIDIARQTARGMDYLH---AKSII 130
Query: 817 HRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDE- 875
           HRD+KSNNI L  D    + DFGLA        S     ++GS  ++APE       +  
Sbjct: 131 HRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPY 190
Query: 876 --KSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWV 909
             +SDVY+FG+VL EL+ G+ P     +   I+  V
Sbjct: 191 SFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMV 226

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 99.0 bits (245), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 74/220 (33%), Positives = 107/220 (48%), Gaps = 29/220 (13%)
Query: 700 IGKGGAGIVYRGSMPDGIDVAIKRL-VGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYV 758
           IG G  G VY+G      DVA+K L V   T      F  E+  L + RH NI+  +GY 
Sbjct: 21  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY- 77
Query: 759 SNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYR------IALEAAKGLCYLHHDCS 812
           S +    ++ ++    SL   LH         ET++       IA + A+G+ YLH   +
Sbjct: 78  STKPQLAIVTQWCEGSSLYHHLHII-------ETKFEMIKLIDIARQTAQGMDYLH---A 127
Query: 813 PLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLK 872
             IIHRD+KSNNI L  D    + DFGLA        S     ++GS  ++APE    ++
Sbjct: 128 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE---VIR 184
Query: 873 VDEK------SDVYSFGVVLLELIAGKKPVGEFGDGVDIV 906
           + +K      SDVY+FG+VL EL+ G+ P     +   I+
Sbjct: 185 MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQII 224

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 99.0 bits (245), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 74/220 (33%), Positives = 107/220 (48%), Gaps = 29/220 (13%)
Query: 700 IGKGGAGIVYRGSMPDGIDVAIKRL-VGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYV 758
           IG G  G VY+G      DVA+K L V   T      F  E+  L + RH NI+  +GY 
Sbjct: 21  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY- 77
Query: 759 SNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYR------IALEAAKGLCYLHHDCS 812
           S +    ++ ++    SL   LH         ET++       IA + A+G+ YLH   +
Sbjct: 78  STKPQLAIVTQWCEGSSLYHHLHII-------ETKFEMIKLIDIARQTAQGMDYLH---A 127
Query: 813 PLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLK 872
             IIHRD+KSNNI L  D    + DFGLA        S     ++GS  ++APE    ++
Sbjct: 128 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE---VIR 184
Query: 873 VDEK------SDVYSFGVVLLELIAGKKPVGEFGDGVDIV 906
           + +K      SDVY+FG+VL EL+ G+ P     +   I+
Sbjct: 185 MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQII 224

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 98.2 bits (243), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 72/235 (30%), Positives = 117/235 (49%), Gaps = 31/235 (13%)
Query: 684 DFKAEDVLESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTL 743
           + +A +V+ S +    IG G  G VY+G     + V I ++V   T      F  E+  L
Sbjct: 32  EIEASEVMLSTR----IGSGSFGTVYKGKWHGDVAVKILKVVD-PTPEQFQAFRNEVAVL 86
Query: 744 GRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYR------IA 797
            + RH NI+  +GY++ +D   ++ ++    SL + LH         ET+++      IA
Sbjct: 87  RKTRHVNILLFMGYMT-KDNLAIVTQWCEGSSLYKHLHVQ-------ETKFQMFQLIDIA 138
Query: 798 LEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVA 857
            + A+G+ YLH   +  IIHRD+KSNNI L       + DFGLA        S+ +    
Sbjct: 139 RQTAQGMDYLH---AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPT 195
Query: 858 GSYGYIAPEYAYTLKVDE------KSDVYSFGVVLLELIAGKKPVGEFGDGVDIV 906
           GS  ++APE    +++ +      +SDVYS+G+VL EL+ G+ P     +   I+
Sbjct: 196 GSVLWMAPE---VIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQII 247

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 98.2 bits (243), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 74/220 (33%), Positives = 107/220 (48%), Gaps = 29/220 (13%)
Query: 700 IGKGGAGIVYRGSMPDGIDVAIKRL-VGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYV 758
           IG G  G VY+G      DVA+K L V   T      F  E+  L + RH NI+  +GY 
Sbjct: 16  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY- 72
Query: 759 SNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYR------IALEAAKGLCYLHHDCS 812
           S +    ++ ++    SL   LH         ET++       IA + A+G+ YLH   +
Sbjct: 73  STKPQLAIVTQWCEGSSLYHHLHII-------ETKFEMIKLIDIARQTAQGMDYLH---A 122
Query: 813 PLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLK 872
             IIHRD+KSNNI L  D    + DFGLA        S     ++GS  ++APE    ++
Sbjct: 123 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPE---VIR 179
Query: 873 VDEK------SDVYSFGVVLLELIAGKKPVGEFGDGVDIV 906
           + +K      SDVY+FG+VL EL+ G+ P     +   I+
Sbjct: 180 MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQII 219

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 98.2 bits (243), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 74/220 (33%), Positives = 107/220 (48%), Gaps = 29/220 (13%)
Query: 700 IGKGGAGIVYRGSMPDGIDVAIKRL-VGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYV 758
           IG G  G VY+G      DVA+K L V   T      F  E+  L + RH NI+  +GY 
Sbjct: 43  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY- 99
Query: 759 SNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYR------IALEAAKGLCYLHHDCS 812
           S +    ++ ++    SL   LH         ET++       IA + A+G+ YLH   +
Sbjct: 100 STKPQLAIVTQWCEGSSLYHHLHII-------ETKFEMIKLIDIARQTAQGMDYLH---A 149
Query: 813 PLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLK 872
             IIHRD+KSNNI L  D    + DFGLA        S     ++GS  ++APE    ++
Sbjct: 150 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE---VIR 206
Query: 873 VDEK------SDVYSFGVVLLELIAGKKPVGEFGDGVDIV 906
           + +K      SDVY+FG+VL EL+ G+ P     +   I+
Sbjct: 207 MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQII 246

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 98.2 bits (243), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 74/220 (33%), Positives = 107/220 (48%), Gaps = 29/220 (13%)
Query: 700 IGKGGAGIVYRGSMPDGIDVAIKRL-VGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYV 758
           IG G  G VY+G      DVA+K L V   T      F  E+  L + RH NI+  +GY 
Sbjct: 44  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY- 100
Query: 759 SNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYR------IALEAAKGLCYLHHDCS 812
           S +    ++ ++    SL   LH         ET++       IA + A+G+ YLH   +
Sbjct: 101 STKPQLAIVTQWCEGSSLYHHLHII-------ETKFEMIKLIDIARQTAQGMDYLH---A 150
Query: 813 PLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLK 872
             IIHRD+KSNNI L  D    + DFGLA        S     ++GS  ++APE    ++
Sbjct: 151 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE---VIR 207
Query: 873 VDEK------SDVYSFGVVLLELIAGKKPVGEFGDGVDIV 906
           + +K      SDVY+FG+VL EL+ G+ P     +   I+
Sbjct: 208 MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQII 247

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 97.8 bits (242), Expect = 3e-20,   Method: Composition-based stats.
 Identities = 69/207 (33%), Positives = 109/207 (52%), Gaps = 12/207 (5%)
Query: 692 ESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNI 751
           ESL+ E  +G+G  G V+ G+      VAIK L  +    +   FL E Q + ++RH  +
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL--KPGTMSPEAFLQEAQVMKKLRHEKL 75
Query: 752 VRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDC 811
           V+L   VS     +++ EYM  GSL + L G  G +L+      +A + A G+ Y+    
Sbjct: 76  VQLYAVVSEEPIYIVI-EYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN 134
Query: 812 SPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSY--GYIAPEYAY 869
               +HRD+++ NIL+  +    VADFGLA+ ++D   +E  +     +   + APE A 
Sbjct: 135 ---YVHRDLRAANILVGENLVCKVADFGLARLIED---NEXTARQGAKFPIKWTAPEAAL 188
Query: 870 TLKVDEKSDVYSFGVVLLELIA-GKKP 895
             +   KSDV+SFG++L EL   G+ P
Sbjct: 189 YGRFTIKSDVWSFGILLTELTTKGRVP 215

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 97.8 bits (242), Expect = 3e-20,   Method: Composition-based stats.
 Identities = 70/207 (33%), Positives = 108/207 (52%), Gaps = 12/207 (5%)
Query: 692 ESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNI 751
           ESL+ E  +G+G  G V+ G+      VAIK L  +    +   FL E Q + +IRH  +
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL--KPGTMSPEAFLQEAQVMKKIRHEKL 75
Query: 752 VRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDC 811
           V+L   VS      ++ EYM  GSL + L G  G +L+      +A + A G+ Y+    
Sbjct: 76  VQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN 134
Query: 812 SPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSY--GYIAPEYAY 869
               +HRD+++ NIL+  +    VADFGLA+ ++D   +E  +     +   + APE A 
Sbjct: 135 ---YVHRDLRAANILVGENLVCKVADFGLARLIED---NEYTARQGAKFPIKWTAPEAAL 188
Query: 870 TLKVDEKSDVYSFGVVLLELIA-GKKP 895
             +   KSDV+SFG++L EL   G+ P
Sbjct: 189 YGRFTIKSDVWSFGILLTELTTKGRVP 215

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 97.8 bits (242), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 84/301 (27%), Positives = 140/301 (46%), Gaps = 36/301 (11%)
Query: 684 DFKAEDVLESLKDENIIGKGGAGIVYRGSM--PDGID--VAIKRLVGRGTGGNDHGFLAE 739
           +F  E  +  +K E +IG G  G V RG +  P   +  VAIK L G  T      FL+E
Sbjct: 8   EFAKEIDVSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSE 67
Query: 740 IQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALE 799
              +G+  H NI+RL G V+N    ++L E+M NG+L   L     G         +   
Sbjct: 68  ASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLR-LNDGQFTVIQLVGMLRG 126
Query: 800 AAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGS 859
            A G+ YL        +HRD+ + NIL++S+    V+DFGL++FL++  +    +S  G 
Sbjct: 127 IASGMRYLAEMS---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGG 183
Query: 860 ---YGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSE 915
                + APE     K    SD +S+G+V+ E+++ G++P  +  +  D++  + +    
Sbjct: 184 KIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQ-DVINAIEQDY-R 241
Query: 916 VSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVV----HMLAN 971
           +  P D  +                   L ++ + C + + +ARP   +VV     M+ N
Sbjct: 242 LPPPPDCPT------------------SLHQLMLDCWQKDRNARPRFPQVVSALDKMIRN 283
Query: 972 P 972
           P
Sbjct: 284 P 284

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 97.8 bits (242), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 74/220 (33%), Positives = 106/220 (48%), Gaps = 29/220 (13%)
Query: 700 IGKGGAGIVYRGSMPDGIDVAIKRL-VGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYV 758
           IG G  G VY+G      DVA+K L V   T      F  E+  L + RH NI+  +GY 
Sbjct: 16  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY- 72
Query: 759 SNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYR------IALEAAKGLCYLHHDCS 812
           S      ++ ++    SL   LH         ET++       IA + A+G+ YLH   +
Sbjct: 73  STAPQLAIVTQWCEGSSLYHHLHII-------ETKFEMIKLIDIARQTAQGMDYLH---A 122
Query: 813 PLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLK 872
             IIHRD+KSNNI L  D    + DFGLA        S     ++GS  ++APE    ++
Sbjct: 123 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE---VIR 179
Query: 873 VDEK------SDVYSFGVVLLELIAGKKPVGEFGDGVDIV 906
           + +K      SDVY+FG+VL EL+ G+ P     +   I+
Sbjct: 180 MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQII 219

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 97.4 bits (241), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 74/220 (33%), Positives = 107/220 (48%), Gaps = 29/220 (13%)
Query: 700 IGKGGAGIVYRGSMPDGIDVAIKRL-VGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYV 758
           IG G  G VY+G      DVA+K L V   T      F  E+  L + RH NI+  +GY 
Sbjct: 36  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY- 92
Query: 759 SNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYR------IALEAAKGLCYLHHDCS 812
           S +    ++ ++    SL   LH         ET++       IA + A+G+ YLH   +
Sbjct: 93  STKPQLAIVTQWCEGSSLYHHLHII-------ETKFEMIKLIDIARQTAQGMDYLH---A 142
Query: 813 PLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLK 872
             IIHRD+KSNNI L  D    + DFGLA        S     ++GS  ++APE    ++
Sbjct: 143 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPE---VIR 199
Query: 873 VDEK------SDVYSFGVVLLELIAGKKPVGEFGDGVDIV 906
           + +K      SDVY+FG+VL EL+ G+ P     +   I+
Sbjct: 200 MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQII 239

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 97.4 bits (241), Expect = 3e-20,   Method: Composition-based stats.
 Identities = 69/207 (33%), Positives = 109/207 (52%), Gaps = 12/207 (5%)
Query: 692 ESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNI 751
           ESL+ E  +G+G  G V+ G+      VAIK L  +    +   FL E Q + ++RH  +
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL--KPGTMSPEAFLQEAQVMKKLRHEKL 75
Query: 752 VRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDC 811
           V+L   VS     +++ EYM  GSL + L G  G +L+      +A + A G+ Y+    
Sbjct: 76  VQLYAVVSEEPIYIVI-EYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN 134
Query: 812 SPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSY--GYIAPEYAY 869
               +HRD+++ NIL+  +    VADFGLA+ ++D   +E  +     +   + APE A 
Sbjct: 135 ---YVHRDLRAANILVGENLVCKVADFGLARLIED---NEYTARQGAKFPIKWTAPEAAL 188
Query: 870 TLKVDEKSDVYSFGVVLLELIA-GKKP 895
             +   KSDV+SFG++L EL   G+ P
Sbjct: 189 YGRFTIKSDVWSFGILLTELTTKGRVP 215

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 97.4 bits (241), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 74/216 (34%), Positives = 107/216 (49%), Gaps = 15/216 (6%)
Query: 700 IGKGGAGIVYRGSMPDGIDVAIKRL-VGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYV 758
           IG G  G VY+G      DVA+K L V   T      F  E+  L + RH NI+  +GY 
Sbjct: 32  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY- 88
Query: 759 SNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRY--RIALEAAKGLCYLHHDCSPLII 816
           S +    ++ ++    SL   LH ++    K+E +    IA + A+G+ YLH   +  II
Sbjct: 89  STKPQLAIVTQWCEGSSLYHHLHASE---TKFEMKKLIDIARQTARGMDYLH---AKSII 142
Query: 817 HRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDE- 875
           HRD+KSNNI L  D    + DFGLA        S     ++GS  ++APE       +  
Sbjct: 143 HRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPY 202
Query: 876 --KSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWV 909
             +SDVY+FG+VL EL+ G+ P     +   I+  V
Sbjct: 203 SFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMV 238

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 97.4 bits (241), Expect = 4e-20,   Method: Composition-based stats.
 Identities = 69/207 (33%), Positives = 108/207 (52%), Gaps = 12/207 (5%)
Query: 692 ESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNI 751
           ESL+ E  +G+G  G V+ G+      VAIK L  +    +   FL E Q + ++RH  +
Sbjct: 8   ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL--KPGTMSPEAFLQEAQVMKKLRHEKL 65
Query: 752 VRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDC 811
           V+L   VS     ++  EYM  GSL + L G  G +L+      +A + A G+ Y+    
Sbjct: 66  VQLYAVVSEEPIXIVT-EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN 124
Query: 812 SPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSY--GYIAPEYAY 869
               +HRD+++ NIL+  +    VADFGLA+ ++D   +E  +     +   + APE A 
Sbjct: 125 ---YVHRDLRAANILVGENLVCKVADFGLARLIED---NEXTARQGAKFPIKWTAPEAAL 178
Query: 870 TLKVDEKSDVYSFGVVLLELIA-GKKP 895
             +   KSDV+SFG++L EL   G+ P
Sbjct: 179 YGRFTIKSDVWSFGILLTELTTKGRVP 205

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 97.1 bits (240), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 69/207 (33%), Positives = 109/207 (52%), Gaps = 12/207 (5%)
Query: 692 ESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNI 751
           ESL+ E  +G+G  G V+ G+      VAIK L  +    +   FL E Q + ++RH  +
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL--KPGTMSPEAFLQEAQVMKKLRHEKL 241
Query: 752 VRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDC 811
           V+L   VS  +   ++ EYM  GSL + L G  G +L+      +A + A G+ Y+    
Sbjct: 242 VQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN 300
Query: 812 SPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSY--GYIAPEYAY 869
               +HRD+++ NIL+  +    VADFGLA+ ++D   +E  +     +   + APE A 
Sbjct: 301 ---YVHRDLRAANILVGENLVCKVADFGLARLIED---NEYTARQGAKFPIKWTAPEAAL 354
Query: 870 TLKVDEKSDVYSFGVVLLELIA-GKKP 895
             +   KSDV+SFG++L EL   G+ P
Sbjct: 355 YGRFTIKSDVWSFGILLTELTTKGRVP 381

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 97.1 bits (240), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 69/207 (33%), Positives = 108/207 (52%), Gaps = 12/207 (5%)
Query: 692 ESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNI 751
           ESL+ E  +G+G  G V+ G+      VAIK L  +    +   FL E Q + ++RH  +
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL--KPGTMSPEAFLQEAQVMKKLRHEKL 241
Query: 752 VRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDC 811
           V+L   VS     ++  EYM  GSL + L G  G +L+      +A + A G+ Y+    
Sbjct: 242 VQLYAVVSEEPIYIVT-EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN 300
Query: 812 SPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSY--GYIAPEYAY 869
               +HRD+++ NIL+  +    VADFGLA+ ++D   +E  +     +   + APE A 
Sbjct: 301 ---YVHRDLRAANILVGENLVCKVADFGLARLIED---NEYTARQGAKFPIKWTAPEAAL 354
Query: 870 TLKVDEKSDVYSFGVVLLELIA-GKKP 895
             +   KSDV+SFG++L EL   G+ P
Sbjct: 355 YGRFTIKSDVWSFGILLTELTTKGRVP 381

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 97.1 bits (240), Expect = 4e-20,   Method: Composition-based stats.
 Identities = 69/207 (33%), Positives = 108/207 (52%), Gaps = 12/207 (5%)
Query: 692 ESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNI 751
           ESL+ E  +G+G  G V+ G+      VAIK L  +    +   FL E Q + ++RH  +
Sbjct: 11  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL--KPGTMSPEAFLQEAQVMKKLRHEKL 68
Query: 752 VRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDC 811
           V+L   VS      ++ EYM  GSL + L G  G +L+      +A + A G+ Y+    
Sbjct: 69  VQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN 127
Query: 812 SPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSY--GYIAPEYAY 869
               +HRD+++ NIL+  +    VADFGLA+ ++D   +E  +     +   + APE A 
Sbjct: 128 ---YVHRDLRAANILVGENLVCKVADFGLARLIED---NEYTARQGAKFPIKWTAPEAAL 181
Query: 870 TLKVDEKSDVYSFGVVLLELIA-GKKP 895
             +   KSDV+SFG++L EL   G+ P
Sbjct: 182 YGRFTIKSDVWSFGILLTELTTKGRVP 208

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 97.1 bits (240), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 74/220 (33%), Positives = 107/220 (48%), Gaps = 29/220 (13%)
Query: 700 IGKGGAGIVYRGSMPDGIDVAIKRL-VGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYV 758
           IG G  G VY+G      DVA+K L V   T      F  E+  L + RH NI+  +GY 
Sbjct: 44  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY- 100
Query: 759 SNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYR------IALEAAKGLCYLHHDCS 812
           S +    ++ ++    SL   LH         ET++       IA + A+G+ YLH   +
Sbjct: 101 STKPQLAIVTQWCEGSSLYHHLHII-------ETKFEMIKLIDIARQTAQGMDYLH---A 150
Query: 813 PLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLK 872
             IIHRD+KSNNI L  D    + DFGLA        S     ++GS  ++APE    ++
Sbjct: 151 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPE---VIR 207
Query: 873 VDEK------SDVYSFGVVLLELIAGKKPVGEFGDGVDIV 906
           + +K      SDVY+FG+VL EL+ G+ P     +   I+
Sbjct: 208 MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQII 247

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 96.7 bits (239), Expect = 5e-20,   Method: Composition-based stats.
 Identities = 69/207 (33%), Positives = 108/207 (52%), Gaps = 12/207 (5%)
Query: 692 ESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNI 751
           ESL+ E  +G+G  G V+ G+      VAIK L  +    +   FL E Q + ++RH  +
Sbjct: 7   ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL--KPGTMSPEAFLQEAQVMKKLRHEKL 64
Query: 752 VRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDC 811
           V+L   VS      ++ EYM  GSL + L G  G +L+      +A + A G+ Y+    
Sbjct: 65  VQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN 123
Query: 812 SPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSY--GYIAPEYAY 869
               +HRD+++ NIL+  +    VADFGLA+ ++D   +E  +     +   + APE A 
Sbjct: 124 ---YVHRDLRAANILVGENLVCKVADFGLARLIED---NEYTARQGAKFPIKWTAPEAAL 177
Query: 870 TLKVDEKSDVYSFGVVLLELIA-GKKP 895
             +   KSDV+SFG++L EL   G+ P
Sbjct: 178 YGRFTIKSDVWSFGILLTELTTKGRVP 204

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 96.7 bits (239), Expect = 5e-20,   Method: Composition-based stats.
 Identities = 69/207 (33%), Positives = 108/207 (52%), Gaps = 12/207 (5%)
Query: 692 ESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNI 751
           ESL+ E  +G+G  G V+ G+      VAIK L  +    +   FL E Q + ++RH  +
Sbjct: 9   ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL--KPGTMSPEAFLQEAQVMKKLRHEKL 66
Query: 752 VRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDC 811
           V+L   VS      ++ EYM  GSL + L G  G +L+      +A + A G+ Y+    
Sbjct: 67  VQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN 125
Query: 812 SPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSY--GYIAPEYAY 869
               +HRD+++ NIL+  +    VADFGLA+ ++D   +E  +     +   + APE A 
Sbjct: 126 ---YVHRDLRAANILVGENLVCKVADFGLARLIED---NEYTARQGAKFPIKWTAPEAAL 179
Query: 870 TLKVDEKSDVYSFGVVLLELIA-GKKP 895
             +   KSDV+SFG++L EL   G+ P
Sbjct: 180 YGRFTIKSDVWSFGILLTELTTKGRVP 206

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 96.7 bits (239), Expect = 5e-20,   Method: Composition-based stats.
 Identities = 69/207 (33%), Positives = 108/207 (52%), Gaps = 12/207 (5%)
Query: 692 ESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNI 751
           ESL+ E  +G+G  G V+ G+      VAIK L  +    +   FL E Q + ++RH  +
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL--KPGTMSPEAFLQEAQVMKKLRHEKL 75
Query: 752 VRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDC 811
           V+L   VS      ++ EYM  GSL + L G  G +L+      +A + A G+ Y+    
Sbjct: 76  VQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN 134
Query: 812 SPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSY--GYIAPEYAY 869
               +HRD+++ NIL+  +    VADFGLA+ ++D   +E  +     +   + APE A 
Sbjct: 135 ---YVHRDLRAANILVGENLVCKVADFGLARLIED---NEYTARQGAKFPIKWTAPEAAL 188
Query: 870 TLKVDEKSDVYSFGVVLLELIA-GKKP 895
             +   KSDV+SFG++L EL   G+ P
Sbjct: 189 YGRFTIKSDVWSFGILLTELTTKGRVP 215

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 96.7 bits (239), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 69/207 (33%), Positives = 109/207 (52%), Gaps = 12/207 (5%)
Query: 692 ESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNI 751
           ESL+ E  +G+G  G V+ G+      VAIK L  +    +   FL E Q + ++RH  +
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL--KPGTMSPEAFLQEAQVMKKLRHEKL 324
Query: 752 VRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDC 811
           V+L   VS  +   ++ EYM  GSL + L G  G +L+      +A + A G+ Y+    
Sbjct: 325 VQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN 383
Query: 812 SPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSY--GYIAPEYAY 869
               +HRD+++ NIL+  +    VADFGLA+ ++D   +E  +     +   + APE A 
Sbjct: 384 ---YVHRDLRAANILVGENLVCKVADFGLARLIED---NEYTARQGAKFPIKWTAPEAAL 437
Query: 870 TLKVDEKSDVYSFGVVLLELIA-GKKP 895
             +   KSDV+SFG++L EL   G+ P
Sbjct: 438 YGRFTIKSDVWSFGILLTELTTKGRVP 464

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 96.3 bits (238), Expect = 7e-20,   Method: Composition-based stats.
 Identities = 69/207 (33%), Positives = 108/207 (52%), Gaps = 12/207 (5%)
Query: 692 ESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNI 751
           ESL+ E  +G+G  G V+ G+      VAIK L  +    +   FL E Q + ++RH  +
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL--KPGTMSPEAFLQEAQVMKKLRHEKL 75
Query: 752 VRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDC 811
           V+L   VS     ++  EYM  GSL + L G  G +L+      +A + A G+ Y+    
Sbjct: 76  VQLYAVVSEEPIYIVC-EYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN 134
Query: 812 SPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSY--GYIAPEYAY 869
               +HRD+++ NIL+  +    VADFGLA+ ++D   +E  +     +   + APE A 
Sbjct: 135 ---YVHRDLRAANILVGENLVCKVADFGLARLIED---NEYTARQGAKFPIKWTAPEAAL 188
Query: 870 TLKVDEKSDVYSFGVVLLELIA-GKKP 895
             +   KSDV+SFG++L EL   G+ P
Sbjct: 189 YGRFTIKSDVWSFGILLTELTTKGRVP 215

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 96.3 bits (238), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 69/207 (33%), Positives = 109/207 (52%), Gaps = 12/207 (5%)
Query: 692 ESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNI 751
           ESL+ E  +G+G  G V+ G+      VAIK L  +    +   FL E Q + ++RH  +
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL--KPGTMSPEAFLQEAQVMKKLRHEKL 241
Query: 752 VRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDC 811
           V+L   VS  +   ++ EYM  GSL + L G  G +L+      +A + A G+ Y+    
Sbjct: 242 VQLYAVVSE-EPIYIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN 300
Query: 812 SPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSY--GYIAPEYAY 869
               +HRD+++ NIL+  +    VADFGLA+ ++D   +E  +     +   + APE A 
Sbjct: 301 ---YVHRDLRAANILVGENLVCKVADFGLARLIED---NEYTARQGAKFPIKWTAPEAAL 354
Query: 870 TLKVDEKSDVYSFGVVLLELIA-GKKP 895
             +   KSDV+SFG++L EL   G+ P
Sbjct: 355 YGRFTIKSDVWSFGILLTELTTKGRVP 381

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 95.9 bits (237), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 74/216 (34%), Positives = 106/216 (49%), Gaps = 15/216 (6%)
Query: 700 IGKGGAGIVYRGSMPDGIDVAIKRL-VGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYV 758
           IG G  G VY+G      DVA+K L V   T      F  E+  L + RH NI+  +GY 
Sbjct: 32  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY- 88
Query: 759 SNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRY--RIALEAAKGLCYLHHDCSPLII 816
           S      ++ ++    SL   LH ++    K+E +    IA + A+G+ YLH   +  II
Sbjct: 89  STAPQLAIVTQWCEGSSLYHHLHASE---TKFEMKKLIDIARQTARGMDYLH---AKSII 142
Query: 817 HRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDE- 875
           HRD+KSNNI L  D    + DFGLA        S     ++GS  ++APE       +  
Sbjct: 143 HRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPY 202
Query: 876 --KSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWV 909
             +SDVY+FG+VL EL+ G+ P     +   I+  V
Sbjct: 203 SFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMV 238

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 95.9 bits (237), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 73/279 (26%), Positives = 133/279 (47%), Gaps = 32/279 (11%)
Query: 700 IGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVS 759
           IG G  G+V+ G   +   VAIK +  R    ++  F+ E + + ++ H  +V+L G   
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTI--REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 72
Query: 760 NRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRD 819
            +    L++E+M +G L + L   +G     ET   + L+  +G+ YL   C   +IHRD
Sbjct: 73  EQAPICLVFEFMEHGCLSDYLRTQRGLFAA-ETLLGMCLDVCEGMAYLEEAC---VIHRD 128
Query: 820 VKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSY--GYIAPEYAYTLKVDEKS 877
           + + N L+  +    V+DFG+ +F+ D    +  SS    +   + +PE     +   KS
Sbjct: 129 LAARNCLVGENQVIKVSDFGMTRFVLD---DQYTSSTGTKFPVKWASPEVFSFSRYSSKS 185
Query: 878 DVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDPRLSGY 936
           DV+SFGV++ E+ + GK P            +  ++ SEV +  D ++   +  PRL+  
Sbjct: 186 DVWSFGVLMWEVFSEGKIP------------YENRSNSEVVE--DISTGFRLYKPRLAS- 230
Query: 937 PLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQS 975
                 H++++   C ++    RP    ++  LA   +S
Sbjct: 231 -----THVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 264

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 95.9 bits (237), Expect = 1e-19,   Method: Composition-based stats.
 Identities = 68/207 (32%), Positives = 108/207 (52%), Gaps = 12/207 (5%)
Query: 692 ESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNI 751
           ESL+ E  +G+G  G V+ G+      VAIK L  +    +   FL E Q + ++RH  +
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL--KPGTMSPEAFLQEAQVMKKLRHEKL 75
Query: 752 VRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDC 811
           V+L   VS     +++ EYM  G L + L G  G +L+      +A + A G+ Y+    
Sbjct: 76  VQLYAVVSEEPIYIVM-EYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN 134
Query: 812 SPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSY--GYIAPEYAY 869
               +HRD+++ NIL+  +    VADFGLA+ ++D   +E  +     +   + APE A 
Sbjct: 135 ---YVHRDLRAANILVGENLVCKVADFGLARLIED---NEYTARQGAKFPIKWTAPEAAL 188
Query: 870 TLKVDEKSDVYSFGVVLLELIA-GKKP 895
             +   KSDV+SFG++L EL   G+ P
Sbjct: 189 YGRFTIKSDVWSFGILLTELTTKGRVP 215

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 95.5 bits (236), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 73/279 (26%), Positives = 133/279 (47%), Gaps = 32/279 (11%)
Query: 700 IGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVS 759
           IG G  G+V+ G   +   VAIK +  R    ++  F+ E + + ++ H  +V+L G   
Sbjct: 13  IGSGQFGLVHLGYWLNKDKVAIKTI--REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 70
Query: 760 NRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRD 819
            +    L++E+M +G L + L   +G     ET   + L+  +G+ YL   C   +IHRD
Sbjct: 71  EQAPICLVFEFMEHGCLSDYLRTQRGLFAA-ETLLGMCLDVCEGMAYLEEAC---VIHRD 126
Query: 820 VKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSY--GYIAPEYAYTLKVDEKS 877
           + + N L+  +    V+DFG+ +F+ D    +  SS    +   + +PE     +   KS
Sbjct: 127 LAARNCLVGENQVIKVSDFGMTRFVLD---DQYTSSTGTKFPVKWASPEVFSFSRYSSKS 183
Query: 878 DVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDPRLSGY 936
           DV+SFGV++ E+ + GK P            +  ++ SEV +  D ++   +  PRL+  
Sbjct: 184 DVWSFGVLMWEVFSEGKIP------------YENRSNSEVVE--DISTGFRLYKPRLAS- 228
Query: 937 PLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQS 975
                 H++++   C ++    RP    ++  LA   +S
Sbjct: 229 -----THVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 95.5 bits (236), Expect = 1e-19,   Method: Composition-based stats.
 Identities = 69/207 (33%), Positives = 107/207 (51%), Gaps = 12/207 (5%)
Query: 692 ESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNI 751
           ESL+ E  +G+G  G V+ G+      VAIK L  +    +   FL E Q + ++RH  +
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL--KPGTMSPEAFLQEAQVMKKLRHEKL 75
Query: 752 VRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDC 811
           V+L   VS      ++ EYM  GSL + L G  G +L+      +A + A G+ Y+    
Sbjct: 76  VQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN 134
Query: 812 SPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSY--GYIAPEYAY 869
               +HRD+ + NIL+  +    VADFGLA+ ++D   +E  +     +   + APE A 
Sbjct: 135 ---YVHRDLAAANILVGENLVCKVADFGLARLIED---NEYTARQGAKFPIKWTAPEAAL 188
Query: 870 TLKVDEKSDVYSFGVVLLELIA-GKKP 895
             +   KSDV+SFG++L EL   G+ P
Sbjct: 189 YGRFTIKSDVWSFGILLTELTTKGRVP 215

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 95.5 bits (236), Expect = 1e-19,   Method: Composition-based stats.
 Identities = 68/207 (32%), Positives = 108/207 (52%), Gaps = 12/207 (5%)
Query: 692 ESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNI 751
           ESL+ E  +G+G  G V+ G+      VAIK L  +    +   FL E Q + ++RH  +
Sbjct: 15  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL--KPGTMSPEAFLQEAQVMKKLRHEKL 72
Query: 752 VRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDC 811
           V+L   VS      ++ EYM  GSL + L G  G +L+      ++ + A G+ Y+    
Sbjct: 73  VQLYAVVSEEPI-YIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERMN 131
Query: 812 SPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSY--GYIAPEYAY 869
               +HRD+++ NIL+  +    VADFGLA+ ++D   +E  +     +   + APE A 
Sbjct: 132 ---YVHRDLRAANILVGENLVCKVADFGLARLIED---NEWTARQGAKFPIKWTAPEAAL 185
Query: 870 TLKVDEKSDVYSFGVVLLELIA-GKKP 895
             +   KSDV+SFG++L EL   G+ P
Sbjct: 186 YGRFTIKSDVWSFGILLTELTTKGRVP 212

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 95.5 bits (236), Expect = 1e-19,   Method: Composition-based stats.
 Identities = 68/207 (32%), Positives = 108/207 (52%), Gaps = 12/207 (5%)
Query: 692 ESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNI 751
           ESL+ E  +G+G  G V+ G+      VAIK L  +    +   FL E Q + ++RH  +
Sbjct: 15  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL--KPGTMSPEAFLQEAQVMKKLRHEKL 72
Query: 752 VRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDC 811
           V+L   VS      ++ EYM  GSL + L G  G +L+      ++ + A G+ Y+    
Sbjct: 73  VQLYAVVSEEPI-YIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERMN 131
Query: 812 SPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSY--GYIAPEYAY 869
               +HRD+++ NIL+  +    VADFGLA+ ++D   +E  +     +   + APE A 
Sbjct: 132 ---YVHRDLRAANILVGENLVCKVADFGLARLIED---NEYTARQGAKFPIKWTAPEAAL 185
Query: 870 TLKVDEKSDVYSFGVVLLELIA-GKKP 895
             +   KSDV+SFG++L EL   G+ P
Sbjct: 186 YGRFTIKSDVWSFGILLTELTTKGRVP 212

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 95.1 bits (235), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 73/279 (26%), Positives = 132/279 (47%), Gaps = 32/279 (11%)
Query: 700 IGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVS 759
           IG G  G+V+ G   +   VAIK +  R    ++  F+ E + + ++ H  +V+L G   
Sbjct: 18  IGSGQFGLVHLGYWLNKDKVAIKTI--REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 75
Query: 760 NRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRD 819
            +    L++E+M +G L + L   +G     ET   + L+  +G+ YL   C   +IHRD
Sbjct: 76  EQAPICLVFEFMEHGCLSDYLRTQRGLFAA-ETLLGMCLDVCEGMAYLEEAC---VIHRD 131
Query: 820 VKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSY--GYIAPEYAYTLKVDEKS 877
           + + N L+  +    V+DFG+ +F+ D    +  SS    +   + +PE     +   KS
Sbjct: 132 LAARNCLVGENQVIKVSDFGMTRFVLD---DQYTSSTGTKFPVKWASPEVFSFSRYSSKS 188
Query: 878 DVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDPRLSGY 936
           DV+SFGV++ E+ + GK P            +  ++ SEV +  D ++   +  PRL+  
Sbjct: 189 DVWSFGVLMWEVFSEGKIP------------YENRSNSEVVE--DISTGFRLYKPRLAS- 233
Query: 937 PLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQS 975
                 H++++   C  +    RP    ++  LA   +S
Sbjct: 234 -----THVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 95.1 bits (235), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 107/207 (51%), Gaps = 12/207 (5%)
Query: 692 ESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNI 751
           ESL+ E  +G+G  G V+ G+      VAIK L  +    +   FL E Q + ++RH  +
Sbjct: 185 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL--KPGNMSPEAFLQEAQVMKKLRHEKL 242
Query: 752 VRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDC 811
           V+L   VS     ++  EYM  GSL + L G  G +L+      +A + A G+ Y+    
Sbjct: 243 VQLYAVVSEEPIYIVT-EYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN 301
Query: 812 SPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSY--GYIAPEYAY 869
               +HRD+++ NIL+  +    VADFGL + ++D   +E  +     +   + APE A 
Sbjct: 302 ---YVHRDLRAANILVGENLVCKVADFGLGRLIED---NEYTARQGAKFPIKWTAPEAAL 355
Query: 870 TLKVDEKSDVYSFGVVLLELIA-GKKP 895
             +   KSDV+SFG++L EL   G+ P
Sbjct: 356 YGRFTIKSDVWSFGILLTELTTKGRVP 382

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 74/279 (26%), Positives = 133/279 (47%), Gaps = 32/279 (11%)
Query: 700 IGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVS 759
           IG G  G+V+ G   +   VAIK  +  G+   D  F+ E + + ++ H  +V+L G   
Sbjct: 35  IGSGQFGLVHLGYWLNKDKVAIK-TIKEGSMSED-DFIEEAEVMMKLSHPKLVQLYGVCL 92
Query: 760 NRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRD 819
            +    L++E+M +G L + L   +G     ET   + L+  +G+ YL   C   +IHRD
Sbjct: 93  EQAPICLVFEFMEHGCLSDYLRTQRGLFAA-ETLLGMCLDVCEGMAYLEEAC---VIHRD 148
Query: 820 VKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSY--GYIAPEYAYTLKVDEKS 877
           + + N L+  +    V+DFG+ +F+ D    +  SS    +   + +PE     +   KS
Sbjct: 149 LAARNCLVGENQVIKVSDFGMTRFVLD---DQYTSSTGTKFPVKWASPEVFSFSRYSSKS 205
Query: 878 DVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDPRLSGY 936
           DV+SFGV++ E+ + GK P            +  ++ SEV +  D ++   +  PRL+  
Sbjct: 206 DVWSFGVLMWEVFSEGKIP------------YENRSNSEVVE--DISTGFRLYKPRLAS- 250
Query: 937 PLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQS 975
                 H++++   C ++    RP    ++  LA   +S
Sbjct: 251 -----THVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 284

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Composition-based stats.
 Identities = 68/207 (32%), Positives = 107/207 (51%), Gaps = 12/207 (5%)
Query: 692 ESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNI 751
           ESL+ E  +G+G  G V+ G+      VAIK L  +    +   FL E Q + ++RH  +
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL--KPGTMSPEAFLQEAQVMKKLRHEKL 75
Query: 752 VRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDC 811
           V+L   VS      ++ EYM  G L + L G  G +L+      +A + A G+ Y+    
Sbjct: 76  VQLYAVVSEEPI-YIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN 134
Query: 812 SPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSY--GYIAPEYAY 869
               +HRD+++ NIL+  +    VADFGLA+ ++D   +E  +     +   + APE A 
Sbjct: 135 ---YVHRDLRAANILVGENLVCKVADFGLARLIED---NEYTARQGAKFPIKWTAPEAAL 188
Query: 870 TLKVDEKSDVYSFGVVLLELIA-GKKP 895
             +   KSDV+SFG++L EL   G+ P
Sbjct: 189 YGRFTIKSDVWSFGILLTELTTKGRVP 215

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 93.6 bits (231), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 80/301 (26%), Positives = 136/301 (45%), Gaps = 36/301 (11%)
Query: 684 DFKAEDVLESLKDENIIGKGGAGIVYRGSMP----DGIDVAIKRLVGRGTGGNDHGFLAE 739
           +F  E  +  +K E +IG G  G V  G +       I VAIK L    T      FL+E
Sbjct: 25  EFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSE 84
Query: 740 IQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALE 799
              +G+  H N++ L G V+     +++ E+M NGSL   L     G         +   
Sbjct: 85  ASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLR-QNDGQFTVIQLVGMLRG 143
Query: 800 AAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGS 859
            A G+ YL        +HRD+ + NIL++S+    V+DFGL++FL+D  +    +S  G 
Sbjct: 144 IAAGMKYL---ADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGG 200
Query: 860 ---YGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSE 915
                + APE     K    SDV+S+G+V+ E+++ G++P  +  +  D++  + +    
Sbjct: 201 KIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ-DVINAIEQDY-R 258
Query: 916 VSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH----MLAN 971
           +  P D  S                   L ++ + C + + + RP   ++V+    M+ N
Sbjct: 259 LPPPMDCPSA------------------LHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 300
Query: 972 P 972
           P
Sbjct: 301 P 301

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 93.2 bits (230), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 73/279 (26%), Positives = 131/279 (46%), Gaps = 32/279 (11%)
Query: 700 IGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVS 759
           IG G  G+V+ G   +   VAIK +  R    ++  F+ E + + ++ H  +V+L G   
Sbjct: 16  IGSGQFGLVHLGYWLNKDKVAIKTI--REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 73
Query: 760 NRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRD 819
            +    L+ E+M +G L + L   +G     ET   + L+  +G+ YL   C   +IHRD
Sbjct: 74  EQAPICLVTEFMEHGCLSDYLRTQRGLFAA-ETLLGMCLDVCEGMAYLEEAC---VIHRD 129
Query: 820 VKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSY--GYIAPEYAYTLKVDEKS 877
           + + N L+  +    V+DFG+ +F+ D    +  SS    +   + +PE     +   KS
Sbjct: 130 LAARNCLVGENQVIKVSDFGMTRFVLD---DQYTSSTGTKFPVKWASPEVFSFSRYSSKS 186
Query: 878 DVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDPRLSGY 936
           DV+SFGV++ E+ + GK P            +  ++ SEV +  D ++   +  PRL+  
Sbjct: 187 DVWSFGVLMWEVFSEGKIP------------YENRSNSEVVE--DISTGFRLYKPRLAS- 231
Query: 937 PLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQS 975
                 H++++   C  +    RP    ++  LA   +S
Sbjct: 232 -----THVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 91.7 bits (226), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 66/205 (32%), Positives = 106/205 (51%), Gaps = 8/205 (3%)
Query: 692 ESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNI 751
           E+LK    +G G AG V+ G       VA+K L  +G+   D  FLAE   + +++H+ +
Sbjct: 13  ETLKLVERLGAGQAGEVWMGYYNGHTKVAVKSL-KQGSMSPD-AFLAEANLMKQLQHQRL 70
Query: 752 VRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDC 811
           VRL   V+ ++   ++ EYM NGSL + L    G  L       +A + A+G+ ++    
Sbjct: 71  VRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 129
Query: 812 SPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTL 871
               IHRD+++ NIL+       +ADFGLA+ ++DA  +           + APE     
Sbjct: 130 ---YIHRDLRAANILVSDTLSCKIADFGLARLIEDAEXT-AREGAKFPIKWTAPEAINYG 185
Query: 872 KVDEKSDVYSFGVVLLELIA-GKKP 895
               KSDV+SFG++L E++  G+ P
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGRIP 210

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 86/298 (28%), Positives = 131/298 (43%), Gaps = 45/298 (15%)
Query: 692 ESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNI 751
           ESL+    +G G  G V+ G+      VAIK L  +    +   FL E Q + +++H  +
Sbjct: 9   ESLQLIKRLGNGQFGEVWMGTWNGNTKVAIKTL--KPGTMSPESFLEEAQIMKKLKHDKL 66
Query: 752 VRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDC 811
           V+L   VS      ++ EYM  GSL + L   +G  LK      +A + A G+ Y+    
Sbjct: 67  VQLYAVVSEEPI-YIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN 125
Query: 812 SPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSY--GYIAPEYAY 869
               IHRD++S NIL+ +     +ADFGLA+ ++D   +E  +     +   + APE A 
Sbjct: 126 ---YIHRDLRSANILVGNGLICKIADFGLARLIED---NEXTARQGAKFPIKWTAPEAAL 179
Query: 870 TLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPS-DAASVLAV 928
             +   KSDV+SFG++L EL+                     T   V  P  +   VL  
Sbjct: 180 YGRFTIKSDVWSFGILLTELV---------------------TKGRVPYPGMNNREVLEQ 218
Query: 929 VDPRLSGY----PLTGVIHLFKVAMMCVEDESSARPTMREVVHML-----ANPPQSAP 977
           V+    GY    P    I L ++ + C + +   RPT   +   L     A  PQ  P
Sbjct: 219 VE---RGYRMPCPQDCPISLHELMIHCWKKDPEERPTFEYLQSFLEDYFTATEPQYQP 273

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 91.3 bits (225), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 84/304 (27%), Positives = 136/304 (44%), Gaps = 54/304 (17%)
Query: 684 DFKAEDVLESLKDENIIGKGGAGIVYRGSMP----DGIDVAIKRLVGRGTGGNDHGFLAE 739
           +F  E     +K E +IG G  G V  G +       I VAIK L    T      FL+E
Sbjct: 21  EFAKEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSE 80
Query: 740 IQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALE 799
              +G+  H NI+ L G V+     +++ EYM NGSL   L    G       R+ +   
Sbjct: 81  ASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDG-------RFTVIQL 133
Query: 800 A------AKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECM 853
                    G+ YL  D S   +HRD+ + NIL++S+    V+DFG+++ L+D    E  
Sbjct: 134 VGMLRGIGSGMKYL-SDMSA--VHRDLAARNILVNSNLVCKVSDFGMSRVLED--DPEAA 188
Query: 854 SSVAGS---YGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWV 909
            +  G      + APE     K    SDV+S+G+V+ E+++ G++P  +  +  D+++ +
Sbjct: 189 YTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ-DVIKAI 247
Query: 910 RKTTSEVSQPSDAASVLAVVDPRLSGY----PLTGVIHLFKVAMMCVEDESSARPTMREV 965
            +                       GY    P+   I L ++ + C + E S RP   ++
Sbjct: 248 EE-----------------------GYRLPPPMDCPIALHQLMLDCWQKERSDRPKFGQI 284
Query: 966 VHML 969
           V+ML
Sbjct: 285 VNML 288

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 90.5 bits (223), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 84/304 (27%), Positives = 136/304 (44%), Gaps = 54/304 (17%)
Query: 684 DFKAEDVLESLKDENIIGKGGAGIVYRGSMP----DGIDVAIKRLVGRGTGGNDHGFLAE 739
           +F  E     +K E +IG G  G V  G +       I VAIK L    T      FL+E
Sbjct: 6   EFAKEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSE 65
Query: 740 IQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALE 799
              +G+  H NI+ L G V+     +++ EYM NGSL   L    G       R+ +   
Sbjct: 66  ASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDG-------RFTVIQL 118
Query: 800 A------AKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECM 853
                    G+ YL  D S   +HRD+ + NIL++S+    V+DFG+++ L+D    E  
Sbjct: 119 VGMLRGIGSGMKYL-SDMS--YVHRDLAARNILVNSNLVCKVSDFGMSRVLED--DPEAA 173
Query: 854 SSVAGS---YGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWV 909
            +  G      + APE     K    SDV+S+G+V+ E+++ G++P  +  +  D+++ +
Sbjct: 174 YTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ-DVIKAI 232
Query: 910 RKTTSEVSQPSDAASVLAVVDPRLSGY----PLTGVIHLFKVAMMCVEDESSARPTMREV 965
            +                       GY    P+   I L ++ + C + E S RP   ++
Sbjct: 233 EE-----------------------GYRLPPPMDCPIALHQLMLDCWQKERSDRPKFGQI 269
Query: 966 VHML 969
           V+ML
Sbjct: 270 VNML 273

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 90.5 bits (223), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 81/287 (28%), Positives = 129/287 (44%), Gaps = 46/287 (16%)
Query: 697 ENIIGKGGAGIVYRGSMP----DGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIV 752
           + ++G G  G V  G +       I VAIK L    T      FL E   +G+  H NI+
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 753 RLLGYVSNRDTNLLLYEYMPNGSLGEML--HGAKGGHLKWETRYRIALEAAKGLCYLHHD 810
           RL G V+     +++ EYM NGSL   L  H A+   ++     R     A G+ YL   
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR---GIASGMKYL--- 163
Query: 811 CSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGS---YGYIAPEY 867
                +HRD+ + NIL++S+    V+DFGLA+ L+D    E   +  G      + +PE 
Sbjct: 164 SDMGYVHRDLAARNILINSNLVCKVSDFGLARVLED--DPEAAYTTRGGKIPIRWTSPEA 221
Query: 868 AYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVL 926
               K    SDV+S+G+VL E+++ G++P  E  +                       V+
Sbjct: 222 IAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN---------------------QDVI 260
Query: 927 AVVDPRLSGY----PLTGVIHLFKVAMMCVEDESSARPTMREVVHML 969
             VD    GY    P+     L+++ + C + + + RP   ++V +L
Sbjct: 261 KAVD---EGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 90.1 bits (222), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 84/303 (27%), Positives = 135/303 (44%), Gaps = 54/303 (17%)
Query: 685 FKAEDVLESLKDENIIGKGGAGIVYRGSMP----DGIDVAIKRLVGRGTGGNDHGFLAEI 740
           F  E     +K E +IG G  G V  G +       I VAIK L    T      FL+E 
Sbjct: 1   FAKEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEA 60
Query: 741 QTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEA 800
             +G+  H NI+ L G V+     +++ EYM NGSL   L    G       R+ +    
Sbjct: 61  SIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDG-------RFTVIQLV 113
Query: 801 ------AKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMS 854
                   G+ YL  D S   +HRD+ + NIL++S+    V+DFG+++ L+D    E   
Sbjct: 114 GMLRGIGSGMKYL-SDMS--YVHRDLAARNILVNSNLVCKVSDFGMSRVLED--DPEAAY 168
Query: 855 SVAGS---YGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVR 910
           +  G      + APE     K    SDV+S+G+V+ E+++ G++P  +  +  D+++ + 
Sbjct: 169 TTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ-DVIKAIE 227
Query: 911 KTTSEVSQPSDAASVLAVVDPRLSGY----PLTGVIHLFKVAMMCVEDESSARPTMREVV 966
           +                       GY    P+   I L ++ + C + E S RP   ++V
Sbjct: 228 E-----------------------GYRLPPPMDCPIALHQLMLDCWQKERSDRPKFGQIV 264
Query: 967 HML 969
           +ML
Sbjct: 265 NML 267

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 90.1 bits (222), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 71/274 (25%), Positives = 130/274 (47%), Gaps = 32/274 (11%)
Query: 700 IGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVS 759
           IG G  G+V+ G   +   VAIK +  R    ++  F+ E + + ++ H  +V+L G   
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTI--REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 72
Query: 760 NRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRD 819
            +    L++E+M +G L + L   +G     ET   + L+  +G+ YL       +IHRD
Sbjct: 73  EQAPICLVFEFMEHGCLSDYLRTQRGLFAA-ETLLGMCLDVCEGMAYLEE---ASVIHRD 128
Query: 820 VKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSY--GYIAPEYAYTLKVDEKS 877
           + + N L+  +    V+DFG+ +F+ D    +  SS    +   + +PE     +   KS
Sbjct: 129 LAARNCLVGENQVIKVSDFGMTRFVLD---DQYTSSTGTKFPVKWASPEVFSFSRYSSKS 185
Query: 878 DVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDPRLSGY 936
           DV+SFGV++ E+ + GK P            +  ++ SEV +  D ++   +  PRL+  
Sbjct: 186 DVWSFGVLMWEVFSEGKIP------------YENRSNSEVVE--DISTGFRLYKPRLAS- 230
Query: 937 PLTGVIHLFKVAMMCVEDESSARPTMREVVHMLA 970
                 H++++   C ++    RP    ++  LA
Sbjct: 231 -----THVYQIMNHCWKERPEDRPAFSRLLRQLA 259

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 90.1 bits (222), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 103/214 (48%), Gaps = 14/214 (6%)
Query: 697 ENIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLL 755
           + +IG G   +V      P    VAIKR+       +    L EIQ + +  H NIV   
Sbjct: 20  QEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYY 79
Query: 756 GYVSNRDTNLLLYEYMPNGSLGEMLHG--AKGGH----LKWETRYRIALEAAKGLCYLHH 809
                +D   L+ + +  GS+ +++    AKG H    L   T   I  E  +GL YLH 
Sbjct: 80  TSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK 139
Query: 810 DCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAG---ASECMSSVAGSYGYIAPE 866
           +     IHRDVK+ NILL  D    +ADFG++ FL   G    ++   +  G+  ++APE
Sbjct: 140 NGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPE 196
Query: 867 YAYTLK-VDEKSDVYSFGVVLLELIAGKKPVGEF 899
               ++  D K+D++SFG+  +EL  G  P  ++
Sbjct: 197 VMEQVRGYDFKADIWSFGITAIELATGAAPYHKY 230

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 90.1 bits (222), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 103/214 (48%), Gaps = 14/214 (6%)
Query: 697 ENIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLL 755
           + +IG G   +V      P    VAIKR+       +    L EIQ + +  H NIV   
Sbjct: 15  QEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYY 74
Query: 756 GYVSNRDTNLLLYEYMPNGSLGEMLHG--AKGGH----LKWETRYRIALEAAKGLCYLHH 809
                +D   L+ + +  GS+ +++    AKG H    L   T   I  E  +GL YLH 
Sbjct: 75  TSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK 134
Query: 810 DCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAG---ASECMSSVAGSYGYIAPE 866
           +     IHRDVK+ NILL  D    +ADFG++ FL   G    ++   +  G+  ++APE
Sbjct: 135 NGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPE 191
Query: 867 YAYTLK-VDEKSDVYSFGVVLLELIAGKKPVGEF 899
               ++  D K+D++SFG+  +EL  G  P  ++
Sbjct: 192 VMEQVRGYDFKADIWSFGITAIELATGAAPYHKY 225

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 89.7 bits (221), Expect = 6e-18,   Method: Composition-based stats.
 Identities = 71/206 (34%), Positives = 102/206 (49%), Gaps = 12/206 (5%)
Query: 697 ENIIGKGGAGIVYRGSM--PDGIDV--AIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIV 752
           E IIG G +G V  G +  P   DV  AIK L    T      FL+E   +G+  H NI+
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 753 RLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCS 812
           RL G V+     +++ EYM NGSL   L     G         +      G+ YL    S
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFLR-THDGQFTIMQLVGMLRGVGAGMRYL----S 168
Query: 813 PL-IIHRDVKSNNILLDSDFEAHVADFGLAKFLQ-DAGASECMSSVAGSYGYIAPEYAYT 870
            L  +HRD+ + N+L+DS+    V+DFGL++ L+ D  A+   +       + APE    
Sbjct: 169 DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKIPIRWTAPEAIAF 228
Query: 871 LKVDEKSDVYSFGVVLLELIA-GKKP 895
                 SDV+SFGVV+ E++A G++P
Sbjct: 229 RTFSSASDVWSFGVVMWEVLAYGERP 254

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 89.7 bits (221), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 80/287 (27%), Positives = 129/287 (44%), Gaps = 46/287 (16%)
Query: 697 ENIIGKGGAGIVYRGSMP----DGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIV 752
           + ++G G  G V  G +       I VAIK L    T      FL E   +G+  H NI+
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 753 RLLGYVSNRDTNLLLYEYMPNGSLGEML--HGAKGGHLKWETRYRIALEAAKGLCYLHHD 810
           RL G V+     +++ EYM NGSL   L  H A+   ++     R     A G+ YL   
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR---GIASGMKYL--- 163
Query: 811 CSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGS---YGYIAPEY 867
                +HRD+ + NIL++S+    V+DFGL++ L+D    E   +  G      + +PE 
Sbjct: 164 SDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLED--DPEAAYTTRGGKIPIRWTSPEA 221
Query: 868 AYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVL 926
               K    SDV+S+G+VL E+++ G++P  E  +                       V+
Sbjct: 222 IAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN---------------------QDVI 260
Query: 927 AVVDPRLSGY----PLTGVIHLFKVAMMCVEDESSARPTMREVVHML 969
             VD    GY    P+     L+++ + C + + + RP   ++V +L
Sbjct: 261 KAVD---EGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 89.7 bits (221), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 80/287 (27%), Positives = 129/287 (44%), Gaps = 46/287 (16%)
Query: 697 ENIIGKGGAGIVYRGSMP----DGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIV 752
           + ++G G  G V  G +       I VAIK L    T      FL E   +G+  H NI+
Sbjct: 38  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 97
Query: 753 RLLGYVSNRDTNLLLYEYMPNGSLGEML--HGAKGGHLKWETRYRIALEAAKGLCYLHHD 810
           RL G V+     +++ EYM NGSL   L  H A+   ++     R     A G+ YL   
Sbjct: 98  RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR---GIASGMKYLS-- 152
Query: 811 CSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGS---YGYIAPEY 867
                +HRD+ + NIL++S+    V+DFGL++ L+D    E   +  G      + +PE 
Sbjct: 153 -DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLED--DPEAAYTTRGGKIPIRWTSPEA 209
Query: 868 AYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVL 926
               K    SDV+S+G+VL E+++ G++P  E  +                       V+
Sbjct: 210 IAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN---------------------QDVI 248
Query: 927 AVVDPRLSGY----PLTGVIHLFKVAMMCVEDESSARPTMREVVHML 969
             VD    GY    P+     L+++ + C + + + RP   ++V +L
Sbjct: 249 KAVD---EGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 292

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 89.7 bits (221), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 81/294 (27%), Positives = 133/294 (45%), Gaps = 34/294 (11%)
Query: 684 DFKAEDVLESLKDENIIGKGGAGIVYRGSMP----DGIDVAIKRLVGRGTGGNDHGFLAE 739
           +F  E     +  E +IG G  G V  G +       + VAIK L    T      FL E
Sbjct: 14  EFAKEIEASCITIERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGE 73
Query: 740 IQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALE 799
              +G+  H NI+ L G V+     +++ EYM NGSL   L     G         +   
Sbjct: 74  ASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFLK-KNDGQFTVIQLVGMLRG 132
Query: 800 AAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGS 859
            + G+ YL  D     +HRD+ + NIL++S+    V+DFGL++ L+D    E   +  G 
Sbjct: 133 ISAGMKYL-SDMG--YVHRDLAARNILINSNLVCKVSDFGLSRVLED--DPEAAYTTRGG 187
Query: 860 ---YGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSE 915
                + APE     K    SDV+S+G+V+ E+++ G++P  E  +  D+++ V +    
Sbjct: 188 KIPIRWTAPEAIAFRKFTSASDVWSYGIVMWEVVSYGERPYWEMTNQ-DVIKAVEEGY-R 245
Query: 916 VSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHML 969
           +  P D  +                   L+++ + C + E ++RP   E+V+ML
Sbjct: 246 LPSPMDCPAA------------------LYQLMLDCWQKERNSRPKFDEIVNML 281

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 89.7 bits (221), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 80/287 (27%), Positives = 129/287 (44%), Gaps = 46/287 (16%)
Query: 697 ENIIGKGGAGIVYRGSMP----DGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIV 752
           + ++G G  G V  G +       I VAIK L    T      FL E   +G+  H NI+
Sbjct: 21  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 80
Query: 753 RLLGYVSNRDTNLLLYEYMPNGSLGEML--HGAKGGHLKWETRYRIALEAAKGLCYLHHD 810
           RL G V+     +++ EYM NGSL   L  H A+   ++     R     A G+ YL   
Sbjct: 81  RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR---GIASGMKYLS-- 135
Query: 811 CSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGS---YGYIAPEY 867
                +HRD+ + NIL++S+    V+DFGL++ L+D    E   +  G      + +PE 
Sbjct: 136 -DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLED--DPEAAYTTRGGKIPIRWTSPEA 192
Query: 868 AYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVL 926
               K    SDV+S+G+VL E+++ G++P  E  +                       V+
Sbjct: 193 IAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN---------------------QDVI 231
Query: 927 AVVDPRLSGY----PLTGVIHLFKVAMMCVEDESSARPTMREVVHML 969
             VD    GY    P+     L+++ + C + + + RP   ++V +L
Sbjct: 232 KAVD---EGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 275

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 89.4 bits (220), Expect = 9e-18,   Method: Composition-based stats.
 Identities = 71/206 (34%), Positives = 102/206 (49%), Gaps = 12/206 (5%)
Query: 697 ENIIGKGGAGIVYRGSM--PDGIDV--AIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIV 752
           E IIG G +G V  G +  P   DV  AIK L    T      FL+E   +G+  H NI+
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 753 RLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCS 812
           RL G V+     +++ EYM NGSL   L     G         +      G+ YL    S
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFLR-THDGQFTIMQLVGMLRGVGAGMRYL----S 168
Query: 813 PL-IIHRDVKSNNILLDSDFEAHVADFGLAKFLQ-DAGASECMSSVAGSYGYIAPEYAYT 870
            L  +HRD+ + N+L+DS+    V+DFGL++ L+ D  A+   +       + APE    
Sbjct: 169 DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAF 228
Query: 871 LKVDEKSDVYSFGVVLLELIA-GKKP 895
                 SDV+SFGVV+ E++A G++P
Sbjct: 229 RTFSSASDVWSFGVVMWEVLAYGERP 254

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 89.4 bits (220), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 80/287 (27%), Positives = 129/287 (44%), Gaps = 46/287 (16%)
Query: 697 ENIIGKGGAGIVYRGSMP----DGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIV 752
           + ++G G  G V  G +       I VAIK L    T      FL E   +G+  H NI+
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 753 RLLGYVSNRDTNLLLYEYMPNGSLGEML--HGAKGGHLKWETRYRIALEAAKGLCYLHHD 810
           RL G V+     +++ EYM NGSL   L  H A+   ++     R     A G+ YL   
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR---GIASGMKYL--- 163
Query: 811 CSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGS---YGYIAPEY 867
                +HRD+ + NIL++S+    V+DFGL++ L+D    E   +  G      + +PE 
Sbjct: 164 SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLED--DPEAAYTTRGGKIPIRWTSPEA 221
Query: 868 AYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVL 926
               K    SDV+S+G+VL E+++ G++P  E  +                       V+
Sbjct: 222 IAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN---------------------QDVI 260
Query: 927 AVVDPRLSGY----PLTGVIHLFKVAMMCVEDESSARPTMREVVHML 969
             VD    GY    P+     L+++ + C + + + RP   ++V +L
Sbjct: 261 KAVD---EGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 80/287 (27%), Positives = 129/287 (44%), Gaps = 46/287 (16%)
Query: 697 ENIIGKGGAGIVYRGSMP----DGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIV 752
           + ++G G  G V  G +       I VAIK L    T      FL E   +G+  H NI+
Sbjct: 48  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 107
Query: 753 RLLGYVSNRDTNLLLYEYMPNGSLGEML--HGAKGGHLKWETRYRIALEAAKGLCYLHHD 810
           RL G V+     +++ EYM NGSL   L  H A+   ++     R     A G+ YL   
Sbjct: 108 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR---GIASGMKYL--- 161
Query: 811 CSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGS---YGYIAPEY 867
                +HRD+ + NIL++S+    V+DFGL++ L+D    E   +  G      + +PE 
Sbjct: 162 SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLED--DPEAAYTTRGGKIPIRWTSPEA 219
Query: 868 AYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVL 926
               K    SDV+S+G+VL E+++ G++P  E  +                       V+
Sbjct: 220 IAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN---------------------QDVI 258
Query: 927 AVVDPRLSGY----PLTGVIHLFKVAMMCVEDESSARPTMREVVHML 969
             VD    GY    P+     L+++ + C + + + RP   ++V +L
Sbjct: 259 KAVD---EGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 302

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 80/287 (27%), Positives = 129/287 (44%), Gaps = 46/287 (16%)
Query: 697 ENIIGKGGAGIVYRGSMP----DGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIV 752
           + ++G G  G V  G +       I VAIK L    T      FL E   +G+  H NI+
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 753 RLLGYVSNRDTNLLLYEYMPNGSLGEML--HGAKGGHLKWETRYRIALEAAKGLCYLHHD 810
           RL G V+     +++ EYM NGSL   L  H A+   ++     R     A G+ YL   
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR---GIASGMKYL--- 163
Query: 811 CSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGS---YGYIAPEY 867
                +HRD+ + NIL++S+    V+DFGL++ L+D    E   +  G      + +PE 
Sbjct: 164 SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLED--DPEAAYTTRGGKIPIRWTSPEA 221
Query: 868 AYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVL 926
               K    SDV+S+G+VL E+++ G++P  E  +                       V+
Sbjct: 222 IAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN---------------------QDVI 260
Query: 927 AVVDPRLSGY----PLTGVIHLFKVAMMCVEDESSARPTMREVVHML 969
             VD    GY    P+     L+++ + C + + + RP   ++V +L
Sbjct: 261 KAVD---EGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 80/287 (27%), Positives = 129/287 (44%), Gaps = 46/287 (16%)
Query: 697 ENIIGKGGAGIVYRGSMP----DGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIV 752
           + ++G G  G V  G +       I VAIK L    T      FL E   +G+  H NI+
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 753 RLLGYVSNRDTNLLLYEYMPNGSLGEML--HGAKGGHLKWETRYRIALEAAKGLCYLHHD 810
           RL G V+     +++ EYM NGSL   L  H A+   ++     R     A G+ YL   
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR---GIASGMKYL--- 163
Query: 811 CSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGS---YGYIAPEY 867
                +HRD+ + NIL++S+    V+DFGL++ L+D    E   +  G      + +PE 
Sbjct: 164 SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLED--DPEAAYTTRGGKIPIRWTSPEA 221
Query: 868 AYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVL 926
               K    SDV+S+G+VL E+++ G++P  E  +                       V+
Sbjct: 222 IAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN---------------------QDVI 260
Query: 927 AVVDPRLSGY----PLTGVIHLFKVAMMCVEDESSARPTMREVVHML 969
             VD    GY    P+     L+++ + C + + + RP   ++V +L
Sbjct: 261 KAVD---EGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 68/212 (32%), Positives = 100/212 (47%), Gaps = 23/212 (10%)
Query: 697 ENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGND-----HGFLAEIQTLGRIRHRNI 751
           E IIG GG G VYR +   G +VA+K    R     D          E +    ++H NI
Sbjct: 12  EEIIGIGGFGKVYR-AFWIGDEVAVK--AARHDPDEDISQTIENVRQEAKLFAMLKHPNI 68
Query: 752 VRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDC 811
           + L G         L+ E+   G L  +L G +   +  +     A++ A+G+ YLH + 
Sbjct: 69  IALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR---IPPDILVNWAVQIARGMNYLHDEA 125
Query: 812 SPLIIHRDVKSNNILLDSDFE--------AHVADFGLAKFLQDAGASECMSSVAGSYGYI 863
              IIHRD+KS+NIL+    E          + DFGLA+            S AG+Y ++
Sbjct: 126 IVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWH----RTTKMSAAGAYAWM 181
Query: 864 APEYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
           APE        + SDV+S+GV+L EL+ G+ P
Sbjct: 182 APEVIRASMFSKGSDVWSYGVLLWELLTGEVP 213

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 80/287 (27%), Positives = 129/287 (44%), Gaps = 46/287 (16%)
Query: 697 ENIIGKGGAGIVYRGSMP----DGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIV 752
           + ++G G  G V  G +       I VAIK L    T      FL E   +G+  H NI+
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 753 RLLGYVSNRDTNLLLYEYMPNGSLGEML--HGAKGGHLKWETRYRIALEAAKGLCYLHHD 810
           RL G V+     +++ EYM NGSL   L  H A+   ++     R     A G+ YL   
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR---GIASGMKYL--- 163
Query: 811 CSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGS---YGYIAPEY 867
                +HRD+ + NIL++S+    V+DFGL++ L+D    E   +  G      + +PE 
Sbjct: 164 SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLED--DPEAAYTTRGGKIPIRWTSPEA 221
Query: 868 AYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVL 926
               K    SDV+S+G+VL E+++ G++P  E  +                       V+
Sbjct: 222 IAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN---------------------QDVI 260
Query: 927 AVVDPRLSGY----PLTGVIHLFKVAMMCVEDESSARPTMREVVHML 969
             VD    GY    P+     L+++ + C + + + RP   ++V +L
Sbjct: 261 KAVD---EGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 88.6 bits (218), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 80/287 (27%), Positives = 128/287 (44%), Gaps = 46/287 (16%)
Query: 697 ENIIGKGGAGIVYRGSMP----DGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIV 752
           + ++G G  G V  G +       I VAIK L    T      FL E   +G+  H NI+
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 753 RLLGYVSNRDTNLLLYEYMPNGSLGEML--HGAKGGHLKWETRYRIALEAAKGLCYLHHD 810
           RL G V+     +++ EYM NGSL   L  H A+   ++     R     A G+ YL   
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR---GIASGMKYL--- 163
Query: 811 CSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGS---YGYIAPEY 867
                +HRD+ + NIL++S+    V+DFGL + L+D    E   +  G      + +PE 
Sbjct: 164 SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLED--DPEAAYTTRGGKIPIRWTSPEA 221
Query: 868 AYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVL 926
               K    SDV+S+G+VL E+++ G++P  E  +                       V+
Sbjct: 222 IAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN---------------------QDVI 260
Query: 927 AVVDPRLSGY----PLTGVIHLFKVAMMCVEDESSARPTMREVVHML 969
             VD    GY    P+     L+++ + C + + + RP   ++V +L
Sbjct: 261 KAVD---EGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 77/294 (26%), Positives = 132/294 (44%), Gaps = 36/294 (12%)
Query: 691 LESLKDENIIGKGGAGIVYRGSMP----DGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRI 746
           +  +K E +IG G  G V  G +       I VAIK L    T      FL+E   +G+ 
Sbjct: 6   ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF 65
Query: 747 RHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCY 806
            H N++ L G V+     +++ E+M NGSL   L     G         +    A G+ Y
Sbjct: 66  DHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLR-QNDGQFTVIQLVGMLRGIAAGMKY 124
Query: 807 LHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGS---YGYI 863
           L        +HR + + NIL++S+    V+DFGL++FL+D  +    +S  G      + 
Sbjct: 125 L---ADMNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWT 181
Query: 864 APEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDA 922
           APE     K    SDV+S+G+V+ E+++ G++P  +  +  D++  + +    +  P D 
Sbjct: 182 APEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ-DVINAIEQDY-RLPPPMDC 239
Query: 923 ASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH----MLANP 972
            S                   L ++ + C + + + RP   ++V+    M+ NP
Sbjct: 240 PSA------------------LHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNP 275

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Composition-based stats.
 Identities = 64/210 (30%), Positives = 105/210 (50%), Gaps = 17/210 (8%)
Query: 694 LKDENI-----IGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRH 748
           LK E I     +G G  G+V  G      DVA+K ++  G+   D  F  E QT+ ++ H
Sbjct: 5   LKREEITLLKELGSGQFGVVKLGKWKGQYDVAVK-MIKEGSMSEDE-FFQEAQTMMKLSH 62
Query: 749 RNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLH 808
             +V+  G  S      ++ EY+ NG L   L  + G  L+      +  +  +G+ +L 
Sbjct: 63  PKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLR-SHGKGLEPSQLLEMCYDVCEGMAFLE 121
Query: 809 HDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSY--GYIAPE 866
              S   IHRD+ + N L+D D    V+DFG+ +++ D    + +SSV   +   + APE
Sbjct: 122 ---SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLD---DQYVSSVGTKFPVKWSAPE 175
Query: 867 YAYTLKVDEKSDVYSFGVVLLELIA-GKKP 895
             +  K   KSDV++FG+++ E+ + GK P
Sbjct: 176 VFHYFKYSSKSDVWAFGILMWEVFSLGKMP 205

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 87.4 bits (215), Expect = 4e-17,   Method: Composition-based stats.
 Identities = 72/273 (26%), Positives = 125/273 (45%), Gaps = 31/273 (11%)
Query: 692 ESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNI 751
           ES+K    +G G  G V+ G   +   VA+K L  +    +   FL E   +  ++H  +
Sbjct: 13  ESIKLVKRLGAGQFGEVWMGYYNNSTKVAVKTL--KPGTMSVQAFLEEANLMKTLQHDKL 70
Query: 752 VRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDC 811
           VRL   V+  +   ++ EYM  GSL + L   +GG +        + + A+G+ Y+    
Sbjct: 71  VRLYAVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN 130
Query: 812 SPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSY--GYIAPEYAY 869
               IHRD+++ N+L+       +ADFGLA+ ++D   +E  +     +   + APE   
Sbjct: 131 ---YIHRDLRAANVLVSESLMCKIADFGLARVIED---NEYTAREGAKFPIKWTAPEAIN 184
Query: 870 TLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAV 928
                 KSDV+SFG++L E++  GK P            +  +T ++V         +  
Sbjct: 185 FGCFTIKSDVWSFGILLYEIVTYGKIP------------YPGRTNADVMTALSQGYRM-- 230
Query: 929 VDPRLSGYPLTGVIHLFKVAMMCVEDESSARPT 961
             PR+   P      L+ +  MC ++++  RPT
Sbjct: 231 --PRVENCP----DELYDIMKMCWKEKAEERPT 257

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 104/205 (50%), Gaps = 8/205 (3%)
Query: 692 ESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNI 751
           E+LK    +G G  G V+ G       VA+K L  +G+   D  FLAE   + +++H+ +
Sbjct: 22  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPD-AFLAEANLMKQLQHQRL 79
Query: 752 VRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDC 811
           VRL   V+ ++   ++ EYM NGSL + L    G  L       +A + A+G+ ++    
Sbjct: 80  VRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 138
Query: 812 SPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTL 871
               IHRD+++ NIL+       +ADFGLA+ ++D   +           + APE     
Sbjct: 139 ---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXT-AREGAKFPIKWTAPEAINYG 194
Query: 872 KVDEKSDVYSFGVVLLELIA-GKKP 895
               KSDV+SFG++L E++  G+ P
Sbjct: 195 TFTIKSDVWSFGILLTEIVTHGRIP 219

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 107/207 (51%), Gaps = 12/207 (5%)
Query: 692 ESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNI 751
           E+LK    +G G  G V+ G       VA+K L  +G+   D  FLAE   + +++H+ +
Sbjct: 19  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPD-AFLAEANLMKQLQHQRL 76
Query: 752 VRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDC 811
           VRL   V+ ++   ++ EYM NGSL + L    G  L       +A + A+G+ ++    
Sbjct: 77  VRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 135
Query: 812 SPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSY--GYIAPEYAY 869
               IHRD+++ NIL+       +ADFGLA+ ++D   +E  +     +   + APE   
Sbjct: 136 ---YIHRDLRAANILVSDTLSCKIADFGLARLIED---NEXTAREGAKFPIKWTAPEAIN 189
Query: 870 TLKVDEKSDVYSFGVVLLELIA-GKKP 895
                 KSDV+SFG++L E++  G+ P
Sbjct: 190 YGTFTIKSDVWSFGILLTEIVTHGRIP 216

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 87.0 bits (214), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 107/207 (51%), Gaps = 12/207 (5%)
Query: 692 ESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNI 751
           E+LK    +G G  G V+ G       VA+K L  +G+   D  FLAE   + +++H+ +
Sbjct: 21  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPD-AFLAEANLMKQLQHQRL 78
Query: 752 VRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDC 811
           VRL   V+ ++   ++ EYM NGSL + L    G  L       +A + A+G+ ++    
Sbjct: 79  VRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 137
Query: 812 SPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSY--GYIAPEYAY 869
               IHRD+++ NIL+       +ADFGLA+ ++D   +E  +     +   + APE   
Sbjct: 138 ---YIHRDLRAANILVSDTLSCKIADFGLARLIED---NEXTAREGAKFPIKWTAPEAIN 191
Query: 870 TLKVDEKSDVYSFGVVLLELIA-GKKP 895
                 KSDV+SFG++L E++  G+ P
Sbjct: 192 YGTFTIKSDVWSFGILLTEIVTHGRIP 218

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 87.0 bits (214), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 107/207 (51%), Gaps = 12/207 (5%)
Query: 692 ESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNI 751
           E+LK    +G G  G V+ G       VA+K L  +G+   D  FLAE   + +++H+ +
Sbjct: 15  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPD-AFLAEANLMKQLQHQRL 72
Query: 752 VRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDC 811
           VRL   V+ ++   ++ EYM NGSL + L    G  L       +A + A+G+ ++    
Sbjct: 73  VRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 131
Query: 812 SPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSY--GYIAPEYAY 869
               IHRD+++ NIL+       +ADFGLA+ ++D   +E  +     +   + APE   
Sbjct: 132 ---YIHRDLRAANILVSDTLSCKIADFGLARLIED---NEXTAREGAKFPIKWTAPEAIN 185
Query: 870 TLKVDEKSDVYSFGVVLLELIA-GKKP 895
                 KSDV+SFG++L E++  G+ P
Sbjct: 186 YGTFTIKSDVWSFGILLTEIVTHGRIP 212

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 86.7 bits (213), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 107/207 (51%), Gaps = 12/207 (5%)
Query: 692 ESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNI 751
           E+LK    +G G  G V+ G       VA+K L  +G+   D  FLAE   + +++H+ +
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPD-AFLAEANLMKQLQHQRL 70
Query: 752 VRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDC 811
           VRL   V+ ++   ++ EYM NGSL + L    G  L       +A + A+G+ ++    
Sbjct: 71  VRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 129
Query: 812 SPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSY--GYIAPEYAY 869
               IHRD+++ NIL+       +ADFGLA+ ++D   +E  +     +   + APE   
Sbjct: 130 ---YIHRDLRAANILVSDTLSCKIADFGLARLIED---NEXTAREGAKFPIKWTAPEAIN 183
Query: 870 TLKVDEKSDVYSFGVVLLELIA-GKKP 895
                 KSDV+SFG++L E++  G+ P
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVTHGRIP 210

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 86.7 bits (213), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 107/207 (51%), Gaps = 12/207 (5%)
Query: 692 ESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNI 751
           E+LK    +G G  G V+ G       VA+K L  +G+   D  FLAE   + +++H+ +
Sbjct: 18  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPD-AFLAEANLMKQLQHQRL 75
Query: 752 VRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDC 811
           VRL   V+ ++   ++ EYM NGSL + L    G  L       +A + A+G+ ++    
Sbjct: 76  VRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 134
Query: 812 SPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSY--GYIAPEYAY 869
               IHRD+++ NIL+       +ADFGLA+ ++D   +E  +     +   + APE   
Sbjct: 135 ---YIHRDLRAANILVSDTLSCKIADFGLARLIED---NEYTAREGAKFPIKWTAPEAIN 188
Query: 870 TLKVDEKSDVYSFGVVLLELIA-GKKP 895
                 KSDV+SFG++L E++  G+ P
Sbjct: 189 YGTFTIKSDVWSFGILLTEIVTHGRIP 215

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 86.7 bits (213), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 107/207 (51%), Gaps = 12/207 (5%)
Query: 692 ESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNI 751
           E+LK    +G G  G V+ G       VA+K L  +G+   D  FLAE   + +++H+ +
Sbjct: 19  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPD-AFLAEANLMKQLQHQRL 76
Query: 752 VRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDC 811
           VRL   V+ ++   ++ EYM NGSL + L    G  L       +A + A+G+ ++    
Sbjct: 77  VRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 135
Query: 812 SPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSY--GYIAPEYAY 869
               IHRD+++ NIL+       +ADFGLA+ ++D   +E  +     +   + APE   
Sbjct: 136 ---YIHRDLRAANILVSDTLSCKIADFGLARLIED---NEYTAREGAKFPIKWTAPEAIN 189
Query: 870 TLKVDEKSDVYSFGVVLLELIA-GKKP 895
                 KSDV+SFG++L E++  G+ P
Sbjct: 190 YGTFTIKSDVWSFGILLTEIVTHGRIP 216

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 86.7 bits (213), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 79/287 (27%), Positives = 129/287 (44%), Gaps = 46/287 (16%)
Query: 697 ENIIGKGGAGIVYRGSMP----DGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIV 752
           + ++G G  G V  G +       I VAIK L    T      FL E   +G+  H NI+
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 753 RLLGYVSNRDTNLLLYEYMPNGSLGEML--HGAKGGHLKWETRYRIALEAAKGLCYLHHD 810
           RL G V+     +++ E M NGSL   L  H A+   ++     R     A G+ YL   
Sbjct: 110 RLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLR---GIASGMKYLSDM 166
Query: 811 CSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGS---YGYIAPEY 867
            +   +HRD+ + NIL++S+    V+DFGL++ L+D    E   +  G      + +PE 
Sbjct: 167 GA---VHRDLAARNILINSNLVCKVSDFGLSRVLED--DPEAAYTTRGGKIPIRWTSPEA 221
Query: 868 AYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVL 926
               K    SDV+S+G+VL E+++ G++P  E  +                       V+
Sbjct: 222 IAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN---------------------QDVI 260
Query: 927 AVVDPRLSGY----PLTGVIHLFKVAMMCVEDESSARPTMREVVHML 969
             VD    GY    P+     L+++ + C + + + RP   ++V +L
Sbjct: 261 KAVD---EGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 86.7 bits (213), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 107/207 (51%), Gaps = 12/207 (5%)
Query: 692 ESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNI 751
           E+LK    +G G  G V+ G       VA+K L  +G+   D  FLAE   + +++H+ +
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPD-AFLAEANLMKQLQHQRL 70
Query: 752 VRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDC 811
           VRL   V+ ++   ++ EYM NGSL + L    G  L       +A + A+G+ ++    
Sbjct: 71  VRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 129
Query: 812 SPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSY--GYIAPEYAY 869
               IHRD+++ NIL+       +ADFGLA+ ++D   +E  +     +   + APE   
Sbjct: 130 ---YIHRDLRAANILVSDTLSCKIADFGLARLIED---NEXTAREGAKFPIKWTAPEAIN 183
Query: 870 TLKVDEKSDVYSFGVVLLELIA-GKKP 895
                 KSDV+SFG++L E++  G+ P
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVTHGRIP 210

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 86.7 bits (213), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 107/207 (51%), Gaps = 12/207 (5%)
Query: 692 ESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNI 751
           E+LK    +G G  G V+ G       VA+K L  +G+   D  FLAE   + +++H+ +
Sbjct: 14  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPD-AFLAEANLMKQLQHQRL 71
Query: 752 VRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDC 811
           VRL   V+ ++   ++ EYM NGSL + L    G  L       +A + A+G+ ++    
Sbjct: 72  VRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 130
Query: 812 SPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSY--GYIAPEYAY 869
               IHRD+++ NIL+       +ADFGLA+ ++D   +E  +     +   + APE   
Sbjct: 131 ---YIHRDLRAANILVSDTLSCKIADFGLARLIED---NEXTAREGAKFPIKWTAPEAIN 184
Query: 870 TLKVDEKSDVYSFGVVLLELIA-GKKP 895
                 KSDV+SFG++L E++  G+ P
Sbjct: 185 YGTFTIKSDVWSFGILLTEIVTHGRIP 211

>pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313

Iteration: 1
 Score = 86.7 bits (213), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 81/291 (27%), Positives = 123/291 (42%), Gaps = 57/291 (19%)
Query: 328 PIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDLCKGGKL 387
           PIPS L + P L  L + G                        N+L G IP  + K  +L
Sbjct: 67  PIPSSLANLPYLNFLYIGG-----------------------INNLVGPIPPAIAKLTQL 103
Query: 388 KSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGTIPAGLFXXXXXXXXXXXXXXXSG 447
             L +      G IP+ L Q K+L  + FS N L+GT+P  +                SG
Sbjct: 104 HYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISG 163
Query: 448 ELPEKMSGAS--LNQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESFNLKM 505
            +P+     S     + ++ N +TGKIP    NL +L  + L  N LEG+  V       
Sbjct: 164 AIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDASVL------ 216
Query: 506 ITXXXXXXXXXXGEIPYSISQCHSLTSVDLSRNSL---YGKIPPGISKLIDLSILNLSRN 562
                                  +   + L++NSL    GK+  G+SK  +L+ L+L  N
Sbjct: 217 ------------------FGSDKNTQKIHLAKNSLAFDLGKV--GLSK--NLNGLDLRNN 254
Query: 563 GITGSIPNEMRNMMSLTTLDLSYNNLIGNIPSGGQFLAFNETSFIGNPNLC 613
            I G++P  +  +  L +L++S+NNL G IP GG    F+ +++  N  LC
Sbjct: 255 RIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLC 305

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 86.7 bits (213), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 107/207 (51%), Gaps = 12/207 (5%)
Query: 692 ESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNI 751
           E+LK    +G G  G V+ G       VA+K L  +G+   D  FLAE   + +++H+ +
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPD-AFLAEANLMKQLQHQRL 70
Query: 752 VRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDC 811
           VRL   V+ ++   ++ EYM NGSL + L    G  L       +A + A+G+ ++    
Sbjct: 71  VRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 129
Query: 812 SPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSY--GYIAPEYAY 869
               IHRD+++ NIL+       +ADFGLA+ ++D   +E  +     +   + APE   
Sbjct: 130 ---YIHRDLRAANILVSDTLSCKIADFGLARLIED---NEYTAREGAKFPIKWTAPEAIN 183
Query: 870 TLKVDEKSDVYSFGVVLLELIA-GKKP 895
                 KSDV+SFG++L E++  G+ P
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVTHGRIP 210

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 86.7 bits (213), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 107/207 (51%), Gaps = 12/207 (5%)
Query: 692 ESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNI 751
           E+LK    +G G  G V+ G       VA+K L  +G+   D  FLAE   + +++H+ +
Sbjct: 23  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPD-AFLAEANLMKQLQHQRL 80
Query: 752 VRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDC 811
           VRL   V+ ++   ++ EYM NGSL + L    G  L       +A + A+G+ ++    
Sbjct: 81  VRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 139
Query: 812 SPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSY--GYIAPEYAY 869
               IHRD+++ NIL+       +ADFGLA+ ++D   +E  +     +   + APE   
Sbjct: 140 ---YIHRDLRAANILVSDTLSCKIADFGLARLIED---NEYTAREGAKFPIKWTAPEAIN 193
Query: 870 TLKVDEKSDVYSFGVVLLELIA-GKKP 895
                 KSDV+SFG++L E++  G+ P
Sbjct: 194 YGTFTIKSDVWSFGILLTEIVTHGRIP 220

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 86.7 bits (213), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 91/311 (29%), Positives = 139/311 (44%), Gaps = 31/311 (9%)
Query: 593 PSGGQFLAFNETSFIGNPNLCLLRNGTCQSLINSAKHSGDGYGSSFGASKIVI-TVIALL 651
           P  G FL    T++ G+  LC+    +C+  +       + Y   + ASK+ I   +   
Sbjct: 99  PETGLFLVRESTNYPGDYTLCV----SCEGKV-------EHYRIMYHASKLSIDEEVYFE 147
Query: 652 TFMLLV--ILTIYQLRKRRLQKSKAWKLTAFQRLDFKAEDV---LESLKDENIIGKGGAG 706
             M LV    T       RL K K  + T   + +F        ++ LK    IGKG  G
Sbjct: 148 NLMQLVEHYTTDADGLCTRLIKPKVMEGTVAAQDEFYRSGWALNMKELKLLQTIGKGEFG 207
Query: 707 IVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNL- 765
            V  G    G  VA+K +    T      FLAE   + ++RH N+V+LLG +      L 
Sbjct: 208 DVMLGDY-RGNKVAVKCIKNDATA---QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY 263
Query: 766 LLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNI 825
           ++ EYM  GSL + L       L  +   + +L+  + + YL  +     +HRD+ + N+
Sbjct: 264 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNV 320
Query: 826 LLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVV 885
           L+  D  A V+DFGL K      AS    +      + APE     K   KSDV+SFG++
Sbjct: 321 LVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGIL 375
Query: 886 LLELIA-GKKP 895
           L E+ + G+ P
Sbjct: 376 LWEIYSFGRVP 386

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 86.3 bits (212), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 106/220 (48%), Gaps = 22/220 (10%)
Query: 685 FKAEDVLESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLG 744
           F+  D++       ++GKG  G   + +  +  +V + + + R        FL E++ + 
Sbjct: 7   FRPSDLIHG----EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMR 62
Query: 745 RIRHRNIVRLLGYVSNRDTNL-LLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKG 803
            + H N+++ +G V  +D  L  + EY+  G+L  ++      +  W  R   A + A G
Sbjct: 63  CLEHPNVLKFIG-VLYKDKRLNFITEYIKGGTLRGIIKSMDSQY-PWSQRVSFAKDIASG 120
Query: 804 LCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS------------E 851
           + YLH   S  IIHRD+ S+N L+  +    VADFGLA+ + D                +
Sbjct: 121 MAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRK 177
Query: 852 CMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA 891
              +V G+  ++APE       DEK DV+SFG+VL E+I 
Sbjct: 178 KRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIG 217

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 86.3 bits (212), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 79/287 (27%), Positives = 128/287 (44%), Gaps = 46/287 (16%)
Query: 697 ENIIGKGGAGIVYRGSMP----DGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIV 752
           + ++G G  G V  G +       I VAIK L    T      FL E   +G+  H NI+
Sbjct: 21  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 80
Query: 753 RLLGYVSNRDTNLLLYEYMPNGSLGEML--HGAKGGHLKWETRYRIALEAAKGLCYLHHD 810
           RL G V+     +++ E M NGSL   L  H A+   ++     R     A G+ YL   
Sbjct: 81  RLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLR---GIASGMKYLS-- 135
Query: 811 CSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGS---YGYIAPEY 867
                +HRD+ + NIL++S+    V+DFGL++ L+D    E   +  G      + +PE 
Sbjct: 136 -DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLED--DPEAAYTTRGGKIPIRWTSPEA 192
Query: 868 AYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVL 926
               K    SDV+S+G+VL E+++ G++P  E  +                       V+
Sbjct: 193 IAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN---------------------QDVI 231
Query: 927 AVVDPRLSGY----PLTGVIHLFKVAMMCVEDESSARPTMREVVHML 969
             VD    GY    P+     L+++ + C + + + RP   ++V +L
Sbjct: 232 KAVD---EGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 275

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 86.3 bits (212), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 107/207 (51%), Gaps = 12/207 (5%)
Query: 692 ESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNI 751
           E+LK    +G G  G V+ G       VA+K L  +G+   D  FLAE   + +++H+ +
Sbjct: 8   ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPD-AFLAEANLMKQLQHQRL 65
Query: 752 VRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDC 811
           VRL   V+ ++   ++ EYM NGSL + L    G  L       +A + A+G+ ++    
Sbjct: 66  VRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 124
Query: 812 SPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSY--GYIAPEYAY 869
               IHRD+++ NIL+       +ADFGLA+ ++D   +E  +     +   + APE   
Sbjct: 125 ---YIHRDLRAANILVSDTLSCKIADFGLARLIED---NEYTAREGAKFPIKWTAPEAIN 178
Query: 870 TLKVDEKSDVYSFGVVLLELIA-GKKP 895
                 KSDV+SFG++L E++  G+ P
Sbjct: 179 YGTFTIKSDVWSFGILLTEIVTHGRIP 205

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 86.3 bits (212), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 75/275 (27%), Positives = 123/275 (44%), Gaps = 48/275 (17%)
Query: 700 IGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVS 759
           +G G  G+V  G      DVAIK ++  G+   D  F+ E + +  + H  +V+L G  +
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIK-MIKEGSMSEDE-FIEEAKVMMNLSHEKLVQLYGVCT 74
Query: 760 NRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIA----LEAAKGLC----YLHHDC 811
            +    ++ EYM NG L   L          E R+R      LE  K +C    YL    
Sbjct: 75  KQRPIFIITEYMANGCLLNYLR---------EMRHRFQTQQLLEMCKDVCEAMEYLE--- 122
Query: 812 SPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSY--GYIAPEYAY 869
           S   +HRD+ + N L++      V+DFGL++++ D    E  SSV   +   +  PE   
Sbjct: 123 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD---DEYTSSVGSKFPVRWSPPEVLM 179
Query: 870 TLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAV 928
             K   KSD+++FGV++ E+ + GK P   F            T SE ++    A  L +
Sbjct: 180 YSKFSSKSDIWAFGVLMWEIYSLGKMPYERF------------TNSETAE--HIAQGLRL 225
Query: 929 VDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMR 963
             P L+   +  +++       C  +++  RPT +
Sbjct: 226 YRPHLASEKVYTIMY------SCWHEKADERPTFK 254

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 86.3 bits (212), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 67/212 (31%), Positives = 110/212 (51%), Gaps = 13/212 (6%)
Query: 696 DENIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRL 754
           D  ++GKG  GIVY G  + + + +AIK +  R +  +      EI     ++H+NIV+ 
Sbjct: 26  DRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYS-QPLHEEIALHKHLKHKNIVQY 84
Query: 755 LGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLK--WETRYRIALEAAKGLCYLHHDCS 812
           LG  S      +  E +P GSL  +L  +K G LK   +T      +  +GL YLH +  
Sbjct: 85  LGSFSENGFIKIFMEQVPGGSLSALLR-SKWGPLKDNEQTIGFYTKQILEGLKYLHDN-- 141
Query: 813 PLIIHRDVKSNNILLDSDFEA-HVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYT- 870
             I+HRD+K +N+L+++      ++DFG +K L  AG + C  +  G+  Y+APE     
Sbjct: 142 -QIVHRDIKGDNVLINTYSGVLKISDFGTSKRL--AGINPCTETFTGTLQYMAPEIIDKG 198
Query: 871 -LKVDEKSDVYSFGVVLLELIAGKKPVGEFGD 901
                + +D++S G  ++E+  GK P  E G+
Sbjct: 199 PRGYGKAADIWSLGCTIIEMATGKPPFYELGE 230

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 85.9 bits (211), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 95/213 (44%), Gaps = 12/213 (5%)
Query: 686 KAEDVLESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRG---TGGNDHGFLAEIQT 742
           K +  LE  +    +GKG  G VY         +   +++ +      G +H    E++ 
Sbjct: 7   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 66
Query: 743 LGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAK 802
              +RH NI+RL GY  +     L+ EY P G + + L        +    Y    E A 
Sbjct: 67  QSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATY--ITELAN 124
Query: 803 GLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGY 862
            L Y H   S  +IHRD+K  N+LL S  E  +ADFG +        S   +++ G+  Y
Sbjct: 125 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVH----APSSRRTTLCGTLDY 177
Query: 863 IAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
           + PE       DEK D++S GV+  E + GK P
Sbjct: 178 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 85.9 bits (211), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 75/275 (27%), Positives = 123/275 (44%), Gaps = 48/275 (17%)
Query: 700 IGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVS 759
           +G G  G+V  G      DVAIK ++  G+   D  F+ E + +  + H  +V+L G  +
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIK-MIKEGSMSEDE-FIEEAKVMMNLSHEKLVQLYGVCT 89
Query: 760 NRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIA----LEAAKGLC----YLHHDC 811
            +    ++ EYM NG L   L          E R+R      LE  K +C    YL    
Sbjct: 90  KQRPIFIITEYMANGCLLNYLR---------EMRHRFQTQQLLEMCKDVCEAMEYLE--- 137
Query: 812 SPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSY--GYIAPEYAY 869
           S   +HRD+ + N L++      V+DFGL++++ D    E  SSV   +   +  PE   
Sbjct: 138 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD---DEYTSSVGSKFPVRWSPPEVLM 194
Query: 870 TLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAV 928
             K   KSD+++FGV++ E+ + GK P   F            T SE ++    A  L +
Sbjct: 195 YSKFSSKSDIWAFGVLMWEIYSLGKMPYERF------------TNSETAE--HIAQGLRL 240
Query: 929 VDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMR 963
             P L+   +  +++       C  +++  RPT +
Sbjct: 241 YRPHLASEKVYTIMY------SCWHEKADERPTFK 269

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 85.9 bits (211), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 79/287 (27%), Positives = 128/287 (44%), Gaps = 46/287 (16%)
Query: 697 ENIIGKGGAGIVYRGSMP----DGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIV 752
           + ++G G  G V  G +       I VAIK L    T      FL E   +G+  H NI+
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 753 RLLGYVSNRDTNLLLYEYMPNGSLGEML--HGAKGGHLKWETRYRIALEAAKGLCYLHHD 810
           RL G V+     +++ E M NGSL   L  H A+   ++     R     A G+ YL   
Sbjct: 110 RLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLR---GIASGMKYL--- 163
Query: 811 CSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGS---YGYIAPEY 867
                +HRD+ + NIL++S+    V+DFGL++ L+D    E   +  G      + +PE 
Sbjct: 164 SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLED--DPEAAYTTRGGKIPIRWTSPEA 221
Query: 868 AYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVL 926
               K    SDV+S+G+VL E+++ G++P  E  +                       V+
Sbjct: 222 IAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN---------------------QDVI 260
Query: 927 AVVDPRLSGY----PLTGVIHLFKVAMMCVEDESSARPTMREVVHML 969
             VD    GY    P+     L+++ + C + + + RP   ++V +L
Sbjct: 261 KAVD---EGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 75/275 (27%), Positives = 123/275 (44%), Gaps = 48/275 (17%)
Query: 700 IGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVS 759
           +G G  G+V  G      DVAIK ++  G+   D  F+ E + +  + H  +V+L G  +
Sbjct: 23  LGTGQFGVVKYGKWRGQYDVAIK-MIKEGSMSEDE-FIEEAKVMMNLSHEKLVQLYGVCT 80
Query: 760 NRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIA----LEAAKGLC----YLHHDC 811
            +    ++ EYM NG L   L          E R+R      LE  K +C    YL    
Sbjct: 81  KQRPIFIITEYMANGCLLNYLR---------EMRHRFQTQQLLEMCKDVCEAMEYLE--- 128
Query: 812 SPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSY--GYIAPEYAY 869
           S   +HRD+ + N L++      V+DFGL++++ D    E  SSV   +   +  PE   
Sbjct: 129 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD---DEYTSSVGSKFPVRWSPPEVLM 185
Query: 870 TLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAV 928
             K   KSD+++FGV++ E+ + GK P   F            T SE ++    A  L +
Sbjct: 186 YSKFSSKSDIWAFGVLMWEIYSLGKMPYERF------------TNSETAE--HIAQGLRL 231
Query: 929 VDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMR 963
             P L+   +  +++       C  +++  RPT +
Sbjct: 232 YRPHLASEKVYTIMY------SCWHEKADERPTFK 260

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/212 (31%), Positives = 110/212 (51%), Gaps = 13/212 (6%)
Query: 696 DENIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRL 754
           D  ++GKG  GIVY G  + + + +AIK +  R +  +      EI     ++H+NIV+ 
Sbjct: 12  DRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYS-QPLHEEIALHKHLKHKNIVQY 70
Query: 755 LGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLK--WETRYRIALEAAKGLCYLHHDCS 812
           LG  S      +  E +P GSL  +L  +K G LK   +T      +  +GL YLH +  
Sbjct: 71  LGSFSENGFIKIFMEQVPGGSLSALLR-SKWGPLKDNEQTIGFYTKQILEGLKYLHDN-- 127
Query: 813 PLIIHRDVKSNNILLDSDFEA-HVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYT- 870
             I+HRD+K +N+L+++      ++DFG +K L  AG + C  +  G+  Y+APE     
Sbjct: 128 -QIVHRDIKGDNVLINTYSGVLKISDFGTSKRL--AGINPCTETFTGTLQYMAPEIIDKG 184
Query: 871 -LKVDEKSDVYSFGVVLLELIAGKKPVGEFGD 901
                + +D++S G  ++E+  GK P  E G+
Sbjct: 185 PRGYGKAADIWSLGCTIIEMATGKPPFYELGE 216

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 75/275 (27%), Positives = 123/275 (44%), Gaps = 48/275 (17%)
Query: 700 IGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVS 759
           +G G  G+V  G      DVAIK ++  G+   D  F+ E + +  + H  +V+L G  +
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIK-MIKEGSMSEDE-FIEEAKVMMNLSHEKLVQLYGVCT 89
Query: 760 NRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIA----LEAAKGLC----YLHHDC 811
            +    ++ EYM NG L   L          E R+R      LE  K +C    YL    
Sbjct: 90  KQRPIFIITEYMANGCLLNYLR---------EMRHRFQTQQLLEMCKDVCEAMEYLE--- 137
Query: 812 SPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSY--GYIAPEYAY 869
           S   +HRD+ + N L++      V+DFGL++++ D    E  SSV   +   +  PE   
Sbjct: 138 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD---DEETSSVGSKFPVRWSPPEVLM 194
Query: 870 TLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAV 928
             K   KSD+++FGV++ E+ + GK P   F            T SE ++    A  L +
Sbjct: 195 YSKFSSKSDIWAFGVLMWEIYSLGKMPYERF------------TNSETAE--HIAQGLRL 240
Query: 929 VDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMR 963
             P L+   +  +++       C  +++  RPT +
Sbjct: 241 YRPHLASEKVYTIMY------SCWHEKADERPTFK 269

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 95/213 (44%), Gaps = 12/213 (5%)
Query: 686 KAEDVLESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGT---GGNDHGFLAEIQT 742
           K +  LE  +    +GKG  G VY         +   +++ +      G +H    E++ 
Sbjct: 28  KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 87
Query: 743 LGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAK 802
              +RH NI+RL GY  +     L+ EY P G++   L        +    Y    E A 
Sbjct: 88  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY--ITELAN 145
Query: 803 GLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGY 862
            L Y H   S  +IHRD+K  N+LL S  E  +ADFG +        S   +++ G+  Y
Sbjct: 146 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVH----APSSRRTTLCGTLDY 198
Query: 863 IAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
           + PE       DEK D++S GV+  E + GK P
Sbjct: 199 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 231

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 77/276 (27%), Positives = 121/276 (43%), Gaps = 30/276 (10%)
Query: 698 NIIGKGGAGIVYRGSMPDG----IDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVR 753
            +IG+G  G VY G++ D     I  A+K L      G    FL E   +    H N++ 
Sbjct: 35  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 94
Query: 754 LLGY-VSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCS 812
           LLG  + +  + L++  YM +G L   +   +  +   +      L+ AKG+ YL    S
Sbjct: 95  LLGICLRSEGSPLVVLPYMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKYL---AS 150
Query: 813 PLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGS--YGYIAPEYAYT 870
              +HRD+ + N +LD  F   VADFGLA+ + D       +         ++A E   T
Sbjct: 151 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALESLQT 210
Query: 871 LKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVD 930
            K   KSDV+SFGV+L EL+    P     +  DI  ++ +    + QP          D
Sbjct: 211 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ-GRRLLQPEYCP------D 263
Query: 931 PRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVV 966
           P            L++V + C   ++  RP+  E+V
Sbjct: 264 P------------LYEVMLKCWHPKAEMRPSFSELV 287

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 95/213 (44%), Gaps = 12/213 (5%)
Query: 686 KAEDVLESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGT---GGNDHGFLAEIQT 742
           K +  LE  +    +GKG  G VY         +   +++ +      G +H    E++ 
Sbjct: 1   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 60
Query: 743 LGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAK 802
              +RH NI+RL GY  +     L+ EY P G++   L        +    Y    E A 
Sbjct: 61  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY--ITELAN 118
Query: 803 GLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGY 862
            L Y H   S  +IHRD+K  N+LL S  E  +ADFG +        S   +++ G+  Y
Sbjct: 119 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVH----APSSRRTTLCGTLDY 171
Query: 863 IAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
           + PE       DEK D++S GV+  E + GK P
Sbjct: 172 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 204

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/278 (25%), Positives = 128/278 (46%), Gaps = 39/278 (14%)
Query: 692 ESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNI 751
           ES+K    +G G  G V+ G   +   VA+K L  +    +   FL E   +  ++H  +
Sbjct: 12  ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTL--KPGTMSVQAFLEEANLMKTLQHDKL 69
Query: 752 VRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDC 811
           VRL   V+  +   ++ E+M  GSL + L   +GG +        + + A+G+ Y+    
Sbjct: 70  VRLYAVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN 129
Query: 812 SPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSY--GYIAPEY-- 867
               IHRD+++ N+L+       +ADFGLA+ ++D   +E  +     +   + APE   
Sbjct: 130 ---YIHRDLRAANVLVSESLMCKIADFGLARVIED---NEYTAREGAKFPIKWTAPEAIN 183
Query: 868 --AYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAAS 924
              +T+    KS+V+SFG++L E++  GK P            +  +T ++V        
Sbjct: 184 FGCFTI----KSNVWSFGILLYEIVTYGKIP------------YPGRTNADVMSALSQGY 227
Query: 925 VLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTM 962
            +    PR+   P      L+ +  MC ++++  RPT 
Sbjct: 228 RM----PRMENCP----DELYDIMKMCWKEKAEERPTF 257

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 95/213 (44%), Gaps = 12/213 (5%)
Query: 686 KAEDVLESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRG---TGGNDHGFLAEIQT 742
           K +  LE  +    +GKG  G VY         +   +++ +      G +H    E++ 
Sbjct: 5   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 64
Query: 743 LGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAK 802
              +RH NI+RL GY  +     L+ EY P G++   L        +    Y    E A 
Sbjct: 65  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY--ITELAN 122
Query: 803 GLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGY 862
            L Y H   S  +IHRD+K  N+LL S  E  +ADFG +        S   +++ G+  Y
Sbjct: 123 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVH----APSSRRTTLCGTLDY 175
Query: 863 IAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
           + PE       DEK D++S GV+  E + GK P
Sbjct: 176 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 107/207 (51%), Gaps = 12/207 (5%)
Query: 692 ESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNI 751
           E+LK    +G G  G V+ G       VA+K L  +G+   D  FLAE   + +++H+ +
Sbjct: 9   ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPD-AFLAEANLMKQLQHQRL 66
Query: 752 VRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDC 811
           VRL   V+ ++   ++ EYM NGSL + L    G  L       +A + A+G+ ++    
Sbjct: 67  VRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 125
Query: 812 SPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSY--GYIAPEYAY 869
               IHR++++ NIL+       +ADFGLA+ ++D   +E  +     +   + APE   
Sbjct: 126 ---YIHRNLRAANILVSDTLSCKIADFGLARLIED---NEYTAREGAKFPIKWTAPEAIN 179
Query: 870 TLKVDEKSDVYSFGVVLLELIA-GKKP 895
                 KSDV+SFG++L E++  G+ P
Sbjct: 180 YGTFTIKSDVWSFGILLTEIVTHGRIP 206

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 96/213 (45%), Gaps = 12/213 (5%)
Query: 686 KAEDVLESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRG---TGGNDHGFLAEIQT 742
           K +  LE  +    +GKG  G VY         +   +++ +      G +H    E++ 
Sbjct: 3   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 62
Query: 743 LGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAK 802
              +RH NI+RL GY  +     L+ EY P G++   L        +    Y    E A 
Sbjct: 63  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY--ITELAN 120
Query: 803 GLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGY 862
            L Y H   S  +IHRD+K  N+LL S  E  +ADFG +        S   ++++G+  Y
Sbjct: 121 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSCH----APSSRRTTLSGTLDY 173
Query: 863 IAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
           + PE       DEK D++S GV+  E + GK P
Sbjct: 174 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 206

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 96/213 (45%), Gaps = 12/213 (5%)
Query: 686 KAEDVLESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGT---GGNDHGFLAEIQT 742
           K +  LE  +    +GKG  G VY     +   +   +++ +      G +H    E++ 
Sbjct: 2   KRQWALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEI 61
Query: 743 LGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAK 802
              +RH NI+RL GY  +     L+ EY P G++   L        +    Y    E A 
Sbjct: 62  QSHLRHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATY--ITELAN 119
Query: 803 GLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGY 862
            L Y H   S  +IHRD+K  N+LL S  E  +ADFG +        S   +++ G+  Y
Sbjct: 120 ALSYCH---SKKVIHRDIKPENLLLGSAGELKIADFGWSVH----APSSRRAALCGTLDY 172
Query: 863 IAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
           + PE       DEK D++S GV+  E + GK P
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 95/213 (44%), Gaps = 12/213 (5%)
Query: 686 KAEDVLESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGT---GGNDHGFLAEIQT 742
           K +  LE  +    +GKG  G VY         +   +++ +      G +H    E++ 
Sbjct: 5   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 64
Query: 743 LGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAK 802
              +RH NI+RL GY  +     L+ EY P G++   L        +    Y    E A 
Sbjct: 65  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY--ITELAN 122
Query: 803 GLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGY 862
            L Y H   S  +IHRD+K  N+LL S  E  +ADFG +        S   +++ G+  Y
Sbjct: 123 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVH----APSSRRTTLCGTLDY 175
Query: 863 IAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
           + PE       DEK D++S GV+  E + GK P
Sbjct: 176 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 95/213 (44%), Gaps = 12/213 (5%)
Query: 686 KAEDVLESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGT---GGNDHGFLAEIQT 742
           K +  LE  +    +GKG  G VY         +   +++ +      G +H    E++ 
Sbjct: 7   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 66
Query: 743 LGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAK 802
              +RH NI+RL GY  +     L+ EY P G++   L        +    Y    E A 
Sbjct: 67  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY--ITELAN 124
Query: 803 GLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGY 862
            L Y H   S  +IHRD+K  N+LL S  E  +ADFG +        S   +++ G+  Y
Sbjct: 125 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVH----APSSRRTTLCGTLDY 177
Query: 863 IAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
           + PE       DEK D++S GV+  E + GK P
Sbjct: 178 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 77/276 (27%), Positives = 121/276 (43%), Gaps = 30/276 (10%)
Query: 698 NIIGKGGAGIVYRGSMPDG----IDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVR 753
            +IG+G  G VY G++ D     I  A+K L      G    FL E   +    H N++ 
Sbjct: 55  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 114
Query: 754 LLGY-VSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCS 812
           LLG  + +  + L++  YM +G L   +   +  +   +      L+ AKG+ YL    S
Sbjct: 115 LLGICLRSEGSPLVVLPYMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKYL---AS 170
Query: 813 PLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGS--YGYIAPEYAYT 870
              +HRD+ + N +LD  F   VADFGLA+ + D       +         ++A E   T
Sbjct: 171 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 230
Query: 871 LKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVD 930
            K   KSDV+SFGV+L EL+    P     +  DI  ++ +    + QP          D
Sbjct: 231 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ-GRRLLQPEYCP------D 283
Query: 931 PRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVV 966
           P            L++V + C   ++  RP+  E+V
Sbjct: 284 P------------LYEVMLKCWHPKAEMRPSFSELV 307

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 95/213 (44%), Gaps = 12/213 (5%)
Query: 686 KAEDVLESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGT---GGNDHGFLAEIQT 742
           K +  LE  +    +GKG  G VY         +   +++ +      G +H    E++ 
Sbjct: 6   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 65
Query: 743 LGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAK 802
              +RH NI+RL GY  +     L+ EY P G++   L        +    Y    E A 
Sbjct: 66  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY--ITELAN 123
Query: 803 GLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGY 862
            L Y H   S  +IHRD+K  N+LL S  E  +ADFG +        S   +++ G+  Y
Sbjct: 124 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVH----APSSRRTTLCGTLDY 176
Query: 863 IAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
           + PE       DEK D++S GV+  E + GK P
Sbjct: 177 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 209

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-16,   Method: Composition-based stats.
 Identities = 63/207 (30%), Positives = 98/207 (47%), Gaps = 9/207 (4%)
Query: 692 ESLKDENIIGKGGAGIVYRGS-MPDGIDVAIKRLV--GRGTGGNDHGFLAEIQTLGRIRH 748
           E  K  + +G GG   VY        I VAIK +    R        F  E+    ++ H
Sbjct: 11  ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSH 70
Query: 749 RNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLH 808
           +NIV ++      D   L+ EY+   +L E +     G L  +T      +   G+ + H
Sbjct: 71  QNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESH--GPLSVDTAINFTNQILDGIKHAH 128
Query: 809 HDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYA 868
                 I+HRD+K  NIL+DS+    + DFG+AK L +   ++  + V G+  Y +PE A
Sbjct: 129 ---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQ-TNHVLGTVQYFSPEQA 184
Query: 869 YTLKVDEKSDVYSFGVVLLELIAGKKP 895
                DE +D+YS G+VL E++ G+ P
Sbjct: 185 KGEATDECTDIYSIGIVLYEMLVGEPP 211

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 95/213 (44%), Gaps = 12/213 (5%)
Query: 686 KAEDVLESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGT---GGNDHGFLAEIQT 742
           K +  LE  +    +GKG  G VY         +   +++ +      G +H    E++ 
Sbjct: 19  KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 78
Query: 743 LGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAK 802
              +RH NI+RL GY  +     L+ EY P G++   L        +    Y    E A 
Sbjct: 79  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY--ITELAN 136
Query: 803 GLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGY 862
            L Y H   S  +IHRD+K  N+LL S  E  +ADFG +        S   +++ G+  Y
Sbjct: 137 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVH----APSSRRTTLCGTLDY 189
Query: 863 IAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
           + PE       DEK D++S GV+  E + GK P
Sbjct: 190 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 222

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 77/276 (27%), Positives = 121/276 (43%), Gaps = 30/276 (10%)
Query: 698 NIIGKGGAGIVYRGSMPDG----IDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVR 753
            +IG+G  G VY G++ D     I  A+K L      G    FL E   +    H N++ 
Sbjct: 54  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 113
Query: 754 LLGY-VSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCS 812
           LLG  + +  + L++  YM +G L   +   +  +   +      L+ AKG+ YL    S
Sbjct: 114 LLGICLRSEGSPLVVLPYMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKYL---AS 169
Query: 813 PLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGS--YGYIAPEYAYT 870
              +HRD+ + N +LD  F   VADFGLA+ + D       +         ++A E   T
Sbjct: 170 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 229
Query: 871 LKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVD 930
            K   KSDV+SFGV+L EL+    P     +  DI  ++ +    + QP          D
Sbjct: 230 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ-GRRLLQPEYCP------D 282
Query: 931 PRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVV 966
           P            L++V + C   ++  RP+  E+V
Sbjct: 283 P------------LYEVMLKCWHPKAEMRPSFSELV 306

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 93/209 (44%), Gaps = 12/209 (5%)
Query: 690 VLESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGT---GGNDHGFLAEIQTLGRI 746
            LE  +    +GKG  G VY         +   +++ +      G +H    E++    +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 747 RHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCY 806
           RH NI+RL GY  +     L+ EY P G++   L        +    Y    E A  L Y
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY--ITELANALSY 123
Query: 807 LHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPE 866
            H   S  +IHRD+K  N+LL S  E  +ADFG +        S   +++ G+  Y+ PE
Sbjct: 124 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVH----APSSRRTTLCGTLDYLPPE 176
Query: 867 YAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
                  DEK D++S GV+  E + GK P
Sbjct: 177 MIEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 95/213 (44%), Gaps = 12/213 (5%)
Query: 686 KAEDVLESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRG---TGGNDHGFLAEIQT 742
           K +  LE  +    +GKG  G VY         +   +++ +      G +H    E++ 
Sbjct: 2   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 61
Query: 743 LGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAK 802
              +RH NI+RL GY  +     L+ EY P G++   L        +    Y    E A 
Sbjct: 62  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY--ITELAN 119
Query: 803 GLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGY 862
            L Y H   S  +IHRD+K  N+LL S  E  +ADFG +        S   +++ G+  Y
Sbjct: 120 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVH----APSSRRAALCGTLDY 172
Query: 863 IAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
           + PE       DEK D++S GV+  E + GK P
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 77/276 (27%), Positives = 121/276 (43%), Gaps = 30/276 (10%)
Query: 698 NIIGKGGAGIVYRGSMPDG----IDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVR 753
            +IG+G  G VY G++ D     I  A+K L      G    FL E   +    H N++ 
Sbjct: 28  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 87
Query: 754 LLGY-VSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCS 812
           LLG  + +  + L++  YM +G L   +   +  +   +      L+ AKG+ YL    S
Sbjct: 88  LLGICLRSEGSPLVVLPYMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKYL---AS 143
Query: 813 PLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGS--YGYIAPEYAYT 870
              +HRD+ + N +LD  F   VADFGLA+ + D       +         ++A E   T
Sbjct: 144 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 203
Query: 871 LKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVD 930
            K   KSDV+SFGV+L EL+    P     +  DI  ++ +    + QP          D
Sbjct: 204 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ-GRRLLQPEYCP------D 256
Query: 931 PRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVV 966
           P            L++V + C   ++  RP+  E+V
Sbjct: 257 P------------LYEVMLKCWHPKAEMRPSFSELV 280

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 94/213 (44%), Gaps = 12/213 (5%)
Query: 686 KAEDVLESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGT---GGNDHGFLAEIQT 742
           K +  LE  +    +GKG  G VY         +   +++ +      G +H    E++ 
Sbjct: 2   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 61
Query: 743 LGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAK 802
              +RH NI+RL GY  +     L+ EY P G++   L        +    Y    E A 
Sbjct: 62  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY--ITELAN 119
Query: 803 GLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGY 862
            L Y H   S  +IHRD+K  N+LL S  E  +ADFG +        S   + + G+  Y
Sbjct: 120 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVH----APSSRRTDLCGTLDY 172
Query: 863 IAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
           + PE       DEK D++S GV+  E + GK P
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 77/276 (27%), Positives = 121/276 (43%), Gaps = 30/276 (10%)
Query: 698 NIIGKGGAGIVYRGSMPDG----IDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVR 753
            +IG+G  G VY G++ D     I  A+K L      G    FL E   +    H N++ 
Sbjct: 36  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 95
Query: 754 LLGY-VSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCS 812
           LLG  + +  + L++  YM +G L   +   +  +   +      L+ AKG+ YL    S
Sbjct: 96  LLGICLRSEGSPLVVLPYMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKYL---AS 151
Query: 813 PLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGS--YGYIAPEYAYT 870
              +HRD+ + N +LD  F   VADFGLA+ + D       +         ++A E   T
Sbjct: 152 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 211
Query: 871 LKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVD 930
            K   KSDV+SFGV+L EL+    P     +  DI  ++ +    + QP          D
Sbjct: 212 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ-GRRLLQPEYCP------D 264
Query: 931 PRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVV 966
           P            L++V + C   ++  RP+  E+V
Sbjct: 265 P------------LYEVMLKCWHPKAEMRPSFSELV 288

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 84.0 bits (206), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 94/213 (44%), Gaps = 12/213 (5%)
Query: 686 KAEDVLESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGT---GGNDHGFLAEIQT 742
           K +  LE  +    +GKG  G VY         +   +++ +      G +H    E++ 
Sbjct: 3   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 62
Query: 743 LGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAK 802
              +RH NI+RL GY  +     L+ EY P G++   L        +    Y    E A 
Sbjct: 63  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY--ITELAN 120
Query: 803 GLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGY 862
            L Y H   S  +IHRD+K  N+LL S  E  +ADFG +        S    ++ G+  Y
Sbjct: 121 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVH----APSSRRDTLCGTLDY 173
Query: 863 IAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
           + PE       DEK D++S GV+  E + GK P
Sbjct: 174 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 206

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 84.0 bits (206), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 94/213 (44%), Gaps = 12/213 (5%)
Query: 686 KAEDVLESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGT---GGNDHGFLAEIQT 742
           K +  LE  +    +GKG  G VY         +   +++ +      G +H    E++ 
Sbjct: 3   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 62
Query: 743 LGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAK 802
              +RH NI+RL GY  +     L+ EY P G++   L        +    Y    E A 
Sbjct: 63  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY--ITELAN 120
Query: 803 GLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGY 862
            L Y H   S  +IHRD+K  N+LL S  E  +ADFG +        S   + + G+  Y
Sbjct: 121 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVH----APSSRRTDLCGTLDY 173
Query: 863 IAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
           + PE       DEK D++S GV+  E + GK P
Sbjct: 174 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 206

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 84.0 bits (206), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 101/207 (48%), Gaps = 14/207 (6%)
Query: 691 LESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRN 750
           ++ LK    IGKG  G V  G    G  VA+K +    T      FLAE   + ++RH N
Sbjct: 5   MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA---QAFLAEASVMTQLRHSN 60
Query: 751 IVRLLGYVSNRDTNL-LLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHH 809
           +V+LLG +      L ++ EYM  GSL + L       L  +   + +L+  + + YL  
Sbjct: 61  LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 120
Query: 810 DCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAY 869
           +     +HRD+ + N+L+  D  A V+DFGL K      AS    +      + APE   
Sbjct: 121 NN---FVHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALR 172
Query: 870 TLKVDEKSDVYSFGVVLLELIA-GKKP 895
             K   KSDV+SFG++L E+ + G+ P
Sbjct: 173 EKKFSTKSDVWSFGILLWEIYSFGRVP 199

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 84.0 bits (206), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 94/213 (44%), Gaps = 12/213 (5%)
Query: 686 KAEDVLESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGT---GGNDHGFLAEIQT 742
           K +  LE  +    +GKG  G VY         +   +++ +      G +H    E++ 
Sbjct: 2   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 61
Query: 743 LGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAK 802
              +RH NI+RL GY  +     L+ EY P G++   L        +    Y    E A 
Sbjct: 62  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY--ITELAN 119
Query: 803 GLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGY 862
            L Y H   S  +IHRD+K  N+LL S  E  +ADFG +        S   + + G+  Y
Sbjct: 120 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVH----APSSRRTDLCGTLDY 172
Query: 863 IAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
           + PE       DEK D++S GV+  E + GK P
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 84.0 bits (206), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 94/213 (44%), Gaps = 12/213 (5%)
Query: 686 KAEDVLESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGT---GGNDHGFLAEIQT 742
           K +  LE  +    +GKG  G VY         +   +++ +      G +H    E++ 
Sbjct: 7   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 66
Query: 743 LGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAK 802
              +RH NI+RL GY  +     L+ EY P G++   L        +    Y    E A 
Sbjct: 67  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY--ITELAN 124
Query: 803 GLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGY 862
            L Y H   S  +IHRD+K  N+LL S  E  +ADFG +        S   + + G+  Y
Sbjct: 125 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVH----APSSRRTDLCGTLDY 177
Query: 863 IAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
           + PE       DEK D++S GV+  E + GK P
Sbjct: 178 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 84.0 bits (206), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 94/213 (44%), Gaps = 12/213 (5%)
Query: 686 KAEDVLESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRG---TGGNDHGFLAEIQT 742
           K +  LE  +    +GKG  G VY         +   +++ +      G +H    E++ 
Sbjct: 2   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 61
Query: 743 LGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAK 802
              +RH NI+RL GY  +     L+ EY P G++   L        +    Y    E A 
Sbjct: 62  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY--ITELAN 119
Query: 803 GLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGY 862
            L Y H   S  +IHRD+K  N+LL S  E  +ADFG +        S   + + G+  Y
Sbjct: 120 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVH----APSSRRTXLCGTLDY 172
Query: 863 IAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
           + PE       DEK D++S GV+  E + GK P
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 84.0 bits (206), Expect = 4e-16,   Method: Composition-based stats.
 Identities = 63/213 (29%), Positives = 95/213 (44%), Gaps = 12/213 (5%)
Query: 686 KAEDVLESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRG---TGGNDHGFLAEIQT 742
           K +  LE  +    +GKG  G VY         +   +++ +      G +H    E++ 
Sbjct: 7   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 66
Query: 743 LGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAK 802
              +RH NI+RL GY  +     L+ EY P G++   L   K      +       E A 
Sbjct: 67  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ--KLSKFDEQRTATYITELAN 124
Query: 803 GLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGY 862
            L Y H   S  +IHRD+K  N+LL S  E  +ADFG +        S   +++ G+  Y
Sbjct: 125 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVH----APSSRRTTLCGTLDY 177
Query: 863 IAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
           + PE       DEK D++S GV+  E + GK P
Sbjct: 178 LPPEXIEGRXHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 84.0 bits (206), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 77/276 (27%), Positives = 121/276 (43%), Gaps = 30/276 (10%)
Query: 698 NIIGKGGAGIVYRGSMPDG----IDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVR 753
            +IG+G  G VY G++ D     I  A+K L      G    FL E   +    H N++ 
Sbjct: 33  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 92
Query: 754 LLGY-VSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCS 812
           LLG  + +  + L++  YM +G L   +   +  +   +      L+ AKG+ YL    S
Sbjct: 93  LLGICLRSEGSPLVVLPYMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKYL---AS 148
Query: 813 PLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGS--YGYIAPEYAYT 870
              +HRD+ + N +LD  F   VADFGLA+ + D       +         ++A E   T
Sbjct: 149 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 208
Query: 871 LKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVD 930
            K   KSDV+SFGV+L EL+    P     +  DI  ++ +    + QP          D
Sbjct: 209 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ-GRRLLQPEYCP------D 261
Query: 931 PRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVV 966
           P            L++V + C   ++  RP+  E+V
Sbjct: 262 P------------LYEVMLKCWHPKAEMRPSFSELV 285

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 84.0 bits (206), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 77/276 (27%), Positives = 121/276 (43%), Gaps = 30/276 (10%)
Query: 698 NIIGKGGAGIVYRGSMPDG----IDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVR 753
            +IG+G  G VY G++ D     I  A+K L      G    FL E   +    H N++ 
Sbjct: 35  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 94
Query: 754 LLGY-VSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCS 812
           LLG  + +  + L++  YM +G L   +   +  +   +      L+ AKG+ YL    S
Sbjct: 95  LLGICLRSEGSPLVVLPYMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKYL---AS 150
Query: 813 PLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGS--YGYIAPEYAYT 870
              +HRD+ + N +LD  F   VADFGLA+ + D       +         ++A E   T
Sbjct: 151 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 210
Query: 871 LKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVD 930
            K   KSDV+SFGV+L EL+    P     +  DI  ++ +    + QP          D
Sbjct: 211 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ-GRRLLQPEYCP------D 263
Query: 931 PRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVV 966
           P            L++V + C   ++  RP+  E+V
Sbjct: 264 P------------LYEVMLKCWHPKAEMRPSFSELV 287

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 84.0 bits (206), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 93/209 (44%), Gaps = 12/209 (5%)
Query: 690 VLESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGT---GGNDHGFLAEIQTLGRI 746
            LE  +    +GKG  G VY         +   +++ +      G +H    E++    +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 747 RHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCY 806
           RH NI+RL GY  +     L+ EY P G++   L        +    Y    E A  L Y
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY--ITELANALSY 123
Query: 807 LHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPE 866
            H   S  +IHRD+K  N+LL S  E  +ADFG +     +  +E    + G+  Y+ PE
Sbjct: 124 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTE----LCGTLDYLPPE 176
Query: 867 YAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
                  DEK D++S GV+  E + GK P
Sbjct: 177 MIEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 84.0 bits (206), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 77/276 (27%), Positives = 121/276 (43%), Gaps = 30/276 (10%)
Query: 698 NIIGKGGAGIVYRGSMPDG----IDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVR 753
            +IG+G  G VY G++ D     I  A+K L      G    FL E   +    H N++ 
Sbjct: 36  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 95
Query: 754 LLGY-VSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCS 812
           LLG  + +  + L++  YM +G L   +   +  +   +      L+ AKG+ YL    S
Sbjct: 96  LLGICLRSEGSPLVVLPYMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKYL---AS 151
Query: 813 PLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGS--YGYIAPEYAYT 870
              +HRD+ + N +LD  F   VADFGLA+ + D       +         ++A E   T
Sbjct: 152 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 211
Query: 871 LKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVD 930
            K   KSDV+SFGV+L EL+    P     +  DI  ++ +    + QP          D
Sbjct: 212 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ-GRRLLQPEYCP------D 264
Query: 931 PRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVV 966
           P            L++V + C   ++  RP+  E+V
Sbjct: 265 P------------LYEVMLKCWHPKAEMRPSFSELV 288

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 93/213 (43%), Gaps = 12/213 (5%)
Query: 686 KAEDVLESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGT---GGNDHGFLAEIQT 742
           K +  LE  +    +GKG  G VY         +   +++ +      G +H    E++ 
Sbjct: 28  KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 87
Query: 743 LGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAK 802
              +RH NI+RL GY  +     L+ EY P G++   L   K      +       E A 
Sbjct: 88  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ--KLSKFDEQRTATYITELAN 145
Query: 803 GLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGY 862
            L Y H   S  +IHRD+K  N+LL S  E  +ADFG +        S     + G+  Y
Sbjct: 146 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVH----APSSRRDDLCGTLDY 198
Query: 863 IAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
           + PE       DEK D++S GV+  E + GK P
Sbjct: 199 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 231

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 83.6 bits (205), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 77/276 (27%), Positives = 121/276 (43%), Gaps = 30/276 (10%)
Query: 698 NIIGKGGAGIVYRGSMPDG----IDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVR 753
            +IG+G  G VY G++ D     I  A+K L      G    FL E   +    H N++ 
Sbjct: 31  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 754 LLGY-VSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCS 812
           LLG  + +  + L++  YM +G L   +   +  +   +      L+ AKG+ YL    S
Sbjct: 91  LLGICLRSEGSPLVVLPYMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKYL---AS 146
Query: 813 PLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGS--YGYIAPEYAYT 870
              +HRD+ + N +LD  F   VADFGLA+ + D       +         ++A E   T
Sbjct: 147 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 206
Query: 871 LKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVD 930
            K   KSDV+SFGV+L EL+    P     +  DI  ++ +    + QP          D
Sbjct: 207 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ-GRRLLQPEYCP------D 259
Query: 931 PRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVV 966
           P            L++V + C   ++  RP+  E+V
Sbjct: 260 P------------LYEVMLKCWHPKAEMRPSFSELV 283

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 83.6 bits (205), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 77/276 (27%), Positives = 121/276 (43%), Gaps = 30/276 (10%)
Query: 698 NIIGKGGAGIVYRGSMPDG----IDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVR 753
            +IG+G  G VY G++ D     I  A+K L      G    FL E   +    H N++ 
Sbjct: 34  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 93
Query: 754 LLGY-VSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCS 812
           LLG  + +  + L++  YM +G L   +   +  +   +      L+ AKG+ YL    S
Sbjct: 94  LLGICLRSEGSPLVVLPYMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKYL---AS 149
Query: 813 PLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGS--YGYIAPEYAYT 870
              +HRD+ + N +LD  F   VADFGLA+ + D       +         ++A E   T
Sbjct: 150 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 209
Query: 871 LKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVD 930
            K   KSDV+SFGV+L EL+    P     +  DI  ++ +    + QP          D
Sbjct: 210 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ-GRRLLQPEYCP------D 262
Query: 931 PRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVV 966
           P            L++V + C   ++  RP+  E+V
Sbjct: 263 P------------LYEVMLKCWHPKAEMRPSFSELV 286

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 83.6 bits (205), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 83/296 (28%), Positives = 130/296 (43%), Gaps = 44/296 (14%)
Query: 693 SLKDENIIGKGGAGIVYRG-SMPDG----IDVAIKRLVGRGTGGNDHGFLAEIQTLGRIR 747
            LK   ++G G  G VY+G  +P+G    I VAIK L        +  F+ E   +  + 
Sbjct: 39  ELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMD 98
Query: 748 HRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGG-----HLKWETRYRIALEAAK 802
           H ++VRLLG V    T  L+ + MP+G L E +H  K        L W       ++ AK
Sbjct: 99  HPHLVRLLG-VCLSPTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNW------CVQIAK 151
Query: 803 GLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGY 862
           G+ YL       ++HRD+ + N+L+ S     + DFGLA+ L+                +
Sbjct: 152 GMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKW 208
Query: 863 IAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSD 921
           +A E  +  K   +SDV+S+GV + EL+  G KP     DG+               P+ 
Sbjct: 209 MALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPY----DGI---------------PTR 249
Query: 922 AASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVV---HMLANPPQ 974
               L     RL   P+   I ++ V + C   ++ +RP  +E+      +A  PQ
Sbjct: 250 EIPDLLEKGERLPQPPIC-TIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDPQ 304

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 83.6 bits (205), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 93/213 (43%), Gaps = 12/213 (5%)
Query: 686 KAEDVLESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGT---GGNDHGFLAEIQT 742
           K +  LE  +    +GKG  G VY         +   +++ +      G +H    E++ 
Sbjct: 7   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 66
Query: 743 LGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAK 802
              +RH NI+RL GY  +     L+ EY P G + + L        +    Y    E A 
Sbjct: 67  QSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATY--ITELAN 124
Query: 803 GLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGY 862
            L Y H   S  +IHRD+K  N+LL S  E  +ADFG +        S     + G+  Y
Sbjct: 125 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVH----APSSRRXXLXGTLDY 177
Query: 863 IAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
           + PE       DEK D++S GV+  E + GK P
Sbjct: 178 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 83.6 bits (205), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 101/207 (48%), Gaps = 14/207 (6%)
Query: 691 LESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRN 750
           ++ LK    IGKG  G V  G    G  VA+K +    T      FLAE   + ++RH N
Sbjct: 20  MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA---QAFLAEASVMTQLRHSN 75
Query: 751 IVRLLGYVSNRDTNL-LLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHH 809
           +V+LLG +      L ++ EYM  GSL + L       L  +   + +L+  + + YL  
Sbjct: 76  LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 135
Query: 810 DCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAY 869
           +     +HRD+ + N+L+  D  A V+DFGL K      AS    +      + APE   
Sbjct: 136 NN---FVHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALR 187
Query: 870 TLKVDEKSDVYSFGVVLLELIA-GKKP 895
             K   KSDV+SFG++L E+ + G+ P
Sbjct: 188 EKKFSTKSDVWSFGILLWEIYSFGRVP 214

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 83.6 bits (205), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 93/209 (44%), Gaps = 12/209 (5%)
Query: 690 VLESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGT---GGNDHGFLAEIQTLGRI 746
            LE  +    +GKG  G VY         +   +++ +      G +H    E++    +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 747 RHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCY 806
           RH NI+RL GY  +     L+ EY P G++   L        +    Y    E A  L Y
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY--ITELANALSY 126
Query: 807 LHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPE 866
            H   S  +IHRD+K  N+LL S  E  +ADFG +        S   +++ G+  Y+ PE
Sbjct: 127 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVH----APSSRRAALCGTLDYLPPE 179
Query: 867 YAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
                  DEK D++S GV+  E + GK P
Sbjct: 180 MIEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 83.6 bits (205), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 74/275 (26%), Positives = 122/275 (44%), Gaps = 48/275 (17%)
Query: 700 IGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVS 759
           +G G  G+V  G      DVAIK ++  G+   D  F+ E + +  + H  +V+L G  +
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIK-MIKEGSMSEDE-FIEEAKVMMNLSHEKLVQLYGVCT 74
Query: 760 NRDTNLLLYEYMPNGSL----GEMLHGAKGGHLKWETRYRIALEAAKGLC----YLHHDC 811
            +    ++ EYM NG L     EM H  +   L         LE  K +C    YL    
Sbjct: 75  KQRPIFIITEYMANGCLLNYLREMRHRFQTQQL---------LEMCKDVCEAMEYLE--- 122
Query: 812 SPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSY--GYIAPEYAY 869
           S   +HRD+ + N L++      V+DFGL++++ D    E  SS    +   +  PE   
Sbjct: 123 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD---DEYTSSRGSKFPVRWSPPEVLM 179
Query: 870 TLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAV 928
             K   KSD+++FGV++ E+ + GK P   F            T SE ++    A  L +
Sbjct: 180 YSKFSSKSDIWAFGVLMWEIYSLGKMPYERF------------TNSETAE--HIAQGLRL 225
Query: 929 VDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMR 963
             P L+   +  +++       C  +++  RPT +
Sbjct: 226 YRPHLASEKVYTIMY------SCWHEKADERPTFK 254

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 83.2 bits (204), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 93/213 (43%), Gaps = 12/213 (5%)
Query: 686 KAEDVLESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGT---GGNDHGFLAEIQT 742
           K +  LE  +    +GKG  G VY         +   +++ +      G +H    E++ 
Sbjct: 4   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 63
Query: 743 LGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAK 802
              +RH NI+RL GY  +     L+ EY P G++   L        +    Y    E A 
Sbjct: 64  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY--ITELAN 121
Query: 803 GLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGY 862
            L Y H   S  +IHRD+K  N+LL S  E  +ADFG +        S     + G+  Y
Sbjct: 122 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVH----APSSRRXXLCGTLDY 174
Query: 863 IAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
           + PE       DEK D++S GV+  E + GK P
Sbjct: 175 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 207

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 83.2 bits (204), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 83/296 (28%), Positives = 130/296 (43%), Gaps = 44/296 (14%)
Query: 693 SLKDENIIGKGGAGIVYRG-SMPDG----IDVAIKRLVGRGTGGNDHGFLAEIQTLGRIR 747
            LK   ++G G  G VY+G  +P+G    I VAIK L        +  F+ E   +  + 
Sbjct: 16  ELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMD 75
Query: 748 HRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGG-----HLKWETRYRIALEAAK 802
           H ++VRLLG V    T  L+ + MP+G L E +H  K        L W       ++ AK
Sbjct: 76  HPHLVRLLG-VCLSPTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNW------CVQIAK 128
Query: 803 GLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGY 862
           G+ YL       ++HRD+ + N+L+ S     + DFGLA+ L+                +
Sbjct: 129 GMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKW 185
Query: 863 IAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSD 921
           +A E  +  K   +SDV+S+GV + EL+  G KP     DG+               P+ 
Sbjct: 186 MALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPY----DGI---------------PTR 226
Query: 922 AASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVV---HMLANPPQ 974
               L     RL   P+   I ++ V + C   ++ +RP  +E+      +A  PQ
Sbjct: 227 EIPDLLEKGERLPQPPIC-TIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDPQ 281

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 83.2 bits (204), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 93/209 (44%), Gaps = 12/209 (5%)
Query: 690 VLESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGT---GGNDHGFLAEIQTLGRI 746
            LE  +    +GKG  G VY         +   +++ +      G +H    E++    +
Sbjct: 3   ALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 62
Query: 747 RHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCY 806
           RH NI+RL GY  +     L+ EY P G++   L        +    Y    E A  L Y
Sbjct: 63  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY--ITELANALSY 120
Query: 807 LHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPE 866
            H   S  +IHRD+K  N+LL S  E  +ADFG +        S   +++ G+  Y+ PE
Sbjct: 121 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVH----APSSRRTTLCGTLDYLPPE 173
Query: 867 YAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
                  DEK D++S GV+  E + GK P
Sbjct: 174 MIEGRMHDEKVDLWSLGVLCYEFLVGKPP 202

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 82.8 bits (203), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 121/276 (43%), Gaps = 30/276 (10%)
Query: 698 NIIGKGGAGIVYRGSMPDG----IDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVR 753
            +IG+G  G VY G++ D     I  A+K L      G    FL E   +    H N++ 
Sbjct: 34  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 93
Query: 754 LLGY-VSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCS 812
           LLG  + +  + L++  YM +G L   +   +  +   +      L+ AKG+ +L    S
Sbjct: 94  LLGICLRSEGSPLVVLPYMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKFL---AS 149
Query: 813 PLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGS--YGYIAPEYAYT 870
              +HRD+ + N +LD  F   VADFGLA+ + D       +         ++A E   T
Sbjct: 150 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 209
Query: 871 LKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVD 930
            K   KSDV+SFGV+L EL+    P     +  DI  ++ +    + QP          D
Sbjct: 210 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ-GRRLLQPEYCP------D 262
Query: 931 PRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVV 966
           P            L++V + C   ++  RP+  E+V
Sbjct: 263 P------------LYEVMLKCWHPKAEMRPSFSELV 286

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 82.8 bits (203), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 93/213 (43%), Gaps = 12/213 (5%)
Query: 686 KAEDVLESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGT---GGNDHGFLAEIQT 742
           K +  LE  +    +GKG  G VY         +   +++ +      G +H    E++ 
Sbjct: 2   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 61
Query: 743 LGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAK 802
              +RH NI+RL GY  +     L+ EY P G++   L        +    Y    E A 
Sbjct: 62  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY--ITELAN 119
Query: 803 GLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGY 862
            L Y H   S  +IHRD+K  N+LL S  E  +ADFG +        S     + G+  Y
Sbjct: 120 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVH----APSSRRXXLCGTLDY 172
Query: 863 IAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
           + PE       DEK D++S GV+  E + GK P
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 82.8 bits (203), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 121/276 (43%), Gaps = 30/276 (10%)
Query: 698 NIIGKGGAGIVYRGSMPDG----IDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVR 753
            +IG+G  G VY G++ D     I  A+K L      G    FL E   +    H N++ 
Sbjct: 95  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154
Query: 754 LLGY-VSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCS 812
           LLG  + +  + L++  YM +G L   +   +  +   +      L+ AKG+ +L    S
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKFL---AS 210
Query: 813 PLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGS--YGYIAPEYAYT 870
              +HRD+ + N +LD  F   VADFGLA+ + D       +         ++A E   T
Sbjct: 211 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 270
Query: 871 LKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVD 930
            K   KSDV+SFGV+L EL+    P     +  DI  ++ +    + QP          D
Sbjct: 271 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ-GRRLLQPEYCP------D 323
Query: 931 PRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVV 966
           P            L++V + C   ++  RP+  E+V
Sbjct: 324 P------------LYEVMLKCWHPKAEMRPSFSELV 347

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 82.8 bits (203), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 95/213 (44%), Gaps = 12/213 (5%)
Query: 686 KAEDVLESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRG---TGGNDHGFLAEIQT 742
           K +  LE  +    +GKG  G VY         +   +++ +      G +H    E++ 
Sbjct: 4   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 63
Query: 743 LGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAK 802
              +RH NI+RL GY  +     L+ EY P G++   L        +    Y    E A 
Sbjct: 64  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY--ITELAN 121
Query: 803 GLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGY 862
            L Y H   S  +IHRD+K  N+LL S  E  +A+FG +        S   +++ G+  Y
Sbjct: 122 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIANFGWSVH----APSSRRTTLCGTLDY 174
Query: 863 IAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
           + PE       DEK D++S GV+  E + GK P
Sbjct: 175 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 207

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 82.8 bits (203), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 121/276 (43%), Gaps = 30/276 (10%)
Query: 698 NIIGKGGAGIVYRGSMPDG----IDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVR 753
            +IG+G  G VY G++ D     I  A+K L      G    FL E   +    H N++ 
Sbjct: 36  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 95
Query: 754 LLGY-VSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCS 812
           LLG  + +  + L++  YM +G L   +   +  +   +      L+ AKG+ +L    S
Sbjct: 96  LLGICLRSEGSPLVVLPYMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKFL---AS 151
Query: 813 PLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGS--YGYIAPEYAYT 870
              +HRD+ + N +LD  F   VADFGLA+ + D       +         ++A E   T
Sbjct: 152 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 211
Query: 871 LKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVD 930
            K   KSDV+SFGV+L EL+    P     +  DI  ++ +    + QP          D
Sbjct: 212 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ-GRRLLQPEYCP------D 264
Query: 931 PRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVV 966
           P            L++V + C   ++  RP+  E+V
Sbjct: 265 P------------LYEVMLKCWHPKAEMRPSFSELV 288

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 82.8 bits (203), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 121/276 (43%), Gaps = 30/276 (10%)
Query: 698 NIIGKGGAGIVYRGSMPDG----IDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVR 753
            +IG+G  G VY G++ D     I  A+K L      G    FL E   +    H N++ 
Sbjct: 41  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 100
Query: 754 LLGY-VSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCS 812
           LLG  + +  + L++  YM +G L   +   +  +   +      L+ AKG+ +L    S
Sbjct: 101 LLGICLRSEGSPLVVLPYMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKFL---AS 156
Query: 813 PLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGS--YGYIAPEYAYT 870
              +HRD+ + N +LD  F   VADFGLA+ + D       +         ++A E   T
Sbjct: 157 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 216
Query: 871 LKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVD 930
            K   KSDV+SFGV+L EL+    P     +  DI  ++ +    + QP          D
Sbjct: 217 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ-GRRLLQPEYCP------D 269
Query: 931 PRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVV 966
           P            L++V + C   ++  RP+  E+V
Sbjct: 270 P------------LYEVMLKCWHPKAEMRPSFSELV 293

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 82.8 bits (203), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 95/213 (44%), Gaps = 12/213 (5%)
Query: 686 KAEDVLESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGT---GGNDHGFLAEIQT 742
           K +  LE  +    +GKG  G VY         +   +++ +      G +H    E++ 
Sbjct: 5   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 64
Query: 743 LGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAK 802
              +RH NI+RL GY  +     L+ EY P G++   L        +    Y    E A 
Sbjct: 65  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY--ITELAN 122
Query: 803 GLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGY 862
            L Y H   S  +IHRD+K  N+LL S  E  +A+FG +        S   +++ G+  Y
Sbjct: 123 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIANFGWSVH----APSSRRTTLCGTLDY 175
Query: 863 IAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
           + PE       DEK D++S GV+  E + GK P
Sbjct: 176 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 82.8 bits (203), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 121/276 (43%), Gaps = 30/276 (10%)
Query: 698 NIIGKGGAGIVYRGSMPDG----IDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVR 753
            +IG+G  G VY G++ D     I  A+K L      G    FL E   +    H N++ 
Sbjct: 36  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 95
Query: 754 LLGY-VSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCS 812
           LLG  + +  + L++  YM +G L   +   +  +   +      L+ AKG+ +L    S
Sbjct: 96  LLGICLRSEGSPLVVLPYMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKFL---AS 151
Query: 813 PLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGS--YGYIAPEYAYT 870
              +HRD+ + N +LD  F   VADFGLA+ + D       +         ++A E   T
Sbjct: 152 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 211
Query: 871 LKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVD 930
            K   KSDV+SFGV+L EL+    P     +  DI  ++ +    + QP          D
Sbjct: 212 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ-GRRLLQPEYCP------D 264
Query: 931 PRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVV 966
           P            L++V + C   ++  RP+  E+V
Sbjct: 265 P------------LYEVMLKCWHPKAEMRPSFSELV 288

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 121/276 (43%), Gaps = 30/276 (10%)
Query: 698 NIIGKGGAGIVYRGSMPDG----IDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVR 753
            +IG+G  G VY G++ D     I  A+K L      G    FL E   +    H N++ 
Sbjct: 37  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 96
Query: 754 LLGY-VSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCS 812
           LLG  + +  + L++  YM +G L   +   +  +   +      L+ AKG+ +L    S
Sbjct: 97  LLGICLRSEGSPLVVLPYMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKFL---AS 152
Query: 813 PLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGS--YGYIAPEYAYT 870
              +HRD+ + N +LD  F   VADFGLA+ + D       +         ++A E   T
Sbjct: 153 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 212
Query: 871 LKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVD 930
            K   KSDV+SFGV+L EL+    P     +  DI  ++ +    + QP          D
Sbjct: 213 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ-GRRLLQPEYCP------D 265
Query: 931 PRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVV 966
           P            L++V + C   ++  RP+  E+V
Sbjct: 266 P------------LYEVMLKCWHPKAEMRPSFSELV 289

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 93/213 (43%), Gaps = 12/213 (5%)
Query: 686 KAEDVLESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGT---GGNDHGFLAEIQT 742
           K +  LE  +    +GKG  G VY         +   +++ +      G +H    E++ 
Sbjct: 5   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 64
Query: 743 LGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAK 802
              +RH NI+RL GY  +     L+ EY P G++   L        +    Y    E A 
Sbjct: 65  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY--ITELAN 122
Query: 803 GLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGY 862
            L Y H   S  +IHRD+K  N+LL S  E  +ADFG +        S     + G+  Y
Sbjct: 123 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVH----APSSRRXXLCGTLDY 175
Query: 863 IAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
           + PE       DEK D++S GV+  E + GK P
Sbjct: 176 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 91/209 (43%), Gaps = 12/209 (5%)
Query: 690 VLESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGT---GGNDHGFLAEIQTLGRI 746
            LE  +    +GKG  G VY         +   +++ +      G +H    E++    +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 747 RHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCY 806
           RH NI+RL GY  +     L+ EY P G++   L        +    Y    E A  L Y
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY--ITELANALSY 126
Query: 807 LHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPE 866
            H   S  +IHRD+K  N+LL S  E  +ADFG +        S     + G+  Y+ PE
Sbjct: 127 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVH----APSSRRDDLCGTLDYLPPE 179
Query: 867 YAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
                  DEK D++S GV+  E + GK P
Sbjct: 180 MIEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 121/276 (43%), Gaps = 30/276 (10%)
Query: 698 NIIGKGGAGIVYRGSMPDG----IDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVR 753
            +IG+G  G VY G++ D     I  A+K L      G    FL E   +    H N++ 
Sbjct: 37  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 96
Query: 754 LLGY-VSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCS 812
           LLG  + +  + L++  YM +G L   +   +  +   +      L+ AKG+ +L    S
Sbjct: 97  LLGICLRSEGSPLVVLPYMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKFL---AS 152
Query: 813 PLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGS--YGYIAPEYAYT 870
              +HRD+ + N +LD  F   VADFGLA+ + D       +         ++A E   T
Sbjct: 153 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALESLQT 212
Query: 871 LKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVD 930
            K   KSDV+SFGV+L EL+    P     +  DI  ++ +    + QP          D
Sbjct: 213 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ-GRRLLQPEYCP------D 265
Query: 931 PRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVV 966
           P            L++V + C   ++  RP+  E+V
Sbjct: 266 P------------LYEVMLKCWHPKAEMRPSFSELV 289

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 100/207 (48%), Gaps = 14/207 (6%)
Query: 691 LESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRN 750
           ++ LK    IGKG  G V  G    G  VA+K +    T      FLAE   + ++RH N
Sbjct: 11  MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA---QAFLAEASVMTQLRHSN 66
Query: 751 IVRLLGYVSNRDTNL-LLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHH 809
           +V+LLG +      L ++ EYM  GSL + L       L  +   + +L+  + + YL  
Sbjct: 67  LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 126
Query: 810 DCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAY 869
           +     +HRD+ + N+L+  D  A V+DFGL K      AS    +      + APE   
Sbjct: 127 NN---FVHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALR 178
Query: 870 TLKVDEKSDVYSFGVVLLELIA-GKKP 895
                 KSDV+SFG++L E+ + G+ P
Sbjct: 179 EAAFSTKSDVWSFGILLWEIYSFGRVP 205

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Composition-based stats.
 Identities = 75/275 (27%), Positives = 122/275 (44%), Gaps = 48/275 (17%)
Query: 700 IGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVS 759
           +G G  G+V  G      DVAIK ++  G+   D  F+ E + +  + H  +V+L G  +
Sbjct: 16  LGTGQFGVVKYGKWRGQYDVAIK-MIKEGSMSEDE-FIEEAKVMMNLSHEKLVQLYGVCT 73
Query: 760 NRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIA----LEAAKGLC----YLHHDC 811
            +    ++ EYM NG L   L          E R+R      LE  K +C    YL    
Sbjct: 74  KQRPIFIITEYMANGCLLNYLR---------EMRHRFQTQQLLEMCKDVCEAMEYLE--- 121
Query: 812 SPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYG--YIAPEYAY 869
           S   +HRD+ + N L++      V+DFGL++++ D    E  SSV   +   +  PE   
Sbjct: 122 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD---DEYTSSVGSKFPVRWSPPEVLM 178
Query: 870 TLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAV 928
             K   KSD+++FGV++ E+ + GK P   F            T SE ++    A  L +
Sbjct: 179 YSKFSSKSDIWAFGVLMWEIYSLGKMPYERF------------TNSETAE--HIAQGLRL 224
Query: 929 VDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMR 963
             P L+         ++ +   C  +++  RPT +
Sbjct: 225 YRPHLASE------KVYTIMYSCWHEKADERPTFK 253

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Composition-based stats.
 Identities = 75/275 (27%), Positives = 122/275 (44%), Gaps = 48/275 (17%)
Query: 700 IGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVS 759
           +G G  G+V  G      DVAIK ++  G+   D  F+ E + +  + H  +V+L G  +
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIK-MIKEGSMSEDE-FIEEAKVMMNLSHEKLVQLYGVCT 69
Query: 760 NRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIA----LEAAKGLC----YLHHDC 811
            +    ++ EYM NG L   L          E R+R      LE  K +C    YL    
Sbjct: 70  KQRPIFIITEYMANGCLLNYLR---------EMRHRFQTQQLLEMCKDVCEAMEYLE--- 117
Query: 812 SPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYG--YIAPEYAY 869
           S   +HRD+ + N L++      V+DFGL++++ D    E  SSV   +   +  PE   
Sbjct: 118 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD---DEYTSSVGSKFPVRWSPPEVLM 174
Query: 870 TLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAV 928
             K   KSD+++FGV++ E+ + GK P   F            T SE ++    A  L +
Sbjct: 175 YSKFSSKSDIWAFGVLMWEIYSLGKMPYERF------------TNSETAE--HIAQGLRL 220
Query: 929 VDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMR 963
             P L+         ++ +   C  +++  RPT +
Sbjct: 221 YRPHLASE------KVYTIMYSCWHEKADERPTFK 249

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 82.0 bits (201), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 96/214 (44%), Gaps = 14/214 (6%)
Query: 686 KAEDVLESLKDENIIGKGGAGIVY--RGSMPDGIDVAIKRLVGRG--TGGNDHGFLAEIQ 741
           K +  LE       +GKG  G VY  R      I +A+K L        G +H    E++
Sbjct: 6   KRQWTLEDFDIGRPLGKGKFGNVYLARERQSKFI-LALKVLFKTQLEKAGVEHQLRREVE 64
Query: 742 TLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAA 801
               +RH NI+RL GY  +     L+ EY P G++   L   K      +       E A
Sbjct: 65  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ--KLSRFDEQRTATYITELA 122
Query: 802 KGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYG 861
             L Y H   S  +IHRD+K  N+LL S+ E  +ADFG +        S   +++ G+  
Sbjct: 123 NALSYCH---SKRVIHRDIKPENLLLGSNGELKIADFGWSVH----APSSRRTTLCGTLD 175
Query: 862 YIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
           Y+ PE       DEK D++S GV+  E + G  P
Sbjct: 176 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPP 209

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/190 (34%), Positives = 92/190 (48%), Gaps = 16/190 (8%)
Query: 719 VAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLG--YVSNRDTNLLLYEYMPNGSL 776
           VA+K+L    T  +   F  EI+ L  ++H NIV+  G  Y + R    L+ EY+P GSL
Sbjct: 45  VAVKKL-QHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSL 103
Query: 777 GEML--HGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAH 834
            + L  H  +  H+K     +   +  KG+ YL    +   IHRD+ + NIL++++    
Sbjct: 104 RDYLQAHAERIDHIKL---LQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVK 157
Query: 835 VADFGLAKFL-QDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-- 891
           + DFGL K L QD    +          + APE     K    SDV+SFGVVL EL    
Sbjct: 158 IGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYI 217
Query: 892 --GKKPVGEF 899
              K P  EF
Sbjct: 218 EKSKSPPAEF 227

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Composition-based stats.
 Identities = 80/300 (26%), Positives = 133/300 (44%), Gaps = 38/300 (12%)
Query: 685 FKAEDVLESLKDENIIGKGGAGIVYRG--SMPDGIDVA--IKRLVGRGTGGNDHGFLAEI 740
           F  E     +K E +IG G  G V  G   +P   DVA  IK L    T      FL E 
Sbjct: 36  FAKELDASCIKIERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEA 95
Query: 741 QTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEA 800
             +G+  H N+V L G V+     +++ E+M NG+L   L     G         +    
Sbjct: 96  SIMGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDAFLR-KHDGQFTVIQLVGMLRGI 154
Query: 801 AKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGS- 859
           A G+ YL        +HRD+ + NIL++S+    V+DFGL++ ++D    E + +  G  
Sbjct: 155 AAGMRYL---ADMGYVHRDLAARNILVNSNLVCKVSDFGLSRVIED--DPEAVYTTTGGK 209
Query: 860 --YGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEV 916
               + APE     K    SDV+S+G+V+ E+++ G++P  +  +  D+++ + +     
Sbjct: 210 IPVRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ-DVIKAIEEGY--- 265
Query: 917 SQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVV----HMLANP 972
                          RL   P+     L ++ + C + E + RP   ++V     M+ NP
Sbjct: 266 ---------------RLPA-PMDCPAGLHQLMLDCWQKERAERPKFEQIVGILDKMIRNP 309

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/190 (34%), Positives = 92/190 (48%), Gaps = 16/190 (8%)
Query: 719 VAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLG--YVSNRDTNLLLYEYMPNGSL 776
           VA+K+L    T  +   F  EI+ L  ++H NIV+  G  Y + R    L+ EY+P GSL
Sbjct: 73  VAVKKL-QHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSL 131
Query: 777 GEML--HGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAH 834
            + L  H  +  H+K     +   +  KG+ YL    +   IHRD+ + NIL++++    
Sbjct: 132 RDYLQKHKERIDHIKL---LQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVK 185
Query: 835 VADFGLAKFL-QDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-- 891
           + DFGL K L QD    +          + APE     K    SDV+SFGVVL EL    
Sbjct: 186 IGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYI 245
Query: 892 --GKKPVGEF 899
              K P  EF
Sbjct: 246 EKSKSPPAEF 255

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/190 (34%), Positives = 92/190 (48%), Gaps = 16/190 (8%)
Query: 719 VAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLG--YVSNRDTNLLLYEYMPNGSL 776
           VA+K+L    T  +   F  EI+ L  ++H NIV+  G  Y + R    L+ EY+P GSL
Sbjct: 41  VAVKKL-QHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSL 99
Query: 777 GEML--HGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAH 834
            + L  H  +  H+K     +   +  KG+ YL    +   IHRD+ + NIL++++    
Sbjct: 100 RDYLQKHKERIDHIKL---LQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVK 153
Query: 835 VADFGLAKFL-QDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-- 891
           + DFGL K L QD    +          + APE     K    SDV+SFGVVL EL    
Sbjct: 154 IGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYI 213
Query: 892 --GKKPVGEF 899
              K P  EF
Sbjct: 214 EKSKSPPAEF 223

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/190 (34%), Positives = 92/190 (48%), Gaps = 16/190 (8%)
Query: 719 VAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLG--YVSNRDTNLLLYEYMPNGSL 776
           VA+K+L    T  +   F  EI+ L  ++H NIV+  G  Y + R    L+ EY+P GSL
Sbjct: 46  VAVKKL-QHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSL 104
Query: 777 GEML--HGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAH 834
            + L  H  +  H+K     +   +  KG+ YL    +   IHRD+ + NIL++++    
Sbjct: 105 RDYLQKHKERIDHIKL---LQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVK 158
Query: 835 VADFGLAKFL-QDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-- 891
           + DFGL K L QD    +          + APE     K    SDV+SFGVVL EL    
Sbjct: 159 IGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYI 218
Query: 892 --GKKPVGEF 899
              K P  EF
Sbjct: 219 EKSKSPPAEF 228

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/190 (34%), Positives = 92/190 (48%), Gaps = 16/190 (8%)
Query: 719 VAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLG--YVSNRDTNLLLYEYMPNGSL 776
           VA+K+L    T  +   F  EI+ L  ++H NIV+  G  Y + R    L+ EY+P GSL
Sbjct: 42  VAVKKL-QHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSL 100
Query: 777 GEML--HGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAH 834
            + L  H  +  H+K     +   +  KG+ YL    +   IHRD+ + NIL++++    
Sbjct: 101 RDYLQKHKERIDHIKL---LQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVK 154
Query: 835 VADFGLAKFL-QDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-- 891
           + DFGL K L QD    +          + APE     K    SDV+SFGVVL EL    
Sbjct: 155 IGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYI 214
Query: 892 --GKKPVGEF 899
              K P  EF
Sbjct: 215 EKSKSPPAEF 224

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/190 (34%), Positives = 92/190 (48%), Gaps = 16/190 (8%)
Query: 719 VAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLG--YVSNRDTNLLLYEYMPNGSL 776
           VA+K+L    T  +   F  EI+ L  ++H NIV+  G  Y + R    L+ EY+P GSL
Sbjct: 40  VAVKKL-QHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSL 98
Query: 777 GEML--HGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAH 834
            + L  H  +  H+K     +   +  KG+ YL    +   IHRD+ + NIL++++    
Sbjct: 99  RDYLQKHKERIDHIKL---LQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVK 152
Query: 835 VADFGLAKFL-QDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-- 891
           + DFGL K L QD    +          + APE     K    SDV+SFGVVL EL    
Sbjct: 153 IGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYI 212
Query: 892 --GKKPVGEF 899
              K P  EF
Sbjct: 213 EKSKSPPAEF 222

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/190 (34%), Positives = 92/190 (48%), Gaps = 16/190 (8%)
Query: 719 VAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLG--YVSNRDTNLLLYEYMPNGSL 776
           VA+K+L    T  +   F  EI+ L  ++H NIV+  G  Y + R    L+ EY+P GSL
Sbjct: 60  VAVKKL-QHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSL 118
Query: 777 GEML--HGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAH 834
            + L  H  +  H+K     +   +  KG+ YL    +   IHRD+ + NIL++++    
Sbjct: 119 RDYLQKHKERIDHIKL---LQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVK 172
Query: 835 VADFGLAKFL-QDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-- 891
           + DFGL K L QD    +          + APE     K    SDV+SFGVVL EL    
Sbjct: 173 IGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYI 232
Query: 892 --GKKPVGEF 899
              K P  EF
Sbjct: 233 EKSKSPPAEF 242

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/190 (34%), Positives = 92/190 (48%), Gaps = 16/190 (8%)
Query: 719 VAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLG--YVSNRDTNLLLYEYMPNGSL 776
           VA+K+L    T  +   F  EI+ L  ++H NIV+  G  Y + R    L+ EY+P GSL
Sbjct: 42  VAVKKL-QHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSL 100
Query: 777 GEML--HGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAH 834
            + L  H  +  H+K     +   +  KG+ YL    +   IHRD+ + NIL++++    
Sbjct: 101 RDYLQKHKERIDHIKL---LQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVK 154
Query: 835 VADFGLAKFL-QDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-- 891
           + DFGL K L QD    +          + APE     K    SDV+SFGVVL EL    
Sbjct: 155 IGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYI 214
Query: 892 --GKKPVGEF 899
              K P  EF
Sbjct: 215 EKSKSPPAEF 224

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 81.3 bits (199), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/190 (34%), Positives = 92/190 (48%), Gaps = 16/190 (8%)
Query: 719 VAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLG--YVSNRDTNLLLYEYMPNGSL 776
           VA+K+L    T  +   F  EI+ L  ++H NIV+  G  Y + R    L+ EY+P GSL
Sbjct: 45  VAVKKL-QHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSL 103
Query: 777 GEML--HGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAH 834
            + L  H  +  H+K     +   +  KG+ YL    +   IHRD+ + NIL++++    
Sbjct: 104 RDYLQKHKERIDHIKL---LQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVK 157
Query: 835 VADFGLAKFL-QDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-- 891
           + DFGL K L QD    +          + APE     K    SDV+SFGVVL EL    
Sbjct: 158 IGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYI 217
Query: 892 --GKKPVGEF 899
              K P  EF
Sbjct: 218 EKSKSPPAEF 227

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 81.3 bits (199), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 95/214 (44%), Gaps = 14/214 (6%)
Query: 686 KAEDVLESLKDENIIGKGGAGIVY--RGSMPDGIDVAIKRLVGRG--TGGNDHGFLAEIQ 741
           K +  LE       +GKG  G VY  R      I +A+K L        G +H    E++
Sbjct: 6   KRQWTLEDFDIGRPLGKGKFGNVYLARERQSKFI-LALKVLFKTQLEKAGVEHQLRREVE 64
Query: 742 TLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAA 801
               +RH NI+RL GY  +     L+ EY P G++   L   K      +       E A
Sbjct: 65  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ--KLSRFDEQRTATYITELA 122
Query: 802 KGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYG 861
             L Y H   S  +IHRD+K  N+LL S+ E  +ADFG +        S    ++ G+  
Sbjct: 123 NALSYCH---SKRVIHRDIKPENLLLGSNGELKIADFGWSVH----APSSRRDTLCGTLD 175
Query: 862 YIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
           Y+ PE       DEK D++S GV+  E + G  P
Sbjct: 176 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPP 209

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 81.3 bits (199), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/190 (34%), Positives = 92/190 (48%), Gaps = 16/190 (8%)
Query: 719 VAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLG--YVSNRDTNLLLYEYMPNGSL 776
           VA+K+L    T  +   F  EI+ L  ++H NIV+  G  Y + R    L+ E++P GSL
Sbjct: 45  VAVKKL-QHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEFLPYGSL 103
Query: 777 GEML--HGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAH 834
            E L  H  +  H+K     +   +  KG+ YL    +   IHRD+ + NIL++++    
Sbjct: 104 REYLQKHKERIDHIKL---LQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVK 157
Query: 835 VADFGLAKFL-QDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-- 891
           + DFGL K L QD    +          + APE     K    SDV+SFGVVL EL    
Sbjct: 158 IGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYI 217
Query: 892 --GKKPVGEF 899
              K P  EF
Sbjct: 218 EKSKSPPAEF 227

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 81.3 bits (199), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/190 (34%), Positives = 92/190 (48%), Gaps = 16/190 (8%)
Query: 719 VAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLG--YVSNRDTNLLLYEYMPNGSL 776
           VA+K+L    T  +   F  EI+ L  ++H NIV+  G  Y + R    L+ EY+P GSL
Sbjct: 47  VAVKKL-QHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSL 105
Query: 777 GEML--HGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAH 834
            + L  H  +  H+K     +   +  KG+ YL    +   IHRD+ + NIL++++    
Sbjct: 106 RDYLQKHKERIDHIKL---LQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVK 159
Query: 835 VADFGLAKFL-QDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-- 891
           + DFGL K L QD    +          + APE     K    SDV+SFGVVL EL    
Sbjct: 160 IGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYI 219
Query: 892 --GKKPVGEF 899
              K P  EF
Sbjct: 220 EKSKSPPAEF 229

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 81.3 bits (199), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/190 (34%), Positives = 92/190 (48%), Gaps = 16/190 (8%)
Query: 719 VAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLG--YVSNRDTNLLLYEYMPNGSL 776
           VA+K+L    T  +   F  EI+ L  ++H NIV+  G  Y + R    L+ EY+P GSL
Sbjct: 48  VAVKKL-QHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSL 106
Query: 777 GEML--HGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAH 834
            + L  H  +  H+K     +   +  KG+ YL    +   IHRD+ + NIL++++    
Sbjct: 107 RDYLQKHKERIDHIKL---LQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVK 160
Query: 835 VADFGLAKFL-QDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-- 891
           + DFGL K L QD    +          + APE     K    SDV+SFGVVL EL    
Sbjct: 161 IGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYI 220
Query: 892 --GKKPVGEF 899
              K P  EF
Sbjct: 221 EKSKSPPAEF 230

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/190 (34%), Positives = 92/190 (48%), Gaps = 16/190 (8%)
Query: 719 VAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLG--YVSNRDTNLLLYEYMPNGSL 776
           VA+K+L    T  +   F  EI+ L  ++H NIV+  G  Y + R    L+ EY+P GSL
Sbjct: 49  VAVKKL-QHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSL 107
Query: 777 GEML--HGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAH 834
            + L  H  +  H+K     +   +  KG+ YL    +   IHRD+ + NIL++++    
Sbjct: 108 RDYLQKHKERIDHIKL---LQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVK 161
Query: 835 VADFGLAKFL-QDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-- 891
           + DFGL K L QD    +          + APE     K    SDV+SFGVVL EL    
Sbjct: 162 IGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYI 221
Query: 892 --GKKPVGEF 899
              K P  EF
Sbjct: 222 EKSKSPPAEF 231

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 115/232 (49%), Gaps = 14/232 (6%)
Query: 669 LQKSKAWK--LTAFQRLDFKAEDVLESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLV 725
           LQ+ K  +  LT  Q++    +D  E + +   +G G  G+V++ S  P G+ +A K + 
Sbjct: 3   LQQRKRLEAFLTQKQKVGELKDDDFEKISE---LGAGNGGVVFKVSHKPSGLVMARKLIH 59
Query: 726 GRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKG 785
                   +  + E+Q L       IV   G   +     +  E+M  GSL ++L   K 
Sbjct: 60  LEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL--KKA 117
Query: 786 GHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQ 845
           G +  +   ++++   KGL YL       I+HRDVK +NIL++S  E  + DFG++  L 
Sbjct: 118 GRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 175
Query: 846 DAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVG 897
           D+ A    +S  G+  Y++PE         +SD++S G+ L+E+  G+ P+G
Sbjct: 176 DSMA----NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIG 223

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/190 (34%), Positives = 92/190 (48%), Gaps = 16/190 (8%)
Query: 719 VAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLG--YVSNRDTNLLLYEYMPNGSL 776
           VA+K+L    T  +   F  EI+ L  ++H NIV+  G  Y + R    L+ EY+P GSL
Sbjct: 60  VAVKKL-QHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSL 118
Query: 777 GEML--HGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAH 834
            + L  H  +  H+K     +   +  KG+ YL    +   IHRD+ + NIL++++    
Sbjct: 119 RDYLQKHKERIDHIKL---LQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVK 172
Query: 835 VADFGLAKFL-QDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-- 891
           + DFGL K L QD    +          + APE     K    SDV+SFGVVL EL    
Sbjct: 173 IGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYI 232
Query: 892 --GKKPVGEF 899
              K P  EF
Sbjct: 233 EKSKSPPAEF 242

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 80.1 bits (196), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 66/239 (27%), Positives = 117/239 (48%), Gaps = 16/239 (6%)
Query: 663 QLRKRRLQKSKAWKLTAF----QRLDFKAEDVLESLKDENIIGKGGAGIVYRGS-MPDGI 717
           +L +  L + +  +L AF    Q++    +D  E + +   +G G  G+V++ S  P G+
Sbjct: 3   KLEELELDEQQRKRLEAFLTQKQKVGELKDDDFEKISE---LGAGNGGVVFKVSHKPSGL 59
Query: 718 DVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLG 777
            +A K +         +  + E+Q L       IV   G   +     +  E+M  GSL 
Sbjct: 60  VMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLD 119
Query: 778 EMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVAD 837
           ++L   K G +  +   ++++   KGL YL       I+HRDVK +NIL++S  E  + D
Sbjct: 120 QVL--KKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCD 175
Query: 838 FGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPV 896
           FG++  L D+ A    +S  G+  Y++PE         +SD++S G+ L+E+  G+ P+
Sbjct: 176 FGVSGQLIDSMA----NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 230

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 80.1 bits (196), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 109/221 (49%), Gaps = 12/221 (5%)
Query: 677 LTAFQRLDFKAEDVLESLKDENIIGKGGAGIVYRGS-MPDGIDVAIKRLVGRGTGGNDHG 735
           LT  Q++    +D  E + +   +G G  G+V++ S  P G+ +A K +         + 
Sbjct: 56  LTQKQKVGELKDDDFEKISE---LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQ 112
Query: 736 FLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYR 795
            + E+Q L       IV   G   +     +  E+M  GSL ++L   K G +  +   +
Sbjct: 113 IIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILGK 170
Query: 796 IALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSS 855
           +++   KGL YL       I+HRDVK +NIL++S  E  + DFG++  L D+ A    +S
Sbjct: 171 VSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA----NS 224
Query: 856 VAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPV 896
             G+  Y++PE         +SD++S G+ L+E+  G+ P+
Sbjct: 225 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 265

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 65/190 (34%), Positives = 92/190 (48%), Gaps = 16/190 (8%)
Query: 719 VAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLG--YVSNRDTNLLLYEYMPNGSL 776
           VA+K+L    T  +   F  EI+ L  ++H NIV+  G  Y + R    L+ EY+P GSL
Sbjct: 42  VAVKKL-QHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSL 100
Query: 777 GEML--HGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAH 834
            + L  H  +  H+K     +   +  KG+ YL    +   IHRD+ + NIL++++    
Sbjct: 101 RDYLQKHKERIDHIKL---LQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVK 154
Query: 835 VADFGLAKFL-QDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-- 891
           + DFGL K L QD    +          + APE     K    SDV+SFGVVL EL    
Sbjct: 155 IGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYI 214
Query: 892 --GKKPVGEF 899
              K P  EF
Sbjct: 215 EKSKSPPAEF 224

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 79.3 bits (194), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/225 (30%), Positives = 109/225 (48%), Gaps = 32/225 (14%)
Query: 698 NIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLG 756
            +  +G  G V++  +  + + V I  +  + +  N++    E+ +L  ++H NI++ +G
Sbjct: 30  EVKARGRFGCVWKAQLLNEYVAVKIFPIQDKQSWQNEY----EVYSLPGMKHENILQFIG 85
Query: 757 YVSNRDTNL-----LLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDC 811
               R T++     L+  +   GSL + L   K   + W     IA   A+GL YLH D 
Sbjct: 86  -AEKRGTSVDVDLWLITAFHEKGSLSDFL---KANVVSWNELCHIAETMARGLAYLHEDI 141
Query: 812 -------SPLIIHRDVKSNNILLDSDFEAHVADFGLA-KFLQDAGASECMSSVAGSYGYI 863
                   P I HRD+KS N+LL ++  A +ADFGLA KF     A +    V G+  Y+
Sbjct: 142 PGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQV-GTRRYM 200
Query: 864 APEY---AYTLKVDE--KSDVYSFGVVLLEL----IAGKKPVGEF 899
           APE    A   + D   + D+Y+ G+VL EL     A   PV E+
Sbjct: 201 APEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEY 245

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 99/203 (48%), Gaps = 11/203 (5%)
Query: 698 NIIGKGGAGIVYRGSMP----DGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVR 753
            I+G+G  G VY G       + I+VA+K      T  N   F++E   +  + H +IV+
Sbjct: 30  RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVK 89
Query: 754 LLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSP 813
           L+G +    T +++ E  P G LG  L   K   LK  T    +L+  K + YL    S 
Sbjct: 90  LIGIIEEEPTWIIM-ELYPYGELGHYLERNKNS-LKVLTLVLYSLQICKAMAYLE---SI 144
Query: 814 LIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKV 873
             +HRD+   NIL+ S     + DFGL+++++D    +  S       +++PE     + 
Sbjct: 145 NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYK-ASVTRLPIKWMSPESINFRRF 203
Query: 874 DEKSDVYSFGVVLLELIA-GKKP 895
              SDV+ F V + E+++ GK+P
Sbjct: 204 TTASDVWMFAVCMWEILSFGKQP 226

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 99/203 (48%), Gaps = 11/203 (5%)
Query: 698 NIIGKGGAGIVYRGSMP----DGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVR 753
            I+G+G  G VY G       + I+VA+K      T  N   F++E   +  + H +IV+
Sbjct: 14  RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVK 73
Query: 754 LLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSP 813
           L+G +    T +++ E  P G LG  L   K   LK  T    +L+  K + YL    S 
Sbjct: 74  LIGIIEEEPTWIIM-ELYPYGELGHYLERNKNS-LKVLTLVLYSLQICKAMAYLE---SI 128
Query: 814 LIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKV 873
             +HRD+   NIL+ S     + DFGL+++++D    +  S       +++PE     + 
Sbjct: 129 NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYK-ASVTRLPIKWMSPESINFRRF 187
Query: 874 DEKSDVYSFGVVLLELIA-GKKP 895
              SDV+ F V + E+++ GK+P
Sbjct: 188 TTASDVWMFAVCMWEILSFGKQP 210

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Composition-based stats.
 Identities = 58/207 (28%), Positives = 104/207 (50%), Gaps = 12/207 (5%)
Query: 692 ESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNI 751
           ESLK E  +G G  G V+  +      VA+K +  +    +   FLAE   +  ++H  +
Sbjct: 15  ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTM--KPGSMSVEAFLAEANVMKTLQHDKL 72
Query: 752 VRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDC 811
           V+L   V+ ++   ++ E+M  GSL + L   +G           + + A+G+ ++    
Sbjct: 73  VKLHAVVT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN 131
Query: 812 SPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSY--GYIAPEYAY 869
               IHRD+++ NIL+ +     +ADFGLA+ ++D   +E  +     +   + APE   
Sbjct: 132 ---YIHRDLRAANILVSASLVCKIADFGLARVIED---NEYTAREGAKFPIKWTAPEAIN 185
Query: 870 TLKVDEKSDVYSFGVVLLELIA-GKKP 895
                 KSDV+SFG++L+E++  G+ P
Sbjct: 186 FGSFTIKSDVWSFGILLMEIVTYGRIP 212

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 99/203 (48%), Gaps = 11/203 (5%)
Query: 698 NIIGKGGAGIVYRGSMP----DGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVR 753
            I+G+G  G VY G       + I+VA+K      T  N   F++E   +  + H +IV+
Sbjct: 18  RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVK 77
Query: 754 LLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSP 813
           L+G +    T +++ E  P G LG  L   K   LK  T    +L+  K + YL    S 
Sbjct: 78  LIGIIEEEPTWIIM-ELYPYGELGHYLERNKNS-LKVLTLVLYSLQICKAMAYLE---SI 132
Query: 814 LIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKV 873
             +HRD+   NIL+ S     + DFGL+++++D    +  S       +++PE     + 
Sbjct: 133 NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYK-ASVTRLPIKWMSPESINFRRF 191
Query: 874 DEKSDVYSFGVVLLELIA-GKKP 895
              SDV+ F V + E+++ GK+P
Sbjct: 192 TTASDVWMFAVCMWEILSFGKQP 214

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/180 (32%), Positives = 89/180 (49%), Gaps = 9/180 (5%)
Query: 716 GIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTN--LLLYEYMPN 773
           G  VA+K L     G +      EI+ L  + H NIV+  G  +    N   L+ E++P+
Sbjct: 50  GEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPS 109
Query: 774 GSLGEMLHGAKGG-HLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFE 832
           GSL E L   K   +LK + +Y  A++  KG+ YL    S   +HRD+ + N+L++S+ +
Sbjct: 110 GSLKEYLPKNKNKINLKQQLKY--AVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQ 164
Query: 833 AHVADFGLAKFLQ-DAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA 891
             + DFGL K ++ D               + APE     K    SDV+SFGV L EL+ 
Sbjct: 165 VKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT 224

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 102/208 (49%), Gaps = 9/208 (4%)
Query: 691 LESLKDENIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRG--TGGNDHGFLAEIQTLGRIR 747
           +E  K  N++GKG    VYR  S+  G++VAIK +  +     G       E++   +++
Sbjct: 10  IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLK 69
Query: 748 HRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYL 807
           H +I+ L  Y  + +   L+ E   NG +   L        + E R+ +  +   G+ YL
Sbjct: 70  HPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMH-QIITGMLYL 128
Query: 808 HHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEY 867
           H   S  I+HRD+  +N+LL  +    +ADFGLA  L+     E   ++ G+  YI+PE 
Sbjct: 129 H---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLK--MPHEKHYTLCGTPNYISPEI 183
Query: 868 AYTLKVDEKSDVYSFGVVLLELIAGKKP 895
           A       +SDV+S G +   L+ G+ P
Sbjct: 184 ATRSAHGLESDVWSLGCMFYTLLIGRPP 211

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/180 (32%), Positives = 89/180 (49%), Gaps = 9/180 (5%)
Query: 716 GIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTN--LLLYEYMPN 773
           G  VA+K L     G +      EI+ L  + H NIV+  G  +    N   L+ E++P+
Sbjct: 38  GEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPS 97
Query: 774 GSLGEMLHGAKGG-HLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFE 832
           GSL E L   K   +LK + +Y  A++  KG+ YL    S   +HRD+ + N+L++S+ +
Sbjct: 98  GSLKEYLPKNKNKINLKQQLKY--AVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQ 152
Query: 833 AHVADFGLAKFLQ-DAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA 891
             + DFGL K ++ D               + APE     K    SDV+SFGV L EL+ 
Sbjct: 153 VKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT 212

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-14,   Method: Composition-based stats.
 Identities = 70/233 (30%), Positives = 109/233 (46%), Gaps = 20/233 (8%)
Query: 700 IGKGGAGIVYRGS--MPDG--IDVAIKRL----VGRGTGGNDHGFLAEIQTLGRIRHRNI 751
           +G G  G+V RG    P G  + VA+K L    + +    +D  F+ E+  +  + HRN+
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDD--FIREVNAMHSLDHRNL 83
Query: 752 VRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDC 811
           +RL G V      ++  E  P GSL + L   +G H    T  R A++ A+G+ YL    
Sbjct: 84  IRLYGVVLTPPMKMVT-ELAPLGSLLDRLRKHQG-HFLLGTLSRYAVQVAEGMGYLE--- 138
Query: 812 SPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAG-SYGYIAPEYAYT 870
           S   IHRD+ + N+LL +     + DFGL + L        M       + + APE   T
Sbjct: 139 SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKT 198
Query: 871 LKVDEKSDVYSFGVVLLELIA-GKKP-VGEFGDGVDIVRWVRKTTSEVSQPSD 921
                 SD + FGV L E+   G++P +G   +G  I+  + K    + +P D
Sbjct: 199 RTFSHASDTWMFGVTLWEMFTYGQEPWIGL--NGSQILHKIDKEGERLPRPED 249

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-14,   Method: Composition-based stats.
 Identities = 70/233 (30%), Positives = 109/233 (46%), Gaps = 20/233 (8%)
Query: 700 IGKGGAGIVYRGS--MPDG--IDVAIKRL----VGRGTGGNDHGFLAEIQTLGRIRHRNI 751
           +G G  G+V RG    P G  + VA+K L    + +    +D  F+ E+  +  + HRN+
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDD--FIREVNAMHSLDHRNL 73
Query: 752 VRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDC 811
           +RL G V      ++  E  P GSL + L   +G H    T  R A++ A+G+ YL    
Sbjct: 74  IRLYGVVLTPPMKMVT-ELAPLGSLLDRLRKHQG-HFLLGTLSRYAVQVAEGMGYLE--- 128
Query: 812 SPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAG-SYGYIAPEYAYT 870
           S   IHRD+ + N+LL +     + DFGL + L        M       + + APE   T
Sbjct: 129 SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKT 188
Query: 871 LKVDEKSDVYSFGVVLLELIA-GKKP-VGEFGDGVDIVRWVRKTTSEVSQPSD 921
                 SD + FGV L E+   G++P +G   +G  I+  + K    + +P D
Sbjct: 189 RTFSHASDTWMFGVTLWEMFTYGQEPWIGL--NGSQILHKIDKEGERLPRPED 239

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 101/201 (50%), Gaps = 11/201 (5%)
Query: 692 ESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNI 751
           ESLK E  +G G  G V+  +      VA+K +  +    +   FLAE   +  ++H  +
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTM--KPGSMSVEAFLAEANVMKTLQHDKL 245
Query: 752 VRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDC 811
           V+L   V+ ++   ++ E+M  GSL + L   +G           + + A+G+ ++    
Sbjct: 246 VKLHAVVT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN 304
Query: 812 SPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSY--GYIAPEYAY 869
               IHRD+++ NIL+ +     +ADFGLA+ ++D   +E  +     +   + APE   
Sbjct: 305 ---YIHRDLRAANILVSASLVCKIADFGLARVIED---NEYTAREGAKFPIKWTAPEAIN 358
Query: 870 TLKVDEKSDVYSFGVVLLELI 890
                 KSDV+SFG++L+E++
Sbjct: 359 FGSFTIKSDVWSFGILLMEIV 379

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/190 (33%), Positives = 92/190 (48%), Gaps = 16/190 (8%)
Query: 719 VAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLG--YVSNRDTNLLLYEYMPNGSL 776
           VA+K+L    T  +   F  EI+ L  ++H NIV+  G  Y + R    L+ EY+P GSL
Sbjct: 43  VAVKKL-QHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSL 101
Query: 777 GEML--HGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAH 834
            + L  H  +  H+K     +   +  KG+ YL    +   IHR++ + NIL++++    
Sbjct: 102 RDYLQKHKERIDHIKL---LQYTSQICKGMEYL---GTKRYIHRNLATRNILVENENRVK 155
Query: 835 VADFGLAKFL-QDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-- 891
           + DFGL K L QD    +          + APE     K    SDV+SFGVVL EL    
Sbjct: 156 IGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYI 215
Query: 892 --GKKPVGEF 899
              K P  EF
Sbjct: 216 EKSKSPPAEF 225

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 104/210 (49%), Gaps = 14/210 (6%)
Query: 693 SLKDENI-----IGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRI 746
            LKD++      +G G  G+V++ S  P G+ +A K +         +  + E+Q L   
Sbjct: 2   ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC 61
Query: 747 RHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCY 806
               IV   G   +     +  E+M  GSL ++L   K G +  +   ++++   KGL Y
Sbjct: 62  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILGKVSIAVIKGLTY 119
Query: 807 LHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPE 866
           L       I+HRDVK +NIL++S  E  + DFG++  L D+ A    +S  G+  Y++PE
Sbjct: 120 LREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA----NSFVGTRSYMSPE 173
Query: 867 YAYTLKVDEKSDVYSFGVVLLELIAGKKPV 896
                    +SD++S G+ L+E+  G+ P+
Sbjct: 174 RLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 104/210 (49%), Gaps = 14/210 (6%)
Query: 693 SLKDENI-----IGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRI 746
            LKD++      +G G  G+V++ S  P G+ +A K +         +  + E+Q L   
Sbjct: 2   ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC 61
Query: 747 RHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCY 806
               IV   G   +     +  E+M  GSL ++L   K G +  +   ++++   KGL Y
Sbjct: 62  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILGKVSIAVIKGLTY 119
Query: 807 LHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPE 866
           L       I+HRDVK +NIL++S  E  + DFG++  L D+ A    +S  G+  Y++PE
Sbjct: 120 LREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA----NSFVGTRSYMSPE 173
Query: 867 YAYTLKVDEKSDVYSFGVVLLELIAGKKPV 896
                    +SD++S G+ L+E+  G+ P+
Sbjct: 174 RLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 104/210 (49%), Gaps = 14/210 (6%)
Query: 693 SLKDENI-----IGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRI 746
            LKD++      +G G  G+V++ S  P G+ +A K +         +  + E+Q L   
Sbjct: 2   ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC 61
Query: 747 RHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCY 806
               IV   G   +     +  E+M  GSL ++L   K G +  +   ++++   KGL Y
Sbjct: 62  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILGKVSIAVIKGLTY 119
Query: 807 LHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPE 866
           L       I+HRDVK +NIL++S  E  + DFG++  L D+ A    +S  G+  Y++PE
Sbjct: 120 LREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA----NSFVGTRSYMSPE 173
Query: 867 YAYTLKVDEKSDVYSFGVVLLELIAGKKPV 896
                    +SD++S G+ L+E+  G+ P+
Sbjct: 174 RLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 104/210 (49%), Gaps = 14/210 (6%)
Query: 693 SLKDENI-----IGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRI 746
            LKD++      +G G  G+V++ S  P G+ +A K +         +  + E+Q L   
Sbjct: 2   ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC 61
Query: 747 RHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCY 806
               IV   G   +     +  E+M  GSL ++L   K G +  +   ++++   KGL Y
Sbjct: 62  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILGKVSIAVIKGLTY 119
Query: 807 LHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPE 866
           L       I+HRDVK +NIL++S  E  + DFG++  L D+ A    +S  G+  Y++PE
Sbjct: 120 LREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA----NSFVGTRSYMSPE 173
Query: 867 YAYTLKVDEKSDVYSFGVVLLELIAGKKPV 896
                    +SD++S G+ L+E+  G+ P+
Sbjct: 174 RLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 104/210 (49%), Gaps = 14/210 (6%)
Query: 693 SLKDENI-----IGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRI 746
            LKD++      +G G  G+V++ S  P G+ +A K +         +  + E+Q L   
Sbjct: 2   ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC 61
Query: 747 RHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCY 806
               IV   G   +     +  E+M  GSL ++L   K G +  +   ++++   KGL Y
Sbjct: 62  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILGKVSIAVIKGLTY 119
Query: 807 LHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPE 866
           L       I+HRDVK +NIL++S  E  + DFG++  L D+ A    +S  G+  Y++PE
Sbjct: 120 LREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA----NSFVGTRSYMSPE 173
Query: 867 YAYTLKVDEKSDVYSFGVVLLELIAGKKPV 896
                    +SD++S G+ L+E+  G+ P+
Sbjct: 174 RLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Composition-based stats.
 Identities = 70/233 (30%), Positives = 109/233 (46%), Gaps = 20/233 (8%)
Query: 700 IGKGGAGIVYRGS--MPDG--IDVAIKRL----VGRGTGGNDHGFLAEIQTLGRIRHRNI 751
           +G G  G+V RG    P G  + VA+K L    + +    +D  F+ E+  +  + HRN+
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDD--FIREVNAMHSLDHRNL 77
Query: 752 VRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDC 811
           +RL G V      ++  E  P GSL + L   +G H    T  R A++ A+G+ YL    
Sbjct: 78  IRLYGVVLTPPMKMVT-ELAPLGSLLDRLRKHQG-HFLLGTLSRYAVQVAEGMGYLE--- 132
Query: 812 SPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAG-SYGYIAPEYAYT 870
           S   IHRD+ + N+LL +     + DFGL + L        M       + + APE   T
Sbjct: 133 SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 192
Query: 871 LKVDEKSDVYSFGVVLLELIA-GKKP-VGEFGDGVDIVRWVRKTTSEVSQPSD 921
                 SD + FGV L E+   G++P +G   +G  I+  + K    + +P D
Sbjct: 193 RTFSHASDTWMFGVTLWEMFTYGQEPWIGL--NGSQILHKIDKEGERLPRPED 243

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Composition-based stats.
 Identities = 70/233 (30%), Positives = 109/233 (46%), Gaps = 20/233 (8%)
Query: 700 IGKGGAGIVYRGS--MPDG--IDVAIKRL----VGRGTGGNDHGFLAEIQTLGRIRHRNI 751
           +G G  G+V RG    P G  + VA+K L    + +    +D  F+ E+  +  + HRN+
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDD--FIREVNAMHSLDHRNL 73
Query: 752 VRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDC 811
           +RL G V      ++  E  P GSL + L   +G H    T  R A++ A+G+ YL    
Sbjct: 74  IRLYGVVLTPPMKMVT-ELAPLGSLLDRLRKHQG-HFLLGTLSRYAVQVAEGMGYLE--- 128
Query: 812 SPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAG-SYGYIAPEYAYT 870
           S   IHRD+ + N+LL +     + DFGL + L        M       + + APE   T
Sbjct: 129 SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 188
Query: 871 LKVDEKSDVYSFGVVLLELIA-GKKP-VGEFGDGVDIVRWVRKTTSEVSQPSD 921
                 SD + FGV L E+   G++P +G   +G  I+  + K    + +P D
Sbjct: 189 RTFSHASDTWMFGVTLWEMFTYGQEPWIGL--NGSQILHKIDKEGERLPRPED 239

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Composition-based stats.
 Identities = 70/233 (30%), Positives = 109/233 (46%), Gaps = 20/233 (8%)
Query: 700 IGKGGAGIVYRGS--MPDG--IDVAIKRL----VGRGTGGNDHGFLAEIQTLGRIRHRNI 751
           +G G  G+V RG    P G  + VA+K L    + +    +D  F+ E+  +  + HRN+
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDD--FIREVNAMHSLDHRNL 83
Query: 752 VRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDC 811
           +RL G V      ++  E  P GSL + L   +G H    T  R A++ A+G+ YL    
Sbjct: 84  IRLYGVVLTPPMKMVT-ELAPLGSLLDRLRKHQG-HFLLGTLSRYAVQVAEGMGYLE--- 138
Query: 812 SPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAG-SYGYIAPEYAYT 870
           S   IHRD+ + N+LL +     + DFGL + L        M       + + APE   T
Sbjct: 139 SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 198
Query: 871 LKVDEKSDVYSFGVVLLELIA-GKKP-VGEFGDGVDIVRWVRKTTSEVSQPSD 921
                 SD + FGV L E+   G++P +G   +G  I+  + K    + +P D
Sbjct: 199 RTFSHASDTWMFGVTLWEMFTYGQEPWIGL--NGSQILHKIDKEGERLPRPED 249

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 81/161 (50%), Gaps = 9/161 (5%)
Query: 739 EIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIAL 798
           EIQ L   RH +I++L   +S      ++ EY+  G L + +   K G L  +   R+  
Sbjct: 66  EIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYI--CKNGRLDEKESRRLFQ 123
Query: 799 EAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAG 858
           +   G+ Y H     +++HRD+K  N+LLD+   A +ADFGL+  + D    E +    G
Sbjct: 124 QILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG---EFLRXSCG 177
Query: 859 SYGYIAPEY-AYTLKVDEKSDVYSFGVVLLELIAGKKPVGE 898
           S  Y APE  +  L    + D++S GV+L  L+ G  P  +
Sbjct: 178 SPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDD 218

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Composition-based stats.
 Identities = 70/233 (30%), Positives = 109/233 (46%), Gaps = 20/233 (8%)
Query: 700 IGKGGAGIVYRGS--MPDG--IDVAIKRL----VGRGTGGNDHGFLAEIQTLGRIRHRNI 751
           +G G  G+V RG    P G  + VA+K L    + +    +D  F+ E+  +  + HRN+
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDD--FIREVNAMHSLDHRNL 73
Query: 752 VRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDC 811
           +RL G V      ++  E  P GSL + L   +G H    T  R A++ A+G+ YL    
Sbjct: 74  IRLYGVVLTPPMKMVT-ELAPLGSLLDRLRKHQG-HFLLGTLSRYAVQVAEGMGYLE--- 128
Query: 812 SPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAG-SYGYIAPEYAYT 870
           S   IHRD+ + N+LL +     + DFGL + L        M       + + APE   T
Sbjct: 129 SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 188
Query: 871 LKVDEKSDVYSFGVVLLELIA-GKKP-VGEFGDGVDIVRWVRKTTSEVSQPSD 921
                 SD + FGV L E+   G++P +G   +G  I+  + K    + +P D
Sbjct: 189 RTFSHASDTWMFGVTLWEMFTYGQEPWIGL--NGSQILHKIDKEGERLPRPED 239

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 75/292 (25%), Positives = 127/292 (43%), Gaps = 35/292 (11%)
Query: 693 SLKDENIIGKGGAGIVYRG-SMPDG----IDVAIKRLVGRGTGGNDHGFLAEIQTLGRIR 747
            L+   ++G G  G V++G  +P+G    I V IK +  +    +       +  +G + 
Sbjct: 32  ELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLD 91
Query: 748 HRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYL 807
           H +IVRLLG        L+  +Y+P GSL + +   +G  L  +      ++ AKG+ YL
Sbjct: 92  HAHIVRLLGLCPGSSLQLVT-QYLPLGSLLDHVRQHRGA-LGPQLLLNWGVQIAKGMYYL 149
Query: 808 HHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEY 867
                  ++HR++ + N+LL S  +  VADFG+A  L         S       ++A E 
Sbjct: 150 EEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALES 206
Query: 868 AYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVL 926
            +  K   +SDV+S+GV + EL+  G +P                  +EV    +    L
Sbjct: 207 IHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGL------------RLAEVPDLLEKGERL 254
Query: 927 AVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVV----HMLANPPQ 974
           A         P    I ++ V + C   + + RPT +E+      M  +PP+
Sbjct: 255 A--------QPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDPPR 298

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 77.4 bits (189), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 75/292 (25%), Positives = 127/292 (43%), Gaps = 35/292 (11%)
Query: 693 SLKDENIIGKGGAGIVYRG-SMPDG----IDVAIKRLVGRGTGGNDHGFLAEIQTLGRIR 747
            L+   ++G G  G V++G  +P+G    I V IK +  +    +       +  +G + 
Sbjct: 14  ELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLD 73
Query: 748 HRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYL 807
           H +IVRLLG        L+  +Y+P GSL + +   +G  L  +      ++ AKG+ YL
Sbjct: 74  HAHIVRLLGLCPGSSLQLVT-QYLPLGSLLDHVRQHRGA-LGPQLLLNWGVQIAKGMYYL 131
Query: 808 HHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEY 867
                  ++HR++ + N+LL S  +  VADFG+A  L         S       ++A E 
Sbjct: 132 EEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALES 188
Query: 868 AYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVL 926
            +  K   +SDV+S+GV + EL+  G +P                  +EV    +    L
Sbjct: 189 IHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGL------------RLAEVPDLLEKGERL 236
Query: 927 AVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVV----HMLANPPQ 974
           A         P    I ++ V + C   + + RPT +E+      M  +PP+
Sbjct: 237 A--------QPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDPPR 280

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 77.4 bits (189), Expect = 4e-14,   Method: Composition-based stats.
 Identities = 79/286 (27%), Positives = 117/286 (40%), Gaps = 48/286 (16%)
Query: 697 ENIIGKGGAGIVYRGSMPDG----IDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIV 752
           + +IGKG  G+VY G   D     I  AIK L           FL E   +  + H N++
Sbjct: 26  DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVL 85
Query: 753 RLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETR-------YRIALEAAKGLC 805
            L+G        +L  E +P+  L  M HG     ++   R           L+ A+G+ 
Sbjct: 86  ALIGI-------MLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGME 138
Query: 806 YLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYG---- 861
           YL        +HRD+ + N +LD  F   VADFGLA+ + D    E  S     +     
Sbjct: 139 YL---AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILD---REYYSVQQHRHARLPV 192
Query: 862 -YIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPS 920
            + A E   T +   KSDV+SFGV+L EL+    P     D  D+  ++ +    + QP 
Sbjct: 193 KWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQ-GRRLPQPE 251
Query: 921 DAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVV 966
                                  L++V   C E + + RPT R +V
Sbjct: 252 YCPD------------------SLYQVMQQCWEADPAVRPTFRVLV 279

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 74/315 (23%), Positives = 132/315 (41%), Gaps = 47/315 (14%)
Query: 691 LESLKDENII-----GKGGAGIVYRGSM------PDGIDVAIKRLVGRGTGGNDHGFLAE 739
           ++ +K  NI+     G+G  G V+           D I VA+K L           F  E
Sbjct: 7   VQHIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARK-DFHRE 65
Query: 740 IQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEML--HG------AKGG---HL 788
            + L  ++H +IV+  G     D  ++++EYM +G L + L  HG      A+G     L
Sbjct: 66  AELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTEL 125
Query: 789 KWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAG 848
                  IA + A G+ YL    S   +HRD+ + N L+  +    + DFG+++ +    
Sbjct: 126 TQSQMLHIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTD 182
Query: 849 ASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVR 907
                        ++ PE     K   +SDV+S GVVL E+   GK+P            
Sbjct: 183 YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP------------ 230
Query: 908 WVRKTTSEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH 967
           W + + +EV        +  +   R+   P T    ++++ + C + E   R  ++ +  
Sbjct: 231 WYQLSNNEV--------IECITQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHT 282
Query: 968 MLANPPQSAPSLITL 982
           +L N  +++P  + +
Sbjct: 283 LLQNLAKASPVYLDI 297

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 74/272 (27%), Positives = 116/272 (42%), Gaps = 36/272 (13%)
Query: 700 IGKGGAGIVYRGSM--PDG--IDVAIKRL----VGRGTGGNDHGFLAEIQTLGRIRHRNI 751
           +G G  G+V RG    P G  + VA+K L    + +    +D  F+ E+  +  + HRN+
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDD--FIREVNAMHSLDHRNL 77
Query: 752 VRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDC 811
           +RL G V      ++  E  P GSL + L   +G H    T  R A++ A+G+ YL    
Sbjct: 78  IRLYGVVLTPPMKMVT-ELAPLGSLLDRLRKHQG-HFLLGTLSRYAVQVAEGMGYLE--- 132
Query: 812 SPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAG-SYGYIAPEYAYT 870
           S   IHRD+ + N+LL +     + DFGL + L        M       + + APE   T
Sbjct: 133 SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 192
Query: 871 LKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVV 929
                 SD + FGV L E+   G++P     +G  I+  + K    + +P D        
Sbjct: 193 RTFSHASDTWMFGVTLWEMFTYGQEPWIGL-NGSQILHKIDKEGERLPRPEDCPQ----- 246
Query: 930 DPRLSGYPLTGVIHLFKVAMMCVEDESSARPT 961
                         ++ V + C   +   RPT
Sbjct: 247 -------------DIYNVMVQCWAHKPEDRPT 265

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 77.0 bits (188), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 70/230 (30%), Positives = 106/230 (46%), Gaps = 31/230 (13%)
Query: 693 SLKDENIIGKGGAGIVYRGS-MPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNI 751
           SL+   I  +G  G V++   M D + V I  L  + +  ++     EI +   ++H N+
Sbjct: 16  SLQLLEIKARGRFGCVWKAQLMNDFVAVKIFPLQDKQSWQSER----EIFSTPGMKHENL 71
Query: 752 VRLLGYVSNRDTNL-----LLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCY 806
           ++ +     R +NL     L+  +   GSL + L   KG  + W     +A   ++GL Y
Sbjct: 72  LQFIA-AEKRGSNLEVELWLITAFHDKGSLTDYL---KGNIITWNELCHVAETMSRGLSY 127
Query: 807 LHHDC--------SPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAG 858
           LH D          P I HRD KS N+LL SD  A +ADFGLA   +            G
Sbjct: 128 LHEDVPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVG 187
Query: 859 SYGYIAPEY---AYTLKVDE--KSDVYSFGVVLLELI----AGKKPVGEF 899
           +  Y+APE    A   + D   + D+Y+ G+VL EL+    A   PV E+
Sbjct: 188 TRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELVSRCKAADGPVDEY 237

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 77.0 bits (188), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 103/211 (48%), Gaps = 14/211 (6%)
Query: 691 LESLKDENI-----IGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLG 744
           L  LKD++      +G G  G+V++ S  P G+ +A K +         +  + E+Q L 
Sbjct: 3   LGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLH 62
Query: 745 RIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGL 804
                 IV   G   +     +  E+M  GSL ++L   K G +  +   ++++   KGL
Sbjct: 63  ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILGKVSIAVIKGL 120
Query: 805 CYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIA 864
            YL       I+HRDVK +NIL++S  E  + DFG++  L D  A+E      G+  Y++
Sbjct: 121 TYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDEMANE----FVGTRSYMS 174
Query: 865 PEYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
           PE         +SD++S G+ L+E+  G+ P
Sbjct: 175 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 205

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 67/244 (27%), Positives = 112/244 (45%), Gaps = 36/244 (14%)
Query: 699 IIGKGGAGIVYRGSMP-DGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRH--------- 748
           ++G+G  G V +     D    AIK++  R T       L+E+  L  + H         
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKI--RHTEEKLSTILSEVMLLASLNHQYVVRYYAA 70
Query: 749 ----RNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGL 804
               RN V+ +  V  + T  +  EY  NG+L +++H       + E  +R+  +  + L
Sbjct: 71  WLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEY-WRLFRQILEAL 129
Query: 805 CYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDA------------GASEC 852
            Y+H   S  IIHRD+K  NI +D      + DFGLAK +  +            G+S+ 
Sbjct: 130 SYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDN 186
Query: 853 MSSVAGSYGYIAPEYAY-TLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRK 911
           ++S  G+  Y+A E    T   +EK D+YS G++  E+I    P     + V+I++ +R 
Sbjct: 187 LTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILKKLRS 243
Query: 912 TTSE 915
            + E
Sbjct: 244 VSIE 247

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 69/228 (30%), Positives = 107/228 (46%), Gaps = 38/228 (16%)
Query: 691 LESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAE--IQTLGRIRH 748
           L++LK   +IG+G  G VY+GS+ D   VA+K      +  N   F+ E  I  +  + H
Sbjct: 12  LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVF----SFANRQNFINEKNIYRVPLMEH 66
Query: 749 RNIVRLLG-----YVSNRDTNLLLYEYMPNGSLGEML--HGAKGGHLKWETRYRIALEAA 801
            NI R +          R   LL+ EY PNGSL + L  H +      W +  R+A    
Sbjct: 67  DNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSD-----WVSSCRLAHSVT 121
Query: 802 KGLCYLHHDC------SPLIIHRDVKSNNILLDSDFEAHVADFGLA------KFLQDAGA 849
           +GL YLH +        P I HRD+ S N+L+ +D    ++DFGL+      + ++    
Sbjct: 122 RGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEE 181
Query: 850 SECMSSVAGSYGYIAPEY---AYTLKVDEKS----DVYSFGVVLLELI 890
                S  G+  Y+APE    A  L+  E +    D+Y+ G++  E+ 
Sbjct: 182 DNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIF 229

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 70/271 (25%), Positives = 117/271 (43%), Gaps = 31/271 (11%)
Query: 699 IIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDH---GFLAEIQTLGRIRHRNIVRLL 755
            +GKGG    +  S  D  +V   ++V +      H       EI     + H+++V   
Sbjct: 28  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 87
Query: 756 GYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLI 815
           G+  + D   ++ E     SL E LH  +    + E RY +  +   G  YLH +    +
Sbjct: 88  GFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLR-QIVLGCQYLHRN---RV 142
Query: 816 IHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDE 875
           IHRD+K  N+ L+ D E  + DFGLA  ++  G  E   ++ G+  YIAPE         
Sbjct: 143 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG--ERKKTLCGTPNYIAPEVLSKKGHSF 200
Query: 876 KSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDPRLSG 935
           + DV+S G ++  L+ GK P   F        ++R   +E S P     V A +  ++  
Sbjct: 201 EVDVWSIGCIMYTLLVGKPP---FETSCLKETYLRIKKNEYSIPKHINPVAASLIQKM-- 255
Query: 936 YPLTGVIHLFKVAMMCVEDESSARPTMREVV 966
                           ++ + +ARPT+ E++
Sbjct: 256 ----------------LQTDPTARPTINELL 270

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 76.6 bits (187), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 70/271 (25%), Positives = 117/271 (43%), Gaps = 31/271 (11%)
Query: 699 IIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDH---GFLAEIQTLGRIRHRNIVRLL 755
            +GKGG    +  S  D  +V   ++V +      H       EI     + H+++V   
Sbjct: 24  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 83
Query: 756 GYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLI 815
           G+  + D   ++ E     SL E LH  +    + E RY +  +   G  YLH +    +
Sbjct: 84  GFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLR-QIVLGCQYLHRN---RV 138
Query: 816 IHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDE 875
           IHRD+K  N+ L+ D E  + DFGLA  ++  G  E   ++ G+  YIAPE         
Sbjct: 139 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG--ERKKTLCGTPNYIAPEVLSKKGHSF 196
Query: 876 KSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDPRLSG 935
           + DV+S G ++  L+ GK P   F        ++R   +E S P     V A +  ++  
Sbjct: 197 EVDVWSIGCIMYTLLVGKPP---FETSCLKETYLRIKKNEYSIPKHINPVAASLIQKM-- 251
Query: 936 YPLTGVIHLFKVAMMCVEDESSARPTMREVV 966
                           ++ + +ARPT+ E++
Sbjct: 252 ----------------LQTDPTARPTINELL 266

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 76.6 bits (187), Expect = 7e-14,   Method: Composition-based stats.
 Identities = 69/220 (31%), Positives = 106/220 (48%), Gaps = 19/220 (8%)
Query: 699 IIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHGFL----AEIQTLGRIRHRNIVR 753
           I+G GG   V+    + D  DVA+K L  R     D  F      E Q    + H  IV 
Sbjct: 19  ILGFGGMSEVHLARDLRDHRDVAVKVL--RADLARDPSFYLRFRREAQNAAALNHPAIVA 76
Query: 754 LL--GYVSNRDTNL--LLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHH 809
           +   G        L  ++ EY+   +L +++H    G +  +    +  +A + L + H 
Sbjct: 77  VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQ 134
Query: 810 DCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSS-VAGSYGYIAPEYA 868
           +    IIHRDVK  NI++ +     V DFG+A+ + D+G S   ++ V G+  Y++PE A
Sbjct: 135 NG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 191
Query: 869 YTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRW 908
               VD +SDVYS G VL E++ G+ P    GD  D V +
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLTGEPPFT--GDSPDSVAY 229

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 70/271 (25%), Positives = 117/271 (43%), Gaps = 31/271 (11%)
Query: 699 IIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDH---GFLAEIQTLGRIRHRNIVRLL 755
            +GKGG    +  S  D  +V   ++V +      H       EI     + H+++V   
Sbjct: 24  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 83
Query: 756 GYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLI 815
           G+  + D   ++ E     SL E LH  +    + E RY +  +   G  YLH +    +
Sbjct: 84  GFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLR-QIVLGCQYLHRN---RV 138
Query: 816 IHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDE 875
           IHRD+K  N+ L+ D E  + DFGLA  ++  G  E   ++ G+  YIAPE         
Sbjct: 139 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG--ERKKTLCGTPNYIAPEVLSKKGHSF 196
Query: 876 KSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDPRLSG 935
           + DV+S G ++  L+ GK P   F        ++R   +E S P     V A +  ++  
Sbjct: 197 EVDVWSIGCIMYTLLVGKPP---FETSCLKETYLRIKKNEYSIPKHINPVAASLIQKM-- 251
Query: 936 YPLTGVIHLFKVAMMCVEDESSARPTMREVV 966
                           ++ + +ARPT+ E++
Sbjct: 252 ----------------LQTDPTARPTINELL 266

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 76.3 bits (186), Expect = 8e-14,   Method: Composition-based stats.
 Identities = 66/207 (31%), Positives = 101/207 (48%), Gaps = 17/207 (8%)
Query: 699 IIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHGFL----AEIQTLGRIRHRNIVR 753
           I+G GG   V+    + D  DVA+K L  R     D  F      E Q    + H  IV 
Sbjct: 19  ILGFGGMSEVHLARDLRDHRDVAVKVL--RADLARDPSFYLRFRREAQNAAALNHPAIVA 76
Query: 754 LL--GYVSNRDTNL--LLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHH 809
           +   G        L  ++ EY+   +L +++H    G +  +    +  +A + L + H 
Sbjct: 77  VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQ 134
Query: 810 DCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS-ECMSSVAGSYGYIAPEYA 868
           +    IIHRDVK  NIL+ +     V DFG+A+ + D+G S    ++V G+  Y++PE A
Sbjct: 135 NG---IIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPEQA 191
Query: 869 YTLKVDEKSDVYSFGVVLLELIAGKKP 895
               VD +SDVYS G VL E++ G+ P
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 76.3 bits (186), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 102/210 (48%), Gaps = 14/210 (6%)
Query: 693 SLKDENI-----IGKGGAGIVYR-GSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRI 746
            LKD++      +G G  G+V +    P G+ +A K +         +  + E+Q L   
Sbjct: 12  ELKDDDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC 71
Query: 747 RHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCY 806
               IV   G   +     +  E+M  GSL ++L  AK   +  E   ++++   +GL Y
Sbjct: 72  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAK--RIPEEILGKVSIAVLRGLAY 129
Query: 807 LHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPE 866
           L       I+HRDVK +NIL++S  E  + DFG++  L D+ A    +S  G+  Y+APE
Sbjct: 130 LREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA----NSFVGTRSYMAPE 183
Query: 867 YAYTLKVDEKSDVYSFGVVLLELIAGKKPV 896
                    +SD++S G+ L+EL  G+ P+
Sbjct: 184 RLQGTHYSVQSDIWSMGLSLVELAVGRYPI 213

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 106/217 (48%), Gaps = 24/217 (11%)
Query: 693 SLKDENIIGKGGAGIVYRGSMP-DGI--DVAIKRLVGRGTGGNDHGFLAEIQTLGRI-RH 748
            +K +++IG+G  G V +  +  DG+  D AIKR+    +  +   F  E++ L ++  H
Sbjct: 26  DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHH 85
Query: 749 RNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAK--------------GGHLKWETRY 794
            NI+ LLG   +R    L  EY P+G+L + L  ++                 L  +   
Sbjct: 86  PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 145
Query: 795 RIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMS 854
             A + A+G+ YL        IHRD+ + NIL+  ++ A +ADFGL++  Q+    + M 
Sbjct: 146 HFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRG-QEVYVKKTMG 201
Query: 855 SVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA 891
            +     ++A E          SDV+S+GV+L E+++
Sbjct: 202 RLPVR--WMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 106/217 (48%), Gaps = 24/217 (11%)
Query: 693 SLKDENIIGKGGAGIVYRGSMP-DGI--DVAIKRLVGRGTGGNDHGFLAEIQTLGRI-RH 748
            +K +++IG+G  G V +  +  DG+  D AIKR+    +  +   F  E++ L ++  H
Sbjct: 16  DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHH 75
Query: 749 RNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAK--------------GGHLKWETRY 794
            NI+ LLG   +R    L  EY P+G+L + L  ++                 L  +   
Sbjct: 76  PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 135
Query: 795 RIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMS 854
             A + A+G+ YL        IHRD+ + NIL+  ++ A +ADFGL++  Q+    + M 
Sbjct: 136 HFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRG-QEVYVKKTMG 191
Query: 855 SVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA 891
            +     ++A E          SDV+S+GV+L E+++
Sbjct: 192 RLPVR--WMAIESLNYSVYTTNSDVWSYGVLLWEIVS 226

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 80/299 (26%), Positives = 129/299 (43%), Gaps = 50/299 (16%)
Query: 693 SLKDENIIGKGGAGIVYRG-SMPDG----IDVAIKRLVGRGTGGNDHGFLAEIQTLGRIR 747
             K   ++G G  G VY+G  +P+G    I VAIK L    +   +   L E   +  + 
Sbjct: 41  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 100
Query: 748 HRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGG-----HLKWETRYRIALEAAK 802
           + ++ RLLG +    T  L+ + MP G L + +   K        L W       ++ AK
Sbjct: 101 NPHVCRLLG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAK 153
Query: 803 GLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGS--- 859
           G+ YL       ++HRD+ + N+L+ +     + DFGLAK L   GA E      G    
Sbjct: 154 GMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL---GAEEKEYHAEGGKVP 207
Query: 860 YGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQ 918
             ++A E         +SDV+S+GV + EL+  G KP     DG+               
Sbjct: 208 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY----DGI--------------- 248
Query: 919 PSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVV---HMLANPPQ 974
           P+   S +     RL   P+   I ++ + + C   ++ +RP  RE++     +A  PQ
Sbjct: 249 PASEISSILEKGERLPQPPIC-TIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQ 306

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 79/299 (26%), Positives = 128/299 (42%), Gaps = 50/299 (16%)
Query: 693 SLKDENIIGKGGAGIVYRG-SMPDG----IDVAIKRLVGRGTGGNDHGFLAEIQTLGRIR 747
             K   ++G G  G VY+G  +P+G    I VAIK L    +   +   L E   +  + 
Sbjct: 17  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 76
Query: 748 HRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGG-----HLKWETRYRIALEAAK 802
           + ++ RLLG        L++ + MP G L + +   K        L W       ++ AK
Sbjct: 77  NPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAK 129
Query: 803 GLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAG---S 859
           G+ YL       ++HRD+ + N+L+ +     + DFGLAK L   GA E      G    
Sbjct: 130 GMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL---GAEEKEYHAEGGKVP 183
Query: 860 YGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQ 918
             ++A E         +SDV+S+GV + EL+  G KP     DG+               
Sbjct: 184 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY----DGI--------------- 224
Query: 919 PSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVV---HMLANPPQ 974
           P+   S +     RL   P+   I ++ + + C   ++ +RP  RE++     +A  PQ
Sbjct: 225 PASEISSILEKGERLPQPPIC-TIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQ 282

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 79/299 (26%), Positives = 128/299 (42%), Gaps = 50/299 (16%)
Query: 693 SLKDENIIGKGGAGIVYRG-SMPDG----IDVAIKRLVGRGTGGNDHGFLAEIQTLGRIR 747
             K   ++G G  G VY+G  +P+G    I VAIK L    +   +   L E   +  + 
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 748 HRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGG-----HLKWETRYRIALEAAK 802
           + ++ RLLG        L++ + MP G L + +   K        L W       ++ AK
Sbjct: 79  NPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAK 131
Query: 803 GLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAG---S 859
           G+ YL       ++HRD+ + N+L+ +     + DFGLAK L   GA E      G    
Sbjct: 132 GMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL---GAEEKEYHAEGGKVP 185
Query: 860 YGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQ 918
             ++A E         +SDV+S+GV + EL+  G KP     DG+               
Sbjct: 186 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY----DGI--------------- 226
Query: 919 PSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVV---HMLANPPQ 974
           P+   S +     RL   P+   I ++ + + C   ++ +RP  RE++     +A  PQ
Sbjct: 227 PASEISSILEKGERLPQPPIC-TIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQ 284

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 79/299 (26%), Positives = 128/299 (42%), Gaps = 50/299 (16%)
Query: 693 SLKDENIIGKGGAGIVYRG-SMPDG----IDVAIKRLVGRGTGGNDHGFLAEIQTLGRIR 747
             K   ++G G  G VY+G  +P+G    I VAIK L    +   +   L E   +  + 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 748 HRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGG-----HLKWETRYRIALEAAK 802
           + ++ RLLG        L++ + MP G L + +   K        L W       ++ AK
Sbjct: 76  NPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAK 128
Query: 803 GLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAG---S 859
           G+ YL       ++HRD+ + N+L+ +     + DFGLAK L   GA E      G    
Sbjct: 129 GMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL---GAEEKEYHAEGGKVP 182
Query: 860 YGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQ 918
             ++A E         +SDV+S+GV + EL+  G KP     DG+               
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY----DGI--------------- 223
Query: 919 PSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVV---HMLANPPQ 974
           P+   S +     RL   P+   I ++ + + C   ++ +RP  RE++     +A  PQ
Sbjct: 224 PASEISSILEKGERLPQPPIC-TIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQ 281

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 79/299 (26%), Positives = 128/299 (42%), Gaps = 50/299 (16%)
Query: 693 SLKDENIIGKGGAGIVYRG-SMPDG----IDVAIKRLVGRGTGGNDHGFLAEIQTLGRIR 747
             K   ++G G  G VY+G  +P+G    I VAIK L    +   +   L E   +  + 
Sbjct: 20  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 79
Query: 748 HRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGG-----HLKWETRYRIALEAAK 802
           + ++ RLLG        L++ + MP G L + +   K        L W       ++ AK
Sbjct: 80  NPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAK 132
Query: 803 GLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAG---S 859
           G+ YL       ++HRD+ + N+L+ +     + DFGLAK L   GA E      G    
Sbjct: 133 GMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL---GAEEKEYHAEGGKVP 186
Query: 860 YGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQ 918
             ++A E         +SDV+S+GV + EL+  G KP     DG+               
Sbjct: 187 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY----DGI--------------- 227
Query: 919 PSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVV---HMLANPPQ 974
           P+   S +     RL   P+   I ++ + + C   ++ +RP  RE++     +A  PQ
Sbjct: 228 PASEISSILEKGERLPQPPIC-TIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQ 285

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 80/299 (26%), Positives = 129/299 (43%), Gaps = 50/299 (16%)
Query: 693 SLKDENIIGKGGAGIVYRG-SMPDG----IDVAIKRLVGRGTGGNDHGFLAEIQTLGRIR 747
             K   ++G G  G VY+G  +P+G    I VAIK L    +   +   L E   +  + 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 748 HRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGG-----HLKWETRYRIALEAAK 802
           + ++ RLLG +    T  L+ + MP G L + +   K        L W       ++ AK
Sbjct: 76  NPHVCRLLG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAK 128
Query: 803 GLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAG---S 859
           G+ YL       ++HRD+ + N+L+ +     + DFGLAK L   GA E      G    
Sbjct: 129 GMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL---GAEEKEYHAEGGKVP 182
Query: 860 YGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQ 918
             ++A E         +SDV+S+GV + EL+  G KP     DG+               
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY----DGI--------------- 223
Query: 919 PSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVV---HMLANPPQ 974
           P+   S +     RL   P+   I ++ + + C   ++ +RP  RE++     +A  PQ
Sbjct: 224 PASEISSILEKGERLPQPPIC-TIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQ 281

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 79/299 (26%), Positives = 128/299 (42%), Gaps = 50/299 (16%)
Query: 693 SLKDENIIGKGGAGIVYRG-SMPDG----IDVAIKRLVGRGTGGNDHGFLAEIQTLGRIR 747
             K   ++G G  G VY+G  +P+G    I VAIK L    +   +   L E   +  + 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 748 HRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGG-----HLKWETRYRIALEAAK 802
           + ++ RLLG        L++ + MP G L + +   K        L W       ++ AK
Sbjct: 78  NPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAK 130
Query: 803 GLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGS--- 859
           G+ YL       ++HRD+ + N+L+ +     + DFGLAK L   GA E      G    
Sbjct: 131 GMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL---GAEEKEYHAEGGKVP 184
Query: 860 YGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQ 918
             ++A E         +SDV+S+GV + EL+  G KP     DG+               
Sbjct: 185 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY----DGI--------------- 225
Query: 919 PSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVV---HMLANPPQ 974
           P+   S +     RL   P+   I ++ + + C   ++ +RP  RE++     +A  PQ
Sbjct: 226 PASEISSILEKGERLPQPPIC-TIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQ 283

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 79/299 (26%), Positives = 128/299 (42%), Gaps = 50/299 (16%)
Query: 693 SLKDENIIGKGGAGIVYRG-SMPDG----IDVAIKRLVGRGTGGNDHGFLAEIQTLGRIR 747
             K   ++G G  G VY+G  +P+G    I VAIK L    +   +   L E   +  + 
Sbjct: 17  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 76
Query: 748 HRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGG-----HLKWETRYRIALEAAK 802
           + ++ RLLG        L++ + MP G L + +   K        L W       ++ AK
Sbjct: 77  NPHVCRLLGICLTSTVQLIM-QLMPFGXLLDYVREHKDNIGSQYLLNW------CVQIAK 129
Query: 803 GLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAG---S 859
           G+ YL       ++HRD+ + N+L+ +     + DFGLAK L   GA E      G    
Sbjct: 130 GMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL---GAEEKEYHAEGGKVP 183
Query: 860 YGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQ 918
             ++A E         +SDV+S+GV + EL+  G KP     DG+               
Sbjct: 184 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY----DGI--------------- 224
Query: 919 PSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVV---HMLANPPQ 974
           P+   S +     RL   P+   I ++ + + C   ++ +RP  RE++     +A  PQ
Sbjct: 225 PASEISSILEKGERLPQPPIC-TIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQ 282

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 80/299 (26%), Positives = 129/299 (43%), Gaps = 50/299 (16%)
Query: 693 SLKDENIIGKGGAGIVYRG-SMPDG----IDVAIKRLVGRGTGGNDHGFLAEIQTLGRIR 747
             K   ++G G  G VY+G  +P+G    I VAIK L    +   +   L E   +  + 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 748 HRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGG-----HLKWETRYRIALEAAK 802
           + ++ RLLG +    T  L+ + MP G L + +   K        L W       ++ AK
Sbjct: 78  NPHVCRLLG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAK 130
Query: 803 GLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAG---S 859
           G+ YL       ++HRD+ + N+L+ +     + DFGLAK L   GA E      G    
Sbjct: 131 GMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL---GAEEKEYHAEGGKVP 184
Query: 860 YGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQ 918
             ++A E         +SDV+S+GV + EL+  G KP     DG+               
Sbjct: 185 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY----DGI--------------- 225
Query: 919 PSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVV---HMLANPPQ 974
           P+   S +     RL   P+   I ++ + + C   ++ +RP  RE++     +A  PQ
Sbjct: 226 PASEISSILEKGERLPQPPIC-TIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQ 283

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 80/299 (26%), Positives = 129/299 (43%), Gaps = 50/299 (16%)
Query: 693 SLKDENIIGKGGAGIVYRG-SMPDG----IDVAIKRLVGRGTGGNDHGFLAEIQTLGRIR 747
             K   ++G G  G VY+G  +P+G    I VAIK L    +   +   L E   +  + 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 748 HRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGG-----HLKWETRYRIALEAAK 802
           + ++ RLLG +    T  L+ + MP G L + +   K        L W       ++ AK
Sbjct: 76  NPHVCRLLG-ICLTSTVQLITQLMPFGXLLDYVREHKDNIGSQYLLNW------CVQIAK 128
Query: 803 GLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAG---S 859
           G+ YL       ++HRD+ + N+L+ +     + DFGLAK L   GA E      G    
Sbjct: 129 GMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL---GAEEKEYHAEGGKVP 182
Query: 860 YGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQ 918
             ++A E         +SDV+S+GV + EL+  G KP     DG+               
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY----DGI--------------- 223
Query: 919 PSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVV---HMLANPPQ 974
           P+   S +     RL   P+   I ++ + + C   ++ +RP  RE++     +A  PQ
Sbjct: 224 PASEISSILEKGERLPQPPIC-TIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQ 281

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Composition-based stats.
 Identities = 65/207 (31%), Positives = 101/207 (48%), Gaps = 17/207 (8%)
Query: 699 IIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHGFL----AEIQTLGRIRHRNIVR 753
           I+G GG   V+    + D  DVA+K L  R     D  F      E Q    + H  IV 
Sbjct: 19  ILGFGGMSEVHLARDLRDHRDVAVKVL--RADLARDPSFYLRFRREAQNAAALNHPAIVA 76
Query: 754 LL--GYVSNRDTNL--LLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHH 809
           +   G        L  ++ EY+   +L +++H    G +  +    +  +A + L + H 
Sbjct: 77  VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQ 134
Query: 810 DCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSS-VAGSYGYIAPEYA 868
           +    IIHRDVK  NI++ +     V DFG+A+ + D+G S   ++ V G+  Y++PE A
Sbjct: 135 NG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 191
Query: 869 YTLKVDEKSDVYSFGVVLLELIAGKKP 895
               VD +SDVYS G VL E++ G+ P
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 80/299 (26%), Positives = 129/299 (43%), Gaps = 50/299 (16%)
Query: 693 SLKDENIIGKGGAGIVYRG-SMPDG----IDVAIKRLVGRGTGGNDHGFLAEIQTLGRIR 747
             K   ++G G  G VY+G  +P+G    I VAIK L    +   +   L E   +  + 
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 748 HRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGG-----HLKWETRYRIALEAAK 802
           + ++ RLLG +    T  L+ + MP G L + +   K        L W       ++ AK
Sbjct: 79  NPHVCRLLG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAK 131
Query: 803 GLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAG---S 859
           G+ YL       ++HRD+ + N+L+ +     + DFGLAK L   GA E      G    
Sbjct: 132 GMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL---GAEEKEYHAEGGKVP 185
Query: 860 YGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQ 918
             ++A E         +SDV+S+GV + EL+  G KP     DG+               
Sbjct: 186 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY----DGI--------------- 226
Query: 919 PSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVV---HMLANPPQ 974
           P+   S +     RL   P+   I ++ + + C   ++ +RP  RE++     +A  PQ
Sbjct: 227 PASEISSILEKGERLPQPPIC-TIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQ 284

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 80/299 (26%), Positives = 129/299 (43%), Gaps = 50/299 (16%)
Query: 693 SLKDENIIGKGGAGIVYRG-SMPDG----IDVAIKRLVGRGTGGNDHGFLAEIQTLGRIR 747
             K   ++G G  G VY+G  +P+G    I VAIK L    +   +   L E   +  + 
Sbjct: 22  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 81
Query: 748 HRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGG-----HLKWETRYRIALEAAK 802
           + ++ RLLG +    T  L+ + MP G L + +   K        L W       ++ AK
Sbjct: 82  NPHVCRLLG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAK 134
Query: 803 GLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAG---S 859
           G+ YL       ++HRD+ + N+L+ +     + DFGLAK L   GA E      G    
Sbjct: 135 GMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL---GAEEKEYHAEGGKVP 188
Query: 860 YGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQ 918
             ++A E         +SDV+S+GV + EL+  G KP     DG+               
Sbjct: 189 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY----DGI--------------- 229
Query: 919 PSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVV---HMLANPPQ 974
           P+   S +     RL   P+   I ++ + + C   ++ +RP  RE++     +A  PQ
Sbjct: 230 PASEISSILEKGERLPQPPIC-TIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQ 287

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 80/299 (26%), Positives = 129/299 (43%), Gaps = 50/299 (16%)
Query: 693 SLKDENIIGKGGAGIVYRG-SMPDG----IDVAIKRLVGRGTGGNDHGFLAEIQTLGRIR 747
             K   ++G G  G VY+G  +P+G    I VAIK L    +   +   L E   +  + 
Sbjct: 23  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 748 HRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGG-----HLKWETRYRIALEAAK 802
           + ++ RLLG +    T  L+ + MP G L + +   K        L W       ++ AK
Sbjct: 83  NPHVCRLLG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAK 135
Query: 803 GLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGS--- 859
           G+ YL       ++HRD+ + N+L+ +     + DFGLAK L   GA E      G    
Sbjct: 136 GMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL---GAEEKEYHAEGGKVP 189
Query: 860 YGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQ 918
             ++A E         +SDV+S+GV + EL+  G KP     DG+               
Sbjct: 190 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY----DGI--------------- 230
Query: 919 PSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVV---HMLANPPQ 974
           P+   S +     RL   P+   I ++ + + C   ++ +RP  RE++     +A  PQ
Sbjct: 231 PASEISSILEKGERLPQPPIC-TIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQ 288

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 80/299 (26%), Positives = 129/299 (43%), Gaps = 50/299 (16%)
Query: 693 SLKDENIIGKGGAGIVYRG-SMPDG----IDVAIKRLVGRGTGGNDHGFLAEIQTLGRIR 747
             K   ++G G  G VY+G  +P+G    I VAIK L    +   +   L E   +  + 
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 748 HRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGG-----HLKWETRYRIALEAAK 802
           + ++ RLLG +    T  L+ + MP G L + +   K        L W       ++ AK
Sbjct: 79  NPHVCRLLG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAK 131
Query: 803 GLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGS--- 859
           G+ YL       ++HRD+ + N+L+ +     + DFGLAK L   GA E      G    
Sbjct: 132 GMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL---GAEEKEYHAEGGKVP 185
Query: 860 YGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQ 918
             ++A E         +SDV+S+GV + EL+  G KP     DG+               
Sbjct: 186 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY----DGI--------------- 226
Query: 919 PSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVV---HMLANPPQ 974
           P+   S +     RL   P+   I ++ + + C   ++ +RP  RE++     +A  PQ
Sbjct: 227 PASEISSILEKGERLPQPPIC-TIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQ 284

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 75.5 bits (184), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 75/313 (23%), Positives = 130/313 (41%), Gaps = 49/313 (15%)
Query: 686 KAEDVLESLKDENIIGKGGAGIVYRGSM------PDGIDVAIKRLVGRGTGGNDHGFLAE 739
           K  D++  LK E  +G+G  G V+           D + VA+K L    T      F  E
Sbjct: 13  KRRDIV--LKRE--LGEGAFGKVFLAECYNLSPTKDKMLVAVKAL-KDPTLAARKDFQRE 67
Query: 740 IQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEML--HGAKG------------ 785
            + L  ++H +IV+  G   + D  ++++EYM +G L + L  HG               
Sbjct: 68  AELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAK 127
Query: 786 GHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQ 845
           G L       IA + A G+ YL    S   +HRD+ + N L+ ++    + DFG+++ + 
Sbjct: 128 GELGLSQMLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVY 184
Query: 846 DAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVD 904
                           ++ PE     K   +SDV+SFGV+L E+   GK+P         
Sbjct: 185 STDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP--------- 235
Query: 905 IVRWVRKTTSEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMRE 964
              W + + +EV        +  +   R+   P      ++ V + C + E   R  ++E
Sbjct: 236 ---WFQLSNTEV--------IECITQGRVLERPRVCPKEVYDVMLGCWQREPQQRLNIKE 284
Query: 965 VVHMLANPPQSAP 977
           +  +L    ++ P
Sbjct: 285 IYKILHALGKATP 297

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 80/299 (26%), Positives = 129/299 (43%), Gaps = 50/299 (16%)
Query: 693 SLKDENIIGKGGAGIVYRG-SMPDG----IDVAIKRLVGRGTGGNDHGFLAEIQTLGRIR 747
             K   ++G G  G VY+G  +P+G    I VAIK L    +   +   L E   +  + 
Sbjct: 10  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 69
Query: 748 HRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGG-----HLKWETRYRIALEAAK 802
           + ++ RLLG +    T  L+ + MP G L + +   K        L W       ++ AK
Sbjct: 70  NPHVCRLLG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAK 122
Query: 803 GLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAG---S 859
           G+ YL       ++HRD+ + N+L+ +     + DFGLAK L   GA E      G    
Sbjct: 123 GMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL---GAEEKEYHAEGGKVP 176
Query: 860 YGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQ 918
             ++A E         +SDV+S+GV + EL+  G KP     DG+               
Sbjct: 177 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY----DGI--------------- 217
Query: 919 PSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVV---HMLANPPQ 974
           P+   S +     RL   P+   I ++ + + C   ++ +RP  RE++     +A  PQ
Sbjct: 218 PASEISSILEKGERLPQPPIC-TIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQ 275

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 80/299 (26%), Positives = 128/299 (42%), Gaps = 50/299 (16%)
Query: 693 SLKDENIIGKGGAGIVYRG-SMPDG----IDVAIKRLVGRGTGGNDHGFLAEIQTLGRIR 747
             K   ++G G  G VY+G  +P+G    I VAIK L    +   +   L E   +  + 
Sbjct: 26  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 85
Query: 748 HRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGG-----HLKWETRYRIALEAAK 802
           + ++ RLLG +    T  L+ + MP G L + +   K        L W       ++ AK
Sbjct: 86  NPHVCRLLG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAK 138
Query: 803 GLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAG---S 859
           G+ YL       ++HRD+ + N+L+ +     + DFGLAK L   GA E      G    
Sbjct: 139 GMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL---GAEEKEYHAEGGKVP 192
Query: 860 YGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQ 918
             ++A E         +SDV+S+GV + EL+  G KP     DG+               
Sbjct: 193 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY----DGI--------------- 233
Query: 919 PSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVV---HMLANPPQ 974
           P+   S +     RL   P+   I ++ +   C   ++ +RP  RE++     +A  PQ
Sbjct: 234 PASEISSILEKGERLPQPPIC-TIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDPQ 291

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 70/271 (25%), Positives = 116/271 (42%), Gaps = 31/271 (11%)
Query: 699 IIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDH---GFLAEIQTLGRIRHRNIVRLL 755
            +GKGG    +  S  D  +V   ++V +      H       EI     + H+++V   
Sbjct: 46  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 105
Query: 756 GYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLI 815
           G+  + D   ++ E     SL E LH  +    + E RY +  +   G  YLH +    +
Sbjct: 106 GFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLR-QIVLGCQYLHRN---RV 160
Query: 816 IHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDE 875
           IHRD+K  N+ L+ D E  + DFGLA  ++  G  E    + G+  YIAPE         
Sbjct: 161 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG--ERKKVLCGTPNYIAPEVLSKKGHSF 218
Query: 876 KSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDPRLSG 935
           + DV+S G ++  L+ GK P   F        ++R   +E S P     V A +  ++  
Sbjct: 219 EVDVWSIGCIMYTLLVGKPP---FETSCLKETYLRIKKNEYSIPKHINPVAASLIQKM-- 273
Query: 936 YPLTGVIHLFKVAMMCVEDESSARPTMREVV 966
                           ++ + +ARPT+ E++
Sbjct: 274 ----------------LQTDPTARPTINELL 288

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 70/271 (25%), Positives = 116/271 (42%), Gaps = 31/271 (11%)
Query: 699 IIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDH---GFLAEIQTLGRIRHRNIVRLL 755
            +GKGG    +  S  D  +V   ++V +      H       EI     + H+++V   
Sbjct: 48  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107
Query: 756 GYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLI 815
           G+  + D   ++ E     SL E LH  +    + E RY +  +   G  YLH +    +
Sbjct: 108 GFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLR-QIVLGCQYLHRN---RV 162
Query: 816 IHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDE 875
           IHRD+K  N+ L+ D E  + DFGLA  ++  G  E    + G+  YIAPE         
Sbjct: 163 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG--ERKKVLCGTPNYIAPEVLSKKGHSF 220
Query: 876 KSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDPRLSG 935
           + DV+S G ++  L+ GK P   F        ++R   +E S P     V A +  ++  
Sbjct: 221 EVDVWSIGCIMYTLLVGKPP---FETSCLKETYLRIKKNEYSIPKHINPVAASLIQKM-- 275
Query: 936 YPLTGVIHLFKVAMMCVEDESSARPTMREVV 966
                           ++ + +ARPT+ E++
Sbjct: 276 ----------------LQTDPTARPTINELL 290

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 74/246 (30%), Positives = 118/246 (47%), Gaps = 24/246 (9%)
Query: 659 LTIYQLR---KRRLQKSKAWKLTAFQRLDFKAEDVLESLKDENIIGKGGAGIVYRGSMPD 715
           L   QLR   +R+L+K     LT      F   DVLE L      G+G  G VY+    +
Sbjct: 2   LETVQLRNPPRRQLKKLDEDSLTKQPEEVF---DVLEKL------GEGSYGSVYKAIHKE 52
Query: 716 -GIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLG-YVSNRDTNLLLYEYMPN 773
            G  VAIK++       +    + EI  + +    ++V+  G Y  N D  +++ EY   
Sbjct: 53  TGQIVAIKQV---PVESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM-EYCGA 108
Query: 774 GSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEA 833
           GS+ +++   +   L  +    I     KGL YLH       IHRD+K+ NILL+++  A
Sbjct: 109 GSVSDIIR-LRNKTLTEDEIATILQSTLKGLEYLHFMRK---IHRDIKAGNILLNTEGHA 164
Query: 834 HVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGK 893
            +ADFG+A  L D  A    + V G+  ++APE    +  +  +D++S G+  +E+  GK
Sbjct: 165 KLADFGVAGQLTDXMAKR--NXVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGK 222
Query: 894 KPVGEF 899
            P  + 
Sbjct: 223 PPYADI 228

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 49/161 (30%), Positives = 81/161 (50%), Gaps = 9/161 (5%)
Query: 739 EIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIAL 798
           EIQ L   RH +I++L   +S      ++ EY+  G L + +   K G ++     R+  
Sbjct: 61  EIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYI--CKHGRVEEMEARRLFQ 118
Query: 799 EAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAG 858
           +    + Y H     +++HRD+K  N+LLD+   A +ADFGL+  + D    E + +  G
Sbjct: 119 QILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG---EFLRTSCG 172
Query: 859 SYGYIAPEY-AYTLKVDEKSDVYSFGVVLLELIAGKKPVGE 898
           S  Y APE  +  L    + D++S GV+L  L+ G  P  +
Sbjct: 173 SPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDD 213

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 80/299 (26%), Positives = 128/299 (42%), Gaps = 50/299 (16%)
Query: 693 SLKDENIIGKGGAGIVYRG-SMPDG----IDVAIKRLVGRGTGGNDHGFLAEIQTLGRIR 747
             K   ++G G  G VY+G  +P+G    I VAIK L    +   +   L E   +  + 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 748 HRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGG-----HLKWETRYRIALEAAK 802
           + ++ RLLG +    T  L+ + MP G L + +   K        L W       ++ AK
Sbjct: 76  NPHVCRLLG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAK 128
Query: 803 GLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGS--- 859
           G+ YL       ++HRD+ + N+L+ +     + DFGLAK L   GA E      G    
Sbjct: 129 GMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL---GAEEKEYHAEGGKVP 182
Query: 860 YGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQ 918
             ++A E         +SDV+S+GV + EL+  G KP     DG+               
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY----DGI--------------- 223
Query: 919 PSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVV---HMLANPPQ 974
           P+   S +     RL   P+   I ++ +   C   ++ +RP  RE++     +A  PQ
Sbjct: 224 PASEISSILEKGERLPQPPIC-TIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDPQ 281

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 108/226 (47%), Gaps = 16/226 (7%)
Query: 692 ESLKDENIIGKGGAG-IVYRGSMPDGIDVAIKRLVGRGTGG--NDHGFLAEIQTLGRIRH 748
           +  K + ++GKG  G ++       G + A+K +  R      +    L E+Q L ++ H
Sbjct: 32  DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 91
Query: 749 RNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLH 808
            NI++L  +  ++    L+ E    G L + +   K          RI  +   G+ Y+H
Sbjct: 92  PNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRK--RFSEVDAARIIRQVLSGITYMH 149
Query: 809 HDCSPLIIHRDVKSNNILLDS---DFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAP 865
            +    I+HRD+K  N+LL+S   D    + DFGL+   +   AS+ M    G+  YIAP
Sbjct: 150 KN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE---ASKKMKDKIGTAYYIAP 203
Query: 866 EYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRK 911
           E  +    DEK DV+S GV+L  L++G  P     +  DI++ V K
Sbjct: 204 EVLHGT-YDEKCDVWSTGVILYILLSGCPPFNG-ANEYDILKKVEK 247

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 78/291 (26%), Positives = 124/291 (42%), Gaps = 34/291 (11%)
Query: 693 SLKDENIIGKGGAGIVYRG-SMPDG----IDVAIKRLVGRGTGGNDHGFLAEIQTLGRIR 747
            L+   ++G G  G VY+G  +PDG    I VAIK L    +   +   L E   +  + 
Sbjct: 18  ELRKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVG 77
Query: 748 HRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYL 807
              + RLLG +    T  L+ + MP G L + +   +G  L  +      ++ AKG+ YL
Sbjct: 78  SPYVSRLLG-ICLTSTVQLVTQLMPYGCLLDHVRENRG-RLGSQDLLNWCMQIAKGMSYL 135
Query: 808 HHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEY 867
                  ++HRD+ + N+L+ S     + DFGLA+ L                 ++A E 
Sbjct: 136 E---DVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALES 192
Query: 868 AYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVL 926
               +   +SDV+S+GV + EL+  G KP     DG+               P+     L
Sbjct: 193 ILRRRFTHQSDVWSYGVTVWELMTFGAKPY----DGI---------------PAREIPDL 233
Query: 927 AVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVV---HMLANPPQ 974
                RL   P+   I ++ + + C   +S  RP  RE+V     +A  PQ
Sbjct: 234 LEKGERLPQPPIC-TIDVYMIMVKCWMIDSECRPRFRELVSEFSRMARDPQ 283

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 70/271 (25%), Positives = 116/271 (42%), Gaps = 31/271 (11%)
Query: 699 IIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDH---GFLAEIQTLGRIRHRNIVRLL 755
            +GKGG    +  S  D  +V   ++V +      H       EI     + H+++V   
Sbjct: 22  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81
Query: 756 GYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLI 815
           G+  + D   ++ E     SL E LH  +    + E RY +  +   G  YLH +    +
Sbjct: 82  GFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLR-QIVLGCQYLHRN---RV 136
Query: 816 IHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDE 875
           IHRD+K  N+ L+ D E  + DFGLA  ++  G  E    + G+  YIAPE         
Sbjct: 137 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG--ERKKVLCGTPNYIAPEVLSKKGHSF 194
Query: 876 KSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDPRLSG 935
           + DV+S G ++  L+ GK P   F        ++R   +E S P     V A +  ++  
Sbjct: 195 EVDVWSIGCIMYTLLVGKPP---FETSCLKETYLRIKKNEYSIPKHINPVAASLIQKM-- 249
Query: 936 YPLTGVIHLFKVAMMCVEDESSARPTMREVV 966
                           ++ + +ARPT+ E++
Sbjct: 250 ----------------LQTDPTARPTINELL 264

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 80/299 (26%), Positives = 128/299 (42%), Gaps = 50/299 (16%)
Query: 693 SLKDENIIGKGGAGIVYRG-SMPDG----IDVAIKRLVGRGTGGNDHGFLAEIQTLGRIR 747
             K   ++G G  G VY+G  +P+G    I VAIK L    +   +   L E   +  + 
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 748 HRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGG-----HLKWETRYRIALEAAK 802
           + ++ RLLG +    T  L+ + MP G L + +   K        L W       ++ AK
Sbjct: 79  NPHVCRLLG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAK 131
Query: 803 GLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGS--- 859
           G+ YL       ++HRD+ + N+L+ +     + DFGLAK L   GA E      G    
Sbjct: 132 GMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL---GAEEKEYHAEGGKVP 185
Query: 860 YGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQ 918
             ++A E         +SDV+S+GV + EL+  G KP     DG+               
Sbjct: 186 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY----DGI--------------- 226
Query: 919 PSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVV---HMLANPPQ 974
           P+   S +     RL   P+   I ++ +   C   ++ +RP  RE++     +A  PQ
Sbjct: 227 PASEISSILEKGERLPQPPIC-TIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDPQ 284

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 98/229 (42%), Gaps = 34/229 (14%)
Query: 691 LESLKDENIIGKGGAGIVYRGSMPDGID------VAIKRLVGRGTGGNDHGFLAEIQTLG 744
           +E ++D   IG+G  G V++   P  +       VA+K L    +      F  E   + 
Sbjct: 49  IEYVRD---IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMA 105
Query: 745 RIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKG------GHLKWETRYR--- 795
              + NIV+LLG  +      LL+EYM  G L E L            H    TR R   
Sbjct: 106 EFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSS 165
Query: 796 -------------IALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAK 842
                        IA + A G+ YL        +HRD+ + N L+  +    +ADFGL++
Sbjct: 166 PGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSR 222
Query: 843 FLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA 891
            +  A   +   + A    ++ PE  +  +   +SDV+++GVVL E+ +
Sbjct: 223 NIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Composition-based stats.
 Identities = 44/131 (33%), Positives = 74/131 (56%), Gaps = 6/131 (4%)
Query: 766 LLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNI 825
           ++ EY+   +L +++H    G +  +    +  +A + L + H +    IIHRDVK  NI
Sbjct: 110 IVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANI 164
Query: 826 LLDSDFEAHVADFGLAKFLQDAGASECMSS-VAGSYGYIAPEYAYTLKVDEKSDVYSFGV 884
           ++ +     V DFG+A+ + D+G S   ++ V G+  Y++PE A    VD +SDVYS G 
Sbjct: 165 MISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGC 224
Query: 885 VLLELIAGKKP 895
           VL E++ G+ P
Sbjct: 225 VLYEVLTGEPP 235

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 66/244 (27%), Positives = 111/244 (45%), Gaps = 36/244 (14%)
Query: 699 IIGKGGAGIVYRGSMP-DGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRH--------- 748
           ++G+G  G V +     D    AIK++  R T       L+E+  L  + H         
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKI--RHTEEKLSTILSEVMLLASLNHQYVVRYYAA 70
Query: 749 ----RNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGL 804
               RN V+ +  V  + T  +  EY  N +L +++H       + E  +R+  +  + L
Sbjct: 71  WLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEY-WRLFRQILEAL 129
Query: 805 CYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDA------------GASEC 852
            Y+H   S  IIHRD+K  NI +D      + DFGLAK +  +            G+S+ 
Sbjct: 130 SYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDN 186
Query: 853 MSSVAGSYGYIAPEYAY-TLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRK 911
           ++S  G+  Y+A E    T   +EK D+YS G++  E+I    P     + V+I++ +R 
Sbjct: 187 LTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILKKLRS 243
Query: 912 TTSE 915
            + E
Sbjct: 244 VSIE 247

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 49/161 (30%), Positives = 80/161 (49%), Gaps = 9/161 (5%)
Query: 739 EIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIAL 798
           EIQ L   RH +I++L   +S      ++ EY+  G L + +   K G ++     R+  
Sbjct: 61  EIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYI--CKHGRVEEMEARRLFQ 118
Query: 799 EAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAG 858
           +    + Y H     +++HRD+K  N+LLD+   A +ADFGL+  + D    E +    G
Sbjct: 119 QILSAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG---EFLRDSCG 172
Query: 859 SYGYIAPEY-AYTLKVDEKSDVYSFGVVLLELIAGKKPVGE 898
           S  Y APE  +  L    + D++S GV+L  L+ G  P  +
Sbjct: 173 SPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDD 213

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 106/217 (48%), Gaps = 24/217 (11%)
Query: 693 SLKDENIIGKGGAGIVYRGSMP-DGI--DVAIKRLVGRGTGGNDHGFLAEIQTLGRI-RH 748
            +K +++IG+G  G V +  +  DG+  D AIKR+    +  +   F  E++ L ++  H
Sbjct: 23  DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHH 82
Query: 749 RNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAK--------------GGHLKWETRY 794
            NI+ LLG   +R    L  EY P+G+L + L  ++                 L  +   
Sbjct: 83  PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 142
Query: 795 RIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMS 854
             A + A+G+ YL        IHR++ + NIL+  ++ A +ADFGL++  Q+    + M 
Sbjct: 143 HFAADVARGMDYLSQ---KQFIHRNLAARNILVGENYVAKIADFGLSRG-QEVYVKKTMG 198
Query: 855 SVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA 891
            +     ++A E          SDV+S+GV+L E+++
Sbjct: 199 RLPVR--WMAIESLNYSVYTTNSDVWSYGVLLWEIVS 233

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 95/207 (45%), Gaps = 18/207 (8%)
Query: 719 VAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSL-G 777
           + I R     T  N    L E+  L  + H NI++L  +  ++    L+ E    G L  
Sbjct: 67  IKIIRKTSVSTSSNSK-LLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFD 125
Query: 778 EMLHGAKGGHLKWETRYRIALEAAKGLCYLH-HDCSPLIIHRDVKSNNILLDS---DFEA 833
           E++H  K   +       I  +   G+ YLH H+    I+HRD+K  N+LL+S   D   
Sbjct: 126 EIIHRMKFNEVDAAV---IIKQVLSGVTYLHKHN----IVHRDLKPENLLLESKEKDALI 178
Query: 834 HVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGK 893
            + DFGL+   ++      M    G+  YIAPE     K DEK DV+S GV+L  L+AG 
Sbjct: 179 KIVDFGLSAVFENQKK---MKERLGTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAGY 234
Query: 894 KPVGEFGDGVDIVRWVRKTTSEVSQPS 920
            P G   D  +I+R V K       P 
Sbjct: 235 PPFGGQTDQ-EILRKVEKGKYTFDSPE 260

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 108/226 (47%), Gaps = 16/226 (7%)
Query: 692 ESLKDENIIGKGGAG-IVYRGSMPDGIDVAIKRLVGRGTGG--NDHGFLAEIQTLGRIRH 748
           +  K + ++GKG  G ++       G + A+K +  R      +    L E+Q L ++ H
Sbjct: 26  DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 85
Query: 749 RNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLH 808
            NI++L  +  ++    L+ E    G L + +   K          RI  +   G+ Y+H
Sbjct: 86  PNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRK--RFSEVDAARIIRQVLSGITYMH 143
Query: 809 HDCSPLIIHRDVKSNNILLDS---DFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAP 865
            +    I+HRD+K  N+LL+S   D    + DFGL+   +   AS+ M    G+  YIAP
Sbjct: 144 KNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE---ASKKMKDKIGTAYYIAP 197
Query: 866 EYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRK 911
           E  +    DEK DV+S GV+L  L++G  P     +  DI++ V K
Sbjct: 198 EVLHGT-YDEKCDVWSTGVILYILLSGCPPFNG-ANEYDILKKVEK 241

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Composition-based stats.
 Identities = 44/131 (33%), Positives = 74/131 (56%), Gaps = 6/131 (4%)
Query: 766 LLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNI 825
           ++ EY+   +L +++H    G +  +    +  +A + L + H +    IIHRDVK  NI
Sbjct: 93  IVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANI 147
Query: 826 LLDSDFEAHVADFGLAKFLQDAGASECMSS-VAGSYGYIAPEYAYTLKVDEKSDVYSFGV 884
           ++ +     V DFG+A+ + D+G S   ++ V G+  Y++PE A    VD +SDVYS G 
Sbjct: 148 MISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGC 207
Query: 885 VLLELIAGKKP 895
           VL E++ G+ P
Sbjct: 208 VLYEVLTGEPP 218

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 73.9 bits (180), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 98/215 (45%), Gaps = 26/215 (12%)
Query: 698 NIIGKGGAGIVYRGS-MPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRI-RHRNIVRLL 755
            ++G G  G VY+G  +  G   AIK  V   TG  +     EI  L +   HRNI    
Sbjct: 30  ELVGNGTYGQVYKGRHVKTGQLAAIK--VMDVTGDEEEEIKQEINMLKKYSHHRNIATYY 87
Query: 756 GYVSNR------DTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHH 809
           G    +      D   L+ E+   GS+ +++   KG  LK E    I  E  +GL +LH 
Sbjct: 88  GAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQ 147
Query: 810 DCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAY 869
                +IHRD+K  N+LL  + E  + DFG++  L         ++  G+  ++APE   
Sbjct: 148 H---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRR--NTFIGTPYWMAPE--- 199
Query: 870 TLKVDE--------KSDVYSFGVVLLELIAGKKPV 896
            +  DE        KSD++S G+  +E+  G  P+
Sbjct: 200 VIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 234

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Composition-based stats.
 Identities = 44/131 (33%), Positives = 74/131 (56%), Gaps = 6/131 (4%)
Query: 766 LLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNI 825
           ++ EY+   +L +++H    G +  +    +  +A + L + H +    IIHRDVK  NI
Sbjct: 93  IVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANI 147
Query: 826 LLDSDFEAHVADFGLAKFLQDAGASECMSS-VAGSYGYIAPEYAYTLKVDEKSDVYSFGV 884
           ++ +     V DFG+A+ + D+G S   ++ V G+  Y++PE A    VD +SDVYS G 
Sbjct: 148 MISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGC 207
Query: 885 VLLELIAGKKP 895
           VL E++ G+ P
Sbjct: 208 VLYEVLTGEPP 218

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 79/299 (26%), Positives = 129/299 (43%), Gaps = 50/299 (16%)
Query: 693 SLKDENIIGKGGAGIVYRG-SMPDG----IDVAIKRLVGRGTGGNDHGFLAEIQTLGRIR 747
             K   ++G G  G VY+G  +P+G    I VAIK L    +   +   L E   +  + 
Sbjct: 13  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 72
Query: 748 HRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGG-----HLKWETRYRIALEAAK 802
           + ++ RLLG +    T  L+ + MP G L + +   K        L W       ++ A+
Sbjct: 73  NPHVCRLLG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAE 125
Query: 803 GLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGS--- 859
           G+ YL       ++HRD+ + N+L+ +     + DFGLAK L   GA E      G    
Sbjct: 126 GMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL---GAEEKEYHAEGGKVP 179
Query: 860 YGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQ 918
             ++A E         +SDV+S+GV + EL+  G KP     DG+               
Sbjct: 180 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY----DGI--------------- 220
Query: 919 PSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVV---HMLANPPQ 974
           P+   S +     RL   P+   I ++ + + C   ++ +RP  RE++     +A  PQ
Sbjct: 221 PASEISSILEKGERLPQPPIC-TIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQ 278

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 94/209 (44%), Gaps = 12/209 (5%)
Query: 700 IGKGGAGIVYR-GSMPDGIDVAIKRL-VGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGY 757
           IG G  G   +     DG  +  K L  G  T       ++E+  L  ++H NIVR    
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 758 VSNRDTNLLLY---EYMPNGSLGEML-HGAKG-GHLKWETRYRIALEAAKGL--CYLHHD 810
           + +R TN  LY   EY   G L  ++  G K   +L  E   R+  +    L  C+   D
Sbjct: 74  IIDR-TNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 811 CSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYT 870
               ++HRD+K  N+ LD      + DFGLA+ L     +    +  G+  Y++PE    
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH--DTSFAKTFVGTPYYMSPEQMNR 190
Query: 871 LKVDEKSDVYSFGVVLLELIAGKKPVGEF 899
           +  +EKSD++S G +L EL A   P   F
Sbjct: 191 MSYNEKSDIWSLGCLLYELCALMPPFTAF 219

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 78/299 (26%), Positives = 127/299 (42%), Gaps = 50/299 (16%)
Query: 693 SLKDENIIGKGGAGIVYRG-SMPDG----IDVAIKRLVGRGTGGNDHGFLAEIQTLGRIR 747
             K   ++G G  G VY+G  +P+G    I VAIK L    +   +   L E   +  + 
Sbjct: 20  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 79
Query: 748 HRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGG-----HLKWETRYRIALEAAK 802
           + ++ RLLG        L++ + MP G L + +   K        L W       ++ AK
Sbjct: 80  NPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAK 132
Query: 803 GLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAG---S 859
           G+ YL       ++HRD+ + N+L+ +     + DFG AK L   GA E      G    
Sbjct: 133 GMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLL---GAEEKEYHAEGGKVP 186
Query: 860 YGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQ 918
             ++A E         +SDV+S+GV + EL+  G KP     DG+               
Sbjct: 187 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY----DGI--------------- 227
Query: 919 PSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVV---HMLANPPQ 974
           P+   S +     RL   P+   I ++ + + C   ++ +RP  RE++     +A  PQ
Sbjct: 228 PASEISSILEKGERLPQPPIC-TIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQ 285

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 78/299 (26%), Positives = 127/299 (42%), Gaps = 50/299 (16%)
Query: 693 SLKDENIIGKGGAGIVYRG-SMPDG----IDVAIKRLVGRGTGGNDHGFLAEIQTLGRIR 747
             K   ++G G  G VY+G  +P+G    I VAIK L    +   +   L E   +  + 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 748 HRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGG-----HLKWETRYRIALEAAK 802
           + ++ RLLG        L++ + MP G L + +   K        L W       ++ AK
Sbjct: 78  NPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAK 130
Query: 803 GLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAG---S 859
           G+ YL       ++HRD+ + N+L+ +     + DFG AK L   GA E      G    
Sbjct: 131 GMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLL---GAEEKEYHAEGGKVP 184
Query: 860 YGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQ 918
             ++A E         +SDV+S+GV + EL+  G KP     DG+               
Sbjct: 185 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY----DGI--------------- 225
Query: 919 PSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVV---HMLANPPQ 974
           P+   S +     RL   P+   I ++ + + C   ++ +RP  RE++     +A  PQ
Sbjct: 226 PASEISSILEKGERLPQPPIC-TIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQ 283

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 79/299 (26%), Positives = 128/299 (42%), Gaps = 50/299 (16%)
Query: 693 SLKDENIIGKGGAGIVYRG-SMPDG----IDVAIKRLVGRGTGGNDHGFLAEIQTLGRIR 747
             K   ++  G  G VY+G  +P+G    I VAIK L    +   +   L E   +  + 
Sbjct: 16  EFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 748 HRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGG-----HLKWETRYRIALEAAK 802
           + ++ RLLG +    T  L+ + MP G L + +   K        L W       ++ AK
Sbjct: 76  NPHVCRLLG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAK 128
Query: 803 GLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAG---S 859
           G+ YL       ++HRD+ + N+L+ +     + DFGLAK L   GA E      G    
Sbjct: 129 GMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL---GAEEKEYHAEGGKVP 182
Query: 860 YGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQ 918
             ++A E         +SDV+S+GV + EL+  G KP     DG+               
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY----DGI--------------- 223
Query: 919 PSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVV---HMLANPPQ 974
           P+   S +     RL   P+   I ++ + + C   ++ +RP  RE++     +A  PQ
Sbjct: 224 PASEISSILEKGERLPQPPIC-TIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQ 281

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 49/153 (32%), Positives = 75/153 (49%), Gaps = 10/153 (6%)
Query: 743 LGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAK 802
           L  + H  I+R+ G   +     ++ +Y+  G L  +L  ++         Y  A E   
Sbjct: 60  LSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFY--AAEVCL 117
Query: 803 GLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGY 862
            L YLH   S  II+RD+K  NILLD +    + DFG AK++ D     C     G+  Y
Sbjct: 118 ALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYXLC-----GTPDY 169
Query: 863 IAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
           IAPE   T   ++  D +SFG+++ E++AG  P
Sbjct: 170 IAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP 202

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 108/226 (47%), Gaps = 16/226 (7%)
Query: 692 ESLKDENIIGKGGAG-IVYRGSMPDGIDVAIKRLVGRGTGG--NDHGFLAEIQTLGRIRH 748
           +  K + ++GKG  G ++       G + A+K +  R      +    L E+Q L ++ H
Sbjct: 49  DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 108
Query: 749 RNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLH 808
            NI++L  +  ++    L+ E    G L + +   K          RI  +   G+ Y+H
Sbjct: 109 PNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRK--RFSEVDAARIIRQVLSGITYMH 166
Query: 809 HDCSPLIIHRDVKSNNILLDS---DFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAP 865
            +    I+HRD+K  N+LL+S   D    + DFGL+   +   AS+ M    G+  YIAP
Sbjct: 167 KNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE---ASKKMKDKIGTAYYIAP 220
Query: 866 EYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRK 911
           E  +    DEK DV+S GV+L  L++G  P     +  DI++ V K
Sbjct: 221 EVLHGT-YDEKCDVWSTGVILYILLSGCPPFNG-ANEYDILKKVEK 264

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 73.6 bits (179), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 79/299 (26%), Positives = 128/299 (42%), Gaps = 50/299 (16%)
Query: 693 SLKDENIIGKGGAGIVYRG-SMPDG----IDVAIKRLVGRGTGGNDHGFLAEIQTLGRIR 747
             K   ++G G  G VY+G  +P+G    I VAI  L    +   +   L E   +  + 
Sbjct: 50  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVD 109
Query: 748 HRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGG-----HLKWETRYRIALEAAK 802
           + ++ RLLG +    T  L+ + MP G L + +   K        L W       ++ AK
Sbjct: 110 NPHVCRLLG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAK 162
Query: 803 GLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAG---S 859
           G+ YL       ++HRD+ + N+L+ +     + DFGLAK L   GA E      G    
Sbjct: 163 GMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL---GAEEKEYHAEGGKVP 216
Query: 860 YGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQ 918
             ++A E         +SDV+S+GV + EL+  G KP     DG+               
Sbjct: 217 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY----DGI--------------- 257
Query: 919 PSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVV---HMLANPPQ 974
           P+   S +     RL   P+   I ++ + + C   ++ +RP  RE++     +A  PQ
Sbjct: 258 PASEISSILEKGERLPQPPIC-TIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQ 315

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 73.6 bits (179), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 94/209 (44%), Gaps = 12/209 (5%)
Query: 700 IGKGGAGIVYR-GSMPDGIDVAIKRL-VGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGY 757
           IG G  G   +     DG  +  K L  G  T       ++E+  L  ++H NIVR    
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 758 VSNRDTNLLLY---EYMPNGSLGEML-HGAKG-GHLKWETRYRIALEAAKGL--CYLHHD 810
           + +R TN  LY   EY   G L  ++  G K   +L  E   R+  +    L  C+   D
Sbjct: 74  IIDR-TNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 811 CSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYT 870
               ++HRD+K  N+ LD      + DFGLA+ L     +    +  G+  Y++PE    
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH--DTSFAKAFVGTPYYMSPEQMNR 190
Query: 871 LKVDEKSDVYSFGVVLLELIAGKKPVGEF 899
           +  +EKSD++S G +L EL A   P   F
Sbjct: 191 MSYNEKSDIWSLGCLLYELCALMPPFTAF 219

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 73.6 bits (179), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 79/299 (26%), Positives = 128/299 (42%), Gaps = 50/299 (16%)
Query: 693 SLKDENIIGKGGAGIVYRG-SMPDG----IDVAIKRLVGRGTGGNDHGFLAEIQTLGRIR 747
             K   ++G G  G VY+G  +P+G    I VAIK L    +   +   L E   +  + 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 748 HRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGG-----HLKWETRYRIALEAAK 802
           + ++ RLLG +    T  L+ + MP G L + +   K        L W       ++ AK
Sbjct: 76  NPHVCRLLG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAK 128
Query: 803 GLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAG---S 859
           G+ YL       ++HRD+ + N+L+ +     + DFG AK L   GA E      G    
Sbjct: 129 GMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLL---GAEEKEYHAEGGKVP 182
Query: 860 YGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQ 918
             ++A E         +SDV+S+GV + EL+  G KP     DG+               
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY----DGI--------------- 223
Query: 919 PSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVV---HMLANPPQ 974
           P+   S +     RL   P+   I ++ + + C   ++ +RP  RE++     +A  PQ
Sbjct: 224 PASEISSILEKGERLPQPPIC-TIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQ 281

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 73.6 bits (179), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 110/228 (48%), Gaps = 20/228 (8%)
Query: 692 ESLKDENIIGKGGAG-IVYRGSMPDGIDVAIK----RLVGRGTGGNDHGFLAEIQTLGRI 746
           +  K + ++GKG  G ++       G + A+K    R V + T  +    L E+Q L ++
Sbjct: 50  DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKT--DKESLLREVQLLKQL 107
Query: 747 RHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCY 806
            H NI++L  +  ++    L+ E    G L + +   K          RI  +   G+ Y
Sbjct: 108 DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRK--RFSEVDAARIIRQVLSGITY 165
Query: 807 LHHDCSPLIIHRDVKSNNILLDS---DFEAHVADFGLAKFLQDAGASECMSSVAGSYGYI 863
           +H +    I+HRD+K  N+LL+S   D    + DFGL+   +   AS+ M    G+  YI
Sbjct: 166 MHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE---ASKKMKDKIGTAYYI 219
Query: 864 APEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRK 911
           APE  +    DEK DV+S GV+L  L++G  P     +  DI++ V K
Sbjct: 220 APEVLHGT-YDEKCDVWSTGVILYILLSGCPPFNG-ANEYDILKKVEK 265

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 78/299 (26%), Positives = 127/299 (42%), Gaps = 50/299 (16%)
Query: 693 SLKDENIIGKGGAGIVYRG-SMPDG----IDVAIKRLVGRGTGGNDHGFLAEIQTLGRIR 747
             K   ++  G  G VY+G  +P+G    I VAIK L    +   +   L E   +  + 
Sbjct: 23  EFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 748 HRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGG-----HLKWETRYRIALEAAK 802
           + ++ RLLG        L++ + MP G L + +   K        L W       ++ AK
Sbjct: 83  NPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAK 135
Query: 803 GLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAG---S 859
           G+ YL       ++HRD+ + N+L+ +     + DFGLAK L   GA E      G    
Sbjct: 136 GMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL---GAEEKEYHAEGGKVP 189
Query: 860 YGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQ 918
             ++A E         +SDV+S+GV + EL+  G KP     DG+               
Sbjct: 190 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY----DGI--------------- 230
Query: 919 PSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVV---HMLANPPQ 974
           P+   S +     RL   P+   I ++ + + C   ++ +RP  RE++     +A  PQ
Sbjct: 231 PASEISSILEKGERLPQPPIC-TIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQ 288

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 79/299 (26%), Positives = 128/299 (42%), Gaps = 50/299 (16%)
Query: 693 SLKDENIIGKGGAGIVYRG-SMPDG----IDVAIKRLVGRGTGGNDHGFLAEIQTLGRIR 747
             K   ++  G  G VY+G  +P+G    I VAIK L    +   +   L E   +  + 
Sbjct: 23  EFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 748 HRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGG-----HLKWETRYRIALEAAK 802
           + ++ RLLG +    T  L+ + MP G L + +   K        L W       ++ AK
Sbjct: 83  NPHVCRLLG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAK 135
Query: 803 GLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAG---S 859
           G+ YL       ++HRD+ + N+L+ +     + DFGLAK L   GA E      G    
Sbjct: 136 GMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL---GAEEKEYHAEGGKVP 189
Query: 860 YGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQ 918
             ++A E         +SDV+S+GV + EL+  G KP     DG+               
Sbjct: 190 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY----DGI--------------- 230
Query: 919 PSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVV---HMLANPPQ 974
           P+   S +     RL   P+   I ++ + + C   ++ +RP  RE++     +A  PQ
Sbjct: 231 PASEISSILEKGERLPQPPIC-TIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQ 288

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 93/209 (44%), Gaps = 12/209 (5%)
Query: 700 IGKGGAGIVYR-GSMPDGIDVAIKRL-VGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGY 757
           IG G  G   +     DG  +  K L  G  T       ++E+  L  ++H NIVR    
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 758 VSNRDTNLLLY---EYMPNGSLGEML-HGAKG-GHLKWETRYRIALEAAKGL--CYLHHD 810
           + +R TN  LY   EY   G L  ++  G K   +L  E   R+  +    L  C+   D
Sbjct: 74  IIDR-TNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 811 CSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYT 870
               ++HRD+K  N+ LD      + DFGLA+ L      +      G+  Y++PE    
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN--HDEDFAKEFVGTPYYMSPEQMNR 190
Query: 871 LKVDEKSDVYSFGVVLLELIAGKKPVGEF 899
           +  +EKSD++S G +L EL A   P   F
Sbjct: 191 MSYNEKSDIWSLGCLLYELCALMPPFTAF 219

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 97/199 (48%), Gaps = 17/199 (8%)
Query: 692 ESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNI 751
           ESLK E  +G G  G V+  +      VA+K +  +    +   FLAE   +  ++H  +
Sbjct: 182 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTM--KPGSMSVEAFLAEANVMKTLQHDKL 239
Query: 752 VRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDC 811
           V+L   V+ ++   ++ E+M  GSL + L   +G           + + A+G+ ++    
Sbjct: 240 VKLHAVVT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN 298
Query: 812 SPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTL 871
               IHRD+++ NIL+ +     +ADFGLA+     GA   +        + APE     
Sbjct: 299 ---YIHRDLRAANILVSASLVCKIADFGLAR----VGAKFPIK-------WTAPEAINFG 344
Query: 872 KVDEKSDVYSFGVVLLELI 890
               KSDV+SFG++L+E++
Sbjct: 345 SFTIKSDVWSFGILLMEIV 363

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 113/229 (49%), Gaps = 14/229 (6%)
Query: 689 DVLESLKDENIIGKGGAGIVYRGS-MPDGIDVAIKR--LVGRGTGGNDHGFLAEIQTLGR 745
           + L + + E  IG+G    VYR + + DG+ VA+K+  +            + EI  L +
Sbjct: 29  NTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQ 88
Query: 746 IRHRNIVRLLG-YVSNRDTNLLLYEYMPNGSLGEML-HGAKGGHLKWE-TRYRIALEAAK 802
           + H N+++    ++ + + N++L E    G L  M+ H  K   L  E T ++  ++   
Sbjct: 89  LNHPNVIKYYASFIEDNELNIVL-ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCS 147
Query: 803 GLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGY 862
            L ++H   S  ++HRD+K  N+ + +     + D GL +F   +  +    S+ G+  Y
Sbjct: 148 ALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLVGTPYY 202
Query: 863 IAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRK 911
           ++PE  +    + KSD++S G +L E+ A + P   +GD +++    +K
Sbjct: 203 MSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF--YGDKMNLYSLCKK 249

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 79/299 (26%), Positives = 128/299 (42%), Gaps = 50/299 (16%)
Query: 693 SLKDENIIGKGGAGIVYRG-SMPDG----IDVAIKRLVGRGTGGNDHGFLAEIQTLGRIR 747
             K   ++G G  G VY+G  +P+G    I VAIK L    +   +   L E   +  + 
Sbjct: 23  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 748 HRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGG-----HLKWETRYRIALEAAK 802
           + ++ RLLG +    T  L+ + MP G L + +   K        L W       ++ AK
Sbjct: 83  NPHVCRLLG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAK 135
Query: 803 GLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGS--- 859
           G+ YL       ++HRD+ + N+L+ +     + DFG AK L   GA E      G    
Sbjct: 136 GMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLL---GAEEKEYHAEGGKVP 189
Query: 860 YGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQ 918
             ++A E         +SDV+S+GV + EL+  G KP     DG+               
Sbjct: 190 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY----DGI--------------- 230
Query: 919 PSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVV---HMLANPPQ 974
           P+   S +     RL   P+   I ++ + + C   ++ +RP  RE++     +A  PQ
Sbjct: 231 PASEISSILEKGERLPQPPIC-TIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQ 288

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Composition-based stats.
 Identities = 50/165 (30%), Positives = 73/165 (44%), Gaps = 9/165 (5%)
Query: 731 GNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKW 790
           G +H    EI+    +RH NI+R+  Y  +R    L+ E+ P G L + L   K G    
Sbjct: 56  GVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQ--KHGRFDE 113
Query: 791 ETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS 850
           +       E A  L Y H      +IHRD+K  N+L+    E  +ADFG +        S
Sbjct: 114 QRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVH----APS 166
Query: 851 ECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
                + G+  Y+ PE       DEK D++  GV+  E + G  P
Sbjct: 167 LRRRXMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPP 211

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Composition-based stats.
 Identities = 50/165 (30%), Positives = 73/165 (44%), Gaps = 9/165 (5%)
Query: 731 GNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKW 790
           G +H    EI+    +RH NI+R+  Y  +R    L+ E+ P G L + L   K G    
Sbjct: 57  GVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQ--KHGRFDE 114
Query: 791 ETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS 850
           +       E A  L Y H      +IHRD+K  N+L+    E  +ADFG +        S
Sbjct: 115 QRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVH----APS 167
Query: 851 ECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
                + G+  Y+ PE       DEK D++  GV+  E + G  P
Sbjct: 168 LRRRXMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPP 212

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 72.8 bits (177), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 78/299 (26%), Positives = 126/299 (42%), Gaps = 50/299 (16%)
Query: 693 SLKDENIIGKGGAGIVYRG-SMPDG----IDVAIKRLVGRGTGGNDHGFLAEIQTLGRIR 747
             K   ++G G  G VY+G  +P+G    I VAIK L    +   +   L E   +  + 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 748 HRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGG-----HLKWETRYRIALEAAK 802
           + ++ RLLG        L++ + MP G L + +   K        L W       ++ AK
Sbjct: 78  NPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAK 130
Query: 803 GLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAG---S 859
           G+ YL       ++HRD+ + N+L+ +     + DFG AK L   GA E      G    
Sbjct: 131 GMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLL---GAEEKEYHAEGGKVP 184
Query: 860 YGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQ 918
             ++A E         +SDV+S+GV + EL+  G KP     DG+               
Sbjct: 185 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY----DGI--------------- 225
Query: 919 PSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVV---HMLANPPQ 974
           P+   S +     RL   P+   I ++ +   C   ++ +RP  RE++     +A  PQ
Sbjct: 226 PASEISSILEKGERLPQPPIC-TIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDPQ 283

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 72.8 bits (177), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 70/227 (30%), Positives = 104/227 (45%), Gaps = 23/227 (10%)
Query: 681 QRLDFKAEDVLESLKDENIIGKGGAGIVYRGSMPDGID------VAIKRLVGRGTGGNDH 734
           + L F++ D  E       IGKG  G V++G     ID      VAIK +          
Sbjct: 16  ENLYFQSMDPEELFTKLEKIGKGSFGEVFKG-----IDNRTQKVVAIKIIDLEEAEDEIE 70
Query: 735 GFLAEIQTLGRIRHRNIVRLLG-YVSNRDTNL-LLYEYMPNGSLGEMLHGAKGGHLKWET 792
               EI  L +     + +  G Y+  +DT L ++ EY+  GS  ++L   + G L    
Sbjct: 71  DIQQEITVLSQCDSPYVTKYYGSYL--KDTKLWIIMEYLGGGSALDLL---EPGPLDETQ 125
Query: 793 RYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASEC 852
              I  E  KGL YLH +     IHRD+K+ N+LL    E  +ADFG+A  L D      
Sbjct: 126 IATILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR- 181
Query: 853 MSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEF 899
            ++  G+  ++APE       D K+D++S G+  +EL  G+ P  E 
Sbjct: 182 -NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSEL 227

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 72.8 bits (177), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 79/299 (26%), Positives = 127/299 (42%), Gaps = 50/299 (16%)
Query: 693 SLKDENIIGKGGAGIVYRG-SMPDG----IDVAIKRLVGRGTGGNDHGFLAEIQTLGRIR 747
             K   ++G G  G VY+G  +P+G    I VAIK L    +   +   L E   +  + 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 748 HRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGG-----HLKWETRYRIALEAAK 802
           + ++ RLLG +    T  L+ + MP G L + +   K        L W       ++ AK
Sbjct: 78  NPHVCRLLG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAK 130
Query: 803 GLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAG---S 859
           G+ YL       ++HRD+ + N+L+ +     + DFG AK L   GA E      G    
Sbjct: 131 GMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLL---GAEEKEYHAEGGKVP 184
Query: 860 YGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQ 918
             ++A E         +SDV+S+GV + EL+  G KP     DG+               
Sbjct: 185 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY----DGI--------------- 225
Query: 919 PSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVV---HMLANPPQ 974
           P+   S +     RL   P+   I ++ +   C   ++ +RP  RE++     +A  PQ
Sbjct: 226 PASEISSILEKGERLPQPPIC-TIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDPQ 283

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 54/190 (28%), Positives = 88/190 (46%), Gaps = 5/190 (2%)
Query: 700 IGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYV 758
           IG+G  G V+ G +  D   VA+K             FL E + L +  H NIVRL+G  
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 759 SNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHR 818
           + +    ++ E +  G     L   +G  L+ +T  ++  +AA G+ YL   C    IHR
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLR-TEGARLRVKTLLQMVGDAAAGMEYLESKCC---IHR 237
Query: 819 DVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSD 878
           D+ + N L+       ++DFG+++   D   +           + APE     +   +SD
Sbjct: 238 DLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTAPEALNYGRYSSESD 297
Query: 879 VYSFGVVLLE 888
           V+SFG++L E
Sbjct: 298 VWSFGILLWE 307

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/192 (29%), Positives = 91/192 (47%), Gaps = 9/192 (4%)
Query: 700 IGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYV 758
           IG+G  G V+ G +  D   VA+K             FL E + L +  H NIVRL+G  
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 759 SNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHR 818
           + +    ++ E +  G     L   +G  L+ +T  ++  +AA G+ YL   C    IHR
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLR-TEGARLRVKTLLQMVGDAAAGMEYLESKCC---IHR 237
Query: 819 DVKSNNILLDSDFEAHVADFGLAKFLQDA--GASECMSSVAGSYGYIAPEYAYTLKVDEK 876
           D+ + N L+       ++DFG+++   D    AS  +  V     + APE     +   +
Sbjct: 238 DLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVP--VKWTAPEALNYGRYSSE 295
Query: 877 SDVYSFGVVLLE 888
           SDV+SFG++L E
Sbjct: 296 SDVWSFGILLWE 307

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 70/255 (27%), Positives = 114/255 (44%), Gaps = 25/255 (9%)
Query: 690 VLESLKDENIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHGFLA--EIQTLGRI 746
           VL+  +    IG G  GIV        GI+VA+K+L  R      H   A  E+  L  +
Sbjct: 20  VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKL-SRPFQNQTHAKRAYRELVLLKCV 78
Query: 747 RHRNIVRLLGYVSNRDT-----NLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAA 801
            H+NI+ LL   + + T     ++ L   + + +L +++H             R++    
Sbjct: 79  NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHE-------RMSYLLY 131
Query: 802 KGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYG 861
           + LC + H  S  IIHRD+K +NI++ SD    + DFGLA+    A  +  M+    +  
Sbjct: 132 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TASTNFMMTPYVVTRY 188
Query: 862 YIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSD 921
           Y APE    +   E  D++S G ++ EL+ G         G D +    K   ++  PS 
Sbjct: 189 YRAPEVILGMGYKENVDIWSVGCIMGELVKG----SVIFQGTDHIDQWNKVIEQLGTPS- 243
Query: 922 AASVLAVVDPRLSGY 936
            A  +A + P +  Y
Sbjct: 244 -AEFMAALQPTVRNY 257

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/267 (24%), Positives = 116/267 (43%), Gaps = 39/267 (14%)
Query: 719 VAIKRLVGRGTGGNDHGFLAEIQTLGRI-RHRNIVRLLGYVSNRDTNLLLYEYMPNGSLG 777
           VA+K L    T  +    ++E++ +  I +H+NI+ LLG  +      ++ EY   G+L 
Sbjct: 104 VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 163
Query: 778 EMLHGAKGGHLKW--------------ETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSN 823
           E L   +   L++              +     A + A+G+ YL    S   IHRD+ + 
Sbjct: 164 EYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAAR 220
Query: 824 NILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFG 883
           N+L+  D    +ADFGLA+ +      +  ++      ++APE  +      +SDV+SFG
Sbjct: 221 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFG 280
Query: 884 VVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDPRLSGYPLTGVI 942
           V+L E+   G  P    G  V+ +  + K    + +PS+  +                  
Sbjct: 281 VLLWEIFTLGGSPYP--GVPVEELFKLLKEGHRMDKPSNCTN------------------ 320
Query: 943 HLFKVAMMCVEDESSARPTMREVVHML 969
            L+ +   C     S RPT +++V  L
Sbjct: 321 ELYMMMRDCWHAVPSQRPTFKQLVEDL 347

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/187 (27%), Positives = 89/187 (47%), Gaps = 18/187 (9%)
Query: 719 VAIKRLVGRGTGGNDHGFLAEIQTLGRI-RHRNIVRLLGYVSNRDTNLLLYEYMPNGSLG 777
           VA+K L    T  +    ++E++ +  I +H+NI+ LLG  +      ++ EY   G+L 
Sbjct: 63  VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 122
Query: 778 EMLHGAKGGHLKW--------------ETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSN 823
           E L   +   L++              +     A + A+G+ YL    S   IHRD+ + 
Sbjct: 123 EYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAAR 179
Query: 824 NILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFG 883
           N+L+  D    +ADFGLA+ +      +  ++      ++APE  +      +SDV+SFG
Sbjct: 180 NVLVTEDNVMKIADFGLARDIHHIDXXKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFG 239
Query: 884 VVLLELI 890
           V+L E+ 
Sbjct: 240 VLLWEIF 246

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Composition-based stats.
 Identities = 76/260 (29%), Positives = 117/260 (45%), Gaps = 26/260 (10%)
Query: 719 VAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTN--LLLYEYMPNGSL 776
           VA+K L       +  G+  EI  L  + H +I++  G   +       L+ EY+P GSL
Sbjct: 63  VAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSL 122
Query: 777 GEML--HGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAH 834
            + L  H      L        A +  +G+ YLH   +   IHRD+ + N+LLD+D    
Sbjct: 123 RDYLPRHSIGLAQL-----LLFAQQICEGMAYLH---AQHYIHRDLAARNVLLDNDRLVK 174
Query: 835 VADFGLAKFLQDAGASECMSSVAGS-YGYIAPEYAYTLKVDEKSDVYSFGVVLLELI--- 890
           + DFGLAK + +      +     S   + APE     K    SDV+SFGV L EL+   
Sbjct: 175 IGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHC 234
Query: 891 -AGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAM 949
            + + P  +F + + I +  + T   +++  +    L    PR    P   V HL K   
Sbjct: 235 DSSQSPPTKFLELIGIAQG-QMTVLRLTELLERGERL----PRPDKCP-AEVYHLMK--- 285
Query: 950 MCVEDESSARPTMREVVHML 969
            C E E+S RPT   ++ +L
Sbjct: 286 NCWETEASFRPTFENLIPIL 305

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 101/210 (48%), Gaps = 17/210 (8%)
Query: 690 VLESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGF----LAEIQTLGR 745
           ++E  +    +G+G  G+VY+     G  VA+KR+        D G     + EI  L  
Sbjct: 19  LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRI---RLDAEDEGIPSTAIREISLLKE 75
Query: 746 IRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIAL-EAAKGL 804
           + H NIV L+  + +     L++E+M    L ++L   K G    +++ +I L +  +G+
Sbjct: 76  LHHPNIVSLIDVIHSERCLTLVFEFM-EKDLKKVLDENKTGLQ--DSQIKIYLYQLLRGV 132
Query: 805 CYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIA 864
            + H      I+HRD+K  N+L++SD    +ADFGLA+       S     V  +  Y A
Sbjct: 133 AHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV--TLWYRA 187
Query: 865 PEYAY-TLKVDEKSDVYSFGVVLLELIAGK 893
           P+    + K     D++S G +  E+I GK
Sbjct: 188 PDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 72/235 (30%), Positives = 103/235 (43%), Gaps = 33/235 (14%)
Query: 700 IGKGGAGIVYRGSMPD-GIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRL---- 754
           +G GG G V R    D G  VAIK+     +  N   +  EIQ + ++ H N+V      
Sbjct: 22  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 81
Query: 755 --LGYVSNRDTNLLLYEYMPNGSLGEMLH------GAKGGHLKWETRYRIALEAAKGLCY 806
             L  ++  D  LL  EY   G L + L+      G K G ++      +  + +  L Y
Sbjct: 82  DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIR-----TLLSDISSALRY 136
Query: 807 LHHDCSPLIIHRDVKSNNILLD---SDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYI 863
           LH +    IIHRD+K  NI+L          + D G AK L D G  E  +   G+  Y+
Sbjct: 137 LHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL-DQG--ELCTEFVGTLQYL 190
Query: 864 APEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRW---VRKTTSE 915
           APE     K     D +SFG +  E I G +P   F      V+W   VR+ ++E
Sbjct: 191 APELLEQKKYTVTVDYWSFGTLAFECITGFRP---FLPNWQPVQWHGKVREKSNE 242

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 101/210 (48%), Gaps = 17/210 (8%)
Query: 690 VLESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGF----LAEIQTLGR 745
           ++E  +    +G+G  G+VY+     G  VA+KR+        D G     + EI  L  
Sbjct: 19  LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRI---RLDAEDEGIPSTAIREISLLKE 75
Query: 746 IRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIAL-EAAKGL 804
           + H NIV L+  + +     L++E+M    L ++L   K G    +++ +I L +  +G+
Sbjct: 76  LHHPNIVSLIDVIHSERCLTLVFEFM-EKDLKKVLDENKTGLQ--DSQIKIYLYQLLRGV 132
Query: 805 CYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIA 864
            + H      I+HRD+K  N+L++SD    +ADFGLA+       S     V  +  Y A
Sbjct: 133 AHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV--TLWYRA 187
Query: 865 PEYAY-TLKVDEKSDVYSFGVVLLELIAGK 893
           P+    + K     D++S G +  E+I GK
Sbjct: 188 PDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 72/235 (30%), Positives = 103/235 (43%), Gaps = 33/235 (14%)
Query: 700 IGKGGAGIVYRGSMPD-GIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRL---- 754
           +G GG G V R    D G  VAIK+     +  N   +  EIQ + ++ H N+V      
Sbjct: 23  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 82
Query: 755 --LGYVSNRDTNLLLYEYMPNGSLGEMLH------GAKGGHLKWETRYRIALEAAKGLCY 806
             L  ++  D  LL  EY   G L + L+      G K G ++      +  + +  L Y
Sbjct: 83  DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIR-----TLLSDISSALRY 137
Query: 807 LHHDCSPLIIHRDVKSNNILLD---SDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYI 863
           LH +    IIHRD+K  NI+L          + D G AK L D G  E  +   G+  Y+
Sbjct: 138 LHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL-DQG--ELCTEFVGTLQYL 191
Query: 864 APEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRW---VRKTTSE 915
           APE     K     D +SFG +  E I G +P   F      V+W   VR+ ++E
Sbjct: 192 APELLEQKKYTVTVDYWSFGTLAFECITGFRP---FLPNWQPVQWHGKVREKSNE 243

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Composition-based stats.
 Identities = 60/184 (32%), Positives = 84/184 (45%), Gaps = 22/184 (11%)
Query: 716 GIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLG--YVSNRDTNLLLYEYMPN 773
           G  VA+K+L   G       F  EIQ L  +    IV+  G  Y   R +  L+ EY+P+
Sbjct: 39  GALVAVKQLQHSGPD-QQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPS 97
Query: 774 GSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPL-------IIHRDVKSNNIL 826
           G L + L            R+R  L+A++ L Y    C  +        +HRD+ + NIL
Sbjct: 98  GCLRDFLQ-----------RHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNIL 146
Query: 827 LDSDFEAHVADFGLAKFLQ-DAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVV 885
           ++S+    +ADFGLAK L  D               + APE         +SDV+SFGVV
Sbjct: 147 VESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVV 206
Query: 886 LLEL 889
           L EL
Sbjct: 207 LYEL 210

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Composition-based stats.
 Identities = 60/184 (32%), Positives = 84/184 (45%), Gaps = 22/184 (11%)
Query: 716 GIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLG--YVSNRDTNLLLYEYMPN 773
           G  VA+K+L   G       F  EIQ L  +    IV+  G  Y   R +  L+ EY+P+
Sbjct: 40  GALVAVKQLQHSGPD-QQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPS 98
Query: 774 GSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPL-------IIHRDVKSNNIL 826
           G L + L            R+R  L+A++ L Y    C  +        +HRD+ + NIL
Sbjct: 99  GCLRDFLQ-----------RHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNIL 147
Query: 827 LDSDFEAHVADFGLAKFLQ-DAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVV 885
           ++S+    +ADFGLAK L  D               + APE         +SDV+SFGVV
Sbjct: 148 VESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVV 207
Query: 886 LLEL 889
           L EL
Sbjct: 208 LYEL 211

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Composition-based stats.
 Identities = 60/184 (32%), Positives = 84/184 (45%), Gaps = 22/184 (11%)
Query: 716 GIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLG--YVSNRDTNLLLYEYMPN 773
           G  VA+K+L   G       F  EIQ L  +    IV+  G  Y   R +  L+ EY+P+
Sbjct: 52  GALVAVKQLQHSGPD-QQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPS 110
Query: 774 GSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPL-------IIHRDVKSNNIL 826
           G L + L            R+R  L+A++ L Y    C  +        +HRD+ + NIL
Sbjct: 111 GCLRDFLQ-----------RHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNIL 159
Query: 827 LDSDFEAHVADFGLAKFLQ-DAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVV 885
           ++S+    +ADFGLAK L  D               + APE         +SDV+SFGVV
Sbjct: 160 VESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVV 219
Query: 886 LLEL 889
           L EL
Sbjct: 220 LYEL 223

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 72/251 (28%), Positives = 109/251 (43%), Gaps = 17/251 (6%)
Query: 669 LQKSKAWKLTAFQRLDFKAEDVLESLKDENIIGKGGAGIVYRG-SMPDGIDVAIKRLVGR 727
           ++ S   K++  Q  DF AED    LKD   IG+G  G V +    P G  +A+KR+   
Sbjct: 3   IESSGKLKISPEQHWDFTAED----LKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRST 58
Query: 728 GTGGNDHGFLAEIQTLGRIRH-RNIVRLLGYVSNRDTNLLLYEYMPNG--SLGEMLHGAK 784
                    L ++  + R      IV+  G +       +  E M        + ++   
Sbjct: 59  VDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVL 118
Query: 785 GGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFL 844
              +  E   +I L   K L +L  +    IIHRD+K +NILLD      + DFG++  L
Sbjct: 119 DDVIPEEILGKITLATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQL 176
Query: 845 QDAGASECMSSVAGSYGYIAPEY----AYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFG 900
            D+ A    +  AG   Y+APE     A     D +SDV+S G+ L EL  G+ P  ++ 
Sbjct: 177 VDSIAK---TRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWN 233
Query: 901 DGVDIVRWVRK 911
              D +  V K
Sbjct: 234 SVFDQLTQVVK 244

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Composition-based stats.
 Identities = 60/184 (32%), Positives = 83/184 (45%), Gaps = 22/184 (11%)
Query: 716 GIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLG--YVSNRDTNLLLYEYMPN 773
           G  VA+K+L   G       F  EIQ L  +    IV+  G  Y   R    L+ EY+P+
Sbjct: 36  GALVAVKQLQHSGPD-QQRDFQREIQILKALHSDFIVKYRGVSYGPGRPELRLVMEYLPS 94
Query: 774 GSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPL-------IIHRDVKSNNIL 826
           G L + L            R+R  L+A++ L Y    C  +        +HRD+ + NIL
Sbjct: 95  GCLRDFLQ-----------RHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNIL 143
Query: 827 LDSDFEAHVADFGLAKFLQ-DAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVV 885
           ++S+    +ADFGLAK L  D               + APE         +SDV+SFGVV
Sbjct: 144 VESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVV 203
Query: 886 LLEL 889
           L EL
Sbjct: 204 LYEL 207

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/202 (32%), Positives = 90/202 (44%), Gaps = 19/202 (9%)
Query: 700 IGKGGAGIVYRGSMPDGID------VAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVR 753
           IGKG  G VY+G     ID      VAIK +              EI  L +     I R
Sbjct: 27  IGKGSFGEVYKG-----IDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITR 81
Query: 754 LLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSP 813
             G         ++ EY+  GS  ++L   K G L+      I  E  KGL YLH   S 
Sbjct: 82  YFGSYLKSTKLWIIMEYLGGGSALDLL---KPGPLEETYIATILREILKGLDYLH---SE 135
Query: 814 LIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKV 873
             IHRD+K+ N+LL    +  +ADFG+A  L D       +   G+  ++APE       
Sbjct: 136 RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR--NXFVGTPFWMAPEVIKQSAY 193
Query: 874 DEKSDVYSFGVVLLELIAGKKP 895
           D K+D++S G+  +EL  G+ P
Sbjct: 194 DFKADIWSLGITAIELAKGEPP 215

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 71/231 (30%), Positives = 104/231 (45%), Gaps = 26/231 (11%)
Query: 677 LTAFQRLDFKAEDVLESLKDENIIGKGGAGIVYRGSMPDGID------VAIKRLVGRGTG 730
           L   Q L    E++   L+    IGKG  G V++G     ID      VAIK +      
Sbjct: 10  LPGMQNLKADPEELFTKLEK---IGKGSFGEVFKG-----IDNRTQKVVAIKIIDLEEAE 61
Query: 731 GNDHGFLAEIQTLGRIRHRNIVRLLG-YVSNRDTNL-LLYEYMPNGSLGEMLHGAKGGHL 788
                   EI  L +     + +  G Y+  +DT L ++ EY+  GS  ++L   + G L
Sbjct: 62  DEIEDIQQEITVLSQCDSPYVTKYYGSYL--KDTKLWIIMEYLGGGSALDLL---EPGPL 116
Query: 789 KWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAG 848
                  I  E  KGL YLH +     IHRD+K+ N+LL    E  +ADFG+A  L D  
Sbjct: 117 DETQIATILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 173
Query: 849 ASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEF 899
                +   G+  ++APE       D K+D++S G+  +EL  G+ P  E 
Sbjct: 174 IKR--NXFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSEL 222

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Composition-based stats.
 Identities = 76/260 (29%), Positives = 118/260 (45%), Gaps = 26/260 (10%)
Query: 719 VAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTN--LLLYEYMPNGSL 776
           VA+K L       +  G+  EI  L  + H +I++  G   ++      L+ EY+P GSL
Sbjct: 46  VAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSL 105
Query: 777 GEML--HGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAH 834
            + L  H      L        A +  +G+ YLH   S   IHR++ + N+LLD+D    
Sbjct: 106 RDYLPRHSIGLAQL-----LLFAQQICEGMAYLH---SQHYIHRNLAARNVLLDNDRLVK 157
Query: 835 VADFGLAKFLQDAGASECMSSVAGS-YGYIAPEYAYTLKVDEKSDVYSFGVVLLELI--- 890
           + DFGLAK + +      +     S   + APE     K    SDV+SFGV L EL+   
Sbjct: 158 IGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHC 217
Query: 891 -AGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAM 949
            + + P  +F + + I +  + T   +++  +    L    PR    P   V HL K   
Sbjct: 218 DSSQSPPTKFLELIGIAQG-QMTVLRLTELLERGERL----PRPDKCPCE-VYHLMK--- 268
Query: 950 MCVEDESSARPTMREVVHML 969
            C E E+S RPT   ++ +L
Sbjct: 269 NCWETEASFRPTFENLIPIL 288

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 92/199 (46%), Gaps = 11/199 (5%)
Query: 700 IGKGG-AGIVYRGSMPDGIDVAIKRLVGRGTGGND-HGFLAEIQTLGRIRHRNIVRLLGY 757
           IGKG  A +     +  G +VA+K +       +       E++ +  + H NIV+L   
Sbjct: 15  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 74
Query: 758 VSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIH 817
           +    T  L+ EY   G + + L  A G   + E R +   +    + Y H      I+H
Sbjct: 75  IETEKTLYLVMEYASGGEVFDYL-VAHGWMKEKEARAKFR-QIVSAVQYCHQ---KFIVH 129
Query: 818 RDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVD-EK 876
           RD+K+ N+LLD+D    +ADFG   F  +      + +  GS  Y APE     K D  +
Sbjct: 130 RDLKAENLLLDADMNIKIADFG---FSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPE 186
Query: 877 SDVYSFGVVLLELIAGKKP 895
            DV+S GV+L  L++G  P
Sbjct: 187 VDVWSLGVILYTLVSGSLP 205

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 51/187 (27%), Positives = 89/187 (47%), Gaps = 18/187 (9%)
Query: 719 VAIKRLVGRGTGGNDHGFLAEIQTLGRI-RHRNIVRLLGYVSNRDTNLLLYEYMPNGSLG 777
           VA+K L    T  +    ++E++ +  I +H+NI+ LLG  +      ++ EY   G+L 
Sbjct: 63  VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 122
Query: 778 EMLHGAKGGHLKW--------------ETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSN 823
           E L   +   L++              +     A + A+G+ YL    S   IHRD+ + 
Sbjct: 123 EYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAAR 179
Query: 824 NILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFG 883
           N+L+  D    +ADFGLA+ +      +  ++      ++APE  +      +SDV+SFG
Sbjct: 180 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFG 239
Query: 884 VVLLELI 890
           V+L E+ 
Sbjct: 240 VLLWEIF 246

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 86/199 (43%), Gaps = 12/199 (6%)
Query: 700 IGKGGAGIVYRG-SMPDGIDVAIKRLVGRG--TGGNDHGFLAEIQTLGRIRHRNIVRLLG 756
           +GKG  G VY          VA+K L        G +H    EI+    + H NI+RL  
Sbjct: 31  LGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHHPNILRLYN 90
Query: 757 YVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLII 816
           Y  +R    L+ EY P G L + L   K      +    I  E A  L Y H      +I
Sbjct: 91  YFYDRRRIYLILEYAPRGELYKELQ--KSCTFDEQRTATIMEELADALMYCH---GKKVI 145
Query: 817 HRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEK 876
           HRD+K  N+LL    E  +ADFG +        S    ++ G+  Y+ PE       +EK
Sbjct: 146 HRDIKPENLLLGLKGELKIADFGWSVH----APSLRRKTMCGTLDYLPPEMIEGRMHNEK 201
Query: 877 SDVYSFGVVLLELIAGKKP 895
            D++  GV+  EL+ G  P
Sbjct: 202 VDLWCIGVLCYELLVGNPP 220

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 51/187 (27%), Positives = 89/187 (47%), Gaps = 18/187 (9%)
Query: 719 VAIKRLVGRGTGGNDHGFLAEIQTLGRI-RHRNIVRLLGYVSNRDTNLLLYEYMPNGSLG 777
           VA+K L    T  +    ++E++ +  I +H+NI+ LLG  +      ++ EY   G+L 
Sbjct: 48  VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 107
Query: 778 EMLHGAKGGHLKW--------------ETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSN 823
           E L   +   L++              +     A + A+G+ YL    S   IHRD+ + 
Sbjct: 108 EYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAAR 164
Query: 824 NILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFG 883
           N+L+  D    +ADFGLA+ +      +  ++      ++APE  +      +SDV+SFG
Sbjct: 165 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFG 224
Query: 884 VVLLELI 890
           V+L E+ 
Sbjct: 225 VLLWEIF 231

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 51/187 (27%), Positives = 89/187 (47%), Gaps = 18/187 (9%)
Query: 719 VAIKRLVGRGTGGNDHGFLAEIQTLGRI-RHRNIVRLLGYVSNRDTNLLLYEYMPNGSLG 777
           VA+K L    T  +    ++E++ +  I +H+NI+ LLG  +      ++ EY   G+L 
Sbjct: 52  VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 111
Query: 778 EMLHGAKGGHLKW--------------ETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSN 823
           E L   +   L++              +     A + A+G+ YL    S   IHRD+ + 
Sbjct: 112 EYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAAR 168
Query: 824 NILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFG 883
           N+L+  D    +ADFGLA+ +      +  ++      ++APE  +      +SDV+SFG
Sbjct: 169 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFG 228
Query: 884 VVLLELI 890
           V+L E+ 
Sbjct: 229 VLLWEIF 235

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 51/187 (27%), Positives = 89/187 (47%), Gaps = 18/187 (9%)
Query: 719 VAIKRLVGRGTGGNDHGFLAEIQTLGRI-RHRNIVRLLGYVSNRDTNLLLYEYMPNGSLG 777
           VA+K L    T  +    ++E++ +  I +H+NI+ LLG  +      ++ EY   G+L 
Sbjct: 63  VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 122
Query: 778 EMLHGAKGGHLKW--------------ETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSN 823
           E L   +   L++              +     A + A+G+ YL    S   IHRD+ + 
Sbjct: 123 EYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAAR 179
Query: 824 NILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFG 883
           N+L+  D    +ADFGLA+ +      +  ++      ++APE  +      +SDV+SFG
Sbjct: 180 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFG 239
Query: 884 VVLLELI 890
           V+L E+ 
Sbjct: 240 VLLWEIF 246

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 51/187 (27%), Positives = 89/187 (47%), Gaps = 18/187 (9%)
Query: 719 VAIKRLVGRGTGGNDHGFLAEIQTLGRI-RHRNIVRLLGYVSNRDTNLLLYEYMPNGSLG 777
           VA+K L    T  +    ++E++ +  I +H+NI+ LLG  +      ++ EY   G+L 
Sbjct: 56  VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 115
Query: 778 EMLHGAKGGHLKW--------------ETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSN 823
           E L   +   L++              +     A + A+G+ YL    S   IHRD+ + 
Sbjct: 116 EYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAAR 172
Query: 824 NILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFG 883
           N+L+  D    +ADFGLA+ +      +  ++      ++APE  +      +SDV+SFG
Sbjct: 173 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFG 232
Query: 884 VVLLELI 890
           V+L E+ 
Sbjct: 233 VLLWEIF 239

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 92/199 (46%), Gaps = 11/199 (5%)
Query: 700 IGKGG-AGIVYRGSMPDGIDVAIKRLVGRGTGGND-HGFLAEIQTLGRIRHRNIVRLLGY 757
           IGKG  A +     +  G +VA+K +       +       E++ +  + H NIV+L   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 758 VSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIH 817
           +    T  L+ EY   G + + L  A G   + E R +   +    + Y H      I+H
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYL-VAHGRMKEKEARAKFR-QIVSAVQYCHQ---KFIVH 136
Query: 818 RDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVD-EK 876
           RD+K+ N+LLD+D    +ADFG   F  +      + +  GS  Y APE     K D  +
Sbjct: 137 RDLKAENLLLDADMNIKIADFG---FSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPE 193
Query: 877 SDVYSFGVVLLELIAGKKP 895
            DV+S GV+L  L++G  P
Sbjct: 194 VDVWSLGVILYTLVSGSLP 212

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 70.9 bits (172), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 92/199 (46%), Gaps = 11/199 (5%)
Query: 700 IGKGG-AGIVYRGSMPDGIDVAIKRLVGRGTGGND-HGFLAEIQTLGRIRHRNIVRLLGY 757
           IGKG  A +     +  G +VA+K +       +       E++ +  + H NIV+L   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 758 VSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIH 817
           +    T  L+ EY   G + + L  A G   + E R +   +    + Y H      I+H
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYL-VAHGRMKEKEARAKFR-QIVSAVQYCHQ---KFIVH 136
Query: 818 RDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVD-EK 876
           RD+K+ N+LLD+D    +ADFG   F  +      + +  GS  Y APE     K D  +
Sbjct: 137 RDLKAENLLLDADMNIKIADFG---FSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPE 193
Query: 877 SDVYSFGVVLLELIAGKKP 895
            DV+S GV+L  L++G  P
Sbjct: 194 VDVWSLGVILYTLVSGSLP 212

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 70.9 bits (172), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 51/187 (27%), Positives = 89/187 (47%), Gaps = 18/187 (9%)
Query: 719 VAIKRLVGRGTGGNDHGFLAEIQTLGRI-RHRNIVRLLGYVSNRDTNLLLYEYMPNGSLG 777
           VA+K L    T  +    ++E++ +  I +H+NI+ LLG  +      ++ EY   G+L 
Sbjct: 55  VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 114
Query: 778 EMLHGAKGGHLKW--------------ETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSN 823
           E L   +   L++              +     A + A+G+ YL    S   IHRD+ + 
Sbjct: 115 EYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAAR 171
Query: 824 NILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFG 883
           N+L+  D    +ADFGLA+ +      +  ++      ++APE  +      +SDV+SFG
Sbjct: 172 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFG 231
Query: 884 VVLLELI 890
           V+L E+ 
Sbjct: 232 VLLWEIF 238

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 97/208 (46%), Gaps = 23/208 (11%)
Query: 700 IGKGGAGIVYRGSMPDGID------VAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVR 753
           IGKG  G V++G     ID      VAIK +              EI  L +     + +
Sbjct: 15  IGKGSFGEVFKG-----IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTK 69
Query: 754 LLG-YVSNRDTNL-LLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDC 811
             G Y+  +DT L ++ EY+  GS  ++L   + G L       I  E  KGL YLH + 
Sbjct: 70  YYGSYL--KDTKLWIIMEYLGGGSALDLL---EPGPLDETQIATILREILKGLDYLHSEK 124
Query: 812 SPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTL 871
               IHRD+K+ N+LL    E  +ADFG+A  L D       ++  G+  ++APE     
Sbjct: 125 K---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR--NTFVGTPFWMAPEVIKQS 179
Query: 872 KVDEKSDVYSFGVVLLELIAGKKPVGEF 899
             D K+D++S G+  +EL  G+ P  E 
Sbjct: 180 AYDSKADIWSLGITAIELARGEPPHSEL 207

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 77/161 (47%), Gaps = 9/161 (5%)
Query: 736 FLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYR 795
              E++ +  + H NIV+L   +    T  L+ EY   G + + L  A G   + E R +
Sbjct: 58  LFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYL-VAHGRMKEKEARSK 116
Query: 796 IALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSS 855
              +    + Y H      I+HRD+K+ N+LLD+D    +ADFG +      G    + +
Sbjct: 117 FR-QIVSAVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK---LDT 169
Query: 856 VAGSYGYIAPEYAYTLKVD-EKSDVYSFGVVLLELIAGKKP 895
             GS  Y APE     K D  + DV+S GV+L  L++G  P
Sbjct: 170 FCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLP 210

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 94/200 (47%), Gaps = 13/200 (6%)
Query: 700 IGKGG-AGIVYRGSMPDGIDVAIKRLVGRGT--GGNDHGFLAEIQTLGRIRHRNIVRLLG 756
           IGKG  A +     +  G +VA+ R++ +      +      E++ +  + H NIV+L  
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAV-RIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFE 80
Query: 757 YVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLII 816
            +    T  L+ EY   G + + L  A G   + E R +   +    + Y H      I+
Sbjct: 81  VIETEKTLYLVMEYASGGEVFDYL-VAHGRMKEKEARAKFR-QIVSAVQYCHQ---KFIV 135
Query: 817 HRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVD-E 875
           HRD+K+ N+LLD+D    +ADFG   F  +      + +  GS  Y APE     K D  
Sbjct: 136 HRDLKAENLLLDADMNIKIADFG---FSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGP 192
Query: 876 KSDVYSFGVVLLELIAGKKP 895
           + DV+S GV+L  L++G  P
Sbjct: 193 EVDVWSLGVILYTLVSGSLP 212

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 70.5 bits (171), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 99/225 (44%), Gaps = 9/225 (4%)
Query: 675 WKLTAFQRLDFKAEDVLESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDH 734
           WK    Q ++ K + VL+       +G G  G+V+R +     +    + V      +  
Sbjct: 140 WKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKE 199
Query: 735 GFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRY 794
               EIQT+  +RH  +V L     + +  +++YE+M  G L E +   +   +  +   
Sbjct: 200 TVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKV-ADEHNKMSEDEAV 258
Query: 795 RIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDF--EAHVADFGLAKFLQDAGASEC 852
               +  KGLC++H +     +H D+K  NI+  +    E  + DFGL   L      + 
Sbjct: 259 EYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD---PKQS 312
Query: 853 MSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVG 897
           +    G+  + APE A    V   +D++S GV+   L++G  P G
Sbjct: 313 VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFG 357

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 70.5 bits (171), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 51/187 (27%), Positives = 89/187 (47%), Gaps = 18/187 (9%)
Query: 719 VAIKRLVGRGTGGNDHGFLAEIQTLGRI-RHRNIVRLLGYVSNRDTNLLLYEYMPNGSLG 777
           VA+K L    T  +    ++E++ +  I +H+NI+ LLG  +      ++ EY   G+L 
Sbjct: 63  VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 122
Query: 778 EMLHGAKGGHLKW--------------ETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSN 823
           E L   +   L++              +     A + A+G+ YL    S   IHRD+ + 
Sbjct: 123 EYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAAR 179
Query: 824 NILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFG 883
           N+L+  D    +ADFGLA+ +      +  ++      ++APE  +      +SDV+SFG
Sbjct: 180 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFG 239
Query: 884 VVLLELI 890
           V+L E+ 
Sbjct: 240 VLLWEIF 246

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 70.5 bits (171), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 100/218 (45%), Gaps = 17/218 (7%)
Query: 685 FKAEDVLESLKDENIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGND--HGFLAEIQ 741
           F  +D  +   D   IG G  G VY    + +   VAIK++   G   N+     + E++
Sbjct: 47  FFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVR 106
Query: 742 TLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAA 801
            L ++RH N ++  G      T  L+ EY   GS  ++L   K    + E    +   A 
Sbjct: 107 FLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIA-AVTHGAL 164
Query: 802 KGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYG 861
           +GL YLH   S  +IHRDVK+ NILL       + DFG A  +  A      +   G+  
Sbjct: 165 QGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA------NXFVGTPY 215
Query: 862 YIAPEYAYTL---KVDEKSDVYSFGVVLLELIAGKKPV 896
           ++APE    +   + D K DV+S G+  +EL   K P+
Sbjct: 216 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 253

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 63/239 (26%), Positives = 106/239 (44%), Gaps = 13/239 (5%)
Query: 698 NIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDH---GFLAEIQTLGRIRHRNIVRL 754
             +GKGG    Y  +  D  +V   ++V +      H       EI     + + ++V  
Sbjct: 48  RFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGF 107
Query: 755 LGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPL 814
            G+  + D   ++ E     SL E LH  +    + E RY    +  +G+ YLH++    
Sbjct: 108 HGFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARY-FMRQTIQGVQYLHNN---R 162
Query: 815 IIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVD 874
           +IHRD+K  N+ L+ D +  + DFGLA  ++  G  E   ++ G+  YIAPE        
Sbjct: 163 VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDG--ERKKTLCGTPNYIAPEVLCKKGHS 220
Query: 875 EKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDPRL 933
            + D++S G +L  L+ GK P   F        ++R   +E S P     V + +  R+
Sbjct: 221 FEVDIWSLGCILYTLLVGKPP---FETSCLKETYIRIKKNEYSVPRHINPVASALIRRM 276

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 100/226 (44%), Gaps = 11/226 (4%)
Query: 675 WKLTAFQRLDFKAEDVLESLKDENIIGKGGAGIVYR-GSMPDGIDVAIKRLVGRGTGGND 733
           WK    Q ++ K + VL+       +G G  G+V+R      G + A K  V      + 
Sbjct: 34  WKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAK-FVMTPHESDK 92
Query: 734 HGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETR 793
                EIQT+  +RH  +V L     + +  +++YE+M  G L E +   +   +  +  
Sbjct: 93  ETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKV-ADEHNKMSEDEA 151
Query: 794 YRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDF--EAHVADFGLAKFLQDAGASE 851
                +  KGLC++H +     +H D+K  NI+  +    E  + DFGL   L      +
Sbjct: 152 VEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD---PKQ 205
Query: 852 CMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVG 897
            +    G+  + APE A    V   +D++S GV+   L++G  P G
Sbjct: 206 SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFG 251

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 89/202 (44%), Gaps = 19/202 (9%)
Query: 700 IGKGGAGIVYRGSMPDGID------VAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVR 753
           IGKG  G V++G     ID      VAIK +              EI  L +     + +
Sbjct: 31  IGKGSFGEVFKG-----IDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVTK 85
Query: 754 LLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSP 813
             G         ++ EY+  GS  ++L        +  T  +   E  KGL YLH +   
Sbjct: 86  YYGSYLKGSKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLK---EILKGLDYLHSEKK- 141
Query: 814 LIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKV 873
             IHRD+K+ N+LL    +  +ADFG+A  L D       ++  G+  ++APE       
Sbjct: 142 --IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR--NTFVGTPFWMAPEVIQQSAY 197
Query: 874 DEKSDVYSFGVVLLELIAGKKP 895
           D K+D++S G+  +EL  G+ P
Sbjct: 198 DSKADIWSLGITAIELAKGEPP 219

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 70.1 bits (170), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 93/200 (46%), Gaps = 13/200 (6%)
Query: 700 IGKGG-AGIVYRGSMPDGIDVAIKRLVGRGT--GGNDHGFLAEIQTLGRIRHRNIVRLLG 756
           IGKG  A +     +  G +VA+ R++ +      +      E++ +  + H NIV+L  
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAV-RIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFE 80
Query: 757 YVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLII 816
            +    T  L+ EY   G + + L  A G   + E R +   +    + Y H      I+
Sbjct: 81  VIETEKTLYLVMEYASGGEVFDYL-VAHGRMKEKEARAKFR-QIVSAVQYCHQ---KFIV 135
Query: 817 HRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVD-E 875
           HRD+K+ N+LLD+D    +ADFG   F  +      +    GS  Y APE     K D  
Sbjct: 136 HRDLKAENLLLDADMNIKIADFG---FSNEFTFGNKLDEFCGSPPYAAPELFQGKKYDGP 192
Query: 876 KSDVYSFGVVLLELIAGKKP 895
           + DV+S GV+L  L++G  P
Sbjct: 193 EVDVWSLGVILYTLVSGSLP 212

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 65/244 (26%), Positives = 108/244 (44%), Gaps = 36/244 (14%)
Query: 699 IIGKGGAGIVYRGSMP-DGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRH--------- 748
           ++G+G  G V +     D    AIK++  R T       L+E+  L  + H         
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKI--RHTEEKLSTILSEVXLLASLNHQYVVRYYAA 70
Query: 749 ----RNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGL 804
               RN V+    V  + T  +  EY  N +L +++H       + E  +R+  +  + L
Sbjct: 71  WLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEY-WRLFRQILEAL 129
Query: 805 CYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDA------------GASEC 852
            Y+H   S  IIHR++K  NI +D      + DFGLAK +  +            G+S+ 
Sbjct: 130 SYIH---SQGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDN 186
Query: 853 MSSVAGSYGYIAPEYAY-TLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRK 911
           ++S  G+  Y+A E    T   +EK D YS G++  E I    P     + V+I++ +R 
Sbjct: 187 LTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXIY---PFSTGXERVNILKKLRS 243
Query: 912 TTSE 915
            + E
Sbjct: 244 VSIE 247

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 68/222 (30%), Positives = 102/222 (45%), Gaps = 22/222 (9%)
Query: 693 SLKDENIIGKGGAGIVYRGSMPD-GIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNI 751
           S  D  +IG G  G+VY+  + D G  VAIK+++      N      E+Q + ++ H NI
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-----RELQIMRKLDHCNI 75
Query: 752 VRL--LGYVSNRDTNL----LLYEYMPNGSLGEMLHGAKGGHLKWETRYRIAL-EAAKGL 804
           VRL    Y S    ++    L+ +Y+P        H ++          ++ + +  + L
Sbjct: 76  VRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 805 CYLHHDCSPLIIHRDVKSNNILLDSDFEA-HVADFGLAKFLQDAGASECMSSVAGSYGYI 863
            Y+H   S  I HRD+K  N+LLD D     + DFG AK  Q       +S +   Y Y 
Sbjct: 136 AYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSXICSRY-YR 189
Query: 864 APEYAY-TLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVD 904
           APE  +         DV+S G VL EL+ G +P+     GVD
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFPGDSGVD 230

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 96/209 (45%), Gaps = 22/209 (10%)
Query: 729 TGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSL-GEMLHGAKGGH 787
           T  N    L E+  L ++ H NI++L  +  ++    L+ E    G L  E++   K   
Sbjct: 61  TTSNSGALLDEVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSE 120
Query: 788 LKWETRYRIALEAAKGLCYLH-HDCSPLIIHRDVKSNNILLDS---DFEAHVADFGLAKF 843
           +       I  +   G  YLH H+    I+HRD+K  N+LL+S   D    + DFGL+  
Sbjct: 121 VDAAV---IMKQVLSGTTYLHKHN----IVHRDLKPENLLLESKSRDALIKIVDFGLSAH 173
Query: 844 LQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGV 903
            +  G    M    G+  YIAPE     K DEK DV+S GV+L  L+ G  P G   D  
Sbjct: 174 FEVGGK---MKERLGTAYYIAPE-VLRKKYDEKCDVWSCGVILYILLCGYPPFGGQTDQ- 228
Query: 904 DIVRWVRK-----TTSEVSQPSDAASVLA 927
           +I++ V K        + +Q SD A  L 
Sbjct: 229 EILKRVEKGKFSFDPPDWTQVSDEAKQLV 257

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Composition-based stats.
 Identities = 75/260 (28%), Positives = 118/260 (45%), Gaps = 26/260 (10%)
Query: 719 VAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTN--LLLYEYMPNGSL 776
           VA+K L       +  G+  EI  L  + H +I++  G   ++      L+ EY+P GSL
Sbjct: 46  VAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSL 105
Query: 777 GEML--HGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAH 834
            + L  H      L        A +  +G+ YLH   +   IHR++ + N+LLD+D    
Sbjct: 106 RDYLPRHSIGLAQL-----LLFAQQICEGMAYLH---AQHYIHRNLAARNVLLDNDRLVK 157
Query: 835 VADFGLAKFLQDAGASECMSSVAGS-YGYIAPEYAYTLKVDEKSDVYSFGVVLLELI--- 890
           + DFGLAK + +      +     S   + APE     K    SDV+SFGV L EL+   
Sbjct: 158 IGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHC 217
Query: 891 -AGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAM 949
            + + P  +F + + I +  + T   +++  +    L    PR    P   V HL K   
Sbjct: 218 DSSQSPPTKFLELIGIAQG-QMTVLRLTELLERGERL----PRPDKCPCE-VYHLMK--- 268
Query: 950 MCVEDESSARPTMREVVHML 969
            C E E+S RPT   ++ +L
Sbjct: 269 NCWETEASFRPTFENLIPIL 288

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 63/239 (26%), Positives = 105/239 (43%), Gaps = 13/239 (5%)
Query: 698 NIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDH---GFLAEIQTLGRIRHRNIVRL 754
             +GKGG    Y  +  D  +V   ++V +      H       EI     + + ++V  
Sbjct: 32  RFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGF 91
Query: 755 LGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPL 814
            G+  + D   ++ E     SL E LH  +    + E RY    +  +G+ YLH++    
Sbjct: 92  HGFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARY-FMRQTIQGVQYLHNN---R 146
Query: 815 IIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVD 874
           +IHRD+K  N+ L+ D +  + DFGLA  ++  G  E    + G+  YIAPE        
Sbjct: 147 VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDG--ERKKDLCGTPNYIAPEVLCKKGHS 204
Query: 875 EKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDPRL 933
            + D++S G +L  L+ GK P   F        ++R   +E S P     V + +  R+
Sbjct: 205 FEVDIWSLGCILYTLLVGKPP---FETSCLKETYIRIKKNEYSVPRHINPVASALIRRM 260

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 71/290 (24%), Positives = 116/290 (40%), Gaps = 44/290 (15%)
Query: 700 IGKGGAGIVYRGSMPDGID------VAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVR 753
           +G+G  G+VY G+  D I       VA+K +    +      FL E   +      ++VR
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 754 LLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETR--------YRIALEAAKGLC 805
           LLG VS     L++ E M +G L   L   +        R         ++A E A G+ 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 806 YLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAP 865
           YL+   +   +HRD+ + N ++  DF   + DFG+ + + +               ++AP
Sbjct: 145 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAP 201
Query: 866 EYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQP----SD 921
           E          SD++SFGVVL E+                       TS   QP    S+
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEI-----------------------TSLAEQPYQGLSN 238
Query: 922 AASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLAN 971
              +  V+D      P      +  +  MC +   + RPT  E+V++L +
Sbjct: 239 EQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLKD 288

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 96/208 (46%), Gaps = 23/208 (11%)
Query: 700 IGKGGAGIVYRGSMPDGID------VAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVR 753
           IGKG  G V++G     ID      VAIK +              EI  L +     + +
Sbjct: 15  IGKGSFGEVFKG-----IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTK 69
Query: 754 LLG-YVSNRDTNL-LLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDC 811
             G Y+  +DT L ++ EY+  GS  ++L   + G L       I  E  KGL YLH + 
Sbjct: 70  YYGSYL--KDTKLWIIMEYLGGGSALDLL---EPGPLDETQIATILREILKGLDYLHSEK 124
Query: 812 SPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTL 871
               IHRD+K+ N+LL    E  +ADFG+A  L D       +   G+  ++APE     
Sbjct: 125 K---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR--NXFVGTPFWMAPEVIKQS 179
Query: 872 KVDEKSDVYSFGVVLLELIAGKKPVGEF 899
             D K+D++S G+  +EL  G+ P  E 
Sbjct: 180 AYDSKADIWSLGITAIELARGEPPHSEL 207

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 96/197 (48%), Gaps = 10/197 (5%)
Query: 700 IGKGGAGIVYRGSMPD-GIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYV 758
           IG+G  GIV   +    G  VA+K++  R     +  F  E+  +    H N+V +    
Sbjct: 53  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLF-NEVVIMRDYHHDNVVDMYSSY 111
Query: 759 SNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHR 818
              D   ++ E++  G+L +++   +    +  T   + L   + L YLH+     +IHR
Sbjct: 112 LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAT---VCLSVLRALSYLHNQG---VIHR 165
Query: 819 DVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSD 878
           D+KS++ILL SD    ++DFG     Q +        + G+  ++APE    L    + D
Sbjct: 166 DIKSDSILLTSDGRIKLSDFGFCA--QVSKEVPKRKXLVGTPYWMAPEVISRLPYGTEVD 223
Query: 879 VYSFGVVLLELIAGKKP 895
           ++S G++++E+I G+ P
Sbjct: 224 IWSLGIMVIEMIDGEPP 240

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 71/290 (24%), Positives = 114/290 (39%), Gaps = 44/290 (15%)
Query: 700 IGKGGAGIVYRGSMPDGID------VAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVR 753
           +G+G  G+VY G+  D I       VA+K +    +      FL E   +      ++VR
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 754 LLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETR--------YRIALEAAKGLC 805
           LLG VS     L++ E M +G L   L   +        R         ++A E A G+ 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 806 YLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAP 865
           YL+   +   +HRD+ + N ++  DF   + DFG+ + + +               ++AP
Sbjct: 145 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAP 201
Query: 866 EYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASV 925
           E          SD++SFGVVL E+                       TS   QP    S 
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEI-----------------------TSLAEQPYQGLSN 238
Query: 926 LAVVDPRLSG----YPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLAN 971
             V+   + G     P      +  +  MC +     RPT  E+V++L +
Sbjct: 239 EQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKD 288

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 100/218 (45%), Gaps = 17/218 (7%)
Query: 685 FKAEDVLESLKDENIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGND--HGFLAEIQ 741
           F  +D  +   D   IG G  G VY    + +   VAIK++   G   N+     + E++
Sbjct: 8   FFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVR 67
Query: 742 TLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAA 801
            L ++RH N ++  G      T  L+ EY   GS  ++L   K    + E    +   A 
Sbjct: 68  FLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIA-AVTHGAL 125
Query: 802 KGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYG 861
           +GL YLH   S  +IHRDVK+ NILL       + DFG A  +  A      +   G+  
Sbjct: 126 QGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA------NXFVGTPY 176
Query: 862 YIAPEYAYTL---KVDEKSDVYSFGVVLLELIAGKKPV 896
           ++APE    +   + D K DV+S G+  +EL   K P+
Sbjct: 177 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 69.7 bits (169), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 69/237 (29%), Positives = 111/237 (46%), Gaps = 19/237 (8%)
Query: 690 VLESLKDENIIGKGGAGIVYRGSMPDGI---DVAIKRLVGRGTGGNDHGFLA--EIQTLG 744
           VL+  ++   IG G  GIV   +  D I   +VAIK+L  R      H   A  E+  + 
Sbjct: 22  VLKRYQNLKPIGSGAQGIV--CAAYDAILERNVAIKKL-SRPFQNQTHAKRAYRELVLMK 78
Query: 745 RIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRY-RIALEAAKG 803
            + H+NI+ LL   + + +   L E+     + E++       ++ E  + R++    + 
Sbjct: 79  VVNHKNIIGLLNVFTPQKS---LEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQM 135
Query: 804 LCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYI 863
           LC + H  S  IIHRD+K +NI++ SD    + DFGLA+    AG S  M+    +  Y 
Sbjct: 136 LCGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLAR---TAGTSFMMTPYVVTRYYR 192
Query: 864 APEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPS 920
           APE    +   E  D++S G ++ E+I G    G    G D +    K   ++  PS
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKG----GVLFPGTDHIDQWNKVIEQLGTPS 245

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 69.7 bits (169), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 95/209 (45%), Gaps = 12/209 (5%)
Query: 692 ESLKDENIIGKGG-AGIVYRGSMPDGIDVAIKRLVGRGT-GGNDHGFLA-EIQTLGRIRH 748
           E  K   I+G+G  + +V    +    + AIK L  R     N   ++  E   + R+ H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 749 RNIVRLLGYVSNRDTNLLLY--EYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCY 806
              V+L  Y + +D   L +   Y  NG L + +    G   +  TR+  A E    L Y
Sbjct: 92  PFFVKL--YFTFQDDEKLYFGLSYAKNGCLLKYIRKI-GSFDETCTRFYTA-EIVSALEY 147
Query: 807 LHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPE 866
           LH      IIHRD+K  NILL+ D    + DFG AK L         +S  G+  Y++PE
Sbjct: 148 LHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 204
Query: 867 YAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
                   + SD+++ G ++ +L+AG  P
Sbjct: 205 LLTEKSASKSSDLWALGCIIYQLVAGLPP 233

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 69.7 bits (169), Expect = 8e-12,   Method: Composition-based stats.
 Identities = 66/247 (26%), Positives = 111/247 (44%), Gaps = 18/247 (7%)
Query: 686 KAEDVLESLKDENIIGKGG-AGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLG 744
           +AED+ +     +++G G  + ++          VAIK +      G +     EI  L 
Sbjct: 12  QAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLH 71
Query: 745 RIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGL 804
           +I+H NIV L     +     L+ + +  G L + +   + G        R+  +    +
Sbjct: 72  KIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRI--VEKGFYTERDASRLIFQVLDAV 129
Query: 805 CYLHHDCSPLIIHRDVKSNNIL---LDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYG 861
            YLH D    I+HRD+K  N+L   LD D +  ++DFGL+K ++D G+   +S+  G+ G
Sbjct: 130 KYLH-DLG--IVHRDLKPENLLYYSLDEDSKIMISDFGLSK-MEDPGS--VLSTACGTPG 183
Query: 862 YIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQP-- 919
           Y+APE        +  D +S GV+   L+ G  P  +  D   +   + K   E   P  
Sbjct: 184 YVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA-KLFEQILKAEYEFDSPYW 242
Query: 920 ---SDAA 923
              SD+A
Sbjct: 243 DDISDSA 249

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 69.7 bits (169), Expect = 8e-12,   Method: Composition-based stats.
 Identities = 66/247 (26%), Positives = 111/247 (44%), Gaps = 18/247 (7%)
Query: 686 KAEDVLESLKDENIIGKGG-AGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLG 744
           +AED+ +     +++G G  + ++          VAIK +      G +     EI  L 
Sbjct: 12  QAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLH 71
Query: 745 RIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGL 804
           +I+H NIV L     +     L+ + +  G L + +   + G        R+  +    +
Sbjct: 72  KIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRI--VEKGFYTERDASRLIFQVLDAV 129
Query: 805 CYLHHDCSPLIIHRDVKSNNIL---LDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYG 861
            YLH D    I+HRD+K  N+L   LD D +  ++DFGL+K ++D G+   +S+  G+ G
Sbjct: 130 KYLH-DLG--IVHRDLKPENLLYYSLDEDSKIMISDFGLSK-MEDPGS--VLSTACGTPG 183
Query: 862 YIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQP-- 919
           Y+APE        +  D +S GV+   L+ G  P  +  D   +   + K   E   P  
Sbjct: 184 YVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA-KLFEQILKAEYEFDSPYW 242
Query: 920 ---SDAA 923
              SD+A
Sbjct: 243 DDISDSA 249

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 69.7 bits (169), Expect = 8e-12,   Method: Composition-based stats.
 Identities = 66/247 (26%), Positives = 111/247 (44%), Gaps = 18/247 (7%)
Query: 686 KAEDVLESLKDENIIGKGG-AGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLG 744
           +AED+ +     +++G G  + ++          VAIK +      G +     EI  L 
Sbjct: 12  QAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLH 71
Query: 745 RIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGL 804
           +I+H NIV L     +     L+ + +  G L + +   + G        R+  +    +
Sbjct: 72  KIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRI--VEKGFYTERDASRLIFQVLDAV 129
Query: 805 CYLHHDCSPLIIHRDVKSNNIL---LDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYG 861
            YLH D    I+HRD+K  N+L   LD D +  ++DFGL+K ++D G+   +S+  G+ G
Sbjct: 130 KYLH-DLG--IVHRDLKPENLLYYSLDEDSKIMISDFGLSK-MEDPGS--VLSTACGTPG 183
Query: 862 YIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQP-- 919
           Y+APE        +  D +S GV+   L+ G  P  +  D   +   + K   E   P  
Sbjct: 184 YVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA-KLFEQILKAEYEFDSPYW 242
Query: 920 ---SDAA 923
              SD+A
Sbjct: 243 DDISDSA 249

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 69.7 bits (169), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 60/239 (25%), Positives = 110/239 (46%), Gaps = 9/239 (3%)
Query: 700 IGKGGAGIVYRGSMPDGIDVAIKRL-VGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYV 758
           IG+G  G+VY+     G   A+K++ + +   G     + EI  L  ++H NIV+L   +
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 759 SNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHR 818
             +   +L++E++ +  L ++L   +GG L+  T     L+   G+ Y H      ++HR
Sbjct: 70  HTKKRLVLVFEHL-DQDLKKLLDVCEGG-LESVTAKSFLLQLLNGIAYCH---DRRVLHR 124
Query: 819 DVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAY-TLKVDEKS 877
           D+K  N+L++ + E  +ADFGLA+             V  +  Y AP+    + K     
Sbjct: 125 DLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV--TLWYRAPDVLMGSKKYSTTI 182
Query: 878 DVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDPRLSGY 936
           D++S G +  E++ G        +   ++R  R   +  S+     + L   DP  + Y
Sbjct: 183 DIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVY 241

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 69.7 bits (169), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 71/290 (24%), Positives = 115/290 (39%), Gaps = 44/290 (15%)
Query: 700 IGKGGAGIVYRGSMPDGID------VAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVR 753
           +G+G  G+VY G+  D I       VA+K +    +      FL E   +      ++VR
Sbjct: 22  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 81
Query: 754 LLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETR--------YRIALEAAKGLC 805
           LLG VS     L++ E M +G L   L   +        R         ++A E A G+ 
Sbjct: 82  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 141
Query: 806 YLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAP 865
           YL+   +   +HRD+ + N ++  DF   + DFG+ + + +               ++AP
Sbjct: 142 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAP 198
Query: 866 EYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQP----SD 921
           E          SD++SFGVVL E+                       TS   QP    S+
Sbjct: 199 ESLKDGVFTTSSDMWSFGVVLWEI-----------------------TSLAEQPYQGLSN 235
Query: 922 AASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLAN 971
              +  V+D      P      +  +  MC +     RPT  E+V++L +
Sbjct: 236 EQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKD 285

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 69.7 bits (169), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 69/237 (29%), Positives = 111/237 (46%), Gaps = 19/237 (8%)
Query: 690 VLESLKDENIIGKGGAGIVYRGSMPDGI---DVAIKRLVGRGTGGNDHGFLA--EIQTLG 744
           VL+  ++   IG G  GIV   +  D I   +VAIK+L  R      H   A  E+  + 
Sbjct: 22  VLKRYQNLKPIGSGAQGIV--CAAYDAILERNVAIKKL-SRPFQNQTHAKRAYRELVLMK 78
Query: 745 RIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRY-RIALEAAKG 803
            + H+NI+ LL   + + +   L E+     + E++       ++ E  + R++    + 
Sbjct: 79  CVNHKNIIGLLNVFTPQKS---LEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQM 135
Query: 804 LCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYI 863
           LC + H  S  IIHRD+K +NI++ SD    + DFGLA+    AG S  M+    +  Y 
Sbjct: 136 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYR 192
Query: 864 APEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPS 920
           APE    +   E  D++S G ++ E+I G    G    G D +    K   ++  PS
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKG----GVLFPGTDHIDQWNKVIEQLGTPS 245

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 69.7 bits (169), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 106/214 (49%), Gaps = 37/214 (17%)
Query: 700 IGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRI--RHRNIVRLLGY 757
           +GKG  G V+RG +  G  VA+K    R    ++  +  E +    +  RH NI   LG+
Sbjct: 16  VGKGRYGEVWRG-LWHGESVAVKIFSSR----DEQSWFRETEIYNTVLLRHDNI---LGF 67
Query: 758 VS------NRDTNL-LLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHD 810
           ++      N  T L L+  Y  +GSL + L       L+     R+A+ AA GL +LH +
Sbjct: 68  IASDMTSRNSSTQLWLITHYHEHGSLYDFLQRQT---LEPHLALRLAVSAACGLAHLHVE 124
Query: 811 C-----SPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECM----SSVAGSYG 861
                  P I HRD KS N+L+ S+ +  +AD GLA  +  +  S+ +    +   G+  
Sbjct: 125 IFGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLA--VMHSQGSDYLDIGNNPRVGTKR 182
Query: 862 YIAPEY-AYTLKVD-----EKSDVYSFGVVLLEL 889
           Y+APE     ++ D     + +D+++FG+VL E+
Sbjct: 183 YMAPEVLDEQIRTDCFESYKWTDIWAFGLVLWEI 216

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 60/239 (25%), Positives = 110/239 (46%), Gaps = 9/239 (3%)
Query: 700 IGKGGAGIVYRGSMPDGIDVAIKRL-VGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYV 758
           IG+G  G+VY+     G   A+K++ + +   G     + EI  L  ++H NIV+L   +
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 759 SNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHR 818
             +   +L++E++ +  L ++L   +GG L+  T     L+   G+ Y H      ++HR
Sbjct: 70  HTKKRLVLVFEHL-DQDLKKLLDVCEGG-LESVTAKSFLLQLLNGIAYCH---DRRVLHR 124
Query: 819 DVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAY-TLKVDEKS 877
           D+K  N+L++ + E  +ADFGLA+             V  +  Y AP+    + K     
Sbjct: 125 DLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV--TLWYRAPDVLMGSKKYSTTI 182
Query: 878 DVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDPRLSGY 936
           D++S G +  E++ G        +   ++R  R   +  S+     + L   DP  + Y
Sbjct: 183 DIWSVGCIFAEMVNGAPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVY 241

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 80/160 (50%), Gaps = 13/160 (8%)
Query: 739 EIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEML--HGAKGGHLKWETRYRI 796
           E++ +  + H NIV+L   +    T  L+ EY   G + + L  HG +    +  +++R 
Sbjct: 64  EVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHG-RMKEKEARSKFRQ 122
Query: 797 ALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSV 856
            + A +   Y H      I+HRD+K+ N+LLD+D    +ADFG +      G    + + 
Sbjct: 123 IVSAVQ---YCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK---LDAF 173
Query: 857 AGSYGYIAPEYAYTLKVD-EKSDVYSFGVVLLELIAGKKP 895
            G+  Y APE     K D  + DV+S GV+L  L++G  P
Sbjct: 174 CGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLP 213

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 63/239 (26%), Positives = 105/239 (43%), Gaps = 13/239 (5%)
Query: 698 NIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDH---GFLAEIQTLGRIRHRNIVRL 754
             +GKGG    Y  +  D  +V   ++V +      H       EI     + + ++V  
Sbjct: 48  RFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGF 107
Query: 755 LGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPL 814
            G+  + D   ++ E     SL E LH  +    + E RY    +  +G+ YLH++    
Sbjct: 108 HGFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARY-FMRQTIQGVQYLHNN---R 162
Query: 815 IIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVD 874
           +IHRD+K  N+ L+ D +  + DFGLA  ++  G  E    + G+  YIAPE        
Sbjct: 163 VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDG--ERKKDLCGTPNYIAPEVLCKKGHS 220
Query: 875 EKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDPRL 933
            + D++S G +L  L+ GK P   F        ++R   +E S P     V + +  R+
Sbjct: 221 FEVDIWSLGCILYTLLVGKPP---FETSCLKETYIRIKKNEYSVPRHINPVASALIRRM 276

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 76/161 (47%), Gaps = 9/161 (5%)
Query: 736 FLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYR 795
              E++ +  + H NIV+L   +    T  L+ EY   G + + L  A G   + E R +
Sbjct: 61  LFREVRIMKILNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYL-VAHGRMKEKEARAK 119
Query: 796 IALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSS 855
              +    + Y H      I+HRD+K+ N+LLD D    +ADFG   F  +      + +
Sbjct: 120 FR-QIVSAVQYCHQ---KYIVHRDLKAENLLLDGDMNIKIADFG---FSNEFTVGNKLDT 172
Query: 856 VAGSYGYIAPEYAYTLKVD-EKSDVYSFGVVLLELIAGKKP 895
             GS  Y APE     K D  + DV+S GV+L  L++G  P
Sbjct: 173 FCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLP 213

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 69/237 (29%), Positives = 111/237 (46%), Gaps = 19/237 (8%)
Query: 690 VLESLKDENIIGKGGAGIVYRGSMPDGI---DVAIKRLVGRGTGGNDHGFLA--EIQTLG 744
           VL+  ++   IG G  GIV   +  D I   +VAIK+L  R      H   A  E+  + 
Sbjct: 22  VLKRYQNLKPIGSGAQGIV--CAAYDAILERNVAIKKL-SRPFQNQTHAKRAYRELVLMK 78
Query: 745 RIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRY-RIALEAAKG 803
            + H+NI+ LL   + + +   L E+     + E++       ++ E  + R++    + 
Sbjct: 79  CVNHKNIIGLLNVFTPQKS---LEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQM 135
Query: 804 LCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYI 863
           LC + H  S  IIHRD+K +NI++ SD    + DFGLA+    AG S  M+    +  Y 
Sbjct: 136 LCGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLAR---TAGTSFMMTPYVVTRYYR 192
Query: 864 APEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPS 920
           APE    +   E  D++S G ++ E+I G    G    G D +    K   ++  PS
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKG----GVLFPGTDHIDQWNKVIEQLGTPS 245

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 92/199 (46%), Gaps = 11/199 (5%)
Query: 700 IGKGG-AGIVYRGSMPDGIDVAIKRLVGRGTGGND-HGFLAEIQTLGRIRHRNIVRLLGY 757
           IGKG  A +     +  G +VA+K +       +       E++ +  + H NIV+L   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 758 VSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIH 817
           +    T  L+ EY   G + + L  A G   + E R +   +    + Y H      I+H
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYL-VAHGRMKEKEARAKFR-QIVSAVQYCHQ---KFIVH 136
Query: 818 RDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVD-EK 876
           RD+K+ N+LLD+D    +ADFG   F  +      + +  G+  Y APE     K D  +
Sbjct: 137 RDLKAENLLLDADMNIKIADFG---FSNEFTFGNKLDAFCGAPPYAAPELFQGKKYDGPE 193
Query: 877 SDVYSFGVVLLELIAGKKP 895
            DV+S GV+L  L++G  P
Sbjct: 194 VDVWSLGVILYTLVSGSLP 212

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 93/211 (44%), Gaps = 15/211 (7%)
Query: 691 LESLKDENIIGKGGAGIVYRGSMPDGIDV-AIKRLVGRGTGGND--HGFLAEIQTLG-RI 746
           +E  +   ++GKG  G V+           AIK L       +D     + E + L    
Sbjct: 17  IEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW 76
Query: 747 RHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCY 806
            H  +  +      ++    + EY+  G L   +       L   T Y  A E   GL +
Sbjct: 77  EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFY--AAEIILGLQF 134
Query: 807 LHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAK--FLQDAGASECMSSVAGSYGYIA 864
           LH   S  I++RD+K +NILLD D    +ADFG+ K   L DA  +E      G+  YIA
Sbjct: 135 LH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNE----FCGTPDYIA 187
Query: 865 PEYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
           PE     K +   D +SFGV+L E++ G+ P
Sbjct: 188 PEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 218

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 60/239 (25%), Positives = 110/239 (46%), Gaps = 9/239 (3%)
Query: 700 IGKGGAGIVYRGSMPDGIDVAIKRL-VGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYV 758
           IG+G  G+VY+     G   A+K++ + +   G     + EI  L  ++H NIV+L   +
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 759 SNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHR 818
             +   +L++E++ +  L ++L   +GG L+  T     L+   G+ Y H      ++HR
Sbjct: 70  HTKKRLVLVFEHL-DQDLKKLLDVCEGG-LESVTAKSFLLQLLNGIAYCH---DRRVLHR 124
Query: 819 DVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAY-TLKVDEKS 877
           D+K  N+L++ + E  +ADFGLA+             V  +  Y AP+    + K     
Sbjct: 125 DLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV--TLWYRAPDVLMGSKKYSTTI 182
Query: 878 DVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDPRLSGY 936
           D++S G +  E++ G        +   ++R  R   +  S+     + L   DP  + Y
Sbjct: 183 DIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVY 241

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/239 (26%), Positives = 105/239 (43%), Gaps = 13/239 (5%)
Query: 698 NIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDH---GFLAEIQTLGRIRHRNIVRL 754
             +GKGG    Y  +  D  +V   ++V +      H       EI     + + ++V  
Sbjct: 48  RFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGF 107
Query: 755 LGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPL 814
            G+  + D   ++ E     SL E LH  +    + E RY    +  +G+ YLH++    
Sbjct: 108 HGFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARY-FMRQTIQGVQYLHNN---R 162
Query: 815 IIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVD 874
           +IHRD+K  N+ L+ D +  + DFGLA  ++  G  E    + G+  YIAPE        
Sbjct: 163 VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDG--ERKKXLCGTPNYIAPEVLCKKGHS 220
Query: 875 EKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDPRL 933
            + D++S G +L  L+ GK P   F        ++R   +E S P     V + +  R+
Sbjct: 221 FEVDIWSLGCILYTLLVGKPP---FETSCLKETYIRIKKNEYSVPRHINPVASALIRRM 276

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 96/199 (48%), Gaps = 14/199 (7%)
Query: 700 IGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYV 758
           IG+G +G VY    +  G +VAI+++  +     +   + EI  +   ++ NIV  L   
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL-IINEILVMRENKNPNIVNYLDSY 86
Query: 759 SNRDTNLLLYEYMPNGSLGEMLHGA--KGGHLKWETRYRIALEAAKGLCYLHHDCSPLII 816
              D   ++ EY+  GSL +++       G +    R     E  + L +LH   S  +I
Sbjct: 87  LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR-----ECLQALEFLH---SNQVI 138
Query: 817 HRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEK 876
           HRD+KS+NILL  D    + DFG    +    +    S++ G+  ++APE         K
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYWMAPEVVTRKAYGPK 196
Query: 877 SDVYSFGVVLLELIAGKKP 895
            D++S G++ +E+I G+ P
Sbjct: 197 VDIWSLGIMAIEMIEGEPP 215

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/196 (26%), Positives = 87/196 (44%), Gaps = 7/196 (3%)
Query: 700 IGKGGAG-IVYRGSMPDGIDVAIKRL-VGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGY 757
           IG+G  G  +   S  DG    IK + + R +         E+  L  ++H NIV+    
Sbjct: 32  IGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRES 91
Query: 758 VSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIH 817
                +  ++ +Y   G L + ++  KG   + +      ++    L ++H      I+H
Sbjct: 92  FEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH---DRKILH 148
Query: 818 RDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKS 877
           RD+KS NI L  D    + DFG+A+ L      E   +  G+  Y++PE       + KS
Sbjct: 149 RDIKSQNIFLTKDGTVQLGDFGIARVLN--STVELARACIGTPYYLSPEICENKPYNNKS 206
Query: 878 DVYSFGVVLLELIAGK 893
           D+++ G VL EL   K
Sbjct: 207 DIWALGCVLYELCTLK 222

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 103/212 (48%), Gaps = 33/212 (15%)
Query: 700 IGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRI--RHRNIVRLLGY 757
           +GKG  G V+RGS   G +VA+K    R    ++  +  E +    +  RH NI   LG+
Sbjct: 45  VGKGRYGEVWRGSW-QGENVAVKIFSSR----DEKSWFRETELYNTVMLRHENI---LGF 96
Query: 758 VSNRDTN-------LLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHD 810
           +++  T+        L+  Y   GSL + L       L   +  RI L  A GL +LH +
Sbjct: 97  IASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT---LDTVSCLRIVLSIASGLAHLHIE 153
Query: 811 C-----SPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSS--VAGSYGYI 863
                  P I HRD+KS NIL+  + +  +AD GLA     +     + +    G+  Y+
Sbjct: 154 IFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYM 213
Query: 864 APEY-AYTLKVD-----EKSDVYSFGVVLLEL 889
           APE    T++VD     ++ D+++FG+VL E+
Sbjct: 214 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 245

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Composition-based stats.
 Identities = 67/217 (30%), Positives = 96/217 (44%), Gaps = 15/217 (6%)
Query: 700 IGKGGAGIVYRG-SMPDGIDVAIKRLVGRG-TGGNDHGFLAEIQTLGRIRHRNIVRLL-- 755
           IG+G    VY+G      ++VA   L  R  T      F  E + L  ++H NIVR    
Sbjct: 34  IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRFYDS 93
Query: 756 --GYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSP 813
               V  +   +L+ E   +G+L   L   K   +K    +    +  KGL +LH   +P
Sbjct: 94  WESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSW--CRQILKGLQFLHTR-TP 150
Query: 814 LIIHRDVKSNNILLDSDF-EAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLK 872
            IIHRD+K +NI +        + D GLA   + + A     +V G+  + APE  Y  K
Sbjct: 151 PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK----AVIGTPEFXAPE-XYEEK 205
Query: 873 VDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWV 909
            DE  DVY+FG   LE    + P  E  +   I R V
Sbjct: 206 YDESVDVYAFGXCXLEXATSEYPYSECQNAAQIYRRV 242

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 69/237 (29%), Positives = 111/237 (46%), Gaps = 19/237 (8%)
Query: 690 VLESLKDENIIGKGGAGIVYRGSMPDGI---DVAIKRLVGRGTGGNDHGFLA--EIQTLG 744
           VL+  ++   IG G  GIV   +  D I   +VAIK+L  R      H   A  E+  + 
Sbjct: 22  VLKRYQNLKPIGSGAQGIV--CAAYDAILERNVAIKKL-SRPFQNQTHAKRAYRELVLMK 78
Query: 745 RIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRY-RIALEAAKG 803
            + H+NI+ LL   + + +   L E+     + E++       ++ E  + R++    + 
Sbjct: 79  CVNHKNIIGLLNVFTPQKS---LEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQM 135
Query: 804 LCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYI 863
           LC + H  S  IIHRD+K +NI++ SD    + DFGLA+    AG S  M+    +  Y 
Sbjct: 136 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYR 192
Query: 864 APEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPS 920
           APE    +   E  D++S G ++ E+I G    G    G D +    K   ++  PS
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKG----GVLFPGTDHIDQWNKVIEQLGTPS 245

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 102/210 (48%), Gaps = 15/210 (7%)
Query: 690 VLESLKDENIIGKGGAGIVYRGSMPDGI---DVAIKRLVGRGTGGNDHGFLA--EIQTLG 744
           VL+  ++   IG G  GIV   +  D +   +VAIK+L  R      H   A  E+  + 
Sbjct: 22  VLKRYQNLKPIGSGAQGIV--CAAYDAVLDRNVAIKKL-SRPFQNQTHAKRAYRELVLMK 78
Query: 745 RIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRY-RIALEAAKG 803
            + H+NI+ LL   + + T   L E+     + E++       ++ E  + R++    + 
Sbjct: 79  XVNHKNIISLLNVFTPQKT---LEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQM 135
Query: 804 LCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYI 863
           LC + H  S  IIHRD+K +NI++ SD    + DFGLA+    AG S  M+    +  Y 
Sbjct: 136 LCGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLAR---TAGTSFMMTPYVVTRYYR 192
Query: 864 APEYAYTLKVDEKSDVYSFGVVLLELIAGK 893
           APE    +   E  D++S G ++ E++  K
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/194 (25%), Positives = 91/194 (46%), Gaps = 22/194 (11%)
Query: 715 DGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRI-RHRNIVRLLGYVSNRDTNLLLYEYMPN 773
           + + VA+K L    T  +    ++E++ +  I +H+NI+ LLG  +      ++ EY   
Sbjct: 66  EAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASK 125
Query: 774 GSLGEMLHGAKGGHLKWETRYRI----------------ALEAAKGLCYLHHDCSPLIIH 817
           G+L E L   +   +  E  Y I                  + A+G+ YL    S   IH
Sbjct: 126 GNLREYLRARRPPGM--EXSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIH 180
Query: 818 RDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKS 877
           RD+ + N+L+  +    +ADFGLA+ + +    +  ++      ++APE  +      +S
Sbjct: 181 RDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNGRLPVKWMAPEALFDRVYTHQS 240
Query: 878 DVYSFGVVLLELIA 891
           DV+SFGV++ E+  
Sbjct: 241 DVWSFGVLMWEIFT 254

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 95/209 (45%), Gaps = 12/209 (5%)
Query: 692 ESLKDENIIGKGG-AGIVYRGSMPDGIDVAIKRLVGRGT-GGNDHGFLA-EIQTLGRIRH 748
           E  K   I+G+G  + +V    +    + AIK L  R     N   ++  E   + R+ H
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 749 RNIVRLLGYVSNRDTNLLLY--EYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCY 806
              V+L  Y + +D   L +   Y  NG L + +    G   +  TR+  A E    L Y
Sbjct: 89  PFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTA-EIVSALEY 144
Query: 807 LHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPE 866
           LH      IIHRD+K  NILL+ D    + DFG AK L         +S  G+  Y++PE
Sbjct: 145 LH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 201
Query: 867 YAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
                   + SD+++ G ++ +L+AG  P
Sbjct: 202 LLTEKSACKSSDLWALGCIIYQLVAGLPP 230

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 102/210 (48%), Gaps = 15/210 (7%)
Query: 690 VLESLKDENIIGKGGAGIVYRGSMPDGI---DVAIKRLVGRGTGGNDHGFLA--EIQTLG 744
           VL+  ++   IG G  GIV   +  D +   +VAIK+L  R      H   A  E+  + 
Sbjct: 22  VLKRYQNLKPIGSGAQGIV--CAAYDAVLDRNVAIKKL-SRPFQNQTHAKRAYRELVLMK 78
Query: 745 RIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRY-RIALEAAKG 803
            + H+NI+ LL   + + T   L E+     + E++       ++ E  + R++    + 
Sbjct: 79  XVNHKNIISLLNVFTPQKT---LEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQM 135
Query: 804 LCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYI 863
           LC + H  S  IIHRD+K +NI++ SD    + DFGLA+    AG S  M+    +  Y 
Sbjct: 136 LCGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLAR---TAGTSFMMTPYVVTRYYR 192
Query: 864 APEYAYTLKVDEKSDVYSFGVVLLELIAGK 893
           APE    +   E  D++S G ++ E++  K
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 69/223 (30%), Positives = 103/223 (46%), Gaps = 24/223 (10%)
Query: 693 SLKDENIIGKGGAGIVYRGSMPD-GIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNI 751
           S  D  +IG G  G+VY+  + D G  VAIK+++      N      E+Q + ++ H NI
Sbjct: 22  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-----RELQIMRKLDHCNI 76
Query: 752 VRLLGYV----SNRDT---NLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIAL-EAAKG 803
           VRL  +       +D    NL+L +Y+P        H ++          ++ + +  + 
Sbjct: 77  VRLRYFFYSSGEKKDEVYLNLVL-DYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 135
Query: 804 LCYLHHDCSPLIIHRDVKSNNILLDSDFEA-HVADFGLAKFLQDAGASECMSSVAGSYGY 862
           L Y+H   S  I HRD+K  N+LLD D     + DFG AK  Q       +S +   Y Y
Sbjct: 136 LAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSXICSRY-Y 189
Query: 863 IAPEYAY-TLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVD 904
            APE  +         DV+S G VL EL+ G +P+     GVD
Sbjct: 190 RAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFPGDSGVD 231

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 69/223 (30%), Positives = 103/223 (46%), Gaps = 24/223 (10%)
Query: 693 SLKDENIIGKGGAGIVYRGSMPD-GIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNI 751
           S  D  +IG G  G+VY+  + D G  VAIK+++      N      E+Q + ++ H NI
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-----RELQIMRKLDHCNI 75
Query: 752 VRLLGYV----SNRDT---NLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIAL-EAAKG 803
           VRL  +       +D    NL+L +Y+P        H ++          ++ + +  + 
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVL-DYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 804 LCYLHHDCSPLIIHRDVKSNNILLDSDFEA-HVADFGLAKFLQDAGASECMSSVAGSYGY 862
           L Y+H   S  I HRD+K  N+LLD D     + DFG AK  Q       +S +   Y Y
Sbjct: 135 LAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSXICSRY-Y 188
Query: 863 IAPEYAY-TLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVD 904
            APE  +         DV+S G VL EL+ G +P+     GVD
Sbjct: 189 RAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFPGDSGVD 230

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 95/209 (45%), Gaps = 12/209 (5%)
Query: 692 ESLKDENIIGKGG-AGIVYRGSMPDGIDVAIKRLVGRGT-GGNDHGFLA-EIQTLGRIRH 748
           E  K   I+G+G  + +V    +    + AIK L  R     N   ++  E   + R+ H
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 749 RNIVRLLGYVSNRDTNLLLY--EYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCY 806
              V+L  Y + +D   L +   Y  NG L + +    G   +  TR+  A E    L Y
Sbjct: 93  PFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTA-EIVSALEY 148
Query: 807 LHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPE 866
           LH      IIHRD+K  NILL+ D    + DFG AK L         +S  G+  Y++PE
Sbjct: 149 LHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 205
Query: 867 YAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
                   + SD+++ G ++ +L+AG  P
Sbjct: 206 LLTEKSACKSSDLWALGCIIYQLVAGLPP 234

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 95/199 (47%), Gaps = 14/199 (7%)
Query: 700 IGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYV 758
           IG+G +G VY    +  G +VAI+++  +     +   + EI  +   ++ NIV  L   
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL-IINEILVMRENKNPNIVNYLDSY 87
Query: 759 SNRDTNLLLYEYMPNGSLGEMLHGA--KGGHLKWETRYRIALEAAKGLCYLHHDCSPLII 816
              D   ++ EY+  GSL +++       G +    R     E  + L +LH   S  +I
Sbjct: 88  LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR-----ECLQALEFLH---SNQVI 139
Query: 817 HRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEK 876
           HRD+KS+NILL  D    + DFG    +    +    S + G+  ++APE         K
Sbjct: 140 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--SXMVGTPYWMAPEVVTRKAYGPK 197
Query: 877 SDVYSFGVVLLELIAGKKP 895
            D++S G++ +E+I G+ P
Sbjct: 198 VDIWSLGIMAIEMIEGEPP 216

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 86/206 (41%), Gaps = 17/206 (8%)
Query: 700 IGKGGAGIVYRGSM------PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVR 753
           +G G  G VY G +      P  + VA+K L    +  ++  FL E   + +  H+NIVR
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 754 LLGYVSNRDTNLLLYEYMPNGSLGEMLHG-----AKGGHLKWETRYRIALEAAKGLCYLH 808
            +G         +L E M  G L   L       ++   L       +A + A G  YL 
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 198
Query: 809 HDCSPLIIHRDVKSNNILLDSDFEAHVA---DFGLAKFLQDAGASECMSSVAGSYGYIAP 865
            +     IHRD+ + N LL       VA   DFG+A+ +  AG             ++ P
Sbjct: 199 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPP 255
Query: 866 EYAYTLKVDEKSDVYSFGVVLLELIA 891
           E         K+D +SFGV+L E+ +
Sbjct: 256 EAFMEGIFTSKTDTWSFGVLLWEIFS 281

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 69/223 (30%), Positives = 103/223 (46%), Gaps = 24/223 (10%)
Query: 693 SLKDENIIGKGGAGIVYRGSMPD-GIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNI 751
           S  D  +IG G  G+VY+  + D G  VAIK+++      N      E+Q + ++ H NI
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-----RELQIMRKLDHCNI 75
Query: 752 VRLLGYV----SNRDT---NLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIAL-EAAKG 803
           VRL  +       +D    NL+L +Y+P        H ++          ++ + +  + 
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVL-DYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 804 LCYLHHDCSPLIIHRDVKSNNILLDSDFEA-HVADFGLAKFLQDAGASECMSSVAGSYGY 862
           L Y+H   S  I HRD+K  N+LLD D     + DFG AK  Q       +S +   Y Y
Sbjct: 135 LAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSXICSRY-Y 188
Query: 863 IAPEYAY-TLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVD 904
            APE  +         DV+S G VL EL+ G +P+     GVD
Sbjct: 189 RAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFPGDSGVD 230

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 69/223 (30%), Positives = 103/223 (46%), Gaps = 24/223 (10%)
Query: 693 SLKDENIIGKGGAGIVYRGSMPD-GIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNI 751
           S  D  +IG G  G+VY+  + D G  VAIK+++      N      E+Q + ++ H NI
Sbjct: 40  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-----RELQIMRKLDHCNI 94
Query: 752 VRLLGYV----SNRDT---NLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIAL-EAAKG 803
           VRL  +       +D    NL+L +Y+P        H ++          ++ + +  + 
Sbjct: 95  VRLRYFFYSSGEKKDEVYLNLVL-DYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 153
Query: 804 LCYLHHDCSPLIIHRDVKSNNILLDSDFEA-HVADFGLAKFLQDAGASECMSSVAGSYGY 862
           L Y+H   S  I HRD+K  N+LLD D     + DFG AK  Q       +S +   Y Y
Sbjct: 154 LAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSXICSRY-Y 207
Query: 863 IAPEYAY-TLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVD 904
            APE  +         DV+S G VL EL+ G +P+     GVD
Sbjct: 208 RAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFPGDSGVD 249

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 105/226 (46%), Gaps = 16/226 (7%)
Query: 692 ESLKDENIIGKGGAG-IVYRGSMPDGIDVAIKRLVGRGTGG--NDHGFLAEIQTLGRIRH 748
           +  K + ++GKG  G ++       G + A+K +  R      +    L E+Q L ++ H
Sbjct: 26  DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 85
Query: 749 RNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLH 808
            NI +L  +  ++    L+ E    G L + +   K          RI  +   G+ Y H
Sbjct: 86  PNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRK--RFSEVDAARIIRQVLSGITYXH 143
Query: 809 HDCSPLIIHRDVKSNNILLDS---DFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAP 865
            +    I+HRD+K  N+LL+S   D    + DFGL+   +   AS+      G+  YIAP
Sbjct: 144 KN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE---ASKKXKDKIGTAYYIAP 197
Query: 866 EYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRK 911
           E  +    DEK DV+S GV+L  L++G  P     +  DI++ V K
Sbjct: 198 EVLHGT-YDEKCDVWSTGVILYILLSGCPPFNG-ANEYDILKKVEK 241

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 71/290 (24%), Positives = 114/290 (39%), Gaps = 44/290 (15%)
Query: 700 IGKGGAGIVYRGSMPDGID------VAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVR 753
           +G+G  G+VY G+  D I       VA+K +    +      FL E   +      ++VR
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 754 LLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETR--------YRIALEAAKGLC 805
           LLG VS     L++ E M +G L   L   +        R         ++A E A G+ 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 806 YLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAP 865
           YL+   +   +HRD+ + N ++  DF   + DFG+ + + +               ++AP
Sbjct: 145 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLLPVRWMAP 201
Query: 866 EYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASV 925
           E          SD++SFGVVL E+                       TS   QP    S 
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEI-----------------------TSLAEQPYQGLSN 238
Query: 926 LAVVDPRLSG----YPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLAN 971
             V+   + G     P      +  +  MC +     RPT  E+V++L +
Sbjct: 239 EQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKD 288

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 95/199 (47%), Gaps = 14/199 (7%)
Query: 700 IGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYV 758
           IG+G +G VY    +  G +VAI+++  +     +   + EI  +   ++ NIV  L   
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL-IINEILVMRENKNPNIVNYLDSY 86
Query: 759 SNRDTNLLLYEYMPNGSLGEMLHGA--KGGHLKWETRYRIALEAAKGLCYLHHDCSPLII 816
              D   ++ EY+  GSL +++       G +    R     E  + L +LH   S  +I
Sbjct: 87  LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR-----ECLQALEFLH---SNQVI 138
Query: 817 HRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEK 876
           HRD+KS+NILL  D    + DFG    +    +    S + G+  ++APE         K
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--SEMVGTPYWMAPEVVTRKAYGPK 196
Query: 877 SDVYSFGVVLLELIAGKKP 895
            D++S G++ +E+I G+ P
Sbjct: 197 VDIWSLGIMAIEMIEGEPP 215

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 69/255 (27%), Positives = 113/255 (44%), Gaps = 25/255 (9%)
Query: 690 VLESLKDENIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHGFLA--EIQTLGRI 746
           VL+  +    IG G  GIV        GI+VA+K+L  R      H   A  E+  L  +
Sbjct: 22  VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKL-SRPFQNQTHAKRAYRELVLLKCV 80
Query: 747 RHRNIVRLLGYVSNRDT-----NLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAA 801
            H+NI+ LL   + + T     ++ L   + + +L +++H             R++    
Sbjct: 81  NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHE-------RMSYLLY 133
Query: 802 KGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYG 861
           + LC + H  S  IIHRD+K +NI++ SD    + DFGLA+    A  +  M+    +  
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TACTNFMMTPYVVTRY 190
Query: 862 YIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSD 921
           Y APE    +      D++S G ++ EL+ G         G D +    K   ++  PS 
Sbjct: 191 YRAPEVILGMGYAANVDIWSVGCIMGELVKG----CVIFQGTDHIDQWNKVIEQLGTPS- 245
Query: 922 AASVLAVVDPRLSGY 936
            A  +A + P +  Y
Sbjct: 246 -AEFMAALQPTVRNY 259

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 99/206 (48%), Gaps = 22/206 (10%)
Query: 699 IIGKGGAGIVYRGSMPDGI---DVAIKRLVGRGTGGNDHG--FLAEIQTLGRIRHRNIVR 753
           ++GKG  G V +    D I   + A+K ++ + +  N      L E++ L ++ H NI++
Sbjct: 29  MLGKGSFGEVLK--CKDRITQQEYAVK-VINKASAKNKDTSTILREVELLKKLDHPNIMK 85
Query: 754 LLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLH-HDCS 812
           L   + +  +  ++ E    G L + +   K          RI  +   G+ Y+H H+  
Sbjct: 86  LFEILEDSSSFYIVGELYTGGELFDEI--IKRKRFSEHDAARIIKQVFSGITYMHKHN-- 141
Query: 813 PLIIHRDVKSNNILLDS---DFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAY 869
             I+HRD+K  NILL+S   D +  + DFGL+   Q       M    G+  YIAPE   
Sbjct: 142 --IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---MKDRIGTAYYIAPE-VL 195
Query: 870 TLKVDEKSDVYSFGVVLLELIAGKKP 895
               DEK DV+S GV+L  L++G  P
Sbjct: 196 RGTYDEKCDVWSAGVILYILLSGTPP 221

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 95/199 (47%), Gaps = 14/199 (7%)
Query: 700 IGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYV 758
           IG+G +G VY    +  G +VAI+++  +     +   + EI  +   ++ NIV  L   
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL-IINEILVMRENKNPNIVNYLDSY 86
Query: 759 SNRDTNLLLYEYMPNGSLGEMLHGA--KGGHLKWETRYRIALEAAKGLCYLHHDCSPLII 816
              D   ++ EY+  GSL +++       G +    R     E  + L +LH   S  +I
Sbjct: 87  LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR-----ECLQALEFLH---SNQVI 138
Query: 817 HRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEK 876
           HRD+KS+NILL  D    + DFG    +    +    S + G+  ++APE         K
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--SXMVGTPYWMAPEVVTRKAYGPK 196
Query: 877 SDVYSFGVVLLELIAGKKP 895
            D++S G++ +E+I G+ P
Sbjct: 197 VDIWSLGIMAIEMIEGEPP 215

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 95/206 (46%), Gaps = 10/206 (4%)
Query: 691 LESLKDENIIGKGGAGIVYRGSMPD-GIDVAIKRLVGRGTGGNDHGF-LAEIQTLGRIRH 748
           +E  ++  ++G+G  G+V +    D G  VAIK+ +            + EI+ L ++RH
Sbjct: 24  MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRH 83
Query: 749 RNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLH 808
            N+V LL     +    L++E++ +  L ++     G   +   +Y   +    G C+ H
Sbjct: 84  ENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSH 143
Query: 809 HDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYA 868
           +     IIHRD+K  NIL+       + DFG A+ L  A   E       +  Y APE  
Sbjct: 144 N-----IIHRDIKPENILVSQSGVVKLCDFGFARTL--AAPGEVYDDEVATRWYRAPELL 196
Query: 869 Y-TLKVDEKSDVYSFGVVLLELIAGK 893
              +K  +  DV++ G ++ E+  G+
Sbjct: 197 VGDVKYGKAVDVWAIGCLVTEMFMGE 222

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 69/223 (30%), Positives = 103/223 (46%), Gaps = 24/223 (10%)
Query: 693 SLKDENIIGKGGAGIVYRGSMPD-GIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNI 751
           S  D  +IG G  G+VY+  + D G  VAIK+++      N      E+Q + ++ H NI
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-----RELQIMRKLDHCNI 75
Query: 752 VRLLGYV----SNRDT---NLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIAL-EAAKG 803
           VRL  +       +D    NL+L +Y+P        H ++          ++ + +  + 
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVL-DYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 804 LCYLHHDCSPLIIHRDVKSNNILLDSDFEA-HVADFGLAKFLQDAGASECMSSVAGSYGY 862
           L Y+H   S  I HRD+K  N+LLD D     + DFG AK  Q       +S +   Y Y
Sbjct: 135 LAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSYICSRY-Y 188
Query: 863 IAPEYAY-TLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVD 904
            APE  +         DV+S G VL EL+ G +P+     GVD
Sbjct: 189 RAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFPGDSGVD 230

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 69/223 (30%), Positives = 103/223 (46%), Gaps = 24/223 (10%)
Query: 693 SLKDENIIGKGGAGIVYRGSMPD-GIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNI 751
           S  D  +IG G  G+VY+  + D G  VAIK+++      N      E+Q + ++ H NI
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-----RELQIMRKLDHCNI 87
Query: 752 VRLLGYV----SNRDT---NLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIAL-EAAKG 803
           VRL  +       +D    NL+L +Y+P        H ++          ++ + +  + 
Sbjct: 88  VRLRYFFYSSGEKKDEVYLNLVL-DYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 146
Query: 804 LCYLHHDCSPLIIHRDVKSNNILLDSDFEA-HVADFGLAKFLQDAGASECMSSVAGSYGY 862
           L Y+H   S  I HRD+K  N+LLD D     + DFG AK  Q       +S +   Y Y
Sbjct: 147 LAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSXICSRY-Y 200
Query: 863 IAPEYAY-TLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVD 904
            APE  +         DV+S G VL EL+ G +P+     GVD
Sbjct: 201 RAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFPGDSGVD 242

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/192 (24%), Positives = 90/192 (46%), Gaps = 18/192 (9%)
Query: 715 DGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRI-RHRNIVRLLGYVSNRDTNLLLYEYMPN 773
           + + VA+K L    T  +    ++E++ +  I +H+NI+ LLG  +      ++ EY   
Sbjct: 66  EAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASK 125
Query: 774 GSLGEMLHGAK--------------GGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRD 819
           G+L E L   +                 + ++       + A+G+ YL    S   IHRD
Sbjct: 126 GNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRD 182
Query: 820 VKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDV 879
           + + N+L+  +    +ADFGLA+ + +    +  ++      ++APE  +      +SDV
Sbjct: 183 LAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDV 242
Query: 880 YSFGVVLLELIA 891
           +SFGV++ E+  
Sbjct: 243 WSFGVLMWEIFT 254

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 103/212 (48%), Gaps = 33/212 (15%)
Query: 700 IGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRI--RHRNIVRLLGY 757
           +GKG  G V+RGS   G +VA+K    R    ++  +  E +    +  RH NI   LG+
Sbjct: 16  VGKGRYGEVWRGSW-QGENVAVKIFSSR----DEKSWFRETELYNTVMLRHENI---LGF 67
Query: 758 VSNRDTN-------LLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHD 810
           +++  T+        L+  Y   GSL + L       L   +  RI L  A GL +LH +
Sbjct: 68  IASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT---LDTVSCLRIVLSIASGLAHLHIE 124
Query: 811 C-----SPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSS--VAGSYGYI 863
                  P I HRD+KS NIL+  + +  +AD GLA     +     + +    G+  Y+
Sbjct: 125 IFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYM 184
Query: 864 APEY-AYTLKVD-----EKSDVYSFGVVLLEL 889
           APE    T++VD     ++ D+++FG+VL E+
Sbjct: 185 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 103/212 (48%), Gaps = 33/212 (15%)
Query: 700 IGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRI--RHRNIVRLLGY 757
           +GKG  G V+RGS   G +VA+K    R    ++  +  E +    +  RH NI   LG+
Sbjct: 16  VGKGRYGEVWRGSW-QGENVAVKIFSSR----DEKSWFRETELYNTVMLRHENI---LGF 67
Query: 758 VSNRDTN-------LLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHD 810
           +++  T+        L+  Y   GSL + L       L   +  RI L  A GL +LH +
Sbjct: 68  IASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT---LDTVSCLRIVLSIASGLAHLHIE 124
Query: 811 C-----SPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSS--VAGSYGYI 863
                  P I HRD+KS NIL+  + +  +AD GLA     +     + +    G+  Y+
Sbjct: 125 IFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYM 184
Query: 864 APEY-AYTLKVD-----EKSDVYSFGVVLLEL 889
           APE    T++VD     ++ D+++FG+VL E+
Sbjct: 185 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/246 (23%), Positives = 112/246 (45%), Gaps = 14/246 (5%)
Query: 684 DFKAEDVLESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTL 743
           D   ED  E + +   +G G  G VY+    +   +A  +++   +      ++ EI  L
Sbjct: 32  DLNPEDFWEIIGE---LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDIL 88
Query: 744 GRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKG 803
               H NIV+LL      +   +L E+   G++  ++   +    + + +  +  +    
Sbjct: 89  ASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQV-VCKQTLDA 147
Query: 804 LCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYI 863
           L YLH +    IIHRD+K+ NIL   D +  +ADFG++   ++    +   S  G+  ++
Sbjct: 148 LNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSA--KNTRTIQRRDSFIGTPYWM 202
Query: 864 APEY-----AYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQ 918
           APE      +     D K+DV+S G+ L+E+   + P  E      +++  +     ++Q
Sbjct: 203 APEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQ 262
Query: 919 PSDAAS 924
           PS  +S
Sbjct: 263 PSRWSS 268

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 86/206 (41%), Gaps = 17/206 (8%)
Query: 700 IGKGGAGIVYRGSM------PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVR 753
           +G G  G VY G +      P  + VA+K L    +  ++  FL E   + +  H+NIVR
Sbjct: 56  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 115
Query: 754 LLGYVSNRDTNLLLYEYMPNGSLGEMLHG-----AKGGHLKWETRYRIALEAAKGLCYLH 808
            +G         +L E M  G L   L       ++   L       +A + A G  YL 
Sbjct: 116 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 175
Query: 809 HDCSPLIIHRDVKSNNILLDSDFEAHVA---DFGLAKFLQDAGASECMSSVAGSYGYIAP 865
            +     IHRD+ + N LL       VA   DFG+A+ +  AG             ++ P
Sbjct: 176 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPP 232
Query: 866 EYAYTLKVDEKSDVYSFGVVLLELIA 891
           E         K+D +SFGV+L E+ +
Sbjct: 233 EAFMEGIFTSKTDTWSFGVLLWEIFS 258

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 69/223 (30%), Positives = 103/223 (46%), Gaps = 24/223 (10%)
Query: 693 SLKDENIIGKGGAGIVYRGSMPD-GIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNI 751
           S  D  +IG G  G+VY+  + D G  VAIK+++      N      E+Q + ++ H NI
Sbjct: 29  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-----RELQIMRKLDHCNI 83
Query: 752 VRLLGYV----SNRDT---NLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIAL-EAAKG 803
           VRL  +       +D    NL+L +Y+P        H ++          ++ + +  + 
Sbjct: 84  VRLRYFFYSSGEKKDEVYLNLVL-DYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 142
Query: 804 LCYLHHDCSPLIIHRDVKSNNILLDSDFEA-HVADFGLAKFLQDAGASECMSSVAGSYGY 862
           L Y+H   S  I HRD+K  N+LLD D     + DFG AK  Q       +S +   Y Y
Sbjct: 143 LAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSXICSRY-Y 196
Query: 863 IAPEYAY-TLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVD 904
            APE  +         DV+S G VL EL+ G +P+     GVD
Sbjct: 197 RAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFPGDSGVD 238

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 69/223 (30%), Positives = 103/223 (46%), Gaps = 24/223 (10%)
Query: 693 SLKDENIIGKGGAGIVYRGSMPD-GIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNI 751
           S  D  +IG G  G+VY+  + D G  VAIK+++      N      E+Q + ++ H NI
Sbjct: 25  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-----RELQIMRKLDHCNI 79
Query: 752 VRLLGYV----SNRDT---NLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIAL-EAAKG 803
           VRL  +       +D    NL+L +Y+P        H ++          ++ + +  + 
Sbjct: 80  VRLRYFFYSSGEKKDEVYLNLVL-DYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 138
Query: 804 LCYLHHDCSPLIIHRDVKSNNILLDSDFEA-HVADFGLAKFLQDAGASECMSSVAGSYGY 862
           L Y+H   S  I HRD+K  N+LLD D     + DFG AK  Q       +S +   Y Y
Sbjct: 139 LAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSXICSRY-Y 192
Query: 863 IAPEYAY-TLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVD 904
            APE  +         DV+S G VL EL+ G +P+     GVD
Sbjct: 193 RAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFPGDSGVD 234

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 77/170 (45%), Gaps = 7/170 (4%)
Query: 746 IRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLC 805
           + H N+V+  G+    +   L  EY   G L + +    G       R+   L A  G+ 
Sbjct: 62  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVV 119
Query: 806 YLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAP 865
           YLH      I HRD+K  N+LLD      ++DFGLA   +       ++ + G+  Y+AP
Sbjct: 120 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 866 EYAYTLKVD-EKSDVYSFGVVLLELIAGKKPVGEFGDGV-DIVRWVRKTT 913
           E     +   E  DV+S G+VL  ++AG+ P  +  D   +   W  K T
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT 226

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 71/290 (24%), Positives = 114/290 (39%), Gaps = 44/290 (15%)
Query: 700 IGKGGAGIVYRGSMPDGID------VAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVR 753
           +G+G  G+VY G+  D I       VA+K +    +      FL E   +      ++VR
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 754 LLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETR--------YRIALEAAKGLC 805
           LLG VS     L++ E M +G L   L   +        R         ++A E A G+ 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 806 YLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAP 865
           YL+   +   +HRD+ + N ++  DF   + DFG+ + + +               ++AP
Sbjct: 145 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 201
Query: 866 EYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASV 925
           E          SD++SFGVVL E+                       TS   QP    S 
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEI-----------------------TSLAEQPYQGLSN 238
Query: 926 LAVVDPRLSG----YPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLAN 971
             V+   + G     P      +  +  MC +     RPT  E+V++L +
Sbjct: 239 EQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKD 288

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 102/210 (48%), Gaps = 15/210 (7%)
Query: 690 VLESLKDENIIGKGGAGIVYRGSMPDGI---DVAIKRLVGRGTGGNDHGFLA--EIQTLG 744
           VL+  ++   IG G  GIV   +  D +   +VAIK+L  R      H   A  E+  + 
Sbjct: 21  VLKRYQNLKPIGSGAQGIV--CAAYDAVLDRNVAIKKL-SRPFQNQTHAKRAYRELVLMK 77
Query: 745 RIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRY-RIALEAAKG 803
            + H+NI+ LL   + + T   L E+     + E++       ++ E  + R++    + 
Sbjct: 78  CVNHKNIISLLNVFTPQKT---LEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQM 134
Query: 804 LCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYI 863
           LC + H  S  IIHRD+K +NI++ SD    + DFGLA+    AG S  M+    +  Y 
Sbjct: 135 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYR 191
Query: 864 APEYAYTLKVDEKSDVYSFGVVLLELIAGK 893
           APE    +   E  D++S G ++ E++  K
Sbjct: 192 APEVILGMGYKENVDIWSVGCIMGEMVRHK 221

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 102/210 (48%), Gaps = 15/210 (7%)
Query: 690 VLESLKDENIIGKGGAGIVYRGSMPDGI---DVAIKRLVGRGTGGNDHGFLA--EIQTLG 744
           VL+  ++   IG G  GIV   +  D +   +VAIK+L  R      H   A  E+  + 
Sbjct: 23  VLKRYQNLKPIGSGAQGIV--CAAYDAVLDRNVAIKKL-SRPFQNQTHAKRAYRELVLMK 79
Query: 745 RIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRY-RIALEAAKG 803
            + H+NI+ LL   + + T   L E+     + E++       ++ E  + R++    + 
Sbjct: 80  CVNHKNIISLLNVFTPQKT---LEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQM 136
Query: 804 LCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYI 863
           LC + H  S  IIHRD+K +NI++ SD    + DFGLA+    AG S  M+    +  Y 
Sbjct: 137 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYR 193
Query: 864 APEYAYTLKVDEKSDVYSFGVVLLELIAGK 893
           APE    +   E  D++S G ++ E++  K
Sbjct: 194 APEVILGMGYKENVDIWSVGCIMGEMVRHK 223

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 77/170 (45%), Gaps = 7/170 (4%)
Query: 746 IRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLC 805
           + H N+V+  G+    +   L  EY   G L + +    G       R+   L A  G+ 
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVV 118
Query: 806 YLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAP 865
           YLH      I HRD+K  N+LLD      ++DFGLA   +       ++ + G+  Y+AP
Sbjct: 119 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 866 EYAYTLKVD-EKSDVYSFGVVLLELIAGKKPVGEFGDGV-DIVRWVRKTT 913
           E     +   E  DV+S G+VL  ++AG+ P  +  D   +   W  K T
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT 225

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 102/210 (48%), Gaps = 15/210 (7%)
Query: 690 VLESLKDENIIGKGGAGIVYRGSMPDGI---DVAIKRLVGRGTGGNDHGFLA--EIQTLG 744
           VL+  ++   IG G  GIV   +  D +   +VAIK+L  R      H   A  E+  + 
Sbjct: 22  VLKRYQNLKPIGSGAQGIV--CAAYDAVLDRNVAIKKL-SRPFQNQTHAKRAYRELVLMK 78
Query: 745 RIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRY-RIALEAAKG 803
            + H+NI+ LL   + + T   L E+     + E++       ++ E  + R++    + 
Sbjct: 79  CVNHKNIISLLNVFTPQKT---LEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQM 135
Query: 804 LCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYI 863
           LC + H  S  IIHRD+K +NI++ SD    + DFGLA+    AG S  M+    +  Y 
Sbjct: 136 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYR 192
Query: 864 APEYAYTLKVDEKSDVYSFGVVLLELIAGK 893
           APE    +   E  D++S G ++ E++  K
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 102/210 (48%), Gaps = 15/210 (7%)
Query: 690 VLESLKDENIIGKGGAGIVYRGSMPDGI---DVAIKRLVGRGTGGNDHGFLA--EIQTLG 744
           VL+  ++   IG G  GIV   +  D +   +VAIK+L  R      H   A  E+  + 
Sbjct: 22  VLKRYQNLKPIGSGAQGIV--CAAYDAVLDRNVAIKKL-SRPFQNQTHAKRAYRELVLMK 78
Query: 745 RIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRY-RIALEAAKG 803
            + H+NI+ LL   + + T   L E+     + E++       ++ E  + R++    + 
Sbjct: 79  CVNHKNIISLLNVFTPQKT---LEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQM 135
Query: 804 LCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYI 863
           LC + H  S  IIHRD+K +NI++ SD    + DFGLA+    AG S  M+    +  Y 
Sbjct: 136 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYR 192
Query: 864 APEYAYTLKVDEKSDVYSFGVVLLELIAGK 893
           APE    +   E  D++S G ++ E++  K
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 96/209 (45%), Gaps = 22/209 (10%)
Query: 729 TGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSL-GEMLHGAKGGH 787
           T  N    L E+  L ++ H NI++L  +  ++    L+ E    G L  E++   K   
Sbjct: 44  TTSNSGALLDEVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSE 103
Query: 788 LKWETRYRIALEAAKGLCYLH-HDCSPLIIHRDVKSNNILLDS---DFEAHVADFGLAKF 843
           +       I  +   G  YLH H+    I+HRD+K  N+LL+S   D    + DFGL+  
Sbjct: 104 VDAAV---IMKQVLSGTTYLHKHN----IVHRDLKPENLLLESKSRDALIKIVDFGLSAH 156
Query: 844 LQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGV 903
            +  G    M    G+  YIAPE     K DEK DV+S GV+L  L+ G  P G   D  
Sbjct: 157 FEVGGK---MKERLGTAYYIAPE-VLRKKYDEKCDVWSCGVILYILLCGYPPFGGQTDQ- 211
Query: 904 DIVRWVRKTT-----SEVSQPSDAASVLA 927
           +I++ V K        + +Q SD A  L 
Sbjct: 212 EILKRVEKGKFSFDPPDWTQVSDEAKQLV 240

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/192 (24%), Positives = 90/192 (46%), Gaps = 18/192 (9%)
Query: 715 DGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRI-RHRNIVRLLGYVSNRDTNLLLYEYMPN 773
           + + VA+K L    T  +    ++E++ +  I +H+NI+ LLG  +      ++ EY   
Sbjct: 112 EAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASK 171
Query: 774 GSLGEMLHGAK--------------GGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRD 819
           G+L E L   +                 + ++       + A+G+ YL    S   IHRD
Sbjct: 172 GNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRD 228
Query: 820 VKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDV 879
           + + N+L+  +    +ADFGLA+ + +    +  ++      ++APE  +      +SDV
Sbjct: 229 LAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDV 288
Query: 880 YSFGVVLLELIA 891
           +SFGV++ E+  
Sbjct: 289 WSFGVLMWEIFT 300

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 102/210 (48%), Gaps = 15/210 (7%)
Query: 690 VLESLKDENIIGKGGAGIVYRGSMPDGI---DVAIKRLVGRGTGGNDHGFLA--EIQTLG 744
           VL+  ++   IG G  GIV   +  D +   +VAIK+L  R      H   A  E+  + 
Sbjct: 15  VLKRYQNLKPIGSGAQGIV--CAAYDAVLDRNVAIKKL-SRPFQNQTHAKRAYRELVLMK 71
Query: 745 RIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRY-RIALEAAKG 803
            + H+NI+ LL   + + T   L E+     + E++       ++ E  + R++    + 
Sbjct: 72  CVNHKNIISLLNVFTPQKT---LEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQM 128
Query: 804 LCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYI 863
           LC + H  S  IIHRD+K +NI++ SD    + DFGLA+    AG S  M+    +  Y 
Sbjct: 129 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYR 185
Query: 864 APEYAYTLKVDEKSDVYSFGVVLLELIAGK 893
           APE    +   E  D++S G ++ E++  K
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMVRHK 215

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 94/209 (44%), Gaps = 12/209 (5%)
Query: 692 ESLKDENIIGKGG-AGIVYRGSMPDGIDVAIKRLVGRGT-GGNDHGFLA-EIQTLGRIRH 748
           E  K   I+G+G  + +V    +    + AIK L  R     N   ++  E   + R+ H
Sbjct: 10  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 69
Query: 749 RNIVRLLGYVSNRDTNLLLY--EYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCY 806
              V+L  Y + +D   L +   Y  NG L + +    G   +  TR+  A E    L Y
Sbjct: 70  PFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTA-EIVSALEY 125
Query: 807 LHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPE 866
           LH      IIHRD+K  NILL+ D    + DFG AK L         +   G+  Y++PE
Sbjct: 126 LHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 182
Query: 867 YAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
                   + SD+++ G ++ +L+AG  P
Sbjct: 183 LLTEKSACKSSDLWALGCIIYQLVAGLPP 211

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 102/210 (48%), Gaps = 15/210 (7%)
Query: 690 VLESLKDENIIGKGGAGIVYRGSMPDGI---DVAIKRLVGRGTGGNDHGFLA--EIQTLG 744
           VL+  ++   IG G  GIV   +  D +   +VAIK+L  R      H   A  E+  + 
Sbjct: 16  VLKRYQNLKPIGSGAQGIV--CAAYDAVLDRNVAIKKL-SRPFQNQTHAKRAYRELVLMK 72
Query: 745 RIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRY-RIALEAAKG 803
            + H+NI+ LL   + + T   L E+     + E++       ++ E  + R++    + 
Sbjct: 73  CVNHKNIISLLNVFTPQKT---LEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQM 129
Query: 804 LCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYI 863
           LC + H  S  IIHRD+K +NI++ SD    + DFGLA+    AG S  M+    +  Y 
Sbjct: 130 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYR 186
Query: 864 APEYAYTLKVDEKSDVYSFGVVLLELIAGK 893
           APE    +   E  D++S G ++ E++  K
Sbjct: 187 APEVILGMGYKENVDIWSVGCIMGEMVRHK 216

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 69/223 (30%), Positives = 103/223 (46%), Gaps = 24/223 (10%)
Query: 693 SLKDENIIGKGGAGIVYRGSMPD-GIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNI 751
           S  D  +IG G  G+VY+  + D G  VAIK+++      N      E+Q + ++ H NI
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-----RELQIMRKLDHCNI 87
Query: 752 VRLLGYV----SNRDT---NLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIAL-EAAKG 803
           VRL  +       +D    NL+L +Y+P        H ++          ++ + +  + 
Sbjct: 88  VRLRYFFYSSGEKKDEVYLNLVL-DYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 146
Query: 804 LCYLHHDCSPLIIHRDVKSNNILLDSDFEA-HVADFGLAKFLQDAGASECMSSVAGSYGY 862
           L Y+H   S  I HRD+K  N+LLD D     + DFG AK  Q       +S +   Y Y
Sbjct: 147 LAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSXICSRY-Y 200
Query: 863 IAPEYAY-TLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVD 904
            APE  +         DV+S G VL EL+ G +P+     GVD
Sbjct: 201 RAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFPGDSGVD 242

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 102/210 (48%), Gaps = 15/210 (7%)
Query: 690 VLESLKDENIIGKGGAGIVYRGSMPDGI---DVAIKRLVGRGTGGNDHGFLA--EIQTLG 744
           VL+  ++   IG G  GIV   +  D +   +VAIK+L  R      H   A  E+  + 
Sbjct: 16  VLKRYQNLKPIGSGAQGIV--CAAYDAVLDRNVAIKKL-SRPFQNQTHAKRAYRELVLMK 72
Query: 745 RIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRY-RIALEAAKG 803
            + H+NI+ LL   + + T   L E+     + E++       ++ E  + R++    + 
Sbjct: 73  CVNHKNIISLLNVFTPQKT---LEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQM 129
Query: 804 LCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYI 863
           LC + H  S  IIHRD+K +NI++ SD    + DFGLA+    AG S  M+    +  Y 
Sbjct: 130 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYR 186
Query: 864 APEYAYTLKVDEKSDVYSFGVVLLELIAGK 893
           APE    +   E  D++S G ++ E++  K
Sbjct: 187 APEVILGMGYKENVDIWSVGCIMGEMVRHK 216

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 68/236 (28%), Positives = 109/236 (46%), Gaps = 19/236 (8%)
Query: 690 VLESLKDENIIGKGGAGIVYRGSMPDGI---DVAIKRLVGRGTGGNDHGFLA--EIQTLG 744
           VL+  ++   IG G  GIV      D I   +VAIK+L  R      H   A  E+  + 
Sbjct: 22  VLKRYQNLKPIGSGAQGIVCAAY--DAILERNVAIKKL-SRPFQNQTHAKRAYRELVLMK 78
Query: 745 RIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRY-RIALEAAKG 803
            + H+NI+ LL   + + +   L E+     + E++       ++ E  + R++    + 
Sbjct: 79  CVNHKNIIGLLNVFTPQKS---LEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQM 135
Query: 804 LCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYI 863
           LC + H  S  IIHRD+K +NI++ SD    + DFGLA+    AG S  M+    +  Y 
Sbjct: 136 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPEVVTRYYR 192
Query: 864 APEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQP 919
           APE    +   E  D++S G ++ E+I G    G    G D +    K   ++  P
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKG----GVLFPGTDHIDQWNKVIEQLGTP 244

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/246 (23%), Positives = 112/246 (45%), Gaps = 14/246 (5%)
Query: 684 DFKAEDVLESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTL 743
           D   ED  E + +   +G G  G VY+    +   +A  +++   +      ++ EI  L
Sbjct: 32  DLNPEDFWEIIGE---LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDIL 88
Query: 744 GRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKG 803
               H NIV+LL      +   +L E+   G++  ++   +    + + +  +  +    
Sbjct: 89  ASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQV-VCKQTLDA 147
Query: 804 LCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYI 863
           L YLH +    IIHRD+K+ NIL   D +  +ADFG++   ++    +   S  G+  ++
Sbjct: 148 LNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSA--KNTRXIQRRDSFIGTPYWM 202
Query: 864 APEY-----AYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQ 918
           APE      +     D K+DV+S G+ L+E+   + P  E      +++  +     ++Q
Sbjct: 203 APEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQ 262
Query: 919 PSDAAS 924
           PS  +S
Sbjct: 263 PSRWSS 268

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 102/210 (48%), Gaps = 15/210 (7%)
Query: 690 VLESLKDENIIGKGGAGIVYRGSMPDGI---DVAIKRLVGRGTGGNDHGFLA--EIQTLG 744
           VL+  ++   IG G  GIV   +  D +   +VAIK+L  R      H   A  E+  + 
Sbjct: 23  VLKRYQNLKPIGSGAQGIV--CAAYDAVLDRNVAIKKL-SRPFQNQTHAKRAYRELVLMK 79
Query: 745 RIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRY-RIALEAAKG 803
            + H+NI+ LL   + + T   L E+     + E++       ++ E  + R++    + 
Sbjct: 80  CVNHKNIISLLNVFTPQKT---LEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQM 136
Query: 804 LCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYI 863
           LC + H  S  IIHRD+K +NI++ SD    + DFGLA+    AG S  M+    +  Y 
Sbjct: 137 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYR 193
Query: 864 APEYAYTLKVDEKSDVYSFGVVLLELIAGK 893
           APE    +   E  D++S G ++ E++  K
Sbjct: 194 APEVILGMGYKENVDIWSVGCIMGEMVRHK 223

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 79/177 (44%), Gaps = 7/177 (3%)
Query: 739 EIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIAL 798
           EI     + H N+V+  G+    +   L  EY   G L + +    G       R+   L
Sbjct: 54  EIXINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL 113
Query: 799 EAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAG 858
            A  G+ YLH      I HRD+K  N+LLD      ++DFGLA   +       ++ + G
Sbjct: 114 MA--GVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCG 168
Query: 859 SYGYIAPEYAYTLKVD-EKSDVYSFGVVLLELIAGKKPVGEFGDGV-DIVRWVRKTT 913
           +  Y+APE     +   E  DV+S G+VL  ++AG+ P  +  D   +   W  K T
Sbjct: 169 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT 225

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 100/224 (44%), Gaps = 12/224 (5%)
Query: 692 ESLKDENIIGKGG-AGIVYRGSMPDGIDVAIKRLVGRGT-GGNDHGFLA-EIQTLGRIRH 748
           E  K   I+G+G  + +V    +    + AIK L  R     N   ++  E   + R+ H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 749 RNIVRLLGYVSNRDTNLLLY--EYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCY 806
              V+L  Y + +D   L +   Y  NG L + +    G   +  TR+  A E    L Y
Sbjct: 92  PFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTA-EIVSALEY 147
Query: 807 LHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPE 866
           LH      IIHRD+K  NILL+ D    + DFG AK L         +   G+  Y++PE
Sbjct: 148 LHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 204
Query: 867 YAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVR 910
                   + SD+++ G ++ +L+AG  P     +G+   + ++
Sbjct: 205 LLTEKSAXKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIK 248

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 69/223 (30%), Positives = 103/223 (46%), Gaps = 24/223 (10%)
Query: 693 SLKDENIIGKGGAGIVYRGSMPD-GIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNI 751
           S  D  +IG G  G+VY+  + D G  VAIK+++      N      E+Q + ++ H NI
Sbjct: 34  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-----RELQIMRKLDHCNI 88
Query: 752 VRLLGYV----SNRDT---NLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIAL-EAAKG 803
           VRL  +       +D    NL+L +Y+P        H ++          ++ + +  + 
Sbjct: 89  VRLRYFFYSSGEKKDEVYLNLVL-DYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 147
Query: 804 LCYLHHDCSPLIIHRDVKSNNILLDSDFEA-HVADFGLAKFLQDAGASECMSSVAGSYGY 862
           L Y+H   S  I HRD+K  N+LLD D     + DFG AK  Q       +S +   Y Y
Sbjct: 148 LAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSYICSRY-Y 201
Query: 863 IAPEYAY-TLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVD 904
            APE  +         DV+S G VL EL+ G +P+     GVD
Sbjct: 202 RAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFPGDSGVD 243

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 94/209 (44%), Gaps = 12/209 (5%)
Query: 692 ESLKDENIIGKGG-AGIVYRGSMPDGIDVAIKRLVGRGT-GGNDHGFLA-EIQTLGRIRH 748
           E  K   I+G+G  + +V    +    + AIK L  R     N   ++  E   + R+ H
Sbjct: 9   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 68
Query: 749 RNIVRLLGYVSNRDTNLLLY--EYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCY 806
              V+L  Y + +D   L +   Y  NG L + +    G   +  TR+  A E    L Y
Sbjct: 69  PFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTA-EIVSALEY 124
Query: 807 LHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPE 866
           LH      IIHRD+K  NILL+ D    + DFG AK L         +   G+  Y++PE
Sbjct: 125 LHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 181
Query: 867 YAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
                   + SD+++ G ++ +L+AG  P
Sbjct: 182 LLTEKSACKSSDLWALGCIIYQLVAGLPP 210

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 69/223 (30%), Positives = 103/223 (46%), Gaps = 24/223 (10%)
Query: 693 SLKDENIIGKGGAGIVYRGSMPD-GIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNI 751
           S  D  +IG G  G+VY+  + D G  VAIK+++      N      E+Q + ++ H NI
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKN-----RELQIMRKLDHCNI 75
Query: 752 VRLLGYV----SNRDT---NLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIAL-EAAKG 803
           VRL  +       +D    NL+L +Y+P        H ++          ++ + +  + 
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVL-DYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 804 LCYLHHDCSPLIIHRDVKSNNILLDSDFEA-HVADFGLAKFLQDAGASECMSSVAGSYGY 862
           L Y+H   S  I HRD+K  N+LLD D     + DFG AK  Q       +S +   Y Y
Sbjct: 135 LAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSYICSRY-Y 188
Query: 863 IAPEYAY-TLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVD 904
            APE  +         DV+S G VL EL+ G +P+     GVD
Sbjct: 189 RAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFPGDSGVD 230

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 69/223 (30%), Positives = 103/223 (46%), Gaps = 24/223 (10%)
Query: 693 SLKDENIIGKGGAGIVYRGSMPD-GIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNI 751
           S  D  +IG G  G+VY+  + D G  VAIK+++      N      E+Q + ++ H NI
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKN-----RELQIMRKLDHCNI 75
Query: 752 VRLLGYV----SNRDT---NLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIAL-EAAKG 803
           VRL  +       +D    NL+L +Y+P        H ++          ++ + +  + 
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVL-DYVPATVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 804 LCYLHHDCSPLIIHRDVKSNNILLDSDFEA-HVADFGLAKFLQDAGASECMSSVAGSYGY 862
           L Y+H   S  I HRD+K  N+LLD D     + DFG AK  Q       +S +   Y Y
Sbjct: 135 LAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSXICSRY-Y 188
Query: 863 IAPEYAY-TLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVD 904
            APE  +         DV+S G VL EL+ G +P+     GVD
Sbjct: 189 RAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFPGDSGVD 230

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 93/204 (45%), Gaps = 20/204 (9%)
Query: 700 IGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYV 758
           +G G    VY+G +   G+ VA+K +      G     + EI  +  ++H NIVRL   +
Sbjct: 13  LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVI 72
Query: 759 SNRDTNLLLYEYMPNG--------SLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHD 810
              +   L++E+M N         ++G    G +   +K+        +  +GL + H +
Sbjct: 73  HTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKY-----FQWQLLQGLAFCHEN 127
Query: 811 CSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYT 870
               I+HRD+K  N+L++   +  + DFGLA+           SS   +  Y AP+    
Sbjct: 128 K---ILHRDLKPQNLLINKRGQLKLGDFGLARAF--GIPVNTFSSEVVTLWYRAPDVLMG 182
Query: 871 LKVDEKS-DVYSFGVVLLELIAGK 893
            +    S D++S G +L E+I GK
Sbjct: 183 SRTYSTSIDIWSCGCILAEMITGK 206

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 71/290 (24%), Positives = 114/290 (39%), Gaps = 44/290 (15%)
Query: 700 IGKGGAGIVYRGSMPDGID------VAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVR 753
           +G+G  G+VY G+  D I       VA+K +    +      FL E   +      ++VR
Sbjct: 24  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 83
Query: 754 LLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETR--------YRIALEAAKGLC 805
           LLG VS     L++ E M +G L   L   +        R         ++A E A G+ 
Sbjct: 84  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 143
Query: 806 YLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAP 865
           YL+   +   +HRD+ + N ++  DF   + DFG+ + + +               ++AP
Sbjct: 144 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 200
Query: 866 EYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASV 925
           E          SD++SFGVVL E+                       TS   QP    S 
Sbjct: 201 ESLKDGVFTTSSDMWSFGVVLWEI-----------------------TSLAEQPYQGLSN 237
Query: 926 LAVVDPRLSG----YPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLAN 971
             V+   + G     P      +  +  MC +     RPT  E+V++L +
Sbjct: 238 EQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKD 287

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 79/177 (44%), Gaps = 7/177 (3%)
Query: 739 EIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIAL 798
           EI     + H N+V+  G+    +   L  EY   G L + +    G       R+   L
Sbjct: 55  EICINAMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL 114
Query: 799 EAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAG 858
            A  G+ YLH      I HRD+K  N+LLD      ++DFGLA   +       ++ + G
Sbjct: 115 MA--GVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCG 169
Query: 859 SYGYIAPEYAYTLKVD-EKSDVYSFGVVLLELIAGKKPVGEFGDGV-DIVRWVRKTT 913
           +  Y+APE     +   E  DV+S G+VL  ++AG+ P  +  D   +   W  K T
Sbjct: 170 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT 226

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 69/223 (30%), Positives = 103/223 (46%), Gaps = 24/223 (10%)
Query: 693 SLKDENIIGKGGAGIVYRGSMPD-GIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNI 751
           S  D  +IG G  G+VY+  + D G  VAIK+++      N      E+Q + ++ H NI
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKN-----RELQIMRKLDHCNI 75
Query: 752 VRLLGYV----SNRDT---NLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIAL-EAAKG 803
           VRL  +       +D    NL+L +Y+P        H ++          ++ + +  + 
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVL-DYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 804 LCYLHHDCSPLIIHRDVKSNNILLDSDFEA-HVADFGLAKFLQDAGASECMSSVAGSYGY 862
           L Y+H   S  I HRD+K  N+LLD D     + DFG AK  Q       +S +   Y Y
Sbjct: 135 LAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSYICSRY-Y 188
Query: 863 IAPEYAY-TLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVD 904
            APE  +         DV+S G VL EL+ G +P+     GVD
Sbjct: 189 RAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFPGDSGVD 230

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 77/170 (45%), Gaps = 7/170 (4%)
Query: 746 IRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLC 805
           + H N+V+  G+    +   L  EY   G L + +    G       R+   L A  G+ 
Sbjct: 62  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVV 119
Query: 806 YLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAP 865
           YLH      I HRD+K  N+LLD      ++DFGLA   +       ++ + G+  Y+AP
Sbjct: 120 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 866 EYAYTLKVD-EKSDVYSFGVVLLELIAGKKPVGEFGDGV-DIVRWVRKTT 913
           E     +   E  DV+S G+VL  ++AG+ P  +  D   +   W  K T
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT 226

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 77/170 (45%), Gaps = 7/170 (4%)
Query: 746 IRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLC 805
           + H N+V+  G+    +   L  EY   G L + +    G       R+   L A  G+ 
Sbjct: 62  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVV 119
Query: 806 YLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAP 865
           YLH      I HRD+K  N+LLD      ++DFGLA   +       ++ + G+  Y+AP
Sbjct: 120 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 866 EYAYTLKVD-EKSDVYSFGVVLLELIAGKKPVGEFGDGV-DIVRWVRKTT 913
           E     +   E  DV+S G+VL  ++AG+ P  +  D   +   W  K T
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT 226

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 77/170 (45%), Gaps = 7/170 (4%)
Query: 746 IRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLC 805
           + H N+V+  G+    +   L  EY   G L + +    G       R+   L A  G+ 
Sbjct: 62  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVV 119
Query: 806 YLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAP 865
           YLH      I HRD+K  N+LLD      ++DFGLA   +       ++ + G+  Y+AP
Sbjct: 120 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 866 EYAYTLKVD-EKSDVYSFGVVLLELIAGKKPVGEFGDGV-DIVRWVRKTT 913
           E     +   E  DV+S G+VL  ++AG+ P  +  D   +   W  K T
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT 226

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 95/209 (45%), Gaps = 12/209 (5%)
Query: 692 ESLKDENIIGKGG-AGIVYRGSMPDGIDVAIKRLVGRGT-GGNDHGFLA-EIQTLGRIRH 748
           E  K   I+G+G  + +V    +    + AIK L  R     N   ++  E   + R+ H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 749 RNIVRLLGYVSNRDTNLLLY--EYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCY 806
              V+L  Y + +D   L +   Y  NG L + +    G   +  TR+  A E    L Y
Sbjct: 90  PFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTA-EIVSALEY 145
Query: 807 LHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPE 866
           LH      IIHRD+K  NILL+ D    + DFG AK L         ++  G+  Y++PE
Sbjct: 146 LHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPE 202
Query: 867 YAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
                   + SD+++ G ++ +L+AG  P
Sbjct: 203 LLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 69/223 (30%), Positives = 103/223 (46%), Gaps = 24/223 (10%)
Query: 693 SLKDENIIGKGGAGIVYRGSMPD-GIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNI 751
           S  D  +IG G  G+VY+  + D G  VAIK+++      N      E+Q + ++ H NI
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-----RELQIMRKLDHCNI 109
Query: 752 VRLLGYV----SNRDT---NLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIAL-EAAKG 803
           VRL  +       +D    NL+L +Y+P        H ++          ++ + +  + 
Sbjct: 110 VRLRYFFYSSGEKKDEVYLNLVL-DYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 168
Query: 804 LCYLHHDCSPLIIHRDVKSNNILLDSDFEA-HVADFGLAKFLQDAGASECMSSVAGSYGY 862
           L Y+H   S  I HRD+K  N+LLD D     + DFG AK  Q       +S +   Y Y
Sbjct: 169 LAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSXICSRY-Y 222
Query: 863 IAPEYAY-TLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVD 904
            APE  +         DV+S G VL EL+ G +P+     GVD
Sbjct: 223 RAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFPGDSGVD 264

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/269 (23%), Positives = 114/269 (42%), Gaps = 32/269 (11%)
Query: 717 IDVAIKRLVGRGTGGNDHGFLAEIQTLGRI-RHRNIVRLLGYVSNRDTNLLLYEYMPNGS 775
           + VA+K L            ++E++ +  + +H NIV LLG  ++    L++ EY   G 
Sbjct: 69  LKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGD 128
Query: 776 LGEMLHGAKGGHLKWETRYRIAL--------EAAKGLCYLHHDCSPLIIHRDVKSNNILL 827
           L   L       L  E    + L        + A+G+ +L    S   IHRDV + N+LL
Sbjct: 129 LLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLL 185
Query: 828 DSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLL 887
            +   A + DFGLA+ + +        +      ++APE  +      +SDV+S+G++L 
Sbjct: 186 TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLW 245
Query: 888 ELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFK 946
           E+ + G  P           + V K   +++QP+ A        P+          +++ 
Sbjct: 246 EIFSLGLNPYPGILVNSKFYKLV-KDGYQMAQPAFA--------PK----------NIYS 286
Query: 947 VAMMCVEDESSARPTMREVVHMLANPPQS 975
           +   C   E + RPT +++   L    Q 
Sbjct: 287 IMQACWALEPTHRPTFQQICSFLQEQAQE 315

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 94/209 (44%), Gaps = 12/209 (5%)
Query: 692 ESLKDENIIGKGG-AGIVYRGSMPDGIDVAIKRLVGRGT-GGNDHGFLA-EIQTLGRIRH 748
           E  K   I+G+G  + +V    +    + AIK L  R     N   ++  E   + R+ H
Sbjct: 7   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 66
Query: 749 RNIVRLLGYVSNRDTNLLLY--EYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCY 806
              V+L  Y + +D   L +   Y  NG L + +    G   +  TR+  A E    L Y
Sbjct: 67  PFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTA-EIVSALEY 122
Query: 807 LHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPE 866
           LH      IIHRD+K  NILL+ D    + DFG AK L         +   G+  Y++PE
Sbjct: 123 LHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 179
Query: 867 YAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
                   + SD+++ G ++ +L+AG  P
Sbjct: 180 LLTEKSACKSSDLWALGCIIYQLVAGLPP 208

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 99/206 (48%), Gaps = 22/206 (10%)
Query: 699 IIGKGGAGIVYRGSMPDGI---DVAIKRLVGRGTGGNDHG--FLAEIQTLGRIRHRNIVR 753
           ++GKG  G V +    D I   + A+K ++ + +  N      L E++ L ++ H NI++
Sbjct: 29  MLGKGSFGEVLK--CKDRITQQEYAVK-VINKASAKNKDTSTILREVELLKKLDHPNIMK 85
Query: 754 LLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLH-HDCS 812
           L   + +  +  ++ E    G L + +   K          RI  +   G+ Y+H H+  
Sbjct: 86  LFEILEDSSSFYIVGELYTGGELFDEI--IKRKRFSEHDAARIIKQVFSGITYMHKHN-- 141
Query: 813 PLIIHRDVKSNNILLDS---DFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAY 869
             I+HRD+K  NILL+S   D +  + DFGL+   Q       M    G+  YIAPE   
Sbjct: 142 --IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---MKDRIGTAYYIAPE-VL 195
Query: 870 TLKVDEKSDVYSFGVVLLELIAGKKP 895
               DEK DV+S GV+L  L++G  P
Sbjct: 196 RGTYDEKCDVWSAGVILYILLSGTPP 221

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 69/237 (29%), Positives = 110/237 (46%), Gaps = 19/237 (8%)
Query: 690 VLESLKDENIIGKGGAGIVYRGSMPDGI---DVAIKRLVGRGTGGNDHGFLA--EIQTLG 744
           VL+  ++   IG G  GIV      D I   +VAIK+L  R      H   A  E+  + 
Sbjct: 22  VLKRYQNLKPIGSGAQGIVVAAY--DAILERNVAIKKL-SRPFQNQTHAKRAYRELVLMK 78
Query: 745 RIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRY-RIALEAAKG 803
            + H+NI+ LL   + + +   L E+     + E++       ++ E  + R++    + 
Sbjct: 79  VVNHKNIIGLLNVFTPQKS---LEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQM 135
Query: 804 LCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYI 863
           L  + H  S  IIHRD+K +NI++ SD    + DFGLA+    AG S  M+    +  Y 
Sbjct: 136 LVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLAR---TAGTSFMMTPYVVTRYYR 192
Query: 864 APEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPS 920
           APE    +   E  D++S GV++ E+I G    G    G D +    K   ++  PS
Sbjct: 193 APEVILGMGYKENVDIWSVGVIMGEMIKG----GVLFPGTDHIDQWNKVIEQLGTPS 245

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 99/206 (48%), Gaps = 22/206 (10%)
Query: 699 IIGKGGAGIVYRGSMPDGI---DVAIKRLVGRGTGGNDHG--FLAEIQTLGRIRHRNIVR 753
           ++GKG  G V +    D I   + A+K ++ + +  N      L E++ L ++ H NI++
Sbjct: 29  MLGKGSFGEVLK--CKDRITQQEYAVK-VINKASAKNKDTSTILREVELLKKLDHPNIMK 85
Query: 754 LLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLH-HDCS 812
           L   + +  +  ++ E    G L + +   K          RI  +   G+ Y+H H+  
Sbjct: 86  LFEILEDSSSFYIVGELYTGGELFDEI--IKRKRFSEHDAARIIKQVFSGITYMHKHN-- 141
Query: 813 PLIIHRDVKSNNILLDS---DFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAY 869
             I+HRD+K  NILL+S   D +  + DFGL+   Q       M    G+  YIAPE   
Sbjct: 142 --IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---MKDRIGTAYYIAPE-VL 195
Query: 870 TLKVDEKSDVYSFGVVLLELIAGKKP 895
               DEK DV+S GV+L  L++G  P
Sbjct: 196 RGTYDEKCDVWSAGVILYILLSGTPP 221

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 102/210 (48%), Gaps = 15/210 (7%)
Query: 690 VLESLKDENIIGKGGAGIVYRGSMPDGI---DVAIKRLVGRGTGGNDHGFLA--EIQTLG 744
           VL+  ++   IG G  GIV   +  D +   +VAIK+L  R      H   A  E+  + 
Sbjct: 60  VLKRYQNLKPIGSGAQGIV--CAAYDAVLDRNVAIKKL-SRPFQNQTHAKRAYRELVLMK 116
Query: 745 RIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRY-RIALEAAKG 803
            + H+NI+ LL   + + T   L E+     + E++       ++ E  + R++    + 
Sbjct: 117 CVNHKNIISLLNVFTPQKT---LEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQM 173
Query: 804 LCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYI 863
           LC + H  S  IIHRD+K +NI++ SD    + DFGLA+    AG S  M+    +  Y 
Sbjct: 174 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYR 230
Query: 864 APEYAYTLKVDEKSDVYSFGVVLLELIAGK 893
           APE    +   E  D++S G ++ E++  K
Sbjct: 231 APEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 79/177 (44%), Gaps = 7/177 (3%)
Query: 739 EIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIAL 798
           EI     + H N+V+  G+    +   L  EY   G L + +    G       R+   L
Sbjct: 54  EIXINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL 113
Query: 799 EAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAG 858
            A  G+ YLH      I HRD+K  N+LLD      ++DFGLA   +       ++ + G
Sbjct: 114 MA--GVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXG 168
Query: 859 SYGYIAPEYAYTLKVD-EKSDVYSFGVVLLELIAGKKPVGEFGDGV-DIVRWVRKTT 913
           +  Y+APE     +   E  DV+S G+VL  ++AG+ P  +  D   +   W  K T
Sbjct: 169 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT 225

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Composition-based stats.
 Identities = 52/177 (29%), Positives = 79/177 (44%), Gaps = 7/177 (3%)
Query: 739 EIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIAL 798
           EI     + H N+V+  G+    +   L  EY   G L + +    G       R+   L
Sbjct: 55  EIXINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL 114
Query: 799 EAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAG 858
            A  G+ YLH      I HRD+K  N+LLD      ++DFGLA   +       ++ + G
Sbjct: 115 MA--GVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXG 169
Query: 859 SYGYIAPEYAYTLKVD-EKSDVYSFGVVLLELIAGKKPVGEFGDGV-DIVRWVRKTT 913
           +  Y+APE     +   E  DV+S G+VL  ++AG+ P  +  D   +   W  K T
Sbjct: 170 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT 226

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 69/223 (30%), Positives = 103/223 (46%), Gaps = 24/223 (10%)
Query: 693 SLKDENIIGKGGAGIVYRGSMPD-GIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNI 751
           S  D  +IG G  G+VY+  + D G  VAIK+++      N      E+Q + ++ H NI
Sbjct: 26  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-----RELQIMRKLDHCNI 80
Query: 752 VRLLGYV----SNRDT---NLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIAL-EAAKG 803
           VRL  +       +D    NL+L +Y+P        H ++          ++ + +  + 
Sbjct: 81  VRLRYFFYSSGEKKDEVYLNLVL-DYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 139
Query: 804 LCYLHHDCSPLIIHRDVKSNNILLDSDFEA-HVADFGLAKFLQDAGASECMSSVAGSYGY 862
           L Y+H   S  I HRD+K  N+LLD D     + DFG AK  Q       +S +   Y Y
Sbjct: 140 LAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSYICSRY-Y 193
Query: 863 IAPEYAY-TLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVD 904
            APE  +         DV+S G VL EL+ G +P+     GVD
Sbjct: 194 RAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFPGDSGVD 235

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 106/227 (46%), Gaps = 13/227 (5%)
Query: 700 IGKGGAGIVYRGSMPDGID-VAIKRL-VGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGY 757
           IG+G  G V++    +  + VA+KR+ +     G     L EI  L  ++H+NIVRL   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 758 VSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIH 817
           + +     L++E+  +  L +       G L  E       +  KGL + H   S  ++H
Sbjct: 70  LHSDKKLTLVFEFC-DQDLKKYFDSC-NGDLDPEIVKSFLFQLLKGLGFCH---SRNVLH 124
Query: 818 RDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKS 877
           RD+K  N+L++ + E  +ADFGLA+         C S+   +  Y  P+  +  K+   S
Sbjct: 125 RDLKPQNLLINRNGELKLADFGLARAF--GIPVRCYSAEVVTLWYRPPDVLFGAKLYSTS 182
Query: 878 -DVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRK---TTSEVSQPS 920
            D++S G +  EL    +P+    D  D ++ + +   T +E   PS
Sbjct: 183 IDMWSAGCIFAELANAARPLFPGNDVDDQLKRIFRLLGTPTEEQWPS 229

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 94/209 (44%), Gaps = 12/209 (5%)
Query: 692 ESLKDENIIGKGG-AGIVYRGSMPDGIDVAIKRLVGRGT-GGNDHGFLA-EIQTLGRIRH 748
           E  K   I+G+G  + +V    +    + AIK L  R     N   ++  E   + R+ H
Sbjct: 8   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 749 RNIVRLLGYVSNRDTNLLLY--EYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCY 806
              V+L  Y + +D   L +   Y  NG L + +    G   +  TR+  A E    L Y
Sbjct: 68  PFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTA-EIVSALEY 123
Query: 807 LHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPE 866
           LH      IIHRD+K  NILL+ D    + DFG AK L         +   G+  Y++PE
Sbjct: 124 LHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 180
Query: 867 YAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
                   + SD+++ G ++ +L+AG  P
Sbjct: 181 LLTEKSACKSSDLWALGCIIYQLVAGLPP 209

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 68/236 (28%), Positives = 110/236 (46%), Gaps = 19/236 (8%)
Query: 690 VLESLKDENIIGKGGAGIVYRGSMPDGI---DVAIKRLVGRGTGGNDHGFLA--EIQTLG 744
           VL+  ++   IG G  GIV   +  D I   +VAIK+L  R      H   A  E+  + 
Sbjct: 23  VLKRYQNLKPIGSGAQGIV--CAAYDAILERNVAIKKL-SRPFQNQTHAKRAYRELVLMK 79
Query: 745 RIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRY-RIALEAAKG 803
            + H+NI+ LL   + + +   L E+     + E++       ++ E  + R++    + 
Sbjct: 80  CVNHKNIIGLLNVFTPQKS---LEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQM 136
Query: 804 LCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYI 863
           LC + H  S  IIHRD+K +NI++ SD    + DFGLA+    AG S  M+    +  Y 
Sbjct: 137 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYR 193
Query: 864 APEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQP 919
           APE    +   E  D++S G ++ E+I G    G    G D +    K   ++  P
Sbjct: 194 APEVILGMGYKENVDIWSVGCIMGEMIKG----GVLFPGTDHIDQWNKVIEQLGTP 245

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 77/170 (45%), Gaps = 7/170 (4%)
Query: 746 IRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLC 805
           + H N+V+  G+    +   L  EY   G L + +    G       R+   L A  G+ 
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVV 118
Query: 806 YLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAP 865
           YLH      I HRD+K  N+LLD      ++DFGLA   +       ++ + G+  Y+AP
Sbjct: 119 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 866 EYAYTLKVD-EKSDVYSFGVVLLELIAGKKPVGEFGDGV-DIVRWVRKTT 913
           E     +   E  DV+S G+VL  ++AG+ P  +  D   +   W  K T
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT 225

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 102/210 (48%), Gaps = 15/210 (7%)
Query: 690 VLESLKDENIIGKGGAGIVYRGSMPDGI---DVAIKRLVGRGTGGNDHGFLA--EIQTLG 744
           VL+  ++   IG G  GIV   +  D +   +VAIK+L  R      H   A  E+  + 
Sbjct: 60  VLKRYQNLKPIGSGAQGIV--CAAYDAVLDRNVAIKKL-SRPFQNQTHAKRAYRELVLMK 116
Query: 745 RIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRY-RIALEAAKG 803
            + H+NI+ LL   + + T   L E+     + E++       ++ E  + R++    + 
Sbjct: 117 CVNHKNIISLLNVFTPQKT---LEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQM 173
Query: 804 LCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYI 863
           LC + H  S  IIHRD+K +NI++ SD    + DFGLA+    AG S  M+    +  Y 
Sbjct: 174 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYR 230
Query: 864 APEYAYTLKVDEKSDVYSFGVVLLELIAGK 893
           APE    +   E  D++S G ++ E++  K
Sbjct: 231 APEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 68/236 (28%), Positives = 110/236 (46%), Gaps = 19/236 (8%)
Query: 690 VLESLKDENIIGKGGAGIVYRGSMPDGI---DVAIKRLVGRGTGGNDHGFLA--EIQTLG 744
           VL+  ++   IG G  GIV   +  D I   +VAIK+L  R      H   A  E+  + 
Sbjct: 22  VLKRYQNLKPIGSGAQGIV--CAAYDAILERNVAIKKL-SRPFQNQTHAKRAYRELVLMK 78
Query: 745 RIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRY-RIALEAAKG 803
            + H+NI+ LL   + + +   L E+     + E++       ++ E  + R++    + 
Sbjct: 79  CVNHKNIIGLLNVFTPQKS---LEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQM 135
Query: 804 LCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYI 863
           LC + H  S  IIHRD+K +NI++ SD    + DFGLA+    AG S  M+    +  Y 
Sbjct: 136 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYR 192
Query: 864 APEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQP 919
           APE    +   E  D++S G ++ E+I G    G    G D +    K   ++  P
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKG----GVLFPGTDHIDQWNKVIEQLGTP 244

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 77/170 (45%), Gaps = 7/170 (4%)
Query: 746 IRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLC 805
           + H N+V+  G+    +   L  EY   G L + +    G       R+   L A  G+ 
Sbjct: 62  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVV 119
Query: 806 YLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAP 865
           YLH      I HRD+K  N+LLD      ++DFGLA   +       ++ + G+  Y+AP
Sbjct: 120 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 866 EYAYTLKVD-EKSDVYSFGVVLLELIAGKKPVGEFGDGV-DIVRWVRKTT 913
           E     +   E  DV+S G+VL  ++AG+ P  +  D   +   W  K T
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT 226

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 77/170 (45%), Gaps = 7/170 (4%)
Query: 746 IRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLC 805
           + H N+V+  G+    +   L  EY   G L + +    G       R+   L A  G+ 
Sbjct: 60  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVV 117
Query: 806 YLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAP 865
           YLH      I HRD+K  N+LLD      ++DFGLA   +       ++ + G+  Y+AP
Sbjct: 118 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 174
Query: 866 EYAYTLKVD-EKSDVYSFGVVLLELIAGKKPVGEFGDGV-DIVRWVRKTT 913
           E     +   E  DV+S G+VL  ++AG+ P  +  D   +   W  K T
Sbjct: 175 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT 224

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 69/223 (30%), Positives = 103/223 (46%), Gaps = 24/223 (10%)
Query: 693 SLKDENIIGKGGAGIVYRGSMPD-GIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNI 751
           S  D  +IG G  G+VY+  + D G  VAIK+++      N      E+Q + ++ H NI
Sbjct: 49  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-----RELQIMRKLDHCNI 103
Query: 752 VRLLGYV----SNRDT---NLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIAL-EAAKG 803
           VRL  +       +D    NL+L +Y+P        H ++          ++ + +  + 
Sbjct: 104 VRLRYFFYSSGEKKDEVYLNLVL-DYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 162
Query: 804 LCYLHHDCSPLIIHRDVKSNNILLDSDFEA-HVADFGLAKFLQDAGASECMSSVAGSYGY 862
           L Y+H   S  I HRD+K  N+LLD D     + DFG AK  Q       +S +   Y Y
Sbjct: 163 LAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSYICSRY-Y 216
Query: 863 IAPEYAY-TLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVD 904
            APE  +         DV+S G VL EL+ G +P+     GVD
Sbjct: 217 RAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFPGDSGVD 258

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 77/170 (45%), Gaps = 7/170 (4%)
Query: 746 IRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLC 805
           + H N+V+  G+    +   L  EY   G L + +    G       R+   L A  G+ 
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVV 118
Query: 806 YLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAP 865
           YLH      I HRD+K  N+LLD      ++DFGLA   +       ++ + G+  Y+AP
Sbjct: 119 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 866 EYAYTLKVD-EKSDVYSFGVVLLELIAGKKPVGEFGDGV-DIVRWVRKTT 913
           E     +   E  DV+S G+VL  ++AG+ P  +  D   +   W  K T
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT 225

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 69/237 (29%), Positives = 111/237 (46%), Gaps = 19/237 (8%)
Query: 690 VLESLKDENIIGKGGAGIVYRGSMPDGI---DVAIKRLVGRGTGGNDHGFLA--EIQTLG 744
           VL+  ++   IG G  GIV   +  D I   +VAIK+L  R      H   A  E+  + 
Sbjct: 22  VLKRYQNLKPIGSGAQGIV--CAAYDAILERNVAIKKL-SRPFQNQTHAKRAYRELVLMK 78
Query: 745 RIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRY-RIALEAAKG 803
            + H+NI+ LL   + + +   L E+     + E++       ++ E  + R++    + 
Sbjct: 79  VVNHKNIIGLLNVFTPQKS---LEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQM 135
Query: 804 LCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYI 863
           L  + H  S  IIHRD+K +NI++ SD    + DFGLA+    AG S  M+    +  Y 
Sbjct: 136 LVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLAR---TAGTSFMMTPYVVTRYYR 192
Query: 864 APEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPS 920
           APE    +   E  D++S GV++ E+I G    G    G D +    K   ++  PS
Sbjct: 193 APEVILGMGYKENVDIWSVGVIMGEMIKG----GVLFPGTDHIDQWNKVIEQLGTPS 245

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/177 (31%), Positives = 83/177 (46%), Gaps = 15/177 (8%)
Query: 739 EIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGE-MLHGAKGGHLKWETRYRIA 797
           EI  L  + H NI++L     ++    L+ E+   G L E +++  K           I 
Sbjct: 96  EISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDEC---DAANIM 152
Query: 798 LEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSD---FEAHVADFGLAKFLQDAGASECMS 854
            +   G+CYLH      I+HRD+K  NILL++        + DFGL+ F         + 
Sbjct: 153 KQILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYK---LR 206
Query: 855 SVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRK 911
              G+  YIAPE     K +EK DV+S GV++  L+ G  P G   D  DI++ V K
Sbjct: 207 DRLGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ-DIIKKVEK 261

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 94/199 (47%), Gaps = 14/199 (7%)
Query: 700 IGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYV 758
           IG+G +G VY    +  G +VAI+++            + EI  +   ++ NIV  L   
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQM-NLQQQPKKELIINEILVMRENKNPNIVNYLDSY 87
Query: 759 SNRDTNLLLYEYMPNGSLGEMLHGA--KGGHLKWETRYRIALEAAKGLCYLHHDCSPLII 816
              D   ++ EY+  GSL +++       G +    R     E  + L +LH   S  +I
Sbjct: 88  LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR-----ECLQALEFLH---SNQVI 139
Query: 817 HRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEK 876
           HR++KS+NILL  D    + DFG    +    +    S++ G+  ++APE         K
Sbjct: 140 HRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYWMAPEVVTRKAYGPK 197
Query: 877 SDVYSFGVVLLELIAGKKP 895
            D++S G++ +E+I G+ P
Sbjct: 198 VDIWSLGIMAIEMIEGEPP 216

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 91/199 (45%), Gaps = 11/199 (5%)
Query: 700 IGKGG-AGIVYRGSMPDGIDVAIKRLVGRGTGGND-HGFLAEIQTLGRIRHRNIVRLLGY 757
           IGKG  A +     +  G +VA+K +       +       E++    + H NIV+L   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNIVKLFEV 81
Query: 758 VSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIH 817
           +    T  L+ EY   G + + L  A G   + E R +   +    + Y H      I+H
Sbjct: 82  IETEKTLYLVXEYASGGEVFDYL-VAHGRXKEKEARAKFR-QIVSAVQYCHQ---KFIVH 136
Query: 818 RDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVD-EK 876
           RD+K+ N+LLD+D    +ADFG   F  +      + +  G+  Y APE     K D  +
Sbjct: 137 RDLKAENLLLDADXNIKIADFG---FSNEFTFGNKLDAFCGAPPYAAPELFQGKKYDGPE 193
Query: 877 SDVYSFGVVLLELIAGKKP 895
            DV+S GV+L  L++G  P
Sbjct: 194 VDVWSLGVILYTLVSGSLP 212

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 100/224 (44%), Gaps = 12/224 (5%)
Query: 692 ESLKDENIIGKGG-AGIVYRGSMPDGIDVAIKRLVGRGT-GGNDHGFLA-EIQTLGRIRH 748
           E  K   I+G+G  + +V    +    + AIK L  R     N   ++  E   + R+ H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 749 RNIVRLLGYVSNRDTNLLLY--EYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCY 806
              V+L  Y + +D   L +   Y  NG L + +    G   +  TR+  A E    L Y
Sbjct: 92  PFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTA-EIVSALEY 147
Query: 807 LHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPE 866
           LH      IIHRD+K  NILL+ D    + DFG AK L         +   G+  Y++PE
Sbjct: 148 LHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 204
Query: 867 YAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVR 910
                   + SD+++ G ++ +L+AG  P     +G+   + ++
Sbjct: 205 LLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIK 248

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 50/194 (25%), Positives = 91/194 (46%), Gaps = 22/194 (11%)
Query: 715 DGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRI-RHRNIVRLLGYVSNRDTNLLLYEYMPN 773
           + + VA+K L    T  +    ++E++ +  I +H+NI+ LLG  +      ++ EY   
Sbjct: 53  EAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASK 112
Query: 774 GSLGEMLHGAKGGHLKWETRYRI----------------ALEAAKGLCYLHHDCSPLIIH 817
           G+L E L   +   +  E  Y I                  + A+G+ YL    S   IH
Sbjct: 113 GNLREYLRARRPPGM--EYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIH 167
Query: 818 RDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKS 877
           RD+ + N+L+  +    +ADFGLA+ + +    +  ++      ++APE  +      +S
Sbjct: 168 RDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQS 227
Query: 878 DVYSFGVVLLELIA 891
           DV+SFGV++ E+  
Sbjct: 228 DVWSFGVLMWEIFT 241

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Composition-based stats.
 Identities = 50/170 (29%), Positives = 77/170 (45%), Gaps = 7/170 (4%)
Query: 746 IRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLC 805
           + H N+V+  G+    +   L  EY   G L + +    G       R+   L A  G+ 
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVV 118
Query: 806 YLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAP 865
           YLH      I HRD+K  N+LLD      ++DFGLA   +       ++ + G+  Y+AP
Sbjct: 119 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 866 EYAYTLKVD-EKSDVYSFGVVLLELIAGKKPVGEFGDGV-DIVRWVRKTT 913
           E     +   E  DV+S G+VL  ++AG+ P  +  D   +   W  K T
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT 225

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Composition-based stats.
 Identities = 50/170 (29%), Positives = 77/170 (45%), Gaps = 7/170 (4%)
Query: 746 IRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLC 805
           + H N+V+  G+    +   L  EY   G L + +    G       R+   L A  G+ 
Sbjct: 62  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVV 119
Query: 806 YLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAP 865
           YLH      I HRD+K  N+LLD      ++DFGLA   +       ++ + G+  Y+AP
Sbjct: 120 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 866 EYAYTLKVD-EKSDVYSFGVVLLELIAGKKPVGEFGDGV-DIVRWVRKTT 913
           E     +   E  DV+S G+VL  ++AG+ P  +  D   +   W  K T
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT 226

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 69/215 (32%), Positives = 101/215 (46%), Gaps = 39/215 (18%)
Query: 700 IGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYV- 758
           IGKG  G V+ G    G  VA+K  V   T         EI     +RH NI   LG++ 
Sbjct: 45  IGKGRYGEVWMGKW-RGEKVAVK--VFFTTEEASWFRETEIYQTVLMRHENI---LGFIA 98
Query: 759 -----SNRDTNL-LLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDC- 811
                +   T L L+ +Y  NGSL + L   K   L  ++  ++A  +  GLC+LH +  
Sbjct: 99  ADIKGTGSWTQLYLITDYHENGSLYDYL---KSTTLDAKSMLKLAYSSVSGLCHLHTEIF 155
Query: 812 ----SPLIIHRDVKSNNILLDSDFEAHVADFGLA-KFLQDAGASEC-MSSVAGSYGYIAP 865
                P I HRD+KS NIL+  +    +AD GLA KF+ D    +   ++  G+  Y+ P
Sbjct: 156 STQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPP 215
Query: 866 EYAYTLKVDEK-----------SDVYSFGVVLLEL 889
           E      +DE            +D+YSFG++L E+
Sbjct: 216 EV-----LDESLNRNHFQSYIMADMYSFGLILWEV 245

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Composition-based stats.
 Identities = 50/170 (29%), Positives = 77/170 (45%), Gaps = 7/170 (4%)
Query: 746 IRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLC 805
           + H N+V+  G+    +   L  EY   G L + +    G       R+   L A  G+ 
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVV 118
Query: 806 YLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAP 865
           YLH      I HRD+K  N+LLD      ++DFGLA   +       ++ + G+  Y+AP
Sbjct: 119 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 866 EYAYTLKVD-EKSDVYSFGVVLLELIAGKKPVGEFGDGV-DIVRWVRKTT 913
           E     +   E  DV+S G+VL  ++AG+ P  +  D   +   W  K T
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT 225

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Composition-based stats.
 Identities = 50/170 (29%), Positives = 77/170 (45%), Gaps = 7/170 (4%)
Query: 746 IRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLC 805
           + H N+V+  G+    +   L  EY   G L + +    G       R+   L A  G+ 
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVV 118
Query: 806 YLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAP 865
           YLH      I HRD+K  N+LLD      ++DFGLA   +       ++ + G+  Y+AP
Sbjct: 119 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 866 EYAYTLKVD-EKSDVYSFGVVLLELIAGKKPVGEFGDGV-DIVRWVRKTT 913
           E     +   E  DV+S G+VL  ++AG+ P  +  D   +   W  K T
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT 225

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Composition-based stats.
 Identities = 50/170 (29%), Positives = 77/170 (45%), Gaps = 7/170 (4%)
Query: 746 IRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLC 805
           + H N+V+  G+    +   L  EY   G L + +    G       R+   L A  G+ 
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVV 118
Query: 806 YLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAP 865
           YLH      I HRD+K  N+LLD      ++DFGLA   +       ++ + G+  Y+AP
Sbjct: 119 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 866 EYAYTLKVD-EKSDVYSFGVVLLELIAGKKPVGEFGDGV-DIVRWVRKTT 913
           E     +   E  DV+S G+VL  ++AG+ P  +  D   +   W  K T
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT 225

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 69/223 (30%), Positives = 103/223 (46%), Gaps = 24/223 (10%)
Query: 693 SLKDENIIGKGGAGIVYRGSMPD-GIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNI 751
           S  D  +IG G  G+VY+  + D G  VAIK+++      N      E+Q + ++ H NI
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-----RELQIMRKLDHCNI 109
Query: 752 VRLLGYV----SNRDT---NLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIAL-EAAKG 803
           VRL  +       +D    NL+L +Y+P        H ++          ++ + +  + 
Sbjct: 110 VRLRYFFYSSGEKKDEVYLNLVL-DYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 168
Query: 804 LCYLHHDCSPLIIHRDVKSNNILLDSDFEA-HVADFGLAKFLQDAGASECMSSVAGSYGY 862
           L Y+H   S  I HRD+K  N+LLD D     + DFG AK  Q       +S +   Y Y
Sbjct: 169 LAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSYICSRY-Y 222
Query: 863 IAPEYAY-TLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVD 904
            APE  +         DV+S G VL EL+ G +P+     GVD
Sbjct: 223 RAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFPGDSGVD 264

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 49/150 (32%), Positives = 71/150 (47%), Gaps = 11/150 (7%)
Query: 748 HRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYL 807
           H  +  +      ++    + EY+  G L   +       L   T Y  A E   GL +L
Sbjct: 77  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFY--AAEIILGLQFL 134
Query: 808 HHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAK--FLQDAGASECMSSVAGSYGYIAP 865
           H   S  I++RD+K +NILLD D    +ADFG+ K   L DA      +   G+  YIAP
Sbjct: 135 H---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT----NXFCGTPDYIAP 187
Query: 866 EYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
           E     K +   D +SFGV+L E++ G+ P
Sbjct: 188 EILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 69/223 (30%), Positives = 103/223 (46%), Gaps = 24/223 (10%)
Query: 693 SLKDENIIGKGGAGIVYRGSMPD-GIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNI 751
           S  D  +IG G  G+VY+  + D G  VAIK+++      N      E+Q + ++ H NI
Sbjct: 57  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-----RELQIMRKLDHCNI 111
Query: 752 VRLLGYV----SNRDT---NLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIAL-EAAKG 803
           VRL  +       +D    NL+L +Y+P        H ++          ++ + +  + 
Sbjct: 112 VRLRYFFYSSGEKKDEVYLNLVL-DYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 170
Query: 804 LCYLHHDCSPLIIHRDVKSNNILLDSDFEA-HVADFGLAKFLQDAGASECMSSVAGSYGY 862
           L Y+H   S  I HRD+K  N+LLD D     + DFG AK  Q       +S +   Y Y
Sbjct: 171 LAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSYICSRY-Y 224
Query: 863 IAPEYAY-TLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVD 904
            APE  +         DV+S G VL EL+ G +P+     GVD
Sbjct: 225 RAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFPGDSGVD 266

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 50/194 (25%), Positives = 91/194 (46%), Gaps = 22/194 (11%)
Query: 715 DGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRI-RHRNIVRLLGYVSNRDTNLLLYEYMPN 773
           + + VA+K L    T  +    ++E++ +  I +H+NI+ LLG  +      ++ EY   
Sbjct: 55  EAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASK 114
Query: 774 GSLGEMLHGAKGGHLKWETRYRI----------------ALEAAKGLCYLHHDCSPLIIH 817
           G+L E L   +   +  E  Y I                  + A+G+ YL    S   IH
Sbjct: 115 GNLREYLRARRPPGM--EYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIH 169
Query: 818 RDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKS 877
           RD+ + N+L+  +    +ADFGLA+ + +    +  ++      ++APE  +      +S
Sbjct: 170 RDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQS 229
Query: 878 DVYSFGVVLLELIA 891
           DV+SFGV++ E+  
Sbjct: 230 DVWSFGVLMWEIFT 243

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 77/170 (45%), Gaps = 7/170 (4%)
Query: 746 IRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLC 805
           + H N+V+  G+    +   L  EY   G L + +    G       R+   L A  G+ 
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVV 118
Query: 806 YLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAP 865
           YLH      I HRD+K  N+LLD      ++DFGLA   +       ++ + G+  Y+AP
Sbjct: 119 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAP 175
Query: 866 EYAYTLKVD-EKSDVYSFGVVLLELIAGKKPVGEFGDGV-DIVRWVRKTT 913
           E     +   E  DV+S G+VL  ++AG+ P  +  D   +   W  K T
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT 225

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 84/320 (26%), Positives = 135/320 (42%), Gaps = 51/320 (15%)
Query: 692 ESLKDENI----IGKGGAGIV-----YRGSMPDGIDVAIKRLVGRGTGGNDHGFL---AE 739
           ++L+DE I    +G G  G V      +      I +  KR    G+       L    E
Sbjct: 6   KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETE 65
Query: 740 IQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALE 799
           I+ L ++ H  I+++  +    D  ++L E M  G L + + G K   LK  T      +
Sbjct: 66  IEILKKLNHPCIIKIKNFFDAEDYYIVL-ELMEGGELFDKVVGNK--RLKEATCKLYFYQ 122
Query: 800 AAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFE---AHVADFGLAKFLQDAGASECMSSV 856
               + YLH +    IIHRD+K  N+LL S  E     + DFG +K L   G +  M ++
Sbjct: 123 MLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL---GETSLMRTL 176
Query: 857 AGSYGYIAPEYAY---TLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDI-------- 905
            G+  Y+APE      T   +   D +S GV+L   ++G  P  E    V +        
Sbjct: 177 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGK 236
Query: 906 VRWVRKTTSEVSQPS-DAASVLAVVDPRLSGYPLTGVIHLFK---------VAMMCVEDE 955
             ++ +  +EVS+ + D    L VVDP+        + H +            ++  E+E
Sbjct: 237 YNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLLSEENE 296
Query: 956 SSARPTMREVVHMLANPPQS 975
           S+A+P       +LA P  S
Sbjct: 297 STAKP------QVLAQPSTS 310

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 94/209 (44%), Gaps = 12/209 (5%)
Query: 692 ESLKDENIIGKGG-AGIVYRGSMPDGIDVAIKRLVGRGT-GGNDHGFLA-EIQTLGRIRH 748
           E  K   I+G+G  + +V    +    + AIK L  R     N   ++  E   + R+ H
Sbjct: 14  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 73
Query: 749 RNIVRLLGYVSNRDTNLLLY--EYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCY 806
              V+L  Y + +D   L +   Y  NG L + +    G   +  TR+  A E    L Y
Sbjct: 74  PFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTA-EIVSALEY 129
Query: 807 LHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPE 866
           LH      IIHRD+K  NILL+ D    + DFG AK L         +   G+  Y++PE
Sbjct: 130 LH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 186
Query: 867 YAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
                   + SD+++ G ++ +L+AG  P
Sbjct: 187 LLTEKSACKSSDLWALGCIIYQLVAGLPP 215

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 103/221 (46%), Gaps = 12/221 (5%)
Query: 686 KAEDVLESLKDENIIGKGG-AGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLG 744
           +AED+ +     +++G G  + ++          VAIK +  +   G +     EI  L 
Sbjct: 12  QAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLH 71
Query: 745 RIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGL 804
           +I+H NIV L     +     L+ + +  G L + +   + G        R+  +    +
Sbjct: 72  KIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRI--VEKGFYTERDASRLIFQVLDAV 129
Query: 805 CYLHHDCSPLIIHRDVKSNNIL---LDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYG 861
            YLH D    I+HRD+K  N+L   LD D +  ++DFGL+K ++D G+   +S+  G+ G
Sbjct: 130 KYLH-DLG--IVHRDLKPENLLYYSLDEDSKIMISDFGLSK-MEDPGS--VLSTACGTPG 183
Query: 862 YIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDG 902
           Y+APE        +  D +S GV+   L+ G  P  +  D 
Sbjct: 184 YVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA 224

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 91/193 (47%), Gaps = 22/193 (11%)
Query: 715 DGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRI-RHRNIVRLLGYVSNRDTNLLLYEYMPN 773
           + + VA+K L    T  +    ++E++ +  I +H+NI+ LLG  +      ++ EY   
Sbjct: 66  EAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASK 125
Query: 774 GSLGEMLHGAKGGHLKWETRYRI----------------ALEAAKGLCYLHHDCSPLIIH 817
           G+L E L   +   +  E  Y I                  + A+G+ YL    S   IH
Sbjct: 126 GNLREYLRARRPPGM--EYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIH 180
Query: 818 RDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKS 877
           RD+ + N+L+  +    +ADFGLA+ + +    +  ++      ++APE  +      +S
Sbjct: 181 RDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTTNGRLPVKWMAPEALFDRVYTHQS 240
Query: 878 DVYSFGVVLLELI 890
           DV+SFGV++ E+ 
Sbjct: 241 DVWSFGVLMWEIF 253

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Composition-based stats.
 Identities = 50/170 (29%), Positives = 77/170 (45%), Gaps = 7/170 (4%)
Query: 746 IRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLC 805
           + H N+V+  G+    +   L  EY   G L + +    G       R+   L A  G+ 
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVV 118
Query: 806 YLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAP 865
           YLH      I HRD+K  N+LLD      ++DFGLA   +       ++ + G+  Y+AP
Sbjct: 119 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAP 175
Query: 866 EYAYTLKVD-EKSDVYSFGVVLLELIAGKKPVGEFGDGV-DIVRWVRKTT 913
           E     +   E  DV+S G+VL  ++AG+ P  +  D   +   W  K T
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT 225

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 69/223 (30%), Positives = 103/223 (46%), Gaps = 24/223 (10%)
Query: 693 SLKDENIIGKGGAGIVYRGSMPD-GIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNI 751
           S  D  +IG G  G+VY+  + D G  VAIK+++      N      E+Q + ++ H NI
Sbjct: 100 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-----RELQIMRKLDHCNI 154
Query: 752 VRLLGYV----SNRDT---NLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIAL-EAAKG 803
           VRL  +       +D    NL+L +Y+P        H ++          ++ + +  + 
Sbjct: 155 VRLRYFFYSSGEKKDEVYLNLVL-DYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 213
Query: 804 LCYLHHDCSPLIIHRDVKSNNILLDSDFEA-HVADFGLAKFLQDAGASECMSSVAGSYGY 862
           L Y+H   S  I HRD+K  N+LLD D     + DFG AK  Q       +S +   Y Y
Sbjct: 214 LAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSYICSRY-Y 267
Query: 863 IAPEYAY-TLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVD 904
            APE  +         DV+S G VL EL+ G +P+     GVD
Sbjct: 268 RAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFPGDSGVD 309

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 69/223 (30%), Positives = 104/223 (46%), Gaps = 24/223 (10%)
Query: 693 SLKDENIIGKGGAGIVYRGSMPD-GIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNI 751
           S  D  +IG G  G+VY+  + D G  VAIK+++      N      E+Q + ++ H NI
Sbjct: 59  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-----RELQIMRKLDHCNI 113
Query: 752 VRLLGYV----SNRDT---NLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIAL-EAAKG 803
           VRL  +       +D    NL+L +Y+P        H ++          ++ + +  + 
Sbjct: 114 VRLRYFFYSSGEKKDEVYLNLVL-DYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 172
Query: 804 LCYLHHDCSPLIIHRDVKSNNILLDSDFEA-HVADFGLAKFLQDAGASECMSSVAGSYGY 862
           L Y+H   S  I HRD+K  N+LLD D     + DFG AK L     +  +S +   Y Y
Sbjct: 173 LAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN--VSYICSRY-Y 226
Query: 863 IAPEYAY-TLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVD 904
            APE  +         DV+S G VL EL+ G +P+     GVD
Sbjct: 227 RAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFPGDSGVD 268

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 94/209 (44%), Gaps = 12/209 (5%)
Query: 692 ESLKDENIIGKGG-AGIVYRGSMPDGIDVAIKRLVGRGT-GGNDHGFLA-EIQTLGRIRH 748
           E  K   I+G+G  + +V    +    + AIK L  R     N   ++  E   + R+ H
Sbjct: 35  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 94
Query: 749 RNIVRLLGYVSNRDTNLLLY--EYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCY 806
              V+L  Y + +D   L +   Y  NG L + +    G   +  TR+  A E    L Y
Sbjct: 95  PFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTA-EIVSALEY 150
Query: 807 LHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPE 866
           LH      IIHRD+K  NILL+ D    + DFG AK L         +   G+  Y++PE
Sbjct: 151 LHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 207
Query: 867 YAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
                   + SD+++ G ++ +L+AG  P
Sbjct: 208 LLTEKSACKSSDLWALGCIIYQLVAGLPP 236

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 96/201 (47%), Gaps = 11/201 (5%)
Query: 700 IGKGGAGIVYRGSM--PD--GIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLL 755
           IG+G  G V++G    P+   + VAIK      +      FL E  T+ +  H +IV+L+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 756 GYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLI 815
           G ++     +++ E    G L   L   K   L   +    A + +  L YL    S   
Sbjct: 78  GVITENPVWIIM-ELCTLGELRSFLQVRKFS-LDLASLILYAYQLSTALAYLE---SKRF 132
Query: 816 IHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDE 875
           +HRD+ + N+L+ S+    + DFGL+++++D+   +  S       ++APE     +   
Sbjct: 133 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKA-SKGKLPIKWMAPESINFRRFTS 191
Query: 876 KSDVYSFGVVLLE-LIAGKKP 895
            SDV+ FGV + E L+ G KP
Sbjct: 192 ASDVWMFGVCMWEILMHGVKP 212

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 94/209 (44%), Gaps = 12/209 (5%)
Query: 692 ESLKDENIIGKGG-AGIVYRGSMPDGIDVAIKRLVGRGT-GGNDHGFLA-EIQTLGRIRH 748
           E  K   I+G+G  + +V    +    + AIK L  R     N   ++  E   + R+ H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 749 RNIVRLLGYVSNRDTNLLLY--EYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCY 806
              V+L  Y + +D   L +   Y  NG L + +    G   +  TR+  A E    L Y
Sbjct: 92  PFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTA-EIVSALEY 147
Query: 807 LHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPE 866
           LH      IIHRD+K  NILL+ D    + DFG AK L         +   G+  Y++PE
Sbjct: 148 LHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 204
Query: 867 YAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
                   + SD+++ G ++ +L+AG  P
Sbjct: 205 LLTEKSACKSSDLWALGCIIYQLVAGLPP 233

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 94/209 (44%), Gaps = 12/209 (5%)
Query: 692 ESLKDENIIGKGG-AGIVYRGSMPDGIDVAIKRLVGRGT-GGNDHGFLA-EIQTLGRIRH 748
           E  K   I+G+G  + +V    +    + AIK L  R     N   ++  E   + R+ H
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 749 RNIVRLLGYVSNRDTNLLLY--EYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCY 806
              V+L  Y + +D   L +   Y  NG L + +    G   +  TR+  A E    L Y
Sbjct: 89  PFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTA-EIVSALEY 144
Query: 807 LHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPE 866
           LH      IIHRD+K  NILL+ D    + DFG AK L         +   G+  Y++PE
Sbjct: 145 LH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 201
Query: 867 YAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
                   + SD+++ G ++ +L+AG  P
Sbjct: 202 LLTEKSACKSSDLWALGCIIYQLVAGLPP 230

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 94/209 (44%), Gaps = 12/209 (5%)
Query: 692 ESLKDENIIGKGG-AGIVYRGSMPDGIDVAIKRLVGRGT-GGNDHGFLA-EIQTLGRIRH 748
           E  K   I+G+G  + +V    +    + AIK L  R     N   ++  E   + R+ H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 749 RNIVRLLGYVSNRDTNLLLY--EYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCY 806
              V+L  Y + +D   L +   Y  NG L + +    G   +  TR+  A E    L Y
Sbjct: 92  PFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTA-EIVSALEY 147
Query: 807 LHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPE 866
           LH      IIHRD+K  NILL+ D    + DFG AK L         +   G+  Y++PE
Sbjct: 148 LHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 204
Query: 867 YAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
                   + SD+++ G ++ +L+AG  P
Sbjct: 205 LLTEKSACKSSDLWALGCIIYQLVAGLPP 233

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 94/209 (44%), Gaps = 12/209 (5%)
Query: 692 ESLKDENIIGKGG-AGIVYRGSMPDGIDVAIKRLVGRGT-GGNDHGFLA-EIQTLGRIRH 748
           E  K   I+G+G  + +V    +    + AIK L  R     N   ++  E   + R+ H
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 749 RNIVRLLGYVSNRDTNLLLY--EYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCY 806
              V+L  Y + +D   L +   Y  NG L + +    G   +  TR+  A E    L Y
Sbjct: 93  PFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTA-EIVSALEY 148
Query: 807 LHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPE 866
           LH      IIHRD+K  NILL+ D    + DFG AK L         +   G+  Y++PE
Sbjct: 149 LHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 205
Query: 867 YAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
                   + SD+++ G ++ +L+AG  P
Sbjct: 206 LLTEKSACKSSDLWALGCIIYQLVAGLPP 234

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 64/269 (23%), Positives = 114/269 (42%), Gaps = 32/269 (11%)
Query: 717 IDVAIKRLVGRGTGGNDHGFLAEIQTLGRI-RHRNIVRLLGYVSNRDTNLLLYEYMPNGS 775
           + VA+K L            ++E++ +  + +H NIV LLG  ++    L++ EY   G 
Sbjct: 77  LKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGD 136
Query: 776 LGEMLHGAKGGHLKWETRYRIAL--------EAAKGLCYLHHDCSPLIIHRDVKSNNILL 827
           L   L       L  E    + L        + A+G+ +L    S   IHRDV + N+LL
Sbjct: 137 LLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLL 193
Query: 828 DSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLL 887
            +   A + DFGLA+ + +        +      ++APE  +      +SDV+S+G++L 
Sbjct: 194 TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLW 253
Query: 888 ELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFK 946
           E+ + G  P           + V K   +++QP+ A        P+          +++ 
Sbjct: 254 EIFSLGLNPYPGILVNSKFYKLV-KDGYQMAQPAFA--------PK----------NIYS 294
Query: 947 VAMMCVEDESSARPTMREVVHMLANPPQS 975
           +   C   E + RPT +++   L    Q 
Sbjct: 295 IMQACWALEPTHRPTFQQICSFLQEQAQE 323

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 94/209 (44%), Gaps = 12/209 (5%)
Query: 692 ESLKDENIIGKGG-AGIVYRGSMPDGIDVAIKRLVGRGT-GGNDHGFLA-EIQTLGRIRH 748
           E  K   I+G+G  + +V    +    + AIK L  R     N   ++  E   + R+ H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 749 RNIVRLLGYVSNRDTNLLLY--EYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCY 806
              V+L  Y + +D   L +   Y  NG L + +    G   +  TR+  A E    L Y
Sbjct: 90  PFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTA-EIVSALEY 145
Query: 807 LHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPE 866
           LH      IIHRD+K  NILL+ D    + DFG AK L         +   G+  Y++PE
Sbjct: 146 LH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 202
Query: 867 YAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
                   + SD+++ G ++ +L+AG  P
Sbjct: 203 LLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 77/170 (45%), Gaps = 7/170 (4%)
Query: 746 IRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLC 805
           + H N+V+  G+    +   L  EY   G L + +    G       R+   L A  G+ 
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVV 118
Query: 806 YLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAP 865
           YLH      I HRD+K  N+LLD      ++DFGLA   +       ++ + G+  Y+AP
Sbjct: 119 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAP 175
Query: 866 EYAYTLKVD-EKSDVYSFGVVLLELIAGKKPVGEFGDGV-DIVRWVRKTT 913
           E     +   E  DV+S G+VL  ++AG+ P  +  D   +   W  K T
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSXQEYSDWKEKKT 225

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 68/236 (28%), Positives = 109/236 (46%), Gaps = 19/236 (8%)
Query: 690 VLESLKDENIIGKGGAGIVYRGSMPDGI---DVAIKRLVGRGTGGNDHGFLA--EIQTLG 744
           VL+  ++   IG G  GIV   +  D I   +VAIK+L  R      H   A  E+  + 
Sbjct: 24  VLKRYQNLKPIGSGAQGIV--CAAYDAILERNVAIKKL-SRPFQNQTHAKRAYRELVLMK 80
Query: 745 RIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRY-RIALEAAKG 803
            + H+NI+ LL   + + +   L E+     + E++       ++ E  + R++    + 
Sbjct: 81  CVNHKNIIGLLNVFTPQKS---LEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQM 137
Query: 804 LCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYI 863
           LC + H  S  IIHRD+K +NI++ SD    + DFGLA+    AG S  M     +  Y 
Sbjct: 138 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMVPFVVTRYYR 194
Query: 864 APEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQP 919
           APE    +   E  D++S G ++ E+I G    G    G D +    K   ++  P
Sbjct: 195 APEVILGMGYKENVDIWSVGCIMGEMIKG----GVLFPGTDHIDQWNKVIEQLGTP 246

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 94/209 (44%), Gaps = 12/209 (5%)
Query: 692 ESLKDENIIGKGG-AGIVYRGSMPDGIDVAIKRLVGRGT-GGNDHGFLA-EIQTLGRIRH 748
           E  K   I+G+G  + +V    +    + AIK L  R     N   ++  E   + R+ H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 749 RNIVRLLGYVSNRDTNLLLY--EYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCY 806
              V+L  Y + +D   L +   Y  NG L + +    G   +  TR+  A E    L Y
Sbjct: 90  PFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTA-EIVSALEY 145
Query: 807 LHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPE 866
           LH      IIHRD+K  NILL+ D    + DFG AK L         +   G+  Y++PE
Sbjct: 146 LHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 202
Query: 867 YAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
                   + SD+++ G ++ +L+AG  P
Sbjct: 203 LLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 76/308 (24%), Positives = 134/308 (43%), Gaps = 44/308 (14%)
Query: 672 SKAWKLTAFQRLDFKAEDVLESLKDENIIGKGGAGIVYR-GSMPDGIDVAIKRLVGRGTG 730
           SKA      Q  + KA+D LE + +   +G+G  G+V +   +P G  +A+KR+      
Sbjct: 35  SKACISIGNQNFEVKADD-LEPIME---LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNS 90
Query: 731 GNDHGFLAEIQ-TLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGA--KGGH 787
                 L ++  ++  +     V   G +       +  E M + SL +       KG  
Sbjct: 91  QEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQT 149
Query: 788 LKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDA 847
           +  +   +IA+   K L +LH   S  +IHRDVK +N+L+++  +  + DFG++ +L D+
Sbjct: 150 IPEDILGKIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDS 207
Query: 848 GASECMSSVAGSYGYIAPEY--------AYTLKVDEKSDVYSFGVVLLELIAGKKPVGEF 899
            A    +  AG   Y+APE          Y++    KSD++S G+ ++EL   + P   +
Sbjct: 208 VAK---TIDAGCKPYMAPERINPELNQKGYSV----KSDIWSLGITMIELAILRFPYDSW 260
Query: 900 GDGVDIVRWVRKTTSEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSAR 959
           G     ++ V      V +PS          P+L     +           C++  S  R
Sbjct: 261 GTPFQQLKQV------VEEPS----------PQLPADKFSA--EFVDFTSQCLKKNSKER 302
Query: 960 PTMREVVH 967
           PT  E++ 
Sbjct: 303 PTYPELMQ 310

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 74/268 (27%), Positives = 117/268 (43%), Gaps = 36/268 (13%)
Query: 692 ESLKDENI----IGKGGAGIV-----YRGSMPDGIDVAIKRLVGRGTGGNDHGFL---AE 739
           ++L+DE I    +G G  G V      +      I +  KR    G+       L    E
Sbjct: 12  KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETE 71
Query: 740 IQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALE 799
           I+ L ++ H  I+++  +    D  ++L E M  G L + + G K   LK  T      +
Sbjct: 72  IEILKKLNHPCIIKIKNFFDAEDYYIVL-ELMEGGELFDKVVGNK--RLKEATCKLYFYQ 128
Query: 800 AAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFE---AHVADFGLAKFLQDAGASECMSSV 856
               + YLH +    IIHRD+K  N+LL S  E     + DFG +K L   G +  M ++
Sbjct: 129 MLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL---GETSLMRTL 182
Query: 857 AGSYGYIAPEYAY---TLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDI-------- 905
            G+  Y+APE      T   +   D +S GV+L   ++G  P  E    V +        
Sbjct: 183 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGK 242
Query: 906 VRWVRKTTSEVSQPS-DAASVLAVVDPR 932
             ++ +  +EVS+ + D    L VVDP+
Sbjct: 243 YNFIPEVWAEVSEKALDLVKKLLVVDPK 270

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 86/206 (41%), Gaps = 17/206 (8%)
Query: 700 IGKGGAGIVYRGSM------PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVR 753
           +G G  G VY G +      P  + VA+K L    +  ++  FL E   + ++ H+NIVR
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 98
Query: 754 LLGYVSNRDTNLLLYEYMPNGSLGEMLHG-----AKGGHLKWETRYRIALEAAKGLCYLH 808
            +G         +L E M  G L   L       ++   L       +A + A G  YL 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 809 HDCSPLIIHRDVKSNNILLDSDFEAHVA---DFGLAKFLQDAGASECMSSVAGSYGYIAP 865
            +     IHRD+ + N LL       VA   DFG+A+ +  A              ++ P
Sbjct: 159 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 215
Query: 866 EYAYTLKVDEKSDVYSFGVVLLELIA 891
           E         K+D +SFGV+L E+ +
Sbjct: 216 EAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 86/206 (41%), Gaps = 17/206 (8%)
Query: 700 IGKGGAGIVYRGSM------PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVR 753
           +G G  G VY G +      P  + VA+K L    +  ++  FL E   + ++ H+NIVR
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 112
Query: 754 LLGYVSNRDTNLLLYEYMPNGSLGEMLHG-----AKGGHLKWETRYRIALEAAKGLCYLH 808
            +G         +L E M  G L   L       ++   L       +A + A G  YL 
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 809 HDCSPLIIHRDVKSNNILLDSDFEAHVA---DFGLAKFLQDAGASECMSSVAGSYGYIAP 865
            +     IHRD+ + N LL       VA   DFG+A+ +  A              ++ P
Sbjct: 173 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 229
Query: 866 EYAYTLKVDEKSDVYSFGVVLLELIA 891
           E         K+D +SFGV+L E+ +
Sbjct: 230 EAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 94/209 (44%), Gaps = 12/209 (5%)
Query: 692 ESLKDENIIGKGG-AGIVYRGSMPDGIDVAIKRLVGRGT-GGNDHGFLA-EIQTLGRIRH 748
           E  K   I+G+G  + +V    +    + AIK L  R     N   ++  E   + R+ H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 749 RNIVRLLGYVSNRDTNLLLY--EYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCY 806
              V+L  Y + +D   L +   Y  NG L + +    G   +  TR+  A E    L Y
Sbjct: 92  PFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTA-EIVSALEY 147
Query: 807 LHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPE 866
           LH      IIHRD+K  NILL+ D    + DFG AK L         +   G+  Y++PE
Sbjct: 148 LH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 204
Query: 867 YAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
                   + SD+++ G ++ +L+AG  P
Sbjct: 205 LLTEKSACKSSDLWALGCIIYQLVAGLPP 233

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 85/206 (41%), Gaps = 17/206 (8%)
Query: 700 IGKGGAGIVYRGSM------PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVR 753
           +G G  G VY G +      P  + VA+K L    +  ++  FL E   + +  H+NIVR
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 754 LLGYVSNRDTNLLLYEYMPNGSLGEMLHG-----AKGGHLKWETRYRIALEAAKGLCYLH 808
            +G         +L E M  G L   L       ++   L       +A + A G  YL 
Sbjct: 98  CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 809 HDCSPLIIHRDVKSNNILLDSDFEAHVA---DFGLAKFLQDAGASECMSSVAGSYGYIAP 865
            +     IHRD+ + N LL       VA   DFG+A+ +  A              ++ P
Sbjct: 158 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 214
Query: 866 EYAYTLKVDEKSDVYSFGVVLLELIA 891
           E         K+D +SFGV+L E+ +
Sbjct: 215 EAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 74/268 (27%), Positives = 117/268 (43%), Gaps = 36/268 (13%)
Query: 692 ESLKDENI----IGKGGAGIV-----YRGSMPDGIDVAIKRLVGRGTGGNDHGFL---AE 739
           ++L+DE I    +G G  G V      +      I +  KR    G+       L    E
Sbjct: 6   KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETE 65
Query: 740 IQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALE 799
           I+ L ++ H  I+++  +    D  ++L E M  G L + + G K   LK  T      +
Sbjct: 66  IEILKKLNHPCIIKIKNFFDAEDYYIVL-ELMEGGELFDKVVGNK--RLKEATCKLYFYQ 122
Query: 800 AAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFE---AHVADFGLAKFLQDAGASECMSSV 856
               + YLH +    IIHRD+K  N+LL S  E     + DFG +K L   G +  M ++
Sbjct: 123 MLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL---GETSLMRTL 176
Query: 857 AGSYGYIAPEYAY---TLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDI-------- 905
            G+  Y+APE      T   +   D +S GV+L   ++G  P  E    V +        
Sbjct: 177 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGK 236
Query: 906 VRWVRKTTSEVSQPS-DAASVLAVVDPR 932
             ++ +  +EVS+ + D    L VVDP+
Sbjct: 237 YNFIPEVWAEVSEKALDLVKKLLVVDPK 264

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 74/268 (27%), Positives = 117/268 (43%), Gaps = 36/268 (13%)
Query: 692 ESLKDENI----IGKGGAGIV-----YRGSMPDGIDVAIKRLVGRGTGGNDHGFL---AE 739
           ++L+DE I    +G G  G V      +      I +  KR    G+       L    E
Sbjct: 6   KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETE 65
Query: 740 IQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALE 799
           I+ L ++ H  I+++  +    D  ++L E M  G L + + G K   LK  T      +
Sbjct: 66  IEILKKLNHPCIIKIKNFFDAEDYYIVL-ELMEGGELFDKVVGNK--RLKEATCKLYFYQ 122
Query: 800 AAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFE---AHVADFGLAKFLQDAGASECMSSV 856
               + YLH +    IIHRD+K  N+LL S  E     + DFG +K L   G +  M ++
Sbjct: 123 MLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL---GETSLMRTL 176
Query: 857 AGSYGYIAPEYAY---TLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDI-------- 905
            G+  Y+APE      T   +   D +S GV+L   ++G  P  E    V +        
Sbjct: 177 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGK 236
Query: 906 VRWVRKTTSEVSQPS-DAASVLAVVDPR 932
             ++ +  +EVS+ + D    L VVDP+
Sbjct: 237 YNFIPEVWAEVSEKALDLVKKLLVVDPK 264

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 66.6 bits (161), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 85/206 (41%), Gaps = 17/206 (8%)
Query: 700 IGKGGAGIVYRGSM------PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVR 753
           +G G  G VY G +      P  + VA+K L    +  ++  FL E   + +  H+NIVR
Sbjct: 55  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 114
Query: 754 LLGYVSNRDTNLLLYEYMPNGSLGEMLHG-----AKGGHLKWETRYRIALEAAKGLCYLH 808
            +G         +L E M  G L   L       ++   L       +A + A G  YL 
Sbjct: 115 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 174
Query: 809 HDCSPLIIHRDVKSNNILLDSDFEAHVA---DFGLAKFLQDAGASECMSSVAGSYGYIAP 865
            +     IHRD+ + N LL       VA   DFG+A+ +  A              ++ P
Sbjct: 175 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 231
Query: 866 EYAYTLKVDEKSDVYSFGVVLLELIA 891
           E         K+D +SFGV+L E+ +
Sbjct: 232 EAFMEGIFTSKTDTWSFGVLLWEIFS 257

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Composition-based stats.
 Identities = 59/225 (26%), Positives = 109/225 (48%), Gaps = 18/225 (8%)
Query: 682 RLDFKAEDVLESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQ 741
           R D    +V E + +   +G G  G VY+    +   +A  +++   +      ++ EI+
Sbjct: 4   RRDLDPNEVWEIVGE---LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIE 60
Query: 742 TLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRY--RIALE 799
            L    H  IV+LLG   +     ++ E+ P G++  ++     G  + + +   R  LE
Sbjct: 61  ILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLE 120
Query: 800 AAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGS 859
           A   L +LH   S  IIHRD+K+ N+L+  + +  +ADFG++   ++    +   S  G+
Sbjct: 121 A---LNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSA--KNLKTLQKRDSFIGT 172
Query: 860 YGYIAPEYAY--TLK---VDEKSDVYSFGVVLLELIAGKKPVGEF 899
             ++APE     T+K    D K+D++S G+ L+E+   + P  E 
Sbjct: 173 PYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL 217

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Composition-based stats.
 Identities = 59/225 (26%), Positives = 109/225 (48%), Gaps = 18/225 (8%)
Query: 682 RLDFKAEDVLESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQ 741
           R D    +V E + +   +G G  G VY+    +   +A  +++   +      ++ EI+
Sbjct: 12  RRDLDPNEVWEIVGE---LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIE 68
Query: 742 TLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRY--RIALE 799
            L    H  IV+LLG   +     ++ E+ P G++  ++     G  + + +   R  LE
Sbjct: 69  ILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLE 128
Query: 800 AAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGS 859
           A   L +LH   S  IIHRD+K+ N+L+  + +  +ADFG++   ++    +   S  G+
Sbjct: 129 A---LNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSA--KNLKTLQKRDSFIGT 180
Query: 860 YGYIAPEYAY--TLK---VDEKSDVYSFGVVLLELIAGKKPVGEF 899
             ++APE     T+K    D K+D++S G+ L+E+   + P  E 
Sbjct: 181 PYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL 225

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Composition-based stats.
 Identities = 58/216 (26%), Positives = 93/216 (43%), Gaps = 24/216 (11%)
Query: 700 IGKGGAGIVYRGS----MP--DGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVR 753
           +G+G  G V+       +P  D + VA+K L    +      F  E + L  ++H++IVR
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKAL-KEASESARQDFQREAELLTMLQHQHIVR 84
Query: 754 LLGYVSNRDTNLLLYEYMPNGSLGEML--HGAKG-----------GHLKWETRYRIALEA 800
             G  +     L+++EYM +G L   L  HG              G L       +A + 
Sbjct: 85  FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 144
Query: 801 AKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSY 860
           A G+ YL        +HRD+ + N L+       + DFG+++ +                
Sbjct: 145 AAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 201
Query: 861 GYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKP 895
            ++ PE     K   +SDV+SFGVVL E+   GK+P
Sbjct: 202 RWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 237

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Composition-based stats.
 Identities = 58/216 (26%), Positives = 93/216 (43%), Gaps = 24/216 (11%)
Query: 700 IGKGGAGIVYRGS----MP--DGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVR 753
           +G+G  G V+       +P  D + VA+K L    +      F  E + L  ++H++IVR
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKAL-KEASESARQDFQREAELLTMLQHQHIVR 78
Query: 754 LLGYVSNRDTNLLLYEYMPNGSLGEML--HGAKG-----------GHLKWETRYRIALEA 800
             G  +     L+++EYM +G L   L  HG              G L       +A + 
Sbjct: 79  FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 138
Query: 801 AKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSY 860
           A G+ YL        +HRD+ + N L+       + DFG+++ +                
Sbjct: 139 AAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 195
Query: 861 GYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKP 895
            ++ PE     K   +SDV+SFGVVL E+   GK+P
Sbjct: 196 RWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 231

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 74/268 (27%), Positives = 117/268 (43%), Gaps = 36/268 (13%)
Query: 692 ESLKDENI----IGKGGAGIV-----YRGSMPDGIDVAIKRLVGRGTGGNDHGFL---AE 739
           ++L+DE I    +G G  G V      +      I +  KR    G+       L    E
Sbjct: 5   KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETE 64
Query: 740 IQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALE 799
           I+ L ++ H  I+++  +    D  ++L E M  G L + + G K   LK  T      +
Sbjct: 65  IEILKKLNHPCIIKIKNFFDAEDYYIVL-ELMEGGELFDKVVGNK--RLKEATCKLYFYQ 121
Query: 800 AAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFE---AHVADFGLAKFLQDAGASECMSSV 856
               + YLH +    IIHRD+K  N+LL S  E     + DFG +K L   G +  M ++
Sbjct: 122 MLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL---GETSLMRTL 175
Query: 857 AGSYGYIAPEYAY---TLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDI-------- 905
            G+  Y+APE      T   +   D +S GV+L   ++G  P  E    V +        
Sbjct: 176 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGK 235
Query: 906 VRWVRKTTSEVSQPS-DAASVLAVVDPR 932
             ++ +  +EVS+ + D    L VVDP+
Sbjct: 236 YNFIPEVWAEVSEKALDLVKKLLVVDPK 263

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 69/222 (31%), Positives = 110/222 (49%), Gaps = 38/222 (17%)
Query: 700 IGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFL--AEIQTLGRIRHRNIVRLLGY 757
           IGKG  G V+RG    G +VA+K    R     +  +   AEI     +RH NI   LG+
Sbjct: 50  IGKGRFGEVWRGKWR-GEEVAVKIFSSR----EERSWFREAEIYQTVMLRHENI---LGF 101
Query: 758 VS--NRDTN-----LLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHD 810
           ++  N+D        L+ +Y  +GSL + L+      +  E   ++AL  A GL +LH +
Sbjct: 102 IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTASGLAHLHME 158
Query: 811 C-----SPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECM----SSVAGSYG 861
                  P I HRD+KS NIL+  +    +AD GLA  ++   A++ +    +   G+  
Sbjct: 159 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPNHRVGTKR 216
Query: 862 YIAPEY---AYTLKVDE---KSDVYSFGVVLLELIAGKKPVG 897
           Y+APE    +  +K  E   ++D+Y+ G+V  E IA +  +G
Sbjct: 217 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWE-IARRCSIG 257

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 85/206 (41%), Gaps = 17/206 (8%)
Query: 700 IGKGGAGIVYRGSM------PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVR 753
           +G G  G VY G +      P  + VA+K L    +  ++  FL E   + +  H+NIVR
Sbjct: 30  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 89
Query: 754 LLGYVSNRDTNLLLYEYMPNGSLGEMLHG-----AKGGHLKWETRYRIALEAAKGLCYLH 808
            +G         +L E M  G L   L       ++   L       +A + A G  YL 
Sbjct: 90  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 149
Query: 809 HDCSPLIIHRDVKSNNILLDSDFEAHVA---DFGLAKFLQDAGASECMSSVAGSYGYIAP 865
            +     IHRD+ + N LL       VA   DFG+A+ +  A              ++ P
Sbjct: 150 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 206
Query: 866 EYAYTLKVDEKSDVYSFGVVLLELIA 891
           E         K+D +SFGV+L E+ +
Sbjct: 207 EAFMEGIFTSKTDTWSFGVLLWEIFS 232

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 85/206 (41%), Gaps = 17/206 (8%)
Query: 700 IGKGGAGIVYRGSM------PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVR 753
           +G G  G VY G +      P  + VA+K L    +  ++  FL E   + +  H+NIVR
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 112
Query: 754 LLGYVSNRDTNLLLYEYMPNGSLGEMLHG-----AKGGHLKWETRYRIALEAAKGLCYLH 808
            +G         +L E M  G L   L       ++   L       +A + A G  YL 
Sbjct: 113 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 809 HDCSPLIIHRDVKSNNILLDSDFEAHVA---DFGLAKFLQDAGASECMSSVAGSYGYIAP 865
            +     IHRD+ + N LL       VA   DFG+A+ +  A              ++ P
Sbjct: 173 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 229
Query: 866 EYAYTLKVDEKSDVYSFGVVLLELIA 891
           E         K+D +SFGV+L E+ +
Sbjct: 230 EAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 85/206 (41%), Gaps = 17/206 (8%)
Query: 700 IGKGGAGIVYRGSM------PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVR 753
           +G G  G VY G +      P  + VA+K L    +  ++  FL E   + +  H+NIVR
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 754 LLGYVSNRDTNLLLYEYMPNGSLGEMLHG-----AKGGHLKWETRYRIALEAAKGLCYLH 808
            +G         +L E M  G L   L       ++   L       +A + A G  YL 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 809 HDCSPLIIHRDVKSNNILLDSDFEAHVA---DFGLAKFLQDAGASECMSSVAGSYGYIAP 865
            +     IHRD+ + N LL       VA   DFG+A+ +  A              ++ P
Sbjct: 159 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 215
Query: 866 EYAYTLKVDEKSDVYSFGVVLLELIA 891
           E         K+D +SFGV+L E+ +
Sbjct: 216 EAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Composition-based stats.
 Identities = 61/214 (28%), Positives = 99/214 (46%), Gaps = 14/214 (6%)
Query: 680 FQRLDFKAEDVLESLKDENIIGKGGAGIVYRGSMPD-GIDVAIKRLVGRGTGGNDHGFLA 738
           FQ +D K E     +  ++ +G G  G VY G      + VA+K L  +        FL 
Sbjct: 21  FQSMD-KWEMERTDITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTL--KEDTMEVEEFLK 77
Query: 739 EIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIAL 798
           E   +  I+H N+V+LLG  +      ++ EYMP G+L + L       +       +A 
Sbjct: 78  EAAVMKEIKHPNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMAT 137
Query: 799 EAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAG 858
           + +  + YL        IHRD+ + N L+  +    VADFGL++ +      +  ++ AG
Sbjct: 138 QISSAMEYLEKKN---FIHRDLAARNCLVGENHVVKVADFGLSRLM----TGDTYTAHAG 190
Query: 859 S---YGYIAPEYAYTLKVDEKSDVYSFGVVLLEL 889
           +     + APE         KSDV++FGV+L E+
Sbjct: 191 AKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEI 224

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 85/206 (41%), Gaps = 17/206 (8%)
Query: 700 IGKGGAGIVYRGSM------PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVR 753
           +G G  G VY G +      P  + VA+K L    +  ++  FL E   + +  H+NIVR
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 754 LLGYVSNRDTNLLLYEYMPNGSLGEMLHG-----AKGGHLKWETRYRIALEAAKGLCYLH 808
            +G         +L E M  G L   L       ++   L       +A + A G  YL 
Sbjct: 98  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 809 HDCSPLIIHRDVKSNNILLDSDFEAHVA---DFGLAKFLQDAGASECMSSVAGSYGYIAP 865
            +     IHRD+ + N LL       VA   DFG+A+ +  A              ++ P
Sbjct: 158 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 214
Query: 866 EYAYTLKVDEKSDVYSFGVVLLELIA 891
           E         K+D +SFGV+L E+ +
Sbjct: 215 EAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 70/290 (24%), Positives = 116/290 (40%), Gaps = 44/290 (15%)
Query: 700 IGKGGAGIVYRGSMPDGID------VAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVR 753
           +G+G  G+VY G+  D I       VA+K +    +      FL E   +      ++VR
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 754 LLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETR--------YRIALEAAKGLC 805
           LLG VS     L++ E M +G L   L   +        R         ++A E A G+ 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 806 YLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAP 865
           YL+   +   +HR++ + N ++  DF   + DFG+ + + +               ++AP
Sbjct: 145 YLN---AKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 201
Query: 866 EYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQP----SD 921
           E          SD++SFGVVL E+                       TS   QP    S+
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEI-----------------------TSLAEQPYQGLSN 238
Query: 922 AASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLAN 971
              +  V+D      P      +  +  MC +   + RPT  E+V++L +
Sbjct: 239 EQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLKD 288

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 58/246 (23%), Positives = 111/246 (45%), Gaps = 14/246 (5%)
Query: 684 DFKAEDVLESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTL 743
           D   ED  E + +   +G G  G VY+    +   +A  +++   +      ++ EI  L
Sbjct: 32  DLNPEDFWEIIGE---LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDIL 88
Query: 744 GRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKG 803
               H NIV+LL      +   +L E+   G++  ++   +    + + +  +  +    
Sbjct: 89  ASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQV-VCKQTLDA 147
Query: 804 LCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYI 863
           L YLH +    IIHRD+K+ NIL   D +  +ADFG++   ++    +      G+  ++
Sbjct: 148 LNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSA--KNTRXIQRRDXFIGTPYWM 202
Query: 864 APEY-----AYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQ 918
           APE      +     D K+DV+S G+ L+E+   + P  E      +++  +     ++Q
Sbjct: 203 APEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQ 262
Query: 919 PSDAAS 924
           PS  +S
Sbjct: 263 PSRWSS 268

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 70/290 (24%), Positives = 116/290 (40%), Gaps = 44/290 (15%)
Query: 700 IGKGGAGIVYRGSMPDGID------VAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVR 753
           +G+G  G+VY G+  D I       VA+K +    +      FL E   +      ++VR
Sbjct: 26  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 85
Query: 754 LLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETR--------YRIALEAAKGLC 805
           LLG VS     L++ E M +G L   L   +        R         ++A E A G+ 
Sbjct: 86  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 145
Query: 806 YLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAP 865
           YL+   +   +HR++ + N ++  DF   + DFG+ + + +               ++AP
Sbjct: 146 YLN---AKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 202
Query: 866 EYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQP----SD 921
           E          SD++SFGVVL E+                       TS   QP    S+
Sbjct: 203 ESLKDGVFTTSSDMWSFGVVLWEI-----------------------TSLAEQPYQGLSN 239
Query: 922 AASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLAN 971
              +  V+D      P      +  +  MC +   + RPT  E+V++L +
Sbjct: 240 EQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLKD 289

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 85/206 (41%), Gaps = 17/206 (8%)
Query: 700 IGKGGAGIVYRGSM------PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVR 753
           +G G  G VY G +      P  + VA+K L    +  ++  FL E   + +  H+NIVR
Sbjct: 45  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 104
Query: 754 LLGYVSNRDTNLLLYEYMPNGSLGEMLHG-----AKGGHLKWETRYRIALEAAKGLCYLH 808
            +G         +L E M  G L   L       ++   L       +A + A G  YL 
Sbjct: 105 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 164
Query: 809 HDCSPLIIHRDVKSNNILLDSDFEAHVA---DFGLAKFLQDAGASECMSSVAGSYGYIAP 865
            +     IHRD+ + N LL       VA   DFG+A+ +  A              ++ P
Sbjct: 165 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 221
Query: 866 EYAYTLKVDEKSDVYSFGVVLLELIA 891
           E         K+D +SFGV+L E+ +
Sbjct: 222 EAFMEGIFTSKTDTWSFGVLLWEIFS 247

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 93/209 (44%), Gaps = 12/209 (5%)
Query: 692 ESLKDENIIGKGG-AGIVYRGSMPDGIDVAIKRLVGRGT-GGNDHGFLA-EIQTLGRIRH 748
           E  K   I+G+G  + +V    +    + AIK L  R     N   ++  E   + R+ H
Sbjct: 37  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 96
Query: 749 RNIVRLLGYVSNRDTNLLLY--EYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCY 806
              V+L  Y   +D   L +   Y  NG L + +    G   +  TR+  A E    L Y
Sbjct: 97  PFFVKL--YFCFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTA-EIVSALEY 152
Query: 807 LHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPE 866
           LH      IIHRD+K  NILL+ D    + DFG AK L         +   G+  Y++PE
Sbjct: 153 LH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 209
Query: 867 YAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
                   + SD+++ G ++ +L+AG  P
Sbjct: 210 LLTEKSACKSSDLWALGCIIYQLVAGLPP 238

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 69/222 (31%), Positives = 110/222 (49%), Gaps = 38/222 (17%)
Query: 700 IGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFL--AEIQTLGRIRHRNIVRLLGY 757
           IGKG  G V+RG    G +VA+K    R     +  +   AEI     +RH NI   LG+
Sbjct: 37  IGKGRFGEVWRGKWR-GEEVAVKIFSSR----EERSWFREAEIYQTVMLRHENI---LGF 88
Query: 758 VS--NRDTN-----LLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHD 810
           ++  N+D        L+ +Y  +GSL + L+      +  E   ++AL  A GL +LH +
Sbjct: 89  IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTASGLAHLHME 145
Query: 811 C-----SPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECM----SSVAGSYG 861
                  P I HRD+KS NIL+  +    +AD GLA  ++   A++ +    +   G+  
Sbjct: 146 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPNHRVGTKR 203
Query: 862 YIAPEY---AYTLKVDE---KSDVYSFGVVLLELIAGKKPVG 897
           Y+APE    +  +K  E   ++D+Y+ G+V  E IA +  +G
Sbjct: 204 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWE-IARRCSIG 244

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 85/206 (41%), Gaps = 17/206 (8%)
Query: 700 IGKGGAGIVYRGSM------PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVR 753
           +G G  G VY G +      P  + VA+K L    +  ++  FL E   + +  H+NIVR
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 754 LLGYVSNRDTNLLLYEYMPNGSLGEMLHG-----AKGGHLKWETRYRIALEAAKGLCYLH 808
            +G         +L E M  G L   L       ++   L       +A + A G  YL 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 809 HDCSPLIIHRDVKSNNILLDSDFEAHVA---DFGLAKFLQDAGASECMSSVAGSYGYIAP 865
            +     IHRD+ + N LL       VA   DFG+A+ +  A              ++ P
Sbjct: 159 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAMLPVKWMPP 215
Query: 866 EYAYTLKVDEKSDVYSFGVVLLELIA 891
           E         K+D +SFGV+L E+ +
Sbjct: 216 EAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 73/292 (25%), Positives = 118/292 (40%), Gaps = 43/292 (14%)
Query: 700 IGKGGAGIVYRGSMPDGID-------VAIKRLVGRGTGGNDHGFLAEIQTLGRI-RHRNI 751
           +G+G  G V       GID       VA+K L    T       ++E++ L  I  H N+
Sbjct: 35  LGRGAFGQVIEADA-FGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 93
Query: 752 VRLLGYVSNRDTNLL-LYEYMPNGSLGEMLHGAKGGHLKWETRYR----------IALEA 800
           V LLG  +     L+ + E+   G+L   L   +   + ++  Y+           + + 
Sbjct: 94  VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYSFQV 153
Query: 801 AKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSY 860
           AKG+ +L    S   IHRD+ + NILL       + DFGLA+ +                
Sbjct: 154 AKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 210
Query: 861 GYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQP 919
            ++APE  +      +SDV+SFGV+L E+ + G  P        +  R +++ T      
Sbjct: 211 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT------ 264
Query: 920 SDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLAN 971
                       R+   P      +++  + C   E S RPT  E+V  L N
Sbjct: 265 ------------RMRA-PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 303

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 85/206 (41%), Gaps = 17/206 (8%)
Query: 700 IGKGGAGIVYRGSM------PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVR 753
           +G G  G VY G +      P  + VA+K L    +  ++  FL E   + +  H+NIVR
Sbjct: 65  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 124
Query: 754 LLGYVSNRDTNLLLYEYMPNGSLGEMLHG-----AKGGHLKWETRYRIALEAAKGLCYLH 808
            +G         +L E M  G L   L       ++   L       +A + A G  YL 
Sbjct: 125 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 184
Query: 809 HDCSPLIIHRDVKSNNILLDSDFEAHVA---DFGLAKFLQDAGASECMSSVAGSYGYIAP 865
            +     IHRD+ + N LL       VA   DFG+A+ +  A              ++ P
Sbjct: 185 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 241
Query: 866 EYAYTLKVDEKSDVYSFGVVLLELIA 891
           E         K+D +SFGV+L E+ +
Sbjct: 242 EAFMEGIFTSKTDTWSFGVLLWEIFS 267

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 74/268 (27%), Positives = 117/268 (43%), Gaps = 36/268 (13%)
Query: 692 ESLKDENI----IGKGGAGIV-----YRGSMPDGIDVAIKRLVGRGTGGNDHGFL---AE 739
           ++L+DE I    +G G  G V      +      I +  KR    G+       L    E
Sbjct: 145 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETE 204
Query: 740 IQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALE 799
           I+ L ++ H  I+++  +    D  ++L E M  G L + + G K   LK  T      +
Sbjct: 205 IEILKKLNHPCIIKIKNFFDAEDYYIVL-ELMEGGELFDKVVGNK--RLKEATCKLYFYQ 261
Query: 800 AAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEA---HVADFGLAKFLQDAGASECMSSV 856
               + YLH +    IIHRD+K  N+LL S  E     + DFG +K L   G +  M ++
Sbjct: 262 MLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL---GETSLMRTL 315
Query: 857 AGSYGYIAPEYAY---TLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDI-------- 905
            G+  Y+APE      T   +   D +S GV+L   ++G  P  E    V +        
Sbjct: 316 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGK 375
Query: 906 VRWVRKTTSEVSQPS-DAASVLAVVDPR 932
             ++ +  +EVS+ + D    L VVDP+
Sbjct: 376 YNFIPEVWAEVSEKALDLVKKLLVVDPK 403

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 74/159 (46%), Gaps = 9/159 (5%)
Query: 739 EIQTLGRIRHRNIVRLLGYVSNRDTNLLLY--EYMPNGSLGEMLHGAKGGHLKWETRYRI 796
           E   + R+ H   V+L  Y + +D   L +   Y  NG L + +    G   +  TR+  
Sbjct: 80  ERDVMSRLDHPFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYT 136
Query: 797 ALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSV 856
           A E    L YLH      IIHRD+K  NILL+ D    + DFG AK L         +  
Sbjct: 137 A-EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 192
Query: 857 AGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
            G+  Y++PE        + SD+++ G ++ +L+AG  P
Sbjct: 193 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 96/201 (47%), Gaps = 11/201 (5%)
Query: 700 IGKGGAGIVYRGSM--PD--GIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLL 755
           IG+G  G V++G    P+   + VAIK      +      FL E  T+ +  H +IV+L+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 756 GYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLI 815
           G ++     +++ E    G L   L   K   L   +    A + +  L YL    S   
Sbjct: 78  GVITENPVWIIM-ELCTLGELRSFLQVRKYS-LDLASLILYAYQLSTALAYLE---SKRF 132
Query: 816 IHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDE 875
           +HRD+ + N+L+ S+    + DFGL+++++D+   +  S       ++APE     +   
Sbjct: 133 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA-SKGKLPIKWMAPESINFRRFTS 191
Query: 876 KSDVYSFGVVLLE-LIAGKKP 895
            SDV+ FGV + E L+ G KP
Sbjct: 192 ASDVWMFGVCMWEILMHGVKP 212

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 96/201 (47%), Gaps = 11/201 (5%)
Query: 700 IGKGGAGIVYRGSM--PD--GIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLL 755
           IG+G  G V++G    P+   + VAIK      +      FL E  T+ +  H +IV+L+
Sbjct: 46  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 105
Query: 756 GYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLI 815
           G ++     +++ E    G L   L   K   L   +    A + +  L YL    S   
Sbjct: 106 GVITENPVWIIM-ELCTLGELRSFLQVRKYS-LDLASLILYAYQLSTALAYLE---SKRF 160
Query: 816 IHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDE 875
           +HRD+ + N+L+ S+    + DFGL+++++D+   +  S       ++APE     +   
Sbjct: 161 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA-SKGKLPIKWMAPESINFRRFTS 219
Query: 876 KSDVYSFGVVLLE-LIAGKKP 895
            SDV+ FGV + E L+ G KP
Sbjct: 220 ASDVWMFGVCMWEILMHGVKP 240

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 95/215 (44%), Gaps = 27/215 (12%)
Query: 700 IGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYV 758
           +G+GG G+V+   +  D  + AIKR+            + E++ L ++ H  IVR     
Sbjct: 13  LGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAW 72
Query: 759 SNRDTNLLLYEYMPNGSLGEMLHGAKGGHLK-W-------ETRYR-----IALEAAKGLC 805
             ++T   L    P   L   +   +  +LK W       E R R     I L+ A+ + 
Sbjct: 73  LEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVE 132
Query: 806 YLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFL-QDAGASECMSSV-------- 856
           +LH   S  ++HRD+K +NI    D    V DFGL   + QD      ++ +        
Sbjct: 133 FLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTG 189
Query: 857 -AGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELI 890
             G+  Y++PE  +      K D++S G++L EL+
Sbjct: 190 QVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 78/161 (48%), Gaps = 10/161 (6%)
Query: 739 EIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIAL 798
           EI  L  +RH +I++L   + ++D  +++ EY  N     ++   K    +   R+   +
Sbjct: 54  EISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSE-QEARRFFQQI 112
Query: 799 EAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAG 858
            +A   C+ H      I+HRD+K  N+LLD      +ADFGL+  + D      + +  G
Sbjct: 113 ISAVEYCHRHK-----IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN---FLKTSCG 164
Query: 859 SYGYIAPEY-AYTLKVDEKSDVYSFGVVLLELIAGKKPVGE 898
           S  Y APE  +  L    + DV+S GV+L  ++  + P  +
Sbjct: 165 SPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDD 205

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 72/252 (28%), Positives = 110/252 (43%), Gaps = 42/252 (16%)
Query: 735 GFLAEIQTLGRIRHRNIVRLLGYVSNR--DTNLLLYEYMPNGSLGEML--HGAKGGHLKW 790
           G+  EI+ L  + H +IV+  G   ++   +  L+ EY+P GSL + L  H      L  
Sbjct: 56  GWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQL-- 113
Query: 791 ETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS 850
                 A +  +G+ YLH   +   IHR + + N+LLD+D    + DFGLAK + +    
Sbjct: 114 ---LLFAQQICEGMAYLH---AQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEY 167
Query: 851 ECMSSVAGS-YGYIAPEYAYTLKVDEKSDVYSFGVVLLELI----AGKKPVGEFGDGVDI 905
             +     S   + APE     K    SDV+SFGV L EL+    + + P  +F      
Sbjct: 168 YRVREDGDSPVFWYAPECLKECKFYYASDVWSFGVTLYELLTYCDSNQSPHTKF------ 221
Query: 906 VRWVRKTTSEVSQPSDAASVLAVVD--------PRLSGYPLTGVIHLFKVAMMCVEDESS 957
                  T  +       +VL + +        PR    P   + HL K    C E E+S
Sbjct: 222 -------TELIGHTQGQMTVLRLTELLERGERLPRPDRCPCE-IYHLMK---NCWETEAS 270
Query: 958 ARPTMREVVHML 969
            RPT + +V +L
Sbjct: 271 FRPTFQNLVPIL 282

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 72/252 (28%), Positives = 110/252 (43%), Gaps = 42/252 (16%)
Query: 735 GFLAEIQTLGRIRHRNIVRLLGYVSNR--DTNLLLYEYMPNGSLGEML--HGAKGGHLKW 790
           G+  EI+ L  + H +IV+  G   ++   +  L+ EY+P GSL + L  H      L  
Sbjct: 57  GWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQL-- 114
Query: 791 ETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS 850
                 A +  +G+ YLH   +   IHR + + N+LLD+D    + DFGLAK + +    
Sbjct: 115 ---LLFAQQICEGMAYLH---AQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEY 168
Query: 851 ECMSSVAGS-YGYIAPEYAYTLKVDEKSDVYSFGVVLLELI----AGKKPVGEFGDGVDI 905
             +     S   + APE     K    SDV+SFGV L EL+    + + P  +F      
Sbjct: 169 YRVREDGDSPVFWYAPECLKECKFYYASDVWSFGVTLYELLTYCDSNQSPHTKF------ 222
Query: 906 VRWVRKTTSEVSQPSDAASVLAVVD--------PRLSGYPLTGVIHLFKVAMMCVEDESS 957
                  T  +       +VL + +        PR    P   + HL K    C E E+S
Sbjct: 223 -------TELIGHTQGQMTVLRLTELLERGERLPRPDRCPCE-IYHLMK---NCWETEAS 271
Query: 958 ARPTMREVVHML 969
            RPT + +V +L
Sbjct: 272 FRPTFQNLVPIL 283

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 96/201 (47%), Gaps = 11/201 (5%)
Query: 700 IGKGGAGIVYRGSM--PD--GIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLL 755
           IG+G  G V++G    P+   + VAIK      +      FL E  T+ +  H +IV+L+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 756 GYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLI 815
           G ++     +++ E    G L   L   K   L   +    A + +  L YL    S   
Sbjct: 78  GVITENPVWIIM-ELCTLGELRSFLQVRKYS-LDLASLILYAYQLSTALAYLE---SKRF 132
Query: 816 IHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDE 875
           +HRD+ + N+L+ S+    + DFGL+++++D+   +  S       ++APE     +   
Sbjct: 133 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA-SKGKLPIKWMAPESINFRRFTS 191
Query: 876 KSDVYSFGVVLLE-LIAGKKP 895
            SDV+ FGV + E L+ G KP
Sbjct: 192 ASDVWMFGVCMWEILMHGVKP 212

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 69/222 (31%), Positives = 110/222 (49%), Gaps = 38/222 (17%)
Query: 700 IGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFL--AEIQTLGRIRHRNIVRLLGY 757
           IGKG  G V+RG    G +VA+K    R     +  +   AEI     +RH NI   LG+
Sbjct: 17  IGKGRFGEVWRGKWR-GEEVAVKIFSSR----EERSWFREAEIYQTVMLRHENI---LGF 68
Query: 758 VS--NRDTN-----LLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHD 810
           ++  N+D        L+ +Y  +GSL + L+      +  E   ++AL  A GL +LH +
Sbjct: 69  IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTASGLAHLHME 125
Query: 811 C-----SPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECM----SSVAGSYG 861
                  P I HRD+KS NIL+  +    +AD GLA  ++   A++ +    +   G+  
Sbjct: 126 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPNHRVGTKR 183
Query: 862 YIAPEY---AYTLKVDE---KSDVYSFGVVLLELIAGKKPVG 897
           Y+APE    +  +K  E   ++D+Y+ G+V  E IA +  +G
Sbjct: 184 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWE-IARRCSIG 224

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 74/268 (27%), Positives = 117/268 (43%), Gaps = 36/268 (13%)
Query: 692 ESLKDENI----IGKGGAGIV-----YRGSMPDGIDVAIKRLVGRGTGGNDHGFL---AE 739
           ++L+DE I    +G G  G V      +      I +  KR    G+       L    E
Sbjct: 131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETE 190
Query: 740 IQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALE 799
           I+ L ++ H  I+++  +    D  ++L E M  G L + + G K   LK  T      +
Sbjct: 191 IEILKKLNHPCIIKIKNFFDAEDYYIVL-ELMEGGELFDKVVGNK--RLKEATCKLYFYQ 247
Query: 800 AAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEA---HVADFGLAKFLQDAGASECMSSV 856
               + YLH +    IIHRD+K  N+LL S  E     + DFG +K L   G +  M ++
Sbjct: 248 MLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL---GETSLMRTL 301
Query: 857 AGSYGYIAPEYAY---TLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDI-------- 905
            G+  Y+APE      T   +   D +S GV+L   ++G  P  E    V +        
Sbjct: 302 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGK 361
Query: 906 VRWVRKTTSEVSQPS-DAASVLAVVDPR 932
             ++ +  +EVS+ + D    L VVDP+
Sbjct: 362 YNFIPEVWAEVSEKALDLVKKLLVVDPK 389

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 78/161 (48%), Gaps = 10/161 (6%)
Query: 739 EIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIAL 798
           EI  L  +RH +I++L   + ++D  +++ EY  N     ++   K    +   R+   +
Sbjct: 58  EISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSE-QEARRFFQQI 116
Query: 799 EAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAG 858
            +A   C+ H      I+HRD+K  N+LLD      +ADFGL+  + D      + +  G
Sbjct: 117 ISAVEYCHRHK-----IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN---FLKTSCG 168
Query: 859 SYGYIAPEY-AYTLKVDEKSDVYSFGVVLLELIAGKKPVGE 898
           S  Y APE  +  L    + DV+S GV+L  ++  + P  +
Sbjct: 169 SPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDD 209

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 96/201 (47%), Gaps = 11/201 (5%)
Query: 700 IGKGGAGIVYRGSM--PD--GIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLL 755
           IG+G  G V++G    P+   + VAIK      +      FL E  T+ +  H +IV+L+
Sbjct: 15  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 74
Query: 756 GYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLI 815
           G ++     +++ E    G L   L   K   L   +    A + +  L YL    S   
Sbjct: 75  GVITENPVWIIM-ELCTLGELRSFLQVRKYS-LDLASLILYAYQLSTALAYLE---SKRF 129
Query: 816 IHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDE 875
           +HRD+ + N+L+ S+    + DFGL+++++D+   +  S       ++APE     +   
Sbjct: 130 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA-SKGKLPIKWMAPESINFRRFTS 188
Query: 876 KSDVYSFGVVLLE-LIAGKKP 895
            SDV+ FGV + E L+ G KP
Sbjct: 189 ASDVWMFGVCMWEILMHGVKP 209

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 55/194 (28%), Positives = 90/194 (46%), Gaps = 13/194 (6%)
Query: 700 IGKGGAGIVYRGSMPD-GIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYV 758
           +G G  G VY G      + VA+K L  +        FL E   +  I+H N+V+LLG  
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTL--KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 76
Query: 759 SNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHR 818
           +      ++ E+M  G+L + L       +       +A + +  + YL        IHR
Sbjct: 77  TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHR 133
Query: 819 DVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGS---YGYIAPEYAYTLKVDE 875
           D+ + N L+  +    VADFGL++ +      +  ++ AG+     + APE     K   
Sbjct: 134 DLAARNCLVGENHLVKVADFGLSRLM----TGDTFTAHAGAKFPIKWTAPESLAYNKFSI 189
Query: 876 KSDVYSFGVVLLEL 889
           KSDV++FGV+L E+
Sbjct: 190 KSDVWAFGVLLWEI 203

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 69/222 (31%), Positives = 110/222 (49%), Gaps = 38/222 (17%)
Query: 700 IGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFL--AEIQTLGRIRHRNIVRLLGY 757
           IGKG  G V+RG    G +VA+K    R     +  +   AEI     +RH NI   LG+
Sbjct: 11  IGKGRFGEVWRGKWR-GEEVAVKIFSSR----EERSWFREAEIYQTVMLRHENI---LGF 62
Query: 758 VS--NRDTN-----LLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHD 810
           ++  N+D        L+ +Y  +GSL + L+      +  E   ++AL  A GL +LH +
Sbjct: 63  IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTASGLAHLHME 119
Query: 811 C-----SPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECM----SSVAGSYG 861
                  P I HRD+KS NIL+  +    +AD GLA  ++   A++ +    +   G+  
Sbjct: 120 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPNHRVGTKR 177
Query: 862 YIAPEY---AYTLKVDE---KSDVYSFGVVLLELIAGKKPVG 897
           Y+APE    +  +K  E   ++D+Y+ G+V  E IA +  +G
Sbjct: 178 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWE-IARRCSIG 218

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 78/161 (48%), Gaps = 10/161 (6%)
Query: 739 EIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIAL 798
           EI  L  +RH +I++L   + ++D  +++ EY  N     ++   K    +   R+   +
Sbjct: 64  EISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSE-QEARRFFQQI 122
Query: 799 EAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAG 858
            +A   C+ H      I+HRD+K  N+LLD      +ADFGL+  + D      + +  G
Sbjct: 123 ISAVEYCHRHK-----IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN---FLKTSCG 174
Query: 859 SYGYIAPEY-AYTLKVDEKSDVYSFGVVLLELIAGKKPVGE 898
           S  Y APE  +  L    + DV+S GV+L  ++  + P  +
Sbjct: 175 SPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDD 215

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 73/292 (25%), Positives = 118/292 (40%), Gaps = 43/292 (14%)
Query: 700 IGKGGAGIVYRGSMPDGID-------VAIKRLVGRGTGGNDHGFLAEIQTLGRI-RHRNI 751
           +G+G  G V       GID       VA+K L    T       ++E++ L  I  H N+
Sbjct: 35  LGRGAFGQVIEADA-FGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 93
Query: 752 VRLLGYVSNRDTNLL-LYEYMPNGSLGEMLHGAKGGHLKWETRYR----------IALEA 800
           V LLG  +     L+ + E+   G+L   L   +   + ++  Y+           + + 
Sbjct: 94  VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYSFQV 153
Query: 801 AKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSY 860
           AKG+ +L    S   IHRD+ + NILL       + DFGLA+ +                
Sbjct: 154 AKGMEFL---ASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDARLPL 210
Query: 861 GYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQP 919
            ++APE  +      +SDV+SFGV+L E+ + G  P        +  R +++ T      
Sbjct: 211 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFXRRLKEGT------ 264
Query: 920 SDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLAN 971
                       R+   P      +++  + C   E S RPT  E+V  L N
Sbjct: 265 ------------RMRA-PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 303

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 69/217 (31%), Positives = 101/217 (46%), Gaps = 28/217 (12%)
Query: 697 ENIIGKGGAG-IVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRI-RHRNIVRL 754
           ++++G G  G IVYRG M D  DVA+KR++       D     E+Q L     H N++R 
Sbjct: 29  KDVLGHGAEGTIVYRG-MFDNRDVAVKRILPECFSFAD----REVQLLRESDEHPNVIRY 83
Query: 755 LGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPL 814
                +R    +  E +   +L E +      HL  E    +  +   GL +LH   S  
Sbjct: 84  FCTEKDRQFQYIAIE-LCAATLQEYVEQKDFAHLGLEP-ITLLQQTTSGLAHLH---SLN 138
Query: 815 IIHRDVKSNNILLD-----SDFEAHVADFGLAKFLQDAGAS-ECMSSVAGSYGYIAPEYA 868
           I+HRD+K +NIL+         +A ++DFGL K L     S    S V G+ G+IAPE  
Sbjct: 139 IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPE-- 196
Query: 869 YTLKVDEKS------DVYSFGVVLLELIA-GKKPVGE 898
             L  D K       D++S G V   +I+ G  P G+
Sbjct: 197 -MLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGK 232

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 78/161 (48%), Gaps = 10/161 (6%)
Query: 739 EIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIAL 798
           EI  L  +RH +I++L   + ++D  +++ EY  N     ++   K    +   R+   +
Sbjct: 63  EISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSE-QEARRFFQQI 121
Query: 799 EAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAG 858
            +A   C+ H      I+HRD+K  N+LLD      +ADFGL+  + D      + +  G
Sbjct: 122 ISAVEYCHRHK-----IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN---FLKTSCG 173
Query: 859 SYGYIAPEY-AYTLKVDEKSDVYSFGVVLLELIAGKKPVGE 898
           S  Y APE  +  L    + DV+S GV+L  ++  + P  +
Sbjct: 174 SPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDD 214

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 69/222 (31%), Positives = 110/222 (49%), Gaps = 38/222 (17%)
Query: 700 IGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFL--AEIQTLGRIRHRNIVRLLGY 757
           IGKG  G V+RG    G +VA+K    R     +  +   AEI     +RH NI   LG+
Sbjct: 12  IGKGRFGEVWRGKWR-GEEVAVKIFSSR----EERSWFREAEIYQTVMLRHENI---LGF 63
Query: 758 VS--NRDTN-----LLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHD 810
           ++  N+D        L+ +Y  +GSL + L+      +  E   ++AL  A GL +LH +
Sbjct: 64  IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTASGLAHLHME 120
Query: 811 C-----SPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECM----SSVAGSYG 861
                  P I HRD+KS NIL+  +    +AD GLA  ++   A++ +    +   G+  
Sbjct: 121 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPNHRVGTKR 178
Query: 862 YIAPEY---AYTLKVDE---KSDVYSFGVVLLELIAGKKPVG 897
           Y+APE    +  +K  E   ++D+Y+ G+V  E IA +  +G
Sbjct: 179 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWE-IARRCSIG 219

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 85/206 (41%), Gaps = 17/206 (8%)
Query: 700 IGKGGAGIVYRGSM------PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVR 753
           +G G  G VY G +      P  + VA+K L    +  ++  FL E   + +  H+NIVR
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNIVR 112
Query: 754 LLGYVSNRDTNLLLYEYMPNGSLGEMLHG-----AKGGHLKWETRYRIALEAAKGLCYLH 808
            +G         +L E M  G L   L       ++   L       +A + A G  YL 
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 809 HDCSPLIIHRDVKSNNILLDSDFEAHVA---DFGLAKFLQDAGASECMSSVAGSYGYIAP 865
            +     IHRD+ + N LL       VA   DFG+A+ +  A              ++ P
Sbjct: 173 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 229
Query: 866 EYAYTLKVDEKSDVYSFGVVLLELIA 891
           E         K+D +SFGV+L E+ +
Sbjct: 230 EAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 102/210 (48%), Gaps = 15/210 (7%)
Query: 690 VLESLKDENIIGKGGAGIVYRGSMPDGI---DVAIKRLVGRGTGGNDHGFLA--EIQTLG 744
           VL+  ++   IG G  GIV   +  D I   +VAIK+L  R      H   A  E+  + 
Sbjct: 16  VLKRYQNLKPIGSGAQGIV--CAAYDAILERNVAIKKL-SRPFQNQTHAKRAYRELVLMK 72
Query: 745 RIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRY-RIALEAAKG 803
            + H+NI+ LL   + + +   L E+     + E++       ++ E  + R++    + 
Sbjct: 73  CVNHKNIIGLLNVFTPQKS---LEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQM 129
Query: 804 LCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYI 863
           LC + H  S  IIHRD+K +NI++ SD    + DFGLA+    AG S  M+    +  Y 
Sbjct: 130 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYR 186
Query: 864 APEYAYTLKVDEKSDVYSFGVVLLELIAGK 893
           APE    +   E  D++S G ++ E++  K
Sbjct: 187 APEVILGMGYKENVDLWSVGCIMGEMVCHK 216

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 69/222 (31%), Positives = 110/222 (49%), Gaps = 38/222 (17%)
Query: 700 IGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFL--AEIQTLGRIRHRNIVRLLGY 757
           IGKG  G V+RG    G +VA+K    R     +  +   AEI     +RH NI   LG+
Sbjct: 14  IGKGRFGEVWRGKWR-GEEVAVKIFSSR----EERSWFREAEIYQTVMLRHENI---LGF 65
Query: 758 VS--NRDTN-----LLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHD 810
           ++  N+D        L+ +Y  +GSL + L+      +  E   ++AL  A GL +LH +
Sbjct: 66  IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTASGLAHLHME 122
Query: 811 C-----SPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECM----SSVAGSYG 861
                  P I HRD+KS NIL+  +    +AD GLA  ++   A++ +    +   G+  
Sbjct: 123 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPNHRVGTKR 180
Query: 862 YIAPEY---AYTLKVDE---KSDVYSFGVVLLELIAGKKPVG 897
           Y+APE    +  +K  E   ++D+Y+ G+V  E IA +  +G
Sbjct: 181 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWE-IARRCSIG 221

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 55/194 (28%), Positives = 90/194 (46%), Gaps = 13/194 (6%)
Query: 700 IGKGGAGIVYRGSMPD-GIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYV 758
           +G G  G VY G      + VA+K L  +        FL E   +  I+H N+V+LLG  
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTL--KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 79
Query: 759 SNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHR 818
           +      ++ E+M  G+L + L       +       +A + +  + YL        IHR
Sbjct: 80  TREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHR 136
Query: 819 DVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGS---YGYIAPEYAYTLKVDE 875
           D+ + N L+  +    VADFGL++ +      +  ++ AG+     + APE     K   
Sbjct: 137 DLAARNCLVGENHLVKVADFGLSRLM----TGDTYTAPAGAKFPIKWTAPESLAYNKFSI 192
Query: 876 KSDVYSFGVVLLEL 889
           KSDV++FGV+L E+
Sbjct: 193 KSDVWAFGVLLWEI 206

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 55/194 (28%), Positives = 90/194 (46%), Gaps = 13/194 (6%)
Query: 700 IGKGGAGIVYRGSMPD-GIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYV 758
           +G G  G VY G      + VA+K L  +        FL E   +  I+H N+V+LLG  
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTL--KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 80
Query: 759 SNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHR 818
           +      ++ E+M  G+L + L       +       +A + +  + YL        IHR
Sbjct: 81  TREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHR 137
Query: 819 DVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGS---YGYIAPEYAYTLKVDE 875
           D+ + N L+  +    VADFGL++ +      +  ++ AG+     + APE     K   
Sbjct: 138 DLAARNCLVGENHLVKVADFGLSRLM----TGDTYTAPAGAKFPIKWTAPESLAYNKFSI 193
Query: 876 KSDVYSFGVVLLEL 889
           KSDV++FGV+L E+
Sbjct: 194 KSDVWAFGVLLWEI 207

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 102/210 (48%), Gaps = 15/210 (7%)
Query: 690 VLESLKDENIIGKGGAGIVYRGSMPDGI---DVAIKRLVGRGTGGNDHGFLA--EIQTLG 744
           VL+  ++   IG G  GIV   +  D I   +VAIK+L  R      H   A  E+  + 
Sbjct: 27  VLKRYQNLKPIGSGAQGIV--CAAYDAILERNVAIKKL-SRPFQNQTHAKRAYRELVLMK 83
Query: 745 RIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRY-RIALEAAKG 803
            + H+NI+ LL   + + +   L E+     + E++       ++ E  + R++    + 
Sbjct: 84  CVNHKNIIGLLNVFTPQKS---LEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQM 140
Query: 804 LCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYI 863
           LC + H  S  IIHRD+K +NI++ SD    + DFGLA+    AG S  M+    +  Y 
Sbjct: 141 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYR 197
Query: 864 APEYAYTLKVDEKSDVYSFGVVLLELIAGK 893
           APE    +   E  D++S G ++ E++  K
Sbjct: 198 APEVILGMGYKENVDLWSVGCIMGEMVCHK 227

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 55/194 (28%), Positives = 90/194 (46%), Gaps = 13/194 (6%)
Query: 700 IGKGGAGIVYRGSMPD-GIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYV 758
           +G G  G VY G      + VA+K L  +        FL E   +  I+H N+V+LLG  
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTL--KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 79
Query: 759 SNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHR 818
           +      ++ E+M  G+L + L       +       +A + +  + YL        IHR
Sbjct: 80  TREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHR 136
Query: 819 DVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGS---YGYIAPEYAYTLKVDE 875
           D+ + N L+  +    VADFGL++ +      +  ++ AG+     + APE     K   
Sbjct: 137 DLAARNCLVGENHLVKVADFGLSRLM----TGDTXTAHAGAKFPIKWTAPESLAYNKFSI 192
Query: 876 KSDVYSFGVVLLEL 889
           KSDV++FGV+L E+
Sbjct: 193 KSDVWAFGVLLWEI 206

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 68/237 (28%), Positives = 110/237 (46%), Gaps = 19/237 (8%)
Query: 690 VLESLKDENIIGKGGAGIVYRGSMPDGI---DVAIKRLVGRGTGGNDHGFLA--EIQTLG 744
           VL+  ++   IG G  GIV   +  D I   +VAIK+L  R      H   A  E+  + 
Sbjct: 22  VLKRYQNLKPIGSGAQGIV--CAAYDAILERNVAIKKL-SRPFQNQTHAKRAYRELVLMK 78
Query: 745 RIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRY-RIALEAAKG 803
            + H+NI+ LL   + + +   L E+     + E++       ++ E  + R++    + 
Sbjct: 79  VVNHKNIIGLLNVFTPQKS---LEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQM 135
Query: 804 LCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYI 863
           L  + H  S  IIHRD+K +NI++ SD    + DFGLA+    AG S  M+    +  Y 
Sbjct: 136 LVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLAR---TAGTSFMMTPYVVTRYYR 192
Query: 864 APEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPS 920
           APE    +   E  D++S G ++ E+I G    G    G D +    K   ++  PS
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKG----GVLFPGTDHIDQWNKVIEQLGTPS 245

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 55/194 (28%), Positives = 90/194 (46%), Gaps = 13/194 (6%)
Query: 700 IGKGGAGIVYRGSMPD-GIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYV 758
           +G G  G VY G      + VA+K L  +        FL E   +  I+H N+V+LLG  
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTL--KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 76
Query: 759 SNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHR 818
           +      ++ E+M  G+L + L       +       +A + +  + YL        IHR
Sbjct: 77  TREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHR 133
Query: 819 DVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGS---YGYIAPEYAYTLKVDE 875
           D+ + N L+  +    VADFGL++ +      +  ++ AG+     + APE     K   
Sbjct: 134 DLAARNCLVGENHLVKVADFGLSRLM----TGDTXTAHAGAKFPIKWTAPESLAYNKFSI 189
Query: 876 KSDVYSFGVVLLEL 889
           KSDV++FGV+L E+
Sbjct: 190 KSDVWAFGVLLWEI 203

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 69/298 (23%), Positives = 119/298 (39%), Gaps = 44/298 (14%)
Query: 700 IGKGGAGIVYRGS----MP--DGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVR 753
           +G+G  G V+       +P  D + VA+K L    +      F  E + L  ++H++IVR
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKAL-KEASESARQDFQREAELLTMLQHQHIVR 107
Query: 754 LLGYVSNRDTNLLLYEYMPNGSLGEML--HGAKG-----------GHLKWETRYRIALEA 800
             G  +     L+++EYM +G L   L  HG              G L       +A + 
Sbjct: 108 FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 167
Query: 801 AKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSY 860
           A G+ YL        +HRD+ + N L+       + DFG+++ +                
Sbjct: 168 AAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 224
Query: 861 GYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQP 919
            ++ PE     K   +SDV+SFGVVL E+   GK+P            W + + +E    
Sbjct: 225 RWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP------------WYQLSNTE---- 268
Query: 920 SDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQSAP 977
               ++  +   R    P      ++ +   C + E   R ++++V   L    Q+ P
Sbjct: 269 ----AIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPP 322

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 55/194 (28%), Positives = 90/194 (46%), Gaps = 13/194 (6%)
Query: 700 IGKGGAGIVYRGSMPD-GIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYV 758
           +G G  G VY G      + VA+K L  +        FL E   +  I+H N+V+LLG  
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTL--KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 83
Query: 759 SNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHR 818
           +      ++ E+M  G+L + L       +       +A + +  + YL        IHR
Sbjct: 84  TREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHR 140
Query: 819 DVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGS---YGYIAPEYAYTLKVDE 875
           D+ + N L+  +    VADFGL++ +      +  ++ AG+     + APE     K   
Sbjct: 141 DLAARNCLVGENHLVKVADFGLSRLM----TGDTXTAHAGAKFPIKWTAPESLAYNKFSI 196
Query: 876 KSDVYSFGVVLLEL 889
           KSDV++FGV+L E+
Sbjct: 197 KSDVWAFGVLLWEI 210

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 55/194 (28%), Positives = 90/194 (46%), Gaps = 13/194 (6%)
Query: 700 IGKGGAGIVYRGSMPD-GIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYV 758
           +G G  G VY G      + VA+K L  +        FL E   +  I+H N+V+LLG  
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTL--KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 83
Query: 759 SNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHR 818
           +      ++ E+M  G+L + L       +       +A + +  + YL        IHR
Sbjct: 84  TREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHR 140
Query: 819 DVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGS---YGYIAPEYAYTLKVDE 875
           D+ + N L+  +    VADFGL++ +      +  ++ AG+     + APE     K   
Sbjct: 141 DLAARNCLVGENHLVKVADFGLSRLM----TGDTYTAHAGAKFPIKWTAPESLAYNKFSI 196
Query: 876 KSDVYSFGVVLLEL 889
           KSDV++FGV+L E+
Sbjct: 197 KSDVWAFGVLLWEI 210

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 55/194 (28%), Positives = 90/194 (46%), Gaps = 13/194 (6%)
Query: 700 IGKGGAGIVYRGSMPD-GIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYV 758
           +G G  G VY G      + VA+K L  +        FL E   +  I+H N+V+LLG  
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTL--KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 759 SNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHR 818
           +      ++ E+M  G+L + L       +       +A + +  + YL        IHR
Sbjct: 79  TREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHR 135
Query: 819 DVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGS---YGYIAPEYAYTLKVDE 875
           D+ + N L+  +    VADFGL++ +      +  ++ AG+     + APE     K   
Sbjct: 136 DLAARNCLVGENHLVKVADFGLSRLM----TGDTYTAHAGAKFPIKWTAPESLAYNKFSI 191
Query: 876 KSDVYSFGVVLLEL 889
           KSDV++FGV+L E+
Sbjct: 192 KSDVWAFGVLLWEI 205

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 55/194 (28%), Positives = 90/194 (46%), Gaps = 13/194 (6%)
Query: 700 IGKGGAGIVYRGSMPD-GIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYV 758
           +G G  G VY G      + VA+K L  +        FL E   +  I+H N+V+LLG  
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTL--KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 759 SNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHR 818
           +      ++ E+M  G+L + L       +       +A + +  + YL        IHR
Sbjct: 79  TREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHR 135
Query: 819 DVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGS---YGYIAPEYAYTLKVDE 875
           D+ + N L+  +    VADFGL++ +      +  ++ AG+     + APE     K   
Sbjct: 136 DLAARNCLVGENHLVKVADFGLSRLM----TGDTYTAHAGAKFPIKWTAPESLAYNKFSI 191
Query: 876 KSDVYSFGVVLLEL 889
           KSDV++FGV+L E+
Sbjct: 192 KSDVWAFGVLLWEI 205

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 101/210 (48%), Gaps = 15/210 (7%)
Query: 690 VLESLKDENIIGKGGAGIVYRGSMPDGI---DVAIKRLVGRGTGGNDHGFLA--EIQTLG 744
           VL+  ++   IG G  GIV   +  D I   +VAIK+L  R      H   A  E+  + 
Sbjct: 22  VLKRYQNLKPIGSGAQGIV--CAAYDAILERNVAIKKL-SRPFQNQTHAKRAYRELVLMK 78
Query: 745 RIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRY-RIALEAAKG 803
            + H+NI+ LL   + + +   L E+     + E++       ++ E  + R++    + 
Sbjct: 79  CVNHKNIIGLLNVFTPQKS---LEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQM 135
Query: 804 LCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYI 863
           LC + H  S  IIHRD+K +NI++ SD    + DFGLA+    AG S  M     +  Y 
Sbjct: 136 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMEPEVVTRYYR 192
Query: 864 APEYAYTLKVDEKSDVYSFGVVLLELIAGK 893
           APE    +   E  D++S G ++ E++  K
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMVCHK 222

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 96/201 (47%), Gaps = 11/201 (5%)
Query: 700 IGKGGAGIVYRGSM--PD--GIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLL 755
           IG+G  G V++G    P+   + VAIK      +      FL E  T+ +  H +IV+L+
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 756 GYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLI 815
           G ++     +++ E    G L   L   K   L   +    A + +  L YL    S   
Sbjct: 83  GVITENPVWIIM-ELCTLGELRSFLQVRKYS-LDLASLILYAYQLSTALAYLE---SKRF 137
Query: 816 IHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDE 875
           +HRD+ + N+L+ S+    + DFGL+++++D+   +  S       ++APE     +   
Sbjct: 138 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA-SKGKLPIKWMAPESINFRRFTS 196
Query: 876 KSDVYSFGVVLLE-LIAGKKP 895
            SDV+ FGV + E L+ G KP
Sbjct: 197 ASDVWMFGVCMWEILMHGVKP 217

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 55/194 (28%), Positives = 90/194 (46%), Gaps = 13/194 (6%)
Query: 700 IGKGGAGIVYRGSMPD-GIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYV 758
           +G G  G VY G      + VA+K L  +        FL E   +  I+H N+V+LLG  
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTL--KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 83
Query: 759 SNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHR 818
           +      ++ E+M  G+L + L       +       +A + +  + YL        IHR
Sbjct: 84  TREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHR 140
Query: 819 DVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGS---YGYIAPEYAYTLKVDE 875
           D+ + N L+  +    VADFGL++ +      +  ++ AG+     + APE     K   
Sbjct: 141 DLAARNCLVGENHLVKVADFGLSRLM----TGDTYTAHAGAKFPIKWTAPESLAYNKFSI 196
Query: 876 KSDVYSFGVVLLEL 889
           KSDV++FGV+L E+
Sbjct: 197 KSDVWAFGVLLWEI 210

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 55/194 (28%), Positives = 90/194 (46%), Gaps = 13/194 (6%)
Query: 700 IGKGGAGIVYRGSMPD-GIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYV 758
           +G G  G VY G      + VA+K L  +        FL E   +  I+H N+V+LLG  
Sbjct: 34  LGGGQYGEVYEGVWKKYSLTVAVKTL--KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 91
Query: 759 SNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHR 818
           +      ++ E+M  G+L + L       +       +A + +  + YL        IHR
Sbjct: 92  TREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHR 148
Query: 819 DVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGS---YGYIAPEYAYTLKVDE 875
           D+ + N L+  +    VADFGL++ +      +  ++ AG+     + APE     K   
Sbjct: 149 DLAARNCLVGENHLVKVADFGLSRLM----TGDTYTAHAGAKFPIKWTAPESLAYNKFSI 204
Query: 876 KSDVYSFGVVLLEL 889
           KSDV++FGV+L E+
Sbjct: 205 KSDVWAFGVLLWEI 218

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 55/194 (28%), Positives = 90/194 (46%), Gaps = 13/194 (6%)
Query: 700 IGKGGAGIVYRGSMPD-GIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYV 758
           +G G  G VY G      + VA+K L  +        FL E   +  I+H N+V+LLG  
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTL--KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 83
Query: 759 SNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHR 818
           +      ++ E+M  G+L + L       +       +A + +  + YL        IHR
Sbjct: 84  TREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHR 140
Query: 819 DVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGS---YGYIAPEYAYTLKVDE 875
           D+ + N L+  +    VADFGL++ +      +  ++ AG+     + APE     K   
Sbjct: 141 DLAARNCLVGENHLVKVADFGLSRLM----TGDTYTAHAGAKFPIKWTAPESLAYNKFSI 196
Query: 876 KSDVYSFGVVLLEL 889
           KSDV++FGV+L E+
Sbjct: 197 KSDVWAFGVLLWEI 210

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 55/194 (28%), Positives = 90/194 (46%), Gaps = 13/194 (6%)
Query: 700 IGKGGAGIVYRGSMPD-GIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYV 758
           +G G  G VY G      + VA+K L  +        FL E   +  I+H N+V+LLG  
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTL--KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 759 SNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHR 818
           +      ++ E+M  G+L + L       +       +A + +  + YL        IHR
Sbjct: 79  TREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHR 135
Query: 819 DVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGS---YGYIAPEYAYTLKVDE 875
           D+ + N L+  +    VADFGL++ +      +  ++ AG+     + APE     K   
Sbjct: 136 DLAARNCLVGENHLVKVADFGLSRLM----TGDTYTAHAGAKFPIKWTAPESLAYNKFSI 191
Query: 876 KSDVYSFGVVLLEL 889
           KSDV++FGV+L E+
Sbjct: 192 KSDVWAFGVLLWEI 205

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 55/194 (28%), Positives = 90/194 (46%), Gaps = 13/194 (6%)
Query: 700 IGKGGAGIVYRGSMPD-GIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYV 758
           +G G  G VY G      + VA+K L  +        FL E   +  I+H N+V+LLG  
Sbjct: 25  LGGGQYGEVYEGVWKKYSLTVAVKTL--KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 82
Query: 759 SNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHR 818
           +      ++ E+M  G+L + L       +       +A + +  + YL        IHR
Sbjct: 83  TREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHR 139
Query: 819 DVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGS---YGYIAPEYAYTLKVDE 875
           D+ + N L+  +    VADFGL++ +      +  ++ AG+     + APE     K   
Sbjct: 140 DLAARNCLVGENHLVKVADFGLSRLM----TGDTYTAHAGAKFPIKWTAPESLAYNKFSI 195
Query: 876 KSDVYSFGVVLLEL 889
           KSDV++FGV+L E+
Sbjct: 196 KSDVWAFGVLLWEI 209

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 55/194 (28%), Positives = 90/194 (46%), Gaps = 13/194 (6%)
Query: 700 IGKGGAGIVYRGSMPD-GIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYV 758
           +G G  G VY G      + VA+K L  +        FL E   +  I+H N+V+LLG  
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTL--KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 759 SNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHR 818
           +      ++ E+M  G+L + L       +       +A + +  + YL        IHR
Sbjct: 79  TREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHR 135
Query: 819 DVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGS---YGYIAPEYAYTLKVDE 875
           D+ + N L+  +    VADFGL++ +      +  ++ AG+     + APE     K   
Sbjct: 136 DLAARNCLVGENHLVKVADFGLSRLM----TGDTYTAHAGAKFPIKWTAPESLAYNKFSI 191
Query: 876 KSDVYSFGVVLLEL 889
           KSDV++FGV+L E+
Sbjct: 192 KSDVWAFGVLLWEI 205

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 55/194 (28%), Positives = 90/194 (46%), Gaps = 13/194 (6%)
Query: 700 IGKGGAGIVYRGSMPD-GIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYV 758
           +G G  G VY G      + VA+K L  +        FL E   +  I+H N+V+LLG  
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTL--KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 80
Query: 759 SNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHR 818
           +      ++ E+M  G+L + L       +       +A + +  + YL        IHR
Sbjct: 81  TREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHR 137
Query: 819 DVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGS---YGYIAPEYAYTLKVDE 875
           D+ + N L+  +    VADFGL++ +      +  ++ AG+     + APE     K   
Sbjct: 138 DLAARNCLVGENHLVKVADFGLSRLM----TGDTYTAHAGAKFPIKWTAPESLAYNKFSI 193
Query: 876 KSDVYSFGVVLLEL 889
           KSDV++FGV+L E+
Sbjct: 194 KSDVWAFGVLLWEI 207

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 55/194 (28%), Positives = 90/194 (46%), Gaps = 13/194 (6%)
Query: 700 IGKGGAGIVYRGSMPD-GIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYV 758
           +G G  G VY G      + VA+K L  +        FL E   +  I+H N+V+LLG  
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTL--KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 80
Query: 759 SNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHR 818
           +      ++ E+M  G+L + L       +       +A + +  + YL        IHR
Sbjct: 81  TREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHR 137
Query: 819 DVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGS---YGYIAPEYAYTLKVDE 875
           D+ + N L+  +    VADFGL++ +      +  ++ AG+     + APE     K   
Sbjct: 138 DLAARNCLVGENHLVKVADFGLSRLM----TGDTYTAHAGAKFPIKWTAPESLAYNKFSI 193
Query: 876 KSDVYSFGVVLLEL 889
           KSDV++FGV+L E+
Sbjct: 194 KSDVWAFGVLLWEI 207

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 55/194 (28%), Positives = 90/194 (46%), Gaps = 13/194 (6%)
Query: 700 IGKGGAGIVYRGSMPD-GIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYV 758
           +G G  G VY G      + VA+K L  +        FL E   +  I+H N+V+LLG  
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTL--KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 759 SNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHR 818
           +      ++ E+M  G+L + L       +       +A + +  + YL        IHR
Sbjct: 79  TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHR 135
Query: 819 DVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGS---YGYIAPEYAYTLKVDE 875
           D+ + N L+  +    VADFGL++ +      +  ++ AG+     + APE     K   
Sbjct: 136 DLAARNCLVGENHLVKVADFGLSRLM----TGDTYTAHAGAKFPIKWTAPESLAYNKFSI 191
Query: 876 KSDVYSFGVVLLEL 889
           KSDV++FGV+L E+
Sbjct: 192 KSDVWAFGVLLWEI 205

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 55/194 (28%), Positives = 90/194 (46%), Gaps = 13/194 (6%)
Query: 700 IGKGGAGIVYRGSMPD-GIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYV 758
           +G G  G VY G      + VA+K L  +        FL E   +  I+H N+V+LLG  
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTL--KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 759 SNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHR 818
           +      ++ E+M  G+L + L       +       +A + +  + YL        IHR
Sbjct: 79  TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHR 135
Query: 819 DVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGS---YGYIAPEYAYTLKVDE 875
           D+ + N L+  +    VADFGL++ +      +  ++ AG+     + APE     K   
Sbjct: 136 DLAARNCLVGENHLVKVADFGLSRLM----TGDTYTAHAGAKFPIKWTAPESLAYNKFSI 191
Query: 876 KSDVYSFGVVLLEL 889
           KSDV++FGV+L E+
Sbjct: 192 KSDVWAFGVLLWEI 205

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 55/194 (28%), Positives = 90/194 (46%), Gaps = 13/194 (6%)
Query: 700 IGKGGAGIVYRGSMPD-GIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYV 758
           +G G  G VY G      + VA+K L  +        FL E   +  I+H N+V+LLG  
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTL--KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 83
Query: 759 SNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHR 818
           +      ++ E+M  G+L + L       +       +A + +  + YL        IHR
Sbjct: 84  TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHR 140
Query: 819 DVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGS---YGYIAPEYAYTLKVDE 875
           D+ + N L+  +    VADFGL++ +      +  ++ AG+     + APE     K   
Sbjct: 141 DLAARNCLVGENHLVKVADFGLSRLM----TGDTYTAHAGAKFPIKWTAPESLAYNKFSI 196
Query: 876 KSDVYSFGVVLLEL 889
           KSDV++FGV+L E+
Sbjct: 197 KSDVWAFGVLLWEI 210

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 96/201 (47%), Gaps = 11/201 (5%)
Query: 700 IGKGGAGIVYRGSM--PD--GIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLL 755
           IG+G  G V++G    P+   + VAIK      +      FL E  T+ +  H +IV+L+
Sbjct: 20  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 79
Query: 756 GYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLI 815
           G ++     +++ E    G L   L   K   L   +    A + +  L YL    S   
Sbjct: 80  GVITENPVWIIM-ELCTLGELRSFLQVRKYS-LDLASLILYAYQLSTALAYLE---SKRF 134
Query: 816 IHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDE 875
           +HRD+ + N+L+ S+    + DFGL+++++D+   +  S       ++APE     +   
Sbjct: 135 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA-SKGKLPIKWMAPESINFRRFTS 193
Query: 876 KSDVYSFGVVLLE-LIAGKKP 895
            SDV+ FGV + E L+ G KP
Sbjct: 194 ASDVWMFGVCMWEILMHGVKP 214

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 96/201 (47%), Gaps = 11/201 (5%)
Query: 700 IGKGGAGIVYRGSM--PD--GIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLL 755
           IG+G  G V++G    P+   + VAIK      +      FL E  T+ +  H +IV+L+
Sbjct: 21  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 80
Query: 756 GYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLI 815
           G ++     +++ E    G L   L   K   L   +    A + +  L YL    S   
Sbjct: 81  GVITENPVWIIM-ELCTLGELRSFLQVRKYS-LDLASLILYAYQLSTALAYLE---SKRF 135
Query: 816 IHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDE 875
           +HRD+ + N+L+ S+    + DFGL+++++D+   +  S       ++APE     +   
Sbjct: 136 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA-SKGKLPIKWMAPESINFRRFTS 194
Query: 876 KSDVYSFGVVLLE-LIAGKKP 895
            SDV+ FGV + E L+ G KP
Sbjct: 195 ASDVWMFGVCMWEILMHGVKP 215

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 55/194 (28%), Positives = 90/194 (46%), Gaps = 13/194 (6%)
Query: 700 IGKGGAGIVYRGSMPD-GIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYV 758
           +G G  G VY G      + VA+K L  +        FL E   +  I+H N+V+LLG  
Sbjct: 19  LGGGQFGEVYEGVWKKYSLTVAVKTL--KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 76
Query: 759 SNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHR 818
           +      ++ E+M  G+L + L       +       +A + +  + YL        IHR
Sbjct: 77  TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHR 133
Query: 819 DVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGS---YGYIAPEYAYTLKVDE 875
           D+ + N L+  +    VADFGL++ +      +  ++ AG+     + APE     K   
Sbjct: 134 DLAARNCLVGENHLVKVADFGLSRLM----TGDTXTAHAGAKFPIKWTAPESLAYNKFSI 189
Query: 876 KSDVYSFGVVLLEL 889
           KSDV++FGV+L E+
Sbjct: 190 KSDVWAFGVLLWEI 203

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/274 (23%), Positives = 117/274 (42%), Gaps = 38/274 (13%)
Query: 717 IDVAIKRLVGRGTGGNDHGFLAEIQTLGRI-RHRNIVRLLGYVSNRDTNLLLYEYMPNGS 775
           + VA+K L            ++E++ +  + +H NIV LLG  ++    L++ EY   G 
Sbjct: 77  LKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGD 136
Query: 776 LGEMLHGAKGGHLKWETRYRIA-------------LEAAKGLCYLHHDCSPLIIHRDVKS 822
           L   L   K   L+ +  + IA              + A+G+ +L    S   IHRDV +
Sbjct: 137 LLNFLR-RKSRVLETDPAFAIANSTLSTRDLLHFSSQVAQGMAFL---ASKNCIHRDVAA 192
Query: 823 NNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSF 882
            N+LL +   A + DFGLA+ + +        +      ++APE  +      +SDV+S+
Sbjct: 193 RNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSY 252
Query: 883 GVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDPRLSGYPLTGV 941
           G++L E+ + G  P           + V K   +++QP+ A        P+         
Sbjct: 253 GILLWEIFSLGLNPYPGILVNSKFYKLV-KDGYQMAQPAFA--------PK--------- 294
Query: 942 IHLFKVAMMCVEDESSARPTMREVVHMLANPPQS 975
            +++ +   C   E + RPT +++   L    Q 
Sbjct: 295 -NIYSIMQACWALEPTHRPTFQQICSFLQEQAQE 327

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 95/197 (48%), Gaps = 10/197 (5%)
Query: 700 IGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYV 758
           IG+G  GIV   ++   G  VA+K++  R     +  F  E+  +   +H N+V +    
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLF-NEVVIMRDYQHENVVEMYNSY 97
Query: 759 SNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHR 818
              D   ++ E++  G+L +++   +   +  E    + L   + L  LH      +IHR
Sbjct: 98  LVGDELWVVMEFLEGGALTDIVTHTR---MNEEQIAAVCLAVLQALSVLHAQG---VIHR 151
Query: 819 DVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSD 878
           D+KS++ILL  D    ++DFG     Q +        + G+  ++APE    L    + D
Sbjct: 152 DIKSDSILLTHDGRVKLSDFGFCA--QVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVD 209
Query: 879 VYSFGVVLLELIAGKKP 895
           ++S G++++E++ G+ P
Sbjct: 210 IWSLGIMVIEMVDGEPP 226

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 102/220 (46%), Gaps = 24/220 (10%)
Query: 692 ESLKDENIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGND--------HGFLAEIQT 742
           E+ + + I+G+G + +V R    P   + A+K +   G G              L E+  
Sbjct: 17  ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 743 LGRIR-HRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAA 801
           L ++  H NI++L           L+++ M  G L + L   K    + ETR +I     
Sbjct: 77  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL-TEKVTLSEKETR-KIMRALL 134
Query: 802 KGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYG 861
           + +C LH      I+HRD+K  NILLD D    + DFG +  L D G  E + SV G+  
Sbjct: 135 EVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL-DPG--EKLRSVCGTPS 188
Query: 862 YIAPEYAYTLKVD------EKSDVYSFGVVLLELIAGKKP 895
           Y+APE       D      ++ D++S GV++  L+AG  P
Sbjct: 189 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 95/197 (48%), Gaps = 10/197 (5%)
Query: 700 IGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYV 758
           IG+G  GIV   ++   G  VA+K++  R     +  F  E+  +   +H N+V +    
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLF-NEVVIMRDYQHENVVEMYNSY 95
Query: 759 SNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHR 818
              D   ++ E++  G+L +++   +   +  E    + L   + L  LH      +IHR
Sbjct: 96  LVGDELWVVMEFLEGGALTDIVTHTR---MNEEQIAAVCLAVLQALSVLHAQG---VIHR 149
Query: 819 DVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSD 878
           D+KS++ILL  D    ++DFG     Q +        + G+  ++APE    L    + D
Sbjct: 150 DIKSDSILLTHDGRVKLSDFGFCA--QVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVD 207
Query: 879 VYSFGVVLLELIAGKKP 895
           ++S G++++E++ G+ P
Sbjct: 208 IWSLGIMVIEMVDGEPP 224

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 106/227 (46%), Gaps = 13/227 (5%)
Query: 700 IGKGGAGIVYRGSMPDGID-VAIKRL-VGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGY 757
           IG+G  G V++    +  + VA+KR+ +     G     L EI  L  ++H+NIVRL   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 758 VSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIH 817
           + +     L++E+  +  L +       G L  E       +  KGL + H   S  ++H
Sbjct: 70  LHSDKKLTLVFEFC-DQDLKKYFDSC-NGDLDPEIVKSFLFQLLKGLGFCH---SRNVLH 124
Query: 818 RDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKS 877
           RD+K  N+L++ + E  +A+FGLA+         C S+   +  Y  P+  +  K+   S
Sbjct: 125 RDLKPQNLLINRNGELKLANFGLARAF--GIPVRCYSAEVVTLWYRPPDVLFGAKLYSTS 182
Query: 878 -DVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRK---TTSEVSQPS 920
            D++S G +  EL    +P+    D  D ++ + +   T +E   PS
Sbjct: 183 IDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPS 229

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 86/204 (42%), Gaps = 17/204 (8%)
Query: 700 IGKGGAGIVYRGSMPDGID------VAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVR 753
           +G+G  G+VY G     +       VAIK +    +      FL E   +      ++VR
Sbjct: 18  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 77
Query: 754 LLGYVSNRDTNLLLYEYMPNGSLG--------EMLHGAKGGHLKWETRYRIALEAAKGLC 805
           LLG VS     L++ E M  G L         EM +             ++A E A G+ 
Sbjct: 78  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 137
Query: 806 YLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAP 865
           YL+ +     +HRD+ + N ++  DF   + DFG+ + + +               +++P
Sbjct: 138 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMSP 194
Query: 866 EYAYTLKVDEKSDVYSFGVVLLEL 889
           E          SDV+SFGVVL E+
Sbjct: 195 ESLKDGVFTTYSDVWSFGVVLWEI 218

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 95/197 (48%), Gaps = 10/197 (5%)
Query: 700 IGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYV 758
           IG+G  GIV   ++   G  VA+K++  R     +  F  E+  +   +H N+V +    
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLF-NEVVIMRDYQHENVVEMYNSY 90
Query: 759 SNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHR 818
              D   ++ E++  G+L +++   +   +  E    + L   + L  LH      +IHR
Sbjct: 91  LVGDELWVVMEFLEGGALTDIVTHTR---MNEEQIAAVCLAVLQALSVLHAQG---VIHR 144
Query: 819 DVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSD 878
           D+KS++ILL  D    ++DFG     Q +        + G+  ++APE    L    + D
Sbjct: 145 DIKSDSILLTHDGRVKLSDFGFCA--QVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVD 202
Query: 879 VYSFGVVLLELIAGKKP 895
           ++S G++++E++ G+ P
Sbjct: 203 IWSLGIMVIEMVDGEPP 219

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 95/197 (48%), Gaps = 10/197 (5%)
Query: 700 IGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYV 758
           IG+G  GIV   ++   G  VA+K++  R     +  F  E+  +   +H N+V +    
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLF-NEVVIMRDYQHENVVEMYNSY 86
Query: 759 SNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHR 818
              D   ++ E++  G+L +++   +   +  E    + L   + L  LH      +IHR
Sbjct: 87  LVGDELWVVMEFLEGGALTDIVTHTR---MNEEQIAAVCLAVLQALSVLHAQG---VIHR 140
Query: 819 DVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSD 878
           D+KS++ILL  D    ++DFG     Q +        + G+  ++APE    L    + D
Sbjct: 141 DIKSDSILLTHDGRVKLSDFGFCA--QVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVD 198
Query: 879 VYSFGVVLLELIAGKKP 895
           ++S G++++E++ G+ P
Sbjct: 199 IWSLGIMVIEMVDGEPP 215

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/274 (23%), Positives = 117/274 (42%), Gaps = 38/274 (13%)
Query: 717 IDVAIKRLVGRGTGGNDHGFLAEIQTLGRI-RHRNIVRLLGYVSNRDTNLLLYEYMPNGS 775
           + VA+K L            ++E++ +  + +H NIV LLG  ++    L++ EY   G 
Sbjct: 77  LKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGD 136
Query: 776 LGEMLHGAKGGHLKWETRYRIA-------------LEAAKGLCYLHHDCSPLIIHRDVKS 822
           L   L   K   L+ +  + IA              + A+G+ +L    S   IHRDV +
Sbjct: 137 LLNFLR-RKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFL---ASKNCIHRDVAA 192
Query: 823 NNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSF 882
            N+LL +   A + DFGLA+ + +        +      ++APE  +      +SDV+S+
Sbjct: 193 RNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSY 252
Query: 883 GVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDPRLSGYPLTGV 941
           G++L E+ + G  P           + V K   +++QP+ A        P+         
Sbjct: 253 GILLWEIFSLGLNPYPGILVNSKFYKLV-KDGYQMAQPAFA--------PK--------- 294
Query: 942 IHLFKVAMMCVEDESSARPTMREVVHMLANPPQS 975
            +++ +   C   E + RPT +++   L    Q 
Sbjct: 295 -NIYSIMQACWALEPTHRPTFQQICSFLQEQAQE 327

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 96/201 (47%), Gaps = 11/201 (5%)
Query: 700 IGKGGAGIVYRGSM--PD--GIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLL 755
           IG+G  G V++G    P+   + VAIK      +      FL E  T+ +  H +IV+L+
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 756 GYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLI 815
           G ++     +++ E    G L   L   K   L   +    A + +  L YL    S   
Sbjct: 458 GVITENPVWIIM-ELCTLGELRSFLQVRKFS-LDLASLILYAYQLSTALAYLE---SKRF 512
Query: 816 IHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDE 875
           +HRD+ + N+L+ S+    + DFGL+++++D+   +  S       ++APE     +   
Sbjct: 513 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA-SKGKLPIKWMAPESINFRRFTS 571
Query: 876 KSDVYSFGVVLLE-LIAGKKP 895
            SDV+ FGV + E L+ G KP
Sbjct: 572 ASDVWMFGVCMWEILMHGVKP 592

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 75/166 (45%), Gaps = 19/166 (11%)
Query: 737 LAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRI 796
             E+Q +  + H  +V L     + +   ++ + +  G L    H  +  H K ET    
Sbjct: 63  FKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLR--YHLQQNVHFKEETVKLF 120
Query: 797 ALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSV 856
             E    L YL    +  IIHRD+K +NILLD     H+ DF +A  L        ++++
Sbjct: 121 ICELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ---ITTM 174
Query: 857 AGSYGYIAPEY-------AYTLKVDEKSDVYSFGVVLLELIAGKKP 895
           AG+  Y+APE         Y+  V    D +S GV   EL+ G++P
Sbjct: 175 AGTKPYMAPEMFSSRKGAGYSFAV----DWWSLGVTAYELLRGRRP 216

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 102/214 (47%), Gaps = 23/214 (10%)
Query: 690 VLESLKDENIIGKGGAGIVYRGSMPDGI---DVAIKRLVGRGTGGNDHGFLA--EIQTLG 744
           VL+  ++   IG G  GIV   +  D +   +VAIK+L  R      H   A  E+  + 
Sbjct: 22  VLKRYQNLKPIGSGAQGIV--CAAYDAVLDRNVAIKKL-SRPFQNQTHAKRAYRELVLMK 78
Query: 745 RIRHRNIVRLLGYVSNRDT-----NLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALE 799
            + H+NI+ LL   + + T     ++ L   + + +L +++       L  E    +  +
Sbjct: 79  XVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQM----ELDHERMSYLLYQ 134
Query: 800 AAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGS 859
              G+ +LH   S  IIHRD+K +NI++ SD    + DFGLA+    AG S  M+    +
Sbjct: 135 MLXGIKHLH---SAGIIHRDLKPSNIVVKSDXTLKILDFGLAR---TAGTSFMMTPYVVT 188
Query: 860 YGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGK 893
             Y APE    +   E  D++S G ++ E++  K
Sbjct: 189 RYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 64/239 (26%), Positives = 109/239 (45%), Gaps = 24/239 (10%)
Query: 670 QKSKAWKLTAFQRLDFKAEDVLESLKDENIIGKGG-AGIVYRGSMPDGIDVAIKRLVGRG 728
           + S +WK         +AED+ +  + +  +G G  + +V       G   A+K +  + 
Sbjct: 8   ESSSSWKK--------QAEDIKKIFEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKA 59
Query: 729 TGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHL 788
             G +     EI  L +I+H NIV L     + +   L+ + +  G L + +   KG + 
Sbjct: 60  LKGKESSIENEIAVLRKIKHENIVALEDIYESPNHLYLVMQLVSGGELFDRI-VEKGFYT 118
Query: 789 KWE--TRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILL---DSDFEAHVADFGLAKF 843
           + +  T  R  L+A   + YLH      I+HRD+K  N+L    D + +  ++DFGL+K 
Sbjct: 119 EKDASTLIRQVLDA---VYYLHR---MGIVHRDLKPENLLYYSQDEESKIMISDFGLSKM 172
Query: 844 LQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDG 902
               G  + MS+  G+ GY+APE        +  D +S GV+   L+ G  P  +  D 
Sbjct: 173 ---EGKGDVMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDS 228

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 89/204 (43%), Gaps = 16/204 (7%)
Query: 737 LAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLG-EMLHGAKGGHLKWETRYR 795
           L E Q L ++  R +V L      +D   L+   M  G L   + H  + G  +    + 
Sbjct: 232 LNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVF- 290
Query: 796 IALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSS 855
            A E   GL  LH +    I++RD+K  NILLD      ++D GLA  + +    + +  
Sbjct: 291 YAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG---QTIKG 344
Query: 856 VAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGV---DIVRWVRKT 912
             G+ GY+APE     +     D ++ G +L E+IAG+ P  +    +   ++ R V++ 
Sbjct: 345 RVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV 404
Query: 913 TSEVS-----QPSDAASVLAVVDP 931
             E S     Q     S L   DP
Sbjct: 405 PEEYSERFSPQARSLCSQLLCKDP 428

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/275 (22%), Positives = 113/275 (41%), Gaps = 38/275 (13%)
Query: 717 IDVAIKRLVGRGTGGNDHGFLAEIQTLGRI-RHRNIVRLLGYVSNRDTNLLLYEYMPNGS 775
           + VA+K L            ++E++ +  + +H NIV LLG  ++    L++ EY   G 
Sbjct: 77  LKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGD 136
Query: 776 LGEMLHGAKGGHLKWETR--------------YRIALEAAKGLCYLHHDCSPLIIHRDVK 821
           L   L   +   L++                    + + A+G+ +L    S   IHRDV 
Sbjct: 137 LLNFLRRKRPPGLEYSYNPSHNPEEQLSSRDLLHFSSQVAQGMAFL---ASKNCIHRDVA 193
Query: 822 SNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYS 881
           + N+LL +   A + DFGLA+ + +        +      ++APE  +      +SDV+S
Sbjct: 194 ARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWS 253
Query: 882 FGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDPRLSGYPLTG 940
           +G++L E+ + G  P           + V K   +++QP+ A                  
Sbjct: 254 YGILLWEIFSLGLNPYPGILVNSKFYKLV-KDGYQMAQPAFAPK---------------- 296
Query: 941 VIHLFKVAMMCVEDESSARPTMREVVHMLANPPQS 975
             +++ +   C   E + RPT +++   L    Q 
Sbjct: 297 --NIYSIMQACWALEPTHRPTFQQICSFLQEQAQE 329

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-10,   Method: Composition-based stats.
 Identities = 49/192 (25%), Positives = 92/192 (47%), Gaps = 22/192 (11%)
Query: 715 DGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRI-RHRNIVRLLGYVSNRDTNLLLYEYMPN 773
           + + VA+K L    T  +    ++E++ +  I +H+NI+ LLG  +      ++ EY   
Sbjct: 66  EAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASK 125
Query: 774 GSLGEMLHGAKGGHLKWETRYRI----------------ALEAAKGLCYLHHDCSPLIIH 817
           G+L E L   +   +++   Y I                  + A+G+ YL    S   IH
Sbjct: 126 GNLREYLRARRPPGMEYS--YDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIH 180
Query: 818 RDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKS 877
           RD+ + N+L+  +    +ADFGLA+ + +    +  ++      ++APE  +      +S
Sbjct: 181 RDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQS 240
Query: 878 DVYSFGVVLLEL 889
           DV+SFGV++ E+
Sbjct: 241 DVWSFGVLMWEI 252

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 95/197 (48%), Gaps = 10/197 (5%)
Query: 700 IGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYV 758
           IG+G  GIV   ++   G  VA+K++  R     +  F  E+  +   +H N+V +    
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLF-NEVVIMRDYQHENVVEMYNSY 140
Query: 759 SNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHR 818
              D   ++ E++  G+L +++   +   +  E    + L   + L  LH      +IHR
Sbjct: 141 LVGDELWVVMEFLEGGALTDIVTHTR---MNEEQIAAVCLAVLQALSVLHAQG---VIHR 194
Query: 819 DVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSD 878
           D+KS++ILL  D    ++DFG     Q +        + G+  ++APE    L    + D
Sbjct: 195 DIKSDSILLTHDGRVKLSDFGFCA--QVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVD 252
Query: 879 VYSFGVVLLELIAGKKP 895
           ++S G++++E++ G+ P
Sbjct: 253 IWSLGIMVIEMVDGEPP 269

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 101/210 (48%), Gaps = 15/210 (7%)
Query: 690 VLESLKDENIIGKGGAGIVYRGSMPDGI---DVAIKRLVGRGTGGNDHGFLA--EIQTLG 744
           VL+  ++   IG G  GIV   +  D I   +VAIK+L  R      H   A  E+  + 
Sbjct: 22  VLKRYQNLKPIGSGAQGIV--CAAYDAILERNVAIKKL-SRPFQNQTHAKRAYRELVLMK 78
Query: 745 RIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRY-RIALEAAKG 803
            + H+NI+ LL   + + +   L E+     + E++       ++ E  + R++    + 
Sbjct: 79  CVNHKNIIGLLNVFTPQKS---LEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQM 135
Query: 804 LCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYI 863
           LC + H  S  IIHRD+K +NI++ SD    + DFGLA+    AG S  M     +  Y 
Sbjct: 136 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMEPEVVTRYYR 192
Query: 864 APEYAYTLKVDEKSDVYSFGVVLLELIAGK 893
           APE    +   E  D++S G ++ E++  K
Sbjct: 193 APEVILGMGYKENVDLWSVGCIMGEMVCHK 222

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 103/224 (45%), Gaps = 24/224 (10%)
Query: 700 IGKGGAGIVYRGS--MPDGIDVAIKRL-VGRGTGGNDHGFLAEIQTLGRIR---HRNIVR 753
           IG+G  G V++       G  VA+KR+ V  G  G     + E+  L  +    H N+VR
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 754 LLGYVS----NRDTNL-LLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLH 808
           L    +    +R+T L L++E++ +  L   L       +  ET   +  +  +GL +LH
Sbjct: 79  LFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 137
Query: 809 HDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYA 868
              S  ++HRD+K  NIL+ S  +  +ADFGLA+      A   ++SV  +  Y APE  
Sbjct: 138 ---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA---LTSVVVTLWYRAPEVL 191
Query: 869 YTLKVDEKSDVYSFGVVLLE------LIAGKKPVGEFGDGVDIV 906
                    D++S G +  E      L  G   V + G  +D++
Sbjct: 192 LQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVI 235

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Composition-based stats.
 Identities = 49/192 (25%), Positives = 92/192 (47%), Gaps = 22/192 (11%)
Query: 715 DGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRI-RHRNIVRLLGYVSNRDTNLLLYEYMPN 773
           + + VA+K L    T  +    ++E++ +  I +H+NI+ LLG  +      ++ EY   
Sbjct: 66  EAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIIHLLGACTQDGPLYVIVEYASK 125
Query: 774 GSLGEMLHGAKGGHLKWETRYRI----------------ALEAAKGLCYLHHDCSPLIIH 817
           G+L E L   +   +++   Y I                  + A+G+ YL    S   IH
Sbjct: 126 GNLREYLRARRPPGMEYS--YDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIH 180
Query: 818 RDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKS 877
           RD+ + N+L+  +    +ADFGLA+ + +    +  ++      ++APE  +      +S
Sbjct: 181 RDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQS 240
Query: 878 DVYSFGVVLLEL 889
           DV+SFGV++ E+
Sbjct: 241 DVWSFGVLMWEI 252

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 93/202 (46%), Gaps = 13/202 (6%)
Query: 699 IIGKGGAG-IVYRGSMPDGIDVAIKRLVGRG--TGGNDHGFLAEIQTLGR-IRHRNIVRL 754
           +IGKG  G ++      + +  A+K L  +       +   ++E   L + ++H  +V L
Sbjct: 45  VIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 104
Query: 755 LGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRI-ALEAAKGLCYLHHDCSP 813
                  D    + +Y+ NG  GE+ +  +      E R R  A E A  L YLH   S 
Sbjct: 105 HFSFQTADKLYFVLDYI-NG--GELFYHLQRERCFLEPRARFYAAEIASALGYLH---SL 158
Query: 814 LIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKV 873
            I++RD+K  NILLDS     + DFGL K  ++   +   S+  G+  Y+APE  +    
Sbjct: 159 NIVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNSTTSTFCGTPEYLAPEVLHKQPY 216
Query: 874 DEKSDVYSFGVVLLELIAGKKP 895
           D   D +  G VL E++ G  P
Sbjct: 217 DRTVDWWCLGAVLYEMLYGLPP 238

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 95/197 (48%), Gaps = 10/197 (5%)
Query: 700 IGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYV 758
           IG+G  GIV   ++   G  VA+K++  R     +  F  E+  +   +H N+V +    
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLF-NEVVIMRDYQHENVVEMYNSY 217
Query: 759 SNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHR 818
              D   ++ E++  G+L +++   +   +  E    + L   + L  LH      +IHR
Sbjct: 218 LVGDELWVVMEFLEGGALTDIVTHTR---MNEEQIAAVCLAVLQALSVLHAQG---VIHR 271
Query: 819 DVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSD 878
           D+KS++ILL  D    ++DFG     Q +        + G+  ++APE    L    + D
Sbjct: 272 DIKSDSILLTHDGRVKLSDFGFCA--QVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVD 329
Query: 879 VYSFGVVLLELIAGKKP 895
           ++S G++++E++ G+ P
Sbjct: 330 IWSLGIMVIEMVDGEPP 346

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 89/204 (43%), Gaps = 16/204 (7%)
Query: 737 LAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLG-EMLHGAKGGHLKWETRYR 795
           L E Q L ++  R +V L      +D   L+   M  G L   + H  + G  +    + 
Sbjct: 232 LNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVF- 290
Query: 796 IALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSS 855
            A E   GL  LH +    I++RD+K  NILLD      ++D GLA  + +    + +  
Sbjct: 291 YAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG---QTIKG 344
Query: 856 VAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGV---DIVRWVRKT 912
             G+ GY+APE     +     D ++ G +L E+IAG+ P  +    +   ++ R V++ 
Sbjct: 345 RVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV 404
Query: 913 TSEVS-----QPSDAASVLAVVDP 931
             E S     Q     S L   DP
Sbjct: 405 PEEYSERFSPQARSLCSQLLCKDP 428

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Composition-based stats.
 Identities = 49/192 (25%), Positives = 92/192 (47%), Gaps = 22/192 (11%)
Query: 715 DGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRI-RHRNIVRLLGYVSNRDTNLLLYEYMPN 773
           + + VA+K L    T  +    ++E++ +  I +H+NI+ LLG  +      ++ EY   
Sbjct: 58  EAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASK 117
Query: 774 GSLGEMLHGAKGGHLKWETRYRI----------------ALEAAKGLCYLHHDCSPLIIH 817
           G+L E L   +   +++   Y I                  + A+G+ YL    S   IH
Sbjct: 118 GNLREYLRARRPPGMEYS--YDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIH 172
Query: 818 RDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKS 877
           RD+ + N+L+  +    +ADFGLA+ + +    +  ++      ++APE  +      +S
Sbjct: 173 RDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQS 232
Query: 878 DVYSFGVVLLEL 889
           DV+SFGV++ E+
Sbjct: 233 DVWSFGVLMWEI 244

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Composition-based stats.
 Identities = 63/207 (30%), Positives = 97/207 (46%), Gaps = 18/207 (8%)
Query: 700 IGKGGAGIVYRGSMP-DGIDVAIKRL-VGRGTGGNDHGFLAEIQTLGRIR---HRNIVRL 754
           IG G  G VY+   P  G  VA+K + V  G  G     + E+  L R+    H N+VRL
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRL 71
Query: 755 LGYVSNRDTN-----LLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHH 809
           +   +   T+      L++E++ +  L   L  A    L  ET   +  +  +GL +LH 
Sbjct: 72  MDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHA 130
Query: 810 DCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAY 869
           +C   I+HRD+K  NIL+ S     +ADFGLA+      A   ++ V  +  Y APE   
Sbjct: 131 NC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA---LAPVVVTLWYRAPEVLL 184
Query: 870 TLKVDEKSDVYSFGVVLLELIAGKKPV 896
                   D++S G +  E+   +KP+
Sbjct: 185 QSTYATPVDMWSVGCIFAEMFR-RKPL 210

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 86/204 (42%), Gaps = 17/204 (8%)
Query: 700 IGKGGAGIVYRGSMPDGID------VAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVR 753
           +G+G  G+VY G     +       VAIK +    +      FL E   +      ++VR
Sbjct: 27  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 86
Query: 754 LLGYVSNRDTNLLLYEYMPNGSLG--------EMLHGAKGGHLKWETRYRIALEAAKGLC 805
           LLG VS     L++ E M  G L         EM +             ++A E A G+ 
Sbjct: 87  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 146
Query: 806 YLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAP 865
           YL+ +     +HRD+ + N ++  DF   + DFG+ + + +               +++P
Sbjct: 147 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMSP 203
Query: 866 EYAYTLKVDEKSDVYSFGVVLLEL 889
           E          SDV+SFGVVL E+
Sbjct: 204 ESLKDGVFTTYSDVWSFGVVLWEI 227

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 73/295 (24%), Positives = 118/295 (40%), Gaps = 46/295 (15%)
Query: 700 IGKGGAGIVYRGSMPDGID-------VAIKRLVGRGTGGNDHGFLAEIQTLGRI-RHRNI 751
           +G+G  G V       GID       VA+K L    T       ++E++ L  I  H N+
Sbjct: 36  LGRGAFGQVIEADA-FGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 94
Query: 752 VRLLGYVSNRDTNLL-LYEYMPNGSLGEMLHGAKGGHLKWETRYRI-------------A 797
           V LLG  +     L+ + E+   G+L   L   +   + ++T   +             +
Sbjct: 95  VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLICYS 154
Query: 798 LEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVA 857
            + AKG+ +L    S   IHRD+ + NILL       + DFGLA+ +             
Sbjct: 155 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 211
Query: 858 GSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEV 916
               ++APE  +      +SDV+SFGV+L E+ + G  P        +  R +++ T   
Sbjct: 212 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT--- 268
Query: 917 SQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLAN 971
                          R+   P      +++  + C   E S RPT  E+V  L N
Sbjct: 269 ---------------RMRA-PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 307

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Composition-based stats.
 Identities = 47/162 (29%), Positives = 83/162 (51%), Gaps = 8/162 (4%)
Query: 736 FLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYR 795
            LAE   + ++ +  IVR++G +   ++ +L+ E    G L + L   +  H+K +    
Sbjct: 59  LLAEANVMQQLDNPYIVRMIG-ICEAESWMLVMEMAELGPLNKYLQQNR--HVKDKNIIE 115
Query: 796 IALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQ-DAGASECMS 854
           +  + + G+ YL        +HRD+ + N+LL +   A ++DFGL+K L+ D    +  +
Sbjct: 116 LVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQT 172
Query: 855 SVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKP 895
                  + APE     K   KSDV+SFGV++ E  + G+KP
Sbjct: 173 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 214

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 83/162 (51%), Gaps = 8/162 (4%)
Query: 736 FLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYR 795
            LAE   + ++ +  IVR++G +   ++ +L+ E    G L + L   +  H+K +    
Sbjct: 417 LLAEANVMQQLDNPYIVRMIG-ICEAESWMLVMEMAELGPLNKYLQQNR--HVKDKNIIE 473
Query: 796 IALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQ-DAGASECMS 854
           +  + + G+ YL        +HRD+ + N+LL +   A ++DFGL+K L+ D    +  +
Sbjct: 474 LVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT 530
Query: 855 SVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKP 895
                  + APE     K   KSDV+SFGV++ E  + G+KP
Sbjct: 531 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 572

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Composition-based stats.
 Identities = 49/192 (25%), Positives = 92/192 (47%), Gaps = 22/192 (11%)
Query: 715 DGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRI-RHRNIVRLLGYVSNRDTNLLLYEYMPN 773
           + + VA+K L    T  +    ++E++ +  I +H+NI+ LLG  +      ++ EY   
Sbjct: 66  EAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASK 125
Query: 774 GSLGEMLHGAKGGHLKWETRYRI----------------ALEAAKGLCYLHHDCSPLIIH 817
           G+L E L   +   +++   Y I                  + A+G+ YL    S   IH
Sbjct: 126 GNLREYLRARRPPGMEYS--YDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIH 180
Query: 818 RDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKS 877
           RD+ + N+L+  +    +ADFGLA+ + +    +  ++      ++APE  +      +S
Sbjct: 181 RDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQS 240
Query: 878 DVYSFGVVLLEL 889
           DV+SFGV++ E+
Sbjct: 241 DVWSFGVLMWEI 252

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Composition-based stats.
 Identities = 49/192 (25%), Positives = 92/192 (47%), Gaps = 22/192 (11%)
Query: 715 DGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRI-RHRNIVRLLGYVSNRDTNLLLYEYMPN 773
           + + VA+K L    T  +    ++E++ +  I +H+NI+ LLG  +      ++ EY   
Sbjct: 66  EAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIITLLGACTQDGPLYVIVEYASK 125
Query: 774 GSLGEMLHGAKGGHLKWETRYRI----------------ALEAAKGLCYLHHDCSPLIIH 817
           G+L E L   +   +++   Y I                  + A+G+ YL    S   IH
Sbjct: 126 GNLREYLRARRPPGMEYS--YDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIH 180
Query: 818 RDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKS 877
           RD+ + N+L+  +    +ADFGLA+ + +    +  ++      ++APE  +      +S
Sbjct: 181 RDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQS 240
Query: 878 DVYSFGVVLLEL 889
           DV+SFGV++ E+
Sbjct: 241 DVWSFGVLMWEI 252

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 76/299 (25%), Positives = 125/299 (41%), Gaps = 43/299 (14%)
Query: 691 LESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRL-VGRGTGGNDHGFLAEIQTLGRIRHR 749
            E L+   +IGKG  G VY G      +VAI+ + + R        F  E+    + RH 
Sbjct: 32  FEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHE 89
Query: 750 NIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHH 809
           N+V  +G   +     ++       +L  ++  AK      +TR +IA E  KG+ YLH 
Sbjct: 90  NVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTR-QIAQEIVKGMGYLH- 147
Query: 810 DCSPLIIHRDVKSNNILLDSDFEAHVADFGL---AKFLQDAGASECMSSVAGSYGYIAPE 866
             +  I+H+D+KS N+  D+  +  + DFGL   +  LQ     + +    G   ++APE
Sbjct: 148 --AKGILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPE 204
Query: 867 YAYTLKVD---------EKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVS 917
               L  D         + SDV++ G +  EL A + P                     +
Sbjct: 205 IIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFK-------------------T 245
Query: 918 QPSDA--ASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQ 974
           QP++A    +   + P LS   +   I    + + C   E   RPT  +++ ML   P+
Sbjct: 246 QPAEAIIWQMGTGMKPNLSQIGMGKEIS--DILLFCWAFEQEERPTFTKLMDMLEKLPK 302

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 95/201 (47%), Gaps = 11/201 (5%)
Query: 700 IGKGGAGIVYRGSM--PD--GIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLL 755
           IG+G  G V++G    P+   + VAIK      +      FL E  T+ +  H +IV+L+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 756 GYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLI 815
           G ++     +++ E    G L   L   K   L   +    A + +  L YL    S   
Sbjct: 78  GVITENPVWIIM-ELCTLGELRSFLQVRKFS-LDLASLILYAYQLSTALAYLE---SKRF 132
Query: 816 IHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDE 875
           +HRD+ + N+L+ +     + DFGL+++++D+   +  S       ++APE     +   
Sbjct: 133 VHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKA-SKGKLPIKWMAPESINFRRFTS 191
Query: 876 KSDVYSFGVVLLE-LIAGKKP 895
            SDV+ FGV + E L+ G KP
Sbjct: 192 ASDVWMFGVCMWEILMHGVKP 212

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 102/214 (47%), Gaps = 23/214 (10%)
Query: 690 VLESLKDENIIGKGGAGIVYRGSMPDGI---DVAIKRLVGRGTGGNDHGFLA--EIQTLG 744
           VL+  ++   IG G  GIV   +  D +   +VAIK+L  R      H   A  E+  + 
Sbjct: 15  VLKRYQNLKPIGSGAQGIV--CAAYDAVLDRNVAIKKL-SRPFQNQTHAKRAYRELVLMK 71
Query: 745 RIRHRNIVRLLGYVSNRDT-----NLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALE 799
            + H+NI+ LL   + + T     ++ L   + + +L +++       L  E    +  +
Sbjct: 72  CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQM----ELDHERMSYLLYQ 127
Query: 800 AAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGS 859
              G+ +LH   S  IIHRD+K +NI++ SD    + DFGLA+    AG S  M+    +
Sbjct: 128 MLXGIKHLH---SAGIIHRDLKPSNIVVKSDXTLKILDFGLAR---TAGTSFMMTPYVVT 181
Query: 860 YGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGK 893
             Y APE    +   E  D++S G ++ E++  K
Sbjct: 182 RYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 83/162 (51%), Gaps = 8/162 (4%)
Query: 736 FLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYR 795
            LAE   + ++ +  IVR++G +   ++ +L+ E    G L + L   +  H+K +    
Sbjct: 418 LLAEANVMQQLDNPYIVRMIG-ICEAESWMLVMEMAELGPLNKYLQQNR--HVKDKNIIE 474
Query: 796 IALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQ-DAGASECMS 854
           +  + + G+ YL        +HRD+ + N+LL +   A ++DFGL+K L+ D    +  +
Sbjct: 475 LVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT 531
Query: 855 SVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKP 895
                  + APE     K   KSDV+SFGV++ E  + G+KP
Sbjct: 532 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 573

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 100/203 (49%), Gaps = 16/203 (7%)
Query: 700 IGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRI-RHRNIVRLLGY 757
           +GKG   +V R   +P G + A K +  +     DH  L     + R+ +H NIVRL   
Sbjct: 12  LGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 71
Query: 758 VSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIA--LEAAKGLCYLHHDCSPLI 815
           +S    + L+++ +  G L E +  A+  + + +  + I   LE+    C+L+      I
Sbjct: 72  ISEEGFHYLVFDLVTGGELFEDI-VAREYYSEADASHCIQQILESVNH-CHLNG-----I 124
Query: 816 IHRDVKSNNILLDSDFE---AHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLK 872
           +HRD+K  N+LL S  +     +ADFGLA  +Q  G  +     AG+ GY++PE      
Sbjct: 125 VHRDLKPENLLLASKSKGAAVKLADFGLAIEVQ--GDQQAWFGFAGTPGYLSPEVLRKDP 182
Query: 873 VDEKSDVYSFGVVLLELIAGKKP 895
             +  D+++ GV+L  L+ G  P
Sbjct: 183 YGKPVDMWACGVILYILLVGYPP 205

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 106/230 (46%), Gaps = 26/230 (11%)
Query: 683 LDFKAEDVLESLKDENIIGKGGAGIVYRGSMPD---GIDVAIKRL---VGRGTGGNDHGF 736
           +D++  + +     +  +G+G  G V+R  M D   G   A+K++   V R         
Sbjct: 84  VDYEYREEVHWATHQLRLGRGSFGEVHR--MEDKQTGFQCAVKKVRLEVFRAE------- 134
Query: 737 LAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRI 796
             E+     +    IV L G V       +  E +  GSLG+++   + G L  +     
Sbjct: 135 --ELMACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLV--KEQGCLPEDRALYY 190
Query: 797 ALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSD-FEAHVADFGLAKFLQDAGASECMSS 855
             +A +GL YLH   S  I+H DVK++N+LL SD   A + DFG A  LQ  G  + + +
Sbjct: 191 LGQALEGLEYLH---SRRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLT 247
Query: 856 ---VAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDG 902
              + G+  ++APE       D K DV+S   ++L ++ G  P  +F  G
Sbjct: 248 GDYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHPWTQFFRG 297

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 102/214 (47%), Gaps = 23/214 (10%)
Query: 690 VLESLKDENIIGKGGAGIVYRGSMPDGI---DVAIKRLVGRGTGGNDHGFLA--EIQTLG 744
           VL+  ++   IG G  GIV   +  D +   +VAIK+L  R      H   A  E+  + 
Sbjct: 22  VLKRYQNLKPIGSGAQGIV--CAAYDAVLDRNVAIKKL-SRPFQNQTHAKRAYRELVLMK 78
Query: 745 RIRHRNIVRLLGYVSNRDT-----NLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALE 799
            + H+NI+ LL   + + T     ++ L   + + +L +++       L  E    +  +
Sbjct: 79  CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQM----ELDHERMSYLLYQ 134
Query: 800 AAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGS 859
              G+ +LH   S  IIHRD+K +NI++ SD    + DFGLA+    AG S  M+    +
Sbjct: 135 MLXGIKHLH---SAGIIHRDLKPSNIVVKSDXTLKILDFGLAR---TAGTSFMMTPYVVT 188
Query: 860 YGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGK 893
             Y APE    +   E  D++S G ++ E++  K
Sbjct: 189 RYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 60/233 (25%), Positives = 103/233 (44%), Gaps = 30/233 (12%)
Query: 700 IGKGGAGIVYRGSM------PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVR 753
           +G+   G VY+G +           VAIK L  +  G     F  E     R++H N+V 
Sbjct: 34  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 93
Query: 754 LLGYVSNRDTNLLLYEYMPNGSLGEML-----HGAKGG---------HLKWETRYRIALE 799
           LLG V+      +++ Y  +G L E L     H   G           L+      +  +
Sbjct: 94  LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 153
Query: 800 AAKGLCYL--HHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVA 857
            A G+ YL  HH     ++H+D+ + N+L+       ++D GL + +  A   + + +  
Sbjct: 154 IAAGMEYLSSHH-----VVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSL 208
Query: 858 GSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFG--DGVDIVR 907
               ++APE     K    SD++S+GVVL E+ + G +P   +   D V+++R
Sbjct: 209 LPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIR 261

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 46/145 (31%), Positives = 70/145 (48%), Gaps = 7/145 (4%)
Query: 751 IVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHD 810
           + +L       D    + EY+  G L  M H  + G  K       A E A GL +L   
Sbjct: 83  LTQLHSCFQTMDRLYFVMEYVNGGDL--MYHIQQVGRFKEPHAVFYAAEIAIGLFFLQ-- 138
Query: 811 CSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYT 870
            S  II+RD+K +N++LDS+    +ADFG+ K  ++           G+  YIAPE    
Sbjct: 139 -SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTKXFCGTPDYIAPEIIAY 195
Query: 871 LKVDEKSDVYSFGVVLLELIAGKKP 895
               +  D ++FGV+L E++AG+ P
Sbjct: 196 QPYGKSVDWWAFGVLLYEMLAGQAP 220

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 101/220 (45%), Gaps = 24/220 (10%)
Query: 692 ESLKDENIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGND--------HGFLAEIQT 742
           E+ + + I+G+G + +V R    P   + A+K +   G G              L E+  
Sbjct: 4   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 63
Query: 743 LGRIR-HRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAA 801
           L ++  H NI++L           L+++ M  G L + L   K    + ETR +I     
Sbjct: 64  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL-TEKVTLSEKETR-KIMRALL 121
Query: 802 KGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYG 861
           + +C LH      I+HRD+K  NILLD D    + DFG +  L D G  E +  V G+  
Sbjct: 122 EVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL-DPG--EKLREVCGTPS 175
Query: 862 YIAPEYAYTLKVD------EKSDVYSFGVVLLELIAGKKP 895
           Y+APE       D      ++ D++S GV++  L+AG  P
Sbjct: 176 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 215

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 63.9 bits (154), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 64/282 (22%), Positives = 115/282 (40%), Gaps = 45/282 (15%)
Query: 717 IDVAIKRLVGRGTGGNDHGFLAEIQTLGRI-RHRNIVRLLGYVSNRDTNLLLYEYMPNGS 775
           + VA+K L            ++E++ +  + +H NIV LLG  ++    L++ EY   G 
Sbjct: 62  LKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGD 121
Query: 776 L---------------------GEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPL 814
           L                      E L    G  L+       + + A+G+ +L    S  
Sbjct: 122 LLNFLRRKAEAMLGPSLAPGQDPEGLDKEDGRPLELRDLLHFSSQVAQGMAFL---ASKN 178
Query: 815 IIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVD 874
            IHRDV + N+LL +   A + DFGLA+ + +        +      ++APE  +     
Sbjct: 179 CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYT 238
Query: 875 EKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDPRL 933
            +SDV+S+G++L E+ + G  P           + V K   +++QP+ A        P+ 
Sbjct: 239 VQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLV-KDGYQMAQPAFA--------PK- 288
Query: 934 SGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQS 975
                    +++ +   C   E + RPT +++   L    Q 
Sbjct: 289 ---------NIYSIMQACWALEPTHRPTFQQICSFLQEQAQE 321

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 63.9 bits (154), Expect = 5e-10,   Method: Composition-based stats.
 Identities = 56/182 (30%), Positives = 90/182 (49%), Gaps = 9/182 (4%)
Query: 717 IDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSL 776
           IDVAIK L       +    + E Q + ++ +  IVRL+G V   +  +L+ E    G L
Sbjct: 38  IDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG-VCQAEALMLVMEMAGGGPL 96
Query: 777 GEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVA 836
            + L G K   +       +  + + G+ YL        +HRD+ + N+LL +   A ++
Sbjct: 97  HKFLVG-KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKIS 152
Query: 837 DFGLAKFLQDAGASECMSSVAGSY--GYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GK 893
           DFGL+K L  A  S   +  AG +   + APE     K   +SDV+S+GV + E ++ G+
Sbjct: 153 DFGLSKAL-GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQ 211
Query: 894 KP 895
           KP
Sbjct: 212 KP 213

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Composition-based stats.
 Identities = 63/207 (30%), Positives = 96/207 (46%), Gaps = 18/207 (8%)
Query: 700 IGKGGAGIVYRGSMP-DGIDVAIKRL-VGRGTGGNDHGFLAEIQTLGRIR---HRNIVRL 754
           IG G  G VY+   P  G  VA+K + V  G  G     + E+  L R+    H N+VRL
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRL 71
Query: 755 LGYVSNRDTN-----LLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHH 809
           +   +   T+      L++E++ +  L   L  A    L  ET   +  +  +GL +LH 
Sbjct: 72  MDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHA 130
Query: 810 DCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAY 869
           +C   I+HRD+K  NIL+ S     +ADFGLA+      A   +  V  +  Y APE   
Sbjct: 131 NC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA---LDPVVVTLWYRAPEVLL 184
Query: 870 TLKVDEKSDVYSFGVVLLELIAGKKPV 896
                   D++S G +  E+   +KP+
Sbjct: 185 QSTYATPVDMWSVGCIFAEMFR-RKPL 210

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 78/308 (25%), Positives = 123/308 (39%), Gaps = 45/308 (14%)
Query: 686 KAEDVLESLKDENIIGKGGAGIVYRGSMPDGID-------VAIKRLVGRGTGGNDHGFLA 738
           K E   + LK    +G+G  G V       GID       VA+K L    T       ++
Sbjct: 23  KWEFPRDRLKLGKPLGRGAFGQVIEADA-FGIDKTATXRTVAVKMLKEGATHSEHRALMS 81
Query: 739 EIQTLGRI-RHRNIVRLLGYVSNRDTNLL-LYEYMPNGSLGEMLHGAKGGHLKW--ETRY 794
           E++ L  I  H N+V LLG  +     L+ + E+   G+L   L   +   + +  E  Y
Sbjct: 82  ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLY 141
Query: 795 R----------IALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFL 844
           +           + + AKG+ +L    S   IHRD+ + NILL       + DFGLA+ +
Sbjct: 142 KDFLTLEHLIXYSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDI 198
Query: 845 QDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGV 903
                            ++APE  +      +SDV+SFGV+L E+ + G  P        
Sbjct: 199 XKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 258
Query: 904 DIVRWVRKTTSEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMR 963
           +  R +++ T                  R+   P      +++  + C   E S RPT  
Sbjct: 259 EFCRRLKEGT------------------RMRA-PDYTTPEMYQTMLDCWHGEPSQRPTFS 299
Query: 964 EVVHMLAN 971
           E+V  L N
Sbjct: 300 ELVEHLGN 307

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Composition-based stats.
 Identities = 56/214 (26%), Positives = 96/214 (44%), Gaps = 28/214 (13%)
Query: 694 LKDENIIGKGGAGIVYRGSMP-DGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIV 752
            K+  +IG GG G V++     DG    IKR+       N+     E++ L ++ H NIV
Sbjct: 13  FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRV-----KYNNEKAEREVKALAKLDHVNIV 67
Query: 753 RLLG-------------YVSNRDTNLLLY---EYMPNGSLGEMLHGAKGGHLKWETRYRI 796
              G               S+R     L+   E+   G+L + +   +G  L       +
Sbjct: 68  HYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALEL 127
Query: 797 ALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSV 856
             +  KG+ Y+H   S  +I+RD+K +NI L    +  + DFGL   L++ G        
Sbjct: 128 FEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR---XRS 181
Query: 857 AGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELI 890
            G+  Y++PE   +    ++ D+Y+ G++L EL+
Sbjct: 182 KGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 215

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 49/193 (25%), Positives = 90/193 (46%), Gaps = 22/193 (11%)
Query: 715 DGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRI-RHRNIVRLLGYVSNRDTNLLLYEYMPN 773
           + + VA+K L    T  +    ++E++ +  I +H+NI+ LLG  +      ++  Y   
Sbjct: 66  EAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVGYASK 125
Query: 774 GSLGEMLHGAKGGHLKWETRYRI----------------ALEAAKGLCYLHHDCSPLIIH 817
           G+L E L   +   +  E  Y I                  + A+G+ YL    S   IH
Sbjct: 126 GNLREYLRARRPPGM--EYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIH 180
Query: 818 RDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKS 877
           RD+ + N+L+  +    +ADFGLA+ + +    +  ++      ++APE  +      +S
Sbjct: 181 RDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQS 240
Query: 878 DVYSFGVVLLELI 890
           DV+SFGV++ E+ 
Sbjct: 241 DVWSFGVLMWEIF 253

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Composition-based stats.
 Identities = 47/162 (29%), Positives = 83/162 (51%), Gaps = 8/162 (4%)
Query: 736 FLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYR 795
            LAE   + ++ +  IVR++G +   ++ +L+ E    G L + L   +  H+K +    
Sbjct: 53  LLAEANVMQQLDNPYIVRMIG-ICEAESWMLVMEMAELGPLNKYLQQNR--HVKDKNIIE 109
Query: 796 IALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQ-DAGASECMS 854
           +  + + G+ YL        +HRD+ + N+LL +   A ++DFGL+K L+ D    +  +
Sbjct: 110 LVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT 166
Query: 855 SVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKP 895
                  + APE     K   KSDV+SFGV++ E  + G+KP
Sbjct: 167 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 208

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Composition-based stats.
 Identities = 47/162 (29%), Positives = 83/162 (51%), Gaps = 8/162 (4%)
Query: 736 FLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYR 795
            LAE   + ++ +  IVR++G +   ++ +L+ E    G L + L   +  H+K +    
Sbjct: 65  LLAEANVMQQLDNPYIVRMIG-ICEAESWMLVMEMAELGPLNKYLQQNR--HVKDKNIIE 121
Query: 796 IALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQ-DAGASECMS 854
           +  + + G+ YL        +HRD+ + N+LL +   A ++DFGL+K L+ D    +  +
Sbjct: 122 LVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT 178
Query: 855 SVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKP 895
                  + APE     K   KSDV+SFGV++ E  + G+KP
Sbjct: 179 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 220

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Composition-based stats.
 Identities = 47/162 (29%), Positives = 83/162 (51%), Gaps = 8/162 (4%)
Query: 736 FLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYR 795
            LAE   + ++ +  IVR++G +   ++ +L+ E    G L + L   +  H+K +    
Sbjct: 75  LLAEANVMQQLDNPYIVRMIG-ICEAESWMLVMEMAELGPLNKYLQQNR--HVKDKNIIE 131
Query: 796 IALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQ-DAGASECMS 854
           +  + + G+ YL        +HRD+ + N+LL +   A ++DFGL+K L+ D    +  +
Sbjct: 132 LVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT 188
Query: 855 SVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKP 895
                  + APE     K   KSDV+SFGV++ E  + G+KP
Sbjct: 189 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 230

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Composition-based stats.
 Identities = 47/162 (29%), Positives = 83/162 (51%), Gaps = 8/162 (4%)
Query: 736 FLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYR 795
            LAE   + ++ +  IVR++G +   ++ +L+ E    G L + L   +  H+K +    
Sbjct: 75  LLAEANVMQQLDNPYIVRMIG-ICEAESWMLVMEMAELGPLNKYLQQNR--HVKDKNIIE 131
Query: 796 IALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQ-DAGASECMS 854
           +  + + G+ YL        +HRD+ + N+LL +   A ++DFGL+K L+ D    +  +
Sbjct: 132 LVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT 188
Query: 855 SVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKP 895
                  + APE     K   KSDV+SFGV++ E  + G+KP
Sbjct: 189 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 230

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Composition-based stats.
 Identities = 47/162 (29%), Positives = 83/162 (51%), Gaps = 8/162 (4%)
Query: 736 FLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYR 795
            LAE   + ++ +  IVR++G +   ++ +L+ E    G L + L   +  H+K +    
Sbjct: 55  LLAEANVMQQLDNPYIVRMIG-ICEAESWMLVMEMAELGPLNKYLQQNR--HVKDKNIIE 111
Query: 796 IALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQ-DAGASECMS 854
           +  + + G+ YL        +HRD+ + N+LL +   A ++DFGL+K L+ D    +  +
Sbjct: 112 LVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT 168
Query: 855 SVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKP 895
                  + APE     K   KSDV+SFGV++ E  + G+KP
Sbjct: 169 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 210

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Composition-based stats.
 Identities = 47/162 (29%), Positives = 83/162 (51%), Gaps = 8/162 (4%)
Query: 736 FLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYR 795
            LAE   + ++ +  IVR++G +   ++ +L+ E    G L + L   +  H+K +    
Sbjct: 59  LLAEANVMQQLDNPYIVRMIG-ICEAESWMLVMEMAELGPLNKYLQQNR--HVKDKNIIE 115
Query: 796 IALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQ-DAGASECMS 854
           +  + + G+ YL        +HRD+ + N+LL +   A ++DFGL+K L+ D    +  +
Sbjct: 116 LVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT 172
Query: 855 SVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKP 895
                  + APE     K   KSDV+SFGV++ E  + G+KP
Sbjct: 173 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 214

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Composition-based stats.
 Identities = 47/162 (29%), Positives = 83/162 (51%), Gaps = 8/162 (4%)
Query: 736 FLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYR 795
            LAE   + ++ +  IVR++G +   ++ +L+ E    G L + L   +  H+K +    
Sbjct: 73  LLAEANVMQQLDNPYIVRMIG-ICEAESWMLVMEMAELGPLNKYLQQNR--HVKDKNIIE 129
Query: 796 IALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQ-DAGASECMS 854
           +  + + G+ YL        +HRD+ + N+LL +   A ++DFGL+K L+ D    +  +
Sbjct: 130 LVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT 186
Query: 855 SVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKP 895
                  + APE     K   KSDV+SFGV++ E  + G+KP
Sbjct: 187 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 228

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 46/145 (31%), Positives = 70/145 (48%), Gaps = 7/145 (4%)
Query: 751 IVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHD 810
           + +L       D    + EY+  G L  M H  + G  K       A E A GL +L   
Sbjct: 404 LTQLHSCFQTMDRLYFVMEYVNGGDL--MYHIQQVGRFKEPHAVFYAAEIAIGLFFLQ-- 459
Query: 811 CSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYT 870
            S  II+RD+K +N++LDS+    +ADFG+ K  ++           G+  YIAPE    
Sbjct: 460 -SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTKXFCGTPDYIAPEIIAY 516
Query: 871 LKVDEKSDVYSFGVVLLELIAGKKP 895
               +  D ++FGV+L E++AG+ P
Sbjct: 517 QPYGKSVDWWAFGVLLYEMLAGQAP 541

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 101/206 (49%), Gaps = 16/206 (7%)
Query: 700 IGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRI-RHRNIVRLLGY 757
           +GKG   +V R   +P G + A K +  +     DH  L     + R+ +H NIVRL   
Sbjct: 12  LGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 71
Query: 758 VSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIA--LEAAKGLCYLHHDCSPLI 815
           +S    + L+++ +  G L E +  A+  + + +  + I   LE+    C+L+      I
Sbjct: 72  ISEEGFHYLVFDLVTGGELFEDI-VAREYYSEADASHCIQQILESVNH-CHLNG-----I 124
Query: 816 IHRDVKSNNILLDSDFE---AHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLK 872
           +HRD+K  N+LL S  +     +ADFGLA  +Q  G  +     AG+ GY++PE      
Sbjct: 125 VHRDLKPENLLLASKSKGAAVKLADFGLAIEVQ--GDQQAWFGFAGTPGYLSPEVLRKDP 182
Query: 873 VDEKSDVYSFGVVLLELIAGKKPVGE 898
             +  D+++ GV+L  L+ G  P  +
Sbjct: 183 YGKPVDMWACGVILYILLVGYPPFWD 208

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 63.5 bits (153), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 54/194 (27%), Positives = 90/194 (46%), Gaps = 13/194 (6%)
Query: 700 IGKGGAGIVYRGSMPD-GIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYV 758
           +G G  G VY G      + VA+K L  +        FL E   +  I+H N+V+LLG  
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTL--KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 285
Query: 759 SNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHR 818
           +      ++ E+M  G+L + L       +       +A + +  + YL        IHR
Sbjct: 286 TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHR 342
Query: 819 DVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSY---GYIAPEYAYTLKVDE 875
           ++ + N L+  +    VADFGL++ +      +  ++ AG+     + APE     K   
Sbjct: 343 NLAARNCLVGENHLVKVADFGLSRLM----TGDTYTAHAGAKFPIKWTAPESLAYNKFSI 398
Query: 876 KSDVYSFGVVLLEL 889
           KSDV++FGV+L E+
Sbjct: 399 KSDVWAFGVLLWEI 412

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 63.5 bits (153), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 101/220 (45%), Gaps = 24/220 (10%)
Query: 692 ESLKDENIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGND--------HGFLAEIQT 742
           E+ + + I+G+G + +V R    P   + A+K +   G G              L E+  
Sbjct: 17  ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 743 LGRIR-HRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAA 801
           L ++  H NI++L           L+++ M  G L + L   K    + ETR +I     
Sbjct: 77  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL-TEKVTLSEKETR-KIMRALL 134
Query: 802 KGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYG 861
           + +C LH      I+HRD+K  NILLD D    + DFG +  L D G  E +  V G+  
Sbjct: 135 EVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL-DPG--EKLREVCGTPS 188
Query: 862 YIAPEYAYTLKVD------EKSDVYSFGVVLLELIAGKKP 895
           Y+APE       D      ++ D++S GV++  L+AG  P
Sbjct: 189 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 63.5 bits (153), Expect = 6e-10,   Method: Composition-based stats.
 Identities = 69/239 (28%), Positives = 110/239 (46%), Gaps = 29/239 (12%)
Query: 690 VLESLKDENIIGKGGAGIVYRGSMPD-GIDVAIKRLVGRGTGGNDHGF----LAEIQTLG 744
           ++E  +    IG+G  G+V++    D G  VAIK+ +      +D       L EI+ L 
Sbjct: 1   MMEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFL---ESEDDPVIKKIALREIRMLK 57
Query: 745 RIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKG--GHL----KWETRYRIAL 798
           +++H N+V LL     +    L++EY  +  L E+    +G   HL     W+T     L
Sbjct: 58  QLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQT-----L 112
Query: 799 EAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAG 858
           +A    C+  H+C    IHRDVK  NIL+       + DFG A+ L   G S+       
Sbjct: 113 QAVN-FCH-KHNC----IHRDVKPENILITKHSVIKLCDFGFARLL--TGPSDYYDDEVA 164
Query: 859 SYGYIAPEYAY-TLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEV 916
           +  Y +PE      +     DV++ G V  EL++G  P+      VD +  +RKT  ++
Sbjct: 165 TRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSG-VPLWPGKSDVDQLYLIRKTLGDL 222

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 72/297 (24%), Positives = 130/297 (43%), Gaps = 44/297 (14%)
Query: 683 LDFKAEDVLESLKDENIIGKGGAGIVYR-GSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQ 741
           ++ KA+D LE + +   +G+G  G+V +   +P G  +A+KR+            L ++ 
Sbjct: 2   MEVKADD-LEPIME---LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLD 57
Query: 742 -TLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGA--KGGHLKWETRYRIAL 798
            ++  +     V   G +       +  E M + SL +       KG  +  +   +IA+
Sbjct: 58  ISMRTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAV 116
Query: 799 EAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAG 858
              K L +LH   S  +IHRDVK +N+L+++  +  + DFG++ +L D  A +     AG
Sbjct: 117 SIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDI---DAG 171
Query: 859 SYGYIAPEY--------AYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVR 910
              Y+APE          Y++    KSD++S G+ ++EL   + P   +G     ++ V 
Sbjct: 172 CKPYMAPERINPELNQKGYSV----KSDIWSLGITMIELAILRFPYDSWGTPFQQLKQV- 226
Query: 911 KTTSEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH 967
                V +PS          P+L     +           C++  S  RPT  E++ 
Sbjct: 227 -----VEEPS----------PQLPADKFSA--EFVDFTSQCLKKNSKERPTYPELMQ 266

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 47/143 (32%), Positives = 70/143 (48%), Gaps = 11/143 (7%)
Query: 762 DTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVK 821
           D    + EY+  G L  M H  + G  K       A E + GL +LH      II+RD+K
Sbjct: 93  DRLYFVMEYVNGGDL--MYHIQQVGKFKEPQAVFYAAEISIGLFFLHKRG---IIYRDLK 147
Query: 822 SNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYS 881
            +N++LDS+    +ADFG+ K     G +       G+  YIAPE        +  D ++
Sbjct: 148 LDNVMLDSEGHIKIADFGMCKEHMMDGVT--TREFCGTPDYIAPEIIAYQPYGKSVDWWA 205
Query: 882 FGVVLLELIAGKKPVGEFGDGVD 904
           +GV+L E++AG+ P     DG D
Sbjct: 206 YGVLLYEMLAGQPPF----DGED 224

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 62/234 (26%), Positives = 104/234 (44%), Gaps = 32/234 (13%)
Query: 700 IGKGGAGIVYRGSM------PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVR 753
           +G+   G VY+G +           VAIK L  +  G     F  E     R++H N+V 
Sbjct: 17  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 754 LLGYVSNRDTNLLLYEYMPNGSLGEML-----HGAKGGHLKWETRYRIALEA-------- 800
           LLG V+      +++ Y  +G L E L     H   G     +   + ALE         
Sbjct: 77  LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDD-DRTVKSALEPPDFVHLVA 135
Query: 801 --AKGLCYL--HHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSV 856
             A G+ YL  HH     ++H+D+ + N+L+       ++D GL + +  A   + + + 
Sbjct: 136 QIAAGMEYLSSHH-----VVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNS 190
Query: 857 AGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFG--DGVDIVR 907
                ++APE     K    SD++S+GVVL E+ + G +P   +   D V+++R
Sbjct: 191 LLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIR 244

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 100/217 (46%), Gaps = 23/217 (10%)
Query: 698 NIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGY 757
            +IG G  G+V++  + +  +VAIK+++      N      E+Q +  ++H N+V L  +
Sbjct: 46  KVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKN-----RELQIMRIVKHPNVVDLKAF 100
Query: 758 V-SNRDT------NLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIAL-EAAKGLCYLHH 809
             SN D       NL+L EY+P        H AK          ++ + +  + L Y+H 
Sbjct: 101 FYSNGDKKDEVFLNLVL-EYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH- 158
Query: 810 DCSPLIIHRDVKSNNILLDSDFEA-HVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYA 868
             S  I HRD+K  N+LLD       + DFG AK L    A E   S   S  Y APE  
Sbjct: 159 --SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILI---AGEPNVSXICSRYYRAPELI 213
Query: 869 Y-TLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVD 904
           +         D++S G V+ EL+ G +P+     G+D
Sbjct: 214 FGATNYTTNIDIWSTGCVMAELMQG-QPLFPGESGID 249

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 95/200 (47%), Gaps = 11/200 (5%)
Query: 700 IGKGGAGIVYRGSMPDGID---VAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLG 756
           IG+G  G+V   S  D ++   VAIK++            L EI+ L R RH NI+ +  
Sbjct: 51  IGEGAYGMV--CSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 108
Query: 757 YVSNRDTNLLLYEYMPNGSLGEMLHGA-KGGHLKWETRYRIALEAAKGLCYLHHDCSPLI 815
            +       +   Y+    +G  L+   K  HL  +       +  +GL Y+H   S  +
Sbjct: 109 IIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANV 165
Query: 816 IHRDVKSNNILLDSDFEAHVADFGLAKFLQ-DAGASECMSSVAGSYGYIAPEYAYTLKVD 874
           +HRD+K +N+LL++  +  + DFGLA+    D   +  ++    +  Y APE     K  
Sbjct: 166 LHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 225
Query: 875 EKS-DVYSFGVVLLELIAGK 893
            KS D++S G +L E+++ +
Sbjct: 226 TKSIDIWSVGCILAEMLSNR 245

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 63.2 bits (152), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 78/310 (25%), Positives = 123/310 (39%), Gaps = 47/310 (15%)
Query: 686 KAEDVLESLKDENIIGKGGAGIVYRGSMPDGID-------VAIKRLVGRGTGGNDHGFLA 738
           K E   + LK    +G+G  G V       GID       VA+K L    T       ++
Sbjct: 21  KWEFPRDRLKLGKPLGRGAFGQVIEADA-FGIDKTATCRTVAVKMLKEGATHSEHRALMS 79
Query: 739 EIQTLGRI-RHRNIVRLLGYVSNRDTNLL-LYEYMPNGSLGEMLHGAKGGHLKW----ET 792
           E++ L  I  H N+V LLG  +     L+ + E+   G+L   L   +   + +    E 
Sbjct: 80  ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPED 139
Query: 793 RYR----------IALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAK 842
            Y+           + + AKG+ +L    S   IHRD+ + NILL       + DFGLA+
Sbjct: 140 LYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 196
Query: 843 FLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGD 901
            +                 ++APE  +      +SDV+SFGV+L E+ + G  P      
Sbjct: 197 DIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 256
Query: 902 GVDIVRWVRKTTSEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPT 961
             +  R +++ T                  R+   P      +++  + C   E S RPT
Sbjct: 257 DEEFCRRLKEGT------------------RMRA-PDYTTPEMYQTMLDCWHGEPSQRPT 297
Query: 962 MREVVHMLAN 971
             E+V  L N
Sbjct: 298 FSELVEHLGN 307

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 85/204 (41%), Gaps = 17/204 (8%)
Query: 700 IGKGGAGIVYRGSMPDGID------VAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVR 753
           +G+G  G+VY G     +       VAIK +    +      FL E   +      ++VR
Sbjct: 20  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 79
Query: 754 LLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKG--------GHLKWETRYRIALEAAKGLC 805
           LLG VS     L++ E M  G L   L   +                  ++A E A G+ 
Sbjct: 80  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 139
Query: 806 YLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAP 865
           YL+ +     +HRD+ + N ++  DF   + DFG+ + + +               +++P
Sbjct: 140 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 196
Query: 866 EYAYTLKVDEKSDVYSFGVVLLEL 889
           E          SDV+SFGVVL E+
Sbjct: 197 ESLKDGVFTTYSDVWSFGVVLWEI 220

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 106/230 (46%), Gaps = 26/230 (11%)
Query: 683 LDFKAEDVLESLKDENIIGKGGAGIVYRGSMPD---GIDVAIKRL---VGRGTGGNDHGF 736
           +D++  + +     +  +G+G  G V+R  M D   G   A+K++   V R         
Sbjct: 65  VDYEYREEVHWATHQLRLGRGSFGEVHR--MEDKQTGFQCAVKKVRLEVFRAE------- 115
Query: 737 LAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRI 796
             E+     +    IV L G V       +  E +  GSLG+++   + G L  +     
Sbjct: 116 --ELMACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLV--KEQGCLPEDRALYY 171
Query: 797 ALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSD-FEAHVADFGLAKFLQDAGASECMSS 855
             +A +GL YLH   S  I+H DVK++N+LL SD   A + DFG A  LQ  G  + + +
Sbjct: 172 LGQALEGLEYLH---SRRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLT 228
Query: 856 ---VAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDG 902
              + G+  ++APE       D K DV+S   ++L ++ G  P  +F  G
Sbjct: 229 GDYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHPWTQFFRG 278

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 54/194 (27%), Positives = 90/194 (46%), Gaps = 13/194 (6%)
Query: 700 IGKGGAGIVYRGSMPD-GIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYV 758
           +G G  G VY G      + VA+K L  +        FL E   +  I+H N+V+LLG  
Sbjct: 267 LGGGQYGEVYEGVWKKYSLTVAVKTL--KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 324
Query: 759 SNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHR 818
           +      ++ E+M  G+L + L       +       +A + +  + YL        IHR
Sbjct: 325 TREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHR 381
Query: 819 DVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSY---GYIAPEYAYTLKVDE 875
           ++ + N L+  +    VADFGL++ +      +  ++ AG+     + APE     K   
Sbjct: 382 NLAARNCLVGENHLVKVADFGLSRLM----TGDTYTAHAGAKFPIKWTAPESLAYNKFSI 437
Query: 876 KSDVYSFGVVLLEL 889
           KSDV++FGV+L E+
Sbjct: 438 KSDVWAFGVLLWEI 451

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Composition-based stats.
 Identities = 63/207 (30%), Positives = 96/207 (46%), Gaps = 18/207 (8%)
Query: 700 IGKGGAGIVYRGSMP-DGIDVAIKRL-VGRGTGGNDHGFLAEIQTLGRIR---HRNIVRL 754
           IG G  G VY+   P  G  VA+K + V  G  G     + E+  L R+    H N+VRL
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRL 71
Query: 755 LGYVSNRDTN-----LLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHH 809
           +   +   T+      L++E++ +  L   L  A    L  ET   +  +  +GL +LH 
Sbjct: 72  MDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHA 130
Query: 810 DCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAY 869
           +C   I+HRD+K  NIL+ S     +ADFGLA+      A   +  V  +  Y APE   
Sbjct: 131 NC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA---LFPVVVTLWYRAPEVLL 184
Query: 870 TLKVDEKSDVYSFGVVLLELIAGKKPV 896
                   D++S G +  E+   +KP+
Sbjct: 185 QSTYATPVDMWSVGCIFAEMFR-RKPL 210

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 78/310 (25%), Positives = 123/310 (39%), Gaps = 47/310 (15%)
Query: 686 KAEDVLESLKDENIIGKGGAGIVYRGSMPDGID-------VAIKRLVGRGTGGNDHGFLA 738
           K E   + LK    +G+G  G V       GID       VA+K L    T       ++
Sbjct: 21  KWEFPRDRLKLGKPLGRGAFGQVIEADA-FGIDKTATCRTVAVKMLKEGATHSEHRALMS 79
Query: 739 EIQTLGRI-RHRNIVRLLGYVSNRDTNLL-LYEYMPNGSLGEMLHGAKGGHLKW----ET 792
           E++ L  I  H N+V LLG  +     L+ + E+   G+L   L   +   + +    E 
Sbjct: 80  ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPED 139
Query: 793 RYR----------IALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAK 842
            Y+           + + AKG+ +L    S   IHRD+ + NILL       + DFGLA+
Sbjct: 140 LYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 196
Query: 843 FLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGD 901
            +                 ++APE  +      +SDV+SFGV+L E+ + G  P      
Sbjct: 197 DIYKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 256
Query: 902 GVDIVRWVRKTTSEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPT 961
             +  R +++ T                  R+   P      +++  + C   E S RPT
Sbjct: 257 DEEFCRRLKEGT------------------RMRA-PDYTTPEMYQTMLDCWHGEPSQRPT 297
Query: 962 MREVVHMLAN 971
             E+V  L N
Sbjct: 298 FSELVEHLGN 307

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 95/201 (47%), Gaps = 11/201 (5%)
Query: 700 IGKGGAGIVYRGSM--PD--GIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLL 755
           IG+G  G V++G    P+   + VAIK      +      FL E  T+ +  H +IV+L+
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 756 GYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLI 815
           G ++     +++ E    G L   L   K   L   +    A + +  L YL    S   
Sbjct: 458 GVITENPVWIIM-ELCTLGELRSFLQVRKFS-LDLASLILYAYQLSTALAYLE---SKRF 512
Query: 816 IHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDE 875
           +HRD+ + N+L+ +     + DFGL+++++D+   +  S       ++APE     +   
Sbjct: 513 VHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKA-SKGKLPIKWMAPESINFRRFTS 571
Query: 876 KSDVYSFGVVLLE-LIAGKKP 895
            SDV+ FGV + E L+ G KP
Sbjct: 572 ASDVWMFGVCMWEILMHGVKP 592

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 53/204 (25%), Positives = 85/204 (41%), Gaps = 17/204 (8%)
Query: 700 IGKGGAGIVYRGSMPDGID------VAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVR 753
           +G+G  G+VY G     +       VAIK +    +      FL E   +      ++VR
Sbjct: 23  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 82
Query: 754 LLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLK--------WETRYRIALEAAKGLC 805
           LLG VS     L++ E M  G L   L   +                  ++A E A G+ 
Sbjct: 83  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 142
Query: 806 YLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAP 865
           YL+ +     +HRD+ + N ++  DF   + DFG+ + + +               +++P
Sbjct: 143 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 199
Query: 866 EYAYTLKVDEKSDVYSFGVVLLEL 889
           E          SDV+SFGVVL E+
Sbjct: 200 ESLKDGVFTTYSDVWSFGVVLWEI 223

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 85/204 (41%), Gaps = 17/204 (8%)
Query: 700 IGKGGAGIVYRGSMPDGID------VAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVR 753
           +G+G  G+VY G     +       VAIK +    +      FL E   +      ++VR
Sbjct: 55  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 114
Query: 754 LLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKG--------GHLKWETRYRIALEAAKGLC 805
           LLG VS     L++ E M  G L   L   +                  ++A E A G+ 
Sbjct: 115 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 174
Query: 806 YLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAP 865
           YL+ +     +HRD+ + N ++  DF   + DFG+ + + +               +++P
Sbjct: 175 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 231
Query: 866 EYAYTLKVDEKSDVYSFGVVLLEL 889
           E          SDV+SFGVVL E+
Sbjct: 232 ESLKDGVFTTYSDVWSFGVVLWEI 255

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 78/310 (25%), Positives = 123/310 (39%), Gaps = 47/310 (15%)
Query: 686 KAEDVLESLKDENIIGKGGAGIVYRGSMPDGID-------VAIKRLVGRGTGGNDHGFLA 738
           K E   + LK    +G+G  G V       GID       VA+K L    T       ++
Sbjct: 12  KWEFPRDRLKLGKPLGRGAFGQVIEADA-FGIDKTATCRTVAVKMLKEGATHSEHRALMS 70
Query: 739 EIQTLGRI-RHRNIVRLLGYVSNRDTNLL-LYEYMPNGSLGEMLHGAKGGHLKW----ET 792
           E++ L  I  H N+V LLG  +     L+ + E+   G+L   L   +   + +    E 
Sbjct: 71  ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPED 130
Query: 793 RYR----------IALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAK 842
            Y+           + + AKG+ +L    S   IHRD+ + NILL       + DFGLA+
Sbjct: 131 LYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 187
Query: 843 FLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGD 901
            +                 ++APE  +      +SDV+SFGV+L E+ + G  P      
Sbjct: 188 DIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 247
Query: 902 GVDIVRWVRKTTSEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPT 961
             +  R +++ T                  R+   P      +++  + C   E S RPT
Sbjct: 248 DEEFCRRLKEGT------------------RMRA-PDYTTPEMYQTMLDCWHGEPSQRPT 288
Query: 962 MREVVHMLAN 971
             E+V  L N
Sbjct: 289 FSELVEHLGN 298

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 85/204 (41%), Gaps = 17/204 (8%)
Query: 700 IGKGGAGIVYRGSMPDGID------VAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVR 753
           +G+G  G+VY G     +       VAIK +    +      FL E   +      ++VR
Sbjct: 27  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 86
Query: 754 LLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKG--------GHLKWETRYRIALEAAKGLC 805
           LLG VS     L++ E M  G L   L   +                  ++A E A G+ 
Sbjct: 87  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 146
Query: 806 YLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAP 865
           YL+ +     +HRD+ + N ++  DF   + DFG+ + + +               +++P
Sbjct: 147 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 203
Query: 866 EYAYTLKVDEKSDVYSFGVVLLEL 889
           E          SDV+SFGVVL E+
Sbjct: 204 ESLKDGVFTTYSDVWSFGVVLWEI 227

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 78/310 (25%), Positives = 123/310 (39%), Gaps = 47/310 (15%)
Query: 686 KAEDVLESLKDENIIGKGGAGIVYRGSMPDGID-------VAIKRLVGRGTGGNDHGFLA 738
           K E   + LK    +G+G  G V       GID       VA+K L    T       ++
Sbjct: 58  KWEFPRDRLKLGKPLGRGAFGQVIEADA-FGIDKTATCRTVAVKMLKEGATHSEHRALMS 116
Query: 739 EIQTLGRI-RHRNIVRLLGYVSNRDTNLL-LYEYMPNGSLGEMLHGAKGGHLKW----ET 792
           E++ L  I  H N+V LLG  +     L+ + E+   G+L   L   +   + +    E 
Sbjct: 117 ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPED 176
Query: 793 RYR----------IALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAK 842
            Y+           + + AKG+ +L    S   IHRD+ + NILL       + DFGLA+
Sbjct: 177 LYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 233
Query: 843 FLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGD 901
            +                 ++APE  +      +SDV+SFGV+L E+ + G  P      
Sbjct: 234 DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 293
Query: 902 GVDIVRWVRKTTSEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPT 961
             +  R +++ T                  R+   P      +++  + C   E S RPT
Sbjct: 294 DEEFCRRLKEGT------------------RMRA-PDYTTPEMYQTMLDCWHGEPSQRPT 334
Query: 962 MREVVHMLAN 971
             E+V  L N
Sbjct: 335 FSELVEHLGN 344

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 53/204 (25%), Positives = 85/204 (41%), Gaps = 17/204 (8%)
Query: 700 IGKGGAGIVYRGSMPDGID------VAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVR 753
           +G+G  G+VY G     +       VAIK +    +      FL E   +      ++VR
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 754 LLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLK--------WETRYRIALEAAKGLC 805
           LLG VS     L++ E M  G L   L   +                  ++A E A G+ 
Sbjct: 93  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 152
Query: 806 YLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAP 865
           YL+ +     +HRD+ + N ++  DF   + DFG+ + + +               +++P
Sbjct: 153 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 209
Query: 866 EYAYTLKVDEKSDVYSFGVVLLEL 889
           E          SDV+SFGVVL E+
Sbjct: 210 ESLKDGVFTTYSDVWSFGVVLWEI 233

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 78/310 (25%), Positives = 123/310 (39%), Gaps = 47/310 (15%)
Query: 686 KAEDVLESLKDENIIGKGGAGIVYRGSMPDGID-------VAIKRLVGRGTGGNDHGFLA 738
           K E   + LK    +G+G  G V       GID       VA+K L    T       ++
Sbjct: 21  KWEFPRDRLKLGKPLGRGAFGQVIEADA-FGIDKTATCRTVAVKMLKEGATHSEHRALMS 79
Query: 739 EIQTLGRI-RHRNIVRLLGYVSNRDTNLL-LYEYMPNGSLGEMLHGAKGGHLKW----ET 792
           E++ L  I  H N+V LLG  +     L+ + E+   G+L   L   +   + +    E 
Sbjct: 80  ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPED 139
Query: 793 RYR----------IALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAK 842
            Y+           + + AKG+ +L    S   IHRD+ + NILL       + DFGLA+
Sbjct: 140 LYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 196
Query: 843 FLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGD 901
            +                 ++APE  +      +SDV+SFGV+L E+ + G  P      
Sbjct: 197 DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 256
Query: 902 GVDIVRWVRKTTSEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPT 961
             +  R +++ T                  R+   P      +++  + C   E S RPT
Sbjct: 257 DEEFCRRLKEGT------------------RMRA-PDYTTPEMYQTMLDCWHGEPSQRPT 297
Query: 962 MREVVHMLAN 971
             E+V  L N
Sbjct: 298 FSELVEHLGN 307

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 78/310 (25%), Positives = 123/310 (39%), Gaps = 47/310 (15%)
Query: 686 KAEDVLESLKDENIIGKGGAGIVYRGSMPDGID-------VAIKRLVGRGTGGNDHGFLA 738
           K E   + LK    +G+G  G V       GID       VA+K L    T       ++
Sbjct: 12  KWEFPRDRLKLGKPLGRGAFGQVIEADA-FGIDKTATCRTVAVKMLKEGATHSEHRALMS 70
Query: 739 EIQTLGRI-RHRNIVRLLGYVSNRDTNLL-LYEYMPNGSLGEMLHGAKGGHLKW----ET 792
           E++ L  I  H N+V LLG  +     L+ + E+   G+L   L   +   + +    E 
Sbjct: 71  ELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPED 130
Query: 793 RYR----------IALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAK 842
            Y+           + + AKG+ +L    S   IHRD+ + NILL       + DFGLA+
Sbjct: 131 LYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 187
Query: 843 FLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGD 901
            +                 ++APE  +      +SDV+SFGV+L E+ + G  P      
Sbjct: 188 DIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 247
Query: 902 GVDIVRWVRKTTSEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPT 961
             +  R +++ T                  R+   P      +++  + C   E S RPT
Sbjct: 248 DEEFCRRLKEGT------------------RMRA-PDYTTPEMYQTMLDCWHGEPSQRPT 288
Query: 962 MREVVHMLAN 971
             E+V  L N
Sbjct: 289 FSELVEHLGN 298

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 78/310 (25%), Positives = 123/310 (39%), Gaps = 47/310 (15%)
Query: 686 KAEDVLESLKDENIIGKGGAGIVYRGSMPDGID-------VAIKRLVGRGTGGNDHGFLA 738
           K E   + LK    +G+G  G V       GID       VA+K L    T       ++
Sbjct: 23  KWEFPRDRLKLGKPLGRGAFGQVIEADA-FGIDKTATCRTVAVKMLKEGATHSEHRALMS 81
Query: 739 EIQTLGRI-RHRNIVRLLGYVSNRDTNLL-LYEYMPNGSLGEMLHGAKGGHLKW----ET 792
           E++ L  I  H N+V LLG  +     L+ + E+   G+L   L   +   + +    E 
Sbjct: 82  ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPED 141
Query: 793 RYR----------IALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAK 842
            Y+           + + AKG+ +L    S   IHRD+ + NILL       + DFGLA+
Sbjct: 142 LYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 198
Query: 843 FLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGD 901
            +                 ++APE  +      +SDV+SFGV+L E+ + G  P      
Sbjct: 199 DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 258
Query: 902 GVDIVRWVRKTTSEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPT 961
             +  R +++ T                  R+   P      +++  + C   E S RPT
Sbjct: 259 DEEFCRRLKEGT------------------RMRA-PDYTTPEMYQTMLDCWHGEPSQRPT 299
Query: 962 MREVVHMLAN 971
             E+V  L N
Sbjct: 300 FSELVEHLGN 309

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 61/227 (26%), Positives = 99/227 (43%), Gaps = 41/227 (18%)
Query: 694 LKDENIIGKGGAGIVYRGSMP-DGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIV 752
            K+  +IG GG G V++     DG    I+R+       N+     E++ L ++ H NIV
Sbjct: 14  FKEIELIGSGGFGQVFKAKHRIDGKTYVIRRV-----KYNNEKAEREVKALAKLDHVNIV 68
Query: 753 RLLGY-------VSNRDTNLLLYEYMPNGSLG-----------EMLHGAKGGHLKWETRY 794
              G            D +L   +Y P  S             +M    KG   +W  + 
Sbjct: 69  HYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR 128
Query: 795 R-------IALE----AAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKF 843
           R       +ALE      KG+ Y+H   S  +IHRD+K +NI L    +  + DFGL   
Sbjct: 129 RGEKLDKVLALELFEQITKGVDYIH---SKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTS 185
Query: 844 LQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELI 890
           L++ G     +   G+  Y++PE   +    ++ D+Y+ G++L EL+
Sbjct: 186 LKNDGKR---TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 229

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 76/161 (47%), Gaps = 10/161 (6%)
Query: 739 EIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIAL 798
           EI  L  +RH +I++L   ++     +++ EY   G L + +   K        R+   +
Sbjct: 59  EISYLKLLRHPHIIKLYDVITTPTDIVMVIEY-AGGELFDYIVEKKRMTEDEGRRFFQQI 117
Query: 799 EAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAG 858
             A   C+ H      I+HRD+K  N+LLD +    +ADFGL+  + D      + +  G
Sbjct: 118 ICAIEYCHRHK-----IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF---LKTSCG 169
Query: 859 SYGYIAPEYAY-TLKVDEKSDVYSFGVVLLELIAGKKPVGE 898
           S  Y APE     L    + DV+S G+VL  ++ G+ P  +
Sbjct: 170 SPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDD 210

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/182 (30%), Positives = 90/182 (49%), Gaps = 9/182 (4%)
Query: 717 IDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSL 776
           IDVAIK L       +    + E Q + ++ +  IVRL+G V   +  +L+ E    G L
Sbjct: 364 IDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG-VCQAEALMLVMEMAGGGPL 422
Query: 777 GEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVA 836
            + L G K   +       +  + + G+ YL        +HR++ + N+LL +   A ++
Sbjct: 423 HKFLVG-KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKIS 478
Query: 837 DFGLAKFLQDAGASECMSSVAGSY--GYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GK 893
           DFGL+K L  A  S   +  AG +   + APE     K   +SDV+S+GV + E ++ G+
Sbjct: 479 DFGLSKAL-GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQ 537
Query: 894 KP 895
           KP
Sbjct: 538 KP 539

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 108/230 (46%), Gaps = 26/230 (11%)
Query: 683 LDFKAEDVLESLKDENIIGKGGAGIVYRGSMPD---GIDVAIKRL---VGRGTGGNDHGF 736
           +D++  + +  +  +  +G+G  G V+R  M D   G   A+K++   V R         
Sbjct: 49  VDYEYREEVHWMTHQPRVGRGSFGEVHR--MKDKQTGFQCAVKKVRLEVFR--------- 97
Query: 737 LAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRI 796
           + E+     +    IV L G V       +  E +  GSLG+++   + G L  +     
Sbjct: 98  VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLI--KQMGCLPEDRALYY 155
Query: 797 ALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSD-FEAHVADFGLAKFLQDAGASECMSS 855
             +A +GL YLH   +  I+H DVK++N+LL SD   A + DFG A  LQ  G  + + +
Sbjct: 156 LGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLT 212
Query: 856 ---VAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDG 902
              + G+  ++APE       D K D++S   ++L ++ G  P  ++  G
Sbjct: 213 GDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRG 262

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 54/204 (26%), Positives = 86/204 (42%), Gaps = 17/204 (8%)
Query: 700 IGKGGAGIVYRGSMPDGID------VAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVR 753
           +G+G  G+VY G     +       VAIK +    +      FL E   +      ++VR
Sbjct: 26  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 85
Query: 754 LLGYVSNRDTNLLLYEYMPNGSLG--------EMLHGAKGGHLKWETRYRIALEAAKGLC 805
           LLG VS     L++ E M  G L         EM +             ++A E A G+ 
Sbjct: 86  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 145
Query: 806 YLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAP 865
           YL+ +     +HRD+ + N ++  DF   + DFG+ + + +               +++P
Sbjct: 146 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 202
Query: 866 EYAYTLKVDEKSDVYSFGVVLLEL 889
           E          SDV+SFGVVL E+
Sbjct: 203 ESLKDGVFTTYSDVWSFGVVLWEI 226

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 48/192 (25%), Positives = 91/192 (47%), Gaps = 22/192 (11%)
Query: 715 DGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRI-RHRNIVRLLGYVSNRDTNLLLYEYMPN 773
           + + VA+K L    T  +    ++E++ +  I +H+NI+ LLG  +      ++  Y   
Sbjct: 66  EAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVAYASK 125
Query: 774 GSLGEMLHGAKGGHLKWETRYRI----------------ALEAAKGLCYLHHDCSPLIIH 817
           G+L E L   +   +++   Y I                  + A+G+ YL    S   IH
Sbjct: 126 GNLREYLRARRPPGMEYS--YDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIH 180
Query: 818 RDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKS 877
           RD+ + N+L+  +    +ADFGLA+ + +    +  ++      ++APE  +      +S
Sbjct: 181 RDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQS 240
Query: 878 DVYSFGVVLLEL 889
           DV+SFGV++ E+
Sbjct: 241 DVWSFGVLMWEI 252

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 65/224 (29%), Positives = 103/224 (45%), Gaps = 24/224 (10%)
Query: 700 IGKGGAGIVY--RGSMPDGIDVAIKRL-VGRGTGGNDHGFLAEIQTLGRIR---HRNIVR 753
           IG+G  G V+  R     G  VA+KR+ V  G  G     + E+  L  +    H N+VR
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 754 LLGYVS----NRDTNL-LLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLH 808
           L    +    +R+T L L++E++ +  L   L       +  ET   +  +  +GL +LH
Sbjct: 79  LFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 137
Query: 809 HDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYA 868
              S  ++HRD+K  NIL+ S  +  +ADFGLA+      A   ++SV  +  Y APE  
Sbjct: 138 ---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA---LTSVVVTLWYRAPEVL 191
Query: 869 YTLKVDEKSDVYSFGVVLLE------LIAGKKPVGEFGDGVDIV 906
                    D++S G +  E      L  G   V + G  +D++
Sbjct: 192 LQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVI 235

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 65/224 (29%), Positives = 103/224 (45%), Gaps = 24/224 (10%)
Query: 700 IGKGGAGIVY--RGSMPDGIDVAIKRL-VGRGTGGNDHGFLAEIQTLGRIR---HRNIVR 753
           IG+G  G V+  R     G  VA+KR+ V  G  G     + E+  L  +    H N+VR
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 754 LLGYVS----NRDTNL-LLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLH 808
           L    +    +R+T L L++E++ +  L   L       +  ET   +  +  +GL +LH
Sbjct: 79  LFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 137
Query: 809 HDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYA 868
              S  ++HRD+K  NIL+ S  +  +ADFGLA+      A   ++SV  +  Y APE  
Sbjct: 138 ---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA---LTSVVVTLWYRAPEVL 191
Query: 869 YTLKVDEKSDVYSFGVVLLE------LIAGKKPVGEFGDGVDIV 906
                    D++S G +  E      L  G   V + G  +D++
Sbjct: 192 LQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVI 235

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 54/204 (26%), Positives = 86/204 (42%), Gaps = 17/204 (8%)
Query: 700 IGKGGAGIVYRGSMPDGID------VAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVR 753
           +G+G  G+VY G     +       VAIK +    +      FL E   +      ++VR
Sbjct: 24  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 83
Query: 754 LLGYVSNRDTNLLLYEYMPNGSLG--------EMLHGAKGGHLKWETRYRIALEAAKGLC 805
           LLG VS     L++ E M  G L         EM +             ++A E A G+ 
Sbjct: 84  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 143
Query: 806 YLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAP 865
           YL+ +     +HRD+ + N ++  DF   + DFG+ + + +               +++P
Sbjct: 144 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 200
Query: 866 EYAYTLKVDEKSDVYSFGVVLLEL 889
           E          SDV+SFGVVL E+
Sbjct: 201 ESLKDGVFTTYSDVWSFGVVLWEI 224

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 97/210 (46%), Gaps = 13/210 (6%)
Query: 689 DVLESLKDENIIGKGGAGIVYRGSMP-DGIDVAIKRL-VGRGTGGNDHGFLAEIQTLGRI 746
           + +E+ +    IG+G  G+VY+      G  VA+K++ +   T G     + EI  L  +
Sbjct: 7   EFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 66
Query: 747 RHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAK--GGHLKWETRYRIALEAAKGL 804
            H NIV+LL  +   +   L++E++ +  L + +  +   G  L     Y   L      
Sbjct: 67  NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 125
Query: 805 CYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIA 864
           C+ H      ++HRD+K  N+L++++    +ADFGLA+       +     V  +  Y A
Sbjct: 126 CHSHR-----VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRA 178
Query: 865 PEYAYTLKVDEKS-DVYSFGVVLLELIAGK 893
           PE     K    + D++S G +  E++  +
Sbjct: 179 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 54/204 (26%), Positives = 86/204 (42%), Gaps = 17/204 (8%)
Query: 700 IGKGGAGIVYRGSMPDGID------VAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVR 753
           +G+G  G+VY G     +       VAIK +    +      FL E   +      ++VR
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 754 LLGYVSNRDTNLLLYEYMPNGSLG--------EMLHGAKGGHLKWETRYRIALEAAKGLC 805
           LLG VS     L++ E M  G L         EM +             ++A E A G+ 
Sbjct: 93  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 152
Query: 806 YLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAP 865
           YL+ +     +HRD+ + N ++  DF   + DFG+ + + +               +++P
Sbjct: 153 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 209
Query: 866 EYAYTLKVDEKSDVYSFGVVLLEL 889
           E          SDV+SFGVVL E+
Sbjct: 210 ESLKDGVFTTYSDVWSFGVVLWEI 233

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 106/227 (46%), Gaps = 29/227 (12%)
Query: 687 AEDVLESLKDENIIGKGGAGIVYRG-SMPDGIDVAIK-------RLVGRGTGGNDHGFLA 738
           A++  +    +++IG+G + +V R      G + A+K       RL              
Sbjct: 89  AKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRR 148
Query: 739 EIQTLGRIR-HRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETR--YR 795
           E   L ++  H +I+ L+    +     L+++ M  G L + L   K    + ETR   R
Sbjct: 149 ETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYL-TEKVALSEKETRSIMR 207
Query: 796 IALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSS 855
             LEA   + +LH +    I+HRD+K  NILLD + +  ++DFG +  L+     E +  
Sbjct: 208 SLLEA---VSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLE---PGEKLRE 258
Query: 856 VAGSYGYIAPEYAYTLKVDE-------KSDVYSFGVVLLELIAGKKP 895
           + G+ GY+APE      +DE       + D+++ GV+L  L+AG  P
Sbjct: 259 LCGTPGYLAPE-ILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP 304

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/237 (25%), Positives = 109/237 (45%), Gaps = 25/237 (10%)
Query: 698 NIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIR-HRNIVRLL 755
            ++G+G    V    S+ +G + A+K ++ +  G +      E++TL + + ++NI+ L+
Sbjct: 19  ELLGEGAYAKVQGAVSLQNGKEYAVK-IIEKQAGHSRSRVFREVETLYQCQGNKNILELI 77
Query: 756 GYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLI 815
            +  +     L++E +  GS+  + H  K  H       R+  + A  L +LH   +  I
Sbjct: 78  EFFEDDTRFYLVFEKLQGGSI--LAHIQKQKHFNEREASRVVRDVAAALDFLH---TKGI 132
Query: 816 IHRDVKSNNILLDSDFE---AHVADFGLAKFLQDAGA-----SECMSSVAGSYGYIAPEY 867
            HRD+K  NIL +S  +     + DF L   ++   +     +  +++  GS  Y+APE 
Sbjct: 133 AHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEV 192
Query: 868 AYTLK-----VDEKSDVYSFGVVLLELIAGKKP-VGEFGDGVDIVRWVRKTTSEVSQ 918
                      D++ D++S GVVL  +++G  P VG  G       W R     V Q
Sbjct: 193 VEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCG---WDRGEVCRVCQ 246

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 108/230 (46%), Gaps = 26/230 (11%)
Query: 683 LDFKAEDVLESLKDENIIGKGGAGIVYRGSMPD---GIDVAIKRL---VGRGTGGNDHGF 736
           +D++  + +  +  +  +G+G  G V+R  M D   G   A+K++   V R         
Sbjct: 65  VDYEYREEVHWMTHQPRVGRGSFGEVHR--MKDKQTGFQCAVKKVRLEVFR--------- 113
Query: 737 LAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRI 796
           + E+     +    IV L G V       +  E +  GSLG+++   + G L  +     
Sbjct: 114 VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLI--KQMGCLPEDRALYY 171
Query: 797 ALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSD-FEAHVADFGLAKFLQDAGASECMSS 855
             +A +GL YLH   +  I+H DVK++N+LL SD   A + DFG A  LQ  G  + + +
Sbjct: 172 LGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLT 228
Query: 856 ---VAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDG 902
              + G+  ++APE       D K D++S   ++L ++ G  P  ++  G
Sbjct: 229 GDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRG 278

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 54/204 (26%), Positives = 86/204 (42%), Gaps = 17/204 (8%)
Query: 700 IGKGGAGIVYRGSMPDGID------VAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVR 753
           +G+G  G+VY G     +       VAIK +    +      FL E   +      ++VR
Sbjct: 26  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 85
Query: 754 LLGYVSNRDTNLLLYEYMPNGSLG--------EMLHGAKGGHLKWETRYRIALEAAKGLC 805
           LLG VS     L++ E M  G L         EM +             ++A E A G+ 
Sbjct: 86  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 145
Query: 806 YLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAP 865
           YL+ +     +HRD+ + N ++  DF   + DFG+ + + +               +++P
Sbjct: 146 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 202
Query: 866 EYAYTLKVDEKSDVYSFGVVLLEL 889
           E          SDV+SFGVVL E+
Sbjct: 203 ESLKDGVFTTYSDVWSFGVVLWEI 226

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 84/204 (41%), Gaps = 17/204 (8%)
Query: 700 IGKGGAGIVYRGSMPDGID------VAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVR 753
           +G+G  G+VY G     +       VAIK +    +      FL E   +      ++VR
Sbjct: 20  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 79
Query: 754 LLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKG--------GHLKWETRYRIALEAAKGLC 805
           LLG VS     L++ E M  G L   L   +                  ++A E A G+ 
Sbjct: 80  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 139
Query: 806 YLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAP 865
           YL+ +     +HRD+ + N  +  DF   + DFG+ + + +               +++P
Sbjct: 140 YLNAN---KFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 196
Query: 866 EYAYTLKVDEKSDVYSFGVVLLEL 889
           E          SDV+SFGVVL E+
Sbjct: 197 ESLKDGVFTTYSDVWSFGVVLWEI 220

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 97/210 (46%), Gaps = 13/210 (6%)
Query: 689 DVLESLKDENIIGKGGAGIVYRGSMP-DGIDVAIKRL-VGRGTGGNDHGFLAEIQTLGRI 746
           + +E+ +    IG+G  G+VY+      G  VA+K++ +   T G     + EI  L  +
Sbjct: 7   EFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 66
Query: 747 RHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAK--GGHLKWETRYRIALEAAKGL 804
            H NIV+LL  +   +   L++E++ +  L + +  +   G  L     Y   L      
Sbjct: 67  NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 125
Query: 805 CYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIA 864
           C+ H      ++HRD+K  N+L++++    +ADFGLA+       +     V  +  Y A
Sbjct: 126 CHSHR-----VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRA 178
Query: 865 PEYAYTLKVDEKS-DVYSFGVVLLELIAGK 893
           PE     K    + D++S G +  E++  +
Sbjct: 179 PEILLGXKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 108/230 (46%), Gaps = 26/230 (11%)
Query: 683 LDFKAEDVLESLKDENIIGKGGAGIVYRGSMPD---GIDVAIKRL---VGRGTGGNDHGF 736
           +D++  + +  +  +  +G+G  G V+R  M D   G   A+K++   V R         
Sbjct: 63  VDYEYREEVHWMTHQPRLGRGSFGEVHR--MKDKQTGFQCAVKKVRLEVFR--------- 111
Query: 737 LAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRI 796
           + E+     +    IV L G V       +  E +  GSLG+++   + G L  +     
Sbjct: 112 VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLI--KQMGCLPEDRALYY 169
Query: 797 ALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSD-FEAHVADFGLAKFLQDAGASECMSS 855
             +A +GL YLH   +  I+H DVK++N+LL SD   A + DFG A  LQ  G  + + +
Sbjct: 170 LGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLT 226
Query: 856 ---VAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDG 902
              + G+  ++APE       D K D++S   ++L ++ G  P  ++  G
Sbjct: 227 GDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRG 276

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 78/310 (25%), Positives = 123/310 (39%), Gaps = 47/310 (15%)
Query: 686 KAEDVLESLKDENIIGKGGAGIVYRGSMPDGID-------VAIKRLVGRGTGGNDHGFLA 738
           K E   + LK    +G+G  G V       GID       VA+K L    T       ++
Sbjct: 12  KWEFPRDRLKLGKPLGRGAFGQVIEADA-FGIDKTATCRTVAVKMLKEGATHSEHRALMS 70
Query: 739 EIQTLGRI-RHRNIVRLLGYVSNRDTNLL-LYEYMPNGSLGEMLHGAKGGHLKW----ET 792
           E++ L  I  H N+V LLG  +     L+ + E+   G+L   L   +   + +    E 
Sbjct: 71  ELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPED 130
Query: 793 RYR----------IALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAK 842
            Y+           + + AKG+ +L    S   IHRD+ + NILL       + DFGLA+
Sbjct: 131 LYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 187
Query: 843 FLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGD 901
            +                 ++APE  +      +SDV+SFGV+L E+ + G  P      
Sbjct: 188 DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 247
Query: 902 GVDIVRWVRKTTSEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPT 961
             +  R +++ T                  R+   P      +++  + C   E S RPT
Sbjct: 248 DEEFCRRLKEGT------------------RMRA-PDYTTPEMYQTMLDCWHGEPSQRPT 288
Query: 962 MREVVHMLAN 971
             E+V  L N
Sbjct: 289 FSELVEHLGN 298

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 61/204 (29%), Positives = 99/204 (48%), Gaps = 18/204 (8%)
Query: 700 IGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRI-RHRNIVRLLGY 757
           IGKG   +V R   +  G + A K +  +     DH  L     + R+ +H NIVRL   
Sbjct: 12  IGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKHSNIVRLHDS 71
Query: 758 VSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIA--LEAAKGLCYLHHDCSPL- 814
           +S    + L+++ +  G L E +  A+  + + +  + I   LEA      LH  C  + 
Sbjct: 72  ISEEGFHYLVFDLVTGGELFEDIV-AREYYSEADASHCIQQILEAV-----LH--CHQMG 123
Query: 815 IIHRDVKSNNILLDSDFEA---HVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTL 871
           ++HRD+K  N+LL S  +     +ADFGLA  +Q  G  +     AG+ GY++PE     
Sbjct: 124 VVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQ--GDQQAWFGFAGTPGYLSPEVLRKE 181
Query: 872 KVDEKSDVYSFGVVLLELIAGKKP 895
              +  D+++ GV+L  L+ G  P
Sbjct: 182 AYGKPVDIWACGVILYILLVGYPP 205

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 78/310 (25%), Positives = 123/310 (39%), Gaps = 47/310 (15%)
Query: 686 KAEDVLESLKDENIIGKGGAGIVYRGSMPDGID-------VAIKRLVGRGTGGNDHGFLA 738
           K E   + LK    +G+G  G V       GID       VA+K L    T       ++
Sbjct: 12  KWEFPRDRLKLGKPLGRGAFGQVIEADA-FGIDKTATCRTVAVKMLKEGATHSEHRALMS 70
Query: 739 EIQTLGRI-RHRNIVRLLGYVSNRDTNLL-LYEYMPNGSLGEMLHGAKGGHLKW----ET 792
           E++ L  I  H N+V LLG  +     L+ + E+   G+L   L   +   + +    E 
Sbjct: 71  ELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPED 130
Query: 793 RYR----------IALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAK 842
            Y+           + + AKG+ +L    S   IHRD+ + NILL       + DFGLA+
Sbjct: 131 LYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 187
Query: 843 FLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGD 901
            +                 ++APE  +      +SDV+SFGV+L E+ + G  P      
Sbjct: 188 DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 247
Query: 902 GVDIVRWVRKTTSEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPT 961
             +  R +++ T                  R+   P      +++  + C   E S RPT
Sbjct: 248 DEEFCRRLKEGT------------------RMRA-PDYTTPEMYQTMLDCWHGEPSQRPT 288
Query: 962 MREVVHMLAN 971
             E+V  L N
Sbjct: 289 FSELVEHLGN 298

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 67/253 (26%), Positives = 108/253 (42%), Gaps = 32/253 (12%)
Query: 697 ENIIGKGGAGIVYRGSM-----PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNI 751
           E+ +G+G   IVYR        P  + V +K+ V +           EI  L R+ H NI
Sbjct: 58  ESELGRGATSIVYRCKQKGTQKPYALKV-LKKTVDKKI------VRTEIGVLLRLSHPNI 110
Query: 752 VRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDC 811
           ++L           L+ E +  G L + +   + G+           +  + + YLH + 
Sbjct: 111 IKLKEIFETPTEISLVLELVTGGELFDRI--VEKGYYSERDAADAVKQILEAVAYLHENG 168
Query: 812 SPLIIHRDVKSNNILLDS---DFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYA 868
              I+HRD+K  N+L  +   D    +ADFGL+K ++       M +V G+ GY APE  
Sbjct: 169 ---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH---QVLMKTVCGTPGYCAPEIL 222
Query: 869 YTLKVDEKSDVYSFGVVLLELIAGKKPV-GEFGDGVDIVR-------WVRKTTSEVS-QP 919
                  + D++S G++   L+ G +P   E GD     R       ++     EVS   
Sbjct: 223 RGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNA 282
Query: 920 SDAASVLAVVDPR 932
            D    L V+DP+
Sbjct: 283 KDLVRKLIVLDPK 295

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 96/208 (46%), Gaps = 13/208 (6%)
Query: 691 LESLKDENIIGKGGAGIVYRGSMP-DGIDVAIKRL-VGRGTGGNDHGFLAEIQTLGRIRH 748
           +E+ +    IG+G  G+VY+      G  VA+K++ +   T G     + EI  L  + H
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 749 RNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAK--GGHLKWETRYRIALEAAKGLCY 806
            NIV+LL  +   +   L++E++ +  L + +  +   G  L     Y   L      C+
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 807 LHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPE 866
            H      ++HRD+K  N+L++++    +ADFGLA+       +     V  +  Y APE
Sbjct: 121 SHR-----VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPE 173
Query: 867 YAYTLKVDEKS-DVYSFGVVLLELIAGK 893
                K    + D++S G +  E++  +
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 96/208 (46%), Gaps = 13/208 (6%)
Query: 691 LESLKDENIIGKGGAGIVYRGSMP-DGIDVAIKRL-VGRGTGGNDHGFLAEIQTLGRIRH 748
           +E+ +    IG+G  G+VY+      G  VA+K++ +   T G     + EI  L  + H
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 749 RNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAK--GGHLKWETRYRIALEAAKGLCY 806
            NIV+LL  +   +   L++E++ +  L + +  +   G  L     Y   L      C+
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 807 LHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPE 866
            H      ++HRD+K  N+L++++    +ADFGLA+       +     V  +  Y APE
Sbjct: 120 SHR-----VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPE 172
Query: 867 YAYTLKVDEKS-DVYSFGVVLLELIAGK 893
                K    + D++S G +  E++  +
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 96/208 (46%), Gaps = 13/208 (6%)
Query: 691 LESLKDENIIGKGGAGIVYRGSMP-DGIDVAIKRL-VGRGTGGNDHGFLAEIQTLGRIRH 748
           +E+ +    IG+G  G+VY+      G  VA+K++ +   T G     + EI  L  + H
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 749 RNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAK--GGHLKWETRYRIALEAAKGLCY 806
            NIV+LL  +   +   L++E++ +  L + +  +   G  L     Y   L      C+
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 807 LHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPE 866
            H      ++HRD+K  N+L++++    +ADFGLA+       +     V  +  Y APE
Sbjct: 121 SHR-----VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPE 173
Query: 867 YAYTLKVDEKS-DVYSFGVVLLELIAGK 893
                K    + D++S G +  E++  +
Sbjct: 174 ILLGXKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 75/161 (46%), Gaps = 8/161 (4%)
Query: 739 EIQTLGRIRHRNIVRLLGYVSNRDTN--LLLYEYMPNGSLGEMLHGAKGGHLKWETRYRI 796
           EIQ L R+RH+N+++L+  + N +     ++ EY   G + EML             +  
Sbjct: 56  EIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGY 114
Query: 797 ALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSV 856
             +   GL YLH   S  I+H+D+K  N+LL +     ++  G+A+ L    A +   + 
Sbjct: 115 FCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTS 171
Query: 857 AGSYGYIAPEYAYTLKVDE--KSDVYSFGVVLLELIAGKKP 895
            GS  +  PE A  L      K D++S GV L  +  G  P
Sbjct: 172 QGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYP 212

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 96/208 (46%), Gaps = 13/208 (6%)
Query: 691 LESLKDENIIGKGGAGIVYRGSMP-DGIDVAIKRL-VGRGTGGNDHGFLAEIQTLGRIRH 748
           +E+ +    IG+G  G+VY+      G  VA+K++ +   T G     + EI  L  + H
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 749 RNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAK--GGHLKWETRYRIALEAAKGLCY 806
            NIV+LL  +   +   L++E++ +  L + +  +   G  L     Y   L      C+
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 807 LHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPE 866
            H      ++HRD+K  N+L++++    +ADFGLA+       +     V  +  Y APE
Sbjct: 121 SHR-----VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPE 173
Query: 867 YAYTLKVDEKS-DVYSFGVVLLELIAGK 893
                K    + D++S G +  E++  +
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 96/208 (46%), Gaps = 13/208 (6%)
Query: 691 LESLKDENIIGKGGAGIVYRGSMP-DGIDVAIKRL-VGRGTGGNDHGFLAEIQTLGRIRH 748
           +E+ +    IG+G  G+VY+      G  VA+K++ +   T G     + EI  L  + H
Sbjct: 3   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 62
Query: 749 RNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAK--GGHLKWETRYRIALEAAKGLCY 806
            NIV+LL  +   +   L++E++ +  L + +  +   G  L     Y   L      C+
Sbjct: 63  PNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 121
Query: 807 LHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPE 866
            H      ++HRD+K  N+L++++    +ADFGLA+       +     V  +  Y APE
Sbjct: 122 SHR-----VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPE 174
Query: 867 YAYTLKVDEKS-DVYSFGVVLLELIAGK 893
                K    + D++S G +  E++  +
Sbjct: 175 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 96/208 (46%), Gaps = 13/208 (6%)
Query: 691 LESLKDENIIGKGGAGIVYRGSMP-DGIDVAIKRL-VGRGTGGNDHGFLAEIQTLGRIRH 748
           +E+ +    IG+G  G+VY+      G  VA+K++ +   T G     + EI  L  + H
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 749 RNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAK--GGHLKWETRYRIALEAAKGLCY 806
            NIV+LL  +   +   L++E++ +  L + +  +   G  L     Y   L      C+
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLSFCH 120
Query: 807 LHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPE 866
            H      ++HRD+K  N+L++++    +ADFGLA+       +     V  +  Y APE
Sbjct: 121 SHR-----VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPE 173
Query: 867 YAYTLKVDEKS-DVYSFGVVLLELIAGK 893
                K    + D++S G +  E++  +
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/224 (25%), Positives = 103/224 (45%), Gaps = 25/224 (11%)
Query: 681 QRLDFKAEDVLESLKDENIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHG--FL 737
           Q L+    +V E  ++ + IG G  G V        G+ VA+K+L  R      H     
Sbjct: 16  QELNKTIWEVPERYQNLSPIGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTY 74
Query: 738 AEIQTLGRIRHRNIVRLLGYVS-----NRDTNLLLYEYMPNGSLGEMLHGAK--GGHLKW 790
            E++ L  ++H N++ LL   +         ++ L  ++    L  ++   K    H+++
Sbjct: 75  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 134
Query: 791 ETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS 850
                +  +  +GL Y+H   S  IIHRD+K +N+ ++ D E  + DFGLA+   D    
Sbjct: 135 -----LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDE--- 183
Query: 851 ECMSSVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELIAGK 893
             M+    +  Y APE     +  ++  D++S G ++ EL+ G+
Sbjct: 184 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 92/198 (46%), Gaps = 7/198 (3%)
Query: 700 IGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYV 758
           IG+G  G+V       + + VAIK++            L EI+ L R RH NI+ +   +
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHENIIGINDII 94
Query: 759 SNRDTNLLLYEYMPNGSLGEMLHGA-KGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIH 817
                  +   Y+    +   L+   K  HL  +       +  +GL Y+H   S  ++H
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVLH 151
Query: 818 RDVKSNNILLDSDFEAHVADFGLAKFLQ-DAGASECMSSVAGSYGYIAPEYAYTLKVDEK 876
           RD+K +N+LL++  +  + DFGLA+    D   +  ++    +  Y APE     K   K
Sbjct: 152 RDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 211
Query: 877 S-DVYSFGVVLLELIAGK 893
           S D++S G +L E+++ +
Sbjct: 212 SIDIWSVGCILAEMLSNR 229

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 94/200 (47%), Gaps = 11/200 (5%)
Query: 700 IGKGGAGIVYRGSMPDGID---VAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLG 756
           IG+G  G+V   S  D ++   VAIK++            L EI+ L R RH NI+ +  
Sbjct: 31  IGEGAYGMV--CSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 88
Query: 757 YVSNRDTNLLLYEYMPNGSLGEMLHGA-KGGHLKWETRYRIALEAAKGLCYLHHDCSPLI 815
            +       +   Y+    +   L+   K  HL  +       +  +GL Y+H   S  +
Sbjct: 89  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANV 145
Query: 816 IHRDVKSNNILLDSDFEAHVADFGLAKFLQ-DAGASECMSSVAGSYGYIAPEYAYTLKVD 874
           +HRD+K +N+LL++  +  + DFGLA+    D   +  ++    +  Y APE     K  
Sbjct: 146 LHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 205
Query: 875 EKS-DVYSFGVVLLELIAGK 893
            KS D++S G +L E+++ +
Sbjct: 206 TKSIDIWSVGCILAEMLSNR 225

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/174 (30%), Positives = 84/174 (48%), Gaps = 9/174 (5%)
Query: 734 HGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNL-LLYEYMPNGSLGEMLHGAKGGHLKWET 792
            G + E + L ++  R IV L  Y     T+L L+   M  G +   ++     +  ++ 
Sbjct: 230 QGAMVEKKILAKVHSRFIVSL-AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQE 288
Query: 793 RYRIALEA--AKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS 850
              I   A    GL +LH      II+RD+K  N+LLD D    ++D GLA  L+ AG +
Sbjct: 289 PRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELK-AGQT 344
Query: 851 ECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVD 904
           +     AG+ G++APE     + D   D ++ GV L E+IA + P    G+ V+
Sbjct: 345 K-TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE 397

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 53/174 (30%), Positives = 84/174 (48%), Gaps = 9/174 (5%)
Query: 734 HGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNL-LLYEYMPNGSLGEMLHGAKGGHLKWET 792
            G + E + L ++  R IV L  Y     T+L L+   M  G +   ++     +  ++ 
Sbjct: 230 QGAMVEKKILAKVHSRFIVSL-AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQE 288
Query: 793 RYRIALEA--AKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS 850
              I   A    GL +LH      II+RD+K  N+LLD D    ++D GLA  L+ AG +
Sbjct: 289 PRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELK-AGQT 344
Query: 851 ECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVD 904
           +     AG+ G++APE     + D   D ++ GV L E+IA + P    G+ V+
Sbjct: 345 K-TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE 397

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/236 (23%), Positives = 100/236 (42%), Gaps = 31/236 (13%)
Query: 684 DFKAEDVLESLKDENIIGKGGAGIVYRGSMPD------GIDVAIKRLVGRGTGGNDHGFL 737
           D K E   E+L+   ++G G  G V   +          I VA+K L  +         +
Sbjct: 37  DLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALM 96
Query: 738 AEIQTLGRI-RHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKG----GHLKWET 792
           +E++ + ++  H NIV LLG  +      L++EY   G L   L   +       +++E 
Sbjct: 97  SELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYEN 156
Query: 793 RYRI-----------------ALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHV 835
           + R+                 A + AKG+ +L        +HRD+ + N+L+       +
Sbjct: 157 QKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSC---VHRDLAARNVLVTHGKVVKI 213
Query: 836 ADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA 891
            DFGLA+ +          +      ++APE  +      KSDV+S+G++L E+ +
Sbjct: 214 CDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 53/174 (30%), Positives = 84/174 (48%), Gaps = 9/174 (5%)
Query: 734 HGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNL-LLYEYMPNGSLGEMLHGAKGGHLKWET 792
            G + E + L ++  R IV L  Y     T+L L+   M  G +   ++     +  ++ 
Sbjct: 230 QGAMVEKKILAKVHSRFIVSL-AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQE 288
Query: 793 RYRIALEA--AKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS 850
              I   A    GL +LH      II+RD+K  N+LLD D    ++D GLA  L+ AG +
Sbjct: 289 PRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELK-AGQT 344
Query: 851 ECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVD 904
           +     AG+ G++APE     + D   D ++ GV L E+IA + P    G+ V+
Sbjct: 345 K-TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE 397

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 96/208 (46%), Gaps = 13/208 (6%)
Query: 691 LESLKDENIIGKGGAGIVYRGSMP-DGIDVAIKRL-VGRGTGGNDHGFLAEIQTLGRIRH 748
           +E+ +    IG+G  G+VY+      G  VA+K++ +   T G     + EI  L  + H
Sbjct: 5   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 64
Query: 749 RNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAK--GGHLKWETRYRIALEAAKGLCY 806
            NIV+LL  +   +   L++E++ +  L + +  +   G  L     Y   L      C+
Sbjct: 65  PNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 123
Query: 807 LHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPE 866
            H      ++HRD+K  N+L++++    +ADFGLA+       +     V  +  Y APE
Sbjct: 124 SHR-----VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPE 176
Query: 867 YAYTLKVDEKS-DVYSFGVVLLELIAGK 893
                K    + D++S G +  E++  +
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 96/208 (46%), Gaps = 13/208 (6%)
Query: 691 LESLKDENIIGKGGAGIVYRGSMP-DGIDVAIKRL-VGRGTGGNDHGFLAEIQTLGRIRH 748
           +E+ +    IG+G  G+VY+      G  VA+K++ +   T G     + EI  L  + H
Sbjct: 4   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 63
Query: 749 RNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAK--GGHLKWETRYRIALEAAKGLCY 806
            NIV+LL  +   +   L++E++ +  L + +  +   G  L     Y   L      C+
Sbjct: 64  PNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 122
Query: 807 LHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPE 866
            H      ++HRD+K  N+L++++    +ADFGLA+       +     V  +  Y APE
Sbjct: 123 SHR-----VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPE 175
Query: 867 YAYTLKVDEKS-DVYSFGVVLLELIAGK 893
                K    + D++S G +  E++  +
Sbjct: 176 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/272 (22%), Positives = 106/272 (38%), Gaps = 40/272 (14%)
Query: 716 GIDVAIKRLVGRGTGGNDHGFLAEIQTLGRI-RHRNIVRLLGYVSNRDTNLLLYEYMPNG 774
            + VA+K L            ++E++ L  +  H NIV LLG  +     L++ EY   G
Sbjct: 76  AMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYG 135
Query: 775 SLGEMLHGAKGGHLKWETRYRI----------------ALEAAKGLCYLHHDCSPLIIHR 818
            L   L   +   +  +T   I                + + AKG+ +L    S   IHR
Sbjct: 136 DLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL---ASKNCIHR 192
Query: 819 DVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSD 878
           D+ + NILL       + DFGLA+ +++        +      ++APE  +      +SD
Sbjct: 193 DLAARNILLTHGRITKICDFGLARHIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESD 252
Query: 879 VYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDPRLSGYP 937
           V+S+G+ L EL + G  P                       P D+     + +      P
Sbjct: 253 VWSYGIFLWELFSLGSSPYP-------------------GMPVDSKFYKMIKEGFRMLSP 293
Query: 938 LTGVIHLFKVAMMCVEDESSARPTMREVVHML 969
                 ++ +   C + +   RPT +++V ++
Sbjct: 294 EHAPAEMYDIMKTCWDADPLKRPTFKQIVQLI 325

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 94/200 (47%), Gaps = 11/200 (5%)
Query: 700 IGKGGAGIVYRGSMPDGID---VAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLG 756
           IG+G  G+V   S  D ++   VAIK++            L EI+ L R RH NI+ +  
Sbjct: 31  IGEGAYGMV--CSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 88
Query: 757 YVSNRDTNLLLYEYMPNGSLGEMLHGA-KGGHLKWETRYRIALEAAKGLCYLHHDCSPLI 815
            +       +   Y+    +   L+   K  HL  +       +  +GL Y+H   S  +
Sbjct: 89  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANV 145
Query: 816 IHRDVKSNNILLDSDFEAHVADFGLAKFLQ-DAGASECMSSVAGSYGYIAPEYAYTLKVD 874
           +HRD+K +N+LL++  +  + DFGLA+    D   +  ++    +  Y APE     K  
Sbjct: 146 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 205
Query: 875 EKS-DVYSFGVVLLELIAGK 893
            KS D++S G +L E+++ +
Sbjct: 206 TKSIDIWSVGCILAEMLSNR 225

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 96/226 (42%), Gaps = 18/226 (7%)
Query: 677 LTAFQRLDFKAEDVLESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGT--GGNDH 734
           +   + L  KAED  E +K   +IG+G  G V          V   +L+ +      +D 
Sbjct: 58  INKIRDLRMKAED-YEVVK---VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDS 113
Query: 735 GFLAEIQTLGRIRHRNIVRLLGYVSNRDTNL-LLYEYMPNGSLGEMLHGAKGGHLKWETR 793
            F  E + +    +   V  L Y    D  L ++ EYMP G L  ++        KW   
Sbjct: 114 AFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPE-KWARF 172
Query: 794 YRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECM 853
           Y    E    L  +H   S   IHRDVK +N+LLD      +ADFG    +   G   C 
Sbjct: 173 Y--TAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCD 227
Query: 854 SSVAGSYGYIAPEYAYTLKVD----EKSDVYSFGVVLLELIAGKKP 895
           ++V G+  YI+PE   +   D     + D +S GV L E++ G  P
Sbjct: 228 TAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 96/208 (46%), Gaps = 13/208 (6%)
Query: 691 LESLKDENIIGKGGAGIVYRGSMP-DGIDVAIKRL-VGRGTGGNDHGFLAEIQTLGRIRH 748
           +E+ +    IG+G  G+VY+      G  VA+K++ +   T G     + EI  L  + H
Sbjct: 6   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 65
Query: 749 RNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAK--GGHLKWETRYRIALEAAKGLCY 806
            NIV+LL  +   +   L++E++ +  L + +  +   G  L     Y   L      C+
Sbjct: 66  PNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 124
Query: 807 LHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPE 866
            H      ++HRD+K  N+L++++    +ADFGLA+       +     V  +  Y APE
Sbjct: 125 SHR-----VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPE 177
Query: 867 YAYTLKVDEKS-DVYSFGVVLLELIAGK 893
                K    + D++S G +  E++  +
Sbjct: 178 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 94/200 (47%), Gaps = 11/200 (5%)
Query: 700 IGKGGAGIVYRGSMPDGID---VAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLG 756
           IG+G  G+V   S  D ++   VAIK++            L EI+ L R RH NI+ +  
Sbjct: 31  IGEGAYGMV--CSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 88
Query: 757 YVSNRDTNLLLYEYMPNGSLGEMLHGA-KGGHLKWETRYRIALEAAKGLCYLHHDCSPLI 815
            +       +   Y+    +   L+   K  HL  +       +  +GL Y+H   S  +
Sbjct: 89  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANV 145
Query: 816 IHRDVKSNNILLDSDFEAHVADFGLAKFLQ-DAGASECMSSVAGSYGYIAPEYAYTLKVD 874
           +HRD+K +N+LL++  +  + DFGLA+    D   +  ++    +  Y APE     K  
Sbjct: 146 LHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 205
Query: 875 EKS-DVYSFGVVLLELIAGK 893
            KS D++S G +L E+++ +
Sbjct: 206 TKSIDIWSVGCILAEMLSNR 225

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 94/200 (47%), Gaps = 11/200 (5%)
Query: 700 IGKGGAGIVYRGSMPDGID---VAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLG 756
           IG+G  G+V   S  D ++   VAIK++            L EI+ L R RH NI+ +  
Sbjct: 33  IGEGAYGMV--CSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 90
Query: 757 YVSNRDTNLLLYEYMPNGSLGEMLHGA-KGGHLKWETRYRIALEAAKGLCYLHHDCSPLI 815
            +       +   Y+    +   L+   K  HL  +       +  +GL Y+H   S  +
Sbjct: 91  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANV 147
Query: 816 IHRDVKSNNILLDSDFEAHVADFGLAKFLQ-DAGASECMSSVAGSYGYIAPEYAYTLKVD 874
           +HRD+K +N+LL++  +  + DFGLA+    D   +  ++    +  Y APE     K  
Sbjct: 148 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 207
Query: 875 EKS-DVYSFGVVLLELIAGK 893
            KS D++S G +L E+++ +
Sbjct: 208 TKSIDIWSVGCILAEMLSNR 227

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 96/226 (42%), Gaps = 18/226 (7%)
Query: 677 LTAFQRLDFKAEDVLESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGT--GGNDH 734
           +   + L  KAED  E +K   +IG+G  G V          V   +L+ +      +D 
Sbjct: 63  INKIRDLRMKAED-YEVVK---VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDS 118
Query: 735 GFLAEIQTLGRIRHRNIVRLLGYVSNRDTNL-LLYEYMPNGSLGEMLHGAKGGHLKWETR 793
            F  E + +    +   V  L Y    D  L ++ EYMP G L  ++        KW   
Sbjct: 119 AFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPE-KWARF 177
Query: 794 YRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECM 853
           Y    E    L  +H   S   IHRDVK +N+LLD      +ADFG    +   G   C 
Sbjct: 178 Y--TAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCD 232
Query: 854 SSVAGSYGYIAPEYAYTLKVD----EKSDVYSFGVVLLELIAGKKP 895
           ++V G+  YI+PE   +   D     + D +S GV L E++ G  P
Sbjct: 233 TAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 277

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 103/224 (45%), Gaps = 25/224 (11%)
Query: 681 QRLDFKAEDVLESLKDENIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHG--FL 737
           Q L+    +V E  ++ + +G G  G V        G+ VA+K+L  R      H     
Sbjct: 11  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTY 69
Query: 738 AEIQTLGRIRHRNIVRLLGYVS-----NRDTNLLLYEYMPNGSLGEMLHGAK--GGHLKW 790
            E++ L  ++H N++ LL   +         ++ L  ++    L  ++   K    H+++
Sbjct: 70  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 129
Query: 791 ETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS 850
                +  +  +GL Y+H   S  IIHRD+K +N+ ++ D E  + DFGLA+   D    
Sbjct: 130 -----LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--- 178
Query: 851 ECMSSVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELIAGK 893
             M+    +  Y APE     +  ++  D++S G ++ EL+ G+
Sbjct: 179 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 96/208 (46%), Gaps = 13/208 (6%)
Query: 691 LESLKDENIIGKGGAGIVYRGSMP-DGIDVAIKRL-VGRGTGGNDHGFLAEIQTLGRIRH 748
           +E+ +    IG+G  G+VY+      G  VA+K++ +   T G     + EI  L  + H
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 749 RNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAK--GGHLKWETRYRIALEAAKGLCY 806
            NIV+LL  +   +   L++E++ +  L + +  +   G  L     Y   L      C+
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFL-HQDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 807 LHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPE 866
            H      ++HRD+K  N+L++++    +ADFGLA+       +     V  +  Y APE
Sbjct: 121 SHR-----VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPE 173
Query: 867 YAYTLKVDEKS-DVYSFGVVLLELIAGK 893
                K    + D++S G +  E++  +
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 100/204 (49%), Gaps = 19/204 (9%)
Query: 700 IGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHGFLA-EIQTLGRIRHRNIVRLLGY 757
           +GKG   +V R      G++ A K +  +     D   L  E +   +++H NIVRL   
Sbjct: 37  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 96
Query: 758 VSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIH 817
           +     + L+++ +  G L E +  A+  + + +  + I  +  + + Y H   S  I+H
Sbjct: 97  IQEESFHYLVFDLVTGGELFEDI-VAREFYSEADASHCIQ-QILESIAYCH---SNGIVH 151
Query: 818 RDVKSNNILLDSDFE---AHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVD 874
           R++K  N+LL S  +     +ADFGLA  + D   SE     AG+ GY++PE    LK D
Sbjct: 152 RNLKPENLLLASKAKGAAVKLADFGLAIEVND---SEAWHGFAGTPGYLSPE---VLKKD 205
Query: 875 EKS---DVYSFGVVLLELIAGKKP 895
             S   D+++ GV+L  L+ G  P
Sbjct: 206 PYSKPVDIWACGVILYILLVGYPP 229

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 96/208 (46%), Gaps = 13/208 (6%)
Query: 691 LESLKDENIIGKGGAGIVYRGSMP-DGIDVAIKRL-VGRGTGGNDHGFLAEIQTLGRIRH 748
           +E+ +    IG+G  G+VY+      G  VA+K++ +   T G     + EI  L  + H
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 749 RNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAK--GGHLKWETRYRIALEAAKGLCY 806
            NIV+LL  +   +   L++E++ +  L + +  +   G  L     Y   L      C+
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 807 LHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPE 866
            H      ++HRD+K  N+L++++    +ADFGLA+       +     V  +  Y APE
Sbjct: 121 SHR-----VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPE 173
Query: 867 YAYTLKVDEKS-DVYSFGVVLLELIAGK 893
                K    + D++S G +  E++  +
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 96/208 (46%), Gaps = 13/208 (6%)
Query: 691 LESLKDENIIGKGGAGIVYRGSMP-DGIDVAIKRL-VGRGTGGNDHGFLAEIQTLGRIRH 748
           +E+ +    IG+G  G+VY+      G  VA+K++ +   T G     + EI  L  + H
Sbjct: 6   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 65
Query: 749 RNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAK--GGHLKWETRYRIALEAAKGLCY 806
            NIV+LL  +   +   L++E++ +  L + +  +   G  L     Y   L      C+
Sbjct: 66  PNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 124
Query: 807 LHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPE 866
            H      ++HRD+K  N+L++++    +ADFGLA+       +     V  +  Y APE
Sbjct: 125 SHR-----VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPE 177
Query: 867 YAYTLKVDEKS-DVYSFGVVLLELIAGK 893
                K    + D++S G +  E++  +
Sbjct: 178 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 96/208 (46%), Gaps = 13/208 (6%)
Query: 691 LESLKDENIIGKGGAGIVYRGSMP-DGIDVAIKRL-VGRGTGGNDHGFLAEIQTLGRIRH 748
           +E+ +    IG+G  G+VY+      G  VA+K++ +   T G     + EI  L  + H
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 749 RNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAK--GGHLKWETRYRIALEAAKGLCY 806
            NIV+LL  +   +   L++E++ +  L + +  +   G  L     Y   L      C+
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 807 LHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPE 866
            H      ++HRD+K  N+L++++    +ADFGLA+       +     V  +  Y APE
Sbjct: 120 SHR-----VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPE 172
Query: 867 YAYTLKVDEKS-DVYSFGVVLLELIAGK 893
                K    + D++S G +  E++  +
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 96/208 (46%), Gaps = 13/208 (6%)
Query: 691 LESLKDENIIGKGGAGIVYRGSMP-DGIDVAIKRL-VGRGTGGNDHGFLAEIQTLGRIRH 748
           +E+ +    IG+G  G+VY+      G  VA+K++ +   T G     + EI  L  + H
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 749 RNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAK--GGHLKWETRYRIALEAAKGLCY 806
            NIV+LL  +   +   L++E++ +  L + +  +   G  L     Y   L      C+
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 807 LHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPE 866
            H      ++HRD+K  N+L++++    +ADFGLA+       +     V  +  Y APE
Sbjct: 121 SHR-----VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPE 173
Query: 867 YAYTLKVDEKS-DVYSFGVVLLELIAGK 893
                K    + D++S G +  E++  +
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 94/200 (47%), Gaps = 11/200 (5%)
Query: 700 IGKGGAGIVYRGSMPDGID---VAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLG 756
           IG+G  G+V   S  D ++   VAIK++            L EI+ L R RH NI+ +  
Sbjct: 51  IGEGAYGMV--CSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 108
Query: 757 YVSNRDTNLLLYEYMPNGSLGEMLHGA-KGGHLKWETRYRIALEAAKGLCYLHHDCSPLI 815
            +       +   Y+    +   L+   K  HL  +       +  +GL Y+H   S  +
Sbjct: 109 IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANV 165
Query: 816 IHRDVKSNNILLDSDFEAHVADFGLAKFLQ-DAGASECMSSVAGSYGYIAPEYAYTLKVD 874
           +HRD+K +N+LL++  +  + DFGLA+    D   +  ++    +  Y APE     K  
Sbjct: 166 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 225
Query: 875 EKS-DVYSFGVVLLELIAGK 893
            KS D++S G +L E+++ +
Sbjct: 226 TKSIDIWSVGCILAEMLSNR 245

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 96/208 (46%), Gaps = 13/208 (6%)
Query: 691 LESLKDENIIGKGGAGIVYRGSMP-DGIDVAIKRL-VGRGTGGNDHGFLAEIQTLGRIRH 748
           +E+ +    IG+G  G+VY+      G  VA+K++ +   T G     + EI  L  + H
Sbjct: 5   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 64
Query: 749 RNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAK--GGHLKWETRYRIALEAAKGLCY 806
            NIV+LL  +   +   L++E++ +  L + +  +   G  L     Y   L      C+
Sbjct: 65  PNIVKLLDVIHTENKLYLVFEFL-SMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCH 123
Query: 807 LHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPE 866
            H      ++HRD+K  N+L++++    +ADFGLA+       +     V  +  Y APE
Sbjct: 124 SHR-----VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPE 176
Query: 867 YAYTLKVDEKS-DVYSFGVVLLELIAGK 893
                K    + D++S G +  E++  +
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 96/208 (46%), Gaps = 13/208 (6%)
Query: 691 LESLKDENIIGKGGAGIVYRGSMP-DGIDVAIKRL-VGRGTGGNDHGFLAEIQTLGRIRH 748
           +E+ +    IG+G  G+VY+      G  VA+K++ +   T G     + EI  L  + H
Sbjct: 5   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 64
Query: 749 RNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAK--GGHLKWETRYRIALEAAKGLCY 806
            NIV+LL  +   +   L++E++ +  L + +  +   G  L     Y   L      C+
Sbjct: 65  PNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 123
Query: 807 LHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPE 866
            H      ++HRD+K  N+L++++    +ADFGLA+       +     V  +  Y APE
Sbjct: 124 SHR-----VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPE 176
Query: 867 YAYTLKVDEKS-DVYSFGVVLLELIAGK 893
                K    + D++S G +  E++  +
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 96/208 (46%), Gaps = 13/208 (6%)
Query: 691 LESLKDENIIGKGGAGIVYRGSMP-DGIDVAIKRL-VGRGTGGNDHGFLAEIQTLGRIRH 748
           +E+ +    IG+G  G+VY+      G  VA+K++ +   T G     + EI  L  + H
Sbjct: 4   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 63
Query: 749 RNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAK--GGHLKWETRYRIALEAAKGLCY 806
            NIV+LL  +   +   L++E++ +  L + +  +   G  L     Y   L      C+
Sbjct: 64  PNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 122
Query: 807 LHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPE 866
            H      ++HRD+K  N+L++++    +ADFGLA+       +     V  +  Y APE
Sbjct: 123 SHR-----VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPE 175
Query: 867 YAYTLKVDEKS-DVYSFGVVLLELIAGK 893
                K    + D++S G +  E++  +
Sbjct: 176 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 94/200 (47%), Gaps = 11/200 (5%)
Query: 700 IGKGGAGIVYRGSMPDGID---VAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLG 756
           IG+G  G+V   S  D ++   VAIK++            L EI+ L R RH NI+ +  
Sbjct: 39  IGEGAYGMV--CSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 96
Query: 757 YVSNRDTNLLLYEYMPNGSLGEMLHGA-KGGHLKWETRYRIALEAAKGLCYLHHDCSPLI 815
            +       +   Y+    +   L+   K  HL  +       +  +GL Y+H   S  +
Sbjct: 97  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANV 153
Query: 816 IHRDVKSNNILLDSDFEAHVADFGLAKFLQ-DAGASECMSSVAGSYGYIAPEYAYTLKVD 874
           +HRD+K +N+LL++  +  + DFGLA+    D   +  ++    +  Y APE     K  
Sbjct: 154 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 213
Query: 875 EKS-DVYSFGVVLLELIAGK 893
            KS D++S G +L E+++ +
Sbjct: 214 TKSIDIWSVGCILAEMLSNR 233

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 94/200 (47%), Gaps = 11/200 (5%)
Query: 700 IGKGGAGIVYRGSMPDGID---VAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLG 756
           IG+G  G+V   S  D ++   VAIK++            L EI+ L R RH NI+ +  
Sbjct: 31  IGEGAYGMV--CSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 88
Query: 757 YVSNRDTNLLLYEYMPNGSLGEMLHGA-KGGHLKWETRYRIALEAAKGLCYLHHDCSPLI 815
            +       +   Y+    +   L+   K  HL  +       +  +GL Y+H   S  +
Sbjct: 89  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANV 145
Query: 816 IHRDVKSNNILLDSDFEAHVADFGLAKFLQ-DAGASECMSSVAGSYGYIAPEYAYTLKVD 874
           +HRD+K +N+LL++  +  + DFGLA+    D   +  ++    +  Y APE     K  
Sbjct: 146 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 205
Query: 875 EKS-DVYSFGVVLLELIAGK 893
            KS D++S G +L E+++ +
Sbjct: 206 TKSIDIWSVGCILAEMLSNR 225

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 103/224 (45%), Gaps = 25/224 (11%)
Query: 681 QRLDFKAEDVLESLKDENIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHG--FL 737
           Q L+    +V E  ++ + +G G  G V        G+ VA+K+L  R      H     
Sbjct: 13  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTY 71
Query: 738 AEIQTLGRIRHRNIVRLLGYVS-----NRDTNLLLYEYMPNGSLGEMLHGAK--GGHLKW 790
            E++ L  ++H N++ LL   +         ++ L  ++    L  ++   K    H+++
Sbjct: 72  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 131
Query: 791 ETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS 850
                +  +  +GL Y+H   S  IIHRD+K +N+ ++ D E  + DFGLA+   D    
Sbjct: 132 -----LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--- 180
Query: 851 ECMSSVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELIAGK 893
             M+    +  Y APE     +  ++  D++S G ++ EL+ G+
Sbjct: 181 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 103/224 (45%), Gaps = 25/224 (11%)
Query: 681 QRLDFKAEDVLESLKDENIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHG--FL 737
           Q L+    +V E  ++ + +G G  G V        G+ VA+K+L  R      H     
Sbjct: 11  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTY 69
Query: 738 AEIQTLGRIRHRNIVRLLGYVS-----NRDTNLLLYEYMPNGSLGEMLHGAK--GGHLKW 790
            E++ L  ++H N++ LL   +         ++ L  ++    L  ++   K    H+++
Sbjct: 70  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 129
Query: 791 ETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS 850
                +  +  +GL Y+H   S  IIHRD+K +N+ ++ D E  + DFGLA+   D    
Sbjct: 130 -----LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--- 178
Query: 851 ECMSSVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELIAGK 893
             M+    +  Y APE     +  ++  D++S G ++ EL+ G+
Sbjct: 179 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 103/224 (45%), Gaps = 25/224 (11%)
Query: 681 QRLDFKAEDVLESLKDENIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHG--FL 737
           Q L+    +V E  ++ + +G G  G V        G+ VA+K+L  R      H     
Sbjct: 11  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTY 69
Query: 738 AEIQTLGRIRHRNIVRLLGYVS-----NRDTNLLLYEYMPNGSLGEMLHGAK--GGHLKW 790
            E++ L  ++H N++ LL   +         ++ L  ++    L  ++   K    H+++
Sbjct: 70  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 129
Query: 791 ETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS 850
                +  +  +GL Y+H   S  IIHRD+K +N+ ++ D E  + DFGLA+   D    
Sbjct: 130 -----LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--- 178
Query: 851 ECMSSVAGSYGYIAPEYAY-TLKVDEKSDVYSFGVVLLELIAGK 893
             M+    +  Y APE     +  ++  D++S G ++ EL+ G+
Sbjct: 179 --MTGYVATRWYRAPEIMLNAMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 53/174 (30%), Positives = 84/174 (48%), Gaps = 9/174 (5%)
Query: 734 HGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNL-LLYEYMPNGSLGEMLHGAKGGHLKWET 792
            G + E + L ++  R IV L  Y     T+L L+   M  G +   ++     +  ++ 
Sbjct: 230 QGAMVEKKILAKVHSRFIVSL-AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQE 288
Query: 793 RYRIALEA--AKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS 850
              I   A    GL +LH      II+RD+K  N+LLD D    ++D GLA  L+ AG +
Sbjct: 289 PRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELK-AGQT 344
Query: 851 ECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVD 904
           +     AG+ G++APE     + D   D ++ GV L E+IA + P    G+ V+
Sbjct: 345 K-TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE 397

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 96/208 (46%), Gaps = 13/208 (6%)
Query: 691 LESLKDENIIGKGGAGIVYRGSMP-DGIDVAIKRL-VGRGTGGNDHGFLAEIQTLGRIRH 748
           +E+ +    IG+G  G+VY+      G  VA+K++ +   T G     + EI  L  + H
Sbjct: 3   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 62
Query: 749 RNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAK--GGHLKWETRYRIALEAAKGLCY 806
            NIV+LL  +   +   L++E++ +  L + +  +   G  L     Y   L      C+
Sbjct: 63  PNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 121
Query: 807 LHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPE 866
            H      ++HRD+K  N+L++++    +ADFGLA+       +     V  +  Y APE
Sbjct: 122 SHR-----VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPE 174
Query: 867 YAYTLKVDEKS-DVYSFGVVLLELIAGK 893
                K    + D++S G +  E++  +
Sbjct: 175 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 96/208 (46%), Gaps = 13/208 (6%)
Query: 691 LESLKDENIIGKGGAGIVYRGSMP-DGIDVAIKRL-VGRGTGGNDHGFLAEIQTLGRIRH 748
           +E+ +    IG+G  G+VY+      G  VA+K++ +   T G     + EI  L  + H
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 749 RNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAK--GGHLKWETRYRIALEAAKGLCY 806
            NIV+LL  +   +   L++E++ +  L + +  +   G  L     Y   L      C+
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 807 LHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPE 866
            H      ++HRD+K  N+L++++    +ADFGLA+       +     V  +  Y APE
Sbjct: 120 SHR-----VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPE 172
Query: 867 YAYTLKVDEKS-DVYSFGVVLLELIAGK 893
                K    + D++S G +  E++  +
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 103/224 (45%), Gaps = 25/224 (11%)
Query: 681 QRLDFKAEDVLESLKDENIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHG--FL 737
           Q L+    +V E  ++ + +G G  G V        G+ VA+K+L  R      H     
Sbjct: 11  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTY 69
Query: 738 AEIQTLGRIRHRNIVRLLGYVS-----NRDTNLLLYEYMPNGSLGEMLHGAK--GGHLKW 790
            E++ L  ++H N++ LL   +         ++ L  ++    L  ++   K    H+++
Sbjct: 70  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 129
Query: 791 ETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS 850
                +  +  +GL Y+H   S  IIHRD+K +N+ ++ D E  + DFGLA+   D    
Sbjct: 130 -----LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--- 178
Query: 851 ECMSSVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELIAGK 893
             M+    +  Y APE     +  ++  D++S G ++ EL+ G+
Sbjct: 179 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 103/224 (45%), Gaps = 25/224 (11%)
Query: 681 QRLDFKAEDVLESLKDENIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHG--FL 737
           Q L+    +V E  ++ + +G G  G V        G+ VA+K+L  R      H     
Sbjct: 11  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTY 69
Query: 738 AEIQTLGRIRHRNIVRLLGYVS-----NRDTNLLLYEYMPNGSLGEMLHGAK--GGHLKW 790
            E++ L  ++H N++ LL   +         ++ L  ++    L  ++   K    H+++
Sbjct: 70  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 129
Query: 791 ETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS 850
                +  +  +GL Y+H   S  IIHRD+K +N+ ++ D E  + DFGLA+   D    
Sbjct: 130 -----LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--- 178
Query: 851 ECMSSVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELIAGK 893
             M+    +  Y APE     +  ++  D++S G ++ EL+ G+
Sbjct: 179 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 103/224 (45%), Gaps = 25/224 (11%)
Query: 681 QRLDFKAEDVLESLKDENIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHG--FL 737
           Q L+    +V E  ++ + +G G  G V        G+ VA+K+L  R      H     
Sbjct: 8   QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTY 66
Query: 738 AEIQTLGRIRHRNIVRLLGYVS-----NRDTNLLLYEYMPNGSLGEMLHGAK--GGHLKW 790
            E++ L  ++H N++ LL   +         ++ L  ++    L  ++   K    H+++
Sbjct: 67  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 126
Query: 791 ETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS 850
                +  +  +GL Y+H   S  IIHRD+K +N+ ++ D E  + DFGLA+   D    
Sbjct: 127 -----LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--- 175
Query: 851 ECMSSVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELIAGK 893
             M+    +  Y APE     +  ++  D++S G ++ EL+ G+
Sbjct: 176 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 103/224 (45%), Gaps = 25/224 (11%)
Query: 681 QRLDFKAEDVLESLKDENIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHG--FL 737
           Q L+    +V E  ++ + +G G  G V        G+ VA+K+L  R      H     
Sbjct: 7   QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTY 65
Query: 738 AEIQTLGRIRHRNIVRLLGYVS-----NRDTNLLLYEYMPNGSLGEMLHGAK--GGHLKW 790
            E++ L  ++H N++ LL   +         ++ L  ++    L  ++   K    H+++
Sbjct: 66  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 125
Query: 791 ETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS 850
                +  +  +GL Y+H   S  IIHRD+K +N+ ++ D E  + DFGLA+   D    
Sbjct: 126 -----LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--- 174
Query: 851 ECMSSVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELIAGK 893
             M+    +  Y APE     +  ++  D++S G ++ EL+ G+
Sbjct: 175 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 68/225 (30%), Positives = 103/225 (45%), Gaps = 27/225 (12%)
Query: 681 QRLDFKAEDVLESLKDENIIGKGGAGIVYRGSMPDG---IDVAIKRLVGRGTGGNDHGFL 737
           Q +   A +V    +D   +G G  G V   S  DG     VAIK+L  R          
Sbjct: 14  QEVTKTAWEVRAVYRDLQPVGSGAYGAV--CSAVDGRTGAKVAIKKLY-RPFQSELFAKR 70
Query: 738 A--EIQTLGRIRHRNIVRLLGYVSNRDT---NLLLYEYMP--NGSLGEMLHGAKGGHLKW 790
           A  E++ L  +RH N++ LL   +  +T       Y  MP     LG+++   K G    
Sbjct: 71  AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLG---- 126
Query: 791 ETRYR-IALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGA 849
           E R + +  +  KGL Y+H   +  IIHRD+K  N+ ++ D E  + DFGLA+       
Sbjct: 127 EDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR----QAD 179
Query: 850 SECMSSVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELIAGK 893
           SE    V   + Y APE     ++  +  D++S G ++ E+I GK
Sbjct: 180 SEMXGXVVTRW-YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 103/224 (45%), Gaps = 25/224 (11%)
Query: 681 QRLDFKAEDVLESLKDENIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHG--FL 737
           Q L+    +V E  ++ + +G G  G V        G+ VA+K+L  R      H     
Sbjct: 11  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTY 69
Query: 738 AEIQTLGRIRHRNIVRLLGYVS-----NRDTNLLLYEYMPNGSLGEMLHGAK--GGHLKW 790
            E++ L  ++H N++ LL   +         ++ L  ++    L  ++   K    H+++
Sbjct: 70  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQF 129
Query: 791 ETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS 850
                +  +  +GL Y+H   S  IIHRD+K +N+ ++ D E  + DFGLA+   D    
Sbjct: 130 -----LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--- 178
Query: 851 ECMSSVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELIAGK 893
             M+    +  Y APE     +  ++  D++S G ++ EL+ G+
Sbjct: 179 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 103/224 (45%), Gaps = 25/224 (11%)
Query: 681 QRLDFKAEDVLESLKDENIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHG--FL 737
           Q L+    +V E  ++ + +G G  G V        G+ VA+K+L  R      H     
Sbjct: 16  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTY 74
Query: 738 AEIQTLGRIRHRNIVRLLGYVS-----NRDTNLLLYEYMPNGSLGEMLHGAK--GGHLKW 790
            E++ L  ++H N++ LL   +         ++ L  ++    L  ++   K    H+++
Sbjct: 75  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 134
Query: 791 ETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS 850
                +  +  +GL Y+H   S  IIHRD+K +N+ ++ D E  + DFGLA+   D    
Sbjct: 135 -----LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--- 183
Query: 851 ECMSSVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELIAGK 893
             M+    +  Y APE     +  ++  D++S G ++ EL+ G+
Sbjct: 184 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 103/224 (45%), Gaps = 25/224 (11%)
Query: 681 QRLDFKAEDVLESLKDENIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHG--FL 737
           Q L+    +V E  ++ + +G G  G V        G+ VA+K+L  R      H     
Sbjct: 11  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTY 69
Query: 738 AEIQTLGRIRHRNIVRLLGYVS-----NRDTNLLLYEYMPNGSLGEMLHGAK--GGHLKW 790
            E++ L  ++H N++ LL   +         ++ L  ++    L  ++   K    H+++
Sbjct: 70  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 129
Query: 791 ETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS 850
                +  +  +GL Y+H   S  IIHRD+K +N+ ++ D E  + DFGLA+   D    
Sbjct: 130 -----LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--- 178
Query: 851 ECMSSVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELIAGK 893
             M+    +  Y APE     +  ++  D++S G ++ EL+ G+
Sbjct: 179 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 103/224 (45%), Gaps = 25/224 (11%)
Query: 681 QRLDFKAEDVLESLKDENIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHG--FL 737
           Q L+    +V E  ++ + +G G  G V        G+ VA+K+L  R      H     
Sbjct: 9   QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTY 67
Query: 738 AEIQTLGRIRHRNIVRLLGYVS-----NRDTNLLLYEYMPNGSLGEMLHGAK--GGHLKW 790
            E++ L  ++H N++ LL   +         ++ L  ++    L  ++   K    H+++
Sbjct: 68  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 127
Query: 791 ETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS 850
                +  +  +GL Y+H   S  IIHRD+K +N+ ++ D E  + DFGLA+   D    
Sbjct: 128 -----LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--- 176
Query: 851 ECMSSVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELIAGK 893
             M+    +  Y APE     +  ++  D++S G ++ EL+ G+
Sbjct: 177 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 218

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 96/208 (46%), Gaps = 13/208 (6%)
Query: 691 LESLKDENIIGKGGAGIVYRGSMP-DGIDVAIKRL-VGRGTGGNDHGFLAEIQTLGRIRH 748
           +E+ +    IG+G  G+VY+      G  VA+K++ +   T G     + EI  L  + H
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 749 RNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAK--GGHLKWETRYRIALEAAKGLCY 806
            NIV+LL  +   +   L++E++ +  L + +  +   G  L     Y   L      C+
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 807 LHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPE 866
            H      ++HRD+K  N+L++++    +ADFGLA+       +     V  +  Y APE
Sbjct: 121 SHR-----VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPE 173
Query: 867 YAYTLKVDEKS-DVYSFGVVLLELIAGK 893
                K    + D++S G +  E++  +
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 96/208 (46%), Gaps = 13/208 (6%)
Query: 691 LESLKDENIIGKGGAGIVYRGSMP-DGIDVAIKRL-VGRGTGGNDHGFLAEIQTLGRIRH 748
           +E+ +    IG+G  G+VY+      G  VA+K++ +   T G     + EI  L  + H
Sbjct: 4   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 63
Query: 749 RNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAK--GGHLKWETRYRIALEAAKGLCY 806
            NIV+LL  +   +   L++E++ +  L + +  +   G  L     Y   L      C+
Sbjct: 64  PNIVKLLDVIHTENKLYLVFEFL-SMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCH 122
Query: 807 LHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPE 866
            H      ++HRD+K  N+L++++    +ADFGLA+       +     V  +  Y APE
Sbjct: 123 SHR-----VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPE 175
Query: 867 YAYTLKVDEKS-DVYSFGVVLLELIAGK 893
                K    + D++S G +  E++  +
Sbjct: 176 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 103/224 (45%), Gaps = 25/224 (11%)
Query: 681 QRLDFKAEDVLESLKDENIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHG--FL 737
           Q L+    +V E  ++ + +G G  G V        G+ VA+K+L  R      H     
Sbjct: 13  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTY 71
Query: 738 AEIQTLGRIRHRNIVRLLGYVS-----NRDTNLLLYEYMPNGSLGEMLHGAK--GGHLKW 790
            E++ L  ++H N++ LL   +         ++ L  ++    L  ++   K    H+++
Sbjct: 72  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 131
Query: 791 ETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS 850
                +  +  +GL Y+H   S  IIHRD+K +N+ ++ D E  + DFGLA+   D    
Sbjct: 132 -----LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--- 180
Query: 851 ECMSSVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELIAGK 893
             M+    +  Y APE     +  ++  D++S G ++ EL+ G+
Sbjct: 181 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 103/224 (45%), Gaps = 25/224 (11%)
Query: 681 QRLDFKAEDVLESLKDENIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHG--FL 737
           Q L+    +V E  ++ + +G G  G V        G+ VA+K+L  R      H     
Sbjct: 18  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTY 76
Query: 738 AEIQTLGRIRHRNIVRLLGYVS-----NRDTNLLLYEYMPNGSLGEMLHGAK--GGHLKW 790
            E++ L  ++H N++ LL   +         ++ L  ++    L  ++   K    H+++
Sbjct: 77  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 136
Query: 791 ETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS 850
                +  +  +GL Y+H   S  IIHRD+K +N+ ++ D E  + DFGLA+   D    
Sbjct: 137 -----LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--- 185
Query: 851 ECMSSVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELIAGK 893
             M+    +  Y APE     +  ++  D++S G ++ EL+ G+
Sbjct: 186 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 103/224 (45%), Gaps = 25/224 (11%)
Query: 681 QRLDFKAEDVLESLKDENIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHG--FL 737
           Q L+    +V E  ++ + +G G  G V        G+ VA+K+L  R      H     
Sbjct: 16  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTY 74
Query: 738 AEIQTLGRIRHRNIVRLLGYVS-----NRDTNLLLYEYMPNGSLGEMLHGAK--GGHLKW 790
            E++ L  ++H N++ LL   +         ++ L  ++    L  ++   K    H+++
Sbjct: 75  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 134
Query: 791 ETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS 850
                +  +  +GL Y+H   S  IIHRD+K +N+ ++ D E  + DFGLA+   D    
Sbjct: 135 -----LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDE--- 183
Query: 851 ECMSSVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELIAGK 893
             M+    +  Y APE     +  ++  D++S G ++ EL+ G+
Sbjct: 184 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 103/224 (45%), Gaps = 25/224 (11%)
Query: 681 QRLDFKAEDVLESLKDENIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHG--FL 737
           Q L+    +V E  ++ + +G G  G V        G+ VA+K+L  R      H     
Sbjct: 11  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTY 69
Query: 738 AEIQTLGRIRHRNIVRLLGYVS-----NRDTNLLLYEYMPNGSLGEMLHGAK--GGHLKW 790
            E++ L  ++H N++ LL   +         ++ L  ++    L  ++   K    H+++
Sbjct: 70  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 129
Query: 791 ETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS 850
                +  +  +GL Y+H   S  IIHRD+K +N+ ++ D E  + DFGLA+   D    
Sbjct: 130 -----LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--- 178
Query: 851 ECMSSVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELIAGK 893
             M+    +  Y APE     +  ++  D++S G ++ EL+ G+
Sbjct: 179 --MTGXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 96/208 (46%), Gaps = 13/208 (6%)
Query: 691 LESLKDENIIGKGGAGIVYRGSMP-DGIDVAIKRL-VGRGTGGNDHGFLAEIQTLGRIRH 748
           +E+ +    IG+G  G+VY+      G  VA+K++ +   T G     + EI  L  + H
Sbjct: 4   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 63
Query: 749 RNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAK--GGHLKWETRYRIALEAAKGLCY 806
            NIV+LL  +   +   L++E++ +  L + +  +   G  L     Y   L      C+
Sbjct: 64  PNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 122
Query: 807 LHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPE 866
            H      ++HRD+K  N+L++++    +ADFGLA+       +     V  +  Y APE
Sbjct: 123 SHR-----VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPE 175
Query: 867 YAYTLKVDEKS-DVYSFGVVLLELIAGK 893
                K    + D++S G +  E++  +
Sbjct: 176 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 103/224 (45%), Gaps = 25/224 (11%)
Query: 681 QRLDFKAEDVLESLKDENIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHG--FL 737
           Q L+    +V E  ++ + +G G  G V        G+ VA+K+L  R      H     
Sbjct: 16  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTY 74
Query: 738 AEIQTLGRIRHRNIVRLLGYVS-----NRDTNLLLYEYMPNGSLGEMLHGAK--GGHLKW 790
            E++ L  ++H N++ LL   +         ++ L  ++    L  ++   K    H+++
Sbjct: 75  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 134
Query: 791 ETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS 850
                +  +  +GL Y+H   S  IIHRD+K +N+ ++ D E  + DFGLA+   D    
Sbjct: 135 -----LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--- 183
Query: 851 ECMSSVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELIAGK 893
             M+    +  Y APE     +  ++  D++S G ++ EL+ G+
Sbjct: 184 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 103/224 (45%), Gaps = 25/224 (11%)
Query: 681 QRLDFKAEDVLESLKDENIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHG--FL 737
           Q L+    +V E  ++ + +G G  G V        G+ VA+K+L  R      H     
Sbjct: 10  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTY 68
Query: 738 AEIQTLGRIRHRNIVRLLGYVS-----NRDTNLLLYEYMPNGSLGEMLHGAK--GGHLKW 790
            E++ L  ++H N++ LL   +         ++ L  ++    L  ++   K    H+++
Sbjct: 69  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 128
Query: 791 ETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS 850
                +  +  +GL Y+H   S  IIHRD+K +N+ ++ D E  + DFGLA+   D    
Sbjct: 129 -----LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--- 177
Query: 851 ECMSSVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELIAGK 893
             M+    +  Y APE     +  ++  D++S G ++ EL+ G+
Sbjct: 178 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 219

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 94/200 (47%), Gaps = 11/200 (5%)
Query: 700 IGKGGAGIVYRGSMPDGID---VAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLG 756
           IG+G  G+V   S  D ++   VAIK++            L EI+ L R RH NI+ +  
Sbjct: 31  IGEGAYGMV--CSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 88
Query: 757 YVSNRDTNLLLYEYMPNGSLGEMLHGA-KGGHLKWETRYRIALEAAKGLCYLHHDCSPLI 815
            +       +   Y+    +   L+   K  HL  +       +  +GL Y+H   S  +
Sbjct: 89  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANV 145
Query: 816 IHRDVKSNNILLDSDFEAHVADFGLAKFLQ-DAGASECMSSVAGSYGYIAPEYAYTLKVD 874
           +HRD+K +N+LL++  +  + DFGLA+    D   +  ++    +  Y APE     K  
Sbjct: 146 LHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 205
Query: 875 EKS-DVYSFGVVLLELIAGK 893
            KS D++S G +L E+++ +
Sbjct: 206 TKSIDIWSVGCILAEMLSNR 225

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 92/198 (46%), Gaps = 7/198 (3%)
Query: 700 IGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYV 758
           IG+G  G+V       + + VAIK++            L EI+ L R RH NI+ +   +
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 759 SNRDTNLLLYEYMPNGSLGEMLHGA-KGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIH 817
                  +   Y+    +   L+   K  HL  +       +  +GL Y+H   S  ++H
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVLH 151
Query: 818 RDVKSNNILLDSDFEAHVADFGLAKFLQ-DAGASECMSSVAGSYGYIAPEYAYTLKVDEK 876
           RD+K +N+LL++  +  + DFGLA+    D   +  ++    +  Y APE     K   K
Sbjct: 152 RDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 211
Query: 877 S-DVYSFGVVLLELIAGK 893
           S D++S G +L E+++ +
Sbjct: 212 SIDIWSVGCILAEMLSNR 229

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 103/224 (45%), Gaps = 25/224 (11%)
Query: 681 QRLDFKAEDVLESLKDENIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHG--FL 737
           Q L+    +V E  ++ + +G G  G V        G+ VA+K+L  R      H     
Sbjct: 11  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTY 69
Query: 738 AEIQTLGRIRHRNIVRLLGYVS-----NRDTNLLLYEYMPNGSLGEMLHGAK--GGHLKW 790
            E++ L  ++H N++ LL   +         ++ L  ++    L  ++   K    H+++
Sbjct: 70  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQF 129
Query: 791 ETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS 850
                +  +  +GL Y+H   S  IIHRD+K +N+ ++ D E  + DFGLA+   D    
Sbjct: 130 -----LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDE--- 178
Query: 851 ECMSSVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELIAGK 893
             M+    +  Y APE     +  ++  D++S G ++ EL+ G+
Sbjct: 179 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 103/224 (45%), Gaps = 25/224 (11%)
Query: 681 QRLDFKAEDVLESLKDENIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHG--FL 737
           Q L+    +V E  ++ + +G G  G V        G+ VA+K+L  R      H     
Sbjct: 34  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTY 92
Query: 738 AEIQTLGRIRHRNIVRLLGYVS-----NRDTNLLLYEYMPNGSLGEMLHGAK--GGHLKW 790
            E++ L  ++H N++ LL   +         ++ L  ++    L  ++   K    H+++
Sbjct: 93  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 152
Query: 791 ETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS 850
                +  +  +GL Y+H   S  IIHRD+K +N+ ++ D E  + DFGLA+   D    
Sbjct: 153 -----LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--- 201
Query: 851 ECMSSVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELIAGK 893
             M+    +  Y APE     +  ++  D++S G ++ EL+ G+
Sbjct: 202 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 95/207 (45%), Gaps = 13/207 (6%)
Query: 692 ESLKDENIIGKGGAGIVYRGSMP-DGIDVAIKRL-VGRGTGGNDHGFLAEIQTLGRIRHR 749
           E+ +    IG+G  G+VY+      G  VA+K++ +   T G     + EI  L  + H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 750 NIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAK--GGHLKWETRYRIALEAAKGLCYL 807
           NIV+LL  +   +   L++E++ +  L + +  +   G  L     Y   L      C+ 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 808 HHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEY 867
           H      ++HRD+K  N+L++++    +ADFGLA+       +     V  +  Y APE 
Sbjct: 121 HR-----VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEI 173
Query: 868 AYTLKVDEKS-DVYSFGVVLLELIAGK 893
               K    + D++S G +  E++  +
Sbjct: 174 LLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 103/224 (45%), Gaps = 25/224 (11%)
Query: 681 QRLDFKAEDVLESLKDENIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHG--FL 737
           Q L+    +V E  ++ + +G G  G V        G+ VA+K+L  R      H     
Sbjct: 31  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTY 89
Query: 738 AEIQTLGRIRHRNIVRLLGYVS-----NRDTNLLLYEYMPNGSLGEMLHGAK--GGHLKW 790
            E++ L  ++H N++ LL   +         ++ L  ++    L  ++   K    H+++
Sbjct: 90  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 149
Query: 791 ETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS 850
                +  +  +GL Y+H   S  IIHRD+K +N+ ++ D E  + DFGLA+   D    
Sbjct: 150 -----LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--- 198
Query: 851 ECMSSVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELIAGK 893
             M+    +  Y APE     +  ++  D++S G ++ EL+ G+
Sbjct: 199 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 96/226 (42%), Gaps = 18/226 (7%)
Query: 677 LTAFQRLDFKAEDVLESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGT--GGNDH 734
           +   + L  KAED  E +K   +IG+G  G V          V   +L+ +      +D 
Sbjct: 63  INKIRDLRMKAED-YEVVK---VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDS 118
Query: 735 GFLAEIQTLGRIRHRNIVRLLGYVSNRDTNL-LLYEYMPNGSLGEMLHGAKGGHLKWETR 793
            F  E + +    +   V  L Y    D  L ++ EYMP G L  ++        KW   
Sbjct: 119 AFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPE-KWARF 177
Query: 794 YRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECM 853
           Y    E    L  +H   S   IHRDVK +N+LLD      +ADFG    +   G   C 
Sbjct: 178 Y--TAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCD 232
Query: 854 SSVAGSYGYIAPEYAYTLKVD----EKSDVYSFGVVLLELIAGKKP 895
           ++V G+  YI+PE   +   D     + D +S GV L E++ G  P
Sbjct: 233 TAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 277

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 103/224 (45%), Gaps = 25/224 (11%)
Query: 681 QRLDFKAEDVLESLKDENIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHG--FL 737
           Q L+    +V E  ++ + +G G  G V        G+ VA+K+L  R      H     
Sbjct: 23  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTY 81
Query: 738 AEIQTLGRIRHRNIVRLLGYVS-----NRDTNLLLYEYMPNGSLGEMLHGAK--GGHLKW 790
            E++ L  ++H N++ LL   +         ++ L  ++    L  ++   K    H+++
Sbjct: 82  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 141
Query: 791 ETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS 850
                +  +  +GL Y+H   S  IIHRD+K +N+ ++ D E  + DFGLA+   D    
Sbjct: 142 -----LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--- 190
Query: 851 ECMSSVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELIAGK 893
             M+    +  Y APE     +  ++  D++S G ++ EL+ G+
Sbjct: 191 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 103/224 (45%), Gaps = 25/224 (11%)
Query: 681 QRLDFKAEDVLESLKDENIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHG--FL 737
           Q L+    +V E  ++ + +G G  G V        G+ VA+K+L  R      H     
Sbjct: 23  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTY 81
Query: 738 AEIQTLGRIRHRNIVRLLGYVS-----NRDTNLLLYEYMPNGSLGEMLHGAK--GGHLKW 790
            E++ L  ++H N++ LL   +         ++ L  ++    L  ++   K    H+++
Sbjct: 82  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 141
Query: 791 ETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS 850
                +  +  +GL Y+H   S  IIHRD+K +N+ ++ D E  + DFGLA+   D    
Sbjct: 142 -----LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--- 190
Query: 851 ECMSSVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELIAGK 893
             M+    +  Y APE     +  ++  D++S G ++ EL+ G+
Sbjct: 191 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 103/224 (45%), Gaps = 25/224 (11%)
Query: 681 QRLDFKAEDVLESLKDENIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHG--FL 737
           Q L+    +V E  ++ + +G G  G V        G+ VA+K+L  R      H     
Sbjct: 8   QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTY 66
Query: 738 AEIQTLGRIRHRNIVRLLGYVS-----NRDTNLLLYEYMPNGSLGEMLHGAK--GGHLKW 790
            E++ L  ++H N++ LL   +         ++ L  ++    L  ++   K    H+++
Sbjct: 67  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 126
Query: 791 ETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS 850
                +  +  +GL Y+H   S  IIHRD+K +N+ ++ D E  + DFGLA+   D    
Sbjct: 127 -----LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--- 175
Query: 851 ECMSSVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELIAGK 893
             M+    +  Y APE     +  ++  D++S G ++ EL+ G+
Sbjct: 176 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 103/224 (45%), Gaps = 25/224 (11%)
Query: 681 QRLDFKAEDVLESLKDENIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHG--FL 737
           Q L+    +V E  ++ + +G G  G V        G+ VA+K+L  R      H     
Sbjct: 11  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTY 69
Query: 738 AEIQTLGRIRHRNIVRLLGYVS-----NRDTNLLLYEYMPNGSLGEMLHGAK--GGHLKW 790
            E++ L  ++H N++ LL   +         ++ L  ++    L  ++   K    H+++
Sbjct: 70  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 129
Query: 791 ETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS 850
                +  +  +GL Y+H   S  IIHRD+K +N+ ++ D E  + DFGLA+   D    
Sbjct: 130 -----LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--- 178
Query: 851 ECMSSVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELIAGK 893
             M+    +  Y APE     +  ++  D++S G ++ EL+ G+
Sbjct: 179 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 103/224 (45%), Gaps = 25/224 (11%)
Query: 681 QRLDFKAEDVLESLKDENIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHG--FL 737
           Q L+    +V E  ++ + +G G  G V        G+ VA+K+L  R      H     
Sbjct: 22  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTY 80
Query: 738 AEIQTLGRIRHRNIVRLLGYVS-----NRDTNLLLYEYMPNGSLGEMLHGAK--GGHLKW 790
            E++ L  ++H N++ LL   +         ++ L  ++    L  ++   K    H+++
Sbjct: 81  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 140
Query: 791 ETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS 850
                +  +  +GL Y+H   S  IIHRD+K +N+ ++ D E  + DFGLA+   D    
Sbjct: 141 -----LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDE--- 189
Query: 851 ECMSSVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELIAGK 893
             M+    +  Y APE     +  ++  D++S G ++ EL+ G+
Sbjct: 190 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 92/198 (46%), Gaps = 7/198 (3%)
Query: 700 IGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYV 758
           IG+G  G+V       + + VAIK++            L EI+ L R RH NI+ +   +
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 95
Query: 759 SNRDTNLLLYEYMPNGSLGEMLHGA-KGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIH 817
                  +   Y+    +   L+   K  HL  +       +  +GL Y+H   S  ++H
Sbjct: 96  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVLH 152
Query: 818 RDVKSNNILLDSDFEAHVADFGLAKFLQ-DAGASECMSSVAGSYGYIAPEYAYTLKVDEK 876
           RD+K +N+LL++  +  + DFGLA+    D   +  ++    +  Y APE     K   K
Sbjct: 153 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 212
Query: 877 S-DVYSFGVVLLELIAGK 893
           S D++S G +L E+++ +
Sbjct: 213 SIDIWSVGCILAEMLSNR 230

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 103/224 (45%), Gaps = 25/224 (11%)
Query: 681 QRLDFKAEDVLESLKDENIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHG--FL 737
           Q L+    +V E  ++ + +G G  G V        G+ VA+K+L  R      H     
Sbjct: 11  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTY 69
Query: 738 AEIQTLGRIRHRNIVRLLGYVS-----NRDTNLLLYEYMPNGSLGEMLHGAK--GGHLKW 790
            E++ L  ++H N++ LL   +         ++ L  ++    L  ++   K    H+++
Sbjct: 70  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 129
Query: 791 ETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS 850
                +  +  +GL Y+H   S  IIHRD+K +N+ ++ D E  + DFGLA+   D    
Sbjct: 130 -----LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--- 178
Query: 851 ECMSSVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELIAGK 893
             M+    +  Y APE     +  ++  D++S G ++ EL+ G+
Sbjct: 179 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 92/198 (46%), Gaps = 7/198 (3%)
Query: 700 IGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYV 758
           IG+G  G+V       + + VAIK++            L EI+ L R RH NI+ +   +
Sbjct: 37  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 96
Query: 759 SNRDTNLLLYEYMPNGSLGEMLHGA-KGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIH 817
                  +   Y+    +   L+   K  HL  +       +  +GL Y+H   S  ++H
Sbjct: 97  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVLH 153
Query: 818 RDVKSNNILLDSDFEAHVADFGLAKFLQ-DAGASECMSSVAGSYGYIAPEYAYTLKVDEK 876
           RD+K +N+LL++  +  + DFGLA+    D   +  ++    +  Y APE     K   K
Sbjct: 154 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 213
Query: 877 S-DVYSFGVVLLELIAGK 893
           S D++S G +L E+++ +
Sbjct: 214 SIDIWSVGCILAEMLSNR 231

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 92/198 (46%), Gaps = 7/198 (3%)
Query: 700 IGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYV 758
           IG+G  G+V       + + VAIK++            L EI+ L R RH NI+ +   +
Sbjct: 28  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 87
Query: 759 SNRDTNLLLYEYMPNGSLGEMLHGA-KGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIH 817
                  +   Y+    +   L+   K  HL  +       +  +GL Y+H   S  ++H
Sbjct: 88  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVLH 144
Query: 818 RDVKSNNILLDSDFEAHVADFGLAKFLQ-DAGASECMSSVAGSYGYIAPEYAYTLKVDEK 876
           RD+K +N+LL++  +  + DFGLA+    D   +  ++    +  Y APE     K   K
Sbjct: 145 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 204
Query: 877 S-DVYSFGVVLLELIAGK 893
           S D++S G +L E+++ +
Sbjct: 205 SIDIWSVGCILAEMLSNR 222

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 96/208 (46%), Gaps = 13/208 (6%)
Query: 691 LESLKDENIIGKGGAGIVYRGSMP-DGIDVAIKRL-VGRGTGGNDHGFLAEIQTLGRIRH 748
           +E+ +    IG+G  G+VY+      G  VA+K++ +   T G     + EI  L  + H
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 749 RNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAK--GGHLKWETRYRIALEAAKGLCY 806
            NIV+LL  +   +   L++E++ +  L + +  +   G  L     Y   L      C+
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 807 LHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPE 866
            H      ++HRD+K  N+L++++    +ADFGLA+       +     V  +  Y APE
Sbjct: 121 SHR-----VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPE 173
Query: 867 YAYTLKVDEKS-DVYSFGVVLLELIAGK 893
                K    + D++S G +  E++  +
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 92/198 (46%), Gaps = 7/198 (3%)
Query: 700 IGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYV 758
           IG+G  G+V       + + VAIK++            L EI+ L R RH NI+ +   +
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 759 SNRDTNLLLYEYMPNGSLGEMLHGA-KGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIH 817
                  +   Y+    +   L+   K  HL  +       +  +GL Y+H   S  ++H
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVLH 151
Query: 818 RDVKSNNILLDSDFEAHVADFGLAKFLQ-DAGASECMSSVAGSYGYIAPEYAYTLKVDEK 876
           RD+K +N+LL++  +  + DFGLA+    D   +  ++    +  Y APE     K   K
Sbjct: 152 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 211
Query: 877 S-DVYSFGVVLLELIAGK 893
           S D++S G +L E+++ +
Sbjct: 212 SIDIWSVGCILAEMLSNR 229

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 96/208 (46%), Gaps = 13/208 (6%)
Query: 691 LESLKDENIIGKGGAGIVYRGSMP-DGIDVAIKRL-VGRGTGGNDHGFLAEIQTLGRIRH 748
           +E+ +    IG+G  G+VY+      G  VA+K++ +   T G     + EI  L  + H
Sbjct: 5   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 64
Query: 749 RNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAK--GGHLKWETRYRIALEAAKGLCY 806
            NIV+LL  +   +   L++E++ +  L + +  +   G  L     Y   L      C+
Sbjct: 65  PNIVKLLDVIHTENKLYLVFEFL-SMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 123
Query: 807 LHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPE 866
            H      ++HRD+K  N+L++++    +ADFGLA+       +     V  +  Y APE
Sbjct: 124 SHR-----VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPE 176
Query: 867 YAYTLKVDEKS-DVYSFGVVLLELIAGK 893
                K    + D++S G +  E++  +
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 103/224 (45%), Gaps = 25/224 (11%)
Query: 681 QRLDFKAEDVLESLKDENIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHG--FL 737
           Q L+    +V E  ++ + +G G  G V        G+ VA+K+L  R      H     
Sbjct: 17  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTY 75
Query: 738 AEIQTLGRIRHRNIVRLLGYVS-----NRDTNLLLYEYMPNGSLGEMLHGAK--GGHLKW 790
            E++ L  ++H N++ LL   +         ++ L  ++    L  ++   K    H+++
Sbjct: 76  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 135
Query: 791 ETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS 850
                +  +  +GL Y+H   S  IIHRD+K +N+ ++ D E  + DFGLA+   D    
Sbjct: 136 -----LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--- 184
Query: 851 ECMSSVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELIAGK 893
             M+    +  Y APE     +  ++  D++S G ++ EL+ G+
Sbjct: 185 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 103/224 (45%), Gaps = 25/224 (11%)
Query: 681 QRLDFKAEDVLESLKDENIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHG--FL 737
           Q L+    +V E  ++ + +G G  G V        G+ VA+K+L  R      H     
Sbjct: 13  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTY 71
Query: 738 AEIQTLGRIRHRNIVRLLGYVS-----NRDTNLLLYEYMPNGSLGEMLHGAK--GGHLKW 790
            E++ L  ++H N++ LL   +         ++ L  ++    L  ++   K    H+++
Sbjct: 72  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 131
Query: 791 ETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS 850
                +  +  +GL Y+H   S  IIHRD+K +N+ ++ D E  + DFGLA+   D    
Sbjct: 132 -----LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--- 180
Query: 851 ECMSSVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELIAGK 893
             M+    +  Y APE     +  ++  D++S G ++ EL+ G+
Sbjct: 181 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 99/204 (48%), Gaps = 18/204 (8%)
Query: 700 IGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRI-RHRNIVRLLGY 757
           +GKG   +V R   +  G + A K +  +     DH  L     + R+ +H NIVRL   
Sbjct: 30  LGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 89
Query: 758 VSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIA--LEAAKGLCYLHHDCSPL- 814
           +S    + L+++ +  G L E +  A+  + + +  + I   LEA      LH  C  + 
Sbjct: 90  ISEEGHHYLIFDLVTGGELFEDI-VAREYYSEADASHCIQQILEAV-----LH--CHQMG 141
Query: 815 IIHRDVKSNNILLDSDFE---AHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTL 871
           ++HRD+K  N+LL S  +     +ADFGLA  ++  G  +     AG+ GY++PE     
Sbjct: 142 VVHRDLKPENLLLASKLKGAAVKLADFGLA--IEVEGEQQAWFGFAGTPGYLSPEVLRKD 199
Query: 872 KVDEKSDVYSFGVVLLELIAGKKP 895
              +  D+++ GV+L  L+ G  P
Sbjct: 200 PYGKPVDLWACGVILYILLVGYPP 223

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 103/224 (45%), Gaps = 25/224 (11%)
Query: 681 QRLDFKAEDVLESLKDENIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHG--FL 737
           Q L+    +V E  ++ + +G G  G V        G+ VA+K+L  R      H     
Sbjct: 30  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTY 88
Query: 738 AEIQTLGRIRHRNIVRLLGYVS-----NRDTNLLLYEYMPNGSLGEMLHGAK--GGHLKW 790
            E++ L  ++H N++ LL   +         ++ L  ++    L  ++   K    H+++
Sbjct: 89  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 148
Query: 791 ETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS 850
                +  +  +GL Y+H   S  IIHRD+K +N+ ++ D E  + DFGLA+   D    
Sbjct: 149 -----LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--- 197
Query: 851 ECMSSVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELIAGK 893
             M+    +  Y APE     +  ++  D++S G ++ EL+ G+
Sbjct: 198 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 96/208 (46%), Gaps = 13/208 (6%)
Query: 691 LESLKDENIIGKGGAGIVYRGSMP-DGIDVAIKRL-VGRGTGGNDHGFLAEIQTLGRIRH 748
           +E+ +    IG+G  G+VY+      G  VA+K++ +   T G     + EI  L  + H
Sbjct: 3   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 62
Query: 749 RNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAK--GGHLKWETRYRIALEAAKGLCY 806
            NIV+LL  +   +   L++E++ +  L + +  +   G  L     Y   L      C+
Sbjct: 63  PNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 121
Query: 807 LHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPE 866
            H      ++HRD+K  N+L++++    +ADFGLA+       +     V  +  Y APE
Sbjct: 122 SHR-----VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPE 174
Query: 867 YAYTLKVDEKS-DVYSFGVVLLELIAGK 893
                K    + D++S G +  E++  +
Sbjct: 175 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 103/224 (45%), Gaps = 25/224 (11%)
Query: 681 QRLDFKAEDVLESLKDENIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHG--FL 737
           Q L+    +V E  ++ + +G G  G V        G+ VA+K+L  R      H     
Sbjct: 22  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTY 80
Query: 738 AEIQTLGRIRHRNIVRLLGYVS-----NRDTNLLLYEYMPNGSLGEMLHGAK--GGHLKW 790
            E++ L  ++H N++ LL   +         ++ L  ++    L  ++   K    H+++
Sbjct: 81  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 140
Query: 791 ETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS 850
                +  +  +GL Y+H   S  IIHRD+K +N+ ++ D E  + DFGLA+   D    
Sbjct: 141 -----LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--- 189
Query: 851 ECMSSVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELIAGK 893
             M+    +  Y APE     +  ++  D++S G ++ EL+ G+
Sbjct: 190 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 92/198 (46%), Gaps = 7/198 (3%)
Query: 700 IGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYV 758
           IG+G  G+V       + + VAIK++            L EI+ L R RH NI+ +   +
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 759 SNRDTNLLLYEYMPNGSLGEMLHGA-KGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIH 817
                  +   Y+    +   L+   K  HL  +       +  +GL Y+H   S  ++H
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHICYFLYQILRGLKYIH---SANVLH 151
Query: 818 RDVKSNNILLDSDFEAHVADFGLAKFLQ-DAGASECMSSVAGSYGYIAPEYAYTLKVDEK 876
           RD+K +N+LL++  +  + DFGLA+    D   +  ++    +  Y APE     K   K
Sbjct: 152 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 211
Query: 877 S-DVYSFGVVLLELIAGK 893
           S D++S G +L E+++ +
Sbjct: 212 SIDIWSVGCILAEMLSNR 229

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 92/198 (46%), Gaps = 7/198 (3%)
Query: 700 IGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYV 758
           IG+G  G+V       + + VAIK++            L EI+ L R RH NI+ +   +
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 88
Query: 759 SNRDTNLLLYEYMPNGSLGEMLHGA-KGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIH 817
                  +   Y+    +   L+   K  HL  +       +  +GL Y+H   S  ++H
Sbjct: 89  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVLH 145
Query: 818 RDVKSNNILLDSDFEAHVADFGLAKFLQ-DAGASECMSSVAGSYGYIAPEYAYTLKVDEK 876
           RD+K +N+LL++  +  + DFGLA+    D   +  ++    +  Y APE     K   K
Sbjct: 146 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 205
Query: 877 S-DVYSFGVVLLELIAGK 893
           S D++S G +L E+++ +
Sbjct: 206 SIDIWSVGCILAEMLSNR 223

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 96/208 (46%), Gaps = 13/208 (6%)
Query: 691 LESLKDENIIGKGGAGIVYRGSMP-DGIDVAIKRL-VGRGTGGNDHGFLAEIQTLGRIRH 748
           +E+ +    IG+G  G+VY+      G  VA+K++ +   T G     + EI  L  + H
Sbjct: 3   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 62
Query: 749 RNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAK--GGHLKWETRYRIALEAAKGLCY 806
            NIV+LL  +   +   L++E++ +  L + +  +   G  L     Y   L      C+
Sbjct: 63  PNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 121
Query: 807 LHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPE 866
            H      ++HRD+K  N+L++++    +ADFGLA+       +     V  +  Y APE
Sbjct: 122 SHR-----VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPE 174
Query: 867 YAYTLKVDEKS-DVYSFGVVLLELIAGK 893
                K    + D++S G +  E++  +
Sbjct: 175 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 92/198 (46%), Gaps = 7/198 (3%)
Query: 700 IGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYV 758
           IG+G  G+V       + + VAIK++            L EI+ L R RH NI+ +   +
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 88
Query: 759 SNRDTNLLLYEYMPNGSLGEMLHGA-KGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIH 817
                  +   Y+    +   L+   K  HL  +       +  +GL Y+H   S  ++H
Sbjct: 89  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVLH 145
Query: 818 RDVKSNNILLDSDFEAHVADFGLAKFLQ-DAGASECMSSVAGSYGYIAPEYAYTLKVDEK 876
           RD+K +N+LL++  +  + DFGLA+    D   +  ++    +  Y APE     K   K
Sbjct: 146 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 205
Query: 877 S-DVYSFGVVLLELIAGK 893
           S D++S G +L E+++ +
Sbjct: 206 SIDIWSVGCILAEMLSNR 223

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 60/272 (22%), Positives = 106/272 (38%), Gaps = 40/272 (14%)
Query: 716 GIDVAIKRLVGRGTGGNDHGFLAEIQTLGRI-RHRNIVRLLGYVSNRDTNLLLYEYMPNG 774
            + VA+K L            ++E++ L  +  H NIV LLG  +     L++ EY   G
Sbjct: 69  AMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYG 128
Query: 775 SLGEMLHGAKGGHLKWETRYRI----------------ALEAAKGLCYLHHDCSPLIIHR 818
            L   L   +   +  +T   I                + + AKG+ +L    S   IHR
Sbjct: 129 DLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL---ASKNCIHR 185
Query: 819 DVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSD 878
           D+ + NILL       + DFGLA+ +++        +      ++APE  +      +SD
Sbjct: 186 DLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESD 245
Query: 879 VYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDPRLSGYP 937
           V+S+G+ L EL + G  P                       P D+     + +      P
Sbjct: 246 VWSYGIFLWELFSLGSSPYP-------------------GMPVDSKFYKMIKEGFRMLSP 286
Query: 938 LTGVIHLFKVAMMCVEDESSARPTMREVVHML 969
                 ++ +   C + +   RPT +++V ++
Sbjct: 287 EHAPAEMYDIMKTCWDADPLKRPTFKQIVQLI 318

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 103/224 (45%), Gaps = 25/224 (11%)
Query: 681 QRLDFKAEDVLESLKDENIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHG--FL 737
           Q L+    +V E  ++ + +G G  G V        G+ VA+K+L  R      H     
Sbjct: 18  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTY 76
Query: 738 AEIQTLGRIRHRNIVRLLGYVS-----NRDTNLLLYEYMPNGSLGEMLHGAK--GGHLKW 790
            E++ L  ++H N++ LL   +         ++ L  ++    L  ++   K    H+++
Sbjct: 77  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 136
Query: 791 ETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS 850
                +  +  +GL Y+H   S  IIHRD+K +N+ ++ D E  + DFGLA+   D    
Sbjct: 137 -----LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE--- 185
Query: 851 ECMSSVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELIAGK 893
             M+    +  Y APE     +  ++  D++S G ++ EL+ G+
Sbjct: 186 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 93/207 (44%), Gaps = 11/207 (5%)
Query: 691 LESLKDENIIGKGGAGIVYRGSMP-DGIDVAIKRL-VGRGTGGNDHGFLAEIQTLGRIRH 748
           +E+ +    IG+G  G+VY+      G  VA+K++ +   T G     + EI  L  + H
Sbjct: 5   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 64
Query: 749 RNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGG-HLKWETRYRIALEAAKGLCYL 807
            NIV+LL  +   +   L++E++       M   A  G  L     Y   L      C+ 
Sbjct: 65  PNIVKLLDVIHTENKLYLVFEFLHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 808 HHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEY 867
           H      ++HRD+K  N+L++++    +ADFGLA+       +     V  +  Y APE 
Sbjct: 125 HR-----VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEI 177
Query: 868 AYTLKVDEKS-DVYSFGVVLLELIAGK 893
               K    + D++S G +  E++  +
Sbjct: 178 LLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 103/224 (45%), Gaps = 25/224 (11%)
Query: 681 QRLDFKAEDVLESLKDENIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHG--FL 737
           Q L+    +V E  ++ + +G G  G V        G+ VA+K+L  R      H     
Sbjct: 18  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTY 76
Query: 738 AEIQTLGRIRHRNIVRLLGYVS-----NRDTNLLLYEYMPNGSLGEMLHGAK--GGHLKW 790
            E++ L  ++H N++ LL   +         ++ L  ++    L  ++   K    H+++
Sbjct: 77  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 136
Query: 791 ETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS 850
                +  +  +GL Y+H   S  IIHRD+K +N+ ++ D E  + DFGLA+   D    
Sbjct: 137 -----LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE--- 185
Query: 851 ECMSSVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELIAGK 893
             M+    +  Y APE     +  ++  D++S G ++ EL+ G+
Sbjct: 186 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 103/224 (45%), Gaps = 25/224 (11%)
Query: 681 QRLDFKAEDVLESLKDENIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHG--FL 737
           Q L+    +V E  ++ + +G G  G V        G+ VA+K+L  R      H     
Sbjct: 18  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTY 76
Query: 738 AEIQTLGRIRHRNIVRLLGYVS-----NRDTNLLLYEYMPNGSLGEMLHGAK--GGHLKW 790
            E++ L  ++H N++ LL   +         ++ L  ++    L  ++   K    H+++
Sbjct: 77  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 136
Query: 791 ETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS 850
                +  +  +GL Y+H   S  IIHRD+K +N+ ++ D E  + DFGLA+   D    
Sbjct: 137 -----LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE--- 185
Query: 851 ECMSSVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELIAGK 893
             M+    +  Y APE     +  ++  D++S G ++ EL+ G+
Sbjct: 186 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 60/272 (22%), Positives = 106/272 (38%), Gaps = 40/272 (14%)
Query: 716 GIDVAIKRLVGRGTGGNDHGFLAEIQTLGRI-RHRNIVRLLGYVSNRDTNLLLYEYMPNG 774
            + VA+K L            ++E++ L  +  H NIV LLG  +     L++ EY   G
Sbjct: 53  AMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYG 112
Query: 775 SLGEMLHGAKGGHLKWETRYRI----------------ALEAAKGLCYLHHDCSPLIIHR 818
            L   L   +   +  +T   I                + + AKG+ +L    S   IHR
Sbjct: 113 DLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL---ASKNCIHR 169
Query: 819 DVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSD 878
           D+ + NILL       + DFGLA+ +++        +      ++APE  +      +SD
Sbjct: 170 DLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESD 229
Query: 879 VYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDPRLSGYP 937
           V+S+G+ L EL + G  P                       P D+     + +      P
Sbjct: 230 VWSYGIFLWELFSLGSSPYP-------------------GMPVDSKFYKMIKEGFRMLSP 270
Query: 938 LTGVIHLFKVAMMCVEDESSARPTMREVVHML 969
                 ++ +   C + +   RPT +++V ++
Sbjct: 271 EHAPAEMYDIMKTCWDADPLKRPTFKQIVQLI 302

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 89/202 (44%), Gaps = 13/202 (6%)
Query: 699 IIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGF---LAEIQTLGRIR-HRNIVRL 754
           ++GKG  G V    + +  D+   +++ +     D      + E + L   R H  + +L
Sbjct: 30  VLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 89
Query: 755 LGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRI-ALEAAKGLCYLHHDCSP 813
                  D    + E++  G L  M H  K      E R R  A E    L +LH     
Sbjct: 90  FCCFQTPDRLFFVMEFVNGGDL--MFHIQKSRRFD-EARARFYAAEIISALMFLH---DK 143
Query: 814 LIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKV 873
            II+RD+K +N+LLD +    +ADFG+ K     G +   ++  G+  YIAPE    +  
Sbjct: 144 GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT--TATFCGTPDYIAPEILQEMLY 201
Query: 874 DEKSDVYSFGVVLLELIAGKKP 895
               D ++ GV+L E++ G  P
Sbjct: 202 GPAVDWWAMGVLLYEMLCGHAP 223

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 60.1 bits (144), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 60/272 (22%), Positives = 106/272 (38%), Gaps = 40/272 (14%)
Query: 716 GIDVAIKRLVGRGTGGNDHGFLAEIQTLGRI-RHRNIVRLLGYVSNRDTNLLLYEYMPNG 774
            + VA+K L            ++E++ L  +  H NIV LLG  +     L++ EY   G
Sbjct: 76  AMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYG 135
Query: 775 SLGEMLHGAKGGHLKWETRYRI----------------ALEAAKGLCYLHHDCSPLIIHR 818
            L   L   +   +  +T   I                + + AKG+ +L    S   IHR
Sbjct: 136 DLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL---ASKNCIHR 192
Query: 819 DVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSD 878
           D+ + NILL       + DFGLA+ +++        +      ++APE  +      +SD
Sbjct: 193 DLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESD 252
Query: 879 VYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDPRLSGYP 937
           V+S+G+ L EL + G  P                       P D+     + +      P
Sbjct: 253 VWSYGIFLWELFSLGSSPYP-------------------GMPVDSKFYKMIKEGFRMLSP 293
Query: 938 LTGVIHLFKVAMMCVEDESSARPTMREVVHML 969
                 ++ +   C + +   RPT +++V ++
Sbjct: 294 EHAPAEMYDIMKTCWDADPLKRPTFKQIVQLI 325

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 60.1 bits (144), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 96/208 (46%), Gaps = 13/208 (6%)
Query: 691 LESLKDENIIGKGGAGIVYRGSMP-DGIDVAIKRL-VGRGTGGNDHGFLAEIQTLGRIRH 748
           +E+ +    IG+G  G+VY+      G  VA+K++ +   T G     + EI  L  + H
Sbjct: 3   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 62
Query: 749 RNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAK--GGHLKWETRYRIALEAAKGLCY 806
            NIV+LL  +   +   L++E++ +  L + +  +   G  L     Y   L      C+
Sbjct: 63  PNIVKLLDVIHTENKLYLVFEFL-SMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 121
Query: 807 LHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPE 866
            H      ++HRD+K  N+L++++    +ADFGLA+       +     V  +  Y APE
Sbjct: 122 SHR-----VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPE 174
Query: 867 YAYTLKVDEKS-DVYSFGVVLLELIAGK 893
                K    + D++S G +  E++  +
Sbjct: 175 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 60/272 (22%), Positives = 106/272 (38%), Gaps = 40/272 (14%)
Query: 716 GIDVAIKRLVGRGTGGNDHGFLAEIQTLGRI-RHRNIVRLLGYVSNRDTNLLLYEYMPNG 774
            + VA+K L            ++E++ L  +  H NIV LLG  +     L++ EY   G
Sbjct: 71  AMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYG 130
Query: 775 SLGEMLHGAKGGHLKWETRYRI----------------ALEAAKGLCYLHHDCSPLIIHR 818
            L   L   +   +  +T   I                + + AKG+ +L    S   IHR
Sbjct: 131 DLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL---ASKNCIHR 187
Query: 819 DVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSD 878
           D+ + NILL       + DFGLA+ +++        +      ++APE  +      +SD
Sbjct: 188 DLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESD 247
Query: 879 VYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDPRLSGYP 937
           V+S+G+ L EL + G  P                       P D+     + +      P
Sbjct: 248 VWSYGIFLWELFSLGSSPYP-------------------GMPVDSKFYKMIKEGFRMLSP 288
Query: 938 LTGVIHLFKVAMMCVEDESSARPTMREVVHML 969
                 ++ +   C + +   RPT +++V ++
Sbjct: 289 EHAPAEMYDIMKTCWDADPLKRPTFKQIVQLI 320

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 103/224 (45%), Gaps = 25/224 (11%)
Query: 681 QRLDFKAEDVLESLKDENIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHG--FL 737
           Q L+    +V E  ++ + +G G  G V        G+ VA+K+L  R      H     
Sbjct: 13  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTY 71
Query: 738 AEIQTLGRIRHRNIVRLLGYVS-----NRDTNLLLYEYMPNGSLGEMLHGAK--GGHLKW 790
            E++ L  ++H N++ LL   +         ++ L  ++    L  ++   K    H+++
Sbjct: 72  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 131
Query: 791 ETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS 850
                +  +  +GL Y+H   S  IIHRD+K +N+ ++ D E  + DFGLA+   D    
Sbjct: 132 -----LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDE--- 180
Query: 851 ECMSSVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELIAGK 893
             M+    +  Y APE     +  ++  D++S G ++ EL+ G+
Sbjct: 181 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 99/205 (48%), Gaps = 14/205 (6%)
Query: 700 IGKGGAGIVYRGSMPDGI-DVAIKRLVGRGTGGNDHGFLAEIQTLGRI-RHRNIVRLLGY 757
           +GKG   +V R        + A K +  +     DH  L     + R+ +H NIVRL   
Sbjct: 39  LGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 98
Query: 758 VSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLH-HDCSPLII 816
           +S    + L+++ +  G L E +  A+  + + +  + I  +  + + ++H HD    I+
Sbjct: 99  ISEEGFHYLVFDLVTGGELFEDI-VAREYYSEADASHCIH-QILESVNHIHQHD----IV 152
Query: 817 HRDVKSNNILLDSDFE---AHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKV 873
           HRD+K  N+LL S  +     +ADFGLA  +Q  G  +     AG+ GY++PE       
Sbjct: 153 HRDLKPENLLLASKCKGAAVKLADFGLAIEVQ--GEQQAWFGFAGTPGYLSPEVLRKDPY 210
Query: 874 DEKSDVYSFGVVLLELIAGKKPVGE 898
            +  D+++ GV+L  L+ G  P  +
Sbjct: 211 GKPVDIWACGVILYILLVGYPPFWD 235

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 103/224 (45%), Gaps = 25/224 (11%)
Query: 681 QRLDFKAEDVLESLKDENIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHG--FL 737
           Q L+    +V E  ++ + +G G  G V        G+ VA+K+L  R      H     
Sbjct: 17  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTY 75
Query: 738 AEIQTLGRIRHRNIVRLLGYVS-----NRDTNLLLYEYMPNGSLGEMLHGAK--GGHLKW 790
            E++ L  ++H N++ LL   +         ++ L  ++    L  ++   K    H+++
Sbjct: 76  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 135
Query: 791 ETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS 850
                +  +  +GL Y+H   S  IIHRD+K +N+ ++ D E  + DFGLA+   D    
Sbjct: 136 -----LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDE--- 184
Query: 851 ECMSSVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELIAGK 893
             M+    +  Y APE     +  ++  D++S G ++ EL+ G+
Sbjct: 185 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Composition-based stats.
 Identities = 60/204 (29%), Positives = 100/204 (49%), Gaps = 19/204 (9%)
Query: 700 IGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHGFLA-EIQTLGRIRHRNIVRLLGY 757
           +GKG   +V R      G++ A K +  +     D   L  E +   +++H NIVRL   
Sbjct: 14  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 73
Query: 758 VSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIH 817
           +     + L+++ +  G L E +  A+  + + +  + I  +  + + Y H   S  I+H
Sbjct: 74  IQEESFHYLVFDLVTGGELFEDIV-AREFYSEADASHCIQ-QILESIAYCH---SNGIVH 128
Query: 818 RDVKSNNILLDSDFEA---HVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVD 874
           R++K  N+LL S  +     +ADFGLA  + D   SE     AG+ GY++PE    LK D
Sbjct: 129 RNLKPENLLLASKAKGAAVKLADFGLAIEVND---SEAWHGFAGTPGYLSPE---VLKKD 182
Query: 875 EKS---DVYSFGVVLLELIAGKKP 895
             S   D+++ GV+L  L+ G  P
Sbjct: 183 PYSKPVDIWACGVILYILLVGYPP 206

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Composition-based stats.
 Identities = 60/204 (29%), Positives = 100/204 (49%), Gaps = 19/204 (9%)
Query: 700 IGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHGFLA-EIQTLGRIRHRNIVRLLGY 757
           +GKG   +V R      G++ A K +  +     D   L  E +   +++H NIVRL   
Sbjct: 13  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 72
Query: 758 VSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIH 817
           +     + L+++ +  G L E +  A+  + + +  + I  +  + + Y H   S  I+H
Sbjct: 73  IQEESFHYLVFDLVTGGELFEDIV-AREFYSEADASHCIQ-QILESIAYCH---SNGIVH 127
Query: 818 RDVKSNNILLDSDFEA---HVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVD 874
           R++K  N+LL S  +     +ADFGLA  + D   SE     AG+ GY++PE    LK D
Sbjct: 128 RNLKPENLLLASKAKGAAVKLADFGLAIEVND---SEAWHGFAGTPGYLSPE---VLKKD 181
Query: 875 EKS---DVYSFGVVLLELIAGKKP 895
             S   D+++ GV+L  L+ G  P
Sbjct: 182 PYSKPVDIWACGVILYILLVGYPP 205

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Composition-based stats.
 Identities = 60/204 (29%), Positives = 100/204 (49%), Gaps = 19/204 (9%)
Query: 700 IGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHGFLA-EIQTLGRIRHRNIVRLLGY 757
           +GKG   +V R      G++ A K +  +     D   L  E +   +++H NIVRL   
Sbjct: 14  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 73
Query: 758 VSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIH 817
           +     + L+++ +  G L E +  A+  + + +  + I  +  + + Y H   S  I+H
Sbjct: 74  IQEESFHYLVFDLVTGGELFEDIV-AREFYSEADASHCIQ-QILESIAYCH---SNGIVH 128
Query: 818 RDVKSNNILLDSDFEA---HVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVD 874
           R++K  N+LL S  +     +ADFGLA  + D   SE     AG+ GY++PE    LK D
Sbjct: 129 RNLKPENLLLASKAKGAAVKLADFGLAIEVND---SEAWHGFAGTPGYLSPE---VLKKD 182
Query: 875 EKS---DVYSFGVVLLELIAGKKP 895
             S   D+++ GV+L  L+ G  P
Sbjct: 183 PYSKPVDIWACGVILYILLVGYPP 206

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 102/224 (45%), Gaps = 25/224 (11%)
Query: 681 QRLDFKAEDVLESLKDENIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHG--FL 737
           Q L+    +V E  ++ + +G G  G V        G+ VA+K+L  R      H     
Sbjct: 34  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTY 92
Query: 738 AEIQTLGRIRHRNIVRLLGYVS-----NRDTNLLLYEYMPNGSLGEMLHGAK--GGHLKW 790
            E++ L  ++H N++ LL   +         ++ L  ++    L  ++   K    H+++
Sbjct: 93  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 152
Query: 791 ETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS 850
                +  +  +GL Y+H   S  IIHRD+K +N+ ++ D E  + DFGLA+   D    
Sbjct: 153 -----LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--- 201
Query: 851 ECMSSVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELIAGK 893
             M     +  Y APE     +  ++  D++S G ++ EL+ G+
Sbjct: 202 --MXGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 96/208 (46%), Gaps = 13/208 (6%)
Query: 691 LESLKDENIIGKGGAGIVYRGSMP-DGIDVAIKRL-VGRGTGGNDHGFLAEIQTLGRIRH 748
           +E+ +    IG+G  G+VY+      G  VA+K++ +   T G     + EI  L  + H
Sbjct: 5   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 64
Query: 749 RNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAK--GGHLKWETRYRIALEAAKGLCY 806
            NIV+LL  +   +   L++E++ +  L + +  +   G  L     Y   L      C+
Sbjct: 65  PNIVKLLDVIHTENKLYLVFEHV-DQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 123
Query: 807 LHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPE 866
            H      ++HRD+K  N+L++++    +ADFGLA+       +     V  +  Y APE
Sbjct: 124 SHR-----VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPE 176
Query: 867 YAYTLKVDEKS-DVYSFGVVLLELIAGK 893
                K    + D++S G +  E++  +
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 103/224 (45%), Gaps = 25/224 (11%)
Query: 681 QRLDFKAEDVLESLKDENIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHG--FL 737
           Q L+    +V E  ++ + +G G  G V        G+ VA+K+L  R      H     
Sbjct: 17  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTY 75
Query: 738 AEIQTLGRIRHRNIVRLLGYVS-----NRDTNLLLYEYMPNGSLGEMLHGAK--GGHLKW 790
            E++ L  ++H N++ LL   +         ++ L  ++    L  ++   K    H+++
Sbjct: 76  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 135
Query: 791 ETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS 850
                +  +  +GL Y+H   S  IIHRD+K +N+ ++ D E  + DFGLA+   D    
Sbjct: 136 -----LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--- 184
Query: 851 ECMSSVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELIAGK 893
             M+    +  Y APE     +  ++  D++S G ++ EL+ G+
Sbjct: 185 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 69/149 (46%), Gaps = 11/149 (7%)
Query: 751 IVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHD 810
           +V+L     +     ++ EYMP G L  ++        KW   Y    E    L  +H  
Sbjct: 137 VVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPE-KWAKFY--TAEVVLALDAIH-- 191
Query: 811 CSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYT 870
            S  +IHRDVK +N+LLD      +ADFG    + + G   C ++V G+  YI+PE   +
Sbjct: 192 -SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAV-GTPDYISPEVLKS 249
Query: 871 LKVD----EKSDVYSFGVVLLELIAGKKP 895
              D     + D +S GV L E++ G  P
Sbjct: 250 QGGDGYYGRECDWWSVGVFLFEMLVGDTP 278

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 91/198 (45%), Gaps = 7/198 (3%)
Query: 700 IGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYV 758
           IG+G  G+V       + + VAIK++            L EI+ L R RH NI+ +   +
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 759 SNRDTNLLLYEYMPNGSLGEMLHGA-KGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIH 817
                  +   Y+    +   L+   K  HL  +       +  +GL Y+H   S  ++H
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVLH 151
Query: 818 RDVKSNNILLDSDFEAHVADFGLAKFLQ-DAGASECMSSVAGSYGYIAPEYAYTLKVDEK 876
           RD+K +N+LL++  +  + DFGLA+    D   +  +     +  Y APE     K   K
Sbjct: 152 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSKGYTK 211
Query: 877 S-DVYSFGVVLLELIAGK 893
           S D++S G +L E+++ +
Sbjct: 212 SIDIWSVGCILAEMLSNR 229

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 91/198 (45%), Gaps = 7/198 (3%)
Query: 700 IGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYV 758
           IG+G  G+V       + + VAIK++            L EI+ L R RH NI+ +   +
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 95
Query: 759 SNRDTNLLLYEYMPNGSLGEMLHGA-KGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIH 817
                  +   Y+    +   L+   K  HL  +       +  +GL Y+H   S  ++H
Sbjct: 96  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVLH 152
Query: 818 RDVKSNNILLDSDFEAHVADFGLAKFLQ-DAGASECMSSVAGSYGYIAPEYAYTLKVDEK 876
           RD+K +N+LL++  +  + DFGLA+    D   +  +     +  Y APE     K   K
Sbjct: 153 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSKGYTK 212
Query: 877 S-DVYSFGVVLLELIAGK 893
           S D++S G +L E+++ +
Sbjct: 213 SIDIWSVGCILAEMLSNR 230

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 56/211 (26%), Positives = 98/211 (46%), Gaps = 30/211 (14%)
Query: 699 IIGKGGAGIVY---RGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLL 755
           ++G+G  G V+   + + PD   +   +++ + T          ++   R+R +    +L
Sbjct: 35  VLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKAT----------LKVRDRVRTKMERDIL 84
Query: 756 GYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHL-----------KWETRYRIALEAAKGL 804
             V++     L Y +   G L  +L   +GG L           + + ++ +A E A GL
Sbjct: 85  ADVNHPFVVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA-ELALGL 143
Query: 805 CYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIA 864
            +LH   S  II+RD+K  NILLD +    + DFGL+K   D    +   S  G+  Y+A
Sbjct: 144 DHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKEAID--HEKKAYSFCGTVEYMA 198
Query: 865 PEYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
           PE          +D +S+GV++ E++ G  P
Sbjct: 199 PEVVNRQGHSHSADWWSYGVLMFEMLTGSLP 229

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 92/198 (46%), Gaps = 7/198 (3%)
Query: 700 IGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYV 758
           IG+G  G+V       + + VAI+++            L EI+ L R RH NI+ +   +
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 759 SNRDTNLLLYEYMPNGSLGEMLHGA-KGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIH 817
                  +   Y+    +   L+   K  HL  +       +  +GL Y+H   S  ++H
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVLH 151
Query: 818 RDVKSNNILLDSDFEAHVADFGLAKFLQ-DAGASECMSSVAGSYGYIAPEYAYTLKVDEK 876
           RD+K +N+LL++  +  + DFGLA+    D   +  ++    +  Y APE     K   K
Sbjct: 152 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 211
Query: 877 S-DVYSFGVVLLELIAGK 893
           S D++S G +L E+++ +
Sbjct: 212 SIDIWSVGCILAEMLSNR 229

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 100/216 (46%), Gaps = 25/216 (11%)
Query: 689 DVLESLKDENIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHG--FLAEIQTLGR 745
           +V E  ++ + +G G  G V        G  VA+K+L  R      H      E++ L  
Sbjct: 15  EVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKL-SRPFQSIIHAKRTYRELRLLKH 73
Query: 746 IRHRNIVRLLGYVS-----NRDTNLLLYEYMPNGSLGEMLHGAK--GGHLKWETRYRIAL 798
           ++H N++ LL   +         ++ L  ++    L  ++  AK    H+++     +  
Sbjct: 74  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCAKLTDDHVQF-----LIY 128
Query: 799 EAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAG 858
           +  +GL Y+H   S  IIHRD+K +N+ ++ D E  + DFGLA+   D      M+    
Sbjct: 129 QILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVA 180
Query: 859 SYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELIAGK 893
           +  Y APE     +  ++  D++S G ++ EL+ G+
Sbjct: 181 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 93/207 (44%), Gaps = 11/207 (5%)
Query: 691 LESLKDENIIGKGGAGIVYRGSMP-DGIDVAIKRL-VGRGTGGNDHGFLAEIQTLGRIRH 748
           +E+ +    IG+G  G+VY+      G  VA+K++ +   T G     + EI  L  + H
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 749 RNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGG-HLKWETRYRIALEAAKGLCYL 807
            NIV+LL  +   +   L++E++       M   A  G  L     Y   L      C+ 
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEHVHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 808 HHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEY 867
           H      ++HRD+K  N+L++++    +ADFGLA+       +     V  +  Y APE 
Sbjct: 121 HR-----VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEI 173
Query: 868 AYTLKVDEKS-DVYSFGVVLLELIAGK 893
               K    + D++S G +  E++  +
Sbjct: 174 LLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 92/206 (44%), Gaps = 17/206 (8%)
Query: 698 NIIGKGGAGIVYRGSMP--DG--IDVAIKRLVGRGTGGND-HGFLAEIQTLGRIRHRNIV 752
            I+G+G  G V  G++   DG  + VA+K +    +   +   FL+E   +    H N++
Sbjct: 40  KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 753 RLLGYVSNRDTN-----LLLYEYMPNGSLGEMLHGAK----GGHLKWETRYRIALEAAKG 803
           RLLG      +      +++  +M  G L   L  ++      H+  +T  +  ++ A G
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 804 LCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYI 863
           + YL +      +HRD+ + N +L  D    VADFGL+K +                 +I
Sbjct: 160 MEYLSNRN---FLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 216
Query: 864 APEYAYTLKVDEKSDVYSFGVVLLEL 889
           A E         KSDV++FGV + E+
Sbjct: 217 AIESLADRVYTSKSDVWAFGVTMWEI 242

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 103/224 (45%), Gaps = 25/224 (11%)
Query: 681 QRLDFKAEDVLESLKDENIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHG--FL 737
           Q L+    +V E  ++ + +G G  G V        G+ VA+K+L  R      H     
Sbjct: 11  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTY 69
Query: 738 AEIQTLGRIRHRNIVRLLGYVS-----NRDTNLLLYEYMPNGSLGEMLHGAK--GGHLKW 790
            E++ L  ++H N++ LL   +         ++ L  ++    L  ++   K    H+++
Sbjct: 70  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 129
Query: 791 ETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS 850
                +  +  +GL Y+H   S  IIHRD+K +N+ ++ D E  + D+GLA+   D    
Sbjct: 130 -----LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDYGLARHTDDE--- 178
Query: 851 ECMSSVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELIAGK 893
             M+    +  Y APE     +  ++  D++S G ++ EL+ G+
Sbjct: 179 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/164 (29%), Positives = 77/164 (46%), Gaps = 14/164 (8%)
Query: 738 AEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEML--HGAKGGHLKWETRYR 795
           AEI+ L  + H NI+++     +     ++ E    G L E +    A+G  L       
Sbjct: 69  AEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAE 128
Query: 796 IALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAH----VADFGLAKFLQDAGASE 851
           +  +    L Y H   S  ++H+D+K  NIL   D   H    + DFGLA+  +   + E
Sbjct: 129 LMKQMMNALAYFH---SQHVVHKDLKPENILF-QDTSPHSPIKIIDFGLAELFK---SDE 181
Query: 852 CMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
             ++ AG+  Y+APE  +   V  K D++S GVV+  L+ G  P
Sbjct: 182 HSTNAAGTALYMAPE-VFKRDVTFKCDIWSAGVVMYFLLTGCLP 224

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 101/219 (46%), Gaps = 18/219 (8%)
Query: 685 FKAEDVLESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTL 743
           ++AE  +  L++   +G G  G V++      G  +A+K++   G    +   L ++  +
Sbjct: 20  YQAE--INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVV 77
Query: 744 GRIRH-RNIVRLLG-YVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAA 801
            +      IV+  G +++N D   +  E M  G+  E L     G +      ++ +   
Sbjct: 78  LKSHDCPYIVQCFGTFITNTDV-FIAMELM--GTCAEKLKKRMQGPIPERILGKMTVAIV 134
Query: 802 KGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYG 861
           K L YL       +IHRDVK +NILLD   +  + DFG++  L D  A +     AG   
Sbjct: 135 KALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKD---RSAGCAA 189
Query: 862 YIAPEY-----AYTLKVDEKSDVYSFGVVLLELIAGKKP 895
           Y+APE            D ++DV+S G+ L+EL  G+ P
Sbjct: 190 YMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFP 228

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 104/228 (45%), Gaps = 33/228 (14%)
Query: 681 QRLDFKAEDVLESLKDENIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHG--FL 737
           Q L+    +V E  +  + +G G  G V     +  G+ +A+K+L  R      H     
Sbjct: 40  QELNKTIWEVPERYQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKL-SRPFQSIIHAKRTY 98
Query: 738 AEIQTLGRIRHRNIVRLLGYVSNRDT-----NLLLYEYMPNGSLGEMLHGAK--GGHLKW 790
            E++ L  ++H N++ LL   +   +     ++ L  ++    L  ++   K    H+++
Sbjct: 99  RELRLLKHMKHENVIGLLDVFTPATSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 158
Query: 791 ETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS 850
                +  +  +GL Y+H   S  IIHRD+K +N+ ++ D E  + DFGLA+   D    
Sbjct: 159 -----LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--- 207
Query: 851 ECMSSVAGSYGYIAPE-----YAYTLKVDEKSDVYSFGVVLLELIAGK 893
             M+    +  Y APE       Y + V    D++S G ++ EL+ G+
Sbjct: 208 --MTGYVATRWYRAPEIMLNWMHYNMTV----DIWSVGCIMAELLTGR 249

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 95/208 (45%), Gaps = 13/208 (6%)
Query: 691 LESLKDENIIGKGGAGIVYRGSMP-DGIDVAIKRL-VGRGTGGNDHGFLAEIQTLGRIRH 748
           +E+ +    IG+G  G+VY+      G  VA+ ++ +   T G     + EI  L  + H
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 749 RNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAK--GGHLKWETRYRIALEAAKGLCY 806
            NIV+LL  +   +   L++E++ +  L + +  +   G  L     Y   L      C+
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 807 LHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPE 866
            H      ++HRD+K  N+L++++    +ADFGLA+       +     V  +  Y APE
Sbjct: 121 SHR-----VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPE 173
Query: 867 YAYTLKVDEKS-DVYSFGVVLLELIAGK 893
                K    + D++S G +  E++  +
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 95/208 (45%), Gaps = 13/208 (6%)
Query: 691 LESLKDENIIGKGGAGIVYRGSMP-DGIDVAIKRL-VGRGTGGNDHGFLAEIQTLGRIRH 748
           +E+ +    IG+G  G+VY+      G  VA+ ++ +   T G     + EI  L  + H
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 749 RNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAK--GGHLKWETRYRIALEAAKGLCY 806
            NIV+LL  +   +   L++E++ +  L + +  +   G  L     Y   L      C+
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 807 LHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPE 866
            H      ++HRD+K  N+L++++    +ADFGLA+       +     V  +  Y APE
Sbjct: 120 SHR-----VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPE 172
Query: 867 YAYTLKVDEKS-DVYSFGVVLLELIAGK 893
                K    + D++S G +  E++  +
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 102/224 (45%), Gaps = 25/224 (11%)
Query: 681 QRLDFKAEDVLESLKDENIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHG--FL 737
           Q L+    +V E  ++ + +G G  G V        G+ VA+K+L  R      H     
Sbjct: 11  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTY 69
Query: 738 AEIQTLGRIRHRNIVRLLGYVS-----NRDTNLLLYEYMPNGSLGEMLHGAK--GGHLKW 790
            E++ L  ++H N++ LL   +         ++ L  ++    L  ++   K    H+++
Sbjct: 70  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKSQKLTDDHVQF 129
Query: 791 ETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS 850
                +  +  +GL Y+H   S  IIHRD+K +N+ ++ D E  + DFGL +   D    
Sbjct: 130 -----LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDSELKILDFGLCRHTDDE--- 178
Query: 851 ECMSSVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELIAGK 893
             M+    +  Y APE     +  ++  D++S G ++ EL+ G+
Sbjct: 179 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 86/165 (52%), Gaps = 19/165 (11%)
Query: 739 EIQTLGRIRHRNIVRLLGYVS--NRDTNLLLYEYMPNGSLGEMLHGAKGGHLK--WETRY 794
           EI  L ++ H N+V+L+  +   N D   +++E +  G + E+        LK   E + 
Sbjct: 86  EIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEV------PTLKPLSEDQA 139
Query: 795 RIALEA-AKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECM 853
           R   +   KG+ YLH+     IIHRD+K +N+L+  D    +ADFG++   +  G+   +
Sbjct: 140 RFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFK--GSDALL 194
Query: 854 SSVAGSYGYIAPE-YAYTLKV--DEKSDVYSFGVVLLELIAGKKP 895
           S+  G+  ++APE  + T K+   +  DV++ GV L   + G+ P
Sbjct: 195 SNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 106/234 (45%), Gaps = 32/234 (13%)
Query: 686 KAEDVL---ESLKDENIIGKGGAGIVYRGSM--PDG--IDVAIKRLVGRGTGGND-HGFL 737
           K EDVL   +      ++GKG  G V    +   DG  + VA+K L       +D   FL
Sbjct: 14  KLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFL 73
Query: 738 AEIQTLGRIRHRNIVRLLGYVSNRDTN-------LLLYEYMPNGSLGEMLHGAKGGH--- 787
            E   +    H ++ +L+G VS R          +++  +M +G L   L  ++ G    
Sbjct: 74  REAACMKEFDHPHVAKLVG-VSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPF 132
Query: 788 -LKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAK--FL 844
            L  +T  R  ++ A G+ YL    S   IHRD+ + N +L  D    VADFGL++  + 
Sbjct: 133 NLPLQTLVRFMVDIACGMEYLS---SRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYS 189
Query: 845 QDAGASECMSSVAGSYGYIA--PEYAYTLKVDEKSDVYSFGVVLLELIA-GKKP 895
            D     C S +   +  +    +  YT+     SDV++FGV + E++  G+ P
Sbjct: 190 GDYYRQGCASKLPVKWLALESLADNLYTV----HSDVWAFGVTMWEIMTRGQTP 239

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 71/298 (23%), Positives = 124/298 (41%), Gaps = 42/298 (14%)
Query: 679 AFQRLDFKAEDVLESLKDENIIGKGGAGIVYRGS-MPDGIDVAIKRLVGRGTGGNDHGFL 737
           A +  + KA+D LE + +   +G+G  G+V +   +P G   A+KR+            L
Sbjct: 25  AXENFEVKADD-LEPIXE---LGRGAYGVVEKXRHVPSGQIXAVKRIRATVNSQEQKRLL 80
Query: 738 AEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGA--KGGHLKWETRYR 795
            ++    R               R+ ++ +   + + SL +       KG  +  +   +
Sbjct: 81  XDLDISXRTVDCPFTVTFYGALFREGDVWICXELXDTSLDKFYKQVIDKGQTIPEDILGK 140
Query: 796 IALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSS 855
           IA+   K L +LH   S  +IHRDVK +N+L+++  +    DFG++ +L D  A +    
Sbjct: 141 IAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAKDID-- 196
Query: 856 VAGSYGYIAPEY--------AYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVR 907
            AG   Y APE          Y++    KSD++S G+  +EL   + P   +G     ++
Sbjct: 197 -AGCKPYXAPERINPELNQKGYSV----KSDIWSLGITXIELAILRFPYDSWGTPFQQLK 251
Query: 908 WVRKTTSEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREV 965
            V      V +PS          P+L     +           C++  S  RPT  E+
Sbjct: 252 QV------VEEPS----------PQLPADKFSA--EFVDFTSQCLKKNSKERPTYPEL 291

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 103/224 (45%), Gaps = 25/224 (11%)
Query: 681 QRLDFKAEDVLESLKDENIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHG--FL 737
           Q L+    +V E  ++ + +G G  G V        G+ VA+K+L  +      H     
Sbjct: 23  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SKPFQSIIHAKRTY 81
Query: 738 AEIQTLGRIRHRNIVRLLGYVS-----NRDTNLLLYEYMPNGSLGEMLHGAK--GGHLKW 790
            E++ L  ++H N++ LL   +         ++ L  ++    L  ++   K    H+++
Sbjct: 82  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 141
Query: 791 ETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS 850
                +  +  +GL Y+H   S  IIHRD+K +N+ ++ D E  + DFGLA+   D    
Sbjct: 142 -----LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--- 190
Query: 851 ECMSSVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELIAGK 893
             M+    +  Y APE     +  ++  D++S G ++ EL+ G+
Sbjct: 191 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 87/202 (43%), Gaps = 13/202 (6%)
Query: 699 IIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRI-----RHRNIVR 753
           +IG+G    V    +     +   R+V +    +D   +  +QT   +      H  +V 
Sbjct: 59  VIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDED-IDWVQTEKHVFEQASNHPFLVG 117
Query: 754 LLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSP 813
           L            + EY+  G L  M H  +   L  E     + E +  L YLH     
Sbjct: 118 LHSCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSAEISLALNYLHERG-- 173
Query: 814 LIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKV 873
            II+RD+K +N+LLDS+    + D+G+ K  +     +  S+  G+  YIAPE       
Sbjct: 174 -IIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAPEILRGEDY 230
Query: 874 DEKSDVYSFGVVLLELIAGKKP 895
               D ++ GV++ E++AG+ P
Sbjct: 231 GFSVDWWALGVLMFEMMAGRSP 252

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 66/293 (22%), Positives = 122/293 (41%), Gaps = 40/293 (13%)
Query: 683 LDFKAEDVLESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRG-TGGNDHGFLAEIQ 741
           +DFK  + L  L + +      +G +++G    G D+ +K L  R  +      F  E  
Sbjct: 7   IDFKQLNFLTKLNENH------SGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECP 59
Query: 742 TLGRIRHRNIVRLLGYVSNRDTN--LLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALE 799
            L    H N++ +LG   +       L+  +MP GSL  +LH      +      + AL+
Sbjct: 60  RLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALD 119
Query: 800 AAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGS 859
            A+G+ +L H   PLI    + S ++++D D  A ++   +    Q  G    M + A  
Sbjct: 120 MARGMAFL-HTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGR---MYAPA-- 173
Query: 860 YGYIAPEYAYTLKVD---EKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEV 916
             ++APE       D     +D++SF V+L EL+  + P  +             +  E+
Sbjct: 174 --WVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADL------------SNMEI 219
Query: 917 SQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHML 969
                   +   + P +S        H+ K+  +C+ ++ + RP    +V +L
Sbjct: 220 GMKVALEGLRPTIPPGISP-------HVSKLMKICMNEDPAKRPKFDMIVPIL 265

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 102/224 (45%), Gaps = 25/224 (11%)
Query: 681 QRLDFKAEDVLESLKDENIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHG--FL 737
           Q L+    +V E  ++ + +G G  G V        G  VA+K+L  R      H     
Sbjct: 7   QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKL-SRPFQSIIHAKRTY 65
Query: 738 AEIQTLGRIRHRNIVRLLGYVS-----NRDTNLLLYEYMPNGSLGEMLHGAK--GGHLKW 790
            E++ L  ++H N++ LL   +         ++ L  ++    L  ++   K    H+++
Sbjct: 66  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 125
Query: 791 ETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS 850
                +  +  +GL Y+H   S  IIHRD+K +N+ ++ D E  + DFGLA+   D    
Sbjct: 126 -----LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--- 174
Query: 851 ECMSSVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELIAGK 893
             M+    +  Y APE     +  ++  D++S G ++ EL+ G+
Sbjct: 175 --MAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 102/224 (45%), Gaps = 25/224 (11%)
Query: 681 QRLDFKAEDVLESLKDENIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHG--FL 737
           Q L+    +V E  ++ + +G G  G V        G  VA+K+L  R      H     
Sbjct: 7   QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKL-SRPFQSIIHAKRTY 65
Query: 738 AEIQTLGRIRHRNIVRLLGYVS-----NRDTNLLLYEYMPNGSLGEMLHGAK--GGHLKW 790
            E++ L  ++H N++ LL   +         ++ L  ++    L  ++   K    H+++
Sbjct: 66  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 125
Query: 791 ETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS 850
                +  +  +GL Y+H   S  IIHRD+K +N+ ++ D E  + DFGLA+   D    
Sbjct: 126 -----LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--- 174
Query: 851 ECMSSVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELIAGK 893
             M+    +  Y APE     +  ++  D++S G ++ EL+ G+
Sbjct: 175 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 102/224 (45%), Gaps = 25/224 (11%)
Query: 681 QRLDFKAEDVLESLKDENIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHG--FL 737
           Q L+    +V E  ++ + +G G  G V        G  VA+K+L  R      H     
Sbjct: 11  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKL-SRPFQSIIHAKRTY 69
Query: 738 AEIQTLGRIRHRNIVRLLGYVS-----NRDTNLLLYEYMPNGSLGEMLHGAK--GGHLKW 790
            E++ L  ++H N++ LL   +         ++ L  ++    L  ++   K    H+++
Sbjct: 70  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 129
Query: 791 ETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS 850
                +  +  +GL Y+H   S  IIHRD+K +N+ ++ D E  + DFGLA+   D    
Sbjct: 130 -----LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--- 178
Query: 851 ECMSSVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELIAGK 893
             M+    +  Y APE     +  ++  D++S G ++ EL+ G+
Sbjct: 179 --MAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 102/224 (45%), Gaps = 25/224 (11%)
Query: 681 QRLDFKAEDVLESLKDENIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHG--FL 737
           Q L+    +V E  ++ + +G G  G V        G  VA+K+L  R      H     
Sbjct: 31  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKL-SRPFQSIIHAKRTY 89
Query: 738 AEIQTLGRIRHRNIVRLLGYVS-----NRDTNLLLYEYMPNGSLGEMLHGAK--GGHLKW 790
            E++ L  ++H N++ LL   +         ++ L  ++    L  ++   K    H+++
Sbjct: 90  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 149
Query: 791 ETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS 850
                +  +  +GL Y+H   S  IIHRD+K +N+ ++ D E  + DFGLA+   D    
Sbjct: 150 -----LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--- 198
Query: 851 ECMSSVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELIAGK 893
             M+    +  Y APE     +  ++  D++S G ++ EL+ G+
Sbjct: 199 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 102/224 (45%), Gaps = 25/224 (11%)
Query: 681 QRLDFKAEDVLESLKDENIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHG--FL 737
           Q L+    +V E  ++ + +G G  G V        G  VA+K+L  R      H     
Sbjct: 11  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKL-SRPFQSIIHAKRTY 69
Query: 738 AEIQTLGRIRHRNIVRLLGYVS-----NRDTNLLLYEYMPNGSLGEMLHGAK--GGHLKW 790
            E++ L  ++H N++ LL   +         ++ L  ++    L  ++   K    H+++
Sbjct: 70  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 129
Query: 791 ETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS 850
                +  +  +GL Y+H   S  IIHRD+K +N+ ++ D E  + DFGLA+   D    
Sbjct: 130 -----LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--- 178
Query: 851 ECMSSVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELIAGK 893
             M+    +  Y APE     +  ++  D++S G ++ EL+ G+
Sbjct: 179 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 102/224 (45%), Gaps = 25/224 (11%)
Query: 681 QRLDFKAEDVLESLKDENIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHG--FL 737
           Q L+    +V E  ++ + +G G  G V        G  VA+K+L  R      H     
Sbjct: 11  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKL-SRPFQSIIHAKRTY 69
Query: 738 AEIQTLGRIRHRNIVRLLGYVS-----NRDTNLLLYEYMPNGSLGEMLHGAK--GGHLKW 790
            E++ L  ++H N++ LL   +         ++ L  ++    L  ++   K    H+++
Sbjct: 70  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 129
Query: 791 ETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS 850
                +  +  +GL Y+H   S  IIHRD+K +N+ ++ D E  + DFGLA+   D    
Sbjct: 130 -----LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--- 178
Query: 851 ECMSSVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELIAGK 893
             M+    +  Y APE     +  ++  D++S G ++ EL+ G+
Sbjct: 179 --MAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 102/224 (45%), Gaps = 25/224 (11%)
Query: 681 QRLDFKAEDVLESLKDENIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHG--FL 737
           Q L+    +V E  ++ + +G G  G V        G  VA+K+L  R      H     
Sbjct: 30  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKL-SRPFQSIIHAKRTY 88
Query: 738 AEIQTLGRIRHRNIVRLLGYVS-----NRDTNLLLYEYMPNGSLGEMLHGAK--GGHLKW 790
            E++ L  ++H N++ LL   +         ++ L  ++    L  ++   K    H+++
Sbjct: 89  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 148
Query: 791 ETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS 850
                +  +  +GL Y+H   S  IIHRD+K +N+ ++ D E  + DFGLA+   D    
Sbjct: 149 -----LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--- 197
Query: 851 ECMSSVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELIAGK 893
             M+    +  Y APE     +  ++  D++S G ++ EL+ G+
Sbjct: 198 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/185 (27%), Positives = 87/185 (47%), Gaps = 15/185 (8%)
Query: 739 EIQTLGRIRHRNIVRLLGYVSNRDTNLLLYE-YMPNGSLGEMLHG-AKGGHLKWETRYRI 796
           E++ L  ++H N++ LL   +   +     E Y+    +G  L+   K   L  E    +
Sbjct: 77  ELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSDEHVQFL 136
Query: 797 ALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSV 856
             +  +GL Y+H   S  IIHRD+K +N+ ++ D E  + DFGLA+      A E M+  
Sbjct: 137 VYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDSELRILDFGLAR-----QADEEMTGY 188
Query: 857 AGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSE 915
             +  Y APE     +  ++  D++S G ++ EL+ GK        G D +  +++    
Sbjct: 189 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKA----LFPGSDYIDQLKRIMEV 244
Query: 916 VSQPS 920
           V  PS
Sbjct: 245 VGTPS 249

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/179 (26%), Positives = 81/179 (45%), Gaps = 12/179 (6%)
Query: 723 RLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHG 782
           + + +     D     EI  L +I+H NIV L     +     L+ + +  G L + +  
Sbjct: 40  KCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRI-L 98
Query: 783 AKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILL---DSDFEAHVADFG 839
            +G + + +    I  +    + YLH +    I+HRD+K  N+L    + + +  + DFG
Sbjct: 99  ERGVYTEKDASLVIQ-QVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFG 154
Query: 840 LAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGE 898
           L+K  Q+      MS+  G+ GY+APE        +  D +S GV+   L+ G  P  E
Sbjct: 155 LSKMEQNG----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYE 209

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 52/198 (26%), Positives = 96/198 (48%), Gaps = 12/198 (6%)
Query: 700 IGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYV 758
           IG+G  GIV        G  VA+K +  R     +  F  E+  +   +H N+V +    
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLF-NEVVIMRDYQHFNVVEMYKSY 111
Query: 759 SNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHR 818
              +   +L E++  G+L +++   +    +  T     L+A   L YLH   +  +IHR
Sbjct: 112 LVGEELWVLMEFLQGGALTDIVSQVRLNEEQIATVCEAVLQA---LAYLH---AQGVIHR 165
Query: 819 DVKSNNILLDSDFEAHVADFGL-AKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKS 877
           D+KS++ILL  D    ++DFG  A+  +D    +    + G+  ++APE         + 
Sbjct: 166 DIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRK---XLVGTPYWMAPEVISRSLYATEV 222
Query: 878 DVYSFGVVLLELIAGKKP 895
           D++S G++++E++ G+ P
Sbjct: 223 DIWSLGIMVIEMVDGEPP 240

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/185 (27%), Positives = 87/185 (47%), Gaps = 15/185 (8%)
Query: 739 EIQTLGRIRHRNIVRLLGYVSNRDTNLLLYE-YMPNGSLGEMLHG-AKGGHLKWETRYRI 796
           E++ L  ++H N++ LL   +   +     E Y+    +G  L+   K   L  E    +
Sbjct: 69  ELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFL 128
Query: 797 ALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSV 856
             +  +GL Y+H   S  IIHRD+K +N+ ++ D E  + DFGLA+      A E M+  
Sbjct: 129 VYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLAR-----QADEEMTGY 180
Query: 857 AGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSE 915
             +  Y APE     +  ++  D++S G ++ EL+ GK        G D +  +++    
Sbjct: 181 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKA----LFPGSDYIDQLKRIMEV 236
Query: 916 VSQPS 920
           V  PS
Sbjct: 237 VGTPS 241

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/185 (27%), Positives = 87/185 (47%), Gaps = 15/185 (8%)
Query: 739 EIQTLGRIRHRNIVRLLGYVSNRDTNLLLYE-YMPNGSLGEMLHG-AKGGHLKWETRYRI 796
           E++ L  ++H N++ LL   +   +     E Y+    +G  L+   K   L  E    +
Sbjct: 77  ELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFL 136
Query: 797 ALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSV 856
             +  +GL Y+H   S  IIHRD+K +N+ ++ D E  + DFGLA+      A E M+  
Sbjct: 137 VYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDSELRILDFGLAR-----QADEEMTGY 188
Query: 857 AGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSE 915
             +  Y APE     +  ++  D++S G ++ EL+ GK        G D +  +++    
Sbjct: 189 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKA----LFPGSDYIDQLKRIMEV 244
Query: 916 VSQPS 920
           V  PS
Sbjct: 245 VGTPS 249

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 40/131 (30%), Positives = 63/131 (48%), Gaps = 7/131 (5%)
Query: 765 LLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNN 824
             + EY+  G L  M H  +   L  E     + E +  L YLH      II+RD+K +N
Sbjct: 86  FFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDN 140
Query: 825 ILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGV 884
           +LLDS+    + D+G+ K  +     +  S   G+  YIAPE           D ++ GV
Sbjct: 141 VLLDSEGHIKLTDYGMCK--EGLRPGDTTSXFCGTPNYIAPEILRGEDYGFSVDWWALGV 198
Query: 885 VLLELIAGKKP 895
           ++ E++AG+ P
Sbjct: 199 LMFEMMAGRSP 209

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 93/200 (46%), Gaps = 11/200 (5%)
Query: 700 IGKGGAGIVYRGSMPDGID---VAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLG 756
           IG+G  G+V   S  D ++   VAIK++            L EI+ L   RH NI+ +  
Sbjct: 33  IGEGAYGMV--CSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGIND 90
Query: 757 YVSNRDTNLLLYEYMPNGSLGEMLHGA-KGGHLKWETRYRIALEAAKGLCYLHHDCSPLI 815
            +       +   Y+    +   L+   K  HL  +       +  +GL Y+H   S  +
Sbjct: 91  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANV 147
Query: 816 IHRDVKSNNILLDSDFEAHVADFGLAKFLQ-DAGASECMSSVAGSYGYIAPEYAYTLKVD 874
           +HRD+K +N+LL++  +  + DFGLA+    D   +  ++    +  Y APE     K  
Sbjct: 148 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 207
Query: 875 EKS-DVYSFGVVLLELIAGK 893
            KS D++S G +L E+++ +
Sbjct: 208 TKSIDIWSVGCILAEMLSNR 227

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 98/219 (44%), Gaps = 31/219 (14%)
Query: 697 ENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLL 755
           ++++G+G  G+V   +  P G  VAIK++            L EI+ L   +H NI+ + 
Sbjct: 16  KSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIF 75
Query: 756 GY-----VSNRDTNLLLYEYMPNGSL----GEMLHGAKGGHLKWETRYRIALEAAKGLCY 806
                    N +   ++ E M          +ML      +  ++T     L A K L  
Sbjct: 76  NIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQT-----LRAVKVL-- 128
Query: 807 LHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASEC--------MSSVAG 858
             H  +  +IHRD+K +N+L++S+ +  V DFGLA+ + ++ A           M+    
Sbjct: 129 --HGSN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEXVA 184
Query: 859 SYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELIAGKKPV 896
           +  Y APE   T  K     DV+S G +L EL   ++P+
Sbjct: 185 TRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRPI 222

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 102/224 (45%), Gaps = 25/224 (11%)
Query: 681 QRLDFKAEDVLESLKDENIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHG--FL 737
           Q L+    +V E  ++ + +G G  G V        G  VA+K+L  R      H     
Sbjct: 17  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKL-SRPFQSIIHAKRTY 75
Query: 738 AEIQTLGRIRHRNIVRLLGYVS-----NRDTNLLLYEYMPNGSLGEMLHGAK--GGHLKW 790
            E++ L  ++H N++ LL   +         ++ L  ++    L  ++   K    H+++
Sbjct: 76  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 135
Query: 791 ETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS 850
                +  +  +GL Y+H   S  IIHRD+K +N+ ++ D E  + DFGLA+   D    
Sbjct: 136 -----LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--- 184
Query: 851 ECMSSVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELIAGK 893
             M+    +  Y APE     +  ++  D++S G ++ EL+ G+
Sbjct: 185 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 48/160 (30%), Positives = 70/160 (43%), Gaps = 9/160 (5%)
Query: 737 LAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRI 796
           + E + L   RH  +  L       D    + EY  NG  GE+        +  E R R 
Sbjct: 53  VTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEY-ANG--GELFFHLSRERVFTEERARF 109
Query: 797 -ALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSS 855
              E    L YLH   S  +++RD+K  N++LD D    + DFGL K     GA+  M +
Sbjct: 110 YGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKT 164
Query: 856 VAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
             G+  Y+APE           D +  GVV+ E++ G+ P
Sbjct: 165 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 98/219 (44%), Gaps = 31/219 (14%)
Query: 697 ENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLL 755
           ++++G+G  G+V   +  P G  VAIK++            L EI+ L   +H NI+ + 
Sbjct: 16  KSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIF 75
Query: 756 GY-----VSNRDTNLLLYEYMPNGSL----GEMLHGAKGGHLKWETRYRIALEAAKGLCY 806
                    N +   ++ E M          +ML      +  ++T     L A K L  
Sbjct: 76  NIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQT-----LRAVKVL-- 128
Query: 807 LHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASEC--------MSSVAG 858
             H  +  +IHRD+K +N+L++S+ +  V DFGLA+ + ++ A           M+    
Sbjct: 129 --HGSN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVA 184
Query: 859 SYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELIAGKKPV 896
           +  Y APE   T  K     DV+S G +L EL   ++P+
Sbjct: 185 TRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRPI 222

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 101/224 (45%), Gaps = 25/224 (11%)
Query: 681 QRLDFKAEDVLESLKDENIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHG--FL 737
           Q L+    +V E  ++ + +G G  G V        G  VA+K+L  R      H     
Sbjct: 31  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKL-SRPFQSIIHAKRTY 89
Query: 738 AEIQTLGRIRHRNIVRLLGYVS-----NRDTNLLLYEYMPNGSLGEMLHGAK--GGHLKW 790
            E++ L  ++H N++ LL   +         ++ L  ++    L  ++   K    H+++
Sbjct: 90  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 149
Query: 791 ETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS 850
                +  +  +GL Y+H   S  IIHRD+K +N+ ++ D E  + DFGLA+   D    
Sbjct: 150 -----LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--- 198
Query: 851 ECMSSVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELIAGK 893
             M     +  Y APE     +  ++  D++S G ++ EL+ G+
Sbjct: 199 --MXGXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 67/159 (42%), Gaps = 7/159 (4%)
Query: 737 LAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRI 796
           + E + L   RH  +  L       D    + EY   G L    H ++      E     
Sbjct: 53  VTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFY 110
Query: 797 ALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSV 856
             E    L YLH   S  +++RD+K  N++LD D    + DFGL K     GA+  M + 
Sbjct: 111 GAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKTF 165
Query: 857 AGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
            G+  Y+APE           D +  GVV+ E++ G+ P
Sbjct: 166 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 40/131 (30%), Positives = 63/131 (48%), Gaps = 7/131 (5%)
Query: 765 LLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNN 824
             + EY+  G L  M H  +   L  E     + E +  L YLH      II+RD+K +N
Sbjct: 82  FFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDN 136
Query: 825 ILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGV 884
           +LLDS+    + D+G+ K  +     +  S   G+  YIAPE           D ++ GV
Sbjct: 137 VLLDSEGHIKLTDYGMCK--EGLRPGDTTSXFCGTPNYIAPEILRGEDYGFSVDWWALGV 194
Query: 885 VLLELIAGKKP 895
           ++ E++AG+ P
Sbjct: 195 LMFEMMAGRSP 205

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 40/131 (30%), Positives = 63/131 (48%), Gaps = 7/131 (5%)
Query: 765 LLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNN 824
             + EY+  G L  M H  +   L  E     + E +  L YLH      II+RD+K +N
Sbjct: 97  FFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDN 151
Query: 825 ILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGV 884
           +LLDS+    + D+G+ K  +     +  S   G+  YIAPE           D ++ GV
Sbjct: 152 VLLDSEGHIKLTDYGMCK--EGLRPGDTTSXFCGTPNYIAPEILRGEDYGFSVDWWALGV 209
Query: 885 VLLELIAGKKP 895
           ++ E++AG+ P
Sbjct: 210 LMFEMMAGRSP 220

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 81/169 (47%), Gaps = 17/169 (10%)
Query: 738 AEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHL--------- 788
           A ++   R+R +    +L  V++     L Y +   G L  +L   +GG L         
Sbjct: 63  ATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVM 122
Query: 789 --KWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQD 846
             + + ++ +A E A  L +LH   S  II+RD+K  NILLD +    + DFGL+K  + 
Sbjct: 123 FTEEDVKFYLA-ELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK--ES 176
Query: 847 AGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
               +   S  G+  Y+APE        + +D +SFGV++ E++ G  P
Sbjct: 177 IDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 225

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 101/224 (45%), Gaps = 25/224 (11%)
Query: 681 QRLDFKAEDVLESLKDENIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHG--FL 737
           Q L+    +V E  ++   +G G  G V        G  VA+K+L  R      H     
Sbjct: 21  QELNKTIWEVPERYQNLAPVGSGAYGSVCAAFDTKTGHRVAVKKL-SRPFQSIIHAKRTY 79
Query: 738 AEIQTLGRIRHRNIVRLLGYVS-----NRDTNLLLYEYMPNGSLGEMLHGAK--GGHLKW 790
            E++ L  ++H N++ LL   +         ++ L  ++    L  ++   K    H+++
Sbjct: 80  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 139
Query: 791 ETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS 850
                +  +  +GL Y+H   S  IIHRD+K +N+ ++ D E  + DFGLA+   D    
Sbjct: 140 -----LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--- 188
Query: 851 ECMSSVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELIAGK 893
             M+    +  Y APE     +  ++  D++S G ++ EL+ G+
Sbjct: 189 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 230

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 72/239 (30%), Positives = 107/239 (44%), Gaps = 20/239 (8%)
Query: 689 DVLESLKDENIIGKGGAGI--VYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRI 746
           D  + +KD   IG G  G+  + R  +   + VA+K  + RG    D     EI     +
Sbjct: 20  DRYDFVKD---IGSGNFGVARLMRDKLTKEL-VAVK-YIERG-AAIDENVQREIINHRSL 73
Query: 747 RHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCY 806
           RH NIVR    +       ++ EY   G L E +  A G   + E R+    +   G+ Y
Sbjct: 74  RHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNA-GRFSEDEARFFFQ-QLLSGVSY 131
Query: 807 LHHDCSPLIIHRDVKSNNILLDSDFEAH--VADFGLAKFLQDAGASECMSSVAGSYGYIA 864
            H   S  I HRD+K  N LLD        + DFG +K       S+  S+V G+  YIA
Sbjct: 132 CH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTV-GTPAYIA 185
Query: 865 PEYAYTLKVDEK-SDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTS-EVSQPSD 921
           PE     + D K +DV+S GV L  ++ G  P  +  +  D  + +++  S + S P D
Sbjct: 186 PEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDD 244

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Composition-based stats.
 Identities = 49/169 (28%), Positives = 81/169 (47%), Gaps = 17/169 (10%)
Query: 738 AEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHL--------- 788
           A ++   R+R +    +L  V++     L Y +   G L  +L   +GG L         
Sbjct: 63  ATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVM 122
Query: 789 --KWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQD 846
             + + ++ +A E A  L +LH   S  II+RD+K  NILLD +    + DFGL+K  + 
Sbjct: 123 FTEEDVKFYLA-ELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK--ES 176
Query: 847 AGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
               +   S  G+  Y+APE        + +D +SFGV++ E++ G  P
Sbjct: 177 IDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 225

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 67/159 (42%), Gaps = 7/159 (4%)
Query: 737 LAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRI 796
           + E + L   RH  +  L       D    + EY   G L    H ++      E     
Sbjct: 56  VTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFY 113
Query: 797 ALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSV 856
             E    L YLH   S  +++RD+K  N++LD D    + DFGL K     GA+  M + 
Sbjct: 114 GAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKTF 168
Query: 857 AGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
            G+  Y+APE           D +  GVV+ E++ G+ P
Sbjct: 169 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 207

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 81/169 (47%), Gaps = 17/169 (10%)
Query: 738 AEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHL--------- 788
           A ++   R+R +    +L  V++     L Y +   G L  +L   +GG L         
Sbjct: 64  ATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVM 123
Query: 789 --KWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQD 846
             + + ++ +A E A  L +LH   S  II+RD+K  NILLD +    + DFGL+K  + 
Sbjct: 124 FTEEDVKFYLA-ELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK--ES 177
Query: 847 AGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
               +   S  G+  Y+APE        + +D +SFGV++ E++ G  P
Sbjct: 178 IDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 226

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 93/200 (46%), Gaps = 11/200 (5%)
Query: 700 IGKGGAGIVYRGSMPDGID---VAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLG 756
           IG+G  G+V   S  D ++   VAIK++            L EI+ L   RH NI+ +  
Sbjct: 33  IGEGAYGMV--CSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGIND 90
Query: 757 YVSNRDTNLLLYEYMPNGSLGEMLHGA-KGGHLKWETRYRIALEAAKGLCYLHHDCSPLI 815
            +       +   Y+    +   L+   K  HL  +       +  +GL Y+H   S  +
Sbjct: 91  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANV 147
Query: 816 IHRDVKSNNILLDSDFEAHVADFGLAKFLQ-DAGASECMSSVAGSYGYIAPEYAYTLKVD 874
           +HRD+K +N+LL++  +  + DFGLA+    D   +  ++    +  Y APE     K  
Sbjct: 148 LHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 207
Query: 875 EKS-DVYSFGVVLLELIAGK 893
            KS D++S G +L E+++ +
Sbjct: 208 TKSIDIWSVGCILAEMLSNR 227

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 102/224 (45%), Gaps = 25/224 (11%)
Query: 681 QRLDFKAEDVLESLKDENIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHG--FL 737
           Q L+    +V E  ++ + +G G  G V        G+ VA+K+L  R      H     
Sbjct: 11  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTY 69
Query: 738 AEIQTLGRIRHRNIVRLLGYVS-----NRDTNLLLYEYMPNGSLGEMLHGAK--GGHLKW 790
            E++ L  ++H N++ LL   +         ++ L  ++    L  ++   K    H+++
Sbjct: 70  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 129
Query: 791 ETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS 850
                +  +  +GL Y+H   S  IIHRD+K +N+ ++ D E  +  FGLA+   D    
Sbjct: 130 -----LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILGFGLARHTDDE--- 178
Query: 851 ECMSSVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELIAGK 893
             M+    +  Y APE     +  ++  D++S G ++ EL+ G+
Sbjct: 179 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 93/202 (46%), Gaps = 16/202 (7%)
Query: 739 EIQTLGRIRHRNIVRLLGYVSNRDTNL-LLYEYMPNGSLGEMLHGAKGGHLKWETRYRIA 797
           E Q L  IR    +  L Y    +T L L+ +Y+  G L    H ++       T + + 
Sbjct: 108 ERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGEL--FTHLSQRERF---TEHEVQ 162
Query: 798 LEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAK-FLQDAGASECMSSV 856
           +   + +  L H     II+RD+K  NILLDS+    + DFGL+K F+ D   +E     
Sbjct: 163 IYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVAD--ETERAYDF 220
Query: 857 AGSYGYIAPEYAY--TLKVDEKSDVYSFGVVLLELIAGKKPV---GEFGDGVDIVRWVRK 911
            G+  Y+AP+         D+  D +S GV++ EL+ G  P    GE     +I R + K
Sbjct: 221 CGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK 280
Query: 912 TTSEVSQPSDAASVLAVVDPRL 933
             SE   P + +++   +  RL
Sbjct: 281 --SEPPYPQEMSALAKDLIQRL 300

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 102/224 (45%), Gaps = 25/224 (11%)
Query: 681 QRLDFKAEDVLESLKDENIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHG--FL 737
           Q L+    +V E  ++ + +G G  G V        G+ VA+K+L  R      H     
Sbjct: 11  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTY 69
Query: 738 AEIQTLGRIRHRNIVRLLGYVS-----NRDTNLLLYEYMPNGSLGEMLHGAK--GGHLKW 790
            E++ L  ++H N++ LL   +         ++ L  ++    L  ++   K    H+++
Sbjct: 70  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 129
Query: 791 ETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS 850
                +  +  +GL Y+H   S  IIHRD+K +N+ ++ D E  + D GLA+   D    
Sbjct: 130 -----LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDRGLARHTDDE--- 178
Query: 851 ECMSSVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELIAGK 893
             M+    +  Y APE     +  ++  D++S G ++ EL+ G+
Sbjct: 179 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 102/224 (45%), Gaps = 25/224 (11%)
Query: 681 QRLDFKAEDVLESLKDENIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHG--FL 737
           Q L+    +V E  ++ + +G G  G V        G+ VA+K+L  R      H     
Sbjct: 11  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTY 69
Query: 738 AEIQTLGRIRHRNIVRLLGYVS-----NRDTNLLLYEYMPNGSLGEMLHGAK--GGHLKW 790
            E++ L  ++H N++ LL   +         ++ L  ++    L  ++   K    H+++
Sbjct: 70  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 129
Query: 791 ETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS 850
                +  +  +GL Y+H   S  IIHRD+K +N+ ++ D E  + D GLA+   D    
Sbjct: 130 -----LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDAGLARHTDDE--- 178
Query: 851 ECMSSVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELIAGK 893
             M+    +  Y APE     +  ++  D++S G ++ EL+ G+
Sbjct: 179 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 97/219 (44%), Gaps = 31/219 (14%)
Query: 697 ENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLL 755
           ++++G+G  G+V   +  P G  VAIK++            L EI+ L   +H NI+ + 
Sbjct: 16  KSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIF 75
Query: 756 GY-----VSNRDTNLLLYEYMPNGSL----GEMLHGAKGGHLKWETRYRIALEAAKGLCY 806
                    N +   ++ E M          +ML      +  ++T     L A K L  
Sbjct: 76  NIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQT-----LRAVKVL-- 128
Query: 807 LHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASEC--------MSSVAG 858
             H  +  +IHRD+K +N+L++S+ +  V DFGLA+ + ++ A           M     
Sbjct: 129 --HGSN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVA 184
Query: 859 SYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELIAGKKPV 896
           +  Y APE   T  K     DV+S G +L EL   ++P+
Sbjct: 185 TRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRPI 222

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 66/159 (41%), Gaps = 7/159 (4%)
Query: 737 LAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRI 796
           + E + L   RH  +  L       D    + EY   G L    H ++      E     
Sbjct: 53  VTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFY 110
Query: 797 ALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSV 856
             E    L YLH   S  +++RD+K  N++LD D    + DFGL K     GA+  M   
Sbjct: 111 GAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKXF 165
Query: 857 AGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
            G+  Y+APE           D +  GVV+ E++ G+ P
Sbjct: 166 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 66/159 (41%), Gaps = 7/159 (4%)
Query: 737 LAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRI 796
           + E + L   RH  +  L       D    + EY   G L    H ++      E     
Sbjct: 58  VTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFY 115
Query: 797 ALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSV 856
             E    L YLH   S  +++RD+K  N++LD D    + DFGL K     GA+  M   
Sbjct: 116 GAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKXF 170
Query: 857 AGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
            G+  Y+APE           D +  GVV+ E++ G+ P
Sbjct: 171 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 209

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 66/159 (41%), Gaps = 7/159 (4%)
Query: 737 LAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRI 796
           + E + L   RH  +  L       D    + EY   G L    H ++      E     
Sbjct: 53  VTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFY 110
Query: 797 ALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSV 856
             E    L YLH   S  +++RD+K  N++LD D    + DFGL K     GA+  M   
Sbjct: 111 GAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKXF 165
Query: 857 AGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
            G+  Y+APE           D +  GVV+ E++ G+ P
Sbjct: 166 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 66/159 (41%), Gaps = 7/159 (4%)
Query: 737 LAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRI 796
           + E + L   RH  +  L       D    + EY   G L    H ++      E     
Sbjct: 53  VTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFY 110
Query: 797 ALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSV 856
             E    L YLH   S  +++RD+K  N++LD D    + DFGL K     GA+  M   
Sbjct: 111 GAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKXF 165
Query: 857 AGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
            G+  Y+APE           D +  GVV+ E++ G+ P
Sbjct: 166 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Composition-based stats.
 Identities = 48/165 (29%), Positives = 79/165 (47%), Gaps = 13/165 (7%)
Query: 737 LAEIQTLGRIRHRNIVRLLGYVSNRDTN-----LLLYEYMPNGSLGEMLHGAKGGHLKWE 791
           +A ++ L    H N+VRL+   +   T+      L++E++ +  L   L  A    L  E
Sbjct: 62  VALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAE 120
Query: 792 TRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASE 851
           T   +  +  +GL +LH +C   I+HRD+K  NIL+ S     +ADFGLA+      A  
Sbjct: 121 TIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA-- 175
Query: 852 CMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPV 896
            ++ V  +  Y APE           D++S G +  E+   +KP+
Sbjct: 176 -LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 218

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 92/200 (46%), Gaps = 11/200 (5%)
Query: 700 IGKGGAGIVYRGSMPDGID---VAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLG 756
           IG+G  G+V   S  D +    VAIK++            L EIQ L R RH N++ +  
Sbjct: 51  IGEGAYGMV--SSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHENVIGIRD 108
Query: 757 YVSNRDTNLLLYEYMPNGSLGEMLHGA-KGGHLKWETRYRIALEAAKGLCYLHHDCSPLI 815
            +       +   Y+    +   L+   K   L  +       +  +GL Y+H   S  +
Sbjct: 109 ILRASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDHICYFLYQILRGLKYIH---SANV 165
Query: 816 IHRDVKSNNILLDSDFEAHVADFGLAKFLQ-DAGASECMSSVAGSYGYIAPEYAYTLKVD 874
           +HRD+K +N+L+++  +  + DFGLA+    +   +  ++    +  Y APE     K  
Sbjct: 166 LHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPEIMLNSKGY 225
Query: 875 EKS-DVYSFGVVLLELIAGK 893
            KS D++S G +L E+++ +
Sbjct: 226 TKSIDIWSVGCILAEMLSNR 245

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 59/228 (25%), Positives = 108/228 (47%), Gaps = 23/228 (10%)
Query: 683 LDFKAEDVLESLKDE----NIIGKGGAGIVYRGSMP-DGIDVAIKRLVGR-GTGGNDHGF 736
           L  ++ DV   + DE      IG G  G+V        G  VAIK++        N    
Sbjct: 42  LKARSFDVTFDVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRT 101
Query: 737 LAEIQTLGRIRHRNIVRL-------LGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLK 789
           L E++ L   +H NI+ +       + Y   +   ++L   +    L +++H ++   L+
Sbjct: 102 LRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLD--LMESDLHQIIHSSQPLTLE 159
Query: 790 WETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGA 849
              RY +  +  +GL Y+H   S  +IHRD+K +N+L++ + E  + DFG+A+ L  + A
Sbjct: 160 -HVRYFL-YQLLRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPA 214
Query: 850 SE--CMSSVAGSYGYIAPEYAYTL-KVDEKSDVYSFGVVLLELIAGKK 894
                M+    +  Y APE   +L +  +  D++S G +  E++A ++
Sbjct: 215 EHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 262

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 98/221 (44%), Gaps = 18/221 (8%)
Query: 685 FKAEDVLESLKDENIIGKGGAGIVYRGSMP-DGIDVAIK-----RLVGRGTGGNDHGFLA 738
           F+ EDV +  +    +G G   IV +      G + A K     RL     G +      
Sbjct: 5   FRQEDVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIER 64
Query: 739 EIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIAL 798
           E+  L  IRH NI+ L     N+   +L+ E +  G L + L  A+   L  +   +   
Sbjct: 65  EVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFL--AEKESLTEDEATQFLK 122
Query: 799 EAAKGLCYLHHDCSPLIIHRDVKSNNI-LLDSDF---EAHVADFGLAKFLQDAGASECMS 854
           +   G+ YLH   S  I H D+K  NI LLD +       + DFG+A  ++   A     
Sbjct: 123 QILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE---AGNEFK 176
Query: 855 SVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
           ++ G+  ++APE      +  ++D++S GV+   L++G  P
Sbjct: 177 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 48/160 (30%), Positives = 71/160 (44%), Gaps = 8/160 (5%)
Query: 737 LAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRI 796
           L E + L   RH  +  L       D    + EY  NG  GE+        +  E R R 
Sbjct: 199 LTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEY-ANG--GELFFHLSRERVFSEDRARF 255
Query: 797 -ALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSS 855
              E    L YLH + +  +++RD+K  N++LD D    + DFGL K     GA+  M +
Sbjct: 256 YGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MKT 311
Query: 856 VAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
             G+  Y+APE           D +  GVV+ E++ G+ P
Sbjct: 312 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 351

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 56.2 bits (134), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 48/160 (30%), Positives = 71/160 (44%), Gaps = 8/160 (5%)
Query: 737 LAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRI 796
           L E + L   RH  +  L       D    + EY  NG  GE+        +  E R R 
Sbjct: 196 LTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEY-ANG--GELFFHLSRERVFSEDRARF 252
Query: 797 -ALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSS 855
              E    L YLH + +  +++RD+K  N++LD D    + DFGL K     GA+  M +
Sbjct: 253 YGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MKT 308
Query: 856 VAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
             G+  Y+APE           D +  GVV+ E++ G+ P
Sbjct: 309 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 348

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 102/224 (45%), Gaps = 25/224 (11%)
Query: 681 QRLDFKAEDVLESLKDENIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHG--FL 737
           Q L+    +V E  ++ + +G G  G V        G+ VA+K+L  R      H     
Sbjct: 11  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTY 69
Query: 738 AEIQTLGRIRHRNIVRLLGYVS-----NRDTNLLLYEYMPNGSLGEMLHGAK--GGHLKW 790
            E++ L  ++H N++ LL   +         ++ L  ++    L  ++   K    H+++
Sbjct: 70  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 129
Query: 791 ETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS 850
                +  +  +GL Y+H   S  IIHRD+K +N+ ++ D E  + D GLA+   D    
Sbjct: 130 -----LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDGGLARHTDDE--- 178
Query: 851 ECMSSVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELIAGK 893
             M+    +  Y APE     +  ++  D++S G ++ EL+ G+
Sbjct: 179 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 56.2 bits (134), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 98/221 (44%), Gaps = 36/221 (16%)
Query: 700 IGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGND-HGFLAEIQTLGRIR-HRNIVRLLG 756
           +GKG  GIV++      G  VA+K++        D      EI  L  +  H NIV LL 
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLN 76
Query: 757 YV---SNRDTNLLLYEYMPNGSLGEMLHGA-KGGHLKWETRYRIALEAAKGLCYLHHDCS 812
            +   ++RD   L+++YM        LH   +   L+   +  +  +  K + YLH   S
Sbjct: 77  VLRADNDRDV-YLVFDYMETD-----LHAVIRANILEPVHKQYVVYQLIKVIKYLH---S 127
Query: 813 PLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQD-------------------AGASECM 853
             ++HRD+K +NILL+++    VADFGL++   +                         +
Sbjct: 128 GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPIL 187
Query: 854 SSVAGSYGYIAPEYAY-TLKVDEKSDVYSFGVVLLELIAGK 893
           +    +  Y APE    + K  +  D++S G +L E++ GK
Sbjct: 188 TDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 56.2 bits (134), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 52/217 (23%), Positives = 93/217 (42%), Gaps = 31/217 (14%)
Query: 735 GFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGE------MLHGAKGGHL 788
            F  E+Q +  I++   +   G ++N D   ++YEYM N S+ +      +L       +
Sbjct: 89  DFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFI 148
Query: 789 KWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAG 848
             +    I         Y+H++ +  I HRDVK +NIL+D +    ++DFG ++++ D  
Sbjct: 149 PIQVIKCIIKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKK 206
Query: 849 ASECMSSVAGSYGYIAPEY-----AYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGV 903
               +    G+Y ++ PE+     +Y      K D++S G+ L  +     P       V
Sbjct: 207 ----IKGSRGTYEFMPPEFFSNESSYN---GAKVDIWSLGICLYVMFYNVVPFSLKISLV 259
Query: 904 DIVRWVRKTTSEVSQPSDAASVLAVVDPRLSGYPLTG 940
           ++   +R  T  +  P D    L         YPLT 
Sbjct: 260 ELFNNIR--TKNIEYPLDRNHFL---------YPLTN 285

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 98/204 (48%), Gaps = 18/204 (8%)
Query: 700 IGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRI-RHRNIVRLLGY 757
           +GKG   +V R   +  G + A   +  +     DH  L     + R+ +H NIVRL   
Sbjct: 19  LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 78
Query: 758 VSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIA--LEAAKGLCYLHHDCSPL- 814
           +S    + L+++ +  G L E +  A+  + + +  + I   LEA      LH  C  + 
Sbjct: 79  ISEEGHHYLIFDLVTGGELFEDI-VAREYYSEADASHCIQQILEAV-----LH--CHQMG 130
Query: 815 IIHRDVKSNNILLDSDFE---AHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTL 871
           ++HR++K  N+LL S  +     +ADFGLA  ++  G  +     AG+ GY++PE     
Sbjct: 131 VVHRNLKPENLLLASKLKGAAVKLADFGLA--IEVEGEQQAWFGFAGTPGYLSPEVLRKD 188
Query: 872 KVDEKSDVYSFGVVLLELIAGKKP 895
              +  D+++ GV+L  L+ G  P
Sbjct: 189 PYGKPVDLWACGVILYILLVGYPP 212

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 59/210 (28%), Positives = 98/210 (46%), Gaps = 24/210 (11%)
Query: 699 IIGKGGAGIVYRG-SMPDGIDVAIK-----RLVGRGTGGNDHGFLAEIQTLGRIRH--RN 750
           ++G GG G VY G  + D + VAIK     R+   G   N      E+  L ++      
Sbjct: 15  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 74
Query: 751 IVRLLGYVSNRDTNLLLYEYM-PNGSLGEML--HGAKGGHLKWETRYRIALEAAKGLCYL 807
           ++RLL +    D+ +L+ E M P   L + +   GA    L     +++ LEA +     
Sbjct: 75  VIRLLDWFERPDSFVLILERMEPVQDLFDFITERGALQEELARSFFWQV-LEAVRHC--- 130
Query: 808 HHDCSPLIIHRDVKSNNILLDSDF-EAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPE 866
            H+C   ++HRD+K  NIL+D +  E  + DFG    L+D       +   G+  Y  PE
Sbjct: 131 -HNCG--VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPE 183
Query: 867 YAYTLKVDEKS-DVYSFGVVLLELIAGKKP 895
           +    +   +S  V+S G++L +++ G  P
Sbjct: 184 WIRYHRYHGRSAAVWSLGILLYDMVCGDIP 213

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/228 (25%), Positives = 108/228 (47%), Gaps = 23/228 (10%)
Query: 683 LDFKAEDVLESLKDE----NIIGKGGAGIVYRGSMP-DGIDVAIKRLVGR-GTGGNDHGF 736
           L  ++ DV   + DE      IG G  G+V        G  VAIK++        N    
Sbjct: 41  LKARSFDVTFDVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRT 100
Query: 737 LAEIQTLGRIRHRNIVRL-------LGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLK 789
           L E++ L   +H NI+ +       + Y   +   ++L   +    L +++H ++   L+
Sbjct: 101 LRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLD--LMESDLHQIIHSSQPLTLE 158
Query: 790 WETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGA 849
              RY +  +  +GL Y+H   S  +IHRD+K +N+L++ + E  + DFG+A+ L  + A
Sbjct: 159 -HVRYFL-YQLLRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPA 213
Query: 850 SE--CMSSVAGSYGYIAPEYAYTL-KVDEKSDVYSFGVVLLELIAGKK 894
                M+    +  Y APE   +L +  +  D++S G +  E++A ++
Sbjct: 214 EHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 261

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/195 (24%), Positives = 85/195 (43%), Gaps = 25/195 (12%)
Query: 719 VAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGE 778
           VA+K L    +       L+E   L ++ H ++++L G  S     LL+ EY   GSL  
Sbjct: 56  VAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRG 115
Query: 779 MLHGAKG---GHLKWETRYR-------------------IALEAAKGLCYLHHDCSPLII 816
            L  ++    G+L                           A + ++G+ YL       ++
Sbjct: 116 FLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL---AEMKLV 172
Query: 817 HRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEK 876
           HRD+ + NIL+    +  ++DFGL++ + +  +    S       ++A E  +      +
Sbjct: 173 HRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQ 232
Query: 877 SDVYSFGVVLLELIA 891
           SDV+SFGV+L E++ 
Sbjct: 233 SDVWSFGVLLWEIVT 247

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/160 (30%), Positives = 70/160 (43%), Gaps = 8/160 (5%)
Query: 737 LAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRI 796
           L E + L   RH  +  L       D    + EY  NG  GE+        +  E R R 
Sbjct: 56  LTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEY-ANG--GELFFHLSRERVFSEDRARF 112
Query: 797 -ALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSS 855
              E    L YLH + +  +++RD+K  N++LD D    + DFGL K     GA+  M  
Sbjct: 113 YGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MKX 168
Query: 856 VAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
             G+  Y+APE           D +  GVV+ E++ G+ P
Sbjct: 169 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 208

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/160 (30%), Positives = 70/160 (43%), Gaps = 8/160 (5%)
Query: 737 LAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRI 796
           L E + L   RH  +  L       D    + EY  NG  GE+        +  E R R 
Sbjct: 58  LTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEY-ANG--GELFFHLSRERVFSEDRARF 114
Query: 797 -ALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSS 855
              E    L YLH + +  +++RD+K  N++LD D    + DFGL K     GA+  M  
Sbjct: 115 YGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MKX 170
Query: 856 VAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
             G+  Y+APE           D +  GVV+ E++ G+ P
Sbjct: 171 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 210

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/195 (24%), Positives = 85/195 (43%), Gaps = 25/195 (12%)
Query: 719 VAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGE 778
           VA+K L    +       L+E   L ++ H ++++L G  S     LL+ EY   GSL  
Sbjct: 56  VAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRG 115
Query: 779 MLHGAKG---GHLKWETRYR-------------------IALEAAKGLCYLHHDCSPLII 816
            L  ++    G+L                           A + ++G+ YL       ++
Sbjct: 116 FLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL---AEMSLV 172
Query: 817 HRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEK 876
           HRD+ + NIL+    +  ++DFGL++ + +  +    S       ++A E  +      +
Sbjct: 173 HRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQ 232
Query: 877 SDVYSFGVVLLELIA 891
           SDV+SFGV+L E++ 
Sbjct: 233 SDVWSFGVLLWEIVT 247

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 92/199 (46%), Gaps = 13/199 (6%)
Query: 698 NIIGKGGAGIVYRGSMPDGID-VAIKRL-VGRGTGGND---HGFLAEIQTLGRIRHRNIV 752
           + +G+G    VY+    +    VAIK++ +G  +   D      L EI+ L  + H NI+
Sbjct: 16  DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 75
Query: 753 RLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCS 812
            LL    ++    L++++M      E++       L         L   +GL YLH    
Sbjct: 76  GLLDAFGHKSNISLVFDFMETDL--EVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW- 132
Query: 813 PLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLK 872
             I+HRD+K NN+LLD +    +ADFGLAK       +     V  +  Y APE  +  +
Sbjct: 133 --ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVV--TRWYRAPELLFGAR 188
Query: 873 V-DEKSDVYSFGVVLLELI 890
           +     D+++ G +L EL+
Sbjct: 189 MYGVGVDMWAVGCILAELL 207

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/160 (30%), Positives = 70/160 (43%), Gaps = 8/160 (5%)
Query: 737 LAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRI 796
           L E + L   RH  +  L       D    + EY  NG  GE+        +  E R R 
Sbjct: 57  LTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEY-ANG--GELFFHLSRERVFSEDRARF 113
Query: 797 -ALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSS 855
              E    L YLH + +  +++RD+K  N++LD D    + DFGL K     GA+  M  
Sbjct: 114 YGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MKX 169
Query: 856 VAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
             G+  Y+APE           D +  GVV+ E++ G+ P
Sbjct: 170 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 209

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 101/224 (45%), Gaps = 25/224 (11%)
Query: 681 QRLDFKAEDVLESLKDENIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHG--FL 737
           Q L+    +V E  ++ + +G G  G V        G  VA+K+L  R      H     
Sbjct: 11  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKL-SRPFQSIIHAKRTY 69
Query: 738 AEIQTLGRIRHRNIVRLLGYVS-----NRDTNLLLYEYMPNGSLGEMLHGAK--GGHLKW 790
            E++ L  ++H N++ LL   +         ++ L  ++    L  ++   K    H+++
Sbjct: 70  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 129
Query: 791 ETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS 850
                +  +  +GL Y+H   S  IIHRD+K +N+ ++ D E  + DF LA+   D    
Sbjct: 130 -----LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFYLARHTDDE--- 178
Query: 851 ECMSSVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELIAGK 893
             M+    +  Y APE     +  ++  D++S G ++ EL+ G+
Sbjct: 179 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 85/206 (41%), Gaps = 16/206 (7%)
Query: 698 NIIGKGGAGIVYRGSMPDG--------IDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHR 749
            ++GKGG G V++     G        + V  K ++ R      H   AE   L  ++H 
Sbjct: 23  RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHT-KAERNILEEVKHP 81
Query: 750 NIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHH 809
            IV L+          L+ EY+  G L   +   + G    +T      E +  L +LH 
Sbjct: 82  FIVDLIYAFQTGGKLYLILEYLSGGEL--FMQLEREGIFMEDTACFYLAEISMALGHLHQ 139
Query: 810 DCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAY 869
                II+RD+K  NI+L+      + DFGL K  +         +  G+  Y+APE   
Sbjct: 140 KG---IIYRDLKPENIMLNHQGHVKLTDFGLCK--ESIHDGTVTHTFCGTIEYMAPEILM 194
Query: 870 TLKVDEKSDVYSFGVVLLELIAGKKP 895
               +   D +S G ++ +++ G  P
Sbjct: 195 RSGHNRAVDWWSLGALMYDMLTGAPP 220

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/195 (24%), Positives = 85/195 (43%), Gaps = 25/195 (12%)
Query: 719 VAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGE 778
           VA+K L    +       L+E   L ++ H ++++L G  S     LL+ EY   GSL  
Sbjct: 56  VAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRG 115
Query: 779 MLHGAKG---GHLKWETRYR-------------------IALEAAKGLCYLHHDCSPLII 816
            L  ++    G+L                           A + ++G+ YL       ++
Sbjct: 116 FLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL---AEMKLV 172
Query: 817 HRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEK 876
           HRD+ + NIL+    +  ++DFGL++ + +  +    S       ++A E  +      +
Sbjct: 173 HRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQ 232
Query: 877 SDVYSFGVVLLELIA 891
           SDV+SFGV+L E++ 
Sbjct: 233 SDVWSFGVLLWEIVT 247

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 91/205 (44%), Gaps = 31/205 (15%)
Query: 718 DVAIKRLVGRGTGGN-------DHGFLAEIQTLGRIRHR---------NIVRLLGYVSNR 761
           D ++ R++GRG  G        D G +  ++ L + R +         N   +L  VS  
Sbjct: 190 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 249
Query: 762 DTNLLL---YEYMPNGSLGEMLHGAKGGHLKWE-------TRYRIALEAAKGLCYLHHDC 811
           D   ++   Y +     L  +L    GG L +        +   +   AA+ +  L H  
Sbjct: 250 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMH 309
Query: 812 SPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYT- 870
           +  +++RD+K  NILLD      ++D GLA    D    +  +SV G++GY+APE     
Sbjct: 310 NRFVVYRDLKPANILLDEHGHVRISDLGLA---CDFSKKKPHASV-GTHGYMAPEVLQKG 365
Query: 871 LKVDEKSDVYSFGVVLLELIAGKKP 895
           +  D  +D +S G +L +L+ G  P
Sbjct: 366 VAYDSSADWFSLGCMLFKLLRGHSP 390

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 91/205 (44%), Gaps = 31/205 (15%)
Query: 718 DVAIKRLVGRGTGGN-------DHGFLAEIQTLGRIRHR---------NIVRLLGYVSNR 761
           D ++ R++GRG  G        D G +  ++ L + R +         N   +L  VS  
Sbjct: 190 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 249
Query: 762 DTNLLL---YEYMPNGSLGEMLHGAKGGHLKWE-------TRYRIALEAAKGLCYLHHDC 811
           D   ++   Y +     L  +L    GG L +        +   +   AA+ +  L H  
Sbjct: 250 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMH 309
Query: 812 SPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYT- 870
           +  +++RD+K  NILLD      ++D GLA    D    +  +SV G++GY+APE     
Sbjct: 310 NRFVVYRDLKPANILLDEHGHVRISDLGLA---CDFSKKKPHASV-GTHGYMAPEVLQKG 365
Query: 871 LKVDEKSDVYSFGVVLLELIAGKKP 895
           +  D  +D +S G +L +L+ G  P
Sbjct: 366 VAYDSSADWFSLGCMLFKLLRGHSP 390

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 41/157 (26%), Positives = 74/157 (47%), Gaps = 10/157 (6%)
Query: 739 EIQTLGRIRHRNIVRLLGYVSNRDTNLLLYE-YMPNGSLGEMLHGAKGGHLKWETRYRIA 797
           E+  L  ++H N++ LL   +   +    Y+ Y+    +   L    G     E    + 
Sbjct: 91  ELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGMEFSEEKIQYLV 150
Query: 798 LEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVA 857
            +  KGL Y+H   S  ++HRD+K  N+ ++ D E  + DFGLA+      A   M+   
Sbjct: 151 YQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLAR-----HADAEMTGYV 202
Query: 858 GSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELIAGK 893
            +  Y APE   + +  ++  D++S G ++ E++ GK
Sbjct: 203 VTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 239

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 103/223 (46%), Gaps = 29/223 (13%)
Query: 699 IIGKGGAGIVYRG-SMPDGIDVAIK-----RLVGRGTGGNDHGFLAEIQTLGRIR--HRN 750
           ++G GG G VY G  + D + VAIK     R+   G   N      E+  L ++      
Sbjct: 58  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 117
Query: 751 IVRLLGYVSNRDTNLLLYEY-MPNGSLGEMLHGAKGGHLKWE---TRYRIALEAAKGLCY 806
           ++RLL +    D+ +L+ E   P   L + +   + G L+ E   + +   LEA +    
Sbjct: 118 VIRLLDWFERPDSFVLILERPEPVQDLFDFI--TERGALQEELARSFFWQVLEAVRHC-- 173
Query: 807 LHHDCSPLIIHRDVKSNNILLDSDF-EAHVADFGLAKFLQDAGASECMSSVAGSYGYIAP 865
             H+C   ++HRD+K  NIL+D +  E  + DFG    L+D       +   G+  Y  P
Sbjct: 174 --HNCG--VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPP 225
Query: 866 EYAYTLKVDEKS-DVYSFGVVLLELIAGKKPVGEFGDGVDIVR 907
           E+    +   +S  V+S G++L +++ G  P   F    +I+R
Sbjct: 226 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIP---FEHDEEIIR 265

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 91/205 (44%), Gaps = 31/205 (15%)
Query: 718 DVAIKRLVGRGTGGN-------DHGFLAEIQTLGRIRHR---------NIVRLLGYVSNR 761
           D ++ R++GRG  G        D G +  ++ L + R +         N   +L  VS  
Sbjct: 190 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 249
Query: 762 DTNLLL---YEYMPNGSLGEMLHGAKGGHLKWE-------TRYRIALEAAKGLCYLHHDC 811
           D   ++   Y +     L  +L    GG L +        +   +   AA+ +  L H  
Sbjct: 250 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMH 309
Query: 812 SPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYT- 870
           +  +++RD+K  NILLD      ++D GLA    D    +  +SV G++GY+APE     
Sbjct: 310 NRFVVYRDLKPANILLDEHGHVRISDLGLA---CDFSKKKPHASV-GTHGYMAPEVLQKG 365
Query: 871 LKVDEKSDVYSFGVVLLELIAGKKP 895
           +  D  +D +S G +L +L+ G  P
Sbjct: 366 VAYDSSADWFSLGCMLFKLLRGHSP 390

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 103/223 (46%), Gaps = 29/223 (13%)
Query: 699 IIGKGGAGIVYRG-SMPDGIDVAIK-----RLVGRGTGGNDHGFLAEIQTLGRIR--HRN 750
           ++G GG G VY G  + D + VAIK     R+   G   N      E+  L ++      
Sbjct: 58  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 117
Query: 751 IVRLLGYVSNRDTNLLLYEY-MPNGSLGEMLHGAKGGHLKWE---TRYRIALEAAKGLCY 806
           ++RLL +    D+ +L+ E   P   L + +   + G L+ E   + +   LEA +    
Sbjct: 118 VIRLLDWFERPDSFVLILERPEPVQDLFDFI--TERGALQEELARSFFWQVLEAVRHC-- 173
Query: 807 LHHDCSPLIIHRDVKSNNILLDSDF-EAHVADFGLAKFLQDAGASECMSSVAGSYGYIAP 865
             H+C   ++HRD+K  NIL+D +  E  + DFG    L+D       +   G+  Y  P
Sbjct: 174 --HNCG--VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPP 225
Query: 866 EYAYTLKVDEKS-DVYSFGVVLLELIAGKKPVGEFGDGVDIVR 907
           E+    +   +S  V+S G++L +++ G  P   F    +I+R
Sbjct: 226 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIP---FEHDEEIIR 265

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 91/205 (44%), Gaps = 31/205 (15%)
Query: 718 DVAIKRLVGRGTGGN-------DHGFLAEIQTLGRIRHR---------NIVRLLGYVSNR 761
           D ++ R++GRG  G        D G +  ++ L + R +         N   +L  VS  
Sbjct: 189 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 248
Query: 762 DTNLLL---YEYMPNGSLGEMLHGAKGGHLKWE-------TRYRIALEAAKGLCYLHHDC 811
           D   ++   Y +     L  +L    GG L +        +   +   AA+ +  L H  
Sbjct: 249 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMH 308
Query: 812 SPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYT- 870
           +  +++RD+K  NILLD      ++D GLA    D    +  +SV G++GY+APE     
Sbjct: 309 NRFVVYRDLKPANILLDEHGHVRISDLGLA---CDFSKKKPHASV-GTHGYMAPEVLQKG 364
Query: 871 LKVDEKSDVYSFGVVLLELIAGKKP 895
           +  D  +D +S G +L +L+ G  P
Sbjct: 365 VAYDSSADWFSLGCMLFKLLRGHSP 389

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 92/206 (44%), Gaps = 18/206 (8%)
Query: 700 IGKGGAGIVYR-GSMPDGIDVAIKRLVGRGTGGNDHG-----FLAEIQTLGRIRHRNIVR 753
           +G G   IV +      G++ A K +  R +  +  G        E+  L ++ H N++ 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 754 LLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSP 813
           L     NR   +L+ E +  G L + L  A+   L  E       +   G+ YLH   + 
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFL--AQKESLSEEEATSFIKQILDGVNYLH---TK 134
Query: 814 LIIHRDVKSNNI-LLDSDF---EAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAY 869
            I H D+K  NI LLD +       + DFGLA  ++D        ++ G+  ++APE   
Sbjct: 135 KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNIFGTPEFVAPEIVN 191
Query: 870 TLKVDEKSDVYSFGVVLLELIAGKKP 895
              +  ++D++S GV+   L++G  P
Sbjct: 192 YEPLGLEADMWSIGVITYILLSGASP 217

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 103/223 (46%), Gaps = 29/223 (13%)
Query: 699 IIGKGGAGIVYRG-SMPDGIDVAIK-----RLVGRGTGGNDHGFLAEIQTLGRIR--HRN 750
           ++G GG G VY G  + D + VAIK     R+   G   N      E+  L ++      
Sbjct: 43  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 102
Query: 751 IVRLLGYVSNRDTNLLLYEY-MPNGSLGEMLHGAKGGHLKWE---TRYRIALEAAKGLCY 806
           ++RLL +    D+ +L+ E   P   L + +   + G L+ E   + +   LEA +    
Sbjct: 103 VIRLLDWFERPDSFVLILERPEPVQDLFDFI--TERGALQEELARSFFWQVLEAVRHC-- 158
Query: 807 LHHDCSPLIIHRDVKSNNILLDSDF-EAHVADFGLAKFLQDAGASECMSSVAGSYGYIAP 865
             H+C   ++HRD+K  NIL+D +  E  + DFG    L+D       +   G+  Y  P
Sbjct: 159 --HNCG--VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPP 210
Query: 866 EYAYTLKVDEKS-DVYSFGVVLLELIAGKKPVGEFGDGVDIVR 907
           E+    +   +S  V+S G++L +++ G  P   F    +I+R
Sbjct: 211 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIP---FEHDEEIIR 250

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 92/206 (44%), Gaps = 18/206 (8%)
Query: 700 IGKGGAGIVYR-GSMPDGIDVAIKRLVGRGTGGNDHG-----FLAEIQTLGRIRHRNIVR 753
           +G G   IV +      G++ A K +  R +  +  G        E+  L ++ H N++ 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 754 LLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSP 813
           L     NR   +L+ E +  G L + L  A+   L  E       +   G+ YLH   + 
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFL--AQKESLSEEEATSFIKQILDGVNYLH---TK 134
Query: 814 LIIHRDVKSNNI-LLDSDF---EAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAY 869
            I H D+K  NI LLD +       + DFGLA  ++D        ++ G+  ++APE   
Sbjct: 135 KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNIFGTPEFVAPEIVN 191
Query: 870 TLKVDEKSDVYSFGVVLLELIAGKKP 895
              +  ++D++S GV+   L++G  P
Sbjct: 192 YEPLGLEADMWSIGVITYILLSGASP 217

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 92/206 (44%), Gaps = 18/206 (8%)
Query: 700 IGKGGAGIVYR-GSMPDGIDVAIKRLVGRGTGGNDHGFLAE-----IQTLGRIRHRNIVR 753
           +G G   IV +      G++ A K +  R +  +  G   E     +  L ++ H NI+ 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 754 LLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSP 813
           L     NR   +L+ E +  G L + L  A+   L  E       +   G+ YLH   + 
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFL--AQKESLSEEEATSFIKQILDGVNYLH---TK 134
Query: 814 LIIHRDVKSNNI-LLDSDF---EAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAY 869
            I H D+K  NI LLD +       + DFGLA  ++D        ++ G+  ++APE   
Sbjct: 135 KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNIFGTPEFVAPEIVN 191
Query: 870 TLKVDEKSDVYSFGVVLLELIAGKKP 895
              +  ++D++S GV+   L++G  P
Sbjct: 192 YEPLGLEADMWSIGVITYILLSGASP 217

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 92/206 (44%), Gaps = 18/206 (8%)
Query: 700 IGKGGAGIVYR-GSMPDGIDVAIKRLVGRGTGGNDHG-----FLAEIQTLGRIRHRNIVR 753
           +G G   IV +      G++ A K +  R +  +  G        E+  L ++ H N++ 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 754 LLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSP 813
           L     NR   +L+ E +  G L + L  A+   L  E       +   G+ YLH   + 
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFL--AQKESLSEEEATSFIKQILDGVNYLH---TK 134
Query: 814 LIIHRDVKSNNI-LLDSDF---EAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAY 869
            I H D+K  NI LLD +       + DFGLA  ++D        ++ G+  ++APE   
Sbjct: 135 KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNIFGTPEFVAPEIVN 191
Query: 870 TLKVDEKSDVYSFGVVLLELIAGKKP 895
              +  ++D++S GV+   L++G  P
Sbjct: 192 YEPLGLEADMWSIGVITYILLSGASP 217

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 97/221 (43%), Gaps = 18/221 (8%)
Query: 685 FKAEDVLESLKDENIIGKGGAGIVYR-GSMPDGIDVAIKRLVGRGTGGNDHG-----FLA 738
           F+ E+V +       +G G   +V +      G+  A K +  R T  +  G        
Sbjct: 4   FRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIER 63
Query: 739 EIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIAL 798
           E+  L  I+H N++ L     N+   +L+ E +  G L + L  A+   L  E       
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL--AEKESLTEEEATEFLK 121
Query: 799 EAAKGLCYLHHDCSPLIIHRDVKSNNI-LLDSDF---EAHVADFGLAKFLQDAGASECMS 854
           +   G+ YLH   S  I H D+K  NI LLD +       + DFGLA  + D G      
Sbjct: 122 QILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI-DFGNE--FK 175
Query: 855 SVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
           ++ G+  ++APE      +  ++D++S GV+   L++G  P
Sbjct: 176 NIFGTPAFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 92/206 (44%), Gaps = 18/206 (8%)
Query: 700 IGKGGAGIVYR-GSMPDGIDVAIKRLVGRGTGGNDHG-----FLAEIQTLGRIRHRNIVR 753
           +G G   IV +      G++ A K +  R +  +  G        E+  L ++ H N++ 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 754 LLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSP 813
           L     NR   +L+ E +  G L + L  A+   L  E       +   G+ YLH   + 
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFL--AQKESLSEEEATSFIKQILDGVNYLH---TK 134
Query: 814 LIIHRDVKSNNI-LLDSDF---EAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAY 869
            I H D+K  NI LLD +       + DFGLA  ++D        ++ G+  ++APE   
Sbjct: 135 KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNIFGTPEFVAPEIVN 191
Query: 870 TLKVDEKSDVYSFGVVLLELIAGKKP 895
              +  ++D++S GV+   L++G  P
Sbjct: 192 YEPLGLEADMWSIGVITYILLSGASP 217

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 84/206 (40%), Gaps = 16/206 (7%)
Query: 698 NIIGKGGAGIVYRGSMPDG--------IDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHR 749
            ++GKGG G V++     G        + V  K ++ R      H   AE   L  ++H 
Sbjct: 23  RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHT-KAERNILEEVKHP 81
Query: 750 NIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHH 809
            IV L+          L+ EY+  G L   +   + G    +T      E +  L +LH 
Sbjct: 82  FIVDLIYAFQTGGKLYLILEYLSGGEL--FMQLEREGIFMEDTACFYLAEISMALGHLHQ 139
Query: 810 DCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAY 869
                II+RD+K  NI+L+      + DFGL K  +            G+  Y+APE   
Sbjct: 140 KG---IIYRDLKPENIMLNHQGHVKLTDFGLCK--ESIHDGTVTHXFCGTIEYMAPEILM 194
Query: 870 TLKVDEKSDVYSFGVVLLELIAGKKP 895
               +   D +S G ++ +++ G  P
Sbjct: 195 RSGHNRAVDWWSLGALMYDMLTGAPP 220

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 72/245 (29%), Positives = 118/245 (48%), Gaps = 46/245 (18%)
Query: 697 ENIIGKGGAG-IVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIR-HRNIVRL 754
           E I+G G +G +V++GS   G  VA+KR++           L EI+ L     H N++R 
Sbjct: 20  EKILGYGSSGTVVFQGSF-QGRPVAVKRMLIDFCDIA----LMEIKLLTESDDHPNVIR- 73
Query: 755 LGYVSNRDTNLLLYEYMP--NGSLGEMLHG--AKGGHLKWETRYR-IAL--EAAKGLCYL 807
             Y  +  T+  LY  +   N +L +++        +LK +  Y  I+L  + A G+ +L
Sbjct: 74  --YYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHL 131
Query: 808 HHDCSPLIIHRDVKSNNILL--DSDFEAH-----------VADFGLAKFLQDAGASECMS 854
           H   S  IIHRD+K  NIL+   S F A            ++DFGL K L D+G S   +
Sbjct: 132 H---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKL-DSGQSSFRT 187
Query: 855 SV---AGSYGYIAPE-------YAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGE-FGDG 902
           ++   +G+ G+ APE            ++    D++S G V   +++ GK P G+ +   
Sbjct: 188 NLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE 247
Query: 903 VDIVR 907
            +I+R
Sbjct: 248 SNIIR 252

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 103/223 (46%), Gaps = 29/223 (13%)
Query: 699 IIGKGGAGIVYRG-SMPDGIDVAIK-----RLVGRGTGGNDHGFLAEIQTLGRIR--HRN 750
           ++G GG G VY G  + D + VAIK     R+   G   N      E+  L ++      
Sbjct: 63  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 122
Query: 751 IVRLLGYVSNRDTNLLLYEY-MPNGSLGEMLHGAKGGHLKWE---TRYRIALEAAKGLCY 806
           ++RLL +    D+ +L+ E   P   L + +   + G L+ E   + +   LEA +    
Sbjct: 123 VIRLLDWFERPDSFVLILERPEPVQDLFDFI--TERGALQEELARSFFWQVLEAVRHC-- 178
Query: 807 LHHDCSPLIIHRDVKSNNILLDSDF-EAHVADFGLAKFLQDAGASECMSSVAGSYGYIAP 865
             H+C   ++HRD+K  NIL+D +  E  + DFG    L+D       +   G+  Y  P
Sbjct: 179 --HNCG--VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPP 230
Query: 866 EYAYTLKVDEKS-DVYSFGVVLLELIAGKKPVGEFGDGVDIVR 907
           E+    +   +S  V+S G++L +++ G  P   F    +I+R
Sbjct: 231 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIP---FEHDEEIIR 270

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 88/199 (44%), Gaps = 14/199 (7%)
Query: 700 IGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHGFLA--EIQTLGRIRHRNIVRLLG 756
           +G G  G V        G  VAIK+L  R          A  E+  L  ++H N++ LL 
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKL-SRPFQSEIFAKRAYRELLLLKHMQHENVIGLLD 90
Query: 757 YVSNRDTNLLLYE-YMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLI 815
             +   +    Y+ Y+    +   L    G     E    +  +  KGL Y+H   S  +
Sbjct: 91  VFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLKGLKYIH---SAGV 147
Query: 816 IHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYT-LKVD 874
           +HRD+K  N+ ++ D E  + DFGLA+      A   M+    +  Y APE   + +  +
Sbjct: 148 VHRDLKPGNLAVNEDCELKILDFGLAR-----HADAEMTGYVVTRWYRAPEVILSWMHYN 202
Query: 875 EKSDVYSFGVVLLELIAGK 893
           +  D++S G ++ E++ GK
Sbjct: 203 QTVDIWSVGCIMAEMLTGK 221

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 92/206 (44%), Gaps = 18/206 (8%)
Query: 700 IGKGGAGIVYR-GSMPDGIDVAIKRLVGRGTGGNDHG-----FLAEIQTLGRIRHRNIVR 753
           +G G   IV +      G++ A K +  R +  +  G        E+  L ++ H N++ 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 754 LLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSP 813
           L     NR   +L+ E +  G L + L  A+   L  E       +   G+ YLH   + 
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFL--AQKESLSEEEATSFIKQILDGVNYLH---TK 134
Query: 814 LIIHRDVKSNNI-LLDSDF---EAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAY 869
            I H D+K  NI LLD +       + DFGLA  ++D        ++ G+  ++APE   
Sbjct: 135 KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNIFGTPEFVAPEIVN 191
Query: 870 TLKVDEKSDVYSFGVVLLELIAGKKP 895
              +  ++D++S GV+   L++G  P
Sbjct: 192 YEPLGLEADMWSIGVITYILLSGASP 217

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 103/223 (46%), Gaps = 29/223 (13%)
Query: 699 IIGKGGAGIVYRG-SMPDGIDVAIK-----RLVGRGTGGNDHGFLAEIQTLGRIR--HRN 750
           ++G GG G VY G  + D + VAIK     R+   G   N      E+  L ++      
Sbjct: 50  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109
Query: 751 IVRLLGYVSNRDTNLLLYEY-MPNGSLGEMLHGAKGGHLKWE---TRYRIALEAAKGLCY 806
           ++RLL +    D+ +L+ E   P   L + +   + G L+ E   + +   LEA +    
Sbjct: 110 VIRLLDWFERPDSFVLILERPEPVQDLFDFI--TERGALQEELARSFFWQVLEAVRHC-- 165
Query: 807 LHHDCSPLIIHRDVKSNNILLDSDF-EAHVADFGLAKFLQDAGASECMSSVAGSYGYIAP 865
             H+C   ++HRD+K  NIL+D +  E  + DFG    L+D       +   G+  Y  P
Sbjct: 166 --HNCG--VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPP 217
Query: 866 EYAYTLKVDEKS-DVYSFGVVLLELIAGKKPVGEFGDGVDIVR 907
           E+    +   +S  V+S G++L +++ G  P   F    +I+R
Sbjct: 218 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIP---FEHDEEIIR 257

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 61/231 (26%), Positives = 106/231 (45%), Gaps = 24/231 (10%)
Query: 686 KAEDVLESLKDENIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLG 744
           + EDV +    E+++G+G    V    ++    + A+K ++ +  G        E++ L 
Sbjct: 9   RFEDVYQ--LQEDVLGEGAHARVQTCINLITSQEYAVK-IIEKQPGHIRSRVFREVEMLY 65
Query: 745 RIR-HRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKG 803
           + + HRN++ L+ +    D   L++E M  GS+   +H  K  H        +  + A  
Sbjct: 66  QCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIH--KRRHFNELEASVVVQDVASA 123
Query: 804 LCYLHHDCSPLIIHRDVKSNNILLDSDFE---AHVADFGLAKFLQDAGASECMS-----S 855
           L +LH   +  I HRD+K  NIL +   +     + DFGL   ++  G    +S     +
Sbjct: 124 LDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLT 180
Query: 856 VAGSYGYIAPEYAYTLK-----VDEKSDVYSFGVVLLELIAGKKP-VGEFG 900
             GS  Y+APE            D++ D++S GV+L  L++G  P VG  G
Sbjct: 181 PCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCG 231

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Composition-based stats.
 Identities = 64/230 (27%), Positives = 106/230 (46%), Gaps = 25/230 (10%)
Query: 680 FQRLDFKAEDVLES-LKDENIIGKGGAGIVYRG-SMPDGIDVAIK-----RLVGRGTGGN 732
           FQ    K ++ LES  +   ++G GG G VY G  + D + VAIK     R+   G   N
Sbjct: 18  FQGPHMKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPN 77
Query: 733 DHGFLAEIQTLGRIRH--RNIVRLLGYVSNRDTNLLLYEY-MPNGSLGEML--HGAKGGH 787
                 E+  L ++      ++RLL +    D+ +L+ E   P   L + +   GA    
Sbjct: 78  GTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEE 137
Query: 788 LKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDF-EAHVADFGLAKFLQD 846
           L     +++ LEA +      H+C   ++HRD+K  NIL+D +  E  + DFG    L+D
Sbjct: 138 LARSFFWQV-LEAVRHC----HNCG--VLHRDIKDENILIDLNRGELKLIDFGSGALLKD 190
Query: 847 AGASECMSSVAGSYGYIAPEYAYTLKVDEKS-DVYSFGVVLLELIAGKKP 895
                  +   G+  Y  PE+    +   +S  V+S G++L +++ G  P
Sbjct: 191 T----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 236

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 90/213 (42%), Gaps = 21/213 (9%)
Query: 689 DVLESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRH 748
           D  E +KD   IG G  G+          ++   + + RG    D     EI     +RH
Sbjct: 19  DRYELVKD---IGAGNFGVARLMRDKQANELVAVKYIERGEKI-DENVKREIINHRSLRH 74
Query: 749 RNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLH 808
            NIVR    +       ++ EY   G L E +  A G   + E R+    +   G+ Y H
Sbjct: 75  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQ-QLISGVSYAH 132
Query: 809 HDCSPLIIHRDVKSNNILLDSDFEAH--VADFGLAKFLQDAGASECMS---SVAGSYGYI 863
              +  + HRD+K  N LLD        +ADFG +K      AS   S   S  G+  YI
Sbjct: 133 ---AMQVAHRDLKLENTLLDGSPAPRLKIADFGYSK------ASVLHSQPKSAVGTPAYI 183
Query: 864 APEYAYTLKVDEK-SDVYSFGVVLLELIAGKKP 895
           APE     + D K +DV+S GV L  ++ G  P
Sbjct: 184 APEVLLKKEYDGKVADVWSCGVTLYVMLVGAYP 216

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 98/211 (46%), Gaps = 26/211 (12%)
Query: 699 IIGKGGAGIVYRG-SMPDGIDVAIK-----RLVGRGTGGNDHGFLAEIQTLGRIRH--RN 750
           ++G GG G VY G  + D + VAIK     R+   G   N      E+  L ++      
Sbjct: 44  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 103
Query: 751 IVRLLGYVSNRDTNLLLYEY-MPNGSLGEMLHGAKGGHLKWE---TRYRIALEAAKGLCY 806
           ++RLL +    D+ +L+ E   P   L + +   + G L+ E   + +   LEA +    
Sbjct: 104 VIRLLDWFERPDSFVLILERPEPVQDLFDFI--TERGALQEELARSFFWQVLEAVRHC-- 159
Query: 807 LHHDCSPLIIHRDVKSNNILLDSDF-EAHVADFGLAKFLQDAGASECMSSVAGSYGYIAP 865
             H+C   ++HRD+K  NIL+D +  E  + DFG    L+D       +   G+  Y  P
Sbjct: 160 --HNCG--VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPP 211
Query: 866 EYAYTLKVDEKS-DVYSFGVVLLELIAGKKP 895
           E+    +   +S  V+S G++L +++ G  P
Sbjct: 212 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 242

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 53.9 bits (128), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 98/211 (46%), Gaps = 26/211 (12%)
Query: 699 IIGKGGAGIVYRG-SMPDGIDVAIK-----RLVGRGTGGNDHGFLAEIQTLGRIRH--RN 750
           ++G GG G VY G  + D + VAIK     R+   G   N      E+  L ++      
Sbjct: 43  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 102
Query: 751 IVRLLGYVSNRDTNLLLYEY-MPNGSLGEMLHGAKGGHLKWE---TRYRIALEAAKGLCY 806
           ++RLL +    D+ +L+ E   P   L + +   + G L+ E   + +   LEA +    
Sbjct: 103 VIRLLDWFERPDSFVLILERPEPVQDLFDFI--TERGALQEELARSFFWQVLEAVRHC-- 158
Query: 807 LHHDCSPLIIHRDVKSNNILLDSDF-EAHVADFGLAKFLQDAGASECMSSVAGSYGYIAP 865
             H+C   ++HRD+K  NIL+D +  E  + DFG    L+D       +   G+  Y  P
Sbjct: 159 --HNCG--VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPP 210
Query: 866 EYAYTLKVDEKS-DVYSFGVVLLELIAGKKP 895
           E+    +   +S  V+S G++L +++ G  P
Sbjct: 211 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 241

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 53.9 bits (128), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 98/211 (46%), Gaps = 26/211 (12%)
Query: 699 IIGKGGAGIVYRG-SMPDGIDVAIK-----RLVGRGTGGNDHGFLAEIQTLGRIRH--RN 750
           ++G GG G VY G  + D + VAIK     R+   G   N      E+  L ++      
Sbjct: 44  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 103
Query: 751 IVRLLGYVSNRDTNLLLYEY-MPNGSLGEMLHGAKGGHLKWE---TRYRIALEAAKGLCY 806
           ++RLL +    D+ +L+ E   P   L + +   + G L+ E   + +   LEA +    
Sbjct: 104 VIRLLDWFERPDSFVLILERPEPVQDLFDFI--TERGALQEELARSFFWQVLEAVRHC-- 159
Query: 807 LHHDCSPLIIHRDVKSNNILLDSDF-EAHVADFGLAKFLQDAGASECMSSVAGSYGYIAP 865
             H+C   ++HRD+K  NIL+D +  E  + DFG    L+D       +   G+  Y  P
Sbjct: 160 --HNCG--VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPP 211
Query: 866 EYAYTLKVDEKS-DVYSFGVVLLELIAGKKP 895
           E+    +   +S  V+S G++L +++ G  P
Sbjct: 212 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 242

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 53.9 bits (128), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 98/211 (46%), Gaps = 26/211 (12%)
Query: 699 IIGKGGAGIVYRG-SMPDGIDVAIK-----RLVGRGTGGNDHGFLAEIQTLGRIR--HRN 750
           ++G GG G VY G  + D + VAIK     R+   G   N      E+  L ++      
Sbjct: 44  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 103
Query: 751 IVRLLGYVSNRDTNLLLYEY-MPNGSLGEMLHGAKGGHLKWE---TRYRIALEAAKGLCY 806
           ++RLL +    D+ +L+ E   P   L + +   + G L+ E   + +   LEA +    
Sbjct: 104 VIRLLDWFERPDSFVLILERPEPVQDLFDFI--TERGALQEELARSFFWQVLEAVRHC-- 159
Query: 807 LHHDCSPLIIHRDVKSNNILLDSDF-EAHVADFGLAKFLQDAGASECMSSVAGSYGYIAP 865
             H+C   ++HRD+K  NIL+D +  E  + DFG    L+D       +   G+  Y  P
Sbjct: 160 --HNCG--VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPP 211
Query: 866 EYAYTLKVDEKS-DVYSFGVVLLELIAGKKP 895
           E+    +   +S  V+S G++L +++ G  P
Sbjct: 212 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 242

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 53.9 bits (128), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 98/211 (46%), Gaps = 26/211 (12%)
Query: 699 IIGKGGAGIVYRG-SMPDGIDVAIK-----RLVGRGTGGNDHGFLAEIQTLGRIR--HRN 750
           ++G GG G VY G  + D + VAIK     R+   G   N      E+  L ++      
Sbjct: 43  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 102
Query: 751 IVRLLGYVSNRDTNLLLYEY-MPNGSLGEMLHGAKGGHLKWE---TRYRIALEAAKGLCY 806
           ++RLL +    D+ +L+ E   P   L + +   + G L+ E   + +   LEA +    
Sbjct: 103 VIRLLDWFERPDSFVLILERPEPVQDLFDFI--TERGALQEELARSFFWQVLEAVRHC-- 158
Query: 807 LHHDCSPLIIHRDVKSNNILLDSDF-EAHVADFGLAKFLQDAGASECMSSVAGSYGYIAP 865
             H+C   ++HRD+K  NIL+D +  E  + DFG    L+D       +   G+  Y  P
Sbjct: 159 --HNCG--VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPP 210
Query: 866 EYAYTLKVDEKS-DVYSFGVVLLELIAGKKP 895
           E+    +   +S  V+S G++L +++ G  P
Sbjct: 211 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 241

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 53.9 bits (128), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 98/211 (46%), Gaps = 26/211 (12%)
Query: 699 IIGKGGAGIVYRG-SMPDGIDVAIK-----RLVGRGTGGNDHGFLAEIQTLGRIR--HRN 750
           ++G GG G VY G  + D + VAIK     R+   G   N      E+  L ++      
Sbjct: 44  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 103
Query: 751 IVRLLGYVSNRDTNLLLYEY-MPNGSLGEMLHGAKGGHLKWE---TRYRIALEAAKGLCY 806
           ++RLL +    D+ +L+ E   P   L + +   + G L+ E   + +   LEA +    
Sbjct: 104 VIRLLDWFERPDSFVLILERPEPVQDLFDFI--TERGALQEELARSFFWQVLEAVRHC-- 159
Query: 807 LHHDCSPLIIHRDVKSNNILLDSDF-EAHVADFGLAKFLQDAGASECMSSVAGSYGYIAP 865
             H+C   ++HRD+K  NIL+D +  E  + DFG    L+D       +   G+  Y  P
Sbjct: 160 --HNCG--VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPP 211
Query: 866 EYAYTLKVDEKS-DVYSFGVVLLELIAGKKP 895
           E+    +   +S  V+S G++L +++ G  P
Sbjct: 212 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 242

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 98/211 (46%), Gaps = 26/211 (12%)
Query: 699 IIGKGGAGIVYRG-SMPDGIDVAIK-----RLVGRGTGGNDHGFLAEIQTLGRIR--HRN 750
           ++G GG G VY G  + D + VAIK     R+   G   N      E+  L ++      
Sbjct: 43  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 102
Query: 751 IVRLLGYVSNRDTNLLLYEY-MPNGSLGEMLHGAKGGHLKWE---TRYRIALEAAKGLCY 806
           ++RLL +    D+ +L+ E   P   L + +   + G L+ E   + +   LEA +    
Sbjct: 103 VIRLLDWFERPDSFVLILERPEPVQDLFDFI--TERGALQEELARSFFWQVLEAVRHC-- 158
Query: 807 LHHDCSPLIIHRDVKSNNILLDSDF-EAHVADFGLAKFLQDAGASECMSSVAGSYGYIAP 865
             H+C   ++HRD+K  NIL+D +  E  + DFG    L+D       +   G+  Y  P
Sbjct: 159 --HNCG--VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPP 210
Query: 866 EYAYTLKVDEKS-DVYSFGVVLLELIAGKKP 895
           E+    +   +S  V+S G++L +++ G  P
Sbjct: 211 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 241

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 97/221 (43%), Gaps = 18/221 (8%)
Query: 685 FKAEDVLESLKDENIIGKGGAGIVYR-GSMPDGIDVAIKRLVGRGTGGNDHG-----FLA 738
           F+ E+V +       +G G   +V +      G+  A K +  R T  +  G        
Sbjct: 4   FRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIER 63
Query: 739 EIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIAL 798
           E+  L  I+H N++ L     N+   +L+ E +  G L + L  A+   L  E       
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL--AEKESLTEEEATEFLK 121
Query: 799 EAAKGLCYLHHDCSPLIIHRDVKSNNI-LLDSDF---EAHVADFGLAKFLQDAGASECMS 854
           +   G+ YLH   S  I H D+K  NI LLD +       + DFGLA  + D G      
Sbjct: 122 QILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI-DFGNE--FK 175
Query: 855 SVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
           ++ G+  ++APE      +  ++D++S GV+   L++G  P
Sbjct: 176 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 97/221 (43%), Gaps = 18/221 (8%)
Query: 685 FKAEDVLESLKDENIIGKGGAGIVYR-GSMPDGIDVAIKRLVGRGTGGNDHG-----FLA 738
           F+ E+V +       +G G   +V +      G+  A K +  R T  +  G        
Sbjct: 4   FRQENVDDYYDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIER 63
Query: 739 EIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIAL 798
           E+  L  I+H N++ L     N+   +L+ E +  G L + L  A+   L  E       
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL--AEKESLTEEEATEFLK 121
Query: 799 EAAKGLCYLHHDCSPLIIHRDVKSNNI-LLDSDF---EAHVADFGLAKFLQDAGASECMS 854
           +   G+ YLH   S  I H D+K  NI LLD +       + DFGLA  + D G      
Sbjct: 122 QILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI-DFGNE--FK 175
Query: 855 SVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
           ++ G+  ++APE      +  ++D++S GV+   L++G  P
Sbjct: 176 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 97/221 (43%), Gaps = 18/221 (8%)
Query: 685 FKAEDVLESLKDENIIGKGGAGIVYR-GSMPDGIDVAIKRLVGRGTGGNDHG-----FLA 738
           F+ E+V +       +G G   +V +      G+  A K +  R T  +  G        
Sbjct: 3   FRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIER 62
Query: 739 EIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIAL 798
           E+  L  I+H N++ L     N+   +L+ E +  G L + L  A+   L  E       
Sbjct: 63  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL--AEKESLTEEEATEFLK 120
Query: 799 EAAKGLCYLHHDCSPLIIHRDVKSNNI-LLDSDF---EAHVADFGLAKFLQDAGASECMS 854
           +   G+ YLH   S  I H D+K  NI LLD +       + DFGLA  + D G      
Sbjct: 121 QILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI-DFGNE--FK 174
Query: 855 SVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
           ++ G+  ++APE      +  ++D++S GV+   L++G  P
Sbjct: 175 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 215

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 97/221 (43%), Gaps = 18/221 (8%)
Query: 685 FKAEDVLESLKDENIIGKGGAGIVYR-GSMPDGIDVAIKRLVGRGTGGNDHG-----FLA 738
           F+ E+V +       +G G   +V +      G+  A K +  R T  +  G        
Sbjct: 4   FRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIER 63
Query: 739 EIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIAL 798
           E+  L  I+H N++ L     N+   +L+ E +  G L + L  A+   L  E       
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL--AEKESLTEEEATEFLK 121
Query: 799 EAAKGLCYLHHDCSPLIIHRDVKSNNI-LLDSDF---EAHVADFGLAKFLQDAGASECMS 854
           +   G+ YLH   S  I H D+K  NI LLD +       + DFGLA  + D G      
Sbjct: 122 QILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI-DFGNE--FK 175
Query: 855 SVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
           ++ G+  ++APE      +  ++D++S GV+   L++G  P
Sbjct: 176 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 49/181 (27%), Positives = 83/181 (45%), Gaps = 12/181 (6%)
Query: 719 VAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGE 778
           +  +RL     G +      E+  L  IRH NI+ L     N+   +L+ E +  G L +
Sbjct: 59  IKKRRLXSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFD 118
Query: 779 MLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNI-LLDSDF---EAH 834
            L  A+   L  +   +   +   G+ YLH   S  I H D+K  NI LLD +       
Sbjct: 119 FL--AEKESLTEDEATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIK 173
Query: 835 VADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKK 894
           + DFG+A  ++   A     ++ G+  ++APE      +  ++D++S GV+   L++G  
Sbjct: 174 LIDFGIAHKIE---AGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGAS 230
Query: 895 P 895
           P
Sbjct: 231 P 231

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 97/221 (43%), Gaps = 18/221 (8%)
Query: 685 FKAEDVLESLKDENIIGKGGAGIVYR-GSMPDGIDVAIKRLVGRGTGGNDHG-----FLA 738
           F+ E+V +       +G G   +V +      G+  A K +  R T  +  G        
Sbjct: 4   FRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIER 63
Query: 739 EIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIAL 798
           E+  L  I+H N++ L     N+   +L+ E +  G L + L  A+   L  E       
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL--AEKESLTEEEATEFLK 121
Query: 799 EAAKGLCYLHHDCSPLIIHRDVKSNNI-LLDSDF---EAHVADFGLAKFLQDAGASECMS 854
           +   G+ YLH   S  I H D+K  NI LLD +       + DFGLA  + D G      
Sbjct: 122 QILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI-DFGNE--FK 175
Query: 855 SVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
           ++ G+  ++APE      +  ++D++S GV+   L++G  P
Sbjct: 176 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 77/300 (25%), Positives = 120/300 (40%), Gaps = 50/300 (16%)
Query: 694 LKDENIIGKGGAGIVYRGS-MPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIR-HRNI 751
           L+   ++ +GG   VY    +  G + A+KRL+      N    + E+  + ++  H NI
Sbjct: 30  LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKN-RAIIQEVCFMKKLSGHPNI 88
Query: 752 VRLLGYVS----NRDT---NLLLYEYMPNGSLGEMLHGAKG-GHLKWETRYRIALEAAKG 803
           V+     S      DT     LL   +  G L E L   +  G L  +T  +I  +  + 
Sbjct: 89  VQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRA 148
Query: 804 LCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFL----------QDAGASECM 853
           + ++H    P IIHRD+K  N+LL +     + DFG A  +          Q     E  
Sbjct: 149 VQHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEE 207
Query: 854 SSVAGSYGYIAPE----YAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWV 909
            +   +  Y  PE    Y+    + EK D+++ G +L  L   + P   F DG  +    
Sbjct: 208 ITRNTTPMYRTPEIIDLYS-NFPIGEKQDIWALGCILYLLCFRQHP---FEDGAKL---- 259
Query: 910 RKTTSEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHML 969
           R    + S P           P  + Y    V H    AM+ V  E   R ++ EVVH L
Sbjct: 260 RIVNGKYSIP-----------PHDTQYT---VFHSLIRAMLQVNPEE--RLSIAEVVHQL 303

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 97/221 (43%), Gaps = 18/221 (8%)
Query: 685 FKAEDVLESLKDENIIGKGGAGIVYR-GSMPDGIDVAIKRLVGRGTGGNDHG-----FLA 738
           F+ E+V +       +G G   +V +      G+  A K +  R T  +  G        
Sbjct: 3   FRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIER 62
Query: 739 EIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIAL 798
           E+  L  I+H N++ L     N+   +L+ E +  G L + L  A+   L  E       
Sbjct: 63  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL--AEKESLTEEEATEFLK 120
Query: 799 EAAKGLCYLHHDCSPLIIHRDVKSNNI-LLDSDF---EAHVADFGLAKFLQDAGASECMS 854
           +   G+ YLH   S  I H D+K  NI LLD +       + DFGLA  + D G      
Sbjct: 121 QILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI-DFGNE--FK 174
Query: 855 SVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
           ++ G+  ++APE      +  ++D++S GV+   L++G  P
Sbjct: 175 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 215

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 97/221 (43%), Gaps = 18/221 (8%)
Query: 685 FKAEDVLESLKDENIIGKGGAGIVYR-GSMPDGIDVAIKRLVGRGTGGNDHG-----FLA 738
           F+ E+V +       +G G   +V +      G+  A K +  R T  +  G        
Sbjct: 4   FRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIER 63
Query: 739 EIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIAL 798
           E+  L  I+H N++ L     N+   +L+ E +  G L + L  A+   L  E       
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL--AEKESLTEEEATEFLK 121
Query: 799 EAAKGLCYLHHDCSPLIIHRDVKSNNI-LLDSDF---EAHVADFGLAKFLQDAGASECMS 854
           +   G+ YLH   S  I H D+K  NI LLD +       + DFGLA  + D G      
Sbjct: 122 QILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI-DFGNE--FK 175
Query: 855 SVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
           ++ G+  ++APE      +  ++D++S GV+   L++G  P
Sbjct: 176 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 97/221 (43%), Gaps = 18/221 (8%)
Query: 685 FKAEDVLESLKDENIIGKGGAGIVYR-GSMPDGIDVAIKRLVGRGTGGNDHG-----FLA 738
           F+ E+V +       +G G   +V +      G+  A K +  R T  +  G        
Sbjct: 4   FRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIER 63
Query: 739 EIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIAL 798
           E+  L  I+H N++ L     N+   +L+ E +  G L + L  A+   L  E       
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL--AEKESLTEEEATEFLK 121
Query: 799 EAAKGLCYLHHDCSPLIIHRDVKSNNI-LLDSDF---EAHVADFGLAKFLQDAGASECMS 854
           +   G+ YLH   S  I H D+K  NI LLD +       + DFGLA  + D G      
Sbjct: 122 QILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI-DFGNE--FK 175
Query: 855 SVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
           ++ G+  ++APE      +  ++D++S GV+   L++G  P
Sbjct: 176 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 90/210 (42%), Gaps = 15/210 (7%)
Query: 689 DVLESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRH 748
           D  E +KD   IG G  G+          ++   + + RG    D     EI     +RH
Sbjct: 18  DRYELVKD---IGSGNFGVARLMRDKQSNELVAVKYIERGEKI-DENVKREIINHRSLRH 73
Query: 749 RNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLH 808
            NIVR    +       ++ EY   G L E +  A G   + E R+    +   G+ Y H
Sbjct: 74  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQ-QLISGVSYCH 131
Query: 809 HDCSPLIIHRDVKSNNILLDSDFEAH--VADFGLAKFLQDAGASECMSSVAGSYGYIAPE 866
              +  + HRD+K  N LLD        + DFG +K       S+  S+V G+  YIAPE
Sbjct: 132 ---AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTV-GTPAYIAPE 185
Query: 867 YAYTLKVDEK-SDVYSFGVVLLELIAGKKP 895
                + D K +DV+S GV L  ++ G  P
Sbjct: 186 VLLKKEYDGKVADVWSCGVTLYVMLVGAYP 215

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Composition-based stats.
 Identities = 63/293 (21%), Positives = 115/293 (39%), Gaps = 40/293 (13%)
Query: 683 LDFKAEDVLESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRG-TGGNDHGFLAEIQ 741
           +DFK  + L  L + +      +G +++G    G D+ +K L  R  +      F  E  
Sbjct: 7   IDFKQLNFLTKLNENH------SGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECP 59
Query: 742 TLGRIRHRNIVRLLGYVSNRDTN--LLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALE 799
            L    H N++ +LG   +       L+  + P GSL  +LH      +      + AL+
Sbjct: 60  RLRIFSHPNVLPVLGACQSPPAPHPTLITHWXPYGSLYNVLHEGTNFVVDQSQAVKFALD 119
Query: 800 AAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGS 859
            A+G  +L H   PLI    + S ++ +D D  A ++   +    Q  G          +
Sbjct: 120 XARGXAFL-HTLEPLIPRHALNSRSVXIDEDXTARISXADVKFSFQSPGRXY-------A 171
Query: 860 YGYIAPEYAYTLKVD---EKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEV 916
             ++APE       D     +D +SF V+L EL+  + P  +             +  E+
Sbjct: 172 PAWVAPEALQKKPEDTNRRSADXWSFAVLLWELVTREVPFADL------------SNXEI 219
Query: 917 SQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHML 969
                   +   + P +S        H+ K+  +C  ++ + RP    +V +L
Sbjct: 220 GXKVALEGLRPTIPPGISP-------HVSKLXKICXNEDPAKRPKFDXIVPIL 265

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 97/221 (43%), Gaps = 18/221 (8%)
Query: 685 FKAEDVLESLKDENIIGKGGAGIVYR-GSMPDGIDVAIKRLVGRGTGGNDHG-----FLA 738
           F+ E+V +       +G G   +V +      G+  A K +  R T  +  G        
Sbjct: 4   FRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIER 63
Query: 739 EIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIAL 798
           E+  L  I+H N++ L     N+   +L+ E +  G L + L  A+   L  E       
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL--AEKESLTEEEATEFLK 121
Query: 799 EAAKGLCYLHHDCSPLIIHRDVKSNNI-LLDSDF---EAHVADFGLAKFLQDAGASECMS 854
           +   G+ YLH   S  I H D+K  NI LLD +       + DFGLA  + D G      
Sbjct: 122 QILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI-DFGNE--FK 175
Query: 855 SVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
           ++ G+  ++APE      +  ++D++S GV+   L++G  P
Sbjct: 176 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 49/181 (27%), Positives = 83/181 (45%), Gaps = 12/181 (6%)
Query: 719 VAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGE 778
           +  +RL     G +      E+  L  IRH NI+ L     N+   +L+ E +  G L +
Sbjct: 38  IKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFD 97
Query: 779 MLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNI-LLDSDF---EAH 834
            L  A+   L  +   +   +   G+ YLH   S  I H D+K  NI LLD +       
Sbjct: 98  FL--AEKESLTEDEATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIK 152
Query: 835 VADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKK 894
           + DFG+A  ++   A     ++ G+  ++APE      +  ++D++S GV+   L++G  
Sbjct: 153 LIDFGIAHKIE---AGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGAS 209
Query: 895 P 895
           P
Sbjct: 210 P 210

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 53.1 bits (126), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 97/221 (43%), Gaps = 18/221 (8%)
Query: 685 FKAEDVLESLKDENIIGKGGAGIVYR-GSMPDGIDVAIKRLVGRGTGGNDHG-----FLA 738
           F+ E+V +       +G G   +V +      G+  A K +  R T  +  G        
Sbjct: 4   FRQENVDDYYDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIER 63
Query: 739 EIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIAL 798
           E+  L  I+H N++ L     N+   +L+ E +  G L + L  A+   L  E       
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL--AEKESLTEEEATEFLK 121
Query: 799 EAAKGLCYLHHDCSPLIIHRDVKSNNI-LLDSDF---EAHVADFGLAKFLQDAGASECMS 854
           +   G+ YLH   S  I H D+K  NI LLD +       + DFGLA  + D G      
Sbjct: 122 QILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI-DFGNE--FK 175
Query: 855 SVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
           ++ G+  ++APE      +  ++D++S GV+   L++G  P
Sbjct: 176 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 53.1 bits (126), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 97/221 (43%), Gaps = 18/221 (8%)
Query: 685 FKAEDVLESLKDENIIGKGGAGIVYR-GSMPDGIDVAIKRLVGRGTGGNDHG-----FLA 738
           F+ E+V +       +G G   +V +      G+  A K +  R T  +  G        
Sbjct: 4   FRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIER 63
Query: 739 EIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIAL 798
           E+  L  I+H N++ L     N+   +L+ E +  G L + L  A+   L  E       
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL--AEKESLTEEEATEFLK 121
Query: 799 EAAKGLCYLHHDCSPLIIHRDVKSNNI-LLDSDF---EAHVADFGLAKFLQDAGASECMS 854
           +   G+ YLH   S  I H D+K  NI LLD +       + DFGLA  + D G      
Sbjct: 122 QILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI-DFGNE--FK 175
Query: 855 SVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
           ++ G+  ++APE      +  ++D++S GV+   L++G  P
Sbjct: 176 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 97/221 (43%), Gaps = 18/221 (8%)
Query: 685 FKAEDVLESLKDENIIGKGGAGIVYR-GSMPDGIDVAIKRLVGRGTGGNDHG-----FLA 738
           F+ E+V +       +G G   +V +      G+  A K +  R T  +  G        
Sbjct: 4   FRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIER 63
Query: 739 EIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIAL 798
           E+  L  I+H N++ L     N+   +L+ E +  G L + L  A+   L  E       
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL--AEKESLTEEEATEFLK 121
Query: 799 EAAKGLCYLHHDCSPLIIHRDVKSNNI-LLDSDF---EAHVADFGLAKFLQDAGASECMS 854
           +   G+ YLH   S  I H D+K  NI LLD +       + DFGLA  + D G      
Sbjct: 122 QILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI-DFGNE--FK 175
Query: 855 SVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
           ++ G+  ++APE      +  ++D++S GV+   L++G  P
Sbjct: 176 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 71/241 (29%), Positives = 118/241 (48%), Gaps = 42/241 (17%)
Query: 697 ENIIGKGGAG-IVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRI-RHRNIVRL 754
           E I+G G +G +V++GS   G  VA+KR++           L EI+ L     H N++R 
Sbjct: 38  EKILGYGSSGTVVFQGSF-QGRPVAVKRMLIDFCDIA----LMEIKLLTESDDHPNVIR- 91
Query: 755 LGYVSNRDTNLLLYEYMP--NGSLGEMLHG--AKGGHLKWETRYR-IAL--EAAKGLCYL 807
             Y  +  T+  LY  +   N +L +++        +LK +  Y  I+L  + A G+ +L
Sbjct: 92  --YYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHL 149
Query: 808 HHDCSPLIIHRDVKSNNILL--DSDFEAH-----------VADFGLAKFLQDAGASEC-- 852
           H   S  IIHRD+K  NIL+   S F A            ++DFGL K L D+G      
Sbjct: 150 H---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKL-DSGQXXFRX 205
Query: 853 -MSSVAGSYGYIAPEY---AYTLKVDEKSDVYSFGVVLLELIA-GKKPVGE-FGDGVDIV 906
            +++ +G+ G+ APE    +   ++    D++S G V   +++ GK P G+ +    +I+
Sbjct: 206 NLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNII 265
Query: 907 R 907
           R
Sbjct: 266 R 266

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 71/241 (29%), Positives = 118/241 (48%), Gaps = 42/241 (17%)
Query: 697 ENIIGKGGAG-IVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRI-RHRNIVRL 754
           E I+G G +G +V++GS   G  VA+KR++           L EI+ L     H N++R 
Sbjct: 38  EKILGYGSSGTVVFQGSF-QGRPVAVKRMLIDFCDIA----LMEIKLLTESDDHPNVIR- 91
Query: 755 LGYVSNRDTNLLLYEYMP--NGSLGEMLHG--AKGGHLKWETRYR-IAL--EAAKGLCYL 807
             Y  +  T+  LY  +   N +L +++        +LK +  Y  I+L  + A G+ +L
Sbjct: 92  --YYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHL 149
Query: 808 HHDCSPLIIHRDVKSNNILL--DSDFEAH-----------VADFGLAKFLQDAGASEC-- 852
           H   S  IIHRD+K  NIL+   S F A            ++DFGL K L D+G      
Sbjct: 150 H---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKL-DSGQXXFRX 205
Query: 853 -MSSVAGSYGYIAPEY---AYTLKVDEKSDVYSFGVVLLELIA-GKKPVGE-FGDGVDIV 906
            +++ +G+ G+ APE    +   ++    D++S G V   +++ GK P G+ +    +I+
Sbjct: 206 NLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNII 265
Query: 907 R 907
           R
Sbjct: 266 R 266

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 58/210 (27%), Positives = 97/210 (46%), Gaps = 24/210 (11%)
Query: 699 IIGKGGAGIVYRG-SMPDGIDVAIK-----RLVGRGTGGNDHGFLAEIQTLGRIRH--RN 750
           ++G GG G VY G  + D + VAIK     R+   G   N      E+  L ++      
Sbjct: 15  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 74
Query: 751 IVRLLGYVSNRDTNLLLYEY-MPNGSLGEML--HGAKGGHLKWETRYRIALEAAKGLCYL 807
           ++RLL +    D+ +L+ E   P   L + +   GA    L     +++ LEA +     
Sbjct: 75  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV-LEAVRHC--- 130
Query: 808 HHDCSPLIIHRDVKSNNILLDSDF-EAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPE 866
            H+C   ++HRD+K  NIL+D +  E  + DFG    L+D       +   G+  Y  PE
Sbjct: 131 -HNCG--VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPE 183
Query: 867 YAYTLKVDEKS-DVYSFGVVLLELIAGKKP 895
           +    +   +S  V+S G++L +++ G  P
Sbjct: 184 WIRYHRYHGRSAAVWSLGILLYDMVCGDIP 213

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 58/210 (27%), Positives = 97/210 (46%), Gaps = 24/210 (11%)
Query: 699 IIGKGGAGIVYRG-SMPDGIDVAIK-----RLVGRGTGGNDHGFLAEIQTLGRIRH--RN 750
           ++G GG G VY G  + D + VAIK     R+   G   N      E+  L ++      
Sbjct: 30  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 89
Query: 751 IVRLLGYVSNRDTNLLLYEY-MPNGSLGEML--HGAKGGHLKWETRYRIALEAAKGLCYL 807
           ++RLL +    D+ +L+ E   P   L + +   GA    L     +++ LEA +     
Sbjct: 90  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV-LEAVRHC--- 145
Query: 808 HHDCSPLIIHRDVKSNNILLDSDF-EAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPE 866
            H+C   ++HRD+K  NIL+D +  E  + DFG    L+D       +   G+  Y  PE
Sbjct: 146 -HNCG--VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPE 198
Query: 867 YAYTLKVDEKS-DVYSFGVVLLELIAGKKP 895
           +    +   +S  V+S G++L +++ G  P
Sbjct: 199 WIRYHRYHGRSAAVWSLGILLYDMVCGDIP 228

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 58/210 (27%), Positives = 97/210 (46%), Gaps = 24/210 (11%)
Query: 699 IIGKGGAGIVYRG-SMPDGIDVAIK-----RLVGRGTGGNDHGFLAEIQTLGRIRH--RN 750
           ++G GG G VY G  + D + VAIK     R+   G   N      E+  L ++      
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 751 IVRLLGYVSNRDTNLLLYEY-MPNGSLGEML--HGAKGGHLKWETRYRIALEAAKGLCYL 807
           ++RLL +    D+ +L+ E   P   L + +   GA    L     +++ LEA +     
Sbjct: 71  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV-LEAVRHC--- 126
Query: 808 HHDCSPLIIHRDVKSNNILLDSDF-EAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPE 866
            H+C   ++HRD+K  NIL+D +  E  + DFG    L+D       +   G+  Y  PE
Sbjct: 127 -HNCG--VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPE 179
Query: 867 YAYTLKVDEKS-DVYSFGVVLLELIAGKKP 895
           +    +   +S  V+S G++L +++ G  P
Sbjct: 180 WIRYHRYHGRSAAVWSLGILLYDMVCGDIP 209

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 58/210 (27%), Positives = 97/210 (46%), Gaps = 24/210 (11%)
Query: 699 IIGKGGAGIVYRG-SMPDGIDVAIK-----RLVGRGTGGNDHGFLAEIQTLGRIRH--RN 750
           ++G GG G VY G  + D + VAIK     R+   G   N      E+  L ++      
Sbjct: 14  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 73
Query: 751 IVRLLGYVSNRDTNLLLYEY-MPNGSLGEML--HGAKGGHLKWETRYRIALEAAKGLCYL 807
           ++RLL +    D+ +L+ E   P   L + +   GA    L     +++ LEA +     
Sbjct: 74  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV-LEAVRHC--- 129
Query: 808 HHDCSPLIIHRDVKSNNILLDSDF-EAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPE 866
            H+C   ++HRD+K  NIL+D +  E  + DFG    L+D       +   G+  Y  PE
Sbjct: 130 -HNCG--VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPE 182
Query: 867 YAYTLKVDEKS-DVYSFGVVLLELIAGKKP 895
           +    +   +S  V+S G++L +++ G  P
Sbjct: 183 WIRYHRYHGRSAAVWSLGILLYDMVCGDIP 212

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 58/210 (27%), Positives = 97/210 (46%), Gaps = 24/210 (11%)
Query: 699 IIGKGGAGIVYRG-SMPDGIDVAIK-----RLVGRGTGGNDHGFLAEIQTLGRIRH--RN 750
           ++G GG G VY G  + D + VAIK     R+   G   N      E+  L ++      
Sbjct: 16  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 75
Query: 751 IVRLLGYVSNRDTNLLLYEY-MPNGSLGEML--HGAKGGHLKWETRYRIALEAAKGLCYL 807
           ++RLL +    D+ +L+ E   P   L + +   GA    L     +++ LEA +     
Sbjct: 76  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV-LEAVRHC--- 131
Query: 808 HHDCSPLIIHRDVKSNNILLDSDF-EAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPE 866
            H+C   ++HRD+K  NIL+D +  E  + DFG    L+D       +   G+  Y  PE
Sbjct: 132 -HNCG--VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPE 184
Query: 867 YAYTLKVDEKS-DVYSFGVVLLELIAGKKP 895
           +    +   +S  V+S G++L +++ G  P
Sbjct: 185 WIRYHRYHGRSAAVWSLGILLYDMVCGDIP 214

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 58/210 (27%), Positives = 97/210 (46%), Gaps = 24/210 (11%)
Query: 699 IIGKGGAGIVYRG-SMPDGIDVAIK-----RLVGRGTGGNDHGFLAEIQTLGRIRH--RN 750
           ++G GG G VY G  + D + VAIK     R+   G   N      E+  L ++      
Sbjct: 16  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 75
Query: 751 IVRLLGYVSNRDTNLLLYEY-MPNGSLGEML--HGAKGGHLKWETRYRIALEAAKGLCYL 807
           ++RLL +    D+ +L+ E   P   L + +   GA    L     +++ LEA +     
Sbjct: 76  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV-LEAVRHC--- 131
Query: 808 HHDCSPLIIHRDVKSNNILLDSDF-EAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPE 866
            H+C   ++HRD+K  NIL+D +  E  + DFG    L+D       +   G+  Y  PE
Sbjct: 132 -HNCG--VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPE 184
Query: 867 YAYTLKVDEKS-DVYSFGVVLLELIAGKKP 895
           +    +   +S  V+S G++L +++ G  P
Sbjct: 185 WIRYHRYHGRSAAVWSLGILLYDMVCGDIP 214

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 58/210 (27%), Positives = 97/210 (46%), Gaps = 24/210 (11%)
Query: 699 IIGKGGAGIVYRG-SMPDGIDVAIK-----RLVGRGTGGNDHGFLAEIQTLGRIRH--RN 750
           ++G GG G VY G  + D + VAIK     R+   G   N      E+  L ++      
Sbjct: 31  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 90
Query: 751 IVRLLGYVSNRDTNLLLYEY-MPNGSLGEML--HGAKGGHLKWETRYRIALEAAKGLCYL 807
           ++RLL +    D+ +L+ E   P   L + +   GA    L     +++ LEA +     
Sbjct: 91  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV-LEAVRHC--- 146
Query: 808 HHDCSPLIIHRDVKSNNILLDSDF-EAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPE 866
            H+C   ++HRD+K  NIL+D +  E  + DFG    L+D       +   G+  Y  PE
Sbjct: 147 -HNCG--VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPE 199
Query: 867 YAYTLKVDEKS-DVYSFGVVLLELIAGKKP 895
           +    +   +S  V+S G++L +++ G  P
Sbjct: 200 WIRYHRYHGRSAAVWSLGILLYDMVCGDIP 229

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 58/210 (27%), Positives = 97/210 (46%), Gaps = 24/210 (11%)
Query: 699 IIGKGGAGIVYRG-SMPDGIDVAIK-----RLVGRGTGGNDHGFLAEIQTLGRIRH--RN 750
           ++G GG G VY G  + D + VAIK     R+   G   N      E+  L ++      
Sbjct: 31  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 90
Query: 751 IVRLLGYVSNRDTNLLLYEY-MPNGSLGEML--HGAKGGHLKWETRYRIALEAAKGLCYL 807
           ++RLL +    D+ +L+ E   P   L + +   GA    L     +++ LEA +     
Sbjct: 91  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV-LEAVRHC--- 146
Query: 808 HHDCSPLIIHRDVKSNNILLDSDF-EAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPE 866
            H+C   ++HRD+K  NIL+D +  E  + DFG    L+D       +   G+  Y  PE
Sbjct: 147 -HNCG--VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPE 199
Query: 867 YAYTLKVDEKS-DVYSFGVVLLELIAGKKP 895
           +    +   +S  V+S G++L +++ G  P
Sbjct: 200 WIRYHRYHGRSAAVWSLGILLYDMVCGDIP 229

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 58/210 (27%), Positives = 97/210 (46%), Gaps = 24/210 (11%)
Query: 699 IIGKGGAGIVYRG-SMPDGIDVAIK-----RLVGRGTGGNDHGFLAEIQTLGRIRH--RN 750
           ++G GG G VY G  + D + VAIK     R+   G   N      E+  L ++      
Sbjct: 31  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 90
Query: 751 IVRLLGYVSNRDTNLLLYEY-MPNGSLGEML--HGAKGGHLKWETRYRIALEAAKGLCYL 807
           ++RLL +    D+ +L+ E   P   L + +   GA    L     +++ LEA +     
Sbjct: 91  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV-LEAVRHC--- 146
Query: 808 HHDCSPLIIHRDVKSNNILLDSDF-EAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPE 866
            H+C   ++HRD+K  NIL+D +  E  + DFG    L+D       +   G+  Y  PE
Sbjct: 147 -HNCG--VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPE 199
Query: 867 YAYTLKVDEKS-DVYSFGVVLLELIAGKKP 895
           +    +   +S  V+S G++L +++ G  P
Sbjct: 200 WIRYHRYHGRSAAVWSLGILLYDMVCGDIP 229

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 58/210 (27%), Positives = 97/210 (46%), Gaps = 24/210 (11%)
Query: 699 IIGKGGAGIVYRG-SMPDGIDVAIK-----RLVGRGTGGNDHGFLAEIQTLGRIRH--RN 750
           ++G GG G VY G  + D + VAIK     R+   G   N      E+  L ++      
Sbjct: 16  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 75
Query: 751 IVRLLGYVSNRDTNLLLYEY-MPNGSLGEML--HGAKGGHLKWETRYRIALEAAKGLCYL 807
           ++RLL +    D+ +L+ E   P   L + +   GA    L     +++ LEA +     
Sbjct: 76  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV-LEAVRHC--- 131
Query: 808 HHDCSPLIIHRDVKSNNILLDSDF-EAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPE 866
            H+C   ++HRD+K  NIL+D +  E  + DFG    L+D       +   G+  Y  PE
Sbjct: 132 -HNCG--VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPE 184
Query: 867 YAYTLKVDEKS-DVYSFGVVLLELIAGKKP 895
           +    +   +S  V+S G++L +++ G  P
Sbjct: 185 WIRYHRYHGRSAAVWSLGILLYDMVCGDIP 214

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 58/210 (27%), Positives = 97/210 (46%), Gaps = 24/210 (11%)
Query: 699 IIGKGGAGIVYRG-SMPDGIDVAIK-----RLVGRGTGGNDHGFLAEIQTLGRIRH--RN 750
           ++G GG G VY G  + D + VAIK     R+   G   N      E+  L ++      
Sbjct: 30  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 89
Query: 751 IVRLLGYVSNRDTNLLLYEY-MPNGSLGEML--HGAKGGHLKWETRYRIALEAAKGLCYL 807
           ++RLL +    D+ +L+ E   P   L + +   GA    L     +++ LEA +     
Sbjct: 90  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV-LEAVRHC--- 145
Query: 808 HHDCSPLIIHRDVKSNNILLDSDF-EAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPE 866
            H+C   ++HRD+K  NIL+D +  E  + DFG    L+D       +   G+  Y  PE
Sbjct: 146 -HNCG--VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPE 198
Query: 867 YAYTLKVDEKS-DVYSFGVVLLELIAGKKP 895
           +    +   +S  V+S G++L +++ G  P
Sbjct: 199 WIRYHRYHGRSAAVWSLGILLYDMVCGDIP 228

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 58/210 (27%), Positives = 97/210 (46%), Gaps = 24/210 (11%)
Query: 699 IIGKGGAGIVYRG-SMPDGIDVAIK-----RLVGRGTGGNDHGFLAEIQTLGRIRH--RN 750
           ++G GG G VY G  + D + VAIK     R+   G   N      E+  L ++      
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 751 IVRLLGYVSNRDTNLLLYEY-MPNGSLGEML--HGAKGGHLKWETRYRIALEAAKGLCYL 807
           ++RLL +    D+ +L+ E   P   L + +   GA    L     +++ LEA +     
Sbjct: 71  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV-LEAVRHC--- 126
Query: 808 HHDCSPLIIHRDVKSNNILLDSDF-EAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPE 866
            H+C   ++HRD+K  NIL+D +  E  + DFG    L+D       +   G+  Y  PE
Sbjct: 127 -HNCG--VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPE 179
Query: 867 YAYTLKVDEKS-DVYSFGVVLLELIAGKKP 895
           +    +   +S  V+S G++L +++ G  P
Sbjct: 180 WIRYHRYHGRSAAVWSLGILLYDMVCGDIP 209

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 46/176 (26%), Positives = 73/176 (41%), Gaps = 23/176 (13%)
Query: 797 ALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSV 856
           + + AKG+ +L    S   IHRD+ + NILL       + DFGLA+ +            
Sbjct: 199 SFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 255
Query: 857 AGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSE 915
                ++APE  +      +SDV+SFGV+L E+ + G  P        +  R +++ T  
Sbjct: 256 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT-- 313
Query: 916 VSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLAN 971
                           R+   P      +++  + C   E S RPT  E+V  L N
Sbjct: 314 ----------------RMRA-PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 352

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 46/176 (26%), Positives = 73/176 (41%), Gaps = 23/176 (13%)
Query: 797 ALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSV 856
           + + AKG+ +L    S   IHRD+ + NILL       + DFGLA+ +            
Sbjct: 204 SFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 260
Query: 857 AGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSE 915
                ++APE  +      +SDV+SFGV+L E+ + G  P        +  R +++ T  
Sbjct: 261 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT-- 318
Query: 916 VSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLAN 971
                           R+   P      +++  + C   E S RPT  E+V  L N
Sbjct: 319 ----------------RMRA-PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 357

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 46/176 (26%), Positives = 73/176 (41%), Gaps = 23/176 (13%)
Query: 797 ALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSV 856
           + + AKG+ +L    S   IHRD+ + NILL       + DFGLA+ +            
Sbjct: 206 SFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 262
Query: 857 AGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSE 915
                ++APE  +      +SDV+SFGV+L E+ + G  P        +  R +++ T  
Sbjct: 263 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT-- 320
Query: 916 VSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLAN 971
                           R+   P      +++  + C   E S RPT  E+V  L N
Sbjct: 321 ----------------RMRA-PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 359

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 97/221 (43%), Gaps = 18/221 (8%)
Query: 685 FKAEDVLESLKDENIIGKGGAGIVYR-GSMPDGIDVAIKRLVGRGTGGNDHG-----FLA 738
           F+ E+V +       +G G   +V +      G+  A K +  R T  +  G        
Sbjct: 4   FRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIER 63
Query: 739 EIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIAL 798
           E+  L  I+H N++ L     N+   +L+ E +  G L + L  A+   L  E       
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILIGELVAGGELFDFL--AEKESLTEEEATEFLK 121
Query: 799 EAAKGLCYLHHDCSPLIIHRDVKSNNI-LLDSDF---EAHVADFGLAKFLQDAGASECMS 854
           +   G+ YLH   S  I H D+K  NI LLD +       + DFGLA  + D G      
Sbjct: 122 QILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI-DFGNE--FK 175
Query: 855 SVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
           ++ G+  ++APE      +  ++D++S GV+   L++G  P
Sbjct: 176 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 40/145 (27%), Positives = 69/145 (47%), Gaps = 8/145 (5%)
Query: 700 IGKGGAGIVYRGS--MPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGY 757
           +G+G    VY+G   + D + VA+K +      G     + E+  L  ++H NIV L   
Sbjct: 10  LGEGTYATVYKGKSKLTDNL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 68
Query: 758 VSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIH 817
           +    +  L++EY+ +  L + L    G  +          +  +GL Y H      ++H
Sbjct: 69  IHTEKSLTLVFEYL-DKDLKQYLDDC-GNIINMHNVKLFLFQLLRGLAYCHRQK---VLH 123
Query: 818 RDVKSNNILLDSDFEAHVADFGLAK 842
           RD+K  N+L++   E  +ADFGLA+
Sbjct: 124 RDLKPQNLLINERGELKLADFGLAR 148

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 46/176 (26%), Positives = 73/176 (41%), Gaps = 23/176 (13%)
Query: 797 ALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSV 856
           + + AKG+ +L    S   IHRD+ + NILL       + DFGLA+ +            
Sbjct: 197 SFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 253
Query: 857 AGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSE 915
                ++APE  +      +SDV+SFGV+L E+ + G  P        +  R +++ T  
Sbjct: 254 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT-- 311
Query: 916 VSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLAN 971
                           R+   P      +++  + C   E S RPT  E+V  L N
Sbjct: 312 ----------------RMRA-PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 350

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 27/79 (34%), Positives = 42/79 (53%), Gaps = 1/79 (1%)
Query: 817 HRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEK 876
           HRDVK  NIL+ +D  A++ DFG+A    D   ++ + +  G+  Y APE         +
Sbjct: 157 HRDVKPENILVSADDFAYLVDFGIASATTDEKLTQ-LGNTVGTLYYXAPERFSESHATYR 215
Query: 877 SDVYSFGVVLLELIAGKKP 895
           +D+Y+   VL E + G  P
Sbjct: 216 ADIYALTCVLYECLTGSPP 234

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 71/245 (28%), Positives = 117/245 (47%), Gaps = 46/245 (18%)
Query: 697 ENIIGKGGAG-IVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIR-HRNIVRL 754
           E I+G G +G +V++GS   G  VA+KR++           L EI+ L     H N++R 
Sbjct: 20  EKILGYGSSGTVVFQGSF-QGRPVAVKRMLIDFCDIA----LMEIKLLTESDDHPNVIR- 73
Query: 755 LGYVSNRDTNLLLYEYMP--NGSLGEMLHG--AKGGHLKWETRYR-IAL--EAAKGLCYL 807
             Y  +  T+  LY  +   N +L +++        +LK +  Y  I+L  + A G+ +L
Sbjct: 74  --YYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHL 131
Query: 808 HHDCSPLIIHRDVKSNNILL--DSDFEAH-----------VADFGLAKFLQDAGASEC-- 852
           H   S  IIHRD+K  NIL+   S F A            ++DFGL K L D+G      
Sbjct: 132 H---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKL-DSGQXXFRX 187
Query: 853 -MSSVAGSYGYIAPE-------YAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGE-FGDG 902
            +++ +G+ G+ APE            ++    D++S G V   +++ GK P G+ +   
Sbjct: 188 NLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE 247
Query: 903 VDIVR 907
            +I+R
Sbjct: 248 SNIIR 252

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 67/221 (30%), Positives = 102/221 (46%), Gaps = 24/221 (10%)
Query: 688 EDVLESLKDENIIGKGGAGIVYRG-SMPDGIDVAIKRL-VGRGT---GGNDHGFLAEIQT 742
           EDV E  +   +IGKG   +V R  +   G   A+K + V + T   G +      E   
Sbjct: 23  EDVYELCE---VIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASI 79
Query: 743 LGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLG-EMLHGAKGGHLKWE---TRY-RIA 797
              ++H +IV LL   S+     +++E+M    L  E++  A  G +  E   + Y R  
Sbjct: 80  CHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQI 139
Query: 798 LEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEA---HVADFGLAKFLQDAGASECMS 854
           LEA   L Y H +    IIHRDVK  N+LL S   +    + DFG+A  L ++G      
Sbjct: 140 LEA---LRYCHDNN---IIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGL--VAG 191
Query: 855 SVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
              G+  ++APE        +  DV+  GV+L  L++G  P
Sbjct: 192 GRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLP 232

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 60/231 (25%), Positives = 105/231 (45%), Gaps = 24/231 (10%)
Query: 686 KAEDVLESLKDENIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLG 744
           + EDV +    E+++G+G    V    ++    + A+K ++ +  G        E++ L 
Sbjct: 9   RFEDVYQ--LQEDVLGEGAHARVQTCINLITSQEYAVK-IIEKQPGHIRSRVFREVEMLY 65
Query: 745 RIR-HRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKG 803
           + + HRN++ L+ +    D   L++E M  GS+   +H  K  H        +  + A  
Sbjct: 66  QCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIH--KRRHFNELEASVVVQDVASA 123
Query: 804 LCYLHHDCSPLIIHRDVKSNNILLDSDFE---AHVADFGLAKFLQDAGASECMS-----S 855
           L +LH   +  I HRD+K  NIL +   +     + DF L   ++  G    +S     +
Sbjct: 124 LDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLT 180
Query: 856 VAGSYGYIAPEYAYTLK-----VDEKSDVYSFGVVLLELIAGKKP-VGEFG 900
             GS  Y+APE            D++ D++S GV+L  L++G  P VG  G
Sbjct: 181 PCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCG 231

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 71/159 (44%), Gaps = 10/159 (6%)
Query: 737 LAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRI 796
           L E + L  +    +V+L     +     ++ EYMP G +    H  + G          
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDM--FSHLRRIGRFSEPHARFY 146
Query: 797 ALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSV 856
           A +      YLH   S  +I+RD+K  N+L+D      VADFG AK ++      C    
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC---- 199
Query: 857 AGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
            G+  Y+APE   +   ++  D ++ GV++ E+ AG  P
Sbjct: 200 -GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 39/130 (30%), Positives = 61/130 (46%), Gaps = 10/130 (7%)
Query: 766 LLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNI 825
           ++ EYMP G +    H  + G          A +      YLH   S  +I+RD+K  N+
Sbjct: 118 MVMEYMPGGDM--FSHLRRIGRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENL 172
Query: 826 LLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVV 885
           L+D      VADFG AK ++      C     G+  Y+APE   +   ++  D ++ GV+
Sbjct: 173 LIDQQGYIKVADFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKAVDWWALGVL 227
Query: 886 LLELIAGKKP 895
           + E+ AG  P
Sbjct: 228 IYEMAAGYPP 237

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Composition-based stats.
 Identities = 54/208 (25%), Positives = 95/208 (45%), Gaps = 20/208 (9%)
Query: 699 IIGKGGAGIVYRG-SMPDGIDVAIK-----RLVGRGTGGNDHGFLAEIQTLGRIRH--RN 750
           ++G GG G VY G  + D + VAIK     R+   G   N      E+  L ++      
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 751 IVRLLGYVSNRDTNLLLYEY-MPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHH 809
           ++RLL +    D+ +L+ E   P   L + +   + G L+ E       +  + + + H+
Sbjct: 71  VIRLLDWFERPDSFVLILERPEPVQDLFDFI--TERGALQEELARSFFWQVLEAVRHCHN 128
Query: 810 DCSPLIIHRDVKSNNILLDSDF-EAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYA 868
                ++HRD+K  NIL+D +  E  + DFG    L+D       +   G+  Y  PE+ 
Sbjct: 129 XG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWI 181
Query: 869 YTLKVDEKS-DVYSFGVVLLELIAGKKP 895
              +   +S  V+S G++L +++ G  P
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIP 209

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 51/160 (31%), Positives = 73/160 (45%), Gaps = 11/160 (6%)
Query: 739 EIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIAL 798
           EI     +RH NIVR    +       ++ EY   G L E +  A G   + E R+    
Sbjct: 65  EIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQ- 122
Query: 799 EAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAH--VADFGLAKFLQDAGASECMSSV 856
           +   G+ Y H   +  + HRD+K  N LLD        + DFG +K       S+  S+V
Sbjct: 123 QLISGVSYCH---AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTV 177
Query: 857 AGSYGYIAPEYAYTLKVDEK-SDVYSFGVVLLELIAGKKP 895
            G+  YIAPE     + D K +DV+S GV L  ++ G  P
Sbjct: 178 -GTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYP 216

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 65/239 (27%), Positives = 104/239 (43%), Gaps = 39/239 (16%)
Query: 677 LTAFQRLDFKAEDVLESLKDENIIGKGGAGIVYRGSMPD-GIDVAIKRLVGRGTGGNDHG 735
           L A    D ++   ++  + E + G+G  G V  G     G+ VAIK+++      N   
Sbjct: 8   LNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRE- 66
Query: 736 FLAEIQTLGRIRHRNIVRL------LGYVSNRDTNL-LLYEYMPNGSLGEMLHGAKGGHL 788
            L  +Q L  + H NIV+L      LG    RD  L ++ EY+P+      LH     + 
Sbjct: 67  -LQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-----TLHRCCRNYY 120
Query: 789 KWETR--------YRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILL-DSDFEAHVADFG 839
           + +          +   L  + G  +L    S  + HRD+K +N+L+ ++D    + DFG
Sbjct: 121 RRQVAPPPILIKVFLFQLIRSIGCLHLP---SVNVCHRDIKPHNVLVNEADGTLKLCDFG 177
Query: 840 LAKFLQDAGASECMSSVAGSYGYIAPE-----YAYTLKVDEKSDVYSFGVVLLELIAGK 893
            AK L     SE   +   S  Y APE       YT  V    D++S G +  E++ G+
Sbjct: 178 SAKKL---SPSEPNVAYICSRYYRAPELIFGNQHYTTAV----DIWSVGCIFAEMMLGE 229

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 49/202 (24%), Positives = 85/202 (42%), Gaps = 25/202 (12%)
Query: 748 HRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYL 807
           H NIV+L     ++    L+ E +  G L E +   K  H        I  +    + ++
Sbjct: 65  HPNIVKLHEVFHDQLHTFLVMELLNGGELFERI--KKKKHFSETEASYIMRKLVSAVSHM 122
Query: 808 HHDCSPLIIHRDVKSNNILL---DSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIA 864
           H      ++HRD+K  N+L    + + E  + DFG A+       ++ + +   +  Y A
Sbjct: 123 H---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARL--KPPDNQPLKTPCFTLHYAA 177
Query: 865 PEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFG------DGVDIVRWVRK------- 911
           PE       DE  D++S GV+L  +++G+ P             V+I++ ++K       
Sbjct: 178 PELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEG 237
Query: 912 -TTSEVSQPS-DAASVLAVVDP 931
                VSQ + D    L  VDP
Sbjct: 238 EAWKNVSQEAKDLIQGLLTVDP 259

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 49/90 (54%), Gaps = 8/90 (8%)
Query: 806 YLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAP 865
           YLH   S  +I+RD+K  N+L+D      V DFG AK ++ A  + C     G+  Y+AP
Sbjct: 177 YLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGATWTLC-----GTPEYLAP 228
Query: 866 EYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
           E   +   ++  D ++ GV++ E+ AG  P
Sbjct: 229 EIILSKGYNKAVDWWALGVLIYEMAAGYPP 258

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 89/210 (42%), Gaps = 15/210 (7%)
Query: 689 DVLESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRH 748
           D  E +KD   IG G  G+          ++   + + RG    D     EI     +RH
Sbjct: 19  DRYELVKD---IGSGNFGVARLMRDKQSNELVAVKYIERGEKI-DENVKREIINHRSLRH 74
Query: 749 RNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLH 808
            NIVR    +       ++ EY   G L E +  A G   + E R+    +   G+ Y H
Sbjct: 75  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQ-QLISGVSYCH 132
Query: 809 HDCSPLIIHRDVKSNNILLDSDFEAH--VADFGLAKFLQDAGASECMSSVAGSYGYIAPE 866
              +  + HRD+K  N LLD        +  FG +K       S+  S+V G+  YIAPE
Sbjct: 133 ---AMQVCHRDLKLENTLLDGSPAPRLKICAFGYSK--SSVLHSQPKSTV-GTPAYIAPE 186
Query: 867 YAYTLKVDEK-SDVYSFGVVLLELIAGKKP 895
                + D K +DV+S GV L  ++ G  P
Sbjct: 187 VLLKKEYDGKVADVWSCGVTLYVMLVGAYP 216

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 31/86 (36%), Positives = 48/86 (55%), Gaps = 8/86 (9%)
Query: 816 IHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVA-GSYGYIAPEYAYTL--- 871
           +HRD+K +N+LLD +    +ADFG    + D G  +  SSVA G+  YI+PE    +   
Sbjct: 213 VHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQ--SSVAVGTPDYISPEILQAMEDG 270
Query: 872 --KVDEKSDVYSFGVVLLELIAGKKP 895
             K   + D +S GV + E++ G+ P
Sbjct: 271 MGKYGPECDWWSLGVCMYEMLYGETP 296

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 31/86 (36%), Positives = 48/86 (55%), Gaps = 8/86 (9%)
Query: 816 IHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVA-GSYGYIAPEYAYTL--- 871
           +HRD+K +N+LLD +    +ADFG    + D G  +  SSVA G+  YI+PE    +   
Sbjct: 197 VHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQ--SSVAVGTPDYISPEILQAMEDG 254
Query: 872 --KVDEKSDVYSFGVVLLELIAGKKP 895
             K   + D +S GV + E++ G+ P
Sbjct: 255 MGKYGPECDWWSLGVCMYEMLYGETP 280

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 74/153 (48%), Gaps = 17/153 (11%)
Query: 752 VRLLGYVSNRDTNL-LLYEYMPNGSLGEMLHGAKGGHLKWETRYRIA--LEAAKGLCYLH 808
           +  L Y    D NL L+ +Y   G L  +L   +    +   R+ +A  + A   +  LH
Sbjct: 136 ITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH 195
Query: 809 HDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVA-GSYGYIAPEY 867
           +      +HRD+K +NIL+D +    +ADFG    L + G  +  SSVA G+  YI+PE 
Sbjct: 196 Y------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQ--SSVAVGTPDYISPEI 247
Query: 868 AYTL-----KVDEKSDVYSFGVVLLELIAGKKP 895
              +     +   + D +S GV + E++ G+ P
Sbjct: 248 LQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 68/148 (45%), Gaps = 13/148 (8%)
Query: 755 LGYVSNRDTNL-LLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSP 813
           L Y    ++NL ++ EY+P G +    H  + G          A +      YLH   S 
Sbjct: 106 LEYSFKDNSNLYMVMEYVPGGEM--FSHLRRIGRFSEPHARFYAAQIVLTFEYLH---SL 160
Query: 814 LIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKV 873
            +I+RD+K  N+L+D      V DFG AK ++      C     G+  Y+APE   +   
Sbjct: 161 DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKGY 215
Query: 874 DEKSDVYSFGVVLLELIAGKKPVGEFGD 901
           ++  D ++ GV++ E+ AG  P   F D
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPF--FAD 241

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 41/142 (28%), Positives = 66/142 (46%), Gaps = 11/142 (7%)
Query: 755 LGYVSNRDTNL-LLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSP 813
           L Y    ++NL ++ EY+P G +    H  + G          A +      YLH   S 
Sbjct: 106 LEYSFKDNSNLYMVMEYVPGGEM--FSHLRRIGRFSEPHARFYAAQIVLTFEYLH---SL 160
Query: 814 LIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKV 873
            +I+RD+K  N+L+D      V DFG AK ++      C     G+  Y+APE   +   
Sbjct: 161 DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKGY 215
Query: 874 DEKSDVYSFGVVLLELIAGKKP 895
           ++  D ++ GV++ E+ AG  P
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPP 237

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 41/142 (28%), Positives = 66/142 (46%), Gaps = 11/142 (7%)
Query: 755 LGYVSNRDTNL-LLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSP 813
           L Y    ++NL ++ EY+P G +    H  + G          A +      YLH   S 
Sbjct: 106 LEYSFKDNSNLYMVMEYVPGGEM--FSHLRRIGRFSEPHARFYAAQIVLTFEYLH---SL 160
Query: 814 LIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKV 873
            +I+RD+K  N+L+D      V DFG AK ++      C     G+  Y+APE   +   
Sbjct: 161 DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKGY 215
Query: 874 DEKSDVYSFGVVLLELIAGKKP 895
           ++  D ++ GV++ E+ AG  P
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPP 237

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 60/247 (24%), Positives = 105/247 (42%), Gaps = 20/247 (8%)
Query: 700 IGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHG-FLAEIQTLGRIRH-RNIVRLLG 756
           +G+G   +V +  S   G + A K L  R  G +     L EI  L   +    ++ L  
Sbjct: 37  LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96
Query: 757 YVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLII 816
              N    +L+ EY   G +  +        +      R+  +  +G+ YLH +    I+
Sbjct: 97  VYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN---IV 153
Query: 817 HRDVKSNNILLDSDF---EAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKV 873
           H D+K  NILL S +   +  + DFG+++ +  A     +  + G+  Y+APE      +
Sbjct: 154 HLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE---LREIMGTPEYLAPEILNYDPI 210
Query: 874 DEKSDVYSFGVVLLELIAGKKP-VGEFGDGVDI------VRWVRKTTSEVSQ-PSDAASV 925
              +D+++ G++   L+    P VGE      +      V +  +T S VSQ  +D    
Sbjct: 211 TTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLATDFIQS 270
Query: 926 LAVVDPR 932
           L V +P 
Sbjct: 271 LLVKNPE 277

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 43/159 (27%), Positives = 71/159 (44%), Gaps = 10/159 (6%)
Query: 737 LAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRI 796
           L E + L  +    +V+L     +     ++ EY+P G +    H  + G          
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM--FSHLRRIGRFSEPHARFY 146
Query: 797 ALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSV 856
           A +      YLH   S  +I+RD+K  N+L+D      VADFG AK ++      C    
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC---- 199
Query: 857 AGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
            G+  Y+APE   +   ++  D ++ GV++ E+ AG  P
Sbjct: 200 -GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 39/136 (28%), Positives = 63/136 (46%), Gaps = 12/136 (8%)
Query: 766 LLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNI 825
           ++ EY+P G +    H  + G          A +      YLH   S  +I+RD+K  N+
Sbjct: 119 MVMEYVPGGEM--FSHLRRIGRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENL 173
Query: 826 LLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVV 885
           L+D      V DFG AK ++    + C     G+  Y+APE   +   ++  D ++ GV+
Sbjct: 174 LIDQQGYIQVTDFGFAKRVKGRTWTLC-----GTPEYLAPEIILSKGYNKAVDWWALGVL 228
Query: 886 LLELIAGKKPVGEFGD 901
           + E+ AG  P   F D
Sbjct: 229 IYEMAAGYPPF--FAD 242

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 71/159 (44%), Gaps = 10/159 (6%)
Query: 737 LAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRI 796
           L E + L  +    +V+L     +     ++ EY+P G +    H  + G          
Sbjct: 75  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM--FSHLRRIGRFSEPHARFY 132
Query: 797 ALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSV 856
           A +      YLH   S  +I+RD+K  N+L+D      V DFG AK ++    + C    
Sbjct: 133 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLC---- 185
Query: 857 AGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
            G+  Y+APE   +   ++  D ++ GV++ E+ AG  P
Sbjct: 186 -GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 223

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 99/212 (46%), Gaps = 26/212 (12%)
Query: 700 IGKGGAGIVYRGSMPD-GIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRL---- 754
           +G GG G+V+     D    VAIK++V        H  L EI+ + R+ H NIV++    
Sbjct: 19  LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHA-LREIKIIRRLDHDNIVKVFEIL 77
Query: 755 ----------LGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGL 804
                     +G ++  ++  ++ EYM    L  +L   + G L  E       +  +GL
Sbjct: 78  GPSGSQLTDDVGSLTELNSVYIVQEYM-ETDLANVL---EQGPLLEEHARLFMYQLLRGL 133
Query: 805 CYLHHDCSPLIIHRDVKSNNILLDS-DFEAHVADFGLAKFLQDAGASE-CMSSVAGSYGY 862
            Y+H   S  ++HRD+K  N+ +++ D    + DFGLA+ +    + +  +S    +  Y
Sbjct: 134 KYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWY 190
Query: 863 IAPEYAYTLKVDEKS-DVYSFGVVLLELIAGK 893
            +P    +     K+ D+++ G +  E++ GK
Sbjct: 191 RSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 47/150 (31%), Positives = 73/150 (48%), Gaps = 15/150 (10%)
Query: 750 NIVRLLGYVSNR--DTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYL 807
           NIV+LL  V ++   T  L++EY+ N     +          ++ RY I  E  K L Y 
Sbjct: 87  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPTLT----DYDIRYYI-YELLKALDYC 141
Query: 808 HHDCSPLIIHRDVKSNNILLDSDF-EAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPE 866
           H   S  I+HRDVK +N+++D +  +  + D+GLA+F       E    VA  Y +  PE
Sbjct: 142 H---SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP--GKEYNVRVASRY-FKGPE 195
Query: 867 YAYTLK-VDEKSDVYSFGVVLLELIAGKKP 895
               L+  D   D++S G +   +I  K+P
Sbjct: 196 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEP 225

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 47/150 (31%), Positives = 73/150 (48%), Gaps = 15/150 (10%)
Query: 750 NIVRLLGYVSNR--DTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYL 807
           NIV+LL  V ++   T  L++EY+ N     +          ++ RY I  E  K L Y 
Sbjct: 87  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPTLT----DYDIRYYI-YELLKALDYC 141
Query: 808 HHDCSPLIIHRDVKSNNILLDSDF-EAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPE 866
           H   S  I+HRDVK +N+++D +  +  + D+GLA+F       E    VA  Y +  PE
Sbjct: 142 H---SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP--GKEYNVRVASRY-FKGPE 195
Query: 867 YAYTLK-VDEKSDVYSFGVVLLELIAGKKP 895
               L+  D   D++S G +   +I  K+P
Sbjct: 196 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEP 225

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 47/150 (31%), Positives = 73/150 (48%), Gaps = 15/150 (10%)
Query: 750 NIVRLLGYVSNR--DTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYL 807
           NIV+LL  V ++   T  L++EY+ N     +          ++ RY I  E  K L Y 
Sbjct: 87  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPTLT----DYDIRYYI-YELLKALDYC 141
Query: 808 HHDCSPLIIHRDVKSNNILLDSDF-EAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPE 866
           H   S  I+HRDVK +N+++D +  +  + D+GLA+F       E    VA  Y +  PE
Sbjct: 142 H---SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP--GKEYNVRVASRY-FKGPE 195
Query: 867 YAYTLK-VDEKSDVYSFGVVLLELIAGKKP 895
               L+  D   D++S G +   +I  K+P
Sbjct: 196 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEP 225

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 47/150 (31%), Positives = 73/150 (48%), Gaps = 15/150 (10%)
Query: 750 NIVRLLGYVSNR--DTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYL 807
           NIV+LL  V ++   T  L++EY+ N     +          ++ RY I  E  K L Y 
Sbjct: 87  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPTLT----DYDIRYYI-YELLKALDYC 141
Query: 808 HHDCSPLIIHRDVKSNNILLDSDF-EAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPE 866
           H   S  I+HRDVK +N+++D +  +  + D+GLA+F       E    VA  Y +  PE
Sbjct: 142 H---SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP--GKEYNVRVASRY-FKGPE 195
Query: 867 YAYTLK-VDEKSDVYSFGVVLLELIAGKKP 895
               L+  D   D++S G +   +I  K+P
Sbjct: 196 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEP 225

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 47/150 (31%), Positives = 73/150 (48%), Gaps = 15/150 (10%)
Query: 750 NIVRLLGYVSNR--DTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYL 807
           NIV+LL  V ++   T  L++EY+ N     +          ++ RY I  E  K L Y 
Sbjct: 87  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPTLT----DYDIRYYI-YELLKALDYC 141
Query: 808 HHDCSPLIIHRDVKSNNILLDSDF-EAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPE 866
           H   S  I+HRDVK +N+++D +  +  + D+GLA+F       E    VA  Y +  PE
Sbjct: 142 H---SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP--GKEYNVRVASRY-FKGPE 195
Query: 867 YAYTLK-VDEKSDVYSFGVVLLELIAGKKP 895
               L+  D   D++S G +   +I  K+P
Sbjct: 196 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEP 225

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 73/168 (43%), Gaps = 10/168 (5%)
Query: 739 EIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIAL 798
           EI  L R+ H NI+++L    N+    L+ E   +G L       +   L       I  
Sbjct: 79  EIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSG-LDLFAFIDRHPRLDEPLASYIFR 137
Query: 799 EAAKGLCYLH-HDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVA 857
           +    + YL   D    IIHRD+K  NI++  DF   + DFG A +L+     +   +  
Sbjct: 138 QLVSAVGYLRLKD----IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERG---KLFYTFC 190
Query: 858 GSYGYIAPEYAY-TLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVD 904
           G+  Y APE          + +++S GV L  L+  + P  E  + V+
Sbjct: 191 GTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVE 238

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 53/247 (21%), Positives = 106/247 (42%), Gaps = 12/247 (4%)
Query: 675 WKLTAFQRLDFKAEDVLESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDH 734
           WK    Q ++ K   V +       +G G  G+V+R        V + + +      + +
Sbjct: 34  WKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKY 93
Query: 735 GFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRY 794
               EI  + ++ H  ++ L     ++   +L+ E++  G L + +  A+   +      
Sbjct: 94  TVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRI-AAEDYKMSEAEVI 152
Query: 795 RIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVA--DFGLAKFLQDAGASEC 852
               +A +GL ++H      I+H D+K  NI+ ++   + V   DFGLA  L      E 
Sbjct: 153 NYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKL---NPDEI 206
Query: 853 MSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKP-VGEFGDGVDIVRWVRK 911
           +     +  + APE      V   +D+++ GV+   L++G  P  GE  D ++ ++ V++
Sbjct: 207 VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGE--DDLETLQNVKR 264
Query: 912 TTSEVSQ 918
              E  +
Sbjct: 265 CDWEFDE 271

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 70/159 (44%), Gaps = 10/159 (6%)
Query: 737 LAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRI 796
           L E + L  +    +V+L     +     ++ EY+P G +    H  + G          
Sbjct: 110 LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM--FSHLRRIGRFSEPHARFY 167
Query: 797 ALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSV 856
           A +      YLH   S  +I+RD+K  N+L+D      V DFG AK ++      C    
Sbjct: 168 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---- 220
Query: 857 AGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
            G+  Y+APE   +   ++  D ++ GV++ E+ AG  P
Sbjct: 221 -GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 258

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/143 (29%), Positives = 68/143 (47%), Gaps = 14/143 (9%)
Query: 766 LLYEYMPNGSLGEMLHGAKGG----HLKWETRY---RIALEAAKGLCYLHHDCSPLIIHR 818
           L + +  N +L  +L  A GG    HL+   R+        AA+ +    +  S  +I+R
Sbjct: 107 LEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 166
Query: 819 DVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSD 878
           D+K  N+L+D      VADFG AK ++      C     G+  Y+APE   +   ++  D
Sbjct: 167 DLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKAVD 221
Query: 879 VYSFGVVLLELIAGKKPVGEFGD 901
            ++ GV++ E+ AG  P   F D
Sbjct: 222 WWALGVLIYEMAAGYPPF--FAD 242

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/165 (26%), Positives = 72/165 (43%), Gaps = 12/165 (7%)
Query: 737 LAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRI 796
           L E + L  +    +V+L     +     ++ EY+P G +    H  + G          
Sbjct: 90  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM--FSHLRRIGRFSEPHARFY 147
Query: 797 ALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSV 856
           A +      YLH   S  +I+RD+K  N+L+D      V DFG AK ++      C    
Sbjct: 148 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---- 200
Query: 857 AGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGD 901
            G+  Y+APE   +   ++  D ++ GV++ E+ AG  P   F D
Sbjct: 201 -GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF--FAD 242

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/165 (26%), Positives = 72/165 (43%), Gaps = 12/165 (7%)
Query: 737 LAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRI 796
           L E + L  +    +V+L     +     ++ EY+P G +    H  + G          
Sbjct: 90  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM--FSHLRRIGRFSEPHARFY 147
Query: 797 ALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSV 856
           A +      YLH   S  +I+RD+K  N+L+D      V DFG AK ++      C    
Sbjct: 148 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---- 200
Query: 857 AGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGD 901
            G+  Y+APE   +   ++  D ++ GV++ E+ AG  P   F D
Sbjct: 201 -GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF--FAD 242

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 88/210 (41%), Gaps = 15/210 (7%)
Query: 689 DVLESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRH 748
           D  E +KD   IG G  G+          ++   + + RG    D     EI     +RH
Sbjct: 19  DRYELVKD---IGSGNFGVARLMRDKQSNELVAVKYIERGEKI-DENVKREIINHRSLRH 74
Query: 749 RNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLH 808
            NIVR    +       ++ EY   G L E +  A G   + E R+    +   G+ Y H
Sbjct: 75  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQ-QLISGVSYCH 132
Query: 809 HDCSPLIIHRDVKSNNILLDSDFEAH--VADFGLAKFLQDAGASECMSSVAGSYGYIAPE 866
              +  + HRD+K  N LLD        +  FG +K       S+   +V G+  YIAPE
Sbjct: 133 ---AMQVCHRDLKLENTLLDGSPAPRLKICAFGYSK--SSVLHSQPKDTV-GTPAYIAPE 186
Query: 867 YAYTLKVDEK-SDVYSFGVVLLELIAGKKP 895
                + D K +DV+S GV L  ++ G  P
Sbjct: 187 VLLKKEYDGKVADVWSCGVTLYVMLVGAYP 216

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 39/136 (28%), Positives = 62/136 (45%), Gaps = 12/136 (8%)
Query: 766 LLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNI 825
           ++ EY+P G +    H  + G          A +      YLH   S  +I+RD+K  N+
Sbjct: 111 MVMEYVPGGEM--FSHLRRIGRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENL 165
Query: 826 LLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVV 885
           L+D      V DFG AK ++      C     G+  Y+APE   +   ++  D ++ GV+
Sbjct: 166 LIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKAVDWWALGVL 220
Query: 886 LLELIAGKKPVGEFGD 901
           + E+ AG  P   F D
Sbjct: 221 IYEMAAGYPPF--FAD 234

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 39/136 (28%), Positives = 62/136 (45%), Gaps = 12/136 (8%)
Query: 766 LLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNI 825
           ++ EY+P G +    H  + G          A +      YLH   S  +I+RD+K  N+
Sbjct: 118 MVMEYVPGGEM--FSHLRRIGRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENL 172
Query: 826 LLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVV 885
           L+D      V DFG AK ++      C     G+  Y+APE   +   ++  D ++ GV+
Sbjct: 173 LIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKAVDWWALGVL 227
Query: 886 LLELIAGKKPVGEFGD 901
           + E+ AG  P   F D
Sbjct: 228 IYEMAAGYPPF--FAD 241

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 64/136 (47%), Gaps = 12/136 (8%)
Query: 766 LLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNI 825
           ++ EY+P G +   L    G   +   R+  A +      YLH   S  +I+RD+K  N+
Sbjct: 111 MVMEYVPGGEMFSHLRRI-GRFXEPHARF-YAAQIVLTFEYLH---SLDLIYRDLKPENL 165
Query: 826 LLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVV 885
           L+D      V DFG AK ++      C     G+  Y+APE   +   ++  D ++ GV+
Sbjct: 166 LIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKAVDWWALGVL 220
Query: 886 LLELIAGKKPVGEFGD 901
           + E+ AG  P   F D
Sbjct: 221 IYEMAAGYPPF--FAD 234

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 74/165 (44%), Gaps = 12/165 (7%)
Query: 737 LAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRI 796
           L E + L  +    +V+L     +     ++ EY+P G +   L    G   +   R+  
Sbjct: 90  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRI-GRFXEPHARF-Y 147
Query: 797 ALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSV 856
           A +      YLH   S  +I+RD+K  N+L+D      V DFG AK ++      C    
Sbjct: 148 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---- 200
Query: 857 AGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGD 901
            G+  Y+APE   +   ++  D ++ GV++ E+ AG  P   F D
Sbjct: 201 -GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF--FAD 242

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/165 (26%), Positives = 72/165 (43%), Gaps = 12/165 (7%)
Query: 737 LAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRI 796
           L E + L  +    +V+L     +     ++ EY+P G +    H  + G          
Sbjct: 90  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM--FSHLRRIGRFSEPHARFY 147
Query: 797 ALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSV 856
           A +      YLH   S  +I+RD+K  N+L+D      V DFG AK ++      C    
Sbjct: 148 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---- 200
Query: 857 AGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGD 901
            G+  Y+APE   +   ++  D ++ GV++ E+ AG  P   F D
Sbjct: 201 -GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF--FAD 242

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 70/159 (44%), Gaps = 10/159 (6%)
Query: 737 LAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRI 796
           L E + L  +    +V+L     +     ++ EY+P G +    H  + G          
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM--FSHLRRIGRFSEPHARFY 146
Query: 797 ALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSV 856
           A +      YLH   S  +I+RD+K  N+L+D      V DFG AK ++      C    
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---- 199
Query: 857 AGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
            G+  Y+APE   +   ++  D ++ GV++ E+ AG  P
Sbjct: 200 -GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 70/159 (44%), Gaps = 10/159 (6%)
Query: 737 LAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRI 796
           L E + L  +    +V+L     +     ++ EY+P G +    H  + G          
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM--FSHLRRIGRFXEPHARFY 146
Query: 797 ALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSV 856
           A +      YLH   S  +I+RD+K  N+L+D      V DFG AK ++      C    
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---- 199
Query: 857 AGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
            G+  Y+APE   +   ++  D ++ GV++ E+ AG  P
Sbjct: 200 -GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 43/159 (27%), Positives = 72/159 (45%), Gaps = 10/159 (6%)
Query: 737 LAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRI 796
           L E + L  +    +V+L     +     ++ EY+P G +   L    G   +   R+  
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRI-GRFXEPHARF-Y 146
Query: 797 ALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSV 856
           A +      YLH   S  +I+RD+K  N+L+D      V DFG AK ++      C    
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---- 199
Query: 857 AGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
            G+  Y+APE   +   ++  D ++ GV++ E+ AG  P
Sbjct: 200 -GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 39/136 (28%), Positives = 62/136 (45%), Gaps = 12/136 (8%)
Query: 766 LLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNI 825
           ++ EY+P G +    H  + G          A +      YLH   S  +I+RD+K  N+
Sbjct: 119 MVMEYVPGGEM--FSHLRRIGRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENL 173
Query: 826 LLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVV 885
           L+D      V DFG AK ++      C     G+  Y+APE   +   ++  D ++ GV+
Sbjct: 174 LIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKAVDWWALGVL 228
Query: 886 LLELIAGKKPVGEFGD 901
           + E+ AG  P   F D
Sbjct: 229 IYEMAAGYPPF--FAD 242

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/130 (28%), Positives = 60/130 (46%), Gaps = 10/130 (7%)
Query: 766 LLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNI 825
           ++ EY+P G +    H  + G          A +      YLH   S  +I+RD+K  N+
Sbjct: 118 MVMEYVPGGEM--FSHLRRIGRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENL 172
Query: 826 LLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVV 885
           L+D      V DFG AK ++      C     G+  Y+APE   +   ++  D ++ GV+
Sbjct: 173 LIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKAVDWWALGVL 227
Query: 886 LLELIAGKKP 895
           + E+ AG  P
Sbjct: 228 IYEMAAGYPP 237

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 39/136 (28%), Positives = 62/136 (45%), Gaps = 12/136 (8%)
Query: 766 LLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNI 825
           ++ EY P G +    H  + G          A +      YLH   S  +I+RD+K  N+
Sbjct: 118 MVMEYAPGGEM--FSHLRRIGRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENL 172
Query: 826 LLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVV 885
           ++D      V DFGLAK ++      C     G+  Y+APE   +   ++  D ++ GV+
Sbjct: 173 MIDQQGYIQVTDFGLAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKAVDWWALGVL 227
Query: 886 LLELIAGKKPVGEFGD 901
           + E+ AG  P   F D
Sbjct: 228 IYEMAAGYPPF--FAD 241

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 89/216 (41%), Gaps = 30/216 (13%)
Query: 697 ENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLA----------EIQTLGRI 746
           +  I  G  G V  G   +GI VAIKR+    + G     L+          EI+ L   
Sbjct: 27  QRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHF 86
Query: 747 RHRNIVRLLGYVSNRDT----NLLLYEYMPNGSLGEMLHGAK----GGHLKWETRYRIAL 798
            H NI+ L     + +      L L   +    L +++H  +      H+++   Y I L
Sbjct: 87  HHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQY-FMYHILL 145
Query: 799 EAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAG 858
               GL  LH      ++HRD+   NILL  + +  + DF LA+  +D   +     V  
Sbjct: 146 ----GLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLAR--EDTADANKTHYVTH 196
Query: 859 SYGYIAPEYAYTLK-VDEKSDVYSFGVVLLELIAGK 893
            + Y APE     K   +  D++S G V+ E+   K
Sbjct: 197 RW-YRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 89/216 (41%), Gaps = 30/216 (13%)
Query: 697 ENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLA----------EIQTLGRI 746
           +  I  G  G V  G   +GI VAIKR+    + G     L+          EI+ L   
Sbjct: 27  QRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHF 86
Query: 747 RHRNIVRLLGYVSNRDT----NLLLYEYMPNGSLGEMLHGAK----GGHLKWETRYRIAL 798
            H NI+ L     + +      L L   +    L +++H  +      H+++   Y I L
Sbjct: 87  HHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQY-FMYHILL 145
Query: 799 EAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAG 858
               GL  LH      ++HRD+   NILL  + +  + DF LA+  +D   +     V  
Sbjct: 146 ----GLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLAR--EDTADANKTHYVTH 196
Query: 859 SYGYIAPEYAYTLK-VDEKSDVYSFGVVLLELIAGK 893
            + Y APE     K   +  D++S G V+ E+   K
Sbjct: 197 RW-YRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 72/150 (48%), Gaps = 15/150 (10%)
Query: 750 NIVRLLGYVSNRDTNL--LLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYL 807
           NIV+LL  V ++ +    L++EY+ N     +          ++ RY I  E  K L Y 
Sbjct: 108 NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPTLTD----YDIRYYI-YELLKALDYC 162
Query: 808 HHDCSPLIIHRDVKSNNILLDSDFEA-HVADFGLAKFLQDAGASECMSSVAGSYGYIAPE 866
           H   S  I+HRDVK +N+++D +     + D+GLA+F       E    VA  Y +  PE
Sbjct: 163 H---SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH--PGKEYNVRVASRY-FKGPE 216
Query: 867 YAYTLK-VDEKSDVYSFGVVLLELIAGKKP 895
               L+  D   D++S G +   +I  K+P
Sbjct: 217 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEP 246

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 72/150 (48%), Gaps = 15/150 (10%)
Query: 750 NIVRLLGYVSNRDTNL--LLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYL 807
           NIV+LL  V ++ +    L++EY+ N     +          ++ RY I  E  K L Y 
Sbjct: 88  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPTLTD----YDIRYYI-YELLKALDYC 142
Query: 808 HHDCSPLIIHRDVKSNNILLDSDFEA-HVADFGLAKFLQDAGASECMSSVAGSYGYIAPE 866
           H   S  I+HRDVK +N+++D +     + D+GLA+F       E    VA  Y +  PE
Sbjct: 143 H---SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH--PGKEYNVRVASRY-FKGPE 196
Query: 867 YAYTLK-VDEKSDVYSFGVVLLELIAGKKP 895
               L+  D   D++S G +   +I  K+P
Sbjct: 197 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEP 226

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 56/216 (25%), Positives = 94/216 (43%), Gaps = 38/216 (17%)
Query: 748 HRNIVRLLGYV----SNRDTNLLLYEYMPNGSLGEMLH--GAKGGHLKWETRYRIALEAA 801
           H NI+RL+ Y       +    LL  +   G+L   +     KG  L  +    + L   
Sbjct: 85  HPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGIC 144
Query: 802 KGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFG-------------LAKFLQDAG 848
           +GL  +H   +    HRD+K  NILL  + +  + D G              A  LQD  
Sbjct: 145 RGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWA 201
Query: 849 ASECMSSVAGSYGYIAPEYAYTLK----VDEKSDVYSFGVVLLELIAGKKP---VGEFGD 901
           A  C  S      Y APE  ++++    +DE++DV+S G VL  ++ G+ P   V + GD
Sbjct: 202 AQRCTIS------YRAPEL-FSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD 254
Query: 902 GVDIVRWVRKTTSEVSQPSDAASVLAVVDPRLSGYP 937
            V +   V+   S    P  ++++  +++  ++  P
Sbjct: 255 SVALA--VQNQLSIPQSPRHSSALWQLLNSMMTVDP 288

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 72/150 (48%), Gaps = 15/150 (10%)
Query: 750 NIVRLLGYVSNRDTNL--LLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYL 807
           NIV+LL  V ++ +    L++EY+ N     +          ++ RY I  E  K L Y 
Sbjct: 88  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPTLTD----YDIRYYI-YELLKALDYC 142
Query: 808 HHDCSPLIIHRDVKSNNILLDSDFEA-HVADFGLAKFLQDAGASECMSSVAGSYGYIAPE 866
           H   S  I+HRDVK +N+++D +     + D+GLA+F       E    VA  Y +  PE
Sbjct: 143 H---SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH--PGKEYNVRVASRY-FKGPE 196
Query: 867 YAYTLK-VDEKSDVYSFGVVLLELIAGKKP 895
               L+  D   D++S G +   +I  K+P
Sbjct: 197 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEP 226

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 72/150 (48%), Gaps = 15/150 (10%)
Query: 750 NIVRLLGYVSNRDTNL--LLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYL 807
           NIV+LL  V ++ +    L++EY+ N     +          ++ RY I  E  K L Y 
Sbjct: 89  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPTLTD----YDIRYYI-YELLKALDYC 143
Query: 808 HHDCSPLIIHRDVKSNNILLDSDFEA-HVADFGLAKFLQDAGASECMSSVAGSYGYIAPE 866
           H   S  I+HRDVK +N+++D +     + D+GLA+F       E    VA  Y +  PE
Sbjct: 144 H---SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH--PGKEYNVRVASRY-FKGPE 197
Query: 867 YAYTLK-VDEKSDVYSFGVVLLELIAGKKP 895
               L+  D   D++S G +   +I  K+P
Sbjct: 198 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEP 227

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 72/150 (48%), Gaps = 15/150 (10%)
Query: 750 NIVRLLGYVSNRDTNL--LLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYL 807
           NIV+LL  V ++ +    L++EY+ N     +          ++ RY I  E  K L Y 
Sbjct: 87  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPTLTD----YDIRYYI-YELLKALDYC 141
Query: 808 HHDCSPLIIHRDVKSNNILLDSDFEA-HVADFGLAKFLQDAGASECMSSVAGSYGYIAPE 866
           H   S  I+HRDVK +N+++D +     + D+GLA+F       E    VA  Y +  PE
Sbjct: 142 H---SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH--PGKEYNVRVASRY-FKGPE 195
Query: 867 YAYTLK-VDEKSDVYSFGVVLLELIAGKKP 895
               L+  D   D++S G +   +I  K+P
Sbjct: 196 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEP 225

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 44/165 (26%), Positives = 72/165 (43%), Gaps = 12/165 (7%)
Query: 737 LAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRI 796
           L E + L  +    +V+L     +     ++ EY P G +    H  + G          
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEM--FSHLRRIGRFSEPHARFY 146
Query: 797 ALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSV 856
           A +      YLH   S  +I+RD+K  N+++D      V DFGLAK ++      C    
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVKGRTWXLC---- 199
Query: 857 AGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGD 901
            G+  Y+APE   +   ++  D ++ GV++ E+ AG  P   F D
Sbjct: 200 -GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF--FAD 241

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 55/210 (26%), Positives = 95/210 (45%), Gaps = 22/210 (10%)
Query: 699 IIGKGGAGIVYRG-SMPDGIDVAIK-----RLVGRGTGGNDHGFLAEIQTLGRIR----H 748
           ++GKGG G V+ G  + D + VAIK     R++G     +      E+  L ++     H
Sbjct: 38  LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 749 RNIVRLLGYVSNRDTNLLLYEY-MPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYL 807
             ++RLL +   ++  +L+ E  +P   L + +   KG   +  +R       A     +
Sbjct: 98  PGVIRLLDWFETQEGFMLVLERPLPAQDLFDYI-TEKGPLGEGPSRCFFGQVVAA----I 152
Query: 808 HHDCSPLIIHRDVKSNNILLDSDFE-AHVADFGLAKFLQDAGASECMSSVAGSYGYIAPE 866
            H  S  ++HRD+K  NIL+D     A + DFG    L D    E  +   G+  Y  PE
Sbjct: 153 QHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHD----EPYTDFDGTRVYSPPE 208
Query: 867 YAYTLKVDE-KSDVYSFGVVLLELIAGKKP 895
           +    +     + V+S G++L +++ G  P
Sbjct: 209 WISRHQYHALPATVWSLGILLYDMVCGDIP 238

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 46/171 (26%), Positives = 79/171 (46%), Gaps = 15/171 (8%)
Query: 739 EIQTLGRIRHR-NIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGG----HLKWETR 793
           ++  L +I H  N  R+L  V+      L + +  N +L  ++  A GG    HL+   R
Sbjct: 79  KVVKLKQIEHTLNEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGR 138
Query: 794 Y---RIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS 850
           +        AA+ +    +  S  +I+RD+K  N+++D      V DFG AK ++     
Sbjct: 139 FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWX 198
Query: 851 ECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGD 901
            C     G+  Y+APE   +   ++  D ++ GV++ E+ AG  P   F D
Sbjct: 199 LC-----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF--FAD 242

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 46/171 (26%), Positives = 79/171 (46%), Gaps = 15/171 (8%)
Query: 739 EIQTLGRIRHR-NIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGG----HLKWETR 793
           ++  L +I H  N  R+L  V+      L + +  N +L  ++  A GG    HL+   R
Sbjct: 79  KVVKLKQIEHTLNEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGR 138
Query: 794 Y---RIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS 850
           +        AA+ +    +  S  +I+RD+K  N+++D      V DFG AK ++     
Sbjct: 139 FXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWX 198
Query: 851 ECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGD 901
            C     G+  Y+APE   +   ++  D ++ GV++ E+ AG  P   F D
Sbjct: 199 LC-----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF--FAD 242

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 46/171 (26%), Positives = 79/171 (46%), Gaps = 15/171 (8%)
Query: 739 EIQTLGRIRHR-NIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGG----HLKWETR 793
           ++  L +I H  N  R+L  V+      L + +  N +L  ++  A GG    HL+   R
Sbjct: 79  KVVKLKQIEHTLNEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGR 138
Query: 794 Y---RIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS 850
           +        AA+ +    +  S  +I+RD+K  N+++D      V DFG AK ++     
Sbjct: 139 FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWX 198
Query: 851 ECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGD 901
            C     G+  Y+APE   +   ++  D ++ GV++ E+ AG  P   F D
Sbjct: 199 LC-----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF--FAD 242

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 30/90 (33%), Positives = 47/90 (52%), Gaps = 8/90 (8%)
Query: 806 YLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAP 865
           YLH   S  +I+RD+K  N+L+D      V DFG AK ++      C     G+  Y+AP
Sbjct: 177 YLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAP 228
Query: 866 EYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
           E   +   ++  D ++ GV++ E+ AG  P
Sbjct: 229 EIILSKGYNKAVDWWALGVLIYEMAAGYPP 258

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 30/90 (33%), Positives = 47/90 (52%), Gaps = 8/90 (8%)
Query: 806 YLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAP 865
           YLH   S  +I+RD+K  N+L+D      V DFG AK ++      C     G+  Y+AP
Sbjct: 156 YLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAP 207
Query: 866 EYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
           E   +   ++  D ++ GV++ E+ AG  P
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 96/200 (48%), Gaps = 11/200 (5%)
Query: 699 IIGKGGAGIVYR-GSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGY 757
           I+G G  G V++      G+ +A K +  RG    +     EI  + ++ H N+++L   
Sbjct: 96  ILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEE-VKNEISVMNQLDHANLIQLYDA 154
Query: 758 VSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIH 817
             +++  +L+ EY+  G L + +        + +T   +  +  +G+ ++H      I+H
Sbjct: 155 FESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMK-QICEGIRHMHQ---MYILH 210
Query: 818 RDVKSNNIL-LDSDF-EAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDE 875
            D+K  NIL ++ D  +  + DFGLA+  +     E +    G+  ++APE      V  
Sbjct: 211 LDLKPENILCVNRDAKQIKIIDFGLARRYK---PREKLKVNFGTPEFLAPEVVNYDFVSF 267
Query: 876 KSDVYSFGVVLLELIAGKKP 895
            +D++S GV+   L++G  P
Sbjct: 268 PTDMWSVGVIAYMLLSGLSP 287

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 32/96 (33%), Positives = 49/96 (51%), Gaps = 10/96 (10%)
Query: 806 YLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAP 865
           YLH   S  +I+RD+K  N+L+D      V DFG AK ++      C     G+  Y+AP
Sbjct: 157 YLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAP 208
Query: 866 EYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGD 901
           E   +   ++  D ++ GV++ E+ AG  P   F D
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAGYPPF--FAD 242

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 30/90 (33%), Positives = 47/90 (52%), Gaps = 8/90 (8%)
Query: 806 YLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAP 865
           YLH   S  +I+RD+K  N+L+D      V DFG AK ++      C     G+  Y+AP
Sbjct: 156 YLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAP 207
Query: 866 EYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
           E   +   ++  D ++ GV++ E+ AG  P
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 30/90 (33%), Positives = 47/90 (52%), Gaps = 8/90 (8%)
Query: 806 YLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAP 865
           YLH   S  +I+RD+K  N+L+D      V DFG AK ++      C     G+  Y+AP
Sbjct: 156 YLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAP 207
Query: 866 EYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
           E   +   ++  D ++ GV++ E+ AG  P
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 30/90 (33%), Positives = 47/90 (52%), Gaps = 8/90 (8%)
Query: 806 YLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAP 865
           YLH   S  +I+RD+K  N+L+D      V DFG AK ++      C     G+  Y+AP
Sbjct: 156 YLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAP 207
Query: 866 EYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
           E   +   ++  D ++ GV++ E+ AG  P
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 30/90 (33%), Positives = 47/90 (52%), Gaps = 8/90 (8%)
Query: 806 YLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAP 865
           YLH   S  +I+RD+K  N+L+D      V DFG AK ++      C     G+  Y+AP
Sbjct: 156 YLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAP 207
Query: 866 EYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
           E   +   ++  D ++ GV++ E+ AG  P
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 32/96 (33%), Positives = 49/96 (51%), Gaps = 10/96 (10%)
Query: 806 YLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAP 865
           YLH   S  +I+RD+K  N+L+D      V DFG AK ++      C     G+  Y+AP
Sbjct: 151 YLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAP 202
Query: 866 EYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGD 901
           E   +   ++  D ++ GV++ E+ AG  P   F D
Sbjct: 203 EIILSKGYNKAVDWWALGVLIYEMAAGYPPF--FAD 236

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 75/159 (47%), Gaps = 15/159 (9%)
Query: 750 NIVRLLGYVSN--RDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYL 807
           NI++L+  V +    T  L++EY+ N    ++        +++        E  K L Y 
Sbjct: 94  NIIKLIDTVKDPVSKTPALVFEYINNTDFKQLYQILTDFDIRF-----YMYELLKALDYC 148
Query: 808 HHDCSPLIIHRDVKSNNILLDSDFEA-HVADFGLAKFLQDAGASECMSSVAGSYGYIAPE 866
           H   S  I+HRDVK +N+++D   +   + D+GLA+F     A E    VA  Y +  PE
Sbjct: 149 H---SKGIMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYH--PAQEYNVRVASRY-FKGPE 202
Query: 867 YAYTLKVDEKS-DVYSFGVVLLELIAGKKPVGEFGDGVD 904
                ++ + S D++S G +L  +I  ++P     D  D
Sbjct: 203 LLVDYQMYDYSLDMWSLGCMLASMIFRREPFFHGQDNYD 241

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 30/90 (33%), Positives = 47/90 (52%), Gaps = 8/90 (8%)
Query: 806 YLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAP 865
           YLH   S  +I+RD+K  N+L+D      V DFG AK ++      C     G+  Y+AP
Sbjct: 143 YLH---SLDLIYRDLKPENLLIDEQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAP 194
Query: 866 EYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
           E   +   ++  D ++ GV++ E+ AG  P
Sbjct: 195 EIILSKGYNKAVDWWALGVLIYEMAAGYPP 224

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 30/90 (33%), Positives = 47/90 (52%), Gaps = 8/90 (8%)
Query: 806 YLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAP 865
           YLH   S  +I+RD+K  N+L+D      V DFG AK ++      C     G+  Y+AP
Sbjct: 156 YLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAP 207
Query: 866 EYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
           E   +   ++  D ++ GV++ E+ AG  P
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 30/90 (33%), Positives = 47/90 (52%), Gaps = 8/90 (8%)
Query: 806 YLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAP 865
           YLH   S  +I+RD+K  N+L+D      V DFG AK ++      C     G+  Y+AP
Sbjct: 156 YLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAP 207
Query: 866 EYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
           E   +   ++  D ++ GV++ E+ AG  P
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 30/90 (33%), Positives = 47/90 (52%), Gaps = 8/90 (8%)
Query: 806 YLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAP 865
           YLH   S  +I+RD+K  N+L+D      V DFG AK ++      C     G+  Y+AP
Sbjct: 156 YLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAP 207
Query: 866 EYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
           E   +   ++  D ++ GV++ E+ AG  P
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 43/165 (26%), Positives = 71/165 (43%), Gaps = 12/165 (7%)
Query: 737 LAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRI 796
           L E + L  +    +V+L     +     ++ EY P G +    H  + G          
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEM--FSHLRRIGRFSEPHARFY 146
Query: 797 ALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSV 856
           A +      YLH   S  +I+RD+K  N+++D      V DFG AK ++      C    
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIQVTDFGFAKRVKGRTWXLC---- 199
Query: 857 AGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGD 901
            G+  Y+APE   +   ++  D ++ GV++ E+ AG  P   F D
Sbjct: 200 -GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF--FAD 241

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 30/90 (33%), Positives = 47/90 (52%), Gaps = 8/90 (8%)
Query: 806 YLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAP 865
           YLH   S  +I+RD+K  N+L+D      V DFG AK ++      C     G+  Y+AP
Sbjct: 156 YLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAP 207
Query: 866 EYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
           E   +   ++  D ++ GV++ E+ AG  P
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 30/90 (33%), Positives = 47/90 (52%), Gaps = 8/90 (8%)
Query: 806 YLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAP 865
           YLH   S  +I+RD+K  N+L+D      V DFG AK ++      C     G+  Y+AP
Sbjct: 156 YLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAP 207
Query: 866 EYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
           E   +   ++  D ++ GV++ E+ AG  P
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score = 47.0 bits (110), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 75/159 (47%), Gaps = 15/159 (9%)
Query: 750 NIVRLLGYVSN--RDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYL 807
           NI++L+  V +    T  L++EY+ N    ++        +++        E  K L Y 
Sbjct: 99  NIIKLIDTVKDPVSKTPALVFEYINNTDFKQLYQILTDFDIRF-----YMYELLKALDYC 153
Query: 808 HHDCSPLIIHRDVKSNNILLDSDFEA-HVADFGLAKFLQDAGASECMSSVAGSYGYIAPE 866
           H   S  I+HRDVK +N+++D   +   + D+GLA+F     A E    VA  Y +  PE
Sbjct: 154 H---SKGIMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYH--PAQEYNVRVASRY-FKGPE 207
Query: 867 YAYTLKVDEKS-DVYSFGVVLLELIAGKKPVGEFGDGVD 904
                ++ + S D++S G +L  +I  ++P     D  D
Sbjct: 208 LLVDYQMYDYSLDMWSLGCMLASMIFRREPFFHGQDNYD 246

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 29/95 (30%), Positives = 48/95 (50%), Gaps = 3/95 (3%)
Query: 797 ALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSV 856
           + + A+G+ +L    S   IHRD+ + NILL  +    + DFGLA+ +            
Sbjct: 205 SFQVARGMEFLS---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDT 261
Query: 857 AGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA 891
                ++APE  +      KSDV+S+GV+L E+ +
Sbjct: 262 RLPLKWMAPESIFDKIYSTKSDVWSYGVLLWEIFS 296

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 46.6 bits (109), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 44/163 (26%), Positives = 78/163 (47%), Gaps = 21/163 (12%)
Query: 751 IVRLLGYVSNRDTNLLLYEY-MPNGSLGEMLHGAKGGHLKWE---TRYRIALEAAKGLCY 806
           ++RLL +    D+ +L+ E   P   L + +   + G L+ E   + +   LEA +    
Sbjct: 118 VIRLLDWFERPDSFVLILERPEPVQDLFDFI--TERGALQEELARSFFWQVLEAVRHC-- 173
Query: 807 LHHDCSPLIIHRDVKSNNILLDSDF-EAHVADFGLAKFLQDAGASECMSSVAGSYGYIAP 865
             H+C   ++HRD+K  NIL+D +  E  + DFG    L+D       +   G+  Y  P
Sbjct: 174 --HNCG--VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPP 225
Query: 866 EYAYTLKVDEKS-DVYSFGVVLLELIAGKKPVGEFGDGVDIVR 907
           E+    +   +S  V+S G++L +++ G  P   F    +I+R
Sbjct: 226 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIP---FEHDEEIIR 265

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 46.6 bits (109), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 41/153 (26%), Positives = 65/153 (42%), Gaps = 13/153 (8%)
Query: 750 NIVRLLGYVSN----RDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLC 805
           +IVR++    N    R   L++ E +  G L   +               I     + + 
Sbjct: 77  HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 136
Query: 806 YLHHDCSPLIIHRDVKSNNILLDSDFEAHV---ADFGLAKFLQDAGASECMSSVAGSYGY 862
           YLH   S  I HRDVK  N+L  S     +    DFG AK   +  +   +++   +  Y
Sbjct: 137 YLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHNSLTTPCYTPYY 190
Query: 863 IAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
           +APE     K D+  D++S GV++  L+ G  P
Sbjct: 191 VAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 223

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 46.6 bits (109), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 32/96 (33%), Positives = 50/96 (52%), Gaps = 10/96 (10%)
Query: 806 YLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAP 865
           YLH   S  +I+RD+K  N+L+D      V DFG AK ++          +AG+  Y+AP
Sbjct: 156 YLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLAGTPEYLAP 207
Query: 866 EYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGD 901
           E   +   ++  D ++ GV++ E+ AG  P   F D
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGYPPF--FAD 241

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 46.6 bits (109), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 43/165 (26%), Positives = 71/165 (43%), Gaps = 12/165 (7%)
Query: 737 LAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRI 796
           L E + L  +    +V+L     +     ++ EY P G +    H  + G          
Sbjct: 90  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEM--FSHLRRIGRFSEPHARFY 147
Query: 797 ALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSV 856
           A +      YLH   S  +I+RD+K  N+++D      V DFG AK ++      C    
Sbjct: 148 AAQIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC---- 200
Query: 857 AGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGD 901
            G+  Y+APE   +   ++  D ++ GV++ E+ AG  P   F D
Sbjct: 201 -GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF--FAD 242

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 46.6 bits (109), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 43/165 (26%), Positives = 71/165 (43%), Gaps = 12/165 (7%)
Query: 737 LAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRI 796
           L E + L  +    +V+L     +     ++ EY P G +    H  + G          
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEM--FSHLRRIGRFSEPHARFY 146
Query: 797 ALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSV 856
           A +      YLH   S  +I+RD+K  N+++D      V DFG AK ++      C    
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC---- 199
Query: 857 AGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGD 901
            G+  Y+APE   +   ++  D ++ GV++ E+ AG  P   F D
Sbjct: 200 -GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF--FAD 241

>pdb|4B8C|D Chain D, Nuclease Module Of The Yeast Ccr4-Not Complex Length = 727

Iteration: 1
 Score = 46.6 bits (109), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 27/97 (27%), Positives = 53/97 (54%), Gaps = 15/97 (15%)
Query: 118 LTSLKVFNISGNVFQGNFAGQI-------------VRGMTELQVLDAYNNNFTGPLPVEI 164
           L++L++FNIS N+F+ +F  ++             ++ ++ L+VLD  +N  T  LP E+
Sbjct: 231 LSNLQIFNISANIFKYDFLTRLYLNGNSLTELPAEIKNLSNLRVLDLSHNRLTS-LPAEL 289
Query: 165 ASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLNG 201
            S   L++  F  N  T  +P  +  + +L+++G+ G
Sbjct: 290 GSCFQLKYFYFFDNMVTT-LPWEFGNLCNLQFLGVEG 325

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 46.6 bits (109), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 41/153 (26%), Positives = 65/153 (42%), Gaps = 13/153 (8%)
Query: 750 NIVRLLGYVSN----RDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLC 805
           +IVR++    N    R   L++ E +  G L   +               I     + + 
Sbjct: 76  HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 135
Query: 806 YLHHDCSPLIIHRDVKSNNILLDSDFEAHV---ADFGLAKFLQDAGASECMSSVAGSYGY 862
           YLH   S  I HRDVK  N+L  S     +    DFG AK   +  +   +++   +  Y
Sbjct: 136 YLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHNSLTTPCYTPYY 189
Query: 863 IAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
           +APE     K D+  D++S GV++  L+ G  P
Sbjct: 190 VAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 222

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 46.6 bits (109), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 41/153 (26%), Positives = 65/153 (42%), Gaps = 13/153 (8%)
Query: 750 NIVRLLGYVSN----RDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLC 805
           +IVR++    N    R   L++ E +  G L   +               I     + + 
Sbjct: 78  HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 137
Query: 806 YLHHDCSPLIIHRDVKSNNILLDSDFEAHV---ADFGLAKFLQDAGASECMSSVAGSYGY 862
           YLH   S  I HRDVK  N+L  S     +    DFG AK   +  +   +++   +  Y
Sbjct: 138 YLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHNSLTTPCYTPYY 191
Query: 863 IAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
           +APE     K D+  D++S GV++  L+ G  P
Sbjct: 192 VAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 224

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 46.6 bits (109), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 41/153 (26%), Positives = 65/153 (42%), Gaps = 13/153 (8%)
Query: 750 NIVRLLGYVSN----RDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLC 805
           +IVR++    N    R   L++ E +  G L   +               I     + + 
Sbjct: 86  HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 145
Query: 806 YLHHDCSPLIIHRDVKSNNILLDSDFEAHV---ADFGLAKFLQDAGASECMSSVAGSYGY 862
           YLH   S  I HRDVK  N+L  S     +    DFG AK   +  +   +++   +  Y
Sbjct: 146 YLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHNSLTTPCYTPYY 199
Query: 863 IAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
           +APE     K D+  D++S GV++  L+ G  P
Sbjct: 200 VAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 232

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 38/136 (27%), Positives = 61/136 (44%), Gaps = 12/136 (8%)
Query: 766 LLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNI 825
           ++ EY P G +    H  + G          A +      YLH   S  +I+RD+K  N+
Sbjct: 118 MVMEYAPGGEM--FSHLRRIGRFXEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENL 172
Query: 826 LLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVV 885
           ++D      V DFG AK ++      C     G+  Y+APE   +   ++  D ++ GV+
Sbjct: 173 MIDQQGYIKVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKAVDWWALGVL 227
Query: 886 LLELIAGKKPVGEFGD 901
           + E+ AG  P   F D
Sbjct: 228 IYEMAAGYPPF--FAD 241

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 46.2 bits (108), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 38/115 (33%), Positives = 56/115 (48%), Gaps = 9/115 (7%)
Query: 803 GLCYLHHDCSPLIIHRDVKSNNILLDSD--FEAHVADFGLAK--FLQDAGASECMSSVAG 858
            L YLH+     I HRD+K  N L  ++  FE  + DFGL+K  +  + G    M++ AG
Sbjct: 180 ALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAG 236
Query: 859 SYGYIAPEYAYTLKVD--EKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRK 911
           +  ++APE   T       K D +S GV+L  L+ G  P     D   I + + K
Sbjct: 237 TPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNK 291

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 46.2 bits (108), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 41/153 (26%), Positives = 65/153 (42%), Gaps = 13/153 (8%)
Query: 750 NIVRLLGYVSN----RDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLC 805
           +IVR++    N    R   L++ E +  G L   +               I     + + 
Sbjct: 71  HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 130
Query: 806 YLHHDCSPLIIHRDVKSNNILLDSDFEAHV---ADFGLAKFLQDAGASECMSSVAGSYGY 862
           YLH   S  I HRDVK  N+L  S     +    DFG AK   +  +   +++   +  Y
Sbjct: 131 YLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHNSLTTPCYTPYY 184
Query: 863 IAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
           +APE     K D+  D++S GV++  L+ G  P
Sbjct: 185 VAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 217

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 41/153 (26%), Positives = 65/153 (42%), Gaps = 13/153 (8%)
Query: 750 NIVRLLGYVSN----RDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLC 805
           +IVR++    N    R   L++ E +  G L   +               I     + + 
Sbjct: 116 HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 175
Query: 806 YLHHDCSPLIIHRDVKSNNILLDSDFEAHV---ADFGLAKFLQDAGASECMSSVAGSYGY 862
           YLH   S  I HRDVK  N+L  S     +    DFG AK   +  +   +++   +  Y
Sbjct: 176 YLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHNSLTTPCYTPYY 229
Query: 863 IAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
           +APE     K D+  D++S GV++  L+ G  P
Sbjct: 230 VAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 262
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	982
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-177
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-148
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-115
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-106
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-104
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-101
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	5e-35
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-85
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-81
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-69
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	3e-50
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-32
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	9e-84
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	8e-29
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-06
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	3e-81
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-78
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	7e-50
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	3e-35
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	3e-27
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	7e-08
3soc_A	322	Activin receptor type-2A; structural genomics cons	2e-78
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	3e-78
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	2e-76
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	1e-68
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	1e-62
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-75
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-60
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	8e-25
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	1e-65
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-53
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	5e-50
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-31
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	4e-24
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	1e-63
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	2e-62
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	3e-62
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	3e-61
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	7e-61
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	1e-60
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	1e-59
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	1e-59
3q4u_A	301	Activin receptor type-1; structural genomics conso	1e-56
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	4e-56
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	1e-55
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	8e-55
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	9e-55
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	2e-54
1o6v_A	466	Internalin A; bacterial infection, extracellular r	1e-51
1o6v_A	466	Internalin A; bacterial infection, extracellular r	9e-51
1o6v_A	466	Internalin A; bacterial infection, extracellular r	9e-45
1o6v_A	466	Internalin A; bacterial infection, extracellular r	7e-15
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	2e-47
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	5e-46
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	1e-42
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	5e-39
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	3e-18
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	7e-07
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	1e-45
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	4e-41
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	1e-45
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	4e-45
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	7e-18
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	8e-17
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	9e-12
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	2e-45
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	2e-39
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	5e-35
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	2e-34
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	2e-44
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	5e-39
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	2e-27
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	1e-10
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	2e-06
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	8e-04
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	4e-43
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	7e-41
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	5e-39
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	4e-32
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	2e-41
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	5e-41
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	7e-35
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	2e-34
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	2e-33
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	3e-13
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	7e-40
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	7e-38
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	1e-37
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	9e-32
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	7e-31
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	2e-26
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	2e-23
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	4e-15
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	2e-08
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	1e-36
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	9e-36
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	2e-31
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	1e-36
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	1e-36
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	1e-30
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	9e-30
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	2e-29
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	1e-23
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	2e-19
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	3e-36
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	3e-35
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	3e-35
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	4e-35
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	4e-35
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	1e-34
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	1e-34
2a19_B	284	Interferon-induced, double-stranded RNA-activated	2e-34
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	2e-34
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	3e-34
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	5e-34
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	6e-31
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	3e-22
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	3e-34
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	3e-34
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	6e-25
3ork_A	311	Serine/threonine protein kinase; structural genomi	4e-34
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	5e-34
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	6e-34
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	7e-34
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	7e-34
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	8e-34
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	9e-34
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	1e-33
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	5e-28
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	3e-26
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	2e-22
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	1e-33
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	2e-33
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	2e-33
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	2e-33
3pls_A	298	Macrophage-stimulating protein receptor; protein k	3e-33
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	4e-33
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	5e-33
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	6e-33
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	6e-33
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	7e-33
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	8e-33
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	9e-33
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	9e-33
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	1e-32
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	2e-32
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	2e-32
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	2e-32
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	2e-32
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	2e-32
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	3e-32
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	3e-32
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	3e-32
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	3e-32
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	4e-32
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	6e-32
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	6e-32
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	9e-32
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	9e-32
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	1e-31
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	2e-31
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	2e-31
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	4e-31
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	1e-27
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	3e-26
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	1e-22
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	9e-15
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	4e-31
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	8e-31
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	2e-30
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	2e-27
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	3e-26
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	4e-20
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	3e-30
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	3e-30
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	3e-30
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	5e-23
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	2e-21
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	6e-14
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	3e-11
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	3e-11
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	4e-30
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	4e-30
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	5e-30
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	3e-20
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	1e-19
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	9e-30
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	2e-29
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	9e-29
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	3e-27
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	1e-26
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	6e-23
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	2e-29
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	2e-29
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	8e-29
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	1e-28
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	1e-28
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	2e-28
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	2e-26
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	1e-18
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	1e-28
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	2e-28
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	2e-28
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	2e-28
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	2e-28
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	4e-28
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	7e-28
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	9e-28
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	1e-27
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	1e-27
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	1e-27
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	2e-27
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	3e-27
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	4e-27
3fme_A	290	Dual specificity mitogen-activated protein kinase;	7e-27
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	1e-26
4aoj_A	329	High affinity nerve growth factor receptor; transf	2e-26
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	2e-26
3aln_A	327	Dual specificity mitogen-activated protein kinase;	2e-26
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	2e-26
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	3e-26
3an0_A	340	Dual specificity mitogen-activated protein kinase;	3e-26
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	6e-26
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	7e-26
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	1e-25
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	1e-25
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	1e-25
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	2e-25
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	2e-25
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	3e-25
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	3e-25
2dyl_A	318	Dual specificity mitogen-activated protein kinase	3e-25
3uqc_A	286	Probable conserved transmembrane protein; structur	3e-25
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	5e-25
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	7e-25
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	8e-25
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	9e-25
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	1e-24
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	2e-24
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	2e-24
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	2e-24
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	5e-24
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	6e-24
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	1e-23
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	3e-23
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	4e-23
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	1e-22
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	2e-21
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	5e-17
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	8e-13
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	1e-04
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	4e-23
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	6e-23
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	6e-23
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	2e-22
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	3e-22
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	5e-22
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	9e-22
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	2e-06
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	1e-22
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	3e-22
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	4e-22
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	5e-22
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	1e-21
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	5e-21
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	7e-21
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	2e-18
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	5e-22
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	6e-22
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	7e-22
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	7e-22
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	8e-22
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	8e-22
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	9e-22
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	9e-22
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	1e-21
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	2e-21
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	2e-21
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	2e-20
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	5e-18
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	1e-17
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	2e-21
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	5e-21
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	4e-19
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	5e-19
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	5e-15
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	9e-21
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	1e-20
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	1e-20
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	1e-20
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	1e-17
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	1e-20
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	1e-20
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	2e-20
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	2e-20
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	2e-20
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	6e-19
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	3e-17
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	2e-15
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	2e-06
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	3e-20
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	6e-20
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	8e-18
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	3e-16
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	8e-15
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	1e-05
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	5e-20
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	5e-20
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	1e-19
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	1e-19
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	2e-19
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	1e-18
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	6e-17
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	6e-17
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	8e-17
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	1e-19
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	1e-19
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	3e-15
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	1e-14
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	2e-14
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	5e-11
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	7e-09
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	4e-06
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	2e-19
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	1e-17
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	3e-17
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	2e-19
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	2e-19
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	2e-19
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	4e-19
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	5e-19
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	8e-19
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	8e-19
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	1e-18
3bhy_A	283	Death-associated protein kinase 3; death associate	1e-18
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	1e-18
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	2e-18
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	3e-18
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	4e-18
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	4e-18
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	5e-18
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	1e-17
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	1e-17
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	3e-17
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	4e-17
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	4e-17
3niz_A	311	Rhodanese family protein; structural genomics, str	4e-17
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	4e-17
3o0g_A	292	Cell division protein kinase 5; kinase activator c	4e-17
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	5e-17
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	8e-17
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	1e-16
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	1e-16
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	5e-16
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	6e-15
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	2e-13
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	3e-12
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	4e-11
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	9e-10
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	1e-05
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	2e-04
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	1e-16
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	3e-15
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	2e-14
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	3e-14
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	2e-13
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	1e-04
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	2e-16
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	2e-16
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	3e-16
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	3e-16
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	4e-16
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	6e-16
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	7e-16
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	7e-16
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	7e-16
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	8e-16
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	8e-16
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	1e-15
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	2e-15
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	3e-15
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	2e-13
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	1e-11
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	7e-06
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	9e-16
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	3e-15
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	3e-15
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	7e-15
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	7e-13
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	2e-05
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	5e-05
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	1e-15
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	1e-13
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	6e-13
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	6e-12
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	2e-15
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	2e-15
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	3e-15
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	3e-15
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	3e-15
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	3e-15
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	4e-15
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	3e-14
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	5e-14
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	8e-13
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	8e-08
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	6e-06
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	4e-15
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	5e-15
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	6e-15
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	1e-14
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	1e-14
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	2e-14
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	2e-14
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	3e-12
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	4e-11
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	2e-14
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	3e-14
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	3e-14
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	4e-14
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	8e-14
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	1e-13
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	2e-13
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	2e-13
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	2e-13
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	2e-13
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	2e-13
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	3e-13
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	3e-13
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	4e-13
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	5e-13
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	5e-13
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	7e-13
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	8e-13
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	9e-13
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	1e-12
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	9e-12
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	3e-10
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	4e-10
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	7e-10
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	9e-04
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	2e-12
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	2e-09
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	2e-09
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	4e-09
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	1e-07
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	7e-06
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	8e-06
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	4e-12
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	4e-12
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	7e-12
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	9e-12
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	1e-10
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	4e-07
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	4e-06
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	4e-12
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-10
3rp9_A	458	Mitogen-activated protein kinase; structural genom	1e-11
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	1e-11
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-07
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	2e-11
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	3e-11
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	3e-08
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	3e-07
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	3e-10
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	8e-10
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	1e-07
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	2e-06
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	4e-04
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	1e-09
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	6e-09
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	2e-08
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	2e-08
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	2e-04
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	2e-09
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	3e-09
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	7e-09
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	3e-08
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	3e-08
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	9e-07
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-06
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-05
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	4e-04
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	4e-04
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	3e-08
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	4e-07
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	5e-07
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	2e-06
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	4e-06
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	1e-05
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	2e-05
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	2e-05
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	3e-08
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	4e-08
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	5e-08
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	5e-08
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	8e-05
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	4e-04
3m19_A	251	Variable lymphocyte receptor A diversity region; a	1e-07
3m19_A	251	Variable lymphocyte receptor A diversity region; a	1e-07
3m19_A	251	Variable lymphocyte receptor A diversity region; a	3e-05
3m19_A	251	Variable lymphocyte receptor A diversity region; a	5e-05
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	1e-07
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	2e-07
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	1e-05
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-07
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-06
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-05
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-05
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	3e-04
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	8e-04
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	2e-07
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	3e-07
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	2e-06
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	2e-05
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	9e-07
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	1e-06
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	1e-06
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	2e-06
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	2e-05
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	2e-05
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	3e-06
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	3e-06
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	9e-06
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	3e-06
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	5e-06
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	4e-05
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	9e-05
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	7e-04
3e6j_A	229	Variable lymphocyte receptor diversity region; var	5e-06
3e6j_A	229	Variable lymphocyte receptor diversity region; var	6e-05
3e6j_A	229	Variable lymphocyte receptor diversity region; var	3e-04
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	1e-05
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	6e-05
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	4e-04
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	2e-05
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	4e-05
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	8e-05
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	1e-04
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	2e-04
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	3e-04
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	3e-04
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	8e-04
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	5e-04
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	8e-04
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	8e-04

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  532 bits (1373), Expect = e-177
 Identities = 182/571 (31%), Positives = 267/571 (46%), Gaps = 22/571 (3%)

Query: 71  SRVVSLNVSFMPLFGSIPPEIGLLTKLVNLTISNVNLTGRLPSEMALLTSLKVFNISGNV 130
             +  L+VS       IP  +G  + L +L IS   L+G     ++  T LK+ NIS N 
Sbjct: 200 VNLEFLDVSSNNFSTGIP-FLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQ 258

Query: 131 FQGNFAGQIVRGMTELQVLDAYNNNFTGPLPVEIA-SLKSLRHLSFGGNYFTGKIPQSYS 189
           F G         +  LQ L    N FTG +P  ++ +  +L  L   GN+F G +P  + 
Sbjct: 259 FVGPIPPLP---LKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFG 315

Query: 190 EIQSLEYIGLNGIGLNGTVPA-FLSRLKNLREMYIGYFNTYTGGIPPGFGALT-QLQVLD 247
               LE + L+    +G +P   L +++ L+ + + + N ++G +P     L+  L  LD
Sbjct: 316 SCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSF-NEFSGELPESLTNLSASLLTLD 374

Query: 248 MASCNISGEIPTSLSRLKL--LHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEI 305
           ++S N SG I  +L +     L  L+LQ N  TG IPP LS    L SL LS NYL+G I
Sbjct: 375 LSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTI 434

Query: 306 PESFAALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLI 365
           P S  +L  L  L+L+ N L G IP  L     LE L +  N+ T E+P  L     L  
Sbjct: 435 PSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNW 494

Query: 366 LDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGTI 425
           + +++N LTG IP+ + +   L  L L  N F G IP ELG C+SL  +  + N  NGTI
Sbjct: 495 ISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTI 554

Query: 426 PAGLFNLPLLNMMELDDNLLSGELPEKMSGASLNQLKVANNN---ITGKIPAAIGNLPSL 482
           PA +F         +  N ++G+    +    + +      N     G     +  L + 
Sbjct: 555 PAAMFKQSGK----IAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTR 610

Query: 483 NILSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYG 542
           N  ++ +    G       N   +  +++S N +SG IP  I     L  ++L  N + G
Sbjct: 611 NPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISG 670

Query: 543 KIPPGISKLIDLSILNLSRNGITGSIPNEMRNMMSLTTLDLSYNNLIGNIPSGGQFLAFN 602
            IP  +  L  L+IL+LS N + G IP  M  +  LT +DLS NNL G IP  GQF  F 
Sbjct: 671 SIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFP 730

Query: 603 ETSFIGNPNLC---LLRNGTCQSLINSAKHS 630
              F+ NP LC   L R     +  +   H 
Sbjct: 731 PAKFLNNPGLCGYPLPRCDPSNA--DGYAHH 759

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  457 bits (1177), Expect = e-148
 Identities = 182/617 (29%), Positives = 277/617 (44%), Gaps = 47/617 (7%)

Query: 23  SCAYSDMDVLLKLKSSMIGPKGSGLKNWEPSSSPSAHCSFSGVTCDQDSRVVSLNVSFMP 82
              Y ++  L+  K  +     + L +W  + +P   C+F GVTC  D +V S+++S  P
Sbjct: 8   QSLYREIHQLISFKDVLPDK--NLLPDWSSNKNP---CTFDGVTCR-DDKVTSIDLSSKP 61

Query: 83  L---FGSIPPEIGLLTKLVNLTISNVNLTGRLPSEMALLTSLKVFNISGNVFQGNF-AGQ 138
           L   F ++   +  LT L +L +SN ++ G +        SL   ++S N   G      
Sbjct: 62  LNVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLDLSRNSLSGPVTTLT 120

Query: 139 IVRGMTELQVLDAYNNNFTGPLPVEI-ASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYI 197
            +   + L+ L+  +N    P  V     L SL  L    N  +G     +         
Sbjct: 121 SLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWV-------- 172

Query: 198 GLNGIGLNGTVPAFLSRLKNLREMYIGYFNTYTGGIPPGFGALTQLQVLDMASCNISGEI 257
                               L+ + I   N  +G +         L+ LD++S N S  I
Sbjct: 173 -------------LSDGCGELKHLAISG-NKISGDVD--VSRCVNLEFLDVSSNNFSTGI 216

Query: 258 PTSLSRLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTL 317
           P  L     L  L +  NKL+G     +S    LK L++S N   G IP     LK+L  
Sbjct: 217 P-FLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQY 273

Query: 318 LQLFKNNLRGPIPSFL-GDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGT 376
           L L +N   G IP FL G    L  L + GN+F   +P   G    L  L ++SN+ +G 
Sbjct: 274 LSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGE 333

Query: 377 IPRD-LCKGGKLKSLILMQNFFIGPIPEELGQCK-SLTKIRFSKNYLNGTIPAGLFNLPL 434
           +P D L K   LK L L  N F G +PE L     SL  +  S N  +G I   L   P 
Sbjct: 334 LPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPK 393

Query: 435 LNMMELD--DNLLSGELPEKMSGAS-LNQLKVANNNITGKIPAAIGNLPSLNILSLQNNR 491
             + EL   +N  +G++P  +S  S L  L ++ N ++G IP+++G+L  L  L L  N 
Sbjct: 394 NTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNM 453

Query: 492 LEGEIPVESFNLKMITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYGKIPPGISKL 551
           LEGEIP E   +K + ++ +  N+++GEIP  +S C +L  + LS N L G+IP  I +L
Sbjct: 454 LEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRL 513

Query: 552 IDLSILNLSRNGITGSIPNEMRNMMSLTTLDLSYNNLIGNIPS--GGQFLAFNETSFIGN 609
            +L+IL LS N  +G+IP E+ +  SL  LDL+ N   G IP+    Q          G 
Sbjct: 514 ENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGK 573

Query: 610 PNLCLLRNGTCQSLINS 626
             + +  +G  +    +
Sbjct: 574 RYVYIKNDGMKKECHGA 590

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  355 bits (914), Expect = e-115
 Identities = 120/281 (42%), Positives = 160/281 (56%), Gaps = 15/281 (5%)

Query: 696 DENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLL 755
           ++NI+G+GG G VY+G + DG  VA+KRL    T G +  F  E++ +    HRN++RL 
Sbjct: 34  NKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLR 93

Query: 756 GYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGH--LKWETRYRIALEAAKGLCYLHHDCSP 813
           G+       LL+Y YM NGS+   L         L W  R RIAL +A+GL YLH  C P
Sbjct: 94  GFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDP 153

Query: 814 LIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKV 873
            IIHRDVK+ NILLD +FEA V DFGLAK L D   +   ++V G+ G+IAPEY  T K 
Sbjct: 154 KIIHRDVKAANILLDEEFEAVVGDFGLAK-LMDYKDTHVTTAVRGTIGHIAPEYLSTGKS 212

Query: 874 DEKSDVYSFGVVLLELIAGKKPV----GEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVV 929
            EK+DV+ +GV+LLELI G++          D V ++ WV+    E         + A+V
Sbjct: 213 SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE-------KKLEALV 265

Query: 930 DPRLSG-YPLTGVIHLFKVAMMCVEDESSARPTMREVVHML 969
           D  L G Y    V  L +VA++C +     RP M EVV ML
Sbjct: 266 DVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  332 bits (854), Expect = e-106
 Identities = 98/279 (35%), Positives = 149/279 (53%), Gaps = 16/279 (5%)

Query: 696 DENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLL 755
            + +IG G  G VY+G + DG  VA+KR     + G +  F  EI+TL   RH ++V L+
Sbjct: 43  HKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEE-FETEIETLSFCRHPHLVSLI 101

Query: 756 GYVSNRDTNLLLYEYMPNGSLGEMLHGAKG--GHLKWETRYRIALEAAKGLCYLHHDCSP 813
           G+   R+  +L+Y+YM NG+L   L+G+      + WE R  I + AA+GL YLH     
Sbjct: 102 GFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA-- 159

Query: 814 LIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKV 873
            IIHRDVKS NILLD +F   + DFG++K   +   +   + V G+ GYI PEY    ++
Sbjct: 160 -IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRL 218

Query: 874 DEKSDVYSFGVVLLELIAGKKPV--GEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDP 931
            EKSDVYSFGVVL E++  +  +      + V++  W  ++        +   +  +VDP
Sbjct: 219 TEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESH-------NNGQLEQIVDP 271

Query: 932 RLSG-YPLTGVIHLFKVAMMCVEDESSARPTMREVVHML 969
            L+       +      A+ C+   S  RP+M +V+  L
Sbjct: 272 NLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  325 bits (836), Expect = e-104
 Identities = 94/276 (34%), Positives = 150/276 (54%), Gaps = 15/276 (5%)

Query: 698 NIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHG---FLAEIQTLGRIRHRNIVRL 754
           N +G+GG G+VY+G + +   VA+K+L        +     F  EI+ + + +H N+V L
Sbjct: 37  NKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVEL 95

Query: 755 LGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGG-HLKWETRYRIALEAAKGLCYLHHDCSP 813
           LG+ S+ D   L+Y YMPNGSL + L    G   L W  R +IA  AA G+ +LH +   
Sbjct: 96  LGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH-- 153

Query: 814 LIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKV 873
             IHRD+KS NILLD  F A ++DFGLA+  +    +   S + G+  Y+APE     ++
Sbjct: 154 -HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEA-LRGEI 211

Query: 874 DEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDPRL 933
             KSD+YSFGVVLLE+I G   V E  +   ++    +         +  ++   +D ++
Sbjct: 212 TPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEE------IEDEEKTIEDYIDKKM 265

Query: 934 SGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHML 969
           +    T V  ++ VA  C+ ++ + RP +++V  +L
Sbjct: 266 NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLL 301

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  330 bits (849), Expect = e-101
 Identities = 103/629 (16%), Positives = 200/629 (31%), Gaps = 78/629 (12%)

Query: 28  DMDVLLKLKSSMIGPKGSG-------LKNWEPSSSPSAHCSFSGVTCDQDSRVVSLNVSF 80
           D   L ++  ++ G   S          NW  +       +  GV+ + + RV  L++  
Sbjct: 31  DYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKELDMWGAQPGVSLNSNGRVTGLSLEG 90

Query: 81  MPLFGSIPPEIGLLTKLVNLTISNVNLTG----RLPSEMALLTSLKVFNISGNVFQGNFA 136
               G +P  IG LT+L  L + +           P  ++   S +        +Q  F 
Sbjct: 91  FGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFV 150

Query: 137 GQIVRG-MTELQVLDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQSLE 195
               R   ++L      ++     +            +    N  T  + ++   +  L 
Sbjct: 151 DYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLR 209

Query: 196 YIGLNGIGLNGTVPAFLSRLKNLREMYIGYFNTYTGGIPPGFGALTQLQVLDMASCNISG 255
              +                +N        +          +  L  L  +++ +C    
Sbjct: 210 QFYMGNSPFVAENICEAWENENSE------YAQQYKTEDLKWDNLKDLTDVEVYNCPNLT 263

Query: 256 EIPTSLSRLKLLHSLFLQMNKLT--------GHIPPQLSGLISLKSLDLSLNYL-TGEIP 306
           ++PT L  L  +  + +  N+                      ++ + +  N L T  + 
Sbjct: 264 KLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVE 323

Query: 307 ESFAALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRN-GKLLI 365
            S   +K L +L+   N L G +P+F G    L  L +  N  T E+P N      ++  
Sbjct: 324 TSLQKMKKLGMLECLYNQLEGKLPAF-GSEIKLASLNLAYNQIT-EIPANFCGFTEQVEN 381

Query: 366 LDVTSNHLTGTIPRDLCKGG--KLKSLILMQNFF-------IGPIPEELGQCKSLTKIRF 416
           L    N L   IP          + ++    N           P+     +  +++ I  
Sbjct: 382 LSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINL 440

Query: 417 SKNYLNGTIPAGLFNLPLLNMMELDDNLLSGELPEKMSGASLNQLKVANNNITGKIPAAI 476
           S N ++            L+ + L  N+L+  +P+               N         
Sbjct: 441 SNNQISKFPKELFSTGSPLSSINLMGNMLTE-IPK---------------NSLKDENENF 484

Query: 477 GNLPSLNILSLQNNRLEGEIPVESF--NLKMITSINISDNNISGEIPYSISQCHSLTS-- 532
            N   L  + L+ N+L   +  +     L  +  I++S N+ S   P       +L    
Sbjct: 485 KNTYLLTSIDLRFNKLTK-LSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFG 542

Query: 533 ----VDLSRNSLYGKIPPGISKLIDLSILNLSRNGITGSIPNEMRNMMSLTTLDLSYNNL 588
                D   N    + P GI+    L+ L +  N I   +  ++    +++ LD+  N  
Sbjct: 543 IRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIR-KVNEKI--TPNISVLDIKDNPN 599

Query: 589 IGNIPS--------GGQFLAFNETSFIGN 609
           I    S        G   L +++T  I  
Sbjct: 600 ISIDLSYVCPYIEAGMYMLFYDKTQDIRG 628

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  141 bits (357), Expect = 5e-35
 Identities = 36/307 (11%), Positives = 91/307 (29%), Gaps = 40/307 (13%)

Query: 305 IPESFAALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPEN-----LGR 359
           +  +   +K+   L+   + L G   S  G          W  N   ++        L  
Sbjct: 22  LSRTAEYIKDYLALKEIWDALNGKNWSQQGFGTQPGAN--WNFNKELDMWGAQPGVSLNS 79

Query: 360 NGKLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFIGP----IPEELGQCKSLTKIR 415
           NG++  L +     +G +P  + +  +L+ L L  +          P+ +    S  + +
Sbjct: 80  NGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQ 139

Query: 416 FSKNYLNGTIPAGLFNLPLLNMMELDDNLLSGELPEKMSGASLNQLKVANNNITGKIPAA 475
             + +   T           ++++   N                     ++     I  +
Sbjct: 140 KMRMHYQKTFVDYDPREDFSDLIKDCIN---------------------SDPQQKSIKKS 178

Query: 476 IGNLPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIPYSISQCHSLTSVDL 535
                    +   +N +   +      L  +    + ++    E       C +  + + 
Sbjct: 179 SRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENI-----CEAWENENS 232

Query: 536 SRNSLYGKIPPGISKLIDLSILNLSRNGITGSIPNEMRNMMSLTTLDLSYNNLIG--NIP 593
                Y         L DL+ + +        +P  ++ +  +  ++++ N  I    + 
Sbjct: 233 EYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLK 292

Query: 594 SGGQFLA 600
              Q LA
Sbjct: 293 DDWQALA 299

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  289 bits (741), Expect = 1e-85
 Identities = 109/545 (20%), Positives = 190/545 (34%), Gaps = 36/545 (6%)

Query: 86  SIPPEIGLLTKLVNLTISNVNLTGRLPSEMALLTSLKVFNISGNVFQGNFAGQIVRGMTE 145
            +P    L T +  L +++  L     +     + L   ++  N           + +  
Sbjct: 18  QVPD--DLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELC-QKLPM 74

Query: 146 LQVLDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLNGIGLN 205
           L+VL+  +N  +       A   +L  L    N         + + ++L  + L+  GL+
Sbjct: 75  LKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLS 134

Query: 206 GTVPAFLSRLKNLREMYIGYFNTYTGGIPPGFGAL--TQLQVLDMASCNISGEIPTSLSR 263
            T      +L+NL+E+ +   N               + L+ L+++S  I    P     
Sbjct: 135 STKLGTQVQLENLQELLLSN-NKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHA 193

Query: 264 LKLLHSLFLQMNKLTGHIPPQLS---GLISLKSLDLSLNYLTGEIPESFAALK--NLTLL 318
           +  L  LFL   +L   +  +L       S+++L LS + L+     +F  LK  NLT+L
Sbjct: 194 IGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTML 253

Query: 319 QLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTIP 378
            L  NNL           P LE   +  NN       +L     +  L++  +       
Sbjct: 254 DLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRS------- 306

Query: 379 RDLCKGGKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMM 438
                        +                K L  +    N + G        L  L  +
Sbjct: 307 --------FTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYL 358

Query: 439 ELDDNLLS-----GELPEKMSGASLNQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLE 493
            L ++  S      E    ++ + L+ L +  N I+     A   L  L +L L  N + 
Sbjct: 359 SLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIG 418

Query: 494 GEIPVESF-NLKMITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYG--KIPPGISK 550
            E+  + +  L+ I  I +S N        S +   SL  + L R +L      P     
Sbjct: 419 QELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQP 478

Query: 551 LIDLSILNLSRNGITGSIPNEMRNMMSLTTLDLSYNNLIGNIPSGGQFLAFNETSFIGNP 610
           L +L+IL+LS N I     + +  +  L  LDL +NNL                   G  
Sbjct: 479 LRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNL--ARLWKHANPGGPIYFLKGLS 536

Query: 611 NLCLL 615
           +L +L
Sbjct: 537 HLHIL 541

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  278 bits (712), Expect = 1e-81
 Identities = 96/556 (17%), Positives = 178/556 (32%), Gaps = 34/556 (6%)

Query: 71  SRVVSLNVSFMPLFGSIPPEIGLLTKLVNLTISNVNLTGRLPSEMALLTSLKVFNISGNV 130
           S++ SL+V F  +    P     L  L  L + +  L+       A  T+L   ++  N 
Sbjct: 49  SQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNS 108

Query: 131 FQGNFAGQIVRGMTELQVLDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQ--SY 188
            Q             L  LD  +N  +         L++L+ L    N       +    
Sbjct: 109 IQKIKNNPF-VKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDI 167

Query: 189 SEIQSLEYIGLNGIGLNGTVPAFLSRLKNLREMYIGYFNTYTGGIPPGFG---ALTQLQV 245
               SL+ + L+   +    P     +  L  +++         +        A T ++ 
Sbjct: 168 FANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNN-VQLGPSLTEKLCLELANTSIRN 226

Query: 246 LDMASCNISGEIPTSLSRLKL--LHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTG 303
           L +++  +S    T+   LK   L  L L  N L        + L  L+   L  N +  
Sbjct: 227 LSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQH 286

Query: 304 EIPESFAALKNLTLLQLFKN---------NLRGPIPSFLGDFPNLEVLQVWGNNFTFELP 354
               S   L N+  L L ++         +L             LE L +  N+      
Sbjct: 287 LFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKS 346

Query: 355 ENLGRNGKLLILDVTSNHLT-GTIPRDLCKG---GKLKSLILMQNFFIGPIPEELGQCKS 410
                   L  L ++++  +  T+  +         L  L L +N       +       
Sbjct: 347 NMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGH 406

Query: 411 LTKIRFSKNYLNGTIPAGLF-NLPLLNMMELDDNLLSGELPEKMSGA-SLNQLKVANNNI 468
           L  +    N +   +    +  L  +  + L  N          +   SL +L +    +
Sbjct: 407 LEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVAL 466

Query: 469 TG--KIPAAIGNLPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNIS--------G 518
                 P+    L +L IL L NN +          L+ +  +++  NN++        G
Sbjct: 467 KNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPG 526

Query: 519 EIPYSISQCHSLTSVDLSRNSLYGKIPPGISKLIDLSILNLSRNGITGSIPNEMRNMMSL 578
              Y +     L  ++L  N            L +L I++L  N +     +   N +SL
Sbjct: 527 GPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSL 586

Query: 579 TTLDLSYNNLIGNIPS 594
            +L+L  N +      
Sbjct: 587 KSLNLQKNLITSVEKK 602

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  244 bits (625), Expect = 1e-69
 Identities = 89/491 (18%), Positives = 169/491 (34%), Gaps = 60/491 (12%)

Query: 144 TELQVLDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLNGIG 203
              +V D  +   T  +P ++    ++  L+   N        +                
Sbjct: 4   VSHEVADCSHLKLTQ-VPDDL--PTNITVLNLTHNQLRRLPAAN---------------- 44

Query: 204 LNGTVPAFLSRLKNLREMYIGYFNTYTGGIPPGFGALTQLQVLDMASCNISGEIPTSLSR 263
                    +R   L  + +G+ NT +   P     L  L+VL++    +S     + + 
Sbjct: 45  --------FTRYSQLTSLDVGF-NTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAF 95

Query: 264 LKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQLFKN 323
              L  L L  N +            +L +LDLS N L+     +   L+NL  L L  N
Sbjct: 96  CTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNN 155

Query: 324 NLRGPIPSFLGDFPN--LEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDL 381
            ++      L  F N  L+ L++  N      P      G+L  L + +  L  ++   L
Sbjct: 156 KIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKL 215

Query: 382 CKGG---KLKSLILMQNFFIGPIPEELGQCK--SLTKIRFSKNYLNGTIPAGLFNLPLLN 436
           C       +++L L  +             K  +LT +  S N LN         LP L 
Sbjct: 216 CLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLE 275

Query: 437 MMELDDNLLSGELPEKMSGAS----------LNQLKVANNNITGKIPAAIGNLPSLNILS 486
              L+ N +       + G              +  ++  ++      +   L  L  L+
Sbjct: 276 YFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLN 335

Query: 487 LQNNRLEGEIPVESFNLKMITSINISDNNISGEIPYSIS----QCHSLTSVDLSRNSLYG 542
           +++N + G        L  +  +++S++  S     + +        L  ++L++N +  
Sbjct: 336 MEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISK 395

Query: 543 KIPPGISKLIDLSILNLSRNGITGSIPNEM-RNMMSLTTLDLSYNNLIGNIPSGGQFLAF 601
                 S L  L +L+L  N I   +  +  R + ++  + LSYN  +    +       
Sbjct: 396 IESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRN------- 448

Query: 602 NETSFIGNPNL 612
              SF   P+L
Sbjct: 449 ---SFALVPSL 456

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  188 bits (480), Expect = 3e-50
 Identities = 77/460 (16%), Positives = 140/460 (30%), Gaps = 86/460 (18%)

Query: 69  QDSRVVSLNVSFMPLFGSIPPEIGLLTKLVNLTISNVNLTGRLPSEMALLTSLKVFNISG 128
           + + +  L++S+  L          L +L    +   N+       +  L +++  N+  
Sbjct: 246 KWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKR 305

Query: 129 NVFQGNFAGQIVRGMTELQVLDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSY 188
           +                         +           LK L HL+   N   G     +
Sbjct: 306 S----------------FTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMF 349

Query: 189 SEIQSLEYIGL--NGIGLNGTVPAFLSRLKNLREMYIGYFNTYTGGIPPGFGALTQLQVL 246
           + + +L+Y+ L  +   L          L +                       + L +L
Sbjct: 350 TGLINLKYLSLSNSFTSLRTLTNETFVSLAH-----------------------SPLHIL 386

Query: 247 DMASCNISGEIPTSLSRLKLLHSLFLQMNKLTGHIPPQ-LSGLISLKSLDLSLNYLTGEI 305
           ++    IS     + S L  L  L L +N++   +  Q   GL ++  + LS N      
Sbjct: 387 NLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLT 446

Query: 306 PESFAALKNLTLLQLFKNNLRG--PIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKL 363
             SFA + +L  L L +  L+     PS      NL +L +  NN      + L    KL
Sbjct: 447 RNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKL 506

Query: 364 LILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNG 423
            ILD+  N+L                  L ++   G     L     L  +    N  + 
Sbjct: 507 EILDLQHNNLA----------------RLWKHANPGGPIYFLKGLSHLHILNLESNGFDE 550

Query: 424 TIPAGLFNLPLLNMMELDDNLLSGELPEKMSGASLNQLKVANNNITGKIPAAIGNLPSLN 483
                  +L                         L  + +  NN+     +   N  SL 
Sbjct: 551 IPVEVFKDLF-----------------------ELKIIDLGLNNLNTLPASVFNNQVSLK 587

Query: 484 ILSLQNNRLEGEIPVESF--NLKMITSINISDNNISGEIP 521
            L+LQ N +      + F    + +T +++  N       
Sbjct: 588 SLNLQKNLITSVEK-KVFGPAFRNLTELDMRFNPFDCTCE 626

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  133 bits (338), Expect = 2e-32
 Identities = 52/291 (17%), Positives = 103/291 (35%), Gaps = 15/291 (5%)

Query: 94  LTKLVNLTISNVNLTGRLPSEMALLTSLKVFNISGNVFQGNFAGQIVRGMTELQVLDAYN 153
            + L  L ++   ++       + L  L+V ++  N       GQ  RG+  +  +    
Sbjct: 380 HSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSY 439

Query: 154 NNFTGPLPVEIASLKSLRHLSFGGNYFTG--KIPQSYSEIQSLEYIGLNGIGLNGTVPAF 211
           N +        A + SL+ L             P  +  +++L  + L+   +       
Sbjct: 440 NKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDM 499

Query: 212 LSRLKNLREMYIGY-------FNTYTGGIPPGFGALTQLQVLDMASCNISGEIPTSLSRL 264
           L  L+ L  + + +        +   GG       L+ L +L++ S             L
Sbjct: 500 LEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDL 559

Query: 265 KLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFA-ALKNLTLLQLFKN 323
             L  + L +N L        +  +SLKSL+L  N +T    + F  A +NLT L +  N
Sbjct: 560 FELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFN 619

Query: 324 NLRGPIPS--FLGDFPNLEVLQVWG--NNFTFELPENLGRNGKLLILDVTS 370
                  S  +  ++ N     +    +++    P +      + + D +S
Sbjct: 620 PFDCTCESIAWFVNWINETHTNIPELSSHYLCNTPPHY-HGFPVRLFDTSS 669

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  288 bits (739), Expect = 9e-84
 Identities = 99/612 (16%), Positives = 190/612 (31%), Gaps = 67/612 (10%)

Query: 27  SDMDVLLKLKSSMIGPK----------GSGLKNWEPSSSPSAHCSFSGVTCDQDSRVVSL 76
            D   L  +  ++ G                 NW  +          GV  D + RV  L
Sbjct: 269 KDYKALKAIWEALDGKNWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGL 328

Query: 77  NVSFMPLFGSIPPEIGLLTKLVNLTISNVNLTGRLPSEMALLTSLKVFNISGNVFQGNFA 136
           +++     G +P  IG LT+L  L+    + T           +  +     +  + ++ 
Sbjct: 329 SLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYK 388

Query: 137 GQIVRGMTELQVLDAYNNNFTG---PLPVEIASLKSLRHLSFGGNY-FTGKIPQSYSEIQ 192
              +     L + D   +         P++  S  SL+    G        I ++   + 
Sbjct: 389 KMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLT 448

Query: 193 SLEYIGLNGIGLNGTVPAFLSRLKNLREMYIGYFNTYTGGIPPGFGALTQLQVLDMASCN 252
            L+ I            A      N        +          +  L  L  +++ +C 
Sbjct: 449 KLQIIYFANSPFTYDNIAVDWEDANSD------YAKQYENEELSWSNLKDLTDVELYNCP 502

Query: 253 ISGEIPTSLSRLKLLHSLFLQMNKLTG---------HIPPQLSGLISLKSLDLSLNYLTG 303
              ++P  L  L  L SL +  N+             +         ++   +  N L  
Sbjct: 503 NMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE- 561

Query: 304 EIPES--FAALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRN- 360
           E P S     +  L LL    N +R  + +F G    L  L++  N    E+PE+     
Sbjct: 562 EFPASASLQKMVKLGLLDCVHNKVRH-LEAF-GTNVKLTDLKLDYNQIE-EIPEDFCAFT 618

Query: 361 GKLLILDVTSNHLTGTIPRDLCKGG--KLKSLILMQNFFIGPIPE-----ELGQCKSLTK 413
            ++  L  + N L   IP          + S+    N             +  +  + + 
Sbjct: 619 DQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINAST 677

Query: 414 IRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLSGELPEKMSGA---------SLNQLKVA 464
           +  S N +             ++ + L +NL++  +PE               L  + + 
Sbjct: 678 VTLSYNEIQKFPTELFATGSPISTIILSNNLMT-SIPENSLKPKDGNYKNTYLLTTIDLR 736

Query: 465 NNNITGKIPAAI--GNLPSLNILSLQNNRLEGEIPVESFNLKMITSINI------SDNNI 516
            N +T  +        LP L+ + +  N      P +  N   + +  I        N I
Sbjct: 737 FNKLTS-LSDDFRATTLPYLSNMDVSYNCFS-SFPTQPLNSSQLKAFGIRHQRDAEGNRI 794

Query: 517 SGEIPYSISQCHSLTSVDLSRNSLYGKIPPGISKLIDLSILNLSRNGITGSIPNEMRNMM 576
             + P  I+ C SL  + +  N +  K+   +     L IL+++ N         +   +
Sbjct: 795 LRQWPTGITTCPSLIQLQIGSNDI-RKVDEKL--TPQLYILDIADNPNISIDVTSVCPYI 851

Query: 577 SLTTLDLSYNNL 588
                 L Y+  
Sbjct: 852 EAGMYVLLYDKT 863

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  123 bits (310), Expect = 8e-29
 Identities = 45/322 (13%), Positives = 94/322 (29%), Gaps = 44/322 (13%)

Query: 304 EIPESFAALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQV-WGNNFTFELPEN-----L 357
           ++ E+   +K+   L+     L G    +     N  +  + W  N   ++  +     L
Sbjct: 260 QLKETAEYIKDYKALKAIWEALDGKNWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDL 319

Query: 358 GRNGKLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFIGPIPEELGQCKSLTKIRFS 417
             NG++  L +      G +P  + +  +LK L    +           +  +       
Sbjct: 320 DNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEER 379

Query: 418 KNYLNGTIPAG-LFNLPLLNMMELDDNLLSGEL------PEKMSGASLNQLKVANNNITG 470
           K+ +        L     LN+ +L  + ++          +        Q+    N IT 
Sbjct: 380 KHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF 439

Query: 471 KIPAAIGNLPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIPYSISQCHSL 530
            I  AI  L  L I+   N+    +                                   
Sbjct: 440 -ISKAIQRLTKLQIIYFANSPFTYDNI-----------------------------AVDW 469

Query: 531 TSVDLSRNSLYGKIPPGISKLIDLSILNLSRNGITGSIPNEMRNMMSLTTLDLSYNNLIG 590
              +      Y       S L DL+ + L        +P+ + ++  L +L+++ N  I 
Sbjct: 470 EDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGIS 529

Query: 591 NIPSGGQFLAFNETSFIGNPNL 612
                  +    +      P +
Sbjct: 530 AAQLKADWTRLAD-DEDTGPKI 550

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 51.0 bits (122), Expect = 2e-06
 Identities = 16/173 (9%), Positives = 52/173 (30%), Gaps = 13/173 (7%)

Query: 457 SLNQLKVANNNITGKIPAAIGNLPSLNILSLQNNRL--EGEIPVESFN----------LK 504
            +      + +   +      ++   +  ++ +N+L  +  +P++             LK
Sbjct: 217 QVVAYTTYSQSGIKRSELETQSVRGESF-TVIDNKLTKDANVPIQLKETAEYIKDYKALK 275

Query: 505 MITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYGKIPPGISKLIDLSILNLSRNGI 564
            I       N        + +      + +   +    +    +     ++ L+L+  G 
Sbjct: 276 AIWEALDGKNWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGA 335

Query: 565 TGSIPNEMRNMMSLTTLDLSYNNLIGNIPSGGQFLAFNETSFIGNPNLCLLRN 617
            G +P+ +  +  L  L    ++   +    G      + S      + +   
Sbjct: 336 KGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYK 388

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  274 bits (704), Expect = 3e-81
 Identities = 112/566 (19%), Positives = 196/566 (34%), Gaps = 48/566 (8%)

Query: 71  SRVVSLNVSFMPLFGSIPPEIGLLTKLVNLTISNVNLTGRLPSEMALLTSLKVFNISGNV 130
               +L++SF PL            +L  L +S   +          L+ L    ++GN 
Sbjct: 28  FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87

Query: 131 FQGNFAGQIVRGMTELQVLDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTG-KIPQSYS 189
            Q    G    G++ LQ L A   N        I  LK+L+ L+   N     K+P+ +S
Sbjct: 88  IQSLALGAF-SGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFS 146

Query: 190 EIQSLEYIGLNGIGLNGTVPAFLSRLKNLREMYIG---YFNTYTGGIPPGFGALTQLQVL 246
            + +LE++ L+   +       L  L  +  + +      N     I PG     +L  L
Sbjct: 147 NLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLHKL 205

Query: 247 DMASCNISGEIP-------TSLSRLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLN 299
            + +   S  +          L   +L+   F     L       L GL +L   +  L 
Sbjct: 206 TLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLA 265

Query: 300 YL---TGEIPESFAALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPEN 356
           YL     +I + F  L N++   L    +              + L++    F  + P  
Sbjct: 266 YLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNFGWQHLELVNCKFG-QFPTL 322

Query: 357 LGRNGKLL--------------------ILDVTSNHLT--GTIPRDLCKGGKLKSLILMQ 394
             ++ K L                     LD++ N L+  G   +       LK L L  
Sbjct: 323 KLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSF 382

Query: 395 NFFIGPIPEELGQCKSLTKIRFSKNYLNGTIPAGLF-NLPLLNMMELDDNLLSGELPEKM 453
           N  I  +       + L  + F  + L       +F +L  L  +++             
Sbjct: 383 NGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIF 441

Query: 454 SG-ASLNQLKVANNNITGKI-PAAIGNLPSLNILSLQNNRLEGEIPVESFNLKMITSINI 511
           +G +SL  LK+A N+      P     L +L  L L   +LE   P    +L  +  +N+
Sbjct: 442 NGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNM 501

Query: 512 SDNNISGEIPYSISQCHSLTSVDLSRNSLYGKIPPGISKLID-LSILNLSRNGITGSIPN 570
           S NN      +     +SL  +D S N +       +      L+ LNL++N    +  +
Sbjct: 502 SHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEH 561

Query: 571 E--MRNMMSLTTLDLSYNNLIGNIPS 594
           +  ++ +     L +    +    PS
Sbjct: 562 QSFLQWIKDQRQLLVEVERMECATPS 587

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  267 bits (685), Expect = 1e-78
 Identities = 108/523 (20%), Positives = 185/523 (35%), Gaps = 36/523 (6%)

Query: 94  LTKLVNLTI--SNVNLTGRLPSEMALLTSLKVFNISGNVFQGNFAGQIVRGMTELQVLDA 151
           +  + N+T     +N   ++P    L  S K  ++S N  +   +        ELQVLD 
Sbjct: 4   VEVVPNITYQCMELNFY-KIPDN--LPFSTKNLDLSFNPLRHLGSYSF-FSFPELQVLDL 59

Query: 152 YNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLNGIGLNGTVPAF 211
                         SL  L  L   GN        ++S + SL+ +      L       
Sbjct: 60  SRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFP 119

Query: 212 LSRLKNLREMYIGYFNTYTGG-IPPGFGALTQLQVLDMASCNISGEIPTSLSRLKLLH-- 268
           +  LK L+E+ +   N      +P  F  LT L+ LD++S  I     T L  L  +   
Sbjct: 120 IGHLKTLKELNVA-HNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLL 178

Query: 269 --SLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPE-SFAALKNLTLLQLFKNNL 325
             SL L +N +   I P     I L  L L  N+ +  + +     L  L + +L     
Sbjct: 179 NLSLDLSLNPMNF-IQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEF 237

Query: 326 RG------PIPSFLGDFPNLEVLQVWGNNFTF---ELPENLGRNGKLLILDVTSNHLTGT 376
           R          S L    NL + +       +   ++ +       +    + S  +   
Sbjct: 238 RNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERV 297

Query: 377 IPRDLCKGGKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGTIPAGLFNLPLLN 436
                      + L L+   F      +L   K LT          G       +LP L 
Sbjct: 298 KDFSYN--FGWQHLELVNCKFGQFPTLKLKSLKRLT-----FTSNKGGNAFSEVDLPSLE 350

Query: 437 MMELDDNLLSGELPEKMSGASLNQLKV---ANNNITGKIPAAIGNLPSLNILSLQNNRLE 493
            ++L  N LS +     S      LK    + N +   + +    L  L  L  Q++ L+
Sbjct: 351 FLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLK 409

Query: 494 GEIPVESF-NLKMITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYGKIPPGI-SKL 551
                  F +L+ +  ++IS  +         +   SL  + ++ NS      P I ++L
Sbjct: 410 QMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTEL 469

Query: 552 IDLSILNLSRNGITGSIPNEMRNMMSLTTLDLSYNNLIGNIPS 594
            +L+ L+LS+  +    P    ++ SL  L++S+NN       
Sbjct: 470 RNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTF 512

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  186 bits (473), Expect = 7e-50
 Identities = 80/414 (19%), Positives = 136/414 (32%), Gaps = 26/414 (6%)

Query: 84  FGSIPPEIGLLTKLVNLTISNVNLTGRLPSEMAL-LTSLKVFNISGNVFQGN-----FAG 137
              I P      +L  LT+ N   +  +       L  L+V  +    F+       F  
Sbjct: 189 MNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDK 248

Query: 138 QIVRGMTELQVLD---AYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQSL 194
             + G+  L + +   AY + +   +      L ++   S            SY+     
Sbjct: 249 SALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYN--FGW 306

Query: 195 EYIGLNGIGLNGTVPAFLSRLKNLREMYIGYFNTYTGGIPPGFGALTQLQVLDMASCNIS 254
           +++ L            L  LK L       F +  GG       L  L+ LD++   +S
Sbjct: 307 QHLELVNCKFGQFPTLKLKSLKRL------TFTSNKGGNAFSEVDLPSLEFLDLSRNGLS 360

Query: 255 --GEIPTSLSRLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPES-FAA 311
             G    S      L  L L  N +   +     GL  L+ LD   + L      S F +
Sbjct: 361 FKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLS 419

Query: 312 LKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFT-FELPENLGRNGKLLILDVTS 370
           L+NL  L +   + R           +LEVL++ GN+F    LP+       L  LD++ 
Sbjct: 420 LRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQ 479

Query: 371 NHLTGTIPRDLCKGGKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGTIPAGLF 430
             L    P        L+ L +  N F            SL  + +S N++  +    L 
Sbjct: 480 CQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQ 539

Query: 431 NLP-LLNMMELDDNLLSGELPEKMSGASLNQLKV---ANNNITGKIPAAIGNLP 480
           + P  L  + L  N  +     +     +   +        +    P+    +P
Sbjct: 540 HFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQGMP 593

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  142 bits (359), Expect = 3e-35
 Identities = 65/296 (21%), Positives = 107/296 (36%), Gaps = 15/296 (5%)

Query: 84  FGSIPPEIGLLTKLVNLTISNVNLTGRLPSEMALLTSLKVFNISGN--VFQGNFAGQIVR 141
           FG  P     L  L  LT ++             L SL+  ++S N   F+G  +     
Sbjct: 316 FGQFPT--LKLKSLKRLTFTSNKGGNAFSE--VDLPSLEFLDLSRNGLSFKGCCSQSD-F 370

Query: 142 GMTELQVLDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSY-SEIQSLEYIGLN 200
           G T L+ LD   N     +      L+ L HL F  +        S    +++L Y+ ++
Sbjct: 371 GTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDIS 429

Query: 201 GIGLNGTVPAFLSRLKNLREMYIGYFNTYTGGIPPG-FGALTQLQVLDMASCNISGEIPT 259
                       + L +L  + +   N++     P  F  L  L  LD++ C +    PT
Sbjct: 430 HTHTRVAFNGIFNGLSSLEVLKMAG-NSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPT 488

Query: 260 SLSRLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAAL-KNLTLL 318
           + + L  L  L +  N            L SL+ LD SLN++     +       +L  L
Sbjct: 489 AFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFL 548

Query: 319 QLFKNNLRG--PIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNH 372
            L +N+        SFL    +   L V         P +  +   +L L++T   
Sbjct: 549 NLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDK-QGMPVLSLNITCQM 603

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  117 bits (294), Expect = 3e-27
 Identities = 49/265 (18%), Positives = 89/265 (33%), Gaps = 11/265 (4%)

Query: 425 IPAGLFNLPLLNMMELDDNLLSGELPEKMSG-ASLNQLKVANNNITGKIPAAIGNLPSLN 483
           IP  L        ++L  N L             L  L ++   I      A  +L  L+
Sbjct: 22  IPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLS 79

Query: 484 ILSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIPYSISQCHSLTSVDLSRNSL-YG 542
            L L  N ++         L  +  +   + N++    + I    +L  ++++ N +   
Sbjct: 80  TLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSF 139

Query: 543 KIPPGISKLIDLSILNLSRNGITGSIPNEMRNMMSLT----TLDLSYNNLIGNIPSGGQF 598
           K+P   S L +L  L+LS N I      ++R +  +     +LDLS N +    P   + 
Sbjct: 140 KLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKE 199

Query: 599 LAFNETSFIGNPNLCLLRNGTCQSLINSAKHSGDGYGSSFGASKIVITVIALLTFMLLVI 658
           +  ++ +   N +   +     Q L    +      G         +          L  
Sbjct: 200 IRLHKLTLRNNFDSLNVMKTCIQGLAGL-EVHRLVLGEFRNEGN--LEKFDKSALEGLCN 256

Query: 659 LTIYQLRKRRLQKSKAWKLTAFQRL 683
           LTI + R   L       +  F  L
Sbjct: 257 LTIEEFRLAYLDYYLDDIIDLFNCL 281

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 55.4 bits (134), Expect = 7e-08
 Identities = 23/121 (19%), Positives = 40/121 (33%), Gaps = 2/121 (1%)

Query: 71  SRVVSLNVSFMPLFGSIPPEIGLLTKLVNLTISNVNLTGRLPSEMALLTSLKVFNISGNV 130
             +  L++S   L    P     L+ L  L +S+ N           L SL+V + S N 
Sbjct: 470 RNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNH 529

Query: 131 FQGNFAGQIVRGMTELQVLDAYNNNFTGPLPVE--IASLKSLRHLSFGGNYFTGKIPQSY 188
              +   ++    + L  L+   N+F      +  +  +K  R L           P   
Sbjct: 530 IMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDK 589

Query: 189 S 189
            
Sbjct: 590 Q 590

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  258 bits (660), Expect = 2e-78
 Identities = 72/304 (23%), Positives = 119/304 (39%), Gaps = 40/304 (13%)

Query: 694 LKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAE--IQTLGRIRHRNI 751
           L+   +  +G  G V++        VA+K         +   +  E  + +L  ++H NI
Sbjct: 26  LQLLEVKARGRFGCVWKA-QLLNEYVAVKIF----PIQDKQSWQNEYEVYSLPGMKHENI 80

Query: 752 VRLLGYV---SNRDTNLLL-YEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYL 807
           ++ +G     ++ D +L L   +   GSL + L       + W     IA   A+GL YL
Sbjct: 81  LQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV---VSWNELCHIAETMARGLAYL 137

Query: 808 HHD-------CSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSY 860
           H D         P I HRD+KS N+LL ++  A +ADFGLA   +   ++       G+ 
Sbjct: 138 HEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTR 197

Query: 861 GYIAPEYA-----YTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDG--VDIVRWVRKTT 913
            Y+APE       +      + D+Y+ G+VL EL +         D   +     +    
Sbjct: 198 RYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIG--- 254

Query: 914 SEVSQPSDAASVLAVV----DPRLSG--YPLTGVIHLFKVAMMCVEDESSARPTMREVVH 967
                PS       VV     P L        G+  L +    C + ++ AR +   V  
Sbjct: 255 ---QHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311

Query: 968 MLAN 971
            +  
Sbjct: 312 RITQ 315

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  257 bits (658), Expect = 3e-78
 Identities = 87/335 (25%), Positives = 142/335 (42%), Gaps = 53/335 (15%)

Query: 282 PPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQLFKNNLRG--PIPSFLGDFPNL 339
           P  LS  +   + D       G + ++      +  L L   NL    PIPS L + P L
Sbjct: 21  PTTLSSWLP--TTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYL 78

Query: 340 EVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFIG 399
             L + G N                       +L G IP  + K  +L  L +      G
Sbjct: 79  NFLYIGGIN-----------------------NLVGPIPPAIAKLTQLHYLYITHTNVSG 115

Query: 400 PIPEELGQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLSGELPEKMSGASLN 459
            IP+ L Q K+L  + FS N L+GT+P  + +LP                       +L 
Sbjct: 116 AIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLP-----------------------NLV 152

Query: 460 QLKVANNNITGKIPAAIGNLPSL-NILSLQNNRLEGEIPVESFNLKMITSINISDNNISG 518
            +    N I+G IP + G+   L   +++  NRL G+IP    NL  +  +++S N + G
Sbjct: 153 GITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEG 211

Query: 519 EIPYSISQCHSLTSVDLSRNSLYGKIPPGISKLIDLSILNLSRNGITGSIPNEMRNMMSL 578
           +         +   + L++NSL   +   +    +L+ L+L  N I G++P  +  +  L
Sbjct: 212 DASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFL 270

Query: 579 TTLDLSYNNLIGNIPSGGQFLAFNETSFIGNPNLC 613
            +L++S+NNL G IP GG    F+ +++  N  LC
Sbjct: 271 HSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLC 305

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  251 bits (644), Expect = 2e-76
 Identities = 87/331 (26%), Positives = 136/331 (41%), Gaps = 37/331 (11%)

Query: 24  CAYSDMDVLLKLKSSMIGPKGSGLKNWEPSSSPSAHCSFSGVTCD---QDSRVVSLNVSF 80
           C   D   LL++K  +  P  + L +W P++    + ++ GV CD   Q  RV +L++S 
Sbjct: 3   CNPQDKQALLQIKKDLGNP--TTLSSWLPTTDCC-NRTWLGVLCDTDTQTYRVNNLDLSG 59

Query: 81  MPLFGS--IPPEIGLLTKLVNLTISNVN-LTGRLPSEMALLTSLKVFNISGNVFQGNFAG 137
           + L     IP  +  L  L  L I  +N L G +P  +A LT L                
Sbjct: 60  LNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQL---------------- 103

Query: 138 QIVRGMTELQVLDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYI 197
                      L   + N +G +P  ++ +K+L  L F  N  +G +P S S + +L  I
Sbjct: 104 ---------HYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGI 154

Query: 198 GLNGIGLNGTVPAFLSRLKNLREMYIGYFNTYTGGIPPGFGALTQLQVLDMASCNISGEI 257
             +G  ++G +P        L        N  TG IPP F  L  L  +D++   + G+ 
Sbjct: 155 TFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDA 213

Query: 258 PTSLSRLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTL 317
                  K    + L  N L   +  ++    +L  LDL  N + G +P+    LK L  
Sbjct: 214 SVLFGSDKNTQKIHLAKNSLAFDL-GKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHS 272

Query: 318 LQLFKNNLRGPIPSFLGDFPNLEVLQVWGNN 348
           L +  NNL G IP   G+    +V     N 
Sbjct: 273 LNVSFNNLCGEIPQ-GGNLQRFDVSAYANNK 302

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  230 bits (589), Expect = 1e-68
 Identities = 72/274 (26%), Positives = 115/274 (41%), Gaps = 6/274 (2%)

Query: 246 LDMASCNISGEIPTSLSRLKLLHSLFLQMNKLTG--HIPPQLSGLISLKSLDLS-LNYLT 302
            D  +    G +  + ++   +++L L    L     IP  L+ L  L  L +  +N L 
Sbjct: 31  TDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLV 90

Query: 303 GEIPESFAALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGK 362
           G IP + A L  L  L +   N+ G IP FL     L  L    N  +  LP ++     
Sbjct: 91  GPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPN 150

Query: 363 LLILDVTSNHLTGTIPRDLCKGGKL-KSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYL 421
           L+ +    N ++G IP       KL  S+ + +N   G IP       +L  +  S+N L
Sbjct: 151 LVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNML 209

Query: 422 NGTIPAGLFNLPLLNMMELDDNLLSGELPEKMSGASLNQLKVANNNITGKIPAAIGNLPS 481
            G       +      + L  N L+ +L +     +LN L + NN I G +P  +  L  
Sbjct: 210 EGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKF 269

Query: 482 LNILSLQNNRLEGEIPVESFNLKMITSINISDNN 515
           L+ L++  N L GEIP +  NL+       ++N 
Sbjct: 270 LHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNK 302

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  213 bits (546), Expect = 1e-62
 Identities = 78/298 (26%), Positives = 129/298 (43%), Gaps = 29/298 (9%)

Query: 173 LSFGGNYFTGKIPQSYSEIQSLEYIGLNGIGLNGT--VPAFLSRLKNLREMYIGYFNTYT 230
                  + G +  + ++   +  + L+G+ L     +P+ L+ L  L  +YIG  N   
Sbjct: 31  TDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLV 90

Query: 231 GGIPPGFGALTQLQVLDMASCNISGEIPTSLSRLKLLHSLFLQMNKLTGHIPPQLSGLIS 290
           G IPP    LTQL  L +   N+SG IP  LS++K L +L    N L+G +PP +S L +
Sbjct: 91  GPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPN 150

Query: 291 LKSLDLSLNYLTGEIPESFAALKNL-TLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNF 349
           L  +    N ++G IP+S+ +   L T + + +N L G IP                   
Sbjct: 151 LVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFA--------------- 195

Query: 350 TFELPENLGRNGKLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFIGPIPEELGQCK 409
                     N  L  +D++ N L G            + + L +N     +  ++G  K
Sbjct: 196 ----------NLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSK 244

Query: 410 SLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLSGELPEKMSGASLNQLKVANNN 467
           +L  +    N + GT+P GL  L  L+ + +  N L GE+P+  +    +    ANN 
Sbjct: 245 NLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNK 302

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  258 bits (662), Expect = 2e-75
 Identities = 95/563 (16%), Positives = 179/563 (31%), Gaps = 19/563 (3%)

Query: 73  VVSLNVSFMPLFGSIPPEIGLLTKLVNLTISNVNLTGRLPSEMALLTSLKVFNISGNVFQ 132
              L  SF  L          L  L  L ++   +             L    ++ N   
Sbjct: 35  TECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLI 94

Query: 133 GNFAGQIVRGMTELQVLDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQ 192
              A   + G   L+ L       +    + + + K+L  L  G N+ +          +
Sbjct: 95  F-MAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTE 153

Query: 193 SLEYIGLNGIGLNGTVPAFLSRLKNLREMYIGYFNTYTGGIPPGFGALTQLQVLDMASCN 252
            L+ +      ++      +S L+    + +        GI PG       Q L+     
Sbjct: 154 KLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQ 213

Query: 253 ISGEIPTSLSRLKL--LHSLFLQMNKLTGHIPPQLSGL--ISLKSLDLSLNYLTGEIPES 308
               I   L    +  L     +        P    GL  +S++S++L  +Y       +
Sbjct: 214 NLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNT 273

Query: 309 FAALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDV 368
           F     L  L L   +L   +PS L     L+ L +  N F      +      L  L +
Sbjct: 274 FHCFSGLQELDLTATHLSE-LPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSI 332

Query: 369 TSNHLTGTIPRDLCKG-GKLKSLILMQNF--FIGPIPEELGQCKSLTKIRFSKNYLNGTI 425
             N     +     +    L+ L L  +          +L     L  +  S N      
Sbjct: 333 KGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLK 392

Query: 426 PAGLFNLPLLNMMELDDNLLSGELPEKMSG--ASLNQLKVANNNITGKIPAAIGNLPSLN 483
                  P L +++L    L  +  +        L  L ++++ +          LP+L 
Sbjct: 393 TEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQ 452

Query: 484 ILSLQNNRLEGEIPVESF---NLKMITSINISDNNISGEIPYSISQCHSLTSVDLSRNSL 540
            L+LQ N        ++     L  +  + +S  ++S    ++ +    +  VDLS N L
Sbjct: 453 HLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRL 512

Query: 541 YGKIPPGISKLIDLSILNLSRNGITGSIPNEMRNMMSLTTLDLSYNNLIGNIPSGGQFLA 600
                      +    LNL+ N I+  +P+ +  +    T++L  N L     +   FL 
Sbjct: 513 TS-SSIEALSHLKGIYLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCSNIY-FLE 570

Query: 601 FNETSFIGNPNLCLLRNGTCQSL 623
           + + +      L    +  C++ 
Sbjct: 571 WYKEN---MQKLEDTEDTLCENP 590

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  216 bits (553), Expect = 2e-60
 Identities = 73/370 (19%), Positives = 127/370 (34%), Gaps = 12/370 (3%)

Query: 233 IPPGFGALTQLQVLDMASCNISGEIPTSLSRLKLLHSLFLQMNKLTGHIPPQLSGLISLK 292
           IP         + L+ +   +     T+ SRL  L  L L   ++             L 
Sbjct: 27  IPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLD 84

Query: 293 SLDLSLNYLTGEIPESFAALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFE 352
           +L L+ N L      + +  K L  L   +  +       L +   LE L +  N+ +  
Sbjct: 85  TLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSI 144

Query: 353 LPENLGRNGKLLILDVTSNHLTGTIPRDLCKGGKLKSLIL-MQNFFIGPIPEELGQCKSL 411
                    KL +LD  +N +      D+    +  +L L +    I  I          
Sbjct: 145 KLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVF 204

Query: 412 TKIRFSKNYLNGTIPAGLFNLPLLNMMELD-----DNLLSGELPEKMSGASLNQLKVANN 466
             + F        I  GL N  + ++         D  +S  + E +   S+  + +  +
Sbjct: 205 QSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKH 264

Query: 467 NITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIPYSISQ 526
                          L  L L    L  E+P     L  +  + +S N        S S 
Sbjct: 265 YFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASN 323

Query: 527 CHSLTSVDLSRNSLYGKIPPG-ISKLIDLSILNLSRNGITGS--IPNEMRNMMSLTTLDL 583
             SLT + +  N+   ++  G +  L +L  L+LS + I  S     ++RN+  L +L+L
Sbjct: 324 FPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNL 383

Query: 584 SYNNLIGNIP 593
           SYN  +    
Sbjct: 384 SYNEPLSLKT 393

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  109 bits (274), Expect = 8e-25
 Identities = 43/207 (20%), Positives = 70/207 (33%), Gaps = 7/207 (3%)

Query: 424 TIPAGLFNLPLLNMMELDDNLLSGELPEKMSG-ASLNQLKVANNNITGKIPAAIGNLPSL 482
            IP  L        +E   N+L        S   +L  L +    I         +   L
Sbjct: 26  EIPGTLP--NSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRL 83

Query: 483 NILSLQNNRLEGEIPVESF-NLKMITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLY 541
           + L L  N L   +   +    K +  +      IS      +    +L S+ L  N + 
Sbjct: 84  DTLVLTANPLIF-MAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHIS 142

Query: 542 GKIPPGISKLIDLSILNLSRNGITGSIPNEMRNMMSLT--TLDLSYNNLIGNIPSGGQFL 599
               P       L +L+   N I      +M ++   T  +L+L+ N++ G  P      
Sbjct: 143 SIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSA 202

Query: 600 AFNETSFIGNPNLCLLRNGTCQSLINS 626
            F   +F G  NL ++  G   S I S
Sbjct: 203 VFQSLNFGGTQNLLVIFKGLKNSTIQS 229

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  231 bits (591), Expect = 1e-65
 Identities = 101/566 (17%), Positives = 181/566 (31%), Gaps = 38/566 (6%)

Query: 52  PSSSPSAHCSFSGVTCDQDSR------------VVSLNVSFMPLFGSIPPEIGLLTKLVN 99
           P S          +T     +              ++++SF PL           ++L  
Sbjct: 1   PGSLNPCIEVVPNITYQCMDQKLSKVPDDIPSSTKNIDLSFNPLKILKSYSFSNFSELQW 60

Query: 100 LTISNVNLTGRLPSEMALLTSLKVFNISGNVFQGNFAGQIVRGMTELQVLDAYNNNFTGP 159
           L +S   +          L  L    ++GN  Q    G    G+T L+ L A        
Sbjct: 61  LDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSF-SGLTSLENLVAVETKLASL 119

Query: 160 LPVEIASLKSLRHLSFGGNYFTG-KIPQSYSEIQSLEYIGLNGIGLNGTVPAFLSRLKNL 218
               I  L +L+ L+   N+    K+P  +S + +L ++ L+   +       L  L+  
Sbjct: 120 ESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLREN 179

Query: 219 RE--MYIGYFNTYTGGIPPGFGALTQLQVLDMASCNISGEIP-------TSLSRLKLLHS 269
            +  + +         I        +L  L +     S  I          L   +L+  
Sbjct: 180 PQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILG 239

Query: 270 LFLQMNKLTGHIPPQLSGL--ISLKSLDLSLNYLTGEIPESFAALKNLTLLQLFKNNLRG 327
            F     L    P  + GL  +++    L+      +    F  L N++ + L   +++ 
Sbjct: 240 EFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKY 299

Query: 328 PIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDLCKGGKL 387
            +      F   + L +           +L     L  L +T N  + +  +       L
Sbjct: 300 -LEDVPKHF-KWQSLSIIRCQLKQFPTLDLPF---LKSLTLTMNKGSISFKKVALP--SL 352

Query: 388 KSLILMQNF--FIGPIPEELGQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLL 445
             L L +N   F G          SL  +  S N     + A    L  L  ++   + L
Sbjct: 353 SYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTL 411

Query: 446 SGELPEKMSG--ASLNQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESF-N 502
                         L  L ++  N           L SLN L +  N  +       F N
Sbjct: 412 KRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFAN 471

Query: 503 LKMITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYGKIPPGISKLIDLSILNLSRN 562
              +T +++S   +           H L  +++S N+L        ++L  LS L+ S N
Sbjct: 472 TTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFN 531

Query: 563 GITGSIPNEMRNMMSLTTLDLSYNNL 588
            I  S         SL   +L+ N++
Sbjct: 532 RIETSKGILQHFPKSLAFFNLTNNSV 557

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  196 bits (500), Expect = 2e-53
 Identities = 68/467 (14%), Positives = 135/467 (28%), Gaps = 50/467 (10%)

Query: 146 LQVLDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLNGIGLN 205
            + +D   N          ++   L+ L            +++  +  L  + L G    
Sbjct: 34  TKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTG---- 89

Query: 206 GTVPAFLSRLKNLREMYIGYFNTYTGGIPPGFGALTQLQVLDMASCNISGEIPTSLSRLK 265
                  + +++                P  F  LT L+ L      ++      + +L 
Sbjct: 90  -------NPIQSF--------------SPGSFSGLTSLENLVAVETKLASLESFPIGQLI 128

Query: 266 LLHSLFLQMNKLTG-HIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTL----LQL 320
            L  L +  N +    +P   S L +L  +DLS NY+          L+        L +
Sbjct: 129 TLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDM 188

Query: 321 FKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRN-GKLLILDVTSNHLTG---- 375
             N +   I         L  L + GN  +  + +   +N   L +  +           
Sbjct: 189 SLNPIDF-IQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNL 247

Query: 376 -TIPRDLCKG---GKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGTIPAGLFN 431
                 + +G     +    L           +     +++ +  +   +   +      
Sbjct: 248 EIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIK-YLEDVPK- 305

Query: 432 LPLLNMMELDDNLLSGELPEKMSGASLNQLKVANNNITGKIPAAIGNLPSLNILSLQNNR 491
                 + +    L       +    L  L +  N  +  I      LPSL+ L L  N 
Sbjct: 306 HFKWQSLSIIRCQLKQFPTLDLP--FLKSLTLTMNKGS--ISFKKVALPSLSYLDLSRNA 361

Query: 492 LE--GEIPVESFNLKMITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYGKIPPG-I 548
           L   G           +  +++S N     +  +      L  +D   ++L         
Sbjct: 362 LSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAF 420

Query: 549 SKLIDLSILNLSRNGITGSIPNEMRNMMSLTTLDLSYNNLIGNIPSG 595
             L  L  L++S              + SL TL ++ N+   N  S 
Sbjct: 421 LSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSN 467

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  186 bits (474), Expect = 5e-50
 Identities = 72/399 (18%), Positives = 135/399 (33%), Gaps = 42/399 (10%)

Query: 233 IPPGFGALTQLQVLDMASCNISGEIPTSLSRLKLLHSLFLQMNKLTGHIPPQLSGLISLK 292
           +P      +  + +D++   +      S S    L  L L   ++         GL  L 
Sbjct: 26  VPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLS 83

Query: 293 SLDLSLNYLTGEIPESFAALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFT-F 351
           +L L+ N +    P SF+ L +L  L   +  L       +G    L+ L V  N     
Sbjct: 84  NLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSC 143

Query: 352 ELPENLGRNGKLLILDVTSNHLTGTIPRDLCKGGKLKSLIL---MQNFFIGPIPEELGQC 408
           +LP        L+ +D++ N++      DL    +   + L   M    I  I ++  Q 
Sbjct: 144 KLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQG 203

Query: 409 KSLTKIRFSKNYLNGTIPAGLF-NLPLLNMMELDDNLLSG---------ELPEKMSGASL 458
             L ++    N+ +  I      NL  L++  L                 + E +   ++
Sbjct: 204 IKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTI 263

Query: 459 NQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIP-------------------VE 499
           ++ ++   N           L +++ +SL    ++                         
Sbjct: 264 DEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFKWQSLSIIRCQLKQFP 323

Query: 500 SFNLKMITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYGKIPPGI---SKLIDLSI 556
           + +L  + S+ ++ N  S  I +      SL+ +DLSRN+L                L  
Sbjct: 324 TLDLPFLKSLTLTMNKGS--ISFKKVALPSLSYLDLSRNALS-FSGCCSYSDLGTNSLRH 380

Query: 557 LNLSRNGITGSIPNEMRNMMSLTTLDLSYNNLIGNIPSG 595
           L+LS NG    +      +  L  LD  ++ L       
Sbjct: 381 LDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFS 418

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  130 bits (328), Expect = 2e-31
 Identities = 51/284 (17%), Positives = 94/284 (33%), Gaps = 14/284 (4%)

Query: 71  SRVVSLNVSFMPLFGSIPPEIGLLTKLVNLTISNVNLTGRLPSEMALLTSLKVFNISGNV 130
           + V +++++ + +      ++    K  +L+I    L    P+    L  LK   ++ N 
Sbjct: 285 ANVSAMSLAGVSI--KYLEDVPKHFKWQSLSIIRCQLKQ-FPT--LDLPFLKSLTLTMNK 339

Query: 131 FQGNFAGQIVRGMTELQVLDAYNNNFT--GPLPVEIASLKSLRHLSFGGNYFTGKIPQSY 188
              +F       +  L  LD   N  +  G          SLRHL    N     +  ++
Sbjct: 340 GSISFKKV---ALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANF 395

Query: 189 SEIQSLEYIGLNGIGLNGTVPA-FLSRLKNLREMYIGYFNTYTGGIPPGFGALTQLQVLD 247
             ++ L+++      L           L+ L  + I Y           F  LT L  L 
Sbjct: 396 MGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISY-TNTKIDFDGIFLGLTSLNTLK 454

Query: 248 MASCNISGEIPTS-LSRLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIP 306
           MA  +      ++  +    L  L L   +L          L  L+ L++S N L     
Sbjct: 455 MAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDS 514

Query: 307 ESFAALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFT 350
             +  L +L+ L    N +            +L    +  N+  
Sbjct: 515 SHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA 558

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  107 bits (269), Expect = 4e-24
 Identities = 50/279 (17%), Positives = 101/279 (36%), Gaps = 15/279 (5%)

Query: 399 GPIPEELGQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLSGELPEKMSG-AS 457
           G +   +    ++T  +     L+  +P  +        ++L  N L        S  + 
Sbjct: 2   GSLNPCIEVVPNIT-YQCMDQKLS-KVPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSE 57

Query: 458 LNQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESF-NLKMITSINISDNNI 516
           L  L ++   I      A   L  L+ L L  N ++      SF  L  + ++   +  +
Sbjct: 58  LQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQS-FSPGSFSGLTSLENLVAVETKL 116

Query: 517 SGEIPYSISQCHSLTSVDLSRNSLYG-KIPPGISKLIDLSILNLSRNGITGSIPNEMRNM 575
           +    + I Q  +L  ++++ N ++  K+P   S L +L  ++LS N I     N+++ +
Sbjct: 117 ASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFL 176

Query: 576 ----MSLTTLDLSYNNLIGNIPSGGQFLAFNETSFIGNPNLCLLRNGTCQSLINSAKHSG 631
                   +LD+S N +        Q +  +E +  GN N   +     Q+L     H  
Sbjct: 177 RENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHR- 235

Query: 632 DGYGSSFGASKIVITVIALLTFMLLVILTIYQLRKRRLQ 670
                     +  + +        L  +TI + R     
Sbjct: 236 --LILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTN 272

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  216 bits (553), Expect = 1e-63
 Identities = 85/281 (30%), Positives = 135/281 (48%), Gaps = 25/281 (8%)

Query: 691 LESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRL-VGRGTGGNDHGFLAEIQTLGRIRHR 749
              L  +  IG G  G V+R     G DVA+K L          + FL E+  + R+RH 
Sbjct: 36  WCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHP 94

Query: 750 NIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGG-HLKWETRYRIALEAAKGLCYLH 808
           NIV  +G V+      ++ EY+  GSL  +LH +     L    R  +A + AKG+ YLH
Sbjct: 95  NIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH 154

Query: 809 HDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYA 868
           +  +P I+HR++KS N+L+D  +   V DFGL++       S    S AG+  ++APE  
Sbjct: 155 N-RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLS--SKSAAGTPEWMAPEVL 211

Query: 869 YTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAV 928
                +EKSDVYSFGV+L EL   ++P G   +   +V  V      +  P +       
Sbjct: 212 RDEPSNEKSDVYSFGVILWELATLQQPWGNL-NPAQVVAAVGFKCKRLEIPRN------- 263

Query: 929 VDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHML 969
           ++P+++         + +    C  +E   RP+   ++ +L
Sbjct: 264 LNPQVA--------AIIE---GCWTNEPWKRPSFATIMDLL 293

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  212 bits (542), Expect = 2e-62
 Identities = 81/295 (27%), Positives = 131/295 (44%), Gaps = 44/295 (14%)

Query: 691 LESLKDENIIGKGGAGIVYRGS-MPDGIDVAIKRLVGRGTGGNDHG------FLAEIQTL 743
              ++ E  IGKGG G+V++G  + D   VAIK L+   + G          F  E+  +
Sbjct: 18  DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIM 77

Query: 744 GRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKG 803
             + H NIV+L G + N     ++ E++P G L   L   K   +KW  + R+ L+ A G
Sbjct: 78  SNLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLD-KAHPIKWSVKLRLMLDIALG 134

Query: 804 LCYLHHDCSPLIIHRDVKSNNILLDSDFE-----AHVADFGLAKFLQDAGASECMSSVAG 858
           + Y+ +  +P I+HRD++S NI L S  E     A VADFGL++          +S + G
Sbjct: 135 IEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQS-----VHSVSGLLG 188

Query: 859 SYGYIAPE--YAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEV 916
           ++ ++APE   A      EK+D YSF ++L  ++ G+ P  E+                 
Sbjct: 189 NFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEY----------------- 231

Query: 917 SQPSDAASVLAVVDP--RLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHML 969
                   +  + +   R +  P      L  V  +C   +   RP    +V  L
Sbjct: 232 -SYGKIKFINMIREEGLRPT-IPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKEL 284

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  212 bits (543), Expect = 3e-62
 Identities = 76/281 (27%), Positives = 127/281 (45%), Gaps = 31/281 (11%)

Query: 691 LESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRN 750
            + ++ E ++G+G  G+V +       DVAIK++    +      F+ E++ L R+ H N
Sbjct: 7   YKEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQI---ESESERKAFIVELRQLSRVNHPN 62

Query: 751 IVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKG-GHLKWETRYRIALEAAKGLCYLHH 809
           IV+L G   N     L+ EY   GSL  +LHGA+   +          L+ ++G+ YLH 
Sbjct: 63  IVKLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHS 120

Query: 810 DCSPLIIHRDVKSNNILLDSDFE-AHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYA 868
                +IHRD+K  N+LL +      + DFG A  +Q       M++  GS  ++APE  
Sbjct: 121 MQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-----MTNNKGSAAWMAPEVF 175

Query: 869 YTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAV 928
                 EK DV+S+G++L E+I  +KP  E G     + W     +      +       
Sbjct: 176 EGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKN------- 228

Query: 929 VDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHML 969
           +   +             +   C   + S RP+M E+V ++
Sbjct: 229 LPKPIE-----------SLMTRCWSKDPSQRPSMEEIVKIM 258

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  208 bits (532), Expect = 3e-61
 Identities = 79/292 (27%), Positives = 120/292 (41%), Gaps = 42/292 (14%)

Query: 691 LESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHG-----FLAEIQTLGR 745
              L  E IIG GG G VYR     G +VA+K    R     D          E +    
Sbjct: 6   FAELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAA--RHDPDEDISQTIENVRQEAKLFAM 62

Query: 746 IRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLC 805
           ++H NI+ L G         L+ E+   G L  +L G +   +  +     A++ A+G+ 
Sbjct: 63  LKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR---IPPDILVNWAVQIARGMN 119

Query: 806 YLHHDCSPLIIHRDVKSNNILLDSDFEAH--------VADFGLAKFLQDAGASECMSSVA 857
           YLH +    IIHRD+KS+NIL+    E          + DFGLA+            S A
Sbjct: 120 YLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT----KMSAA 175

Query: 858 GSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVS 917
           G+Y ++APE        + SDV+S+GV+L EL+ G+ P     DG+ +   V      + 
Sbjct: 176 GAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGI-DGLAVAYGVAMNKLALP 234

Query: 918 QPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHML 969
            PS             +           K+   C   +  +RP+   ++  L
Sbjct: 235 IPST-------CPEPFA-----------KLMEDCWNPDPHSRPSFTNILDQL 268

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  210 bits (535), Expect = 7e-61
 Identities = 77/329 (23%), Positives = 127/329 (38%), Gaps = 54/329 (16%)

Query: 683 LDFKAEDV---LESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAE 739
           ++  A +    L++LK   +IG+G  G VY+GS+ D   VA+K      +  N   F+ E
Sbjct: 1   MEAAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVF----SFANRQNFINE 55

Query: 740 --IQTLGRIRHRNIVRLLGYV----SNRDTNLLL-YEYMPNGSLGEMLHGAKGGHLKWET 792
             I  +  + H NI R +       ++     LL  EY PNGSL + L         W +
Sbjct: 56  KNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT---SDWVS 112

Query: 793 RYRIALEAAKGLCYLHHD------CSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFL-- 844
             R+A    +GL YLH +        P I HRD+ S N+L+ +D    ++DFGL+  L  
Sbjct: 113 SCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTG 172

Query: 845 ----QDAGASECMSSVAGSYGYIAPEYA-------YTLKVDEKSDVYSFGVVLLELIAGK 893
               +         S  G+  Y+APE               ++ D+Y+ G++  E+    
Sbjct: 173 NRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRC 232

Query: 894 KPVGEFGDGVDIV----RWVRKTTSEVSQPSDAASVLAVVD-------PRLSGYPLTGVI 942
             +       +        V       + P+     + V         P         V 
Sbjct: 233 TDLFPGESVPEYQMAFQTEVG------NHPTFEDMQVLVSREKQRPKFPEAWKENSLAVR 286

Query: 943 HLFKVAMMCVEDESSARPTMREVVHMLAN 971
            L +    C + ++ AR T +     +A 
Sbjct: 287 SLKETIEDCWDQDAEARLTAQXAEERMAE 315

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  206 bits (527), Expect = 1e-60
 Identities = 58/285 (20%), Positives = 111/285 (38%), Gaps = 34/285 (11%)

Query: 691 LESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHG-FLAEIQTLGRIRHR 749
            + L     + +  +G +++G    G D+ +K L  R         F  E   L    H 
Sbjct: 9   FKQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHP 67

Query: 750 NIVRLLGYVSNRDTNLL--LYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYL 807
           N++ +LG   +        +  +MP GSL  +LH      +      + AL+ A+G+ +L
Sbjct: 68  NVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFL 127

Query: 808 HHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPE- 866
           H    PLI    + S ++++D D  A ++   +    Q             +  ++APE 
Sbjct: 128 HT-LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ-------SPGRMYAPAWVAPEA 179

Query: 867 --YAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAAS 924
                       +D++SF V+L EL+  + P  +    ++I   V       + P     
Sbjct: 180 LQKKPEDTNRRSADMWSFAVLLWELVTREVPFADL-SNMEIGMKVALEGLRPTIPPG--- 235

Query: 925 VLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHML 969
               + P +S           K+  +C+ ++ + RP    +V +L
Sbjct: 236 ----ISPHVS-----------KLMKICMNEDPAKRPKFDMIVPIL 265

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  204 bits (522), Expect = 1e-59
 Identities = 78/290 (26%), Positives = 119/290 (41%), Gaps = 42/290 (14%)

Query: 692 ESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRL-VGRGTGGNDHGFLAEIQTLGRIRHRN 750
             +     IG G  G VY+G      DVA+K L V   T      F  E+  L + RH N
Sbjct: 24  GQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 81

Query: 751 IVRLLGYVSNRDTNLLLY---EYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYL 807
           I+  +GY +       L    ++    SL   LH       + +    IA + A+G+ YL
Sbjct: 82  ILLFMGYSTAPQ----LAIVTQWCEGSSLYHHLHA-SETKFEMKKLIDIARQTARGMDYL 136

Query: 808 HHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPE- 866
           H   +  IIHRD+KSNNI L  D    + DFGLA        S     ++GS  ++APE 
Sbjct: 137 H---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEV 193

Query: 867 --YAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAAS 924
                +     +SDVY+FG+VL EL+ G+ P                         D   
Sbjct: 194 IRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNI------------------NNRDQ-- 233

Query: 925 VLAVVD-----PRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHML 969
           ++ +V      P LS         + ++   C++ +   RP+   ++  +
Sbjct: 234 IIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEI 283

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  197 bits (502), Expect = 1e-56
 Identities = 76/309 (24%), Positives = 115/309 (37%), Gaps = 46/309 (14%)

Query: 692 ESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAE--IQTLGRIRHR 749
             +     +GKG  G V+RGS   G +VA+K    R    ++  +  E  +     +RH 
Sbjct: 8   RDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR----DEKSWFRETELYNTVMLRHE 62

Query: 750 NIVRLLGYV---SNRDTNLLLY-EYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLC 805
           NI+  +       +  T L L   Y   GSL + L       L   +  RI L  A GL 
Sbjct: 63  NILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT---LDTVSCLRIVLSIASGLA 119

Query: 806 YLHHD-----CSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASE--CMSSVAG 858
           +LH +       P I HRD+KS NIL+  + +  +AD GLA     +        +   G
Sbjct: 120 HLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVG 179

Query: 859 SYGYIAPE------YAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGV----DIVRW 908
           +  Y+APE              ++ D+++FG+VL E+       G   D      D+V  
Sbjct: 180 TKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVP- 238

Query: 909 VRKTTSEVSQPSDAASVLAVVD----PRLSGYPLTGVIHLFKVAMM--CVEDESSARPTM 962
                   + PS       V      P +     +         +M  C     SAR T 
Sbjct: 239 --------NDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTA 290

Query: 963 REVVHMLAN 971
             +   L  
Sbjct: 291 LRIKKTLTK 299

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  195 bits (498), Expect = 4e-56
 Identities = 70/296 (23%), Positives = 123/296 (41%), Gaps = 46/296 (15%)

Query: 692 ESLKDENIIGKGGAGIVYRGS-MPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRN 750
             L    ++GKG  G   + +    G  + +K L+ R        FL E++ +  + H N
Sbjct: 10  SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELI-RFDEETQRTFLKEVKVMRCLEHPN 68

Query: 751 IVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHD 810
           +++ +G +        + EY+  G+L  ++         W  R   A + A G+ YLH  
Sbjct: 69  VLKFIGVLYKDKRLNFITEYIKGGTLRGIIKS-MDSQYPWSQRVSFAKDIASGMAYLH-- 125

Query: 811 CSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQD------------AGASECMSSVAG 858
            S  IIHRD+ S+N L+  +    VADFGLA+ + D                +   +V G
Sbjct: 126 -SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVG 184

Query: 859 SYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGD-----GVDIVRWVRKTT 913
           +  ++APE       DEK DV+SFG+VL E+I       ++       G+++  ++ +  
Sbjct: 185 NPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRY- 243

Query: 914 SEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHML 969
                P +         P             F + + C + +   RP+  ++ H L
Sbjct: 244 ----CPPN-------CPP-----------SFFPITVRCCDLDPEKRPSFVKLEHWL 277

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  194 bits (495), Expect = 1e-55
 Identities = 72/302 (23%), Positives = 119/302 (39%), Gaps = 39/302 (12%)

Query: 691 LESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRL-VGRGTGGNDHGFLAEIQTLGRIRHR 749
            E L+   +IGKG  G VY G      +VAI+ + + R        F  E+    + RH 
Sbjct: 32  FEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHE 89

Query: 750 NIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHH 809
           N+V  +G   +     ++       +L  ++  AK   L      +IA E  KG+ YLH 
Sbjct: 90  NVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKI-VLDVNKTRQIAQEIVKGMGYLH- 147

Query: 810 DCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKF---LQDAGASECMSSVAGSYGYIAPE 866
             +  I+H+D+KS N+  D + +  + DFGL      LQ     + +    G   ++APE
Sbjct: 148 --AKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPE 204

Query: 867 ---------YAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVS 917
                        L   + SDV++ G +  EL A + P   F                  
Sbjct: 205 IIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWP---FKT---------------- 245

Query: 918 QPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQSAP 977
           QP++A         + +   +     +  + + C   E   RPT  +++ ML   P+   
Sbjct: 246 QPAEAIIWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNR 305

Query: 978 SL 979
            L
Sbjct: 306 RL 307

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  193 bits (491), Expect = 8e-55
 Identities = 72/309 (23%), Positives = 115/309 (37%), Gaps = 38/309 (12%)

Query: 688 EDVLESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFL--AEIQTLGR 745
             + + ++    IGKG  G V+ G    G  VA+K          +  +    EI     
Sbjct: 33  RTIAKQIQMVKQIGKGRYGEVWMGKW-RGEKVAVKVFFTT----EEASWFRETEIYQTVL 87

Query: 746 IRHRNIVRLLGYV---SNRDTNLLL-YEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAA 801
           +RH NI+  +      +   T L L  +Y  NGSL + L       L  ++  ++A  + 
Sbjct: 88  MRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTT---LDAKSMLKLAYSSV 144

Query: 802 KGLCYLH-----HDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASE--CMS 854
            GLC+LH         P I HRD+KS NIL+  +    +AD GLA              +
Sbjct: 145 SGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPN 204

Query: 855 SVAGSYGYIAPE------YAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRW 908
           +  G+  Y+ PE           +    +D+YSFG++L E+       G   +    + +
Sbjct: 205 TRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQ--LPY 262

Query: 909 VRKTTSEVSQPSDAASVLAVVDPRL-----SGYPLTGVIHLFKVAMM-CVEDESSARPTM 962
                   S PS       V   +L     + +     +      M  C     ++R T 
Sbjct: 263 HDLVP---SDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTA 319

Query: 963 REVVHMLAN 971
             V   LA 
Sbjct: 320 LRVKKTLAK 328

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  193 bits (491), Expect = 9e-55
 Identities = 75/316 (23%), Positives = 122/316 (38%), Gaps = 52/316 (16%)

Query: 688 EDVLESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAE--IQTLGR 745
             +  ++  +  IGKG  G V+RG    G +VA+K    R     +  +  E  I     
Sbjct: 38  RTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR----EERSWFREAEIYQTVM 92

Query: 746 IRHRNIVRLLGYV---SNRDTNLLLY-EYMPNGSLGEMLHGAKGGHLKWETRYRIALEAA 801
           +RH NI+  +      +   T L L  +Y  +GSL + L+      +  E   ++AL  A
Sbjct: 93  LRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTA 149

Query: 802 KGLCYLHHD-----CSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASEC--MS 854
            GL +LH +       P I HRD+KS NIL+  +    +AD GLA     A  +     +
Sbjct: 150 SGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPN 209

Query: 855 SVAGSYGYIAPE------YAYTLKVDEKSDVYSFGVVLLELIAGKKPVGE-------FGD 901
              G+  Y+APE           +  +++D+Y+ G+V  E+       G        + D
Sbjct: 210 HRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD 269

Query: 902 GVDIVRWVRKTTSEVSQPSDAASVLAVVDPRL------SGYPLTGVIHLFKVAMMCVEDE 955
            V             S PS       V + +L             +  + K+   C    
Sbjct: 270 LVP------------SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYAN 317

Query: 956 SSARPTMREVVHMLAN 971
            +AR T   +   L+ 
Sbjct: 318 GAARLTALRIKKTLSQ 333

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  187 bits (478), Expect = 1e-51
 Identities = 98/449 (21%), Positives = 169/449 (37%), Gaps = 57/449 (12%)

Query: 164 IASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLNGIGLNGTVPAFLSRLKNLREMYI 223
             +L        G    T  + Q+  ++  +  +  + +G+       +  L NL ++  
Sbjct: 20  DTALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGI--KSIDGVEYLNNLTQINF 75

Query: 224 GYFNTYTGGIPPGFGALTQLQVLDMASCNISGEIPTSLSRLKLLHSLFLQMNKLTGHIPP 283
              N  T  I P    LT+L  + M +  I+   P  L+ L  L  L L  N++T   P 
Sbjct: 76  -SNNQLTD-ITP-LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP- 129

Query: 284 QLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQ 343
            L  L +L  L+LS N ++     + + L +L  L    N +    P  L +   LE L 
Sbjct: 130 -LKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSF-GNQVTDLKP--LANLTTLERLD 183

Query: 344 VWGNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFIGPIPE 403
           +  N  +      L +   L  L  T+N ++   P                         
Sbjct: 184 ISSNKVSD--ISVLAKLTNLESLIATNNQISDITP------------------------- 216

Query: 404 ELGQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLSGELPEKMSGASLNQLKV 463
            LG   +L ++  + N L       L +L  L  ++L +N +S  L        L +LK+
Sbjct: 217 -LGILTNLDELSLNGNQL--KDIGTLASLTNLTDLDLANNQISN-LAPLSGLTKLTELKL 272

Query: 464 ANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIPYS 523
             N I+   P  +  L +L  L L  N+LE   P+   NLK +T + +  NNIS   P  
Sbjct: 273 GANQISNISP--LAGLTALTNLELNENQLEDISPIS--NLKNLTYLTLYFNNISDISP-- 326

Query: 524 ISQCHSLTSVDLSRNSLYGKIPPGISKLIDLSILNLSRNGITGSIPNEMRNMMSLTTLDL 583
           +S    L  +    N +       ++ L +++ L+   N I+   P  + N+  +T L L
Sbjct: 327 VSSLTKLQRLFFYNNKV--SDVSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGL 382

Query: 584 SYNNLIGNIPSGGQFLAFNETSFIGNPNL 612
           +         +    ++   T       L
Sbjct: 383 NDQAWTNAPVNYKANVSIPNTVKNVTGAL 411

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  185 bits (471), Expect = 9e-51
 Identities = 98/447 (21%), Positives = 153/447 (34%), Gaps = 35/447 (7%)

Query: 142 GMTELQVLDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLNG 201
            + E         N T  +      L  +  L                 + +L  I  + 
Sbjct: 22  ALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK--SIDGVEYLNNLTQINFSN 77

Query: 202 IGLNGTVPAFLSRLKNLREMYIGYFNTYTGGIPPGFGALTQLQVLDMASCNISGEIPTSL 261
             L    P  L  L  L ++ +   N            LT L  L + +  I+   P  L
Sbjct: 78  NQLTDITP--LKNLTKLVDILM-NNNQIAD--ITPLANLTNLTGLTLFNNQITDIDP--L 130

Query: 262 SRLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQLF 321
             L  L+ L L  N ++      LSGL SL+ L    N +T   P   A L  L  L + 
Sbjct: 131 KNLTNLNRLELSSNTISD--ISALSGLTSLQQLSFG-NQVTDLKP--LANLTTLERLDIS 185

Query: 322 KNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDL 381
            N +     S L    NLE L    N  +      LG    L  L +  N L       L
Sbjct: 186 SNKVSDI--SVLAKLTNLESLIATNNQIS--DITPLGILTNLDELSLNGNQLKDIGT--L 239

Query: 382 CKGGKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELD 441
                L  L L  N      P  L     LT+++   N ++   P  L  L  L  +EL+
Sbjct: 240 ASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELN 295

Query: 442 DNLLSGELPEKMSGASLNQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESF 501
           +N L   +    +  +L  L +  NNI+   P  + +L  L  L   NN++     +   
Sbjct: 296 ENQLED-ISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDVSSLA-- 350

Query: 502 NLKMITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYGKIPPGISKLIDLSILNLSR 561
           NL  I  ++   N IS   P  ++    +T + L+  +     P      + +     + 
Sbjct: 351 NLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTN-APVNYKANVSIPNTVKNV 407

Query: 562 NGITGSIPNEMRNMMSLTTLDLSYNNL 588
            G     P  + +  S T  D+++N  
Sbjct: 408 TGAL-IAPATISDGGSYTEPDITWNLP 433

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  167 bits (426), Expect = 9e-45
 Identities = 91/436 (20%), Positives = 147/436 (33%), Gaps = 33/436 (7%)

Query: 86  SIPPEIGLLTKLVNLTISNVNLTGRLPSEMALLTSLKVFNISGNVFQGNFAGQIVRGMTE 145
                +  L  L  +  SN  LT    + +  LT L    ++ N          +  +T 
Sbjct: 59  KSIDGVEYLNNLTQINFSNNQLTD--ITPLKNLTKLVDILMNNNQIADITP---LANLTN 113

Query: 146 LQVLDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLNGIGLN 205
           L  L  +NN  T   P  + +L +L  L    N  +     + S + SL+ +        
Sbjct: 114 LTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSFGN---Q 166

Query: 206 GTVPAFLSRLKNLREMYIGYFNTYTGGIPPGFGALTQLQVLDMASCNISGEIPTSLSRLK 265
            T    L+ L  L  + I   N  +         LT L+ L   +  IS   P  L  L 
Sbjct: 167 VTDLKPLANLTTLERLDISS-NKVSD--ISVLAKLTNLESLIATNNQISDITP--LGILT 221

Query: 266 LLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQLFKNNL 325
            L  L L  N+L       L+ L +L  LDL+ N ++   P   + L  LT L+L  N +
Sbjct: 222 NLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQI 277

Query: 326 RGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDLCKGG 385
               P  L     L  L++  N         +     L  L +  N+++   P  +    
Sbjct: 278 SNISP--LAGLTALTNLELNENQLED--ISPISNLKNLTYLTLYFNNISDISP--VSSLT 331

Query: 386 KLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLL 445
           KL+ L    N         L    ++  +    N ++   P  L NL  +  + L+D   
Sbjct: 332 KLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAW 387

Query: 446 SGELPEKMSGASLNQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESFNLKM 505
           +       +  S+    V N       PA I +  S     +  N         S+    
Sbjct: 388 TNAPVNYKANVSIPNT-VKNVTGALIAPATISDGGSYTEPDITWNLPS-YTNEVSYTFSQ 445

Query: 506 ITSINISDNNISGEIP 521
             +I       SG + 
Sbjct: 446 PVTIGKGTTTFSGTVT 461

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 77.3 bits (191), Expect = 7e-15
 Identities = 24/132 (18%), Positives = 46/132 (34%), Gaps = 9/132 (6%)

Query: 457 SLNQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNI 516
            L    +  +    +I      L       L    +   +     +L  +T++      I
Sbjct: 2   PLGSATITQDTPINQIFT-DTALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGI 58

Query: 517 SGEIPYSISQCHSLTSVDLSRNSLYGKIPPGISKLIDLSILNLSRNGITGSIPNEMRNMM 576
                  +   ++LT ++ S N L    P  +  L  L  + ++ N I    P  + N+ 
Sbjct: 59  K--SIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLT 112

Query: 577 SLTTLDLSYNNL 588
           +LT L L  N +
Sbjct: 113 NLTGLTLFNNQI 124

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  171 bits (437), Expect = 2e-47
 Identities = 77/352 (21%), Positives = 132/352 (37%), Gaps = 26/352 (7%)

Query: 243 LQVLDMASCNISGEIPTSLSRLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLT 302
              L      I+   P   + L       LQ   +T  +      L S+  L ++   + 
Sbjct: 2   AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA 57

Query: 303 GEIPESFAALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGK 362
               +    L NL  L L  N +    P  L +   L  L +  N  T      L     
Sbjct: 58  S--IQGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKIT--DISALQNLTN 111

Query: 363 LLILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLN 422
           L  L +  ++++   P  L    K+ SL L  N  +      L     L  +  +++ + 
Sbjct: 112 LRELYLNEDNISDISP--LANLTKMYSLNLGANHNLS-DLSPLSNMTGLNYLTVTESKVK 168

Query: 423 GTIPAGLFNLPLLNMMELDDNLLSGELP-EKMSGASLNQLKVANNNITGKIPAAIGNLPS 481
              P  + NL  L  + L+ N +    P   ++  SL+      N IT   P  + N+  
Sbjct: 169 DVTP--IANLTDLYSLSLNYNQIEDISPLASLT--SLHYFTAYVNQITDITP--VANMTR 222

Query: 482 LNILSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLY 541
           LN L + NN++    P+   NL  +T + I  N IS  I  ++     L  +++  N + 
Sbjct: 223 LNSLKIGNNKITDLSPLA--NLSQLTWLEIGTNQISD-IN-AVKDLTKLKMLNVGSNQI- 277

Query: 542 GKIPPGISKLIDLSILNLSRNGITGSIPNEMRNMMSLTTLDLSYNNLIGNIP 593
                 ++ L  L+ L L+ N +       +  + +LTTL LS N++    P
Sbjct: 278 -SDISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP 328

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  168 bits (427), Expect = 5e-46
 Identities = 78/350 (22%), Positives = 144/350 (41%), Gaps = 26/350 (7%)

Query: 240 LTQLQVLDMASCNISGEIPTSLSRLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLN 299
           L +     +   +++  +      L+ +  L +   K+   I   +  L +L+ L+L+ N
Sbjct: 21  LAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA-SIQG-IEYLTNLEYLNLNGN 76

Query: 300 YLTGEIPESFAALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGR 359
            +T   P   + L  LT L +  N +     S L +  NL  L +  +N +      L  
Sbjct: 77  QITDISP--LSNLVKLTNLYIGTNKIT--DISALQNLTNLRELYLNEDNIS--DISPLAN 130

Query: 360 NGKLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKN 419
             K+  L++ +NH   +    L     L  L + ++      P  +     L  +  + N
Sbjct: 131 LTKMYSLNLGANHNL-SDLSPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYN 187

Query: 420 YLNGTIPAGLFNLPLLNMMELDDNLLSGELP-EKMSGASLNQLKVANNNITGKIPAAIGN 478
            +    P  L +L  L+      N ++   P   M+   LN LK+ NN IT   P  + N
Sbjct: 188 QIEDISP--LASLTSLHYFTAYVNQITDITPVANMT--RLNSLKIGNNKITDLSP--LAN 241

Query: 479 LPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIPYSISQCHSLTSVDLSRN 538
           L  L  L +  N++     V+  +L  +  +N+  N IS +I   ++    L S+ L+ N
Sbjct: 242 LSQLTWLEIGTNQISDINAVK--DLTKLKMLNVGSNQIS-DIS-VLNNLSQLNSLFLNNN 297

Query: 539 SLYGKIPPGISKLIDLSILNLSRNGITGSIPNEMRNMMSLTTLDLSYNNL 588
            L  +    I  L +L+ L LS+N IT   P  + ++  + + D +   +
Sbjct: 298 QLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVI 345

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  158 bits (402), Expect = 1e-42
 Identities = 72/372 (19%), Positives = 134/372 (36%), Gaps = 27/372 (7%)

Query: 146 LQVLDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLNGIGLN 205
              L           P   A L             T  + Q   E++S+  + + G  + 
Sbjct: 2   AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVTQE--ELESITKLVVAGEKV- 56

Query: 206 GTVPAFLSRLKNLREMYIGYFNTYTGGIPPGFGALTQLQVLDMASCNISGEIPTSLSRLK 265
                 +  L NL  + +         I P    L +L  L + +  I+    ++L  L 
Sbjct: 57  -ASIQGIEYLTNLEYLNLN--GNQITDISP-LSNLVKLTNLYIGTNKIT--DISALQNLT 110

Query: 266 LLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQLFKNNL 325
            L  L+L  + ++  I P L+ L  + SL+L  N+         + +  L  L + ++ +
Sbjct: 111 NLRELYLNEDNIS-DISP-LANLTKMYSLNLGANHNLS-DLSPLSNMTGLNYLTVTESKV 167

Query: 326 RGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDLCKGG 385
           +   P  + +  +L  L +  N         L     L       N +T   P  +    
Sbjct: 168 KDVTP--IANLTDLYSLSLNYNQIED--ISPLASLTSLHYFTAYVNQITDITP--VANMT 221

Query: 386 KLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLL 445
           +L SL +  N      P  L     LT +    N +  +    + +L  L M+ +  N +
Sbjct: 222 RLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQI--SDINAVKDLTKLKMLNVGSNQI 277

Query: 446 SGELPEKMSGASLNQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESFNLKM 505
           S ++    + + LN L + NN +  +    IG L +L  L L  N +    P+   +L  
Sbjct: 278 S-DISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRPLA--SLSK 334

Query: 506 ITSINISDNNIS 517
           + S + ++  I 
Sbjct: 335 MDSADFANQVIK 346

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  147 bits (374), Expect = 5e-39
 Identities = 71/358 (19%), Positives = 138/358 (38%), Gaps = 37/358 (10%)

Query: 94  LTKLVNLTISNVNLTGRLPSEMALLTSLKVFNISGNVFQGNFAGQI-----VRGMTELQV 148
           L + +   +   ++T         L S+    ++G         ++     +  +T L+ 
Sbjct: 21  LAEGIRAVLQKASVTD--VVTQEELESITKLVVAGE--------KVASIQGIEYLTNLEY 70

Query: 149 LDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLNGIGLNGTV 208
           L+   N  T   P  +++L  L +L  G N  T     +   + +L  + LN   +  + 
Sbjct: 71  LNLNGNQITDISP--LSNLVKLTNLYIGTNKIT--DISALQNLTNLRELYLNEDNI--SD 124

Query: 209 PAFLSRLKNLREMYIGYFNTYTGGIPPGFGALTQLQVLDMASCNISGEIPTSLSRLKLLH 268
            + L+ L  +  + +   N            +T L  L +    +    P  ++ L  L+
Sbjct: 125 ISPLANLTKMYSLNL-GANHNL-SDLSPLSNMTGLNYLTVTESKVKDVTP--IANLTDLY 180

Query: 269 SLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQLFKNNLRGP 328
           SL L  N++    P  L+ L SL      +N +T   P   A +  L  L++  N +   
Sbjct: 181 SLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDL 236

Query: 329 IPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDLCKGGKLK 388
            P  L +   L  L++  N  +      +    KL +L+V SN ++      L    +L 
Sbjct: 237 SP--LANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQISDISV--LNNLSQLN 290

Query: 389 SLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLS 446
           SL L  N       E +G   +LT +  S+N++    P  L +L  ++  +  + ++ 
Sbjct: 291 SLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 86.4 bits (215), Expect = 3e-18
 Identities = 25/139 (17%), Positives = 59/139 (42%), Gaps = 10/139 (7%)

Query: 456 ASLNQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNN 515
           A   +  +   ++T  +      L S+  L +   ++     +E   L  +  +N++ N 
Sbjct: 22  AEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVASIQGIE--YLTNLEYLNLNGNQ 77

Query: 516 ISGEIPYSISQCHSLTSVDLSRNSLYGKIPPGISKLIDLSILNLSRNGITGSIPNEMRNM 575
           I+   P  +S    LT++ +  N +       +  L +L  L L+ + I+   P  + N+
Sbjct: 78  ITDISP--LSNLVKLTNLYIGTNKI--TDISALQNLTNLRELYLNEDNISDISP--LANL 131

Query: 576 MSLTTLDLSYNNLIGNIPS 594
             + +L+L  N+ + ++  
Sbjct: 132 TKMYSLNLGANHNLSDLSP 150

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 51.4 bits (124), Expect = 7e-07
 Identities = 23/118 (19%), Positives = 42/118 (35%), Gaps = 17/118 (14%)

Query: 89  PEIGLLTKLVNLTISNVNLTGRLPSEMALLTSLKVFNISGNVFQGNFAGQI-----VRGM 143
             +  L++L  L I    ++    + +  LT LK+ N+  N        QI     +  +
Sbjct: 237 SPLANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSN--------QISDISVLNNL 286

Query: 144 TELQVLDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLNG 201
           ++L  L   NN         I  L +L  L    N+ T   P   + +  ++      
Sbjct: 287 SQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFAN 342

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  172 bits (439), Expect = 1e-45
 Identities = 76/471 (16%), Positives = 148/471 (31%), Gaps = 40/471 (8%)

Query: 148 VLDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLNGIGLNGT 207
                  NF   +P  +    S ++L    N        S+     L+ + L+   +   
Sbjct: 11  TYQCMELNFYK-IPDNLPF--STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTI 67

Query: 208 VPAFLSRLKNLREMYIGYFNTYTGGIPPG-FGALTQLQVLDMASCNISGEIPTSLSRLKL 266
                  L +L  + +   N     +  G F  L+ LQ L     N++      +  LK 
Sbjct: 68  EDGAYQSLSHLSTLILTG-NPIQS-LALGAFSGLSSLQKLVAVETNLASLENFPIGHLKT 125

Query: 267 LHSLFLQMNKLT-GHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTL----LQLF 321
           L  L +  N +    +P   S L +L+ LDLS N +          L  + L    L L 
Sbjct: 126 LKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLS 185

Query: 322 KNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRN-GKLLILDVTSNHLTG----- 375
            N +   I         L  L +  N  +  + +   +    L +  +            
Sbjct: 186 LNPMNF-IQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLE 244

Query: 376 TIPRDLCKGGKLKSLILMQN------FFIGPIPEELGQCKSLTKIRFSKNYLNGTIPAGL 429
              +   +G  L +L + +       +++  I +      +++        +   +    
Sbjct: 245 KFDKSALEG--LCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFS 301

Query: 430 F--NLPLLNMMELDDNLLSGELPEKMSGASLNQLKVANNNITGKIPAAIGNLPSLNILSL 487
           +      L ++            +     SL +L   +N           +LPSL  L L
Sbjct: 302 YNFGWQHLELVNCKFGQFPTLKLK-----SLKRLTFTSNKGGNAFSEV--DLPSLEFLDL 354

Query: 488 QNNRLE--GEIPVESFNLKMITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYGKIP 545
             N L   G      F    +  +++S N +   +  +      L  +D   ++L     
Sbjct: 355 SRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSE 413

Query: 546 PGI-SKLIDLSILNLSRNGITGSIPNEMRNMMSLTTLDLSYNNLIGNIPSG 595
             +   L +L  L++S      +       + SL  L ++ N+   N    
Sbjct: 414 FSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPD 464

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  159 bits (404), Expect = 4e-41
 Identities = 92/528 (17%), Positives = 168/528 (31%), Gaps = 76/528 (14%)

Query: 86  SIPPE-IGLLTKLVNLTISNVNLTGRLPSEMALLTSLKVFNISGNVFQGNFAGQIVRGMT 144
           +I       L+ L  L ++   +        + L+SL+           +     +  + 
Sbjct: 66  TIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLK 124

Query: 145 ELQVLDAYNNNFT-GPLPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLNGIG 203
            L+ L+  +N      LP   ++L +L HL    N            +  +  + L+   
Sbjct: 125 TLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLS--- 181

Query: 204 LNGTVPAFLSRLKNLREMYIGYFNTYTGGIPPGFGALTQLQVLDMASCNISGEIP----- 258
           L+      LS             N     I PG     +L  L + +   S  +      
Sbjct: 182 LD------LSL------------NPMN-FIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQ 222

Query: 259 --TSLSRLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTG---EIPESFAALK 313
               L   +L+   F     L       L GL +L   +  L YL     +I + F  L 
Sbjct: 223 GLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLT 282

Query: 314 NLTLLQLFKNNLRG-PIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNH 372
           N++   L    +      S+   + +LE++      F     ++      L  L  TSN 
Sbjct: 283 NVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKS------LKRLTFTSNK 336

Query: 373 LTGTIPRDLCKGGKLKSLILMQNF--FIGPIPEELGQCKSLTKIRFSKNYLNGTIPAGLF 430
                         L+ L L +N   F G   +      SL  +  S N +  T+ +   
Sbjct: 337 GGNAFSEVDLP--SLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFL 393

Query: 431 NLPLLNMMELDDNLLSGELPEKMSGASLNQLKVANNNITGKIPA-AIGNLPSLNILSLQN 489
            L                         L  L   ++N+          +L +L  L + +
Sbjct: 394 GLE-----------------------QLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISH 430

Query: 490 NRLEGEIPVESF-NLKMITSINISDNNISGEI-PYSISQCHSLTSVDLSRNSLYGKIPPG 547
                      F  L  +  + ++ N+      P   ++  +LT +DLS+  L  ++ P 
Sbjct: 431 THTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQL-EQLSPT 488

Query: 548 I-SKLIDLSILNLSRNGITGSIPNEMRNMMSLTTLDLSYNNLIGNIPS 594
             + L  L +LN++ N +          + SL  + L  N    + P 
Sbjct: 489 AFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 536

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  172 bits (437), Expect = 1e-45
 Identities = 85/493 (17%), Positives = 177/493 (35%), Gaps = 55/493 (11%)

Query: 144 TELQVLDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLNGIG 203
             ++ LD   N  T     ++ +  +L+ L    +        ++  + SLE++ L+   
Sbjct: 26  AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNH 85

Query: 204 LNGTVPAFLSRLKNLREMYIGYFNTYTGGIPPG-FGALTQLQVLDMASCNISGEIP-TSL 261
           L+    ++   L +L+ + +   N Y        F  LT LQ L + +     EI     
Sbjct: 86  LSSLSSSWFGPLSSLKYLNL-MGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDF 144

Query: 262 SRLKLLHSLFLQMNKLTGHIPPQ-LSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQL 320
           + L  L+ L ++   L  +   Q L  +  +  L L L+     +      L ++  L+L
Sbjct: 145 AGLTSLNELEIKALSLR-NYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLEL 203

Query: 321 FKNNLRGPIPSFLGDFPNLEVLQVWGN----------NFTFELPENLGRNGKLLILDVTS 370
              NL     S L        ++              N   +L   +    ++   D T 
Sbjct: 204 RDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTL 263

Query: 371 NHLT---GTIPRDLCKGGKLKSLIL----MQNFFIGPIPEE-LGQCKSLTKIRFSKNYLN 422
           N L     +    + + GK++++ +    +  F++           + + +I    + + 
Sbjct: 264 NGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF 323

Query: 423 GTIPAGLF-NLPLLNMMELDDNLLSGELPEKMSG----ASLNQLKVANNNIT--GKIPAA 475
             +P     +L  L  ++L +NL+  E  +  +      SL  L ++ N++    K    
Sbjct: 324 -LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEI 382

Query: 476 IGNLPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIPYSISQCHSLTSVDL 535
           +  L +L  L +  N     +P      + +  +N+S   I   +   I Q  +L  +D+
Sbjct: 383 LLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKTCIPQ--TLEVLDV 438

Query: 536 SRNSLYGKIPPGISKL--IDLS-----------------ILNLSRNGITGSIPNEMRNMM 576
           S N+L       + +L  + +S                 ++ +SRN +          + 
Sbjct: 439 SNNNL-DSFSLFLPRLQELYISRNKLKTLPDASLFPVLLVMKISRNQLKSVPDGIFDRLT 497

Query: 577 SLTTLDLSYNNLI 589
           SL  + L  N   
Sbjct: 498 SLQKIWLHTNPWD 510

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  170 bits (433), Expect = 4e-45
 Identities = 92/502 (18%), Positives = 190/502 (37%), Gaps = 32/502 (6%)

Query: 103 SNVNLTGRLPSEMALLTSLKVFNISGNVFQGNFAGQIVRGMTELQVLDAYNNNFTGPLPV 162
            + + T  +PS   L  ++K  ++S N          +R    LQVL   ++     +  
Sbjct: 13  RSRSFT-SIPSG--LTAAMKSLDLSFNKIT-YIGHGDLRACANLQVLILKSSRINT-IEG 67

Query: 163 EI-ASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLNGIGLNG-TVPAFLSRLKNLRE 220
           +   SL SL HL    N+ +      +  + SL+Y+ L G       V +    L NL+ 
Sbjct: 68  DAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQT 127

Query: 221 MYIGYFNTYTGGIPPGFGALTQLQVLDMASCNISGEIPTSLSRLKLLHSLFLQMNKLTGH 280
           + IG   T++      F  LT L  L++ + ++      SL  ++ +H L L +++    
Sbjct: 128 LRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFL 187

Query: 281 IPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQLFKNNLRGPIPSFLGDFPNLE 340
           +      L S++ L+L    L           +  + ++               +   L 
Sbjct: 188 LEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLL 247

Query: 341 VLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFIGP 400
              +  +   F   ++   NG        S+ ++     +      ++ L + Q +    
Sbjct: 248 RYILELSEVEF---DDCTLNGLGDFNPSESDVVSELGKVET---VTIRRLHIPQFYLFYD 301

Query: 401 IPEELGQCKSLTKIRFSKNYLNGTIPAGLF-NLPLLNMMELDDNLLSGELPEKMSG---- 455
           +       + + +I    + +   +P     +L  L  ++L +NL+  E  +  +     
Sbjct: 302 LSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAW 360

Query: 456 ASLNQLKVANNNIT--GKIPAAIGNLPSLNILSLQNNRLEGEIPVESFNLKMITSINISD 513
            SL  L ++ N++    K    +  L +L  L +  N     +P      + +  +N+S 
Sbjct: 361 PSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSS 419

Query: 514 NNISGEIPYSISQCHSLTSVDLSRNSLYGKIPPGISKLIDLSILNLSRNGITGSIPNEMR 573
             I   +   I Q  +L  +D+S N+L       + +   L  L +SRN +  ++P+   
Sbjct: 420 TGIR-VVKTCIPQ--TLEVLDVSNNNL-DSFSLFLPR---LQELYISRNKLK-TLPDAS- 470

Query: 574 NMMSLTTLDLSYNNLIGNIPSG 595
               L  + +S  N + ++P G
Sbjct: 471 LFPVLLVMKIS-RNQLKSVPDG 491

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 87.1 bits (216), Expect = 7e-18
 Identities = 55/301 (18%), Positives = 101/301 (33%), Gaps = 48/301 (15%)

Query: 61  SFSGVTCDQDSRVVSLNVSFMPLFGSIPPEIGLLTKLVNLTISNVNLTGRLPSEM-ALLT 119
             S +   +   +  L++    LF  +     LL K+  +T+ N  +   +P      L 
Sbjct: 276 VVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLK 334

Query: 120 SLKVFNISGNVFQGNFAGQ--IVRGMTELQVLDAYNNNFT--GPLPVEIASLKSLRHLSF 175
           SL+  ++S N+    +            LQ L    N+          + +LK+L  L  
Sbjct: 335 SLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDI 394

Query: 176 GGNYFTGKIPQSYSEIQSLEYIGLNGIGLNGTVPAFLSRLKNLREMYIGYFNTYTGGIPP 235
             N F                           +P      + +R + +   +T    +  
Sbjct: 395 SRNTFH-------------------------PMPDSCQWPEKMRFLNLS--STGIRVVKT 427

Query: 236 GFGALTQLQVLDMASCNISGEIPTSLSRLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLD 295
                  L+VLD+++ N+       L RL+    L++  NKL   +P   S    L  + 
Sbjct: 428 --CIPQTLEVLDVSNNNLD-SFSLFLPRLQ---ELYISRNKLK-TLPD-ASLFPVLLVMK 479

Query: 296 LSLNYLTGEIPESFAALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPE 355
           +S N L       F  L +L  + L  N        +    P ++ L  W N  + +   
Sbjct: 480 ISRNQLKSVPDGIFDRLTSLQKIWLHTNP-------WDCSCPRIDYLSRWLNKNSQKEQG 532

Query: 356 N 356
           +
Sbjct: 533 S 533

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 84.0 bits (208), Expect = 8e-17
 Identities = 54/324 (16%), Positives = 104/324 (32%), Gaps = 42/324 (12%)

Query: 365 ILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGT 424
           + D  S   T +IP  L     +KSL L  N        +L  C +L  +    + +N T
Sbjct: 9   VCDGRSRSFT-SIPSGLTA--AMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRIN-T 64

Query: 425 IPAGLFNLPLLNMMELDDNLLSGELPEKMSGASLNQLKVANNNITGKIPAAIGNLPSLNI 484
           I    F            +L            SL  L +++N+++    +  G L SL  
Sbjct: 65  IEGDAF-----------YSL-----------GSLEHLDLSDNHLSSLSSSWFGPLSSLKY 102

Query: 485 LSLQNNRLEGEIPVESF-NLKMITSINISDNNISGEIPY-SISQCHSLTSVDLSRNSLYG 542
           L+L  N  +       F NL  + ++ I +     EI     +   SL  +++   SL  
Sbjct: 103 LNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLR- 161

Query: 543 KIPPG-ISKLIDLSILNLSRNGITGSIPNEMRNMMSLTTLDLSYNNLIGNIPSGGQFLAF 601
                 +  + D+  L L  +     +      + S+  L+L   NL     S       
Sbjct: 162 NYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEV 221

Query: 602 NETSFIGNPNLCLLRNGTCQSLINSAKHSGDGYGSSFGASKIVITVIALLTFMLLVILTI 661
           +           +L + +   L+   ++  +            ++ +      L  +   
Sbjct: 222 SSPMKKLAFRGSVLTDESFNELLKLLRYILE------------LSEVEFDDCTLNGLGDF 269

Query: 662 YQLRKRRLQKSKAWKLTAFQRLDF 685
                  + +    +    +RL  
Sbjct: 270 NPSESDVVSELGKVETVTIRRLHI 293

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 67.8 bits (166), Expect = 9e-12
 Identities = 25/153 (16%), Positives = 51/153 (33%), Gaps = 11/153 (7%)

Query: 478 NLPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIPYSISQCHSLTSVDLSR 537
           +  +  +   ++      IP        + S+++S N I+      +  C +L  + L  
Sbjct: 3   SCDASGVCDGRSRSFT-SIPSGLTA--AMKSLDLSFNKITYIGHGDLRACANLQVLILKS 59

Query: 538 NSLYGKIPPGI-SKLIDLSILNLSRNGITGSIPNEM-RNMMSLTTLDLSYNNLIGNIPSG 595
           + +   I       L  L  L+LS N ++ S+ +     + SL  L+L  N     +   
Sbjct: 60  SRI-NTIEGDAFYSLGSLEHLDLSDNHLS-SLSSSWFGPLSSLKYLNLMGNPYQ-TLGVT 116

Query: 596 GQFLAFNETSFI---GNPNLCLLRNGTCQSLIN 625
             F        +          +R      L +
Sbjct: 117 SLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTS 149

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  169 bits (430), Expect = 2e-45
 Identities = 90/504 (17%), Positives = 174/504 (34%), Gaps = 76/504 (15%)

Query: 86  SIPPEIGLLTKLVNLTISNVNLTGRLPSEMALLTSLKVFNISGNVFQGNFAGQIVRGMTE 145
            +P E   +        +        P        + V  +   +              +
Sbjct: 25  EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCL------------DRQ 72

Query: 146 LQVLDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLNGIGLN 205
              L+  N   +  LP     L+SL   S   N  T ++P+    ++SL     N   L+
Sbjct: 73  AHELELNNLGLS-SLPELPPHLESL-VAS--CNSLT-ELPELPQSLKSLLVDNNNLKALS 127

Query: 206 GTVPAFLSRLKNLREMYIGYFNTYTGGIPPGFGALTQLQVLDMASCNISGEIPTSLSRLK 265
             +P  L  L  +    +           P     + L+++D+ + ++  ++P     L+
Sbjct: 128 D-LPPLLEYL-GVSNNQLEKL--------PELQNSSFLKIIDVDNNSLK-KLPDLPPSLE 176

Query: 266 LLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQLFKNNL 325
            +       N+L     P+L  L  L ++    N L  ++P+      +L  +    N L
Sbjct: 177 FIA---AGNNQLE--ELPELQNLPFLTAIYADNNSLK-KLPDL---PLSLESIVAGNNIL 227

Query: 326 RGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDLCKGG 385
                  L + P L  +    N     LP+       L  L+V  N+LT  +P       
Sbjct: 228 E--ELPELQNLPFLTTIYADNNLLK-TLPDLP---PSLEALNVRDNYLT-DLPELP---Q 277

Query: 386 KLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLL 445
            L  L + +N F G + E      +L  +  S N +  ++     +L  LN   + +N L
Sbjct: 278 SLTFLDVSENIFSG-LSELPP---NLYYLNASSNEIR-SLCDLPPSLEELN---VSNNKL 329

Query: 446 SGELPEKMSGASLNQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESFNLKM 505
             ELP       L +L  + N++  ++P    NL  L+   ++ N L  E P    +++ 
Sbjct: 330 I-ELPALPP--RLERLIASFNHLA-EVPELPQNLKQLH---VEYNPLR-EFPDIPESVE- 380

Query: 506 ITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYGKIPPGISKLIDLSILNLSRNGIT 565
               ++  N+   E+P       +L  + +  N L  + P     + D   L ++   + 
Sbjct: 381 ----DLRMNSHLAEVPELPQ---NLKQLHVETNPLR-EFPDIPESVED---LRMNSERVV 429

Query: 566 GSIPNEMRNMMSLTTLDLSYNNLI 589
                           D+  ++  
Sbjct: 430 -DPYEFAHETTDKLEDDVFEHHHH 452

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  152 bits (385), Expect = 2e-39
 Identities = 93/443 (20%), Positives = 154/443 (34%), Gaps = 64/443 (14%)

Query: 75  SLNVSFMPLFGSIPPEIGLLTKLVNLTISNVNLTGRLPSEMALLTSLKVFNISGNVFQGN 134
            L ++ + L  S+P        L +L  S  +LT  LP     L SL V N +       
Sbjct: 75  ELELNNLGL-SSLPELPP---HLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDL 129

Query: 135 FAGQIVRGMTELQVLDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQSL 194
                      L+ L   NN     LP E+ +   L+ +    N    K+P       SL
Sbjct: 130 --------PPLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLK-KLP---DLPPSL 175

Query: 195 EYIGLNGIGLNGTVPAFLSRLKNLREMYIGYFNTYTGGIPPGFGALTQLQVLDMASCNIS 254
           E+I      L       L  L  L  +Y    N+    +P        L+ +   +  + 
Sbjct: 176 EFIAAGNNQL--EELPELQNLPFLTAIYADN-NSLKK-LPDL---PLSLESIVAGNNILE 228

Query: 255 GEIPTSLSRLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKN 314
                 L  L  L +++   N L   +P       SL++L++  NYLT ++PE   +L  
Sbjct: 229 --ELPELQNLPFLTTIYADNNLLK-TLPDLPP---SLEALNVRDNYLT-DLPELPQSLTF 281

Query: 315 LTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLT 374
           L + +   + L           PNL  L    N     L +       L  L+V++N L 
Sbjct: 282 LDVSENIFSGL----SELP---PNLYYLNASSNEIR-SLCDLPP---SLEELNVSNNKLI 330

Query: 375 GTIPRDLCKGGKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGTIPAGLFNLPL 434
             +P       +L+ LI   N  +  +PE      +L ++    N L    P    ++  
Sbjct: 331 -ELPALP---PRLERLIASFNH-LAEVPELPQ---NLKQLHVEYNPLR-EFPDIPESVED 381

Query: 435 LNMMELDDNLLSGELPEKMSGASLNQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLEG 494
           L M     N    E+PE     +L QL V  N +  + P    ++  L    + + R+  
Sbjct: 382 LRM-----NSHLAEVPELPQ--NLKQLHVETNPLR-EFPDIPESVEDLR---MNSERVVD 430

Query: 495 EIPVESFNLKMITSINISDNNIS 517
                      +       ++  
Sbjct: 431 PYEFAHETTDKLEDDVFEHHHHH 453

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  138 bits (350), Expect = 5e-35
 Identities = 75/334 (22%), Positives = 123/334 (36%), Gaps = 43/334 (12%)

Query: 264 LKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQLFKN 323
              L       + LT  +P +   + S      + +      P      + + + +L   
Sbjct: 10  NTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDC 68

Query: 324 NLRG---------PIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLT 374
             R           + S     P+LE L    N+ T ELPE       LL+ +     L+
Sbjct: 69  LDRQAHELELNNLGLSSLPELPPHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALS 127

Query: 375 GTIPRDLCKGGKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGTIPAGLFNLPL 434
              P        L+ L +  N  +  +P EL     L  I    N L   +P    +L  
Sbjct: 128 DLPP-------LLEYLGVSNN-QLEKLP-ELQNSSFLKIIDVDNNSLK-KLPDLPPSLEF 177

Query: 435 LNMMELDDNLLSGELPEKMSGASLNQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLEG 494
           +      +N L  ELPE  +   L  +   NN++  K+P    +L S+      NN LE 
Sbjct: 178 IA---AGNNQLE-ELPELQNLPFLTAIYADNNSLK-KLPDLPLSLESIV---AGNNILE- 228

Query: 495 EIPVESFNLKMITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYGKIPPGISKLIDL 554
           E+P E  NL  +T+I   +N +   +P       SL ++++  N L   +P     L  L
Sbjct: 229 ELP-ELQNLPFLTTIYADNNLLK-TLPDLPP---SLEALNVRDNYL-TDLPELPQSLTFL 282

Query: 555 SILNLSRNGITGSIPNEMRNMMSLTTLDLSYNNL 588
            +     +G++   PN       L  L+ S N +
Sbjct: 283 DVSENIFSGLSELPPN-------LYYLNASSNEI 309

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  137 bits (346), Expect = 2e-34
 Identities = 70/330 (21%), Positives = 128/330 (38%), Gaps = 48/330 (14%)

Query: 280 HIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQLFKNNLRGPIPSFLGDFPNL 339
            I P+      L+      + LT E+P     +K+ T      +      P   G+   +
Sbjct: 2   FINPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREM 60

Query: 340 EVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFIG 399
            V +         L + L R      L++ +  L+ ++P        L+SL+   N  + 
Sbjct: 61  AVSR---------LRDCLDRQ--AHELELNNLGLS-SLPELP---PHLESLVASCN-SLT 104

Query: 400 PIPEELGQCKSLTKIRFSKNYLNGTIPA---------------GLFNLPLLNMMELDDNL 444
            +PE     KSL     +   L+   P                 L N   L ++++D+N 
Sbjct: 105 ELPELPQSLKSLLVDNNNLKALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNS 164

Query: 445 LSGELPEKMSGASLNQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESFNLK 504
           L  +LP+     SL  +   NN +  ++P  + NLP L  +   NN L+ ++P    +L+
Sbjct: 165 LK-KLPDLPP--SLEFIAAGNNQLE-ELP-ELQNLPFLTAIYADNNSLK-KLPDLPLSLE 218

Query: 505 MITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYGKIPPGISKLIDLSILNLSRNGI 564
              SI   +N +  E+P  +     LT++    N L   +P        L  LN+  N +
Sbjct: 219 ---SIVAGNNILE-ELP-ELQNLPFLTTIYADNNLL-KTLPDLPPS---LEALNVRDNYL 269

Query: 565 TGSIPNEMRNMMSLTTLDLSYNNLIGNIPS 594
           T  +P   +++  L   +  ++ L    P+
Sbjct: 270 T-DLPELPQSLTFLDVSENIFSGLSELPPN 298

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  162 bits (413), Expect = 2e-44
 Identities = 48/357 (13%), Positives = 103/357 (28%), Gaps = 51/357 (14%)

Query: 240 LTQLQVLDMASCNISGEIPTSLSRLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLN 299
            +  + L              LS+ +  ++          H   + +   + +    +  
Sbjct: 11  SSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRW----HSAWRQANSNNPQIETRTGR 66

Query: 300 YLTGEIPESF--AALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENL 357
            L     +    A       L+L    L    P       +L+ + +       ELP+ +
Sbjct: 67  ALK-ATADLLEDATQPGRVALELRSVPLPQ-FPDQAFRLSHLQHMTIDAAGLM-ELPDTM 123

Query: 358 GRNGKLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFIGPIPEELGQCKSLTKIRFS 417
            +   L  L +  N L                           +P  +     L ++   
Sbjct: 124 QQFAGLETLTLARNPLRA-------------------------LPASIASLNRLRELSIR 158

Query: 418 KNYLNGTIPAGLFNLPLLNMMELDDNLLSGELPEKMSGASLNQLKVANNNITGKIPAAIG 477
                  +P  L +                 L       +L  L++    I   +PA+I 
Sbjct: 159 ACPELTELPEPLASTDASGEH--------QGLV------NLQSLRLEWTGIR-SLPASIA 203

Query: 478 NLPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIPYSISQCHSLTSVDLSR 537
           NL +L  L ++N+ L   +     +L  +  +++         P        L  + L  
Sbjct: 204 NLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKD 262

Query: 538 NSLYGKIPPGISKLIDLSILNLSRNGITGSIPNEMRNMMSLTTLDLSYNNLIGNIPS 594
            S    +P  I +L  L  L+L        +P+ +  + +   + +   +L   +  
Sbjct: 263 CSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVP-PHLQAQLDQ 318

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  147 bits (373), Expect = 5e-39
 Identities = 58/352 (16%), Positives = 112/352 (31%), Gaps = 29/352 (8%)

Query: 84  FGSIPPEIGLLTKLVNLTISNVNLTGRLPSEMALLTSLKVFNISGNVFQGNFAGQIVRGM 143
            GS        +   NL              ++        + +        A       
Sbjct: 1   MGSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQAN-----S 55

Query: 144 TELQVLDAYNNNFTG-PLPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLNGI 202
              Q+              +E A+      L         + P     +  L+++ ++  
Sbjct: 56  NNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAA 114

Query: 203 GLNGTVPAFLSRLKNLREMYIGYFNTYTGGIPPGFGALTQLQVLDMASCNISGEIPTSLS 262
           GL   +P  + +   L  + +   N     +P    +L +L+ L + +C    E+P  L+
Sbjct: 115 GLM-ELPDTMQQFAGLETLTLAR-NPLRA-LPASIASLNRLRELSIRACPELTELPEPLA 171

Query: 263 RLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQLFK 322
                                +  GL++L+SL L    +   +P S A L+NL  L++  
Sbjct: 172 STDA---------------SGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRN 215

Query: 323 NNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTS-NHLTGTIPRDL 381
           + L   +   +   P LE L + G       P   G    L  L +   ++L  T+P D+
Sbjct: 216 SPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL-TLPLDI 273

Query: 382 CKGGKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGTIPAGLFNLP 433
            +  +L+ L L     +  +P  + Q  +   I    +             P
Sbjct: 274 HRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHRPVARP 325

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  113 bits (285), Expect = 2e-27
 Identities = 39/214 (18%), Positives = 76/214 (35%), Gaps = 12/214 (5%)

Query: 86  SIPPEIGLLTKLVNLTISNVNLTGRLPSEMALLTSLKVFNISGN--------VFQGNFAG 137
            +P  +     L  LT++   L   LP+ +A L  L+  +I                 A 
Sbjct: 118 ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDAS 176

Query: 138 QIVRGMTELQVLDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYI 197
              +G+  LQ L          LP  IA+L++L+ L    +  +  +  +   +  LE +
Sbjct: 177 GEHQGLVNLQSLRLEWTGIRS-LPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEEL 234

Query: 198 GLNGIGLNGTVPAFLSRLKNLREMYIGYFNTYTGGIPPGFGALTQLQVLDMASCNISGEI 257
            L G       P        L+ + +   +     +P     LTQL+ LD+  C     +
Sbjct: 235 DLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLT-LPLDIHRLTQLEKLDLRGCVNLSRL 293

Query: 258 PTSLSRLKLLHSLFLQMNKLTGHIPPQLSGLISL 291
           P+ +++L     + +  +        +     + 
Sbjct: 294 PSLIAQLPANCIILVPPHLQAQLDQHRPVARPAE 327

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 63.0 bits (154), Expect = 1e-10
 Identities = 17/134 (12%), Positives = 36/134 (26%), Gaps = 23/134 (17%)

Query: 476 IGNLPSLNILSLQNNR-----------------LEGEIPVESFNLKMITSINISDNNISG 518
             +      L  Q +                   +      ++      +  I       
Sbjct: 8   HHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRA 67

Query: 519 --EIPYSISQCHS--LTSVDLSRNSLYGKIPPGISKLIDLSILNLSRNGITGSIPNEMRN 574
                  +         +++L    L  + P    +L  L  + +   G+   +P+ M+ 
Sbjct: 68  LKATADLLEDATQPGRVALELRSVPL-PQFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQ 125

Query: 575 MMSLTTLDLSYNNL 588
              L TL L+ N L
Sbjct: 126 FAGLETLTLARNPL 139

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 49.9 bits (120), Expect = 2e-06
 Identities = 18/103 (17%), Positives = 32/103 (31%), Gaps = 25/103 (24%)

Query: 76  LNVSFMPLFGSIPPEIGLLTKLVNLTISNVNLTGRLPSEMALLTSLKVFNISGNVFQGNF 135
           L++       + PP  G    L  L + + +    LP ++  LT L+  ++ G       
Sbjct: 234 LDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGC------ 287

Query: 136 AGQIVRGMTELQVLDAYNNNFTGPLPVEIASLKSLRHLSFGGN 178
                     L             LP  IA L +   +    +
Sbjct: 288 --------VNLSR-----------LPSLIAQLPANCIILVPPH 311

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 41.9 bits (99), Expect = 8e-04
 Identities = 16/57 (28%), Positives = 29/57 (50%), Gaps = 2/57 (3%)

Query: 75  SLNVSFMPLFGSIPPEIGLLTKLVNLTIS-NVNLTGRLPSEMALLTSLKVFNISGNV 130
            L +       ++P +I  LT+L  L +   VNL+ RLPS +A L +  +  +  ++
Sbjct: 257 RLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLS-RLPSLIAQLPANCIILVPPHL 312

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  168 bits (428), Expect = 4e-43
 Identities = 95/555 (17%), Positives = 176/555 (31%), Gaps = 71/555 (12%)

Query: 66  TCDQDSRVVSLNVSFMPLFGSIPPEIGLLTKLVNLTISNVNLTGRLPSEMALLTSLKVFN 125
           +C  D R+      F  L   +P    +L     L +S   +     S    L  L++  
Sbjct: 1   SCSFDGRIA--FYRFCNLT-QVPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLE 54

Query: 126 ISGNVFQGNFAGQIVRGMTELQVLDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIP 185
           +           +  R +  L++LD  ++      P     L  L  L       +  + 
Sbjct: 55  LGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVL 114

Query: 186 QSYSEIQSLEYIGLNGIGLNGTVPAFLSRLKNLREMYIGYFNTYTGGIPPGFGALTQLQV 245
           +                        +   LK L  + +      +  + P FG L  L+ 
Sbjct: 115 K----------------------DGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKS 152

Query: 246 LDMASCNISGEIPTSLSRLKLLH--SLFLQMNKLTGHIPPQLSGL------ISLKSLDLS 297
           +D +S  I       L  L+        L  N L   +             + L+ LD+S
Sbjct: 153 IDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVS 212

Query: 298 LNYLTGEIP------------ESFAALKNLTLLQLFKNNLRGPIPSFLGDFP--NLEVLQ 343
            N  T +I              S     ++       +N++ P  +        ++  L 
Sbjct: 213 GNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLD 272

Query: 344 VWGNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFIGPIPE 403
           +                  L +L++  N +             L+ L L  N        
Sbjct: 273 LSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSS 332

Query: 404 ELGQCKSLTKIRFSKNYLNGTIPAGLF-NLPLLNMMELDDNLLSGELPEKMSGASLNQLK 462
                  +  I   KN++   I    F  L  L  ++L DN L+          S+  + 
Sbjct: 333 NFYGLPKVAYIDLQKNHIA-IIQDQTFKFLEKLQTLDLRDNALT----TIHFIPSIPDIF 387

Query: 463 VANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESF--NLKMITSINISDNNISG-E 519
           ++ N +   +P       + N++ L  NRLE  + +  F   +  +  + ++ N  S   
Sbjct: 388 LSGNKLV-TLPK---INLTANLIHLSENRLEN-LDILYFLLRVPHLQILILNQNRFSSCS 442

Query: 520 IPYSISQCHSLTSVDLSRNSLYGKIPPGISK-----LIDLSILNLSRNGITGSIPNEM-R 573
              + S+  SL  + L  N L       +       L  L +L L+ N +  S+P  +  
Sbjct: 443 GDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLN-SLPPGVFS 501

Query: 574 NMMSLTTLDLSYNNL 588
           ++ +L  L L+ N L
Sbjct: 502 HLTALRGLSLNSNRL 516

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  161 bits (409), Expect = 7e-41
 Identities = 76/416 (18%), Positives = 142/416 (34%), Gaps = 41/416 (9%)

Query: 233 IPPGFGALTQLQVLDMASCNISGEIPTSLSRLKLLHSLFLQMNKLTGHIPPQ-LSGLISL 291
           +P     L   + L ++   I     +S   L+ L  L L        I  +    L +L
Sbjct: 19  VPQV---LNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNL 75

Query: 292 KSLDLSLNYLTGEIPESFAALKNLTLLQLFKNNLRGPI--PSFLGDFPNLEVLQVWGNNF 349
           + LDL  + +    P++F  L +L  L+L+   L   +    +  +   L  L +  N  
Sbjct: 76  RILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQI 135

Query: 350 T-FELPENLGRNGKLLILDVTSNHLTGTIPRDL--CKGGKLKSLILMQNFFIGPIPEELG 406
               L  + G+   L  +D +SN +      +L   +G  L    L  N     +  + G
Sbjct: 136 RSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWG 195

Query: 407 QC------KSLTKIRFSKNYLNGTIPAGLFN------------LPLLNMMELDDNLLSG- 447
           +C        L  +  S N     I     N               +       + +   
Sbjct: 196 KCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDP 255

Query: 448 --ELPEKMSGASLNQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESF-NLK 504
                  ++ +S+  L +++  +          L  L +L+L  N++  +I  E+F  L 
Sbjct: 256 DQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKIN-KIADEAFYGLD 314

Query: 505 MITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYGKIPPGI-SKLIDLSILNLSRNG 563
            +  +N+S N +      +      +  +DL +N +   I       L  L  L+L  N 
Sbjct: 315 NLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIA-IIQDQTFKFLEKLQTLDLRDNA 373

Query: 564 ITGSIPNEMRNMMSLTTLDLSYNNL--IGNIPSGGQFLAFNETSFIGNPNLCLLRN 617
           +T      +  + S+  + LS N L  +  I      +  +E        L  L  
Sbjct: 374 LT-----TIHFIPSIPDIFLSGNKLVTLPKINLTANLIHLSENRLENLDILYFLLR 424

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  155 bits (394), Expect = 5e-39
 Identities = 110/638 (17%), Positives = 205/638 (32%), Gaps = 103/638 (16%)

Query: 94  LTKLVNLTISNVNLTGRLPSEMAL--LTSLKVFNISGNVFQGNFAGQIVRGMTELQVLDA 151
           L  L  L +    L+  +  +     L +L   ++S N  +  +       +  L+ +D 
Sbjct: 96  LFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDF 155

Query: 152 YNNNFTGPLPVEIASL--KSLRHLSFGGNYFTGKIPQSYSE-IQSLEYIGL-------NG 201
            +N        E+  L  K+L   S   N    ++   + + +     + L       NG
Sbjct: 156 SSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNG 215

Query: 202 I----------GLNGTVPAFLSRLKNLREMYIGYFNTYTGGIPPG-FGAL--TQLQVLDM 248
                       ++ +    L    ++     G+ N          F  L  + ++ LD+
Sbjct: 216 WTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKD--PDQNTFAGLARSSVRHLDL 273

Query: 249 ASCNISGEIPTSLSRLKLLHSLFLQMNKLTGHIPPQ-LSGLISLKSLDLSLNYLTGEIPE 307
           +   +          LK L  L L  NK+   I  +   GL +L+ L+LS N L      
Sbjct: 274 SHGFVFSLNSRVFETLKDLKVLNLAYNKIN-KIADEAFYGLDNLQVLNLSYNLLGELYSS 332

Query: 308 SFAALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILD 367
           +F  L  +  + L KN++             L+                         LD
Sbjct: 333 NFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQT------------------------LD 368

Query: 368 VTSNHLTGTIPRDLCKGGKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGTIPA 427
           +  N LT      +     +  + L  N           +  +L KI  + N ++     
Sbjct: 369 LRDNALT-----TIHFIPSIPDIFLSGN-----------KLVTLPKINLTANLIH----- 407

Query: 428 GLFNLPLLNMMELDDNLLSGELPEKMSGASLNQLKVANNNITG-KIPAAIGNLPSLNILS 486
            L    L       +NL       ++    L  L +  N  +           PSL  L 
Sbjct: 408 -LSENRL-------ENLDILYFLLRVP--HLQILILNQNRFSSCSGDQTPSENPSLEQLF 457

Query: 487 LQNNRLEG----EIPVESF-NLKMITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLY 541
           L  N L+     E+  + F  L  +  + ++ N ++   P   S   +L  + L+ N L 
Sbjct: 458 LGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRL- 516

Query: 542 GKIPPGISKLIDLSILNLSRNGITGSIPNEMRNMMSLTTLDLSYNNLIGNIPSGG--QFL 599
             +        +L IL++SRN +    P+   +   L+ LD+++N  I          +L
Sbjct: 517 TVLSHN-DLPANLEILDISRNQLLAPNPDVFVS---LSVLDITHNKFICECELSTFINWL 572

Query: 600 AFNETSFIGNPNLCL------LRNGTCQSLINSAKHSGDGYGSSFGASKIVITVIALLTF 653
                +  G P              +  SL        +   S   +  IV TV   L  
Sbjct: 573 NHTNVTIAGPPADIYCVYPDSFSGVSLFSLSTEGCDEEEVLKSLKFSLFIVCTVTLTLFL 632

Query: 654 MLLVILTIYQLRKRRLQKSKAWKLTAFQRLDFKAEDVL 691
           M ++ +T ++       K+    +        + +   
Sbjct: 633 MTILTVTKFRGFCFICYKTAQRLVFKDHPQGTEPDMYK 670

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  133 bits (337), Expect = 4e-32
 Identities = 77/396 (19%), Positives = 127/396 (32%), Gaps = 59/396 (14%)

Query: 250 SCNISGEIPTSLSRLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESF 309
           SC+  G I             F +   LT  +P  L+   + + L LS NY+      SF
Sbjct: 1   SCSFDGRI------------AFYRFCNLT-QVPQVLN---TTERLLLSFNYIRTVTASSF 44

Query: 310 AALKNLTLLQLFKNNLRGPI-PSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDV 368
             L+ L LL+L        I      + PNL +L +  +   F  P+       L  L +
Sbjct: 45  PFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRL 104

Query: 369 TSNHLT-GTIPRDLCKG-GKLKSLILMQNFFIG-PIPEELGQCKSLTKIRFSKNYLNGTI 425
               L+   +     +    L  L L +N      +    G+  SL  I FS N +   +
Sbjct: 105 YFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIF-LV 163

Query: 426 PAGLFN---LPLLNMMELDDNLLS-------GELPEKMSGASLNQLKVANNNITGKIPAA 475
                       L+   L  N L        G+         L  L V+ N  T  I   
Sbjct: 164 CEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGN 223

Query: 476 IGN------------LPSLNILSLQNNRLEGEIPVESF-NLKM--ITSINISDNNISGEI 520
             N               +       + ++ +    +F  L    +  +++S   +    
Sbjct: 224 FSNAISKSQAFSLILAHHIMGAGFGFHNIK-DPDQNTFAGLARSSVRHLDLSHGFVFSLN 282

Query: 521 PYSISQCHSLTSVDLSRNSLYGKIPPGI-SKLIDLSILNLSRNGITGSIPNEMRNMMSLT 579
                    L  ++L+ N +  KI       L +L +LNLS N +     +    +  + 
Sbjct: 283 SRVFETLKDLKVLNLAYNKI-NKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVA 341

Query: 580 TLDLSYNNLIGNIPSGGQFLAFNETSFIGNPNLCLL 615
            +DL  N+ I  I            +F     L  L
Sbjct: 342 YIDLQKNH-IAIIQDQ---------TFKFLEKLQTL 367

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  152 bits (387), Expect = 2e-41
 Identities = 64/213 (30%), Positives = 99/213 (46%), Gaps = 15/213 (7%)

Query: 694 LKDENIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGND-HGFLAEIQTLGRIRHRNI 751
           LK +  IG+G    VY+G      ++VA   L  R    ++   F  E + L  ++H NI
Sbjct: 28  LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 87

Query: 752 VRLLG-YVSNRDTNLLLY---EYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYL 807
           VR    + S       +    E M +G+L   L   +   +K +       +  KGL +L
Sbjct: 88  VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLK--RFKVMKIKVLRSWCRQILKGLQFL 145

Query: 808 HHDCSPLIIHRDVKSNNILLDS-DFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPE 866
           H   +P IIHRD+K +NI +        + D GLA   + + A     +V G+  ++APE
Sbjct: 146 H-TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA----KAVIGTPEFMAPE 200

Query: 867 YAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEF 899
             Y  K DE  DVY+FG+ +LE+   + P  E 
Sbjct: 201 M-YEEKYDESVDVYAFGMCMLEMATSEYPYSEC 232

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  157 bits (398), Expect = 5e-41
 Identities = 58/358 (16%), Positives = 115/358 (32%), Gaps = 21/358 (5%)

Query: 237 FGALTQLQVLDMASCNISGEIPTSLSRLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDL 296
                + ++  +   ++   + +       +  L L  N L+      L+    L+ L+L
Sbjct: 6   KQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNL 65

Query: 297 SLNYLTGEIPESFAALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPEN 356
           S N L  E  +   +L  L  L L  N +       L   P++E L    NN +  +  +
Sbjct: 66  SSNVLY-ETLD-LESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS-RVSCS 117

Query: 357 LGRNGKLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFIG-PIPEELGQCKSLTKIR 415
            G+      + + +N +T     D     +++ L L  N        E      +L  + 
Sbjct: 118 RGQG--KKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLN 175

Query: 416 FSKNYLNGTIPAGLFNLPLLNMMELDDNLLSGELPEKMSG-ASLNQLKVANNNITGKIPA 474
              N++   +   +     L  ++L  N L+  +  +    A +  + + NN +   I  
Sbjct: 176 LQYNFIY-DVKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEK 231

Query: 475 AIGNLPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIPYSISQCHSLTSVD 534
           A+    +L    L+ N       +  F  K      ++   +      +  +C   T   
Sbjct: 232 ALRFSQNLEHFDLRGNGFHC-GTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGH 290

Query: 535 LSRNSLYGKIPPGISKLIDLSILNLSRNGITGS----IPNEMRNMMSLTTLDLSYNNL 588
                      P   +LI L     +     GS    +  E  N      +D      
Sbjct: 291 YGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQY 348

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  138 bits (350), Expect = 7e-35
 Identities = 76/482 (15%), Positives = 151/482 (31%), Gaps = 39/482 (8%)

Query: 86  SIPPEIGLLTKLVNLTISNVNLTGRLPSEMALLTSLKVFNISGNVFQGNFAGQIVRGMTE 145
           +I        +     +++ +L   L S      ++K  ++SGN      A  +    T+
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADL-APFTK 59

Query: 146 LQVLDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLNGIGLN 205
           L++L+  +N     L   + SL +LR L    NY   ++        S+E +      ++
Sbjct: 60  LELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQ-ELLVG----PSIETLHAANNNIS 112

Query: 206 GTVPAFLSRLKNLREMYIGYFNTYTGGIPPGFGALTQLQVLDMASCNISG-EIPTSLSRL 264
             V    SR +  + +Y+   N  T       G  +++Q LD+    I         +  
Sbjct: 113 -RVSC--SRGQGKKNIYLAN-NKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASS 168

Query: 265 KLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQLFKNN 324
             L  L LQ N +   +  Q+     LK+LDLS N L   +   F +   +T + L  N 
Sbjct: 169 DTLEHLNLQYNFIY-DVKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNK 225

Query: 325 LRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDLCKG 384
           L   I   L    NLE   + GN F      +        +  V    +   +     + 
Sbjct: 226 LVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKN-QRVQTVAKQTVK-KLTGQNEEE 282

Query: 385 GKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNL 444
             + +L     +    +P                 + +  I        LL+      + 
Sbjct: 283 CTVPTLGHYGAYCCEDLP---------------APFADRLIALKRKEHALLS---GQGSE 324

Query: 445 LSGELPEKMSGASLNQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESFNLK 504
                 E+ + A   ++          I        +   L  +   L+ E         
Sbjct: 325 TERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALD-EQVSNGRRAH 383

Query: 505 MITSINISDNNISGEIPYSISQCHSLTSVDLSRNSL-YGKIPPGISKLIDLSILNLSRNG 563
                 +       E+ ++  +   L  +           +     +   +   ++ ++ 
Sbjct: 384 AELDGTLQQAVGQIELQHATEEQSPLQLLRAIVKRYEEMYVEQQSVQNNAIRDWDMYQHK 443

Query: 564 IT 565
            T
Sbjct: 444 ET 445

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  137 bits (347), Expect = 2e-34
 Identities = 54/321 (16%), Positives = 106/321 (33%), Gaps = 41/321 (12%)

Query: 305 IPESFAALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLL 364
           I E         + ++  ++L+  + S      N++ L + GN  +     +L    KL 
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61

Query: 365 ILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGT 424
           +L+++SN L      DL     L++L L  N+      +EL    S+  +  + N ++  
Sbjct: 62  LLNLSSNVLYE--TLDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS-R 113

Query: 425 IPAGLFNLPLLNMMELDDNLLSGELPEKMSGASLNQLKVANNNITGKIPAAIGNLPSLNI 484
           +                                   + +ANN IT       G    +  
Sbjct: 114 VSCSRGQ-------------------------GKKNIYLANNKITMLRDLDEGCRSRVQY 148

Query: 485 LSLQNNRLEGEIPVESF--NLKMITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYG 542
           L L+ N ++  +       +   +  +N+  N I  ++         L ++DLS N L  
Sbjct: 149 LDLKLNEID-TVNFAELAASSDTLEHLNLQYNFIY-DVK-GQVVFAKLKTLDLSSNKL-A 204

Query: 543 KIPPGISKLIDLSILNLSRNGITGSIPNEMRNMMSLTTLDLSYNNLIGNIPSGGQFLAFN 602
            + P       ++ ++L  N +   I   +R   +L   DL  N           F    
Sbjct: 205 FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDF-FSKNQ 262

Query: 603 ETSFIGNPNLCLLRNGTCQSL 623
               +    +  L     +  
Sbjct: 263 RVQTVAKQTVKKLTGQNEEEC 283

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  134 bits (338), Expect = 2e-33
 Identities = 65/454 (14%), Positives = 136/454 (29%), Gaps = 25/454 (5%)

Query: 71  SRVVSLNVSFMPLFGSIPPEIGLLTKLVNLTISNVNLTGRLPSEMALLTSLKVFNISGNV 130
           +R     V+   L  ++         +  L +S   L+    +++A  T L++ N+S NV
Sbjct: 10  NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNV 69

Query: 131 FQGNFAGQIVRGMTELQVLDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSYSE 190
                    +  ++ L+ LD  NN        E+    S+  L    N  + ++  S   
Sbjct: 70  LYETLD---LESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVSCSR-- 118

Query: 191 IQSLEYIGLNGIGLNGTVPAFLSRLKNLREMYIGYFNTYTGGIPPGFGALTQLQVLDMAS 250
            Q  + I L    +             ++ + +      T        +   L+ L++  
Sbjct: 119 GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQY 178

Query: 251 CNISGEIPTSLSRLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFA 310
             I  ++   +     L +L L  NKL   + P+      +  + L  N L   I ++  
Sbjct: 179 NFIY-DVKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALR 234

Query: 311 ALKNLTLLQLFKNNLR-GPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVT 369
             +NL    L  N    G +  F      ++ +            +N        +    
Sbjct: 235 FSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVA--KQTVKKLTGQNEEECTVPTLGHYG 292

Query: 370 SNHLTGTIPRDLCKGGKLK----SLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGTI 425
           +            +   LK    +L+  Q      +  E        +I   K     T+
Sbjct: 293 AYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYR-TV 351

Query: 426 PAGLF-NLPLLNMMELDDNLLSGELPEKMSGASLNQLKVANNNITGKIPAAIGNLPSLNI 484
              +         +E     L  ++       +     +       ++  A      L +
Sbjct: 352 IDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQIELQHATEEQSPLQL 411

Query: 485 LSLQNNRL-EGEIPVESFNLKMITSINISDNNIS 517
           L     R  E  +  +S     I   ++  +  +
Sbjct: 412 LRAIVKRYEEMYVEQQSVQNNAIRDWDMYQHKET 445

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 72.2 bits (177), Expect = 3e-13
 Identities = 38/310 (12%), Positives = 77/310 (24%), Gaps = 42/310 (13%)

Query: 86  SIPPEIGLLTKLVNLTISNVNLTGRLPSEMALLTSLKVFNISGN---VFQGNFAGQIVRG 142
           +          L +L +    +   +  +  +   LK  ++S N        F       
Sbjct: 160 NFAELAASSDTLEHLNLQYNFIY-DVKGQ-VVFAKLKTLDLSSNKLAFMGPEFQS----- 212

Query: 143 MTELQVLDAYNNNFTGPLPVEIASLKSLRHLSFGGNYF-TGKIPQSYSEIQSLEYIGLNG 201
              +  +   NN     +   +   ++L H    GN F  G +   +S+ Q ++ +    
Sbjct: 213 AAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQT 271

Query: 202 I-------------------------GLNGTVPAFLSRLKNLREMYIGYFNTYTGGIPPG 236
           +                          L       L  LK      +    + T  +   
Sbjct: 272 VKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECE 331

Query: 237 FGALTQLQVLDMASCNISGEIPTSLSRLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDL 296
                + + +D         I     R +   +L  +   L   +         L     
Sbjct: 332 RENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQ 391

Query: 297 SLNYLTGEIPESFAALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWG--NNFTFELP 354
                  E+  +      L LL+                      ++ W    +   +L 
Sbjct: 392 QAVGQI-ELQHATEEQSPLQLLRAIVKRY--EEMYVEQQSVQNNAIRDWDMYQHKETQLA 448

Query: 355 ENLGRNGKLL 364
           E   R  KL 
Sbjct: 449 EENARLKKLN 458

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  150 bits (382), Expect = 7e-40
 Identities = 68/289 (23%), Positives = 114/289 (39%), Gaps = 44/289 (15%)

Query: 692 ESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRN 750
           E L     IG+G  G V+ G +  D   VA+K             FL E + L +  H N
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPN 173

Query: 751 IVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHD 810
           IVRL+G  + +    ++ E +  G     L   +G  L+ +T  ++  +AA G+ YL   
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTFLRT-EGARLRVKTLLQMVGDAAAGMEYLE-- 230

Query: 811 CSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYI-----AP 865
            S   IHRD+ + N L+       ++DFG+++   D      + + +G    +     AP
Sbjct: 231 -SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADG-----VYAASGGLRQVPVKWTAP 284

Query: 866 EYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAAS 924
           E     +   +SDV+SFG++L E  + G  P            +   +  +         
Sbjct: 285 EALNYGRYSSESDVWSFGILLWETFSLGASP------------YPNLSNQQ--------- 323

Query: 925 VLAVVDPRLSGY----PLTGVIHLFKVAMMCVEDESSARPTMREVVHML 969
               V+    G     P      +F++   C   E   RP+   +   L
Sbjct: 324 TREFVE---KGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQEL 369

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  150 bits (379), Expect = 7e-38
 Identities = 70/299 (23%), Positives = 116/299 (38%), Gaps = 43/299 (14%)

Query: 290 SLKSLDLSLNYLTGEIPESFAALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNF 349
               L++  + LT  +P+      ++T L +  NNL   +P+       L  L+V GN  
Sbjct: 41  GNAVLNVGESGLT-TLPDCL--PAHITTLVIPDNNLTS-LPALPP---ELRTLEVSGNQL 93

Query: 350 TFELPENLGRNGKLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFIGPIPEELGQCK 409
           T  LP       +L I      HL             L  L +  N     +P      +
Sbjct: 94  T-SLPVLPPGLLELSIFSNPLTHLPALPS-------GLCKLWIFGNQLTS-LPVLPPGLQ 144

Query: 410 SLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLSGELPEKMSGASLNQLKVANNNIT 469
            L+    S N L  ++PA    L  L      +N L+  LP   S   L +L V++N + 
Sbjct: 145 ELS---VSDNQLA-SLPALPSELCKLW---AYNNQLT-SLPMLPS--GLQELSVSDNQLA 194

Query: 470 GKIPAAIGNLPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIPYSISQCHS 529
             +P     L  L   + +   L          L     + +S N ++  +P   S+   
Sbjct: 195 -SLPTLPSELYKLWAYNNRLTSLPALPS----GL---KELIVSGNRLT-SLPVLPSE--- 242

Query: 530 LTSVDLSRNSLYGKIPPGISKLIDLSILNLSRNGITGSIPNEMRNMMSLTTLDLSYNNL 588
           L  + +S N L   +P   S L+    L++ RN +T  +P  + ++ S TT++L  N L
Sbjct: 243 LKELMVSGNRL-TSLPMLPSGLL---SLSVYRNQLT-RLPESLIHLSSETTVNLEGNPL 296

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  149 bits (378), Expect = 1e-37
 Identities = 80/357 (22%), Positives = 133/357 (37%), Gaps = 46/357 (12%)

Query: 240 LTQLQVLDMASCNISGEIPTSLSRLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLN 299
                VL++    ++  +P  L     + +L +  N LT  +P        L++L++S N
Sbjct: 39  NNGNAVLNVGESGLT-TLPDCL--PAHITTLVIPDNNLT-SLPALPP---ELRTLEVSGN 91

Query: 300 YLTGEIPESFAALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGR 359
            LT  +P     L  L++      +L    P+       L  L ++GN  T  LP     
Sbjct: 92  QLT-SLPVLPPGLLELSIFSNPLTHL----PALP---SGLCKLWIFGNQLT-SLPVLPP- 141

Query: 360 NGKLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKN 419
              L  L V+ N L  ++P       +L  L    N  +  +P        L ++  S N
Sbjct: 142 --GLQELSVSDNQLA-SLPALP---SELCKLWAYNNQ-LTSLPMLPS---GLQELSVSDN 191

Query: 420 YLNGTIPAGLFNLPLLNMMELDDNLLSGELPEKMSGASLNQLKVANNNITGKIPAAIGNL 479
            L  ++P     L  L      +N L+  LP   S   L +L V+ N +T  +P     L
Sbjct: 192 QLA-SLPTLPSELYKL---WAYNNRLT-SLPALPS--GLKELIVSGNRLTS-LPVLPSEL 243

Query: 480 PSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIPYSISQCHSLTSVDLSRNS 539
             L    +  NRL   +P+    L    S+++  N ++  +P S+    S T+V+L  N 
Sbjct: 244 KELM---VSGNRLT-SLPMLPSGL---LSLSVYRNQLT-RLPESLIHLSSETTVNLEGNP 295

Query: 540 LY---GKIPPGISKLIDLSILNLSRNGITGSIPNEMRNMMSLTTLDLSYNNLIGNIP 593
           L     +    I+     S   +  +    S P E R +       L         P
Sbjct: 296 LSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWLVPAREGEPAP 352

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  131 bits (330), Expect = 9e-32
 Identities = 68/344 (19%), Positives = 115/344 (33%), Gaps = 51/344 (14%)

Query: 233 IPPGFGALTQLQVLDMASCNISGEIPTSLSRLKLLHSLFLQMNKLTGHIPPQLSGLISLK 292
           +P        +  L +   N++  +P     L+   +L +  N+LT  +P    GL+ L 
Sbjct: 55  LPDCLP--AHITTLVIPDNNLT-SLPALPPELR---TLEVSGNQLT-SLPVLPPGLLELS 107

Query: 293 SLDLSLNYLTGEIPESF--------------AALKNLTLLQLFKNNLRGPIPSFLGDFPN 338
                L +L   +P                      L  L +  N L     S       
Sbjct: 108 IFSNPLTHLP-ALPSGLCKLWIFGNQLTSLPVLPPGLQELSVSDNQLA----SLPALPSE 162

Query: 339 LEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFI 398
           L  L  + N  T  LP        L  L V+ N L  ++P       +L  L    N   
Sbjct: 163 LCKLWAYNNQLT-SLPMLPS---GLQELSVSDNQLA-SLPTLP---SELYKLWAYNNRLT 214

Query: 399 GPIPEELGQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLSGELPEKMSGASL 458
             +P        L ++  S N L  ++P     L  L    +  N L+  LP   S   L
Sbjct: 215 -SLPALPS---GLKELIVSGNRLT-SLPVLPSELKELM---VSGNRLT-SLPMLPS--GL 263

Query: 459 NQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNISG 518
             L V  N +T ++P ++ +L S   ++L+ N L  E  ++   L+ ITS       I  
Sbjct: 264 LSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLS-ERTLQ--ALREITSAPGYSGPII- 318

Query: 519 EIPYSISQCHSLTSVDLSRNSLYGKIPPGISKLIDLSILNLSRN 562
               + +     T       + +  +P    +       ++   
Sbjct: 319 RFDMAGASAPRETRALHLAAADW-LVPAREGEPAPADRWHMFGQ 361

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  128 bits (323), Expect = 7e-31
 Identities = 85/409 (20%), Positives = 125/409 (30%), Gaps = 78/409 (19%)

Query: 93  LLTKLVNLTISNVNLTGRLPSEMALLTSLKVFNISGNVFQGNFAGQIVRGMTELQVLDAY 152
           L      L +    LT  LP    L   +    I  N         +     EL+ L+  
Sbjct: 38  LNNGNAVLNVGESGLT-TLPDC--LPAHITTLVIPDNNLT-----SLPALPPELRTLEVS 89

Query: 153 NNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLNGIGLNGTVPAFL 212
            N  T  LPV    L  L   S    +         +    L  + + G  L        
Sbjct: 90  GNQLTS-LPVLPPGLLELSIFSNPLTHLP-------ALPSGLCKLWIFGNQLT------- 134

Query: 213 SRLKNLREMYIGYFNTYTGGIPPGFGALTQLQVLDMASCNISGEIPTSLSRLKLLHSLFL 272
                               +P     L +L V D    N    +P   S L     L+ 
Sbjct: 135 -------------------SLPVLPPGLQELSVSD----NQLASLPALPSELC---KLWA 168

Query: 273 QMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQLFKNNLRGPIPSF 332
             N+LT  +P   S    L+ L +S N L   +P   + L  L       N L   +P+ 
Sbjct: 169 YNNQLT-SLPMLPS---GLQELSVSDNQLA-SLPTLPSELYKLWAYN---NRLT-SLPAL 219

Query: 333 LGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDLCKGGKLKSLIL 392
                 L+ L V GN  T  LP       +L  L V+ N LT ++P        L SL +
Sbjct: 220 PS---GLKELIVSGNRLT-SLPVLP---SELKELMVSGNRLT-SLPMLP---SGLLSLSV 268

Query: 393 MQNFFIGPIPEELGQCKSLTKIRFSKNYLNGTIPAGLFNLPLL----NMMELDDNLLSGE 448
            +N  +  +PE L    S T +    N L+      L  +         +   D   +  
Sbjct: 269 YRN-QLTRLPESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASA 327

Query: 449 LPEKMSGASLNQLKVANNNITGKIPA----AIGNLPSLNILSLQNNRLE 493
             E  +        +         PA      G   + +  SL  +RL 
Sbjct: 328 PRETRALHLAAADWLVPAREGEPAPADRWHMFGQEDNADAFSLFLDRLS 376

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  114 bits (288), Expect = 2e-26
 Identities = 67/345 (19%), Positives = 109/345 (31%), Gaps = 45/345 (13%)

Query: 71  SRVVSLNVSFMPLFGSIPPEIGLLTKLVNLTISNVNLTGRLPSEMALLTSLKVFNISGNV 130
           + + +L +    L  S+P       +L  L +S   LT  LP     L  L +F+     
Sbjct: 61  AHITTLVIPDNNL-TSLPALPP---ELRTLEVSGNQLT-SLPVLPPGLLELSIFSNPLT- 114

Query: 131 FQGNFAGQIVRGMTELQVLDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSYSE 190
                   +    + L  L  + N  T  LPV    L+    LS   N     +P   + 
Sbjct: 115 -------HLPALPSGLCKLWIFGNQLTS-LPVLPPGLQE---LSVSDNQLA-SLP---AL 159

Query: 191 IQSLEYIGLNGIGLNGTVPAFLSRLKNLREMYIGYFNTYTGGIPPGFGALTQLQVLDMAS 250
              L  +      L  ++P   S L+ L    +   N     +P     L +L   +   
Sbjct: 160 PSELCKLWAYNNQLT-SLPMLPSGLQEL---SVSD-NQLA-SLPTLPSELYKLWAYN--- 210

Query: 251 CNISGEIPTSLSRLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFA 310
            N    +P   S LK    L +  N+LT  +P   S    LK L +S N LT  +P    
Sbjct: 211 -NRLTSLPALPSGLK---ELIVSGNRLT-SLPVLPS---ELKELMVSGNRLT-SLPML-- 259

Query: 311 ALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTS 370
               L  L +++N L   +P  L    +   + + GN  + E      R           
Sbjct: 260 -PSGLLSLSVYRNQLTR-LPESLIHLSSETTVNLEGNPLS-ERTLQALREITSAPGYSGP 316

Query: 371 NHLTGTIPRDLCKGGKLKSLILMQNFFIGPIPEELGQCKSLTKIR 415
                       +  +   L    ++ +     E           
Sbjct: 317 IIRFDMAGASAPRETRALHLAA-ADWLVPAREGEPAPADRWHMFG 360

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  104 bits (262), Expect = 2e-23
 Identities = 70/322 (21%), Positives = 103/322 (31%), Gaps = 41/322 (12%)

Query: 74  VSLNVSFMPLFGSIPPEIGLLTKLVNLTISNVNLTGRLPSEMALLTSLKVFNISGNVFQG 133
            +L VS   L  S+P     L +L   +    +L        AL + L    I GN    
Sbjct: 84  RTLEVSGNQL-TSLPVLPPGLLELSIFSNPLTHLP-------ALPSGLCKLWIFGNQLT- 134

Query: 134 NFAGQIVRGMTELQVLDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQS 193
                +      LQ L   +N     LP   + L  L       N  T  +P        
Sbjct: 135 ----SLPVLPPGLQELSVSDNQLAS-LPALPSELCKLWAY---NNQLT-SLP---MLPSG 182

Query: 194 LEYIGLNGIGLNGTVPAFLSRLKNLREMYIGYFNTYTGGIPPGFGALTQLQVLDMASCNI 253
           L+ + ++   L  ++P   S L  L        N  T  +P     L +L V    S N 
Sbjct: 183 LQELSVSDNQLA-SLPTLPSELYKLWAYN----NRLT-SLPALPSGLKELIV----SGNR 232

Query: 254 SGEIPTSLSRLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALK 313
              +P   S LK    L +  N+LT  +P   S    L SL +  N LT  +PES   L 
Sbjct: 233 LTSLPVLPSELK---ELMVSGNRLT-SLPMLPS---GLLSLSVYRNQLT-RLPESLIHLS 284

Query: 314 NLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHL 373
           + T + L  N L       L +  +                 +  R  + L L    + L
Sbjct: 285 SETTVNLEGNPLSERTLQALREITSAP-GYSGPIIRFDMAGASAPRETRALHLAAA-DWL 342

Query: 374 TGTIPRDLCKGGKLKSLILMQN 395
                 +     +        N
Sbjct: 343 VPAREGEPAPADRWHMFGQEDN 364

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 78.8 bits (194), Expect = 4e-15
 Identities = 52/283 (18%), Positives = 89/283 (31%), Gaps = 38/283 (13%)

Query: 75  SLNVSFMPLFGSIPPEIGLLTKLVNLTISNVNLTGRLPSEMALLTSLKVFNISGNVFQGN 134
            L +    L  S+P     L     L++S+  L   LP+  + L  L       N     
Sbjct: 125 KLWIFGNQL-TSLPVLPPGLQ---ELSVSDNQLA-SLPALPSELCKL---WAYNNQLT-- 174

Query: 135 FAGQIVRGMTELQVLDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQSL 194
               +    + LQ L   +N     LP   + L  L   +   N  T  +P   +    L
Sbjct: 175 ---SLPMLPSGLQELSVSDNQLAS-LPTLPSELYKLWAYN---NRLT-SLP---ALPSGL 223

Query: 195 EYIGLNGIGLNGTVPAFLSRLKNLREMYIGYFNTYTGGIPPGFGALTQLQVLDMASCNIS 254
           + + ++G  L  ++P   S LK L              +P      + L  L +    ++
Sbjct: 224 KELIVSGNRLT-SLPVLPSELKELM-----VSGNRLTSLPML---PSGLLSLSVYRNQLT 274

Query: 255 GEIPTSLSRLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLN---YLTGEIPESFAA 311
             +P SL  L    ++ L+ N L+      L  + S       +          P    A
Sbjct: 275 -RLPESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRA 333

Query: 312 LKNLTLLQLFKNNLRGPIP----SFLGDFPNLEVLQVWGNNFT 350
           L       L       P P       G   N +   ++ +  +
Sbjct: 334 LHLAAADWLVPAREGEPAPADRWHMFGQEDNADAFSLFLDRLS 376

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 56.8 bits (137), Expect = 2e-08
 Identities = 15/88 (17%), Positives = 37/88 (42%), Gaps = 8/88 (9%)

Query: 507 TSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYGKIPPGISKLIDLSILNLSRNGITG 566
             +N+ ++ ++  +P  +     +T++ +  N+L   +P    +L     L +S N +T 
Sbjct: 43  AVLNVGESGLT-TLPDCLPA--HITTLVIPDNNL-TSLPALPPEL---RTLEVSGNQLT- 94

Query: 567 SIPNEMRNMMSLTTLDLSYNNLIGNIPS 594
           S+P     ++ L+       +L      
Sbjct: 95  SLPVLPPGLLELSIFSNPLTHLPALPSG 122

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  142 bits (359), Expect = 1e-36
 Identities = 72/370 (19%), Positives = 139/370 (37%), Gaps = 29/370 (7%)

Query: 257 IPTSLSRLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLT 316
           I ++L    + + + + M     +   +   L + K +    + +         + + + 
Sbjct: 13  IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVE 72

Query: 317 LLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRN-GKLLILDVTSNHLTG 375
           LL L    +             ++ L +  N     LP ++ +N   L +L +  N L+ 
Sbjct: 73  LLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS- 130

Query: 376 TIPRDLCKG-GKLKSLILMQNFFIGPIPEELGQ-CKSLTKIRFSKNYLNGTIPAGLF-NL 432
           ++PR +     KL +L +  N  +  I ++  Q   SL  ++ S N L   +   L  +L
Sbjct: 131 SLPRGIFHNTPKLTTLSMSNNN-LERIEDDTFQATTSLQNLQLSSNRLT-HVDLSLIPSL 188

Query: 433 PLLNMMELDDNLLSGELPEKMSGASLNQLKVANNNITGKIPAAIGNLPSLNILSLQNNRL 492
              N   +  NLLS  L       ++ +L  ++N+I   +         L IL LQ+N L
Sbjct: 189 FHAN---VSYNLLS-TLA---IPIAVEELDASHNSIN-VVRG--PVNVELTILKLQHNNL 238

Query: 493 EGEIPVESFNLKMITSINISDNNISGEIPYSI-SQCHSLTSVDLSRNSLYGKIPPGISKL 551
             +      N   +  +++S N +  +I Y    +   L  + +S N L   +      +
Sbjct: 239 T-DTAWLL-NYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRL-VALNLYGQPI 294

Query: 552 IDLSILNLSRNGITGSIPNEMRNMMSLTTLDLSYNNLIGNIPSGG----QFLAFNETSFI 607
             L +L+LS N +   +         L  L L  +N I  +        + L  +   + 
Sbjct: 295 PTLKVLDLSHNHLL-HVERNQPQFDRLENLYLD-HNSIVTLKLSTHHTLKNLTLSHNDWD 352

Query: 608 GNPNLCLLRN 617
            N    L RN
Sbjct: 353 CNSLRALFRN 362

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  139 bits (352), Expect = 9e-36
 Identities = 72/391 (18%), Positives = 127/391 (32%), Gaps = 72/391 (18%)

Query: 153 NNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLNGIGLNGTVPAFL 212
                     E  +L + + ++F  +    K+P                        A L
Sbjct: 30  MQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLP-----------------------AALL 65

Query: 213 SRLKNLREMYIGYFNTYTGGIPPG-FGALTQLQVLDMASCNISGEIPTSLSRLKLLHSLF 271
              + +  + +         I    F     +Q L M    I    P     + LL  L 
Sbjct: 66  DSFRQVELLNLND-LQIEE-IDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLV 123

Query: 272 LQMNKLTGHIPPQL-SGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQLFKNNLRGPIP 330
           L+ N L+  +P  +      L +L +S N L     ++F A  +L  LQL  N L   + 
Sbjct: 124 LERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTH-VD 181

Query: 331 SFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDLCKGGKLKSL 390
             L   P+L    V  N  +      L     +  LD + N +   +   +    +L  L
Sbjct: 182 --LSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRGPVNV--ELTIL 231

Query: 391 ILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGTIPAGLF-NLPLLNMMELDDNLLSGEL 449
            L  N  +      L     L ++  S N L   I    F  +                 
Sbjct: 232 KLQHN-NLTDTA-WLLNYPGLVEVDLSYNELE-KIMYHPFVKMQ---------------- 272

Query: 450 PEKMSGASLNQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESFNLKMITSI 509
                   L +L ++NN +   +      +P+L +L L +N L   +         + ++
Sbjct: 273 -------RLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENL 323

Query: 510 NISDNNISGEIPYSISQCHSLTSVDLSRNSL 540
            +  N+I   +   +S  H+L ++ LS N  
Sbjct: 324 YLDHNSIV-TLK--LSTHHTLKNLTLSHNDW 351

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  126 bits (319), Expect = 2e-31
 Identities = 67/402 (16%), Positives = 134/402 (33%), Gaps = 29/402 (7%)

Query: 81  MPLFGSIPPEIGLLTKLVNLTISNVNLTGRLPSEMALLTSLKVFNISGNVFQGNFAGQIV 140
            P +  I   +       ++ I           E   L + K+     +  +      ++
Sbjct: 7   QPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALL 65

Query: 141 RGMTELQVLDAYNNNFTGPLPVEI-ASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGL 199
               ++++L+  +      +     A   +++ L  G N      P  +  +  L  + L
Sbjct: 66  DSFRQVELLNLNDLQIEE-IDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVL 124

Query: 200 NGIGLNGTVPAFLSRLKNLREMYIGYFNTYTGGIPPG-FGALTQLQVLDMASCNISGEIP 258
               L+            L  + +   N     I    F A T LQ L ++S  ++  + 
Sbjct: 125 ERNDLSSLPRGIFHNTPKLTTLSMSN-NNLE-RIEDDTFQATTSLQNLQLSSNRLT-HVD 181

Query: 259 TSLSRLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLL 318
             LS +  L    +  N L+      L+  I+++ LD S N +   +         LT+L
Sbjct: 182 --LSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRGP--VNVELTIL 231

Query: 319 QLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPEN-LGRNGKLLILDVTSNHLTGTI 377
           +L  NNL       L  +P L  + +  N    ++  +   +  +L  L +++N L   +
Sbjct: 232 KLQHNNLT-DTAWLLN-YPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-AL 287

Query: 378 PRDLCKGGKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGTIPAGLF-NLPLLN 436
                    LK L L  N  +  +     Q   L  +    N +  T+       L  L 
Sbjct: 288 NLYGQPIPTLKVLDLSHN-HLLHVERNQPQFDRLENLYLDHNSIV-TLKLSTHHTLKNLT 345

Query: 437 MMELDDNLLSGELPEKMSGASLNQLKVANNNITGKIPAAIGN 478
              L  N        +    ++ +  V + +   KI   + +
Sbjct: 346 ---LSHNDWD-CNSLRALFRNVARPAVDDADQHCKIDYQLEH 383

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  139 bits (353), Expect = 1e-36
 Identities = 53/326 (16%), Positives = 108/326 (33%), Gaps = 17/326 (5%)

Query: 237 FGALTQLQVLDMASCNISGEIPTSLSRLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDL 296
                + ++  +   ++   + +       +  L L  N L+      L+    L+ L+L
Sbjct: 6   KQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNL 65

Query: 297 SLNYLTGEIPESFAALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPEN 356
           S N L  E  +   +L  L  L L  N +       L   P++E L    NN +  +  +
Sbjct: 66  SSNVLY-ETLD-LESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS-RVSCS 117

Query: 357 LGRNGKLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFIG-PIPEELGQCKSLTKIR 415
            G+      + + +N +T     D     +++ L L  N        E      +L  + 
Sbjct: 118 RGQG--KKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLN 175

Query: 416 FSKNYLNGTIPAGLFNLPLLNMMELDDNLLSGELPEKMSG-ASLNQLKVANNNITGKIPA 474
              N++   +   +     L  ++L  N L+  +  +    A +  + + NN +   I  
Sbjct: 176 LQYNFIY-DVKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEK 231

Query: 475 AIGNLPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIPYSISQCHSLTSVD 534
           A+    +L    L+ N       +  F  K      ++   +      +  +C   T   
Sbjct: 232 ALRFSQNLEHFDLRGNGFH-CGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGH 290

Query: 535 LSRNSLYGKIPPGISKLIDLSILNLS 560
                      P   +LI L   +  
Sbjct: 291 YGAYCCEDLPAPFADRLIALGHHHHH 316

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  139 bits (353), Expect = 1e-36
 Identities = 51/309 (16%), Positives = 109/309 (35%), Gaps = 18/309 (5%)

Query: 288 LISLKSLDLSLNYLTGEIPESFAALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGN 347
               K   ++ + L   +     +  N+  L L  N L     + L  F  LE+L +  N
Sbjct: 9   GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68

Query: 348 NFTFELPENLGRNGKLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFIGPIPEELGQ 407
               E  + L     L  LD+ +N++      +L  G  +++L    N  I  +    GQ
Sbjct: 69  VLY-ETLD-LESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANN-NISRVSCSRGQ 120

Query: 408 CKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLSGELPEKMSG--ASLNQLKVAN 465
                 I  + N +             +  ++L  N +      +++    +L  L +  
Sbjct: 121 --GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQY 178

Query: 466 NNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIPYSIS 525
           N I   +   +     L  L L +N+L   +  E  +   +T I++ +N +   I  ++ 
Sbjct: 179 NFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALR 234

Query: 526 QCHSLTSVDLSRNSLYGKIPPGISKLIDLSILNLSRNGITGSIPNEMRNMMSLTTLDLSY 585
              +L   DL  N  +           +  +  +++  +   +  +     ++ TL    
Sbjct: 235 FSQNLEHFDLRGNGFHC-GTLRDFFSKNQRVQTVAKQTVK-KLTGQNEEECTVPTLGHYG 292

Query: 586 NNLIGNIPS 594
                ++P+
Sbjct: 293 AYCCEDLPA 301

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  122 bits (309), Expect = 1e-30
 Identities = 48/356 (13%), Positives = 105/356 (29%), Gaps = 45/356 (12%)

Query: 139 IVRGMTELQVLDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIG 198
           I +     ++    +++    L     S  +++ L   GN  +       +    LE + 
Sbjct: 5   IKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLN 64

Query: 199 LNGIGLNGTVPAFLSRLKNLREMYIGYFNTYTGGIPPGFGALTQLQVLDMASCNISGEIP 258
           L+    N         L                       +L+ L+ LD+ +  +     
Sbjct: 65  LSS---N--------VLYET----------------LDLESLSTLRTLDLNNNYV----- 92

Query: 259 TSLSRLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLL 318
             L     + +L    N ++  +    S     K++ L+ N +T            +  L
Sbjct: 93  QELLVGPSIETLHAANNNIS-RVSC--SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYL 149

Query: 319 QLFKNNLRG-PIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTI 377
            L  N +              LE L +  N    ++   +    KL  LD++SN L   +
Sbjct: 150 DLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQVV-FAKLKTLDLSSNKLA-FM 206

Query: 378 PRDLCKGGKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNM 437
             +      +  + L  N  +  I + L   ++L       N  +       F      +
Sbjct: 207 GPEFQSAAGVTWISLRNN-KLVLIEKALRFSQNLEHFDLRGNGFH-CGTLRDFFSKNQRV 264

Query: 438 MELDDNLLSGELPEKMSGASLNQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLE 493
             +    +     +     ++  L          +PA         +++L ++   
Sbjct: 265 QTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFA----DRLIALGHHHHH 316

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  120 bits (302), Expect = 9e-30
 Identities = 53/292 (18%), Positives = 93/292 (31%), Gaps = 32/292 (10%)

Query: 352 ELPENLGRNGKLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFIGPIPEELGQCKSL 411
           E+ +N  R     I  VT + L   +         +K L L  N        +L     L
Sbjct: 4   EIKQNGNR---YKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60

Query: 412 TKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLSGELPE------------------KM 453
             +  S N L       L +L  L  ++L++N +  EL                      
Sbjct: 61  ELLNLSSNVLY-ETLD-LESLSTLRTLDLNNNYVQ-ELLVGPSIETLHAANNNISRVSCS 117

Query: 454 SGASLNQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESF--NLKMITSINI 511
            G     + +ANN IT       G    +  L L+ N ++  +       +   +  +N+
Sbjct: 118 RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEID-TVNFAELAASSDTLEHLNL 176

Query: 512 SDNNISGEIPYSISQCHSLTSVDLSRNSLYGKIPPGISKLIDLSILNLSRNGITGSIPNE 571
             N I  ++   +     L ++DLS N L   + P       ++ ++L  N +   I   
Sbjct: 177 QYNFIY-DVKGQV-VFAKLKTLDLSSNKL-AFMGPEFQSAAGVTWISLRNNKLV-LIEKA 232

Query: 572 MRNMMSLTTLDLSYNNLIGNIPSGGQFLAFNETSFIGNPNLCLLRNGTCQSL 623
           +R   +L   DL  N           F        +    +  L     +  
Sbjct: 233 LRFSQNLEHFDLRGNGFH-CGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEEC 283

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  118 bits (298), Expect = 2e-29
 Identities = 64/324 (19%), Positives = 117/324 (36%), Gaps = 21/324 (6%)

Query: 86  SIPPEIGLLTKLVNLTISNVNLTGRLPSEMALLTSLKVFNISGNVFQGNFAGQIVRGMTE 145
           +I        +     +++ +L   L S      ++K  ++SGN      +   +   T+
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLS-QISAADLAPFTK 59

Query: 146 LQVLDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLNGIGLN 205
           L++L+  +N     L   + SL +LR L    NY   ++        S+E +      ++
Sbjct: 60  LELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQ-ELLVG----PSIETLHAANNNIS 112

Query: 206 GTVPAFLSRLKNLREMYIGYFNTYTGGIPPGFGALTQLQVLDMASCNISG-EIPTSLSRL 264
             V    SR +  + +Y+   N  T       G  +++Q LD+    I         +  
Sbjct: 113 -RVSC--SRGQGKKNIYLAN-NKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASS 168

Query: 265 KLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQLFKNN 324
             L  L LQ N +   +         LK+LDLS N L   +   F +   +T + L  N 
Sbjct: 169 DTLEHLNLQYNFIY-DVKG-QVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNK 225

Query: 325 LRGPIPSFLGDFPNLEVLQVWGNNFT-FELPENLGRNGKLLILDVTSNHLTGTIPRDLCK 383
           L   I   L    NLE   + GN F    L +   +N ++  +   +         + C 
Sbjct: 226 LVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEEC- 283

Query: 384 GGKLKSLILMQNFFIGPIPEELGQ 407
              + +L     +    +P     
Sbjct: 284 --TVPTLGHYGAYCCEDLPAPFAD 305

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  101 bits (255), Expect = 1e-23
 Identities = 46/292 (15%), Positives = 101/292 (34%), Gaps = 28/292 (9%)

Query: 86  SIPPE-IGLLTKLVNLTISNVNLTGRLPSEMALLTSLKVFNISGNVFQGNFAGQI--VRG 142
            I    +   TKL  L +S+  L      ++  L++L+  +++ N         +  +  
Sbjct: 48  QISAADLAPFTKLELLNLSSNVLYE--TLDLESLSTLRTLDLNNN--------YVQELLV 97

Query: 143 MTELQVLDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLNGI 202
              ++ L A NNN +    V  +  +  +++    N  T            ++Y+ L   
Sbjct: 98  GPSIETLHAANNNISR---VSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLN 154

Query: 203 GLNG-TVPAFLSRLKNLREMYIGYFNTYTGGIPPGFGALTQLQVLDMASCNISGEIPTSL 261
            ++        +    L  + + Y N     +        +L+ LD++S  ++  +    
Sbjct: 155 EIDTVNFAELAASSDTLEHLNLQY-NFIY-DVKGQVV-FAKLKTLDLSSNKLA-FMGPEF 210

Query: 262 SRLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQLF 321
                +  + L+ NKL   I   L    +L+  DL  N         F   KN  +  + 
Sbjct: 211 QSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDF-FSKNQRVQTVA 268

Query: 322 KNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHL 373
           K  ++  +     +   +  L  +G     +LP          ++ +  +H 
Sbjct: 269 KQTVKK-LTGQNEEECTVPTLGHYGAYCCEDLPAPFA----DRLIALGHHHH 315

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 89.3 bits (222), Expect = 2e-19
 Identities = 37/199 (18%), Positives = 76/199 (38%), Gaps = 17/199 (8%)

Query: 401 IPEELGQCKSLTKIRFSKNYLNGTIPAGLF-NLPLLNMMELDDNLLSGELPEKMSG-ASL 458
           I E           + + + L     A L  +   +  ++L  N LS      ++    L
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLK-QALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60

Query: 459 NQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNISG 518
             L +++N +       + +L +L  L L NN ++ E+         I +++ ++NNIS 
Sbjct: 61  ELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-ELL----VGPSIETLHAANNNIS- 112

Query: 519 EIPYSISQCHSLTSVDLSRNSLYGKIPPG-ISKLIDLSILNLSRNGITG-SIPNEMRNMM 576
            +  S  Q     ++ L+ N +   +          +  L+L  N I   +      +  
Sbjct: 113 RVSCSRGQ--GKKNIYLANNKI-TMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSD 169

Query: 577 SLTTLDLSYNNLIGNIPSG 595
           +L  L+L YN +  ++   
Sbjct: 170 TLEHLNLQYNFIY-DVKGQ 187

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  143 bits (362), Expect = 3e-36
 Identities = 63/286 (22%), Positives = 108/286 (37%), Gaps = 40/286 (13%)

Query: 692 ESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRN 750
             +  ++ +G G  G VY G      + VA+K L        +  FL E   +  I+H N
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPN 277

Query: 751 IVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHD 810
           +V+LLG  +      ++ E+M  G+L + L       +       +A + +  + YL   
Sbjct: 278 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE-- 335

Query: 811 CSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGY--IAPEYA 868
                IHR++ + N L+  +    VADFGL++ +         +     +     APE  
Sbjct: 336 -KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTG---DTYTAHAGAKFPIKWTAPESL 391

Query: 869 YTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLA 927
              K   KSDV++FGV+L E+   G  P     D   +   + K                
Sbjct: 392 AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI-DLSQVYELLEK---------------- 434

Query: 928 VVDPRLSGY----PLTGVIHLFKVAMMCVEDESSARPTMREVVHML 969
                   Y    P      ++++   C +   S RP+  E+    
Sbjct: 435 -------DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF 473

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  135 bits (342), Expect = 3e-35
 Identities = 61/203 (30%), Positives = 95/203 (46%), Gaps = 17/203 (8%)

Query: 700 IGKGGAGIVYRGSMPDGI---DVAIKRLVGRGTGGNDHGFLA----EIQTLGRIRHRNIV 752
           +G GG   VY     D I    VAIK +            L     E+    ++ H+NIV
Sbjct: 19  LGGGGMSTVYLAE--DTILNIKVAIKAI--FIPPREKEETLKRFEREVHNSSQLSHQNIV 74

Query: 753 RLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCS 812
            ++      D   L+ EY+   +L E +     G L  +T      +   G+ + H    
Sbjct: 75  SMIDVDEEDDCYYLVMEYIEGPTLSEYIE--SHGPLSVDTAINFTNQILDGIKHAHDMR- 131

Query: 813 PLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLK 872
             I+HRD+K  NIL+DS+    + DFG+AK L +   ++  + V G+  Y +PE A    
Sbjct: 132 --IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQ-TNHVLGTVQYFSPEQAKGEA 188

Query: 873 VDEKSDVYSFGVVLLELIAGKKP 895
            DE +D+YS G+VL E++ G+ P
Sbjct: 189 TDECTDIYSIGIVLYEMLVGEPP 211

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  139 bits (352), Expect = 3e-35
 Identities = 80/285 (28%), Positives = 125/285 (43%), Gaps = 40/285 (14%)

Query: 692 ESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNI 751
           ESL+ E  +G+G  G V+ G+      VAIK L  +    +   FL E Q + ++RH  +
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL--KPGTMSPEAFLQEAQVMKKLRHEKL 241

Query: 752 VRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDC 811
           V+L   VS  +   ++ EYM  GSL + L G  G +L+      +A + A G+ Y+    
Sbjct: 242 VQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE--- 297

Query: 812 SPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGS--YGYIAPEYAY 869
               +HRD+++ NIL+  +    VADFGLA+ ++D   +E  +         + APE A 
Sbjct: 298 RMNYVHRDLRAANILVGENLVCKVADFGLARLIED---NEYTARQGAKFPIKWTAPEAAL 354

Query: 870 TLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAV 928
             +   KSDV+SFG++L EL   G+ P        +++  V +                 
Sbjct: 355 YGRFTIKSDVWSFGILLTELTTKGRVPYPGM-VNREVLDQVER----------------- 396

Query: 929 VDPRLSGY----PLTGVIHLFKVAMMCVEDESSARPTMREVVHML 969
                 GY    P      L  +   C   E   RPT   +   L
Sbjct: 397 ------GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFL 435

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  135 bits (342), Expect = 4e-35
 Identities = 81/294 (27%), Positives = 129/294 (43%), Gaps = 50/294 (17%)

Query: 692 ESLKDENIIGKGGAGIVYRG--SMPDG--IDVAIKRLVGRGTGGNDHGFLAEIQTLGRIR 747
             +  E IIG G +G V  G   +P    + VAIK L    T      FL+E   +G+  
Sbjct: 49  SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFD 108

Query: 748 HRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYL 807
           H NI+RL G V+     +++ EYM NGSL   L     G         +      G+ YL
Sbjct: 109 HPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLR-THDGQFTIMQLVGMLRGVGAGMRYL 167

Query: 808 --HHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYI-- 863
                     +HRD+ + N+L+DS+    V+DFGL++ L+D    +  ++   + G I  
Sbjct: 168 SDLG-----YVHRDLAARNVLVDSNLVCKVSDFGLSRVLED----DPDAAYTTTGGKIPI 218

Query: 864 ---APEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQP 919
              APE          SDV+SFGVV+ E++A G++P            +   T  +    
Sbjct: 219 RWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERP------------YWNMTNRD---- 262

Query: 920 SDAASVLAVVDPRLSGY----PLTGVIHLFKVAMMCVEDESSARPTMREVVHML 969
                V++ V+    GY    P+     L ++ + C   + + RP   ++V +L
Sbjct: 263 -----VISSVE---EGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVL 308

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  134 bits (339), Expect = 4e-35
 Identities = 63/207 (30%), Positives = 103/207 (49%), Gaps = 12/207 (5%)

Query: 692 ESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNI 751
           E+LK    +G G  G V+ G       VA+K L       +   FLAE   + +++H+ +
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA--FLAEANLMKQLQHQRL 70

Query: 752 VRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDC 811
           VRL   V+ ++   ++ EYM NGSL + L    G  L       +A + A+G+ ++    
Sbjct: 71  VRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE--- 126

Query: 812 SPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGY--IAPEYAY 869
               IHRD+++ NIL+       +ADFGLA+ ++D   +E  +     +     APE   
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIED---NEYTAREGAKFPIKWTAPEAIN 183

Query: 870 TLKVDEKSDVYSFGVVLLELIA-GKKP 895
                 KSDV+SFG++L E++  G+ P
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVTHGRIP 210

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  134 bits (340), Expect = 1e-34
 Identities = 84/308 (27%), Positives = 139/308 (45%), Gaps = 51/308 (16%)

Query: 692 ESLKDENIIGKGGAGIVYRG-----SMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRI 746
             +  + +IG G  G VY+G     S    + VAIK L    T      FL E   +G+ 
Sbjct: 44  SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 103

Query: 747 RHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCY 806
            H NI+RL G +S     +++ EYM NG+L + L   K G         +    A G+ Y
Sbjct: 104 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE-KDGEFSVLQLVGMLRGIAAGMKY 162

Query: 807 L--HHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYI- 863
           L   +      +HRD+ + NIL++S+    V+DFGL++ L+D    +  ++   S G I 
Sbjct: 163 LANMN-----YVHRDLAARNILVNSNLVCKVSDFGLSRVLED----DPEATYTTSGGKIP 213

Query: 864 ----APEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQ 918
               APE     K    SDV+SFG+V+ E++  G++P            +   +  E   
Sbjct: 214 IRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERP------------YWELSNHE--- 258

Query: 919 PSDAASVLAVVDPRLSGY----PLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQ 974
                 V+  ++    G+    P+     ++++ M C + E + RP   ++V +L    +
Sbjct: 259 ------VMKAIN---DGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 309

Query: 975 SAPSLITL 982
           +  SL TL
Sbjct: 310 APDSLKTL 317

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  137 bits (347), Expect = 1e-34
 Identities = 69/285 (24%), Positives = 123/285 (43%), Gaps = 40/285 (14%)

Query: 692 ESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNI 751
           ESLK E  +G G  G V+  +      VA+K +           FLAE   +  ++H  +
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA--FLAEANVMKTLQHDKL 245

Query: 752 VRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDC 811
           V+L   V+ ++   ++ E+M  GSL + L   +G           + + A+G+ ++    
Sbjct: 246 VKLHAVVT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE--- 301

Query: 812 SPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGY--IAPEYAY 869
               IHRD+++ NIL+ +     +ADFGLA+ ++D   +E  +     +     APE   
Sbjct: 302 QRNYIHRDLRAANILVSASLVCKIADFGLARVIED---NEYTAREGAKFPIKWTAPEAIN 358

Query: 870 TLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAV 928
                 KSDV+SFG++L+E++  G+ P        +++R + +                 
Sbjct: 359 FGSFTIKSDVWSFGILLMEIVTYGRIPYPGM-SNPEVIRALER----------------- 400

Query: 929 VDPRLSGY----PLTGVIHLFKVAMMCVEDESSARPTMREVVHML 969
                 GY    P      L+ + M C ++    RPT   +  +L
Sbjct: 401 ------GYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVL 439

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  132 bits (335), Expect = 2e-34
 Identities = 55/215 (25%), Positives = 95/215 (44%), Gaps = 28/215 (13%)

Query: 698 NIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLG 756
            +IG GG G V++     DG    IKR+       N+     E++ L ++ H NIV   G
Sbjct: 17  ELIGSGGFGQVFKAKHRIDGKTYVIKRV-----KYNNEKAEREVKALAKLDHVNIVHYNG 71

Query: 757 Y-------------VSNRDTNLLLY---EYMPNGSLGEMLHGAKGGHLKWETRYRIALEA 800
                          S+R     L+   E+   G+L + +   +G  L       +  + 
Sbjct: 72  CWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQI 131

Query: 801 AKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSY 860
            KG+ Y+H   S  +I+RD+K +NI L    +  + DFGL   L++ G     +   G+ 
Sbjct: 132 TKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK---RTRSKGTL 185

Query: 861 GYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
            Y++PE   +    ++ D+Y+ G++L EL+     
Sbjct: 186 RYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT 220

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  138 bits (348), Expect = 2e-34
 Identities = 80/285 (28%), Positives = 125/285 (43%), Gaps = 40/285 (14%)

Query: 692 ESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNI 751
           ESL+ E  +G+G  G V+ G+      VAIK L  +    +   FL E Q + ++RH  +
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL--KPGTMSPEAFLQEAQVMKKLRHEKL 324

Query: 752 VRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDC 811
           V+L   VS  +   ++ EYM  GSL + L G  G +L+      +A + A G+ Y+    
Sbjct: 325 VQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE--- 380

Query: 812 SPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGS--YGYIAPEYAY 869
               +HRD+++ NIL+  +    VADFGLA+ ++D   +E  +         + APE A 
Sbjct: 381 RMNYVHRDLRAANILVGENLVCKVADFGLARLIED---NEYTARQGAKFPIKWTAPEAAL 437

Query: 870 TLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAV 928
             +   KSDV+SFG++L EL   G+ P        +++  V +                 
Sbjct: 438 YGRFTIKSDVWSFGILLTELTTKGRVPYPGM-VNREVLDQVER----------------- 479

Query: 929 VDPRLSGY----PLTGVIHLFKVAMMCVEDESSARPTMREVVHML 969
                 GY    P      L  +   C   E   RPT   +   L
Sbjct: 480 ------GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFL 518

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  138 bits (350), Expect = 3e-34
 Identities = 72/387 (18%), Positives = 145/387 (37%), Gaps = 27/387 (6%)

Query: 256 EIPTSLSRLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNL 315
            I ++L    + + + + M     +   +   L + K +    + +         + + +
Sbjct: 18  CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQV 77

Query: 316 TLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRN-GKLLILDVTSNHLT 374
            LL L    +             ++ L +  N     LP ++ +N   L +L +  N L+
Sbjct: 78  ELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS 136

Query: 375 GTIPRDLCKG-GKLKSLILMQNFFIGPIPEELGQ-CKSLTKIRFSKNYLNGTIPAGLF-N 431
            ++PR +     KL +L +  N  +  I ++  Q   SL  ++ S N L   +   L  +
Sbjct: 137 -SLPRGIFHNTPKLTTLSMSNNN-LERIEDDTFQATTSLQNLQLSSNRLT-HVDLSLIPS 193

Query: 432 LPLLNMMELDDNLLSGELPEKMSGASLNQLKVANNNITGKIPAAIGNLPSLNILSLQNNR 491
           L   N   +  NLLS  L       ++ +L  ++N+I   +         L IL LQ+N 
Sbjct: 194 LFHAN---VSYNLLS-TLAI---PIAVEELDASHNSIN-VVRG--PVNVELTILKLQHNN 243

Query: 492 LEGEIPVESFNLKMITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYGKIPPGISKL 551
           L  +      N   +  +++S N +   + +   +   L  + +S N L   +      +
Sbjct: 244 LT-DTAWLL-NYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRL-VALNLYGQPI 300

Query: 552 IDLSILNLSRNGITGSIPNEMRNMMSLTTLDLSYNNLIGNIPSGG----QFLAFNETSFI 607
             L +L+LS N +   +         L  L L  +N I  +        + L  +   + 
Sbjct: 301 PTLKVLDLSHNHLL-HVERNQPQFDRLENLYLD-HNSIVTLKLSTHHTLKNLTLSHNDWD 358

Query: 608 GNPNLCLLRNGTCQSLINSAKHSGDGY 634
            N    L RN    ++ ++ +H    Y
Sbjct: 359 CNSLRALFRNVARPAVDDADQHCKIDY 385

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  138 bits (348), Expect = 5e-34
 Identities = 72/400 (18%), Positives = 128/400 (32%), Gaps = 72/400 (18%)

Query: 144 TELQVLDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLNGIG 203
                +             E  +L + + ++F  +    K+P                  
Sbjct: 27  CVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLP------------------ 67

Query: 204 LNGTVPAFLSRLKNLREMYIGYFNTYTGGIPPG-FGALTQLQVLDMASCNISGEIPTSLS 262
                 A L   + +  + +         I    F     +Q L M    I    P    
Sbjct: 68  -----AALLDSFRQVELLNLND-LQIEE-IDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQ 120

Query: 263 RLKLLHSLFLQMNKLTGHIPPQL-SGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQLF 321
            + LL  L L+ N L+  +P  +      L +L +S N L     ++F A  +L  LQL 
Sbjct: 121 NVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLS 179

Query: 322 KNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDL 381
            N L   +   L   P+L    V  N  +      L     +  LD + N +   +   +
Sbjct: 180 SNRLTH-VD--LSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRGPV 230

Query: 382 CKGGKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGTIPAGLF-NLPLLNMMEL 440
               +L  L L  N  +      L     L ++  S N L   I    F  +        
Sbjct: 231 NV--ELTILKLQHN-NLTDTA-WLLNYPGLVEVDLSYNELE-KIMYHPFVKMQ------- 278

Query: 441 DDNLLSGELPEKMSGASLNQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVES 500
                            L +L ++NN +   +      +P+L +L L +N L   +    
Sbjct: 279 ----------------RLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQ 320

Query: 501 FNLKMITSINISDNNISGEIPYSISQCHSLTSVDLSRNSL 540
                + ++ +  N+I   +   +S  H+L ++ LS N  
Sbjct: 321 PQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDW 357

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  128 bits (323), Expect = 6e-31
 Identities = 76/510 (14%), Positives = 166/510 (32%), Gaps = 37/510 (7%)

Query: 81  MPLFGSIPPEIGLLTKLVNLTISNVNLTGRLPSEMALLTSLKVFNISGNVFQGNFAGQIV 140
            P +  I   +       ++ I           E   L + K+     +  +      ++
Sbjct: 13  QPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALL 71

Query: 141 RGMTELQVLDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLN 200
               ++++L+  +           A   +++ L  G N      P  +  +  L  + L 
Sbjct: 72  DSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLE 131

Query: 201 GIGLNGTVPAFLSRLKNLREMYIGYFNTYTGGIPPG-FGALTQLQVLDMASCNISGEIPT 259
              L+            L  + +   N     I    F A T LQ L ++S  ++  +  
Sbjct: 132 RNDLSSLPRGIFHNTPKLTTLSMSN-NNLE-RIEDDTFQATTSLQNLQLSSNRLT-HVD- 187

Query: 260 SLSRLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQ 319
            LS +  L    +  N L+      L+  I+++ LD S N +   +         LT+L+
Sbjct: 188 -LSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRGP--VNVELTILK 238

Query: 320 LFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPEN-LGRNGKLLILDVTSNHLTGTIP 378
           L  NNL       L  +P L  + +  N    ++  +   +  +L  L +++N L   + 
Sbjct: 239 LQHNNLT-DTAWLLN-YPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALN 294

Query: 379 RDLCKGGKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGTIPAGLF-NLPLLNM 437
                   LK L L  N  +  +     Q   L  +    N +  T+       L  L  
Sbjct: 295 LYGQPIPTLKVLDLSHN-HLLHVERNQPQFDRLENLYLDHNSIV-TLKLSTHHTLKNLT- 351

Query: 438 MELDDNLLSGELPEKMSGASLNQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIP 497
             L  N         +   ++ +  V + +   KI   + +     +   ++++     P
Sbjct: 352 --LSHNDWDCNSLRALF-RNVARPAVDDADQHCKIDYQLEHG----LCCKESDK-----P 399

Query: 498 VESFNLKMITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYGKIPPGISKLIDLSIL 557
                L+ I   ++ +     +   S +   +         +  G +P   ++ ++  + 
Sbjct: 400 YLDRLLQYIALTSVVEKVQRAQGRCSATDTINSVQSLSHYITQQGGVPLQGNEQLEAEVN 459

Query: 558 NLSRNGITGSIPNEMRNMMSLTTLDLSYNN 587
            L    +      +++    L  L    + 
Sbjct: 460 ELRAE-VQQLTNEQIQQEQLLQGLHAEIDT 488

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  101 bits (252), Expect = 3e-22
 Identities = 70/446 (15%), Positives = 148/446 (33%), Gaps = 31/446 (6%)

Query: 86  SIPPEIGL-LTKLVNLTISNVNLTGRLPSEM-ALLTSLKVFNISGNVFQGNFAGQIVRGM 143
            +PP +   +  L  L +   +L+  LP  +      L   ++S N  +        +  
Sbjct: 113 YLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQAT 170

Query: 144 TELQVLDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLNGIG 203
           T LQ L   +N  T    V+++ + SL H +   N  +     + +   ++E +  +   
Sbjct: 171 TSLQNLQLSSNRLTH---VDLSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNS 222

Query: 204 LNGTVPAFLSRLKNLREMYIGYFNTYTGGIPPGFGALTQLQVLDMASCNISGEIPTSLSR 263
           +N  V   +     L  + + + N  T            L  +D++   +   +     +
Sbjct: 223 IN-VVRGPV--NVELTILKLQH-NNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVK 276

Query: 264 LKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQLFKN 323
           ++ L  L++  N+L   +      + +LK LDLS N+L   +  +      L  L L  N
Sbjct: 277 MQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHN 334

Query: 324 NLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTG--TIPRDL 381
           ++   +   L     L+ L +  N++       L RN     +D    H      +   L
Sbjct: 335 SIV-TLK--LSTHHTLKNLTLSHNDWDCNSLRALFRNVARPAVDDADQHCKIDYQLEHGL 391

Query: 382 CKGGKLKSLILMQNFFIGP------IPEELGQCKSLTKIRFSKNYLNGTIPAGLFNLPLL 435
           C     K  +     +I        +    G+C +   I   ++  +     G   L   
Sbjct: 392 CCKESDKPYLDRLLQYIALTSVVEKVQRAQGRCSATDTINSVQSLSHYITQQGGVPLQGN 451

Query: 436 NMMELDDNLLSGELPEKMSGASLNQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLEGE 495
             +E + N L  E+ +  +     +  +   +           LP   +    +N  +  
Sbjct: 452 EQLEAEVNELRAEVQQLTNEQIQQEQLLQGLHAEIDTNLRRYRLPKDGLARSSDNLNKVF 511

Query: 496 IPVESFNLKMITSINISDNNISGEIP 521
             ++      +            +  
Sbjct: 512 THLKERQAFKLRETQARRTEADAKQK 537

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  134 bits (339), Expect = 3e-34
 Identities = 77/294 (26%), Positives = 128/294 (43%), Gaps = 50/294 (17%)

Query: 692 ESLKDENIIGKGGAGIVYRG--SMPDG--IDVAIKRLVGRGTGGNDHGFLAEIQTLGRIR 747
            ++  + ++G G  G V  G   +P    I VAIK L    T      FL E   +G+  
Sbjct: 45  TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD 104

Query: 748 HRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYL 807
           H NI+RL G V+     +++ EYM NGSL   L               +    A G+ YL
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRK-HDAQFTVIQLVGMLRGIASGMKYL 163

Query: 808 --HHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYI-- 863
                     +HRD+ + NIL++S+    V+DFGL + L+D    +  ++     G I  
Sbjct: 164 SDMG-----YVHRDLAARNILINSNLVCKVSDFGLGRVLED----DPEAAYTTRGGKIPI 214

Query: 864 ---APEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQP 919
              +PE     K    SDV+S+G+VL E+++ G++P            +   +  +    
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP------------YWEMSNQD---- 258

Query: 920 SDAASVLAVVDPRLSGY----PLTGVIHLFKVAMMCVEDESSARPTMREVVHML 969
                V+  VD    GY    P+     L+++ + C + + + RP   ++V +L
Sbjct: 259 -----VIKAVD---EGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  136 bits (345), Expect = 3e-34
 Identities = 75/364 (20%), Positives = 129/364 (35%), Gaps = 63/364 (17%)

Query: 233 IPPGFGALTQLQVLDMASCNISGEIPTSLSRLKLLHSLFLQMNKLTGHIPPQ-LSGLISL 291
           +P G    T+ ++LD+    I        +    L  L L  N ++  + P   + L +L
Sbjct: 26  VPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVS-AVEPGAFNNLFNL 82

Query: 292 KSLDLSLNYLTGEIP-ESFAALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFT 350
           ++L L  N L   IP   F  L NLT L + +N +   +     D  NL+ L+V  N+  
Sbjct: 83  RTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLV 141

Query: 351 FELPENLGRN-GKLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFIGPIPEELGQCK 409
             +          L  L +   +LT +IP +                        L    
Sbjct: 142 -YISHRAFSGLNSLEQLTLEKCNLT-SIPTEA-----------------------LSHLH 176

Query: 410 SLTKIRFSKNYLNGTIPAGLF-NLPLLNMMELDDNLLSGELPEKMSGASLNQLKVANNNI 468
            L  +R     +N  I    F  L                         L  L++++   
Sbjct: 177 GLIVLRLRHLNIN-AIRDYSFKRLY-----------------------RLKVLEISHWPY 212

Query: 469 TGKIPAAIGNLPSLNILSLQNNRLEGEIPVESF-NLKMITSINISDNNISGEIPYSISQC 527
              +        +L  LS+ +  L   +P  +  +L  +  +N+S N IS      + + 
Sbjct: 213 LDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHEL 271

Query: 528 HSLTSVDLSRNSLYGKIPPGI-SKLIDLSILNLSRNGITGSIPNEM-RNMMSLTTLDLSY 585
             L  + L    L   + P     L  L +LN+S N +T ++   +  ++ +L TL L  
Sbjct: 272 LRLQEIQLVGGQL-AVVEPYAFRGLNYLRVLNVSGNQLT-TLEESVFHSVGNLETLILDS 329

Query: 586 NNLI 589
           N L 
Sbjct: 330 NPLA 333

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  108 bits (272), Expect = 6e-25
 Identities = 67/364 (18%), Positives = 119/364 (32%), Gaps = 45/364 (12%)

Query: 66  TCDQDSRVVSLNVSFMPLFGSIPPEIGLLTKLVNLTISNVNLTGRLPSEMALLTSLKVFN 125
            C    R V  +        ++P   G+ T+   L +    +      E A    L+   
Sbjct: 8   ECSAQDRAVLCHRKRFV---AVPE--GIPTETRLLDLGKNRIKTLNQDEFASFPHLEELE 62

Query: 126 ISGNVFQGNFAGQIVRGMTELQVLDAYNNNFTGPLPVEI-ASLKSLRHLSFGGNYFTGKI 184
           ++ N+            +  L+ L   +N     +P+ +   L +L  L    N      
Sbjct: 63  LNENIVS-AVEPGAFNNLFNLRTLGLRSNRLKL-IPLGVFTGLSNLTKLDISEN------ 114

Query: 185 PQSYSEIQSLEYIGLNGIGLNGTVPAFLSRLKNLREMYIGYFNTYTGGIPPG-FGALTQL 243
                +I  L                    L NL+ + +G  N     I    F  L  L
Sbjct: 115 -----KIVILL-------------DYMFQDLYNLKSLEVGD-NDLVY-ISHRAFSGLNSL 154

Query: 244 QVLDMASCNISGEIPT-SLSRLKLLHSLFLQMNKLTGHIPPQ-LSGLISLKSLDLSLNYL 301
           + L +  CN++  IPT +LS L  L  L L+   +   I       L  LK L++S    
Sbjct: 155 EQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNIN-AIRDYSFKRLYRLKVLEISHWPY 212

Query: 302 TGEIPESFAALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRN- 360
              +  +     NLT L +   NL       +     L  L +  N  +  +  ++    
Sbjct: 213 LDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPIS-TIEGSMLHEL 271

Query: 361 GKLLILDVTSNHLTGTIPRDLCKG-GKLKSLILMQNFFIGPIPEEL-GQCKSLTKIRFSK 418
            +L  + +    L   +     +G   L+ L +  N  +  + E +     +L  +    
Sbjct: 272 LRLQEIQLVGGQLA-VVEPYAFRGLNYLRVLNVSGN-QLTTLEESVFHSVGNLETLILDS 329

Query: 419 NYLN 422
           N L 
Sbjct: 330 NPLA 333

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  132 bits (334), Expect = 4e-34
 Identities = 63/208 (30%), Positives = 96/208 (46%), Gaps = 21/208 (10%)

Query: 700 IGKGGAGIVYRGSMPDGI---DVAIKRLVGRGTGGNDHGFLA----EIQTLGRIRHRNIV 752
           +G GG   V+     D     DVA+K L  R     D  F      E Q    + H  IV
Sbjct: 20  LGFGGMSEVHLAR--DLRDHRDVAVKVL--RADLARDPSFYLRFRREAQNAAALNHPAIV 75

Query: 753 RLLGYVSNRDTNLLLY----EYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLH 808
            +            L     EY+   +L +++H    G +  +    +  +A + L + H
Sbjct: 76  AVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH--TEGPMTPKRAIEVIADACQALNFSH 133

Query: 809 HDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECM-SSVAGSYGYIAPEY 867
            +    IIHRDVK  NI++ +     V DFG+A+ + D+G S    ++V G+  Y++PE 
Sbjct: 134 QNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 190

Query: 868 AYTLKVDEKSDVYSFGVVLLELIAGKKP 895
           A    VD +SDVYS G VL E++ G+ P
Sbjct: 191 ARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  131 bits (332), Expect = 5e-34
 Identities = 72/297 (24%), Positives = 117/297 (39%), Gaps = 50/297 (16%)

Query: 697 ENIIGKGGAGIVYRG---SMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVR 753
           +  +G G  G V +G        IDVAIK L       +    + E Q + ++ +  IVR
Sbjct: 15  DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74

Query: 754 LLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYL--HHDC 811
           L+G V   +  +L+ E    G L + L G K   +       +  + + G+ YL   +  
Sbjct: 75  LIG-VCQAEALMLVMEMAGGGPLHKFLVG-KREEIPVSNVAELLHQVSMGMKYLEEKN-- 130

Query: 812 SPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYI-----APE 866
               +HRD+ + N+LL +   A ++DFGL+K L      +     A S G       APE
Sbjct: 131 ---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA----DDSYYTARSAGKWPLKWYAPE 183

Query: 867 YAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASV 925
                K   +SDV+S+GV + E ++ G+KP            + +    E         V
Sbjct: 184 CINFRKFSSRSDVWSYGVTMWEALSYGQKP------------YKKMKGPE---------V 222

Query: 926 LAVVDPRLSGY----PLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQSAPS 978
           +A ++    G     P      L+ +   C   +   RP    V   +     S  S
Sbjct: 223 MAFIE---QGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 276

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  132 bits (335), Expect = 6e-34
 Identities = 52/199 (26%), Positives = 86/199 (43%), Gaps = 7/199 (3%)

Query: 699 IIGKGGAGIVYRG-SMPDGIDVAIKRL-VGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLG 756
            IG+G  G      S  DG    IK + + R +         E+  L  ++H NIV+   
Sbjct: 31  KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90

Query: 757 YVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLII 816
                 +  ++ +Y   G L + ++  KG   + +      ++    L ++H      I+
Sbjct: 91  SFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH---DRKIL 147

Query: 817 HRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEK 876
           HRD+KS NI L  D    + DFG+A+ L      E   +  G+  Y++PE       + K
Sbjct: 148 HRDIKSQNIFLTKDGTVQLGDFGIARVLN--STVELARACIGTPYYLSPEICENKPYNNK 205

Query: 877 SDVYSFGVVLLELIAGKKP 895
           SD+++ G VL EL   K  
Sbjct: 206 SDIWALGCVLYELCTLKHA 224

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  131 bits (331), Expect = 7e-34
 Identities = 55/208 (26%), Positives = 90/208 (43%), Gaps = 12/208 (5%)

Query: 692 ESLKDENIIGKGGAGIVYRGSMPDG-IDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRN 750
             +  ++ +G G  G VY G      + VA+K L        +  FL E   +  I+H N
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPN 70

Query: 751 IVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHD 810
           +V+LLG  +      ++ E+M  G+L + L       +       +A + +  + YL   
Sbjct: 71  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE-- 128

Query: 811 CSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGY--IAPEYA 868
                IHRD+ + N L+  +    VADFGL++ +         +     +     APE  
Sbjct: 129 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG---DTYTAHAGAKFPIKWTAPESL 184

Query: 869 YTLKVDEKSDVYSFGVVLLELIA-GKKP 895
              K   KSDV++FGV+L E+   G  P
Sbjct: 185 AYNKFSIKSDVWAFGVLLWEIATYGMSP 212

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  130 bits (329), Expect = 7e-34
 Identities = 59/207 (28%), Positives = 99/207 (47%), Gaps = 12/207 (5%)

Query: 692 ESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNI 751
           E +     +G G  G+V  G      DVA+K +       ++  F  E QT+ ++ H  +
Sbjct: 8   EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDE--FFQEAQTMMKLSHPKL 65

Query: 752 VRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDC 811
           V+  G  S      ++ EY+ NG L   L    G  L+      +  +  +G+ +L    
Sbjct: 66  VKFYGVCSKEYPIYIVTEYISNGCLLNYLRS-HGKGLEPSQLLEMCYDVCEGMAFLE--- 121

Query: 812 SPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGY--IAPEYAY 869
           S   IHRD+ + N L+D D    V+DFG+ +++ D    + +SSV   +     APE  +
Sbjct: 122 SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLD---DQYVSSVGTKFPVKWSAPEVFH 178

Query: 870 TLKVDEKSDVYSFGVVLLELIA-GKKP 895
             K   KSDV++FG+++ E+ + GK P
Sbjct: 179 YFKYSSKSDVWAFGILMWEVFSLGKMP 205

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  131 bits (332), Expect = 8e-34
 Identities = 53/203 (26%), Positives = 86/203 (42%), Gaps = 17/203 (8%)

Query: 700 IGKGGAGIVYRGSMPDGI---DVAIKRLVGRGTGGNDHGFLA----EIQTLGRIRHRNIV 752
           +G+GG G VY     D +    VA+K +    T  +D  F      E +T GR++  ++V
Sbjct: 42  VGRGGMGDVYEAE--DTVRERIVALKLM--SETLSSDPVFRTRMQREARTAGRLQEPHVV 97

Query: 753 RLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCS 812
            +  +        +    +    L  ML   + G L       I  +    L   H    
Sbjct: 98  PIHDFGEIDGQLYVDMRLINGVDLAAMLR--RQGPLAPPRAVAIVRQIGSALDAAHAAG- 154

Query: 813 PLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLK 872
               HRDVK  NIL+ +D  A++ DFG+A    D   ++ + +  G+  Y+APE      
Sbjct: 155 --ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQ-LGNTVGTLYYMAPERFSESH 211

Query: 873 VDEKSDVYSFGVVLLELIAGKKP 895
              ++D+Y+   VL E + G  P
Sbjct: 212 ATYRADIYALTCVLYECLTGSPP 234

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  131 bits (333), Expect = 9e-34
 Identities = 68/314 (21%), Positives = 123/314 (39%), Gaps = 65/314 (20%)

Query: 692 ESLKDENIIGKGGAGIVYRGS-MPDG----IDVAIKRLVGRGTGGNDHGFLAEIQTLGRI 746
              K   ++G G  G VY+G  +P+G    I VAIK L    +   +   L E   +  +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74

Query: 747 RHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCY 806
            + ++ RLLG +    T  L+ + MP G L + +      ++  +      ++ AKG+ Y
Sbjct: 75  DNPHVCRLLG-ICLTSTVQLITQLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQIAKGMNY 132

Query: 807 L--HHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGY-- 862
           L         ++HRD+ + N+L+ +     + DFGLAK L                 Y  
Sbjct: 133 LEDRR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGA-----------EEKEYHA 176

Query: 863 ---------IAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKT 912
                    +A E         +SDV+S+GV + EL+  G KP            +    
Sbjct: 177 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP------------YDGIP 224

Query: 913 TSEVSQPSDAASVLAVVDPRLSGY----PLTGVIHLFKVAMMCVEDESSARPTMREVVHM 968
            SE         + ++++    G     P    I ++ +   C   ++ +RP  RE++  
Sbjct: 225 ASE---------ISSILE---KGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIE 272

Query: 969 LANPPQSAPSLITL 982
            +   +     + +
Sbjct: 273 FSKMARDPQRYLVI 286

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  134 bits (339), Expect = 1e-33
 Identities = 84/431 (19%), Positives = 142/431 (32%), Gaps = 47/431 (10%)

Query: 194 LEYIGLNGIGLNGTVPAFLSRLKNLREMYIGYFNTYTGGIPPGFGALTQLQVLDMASCNI 253
                     +  T      +L  L  +     +        G   LT L  L   S NI
Sbjct: 20  FASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITD---MTGIEKLTGLTKLICTSNNI 76

Query: 254 SGEIPTSLSRLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALK 313
           +  +   LS+   L  L    NKLT ++   ++ L  L  L+   N LT ++  S     
Sbjct: 77  T-TLD--LSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLT-KLDVS--QNP 127

Query: 314 NLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHL 373
            LT L   +N L   I   +     L  L    N    +L   +    +L  LD + N +
Sbjct: 128 LLTYLNCARNTLT-EID--VSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKI 182

Query: 374 TGTIPRDLCKGGKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGTIPAGLFNLP 433
           T  +  D+ +   L  L    N  I  +   L Q   LT +  S N L   I   +  L 
Sbjct: 183 T-EL--DVSQNKLLNRLNCDTNN-ITKLD--LNQNIQLTFLDCSSNKLT-EID--VTPLT 233

Query: 434 LLNMMELDDNLLSGELPEKMSGASLNQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLE 493
            L   +   N L+ EL    + + L  L     ++  +I   + +   L     +  R  
Sbjct: 234 QLTYFDCSVNPLT-ELDVS-TLSKLTTLHCIQTDLL-EID--LTHNTQLIYFQAEGCRKI 288

Query: 494 GEIPVESFNLKMITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYGKIPPGISKLID 553
            E+ V   +   +  ++     I+ E+   +SQ   L  + L+   L  ++   +S    
Sbjct: 289 KELDVT--HNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTELT-ELD--VSHNTK 340

Query: 554 LSILNLSRNGITGSIPNEMRNMMSLTTLDLSYNNLIGNIPSGGQFLAF------NETSFI 607
           L  L+     I       +  + +L     +    I          +       +     
Sbjct: 341 LKSLSCVNAHIQ-DFS-SVGKIPALNNNFEAEGQTITMPKETLTNNSLTIAVSPDLLDQF 398

Query: 608 GNPNLCLLRNG 618
           GNP      +G
Sbjct: 399 GNPMNIEPGDG 409

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  117 bits (296), Expect = 5e-28
 Identities = 85/505 (16%), Positives = 157/505 (31%), Gaps = 98/505 (19%)

Query: 94  LTKLVNLTISNVNLTGRLPSEMALLTSLKVFNISGNVFQGNFAGQIVRGMTELQVLDAYN 153
               V                   L +L   +   +    +  G  +  +T L  L   +
Sbjct: 20  FASEVAAAFEMQATD---TISEEQLATLTSLDCHNSSIT-DMTG--IEKLTGLTKLICTS 73

Query: 154 NNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLNGIGLNGTVPAFLS 213
           NN T    ++++   +L +L+   N  T  +                           ++
Sbjct: 74  NNITT---LDLSQNTNLTYLACDSNKLT-NLD--------------------------VT 103

Query: 214 RLKNLREMYIGYFNTYTGGIPPGFGALTQLQVLDMASCNISGEIPTSLSRLKLLHSLFLQ 273
            L  L  +     N  T  +         L  L+ A   ++ EI   +S    L  L   
Sbjct: 104 PLTKLTYLNCDT-NKLTK-LD--VSQNPLLTYLNCARNTLT-EID--VSHNTQLTELDCH 156

Query: 274 MNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQLFKNNLRGPIPSFL 333
           +NK        ++    L +LD S N +T E+    +  K L  L    NN+   +   L
Sbjct: 157 LNKKIT--KLDVTPQTQLTTLDCSFNKIT-ELD--VSQNKLLNRLNCDTNNITK-LD--L 208

Query: 334 GDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDLCKGGKLKSLILM 393
                L  L    N  T E+   +    +L   D + N LT  +        KL +L  +
Sbjct: 209 NQNIQLTFLDCSSNKLT-EID--VTPLTQLTYFDCSVNPLT-ELDVSTLS--KLTTLHCI 262

Query: 394 QNFFIGPIPEELGQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLSGELPEKM 453
           Q                L +I  + N         L         ++ +  ++       
Sbjct: 263 QT--------------DLLEIDLTHN-------TQLIYFQAEGCRKIKELDVTH-NT--- 297

Query: 454 SGASLNQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESFNLKMITSINISD 513
               L  L      IT ++   +   P L  L L N  L  E+ V   +   + S++  +
Sbjct: 298 ---QLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTELT-ELDVS--HNTKLKSLSCVN 348

Query: 514 NNISGEIPYSISQCHSLTSVDLSRNSLYGKIPPGISKLIDLSIL----NLSRNGITGSIP 569
            +I  +   S+ +  +L +   +       +P        L+I      L + G   +I 
Sbjct: 349 AHIQ-DFS-SVGKIPALNNNFEAEGQTI-TMPKETLTNNSLTIAVSPDLLDQFGNPMNIE 405

Query: 570 NEMRNMMSLTTLDLSYNNLIGNIPS 594
                +    T  +++ NL  + P+
Sbjct: 406 PGDGGVYDQATNTITWENLSTDNPA 430

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  112 bits (281), Expect = 3e-26
 Identities = 81/438 (18%), Positives = 138/438 (31%), Gaps = 71/438 (16%)

Query: 89  PEIGLLTKLVNLTISNVNLTGRLPSEMALLTSLKVFNISGNVFQGNFAGQIVRGMTELQV 148
             I  LT L  L  ++ N+T  L   ++  T+L       N          V  +T+L  
Sbjct: 58  TGIEKLTGLTKLICTSNNITT-LD--LSQNTNLTYLACDSN----KLTNLDVTPLTKLTY 110

Query: 149 LDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLNGIGLNGTV 208
           L+   N  T    ++++    L +L+   N            +  ++             
Sbjct: 111 LNCDTNKLT---KLDVSQNPLLTYLNCARN-----------TLTEID------------- 143

Query: 209 PAFLSRLKNLREMYIGYFNTYTGGIPPGFGALTQLQVLDMASCNISGEIPTSLSRLKLLH 268
              +S    L E+        T          TQL  LD +   I+ E+   +S+ KLL+
Sbjct: 144 ---VSHNTQLTELDCHLNKKIT---KLDVTPQTQLTTLDCSFNKIT-ELD--VSQNKLLN 194

Query: 269 SLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQLFKNNLRGP 328
            L    N +T  +   L+  I L  LD S N LT EI      L  LT      N L   
Sbjct: 195 RLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLT-EID--VTPLTQLTYFDCSVNPLT-E 247

Query: 329 IPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDLCKGGKLK 388
           +   +     L  L     +   E+   L  N +L+            +  D+    +L 
Sbjct: 248 LD--VSTLSKLTTLHCIQTDLL-EID--LTHNTQLIYFQAEGCRKIKEL--DVTHNTQLY 300

Query: 389 SLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLSGE 448
            L       I  +   L Q   L  +  +   L   +     +   L  +   +  +  +
Sbjct: 301 LLDCQAA-GITELD--LSQNPKLVYLYLNNTELT-ELDVS--HNTKLKSLSCVNAHIQ-D 353

Query: 449 LPEKMSGASLNQLKVANNNITGKIPAAIGNLP-----SLNILSLQNNRLEGEIPVESFNL 503
                   +LN    A           + N       S ++L    N +   I      +
Sbjct: 354 FSSVGKIPALNNNFEAEGQTITMPKETLTNNSLTIAVSPDLLDQFGNPM--NIEPGDGGV 411

Query: 504 KMITSINISDNNISGEIP 521
               +  I+  N+S + P
Sbjct: 412 YDQATNTITWENLSTDNP 429

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  100 bits (251), Expect = 2e-22
 Identities = 57/276 (20%), Positives = 102/276 (36%), Gaps = 27/276 (9%)

Query: 313 KNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNH 372
            N          ++            L  L    ++ T ++   + +   L  L  TSN+
Sbjct: 18  DNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMTG-IEKLTGLTKLICTSNN 75

Query: 373 LTGTIPRDLCKGGKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGTIPAGLFNL 432
           +T     DL +   L  L    N  +  +   +     LT +    N L   +   +   
Sbjct: 76  ITTL---DLSQNTNLTYLACDSN-KLTNLD--VTPLTKLTYLNCDTNKLT-KLD--VSQN 126

Query: 433 PLLNMMELDDNLLSGELPEKMSGASLNQLKVANNNITGKIPAAIGNLPSLNILSLQNNRL 492
           PLL  +    N L+ E+    +   L +L    N    K+   +     L  L    N++
Sbjct: 127 PLLTYLNCARNTLT-EIDVSHN-TQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKI 182

Query: 493 EGEIPVESFNLKMITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYGKIPPGISKLI 552
             E+ V     K++  +N   NNI+ ++   ++Q   LT +D S N L  +I   ++ L 
Sbjct: 183 T-ELDVS--QNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLT-EID--VTPLT 233

Query: 553 DLSILNLSRNGITGSIPNEMRNMMSLTTLDLSYNNL 588
            L+  + S N +T  +      +  LTTL     +L
Sbjct: 234 QLTYFDCSVNPLT-ELDVS--TLSKLTTLHCIQTDL 266

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  130 bits (330), Expect = 1e-33
 Identities = 75/295 (25%), Positives = 114/295 (38%), Gaps = 33/295 (11%)

Query: 692 ESLKDENIIGKGGAGIVYRG-----SMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRI 746
             LK    +G+G  G V        +   G  VA+K L       +  G+  EI  L  +
Sbjct: 31  RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTL 90

Query: 747 RHRNIVRLLGYVSNRDTN--LLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGL 804
            H +I++  G   +       L+ EY+P GSL + L       +        A +  +G+
Sbjct: 91  YHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS---IGLAQLLLFAQQICEGM 147

Query: 805 CYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGS----Y 860
            YLH   +   IHRD+ + N+LLD+D    + DFGLAK + +      +     S    Y
Sbjct: 148 AYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY 204

Query: 861 GYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPS 920
              APE     K    SDV+SFGV L EL                     K    +    
Sbjct: 205 ---APECLKEYKFYYASDVWSFGVTLYEL---------LTHCDSSQSPPTKFLELIGIAQ 252

Query: 921 DAASVLAVVDPRLSGY----PLTGVIHLFKVAMMCVEDESSARPTMREVVHMLAN 971
              +VL + +    G     P      ++ +   C E E+S RPT   ++ +L  
Sbjct: 253 GQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKT 307

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  130 bits (329), Expect = 2e-33
 Identities = 68/302 (22%), Positives = 115/302 (38%), Gaps = 49/302 (16%)

Query: 692 ESLKDENIIGKGGAGIVYRGSMP-----DGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRI 746
             LK    +G+G  G V            G  VA+K L     G +      EI+ L  +
Sbjct: 21  RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL 80

Query: 747 RHRNIVRLLGYVSNRDTN--LLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGL 804
            H NIV+  G  +    N   L+ E++P+GSL E L       +  + + + A++  KG+
Sbjct: 81  YHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLP-KNKNKINLKQQLKYAVQICKGM 139

Query: 805 CYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYI- 863
            YL    S   +HRD+ + N+L++S+ +  + DFGL K ++                Y  
Sbjct: 140 DYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET-----------DKEYYTV 185

Query: 864 -----------APEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKT 912
                      APE     K    SDV+SFGV L EL+        + D       +   
Sbjct: 186 KDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT-------YCDSDSSPMALFLK 238

Query: 913 TSEVSQPS-DAASVLAVVDPRLSGY----PLTGVIHLFKVAMMCVEDESSARPTMREVVH 967
               +        ++  +     G     P      ++++   C E + S R + + ++ 
Sbjct: 239 MIGPTHGQMTVTRLVNTLK---EGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295

Query: 968 ML 969
             
Sbjct: 296 GF 297

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  129 bits (326), Expect = 2e-33
 Identities = 69/287 (24%), Positives = 122/287 (42%), Gaps = 44/287 (15%)

Query: 692 ESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNI 751
             L     IG G  G+V+ G   +   VAIK +        D  F+ E + + ++ H  +
Sbjct: 8   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEED--FIEEAEVMMKLSHPKL 65

Query: 752 VRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYL--HH 809
           V+L G    +    L+ E+M +G L + L   + G    ET   + L+  +G+ YL    
Sbjct: 66  VQLYGVCLEQAPICLVTEFMEHGCLSDYLRT-QRGLFAAETLLGMCLDVCEGMAYLEEAC 124

Query: 810 DCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGY--IAPEY 867
                +IHRD+ + N L+  +    V+DFG+ +F+ D    +  SS    +     +PE 
Sbjct: 125 -----VIHRDLAARNCLVGENQVIKVSDFGMTRFVLD---DQYTSSTGTKFPVKWASPEV 176

Query: 868 AYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVL 926
               +   KSDV+SFGV++ E+ + GK P            +  ++ SE         V+
Sbjct: 177 FSFSRYSSKSDVWSFGVLMWEVFSEGKIP------------YENRSNSE---------VV 215

Query: 927 AVVDPRLSGY----PLTGVIHLFKVAMMCVEDESSARPTMREVVHML 969
             +    +G+    P     H++++   C  +    RP    ++  L
Sbjct: 216 EDIS---TGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQL 259

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  129 bits (326), Expect = 2e-33
 Identities = 53/210 (25%), Positives = 95/210 (45%), Gaps = 18/210 (8%)

Query: 692 ESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNI 751
           + L     +G G  G+V  G      DVAIK +       ++  F+ E + +  + H  +
Sbjct: 24  KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDE--FIEEAKVMMNLSHEKL 81

Query: 752 VRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYL--HH 809
           V+L G  + +    ++ EYM NG L   L        + +    +  +  + + YL    
Sbjct: 82  VQLYGVCTKQRPIFIITEYMANGCLLNYLR-EMRHRFQTQQLLEMCKDVCEAMEYLESKQ 140

Query: 810 DCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYI---APE 866
                 +HRD+ + N L++      V+DFGL++++ D    +  +S  GS   +    PE
Sbjct: 141 -----FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD----DEYTSSVGSKFPVRWSPPE 191

Query: 867 YAYTLKVDEKSDVYSFGVVLLELIA-GKKP 895
                K   KSD+++FGV++ E+ + GK P
Sbjct: 192 VLMYSKFSSKSDIWAFGVLMWEIYSLGKMP 221

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  129 bits (326), Expect = 3e-33
 Identities = 64/215 (29%), Positives = 96/215 (44%), Gaps = 18/215 (8%)

Query: 692 ESLKDENIIGKGGAGIVYRGSMPDG----IDVAIKRLVGRGTGGNDHGFLAEIQTLGRIR 747
                + +IGKG  G+VY G   D     I  AIK L           FL E   +  + 
Sbjct: 21  VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLN 80

Query: 748 HRNIVRLLGYVSNRD-TNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCY 806
           H N++ L+G +   +    +L  YM +G L + +  +   +   +      L+ A+G+ Y
Sbjct: 81  HPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIR-SPQRNPTVKDLISFGLQVARGMEY 139

Query: 807 LHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYI--- 863
           L        +HRD+ + N +LD  F   VADFGLA+ + D    E  S     +  +   
Sbjct: 140 LA---EQKFVHRDLAARNCMLDESFTVKVADFGLARDILD---REYYSVQQHRHARLPVK 193

Query: 864 --APEYAYTLKVDEKSDVYSFGVVLLELIA-GKKP 895
             A E   T +   KSDV+SFGV+L EL+  G  P
Sbjct: 194 WTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPP 228

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  130 bits (328), Expect = 4e-33
 Identities = 62/243 (25%), Positives = 105/243 (43%), Gaps = 22/243 (9%)

Query: 661 IYQLRKRRLQKSKAWKLTAFQRLDFKAEDVLESLKDENIIGKGGAGIVYRGSMPD-GIDV 719
           + +L                + +D++  + +  +  +  +G+G  G V+R      G   
Sbjct: 27  LQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQC 86

Query: 720 AIK--RLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLG 777
           A+K  RL        +   + E+     +    IV L G V       +  E +  GSLG
Sbjct: 87  AVKKVRL--------EVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLG 138

Query: 778 EMLHGAKGGHLKWETRYR-IALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSD-FEAHV 835
           +++   + G L  E R      +A +GL YLH      I+H DVK++N+LL SD   A +
Sbjct: 139 QLIK--QMGCLP-EDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAAL 192

Query: 836 ADFGLAKFLQDAGASECMS---SVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAG 892
            DFG A  LQ  G  + +     + G+  ++APE       D K D++S   ++L ++ G
Sbjct: 193 CDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 252

Query: 893 KKP 895
             P
Sbjct: 253 CHP 255

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  128 bits (324), Expect = 5e-33
 Identities = 74/294 (25%), Positives = 116/294 (39%), Gaps = 48/294 (16%)

Query: 692 ESLKDENIIGKGGAGIVYRGS--MPDG--IDVAIKRLVGRGTGGNDHG--FLAEIQTLGR 745
           + L+    +G G  G+V RG    P G  + VA+K L        +    F+ E+  +  
Sbjct: 18  KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77

Query: 746 IRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLC 805
           + HRN++RL G V       ++ E  P GSL + L     GH    T  R A++ A+G+ 
Sbjct: 78  LDHRNLIRLYG-VVLTPPMKMVTELAPLGSLLDRLRK-HQGHFLLGTLSRYAVQVAEGMG 135

Query: 806 YL--HHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGS---Y 860
           YL          IHRD+ + N+LL +     + DFGL + L      +           +
Sbjct: 136 YLESKR-----FIHRDLAARNLLLATRDLVKIGDFGLMRALPQ--NDDHYVMQEHRKVPF 188

Query: 861 GYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQP 919
            + APE   T      SD + FGV L E+   G++P            W+    S+    
Sbjct: 189 AWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP------------WIGLNGSQ---- 232

Query: 920 SDAASVLAVVDPRLSGY----PLTGVIHLFKVAMMCVEDESSARPTMREVVHML 969
                +L  +D    G     P      ++ V + C   +   RPT   +   L
Sbjct: 233 -----ILHKIDK--EGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFL 279

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  128 bits (323), Expect = 6e-33
 Identities = 71/290 (24%), Positives = 118/290 (40%), Gaps = 45/290 (15%)

Query: 692 ESLKDENIIGKGGAGIVYRGS--MPDG--IDVAIKRLVGRGTGGNDHGFLAEIQTLGRIR 747
           E +    I+G+G  G VY G      G  I+VA+K      T  N   F++E   +  + 
Sbjct: 12  EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLD 71

Query: 748 HRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYL 807
           H +IV+L+G +   +   ++ E  P G LG  L       LK  T    +L+  K + YL
Sbjct: 72  HPHIVKLIGIIE-EEPTWIIMELYPYGELGHYLE-RNKNSLKVLTLVLYSLQICKAMAYL 129

Query: 808 --HHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYI-- 863
              +      +HRD+   NIL+ S     + DFGL+++++D            S   +  
Sbjct: 130 ESIN-----CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDY------YKASVTRLPI 178

Query: 864 ---APEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQP 919
              +PE     +    SDV+ F V + E+++ GK+P            +      +V   
Sbjct: 179 KWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQP------------FFWLENKDVIGV 226

Query: 920 SDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHML 969
            +    L    P+    P      L+ +   C + + S RP   E+V  L
Sbjct: 227 LEKGDRL----PKPDLCP----PVLYTLMTRCWDYDPSDRPRFTELVCSL 268

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  128 bits (323), Expect = 6e-33
 Identities = 64/212 (30%), Positives = 94/212 (44%), Gaps = 26/212 (12%)

Query: 692 ESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNI 751
           + LK    IGKG  G V  G    G  VA+K +           FLAE   + ++RH N+
Sbjct: 21  KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKN---DATAQAFLAEASVMTQLRHSNL 76

Query: 752 VRLLGYVSNRDTNLLL-YEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHD 810
           V+LLG +      L +  EYM  GSL + L       L  +   + +L+  + + YL   
Sbjct: 77  VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE-- 134

Query: 811 CSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYG------YIA 864
                +HRD+ + N+L+  D  A V+DFGL K                         + A
Sbjct: 135 -GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-----------QDTGKLPVKWTA 182

Query: 865 PEYAYTLKVDEKSDVYSFGVVLLELIA-GKKP 895
           PE     K   KSDV+SFG++L E+ + G+ P
Sbjct: 183 PEALREKKFSTKSDVWSFGILLWEIYSFGRVP 214

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  128 bits (324), Expect = 7e-33
 Identities = 67/223 (30%), Positives = 97/223 (43%), Gaps = 18/223 (8%)

Query: 684 DFKAEDVLESLKDENIIGKGGAGIVYRGSMPDG----IDVAIKRLVGRGTGGNDHGFLAE 739
                     +    +IG+G  G VY G++ D     I  A+K L      G    FL E
Sbjct: 17  HVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTE 76

Query: 740 IQTLGRIRHRNIVRLLGYVSNRDTNLL-LYEYMPNGSLGEMLHGAKGGHLKWETRYRIAL 798
              +    H N++ LLG     + + L +  YM +G L   +   +  +   +      L
Sbjct: 77  GIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR-NETHNPTVKDLIGFGL 135

Query: 799 EAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAG 858
           + AKG+ YL    S   +HRD+ + N +LD  F   VADFGLA+ + D    E  S    
Sbjct: 136 QVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD---KEYYSVHNK 189

Query: 859 SYGYI-----APEYAYTLKVDEKSDVYSFGVVLLELIA-GKKP 895
           +   +     A E   T K   KSDV+SFGV+L EL+  G  P
Sbjct: 190 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 232

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  128 bits (323), Expect = 8e-33
 Identities = 80/293 (27%), Positives = 121/293 (41%), Gaps = 31/293 (10%)

Query: 692 ESLKDENIIGKGGAGIVYRG---SMPD--GIDVAIKRLVGRGTGGNDHGFLAEIQTLGRI 746
             LK    +GKG  G V       + D  G  VA+K+L    T  +   F  EI+ L  +
Sbjct: 10  RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFEREIEILKSL 68

Query: 747 RHRNIVRLLG--YVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGL 804
           +H NIV+  G  Y + R    L+ EY+P GSL + L       +      +   +  KG+
Sbjct: 69  QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ-KHKERIDHIKLLQYTSQICKGM 127

Query: 805 CYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGS----Y 860
            YL    +   IHRD+ + NIL++++    + DFGL K L        +     S    Y
Sbjct: 128 EYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWY 184

Query: 861 GYIAPEYAYTLKVDEKSDVYSFGVVLLELI----AGKKPVGEFGDGVDIVRWVRKTTSEV 916
              APE     K    SDV+SFGVVL EL       K P  EF   +   +  +     +
Sbjct: 185 ---APESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL 241

Query: 917 SQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHML 969
            +       L    PR  G P      ++ +   C  +  + RP+ R++   +
Sbjct: 242 IELLKNNGRL----PRPDGCP----DEIYMIMTECWNNNVNQRPSFRDLALRV 286

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  127 bits (322), Expect = 9e-33
 Identities = 57/205 (27%), Positives = 89/205 (43%), Gaps = 10/205 (4%)

Query: 699 IIGKGGAGIVYRG-SMPDGIDVAIKRL-VGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLG 756
            IG G  G   +     DG  +  K L  G  T       ++E+  L  ++H NIVR   
Sbjct: 13  TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72

Query: 757 -YVSNRDTNLLLY-EYMPNGSLGEML--HGAKGGHLKWETRYRIALEAAKGLCYLH--HD 810
             +   +T L +  EY   G L  ++     +  +L  E   R+  +    L   H   D
Sbjct: 73  RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132

Query: 811 CSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYT 870
               ++HRD+K  N+ LD      + DFGLA+ L     +    +  G+  Y++PE    
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH--DTSFAKTFVGTPYYMSPEQMNR 190

Query: 871 LKVDEKSDVYSFGVVLLELIAGKKP 895
           +  +EKSD++S G +L EL A   P
Sbjct: 191 MSYNEKSDIWSLGCLLYELCALMPP 215

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  128 bits (324), Expect = 9e-33
 Identities = 60/261 (22%), Positives = 95/261 (36%), Gaps = 32/261 (12%)

Query: 698 NIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGND-HGFLAEIQTLGRIRHRN--IVRL 754
             IG GG+  V++         AIK +            +  EI  L +++  +  I+RL
Sbjct: 34  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93

Query: 755 LGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLH-HDCSP 813
             Y        ++ E   N  L   L   K   +    R        + +  +H H    
Sbjct: 94  YDYEITDQYIYMVMECG-NIDLNSWLK--KKKSIDPWERKSYWKNMLEAVHTIHQHG--- 147

Query: 814 LIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPE------- 866
            I+H D+K  N L+       + DFG+A  +Q    S    S  G+  Y+ PE       
Sbjct: 148 -IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 205

Query: 867 ----YAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPS-- 920
                    K+  KSDV+S G +L  +  GK P  +  + +  +  +     E+  P   
Sbjct: 206 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIP 265

Query: 921 --DAASVLA---VVDP--RLS 934
             D   VL      DP  R+S
Sbjct: 266 EKDLQDVLKCCLKRDPKQRIS 286

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  128 bits (323), Expect = 1e-32
 Identities = 50/215 (23%), Positives = 90/215 (41%), Gaps = 27/215 (12%)

Query: 700 IGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGY- 757
           +G+GG G+V+   +  D  + AIKR+            + E++ L ++ H  IVR     
Sbjct: 13  LGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAW 72

Query: 758 --------VSNRDTNLLLY---EYMPNGSLGEMLHGAKGGHLKWETR-YRIALEAAKGLC 805
                   +      + LY   +     +L + ++G      +  +    I L+ A+ + 
Sbjct: 73  LEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVE 132

Query: 806 YLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQ----------DAGASECMSS 855
           +LH   S  ++HRD+K +NI    D    V DFGL   +              A    + 
Sbjct: 133 FLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTG 189

Query: 856 VAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELI 890
             G+  Y++PE  +      K D++S G++L EL+
Sbjct: 190 QVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  128 bits (324), Expect = 2e-32
 Identities = 53/238 (22%), Positives = 86/238 (36%), Gaps = 23/238 (9%)

Query: 698 NIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGND-HGFLAEIQTLGRIRH--RNIVRL 754
             IG GG+  V++         AIK +            +  EI  L +++     I+RL
Sbjct: 15  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74

Query: 755 LGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLH-HDCSP 813
             Y        ++ E   N  L   L   K   +    R        + +  +H H    
Sbjct: 75  YDYEITDQYIYMVMEC-GNIDLNSWLK--KKKSIDPWERKSYWKNMLEAVHTIHQHG--- 128

Query: 814 LIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPE------- 866
            I+H D+K  N L+       + DFG+A  +Q    S    S  G+  Y+ PE       
Sbjct: 129 -IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 186

Query: 867 ----YAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPS 920
                    K+  KSDV+S G +L  +  GK P  +  + +  +  +     E+  P 
Sbjct: 187 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPD 244

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  130 bits (330), Expect = 2e-32
 Identities = 65/212 (30%), Positives = 97/212 (45%), Gaps = 26/212 (12%)

Query: 692 ESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNI 751
           + LK    IGKG  G V  G    G  VA+K +           FLAE   + ++RH N+
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIK---NDATAQAFLAEASVMTQLRHSNL 248

Query: 752 VRLLGYVSNRDTNLLL-YEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYL-HH 809
           V+LLG +      L +  EYM  GSL + L       L  +   + +L+  + + YL  +
Sbjct: 249 VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 308

Query: 810 DCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYI-----A 864
           +     +HRD+ + N+L+  D  A V+DFGL K                  G +     A
Sbjct: 309 NF----VHRDLAARNVLVSEDNVAKVSDFGLTKEASS----------TQDTGKLPVKWTA 354

Query: 865 PEYAYTLKVDEKSDVYSFGVVLLELIA-GKKP 895
           PE     K   KSDV+SFG++L E+ + G+ P
Sbjct: 355 PEALREKKFSTKSDVWSFGILLWEIYSFGRVP 386

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  127 bits (322), Expect = 2e-32
 Identities = 79/294 (26%), Positives = 120/294 (40%), Gaps = 33/294 (11%)

Query: 692 ESLKDENIIGKGGAGIVYRG---SMPD--GIDVAIKRLVGRGTGGNDHGFLAEIQTLGRI 746
             LK    +GKG  G V       + D  G  VA+K+L    T  +   F  EI+ L  +
Sbjct: 41  RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFEREIEILKSL 99

Query: 747 RHRNIVRLLG--YVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGL 804
           +H NIV+  G  Y + R    L+ EY+P GSL + L       +      +   +  KG+
Sbjct: 100 QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ-KHKERIDHIKLLQYTSQICKGM 158

Query: 805 CYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYI- 863
            YL    +   IHRD+ + NIL++++    + DFGL K L      +         G   
Sbjct: 159 EYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ----DKEYYKVKEPGESP 211

Query: 864 ----APEYAYTLKVDEKSDVYSFGVVLLELI----AGKKPVGEFGDGVDIVRWVRKTTSE 915
               APE     K    SDV+SFGVVL EL       K P  EF   +   +  +     
Sbjct: 212 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 271

Query: 916 VSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHML 969
           + +       L    PR  G P      ++ +   C  +  + RP+ R++   +
Sbjct: 272 LIELLKNNGRL----PRPDGCP----DEIYMIMTECWNNNVNQRPSFRDLALRV 317

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  129 bits (325), Expect = 2e-32
 Identities = 66/223 (29%), Positives = 97/223 (43%), Gaps = 18/223 (8%)

Query: 684 DFKAEDVLESLKDENIIGKGGAGIVYRGSMPDG----IDVAIKRLVGRGTGGNDHGFLAE 739
                     +    +IG+G  G VY G++ D     I  A+K L      G    FL E
Sbjct: 81  HVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTE 140

Query: 740 IQTLGRIRHRNIVRLLGYVSNRDTNLLL-YEYMPNGSLGEMLHGAKGGHLKWETRYRIAL 798
              +    H N++ LLG     + + L+   YM +G L   +   +  +   +      L
Sbjct: 141 GIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR-NETHNPTVKDLIGFGL 199

Query: 799 EAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAG 858
           + AKG+ +L    S   +HRD+ + N +LD  F   VADFGLA+ + D    E  S    
Sbjct: 200 QVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD---KEFDSVHNK 253

Query: 859 SYGYI-----APEYAYTLKVDEKSDVYSFGVVLLELIA-GKKP 895
           +   +     A E   T K   KSDV+SFGV+L EL+  G  P
Sbjct: 254 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 296

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  127 bits (321), Expect = 2e-32
 Identities = 48/204 (23%), Positives = 90/204 (44%), Gaps = 16/204 (7%)

Query: 700 IGKGGAGIVYRG-SMPDGIDVAIK--RLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLG 756
           IG+G    VYR   + DG+ VA+K  ++            + EI  L ++ H N+++   
Sbjct: 40  IGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 99

Query: 757 YVSNRDTNLLLY---EYMPNGSLGEML--HGAKGGHLKWETRYRIALEAAKGLCYLHHDC 811
                +    L    E    G L  M+     +   +   T ++  ++    L ++H   
Sbjct: 100 SFIEDNE---LNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH--- 153

Query: 812 SPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTL 871
           S  ++HRD+K  N+ + +     + D GL +F      +    S+ G+  Y++PE  +  
Sbjct: 154 SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS--SKTTAAHSLVGTPYYMSPERIHEN 211

Query: 872 KVDEKSDVYSFGVVLLELIAGKKP 895
             + KSD++S G +L E+ A + P
Sbjct: 212 GYNFKSDIWSLGCLLYEMAALQSP 235

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  127 bits (321), Expect = 3e-32
 Identities = 72/306 (23%), Positives = 129/306 (42%), Gaps = 49/306 (16%)

Query: 692 ESLKDENIIGKGGAGIVYRGS-MPDG----IDVAIKRLVGRGTGGNDHGFLAEIQTLGRI 746
             L+   ++G G  G V++G  +P+G    I V IK +  +    +       +  +G +
Sbjct: 13  TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL 72

Query: 747 RHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCY 806
            H +IVRLLG +    +  L+ +Y+P GSL + +     G L  +      ++ AKG+ Y
Sbjct: 73  DHAHIVRLLG-LCPGSSLQLVTQYLPLGSLLDHVR-QHRGALGPQLLLNWGVQIAKGMYY 130

Query: 807 L--HHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYI- 863
           L  H      ++HR++ + N+LL S  +  VADFG+A  L      +     + +   I 
Sbjct: 131 LEEHG-----MVHRNLAARNVLLKSPSQVQVADFGVADLLPP---DDKQLLYSEAKTPIK 182

Query: 864 --APEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPS 920
             A E  +  K   +SDV+S+GV + EL+  G +P        ++   + K         
Sbjct: 183 WMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGL-RLAEVPDLLEK--------- 232

Query: 921 DAASVLAVVDPRLSGY----PLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQSA 976
                         G     P    I ++ V + C   + + RPT +E+ +      +  
Sbjct: 233 --------------GERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDP 278

Query: 977 PSLITL 982
           P  + +
Sbjct: 279 PRYLVI 284

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  132 bits (334), Expect = 3e-32
 Identities = 73/299 (24%), Positives = 120/299 (40%), Gaps = 44/299 (14%)

Query: 692 ESLKDENIIGKGGAGIVYRG--SMPDG-IDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRH 748
             L  +  +G G  G V +G   M    IDVAIK L       +    + E Q + ++ +
Sbjct: 336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDN 395

Query: 749 RNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYL- 807
             IVRL+G V   +  +L+ E    G L + L G K   +       +  + + G+ YL 
Sbjct: 396 PYIVRLIG-VCQAEALMLVMEMAGGGPLHKFLVG-KREEIPVSNVAELLHQVSMGMKYLE 453

Query: 808 -HHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGY--IA 864
             +      +HR++ + N+LL +   A ++DFGL+K L     S   +  AG +     A
Sbjct: 454 EKN-----FVHRNLAARNVLLVNRHYAKISDFGLSKALGA-DDSYYTARSAGKWPLKWYA 507

Query: 865 PEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAA 923
           PE     K   +SDV+S+GV + E ++ G+KP            + +    E        
Sbjct: 508 PECINFRKFSSRSDVWSYGVTMWEALSYGQKP------------YKKMKGPE-------- 547

Query: 924 SVLAVVDPRLSGY----PLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQSAPS 978
            V+A ++    G     P      L+ +   C   +   RP    V   +     S  S
Sbjct: 548 -VMAFIE---QGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 602

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  126 bits (318), Expect = 3e-32
 Identities = 56/215 (26%), Positives = 97/215 (45%), Gaps = 23/215 (10%)

Query: 692 ESLKDENIIGKGGAGIVYRG--SMPDG--IDVAIKRLVGRGTGGNDHGFLAEIQTLGRIR 747
           E ++    IG+G  G V++G    P+   + VAIK      +      FL E  T+ +  
Sbjct: 15  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 74

Query: 748 HRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYL 807
           H +IV+L+G ++  +   ++ E    G L   L   +   L   +    A + +  L YL
Sbjct: 75  HPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQ-VRKYSLDLASLILYAYQLSTALAYL 132

Query: 808 -HHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYI--- 863
                    +HRD+ + N+L+ S+    + DFGL+++++D+           S G +   
Sbjct: 133 ESKRF----VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY------YKASKGKLPIK 182

Query: 864 --APEYAYTLKVDEKSDVYSFGVVLLELIA-GKKP 895
             APE     +    SDV+ FGV + E++  G KP
Sbjct: 183 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 217

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  126 bits (318), Expect = 3e-32
 Identities = 69/291 (23%), Positives = 119/291 (40%), Gaps = 52/291 (17%)

Query: 697 ENIIGKGGAGIVYRGSMPDG---IDVAIKRL-VGRGTGGNDHGFLAEIQTLGRIRHRNIV 752
           +  +G G  G V +G          VA+K L             LAE   + ++ +  IV
Sbjct: 22  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 81

Query: 753 RLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYL--HHD 810
           R++G +   ++ +L+ E    G L + L   +  H+K +    +  + + G+ YL   + 
Sbjct: 82  RMIG-ICEAESWMLVMEMAELGPLNKYLQ--QNRHVKDKNIIELVHQVSMGMKYLEESN- 137

Query: 811 CSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYI-----AP 865
                +HRD+ + N+LL +   A ++DFGL+K L+     +     A ++G       AP
Sbjct: 138 ----FVHRDLAARNVLLVTQHYAKISDFGLSKALRA----DENYYKAQTHGKWPVKWYAP 189

Query: 866 EYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAAS 924
           E     K   KSDV+SFGV++ E  + G+KP            +     SE         
Sbjct: 190 ECINYYKFSSKSDVWSFGVLMWEAFSYGQKP------------YRGMKGSE--------- 228

Query: 925 VLAVVDPRLSGY----PLTGVIHLFKVAMMCVEDESSARPTMREVVHMLAN 971
           V A+++    G     P      ++ +  +C   +   RP    V   L N
Sbjct: 229 VTAMLE---KGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 276

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  128 bits (324), Expect = 4e-32
 Identities = 60/261 (22%), Positives = 94/261 (36%), Gaps = 32/261 (12%)

Query: 698 NIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGND-HGFLAEIQTLGRIRH--RNIVRL 754
             IG GG+  V++         AIK +            +  EI  L +++     I+RL
Sbjct: 62  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121

Query: 755 LGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLH-HDCSP 813
             Y        ++ E   N  L   L   K   +    R        + +  +H H    
Sbjct: 122 YDYEITDQYIYMVMEC-GNIDLNSWLK--KKKSIDPWERKSYWKNMLEAVHTIHQHG--- 175

Query: 814 LIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPE------- 866
            I+H D+K  N L+       + DFG+A  +Q    S    S  G+  Y+ PE       
Sbjct: 176 -IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSS 233

Query: 867 ----YAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPS-- 920
                    K+  KSDV+S G +L  +  GK P  +  + +  +  +     E+  P   
Sbjct: 234 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIP 293

Query: 921 --DAASVLA---VVDP--RLS 934
             D   VL      DP  R+S
Sbjct: 294 EKDLQDVLKCCLKRDPKQRIS 314

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  126 bits (319), Expect = 6e-32
 Identities = 78/295 (26%), Positives = 117/295 (39%), Gaps = 36/295 (12%)

Query: 692 ESLKDENIIGKGGAGIVYRG-----SMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRI 746
             LK  + +GKG  G V            G  VA+K+L   G       F  EIQ L  +
Sbjct: 23  RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPD-QQRDFQREIQILKAL 81

Query: 747 RHRNIVRLLG--YVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGL 804
               IV+  G  Y   R +  L+ EY+P+G L + L       L        + +  KG+
Sbjct: 82  HSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQ-RHRARLDASRLLLYSSQICKGM 140

Query: 805 CYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYI- 863
            YL    S   +HRD+ + NIL++S+    +ADFGLAK L      +    V    G   
Sbjct: 141 EYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPL----DKDYYVVREPGQSP 193

Query: 864 ----APEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQ 918
               APE         +SDV+SFGVVL EL     K      +      ++R    E   
Sbjct: 194 IFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAE------FLRMMGCERDV 247

Query: 919 PSDAASVLAVVDPRLSGY----PLTGVIHLFKVAMMCVEDESSARPTMREVVHML 969
           P+  + +L +++    G     P      + ++  +C       RP+   +   L
Sbjct: 248 PA-LSRLLELLE---EGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQL 298

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  125 bits (317), Expect = 6e-32
 Identities = 59/221 (26%), Positives = 103/221 (46%), Gaps = 33/221 (14%)

Query: 699 IIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLG- 756
           ++G+G  G V +  +  D    AIK++  R T       L+E+  L  + H+ +VR    
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKI--RHTEEKLSTILSEVMLLASLNHQYVVRYYAA 70

Query: 757 ---------YVSNRDTNLLLY---EYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGL 804
                     ++       L+   EY  NG+L +++H ++  + + +  +R+  +  + L
Sbjct: 71  WLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIH-SENLNQQRDEYWRLFRQILEAL 129

Query: 805 CYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQD------------AGASEC 852
            Y+H   S  IIHRD+K  NI +D      + DFGLAK +               G+S+ 
Sbjct: 130 SYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDN 186

Query: 853 MSSVAGSYGYIAPE-YAYTLKVDEKSDVYSFGVVLLELIAG 892
           ++S  G+  Y+A E    T   +EK D+YS G++  E+I  
Sbjct: 187 LTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  125 bits (315), Expect = 9e-32
 Identities = 63/215 (29%), Positives = 102/215 (47%), Gaps = 21/215 (9%)

Query: 699 IIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGY 757
           ++GKG  GIVY G  + + + +AIK  +             EI     ++H+NIV+ LG 
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKE-IPERDSRYSQPLHEEIALHKHLKHKNIVQYLGS 87

Query: 758 VSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYR-IALEAAKGLCYLHHDCSPLII 816
            S      +  E +P GSL  +L    G     E        +  +GL YLH +    I+
Sbjct: 88  FSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IV 144

Query: 817 HRDVKSNNILLDSDFEAHV--ADFGLAKFLQDAGASECMSSVAGSYGYIAPE------YA 868
           HRD+K +N+L+++ +   +  +DFG +K L  AG + C  +  G+  Y+APE        
Sbjct: 145 HRDIKGDNVLINT-YSGVLKISDFGTSKRL--AGINPCTETFTGTLQYMAPEIIDKGPRG 201

Query: 869 YTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGV 903
           Y       +D++S G  ++E+  GK P  E G+  
Sbjct: 202 YGK----AADIWSLGCTIIEMATGKPPFYELGEPQ 232

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  131 bits (332), Expect = 9e-32
 Identities = 56/238 (23%), Positives = 89/238 (37%), Gaps = 32/238 (13%)

Query: 700 IGKGGAGIVYRG--SMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGY 757
           I  GG G +Y       +G  V +K LV  G        +AE Q L  + H +IV++  +
Sbjct: 88  IAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNF 147

Query: 758 VS--NRDTNLLLY---EYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCS 812
           V   +R  + + Y   EY+   SL        G  L         LE    L YLH    
Sbjct: 148 VEHTDRHGDPVGYIVMEYVGGQSLKRSK----GQKLPVAEAIAYLLEILPALSYLHSIG- 202

Query: 813 PLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLK 872
             +++ D+K  NI+L  + +  + D G    +   G       + G+ G+ APE   T  
Sbjct: 203 --LVYNDLKPENIMLTEE-QLKLIDLGAVSRINSFGY------LYGTPGFQAPEIVRT-G 252

Query: 873 VDEKSDVYSFGVVLLELIAGKKP-VGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVV 929
               +D+Y+ G  L  L        G + DG+           +        S   ++
Sbjct: 253 PTVATDIYTVGRTLAALTLDLPTRNGRYVDGL---------PEDDPVLKTYDSYGRLL 301

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  124 bits (314), Expect = 1e-31
 Identities = 43/229 (18%), Positives = 84/229 (36%), Gaps = 43/229 (18%)

Query: 692 ESLKDENIIGKGGAGIVYRG--------SMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTL 743
           E L     +G+G    +++G              +V +K L  +        F      +
Sbjct: 8   EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVL-DKAHRNYSESFFEAASMM 66

Query: 744 GRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKG 803
            ++ H+++V   G     D N+L+ E++  GSL   L       +    +  +A + A  
Sbjct: 67  SKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKK-NKNCINILWKLEVAKQLAAA 125

Query: 804 LCYL--HHDCSPLIIHRDVKSNNILLDSDFEAH--------VADFGLAKFLQDAGASECM 853
           + +L  +      +IH +V + NILL  + +          ++D G++  +         
Sbjct: 126 MHFLEENT-----LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK------ 174

Query: 854 SSVAGSYGYI-----APE-YAYTLKVDEKSDVYSFGVVLLELIA-GKKP 895
                           PE       ++  +D +SFG  L E+ + G KP
Sbjct: 175 -----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKP 218

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  125 bits (315), Expect = 2e-31
 Identities = 68/312 (21%), Positives = 120/312 (38%), Gaps = 61/312 (19%)

Query: 692 ESLKDENIIGKGGAGIVYRGS-MPDG----IDVAIKRLVGRGTGGNDHGFLAEIQTLGRI 746
              K   ++G G  G VY+G  +P+G    I VAIK L    +   +   L E   +  +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74

Query: 747 RHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCY 806
            + ++ RLLG +    T  L+ + MP G L + +      ++  +      ++ AKG+ Y
Sbjct: 75  DNPHVCRLLG-ICLTSTVQLITQLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQIAKGMNY 132

Query: 807 LHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGY---- 862
           L       ++HRD+ + N+L+ +     + DFGLAK L                 Y    
Sbjct: 133 LEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGA-----------EEKEYHAEG 178

Query: 863 -------IAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTS 914
                  +A E         +SDV+S+GV + EL+  G KP        +I   + K   
Sbjct: 179 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEK--- 234

Query: 915 EVSQPSDAASVLAVVDPRLSGY----PLTGVIHLFKVAMMCVEDESSARPTMREVVHMLA 970
                               G     P    I ++ + + C   ++ +RP  RE++   +
Sbjct: 235 --------------------GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFS 274

Query: 971 NPPQSAPSLITL 982
              +     + +
Sbjct: 275 KMARDPQRYLVI 286

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  124 bits (314), Expect = 2e-31
 Identities = 68/306 (22%), Positives = 114/306 (37%), Gaps = 50/306 (16%)

Query: 697 ENIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLL 755
              +G+GG   V     + DG   A+KR++       +     E        H NI+RL+
Sbjct: 34  IQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREE-AQREADMHRLFNHPNILRLV 92

Query: 756 GYVSNRDTN----LLLYEYMPNGSLGEML--HGAKGGHLKWETRYRIALEAAKGLCYLHH 809
            Y            LL  +   G+L   +     KG  L  +    + L   +GL  +H 
Sbjct: 93  AYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH- 151

Query: 810 DCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFL-------QDAGASECMSSVAGSYGY 862
             +    HRD+K  NILL  + +  + D G            + A   +  ++   +  Y
Sbjct: 152 --AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISY 209

Query: 863 IAPE----YAYTLKVDEKSDVYSFGVVLLELIAGKKP---VGEFGDGVDIVRWVRKTTSE 915
            APE     ++   +DE++DV+S G VL  ++ G+ P   V + GD V          ++
Sbjct: 210 RAPELFSVQSHC-VIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSV-----ALAVQNQ 263

Query: 916 VSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREV---VHMLANP 972
           +S P           PR S    + +  L  +  M   D    RP +  +   +  L  P
Sbjct: 264 LSIPQ---------SPRHS----SALWQL--LNSMMTVD-PHQRPHIPLLLSQLEALQPP 307

Query: 973 PQSAPS 978
                +
Sbjct: 308 APGQHT 313

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  124 bits (313), Expect = 4e-31
 Identities = 72/328 (21%), Positives = 127/328 (38%), Gaps = 37/328 (11%)

Query: 242 QLQVLDMASCNISGEIPTSLSRLKLLHSLFLQMNKLTGHIPP-QLSGLISLKSLDLSLNY 300
            L+V+  +   +  ++P  L        L LQ NK+T  I       L +L +L L  N 
Sbjct: 32  HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKIT-EIKDGDFKNLKNLHTLILINNK 87

Query: 301 LTGEIPESFAALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRN 360
           ++   P +FA L  L  L L KN L+  +P  +     L+ L+V  N  T          
Sbjct: 88  ISKISPGAFAPLVKLERLYLSKNQLKE-LPEKM--PKTLQELRVHENEITKVRKSVFNGL 144

Query: 361 GKLLILDVTSNHLT-GTIPRDLCKG-GKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSK 418
            +++++++ +N L    I     +G  KL  + +     I  IP+ L    SLT++    
Sbjct: 145 NQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADT-NITTIPQGL--PPSLTELHLDG 201

Query: 419 NYLNGTIPAGLF-NLPLLNMMELDDNLLSGELPEKMSG-ASLNQLKVANNNITGKIPAAI 476
           N +   + A     L  L  + L  N +S      ++    L +L + NN +  K+P  +
Sbjct: 202 NKIT-KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGL 259

Query: 477 GNLPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIPYSISQCHSLTSVDLS 536
            +   + ++ L NN +   I    F                   P   ++  S + V L 
Sbjct: 260 ADHKYIQVVYLHNNNIS-AIGSNDFCP-----------------PGYNTKKASYSGVSLF 301

Query: 537 RNSL-YGKIPPGI-SKLIDLSILNLSRN 562
            N + Y +I P     +   + + L   
Sbjct: 302 SNPVQYWEIQPSTFRCVYVRAAVQLGNY 329

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  113 bits (286), Expect = 1e-27
 Identities = 66/320 (20%), Positives = 122/320 (38%), Gaps = 52/320 (16%)

Query: 290 SLKSLDLSLNYLTGEIPESFAALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNF 349
            L+ +  S   L  ++P+      +  LL L  N +         +  NL  L +  N  
Sbjct: 32  HLRVVQCSDLGLE-KVPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 88

Query: 350 TFELPENLGRN-GKLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFIGPIPEELGQC 408
           + ++         KL  L ++ N L   +P  +                           
Sbjct: 89  S-KISPGAFAPLVKLERLYLSKNQLK-ELPEKM---------------P----------- 120

Query: 409 KSLTKIRFSKNYLNGTIPAGLF-NLPLLNMMELDDNLL-SGELPEKM-SG-ASLNQLKVA 464
           K+L ++R  +N +   +   +F  L  + ++EL  N L S  +      G   L+ +++A
Sbjct: 121 KTLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIA 179

Query: 465 NNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESF-NLKMITSINISDNNISGEIPYS 523
           + NIT  IP   G  PSL  L L  N++  ++   S   L  +  + +S N+IS     S
Sbjct: 180 DTNIT-TIPQ--GLPPSLTELHLDGNKIT-KVDAASLKGLNNLAKLGLSFNSISAVDNGS 235

Query: 524 ISQCHSLTSVDLSRNSLYGKIPPGISKLIDLSILNLSRNGITGSIPNEM-------RNMM 576
           ++    L  + L+ N L  K+P G++    + ++ L  N I+ +I +             
Sbjct: 236 LANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS-AIGSNDFCPPGYNTKKA 293

Query: 577 SLTTLDLSYNNL-IGNIPSG 595
           S + + L  N +    I   
Sbjct: 294 SYSGVSLFSNPVQYWEIQPS 313

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  110 bits (276), Expect = 3e-26
 Identities = 60/274 (21%), Positives = 108/274 (39%), Gaps = 25/274 (9%)

Query: 233 IPPG-FGALTQLQVLDMASCNISGEIPTSLSRLKLLHSLFLQMNKLTGHIPPQLSGLISL 291
           I  G F  L  L  L + +  IS   P + + L  L  L+L  N+L   +P ++    +L
Sbjct: 67  IKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKM--PKTL 123

Query: 292 KSLDLSLNYLTGEIPESFAALKNLTLLQLFKNNLR-GPIPS--FLGDFPNLEVLQVWGNN 348
           + L +  N +T      F  L  + +++L  N L+   I +  F G    L  +++   N
Sbjct: 124 QELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQG-MKKLSYIRIADTN 182

Query: 349 FTFELPENLGRNGKLLILDVTSNHLTGTIPRDLCKG-GKLKSLILMQNFFIGPIPEE-LG 406
            T  +P+ L  +  L  L +  N +T  +     KG   L  L L  N  I  +    L 
Sbjct: 183 IT-TIPQGLPPS--LTELHLDGNKIT-KVDAASLKGLNNLAKLGLSFN-SISAVDNGSLA 237

Query: 407 QCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLS-------GELPEKMSGASLN 459
               L ++  + N L   +P GL +   + ++ L +N +S                AS +
Sbjct: 238 NTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYS 296

Query: 460 QLKVANNNITGKI--PAAIGNLPSLNILSLQNNR 491
            + + +N +      P+    +     + L N +
Sbjct: 297 GVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 99.3 bits (248), Expect = 1e-22
 Identities = 62/267 (23%), Positives = 99/267 (37%), Gaps = 22/267 (8%)

Query: 141 RGMTELQVLDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQS-YSEIQSLEYIGL 199
           + +  L  L   NN  +   P   A L  L  L    N    ++P+     +Q L  +  
Sbjct: 73  KNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMPKTLQEL-RVHE 130

Query: 200 NGIGLNGTVPAF-LSRLKNLREMYIGYFNTYTGGIPPG-FGALTQLQVLDMASCNISGEI 257
           N I     V     + L  +  + +G     + GI  G F  + +L  + +A  NI+  I
Sbjct: 131 NEI---TKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TI 186

Query: 258 PTSLSRLKLLHSLFLQMNKLTGHIPPQ-LSGLISLKSLDLSLNYLTGEIPESFAALKNLT 316
           P  L     L  L L  NK+T  +    L GL +L  L LS N ++     S A   +L 
Sbjct: 187 PQGL--PPSLTELHLDGNKIT-KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLR 243

Query: 317 LLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFT------FELPENLGRNGKLLILDVTS 370
            L L  N L   +P  L D   ++V+ +  NN +      F  P    +      + + S
Sbjct: 244 ELHLNNNKLVK-VPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFS 302

Query: 371 NHLTGT-IPRDLCKG-GKLKSLILMQN 395
           N +    I     +      ++ L   
Sbjct: 303 NPVQYWEIQPSTFRCVYVRAAVQLGNY 329

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 75.8 bits (187), Expect = 9e-15
 Identities = 42/250 (16%), Positives = 84/250 (33%), Gaps = 46/250 (18%)

Query: 86  SIPPEIGLLTKLVNLTISNVNLTGRLPSEM-ALLTSLKVFNISGNVFQ-GNFAGQIVRGM 143
            +P    +   L  L +    +T ++   +   L  + V  +  N  +         +GM
Sbjct: 114 ELPE--KMPKTLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGM 170

Query: 144 TELQVLDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLNGIG 203
            +L  +   + N T    +      SL  L   GN           +I  ++        
Sbjct: 171 KKLSYIRIADTNITT---IPQGLPPSLTELHLDGN-----------KITKVD-------- 208

Query: 204 LNGTVPAFLSRLKNLREMYIGYFNTYTGGIPPG-FGALTQLQVLDMASCNISGEIPTSLS 262
                 A L  L NL ++ + + N+ +  +  G       L+ L + +  +  ++P  L+
Sbjct: 209 -----AASLKGLNNLAKLGLSF-NSIS-AVDNGSLANTPHLRELHLNNNKLV-KVPGGLA 260

Query: 263 RLKLLHSLFLQMNKLTGHIPPQ-------LSGLISLKSLDLSLNYLT-GEIPES-FAALK 313
             K +  ++L  N ++  I           +   S   + L  N +   EI  S F  + 
Sbjct: 261 DHKYIQVVYLHNNNIS-AIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVY 319

Query: 314 NLTLLQLFKN 323
               +QL   
Sbjct: 320 VRAAVQLGNY 329

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  124 bits (314), Expect = 4e-31
 Identities = 68/300 (22%), Positives = 135/300 (45%), Gaps = 16/300 (5%)

Query: 663 QLRKRRLQKSKAWKLTAFQRLDFKAEDVLESLKDENIIGKGGAGIVYRGS-MPDGIDVAI 721
           +L +++ ++ +A+     +  + K +D     +  + +G G  G+V++ S  P G+ +A 
Sbjct: 8   ELDEQQRKRLEAFLTQKQKVGELKDDD----FEKISELGAGNGGVVFKVSHKPSGLVMAR 63

Query: 722 KRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLG-YVSNRDTNLLLYEYMPNGSLGEML 780
           K +         +  + E+Q L       IV   G + S+ + ++ + E+M  GSL ++L
Sbjct: 64  KLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVL 122

Query: 781 HGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGL 840
              K G +  +   ++++   KGL YL       I+HRDVK +NIL++S  E  + DFG+
Sbjct: 123 K--KAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGV 178

Query: 841 AKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFG 900
           +  L D+ A    +S  G+  Y++PE         +SD++S G+ L+E+  G+ P+    
Sbjct: 179 SGQLIDSMA----NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP-P 233

Query: 901 DGVDIVRWVRKTTSEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARP 960
           D  ++           +  +              G      + +F++    V +     P
Sbjct: 234 DAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLP 293

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  128 bits (324), Expect = 8e-31
 Identities = 79/392 (20%), Positives = 141/392 (35%), Gaps = 45/392 (11%)

Query: 591 NIPSGGQF--LAFNETSFIGNPNLCLLRNGTCQSLINSAKHSGDGYGSSFGASKIVITVI 648
            +   G    L     S     N+  L +G C+ +  + +            +   I  +
Sbjct: 287 QLKIAGAPEPLTVTAPSLTIAENMADLIDGYCRLVNGATQSFIIRPQKEGERALPSIPKL 346

Query: 649 ALLTFMLLVILTIYQLRKRRLQKSKAWKLTAFQRLDFKAEDVLESLKDENIIGKGGAGIV 708
           A      +   T+         +    + T         E   E ++    IG+G  G V
Sbjct: 347 ANNEKQGVRSHTVSVSETDDYAEIIDEEDTYTMPSTRDYEIQRERIELGRCIGEGQFGDV 406

Query: 709 YRGS--MPDG--IDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTN 764
           ++G    P+   + VAIK      +      FL E  T+ +  H +IV+L+G ++  +  
Sbjct: 407 HQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 465

Query: 765 LLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLH-HDCSPLIIHRDVKSN 823
            ++ E    G L   L   +   L   +    A + +  L YL         +HRD+ + 
Sbjct: 466 WIIMELCTLGELRSFLQ-VRKFSLDLASLILYAYQLSTALAYLESKRF----VHRDIAAR 520

Query: 824 NILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYI-----APEYAYTLKVDEKSD 878
           N+L+ S+    + DFGL+++++D+           S G +     APE     +    SD
Sbjct: 521 NVLVSSNDCVKLGDFGLSRYMEDSTY------YKASKGKLPIKWMAPESINFRRFTSASD 574

Query: 879 VYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDPRLSGYP 937
           V+ FGV + E++  G KP            +     ++V    +    L    P     P
Sbjct: 575 VWMFGVCMWEILMHGVKP------------FQGVKNNDVIGRIENGERL----PMPPNCP 618

Query: 938 LTGVIHLFKVAMMCVEDESSARPTMREVVHML 969
                 L+ +   C   + S RP   E+   L
Sbjct: 619 ----PTLYSLMTKCWAYDPSRRPRFTELKAQL 646

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score =  122 bits (308), Expect = 2e-30
 Identities = 59/314 (18%), Positives = 122/314 (38%), Gaps = 34/314 (10%)

Query: 242 QLQVLDMASCNISGEIPTSLSRLKLLHSLFLQMNKLTGHIPP-QLSGLISLKSLDLSLNY 300
            L+V+  +   +   +P  +S       L LQ N ++  +      GL  L +L L  N 
Sbjct: 34  HLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDIS-ELRKDDFKGLQHLYALVLVNNK 89

Query: 301 LTGEIPESFAALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRN 360
           ++    ++F+ L+ L  L + KN+L   IP  L    +L  L++  N             
Sbjct: 90  ISKIHEKAFSPLRKLQKLYISKNHLVE-IPPNL--PSSLVELRIHDNRIRKVPKGVFSGL 146

Query: 361 GKLLILDVTSNHLTGT-IPRDLCKGGKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKN 419
             +  +++  N L  +        G KL  L + +   +  IP++L   ++L ++    N
Sbjct: 147 RNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAK-LTGIPKDL--PETLNELHLDHN 203

Query: 420 YLNGTIPAGLF-NLPLLNMMELDDNLLSGELPEKMSGA-----SLNQLKVANNNITGKIP 473
            +   I          L  + L  N +   +     G+     +L +L + NN ++ ++P
Sbjct: 204 KIQ-AIELEDLLRYSKLYRLGLGHNQIR-MIEN---GSLSFLPTLRELHLDNNKLS-RVP 257

Query: 474 AAIGNLPSLNILSLQNNRLEGEIPVESF-------NLKMITSINISDNNIS-GEIPYSIS 525
           A + +L  L ++ L  N +  ++ V  F              I++ +N +   E+  +  
Sbjct: 258 AGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATF 316

Query: 526 QC-HSLTSVDLSRN 538
           +C     ++     
Sbjct: 317 RCVTDRLAIQFGNY 330

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score =  113 bits (284), Expect = 2e-27
 Identities = 65/318 (20%), Positives = 114/318 (35%), Gaps = 49/318 (15%)

Query: 290 SLKSLDLSLNYLTGEIPESFAALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNF 349
            L+ +  S   L   +P+  +   + TLL L  N++            +L  L +  N  
Sbjct: 34  HLRVVQCSDLGLK-AVPKEISP--DTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKI 90

Query: 350 TFELPENLGRNGKLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFIGPIPEELGQCK 409
           +    +      KL  L ++ NHL   IP +L                            
Sbjct: 91  SKIHEKAFSPLRKLQKLYISKNHLV-EIPPNL---------------P-----------S 123

Query: 410 SLTKIRFSKNYLNGTIPAGLF-NLPLLNMMELDDNLL-SGELPEKM-SGASLNQLKVANN 466
           SL ++R   N +   +P G+F  L  +N +E+  N L +         G  LN L+++  
Sbjct: 124 SLVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEA 182

Query: 467 NITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESF-NLKMITSINISDNNISGEIPYSIS 525
            +T  IP       +LN L L +N+++  I +E       +  + +  N I      S+S
Sbjct: 183 KLT-GIPK--DLPETLNELHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIRMIENGSLS 238

Query: 526 QCHSLTSVDLSRNSLYGKIPPGISKLIDLSILNLSRNGITGSIPNEM-------RNMMSL 578
              +L  + L  N L  ++P G+  L  L ++ L  N IT  +                 
Sbjct: 239 FLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYY 296

Query: 579 TTLDLSYNNL-IGNIPSG 595
             + L  N +    +   
Sbjct: 297 NGISLFNNPVPYWEVQPA 314

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score =  110 bits (276), Expect = 3e-26
 Identities = 62/272 (22%), Positives = 103/272 (37%), Gaps = 22/272 (8%)

Query: 233 IPPG-FGALTQLQVLDMASCNISGEIPTSLSRLKLLHSLFLQMNKLTGHIPPQLSGLISL 291
           +    F  L  L  L + +  IS     + S L+ L  L++  N L   IPP L    SL
Sbjct: 69  LRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNL--PSSL 125

Query: 292 KSLDLSLNYLTGEIPESFAALKNLTLLQLFKNNLR-GPIPSFLGDFPNLEVLQVWGNNFT 350
             L +  N +       F+ L+N+  +++  N L          D   L  L++     T
Sbjct: 126 VELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT 185

Query: 351 FELPENLGRNGKLLILDVTSNHLTGTIPRDLCKG-GKLKSLILMQNFFIGPIPEE-LGQC 408
             +P++L     L  L +  N +   I  +      KL  L L  N  I  I    L   
Sbjct: 186 -GIPKDLPET--LNELHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQ-IRMIENGSLSFL 240

Query: 409 KSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLS-------GELPEKMSGASLNQL 461
            +L ++    N L+  +PAGL +L LL ++ L  N ++         +   +  A  N +
Sbjct: 241 PTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGI 299

Query: 462 KVANNNITGKI--PAAIGNLPSLNILSLQNNR 491
            + NN +      PA    +     +   N +
Sbjct: 300 SLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 91.6 bits (228), Expect = 4e-20
 Identities = 60/319 (18%), Positives = 106/319 (33%), Gaps = 44/319 (13%)

Query: 86  SIPPEIGLLTKLVNLTISNVNLTGRLPSEMALLTSLKVFNISGNVFQGNFAGQIVRGMTE 145
           ++P EI   T L++L   N +++     +   L  L    +  N        +    + +
Sbjct: 47  AVPKEISPDTTLLDL--QNNDISELRKDDFKGLQHLYALVLVNNKIS-KIHEKAFSPLRK 103

Query: 146 LQVLDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLNGIGLN 205
           LQ L    N+    +P  +    SL  L    N            I+ +           
Sbjct: 104 LQKLYISKNHLVE-IPPNL--PSSLVELRIHDN-----------RIRKVP---------- 139

Query: 206 GTVPAFLSRLKNLREMYIGYFNTYTGGIPPGFGALTQLQVLDMASCNISGEIPTSLSRLK 265
                  S L+N+  + +G       G  PG     +L  L ++   ++  IP  L   +
Sbjct: 140 ---KGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPKDL--PE 193

Query: 266 LLHSLFLQMNKLTGHIPPQ-LSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQLFKNN 324
            L+ L L  NK+   I  + L     L  L L  N +      S + L  L  L L  N 
Sbjct: 194 TLNELHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNK 252

Query: 325 LRGPIPSFLGDFPNLEVLQVWGNNFT------FELPENLGRNGKLLILDVTSNHLT-GTI 377
           L   +P+ L D   L+V+ +  NN T      F       +      + + +N +    +
Sbjct: 253 LSR-VPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEV 311

Query: 378 PRDLCKG-GKLKSLILMQN 395
                +      ++     
Sbjct: 312 QPATFRCVTDRLAIQFGNY 330

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  122 bits (307), Expect = 3e-30
 Identities = 55/203 (27%), Positives = 84/203 (41%), Gaps = 18/203 (8%)

Query: 700 IGKGGAGIVYRG-SMPDGIDVAIK-----RLVGRGTGGNDHGFLAEIQTLGRIRHRNIVR 753
           +GKGG    +           A K      L+             EI     + H+++V 
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLL---KPHQREKMSMEISIHRSLAHQHVVG 105

Query: 754 LLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLK-WETRYRIALEAAKGLCYLHHDCS 812
             G+  + D   ++ E     SL E+    +   L   E RY    +   G  YLH +  
Sbjct: 106 FHGFFEDNDFVFVVLELCRRRSLLELH--KRRKALTEPEARY-YLRQIVLGCQYLHRNR- 161

Query: 813 PLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLK 872
             +IHRD+K  N+ L+ D E  + DFGLA  ++  G  E    + G+  YIAPE      
Sbjct: 162 --VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG--ERKKVLCGTPNYIAPEVLSKKG 217

Query: 873 VDEKSDVYSFGVVLLELIAGKKP 895
              + DV+S G ++  L+ GK P
Sbjct: 218 HSFEVDVWSIGCIMYTLLVGKPP 240

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  120 bits (304), Expect = 3e-30
 Identities = 55/201 (27%), Positives = 84/201 (41%), Gaps = 14/201 (6%)

Query: 700 IGKGGAGIVYRG-SMPDGIDVAIKRLVGR---GTGGNDHGFLAEIQTLGRIRHRNIVRLL 755
           +GKGG    +           A K +V +              EI     + H+++V   
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGK-IVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81

Query: 756 GYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLK-WETRYRIALEAAKGLCYLHHDCSPL 814
           G+  + D   ++ E     SL E+    +   L   E RY    +   G  YLH      
Sbjct: 82  GFFEDNDFVFVVLELCRRRSLLELH--KRRKALTEPEARY-YLRQIVLGCQYLH---RNR 135

Query: 815 IIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVD 874
           +IHRD+K  N+ L+ D E  + DFGLA  ++  G  E    + G+  YIAPE        
Sbjct: 136 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG--ERKKVLCGTPNYIAPEVLSKKGHS 193

Query: 875 EKSDVYSFGVVLLELIAGKKP 895
            + DV+S G ++  L+ GK P
Sbjct: 194 FEVDVWSIGCIMYTLLVGKPP 214

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score =  124 bits (313), Expect = 3e-30
 Identities = 74/385 (19%), Positives = 139/385 (36%), Gaps = 44/385 (11%)

Query: 241 TQLQVLDMASCNISGEIPTSLSRLKLLHSLFLQMNKLTGHIPPQL-SGLISLKSLDLSLN 299
             +  +D++  +I+    TS SRL+ L  L ++       I      GL SL  L L  N
Sbjct: 30  AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN 89

Query: 300 YLTGEIPES-FAALKNLTLLQLFKNNLRGPI--PSFLGDFPNLEVLQVWGNNFTFELPEN 356
               ++    F  L NL +L L + NL G +   +F     +LE+L +  NN     P +
Sbjct: 90  QFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPAS 148

Query: 357 L-GRNGKLLILDVTSNHLTGTIPRDL---CKGGKLKSLILMQN--------FFIGPIPEE 404
                 +  +LD+T N +  +I  +     +G     L L           +        
Sbjct: 149 FFLNMRRFHVLDLTFNKVK-SICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGN 207

Query: 405 LGQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMME-------------LDDNL---LSGE 448
             +  S+T +  S N    ++    F+      ++                         
Sbjct: 208 PFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNF 267

Query: 449 LPEKMSGASLNQLKVANNNITGKIPAAI-GNLPSLNILSLQNNRLEGEIPVESF-NLKMI 506
             + +  + +    ++ + I   +  ++  +   L  L+L  N +  +I   +F  L  +
Sbjct: 268 TFKGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHL 325

Query: 507 TSINISDNNISGEIPYSI-SQCHSLTSVDLSRNSLYGKIPPGI-SKLIDLSILNLSRNGI 564
             +N+S N +   I   +      L  +DLS N +   +       L +L  L L  N +
Sbjct: 326 LKLNLSQNFLG-SIDSRMFENLDKLEVLDLSYNHI-RALGDQSFLGLPNLKELALDTNQL 383

Query: 565 TGSIPNEM-RNMMSLTTLDLSYNNL 588
             S+P+ +   + SL  + L  N  
Sbjct: 384 K-SVPDGIFDRLTSLQKIWLHTNPW 407

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score =  102 bits (256), Expect = 5e-23
 Identities = 66/340 (19%), Positives = 119/340 (35%), Gaps = 63/340 (18%)

Query: 290 SLKSLDLSLNYLTGEIPESFAALKNLTLLQLFKNNLRGPIPSFLGDF---PNLEVLQVWG 346
            +  +DLSLN +      SF+ L++L  L++ +      I +    F    +L +L++  
Sbjct: 31  HVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRN--NTFRGLSSLIILKLDY 88

Query: 347 NNFTFELPEN-LGRNGKLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFIGPIPEEL 405
           N F  +L          L +L +T                 L   +L  NFF        
Sbjct: 89  NQFL-QLETGAFNGLANLEVLTLTQC--------------NLDGAVLSGNFFKP------ 127

Query: 406 GQCKSLTKIRFSKNYLNGTIPAGLF-NLPLLNMMELDDNLLSGELPE----KMSGASLNQ 460
               SL  +    N +    PA  F N+   ++++L  N +   + E       G     
Sbjct: 128 --LTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVK-SICEEDLLNFQGKHFTL 184

Query: 461 LKVANNNIT--------GKIPAAIGNLPSLNILSLQNNRLEGEIPVESFNLKMITSINIS 512
           L++++  +          +         S+  L L  N  +  +    F+    T I   
Sbjct: 185 LRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSL 244

Query: 513 DNNISGEIPYSIS---------------QCHSLTSVDLSRNSLYGKIPPGI-SKLIDLSI 556
             + S  +  S                 +   + + DLS++ +   +   + S   DL  
Sbjct: 245 ILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKI-FALLKSVFSHFTDLEQ 303

Query: 557 LNLSRNGITGSIPNEM-RNMMSLTTLDLSYNNLIGNIPSG 595
           L L++N I   I +     +  L  L+LS N L G+I S 
Sbjct: 304 LTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFL-GSIDSR 341

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 97.9 bits (244), Expect = 2e-21
 Identities = 75/450 (16%), Positives = 142/450 (31%), Gaps = 87/450 (19%)

Query: 86  SIPPEIGLLTKLVNLTISNVNLTGRLPSEMALLTSLKVFNISGNVFQGNFAGQIVRGMTE 145
            +P    L   +  + +S  ++     +  + L  L+   +              RG++ 
Sbjct: 24  QVPE---LPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSS 80

Query: 146 LQVLDAYNNNFTGPLPVEI-ASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLNGIGL 204
           L +L    N F   L       L +L  L+                +             
Sbjct: 81  LIILKLDYNQFLQ-LETGAFNGLANLEVLTLTQC-----------NLDGAV--------- 119

Query: 205 NGTVPAFLSRLKNLREMYIGYFNTYTGGIPPG-FGALTQLQVLDMASCNISGEIPTSL-S 262
                                       +    F  LT L++L +   NI    P S   
Sbjct: 120 ----------------------------LSGNFFKPLTSLEMLVLRDNNIKKIQPASFFL 151

Query: 263 RLKLLHSLFLQMNKLTGHIPP-----------QLSGLISLKSLDLSLNYLTGEIPESFAA 311
            ++  H L L  NK+   I              L  L S+   D++  +L  E   +   
Sbjct: 152 NMRRFHVLDLTFNKVK-SICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFK 210

Query: 312 LKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSN 371
             ++T L L  N  +  +     D      +Q    + ++ +  + G        + T  
Sbjct: 211 NTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFK 270

Query: 372 HLTGTIPRDLCKGGKLKSLILMQNFFIGPIPEEL-GQCKSLTKIRFSKNYLNGTIPAGLF 430
            L  +          +K+  L ++  I  + + +      L ++  ++N +N  I    F
Sbjct: 271 GLEAS---------GVKTCDLSKS-KIFALLKSVFSHFTDLEQLTLAQNEIN-KIDDNAF 319

Query: 431 -NLPLLNMMELDDNLLSGELPEKM-SG-ASLNQLKVANNNITGKIPA-AIGNLPSLNILS 486
             L  L  + L  N L   +  +M      L  L ++ N+I   +   +   LP+L  L+
Sbjct: 320 WGLTHLLKLNLSQNFLG-SIDSRMFENLDKLEVLDLSYNHIRA-LGDQSFLGLPNLKELA 377

Query: 487 LQNNRLEGEIPVESF-NLKMITSINISDNN 515
           L  N+L+  +P   F  L  +  I +  N 
Sbjct: 378 LDTNQLK-SVPDGIFDRLTSLQKIWLHTNP 406

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 74.4 bits (183), Expect = 6e-14
 Identities = 45/225 (20%), Positives = 88/225 (39%), Gaps = 20/225 (8%)

Query: 409 KSLTKIRFSKNYLNGTIPAGLF-NLPLLNMMELDDNLLSGELPEKM--SGASLNQLKVAN 465
           + L  ++  +      I    F  L  L +++LD N    +L        A+L  L +  
Sbjct: 54  QDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFL-QLETGAFNGLANLEVLTLTQ 112

Query: 466 NNITG-KIPAAI-GNLPSLNILSLQNNRLEGEIPVESF-NLKMITSINISDNNIS---GE 519
            N+ G  +       L SL +L L++N ++   P   F N++    ++++ N +     E
Sbjct: 113 CNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEE 172

Query: 520 IPYSISQCH-------SLTSVDLSRNSLYGKIPPGISKLIDLSILNLSRNGITGSIPNEM 572
              +    H       S+T  D++   L  +      K   ++ L+LS NG   S+    
Sbjct: 173 DLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRF 232

Query: 573 RNMMSLT---TLDLSYNNLIGNIPSGGQFLAFNETSFIGNPNLCL 614
            + ++ T   +L LS +  +G+      F   +  +F G     +
Sbjct: 233 FDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGV 277

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 65.9 bits (161), Expect = 3e-11
 Identities = 40/227 (17%), Positives = 74/227 (32%), Gaps = 23/227 (10%)

Query: 118 LTSLKVFNISGNVFQGNFAGQIVRGMTELQVLDAYNNNFTGPLPVEIASLKSLRHLSFGG 177
           L+S+ + +++         G      T +  LD   N F   +        +   +    
Sbjct: 187 LSSITLQDMNEYWLGWEKCGNP-FKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLI 245

Query: 178 NYFTGKIPQS--YSEIQSLEYIGLNGIGLNGT------------VPA-FLSRLKNLREMY 222
              +  +  S  ++  +  +     G+  +G             +     S   +L ++ 
Sbjct: 246 LSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLT 305

Query: 223 IGYFNTYTGGIPPG-FGALTQLQVLDMASCNISGEIPTSLSRLKLLHSLFLQMNKLTGHI 281
           +   N     I    F  LT L  L+++   +          L  L  L L  N +   +
Sbjct: 306 LAQ-NEINK-IDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIR-AL 362

Query: 282 PPQL-SGLISLKSLDLSLNYLTGEIPES-FAALKNLTLLQLFKNNLR 326
             Q   GL +LK L L  N L   +P+  F  L +L  + L  N   
Sbjct: 363 GDQSFLGLPNLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTNPWD 408

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 65.5 bits (160), Expect = 3e-11
 Identities = 35/216 (16%), Positives = 67/216 (31%), Gaps = 37/216 (17%)

Query: 410 SLTKIRFSKNYLNGTIPAGLF-NLPLLNMMELDDNLLSGELPEKMSGASLNQLKVANNNI 468
            +  +  S N +   +    F  L  L  ++++       +                   
Sbjct: 31  HVNYVDLSLNSIA-ELNETSFSRLQDLQFLKVEQQTPGLVIR------------------ 71

Query: 469 TGKIPAAIGNLPSLNILSLQNNRLEGEIPVESF-NLKMITSINISDNNI-SGEIPYSI-S 525
                     L SL IL L  N+   ++   +F  L  +  + ++  N+    +  +   
Sbjct: 72  ----NNTFRGLSSLIILKLDYNQFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFK 126

Query: 526 QCHSLTSVDLSRNSLYGKIPPGI--SKLIDLSILNLSRNGITGSIPNEM---RNMMSLTT 580
              SL  + L  N++  KI P      +    +L+L+ N +  SI  E          T 
Sbjct: 127 PLTSLEMLVLRDNNI-KKIQPASFFLNMRRFHVLDLTFNKVK-SICEEDLLNFQGKHFTL 184

Query: 581 LDLSYNNLIGNIPSGGQFLAFNETSFIGNPNLCLLR 616
           L LS   L     +          +   N ++  L 
Sbjct: 185 LRLSSITLQDM--NEYWLGWEKCGNPFKNTSITTLD 218

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  119 bits (302), Expect = 4e-30
 Identities = 59/203 (29%), Positives = 96/203 (47%), Gaps = 17/203 (8%)

Query: 700 IGKGGAGIVYRG-SMPDGIDVAIK-----RLVGRGTGGNDHGFLAEIQTLGRIRHRNIVR 753
           +GKG    VYR  S+  G++VAIK      +      G       E++   +++H +I+ 
Sbjct: 19  LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMY---KAGMVQRVQNEVKIHCQLKHPSILE 75

Query: 754 LLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLK-WETRYRIALEAAKGLCYLHHDCS 812
           L  Y  + +   L+ E   NG +   L   +       E R+ +  +   G+ YLH   S
Sbjct: 76  LYNYFEDSNYVYLVLEMCHNGEMNRYLK-NRVKPFSENEARHFMH-QIITGMLYLH---S 130

Query: 813 PLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLK 872
             I+HRD+  +N+LL  +    +ADFGLA  L+     E   ++ G+  YI+PE A    
Sbjct: 131 HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH--EKHYTLCGTPNYISPEIATRSA 188

Query: 873 VDEKSDVYSFGVVLLELIAGKKP 895
              +SDV+S G +   L+ G+ P
Sbjct: 189 HGLESDVWSLGCMFYTLLIGRPP 211

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  120 bits (304), Expect = 4e-30
 Identities = 55/226 (24%), Positives = 91/226 (40%), Gaps = 32/226 (14%)

Query: 692 ESLKDENIIGKGGAGIVYRGSMPDG----IDVAIKRLVGRGTGGNDHG-FLAEIQTLGRI 746
             L    I+G+G  G V  G++       + VA+K +    +   +   FL+E   +   
Sbjct: 34  NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDF 93

Query: 747 RHRNIVRLLGYVSNRDTN-----LLLYEYMPNGSLGEML----HGAKGGHLKWETRYRIA 797
            H N++RLLG      +      +++  +M  G L   L          H+  +T  +  
Sbjct: 94  SHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFM 153

Query: 798 LEAAKGLCYL--HHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSS 855
           ++ A G+ YL   +      +HRD+ + N +L  D    VADFGL+K +           
Sbjct: 154 VDIALGMEYLSNRN-----FLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYR---- 204

Query: 856 VAGSYGYI-----APEYAYTLKVDEKSDVYSFGVVLLELIA-GKKP 895
             G    +     A E         KSDV++FGV + E+   G  P
Sbjct: 205 -QGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTP 249

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score =  125 bits (315), Expect = 5e-30
 Identities = 67/298 (22%), Positives = 110/298 (36%), Gaps = 34/298 (11%)

Query: 288 LISLKSLDLSLNYLTGEIPESFAALKNLTLLQLF---KNNLRGPIPSFLGDFPNLEVLQV 344
             SL S +   N ++G   + F+A        L    +N     +   L        LQ+
Sbjct: 10  NFSL-SQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECL--INQFSELQL 66

Query: 345 WGNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFIGPIPEE 404
              N +  LP+NL     + +L++T N L  ++P        L+ L    N  +  +PE 
Sbjct: 67  NRLNLS-SLPDNLPPQ--ITVLEITQNALI-SLPELP---ASLEYLDACDNR-LSTLPEL 118

Query: 405 LGQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLSGELPEKMSGASLNQLKVA 464
               K L       N L   +P     L  +N    D+N L+  LPE  +  SL  L V 
Sbjct: 119 PASLKHL---DVDNNQLT-MLPELPALLEYIN---ADNNQLT-MLPELPT--SLEVLSVR 168

Query: 465 NNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESFNL----KMITSINISDNNISGEI 520
           NN +T  +P    +L +L+   +  N LE  +P          +        +N I+  I
Sbjct: 169 NNQLT-FLPELPESLEALD---VSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRIT-HI 222

Query: 521 PYSISQCHSLTSVDLSRNSLYGKIPPGISKLIDLSILNLSRNGITGSIPNEMRNMMSL 578
           P +I       ++ L  N L  +I   +S+       +  R   + S   +      L
Sbjct: 223 PENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQNTLHRPL 280

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 94.7 bits (235), Expect = 3e-20
 Identities = 65/380 (17%), Positives = 124/380 (32%), Gaps = 39/380 (10%)

Query: 86  SIPPEIGLLTKLVNLTISNVNLTGRLPSEMALLTSLKVFNISGNVFQGNFAGQIVRGMTE 145
           S+  E  L+ +   L ++ +NL+  LP    L   + V  I+ N         +      
Sbjct: 51  SLLKEC-LINQFSELQLNRLNLS-SLPDN--LPPQITVLEITQNALI-----SLPELPAS 101

Query: 146 LQVLDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLNGIGLN 205
           L+ LDA +N  +  LP       SL+HL    N  T  +P        LEYI  +   L 
Sbjct: 102 LEYLDACDNRLST-LP---ELPASLKHLDVDNNQLT-MLP---ELPALLEYINADNNQLT 153

Query: 206 GTVPAFLSRLKNLREMYIGYFNTYTGGIPPGFGALTQLQVLDMASCNISGEIPTSLSRL- 264
             +P   + L+ L    +   N  T  +P        L+ LD+++  +   +P    R  
Sbjct: 154 -MLPELPTSLEVL---SVRN-NQLT-FLPEL---PESLEALDVSTNLLE-SLPAVPVRNH 203

Query: 265 ---KLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQLF 321
              +       + N++T HIP  +  L    ++ L  N L+  I ES +           
Sbjct: 204 HSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHG- 261

Query: 322 KNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDL 381
              +   +     +  +  +       F      ++ +       +  +N  +      L
Sbjct: 262 -PRIYFSMSDGQQNTLHRPLADAVTAWFPENKQSDVSQIWHAFEHEEHANTFS-AFLDRL 319

Query: 382 CKGGKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELD 441
                 ++    +      +   L +  +  ++R     +         +   L    L 
Sbjct: 320 SDTVSARNTSGFRE----QVAAWLEKLSASAELRQQSFAVAADATESCEDRVALTWNNLR 375

Query: 442 DNLLSGELPEKMSGASLNQL 461
             LL  +  E +       L
Sbjct: 376 KTLLVHQASEGLFDNDTGAL 395

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 93.1 bits (231), Expect = 1e-19
 Identities = 72/341 (21%), Positives = 113/341 (33%), Gaps = 39/341 (11%)

Query: 167 LKSLRHLSFGGNYFTGKIPQSYSEI----QSLEYIGLNGIGLNGTVPA-FLSRLKNLREM 221
           L    + S   N F   I  +Y++        E   L G   N  V       +    E+
Sbjct: 5   LPINNNFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECLINQFSEL 64

Query: 222 YIGYFNTYTGGIPPGFGALTQLQVLDMASCNISGEIPTSLSRLKLLHSLFLQMNKLTGHI 281
            +   N  +  +P       Q+ VL++    +   +P   + L+ L       N+L+  +
Sbjct: 65  QLNRLNLSS--LPDNLP--PQITVLEITQNALI-SLPELPASLEYLD---ACDNRLS-TL 115

Query: 282 PPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQLFKNNLRGPIPSFLGDFPNLEV 341
           P   +   SLK LD+  N LT  +PE  A L+ +       NN    +P       +LEV
Sbjct: 116 PELPA---SLKHLDVDNNQLT-MLPELPALLEYINA----DNNQLTMLPELPT---SLEV 164

Query: 342 LQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFF---I 398
           L V  N  T  LPE       L  LDV++N L  ++P    +    +   +        I
Sbjct: 165 LSVRNNQLT-FLPELPES---LEALDVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRI 219

Query: 399 GPIPEELGQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLSGELP------EK 452
             IPE +        I    N L+  I   L                S            
Sbjct: 220 THIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQNTLHRP 279

Query: 453 MSGASLNQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLE 493
           ++ A          +   +I  A  +    N  S   +RL 
Sbjct: 280 LADAVTAWFPENKQSDVSQIWHAFEHEEHANTFSAFLDRLS 320

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  120 bits (302), Expect = 9e-30
 Identities = 53/227 (23%), Positives = 89/227 (39%), Gaps = 33/227 (14%)

Query: 692 ESLKDENIIGKGGAGIVYRGSMPDG----IDVAIKRLVGRGTGGNDHG-FLAEIQTLGRI 746
           +      ++GKG  G V    +       + VA+K L       +D   FL E   +   
Sbjct: 23  QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF 82

Query: 747 RHRNIVRLLGYVSNRDTN------LLLYEYMPNGSLGEML----HGAKGGHLKWETRYRI 796
            H ++ +L+G              +++  +M +G L   L     G    +L  +T  R 
Sbjct: 83  DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRF 142

Query: 797 ALEAAKGLCYL--HHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMS 854
            ++ A G+ YL   +      IHRD+ + N +L  D    VADFGL++ +          
Sbjct: 143 MVDIACGMEYLSSRN-----FIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYR--- 194

Query: 855 SVAGSYGYI-----APEYAYTLKVDEKSDVYSFGVVLLELIA-GKKP 895
              G    +     A E          SDV++FGV + E++  G+ P
Sbjct: 195 --QGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  119 bits (299), Expect = 2e-29
 Identities = 56/251 (22%), Positives = 92/251 (36%), Gaps = 26/251 (10%)

Query: 699 IIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGY 757
           I+G+G    V+RG     G   AIK              + E + L ++ H+NIV+L   
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFA- 74

Query: 758 VSNRDTNLLLY---EYMPNGSLGEML--HGAKGGHLKWETRYRIALEAAKGLCYLHHDCS 812
           +    T        E+ P GSL  +L       G  + E    +  +   G+ +L     
Sbjct: 75  IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFL-IVLRDVVGGMNHLR---E 130

Query: 813 PLIIHRDVKSNNILLDSDFEAH----VADFGLAKFLQDAGASECMSSVAGSYGYIAPE-- 866
             I+HR++K  NI+     +      + DFG A+ L+D    E   S+ G+  Y+ P+  
Sbjct: 131 NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED---DEQFVSLYGTEEYLHPDMY 187

Query: 867 ------YAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPS 920
                   +  K     D++S GV       G  P   F         + K  +     +
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGA 247

Query: 921 DAASVLAVVDP 931
            +    A   P
Sbjct: 248 ISGVQKAENGP 258

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  118 bits (299), Expect = 2e-29
 Identities = 59/226 (26%), Positives = 90/226 (39%), Gaps = 32/226 (14%)

Query: 692 ESLKDENIIGKGGAGIVYRG------SMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGR 745
           +++     +G G  G VY G      + P  + VA+K L    +  ++  FL E   + +
Sbjct: 30  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 89

Query: 746 IRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEML-----HGAKGGHLKWETRYRIALEA 800
             H+NIVR +G         +L E M  G L   L       ++   L       +A + 
Sbjct: 90  FNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 149

Query: 801 AKGLCYL--HHDCSPLIIHRDVKSNNILLDSDFEAHV---ADFGLAKFLQDAGASECMSS 855
           A G  YL  +H      IHRD+ + N LL       V    DFG+A+ +  A        
Sbjct: 150 ACGCQYLEENH-----FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR---- 200

Query: 856 VAGSYGYI-----APEYAYTLKVDEKSDVYSFGVVLLELIA-GKKP 895
             G    +      PE         K+D +SFGV+L E+ + G  P
Sbjct: 201 -KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 245

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  116 bits (292), Expect = 8e-29
 Identities = 62/202 (30%), Positives = 89/202 (44%), Gaps = 18/202 (8%)

Query: 700 IGKGGAGIVYRG-SMPDGIDVAIK-----RLVGRGTGGNDHGFLAEIQTLGRIRHRNIVR 753
           +GKG  G VY          +A+K     +L      G +H    E++    +RH NI+R
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLE---KAGVEHQLRREVEIQSHLRHPNILR 73

Query: 754 LLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSP 813
           L GY  +     L+ EY P G++   L   K      +       E A  L Y H   S 
Sbjct: 74  LYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALSYCH---SK 128

Query: 814 LIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKV 873
            +IHRD+K  N+LL S  E  +ADFG +            + + G+  Y+ PE       
Sbjct: 129 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS----SRRTDLCGTLDYLPPEMIEGRMH 184

Query: 874 DEKSDVYSFGVVLLELIAGKKP 895
           DEK D++S GV+  E + GK P
Sbjct: 185 DEKVDLWSLGVLCYEFLVGKPP 206

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  118 bits (298), Expect = 1e-28
 Identities = 57/264 (21%), Positives = 94/264 (35%), Gaps = 26/264 (9%)

Query: 699 IIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGY 757
           I+G+G    V+RG     G   AIK              + E + L ++ H+NIV+L   
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFA- 74

Query: 758 VSNRDTNLLLY---EYMPNGSLGEML--HGAKGGHLKWETRYRIALEAAKGLCYLHHDCS 812
           +    T        E+ P GSL  +L       G  + E    +  +   G+ +L     
Sbjct: 75  IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFL-IVLRDVVGGMNHLR---E 130

Query: 813 PLIIHRDVKSNNILLDSDFEAH----VADFGLAKFLQDAGASECMSSVAGSYGYIAPE-- 866
             I+HR++K  NI+     +      + DFG A+ L+D    E   S+ G+  Y+ P+  
Sbjct: 131 NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED---DEQFVSLYGTEEYLHPDMY 187

Query: 867 ------YAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPS 920
                   +  K     D++S GV       G  P   F         + K  +     +
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGA 247

Query: 921 DAASVLAVVDPRLSGYPLTGVIHL 944
            +    A   P      +     L
Sbjct: 248 ISGVQKAENGPIDWSGDMPVSCSL 271

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score =  120 bits (303), Expect = 1e-28
 Identities = 88/461 (19%), Positives = 174/461 (37%), Gaps = 41/461 (8%)

Query: 144 TELQVLDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLNGIG 203
            +  +L+   N  +     +I SL  LR L    N         +   Q LEY+ L+   
Sbjct: 21  QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNK 80

Query: 204 LNGTVPAFLSRLKNLREMYIGYFNTYTG-GIPPGFGALTQLQVLDMASCNISGEIPTSLS 262
           L   +        NL+ + +  FN +    I   FG ++QL+ L +++ ++       ++
Sbjct: 81  LV-KIS--CHPTVNLKHLDL-SFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIA 136

Query: 263 RLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQLFK 322
            L +   L +          P   GL    +  L + + T +       +   T+  L  
Sbjct: 137 HLNISKVLLVLGETYGEKEDP--EGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLEL 194

Query: 323 NNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDLC 382
           +N++              VL+    ++   +   L  N KL  L + +   T      + 
Sbjct: 195 SNIKC-------------VLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRIL 241

Query: 383 K---GGKLKSLILMQNFFIGPIPEEL--GQCKSLTKIRFSKNYLN--GTIPAGLFN-LPL 434
           +      +    +      G +          SL  +   +   +  G   + ++     
Sbjct: 242 QLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSN 301

Query: 435 LNMMELDDN---LLSGELPEKMSGASLNQLKVANNNITGKIPAAIGNLPSLNILSLQNNR 491
           +N+     +   ++    P K+S      L  +NN +T  +    G+L  L  L LQ N+
Sbjct: 302 MNIKNFTVSGTRMVHMLCPSKIS--PFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQ 359

Query: 492 LEGEIPVESF---NLKMITSINISDNNISGEIPYSI-SQCHSLTSVDLSRNSLYGKIPPG 547
           L+ E+   +     +K +  ++IS N++S +      S   SL S+++S N L   I   
Sbjct: 360 LK-ELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRC 418

Query: 548 ISKLIDLSILNLSRNGITGSIPNEMRNMMSLTTLDLSYNNL 588
           +     + +L+L  N I  SIP ++  + +L  L+++ N L
Sbjct: 419 LPPR--IKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQL 456

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score =  119 bits (301), Expect = 2e-28
 Identities = 82/515 (15%), Positives = 164/515 (31%), Gaps = 60/515 (11%)

Query: 86  SIPPEIGLLTKLVNLTISNVNLTGRLPSEMALLTSLKVFNISGNVFQGNFAGQIVRGMTE 145
            +P ++   T    L IS   ++    S++  L+ L++  IS N  Q      + +   E
Sbjct: 14  HVPKDLSQKTT--ILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDIS-VFKFNQE 70

Query: 146 LQVLDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLNGIGLN 205
           L+ LD  +N     +        +L+HL    N F   +P                    
Sbjct: 71  LEYLDLSHNKLVK-IS--CHPTVNLKHLDLSFNAFD-ALPI------------------- 107

Query: 206 GTVPAFLSRLKNLREMYIGYFNTYTGGIPPGFGALTQLQV-LDMASCNISGEIPTSLSRL 264
                    +  L+ + +                L   +V L +       E P  L   
Sbjct: 108 ---CKEFGNMSQLKFLGL-STTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDF 163

Query: 265 KL--LHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQLFK 322
               LH +F    +    +   +  + +L+  ++       +     + L  L       
Sbjct: 164 NTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLS 223

Query: 323 NNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPEN-LGRNGKLLILDVTSNHLTGTIPRDL 381
           N     I +    F  +  L      + F +    L         D +   L        
Sbjct: 224 NLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLK------- 276

Query: 382 CKGGKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGTIPAGLFN-LPLLNMMEL 440
                L    ++ + F  P         ++    F+ +     +     + +     ++ 
Sbjct: 277 ----ALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTR-MVHMLCPSKISPFLHLDF 331

Query: 441 DDNLLSGELPEKMSGA--SLNQLKVANNNITGKIPAAIG---NLPSLNILSLQNNRLEGE 495
            +NLL+ +   +  G    L  L +  N +  ++         + SL  L +  N +  +
Sbjct: 332 SNNLLT-DTVFENCGHLTELETLILQMNQLK-ELSKIAEMTTQMKSLQQLDISQNSVSYD 389

Query: 496 IPVESF-NLKMITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYGKIPPGISKLIDL 554
                    K + S+N+S N ++  I   +     +  +DL  N +   IP  + KL  L
Sbjct: 390 EKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKI-KSIPKQVVKLEAL 446

Query: 555 SILNLSRNGITGSIPNEM-RNMMSLTTLDLSYNNL 588
             LN++ N +  S+P+ +   + SL  + L  N  
Sbjct: 447 QELNVASNQLK-SVPDGIFDRLTSLQKIWLHTNPW 480

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score =  113 bits (285), Expect = 2e-26
 Identities = 61/374 (16%), Positives = 117/374 (31%), Gaps = 27/374 (7%)

Query: 233 IPPG-FGALTQLQVLDMASCNISGEIPTSLSRLKLLHSLFLQMNKLTGHIPPQLSGLISL 291
           +      +L++L++L ++   I     +     + L  L L  NKL   I       ++L
Sbjct: 36  LWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-KISCH--PTVNL 92

Query: 292 KSLDLSLNYLTGEIPES--FAALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNF 349
           K LDLS N     +P    F  +  L  L L   +L       +      +VL V G  +
Sbjct: 93  KHLDLSFNAFD-ALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETY 151

Query: 350 TFELPENLGRNGKLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFIGPIPEELGQCK 409
             +  E+           +     T      +          L  +         +    
Sbjct: 152 GEK--EDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELS--------NIKCVL 201

Query: 410 SLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLSGELPEKMSGASLNQLKVANNNIT 469
              K  +  + L         +   LN +E   N     + + +   ++    ++N  + 
Sbjct: 202 EDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFI-RILQLVWHTTVWYFSISNVKLQ 260

Query: 470 G-----KIPAAIGNLPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIPYSI 524
           G         +  +L +L+I  + ++               +   N + +          
Sbjct: 261 GQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCP 320

Query: 525 SQCHSLTSVDLSRNSLYGKIPPGISKLIDLSILNLSRNGITGSIPNEMR---NMMSLTTL 581
           S+      +D S N L   +      L +L  L L  N +   +         M SL  L
Sbjct: 321 SKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK-ELSKIAEMTTQMKSLQQL 379

Query: 582 DLSYNNLIGNIPSG 595
           D+S N++  +   G
Sbjct: 380 DISQNSVSYDEKKG 393

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 89.5 bits (222), Expect = 1e-18
 Identities = 71/425 (16%), Positives = 130/425 (30%), Gaps = 66/425 (15%)

Query: 84  FGSIPP--EIGLLTKLVNLTISNVNLTGRLPSEMALLTSLKVFNISGNVFQGNFAGQIVR 141
           F ++P   E G +++L  L +S  +L       +A L   KV  + G  +      + ++
Sbjct: 102 FDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQ 161

Query: 142 G--MTELQVLDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIG- 198
                 L ++   N  F   L V + ++ +L   +        K     S +  L+    
Sbjct: 162 DFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPK 221

Query: 199 ---LNGIGLNGTVPAFLSRLKNLREMYIGYFNTY---------TGGIPPGFGALTQLQVL 246
              L    +  T  +F+  L+ +    + YF+                    +L  L + 
Sbjct: 222 LSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIH 281

Query: 247 DMASCNISGEIPTSLSRLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIP 306
            + S                ++     ++          S +     LD S N LT  + 
Sbjct: 282 QVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVF 341

Query: 307 ESFAALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLIL 366
           E+   L  L  L L  N L+  +         ++ LQ                      L
Sbjct: 342 ENCGHLTELETLILQMNQLKE-LSKIAEMTTQMKSLQ---------------------QL 379

Query: 367 DVTSNHLTGTIPRDLCKG-GKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGTI 425
           D++ N ++    +  C     L SL +  N     I   L     +  +    N +  +I
Sbjct: 380 DISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPP--RIKVLDLHSNKIK-SI 436

Query: 426 PAGLFNLPLLNMMELDDNLLSGELPEKMSGASLNQLKVANNNITGKIPAAIGNLPSLNIL 485
           P  +  L                        +L +L VA+N +          L SL  +
Sbjct: 437 PKQVVKLE-----------------------ALQELNVASNQLKSVPDGIFDRLTSLQKI 473

Query: 486 SLQNN 490
            L  N
Sbjct: 474 WLHTN 478

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  119 bits (300), Expect = 1e-28
 Identities = 58/209 (27%), Positives = 89/209 (42%), Gaps = 19/209 (9%)

Query: 697 ENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRI-RHRNIVRLL 755
           ++++G G  G +    M D  DVA+KR++       D     E+Q L     H N++R  
Sbjct: 29  KDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADR----EVQLLRESDEHPNVIRYF 84

Query: 756 GYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLI 815
               +R    +  E     +L E +      HL  E    +  +   GL +LH   S  I
Sbjct: 85  CTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPI-TLLQQTTSGLAHLH---SLNI 139

Query: 816 IHRDVKSNNILL-----DSDFEAHVADFGLAKFLQDAGAS-ECMSSVAGSYGYIAPEY-- 867
           +HRD+K +NIL+         +A ++DFGL K L     S    S V G+ G+IAPE   
Sbjct: 140 VHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLS 199

Query: 868 -AYTLKVDEKSDVYSFGVVLLELIAGKKP 895
                      D++S G V   +I+    
Sbjct: 200 EDCKENPTYTVDIFSAGCVFYYVISEGSH 228

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  117 bits (294), Expect = 2e-28
 Identities = 31/264 (11%), Positives = 63/264 (23%), Gaps = 46/264 (17%)

Query: 693 SLKDENIIGKGGAGIVYRG-SMPDGIDVAIK--RLVGRGTGGNDHGFLAEIQTLGRIRHR 749
            LK    +  G   +V+    +    D A+K   +    +               R+   
Sbjct: 63  KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGE 122

Query: 750 NIVRLL-------------------------GYVSNRDTNLLLYEYMPNGSLGEML---- 780
           +                              G       N LL     +  L  +     
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD 182

Query: 781 -HGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFG 839
                 G       + +  +  +    L       ++H     +N+ +  D    + D  
Sbjct: 183 FVYVFRGDEGILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVS 239

Query: 840 LAKFLQDAGASECMSSVAGSYGYIAPEY--AYTLKVDEKSDVYSFGVVLLELIAGKKPVG 897
               +   G +           Y   E+  A T       + +  G+ +  +     P  
Sbjct: 240 ALWKVGTRGPASS-----VPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP-- 292

Query: 898 EFGDGVDIVRWVRKTTSEVSQPSD 921
            FG     ++   K  S     +D
Sbjct: 293 -FGLVTPGIKGSWKRPSLRVPGTD 315

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  115 bits (290), Expect = 2e-28
 Identities = 55/232 (23%), Positives = 94/232 (40%), Gaps = 38/232 (16%)

Query: 692 ESLKDENIIGKGGAGIVYRGSMPDG------IDVAIKRLVGRGTGGNDHGFLAEIQTLGR 745
            +++    +G+   G VY+G +           VAIK L  +  G     F  E     R
Sbjct: 9   SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRAR 68

Query: 746 IRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEML--------------HGAKGGHLKWE 791
           ++H N+V LLG V+      +++ Y  +G L E L                     L+  
Sbjct: 69  LQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPP 128

Query: 792 TRYRIALEAAKGLCYL--HHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGA 849
               +  + A G+ YL  HH     ++H+D+ + N+L+       ++D GL + +  A  
Sbjct: 129 DFVHLVAQIAAGMEYLSSHH-----VVHKDLATRNVLVYDKLNVKISDLGLFREVYAADY 183

Query: 850 SECMSSVAGSYGYI-----APEYAYTLKVDEKSDVYSFGVVLLELIA-GKKP 895
            +           +     APE     K    SD++S+GVVL E+ + G +P
Sbjct: 184 YK-----LLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 230

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  118 bits (296), Expect = 2e-28
 Identities = 40/331 (12%), Positives = 82/331 (24%), Gaps = 58/331 (17%)

Query: 694 LKDENIIGKGGAGIVYRGSMP-DGIDVAIK--RLVGRGTGGNDHGFLAEIQTLGRIRH-- 748
           L    ++G+         +    G    +       R           E+  L  +R   
Sbjct: 80  LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 139

Query: 749 --------------RNIVRLLGYVSNRD----------TNLLLYEYMPNGSLGEML---- 780
                          ++V+                    +          +L        
Sbjct: 140 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 199

Query: 781 -HGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFG 839
            H +    L    R ++ L+  + L  LHH     ++H  ++  +I+LD      +  F 
Sbjct: 200 SHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFE 256

Query: 840 LAKFLQDAGASECMSSVAGSYGYIAPEYAY-----TLKVDEKSDVYSFGVVLLELIAGKK 894
                  +  S             A             +    D ++ G+ +  +     
Sbjct: 257 HLVRDGASAVSPIGRGF-APPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADL 315

Query: 895 PVGEFGDG--VDIVRWVRKTTSEVSQPSDAASVLA---VVDP--RLSGYPLTGVIH-LFK 946
           P     D   +    W+ ++   + QP    ++L          RL   PL  +    ++
Sbjct: 316 P---NTDDAALGGSEWIFRSCKNIPQP--VRALLEGFLRYPKEDRLL--PLQAMETPEYE 368

Query: 947 VAMMCVEDESSARPTMREVVHMLANPPQSAP 977
                +        T  E       PP    
Sbjct: 369 QLRTELSAALPLYQTDGEPTREGGAPPSGTS 399

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  121 bits (304), Expect = 2e-28
 Identities = 61/210 (29%), Positives = 86/210 (40%), Gaps = 19/210 (9%)

Query: 699 IIGKGGAGIVYRGS-MPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLL-- 755
            +G GG G V R      G  VAIK+     +  N   +  EIQ + ++ H N+V     
Sbjct: 21  RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV 80

Query: 756 ----GYVSNRDTNLLLYEYMPNGSLGEML--HGAKGGHLKWETRYRIALEAAKGLCYLHH 809
                 ++  D  LL  EY   G L + L       G  +   R  +  + +  L YLH 
Sbjct: 81  PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIR-TLLSDISSALRYLH- 138

Query: 810 DCSPLIIHRDVKSNNILLDSDFEAH---VADFGLAKFLQDAGASECMSSVAGSYGYIAPE 866
                IIHRD+K  NI+L    +     + D G AK L      E  +   G+  Y+APE
Sbjct: 139 --ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ---GELCTEFVGTLQYLAPE 193

Query: 867 YAYTLKVDEKSDVYSFGVVLLELIAGKKPV 896
                K     D +SFG +  E I G +P 
Sbjct: 194 LLEQKKYTVTVDYWSFGTLAFECITGFRPF 223

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  114 bits (288), Expect = 4e-28
 Identities = 64/213 (30%), Positives = 92/213 (43%), Gaps = 26/213 (12%)

Query: 700 IGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLG-Y 757
           IG G   +V      P    VAIKR+       +    L EIQ + +  H NIV     +
Sbjct: 23  IGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSF 82

Query: 758 VSNRDTNL-LLYEYMPNGSLGEMLHGAKGGHLKWETRYR---IAL---EAAKGLCYLHHD 810
           V      L L+ + +  GS+ +++                  IA    E  +GL YLH +
Sbjct: 83  V--VKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN 140

Query: 811 CSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMS---SVAGSYGYIAPE- 866
                IHRDVK+ NILL  D    +ADFG++ FL   G         +  G+  ++APE 
Sbjct: 141 G---QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEV 197

Query: 867 ----YAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
                 Y    D K+D++SFG+  +EL  G  P
Sbjct: 198 MEQVRGY----DFKADIWSFGITAIELATGAAP 226

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  115 bits (290), Expect = 7e-28
 Identities = 60/226 (26%), Positives = 91/226 (40%), Gaps = 32/226 (14%)

Query: 692 ESLKDENIIGKGGAGIVYRG------SMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGR 745
           +++     +G G  G VY G      + P  + VA+K L    +  ++  FL E   + +
Sbjct: 71  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 130

Query: 746 IRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEML-----HGAKGGHLKWETRYRIALEA 800
             H+NIVR +G         +L E M  G L   L       ++   L       +A + 
Sbjct: 131 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 190

Query: 801 AKGLCYL--HHDCSPLIIHRDVKSNNILLDSDFEAHV---ADFGLAKFLQDAGASECMSS 855
           A G  YL  +H      IHRD+ + N LL       V    DFG+A+ +  AG       
Sbjct: 191 ACGCQYLEENH-----FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYR---- 241

Query: 856 VAGSYGYI-----APEYAYTLKVDEKSDVYSFGVVLLELIA-GKKP 895
             G    +      PE         K+D +SFGV+L E+ + G  P
Sbjct: 242 -KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 286

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  114 bits (287), Expect = 9e-28
 Identities = 55/230 (23%), Positives = 91/230 (39%), Gaps = 30/230 (13%)

Query: 697 ENIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIR-HRNIVRL 754
             ++ +GG   VY    +  G + A+KRL+      N    + E+  + ++  H NIV+ 
Sbjct: 33  RRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRA-IIQEVCFMKKLSGHPNIVQF 91

Query: 755 LGYVSNRDTN--------LLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCY 806
               S             LLL E      +  +      G L  +T  +I  +  + + +
Sbjct: 92  CSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQH 151

Query: 807 LHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFL----------QDAGASECMSSV 856
           +H    P IIHRD+K  N+LL +     + DFG A  +          Q     E   + 
Sbjct: 152 MHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITR 210

Query: 857 AGSYGYIAPE----YAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDG 902
             +  Y  PE    Y+    + EK D+++ G +L  L   + P   F DG
Sbjct: 211 NTTPMYRTPEIIDLYSN-FPIGEKQDIWALGCILYLLCFRQHP---FEDG 256

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  113 bits (286), Expect = 1e-27
 Identities = 57/224 (25%), Positives = 90/224 (40%), Gaps = 28/224 (12%)

Query: 692 ESLKDENIIGKGGAGIVYRG------SMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGR 745
           E +     +G+G  G+VY G             VAIK +    +      FL E   +  
Sbjct: 25  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 84

Query: 746 IRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEML--------HGAKGGHLKWETRYRIA 797
               ++VRLLG VS     L++ E M  G L   L        +             ++A
Sbjct: 85  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 144

Query: 798 LEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVA 857
            E A G+ YL+   +   +HRD+ + N ++  DF   + DFG+ + + +           
Sbjct: 145 GEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR-----K 196

Query: 858 GSYGYI-----APEYAYTLKVDEKSDVYSFGVVLLELIA-GKKP 895
           G  G +     +PE          SDV+SFGVVL E+    ++P
Sbjct: 197 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 240

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  113 bits (286), Expect = 1e-27
 Identities = 65/233 (27%), Positives = 106/233 (45%), Gaps = 45/233 (19%)

Query: 692 ESLKDENIIGKGGAGIVYRGSMPDG---IDVAIKRLVGRGTGGNDHG-FLAEIQTLGRI- 746
             +K +++IG+G  G V +  +      +D AIKR+       +DH  F  E++ L ++ 
Sbjct: 25  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRM-KEYASKDDHRDFAGELEVLCKLG 83

Query: 747 RHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEML--------------HGAKGGHLKWET 792
            H NI+ LLG   +R    L  EY P+G+L + L                +    L  + 
Sbjct: 84  HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 143

Query: 793 RYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASEC 852
               A + A+G+ YL        IHRD+ + NIL+  ++ A +ADFGL++  +       
Sbjct: 144 LLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY----- 195

Query: 853 MSSVAGSYGYI-----APE----YAYTLKVDEKSDVYSFGVVLLELIA-GKKP 895
              V  + G +     A E      YT      SDV+S+GV+L E+++ G  P
Sbjct: 196 ---VKKTMGRLPVRWMAIESLNYSVYT----TNSDVWSYGVLLWEIVSLGGTP 241

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  113 bits (285), Expect = 1e-27
 Identities = 65/222 (29%), Positives = 98/222 (44%), Gaps = 13/222 (5%)

Query: 677 LTAFQRLDFKAEDVLESLKDENIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHG 735
            +    +     D  E       IGKG  G V++G        VAIK +           
Sbjct: 7   QSGLPGMQNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIED 66

Query: 736 FLAEIQTLGRIRHRNIVRLLG-YVSNRDTNL-LLYEYMPNGSLGEMLHGAKGGHLKWETR 793
              EI  L +     + +  G Y+  +DT L ++ EY+  GS  ++L   + G L     
Sbjct: 67  IQQEITVLSQCDSPYVTKYYGSYL--KDTKLWIIMEYLGGGSALDLL---EPGPLDETQI 121

Query: 794 YRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECM 853
             I  E  KGL YLH +     IHRD+K+ N+LL    E  +ADFG+A  L D       
Sbjct: 122 ATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR-- 176

Query: 854 SSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
           ++  G+  ++APE       D K+D++S G+  +EL  G+ P
Sbjct: 177 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPP 218

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  114 bits (287), Expect = 2e-27
 Identities = 49/216 (22%), Positives = 81/216 (37%), Gaps = 32/216 (14%)

Query: 700 IGKGGA--GIVYRG-SMPDGIDVAIKRL-VGRGTGGNDHGFLAEIQTLGRIRHRNIVRLL 755
           IGKG      V      P G  V ++R+ +   +         E+       H NIV   
Sbjct: 33  IGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYR 92

Query: 756 G-YVSNRDTNL-LLYEYMPNGSLGEMLHGAKGGHLKWETRYRIAL---EAAKGLCYLHHD 810
             ++   D  L ++  +M  GS  +++       +  E    IA       K L Y+HH 
Sbjct: 93  ATFI--ADNELWVVTSFMAYGSAKDLICTHFMDGMN-ELA--IAYILQGVLKALDYIHHM 147

Query: 811 CSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGA-----SECMSSVAGSYGYIAP 865
                +HR VK+++IL+  D + +++       +   G       +          +++P
Sbjct: 148 G---YVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSP 204

Query: 866 E------YAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
           E        Y    D KSD+YS G+   EL  G  P
Sbjct: 205 EVLQQNLQGY----DAKSDIYSVGITACELANGHVP 236

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  112 bits (282), Expect = 3e-27
 Identities = 57/232 (24%), Positives = 96/232 (41%), Gaps = 39/232 (16%)

Query: 692 ESLKDENIIGKGGAGIVYRG------SMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGR 745
             +  +  +G+G  G V+           D + VA+K L    T      F  E + L  
Sbjct: 15  RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKD-PTLAARKDFQREAELLTN 73

Query: 746 IRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEML--------------HGAKGGHLKWE 791
           ++H +IV+  G   + D  ++++EYM +G L + L                   G L   
Sbjct: 74  LQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLS 133

Query: 792 TRYRIALEAAKGLCYL--HHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGA 849
               IA + A G+ YL   H      +HRD+ + N L+ ++    + DFG+++ +     
Sbjct: 134 QMLHIASQIASGMVYLASQH-----FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDY 188

Query: 850 SECMSSVAGSYGYI-----APEYAYTLKVDEKSDVYSFGVVLLELIA-GKKP 895
                   G +  +      PE     K   +SDV+SFGV+L E+   GK+P
Sbjct: 189 YR-----VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  112 bits (281), Expect = 4e-27
 Identities = 57/207 (27%), Positives = 81/207 (39%), Gaps = 28/207 (13%)

Query: 700 IGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHG-FLAEIQTLGRI-RHRNIVRLLG 756
           +G G  G V++  S  DG   A+KR +    G  D    LAE+ +  ++ +H   VRL  
Sbjct: 65  LGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQ 124

Query: 757 YVSNRDTNLLLY---EYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSP 813
                     LY   E     SL +    A G  L     +    +    L +LH   S 
Sbjct: 125 AWEEGGI---LYLQTELC-GPSLQQHCE-AWGASLPEAQVWGYLRDTLLALAHLH---SQ 176

Query: 814 LIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPE-----YA 868
            ++H DVK  NI L       + DFGL   L  AG         G   Y+APE     Y 
Sbjct: 177 GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG---AGEVQEGDPRYMAPELLQGSY- 232

Query: 869 YTLKVDEKSDVYSFGVVLLELIAGKKP 895
                   +DV+S G+ +LE+    + 
Sbjct: 233 -----GTAADVFSLGLTILEVACNMEL 254

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  110 bits (278), Expect = 7e-27
 Identities = 61/224 (27%), Positives = 104/224 (46%), Gaps = 24/224 (10%)

Query: 683 LDFKAEDVLESLKDENIIGKGGAGIVYRGS-MPDGIDVAIKRLVGRGTGGND--HGFLAE 739
           ++ KA+D    L+    +G+G  G+V +   +P G  +A+KR+  R T  +      L +
Sbjct: 2   MEVKADD----LEPIMELGRGAYGVVEKMRHVPSGQIMAVKRI--RATVNSQEQKRLLMD 55

Query: 740 IQTLGR-IRHRNIVRLLG-YVSNRDTNLLLYEYMPNGSLGEMLHG--AKGGHLKWETRYR 795
           +    R +     V   G      D  + + E M + SL +       KG  +  +   +
Sbjct: 56  LDISMRTVDCPFTVTFYGALFREGDVWICM-ELM-DTSLDKFYKQVIDKGQTIPEDILGK 113

Query: 796 IALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSS 855
           IA+   K L +LH   S  +IHRDVK +N+L+++  +  + DFG++ +L D  A      
Sbjct: 114 IAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVA---KDI 168

Query: 856 VAGSYGYIAPE----YAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
            AG   Y+APE             KSD++S G+ ++EL   + P
Sbjct: 169 DAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFP 212

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  110 bits (278), Expect = 1e-26
 Identities = 58/263 (22%), Positives = 103/263 (39%), Gaps = 37/263 (14%)

Query: 662 YQLRKRRLQKSKAWKLTAFQRLDFKAEDVLE----SLKDENIIGKGGAGIVYRGSMPD-- 715
           YQ+R + ++  +    T          +  E    +L+    +G G  G V   +     
Sbjct: 12  YQVRWKIIESYEGNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLG 71

Query: 716 ----GIDVAIKRLVGRGTGGNDHGFLAEIQTLGRI-RHRNIVRLLGYVSNRDTNLLLYEY 770
                + VA+K L            ++E++ +  + +H NIV LLG  ++    L++ EY
Sbjct: 72  KEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEY 131

Query: 771 MPNGSLGEML------------HGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHR 818
              G L   L                            + + A+G+ +L    S   IHR
Sbjct: 132 CCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA---SKNCIHR 188

Query: 819 DVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYI-----APEYAYTLKV 873
           DV + N+LL +   A + DFGLA+ + +         +      +     APE  +    
Sbjct: 189 DVAARNVLLTNGHVAKIGDFGLARDIMNDSN-----YIVKGNARLPVKWMAPESIFDCVY 243

Query: 874 DEKSDVYSFGVVLLELIA-GKKP 895
             +SDV+S+G++L E+ + G  P
Sbjct: 244 TVQSDVWSYGILLWEIFSLGLNP 266

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  110 bits (278), Expect = 2e-26
 Identities = 67/321 (20%), Positives = 115/321 (35%), Gaps = 64/321 (19%)

Query: 692 ESLKDENIIGKGGAGIVYRGSMPDGID------VAIKRLVGRGTGGNDHGFLAEIQTLGR 745
             +  +  +G+G  G V+     + +       VA+K L    +      F  E + L  
Sbjct: 41  RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE-ASESARQDFQREAELLTM 99

Query: 746 IRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEML-------------HGAKGGHLKWET 792
           ++H++IVR  G  +     L+++EYM +G L   L                  G L    
Sbjct: 100 LQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQ 159

Query: 793 RYRIALEAAKGLCYL--HHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS 850
              +A + A G+ YL   H      +HRD+ + N L+       + DFG+++ +      
Sbjct: 160 LLAVASQVAAGMVYLAGLH-----FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYY 214

Query: 851 ECMSSVAGSYGYI-----APEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDI 905
                  G    +      PE     K   +SDV+SFGVVL E+         +G     
Sbjct: 215 R-----VGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT-------YG----- 257

Query: 906 VRWVRKTTSEVSQPSDAASVLAVVDPRLSGY----PLTGVIHLFKVAMMCVEDESSARPT 961
                       QP    S    +D    G     P      ++ +   C + E   R +
Sbjct: 258 -----------KQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHS 306

Query: 962 MREVVHMLANPPQSAPSLITL 982
           +++V   L    Q+ P  + +
Sbjct: 307 IKDVHARLQALAQAPPVYLDV 327

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  110 bits (278), Expect = 2e-26
 Identities = 47/227 (20%), Positives = 86/227 (37%), Gaps = 45/227 (19%)

Query: 700 IGKGGAGIVYRGSMPDGIDVAIK----------------RLVGRGTGGNDHGFLAEIQTL 743
           + +G    +      D    A+K                             F  E+Q +
Sbjct: 39  LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97

Query: 744 GRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAK- 802
             I++   +   G ++N D   ++YEYM N S+ +         L       I ++  K 
Sbjct: 98  TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDE--YFFVLDKNYTCFIPIQVIKC 155

Query: 803 -------GLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSS 855
                     Y+H++ +  I HRDVK +NIL+D +    ++DFG ++++ D    + +  
Sbjct: 156 IIKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYMVD----KKIKG 209

Query: 856 VAGSYGYIAPE-------YAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
             G+Y ++ PE       Y        K D++S G+ L  +     P
Sbjct: 210 SRGTYEFMPPEFFSNESSYN-----GAKVDIWSLGICLYVMFYNVVP 251

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  110 bits (277), Expect = 2e-26
 Identities = 73/240 (30%), Positives = 107/240 (44%), Gaps = 25/240 (10%)

Query: 668 RLQKSKAWKLTAFQRLDFKAEDVLESLKDENIIGKGGAGIVYRGS-MPDGIDVAIKRLVG 726
            ++ S   K++  Q  DF AED    LKD   IG+G  G V +    P G  +A+KR+  
Sbjct: 2   SIESSGKLKISPEQHWDFTAED----LKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRI-- 55

Query: 727 RGTGGND--HGFLAEIQTLGR-IRHRNIVRLLG-YVSNRDTNLLLYEYMPNGSLGEML-- 780
           R T         L ++  + R      IV+  G      D  + + E M + S  +    
Sbjct: 56  RSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM-ELM-STSFDKFYKY 113

Query: 781 -HGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFG 839
            +      +  E   +I L   K L +L  +    IIHRD+K +NILLD      + DFG
Sbjct: 114 VYSVLDDVIPEEILGKITLATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFG 171

Query: 840 LAKFLQDAGASECMSSVAGSYGYIAPE----YAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
           ++  L D+ A    +  AG   Y+APE     A     D +SDV+S G+ L EL  G+ P
Sbjct: 172 ISGQLVDSIA---KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFP 228

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  110 bits (276), Expect = 2e-26
 Identities = 57/233 (24%), Positives = 86/233 (36%), Gaps = 37/233 (15%)

Query: 692 ESLKDENIIGKGGAGIVYRG------SMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGR 745
             L     +G G  G V              + VA+K L            ++E++ L  
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82

Query: 746 I-RHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEML----------------HGAKGGHL 788
           +  H NIV LLG  +     L++ EY   G L   L                       L
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 789 KWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAG 848
             E     + + AKG+ +L    S   IHRD+ + NILL       + DFGLA+ +++  
Sbjct: 143 DLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199

Query: 849 ASECMSSVAGSYGYI-----APEYAYTLKVDEKSDVYSFGVVLLELIA-GKKP 895
                         +     APE  +      +SDV+S+G+ L EL + G  P
Sbjct: 200 NYV-----VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  110 bits (276), Expect = 3e-26
 Identities = 55/233 (23%), Positives = 98/233 (42%), Gaps = 37/233 (15%)

Query: 692 ESLKDENIIGKGGAGIVYRG--------SMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTL 743
           + L     +G+G  G V              + + VA+K L    T  +    ++E++ +
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94

Query: 744 GRI-RHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEML--------------HGAKGGHL 788
             I +H+NI+ LLG  +      ++ EY   G+L E L              +      +
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154

Query: 789 KWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAG 848
            ++       + A+G+ YL    S   IHRD+ + N+L+  +    +ADFGLA+ + +  
Sbjct: 155 TFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211

Query: 849 ASECMSSVAGSYGYI-----APEYAYTLKVDEKSDVYSFGVVLLELIA-GKKP 895
                     + G +     APE  +      +SDV+SFGV++ E+   G  P
Sbjct: 212 -----YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  108 bits (272), Expect = 6e-26
 Identities = 64/235 (27%), Positives = 111/235 (47%), Gaps = 15/235 (6%)

Query: 664 LRKRRLQKSKAWKLTAFQRLDFKAEDVLESLKDENIIGKGGAGIVYRGS-MPDGIDVAIK 722
           L   +L+     +L      D   +   E       +G+G  G VY+      G  VAIK
Sbjct: 2   LETVQLRNPPRRQLKKL-DEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIK 60

Query: 723 RLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLG-YVSNRDTNL-LLYEYMPNGSLGEML 780
           ++       +    + EI  + +    ++V+  G Y   ++T+L ++ EY   GS+ +++
Sbjct: 61  QV---PVESDLQEIIKEISIMQQCDSPHVVKYYGSYF--KNTDLWIVMEYCGAGSVSDII 115

Query: 781 HGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGL 840
              +   L  +    I     KGL YLH       IHRD+K+ NILL+++  A +ADFG+
Sbjct: 116 R-LRNKTLTEDEIATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGV 171

Query: 841 AKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
           A  L D  A    ++V G+  ++APE    +  +  +D++S G+  +E+  GK P
Sbjct: 172 AGQLTDTMAK--RNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPP 224

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  108 bits (272), Expect = 7e-26
 Identities = 66/225 (29%), Positives = 101/225 (44%), Gaps = 27/225 (12%)

Query: 691 LESLKD-------ENIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHGFLAEIQT 742
           L +L+D         ++G G  G VY+G  +  G   AIK +    TG  +     EI  
Sbjct: 16  LSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVM--DVTGDEEEEIKQEINM 73

Query: 743 LGRI-RHRNIVRLLG-----YVSNRDTNL-LLYEYMPNGSLGEMLHGAKGGHLKWETRYR 795
           L +   HRNI    G          D  L L+ E+   GS+ +++   KG  LK E    
Sbjct: 74  LKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY 133

Query: 796 IALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSS 855
           I  E  +GL +LH      +IHRD+K  N+LL  + E  + DFG++  L         ++
Sbjct: 134 ICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGR--RNT 188

Query: 856 VAGSYGYIAPEYAYTLKV-----DEKSDVYSFGVVLLELIAGKKP 895
             G+  ++APE     +      D KSD++S G+  +E+  G  P
Sbjct: 189 FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  107 bits (269), Expect = 1e-25
 Identities = 59/203 (29%), Positives = 86/203 (42%), Gaps = 20/203 (9%)

Query: 700 IGKGGAGIVYRG-SMPDGIDVAIK-----RLVGRGTGGNDHGFLAEIQTLGRIRHRNIVR 753
           +GKG  G VY      +   +A+K     +L      G +H    EI+    +RH NI+R
Sbjct: 22  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLE---KEGVEHQLRREIEIQSHLRHPNILR 78

Query: 754 LLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSP 813
           +  Y  +R    L+ E+ P G L + L   K G    +       E A  L Y H     
Sbjct: 79  MYNYFHDRKRIYLMLEFAPRGELYKEL--QKHGRFDEQRSATFMEELADALHYCH---ER 133

Query: 814 LIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS-ECMSSVAGSYGYIAPEYAYTLK 872
            +IHRD+K  N+L+    E  +ADFG +           C     G+  Y+ PE      
Sbjct: 134 KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMC-----GTLDYLPPEMIEGKT 188

Query: 873 VDEKSDVYSFGVVLLELIAGKKP 895
            DEK D++  GV+  E + G  P
Sbjct: 189 HDEKVDLWCAGVLCYEFLVGMPP 211

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  109 bits (273), Expect = 1e-25
 Identities = 34/286 (11%), Positives = 72/286 (25%), Gaps = 62/286 (21%)

Query: 699 IIGKGGAGIVYRG-SMPDGIDVAIK--RLVGRGTGGNDHGFLAEIQTLGRIR-------- 747
           ++G+              G    +       R           E+  L  +R        
Sbjct: 80  VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139

Query: 748 -----------------HRNIVRLLGYVSNRD-TNLLLYEYMPNGSLGEML-----HGAK 784
                             + ++R+     +    +          +L         H + 
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199

Query: 785 GGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFL 844
              L    R ++ L+  + L  LHH     ++H  ++  +I+LD      +  F      
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 256

Query: 845 QDAGASECMSSVAGSYGYIAPEY-----------AYTLKVDEKSDVYSFGVVLLELIAGK 893
                       + S G+  PE                 +    D ++ G+V+  +    
Sbjct: 257 GA------RVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310

Query: 894 KPVGEFGD--GVDIVRWVRKTTSEVSQP-SDAASVLAVVDP--RLS 934
            P         +    W+ ++   + QP               RL 
Sbjct: 311 LP---ITKDAALGGSEWIFRSCKNIPQPVRALLEGFLRYPKEDRLL 353

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  108 bits (272), Expect = 1e-25
 Identities = 29/219 (13%), Positives = 70/219 (31%), Gaps = 24/219 (10%)

Query: 697 ENIIGKGGAGIVYRGSMPDGID------VAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRN 750
            +++G+G    VY  +  D  D        +K           +     ++ L       
Sbjct: 70  HHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQK-PANPWEFYIGTQLMERLKPSMQHM 128

Query: 751 IVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAK---GGHLKWETRYRIALEAAKGLCYL 807
            ++       ++ ++L+ E    G+L   ++  K      +        A+     +  +
Sbjct: 129 FMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQV 188

Query: 808 HHDCSPLIIHRDVKSNNILLDSDFEAH-----------VADFGLAKFLQDAGASECMSSV 856
           H      IIH D+K +N +L + F              + D G +  ++        ++ 
Sbjct: 189 H---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAK 245

Query: 857 AGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
             + G+   E       + + D +     +  ++ G   
Sbjct: 246 CETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM 284

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  109 bits (274), Expect = 2e-25
 Identities = 63/303 (20%), Positives = 107/303 (35%), Gaps = 63/303 (20%)

Query: 697 ENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRI-RHRNIVRLL 755
           E I+G G +G V       G  VA+KR++           L EI+ L     H N++R  
Sbjct: 20  EKILGYGSSGTVVFQGSFQGRPVAVKRMLID----FCDIALMEIKLLTESDDHPNVIRYY 75

Query: 756 GYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAK-------GLCYLH 808
              +      +  E   N +L +++            + +              G+ +LH
Sbjct: 76  CSETTDRFLYIALELC-NLNLQDLV--ESKNVSDENLKLQKEYNPISLLRQIASGVAHLH 132

Query: 809 HDCSPLIIHRDVKSNNILLDS-------------DFEAHVADFGLAKFLQDAGASEC--M 853
              S  IIHRD+K  NIL+ +             +    ++DFGL K L    +S    +
Sbjct: 133 ---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNL 189

Query: 854 SSVAGSYGYIAPE-------YAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVD-- 904
           ++ +G+ G+ APE            ++    D++S G V   +++  K    FGD     
Sbjct: 190 NNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH--PFGDKYSRE 247

Query: 905 --IVRWVRKTTSEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTM 962
             I+R +            +    A                L    M+    +   RPT 
Sbjct: 248 SNIIRGIFSLDEMKCLHDRSLIAEA--------------TDLIS-QMIDH--DPLKRPTA 290

Query: 963 REV 965
            +V
Sbjct: 291 MKV 293

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  108 bits (271), Expect = 2e-25
 Identities = 66/312 (21%), Positives = 116/312 (37%), Gaps = 63/312 (20%)

Query: 692 ESLKDENIIGKGGAGIVYRG--------SMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTL 743
           + L     +G+G  G V              + + VA+K L    T  +    ++E++ +
Sbjct: 81  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140

Query: 744 GRI-RHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEML--------------HGAKGGHL 788
             I +H+NI+ LLG  +      ++ EY   G+L E L              +      +
Sbjct: 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200

Query: 789 KWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAG 848
            ++       + A+G+ YL    S   IHRD+ + N+L+  +    +ADFGLA+ + +  
Sbjct: 201 TFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 257

Query: 849 ASECMSSVAGSYGYI-----APEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGV 903
                     + G +     APE  +      +SDV+SFGV++ E+          G   
Sbjct: 258 -----YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT-------LG--- 302

Query: 904 DIVRWVRKTTSEVSQPSDAASVLAVVDPRLSGY----PLTGVIHLFKVAMMCVEDESSAR 959
                          P     V  +      G+    P      L+ +   C     S R
Sbjct: 303 -------------GSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQR 349

Query: 960 PTMREVVHMLAN 971
           PT +++V  L  
Sbjct: 350 PTFKQLVEDLDR 361

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  108 bits (271), Expect = 3e-25
 Identities = 57/227 (25%), Positives = 93/227 (40%), Gaps = 36/227 (15%)

Query: 692 ESLKDENIIGKGGAGIVYRGSMPD--------GIDVAIKRLVGRGTGGNDHGFLAEIQTL 743
           + L     +G+G  G V                  VA+K L    T  +    ++E++ +
Sbjct: 69  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 128

Query: 744 GRI-RHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEML--------------HGAKGGHL 788
             I +H+NI+ LLG  +      ++ EY   G+L E L                     L
Sbjct: 129 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 188

Query: 789 KWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAG 848
             +     A + A+G+ YL    S   IHRD+ + N+L+  D    +ADFGLA+ +    
Sbjct: 189 SSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 245

Query: 849 ASECMSSVAGSYGYI-----APEYAYTLKVDEKSDVYSFGVVLLELI 890
             +       + G +     APE  +      +SDV+SFGV+L E+ 
Sbjct: 246 YYK-----KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIF 287

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  106 bits (267), Expect = 3e-25
 Identities = 59/232 (25%), Positives = 89/232 (38%), Gaps = 36/232 (15%)

Query: 692 ESLKDENIIGKGGAGIVYRG------SMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGR 745
           + LK    +G+G  G V                VA+K L    T       ++E++ L  
Sbjct: 27  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 86

Query: 746 I-RHRNIVRLLGYVSNRDTNLLL-YEYMPNGSLGEML--------------HGAKGGHLK 789
           I  H N+V LLG  +     L++  E+   G+L   L                     L 
Sbjct: 87  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 146

Query: 790 WETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGA 849
            E     + + AKG+ +L    S   IHRD+ + NILL       + DFGLA+ +     
Sbjct: 147 LEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 203

Query: 850 SECMSSVAGSYGYI-----APEYAYTLKVDEKSDVYSFGVVLLELIA-GKKP 895
                        +     APE  +      +SDV+SFGV+L E+ + G  P
Sbjct: 204 YV-----RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  106 bits (267), Expect = 3e-25
 Identities = 59/225 (26%), Positives = 99/225 (44%), Gaps = 24/225 (10%)

Query: 681 QRLDFKAEDVLESLKDENIIGKGGAGIVYRGS-MPDGIDVAIKRLVGRGTGGND--HGFL 737
           QR   +  D    L++   +G G  G V++      G  +A+K++  R +G  +     L
Sbjct: 18  QRYQAEIND----LENLGEMGSGTCGQVWKMRFRKTGHVIAVKQM--RRSGNKEENKRIL 71

Query: 738 AEIQTLGR-IRHRNIVRLLG-YVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYR 795
            ++  + +      IV+  G +++N D  + + E M   +          G +      +
Sbjct: 72  MDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM-ELMGTCAEKLKKR--MQGPIPERILGK 128

Query: 796 IALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSS 855
           + +   K L YL       +IHRDVK +NILLD   +  + DFG++  L D  A      
Sbjct: 129 MTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKA---KDR 183

Query: 856 VAGSYGYIAPE-----YAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
            AG   Y+APE            D ++DV+S G+ L+EL  G+ P
Sbjct: 184 SAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFP 228

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score =  105 bits (265), Expect = 3e-25
 Identities = 41/287 (14%), Positives = 80/287 (27%), Gaps = 62/287 (21%)

Query: 700 IGKGGAGIVYRGSMPDGI---DVAIKRLVGRGTGGNDHGFLA----EIQTLGRIRHRNIV 752
            G       ++    D      VA+  +     G      L         L RI    + 
Sbjct: 39  HGGVPPLQFWQAL--DTALDRQVALTFV--DPQGVLPDDVLQETLSRTLRLSRIDKPGVA 94

Query: 753 RLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCS 812
           R+L  V  R   L++ E++  GSL E+   +           R     A      H    
Sbjct: 95  RVLDVVHTRAGGLVVAEWIRGGSLQEVADTS----PSPVGAIRAMQSLAAAADAAHRAG- 149

Query: 813 PLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLK 872
             +       + + +  D +  +A                          +         
Sbjct: 150 --VALSIDHPSRVRVSIDGDVVLAYP----------------------ATMPD------- 178

Query: 873 VDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDPR 932
            + + D+   G  L  L+  + P+ E G    +    R T  +  +P+D       +  +
Sbjct: 179 ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADID---RDIPFQ 235

Query: 933 LSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQSAPSL 979
           +S            VA   V+ +   R     +++++      A   
Sbjct: 236 IS-----------AVAARSVQGDGGIRSAS-TLLNLMQQATAVADRT 270

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  105 bits (264), Expect = 5e-25
 Identities = 57/218 (26%), Positives = 100/218 (45%), Gaps = 16/218 (7%)

Query: 682 RLDFKAEDVLESLKDENIIGKGGAGIVYRG-SMPDGIDVAIKRL-VGRGTGGNDHGFLAE 739
           R      D  +       IG+G +G VY    +  G +VAI+++ + +         + E
Sbjct: 10  RSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL--IINE 67

Query: 740 IQTLGRIRHRNIVRLLG-YVSNRDTNL-LLYEYMPNGSLGEMLHGAKGGHLKWETRYRIA 797
           I  +   ++ NIV  L  Y+      L ++ EY+  GSL +++       +       + 
Sbjct: 68  ILVMRENKNPNIVNYLDSYL--VGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVC 122

Query: 798 LEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVA 857
            E  + L +LH   S  +IHRD+KS+NILL  D    + DFG    +    +    S++ 
Sbjct: 123 RECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMV 177

Query: 858 GSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
           G+  ++APE         K D++S G++ +E+I G+ P
Sbjct: 178 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  105 bits (263), Expect = 7e-25
 Identities = 55/219 (25%), Positives = 101/219 (46%), Gaps = 17/219 (7%)

Query: 685 FKAEDVLESLKDENIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTL 743
            +  D  E  +    +G G  G VY+  +   G   A K ++   +      ++ EI+ L
Sbjct: 12  RRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAK-VIETKSEEELEDYIVEIEIL 70

Query: 744 GRIRHRNIVRLLG-YVSNRDTNL-LLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAA 801
               H  IV+LLG Y    D  L ++ E+ P G++  ++     G  + + +  +  +  
Sbjct: 71  ATCDHPYIVKLLGAYY--HDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV-VCRQML 127

Query: 802 KGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYG 861
           + L +LH   S  IIHRD+K+ N+L+  + +  +ADFG++             S  G+  
Sbjct: 128 EALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQK--RDSFIGTPY 182

Query: 862 YIAPEYAYTLKV-----DEKSDVYSFGVVLLELIAGKKP 895
           ++APE      +     D K+D++S G+ L+E+   + P
Sbjct: 183 WMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 221

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  105 bits (264), Expect = 8e-25
 Identities = 53/211 (25%), Positives = 93/211 (44%), Gaps = 14/211 (6%)

Query: 688 EDVLESLKDENIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRI 746
            D    L     IG+G  GIV        G  VA+K +  R           E+  +   
Sbjct: 41  GDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK-QQRRELLFNEVVIMRDY 99

Query: 747 RHRNIVRLLG-YVSNRDTNL-LLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGL 804
           +H N+V +   Y+      L +L E++  G+L +++       L  E    +     + L
Sbjct: 100 QHFNVVEMYKSYL--VGEELWVLMEFLQGGALTDIV---SQVRLNEEQIATVCEAVLQAL 154

Query: 805 CYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIA 864
            YLH   +  +IHRD+KS++ILL  D    ++DFG    +          S+ G+  ++A
Sbjct: 155 AYLH---AQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK--RKSLVGTPYWMA 209

Query: 865 PEYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
           PE         + D++S G++++E++ G+ P
Sbjct: 210 PEVISRSLYATEVDIWSLGIMVIEMVDGEPP 240

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  104 bits (262), Expect = 9e-25
 Identities = 42/228 (18%), Positives = 79/228 (34%), Gaps = 48/228 (21%)

Query: 700 IGKGGAGIVYRG-SMPDGIDVAIKRL-VGRGTGGNDHGFLAEIQTLGRI-RHRNIVRLLG 756
           IG G  G V++     DG   AIKR         ++   L E+     + +H ++VR   
Sbjct: 19  IGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFS 78

Query: 757 YVSNRDTNLLLY---EYMPNGSLGEML--HGAKGGHLKWETRYRIALEAAKGLCYLHHDC 811
             +  D    +    EY   GSL + +  +     + K      + L+  +GL Y+H   
Sbjct: 79  AWAEDDH---MLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH--- 132

Query: 812 SPLIIHRDVKSNNILLDSDFEAHV-------------------ADFGLAKFLQDAGASEC 852
           S  ++H D+K +NI +      +                     D G    +        
Sbjct: 133 SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP----- 187

Query: 853 MSSVAGSYGYIAPE-----YAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
                G   ++A E     Y +      K+D+++  + ++     +  
Sbjct: 188 -QVEEGDSRFLANEVLQENYTH----LPKADIFALALTVVCAAGAEPL 230

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  104 bits (262), Expect = 1e-24
 Identities = 57/244 (23%), Positives = 95/244 (38%), Gaps = 54/244 (22%)

Query: 692 ESLKDENIIGKGGAGIVYRG------SMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGR 745
           ++L     +G+G  G V +              VA+K L    +       L+E   L +
Sbjct: 23  KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82

Query: 746 IRHRNIVRLLGYVSNRDTNLLLYEYMPNGSL----------------------GEMLHGA 783
           + H ++++L G  S     LL+ EY   GSL                         L   
Sbjct: 83  VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142

Query: 784 KGGHLKWETRYRIALEAAKGLCYL--HHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLA 841
               L        A + ++G+ YL         ++HRD+ + NIL+    +  ++DFGL+
Sbjct: 143 DERALTMGDLISFAWQISQGMQYLAEMK-----LVHRDLAARNILVAEGRKMKISDFGLS 197

Query: 842 KFLQDAGASECMSSVAGSYGYI-----APE----YAYTLKVDEKSDVYSFGVVLLELIA- 891
           + + +  +         S G I     A E    + YT     +SDV+SFGV+L E++  
Sbjct: 198 RDVYEEDSYV-----KRSQGRIPVKWMAIESLFDHIYTT----QSDVWSFGVLLWEIVTL 248

Query: 892 GKKP 895
           G  P
Sbjct: 249 GGNP 252

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  104 bits (262), Expect = 2e-24
 Identities = 57/242 (23%), Positives = 94/242 (38%), Gaps = 50/242 (20%)

Query: 692 ESLKDENIIGKGGAGIVYRGSMPDG------IDVAIKRLVGRGTGGNDHGFLAEIQTLGR 745
           E+L+   ++G G  G V   +          I VA+K L  +         ++E++ + +
Sbjct: 45  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 104

Query: 746 I-RHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYR--------- 795
           +  H NIV LLG  +      L++EY   G L   L   +    + E  Y          
Sbjct: 105 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 164

Query: 796 ------------IALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKF 843
                        A + AKG+ +L        +HRD+ + N+L+       + DFGLA+ 
Sbjct: 165 DLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARD 221

Query: 844 LQDAGASECMSSVAGSYGYI-----APE----YAYTLKVDEKSDVYSFGVVLLELIA-GK 893
           +                  +     APE      YT     KSDV+S+G++L E+ + G 
Sbjct: 222 IMSDSNYV-----VRGNARLPVKWMAPESLFEGIYT----IKSDVWSYGILLWEIFSLGV 272

Query: 894 KP 895
            P
Sbjct: 273 NP 274

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  104 bits (262), Expect = 2e-24
 Identities = 69/239 (28%), Positives = 104/239 (43%), Gaps = 25/239 (10%)

Query: 665 RKRRLQKSKAWKLTAFQRLDFKAEDVLESLKDENIIGKGGAGIVYRG-SMPDGIDVAIKR 723
              R    K   +       F  +D  +   D   IG G  G VY    + +   VAIK+
Sbjct: 31  AGGRAGSLKDPDVAEL----FFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKK 86

Query: 724 --LVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLG-YVSNRDTNL-LLYEYMPNGSLGEM 779
               G+ +       + E++ L ++RH N ++  G Y+  R+    L+ EY   GS  ++
Sbjct: 87  MSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL--REHTAWLVMEYCL-GSASDL 143

Query: 780 LHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFG 839
           L   K    + E    +   A +GL YLH   S  +IHRDVK+ NILL       + DFG
Sbjct: 144 LEVHKKPLQEVEIAA-VTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFG 199

Query: 840 LAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKV---DEKSDVYSFGVVLLELIAGKKP 895
            A  +  A      +S  G+  ++APE    +     D K DV+S G+  +EL   K P
Sbjct: 200 SASIMAPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 252

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  107 bits (268), Expect = 2e-24
 Identities = 62/235 (26%), Positives = 98/235 (41%), Gaps = 14/235 (5%)

Query: 666 KRRLQKSKAWKLTAFQRLDFKAEDVLESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRL 724
           +  L      + T    +  K   + E  +    +G G  G V         ++ AIK +
Sbjct: 11  RENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKII 70

Query: 725 VGRGTGGNDHG-FLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGA 783
                  + +   L E+  L  + H NI++L  +  ++    L+ E    G L + +   
Sbjct: 71  RKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEI--I 128

Query: 784 KGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDS---DFEAHVADFGL 840
                       I  +   G+ YLH      I+HRD+K  N+LL+S   D    + DFGL
Sbjct: 129 HRMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGL 185

Query: 841 AKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
           +   ++    + M    G+  YIAPE     K DEK DV+S GV+L  L+AG  P
Sbjct: 186 SAVFEN---QKKMKERLGTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAGYPP 236

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  103 bits (259), Expect = 5e-24
 Identities = 58/240 (24%), Positives = 95/240 (39%), Gaps = 46/240 (19%)

Query: 692 ESLKDENIIGKGGAGIVYRGSMPDGID------VAIKRLVGRGTGGNDHGFLAEIQTLGR 745
            +++    IG+G  G V++   P  +       VA+K L    +      F  E   +  
Sbjct: 47  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 106

Query: 746 IRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRY----------- 794
             + NIV+LLG  +      LL+EYM  G L E L       +   +             
Sbjct: 107 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 166

Query: 795 -----------RIALEAAKGLCYL--HHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLA 841
                       IA + A G+ YL          +HRD+ + N L+  +    +ADFGL+
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYLSERK-----FVHRDLATRNCLVGENMVVKIADFGLS 221

Query: 842 KFLQDAGASECMSSVAGSYGYI-----APEYAYTLKVDEKSDVYSFGVVLLELIA-GKKP 895
           + +  A   +     A     I      PE  +  +   +SDV+++GVVL E+ + G +P
Sbjct: 222 RNIYSADYYK-----ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  103 bits (257), Expect = 6e-24
 Identities = 44/261 (16%), Positives = 90/261 (34%), Gaps = 31/261 (11%)

Query: 660 TIYQLRKRRLQKSKAWKLTAFQRLDFKAEDV------LESLKDENIIGKGGAGIV----- 708
            +++ + +    + A K       +   E V      L  L+   I+    A +      
Sbjct: 21  VVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEK 80

Query: 709 YRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLY 768
           ++  M +             +         +I+ +     +N V     +      + LY
Sbjct: 81  WQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG---QLQPSSPKVYLY 137

Query: 769 ---EYMPNGSLGEMLHGAKGGHLKWETR-YRIALEAAKGLCYLHHDCSPLIIHRDVKSNN 824
              +     +L + ++       +       I ++ A+ + +LH   S  ++HRD+K +N
Sbjct: 138 IQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLH---SKGLMHRDLKPSN 194

Query: 825 ILLDSDFEAHVADFGLAKFLQDAG----------ASECMSSVAGSYGYIAPEYAYTLKVD 874
           I    D    V DFGL   +              A    +   G+  Y++PE  +     
Sbjct: 195 IFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYS 254

Query: 875 EKSDVYSFGVVLLELIAGKKP 895
            K D++S G++L EL+     
Sbjct: 255 HKVDIFSLGLILFELLYSFST 275

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  104 bits (260), Expect = 1e-23
 Identities = 56/214 (26%), Positives = 86/214 (40%), Gaps = 31/214 (14%)

Query: 700 IGKGGAGIVYRG-SMPDGIDVAIK-----RLVGRGTGGND--HGFLAEIQTLGRIRHRNI 751
           +G G  G V           VAI+     +         D       EI+ L ++ H  I
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202

Query: 752 VRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDC 811
           +++  +    D  ++L E M  G L + +       LK  T      +    + YLH   
Sbjct: 203 IKIKNFFDAEDYYIVL-ELMEGGELFDKV--VGNKRLKEATCKLYFYQMLLAVQYLH--- 256

Query: 812 SPLIIHRDVKSNNILLDSDFEAH---VADFGLAKFLQDAGASECMSSVAGSYGYIAPE-- 866
              IIHRD+K  N+LL S  E     + DFG +K L +   +  M ++ G+  Y+APE  
Sbjct: 257 ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE---TSLMRTLCGTPTYLAPEVL 313

Query: 867 -----YAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
                  Y   V    D +S GV+L   ++G  P
Sbjct: 314 VSVGTAGYNRAV----DCWSLGVILFICLSGYPP 343

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  103 bits (259), Expect = 3e-23
 Identities = 61/219 (27%), Positives = 98/219 (44%), Gaps = 15/219 (6%)

Query: 683 LDFKAEDVLESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGR--GTGGNDHGFLAE 739
           +        +  K + ++GKG  G V        G + A+K +  R      +    L E
Sbjct: 17  VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLRE 76

Query: 740 IQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALE 799
           +Q L ++ H NI++L  +  ++    L+ E    G L + +              RI  +
Sbjct: 77  VQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEI--ISRKRFSEVDAARIIRQ 134

Query: 800 AAKGLCYLHHDCSPLIIHRDVKSNNILLDS---DFEAHVADFGLAKFLQDAGASECMSSV 856
              G+ Y+H +    I+HRD+K  N+LL+S   D    + DFGL+   +    S+ M   
Sbjct: 135 VLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA---SKKMKDK 188

Query: 857 AGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
            G+  YIAPE       DEK DV+S GV+L  L++G  P
Sbjct: 189 IGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGCPP 226

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score =  103 bits (259), Expect = 4e-23
 Identities = 73/467 (15%), Positives = 154/467 (32%), Gaps = 33/467 (7%)

Query: 144 TELQVLDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLNGIG 203
              + L    N+ +     +I+ L  LR L    N         +   Q LEY+ ++   
Sbjct: 52  PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNR 111

Query: 204 LNGTVPAFLSRLKNLREMYIGYFNTYTGGIPPG--FGALTQLQVLDMASCNISGEIPTSL 261
           L   +      + +LR + +  FN +   +P    FG LT+L  L +++          +
Sbjct: 112 L-QNISC--CPMASLRHLDL-SFNDFDV-LPVCKEFGNLTKLTFLGLSAAKFRQLDLLPV 166

Query: 262 SRLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQLF 321
           + L L   L   ++        +   + +   L L  +  +    +   ++  L  LQL 
Sbjct: 167 AHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLS 226

Query: 322 KNNL-RGPIPSFLGDFP---------NLEVLQVWGNNFTFELPENLGRNGKLLILDVTSN 371
              L        +             N+ +  +                  +  L++ + 
Sbjct: 227 NIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNL 286

Query: 372 HLTGTIPRDLCK--GGKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLN--GTIPA 427
            +T  I R+        LKSL++        +  +        ++      ++    I  
Sbjct: 287 TITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHM 346

Query: 428 GLFNLPL-LNMMELDDNLLSGELPEKMSG-ASLNQLKVANNNITGKIPAAIGNLPSLNIL 485
                P     +    N+ +  + +  S    L  L +  N +            +++ L
Sbjct: 347 VCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFKVALMTKNMSSL 405

Query: 486 SLQNNRL----EGEIPVESFNLKMITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLY 541
              +  L               + I  +N+S N ++G +   +     +  +DL  N + 
Sbjct: 406 ETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLPP--KVKVLDLHNNRI- 462

Query: 542 GKIPPGISKLIDLSILNLSRNGITGSIPNEM-RNMMSLTTLDLSYNN 587
             IP  ++ L  L  LN++ N +  S+P+ +   + SL  + L  N 
Sbjct: 463 MSIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDNP 508

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score =  102 bits (255), Expect = 1e-22
 Identities = 67/406 (16%), Positives = 124/406 (30%), Gaps = 60/406 (14%)

Query: 233 IPPG-FGALTQLQVLDMASCNISGEIPTSL-SRLKLLHSLFLQMNKLTGHIPPQLSGLIS 290
           +       L++L+VL ++   I   +   +    + L  L +  N+L  +I      + S
Sbjct: 67  LRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDLEYLDVSHNRLQ-NISCC--PMAS 122

Query: 291 LKSLDLSLNYLTGEIPES--FAALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNN 348
           L+ LDLS N     +P    F  L  LT L L     R      L    +L +  +  + 
Sbjct: 123 LRHLDLSFNDFD-VLPVCKEFGNLTKLTFLGLSAAKFRQ---LDLLPVAHLHLSCILLDL 178

Query: 349 FTFELPEN-----LGRNGKLLILDVTSNHLTGTIPRDL---CKGGKLKSLILMQNFFIGP 400
            ++ +           N  +L L    N L               +L ++ L        
Sbjct: 179 VSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRL 238

Query: 401 IPEELGQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMM-----ELDDNLLSGELPEKMSG 455
           +       +  T +  +  ++  T    +               + +  ++  +  +   
Sbjct: 239 MTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFT 298

Query: 456 ASLNQLK------VANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESFNLKMITSI 509
            S   LK      V N        A       +NI  L  +       V   +    T +
Sbjct: 299 YSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFL 358

Query: 510 NISDNNISGEIPYSISQCHSLTSVDLSRNSL----------------------YGKIPPG 547
           N + N  +  +    S    L ++ L RN L                         +   
Sbjct: 359 NFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSH 418

Query: 548 I-----SKLIDLSILNLSRNGITGSIPNEMRNMMSLTTLDLSYNNL 588
                 +    + +LNLS N +TGS+   +     +  LDL  N +
Sbjct: 419 AYDRTCAWAESILVLNLSSNMLTGSVFRCLPP--KVKVLDLHNNRI 462

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 98.8 bits (246), Expect = 2e-21
 Identities = 80/443 (18%), Positives = 156/443 (35%), Gaps = 30/443 (6%)

Query: 94  LTKLVNLTISNVNLTGRLPSEM-ALLTSLKVFNISGNVFQGNFAGQIVRGMTELQVLDAY 152
           L++L  L +S+  +   L   +      L+  ++S N  Q          M  L+ LD  
Sbjct: 75  LSELRVLRLSHNRIR-SLDFHVFLFNQDLEYLDVSHNRLQNISCC----PMASLRHLDLS 129

Query: 153 NNNFTG-PLPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLNGIGLNGTVPAF 211
            N+F   P+  E  +L  L  L      F  ++         L  I L+ +  +      
Sbjct: 130 FNDFDVLPVCKEFGNLTKLTFLGLSAAKFR-QLDLLPVAHLHLSCILLDLVSYHIKGGET 188

Query: 212 LSRLKNLREMYIGYFNTYTGGIPPGFGALTQLQVL-------DMASCNISGEIPTSLSRL 264
            S       +    F+  +        ++  L  L       +  +C       + L+R 
Sbjct: 189 ESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRG 248

Query: 265 KLLHSLFLQMNKLTGHIPPQLSGLI---SLKSLDLSLNYLTGEIPESFAALKNLTLLQLF 321
             L ++ LQ  + T     +L        ++ L++    +T  I           L  L 
Sbjct: 249 PTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLM 308

Query: 322 KNNLRGPIPSFLGD-----FPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGT 376
             +++  +  F  +     F  + +  +  ++  F              L+ T N  T +
Sbjct: 309 IEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDS 368

Query: 377 IPRDLCKGGKLKSLILMQNFF--IGPIPEELGQCKSLTKIRFSKNYLNGTIPAGLFNLPL 434
           + +      +L++LIL +N       +        SL  +  S N LN            
Sbjct: 369 VFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAE 428

Query: 435 -LNMMELDDNLLSGELPEKMSGASLNQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLE 493
            + ++ L  N+L+G +   +    +  L + NN I   IP  + +L +L  L++ +N+L+
Sbjct: 429 SILVLNLSSNMLTGSVFRCLP-PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK 486

Query: 494 GEIPVESF-NLKMITSINISDNN 515
             +P   F  L  +  I + DN 
Sbjct: 487 -SVPDGVFDRLTSLQYIWLHDNP 508

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 84.5 bits (209), Expect = 5e-17
 Identities = 50/265 (18%), Positives = 90/265 (33%), Gaps = 39/265 (14%)

Query: 94  LTKLVNLTISNVNLTGRLPSEMA-----LLTSLKVFNISGNVFQGNFAGQIVRGMTELQV 148
              +  L I N+ +T R+  E        L SL + ++   VF  +    +     E+ +
Sbjct: 275 PRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEA-LYSVFAEMNI 333

Query: 149 LDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLNGIGLNGTV 208
                ++      V   S  S   L+F  N FT  + Q  S ++ L+ + L         
Sbjct: 334 KMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQR------- 386

Query: 209 PAFLSRLKNLREMYIGYFNTYTGGIPPGFGALTQLQVLDMASCNI----SGEIPTSLSRL 264
               + LKN                         +  L+    ++    S     + +  
Sbjct: 387 ----NGLKNF---------------FKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWA 427

Query: 265 KLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQLFKNN 324
           + +  L L  N LTG +   L     +K LDL  N +   IP+    L+ L  L +  N 
Sbjct: 428 ESILVLNLSSNMLTGSVFRCLPP--KVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQ 484

Query: 325 LRGPIPSFLGDFPNLEVLQVWGNNF 349
           L+           +L+ + +  N +
Sbjct: 485 LKSVPDGVFDRLTSLQYIWLHDNPW 509

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 71.1 bits (174), Expect = 8e-13
 Identities = 61/352 (17%), Positives = 111/352 (31%), Gaps = 55/352 (15%)

Query: 275 NKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQLFKNNLRGPIPSFLG 334
             LT H+P  L      K+L LS N ++       + L  L +L+L  N +R        
Sbjct: 41  RNLT-HVPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-------- 89

Query: 335 DFPNLEVLQVWGNNFTFELPENL-GRNGKLLILDVTSNHLTGTIPRDLCKGGKLKSLILM 393
                             L  ++   N  L  LDV+ N L   I         L+ L L 
Sbjct: 90  -----------------SLDFHVFLFNQDLEYLDVSHNRLQ-NISCCPMA--SLRHLDLS 129

Query: 394 QNFFIG-PIPEELGQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMM-ELDDNLLSGELPE 451
            N F   P+ +E G    LT +  S           + +L L  ++ +L    + G   E
Sbjct: 130 FNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETE 189

Query: 452 KMSGASLNQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLEG-------EIPVESFNLK 504
            +   +   L +  +  +        ++ +L  L L N +L             E     
Sbjct: 190 SLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGP 249

Query: 505 MITSINISDNNISGEIPYSISQC---HSLTSVDLSRNSLYGKIPPGI-----SKLIDLSI 556
            + ++ +     + +    + Q      +  +++   ++  +I         + L  L I
Sbjct: 250 TLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMI 309

Query: 557 LNLSRNGITGSIPNEMRNMMSLTTLDLSYNNL------IGNIPSGGQFLAFN 602
            ++       S          +    LS ++           PS   FL F 
Sbjct: 310 EHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFT 361

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 44.9 bits (106), Expect = 1e-04
 Identities = 18/90 (20%), Positives = 35/90 (38%), Gaps = 13/90 (14%)

Query: 523 SISQCHSLTSVDLSRNSLYGKIPPGISKLIDLSILNLSRNGITGSIPNEMRNMMSLTTLD 582
           +       + VD S  +L   +P  +        L+LS+N I+     ++  +  L  L 
Sbjct: 26  TPFSNELESMVDYSNRNLT-HVPKDLPP--RTKALSLSQNSISELRMPDISFLSELRVLR 82

Query: 583 LSYNNLIGNIPSGGQFLAFNETSFIGNPNL 612
           LS+N +  ++             F+ N +L
Sbjct: 83  LSHNRI-RSLDFH---------VFLFNQDL 102

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 99.6 bits (249), Expect = 4e-23
 Identities = 52/220 (23%), Positives = 89/220 (40%), Gaps = 19/220 (8%)

Query: 685 FKAEDVLESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTL 743
           +    + +    +  +G G  G V+       G++  IK +    +        AEI+ L
Sbjct: 15  YFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVL 74

Query: 744 GRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGE--MLHGAKGGHLKWETRYRIALEAA 801
             + H NI+++     +     ++ E    G L E  +   A+G  L       +  +  
Sbjct: 75  KSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMM 134

Query: 802 KGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAH---VADFGLAKFLQDAGASECMSSVAG 858
             L Y H   S  ++H+D+K  NIL           + DFGLA+  +     E  ++ AG
Sbjct: 135 NALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS---DEHSTNAAG 188

Query: 859 SYGYIAPE---YAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
           +  Y+APE            K D++S GVV+  L+ G  P
Sbjct: 189 TALYMAPEVFKRDV----TFKCDIWSAGVVMYFLLTGCLP 224

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  100 bits (251), Expect = 6e-23
 Identities = 51/259 (19%), Positives = 84/259 (32%), Gaps = 52/259 (20%)

Query: 686 KAEDVLESLKDENIIGKGGAGIVYRG-SMPDGIDVAIK----RLVGRGTGGNDHGFLAEI 740
              ++ +    +  IG+G  G+V            AIK      + +    +      E+
Sbjct: 20  SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEV 79

Query: 741 QTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSL------------------------ 776
           + + ++ H NI RL     +     L+ E    G L                        
Sbjct: 80  RLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQI 139

Query: 777 ----GEMLHGAKGGHLKWETRYRIAL---EAAK-------GLCYLHHDCSPLIIHRDVKS 822
                       G    +             +         L YLH   +  I HRD+K 
Sbjct: 140 CPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIKP 196

Query: 823 NNILLDSDFEAHV--ADFGLAKFLQ--DAGASECMSSVAGSYGYIAPE--YAYTLKVDEK 876
            N L  ++    +   DFGL+K     + G    M++ AG+  ++APE           K
Sbjct: 197 ENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK 256

Query: 877 SDVYSFGVVLLELIAGKKP 895
            D +S GV+L  L+ G  P
Sbjct: 257 CDAWSAGVLLHLLLMGAVP 275

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 99.7 bits (249), Expect = 6e-23
 Identities = 56/269 (20%), Positives = 94/269 (34%), Gaps = 34/269 (12%)

Query: 86  SIPPEIGLLTKLVNLTISNVNLTGRLPSEMALLTSLKVFNISGNVFQGNFAGQIV-RGMT 144
           S+P   G+ +    L + +  L          LT L   ++S N             G T
Sbjct: 21  SVPT--GIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTT 78

Query: 145 ELQVLDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLNGIGL 204
            L+ LD   N     +      L+ L HL F  +            ++ +    +     
Sbjct: 79  SLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHS-----------NLKQMSEFSV----- 121

Query: 205 NGTVPAFLSRLKNLREMYIGYFNTYTGGIPPG-FGALTQLQVLDMASCNISGEI-PTSLS 262
                     L+NL  + I   +T+T     G F  L+ L+VL MA  +      P   +
Sbjct: 122 -------FLSLRNLIYLDIS--HTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFT 172

Query: 263 RLKLLHSLFLQMNKLTGHIPPQ-LSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQLF 321
            L+ L  L L   +L   + P   + L SL+ L++S N         +  L +L +L   
Sbjct: 173 ELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYS 231

Query: 322 KNNLRG-PIPSFLGDFPNLEVLQVWGNNF 349
            N++             +L  L +  N+F
Sbjct: 232 LNHIMTSKKQELQHFPSSLAFLNLTQNDF 260

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 98.2 bits (245), Expect = 2e-22
 Identities = 52/221 (23%), Positives = 85/221 (38%), Gaps = 15/221 (6%)

Query: 233 IPPG-FGALTQLQVLDMASCNISGEIPTSLSRLKL--LHSLFLQMNKLTGHIPPQLSGLI 289
           +P G F  LTQL  L ++S  +S +   S S      L  L L  N +   +     GL 
Sbjct: 43  LPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLE 101

Query: 290 SLKSLDLSLNYLTGEIPES--FAALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGN 347
            L+ LD   + L  ++ E   F +L+NL  L +   + R           +LEVL++ GN
Sbjct: 102 QLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGN 160

Query: 348 NFTFELPENLGRN-GKLLILDVTSNHLTGTIPRDLCKG-GKLKSLILMQNFFIGPIPEE- 404
           +F      ++      L  LD++   L   +          L+ L +  N     +    
Sbjct: 161 SFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHN-NFFSLDTFP 218

Query: 405 LGQCKSLTKIRFSKNYLNGTIPAGLF-NLP-LLNMMELDDN 443
                SL  + +S N++  T       + P  L  + L  N
Sbjct: 219 YKCLNSLQVLDYSLNHIM-TSKKQELQHFPSSLAFLNLTQN 258

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 97.8 bits (244), Expect = 3e-22
 Identities = 51/308 (16%), Positives = 116/308 (37%), Gaps = 23/308 (7%)

Query: 290 SLKSLDLSLNYLTGEIPESFAALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNF 349
           S   +  +   LT  +P       + T L+L  N L+            L  L +  N  
Sbjct: 8   SGTEIRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGL 64

Query: 350 TFELPENLGRNG--KLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFIGPIPEE--L 405
           +F+   +    G   L  LD++ N +  T+  +     +L+ L    +  +  + E    
Sbjct: 65  SFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHS-NLKQMSEFSVF 122

Query: 406 GQCKSLTKIRFSKNYLNGTIPAGLF-NLPLLNMMELDDNLLSGELPEKMSG--ASLNQLK 462
              ++L  +  S  +       G+F  L  L ++++  N         +     +L  L 
Sbjct: 123 LSLRNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLD 181

Query: 463 VANNNITGKIPA-AIGNLPSLNILSLQNNRLEGEIPVESF-NLKMITSINISDNNISGEI 520
           ++   +  ++   A  +L SL +L++ +N     +    +  L  +  ++ S N+I    
Sbjct: 182 LSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFF-SLDTFPYKCLNSLQVLDYSLNHIM-TS 238

Query: 521 PYSISQ--CHSLTSVDLSRNSLY--GKIPPGISKLIDLSILNLSRNGITGSIPNEMRNMM 576
                Q    SL  ++L++N      +    +  + D   L +    +  + P++ +  M
Sbjct: 239 KKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQG-M 297

Query: 577 SLTTLDLS 584
            + +L+++
Sbjct: 298 PVLSLNIT 305

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 97.0 bits (242), Expect = 5e-22
 Identities = 47/239 (19%), Positives = 89/239 (37%), Gaps = 18/239 (7%)

Query: 366 LDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLN-GT 424
           +   S  LT ++P  +        L L  N           +   LTK+  S N L+   
Sbjct: 12  IRCNSKGLT-SVPTGIPSS--ATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKG 68

Query: 425 IPAGLF-NLPLLNMMELDDNLLSGELPEKMSG-ASLNQLKVANNNITGKIPA--AIGNLP 480
             +        L  ++L  N +   +     G   L  L   ++N+  ++       +L 
Sbjct: 69  CCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLR 126

Query: 481 SLNILSLQNNRLEGEIPVESF-NLKMITSINISDNNISGEIPYSI-SQCHSLTSVDLSRN 538
           +L  L + +           F  L  +  + ++ N+        I ++  +LT +DLS+ 
Sbjct: 127 NLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQC 185

Query: 539 SLYGKIPPGI-SKLIDLSILNLSRNGITGSIPNEM-RNMMSLTTLDLSYNNLIGNIPSG 595
            L  ++ P   + L  L +LN+S N    S+     + + SL  LD S N+++      
Sbjct: 186 QL-EQLSPTAFNSLSSLQVLNMSHNNFF-SLDTFPYKCLNSLQVLDYSLNHIM-TSKKQ 241

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 96.2 bits (240), Expect = 9e-22
 Identities = 51/253 (20%), Positives = 96/253 (37%), Gaps = 16/253 (6%)

Query: 345 WGNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQNF--FIGPIP 402
                T  +P  +  +     L++ SN L         K  +L  L L  N   F G   
Sbjct: 15  NSKGLT-SVPTGIPSS--ATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCS 71

Query: 403 EELGQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLSGELPEKMSGASLNQLK 462
           +      SL  +  S N +  T+ +    L  L  ++   + L  ++ E     SL  L 
Sbjct: 72  QSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLI 129

Query: 463 V---ANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESF-NLKMITSINISDNNISG 518
               ++ +           L SL +L +  N  +     + F  L+ +T +++S   +  
Sbjct: 130 YLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE- 188

Query: 519 EIPYSISQC-HSLTSVDLSRNSLYGKIPPGI-SKLIDLSILNLSRNGITGSIPNEMRNMM 576
           ++  +      SL  +++S N+    +       L  L +L+ S N I  S   E+++  
Sbjct: 189 QLSPTAFNSLSSLQVLNMSHNNF-FSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFP 247

Query: 577 -SLTTLDLSYNNL 588
            SL  L+L+ N+ 
Sbjct: 248 SSLAFLNLTQNDF 260

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 50.0 bits (120), Expect = 2e-06
 Identities = 23/92 (25%), Positives = 31/92 (33%), Gaps = 12/92 (13%)

Query: 525 SQCH-SLTSVDLSRNSLYGKIPPGISKLIDLSILNLSRNGITGSIPNEMRNMMSLTTLDL 583
           S+C  S T +  +   L   +P GI      + L L  N +          +  LT L L
Sbjct: 3   SRCSCSGTEIRCNSKGL-TSVPTGIPS--SATRLELESNKLQSLPHGVFDKLTQLTKLSL 59

Query: 584 SYNNLIGNIPSGGQFLAFNETSFIGNPNLCLL 615
           S N L         F      S  G  +L  L
Sbjct: 60  SSNGL--------SFKGCCSQSDFGTTSLKYL 83

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  101 bits (254), Expect = 1e-22
 Identities = 59/229 (25%), Positives = 88/229 (38%), Gaps = 25/229 (10%)

Query: 683 LDFKAEDVLESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRL------------VGRGT 729
           +  K   + ES      +G G  G V          + AIK +              +  
Sbjct: 27  VRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNI 86

Query: 730 GGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLK 789
                    EI  L  + H NI++L     ++    L+ E+   G L E +         
Sbjct: 87  EKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQI--INRHKFD 144

Query: 790 WETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDS---DFEAHVADFGLAKFLQD 846
                 I  +   G+CYLH      I+HRD+K  NILL++        + DFGL+ F   
Sbjct: 145 ECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSK 201

Query: 847 AGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
                 +    G+  YIAPE     K +EK DV+S GV++  L+ G  P
Sbjct: 202 ---DYKLRDRLGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGYPP 246

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 96.5 bits (241), Expect = 3e-22
 Identities = 57/252 (22%), Positives = 96/252 (38%), Gaps = 34/252 (13%)

Query: 700 IGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYV 758
           +G+G  G V    +      VA+K +  +           EI     + H N+V+  G+ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74

Query: 759 SNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAK-------GLCYLHHDC 811
              +   L  EY   G L + +       +          +A +       G+ YLH   
Sbjct: 75  REGNIQYLFLEYCSGGELFDRI--EPDIGMPEP-------DAQRFFHQLMAGVVYLH--- 122

Query: 812 SPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTL 871
              I HRD+K  N+LLD      ++DFGLA   +       ++ + G+  Y+APE     
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182

Query: 872 KVD-EKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTS-EVSQP------SDAA 923
           +   E  DV+S G+VL  ++AG+ P   +    D  +        +          S   
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELP---WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 239

Query: 924 SVLA---VVDPR 932
           ++L    V +P 
Sbjct: 240 ALLHKILVENPS 251

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 97.4 bits (243), Expect = 4e-22
 Identities = 58/217 (26%), Positives = 88/217 (40%), Gaps = 35/217 (16%)

Query: 692 ESLKDE----NIIGKGGAGIVYRGS-MPDGIDVAIK-----RLVGRGTGGND--HGFLAE 739
           ++L+DE      +G G  G V           VAIK     +         D       E
Sbjct: 6   KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETE 65

Query: 740 IQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALE 799
           I+ L ++ H  I+++  +    D  ++L E M  G L + +       LK  T      +
Sbjct: 66  IEILKKLNHPCIIKIKNFFDAEDYYIVL-ELMEGGELFDKV--VGNKRLKEATCKLYFYQ 122

Query: 800 AAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAH---VADFGLAKFLQDAGASECMSSV 856
               + YLH      IIHRD+K  N+LL S  E     + DFG +K L +   +  M ++
Sbjct: 123 MLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE---TSLMRTL 176

Query: 857 AGSYGYIAPE-------YAYTLKVDEKSDVYSFGVVL 886
            G+  Y+APE         Y   V    D +S GV+L
Sbjct: 177 CGTPTYLAPEVLVSVGTAGYNRAV----DCWSLGVIL 209

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 99.4 bits (248), Expect = 5e-22
 Identities = 63/265 (23%), Positives = 109/265 (41%), Gaps = 29/265 (10%)

Query: 360 NGKLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKN 419
           + +   +  T   L+  +P+ +      + L LM+N       +       L  ++  +N
Sbjct: 53  SNQFSKVVCTRRGLS-EVPQGIPSN--TRYLNLMENNIQMIQADTFRHLHHLEVLQLGRN 109

Query: 420 YLNGTIPAGLF-NLPLLNMMELDDNLLSGELPEKM-SG-ASLNQLKVANNNITGKIPAAI 476
            +   I  G F  L  LN +EL DN L+  +P       + L +L + NN I   IP+  
Sbjct: 110 SIR-QIEVGAFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIE-SIPSYA 166

Query: 477 -GNLPSLNILSLQN-NRLEGEIPVESF-NLKMITSINISDNNISGEIPYSISQCHSLTSV 533
              +PSL  L L    +LE  I   +F  L  +  +N+   NI  ++P +++    L  +
Sbjct: 167 FNRVPSLMRLDLGELKKLE-YISEGAFEGLFNLKYLNLGMCNIK-DMP-NLTPLVGLEEL 223

Query: 534 DLSRNSLYGKIPPG-ISKLIDLSILNLSRNGITGSIPNEM-RNMMSLTTLDLSYNNLIGN 591
           ++S N    +I PG    L  L  L +  + ++  I       + SL  L+L++NNL  +
Sbjct: 224 EMSGNHF-PEIRPGSFHGLSSLKKLWVMNSQVS-LIERNAFDGLASLVELNLAHNNLS-S 280

Query: 592 IPSGGQFLAFNETSFIGNPNLCLLR 616
           +P            F     L  L 
Sbjct: 281 LPHD---------LFTPLRYLVELH 296

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 98.3 bits (245), Expect = 1e-21
 Identities = 58/286 (20%), Positives = 95/286 (33%), Gaps = 58/286 (20%)

Query: 233 IPPGFGALTQLQVLDMASCNISGEIPTSLSRLKLLHSLFLQMNKLTGHIPPQ-LSGLISL 291
           +P G    +  + L++   NI      +   L  L  L L  N +   I     +GL SL
Sbjct: 69  VPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIR-QIEVGAFNGLASL 125

Query: 292 KSLDLSLNYLTGEIPESFAALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTF 351
            +L+L  N+LT     +F  L  L  L L  N +           P+L  L +       
Sbjct: 126 NTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLE 185

Query: 352 ELPENLGRN-GKLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFIGPIPEELGQCKS 410
            + E        L  L++   ++   +P +L     L+ L +  N               
Sbjct: 186 YISEGAFEGLFNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMSGN--------------- 228

Query: 411 LTKIRFSKNYLNGTIPAGLF-NLPLLNMMELDDNLLSGELPEKMSGASLNQLKVANNNIT 469
                         I  G F  L                        SL +L V N+ ++
Sbjct: 229 --HFP--------EIRPGSFHGLS-----------------------SLKKLWVMNSQVS 255

Query: 470 GKIPAAIGNLPSLNILSLQNNRLEGEIPVESF-NLKMITSINISDN 514
                A   L SL  L+L +N L   +P + F  L+ +  +++  N
Sbjct: 256 LIERNAFDGLASLVELNLAHNNLS-SLPHDLFTPLRYLVELHLHHN 300

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 96.4 bits (240), Expect = 5e-21
 Identities = 51/231 (22%), Positives = 84/231 (36%), Gaps = 8/231 (3%)

Query: 144 TELQVLDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLNGIG 203
           +  + L+   NN           L  L  L  G N        +++ + SL  + L    
Sbjct: 75  SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNW 134

Query: 204 LNGTVPAFLSRLKNLREMYIGYFNTYTGGIPPG-FGALTQLQVLDMASCNISGEIPT-SL 261
           L          L  LRE+++   N     IP   F  +  L  LD+        I   + 
Sbjct: 135 LTVIPSGAFEYLSKLRELWLRN-NPIES-IPSYAFNRVPSLMRLDLGELKKLEYISEGAF 192

Query: 262 SRLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQLF 321
             L  L  L L M  +   +P  L+ L+ L+ L++S N+     P SF  L +L  L + 
Sbjct: 193 EGLFNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVM 250

Query: 322 KNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPEN-LGRNGKLLILDVTSN 371
            + +     +      +L  L +  NN +  LP +       L+ L +  N
Sbjct: 251 NSQVSLIERNAFDGLASLVELNLAHNNLSS-LPHDLFTPLRYLVELHLHHN 300

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 96.0 bits (239), Expect = 7e-21
 Identities = 62/291 (21%), Positives = 98/291 (33%), Gaps = 46/291 (15%)

Query: 66  TCDQDSRVVSLNVSFMPLFGSIPPEIGLLTKLVNLTISNVNLTGRLPSEMALLTSLKVFN 125
           +C      V            +P   G+ +    L +   N+          L  L+V  
Sbjct: 51  SCSNQFSKVVCTRRG---LSEVPQ--GIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQ 105

Query: 126 ISGN----VFQGNFAGQIVRGMTELQVLDAYNNNFTGPLPVEI-ASLKSLRHLSFGGNYF 180
           +  N    +  G F      G+  L  L+ ++N  T  +P      L  LR L    N  
Sbjct: 106 LGRNSIRQIEVGAF-----NGLASLNTLELFDNWLTV-IPSGAFEYLSKLRELWLRNN-- 157

Query: 181 TGKIPQSYSEIQSLEYIGLNGIGLNGTVPAFLSRLKNLREMYIGYFNTYTGGIPPG-FGA 239
                     I+S+                  +R+ +L  + +G        I  G F  
Sbjct: 158 ---------PIESIP-------------SYAFNRVPSLMRLDLGELKKLEY-ISEGAFEG 194

Query: 240 LTQLQVLDMASCNISGEIPTSLSRLKLLHSLFLQMNKLTGHIPPQ-LSGLISLKSLDLSL 298
           L  L+ L++  CNI  ++P  L+ L  L  L +  N     I P    GL SLK L +  
Sbjct: 195 LFNLKYLNLGMCNIK-DMPN-LTPLVGLEELEMSGNHFP-EIRPGSFHGLSSLKKLWVMN 251

Query: 299 NYLTGEIPESFAALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNF 349
           + ++     +F  L +L  L L  NNL             L  L +  N +
Sbjct: 252 SQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPW 302

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 88.7 bits (220), Expect = 2e-18
 Identities = 60/327 (18%), Positives = 110/327 (33%), Gaps = 85/327 (25%)

Query: 267 LHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQLFKNNLR 326
              +      L+  +P  +    + + L+L  N +     ++F  L +L +LQL +N++R
Sbjct: 56  FSKVVCTRRGLS-EVPQGIPS--NTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIR 112

Query: 327 GPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDLCKG-G 385
             I    G F  L                       L  L++  N LT  IP    +   
Sbjct: 113 Q-IEV--GAFNGL---------------------ASLNTLELFDNWLT-VIPSGAFEYLS 147

Query: 386 KLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGTIPAGLF-NLPLLNMMELDDNL 444
           KL+ L L                          N +  +IP+  F  +P L  ++L +  
Sbjct: 148 KLRELWL------------------------RNNPIE-SIPSYAFNRVPSLMRLDLGEL- 181

Query: 445 LSGELPEKMSGASLNQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESF-NL 503
                                  +      A   L +L  L+L    ++    + +   L
Sbjct: 182 ---------------------KKLEYISEGAFEGLFNLKYLNLGMCNIKD---MPNLTPL 217

Query: 504 KMITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYGKIPPG-ISKLIDLSILNLSRN 562
             +  + +S N+     P S     SL  + +  + +   I       L  L  LNL+ N
Sbjct: 218 VGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQV-SLIERNAFDGLASLVELNLAHN 276

Query: 563 GITGSIPNEM-RNMMSLTTLDLSYNNL 588
            ++ S+P+++   +  L  L L +N  
Sbjct: 277 NLS-SLPHDLFTPLRYLVELHLHHNPW 302

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 96.6 bits (241), Expect = 5e-22
 Identities = 56/226 (24%), Positives = 93/226 (41%), Gaps = 24/226 (10%)

Query: 686 KAEDVLESLKDENIIGKGGAGIVYRGS-MPDGIDVAIK--------RLVGRGTGGNDHGF 736
                 E+ + + I+G+G + +V R    P   + A+K                      
Sbjct: 11  STHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREAT 70

Query: 737 LAEIQTLGRI-RHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYR 795
           L E+  L ++  H NI++L           L+++ M  G L + L   +   L  +   +
Sbjct: 71  LKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL--TEKVTLSEKETRK 128

Query: 796 IALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSS 855
           I     + +C LH      I+HRD+K  NILLD D    + DFG +  L      E +  
Sbjct: 129 IMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP---GEKLRE 182

Query: 856 VAGSYGYIAPE------YAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
           V G+  Y+APE              ++ D++S GV++  L+AG  P
Sbjct: 183 VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 99.4 bits (248), Expect = 6e-22
 Identities = 60/216 (27%), Positives = 95/216 (43%), Gaps = 14/216 (6%)

Query: 685 FKAEDVLESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGND-HGFLAEIQT 742
           +      E      ++GKG  G V +        + A+K +        D    L E++ 
Sbjct: 15  YFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVEL 74

Query: 743 LGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAK 802
           L ++ H NI++L   + +  +  ++ E    G L + +   K          RI  +   
Sbjct: 75  LKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEI--IKRKRFSEHDAARIIKQVFS 132

Query: 803 GLCYLHHDCSPLIIHRDVKSNNILLDS---DFEAHVADFGLAKFLQDAGASECMSSVAGS 859
           G+ Y+H      I+HRD+K  NILL+S   D +  + DFGL+   Q    +  M    G+
Sbjct: 133 GITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ---NTKMKDRIGT 186

Query: 860 YGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
             YIAPE       DEK DV+S GV+L  L++G  P
Sbjct: 187 AYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGTPP 221

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 97.0 bits (242), Expect = 7e-22
 Identities = 58/251 (23%), Positives = 97/251 (38%), Gaps = 34/251 (13%)

Query: 700 IGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYV 758
           +G+G  G V    +      VA+K +  +           EI     + H N+V+  G+ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74

Query: 759 SNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAK-------GLCYLHHDC 811
              +   L  EY   G L + +       +  E       +A +       G+ YLH   
Sbjct: 75  REGNIQYLFLEYCSGGELFDRI--EPDIGMP-EP------DAQRFFHQLMAGVVYLH--- 122

Query: 812 SPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTL 871
              I HRD+K  N+LLD      ++DFGLA   +       ++ + G+  Y+APE     
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182

Query: 872 KVD-EKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRK-TTSEVSQP------SDAA 923
           +   E  DV+S G+VL  ++AG+ P   +    D  +        +          S   
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELP---WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 239

Query: 924 SVLA---VVDP 931
           ++L    V +P
Sbjct: 240 ALLHKILVENP 250

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 95.8 bits (239), Expect = 7e-22
 Identities = 57/205 (27%), Positives = 91/205 (44%), Gaps = 20/205 (9%)

Query: 699 IIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGND-HGFLAEIQTLGRIRHRNIVRLLG 756
           ++GKG  G V +        + A+K +        D    L E++ L ++ H NI++L  
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88

Query: 757 YVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLII 816
            + +  +  ++ E    G L + +   K          RI  +   G+ Y+H      I+
Sbjct: 89  ILEDSSSFYIVGELYTGGELFDEI--IKRKRFSEHDAARIIKQVFSGITYMH---KHNIV 143

Query: 817 HRDVKSNNILLDSDFEAH---VADFGLAKFLQDAGASECMSSVAGSYGYIAPE---YAYT 870
           HRD+K  NILL+S  +     + DFGL+   Q    +  M    G+  YIAPE     Y 
Sbjct: 144 HRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ---NTKMKDRIGTAYYIAPEVLRGTYD 200

Query: 871 LKVDEKSDVYSFGVVLLELIAGKKP 895
            K     DV+S GV+L  L++G  P
Sbjct: 201 EKC----DVWSAGVILYILLSGTPP 221

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 96.1 bits (240), Expect = 8e-22
 Identities = 51/210 (24%), Positives = 88/210 (41%), Gaps = 22/210 (10%)

Query: 685 FKAEDVLESLKDENIIGKGGAGIVYRGS-MPDGIDVAIKRLVGRGTGGNDHGFLAEIQTL 743
            +  ++ ++     ++G G    V+       G   A+K  + +     D     EI  L
Sbjct: 2   MQTTNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALK-CIKKSPAFRDSSLENEIAVL 60

Query: 744 GRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKG 803
            +I+H NIV L     +     L+ + +  G L + +   + G    +    +  +    
Sbjct: 61  KKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRI--LERGVYTEKDASLVIQQVLSA 118

Query: 804 LCYLHHDCSPLIIHRDVKSNNILLDSDFEAH---VADFGLAKFLQDAGASECMSSVAGSY 860
           + YLH      I+HRD+K  N+L  +  E     + DFGL+K  Q+      MS+  G+ 
Sbjct: 119 VKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN----GIMSTACGTP 171

Query: 861 GYIAPE----YAYTLKVDEKSDVYSFGVVL 886
           GY+APE      Y+  V    D +S GV+ 
Sbjct: 172 GYVAPEVLAQKPYSKAV----DCWSIGVIT 197

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 96.6 bits (241), Expect = 8e-22
 Identities = 58/247 (23%), Positives = 104/247 (42%), Gaps = 30/247 (12%)

Query: 700 IGKGGAGIVYRGS-MPDGIDVAIK-----RLVGRGTGGNDHGFLAEIQTLGRIRHR--NI 751
           +G GG G VY G  + D + VAIK     R+   G   N      E+  L ++      +
Sbjct: 51  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110

Query: 752 VRLLGYVSNRDTNLLLYEYMPNGSLGEML-HGAKGGHLK-WETRYRIALEAAKGLCYLHH 809
           +RLL +    D+ +L+ E        ++     + G L+    R     +  + + + H 
Sbjct: 111 IRLLDWFERPDSFVLILERPEPV--QDLFDFITERGALQEELAR-SFFWQVLEAVRHCH- 166

Query: 810 DCSPLIIHRDVKSNNILLDSD-FEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYA 868
             +  ++HRD+K  NIL+D +  E  + DFG    L+D       +   G+  Y  PE+ 
Sbjct: 167 --NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD----TVYTDFDGTRVYSPPEWI 220

Query: 869 YTLKVD-EKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLA 927
              +     + V+S G++L +++ G  P   F    +I+R        VS  S+   ++ 
Sbjct: 221 RYHRYHGRSAAVWSLGILLYDMVCGDIP---FEHDEEIIRGQVFFRQRVS--SECQHLIR 275

Query: 928 ---VVDP 931
               + P
Sbjct: 276 WCLALRP 282

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 96.2 bits (240), Expect = 9e-22
 Identities = 55/207 (26%), Positives = 85/207 (41%), Gaps = 18/207 (8%)

Query: 700 IGKGGAGIVYRG-SMPDGIDVAIK---RLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLL 755
           +G+G  G V            A+K   +   R     +     EIQ L R+RH+N+++L 
Sbjct: 13  LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL- 71

Query: 756 GY-VSNRDTNLLLY---EYMPNGSLGEMLHGAKGGHLK-WETRYRIALEAAKGLCYLHHD 810
              V   +    +Y   EY   G + EML           +       +   GL YLH  
Sbjct: 72  -VDVLYNEEKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAH-GYFCQLIDGLEYLH-- 126

Query: 811 CSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYT 870
            S  I+H+D+K  N+LL +     ++  G+A+ L    A +   +  GS  +  PE A  
Sbjct: 127 -SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANG 185

Query: 871 LKVDE--KSDVYSFGVVLLELIAGKKP 895
           L      K D++S GV L  +  G  P
Sbjct: 186 LDTFSGFKVDIWSAGVTLYNITTGLYP 212

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 96.2 bits (240), Expect = 9e-22
 Identities = 60/254 (23%), Positives = 107/254 (42%), Gaps = 34/254 (13%)

Query: 700 IGKGGAGIVYRGS-MPDGIDVAIK-----RLVGRGTGGNDHGFLAEIQTLGRIR----HR 749
           +GKGG G V+ G  + D + VAIK     R++G     +      E+  L ++     H 
Sbjct: 39  LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98

Query: 750 NIVRLLGYVSNRDTNLLLYEYMPNGSLGEML-HGAKGGHLK-WETRYRIALEAAKGLCYL 807
            ++RLL +   ++  +L+ E        ++  +  + G L    +R     +    + + 
Sbjct: 99  GVIRLLDWFETQEGFMLVLERPLPA--QDLFDYITEKGPLGEGPSR-CFFGQVVAAIQHC 155

Query: 808 HHDCSPLIIHRDVKSNNILLDSD-FEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPE 866
           H   S  ++HRD+K  NIL+D     A + DFG    L D    E  +   G+  Y  PE
Sbjct: 156 H---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHD----EPYTDFDGTRVYSPPE 208

Query: 867 YAYTLKVD-EKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASV 925
           +    +     + V+S G++L +++ G  P   F    +I+       + VS   D  ++
Sbjct: 209 WISRHQYHALPATVWSLGILLYDMVCGDIP---FERDQEILEAELHFPAHVS--PDCCAL 263

Query: 926 LA---VVDP--RLS 934
           +       P  R S
Sbjct: 264 IRRCLAPKPSSRPS 277

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 95.3 bits (238), Expect = 1e-21
 Identities = 57/218 (26%), Positives = 96/218 (44%), Gaps = 21/218 (9%)

Query: 687 AEDVLESLKDENIIGKGGAGIVYRGS-MPDGIDVAIKRLVGRGTGGND-HGFLAEIQTLG 744
           +    ++   +  +GKG   +V R      G++ A K +  +     D      E +   
Sbjct: 1   STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60

Query: 745 RIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGL 804
           +++H NIVRL   +     + L+++ +  G L E +                  +  + +
Sbjct: 61  KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDI--VAREFYSEADASHCIQQILESI 118

Query: 805 CYLHHDCSPLIIHRDVKSNNILLDSDFE-AHV--ADFGLAKFLQDAGASECMSSVAGSYG 861
            Y H   S  I+HR++K  N+LL S  + A V  ADFGLA  + D   SE     AG+ G
Sbjct: 119 AYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND---SEAWHGFAGTPG 172

Query: 862 YIAPE----YAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
           Y++PE      Y+  V    D+++ GV+L  L+ G  P
Sbjct: 173 YLSPEVLKKDPYSKPV----DIWACGVILYILLVGYPP 206

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 97.5 bits (243), Expect = 2e-21
 Identities = 63/291 (21%), Positives = 107/291 (36%), Gaps = 46/291 (15%)

Query: 66  TCDQDSRVVSLNVSFMPLFGSIPPEIGLLTKLVNLTISNVNLTGRLPSEMALLTSLKVFN 125
           +C      V            +P   G+ T    L +    +     +    L  L++  
Sbjct: 40  SCSNQFSKVICVRKN---LREVPD--GISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQ 94

Query: 126 ISGN----VFQGNFAGQIVRGMTELQVLDAYNNNFTGPLPVEI-ASLKSLRHLSFGGNYF 180
           +S N    +  G F G     +  L  L+ ++N  T  +P      L  L+ L    N  
Sbjct: 95  LSRNHIRTIEIGAFNG-----LANLNTLELFDNRLTT-IPNGAFVYLSKLKELWLRNN-- 146

Query: 181 TGKIPQSYSEIQSLEYIGLNGIGLNGTVPAFLSRLKNLREMYIGYFNTYTGGIPPG-FGA 239
                     I+S+                  +R+ +LR + +G     +  I  G F  
Sbjct: 147 ---------PIESIP-------------SYAFNRIPSLRRLDLGELKRLSY-ISEGAFEG 183

Query: 240 LTQLQVLDMASCNISGEIPTSLSRLKLLHSLFLQMNKLTGHIPPQ-LSGLISLKSLDLSL 298
           L+ L+ L++A CN+  EIP  L+ L  L  L L  N L+  I P    GL+ L+ L +  
Sbjct: 184 LSNLRYLNLAMCNLR-EIPN-LTPLIKLDELDLSGNHLS-AIRPGSFQGLMHLQKLWMIQ 240

Query: 299 NYLTGEIPESFAALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNF 349
           + +      +F  L++L  + L  NNL            +LE + +  N +
Sbjct: 241 SQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPW 291

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 97.1 bits (242), Expect = 2e-21
 Identities = 66/264 (25%), Positives = 101/264 (38%), Gaps = 36/264 (13%)

Query: 256 EIPTSLSRLKLLHSLFLQMNKLTGHIPP-QLSGLISLKSLDLSLNYLTGEIPESFAALKN 314
           E+P  +S       L L  N++   I       L  L+ L LS N++      +F  L N
Sbjct: 57  EVPDGISTN--TRLLNLHENQIQ-IIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLAN 113

Query: 315 LTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLT 374
           L  L+LF N L   IP+  G F  L  L+                      L + +N + 
Sbjct: 114 LNTLELFDNRLTT-IPN--GAFVYLSKLKE---------------------LWLRNNPIE 149

Query: 375 GTIPRDLCKG-GKLKSLILMQNFFIGPIPEE-LGQCKSLTKIRFSKNYLNGTIPAGLFNL 432
            +IP         L+ L L +   +  I E       +L  +  +   L   IP  L  L
Sbjct: 150 -SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIPN-LTPL 206

Query: 433 PLLNMMELDDNLLSGELPEKMSG-ASLNQLKVANNNITGKIPAAIGNLPSLNILSLQNNR 491
             L+ ++L  N LS   P    G   L +L +  + I      A  NL SL  ++L +N 
Sbjct: 207 IKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNN 266

Query: 492 LEGEIPVESF-NLKMITSINISDN 514
           L   +P + F  L  +  I++  N
Sbjct: 267 LT-LLPHDLFTPLHHLERIHLHHN 289

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 94.4 bits (235), Expect = 2e-20
 Identities = 53/231 (22%), Positives = 90/231 (38%), Gaps = 8/231 (3%)

Query: 144 TELQVLDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLNGIG 203
           T  ++L+ + N            L+ L  L    N+       +++ + +L  + L    
Sbjct: 64  TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNR 123

Query: 204 LNGTVPAFLSRLKNLREMYIGYFNTYTGGIPPG-FGALTQLQVLDMASCNISGEIPT-SL 261
           L          L  L+E+++   N     IP   F  +  L+ LD+        I   + 
Sbjct: 124 LTTIPNGAFVYLSKLKELWLRN-NPIES-IPSYAFNRIPSLRRLDLGELKRLSYISEGAF 181

Query: 262 SRLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQLF 321
             L  L  L L M  L   IP  L+ LI L  LDLS N+L+   P SF  L +L  L + 
Sbjct: 182 EGLSNLRYLNLAMCNLR-EIPN-LTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMI 239

Query: 322 KNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPEN-LGRNGKLLILDVTSN 371
           ++ ++    +   +  +L  + +  NN T  LP +       L  + +  N
Sbjct: 240 QSQIQVIERNAFDNLQSLVEINLAHNNLTL-LPHDLFTPLHHLERIHLHHN 289

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 86.7 bits (215), Expect = 5e-18
 Identities = 63/326 (19%), Positives = 114/326 (34%), Gaps = 83/326 (25%)

Query: 267 LHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQLFKNNLR 326
              +      L   +P  +S   + + L+L  N +      SF  L++L +LQL +N++R
Sbjct: 45  FSKVICVRKNLR-EVPDGIST--NTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIR 101

Query: 327 GPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDLCKGGK 386
             I    G F  L                       L  L++  N LT TIP        
Sbjct: 102 T-IEI--GAFNGLA---------------------NLNTLELFDNRLT-TIPNGA----- 131

Query: 387 LKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGTIPAGLF-NLPLLNMMELDDNLL 445
                     F+            L ++    N +  +IP+  F  +P L  ++L +   
Sbjct: 132 ----------FVYL--------SKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGEL-- 170

Query: 446 SGELPEKMSGASLNQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESF-NLK 504
                                 ++     A   L +L  L+L    L  EIP  +   L 
Sbjct: 171 --------------------KRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP--NLTPLI 207

Query: 505 MITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYGKIPPG-ISKLIDLSILNLSRNG 563
            +  +++S N++S   P S      L  + + ++ +   I       L  L  +NL+ N 
Sbjct: 208 KLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQI-QVIERNAFDNLQSLVEINLAHNN 266

Query: 564 ITGSIPNEM-RNMMSLTTLDLSYNNL 588
           +T  +P+++   +  L  + L +N  
Sbjct: 267 LT-LLPHDLFTPLHHLERIHLHHNPW 291

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 86.0 bits (213), Expect = 1e-17
 Identities = 47/214 (21%), Positives = 92/214 (42%), Gaps = 24/214 (11%)

Query: 410 SLTKIRFSKNYLNGTIPAGLF-NLPLLNMMELDDNLLSGELPEKM-SG-ASLNQLKVANN 466
           +   +   +N +   I    F +L  L +++L  N +   +     +G A+LN L++ +N
Sbjct: 65  NTRLLNLHENQIQ-IIKVNSFKHLRHLEILQLSRNHIR-TIEIGAFNGLANLNTLELFDN 122

Query: 467 NITGKIPA-AIGNLPSLNILSLQNNRLEGEIPVESF-NLKMITSINISDNNISGEIP-YS 523
            +T  IP  A   L  L  L L+NN +E  IP  +F  +  +  +++ +      I   +
Sbjct: 123 RLT-TIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYISEGA 180

Query: 524 ISQCHSLTSVDLSRNSLYGKIPPGISKLIDLSILNLSRNGITGSIPNEM-RNMMSLTTLD 582
                +L  ++L+  +L  +  P ++ LI L  L+LS N ++ +I     + +M L  L 
Sbjct: 181 FEGLSNLRYLNLAMCNL--REIPNLTPLIKLDELDLSGNHLS-AIRPGSFQGLMHLQKLW 237

Query: 583 LSYNNLIGNIPSGGQFLAFNETSFIGNPNLCLLR 616
           +  +  I  I            +F    +L  + 
Sbjct: 238 MIQSQ-IQVIERN---------AFDNLQSLVEIN 261

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 96.2 bits (240), Expect = 2e-21
 Identities = 55/212 (25%), Positives = 99/212 (46%), Gaps = 25/212 (11%)

Query: 686 KAEDVLESLKDENIIGKGGAGIVYRGS-MPDGIDVAIKRLVGRGTGGNDH-GFLAEIQTL 743
            +    ++   +  +GKG   +V R      G++ A K +  +     D      E +  
Sbjct: 23  ASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARIC 82

Query: 744 GRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRY--RIALEAA 801
            +++H NIVRL   +     + L+++ +  G L E +  A+  + + +  +  +  LE+ 
Sbjct: 83  RKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV-AREFYSEADASHCIQQILES- 140

Query: 802 KGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAH---VADFGLAKFLQDAGASECMSSVAG 858
             + Y H   S  I+HR++K  N+LL S  +     +ADFGLA  + D   SE     AG
Sbjct: 141 --IAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND---SEAWHGFAG 192

Query: 859 SYGYIAPE----YAYTLKVDEKSDVYSFGVVL 886
           + GY++PE      Y+  V    D+++ GV+L
Sbjct: 193 TPGYLSPEVLKKDPYSKPV----DIWACGVIL 220

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 94.2 bits (234), Expect = 5e-21
 Identities = 58/283 (20%), Positives = 95/283 (33%), Gaps = 30/283 (10%)

Query: 324 NLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDLCK 383
           N   P P +   F  L            EL    GR+ + L+  V +    G    D+ K
Sbjct: 16  NFSDPKPDWSSAFNCL-------GAADVELYGG-GRSLEYLLKRVDTEADLGQFT-DIIK 66

Query: 384 GGKLKSLILMQNFFIGPIPEELGQCKSLTKIR---FSKNYLNGTIPAGLFNLPLLNMMEL 440
              LK L +        I     +   ++ ++        + GT P  L      ++  L
Sbjct: 67  SLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNIL 126

Query: 441 D--DNLLSGELPE-----KMSGASLNQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLE 493
           +  +   +          +     L  L +A  +        +   P+L+ L L +N   
Sbjct: 127 NLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPEL 186

Query: 494 GEIPVES----FNLKMITSINISDNN---ISGEIPYSISQCHSLTSVDLSRNSLYGKIPP 546
           GE  + S         +  + + +      SG      +    L  +DLS NSL      
Sbjct: 187 GERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGA 246

Query: 547 GI-SKLIDLSILNLSRNGITGSIPNEMRNMMSLTTLDLSYNNL 588
                   L+ LNLS  G+   +P  +     L+ LDLSYN L
Sbjct: 247 PSCDWPSQLNSLNLSFTGLK-QVPKGLPA--KLSVLDLSYNRL 286

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 88.4 bits (219), Expect = 4e-19
 Identities = 59/329 (17%), Positives = 93/329 (28%), Gaps = 44/329 (13%)

Query: 59  HCSFSGVTCDQDSRVVSLNVSFMPLFGSIPPEIGLLTKLVNLTISNVNLTGRLPSEMALL 118
            C+FS    D  S    L  + + L+G      G  +    L   +        +++   
Sbjct: 14  SCNFSDPKPDWSSAFNCLGAADVELYG------GGRSLEYLLKRVDTEADLGQFTDIIKS 67

Query: 119 TSLKVFNISGNVFQGNFAGQIVR--GMTELQVLDAYNNNFTGPLPVEIASL--KSLRHLS 174
            SLK   +             +R  G++ LQ L   N   TG  P  +       L  L+
Sbjct: 68  LSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILN 127

Query: 175 FGGNYFTGKIPQSYSEIQSLEYIGLNGIGLNGTVPAFLSRLKNLREMYIGYFNTYTGGIP 234
                +        +E+Q     GL  + +                              
Sbjct: 128 LRNVSWAT-RDAWLAELQQWLKPGLKVLSIAQ--------------------AHSLNFSC 166

Query: 235 PGFGALTQLQVLDMASCNISGEI-------PTSLSRLKLLHSLFLQMNKLTGHIPPQLSG 287
                   L  LD++     GE        P     L++L      M   +G      + 
Sbjct: 167 EQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAA 226

Query: 288 LISLKSLDLSLNYLTGEIPE-SFAALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWG 346
            + L+ LDLS N L       S      L  L L    L+  +P  L     L VL +  
Sbjct: 227 RVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQ-VPKGL--PAKLSVLDLSY 283

Query: 347 NNFTFELPENLGRNGKLLILDVTSNHLTG 375
           N      P       ++  L +  N    
Sbjct: 284 NRLD-RNPSPDE-LPQVGNLSLKGNPFLD 310

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 88.0 bits (218), Expect = 5e-19
 Identities = 69/350 (19%), Positives = 113/350 (32%), Gaps = 56/350 (16%)

Query: 234 PPGFGALTQLQVLDMASCNISGEIPTSLSRLKLLHSLFLQMNKLTGHIPPQLSGLISLKS 293
            P    L +    +  SCN S   P   S    L +  +++            G  SL+ 
Sbjct: 2   DPEPCELDE----ESCSCNFSDPKPDWSSAFNCLGAADVEL----------YGGGRSLEY 47

Query: 294 LDLSLNYLTGEIPESFAALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFEL 353
           L   ++            +K+L+L +L     R P     G    L +            
Sbjct: 48  LLKRVDTEADLGQ-FTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISG---------- 96

Query: 354 PENLGRNGKLLILDVTSNHLTGTIPRDL--CKGGKLKSLILMQNFFIGPIPEELGQC--- 408
                    L  L + +  +TGT P  L    G  L  L L +N         L +    
Sbjct: 97  ---------LQELTLENLEVTGTAPPPLLEATGPDLNILNL-RNVSWATRDAWLAELQQW 146

Query: 409 --KSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLSGELPEKMSGA-----SLNQL 461
               L  +  ++ +        +   P L+ ++L DN   GE     +       +L  L
Sbjct: 147 LKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVL 206

Query: 462 KVANNNIT---GKIPAAIGNLPSLNILSLQNNRLEGEIPVESF-NLKMITSINISDNNIS 517
            + N  +    G   A       L  L L +N L       S      + S+N+S   + 
Sbjct: 207 ALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK 266

Query: 518 GEIPYSISQCHSLTSVDLSRNSLYGKIPPGISKLIDLSILNLSRNGITGS 567
            ++P  +     L+ +DLS N L     P   +L  +  L+L  N    S
Sbjct: 267 -QVPKGLPA--KLSVLDLSYNRLDRN--PSPDELPQVGNLSLKGNPFLDS 311

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 76.1 bits (187), Expect = 5e-15
 Identities = 32/168 (19%), Positives = 63/168 (37%), Gaps = 13/168 (7%)

Query: 443 NLLSGELPEKMSGASLNQLKVANNNITGKIPAAIGNL--PSLNILSLQNNRLEGEIP--- 497
           + +       +  + L +L + N  +TG  P  +     P LNIL+L+N           
Sbjct: 82  SRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLA 141

Query: 498 -VESFNLKMITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYGKI-------PPGIS 549
            ++ +    +  ++I+  +        +    +L+++DLS N   G+        P    
Sbjct: 142 ELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFP 201

Query: 550 KLIDLSILNLSRNGITGSIPNEMRNMMSLTTLDLSYNNLIGNIPSGGQ 597
            L  L++ N      +G         + L  LDLS+N+L     +   
Sbjct: 202 TLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSC 249

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 94.3 bits (235), Expect = 9e-21
 Identities = 56/219 (25%), Positives = 87/219 (39%), Gaps = 39/219 (17%)

Query: 699 IIGKGGAGIVYRGS-MPDGIDVAIK----RLVGRGTGGNDHGFLAEIQTLGRIRHRNIVR 753
           +IGKG   +V R      G   A+K           G +      E      ++H +IV 
Sbjct: 31  VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90

Query: 754 LLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRY---------RIALEAAKGL 804
           LL   S+     +++E+M    L   +   +         Y         R  LEA   L
Sbjct: 91  LLETYSSDGMLYMVFEFMDGADLCFEIV-KRA---DAGFVYSEAVASHYMRQILEA---L 143

Query: 805 CYLH-HDCSPLIIHRDVKSNNILLDSDFEAH---VADFGLAKFLQDAGASECMSSVAGSY 860
            Y H ++    IIHRDVK + +LL S   +    +  FG+A  L ++G         G+ 
Sbjct: 144 RYCHDNN----IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESG--LVAGGRVGTP 197

Query: 861 GYIAPE----YAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
            ++APE      Y     +  DV+  GV+L  L++G  P
Sbjct: 198 HFMAPEVVKREPY----GKPVDVWGCGVILFILLSGCLP 232

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 95.1 bits (237), Expect = 1e-20
 Identities = 53/219 (24%), Positives = 91/219 (41%), Gaps = 38/219 (17%)

Query: 686 KAEDVLESLKDENIIGKGGAGIVYRGS-MPDGIDVAIKRLVGRGTGGNDH-GFLAEIQTL 743
                 E  +    +GKG   +V R   +  G + A   +  +     DH     E +  
Sbjct: 5   TCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARIC 64

Query: 744 GRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRY--------- 794
             ++H NIVRL   +S    + L+++ +  G L E +  A+         Y         
Sbjct: 65  RLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIV-ARE-------YYSEADASHCI 116

Query: 795 RIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAH---VADFGLAKFLQDAGASE 851
           +  LEA   + + H      ++HR++K  N+LL S  +     +ADFGLA  ++     +
Sbjct: 117 QQILEA---VLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ--Q 168

Query: 852 CMSSVAGSYGYIAPE----YAYTLKVDEKSDVYSFGVVL 886
                AG+ GY++PE      Y   V    D+++ GV+L
Sbjct: 169 AWFGFAGTPGYLSPEVLRKDPYGKPV----DLWACGVIL 203

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 92.3 bits (230), Expect = 1e-20
 Identities = 53/220 (24%), Positives = 84/220 (38%), Gaps = 24/220 (10%)

Query: 685 FKAEDVLESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTL 743
               D+ +    EN IG+G  G V         I  A K++        D  F  EI+ +
Sbjct: 2   STKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDR-FKQEIEIM 60

Query: 744 GRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKG 803
             + H NI+RL     +     L+ E    G L E +        +     RI  +    
Sbjct: 61  KSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERV--VHKRVFRESDAARIMKDVLSA 118

Query: 804 LCYLHHDCSPLIIHRDVKSNNILLDS---DFEAHVADFGLAKFLQDAGASECMSSVAGSY 860
           + Y H      + HRD+K  N L  +   D    + DFGLA   +     + M +  G+ 
Sbjct: 119 VAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP---GKMMRTKVGTP 172

Query: 861 GYIAPE-----YAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
            Y++P+     Y        + D +S GV++  L+ G  P
Sbjct: 173 YYVSPQVLEGLY------GPECDEWSAGVMMYVLLCGYPP 206

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 95.0 bits (237), Expect = 1e-20
 Identities = 82/427 (19%), Positives = 138/427 (32%), Gaps = 73/427 (17%)

Query: 216 KNLREMYIGYFNTYTGGIPPGFGALTQLQVLDMASCNISGE----IPTSLSRLKLLHSLF 271
            +++ + I                L Q QV+ +  C ++      I ++L     L  L 
Sbjct: 3   LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62

Query: 272 LQMNKLTG----HIPPQL-SGLISLKSLDLSLNYLTGE----IPESFAALKNLTLLQLFK 322
           L+ N+L       +   L +    ++ L L    LTG     +  +   L  L  L L  
Sbjct: 63  LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSD 122

Query: 323 NNLRGPIPSFLGDF-----PNLEVLQVWGNNFTFE----LPENLGRNGKLLILDVTSNHL 373
           N L       L +        LE LQ+   + +      L   L        L V++N +
Sbjct: 123 NLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDI 182

Query: 374 TGTIPRDLCKG-----GKLKSLILMQNFFIGP-----IPEELGQCKSLTKIRFSKNYLNG 423
                R LC+G      +L++L L     +       +   +    SL ++    N L  
Sbjct: 183 NEAGVRVLCQGLKDSPCQLEALKLESCG-VTSDNCRDLCGIVASKASLRELALGSNKLGD 241

Query: 424 TIPAGLFNLPLLNMMELDDNLLSGELPEKMSGASLNQLKVANNNITGK----IPAAIGNL 479
                        M EL   LL          + L  L +    IT K    +   +   
Sbjct: 242 V-----------GMAELCPGLLH-------PSSRLRTLWIWECGITAKGCGDLCRVLRAK 283

Query: 480 PSLNILSLQNNRLEGE-----IPVESFNLKMITSINISDNNISGE----IPYSISQCHSL 530
            SL  LSL  N L  E               + S+ +   + +          ++Q   L
Sbjct: 284 ESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFL 343

Query: 531 TSVDLSRNSLYGKIPPGISKLID-----LSILNLSRNGIT----GSIPNEMRNMMSLTTL 581
             + +S N L       + + +      L +L L+   ++     S+   +    SL  L
Sbjct: 344 LELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLREL 403

Query: 582 DLSYNNL 588
           DLS N L
Sbjct: 404 DLSNNCL 410

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 86.2 bits (214), Expect = 1e-17
 Identities = 88/505 (17%), Positives = 157/505 (31%), Gaps = 125/505 (24%)

Query: 119 TSLKVFNISGNVFQGNFAGQIVRGMTELQVLDAYNNNFT----GPLPVEIASLKSLRHLS 174
             ++  +I           +++  + + QV+   +   T      +   +    +L  L+
Sbjct: 3   LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62

Query: 175 FGGNYFTGKIPQSYSEIQSLEYIGLNGIGLNGTVPAFLSRLKNLREMYIGYFNTYTGGIP 234
                                    N +G  G V   L  L+                  
Sbjct: 63  LRS----------------------NELGDVG-VHCVLQGLQTPS--------------- 84

Query: 235 PGFGALTQLQVLDMASCNISGE----IPTSLSRLKLLHSLFLQMNKLTGHIPPQLSGLI- 289
                  ++Q L + +C ++G     + ++L  L  L  L L  N L       L   + 
Sbjct: 85  ------CKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLL 138

Query: 290 ----SLKSLDLSLNYLTGEIPESFAAL----KNLTLLQLFKNNLRGPIPSFLGDF----- 336
                L+ L L    L+    E  A++     +   L +  N++       L        
Sbjct: 139 DPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSP 198

Query: 337 PNLEVLQVWGNNFTFE----LPENLGRNGKLLILDVTSNHLTGTIPRDLCKGGK-----L 387
             LE L++     T +    L   +     L  L + SN L      +LC G       L
Sbjct: 199 CQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRL 258

Query: 388 KSLILMQNFFIGP-----IPEELGQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDD 442
           ++L + +   I       +   L   +SL ++  + N L      G              
Sbjct: 259 RTLWIWEC-GITAKGCGDLCRVLRAKESLKELSLAGNELG---DEGA------------- 301

Query: 443 NLLSGELPEKMSGASLNQLKVANNNITGK----IPAAIGNLPSLNILSLQNNRLEGEIPV 498
            LL   L E      L  L V + + T        + +     L  L + NNRLE    V
Sbjct: 302 RLLCETLLEPGC--QLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAG-V 358

Query: 499 ESF------NLKMITSINISDNNISGE----IPYSISQCHSLTSVDLSRNSLYGKIPPGI 548
                       ++  + ++D ++S      +  ++   HSL  +DLS N L G    GI
Sbjct: 359 RELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCL-G--DAGI 415

Query: 549 SKLID--------LSILNLSRNGIT 565
            +L++        L  L L     +
Sbjct: 416 LQLVESVRQPGCLLEQLVLYDIYWS 440

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 93.1 bits (232), Expect = 1e-20
 Identities = 56/204 (27%), Positives = 87/204 (42%), Gaps = 21/204 (10%)

Query: 700 IGKGGAGIVYRGS-MPDGIDVAIKRLVGRGTGGNDHGFLA-EIQTLGRIRHRNIVRLLGY 757
           IGKG    V     +  G +VAIK +            L  E++ +  + H NIV+L   
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82

Query: 758 VSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIH 817
           +    T  L+ EY   G + + L     G +K +       +    + Y H      I+H
Sbjct: 83  IETEKTLYLIMEYASGGEVFDYL--VAHGRMKEKEARSKFRQIVSAVQYCHQKR---IVH 137

Query: 818 RDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPE------YAYTL 871
           RD+K+ N+LLD+D    +ADFG +           + +  G+  Y APE      Y    
Sbjct: 138 RDLKAENLLLDADMNIKIADFGFSNEFTV---GGKLDAFCGAPPYAAPELFQGKKYD--- 191

Query: 872 KVDEKSDVYSFGVVLLELIAGKKP 895
               + DV+S GV+L  L++G  P
Sbjct: 192 --GPEVDVWSLGVILYTLVSGSLP 213

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 93.5 bits (233), Expect = 1e-20
 Identities = 66/247 (26%), Positives = 105/247 (42%), Gaps = 53/247 (21%)

Query: 676 KLTAFQRLDFKAEDVLESLKDENIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDH 734
            L A    D ++   ++  + E + G+G  G V  G     G+ VAIK+++       D 
Sbjct: 7   SLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVI------QDP 60

Query: 735 GF----LAEIQTLGRIRHRNIVRLL------GYVSNRDTNL-LLYEYMPNGSLGEMLHGA 783
            F    L  +Q L  + H NIV+L       G    RD  L ++ EY+P     + LH  
Sbjct: 61  RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP-----DTLHR- 114

Query: 784 KGGHLKWETRYRIALEAA----------KGLCYLHHDCSPLIIHRDVKSNNILLD-SDFE 832
                +   R ++A              + +  LH   S  + HRD+K +N+L++ +D  
Sbjct: 115 ---CCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLP-SVNVCHRDIKPHNVLVNEADGT 170

Query: 833 AHVADFGLAKFLQDAGASECMSS-VAGSYGYIAPE-----YAYTLKVDEKSDVYSFGVVL 886
             + DFG AK L     SE   + +   Y Y APE       YT  V    D++S G + 
Sbjct: 171 LKLCDFGSAKKL---SPSEPNVAYICSRY-YRAPELIFGNQHYTTAV----DIWSVGCIF 222

Query: 887 LELIAGK 893
            E++ G+
Sbjct: 223 AEMMLGE 229

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 93.6 bits (233), Expect = 2e-20
 Identities = 55/232 (23%), Positives = 99/232 (42%), Gaps = 37/232 (15%)

Query: 686 KAEDVLESLKDENIIGKGGAGIVYRGS-MPDGIDVAIK-------RLVGRGTGGNDHGFL 737
            A++  +    +++IG+G + +V R      G + A+K       RL             
Sbjct: 88  AAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATR 147

Query: 738 AEIQTLGRIR-HRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRI 796
            E   L ++  H +I+ L+    +     L+++ M  G L + L   +   L  E     
Sbjct: 148 RETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYL--TEKVALS-EK---- 200

Query: 797 ALEAAK-------GLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGA 849
             E           + +LH   +  I+HRD+K  NILLD + +  ++DFG +  L+    
Sbjct: 201 --ETRSIMRSLLEAVSFLH---ANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEP--- 252

Query: 850 SECMSSVAGSYGYIAPE------YAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
            E +  + G+ GY+APE              ++ D+++ GV+L  L+AG  P
Sbjct: 253 GEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP 304

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 91.9 bits (229), Expect = 2e-20
 Identities = 57/232 (24%), Positives = 91/232 (39%), Gaps = 49/232 (21%)

Query: 700 IGKGGAGIVYRG-SMPDGIDVAIK---------------------RLVGRGTGGNDHGFL 737
           IGKG  G+V    +  D    A+K                          G      G +
Sbjct: 21  IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80

Query: 738 A----EIQTLGRIRHRNIVRLLGY-VSNRDTNLLLY---EYMPNGSLGEMLHGAKGGHLK 789
                EI  L ++ H N+V+L    V +      LY   E +  G    ++       L 
Sbjct: 81  EQVYQEIAILKKLDHPNVVKL--VEVLDDPNEDHLYMVFELVNQG---PVMEVPTLKPLS 135

Query: 790 WETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGA 849
            +       +  KG+ YLH      IIHRD+K +N+L+  D    +ADFG++   + + A
Sbjct: 136 EDQARFYFQDLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA 192

Query: 850 SECMSSVAGSYGYIAPEYAYTLKVDEK------SDVYSFGVVLLELIAGKKP 895
              +S+  G+  ++APE   +L    K       DV++ GV L   + G+ P
Sbjct: 193 L--LSNTVGTPAFMAPE---SLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 92.1 bits (229), Expect = 2e-20
 Identities = 57/302 (18%), Positives = 109/302 (36%), Gaps = 43/302 (14%)

Query: 239 ALTQLQVLDMASCNISGEIPTSLSRLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSL 298
           AL     +     N++  +    + L  + +L      +T  I   +  L +L  L+L  
Sbjct: 17  ALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLELKD 72

Query: 299 NYLTGEIPESFAALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLG 358
           N +T         L  +T L+L  N L+      +    +++ L +     T      L 
Sbjct: 73  NQITD--LAPLKNLTKITELELSGNPLKNVSA--IAGLQSIKTLDLTSTQITD--VTPLA 126

Query: 359 RNGKLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSK 418
               L +L +  N +T   P                          L    +L  +    
Sbjct: 127 GLSNLQVLYLDLNQITNISP--------------------------LAGLTNLQYLSIGN 160

Query: 419 NYLNGTIPAGLFNLPLLNMMELDDNLLSGELPEKMSGASLNQLKVANNNITGKIPAAIGN 478
             ++   P  L NL  L  ++ DDN +S ++    S  +L ++ + NN I+   P  + N
Sbjct: 161 AQVSDLTP--LANLSKLTTLKADDNKIS-DISPLASLPNLIEVHLKNNQISDVSP--LAN 215

Query: 479 LPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIPYSISQCHSLTSVDLSRN 538
             +L I++L N  +  +    + NL +     +   + +   P +IS   +  S +L+ N
Sbjct: 216 TSNLFIVTLTNQTITNQPVFYNNNLVV--PNVVKGPSGAPIAPATISDNGTYASPNLTWN 273

Query: 539 SL 540
             
Sbjct: 274 LT 275

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 87.8 bits (218), Expect = 6e-19
 Identities = 55/280 (19%), Positives = 105/280 (37%), Gaps = 41/280 (14%)

Query: 310 AALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVT 369
            AL N   +   K+N+   +     D   +  L  +G   T  + E +     L+ L++ 
Sbjct: 16  PALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TI-EGVQYLNNLIGLELK 71

Query: 370 SNHLTGTIPRDLCKGGKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGTIPAGL 429
            N +T     DL                       L     +T++  S N L     + +
Sbjct: 72  DNQIT-----DL---------------------APLKNLTKITELELSGNPL--KNVSAI 103

Query: 430 FNLPLLNMMELDDNLLSGELPEKMSGASLNQLKVANNNITGKIPAAIGNLPSLNILSLQN 489
             L  +  ++L    ++ ++      ++L  L +  N IT  I   +  L +L  LS+ N
Sbjct: 104 AGLQSIKTLDLTSTQIT-DVTPLAGLSNLQVLYLDLNQIT-NISP-LAGLTNLQYLSIGN 160

Query: 490 NRLEGEIPVESFNLKMITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYGKIPPGIS 549
            ++    P+   NL  +T++   DN IS +I   ++   +L  V L  N +   + P ++
Sbjct: 161 AQVSDLTPLA--NLSKLTTLKADDNKIS-DIS-PLASLPNLIEVHLKNNQI-SDVSP-LA 214

Query: 550 KLIDLSILNLSRNGITGSIPNEMRNMMSLTTLDLSYNNLI 589
              +L I+ L+   IT        N++    +       I
Sbjct: 215 NTSNLFIVTLTNQTITNQPVFYNNNLVVPNVVKGPSGAPI 254

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 82.8 bits (205), Expect = 3e-17
 Identities = 60/291 (20%), Positives = 105/291 (36%), Gaps = 25/291 (8%)

Query: 189 SEIQSLEYIGLNGIGLNGTVPAFLSRLKNLREMYIGYFNTYTGGIPPGFGALTQLQVLDM 248
             + +   I      +  TV    + L  +  +        T     G   L  L  L++
Sbjct: 16  PALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTT---IEGVQYLNNLIGLEL 70

Query: 249 ASCNISGEIPTSLSRLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPES 308
               I+ ++   L  L  +  L L  N L  ++   ++GL S+K+LDL+   +T      
Sbjct: 71  KDNQIT-DLA-PLKNLTKITELELSGNPLK-NVSA-IAGLQSIKTLDLTSTQITD--VTP 124

Query: 309 FAALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDV 368
            A L NL +L L  N +    P  L    NL+ L +     + +L   L    KL  L  
Sbjct: 125 LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVS-DL-TPLANLSKLTTLKA 180

Query: 369 TSNHLTGTIPRDLCKGGKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGTIPAG 428
             N ++  I   L     L  + L  N  I  +   L    +L  +  +   +       
Sbjct: 181 DDNKIS-DIS-PLASLPNLIEVHLKNN-QISDV-SPLANTSNLFIVTLTNQTITNQPVFY 236

Query: 429 LFNLPLLNMMELDDNLLSGELPEKMSGASLNQLKVANNNITGKIPAAIGNL 479
             NL + N+++          P  +S    +    A+ N+T  + + I N+
Sbjct: 237 NNNLVVPNVVKGPSGAPI--APATIS----DNGTYASPNLTWNLTSFINNV 281

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 77.4 bits (191), Expect = 2e-15
 Identities = 47/237 (19%), Positives = 93/237 (39%), Gaps = 20/237 (8%)

Query: 142 GMTELQVLDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLNG 201
            +  +  L A+    T      +  L +L  L    N  T  +      +  +  + L+G
Sbjct: 39  DLDGITTLSAFGTGVTTIEG--VQYLNNLIGLELKDNQIT-DLA-PLKNLTKITELELSG 94

Query: 202 IGLNGTVPAFLSRLKNLREMYIGYFNTYTGGIPPGFGALTQLQVLDMASCNISGEIPTSL 261
             L       ++ L++++ + +   +T    + P    L+ LQVL +    I+  I   L
Sbjct: 95  NPLKNVSA--IAGLQSIKTLDLT--STQITDVTP-LAGLSNLQVLYLDLNQIT-NIS-PL 147

Query: 262 SRLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQLF 321
           + L  L  L +   +++  + P L+ L  L +L    N ++ +I    A+L NL  + L 
Sbjct: 148 AGLTNLQYLSIGNAQVS-DLTP-LANLSKLTTLKADDNKIS-DIS-PLASLPNLIEVHLK 203

Query: 322 KNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTIP 378
            N +    P  L +  NL ++ +     T    + +  N  L++ +V        I 
Sbjct: 204 NNQISDVSP--LANTSNLFIVTLTNQTIT---NQPVFYNNNLVVPNVVKGPSGAPIA 255

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 49.7 bits (119), Expect = 2e-06
 Identities = 42/214 (19%), Positives = 86/214 (40%), Gaps = 16/214 (7%)

Query: 89  PEIGLLTKLVNLTISNVNLTGRLPSEMALLTSLKVFNISGNVFQGNFAGQIVRGMTELQV 148
             +  LTK+  L +S   L     S +A L S+K  +++            + G++ LQV
Sbjct: 79  APLKNLTKITELELSGNPLKN--VSAIAGLQSIKTLDLTSTQITDVTP---LAGLSNLQV 133

Query: 149 LDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLNGIGLNGTV 208
           L    N  T   P  +A L +L++LS G    +  +    + +  L  +  +   ++   
Sbjct: 134 LYLDLNQITNISP--LAGLTNLQYLSIGNAQVS-DLT-PLANLSKLTTLKADDNKISDIS 189

Query: 209 PAFLSRLKNLREMYIGYFNTYTGGIPPGFGALTQLQVLDMASCNISGEIPTSLSRLKLLH 268
           P  L+ L NL E+++   N     + P     + L ++ + +  I+ +     + L + +
Sbjct: 190 P--LASLPNLIEVHLK--NNQISDVSP-LANTSNLFIVTLTNQTITNQPVFYNNNLVVPN 244

Query: 269 SLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLT 302
            +           P  +S   +  S +L+ N  +
Sbjct: 245 VVKGPSGAPI--APATISDNGTYASPNLTWNLTS 276

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 92.5 bits (230), Expect = 3e-20
 Identities = 57/304 (18%), Positives = 110/304 (36%), Gaps = 48/304 (15%)

Query: 144 TELQVLDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLNGIG 203
             ++ LD  NN  T     ++    +L+ L    N            I ++E        
Sbjct: 52  EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSN-----------GINTIE-------- 92

Query: 204 LNGTVPAFLSRLKNLREMYIGYFNTYTGGIPPG-FGALTQLQVLDMASCNISGEIPTSL- 261
                    S L +L  + + Y N  +  +    F  L+ L  L++          TSL 
Sbjct: 93  -----EDSFSSLGSLEHLDLSY-NYLSN-LSSSWFKPLSSLTFLNLLGNPYKTLGETSLF 145

Query: 262 SRLKLLHSLFLQMNKLTGHIPPQ-LSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQL 320
           S L  L  L +        I  +  +GL  L+ L++  + L    P+S  +++N++ L L
Sbjct: 146 SHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLIL 205

Query: 321 FKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRD 380
                   +  F+    ++E L++   +                +     + L+      
Sbjct: 206 HMKQHILLLEIFVDVTSSVECLELRDTD----------------LDTFHFSELSTGETNS 249

Query: 381 LCKGGKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGTIPAGLF-NLPLLNMME 439
           L K    +++ +     +  + + L Q   L ++ FS+N L  ++P G+F  L  L  + 
Sbjct: 250 LIKKFTFRNVKITDE-SLFQVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIW 307

Query: 440 LDDN 443
           L  N
Sbjct: 308 LHTN 311

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 91.7 bits (228), Expect = 6e-20
 Identities = 52/314 (16%), Positives = 113/314 (35%), Gaps = 47/314 (14%)

Query: 290 SLKSLDLSLNYLTGEIPESFAALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNF 349
                  S   L   IP        +  L L  N +     S L    NL+ L +  N  
Sbjct: 32  RNGICKGSSGSLN-SIPSGLTE--AVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGI 88

Query: 350 TFELPENLGRN-GKLLILDVTSNHLTGTIPRDLCKG-GKLKSLILMQNFFIGPIPEELGQ 407
              + E+   + G L  LD++ N+L+  +     K    L  L L+ N            
Sbjct: 89  N-TIEEDSFSSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGN------------ 134

Query: 408 CKSLTKIRFSKNYLNGTIPAGLF-NLPLLNMMELDDNLLSGELPEKM-SG-ASLNQLKVA 464
                 +              LF +L  L ++ + +     ++  K  +G   L +L++ 
Sbjct: 135 --PYKTLG----------ETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEID 182

Query: 465 NNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESF-NLKMITSINISDNNISGEIPYS 523
            +++    P ++ ++ +++ L L   +    +          +  + + D ++       
Sbjct: 183 ASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDTFHFSE 241

Query: 524 IS--------QCHSLTSVDLSRNSLYGKIPPGISKLIDLSILNLSRNGITGSIPNEM-RN 574
           +S        +  +  +V ++  SL+ ++   ++++  L  L  SRN +  S+P+ +   
Sbjct: 242 LSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLK-SVPDGIFDR 299

Query: 575 MMSLTTLDLSYNNL 588
           + SL  + L  N  
Sbjct: 300 LTSLQKIWLHTNPW 313

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 85.2 bits (211), Expect = 8e-18
 Identities = 49/310 (15%), Positives = 108/310 (34%), Gaps = 23/310 (7%)

Query: 53  SSSPSAHCSFSGVTCDQDSRVVSLNVSFMPLFGSIPPEIGLLTKLVNLTISNVNLTGRLP 112
           S S     + + ++CD++      + S      SIP   GL   + +L +SN  +T    
Sbjct: 16  SLSKEESSNQASLSCDRNGICKGSSGSL----NSIPS--GLTEAVKSLDLSNNRITYISN 69

Query: 113 SEMALLTSLKVFNISGNVFQGNFAGQIVRGMTELQVLDAYNNNFTGPLPVEI-ASLKSLR 171
           S++    +L+   ++ N             +  L+ LD   N  +  L       L SL 
Sbjct: 70  SDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNYLSN-LSSSWFKPLSSLT 127

Query: 172 HLSFGGNYFTGKIPQS-YSEIQSLEYIGLNGIGLNGTVPA-FLSRLKNLREMYIGYFNTY 229
            L+  GN +      S +S +  L+ + +  +     +     + L  L E+ I   +  
Sbjct: 128 FLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDA-SDL 186

Query: 230 TGGIPPG-FGALTQLQVLDMASCNISGEIPTSLSRLKLLHSLFLQMNKLTGHIPPQLS-- 286
                P    ++  +  L +        +   +     +  L L+   L      +LS  
Sbjct: 187 QS-YEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTG 245

Query: 287 ------GLISLKSLDLSLNYLTGEIPESFAALKNLTLLQLFKNNLRGPIPSFLGDFPNLE 340
                    + +++ ++   L  ++ +    +  L  L+  +N L+           +L+
Sbjct: 246 ETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQ 304

Query: 341 VLQVWGNNFT 350
            + +  N + 
Sbjct: 305 KIWLHTNPWD 314

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 80.5 bits (199), Expect = 3e-16
 Identities = 46/239 (19%), Positives = 87/239 (36%), Gaps = 20/239 (8%)

Query: 365 ILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGT 424
           I   +S  L  +IP  L +   +KSL L  N        +L +C +L  +  + N +N T
Sbjct: 35  ICKGSSGSLN-SIPSGLTEA--VKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-T 90

Query: 425 IPAGLF-NLPLLNMMELDDNLLSGELPEKM--SGASLNQLKVANNNITGKIPAAI-GNLP 480
           I    F +L  L  ++L  N LS  L        +SL  L +  N        ++  +L 
Sbjct: 91  IEEDSFSSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLT 149

Query: 481 SLNILSLQNNRLEGEIPVESF-NLKMITSINISDNNISGEIPYSISQCHSLTSVDLSRNS 539
            L IL + N     +I  + F  L  +  + I  +++    P S+    +++ + L    
Sbjct: 150 KLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQ 209

Query: 540 LYGKIPPGI-SKLIDLSILNLSRNGITGSIPNEM--------RNMMSLTTLDLSYNNLI 589
               +          +  L L    +     +E+            +   + ++  +L 
Sbjct: 210 HI-LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF 267

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 76.3 bits (188), Expect = 8e-15
 Identities = 34/216 (15%), Positives = 70/216 (32%), Gaps = 18/216 (8%)

Query: 410 SLTKIRFSKNYLNGTIPAGLF-NLPLLNMMELDDNLLSGELPEKM--SGASLNQLKVANN 466
           ++  +  S N +   I          L  + L  N ++  + E    S  SL  L ++ N
Sbjct: 53  AVKSLDLSNNRIT-YISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYN 110

Query: 467 NITGKIPA-AIGNLPSLNILSLQNNRLEGEIPVESF-NLKMITSINISDNNISGEIPYSI 524
            ++  + +     L SL  L+L  N  +       F +L  +  + + + +   +I    
Sbjct: 111 YLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKD 169

Query: 525 -SQCHSLTSVDLSRNSLYGKIPPGI-SKLIDLSILNLSRNGITGSIPNEM-RNMMSLTTL 581
            +    L  +++  + L     P     + ++S L L        +         S+  L
Sbjct: 170 FAGLTFLEELEIDASDL-QSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECL 227

Query: 582 DLSYNNLIGNIPSGGQFLAFNETSFIGNPNLCLLRN 617
           +L   +L         F   +             RN
Sbjct: 228 ELRDTDLDTF-----HFSELSTGETNSLIKKFTFRN 258

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 47.4 bits (113), Expect = 1e-05
 Identities = 23/91 (25%), Positives = 35/91 (38%), Gaps = 13/91 (14%)

Query: 526 QCHSLTSVDLSRNSLYGKIPPGISKLIDLSILNLSRNGITGSIPNEMRNMMSLTTLDLSY 585
            C        S  SL   IP G++    +  L+LS N IT    ++++  ++L  L L+ 
Sbjct: 29  SCDRNGICKGSSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTS 85

Query: 586 NNLIGNIPSGGQFLAFNETSFIGNPNLCLLR 616
           N  I  I            SF    +L  L 
Sbjct: 86  NG-INTIEED---------SFSSLGSLEHLD 106

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 91.7 bits (228), Expect = 5e-20
 Identities = 57/250 (22%), Positives = 95/250 (38%), Gaps = 36/250 (14%)

Query: 700 IGKGGAGIVYRGS-MPDGIDVAIKRL----VGRGTGGNDHGFLA---EIQTLGRIRHRNI 751
           +G G  G V+         +V +K +    V       D        EI  L R+ H NI
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91

Query: 752 VRLLGYVSNRDTNLLLYEYMPNGSLGEML-HGAKGGHLKWETRYRIALEAAKGLCYLHHD 810
           +++L    N+    L+ E   +G   ++     +   L       I  +    + YL   
Sbjct: 92  IKVLDIFENQGFFQLVMEKHGSG--LDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLK 149

Query: 811 CSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPE---- 866
               IIHRD+K  NI++  DF   + DFG A +L+         +  G+  Y APE    
Sbjct: 150 D---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGK---LFYTFCGTIEYCAPEVLMG 203

Query: 867 --YAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAAS 924
             Y        + +++S GV L  L+  + P   F +  + V         VS+  +  S
Sbjct: 204 NPYR-----GPELEMWSLGVTLYTLVFEENP---FCELEETVEAAIHPPYLVSK--ELMS 253

Query: 925 VLA---VVDP 931
           +++      P
Sbjct: 254 LVSGLLQPVP 263

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 91.2 bits (227), Expect = 5e-20
 Identities = 53/219 (24%), Positives = 89/219 (40%), Gaps = 32/219 (14%)

Query: 685 FKAEDVLESLKDENIIGKGGAGIVYRG-SMPDGIDVAIK-----RLVGRGTGGNDHGFLA 738
           FK + V +       +G G   IV +      G++ A K     +      G +      
Sbjct: 5   FKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIER 64

Query: 739 EIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIAL 798
           E+  L ++ H N++ L     NR   +L+ E +  G L + L  A+   L  E       
Sbjct: 65  EVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL--AQKESLS-E------E 115

Query: 799 EAAK-------GLCYLHHDCSPLIIHRDVKSNNILLDSDFEAH----VADFGLAKFLQDA 847
           EA         G+ YLH   +  I H D+K  NI+L           + DFGLA  ++D 
Sbjct: 116 EATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED- 171

Query: 848 GASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVL 886
                  ++ G+  ++APE      +  ++D++S GV+ 
Sbjct: 172 --GVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 93.0 bits (231), Expect = 1e-19
 Identities = 57/227 (25%), Positives = 97/227 (42%), Gaps = 11/227 (4%)

Query: 672 SKAWKLTAFQRLDFKAEDVLESLKDENIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTG 730
              WK    Q ++ K + VL+       +G G  G+V+R      G + A K  V     
Sbjct: 137 FDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAK-FVMTPHE 195

Query: 731 GNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKW 790
            +      EIQT+  +RH  +V L     + +  +++YE+M  G L E +   +   +  
Sbjct: 196 SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKV-ADEHNKMSE 254

Query: 791 ETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHV--ADFGLAKFLQDAG 848
           +       +  KGLC++H       +H D+K  NI+  +     +   DFGL   L    
Sbjct: 255 DEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP-- 309

Query: 849 ASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
             + +    G+  + APE A    V   +D++S GV+   L++G  P
Sbjct: 310 -KQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP 355

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 89.3 bits (222), Expect = 1e-19
 Identities = 48/215 (22%), Positives = 83/215 (38%), Gaps = 24/215 (11%)

Query: 410 SLTKIRFSKNYLNGTIPAGLF-NLPLLNMMELDDNLLSGELPEKM-SG-ASLNQLKVANN 466
           +  +I    N ++  +PA  F     L ++ L  N+L+  +     +G A L QL +++N
Sbjct: 33  ASQRIFLHGNRIS-HVPAASFRACRNLTILWLHSNVLA-RIDAAAFTGLALLEQLDLSDN 90

Query: 467 NITGKIPA-AIGNLPSLNILSLQNNRLEGEIPVESF-NLKMITSINISDNNISGEIPYSI 524
                +       L  L+ L L    L+ E+    F  L  +  + + DN +   +P   
Sbjct: 91  AQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ-ALPDDT 148

Query: 525 -SQCHSLTSVDLSRNSLYGKIPPGI-SKLIDLSILNLSRNGITGSIPNEM-RNMMSLTTL 581
                +LT + L  N +   +P      L  L  L L +N +   +     R++  L TL
Sbjct: 149 FRDLGNLTHLFLHGNRI-SSVPERAFRGLHSLDRLLLHQNRVA-HVHPHAFRDLGRLMTL 206

Query: 582 DLSYNNLIGNIPSGGQFLAFNETSFIGNPNLCLLR 616
            L  NNL   +P+          +      L  LR
Sbjct: 207 YLFANNLS-ALPTE---------ALAPLRALQYLR 231

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 88.5 bits (220), Expect = 2e-19
 Identities = 52/227 (22%), Positives = 90/227 (39%), Gaps = 15/227 (6%)

Query: 369 TSNHLTGTIPRDLCKGGKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGTIPAG 428
               L   +P  +      + + L  N            C++LT +    N L   I A 
Sbjct: 19  PQQGLQ-AVPVGIPAA--SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVL-ARIDAA 74

Query: 429 LF-NLPLLNMMELDDNLLSGELPEKM-SG-ASLNQLKVANNNITGKIPA-AIGNLPSLNI 484
            F  L LL  ++L DN     +      G   L+ L +    +  ++       L +L  
Sbjct: 75  AFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQY 133

Query: 485 LSLQNNRLEGEIPVESF-NLKMITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYGK 543
           L LQ+N L+  +P ++F +L  +T + +  N IS     +    HSL  + L +N +   
Sbjct: 134 LYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRV-AH 191

Query: 544 IPPGI-SKLIDLSILNLSRNGITGSIPNE-MRNMMSLTTLDLSYNNL 588
           + P     L  L  L L  N ++ ++P E +  + +L  L L+ N  
Sbjct: 192 VHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDNPW 237

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 86.2 bits (214), Expect = 1e-18
 Identities = 47/210 (22%), Positives = 79/210 (37%), Gaps = 8/210 (3%)

Query: 144 TELQVLDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLNGIG 203
              Q +  + N  +        + ++L  L    N        +++ +  LE + L+   
Sbjct: 32  AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91

Query: 204 LNGTVPA-FLSRLKNLREMYIGYFNTYTGGIPPG-FGALTQLQVLDMASCNISGEIPT-S 260
              +V       L  L  +++         + PG F  L  LQ L +    +   +P  +
Sbjct: 92  QLRSVDPATFHGLGRLHTLHLDR-CGLQE-LGPGLFRGLAALQYLYLQDNALQ-ALPDDT 148

Query: 261 LSRLKLLHSLFLQMNKLTGHIPPQ-LSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQ 319
              L  L  LFL  N+++  +P +   GL SL  L L  N +    P +F  L  L  L 
Sbjct: 149 FRDLGNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLY 207

Query: 320 LFKNNLRGPIPSFLGDFPNLEVLQVWGNNF 349
           LF NNL       L     L+ L++  N +
Sbjct: 208 LFANNLSALPTEALAPLRALQYLRLNDNPW 237

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 81.6 bits (202), Expect = 6e-17
 Identities = 50/209 (23%), Positives = 87/209 (41%), Gaps = 12/209 (5%)

Query: 193 SLEYIGLNGIGLNGTVPAFLSRLKNLREMYIGYFNTYTGGIPPG-FGALTQLQVLDMASC 251
           + + I L+G  ++    A     +NL  +++   N     I    F  L  L+ LD++  
Sbjct: 33  ASQRIFLHGNRISHVPAASFRACRNLTILWLHS-NVLAR-IDAAAFTGLALLEQLDLSDN 90

Query: 252 NISGEIP-TSLSRLKLLHSLFLQMNKLTGHIPPQ-LSGLISLKSLDLSLNYLTGEIPE-S 308
                +   +   L  LH+L L    L   + P    GL +L+ L L  N L   +P+ +
Sbjct: 91  AQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ-ALPDDT 148

Query: 309 FAALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRN-GKLLILD 367
           F  L NLT L L  N +            +L+ L +  N     +  +  R+ G+L+ L 
Sbjct: 149 FRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA-HVHPHAFRDLGRLMTLY 207

Query: 368 VTSNHLTGTIPRDLCKG-GKLKSLILMQN 395
           + +N+L+  +P +       L+ L L  N
Sbjct: 208 LFANNLS-ALPTEALAPLRALQYLRLNDN 235

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 81.6 bits (202), Expect = 6e-17
 Identities = 36/144 (25%), Positives = 67/144 (46%), Gaps = 8/144 (5%)

Query: 456 ASLNQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESF-NLKMITSINISDN 514
           A+  ++ +  N I+    A+     +L IL L +N L   I   +F  L ++  +++SDN
Sbjct: 32  AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-RIDAAAFTGLALLEQLDLSDN 90

Query: 515 NISGEIPYSI-SQCHSLTSVDLSRNSLYGKIPPGI-SKLIDLSILNLSRNGITGSIPNEM 572
                +  +       L ++ L R  L  ++ PG+   L  L  L L  N +  ++P++ 
Sbjct: 91  AQLRSVDPATFHGLGRLHTLHLDRCGL-QELGPGLFRGLAALQYLYLQDNALQ-ALPDDT 148

Query: 573 -RNMMSLTTLDLSYNNLIGNIPSG 595
            R++ +LT L L  N  I ++P  
Sbjct: 149 FRDLGNLTHLFLHGNR-ISSVPER 171

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 80.8 bits (200), Expect = 8e-17
 Identities = 47/244 (19%), Positives = 77/244 (31%), Gaps = 33/244 (13%)

Query: 86  SIPPEIGLLTKLVNLTISNVNLTGRLPSEMALLTSLKVFNISGNVFQGNFAGQIVRGMTE 145
           ++P   G+      + +    ++    +      +L +  +  NV           G+  
Sbjct: 25  AVPV--GIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-RIDAAAFTGLAL 81

Query: 146 LQVLDAYNNNFTGPLPVEI-ASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLNGIGL 204
           L+ LD  +N     +       L  L  L                 +Q L          
Sbjct: 82  LEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRC-----------GLQELG--------- 121

Query: 205 NGTVPAFLSRLKNLREMYIGYFNTYTGGIPPG-FGALTQLQVLDMASCNISGEIPTSLSR 263
               P     L  L+ +Y+   N     +P   F  L  L  L +    IS     +   
Sbjct: 122 ----PGLFRGLAALQYLYLQD-NALQA-LPDDTFRDLGNLTHLFLHGNRISSVPERAFRG 175

Query: 264 LKLLHSLFLQMNKLTGHIPPQ-LSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQLFK 322
           L  L  L L  N++  H+ P     L  L +L L  N L+    E+ A L+ L  L+L  
Sbjct: 176 LHSLDRLLLHQNRVA-HVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLND 234

Query: 323 NNLR 326
           N   
Sbjct: 235 NPWV 238

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 90.9 bits (226), Expect = 1e-19
 Identities = 52/212 (24%), Positives = 87/212 (41%), Gaps = 18/212 (8%)

Query: 685 FKAEDVLESLKDENIIGKGGAGIVYRG-SMPDGIDVAIK-----RLVGRGTGGNDHGFLA 738
           FK + V +       +G G   IV +      G++ A K     +      G        
Sbjct: 5   FKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIER 64

Query: 739 EIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIAL 798
           E+  L ++ H NI+ L     NR   +L+ E +  G L + L  A+   L  E       
Sbjct: 65  EVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFL--AQKESLSEEEATSFIK 122

Query: 799 EAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAH----VADFGLAKFLQDAGASECMS 854
           +   G+ YLH   +  I H D+K  NI+L           + DFGLA  ++D        
Sbjct: 123 QILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED---GVEFK 176

Query: 855 SVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVL 886
           ++ G+  ++APE      +  ++D++S GV+ 
Sbjct: 177 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 90.7 bits (225), Expect = 1e-19
 Identities = 44/265 (16%), Positives = 82/265 (30%), Gaps = 37/265 (13%)

Query: 233 IPPGFGALTQLQVLDMASCNISGEIPTSLSRLKLLHSLFLQMNKLTGHIPPQ-LSGLISL 291
           IP           L      +      + S    L  + +  N +   I     S L  L
Sbjct: 24  IPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKL 81

Query: 292 KSLDLS-LNYLTGEIPESFAALKNLTLLQLFKNNLRGPIPSFLGDF-PNLEVLQVWGNNF 349
             + +   N L    PE+F  L NL  L +    ++  +P           +L +  N  
Sbjct: 82  HEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKH-LPDVHKIHSLQKVLLDIQDNIN 140

Query: 350 TFELPENL--GRNGKLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFIGPIPEE-LG 406
              +  N   G + + +IL +  N +   I      G +L  L L  N  +  +P +   
Sbjct: 141 IHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFH 199

Query: 407 QCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLSGELPEKMSGASLNQLKVANN 466
                  +  S+  ++ ++P+                             +L +L+  + 
Sbjct: 200 GASGPVILDISRTRIH-SLPSYGL-------------------------ENLKKLRARST 233

Query: 467 NITGKIPAAIGNLPSLNILSLQNNR 491
               K+P  +  L +L   SL    
Sbjct: 234 YNLKKLPT-LEKLVALMEASLTYPS 257

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 77.6 bits (191), Expect = 3e-15
 Identities = 46/305 (15%), Positives = 87/305 (28%), Gaps = 66/305 (21%)

Query: 290 SLKSLDLSLNYLTGEIPESFAALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNF 349
           S +      + +T EIP      +N   L+     LR  I    G F             
Sbjct: 10  SNRVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRV-IQK--GAFSGF---------- 53

Query: 350 TFELPENLGRNGKLLILDVTSNHLTGTIPRDLCKG-GKLKSLILMQNFFIGPIPEE-LGQ 407
                      G L  ++++ N +   I  D+     KL  + + +   +  I  E    
Sbjct: 54  -----------GDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQN 102

Query: 408 CKSLTKIRFSKNYLNGTIPAGLF-NLPLLNMMELDDNLLSGELPEKMS---GASLNQLKV 463
             +L  +  S   +   +P     +     ++++ DN+    +              L +
Sbjct: 103 LPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWL 161

Query: 464 ANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESF-NLKMITSINISDNNISGEIPY 522
             N I     +A        +    NN LE E+P + F        ++IS   I      
Sbjct: 162 NKNGIQEIHNSAFNGTQLDELNLSDNNNLE-ELPNDVFHGASGPVILDISRTRIH----- 215

Query: 523 SISQCHSLTSVDLSRNSLYGKIPPGI-SKLIDLSILNLSRNGITGSIPNEMRNMMSLTTL 581
                                +P      L  L   +        ++      +++L   
Sbjct: 216 --------------------SLPSYGLENLKKLRARSTYNLKKLPTL----EKLVALMEA 251

Query: 582 DLSYN 586
            L+Y 
Sbjct: 252 SLTYP 256

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 75.6 bits (186), Expect = 1e-14
 Identities = 47/181 (25%), Positives = 75/181 (41%), Gaps = 16/181 (8%)

Query: 424 TIPAGLF-NLPLLNMMELDDNLLSGELPEKM-SG-ASLNQLKVANNNITGKIPA-AIGNL 479
            IP+ L  N   L         L   + +   SG   L +++++ N++   I A    NL
Sbjct: 23  EIPSDLPRNAIELR---FVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNL 78

Query: 480 PSLNILSLQN-NRLEGEIPVESF-NLKMITSINISDNNISGEIP-YSISQCHSLTSVDLS 536
           P L+ + ++  N L   I  E+F NL  +  + IS+  I   +P            +D+ 
Sbjct: 79  PKLHEIRIEKANNLL-YINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQ 136

Query: 537 RNSLYGKIPPG-ISKL-IDLSILNLSRNGITGSIPNEMRNMMSLTTLDLSYNNLIGNIPS 594
            N     I       L  +  IL L++NGI   I N   N   L  L+LS NN +  +P+
Sbjct: 137 DNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPN 195

Query: 595 G 595
            
Sbjct: 196 D 196

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 74.9 bits (184), Expect = 2e-14
 Identities = 51/237 (21%), Positives = 91/237 (38%), Gaps = 18/237 (7%)

Query: 366 LDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFIGPIPEE-LGQCKSLTKIRFSKNYLNGT 424
                + +T  IP DL +      L  +    +  I +        L KI  S+N +   
Sbjct: 14  FLCQESKVT-EIPSDLPRN--AIELRFVLTK-LRVIQKGAFSGFGDLEKIEISQNDVLEV 69

Query: 425 IPAGLF-NLPLLNMMELDD-NLLSGELPEKMSG--ASLNQLKVANNNITGKIPA-AIGNL 479
           I A +F NLP L+ + ++  N L   +  +      +L  L ++N  I   +P     + 
Sbjct: 70  IEADVFSNLPKLHEIRIEKANNLL-YINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHS 127

Query: 480 PSLNILSLQNNRLEGEIPVESFN--LKMITSINISDNNISGEIPYSISQCHSLTSVDLSR 537
               +L +Q+N     I   SF         + ++ N I  EI  S      L  ++LS 
Sbjct: 128 LQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSD 186

Query: 538 NSLYGKIPPGI-SKLIDLSILNLSRNGITGSIPNE-MRNMMSLTTLDLSYNNLIGNI 592
           N+   ++P  +        IL++SR  I  S+P+  + N+  L          +  +
Sbjct: 187 NNNLEELPNDVFHGASGPVILDISRTRIH-SLPSYGLENLKKLRARSTYNLKKLPTL 242

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 64.5 bits (157), Expect = 5e-11
 Identities = 39/218 (17%), Positives = 54/218 (24%), Gaps = 30/218 (13%)

Query: 144 TELQVLDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLNGIG 203
                L               +    L  +    N               LE I  +   
Sbjct: 30  RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQN-------------DVLEVIEAD--- 73

Query: 204 LNGTVPAFLSRLKNLREMYIGYFNTYTGGIPPG-FGALTQLQVLDMASCNISGEIP-TSL 261
                  F S L  L E+ I   N     I P  F  L  LQ L +++  I   +P    
Sbjct: 74  ------VF-SNLPKLHEIRIEKANNLLY-INPEAFQNLPNLQYLLISNTGIK-HLPDVHK 124

Query: 262 SRLKLLHSLFLQMNKLTGHIPPQ-LSGL-ISLKSLDLSLNYLTGEIPESFAALKNLTLLQ 319
                   L +Q N     I      GL      L L+ N +      +F   +   L  
Sbjct: 125 IHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNL 184

Query: 320 LFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENL 357
              NNL               +L +        LP   
Sbjct: 185 SDNNNLEELPNDVFHGASGPVILDISRTRIH-SLPSYG 221

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 57.9 bits (140), Expect = 7e-09
 Identities = 34/260 (13%), Positives = 60/260 (23%), Gaps = 59/260 (22%)

Query: 94  LTKLVNLTISNVNLTGRLPSEM-ALLTSLKVFNISGNVFQGNFAGQIVRGMTELQVLDAY 152
              L  + IS  ++   + +++ + L  L    I           +  + +  LQ L   
Sbjct: 53  FGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLIS 112

Query: 153 NNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLNGIGLNGTVPAFL 212
           N        V          L    N            I +                   
Sbjct: 113 NTGIKHLPDVHKIHSLQKVLLDIQDN----------INIHT------------------- 143

Query: 213 SRLKNLREMYIGYFNTYTGGIPPG-FGALT-QLQVLDMASCNISGEIPTSLSRLKLLHSL 270
                               I    F  L+ +  +L +    I     ++ +  +L    
Sbjct: 144 --------------------IERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELN 183

Query: 271 FLQMNKLTGHIPPQ-LSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQLFKNNLRGPI 329
               N L   +P     G      LD+S   +          LK L        NL+  +
Sbjct: 184 LSDNNNLE-ELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST--YNLKK-L 239

Query: 330 PSFLGDFPNLEVLQVWGNNF 349
           P+       L          
Sbjct: 240 PTLEK-LVALMEAS-LTYPS 257

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 49.1 bits (117), Expect = 4e-06
 Identities = 14/91 (15%), Positives = 29/91 (31%), Gaps = 13/91 (14%)

Query: 527 CH-SLTSVDLSRNSLYGKIPPGISKLIDLSILNLSRNGITGSIPNEMRNMMSLTTLDLSY 585
           CH S        + +  +IP  + +  +   L      +             L  +++S 
Sbjct: 7   CHCSNRVFLCQESKV-TEIPSDLPR--NAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQ 63

Query: 586 NNLIGNIPSGGQFLAFNETSFIGNPNLCLLR 616
           N+++  I +           F   P L  +R
Sbjct: 64  NDVLEVIEAD---------VFSNLPKLHEIR 85

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 92.9 bits (230), Expect = 2e-19
 Identities = 51/272 (18%), Positives = 99/272 (36%), Gaps = 19/272 (6%)

Query: 267 LHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQLFKNNLR 326
           +         +   I P           +L    +T  +      L ++  +    ++++
Sbjct: 1   MGETITVSTPIK-QIFP-DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK 56

Query: 327 GPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDLCKGGK 386
                 +   PN+  L + GN  T ++ + L     L  L +  N +       L    K
Sbjct: 57  --SVQGIQYLPNVTKLFLNGNKLT-DI-KPLTNLKNLGWLFLDENKIKDLSS--LKDLKK 110

Query: 387 LKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLS 446
           LKSL L  N  I  I   L     L  +    N +  T    L  L  L+ + L+DN +S
Sbjct: 111 LKSLSLEHNG-ISDI-NGLVHLPQLESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQIS 166

Query: 447 GELPEKMSGASLNQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESFNLKMI 506
            ++        L  L ++ N+I+  + A +  L +L++L L +     +      NL + 
Sbjct: 167 -DIVPLAGLTKLQNLYLSKNHIS-DLRA-LAGLKNLDVLELFSQECLNKPINHQSNLVVP 223

Query: 507 TSINISDNNISGEIPYSISQCHSLTSVDLSRN 538
            ++  +D ++    P  IS        ++  +
Sbjct: 224 NTVKNTDGSL--VTPEIISDDGDYEKPNVKWH 253

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 86.7 bits (214), Expect = 1e-17
 Identities = 48/274 (17%), Positives = 102/274 (37%), Gaps = 23/274 (8%)

Query: 362 KLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYL 421
           + +  ++    +T  + ++      +  +I   +  I  + + +    ++TK+  + N L
Sbjct: 22  ETIKDNLKKKSVTDAVTQNELN--SIDQIIANNSD-IKSV-QGIQYLPNVTKLFLNGNKL 77

Query: 422 NGTIPAGLFNLPLLNMMELDDNLLSGELPEKMSG----ASLNQLKVANNNITGKIPAAIG 477
              I   L NL  L  + LD+N +       +S       L  L + +N I+  I   + 
Sbjct: 78  T-DIK-PLTNLKNLGWLFLDENKIK-----DLSSLKDLKKLKSLSLEHNGIS-DING-LV 128

Query: 478 NLPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIPYSISQCHSLTSVDLSR 537
           +LP L  L L NN++     +    L  + ++++ DN IS +I   ++    L ++ LS+
Sbjct: 129 HLPQLESLYLGNNKITDITVLS--RLTKLDTLSLEDNQIS-DIV-PLAGLTKLQNLYLSK 184

Query: 538 NSLYGKIPPGISKLIDLSILNLSRNGITGSIPNEMRNMMSLTTLDLSYNNLIGNIPSGGQ 597
           N +       ++ L +L +L L          N   N++   T+  +  +L+        
Sbjct: 185 NHI--SDLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDD 242

Query: 598 FLAFNETSFIGNPNLCLLRNGTCQSLINSAKHSG 631
                       P      +      +   K   
Sbjct: 243 GDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKA 276

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 85.5 bits (211), Expect = 3e-17
 Identities = 57/286 (19%), Positives = 106/286 (37%), Gaps = 54/286 (18%)

Query: 94  LTKLVNLTISNVNLTGRLPSEMALLTSLKVFNISGNVFQGNFAGQI-----VRGMTELQV 148
             + +   +   ++T         L S+     + +         I     ++ +  +  
Sbjct: 20  FAETIKDNLKKKSVTD--AVTQNELNSIDQIIANNS--------DIKSVQGIQYLPNVTK 69

Query: 149 LDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLNGIGLNGTV 208
           L    N  T   P  + +LK+L  L    N           +I+ L              
Sbjct: 70  LFLNGNKLTDIKP--LTNLKNLGWLFLDEN-----------KIKDLS------------- 103

Query: 209 PAFLSRLKNLREMYIGYFNTYTGGIPPGFGALTQLQVLDMASCNISGEIPTSLSRLKLLH 268
              L  LK L+ + +   +     I      L QL+ L + +  I+    T LSRL  L 
Sbjct: 104 --SLKDLKKLKSLSLE--HNGISDING-LVHLPQLESLYLGNNKIT--DITVLSRLTKLD 156

Query: 269 SLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQLFKNNLRGP 328
           +L L+ N+++  I P L+GL  L++L LS N+++ ++  + A LKNL +L+LF       
Sbjct: 157 TLSLEDNQIS-DIVP-LAGLTKLQNLYLSKNHIS-DL-RALAGLKNLDVLELFSQECLNK 212

Query: 329 IPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLT 374
             +   +        V   + +   PE +  +G     +V  +   
Sbjct: 213 PINHQSNLVVPN--TVKNTDGSLVTPEIISDDGDYEKPNVKWHLPE 256

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 91.3 bits (227), Expect = 2e-19
 Identities = 67/229 (29%), Positives = 97/229 (42%), Gaps = 51/229 (22%)

Query: 690 VLESLKDENIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHGF-LAEIQTLGRIR 747
              S  D  +IG G  G+VY+      G  VAIK+++       D  F   E+Q + ++ 
Sbjct: 52  QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL------QDKRFKNRELQIMRKLD 105

Query: 748 HRNIVRLLGYV---SNRDTNLLLY---EYMPNGSLGEMLHGAKGGHLKWETRYRIALEAA 801
           H NIVRL  +      +   + L    +Y+P     E ++       +  +R +  L   
Sbjct: 106 HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP-----ETVYR----VARHYSRAKQTLPVI 156

Query: 802 ----------KGLCYLHHDCSPLIIHRDVKSNNILLDSD-FEAHVADFGLAKFLQDAGAS 850
                     + L Y+H   S  I HRD+K  N+LLD D     + DFG AK L      
Sbjct: 157 YVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV---RG 210

Query: 851 ECMSS-VAGSYGYIAPE-----YAYTLKVDEKSDVYSFGVVLLELIAGK 893
           E   S +   Y Y APE       YT  +    DV+S G VL EL+ G+
Sbjct: 211 EPNVSYICSRY-YRAPELIFGATDYTSSI----DVWSAGCVLAELLLGQ 254

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 90.5 bits (225), Expect = 2e-19
 Identities = 49/224 (21%), Positives = 91/224 (40%), Gaps = 11/224 (4%)

Query: 675 WKLTAFQRLDFKAEDVLESLKDENIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGND 733
           WK    Q ++ K   V +       +G G  G+V+R      G     K +         
Sbjct: 34  WKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKY 93

Query: 734 HGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETR 793
                EI  + ++ H  ++ L     ++   +L+ E++  G L + +  A+   +     
Sbjct: 94  T-VKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRI-AAEDYKMSEAEV 151

Query: 794 YRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHV--ADFGLAKFLQDAGASE 851
                +A +GL ++H      I+H D+K  NI+ ++   + V   DFGLA  L      E
Sbjct: 152 INYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP---DE 205

Query: 852 CMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
            +     +  + APE      V   +D+++ GV+   L++G  P
Sbjct: 206 IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSP 249

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 89.6 bits (223), Expect = 2e-19
 Identities = 48/235 (20%), Positives = 87/235 (37%), Gaps = 29/235 (12%)

Query: 667 RRLQKSKAWKLTAFQRLDFKAEDVLE--SLKDENIIGKGGAGIVYRG-SMPDGIDVAIKR 723
                S    L          E+      L  +  +G+G   +V +  S   G + A K 
Sbjct: 3   HHHHHSSGVDLGTENLYFQSMENFNNFYILTSK-ELGRGKFAVVRQCISKSTGQEYAAKF 61

Query: 724 LVGRGTGGNDHG-FLAEIQTLGRIRHR-NIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLH 781
           L  R  G +     L EI  L   +    ++ L     N    +L+ EY   G +  +  
Sbjct: 62  LKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCL 121

Query: 782 GAKGGHLKWETRYRIALEAAK-------GLCYLHHDCSPLIIHRDVKSNNILLDSDFEAH 834
                 +  E       +  +       G+ YLH      I+H D+K  NILL S +   
Sbjct: 122 PELAEMVS-EN------DVIRLIKQILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLG 171

Query: 835 ---VADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVL 886
              + DFG+++ +     +  +  + G+  Y+APE      +   +D+++ G++ 
Sbjct: 172 DIKIVDFGMSRKIGH---ACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIA 223

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 88.8 bits (221), Expect = 4e-19
 Identities = 45/209 (21%), Positives = 82/209 (39%), Gaps = 26/209 (12%)

Query: 688 EDVLESLKDENIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRI 746
           +++ E       +G+G  GIV+R            K +  +GT         EI  L   
Sbjct: 1   KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVL--VKKEISILNIA 58

Query: 747 RHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAK---- 802
           RHRNI+ L     + +  ++++E++    + E +       L  E       E       
Sbjct: 59  RHRNILHLHESFESMEELVMIFEFISGLDIFERI-NTSAFELN-ER------EIVSYVHQ 110

Query: 803 ---GLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHV--ADFGLAKFLQDAGASECMSSVA 857
               L +LH   S  I H D++  NI+  +   + +   +FG A+ L+     +    + 
Sbjct: 111 VCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP---GDNFRLLF 164

Query: 858 GSYGYIAPEYAYTLKVDEKSDVYSFGVVL 886
            +  Y APE      V   +D++S G ++
Sbjct: 165 TAPEYYAPEVHQHDVVSTATDMWSLGTLV 193

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 89.4 bits (222), Expect = 5e-19
 Identities = 50/215 (23%), Positives = 96/215 (44%), Gaps = 25/215 (11%)

Query: 683 LDFKAEDVLE--SLKDENIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHGFLAE 739
           +  K   V    ++    I+G G  G V++      G+ +A K +  RG    +     E
Sbjct: 78  VTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEE-VKNE 136

Query: 740 IQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLK-WETRY--RI 796
           I  + ++ H N+++L     +++  +L+ EY+  G L + +   +  +L   +T    + 
Sbjct: 137 ISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRII-DESYNLTELDTILFMKQ 195

Query: 797 ALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHV--ADFGLAKFLQDAGASECMS 854
             E   G+ ++H      I+H D+K  NIL  +     +   DFGLA+  +     E + 
Sbjct: 196 ICE---GIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKP---REKLK 246

Query: 855 SVAGSYGYIAPE---YAYTLKVDEKSDVYSFGVVL 886
              G+  ++APE   Y +   V   +D++S GV+ 
Sbjct: 247 VNFGTPEFLAPEVVNYDF---VSFPTDMWSVGVIA 278

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 87.7 bits (218), Expect = 8e-19
 Identities = 54/219 (24%), Positives = 90/219 (41%), Gaps = 32/219 (14%)

Query: 685 FKAEDVLESLKDENIIGKGGAGIVYRG-SMPDGIDVAIK-----RLVGRGTGGNDHGFLA 738
           F+ E+V +       +G G   +V +      G+  A K     R      G +      
Sbjct: 4   FRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIER 63

Query: 739 EIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIAL 798
           E+  L  I+H N++ L     N+   +L+ E +  G L + L  A+   L  E       
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL--AEKESLT-E------E 114

Query: 799 EAAK-------GLCYLHHDCSPLIIHRDVKSNNILL-DSDFEAH---VADFGLAKFLQDA 847
           EA +       G+ YLH   S  I H D+K  NI+L D +       + DFGLA  +   
Sbjct: 115 EATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF- 170

Query: 848 GASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVL 886
                  ++ G+  ++APE      +  ++D++S GV+ 
Sbjct: 171 --GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 207

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 88.2 bits (219), Expect = 8e-19
 Identities = 62/211 (29%), Positives = 93/211 (44%), Gaps = 35/211 (16%)

Query: 699 IIGKGGAGIVYRGS-MPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGY 757
            +G+G   IVYR          A+K L       +      EI  L R+ H NI++L   
Sbjct: 60  ELGRGATSIVYRCKQKGTQKPYALKVLKKTV---DKKIVRTEIGVLLRLSHPNIIKLKEI 116

Query: 758 VSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRY--RIALEAAK----GLCYLHHDC 811
                   L+ E +  G L + +   KG        Y  R A +A K     + YLH   
Sbjct: 117 FETPTEISLVLELVTGGELFDRIV-EKG-------YYSERDAADAVKQILEAVAYLH--- 165

Query: 812 SPLIIHRDVKSNNILLDS-DFEAHV--ADFGLAKFLQDAGASECMSSVAGSYGYIAPE-- 866
              I+HRD+K  N+L  +   +A +  ADFGL+K ++       M +V G+ GY APE  
Sbjct: 166 ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH---QVLMKTVCGTPGYCAPEIL 222

Query: 867 --YAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
              AY  +V    D++S G++   L+ G +P
Sbjct: 223 RGCAYGPEV----DMWSVGIITYILLCGFEP 249

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 87.7 bits (218), Expect = 1e-18
 Identities = 49/226 (21%), Positives = 90/226 (39%), Gaps = 26/226 (11%)

Query: 680 FQRLDFKAEDVLESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLA 738
            Q+L   +    +  + +  IG G   +  R       ++ A+K +        +     
Sbjct: 10  VQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE----- 64

Query: 739 EIQTLGR-IRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIA 797
           EI+ L R  +H NI+ L     +     ++ E M  G L + +   +    + E    + 
Sbjct: 65  EIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKIL-RQKFFSEREAS-AVL 122

Query: 798 LEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAH----VADFGLAKFLQDAGASECM 853
               K + YLH   +  ++HRD+K +NIL   +        + DFG AK L+       +
Sbjct: 123 FTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN--GLL 177

Query: 854 SSVAGSYGYIAPE----YAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
            +   +  ++APE      Y        D++S GV+L  ++ G  P
Sbjct: 178 MTPCYTANFVAPEVLERQGYDAAC----DIWSLGVLLYTMLTGYTP 219

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 86.5 bits (215), Expect = 1e-18
 Identities = 53/204 (25%), Positives = 85/204 (41%), Gaps = 32/204 (15%)

Query: 700 IGKGGAGIVYRG-SMPDGIDVAIK-----RLVGRGTGGNDHGFLAEIQTLGRIRHRNIVR 753
           +G G   IV +      G + A K     RL     G +      E+  L  IRH NI+ 
Sbjct: 13  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72

Query: 754 LLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAK-------GLCY 806
           L     N+   +L+ E +  G L + L  A+   L  E       EA +       G+ Y
Sbjct: 73  LHDIFENKTDVVLILELVSGGELFDFL--AEKESLT-ED------EATQFLKQILDGVHY 123

Query: 807 LHHDCSPLIIHRDVKSNNILLDS-DFEAH---VADFGLAKFLQDAGASECMSSVAGSYGY 862
           LH   S  I H D+K  NI+L   +       + DFG+A  ++         ++ G+  +
Sbjct: 124 LH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA---GNEFKNIFGTPEF 177

Query: 863 IAPEYAYTLKVDEKSDVYSFGVVL 886
           +APE      +  ++D++S GV+ 
Sbjct: 178 VAPEIVNYEPLGLEADMWSIGVIT 201

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 86.9 bits (216), Expect = 1e-18
 Identities = 57/247 (23%), Positives = 104/247 (42%), Gaps = 25/247 (10%)

Query: 697 ENIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIR-HRNIVRL 754
           E+++G+G    V    ++    + A+K +  +           E++ L + + HRN++ L
Sbjct: 18  EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSR-VFREVEMLYQCQGHRNVLEL 76

Query: 755 LGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPL 814
           + +    D   L++E M  GS+   +H  +    + E    +  + A  L +LH   +  
Sbjct: 77  IEFFEEEDRFYLVFEKMRGGSILSHIH-KRRHFNELEAS-VVVQDVASALDFLH---NKG 131

Query: 815 IIHRDVKSNNILLDSDFEAH---VADFGLAKFLQDAG-----ASECMSSVAGSYGYIAPE 866
           I HRD+K  NIL +   +     + DF L   ++  G     ++  + +  GS  Y+APE
Sbjct: 132 IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPE 191

Query: 867 -----YAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEF-GDGVDIVRWVRKTTSEVSQPS 920
                       D++ D++S GV+L  L++G  P   F G       W R       Q  
Sbjct: 192 VVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP---FVGRCGSDCGWDRGEACPACQNM 248

Query: 921 DAASVLA 927
              S+  
Sbjct: 249 LFESIQE 255

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 85.7 bits (213), Expect = 2e-18
 Identities = 58/201 (28%), Positives = 93/201 (46%), Gaps = 14/201 (6%)

Query: 700 IGKGGAGIVYRGS-MPDGIDVAIKRLVGR---GTGGNDHGFLAEIQTLGRIRHRNIVRLL 755
           +G G  G V  G     G  VA+K ++ R    +         EIQ L   RH +I++L 
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVK-ILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLY 77

Query: 756 GYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLI 815
             +S      ++ EY+  G L + +   K G ++     R+  +    + Y H     ++
Sbjct: 78  QVISTPTDFFMVMEYVSGGELFDYI--CKHGRVEEMEARRLFQQILSAVDYCH---RHMV 132

Query: 816 IHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVD- 874
           +HRD+K  N+LLD+   A +ADFGL+  + D    E + +  GS  Y APE         
Sbjct: 133 VHRDLKPENVLLDAHMNAKIADFGLSNMMSDG---EFLRTSCGSPNYAAPEVISGRLYAG 189

Query: 875 EKSDVYSFGVVLLELIAGKKP 895
            + D++S GV+L  L+ G  P
Sbjct: 190 PEVDIWSCGVILYALLCGTLP 210

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 86.6 bits (215), Expect = 3e-18
 Identities = 67/258 (25%), Positives = 96/258 (37%), Gaps = 46/258 (17%)

Query: 700 IGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYV 758
           IG G  G+            VA+K  + RG   +++    EI     +RH NIVR    +
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVK-YIERGAAIDENVQR-EIINHRSLRHPNIVRFKEVI 85

Query: 759 SNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAK-------GLCYLHHDC 811
                  ++ EY   G L E +     G    E       EA         G+ Y H   
Sbjct: 86  LTPTHLAIIMEYASGGELYERI--CNAGRFS-ED------EARFFFQQLLSGVSYCH--- 133

Query: 812 SPLIIHRDVKSNNILLDSDFEAH--VADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAY 869
           S  I HRD+K  N LLD        + DFG +K            S  G+  YIAPE   
Sbjct: 134 SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLL 190

Query: 870 TLKVD-EKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQ---------- 918
             + D + +DV+S GV L  ++ G  P   F +  +  R  RKT   +            
Sbjct: 191 RQEYDGKIADVWSCGVTLYVMLVGAYP---F-EDPEEPRDYRKTIQRILSVKYSIPDDIR 246

Query: 919 -PSDAASVLA---VVDPR 932
              +   +++   V DP 
Sbjct: 247 ISPECCHLISRIFVADPA 264

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 87.0 bits (216), Expect = 4e-18
 Identities = 59/230 (25%), Positives = 99/230 (43%), Gaps = 50/230 (21%)

Query: 688 EDVLESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGF-LAEIQTLGRI 746
           E    +  +  +IG G  G+V++  + +  +VAIK+++       D  F   E+Q +  +
Sbjct: 36  EQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVL------QDKRFKNRELQIMRIV 89

Query: 747 RHRNIVRLLGYV---SNRDTNLLLY---EYMPNGSLGEMLHGAKGGHLKWETRYRIALEA 800
           +H N+V L  +     ++   + L    EY+P     E ++       +   + +  +  
Sbjct: 90  KHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVP-----ETVYR----ASRHYAKLKQTMPM 140

Query: 801 A----------KGLCYLHHDCSPLIIHRDVKSNNILLDSD-FEAHVADFGLAKFLQDAGA 849
                      + L Y+H   S  I HRD+K  N+LLD       + DFG AK L    A
Sbjct: 141 LLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILI---A 194

Query: 850 SECMSS-VAGSYGYIAPE-----YAYTLKVDEKSDVYSFGVVLLELIAGK 893
            E   S +   Y Y APE       YT  +    D++S G V+ EL+ G+
Sbjct: 195 GEPNVSYICSRY-YRAPELIFGATNYTTNI----DIWSTGCVMAELMQGQ 239

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 85.9 bits (213), Expect = 4e-18
 Identities = 63/306 (20%), Positives = 103/306 (33%), Gaps = 71/306 (23%)

Query: 670 QKSKAWKLTAFQRLDFKAEDVLESLK-DENIIGKGGAGIVYRGSM-PDGIDVAIK----- 722
               +     FQ  + K   V +  +  + ++G G  G V        G   A+K     
Sbjct: 6   HHHSSGLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS 65

Query: 723 RLVGRGTGGNDHGFLAEIQTLGRI-RHRNIVRLLG-YVSNRDTNLLLY---EYMPNGSLG 777
               +           E+    +     +IV +L  Y +       L    E M      
Sbjct: 66  PKARQ-----------EVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECM------ 108

Query: 778 EMLHGAKGGHL------KWETRY------RIALEAAKGLCYLHHDCSPLIIHRDVKSNNI 825
                 +GG L      + +  +       I  +    + +LH      I HRDVK  N+
Sbjct: 109 ------EGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENL 159

Query: 826 LL---DSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSF 882
           L    + D    + DFG AK          + +   +  Y+APE     K D+  D++S 
Sbjct: 160 LYTSKEKDAVLKLTDFGFAKETTQ----NALQTPCYTPYYVAPEVLGPEKYDKSCDMWSL 215

Query: 883 GVVLLELIAGKKP-VGEFGDGV--DIVRWVRKTTSEVSQP-----SDAA----SVLAVVD 930
           GV++  L+ G  P     G  +   + R +R        P     S+ A     +L   D
Sbjct: 216 GVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTD 275

Query: 931 P--RLS 934
           P  RL+
Sbjct: 276 PTERLT 281

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 86.2 bits (214), Expect = 5e-18
 Identities = 47/167 (28%), Positives = 76/167 (45%), Gaps = 21/167 (12%)

Query: 737 LAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRI 796
             E+Q +  + H  +V L     + +   ++ + +  G L    H  +  H K E   ++
Sbjct: 63  FKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDL--RYHLQQNVHFK-EETVKL 119

Query: 797 -ALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSS 855
              E    L YL    +  IIHRD+K +NILLD     H+ DF +A  L        +++
Sbjct: 120 FICELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR---ETQITT 173

Query: 856 VAGSYGYIAPE-------YAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
           +AG+  Y+APE         Y+  V    D +S GV   EL+ G++P
Sbjct: 174 MAGTKPYMAPEMFSSRKGAGYSFAV----DWWSLGVTAYELLRGRRP 216

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 84.3 bits (209), Expect = 1e-17
 Identities = 48/217 (22%), Positives = 86/217 (39%), Gaps = 24/217 (11%)

Query: 688 EDVLESLKDENIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRI 746
               +    +  +G+G   I  +          A+K +  R     +     EI  L   
Sbjct: 7   YQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR----MEANTQKEITALKLC 62

Query: 747 R-HRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLC 805
             H NIV+L     ++    L+ E +  G L E +   K    + E    I  +    + 
Sbjct: 63  EGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIK-KKKHFSETEAS-YIMRKLVSAVS 120

Query: 806 YLHHDCSPLIIHRDVKSNNILL---DSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGY 862
           ++H      ++HRD+K  N+L    + + E  + DFG A+        + + +   +  Y
Sbjct: 121 HMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN--QPLKTPCFTLHY 175

Query: 863 IAPE----YAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
            APE      Y    DE  D++S GV+L  +++G+ P
Sbjct: 176 AAPELLNQNGY----DESCDLWSLGVILYTMLSGQVP 208

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 83.0 bits (206), Expect = 3e-17
 Identities = 48/161 (29%), Positives = 70/161 (43%), Gaps = 9/161 (5%)

Query: 737 LAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRI 796
             E   + R+ H   V+L     + +       Y  NG L  + +  K G    ET  R 
Sbjct: 78  TRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGEL--LKYIRKIGSFD-ETCTRF 134

Query: 797 -ALEAAKGLCYLH-HDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMS 854
              E    L YLH       IIHRD+K  NILL+ D    + DFG AK L         +
Sbjct: 135 YTAEIVSALEYLHGKG----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARAN 190

Query: 855 SVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
           S  G+  Y++PE        + SD+++ G ++ +L+AG  P
Sbjct: 191 SFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 84.5 bits (209), Expect = 4e-17
 Identities = 61/209 (29%), Positives = 94/209 (44%), Gaps = 30/209 (14%)

Query: 700 IGKGGAGIVYRGS-MPDGIDVAIKRLVGRGTGGNDHGFLA----EIQTLGRIRHRNIVRL 754
           +G G  G V  G     G  VA+K ++ R         +     EIQ L   RH +I++L
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVK-ILNR-QKIRSLDVVGKIRREIQNLKLFRHPHIIKL 81

Query: 755 LGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAK-------GLCYL 807
              +S      ++ EY+  G L + +   K G L  E       E+ +       G+ Y 
Sbjct: 82  YQVISTPSDIFMVMEYVSGGELFDYI--CKNGRLD-EK------ESRRLFQQILSGVDYC 132

Query: 808 HHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEY 867
           H     +++HRD+K  N+LLD+   A +ADFGL+  + D    E + +  GS  Y APE 
Sbjct: 133 H---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG---EFLRTSCGSPNYAAPEV 186

Query: 868 AYTLKVD-EKSDVYSFGVVLLELIAGKKP 895
                    + D++S GV+L  L+ G  P
Sbjct: 187 ISGRLYAGPEVDIWSSGVILYALLCGTLP 215

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 84.8 bits (210), Expect = 4e-17
 Identities = 64/211 (30%), Positives = 90/211 (42%), Gaps = 31/211 (14%)

Query: 699 IIGKGGAGIVYRGSMPD-GIDVAIK-----RLVGRGTGGNDHGFLAEIQTLGRIRHRNIV 752
           ++GKGG G V    +   G   A K     R+  R   G     L E Q L ++  R +V
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRK--GEAMA-LNEKQILEKVNSRFVV 247

Query: 753 RLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKW-ETRYRI-ALEAAKGLCYLHHD 810
            L      +D   L+   M  G L    H    G   + E R    A E   GL  LH  
Sbjct: 248 SLAYAYETKDALCLVLTLMNGGDL--KFHIYHMGQAGFPEARAVFYAAEICCGLEDLH-- 303

Query: 811 CSPLIIHRDVKSNNILLDSDFEAHV--ADFGLAKFLQDAGASECMSSVAGSYGYIAPE-- 866
               I++RD+K  NILLD     H+  +D GLA  + +    + +    G+ GY+APE  
Sbjct: 304 -RERIVYRDLKPENILLDDH--GHIRISDLGLAVHVPE---GQTIKGRVGTVGYMAPEVV 357

Query: 867 --YAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
               YT       D ++ G +L E+IAG+ P
Sbjct: 358 KNERYTFSP----DWWALGCLLYEMIAGQSP 384

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 82.2 bits (204), Expect = 4e-17
 Identities = 58/224 (25%), Positives = 101/224 (45%), Gaps = 23/224 (10%)

Query: 679 AFQRLDFKAEDVLESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGF-- 736
           +  R +   + ++E  +    +G+G  G+VY+     G  VA+KR+        D G   
Sbjct: 8   SSGRENLYFQGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIR---LDAEDEGIPS 64

Query: 737 --LAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRY 794
             + EI  L  + H NIV L+  + +     L++E+M    L ++L   K G    + + 
Sbjct: 65  TAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKI 123

Query: 795 RIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMS 854
               +  +G+ + H      I+HRD+K  N+L++SD    +ADFGLA+           +
Sbjct: 124 -YLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGI--PVRSYT 177

Query: 855 SVAGSYGYIAPEY-----AYTLKVDEKSDVYSFGVVLLELIAGK 893
               +  Y AP+       Y+  V    D++S G +  E+I GK
Sbjct: 178 HEVVTLWYRAPDVLMGSKKYSTSV----DIWSIGCIFAEMITGK 217

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 83.1 bits (206), Expect = 4e-17
 Identities = 59/230 (25%), Positives = 91/230 (39%), Gaps = 42/230 (18%)

Query: 689 DVLESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGN-----DHGFLA----- 738
            +      +  I  G  G V  G   +GI VAIKR+    + G         FL      
Sbjct: 19  AMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLR 78

Query: 739 EIQTLGRIRHRNIVRLLGYVSNRDTNL-----LLYEYMPNGSLGEMLHGAKGG----HLK 789
           EI+ L    H NI+ L     + +        L+ E M    L +++H  +      H++
Sbjct: 79  EIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQ 137

Query: 790 WETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGA 849
           +   Y I      GL  LH      ++HRD+   NILL  + +  + DF LA+   +  A
Sbjct: 138 YFM-YHIL----LGLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLAR---EDTA 186

Query: 850 SECMSS-VAGSYGYIAPE-----YAYTLKVDEKSDVYSFGVVLLELIAGK 893
               +  V   + Y APE       +T  V    D++S G V+ E+   K
Sbjct: 187 DANKTHYVTHRW-YRAPELVMQFKGFTKLV----DMWSAGCVMAEMFNRK 231

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 81.8 bits (203), Expect = 4e-17
 Identities = 52/208 (25%), Positives = 90/208 (43%), Gaps = 24/208 (11%)

Query: 698 NIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHGF----LAEIQTLGRIRHRNIV 752
             IG+G  G V++  +      VA+KR+       +D G     L EI  L  ++H+NIV
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRVR---LDDDDEGVPSSALREICLLKELKHKNIV 64

Query: 753 RLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCS 812
           RL   + +     L++E+     L +      G       +     +  KGL + H    
Sbjct: 65  RLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKS-FLFQLLKGLGFCHSRN- 121

Query: 813 PLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEY----- 867
             ++HRD+K  N+L++ + E  +A+FGLA+         C S+   +  Y  P+      
Sbjct: 122 --VLHRDLKPQNLLINRNGELKLANFGLARAFGI--PVRCYSAEVVTLWYRPPDVLFGAK 177

Query: 868 AYTLKVDEKSDVYSFGVVLLELIAGKKP 895
            Y+  +    D++S G +  EL    +P
Sbjct: 178 LYSTSI----DMWSAGCIFAELANAGRP 201

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 82.6 bits (205), Expect = 5e-17
 Identities = 56/206 (27%), Positives = 88/206 (42%), Gaps = 21/206 (10%)

Query: 698 NIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHGF----LAEIQTLGRIRHRNIV 752
           + +G+G    VY+         VAIK++          G     L EI+ L  + H NI+
Sbjct: 16  DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 75

Query: 753 RLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCS 812
            LL    ++    L++++M    L  ++       L         L   +GL YLH    
Sbjct: 76  GLLDAFGHKSNISLVFDFMET-DLEVIIK-DNSLVLTPSHIKAYMLMTLQGLEYLHQHW- 132

Query: 813 PLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEY----- 867
             I+HRD+K NN+LLD +    +ADFGLAK       +   +    +  Y APE      
Sbjct: 133 --ILHRDLKPNNLLLDENGVLKLADFGLAKSFGS--PNRAYTHQVVTRWYRAPELLFGAR 188

Query: 868 AYTLKVDEKSDVYSFGVVLLELIAGK 893
            Y + V    D+++ G +L EL+   
Sbjct: 189 MYGVGV----DMWAVGCILAELLLRV 210

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 81.5 bits (202), Expect = 8e-17
 Identities = 40/156 (25%), Positives = 71/156 (45%), Gaps = 19/156 (12%)

Query: 698 NIIGKGGAGIVYRG-SMPDGIDVAIK--RLVGRGTGGNDHGF----LAEIQTLGRIRHRN 750
             +G G    VY+G +   G+ VA+K  +L       ++ G     + EI  +  ++H N
Sbjct: 11  EKLGNGTYATVYKGLNKTTGVYVALKEVKL------DSEEGTPSTAIREISLMKELKHEN 64

Query: 751 IVRLLGYVSNRDTNLLLYEYMPN---GSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYL 807
           IVRL   +   +   L++E+M N     +     G     L+         +  +GL + 
Sbjct: 65  IVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFC 124

Query: 808 HHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKF 843
           H +    I+HRD+K  N+L++   +  + DFGLA+ 
Sbjct: 125 HENK---ILHRDLKPQNLLINKRGQLKLGDFGLARA 157

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 80.6 bits (200), Expect = 1e-16
 Identities = 52/205 (25%), Positives = 94/205 (45%), Gaps = 23/205 (11%)

Query: 698 NIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGF----LAEIQTLGRIRHRNIVR 753
             IG+G  G+VY+     G   A+K++  R     D G     + EI  L  ++H NIV+
Sbjct: 8   EKIGEGTYGVVYKAQNNYGETFALKKI--R-LEKEDEGIPSTTIREISILKELKHSNIVK 64

Query: 754 LLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSP 813
           L   +  +   +L++E++    L ++L   +GG      +    L+   G+ Y H     
Sbjct: 65  LYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKS-FLLQLLNGIAYCHDRR-- 120

Query: 814 LIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPE-----YA 868
            ++HRD+K  N+L++ + E  +ADFGLA+           +    +  Y AP+       
Sbjct: 121 -VLHRDLKPQNLLINREGELKIADFGLARAFGI--PVRKYTHEIVTLWYRAPDVLMGSKK 177

Query: 869 YTLKVDEKSDVYSFGVVLLELIAGK 893
           Y+  +    D++S G +  E++ G 
Sbjct: 178 YSTTI----DIWSVGCIFAEMVNGT 198

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 78.1 bits (193), Expect = 1e-16
 Identities = 35/174 (20%), Positives = 62/174 (35%), Gaps = 8/174 (4%)

Query: 202 IGLNGTVPAFLSRLKNLREMYIGYFNTYTGGIPPGFGALTQLQVLDMASCNISGEIPTSL 261
           +G + T     +++ +L  + +      T     G      ++ L + + + +      +
Sbjct: 30  LGQSSTANITEAQMNSLTYITL-ANINVTD--LTGIEYAHNIKDLTINNIHATN--YNPI 84

Query: 262 SRLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQLF 321
           S L  L  L +    +T    P LSGL SL  LD+S +     I      L  +  + L 
Sbjct: 85  SGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLS 144

Query: 322 KNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTG 375
            N     I   L   P L+ L +  +    +    +    KL  L   S  + G
Sbjct: 145 YNGAITDI-MPLKTLPELKSLNIQFDGVH-DY-RGIEDFPKLNQLYAFSQTIGG 195

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 76.5 bits (189), Expect = 5e-16
 Identities = 26/139 (18%), Positives = 56/139 (40%), Gaps = 4/139 (2%)

Query: 456 ASLNQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNN 515
           ++           +         + SL  ++L N  +     +E      I  + I++ +
Sbjct: 20  STFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVTDLTGIE--YAHNIKDLTINNIH 77

Query: 516 ISGEIPYSISQCHSLTSVDLSRNSLYGKIPPGISKLIDLSILNLSRNGITGSIPNEMRNM 575
            +   P  IS   +L  + +    +     P +S L  L++L++S +    SI  ++  +
Sbjct: 78  ATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTL 135

Query: 576 MSLTTLDLSYNNLIGNIPS 594
             + ++DLSYN  I +I  
Sbjct: 136 PKVNSIDLSYNGAITDIMP 154

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 73.5 bits (181), Expect = 6e-15
 Identities = 28/191 (14%), Positives = 65/191 (34%), Gaps = 22/191 (11%)

Query: 94  LTKLVNLTISNVNLTGRLPSEMALLTSLKVFNISGNVFQGNFAGQI-----VRGMTELQV 148
               +N  +   +      ++M  LT +    ++           +     +     ++ 
Sbjct: 22  FKAYLNGLLGQSSTANITEAQMNSLTYI---TLANI--------NVTDLTGIEYAHNIKD 70

Query: 149 LDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLNGIGLNGTV 208
           L   N + T   P  I+ L +L  L   G   T     + S + SL  + ++    + ++
Sbjct: 71  LTINNIHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSI 128

Query: 209 PAFLSRLKNLREMYIGYFNTYTGGIPPGFGALTQLQVLDMASCNISGEIPTSLSRLKLLH 268
              ++ L  +  + + Y N     I P    L +L+ L++    +       +     L+
Sbjct: 129 LTKINTLPKVNSIDLSY-NGAITDIMP-LKTLPELKSLNIQFDGVHDYRG--IEDFPKLN 184

Query: 269 SLFLQMNKLTG 279
            L+     + G
Sbjct: 185 QLYAFSQTIGG 195

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 69.2 bits (170), Expect = 2e-13
 Identities = 33/182 (18%), Positives = 70/182 (38%), Gaps = 11/182 (6%)

Query: 386 KLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLL 445
              + +L Q+     I E   Q  SLT I  +   +      G+     +  + +++   
Sbjct: 24  AYLNGLLGQSS-TANITEA--QMNSLTYITLANINVTDL--TGIEYAHNIKDLTINNIHA 78

Query: 446 SGELP-EKMSGASLNQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESFNLK 504
           +   P   +S  +L +L++   ++T      +  L SL +L + ++  +  I  +   L 
Sbjct: 79  TNYNPISGLS--NLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLP 136

Query: 505 MITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYGKIPPGISKLIDLSILNLSRNGI 564
            + SI++S N    +I   +     L S+++  + +       I     L+ L      I
Sbjct: 137 KVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDGV-HDYRG-IEDFPKLNQLYAFSQTI 193

Query: 565 TG 566
            G
Sbjct: 194 GG 195

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 65.4 bits (160), Expect = 3e-12
 Identities = 25/137 (18%), Positives = 56/137 (40%), Gaps = 11/137 (8%)

Query: 459 NQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNISG 518
             LK + +N+   IP +     +     L  +       +    +  +T I +++ N++ 
Sbjct: 6   TGLKASQDNVN--IPDS--TFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINVT- 57

Query: 519 EIPYSISQCHSLTSVDLSRNSLYGKIPPGISKLIDLSILNLSRNGITGSIPNEMRNMMSL 578
           ++   I   H++  + ++         P IS L +L  L +    +T      +  + SL
Sbjct: 58  DLT-GIEYAHNIKDLTINNIHA-TNYNP-ISGLSNLERLRIMGKDVTSDKIPNLSGLTSL 114

Query: 579 TTLDLSYNNLIGNIPSG 595
           T LD+S++    +I + 
Sbjct: 115 TLLDISHSAHDDSILTK 131

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 62.3 bits (152), Expect = 4e-11
 Identities = 23/189 (12%), Positives = 60/189 (31%), Gaps = 31/189 (16%)

Query: 260 SLSRLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQ 319
           + +++  L  + L    +T  +   +    ++K L ++  + T       + L NL  L+
Sbjct: 39  TEAQMNSLTYITLANINVT-DLTG-IEYAHNIKDLTINNIHATN--YNPISGLSNLERLR 94

Query: 320 LFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTIPR 379
           +   ++       L    +L +L +  +     +   +    K+  +D++ N     I  
Sbjct: 95  IMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-- 152

Query: 380 DLCKGGKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMME 439
                                    L     L  +    + ++      + + P LN + 
Sbjct: 153 -----------------------MPLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLY 187

Query: 440 LDDNLLSGE 448
                + G+
Sbjct: 188 AFSQTIGGK 196

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 58.4 bits (142), Expect = 9e-10
 Identities = 28/168 (16%), Positives = 56/168 (33%), Gaps = 19/168 (11%)

Query: 94  LTKLVNLTISNVNLTGRLPSEMALLTSLKVFNISGNVFQGNFAGQI-----VRGMTELQV 148
           +  L  +T++N+N+T    + +    ++K   I+                 + G++ L+ 
Sbjct: 43  MNSLTYITLANINVTD--LTGIEYAHNIKDLTINNI--------HATNYNPISGLSNLER 92

Query: 149 LDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLNGIGLNGTV 208
           L     + T      ++ L SL  L    +     I    + +  +  I L+  G    +
Sbjct: 93  LRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI 152

Query: 209 PAFLSRLKNLREMYIGYFNTYTGGIPPGFGALTQLQVLDMASCNISGE 256
              L  L  L+ + I                  +L  L   S  I G+
Sbjct: 153 MP-LKTLPELKSLNIQ--FDGVHDYRG-IEDFPKLNQLYAFSQTIGGK 196

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 46.1 bits (110), Expect = 1e-05
 Identities = 18/108 (16%), Positives = 36/108 (33%), Gaps = 4/108 (3%)

Query: 75  SLNVSFMPLFGSIPPEIGLLTKLVNLTISNVNLTGRLPSEMALLTSLKVFNISGNVFQGN 134
            L +    +     P +  LT L  L IS+      + +++  L  +   ++S N    +
Sbjct: 92  RLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITD 151

Query: 135 FAGQIVRGMTELQVLDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTG 182
                ++ + EL+ L+   +         I     L  L        G
Sbjct: 152 IMP--LKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGG 195

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 42.6 bits (101), Expect = 2e-04
 Identities = 21/92 (22%), Positives = 42/92 (45%), Gaps = 4/92 (4%)

Query: 91  IGLLTKLVNLTISNVNLTGRLPSEMALLTSLKVFNISGNVFQGNFAGQIVRGMTELQVLD 150
           I  L+ L  L I   ++T      ++ LTSL + +IS +    +   +I   + ++  +D
Sbjct: 84  ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKI-NTLPKVNSID 142

Query: 151 -AYNNNFTGPLPVEIASLKSLRHLSFGGNYFT 181
            +YN   T  +P  + +L  L+ L+   +   
Sbjct: 143 LSYNGAITDIMP--LKTLPELKSLNIQFDGVH 172

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 80.0 bits (198), Expect = 1e-16
 Identities = 50/198 (25%), Positives = 76/198 (38%), Gaps = 17/198 (8%)

Query: 233 IPPG-FGALTQLQVLDMASCNISGEIPTSL-SRLKLLHSLFLQMNKLTGHIPPQL-SGLI 289
           +    F +  +LQVLD++ C I   I       L  L +L L  N +   +     SGL 
Sbjct: 43  LGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQ-SLALGAFSGLS 100

Query: 290 SLKSLDLSLNYLTGEIPE-SFAALKNLTLLQLFKNNLRG-PIPSFLGDFPNLEVLQVWGN 347
           SL+ L      L   +       LK L  L +  N ++   +P +  +  NLE L +  N
Sbjct: 101 SLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSN 159

Query: 348 NFTFELPENLGRN-----GKLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFIGPIP 402
                +     R         L LD++ N +   I     K  +LK L L  N  +  +P
Sbjct: 160 KIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKELALDTN-QLKSVP 216

Query: 403 EE-LGQCKSLTKIRFSKN 419
           +    +  SL KI    N
Sbjct: 217 DGIFDRLTSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 76.2 bits (188), Expect = 3e-15
 Identities = 48/188 (25%), Positives = 80/188 (42%), Gaps = 17/188 (9%)

Query: 410 SLTKIRFSKNYLNGTIPAGLF-NLPLLNMMELDDNLLSGELPEKMSG--ASLNQLKVANN 466
            L  +  S+  +  TI  G + +L  L+ + L  N +   L        +SL +L     
Sbjct: 53  ELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVET 110

Query: 467 NITGKIPA-AIGNLPSLNILSLQNNRLEGEIPVESF-NLKMITSINISDNNISGEIPYSI 524
           N+   +    IG+L +L  L++ +N ++     E F NL  +  +++S N I   I  + 
Sbjct: 111 NLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTD 168

Query: 525 -SQCHSLTSV----DLSRNSLYGKIPPGISKLIDLSILNLSRNGITGSIPNE-MRNMMSL 578
               H +  +    DLS N +   I PG  K I L  L L  N +  S+P+     + SL
Sbjct: 169 LRVLHQMPLLNLSLDLSLNPM-NFIQPGAFKEIRLKELALDTNQLK-SVPDGIFDRLTSL 226

Query: 579 TTLDLSYN 586
             + L  N
Sbjct: 227 QKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 73.5 bits (181), Expect = 2e-14
 Identities = 46/200 (23%), Positives = 79/200 (39%), Gaps = 24/200 (12%)

Query: 410 SLTKIRFSKNYLNGTIPAGLF-NLPLLNMMELDDNLLSGELPEKMSGA-----SLNQLKV 463
           S   +  S N L   + +  F + P L +++L    +   + +   GA      L+ L +
Sbjct: 29  STKNLDLSFNPL-RHLGSYSFFSFPELQVLDLSRCEIQ-TIED---GAYQSLSHLSTLIL 83

Query: 464 ANNNITGKIPAAI-GNLPSLNILSLQNNRLEGEIPVESF-NLKMITSINISDNNI-SGEI 520
             N I   +       L SL  L      L   +      +LK +  +N++ N I S ++
Sbjct: 84  TGNPIQ-SLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKL 141

Query: 521 PYSISQCHSLTSVDLSRNSLYGKIPPGI----SKLIDLSI-LNLSRNGITGSIPNEMRNM 575
           P   S   +L  +DLS N +   I         ++  L++ L+LS N +   I       
Sbjct: 142 PEYFSNLTNLEHLDLSSNKI-QSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKE 199

Query: 576 MSLTTLDLSYNNLIGNIPSG 595
           + L  L L  N L  ++P G
Sbjct: 200 IRLKELALDTNQL-KSVPDG 218

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 73.1 bits (180), Expect = 3e-14
 Identities = 47/243 (19%), Positives = 79/243 (32%), Gaps = 43/243 (17%)

Query: 257 IPTSLSRLKLLHSLFLQMNKLTGHIPP-QLSGLISLKSLDLSLNYLTGEIPES-FAALKN 314
           +P S   L       L  N L  H+          L+ LDLS   +   I +  + +L +
Sbjct: 26  LPFSTKNL------DLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSH 77

Query: 315 LTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRN-GKLLILDVTSNHL 373
           L+ L L  N ++           +L+ L     N    L      +   L  L+V  N +
Sbjct: 78  LSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLI 136

Query: 374 TGTIPRDLCKGGKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGTIPAGLF--- 430
                          S           +PE      +L  +  S N +  +I        
Sbjct: 137 Q--------------SF---------KLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVL 172

Query: 431 -NLPLLNM-MELDDNLLSGELPEKM-SGASLNQLKVANNNITGKIPAAIGNLPSLNILSL 487
             +PLLN+ ++L  N ++  +         L +L +  N +          L SL  + L
Sbjct: 173 HQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWL 231

Query: 488 QNN 490
             N
Sbjct: 232 HTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 70.8 bits (174), Expect = 2e-13
 Identities = 53/191 (27%), Positives = 75/191 (39%), Gaps = 13/191 (6%)

Query: 141 RGMTELQVLDAYNNNFTGPLPVEI-ASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGL 199
               ELQVLD         +      SL  L  L   GN        ++S + SL+ +  
Sbjct: 49  FSFPELQVLDLSRCEIQT-IEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 107

Query: 200 NGIGLNGTVPAFL-SRLKNLREMYIGYFNTYTGGIPPG-FGALTQLQVLDMASCNISGEI 257
               L  ++  F    LK L+E+ + + N       P  F  LT L+ LD++S  I   I
Sbjct: 108 VETNLA-SLENFPIGHLKTLKELNVAH-NLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-SI 164

Query: 258 P----TSLSRLKLLH-SLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAAL 312
                  L ++ LL+ SL L +N +   I P     I LK L L  N L       F  L
Sbjct: 165 YCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKELALDTNQLKSVPDGIFDRL 223

Query: 313 KNLTLLQLFKN 323
            +L  + L  N
Sbjct: 224 TSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 43.8 bits (104), Expect = 1e-04
 Identities = 18/93 (19%), Positives = 27/93 (29%), Gaps = 14/93 (15%)

Query: 525 SQCH-SLTSVDLSRNSLYGKIPPGISKLIDLSILNLSRNGITGSIPNEMRNMMSLTTLDL 583
                   +      + Y KIP  +        L+LS N +         +   L  LDL
Sbjct: 3   CVEVVPNITYQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDL 59

Query: 584 SYNNLIGNIPSGGQFLAFNETSFIGNPNLCLLR 616
           S    I  I  G         ++    +L  L 
Sbjct: 60  SRCE-IQTIEDG---------AYQSLSHLSTLI 82

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 82.5 bits (204), Expect = 2e-16
 Identities = 58/212 (27%), Positives = 86/212 (40%), Gaps = 30/212 (14%)

Query: 699 IIGKGGAGIVYRGSMPDGIDV-AIK-----RLVGRGTGGNDHGFLAEIQTLGRIRHRNIV 752
           ++G+GG G V+   M     + A K     RL  R   G     + E + L ++  R IV
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRK--GYQGA-MVEKKILAKVHSRFIV 248

Query: 753 RLLGYVSNRDTNLLLYEYMPNGSLGEMLH----GAKGGHLKWETRYRI-ALEAAKGLCYL 807
            L      +    L+   M  G +    H           + E R      +   GL +L
Sbjct: 249 SLAYAFETKTDLCLVMTIMNGGDI--RYHIYNVDEDNPGFQ-EPRAIFYTAQIVSGLEHL 305

Query: 808 HHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPE- 866
           H      II+RD+K  N+LLD D    ++D GLA   +           AG+ G++APE 
Sbjct: 306 H---QRNIIYRDLKPENVLLDDDGNVRISDLGLAV--ELKAGQTKTKGYAGTPGFMAPEL 360

Query: 867 ---YAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
                Y   V    D ++ GV L E+IA + P
Sbjct: 361 LLGEEYDFSV----DYFALGVTLYEMIAARGP 388

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 80.9 bits (200), Expect = 3e-16
 Identities = 52/254 (20%), Positives = 87/254 (34%), Gaps = 65/254 (25%)

Query: 688 EDVLESLKDENIIGKGGAGIVYRGS-MPDGIDVAIKRLVGRGTGGNDHGF-LAEIQTLGR 745
           E   +       +G G  GIV     +  G   A+K+++       D  +   E+  +  
Sbjct: 3   ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVL------QDPRYKNRELDIMKV 56

Query: 746 IRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKW--------------- 790
           + H NI++L+ Y              P+             +                  
Sbjct: 57  LDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVI 116

Query: 791 -----ETRYRIALEAAK-------------------GLCYLHHDCSPLIIHRDVKSNNIL 826
                +T +++     +                    + ++H   S  I HRD+K  N+L
Sbjct: 117 MEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH---SLGICHRDIKPQNLL 173

Query: 827 LDS-DFEAHVADFGLAKFLQDAGASECMSS-VAGSYGYIAPE-----YAYTLKVDEKSDV 879
           ++S D    + DFG AK L     SE   + +   + Y APE       YT  +    D+
Sbjct: 174 VNSKDNTLKLCDFGSAKKLIP---SEPSVAYICSRF-YRAPELMLGATEYTPSI----DL 225

Query: 880 YSFGVVLLELIAGK 893
           +S G V  ELI GK
Sbjct: 226 WSIGCVFGELILGK 239

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 80.9 bits (200), Expect = 3e-16
 Identities = 51/226 (22%), Positives = 83/226 (36%), Gaps = 55/226 (24%)

Query: 696 DENIIGKGGAGIVYRGSM-PDGIDVAIKRL-----VGRGTGGNDHGFLAEIQTLGRI-RH 748
              ++G G  G V +          A+K L       R           E++   R  + 
Sbjct: 66  TSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR-----------EVELHWRASQC 114

Query: 749 RNIVRLLGY----VSNRDTNLLLYEYMPNGSLGEMLHGAKGGHL------KWETRY---- 794
            +IVR++       + R   L++ E +             GG L      + +  +    
Sbjct: 115 PHIVRIVDVYENLYAGRKCLLIVMECL------------DGGELFSRIQDRGDQAFTERE 162

Query: 795 --RIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAH---VADFGLAKFLQDAGA 849
              I     + + YLH   S  I HRDVK  N+L  S        + DFG AK       
Sbjct: 163 ASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS--- 216

Query: 850 SECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
              +++   +  Y+APE     K D+  D++S GV++  L+ G  P
Sbjct: 217 HNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 262

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 80.0 bits (198), Expect = 4e-16
 Identities = 51/202 (25%), Positives = 87/202 (43%), Gaps = 17/202 (8%)

Query: 700 IGKGGAGIVYRGS-MPDGIDVAIKRLVGRGTGGNDHGFLA----EIQTLGRIRHRNIVRL 754
           +G+G  G V   +       VA+K  + R               EI  L  +RH +I++L
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALK-FISR-QLLKKSDMHMRVEREISYLKLLRHPHIIKL 74

Query: 755 LGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPL 814
              ++     +++ EY   G L + +   +   +  +   R   +    + Y H      
Sbjct: 75  YDVITTPTDIVMVIEYA-GGELFDYI--VEKKRMTEDEGRRFFQQIICAIEYCH---RHK 128

Query: 815 IIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVD 874
           I+HRD+K  N+LLD +    +ADFGL+  + D      + +  GS  Y APE        
Sbjct: 129 IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG---NFLKTSCGSPNYAAPEVINGKLYA 185

Query: 875 -EKSDVYSFGVVLLELIAGKKP 895
             + DV+S G+VL  ++ G+ P
Sbjct: 186 GPEVDVWSCGIVLYVMLVGRLP 207

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 79.2 bits (196), Expect = 6e-16
 Identities = 53/210 (25%), Positives = 91/210 (43%), Gaps = 37/210 (17%)

Query: 700 IGKGGAGIVYRGS-MPDGIDVAIK--RLVGRGTGGNDHGFLAEIQTLGRIR-HRNIVRLL 755
           +G+G    V+    + +   V +K  + V             EI+ L  +R   NI+ L 
Sbjct: 44  LGRGKYSEVFEAINITNNEKVVVKILKPV------KKKKIKREIKILENLRGGPNIITLA 97

Query: 756 GYVSNRDTN--LLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSP 813
             V +  +    L++E++ N    ++        +    R+ +  E  K L Y H   S 
Sbjct: 98  DIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDI----RFYM-YEILKALDYCH---SM 149

Query: 814 LIIHRDVKSNNILLDSDF-EAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPE------ 866
            I+HRDVK +N+++D +  +  + D+GLA+F       E    VA  Y +  PE      
Sbjct: 150 GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP--GQEYNVRVASRY-FKGPELLVDYQ 206

Query: 867 -YAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
            Y Y+L      D++S G +L  +I  K+P
Sbjct: 207 MYDYSL------DMWSLGCMLASMIFRKEP 230

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 79.3 bits (196), Expect = 7e-16
 Identities = 56/223 (25%), Positives = 91/223 (40%), Gaps = 40/223 (17%)

Query: 689 DVLESLKDENIIGKGGAGIVYRGS-MPDGIDVAIKRLVGRGTGGNDHGFLA-----EIQT 742
           ++ ++      +G G  G V        G  VAIK+L    +        A     E+  
Sbjct: 21  ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKL----SRPFQSEIFAKRAYRELLL 76

Query: 743 LGRIRHRNIVRLLG--YVSNRDTNL----LLYEYMPNGSLGEMLHGAKGGHLKWETRYRI 796
           L  ++H N++ LL     ++   N     L+  +M        L    G     E    +
Sbjct: 77  LKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFM-----QTDLQKIMGLKFSEEKIQYL 131

Query: 797 ALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSS- 855
             +  KGL Y+H   S  ++HRD+K  N+ ++ D E  + DFGLA+      A   M+  
Sbjct: 132 VYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLAR-----HADAEMTGY 183

Query: 856 VAGSYGYIAPE-----YAYTLKVDEKSDVYSFGVVLLELIAGK 893
           V   + Y APE       Y   V    D++S G ++ E++ GK
Sbjct: 184 VVTRW-YRAPEVILSWMHYNQTV----DIWSVGCIMAEMLTGK 221

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 81.5 bits (201), Expect = 7e-16
 Identities = 58/212 (27%), Positives = 86/212 (40%), Gaps = 32/212 (15%)

Query: 699 IIGKGGAGIVYRGSMPDGIDV-AIK-----RLVGRGTGGNDHGFLAEIQTLGRI---RHR 749
           IIG+GG G VY     D   + A+K     R+  +   G     L E   L  +      
Sbjct: 196 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQ--GETLA-LNERIMLSLVSTGDCP 252

Query: 750 NIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRI-ALEAAKGLCYLH 808
            IV +       D    + + M  G L    H ++ G    E   R  A E   GL ++H
Sbjct: 253 FIVCMSYAFHTPDKLSFILDLMNGGDL--HYHLSQHGVFS-EADMRFYAAEIILGLEHMH 309

Query: 809 HDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPE-- 866
              +  +++RD+K  NILLD      ++D GLA             +  G++GY+APE  
Sbjct: 310 ---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP----HASVGTHGYMAPEVL 362

Query: 867 ---YAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
               AY        D +S G +L +L+ G  P
Sbjct: 363 QKGVAYDSSA----DWFSLGCMLFKLLRGHSP 390

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 79.2 bits (196), Expect = 7e-16
 Identities = 53/224 (23%), Positives = 90/224 (40%), Gaps = 48/224 (21%)

Query: 698 NIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHGF----LAEIQTLGRIRHRNIV 752
             IG+G  G V++      G  VA+K++          GF    L EI+ L  ++H N+V
Sbjct: 23  AKIGQGTFGEVFKARHRKTGQKVALKKV--L-MENEKEGFPITALREIKILQLLKHENVV 79

Query: 753 RLLGYVSNRDTNL--------LLYEYMPN---GSLGEMLHGAKGGHLKWETRYRIALEAA 801
            L+     + +          L++++  +   G L  +L       +K     R+     
Sbjct: 80  NLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIK-----RVMQMLL 134

Query: 802 KGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYG 861
            GL Y+H +    I+HRD+K+ N+L+  D    +ADFGLA+       S   +S    Y 
Sbjct: 135 NGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAF-----SLAKNSQPNRYT 186

Query: 862 -------YIAPEY-----AYTLKVDEKSDVYSFGVVLLELIAGK 893
                  Y  PE       Y   +    D++  G ++ E+    
Sbjct: 187 NRVVTLWYRPPELLLGERDYGPPI----DLWGAGCIMAEMWTRS 226

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 79.3 bits (196), Expect = 8e-16
 Identities = 60/219 (27%), Positives = 99/219 (45%), Gaps = 31/219 (14%)

Query: 689 DVLESLKDENIIGKGGAGIVYRGS-MPDGIDVAIKRLVGRGTGGNDHGFLA-----EIQT 742
            VL+  ++   IG G  GIV          +VAIK+L    +    +   A     E+  
Sbjct: 22  TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKL----SRPFQNQTHAKRAYRELVL 77

Query: 743 LGRIRHRNIVRLLG-YVSNRDTNL-----LLYEYMPNGSLGEMLH-GAKGGHLKWETRYR 795
           +  + H+NI+ LL  +   +         ++ E M   +L +++        + +   Y+
Sbjct: 78  MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQMELDHERMSYLL-YQ 135

Query: 796 IALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMS- 854
           +      G+ +LH   S  IIHRD+K +NI++ SD    + DFGLA+    AG S  M+ 
Sbjct: 136 ML----CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTP 185

Query: 855 SVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGK 893
            V   Y Y APE    +   E  D++S G ++ E+I G 
Sbjct: 186 YVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 78.2 bits (193), Expect = 8e-16
 Identities = 46/232 (19%), Positives = 99/232 (42%), Gaps = 23/232 (9%)

Query: 362 KLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYL 421
           + +  ++    +T  + ++      +  +I   +  I  + + +    ++TK+  + N L
Sbjct: 25  ETIKDNLKKKSVTDAVTQNELN--SIDQIIANNSD-IKSV-QGIQYLPNVTKLFLNGNKL 80

Query: 422 NGTIPAGLFNLPLLNMMELDDNLLSGELPEKMSG----ASLNQLKVANNNITGKIPAAIG 477
               P  L NL  L  + LD+N +       +S       L  L + +N I+  I   + 
Sbjct: 81  TDIKP--LANLKNLGWLFLDENKVK-----DLSSLKDLKKLKSLSLEHNGIS-DING-LV 131

Query: 478 NLPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIPYSISQCHSLTSVDLSR 537
           +LP L  L L NN++     +    L  + ++++ DN IS +I   ++    L ++ LS+
Sbjct: 132 HLPQLESLYLGNNKITDITVLS--RLTKLDTLSLEDNQIS-DIV-PLAGLTKLQNLYLSK 187

Query: 538 NSLYGKIPPGISKLIDLSILNLSRNGITGSIPNEMRNMMSLTTLDLSYNNLI 589
           N +   +   ++ L +L +L L          N   N++   T+  +  +L+
Sbjct: 188 NHI-SDLRA-LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLV 237

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 77.4 bits (191), Expect = 1e-15
 Identities = 49/290 (16%), Positives = 102/290 (35%), Gaps = 43/290 (14%)

Query: 239 ALTQLQVLDMASCNISGEIPTSLSRLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSL 298
           A  +    ++   +++  +    + L  +  +    + +   +   +  L ++  L L+ 
Sbjct: 22  AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQG-IQYLPNVTKLFLNG 77

Query: 299 NYLTGEIPESFAALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLG 358
           N LT +I +  A LKNL  L L +N ++    S L D   L+ L +  N  + ++   L 
Sbjct: 78  NKLT-DI-KPLANLKNLGWLFLDENKVK--DLSSLKDLKKLKSLSLEHNGIS-DI-NGLV 131

Query: 359 RNGKLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSK 418
              +L  L + +N +T     D+                       L +   L  +    
Sbjct: 132 HLPQLESLYLGNNKIT-----DI---------------------TVLSRLTKLDTLSLED 165

Query: 419 NYLNGTIPAGLFNLPLLNMMELDDNLLSGELPEKMSGASLNQLKVANNNITGKIPAAIGN 478
           N +  +    L  L  L  + L  N +S +L       +L+ L++ +     K      N
Sbjct: 166 NQI--SDIVPLAGLTKLQNLYLSKNHIS-DLRALAGLKNLDVLELFSQECLNKPINHQSN 222

Query: 479 LPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNI--SGEIPYSISQ 526
           L   N +   +  L     +   +       N+  +    + E+ +   Q
Sbjct: 223 LVVPNTVKNTDGSLVTPEIIS--DDGDYEKPNVKWHLPEFTNEVSFIFYQ 270

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 77.0 bits (190), Expect = 2e-15
 Identities = 44/282 (15%), Positives = 106/282 (37%), Gaps = 41/282 (14%)

Query: 307 ESFAALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLIL 366
            S  A        L K ++   +     +  +++ +    ++    + + +     +  L
Sbjct: 18  FSDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKL 73

Query: 367 DVTSNHLTGTIPRDLCKGGKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGTIP 426
            +  N LT     D+                     + L   K+L  +   +N +   + 
Sbjct: 74  FLNGNKLT-----DI---------------------KPLANLKNLGWLFLDENKVK-DLS 106

Query: 427 AGLFNLPLLNMMELDDNLLSGELPEKMSGASLNQLKVANNNITGKIPAAIGNLPSLNILS 486
             L +L  L  + L+ N +S ++   +    L  L + NN IT  I   +  L  L+ LS
Sbjct: 107 -SLKDLKKLKSLSLEHNGIS-DINGLVHLPQLESLYLGNNKIT-DIT-VLSRLTKLDTLS 162

Query: 487 LQNNRLEGEIPVESFNLKMITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYGKIPP 546
           L++N++   +P+    L  + ++ +S N+IS ++  +++   +L  ++L       K   
Sbjct: 163 LEDNQISDIVPLA--GLTKLQNLYLSKNHIS-DLR-ALAGLKNLDVLELFSQECLNKPIN 218

Query: 547 GISKLIDLSILNLSRNGITGSIPNEMRNMMSLTTLDLSYNNL 588
             S L+  + +  +   +    P  + +       ++ ++  
Sbjct: 219 HQSNLVVPNTVKNTDGSLVT--PEIISDDGDYEKPNVKWHLP 258

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 76.2 bits (188), Expect = 3e-15
 Identities = 41/219 (18%), Positives = 94/219 (42%), Gaps = 15/219 (6%)

Query: 386 KLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLL 445
           +     L +      +     +  S+ +I  + + +  ++  G+  LP +  + L+ N L
Sbjct: 25  ETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNGNKL 80

Query: 446 SGELPEKMSGASLNQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESFNLKM 505
           + ++    +  +L  L +  N +   + + + +L  L  LSL++N +     +   +L  
Sbjct: 81  T-DIKPLANLKNLGWLFLDENKVK-DLSS-LKDLKKLKSLSLEHNGISDINGLV--HLPQ 135

Query: 506 ITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYGKIPPGISKLIDLSILNLSRNGIT 565
           + S+ + +N I+ +I   +S+   L ++ L  N +   I P ++ L  L  L LS+N I+
Sbjct: 136 LESLYLGNNKIT-DIT-VLSRLTKLDTLSLEDNQIS-DIVP-LAGLTKLQNLYLSKNHIS 191

Query: 566 GSIPNEMRNMMSLTTLDLSYNNLIGNIPSGGQFLAFNET 604
             +   +  + +L  L+L     +    +    L    T
Sbjct: 192 -DLRA-LAGLKNLDVLELFSQECLNKPINHQSNLVVPNT 228

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 70.9 bits (174), Expect = 2e-13
 Identities = 55/259 (21%), Positives = 103/259 (39%), Gaps = 20/259 (7%)

Query: 118 LTSLKVFNISGNVFQGNFAGQIVRGMTELQVLDAYNNNFTGPLPVEIASLKSLRHLSFGG 177
                  N+                +  +  + A N++        I  L ++  L   G
Sbjct: 23  FAETIKDNLKKKSVTDA---VTQNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNG 77

Query: 178 NYFTGKIPQSYSEIQSLEYIGLNGIGLNGTVPAFLSRLKNLREMYIGYFNTYTGGIPPGF 237
           N  T  I    + +++L ++ L+   +       L  LK L+ + +   +     I    
Sbjct: 78  NKLT-DIK-PLANLKNLGWLFLDENKVKDLSS--LKDLKKLKSLSLE--HNGISDING-L 130

Query: 238 GALTQLQVLDMASCNISGEIPTSLSRLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLS 297
             L QL+ L + +  I+    T LSRL  L +L L+ N+++  I P L+GL  L++L LS
Sbjct: 131 VHLPQLESLYLGNNKIT--DITVLSRLTKLDTLSLEDNQIS-DIVP-LAGLTKLQNLYLS 186

Query: 298 LNYLTGEIPESFAALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENL 357
            N+++ ++  + A LKNL +L+LF         +   +        V   + +   PE +
Sbjct: 187 KNHIS-DL-RALAGLKNLDVLELFSQECLNKPINHQSNLVVPN--TVKNTDGSLVTPEII 242

Query: 358 GRNGKLLILDVTSNHLTGT 376
             +G     +V  +    T
Sbjct: 243 SDDGDYEKPNVKWHLPEFT 261

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 65.8 bits (161), Expect = 1e-11
 Identities = 53/280 (18%), Positives = 94/280 (33%), Gaps = 60/280 (21%)

Query: 94  LTKLVNLTISNVNLTGRLPSEMALLTSLKVFNISGNVFQGNFAGQI-----VRGMTELQV 148
           L  +  +  +N ++   +   +  L ++    ++GN        ++     +  +  L  
Sbjct: 45  LNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFLNGN--------KLTDIKPLANLKNLGW 94

Query: 149 LDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLNGIGLNGTV 208
           L    N         +  LK L+ LS   N            I  +              
Sbjct: 95  LFLDENKVKDLSS--LKDLKKLKSLSLEHN-----------GISDIN------------- 128

Query: 209 PAFLSRLKNLREMYIGYFNTYTGGIPPGFGALTQLQVLDMASCNISGEIPTSLSRLKLLH 268
              L  L  L  +Y+G  N     I      LT+L  L +    IS +I   L+ L  L 
Sbjct: 129 --GLVHLPQLESLYLG--NNKITDITV-LSRLTKLDTLSLEDNQIS-DIV-PLAGLTKLQ 181

Query: 269 SLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQLFKNNLRGP 328
           +L+L  N ++  +   L+GL +L  L+L       +     + L     ++    +L  P
Sbjct: 182 NLYLSKNHIS-DLRA-LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTP 239

Query: 329 IP-SFLGDFPNLEVLQVWGN-------NFTFELPENLGRN 360
              S  GD+    V   W         +F F  P  +G+ 
Sbjct: 240 EIISDDGDYEKPNVK--WHLPEFTNEVSFIFYQPVTIGKA 277

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 48.1 bits (115), Expect = 7e-06
 Identities = 36/217 (16%), Positives = 76/217 (35%), Gaps = 26/217 (11%)

Query: 91  IGLLTKLVNLTISNVNLTGRLPSEMALLTSLKVFNISGNVFQGNFAGQI-----VRGMTE 145
           I  L  +  L ++   LT  +   +A L +L    +  N        ++     ++ + +
Sbjct: 64  IQYLPNVTKLFLNGNKLT-DI-KPLANLKNLGWLFLDEN--------KVKDLSSLKDLKK 113

Query: 146 LQVLDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLNGIGLN 205
           L+ L   +N  +      +  L  L  L  G N  T  I    S +  L+ + L    + 
Sbjct: 114 LKSLSLEHNGISDING--LVHLPQLESLYLGNNKIT-DI-TVLSRLTKLDTLSLEDNQI- 168

Query: 206 GTVPAFLSRLKNLREMYIGYFNTYTGGIPPGFGALTQLQVLDMASCNISGEIPTSLSRLK 265
            +    L+ L  L+ +Y+     +   +      L  L VL++ S     +     S L 
Sbjct: 169 -SDIVPLAGLTKLQNLYLS--KNHISDLRA-LAGLKNLDVLELFSQECLNKPINHQSNLV 224

Query: 266 LLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLT 302
           + +++      L    P  +S     +  ++  +   
Sbjct: 225 VPNTVKNTDGSLVT--PEIISDDGDYEKPNVKWHLPE 259

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 78.2 bits (193), Expect = 9e-16
 Identities = 45/206 (21%), Positives = 71/206 (34%), Gaps = 33/206 (16%)

Query: 144 TELQVLDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLNGIG 203
            +  +L    N         +     L  L+               E+  L         
Sbjct: 31  KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRA-----------ELTKL--------- 70

Query: 204 LNGTVPAFLSRLKNLREMYIGYFNTYTGGIPPGFGALTQLQVLDMASCNISGEIPTSLSR 263
                      L  L  + + + N     +P     L  L VLD++   ++     +L  
Sbjct: 71  -----QVD-GTLPVLGTLDLSH-NQLQS-LPLLGQTLPALTVLDVSFNRLTSLPLGALRG 122

Query: 264 LKLLHSLFLQMNKLTGHIPPQL-SGLISLKSLDLSLNYLTGEIPES-FAALKNLTLLQLF 321
           L  L  L+L+ N+L   +PP L +    L+ L L+ N LT E+P      L+NL  L L 
Sbjct: 123 LGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQ 180

Query: 322 KNNLRGPIPSFLGDFPNLEVLQVWGN 347
           +N+L   IP        L    + GN
Sbjct: 181 ENSLYT-IPKGFFGSHLLPFAFLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 76.7 bits (189), Expect = 3e-15
 Identities = 54/216 (25%), Positives = 77/216 (35%), Gaps = 40/216 (18%)

Query: 233 IPPGFGALTQLQVLDMASCNISGEIPTSLSRLKLLHSLFLQMNKLTGHIPPQLSGLISLK 292
           +PP         +L ++   +      +L     L  L L   +LT  +      L  L 
Sbjct: 25  LPPD--LPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQV-DGTLPVLG 80

Query: 293 SLDLSLNYLTGEIPESFAALKNLTLLQLFKNNLRGPIPSFLGDF---PNLEVLQVWGNNF 349
           +LDLS N L   +P     L  LT+L +  N L   +P   G       L+ L + GN  
Sbjct: 81  TLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTS-LPL--GALRGLGELQELYLKGNEL 136

Query: 350 TFELPENLGRN-GKLLILDVTSNHLTGTIPRDLCKG-GKLKSLILMQNFFIGPIPEELGQ 407
              LP  L     KL  L + +N+LT  +P  L  G   L +L+L +N            
Sbjct: 137 K-TLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQEN-----------S 183

Query: 408 CKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDN 443
             +              IP G F   LL    L  N
Sbjct: 184 LYT--------------IPKGFFGSHLLPFAFLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 76.7 bits (189), Expect = 3e-15
 Identities = 61/250 (24%), Positives = 86/250 (34%), Gaps = 58/250 (23%)

Query: 267 LHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQLFKNNLR 326
              +      LT  +PP L        L LS N L      +      LT L L +  L 
Sbjct: 12  HLEVNCDKRNLT-ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT 68

Query: 327 GPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDLCKG-G 385
             +    G  P L  L +  N     LP        L +LDV+ N LT ++P    +G G
Sbjct: 69  K-LQVD-GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLG 124

Query: 386 KLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLL 445
           +L+ L L  N               L            T+P GL                
Sbjct: 125 ELQELYLKGN--------------ELK-----------TLPPGLL-----------TPT- 147

Query: 446 SGELPEKMSGASLNQLKVANNNITGKIPAAI-GNLPSLNILSLQNNRLEGEIPVESFNLK 504
                       L +L +ANNN+T ++PA +   L +L+ L LQ N L   IP   F   
Sbjct: 148 ----------PKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLYT-IPKGFFGSH 195

Query: 505 MITSINISDN 514
           ++    +  N
Sbjct: 196 LLPFAFLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 75.1 bits (185), Expect = 7e-15
 Identities = 44/189 (23%), Positives = 73/189 (38%), Gaps = 33/189 (17%)

Query: 410 SLTKIRFSKNYLNGTIPAGLF-NLPLLNMMELDDNLLSGELPEKMSGASLNQLKVANNNI 468
             T +  S+N L  T           L  + LD   L+ +L    +   L  L +++N +
Sbjct: 32  DTTILHLSENLL-YTFSLATLMPYTRLTQLNLDRAELT-KLQVDGTLPVLGTLDLSHNQL 89

Query: 469 TGKIPAAIGNLPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIPYSISQCH 528
              +P     LP+L +L +  NRL   +P+ +                            
Sbjct: 90  Q-SLPLLGQTLPALTVLDVSFNRLT-SLPLGALR-----------------------GLG 124

Query: 529 SLTSVDLSRNSLYGKIPPGI-SKLIDLSILNLSRNGITGSIPNEM-RNMMSLTTLDLSYN 586
            L  + L  N L   +PPG+ +    L  L+L+ N +T  +P  +   + +L TL L  N
Sbjct: 125 ELQELYLKGNEL-KTLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQEN 182

Query: 587 NLIGNIPSG 595
           +L   IP G
Sbjct: 183 SL-YTIPKG 190

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 69.4 bits (170), Expect = 7e-13
 Identities = 32/135 (23%), Positives = 58/135 (42%), Gaps = 7/135 (5%)

Query: 456 ASLNQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNN 515
                L ++ N +     A +     L  L+L    L  ++ V+   L ++ ++++S N 
Sbjct: 31  KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQVDG-TLPVLGTLDLSHNQ 88

Query: 516 ISGEIPYSISQCHSLTSVDLSRNSLYGKIPPGI-SKLIDLSILNLSRNGITGSIPNEM-R 573
           +   +P       +LT +D+S N L   +P G    L +L  L L  N +  ++P  +  
Sbjct: 89  LQ-SLPLLGQTLPALTVLDVSFNRL-TSLPLGALRGLGELQELYLKGNELK-TLPPGLLT 145

Query: 574 NMMSLTTLDLSYNNL 588
               L  L L+ NNL
Sbjct: 146 PTPKLEKLSLANNNL 160

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 46.6 bits (111), Expect = 2e-05
 Identities = 17/65 (26%), Positives = 27/65 (41%), Gaps = 4/65 (6%)

Query: 525 SQCH-SLTSVDLSRNSLYGKIPPGISKLIDLSILNLSRNGITGSIPNEMRNMMSLTTLDL 583
                S   V+  + +L   +PP + K  D +IL+LS N +       +     LT L+L
Sbjct: 6   VSKVASHLEVNCDKRNL-TALPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLNL 62

Query: 584 SYNNL 588
               L
Sbjct: 63  DRAEL 67

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 45.5 bits (108), Expect = 5e-05
 Identities = 52/266 (19%), Positives = 78/266 (29%), Gaps = 88/266 (33%)

Query: 57  SAHCSFSGVTCDQDSRVVSLNVSFMPLFGSIPPEIGLLTKLVNLTISNVNLTGRLPSEMA 116
                 S +  + D R  +L         ++PP   L      L +S   L     + + 
Sbjct: 5   EVSKVASHLEVNCDKR--NL--------TALPP--DLPKDTTILHLSENLLYTFSLATLM 52

Query: 117 LLTSLKVFNISGN------VFQGNFAGQIVR--------------GMTELQVLDAYNNNF 156
             T L   N+         V         +                +  L VLD   N  
Sbjct: 53  PYTRLTQLNLDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRL 112

Query: 157 TGPLPVEI-ASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLNGIGLNGTVPAFLSRL 215
           T  LP+     L  L+ L   GN           E+++L                     
Sbjct: 113 TS-LPLGALRGLGELQELYLKGN-----------ELKTL--------------------- 139

Query: 216 KNLREMYIGYFNTYTGGIPPG-FGALTQLQVLDMASCNISGEIPTSL-SRLKLLHSLFLQ 273
                             PPG      +L+ L +A+ N++ E+P  L + L+ L +L LQ
Sbjct: 140 ------------------PPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQ 180

Query: 274 MNKLTGHIPPQLSGLISLKSLDLSLN 299
            N L   IP    G   L    L  N
Sbjct: 181 ENSLY-TIPKGFFGSHLLPFAFLHGN 205

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 76.2 bits (188), Expect = 1e-15
 Identities = 32/193 (16%), Positives = 70/193 (36%), Gaps = 33/193 (17%)

Query: 410 SLTKIRFSKNYLNGTIPAGLF-NLPLLNMMELDDNLLSGELPEKMSGASLNQLKVANNNI 468
           S   ++  + +L  TIP+  F NLP ++ + +  +                        +
Sbjct: 32  STQTLKLIETHLR-TIPSHAFSNLPNISRIYVSID----------------------VTL 68

Query: 469 TGKIPA-AIGNLPSLNILSLQNNRLEGEIPVESF-NLKMITSINISDNNISGEIP--YSI 524
             ++ + +  NL  +  + ++N R    I  ++   L ++  + I +  +    P    +
Sbjct: 69  Q-QLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKV 126

Query: 525 SQCHSLTSVDLSRNSLYGKIPPGI-SKLIDLSI-LNLSRNGITGSIPNEMRNMMSLTTLD 582
                   ++++ N     IP      L + ++ L L  NG T S+     N   L  + 
Sbjct: 127 YSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVY 185

Query: 583 LSYNNLIGNIPSG 595
           L+ N  +  I   
Sbjct: 186 LNKNKYLTVIDKD 198

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 70.4 bits (173), Expect = 1e-13
 Identities = 41/245 (16%), Positives = 81/245 (33%), Gaps = 47/245 (19%)

Query: 257 IPTSLSRLKLLHSLFLQMNKLTGHIPPQ-LSGLISLKSLDLSLNYLTGEIPE-SFAALKN 314
           +P S   L       L    L   IP    S L ++  + +S++    ++   SF  L  
Sbjct: 29  LPPSTQTL------KLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSK 81

Query: 315 LTLLQLFKNNLRGPIPS--FLGDFPNLEVLQVWGNNFTFELPEN--LGRNGKLLILDVTS 370
           +T +++        I         P L+ L ++        P+   +       IL++T 
Sbjct: 82  VTHIEIRNTRNLTYIDPDALKE-LPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITD 139

Query: 371 NHLTGTIPRDLCKG--GKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGTIPAG 428
           N    +IP +  +G   +  +L L  N                            ++   
Sbjct: 140 NPYMTSIPVNAFQGLCNETLTLKLYNN-----------------GFT--------SVQGY 174

Query: 429 LFNLPLLNMMELDDNLLSGELPEKM-SGA--SLNQLKVANNNITGKIPAAI-GNLPSLNI 484
            FN   L+ + L+ N     + +    G     + L V+  ++T  +P+    +L  L  
Sbjct: 175 AFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSKGLEHLKELIA 233

Query: 485 LSLQN 489
            +   
Sbjct: 234 RNTWT 238

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 68.5 bits (168), Expect = 6e-13
 Identities = 38/183 (20%), Positives = 68/183 (37%), Gaps = 21/183 (11%)

Query: 456 ASLNQLKVANNNITGKIPA-AIGNLPSLNILSL-QNNRLEGEIPVESF-NLKMITSINIS 512
            S   LK+   ++   IP+ A  NLP+++ + +  +  L+ ++   SF NL  +T I I 
Sbjct: 31  PSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQ-QLESHSFYNLSKVTHIEIR 88

Query: 513 DNNISGEIPYSI-SQCHSLTSVDLSRNSLYGKIPPG--ISKLIDLSILNLSRNGITGSIP 569
           +      I      +   L  + +    L    P    +       IL ++ N    SIP
Sbjct: 89  NTRNLTYIDPDALKELPLLKFLGIFNTGL-KMFPDLTKVYSTDIFFILEITDNPYMTSIP 147

Query: 570 NEM-RNMMSLT-TLDLSYNNLIGNIPSGGQFLAFNETSFI-----GNPNLCLLRNGTCQS 622
               + + + T TL L  N    ++       AFN T         N  L ++       
Sbjct: 148 VNAFQGLCNETLTLKLYNNG-FTSVQGY----AFNGTKLDAVYLNKNKYLTVIDKDAFGG 202

Query: 623 LIN 625
           + +
Sbjct: 203 VYS 205

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 65.8 bits (161), Expect = 6e-12
 Identities = 38/213 (17%), Positives = 68/213 (31%), Gaps = 16/213 (7%)

Query: 169 SLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLNGIGLNGTVP--AFLSRLKNLREMYIGYF 226
           S + L     +       ++S + ++  I ++       +   +F   L  +  + I   
Sbjct: 32  STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSF-YNLSKVTHIEIRN- 89

Query: 227 NTYTGGIPPG-FGALTQLQVLDMASCNISGEIP--TSLSRLKLLHSLFLQMNKLTGHIPP 283
                 I P     L  L+ L + +  +    P  T +    +   L +  N     IP 
Sbjct: 90  TRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPV 148

Query: 284 Q-LSGLIS-LKSLDLSLNYLTGEIPESFAALKNLTLLQLFKNNLRGPIP--SFLGDFPNL 339
               GL +   +L L  N  T  +         L  + L KN     I   +F G +   
Sbjct: 149 NAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGP 207

Query: 340 EVLQVWGNNFTFELPENLGRNGKLLILDVTSNH 372
            +L V   + T  LP     +  L  L   +  
Sbjct: 208 SLLDVSQTSVT-ALPSKGLEH--LKELIARNTW 237

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 79.1 bits (195), Expect = 2e-15
 Identities = 61/218 (27%), Positives = 93/218 (42%), Gaps = 29/218 (13%)

Query: 689 DVLESLKDENIIGKGGAGIVYRGS-MPDGIDVAIKRLVGRGTGGNDHGFLA-----EIQT 742
            VL+  ++   IG G  GIV          +VAIK+L    +    +   A     E+  
Sbjct: 59  TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKL----SRPFQNQTHAKRAYRELVL 114

Query: 743 LGRIRHRNIVRLL------GYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRI 796
           +  + H+NI+ LL        +       L+ E M        L       L  E    +
Sbjct: 115 MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-----LCQVIQMELDHERMSYL 169

Query: 797 ALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMS-S 855
             +   G+ +LH   S  IIHRD+K +NI++ SD    + DFGLA+    AG S  M+  
Sbjct: 170 LYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPY 223

Query: 856 VAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGK 893
           V   Y Y APE    +   E  D++S G ++ E++  K
Sbjct: 224 VVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 78.7 bits (194), Expect = 2e-15
 Identities = 52/255 (20%), Positives = 98/255 (38%), Gaps = 56/255 (21%)

Query: 666 KRRLQKSKAWKLTAFQRLDFKAEDVLESLKDENIIGKGGAGIVYRG---SMPDGIDVAIK 722
           K +L   +      F+    K             +G+G  G VY+       D  D A+K
Sbjct: 8   KVKLSSERERVEDLFEYEGCK-------------VGRGTYGHVYKAKRKDGKDDKDYALK 54

Query: 723 RLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLG-YVSNRDTNL-LLYEYMPNGSLGEML 780
           ++      G       EI  L  ++H N++ L   ++S+ D  + LL++Y  +  L  ++
Sbjct: 55  QI---EGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHII 110

Query: 781 HGAKGGHLKWETRYRIALEAA----------KGLCYLHHDCSPLIIHRDVKSNNILLDSD 830
              +        +  + L              G+ YLH +    ++HRD+K  NIL+  +
Sbjct: 111 KFHRASK---ANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGE 164

Query: 831 FEAH----VADFGLAKFLQDAGASECMSSVAGS---YGYIAPE-----YAYTLKVDEKSD 878
                   +AD G A+        + ++ +      + Y APE       YT  +    D
Sbjct: 165 GPERGRVKIADMGFARLFNS--PLKPLADLDPVVVTFWYRAPELLLGARHYTKAI----D 218

Query: 879 VYSFGVVLLELIAGK 893
           +++ G +  EL+  +
Sbjct: 219 IWAIGCIFAELLTSE 233

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 77.8 bits (192), Expect = 3e-15
 Identities = 62/224 (27%), Positives = 92/224 (41%), Gaps = 41/224 (18%)

Query: 689 DVLESLKDENIIGKGGAGIVYRGS-MPDGIDVAIKRLVGRGTGGNDHGFLA-----EIQT 742
           +V    +D   +G G  G V        G  VAIK+L             A     E++ 
Sbjct: 22  EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKL----YRPFQSELFAKRAYRELRL 77

Query: 743 LGRIRHRNIVRLLG--YVSNRDTNL----LLYEYMPNGSLGEMLHGA-KGGHLKWETRYR 795
           L  +RH N++ LL          +     L+  +M     G  L    K   L  +    
Sbjct: 78  LKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-----GTDLGKLMKHEKLGEDRIQF 132

Query: 796 IALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSS 855
           +  +  KGL Y+H   +  IIHRD+K  N+ ++ D E  + DFGLA+      A   M+ 
Sbjct: 133 LVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR-----QADSEMTG 184

Query: 856 -VAGSYGYIAPE-----YAYTLKVDEKSDVYSFGVVLLELIAGK 893
            V   + Y APE       YT  V    D++S G ++ E+I GK
Sbjct: 185 YVVTRW-YRAPEVILNWMRYTQTV----DIWSVGCIMAEMITGK 223

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 77.3 bits (191), Expect = 3e-15
 Identities = 47/218 (21%), Positives = 80/218 (36%), Gaps = 44/218 (20%)

Query: 698 NIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHGF----LAEIQTLGRIRHRNIV 752
             +G+G  G VY+         VAIKR+        + G     + E+  L  ++HRNI+
Sbjct: 40  TKLGEGTYGEVYKAIDTVTNETVAIKRIR---LEHEEEGVPGTAIREVSLLKELQHRNII 96

Query: 753 RLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCS 812
            L   + +     L++EY  N  L + +   K   +          +   G+ + H   S
Sbjct: 97  ELKSVIHHNHRLHLIFEYAEN-DLKKYMD--KNPDVSMRVIKSFLYQLINGVNFCH---S 150

Query: 813 PLIIHRDVKSNNILLDSDFEAH-----VADFGLAKFLQDAGASECMSSVAGSYG------ 861
              +HRD+K  N+LL     +      + DFGLA+                 +       
Sbjct: 151 RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA---------FGIPIRQFTHEIITL 201

Query: 862 -YIAPEY-----AYTLKVDEKSDVYSFGVVLLELIAGK 893
            Y  PE       Y+  V    D++S   +  E++   
Sbjct: 202 WYRPPEILLGSRHYSTSV----DIWSIACIWAEMLMKT 235

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 77.2 bits (191), Expect = 3e-15
 Identities = 59/214 (27%), Positives = 95/214 (44%), Gaps = 32/214 (14%)

Query: 698 NIIGKGGAGIVYRG--SMPDGIDVAIKRLVGRGTGGNDHGF----LAEIQTLGRIR---H 748
             IG+G  G V++       G  VA+KR+  R     + G     + E+  L  +    H
Sbjct: 17  AEIGEGAYGKVFKARDLKNGGRFVALKRV--R-VQTGEEGMPLSTIREVAVLRHLETFEH 73

Query: 749 RNIVRLL----GYVSNRDTNLLL-YEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKG 803
            N+VRL        ++R+T L L +E++    L   L       +  ET   +  +  +G
Sbjct: 74  PNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRG 132

Query: 804 LCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYI 863
           L +LH      ++HRD+K  NIL+ S  +  +ADFGLA+          ++SV  +  Y 
Sbjct: 133 LDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVTLWYR 186

Query: 864 APEY----AYTLKVDEKSDVYSFGVVLLELIAGK 893
           APE     +Y   V    D++S G +  E+   K
Sbjct: 187 APEVLLQSSYATPV----DLWSVGCIFAEMFRRK 216

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 77.3 bits (191), Expect = 3e-15
 Identities = 50/215 (23%), Positives = 93/215 (43%), Gaps = 29/215 (13%)

Query: 691 LESLKDENIIGKGGAGIVYRG-SMPDGIDVAIK--RLVGRGTGGNDHGF----LAEIQTL 743
           +E+    + +G+G    VY+G S      VA+K  RL       ++ G     + E+  L
Sbjct: 1   METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRL------EHEEGAPCTAIREVSLL 54

Query: 744 GRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKG 803
             ++H NIV L   +    +  L++EY+    L + L    G  +          +  +G
Sbjct: 55  KDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLD-DCGNIINMHNVKLFLFQLLRG 112

Query: 804 LCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYI 863
           L Y H      ++HRD+K  N+L++   E  +ADFGLA+       ++   +   +  Y 
Sbjct: 113 LAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSI--PTKTYDNEVVTLWYR 167

Query: 864 APEY-----AYTLKVDEKSDVYSFGVVLLELIAGK 893
            P+       Y+ ++    D++  G +  E+  G+
Sbjct: 168 PPDILLGSTDYSTQI----DMWGVGCIFYEMATGR 198

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 78.6 bits (193), Expect = 4e-15
 Identities = 48/305 (15%), Positives = 93/305 (30%), Gaps = 19/305 (6%)

Query: 294 LDLSLNYLTGEIPESFAALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFEL 353
           +      L+            +  L L  +     +     D  N        +     L
Sbjct: 250 VSREEACLSVCFSRPLTVGSRMGTLLLMVDEAPLSVEWRTPDGRNRPSHVWLCDLPAASL 309

Query: 354 PENLGRNGKLLILD--------VTSNHLTGTIPRDLCKGGKLKSLILMQNFFIGPIPEEL 405
            + L ++   +I          V          RD     +L    L        +  EL
Sbjct: 310 NDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCEL-SVEKSTVLQSEL 368

Query: 406 GQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLSGELPEKMSGASLNQLKVAN 465
             CK L ++     +   TI   +  L  L      + L      + +       L    
Sbjct: 369 ESCKELQELEPENKWCLLTIILLMRALDPLLY--EKETLQYFSTLKAVDPMRAAYLDDLR 426

Query: 466 NNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIPYSIS 525
           +    +          + +L L +  L     +E   L ++T +++S N +   +P +++
Sbjct: 427 SKFLLENSVLKMEYADVRVLHLAHKDLTVLCHLE--QLLLVTHLDLSHNRLR-ALPPALA 483

Query: 526 QCHSLTSVDLSRNSLYGKIPPGISKLIDLSILNLSRNGITGSIPN--EMRNMMSLTTLDL 583
               L  +  S N+L  +   G++ L  L  L L  N +         + +   L  L+L
Sbjct: 484 ALRCLEVLQASDNAL--ENVDGVANLPRLQELLLCNNRLQ-QSAAIQPLVSCPRLVLLNL 540

Query: 584 SYNNL 588
             N+L
Sbjct: 541 QGNSL 545

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 75.9 bits (186), Expect = 3e-14
 Identities = 45/210 (21%), Positives = 77/210 (36%), Gaps = 13/210 (6%)

Query: 143 MTELQVLDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLNGI 202
             +L   +  +   +  L  E+ S K L+ L     +    I      +  L Y      
Sbjct: 348 DEQLFRCE-LSVEKSTVLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQ 406

Query: 203 GLNGTVPAFLSRLKNLREMYIGYF-NTYTGGIPPGFGALTQLQVLDMASCNISGEIPTSL 261
             +      L  +  +R  Y+    + +             ++VL +A  +++  +   L
Sbjct: 407 YFST-----LKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT-VLC-HL 459

Query: 262 SRLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQLF 321
            +L L+  L L  N+L   +PP L+ L  L+ L  S N L   +    A L  L  L L 
Sbjct: 460 EQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVDG-VANLPRLQELLLC 516

Query: 322 KNNLRG-PIPSFLGDFPNLEVLQVWGNNFT 350
            N L+       L   P L +L + GN+  
Sbjct: 517 NNRLQQSAAIQPLVSCPRLVLLNLQGNSLC 546

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 75.2 bits (184), Expect = 5e-14
 Identities = 31/198 (15%), Positives = 72/198 (36%), Gaps = 19/198 (9%)

Query: 402 PEELGQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLSGELPEKMSGASLNQL 461
             +    + L +   S       + + L +   L  +E ++      +   M   +L+ L
Sbjct: 342 CRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMR--ALDPL 398

Query: 462 KVANNNITGKIPAAIGNLPSLNILSLQNNRLE-----GEIPVESFNLKMITSINISDNNI 516
                 +          L +++ +              E  V       +  ++++  ++
Sbjct: 399 LYEKETLQY-----FSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDL 453

Query: 517 SGEIPYSISQCHSLTSVDLSRNSLYGKIPPGISKLIDLSILNLSRNGITGSIPNEMRNMM 576
           +  + + + Q   +T +DLS N L   +PP ++ L  L +L  S N +  ++   + N+ 
Sbjct: 454 T-VLCH-LEQLLLVTHLDLSHNRL-RALPPALAALRCLEVLQASDNALE-NVDG-VANLP 508

Query: 577 SLTTLDLSYNNLIGNIPS 594
            L  L L  NN +    +
Sbjct: 509 RLQELLLC-NNRLQQSAA 525

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 71.3 bits (174), Expect = 8e-13
 Identities = 48/319 (15%), Positives = 103/319 (32%), Gaps = 11/319 (3%)

Query: 261 LSRLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQL 320
           +SR +   S+        G     L  ++    L +      G    S   L +L    L
Sbjct: 250 VSREEACLSVCFSRPLTVGSRMGTLLLMVDEAPLSVEWRTPDGRNRPSHVWLCDLPAASL 309

Query: 321 FKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRD 380
                +      +    + +   V   +       +   + +L   +++    T  +  +
Sbjct: 310 NDQLPQ-HTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVEKST-VLQSE 367

Query: 381 LCKGGKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMEL 440
           L    +L+ L     + +  I   +     L   + +  Y +      +  +    + +L
Sbjct: 368 LESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFST--LKAVDPMRAAYLDDL 425

Query: 441 DDNLLSGELPEKMSGASLNQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVES 500
               L      KM  A +  L +A+ ++T  +   +  L  +  L L +NRL   +P   
Sbjct: 426 RSKFLLENSVLKMEYADVRVLHLAHKDLT-VLCH-LEQLLLVTHLDLSHNRLR-ALPPAL 482

Query: 501 FNLKMITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYG-KIPPGISKLIDLSILNL 559
             L+ +  +  SDN +   +   ++    L  + L  N L        +     L +LNL
Sbjct: 483 AALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNL 540

Query: 560 SRNGITGSIPNEMRNMMSL 578
             N +          +  +
Sbjct: 541 QGNSLC-QEEGIQERLAEM 558

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 55.1 bits (132), Expect = 8e-08
 Identities = 35/209 (16%), Positives = 59/209 (28%), Gaps = 30/209 (14%)

Query: 234 PPGFGALTQLQVLDMASCNISGEIPTSLSRLKLLHSLFLQMNKLTGHIPPQLSGLISLKS 293
                   QL   ++ S   S  + + L   K L  L  +       I   +  L  L  
Sbjct: 342 CRDSATDEQLFRCEL-SVEKSTVLQSELESCKELQELEPENKWCLLTIILLMRALDPLLY 400

Query: 294 LDLSLNYLTG---------------------EIPESFAALKNLTLLQLFKNNLRGPIPSF 332
              +L Y +                      E         ++ +L L   +L   +   
Sbjct: 401 EKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT--VLCH 458

Query: 333 LGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDLCKGGKLKSLIL 392
           L     +  L +  N     LP  L     L +L  + N L   +   +    +L+ L+L
Sbjct: 459 LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLL 515

Query: 393 MQNFFIGPIPE--ELGQCKSLTKIRFSKN 419
             N  +        L  C  L  +    N
Sbjct: 516 CNN-RLQQSAAIQPLVSCPRLVLLNLQGN 543

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 49.4 bits (117), Expect = 6e-06
 Identities = 25/91 (27%), Positives = 36/91 (39%), Gaps = 5/91 (5%)

Query: 89  PEIGLLTKLVNLTISNVNLTGRLPSEMALLTSLKVFNISGNVFQGNFAGQIVRGMTELQV 148
             +  L  + +L +S+  L   LP  +A L  L+V   S N  + N  G  V  +  LQ 
Sbjct: 457 CHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVDG--VANLPRLQE 512

Query: 149 LDAYNNNFTG-PLPVEIASLKSLRHLSFGGN 178
           L   NN          + S   L  L+  GN
Sbjct: 513 LLLCNNRLQQSAAIQPLVSCPRLVLLNLQGN 543

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 76.1 bits (188), Expect = 4e-15
 Identities = 63/214 (29%), Positives = 95/214 (44%), Gaps = 30/214 (14%)

Query: 698 NIIGKGGAGIVYRG-SMPDGIDVAIKRL-VGRGTGGNDHGF----LAEI---QTLGRIRH 748
             IG G  G VY+      G  VA+K + V  G GG   G     + E+   + L    H
Sbjct: 15  AEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGG-GLPISTVREVALLRRLEAFEH 73

Query: 749 RNIVRLL----GYVSNRDTNLLL-YEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKG 803
            N+VRL+       ++R+  + L +E++    L   L  A    L  ET   +  +  +G
Sbjct: 74  PNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRG 132

Query: 804 LCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYI 863
           L +LH +C   I+HRD+K  NIL+ S     +ADFGLA+          ++ V  +  Y 
Sbjct: 133 LDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY---SYQMALTPVVVTLWYR 186

Query: 864 APEY----AYTLKVDEKSDVYSFGVVLLELIAGK 893
           APE      Y   V    D++S G +  E+   K
Sbjct: 187 APEVLLQSTYATPV----DMWSVGCIFAEMFRRK 216

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 77.4 bits (191), Expect = 5e-15
 Identities = 50/179 (27%), Positives = 76/179 (42%), Gaps = 41/179 (22%)

Query: 736 FLAEIQTLGRIRHRNIVRLLGYVSNRDTNL-LLYEYMPNGSLGEMLHGAKGGHLKWETRY 794
           F  E   +       +V+L  Y    D  L ++ EYMP G  G++++      +     Y
Sbjct: 116 FWEERDIMAFANSPWVVQLF-YAFQDDRYLYMVMEYMP-G--GDLVN-----LMS---NY 163

Query: 795 RIALEAAK--------GLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHV--ADFGLAKFL 844
            +  + A+         L  +H   S   IHRDVK +N+LLD     H+  ADFG    +
Sbjct: 164 DVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKS--GHLKLADFGTCMKM 218

Query: 845 QDAGASECMSSVAGSYGYIAPE--------YAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
              G   C ++V G+  YI+PE          Y  +     D +S GV L E++ G  P
Sbjct: 219 NKEGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGREC----DWWSVGVFLYEMLVGDTP 272

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 77.5 bits (191), Expect = 6e-15
 Identities = 47/164 (28%), Positives = 70/164 (42%), Gaps = 16/164 (9%)

Query: 737 LAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRI 796
           L E + L   RH  +  L       D    + EY   G L    H ++      E R R 
Sbjct: 196 LTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFS-EDRARF 252

Query: 797 -ALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSS 855
              E    L YLH + +  +++RD+K  N++LD D    + DFGL K  +       M +
Sbjct: 253 YGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKT 308

Query: 856 VAGSYGYIAPE----YAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
             G+  Y+APE      Y   V    D +  GVV+ E++ G+ P
Sbjct: 309 FCGTPEYLAPEVLEDNDYGRAV----DWWGLGVVMYEMMCGRLP 348

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 74.9 bits (185), Expect = 1e-14
 Identities = 45/153 (29%), Positives = 70/153 (45%), Gaps = 21/153 (13%)

Query: 698 NIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHGF----LAEIQTLGRIRHRNIV 752
             IG+G  G+V++  +   G  VAIK+ +      +D       L EI+ L +++H N+V
Sbjct: 9   GKIGEGSYGVVFKCRNRDTGQIVAIKKFL---ESEDDPVIKKIALREIRMLKQLKHPNLV 65

Query: 753 RLLGYVSNRDTNL-LLYEYMPNGSLGEMLHGAKG---GHLKWETRYRIALEAAKGLCYLH 808
            LL  V  R   L L++EY  +  L E+    +G     +K      I  +  + + + H
Sbjct: 66  NLLE-VFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVK-----SITWQTLQAVNFCH 119

Query: 809 HDCSPLIIHRDVKSNNILLDSDFEAHVADFGLA 841
                  IHRDVK  NIL+       + DFG A
Sbjct: 120 KHN---CIHRDVKPENILITKHSVIKLCDFGFA 149

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 75.9 bits (187), Expect = 1e-14
 Identities = 56/229 (24%), Positives = 87/229 (37%), Gaps = 27/229 (11%)

Query: 681 QRLDFKAEDVLESLKDENIIGKGGAGIVYRGSMPDGIDV-AIKRLVGRGTGGNDHG--FL 737
           + +  + +D  E LK   +IG+G    V    M     V A+K +             F 
Sbjct: 54  KEVRLQRDD-FEILK---VIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFR 109

Query: 738 AEIQTLGRIRHRNIVRLLGYVSNRDTNL-LLYEYMPNGSLGEMLHGAKGGHLKWETRYRI 796
            E   L     R I +L  +    +  L L+ EY   G L  +   +K G        R 
Sbjct: 110 EERDVLVNGDRRWITQLH-FAFQDENYLYLVMEYYVGGDL--LTLLSKFGERIPAEMARF 166

Query: 797 -ALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHV--ADFGLAKFLQDAGASECM 853
              E    +  +H       +HRD+K +NILLD     H+  ADFG    L+  G    +
Sbjct: 167 YLAEIVMAIDSVH---RLGYVHRDIKPDNILLDRC--GHIRLADFGSCLKLRADGTVRSL 221

Query: 854 SSVAGSYGYIAPEYAYTLKVDEKSDVY-------SFGVVLLELIAGKKP 895
            +V G+  Y++PE    +     +  Y       + GV   E+  G+ P
Sbjct: 222 VAV-GTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 74.6 bits (184), Expect = 2e-14
 Identities = 39/150 (26%), Positives = 70/150 (46%), Gaps = 15/150 (10%)

Query: 698 NIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHGF----LAEIQTLGRIRHRNIV 752
            ++G+G  G+V +  +   G  VAIK+ +      +D       + EI+ L ++RH N+V
Sbjct: 31  GLVGEGSYGMVMKCRNKDTGRIVAIKKFL---ESDDDKMVKKIAMREIKLLKQLRHENLV 87

Query: 753 RLLGYVSNRDTNL-LLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDC 811
            LL  V  +     L++E++ +  L ++        L ++   +   +   G+ + H   
Sbjct: 88  NLLE-VCKKKKRWYLVFEFVDHTILDDL--ELFPNGLDYQVVQKYLFQIINGIGFCHSHN 144

Query: 812 SPLIIHRDVKSNNILLDSDFEAHVADFGLA 841
              IIHRD+K  NIL+       + DFG A
Sbjct: 145 ---IIHRDIKPENILVSQSGVVKLCDFGFA 171

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 73.1 bits (180), Expect = 2e-14
 Identities = 32/191 (16%), Positives = 73/191 (38%), Gaps = 22/191 (11%)

Query: 403 EELGQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLSGELPEKMSG----ASL 458
                  +  K    K  +  T       L  +     D++ +       ++G     +L
Sbjct: 13  FPDPGLANAVKQNLGKQSV--TDLVSQKELSGVQNFNGDNSNIQ-----SLAGMQFFTNL 65

Query: 459 NQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNISG 518
            +L +++N I+  +   + +L  L  LS+  NRL+    +       ++ + + +N +  
Sbjct: 66  KELHLSHNQIS-DLSP-LKDLTKLEELSVNRNRLKN---LNGIPSACLSRLFLDNNELR- 119

Query: 519 EIPYSISQCHSLTSVDLSRNSLYGKIPPGISKLIDLSILNLSRNGITGSIPNEMRNMMSL 578
           +   S+    +L  + +  N L  K    +  L  L +L+L  N IT +    +  +  +
Sbjct: 120 DTD-SLIHLKNLEILSIRNNKL--KSIVMLGFLSKLEVLDLHGNEIT-NTGG-LTRLKKV 174

Query: 579 TTLDLSYNNLI 589
             +DL+    +
Sbjct: 175 NWIDLTGQKCV 185

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 67.0 bits (164), Expect = 3e-12
 Identities = 46/256 (17%), Positives = 75/256 (29%), Gaps = 40/256 (15%)

Query: 285 LSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQV 344
             GL +    +L    +T     S   L  +       +N++    + +  F NL+ L +
Sbjct: 15  DPGLANAVKQNLGKQSVTDL--VSQKELSGVQNFNGDNSNIQ--SLAGMQFFTNLKELHL 70

Query: 345 WGNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFIGPIPEE 404
             N  + +L   L    KL  L V  N L             L  L L  N         
Sbjct: 71  SHNQIS-DL-SPLKDLTKLEELSVNRNRLKNLNGIPSAC---LSRLFLDNN--------- 116

Query: 405 LGQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLSGELPEKMSGASLNQLKVA 464
                 L                 L +L  L ++ + +N L   +      + L  L + 
Sbjct: 117 -----ELRDTD------------SLIHLKNLEILSIRNNKLK-SIVMLGFLSKLEVLDLH 158

Query: 465 NNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIPYSI 524
            N IT      +  L  +N + L   +   E       L +  ++   D       PY I
Sbjct: 159 GNEITNTGG--LTRLKKVNWIDLTGQKCVNEPVKYQPELYITNTVKDPDGRWIS--PYYI 214

Query: 525 SQCHSLTSVDLSRNSL 540
           S   S     +     
Sbjct: 215 SNGGSYVDGCVLWELP 230

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 63.9 bits (156), Expect = 4e-11
 Identities = 41/238 (17%), Positives = 77/238 (32%), Gaps = 24/238 (10%)

Query: 142 GMTELQVLDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIP--QSYSEIQSLEYIGL 199
           G+      +    + T  +      L  +++ +   +     +   Q ++ ++ L ++  
Sbjct: 17  GLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQ-SLAGMQFFTNLKEL-HLSH 72

Query: 200 NGIGLNGTVPAFLSRLKNLREMYIGYFNTYTGGIPPGFGALTQLQVLDMASCNISGEIPT 259
           N I    +  + L  L  L E+ +         +         L  L + +  +      
Sbjct: 73  NQI----SDLSPLKDLTKLEELSVN--RNRLKNLNGI--PSACLSRLFLDNNELRD--TD 122

Query: 260 SLSRLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQ 319
           SL  LK L  L ++ NKL   I   L  L  L+ LDL  N +T         LK +  + 
Sbjct: 123 SLIHLKNLEILSIRNNKLK-SIVM-LGFLSKLEVLDLHGNEIT-NT-GGLTRLKKVNWID 178

Query: 320 LFKNNLRGPIPSFLGDFPNLEVL-QVWGNNFTFELPENLGRNGKLLILDVTSNHLTGT 376
           L           +    P L +   V   +  +  P  +   G  +   V       T
Sbjct: 179 LTGQKCVNEPVKYQ---PELYITNTVKDPDGRWISPYYISNGGSYVDGCVLWELPVYT 233

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 74.7 bits (184), Expect = 2e-14
 Identities = 59/225 (26%), Positives = 101/225 (44%), Gaps = 43/225 (19%)

Query: 689 DVLESLKDENIIGKGGAGIVYRGS-MPDGIDVAIKRLVGRGTGGNDHGFLA-----EIQT 742
           +V E  ++ + +G G  G V        G+ VA+K+L    +        A     E++ 
Sbjct: 26  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL----SRPFQSIIHAKRTYRELRL 81

Query: 743 LGRIRHRNIVRLLG--YVSNRDTNL----LLYEYMPNGSLGEMLHGAK--GGHLKWETRY 794
           L  ++H N++ LL     +          L+   M    L  ++   K    H+++   Y
Sbjct: 82  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQKLTDDHVQFLI-Y 139

Query: 795 RIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMS 854
           +I     +GL Y+H   S  IIHRD+K +N+ ++ D E  + DFGLA+       ++ M+
Sbjct: 140 QIL----RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTADEMT 187

Query: 855 S-VAGSYGYIAPE-----YAYTLKVDEKSDVYSFGVVLLELIAGK 893
             VA  + Y APE       Y   V    D++S G ++ EL+ G+
Sbjct: 188 GYVATRW-YRAPEIMLNWMHYNQTV----DIWSVGCIMAELLTGR 227

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 74.2 bits (183), Expect = 3e-14
 Identities = 48/166 (28%), Positives = 70/166 (42%), Gaps = 21/166 (12%)

Query: 737 LAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRI 796
           + E + L   RH  +  L       D    + EY   G L    H ++      E R R 
Sbjct: 53  VTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFT-EERARF 109

Query: 797 -ALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHV--ADFGLAKFLQDAGASECM 853
              E    L YLH   S  +++RD+K  N++LD D   H+   DFGL K  +       M
Sbjct: 110 YGAEIVSALEYLH---SRDVVYRDIKLENLMLDKD--GHIKITDFGLCK--EGISDGATM 162

Query: 854 SSVAGSYGYIAPE----YAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
            +  G+  Y+APE      Y   V    D +  GVV+ E++ G+ P
Sbjct: 163 KTFCGTPEYLAPEVLEDNDYGRAV----DWWGLGVVMYEMMCGRLP 204

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 74.8 bits (184), Expect = 3e-14
 Identities = 62/234 (26%), Positives = 95/234 (40%), Gaps = 39/234 (16%)

Query: 681 QRLDFKAEDVLESLKDENIIGKGGAGIVYRGSMPDGIDV-AIKRL-----VGRGTGGNDH 734
           +++    ED  E LK   +IG+G  G V    + +   V A+K L     + R       
Sbjct: 67  KQMRLHRED-FEILK---VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAE--TAC 120

Query: 735 GFLAEIQTLGRIRHRNIVRLLGYVSNRDTNL-LLYEYMPNGSLGEMLHGAKGGHLKWETR 793
            F  E   L     + I  L  Y    D NL L+ +Y   G L  +   +K      E  
Sbjct: 121 -FREERDVLVNGDSKWITTLH-YAFQDDNNLYLVMDYYVGGDL--LTLLSKFEDRLPEEM 176

Query: 794 YRI-ALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHV--ADFGLAKFLQDAGAS 850
            R    E    +  +H       +HRD+K +NIL+D +   H+  ADFG    L + G  
Sbjct: 177 ARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMN--GHIRLADFGSCLKLMEDGTV 231

Query: 851 ECMSSVAGSYGYIAPE---------YAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
           +   +V G+  YI+PE           Y  +     D +S GV + E++ G+ P
Sbjct: 232 QSSVAV-GTPDYISPEILQAMEGGKGRYGPEC----DWWSLGVCMYEMLYGETP 280

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 73.9 bits (182), Expect = 4e-14
 Identities = 44/165 (26%), Positives = 70/165 (42%), Gaps = 22/165 (13%)

Query: 737 LAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRI 796
           L E + L  +    +V+L     +     ++ EY+  G +    H  + G    E   R 
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM--FSHLRRIGRFS-EPHARF 145

Query: 797 -ALEAAKGLCYLH-HDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMS 854
            A +      YLH  D    +I+RD+K  N+L+D      V DFG AK ++    + C  
Sbjct: 146 YAAQIVLTFEYLHSLD----LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLC-- 199

Query: 855 SVAGSYGYIAPE----YAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
              G+   +APE      Y   V    D ++ GV++ E+ AG  P
Sbjct: 200 ---GTPEALAPEIILSKGYNKAV----DWWALGVLIYEMAAGYPP 237

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 74.7 bits (183), Expect = 8e-14
 Identities = 48/134 (35%), Positives = 69/134 (51%), Gaps = 21/134 (15%)

Query: 769 EYMPNGSLGEMLHGAKGGHLKWETRYRI-ALEAAKGLCYLHHDCSPLIIHRDVKSNNILL 827
           EY+  G L  M H  + G  K E      A E A GL +L    S  II+RD+K +N++L
Sbjct: 422 EYVNGGDL--MYHIQQVGRFK-EPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVML 475

Query: 828 DSDFEAHV--ADFGLAKFLQDAGASECMSSVAGSYGYIAPE----YAYTLKVDEKSDVYS 881
           DS+   H+  ADFG+ K  ++        +  G+  YIAPE      Y   V    D ++
Sbjct: 476 DSE--GHIKIADFGMCK--ENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSV----DWWA 527

Query: 882 FGVVLLELIAGKKP 895
           FGV+L E++AG+ P
Sbjct: 528 FGVLLYEMLAGQAP 541

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 72.7 bits (179), Expect = 1e-13
 Identities = 57/227 (25%), Positives = 101/227 (44%), Gaps = 43/227 (18%)

Query: 689 DVLESLKDENIIGKGGAGIVYRGS-MPDGIDVAIKRLVGRGTGGN--DHGFLA-----EI 740
           DV     + + IG+G  G+V       + + VAIK++       +  +H         EI
Sbjct: 24  DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKI-------SPFEHQTYCQRTLREI 76

Query: 741 QTLGRIRHRNIVRLLGYVSNRDTNL-----LLYEYMPNGSLGEMLHGA-KGGHLKWE-TR 793
           + L R RH NI+ +   +            ++ + M        L+   K  HL  +   
Sbjct: 77  KILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM-----ETDLYKLLKTQHLSNDHIC 131

Query: 794 YRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFL-QDAGASEC 852
           Y    +  +GL Y+H   S  ++HRD+K +N+LL++  +  + DFGLA+    D   +  
Sbjct: 132 Y-FLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 187

Query: 853 MSS-VAGSYGYIAPE-----YAYTLKVDEKSDVYSFGVVLLELIAGK 893
           ++  VA  + Y APE       YT  +    D++S G +L E+++ +
Sbjct: 188 LTEYVATRW-YRAPEIMLNSKGYTKSI----DIWSVGCILAEMLSNR 229

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 71.8 bits (177), Expect = 2e-13
 Identities = 50/168 (29%), Positives = 75/168 (44%), Gaps = 28/168 (16%)

Query: 737 LAEIQTLGRIRHRNIVRLLGYVSNRDTNL-LLYEYMPNGSLGEMLHGAKGGHLKWETRYR 795
             E   L  + H  I+R+ G   +    + ++ +Y+  G L       K          +
Sbjct: 54  NDERLMLSIVTHPFIIRMWGTFQD-AQQIFMIMDYIEGGEL--FSLLRKSQRFP-NPVAK 109

Query: 796 I-ALEAAKGLCYLH-HDCSPLIIHRDVKSNNILLDSDFEAHV--ADFGLAKFLQDAGASE 851
             A E    L YLH  D    II+RD+K  NILLD +   H+   DFG AK++ D   + 
Sbjct: 110 FYAAEVCLALEYLHSKD----IIYRDLKPENILLDKN--GHIKITDFGFAKYVPDVTYTL 163

Query: 852 CMSSVAGSYGYIAPE----YAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
           C     G+  YIAPE      Y   +    D +SFG+++ E++AG  P
Sbjct: 164 C-----GTPDYIAPEVVSTKPYNKSI----DWWSFGILIYEMLAGYTP 202

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 71.5 bits (176), Expect = 2e-13
 Identities = 53/235 (22%), Positives = 97/235 (41%), Gaps = 50/235 (21%)

Query: 689 DVLESLKDENIIGKGGAGIVYRGS-MPDGIDVAIKRLVGRGTGGNDHGFLA-----EIQT 742
           D+     D   +G GG G+V+          VAIK++V                  EI+ 
Sbjct: 8   DLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIV------LTDPQSVKHALREIKI 61

Query: 743 LGRIRHRNIVRLL-------GYVSNRDTNL-------LLYEYMPNGSLGEMLHGAK--GG 786
           + R+ H NIV++          +++   +L       ++ EYM    L  +L        
Sbjct: 62  IRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVLEQGPLLEE 120

Query: 787 HLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDS-DFEAHVADFGLAKFL- 844
           H +    Y++     +GL Y+H   S  ++HRD+K  N+ +++ D    + DFGLA+ + 
Sbjct: 121 HARLFM-YQLL----RGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMD 172

Query: 845 QDAGASECMSS-VAGSYGYIAPE-----YAYTLKVDEKSDVYSFGVVLLELIAGK 893
                   +S  +   + Y +P        YT  +    D+++ G +  E++ GK
Sbjct: 173 PHYSHKGHLSEGLVTKW-YRSPRLLLSPNNYTKAI----DMWAAGCIFAEMLTGK 222

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 72.3 bits (178), Expect = 2e-13
 Identities = 53/239 (22%), Positives = 99/239 (41%), Gaps = 60/239 (25%)

Query: 689 DVLESLKDENIIGKGGAGIVYRGS-MPDGIDVAIKRLVGRGTGGN--DHGFLA-----EI 740
           ++    + ++++G+G  G+V   +  P G  VAIK++          D    A     EI
Sbjct: 8   NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKI-------EPFDKPLFALRTLREI 60

Query: 741 QTLGRIRHRNIVRLLG--YVSNRDTNLLLY---EYMP--------NGSLGEMLHGAKGGH 787
           + L   +H NI+ +       + +    +Y   E M            L +        H
Sbjct: 61  KILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDD-------H 113

Query: 788 LKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDA 847
           +++   Y+      + +  LH      +IHRD+K +N+L++S+ +  V DFGLA+ + ++
Sbjct: 114 IQYFI-YQTL----RAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDES 165

Query: 848 GASECMSSVAGSY--GYI------APE-----YAYTLKVDEKSDVYSFGVVLLELIAGK 893
            A     +   S    ++      APE       Y+  +    DV+S G +L EL   +
Sbjct: 166 AADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAM----DVWSCGCILAELFLRR 220

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 71.8 bits (177), Expect = 2e-13
 Identities = 38/140 (27%), Positives = 58/140 (41%), Gaps = 26/140 (18%)

Query: 767 LY---EYMPNGSLGEMLHGAKGGHLKWETRYRI-ALEAAKGLCYLH-HDCSPLIIHRDVK 821
           LY   EY+  G L   +   + G    E        E +  L +LH       II+RD+K
Sbjct: 96  LYLILEYLSGGEL--FMQLEREGIFM-EDTACFYLAEISMALGHLHQKG----IIYRDLK 148

Query: 822 SNNILLDSDFEAHV--ADFGLAKFLQDAGASECMSSVAGSYGYIAPE----YAYTLKVDE 875
             NI+L+     HV   DFGL K  +         +  G+  Y+APE      +   V  
Sbjct: 149 PENIMLNHQ--GHVKLTDFGLCK--ESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAV-- 202

Query: 876 KSDVYSFGVVLLELIAGKKP 895
             D +S G ++ +++ G  P
Sbjct: 203 --DWWSLGALMYDMLTGAPP 220

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 71.5 bits (176), Expect = 2e-13
 Identities = 45/139 (32%), Positives = 64/139 (46%), Gaps = 24/139 (17%)

Query: 767 LY---EYMPNGSLGEMLHGAKGGHLKWETRYRI-ALEAAKGLCYLHHDCSPLIIHRDVKS 822
           L+   E++  G L  M H  K      E R R  A E    L +LH      II+RD+K 
Sbjct: 99  LFFVMEFVNGGDL--MFHIQKSRRFD-EARARFYAAEIISALMFLH---DKGIIYRDLKL 152

Query: 823 NNILLDSDFEAHV--ADFGLAKFLQDAGASECMSSVAGSYGYIAPE----YAYTLKVDEK 876
           +N+LLD +   H   ADFG+ K  +        ++  G+  YIAPE      Y   V   
Sbjct: 153 DNVLLDHE--GHCKLADFGMCK--EGICNGVTTATFCGTPDYIAPEILQEMLYGPAV--- 205

Query: 877 SDVYSFGVVLLELIAGKKP 895
            D ++ GV+L E++ G  P
Sbjct: 206 -DWWAMGVLLYEMLCGHAP 223

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 71.6 bits (176), Expect = 3e-13
 Identities = 44/143 (30%), Positives = 64/143 (44%), Gaps = 29/143 (20%)

Query: 767 LY---EYMPNGSLGEMLHGAKGGHLKWETRYRI-ALEAAKGLCYLH-HDCSPLIIHRDVK 821
           L+   +Y+  G L    H ++      E   +I   E    L +LH       II+RD+K
Sbjct: 134 LHLILDYINGGEL--FTHLSQRERFT-EHEVQIYVGEIVLALEHLHKLG----IIYRDIK 186

Query: 822 SNNILLDSDFEAHV--ADFGLAK-FLQDAGASECMSSVAGSYGYIAPE------YAYTLK 872
             NILLDS+   HV   DFGL+K F+ D           G+  Y+AP+        +   
Sbjct: 187 LENILLDSN--GHVVLTDFGLSKEFVADETER--AYDFCGTIEYMAPDIVRGGDSGHDKA 242

Query: 873 VDEKSDVYSFGVVLLELIAGKKP 895
           V    D +S GV++ EL+ G  P
Sbjct: 243 V----DWWSLGVLMYELLTGASP 261

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 71.0 bits (175), Expect = 3e-13
 Identities = 43/139 (30%), Positives = 64/139 (46%), Gaps = 24/139 (17%)

Query: 767 LY---EYMPNGSLGEMLHGAKGGHLKWETRYRI-ALEAAKGLCYLHHDCSPLIIHRDVKS 822
           LY   +++  G L      +K      E   +    E A  L +LH   S  II+RD+K 
Sbjct: 101 LYLILDFLRGGDL--FTRLSKEVMFT-EEDVKFYLAELALALDHLH---SLGIIYRDLKP 154

Query: 823 NNILLDSDFEAHV--ADFGLAKFLQDAGASECMSSVAGSYGYIAPE----YAYTLKVDEK 876
            NILLD +   H+   DFGL+K  +     +   S  G+  Y+APE      +T      
Sbjct: 155 ENILLDEE--GHIKLTDFGLSK--ESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSA--- 207

Query: 877 SDVYSFGVVLLELIAGKKP 895
            D +SFGV++ E++ G  P
Sbjct: 208 -DWWSFGVLMFEMLTGTLP 225

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 71.1 bits (175), Expect = 4e-13
 Identities = 48/157 (30%), Positives = 72/157 (45%), Gaps = 24/157 (15%)

Query: 769 EYMPNGSLGEMLHGAKGGHLKWETRYRI-ALEAAKGLCYLHHDCSPLIIHRDVKSNNILL 827
           EY+  G L  M H  +   L  E   R  + E +  L YLH      II+RD+K +N+LL
Sbjct: 90  EYVNGGDL--MFHMQRQRKLP-EEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLL 143

Query: 828 DSDFEAHV--ADFGLAKFLQDAGASECMSSVAGSYGYIAPE----YAYTLKVDEKSDVYS 881
           DS  E H+   D+G+ K  +     +  S+  G+  YIAPE      Y   V    D ++
Sbjct: 144 DS--EGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSV----DWWA 195

Query: 882 FGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQ 918
            GV++ E++AG+ P   F          + T   + Q
Sbjct: 196 LGVLMFEMMAGRSP---FDIVGSSDNPDQNTEDYLFQ 229

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 70.7 bits (174), Expect = 5e-13
 Identities = 50/139 (35%), Positives = 71/139 (51%), Gaps = 24/139 (17%)

Query: 767 LY---EYMPNGSLGEMLHGAKGGHLKWETRYRI-ALEAAKGLCYLHHDCSPLIIHRDVKS 822
           LY   EY+  G L  M H  + G  K E      A E A GL +L    S  II+RD+K 
Sbjct: 96  LYFVMEYVNGGDL--MYHIQQVGRFK-EPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKL 149

Query: 823 NNILLDSDFEAHV--ADFGLAKFLQDAGASECMSSVAGSYGYIAPE----YAYTLKVDEK 876
           +N++LDS+   H+  ADFG+ K  ++        +  G+  YIAPE      Y   V   
Sbjct: 150 DNVMLDSE--GHIKIADFGMCK--ENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSV--- 202

Query: 877 SDVYSFGVVLLELIAGKKP 895
            D ++FGV+L E++AG+ P
Sbjct: 203 -DWWAFGVLLYEMLAGQAP 220

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 70.8 bits (174), Expect = 5e-13
 Identities = 48/139 (34%), Positives = 64/139 (46%), Gaps = 24/139 (17%)

Query: 767 LY---EYMPNGSLGEMLHGAKGGHLKWETRYRI-ALEAAKGLCYLHHDCSPLIIHRDVKS 822
           LY   +Y+  G L    H  +      E R R  A E A  L YLH   S  I++RD+K 
Sbjct: 114 LYFVLDYINGGEL--FYHLQRERCFL-EPRARFYAAEIASALGYLH---SLNIVYRDLKP 167

Query: 823 NNILLDSDFEAHV--ADFGLAKFLQDAGASECMSSVAGSYGYIAPE----YAYTLKVDEK 876
            NILLDS    H+   DFGL K  ++   +   S+  G+  Y+APE      Y   V   
Sbjct: 168 ENILLDSQ--GHIVLTDFGLCK--ENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTV--- 220

Query: 877 SDVYSFGVVLLELIAGKKP 895
            D +  G VL E++ G  P
Sbjct: 221 -DWWCLGAVLYEMLYGLPP 238

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 69.9 bits (172), Expect = 7e-13
 Identities = 46/134 (34%), Positives = 66/134 (49%), Gaps = 21/134 (15%)

Query: 769 EYMPNGSLGEMLHGAKGGHLKWETRYRI-ALEAAKGLCYLHHDCSPLIIHRDVKSNNILL 827
           EY+  G L  M H          +R    A E   GL +LH   S  I++RD+K +NILL
Sbjct: 98  EYLNGGDL--MYHIQSCHKFD-LSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILL 151

Query: 828 DSDFEAHV--ADFGLAKFLQDAGASECMSSVAGSYGYIAPE----YAYTLKVDEKSDVYS 881
           D   + H+  ADFG+ K  ++       ++  G+  YIAPE      Y   V    D +S
Sbjct: 152 DK--DGHIKIADFGMCK--ENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSV----DWWS 203

Query: 882 FGVVLLELIAGKKP 895
           FGV+L E++ G+ P
Sbjct: 204 FGVLLYEMLIGQSP 217

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 70.5 bits (173), Expect = 8e-13
 Identities = 56/259 (21%), Positives = 89/259 (34%), Gaps = 68/259 (26%)

Query: 689 DVLESLKDENIIGKGGAGIVYRGS-MPDGIDVAIKRLVGRGTGGNDHGFLA-----EIQT 742
            V ++   +++IG+G  G VY         +VAIK++        +          EI  
Sbjct: 23  HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKV----NRMFEDLIDCKRILREITI 78

Query: 743 LGRIRHRNIVRLLG--YVSNRDTNLLLY---EYMP---------NGSLGEMLHGAKGGHL 788
           L R++   I+RL       +      LY   E               L E        H+
Sbjct: 79  LNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEE-------HI 131

Query: 789 KWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAG 848
           K    Y + L    G  ++H      IIHRD+K  N LL+ D    V DFGLA+ +    
Sbjct: 132 KTIL-YNL-L---LGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEK 183

Query: 849 ASECMSSVAGSYG--------------------YIAPE-----YAYTLKVDEKSDVYSFG 883
            +  ++ +  +                      Y APE       YT  +    D++S G
Sbjct: 184 DTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSI----DIWSTG 239

Query: 884 VVLLELIAGKKPVGEFGDG 902
            +  EL+   +        
Sbjct: 240 CIFAELLNMLQSHINDPTN 258

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 70.5 bits (173), Expect = 9e-13
 Identities = 48/157 (30%), Positives = 72/157 (45%), Gaps = 24/157 (15%)

Query: 769 EYMPNGSLGEMLHGAKGGHLKWETRYRI-ALEAAKGLCYLHHDCSPLIIHRDVKSNNILL 827
           EY+  G L  M H  +   L  E   R  + E +  L YLH      II+RD+K +N+LL
Sbjct: 133 EYVNGGDL--MFHMQRQRKLP-EEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLL 186

Query: 828 DSDFEAHV--ADFGLAKFLQDAGASECMSSVAGSYGYIAPE----YAYTLKVDEKSDVYS 881
           DS  E H+   D+G+ K  +     +  S+  G+  YIAPE      Y   V    D ++
Sbjct: 187 DS--EGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSV----DWWA 238

Query: 882 FGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQ 918
            GV++ E++AG+ P   F          + T   + Q
Sbjct: 239 LGVLMFEMMAGRSP---FDIVGSSDNPDQNTEDYLFQ 272

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 68.1 bits (167), Expect = 1e-12
 Identities = 47/184 (25%), Positives = 77/184 (41%), Gaps = 9/184 (4%)

Query: 144 TELQVLDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLNGIG 203
            + + LD  +N  +         L  LR L    N         + E+++LE + +    
Sbjct: 37  ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNK 96

Query: 204 LNGTVPA-FLSRLKNLREMYIGYFNTYTGGIPPG-FGALTQLQVLDMASCNISGEIPTSL 261
           L   +P     +L NL E+ +   N     +PP  F +LT+L  L +    +   +P  +
Sbjct: 97  LQ-ALPIGVFDQLVNLAELRLDR-NQLKS-LPPRVFDSLTKLTYLSLGYNELQ-SLPKGV 152

Query: 262 -SRLKLLHSLFLQMNKLTGHIPPQL-SGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQ 319
             +L  L  L L  N+L   +P      L  LK+L L  N L      +F +L+ L +LQ
Sbjct: 153 FDKLTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQ 211

Query: 320 LFKN 323
           L +N
Sbjct: 212 LQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 65.8 bits (161), Expect = 9e-12
 Identities = 41/144 (28%), Positives = 71/144 (49%), Gaps = 9/144 (6%)

Query: 456 ASLNQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESFN-LKMITSINISDN 514
           A   +L + +N ++     A   L  L +L L +N+L+  +P   F  LK + ++ ++DN
Sbjct: 37  ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDN 95

Query: 515 NISGEIPYSI-SQCHSLTSVDLSRNSLYGKIPPGI-SKLIDLSILNLSRNGITGSIPNEM 572
            +   +P  +  Q  +L  + L RN L   +PP +   L  L+ L+L  N +  S+P  +
Sbjct: 96  KLQ-ALPIGVFDQLVNLAELRLDRNQL-KSLPPRVFDSLTKLTYLSLGYNELQ-SLPKGV 152

Query: 573 -RNMMSLTTLDLSYNNLIGNIPSG 595
              + SL  L L YNN +  +P G
Sbjct: 153 FDKLTSLKELRL-YNNQLKRVPEG 175

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 61.1 bits (149), Expect = 3e-10
 Identities = 57/232 (24%), Positives = 91/232 (39%), Gaps = 61/232 (26%)

Query: 290 SLKSLDLSLNYLTGEIPESFAALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNF 349
             K LDL  N L+    ++F  L  L LL L  N L+  +P+  G F  L+ L+      
Sbjct: 38  DTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQT-LPA--GIFKELKNLET----- 89

Query: 350 TFELPENLGRNGKLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFIGPIPEELGQCK 409
                           L VT N L   +P  +               F            
Sbjct: 90  ----------------LWVTDNKLQ-ALPIGV---------------FDQL--------V 109

Query: 410 SLTKIRFSKNYLNGTIPAGLF-NLPLLNMMELDDNLLSGELPEKMSGA-----SLNQLKV 463
           +L ++R  +N L  ++P  +F +L  L  + L  N L   LP+   G      SL +L++
Sbjct: 110 NLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPK---GVFDKLTSLKELRL 164

Query: 464 ANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESF-NLKMITSINISDN 514
            NN +      A   L  L  L L NN+L+  +P  +F +L+ +  + + +N
Sbjct: 165 YNNQLKRVPEGAFDKLTELKTLKLDNNQLK-RVPEGAFDSLEKLKMLQLQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 60.8 bits (148), Expect = 4e-10
 Identities = 48/180 (26%), Positives = 76/180 (42%), Gaps = 18/180 (10%)

Query: 424 TIPAGLF-NLPLLNMMELDDNLLSGELPEK--MSGASLNQLKVANNNITGKIPAAI-GNL 479
            IP+ +  +   L+   L  N LS  LP K       L  L + +N +   +PA I   L
Sbjct: 30  AIPSNIPADTKKLD---LQSNKLS-SLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKEL 84

Query: 480 PSLNILSLQNNRLEGEIPVESF-NLKMITSINISDNNISGEIPYSI-SQCHSLTSVDLSR 537
            +L  L + +N+L+  +P+  F  L  +  + +  N +   +P  +      LT + L  
Sbjct: 85  KNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGY 142

Query: 538 NSLYGKIPPGI-SKLIDLSILNLSRNGITGSIPNEM-RNMMSLTTLDLSYNNLIGNIPSG 595
           N L   +P G+  KL  L  L L  N +   +P      +  L TL L  N L   +P G
Sbjct: 143 NEL-QSLPKGVFDKLTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLK-RVPEG 199

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 60.0 bits (146), Expect = 7e-10
 Identities = 45/171 (26%), Positives = 78/171 (45%), Gaps = 14/171 (8%)

Query: 424 TIPAGLF-NLPLLNMMELDDNLLSGELPEKM--SGASLNQLKVANNNITGKIPAAI-GNL 479
           ++P+  F  L  L ++ L+DN L   LP  +     +L  L V +N +   +P  +   L
Sbjct: 51  SLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQ-ALPIGVFDQL 108

Query: 480 PSLNILSLQNNRLEGEIPVESF-NLKMITSINISDNNISGEIPYSI-SQCHSLTSVDLSR 537
            +L  L L  N+L+  +P   F +L  +T +++  N +   +P  +  +  SL  + L  
Sbjct: 109 VNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYN 166

Query: 538 NSLYGKIPPGI-SKLIDLSILNLSRNGITGSIPNEM-RNMMSLTTLDLSYN 586
           N L  ++P G   KL +L  L L  N +   +P     ++  L  L L  N
Sbjct: 167 NQL-KRVPEGAFDKLTELKTLKLDNNQLK-RVPEGAFDSLEKLKMLQLQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 41.1 bits (97), Expect = 9e-04
 Identities = 19/66 (28%), Positives = 26/66 (39%), Gaps = 4/66 (6%)

Query: 530 LTSVDLSRNSLYGKIPPGISKLIDLSILNLSRNGITGSIPNEMRNMMSLTTLDLSYNNLI 589
             SVD S   L   IP  I    D   L+L  N ++         +  L  L L+ N L 
Sbjct: 18  KNSVDCSSKKL-TAIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKL- 73

Query: 590 GNIPSG 595
             +P+G
Sbjct: 74  QTLPAG 79

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 66.6 bits (163), Expect = 2e-12
 Identities = 38/120 (31%), Positives = 61/120 (50%), Gaps = 5/120 (4%)

Query: 233 IPPG-FGALTQLQVLDMASCNISGEIPT-SLSRLKLLHSLFLQMNKLTGHIPPQL-SGLI 289
           IPPG F    +L+ +D+++  IS E+   +   L+ L+SL L  NK+T  +P  L  GL 
Sbjct: 47  IPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKIT-ELPKSLFEGLF 104

Query: 290 SLKSLDLSLNYLTGEIPESFAALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNF 349
           SL+ L L+ N +     ++F  L NL LL L+ N L+            ++ + +  N F
Sbjct: 105 SLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPF 164

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 58.1 bits (141), Expect = 2e-09
 Identities = 30/136 (22%), Positives = 63/136 (46%), Gaps = 9/136 (6%)

Query: 456 ASLNQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESFN-LKMITSINISDN 514
            ++ ++++  N I    P A      L  + L NN++  E+  ++F  L+ + S+ +  N
Sbjct: 32  ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGN 90

Query: 515 NISGEIPYSI-SQCHSLTSVDLSRNSLYGKIPPGI-SKLIDLSILNLSRNGITGSIPNEM 572
            I+ E+P S+     SL  + L+ N +   +       L +L++L+L  N +  +I    
Sbjct: 91  KIT-ELPKSLFEGLFSLQLLLLNANKI-NCLRVDAFQDLHNLNLLSLYDNKLQ-TIAKGT 147

Query: 573 -RNMMSLTTLDLSYNN 587
              + ++ T+ L   N
Sbjct: 148 FSPLRAIQTMHL-AQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 58.1 bits (141), Expect = 2e-09
 Identities = 31/141 (21%), Positives = 49/141 (34%), Gaps = 6/141 (4%)

Query: 233 IPPGFGALTQLQVLDMASCNISGEIPTSLSRLKLLHSLFLQMNKLTGHIPPQL-SGLISL 291
           IP           + +    I    P + S  K L  + L  N+++  + P    GL SL
Sbjct: 26  IPTNLPETIT--EIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSL 82

Query: 292 KSLDLSLNYLTGEIPESFAALKNLTLLQLFKNNLRGPIPSFLGD-FPNLEVLQVWGNNFT 350
            SL L  N +T      F  L +L LL L  N +   +         NL +L ++ N   
Sbjct: 83  NSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINC-LRVDAFQDLHNLNLLSLYDNKLQ 141

Query: 351 FELPENLGRNGKLLILDVTSN 371
                       +  + +  N
Sbjct: 142 TIAKGTFSPLRAIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 57.0 bits (138), Expect = 4e-09
 Identities = 34/146 (23%), Positives = 66/146 (45%), Gaps = 20/146 (13%)

Query: 257 IPTSLSRLKLLHSLFLQMNKLTGHIPPQ-LSGLISLKSLDLSLNYLTGEIPE-SFAALKN 314
           +P +++ +       L+ N +   IPP   S    L+ +DLS N ++ E+   +F  L++
Sbjct: 30  LPETITEI------RLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRS 81

Query: 315 LTLLQLFKNNLRGPIPSFLGDF---PNLEVLQVWGNNFTFELPENLGRN-GKLLILDVTS 370
           L  L L+ N +   +P     F    +L++L +  N     L  +  ++   L +L +  
Sbjct: 82  LNSLVLYGNKITE-LPK--SLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYD 137

Query: 371 NHLTGTIPRDLCKG-GKLKSLILMQN 395
           N L  TI +        ++++ L QN
Sbjct: 138 NKLQ-TIAKGTFSPLRAIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 52.3 bits (126), Expect = 1e-07
 Identities = 33/111 (29%), Positives = 57/111 (51%), Gaps = 9/111 (8%)

Query: 409 KSLTKIRFSKNYLNGTIPAGLFN-LPLLNMMELDDNLLSGELPEKM--SGASLNQLKVAN 465
           K L +I  S N ++  +    F  L  LN + L  N ++ ELP+ +     SL  L +  
Sbjct: 56  KKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNA 113

Query: 466 NNITGKIPA-AIGNLPSLNILSLQNNRLEGEIPVESF-NLKMITSINISDN 514
           N I   +   A  +L +LN+LSL +N+L+  I   +F  L+ I +++++ N
Sbjct: 114 NKIN-CLRVDAFQDLHNLNLLSLYDNKLQ-TIAKGTFSPLRAIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 47.3 bits (113), Expect = 7e-06
 Identities = 33/148 (22%), Positives = 59/148 (39%), Gaps = 9/148 (6%)

Query: 275 NKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQLFKNNLRG-PIPSFL 333
             LT  IP  L    ++  + L  N +    P +F+  K L  + L  N +      +F 
Sbjct: 21  KGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQ 77

Query: 334 GDFPNLEVLQVWGNNFTFELPENLGRN-GKLLILDVTSNHLTGTIPRDLCKG-GKLKSLI 391
           G   +L  L ++GN  T ELP++L      L +L + +N +   +  D  +    L  L 
Sbjct: 78  G-LRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLS 134

Query: 392 LMQNFFIGPIPEELGQCKSLTKIRFSKN 419
           L  N             +++  +  ++N
Sbjct: 135 LYDNKLQTIAKGTFSPLRAIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 46.9 bits (112), Expect = 8e-06
 Identities = 25/91 (27%), Positives = 38/91 (41%), Gaps = 5/91 (5%)

Query: 507 TSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYGKIPPGI-SKLIDLSILNLSRNGIT 565
           T I +  N I    P + S    L  +DLS N +  ++ P     L  L+ L L  N IT
Sbjct: 35  TEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQI-SELAPDAFQGLRSLNSLVLYGNKIT 93

Query: 566 GSIPNEM-RNMMSLTTLDLSYNNLIGNIPSG 595
             +P  +   + SL  L L+ N +   +   
Sbjct: 94  -ELPKSLFEGLFSLQLLLLNANKI-NCLRVD 122

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 67.9 bits (166), Expect = 4e-12
 Identities = 34/146 (23%), Positives = 56/146 (38%), Gaps = 13/146 (8%)

Query: 211 FLSRLKNLREMYIGYFNTYTGGIPPG-FGALTQLQVLDMASCNISGEIPT-SLSRLKLLH 268
             +RL NL  + + + N     I    F  +  L+ LD++S ++   +     S L+ L 
Sbjct: 59  TPTRLTNLHSLLLSH-NHLNF-ISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALE 115

Query: 269 SLFLQMNKLTGHIPP-QLSGLISLKSLDLSLNYLTGEIPE----SFAALKNLTLLQLFKN 323
            L L  N +   +       +  L+ L LS N ++   P         L  L LL L  N
Sbjct: 116 VLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSN 173

Query: 324 NLRGPIPSFLGDFPNLEVLQVW-GNN 348
            L+    + L   P      ++  NN
Sbjct: 174 KLKKLPLTDLQKLPAWVKNGLYLHNN 199

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 67.9 bits (166), Expect = 4e-12
 Identities = 42/158 (26%), Positives = 73/158 (46%), Gaps = 19/158 (12%)

Query: 233 IPPGFGALTQLQVLDMASCNISGEIP--TSLSRLKLLHSLFLQMNKLTGHIPPQ-LSGLI 289
           +P    + T   +LD++  N+S  +    + +RL  LHSL L  N L   I  +    + 
Sbjct: 33  VPQSLPSYTA--LLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVP 88

Query: 290 SLKSLDLSLNYLTGEIPESFAALKNLTLLQLFKNNLRGPIPSFLGDF---PNLEVLQVWG 346
           +L+ LDLS N+L       F+ L+ L +L L+ N++   +      F     L+ L +  
Sbjct: 89  NLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVV-VDR--NAFEDMAQLQKLYLSQ 145

Query: 347 NNFTFELPE----NLGRNGKLLILDVTSNHLTGTIPRD 380
           N  +   P     +  +  KL++LD++SN L   +P  
Sbjct: 146 NQIS-RFPVELIKDGNKLPKLMLLDLSSNKLK-KLPLT 181

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 67.2 bits (164), Expect = 7e-12
 Identities = 37/171 (21%), Positives = 70/171 (40%), Gaps = 19/171 (11%)

Query: 456 ASLNQLKVANNNITGKIPA--AIGNLPSLNILSLQNNRLEGEIPVESF-NLKMITSINIS 512
           +    L +++NN++ ++ A      L +L+ L L +N L   I  E+F  +  +  +++S
Sbjct: 39  SYTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLS 96

Query: 513 DNNISGEIPYSI-SQCHSLTSVDLSRNSLYGKIPPGI-SKLIDLSILNLSRNGITGSIPN 570
            N++   +   + S   +L  + L  N +   +       +  L  L LS+N I+   P 
Sbjct: 97  SNHLH-TLDEFLFSDLQALEVLLLYNNHI-VVVDRNAFEDMAQLQKLYLSQNQIS-RFPV 153

Query: 571 E----MRNMMSLTTLDLSYNNLIGNIPSGGQFLAFNETSFIGNPNLCLLRN 617
           E       +  L  LDLS +N +  +P         +        L L  N
Sbjct: 154 ELIKDGNKLPKLMLLDLS-SNKLKKLPLT----DLQKLPAWVKNGLYLHNN 199

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 66.8 bits (163), Expect = 9e-12
 Identities = 36/173 (20%), Positives = 75/173 (43%), Gaps = 15/173 (8%)

Query: 424 TIPAGLFNLPLLNMMELDDNLLSGELPEKMSGASLNQLK---VANNNITGKIPA-AIGNL 479
            +P  L       +++L  N LS  L  + +   L  L    +++N++   I + A   +
Sbjct: 32  NVPQSLP--SYTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPV 87

Query: 480 PSLNILSLQNNRLEGEIPVESF-NLKMITSINISDNNISGEIPYSISQCHSLTSVDLSRN 538
           P+L  L L +N L   +    F +L+ +  + + +N+I      +      L  + LS+N
Sbjct: 88  PNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQN 146

Query: 539 SLYGKIPPGI----SKLIDLSILNLSRNGITGSIPNEMRNMMSLTTLDLSYNN 587
            +  + P  +    +KL  L +L+LS N +      +++ + +     L  +N
Sbjct: 147 QIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHN 198

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 63.7 bits (155), Expect = 1e-10
 Identities = 34/130 (26%), Positives = 53/130 (40%), Gaps = 14/130 (10%)

Query: 472 IPAAIGNLPS-LNILSLQNNRLEGEIPVESF--NLKMITSINISDNNISGEIPYSI-SQC 527
           +P    +LPS   +L L +N L   +  E     L  + S+ +S N+++  I        
Sbjct: 33  VPQ---SLPSYTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPV 87

Query: 528 HSLTSVDLSRNSLYGKIPPGI-SKLIDLSILNLSRNGITGSIPNEM-RNMMSLTTLDLSY 585
            +L  +DLS N L   +   + S L  L +L L  N I   +      +M  L  L LS 
Sbjct: 88  PNLRYLDLSSNHL-HTLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQ 145

Query: 586 NNLIGNIPSG 595
           N +    P  
Sbjct: 146 NQIS-RFPVE 154

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 52.5 bits (126), Expect = 4e-07
 Identities = 45/227 (19%), Positives = 71/227 (31%), Gaps = 74/227 (32%)

Query: 86  SIPPEIGLLTKLVNLTISNVNLTGRLPSEMAL--LTSLKVFNISGNVFQ----GNFAGQI 139
           ++P    L +    L +S+ NL+ RL +E     LT+L    +S N         F    
Sbjct: 32  NVPQ--SLPSYTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLNFISSEAF---- 84

Query: 140 VRGMTELQVLDAYNNNFTGPLPVEI-ASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIG 198
              +  L+ LD  +N+    L   + + L++L  L    N            I       
Sbjct: 85  -VPVPNLRYLDLSSNHLHT-LDEFLFSDLQALEVLLLYNN-----------HIVV----- 126

Query: 199 LNGIGLNGTVPAFLSRLKNLREMYIGYFNTYTGGIPPG-FGALTQLQVLDMASCNISGEI 257
                                             +    F  + QLQ L ++   IS   
Sbjct: 127 ----------------------------------VDRNAFEDMAQLQKLYLSQNQIS-RF 151

Query: 258 P----TSLSRLKLLHSLFLQMNKLTGHIPPQ-LSGLISLKSLDLSLN 299
           P       ++L  L  L L  NKL   +P   L  L +     L L+
Sbjct: 152 PVELIKDGNKLPKLMLLDLSSNKLK-KLPLTDLQKLPAWVKNGLYLH 197

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 49.1 bits (117), Expect = 4e-06
 Identities = 25/101 (24%), Positives = 41/101 (40%), Gaps = 17/101 (16%)

Query: 519 EIPYSISQCHSLTSVDLSRNSLYGKIPPGI--SKLIDLSILNLSRNGITGSIPNEM-RNM 575
            +P S+        +DLS N+L  ++      ++L +L  L LS N +   I +E    +
Sbjct: 32  NVPQSLP--SYTALLDLSHNNL-SRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPV 87

Query: 576 MSLTTLDLSYNNLIGNIPSGGQFLAFNETSFIGNPNLCLLR 616
            +L  LDLS N+L   +             F     L +L 
Sbjct: 88  PNLRYLDLSSNHL-HTLDEF---------LFSDLQALEVLL 118

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 69.5 bits (169), Expect = 4e-12
 Identities = 99/761 (13%), Positives = 212/761 (27%), Gaps = 271/761 (35%)

Query: 298 LNYLTGEIPESFAALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFT------- 350
           +++ TGE        +   +L +F         +F+ +F   +V  +  +  +       
Sbjct: 7   MDFETGEH-----QYQYKDILSVF-------EDAFVDNFDCKDVQDMPKSILSKEEIDHI 54

Query: 351 FELPENLGRNGKLLILDVTSNHLTGTIPRDLCKGGK--LKSLI---LMQN--FFIGPIPE 403
               + +    +L                 L    +  ++  +   L  N  F + PI  
Sbjct: 55  IMSKDAVSGTLRLFWT--------------LLSKQEEMVQKFVEEVLRINYKFLMSPIKT 100

Query: 404 ELGQCKSLTKIRFS--KNYLNGTIPAGLF---NLPLLNMM-ELDDNLLSGEL-PEK---- 452
           E  Q  S+    +   ++ L       +F   N+  L    +L   LL  EL P K    
Sbjct: 101 EQRQ-PSMMTRMYIEQRDRLYNDNQ--VFAKYNVSRLQPYLKLRQALL--ELRPAKNVLI 155

Query: 453 --MSGASLNQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESFNLKMITSIN 510
             + G+             GK          + +    + +++ ++  + F L       
Sbjct: 156 DGVLGS-------------GK--------TWVALDVCLSYKVQCKMDFKIFWL------- 187

Query: 511 ISDNNISGEIPYSISQCHSLTSVDLSRNSLYGKIPPGISKLIDLSILNLSRNGITGSIPN 570
                       ++  C+S  +V      L  +I P  +   D S  N+       SI  
Sbjct: 188 ------------NLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSS-NIKLR--IHSIQA 232

Query: 571 EMRNMM-------SLTTLDLSYNNLIGNIPSGGQFLAFNETSFIGNPNLCLLRNGTCQSL 623
           E+R ++        L  L         N+ +   + AF               N +C+ L
Sbjct: 233 ELRRLLKSKPYENCLLVLL--------NVQNAKAWNAF---------------NLSCKIL 269

Query: 624 I-------------NSAKH-SGDGYGSSFGASK---IVITVIALLTFML---------LV 657
           +              +  H S D +  +    +   +++  +      L           
Sbjct: 270 LTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRR 329

Query: 658 ILTIYQLRKRRLQKSKAWKLTAFQRLDFKAEDVLESLKDENIIGKGGAGIVYR--GSMPD 715
           +  I +  +  L     WK     +L    E  L  L+      +     ++      P 
Sbjct: 330 LSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEY--RK----MFDRLSVFPP 383

Query: 716 GIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGS 775
              +    L                             +   V   D  +++ + +   S
Sbjct: 384 SAHIPTILL---------------------------SLIWFDVIKSDVMVVVNK-LHKYS 415

Query: 776 LGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAH- 834
           L E          K      I          +        I+ ++K     L++++  H 
Sbjct: 416 LVE----------KQPKESTI---------SIPS------IYLELKVK---LENEYALHR 447

Query: 835 --VADFGLAK-FLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYS-FGVVLLELI 890
             V  + + K F  D      +        Y      + LK  E  +  + F +V L+  
Sbjct: 448 SIVDHYNIPKTFDSDDLIPPYLD------QYFYSHIGHHLKNIEHPERMTLFRMVFLDF- 500

Query: 891 AGKKPVGEFGDGVDIVRW----VRKTTSEVSQPSDAASVLAVV----------DPRLSGY 936
                           R+    +R  ++  +      + L  +          DP+    
Sbjct: 501 ----------------RFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYERL 544

Query: 937 PLTGVIH-LFKVAMMCVEDESSARPTMREVVHMLANPPQSA 976
            +  ++  L K+    +  + +      +++ +       A
Sbjct: 545 -VNAILDFLPKIEENLICSKYT------DLLRIALMAEDEA 578

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 64.9 bits (157), Expect = 1e-10
 Identities = 83/567 (14%), Positives = 168/567 (29%), Gaps = 158/567 (27%)

Query: 117 LLTSLKVFNISGNVFQGNFAGQIVRGMTELQVLDAYNNNFTGPLPVEIASLKSLRHLSFG 176
           L++ +K      ++    +  Q  R   + QV   YN             L+  + L   
Sbjct: 94  LMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNV----SRLQPYLKLR--QALL-- 145

Query: 177 GNYFTGKIPQSYSEIQSLEYIGLNGIGLNG-TVPAFLSRLKNLREMYIGYFNTYTGGIPP 235
                        E++  + + ++G+  +G T  A L    + +      F  +      
Sbjct: 146 -------------ELRPAKNVLIDGVLGSGKTWVA-LDVCLSYKVQCKMDFKIFW----- 186

Query: 236 GFGALTQLQVLDMASCNISGEIPTSLSRLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLD 295
                     L++ +CN    +      L++L  L  Q++      P   S      ++ 
Sbjct: 187 ----------LNLKNCNSPETV------LEMLQKLLYQID------PNWTSRSDHSSNIK 224

Query: 296 LSLNYLTGEIPESFAALKNLTLLQLFKNNL--------RGPIPSFLGDFP--------NL 339
           L ++ +  E       L+ L   + ++N L             +F  +            
Sbjct: 225 LRIHSIQAE-------LRRLLKSKPYENCLLVLLNVQNAKAWNAF--NLSCKILLTTRFK 275

Query: 340 EVLQVWGNNFTFELPENLGRNG-------KLL--ILDVTSNHLTGTIPRDLCKGGKLK-S 389
           +V        T  +  +             LL   LD     L    PR++      + S
Sbjct: 276 QVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDL----PREVLTTNPRRLS 331

Query: 390 LI--LMQNFFIGPIPEELGQCKSLTKIR-----------FSKNYL-------NGTIPAGL 429
           +I   +++        +   C  LT I            + K +        +  IP  L
Sbjct: 332 IIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTIL 391

Query: 430 FNLPLL--NMMELDDNLLSGELPEKMSGASLNQLKVANNNITGKIPAAIGNLPSLNILSL 487
             L L+  ++++ D  ++  +L +     SL    V        I     ++PS+ +   
Sbjct: 392 --LSLIWFDVIKSDVMVVVNKLHKY----SL----VEKQPKESTI-----SIPSIYLELK 436

Query: 488 QNNRLEGEI---PVESFNLKMI-----TSINISDNNISGEIPYSISQCHSLTSVDLSRNS 539
                E  +    V+ +N+              D      I + +        + L R  
Sbjct: 437 VKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRM- 495

Query: 540 LYGKIPPGISKLIDLSILN--LSRNGITGSIPNEMRNMMS--------LTTLDLSYNNLI 589
           ++          +D   L   +  +    +    + N +         +   D  Y  L+
Sbjct: 496 VF----------LDFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYERLV 545

Query: 590 GNIPSGGQFLAFNETSFIGNPNLCLLR 616
             I     FL   E + I +    LLR
Sbjct: 546 NAI---LDFLPKIEENLICSKYTDLLR 569

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 67.5 bits (165), Expect = 1e-11
 Identities = 46/199 (23%), Positives = 76/199 (38%), Gaps = 39/199 (19%)

Query: 663 QLRKRRLQKSKAWKLTAFQRLDFKAEDVLESLKDENIIGKGGAGIVYRGS-MPDGIDVAI 721
           Q   ++ ++  + K TA          + +  +  ++IG G  G V       +   VAI
Sbjct: 24  QQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAI 83

Query: 722 KRLVGRGTGGNDHGFLA-----EIQTLGRIRHRNIVRLLG--YVSNRDTNLLLY---EYM 771
           K++        +          EI  L R+ H ++V++L      + +    LY   E  
Sbjct: 84  KKI----LRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA 139

Query: 772 P---------NGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKS 822
                        L E+       H+K    Y +      G+ Y+H   S  I+HRD+K 
Sbjct: 140 DSDFKKLFRTPVYLTEL-------HIKTLL-YNLL----VGVKYVH---SAGILHRDLKP 184

Query: 823 NNILLDSDFEAHVADFGLA 841
            N L++ D    V DFGLA
Sbjct: 185 ANCLVNQDCSVKVCDFGLA 203

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 66.5 bits (162), Expect = 1e-11
 Identities = 37/150 (24%), Positives = 62/150 (41%), Gaps = 4/150 (2%)

Query: 747 RHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCY 806
             R +  +    S+  +  +  + + +    E         L  E     + + AKG+ +
Sbjct: 149 LKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEF 208

Query: 807 LHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPE 866
           L    S   IHRD+ + NILL       + DFGLA+ +                 ++APE
Sbjct: 209 L---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE 265

Query: 867 YAYTLKVDEKSDVYSFGVVLLELIA-GKKP 895
             +      +SDV+SFGV+L E+ + G  P
Sbjct: 266 TIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 53.4 bits (128), Expect = 2e-07
 Identities = 37/170 (21%), Positives = 56/170 (32%), Gaps = 17/170 (10%)

Query: 692 ESLKDENIIGKGGAGIVYRGS------MPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGR 745
           + LK    +G+G  G V                VA+K L    T       ++E++ L  
Sbjct: 22  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 81

Query: 746 I-RHRNIVRLLGYVSNRDTNLLL-YEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKG 803
           I  H N+V LLG  +     L++  E+   G+L   L            R        KG
Sbjct: 82  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLR---------SKRNEFVPYKTKG 132

Query: 804 LCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECM 853
             +         I  D+K     + S   +  + F   K L D    E  
Sbjct: 133 ARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAP 182

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 65.9 bits (161), Expect = 2e-11
 Identities = 63/247 (25%), Positives = 106/247 (42%), Gaps = 55/247 (22%)

Query: 682 RLDFKAEDVLESLKDENIIGKGGAGIVYRGS-MPDGIDVAIKRLVGRGTGGNDHGFLA-- 738
           R+D     VL   +    +GKG  GIV++      G  VA+K++         +   A  
Sbjct: 2   RVDR---HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKI----FDAFQNSTDAQR 54

Query: 739 ---EIQTLGRIR-HRNIVRLLG-YVSNRDTNL-LLYEYMPNGSLGEMLHGAK--GGHLKW 790
              EI  L  +  H NIV LL    ++ D ++ L+++YM    L  ++        H ++
Sbjct: 55  TFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYMET-DLHAVIRANILEPVHKQY 113

Query: 791 ETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS 850
              Y++     K + YLH   S  ++HRD+K +NILL+++    VADFGL++   +    
Sbjct: 114 VV-YQLI----KVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRV 165

Query: 851 ECMSSVAGSYG-------------------YIAPE-----YAYTLKVDEKSDVYSFGVVL 886
                ++ +                     Y APE       YT  +    D++S G +L
Sbjct: 166 TNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGI----DMWSLGCIL 221

Query: 887 LELIAGK 893
            E++ GK
Sbjct: 222 GEILCGK 228

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 65.1 bits (159), Expect = 3e-11
 Identities = 54/340 (15%), Positives = 112/340 (32%), Gaps = 70/340 (20%)

Query: 290 SLKSLDLSLNYLTGE----IPESFAALKNLTLLQLFKNNLRGP-----IPSFLGDFPNLE 340
           S++   L L+ +T E    +        ++  + L  N + G      +   +    +LE
Sbjct: 5   SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTI-GTEAARWLSENIASKKDLE 63

Query: 341 VLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFF--- 397
           + + + + FT       GR    +   +        + + L K  KL ++ L  N F   
Sbjct: 64  IAE-FSDIFT-------GRVKDEIPEALRL------LLQALLKCPKLHTVRLSDNAFGPT 109

Query: 398 -IGPIPEELGQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLSGELPEKMSGA 456
              P+ + L +   L  +    N L    P            ++   L    + +K   A
Sbjct: 110 AQEPLIDFLSKHTPLEHLYLHNNGLG---PQA--------GAKIARALQELAVNKKAKNA 158

Query: 457 -SLNQLKVANNNITGK----IPAAIGNLPSLNILSLQNNRL--EGEIPVESFNLKM---I 506
             L  +    N +             +   L+ + +  N +  EG   +    L     +
Sbjct: 159 PPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQEL 218

Query: 507 TSINISDNNISGE----IPYSISQCHSLTSVDLSRNSLYGKIPPGISKLID--------- 553
             +++ DN  +      +  ++    +L  + L+   L  +   G + ++D         
Sbjct: 219 KVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSAR---GAAAVVDAFSKLENIG 275

Query: 554 LSILNLSRNGITG----SIPNEMR-NMMSLTTLDLSYNNL 588
           L  L L  N I      ++   +   M  L  L+L+ N  
Sbjct: 276 LQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRF 315

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 55.9 bits (135), Expect = 3e-08
 Identities = 36/248 (14%), Positives = 69/248 (27%), Gaps = 50/248 (20%)

Query: 387 LKSLILMQNFF----IGPIPEELGQCKSLTKIRFSKNYLNGT----IPAGLFNLPLLNMM 438
           ++   L  +         +   L +  S+ +I  S N +       +   + +   L + 
Sbjct: 6   IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 65

Query: 439 ELDDNLLSGELPEKMSGASLNQLKVANNNITGKIPAAIGNLPSLNILSLQNNRL--EGEI 496
           E  D        E      L             +  A+   P L+ + L +N      + 
Sbjct: 66  EFSDIFTGRVKDEIPEALRL-------------LLQALLKCPKLHTVRLSDNAFGPTAQE 112

Query: 497 PVESF--NLKMITSINISDNNISGE-------------IPYSISQCHSLTSVDLSRNSLY 541
           P+  F      +  + + +N +  +             +         L S+   RN L 
Sbjct: 113 PLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLE 172

Query: 542 GK----IPPGISKLIDLSILNLSRNGIT-----GSIPNEMRNMMSLTTLDLSYNNLIGNI 592
                           L  + + +NGI        +   +     L  LDL  N    + 
Sbjct: 173 NGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNT-FTH- 230

Query: 593 PSGGQFLA 600
             G   LA
Sbjct: 231 -LGSSALA 237

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 53.2 bits (128), Expect = 3e-07
 Identities = 51/332 (15%), Positives = 100/332 (30%), Gaps = 70/332 (21%)

Query: 97  LVNLTISNVNLTGR---------LPSEMALLTSLKVFNISGNVFQGNFA---GQIVRGMT 144
           +   +I   +L            + + +    S+K   +SGN      A    + +    
Sbjct: 1   MARFSIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKK 60

Query: 145 ELQVLDAYNNNFTGPLPVEIAS-----------LKSLRHLSFGGNYFT-------GKIPQ 186
           +L++ + +++ FTG +  EI                L  +    N F             
Sbjct: 61  DLEIAE-FSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLS 119

Query: 187 SYSEIQSLEYIGLNGIGLNGTVPAFLSRLKNLREMYIGYFNTYTGGIPPGFGALTQLQVL 246
            ++ ++ L Y+  NG+G           L+ L                        L+ +
Sbjct: 120 KHTPLEHL-YLHNNGLGPQA-GAKIARALQELAVNKKAKNAP-------------PLRSI 164

Query: 247 DMASCNISGE----IPTSLSRLKLLHSLFLQMNKLTGH-----IPPQLSGLISLKSLDLS 297
                 +          +    +LLH++ +  N +        +   L+    LK LDL 
Sbjct: 165 ICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQ 224

Query: 298 LNYLTGE----IPESFAALKNLTLLQLFKNNLRGP----IPSFLGDFPN--LEVLQVWGN 347
            N  T      +  +  +  NL  L L    L       +        N  L+ L++  N
Sbjct: 225 DNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYN 284

Query: 348 NFTFE----LPENLGRNGK-LLILDVTSNHLT 374
               +    L   +      LL L++  N  +
Sbjct: 285 EIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 316

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 62.4 bits (152), Expect = 3e-10
 Identities = 46/217 (21%), Positives = 88/217 (40%), Gaps = 32/217 (14%)

Query: 699 IIGKGGAGIVYRGS-MPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIR---------- 747
            +G G    V+    M +   VA+K  + RG          EI+ L R+           
Sbjct: 26  KLGWGHFSTVWLAKDMVNNTHVAMK--IVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSM 83

Query: 748 -HRNIVRLLGYVSNRDTNL----LLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAK 802
              +I++LL + +++  N     +++E +   +L  ++   +   +      +I+ +   
Sbjct: 84  GANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLL 142

Query: 803 GLCYLHHDCSPLIIHRDVKSNNILLDSDFEAH------VADFGLAKFLQDAGASECMSSV 856
           GL Y+H  C   IIH D+K  N+L++            +AD G A +       E  ++ 
Sbjct: 143 GLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW-----YDEHYTNS 195

Query: 857 AGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGK 893
             +  Y +PE          +D++S   ++ ELI G 
Sbjct: 196 IQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 58.5 bits (142), Expect = 8e-10
 Identities = 32/144 (22%), Positives = 63/144 (43%), Gaps = 16/144 (11%)

Query: 451 EKMSGASLNQLKV-----ANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESF-NLK 504
           E+       + +          I  K+ A +  L +   L+L  N +E    + S   ++
Sbjct: 15  EERKSVVATEAEKVELHGMIPPIE-KMDATLSTLKACKHLALSTNNIE---KISSLSGME 70

Query: 505 MITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYGKIPPGISKLIDLSILNLSRNGI 564
            +  +++  N I  +I    +   +L  + +S N +   +  GI KL++L +L +S N I
Sbjct: 71  NLRILSLGRNLIK-KIENLDAVADTLEELWISYNQI-ASL-SGIEKLVNLRVLYMSNNKI 127

Query: 565 T--GSIPNEMRNMMSLTTLDLSYN 586
           T  G I +++  +  L  L L+ N
Sbjct: 128 TNWGEI-DKLAALDKLEDLLLAGN 150

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 52.0 bits (125), Expect = 1e-07
 Identities = 24/98 (24%), Positives = 44/98 (44%), Gaps = 5/98 (5%)

Query: 491 RLEGEIPVESFNLKMITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYGKIPPGISK 550
             E    V +   + +  ++     I  ++  ++S   +   + LS N++  KI   +S 
Sbjct: 13  IFEERKSVVATEAEKV-ELHGMIPPIE-KMDATLSTLKACKHLALSTNNI-EKIS-SLSG 68

Query: 551 LIDLSILNLSRNGITGSIPNEMRNMMSLTTLDLSYNNL 588
           + +L IL+L RN I   I N      +L  L +SYN +
Sbjct: 69  MENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQI 105

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 48.9 bits (117), Expect = 2e-06
 Identities = 36/150 (24%), Positives = 53/150 (35%), Gaps = 9/150 (6%)

Query: 246 LDMASCNISGEIPTSLSRLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEI 305
           L      I  ++  +LS LK    L L  N +   I   LSG+ +L+ L L  N +  +I
Sbjct: 30  LHGMIPPIE-KMDATLSTLKACKHLALSTNNIE-KISS-LSGMENLRILSLGRNLIK-KI 85

Query: 306 PESFAALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPE--NLGRNGKL 363
               A    L  L +  N +     S +    NL VL +  NN      E   L    KL
Sbjct: 86  ENLDAVADTLEELWISYNQIA--SLSGIEKLVNLRVLYM-SNNKITNWGEIDKLAALDKL 142

Query: 364 LILDVTSNHLTGTIPRDLCKGGKLKSLILM 393
             L +  N L      +         ++  
Sbjct: 143 EDLLLAGNPLYNDYKENNATSEYRIEVVKR 172

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 41.6 bits (98), Expect = 4e-04
 Identities = 39/189 (20%), Positives = 72/189 (38%), Gaps = 46/189 (24%)

Query: 144 TELQVLDAYN--NNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLNG 201
           TE + ++ +         +   +++LK+ +HL+   N            I+ +       
Sbjct: 23  TEAEKVELHGMIPPIEK-MDATLSTLKACKHLALSTN-----------NIEKIS------ 64

Query: 202 IGLNGTVPAFLSRLKNLREMYIGYFNTYTGGIPPGFGALTQLQVLDMASCNISGEIPTSL 261
                     LS ++NLR + +G  N     I         L+ L ++   I+  + + +
Sbjct: 65  ---------SLSGMENLRILSLGR-NLIK-KIENLDAVADTLEELWISYNQIA-SL-SGI 111

Query: 262 SRLKLLHSLFLQMNKLT--GHIPPQLSGLISLKSLDLSLNYLTGEIPES----------F 309
            +L  L  L++  NK+T  G I   L+ L  L+ L L+ N L  +  E+           
Sbjct: 112 EKLVNLRVLYMSNNKITNWGEIDK-LAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVV 170

Query: 310 AALKNLTLL 318
             L NL  L
Sbjct: 171 KRLPNLKKL 179

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 58.5 bits (142), Expect = 1e-09
 Identities = 29/115 (25%), Positives = 52/115 (45%), Gaps = 4/115 (3%)

Query: 237 FGALTQLQVLDMASCNISGEIPTSLSRLKLLHSLFLQMNKLTGHIPPQL-SGLISLKSLD 295
           F  L QL+ ++ ++  I+     +      ++ + L  N+L   +  ++  GL SLK+L 
Sbjct: 53  FKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLEN-VQHKMFKGLESLKTLM 111

Query: 296 LSLNYLTGEIPE-SFAALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNF 349
           L  N +T  +   SF  L ++ LL L+ N +    P       +L  L +  N F
Sbjct: 112 LRSNRIT-CVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPF 165

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 56.6 bits (137), Expect = 6e-09
 Identities = 33/128 (25%), Positives = 48/128 (37%), Gaps = 10/128 (7%)

Query: 472 IPAAIGNLPSLNILSLQNNRLEGEIPVESF-NLKMITSINISDNNISGEIPYSI-SQCHS 529
           IP  I        L L NN          F  L  +  IN S+N I+ +I          
Sbjct: 26  IPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASG 82

Query: 530 LTSVDLSRNSLYGKIPPGI-SKLIDLSILNLSRNGITGSIPNEM-RNMMSLTTLDLSYNN 587
           +  + L+ N L   +   +   L  L  L L  N IT  + N+    + S+  L L Y+N
Sbjct: 83  VNEILLTSNRL-ENVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSL-YDN 139

Query: 588 LIGNIPSG 595
            I  +  G
Sbjct: 140 QITTVAPG 147

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 55.0 bits (133), Expect = 2e-08
 Identities = 30/147 (20%), Positives = 54/147 (36%), Gaps = 21/147 (14%)

Query: 257 IPTSLSRLKLLHSLFLQMNKLTGHIPPQ--LSGLISLKSLDLSLNYLTGEIPE-SFAALK 313
           IP   + L       L  N+ T  +        L  L+ ++ S N +T +I E +F    
Sbjct: 30  IPQYTAEL------RLNNNEFT-VLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGAS 81

Query: 314 NLTLLQLFKNNLRGPIPSFLGDF---PNLEVLQVWGNNFTFELPENLGRN-GKLLILDVT 369
            +  + L  N L   +      F    +L+ L +  N  T  +  +       + +L + 
Sbjct: 82  GVNEILLTSNRLEN-VQH--KMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLY 137

Query: 370 SNHLTGTIPRDLCKG-GKLKSLILMQN 395
            N +T T+          L +L L+ N
Sbjct: 138 DNQIT-TVAPGAFDTLHSLSTLNLLAN 163

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 55.0 bits (133), Expect = 2e-08
 Identities = 31/111 (27%), Positives = 51/111 (45%), Gaps = 9/111 (8%)

Query: 409 KSLTKIRFSKNYLNGTIPAGLFN-LPLLNMMELDDNLLSGELPEKM--SGASLNQLKVAN 465
             L KI FS N +   I  G F     +N + L  N L   +  KM     SL  L + +
Sbjct: 57  PQLRKINFSNNKIT-DIEEGAFEGASGVNEILLTSNRLE-NVQHKMFKGLESLKTLMLRS 114

Query: 466 NNITGKIPA-AIGNLPSLNILSLQNNRLEGEIPVESF-NLKMITSINISDN 514
           N IT  +   +   L S+ +LSL +N++   +   +F  L  ++++N+  N
Sbjct: 115 NRIT-CVGNDSFIGLSSVRLLSLYDNQIT-TVAPGAFDTLHSLSTLNLLAN 163

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 43.1 bits (102), Expect = 2e-04
 Identities = 30/133 (22%), Positives = 51/133 (38%), Gaps = 14/133 (10%)

Query: 366 LDVTSNHLTGTIPRDLCKG-GKLKSLILMQNFFIGPIPEE-LGQCKSLTKIRFSKNYLNG 423
           L + +N  T      + K   +L+ +    N  I  I E        + +I  + N L  
Sbjct: 37  LRLNNNEFTVLEATGIFKKLPQLRKINFSNNK-ITDIEEGAFEGASGVNEILLTSNRLE- 94

Query: 424 TIPAGLF-NLPLLNMMELDDNLLSGELPEKMSGA-----SLNQLKVANNNITGKIPAAIG 477
            +   +F  L  L  + L  N ++  +      +     S+  L + +N IT   P A  
Sbjct: 95  NVQHKMFKGLESLKTLMLRSNRIT-CVGN---DSFIGLSSVRLLSLYDNQITTVAPGAFD 150

Query: 478 NLPSLNILSLQNN 490
            L SL+ L+L  N
Sbjct: 151 TLHSLSTLNLLAN 163

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 59.7 bits (145), Expect = 2e-09
 Identities = 53/218 (24%), Positives = 87/218 (39%), Gaps = 44/218 (20%)

Query: 698 NIIGKGGAGIVYRGS-MPDGIDVAIKRLVGRGTGGNDHGF----LAEIQTLGRIRHR--- 749
           ++IGKG  G V +     +   VAIK  + +    N   F      E++ L  +      
Sbjct: 60  SLIGKGSFGQVVKAYDRVEQEWVAIK--IIK----NKKAFLNQAQIEVRLLELMNKHDTE 113

Query: 750 ---NIVRLLGYVSNRD-----TNLL---LYEYMPNGSLGEMLHGAKGGHLKWETRYRIAL 798
               IV L  +   R+       +L   LY+ + N          +G  L   TR + A 
Sbjct: 114 MKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRN-------TNFRGVSLN-LTR-KFAQ 164

Query: 799 EAAKGLCYLH-HDCSPLIIHRDVKSNNILLDSDFEAH--VADFGLAKFLQDAGASECMSS 855
           +    L +L   + S  IIH D+K  NILL +   +   + DFG +         + +  
Sbjct: 165 QMCTALLFLATPELS--IIHCDLKPENILLCNPKRSAIKIVDFGSSCQ-----LGQRIYQ 217

Query: 856 VAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGK 893
              S  Y +PE    +  D   D++S G +L+E+  G+
Sbjct: 218 YIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 59.4 bits (144), Expect = 3e-09
 Identities = 56/216 (25%), Positives = 85/216 (39%), Gaps = 44/216 (20%)

Query: 699 IIGKGGAGIVYRGS-MPDGIDVAIKRLVGRGTGGNDHGF----LAEIQTLGRIRHR---- 749
           +IGKG  G V +         VA+K  + R    N+  F      EI+ L  +R +    
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALK--MVR----NEKRFHRQAAEEIRILEHLRKQDKDN 157

Query: 750 --NIVRLLGYVSNRD-----TNLL---LYEYMPNGSLGEMLHGAKGGHLKWETRYRIALE 799
             N++ +L   + R+       LL   LYE +            +G  L    R + A  
Sbjct: 158 TMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKF-------QGFSLP-LVR-KFAHS 208

Query: 800 AAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAH--VADFGLAKFLQDAGASECMSSVA 857
             + L  LH      IIH D+K  NILL     +   V DFG + +       + + +  
Sbjct: 209 ILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYE-----HQRVYTYI 260

Query: 858 GSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGK 893
            S  Y APE     +     D++S G +L EL+ G 
Sbjct: 261 QSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGY 296

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 57.3 bits (139), Expect = 7e-09
 Identities = 45/224 (20%), Positives = 71/224 (31%), Gaps = 78/224 (34%)

Query: 699 IIGKGGAGIVYRGSM-PDGIDVAIK-----RLVGRGTGGNDHGFLAEIQTLGRI-RHRNI 751
           ++G G  G V +          A+K         R           E++   R  +  +I
Sbjct: 25  VLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR-----------EVELHWRASQCPHI 73

Query: 752 VRLLG-YVSNRDTNLLLY---EYMPNGSLGEMLHGAKGGHL------KWETRY------R 795
           VR++  Y +       L    E +             GG L      + +  +       
Sbjct: 74  VRIVDVYENLYAGRKCLLIVMECL------------DGGELFSRIQDRGDQAFTEREASE 121

Query: 796 IALEAAKGLCYLH-HDCSPLIIHRDVKSNNILLDSDFEAH---VADFGLAKFLQDAGASE 851
           I     + + YLH  +    I HRDVK  N+L  S        + DFG AK         
Sbjct: 122 IMKSIGEAIQYLHSIN----IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT------ 171

Query: 852 CMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
                   Y             D+  D++S GV++  L+ G  P
Sbjct: 172 -----GEKY-------------DKSCDMWSLGVIMYILLCGYPP 197

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 55.7 bits (133), Expect = 3e-08
 Identities = 43/242 (17%), Positives = 58/242 (23%), Gaps = 60/242 (24%)

Query: 684 DFKAEDVLESLKDENIIGKGGAGIVYRGSMPDGIDVAIK-------RLVGRGTGGNDHGF 736
                + L+  +    IG+G  G V++    D   VAIK        LV           
Sbjct: 15  HCLPTEKLQRCEK---IGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEI 70

Query: 737 LAEIQTL---------GRIRHRNIVRLLGY--VSNRDTNLLLYEYM----PNGSL----- 776
           L EI               R    + L     V      LLL  +       GS      
Sbjct: 71  LPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPD 130

Query: 777 ----------------GEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDV 820
                           G  L   +       T   I  +    L            HRD+
Sbjct: 131 FFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLR--FEHRDL 188

Query: 821 KSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVY 880
              N+LL       +      K                S G       YTL   E+  + 
Sbjct: 189 HWGNVLLKKTSLKKLHYTLNGKSSTI-----------PSCGLQVSIIDYTLSRLERDGIV 237

Query: 881 SF 882
            F
Sbjct: 238 VF 239

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 52.8 bits (127), Expect = 3e-08
 Identities = 30/110 (27%), Positives = 45/110 (40%), Gaps = 5/110 (4%)

Query: 239 ALTQLQVLDMASCNISGEIPTSLSRLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSL 298
            + +L VLD +  N  G++       + L  L      LT  I   L  L  LK L+LS 
Sbjct: 18  DVKEL-VLDNSRSNE-GKLEGLTDEFEELEFLSTINVGLT-SIA-NLPKLNKLKKLELSD 73

Query: 299 NYLTGEIPESFAALKNLTLLQLFKNNLRGP-IPSFLGDFPNLEVLQVWGN 347
           N ++G +        NLT L L  N ++       L    NL+ L ++  
Sbjct: 74  NRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 48.5 bits (116), Expect = 9e-07
 Identities = 18/88 (20%), Positives = 35/88 (39%), Gaps = 3/88 (3%)

Query: 502 NLKMITSINISDNNIS-GEIPYSISQCHSLTSVDLSRNSLYGKIPPGISKLIDLSILNLS 560
               +  + + ++  + G++     +   L  +      L   I   + KL  L  L LS
Sbjct: 15  TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGL-TSIA-NLPKLNKLKKLELS 72

Query: 561 RNGITGSIPNEMRNMMSLTTLDLSYNNL 588
            N ++G +        +LT L+LS N +
Sbjct: 73  DNRVSGGLEVLAEKCPNLTHLNLSGNKI 100

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 48.1 bits (115), Expect = 1e-06
 Identities = 26/110 (23%), Positives = 40/110 (36%), Gaps = 4/110 (3%)

Query: 267 LHSLFLQMNKLT-GHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQLFKNNL 325
           +  L L  ++   G +         L+ L      LT  I  +   L  L  L+L  N +
Sbjct: 19  VKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELSDNRV 76

Query: 326 RGPIPSFLGDFPNLEVLQVWGNNFT-FELPENLGRNGKLLILDVTSNHLT 374
            G +       PNL  L + GN        E L +   L  LD+ +  +T
Sbjct: 77  SGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVT 126

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 45.4 bits (108), Expect = 1e-05
 Identities = 24/84 (28%), Positives = 37/84 (44%), Gaps = 5/84 (5%)

Query: 457 SLNQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNI 516
            L  L   N  +T  I A +  L  L  L L +NR+ G + V +     +T +N+S N I
Sbjct: 43  ELEFLSTINVGLT-SI-ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKI 100

Query: 517 S--GEIPYSISQCHSLTSVDLSRN 538
                I   + +  +L S+DL   
Sbjct: 101 KDLSTIEP-LKKLENLKSLDLFNC 123

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 40.8 bits (96), Expect = 4e-04
 Identities = 33/141 (23%), Positives = 54/141 (38%), Gaps = 17/141 (12%)

Query: 186 QSYSEIQSLEYIGLNGIGLN-GTVPAFLSRLKNLREMYIGYFNTYTGGIP--PGFGALTQ 242
           ++ S+++ L    L+    N G +       + L  +          G+        L +
Sbjct: 14  RTPSDVKELV---LDNSRSNEGKLEGLTDEFEELEFLST-INV----GLTSIANLPKLNK 65

Query: 243 LQVLDMASCNISGEIPTSLSRLKLLHSLFLQMNKLT--GHIPPQLSGLISLKSLDLSLNY 300
           L+ L+++   +SG +     +   L  L L  NK+     I P L  L +LKSLDL    
Sbjct: 66  LKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEP-LKKLENLKSLDLFNCE 124

Query: 301 LTGEI---PESFAALKNLTLL 318
           +T         F  L  LT L
Sbjct: 125 VTNLNDYRENVFKLLPQLTYL 145

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 40.8 bits (96), Expect = 4e-04
 Identities = 24/114 (21%), Positives = 42/114 (36%), Gaps = 5/114 (4%)

Query: 307 ESFAALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLIL 366
            + + +K L L      +  G +     +F  LE L       T  +  NL +  KL  L
Sbjct: 14  RTPSDVKELVLDNS--RSNEGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKL 69

Query: 367 DVTSNHLTGTIPRDLCKGGKLKSLILMQNFFIGP-IPEELGQCKSLTKIRFSKN 419
           +++ N ++G +     K   L  L L  N        E L + ++L  +     
Sbjct: 70  ELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 55.5 bits (133), Expect = 3e-08
 Identities = 21/96 (21%), Positives = 40/96 (41%), Gaps = 2/96 (2%)

Query: 256 EIPTSLSRLKLLHSLFLQMNKLTGHIPPQ-LSGLISLKSLDLSLNYLTGEIPESFAALKN 314
           +    L   + L  L+++  +   H+  + L GL  L++L +  + L    P++F     
Sbjct: 22  DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPR 81

Query: 315 LTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFT 350
           L+ L L  N L   +        +L+ L + GN   
Sbjct: 82  LSRLNLSFNALES-LSWKTVQGLSLQELVLSGNPLH 116

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 52.4 bits (125), Expect = 4e-07
 Identities = 20/102 (19%), Positives = 29/102 (28%), Gaps = 2/102 (1%)

Query: 274 MNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIP-ESFAALKNLTLLQLFKNNLRGPIPSF 332
                      L G  +L  L +        +       L  L  L + K+ LR   P  
Sbjct: 16  TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDA 75

Query: 333 LGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLT 374
               P L  L +  N     L     +   L  L ++ N L 
Sbjct: 76  FHFTPRLSRLNLSFNALES-LSWKTVQGLSLQELVLSGNPLH 116

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 52.0 bits (124), Expect = 5e-07
 Identities = 22/97 (22%), Positives = 35/97 (36%), Gaps = 3/97 (3%)

Query: 207 TVPAFLSRLKNLREMYIGYFNTYTGGIPPG-FGALTQLQVLDMASCNISGEIPTSLSRLK 265
                L   +NL E+YI     +   +       L +L+ L +    +    P +     
Sbjct: 22  DSLHHLPGAENLTELYIEN-QQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTP 80

Query: 266 LLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLT 302
            L  L L  N L   +  +    +SL+ L LS N L 
Sbjct: 81  RLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 50.1 bits (119), Expect = 2e-06
 Identities = 18/95 (18%), Positives = 34/95 (35%), Gaps = 2/95 (2%)

Query: 304 EIPESFAALKNLTLLQLFKNNLRGPIPSF-LGDFPNLEVLQVWGNNFTFELPENLGRNGK 362
           +        +NLT L +        +    L     L  L +  +   F  P+      +
Sbjct: 22  DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPR 81

Query: 363 LLILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFF 397
           L  L+++ N L  ++     +G  L+ L+L  N  
Sbjct: 82  LSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 49.0 bits (116), Expect = 4e-06
 Identities = 16/92 (17%), Positives = 36/92 (39%), Gaps = 2/92 (2%)

Query: 472 IPAAIGNLPSLNILSLQNNRLEGEIPVESF-NLKMITSINISDNNISGEIPYSISQCHSL 530
               +    +L  L ++N +    + +     L  + ++ I  + +    P +      L
Sbjct: 23  SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRL 82

Query: 531 TSVDLSRNSLYGKIPPGISKLIDLSILNLSRN 562
           + ++LS N+L   +     + + L  L LS N
Sbjct: 83  SRLNLSFNAL-ESLSWKTVQGLSLQELVLSGN 113

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 47.4 bits (112), Expect = 1e-05
 Identities = 19/109 (17%), Positives = 42/109 (38%), Gaps = 4/109 (3%)

Query: 507 TSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYGKIPPG-ISKLIDLSILNLSRNGIT 565
           + +  + +    +  + +    +LT + +        +    +  L +L  L + ++G+ 
Sbjct: 11  SGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR 69

Query: 566 GSIPNEM-RNMMSLTTLDLSYNNLIGNIPSGGQFLAFNETSFIGNPNLC 613
             +  +       L+ L+LS+N L        Q L+  E    GNP  C
Sbjct: 70  -FVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHC 117

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 47.4 bits (112), Expect = 2e-05
 Identities = 19/117 (16%), Positives = 27/117 (23%), Gaps = 7/117 (5%)

Query: 66  TCDQDSRVVSLNVSFMPLFGSIPPEIGLLTKLVNLTISNVNLTGRLPSEM-ALLTSLKVF 124
                S +                 +     L  L I N      L       L  L+  
Sbjct: 6   CPHGSSGLRCTR----DGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNL 61

Query: 125 NISGNVFQGNFAGQIVRGMTELQVLDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFT 181
            I  +  +   A         L  L+   N     L  +     SL+ L   GN   
Sbjct: 62  TIVKSGLR-FVAPDAFHFTPRLSRLNLSFNALES-LSWKTVQGLSLQELVLSGNPLH 116

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 47.0 bits (111), Expect = 2e-05
 Identities = 18/109 (16%), Positives = 39/109 (35%), Gaps = 4/109 (3%)

Query: 408 CKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLSGELPEKM-SG-ASLNQLKVAN 465
               + +R +++         L     L  + +++      L  +   G   L  L +  
Sbjct: 7   PHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVK 65

Query: 466 NNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESFNLKMITSINISDN 514
           + +    P A    P L+ L+L  N LE  +  ++     +  + +S N
Sbjct: 66  SGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGN 113

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594

 Score = 56.4 bits (136), Expect = 3e-08
 Identities = 82/563 (14%), Positives = 162/563 (28%), Gaps = 66/563 (11%)

Query: 47  LKNWEPSSSPSAHCSFSGVT---CDQDSRVVSLNVSFMPLFGSIPPEIGLL----TKLVN 99
           + N    S  +    F  V              N+      G + P I  +    T L  
Sbjct: 50  IGNCYAVSPATVIRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLEE 109

Query: 100 LTISNVNLT----GRLPSEMALLTSLKVFNISGNVFQGNFAGQIVRGMTELQVLDAYNNN 155
           + +  + +T      +         L + +  G  F  +    I      L+ LD   ++
Sbjct: 110 IRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEG--FSTDGLAAIAATCRNLKELDLRESD 167

Query: 156 FTGPLPVEIASL----KSLRHLSFGG--NYFTGK-IPQSYSEIQSLEYIGLNGIGLNGTV 208
                   ++       SL  L+     +  +   + +  +   +L+ + LN       +
Sbjct: 168 VDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEKL 227

Query: 209 PAFLSRLKNLREMYIGYFNTYTG-----GIPPGFGALTQLQVLDMASCNISGEIPTSLSR 263
              L R   L E+  G +          G+        +L+ L      +   +P   S 
Sbjct: 228 ATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVYSV 287

Query: 264 LKLLHSLFLQMNKLTGH-IPPQLSGLISLKSLDLSLNYLTGEIPESFAA-LKNLTLLQLF 321
              L +L L    +  + +   L     L+ L +  +Y+     E  A+  K+L  L++F
Sbjct: 288 CSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVL-DYIEDAGLEVLASTCKDLRELRVF 346

Query: 322 K-NNLRGPIPSFLGD---------FPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSN 371
                       L +          P LE +  +    T      + RN   +       
Sbjct: 347 PSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNM------T 400

Query: 372 HLTGTIPRDLCKGGKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGTIPAGLFN 431
                    LC         L            +  CK L ++  S    +         
Sbjct: 401 RF------RLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSGLLTDKVFEYIGTY 454

Query: 432 LPLLNMMELDDNLLSGELPEKMSGA--SLNQLKVANNNITGK-IPAAIGNLPSLNILSLQ 488
              + M+ +     S      +     SL +L++ +     K + A    L ++  L + 
Sbjct: 455 AKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMS 514

Query: 489 NNRL--EGEIPVESFNLKM----ITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYG 542
           +  +        +    KM    +  I+      S      + +     +V   R     
Sbjct: 515 SCSVSFGA---CKLLGQKMPKLNVEVIDERGAPDSRPESCPVERVFIYRTVAGPRFD--- 568

Query: 543 KIPPGISKLIDLSILNLSRNGIT 565
            +P  +  +   S +  SR  IT
Sbjct: 569 -MPGFVWNMDQDSTMRFSRQIIT 590

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 55.5 bits (134), Expect = 4e-08
 Identities = 35/170 (20%), Positives = 63/170 (37%), Gaps = 25/170 (14%)

Query: 700 IGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFL----------------AEIQTL 743
           IG+GG G +Y   M     V            +D+G L                 +    
Sbjct: 43  IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102

Query: 744 GRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLG---EMLHGAKGGHLKWETRYRIALEA 800
            ++++  + +  G   + D N   Y +M     G   + ++ A       +T  +++L  
Sbjct: 103 RKLKYLGVPKYWGSGLH-DKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRI 161

Query: 801 AKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHV--ADFGLAKFLQDAG 848
              L Y+H       +H D+K++N+LL+      V   D+GLA      G
Sbjct: 162 LDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEG 208

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 55.1 bits (133), Expect = 5e-08
 Identities = 33/171 (19%), Positives = 61/171 (35%), Gaps = 27/171 (15%)

Query: 700 IGKGGAGIVYRG---------SMPDGIDVAIKRLVGRGTGGNDHGF---------LAEIQ 741
             +   GI+Y           S P     ++K     G   N+  F         + + +
Sbjct: 50  QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109

Query: 742 TLGRIRHRNIVRLLGYVSNRDT-NLLLYEYMPNG-SLGEMLHGAKGGHLKWETRYRIALE 799
            L       I   +G+  ++D    L+   +  G SL   L  +    L   +  ++A  
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALDVSPKHVLSERSVLQVACR 167

Query: 800 AAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHV--ADFGLAKFLQDAG 848
               L +LH       +H +V + NI +D + ++ V  A +G A     +G
Sbjct: 168 LLDALEFLH---ENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSG 215

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 53.1 bits (128), Expect = 5e-08
 Identities = 37/120 (30%), Positives = 53/120 (44%), Gaps = 12/120 (10%)

Query: 233 IPPGFGALTQLQVLDMASCNISGEIPTSLSRLKLLHSLFLQMNKLTGHIPPQL-SGLISL 291
           +P G         LD    N    +P  LS  K L  + L  N+++  +  Q  S +  L
Sbjct: 25  LPKGIPRDVTELYLDG---NQFTLVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQL 80

Query: 292 KSLDLSLNYLTGEIPE-SFAALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQ-VW-GNN 348
            +L LS N L   IP  +F  LK+L LL L  N++   +P   G F +L  L  +  G N
Sbjct: 81  LTLILSYNRLR-CIPPRTFDGLKSLRLLSLHGNDISV-VPE--GAFNDLSALSHLAIGAN 136

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 43.8 bits (104), Expect = 8e-05
 Identities = 29/92 (31%), Positives = 39/92 (42%), Gaps = 9/92 (9%)

Query: 513 DNNISGEIPYSISQCHSLTSVDLSRNSLYGKIPPGI-SKLIDLSILNLSRNGITGSIPNE 571
           D N    +P  +S    LT +DLS N +   +     S +  L  L LS N +   IP  
Sbjct: 39  DGNQFTLVPKELSNYKHLTLIDLSNNRI-STLSNQSFSNMTQLLTLILSYNRLR-CIPPR 96

Query: 572 M-RNMMSLTTLDLSYNNLIGNIPSGGQFLAFN 602
               + SL  L L + N I  +P G    AFN
Sbjct: 97  TFDGLKSLRLLSL-HGNDISVVPEG----AFN 123

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 41.5 bits (98), Expect = 4e-04
 Identities = 22/65 (33%), Positives = 32/65 (49%), Gaps = 5/65 (7%)

Query: 525 SQCH-SLTSVDLSRNSLYGKIPPGISKLIDLSILNLSRNGITGSIPNEMRNMMSLTTLDL 583
           ++C    T V  S   L   +P GI +  D++ L L  N  T  +P E+ N   LT +DL
Sbjct: 6   TECTCLDTVVRCSNKGL-KVLPKGIPR--DVTELYLDGNQFT-LVPKELSNYKHLTLIDL 61

Query: 584 SYNNL 588
           S N +
Sbjct: 62  SNNRI 66

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 53.2 bits (128), Expect = 1e-07
 Identities = 43/183 (23%), Positives = 63/183 (34%), Gaps = 31/183 (16%)

Query: 144 TELQVLDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLNGIG 203
            + + LD  +             L  L  L+   N           ++Q+L         
Sbjct: 35  ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYN-----------QLQTLS-------- 75

Query: 204 LNGTVPAFLSRLKNLREMYIGYFNTYTGGIPPG-FGALTQLQVLDMASCNISGEIPTSL- 261
                      L  L  + +   N     +P G F  LTQL  L +   N    +P+ + 
Sbjct: 76  -----AGVFDDLTELGTLGLAN-NQLAS-LPLGVFDHLTQLDKLYL-GGNQLKSLPSGVF 127

Query: 262 SRLKLLHSLFLQMNKLTGHIPPQL-SGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQL 320
            RL  L  L L  N+L   IP      L +L++L LS N L      +F  L  L  + L
Sbjct: 128 DRLTKLKELRLNTNQLQS-IPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITL 186

Query: 321 FKN 323
           F N
Sbjct: 187 FGN 189

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 52.8 bits (127), Expect = 1e-07
 Identities = 34/144 (23%), Positives = 64/144 (44%), Gaps = 9/144 (6%)

Query: 456 ASLNQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESFN-LKMITSINISDN 514
           A   +L + +  +     A    L  L  L+L  N+L+  +    F+ L  + ++ +++N
Sbjct: 35  ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQT-LSAGVFDDLTELGTLGLANN 93

Query: 515 NISGEIPYSI-SQCHSLTSVDLSRNSLYGKIPPGI-SKLIDLSILNLSRNGITGSIPNEM 572
            ++  +P  +      L  + L  N L   +P G+  +L  L  L L+ N +  SIP   
Sbjct: 94  QLA-SLPLGVFDHLTQLDKLYLGGNQL-KSLPSGVFDRLTKLKELRLNTNQLQ-SIPAGA 150

Query: 573 -RNMMSLTTLDLSYNNLIGNIPSG 595
              + +L TL L   N + ++P G
Sbjct: 151 FDKLTNLQTLSL-STNQLQSVPHG 173

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 45.8 bits (109), Expect = 3e-05
 Identities = 45/202 (22%), Positives = 66/202 (32%), Gaps = 53/202 (26%)

Query: 292 KSLDLSLNYLTGEIPESFAALKNLTLLQLFKNNLRGPIPSFLGDFP-NLEVLQVWGNNFT 350
           + LDL    L      +F  L  LT L L  N L+  + + + D    L  L +  N   
Sbjct: 38  EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQT-LSAGVFDDLTELGTLGLANNQLA 96

Query: 351 FELPENL-GRNGKLLILDVTSNHLTGTIPRDLCKG-GKLKSLILMQNFFIGPIPEELGQC 408
             LP  +     +L  L +  N L  ++P  +     KLK L L  N           Q 
Sbjct: 97  S-LPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTN-----------QL 143

Query: 409 KSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLSGELPEKMSGASLNQLKVANNNI 468
           +S+              PAG F           D L            +L  L ++ N +
Sbjct: 144 QSI--------------PAGAF-----------DKL-----------TNLQTLSLSTNQL 167

Query: 469 TGKIPAAIGNLPSLNILSLQNN 490
                 A   L  L  ++L  N
Sbjct: 168 QSVPHGAFDRLGKLQTITLFGN 189

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 45.1 bits (107), Expect = 5e-05
 Identities = 43/169 (25%), Positives = 71/169 (42%), Gaps = 18/169 (10%)

Query: 425 IPAGLFNLPLLNMMELDDNLLSGELPEKMSG-ASLNQLKVANNNITGKIPAAI-GNLPSL 482
           IPA    L      +L    L+        G   L  L +  N +   + A +  +L  L
Sbjct: 33  IPADTEKL------DLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTEL 85

Query: 483 NILSLQNNRLEGEIPVESF-NLKMITSINISDNNISGEIPYSI-SQCHSLTSVDLSRNSL 540
             L L NN+L   +P+  F +L  +  + +  N +   +P  +  +   L  + L+ N L
Sbjct: 86  GTLGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQL 143

Query: 541 YGKIPPGI-SKLIDLSILNLSRNGITGSIPNEM-RNMMSLTTLDLSYNN 587
              IP G   KL +L  L+LS N +  S+P+     +  L T+ L + N
Sbjct: 144 -QSIPAGAFDKLTNLQTLSLSTNQLQ-SVPHGAFDRLGKLQTITL-FGN 189

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 53.8 bits (128), Expect = 1e-07
 Identities = 33/215 (15%), Positives = 70/215 (32%), Gaps = 29/215 (13%)

Query: 200 NGIGLNGTVPAFLSRLKNLREMYIGYFN--------TYTGGIPPGFGALTQLQVLDMASC 251
           +   +   +     +  +   ++ G  +             + P   A+  L  L +   
Sbjct: 123 DCSDIADGIVENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGT 182

Query: 252 NISGEIPTSLSRLKLLHSLFLQMNKLTGHIPPQL--SGLISLKSLDLSL---NYLTGEIP 306
           N           LK   SL +    L   +   +  S L +L+ L L +   +Y      
Sbjct: 183 NNLSIGKKPRPNLK---SLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDM 239

Query: 307 ESFAAL------KNLTLLQLFKNNLRGPIPSFLGDFP---NLEVLQVWGNNFTFE----L 353
             F  L       NL  L +     +  +     +      LE + +     T E    L
Sbjct: 240 NVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLL 299

Query: 354 PENLGRNGKLLILDVTSNHLTGTIPRDLCKGGKLK 388
            +++ +   L  +++  N+L+  + ++L K   +K
Sbjct: 300 LDHVDKIKHLKFINMKYNYLSDEMKKELQKSLPMK 334

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 53.0 bits (126), Expect = 2e-07
 Identities = 27/233 (11%), Positives = 66/233 (28%), Gaps = 39/233 (16%)

Query: 106 NLTGRLPSEMALLTSLKVFNISGNVFQGN-----FAGQIVRGMTELQVLDAYNNNFTGPL 160
           ++   +          +        F+           +   +  + +L+      T  L
Sbjct: 126 DIADGIVENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNL 185

Query: 161 PVEIASLKSLRHLSFGGNYFTGKIPQS--YSEIQSLE----YIGLNGIGLNGTVPAFLSR 214
            +      +L+ L          + +    S++ +LE    Y+G+   G +G +  F   
Sbjct: 186 SIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPL 245

Query: 215 LKNLREMYIGYFNTYTGGIPPGFGALTQLQVLDMASCNISGEIPTSLSR---LKLLHSLF 271
                                       L+ L +        +         L  L ++ 
Sbjct: 246 FSK--------------------DRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMD 285

Query: 272 LQMNKLTG----HIPPQLSGLISLKSLDLSLNYLTGEIPESFA-ALKNLTLLQ 319
           +    LT      +   +  +  LK +++  NYL+ E+ +    +L     + 
Sbjct: 286 ISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKSLPMKIDVS 338

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 48.0 bits (113), Expect = 1e-05
 Identities = 26/177 (14%), Positives = 61/177 (34%), Gaps = 28/177 (15%)

Query: 422 NGTIPAGLFNLPLLNMMELDDNLLSGELPEKMSGASLNQLKVANNNITGKIPAAIG--NL 479
              +   L  +PLLN +++     +     K    +L  L++ +  +   +   I   +L
Sbjct: 161 QVDLSPVLDAMPLLNNLKIKGT--NNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDL 218

Query: 480 PSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIPY-SISQCHSLTSVDLSRN 538
           P+L  L                 L +       D +++   P  S  +  +L  + +   
Sbjct: 219 PNLEKL----------------VLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDA 262

Query: 539 SLYGKIPPGISK---LIDLSILNLSRNGITGS----IPNEMRNMMSLTTLDLSYNNL 588
                +     +   L  L  +++S   +T      + + +  +  L  +++ YN L
Sbjct: 263 EEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYL 319

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 51.3 bits (123), Expect = 1e-07
 Identities = 32/110 (29%), Positives = 44/110 (40%), Gaps = 5/110 (4%)

Query: 239 ALTQLQVLDMASCNISGEIPTSLSRLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSL 298
           A+ +L VLD    N  G+I    +    L  L L    L   +   L  L  LK L+LS 
Sbjct: 25  AVREL-VLDNCKSND-GKIEGLTAEFVNLEFLSLINVGLI-SVSN-LPKLPKLKKLELSE 80

Query: 299 NYLTGEIPESFAALKNLTLLQLFKNNLRGP-IPSFLGDFPNLEVLQVWGN 347
           N + G +      L NLT L L  N L+       L     L+ L ++  
Sbjct: 81  NRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 47.8 bits (114), Expect = 2e-06
 Identities = 21/75 (28%), Positives = 33/75 (44%), Gaps = 2/75 (2%)

Query: 514 NNISGEIPYSISQCHSLTSVDLSRNSLYGKIPPGISKLIDLSILNLSRNGITGSIPNEMR 573
            +  G+I    ++  +L  + L    L   +   + KL  L  L LS N I G +     
Sbjct: 35  KSNDGKIEGLTAEFVNLEFLSLINVGL-ISVS-NLPKLPKLKKLELSENRIFGGLDMLAE 92

Query: 574 NMMSLTTLDLSYNNL 588
            + +LT L+LS N L
Sbjct: 93  KLPNLTHLNLSGNKL 107

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 45.9 bits (109), Expect = 1e-05
 Identities = 27/110 (24%), Positives = 43/110 (39%), Gaps = 4/110 (3%)

Query: 267 LHSLFLQMNKLT-GHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQLFKNNL 325
           +  L L   K   G I    +  ++L+ L L    L   +  +   L  L  L+L +N +
Sbjct: 26  VRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SV-SNLPKLPKLKKLELSENRI 83

Query: 326 RGPIPSFLGDFPNLEVLQVWGNNFT-FELPENLGRNGKLLILDVTSNHLT 374
            G +       PNL  L + GN        E L +   L  LD+ +  +T
Sbjct: 84  FGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVT 133

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 45.9 bits (109), Expect = 1e-05
 Identities = 20/84 (23%), Positives = 38/84 (45%), Gaps = 5/84 (5%)

Query: 457 SLNQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNI 516
           +L  L + N  +   + + +  LP L  L L  NR+ G + + +  L  +T +N+S N +
Sbjct: 50  NLEFLSLINVGLI-SV-SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKL 107

Query: 517 S--GEIPYSISQCHSLTSVDLSRN 538
                +   + +   L S+DL   
Sbjct: 108 KDISTLEP-LKKLECLKSLDLFNC 130

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 41.6 bits (98), Expect = 3e-04
 Identities = 27/114 (23%), Positives = 44/114 (38%), Gaps = 7/114 (6%)

Query: 308 SFAALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILD 367
           + AA++ L L      +  G I     +F NLE L +        +  NL +  KL  L+
Sbjct: 22  TPAAVRELVLDNC--KSNDGKIEGLTAEFVNLEFLSLINVGLI-SV-SNLPKLPKLKKLE 77

Query: 368 VTSNHLTGTIPRDLCKGGKLKSLILMQNFF--IGPIPEELGQCKSLTKIRFSKN 419
           ++ N + G +     K   L  L L  N    I  + E L + + L  +     
Sbjct: 78  LSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTL-EPLKKLECLKSLDLFNC 130

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 40.1 bits (94), Expect = 8e-04
 Identities = 34/141 (24%), Positives = 54/141 (38%), Gaps = 17/141 (12%)

Query: 186 QSYSEIQSLEYIGLNGIGLN-GTVPAFLSRLKNLREMYIGYFNTYTGGIP--PGFGALTQ 242
           ++ + ++ L    L+    N G +    +   NL  + +        G+        L +
Sbjct: 21  RTPAAVRELV---LDNCKSNDGKIEGLTAEFVNLEFLSL-INV----GLISVSNLPKLPK 72

Query: 243 LQVLDMASCNISGEIPTSLSRLKLLHSLFLQMNKLT--GHIPPQLSGLISLKSLDLSLNY 300
           L+ L+++   I G +     +L  L  L L  NKL     + P L  L  LKSLDL    
Sbjct: 73  LKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEP-LKKLECLKSLDLFNCE 131

Query: 301 LTGEI---PESFAALKNLTLL 318
           +T         F  L  LT L
Sbjct: 132 VTNLNDYRESVFKLLPQLTYL 152

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 52.8 bits (127), Expect = 2e-07
 Identities = 44/155 (28%), Positives = 67/155 (43%), Gaps = 17/155 (10%)

Query: 700 IGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHGFLA-EIQTLGRIRH-RNIVRLLG 756
           IG G  G +Y G  +  G +VAIK    +      H  L  E +    ++    I  +  
Sbjct: 17  IGSGSFGDIYLGTDIAAGEEVAIKLECVK----TKHPQLHIESKIYKMMQGGVGIPTIRW 72

Query: 757 YVSNRDTNLLLYEYMPNG-SLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLI 815
             +  D N+++ E +  G SL E L          +T   +A +    + Y+H   S   
Sbjct: 73  CGAEGDYNVMVMELL--GPSL-EDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNF 126

Query: 816 IHRDVKSNNILL---DSDFEAHVADFGLAKFLQDA 847
           IHRDVK +N L+         ++ DFGLAK  +DA
Sbjct: 127 IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 161

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 50.8 bits (122), Expect = 3e-07
 Identities = 24/117 (20%), Positives = 41/117 (35%), Gaps = 4/117 (3%)

Query: 235 PGFGALTQLQVLDMASCNISGEIPTSLSRLKLLHSLFLQMNKLTGHIPPQLSGLISLKSL 294
             +    + + LD+    I   I    + L    ++    N++          L  LK+L
Sbjct: 13  AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTL 69

Query: 295 DLSLNYLTGEIPESFAALKNLTLLQLFKNNLRGP-IPSFLGDFPNLEVLQVWGNNFT 350
            ++ N +         AL +LT L L  N+L        L    +L  L +  N  T
Sbjct: 70  LVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT 126

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 48.1 bits (115), Expect = 2e-06
 Identities = 19/87 (21%), Positives = 33/87 (37%), Gaps = 3/87 (3%)

Query: 502 NLKMITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYGKIPPGISKLIDLSILNLSR 561
           N      +++    I   I    +      ++D S N +  K+  G   L  L  L ++ 
Sbjct: 17  NAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI-RKLD-GFPLLRRLKTLLVNN 73

Query: 562 NGITGSIPNEMRNMMSLTTLDLSYNNL 588
           N I        + +  LT L L+ N+L
Sbjct: 74  NRICRIGEGLDQALPDLTELILTNNSL 100

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 45.0 bits (107), Expect = 2e-05
 Identities = 28/145 (19%), Positives = 49/145 (33%), Gaps = 14/145 (9%)

Query: 403 EELGQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLSGELPEKMSG----ASL 458
            +        ++      +   I      L   + ++  DN +      K+ G      L
Sbjct: 13  AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-----KLDGFPLLRRL 66

Query: 459 NQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESF-NLKMITSINISDNNIS 517
             L V NN I          LP L  L L NN L     ++   +LK +T + I  N ++
Sbjct: 67  KTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT 126

Query: 518 GEI---PYSISQCHSLTSVDLSRNS 539
            +     Y I +   +  +D  +  
Sbjct: 127 NKKHYRLYVIYKVPQVRVLDFQKVK 151

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372

 Score = 51.3 bits (123), Expect = 9e-07
 Identities = 38/274 (13%), Positives = 82/274 (29%), Gaps = 36/274 (13%)

Query: 452 KMSGASLNQLKVANNNITGKIPAAIGN-LPSLNILSLQNNRLEGEIPVESF------NLK 504
                +L+++ +A+  +       +         L LQ N L G    +        +  
Sbjct: 97  GSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSL-GPEACKDLRDLLLHDQC 155

Query: 505 MITSINISDNNISGE----IPYSISQCHSLTSVDLSRNSLYGK----IPPGISKLIDLSI 556
            IT++ +S+N ++      +   ++   S+T + L    L  +    +   + +   L  
Sbjct: 156 QITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQE 215

Query: 557 LNLSRNGITGS----IPNEMRNMMSLTTLDLSYNNLIGNIPSGGQFLAFNETSFIGNPNL 612
           LN++ NG   +    +    R   SL  L L +N  +     G Q L     +  G   +
Sbjct: 216 LNVAYNGAGDTAALALARAAREHPSLELLHLYFNE-LS--SEGRQVLRDLGGAAEGGARV 272

Query: 613 CLLRNGTCQSLINSAKHSGDGYGSSFGASKIVITVIALLTFMLLVILTIYQLRKRRLQKS 672
            +                 + +       +  +           + L +  L   R    
Sbjct: 273 VVSLTEGTA--------VSEYWSVILSEVQRNLNSWDRARVQRHLELLLRDLEDSRGATL 324

Query: 673 KAWKLTAFQRLDFKAEDVLESLK-DENIIGKGGA 705
             W+         + E  + +L       G    
Sbjct: 325 NPWRKAQL----LRVEGEVRALLEQLGSSGSPSG 354

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372

 Score = 51.3 bits (123), Expect = 1e-06
 Identities = 50/289 (17%), Positives = 87/289 (30%), Gaps = 44/289 (15%)

Query: 239 ALTQLQVLDMASCNISGEIPTSLSRL-----KLLHSLFLQMNKLTG----HIPPQLSGLI 289
            L+ L+ L++A   ++    T ++ +       L  + L   +L       +   L   +
Sbjct: 70  VLSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTL---LPVFL 126

Query: 290 SLKSLDLSLNYLTGEIPESFA-ALK----NLTLLQLFKNNLRGP----IPSFLGDFPNLE 340
             + L L LN L  E  +     L      +T L+L  N L       +   L    ++ 
Sbjct: 127 RARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVT 186

Query: 341 VLQVWGNNFTFE----LPENLGRNGKLLILDVTSNHLTGTIPRDLCKG----GKLKSLIL 392
            L +       E    L   L RN +L  L+V  N    T    L +       L+ L L
Sbjct: 187 HLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHL 246

Query: 393 MQNFFIGP-----IPEELGQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLSG 447
             N  +       + +  G  +   ++  S              L      E+  NL S 
Sbjct: 247 YFN-ELSSEGRQVLRDLGGAAEGGARVVVSLTEGTAVSEYWSVIL-----SEVQRNLNSW 300

Query: 448 ELPEKMSGASLNQLKVANNNITGKIPAAIGNL----PSLNILSLQNNRL 492
           +         L    + ++      P     L      +  L  Q    
Sbjct: 301 DRARVQRHLELLLRDLEDSRGATLNPWRKAQLLRVEGEVRALLEQLGSS 349

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 50.4 bits (121), Expect = 1e-06
 Identities = 38/157 (24%), Positives = 67/157 (42%), Gaps = 19/157 (12%)

Query: 700 IGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHGFLA-EIQTLGRIRH-RNIVRLLG 756
           IG+G  G+++ G ++ +   VAIK    R    +D   L  E +T   +     I  +  
Sbjct: 18  IGEGSFGVIFEGTNLLNNQQVAIKFEPRR----SDAPQLRDEYRTYKLLAGCTGIPNVYY 73

Query: 757 YVSNRDTNLLLYEYMPNG-SLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLI 815
           +      N+L+ + +  G SL E L    G     +T    A +    +  +H      +
Sbjct: 74  FGQEGLHNVLVIDLL--GPSL-EDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSL 127

Query: 816 IHRDVKSNNILLDSDFEA-----HVADFGLAKFLQDA 847
           ++RD+K +N L+           +V DFG+ KF +D 
Sbjct: 128 VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP 164

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 49.6 bits (119), Expect = 2e-06
 Identities = 43/161 (26%), Positives = 79/161 (49%), Gaps = 14/161 (8%)

Query: 439 ELDDNLLSGELPEKMSGASLNQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPV 498
            L    ++ +   +    S++Q+   N++I   +   I  LP++  L+L  N+L  +I  
Sbjct: 25  NLKKKSVT-DAVTQNELNSIDQIIANNSDIK-SVQG-IQYLPNVRYLALGGNKLH-DISA 80

Query: 499 ESF-NLKMITSINISDNNISGEIPYSISQC-HSLTSVDLSRNSLYGKIPPGI-SKLIDLS 555
                L  +T + ++ N +   +P  +     +L  + L  N L   +P G+  KL +L+
Sbjct: 81  --LKELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQL-QSLPDGVFDKLTNLT 136

Query: 556 ILNLSRNGITGSIPNEM-RNMMSLTTLDLSYNNLIGNIPSG 595
            LNL+ N +  S+P  +   + +LT LDLSYN L  ++P G
Sbjct: 137 YLNLAHNQLQ-SLPKGVFDKLTNLTELDLSYNQL-QSLPEG 175

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 46.5 bits (111), Expect = 2e-05
 Identities = 55/215 (25%), Positives = 80/215 (37%), Gaps = 40/215 (18%)

Query: 235 PGFGALTQLQVLDMASCNISGEIPTSLSRLKLLHSLFLQMNKLTGHIPPQLSGLISLKSL 294
                L  +  +   + +    +   +  L  +  L L  NKL       L  L +L  L
Sbjct: 35  VTQNELNSIDQIIA-NNSDIKSVQ-GIQYLPNVRYLALGGNKLHD--ISALKELTNLTYL 90

Query: 295 DLSLNYLTGEIPESFAALKNLTLLQLFKNNLRGPIPSFLGDFP-NLEVLQVWGNNFTFEL 353
            L+ N L       F  L NL  L L +N L+  +P  + D   NL  L +  N     L
Sbjct: 91  ILTGNQLQSLPNGVFDKLTNLKELVLVENQLQS-LPDGVFDKLTNLTYLNLAHNQLQ-SL 148

Query: 354 PENL-GRNGKLLILDVTSNHLTGTIPR---DLCKGGKLKSLILMQNFFIGPIPEELGQCK 409
           P+ +  +   L  LD++ N L  ++P    D  K  +LK L L QN           Q K
Sbjct: 149 PKGVFDKLTNLTELDLSYNQLQ-SLPEGVFD--KLTQLKDLRLYQN-----------QLK 194

Query: 410 SLTKIRFSKNYLNGTIPAGLF-NLPLLNMMELDDN 443
           S              +P G+F  L  L  + L DN
Sbjct: 195 S--------------VPDGVFDRLTSLQYIWLHDN 215

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 46.2 bits (110), Expect = 2e-05
 Identities = 42/197 (21%), Positives = 85/197 (43%), Gaps = 18/197 (9%)

Query: 410 SLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLSGELPEKMSGASLNQLKVANNNIT 469
              K    K  +          L  ++ +  +++ +   +       ++  L +  N + 
Sbjct: 20  ETIKANLKKKSVT-DAVTQN-ELNSIDQIIANNSDIK-SVQGIQYLPNVRYLALGGNKLH 76

Query: 470 GKIPAAIGNLPSLNILSLQNNRLEGEIPVESFN-LKMITSINISDNNISGEIPYSI-SQC 527
             I A +  L +L  L L  N+L+  +P   F+ L  +  + + +N +   +P  +  + 
Sbjct: 77  -DISA-LKELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKL 132

Query: 528 HSLTSVDLSRNSLYGKIPPGI-SKLIDLSILNLSRNGITGSIPNEM-RNMMSLTTLDLSY 585
            +LT ++L+ N L   +P G+  KL +L+ L+LS N +  S+P  +   +  L  L L  
Sbjct: 133 TNLTYLNLAHNQL-QSLPKGVFDKLTNLTELDLSYNQLQ-SLPEGVFDKLTQLKDLRLYQ 190

Query: 586 NNLIGNIPSGGQFLAFN 602
           N L  ++P G     F+
Sbjct: 191 NQL-KSVPDG----VFD 202

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 50.0 bits (119), Expect = 3e-06
 Identities = 41/155 (26%), Positives = 68/155 (43%), Gaps = 17/155 (10%)

Query: 700 IGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHGFLA-EIQTLGRIR-HRNIVRLLG 756
           IG G  G +Y G ++    +VAIK    +      H  L  E +    ++    I  +  
Sbjct: 15  IGSGSFGEIYLGTNIQTNEEVAIKLENVK----TKHPQLLYESKIYRILQGGTGIPNVRW 70

Query: 757 YVSNRDTNLLLYEYMPNG-SLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLI 815
           +    D N+L+ + +  G SL E L       L  +T   +A +    + ++H   S   
Sbjct: 71  FGVEGDYNVLVMDLL--GPSL-EDLFNFCSRKLSLKTVLMLADQMINRVEFVH---SKSF 124

Query: 816 IHRDVKSNNILLDSDFEAH---VADFGLAKFLQDA 847
           +HRD+K +N L+     A+   + DFGLAK  +D 
Sbjct: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592

 Score = 49.9 bits (119), Expect = 3e-06
 Identities = 48/387 (12%), Positives = 111/387 (28%), Gaps = 57/387 (14%)

Query: 238 GALTQLQVLDMASC-NISGEIPTSLSR-LKLLHSLFLQMNKLTGHIPPQLS----GLISL 291
                L+ L +  C   + +   S+    + + +L ++ +  +      L        SL
Sbjct: 135 ARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSL 194

Query: 292 KSLDLSLNYLTGEIPESFAAL----KNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGN 347
           + L+  +       P+    +    ++L  +++  +     +  F     NLE       
Sbjct: 195 EVLNFYMTEFAKISPKDLETIARNCRSLVSVKV-GDFEILELVGFFKAAANLEEFCGGSL 253

Query: 348 NFTFELPENLGRNGKLLILDVTSNHLTG--TIPRDLCKGGKLKSLILMQNFFIGP-IPEE 404
           N    +PE          L        G   +P       +++ L L+            
Sbjct: 254 NEDIGMPEKYMNLVFPRKLCRLGLSYMGPNEMPILFPFAAQIRKLDLLYALLETEDHCTL 313

Query: 405 LGQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLSGELPEKMSGAS------- 457
           + +C +L  +       +  +         L  + ++       + ++    S       
Sbjct: 314 IQKCPNLEVLETRNVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIAL 373

Query: 458 ------LNQLKVANNNITGKIPAAIG----NLPSLNILSLQNNRLEGEIPVESFNLKMIT 507
                 L  + V  ++IT +   +IG    NL    ++ L                    
Sbjct: 374 AQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREE---------------- 417

Query: 508 SINISDNNISGEIPYSISQCHSLTSVDLSRNSLYGKIP-PGISKLID----LSILNLSRN 562
              I+D  +   +   +  C  L           G +   G+S +      +  + L   
Sbjct: 418 --RITDLPLDNGVRSLLIGCKKLRRFAFYLRQ--GGLTDLGLSYIGQYSPNVRWMLLGYV 473

Query: 563 GIT-GSIPNEMRNMMSLTTLDLSYNNL 588
           G +   +    R   +L  L++     
Sbjct: 474 GESDEGLMEFSRGCPNLQKLEMRGCCF 500

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592

 Score = 48.8 bits (116), Expect = 9e-06
 Identities = 53/359 (14%), Positives = 105/359 (29%), Gaps = 34/359 (9%)

Query: 118 LTSLKVFNISGNVFQG-NFAG--QIVRGMTELQVLDAYNNNFTGP--LPVEIASLKSLRH 172
            TSL+V N     F   +      I R    L  +   +             A+L+    
Sbjct: 191 NTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILELVGFFKAAANLEEFCG 250

Query: 173 LSFGGNYFTGKIPQSYSEIQSLEYIGLNGIGLNGTVPAFLSRLKNLREMYIGYFNTYTGG 232
            S   +    +   +    + L  +GL+ +G N  +P        +R++ + Y    T  
Sbjct: 251 GSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPNE-MPILFPFAAQIRKLDLLYALLETED 309

Query: 233 IPPGFGALTQLQVLDMASCNISGEIPTSLSRLKLLHSLFLQMNKLTGHIPPQLS------ 286
                     L+VL+  +      +       K L  L ++       +  +        
Sbjct: 310 HCTLIQKCPNLEVLETRNVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRG 369

Query: 287 ------GLISLKSLDLSLNYLTGEIPESFAA-LKNLTLLQLFKNNLRGPIPSFLGD---- 335
                 G   L+ + + ++ +T E  ES    LKNL   +L   +    I     D    
Sbjct: 370 LIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVR 429

Query: 336 -----FPNLEVLQVWGN--NFTFELPENLGRNGKLL-ILDVTSNHLTGTIPRDLCKG-GK 386
                   L     +      T      +G+    +  + +     +     +  +G   
Sbjct: 430 SLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPN 489

Query: 387 LKSLILMQNFFIGP-IPEELGQCKSLTKIRFSKNYLNGTIPAGL-FNLPLLNMMELDDN 443
           L+ L +    F    I   + +  SL  +       + T    +    P  N+  +   
Sbjct: 490 LQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASMTGQDLMQMARPYWNIELIPSR 548

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 49.3 bits (118), Expect = 3e-06
 Identities = 38/152 (25%), Positives = 61/152 (40%), Gaps = 19/152 (12%)

Query: 700 IGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHGFLA-EIQTLGRIRH-RNIVRLLG 756
           IG G  G +  G ++     VAIK    +    +    L  E +   ++     I ++  
Sbjct: 17  IGCGNFGELRLGKNLYTNEYVAIKLEPMK----SRAPQLHLEYRFYKQLGSGDGIPQVYY 72

Query: 757 YVSNRDTNLLLYEYMPNG-SLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLI 815
           +      N ++ E +  G SL E L          +T   IA++    + Y+H   S  +
Sbjct: 73  FGPCGKYNAMVLELL--GPSL-EDLFDLCDRTFSLKTVLMIAIQLISRMEYVH---SKNL 126

Query: 816 IHRDVKSNNILLDSDFEA-----HVADFGLAK 842
           I+RDVK  N L+           H+ DF LAK
Sbjct: 127 IYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 47.3 bits (113), Expect = 5e-06
 Identities = 32/114 (28%), Positives = 43/114 (37%), Gaps = 10/114 (8%)

Query: 233 IPPGFGALTQLQVLDMASCNISGEIPTSL-SRLKLLHSLFLQMNKLTGHIPPQL-SGLIS 290
           IP      T    L +    +       L  RL  L  L L+ N+LTG I P    G   
Sbjct: 23  IPRDIPLHTT--ELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTG-IEPNAFEGASH 79

Query: 291 LKSLDLSLNYLTGEIPE-SFAALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQ 343
           ++ L L  N +  EI    F  L  L  L L+ N +   +    G F +L  L 
Sbjct: 80  IQELQLGENKIK-EISNKMFLGLHQLKTLNLYDNQISC-VMP--GSFEHLNSLT 129

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 44.6 bits (106), Expect = 4e-05
 Identities = 29/103 (28%), Positives = 42/103 (40%), Gaps = 7/103 (6%)

Query: 225 YFNTYTGGIPPG-FGALTQLQVLDMASCNISGEIPTSL-SRLKLLHSLFLQMNKLTGHIP 282
             N        G FG L  L  L++   N    I  +       +  L L  NK+   I 
Sbjct: 37  NDNELGRISSDGLFGRLPHLVKLEL-KRNQLTGIEPNAFEGASHIQELQLGENKIK-EIS 94

Query: 283 PQL-SGLISLKSLDLSLNYLTGEIPE-SFAALKNLTLLQLFKN 323
            ++  GL  LK+L+L  N ++  +   SF  L +LT L L  N
Sbjct: 95  NKMFLGLHQLKTLNLYDNQISC-VMPGSFEHLNSLTSLNLASN 136

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 43.5 bits (103), Expect = 9e-05
 Identities = 23/75 (30%), Positives = 32/75 (42%), Gaps = 9/75 (12%)

Query: 530 LTSVDLSRNSLYGKIPPGI-SKLIDLSILNLSRNGITGSIPNEM-RNMMSLTTLDLSYNN 587
           L  ++L RN L   I P        +  L L  N I   I N+M   +  L TL+L Y+N
Sbjct: 56  LVKLELKRNQL-TGIEPNAFEGASHIQELQLGENKIK-EISNKMFLGLHQLKTLNL-YDN 112

Query: 588 LIGNIPSGGQFLAFN 602
            I  +  G    +F 
Sbjct: 113 QISCVMPG----SFE 123

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 40.8 bits (96), Expect = 7e-04
 Identities = 26/96 (27%), Positives = 39/96 (40%), Gaps = 15/96 (15%)

Query: 257 IPTSLSRLKLLHSLFLQMNKLTGHIPPQ--LSGLISLKSLDLSLNYLTGEIPESFAALKN 314
           IP   + L L        N+L   I        L  L  L+L  N LTG  P +F    +
Sbjct: 27  IPLHTTELLL------NDNELG-RISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASH 79

Query: 315 LTLLQLFKNNLRGPIPSFLGDF---PNLEVLQVWGN 347
           +  LQL +N ++  I +    F     L+ L ++ N
Sbjct: 80  IQELQLGENKIKE-ISN--KMFLGLHQLKTLNLYDN 112

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 47.8 bits (114), Expect = 5e-06
 Identities = 41/181 (22%), Positives = 58/181 (32%), Gaps = 52/181 (28%)

Query: 144 TELQVLDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLNGIG 203
           T  Q+L  ++N  T   P    SL +L+ L  G N           ++ +L         
Sbjct: 40  TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSN-----------QLGALP-------- 80

Query: 204 LNGTVPAFLSRLKNLREMYIGYFNTYTGGIPPG-FGALTQLQVLDMASCNISGEIPTSLS 262
                      L  L  + +G  N  T  +P   F  L  L+ L                
Sbjct: 81  -----VGVFDSLTQLTVLDLGT-NQLTV-LPSAVFDRLVHLKELF--------------- 118

Query: 263 RLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQLFK 322
                    +  NKLT  +P  +  L  L  L L  N L      +F  L +LT   LF 
Sbjct: 119 ---------MCCNKLTE-LPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFG 168

Query: 323 N 323
           N
Sbjct: 169 N 169

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 44.7 bits (106), Expect = 6e-05
 Identities = 38/148 (25%), Positives = 59/148 (39%), Gaps = 32/148 (21%)

Query: 456 ASLNQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNN 515
            +   L + +N IT   P    +L +L  L L +N+L   +PV  F+             
Sbjct: 40  TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFD------------- 85

Query: 516 ISGEIPYSISQCHSLTSVDLSRNSLYGKIPPGI-SKLIDLSILNLSRNGITGSIPNEMRN 574
                         LT +DL  N L   +P  +  +L+ L  L +  N +T  +P  +  
Sbjct: 86  ----------SLTQLTVLDLGTNQL-TVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIER 133

Query: 575 MMSLTTLDLSYNNLIGNIPSGGQFLAFN 602
           +  LT L L  N L  +IP G    AF+
Sbjct: 134 LTHLTHLALDQNQL-KSIPHG----AFD 156

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 42.8 bits (101), Expect = 3e-04
 Identities = 44/154 (28%), Positives = 53/154 (34%), Gaps = 29/154 (18%)

Query: 292 KSLDLSLNYLTGEIPESFAALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTF 351
           + L L  N +T   P  F +L NL  L L  N L             L VL +  N  T 
Sbjct: 43  QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLT- 101

Query: 352 ELPENL-GRNGKLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFIGPIPEELGQCKS 410
            LP  +  R   L  L +  N LT  +PR + +   L  L L QN           Q KS
Sbjct: 102 VLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQN-----------QLKS 149

Query: 411 LTKIRFSKNYLNGTIPAGLF-NLPLLNMMELDDN 443
                         IP G F  L  L    L  N
Sbjct: 150 --------------IPHGAFDRLSSLTHAYLFGN 169

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 47.8 bits (114), Expect = 1e-05
 Identities = 59/341 (17%), Positives = 106/341 (31%), Gaps = 78/341 (22%)

Query: 290 SLKSLDLSLNYLTGEIPESFA-ALKN----LTLLQLFKNNLRGP----IPSFLGDFP-NL 339
            + SLDLSLN L          A  N    +T L L  N+L       +   L   P N+
Sbjct: 23  GVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANV 82

Query: 340 EVLQVWGNNFTFE----LPENL-GRNGKLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQ 394
             L + GN  +++    L + L      + +LD+  N  +     +  +     +     
Sbjct: 83  TSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQA--FSN----- 135

Query: 395 NFFIGPIPEELGQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLSGELPEKMS 454
                          S+T +    N L                     + L   L     
Sbjct: 136 ------------LPASITSLNLRGNDLG---IKSS-------------DELIQIL--AAI 165

Query: 455 GASLNQLKVANNNITGK----IPAAIGNLP-SLNILSLQNNRLEGE-----IPVESFNLK 504
            A++N L +  NN+  K    +   + ++P S+  L L  N L  +       + S    
Sbjct: 166 PANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPN 225

Query: 505 MITSINISDNNISGE----IPYSISQCHSLTSVDLSRNSLYGKIPPGISKLID------- 553
            + S+N+  N + G     +         L +V L  + +          L         
Sbjct: 226 HVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQK 285

Query: 554 LSILNLSRNGITGSIPNEMRNMM-----SLTTLDLSYNNLI 589
           + +++ +   I  S    + N++           L    LI
Sbjct: 286 IILVDKNGKEIHPSHSIPISNLIRELSGKADVPSLLNQCLI 326

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 45.5 bits (108), Expect = 6e-05
 Identities = 31/173 (17%), Positives = 64/173 (36%), Gaps = 36/173 (20%)

Query: 457 SLNQLKVANNNITGKIPAAIG-----NLPSLNILSLQNNRLEGEIPVESF------NLKM 505
            +  L ++ NN+       +         S+  L+L  N L G    +            
Sbjct: 23  GVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSL-GFKNSDELVQILAAIPAN 81

Query: 506 ITSINISDNNISGE----IPYSISQCH-SLTSVDLSRNSLYGKIPPGISKLID------- 553
           +TS+N+S N +S +    +  +++    ++T +DL  N    K     S+          
Sbjct: 82  VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSK---SSSEFKQAFSNLPA 138

Query: 554 -LSILNLSRNGITG----SIPNEMRNM-MSLTTLDLSYNNLIGNIPSGGQFLA 600
            ++ LNL  N +       +   +  +  ++ +L+L  NN + +       LA
Sbjct: 139 SITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNN-LAS--KNCAELA 188

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 42.8 bits (101), Expect = 4e-04
 Identities = 37/183 (20%), Positives = 64/183 (34%), Gaps = 46/183 (25%)

Query: 452 KMSGASLNQLKVANNNITGKIPAAIG-----NLPSLNILSLQNNRLEGEIPVESF----- 501
             + AS+  L ++ N++  K    +         ++  L+L  N L      +       
Sbjct: 47  ANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFL-SYKSSDELVKTLA 105

Query: 502 -NLKMITSINISDNNISGE----IPYSISQCH-SLTSVDLSRNSLYGKIPPGISKLID-- 553
                IT +++  N+ S +       + S    S+TS++L  N L  K      +LI   
Sbjct: 106 AIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIK---SSDELIQIL 162

Query: 554 ------LSILNLSRNGITGS----------IPNEMRNMMSLTTLDLSYNNLIGNIPSGGQ 597
                 ++ LNL  N +                      S+T+LDLS N  +G       
Sbjct: 163 AAIPANVNSLNLRGNNLASKNCAELAKFLASIPA-----SVTSLDLSANL-LGL--KSYA 214

Query: 598 FLA 600
            LA
Sbjct: 215 ELA 217

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 46.8 bits (111), Expect = 2e-05
 Identities = 44/237 (18%), Positives = 73/237 (30%), Gaps = 73/237 (30%)

Query: 719 VAIKRLVGRGTGGNDHGFLAEIQTLGRIR--------HRNIVRLLGYVSNRDTN----LL 766
           VA+K  V +         L EI+ L  +R           +V+LL        N     +
Sbjct: 65  VAMK--VVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICM 122

Query: 767 LYEYMPNG-SLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNI 825
           ++E +  G  L + +  +    L      +I  +  +GL YLH  C   IIH D+K  NI
Sbjct: 123 VFEVL--GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR--IIHTDIKPENI 178

Query: 826 LL-------------------------------------------------DSDFEAHVA 836
           LL                                                     +  +A
Sbjct: 179 LLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIA 238

Query: 837 DFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGK 893
           D G A ++      +  +       Y + E       +  +D++S   +  EL  G 
Sbjct: 239 DLGNACWVHKHFTEDIQTRQ-----YRSLEVLIGSGYNTPADIWSTACMAFELATGD 290

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 45.9 bits (109), Expect = 4e-05
 Identities = 33/176 (18%), Positives = 58/176 (32%), Gaps = 40/176 (22%)

Query: 700 IGKGGAGIVYRG-SMPDGIDVAIK-------------------RLVGRGTGGNDHGFLAE 739
           IG GG G++Y           A                     + V +           +
Sbjct: 45  IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQ 104

Query: 740 IQTLGRIRHRNIVRLLGY----VSNRDTNLLLYEYMPNG-SLGEMLHGAKGGHLKWETRY 794
           +  LG      I    G        R    ++ E +  G  L ++    + G  K  T  
Sbjct: 105 LDYLG------IPLFYGSGLTEFKGRSYRFMVMERL--GIDLQKISG--QNGTFKKSTVL 154

Query: 795 RIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFE--AHVADFGLAKFLQDAG 848
           ++ +     L Y+H +     +H D+K+ N+LL        ++AD+GL+      G
Sbjct: 155 QLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNG 207

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 45.0 bits (107), Expect = 8e-05
 Identities = 46/234 (19%), Positives = 77/234 (32%), Gaps = 62/234 (26%)

Query: 699 IIGKGGAGIVYRG--SMPDGIDVAIKRLVGRGTGGNDHGF----LAEIQTLGRIRHR--- 749
            +G+G  G V            VA+K  + R    N   +      EI  L +I+ +   
Sbjct: 26  NLGEGTFGKVVECLDHARGKSQVALK--IIR----NVGKYREAARLEINVLKKIKEKDKE 79

Query: 750 ---NIVRLLGYVSNRD-----TNLL---LYEYMPNGSLGEMLHGAKGGHLKWETRYRIAL 798
                V +  + +          LL    +E++         +  +   L    R  +A 
Sbjct: 80  NKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKE-------NNFQPYPLP-HVR-HMAY 130

Query: 799 EAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVA-------------------DFG 839
           +    L +LH +    + H D+K  NIL  +     +                    DFG
Sbjct: 131 QLCHALRFLH-ENQ--LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG 187

Query: 840 LAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGK 893
            A F       E  +++  +  Y  PE    L   +  DV+S G +L E   G 
Sbjct: 188 SATF-----DHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGF 236

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 44.6 bits (106), Expect = 1e-04
 Identities = 46/188 (24%), Positives = 62/188 (32%), Gaps = 45/188 (23%)

Query: 739 EIQTLGRIRHR-----NIVRLLGYVSNRD-----TNLL---LYEYMPNGSLGEMLHGAKG 785
           E   L +I++      NIV+  G     D        L   LYE +         +   G
Sbjct: 81  EADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPLGPSLYEIITR-------NNYNG 133

Query: 786 GHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQ 845
            H++ + +    +E  K L YL    S  + H D+K  NILLD  +              
Sbjct: 134 FHIE-DIK-LYCIEILKALNYLR-KMS--LTHTDLKPENILLDDPYFEKSLITVRRVTDG 188

Query: 846 DAGASECMSSVA------GS--------YGYI------APEYAYTLKVDEKSDVYSFGVV 885
                    S        G            I      APE    L  D  SD++SFG V
Sbjct: 189 KKIQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCV 248

Query: 886 LLELIAGK 893
           L EL  G 
Sbjct: 249 LAELYTGS 256

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 43.4 bits (103), Expect = 2e-04
 Identities = 52/234 (22%), Positives = 84/234 (35%), Gaps = 62/234 (26%)

Query: 699 IIGKGGAGIVYRG--SMPDGIDVAIKRLVGRGTGGNDHGF----LAEIQTLGRIRHR--- 749
            +G+G  G V         G  VA+K  + +    N   +     +EIQ L  +      
Sbjct: 21  TLGEGAFGKVVECIDHKAGGRHVAVK--IVK----NVDRYCEAARSEIQVLEHLNTTDPN 74

Query: 750 ---NIVRLLGYVSNRD-----TNLL---LYEYMPNGSLGEMLHGAKGGHLKWETRYRIAL 798
                V++L +  +         LL    Y+++         +G     L    R ++A 
Sbjct: 75  STFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKE-------NGFLPFRLD-HIR-KMAY 125

Query: 799 EAAKGLCYLHHDCSPLIIHRDVKSNNILL-DSDFEAH------------------VADFG 839
           +  K + +LH      + H D+K  NIL   SD+                     V DFG
Sbjct: 126 QICKSVNFLH-SNK--LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG 182

Query: 840 LAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGK 893
            A +       E  S++  +  Y APE    L   +  DV+S G +L+E   G 
Sbjct: 183 SATY-----DDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGF 231

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336

 Score = 43.3 bits (102), Expect = 3e-04
 Identities = 31/214 (14%), Positives = 74/214 (34%), Gaps = 9/214 (4%)

Query: 93  LLTKLVNLTISNVNLTGRLPSEMALLTSLKVFNISGNVFQGNFAGQIVRGMTELQVLDAY 152
           LL++ V       +   +  +E      ++  ++S +V + +    I+   ++LQ L   
Sbjct: 67  LLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLE 126

Query: 153 NNNFTGPLPVEIASLKSLRHLSFGG-NYFT----GKIPQSYSEIQSLEYIGLNGIGLNGT 207
               + P+   +A   +L  L+  G + F+      +  S S +  L             
Sbjct: 127 GLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHV 186

Query: 208 VPAFLSRLKNLREMYIGYFNTYTG--GIPPGFGALTQLQVLDMASC-NISGEIPTSLSRL 264
             A     + + ++ +  +        +         L  LD++    +  +      +L
Sbjct: 187 QVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQL 246

Query: 265 KLLHSLFL-QMNKLTGHIPPQLSGLISLKSLDLS 297
             L  L L +   +      +L  + +LK+L + 
Sbjct: 247 NYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVF 280

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 41.9 bits (99), Expect = 3e-04
 Identities = 31/114 (27%), Positives = 43/114 (37%), Gaps = 13/114 (11%)

Query: 232 GIPPGFGALTQLQVLDMASCNISGEIPTSLSRLKLLHSLFLQMNKLTGHIPPQL-SGLIS 290
           GIP      +    L++ S  +         +L  L  L L  N++   +P  +   L  
Sbjct: 25  GIP------SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQS-LPDGVFDKLTK 77

Query: 291 LKSLDLSLNYLTGEIPES-FAALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQ 343
           L  L L  N L   +P   F  L  L  L L  N L+  +P   G F  L  LQ
Sbjct: 78  LTILYLHENKLQ-SLPNGVFDKLTQLKELALDTNQLKS-VPD--GIFDRLTSLQ 127

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 40.3 bits (95), Expect = 8e-04
 Identities = 33/102 (32%), Positives = 43/102 (42%), Gaps = 21/102 (20%)

Query: 233 IPPG-FGALTQLQVLDMASCNISGEIPTSLS-----RLKLLHSLFLQMNKLTGHIPPQLS 286
           +P G F  LTQL  L ++   I      SL      +L  L  L+L  NKL   +P    
Sbjct: 43  LPHGVFDKLTQLTKLSLSQNQI-----QSLPDGVFDKLTKLTILYLHENKLQS-LPN--- 93

Query: 287 G----LISLKSLDLSLNYLTGEIPE-SFAALKNLTLLQLFKN 323
           G    L  LK L L  N L   +P+  F  L +L  + L  N
Sbjct: 94  GVFDKLTQLKELALDTNQLKS-VPDGIFDRLTSLQKIWLHTN 134

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170

 Score = 41.1 bits (97), Expect = 5e-04
 Identities = 32/88 (36%), Positives = 39/88 (44%), Gaps = 11/88 (12%)

Query: 257 IPTSLSRLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPES-FAALKNL 315
           IPT+   L      +L  N++T   P     L  L  LDL  N LT  +P   F  L  L
Sbjct: 28  IPTTTQVL------YLYDNQITKLEPGVFDRLTQLTRLDLDNNQLT-VLPAGVFDKLTQL 80

Query: 316 TLLQLFKNNLRGPIPSFLGDFPNLEVLQ 343
           T L L  N L+  IP   G F NL+ L 
Sbjct: 81  TQLSLNDNQLKS-IPR--GAFDNLKSLT 105

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 40.8 bits (96), Expect = 8e-04
 Identities = 38/139 (27%), Positives = 64/139 (46%), Gaps = 15/139 (10%)

Query: 456 ASLNQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESFN-LKMITSINISDN 514
           A    L +  N++          L SL  L L  N+L+  +P   FN L  +T +N+S N
Sbjct: 28  AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTN 86

Query: 515 NISGEIPY----SISQCHSLTSVDLSRNSLYGKIPPGI-SKLIDLSILNLSRNGITGSIP 569
            +   +P      ++Q   L  + L+ N L   +P G+  KL  L  L L +N +  S+P
Sbjct: 87  QLQ-SLPNGVFDKLTQ---LKELALNTNQL-QSLPDGVFDKLTQLKDLRLYQNQLK-SVP 140

Query: 570 NEM-RNMMSLTTLDLSYNN 587
           + +   + SL  + L ++N
Sbjct: 141 DGVFDRLTSLQYIWL-HDN 158

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174

 Score = 40.3 bits (95), Expect = 8e-04
 Identities = 32/88 (36%), Positives = 42/88 (47%), Gaps = 11/88 (12%)

Query: 257 IPTSLSRLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPES-FAALKNL 315
           IPT   RL      +L  N++T   P     L++L+ L  + N LT  IP   F  L  L
Sbjct: 31  IPTDKQRL------WLNNNQITKLEPGVFDHLVNLQQLYFNSNKLT-AIPTGVFDKLTQL 83

Query: 316 TLLQLFKNNLRGPIPSFLGDFPNLEVLQ 343
           T L L  N+L+  IP   G F NL+ L 
Sbjct: 84  TQLDLNDNHLKS-IPR--GAFDNLKSLT 108

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	982
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	100.0
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	100.0
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	100.0
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	100.0
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	100.0
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	100.0
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	100.0
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	100.0
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	100.0
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	100.0
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	100.0
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	100.0
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	100.0
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	100.0
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	100.0
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	100.0
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	100.0
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	100.0
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
1o6v_A	466	Internalin A; bacterial infection, extracellular r	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
1o6v_A	466	Internalin A; bacterial infection, extracellular r	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	100.0
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	100.0
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	100.0
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	100.0
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	99.98
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	99.98
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	99.98
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	99.97
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	99.96
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	99.96
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	99.96
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	99.96
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	99.95
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	99.95
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	99.95
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	99.95
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	99.95
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	99.95
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.95
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	99.95
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	99.95
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	99.95
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	99.95
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	99.95
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	99.95
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	99.95
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	99.94
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	99.94
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	99.94
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	99.94
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.93
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.93
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	99.93
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	99.92
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	99.91
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	99.91
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	99.91
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.91
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.91
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.9
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	99.9
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	99.9
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	99.9
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	99.89
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	99.89
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	99.88
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	99.88
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	99.88
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	99.88
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	99.88
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	99.87
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.87
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	99.86
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	99.86
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.86
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	99.85
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.85
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.84
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	99.84
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	99.84
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	99.83
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.82
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	99.81
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.81
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.8
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.79
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	99.79
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	99.78
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	99.78
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	99.77
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	99.77
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.77
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	99.77
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	99.77
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.77
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	99.76
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.75
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.75
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	99.72
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	99.72
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	99.71
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	99.7
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	99.7
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	99.7
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.7
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.69
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	99.68
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.67
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.65
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.63
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.63
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.63
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.61
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.6
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.59
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	99.57
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.55
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	99.55
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	99.54
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	99.52
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.51
4fs7_A	394	Uncharacterized protein; leucine-rich repeats, pro	99.48
4fs7_A	394	Uncharacterized protein; leucine-rich repeats, pro	99.48
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.47
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	99.47
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	99.47
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.42
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.42
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	99.37
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	99.29
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	99.27
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	99.25
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	99.21
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	99.18
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.18
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.01
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	98.96
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	98.95
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	98.94
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	98.91
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.9
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	98.82
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.75
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.54
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	98.49
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	98.47
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.41
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.3
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.19
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.14
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.11
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.07
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.88
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	97.84
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	97.77
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.67
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.65
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.64
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.49
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	97.44
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	97.07
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.06
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.04
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	96.91
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	96.61
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	96.61
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	96.58
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	96.55
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	96.5
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.49
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.34
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.33
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	96.05
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.23
3mes_A	424	Choline kinase; malaria, structural genomics, stru	94.75
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	89.75
2jwa_A	44	Receptor tyrosine-protein kinase ERBB-2; transmemb	84.88
2ks1_B	44	Epidermal growth factor receptor; ERBB1, ERBB2, tr	81.84

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=100.00  E-value=2.8e-84  Score=802.39  Aligned_cols=595  Identities=33%  Similarity=0.503  Sum_probs=512.3

Q ss_pred             hcCchhHHHHHHHHHhcccCCCCCCCCCCCCCCCCCCCCccceeeeCCCCCEEEEEeccCCcccc---CC----------
Q 002010           22 LSCAYSDMDVLLKLKSSMIGPKGSGLKNWEPSSSPSAHCSFSGVTCDQDSRVVSLNVSFMPLFGS---IP----------   88 (982)
Q Consensus        22 ~~~~~~~~~~ll~~k~~~~~~~~~~~~~w~~~~~~~~~C~w~gv~C~~~~~v~~l~l~~~~l~g~---~~----------   88 (982)
                      ..+.++|++|||+||+++.+|.  .+++|+.   ..+||+|.||+|+ .+||+.++|++.++.|.   +|          
T Consensus         7 ~~~~~~~~~all~~k~~~~~~~--~l~~W~~---~~~~C~w~gv~C~-~~~v~~L~L~~~~l~g~~~~l~~~l~~L~~L~   80 (768)
T 3rgz_A            7 SQSLYREIHQLISFKDVLPDKN--LLPDWSS---NKNPCTFDGVTCR-DDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLE   80 (768)
T ss_dssp             -CCHHHHHHHHHHHHTTCSCTT--SSTTCCT---TSCGGGSTTEEEE-TTEEEEEECTTSCCCEEHHHHHHHTTTCTTCC
T ss_pred             ccCCHHHHHHHHHHHhhCCCcc--cccCCCC---CCCCcCCcceEEC-CCcEEEEECCCCCcCCccCccChhHhccCccc
Confidence            3456789999999999998665  7999973   3579999999999 78999999999999887   43          


Q ss_pred             -------------cCccccccccEEEeccCCCCCCCCh--hhhhhcccceeeccCCccccccchhhhhcCCCccEEeccC
Q 002010           89 -------------PEIGLLTKLVNLTISNVNLTGRLPS--EMALLTSLKVFNISGNVFQGNFAGQIVRGMTELQVLDAYN  153 (982)
Q Consensus        89 -------------~~i~~l~~L~~L~l~~n~l~~~~p~--~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~  153 (982)
                                   +.++.+++|++|+|++|.++|.+|.  .++++++|++|+|++|.+.+..+..++.++++|++|+|++
T Consensus        81 ~l~~~~~~~~~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~  160 (768)
T 3rgz_A           81 SLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSA  160 (768)
T ss_dssp             EEECTTSCEEECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEECCS
T ss_pred             ccCCcCCCcCCCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEECCC
Confidence                         5788899999999999999999998  8999999999999999998777765545666666666666


Q ss_pred             ccccCCCchh---c----------------------cccccccEEeecCcccccccCCCccccCcceEeeccCcccccch
Q 002010          154 NNFTGPLPVE---I----------------------ASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLNGIGLNGTV  208 (982)
Q Consensus       154 n~l~~~~p~~---l----------------------~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~i~~~~  208 (982)
                      |++++..|..   +                      +.+++|++|+|++|++++.+|. ++++++|++|++++|.+.+.+
T Consensus       161 n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~n~l~~~~  239 (768)
T 3rgz_A          161 NSISGANVVGWVLSDGCGELKHLAISGNKISGDVDVSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDF  239 (768)
T ss_dssp             SCCEEETHHHHHHTTCCTTCCEEECCSSEEESCCBCTTCTTCCEEECCSSCCCSCCCB-CTTCCSCCEEECCSSCCCSCH
T ss_pred             CccCCcCChhhhhhccCCCCCEEECCCCcccccCCcccCCcCCEEECcCCcCCCCCcc-cccCCCCCEEECcCCcCCCcc
Confidence            6665554443   2                      4566777777777777776776 888888888888888888888


Q ss_pred             hhHHhhhhhHHHHhhcccc---------------------cccccCCCCCCCC-CCCCEEecccCcCcccCchhhcCCCc
Q 002010          209 PAFLSRLKNLREMYIGYFN---------------------TYTGGIPPGFGAL-TQLQVLDMASCNISGEIPTSLSRLKL  266 (982)
Q Consensus       209 ~~~l~~l~~L~~L~l~~~n---------------------~~~~~~p~~~~~l-~~L~~L~L~~n~l~~~~~~~l~~l~~  266 (982)
                      |..+.++++|++|++++|.                     .+++.+|..+..+ ++|++|+|++|++++.+|..|+++++
T Consensus       240 ~~~l~~l~~L~~L~Ls~n~l~~~~~~~~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~~l~~  319 (768)
T 3rgz_A          240 SRAISTCTELKLLNISSNQFVGPIPPLPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSL  319 (768)
T ss_dssp             HHHTTTCSSCCEEECCSSCCEESCCCCCCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEECCCGGGGGCTT
T ss_pred             cHHHhcCCCCCEEECCCCcccCccCccccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCccchHHhcCCC
Confidence            8888888888888877642                     2233556666554 77777777777777777777777777


Q ss_pred             cceeecccccCCCCCCcc-ccCCCCCCEEEeeCCcccCcCchhhhccc-chhhhhhccCCCCCCCCCcCCC--CCCccEE
Q 002010          267 LHSLFLQMNKLTGHIPPQ-LSGLISLKSLDLSLNYLTGEIPESFAALK-NLTLLQLFKNNLRGPIPSFLGD--FPNLEVL  342 (982)
Q Consensus       267 L~~L~L~~N~l~~~~~~~-l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~-~L~~L~L~~N~l~~~~p~~~~~--l~~L~~L  342 (982)
                      |++|++++|++++.+|.. +..+++|++|++++|++++.+|..+..++ +|++|++++|++++.+|..+..  +++|++|
T Consensus       320 L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L  399 (768)
T 3rgz_A          320 LESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQEL  399 (768)
T ss_dssp             CCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCCEE
T ss_pred             ccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCccEE
Confidence            777777777777666654 77777777777777777777777777776 7888888888887777777766  7889999


Q ss_pred             EccCCCcccccCccccCCCcccEEEeccccccccCCccccCccccceeecccccccccCCccccCCCCCCEEEccCCccC
Q 002010          343 QVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLN  422 (982)
Q Consensus       343 ~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~l~~N~~~~~~~~~l~~l~~L~~L~Ls~N~l~  422 (982)
                      ++++|.+++.+|..+..+++|++|++++|++++.+|..+..+++|++|++++|.+.+.+|..+..+++|++|++++|+++
T Consensus       400 ~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~  479 (768)
T 3rgz_A          400 YLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLT  479 (768)
T ss_dssp             ECCSSEEEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCC
T ss_pred             ECCCCccccccCHHHhcCCCCCEEECcCCcccCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEecCCccc
Confidence            99999999899999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCccccCCCccccccCCCccccccCCccccc-CCccEEEeeccccCCCCchhccCCCCcceeeeccccccCCCccccc
Q 002010          423 GTIPAGLFNLPLLNMMELDDNLLSGELPEKMSG-ASLNQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESF  501 (982)
Q Consensus       423 ~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~-~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~  501 (982)
                      +.+|..+.++++|++|++++|++++.+|..+.. ++|++|++++|++++.+|..++.+++|++|++++|+++|.+|..++
T Consensus       480 ~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~  559 (768)
T 3rgz_A          480 GEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMF  559 (768)
T ss_dssp             SCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGG
T ss_pred             CcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHh
Confidence            999999999999999999999999999988765 7899999999999999999999999999999999999988886543


Q ss_pred             ----------------------------------------------------------------------cccccceeee
Q 002010          502 ----------------------------------------------------------------------NLKMITSINI  511 (982)
Q Consensus       502 ----------------------------------------------------------------------~l~~L~~L~L  511 (982)
                                                                                            .++.|++|||
T Consensus       560 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdL  639 (768)
T 3rgz_A          560 KQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDM  639 (768)
T ss_dssp             TTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEEC
T ss_pred             cccchhhhhccccccccccccccccccccccccccccccccchhhhccccccccccccceecccCchhhhccccccEEEC
Confidence                                                                                  3567899999


Q ss_pred             eccccCCCCCcccccccCCCeeeCCCCcccCCCCcccccccccceEEcccccccccCccccccccccceecccCCccccC
Q 002010          512 SDNNISGEIPYSISQCHSLTSVDLSRNSLYGKIPPGISKLIDLSILNLSRNGITGSIPNEMRNMMSLTTLDLSYNNLIGN  591 (982)
Q Consensus       512 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~  591 (982)
                      ++|+++|.+|..|++++.|+.|+|++|+++|.+|..|+++++|+.|||++|+++|.+|..+..+++|++|||++|+|+|.
T Consensus       640 s~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~  719 (768)
T 3rgz_A          640 SYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGP  719 (768)
T ss_dssp             CSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEE
T ss_pred             cCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCccccc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCccccccccccccCCcCcccCCCCCCccC
Q 002010          592 IPSGGQFLAFNETSFIGNPNLCLLRNGTCQSL  623 (982)
Q Consensus       592 ip~~~~~~~~~~~~~~~n~~~c~~~~~~c~~~  623 (982)
                      ||.+++|.++...+|.|||++||.|.++|+..
T Consensus       720 iP~~~~~~~~~~~~~~gN~~Lcg~~l~~C~~~  751 (768)
T 3rgz_A          720 IPEMGQFETFPPAKFLNNPGLCGYPLPRCDPS  751 (768)
T ss_dssp             CCSSSSGGGSCGGGGCSCTEEESTTSCCCCSC
T ss_pred             CCCchhhccCCHHHhcCCchhcCCCCcCCCCC
Confidence            99999999999999999999999998888644

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=100.00  E-value=2.4e-64  Score=624.06  Aligned_cols=514  Identities=32%  Similarity=0.454  Sum_probs=380.1

Q ss_pred             CEEEEEeccCCccccCCcCc-cccccccEEEeccCCCCCCCChh---hhhhcc----------------------cceee
Q 002010           72 RVVSLNVSFMPLFGSIPPEI-GLLTKLVNLTISNVNLTGRLPSE---MALLTS----------------------LKVFN  125 (982)
Q Consensus        72 ~v~~l~l~~~~l~g~~~~~i-~~l~~L~~L~l~~n~l~~~~p~~---l~~l~~----------------------L~~L~  125 (982)
                      +...|+++++.+.+.+|..+ +.+++|++|+|++|++++..|..   +.++++                      |++|+
T Consensus       127 ~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~l~~L~~L~  206 (768)
T 3rgz_A          127 GLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVDVSRCVNLEFLD  206 (768)
T ss_dssp             TCCEEECCSSEEECCSSCCSCCCCTTCSEEECCSSCCEEETHHHHHHTTCCTTCCEEECCSSEEESCCBCTTCTTCCEEE
T ss_pred             CCCEEECcCCccCCcCCHHHhccCCCCCEEECCCCccCCcCChhhhhhccCCCCCEEECCCCcccccCCcccCCcCCEEE
Confidence            56677777777777777665 66777777777777776665554   444444                      44444


Q ss_pred             ccCCccccccchhhhhcCCCccEEeccCccccCCCchhccccccccEEeecCcccccccCCCccccCcceEeeccCcccc
Q 002010          126 ISGNVFQGNFAGQIVRGMTELQVLDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLNGIGLN  205 (982)
Q Consensus       126 Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~i~  205 (982)
                      |++|.+.+.++.  +.++++|++|++++|++++.+|..++++++|++|+|++|++++.+|..  .+++|++|++++|.+.
T Consensus       207 Ls~n~l~~~~~~--l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~--~l~~L~~L~L~~n~l~  282 (768)
T 3rgz_A          207 VSSNNFSTGIPF--LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFT  282 (768)
T ss_dssp             CCSSCCCSCCCB--CTTCCSCCEEECCSSCCCSCHHHHTTTCSSCCEEECCSSCCEESCCCC--CCTTCCEEECCSSEEE
T ss_pred             CcCCcCCCCCcc--cccCCCCCEEECcCCcCCCcccHHHhcCCCCCEEECCCCcccCccCcc--ccCCCCEEECcCCccC
Confidence            444444443332  445555666666666665555656666666666666666555555543  5555666666666666


Q ss_pred             cchhhHHhhh-hhHHHHhhcccccccccCCCCCCCCCCCCEEecccCcCcccCchh-hcCCCccceeecccccCCCCCCc
Q 002010          206 GTVPAFLSRL-KNLREMYIGYFNTYTGGIPPGFGALTQLQVLDMASCNISGEIPTS-LSRLKLLHSLFLQMNKLTGHIPP  283 (982)
Q Consensus       206 ~~~~~~l~~l-~~L~~L~l~~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~-l~~l~~L~~L~L~~N~l~~~~~~  283 (982)
                      +.+|..+.++ ++|++|+++. |.+++.+|..|+++++|++|++++|++++.+|.. +.++++|++|++++|++++.+|.
T Consensus       283 ~~ip~~~~~~~~~L~~L~Ls~-n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~  361 (768)
T 3rgz_A          283 GEIPDFLSGACDTLTGLDLSG-NHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPE  361 (768)
T ss_dssp             ESCCCCSCTTCTTCSEEECCS-SEEEECCCGGGGGCTTCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCT
T ss_pred             CccCHHHHhhcCcCCEEECcC-CcCCCccchHHhcCCCccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccH
Confidence            6666666664 7777777775 5666777777777888888888888777777755 77777788888888877777777


Q ss_pred             cccCCC-CCCEEEeeCCcccCcCchhhhc--ccchhhhhhccCCCCCCCCCcCCCCCCccEEEccCCCcccccCccccCC
Q 002010          284 QLSGLI-SLKSLDLSLNYLTGEIPESFAA--LKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRN  360 (982)
Q Consensus       284 ~l~~l~-~L~~L~Ls~N~l~~~~~~~l~~--l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l  360 (982)
                      .+..++ +|++|++++|.+++.+|..+..  +++|++|++++|++++.+|..++.+++|++|++++|++++.+|..++.+
T Consensus       362 ~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l  441 (768)
T 3rgz_A          362 SLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSL  441 (768)
T ss_dssp             THHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCCEEECCSSEEEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGC
T ss_pred             HHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCccEEECCCCccccccCHHHhcCCCCCEEECcCCcccCcccHHHhcC
Confidence            777765 7777777777777766666655  6677777777777777777777777777777777777777777777777


Q ss_pred             CcccEEEeccccccccCCccccCccccceeecccccccccCCccccCCCCCCEEEccCCccCCCCCccccCCCccccccC
Q 002010          361 GKLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMEL  440 (982)
Q Consensus       361 ~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~l~~N~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  440 (982)
                      ++|++|++++|++++.+|..+..+++|++|++++|.+.+.+|..+.++++|++|++++|++++.+|.++..+++|++|++
T Consensus       442 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L  521 (768)
T 3rgz_A          442 SKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKL  521 (768)
T ss_dssp             TTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEEC
T ss_pred             CCCCEEECCCCcccCcCCHHHcCCCCceEEEecCCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEEC
Confidence            77777777777777777777777777777777777777777777777777777777777777777777777777777777


Q ss_pred             CCccccccCCccccc-CCccEEEeeccccCCCCchh--------------------------------------------
Q 002010          441 DDNLLSGELPEKMSG-ASLNQLKVANNNITGKIPAA--------------------------------------------  475 (982)
Q Consensus       441 ~~N~l~~~~~~~~~~-~~L~~L~L~~N~i~~~~p~~--------------------------------------------  475 (982)
                      ++|++++.+|..+.. ++|+.|++++|+++|.+|..                                            
T Consensus       522 ~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  601 (768)
T 3rgz_A          522 SNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRS  601 (768)
T ss_dssp             CSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCG
T ss_pred             CCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhccccccccccccccccccccccccccccccccc
Confidence            777777777766654 56777777777776666543                                            


Q ss_pred             --------------------------ccCCCCcceeeeccccccCCCccccccccccceeeeeccccCCCCCcccccccC
Q 002010          476 --------------------------IGNLPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIPYSISQCHS  529 (982)
Q Consensus       476 --------------------------~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~  529 (982)
                                                ++.+++|++|+|++|+++|.+|..+..++.|+.|+|++|+++|.+|..|+++++
T Consensus       602 ~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~  681 (768)
T 3rgz_A          602 EQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRG  681 (768)
T ss_dssp             GGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTT
T ss_pred             hhhhccccccccccccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCC
Confidence                                      445678999999999999999999999999999999999999999999999999


Q ss_pred             CCeeeCCCCcccCCCCcccccccccceEEcccccccccCccccccccccceecccCCc-cccC
Q 002010          530 LTSVDLSRNSLYGKIPPGISKLIDLSILNLSRNGITGSIPNEMRNMMSLTTLDLSYNN-LIGN  591 (982)
Q Consensus       530 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~-l~~~  591 (982)
                      |+.||||+|+++|.+|..+.++++|++|||++|+++|.+|.. ..+.++....+.+|+ |+|.
T Consensus       682 L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~-~~~~~~~~~~~~gN~~Lcg~  743 (768)
T 3rgz_A          682 LNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEM-GQFETFPPAKFLNNPGLCGY  743 (768)
T ss_dssp             CCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEECCSS-SSGGGSCGGGGCSCTEEEST
T ss_pred             CCEEECCCCcccCcCChHHhCCCCCCEEECcCCcccccCCCc-hhhccCCHHHhcCCchhcCC
Confidence            999999999999999999999999999999999999999964 455666677788886 7764

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=100.00  E-value=2.1e-60  Score=583.75  Aligned_cols=556  Identities=18%  Similarity=0.162  Sum_probs=487.1

Q ss_pred             CCccceeeeCC----------CCCEEEEEeccCCccccCCcCccccccccEEEeccCCCCCCCChhhhhhcccceeeccC
Q 002010           59 HCSFSGVTCDQ----------DSRVVSLNVSFMPLFGSIPPEIGLLTKLVNLTISNVNLTGRLPSEMALLTSLKVFNISG  128 (982)
Q Consensus        59 ~C~w~gv~C~~----------~~~v~~l~l~~~~l~g~~~~~i~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~  128 (982)
                      .|.+..|.|..          ..+++.|+++++.+.+..+..++.+++|++|+|++|++++..|..++++++|++|+|++
T Consensus         3 ~~~~~~~~cs~~~L~~ip~~~~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~   82 (680)
T 1ziw_A            3 TVSHEVADCSHLKLTQVPDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQH   82 (680)
T ss_dssp             -CBSSEEECCSSCCSSCCSCSCTTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCS
T ss_pred             eeECCeeECCCCCccccccccCCCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCC
Confidence            46666777753          13689999999999887777899999999999999999999999999999999999999


Q ss_pred             CccccccchhhhhcCCCccEEeccCccccCCCchhccccccccEEeecCcccccccCCCccccCcceEeeccCcccccch
Q 002010          129 NVFQGNFAGQIVRGMTELQVLDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLNGIGLNGTV  208 (982)
Q Consensus       129 n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~i~~~~  208 (982)
                      |.+++ ++...+.++++|++|+|++|++++..|..++++++|++|+|++|.+++..|..++++++|++|++++|.+.+..
T Consensus        83 n~l~~-l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~  161 (680)
T 1ziw_A           83 NELSQ-LSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALK  161 (680)
T ss_dssp             SCCCC-CCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBC
T ss_pred             CccCc-cChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccC
Confidence            99984 56667889999999999999999888889999999999999999999999999999999999999999999988


Q ss_pred             hhHHh--hhhhHHHHhhcccccccccCCCCCCCC---------------------------CCCCEEecccCcCcccCch
Q 002010          209 PAFLS--RLKNLREMYIGYFNTYTGGIPPGFGAL---------------------------TQLQVLDMASCNISGEIPT  259 (982)
Q Consensus       209 ~~~l~--~l~~L~~L~l~~~n~~~~~~p~~~~~l---------------------------~~L~~L~L~~n~l~~~~~~  259 (982)
                      +..+.  .+++|++|+++. |.+.+..|..++.+                           ++|+.|++++|.+++..|.
T Consensus       162 ~~~~~~~~~~~L~~L~L~~-n~l~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~  240 (680)
T 1ziw_A          162 SEELDIFANSSLKKLELSS-NQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNT  240 (680)
T ss_dssp             HHHHGGGTTCEESEEECTT-CCCCCBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTT
T ss_pred             HHHhhccccccccEEECCC-CcccccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChh
Confidence            88776  458999999986 46676667666544                           5678888999999988888


Q ss_pred             hhcCCCc--cceeecccccCCCCCCccccCCCCCCEEEeeCCcccCcCchhhhcccchhhhhhccCCCCC-----CCCC-
Q 002010          260 SLSRLKL--LHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQLFKNNLRG-----PIPS-  331 (982)
Q Consensus       260 ~l~~l~~--L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~-----~~p~-  331 (982)
                      .|..++.  |++|++++|++++..|..|..+++|++|++++|.+++..|..|..+++|++|++++|...+     .+|. 
T Consensus       241 ~~~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i  320 (680)
T 1ziw_A          241 TFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKI  320 (680)
T ss_dssp             TTGGGGGSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEE
T ss_pred             HhhccCcCCCCEEECCCCCcCccCcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhccccccccccc
Confidence            8988865  9999999999998888889999999999999999998889999999999999999876554     2332 


Q ss_pred             ---cCCCCCCccEEEccCCCcccccCccccCCCcccEEEeccccccccC--CccccCc--cccceeecccccccccCCcc
Q 002010          332 ---FLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTI--PRDLCKG--GKLKSLILMQNFFIGPIPEE  404 (982)
Q Consensus       332 ---~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~--p~~~~~~--~~L~~L~l~~N~~~~~~~~~  404 (982)
                         .|..+++|++|++++|.+++..+..+..+++|++|++++|.+....  +..+..+  ++|+.|++++|.+.+..|..
T Consensus       321 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~  400 (680)
T 1ziw_A          321 DDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDA  400 (680)
T ss_dssp             CTTTTTTCTTCCEEECCSCCBCCCCTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTT
T ss_pred             ChhhcccCCCCCEEECCCCccCCCChhHhccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhh
Confidence               7888999999999999999988889999999999999999865322  2233333  58999999999999999999


Q ss_pred             ccCCCCCCEEEccCCccCCCCC-ccccCCCccccccCCCccccccCCccccc-CCccEEEeeccccC--CCCchhccCCC
Q 002010          405 LGQCKSLTKIRFSKNYLNGTIP-AGLFNLPLLNMMELDDNLLSGELPEKMSG-ASLNQLKVANNNIT--GKIPAAIGNLP  480 (982)
Q Consensus       405 l~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~-~~L~~L~L~~N~i~--~~~p~~~~~l~  480 (982)
                      +..+++|++|++++|++++.+| ..+..+++|++|++++|++.+..+..+.. ++|+.|++++|.++  +.+|..|..++
T Consensus       401 ~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~  480 (680)
T 1ziw_A          401 FSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLR  480 (680)
T ss_dssp             TTTCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCT
T ss_pred             hhCCCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCC
Confidence            9999999999999999988776 68889999999999999999888877765 78999999999987  67899999999


Q ss_pred             CcceeeeccccccCCCccccccccccceeeeeccccCCCCC--------cccccccCCCeeeCCCCcccCCCCccccccc
Q 002010          481 SLNILSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIP--------YSISQCHSLTSVDLSRNSLYGKIPPGISKLI  552 (982)
Q Consensus       481 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p--------~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~  552 (982)
                      +|++|++++|++++..|..+..+++|++|+|++|++++..+        ..|.++++|+.|+|++|+++...+..|.+++
T Consensus       481 ~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~  560 (680)
T 1ziw_A          481 NLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLF  560 (680)
T ss_dssp             TCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCT
T ss_pred             CCCEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHccccc
Confidence            99999999999998777789999999999999999986422        3478999999999999999955556799999


Q ss_pred             ccceEEcccccccccCccccccccccceecccCCccccCCCCCc--cccccccccccCCcCcccCC
Q 002010          553 DLSILNLSRNGITGSIPNEMRNMMSLTTLDLSYNNLIGNIPSGG--QFLAFNETSFIGNPNLCLLR  616 (982)
Q Consensus       553 ~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~~--~~~~~~~~~~~~n~~~c~~~  616 (982)
                      +|+.|+|++|+|++..+..|..+++|+.|+|++|++++.+|...  .+.++....+.||||.|+++
T Consensus       561 ~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c~  626 (680)
T 1ziw_A          561 ELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCE  626 (680)
T ss_dssp             TCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCCC
T ss_pred             CcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccCCc
Confidence            99999999999998777888999999999999999999877532  46778888999999999865

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=100.00  E-value=1.2e-59  Score=568.69  Aligned_cols=490  Identities=21%  Similarity=0.302  Sum_probs=313.2

Q ss_pred             hhHHHHHHHHHhcccCCCCCCC-------CCCCCCCCCCCCCcc---ceeeeCCCCCEEEEEeccCCccccCCcCccccc
Q 002010           26 YSDMDVLLKLKSSMIGPKGSGL-------KNWEPSSSPSAHCSF---SGVTCDQDSRVVSLNVSFMPLFGSIPPEIGLLT   95 (982)
Q Consensus        26 ~~~~~~ll~~k~~~~~~~~~~~-------~~w~~~~~~~~~C~w---~gv~C~~~~~v~~l~l~~~~l~g~~~~~i~~l~   95 (982)
                      ..|++||.+||+++.++.+...       .+|..+   .+||.|   .||+|+..+||++|+|+++++.|.+|++++.++
T Consensus        29 ~~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~~---~~~c~w~~~~GV~C~~~~~V~~L~L~~~~l~g~lp~~l~~L~  105 (636)
T 4eco_A           29 IKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFN---KELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLT  105 (636)
T ss_dssp             HHHHHHHHHHHHHTTGGGCCCCC------CCCCCS---SCGGGTTCCTTEEECTTCCEEEEECTTSCCEEEECGGGGGCT
T ss_pred             HHHHHHHHHHHHHcCCCCcccCCcCCccCCCCCCC---CCcccccCCCCeEEcCCCCEEEEEecCcccCCcCChHHhcCc
Confidence            4699999999999987766533       389753   679999   999999889999999999999999999999999


Q ss_pred             cccEEEeccCCC------CC------CCChhhhhhcccceeeccCCccccccchhhhhcCCCccEEecc-----------
Q 002010           96 KLVNLTISNVNL------TG------RLPSEMALLTSLKVFNISGNVFQGNFAGQIVRGMTELQVLDAY-----------  152 (982)
Q Consensus        96 ~L~~L~l~~n~l------~~------~~p~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls-----------  152 (982)
                      +|++|+|++|.+      .|      .+|...  +..|+ ++++.|.+.+.++..+..-+..+..+++.           
T Consensus       106 ~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~--~~~l~-l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~  182 (636)
T 4eco_A          106 ELEVLALGSHGEKVNERLFGPKGISANMSDEQ--KQKMR-MHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRIT  182 (636)
T ss_dssp             TCCEEESCCGGGGGTCCSBSTTSBCTTCCHHH--HHHHH-THHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCCCCCCC
T ss_pred             cceEEECcCCccccCCccccccccccCchHHH--HHHHH-hhHHHhhhccCchhhHHHHHHHHhhcCccccccccccccc
Confidence            999999999976      34      667665  77788 99999988877665543333333333333           


Q ss_pred             ---------CccccCCCchhccccccccEEeecCcccccc-----------------cCCCcc--ccCcceEeeccCccc
Q 002010          153 ---------NNNFTGPLPVEIASLKSLRHLSFGGNYFTGK-----------------IPQSYS--EIQSLEYIGLNGIGL  204 (982)
Q Consensus       153 ---------~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~-----------------~p~~~~--~l~~L~~L~L~~n~i  204 (982)
                               .|+++| +|..++++++|++|+|++|++++.                 +|..++  ++++|++|++++|.+
T Consensus       183 l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l  261 (636)
T 4eco_A          183 LKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPN  261 (636)
T ss_dssp             CCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTT
T ss_pred             hhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcC
Confidence                     466666 666677777777777777776664                 555555  555555555554333


Q ss_pred             ccchhhHHhhhhhHHHHhhcccccccccCCCCCCCCCCCCEEecccCc-Ccc-cCchhhcCC------Cccceeeccccc
Q 002010          205 NGTVPAFLSRLKNLREMYIGYFNTYTGGIPPGFGALTQLQVLDMASCN-ISG-EIPTSLSRL------KLLHSLFLQMNK  276 (982)
Q Consensus       205 ~~~~~~~l~~l~~L~~L~l~~~n~~~~~~p~~~~~l~~L~~L~L~~n~-l~~-~~~~~l~~l------~~L~~L~L~~N~  276 (982)
                                               .+.+|..|+++++|++|++++|+ ++| .+|..++.+      ++|++|++++|+
T Consensus       262 -------------------------~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~  316 (636)
T 4eco_A          262 -------------------------LTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNN  316 (636)
T ss_dssp             -------------------------CSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSC
T ss_pred             -------------------------CccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCc
Confidence                                     23344455555666666666665 555 555555554      566666666666


Q ss_pred             CCCCCCc--cccCCCCCCEEEeeCCcccCcCchhhhcccchhhhhhccCCCCCCCCCcCCCCCC-ccEEEccCCCccccc
Q 002010          277 LTGHIPP--QLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQLFKNNLRGPIPSFLGDFPN-LEVLQVWGNNFTFEL  353 (982)
Q Consensus       277 l~~~~~~--~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~-L~~L~L~~N~l~~~~  353 (982)
                      ++ .+|.  .++.+++|++|++++|+++|.+| .|..+++|++|++++|+++ .+|..+..+++ |++|++++|.++ .+
T Consensus       317 l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~-~l  392 (636)
T 4eco_A          317 LK-TFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLK-YI  392 (636)
T ss_dssp             CS-SCCCHHHHTTCTTCCEEECCSCCCEEECC-CCEEEEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCS-SC
T ss_pred             CC-ccCchhhhccCCCCCEEeCcCCcCccchh-hhCCCCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCc-cc
Confidence            65 4555  55566666666666666655555 5555556666666666555 45555555555 666666665555 44


Q ss_pred             CccccCCC--cccEEEeccccccccCCcccc-------CccccceeecccccccccCCccccCCCCCCEEEccCCccCCC
Q 002010          354 PENLGRNG--KLLILDVTSNHLTGTIPRDLC-------KGGKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGT  424 (982)
Q Consensus       354 ~~~l~~l~--~L~~L~L~~N~l~~~~p~~~~-------~~~~L~~L~l~~N~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~  424 (982)
                      |..+..+.  +|++|++++|++++.+|..+.       .+.+|++|++++|.+....+..+..+++|++|+|++|+++ .
T Consensus       393 p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~-~  471 (636)
T 4eco_A          393 PNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLT-E  471 (636)
T ss_dssp             CSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCS-B
T ss_pred             chhhhhcccCccCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCC-C
Confidence            55444433  555555555555555555444       4444444444444444322223333444444444444444 3


Q ss_pred             CCccccCCCccccccCCCccccccCCcccccCCccEEEeeccccCCCCchhcc--CCCCcceeeeccccccCCCcccccc
Q 002010          425 IPAGLFNLPLLNMMELDDNLLSGELPEKMSGASLNQLKVANNNITGKIPAAIG--NLPSLNILSLQNNRLEGEIPVESFN  502 (982)
Q Consensus       425 ~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~L~~N~i~~~~p~~~~--~l~~L~~L~L~~N~l~~~~p~~~~~  502 (982)
                      +|.......               .+..-...+|++|+|++|+++ .+|..+.  .+++|+.|+|++|++++ +|..+..
T Consensus       472 i~~~~~~~~---------------~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~  534 (636)
T 4eco_A          472 IPKNSLKDE---------------NENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLN  534 (636)
T ss_dssp             CCSSSSEET---------------TEECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGG
T ss_pred             cCHHHhccc---------------cccccccCCccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhc
Confidence            332221100               000000127888999999998 6777776  89999999999999986 8888888


Q ss_pred             ccccceeeeeccccCCCCCcccccccCCCeeeCCCCcccCCCCcccccccccceEEcccccccccCccccccccccceec
Q 002010          503 LKMITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYGKIPPGISKLIDLSILNLSRNGITGSIPNEMRNMMSLTTLD  582 (982)
Q Consensus       503 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~  582 (982)
                      +++|++|+|++|+                  ++++|++.+.+|..+.++++|+.|+|++|+| +.+|..+.  ++|+.||
T Consensus       535 l~~L~~L~Ls~N~------------------~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l-~~ip~~~~--~~L~~L~  593 (636)
T 4eco_A          535 SSTLKGFGIRNQR------------------DAQGNRTLREWPEGITLCPSLTQLQIGSNDI-RKVNEKIT--PNISVLD  593 (636)
T ss_dssp             CSSCCEEECCSCB------------------CTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--TTCCEEE
T ss_pred             CCCCCEEECCCCc------------------ccccCcccccChHHHhcCCCCCEEECCCCcC-CccCHhHh--CcCCEEE
Confidence            9999999997665                  4555666666666666666666666666666 35555544  5666666


Q ss_pred             ccCCcccc
Q 002010          583 LSYNNLIG  590 (982)
Q Consensus       583 Ls~N~l~~  590 (982)
                      |++|++..
T Consensus       594 Ls~N~l~~  601 (636)
T 4eco_A          594 IKDNPNIS  601 (636)
T ss_dssp             CCSCTTCE
T ss_pred             CcCCCCcc
Confidence            66665543

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=100.00  E-value=4.5e-57  Score=564.83  Aligned_cols=509  Identities=17%  Similarity=0.165  Sum_probs=316.7

Q ss_pred             ccccEEEeccCCCCCCCChhhhhhcccceeeccCCccccccchhhhhcCCCccEEeccCccccCCCchhccccccccEEe
Q 002010           95 TKLVNLTISNVNLTGRLPSEMALLTSLKVFNISGNVFQGNFAGQIVRGMTELQVLDAYNNNFTGPLPVEIASLKSLRHLS  174 (982)
Q Consensus        95 ~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~  174 (982)
                      ++|++|+|++|.+++..|..+.++++|++|+|++|.+.+.++...+.++++|++|+|++|++++..|..|+++++|++|+
T Consensus        24 ~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~  103 (844)
T 3j0a_A           24 NTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELR  103 (844)
T ss_dssp             TTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSCSCSSCCCEE
T ss_pred             CCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHccCCcccCEee
Confidence            45555555555555555555555555555555555444444444555555555555555555555555555555555555


Q ss_pred             ecCcccccccCCC--ccccCcceEeeccCcccccchh-hHHhhhhhHHHHhhcccccccccCCCCCCCC--CCCCEEecc
Q 002010          175 FGGNYFTGKIPQS--YSEIQSLEYIGLNGIGLNGTVP-AFLSRLKNLREMYIGYFNTYTGGIPPGFGAL--TQLQVLDMA  249 (982)
Q Consensus       175 L~~N~l~~~~p~~--~~~l~~L~~L~L~~n~i~~~~~-~~l~~l~~L~~L~l~~~n~~~~~~p~~~~~l--~~L~~L~L~  249 (982)
                      |++|.+++.+|..  |+++++|++|+|++|.+.+..+ ..++++++|++|+++. |.+.+..|..++.+  ++|+.|+++
T Consensus       104 Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~-N~i~~~~~~~l~~l~~~~L~~L~L~  182 (844)
T 3j0a_A          104 LYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSS-NQIFLVCEHELEPLQGKTLSFFSLA  182 (844)
T ss_dssp             CTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEES-SCCCCCCSGGGHHHHHCSSCCCEEC
T ss_pred             CcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCC-CcCCeeCHHHcccccCCccceEECC
Confidence            5555555544433  5555555555555555554433 3455555555555543 33444444445444  556666666


Q ss_pred             cCcCcccCchhhcCCCc------cceeecccccCCCCCCccccCC---CCCCEEEeeC---------CcccCcCchhhhc
Q 002010          250 SCNISGEIPTSLSRLKL------LHSLFLQMNKLTGHIPPQLSGL---ISLKSLDLSL---------NYLTGEIPESFAA  311 (982)
Q Consensus       250 ~n~l~~~~~~~l~~l~~------L~~L~L~~N~l~~~~~~~l~~l---~~L~~L~Ls~---------N~l~~~~~~~l~~  311 (982)
                      .|.+.+..|..++.+.+      |++|++++|++++..+..+...   .+++.|+++.         |.+.+..+..|..
T Consensus       183 ~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~~l~~~~~~~f~~  262 (844)
T 3j0a_A          183 ANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAG  262 (844)
T ss_dssp             CSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCSSSTTGGGTTTTT
T ss_pred             CCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceecccccccccccccccCCCChhhhhc
Confidence            66666555555544443      6666666666665555544432   4455565552         2333333334444


Q ss_pred             c--cchhhhhhccCCCCCCCCCcCCCCCCccEEEccCCCcccccCccccCCCcccEEEeccccccccCCccccCccccce
Q 002010          312 L--KNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDLCKGGKLKS  389 (982)
Q Consensus       312 l--~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~  389 (982)
                      +  ++|+.|++++|.+.+..|..|..+++|+.|+|++|.+++..|..+..+++|++|++++|++++..|..+..+++|++
T Consensus       263 l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~  342 (844)
T 3j0a_A          263 LARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAY  342 (844)
T ss_dssp             TTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCSCSCSSCTTCCE
T ss_pred             cccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccCHHHhcCCCCCCE
Confidence            3  56777777777777666777777777777777777777666677777777777777777777666777777777777


Q ss_pred             eecccccccccCCccccCCCCCCEEEccCCccCCCCCccccCCCccccccCCCccccccCCcccccCCccEEEeeccccC
Q 002010          390 LILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLSGELPEKMSGASLNQLKVANNNIT  469 (982)
Q Consensus       390 L~l~~N~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~L~~N~i~  469 (982)
                      |++++|.+.+..+..|..+++|++|+|++|.+++     +..+++|+.|++++|+++.. |..  ..+++.|++++|+++
T Consensus       343 L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~-----i~~~~~L~~L~l~~N~l~~l-~~~--~~~l~~L~ls~N~l~  414 (844)
T 3j0a_A          343 IDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTT-----IHFIPSIPDIFLSGNKLVTL-PKI--NLTANLIHLSENRLE  414 (844)
T ss_dssp             EECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCC-----CSSCCSCSEEEEESCCCCCC-CCC--CTTCCEEECCSCCCC
T ss_pred             EECCCCCCCccChhhhcCCCCCCEEECCCCCCCc-----ccCCCCcchhccCCCCcccc-ccc--ccccceeecccCccc
Confidence            7777777776666677777777777777777763     22266677777777777633 322  245777777777777


Q ss_pred             CCC-chhccCCCCcceeeeccccccCCCcc-ccccccccceeeeeccccC-----CCCCcccccccCCCeeeCCCCcccC
Q 002010          470 GKI-PAAIGNLPSLNILSLQNNRLEGEIPV-ESFNLKMITSINISDNNIS-----GEIPYSISQCHSLTSVDLSRNSLYG  542 (982)
Q Consensus       470 ~~~-p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~-----~~~p~~~~~l~~L~~L~Ls~N~l~~  542 (982)
                      +.. +..+.++++|++|+|++|++++..+. .+..+++|++|+|++|.++     +..+..|.++++|+.|+|++|+|++
T Consensus       415 ~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~  494 (844)
T 3j0a_A          415 NLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNS  494 (844)
T ss_dssp             SSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTT
T ss_pred             cCchhhhhhcCCccceeeCCCCcccccccccccccCCccccccCCCCccccccccccchhhhcCcccccEEECCCCcccc
Confidence            532 22345777777777777777754332 2445677777777777776     3444567777777777777777777


Q ss_pred             CCCcccccccccceEEcccccccccCccccccccccceecccCCccccCCCCCccccccccccccCCcCcccCC
Q 002010          543 KIPPGISKLIDLSILNLSRNGITGSIPNEMRNMMSLTTLDLSYNNLIGNIPSGGQFLAFNETSFIGNPNLCLLR  616 (982)
Q Consensus       543 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~~~~~~~~~~~~~~n~~~c~~~  616 (982)
                      ..|..|.++++|+.|+|++|+|++..|..+.  ++|+.|||++|+|++.+|..  +..+....+.|||+.|+++
T Consensus       495 ~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~~--~~~L~~l~l~~Np~~C~c~  564 (844)
T 3j0a_A          495 LPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNPDV--FVSLSVLDITHNKFICECE  564 (844)
T ss_dssp             CCTTSSSSCCSCSEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCCSCC--CSSCCEEEEEEECCCCSSS
T ss_pred             cChhHccchhhhheeECCCCCCCccChhhhh--ccccEEECCCCcCCCCChhH--hCCcCEEEecCCCcccccc
Confidence            7777777777777777777777766665555  67777777777777777743  4566666777777777554

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=100.00  E-value=2.3e-57  Score=549.22  Aligned_cols=491  Identities=19%  Similarity=0.141  Sum_probs=273.2

Q ss_pred             cccEEEeccCCCCCCCChhhhhhcccceeeccCCccccccchhhhhcCCCccEEeccCccccCCCchhccccccccEEee
Q 002010           96 KLVNLTISNVNLTGRLPSEMALLTSLKVFNISGNVFQGNFAGQIVRGMTELQVLDAYNNNFTGPLPVEIASLKSLRHLSF  175 (982)
Q Consensus        96 ~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L  175 (982)
                      ++++|+|++|++++..|..|.++++|++|+|++|.+.+. .+..|.++++|++|+|++|++++..|..++++++|++|+|
T Consensus        34 ~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~-~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L  112 (606)
T 3t6q_A           34 STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWI-HEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFF  112 (606)
T ss_dssp             TCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEE-CTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEEEC
T ss_pred             cCcEEEccCCccCcCChhHhccCccceEEECCCCcccee-ChhhccCccccCeeeCCCCcccccChhhhcccccccEeec
Confidence            566777777777666666667777777777777766543 2344566667777777777666666666666777777777


Q ss_pred             cCcccccccCCCccccCcceEeeccCcccccchhhHHhhhhhHHHHhhcccccccccCCCCCCCCCCCCEEecccCcCcc
Q 002010          176 GGNYFTGKIPQSYSEIQSLEYIGLNGIGLNGTVPAFLSRLKNLREMYIGYFNTYTGGIPPGFGALTQLQVLDMASCNISG  255 (982)
Q Consensus       176 ~~N~l~~~~p~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~l~~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~  255 (982)
                      ++|++++..|..|+++++|++|++++|.+.+..+..+                         ..+++|++|++++|.+++
T Consensus       113 ~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~-------------------------~~l~~L~~L~L~~n~l~~  167 (606)
T 3t6q_A          113 IQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKG-------------------------FPTEKLKVLDFQNNAIHY  167 (606)
T ss_dssp             TTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTT-------------------------CCCTTCCEEECCSSCCCE
T ss_pred             cccCcccCCcchhccCCcccEEECCCCcccccCcccc-------------------------cCCcccCEEEcccCcccc
Confidence            7777666656666666667777666666553221111                         123344444444444443


Q ss_pred             cCchhhcCCCccc--eeecccccCCCCCCccccCCCCCCEEEeeCCc---------------------c-----cCcCch
Q 002010          256 EIPTSLSRLKLLH--SLFLQMNKLTGHIPPQLSGLISLKSLDLSLNY---------------------L-----TGEIPE  307 (982)
Q Consensus       256 ~~~~~l~~l~~L~--~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~---------------------l-----~~~~~~  307 (982)
                      ..|..|+.+++|+  +|++++|++++..|..+.. .+|+.|++++|.                     +     ....+.
T Consensus       168 ~~~~~~~~l~~L~~l~L~l~~n~l~~~~~~~~~~-~~L~~L~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~  246 (606)
T 3t6q_A          168 LSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDS-AVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPA  246 (606)
T ss_dssp             ECHHHHHTTTTCCSEEEECTTCCCCEECTTTTTT-CEEEEEECTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGG
T ss_pred             cChhhhhhhcccceeEEecCCCccCccChhHhhh-ccccccccCCchhHHHHhhhccccchhheechhhccccccccChh
Confidence            3333344444443  3344444444333322222 233333333332                     0     001112


Q ss_pred             hhhccc--chhhhhhccCCCCCCCCCcCCCCCCccEEEccCCCcccccCccccCCCcccEEEeccccccccCCccccCcc
Q 002010          308 SFAALK--NLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDLCKGG  385 (982)
Q Consensus       308 ~l~~l~--~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~  385 (982)
                      .+..+.  +|+.|++++|.+++..+..|+.+++|++|++++|.++ .+|..+..+++|++|++++|++++..|..+..++
T Consensus       247 ~~~~l~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~  325 (606)
T 3t6q_A          247 VFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFP  325 (606)
T ss_dssp             GGGGGGGSEEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCT
T ss_pred             HhchhhcCceeEEEeecCccCccCHHHhccccCCCEEeccCCccC-CCChhhcccccCCEEECccCCcCcCchhhhhccC
Confidence            222222  4555666666666555555666666666666666655 4555555566666666666666655555556666


Q ss_pred             ccceeecccccccccCCc-cccCCCCCCEEEccCCccCCCC--CccccCCCccccccCCCccccccCCccccc-CCccEE
Q 002010          386 KLKSLILMQNFFIGPIPE-ELGQCKSLTKIRFSKNYLNGTI--PAGLFNLPLLNMMELDDNLLSGELPEKMSG-ASLNQL  461 (982)
Q Consensus       386 ~L~~L~l~~N~~~~~~~~-~l~~l~~L~~L~Ls~N~l~~~~--p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~-~~L~~L  461 (982)
                      +|++|++++|.+.+.+|. .+..+++|++|++++|++++..  +..+..+++|++|++++|.+.+..+..+.. ++|++|
T Consensus       326 ~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L  405 (606)
T 3t6q_A          326 SLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELL  405 (606)
T ss_dssp             TCSEEECCSCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEE
T ss_pred             cCCEEECCCCCcccccchhhhhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeE
Confidence            666666666655544433 3555666666666666665443  555556666666666666665555554443 456666


Q ss_pred             EeeccccCCCCch-hccCCCCcceeeeccccccCCCccccccccccceeeeeccccCCC---CCcccccccCCCeeeCCC
Q 002010          462 KVANNNITGKIPA-AIGNLPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNISGE---IPYSISQCHSLTSVDLSR  537 (982)
Q Consensus       462 ~L~~N~i~~~~p~-~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~---~p~~~~~l~~L~~L~Ls~  537 (982)
                      ++++|++++..|. .+..+++|++|++++|++++..|..+..+++|++|++++|++++.   .+..+..+++|+.|+|++
T Consensus       406 ~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~  485 (606)
T 3t6q_A          406 DLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSF  485 (606)
T ss_dssp             ECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTT
T ss_pred             ECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCC
Confidence            6666666554433 255666666666666666655555555666666666666666541   224455666666666666


Q ss_pred             CcccCCCCcccccccccceEEcccccccccCccccccccccceecccCCccccCCCCC-ccccccccccccCCcCcccC
Q 002010          538 NSLYGKIPPGISKLIDLSILNLSRNGITGSIPNEMRNMMSLTTLDLSYNNLIGNIPSG-GQFLAFNETSFIGNPNLCLL  615 (982)
Q Consensus       538 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~-~~~~~~~~~~~~~n~~~c~~  615 (982)
                      |++++..|..|.++++|+.|+|++|++++..|..+..+++| +|+|++|++++.+|.. ..+.++....+.|||+.|++
T Consensus       486 n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c  563 (606)
T 3t6q_A          486 CDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTC  563 (606)
T ss_dssp             SCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECSG
T ss_pred             CccCccChhhhccccCCCEEECCCCccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCccccC
Confidence            66665555666666666666666666666666666666666 6666666666555542 23344555555666666643

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=100.00  E-value=6.2e-57  Score=552.20  Aligned_cols=500  Identities=21%  Similarity=0.271  Sum_probs=282.2

Q ss_pred             cCchhHHHHHHHHHhcccCCCCCCCCCCCCCC----CCCCCCcc------------ceeeeCCCCCEEEEEeccCCcccc
Q 002010           23 SCAYSDMDVLLKLKSSMIGPKGSGLKNWEPSS----SPSAHCSF------------SGVTCDQDSRVVSLNVSFMPLFGS   86 (982)
Q Consensus        23 ~~~~~~~~~ll~~k~~~~~~~~~~~~~w~~~~----~~~~~C~w------------~gv~C~~~~~v~~l~l~~~~l~g~   86 (982)
                      ++..+|++||++||+++.+|      +|+.+.    ..+++|.|            .||+|+..+||++|+|+++++.|.
T Consensus       265 ~~~~~d~~ALl~~k~~l~~~------~W~~~~~~~~~~~~~C~W~~~~~~~~w~~~~GV~C~~~~~V~~L~Ls~~~L~G~  338 (876)
T 4ecn_A          265 AEYIKDYKALKAIWEALDGK------NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGR  338 (876)
T ss_dssp             CHHHHHHHHHHHHHHHTTGG------GCCCCCSSCSSCCCCCSCCCSSCGGGTTCCTTEEECTTSCEEEEECTTTCCEEE
T ss_pred             ccchHHHHHHHHHHHHcCCC------CCCcCCCcccccCCccccccccccccccCcCceEecCCCCEEEEECccCCCCCc
Confidence            34567999999999999765      676543    23345999            999999889999999999999999


Q ss_pred             CCcCccccccccEEEe-ccCCCCCCCChhhhhh---------cccceeec-------cCCccccccchhh----------
Q 002010           87 IPPEIGLLTKLVNLTI-SNVNLTGRLPSEMALL---------TSLKVFNI-------SGNVFQGNFAGQI----------  139 (982)
Q Consensus        87 ~~~~i~~l~~L~~L~l-~~n~l~~~~p~~l~~l---------~~L~~L~L-------s~n~l~~~~~~~~----------  139 (982)
                      +|++++.|++|+.|+| ++|.+.|..|......         ..++...+       ....+.+.....+          
T Consensus       339 ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~~~~i~  418 (876)
T 4ecn_A          339 VPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIK  418 (876)
T ss_dssp             ECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTTSCCCC
T ss_pred             CchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCccccccc
Confidence            9999999999999999 8898877644221100         00000000       0000000000000          


Q ss_pred             hhcCCCccEEeccC--ccccCCCchhccccccccEEeecCccccc-----------------ccCCCcc--ccCcceEee
Q 002010          140 VRGMTELQVLDAYN--NNFTGPLPVEIASLKSLRHLSFGGNYFTG-----------------KIPQSYS--EIQSLEYIG  198 (982)
Q Consensus       140 ~~~l~~L~~L~Ls~--n~l~~~~p~~l~~l~~L~~L~L~~N~l~~-----------------~~p~~~~--~l~~L~~L~  198 (982)
                      ......++.+.+..  |++++ +|..++++++|++|+|++|+|++                 .+|..++  ++++|++|+
T Consensus       419 ~~~~l~l~~l~l~~~~N~L~~-IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~  497 (876)
T 4ecn_A          419 KDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVE  497 (876)
T ss_dssp             CCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEE
T ss_pred             cccccchhhceeccccCcccc-hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEE
Confidence            00111222222322  55554 55555555555555555555555                 2555554  555555555


Q ss_pred             ccCcccccchhhHHhhhhhHHHHhhcccccccccCCCCCCCCCCCCEEecccCc-Ccc-cCchhhcCCC-------ccce
Q 002010          199 LNGIGLNGTVPAFLSRLKNLREMYIGYFNTYTGGIPPGFGALTQLQVLDMASCN-ISG-EIPTSLSRLK-------LLHS  269 (982)
Q Consensus       199 L~~n~i~~~~~~~l~~l~~L~~L~l~~~n~~~~~~p~~~~~l~~L~~L~L~~n~-l~~-~~~~~l~~l~-------~L~~  269 (982)
                      |++|.+.+.+|                         ..|+++++|++|+|++|+ +++ .+|..+++++       +|++
T Consensus       498 Ls~N~l~~~iP-------------------------~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~  552 (876)
T 4ecn_A          498 LYNCPNMTQLP-------------------------DFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQI  552 (876)
T ss_dssp             EESCTTCCSCC-------------------------GGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCE
T ss_pred             CcCCCCCccCh-------------------------HHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccE
Confidence            55555443322                         223334444445555554 444 4444443333       5555


Q ss_pred             eecccccCCCCCCc--cccCCCCCCEEEeeCCcccCcCchhhhcccchhhhhhccCCCCCCCCCcCCCCCC-ccEEEccC
Q 002010          270 LFLQMNKLTGHIPP--QLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQLFKNNLRGPIPSFLGDFPN-LEVLQVWG  346 (982)
Q Consensus       270 L~L~~N~l~~~~~~--~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~-L~~L~L~~  346 (982)
                      |+|++|+++ .+|.  .++.+++|+.|+|++|+++ .+| .|..+++|+.|+|++|+++ .+|..+..+++ |+.|++++
T Consensus       553 L~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~  628 (876)
T 4ecn_A          553 FYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSH  628 (876)
T ss_dssp             EECCSSCCC-BCCCHHHHTTCTTCCEEECTTSCCC-BCC-CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCS
T ss_pred             EEeeCCcCC-ccCChhhhhcCCCCCEEECCCCCcc-cch-hhcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcC
Confidence            555555555 4444  4555555555555555555 444 4555555555555555555 44555555555 55555555


Q ss_pred             CCcccccCccccCCCc--ccEEEeccccccccCCccc---c--CccccceeecccccccccCCccccCCCCCCEEEccCC
Q 002010          347 NNFTFELPENLGRNGK--LLILDVTSNHLTGTIPRDL---C--KGGKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKN  419 (982)
Q Consensus       347 N~l~~~~~~~l~~l~~--L~~L~L~~N~l~~~~p~~~---~--~~~~L~~L~l~~N~~~~~~~~~l~~l~~L~~L~Ls~N  419 (982)
                      |.++ .+|..+..+..  |+.|++++|++++.+|...   .  .+.+|+.|++++|.+....+..+..+++|+.|+|++|
T Consensus       629 N~L~-~lp~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~~lp~~~~~~l~~L~~L~Ls~N  707 (876)
T 4ecn_A          629 NKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNN  707 (876)
T ss_dssp             SCCC-SCCSCCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCCSCCHHHHHTTCCCSEEECCSC
T ss_pred             CCCC-cCchhhhccccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCCccCHHHHccCCCCCEEECCCC
Confidence            5555 44444444432  5555555555555444322   1  2346777777777776333333447788888888888


Q ss_pred             ccCCCCCccccCCC--------ccccccCCCccccccCCcccccCCccEEEeeccccCCCCchhcc--CCCCcceeeecc
Q 002010          420 YLNGTIPAGLFNLP--------LLNMMELDDNLLSGELPEKMSGASLNQLKVANNNITGKIPAAIG--NLPSLNILSLQN  489 (982)
Q Consensus       420 ~l~~~~p~~~~~l~--------~L~~L~L~~N~l~~~~~~~~~~~~L~~L~L~~N~i~~~~p~~~~--~l~~L~~L~L~~  489 (982)
                      +++ .+|..+....        +|+.|+|++|++                       + .+|..+.  .+++|+.|+|++
T Consensus       708 ~L~-~ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L-----------------------~-~lp~~l~~~~l~~L~~L~Ls~  762 (876)
T 4ecn_A          708 LMT-SIPENSLKPKDGNYKNTYLLTTIDLRFNKL-----------------------T-SLSDDFRATTLPYLSNMDVSY  762 (876)
T ss_dssp             CCS-CCCTTSSSCTTSCCTTGGGCCEEECCSSCC-----------------------C-CCCGGGSTTTCTTCCEEECCS
T ss_pred             cCC-ccChHHhccccccccccCCccEEECCCCCC-----------------------c-cchHHhhhccCCCcCEEEeCC
Confidence            887 6666554322        444444444444                       4 3444444  555555555555


Q ss_pred             ccccCCCccccccccccceeeeec------cccCCCCCcccccccCCCeeeCCCCcccCCCCcccccccccceEEccccc
Q 002010          490 NRLEGEIPVESFNLKMITSINISD------NNISGEIPYSISQCHSLTSVDLSRNSLYGKIPPGISKLIDLSILNLSRNG  563 (982)
Q Consensus       490 N~l~~~~p~~~~~l~~L~~L~Ls~------N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~  563 (982)
                      |++++ +|..+..+++|+.|+|++      |++.+.+|..|.++++|+.|+|++|+| +.+|..+.  ++|+.|+|++|+
T Consensus       763 N~L~~-lp~~l~~L~~L~~L~Ls~N~~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~l~--~~L~~LdLs~N~  838 (876)
T 4ecn_A          763 NCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKLT--PQLYILDIADNP  838 (876)
T ss_dssp             SCCSS-CCCGGGGCTTCCEEECCCCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--SSSCEEECCSCT
T ss_pred             CCCCc-cchhhhcCCCCCEEECCCCCCcccccccccChHHHhcCCCCCEEECCCCCC-CccCHhhc--CCCCEEECCCCC
Confidence            55554 455555555555555554      666666666666667777777777766 46666554  466666666666


Q ss_pred             ccccCccccccccccceecccCCcc
Q 002010          564 ITGSIPNEMRNMMSLTTLDLSYNNL  588 (982)
Q Consensus       564 l~~~~p~~l~~l~~L~~L~Ls~N~l  588 (982)
                      +....+..+.....+..+.|.+|++
T Consensus       839 l~~i~~~~~~~~~~~~~~~L~~n~~  863 (876)
T 4ecn_A          839 NISIDVTSVCPYIEAGMYVLLYDKT  863 (876)
T ss_dssp             TCEEECGGGHHHHHTTCCEEECCTT
T ss_pred             CCccChHHccccccchheeecCCCc
Confidence            6655555555555555555555543

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=100.00  E-value=6.1e-56  Score=544.10  Aligned_cols=522  Identities=22%  Similarity=0.236  Sum_probs=459.8

Q ss_pred             CCEEEEEeccCCccccCCcCccccccccEEEeccCCCCCCCChhhhhhcccceeeccCCccccccchhhhhcCCCccEEe
Q 002010           71 SRVVSLNVSFMPLFGSIPPEIGLLTKLVNLTISNVNLTGRLPSEMALLTSLKVFNISGNVFQGNFAGQIVRGMTELQVLD  150 (982)
Q Consensus        71 ~~v~~l~l~~~~l~g~~~~~i~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~  150 (982)
                      .++..|+++++.+.+..|..++.+++|++|+|++|++++..+..++.+++|++|+|++|.+.+ ++...+.++++|++|+
T Consensus        49 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~  127 (680)
T 1ziw_A           49 SQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQK-IKNNPFVKQKNLITLD  127 (680)
T ss_dssp             TTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCC-CCSCTTTTCTTCCEEE
T ss_pred             CcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEECCCCccCc-cChhHccccCCCCEEE
Confidence            468899999999999888889999999999999999997666689999999999999999975 4445678899999999


Q ss_pred             ccCccccCCCchhccccccccEEeecCcccccccCCCcc--ccCcceEeeccCcccccchhhHHhhhhhH----------
Q 002010          151 AYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSYS--EIQSLEYIGLNGIGLNGTVPAFLSRLKNL----------  218 (982)
Q Consensus       151 Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~l~~L~~L~L~~n~i~~~~~~~l~~l~~L----------  218 (982)
                      |++|.+++..|..++++++|++|+|++|.+++..+..++  .+++|++|++++|.+.+..|..+..+.+|          
T Consensus       128 Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~~~l  207 (680)
T 1ziw_A          128 LSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQL  207 (680)
T ss_dssp             CCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHHHHGGGTTCEESEEECTTCCCCCBCTTGGGGSSEECEEECTTCCC
T ss_pred             CCCCcccccCchhhcccccCCEEEccCCcccccCHHHhhccccccccEEECCCCcccccChhhhhhhhhhhhhhcccccc
Confidence            999999998999999999999999999999988777665  45899999999999998888887766554          


Q ss_pred             -----------------HHHhhcccccccccCCCCCCCCCC--CCEEecccCcCcccCchhhcCCCccceeecccccCCC
Q 002010          219 -----------------REMYIGYFNTYTGGIPPGFGALTQ--LQVLDMASCNISGEIPTSLSRLKLLHSLFLQMNKLTG  279 (982)
Q Consensus       219 -----------------~~L~l~~~n~~~~~~p~~~~~l~~--L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~  279 (982)
                                       ++|++++ +.+.+..|..|.+++.  |++|++++|++++..|..|+.+++|++|++++|++++
T Consensus       208 ~~~~~~~~~~~l~~~~L~~L~L~~-n~l~~~~~~~~~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~  286 (680)
T 1ziw_A          208 GPSLTEKLCLELANTSIRNLSLSN-SQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQH  286 (680)
T ss_dssp             HHHHHHHHHHHHTTSCCCEEECTT-SCCCEECTTTTGGGGGSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSCCBSE
T ss_pred             ChhhHHHHHHHhhhccccEEEccC-CcccccChhHhhccCcCCCCEEECCCCCcCccCcccccCcccccEeeCCCCccCc
Confidence                             4555554 4566777888988865  9999999999999999999999999999999999999


Q ss_pred             CCCccccCCCCCCEEEeeCCcccCc-----Cc----hhhhcccchhhhhhccCCCCCCCCCcCCCCCCccEEEccCCCcc
Q 002010          280 HIPPQLSGLISLKSLDLSLNYLTGE-----IP----ESFAALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFT  350 (982)
Q Consensus       280 ~~~~~l~~l~~L~~L~Ls~N~l~~~-----~~----~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~  350 (982)
                      ..|..+.++++|++|++++|...+.     +|    ..|..+++|++|++++|++.+..+..|.++++|++|++++|.+.
T Consensus       287 ~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~  366 (680)
T 1ziw_A          287 LFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTS  366 (680)
T ss_dssp             ECTTTTTTCTTCCEEECTTCBCCC------CCEECTTTTTTCTTCCEEECCSCCBCCCCTTTTTTCTTCCEEECTTCBSC
T ss_pred             cChhhhcCCCCccEEeccchhhhcccccccccccChhhcccCCCCCEEECCCCccCCCChhHhccccCCcEEECCCCchh
Confidence            9999999999999999998876542     23    27888999999999999999999999999999999999999865


Q ss_pred             cc--cCccccC--CCcccEEEeccccccccCCccccCccccceeecccccccccCC-ccccCCCCCCEEEccCCccCCCC
Q 002010          351 FE--LPENLGR--NGKLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFIGPIP-EELGQCKSLTKIRFSKNYLNGTI  425 (982)
Q Consensus       351 ~~--~~~~l~~--l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~l~~N~~~~~~~-~~l~~l~~L~~L~Ls~N~l~~~~  425 (982)
                      ..  ....+..  .++|+.|++++|++++..|..+..+++|++|++++|.+.+.+| ..+.++++|++|++++|++++..
T Consensus       367 ~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~  446 (680)
T 1ziw_A          367 LRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLT  446 (680)
T ss_dssp             CCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECC
T ss_pred             hhhcchhhhcccccCcCceEECCCCCCCeEChhhhhCCCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeC
Confidence            32  2233433  3689999999999999999999999999999999999998766 78999999999999999999888


Q ss_pred             CccccCCCccccccCCCcccc--ccCCccccc-CCccEEEeeccccCCCCchhccCCCCcceeeeccccccCCCc-----
Q 002010          426 PAGLFNLPLLNMMELDDNLLS--GELPEKMSG-ASLNQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIP-----  497 (982)
Q Consensus       426 p~~~~~l~~L~~L~L~~N~l~--~~~~~~~~~-~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-----  497 (982)
                      +..|..++.|+.|++++|.+.  +..|..+.. .+|+.|++++|++++..+..|.++++|++|++++|++++..+     
T Consensus       447 ~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~  526 (680)
T 1ziw_A          447 RNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPG  526 (680)
T ss_dssp             TTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTT
T ss_pred             hhhhhcCcccccchhccccccccccCCcccccCCCCCEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccC
Confidence            999999999999999999987  456666655 789999999999999888899999999999999999985321     


Q ss_pred             ---cccccccccceeeeeccccCCCCCcccccccCCCeeeCCCCcccCCCCcccccccccceEEcccccccccCccccc-
Q 002010          498 ---VESFNLKMITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYGKIPPGISKLIDLSILNLSRNGITGSIPNEMR-  573 (982)
Q Consensus       498 ---~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~-  573 (982)
                         ..+..+++|++|+|++|+++...+..|.++++|+.|+|++|+|++..+..|.++++|+.|+|++|+|++..|..+. 
T Consensus       527 ~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~  606 (680)
T 1ziw_A          527 GPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGP  606 (680)
T ss_dssp             SCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHH
T ss_pred             CcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcc
Confidence               2378899999999999999966566799999999999999999977777889999999999999999998888887 


Q ss_pred             cccccceecccCCccccCCCC
Q 002010          574 NMMSLTTLDLSYNNLIGNIPS  594 (982)
Q Consensus       574 ~l~~L~~L~Ls~N~l~~~ip~  594 (982)
                      .+++|+.|++++|++.+..+.
T Consensus       607 ~~~~L~~l~l~~N~~~c~c~~  627 (680)
T 1ziw_A          607 AFRNLTELDMRFNPFDCTCES  627 (680)
T ss_dssp             HHTTCSEEECTTCCCCBCCCC
T ss_pred             cccccCEEEccCCCcccCCcc
Confidence            899999999999999988764

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=100.00  E-value=4.4e-56  Score=537.98  Aligned_cols=464  Identities=19%  Similarity=0.155  Sum_probs=403.1

Q ss_pred             ccceeeccCCccccccchhhhhcCCCccEEeccCccccCCCchhccccccccEEeecCcccccccCCCccccCcceEeec
Q 002010          120 SLKVFNISGNVFQGNFAGQIVRGMTELQVLDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGL  199 (982)
Q Consensus       120 ~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L  199 (982)
                      ++++|+|++|.+++.. ...+.++++|++|+|++|++++..|..|+++++|++|+|++|++++..|..|+++++|++|++
T Consensus        34 ~l~~L~Ls~n~i~~~~-~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L  112 (606)
T 3t6q_A           34 STECLEFSFNVLPTIQ-NTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFF  112 (606)
T ss_dssp             TCCEEECTTCCCSEEC-TTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEEEC
T ss_pred             cCcEEEccCCccCcCC-hhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhcccccccEeec
Confidence            6899999999998644 456789999999999999999888999999999999999999999999999999999999999


Q ss_pred             cCcccccchhhHHhhhhhHHHHhhcccccccccCCCCCCCCCCCCEEecccCcCcccCchhhcCCCccceeecccccCCC
Q 002010          200 NGIGLNGTVPAFLSRLKNLREMYIGYFNTYTGGIPPGFGALTQLQVLDMASCNISGEIPTSLSRLKLLHSLFLQMNKLTG  279 (982)
Q Consensus       200 ~~n~i~~~~~~~l~~l~~L~~L~l~~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~  279 (982)
                      ++|.+.+.                         .|..++++++|++|++++|++++..+..+..+++|++|++++|++++
T Consensus       113 ~~n~i~~l-------------------------~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~  167 (606)
T 3t6q_A          113 IQTGISSI-------------------------DFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHY  167 (606)
T ss_dssp             TTSCCSCG-------------------------GGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCE
T ss_pred             cccCcccC-------------------------CcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccc
Confidence            99877632                         23457888999999999999997554556669999999999999998


Q ss_pred             CCCccccCCCCCC--EEEeeCCcccCcCchhhhcccchhhhhhccCCC--------------------------CCCCCC
Q 002010          280 HIPPQLSGLISLK--SLDLSLNYLTGEIPESFAALKNLTLLQLFKNNL--------------------------RGPIPS  331 (982)
Q Consensus       280 ~~~~~l~~l~~L~--~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l--------------------------~~~~p~  331 (982)
                      ..+..++.+++|+  .|++++|.+++..|..+.. .+|+.|++++|..                          ....+.
T Consensus       168 ~~~~~~~~l~~L~~l~L~l~~n~l~~~~~~~~~~-~~L~~L~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~  246 (606)
T 3t6q_A          168 LSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDS-AVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPA  246 (606)
T ss_dssp             ECHHHHHTTTTCCSEEEECTTCCCCEECTTTTTT-CEEEEEECTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGG
T ss_pred             cChhhhhhhcccceeEEecCCCccCccChhHhhh-ccccccccCCchhHHHHhhhccccchhheechhhccccccccChh
Confidence            8888999999999  9999999999888877654 5788888887641                          011122


Q ss_pred             cCCCCC--CccEEEccCCCcccccCccccCCCcccEEEeccccccccCCccccCccccceeecccccccccCCccccCCC
Q 002010          332 FLGDFP--NLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFIGPIPEELGQCK  409 (982)
Q Consensus       332 ~~~~l~--~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~l~~N~~~~~~~~~l~~l~  409 (982)
                      .+..+.  +|+.|++++|.+++..+..+..+++|++|++++|+++ .+|..+..+++|++|++++|.+.+..|..+..++
T Consensus       247 ~~~~l~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~  325 (606)
T 3t6q_A          247 VFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFP  325 (606)
T ss_dssp             GGGGGGGSEEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCT
T ss_pred             HhchhhcCceeEEEeecCccCccCHHHhccccCCCEEeccCCccC-CCChhhcccccCCEEECccCCcCcCchhhhhccC
Confidence            233332  7999999999999888888999999999999999999 8899999999999999999999999999999999


Q ss_pred             CCCEEEccCCccCCCCCcc-ccCCCccccccCCCccccccC--Cccccc-CCccEEEeeccccCCCCchhccCCCCccee
Q 002010          410 SLTKIRFSKNYLNGTIPAG-LFNLPLLNMMELDDNLLSGEL--PEKMSG-ASLNQLKVANNNITGKIPAAIGNLPSLNIL  485 (982)
Q Consensus       410 ~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~L~~N~l~~~~--~~~~~~-~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L  485 (982)
                      +|++|++++|.+.+.+|.. +..+++|++|++++|.+++..  +..+.. ++|++|++++|++++..|..|..+++|++|
T Consensus       326 ~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L  405 (606)
T 3t6q_A          326 SLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELL  405 (606)
T ss_dssp             TCSEEECCSCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEE
T ss_pred             cCCEEECCCCCcccccchhhhhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeE
Confidence            9999999999999877765 889999999999999999875  544443 789999999999999999999999999999


Q ss_pred             eeccccccCCCccc-cccccccceeeeeccccCCCCCcccccccCCCeeeCCCCcccCC---CCcccccccccceEEccc
Q 002010          486 SLQNNRLEGEIPVE-SFNLKMITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYGK---IPPGISKLIDLSILNLSR  561 (982)
Q Consensus       486 ~L~~N~l~~~~p~~-~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~---~p~~~~~l~~L~~L~Ls~  561 (982)
                      ++++|++++..|.. +..+++|++|++++|++++..|..+..+++|++|+|++|++++.   .+..+..+++|+.|+|++
T Consensus       406 ~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~  485 (606)
T 3t6q_A          406 DLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSF  485 (606)
T ss_dssp             ECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTT
T ss_pred             ECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCC
Confidence            99999999876654 88999999999999999999999999999999999999999873   346799999999999999


Q ss_pred             ccccccCccccccccccceecccCCccccCCCCC-ccccccccccccCCcCc
Q 002010          562 NGITGSIPNEMRNMMSLTTLDLSYNNLIGNIPSG-GQFLAFNETSFIGNPNL  612 (982)
Q Consensus       562 N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~-~~~~~~~~~~~~~n~~~  612 (982)
                      |++++..|..|..+++|+.|+|++|++++.+|.. ..+..+ ...+.+|...
T Consensus       486 n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~  536 (606)
T 3t6q_A          486 CDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHIS  536 (606)
T ss_dssp             SCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCCC
T ss_pred             CccCccChhhhccccCCCEEECCCCccCcCChhHhCccccc-EEECcCCccc
Confidence            9999999999999999999999999999988753 223344 4455666443

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=100.00  E-value=1e-55  Score=534.84  Aligned_cols=517  Identities=19%  Similarity=0.187  Sum_probs=408.5

Q ss_pred             cCCcCccccccccEEEeccCCCCCCCChhhhhhcccceeeccCCccccccchhhhhcCCCccEEeccCccccCCCchhcc
Q 002010           86 SIPPEIGLLTKLVNLTISNVNLTGRLPSEMALLTSLKVFNISGNVFQGNFAGQIVRGMTELQVLDAYNNNFTGPLPVEIA  165 (982)
Q Consensus        86 ~~~~~i~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~l~  165 (982)
                      .+|..+.  +++++|+|++|++++..+..+.++++|++|+|++|.+++.. +..|.++++|++|+|++|++++..|..|+
T Consensus        25 ~ip~~~~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~-~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~  101 (606)
T 3vq2_A           25 KVPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIE-DKAWHGLHHLSNLILTGNPIQSFSPGSFS  101 (606)
T ss_dssp             SCCTTSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEEC-TTTTTTCTTCCEEECTTCCCCCCCTTSST
T ss_pred             cCCCCCC--CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccC-HHHhhchhhcCEeECCCCcccccChhhcC
Confidence            5676554  78999999999999888889999999999999999998544 45678899999999999999988899999


Q ss_pred             ccccccEEeecCcccccccCCCccccCcceEeeccCccccc-chhhHHhhhhhHHHHhhcccccccccCCCCCCCCCCCC
Q 002010          166 SLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLNGIGLNG-TVPAFLSRLKNLREMYIGYFNTYTGGIPPGFGALTQLQ  244 (982)
Q Consensus       166 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~i~~-~~~~~l~~l~~L~~L~l~~~n~~~~~~p~~~~~l~~L~  244 (982)
                      ++++|++|+|++|++++..+..|+++++|++|++++|.+.+ .+|..++++++|++|++++ |.+++..|..|+.+++|+
T Consensus       102 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~-n~l~~~~~~~~~~l~~L~  180 (606)
T 3vq2_A          102 GLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSY-NYIQTITVNDLQFLRENP  180 (606)
T ss_dssp             TCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCS-SCCCEECTTTTHHHHHCT
T ss_pred             CcccCCEEEccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccC-CcceecChhhhhhhhccc
Confidence            99999999999999998888889999999999999999986 5688888898999888886 566667777788777665


Q ss_pred             ----EEecccCcCcccCchhhcCCCccceeecccccCC-CCCCccccCCCCCCEEEeeCCcccCc------Cchhhhccc
Q 002010          245 ----VLDMASCNISGEIPTSLSRLKLLHSLFLQMNKLT-GHIPPQLSGLISLKSLDLSLNYLTGE------IPESFAALK  313 (982)
Q Consensus       245 ----~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~-~~~~~~l~~l~~L~~L~Ls~N~l~~~------~~~~l~~l~  313 (982)
                          +|++++|.+++..+..+... +|++|++++|.++ +..|..+.++++|+.+++..+.+.+.      .+..+..+.
T Consensus       181 ~~l~~L~l~~n~l~~~~~~~~~~~-~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~~~~~~~l~  259 (606)
T 3vq2_A          181 QVNLSLDMSLNPIDFIQDQAFQGI-KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLC  259 (606)
T ss_dssp             TCCCEEECTTCCCCEECTTTTTTC-EEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCGGGGTTGG
T ss_pred             cccceeeccCCCcceeCcccccCc-eeeeeeccCCccchhHHHHHhccccccccccccccccccCCcccccChHHhhhhh
Confidence                79999999987666666554 8999999999887 45667788888888888865544321      112222222


Q ss_pred             --chhhhhh-ccCCCCCCCCCcCCCCCCccEEEccCCCcccccCccccCCCcccEEEeccccccccCCccccCcccccee
Q 002010          314 --NLTLLQL-FKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDLCKGGKLKSL  390 (982)
Q Consensus       314 --~L~~L~L-~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L  390 (982)
                        .++.+++ ..|.+.+.+|. +..+++|+.|++++|.+.. +| .+..+++|+.|++++|++ +.+| .+ .+++|++|
T Consensus       260 ~l~l~~l~l~~~~~~~~~~~~-~~~l~~L~~L~l~~~~~~~-l~-~l~~~~~L~~L~l~~n~l-~~lp-~~-~l~~L~~L  333 (606)
T 3vq2_A          260 DVTIDEFRLTYTNDFSDDIVK-FHCLANVSAMSLAGVSIKY-LE-DVPKHFKWQSLSIIRCQL-KQFP-TL-DLPFLKSL  333 (606)
T ss_dssp             GSEEEEEEECCCTTCCGGGGS-CGGGTTCSEEEEESCCCCC-CC-CCCTTCCCSEEEEESCCC-SSCC-CC-CCSSCCEE
T ss_pred             hccHhheeccccccccccccc-cccCCCCCEEEecCccchh-hh-hccccccCCEEEcccccC-cccc-cC-CCCcccee
Confidence              3444555 66777777776 7888888888888888864 44 777888888888888888 5777 44 88888888


Q ss_pred             ecccccccccCCccccCCCCCCEEEccCCccCCC--CCccccCCCccccccCCCccccccCCcccccCCccEEEeecccc
Q 002010          391 ILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGT--IPAGLFNLPLLNMMELDDNLLSGELPEKMSGASLNQLKVANNNI  468 (982)
Q Consensus       391 ~l~~N~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~--~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~L~~N~i  468 (982)
                      ++++|...+..  .+..+++|++|++++|++++.  +|..+..+++|++|++++|.+++.........+|+.|++++|++
T Consensus       334 ~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~l~~L~~L~l~~n~l  411 (606)
T 3vq2_A          334 TLTMNKGSISF--KKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAIIMSANFMGLEELQHLDFQHSTL  411 (606)
T ss_dssp             EEESCSSCEEC--CCCCCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEEEECCCCTTCTTCCEEECTTSEE
T ss_pred             eccCCcCccch--hhccCCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCccccchhhccCCCCCCeeECCCCcc
Confidence            88888655444  566788888888888888765  37778888888888888888876543333347788888888888


Q ss_pred             CCCCc-hhccCCCCcceeeeccccccCCCccccccccccceeeeeccccCC-CCCcccccccCCCeeeCCCCcccCCCCc
Q 002010          469 TGKIP-AAIGNLPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNISG-EIPYSISQCHSLTSVDLSRNSLYGKIPP  546 (982)
Q Consensus       469 ~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~  546 (982)
                      ++..| ..+..+++|++|++++|++++..|..+..+++|++|++++|++++ .+|..|+.+++|+.|+|++|++++..|.
T Consensus       412 ~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~  491 (606)
T 3vq2_A          412 KRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWG  491 (606)
T ss_dssp             ESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTT
T ss_pred             CCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChh
Confidence            87777 678888888888888888888788888888888888888888887 4677888888888888888888888888


Q ss_pred             ccccccccceEEcccccccccCccccccccccceecccCCccccCCCCC-cccc-ccccccccCCcCcccCC
Q 002010          547 GISKLIDLSILNLSRNGITGSIPNEMRNMMSLTTLDLSYNNLIGNIPSG-GQFL-AFNETSFIGNPNLCLLR  616 (982)
Q Consensus       547 ~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~-~~~~-~~~~~~~~~n~~~c~~~  616 (982)
                      .|.++++|+.|+|++|++++.+|..+..+++|++|||++|+++. +|.. ..+. .+....+.|||+.|+++
T Consensus       492 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~-~p~~~~~l~~~L~~l~l~~N~~~c~c~  562 (606)
T 3vq2_A          492 VFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIET-SKGILQHFPKSLAFFNLTNNSVACICE  562 (606)
T ss_dssp             TTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCCC-EESCGGGSCTTCCEEECCSCCCCCSST
T ss_pred             hhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCcc-cCHhHhhhcccCcEEEccCCCcccCCc
Confidence            88888888888888888888888888888888888888888884 4433 3333 36667778888888665

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=100.00  E-value=1.7e-54  Score=541.50  Aligned_cols=518  Identities=21%  Similarity=0.219  Sum_probs=453.9

Q ss_pred             CccceeeeCCCCCEEEEEeccCCccccCCcCccccccccEEEeccCCCCCCC-ChhhhhhcccceeeccCCccccccchh
Q 002010           60 CSFSGVTCDQDSRVVSLNVSFMPLFGSIPPEIGLLTKLVNLTISNVNLTGRL-PSEMALLTSLKVFNISGNVFQGNFAGQ  138 (982)
Q Consensus        60 C~w~gv~C~~~~~v~~l~l~~~~l~g~~~~~i~~l~~L~~L~l~~n~l~~~~-p~~l~~l~~L~~L~Ls~n~l~~~~~~~  138 (982)
                      |+|..|.+ -..++..|||+++.+.+..|..++.+++|++|+|++|+..+.+ |..+.++++|++|+|++|.+.+..+ .
T Consensus        14 ~~L~~vP~-lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p-~   91 (844)
T 3j0a_A           14 CNLTQVPQ-VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHP-D   91 (844)
T ss_dssp             CCSSCCCS-SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECT-T
T ss_pred             CCCCCCCC-CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCH-h
Confidence            57888888 5578999999999999999999999999999999999877777 7889999999999999999986544 5


Q ss_pred             hhhcCCCccEEeccCccccCCCchh--ccccccccEEeecCcccccccC-CCccccCcceEeeccCcccccchhhHHhhh
Q 002010          139 IVRGMTELQVLDAYNNNFTGPLPVE--IASLKSLRHLSFGGNYFTGKIP-QSYSEIQSLEYIGLNGIGLNGTVPAFLSRL  215 (982)
Q Consensus       139 ~~~~l~~L~~L~Ls~n~l~~~~p~~--l~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l  215 (982)
                      .+.++++|++|+|++|++++.+|..  ++++++|++|+|++|.+++..+ ..|+++++|++|++++|.+.+..+..+..+
T Consensus        92 ~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l  171 (844)
T 3j0a_A           92 AFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPL  171 (844)
T ss_dssp             SSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHH
T ss_pred             HccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccc
Confidence            6789999999999999999877776  9999999999999999998766 579999999999999999999999999988


Q ss_pred             --hhHHHHhhcccccccccCCCCCCCCCC------CCEEecccCcCcccCchhhcCC---Cccceeeccc---------c
Q 002010          216 --KNLREMYIGYFNTYTGGIPPGFGALTQ------LQVLDMASCNISGEIPTSLSRL---KLLHSLFLQM---------N  275 (982)
Q Consensus       216 --~~L~~L~l~~~n~~~~~~p~~~~~l~~------L~~L~L~~n~l~~~~~~~l~~l---~~L~~L~L~~---------N  275 (982)
                        ++|+.|+++. |.+.+..|..++.+++      |++|++++|++++..+..+...   ..++.|.++.         +
T Consensus       172 ~~~~L~~L~L~~-n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~  250 (844)
T 3j0a_A          172 QGKTLSFFSLAA-NSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFH  250 (844)
T ss_dssp             HHCSSCCCEECC-SBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCS
T ss_pred             cCCccceEECCC-CccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceeccccccccccccc
Confidence              8899999986 6677788887777766      9999999999998888777654   5678888773         3


Q ss_pred             cCCCCCCccccCC--CCCCEEEeeCCcccCcCchhhhcccchhhhhhccCCCCCCCCCcCCCCCCccEEEccCCCccccc
Q 002010          276 KLTGHIPPQLSGL--ISLKSLDLSLNYLTGEIPESFAALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFEL  353 (982)
Q Consensus       276 ~l~~~~~~~l~~l--~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~  353 (982)
                      .+.+..+..|.++  ++|+.|+|++|.+++..+..|..+++|+.|+|++|++++..|..|..+++|++|++++|.+++..
T Consensus       251 ~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~  330 (844)
T 3j0a_A          251 NIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELY  330 (844)
T ss_dssp             SSTTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCC
T ss_pred             ccCCCChhhhhccccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccC
Confidence            4444444556655  78999999999999888999999999999999999999999999999999999999999999888


Q ss_pred             CccccCCCcccEEEeccccccccCCccccCccccceeecccccccccCCccccCCCCCCEEEccCCccCCCCCccccCCC
Q 002010          354 PENLGRNGKLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGTIPAGLFNLP  433 (982)
Q Consensus       354 ~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~l~~N~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~  433 (982)
                      |..+..+++|+.|++++|++++..+..|..+++|++|++++|.+++.     ..+++|+.|++++|+++ .+|..   ..
T Consensus       331 ~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i-----~~~~~L~~L~l~~N~l~-~l~~~---~~  401 (844)
T 3j0a_A          331 SSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTI-----HFIPSIPDIFLSGNKLV-TLPKI---NL  401 (844)
T ss_dssp             SCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCCC-----SSCCSCSEEEEESCCCC-CCCCC---CT
T ss_pred             HHHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCcc-----cCCCCcchhccCCCCcc-ccccc---cc
Confidence            99999999999999999999988888899999999999999998743     33889999999999998 56654   45


Q ss_pred             ccccccCCCccccccCCccc--ccCCccEEEeeccccCCCCch-hccCCCCcceeeecccccc-----CCCccccccccc
Q 002010          434 LLNMMELDDNLLSGELPEKM--SGASLNQLKVANNNITGKIPA-AIGNLPSLNILSLQNNRLE-----GEIPVESFNLKM  505 (982)
Q Consensus       434 ~L~~L~L~~N~l~~~~~~~~--~~~~L~~L~L~~N~i~~~~p~-~~~~l~~L~~L~L~~N~l~-----~~~p~~~~~l~~  505 (982)
                      .++.|++++|.+++.....+  ..++|+.|+|++|++++..+. .+..+++|+.|+|++|.++     +..+..+..+++
T Consensus       402 ~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~  481 (844)
T 3j0a_A          402 TANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSH  481 (844)
T ss_dssp             TCCEEECCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCC
T ss_pred             ccceeecccCccccCchhhhhhcCCccceeeCCCCcccccccccccccCCccccccCCCCccccccccccchhhhcCccc
Confidence            78899999999997543322  347899999999999976554 4667899999999999997     444566889999


Q ss_pred             cceeeeeccccCCCCCcccccccCCCeeeCCCCcccCCCCcccccccccceEEcccccccccCccccccccccceecccC
Q 002010          506 ITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYGKIPPGISKLIDLSILNLSRNGITGSIPNEMRNMMSLTTLDLSY  585 (982)
Q Consensus       506 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~  585 (982)
                      |++|+|++|+|++..|..|.++++|+.|+|++|+|++..|..+.  ++|+.|+|++|+|++.+|..|   .+|+.|++++
T Consensus       482 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~~~---~~L~~l~l~~  556 (844)
T 3j0a_A          482 LQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNPDVF---VSLSVLDITH  556 (844)
T ss_dssp             EECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCCSCCC---SSCCEEEEEE
T ss_pred             ccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhh--ccccEEECCCCcCCCCChhHh---CCcCEEEecC
Confidence            99999999999999999999999999999999999987777776  899999999999999999775   4789999999


Q ss_pred             CccccCCCC
Q 002010          586 NNLIGNIPS  594 (982)
Q Consensus       586 N~l~~~ip~  594 (982)
                      |++.+..+.
T Consensus       557 Np~~C~c~~  565 (844)
T 3j0a_A          557 NKFICECEL  565 (844)
T ss_dssp             ECCCCSSSC
T ss_pred             CCccccccc
Confidence            999987763

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=100.00  E-value=3.3e-54  Score=521.55  Aligned_cols=511  Identities=19%  Similarity=0.175  Sum_probs=451.5

Q ss_pred             CCEEEEEeccCCccccCCcCccccccccEEEeccCCCCCCCChhhhhhcccceeeccCCccccccchhhhhcCCCccEEe
Q 002010           71 SRVVSLNVSFMPLFGSIPPEIGLLTKLVNLTISNVNLTGRLPSEMALLTSLKVFNISGNVFQGNFAGQIVRGMTELQVLD  150 (982)
Q Consensus        71 ~~v~~l~l~~~~l~g~~~~~i~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~  150 (982)
                      .+++.|+++++.+.+..+..++.+++|++|+|++|++++..|..|.++++|++|+|++|.+++..| ..+.++++|++|+
T Consensus        32 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p-~~~~~l~~L~~L~  110 (606)
T 3vq2_A           32 SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSP-GSFSGLTSLENLV  110 (606)
T ss_dssp             TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCT-TSSTTCTTCCEEE
T ss_pred             CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccCh-hhcCCcccCCEEE
Confidence            368899999999999888899999999999999999998889999999999999999999986544 5678999999999


Q ss_pred             ccCccccCCCchhccccccccEEeecCccccc-ccCCCccccCcceEeeccCcccccchhhHHhhhhhHH----HHhhcc
Q 002010          151 AYNNNFTGPLPVEIASLKSLRHLSFGGNYFTG-KIPQSYSEIQSLEYIGLNGIGLNGTVPAFLSRLKNLR----EMYIGY  225 (982)
Q Consensus       151 Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~----~L~l~~  225 (982)
                      |++|++++..|..++++++|++|+|++|++++ .+|..|+++++|++|++++|.+.+..+..+..+++|+    +|+++.
T Consensus       111 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~~l~~L~l~~  190 (606)
T 3vq2_A          111 AVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSL  190 (606)
T ss_dssp             CTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTTTTHHHHHCTTCCCEEECTT
T ss_pred             ccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecChhhhhhhhccccccceeeccC
Confidence            99999998888899999999999999999986 6799999999999999999999999999999999887    588876


Q ss_pred             cccccccCCCCCCCCCCCCEEecccCcCc-ccCchhhcCCCccceeecccccCCCC------CCccccCCC--CCCEEEe
Q 002010          226 FNTYTGGIPPGFGALTQLQVLDMASCNIS-GEIPTSLSRLKLLHSLFLQMNKLTGH------IPPQLSGLI--SLKSLDL  296 (982)
Q Consensus       226 ~n~~~~~~p~~~~~l~~L~~L~L~~n~l~-~~~~~~l~~l~~L~~L~L~~N~l~~~------~~~~l~~l~--~L~~L~L  296 (982)
                       |.+.+..+..+.. .+|+.|++++|.++ +..|..+.+++.|+.+++..+.+.+.      .+..+..+.  +++.+++
T Consensus       191 -n~l~~~~~~~~~~-~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l  268 (606)
T 3vq2_A          191 -NPIDFIQDQAFQG-IKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRL  268 (606)
T ss_dssp             -CCCCEECTTTTTT-CEEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCGGGGTTGGGSEEEEEEE
T ss_pred             -CCcceeCcccccC-ceeeeeeccCCccchhHHHHHhccccccccccccccccccCCcccccChHHhhhhhhccHhheec
Confidence             4455444444444 49999999999997 46778899999999999876655432      222233332  4667777


Q ss_pred             -eCCcccCcCchhhhcccchhhhhhccCCCCCCCCCcCCCCCCccEEEccCCCcccccCccccCCCcccEEEeccccccc
Q 002010          297 -SLNYLTGEIPESFAALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTG  375 (982)
Q Consensus       297 -s~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~  375 (982)
                       ..|.+++.+|. +..+++|+.|++++|.+. .+| .+..+++|+.|++++|.+ +.+| .+ .+++|+.|++++|+..+
T Consensus       269 ~~~~~~~~~~~~-~~~l~~L~~L~l~~~~~~-~l~-~l~~~~~L~~L~l~~n~l-~~lp-~~-~l~~L~~L~l~~n~~~~  342 (606)
T 3vq2_A          269 TYTNDFSDDIVK-FHCLANVSAMSLAGVSIK-YLE-DVPKHFKWQSLSIIRCQL-KQFP-TL-DLPFLKSLTLTMNKGSI  342 (606)
T ss_dssp             CCCTTCCGGGGS-CGGGTTCSEEEEESCCCC-CCC-CCCTTCCCSEEEEESCCC-SSCC-CC-CCSSCCEEEEESCSSCE
T ss_pred             cccccccccccc-cccCCCCCEEEecCccch-hhh-hccccccCCEEEcccccC-cccc-cC-CCCccceeeccCCcCcc
Confidence             77889888887 999999999999999997 456 889999999999999999 5677 45 99999999999997665


Q ss_pred             cCCccccCccccceeeccccccccc--CCccccCCCCCCEEEccCCccCCCCCccccCCCccccccCCCccccccCC-cc
Q 002010          376 TIPRDLCKGGKLKSLILMQNFFIGP--IPEELGQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLSGELP-EK  452 (982)
Q Consensus       376 ~~p~~~~~~~~L~~L~l~~N~~~~~--~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~-~~  452 (982)
                      .+  .+..+++|++|++++|.+++.  .|..+..+++|++|++++|.++ .+|..+..+++|+.|++++|.+.+..+ ..
T Consensus       343 ~~--~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~  419 (606)
T 3vq2_A          343 SF--KKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSA  419 (606)
T ss_dssp             EC--CCCCCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEE-EECCCCTTCTTCCEEECTTSEEESTTTTTT
T ss_pred             ch--hhccCCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCccc-cchhhccCCCCCCeeECCCCccCCccChhh
Confidence            44  677899999999999999877  4889999999999999999998 477899999999999999999998877 44


Q ss_pred             cc-cCCccEEEeeccccCCCCchhccCCCCcceeeeccccccC-CCccccccccccceeeeeccccCCCCCcccccccCC
Q 002010          453 MS-GASLNQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLEG-EIPVESFNLKMITSINISDNNISGEIPYSISQCHSL  530 (982)
Q Consensus       453 ~~-~~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L  530 (982)
                      +. .++|++|++++|++++..|..++.+++|++|++++|++++ .+|..+..+++|++|+|++|++++..|..|.++++|
T Consensus       420 ~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L  499 (606)
T 3vq2_A          420 FLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRL  499 (606)
T ss_dssp             TTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTC
T ss_pred             hhccccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccC
Confidence            44 4799999999999999999999999999999999999997 478889999999999999999999999999999999


Q ss_pred             CeeeCCCCcccCCCCcccccccccceEEcccccccccCcccccccc-ccceecccCCccccCCCC
Q 002010          531 TSVDLSRNSLYGKIPPGISKLIDLSILNLSRNGITGSIPNEMRNMM-SLTTLDLSYNNLIGNIPS  594 (982)
Q Consensus       531 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~-~L~~L~Ls~N~l~~~ip~  594 (982)
                      +.|+|++|++++.+|..|.++++|+.|+|++|+|+ .+|..+..++ +|++|++++|++.+..+.
T Consensus       500 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~p~~~~~l~~~L~~l~l~~N~~~c~c~~  563 (606)
T 3vq2_A          500 QLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIE-TSKGILQHFPKSLAFFNLTNNSVACICEH  563 (606)
T ss_dssp             CEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCC-CEESCGGGSCTTCCEEECCSCCCCCSSTT
T ss_pred             CEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCc-ccCHhHhhhcccCcEEEccCCCcccCCcc
Confidence            99999999999999999999999999999999999 6787799997 599999999999987764

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=1.8e-52  Score=452.21  Aligned_cols=266  Identities=23%  Similarity=0.426  Sum_probs=221.8

Q ss_pred             hhcccccccccccceEEEEEEeC------CCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccE
Q 002010          692 ESLKDENIIGKGGAGIVYRGSMP------DGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNL  765 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  765 (982)
                      ++|...+.||+|+||+||+|++.      +++.||||++.. ......++|.+|++++++++|||||+++|++.+++..+
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~-~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~   91 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKD-ASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI   91 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCC-CChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence            46888899999999999999753      477899999853 34445678999999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHhhcC-----------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEE
Q 002010          766 LLYEYMPNGSLGEMLHGA-----------KGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAH  834 (982)
Q Consensus       766 lv~e~~~~~sL~~~l~~~-----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~k  834 (982)
                      +|||||++|+|.++++..           ....++|.++..++.||++||+|||+++   ||||||||+|||+++++.+|
T Consensus        92 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~K  168 (299)
T 4asz_A           92 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVK  168 (299)
T ss_dssp             EEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEE
T ss_pred             EEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEE
Confidence            999999999999999753           2357999999999999999999999988   99999999999999999999


Q ss_pred             EeccccchhccccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHhc
Q 002010          835 VADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTT  913 (982)
Q Consensus       835 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~  913 (982)
                      |+|||+|+...............||+.|||||++.+..|+.++|||||||++|||+| |+.||...... ++...+....
T Consensus       169 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~-~~~~~i~~~~  247 (299)
T 4asz_A          169 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN-EVIECITQGR  247 (299)
T ss_dssp             ECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH-HHHHHHHHTC
T ss_pred             ECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH-HHHHHHHcCC
Confidence            999999987765444444445679999999999999999999999999999999999 89999875433 2333332211


Q ss_pred             cCCCCCCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCCCCCCCCC
Q 002010          914 SEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQSAPSLIT  981 (982)
Q Consensus       914 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~~~~~~~~~  981 (982)
                      .                   ...|..++.++.+++.+||+.||++|||++||++.|+++.+..|.+..
T Consensus       248 ~-------------------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~~p~~ld  296 (299)
T 4asz_A          248 V-------------------LQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKASPVYLD  296 (299)
T ss_dssp             C-------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCCCSC
T ss_pred             C-------------------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCCcccc
Confidence            1                   122344556899999999999999999999999999998887776653

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=100.00  E-value=6.3e-51  Score=489.33  Aligned_cols=518  Identities=17%  Similarity=0.152  Sum_probs=411.8

Q ss_pred             cCCcCccccccccEEEeccCCCCCCCChhhhhhcccceeeccCCccccccchhhhhcCCCccEEeccCccccCCCchhcc
Q 002010           86 SIPPEIGLLTKLVNLTISNVNLTGRLPSEMALLTSLKVFNISGNVFQGNFAGQIVRGMTELQVLDAYNNNFTGPLPVEIA  165 (982)
Q Consensus        86 ~~~~~i~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~l~  165 (982)
                      .+|..+.  ++++.|+|++|++++..+..+..+++|++|+|++|.+++ ++...+.++++|++|+|++|++++..|..|+
T Consensus        21 ~ip~~l~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~-i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~   97 (570)
T 2z63_A           21 KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQT-IEDGAYQSLSHLSTLILTGNPIQSLALGAFS   97 (570)
T ss_dssp             SCCSSSC--SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCE-ECTTTTTTCTTCCEEECTTCCCCEECTTTTT
T ss_pred             ccCCCcc--ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCc-cCcccccCchhCCEEeCcCCcCCccCHhhhc
Confidence            4565443  578899999999988778889999999999999998875 4455678889999999999999877778899


Q ss_pred             ccccccEEeecCcccccccCCCccccCcceEeeccCccccc-chhhHHhhhhhHHHHhhcccccccccCCCCCCCCCCC-
Q 002010          166 SLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLNGIGLNG-TVPAFLSRLKNLREMYIGYFNTYTGGIPPGFGALTQL-  243 (982)
Q Consensus       166 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~i~~-~~~~~l~~l~~L~~L~l~~~n~~~~~~p~~~~~l~~L-  243 (982)
                      ++++|++|++++|++++..+..|+++++|++|++++|.+.+ .+|..++++++|++|++++ |.+.+..|..++.+++| 
T Consensus        98 ~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~-n~l~~~~~~~~~~l~~L~  176 (570)
T 2z63_A           98 GLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSS-NKIQSIYCTDLRVLHQMP  176 (570)
T ss_dssp             TCTTCCEEECTTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTT-SCCCEECGGGGHHHHTCT
T ss_pred             CccccccccccccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcC-CccceecHHHccchhccc
Confidence            99999999999999987776678899999999999888876 4566677776666666664 34444455556666666 


Q ss_pred             ---CEEecccCcCcccCchhhcCCCccceeecccccCCC-CCCccccCCCCCCEEEeeCCccc------CcCchhhhccc
Q 002010          244 ---QVLDMASCNISGEIPTSLSRLKLLHSLFLQMNKLTG-HIPPQLSGLISLKSLDLSLNYLT------GEIPESFAALK  313 (982)
Q Consensus       244 ---~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~-~~~~~l~~l~~L~~L~Ls~N~l~------~~~~~~l~~l~  313 (982)
                         +.|++++|.+++..|..+..+ +|++|++++|.... .++..+..+++++.+.+..+.+.      ......+..+.
T Consensus       177 ~~~~~L~l~~n~l~~~~~~~~~~~-~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~  255 (570)
T 2z63_A          177 LLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLC  255 (570)
T ss_dssp             TCCCEEECTTCCCCEECTTTTTTC-EEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGG
T ss_pred             hhhhhcccCCCCceecCHHHhccC-cceeEecccccccccchhhhhcCccccceeeeccccccCchhhhhcchhhhcccc
Confidence               677777777776666666554 67777777764432 23444556666666555433221      11222333333


Q ss_pred             --chhhhhhccC-CCCCCCCCcCCCCCCccEEEccCCCcccccCccccCCCcccEEEeccccccccCCccccCcccccee
Q 002010          314 --NLTLLQLFKN-NLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDLCKGGKLKSL  390 (982)
Q Consensus       314 --~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L  390 (982)
                        .++.+++++| .+.+..|..+..+++|+.|++++|.++ .+|..+..+ +|+.|++++|.+. .+|.  ..+++|+.|
T Consensus       256 ~l~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~l~~~~l~-~l~~~~~~~-~L~~L~l~~n~~~-~l~~--~~l~~L~~L  330 (570)
T 2z63_A          256 NLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNF-GWQHLELVNCKFG-QFPT--LKLKSLKRL  330 (570)
T ss_dssp             GSEEEEEEEEETTEEESCSTTTTGGGTTCSEEEEESCEEC-SCCBCCSCC-CCSEEEEESCBCS-SCCB--CBCSSCCEE
T ss_pred             ccchhhhhhhcchhhhhhchhhhcCcCcccEEEecCccch-hhhhhhccC-CccEEeeccCccc-ccCc--ccccccCEE
Confidence              3466677777 777888999999999999999999998 578888888 9999999999998 6665  478899999


Q ss_pred             ecccccccccCCccccCCCCCCEEEccCCccCCCC--CccccCCCccccccCCCccccccCCcccccCCccEEEeecccc
Q 002010          391 ILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGTI--PAGLFNLPLLNMMELDDNLLSGELPEKMSGASLNQLKVANNNI  468 (982)
Q Consensus       391 ~l~~N~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~--p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~L~~N~i  468 (982)
                      ++++|.+.+..+.  ..+++|++|++++|++++..  |..+..+++|++|++++|.+.+..+......+|++|++++|++
T Consensus       331 ~l~~n~~~~~~~~--~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~l~~L~~L~l~~n~l  408 (570)
T 2z63_A          331 TFTSNKGGNAFSE--VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNL  408 (570)
T ss_dssp             EEESCBSCCBCCC--CBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEEEEETCTTCCEEECTTSEE
T ss_pred             eCcCCcccccccc--ccCCCCCEEeCcCCccCccccccccccccCccCEEECCCCccccccccccccCCCCEEEccCCcc
Confidence            9999998877665  78999999999999998654  6788899999999999999998766643457899999999999


Q ss_pred             CCCCc-hhccCCCCcceeeeccccccCCCccccccccccceeeeeccccC-CCCCcccccccCCCeeeCCCCcccCCCCc
Q 002010          469 TGKIP-AAIGNLPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNIS-GEIPYSISQCHSLTSVDLSRNSLYGKIPP  546 (982)
Q Consensus       469 ~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~  546 (982)
                      ++..| ..+..+++|++|++++|++++..|..+..+++|++|++++|+++ +.+|..+..+++|+.|+|++|++++..|.
T Consensus       409 ~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~  488 (570)
T 2z63_A          409 KQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPT  488 (570)
T ss_dssp             ESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTT
T ss_pred             ccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChh
Confidence            98766 57899999999999999999889999999999999999999998 57899999999999999999999998899


Q ss_pred             ccccccccceEEcccccccccCccccccccccceecccCCccccCCCCCcc---ccccccccccCCcCcccCC
Q 002010          547 GISKLIDLSILNLSRNGITGSIPNEMRNMMSLTTLDLSYNNLIGNIPSGGQ---FLAFNETSFIGNPNLCLLR  616 (982)
Q Consensus       547 ~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~~~---~~~~~~~~~~~n~~~c~~~  616 (982)
                      .|.++++|+.|+|++|++++.+|..+..+++|+.|++++|++++.+|....   |..-....+.+.+ .|..+
T Consensus       489 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~wl~~~~~~~~~~~-~C~~~  560 (570)
T 2z63_A          489 AFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYLSRWLNKNSQKEQGSA-KCSGS  560 (570)
T ss_dssp             TTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTTHHHHHHHHHTGGGEESCC-BBTTT
T ss_pred             hhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCcchHHHHHHHHhccccCCCch-hhCCC
Confidence            999999999999999999998888899999999999999999999986532   2222334455555 66544

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1e-51  Score=448.26  Aligned_cols=259  Identities=24%  Similarity=0.395  Sum_probs=218.3

Q ss_pred             hhcccccccccccceEEEEEEe------CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccE
Q 002010          692 ESLKDENIIGKGGAGIVYRGSM------PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNL  765 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  765 (982)
                      ..++..+.||+|+||+||+|.+      .+++.||||++.........++|.+|+.++++++|||||+++|++.+++..+
T Consensus        26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~  105 (308)
T 4gt4_A           26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS  105 (308)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence            4567778899999999999975      2467899999976666666788999999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCC
Q 002010          766 LLYEYMPNGSLGEMLHGAK--------------GGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDF  831 (982)
Q Consensus       766 lv~e~~~~~sL~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~  831 (982)
                      +|||||++|+|.+++....              ...+++.++.+++.|||+||+|||+++   ||||||||+|||+++++
T Consensus       106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~  182 (308)
T 4gt4_A          106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKL  182 (308)
T ss_dssp             EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGG
T ss_pred             EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCC
Confidence            9999999999999996432              246899999999999999999999988   99999999999999999


Q ss_pred             CEEEeccccchhccccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHH
Q 002010          832 EAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVR  910 (982)
Q Consensus       832 ~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~  910 (982)
                      ++||+|||+|+...............||+.|||||++.+..|+.++|||||||++|||+| |..||.+... .++...+.
T Consensus       183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~-~~~~~~i~  261 (308)
T 4gt4_A          183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN-QDVVEMIR  261 (308)
T ss_dssp             CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH-HHHHHHHH
T ss_pred             CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH-HHHHHHHH
Confidence            999999999987765544444556789999999999999999999999999999999999 8999987543 23333332


Q ss_pred             HhccCCCCCCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 002010          911 KTTSEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPP  973 (982)
Q Consensus       911 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~  973 (982)
                      ....                   ...|.+++..+.++|.+||+.||++||||+||++.|+...
T Consensus       262 ~~~~-------------------~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~  305 (308)
T 4gt4_A          262 NRQV-------------------LPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG  305 (308)
T ss_dssp             TTCC-------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred             cCCC-------------------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcc
Confidence            2111                   1234455668999999999999999999999999998753

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1.4e-51  Score=444.66  Aligned_cols=265  Identities=30%  Similarity=0.442  Sum_probs=212.7

Q ss_pred             hhcccccccccccceEEEEEEeCCCcEEEEEEeccCC-CCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEec
Q 002010          692 ESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRG-TGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEY  770 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  770 (982)
                      ++++..+.||+|+||+||+|++.+  .||||+++... .....+.|.+|+.++++++|||||+++|++.+ +..++||||
T Consensus        36 ~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy  112 (307)
T 3omv_A           36 SEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQW  112 (307)
T ss_dssp             TSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEc
Confidence            567788899999999999998743  69999985433 22345679999999999999999999998754 668999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCc
Q 002010          771 MPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS  850 (982)
Q Consensus       771 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  850 (982)
                      |++|+|.++++. ...++++.++..++.||++||+|||+++   ||||||||+|||+++++++||+|||+|+........
T Consensus       113 ~~gGsL~~~l~~-~~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~  188 (307)
T 3omv_A          113 CEGSSLYKHLHV-QETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGS  188 (307)
T ss_dssp             CSSCBHHHHHHT-SCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC-------
T ss_pred             CCCCCHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccCCcc
Confidence            999999999974 3467999999999999999999999988   999999999999999999999999999876544444


Q ss_pred             cccccccccccccccccccc---CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccce
Q 002010          851 ECMSSVAGSYGYIAPEYAYT---LKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLA  927 (982)
Q Consensus       851 ~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  927 (982)
                      .......||+.|||||++.+   ..|+.++|||||||++|||+||+.||............+.....             
T Consensus       189 ~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~-------------  255 (307)
T 3omv_A          189 QQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYA-------------  255 (307)
T ss_dssp             -----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCC-------------
T ss_pred             eeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCC-------------
Confidence            44556789999999999864   45899999999999999999999999876554444444333221             


Q ss_pred             eecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCCCCCC
Q 002010          928 VVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQSAPS  978 (982)
Q Consensus       928 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~~~~~~  978 (982)
                        .|.....+.+++..+.+++.+||+.||++||||+||++.|+.+..+.|.
T Consensus       256 --~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lpk  304 (307)
T 3omv_A          256 --SPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPK  304 (307)
T ss_dssp             --CCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCCC
T ss_pred             --CCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCCC
Confidence              2233344556677899999999999999999999999999877666553

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=1.1e-51  Score=452.42  Aligned_cols=265  Identities=24%  Similarity=0.399  Sum_probs=210.9

Q ss_pred             hhcccccccccccceEEEEEEeC------CCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccE
Q 002010          692 ESLKDENIIGKGGAGIVYRGSMP------DGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNL  765 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  765 (982)
                      ++|...+.||+|+||+||+|++.      +++.||||++.. ......++|.+|++++++++|||||+++|++.+++..+
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~-~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~  119 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE-ASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLL  119 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESC-CSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECc-CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            45677789999999999999753      478899999853 34445678999999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCC
Q 002010          766 LLYEYMPNGSLGEMLHGAK-------------GGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFE  832 (982)
Q Consensus       766 lv~e~~~~~sL~~~l~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~  832 (982)
                      +|||||++|+|.++++...             ..+++|.++..++.||++||+|||+.+   ||||||||+|||+++++.
T Consensus       120 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~  196 (329)
T 4aoj_A          120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLV  196 (329)
T ss_dssp             EEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTE
T ss_pred             EEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCc
Confidence            9999999999999997532             246999999999999999999999988   999999999999999999


Q ss_pred             EEEeccccchhccccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHH
Q 002010          833 AHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRK  911 (982)
Q Consensus       833 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~  911 (982)
                      +||+|||+|+...............||+.|||||++.+..|+.++|||||||++|||+| |+.||......+ ....+..
T Consensus       197 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~-~~~~i~~  275 (329)
T 4aoj_A          197 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE-AIDCITQ  275 (329)
T ss_dssp             EEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHH-HHHHHHH
T ss_pred             EEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHH-HHHHHHc
Confidence            99999999997765444444456789999999999999999999999999999999999 899998754332 2333322


Q ss_pred             hccCCCCCCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCCCCCCCC
Q 002010          912 TTSEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQSAPSLI  980 (982)
Q Consensus       912 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~~~~~~~~  980 (982)
                      ...                   ...|..++.++.+++.+||+.||++|||++||++.|+.+.+.-|.+.
T Consensus       276 g~~-------------------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~pp~~l  325 (329)
T 4aoj_A          276 GRE-------------------LERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYL  325 (329)
T ss_dssp             TCC-------------------CCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHSCC---
T ss_pred             CCC-------------------CCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhCCcccc
Confidence            111                   12233455689999999999999999999999999999887766554

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=100.00  E-value=5.8e-51  Score=487.12  Aligned_cols=493  Identities=18%  Similarity=0.201  Sum_probs=340.1

Q ss_pred             CCccceeeeCCCCCEEEEEeccCCccccCCcCccccccccEEEeccCCCCCCCChhhhhhcccceeeccCCccccccchh
Q 002010           59 HCSFSGVTCDQDSRVVSLNVSFMPLFGSIPPEIGLLTKLVNLTISNVNLTGRLPSEMALLTSLKVFNISGNVFQGNFAGQ  138 (982)
Q Consensus        59 ~C~w~gv~C~~~~~v~~l~l~~~~l~g~~~~~i~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~~~~  138 (982)
                      .|.|.|| |+..+         +++ ..+|+.+.  ++|++|+|++|++++..|..+.++++|++|+|++|.+.+.. ..
T Consensus         3 ~C~~~~~-c~~~~---------~~l-~~ip~~~~--~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~-~~   68 (549)
T 2z81_A            3 SCDASGV-CDGRS---------RSF-TSIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIE-GD   68 (549)
T ss_dssp             EECTTSE-EECTT---------SCC-SSCCSCCC--TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEEC-TT
T ss_pred             cCCCCce-EECCC---------Ccc-ccccccCC--CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccC-hh
Confidence            5999999 97432         222 36777664  78999999999999888999999999999999999998644 45


Q ss_pred             hhhcCCCccEEeccCccccCCCchhccccccccEEeecCccccc-ccCCCccccCcceEeeccCcccccchh-hHHhhhh
Q 002010          139 IVRGMTELQVLDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTG-KIPQSYSEIQSLEYIGLNGIGLNGTVP-AFLSRLK  216 (982)
Q Consensus       139 ~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~L~~n~i~~~~~-~~l~~l~  216 (982)
                      .+.++++|++|+|++|++++..|..++++++|++|+|++|++++ ..|..++++++|++|++++|.+.+.+| ..+.+++
T Consensus        69 ~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~  148 (549)
T 2z81_A           69 AFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLT  148 (549)
T ss_dssp             TTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCC
T ss_pred             hccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhccc
Confidence            67889999999999999998888889999999999999999987 467889999999999999987443333 4566666


Q ss_pred             hHHHHhhcccccccccCCCCCCCCCCCCEEecccCcCcccCchhhcCCCccceeecccccCCCCC--C-ccccCCCCCCE
Q 002010          217 NLREMYIGYFNTYTGGIPPGFGALTQLQVLDMASCNISGEIPTSLSRLKLLHSLFLQMNKLTGHI--P-PQLSGLISLKS  293 (982)
Q Consensus       217 ~L~~L~l~~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~--~-~~l~~l~~L~~  293 (982)
                      +|++|++++ |.+.+.+|..++.+++|++|+++.|.+.......+..+++|++|++++|++++..  + .....+++|+.
T Consensus       149 ~L~~L~L~~-n~l~~~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~  227 (549)
T 2z81_A          149 SLNELEIKA-LSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKK  227 (549)
T ss_dssp             EEEEEEEEE-TTCCEECTTTTTTCSEEEEEEEECSBSTTHHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCE
T ss_pred             ccCeeeccC-CcccccChhhhhccccCceEecccCcccccchhhHhhcccccEEEccCCccccccccccchhhhhhcccc
Confidence            666666654 4455555666666666666666666655322222345666666666666666431  1 11233455666


Q ss_pred             EEeeCCcccCcCchhh----hcccchhhhhhccCCCCCCCCCcCCCCCCccEEEccCCCcccccCccccCCCcccEEEec
Q 002010          294 LDLSLNYLTGEIPESF----AALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVT  369 (982)
Q Consensus       294 L~Ls~N~l~~~~~~~l----~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~  369 (982)
                      |++++|.+++..+..+    ..+++|+.+++++|.+.+...-.                  ......+..+.+|+.|++.
T Consensus       228 L~l~~n~l~~~~~~~l~~~~~~~~~L~~l~l~~~~~~~~~~~~------------------~~~~~~~~~l~~L~~L~l~  289 (549)
T 2z81_A          228 LAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFN------------------PSESDVVSELGKVETVTIR  289 (549)
T ss_dssp             EEEESCEEEHHHHHHHHGGGGGCTTCCEEEEESCEEECCSCCC------------------CCTTTCCCCCTTCCEEEEE
T ss_pred             eeccccccchhHHHHHHHHhhhhcccccccccccccccccccc------------------ccchhhhhhhccccccccc
Confidence            6666666554333222    33445555555555544321000                  0001122333444444444


Q ss_pred             ccccccc-----CCccccCccccceeecccccccccCCccc-cCCCCCCEEEccCCccCCCCC---ccccCCCccccccC
Q 002010          370 SNHLTGT-----IPRDLCKGGKLKSLILMQNFFIGPIPEEL-GQCKSLTKIRFSKNYLNGTIP---AGLFNLPLLNMMEL  440 (982)
Q Consensus       370 ~N~l~~~-----~p~~~~~~~~L~~L~l~~N~~~~~~~~~l-~~l~~L~~L~Ls~N~l~~~~p---~~~~~l~~L~~L~L  440 (982)
                      ++.+...     ++..+....+|+.|++++|.+. .+|..+ ..+++|++|++++|++++.+|   ..+..+++|++|++
T Consensus       290 ~~~i~~~~~~~~l~~~~~~~~~L~~L~l~~n~l~-~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~L  368 (549)
T 2z81_A          290 RLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVL  368 (549)
T ss_dssp             SCBCSCGGGSCCCCHHHHHSTTCCEEEEESSCCC-CCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEEC
T ss_pred             ccccchhhhcccchhhhhhcccceEEEeccCccc-cCCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEc
Confidence            4443321     1111222345666666666654 344443 456666666666666665543   23556666667777


Q ss_pred             CCccccccCC--ccc-ccCCccEEEeeccccCCCCchhccCCCCcceeeeccccccCCCccccccccccceeeeeccccC
Q 002010          441 DDNLLSGELP--EKM-SGASLNQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNIS  517 (982)
Q Consensus       441 ~~N~l~~~~~--~~~-~~~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  517 (982)
                      ++|++++..+  ..+ ...+|++|++++|+++ .+|..+..+++|++|++++|+++ .+|..+  .++|++|+|++|+|+
T Consensus       369 s~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~~L~~L~Ls~N~l~-~l~~~~--~~~L~~L~Ls~N~l~  444 (549)
T 2z81_A          369 SQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKTCI--PQTLEVLDVSNNNLD  444 (549)
T ss_dssp             TTSCCCCHHHHHHHGGGCTTCCEEECTTCCCC-CCCSCCCCCTTCCEEECTTSCCS-CCCTTS--CTTCSEEECCSSCCS
T ss_pred             cCCcccccccchhhhhcCCCCCEEECCCCCCc-cCChhhcccccccEEECCCCCcc-cccchh--cCCceEEECCCCChh
Confidence            7776665432  122 2367888888888888 67888888999999999999997 455444  368999999999999


Q ss_pred             CCCCcccccccCCCeeeCCCCcccCCCCcccccccccceEEcccccccccCccccccccccceecccCCccccCCCCC
Q 002010          518 GEIPYSISQCHSLTSVDLSRNSLYGKIPPGISKLIDLSILNLSRNGITGSIPNEMRNMMSLTTLDLSYNNLIGNIPSG  595 (982)
Q Consensus       518 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~  595 (982)
                      +.+    ..+++|++|+|++|+|+ .+|. ...+++|++|+|++|+|++.+|..+..+++|+.|++++|++++.+|..
T Consensus       445 ~~~----~~l~~L~~L~Ls~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~  516 (549)
T 2z81_A          445 SFS----LFLPRLQELYISRNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRI  516 (549)
T ss_dssp             CCC----CCCTTCCEEECCSSCCS-SCCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCCHHHH
T ss_pred             hhc----ccCChhcEEECCCCccC-cCCC-cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCCCccH
Confidence            753    57899999999999998 6776 578999999999999999989989999999999999999999988843

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=100.00  E-value=9.2e-51  Score=490.91  Aligned_cols=467  Identities=21%  Similarity=0.286  Sum_probs=317.0

Q ss_pred             cccceeeccCCccccccchhhhhcCCCccEEeccCccc------cC------CCchhccccccccEEeecCcccccccCC
Q 002010          119 TSLKVFNISGNVFQGNFAGQIVRGMTELQVLDAYNNNF------TG------PLPVEIASLKSLRHLSFGGNYFTGKIPQ  186 (982)
Q Consensus       119 ~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l------~~------~~p~~l~~l~~L~~L~L~~N~l~~~~p~  186 (982)
                      .+++.|+|++|.+.|.+|. .+.++++|++|+|++|.+      .|      .+|...  +..|+ +++++|.+.+.+|.
T Consensus        81 ~~V~~L~L~~~~l~g~lp~-~l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~--~~~l~-l~l~~~~l~~~~~~  156 (636)
T 4eco_A           81 GRVTGLSLEGFGASGRVPD-AIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQ--KQKMR-MHYQKTFVDYDPRE  156 (636)
T ss_dssp             CCEEEEECTTSCCEEEECG-GGGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHH--HHHHH-THHHHHHTCCCGGG
T ss_pred             CCEEEEEecCcccCCcCCh-HHhcCccceEEECcCCccccCCccccccccccCchHHH--HHHHH-hhHHHhhhccCchh
Confidence            3567777777777777664 456777777777777765      22      334333  45555 66666666666665


Q ss_pred             Cccc-cCcceEeeccCcccccchhhHHhhhhhHHHHhhcc-cccccccCCCCCCCCCCCCEEecccCcCccc--------
Q 002010          187 SYSE-IQSLEYIGLNGIGLNGTVPAFLSRLKNLREMYIGY-FNTYTGGIPPGFGALTQLQVLDMASCNISGE--------  256 (982)
Q Consensus       187 ~~~~-l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~l~~-~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~--------  256 (982)
                      .++. +..+..+++....+..      .....++.++++. +|.+++ +|..|+++++|++|+|++|++++.        
T Consensus       157 ~~~~~~~~l~~~~l~~~~~~~------~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~  229 (636)
T 4eco_A          157 DFSDLIKDCINSDPQQKSIKK------SSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWEN  229 (636)
T ss_dssp             GSCHHHHHHHHHCTTSCCCCC------CCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSC
T ss_pred             hHHHHHHHHhhcCcccccccc------ccccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccc
Confidence            5542 2223333332222110      1111233333333 456666 777777777777777777777764        


Q ss_pred             ---------Cchhhc--CCCccceeecccccCCCCCCccccCCCCCCEEEeeCCc-ccC-cCchhhhcc------cchhh
Q 002010          257 ---------IPTSLS--RLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNY-LTG-EIPESFAAL------KNLTL  317 (982)
Q Consensus       257 ---------~~~~l~--~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~-l~~-~~~~~l~~l------~~L~~  317 (982)
                               +|..++  ++++|++|+|++|++.+.+|..++++++|++|+|++|+ +++ .+|..+..+      ++|++
T Consensus       230 ~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~  309 (636)
T 4eco_A          230 ENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQI  309 (636)
T ss_dssp             TTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCE
T ss_pred             cccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCE
Confidence                     677766  77777777777777777777777777777777777776 776 667666665      66666


Q ss_pred             hhhccCCCCCCCCC--cCCCCCCccEEEccCCCcccccCccccCCCcccEEEeccccccccCCccccCccc-cceeeccc
Q 002010          318 LQLFKNNLRGPIPS--FLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDLCKGGK-LKSLILMQ  394 (982)
Q Consensus       318 L~L~~N~l~~~~p~--~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~~-L~~L~l~~  394 (982)
                      |++++|+++ .+|.  .++.+++|++|++++|.+++.+| .++.+++|++|++++|+++ .+|..+..+++ |++|++++
T Consensus       310 L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~  386 (636)
T 4eco_A          310 IYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAH  386 (636)
T ss_dssp             EECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECC-CCEEEEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCS
T ss_pred             EECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCccchh-hhCCCCCCCEEECCCCccc-cccHhhhhhcccCcEEEccC
Confidence            666666666 5666  66666666666666666666666 6666666666666666666 55555666655 66666666


Q ss_pred             ccccccCCccccCCC--CCCEEEccCCccCCCCCccccCCCccccccCCCccccccCCcccccCCccEEEeeccccCCCC
Q 002010          395 NFFIGPIPEELGQCK--SLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLSGELPEKMSGASLNQLKVANNNITGKI  472 (982)
Q Consensus       395 N~~~~~~~~~l~~l~--~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~L~~N~i~~~~  472 (982)
                      |.++ .+|..+..++  +|++|++++|++++.+|..+....                ...+...+|++|++++|++++..
T Consensus       387 N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~----------------~~~~~~~~L~~L~Ls~N~l~~lp  449 (636)
T 4eco_A          387 NKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLD----------------PTPFKGINVSSINLSNNQISKFP  449 (636)
T ss_dssp             SCCS-SCCSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTC----------------SSCCCCCCEEEEECCSSCCCSCC
T ss_pred             CcCc-ccchhhhhcccCccCEEECcCCcCCCcchhhhcccc----------------cccccCCCCCEEECcCCccCcCC
Confidence            6655 4555554433  556666666666555555444100                01112246788888888888555


Q ss_pred             chhccCCCCcceeeeccccccCCCccccccc--------cccceeeeeccccCCCCCcccc--cccCCCeeeCCCCcccC
Q 002010          473 PAAIGNLPSLNILSLQNNRLEGEIPVESFNL--------KMITSINISDNNISGEIPYSIS--QCHSLTSVDLSRNSLYG  542 (982)
Q Consensus       473 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l--------~~L~~L~Ls~N~l~~~~p~~~~--~l~~L~~L~Ls~N~l~~  542 (982)
                      +..+..+++|++|+|++|+++ .+|......        ++|++|+|++|+|+ .+|..+.  .+++|+.|+|++|+|++
T Consensus       450 ~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~  527 (636)
T 4eco_A          450 KELFSTGSPLSSINLMGNMLT-EIPKNSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK  527 (636)
T ss_dssp             THHHHTTCCCSEEECCSSCCS-BCCSSSSEETTEECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS
T ss_pred             HHHHccCCCCCEEECCCCCCC-CcCHHHhccccccccccCCccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC
Confidence            555667889999999999988 666655442        28999999999999 6788876  89999999999999987


Q ss_pred             CCCcccccccccceEEc------ccccccccCccccccccccceecccCCccccCCCCCccccccccccccCCcCcccCC
Q 002010          543 KIPPGISKLIDLSILNL------SRNGITGSIPNEMRNMMSLTTLDLSYNNLIGNIPSGGQFLAFNETSFIGNPNLCLLR  616 (982)
Q Consensus       543 ~~p~~~~~l~~L~~L~L------s~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~~~~~~~~~~~~~~n~~~c~~~  616 (982)
                       +|..+.++++|+.|+|      ++|++.+.+|..+..+++|+.|+|++|++ +.+|... +.++....+.+||+.|...
T Consensus       528 -ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l-~~ip~~~-~~~L~~L~Ls~N~l~~~~~  604 (636)
T 4eco_A          528 -FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDI-RKVNEKI-TPNISVLDIKDNPNISIDL  604 (636)
T ss_dssp             -CCCGGGGCSSCCEEECCSCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCC-CTTCCEEECCSCTTCEEEC
T ss_pred             -cChhhhcCCCCCEEECCCCcccccCcccccChHHHhcCCCCCEEECCCCcC-CccCHhH-hCcCCEEECcCCCCccccH
Confidence             8889999999999999      56889999999999999999999999999 7888653 3788888899999999665


Q ss_pred             CCCCc
Q 002010          617 NGTCQ  621 (982)
Q Consensus       617 ~~~c~  621 (982)
                      ...|+
T Consensus       605 ~~~~~  609 (636)
T 4eco_A          605 SYVCP  609 (636)
T ss_dssp             TTTHH
T ss_pred             Hhcch
Confidence            44443

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=1.8e-50  Score=441.94  Aligned_cols=251  Identities=22%  Similarity=0.302  Sum_probs=206.4

Q ss_pred             hhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCC-CCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEe
Q 002010          692 ESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGT-GGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYE  769 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  769 (982)
                      ++|++.+.||+|+||+||+|+. .+|+.||||++..... ....+.+.+|+.++++++|||||++++++.+++..|+|||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE  103 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD  103 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence            5799999999999999999965 5699999999965432 2345678999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCC
Q 002010          770 YMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGA  849 (982)
Q Consensus       770 ~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  849 (982)
                      ||+||+|.+++...+...+++.+++.++.||+.||+|||+++   ||||||||+|||++.++.+||+|||+|+.+...  
T Consensus       104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~--  178 (350)
T 4b9d_A          104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST--  178 (350)
T ss_dssp             CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHH--
T ss_pred             CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCC--
Confidence            999999999998767778899999999999999999999998   999999999999999999999999999876532  


Q ss_pred             cccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceee
Q 002010          850 SECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVV  929 (982)
Q Consensus       850 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  929 (982)
                      .......+||+.|||||++.+..|+.++||||+||++|||+||++||........+..+.....                
T Consensus       179 ~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~----------------  242 (350)
T 4b9d_A          179 VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSF----------------  242 (350)
T ss_dssp             HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC----------------
T ss_pred             cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC----------------
Confidence            1223456899999999999999999999999999999999999999976433322222222111                


Q ss_pred             cCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          930 DPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       930 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                          +..+...+.++.+|+.+||++||++|||++|+++
T Consensus       243 ----~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  276 (350)
T 4b9d_A          243 ----PPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE  276 (350)
T ss_dssp             ----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ----CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                1122233457899999999999999999999975

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=2.9e-50  Score=432.94  Aligned_cols=248  Identities=24%  Similarity=0.331  Sum_probs=211.3

Q ss_pred             hhcccccccccccceEEEEEEe-CCCcEEEEEEeccCC--CCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEE
Q 002010          692 ESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRG--TGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLY  768 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  768 (982)
                      ++|++.+.||+|+||+||+|+. .+|+.||||++.+..  .....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            5699999999999999999965 579999999985432  2345667899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccC
Q 002010          769 EYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAG  848 (982)
Q Consensus       769 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  848 (982)
                      ||++||+|.+++.  +.+.+++.++..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+|+.+....
T Consensus       112 Ey~~gG~L~~~i~--~~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~  186 (311)
T 4aw0_A          112 SYAKNGELLKYIR--KIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPES  186 (311)
T ss_dssp             CCCTTEEHHHHHH--HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTTT
T ss_pred             ecCCCCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCCC
Confidence            9999999999997  3468999999999999999999999998   9999999999999999999999999999876554


Q ss_pred             CcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCccccccee
Q 002010          849 ASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAV  928 (982)
Q Consensus       849 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  928 (982)
                      ........+||+.|||||++.+..|+.++||||+||++|||++|++||...........+... ..              
T Consensus       187 ~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~-~~--------------  251 (311)
T 4aw0_A          187 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKL-EY--------------  251 (311)
T ss_dssp             TCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT-CC--------------
T ss_pred             CcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC-CC--------------
Confidence            445556789999999999999999999999999999999999999999764333222222221 11              


Q ss_pred             ecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHH
Q 002010          929 VDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREV  965 (982)
Q Consensus       929 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~el  965 (982)
                            .+|...+.++.+|+.+||++||++|||++|+
T Consensus       252 ------~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~  282 (311)
T 4aw0_A          252 ------DFPEKFFPKARDLVEKLLVLDATKRLGCEEM  282 (311)
T ss_dssp             ------CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGG
T ss_pred             ------CCCcccCHHHHHHHHHHccCCHhHCcChHHH
Confidence                  1122233468899999999999999999986

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=1.4e-49  Score=434.25  Aligned_cols=249  Identities=23%  Similarity=0.352  Sum_probs=209.9

Q ss_pred             hhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEec
Q 002010          692 ESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEY  770 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  770 (982)
                      +.|+..+.||+|+||+||+|.. .+|+.||||++... .....+.+.+|+.++++++|||||++++++.+++..|+||||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~-~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy  152 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLR-KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF  152 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGG-GCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecC-chhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeC
Confidence            5688889999999999999965 56999999998543 334456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCc
Q 002010          771 MPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS  850 (982)
Q Consensus       771 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  850 (982)
                      |+||+|.+++..   .++++.++..++.||+.||+|||+++   ||||||||+|||++.++.+||+|||+|+.+...  .
T Consensus       153 ~~gg~L~~~l~~---~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~--~  224 (346)
T 4fih_A          153 LEGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE--V  224 (346)
T ss_dssp             CTTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSS--S
T ss_pred             CCCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCC--C
Confidence            999999999964   46999999999999999999999998   999999999999999999999999999876543  2


Q ss_pred             ccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceeec
Q 002010          851 ECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVD  930 (982)
Q Consensus       851 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  930 (982)
                      ......+||+.|||||++.+..|+.++||||+||++|||++|++||..... ......+......               
T Consensus       225 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~-~~~~~~i~~~~~~---------------  288 (346)
T 4fih_A          225 PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP-LKAMKMIRDNLPP---------------  288 (346)
T ss_dssp             CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-HHHHHHHHHSSCC---------------
T ss_pred             CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH-HHHHHHHHcCCCC---------------
Confidence            234567899999999999999999999999999999999999999976433 2223333221110               


Q ss_pred             CCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          931 PRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       931 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                       .+ ..+...+.++.+|+.+||++||++|||++|+++
T Consensus       289 -~~-~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~  323 (346)
T 4fih_A          289 -RL-KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  323 (346)
T ss_dssp             -CC-SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -CC-CccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence             00 112233457899999999999999999999987

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1.9e-49  Score=432.01  Aligned_cols=252  Identities=24%  Similarity=0.322  Sum_probs=208.0

Q ss_pred             HhhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEe
Q 002010          691 LESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYE  769 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  769 (982)
                      .+.|+..+.||+|+||+||+|+. .+|+.||||++.....      ..+|+.++++++|||||++++++.+++..|+|||
T Consensus        57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmE  130 (336)
T 4g3f_A           57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF------RVEELVACAGLSSPRIVPLYGAVREGPWVNIFME  130 (336)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            45688888999999999999975 5699999999854321      2479999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCC-CEEEeccccchhccccC
Q 002010          770 YMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDF-EAHVADFGLAKFLQDAG  848 (982)
Q Consensus       770 ~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~-~~kl~DfG~a~~~~~~~  848 (982)
                      ||+||+|.++++.  .+.+++.++..++.||+.||+|||+++   ||||||||+|||++.+| ++||+|||+|+.+....
T Consensus       131 y~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~  205 (336)
T 4g3f_A          131 LLEGGSLGQLIKQ--MGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG  205 (336)
T ss_dssp             CCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred             ccCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence            9999999999973  467999999999999999999999988   99999999999999987 69999999998776432


Q ss_pred             Ccc---cccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCccccc
Q 002010          849 ASE---CMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASV  925 (982)
Q Consensus       849 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  925 (982)
                      ...   .....+||+.|||||++.+..|+.++||||+||++|||+||++||...........+......           
T Consensus       206 ~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~-----------  274 (336)
T 4g3f_A          206 LGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPP-----------  274 (336)
T ss_dssp             --------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCG-----------
T ss_pred             cccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCC-----------
Confidence            221   223467999999999999999999999999999999999999999876554444443322111           


Q ss_pred             ceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 002010          926 LAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLAN  971 (982)
Q Consensus       926 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~  971 (982)
                             ....+...+..+.+++.+||++||++|||++|+++.|..
T Consensus       275 -------~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~  313 (336)
T 4g3f_A          275 -------IREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGK  313 (336)
T ss_dssp             -------GGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             -------chhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence                   112334455678999999999999999999999887643

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=1.2e-49  Score=439.65  Aligned_cols=263  Identities=27%  Similarity=0.390  Sum_probs=220.4

Q ss_pred             HhhcccccccccccceEEEEEEeCC------CcEEEEEEeccCCCCCchhhHHHHHHHHhcCCC-CcccceEeEEEcC-C
Q 002010          691 LESLKDENIIGKGGAGIVYRGSMPD------GIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRH-RNIVRLLGYVSNR-D  762 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~-~  762 (982)
                      .++|+..+.||+|+||+||+|.+..      ++.||||++.........+.|.+|+.++.+++| ||||+++|+|.++ .
T Consensus        63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~  142 (353)
T 4ase_A           63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG  142 (353)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTS
T ss_pred             HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCC
Confidence            4679999999999999999996532      357999999665555556789999999999975 8999999998764 5


Q ss_pred             ccEEEEeccCCCCHHHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEc
Q 002010          763 TNLLLYEYMPNGSLGEMLHGAK--------------GGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLD  828 (982)
Q Consensus       763 ~~~lv~e~~~~~sL~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~  828 (982)
                      ..++|||||++|+|.++++..+              ...+++.++..++.|||+||+|||+++   ||||||||+|||++
T Consensus       143 ~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDLK~~NILl~  219 (353)
T 4ase_A          143 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLS  219 (353)
T ss_dssp             CCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEC
T ss_pred             EEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCccCccceeeC
Confidence            6899999999999999997532              245899999999999999999999988   99999999999999


Q ss_pred             CCCCEEEeccccchhccccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHH
Q 002010          829 SDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVR  907 (982)
Q Consensus       829 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~  907 (982)
                      +++++||+|||+|+.+.............||+.|||||++.+..|+.++|||||||++|||+| |+.||........+..
T Consensus       220 ~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~  299 (353)
T 4ase_A          220 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR  299 (353)
T ss_dssp             GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHH
T ss_pred             CCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            999999999999997765444444556789999999999999999999999999999999998 9999987665555555


Q ss_pred             HHHHhccCCCCCCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCCC
Q 002010          908 WVRKTTSEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQS  975 (982)
Q Consensus       908 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~~~  975 (982)
                      .+..... .                  ..|..++.++.++|.+||+.||++|||++||++.|+.+.+.
T Consensus       300 ~i~~g~~-~------------------~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~  348 (353)
T 4ase_A          300 RLKEGTR-M------------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  348 (353)
T ss_dssp             HHHHTCC-C------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHcCCC-C------------------CCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence            5544322 1                  12333455789999999999999999999999999876553

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=100.00  E-value=5e-49  Score=482.32  Aligned_cols=474  Identities=20%  Similarity=0.249  Sum_probs=332.6

Q ss_pred             ccccEEEeccCCCCCCCChhhhhhcccceeec-cCCccccccchhhhhc---CCC-----ccE------Ee-ccCccccC
Q 002010           95 TKLVNLTISNVNLTGRLPSEMALLTSLKVFNI-SGNVFQGNFAGQIVRG---MTE-----LQV------LD-AYNNNFTG  158 (982)
Q Consensus        95 ~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L-s~n~l~~~~~~~~~~~---l~~-----L~~------L~-Ls~n~l~~  158 (982)
                      .+++.|+|++|++.|.+|+++++|++|++|+| ++|.+.|..+......   +..     ++.      ++ .....+++
T Consensus       323 ~~V~~L~Ls~~~L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~  402 (876)
T 4ecn_A          323 GRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSD  402 (876)
T ss_dssp             SCEEEEECTTTCCEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCH
T ss_pred             CCEEEEECccCCCCCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhH
Confidence            57899999999999999999999999999999 9999887633211000   000     000      00 00011111


Q ss_pred             C-----------CchhccccccccEEeecC--cccccccCCCccccCcceEeeccCccccc-chhhHHhhhhhHHHHhhc
Q 002010          159 P-----------LPVEIASLKSLRHLSFGG--NYFTGKIPQSYSEIQSLEYIGLNGIGLNG-TVPAFLSRLKNLREMYIG  224 (982)
Q Consensus       159 ~-----------~p~~l~~l~~L~~L~L~~--N~l~~~~p~~~~~l~~L~~L~L~~n~i~~-~~~~~l~~l~~L~~L~l~  224 (982)
                      .           .+........++.+.++.  |++++ +|..|+++++|++|+|++|.+.+ .++..+..+         
T Consensus       403 l~~~~l~~~~~~~~i~~~~~l~l~~l~l~~~~N~L~~-IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~---------  472 (876)
T 4ecn_A          403 LLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDA---------  472 (876)
T ss_dssp             HHHHHHHTCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCT---------
T ss_pred             HHHHHhhhCccccccccccccchhhceeccccCcccc-hhHHHhcCCCCCEEECcCCcCCCCccccccccc---------
Confidence            1           111112334556666655  89998 99999999999999999999987 222211110         


Q ss_pred             ccccccccCCCCCC--CCCCCCEEecccCcCcccCchhhcCCCccceeeccccc-CCC-CCCccccCCC-------CCCE
Q 002010          225 YFNTYTGGIPPGFG--ALTQLQVLDMASCNISGEIPTSLSRLKLLHSLFLQMNK-LTG-HIPPQLSGLI-------SLKS  293 (982)
Q Consensus       225 ~~n~~~~~~p~~~~--~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~-l~~-~~~~~l~~l~-------~L~~  293 (982)
                      ..+...+.+|..++  ++++|++|+|++|++.+.+|..|+++++|++|+|++|+ +++ .+|..++.++       +|++
T Consensus       473 s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~  552 (876)
T 4ecn_A          473 NSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQI  552 (876)
T ss_dssp             TSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCE
T ss_pred             ccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccE
Confidence            01344566888877  88888888888888888888888888888888888887 777 6776555444       7888


Q ss_pred             EEeeCCcccCcCch--hhhcccchhhhhhccCCCCCCCCCcCCCCCCccEEEccCCCcccccCccccCCCc-ccEEEecc
Q 002010          294 LDLSLNYLTGEIPE--SFAALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGK-LLILDVTS  370 (982)
Q Consensus       294 L~Ls~N~l~~~~~~--~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~-L~~L~L~~  370 (982)
                      |+|++|+++ .+|.  .|..+++|+.|+|++|+++ .+| .|+.+++|+.|++++|.++ .+|..+..+++ |+.|+|++
T Consensus       553 L~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~  628 (876)
T 4ecn_A          553 FYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSH  628 (876)
T ss_dssp             EECCSSCCC-BCCCHHHHTTCTTCCEEECTTSCCC-BCC-CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCS
T ss_pred             EEeeCCcCC-ccCChhhhhcCCCCCEEECCCCCcc-cch-hhcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcC
Confidence            888888877 6666  7777777777777777777 666 6777777777777777777 66666777766 77777777


Q ss_pred             ccccccCCccccCccc--cceeecccccccccCCccc---c--CCCCCCEEEccCCccCCCCCcccc-CCCccccccCCC
Q 002010          371 NHLTGTIPRDLCKGGK--LKSLILMQNFFIGPIPEEL---G--QCKSLTKIRFSKNYLNGTIPAGLF-NLPLLNMMELDD  442 (982)
Q Consensus       371 N~l~~~~p~~~~~~~~--L~~L~l~~N~~~~~~~~~l---~--~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~L~~  442 (982)
                      |+++ .+|..+..+..  |+.|++++|.+.+.+|...   .  .+++|+.|+|++|+++ .+|..+. .++         
T Consensus       629 N~L~-~lp~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~-~lp~~~~~~l~---------  697 (876)
T 4ecn_A          629 NKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQ-KFPTELFATGS---------  697 (876)
T ss_dssp             SCCC-SCCSCCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCC-SCCHHHHHTTC---------
T ss_pred             CCCC-cCchhhhccccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCC-ccCHHHHccCC---------
Confidence            7776 56665555433  6666666666655444221   1  2235555555555555 3333332 344         


Q ss_pred             ccccccCCcccccCCccEEEeeccccCCCCchhc--------cCCCCcceeeeccccccCCCccccc--cccccceeeee
Q 002010          443 NLLSGELPEKMSGASLNQLKVANNNITGKIPAAI--------GNLPSLNILSLQNNRLEGEIPVESF--NLKMITSINIS  512 (982)
Q Consensus       443 N~l~~~~~~~~~~~~L~~L~L~~N~i~~~~p~~~--------~~l~~L~~L~L~~N~l~~~~p~~~~--~l~~L~~L~Ls  512 (982)
                                    +|+.|+|++|+|+ .+|..+        .++++|+.|+|++|+|+ .+|..+.  .+++|+.|+|+
T Consensus       698 --------------~L~~L~Ls~N~L~-~ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls  761 (876)
T 4ecn_A          698 --------------PISTIILSNNLMT-SIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVS  761 (876)
T ss_dssp             --------------CCSEEECCSCCCS-CCCTTSSSCTTSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECC
T ss_pred             --------------CCCEEECCCCcCC-ccChHHhccccccccccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeC
Confidence                          4555555555555 333332        23459999999999999 7898887  99999999999


Q ss_pred             ccccCCCCCcccccccCCCeeeCCC------CcccCCCCcccccccccceEEcccccccccCccccccccccceecccCC
Q 002010          513 DNNISGEIPYSISQCHSLTSVDLSR------NSLYGKIPPGISKLIDLSILNLSRNGITGSIPNEMRNMMSLTTLDLSYN  586 (982)
Q Consensus       513 ~N~l~~~~p~~~~~l~~L~~L~Ls~------N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N  586 (982)
                      +|+|++ +|..+..+++|+.|+|++      |++.+.+|..|.++++|+.|+|++|+| +.+|..+.  ++|+.|||++|
T Consensus       762 ~N~L~~-lp~~l~~L~~L~~L~Ls~N~~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~l~--~~L~~LdLs~N  837 (876)
T 4ecn_A          762 YNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKLT--PQLYILDIADN  837 (876)
T ss_dssp             SSCCSS-CCCGGGGCTTCCEEECCCCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--SSSCEEECCSC
T ss_pred             CCCCCc-cchhhhcCCCCCEEECCCCCCcccccccccChHHHhcCCCCCEEECCCCCC-CccCHhhc--CCCCEEECCCC
Confidence            999997 799999999999999977      889999999999999999999999999 68898766  69999999999


Q ss_pred             ccccCCCCCc-cccccccccccCCcCcc
Q 002010          587 NLIGNIPSGG-QFLAFNETSFIGNPNLC  613 (982)
Q Consensus       587 ~l~~~ip~~~-~~~~~~~~~~~~n~~~c  613 (982)
                      ++...-+... .........+.+|+..|
T Consensus       838 ~l~~i~~~~~~~~~~~~~~~L~~n~~~~  865 (876)
T 4ecn_A          838 PNISIDVTSVCPYIEAGMYVLLYDKTQD  865 (876)
T ss_dssp             TTCEEECGGGHHHHHTTCCEEECCTTSE
T ss_pred             CCCccChHHccccccchheeecCCCccc
Confidence            9876544321 11223344456666555

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=7.8e-49  Score=420.28  Aligned_cols=248  Identities=27%  Similarity=0.442  Sum_probs=200.7

Q ss_pred             cccccccccccceEEEEEEe-CCCcEEEEEEeccCC-CCCchhhHHHHHHHHhcCCCCcccceEeEEEc----CCccEEE
Q 002010          694 LKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRG-TGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSN----RDTNLLL  767 (982)
Q Consensus       694 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~lv  767 (982)
                      |+..+.||+|+||+||+|.. .+++.||+|++.... .....+.|.+|+.++++++|||||++++++.+    +...|+|
T Consensus        28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv  107 (290)
T 3fpq_A           28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV  107 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence            35667899999999999965 568999999985543 23345678999999999999999999999865    3457999


Q ss_pred             EeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcC-CCCEEEeccccchhccc
Q 002010          768 YEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDS-DFEAHVADFGLAKFLQD  846 (982)
Q Consensus       768 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~-~~~~kl~DfG~a~~~~~  846 (982)
                      ||||++|+|.+++.  +...+++..+..++.||+.||+|||+++ ++||||||||+|||++. ++.+||+|||+|+....
T Consensus       108 mEy~~gg~L~~~l~--~~~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~  184 (290)
T 3fpq_A          108 TELMTSGTLKTYLK--RFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  184 (290)
T ss_dssp             EECCCSCBHHHHHH--HHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             EeCCCCCCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence            99999999999997  3467999999999999999999999864 45999999999999984 79999999999986432


Q ss_pred             cCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccc
Q 002010          847 AGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVL  926 (982)
Q Consensus       847 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  926 (982)
                          ......+||+.|||||++.+ .|+.++||||+||++|||+||++||........+...+.......          
T Consensus       185 ----~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~----------  249 (290)
T 3fpq_A          185 ----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPA----------  249 (290)
T ss_dssp             ----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCG----------
T ss_pred             ----CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCC----------
Confidence                23345789999999998865 699999999999999999999999976544433333332211100          


Q ss_pred             eeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          927 AVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       927 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                              ..+...+.++.+++.+||++||++|||++|+++
T Consensus       250 --------~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~  282 (290)
T 3fpq_A          250 --------SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             --------GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             --------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                    011122346889999999999999999999975

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=100.00  E-value=3.8e-48  Score=465.18  Aligned_cols=483  Identities=19%  Similarity=0.175  Sum_probs=408.7

Q ss_pred             cceeeccCCccccccchhhhhcCCCccEEeccCccccCCCchhccccccccEEeecCcccccccCCCccccCcceEeecc
Q 002010          121 LKVFNISGNVFQGNFAGQIVRGMTELQVLDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLN  200 (982)
Q Consensus       121 L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~  200 (982)
                      .++.+-++..++. +|..+   .+++++|+|++|++++..+..|+++++|++|+|++|++++..|..|+++++|++|+++
T Consensus         9 ~~~~~c~~~~l~~-ip~~l---~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~   84 (570)
T 2z63_A            9 NITYQCMELNFYK-IPDNL---PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILT   84 (570)
T ss_dssp             TTEEECCSSCCSS-CCSSS---CSSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECT
T ss_pred             CcEEEeCCCCccc-cCCCc---cccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCc
Confidence            3456666666653 44322   3579999999999998888899999999999999999998888999999999999999


Q ss_pred             CcccccchhhHHhhhhhHHHHhhcccccccccCCCCCCCCCCCCEEecccCcCcc-cCchhhcCCCccceeecccccCCC
Q 002010          201 GIGLNGTVPAFLSRLKNLREMYIGYFNTYTGGIPPGFGALTQLQVLDMASCNISG-EIPTSLSRLKLLHSLFLQMNKLTG  279 (982)
Q Consensus       201 ~n~i~~~~~~~l~~l~~L~~L~l~~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~-~~~~~l~~l~~L~~L~L~~N~l~~  279 (982)
                      +|.+.+..|..|.++++|++|++++ |.+.+..+..++++++|++|++++|.+++ .+|..|+++++|++|++++|++++
T Consensus        85 ~n~l~~~~~~~~~~l~~L~~L~L~~-n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~  163 (570)
T 2z63_A           85 GNPIQSLALGAFSGLSSLQKLVAVE-TNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQS  163 (570)
T ss_dssp             TCCCCEECTTTTTTCTTCCEEECTT-SCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCE
T ss_pred             CCcCCccCHhhhcCccccccccccc-cccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccce
Confidence            9999988888999999999999986 44554444468899999999999999987 468889999999999999999998


Q ss_pred             CCCccccCCCCC----CEEEeeCCcccCcCchhhhcccchhhhhhccCCCCC----------------------------
Q 002010          280 HIPPQLSGLISL----KSLDLSLNYLTGEIPESFAALKNLTLLQLFKNNLRG----------------------------  327 (982)
Q Consensus       280 ~~~~~l~~l~~L----~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~----------------------------  327 (982)
                      ..+..++.+++|    +.|++++|.+++..|..+..+ +|+.|++++|....                            
T Consensus       164 ~~~~~~~~l~~L~~~~~~L~l~~n~l~~~~~~~~~~~-~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~  242 (570)
T 2z63_A          164 IYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGN  242 (570)
T ss_dssp             ECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTTTTC-EEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSS
T ss_pred             ecHHHccchhccchhhhhcccCCCCceecCHHHhccC-cceeEecccccccccchhhhhcCccccceeeeccccccCchh
Confidence            777888888888    889999999998888777765 78889888874321                            


Q ss_pred             ---CCCCcCCCCC--CccEEEccCC-CcccccCccccCCCcccEEEeccccccccCCccccCccccceeecccccccccC
Q 002010          328 ---PIPSFLGDFP--NLEVLQVWGN-NFTFELPENLGRNGKLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFIGPI  401 (982)
Q Consensus       328 ---~~p~~~~~l~--~L~~L~L~~N-~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~l~~N~~~~~~  401 (982)
                         .....+..++  .++.+++++| .+.+..|..+..+++|+.|++++|.++ .+|..+..+ +|++|++++|.+. .+
T Consensus       243 l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~l~~~~l~-~l~~~~~~~-~L~~L~l~~n~~~-~l  319 (570)
T 2z63_A          243 LEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNF-GWQHLELVNCKFG-QF  319 (570)
T ss_dssp             CEECCTTTTGGGGGSEEEEEEEEETTEEESCSTTTTGGGTTCSEEEEESCEEC-SCCBCCSCC-CCSEEEEESCBCS-SC
T ss_pred             hhhcchhhhccccccchhhhhhhcchhhhhhchhhhcCcCcccEEEecCccch-hhhhhhccC-CccEEeeccCccc-cc
Confidence               1111222222  2456677776 677778889999999999999999998 688888888 9999999999988 55


Q ss_pred             CccccCCCCCCEEEccCCccCCCCCccccCCCccccccCCCccccccC--Cccc-ccCCccEEEeeccccCCCCchhccC
Q 002010          402 PEELGQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLSGEL--PEKM-SGASLNQLKVANNNITGKIPAAIGN  478 (982)
Q Consensus       402 ~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~--~~~~-~~~~L~~L~L~~N~i~~~~p~~~~~  478 (982)
                      |.  ..+++|++|++++|.+.+..+.  ..+++|++|++++|.+++..  +..+ ...+|++|++++|++++..+. +..
T Consensus       320 ~~--~~l~~L~~L~l~~n~~~~~~~~--~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~-~~~  394 (570)
T 2z63_A          320 PT--LKLKSLKRLTFTSNKGGNAFSE--VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSN-FLG  394 (570)
T ss_dssp             CB--CBCSSCCEEEEESCBSCCBCCC--CBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEEE-EET
T ss_pred             Cc--ccccccCEEeCcCCcccccccc--ccCCCCCEEeCcCCccCccccccccccccCccCEEECCCCcccccccc-ccc
Confidence            54  5789999999999999877665  78899999999999998764  3333 347899999999999966555 999


Q ss_pred             CCCcceeeeccccccCCCc-cccccccccceeeeeccccCCCCCcccccccCCCeeeCCCCccc-CCCCcccccccccce
Q 002010          479 LPSLNILSLQNNRLEGEIP-VESFNLKMITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLY-GKIPPGISKLIDLSI  556 (982)
Q Consensus       479 l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~  556 (982)
                      +++|++|++++|++++..| ..+..+++|++|++++|++++..|..|.++++|+.|+|++|.++ +.+|..+..+++|++
T Consensus       395 l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~  474 (570)
T 2z63_A          395 LEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTF  474 (570)
T ss_dssp             CTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCE
T ss_pred             cCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCE
Confidence            9999999999999997766 46889999999999999999999999999999999999999998 679999999999999


Q ss_pred             EEcccccccccCccccccccccceecccCCccccCCCCC-ccccccccccccCCcCcccCCC
Q 002010          557 LNLSRNGITGSIPNEMRNMMSLTTLDLSYNNLIGNIPSG-GQFLAFNETSFIGNPNLCLLRN  617 (982)
Q Consensus       557 L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~-~~~~~~~~~~~~~n~~~c~~~~  617 (982)
                      |+|++|++++..|..+..+++|++|++++|++++.+|.. ..+..+....+.+||+.|.++.
T Consensus       475 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~  536 (570)
T 2z63_A          475 LDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR  536 (570)
T ss_dssp             EECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTT
T ss_pred             EECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCcc
Confidence            999999999998999999999999999999999988763 4567888889999999997653

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=2e-48  Score=435.66  Aligned_cols=250  Identities=23%  Similarity=0.340  Sum_probs=210.6

Q ss_pred             HhhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEe
Q 002010          691 LESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYE  769 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  769 (982)
                      .+.|+..+.||+|+||.||+|.. .+|+.||||++... .....+.+.+|+.+|++++|||||+++++|.+++..|+|||
T Consensus       150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~-~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmE  228 (423)
T 4fie_A          150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLR-KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME  228 (423)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEST-TCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEecc-chhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEe
Confidence            35799999999999999999965 56999999998543 34456678999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCC
Q 002010          770 YMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGA  849 (982)
Q Consensus       770 ~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  849 (982)
                      ||+||+|.+++..   ..+++.++..++.||+.||+|||+++   ||||||||+|||++.+|.+||+|||+|+.+...  
T Consensus       229 y~~gG~L~~~i~~---~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~--  300 (423)
T 4fie_A          229 FLEGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE--  300 (423)
T ss_dssp             CCTTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSS--
T ss_pred             CCCCCcHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCC--
Confidence            9999999999963   46999999999999999999999998   999999999999999999999999999876543  


Q ss_pred             cccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceee
Q 002010          850 SECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVV  929 (982)
Q Consensus       850 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  929 (982)
                      .......+||+.|||||++.+..|+.++||||+||++|||++|++||...... .....+......              
T Consensus       301 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~-~~~~~i~~~~~~--------------  365 (423)
T 4fie_A          301 VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL-KAMKMIRDNLPP--------------  365 (423)
T ss_dssp             CCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-HHHHHHHHSCCC--------------
T ss_pred             CccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH-HHHHHHHcCCCC--------------
Confidence            22345678999999999999999999999999999999999999999764332 223333222110              


Q ss_pred             cCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          930 DPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       930 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                        .+ ..+...+..+.+|+.+||++||++|||++|+++
T Consensus       366 --~~-~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~  400 (423)
T 4fie_A          366 --RL-KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  400 (423)
T ss_dssp             --CC-SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             --CC-cccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence              00 111223457889999999999999999999987

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=1.4e-48  Score=414.45  Aligned_cols=247  Identities=21%  Similarity=0.322  Sum_probs=192.8

Q ss_pred             HhhcccccccccccceEEEEEEe-CCCcEEEEEEeccCC--CCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEE
Q 002010          691 LESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRG--TGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLL  767 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  767 (982)
                      .++|++.+.||+|+||+||+|.. .+|+.||||++....  .......+.+|+.++++++|||||++++++.+++..|+|
T Consensus        12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv   91 (275)
T 3hyh_A           12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV   91 (275)
T ss_dssp             --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence            46899999999999999999975 569999999986543  233456789999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhcccc
Q 002010          768 YEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDA  847 (982)
Q Consensus       768 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  847 (982)
                      |||+ +|+|.+++..  ..++++.++..++.||+.|++|||+++   |+||||||+||++++++.+||+|||+|+...+.
T Consensus        92 mEy~-~g~L~~~l~~--~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~  165 (275)
T 3hyh_A           92 IEYA-GNELFDYIVQ--RDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG  165 (275)
T ss_dssp             EECC-CEEHHHHHHH--SCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred             EeCC-CCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence            9999 6899999973  468999999999999999999999998   999999999999999999999999999876533


Q ss_pred             CCcccccccccccccccccccccCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccc
Q 002010          848 GASECMSSVAGSYGYIAPEYAYTLKV-DEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVL  926 (982)
Q Consensus       848 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  926 (982)
                         ......+||+.|||||++.+..| +.++||||+||++|||+||+.||...... ...+.+.....            
T Consensus       166 ---~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~-~~~~~i~~~~~------------  229 (275)
T 3hyh_A          166 ---NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIP-VLFKNISNGVY------------  229 (275)
T ss_dssp             ------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHTCC------------
T ss_pred             ---CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHH-HHHHHHHcCCC------------
Confidence               23345789999999999998886 58999999999999999999999764322 22222221111            


Q ss_pred             eeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          927 AVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       927 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                              ..|...+.++.+++.+||+.||++|||++|+++
T Consensus       230 --------~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~  262 (275)
T 3hyh_A          230 --------TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ  262 (275)
T ss_dssp             --------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             --------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence                    112223457889999999999999999999987

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=100.00  E-value=4.2e-48  Score=462.41  Aligned_cols=478  Identities=20%  Similarity=0.203  Sum_probs=363.1

Q ss_pred             EEeccCCCCCCCChhhhhhcccceeeccCCccccccchhhhhcCCCccEEeccCccccCCCchhccccccccEEeecCcc
Q 002010          100 LTISNVNLTGRLPSEMALLTSLKVFNISGNVFQGNFAGQIVRGMTELQVLDAYNNNFTGPLPVEIASLKSLRHLSFGGNY  179 (982)
Q Consensus       100 L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~  179 (982)
                      .+.++++++ .+|..+.  ++|++|+|++|.+++..+ ..+.++++|++|+|++|++++..|..|+++++|++|+|++|+
T Consensus        10 c~~~~~~l~-~ip~~~~--~~L~~L~Ls~n~l~~~~~-~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~   85 (549)
T 2z81_A           10 CDGRSRSFT-SIPSGLT--AAMKSLDLSFNKITYIGH-GDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNH   85 (549)
T ss_dssp             EECTTSCCS-SCCSCCC--TTCCEEECCSSCCCEECS-STTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSC
T ss_pred             EECCCCccc-cccccCC--CCccEEECcCCccCccCh-hhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCc
Confidence            456666666 4554433  456666666665553322 234455555555555555555555555555555555555555


Q ss_pred             cccccCCCccccCcceEeeccCcccccchhhHHhhhhhHHHHhhcccccccccCCCCCCCCCCCCEEecccCcCcccC-c
Q 002010          180 FTGKIPQSYSEIQSLEYIGLNGIGLNGTVPAFLSRLKNLREMYIGYFNTYTGGIPPGFGALTQLQVLDMASCNISGEI-P  258 (982)
Q Consensus       180 l~~~~p~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~l~~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~-~  258 (982)
                      +++..|..|+++++|++|++++|.+.                        ...+|..++++++|++|++++|.+.+.+ +
T Consensus        86 l~~~~~~~~~~l~~L~~L~Ls~n~l~------------------------~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~  141 (549)
T 2z81_A           86 LSSLSSSWFGPLSSLKYLNLMGNPYQ------------------------TLGVTSLFPNLTNLQTLRIGNVETFSEIRR  141 (549)
T ss_dssp             CCSCCHHHHTTCTTCCEEECTTCCCS------------------------SSCSSCSCTTCTTCCEEEEEESSSCCEECT
T ss_pred             cCccCHHHhccCCCCcEEECCCCccc------------------------ccchhhhhhccCCccEEECCCCccccccCH
Confidence            55554444555555555555554443                        1145677899999999999999854444 4


Q ss_pred             hhhcCCCccceeecccccCCCCCCccccCCCCCCEEEeeCCcccCcCchhhhcccchhhhhhccCCCCCCC---CCcCCC
Q 002010          259 TSLSRLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQLFKNNLRGPI---PSFLGD  335 (982)
Q Consensus       259 ~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~---p~~~~~  335 (982)
                      ..|.++++|++|++++|++++..|..+..+++|++|++++|.+.......+..+++|++|++++|++++..   ......
T Consensus       142 ~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~  221 (549)
T 2z81_A          142 IDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEV  221 (549)
T ss_dssp             TTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSBSTTHHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCC
T ss_pred             hhhhcccccCeeeccCCcccccChhhhhccccCceEecccCcccccchhhHhhcccccEEEccCCccccccccccchhhh
Confidence            68999999999999999999989999999999999999999987443333467899999999999998752   223456


Q ss_pred             CCCccEEEccCCCcccccC----ccccCCCcccEEEeccccccccC------CccccCccccceeeccccccccc-----
Q 002010          336 FPNLEVLQVWGNNFTFELP----ENLGRNGKLLILDVTSNHLTGTI------PRDLCKGGKLKSLILMQNFFIGP-----  400 (982)
Q Consensus       336 l~~L~~L~L~~N~l~~~~~----~~l~~l~~L~~L~L~~N~l~~~~------p~~~~~~~~L~~L~l~~N~~~~~-----  400 (982)
                      +++|+.|++++|.+++..+    ..+..+.+|+.+++++|.+.+..      ...+..+++|+.|.+.++.+...     
T Consensus       222 ~~~L~~L~l~~n~l~~~~~~~l~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~  301 (549)
T 2z81_A          222 SSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYD  301 (549)
T ss_dssp             CCCCCEEEEESCEEEHHHHHHHHGGGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGGSCC
T ss_pred             hhcccceeccccccchhHHHHHHHHhhhhccccccccccccccccccccccchhhhhhhcccccccccccccchhhhccc
Confidence            8899999999999986544    34567789999999999988642      23456778999999999876532     


Q ss_pred             CCccccCCCCCCEEEccCCccCCCCCccc-cCCCccccccCCCccccccCCcc---c-ccCCccEEEeeccccCCCCc--
Q 002010          401 IPEELGQCKSLTKIRFSKNYLNGTIPAGL-FNLPLLNMMELDDNLLSGELPEK---M-SGASLNQLKVANNNITGKIP--  473 (982)
Q Consensus       401 ~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~L~~N~l~~~~~~~---~-~~~~L~~L~L~~N~i~~~~p--  473 (982)
                      ++..+....+|+.|++++|+++ .+|..+ ..+++|++|++++|.+++.+|..   + ..++|++|++++|++++..+  
T Consensus       302 l~~~~~~~~~L~~L~l~~n~l~-~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~  380 (549)
T 2z81_A          302 LSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTG  380 (549)
T ss_dssp             CCHHHHHSTTCCEEEEESSCCC-CCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHH
T ss_pred             chhhhhhcccceEEEeccCccc-cCCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEccCCcccccccch
Confidence            2222344678999999999998 778776 47999999999999999876432   2 23789999999999996543  


Q ss_pred             hhccCCCCcceeeeccccccCCCccccccccccceeeeeccccCCCCCcccccccCCCeeeCCCCcccCCCCcccccccc
Q 002010          474 AAIGNLPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYGKIPPGISKLID  553 (982)
Q Consensus       474 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~  553 (982)
                      ..+..+++|++|++++|+++ .+|..+..+++|++|++++|+|+ .+|..+  .++|+.|+|++|+|++.+    ..+++
T Consensus       381 ~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~~L~~L~Ls~N~l~-~l~~~~--~~~L~~L~Ls~N~l~~~~----~~l~~  452 (549)
T 2z81_A          381 EILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKTCI--PQTLEVLDVSNNNLDSFS----LFLPR  452 (549)
T ss_dssp             HHGGGCTTCCEEECTTCCCC-CCCSCCCCCTTCCEEECTTSCCS-CCCTTS--CTTCSEEECCSSCCSCCC----CCCTT
T ss_pred             hhhhcCCCCCEEECCCCCCc-cCChhhcccccccEEECCCCCcc-cccchh--cCCceEEECCCCChhhhc----ccCCh
Confidence            56899999999999999999 78989999999999999999998 445444  268999999999999753    57899


Q ss_pred             cceEEcccccccccCccccccccccceecccCCccccCCCC-CccccccccccccCCcCcccCC
Q 002010          554 LSILNLSRNGITGSIPNEMRNMMSLTTLDLSYNNLIGNIPS-GGQFLAFNETSFIGNPNLCLLR  616 (982)
Q Consensus       554 L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~-~~~~~~~~~~~~~~n~~~c~~~  616 (982)
                      |++|+|++|+|+ .+|. ...+++|++|||++|++++.+|. ...+..+....+.+||+.|+++
T Consensus       453 L~~L~Ls~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~  514 (549)
T 2z81_A          453 LQELYISRNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  514 (549)
T ss_dssp             CCEEECCSSCCS-SCCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCCHH
T ss_pred             hcEEECCCCccC-cCCC-cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCCCc
Confidence            999999999999 6776 57899999999999999998886 3466778888999999998653

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=100.00  E-value=4.8e-48  Score=458.40  Aligned_cols=453  Identities=18%  Similarity=0.197  Sum_probs=365.1

Q ss_pred             cEEEeccCCCCCCCChhhhhhcccceeeccCCccccccchhhhhcCCCccEEeccCccccCCCchhccccccccEEeecC
Q 002010           98 VNLTISNVNLTGRLPSEMALLTSLKVFNISGNVFQGNFAGQIVRGMTELQVLDAYNNNFTGPLPVEIASLKSLRHLSFGG  177 (982)
Q Consensus        98 ~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~  177 (982)
                      ++|++++|+++ .+|..+.  ++|++|+|++|.+++. +...+.++++|++|+|++|++++..|..|+++++|++|+|++
T Consensus         3 ~~l~ls~n~l~-~ip~~~~--~~L~~L~Ls~n~i~~~-~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~   78 (520)
T 2z7x_B            3 FLVDRSKNGLI-HVPKDLS--QKTTILNISQNYISEL-WTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSH   78 (520)
T ss_dssp             CEEECTTSCCS-SCCCSCC--TTCSEEECCSSCCCCC-CHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCS
T ss_pred             ceEecCCCCcc-ccccccc--ccccEEECCCCccccc-ChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCC
Confidence            57899999998 5777665  8899999999988754 345677889999999999999887788899999999999999


Q ss_pred             cccccccCCCccccCcceEeeccCcccccchhhHHhhhhhHHHHhhcccccccccCCCCCCCCCCCCEEecccCcCcccC
Q 002010          178 NYFTGKIPQSYSEIQSLEYIGLNGIGLNGTVPAFLSRLKNLREMYIGYFNTYTGGIPPGFGALTQLQVLDMASCNISGEI  257 (982)
Q Consensus       178 N~l~~~~p~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~l~~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~  257 (982)
                      |+++ .+|..  .+++|++|++++|.+.+.                        .+|..|+++++|++|++++|++++  
T Consensus        79 N~l~-~lp~~--~l~~L~~L~L~~N~l~~~------------------------~~p~~~~~l~~L~~L~L~~n~l~~--  129 (520)
T 2z7x_B           79 NKLV-KISCH--PTVNLKHLDLSFNAFDAL------------------------PICKEFGNMSQLKFLGLSTTHLEK--  129 (520)
T ss_dssp             SCCC-EEECC--CCCCCSEEECCSSCCSSC------------------------CCCGGGGGCTTCCEEEEEESSCCG--
T ss_pred             Ccee-ecCcc--ccCCccEEeccCCccccc------------------------cchhhhccCCcceEEEecCcccch--
Confidence            9988 56655  788888888888776521                        345677888899999999999986  


Q ss_pred             chhhcCCCcc--ceeecccccC--CCCCCccccCCC-CCCEEEeeCCcccCcCc-hhhhcccchhhhhhccCC-------
Q 002010          258 PTSLSRLKLL--HSLFLQMNKL--TGHIPPQLSGLI-SLKSLDLSLNYLTGEIP-ESFAALKNLTLLQLFKNN-------  324 (982)
Q Consensus       258 ~~~l~~l~~L--~~L~L~~N~l--~~~~~~~l~~l~-~L~~L~Ls~N~l~~~~~-~~l~~l~~L~~L~L~~N~-------  324 (982)
                       ..+..+++|  ++|++++|++  .+..|..+..+. +...+++++|.+.+.++ ..+..+++|+.|++++|.       
T Consensus       130 -~~~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~  208 (520)
T 2z7x_B          130 -SSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSY  208 (520)
T ss_dssp             -GGGGGGTTSCEEEEEEEECTTTTSSCCTTTTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHH
T ss_pred             -hhccccccceeeEEEeecccccccccccccccccccceEEEEeccCcchhhhhhhhhhcccceeeccccccccccccce
Confidence             357777777  9999999999  778888777765 34467788888876554 457788999999999987       


Q ss_pred             CCCCCCCcCCCCCCccEEEccCCCcccccCcccc---CCCcccEEEeccccccccCCccc-----cCccccceeeccccc
Q 002010          325 LRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLG---RNGKLLILDVTSNHLTGTIPRDL-----CKGGKLKSLILMQNF  396 (982)
Q Consensus       325 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~---~l~~L~~L~L~~N~l~~~~p~~~-----~~~~~L~~L~l~~N~  396 (982)
                      +.+.+| .++.+++|+.|++++|.+++..+..+.   ..++|++|++++|+++|.+|..+     .++++|+.+++++|.
T Consensus       209 ~~~~~~-~l~~l~~L~~L~l~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~  287 (520)
T 2z7x_B          209 FLSILA-KLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDV  287 (520)
T ss_dssp             HHHHHH-GGGGCTTCCEEEEEEEEEEHHHHHHHHHHHHTSSCSEEEEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECC
T ss_pred             eecchh-hhccccchhhccccccccCHHHHHHHHHHhhhCcccEEEeecccccCccccchhhcccccCceeEeccccccc
Confidence            666665 678899999999999988764333222   24589999999999998999888     888999999999998


Q ss_pred             ccccCC-ccccCC---CCCCEEEccCCccCCCCCccccCCCccccccCCCccccccCCccccc-CCccEEEeeccccCC-
Q 002010          397 FIGPIP-EELGQC---KSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLSGELPEKMSG-ASLNQLKVANNNITG-  470 (982)
Q Consensus       397 ~~~~~~-~~l~~l---~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~-~~L~~L~L~~N~i~~-  470 (982)
                      +  .+| ..+..+   .+|+.|++++|.+.+..  .+..+++|++|++++|.+++.+|..+.. ++|++|++++|++++ 
T Consensus       288 ~--~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~--~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l  363 (520)
T 2z7x_B          288 F--GFPQSYIYEIFSNMNIKNFTVSGTRMVHML--CPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKEL  363 (520)
T ss_dssp             C--CSCTHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBH
T ss_pred             e--ecchhhhhcccccCceeEEEcCCCcccccc--chhhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCcc
Confidence            8  455 555554   67999999999886432  1267888999999999999877776654 789999999999986 


Q ss_pred             -CCchhccCCCCcceeeeccccccCCCccc-cccccccceeeeeccccCCCCCcccccccCCCeeeCCCCcccCCCCccc
Q 002010          471 -KIPAAIGNLPSLNILSLQNNRLEGEIPVE-SFNLKMITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYGKIPPGI  548 (982)
Q Consensus       471 -~~p~~~~~l~~L~~L~L~~N~l~~~~p~~-~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~  548 (982)
                       .+|..++.+++|++|++++|++++.+|.. +..+++|++|++++|++++.+|..+.  ++|+.|+|++|+|+ .+|..+
T Consensus       364 ~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~  440 (520)
T 2z7x_B          364 SKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQV  440 (520)
T ss_dssp             HHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGG
T ss_pred             ccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhh
Confidence             55678889999999999999998757764 77788999999999999887777664  78999999999998 788888


Q ss_pred             ccccccceEEcccccccccCccc-cccccccceecccCCccccCCC
Q 002010          549 SKLIDLSILNLSRNGITGSIPNE-MRNMMSLTTLDLSYNNLIGNIP  593 (982)
Q Consensus       549 ~~l~~L~~L~Ls~N~l~~~~p~~-l~~l~~L~~L~Ls~N~l~~~ip  593 (982)
                      ..+++|+.|+|++|+|++ +|.. +..+++|++|++++|++++..+
T Consensus       441 ~~l~~L~~L~L~~N~l~~-l~~~~~~~l~~L~~L~l~~N~~~c~c~  485 (520)
T 2z7x_B          441 VKLEALQELNVASNQLKS-VPDGIFDRLTSLQKIWLHTNPWDCSCP  485 (520)
T ss_dssp             GGCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred             hcCCCCCEEECCCCcCCc-cCHHHhccCCcccEEECcCCCCcccCC
Confidence            899999999999999984 5554 8889999999999999988765

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=100.00  E-value=9.8e-48  Score=455.76  Aligned_cols=451  Identities=19%  Similarity=0.201  Sum_probs=318.9

Q ss_pred             EEEeccCCccccCCcCccccccccEEEeccCCCCCCCChhhhhhcccceeeccCCccccccchhhhhcCCCccEEeccCc
Q 002010           75 SLNVSFMPLFGSIPPEIGLLTKLVNLTISNVNLTGRLPSEMALLTSLKVFNISGNVFQGNFAGQIVRGMTELQVLDAYNN  154 (982)
Q Consensus        75 ~l~l~~~~l~g~~~~~i~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n  154 (982)
                      .+|++++++. .+|..+.  ++|++|+|++|++++..|..+..+++|++|+|++|.+++..+ ..+.++++|++|+|++|
T Consensus         4 ~l~ls~n~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~-~~~~~l~~L~~L~Ls~N   79 (520)
T 2z7x_B            4 LVDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDI-SVFKFNQELEYLDLSHN   79 (520)
T ss_dssp             EEECTTSCCS-SCCCSCC--TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEG-GGGTTCTTCCEEECCSS
T ss_pred             eEecCCCCcc-ccccccc--ccccEEECCCCcccccChhhccccccccEEecCCCccCCcCh-HHhhcccCCCEEecCCC
Confidence            4677777776 5777666  778888888888887766778888888888888888775433 45677888888888888


Q ss_pred             cccCCCchhccccccccEEeecCccccc-ccCCCccccCcceEeeccCcccccchhhHHhhhhhHHHHhhcccccccccC
Q 002010          155 NFTGPLPVEIASLKSLRHLSFGGNYFTG-KIPQSYSEIQSLEYIGLNGIGLNGTVPAFLSRLKNLREMYIGYFNTYTGGI  233 (982)
Q Consensus       155 ~l~~~~p~~l~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~l~~~n~~~~~~  233 (982)
                      +++ .+|..  .+++|++|+|++|++++ .+|..|+++++|++|++++|.+.+.                          
T Consensus        80 ~l~-~lp~~--~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~~--------------------------  130 (520)
T 2z7x_B           80 KLV-KISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKS--------------------------  130 (520)
T ss_dssp             CCC-EEECC--CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCGG--------------------------
T ss_pred             cee-ecCcc--ccCCccEEeccCCccccccchhhhccCCcceEEEecCcccchh--------------------------
Confidence            887 46655  77888888888888876 4677788888888888887776531                          


Q ss_pred             CCCCCCCCCC--CEEecccCcC--cccCchhhcCCC-ccceeecccccCCCCCCc-cccCCCCCCEEEeeCCc-------
Q 002010          234 PPGFGALTQL--QVLDMASCNI--SGEIPTSLSRLK-LLHSLFLQMNKLTGHIPP-QLSGLISLKSLDLSLNY-------  300 (982)
Q Consensus       234 p~~~~~l~~L--~~L~L~~n~l--~~~~~~~l~~l~-~L~~L~L~~N~l~~~~~~-~l~~l~~L~~L~Ls~N~-------  300 (982)
                        .++.+++|  ++|++++|.+  .+..|..+..+. +...+++++|++.+.++. .+..+++|+.|++++|.       
T Consensus       131 --~~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~  208 (520)
T 2z7x_B          131 --SVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSY  208 (520)
T ss_dssp             --GGGGGTTSCEEEEEEEECTTTTSSCCTTTTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHH
T ss_pred             --hccccccceeeEEEeecccccccccccccccccccceEEEEeccCcchhhhhhhhhhcccceeeccccccccccccce
Confidence              12334445  7788888887  667777776665 344567777777765543 46667788888888876       


Q ss_pred             ccCcCchhhhcccchhhhhhccCCCCCCCCCcCC---CCCCccEEEccCCCcccccCccc-----cCCCcccEEEecccc
Q 002010          301 LTGEIPESFAALKNLTLLQLFKNNLRGPIPSFLG---DFPNLEVLQVWGNNFTFELPENL-----GRNGKLLILDVTSNH  372 (982)
Q Consensus       301 l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~---~l~~L~~L~L~~N~l~~~~~~~l-----~~l~~L~~L~L~~N~  372 (982)
                      +.+.+| .+..+++|+.|++++|.+++..+..+.   ..++|++|++++|.+++.+|..+     +.+++|+.+++++|.
T Consensus       209 ~~~~~~-~l~~l~~L~~L~l~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~  287 (520)
T 2z7x_B          209 FLSILA-KLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDV  287 (520)
T ss_dssp             HHHHHH-GGGGCTTCCEEEEEEEEEEHHHHHHHHHHHHTSSCSEEEEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECC
T ss_pred             eecchh-hhccccchhhccccccccCHHHHHHHHHHhhhCcccEEEeecccccCccccchhhcccccCceeEeccccccc
Confidence            555554 677777888888877777643221111   13577888888888877777777     777888888888887


Q ss_pred             ccccCC-ccccCc---cccceeecccccccccCCccccCCCCCCEEEccCCccCCCCCccccCCCccccccCCCccccc-
Q 002010          373 LTGTIP-RDLCKG---GKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLSG-  447 (982)
Q Consensus       373 l~~~~p-~~~~~~---~~L~~L~l~~N~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-  447 (982)
                      +  .+| ..+..+   .+|+.|++++|.+.+..  .+..+++|++|++++|++++.+|..+..+++|++|++++|++++ 
T Consensus       288 ~--~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~--~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l  363 (520)
T 2z7x_B          288 F--GFPQSYIYEIFSNMNIKNFTVSGTRMVHML--CPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKEL  363 (520)
T ss_dssp             C--CSCTHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBH
T ss_pred             e--ecchhhhhcccccCceeEEEcCCCcccccc--chhhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCcc
Confidence            7  455 444444   56788888888765432  12567778888888888887777778888888888888888875 


Q ss_pred             -cCCcccc-cCCccEEEeeccccCCCCch-hccCCCCcceeeeccccccCCCccccccccccceeeeeccccCCCCCccc
Q 002010          448 -ELPEKMS-GASLNQLKVANNNITGKIPA-AIGNLPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIPYSI  524 (982)
Q Consensus       448 -~~~~~~~-~~~L~~L~L~~N~i~~~~p~-~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~  524 (982)
                       .+|..+. .++|++|++++|++++.+|. .+..+++|++|++++|++++.+|..+.  ++|++|+|++|+|+ .+|..+
T Consensus       364 ~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~  440 (520)
T 2z7x_B          364 SKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQV  440 (520)
T ss_dssp             HHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGG
T ss_pred             ccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhh
Confidence             3334343 36788888888888764554 477778888888888888766666553  67888888888887 677766


Q ss_pred             ccccCCCeeeCCCCcccCCCCcc-cccccccceEEcccccccccCc
Q 002010          525 SQCHSLTSVDLSRNSLYGKIPPG-ISKLIDLSILNLSRNGITGSIP  569 (982)
Q Consensus       525 ~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~Ls~N~l~~~~p  569 (982)
                      ..+++|+.|+|++|+|+ .+|.. |..+++|++|+|++|++++..+
T Consensus       441 ~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~l~~N~~~c~c~  485 (520)
T 2z7x_B          441 VKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSCP  485 (520)
T ss_dssp             GGCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred             hcCCCCCEEECCCCcCC-ccCHHHhccCCcccEEECcCCCCcccCC
Confidence            77888888888888887 45544 7778888888888888775433

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=1.2e-48  Score=420.80  Aligned_cols=248  Identities=24%  Similarity=0.249  Sum_probs=199.1

Q ss_pred             hhcccccccccccceEEEEEEe----CCCcEEEEEEeccCC-CCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEE
Q 002010          692 ESLKDENIIGKGGAGIVYRGSM----PDGIDVAIKRLVGRG-TGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLL  766 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  766 (982)
                      ++|++.+.||+|+||+||+|+.    .+++.||||++.... .......+.+|+.++++++|||||++++++.+++..|+
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            5799999999999999999965    247889999985432 12233468899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccc
Q 002010          767 LYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQD  846 (982)
Q Consensus       767 v~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  846 (982)
                      |||||+||+|.+++.  +.+.+++.++..++.||+.||+|||+++   |+||||||+|||+++++.+||+|||+|+...+
T Consensus       104 vmEy~~gg~L~~~l~--~~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~  178 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLS--KEVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESID  178 (304)
T ss_dssp             EECCCTTCEEHHHHH--HHCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC---
T ss_pred             EEEcCCCCCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceeccC
Confidence            999999999999997  3467999999999999999999999998   99999999999999999999999999986543


Q ss_pred             cCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccc
Q 002010          847 AGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVL  926 (982)
Q Consensus       847 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  926 (982)
                      .  .......+||+.|||||++.+..|+.++||||+||++|||+||++||......+....+ .....            
T Consensus       179 ~--~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i-~~~~~------------  243 (304)
T 3ubd_A          179 H--EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMI-LKAKL------------  243 (304)
T ss_dssp             ----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-HHCCC------------
T ss_pred             C--CccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHH-HcCCC------------
Confidence            2  22345678999999999999999999999999999999999999999764332222222 21111            


Q ss_pred             eeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCH-----HHHHH
Q 002010          927 AVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTM-----REVVH  967 (982)
Q Consensus       927 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~-----~ell~  967 (982)
                              ..|...+.++.+++.+||++||++|||+     +|+++
T Consensus       244 --------~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~  281 (304)
T 3ubd_A          244 --------GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR  281 (304)
T ss_dssp             --------CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred             --------CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence                    1122334578899999999999999984     67764

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=100.00  E-value=1.2e-46  Score=458.31  Aligned_cols=552  Identities=18%  Similarity=0.141  Sum_probs=376.1

Q ss_pred             CCCCCCCCCCCCCCCccceeeeCCCCCEEEEEeccCCccccCCcCccccccccEEEeccCCCCCCCChhhhhhcccceee
Q 002010           46 GLKNWEPSSSPSAHCSFSGVTCDQDSRVVSLNVSFMPLFGSIPPEIGLLTKLVNLTISNVNLTGRLPSEMALLTSLKVFN  125 (982)
Q Consensus        46 ~~~~w~~~~~~~~~C~w~gv~C~~~~~v~~l~l~~~~l~g~~~~~i~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~  125 (982)
                      .+++|..+.|    ..|..+.|......+  +.++.++. .||+.|.  +++++|+|++|+|++..|..|.++++|++||
T Consensus        12 ~~~~~~~~~p----~~~~~c~~~~~~~~~--~c~~~~l~-~vP~~lp--~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~   82 (635)
T 4g8a_A           12 KLAAANSSIP----ESWEPCVEVVPNITY--QCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLD   82 (635)
T ss_dssp             -----------------CCSEEEETTTEE--ECTTSCCS-SCCSSSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEE
T ss_pred             hhhcccCCCC----CCCCCccccCCCCEE--ECCCCCcC-ccCCCCC--cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEE
Confidence            4777765422    245555554333332  33333433 5676553  5788999999999877777889999999999


Q ss_pred             ccCCccccccchhhhhcCCCccEEeccCccccCCCchhccccccccEEeecCcccccccCCCccccCcceEeeccCcccc
Q 002010          126 ISGNVFQGNFAGQIVRGMTELQVLDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLNGIGLN  205 (982)
Q Consensus       126 Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~i~  205 (982)
                      |++|.+++ ++..+|.++++|++|+|++|+|++..|..|+++++|++|+|++|++++..+..|+++++|++|++++|.+.
T Consensus        83 Ls~N~i~~-i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~  161 (635)
T 4g8a_A           83 LSRCEIQT-IEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ  161 (635)
T ss_dssp             CTTCCCCE-ECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCC
T ss_pred             CCCCcCCC-cChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCccc
Confidence            99998874 45567788899999999999988766777888999999999999998877778889999999999888876


Q ss_pred             c-chhhHHhhhhhHHHHhhcccccccccCCCCCCCCCCCC----EEecccCcCcccCchhhcCCCccceeecccccCCCC
Q 002010          206 G-TVPAFLSRLKNLREMYIGYFNTYTGGIPPGFGALTQLQ----VLDMASCNISGEIPTSLSRLKLLHSLFLQMNKLTGH  280 (982)
Q Consensus       206 ~-~~~~~l~~l~~L~~L~l~~~n~~~~~~p~~~~~l~~L~----~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~  280 (982)
                      + ..|..+..+++|++|+++. |.+.+..|..|..+.+++    .++++.|.++...+..+ ....++.+++++|.....
T Consensus       162 ~~~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~l~~L~~l~~~~~~~~ls~n~l~~i~~~~~-~~~~~~~l~l~~n~~~~~  239 (635)
T 4g8a_A          162 SFKLPEYFSNLTNLEHLDLSS-NKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAF-KEIRLHKLTLRNNFDSLN  239 (635)
T ss_dssp             CCCCCGGGGGCTTCCEEECCS-SCCCEECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTT-TTCEEEEEEEESCCSSHH
T ss_pred             cCCCchhhccchhhhhhcccC-ccccccccccccchhhhhhhhhhhhcccCcccccCcccc-cchhhhhhhhhccccccc
Confidence            5 3455666666666666654 344444444444443332    45566666654433333 223445555555544321


Q ss_pred             -CCccccCCCCCCEEEeeCCc------ccCcCchhhhcccchhhhhhccCCCCC---CCCCcCCCCCCccEEEccCCCcc
Q 002010          281 -IPPQLSGLISLKSLDLSLNY------LTGEIPESFAALKNLTLLQLFKNNLRG---PIPSFLGDFPNLEVLQVWGNNFT  350 (982)
Q Consensus       281 -~~~~l~~l~~L~~L~Ls~N~------l~~~~~~~l~~l~~L~~L~L~~N~l~~---~~p~~~~~l~~L~~L~L~~N~l~  350 (982)
                       .+..+..+..++...+..+.      +.......+..+..+...++..+....   ..+..+..+.+++.+.+.+|.+.
T Consensus       240 ~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~  319 (635)
T 4g8a_A          240 VMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDGIIDLFNCLTNVSSFSLVSVTIE  319 (635)
T ss_dssp             HHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEECCCSCEEECTTTTGGGTTCSEEEEESCEEE
T ss_pred             ccchhhcCCcccccccccccccccccccccccccccccccchhhhhhhhhhhcccccchhhhhhhhcccccccccccccc
Confidence             22334455555554443322      121222333334444444443333221   23344556677888888888776


Q ss_pred             cccCccccCCCcccEEEeccccccccCCccccCccccceeecccccccccCCccccCCCCCCEEEccCCccCC--CCCcc
Q 002010          351 FELPENLGRNGKLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNG--TIPAG  428 (982)
Q Consensus       351 ~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~l~~N~~~~~~~~~l~~l~~L~~L~Ls~N~l~~--~~p~~  428 (982)
                      ..  ..+.....|+.|++++|.+.+..+.   .+..|+.+++..|.+...  .....+++|+.|++++|.+..  ..+..
T Consensus       320 ~~--~~~~~~~~L~~L~l~~~~~~~~~~~---~l~~L~~l~l~~n~~~~~--~~~~~l~~L~~L~ls~n~l~~~~~~~~~  392 (635)
T 4g8a_A          320 RV--KDFSYNFGWQHLELVNCKFGQFPTL---KLKSLKRLTFTSNKGGNA--FSEVDLPSLEFLDLSRNGLSFKGCCSQS  392 (635)
T ss_dssp             EC--GGGGSCCCCSEEEEESCEESSCCCC---BCTTCCEEEEESCCSCCB--CCCCBCTTCCEEECCSSCCBEEEECCHH
T ss_pred             cc--cccccchhhhhhhcccccccCcCcc---cchhhhhcccccccCCCC--cccccccccccchhhccccccccccccc
Confidence            43  3355667788888888888754432   456777888888876543  234568888889998888753  44566


Q ss_pred             ccCCCccccccCCCccccccCCcccccCCccEEEeeccccCCCCc-hhccCCCCcceeeeccccccCCCccccccccccc
Q 002010          429 LFNLPLLNMMELDDNLLSGELPEKMSGASLNQLKVANNNITGKIP-AAIGNLPSLNILSLQNNRLEGEIPVESFNLKMIT  507 (982)
Q Consensus       429 ~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~L~~N~i~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~  507 (982)
                      +..+.+|+.+++..|.+....+......+|+.+++++|+.....+ ..|..+++++.+++++|++++..+..+..++.|+
T Consensus       393 ~~~~~~L~~L~~~~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~  472 (635)
T 4g8a_A          393 DFGTISLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLE  472 (635)
T ss_dssp             HHSCSCCCEEECCSCSEEEECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCC
T ss_pred             hhhhhhhhhhhccccccccccccccccccccchhhhhccccccccccccccccccccccccccccccccccccccchhhh
Confidence            677888888888888887766665566788888888877765544 4577888899999999998888888888888999


Q ss_pred             eeeeecccc-CCCCCcccccccCCCeeeCCCCcccCCCCcccccccccceEEcccccccccCccccccccccceecccCC
Q 002010          508 SINISDNNI-SGEIPYSISQCHSLTSVDLSRNSLYGKIPPGISKLIDLSILNLSRNGITGSIPNEMRNMMSLTTLDLSYN  586 (982)
Q Consensus       508 ~L~Ls~N~l-~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N  586 (982)
                      .|+|++|++ .+.+|..|..+++|++|||++|+|++.+|..|.++++|++|+|++|+|++..|..|..+++|++|||++|
T Consensus       473 ~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N  552 (635)
T 4g8a_A          473 VLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLN  552 (635)
T ss_dssp             EEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTS
T ss_pred             hhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCC
Confidence            999998875 4457788888999999999999998888888999999999999999998888888888999999999999


Q ss_pred             ccccCCCCCcc-c-cccccccccCCcCcccCC
Q 002010          587 NLIGNIPSGGQ-F-LAFNETSFIGNPNLCLLR  616 (982)
Q Consensus       587 ~l~~~ip~~~~-~-~~~~~~~~~~n~~~c~~~  616 (982)
                      +|++.+|...+ + .++....+.||||.|++.
T Consensus       553 ~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C~  584 (635)
T 4g8a_A          553 HIMTSKKQELQHFPSSLAFLNLTQNDFACTCE  584 (635)
T ss_dssp             CCCBCCSSCTTCCCTTCCEEECTTCCBCCSGG
T ss_pred             cCCCCCHHHHHhhhCcCCEEEeeCCCCcccCC
Confidence            99988886432 2 456677788999999664

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=1.4e-47  Score=417.33  Aligned_cols=267  Identities=27%  Similarity=0.341  Sum_probs=200.7

Q ss_pred             hhcccccccccccceEEEEEEeCCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCC----ccEEE
Q 002010          692 ESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRD----TNLLL  767 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~lv  767 (982)
                      ++|...+.||+|+||+||+|++ +|+.||||++....  .....+..|+..+.+++|||||+++|++.+++    ..++|
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~--~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV   79 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE--ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV   79 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc--hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEE
Confidence            5678889999999999999988 78999999984321  11222334566667889999999999997654    46999


Q ss_pred             EeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC-----CCcEEecCCCCCcEEEcCCCCEEEeccccch
Q 002010          768 YEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDC-----SPLIIHRDVKSNNILLDSDFEAHVADFGLAK  842 (982)
Q Consensus       768 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-----~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~  842 (982)
                      ||||++|+|.++++.   .+++++.+.+++.|+++||+|||++.     .++||||||||+|||++.++++||+|||+|+
T Consensus        80 ~Ey~~~gsL~~~l~~---~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~  156 (303)
T 3hmm_A           80 SDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  156 (303)
T ss_dssp             EECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             ecCCCCCcHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence            999999999999974   46899999999999999999999761     2349999999999999999999999999998


Q ss_pred             hccccCCc--ccccccccccccccccccccC------CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCch----------
Q 002010          843 FLQDAGAS--ECMSSVAGSYGYIAPEYAYTL------KVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVD----------  904 (982)
Q Consensus       843 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslG~il~elltg~~p~~~~~~~~~----------  904 (982)
                      ........  ......+||+.|||||++.+.      .++.++|||||||++|||+||.+||....+...          
T Consensus       157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~  236 (303)
T 3hmm_A          157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP  236 (303)
T ss_dssp             EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred             cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccc
Confidence            76543221  122346799999999998754      467899999999999999999887754322110          


Q ss_pred             HHHHHHHhccCCCCCCcccccceeecCCCCC--CChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCCC
Q 002010          905 IVRWVRKTTSEVSQPSDAASVLAVVDPRLSG--YPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQS  975 (982)
Q Consensus       905 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~~~  975 (982)
                      ....+.....           ....+|.++.  .+.+.+..+.+++.+||+.||++||||+||++.|+++.+.
T Consensus       237 ~~~~~~~~~~-----------~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~  298 (303)
T 3hmm_A          237 SVEEMRKVVC-----------EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  298 (303)
T ss_dssp             CHHHHHHHHT-----------TSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             hHHHHHHHHh-----------cccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence            0011111000           0112223321  1234567899999999999999999999999999876543

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=1.3e-46  Score=407.27  Aligned_cols=257  Identities=21%  Similarity=0.346  Sum_probs=193.0

Q ss_pred             HhhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCc------
Q 002010          691 LESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDT------  763 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~------  763 (982)
                      .++|+..+.||+|+||+||+|+. .+|+.||||++.........+.+.+|+.++++++|||||++++++.+.+.      
T Consensus         4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~   83 (299)
T 4g31_A            4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP   83 (299)
T ss_dssp             HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred             chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence            45799999999999999999965 56999999999655444455678999999999999999999999875443      


Q ss_pred             ------cEEEEeccCCCCHHHHhhcCCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEe
Q 002010          764 ------NLLLYEYMPNGSLGEMLHGAKG-GHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVA  836 (982)
Q Consensus       764 ------~~lv~e~~~~~sL~~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~  836 (982)
                            .|+|||||++|+|.+++..... ...++..+..++.||+.||+|||+++   |+||||||+||+++.++.+||+
T Consensus        84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~  160 (299)
T 4g31_A           84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVG  160 (299)
T ss_dssp             ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEEC
T ss_pred             cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEc
Confidence                  5899999999999999974332 34566778899999999999999998   9999999999999999999999


Q ss_pred             ccccchhccccCCc----------ccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHH
Q 002010          837 DFGLAKFLQDAGAS----------ECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIV  906 (982)
Q Consensus       837 DfG~a~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~  906 (982)
                      |||+|+.+......          ......+||+.|||||++.+..|+.++||||+||++|||++   ||...   .+..
T Consensus       161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~---~~~~  234 (299)
T 4g31_A          161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQ---MERV  234 (299)
T ss_dssp             CCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSH---HHHH
T ss_pred             cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCc---cHHH
Confidence            99999877543211          12344679999999999999999999999999999999996   77532   1111


Q ss_pred             HHHHHhccCCCCCCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH--HhcCC
Q 002010          907 RWVRKTTSEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH--MLANP  972 (982)
Q Consensus       907 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~--~L~~~  972 (982)
                      ..+.....                ..++...........+++.+||++||++|||++|+++  .++++
T Consensus       235 ~~~~~~~~----------------~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~  286 (299)
T 4g31_A          235 RTLTDVRN----------------LKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDL  286 (299)
T ss_dssp             HHHHHHHT----------------TCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC
T ss_pred             HHHHHHhc----------------CCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCC
Confidence            21111111                0011111222335678999999999999999999987  45544

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=100.00  E-value=2.8e-44  Score=437.45  Aligned_cols=520  Identities=21%  Similarity=0.201  Sum_probs=428.9

Q ss_pred             ceeeeCCC----------CCEEEEEeccCCccccCCcCccccccccEEEeccCCCCCCCChhhhhhcccceeeccCCccc
Q 002010           63 SGVTCDQD----------SRVVSLNVSFMPLFGSIPPEIGLLTKLVNLTISNVNLTGRLPSEMALLTSLKVFNISGNVFQ  132 (982)
Q Consensus        63 ~gv~C~~~----------~~v~~l~l~~~~l~g~~~~~i~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~  132 (982)
                      ..|.|...          ..++.|||+++.+.+-.|.+++.+++|++|+|++|++++..|.+|.++++|++|+|++|+++
T Consensus        34 ~~~~c~~~~l~~vP~~lp~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~  113 (635)
T 4g8a_A           34 ITYQCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ  113 (635)
T ss_dssp             TEEECTTSCCSSCCSSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCC
T ss_pred             CEEECCCCCcCccCCCCCcCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCC
Confidence            45778642          25789999999998777778999999999999999999887889999999999999999997


Q ss_pred             cccchhhhhcCCCccEEeccCccccCCCchhccccccccEEeecCccccc-ccCCCccccCcceEeeccCcccccchhhH
Q 002010          133 GNFAGQIVRGMTELQVLDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTG-KIPQSYSEIQSLEYIGLNGIGLNGTVPAF  211 (982)
Q Consensus       133 ~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~L~~n~i~~~~~~~  211 (982)
                      + ++..+|.++++|++|+|++|++++..+..|+++++|++|+|++|++++ ..|..++.+++|++|++++|.+.+..+..
T Consensus       114 ~-l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~  192 (635)
T 4g8a_A          114 S-LALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTD  192 (635)
T ss_dssp             E-ECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGG
T ss_pred             C-CCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCcccccccccc
Confidence            5 566778999999999999999998777889999999999999999976 46888999999999999999999999999


Q ss_pred             HhhhhhHHHHh----hcccccccccCCCCCCCCCCCCEEecccCcCccc-CchhhcCCCccceeecccccC------CCC
Q 002010          212 LSRLKNLREMY----IGYFNTYTGGIPPGFGALTQLQVLDMASCNISGE-IPTSLSRLKLLHSLFLQMNKL------TGH  280 (982)
Q Consensus       212 l~~l~~L~~L~----l~~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~-~~~~l~~l~~L~~L~L~~N~l------~~~  280 (982)
                      +..+.+++.+.    ++. |.+. .+++.......++.|++.+|..... .+..+..+..++...+..+..      ...
T Consensus       193 l~~L~~l~~~~~~~~ls~-n~l~-~i~~~~~~~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~  270 (635)
T 4g8a_A          193 LRVLHQMPLLNLSLDLSL-NPMN-FIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKF  270 (635)
T ss_dssp             GHHHHTCTTCCCEEECTT-CCCC-EECTTTTTTCEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCC
T ss_pred             ccchhhhhhhhhhhhccc-Cccc-ccCcccccchhhhhhhhhcccccccccchhhcCCcccccccccccccccccccccc
Confidence            99888877543    332 3333 3455555566788899999877643 345678888888777654433      333


Q ss_pred             CCccccCCCCCCEEEeeCCcccC---cCchhhhcccchhhhhhccCCCCCCCCCcCCCCCCccEEEccCCCcccccCccc
Q 002010          281 IPPQLSGLISLKSLDLSLNYLTG---EIPESFAALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENL  357 (982)
Q Consensus       281 ~~~~l~~l~~L~~L~Ls~N~l~~---~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l  357 (982)
                      ....+..+..+..+++..+....   ..+..+..+.+++.+++.+|.+....  .+....+|+.|++.+|.+....+.  
T Consensus       271 ~~~~~~~~~~l~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~--~~~~~~~L~~L~l~~~~~~~~~~~--  346 (635)
T 4g8a_A          271 DKSALEGLCNLTIEEFRLAYLDYYLDGIIDLFNCLTNVSSFSLVSVTIERVK--DFSYNFGWQHLELVNCKFGQFPTL--  346 (635)
T ss_dssp             CTTTTGGGGGSEEEEEEEECCCSCEEECTTTTGGGTTCSEEEEESCEEEECG--GGGSCCCCSEEEEESCEESSCCCC--
T ss_pred             cccccccccchhhhhhhhhhhcccccchhhhhhhhccccccccccccccccc--ccccchhhhhhhcccccccCcCcc--
Confidence            34455566677777776655432   23345666778888888888877433  356677899999999998855443  


Q ss_pred             cCCCcccEEEeccccccccCCccccCccccceeeccccccc--ccCCccccCCCCCCEEEccCCccCCCCCccccCCCcc
Q 002010          358 GRNGKLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFI--GPIPEELGQCKSLTKIRFSKNYLNGTIPAGLFNLPLL  435 (982)
Q Consensus       358 ~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~l~~N~~~--~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L  435 (982)
                       .+..|+.++++.|.+...  .....+++|+.|++++|.+.  +..+..+..+.+|++++++.|.+. ..+..+..++.|
T Consensus       347 -~l~~L~~l~l~~n~~~~~--~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~-~~~~~~~~l~~L  422 (635)
T 4g8a_A          347 -KLKSLKRLTFTSNKGGNA--FSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVI-TMSSNFLGLEQL  422 (635)
T ss_dssp             -BCTTCCEEEEESCCSCCB--CCCCBCTTCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEE-EECSCCTTCTTC
T ss_pred             -cchhhhhcccccccCCCC--cccccccccccchhhccccccccccccchhhhhhhhhhhccccccc-cccccccccccc
Confidence             456788999999988643  34557889999999999875  456777888999999999999987 566778899999


Q ss_pred             ccccCCCccccccCCcc-cc-cCCccEEEeeccccCCCCchhccCCCCcceeeeccccc-cCCCccccccccccceeeee
Q 002010          436 NMMELDDNLLSGELPEK-MS-GASLNQLKVANNNITGKIPAAIGNLPSLNILSLQNNRL-EGEIPVESFNLKMITSINIS  512 (982)
Q Consensus       436 ~~L~L~~N~l~~~~~~~-~~-~~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l-~~~~p~~~~~l~~L~~L~Ls  512 (982)
                      +.+++..|......+.. +. ...++.+++++|++.+..+..+..+++|+.|++++|++ .+..|..+..+++|++|+|+
T Consensus       423 ~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls  502 (635)
T 4g8a_A          423 EHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLS  502 (635)
T ss_dssp             CEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECT
T ss_pred             cchhhhhccccccccccccccccccccccccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECC
Confidence            99999998887765543 22 37899999999999999999999999999999999985 44678889999999999999


Q ss_pred             ccccCCCCCcccccccCCCeeeCCCCcccCCCCcccccccccceEEcccccccccCccccccc-cccceecccCCccccC
Q 002010          513 DNNISGEIPYSISQCHSLTSVDLSRNSLYGKIPPGISKLIDLSILNLSRNGITGSIPNEMRNM-MSLTTLDLSYNNLIGN  591 (982)
Q Consensus       513 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l-~~L~~L~Ls~N~l~~~  591 (982)
                      +|+|++..|..|.++++|++|+|++|+|++..|..|.++++|++|+|++|+|++..|..+..+ ++|++|+|++|++++.
T Consensus       503 ~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~  582 (635)
T 4g8a_A          503 QCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACT  582 (635)
T ss_dssp             TSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCS
T ss_pred             CCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCccc
Confidence            999999999999999999999999999999889999999999999999999999999999998 6899999999999886


Q ss_pred             CC
Q 002010          592 IP  593 (982)
Q Consensus       592 ip  593 (982)
                      -.
T Consensus       583 C~  584 (635)
T 4g8a_A          583 CE  584 (635)
T ss_dssp             GG
T ss_pred             CC
Confidence            54

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=100.00  E-value=8.9e-45  Score=433.97  Aligned_cols=455  Identities=19%  Similarity=0.183  Sum_probs=345.7

Q ss_pred             cccEEEeccCCCCCCCChhhhhhcccceeeccCCccccccchhhhhcCCCccEEeccCccccCCCchhccccccccEEee
Q 002010           96 KLVNLTISNVNLTGRLPSEMALLTSLKVFNISGNVFQGNFAGQIVRGMTELQVLDAYNNNFTGPLPVEIASLKSLRHLSF  175 (982)
Q Consensus        96 ~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L  175 (982)
                      ..+++++++|++++ +|..+.  ++|++|+|++|.+.+. +...+.++++|++|+|++|++++..|..|+++++|++|+|
T Consensus        32 ~~~~l~ls~~~L~~-ip~~~~--~~L~~L~Ls~N~i~~~-~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  107 (562)
T 3a79_B           32 LESMVDYSNRNLTH-VPKDLP--PRTKALSLSQNSISEL-RMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDV  107 (562)
T ss_dssp             -CCEEECTTSCCCS-CCTTSC--TTCCEEECCSSCCCCC-CGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEEC
T ss_pred             CCcEEEcCCCCCcc-CCCCCC--CCcCEEECCCCCcccc-ChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEEC
Confidence            34789999999985 776554  7888888888888754 3455678888888888888888777888888888888888


Q ss_pred             cCcccccccCCCccccCcceEeeccCcccccchhhHHhhhhhHHHHhhcccccccccCCCCCCCCCCCCEEecccCcCcc
Q 002010          176 GGNYFTGKIPQSYSEIQSLEYIGLNGIGLNGTVPAFLSRLKNLREMYIGYFNTYTGGIPPGFGALTQLQVLDMASCNISG  255 (982)
Q Consensus       176 ~~N~l~~~~p~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~l~~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~  255 (982)
                      ++|+++ .+|..  .+++|++|++++|.+.+.                        .+|..|+++++|++|++++|++++
T Consensus       108 s~N~l~-~lp~~--~l~~L~~L~Ls~N~l~~l------------------------~~p~~~~~l~~L~~L~L~~n~l~~  160 (562)
T 3a79_B          108 SHNRLQ-NISCC--PMASLRHLDLSFNDFDVL------------------------PVCKEFGNLTKLTFLGLSAAKFRQ  160 (562)
T ss_dssp             TTSCCC-EECSC--CCTTCSEEECCSSCCSBC------------------------CCCGGGGGCTTCCEEEEECSBCCT
T ss_pred             CCCcCC-ccCcc--ccccCCEEECCCCCcccc------------------------CchHhhcccCcccEEecCCCcccc
Confidence            888887 56655  778888888887766521                        234567788899999999999886


Q ss_pred             cCchhhcCCCcc--ceeecccccC--CCCCCccccCCC-CCCEEEeeCCcccCcCc-hhhhcccchhhhhhccCCC----
Q 002010          256 EIPTSLSRLKLL--HSLFLQMNKL--TGHIPPQLSGLI-SLKSLDLSLNYLTGEIP-ESFAALKNLTLLQLFKNNL----  325 (982)
Q Consensus       256 ~~~~~l~~l~~L--~~L~L~~N~l--~~~~~~~l~~l~-~L~~L~Ls~N~l~~~~~-~~l~~l~~L~~L~L~~N~l----  325 (982)
                      .   .+..+++|  ++|++++|++  ++..|..+..+. ..-.+++++|.+.+.++ ..+..+++|+.|++++|+.    
T Consensus       161 ~---~~~~l~~L~L~~L~L~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~  237 (562)
T 3a79_B          161 L---DLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQR  237 (562)
T ss_dssp             T---TTGGGTTSCEEEEEEEESSCCCCSSSCCEEEECCEEEEEEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHH
T ss_pred             C---chhhhhhceeeEEEeecccccccccCcccccccCcceEEEEecCccchhhhhhhcccccceEEEecccccccccch
Confidence            3   34555555  9999999998  878888887765 12256788888876554 3466788899999988852    


Q ss_pred             -CCCCCCcCCCCCCccEEEccCCCccccc----CccccCCCcccEEEeccccccccCCccc-----cCccccceeecccc
Q 002010          326 -RGPIPSFLGDFPNLEVLQVWGNNFTFEL----PENLGRNGKLLILDVTSNHLTGTIPRDL-----CKGGKLKSLILMQN  395 (982)
Q Consensus       326 -~~~~p~~~~~l~~L~~L~L~~N~l~~~~----~~~l~~l~~L~~L~L~~N~l~~~~p~~~-----~~~~~L~~L~l~~N  395 (982)
                       .+ .+..+..+++|+.|+++++.+.+..    +..+ ...+|++|++++|.++|.+|..+     .++..|+.+++..|
T Consensus       238 l~~-~~~~l~~l~~L~~L~L~~~~l~~~~~~~~~~~~-~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~  315 (562)
T 3a79_B          238 LMT-FLSELTRGPTLLNVTLQHIETTWKCSVKLFQFF-WPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQ  315 (562)
T ss_dssp             HHH-HHHHHHSCSSCEEEEEEEEEECHHHHHHHHHHH-TTSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEEC
T ss_pred             HHH-HHHHHhccCcceEEEecCCcCcHHHHHHHHHhh-hcccccEEEEeccEeeccccchhhhcccccchheehhhcccc
Confidence             21 1234667788888888888776432    1222 23489999999999998888877     66677777777777


Q ss_pred             cccccCC-ccccC---CCCCCEEEccCCccCCCCCccccCCCccccccCCCccccccCCccccc-CCccEEEeeccccCC
Q 002010          396 FFIGPIP-EELGQ---CKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLSGELPEKMSG-ASLNQLKVANNNITG  470 (982)
Q Consensus       396 ~~~~~~~-~~l~~---l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~-~~L~~L~L~~N~i~~  470 (982)
                      .+  .+| ..+..   ..+|++|++++|.+....  ....+++|++|++++|.+++.+|..+.. ++|++|++++|++++
T Consensus       316 ~~--~~p~~~~~~~~~~~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~  391 (562)
T 3a79_B          316 VF--LFSKEALYSVFAEMNIKMLSISDTPFIHMV--CPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKN  391 (562)
T ss_dssp             CC--SSCHHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCB
T ss_pred             ee--ecChhhhhhhhccCcceEEEccCCCccccc--CccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCC
Confidence            66  344 23322   267999999999886322  1267888999999999999877777654 789999999999986


Q ss_pred             C--CchhccCCCCcceeeeccccccCCCccc-cccccccceeeeeccccCCCCCcccccccCCCeeeCCCCcccCCCCcc
Q 002010          471 K--IPAAIGNLPSLNILSLQNNRLEGEIPVE-SFNLKMITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYGKIPPG  547 (982)
Q Consensus       471 ~--~p~~~~~l~~L~~L~L~~N~l~~~~p~~-~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~  547 (982)
                      .  +|..++.+++|++|++++|++++.+|.. +..+++|++|++++|++++.+|..+.  ++|+.|+|++|+|+ .+|..
T Consensus       392 ~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~  468 (562)
T 3a79_B          392 FFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKD  468 (562)
T ss_dssp             TTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTT
T ss_pred             cccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChh
Confidence            3  3567889999999999999998756654 77889999999999999877776654  78999999999998 77877


Q ss_pred             cccccccceEEcccccccccCccc-cccccccceecccCCccccCCCC
Q 002010          548 ISKLIDLSILNLSRNGITGSIPNE-MRNMMSLTTLDLSYNNLIGNIPS  594 (982)
Q Consensus       548 ~~~l~~L~~L~Ls~N~l~~~~p~~-l~~l~~L~~L~Ls~N~l~~~ip~  594 (982)
                      +.++++|+.|+|++|+|++ +|.. +..+++|+.|++++|++++..|.
T Consensus       469 ~~~l~~L~~L~L~~N~l~~-l~~~~~~~l~~L~~L~l~~N~~~c~c~~  515 (562)
T 3a79_B          469 VTHLQALQELNVASNQLKS-VPDGVFDRLTSLQYIWLHDNPWDCTCPG  515 (562)
T ss_dssp             TTSSCCCSEEECCSSCCCC-CCTTSTTTCTTCCCEECCSCCBCCCHHH
T ss_pred             hcCCCCCCEEECCCCCCCC-CCHHHHhcCCCCCEEEecCCCcCCCcch
Confidence            7799999999999999984 5554 88899999999999999887764

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=100.00  E-value=1.8e-44  Score=431.25  Aligned_cols=450  Identities=19%  Similarity=0.236  Sum_probs=349.8

Q ss_pred             EEEEeccCCccccCCcCccccccccEEEeccCCCCCCCChhhhhhcccceeeccCCccccccchhhhhcCCCccEEeccC
Q 002010           74 VSLNVSFMPLFGSIPPEIGLLTKLVNLTISNVNLTGRLPSEMALLTSLKVFNISGNVFQGNFAGQIVRGMTELQVLDAYN  153 (982)
Q Consensus        74 ~~l~l~~~~l~g~~~~~i~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~  153 (982)
                      ..+|++++++.+ +|..+.  ++|++|+|++|++++..|..+..+++|++|+|++|.+++.. +..+.++++|++|+|++
T Consensus        34 ~~l~ls~~~L~~-ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~-~~~~~~l~~L~~L~Ls~  109 (562)
T 3a79_B           34 SMVDYSNRNLTH-VPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLD-FHVFLFNQDLEYLDVSH  109 (562)
T ss_dssp             CEEECTTSCCCS-CCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEEC-TTTTTTCTTCCEEECTT
T ss_pred             cEEEcCCCCCcc-CCCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCC-HHHhCCCCCCCEEECCC
Confidence            567888888875 888765  89999999999999888899999999999999999998644 45678999999999999


Q ss_pred             ccccCCCchhccccccccEEeecCccccc-ccCCCccccCcceEeeccCcccccchhhHHhhhhhHHHHhhccccccccc
Q 002010          154 NNFTGPLPVEIASLKSLRHLSFGGNYFTG-KIPQSYSEIQSLEYIGLNGIGLNGTVPAFLSRLKNLREMYIGYFNTYTGG  232 (982)
Q Consensus       154 n~l~~~~p~~l~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~l~~~n~~~~~  232 (982)
                      |+++ .+|..  .+++|++|+|++|++++ .+|..|+++++|++|++++|.+.+.                         
T Consensus       110 N~l~-~lp~~--~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~-------------------------  161 (562)
T 3a79_B          110 NRLQ-NISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL-------------------------  161 (562)
T ss_dssp             SCCC-EECSC--CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT-------------------------
T ss_pred             CcCC-ccCcc--ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCccccC-------------------------
Confidence            9999 67776  89999999999999997 4578999999999999999988632                         


Q ss_pred             CCCCCCCCCCC--CEEecccCcC--cccCchhhcCCC--ccceeecccccCCCCCCc-cccCCCCCCEEEeeCCc-----
Q 002010          233 IPPGFGALTQL--QVLDMASCNI--SGEIPTSLSRLK--LLHSLFLQMNKLTGHIPP-QLSGLISLKSLDLSLNY-----  300 (982)
Q Consensus       233 ~p~~~~~l~~L--~~L~L~~n~l--~~~~~~~l~~l~--~L~~L~L~~N~l~~~~~~-~l~~l~~L~~L~Ls~N~-----  300 (982)
                         .+..+++|  ++|++++|.+  ++..|..+..+.  .| .+++++|.+.+.++. .+..+++|+.|++++|.     
T Consensus       162 ---~~~~l~~L~L~~L~L~~n~l~~~~~~~~~l~~l~~~~l-~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~  237 (562)
T 3a79_B          162 ---DLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVL-HLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQR  237 (562)
T ss_dssp             ---TTGGGTTSCEEEEEEEESSCCCCSSSCCEEEECCEEEE-EEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHH
T ss_pred             ---chhhhhhceeeEEEeecccccccccCcccccccCcceE-EEEecCccchhhhhhhcccccceEEEecccccccccch
Confidence               12233334  7777777777  667777766654  33 456777777765543 35566777778887774     


Q ss_pred             ccCcCchhhhcccchhhhhhccCCCCCC----CCCcCCCCCCccEEEccCCCcccccCccc-----cCCCcccEEEeccc
Q 002010          301 LTGEIPESFAALKNLTLLQLFKNNLRGP----IPSFLGDFPNLEVLQVWGNNFTFELPENL-----GRNGKLLILDVTSN  371 (982)
Q Consensus       301 l~~~~~~~l~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~~~~l-----~~l~~L~~L~L~~N  371 (982)
                      +.+ ....+..+++|+.|++.++.+.+.    ++..+ ..++|++|++++|.+++.+|..+     ..++.|+.++++.|
T Consensus       238 l~~-~~~~l~~l~~L~~L~L~~~~l~~~~~~~~~~~~-~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~  315 (562)
T 3a79_B          238 LMT-FLSELTRGPTLLNVTLQHIETTWKCSVKLFQFF-WPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQ  315 (562)
T ss_dssp             HHH-HHHHHHSCSSCEEEEEEEEEECHHHHHHHHHHH-TTSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEEC
T ss_pred             HHH-HHHHHhccCcceEEEecCCcCcHHHHHHHHHhh-hcccccEEEEeccEeeccccchhhhcccccchheehhhcccc
Confidence            221 223456667777777776665532    11111 23478888888888887777776     67777777777777


Q ss_pred             cccccCC-ccccC---ccccceeecccccccccCCccccCCCCCCEEEccCCccCCCCCccccCCCccccccCCCccccc
Q 002010          372 HLTGTIP-RDLCK---GGKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLSG  447 (982)
Q Consensus       372 ~l~~~~p-~~~~~---~~~L~~L~l~~N~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~  447 (982)
                      .+  .+| ..+..   ..+|++|++++|.+....  ..+.+++|++|++++|++++.+|..+..+++|++|++++|++++
T Consensus       316 ~~--~~p~~~~~~~~~~~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~  391 (562)
T 3a79_B          316 VF--LFSKEALYSVFAEMNIKMLSISDTPFIHMV--CPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKN  391 (562)
T ss_dssp             CC--SSCHHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCB
T ss_pred             ee--ecChhhhhhhhccCcceEEEccCCCccccc--CccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCC
Confidence            77  444 22222   256888888888875322  12678889999999999998888889999999999999999886


Q ss_pred             cC--Ccccc-cCCccEEEeeccccCCCCc-hhccCCCCcceeeeccccccCCCccccccccccceeeeeccccCCCCCcc
Q 002010          448 EL--PEKMS-GASLNQLKVANNNITGKIP-AAIGNLPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIPYS  523 (982)
Q Consensus       448 ~~--~~~~~-~~~L~~L~L~~N~i~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~  523 (982)
                      ..  |..+. ..+|++|++++|++++.+| ..+..+++|++|++++|++++.+|..+.  ++|++|+|++|+|+ .+|..
T Consensus       392 ~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~  468 (562)
T 3a79_B          392 FFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKD  468 (562)
T ss_dssp             TTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTT
T ss_pred             cccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChh
Confidence            43  33343 3789999999999998444 4688999999999999999987776654  79999999999999 67877


Q ss_pred             cccccCCCeeeCCCCcccCCCCcc-cccccccceEEcccccccccCc
Q 002010          524 ISQCHSLTSVDLSRNSLYGKIPPG-ISKLIDLSILNLSRNGITGSIP  569 (982)
Q Consensus       524 ~~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~Ls~N~l~~~~p  569 (982)
                      +..+++|+.|+|++|+|+ .+|.. |..+++|+.|+|++|.+++..+
T Consensus       469 ~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~l~~N~~~c~c~  514 (562)
T 3a79_B          469 VTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDNPWDCTCP  514 (562)
T ss_dssp             TTSSCCCSEEECCSSCCC-CCCTTSTTTCTTCCCEECCSCCBCCCHH
T ss_pred             hcCCCCCCEEECCCCCCC-CCCHHHHhcCCCCCEEEecCCCcCCCcc
Confidence            779999999999999999 56665 9999999999999999997555

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.9e-44  Score=405.25  Aligned_cols=276  Identities=22%  Similarity=0.286  Sum_probs=209.1

Q ss_pred             hhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCC-CchhhHHHHHHHHhcCCCCcccceEeEEEcC------Cc
Q 002010          692 ESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTG-GNDHGFLAEIQTLGRIRHRNIVRLLGYVSNR------DT  763 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~  763 (982)
                      ++|++.+.||+|+||+||+|.. .+|+.||||++...... ...+.+.+|+.+|++++|||||++++++...      ..
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            5799999999999999999965 57999999999544322 2345688999999999999999999987643      56


Q ss_pred             cEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchh
Q 002010          764 NLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKF  843 (982)
Q Consensus       764 ~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~  843 (982)
                      .|+|||||+ |+|.+++.  +.+.+++.++..++.||+.||+|||+++   ||||||||+||+++.++.+||+|||+|+.
T Consensus       134 ~~ivmE~~~-g~L~~~i~--~~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla~~  207 (398)
T 4b99_A          134 VYVVLDLME-SDLHQIIH--SSQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMARG  207 (398)
T ss_dssp             EEEEEECCS-EEHHHHHT--SSSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred             EEEEEeCCC-CCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecceeee
Confidence            799999995 68999997  4568999999999999999999999998   99999999999999999999999999987


Q ss_pred             ccccC--CcccccccccccccccccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCC
Q 002010          844 LQDAG--ASECMSSVAGSYGYIAPEYAYTL-KVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPS  920 (982)
Q Consensus       844 ~~~~~--~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  920 (982)
                      +....  ........+||+.|||||++.+. .|+.++||||+||++|||++|++||.+......+..+............
T Consensus       208 ~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~  287 (398)
T 4b99_A          208 LCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVI  287 (398)
T ss_dssp             C-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGT
T ss_pred             cccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHh
Confidence            64331  22334567899999999998875 4699999999999999999999999875444444444333332211100


Q ss_pred             cc---cccceeec--CCCCCC-----ChHhHHHHHHHHhhccCCCCCCCCCHHHHHH--HhcCCC
Q 002010          921 DA---ASVLAVVD--PRLSGY-----PLTGVIHLFKVAMMCVEDESSARPTMREVVH--MLANPP  973 (982)
Q Consensus       921 ~~---~~~~~~~~--~~~~~~-----~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~--~L~~~~  973 (982)
                      ..   ......+.  +.....     .......+.+|+.+||+.||++|||++|+++  .+.+..
T Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~  352 (398)
T 4b99_A          288 QAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYH  352 (398)
T ss_dssp             C-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTC
T ss_pred             hhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCC
Confidence            00   00000000  000111     1123456889999999999999999999987  454443

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=2.6e-43  Score=392.03  Aligned_cols=267  Identities=22%  Similarity=0.302  Sum_probs=201.4

Q ss_pred             HHhhcccccccccccceEEEEEEe----CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcC-CCCcccceEeEEEcCCcc
Q 002010          690 VLESLKDENIIGKGGAGIVYRGSM----PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRI-RHRNIVRLLGYVSNRDTN  764 (982)
Q Consensus       690 ~~~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~  764 (982)
                      +.++|++.+.||+|+||+||+|+.    ..++.||+|++...   .....+.+|+++++.+ +|||||++++++.+++..
T Consensus        19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~---~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~   95 (361)
T 4f9c_A           19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT---SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV   95 (361)
T ss_dssp             GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT---SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred             ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc---cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence            456799999999999999999964    24788999988443   3456688999999998 699999999999999999


Q ss_pred             EEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCC-CCEEEeccccchh
Q 002010          765 LLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSD-FEAHVADFGLAKF  843 (982)
Q Consensus       765 ~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~-~~~kl~DfG~a~~  843 (982)
                      |+||||+++|+|.+++.     .+++.++..++.||+.||+|||++|   |+||||||+|||++.+ +.+||+|||+|+.
T Consensus        96 ~lvmE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~~  167 (361)
T 4f9c_A           96 VIAMPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQG  167 (361)
T ss_dssp             EEEEECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             EEEEeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCcc
Confidence            99999999999999984     5899999999999999999999998   9999999999999877 7999999999976


Q ss_pred             ccccCC--------------------------cccccccccccccccccccccC-CCCcchhhHHHHHHHHHHHhCCCCC
Q 002010          844 LQDAGA--------------------------SECMSSVAGSYGYIAPEYAYTL-KVDEKSDVYSFGVVLLELIAGKKPV  896 (982)
Q Consensus       844 ~~~~~~--------------------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~  896 (982)
                      ..+...                          .......+||+.|||||++.+. .|+.++||||+||++|||++|+.||
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf  247 (361)
T 4f9c_A          168 THDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPF  247 (361)
T ss_dssp             CTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred             cCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCC
Confidence            543211                          1122346799999999999875 5899999999999999999999999


Q ss_pred             CCCCCCchHHHHHHHhccC-----------------CCCCCc-ccccc---eeec---CCCC----------CCChHhHH
Q 002010          897 GEFGDGVDIVRWVRKTTSE-----------------VSQPSD-AASVL---AVVD---PRLS----------GYPLTGVI  942 (982)
Q Consensus       897 ~~~~~~~~~~~~~~~~~~~-----------------~~~~~~-~~~~~---~~~~---~~~~----------~~~~~~~~  942 (982)
                      ....+..+....+......                 ...+.. .....   ...+   |...          ......+.
T Consensus       248 ~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~  327 (361)
T 4f9c_A          248 YKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPD  327 (361)
T ss_dssp             SCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCH
T ss_pred             CCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCH
Confidence            7655443333222211100                 000000 00000   0000   0000          11122345


Q ss_pred             HHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          943 HLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       943 ~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                      +..+|+.+||+.||++|||++|+++
T Consensus       328 ~a~DLl~~lL~~dP~~R~ta~eaL~  352 (361)
T 4f9c_A          328 EAYDLLDKLLDLNPASRITAEEALL  352 (361)
T ss_dssp             HHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             HHHHHHHHHCcCChhHCcCHHHHhc
Confidence            6789999999999999999999985

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=6e-43  Score=407.97  Aligned_cols=250  Identities=24%  Similarity=0.269  Sum_probs=201.3

Q ss_pred             HhhcccccccccccceEEEEEEe-CCCcEEEEEEeccCC--CCCchhhHH---HHHHHHhcCCCCcccceEeEEEcCCcc
Q 002010          691 LESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRG--TGGNDHGFL---AEIQTLGRIRHRNIVRLLGYVSNRDTN  764 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~---~E~~~l~~l~h~niv~~~~~~~~~~~~  764 (982)
                      .++|++.+.||+|+||.||+|+. .+|+.||||++.+..  .......+.   +++.+++.++|||||+++++|.+++..
T Consensus       188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l  267 (689)
T 3v5w_A          188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL  267 (689)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence            35799999999999999999965 569999999985431  112222333   346677788999999999999999999


Q ss_pred             EEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhc
Q 002010          765 LLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFL  844 (982)
Q Consensus       765 ~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~  844 (982)
                      |+||||++||+|.+++.  +.+.+++..+..++.||+.||+|||+++   ||||||||+|||++.+|++||+|||+|+.+
T Consensus       268 ylVmEy~~GGdL~~~l~--~~~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~~  342 (689)
T 3v5w_A          268 SFILDLMNGGDLHYHLS--QHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF  342 (689)
T ss_dssp             EEEECCCCSCBHHHHHH--HHCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEEecCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeeec
Confidence            99999999999999997  4468999999999999999999999988   999999999999999999999999999876


Q ss_pred             cccCCccccccccccccccccccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCccc
Q 002010          845 QDAGASECMSSVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAA  923 (982)
Q Consensus       845 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  923 (982)
                      ...    .....+||+.|||||++.+ ..|+.++||||+||++|||++|++||........ ...........       
T Consensus       343 ~~~----~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~-~~i~~~i~~~~-------  410 (689)
T 3v5w_A          343 SKK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEIDRMTLTMA-------  410 (689)
T ss_dssp             SSC----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCH-HHHHHHHHHCC-------
T ss_pred             CCC----CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHhhcCCC-------
Confidence            533    2345789999999999964 5799999999999999999999999976433221 12222111100       


Q ss_pred             ccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 002010          924 SVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPT-----MREVVH  967 (982)
Q Consensus       924 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt-----~~ell~  967 (982)
                                ..+|...+.++.+|+.+||++||.+|++     ++||++
T Consensus       411 ----------~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~  449 (689)
T 3v5w_A          411 ----------VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  449 (689)
T ss_dssp             ----------CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred             ----------CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence                      0122233457899999999999999998     677765

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=100.00  E-value=2.9e-42  Score=401.62  Aligned_cols=387  Identities=17%  Similarity=0.176  Sum_probs=270.7

Q ss_pred             EEeccCccccCCCchhccccccccEEeecCcccccccCCCccccCcceEeeccCcccccchhhHHhhhhhHHHHhhcccc
Q 002010          148 VLDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLNGIGLNGTVPAFLSRLKNLREMYIGYFN  227 (982)
Q Consensus       148 ~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~l~~~n  227 (982)
                      .++.++++++ .+|. +.  ++|++|+|++|.+++..|..|+++++|++|++++|.+.+.+                   
T Consensus        14 ~~~c~~~~l~-~lp~-l~--~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i-------------------   70 (455)
T 3v47_A           14 NAICINRGLH-QVPE-LP--AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVI-------------------   70 (455)
T ss_dssp             EEECCSSCCS-SCCC-CC--TTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEE-------------------
T ss_pred             ccCcCCCCcc-cCCC-CC--CccCEEEecCCccCcCChhHhccCccccEEECcCCcccceE-------------------
Confidence            4555555555 4444 22  56666666666666666666666666666666665443211                   


Q ss_pred             cccccCCCCCCCCCCCCEEecccCcCcccCchhhcCCCccceeecccccCCCCCCcc--ccCCCCCCEEEeeCCcccCcC
Q 002010          228 TYTGGIPPGFGALTQLQVLDMASCNISGEIPTSLSRLKLLHSLFLQMNKLTGHIPPQ--LSGLISLKSLDLSLNYLTGEI  305 (982)
Q Consensus       228 ~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~--l~~l~~L~~L~Ls~N~l~~~~  305 (982)
                           .+..|.++++|++|+|++|++++..|..|+++++|++|+|++|++++..+..  +..+++|++|+|++|++++..
T Consensus        71 -----~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~  145 (455)
T 3v47_A           71 -----RNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQ  145 (455)
T ss_dssp             -----CTTTTTTCTTCCEEECTTCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCC
T ss_pred             -----CcccccccccCCEEeCCCCccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccC
Confidence                 1234566667777777777777666667777777777777777776544433  666777777777777777665


Q ss_pred             chh-hhcccchhhhhhccCCCCCCCCCcCCCC--CCccEEEccCCCcccccCccc--------cCCCcccEEEecccccc
Q 002010          306 PES-FAALKNLTLLQLFKNNLRGPIPSFLGDF--PNLEVLQVWGNNFTFELPENL--------GRNGKLLILDVTSNHLT  374 (982)
Q Consensus       306 ~~~-l~~l~~L~~L~L~~N~l~~~~p~~~~~l--~~L~~L~L~~N~l~~~~~~~l--------~~l~~L~~L~L~~N~l~  374 (982)
                      |.. +..+++|++|++++|++.+..|..+..+  .+|+.|++++|.+....+..+        ..+++|++|++++|+++
T Consensus       146 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~  225 (455)
T 3v47_A          146 PASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFK  225 (455)
T ss_dssp             CCGGGGGCTTCCEEECTTCCBSCCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCC
T ss_pred             cccccCCCCcccEEeCCCCcccccChhhhhccccccccccccccCcccccchhhccccccccccccceeeeEecCCCccc
Confidence            554 6666677777777777666666666554  566666666666664433322        23345555555555555


Q ss_pred             ccCCccccCccccceeecccccccccCCccccCCCCCCEEEccCCccCCCCCccccCCCccccccCCCccccccCCcc--
Q 002010          375 GTIPRDLCKGGKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLSGELPEK--  452 (982)
Q Consensus       375 ~~~p~~~~~~~~L~~L~l~~N~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~--  452 (982)
                      +..|..+...                     ...++|+.|++++|.+.+...              ..+.+....+..  
T Consensus       226 ~~~~~~~~~~---------------------~~~~~L~~L~l~~~~~~~~~~--------------~~~~~~~~~~~~~~  270 (455)
T 3v47_A          226 ESMAKRFFDA---------------------IAGTKIQSLILSNSYNMGSSF--------------GHTNFKDPDNFTFK  270 (455)
T ss_dssp             HHHHHHHHHH---------------------TTTCCEEEEECTTCTTTSCCT--------------TCCSSCCCCTTTTG
T ss_pred             ccchhhhhcc---------------------ccccceeeEeecccccccccc--------------chhhhccCcccccc
Confidence            4444433322                     012556666666665543211              111111111111  


Q ss_pred             -cccCCccEEEeeccccCCCCchhccCCCCcceeeeccccccCCCccccccccccceeeeeccccCCCCCcccccccCCC
Q 002010          453 -MSGASLNQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIPYSISQCHSLT  531 (982)
Q Consensus       453 -~~~~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~  531 (982)
                       ....+|+.|++++|++++.+|..++.+++|++|++++|++++..|..+..+++|++|+|++|++++..|..|.++++|+
T Consensus       271 ~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~  350 (455)
T 3v47_A          271 GLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLE  350 (455)
T ss_dssp             GGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCC
T ss_pred             cccccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCC
Confidence             1225799999999999999999999999999999999999988888999999999999999999988899999999999


Q ss_pred             eeeCCCCcccCCCCcccccccccceEEcccccccccCccccccccccceecccCCccccCCCCCcc
Q 002010          532 SVDLSRNSLYGKIPPGISKLIDLSILNLSRNGITGSIPNEMRNMMSLTTLDLSYNNLIGNIPSGGQ  597 (982)
Q Consensus       532 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~~~  597 (982)
                      .|+|++|++++..|..|.++++|++|+|++|+|++..+..+..+++|++|++++|++++.+|....
T Consensus       351 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~  416 (455)
T 3v47_A          351 VLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDY  416 (455)
T ss_dssp             EEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTTHH
T ss_pred             EEECCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCCcchH
Confidence            999999999998899999999999999999999987777889999999999999999999996543

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=2.4e-42  Score=407.93  Aligned_cols=254  Identities=23%  Similarity=0.352  Sum_probs=209.9

Q ss_pred             HHHhhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEE
Q 002010          689 DVLESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLL  767 (982)
Q Consensus       689 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  767 (982)
                      .+.++|++.+.||+|+||.||+|.. .+|+.||+|++... .....+.+.+|+.+|+.++|||||++++++.++...|+|
T Consensus       154 ~il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv  232 (573)
T 3uto_A          154 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP-HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMI  232 (573)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEecc-chhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence            3457899999999999999999965 56999999998543 233456788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCC--CCEEEeccccchhcc
Q 002010          768 YEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSD--FEAHVADFGLAKFLQ  845 (982)
Q Consensus       768 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~--~~~kl~DfG~a~~~~  845 (982)
                      ||||+||+|.+++.. +...+++.++..++.||+.||+|||+++   |+||||||+||+++.+  +.+||+|||+|+.+.
T Consensus       233 ~E~~~gg~L~~~i~~-~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~  308 (573)
T 3uto_A          233 YEFMSGGELFEKVAD-EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD  308 (573)
T ss_dssp             EECCCCCBHHHHHTC-TTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECC
T ss_pred             EeecCCCcHHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEcc
Confidence            999999999999963 3467999999999999999999999998   9999999999999854  899999999998775


Q ss_pred             ccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCccccc
Q 002010          846 DAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASV  925 (982)
Q Consensus       846 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  925 (982)
                      ..   ......+||+.|||||++.+..|+.++||||+||++|||++|++||.+....+.+ ..+.........       
T Consensus       309 ~~---~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~-~~i~~~~~~~~~-------  377 (573)
T 3uto_A          309 PK---QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETL-RNVKSCDWNMDD-------  377 (573)
T ss_dssp             TT---SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH-HHHHTTCCCCCS-------
T ss_pred             CC---CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHH-HHHHhCCCCCCc-------
Confidence            43   3345568999999999999999999999999999999999999999865433222 222221110000       


Q ss_pred             ceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          926 LAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       926 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                               ......+..+.+|+.+||+.||.+|||++|+++
T Consensus       378 ---------~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~  410 (573)
T 3uto_A          378 ---------SAFSGISEDGKDFIRKLLLADPNTRMTIHQALE  410 (573)
T ss_dssp             ---------GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ---------ccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                     001122346889999999999999999999987

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=100.00  E-value=4.2e-42  Score=378.08  Aligned_cols=292  Identities=29%  Similarity=0.467  Sum_probs=244.1

Q ss_pred             cCchhHHHHHHHHHhcccCCCCCCCCCCCCCCCCCCCCc--cceeeeCCC---CCEEEEEeccCCccc--cCCcCccccc
Q 002010           23 SCAYSDMDVLLKLKSSMIGPKGSGLKNWEPSSSPSAHCS--FSGVTCDQD---SRVVSLNVSFMPLFG--SIPPEIGLLT   95 (982)
Q Consensus        23 ~~~~~~~~~ll~~k~~~~~~~~~~~~~w~~~~~~~~~C~--w~gv~C~~~---~~v~~l~l~~~~l~g--~~~~~i~~l~   95 (982)
                      .|.++|++||++||+++.+|.  .+++|..+   .+||.  |.||+|+..   ++|+.++++++.+.|  .+|+.++.++
T Consensus         2 ~c~~~~~~aL~~~k~~~~~~~--~l~~W~~~---~~~C~~~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~~l~~l~   76 (313)
T 1ogq_A            2 LCNPQDKQALLQIKKDLGNPT--TLSSWLPT---TDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLP   76 (313)
T ss_dssp             CSCHHHHHHHHHHHHHTTCCG--GGTTCCTT---SCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCT
T ss_pred             CCCHHHHHHHHHHHHhcCCcc--cccCCCCC---CCCCcCCCcceEeCCCCCCceEEEEECCCCCccCCcccChhHhCCC
Confidence            599999999999999997664  68999753   46787  999999864   799999999999999  9999999999


Q ss_pred             cccEEEecc-CCCCCCCChhhhhhcccceeeccCCccccccchhhhhcCCCccEEeccCccccCCCchhccccccccEEe
Q 002010           96 KLVNLTISN-VNLTGRLPSEMALLTSLKVFNISGNVFQGNFAGQIVRGMTELQVLDAYNNNFTGPLPVEIASLKSLRHLS  174 (982)
Q Consensus        96 ~L~~L~l~~-n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~  174 (982)
                      +|++|+|++ |++++.+|..++.+++|++|+|++|.+.+.++. .+.++++|++|+|++|++++.+|..++.+++|++|+
T Consensus        77 ~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~  155 (313)
T 1ogq_A           77 YLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPD-FLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGIT  155 (313)
T ss_dssp             TCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCG-GGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEE
T ss_pred             CCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCH-HHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEE
Confidence            999999995 999999999999999999999999999877775 467899999999999999999999999999999999


Q ss_pred             ecCcccccccCCCccccC-cceEeeccCcccccchhhHHhhhhhHHHHhhcccccccccCCCCCCCCCCCCEEecccCcC
Q 002010          175 FGGNYFTGKIPQSYSEIQ-SLEYIGLNGIGLNGTVPAFLSRLKNLREMYIGYFNTYTGGIPPGFGALTQLQVLDMASCNI  253 (982)
Q Consensus       175 L~~N~l~~~~p~~~~~l~-~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~l~~~n~~~~~~p~~~~~l~~L~~L~L~~n~l  253 (982)
                      |++|++++.+|..++.++ +|++|++++|.+.+..|..+                         +.++ |++|++++|++
T Consensus       156 L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~-------------------------~~l~-L~~L~Ls~N~l  209 (313)
T 1ogq_A          156 FDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTF-------------------------ANLN-LAFVDLSRNML  209 (313)
T ss_dssp             CCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGG-------------------------GGCC-CSEEECCSSEE
T ss_pred             CcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHH-------------------------hCCc-ccEEECcCCcc
Confidence            999999999999999998 99999999988766555544                         4444 77777777777


Q ss_pred             cccCchhhcCCCccceeecccccCCCCCCccccCCCCCCEEEeeCCcccCcCchhhhcccchhhhhhccCCCCCCCCCcC
Q 002010          254 SGEIPTSLSRLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQLFKNNLRGPIPSFL  333 (982)
Q Consensus       254 ~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~  333 (982)
                      ++..|..|..+++|++|+|++|++++.+|. +..+++|++|+|++|++++.+|..|..+++|++|+|++|++++.+|.. 
T Consensus       210 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~-  287 (313)
T 1ogq_A          210 EGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-  287 (313)
T ss_dssp             EECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCS-
T ss_pred             cCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCC-
Confidence            777777777777777777777777755554 666777777777777777777777777777777777777777777765 


Q ss_pred             CCCCCccEEEccCCC
Q 002010          334 GDFPNLEVLQVWGNN  348 (982)
Q Consensus       334 ~~l~~L~~L~L~~N~  348 (982)
                      ..+++|+.|++++|+
T Consensus       288 ~~l~~L~~l~l~~N~  302 (313)
T 1ogq_A          288 GNLQRFDVSAYANNK  302 (313)
T ss_dssp             TTGGGSCGGGTCSSS
T ss_pred             ccccccChHHhcCCC
Confidence            667777777777776

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=100.00  E-value=2.3e-41  Score=390.71  Aligned_cols=402  Identities=23%  Similarity=0.304  Sum_probs=148.5

Q ss_pred             CCccEEeccCccccCCCchhccccccccEEeecCcccccccCCCccccCcceEeeccCcccccchhhHHhhhhhHHHHhh
Q 002010          144 TELQVLDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLNGIGLNGTVPAFLSRLKNLREMYI  223 (982)
Q Consensus       144 ~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~l  223 (982)
                      +.|++|++++|++ |.+|.+++++++|++|++++|+++|.+|.+++++++|+.+++.+|.           ..++++|++
T Consensus        11 ~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~-----------~~~l~~L~l   78 (454)
T 1jl5_A           11 TFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCL-----------DRQAHELEL   78 (454)
T ss_dssp             ------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHH-----------HHTCSEEEC
T ss_pred             ccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhh-----------ccCCCEEEe
Confidence            4455555555555 3555555555555555555555555555555555544332222211           012222222


Q ss_pred             cccccccccCCCCCCCCCCCCEEecccCcCcccCchhhcCCCccceeecccccCCCCCCccccCCCCCCEEEeeCCcccC
Q 002010          224 GYFNTYTGGIPPGFGALTQLQVLDMASCNISGEIPTSLSRLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTG  303 (982)
Q Consensus       224 ~~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~  303 (982)
                      +++ .+++ +|..   .++|++|++++|++++ +|..   +++|++|++++|++++. +..   .++|++|++++|++++
T Consensus        79 ~~~-~l~~-lp~~---~~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~l-~~~---~~~L~~L~L~~n~l~~  145 (454)
T 1jl5_A           79 NNL-GLSS-LPEL---PPHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKAL-SDL---PPLLEYLGVSNNQLEK  145 (454)
T ss_dssp             TTS-CCSC-CCSC---CTTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSCC-CSC---CTTCCEEECCSSCCSS
T ss_pred             cCC-cccc-CCCC---cCCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCcc-cCC---CCCCCEEECcCCCCCC
Confidence            221 1111 1211   1344445555554443 3321   24444455555544421 111   1344555555555443


Q ss_pred             cCchhhhcccchhhhhhccCCCCCCCCCcCCCCCCccEEEccCCCcccccCccccCCCcccEEEeccccccccCCccccC
Q 002010          304 EIPESFAALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDLCK  383 (982)
Q Consensus       304 ~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~  383 (982)
                       +| .|+.+++|++|++++|++++ +|..+   ++|++|++++|++++ +| .++.+++|++|++++|++++ +|...  
T Consensus       146 -lp-~~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~-l~~~~--  214 (454)
T 1jl5_A          146 -LP-ELQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKK-LPDLP--  214 (454)
T ss_dssp             -CC-CCTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSS-CCCCC--
T ss_pred             -Cc-ccCCCCCCCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCc-CCCCc--
Confidence             33 34444455555555554443 33222   244555555554443 22 34444555555555555443 22211  


Q ss_pred             ccccceeecccccccccCCccccCCCCCCEEEccCCccCCCCCccccCCCccccccCCCccccccCCcccccCCccEEEe
Q 002010          384 GGKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLSGELPEKMSGASLNQLKV  463 (982)
Q Consensus       384 ~~~L~~L~l~~N~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~L  463 (982)
                       .+|++|++++|.+. .+| .++.+++|++|++++|++++ +|..   .++|+.|++++|++++ +|...  .+|++|++
T Consensus       215 -~~L~~L~l~~n~l~-~lp-~~~~l~~L~~L~l~~N~l~~-l~~~---~~~L~~L~l~~N~l~~-l~~~~--~~L~~L~l  284 (454)
T 1jl5_A          215 -LSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLKT-LPDL---PPSLEALNVRDNYLTD-LPELP--QSLTFLDV  284 (454)
T ss_dssp             -TTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCSS-CCSC---CTTCCEEECCSSCCSC-CCCCC--TTCCEEEC
T ss_pred             -CcccEEECcCCcCC-ccc-ccCCCCCCCEEECCCCcCCc-cccc---ccccCEEECCCCcccc-cCccc--CcCCEEEC
Confidence             24455555555444 333 24445555555555555542 2321   2344555555555443 22211  34555555


Q ss_pred             eccccCCCCchhccCCCCcceeeeccccccCCCccccccc-cccceeeeeccccCCCCCcccccccCCCeeeCCCCcccC
Q 002010          464 ANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESFNL-KMITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYG  542 (982)
Q Consensus       464 ~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~  542 (982)
                      ++|++++. |.   -.++|++|++++|++++ ++    .+ ++|++|++++|++++ +|..   +++|+.|++++|+++ 
T Consensus       285 s~N~l~~l-~~---~~~~L~~L~l~~N~l~~-i~----~~~~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~l~-  350 (454)
T 1jl5_A          285 SENIFSGL-SE---LPPNLYYLNASSNEIRS-LC----DLPPSLEELNVSNNKLIE-LPAL---PPRLERLIASFNHLA-  350 (454)
T ss_dssp             CSSCCSEE-SC---CCTTCCEEECCSSCCSE-EC----CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCS-
T ss_pred             cCCccCcc-cC---cCCcCCEEECcCCcCCc-cc----CCcCcCCEEECCCCcccc-cccc---CCcCCEEECCCCccc-
Confidence            55555431 11   01345555555555542 11    11 345555555555553 3322   344555555555554 


Q ss_pred             CCCcccccccccceEEcccccccc--cCccccccc-------------cccceecccCCcccc--CCCCCcccccccccc
Q 002010          543 KIPPGISKLIDLSILNLSRNGITG--SIPNEMRNM-------------MSLTTLDLSYNNLIG--NIPSGGQFLAFNETS  605 (982)
Q Consensus       543 ~~p~~~~~l~~L~~L~Ls~N~l~~--~~p~~l~~l-------------~~L~~L~Ls~N~l~~--~ip~~~~~~~~~~~~  605 (982)
                      .+|.   .+++|++|+|++|++++  .+|.++..+             ++|++||+++|+++|  .+|..     +....
T Consensus       351 ~lp~---~l~~L~~L~L~~N~l~~l~~ip~~l~~L~~n~~~~~i~~~~~~L~~L~ls~N~l~~~~~iP~s-----l~~L~  422 (454)
T 1jl5_A          351 EVPE---LPQNLKQLHVEYNPLREFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLREFPDIPES-----VEDLR  422 (454)
T ss_dssp             CCCC---CCTTCCEEECCSSCCSSCCCCCTTCCEEECCC-----------------------------------------
T ss_pred             cccc---hhhhccEEECCCCCCCcCCCChHHHHhhhhcccccccccccCcCCEEECCCCcCCccccchhh-----Hhhee
Confidence            2333   24455555555555554  444444444             789999999999998  67753     23334


Q ss_pred             ccCCcCcc
Q 002010          606 FIGNPNLC  613 (982)
Q Consensus       606 ~~~n~~~c  613 (982)
                      +.+|...|
T Consensus       423 ~~~~~~~~  430 (454)
T 1jl5_A          423 MNSERVVD  430 (454)
T ss_dssp             --------
T ss_pred             CcCcccCC
Confidence            44554444

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=100.00  E-value=4.7e-42  Score=396.47  Aligned_cols=420  Identities=22%  Similarity=0.265  Sum_probs=225.6

Q ss_pred             CCEEEEEeccCCccccCCcCccccccccEEEeccCCCCCCCChhhhhhcccceeeccCCccccccchhhhhcCCCccEEe
Q 002010           71 SRVVSLNVSFMPLFGSIPPEIGLLTKLVNLTISNVNLTGRLPSEMALLTSLKVFNISGNVFQGNFAGQIVRGMTELQVLD  150 (982)
Q Consensus        71 ~~v~~l~l~~~~l~g~~~~~i~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~  150 (982)
                      .++..++++++.+ |.+|++++.+++|++|++++|+++|.+|..++.+.+|+.+++++|..            .++++|+
T Consensus        11 ~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~------------~~l~~L~   77 (454)
T 1jl5_A           11 TFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLD------------RQAHELE   77 (454)
T ss_dssp             ------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHH------------HTCSEEE
T ss_pred             ccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhc------------cCCCEEE
Confidence            3555666666666 67777777777777777777777777777777766666666654431            4568888


Q ss_pred             ccCccccCCCchhccccccccEEeecCcccccccCCCccccCcceEeeccCcccccchhhHHhhhhhHHHHhhccccccc
Q 002010          151 AYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLNGIGLNGTVPAFLSRLKNLREMYIGYFNTYT  230 (982)
Q Consensus       151 Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~l~~~n~~~  230 (982)
                      +++|++++ +|..   .++|++|++++|++++ +|..   +++|++|++++|.+.+.                       
T Consensus        78 l~~~~l~~-lp~~---~~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~l-----------------------  126 (454)
T 1jl5_A           78 LNNLGLSS-LPEL---PPHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKAL-----------------------  126 (454)
T ss_dssp             CTTSCCSC-CCSC---CTTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSCC-----------------------
T ss_pred             ecCCcccc-CCCC---cCCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCcc-----------------------
Confidence            88888875 4442   3678888888888886 6643   36778888887766521                       


Q ss_pred             ccCCCCCCCCCCCCEEecccCcCcccCchhhcCCCccceeecccccCCCCCCccccCCCCCCEEEeeCCcccCcCchhhh
Q 002010          231 GGIPPGFGALTQLQVLDMASCNISGEIPTSLSRLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFA  310 (982)
Q Consensus       231 ~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~  310 (982)
                         |..   .++|++|++++|++++ +| .|+++++|++|++++|++++ +|..+   .+|++|++++|++++ +| .++
T Consensus       127 ---~~~---~~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~-~~~  192 (454)
T 1jl5_A          127 ---SDL---PPLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEE-LP-ELQ  192 (454)
T ss_dssp             ---CSC---CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSS-CC-CCT
T ss_pred             ---cCC---CCCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCc-Cc-ccc
Confidence               110   1567778888887775 55 47777778888888877774 44332   477777887777775 45 477


Q ss_pred             cccchhhhhhccCCCCCCCCCcCCCCCCccEEEccCCCcccccCccccCCCcccEEEeccccccccCCccccCcccccee
Q 002010          311 ALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDLCKGGKLKSL  390 (982)
Q Consensus       311 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L  390 (982)
                      .+++|++|++++|++++ +|...   ++|++|++++|.++ .+| .++.+++|++|++++|++++ +|..   .++|++|
T Consensus       193 ~l~~L~~L~l~~N~l~~-l~~~~---~~L~~L~l~~n~l~-~lp-~~~~l~~L~~L~l~~N~l~~-l~~~---~~~L~~L  262 (454)
T 1jl5_A          193 NLPFLTAIYADNNSLKK-LPDLP---LSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLKT-LPDL---PPSLEAL  262 (454)
T ss_dssp             TCTTCCEEECCSSCCSS-CCCCC---TTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCSS-CCSC---CTTCCEE
T ss_pred             CCCCCCEEECCCCcCCc-CCCCc---CcccEEECcCCcCC-ccc-ccCCCCCCCEEECCCCcCCc-cccc---ccccCEE
Confidence            77777777777777775 44332   47777777777777 455 37777777777777777774 4432   3567777


Q ss_pred             ecccccccccCCccccCCCCCCEEEccCCccCCCCCccccCCCccccccCCCccccccCCcccccCCccEEEeeccccCC
Q 002010          391 ILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLSGELPEKMSGASLNQLKVANNNITG  470 (982)
Q Consensus       391 ~l~~N~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~L~~N~i~~  470 (982)
                      ++++|.+.+ +|..   .++|++|++++|++++ +|..   .++|+.|++++|.+++.. ..  ..+|++|++++|++++
T Consensus       263 ~l~~N~l~~-l~~~---~~~L~~L~ls~N~l~~-l~~~---~~~L~~L~l~~N~l~~i~-~~--~~~L~~L~Ls~N~l~~  331 (454)
T 1jl5_A          263 NVRDNYLTD-LPEL---PQSLTFLDVSENIFSG-LSEL---PPNLYYLNASSNEIRSLC-DL--PPSLEELNVSNNKLIE  331 (454)
T ss_dssp             ECCSSCCSC-CCCC---CTTCCEEECCSSCCSE-ESCC---CTTCCEEECCSSCCSEEC-CC--CTTCCEEECCSSCCSC
T ss_pred             ECCCCcccc-cCcc---cCcCCEEECcCCccCc-ccCc---CCcCCEEECcCCcCCccc-CC--cCcCCEEECCCCcccc
Confidence            777777665 3432   3567777777777764 2211   145666667766666421 11  1356677777777664


Q ss_pred             CCchhccCCCCcceeeeccccccCCCccccccccccceeeeeccccCC--CCCcccccccCCCeeeCCCCcccCCCCccc
Q 002010          471 KIPAAIGNLPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNISG--EIPYSISQCHSLTSVDLSRNSLYGKIPPGI  548 (982)
Q Consensus       471 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~  548 (982)
                       +|..   +++|++|++++|+++ .+|.   .+++|++|++++|++++  .+|.++..        |+.|.+.|.+|.. 
T Consensus       332 -lp~~---~~~L~~L~L~~N~l~-~lp~---~l~~L~~L~L~~N~l~~l~~ip~~l~~--------L~~n~~~~~i~~~-  394 (454)
T 1jl5_A          332 -LPAL---PPRLERLIASFNHLA-EVPE---LPQNLKQLHVEYNPLREFPDIPESVED--------LRMNSHLAEVPEL-  394 (454)
T ss_dssp             -CCCC---CTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCSSCCCCCTTCCE--------EECCC---------
T ss_pred             -cccc---CCcCCEEECCCCccc-cccc---hhhhccEEECCCCCCCcCCCChHHHHh--------hhhcccccccccc-
Confidence             3432   466677777777766 3554   35667777777777766  45554432        2335555566653 


Q ss_pred             ccccccceEEcccccccc--cCccccccccccceecccCCccccCCCC
Q 002010          549 SKLIDLSILNLSRNGITG--SIPNEMRNMMSLTTLDLSYNNLIGNIPS  594 (982)
Q Consensus       549 ~~l~~L~~L~Ls~N~l~~--~~p~~l~~l~~L~~L~Ls~N~l~~~ip~  594 (982)
                        +++|+.|++++|++++  .+|.      +++.|.+.+|.+.+.+|.
T Consensus       395 --~~~L~~L~ls~N~l~~~~~iP~------sl~~L~~~~~~~~~~~~~  434 (454)
T 1jl5_A          395 --PQNLKQLHVETNPLREFPDIPE------SVEDLRMNSERVVDPYEF  434 (454)
T ss_dssp             ------------------------------------------------
T ss_pred             --cCcCCEEECCCCcCCccccchh------hHhheeCcCcccCCcccc
Confidence              4789999999999997  6665      456678899999988774

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=2.8e-41  Score=373.85  Aligned_cols=276  Identities=35%  Similarity=0.603  Sum_probs=226.4

Q ss_pred             HHhhcccccccccccceEEEEEEeCCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEe
Q 002010          690 VLESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYE  769 (982)
Q Consensus       690 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  769 (982)
                      ..++|+..+.||+|+||.||+|...+++.||+|++... .....+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus        37 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  115 (321)
T 2qkw_B           37 ATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPE-SSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYK  115 (321)
T ss_dssp             CCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSC-CSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEE
T ss_pred             HHhccCccceeecCCCeeEEEEEECCCCEEEEEEeccc-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEE
Confidence            45689999999999999999999888999999987443 34456778999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhcccc
Q 002010          770 YMPNGSLGEMLHGAK--GGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDA  847 (982)
Q Consensus       770 ~~~~~sL~~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  847 (982)
                      |+++++|.+++....  ...+++..+..++.|++.|++|||+.+   |+||||||+||+++.++.+||+|||++......
T Consensus       116 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  192 (321)
T 2qkw_B          116 YMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTEL  192 (321)
T ss_dssp             CCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTTCEECSSS
T ss_pred             cCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence            999999999997543  235899999999999999999999988   999999999999999999999999999865433


Q ss_pred             CCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCC--chHHHHHHHhccCCCCCCccccc
Q 002010          848 GASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDG--VDIVRWVRKTTSEVSQPSDAASV  925 (982)
Q Consensus       848 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  925 (982)
                      ..........||+.|+|||++.+..++.++||||+|+++|||++|+.||......  .....|......       ....
T Consensus       193 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~-------~~~~  265 (321)
T 2qkw_B          193 DQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHN-------NGQL  265 (321)
T ss_dssp             SCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHT-------TTCC
T ss_pred             cccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccc-------cccH
Confidence            3333334556899999999999889999999999999999999999999764322  222333222211       1112


Q ss_pred             ceeecCCCC-CCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCCCC
Q 002010          926 LAVVDPRLS-GYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQSA  976 (982)
Q Consensus       926 ~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~~~~  976 (982)
                      ...+++... ..+...+..+.+++.+||+.||++|||++|+++.|+.+....
T Consensus       266 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~  317 (321)
T 2qkw_B          266 EQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQ  317 (321)
T ss_dssp             CSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred             HHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhcc
Confidence            233344443 567788899999999999999999999999999998765443

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=100.00  E-value=9.5e-42  Score=397.31  Aligned_cols=376  Identities=18%  Similarity=0.178  Sum_probs=290.7

Q ss_pred             CCccce--eeeCCCCCEEEEEeccCCccccCCcCccccccccEEEeccCCCCCCCChhhhhhcccceeeccCCccccccc
Q 002010           59 HCSFSG--VTCDQDSRVVSLNVSFMPLFGSIPPEIGLLTKLVNLTISNVNLTGRLPSEMALLTSLKVFNISGNVFQGNFA  136 (982)
Q Consensus        59 ~C~w~g--v~C~~~~~v~~l~l~~~~l~g~~~~~i~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~~  136 (982)
                      .|.|.+  |.|+..+            ...+|.   ..++|++|+|++|++++..|..+.++++|++|+|++|.+.+.++
T Consensus         7 ~c~~~~~~~~c~~~~------------l~~lp~---l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~   71 (455)
T 3v47_A            7 ECSVIGYNAICINRG------------LHQVPE---LPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIR   71 (455)
T ss_dssp             CCEEETTEEECCSSC------------CSSCCC---CCTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEEC
T ss_pred             eeEEEccccCcCCCC------------cccCCC---CCCccCEEEecCCccCcCChhHhccCccccEEECcCCcccceEC
Confidence            455544  8887543            234554   23789999999999998889999999999999999999988888


Q ss_pred             hhhhhcCCCccEEeccCccccCCCchhccccccccEEeecCcccccccCCC--ccccCcceEeeccCcccccchhhHHhh
Q 002010          137 GQIVRGMTELQVLDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQS--YSEIQSLEYIGLNGIGLNGTVPAFLSR  214 (982)
Q Consensus       137 ~~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~--~~~l~~L~~L~L~~n~i~~~~~~~l~~  214 (982)
                      ...+.++++|++|+|++|++++..|..++++++|++|+|++|++++..|..  |+.+++|++|++++|.+.+..|..   
T Consensus        72 ~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~---  148 (455)
T 3v47_A           72 NNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPAS---  148 (455)
T ss_dssp             TTTTTTCTTCCEEECTTCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCG---
T ss_pred             cccccccccCCEEeCCCCccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCccc---
Confidence            888899999999999999999888999999999999999999999866554  999999999999998877554433   


Q ss_pred             hhhHHHHhhcccccccccCCCCCCCCCCCCEEecccCcCcccCchhhcCC--CccceeecccccCCCCCCcc--------
Q 002010          215 LKNLREMYIGYFNTYTGGIPPGFGALTQLQVLDMASCNISGEIPTSLSRL--KLLHSLFLQMNKLTGHIPPQ--------  284 (982)
Q Consensus       215 l~~L~~L~l~~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l--~~L~~L~L~~N~l~~~~~~~--------  284 (982)
                                           .++++++|++|++++|++++..+..+..+  .+|+.|++++|.+.+..+..        
T Consensus       149 ---------------------~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~  207 (455)
T 3v47_A          149 ---------------------FFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGN  207 (455)
T ss_dssp             ---------------------GGGGCTTCCEEECTTCCBSCCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCC
T ss_pred             ---------------------ccCCCCcccEEeCCCCcccccChhhhhccccccccccccccCcccccchhhcccccccc
Confidence                                 14556667777777777776666666555  56777777777776544332        


Q ss_pred             ccCCCCCCEEEeeCCcccCcCchhhhcc---cchhhhhhccCCCCCC----------CCCcCCC--CCCccEEEccCCCc
Q 002010          285 LSGLISLKSLDLSLNYLTGEIPESFAAL---KNLTLLQLFKNNLRGP----------IPSFLGD--FPNLEVLQVWGNNF  349 (982)
Q Consensus       285 l~~l~~L~~L~Ls~N~l~~~~~~~l~~l---~~L~~L~L~~N~l~~~----------~p~~~~~--l~~L~~L~L~~N~l  349 (982)
                      +..+++|++|++++|++++..|..+..+   ++|+.|++++|.+.+.          .+..+..  .++|+.|++++|.+
T Consensus       208 ~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l  287 (455)
T 3v47_A          208 PFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKI  287 (455)
T ss_dssp             TTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTSCCTTCCSSCCCCTTTTGGGTTSCCCEEECCSSCC
T ss_pred             ccccceeeeEecCCCcccccchhhhhccccccceeeEeeccccccccccchhhhccCcccccccccccCceEEEecCccc
Confidence            2245667777777777776666665544   6677777776654432          1222222  35788888888888


Q ss_pred             ccccCccccCCCcccEEEeccccccccCCccccCccccceeecccccccccCCccccCCCCCCEEEccCCccCCCCCccc
Q 002010          350 TFELPENLGRNGKLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGTIPAGL  429 (982)
Q Consensus       350 ~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~l~~N~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~  429 (982)
                      ++..|..++.+++|++|++++|++++..|..+..+++|++|++++|.+.+..|..++++++|++|+|++|++++..|..+
T Consensus       288 ~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~  367 (455)
T 3v47_A          288 FALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSF  367 (455)
T ss_dssp             CEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTT
T ss_pred             cccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhc
Confidence            88888888888888888888888888888888888888888888888888888888888888888888888887778888


Q ss_pred             cCCCccccccCCCccccccCCccccc-CCccEEEeeccccCCCCc
Q 002010          430 FNLPLLNMMELDDNLLSGELPEKMSG-ASLNQLKVANNNITGKIP  473 (982)
Q Consensus       430 ~~l~~L~~L~L~~N~l~~~~~~~~~~-~~L~~L~L~~N~i~~~~p  473 (982)
                      ..+++|++|++++|++++..+..+.. ++|++|++++|++++..|
T Consensus       368 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~  412 (455)
T 3v47_A          368 LGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  412 (455)
T ss_dssp             TTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred             cccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCC
Confidence            88888888888888888766666543 788888888888887665

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=2.4e-41  Score=381.04  Aligned_cols=261  Identities=24%  Similarity=0.399  Sum_probs=216.0

Q ss_pred             HhhcccccccccccceEEEEEEe--------CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcC-CCCcccceEeEEEcC
Q 002010          691 LESLKDENIIGKGGAGIVYRGSM--------PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRI-RHRNIVRLLGYVSNR  761 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~--------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~  761 (982)
                      .++|+..+.||+|+||.||+|+.        .++..||||++...........+.+|+.+++++ +||||+++++++.++
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  159 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  159 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence            36789999999999999999964        235679999986554444456789999999999 899999999999999


Q ss_pred             CccEEEEeccCCCCHHHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEE
Q 002010          762 DTNLLLYEYMPNGSLGEMLHGAK--------------GGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILL  827 (982)
Q Consensus       762 ~~~~lv~e~~~~~sL~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill  827 (982)
                      +..++||||+++|+|.+++....              ...+++.++..++.||+.||+|||+.+   |+||||||+||++
T Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll  236 (370)
T 2psq_A          160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV  236 (370)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred             CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEE
Confidence            99999999999999999997543              245899999999999999999999998   9999999999999


Q ss_pred             cCCCCEEEeccccchhccccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHH
Q 002010          828 DSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIV  906 (982)
Q Consensus       828 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~  906 (982)
                      +.++.+||+|||+++...............+|+.|+|||++.+..++.++||||+||++|||++ |+.||...... ...
T Consensus       237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~-~~~  315 (370)
T 2psq_A          237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE-ELF  315 (370)
T ss_dssp             CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG-GHH
T ss_pred             CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH-HHH
Confidence            9999999999999987654433333445567889999999999999999999999999999999 99999865432 222


Q ss_pred             HHHHHhccCCCCCCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCC
Q 002010          907 RWVRKTTSEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQ  974 (982)
Q Consensus       907 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~~  974 (982)
                      ..+.....                   ...+..++..+.+++.+||+.||++|||++|+++.|+++.+
T Consensus       316 ~~~~~~~~-------------------~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~  364 (370)
T 2psq_A          316 KLLKEGHR-------------------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT  364 (370)
T ss_dssp             HHHHTTCC-------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHhcCCC-------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            22222111                   12233445679999999999999999999999999987643

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=5.9e-41  Score=372.25  Aligned_cols=278  Identities=42%  Similarity=0.709  Sum_probs=225.8

Q ss_pred             HHHhhcccccccccccceEEEEEEeCCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEE
Q 002010          689 DVLESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLY  768 (982)
Q Consensus       689 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  768 (982)
                      ...++|+..+.||+|+||.||+|+..+++.||||++...........+.+|+.++++++||||+++++++.++...++||
T Consensus        27 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  106 (326)
T 3uim_A           27 VASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY  106 (326)
T ss_dssp             TTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEEEE
T ss_pred             HHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecCCceEEEE
Confidence            34568999999999999999999887899999999966555555567899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccc
Q 002010          769 EYMPNGSLGEMLHGAK--GGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQD  846 (982)
Q Consensus       769 e~~~~~sL~~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  846 (982)
                      ||+++++|.+++....  ...+++..+..++.|++.|++|||+...++|+||||||+||+++.++.+||+|||++.....
T Consensus       107 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  186 (326)
T 3uim_A          107 PYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY  186 (326)
T ss_dssp             ECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEECCS
T ss_pred             EeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCccccccCc
Confidence            9999999999998543  34599999999999999999999998111299999999999999999999999999987653


Q ss_pred             cCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCC----CCCCchHHHHHHHhccCCCCCCcc
Q 002010          847 AGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGE----FGDGVDIVRWVRKTTSEVSQPSDA  922 (982)
Q Consensus       847 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~----~~~~~~~~~~~~~~~~~~~~~~~~  922 (982)
                      . .........||+.|+|||++.+..++.++||||+|+++|||++|+.||..    .........++......       
T Consensus       187 ~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-------  258 (326)
T 3uim_A          187 K-DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE-------  258 (326)
T ss_dssp             S-SSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSS-------
T ss_pred             c-cccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhc-------
Confidence            3 22333455699999999999988899999999999999999999999962    22333444554433321       


Q ss_pred             cccceeecCCCC-CCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCC
Q 002010          923 ASVLAVVDPRLS-GYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQ  974 (982)
Q Consensus       923 ~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~~  974 (982)
                      .......+.... ..+...+..+.+++.+||+.||.+|||++||++.|++...
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~  311 (326)
T 3uim_A          259 KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGL  311 (326)
T ss_dssp             CCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSC
T ss_pred             hhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcch
Confidence            122223333333 5677888899999999999999999999999999976443

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=1.1e-40  Score=364.24  Aligned_cols=250  Identities=24%  Similarity=0.347  Sum_probs=209.6

Q ss_pred             HhhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEe
Q 002010          691 LESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYE  769 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  769 (982)
                      .++|+..+.||+|+||+||+|.. .+++.||+|++... .......+.+|+.++++++||||+++++++...+..++|||
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   97 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQ-QQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME   97 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGG-GCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecc-cccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence            46799999999999999999974 57899999998543 33446678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCC
Q 002010          770 YMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGA  849 (982)
Q Consensus       770 ~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  849 (982)
                      |+++++|.+++..   ..+++..+..++.|++.|++|||+.+   |+||||||+||+++.++.+||+|||++....... 
T Consensus        98 ~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-  170 (297)
T 3fxz_A           98 YLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-  170 (297)
T ss_dssp             CCTTCBHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT-
T ss_pred             CCCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc-
Confidence            9999999999964   36899999999999999999999998   9999999999999999999999999998765432 


Q ss_pred             cccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceee
Q 002010          850 SECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVV  929 (982)
Q Consensus       850 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  929 (982)
                       .......||+.|+|||++.+..++.++||||+||++|||++|+.||....................             
T Consensus       171 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~-------------  236 (297)
T 3fxz_A          171 -SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPEL-------------  236 (297)
T ss_dssp             -CCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCC-------------
T ss_pred             -cccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC-------------
Confidence             223456799999999999999999999999999999999999999976543332222222211111             


Q ss_pred             cCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          930 DPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       930 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                           ..+...+..+.+++.+||+.||++|||++|+++
T Consensus       237 -----~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  269 (297)
T 3fxz_A          237 -----QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ  269 (297)
T ss_dssp             -----SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -----CCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence                 112334457899999999999999999999987

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=6e-41  Score=371.31  Aligned_cols=263  Identities=29%  Similarity=0.449  Sum_probs=213.1

Q ss_pred             HhhcccccccccccceEEEEEEeC----CCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEE
Q 002010          691 LESLKDENIIGKGGAGIVYRGSMP----DGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLL  766 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  766 (982)
                      .++|++.+.||+|+||.||+|...    .+..||||++.........+.+.+|+.++++++||||+++++++.+.+..++
T Consensus        48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  127 (325)
T 3kul_A           48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI  127 (325)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred             hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence            357889999999999999999763    3456999999655455556679999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccc
Q 002010          767 LYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQD  846 (982)
Q Consensus       767 v~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  846 (982)
                      ||||+++++|.+++.. ....+++..+..++.|++.|++|||+.+   |+||||||+||+++.++.+||+|||+++....
T Consensus       128 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  203 (325)
T 3kul_A          128 VTEYMENGSLDTFLRT-HDGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLED  203 (325)
T ss_dssp             EEECCTTCBHHHHHHT-TTTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC-
T ss_pred             EeeCCCCCcHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCccccccc
Confidence            9999999999999964 3457999999999999999999999998   99999999999999999999999999987654


Q ss_pred             cCC-cccccccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHhccCCCCCCcccc
Q 002010          847 AGA-SECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAAS  924 (982)
Q Consensus       847 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  924 (982)
                      ... ........+|+.|+|||++.+..++.++||||+|+++|||++ |..||....... ....+.....          
T Consensus       204 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~-~~~~~~~~~~----------  272 (325)
T 3kul_A          204 DPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD-VISSVEEGYR----------  272 (325)
T ss_dssp             ---CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH-HHHHHHTTCC----------
T ss_pred             CccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHH-HHHHHHcCCC----------
Confidence            321 112233456778999999998999999999999999999999 999997654322 2222221111          


Q ss_pred             cceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCCCCC
Q 002010          925 VLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQSAP  977 (982)
Q Consensus       925 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~~~~~  977 (982)
                               ...+...+..+.+++.+||+.||++|||++|+++.|+.+.....
T Consensus       273 ---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~  316 (325)
T 3kul_A          273 ---------LPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPE  316 (325)
T ss_dssp             ---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC
T ss_pred             ---------CCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcc
Confidence                     01223345678999999999999999999999999987655433

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=1.6e-40  Score=367.41  Aligned_cols=255  Identities=23%  Similarity=0.291  Sum_probs=208.4

Q ss_pred             HHhhcccccccccccceEEEEEEeC-CCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEE
Q 002010          690 VLESLKDENIIGKGGAGIVYRGSMP-DGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLY  768 (982)
Q Consensus       690 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  768 (982)
                      +.++|+..+.||+|+||.||+|... +++.||+|++.........+.+.+|+.+++.++||||+++++++.+++..++||
T Consensus         5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~   84 (323)
T 3tki_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL   84 (323)
T ss_dssp             TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence            3578999999999999999999754 789999999865555455567899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccC
Q 002010          769 EYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAG  848 (982)
Q Consensus       769 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  848 (982)
                      ||+++++|.+++.  ....+++..+..++.||+.|++|||+.+   |+||||||+||+++.++.+||+|||++..+....
T Consensus        85 e~~~~~~L~~~l~--~~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  159 (323)
T 3tki_A           85 EYCSGGELFDRIE--PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN  159 (323)
T ss_dssp             ECCTTEEGGGGSB--TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred             EcCCCCcHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence            9999999999996  4457999999999999999999999998   9999999999999999999999999998765443


Q ss_pred             CcccccccccccccccccccccCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccce
Q 002010          849 ASECMSSVAGSYGYIAPEYAYTLKV-DEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLA  927 (982)
Q Consensus       849 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  927 (982)
                      .........||+.|+|||++.+..+ +.++||||+||++|||++|+.||....................           
T Consensus       160 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~-----------  228 (323)
T 3tki_A          160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL-----------  228 (323)
T ss_dssp             EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTS-----------
T ss_pred             cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccC-----------
Confidence            3344456789999999999987775 7899999999999999999999987544332222221111100           


Q ss_pred             eecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          928 VVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       928 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                             ......+..+.+++.+||+.||++|||++|+++
T Consensus       229 -------~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~  261 (323)
T 3tki_A          229 -------NPWKKIDSAPLALLHKILVENPSARITIPDIKK  261 (323)
T ss_dssp             -------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -------CccccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence                   001223456789999999999999999999987

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=1.6e-40  Score=367.30  Aligned_cols=248  Identities=24%  Similarity=0.349  Sum_probs=207.3

Q ss_pred             HhhcccccccccccceEEEEEEe-CCCcEEEEEEeccCC-CCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEE
Q 002010          691 LESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRG-TGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLY  768 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  768 (982)
                      .++|+..+.||+|+||.||+|.. .+|+.||||++.... .....+.+.+|+.+++.++||||+++++++..++..++||
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   93 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM   93 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence            35799999999999999999975 679999999985543 2234456889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccC
Q 002010          769 EYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAG  848 (982)
Q Consensus       769 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  848 (982)
                      ||+++++|.+++..  ...+++.++..++.|++.|++|||+.+   |+||||||+||+++.++.+||+|||++...... 
T Consensus        94 e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~-  167 (328)
T 3fe3_A           94 EYASGGEVFDYLVA--HGRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVG-  167 (328)
T ss_dssp             CCCTTCBHHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS-
T ss_pred             ECCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCCC-
Confidence            99999999999973  357999999999999999999999998   999999999999999999999999999876533 


Q ss_pred             CcccccccccccccccccccccCCCC-cchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccce
Q 002010          849 ASECMSSVAGSYGYIAPEYAYTLKVD-EKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLA  927 (982)
Q Consensus       849 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  927 (982)
                        .......||+.|+|||++.+..+. .++||||+||++|||++|+.||...... .....+.....             
T Consensus       168 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~~~~i~~~~~-------------  231 (328)
T 3fe3_A          168 --GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLK-ELRERVLRGKY-------------  231 (328)
T ss_dssp             --CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHCCC-------------
T ss_pred             --CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHH-HHHHHHHhCCC-------------
Confidence              234567899999999999888775 7999999999999999999999764322 22222221111             


Q ss_pred             eecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          928 VVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       928 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                             ..|...+..+.+++.+||+.||.+|||++|+++
T Consensus       232 -------~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~  264 (328)
T 3fe3_A          232 -------RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMK  264 (328)
T ss_dssp             -------CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred             -------CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence                   112223457889999999999999999999987

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=2.7e-40  Score=363.10  Aligned_cols=262  Identities=32%  Similarity=0.481  Sum_probs=204.7

Q ss_pred             HhhcccccccccccceEEEEEEeCCCcEEEEEEeccCCCC-CchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEe
Q 002010          691 LESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTG-GNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYE  769 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  769 (982)
                      .++|++.+.||+|+||+||+|+. ++..||||++...... .....+.+|+.++++++||||+++++++.+.+..++|||
T Consensus        36 ~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e  114 (309)
T 3p86_A           36 WCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTE  114 (309)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEE
T ss_pred             hhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEe
Confidence            45789999999999999999987 7889999998544322 234578899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhcCCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccC
Q 002010          770 YMPNGSLGEMLHGAKG-GHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAG  848 (982)
Q Consensus       770 ~~~~~sL~~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  848 (982)
                      |+++++|.+++..... ..+++..+..++.|++.|++|||+.+ ++|+||||||+||+++.++.+||+|||+++..... 
T Consensus       115 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~-  192 (309)
T 3p86_A          115 YLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAST-  192 (309)
T ss_dssp             CCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC---------
T ss_pred             cCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCcccccc-
Confidence            9999999999974321 23899999999999999999999764 34999999999999999999999999999865432 


Q ss_pred             CcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCccccccee
Q 002010          849 ASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAV  928 (982)
Q Consensus       849 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  928 (982)
                       ........||+.|+|||++.+..++.++||||+|+++|||++|+.||....... ....+......             
T Consensus       193 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~-~~~~~~~~~~~-------------  257 (309)
T 3p86_A          193 -FLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ-VVAAVGFKCKR-------------  257 (309)
T ss_dssp             ----------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHH-HHHHHHHSCCC-------------
T ss_pred             -ccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhcCCC-------------
Confidence             122345678999999999999999999999999999999999999997653322 22222111111             


Q ss_pred             ecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCCC
Q 002010          929 VDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQS  975 (982)
Q Consensus       929 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~~~  975 (982)
                           ...+...+..+.+++.+||+.||++|||++|+++.|+.+...
T Consensus       258 -----~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~  299 (309)
T 3p86_A          258 -----LEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS  299 (309)
T ss_dssp             -----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred             -----CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence                 122334455789999999999999999999999999876554

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-40  Score=372.26  Aligned_cols=267  Identities=25%  Similarity=0.425  Sum_probs=216.0

Q ss_pred             HhhcccccccccccceEEEEEEeC------CCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCcc
Q 002010          691 LESLKDENIIGKGGAGIVYRGSMP------DGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTN  764 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  764 (982)
                      .++|+..+.||+|+||.||+|+..      +++.||+|++...........+.+|+.++++++||||+++++++.+.+..
T Consensus        46 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  125 (343)
T 1luf_A           46 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPM  125 (343)
T ss_dssp             GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred             HHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCce
Confidence            367889999999999999999763      34789999986554444556789999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHhhcCC----------------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCC
Q 002010          765 LLLYEYMPNGSLGEMLHGAK----------------------GGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKS  822 (982)
Q Consensus       765 ~lv~e~~~~~sL~~~l~~~~----------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp  822 (982)
                      ++||||+++++|.+++....                      ...+++.+++.++.||+.|++|||+.+   |+||||||
T Consensus       126 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp  202 (343)
T 1luf_A          126 CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLAT  202 (343)
T ss_dssp             EEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSG
T ss_pred             EEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCc
Confidence            99999999999999997532                      157899999999999999999999998   99999999


Q ss_pred             CcEEEcCCCCEEEeccccchhccccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCC
Q 002010          823 NNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGD  901 (982)
Q Consensus       823 ~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~  901 (982)
                      +||+++.++.+||+|||++................+|+.|+|||++.+..++.++||||+|+++|||++ |..||.....
T Consensus       203 ~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~  282 (343)
T 1luf_A          203 RNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH  282 (343)
T ss_dssp             GGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred             ceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCCh
Confidence            999999999999999999987654433333445678899999999998899999999999999999999 9999976433


Q ss_pred             CchHHHHHHHhccCCCCCCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCCCCCCCC
Q 002010          902 GVDIVRWVRKTTSEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQSAPSLI  980 (982)
Q Consensus       902 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~~~~~~~~  980 (982)
                      . .....+....                   ....+...+..+.+++.+||+.||++|||++|+++.|+++.+....-+
T Consensus       283 ~-~~~~~~~~~~-------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~~~~~  341 (343)
T 1luf_A          283 E-EVIYYVRDGN-------------------ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAEGTV  341 (343)
T ss_dssp             H-HHHHHHHTTC-------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC------
T ss_pred             H-HHHHHHhCCC-------------------cCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhhhhhc
Confidence            2 2222221111                   112233445679999999999999999999999999999888765543

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=4.4e-41  Score=380.34  Aligned_cols=259  Identities=26%  Similarity=0.386  Sum_probs=211.8

Q ss_pred             HhhcccccccccccceEEEEEEeC-CCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEe
Q 002010          691 LESLKDENIIGKGGAGIVYRGSMP-DGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYE  769 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  769 (982)
                      .++|+..+.||+|+||.||+|... +++.||||++...........+.+|+.++++++||||+++++++..++..++|||
T Consensus       113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  192 (377)
T 3cbl_A          113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME  192 (377)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence            357889999999999999999775 6899999998654333344578899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCC
Q 002010          770 YMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGA  849 (982)
Q Consensus       770 ~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  849 (982)
                      |+++|+|.+++.. ....+++..+..++.||+.|++|||+.+   |+||||||+||+++.++.+||+|||+++...+...
T Consensus       193 ~~~~g~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~  268 (377)
T 3cbl_A          193 LVQGGDFLTFLRT-EGARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVY  268 (377)
T ss_dssp             CCTTCBHHHHHHH-HGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTTSEE
T ss_pred             cCCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCCCce
Confidence            9999999999973 2346899999999999999999999998   99999999999999999999999999986543211


Q ss_pred             cccccccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHhccCCCCCCccccccee
Q 002010          850 SECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAV  928 (982)
Q Consensus       850 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  928 (982)
                      ........+++.|+|||++.+..++.++|||||||++|||++ |..||...... .....+.....              
T Consensus       269 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~-~~~~~~~~~~~--------------  333 (377)
T 3cbl_A          269 AASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ-QTREFVEKGGR--------------  333 (377)
T ss_dssp             ECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH-HHHHHHHTTCC--------------
T ss_pred             eecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHHHcCCC--------------
Confidence            111122345778999999998899999999999999999999 99999765332 22222222111              


Q ss_pred             ecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 002010          929 VDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPP  973 (982)
Q Consensus       929 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~  973 (982)
                           ...+..++..+.+++.+||+.||++|||++|+++.|+++.
T Consensus       334 -----~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~  373 (377)
T 3cbl_A          334 -----LPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR  373 (377)
T ss_dssp             -----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -----CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence                 1123334567899999999999999999999999998654

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.6e-40  Score=368.86  Aligned_cols=267  Identities=23%  Similarity=0.392  Sum_probs=216.4

Q ss_pred             HhhcccccccccccceEEEEEEe------CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcC-CCCcccceEeEEEcCCc
Q 002010          691 LESLKDENIIGKGGAGIVYRGSM------PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRI-RHRNIVRLLGYVSNRDT  763 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~  763 (982)
                      .++|+..+.||+|+||.||+|..      .++..||+|++...........+.+|+.++.++ +||||+++++++...+.
T Consensus        44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~  123 (344)
T 1rjb_A           44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP  123 (344)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCc
Confidence            46899999999999999999975      246689999997655555667899999999999 89999999999999999


Q ss_pred             cEEEEeccCCCCHHHHhhcCCC---------------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCC
Q 002010          764 NLLLYEYMPNGSLGEMLHGAKG---------------------GHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKS  822 (982)
Q Consensus       764 ~~lv~e~~~~~sL~~~l~~~~~---------------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp  822 (982)
                      .++||||+++|+|.+++.....                     ..+++..+..++.||+.|++|||+.+   |+||||||
T Consensus       124 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp  200 (344)
T 1rjb_A          124 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAA  200 (344)
T ss_dssp             CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSG
T ss_pred             cEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCh
Confidence            9999999999999999975432                     24799999999999999999999998   99999999


Q ss_pred             CcEEEcCCCCEEEeccccchhccccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCC
Q 002010          823 NNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGD  901 (982)
Q Consensus       823 ~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~  901 (982)
                      +||+++.++.+||+|||++................+|+.|+|||++.+..++.++||||+|+++|||+| |..||.....
T Consensus       201 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~  280 (344)
T 1rjb_A          201 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV  280 (344)
T ss_dssp             GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred             hhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCc
Confidence            999999999999999999987765443334445667889999999999999999999999999999998 9999987665


Q ss_pred             CchHHHHHHHhccCCCCCCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCCCCCCC
Q 002010          902 GVDIVRWVRKTTSEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQSAPSL  979 (982)
Q Consensus       902 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~~~~~~~  979 (982)
                      .......+......                   ..+...+..+.+++.+||+.||.+|||++|+++.|+.+....+++
T Consensus       281 ~~~~~~~~~~~~~~-------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~  339 (344)
T 1rjb_A          281 DANFYKLIQNGFKM-------------------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAEEA  339 (344)
T ss_dssp             SHHHHHHHHTTCCC-------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC------
T ss_pred             HHHHHHHHhcCCCC-------------------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHHHH
Confidence            55444444332110                   112233457899999999999999999999999999888776553

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=1.5e-39  Score=357.80  Aligned_cols=267  Identities=36%  Similarity=0.602  Sum_probs=220.5

Q ss_pred             ccccccccceEEEEEEeCCCcEEEEEEeccCC---CCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEeccCC
Q 002010          697 ENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRG---TGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPN  773 (982)
Q Consensus       697 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  773 (982)
                      ++.||+|+||.||+|.. +++.||+|++....   .....+.+.+|+.++++++||||+++++++.+.+..++||||+++
T Consensus        36 ~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~  114 (307)
T 2nru_A           36 GNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPN  114 (307)
T ss_dssp             CCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred             CCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEecCC
Confidence            48899999999999987 78899999985432   223456788999999999999999999999999999999999999


Q ss_pred             CCHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCccc
Q 002010          774 GSLGEMLHGAK-GGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASEC  852 (982)
Q Consensus       774 ~sL~~~l~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~  852 (982)
                      ++|.+++.... ...+++..+..++.|++.|++|||+.+   |+||||||+||+++.++.+||+|||++...........
T Consensus       115 ~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~  191 (307)
T 2nru_A          115 GSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVM  191 (307)
T ss_dssp             CBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEE
T ss_pred             CcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEcCCCcEEEeeccccccccccccccc
Confidence            99999997432 356999999999999999999999998   99999999999999999999999999987654333333


Q ss_pred             ccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceeecCC
Q 002010          853 MSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDPR  932 (982)
Q Consensus       853 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  932 (982)
                      .....|++.|+|||++.+ .++.++||||+|+++|+|++|..||...........+.......      ...+...+++.
T Consensus       192 ~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~  264 (307)
T 2nru_A          192 TSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDE------EKTIEDYIDKK  264 (307)
T ss_dssp             CSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTT------SCCHHHHSCSS
T ss_pred             ccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhh------hhhhhhhcccc
Confidence            445678999999998765 58999999999999999999999998765544444443332221      11223344555


Q ss_pred             CCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCC
Q 002010          933 LSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQ  974 (982)
Q Consensus       933 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~~  974 (982)
                      +...+...+..+.+++.+||+.||.+|||++|+++.|+++.+
T Consensus       265 ~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~  306 (307)
T 2nru_A          265 MNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA  306 (307)
T ss_dssp             CSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred             ccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence            566778888899999999999999999999999999987754

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=4.3e-40  Score=354.43  Aligned_cols=258  Identities=23%  Similarity=0.409  Sum_probs=213.6

Q ss_pred             hhcccccccccccceEEEEEEeCCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEecc
Q 002010          692 ESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYM  771 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  771 (982)
                      ++|+..+.||+|+||.||+|+..++..||+|++...  .....++.+|+.++++++||||+++++++.++...++||||+
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (268)
T 3sxs_A            8 EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEG--SMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI   85 (268)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBT--TBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             hheeeeeeeccCCCceEEEEEecCceeEEEEEeccC--CCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence            578899999999999999999888889999998543  234567899999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCcc
Q 002010          772 PNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASE  851 (982)
Q Consensus       772 ~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~  851 (982)
                      ++++|.+++... ...+++..++.++.|++.|++|||+.+   |+||||||+||+++.++.+||+|||.+....... ..
T Consensus        86 ~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~~  160 (268)
T 3sxs_A           86 SNGCLLNYLRSH-GKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ-YV  160 (268)
T ss_dssp             TTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTC-EE
T ss_pred             CCCcHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhh-hh
Confidence            999999999742 346899999999999999999999998   9999999999999999999999999998765432 22


Q ss_pred             cccccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceeec
Q 002010          852 CMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVD  930 (982)
Q Consensus       852 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  930 (982)
                      ......+++.|+|||++.+..++.++||||+|+++|||++ |+.||............ .....                
T Consensus       161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~-~~~~~----------------  223 (268)
T 3sxs_A          161 SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKV-SQGHR----------------  223 (268)
T ss_dssp             ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH-HTTCC----------------
T ss_pred             cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHH-HcCCC----------------
Confidence            2334556778999999998899999999999999999999 99999765433222221 11110                


Q ss_pred             CCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCCCC
Q 002010          931 PRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQSA  976 (982)
Q Consensus       931 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~~~~  976 (982)
                         ...+...+..+.+++.+||+.||++|||++|+++.|+.+....
T Consensus       224 ---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~~  266 (268)
T 3sxs_A          224 ---LYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREKD  266 (268)
T ss_dssp             ---CCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC--
T ss_pred             ---CCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhcc
Confidence               0112223447899999999999999999999999999987754

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=7.2e-41  Score=370.41  Aligned_cols=272  Identities=25%  Similarity=0.340  Sum_probs=207.0

Q ss_pred             hhcccccccccccceEEEEEEeCCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCc----cEEE
Q 002010          692 ESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDT----NLLL  767 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~----~~lv  767 (982)
                      ++|+..+.||+|+||.||+|+. .++.||||++...  ......+.+|+.++++++||||+++++++.....    .++|
T Consensus        24 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv  100 (322)
T 3soc_A           24 MPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQ--DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI  100 (322)
T ss_dssp             EEEEEEEEEECSTTCEEEEEEE-TTEEEEEEEECGG--GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             hhchhhheecccCceEEEEEEE-CCCEEEEEEeecC--chHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence            5789999999999999999987 4889999998432  2233455678999999999999999999987543    5999


Q ss_pred             EeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhc----------CCCcEEecCCCCCcEEEcCCCCEEEec
Q 002010          768 YEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHD----------CSPLIIHRDVKSNNILLDSDFEAHVAD  837 (982)
Q Consensus       768 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~----------~~~~ivHrDlkp~Nill~~~~~~kl~D  837 (982)
                      |||+++|+|.+++..   ..+++..+..++.|++.|++|||+.          +   |+||||||+||+++.++.+||+|
T Consensus       101 ~e~~~~g~L~~~l~~---~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~kL~D  174 (322)
T 3soc_A          101 TAFHEKGSLSDFLKA---NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTACIAD  174 (322)
T ss_dssp             EECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEEECC
T ss_pred             EecCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEEEcc
Confidence            999999999999964   3599999999999999999999987          7   99999999999999999999999


Q ss_pred             cccchhccccCCccccccccccccccccccccc-----CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHh
Q 002010          838 FGLAKFLQDAGASECMSSVAGSYGYIAPEYAYT-----LKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKT  912 (982)
Q Consensus       838 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~  912 (982)
                      ||+++.+.............||+.|+|||++.+     ..++.++||||+||++|||++|+.||....+..... +....
T Consensus       175 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~-~~~~~  253 (322)
T 3soc_A          175 FGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLP-FEEEI  253 (322)
T ss_dssp             CTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCT-THHHH
T ss_pred             CCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccc-hhhhh
Confidence            999987765443333445679999999999886     356678999999999999999999997643321110 00000


Q ss_pred             ccCCCCCCcc-cccceeecCCCCC--CChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 002010          913 TSEVSQPSDA-ASVLAVVDPRLSG--YPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPP  973 (982)
Q Consensus       913 ~~~~~~~~~~-~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~  973 (982)
                      ...+...... ........+....  .....+..+.+++.+||+.||++|||++|+++.|+++.
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~  317 (322)
T 3soc_A          254 GQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQ  317 (322)
T ss_dssp             CSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            0000000000 0000011111111  12345667999999999999999999999999998654

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=3.3e-40  Score=363.45  Aligned_cols=255  Identities=26%  Similarity=0.451  Sum_probs=209.5

Q ss_pred             hhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEec
Q 002010          692 ESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEY  770 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  770 (982)
                      ++|+..+.||+|+||+||+|.. .+++.||+|++.. ......+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus        10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   88 (310)
T 3s95_A           10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR-FDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY   88 (310)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESC-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hHeeccceecCCCCEEEEEEEECCCCcEEEEEEecc-CCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence            5788999999999999999976 4689999998833 3344566789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCc
Q 002010          771 MPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS  850 (982)
Q Consensus       771 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  850 (982)
                      +++++|.+++... ...+++.++..++.|++.|++|||+.+   |+||||||+||+++.++.+||+|||++..+......
T Consensus        89 ~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  164 (310)
T 3s95_A           89 IKGGTLRGIIKSM-DSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQ  164 (310)
T ss_dssp             CTTCBHHHHHHHC-CTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC-----
T ss_pred             cCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceeccccccc
Confidence            9999999999743 467999999999999999999999998   999999999999999999999999999876433211


Q ss_pred             c------------cccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCch-----HHHHHHHhc
Q 002010          851 E------------CMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVD-----IVRWVRKTT  913 (982)
Q Consensus       851 ~------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~-----~~~~~~~~~  913 (982)
                      .            ......||+.|+|||++.+..++.++||||+|+++|||++|..|+........     .......  
T Consensus       165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~--  242 (310)
T 3s95_A          165 PEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDR--  242 (310)
T ss_dssp             ---------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHH--
T ss_pred             ccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccc--
Confidence            1            11245799999999999999999999999999999999999999875322211     1111110  


Q ss_pred             cCCCCCCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCC
Q 002010          914 SEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQ  974 (982)
Q Consensus       914 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~~  974 (982)
                                           ..+...+..+.+++.+||+.||++|||++|+++.|+.+..
T Consensus       243 ---------------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~  282 (310)
T 3s95_A          243 ---------------------YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRM  282 (310)
T ss_dssp             ---------------------TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---------------------cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence                                 1122233468899999999999999999999999987643

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=100.00  E-value=2.2e-39  Score=374.48  Aligned_cols=364  Identities=21%  Similarity=0.195  Sum_probs=276.5

Q ss_pred             ccCCcCccccccccEEEeccCCCCCCCChhhhhhcccceeeccCCccccccchhhhhcCCCccEEeccCccccCCCchhc
Q 002010           85 GSIPPEIGLLTKLVNLTISNVNLTGRLPSEMALLTSLKVFNISGNVFQGNFAGQIVRGMTELQVLDAYNNNFTGPLPVEI  164 (982)
Q Consensus        85 g~~~~~i~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~l  164 (982)
                      +..+..++.+++|++|++++|++++. | .+..+++|++|+|++|.+++. +   +..+++|++|++++|++++. |  +
T Consensus        32 ~~~~~~~~~l~~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~~-~---~~~l~~L~~L~Ls~N~l~~~-~--~  102 (457)
T 3bz5_A           32 ATDTISEEQLATLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITTL-D---LSQNTNLTYLACDSNKLTNL-D--V  102 (457)
T ss_dssp             TTSEEEHHHHTTCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSCC-C---CTTCTTCSEEECCSSCCSCC-C--C
T ss_pred             cccccChhHcCCCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCeE-c---cccCCCCCEEECcCCCCcee-e--c
Confidence            34445677888888888888888864 5 688888888888888888764 2   56788888888888888864 3  7


Q ss_pred             cccccccEEeecCcccccccCCCccccCcceEeeccCcccccchhhHHhhhhhHHHHhhcccccccccCCCCCCCCCCCC
Q 002010          165 ASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLNGIGLNGTVPAFLSRLKNLREMYIGYFNTYTGGIPPGFGALTQLQ  244 (982)
Q Consensus       165 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~l~~~n~~~~~~p~~~~~l~~L~  244 (982)
                      +++++|++|+|++|++++. |  ++.+++|++|++++|.+.+.                            .++.+++|+
T Consensus       103 ~~l~~L~~L~L~~N~l~~l-~--~~~l~~L~~L~l~~N~l~~l----------------------------~l~~l~~L~  151 (457)
T 3bz5_A          103 TPLTKLTYLNCDTNKLTKL-D--VSQNPLLTYLNCARNTLTEI----------------------------DVSHNTQLT  151 (457)
T ss_dssp             TTCTTCCEEECCSSCCSCC-C--CTTCTTCCEEECTTSCCSCC----------------------------CCTTCTTCC
T ss_pred             CCCCcCCEEECCCCcCCee-c--CCCCCcCCEEECCCCcccee----------------------------ccccCCcCC
Confidence            8888888888888888863 3  78888888888888776521                            156677788


Q ss_pred             EEecccCcCcccCchhhcCCCccceeecccccCCCCCCccccCCCCCCEEEeeCCcccCcCchhhhcccchhhhhhccCC
Q 002010          245 VLDMASCNISGEIPTSLSRLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQLFKNN  324 (982)
Q Consensus       245 ~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~  324 (982)
                      +|++++|+..+.+  .+..+++|++|++++|++++ +|  +..+++|+.|++++|++++.   .+..+++|++|++++|+
T Consensus       152 ~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~  223 (457)
T 3bz5_A          152 ELDCHLNKKITKL--DVTPQTQLTTLDCSFNKITE-LD--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNK  223 (457)
T ss_dssp             EEECTTCSCCCCC--CCTTCTTCCEEECCSSCCCC-CC--CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSC
T ss_pred             EEECCCCCccccc--ccccCCcCCEEECCCCccce-ec--cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCc
Confidence            8888888655555  47778888888888888886 33  77778888888888888864   37777888888888888


Q ss_pred             CCCCCCCcCCCCCCccEEEccCCCcccccCccccCCCcccEEEeccccccccCCccccCccccceeecccccccccCCcc
Q 002010          325 LRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFIGPIPEE  404 (982)
Q Consensus       325 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~l~~N~~~~~~~~~  404 (982)
                      +++ +|  ++.+++|+.|++++|++++..   ++.+++|+.|+++.|+              |+.|++++|.+.+.+|  
T Consensus       224 l~~-ip--~~~l~~L~~L~l~~N~l~~~~---~~~l~~L~~L~l~~n~--------------L~~L~l~~n~~~~~~~--  281 (457)
T 3bz5_A          224 LTE-ID--VTPLTQLTYFDCSVNPLTELD---VSTLSKLTTLHCIQTD--------------LLEIDLTHNTQLIYFQ--  281 (457)
T ss_dssp             CSC-CC--CTTCTTCSEEECCSSCCSCCC---CTTCTTCCEEECTTCC--------------CSCCCCTTCTTCCEEE--
T ss_pred             ccc-cC--ccccCCCCEEEeeCCcCCCcC---HHHCCCCCEEeccCCC--------------CCEEECCCCccCCccc--
Confidence            886 45  777888888888888888643   4556777778777664              4567888888777776  


Q ss_pred             ccCCCCCCEEEccCCccCCCCCccccCCCccccccCCCccccccCCcccccCCccEEEeeccccCCCCchhccCCCCcce
Q 002010          405 LGQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLSGELPEKMSGASLNQLKVANNNITGKIPAAIGNLPSLNI  484 (982)
Q Consensus       405 l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~L~~N~i~~~~p~~~~~l~~L~~  484 (982)
                      ++.+++|+.|++++|...+.+|.   ..+.|+.|++++|            ++|++|++++|++++. +  ++.+++|+.
T Consensus       282 ~~~l~~L~~L~Ls~n~~l~~l~~---~~~~L~~L~l~~~------------~~L~~L~L~~N~l~~l-~--l~~l~~L~~  343 (457)
T 3bz5_A          282 AEGCRKIKELDVTHNTQLYLLDC---QAAGITELDLSQN------------PKLVYLYLNNTELTEL-D--VSHNTKLKS  343 (457)
T ss_dssp             CTTCTTCCCCCCTTCTTCCEEEC---TTCCCSCCCCTTC------------TTCCEEECTTCCCSCC-C--CTTCTTCSE
T ss_pred             ccccccCCEEECCCCcccceecc---CCCcceEechhhc------------ccCCEEECCCCccccc-c--cccCCcCcE
Confidence            46788888888888888877774   3456677777766            4688888888888874 3  788888888


Q ss_pred             eeeccccccCCCccccccccccceeeeeccccCCCCCcccccccCCCeeeCCCCcccCCCCcccc
Q 002010          485 LSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYGKIPPGIS  549 (982)
Q Consensus       485 L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~  549 (982)
                      |++++|++++        ++.|..|++++|+++|.     ..+..|+.+++++|+++|.+|..+.
T Consensus       344 L~l~~N~l~~--------l~~L~~L~l~~n~l~g~-----~~~~~l~~l~l~~N~l~g~ip~~~~  395 (457)
T 3bz5_A          344 LSCVNAHIQD--------FSSVGKIPALNNNFEAE-----GQTITMPKETLTNNSLTIAVSPDLL  395 (457)
T ss_dssp             EECCSSCCCB--------CTTGGGSSGGGTSEEEE-----EEEEECCCBCCBTTBEEEECCTTCB
T ss_pred             EECCCCCCCC--------ccccccccccCCcEEec-----ceeeecCccccccCcEEEEcChhHh
Confidence            8888888874        35677778888888865     3566788888888888888887653

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=3.7e-40  Score=355.11  Aligned_cols=256  Identities=25%  Similarity=0.443  Sum_probs=212.6

Q ss_pred             hhcccccccccccceEEEEEEeCCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEecc
Q 002010          692 ESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYM  771 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  771 (982)
                      ++|+..+.||+|+||.||+|...+++.||+|++...  ....+.+.+|+.++++++||||+++++++.++...++||||+
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   87 (269)
T 4hcu_A           10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG--AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM   87 (269)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTT--SBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             hhceeeheecCCCccEEEEEEecCCCeEEEEEeccc--ccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence            578889999999999999999888999999998543  334567899999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCcc
Q 002010          772 PNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASE  851 (982)
Q Consensus       772 ~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~  851 (982)
                      ++++|.+++.. ....+++..+..++.|++.|++|||+.+   |+||||||+||+++.++.+||+|||++...... ...
T Consensus        88 ~~~~L~~~l~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~  162 (269)
T 4hcu_A           88 EHGCLSDYLRT-QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD-QYT  162 (269)
T ss_dssp             TTCBHHHHHHT-TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCH-HHH
T ss_pred             CCCcHHHHHHh-cCcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEecccccccccccc-ccc
Confidence            99999999974 3457899999999999999999999998   999999999999999999999999999876532 122


Q ss_pred             cccccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceeec
Q 002010          852 CMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVD  930 (982)
Q Consensus       852 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  930 (982)
                      ......+++.|+|||++.+..++.++||||+|+++|||++ |+.||....... ....+.....                
T Consensus       163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~-~~~~~~~~~~----------------  225 (269)
T 4hcu_A          163 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE-VVEDISTGFR----------------  225 (269)
T ss_dssp             STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-HHHHHHTTCC----------------
T ss_pred             cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHH-HHHHHhcCcc----------------
Confidence            2334556788999999998999999999999999999999 999997643322 2222211111                


Q ss_pred             CCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCC
Q 002010          931 PRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQ  974 (982)
Q Consensus       931 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~~  974 (982)
                         ...+...+..+.+++.+||+.||++|||++|+++.|+++..
T Consensus       226 ---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~  266 (269)
T 4hcu_A          226 ---LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE  266 (269)
T ss_dssp             ---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---CCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence               01122234578999999999999999999999999987543

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=3.1e-40  Score=364.23  Aligned_cols=266  Identities=23%  Similarity=0.385  Sum_probs=221.5

Q ss_pred             HhhcccccccccccceEEEEEEe------CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcC-CCCcccceEeEEEcCCc
Q 002010          691 LESLKDENIIGKGGAGIVYRGSM------PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRI-RHRNIVRLLGYVSNRDT  763 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~  763 (982)
                      .++|+..+.||+|+||.||+|..      .+++.||+|++.........+.+.+|+.+++++ +||||+++++++.+++.
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~  101 (313)
T 1t46_A           22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP  101 (313)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence            35789999999999999999964      346789999986554444557789999999999 99999999999999999


Q ss_pred             cEEEEeccCCCCHHHHhhcCCC----------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEE
Q 002010          764 NLLLYEYMPNGSLGEMLHGAKG----------------GHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILL  827 (982)
Q Consensus       764 ~~lv~e~~~~~sL~~~l~~~~~----------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill  827 (982)
                      .++||||+++|+|.+++.....                ..+++..++.++.|++.|++|||+.+   |+||||||+||++
T Consensus       102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~  178 (313)
T 1t46_A          102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL  178 (313)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred             cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEE
Confidence            9999999999999999975432                25899999999999999999999998   9999999999999


Q ss_pred             cCCCCEEEeccccchhccccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHH
Q 002010          828 DSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIV  906 (982)
Q Consensus       828 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~  906 (982)
                      +.++.+||+|||++................+++.|+|||++.+..++.++||||+|+++|||++ |..||..........
T Consensus       179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~  258 (313)
T 1t46_A          179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY  258 (313)
T ss_dssp             ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHH
T ss_pred             cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHH
Confidence            9999999999999987765433333445567889999999999999999999999999999999 999998765555444


Q ss_pred             HHHHHhccCCCCCCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCCCCCC
Q 002010          907 RWVRKTTSEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQSAPS  978 (982)
Q Consensus       907 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~~~~~~  978 (982)
                      ..+......                   ..+...+..+.+++.+||+.||.+|||++|+++.|+++.+..+.
T Consensus       259 ~~~~~~~~~-------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~  311 (313)
T 1t46_A          259 KMIKEGFRM-------------------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISESTN  311 (313)
T ss_dssp             HHHHHTCCC-------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTCC
T ss_pred             HHhccCCCC-------------------CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHhhc
Confidence            444332221                   11223345789999999999999999999999999877655544

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=2.2e-40  Score=373.02  Aligned_cols=259  Identities=24%  Similarity=0.380  Sum_probs=213.7

Q ss_pred             hhcccccccccccceEEEEEEeC------CCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccE
Q 002010          692 ESLKDENIIGKGGAGIVYRGSMP------DGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNL  765 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  765 (982)
                      ++|+..+.||+|+||.||+|...      +++.||||++...........+.+|+.++++++||||+++++++..+...+
T Consensus        71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  150 (367)
T 3l9p_A           71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF  150 (367)
T ss_dssp             GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCE
Confidence            57889999999999999999742      467899999865545555667899999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHhhcCC-----CCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCC---CEEEec
Q 002010          766 LLYEYMPNGSLGEMLHGAK-----GGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDF---EAHVAD  837 (982)
Q Consensus       766 lv~e~~~~~sL~~~l~~~~-----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~---~~kl~D  837 (982)
                      +||||+++|+|.+++....     ...+++.+++.++.||+.|++|||+.+   |+||||||+||+++.++   .+||+|
T Consensus       151 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~D  227 (367)
T 3l9p_A          151 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGD  227 (367)
T ss_dssp             EEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred             EEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEECC
Confidence            9999999999999997532     246899999999999999999999998   99999999999999554   599999


Q ss_pred             cccchhccccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHhccCC
Q 002010          838 FGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEV  916 (982)
Q Consensus       838 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  916 (982)
                      ||+++.+.............+|+.|+|||++.+..++.++||||+||++|||++ |..||..... ......+.....  
T Consensus       228 FG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~-~~~~~~i~~~~~--  304 (367)
T 3l9p_A          228 FGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN-QEVLEFVTSGGR--  304 (367)
T ss_dssp             CHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-HHHHHHHHTTCC--
T ss_pred             CccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHHHcCCC--
Confidence            999987654444444455678999999999999999999999999999999998 9999976433 222222222111  


Q ss_pred             CCCCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 002010          917 SQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPP  973 (982)
Q Consensus       917 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~  973 (982)
                                       ...+...+..+.+++.+||+.||++|||++||++.|+.+.
T Consensus       305 -----------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~  344 (367)
T 3l9p_A          305 -----------------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT  344 (367)
T ss_dssp             -----------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -----------------CCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence                             1122334457899999999999999999999999986543

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=4.8e-40  Score=358.81  Aligned_cols=263  Identities=26%  Similarity=0.369  Sum_probs=209.4

Q ss_pred             hhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCC--CchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEE
Q 002010          692 ESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTG--GNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLY  768 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  768 (982)
                      ++|+..+.||+|+||.||+|.. .+++.||+|.+......  ...+.+.+|+.++++++||||+++++++.+++..++||
T Consensus        11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   90 (294)
T 4eqm_A           11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVM   90 (294)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEE
Confidence            5799999999999999999965 56899999998544332  23457889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccC
Q 002010          769 EYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAG  848 (982)
Q Consensus       769 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  848 (982)
                      ||+++++|.+++..  ...+++..+..++.|++.|++|||+.+   |+||||||+||+++.++.+||+|||++.......
T Consensus        91 e~~~g~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  165 (294)
T 4eqm_A           91 EYIEGPTLSEYIES--HGPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS  165 (294)
T ss_dssp             ECCCSCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC----
T ss_pred             eCCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCcccccccc
Confidence            99999999999973  357999999999999999999999998   9999999999999999999999999998765332


Q ss_pred             CcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCccccccee
Q 002010          849 ASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAV  928 (982)
Q Consensus       849 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  928 (982)
                       ........||+.|+|||++.+..++.++||||+|+++|||++|+.||..................   .          
T Consensus       166 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~---~----------  231 (294)
T 4eqm_A          166 -LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVP---N----------  231 (294)
T ss_dssp             ----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCC---C----------
T ss_pred             -ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCC---C----------
Confidence             22234467899999999999999999999999999999999999999764332222221111000   0          


Q ss_pred             ecCCCCCCChHhHHHHHHHHhhccCCCCCCCC-CHHHHHHHhcCCCCCC
Q 002010          929 VDPRLSGYPLTGVIHLFKVAMMCVEDESSARP-TMREVVHMLANPPQSA  976 (982)
Q Consensus       929 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-t~~ell~~L~~~~~~~  976 (982)
                         .....+...+..+.+++.+||+.||++|| +++++.+.|+.+....
T Consensus       232 ---~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~  277 (294)
T 4eqm_A          232 ---VTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHEN  277 (294)
T ss_dssp             ---HHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSS
T ss_pred             ---cchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhc
Confidence               00012233456789999999999999999 9999999998876643

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=8.4e-40  Score=362.51  Aligned_cols=248  Identities=23%  Similarity=0.268  Sum_probs=207.1

Q ss_pred             hhcccccccccccceEEEEEEe-CCCcEEEEEEeccCC--CCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEE
Q 002010          692 ESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRG--TGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLY  768 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  768 (982)
                      ++|+..+.||+|+||.||+|+. .+|+.||+|++....  .......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~   84 (337)
T 1o6l_A            5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence            5789999999999999999976 468999999985432  2344567889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccC
Q 002010          769 EYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAG  848 (982)
Q Consensus       769 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  848 (982)
                      ||+++|+|.+++.  +...+++..+..++.||+.|++|||+++   |+||||||+||+++.++.+||+|||+++..... 
T Consensus        85 E~~~gg~L~~~l~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~-  158 (337)
T 1o6l_A           85 EYANGGELFFHLS--RERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD-  158 (337)
T ss_dssp             ECCTTCBHHHHHH--HHSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT-
T ss_pred             eCCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhcccC-
Confidence            9999999999997  3457899999999999999999999998   999999999999999999999999999754322 


Q ss_pred             CcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCccccccee
Q 002010          849 ASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAV  928 (982)
Q Consensus       849 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  928 (982)
                       ........||+.|+|||++.+..++.++||||+||++|||++|+.||...... .....+.....              
T Consensus       159 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-~~~~~i~~~~~--------------  222 (337)
T 1o6l_A          159 -GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-RLFELILMEEI--------------  222 (337)
T ss_dssp             -TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHCCC--------------
T ss_pred             -CCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHH-HHHHHHHcCCC--------------
Confidence             22345578999999999999999999999999999999999999999764322 22222211111              


Q ss_pred             ecCCCCCCChHhHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 002010          929 VDPRLSGYPLTGVIHLFKVAMMCVEDESSARP-----TMREVVH  967 (982)
Q Consensus       929 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~ell~  967 (982)
                            .++...+..+.+++.+||+.||++||     +++|+++
T Consensus       223 ------~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~  260 (337)
T 1o6l_A          223 ------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             ------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             ------CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence                  11223345789999999999999999     8999876

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=1.1e-39  Score=365.01  Aligned_cols=254  Identities=22%  Similarity=0.290  Sum_probs=208.6

Q ss_pred             HHHhhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCCC-----chhhHHHHHHHHhcCCCCcccceEeEEEcCC
Q 002010          689 DVLESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGG-----NDHGFLAEIQTLGRIRHRNIVRLLGYVSNRD  762 (982)
Q Consensus       689 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  762 (982)
                      .+.+.|+..+.||+|+||.||+|.. .+|+.||+|.+.......     ....+.+|+.++++++||||+++++++.+..
T Consensus         9 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~   88 (361)
T 2yab_A            9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRT   88 (361)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             ChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCC
Confidence            3457899999999999999999975 468999999996554322     3467899999999999999999999999999


Q ss_pred             ccEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCC----CEEEecc
Q 002010          763 TNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDF----EAHVADF  838 (982)
Q Consensus       763 ~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~----~~kl~Df  838 (982)
                      ..++||||+++|+|.+++.  +...+++..+..++.||+.|++|||+.+   |+||||||+||+++.++    .+||+||
T Consensus        89 ~~~lv~e~~~gg~L~~~l~--~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DF  163 (361)
T 2yab_A           89 DVVLILELVSGGELFDFLA--QKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDF  163 (361)
T ss_dssp             EEEEEEECCCSCBHHHHHT--TCSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred             EEEEEEEcCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEec
Confidence            9999999999999999996  4567999999999999999999999998   99999999999998876    7999999


Q ss_pred             ccchhccccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCC
Q 002010          839 GLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQ  918 (982)
Q Consensus       839 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  918 (982)
                      |++......   .......||+.|+|||++.+..++.++||||+||++|+|++|..||...........+ .......  
T Consensus       164 G~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i-~~~~~~~--  237 (361)
T 2yab_A          164 GLAHEIEDG---VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANI-TAVSYDF--  237 (361)
T ss_dssp             SSCEECCTT---CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH-HTTCCCC--
T ss_pred             CCceEcCCC---CccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-HhcCCCC--
Confidence            999876542   2234567999999999999999999999999999999999999999764332222222 1111000  


Q ss_pred             CCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          919 PSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       919 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                      +.              ......+..+.+++.+||+.||++|||++|+++
T Consensus       238 ~~--------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  272 (361)
T 2yab_A          238 DE--------------EFFSQTSELAKDFIRKLLVKETRKRLTIQEALR  272 (361)
T ss_dssp             CH--------------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             Cc--------------hhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            00              001122346889999999999999999999985

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=1.3e-39  Score=354.45  Aligned_cols=269  Identities=22%  Similarity=0.334  Sum_probs=207.7

Q ss_pred             hhcccccccccccceEEEEEEeCCCcEEEEEEeccCCC-CCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEec
Q 002010          692 ESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGT-GGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEY  770 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  770 (982)
                      ++|+..+.||+|+||+||+|+..+++.||+|++..... ......+.+|+.++++++||||+++++++.+++..++||||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence            46889999999999999999887899999999854432 23346788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCc
Q 002010          771 MPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS  850 (982)
Q Consensus       771 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  850 (982)
                      +++ +|.+++.. ....+++..+..++.|++.|++|||+.+   |+||||||+||+++.++.+||+|||++......  .
T Consensus        82 ~~~-~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~  154 (288)
T 1ob3_A           82 LDQ-DLKKLLDV-CEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIP--V  154 (288)
T ss_dssp             CSE-EHHHHHHT-STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred             cCC-CHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCcc--c
Confidence            975 99998874 3367899999999999999999999998   999999999999999999999999999876432  1


Q ss_pred             ccccccccccccccccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceee
Q 002010          851 ECMSSVAGSYGYIAPEYAYTL-KVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVV  929 (982)
Q Consensus       851 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  929 (982)
                      .......+|+.|+|||++.+. .++.++||||+||++|||++|+.||.................................
T Consensus       155 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (288)
T 1ob3_A          155 RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY  234 (288)
T ss_dssp             -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred             cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccccc
Confidence            223445789999999998764 5899999999999999999999999876544444444433322211111100101111


Q ss_pred             cCCCC--------CCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          930 DPRLS--------GYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       930 ~~~~~--------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                      ++.+.        ......+..+.+++.+||+.||++|||++|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  280 (288)
T 1ob3_A          235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (288)
T ss_dssp             CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            11111        122334567889999999999999999999985

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=3e-40  Score=374.38  Aligned_cols=260  Identities=25%  Similarity=0.388  Sum_probs=215.7

Q ss_pred             hhcccccccccccceEEEEEEe--------CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcC-CCCcccceEeEEEcCC
Q 002010          692 ESLKDENIIGKGGAGIVYRGSM--------PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRI-RHRNIVRLLGYVSNRD  762 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~--------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~  762 (982)
                      ++|+..+.||+|+||.||+|..        ..+..||+|++...........+.+|+++++++ +||||+++++++..++
T Consensus        69 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~  148 (382)
T 3tt0_A           69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG  148 (382)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             hheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCC
Confidence            5788999999999999999964        224579999986655445557789999999999 8999999999999999


Q ss_pred             ccEEEEeccCCCCHHHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEc
Q 002010          763 TNLLLYEYMPNGSLGEMLHGAK--------------GGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLD  828 (982)
Q Consensus       763 ~~~lv~e~~~~~sL~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~  828 (982)
                      ..++||||+++|+|.+++....              ...+++..++.++.||+.||+|||+.+   |+||||||+||+++
T Consensus       149 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~  225 (382)
T 3tt0_A          149 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVT  225 (382)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEC
T ss_pred             ceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEEEc
Confidence            9999999999999999997543              246999999999999999999999998   99999999999999


Q ss_pred             CCCCEEEeccccchhccccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHH
Q 002010          829 SDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVR  907 (982)
Q Consensus       829 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~  907 (982)
                      .++.+||+|||+++...............+|+.|+|||++.+..++.++||||+||++|||++ |..||..... .....
T Consensus       226 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~-~~~~~  304 (382)
T 3tt0_A          226 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV-EELFK  304 (382)
T ss_dssp             TTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-HHHHH
T ss_pred             CCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH-HHHHH
Confidence            999999999999987664433344445667889999999999999999999999999999999 9999976432 22233


Q ss_pred             HHHHhccCCCCCCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCC
Q 002010          908 WVRKTTSEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQ  974 (982)
Q Consensus       908 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~~  974 (982)
                      .+.....                   ...+...+..+.+++.+||+.||++|||++|+++.|+++.+
T Consensus       305 ~~~~~~~-------------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~  352 (382)
T 3tt0_A          305 LLKEGHR-------------------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA  352 (382)
T ss_dssp             HHHTTCC-------------------CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHcCCC-------------------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            2222111                   11122344578999999999999999999999999977654

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=2.5e-40  Score=372.62  Aligned_cols=261  Identities=27%  Similarity=0.391  Sum_probs=215.5

Q ss_pred             HhhcccccccccccceEEEEEEe------CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcC-CCCcccceEeEEEcCCc
Q 002010          691 LESLKDENIIGKGGAGIVYRGSM------PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRI-RHRNIVRLLGYVSNRDT  763 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~  763 (982)
                      .++|+..+.||+|+||.||+|++      .+++.||||++.........+.+.+|+.++.++ +||||+++++++.+++.
T Consensus        21 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~  100 (359)
T 3vhe_A           21 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG  100 (359)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred             ccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCC
Confidence            46799999999999999999963      346789999996554444556789999999999 78999999999887654


Q ss_pred             -cEEEEeccCCCCHHHHhhcCCC---------------------------------------------------------
Q 002010          764 -NLLLYEYMPNGSLGEMLHGAKG---------------------------------------------------------  785 (982)
Q Consensus       764 -~~lv~e~~~~~sL~~~l~~~~~---------------------------------------------------------  785 (982)
                       .++||||+++|+|.+++.....                                                         
T Consensus       101 ~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  180 (359)
T 3vhe_A          101 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE  180 (359)
T ss_dssp             CCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------------------------------------------
T ss_pred             ceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhcc
Confidence             8999999999999999975432                                                         


Q ss_pred             -------CCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCccccccccc
Q 002010          786 -------GHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAG  858 (982)
Q Consensus       786 -------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~g  858 (982)
                             ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++................|
T Consensus       181 ~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~  257 (359)
T 3vhe_A          181 APEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL  257 (359)
T ss_dssp             ---CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEE
T ss_pred             cccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCC
Confidence                   12889999999999999999999998   99999999999999999999999999987654444444456678


Q ss_pred             ccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceeecCCCCCCC
Q 002010          859 SYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDPRLSGYP  937 (982)
Q Consensus       859 t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  937 (982)
                      |+.|+|||++.+..++.++||||+|+++|||++ |+.||............+......                   ..+
T Consensus       258 t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~-------------------~~~  318 (359)
T 3vhe_A          258 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM-------------------RAP  318 (359)
T ss_dssp             CGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCC-------------------CCC
T ss_pred             CceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCC-------------------CCC
Confidence            999999999999999999999999999999998 999998765555444444432221                   112


Q ss_pred             hHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 002010          938 LTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPP  973 (982)
Q Consensus       938 ~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~  973 (982)
                      ...+..+.+++.+||+.||++|||++|+++.|+++.
T Consensus       319 ~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~  354 (359)
T 3vhe_A          319 DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  354 (359)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence            233457899999999999999999999999998654

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=5.4e-40  Score=380.71  Aligned_cols=259  Identities=25%  Similarity=0.447  Sum_probs=215.2

Q ss_pred             hhcccccccccccceEEEEEEeCCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEecc
Q 002010          692 ESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYM  771 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  771 (982)
                      ++|+..+.||+|+||.||+|...++..||||++...  ....+.+.+|+.++++++||||+++++++. .+..++||||+
T Consensus       188 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~  264 (454)
T 1qcf_A          188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG--SMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFM  264 (454)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTT--SBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCC
T ss_pred             HHeEEEEEcccCCceEEEEEEECCccEEEEEEecCC--CccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeec
Confidence            568888999999999999999888899999998543  245678999999999999999999999886 66789999999


Q ss_pred             CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCcc
Q 002010          772 PNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASE  851 (982)
Q Consensus       772 ~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~  851 (982)
                      ++|+|.+++.......+++..+..++.||+.||+|||+++   |+||||||+||+++.++.+||+|||+++...... ..
T Consensus       265 ~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~-~~  340 (454)
T 1qcf_A          265 AKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNE-YT  340 (454)
T ss_dssp             TTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHH-HH
T ss_pred             CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCc-ee
Confidence            9999999997544457899999999999999999999998   9999999999999999999999999998765321 12


Q ss_pred             cccccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceeec
Q 002010          852 CMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVD  930 (982)
Q Consensus       852 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  930 (982)
                      ......+++.|+|||++....++.++|||||||++|||++ |+.||...... .....+..... .              
T Consensus       341 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~-~~~~~i~~~~~-~--------------  404 (454)
T 1qcf_A          341 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP-EVIRALERGYR-M--------------  404 (454)
T ss_dssp             TTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-HHHHHHHHTCC-C--------------
T ss_pred             ccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH-HHHHHHHcCCC-C--------------
Confidence            2233456789999999998899999999999999999999 99999765432 22222222111 0              


Q ss_pred             CCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCCCCC
Q 002010          931 PRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQSAP  977 (982)
Q Consensus       931 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~~~~~  977 (982)
                          ..+..++..+.++|.+||+.||++|||+++|++.|+.+.....
T Consensus       405 ----~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~~  447 (454)
T 1qcf_A          405 ----PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATE  447 (454)
T ss_dssp             ----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSSC
T ss_pred             ----CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhccc
Confidence                1123445679999999999999999999999999999876543

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=5.3e-40  Score=362.62  Aligned_cols=260  Identities=23%  Similarity=0.367  Sum_probs=215.3

Q ss_pred             HhhcccccccccccceEEEEEEe------CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCcc
Q 002010          691 LESLKDENIIGKGGAGIVYRGSM------PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTN  764 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  764 (982)
                      .++|+..+.||+|+||.||+|..      .++..||+|++.........+.+.+|+.++++++||||+++++++.+.+..
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  101 (314)
T 2ivs_A           22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL  101 (314)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred             hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence            36789999999999999999964      345789999986554444556789999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHhhcCCC----------------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCC
Q 002010          765 LLLYEYMPNGSLGEMLHGAKG----------------------GHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKS  822 (982)
Q Consensus       765 ~lv~e~~~~~sL~~~l~~~~~----------------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp  822 (982)
                      ++||||+++++|.+++.....                      ..+++.++..++.||+.|++|||+.+   |+||||||
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dikp  178 (314)
T 2ivs_A          102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLAA  178 (314)
T ss_dssp             EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCSG
T ss_pred             EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccccch
Confidence            999999999999999975432                      34889999999999999999999998   99999999


Q ss_pred             CcEEEcCCCCEEEeccccchhccccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCC
Q 002010          823 NNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGD  901 (982)
Q Consensus       823 ~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~  901 (982)
                      +||+++.++.+||+|||++................+++.|+|||++.+..++.++||||+|+++|||++ |..||.....
T Consensus       179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~  258 (314)
T 2ivs_A          179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP  258 (314)
T ss_dssp             GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred             heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence            999999999999999999987654433333344567889999999999889999999999999999999 9999976543


Q ss_pred             CchHHHHHHHhccCCCCCCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 002010          902 GVDIVRWVRKTTSEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPP  973 (982)
Q Consensus       902 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~  973 (982)
                      . .....+.....                   ...+...+..+.+++.+||+.||++|||++|+++.|+++.
T Consensus       259 ~-~~~~~~~~~~~-------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~  310 (314)
T 2ivs_A          259 E-RLFNLLKTGHR-------------------MERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMM  310 (314)
T ss_dssp             G-GHHHHHHTTCC-------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             H-HHHHHhhcCCc-------------------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            3 22333222111                   1122334457899999999999999999999999987654

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=3.6e-40  Score=371.67  Aligned_cols=259  Identities=28%  Similarity=0.464  Sum_probs=200.7

Q ss_pred             HhhcccccccccccceEEEEEEeC----CCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEE
Q 002010          691 LESLKDENIIGKGGAGIVYRGSMP----DGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLL  766 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  766 (982)
                      .++|+..+.||+|+||.||+|+..    ++..||||++.........+.+.+|+.++++++||||+++++++.+....++
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  123 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI  123 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence            357889999999999999999764    5778999998654444455679999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccc
Q 002010          767 LYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQD  846 (982)
Q Consensus       767 v~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  846 (982)
                      ||||+++++|.++++. ....+++.++..++.||+.||+|||+.+   |+||||||+||+++.++.+||+|||+++....
T Consensus       124 v~e~~~~~sL~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  199 (373)
T 2qol_A          124 VTEYMENGSLDSFLRK-HDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLED  199 (373)
T ss_dssp             EEECCTTCBHHHHHHT-TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             EEeCCCCCcHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCcccccccc
Confidence            9999999999999974 3457999999999999999999999998   99999999999999999999999999987654


Q ss_pred             cCCc-ccccccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHhccCCCCCCcccc
Q 002010          847 AGAS-ECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAAS  924 (982)
Q Consensus       847 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  924 (982)
                      .... .......+++.|+|||++.+..++.++||||+|+++|||++ |+.||...... .....+.....          
T Consensus       200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~-~~~~~i~~~~~----------  268 (373)
T 2qol_A          200 DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ-DVIKAVDEGYR----------  268 (373)
T ss_dssp             --------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHH-HHHHHHHTTEE----------
T ss_pred             CCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHHHcCCC----------
Confidence            3211 11122345778999999999999999999999999999998 99999765332 22222221111          


Q ss_pred             cceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 002010          925 VLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPP  973 (982)
Q Consensus       925 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~  973 (982)
                               ...+...+..+.+++.+||+.||++||+++|+++.|+.+.
T Consensus       269 ---------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~  308 (373)
T 2qol_A          269 ---------LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI  308 (373)
T ss_dssp             ---------CCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ---------CCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHH
Confidence                     0112234567899999999999999999999999987653

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=3.6e-39  Score=354.77  Aligned_cols=271  Identities=21%  Similarity=0.288  Sum_probs=211.4

Q ss_pred             HHhhcccccccccccceEEEEEEeCCCcEEEEEEeccCCCC-CchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEE
Q 002010          690 VLESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTG-GNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLY  768 (982)
Q Consensus       690 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  768 (982)
                      +.++|+..+.||+|+||+||+|...+++.||+|++...... .....+.+|+.++++++||||+++++++.++...++||
T Consensus        19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   98 (311)
T 3niz_A           19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF   98 (311)
T ss_dssp             SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred             hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence            45789999999999999999998888999999998544332 23467889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccC
Q 002010          769 EYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAG  848 (982)
Q Consensus       769 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  848 (982)
                      ||+++ +|.+++.. ....+++..+..++.|++.|++|||+.+   |+||||||+||+++.++.+||+|||+++..... 
T Consensus        99 e~~~~-~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~-  172 (311)
T 3niz_A           99 EFMEK-DLKKVLDE-NKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIP-  172 (311)
T ss_dssp             ECCSE-EHHHHHHT-CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSC-
T ss_pred             cCCCC-CHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCC-
Confidence            99974 88888864 3456999999999999999999999998   999999999999999999999999999876432 


Q ss_pred             Cccccccccccccccccccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccc-
Q 002010          849 ASECMSSVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVL-  926 (982)
Q Consensus       849 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  926 (982)
                       ........+|+.|+|||++.+ ..++.++||||+||++|||++|+.||....+......+........+......... 
T Consensus       173 -~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  251 (311)
T 3niz_A          173 -VRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELP  251 (311)
T ss_dssp             -CC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSH
T ss_pred             -cccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccc
Confidence             222344678999999999876 56899999999999999999999999887666665555554443222111110000 


Q ss_pred             eeecCCCC--------CCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          927 AVVDPRLS--------GYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       927 ~~~~~~~~--------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                      ...+....        ........++.+++.+||+.||++|||++|+++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  300 (311)
T 3niz_A          252 LWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN  300 (311)
T ss_dssp             HHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             hhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            00000000        111223457889999999999999999999987

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=5.3e-39  Score=355.02  Aligned_cols=248  Identities=23%  Similarity=0.336  Sum_probs=205.6

Q ss_pred             hcccccccccccceEEEEEEeC-CCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEecc
Q 002010          693 SLKDENIIGKGGAGIVYRGSMP-DGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYM  771 (982)
Q Consensus       693 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  771 (982)
                      .|+..+.||+|+||.||+|... +|+.||||++... .....+.+.+|+.++++++||||+++++++...+..++||||+
T Consensus        46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  124 (321)
T 2c30_A           46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLR-KQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFL  124 (321)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETT-TCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEecc-chhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecC
Confidence            4667778999999999999765 7999999998543 3445667889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCcc
Q 002010          772 PNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASE  851 (982)
Q Consensus       772 ~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~  851 (982)
                      ++++|.+++.   ...+++..+..++.|++.|++|||+.+   |+||||||+||+++.++.+||+|||++.......  .
T Consensus       125 ~~~~L~~~l~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~  196 (321)
T 2c30_A          125 QGGALTDIVS---QVRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV--P  196 (321)
T ss_dssp             CSCBHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSS--C
T ss_pred             CCCCHHHHHH---hcCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCcEEEeeeeeeeecccCc--c
Confidence            9999999985   346999999999999999999999988   9999999999999999999999999998765322  2


Q ss_pred             cccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceeecC
Q 002010          852 CMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDP  931 (982)
Q Consensus       852 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  931 (982)
                      ......||+.|+|||++.+..++.++||||+|+++|||++|+.||...... .....+.....                +
T Consensus       197 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~-~~~~~~~~~~~----------------~  259 (321)
T 2c30_A          197 KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPV-QAMKRLRDSPP----------------P  259 (321)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-HHHHHHHHSSC----------------C
T ss_pred             ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHhcCCC----------------C
Confidence            234567999999999999999999999999999999999999999764322 22222221111                0


Q ss_pred             CCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          932 RLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       932 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                      .. ..+...+..+.+++.+||+.||++|||++|+++
T Consensus       260 ~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  294 (321)
T 2c30_A          260 KL-KNSHKVSPVLRDFLERMLVRDPQERATAQELLD  294 (321)
T ss_dssp             CC-TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             Cc-CccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            00 011233457889999999999999999999987

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=2.6e-39  Score=357.10  Aligned_cols=279  Identities=21%  Similarity=0.300  Sum_probs=200.9

Q ss_pred             HhhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEe
Q 002010          691 LESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYE  769 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  769 (982)
                      .++|+..+.||+|+||.||+|.. .+++.||+|++...........+.+|+.++++++||||+++++++.+++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   83 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE   83 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence            35788899999999999999975 46899999999665555556778999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhcC----CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhcc
Q 002010          770 YMPNGSLGEMLHGA----KGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQ  845 (982)
Q Consensus       770 ~~~~~sL~~~l~~~----~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~  845 (982)
                      |++ ++|.+++...    ....+++..+..++.||+.|++|||+.+   |+||||||+||+++.++.+||+|||++....
T Consensus        84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  159 (317)
T 2pmi_A           84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG  159 (317)
T ss_dssp             CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred             ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence            997 5999988642    2246899999999999999999999998   9999999999999999999999999998664


Q ss_pred             ccCCccccccccccccccccccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccc
Q 002010          846 DAGASECMSSVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAAS  924 (982)
Q Consensus       846 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  924 (982)
                      ..  ........||+.|+|||++.+ ..++.++||||+||++|||++|+.||....+......+................
T Consensus       160 ~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  237 (317)
T 2pmi_A          160 IP--VNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVT  237 (317)
T ss_dssp             SC--CCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGG
T ss_pred             CC--cccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhh
Confidence            32  122345678999999999876 468999999999999999999999998765444443333332221111100000


Q ss_pred             cceeecCCCC-------------CCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH--HhcCCCCC
Q 002010          925 VLAVVDPRLS-------------GYPLTGVIHLFKVAMMCVEDESSARPTMREVVH--MLANPPQS  975 (982)
Q Consensus       925 ~~~~~~~~~~-------------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~--~L~~~~~~  975 (982)
                      ......+...             ..+...+..+.+++.+||+.||++|||++|+++  .+.+....
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~  303 (317)
T 2pmi_A          238 KLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHH  303 (317)
T ss_dssp             GCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC-
T ss_pred             hhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccch
Confidence            0000111110             011123457899999999999999999999986  34444433

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=8.5e-40  Score=362.68  Aligned_cols=257  Identities=25%  Similarity=0.421  Sum_probs=203.8

Q ss_pred             hhcccccccccccceEEEEEEe-CCCc----EEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEE
Q 002010          692 ESLKDENIIGKGGAGIVYRGSM-PDGI----DVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLL  766 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  766 (982)
                      ++|+..+.||+|+||+||+|.. .+++    +||+|.+.........+.+.+|+.++++++||||+++++++.+.. .++
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~   93 (327)
T 3poz_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL   93 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred             HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence            5688999999999999999975 3444    468888765555566778999999999999999999999998754 788


Q ss_pred             EEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccc
Q 002010          767 LYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQD  846 (982)
Q Consensus       767 v~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  846 (982)
                      |+||+++|+|.+++... ...+++..+..++.||+.|++|||+.+   |+||||||+||+++.++.+||+|||+++....
T Consensus        94 v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~  169 (327)
T 3poz_A           94 ITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  169 (327)
T ss_dssp             EEECCTTCBHHHHHHHS-TTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHHTT
T ss_pred             EEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEccC
Confidence            99999999999999753 467999999999999999999999998   99999999999999999999999999998765


Q ss_pred             cCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHhccCCCCCCccccc
Q 002010          847 AGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASV  925 (982)
Q Consensus       847 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  925 (982)
                      ...........+|+.|+|||++.+..++.++||||+||++|||++ |+.||...... .....+..... .         
T Consensus       170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-~~~~~~~~~~~-~---------  238 (327)
T 3poz_A          170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-EISSILEKGER-L---------  238 (327)
T ss_dssp             TCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG-GHHHHHHTTCC-C---------
T ss_pred             CcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHH-HHHHHHHcCCC-C---------
Confidence            443333445567889999999999999999999999999999999 99999765432 33333322211 0         


Q ss_pred             ceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 002010          926 LAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPP  973 (982)
Q Consensus       926 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~  973 (982)
                               ..+...+..+.+++.+||+.||++|||++|+++.|+.+.
T Consensus       239 ---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~  277 (327)
T 3poz_A          239 ---------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA  277 (327)
T ss_dssp             ---------CCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHH
T ss_pred             ---------CCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence                     122334457899999999999999999999999886543

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=5.5e-39  Score=355.14  Aligned_cols=274  Identities=20%  Similarity=0.249  Sum_probs=215.8

Q ss_pred             hhcccccccccccceEEEEEEeC-CCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCC--ccEEEE
Q 002010          692 ESLKDENIIGKGGAGIVYRGSMP-DGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRD--TNLLLY  768 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~lv~  768 (982)
                      ++|+..+.||+|+||+||+|... +++.||||++...........+.+|+.++++++||||+++++++....  ..++||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   88 (319)
T 4euu_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM   88 (319)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence            57899999999999999999764 589999999865544555677889999999999999999999988765  669999


Q ss_pred             eccCCCCHHHHhhcCCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEE----cCCCCEEEeccccchh
Q 002010          769 EYMPNGSLGEMLHGAKG-GHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILL----DSDFEAHVADFGLAKF  843 (982)
Q Consensus       769 e~~~~~sL~~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill----~~~~~~kl~DfG~a~~  843 (982)
                      ||+++++|.+++..... ..+++..+..++.||+.|++|||+.+   |+||||||+||++    +.++.+||+|||+++.
T Consensus        89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~  165 (319)
T 4euu_A           89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE  165 (319)
T ss_dssp             ECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred             eCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence            99999999999975332 34999999999999999999999998   9999999999999    7788899999999987


Q ss_pred             ccccCCcccccccccccccccccccc--------cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccC
Q 002010          844 LQDAGASECMSSVAGSYGYIAPEYAY--------TLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSE  915 (982)
Q Consensus       844 ~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  915 (982)
                      .....   ......||+.|+|||++.        +..++.++||||+||++|||++|+.||...................
T Consensus       166 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  242 (319)
T 4euu_A          166 LEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG  242 (319)
T ss_dssp             CCTTC---CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHH
T ss_pred             cCCCC---ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcC
Confidence            65432   234467899999999876        5678999999999999999999999998655443333333322221


Q ss_pred             CCCCC--ccc---ccceeecCCCC---CCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 002010          916 VSQPS--DAA---SVLAVVDPRLS---GYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLAN  971 (982)
Q Consensus       916 ~~~~~--~~~---~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~  971 (982)
                      .+...  ...   ...-.+.+.++   ..+...+..+.+++.+||+.||++|||++|+++-..+
T Consensus       243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d  306 (319)
T 4euu_A          243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSD  306 (319)
T ss_dssp             CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHH
T ss_pred             CCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHH
Confidence            11100  000   00001111222   4567778889999999999999999999999987643

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.6e-39  Score=357.16  Aligned_cols=255  Identities=22%  Similarity=0.301  Sum_probs=209.1

Q ss_pred             HHHHhhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCCC-----chhhHHHHHHHHhcCCCCcccceEeEEEcC
Q 002010          688 EDVLESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGG-----NDHGFLAEIQTLGRIRHRNIVRLLGYVSNR  761 (982)
Q Consensus       688 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  761 (982)
                      +.+.+.|+..+.||+|+||.||+|.. .+++.||+|++.......     ....+.+|+.++++++||||+++++++.++
T Consensus         7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   86 (326)
T 2y0a_A            7 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK   86 (326)
T ss_dssp             SCHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             CCcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence            34567899999999999999999976 468999999986543321     356789999999999999999999999999


Q ss_pred             CccEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCC----CEEEec
Q 002010          762 DTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDF----EAHVAD  837 (982)
Q Consensus       762 ~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~----~~kl~D  837 (982)
                      ...++||||+++++|.+++.  +...+++..+..++.||+.|++|||+.+   |+||||||+||+++.++    .+||+|
T Consensus        87 ~~~~lv~e~~~~~~L~~~l~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~D  161 (326)
T 2y0a_A           87 TDVILILELVAGGELFDFLA--EKESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIID  161 (326)
T ss_dssp             SEEEEEEECCCSCBHHHHHT--TSSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECC
T ss_pred             CEEEEEEEcCCCCCHHHHHH--hcCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEE
Confidence            99999999999999999996  4467999999999999999999999998   99999999999999887    899999


Q ss_pred             cccchhccccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCC
Q 002010          838 FGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVS  917 (982)
Q Consensus       838 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  917 (982)
                      ||++......   .......||+.|+|||++.+..++.++||||+||++|+|++|+.||........... +....... 
T Consensus       162 fg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~-~~~~~~~~-  236 (326)
T 2y0a_A          162 FGLAHKIDFG---NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLAN-VSAVNYEF-  236 (326)
T ss_dssp             CTTCEECCTT---SCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHH-HHHTCCCC-
T ss_pred             CCCCeECCCC---CccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHH-HHhcCCCc-
Confidence            9999876532   223456799999999999999999999999999999999999999976433222222 21111100 


Q ss_pred             CCCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          918 QPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       918 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                       +.              ......+..+.+++.+||+.||++|||++|+++
T Consensus       237 -~~--------------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  271 (326)
T 2y0a_A          237 -ED--------------EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  271 (326)
T ss_dssp             -CH--------------HHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             -Cc--------------cccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence             00              001123356889999999999999999999987

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=2e-39  Score=353.20  Aligned_cols=262  Identities=29%  Similarity=0.448  Sum_probs=202.8

Q ss_pred             HhhcccccccccccceEEEEEEeCCCcEEEEEEeccCCC-CCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEe
Q 002010          691 LESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGT-GGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYE  769 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  769 (982)
                      .++|+..+.||+|+||.||+|....  .||+|++..... ....+.+.+|+.++++++||||++++++. .....++|||
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e   99 (289)
T 3og7_A           23 DGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ   99 (289)
T ss_dssp             TTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred             ccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence            3579999999999999999997633  699999854432 23346788999999999999999999965 5667899999


Q ss_pred             ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCC
Q 002010          770 YMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGA  849 (982)
Q Consensus       770 ~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  849 (982)
                      |+++++|.+++.. ....+++..+..++.|++.|++|||+.+   |+||||||+||+++.++.+||+|||++........
T Consensus       100 ~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  175 (289)
T 3og7_A          100 WCEGSSLYHHLHA-SETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSG  175 (289)
T ss_dssp             CCCEEEHHHHHTT-C---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC----------
T ss_pred             ecCCCcHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceeccccccccc
Confidence            9999999999963 3467999999999999999999999998   99999999999999999999999999987654333


Q ss_pred             cccccccccccccccccccc---cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccc
Q 002010          850 SECMSSVAGSYGYIAPEYAY---TLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVL  926 (982)
Q Consensus       850 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  926 (982)
                      ........||+.|+|||++.   +..++.++||||+|+++|||++|+.||............+......           
T Consensus       176 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~-----------  244 (289)
T 3og7_A          176 SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLS-----------  244 (289)
T ss_dssp             --------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCC-----------
T ss_pred             cccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccC-----------
Confidence            33345567999999999986   5678899999999999999999999998766655555544433221           


Q ss_pred             eeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCC
Q 002010          927 AVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQ  974 (982)
Q Consensus       927 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~~  974 (982)
                          +.....+...+..+.+++.+||+.||++|||++|+++.|+++.+
T Consensus       245 ----~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~  288 (289)
T 3og7_A          245 ----PDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR  288 (289)
T ss_dssp             ----CCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             ----cchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence                11222334455689999999999999999999999999998765

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=2.1e-39  Score=379.32  Aligned_cols=259  Identities=24%  Similarity=0.370  Sum_probs=217.6

Q ss_pred             hhcccccccccccceEEEEEEeCC-CcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEec
Q 002010          692 ESLKDENIIGKGGAGIVYRGSMPD-GIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEY  770 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  770 (982)
                      ++|+..+.||+|+||.||+|.... +..||||.+...  ....+.+.+|+.++++++||||+++++++...+..++||||
T Consensus       220 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~  297 (495)
T 1opk_A          220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED--TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF  297 (495)
T ss_dssp             GGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSS--SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             HHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCc--ccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence            468888999999999999997654 889999998543  33467899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCc
Q 002010          771 MPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS  850 (982)
Q Consensus       771 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  850 (982)
                      +++|+|.+++.......+++..+..++.||+.||+|||+++   |+||||||+||+++.++.+||+|||+++..... ..
T Consensus       298 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~-~~  373 (495)
T 1opk_A          298 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGD-TY  373 (495)
T ss_dssp             CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTC-CE
T ss_pred             cCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCC-ce
Confidence            99999999998766677999999999999999999999998   999999999999999999999999999876532 22


Q ss_pred             ccccccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceee
Q 002010          851 ECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVV  929 (982)
Q Consensus       851 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  929 (982)
                      .......+++.|+|||++.+..++.++|||||||++|||++ |..||...... .....+.....               
T Consensus       374 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~-~~~~~~~~~~~---------------  437 (495)
T 1opk_A          374 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-QVYELLEKDYR---------------  437 (495)
T ss_dssp             ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG-GHHHHHHTTCC---------------
T ss_pred             eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH-HHHHHHHcCCC---------------
Confidence            22334456789999999998899999999999999999999 99999765432 23333222111               


Q ss_pred             cCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCCCC
Q 002010          930 DPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQSA  976 (982)
Q Consensus       930 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~~~~  976 (982)
                          ...+..++..+.++|.+||+.||++|||++||++.|+.+.+..
T Consensus       438 ----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~~  480 (495)
T 1opk_A          438 ----MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES  480 (495)
T ss_dssp             ----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSSS
T ss_pred             ----CCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhcc
Confidence                1123345568899999999999999999999999999987653

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=1.2e-39  Score=354.01  Aligned_cols=256  Identities=22%  Similarity=0.383  Sum_probs=209.6

Q ss_pred             HhhcccccccccccceEEEEEEeCCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEec
Q 002010          691 LESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEY  770 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  770 (982)
                      .++|+..+.||+|+||.||+|+..++..||+|++...  ....+++.+|+.++++++||||+++++++.+....++||||
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  100 (283)
T 3gen_A           23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG--SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY  100 (283)
T ss_dssp             GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTT--SBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECC
T ss_pred             HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCC--CCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEec
Confidence            3578999999999999999999888889999998543  23456789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCc
Q 002010          771 MPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS  850 (982)
Q Consensus       771 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  850 (982)
                      +++++|.+++... ...+++..+..++.|++.|++|||+.+   |+||||||+||+++.++.+||+|||++....... .
T Consensus       101 ~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-~  175 (283)
T 3gen_A          101 MANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-Y  175 (283)
T ss_dssp             CTTCBHHHHHHCG-GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH-H
T ss_pred             cCCCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEccccccccccccc-c
Confidence            9999999999742 356999999999999999999999998   9999999999999999999999999998765321 1


Q ss_pred             ccccccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceee
Q 002010          851 ECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVV  929 (982)
Q Consensus       851 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  929 (982)
                      .......+|+.|+|||++.+..++.++||||+|+++|||++ |+.||......... ..+.....               
T Consensus       176 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~-~~~~~~~~---------------  239 (283)
T 3gen_A          176 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETA-EHIAQGLR---------------  239 (283)
T ss_dssp             HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH-HHHHTTCC---------------
T ss_pred             ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHH-HHHhcccC---------------
Confidence            22234456788999999998899999999999999999998 99999865433222 22211111               


Q ss_pred             cCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 002010          930 DPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPP  973 (982)
Q Consensus       930 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~  973 (982)
                          ...+...+..+.+++.+||+.||++|||++|+++.|+++.
T Consensus       240 ----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~  279 (283)
T 3gen_A          240 ----LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVM  279 (283)
T ss_dssp             ----CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ----CCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHh
Confidence                0112223457889999999999999999999999987654

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=9e-39  Score=345.70  Aligned_cols=255  Identities=23%  Similarity=0.291  Sum_probs=211.8

Q ss_pred             HHhhcccccccccccceEEEEEEeC-CCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEE
Q 002010          690 VLESLKDENIIGKGGAGIVYRGSMP-DGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLY  768 (982)
Q Consensus       690 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  768 (982)
                      +.++|+..+.||+|+||.||+|... +++.||+|++...........+.+|+.++++++||||+++++++.+++..++||
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (276)
T 2yex_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL   84 (276)
T ss_dssp             HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence            5678999999999999999999764 689999999865555555678899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccC
Q 002010          769 EYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAG  848 (982)
Q Consensus       769 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  848 (982)
                      ||+++++|.+++.  ....+++..+..++.|++.|++|||+.+   |+||||||+||+++.++.+||+|||.+..+....
T Consensus        85 e~~~~~~L~~~l~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~  159 (276)
T 2yex_A           85 EYCSGGELFDRIE--PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN  159 (276)
T ss_dssp             ECCTTEEGGGGSB--TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred             EecCCCcHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence            9999999999996  4467999999999999999999999998   9999999999999999999999999998765433


Q ss_pred             CcccccccccccccccccccccCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccce
Q 002010          849 ASECMSSVAGSYGYIAPEYAYTLKV-DEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLA  927 (982)
Q Consensus       849 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  927 (982)
                      .........|++.|+|||++.+..+ +.++||||+|+++|||++|+.||....................           
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-----------  228 (276)
T 2yex_A          160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL-----------  228 (276)
T ss_dssp             EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTS-----------
T ss_pred             chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhccccc-----------
Confidence            3333455678999999999987765 7899999999999999999999987544332222221111100           


Q ss_pred             eecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          928 VVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       928 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                             ......+..+.+++.+||+.||++|||++|+++
T Consensus       229 -------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (276)
T 2yex_A          229 -------NPWKKIDSAPLALLHKILVENPSARITIPDIKK  261 (276)
T ss_dssp             -------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -------CchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence                   011223457889999999999999999999986

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=3.6e-39  Score=373.12  Aligned_cols=253  Identities=29%  Similarity=0.415  Sum_probs=209.9

Q ss_pred             HhhcccccccccccceEEEEEEeCCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCC-ccEEEEe
Q 002010          691 LESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRD-TNLLLYE  769 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e  769 (982)
                      .++|+..+.||+|+||.||+|.. .++.||||++...   ...+.+.+|+.++++++||||+++++++...+ ..++|||
T Consensus       192 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e  267 (450)
T 1k9a_A          192 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND---ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE  267 (450)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEESSC---TTSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEE
T ss_pred             hHHeEEEeeecCcCCeeEEEEEe-cCCeEEEEEeCCc---hHHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEE
Confidence            35788899999999999999987 5789999998543   24567999999999999999999999987665 6899999


Q ss_pred             ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCC
Q 002010          770 YMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGA  849 (982)
Q Consensus       770 ~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  849 (982)
                      |+++|+|.+++.......+++..+..++.||+.||+|||+++   |+||||||+||+++.++.+||+|||+++.....  
T Consensus       268 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--  342 (450)
T 1k9a_A          268 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--  342 (450)
T ss_dssp             CCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC----
T ss_pred             ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccccccc--
Confidence            999999999998655556899999999999999999999998   999999999999999999999999999854321  


Q ss_pred             cccccccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHhccCCCCCCccccccee
Q 002010          850 SECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAV  928 (982)
Q Consensus       850 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  928 (982)
                         .....+++.|+|||++.+..++.++||||||+++|||++ |+.||......+. ...+.....              
T Consensus       343 ---~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~-~~~i~~~~~--------------  404 (450)
T 1k9a_A          343 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV-VPRVEKGYK--------------  404 (450)
T ss_dssp             -------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTH-HHHHHTTCC--------------
T ss_pred             ---ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH-HHHHHcCCC--------------
Confidence               122356889999999999999999999999999999999 9999987544332 222222111              


Q ss_pred             ecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCCC
Q 002010          929 VDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQS  975 (982)
Q Consensus       929 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~~~  975 (982)
                           ...+..++..+.++|.+||+.||++|||++|+++.|+.+...
T Consensus       405 -----~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~  446 (450)
T 1k9a_A          405 -----MDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH  446 (450)
T ss_dssp             -----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             -----CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence                 112334556899999999999999999999999999876543

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=1.8e-39  Score=361.33  Aligned_cols=261  Identities=24%  Similarity=0.400  Sum_probs=213.4

Q ss_pred             HhhcccccccccccceEEEEEEe--------CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcC-CCCcccceEeEEEcC
Q 002010          691 LESLKDENIIGKGGAGIVYRGSM--------PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRI-RHRNIVRLLGYVSNR  761 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~--------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~  761 (982)
                      .++|+..+.||+|+||.||+|..        .++..||+|++...........+.+|+.+++++ +||||+++++++..+
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  113 (334)
T 2pvf_A           34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  113 (334)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence            36799999999999999999975        346789999986554444556788999999999 899999999999999


Q ss_pred             CccEEEEeccCCCCHHHHhhcCCC--------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEE
Q 002010          762 DTNLLLYEYMPNGSLGEMLHGAKG--------------GHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILL  827 (982)
Q Consensus       762 ~~~~lv~e~~~~~sL~~~l~~~~~--------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill  827 (982)
                      +..++||||+++++|.+++.....              ..+++..++.++.||+.|++|||+.+   |+||||||+||++
T Consensus       114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll  190 (334)
T 2pvf_A          114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV  190 (334)
T ss_dssp             SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEE
T ss_pred             CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEEE
Confidence            999999999999999999975432              35899999999999999999999998   9999999999999


Q ss_pred             cCCCCEEEeccccchhccccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHH
Q 002010          828 DSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIV  906 (982)
Q Consensus       828 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~  906 (982)
                      +.++.+||+|||++................+++.|+|||++.+..++.++||||+|+++|||++ |+.||..... ....
T Consensus       191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-~~~~  269 (334)
T 2pvf_A          191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV-EELF  269 (334)
T ss_dssp             CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCH-HHHH
T ss_pred             cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCH-HHHH
Confidence            9999999999999987654433333344567889999999998889999999999999999999 9999976432 2222


Q ss_pred             HHHHHhccCCCCCCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCC
Q 002010          907 RWVRKTTSEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQ  974 (982)
Q Consensus       907 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~~  974 (982)
                      ..+.....                   ...+...+..+.+++.+||+.||.+|||++|+++.|+++.+
T Consensus       270 ~~~~~~~~-------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~  318 (334)
T 2pvf_A          270 KLLKEGHR-------------------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT  318 (334)
T ss_dssp             HHHHHTCC-------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHhcCCC-------------------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            22222111                   11222344578999999999999999999999999987644

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.9e-39  Score=358.17  Aligned_cols=251  Identities=20%  Similarity=0.238  Sum_probs=206.4

Q ss_pred             HhhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEe
Q 002010          691 LESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYE  769 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  769 (982)
                      .++|+..+.||+|+||.||+|.. .+++.||+|.+...  ......+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   81 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK--GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE   81 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC--THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC--cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEE
Confidence            46899999999999999999965 46889999988432  3344568899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcC--CCCEEEeccccchhcccc
Q 002010          770 YMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDS--DFEAHVADFGLAKFLQDA  847 (982)
Q Consensus       770 ~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~--~~~~kl~DfG~a~~~~~~  847 (982)
                      |+++++|.+++.. ....+++.++..++.||+.|++|||+.+   |+||||||+||+++.  ++.+||+|||++..+...
T Consensus        82 ~~~g~~L~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~  157 (321)
T 1tki_A           82 FISGLDIFERINT-SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG  157 (321)
T ss_dssp             CCCCCBHHHHHTS-SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred             eCCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence            9999999999963 3357999999999999999999999998   999999999999987  789999999999876533


Q ss_pred             CCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccce
Q 002010          848 GASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLA  927 (982)
Q Consensus       848 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  927 (982)
                         .......||+.|+|||++.+..++.++||||+||++|+|++|..||...........+. ........         
T Consensus       158 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~-~~~~~~~~---------  224 (321)
T 1tki_A          158 ---DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIM-NAEYTFDE---------  224 (321)
T ss_dssp             ---CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH-HTCCCCCH---------
T ss_pred             ---CccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHH-cCCCCCCh---------
Confidence               22345678999999999998889999999999999999999999997644332222222 11110000         


Q ss_pred             eecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          928 VVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       928 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                             ......+..+.+++.+||+.||++|||++|+++
T Consensus       225 -------~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~  257 (321)
T 1tki_A          225 -------EAFKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             -------HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             -------hhhccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence                   000123457889999999999999999999987

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=5.2e-39  Score=368.89  Aligned_cols=256  Identities=20%  Similarity=0.257  Sum_probs=208.2

Q ss_pred             HHHHhhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCC-CCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccE
Q 002010          688 EDVLESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGT-GGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNL  765 (982)
Q Consensus       688 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  765 (982)
                      ..+.++|+..+.||+|+||.||+|.. .+|+.||+|++..... ......+.+|+.++++++||||+++++++.+++..+
T Consensus         7 ~~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~   86 (444)
T 3soa_A            7 TRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHY   86 (444)
T ss_dssp             CHHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEE
T ss_pred             ccccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEE
Confidence            34668899999999999999999964 5789999999855432 223456889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEc---CCCCEEEeccccch
Q 002010          766 LLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLD---SDFEAHVADFGLAK  842 (982)
Q Consensus       766 lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~---~~~~~kl~DfG~a~  842 (982)
                      +||||+++|+|.+++..  ...+++..+..++.||+.|++|||+.+   |+||||||+||+++   .++.+||+|||++.
T Consensus        87 lv~E~~~gg~L~~~i~~--~~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~  161 (444)
T 3soa_A           87 LIFDLVTGGELFEDIVA--REYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAI  161 (444)
T ss_dssp             EEECCCBCCBHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred             EEEEeCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence            99999999999999974  457999999999999999999999998   99999999999998   46889999999998


Q ss_pred             hccccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcc
Q 002010          843 FLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDA  922 (982)
Q Consensus       843 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  922 (982)
                      .....  ........||+.|+|||++.+..++.++||||+||++|+|++|.+||....... ....+.......+.+   
T Consensus       162 ~~~~~--~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~-~~~~i~~~~~~~~~~---  235 (444)
T 3soa_A          162 EVEGE--QQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHR-LYQQIKAGAYDFPSP---  235 (444)
T ss_dssp             CCCTT--CCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHTCCCCCTT---
T ss_pred             EecCC--CceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHH-HHHHHHhCCCCCCcc---
Confidence            76533  223345689999999999999999999999999999999999999997643322 222222222111110   


Q ss_pred             cccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          923 ASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       923 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                               .    ....+..+.+++.+||+.||++|||++|+++
T Consensus       236 ---------~----~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~  267 (444)
T 3soa_A          236 ---------E----WDTVTPEAKDLINKMLTINPSKRITAAEALK  267 (444)
T ss_dssp             ---------T----TTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             ---------c----cccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence                     0    1123457889999999999999999999987

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=8.1e-39  Score=359.74  Aligned_cols=251  Identities=24%  Similarity=0.327  Sum_probs=206.3

Q ss_pred             HhhcccccccccccceEEEEEEe-CCCcEEEEEEeccCC--CCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEE
Q 002010          691 LESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRG--TGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLL  767 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  767 (982)
                      .++|+..+.||+|+||.||+|.. .+++.||+|++....  .......+.+|+.++++++|||||++++++.+.+..++|
T Consensus        14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv   93 (384)
T 4fr4_A           14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV   93 (384)
T ss_dssp             GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            46799999999999999999965 458899999985432  234456788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhcccc
Q 002010          768 YEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDA  847 (982)
Q Consensus       768 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  847 (982)
                      |||+++|+|.+++.  +...+++..+..++.||+.|++|||+.+   |+||||||+||+++.++.+||+|||++..+...
T Consensus        94 ~e~~~gg~L~~~l~--~~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~  168 (384)
T 4fr4_A           94 VDLLLGGDLRYHLQ--QNVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE  168 (384)
T ss_dssp             ECCCTTEEHHHHHH--TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             EecCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence            99999999999997  4567999999999999999999999998   999999999999999999999999999876532


Q ss_pred             CCccccccccccccccccccccc---CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccc
Q 002010          848 GASECMSSVAGSYGYIAPEYAYT---LKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAAS  924 (982)
Q Consensus       848 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  924 (982)
                         .......||+.|+|||++.+   ..++.++||||+||++|||++|+.||........ ..........         
T Consensus       169 ---~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~-~~~~~~~~~~---------  235 (384)
T 4fr4_A          169 ---TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSS-KEIVHTFETT---------  235 (384)
T ss_dssp             ---CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCH-HHHHHHHHHC---------
T ss_pred             ---CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccH-HHHHHHHhhc---------
Confidence               23456789999999999874   4589999999999999999999999975433221 1222111110         


Q ss_pred             cceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCC-HHHHHH
Q 002010          925 VLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPT-MREVVH  967 (982)
Q Consensus       925 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt-~~ell~  967 (982)
                              ...++...+..+.+++.+||+.||.+||+ ++++.+
T Consensus       236 --------~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          236 --------VVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             --------CCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             --------ccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence                    01122334457899999999999999998 677664

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=3.9e-39  Score=354.57  Aligned_cols=246  Identities=24%  Similarity=0.312  Sum_probs=206.0

Q ss_pred             HhhcccccccccccceEEEEEEe-CCCcEEEEEEeccCC--CCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEE
Q 002010          691 LESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRG--TGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLL  767 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  767 (982)
                      .++|+..+.||+|+||.||+|+. .+|+.||+|++....  .......+.+|+.+++.++||||+++++++.+....++|
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv   84 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI   84 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence            35789999999999999999976 469999999985432  223456678999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhcccc
Q 002010          768 YEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDA  847 (982)
Q Consensus       768 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  847 (982)
                      |||+++|+|.+++..  ...+++..+..++.||+.|++|||+.+   |+||||||+||+++.++.+||+|||+++.... 
T Consensus        85 ~e~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~-  158 (318)
T 1fot_A           85 MDYIEGGELFSLLRK--SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD-  158 (318)
T ss_dssp             ECCCCSCBHHHHHHH--TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS-
T ss_pred             EeCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCC-
Confidence            999999999999973  457999999999999999999999988   99999999999999999999999999986542 


Q ss_pred             CCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccce
Q 002010          848 GASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLA  927 (982)
Q Consensus       848 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  927 (982)
                          ......||+.|+|||++.+..++.++||||+||++|||++|+.||...........+.....              
T Consensus       159 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~--------------  220 (318)
T 1fot_A          159 ----VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAEL--------------  220 (318)
T ss_dssp             ----CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCC--------------
T ss_pred             ----ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC--------------
Confidence                12356799999999999999999999999999999999999999976433222222221110              


Q ss_pred             eecCCCCCCChHhHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 002010          928 VVDPRLSGYPLTGVIHLFKVAMMCVEDESSARP-----TMREVVH  967 (982)
Q Consensus       928 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~ell~  967 (982)
                             .++...+..+.+++.+|++.||++||     +++|+++
T Consensus       221 -------~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~  258 (318)
T 1fot_A          221 -------RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  258 (318)
T ss_dssp             -------CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             -------CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence                   11222345788999999999999999     8999885

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=1.3e-39  Score=360.84  Aligned_cols=257  Identities=26%  Similarity=0.433  Sum_probs=207.2

Q ss_pred             hhcccccccccccceEEEEEEe-CCCcE----EEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEE
Q 002010          692 ESLKDENIIGKGGAGIVYRGSM-PDGID----VAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLL  766 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~----vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  766 (982)
                      ++|+..+.||+|+||.||+|.. .+++.    ||+|.+...........+.+|+.++++++||||+++++++. ++..++
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~   91 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL   91 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred             hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence            4688899999999999999975 34443    78888755544555567889999999999999999999886 566889


Q ss_pred             EEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccc
Q 002010          767 LYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQD  846 (982)
Q Consensus       767 v~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  846 (982)
                      ||||+++|+|.+++... ...+++..+..++.|++.|++|||+.+   |+||||||+||+++.++.+||+|||+++.+..
T Consensus        92 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~  167 (325)
T 3kex_A           92 VTQYLPLGSLLDHVRQH-RGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPP  167 (325)
T ss_dssp             EEECCTTCBSHHHHHSS-GGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGSCC
T ss_pred             EEEeCCCCCHHHHHHHc-cccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccccCc
Confidence            99999999999999743 357899999999999999999999998   99999999999999999999999999998765


Q ss_pred             cCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHhccCCCCCCccccc
Q 002010          847 AGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASV  925 (982)
Q Consensus       847 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  925 (982)
                      ...........+++.|+|||++.+..++.++||||+|+++|||++ |+.||....... ....+..... ..        
T Consensus       168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-~~~~~~~~~~-~~--------  237 (325)
T 3kex_A          168 DDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE-VPDLLEKGER-LA--------  237 (325)
T ss_dssp             CTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH-HHHHHHTTCB-CC--------
T ss_pred             ccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH-HHHHHHcCCC-CC--------
Confidence            544444455678889999999999999999999999999999999 999998754332 2333322211 11        


Q ss_pred             ceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 002010          926 LAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPP  973 (982)
Q Consensus       926 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~  973 (982)
                                .+...+..+.+++.+||+.||++|||++|+++.|+.+.
T Consensus       238 ----------~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~  275 (325)
T 3kex_A          238 ----------QPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMA  275 (325)
T ss_dssp             ----------CCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred             ----------CCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence                      11122335779999999999999999999999987654

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=1.6e-39  Score=376.19  Aligned_cols=258  Identities=30%  Similarity=0.455  Sum_probs=208.4

Q ss_pred             hhcccccccccccceEEEEEEeCCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEecc
Q 002010          692 ESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYM  771 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  771 (982)
                      ++|+..+.||+|+||.||+|...++..||||++....  ...+.+.+|+.++++++||||+++++++.+ +..++||||+
T Consensus       184 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~  260 (452)
T 1fmk_A          184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM  260 (452)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred             hHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC--CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhh
Confidence            5688889999999999999998788889999985432  345679999999999999999999999876 6789999999


Q ss_pred             CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCcc
Q 002010          772 PNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASE  851 (982)
Q Consensus       772 ~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~  851 (982)
                      ++|+|.+++.......+++..+..++.||+.||+|||+++   |+||||||+||++++++.+||+|||+++...... ..
T Consensus       261 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-~~  336 (452)
T 1fmk_A          261 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YT  336 (452)
T ss_dssp             TTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred             cCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCCc-ee
Confidence            9999999997544456899999999999999999999998   9999999999999999999999999998765332 22


Q ss_pred             cccccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceeec
Q 002010          852 CMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVD  930 (982)
Q Consensus       852 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  930 (982)
                      ......+++.|+|||++.+..++.++||||||+++|||++ |+.||...... .....+.....                
T Consensus       337 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~-~~~~~i~~~~~----------------  399 (452)
T 1fmk_A          337 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-EVLDQVERGYR----------------  399 (452)
T ss_dssp             ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-HHHHHHHTTCC----------------
T ss_pred             cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH-HHHHHHHcCCC----------------
Confidence            2234456789999999998999999999999999999999 99999765332 22222221111                


Q ss_pred             CCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCCCC
Q 002010          931 PRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQSA  976 (982)
Q Consensus       931 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~~~~  976 (982)
                         ...+..++..+.++|.+||+.||++|||++++++.|+.+....
T Consensus       400 ---~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~  442 (452)
T 1fmk_A          400 ---MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST  442 (452)
T ss_dssp             ---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred             ---CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccC
Confidence               1123345567899999999999999999999999999886644

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=5.6e-39  Score=360.36  Aligned_cols=254  Identities=21%  Similarity=0.305  Sum_probs=207.7

Q ss_pred             HHHhhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCC-CCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEE
Q 002010          689 DVLESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGT-GGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLL  766 (982)
Q Consensus       689 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  766 (982)
                      .+.++|+..+.||+|+||.||+|.. .+++.||+|++..... ....+.+.+|+.++++++||||+++++++.+++..++
T Consensus        26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l  105 (362)
T 2bdw_A           26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL  105 (362)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence            4567899999999999999999965 4689999999865432 2234568899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCC---CCEEEeccccchh
Q 002010          767 LYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSD---FEAHVADFGLAKF  843 (982)
Q Consensus       767 v~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~---~~~kl~DfG~a~~  843 (982)
                      ||||+++++|.+++.  ....+++..+..++.||+.|++|||+.+   |+||||||+||+++.+   +.+||+|||++..
T Consensus       106 v~e~~~gg~L~~~l~--~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~  180 (362)
T 2bdw_A          106 VFDLVTGGELFEDIV--AREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE  180 (362)
T ss_dssp             EECCCCSCBHHHHHT--TCSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred             EEecCCCCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence            999999999999996  4467999999999999999999999998   9999999999999865   4599999999987


Q ss_pred             ccccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCccc
Q 002010          844 LQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAA  923 (982)
Q Consensus       844 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  923 (982)
                      ....   .......||+.|+|||++.+..++.++||||+||++|+|++|++||...... .....+.......+.+    
T Consensus       181 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~-~~~~~i~~~~~~~~~~----  252 (362)
T 2bdw_A          181 VNDS---EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH-RLYAQIKAGAYDYPSP----  252 (362)
T ss_dssp             CTTC---CSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHTCCCCCTT----
T ss_pred             ecCC---cccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH-HHHHHHHhCCCCCCcc----
Confidence            6532   2234567999999999999999999999999999999999999999764332 2222222211111100    


Q ss_pred             ccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          924 SVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       924 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                                  .....+..+.+++.+||+.||++|||++|+++
T Consensus       253 ------------~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  284 (362)
T 2bdw_A          253 ------------EWDTVTPEAKSLIDSMLTVNPKKRITADQALK  284 (362)
T ss_dssp             ------------GGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             ------------cccCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence                        01123457889999999999999999999875

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=100.00  E-value=1.2e-38  Score=368.43  Aligned_cols=368  Identities=17%  Similarity=0.174  Sum_probs=242.4

Q ss_pred             ccCCCCCCCChhhhhhcccceeeccCCccccccchhhhhcCCCccEEeccCccccCCCchhccccccccEEeecCccccc
Q 002010          103 SNVNLTGRLPSEMALLTSLKVFNISGNVFQGNFAGQIVRGMTELQVLDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTG  182 (982)
Q Consensus       103 ~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~  182 (982)
                      ......+..+..++.+++|++|++++|.+++. +  .+..+++|++|+|++|++++. |  ++.+++|++|+|++|++++
T Consensus        26 ~~~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~-~--~l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~   99 (457)
T 3bz5_A           26 AAFEMQATDTISEEQLATLTSLDCHNSSITDM-T--GIEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTN   99 (457)
T ss_dssp             HHTTCCTTSEEEHHHHTTCCEEECCSSCCCCC-T--TGGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSC
T ss_pred             HhcCcCcccccChhHcCCCCEEEccCCCcccC-h--hhcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCce
Confidence            34455566667788888888888888888764 3  367788888888888888863 4  7788888888888888876


Q ss_pred             ccCCCccccCcceEeeccCcccccchhhHHhhhhhHHHHhhcccccccccCCCCCCCCCCCCEEecccCcCcccCchhhc
Q 002010          183 KIPQSYSEIQSLEYIGLNGIGLNGTVPAFLSRLKNLREMYIGYFNTYTGGIPPGFGALTQLQVLDMASCNISGEIPTSLS  262 (982)
Q Consensus       183 ~~p~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~l~~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~  262 (982)
                      . |  ++++++|++|++++|.+.+                          +|  ++.+++|++|++++|++++. +  ++
T Consensus       100 ~-~--~~~l~~L~~L~L~~N~l~~--------------------------l~--~~~l~~L~~L~l~~N~l~~l-~--l~  145 (457)
T 3bz5_A          100 L-D--VTPLTKLTYLNCDTNKLTK--------------------------LD--VSQNPLLTYLNCARNTLTEI-D--VS  145 (457)
T ss_dssp             C-C--CTTCTTCCEEECCSSCCSC--------------------------CC--CTTCTTCCEEECTTSCCSCC-C--CT
T ss_pred             e-e--cCCCCcCCEEECCCCcCCe--------------------------ec--CCCCCcCCEEECCCCcccee-c--cc
Confidence            4 2  6677777777777665541                          12  55666777777777777753 2  66


Q ss_pred             CCCccceeecccccCCCCCCccccCCCCCCEEEeeCCcccCcCchhhhcccchhhhhhccCCCCCCCCCcCCCCCCccEE
Q 002010          263 RLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVL  342 (982)
Q Consensus       263 ~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L  342 (982)
                      ++++|++|++++|+..+.+  .+..+++|++|++++|++++ +|  +..+++|+.|++++|++++.   .++.+++|++|
T Consensus       146 ~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L  217 (457)
T 3bz5_A          146 HNTQLTELDCHLNKKITKL--DVTPQTQLTTLDCSFNKITE-LD--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFL  217 (457)
T ss_dssp             TCTTCCEEECTTCSCCCCC--CCTTCTTCCEEECCSSCCCC-CC--CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEE
T ss_pred             cCCcCCEEECCCCCccccc--ccccCCcCCEEECCCCccce-ec--cccCCCCCEEECcCCcCCee---ccccCCCCCEE
Confidence            6677777777777544444  35666677777777777664 33  55566666666666666643   25556666666


Q ss_pred             EccCCCcccccCccccCCCcccEEEeccccccccCCccccCccccceeecccccccccCCccccCCCCCCEEEccCCccC
Q 002010          343 QVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLN  422 (982)
Q Consensus       343 ~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~l~~N~~~~~~~~~l~~l~~L~~L~Ls~N~l~  422 (982)
                      ++++|++++ +|  ++.+++|+.|++++|++++..                           ++.+++|+.|++++|+  
T Consensus       218 ~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l~~~~---------------------------~~~l~~L~~L~l~~n~--  265 (457)
T 3bz5_A          218 DCSSNKLTE-ID--VTPLTQLTYFDCSVNPLTELD---------------------------VSTLSKLTTLHCIQTD--  265 (457)
T ss_dssp             ECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCCC---------------------------CTTCTTCCEEECTTCC--
T ss_pred             ECcCCcccc-cC--ccccCCCCEEEeeCCcCCCcC---------------------------HHHCCCCCEEeccCCC--
Confidence            666666664 33  555555555555555555432                           2234444444444432  


Q ss_pred             CCCCccccCCCccccccCCCccccccCCcccccCCccEEEeeccccCCCCchhccCCCCcceeeeccccccCCCcccccc
Q 002010          423 GTIPAGLFNLPLLNMMELDDNLLSGELPEKMSGASLNQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESFN  502 (982)
Q Consensus       423 ~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~  502 (982)
                                  |+.|++++|.+.+.+|. ....+|+.|++++|.+.+.+|.   ..++|+.|++++|            
T Consensus       266 ------------L~~L~l~~n~~~~~~~~-~~l~~L~~L~Ls~n~~l~~l~~---~~~~L~~L~l~~~------------  317 (457)
T 3bz5_A          266 ------------LLEIDLTHNTQLIYFQA-EGCRKIKELDVTHNTQLYLLDC---QAAGITELDLSQN------------  317 (457)
T ss_dssp             ------------CSCCCCTTCTTCCEEEC-TTCTTCCCCCCTTCTTCCEEEC---TTCCCSCCCCTTC------------
T ss_pred             ------------CCEEECCCCccCCcccc-cccccCCEEECCCCcccceecc---CCCcceEechhhc------------
Confidence                        23444455544444431 1224566666666665555553   3456666666655            


Q ss_pred             ccccceeeeeccccCCCCCcccccccCCCeeeCCCCcccCCCCcccccccccceEEcccccccccCccccccccccceec
Q 002010          503 LKMITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYGKIPPGISKLIDLSILNLSRNGITGSIPNEMRNMMSLTTLD  582 (982)
Q Consensus       503 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~  582 (982)
                       ++|++|++++|+|++. +  ++.+++|+.|++++|+|++        ++.|..|++++|+++|.     ..+..|..++
T Consensus       318 -~~L~~L~L~~N~l~~l-~--l~~l~~L~~L~l~~N~l~~--------l~~L~~L~l~~n~l~g~-----~~~~~l~~l~  380 (457)
T 3bz5_A          318 -PKLVYLYLNNTELTEL-D--VSHNTKLKSLSCVNAHIQD--------FSSVGKIPALNNNFEAE-----GQTITMPKET  380 (457)
T ss_dssp             -TTCCEEECTTCCCSCC-C--CTTCTTCSEEECCSSCCCB--------CTTGGGSSGGGTSEEEE-----EEEEECCCBC
T ss_pred             -ccCCEEECCCCccccc-c--cccCCcCcEEECCCCCCCC--------ccccccccccCCcEEec-----ceeeecCccc
Confidence             5788888888888874 3  8889999999999999985        24677778999999876     3567788899


Q ss_pred             ccCCccccCCCCC
Q 002010          583 LSYNNLIGNIPSG  595 (982)
Q Consensus       583 Ls~N~l~~~ip~~  595 (982)
                      +++|+++|.||..
T Consensus       381 l~~N~l~g~ip~~  393 (457)
T 3bz5_A          381 LTNNSLTIAVSPD  393 (457)
T ss_dssp             CBTTBEEEECCTT
T ss_pred             cccCcEEEEcChh
Confidence            9999999999864

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=8.5e-40  Score=364.94  Aligned_cols=249  Identities=21%  Similarity=0.269  Sum_probs=201.5

Q ss_pred             HhhcccccccccccceEEEEEEe-CCCcEEEEEEeccCC--CCCchhhHHHHHHHHhcC-CCCcccceEeEEEcCCccEE
Q 002010          691 LESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRG--TGGNDHGFLAEIQTLGRI-RHRNIVRLLGYVSNRDTNLL  766 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~l  766 (982)
                      .++|+..+.||+|+||.||+|+. .+++.||||++....  .......+.+|..+++.+ +||||+++++++.+.+..|+
T Consensus        22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  101 (353)
T 3txo_A           22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF  101 (353)
T ss_dssp             -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence            46799999999999999999975 468999999985431  223455678899999988 79999999999999999999


Q ss_pred             EEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccc
Q 002010          767 LYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQD  846 (982)
Q Consensus       767 v~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  846 (982)
                      ||||+++|+|.+++..  ...+++..+..++.||+.||+|||+.+   |+||||||+||+++.++.+||+|||+|+....
T Consensus       102 v~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~~~  176 (353)
T 3txo_A          102 VMEFVNGGDLMFHIQK--SRRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC  176 (353)
T ss_dssp             EEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred             EEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeeccc
Confidence            9999999999999973  457999999999999999999999998   99999999999999999999999999975432


Q ss_pred             cCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccc
Q 002010          847 AGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVL  926 (982)
Q Consensus       847 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  926 (982)
                      .  .......+||+.|+|||++.+..++.++||||+||++|||++|+.||...........+... ..            
T Consensus       177 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~-~~------------  241 (353)
T 3txo_A          177 N--GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND-EV------------  241 (353)
T ss_dssp             -----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-CC------------
T ss_pred             C--CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcC-CC------------
Confidence            2  22344568999999999999989999999999999999999999999765333222222211 11            


Q ss_pred             eeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCH------HHHHH
Q 002010          927 AVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTM------REVVH  967 (982)
Q Consensus       927 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~------~ell~  967 (982)
                              .++...+..+.+++.+||++||.+||++      +|+++
T Consensus       242 --------~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~  280 (353)
T 3txo_A          242 --------VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR  280 (353)
T ss_dssp             --------CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred             --------CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence                    1122234578899999999999999998      77765

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=3.7e-39  Score=368.59  Aligned_cols=256  Identities=20%  Similarity=0.198  Sum_probs=207.7

Q ss_pred             HhhcccccccccccceEEEEEEeC-CCcEEEEEEeccCC--CCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEE
Q 002010          691 LESLKDENIIGKGGAGIVYRGSMP-DGIDVAIKRLVGRG--TGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLL  767 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  767 (982)
                      .++|+..+.||+|+||+||+|+.. +++.||+|++....  .......+.+|+.++..++||||+++++++.+++..++|
T Consensus        73 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV  152 (437)
T 4aw2_A           73 REDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLV  152 (437)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEE
T ss_pred             hhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEE
Confidence            468999999999999999999764 47899999985421  223344588999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhcccc
Q 002010          768 YEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDA  847 (982)
Q Consensus       768 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  847 (982)
                      |||+++|+|.+++.. ....+++..+..++.||+.|++|||+.+   |+||||||+||+++.++.+||+|||+|+.....
T Consensus       153 ~Ey~~gg~L~~~l~~-~~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~  228 (437)
T 4aw2_A          153 MDYYVGGDLLTLLSK-FEDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMED  228 (437)
T ss_dssp             ECCCTTCBHHHHHHT-TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             EecCCCCcHHHHHHH-ccCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcchhhhhhcccC
Confidence            999999999999974 2467999999999999999999999998   999999999999999999999999999766533


Q ss_pred             CCcccccccccccccccccccc-----cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcc
Q 002010          848 GASECMSSVAGSYGYIAPEYAY-----TLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDA  922 (982)
Q Consensus       848 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  922 (982)
                      . .......+||+.|+|||++.     ...++.++||||+||++|||++|+.||......+....++..... ...+   
T Consensus       229 ~-~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~-~~~p---  303 (437)
T 4aw2_A          229 G-TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKER-FQFP---  303 (437)
T ss_dssp             S-CEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH-CCCC---
T ss_pred             C-CcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhcccc-ccCC---
Confidence            2 22334568999999999987     567899999999999999999999999865433333333222111 1111   


Q ss_pred             cccceeecCCCCCCChHhHHHHHHHHhhccCCCCCC--CCCHHHHHH
Q 002010          923 ASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSA--RPTMREVVH  967 (982)
Q Consensus       923 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--Rpt~~ell~  967 (982)
                                  ......+..+.+++.+|+..+|++  ||+++|+++
T Consensus       304 ------------~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~  338 (437)
T 4aw2_A          304 ------------TQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKK  338 (437)
T ss_dssp             ------------SSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred             ------------cccccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence                        111123447889999999999998  999999987

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=1.8e-39  Score=352.13  Aligned_cols=257  Identities=24%  Similarity=0.358  Sum_probs=199.1

Q ss_pred             HhhcccccccccccceEEEEEEeCC----CcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEE
Q 002010          691 LESLKDENIIGKGGAGIVYRGSMPD----GIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLL  766 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  766 (982)
                      .++|+..+.||+|+||.||+|....    +..||+|+..........+.+.+|+.++++++||||+++++++. ++..++
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l   92 (281)
T 1mp8_A           14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI   92 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence            3679999999999999999997532    45799998865444444567899999999999999999999874 567899


Q ss_pred             EEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccc
Q 002010          767 LYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQD  846 (982)
Q Consensus       767 v~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  846 (982)
                      ||||+++++|.+++... ...+++..+..++.|++.|++|||+.+   |+||||||+||+++.++.+||+|||+++....
T Consensus        93 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  168 (281)
T 1mp8_A           93 IMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMED  168 (281)
T ss_dssp             EEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC---------
T ss_pred             EEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccccccCc
Confidence            99999999999999743 357899999999999999999999998   99999999999999999999999999987654


Q ss_pred             cCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHhccCCCCCCccccc
Q 002010          847 AGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASV  925 (982)
Q Consensus       847 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  925 (982)
                      .. ........+++.|+|||++.+..++.++||||+|+++|||++ |..||........ ...+.....           
T Consensus       169 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~-~~~i~~~~~-----------  235 (281)
T 1mp8_A          169 ST-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV-IGRIENGER-----------  235 (281)
T ss_dssp             -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH-HHHHHTTCC-----------
T ss_pred             cc-ccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHH-HHHHHcCCC-----------
Confidence            32 122234456789999999998899999999999999999997 9999986544332 222221111           


Q ss_pred             ceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 002010          926 LAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPP  973 (982)
Q Consensus       926 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~  973 (982)
                              ...+...+..+.+++.+||+.||++|||++|+++.|+.+.
T Consensus       236 --------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~  275 (281)
T 1mp8_A          236 --------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL  275 (281)
T ss_dssp             --------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             --------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence                    1123344567899999999999999999999999987653

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=1.9e-39  Score=359.66  Aligned_cols=259  Identities=22%  Similarity=0.334  Sum_probs=195.8

Q ss_pred             hhcccccccccccceEEEEEEeCC-C---cEEEEEEeccCC-CCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCcc--
Q 002010          692 ESLKDENIIGKGGAGIVYRGSMPD-G---IDVAIKRLVGRG-TGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTN--  764 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~~~-~---~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~--  764 (982)
                      ++|+..+.||+|+||.||+|.... +   ..||||++.... .....+.+.+|+.++++++||||+++++++......  
T Consensus        23 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  102 (323)
T 3qup_A           23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGR  102 (323)
T ss_dssp             --CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-----
T ss_pred             hHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccC
Confidence            578999999999999999997643 2   379999985443 333456789999999999999999999999877665  


Q ss_pred             ----EEEEeccCCCCHHHHhhcCC----CCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEe
Q 002010          765 ----LLLYEYMPNGSLGEMLHGAK----GGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVA  836 (982)
Q Consensus       765 ----~lv~e~~~~~sL~~~l~~~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~  836 (982)
                          ++||||+++++|.+++....    ...+++..+..++.|++.|++|||+.+   |+||||||+||++++++.+||+
T Consensus       103 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~kl~  179 (323)
T 3qup_A          103 LPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVCVA  179 (323)
T ss_dssp             --CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEEC
T ss_pred             CCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCEEEe
Confidence                99999999999999986422    236899999999999999999999998   9999999999999999999999


Q ss_pred             ccccchhccccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHhccC
Q 002010          837 DFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSE  915 (982)
Q Consensus       837 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  915 (982)
                      |||+++...............+++.|+|||++.+..++.++||||+||++|||++ |..||............ ..... 
T Consensus       180 Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~-~~~~~-  257 (323)
T 3qup_A          180 DFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYL-IGGNR-  257 (323)
T ss_dssp             CCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH-HTTCC-
T ss_pred             eccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHH-hcCCC-
Confidence            9999987654433333444567889999999999999999999999999999999 99999875443332222 21111 


Q ss_pred             CCCCCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 002010          916 VSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPP  973 (982)
Q Consensus       916 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~  973 (982)
                                        ...+...+..+.+++.+||+.||++|||+.|+++.|+++.
T Consensus       258 ------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l  297 (323)
T 3qup_A          258 ------------------LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENIL  297 (323)
T ss_dssp             ------------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ------------------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence                              1122334457899999999999999999999999987654

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=1.4e-38  Score=347.18  Aligned_cols=268  Identities=22%  Similarity=0.294  Sum_probs=207.4

Q ss_pred             hhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCC-CchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEe
Q 002010          692 ESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTG-GNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYE  769 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  769 (982)
                      ++|+..+.||+|+||+||+|.. .+++.||+|++...... .....+.+|+.++++++||||+++++++.+++..++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            5788999999999999999976 46899999999654433 334678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCC
Q 002010          770 YMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGA  849 (982)
Q Consensus       770 ~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  849 (982)
                      |+++ ++.+++.. ....+++..+..++.|++.|++|||+.+   |+||||||+||+++.++.+||+|||++......  
T Consensus        82 ~~~~-~l~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~--  154 (292)
T 3o0g_A           82 FCDQ-DLKKYFDS-CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIP--  154 (292)
T ss_dssp             CCSE-EHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSC--
T ss_pred             cCCC-CHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCc--
Confidence            9975 56665543 3467999999999999999999999998   999999999999999999999999999866432  


Q ss_pred             cccccccccccccccccccccCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCccccccee
Q 002010          850 SECMSSVAGSYGYIAPEYAYTLK-VDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAV  928 (982)
Q Consensus       850 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  928 (982)
                      ........||+.|+|||++.+.. ++.++||||+||++|||++|..||....+.......+......+...... .....
T Consensus       155 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~-~~~~~  233 (292)
T 3o0g_A          155 VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWP-SMTKL  233 (292)
T ss_dssp             CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCT-TGGGS
T ss_pred             cccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhh-hhccc
Confidence            22334567899999999988766 89999999999999999998888654444333333333322221111100 00000


Q ss_pred             e----------cCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          929 V----------DPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       929 ~----------~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                      .          ...........+..+.+++.+||+.||++|||++|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  282 (292)
T 3o0g_A          234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence            0          00111223345667899999999999999999999986

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=3.6e-39  Score=356.97  Aligned_cols=247  Identities=22%  Similarity=0.307  Sum_probs=205.2

Q ss_pred             HhhcccccccccccceEEEEEEe-CCCcEEEEEEeccCC--CCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEE
Q 002010          691 LESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRG--TGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLL  767 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  767 (982)
                      .++|++.+.||+|+||.||+|.. .+++.||+|++....  .......+.+|+.+++.++||||+++++++.++...++|
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   87 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV   87 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            35799999999999999999975 678999999985431  223345788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhcccc
Q 002010          768 YEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDA  847 (982)
Q Consensus       768 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  847 (982)
                      |||+ +|+|.+++..  ...+++.++..++.||+.|++|||+.+   |+||||||+||++++++.+||+|||++....+.
T Consensus        88 ~E~~-~g~l~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~  161 (336)
T 3h4j_B           88 IEYA-GGELFDYIVE--KKRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG  161 (336)
T ss_dssp             ECCC-CEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS
T ss_pred             EECC-CCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccCC
Confidence            9999 7899998863  357999999999999999999999998   999999999999999999999999999876533


Q ss_pred             CCcccccccccccccccccccccCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccc
Q 002010          848 GASECMSSVAGSYGYIAPEYAYTLKV-DEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVL  926 (982)
Q Consensus       848 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  926 (982)
                         .......||+.|+|||++.+..+ +.++||||+||++|+|++|+.||........                     .
T Consensus       162 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~---------------------~  217 (336)
T 3h4j_B          162 ---NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL---------------------F  217 (336)
T ss_dssp             ---BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC---------------------B
T ss_pred             ---cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH---------------------H
Confidence               22345679999999999988776 7899999999999999999999975322110                     0


Q ss_pred             eeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          927 AVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       927 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                      ..+.......+...+..+.+++.+||+.||.+|||++|+++
T Consensus       218 ~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~  258 (336)
T 3h4j_B          218 KKVNSCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR  258 (336)
T ss_dssp             CCCCSSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred             HHHHcCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence            01111111234445567899999999999999999999986

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=7.4e-40  Score=357.91  Aligned_cols=275  Identities=25%  Similarity=0.337  Sum_probs=206.8

Q ss_pred             hhcccccccccccceEEEEEEe-----CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcC--Ccc
Q 002010          692 ESLKDENIIGKGGAGIVYRGSM-----PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNR--DTN  764 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~  764 (982)
                      ++|+..+.||+|+||+||+|++     .+++.||||++.. ......+.+.+|+.++++++||||+++++++...  ...
T Consensus        10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   88 (295)
T 3ugc_A           10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH-STEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   88 (295)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESC-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred             HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEccc-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence            6789999999999999999973     3688999999843 2333446788999999999999999999998653  458


Q ss_pred             EEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhc
Q 002010          765 LLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFL  844 (982)
Q Consensus       765 ~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~  844 (982)
                      ++||||+++++|.+++... ...+++..+..++.|++.|++|||+.+   |+||||||+||+++.++.+||+|||++...
T Consensus        89 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~  164 (295)
T 3ugc_A           89 KLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVL  164 (295)
T ss_dssp             EEEEECCTTCBHHHHHHHC-GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC--
T ss_pred             EEEEEeCCCCCHHHHHHhc-ccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCcccccc
Confidence            9999999999999999743 346899999999999999999999988   999999999999999999999999999876


Q ss_pred             cccCC-cccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCccc
Q 002010          845 QDAGA-SECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAA  923 (982)
Q Consensus       845 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  923 (982)
                      ..... ........++..|+|||++.+..++.++||||+|+++|||++|..|+....  ..........   ........
T Consensus       165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~--~~~~~~~~~~---~~~~~~~~  239 (295)
T 3ugc_A          165 PQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPP--AEFMRMIGND---KQGQMIVF  239 (295)
T ss_dssp             -----------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHH--HHHHHHHCTT---CCTHHHHH
T ss_pred             cCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCCh--HHHHhhhcCc---cccchhHH
Confidence            54322 122234457788999999999999999999999999999999999986421  1111111000   00000000


Q ss_pred             ccceee-cCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCCCC
Q 002010          924 SVLAVV-DPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQSA  976 (982)
Q Consensus       924 ~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~~~~  976 (982)
                      .....+ .......+..++..+.+++.+||+.||++|||++|+++.|+++.+..
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l  293 (295)
T 3ugc_A          240 HLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM  293 (295)
T ss_dssp             HHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred             HHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence            000001 11112334456678999999999999999999999999998776543

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=4.7e-39  Score=346.93  Aligned_cols=254  Identities=29%  Similarity=0.407  Sum_probs=198.4

Q ss_pred             hhcccccccccccceEEEEEEeCCCcEEEEEEeccCCC---CCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEE
Q 002010          692 ESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGT---GGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLY  768 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  768 (982)
                      ++|+..+.||+|+||.||+|.. .++.||+|++.....   ....+.+.+|+.+++.++||||+++++++.+++..++||
T Consensus         7 ~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   85 (271)
T 3dtc_A            7 AELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM   85 (271)
T ss_dssp             TSEEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred             hheeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence            5788899999999999999987 588999999854432   233467889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcC--------CCCEEEecccc
Q 002010          769 EYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDS--------DFEAHVADFGL  840 (982)
Q Consensus       769 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~--------~~~~kl~DfG~  840 (982)
                      ||+++++|.+++.   ...+++..+..++.|++.|++|||+.+..+|+||||||+||+++.        ++.+||+|||.
T Consensus        86 e~~~~~~L~~~~~---~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~  162 (271)
T 3dtc_A           86 EFARGGPLNRVLS---GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGL  162 (271)
T ss_dssp             ECCTTEEHHHHHT---SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC
T ss_pred             EcCCCCCHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCc
Confidence            9999999999985   457999999999999999999999987455889999999999986        67899999999


Q ss_pred             chhccccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCC
Q 002010          841 AKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPS  920 (982)
Q Consensus       841 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  920 (982)
                      +.......    .....|++.|+|||++.+..++.++||||+|+++|+|++|+.||............. ....      
T Consensus       163 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~-~~~~------  231 (271)
T 3dtc_A          163 AREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVA-MNKL------  231 (271)
T ss_dssp             -----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHH-TSCC------
T ss_pred             cccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhh-cCCC------
Confidence            98665322    234578999999999999999999999999999999999999997643322211111 1111      


Q ss_pred             cccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 002010          921 DAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANP  972 (982)
Q Consensus       921 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~  972 (982)
                                  ....+...+..+.+++.+||+.||++|||++|+++.|+++
T Consensus       232 ------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          232 ------------ALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             ------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             ------------CCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence                        0112334456799999999999999999999999999864

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=2.1e-39  Score=359.06  Aligned_cols=262  Identities=25%  Similarity=0.404  Sum_probs=215.2

Q ss_pred             HhhcccccccccccceEEEEEEeC------CCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCcc
Q 002010          691 LESLKDENIIGKGGAGIVYRGSMP------DGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTN  764 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  764 (982)
                      .++|+..+.||+|+||.||+|...      +++.||+|.+...........+.+|+.++++++||||+++++++.+.+..
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~  103 (322)
T 1p4o_A           24 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT  103 (322)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred             hhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCcc
Confidence            467999999999999999999653      36789999986544444456788999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHhhcCC--------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEe
Q 002010          765 LLLYEYMPNGSLGEMLHGAK--------GGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVA  836 (982)
Q Consensus       765 ~lv~e~~~~~sL~~~l~~~~--------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~  836 (982)
                      ++||||+++++|.+++....        ...+++..+..++.||+.|++|||+.+   |+||||||+||+++.++.+||+
T Consensus       104 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~~~~kl~  180 (322)
T 1p4o_A          104 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIG  180 (322)
T ss_dssp             EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEEC
T ss_pred             EEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCCCeEEEC
Confidence            99999999999999996422        246789999999999999999999998   9999999999999999999999


Q ss_pred             ccccchhccccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHhccC
Q 002010          837 DFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSE  915 (982)
Q Consensus       837 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  915 (982)
                      |||++................+++.|+|||++.+..++.++||||+|+++|||++ |..||...... .....+....  
T Consensus       181 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-~~~~~~~~~~--  257 (322)
T 1p4o_A          181 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE-QVLRFVMEGG--  257 (322)
T ss_dssp             CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH-HHHHHHHTTC--
T ss_pred             cCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHH-HHHHHHHcCC--
Confidence            9999987654433333344567889999999999899999999999999999999 89999764322 2222221111  


Q ss_pred             CCCCCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCCC
Q 002010          916 VSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQS  975 (982)
Q Consensus       916 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~~~  975 (982)
                                       ....+...+..+.+++.+||+.||++|||++|+++.|++...+
T Consensus       258 -----------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~  300 (322)
T 1p4o_A          258 -----------------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP  300 (322)
T ss_dssp             -----------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred             -----------------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhcc
Confidence                             1112234455789999999999999999999999999887654

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=3.8e-39  Score=347.54  Aligned_cols=256  Identities=22%  Similarity=0.350  Sum_probs=209.0

Q ss_pred             HhhcccccccccccceEEEEEEeCCCcEEEEEEeccCCC-CCchhhHHHHHHHHhcCCCCcccceEeEEEcC--CccEEE
Q 002010          691 LESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGT-GGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNR--DTNLLL  767 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv  767 (982)
                      .++|+..+.||+|+||.||+|.. +++.||+|++..... ....+.+.+|+.++++++||||+++++++.+.  ...++|
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (271)
T 3kmu_A            9 FKQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI   87 (271)
T ss_dssp             GGGCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred             HHHhHHHHHhcCCCcceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence            35788999999999999999988 588999999865432 23345789999999999999999999999887  778999


Q ss_pred             EeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhcccc
Q 002010          768 YEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDA  847 (982)
Q Consensus       768 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  847 (982)
                      |||+++++|.+++.......+++..+..++.|++.|++|||+.+ .+|+||||||+||+++.++.++++|||.+....  
T Consensus        88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~--  164 (271)
T 3kmu_A           88 THWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQ--  164 (271)
T ss_dssp             EECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS--
T ss_pred             ecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeec--
Confidence            99999999999998665557999999999999999999999764 459999999999999999999999998875432  


Q ss_pred             CCcccccccccccccccccccccCCCCc---chhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccc
Q 002010          848 GASECMSSVAGSYGYIAPEYAYTLKVDE---KSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAAS  924 (982)
Q Consensus       848 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  924 (982)
                           .....||+.|+|||++.+..++.   ++||||+|+++|||++|+.||............... ..          
T Consensus       165 -----~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~-~~----------  228 (271)
T 3kmu_A          165 -----SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALE-GL----------  228 (271)
T ss_dssp             -----CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHS-CC----------
T ss_pred             -----ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhc-CC----------
Confidence                 23456899999999998765544   899999999999999999999765433222222111 11          


Q ss_pred             cceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCC
Q 002010          925 VLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQ  974 (982)
Q Consensus       925 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~~  974 (982)
                              ....+...+..+.+++.+||+.||++|||++|+++.|+++.+
T Consensus       229 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~  270 (271)
T 3kmu_A          229 --------RPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD  270 (271)
T ss_dssp             --------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred             --------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence                    112233445578999999999999999999999999987654

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=5.6e-39  Score=358.14  Aligned_cols=246  Identities=21%  Similarity=0.224  Sum_probs=206.5

Q ss_pred             HhhcccccccccccceEEEEEEe-CCCcEEEEEEeccCC--CCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEE
Q 002010          691 LESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRG--TGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLL  767 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  767 (982)
                      .++|+..+.||+|+||.||+|+. .+|+.||+|++....  .......+.+|+.++++++||||+++++++.+.+..++|
T Consensus        40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv  119 (350)
T 1rdq_E           40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV  119 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence            36799999999999999999976 468999999985432  234456788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhcccc
Q 002010          768 YEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDA  847 (982)
Q Consensus       768 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  847 (982)
                      |||+++|+|.+++..  ...+++..+..++.||+.||+|||+.+   |+||||||+||+++.++.+||+|||+++.....
T Consensus       120 ~e~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~  194 (350)
T 1rdq_E          120 MEYVAGGEMFSHLRR--IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR  194 (350)
T ss_dssp             EECCTTCBHHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred             EcCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccCC
Confidence            999999999999973  357999999999999999999999998   999999999999999999999999999866432


Q ss_pred             CCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccce
Q 002010          848 GASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLA  927 (982)
Q Consensus       848 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  927 (982)
                           .....||+.|+|||++.+..++.++||||+||++|||++|+.||...........+. ....             
T Consensus       195 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~-~~~~-------------  255 (350)
T 1rdq_E          195 -----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIV-SGKV-------------  255 (350)
T ss_dssp             -----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-HCCC-------------
T ss_pred             -----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHH-cCCC-------------
Confidence                 234679999999999999999999999999999999999999997643322222222 1111             


Q ss_pred             eecCCCCCCChHhHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 002010          928 VVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPT-----MREVVH  967 (982)
Q Consensus       928 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt-----~~ell~  967 (982)
                             .++...+..+.+++.+||+.||.+||+     ++|+++
T Consensus       256 -------~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~  293 (350)
T 1rdq_E          256 -------RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             -------CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             -------CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence                   112233457899999999999999998     888875

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=1.9e-39  Score=361.37  Aligned_cols=260  Identities=23%  Similarity=0.391  Sum_probs=215.4

Q ss_pred             HhhcccccccccccceEEEEEEeCC------CcEEEEEEeccCCCCCchhhHHHHHHHHhcC-CCCcccceEeEEEcCCc
Q 002010          691 LESLKDENIIGKGGAGIVYRGSMPD------GIDVAIKRLVGRGTGGNDHGFLAEIQTLGRI-RHRNIVRLLGYVSNRDT  763 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~  763 (982)
                      .++|+..+.||+|+||.||+|....      ...||+|.+...........+.+|+.+++++ +||||+++++++.+.+.
T Consensus        45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  124 (333)
T 2i1m_A           45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGP  124 (333)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCc
Confidence            4678899999999999999997532      2479999986554444566789999999999 89999999999999999


Q ss_pred             cEEEEeccCCCCHHHHhhcCC------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCC
Q 002010          764 NLLLYEYMPNGSLGEMLHGAK------------GGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDF  831 (982)
Q Consensus       764 ~~lv~e~~~~~sL~~~l~~~~------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~  831 (982)
                      .++||||+++|+|.+++....            ...+++..+..++.|++.|++|||+.+   |+||||||+||+++.++
T Consensus       125 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~  201 (333)
T 2i1m_A          125 VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGH  201 (333)
T ss_dssp             CEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEEGGG
T ss_pred             eEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEECCCC
Confidence            999999999999999986421            346899999999999999999999998   99999999999999999


Q ss_pred             CEEEeccccchhccccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHH
Q 002010          832 EAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVR  910 (982)
Q Consensus       832 ~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~  910 (982)
                      .+||+|||++................+|+.|+|||++.+..++.++||||+|+++|||++ |..||............+.
T Consensus       202 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~  281 (333)
T 2i1m_A          202 VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVK  281 (333)
T ss_dssp             EEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHHH
T ss_pred             eEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHHh
Confidence            999999999987654433333445567889999999999899999999999999999999 9999987655554444443


Q ss_pred             HhccCCCCCCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 002010          911 KTTSEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANP  972 (982)
Q Consensus       911 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~  972 (982)
                      .....                   ..+...+..+.+++.+||+.||.+|||++|+++.|+++
T Consensus       282 ~~~~~-------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~  324 (333)
T 2i1m_A          282 DGYQM-------------------AQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQ  324 (333)
T ss_dssp             HTCCC-------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             cCCCC-------------------CCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHH
Confidence            32211                   11222345789999999999999999999999998754

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=5.9e-39  Score=351.88  Aligned_cols=260  Identities=27%  Similarity=0.364  Sum_probs=202.4

Q ss_pred             HhhcccccccccccceEEEEEEeCCCcEEEEEEeccCCCCCchhhHHHHHHHHhc--CCCCcccceEeEEEcC----Ccc
Q 002010          691 LESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGR--IRHRNIVRLLGYVSNR----DTN  764 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~~~----~~~  764 (982)
                      .++|+..+.||+|+||+||+|.. +++.||||++..    .....+.+|.+++..  ++||||+++++++...    ...
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~----~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~   81 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSS----RDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL   81 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECG----GGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEecc----ccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence            46799999999999999999987 789999999843    234556667666665  7999999999986543    457


Q ss_pred             EEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHh--------hcCCCcEEecCCCCCcEEEcCCCCEEEe
Q 002010          765 LLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLH--------HDCSPLIIHRDVKSNNILLDSDFEAHVA  836 (982)
Q Consensus       765 ~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH--------~~~~~~ivHrDlkp~Nill~~~~~~kl~  836 (982)
                      ++||||+++|+|.++++   ...+++..+..++.|++.|++|||        +.+   |+||||||+||+++.++.+||+
T Consensus        82 ~lv~e~~~~g~L~~~l~---~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl~  155 (301)
T 3q4u_A           82 WLITHYHEMGSLYDYLQ---LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCIA  155 (301)
T ss_dssp             EEEECCCTTCBHHHHHT---TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEEC
T ss_pred             EEehhhccCCCHHHHHh---hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEEe
Confidence            89999999999999995   357999999999999999999999        777   9999999999999999999999


Q ss_pred             ccccchhccccCCcc--cccccccccccccccccccC------CCCcchhhHHHHHHHHHHHhC----------CCCCCC
Q 002010          837 DFGLAKFLQDAGASE--CMSSVAGSYGYIAPEYAYTL------KVDEKSDVYSFGVVLLELIAG----------KKPVGE  898 (982)
Q Consensus       837 DfG~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslG~il~elltg----------~~p~~~  898 (982)
                      |||+++.........  ......||+.|+|||++.+.      .++.++||||+||++|||++|          +.||..
T Consensus       156 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~  235 (301)
T 3q4u_A          156 DLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD  235 (301)
T ss_dssp             CCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred             eCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccc
Confidence            999998665432211  12345799999999998876      456799999999999999999          888866


Q ss_pred             CCCCchHHHHHHHhccCCCCCCcccccceeecCCCC--CCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 002010          899 FGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDPRLS--GYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANP  972 (982)
Q Consensus       899 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~  972 (982)
                      ...................           ..+..+  ..+...+..+.+++.+||+.||++|||++|+++.|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          236 VVPNDPSFEDMRKVVCVDQ-----------QRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             TSCSSCCHHHHHHHHTTSC-----------CCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             cCCCCcchhhhhHHHhccC-----------CCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence            4332222222222111000           001111  12335667899999999999999999999999999754

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.6e-38  Score=347.77  Aligned_cols=249  Identities=23%  Similarity=0.324  Sum_probs=196.7

Q ss_pred             hhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCC-------------------------CchhhHHHHHHHHhc
Q 002010          692 ESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTG-------------------------GNDHGFLAEIQTLGR  745 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-------------------------~~~~~~~~E~~~l~~  745 (982)
                      ++|+..+.||+|+||.||+|.. .+++.||||++......                         ...+.+.+|+.++++
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~   92 (298)
T 2zv2_A           13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK   92 (298)
T ss_dssp             TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred             cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence            5789999999999999999965 56889999998544211                         123568899999999


Q ss_pred             CCCCcccceEeEEEc--CCccEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCC
Q 002010          746 IRHRNIVRLLGYVSN--RDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSN  823 (982)
Q Consensus       746 l~h~niv~~~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~  823 (982)
                      ++||||+++++++.+  ....++||||+++++|.+++.   ...+++..+..++.||+.|++|||+.+   |+||||||+
T Consensus        93 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~  166 (298)
T 2zv2_A           93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT---LKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKPS  166 (298)
T ss_dssp             CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC---SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGG
T ss_pred             CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHH
Confidence            999999999999986  567899999999999988753   457999999999999999999999998   999999999


Q ss_pred             cEEEcCCCCEEEeccccchhccccCCcccccccccccccccccccccCC---CCcchhhHHHHHHHHHHHhCCCCCCCCC
Q 002010          824 NILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLK---VDEKSDVYSFGVVLLELIAGKKPVGEFG  900 (982)
Q Consensus       824 Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslG~il~elltg~~p~~~~~  900 (982)
                      ||+++.++.+||+|||++......  ........||+.|+|||++.+..   ++.++||||+||++|||++|+.||....
T Consensus       167 Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~  244 (298)
T 2zv2_A          167 NLLVGEDGHIKIADFGVSNEFKGS--DALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER  244 (298)
T ss_dssp             GEEECTTSCEEECCCTTCEECSSS--SCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             HEEECCCCCEEEecCCCccccccc--cccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc
Confidence            999999999999999999876532  22234567999999999998665   4788999999999999999999997532


Q ss_pred             CCchHHHHHHHhccCCCCCCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          901 DGVDIVRWVRKTTSEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       901 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                      . ......+......  .+                .....+..+.+++.+||+.||++|||++|+++
T Consensus       245 ~-~~~~~~~~~~~~~--~~----------------~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~  292 (298)
T 2zv2_A          245 I-MCLHSKIKSQALE--FP----------------DQPDIAEDLKDLITRMLDKNPESRIVVPEIKL  292 (298)
T ss_dssp             H-HHHHHHHHHCCCC--CC----------------SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             H-HHHHHHHhcccCC--CC----------------CccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence            2 1111222111110  00                01123357899999999999999999999874

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=1.1e-38  Score=362.89  Aligned_cols=274  Identities=19%  Similarity=0.219  Sum_probs=209.1

Q ss_pred             Hhhcccccccccc--cceEEEEEEeC-CCcEEEEEEeccCCCC-CchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEE
Q 002010          691 LESLKDENIIGKG--GAGIVYRGSMP-DGIDVAIKRLVGRGTG-GNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLL  766 (982)
Q Consensus       691 ~~~~~~~~~lg~G--~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  766 (982)
                      .++|++.+.||+|  +||.||+|+.. +++.||||++...... .....+.+|+.++++++|||||++++++.+++..++
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  103 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV  103 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence            3679999999999  99999999764 6999999999654322 234567889999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccc
Q 002010          767 LYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQD  846 (982)
Q Consensus       767 v~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  846 (982)
                      ||||+++++|.+++.......+++..+..++.||+.||+|||+.+   |+||||||+||+++.++.+||+|||.+.....
T Consensus       104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~  180 (389)
T 3gni_B          104 VTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMIS  180 (389)
T ss_dssp             EEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred             EEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence            999999999999998766678999999999999999999999998   99999999999999999999999999875543


Q ss_pred             cCC-----ccccccccccccccccccccc--CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCC
Q 002010          847 AGA-----SECMSSVAGSYGYIAPEYAYT--LKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQP  919 (982)
Q Consensus       847 ~~~-----~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  919 (982)
                      .+.     ........||+.|+|||++.+  ..++.++||||+||++|||++|+.||.......................
T Consensus       181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  260 (389)
T 3gni_B          181 HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDT  260 (389)
T ss_dssp             TTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-----------
T ss_pred             ccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccc
Confidence            211     111233478999999999987  6799999999999999999999999987655444433332221100000


Q ss_pred             Cccc---------------cccee----------ecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          920 SDAA---------------SVLAV----------VDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       920 ~~~~---------------~~~~~----------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                      ....               .....          .+......+...+..+.+++.+||+.||++|||++|+++
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~  333 (389)
T 3gni_B          261 STIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLN  333 (389)
T ss_dssp             ---------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             cccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence            0000               00000          000000123344567999999999999999999999986

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=4e-39  Score=356.92  Aligned_cols=258  Identities=25%  Similarity=0.414  Sum_probs=204.1

Q ss_pred             hhcccccccccccceEEEEEEe-CCCcE----EEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEE
Q 002010          692 ESLKDENIIGKGGAGIVYRGSM-PDGID----VAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLL  766 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~----vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  766 (982)
                      ++|+..+.||+|+||.||+|.. .+++.    ||+|.+...........+.+|+.++++++||||+++++++..+. .++
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~   93 (327)
T 3lzb_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL   93 (327)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEE
T ss_pred             hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceE
Confidence            5789999999999999999975 34443    57787765556667788999999999999999999999998754 789


Q ss_pred             EEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccc
Q 002010          767 LYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQD  846 (982)
Q Consensus       767 v~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  846 (982)
                      |+||+++|+|.+++... ...+++..+..++.|++.|++|||+.+   |+||||||+||+++.++.+||+|||+++....
T Consensus        94 v~~~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~  169 (327)
T 3lzb_A           94 ITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  169 (327)
T ss_dssp             EECCCSSCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC------
T ss_pred             EEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEccC
Confidence            99999999999999753 457999999999999999999999998   99999999999999999999999999987754


Q ss_pred             cCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHhccCCCCCCccccc
Q 002010          847 AGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASV  925 (982)
Q Consensus       847 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  925 (982)
                      ...........+|+.|+|||++.+..++.++||||+||++|||++ |..||...... .....+.....           
T Consensus       170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~-~~~~~~~~~~~-----------  237 (327)
T 3lzb_A          170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-EISSILEKGER-----------  237 (327)
T ss_dssp             ----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG-GHHHHHHTTCC-----------
T ss_pred             ccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHH-HHHHHHHcCCC-----------
Confidence            433333444567889999999999999999999999999999999 99999865433 33333322211           


Q ss_pred             ceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCC
Q 002010          926 LAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQ  974 (982)
Q Consensus       926 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~~  974 (982)
                              ...+...+..+.+++.+||+.||++|||++|+++.|+.+..
T Consensus       238 --------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  278 (327)
T 3lzb_A          238 --------LPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR  278 (327)
T ss_dssp             --------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred             --------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence                    11223344578999999999999999999999999976543

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=9.2e-39  Score=360.44  Aligned_cols=250  Identities=21%  Similarity=0.271  Sum_probs=202.7

Q ss_pred             HhhcccccccccccceEEEEEEeC-CCcEEEEEEeccCC--CCCchhhHHHHHHHHhcC-CCCcccceEeEEEcCCccEE
Q 002010          691 LESLKDENIIGKGGAGIVYRGSMP-DGIDVAIKRLVGRG--TGGNDHGFLAEIQTLGRI-RHRNIVRLLGYVSNRDTNLL  766 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~l  766 (982)
                      .++|+..+.||+|+||.||+|+.+ +++.||+|++....  .......+.+|..++.++ +||||+++++++.+++..++
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  130 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF  130 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence            357999999999999999999764 58899999986543  223345678899999887 89999999999999999999


Q ss_pred             EEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccc
Q 002010          767 LYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQD  846 (982)
Q Consensus       767 v~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  846 (982)
                      ||||+++|+|..++..  ...+++..+..++.||+.||+|||+.+   |+||||||+||+++.++.+||+|||+|+....
T Consensus       131 V~E~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~~  205 (396)
T 4dc2_A          131 VIEYVNGGDLMFHMQR--QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR  205 (396)
T ss_dssp             EEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             EEEcCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeeccc
Confidence            9999999999999973  457999999999999999999999998   99999999999999999999999999975332


Q ss_pred             cCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCc--------hHHHHHHHhccCCCC
Q 002010          847 AGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGV--------DIVRWVRKTTSEVSQ  918 (982)
Q Consensus       847 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~--------~~~~~~~~~~~~~~~  918 (982)
                      .  .......+||+.|+|||++.+..++.++||||+||++|||++|+.||.......        .....+....     
T Consensus       206 ~--~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~-----  278 (396)
T 4dc2_A          206 P--GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ-----  278 (396)
T ss_dssp             T--TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCC-----
T ss_pred             C--CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccc-----
Confidence            2  233456789999999999999999999999999999999999999996432211        0111111110     


Q ss_pred             CCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCH------HHHHH
Q 002010          919 PSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTM------REVVH  967 (982)
Q Consensus       919 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~------~ell~  967 (982)
                                     ..+|...+..+.+++.+||+.||.+||++      +|+++
T Consensus       279 ---------------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~  318 (396)
T 4dc2_A          279 ---------------IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG  318 (396)
T ss_dssp             ---------------CCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHH
T ss_pred             ---------------cCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhc
Confidence                           11233344578899999999999999995      56655

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-38  Score=359.66  Aligned_cols=255  Identities=19%  Similarity=0.251  Sum_probs=207.8

Q ss_pred             HHHHhhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEE
Q 002010          688 EDVLESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLL  766 (982)
Q Consensus       688 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  766 (982)
                      ..+.+.|+..+.||+|+||.||+|.. .+++.||+|++... .......+.+|+.++++++||||+++++++.+....++
T Consensus        47 ~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l  125 (387)
T 1kob_A           47 GSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP-YPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVL  125 (387)
T ss_dssp             SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-SHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEE
T ss_pred             CccccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEeccc-chhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEE
Confidence            34567899999999999999999965 46889999988433 22234578899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcC--CCCEEEeccccchhc
Q 002010          767 LYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDS--DFEAHVADFGLAKFL  844 (982)
Q Consensus       767 v~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~--~~~~kl~DfG~a~~~  844 (982)
                      ||||+++++|.+++.. ....+++..+..++.||+.||+|||+.+   |+||||||+||+++.  ++.+||+|||++...
T Consensus       126 v~E~~~gg~L~~~l~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~  201 (387)
T 1kob_A          126 ILEFLSGGELFDRIAA-EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKL  201 (387)
T ss_dssp             EEECCCCCBHHHHTTC-TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred             EEEcCCCCcHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceec
Confidence            9999999999999963 3357999999999999999999999998   999999999999974  478999999999876


Q ss_pred             cccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccc
Q 002010          845 QDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAAS  924 (982)
Q Consensus       845 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  924 (982)
                      ...   .......||+.|+|||++.+..++.++||||+||++|||++|..||....... ....+........       
T Consensus       202 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~-~~~~i~~~~~~~~-------  270 (387)
T 1kob_A          202 NPD---EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE-TLQNVKRCDWEFD-------  270 (387)
T ss_dssp             CTT---SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH-HHHHHHHCCCCCC-------
T ss_pred             CCC---cceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHH-HHHHHHhCCCCCC-------
Confidence            532   22334578999999999999999999999999999999999999997643322 2222222111000       


Q ss_pred             cceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          925 VLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       925 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                               .......+..+.+++.+||+.||++|||++|+++
T Consensus       271 ---------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  304 (387)
T 1kob_A          271 ---------EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE  304 (387)
T ss_dssp             ---------SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             ---------ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence                     0111233457889999999999999999999987

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=8.6e-39  Score=354.27  Aligned_cols=249  Identities=23%  Similarity=0.284  Sum_probs=196.7

Q ss_pred             HhhcccccccccccceEEEEEEe----CCCcEEEEEEeccCCC---CCchhhHHHHHHHHhcCCCCcccceEeEEEcCCc
Q 002010          691 LESLKDENIIGKGGAGIVYRGSM----PDGIDVAIKRLVGRGT---GGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDT  763 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  763 (982)
                      .++|+..+.||+|+||.||+|+.    .+++.||+|++.....   ......+.+|+.++++++||||+++++++..++.
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   95 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK   95 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence            36799999999999999999976    4789999999865422   2334567889999999999999999999999999


Q ss_pred             cEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchh
Q 002010          764 NLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKF  843 (982)
Q Consensus       764 ~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~  843 (982)
                      .++||||+++++|.+++..  ...+++..+..++.||+.|++|||+.+   |+||||||+||+++.++.+||+|||+++.
T Consensus        96 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~  170 (327)
T 3a62_A           96 LYLILEYLSGGELFMQLER--EGIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKE  170 (327)
T ss_dssp             EEEEEECCTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC--
T ss_pred             EEEEEeCCCCCcHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCcccc
Confidence            9999999999999999973  457899999999999999999999998   99999999999999999999999999976


Q ss_pred             ccccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCccc
Q 002010          844 LQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAA  923 (982)
Q Consensus       844 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  923 (982)
                      ....  ........||+.|+|||++.+..++.++||||+|+++|||++|+.||............... ..         
T Consensus       171 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~-~~---------  238 (327)
T 3a62_A          171 SIHD--GTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKC-KL---------  238 (327)
T ss_dssp             ----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT-CC---------
T ss_pred             cccC--CccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhC-CC---------
Confidence            4322  12234567999999999999999999999999999999999999999764332222222211 11         


Q ss_pred             ccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 002010          924 SVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARP-----TMREVVH  967 (982)
Q Consensus       924 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~ell~  967 (982)
                                 ..+...+..+.+++.+||+.||++||     +++|+++
T Consensus       239 -----------~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~  276 (327)
T 3a62_A          239 -----------NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA  276 (327)
T ss_dssp             -----------CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred             -----------CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence                       11223345788999999999999999     7888876

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=5.1e-39  Score=345.82  Aligned_cols=256  Identities=25%  Similarity=0.438  Sum_probs=211.9

Q ss_pred             hhcccccccccccceEEEEEEeCCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEecc
Q 002010          692 ESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYM  771 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  771 (982)
                      ++|+..+.||+|+||.||+|...+++.||+|++....  ...+.+.+|+.++++++||||+++++++.+++..++||||+
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (267)
T 3t9t_A            8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA--MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM   85 (267)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTT--BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred             hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccC--CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence            5788899999999999999988888999999985432  34567899999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCcc
Q 002010          772 PNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASE  851 (982)
Q Consensus       772 ~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~  851 (982)
                      ++++|.+++... ...+++..+..++.|++.|++|||+.+   |+||||||+||+++.++.+||+|||.+...... ...
T Consensus        86 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~-~~~  160 (267)
T 3t9t_A           86 EHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD-QYT  160 (267)
T ss_dssp             TTCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH-HHH
T ss_pred             CCCcHHHHHhhC-cccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEcccccccccccc-ccc
Confidence            999999999743 356899999999999999999999998   999999999999999999999999999876432 112


Q ss_pred             cccccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceeec
Q 002010          852 CMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVD  930 (982)
Q Consensus       852 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  930 (982)
                      ......+++.|+|||++.+..++.++||||+|+++|||++ |+.||...... .....+.....                
T Consensus       161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-~~~~~i~~~~~----------------  223 (267)
T 3t9t_A          161 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS-EVVEDISTGFR----------------  223 (267)
T ss_dssp             STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-HHHHHHHTTCC----------------
T ss_pred             ccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHH-HHHHHHhcCCc----------------
Confidence            2234567789999999998899999999999999999999 89999764322 22222211111                


Q ss_pred             CCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCC
Q 002010          931 PRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQ  974 (982)
Q Consensus       931 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~~  974 (982)
                         ...+...+..+.+++.+||+.||++|||++|+++.|+++.+
T Consensus       224 ---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~  264 (267)
T 3t9t_A          224 ---LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE  264 (267)
T ss_dssp             ---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---CCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence               01122234578999999999999999999999999987643

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=4e-38  Score=342.66  Aligned_cols=254  Identities=32%  Similarity=0.544  Sum_probs=205.4

Q ss_pred             hhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCCCch------hhHHHHHHHHhcCCCCcccceEeEEEcCCcc
Q 002010          692 ESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGND------HGFLAEIQTLGRIRHRNIVRLLGYVSNRDTN  764 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  764 (982)
                      ++|+..+.||+|+||.||+|.. .+++.||+|++.........      +.+.+|+.++++++||||+++++++.+..  
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--   96 (287)
T 4f0f_A           19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--   96 (287)
T ss_dssp             TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred             ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence            5788899999999999999975 57899999998554433222      57889999999999999999999986544  


Q ss_pred             EEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCC-----EEEeccc
Q 002010          765 LLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFE-----AHVADFG  839 (982)
Q Consensus       765 ~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~-----~kl~DfG  839 (982)
                      ++||||+++++|.+++.. +...+++..+..++.|++.|++|||+.+ ++|+||||||+||+++.++.     +||+|||
T Consensus        97 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg  174 (287)
T 4f0f_A           97 RMVMEFVPCGDLYHRLLD-KAHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFG  174 (287)
T ss_dssp             EEEEECCTTCBHHHHHHC-TTSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECCCT
T ss_pred             eEEEEecCCCCHHHHHhc-ccCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCCCC
Confidence            799999999999998864 3467999999999999999999999764 44999999999999988776     9999999


Q ss_pred             cchhccccCCcccccccccccccccccccc--cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCch-HHHHHHHhccCC
Q 002010          840 LAKFLQDAGASECMSSVAGSYGYIAPEYAY--TLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVD-IVRWVRKTTSEV  916 (982)
Q Consensus       840 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~-~~~~~~~~~~~~  916 (982)
                      +++....     ......||+.|+|||++.  ...++.++||||+|+++|||++|+.||........ ........... 
T Consensus       175 ~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-  248 (287)
T 4f0f_A          175 LSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLR-  248 (287)
T ss_dssp             TCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCC-
T ss_pred             ccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCC-
Confidence            9974432     234567899999999984  55678999999999999999999999987544322 12222221111 


Q ss_pred             CCCCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 002010          917 SQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANP  972 (982)
Q Consensus       917 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~  972 (982)
                                       ...+...+..+.+++.+||+.||++|||++|+++.|+++
T Consensus       249 -----------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          249 -----------------PTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             -----------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             -----------------CCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence                             122334456799999999999999999999999999864

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=1.4e-38  Score=355.68  Aligned_cols=251  Identities=23%  Similarity=0.308  Sum_probs=192.2

Q ss_pred             HHhhcccccccccccceEEEEEEeC-CCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEE
Q 002010          690 VLESLKDENIIGKGGAGIVYRGSMP-DGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLY  768 (982)
Q Consensus       690 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  768 (982)
                      +.+.|+..+.||+|+||.||+|... +++.||||++....   ..+.+.+|+.++++++||||+++++++.+++..++||
T Consensus        51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  127 (349)
T 2w4o_A           51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV---DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVL  127 (349)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-------------CHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch---hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEE
Confidence            3467899999999999999999764 58899999985432   3456788999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcC---CCCEEEeccccchhcc
Q 002010          769 EYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDS---DFEAHVADFGLAKFLQ  845 (982)
Q Consensus       769 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~---~~~~kl~DfG~a~~~~  845 (982)
                      ||+++++|.+++.  +...+++.++..++.||+.|++|||+.+   |+||||||+||+++.   ++.+||+|||+++...
T Consensus       128 e~~~~~~L~~~l~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~  202 (349)
T 2w4o_A          128 ELVTGGELFDRIV--EKGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE  202 (349)
T ss_dssp             CCCCSCBHHHHHT--TCSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred             EeCCCCCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence            9999999999997  4457999999999999999999999998   999999999999975   8899999999998765


Q ss_pred             ccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCccccc
Q 002010          846 DAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASV  925 (982)
Q Consensus       846 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  925 (982)
                      ..   .......||+.|+|||++.+..++.++||||+||++|||++|+.||............+........        
T Consensus       203 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~--------  271 (349)
T 2w4o_A          203 HQ---VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFI--------  271 (349)
T ss_dssp             -------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCC--------
T ss_pred             cc---cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccC--------
Confidence            32   2234567899999999999999999999999999999999999999765443323222222111000        


Q ss_pred             ceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          926 LAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       926 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                              .......+..+.+++.+||+.||++|||++|+++
T Consensus       272 --------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  305 (349)
T 2w4o_A          272 --------SPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ  305 (349)
T ss_dssp             --------TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             --------CchhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                    0111233457889999999999999999999987

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=4.2e-39  Score=353.23  Aligned_cols=271  Identities=23%  Similarity=0.351  Sum_probs=209.1

Q ss_pred             hhcccccccccccceEEEEEEe-----CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcC--Ccc
Q 002010          692 ESLKDENIIGKGGAGIVYRGSM-----PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNR--DTN  764 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~  764 (982)
                      +.|+..+.||+|+||.||+|.+     .+++.||+|++...........+.+|+.++++++||||+++++++..+  ...
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  100 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI  100 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence            4588899999999999999973     468899999997665556667899999999999999999999999876  567


Q ss_pred             EEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhc
Q 002010          765 LLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFL  844 (982)
Q Consensus       765 ~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~  844 (982)
                      ++||||+++++|.+++.. ....+++..+..++.|++.|++|||+.+   |+||||||+||+++.++.+||+|||++...
T Consensus       101 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~  176 (302)
T 4e5w_A          101 KLIMEFLPSGSLKEYLPK-NKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAI  176 (302)
T ss_dssp             EEEEECCTTCBHHHHHHH-HTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEEEEeCCCCcHHHHHHh-ccccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECcccccccc
Confidence            999999999999999964 2356999999999999999999999998   999999999999999999999999999876


Q ss_pred             cccCCc-ccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCccc
Q 002010          845 QDAGAS-ECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAA  923 (982)
Q Consensus       845 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  923 (982)
                      ...... .......+|..|+|||++.+..++.++||||+|+++|||++|..|+...     .......... ........
T Consensus       177 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~-----~~~~~~~~~~-~~~~~~~~  250 (302)
T 4e5w_A          177 ETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSP-----MALFLKMIGP-THGQMTVT  250 (302)
T ss_dssp             CTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSH-----HHHHHHHHCS-CCGGGHHH
T ss_pred             cCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcch-----hhHHhhccCC-cccccCHH
Confidence            543221 2234566888999999999999999999999999999999999986431     0011110000 00000000


Q ss_pred             ccceee-cCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 002010          924 SVLAVV-DPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANP  972 (982)
Q Consensus       924 ~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~  972 (982)
                      .....+ .......+...+..+.+++.+||+.||.+|||++|+++.|+++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  300 (302)
T 4e5w_A          251 RLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL  300 (302)
T ss_dssp             HHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence            000111 1111233445567899999999999999999999999999765

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=4.7e-39  Score=355.36  Aligned_cols=262  Identities=27%  Similarity=0.395  Sum_probs=215.7

Q ss_pred             HhhcccccccccccceEEEEEEe------CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcC-CCCcccceEeEEEcCC-
Q 002010          691 LESLKDENIIGKGGAGIVYRGSM------PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRI-RHRNIVRLLGYVSNRD-  762 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~-  762 (982)
                      .++|+..+.||+|+||.||+|..      .+++.||||++...........+.+|+.++.++ +||||+++++++..++ 
T Consensus        26 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~  105 (316)
T 2xir_A           26 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG  105 (316)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTS
T ss_pred             hhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCC
Confidence            36799999999999999999963      356889999986554444556789999999999 7899999999987754 


Q ss_pred             ccEEEEeccCCCCHHHHhhcCCC--------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEc
Q 002010          763 TNLLLYEYMPNGSLGEMLHGAKG--------------GHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLD  828 (982)
Q Consensus       763 ~~~lv~e~~~~~sL~~~l~~~~~--------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~  828 (982)
                      ..++||||+++++|.+++.....              ..+++..+..++.|++.|++|||+.+   |+||||||+||+++
T Consensus       106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~  182 (316)
T 2xir_A          106 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLS  182 (316)
T ss_dssp             CCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEC
T ss_pred             ceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEEC
Confidence            48999999999999999975432              12889999999999999999999998   99999999999999


Q ss_pred             CCCCEEEeccccchhccccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHH
Q 002010          829 SDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVR  907 (982)
Q Consensus       829 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~  907 (982)
                      .++.+||+|||+++...............+|+.|+|||++.+..++.++||||+|+++|||++ |..||...........
T Consensus       183 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~  262 (316)
T 2xir_A          183 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR  262 (316)
T ss_dssp             GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHH
T ss_pred             CCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHHH
Confidence            999999999999987654433333445668889999999999999999999999999999998 9999987655544444


Q ss_pred             HHHHhccCCCCCCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCC
Q 002010          908 WVRKTTSEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQ  974 (982)
Q Consensus       908 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~~  974 (982)
                      .+......                   ..+...+..+.+++.+||+.||.+|||++|+++.|+.+.+
T Consensus       263 ~~~~~~~~-------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  310 (316)
T 2xir_A          263 RLKEGTRM-------------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  310 (316)
T ss_dssp             HHHHTCCC-------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HhccCccC-------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            44332210                   1122234578999999999999999999999999987654

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.5e-38  Score=349.21  Aligned_cols=254  Identities=30%  Similarity=0.488  Sum_probs=199.4

Q ss_pred             hhcccccccccccceEEEEEEeCCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEecc
Q 002010          692 ESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYM  771 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  771 (982)
                      ++|+..+.||+|+||.||+|.. .++.||+|++..   ....+.+.+|+.++++++||||+++++++.  +..++||||+
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~   81 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIES---ESERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYA   81 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSS---TTHHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECC
T ss_pred             hHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecC---hhHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcC
Confidence            5788899999999999999987 578999998842   344567899999999999999999999876  4589999999


Q ss_pred             CCCCHHHHhhcCCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCC-EEEeccccchhccccCC
Q 002010          772 PNGSLGEMLHGAKG-GHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFE-AHVADFGLAKFLQDAGA  849 (982)
Q Consensus       772 ~~~sL~~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~-~kl~DfG~a~~~~~~~~  849 (982)
                      ++++|.+++..... ..+++..+..++.|+++|++|||+.+..+|+||||||+||+++.++. +||+|||++......  
T Consensus        82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~--  159 (307)
T 2eva_A           82 EGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--  159 (307)
T ss_dssp             TTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---------
T ss_pred             CCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc--
Confidence            99999999975432 35789999999999999999999932233999999999999998886 799999999765422  


Q ss_pred             cccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceee
Q 002010          850 SECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVV  929 (982)
Q Consensus       850 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  929 (982)
                         .....||+.|+|||++.+..++.++||||+|+++|||++|+.||...........+.......              
T Consensus       160 ---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~--------------  222 (307)
T 2eva_A          160 ---MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTR--------------  222 (307)
T ss_dssp             --------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCC--------------
T ss_pred             ---cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCC--------------
Confidence               234568999999999999999999999999999999999999998654432222221111111              


Q ss_pred             cCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCC
Q 002010          930 DPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQ  974 (982)
Q Consensus       930 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~~  974 (982)
                          ...+...+..+.+++.+||+.||++|||++|+++.|+.+.+
T Consensus       223 ----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  263 (307)
T 2eva_A          223 ----PPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMR  263 (307)
T ss_dssp             ----CCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGG
T ss_pred             ----CCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence                11122334578899999999999999999999999876544

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.1e-38  Score=356.26  Aligned_cols=251  Identities=22%  Similarity=0.289  Sum_probs=196.9

Q ss_pred             hhcccccccccccceEEEEEEeCCCcEEEEEEeccCCCC-CchhhHHHHHHHHhcCCC--CcccceEeEEEcCCccEEEE
Q 002010          692 ESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTG-GNDHGFLAEIQTLGRIRH--RNIVRLLGYVSNRDTNLLLY  768 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~lv~  768 (982)
                      ++|++.+.||+|+||.||+|...+++.||||++...... .....+.+|+.++.+++|  |||+++++++.++...++||
T Consensus         9 ~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~   88 (343)
T 3dbq_A            9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM   88 (343)
T ss_dssp             CEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             CEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEE
Confidence            468899999999999999998888999999998544322 234578899999999976  99999999999999999999


Q ss_pred             eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccC
Q 002010          769 EYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAG  848 (982)
Q Consensus       769 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  848 (982)
                      |+ .+++|.+++..  ...+++.++..++.||+.|++|||+.+   |+||||||+||+++ ++.+||+|||+++.+....
T Consensus        89 e~-~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~  161 (343)
T 3dbq_A           89 EC-GNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT  161 (343)
T ss_dssp             CC-CSEEHHHHHHH--SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC----
T ss_pred             eC-CCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccCccc
Confidence            95 58899999974  467999999999999999999999998   99999999999997 6789999999998776443


Q ss_pred             Cccccccccccccccccccccc-----------CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCC
Q 002010          849 ASECMSSVAGSYGYIAPEYAYT-----------LKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVS  917 (982)
Q Consensus       849 ~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  917 (982)
                      .........||+.|+|||++.+           ..++.++||||+||++|||++|+.||....+.............   
T Consensus       162 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~---  238 (343)
T 3dbq_A          162 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNH---  238 (343)
T ss_dssp             --------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTS---
T ss_pred             ccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCc---
Confidence            3333446689999999999864           67899999999999999999999999764332211111111000   


Q ss_pred             CCCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          918 QPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       918 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                                     ....+...+..+.+++.+||+.||.+|||++|+++
T Consensus       239 ---------------~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~  273 (343)
T 3dbq_A          239 ---------------EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA  273 (343)
T ss_dssp             ---------------CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ---------------ccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHh
Confidence                           00122233457889999999999999999999986

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=2.8e-39  Score=359.26  Aligned_cols=248  Identities=24%  Similarity=0.336  Sum_probs=204.9

Q ss_pred             HhhcccccccccccceEEEEEEe-CCCcEEEEEEeccCC--CCCchhhHHHHHHHHhcC-CCCcccceEeEEEcCCccEE
Q 002010          691 LESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRG--TGGNDHGFLAEIQTLGRI-RHRNIVRLLGYVSNRDTNLL  766 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~l  766 (982)
                      .++|+..+.||+|+||.||+|+. .+++.||+|++....  .......+..|..++..+ +||||+++++++.+.+..|+
T Consensus        16 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~l   95 (345)
T 1xjd_A           16 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF   95 (345)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEE
Confidence            46799999999999999999976 468999999985432  234456678899999877 89999999999999999999


Q ss_pred             EEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccc
Q 002010          767 LYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQD  846 (982)
Q Consensus       767 v~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  846 (982)
                      ||||+++|+|.+++..  ...+++..+..++.||+.|++|||+.+   |+||||||+||+++.++.+||+|||+++....
T Consensus        96 v~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  170 (345)
T 1xjd_A           96 VMEYLNGGDLMYHIQS--CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML  170 (345)
T ss_dssp             EEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             EEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhhccc
Confidence            9999999999999973  357999999999999999999999998   99999999999999999999999999975432


Q ss_pred             cCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccc
Q 002010          847 AGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVL  926 (982)
Q Consensus       847 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  926 (982)
                      .  .......+||+.|+|||++.+..++.++||||+||++|||++|+.||...... .....+.....            
T Consensus       171 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-~~~~~i~~~~~------------  235 (345)
T 1xjd_A          171 G--DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE-ELFHSIRMDNP------------  235 (345)
T ss_dssp             T--TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHCCC------------
T ss_pred             C--CCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHH-HHHHHHHhCCC------------
Confidence            2  12245578999999999999999999999999999999999999999764332 22222221111            


Q ss_pred             eeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHH-HHH
Q 002010          927 AVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMR-EVV  966 (982)
Q Consensus       927 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~-ell  966 (982)
                              .++...+..+.+++.+||+.||++||++. |++
T Consensus       236 --------~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~  268 (345)
T 1xjd_A          236 --------FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR  268 (345)
T ss_dssp             --------CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             --------CCCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence                    11222345788999999999999999997 664

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=7.7e-39  Score=356.22  Aligned_cols=253  Identities=20%  Similarity=0.311  Sum_probs=201.5

Q ss_pred             HHhhcccccccccccceEEEEEEeC-CCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCC------
Q 002010          690 VLESLKDENIIGKGGAGIVYRGSMP-DGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRD------  762 (982)
Q Consensus       690 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------  762 (982)
                      +.++|+..+.||+|+||.||+|... +++.||||++.........+.+.+|+.++++++||||+++++++.+..      
T Consensus         4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~   83 (332)
T 3qd2_B            4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE   83 (332)
T ss_dssp             HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred             hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence            5678999999999999999999764 799999999976555556678999999999999999999999886543      


Q ss_pred             ---------------------------------------------------ccEEEEeccCCCCHHHHhhcCCC-CCCCH
Q 002010          763 ---------------------------------------------------TNLLLYEYMPNGSLGEMLHGAKG-GHLKW  790 (982)
Q Consensus       763 ---------------------------------------------------~~~lv~e~~~~~sL~~~l~~~~~-~~l~~  790 (982)
                                                                         ..++||||+++++|.+++..... ...++
T Consensus        84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~  163 (332)
T 3qd2_B           84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH  163 (332)
T ss_dssp             HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred             hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence                                                               27899999999999999975432 34567


Q ss_pred             HHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCC----------ccccccccccc
Q 002010          791 ETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGA----------SECMSSVAGSY  860 (982)
Q Consensus       791 ~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~----------~~~~~~~~gt~  860 (982)
                      ..++.++.||+.|++|||+.+   |+||||||+||+++.++.+||+|||+++.......          ........||+
T Consensus       164 ~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~  240 (332)
T 3qd2_B          164 GVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK  240 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence            778999999999999999998   99999999999999999999999999987654321          12234467999


Q ss_pred             ccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceeecCCCCCCChHh
Q 002010          861 GYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDPRLSGYPLTG  940 (982)
Q Consensus       861 ~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  940 (982)
                      .|+|||++.+..++.++||||+|+++|||++|..|+..      ..........                ...+......
T Consensus       241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~------~~~~~~~~~~----------------~~~~~~~~~~  298 (332)
T 3qd2_B          241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME------RVRIITDVRN----------------LKFPLLFTQK  298 (332)
T ss_dssp             GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH------HHHHHHHHHT----------------TCCCHHHHHH
T ss_pred             CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH------HHHHHHHhhc----------------cCCCcccccC
Confidence            99999999999999999999999999999998776432      1111111111                0011111233


Q ss_pred             HHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          941 VIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       941 ~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                      ...+.+++.+||+.||++|||++|+++
T Consensus       299 ~~~~~~li~~~l~~~p~~Rps~~~~l~  325 (332)
T 3qd2_B          299 YPQEHMMVQDMLSPSPTERPEATDIIE  325 (332)
T ss_dssp             CHHHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred             ChhHHHHHHHHccCCCCcCCCHHHHhh
Confidence            346789999999999999999999986

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=1.7e-38  Score=355.48  Aligned_cols=254  Identities=22%  Similarity=0.240  Sum_probs=204.8

Q ss_pred             HhhcccccccccccceEEEEEEe-CCCcEEEEEEeccC----CCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccE
Q 002010          691 LESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGR----GTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNL  765 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  765 (982)
                      .+.|+..+.||+|+||.||+|.. .+++.||||++...    ......+.+.+|+.++++++||||+++++++.+++..+
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  102 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY  102 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            46799999999999999999965 56899999998432    12234667899999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCC---EEEecccc
Q 002010          766 LLYEYMPNGSLGEMLHGA--KGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFE---AHVADFGL  840 (982)
Q Consensus       766 lv~e~~~~~sL~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~---~kl~DfG~  840 (982)
                      +||||+++++|.+++...  ....+++..+..++.||+.|++|||+.+   |+||||||+||+++.++.   +||+|||+
T Consensus       103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~  179 (351)
T 3c0i_A          103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGV  179 (351)
T ss_dssp             EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred             EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcc
Confidence            999999999999887542  2346899999999999999999999998   999999999999987654   99999999


Q ss_pred             chhccccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCC
Q 002010          841 AKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPS  920 (982)
Q Consensus       841 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  920 (982)
                      +......  ........||+.|+|||++.+..++.++||||+||++|+|++|+.||....  ......+........ + 
T Consensus       180 a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~--~~~~~~i~~~~~~~~-~-  253 (351)
T 3c0i_A          180 AIQLGES--GLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK--ERLFEGIIKGKYKMN-P-  253 (351)
T ss_dssp             CEECCTT--SCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH--HHHHHHHHHTCCCCC-H-
T ss_pred             eeEecCC--CeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH--HHHHHHHHcCCCCCC-c-
Confidence            9876542  222345679999999999999999999999999999999999999997631  222222211111000 0 


Q ss_pred             cccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          921 DAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       921 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                                    ......+..+.+++.+||+.||++|||++|+++
T Consensus       254 --------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  286 (351)
T 3c0i_A          254 --------------RQWSHISESAKDLVRRMLMLDPAERITVYEALN  286 (351)
T ss_dssp             --------------HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             --------------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence                          000122357889999999999999999999986

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=2.2e-38  Score=344.14  Aligned_cols=254  Identities=22%  Similarity=0.300  Sum_probs=203.2

Q ss_pred             HHHhhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEE
Q 002010          689 DVLESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLL  767 (982)
Q Consensus       689 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  767 (982)
                      ++.++|+..+.||+|+||.||+|.. .++..||+|++...........+.+|+.++++++||||+++++++.+....++|
T Consensus        19 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   98 (285)
T 3is5_A           19 TIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIV   98 (285)
T ss_dssp             CHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEE
Confidence            4567899999999999999999965 568999999997766666678899999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEE---cCCCCEEEeccccch
Q 002010          768 YEYMPNGSLGEMLHGA--KGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILL---DSDFEAHVADFGLAK  842 (982)
Q Consensus       768 ~e~~~~~sL~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill---~~~~~~kl~DfG~a~  842 (982)
                      |||+++++|.+++...  ....+++..+..++.|++.|++|||+.+   |+||||||+||++   +.++.+||+|||++.
T Consensus        99 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~  175 (285)
T 3is5_A           99 METCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAE  175 (285)
T ss_dssp             ECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCC
T ss_pred             EEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecce
Confidence            9999999999988532  2467999999999999999999999998   9999999999999   456889999999998


Q ss_pred             hccccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcc
Q 002010          843 FLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDA  922 (982)
Q Consensus       843 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  922 (982)
                      .+...   .......|++.|+|||++. ..++.++||||+|+++|||++|+.||....... ..........        
T Consensus       176 ~~~~~---~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~-~~~~~~~~~~--------  242 (285)
T 3is5_A          176 LFKSD---EHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEE-VQQKATYKEP--------  242 (285)
T ss_dssp             C-------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHCCC--------
T ss_pred             ecCCc---ccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHH-HHhhhccCCc--------
Confidence            66532   2234567899999999875 568999999999999999999999997643221 1111111111        


Q ss_pred             cccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          923 ASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       923 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                               .........+..+.+++.+||+.||++|||++|+++
T Consensus       243 ---------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          243 ---------NYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             ---------CCCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             ---------ccccccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                     000001112346889999999999999999999985

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=9.1e-39  Score=346.26  Aligned_cols=257  Identities=27%  Similarity=0.436  Sum_probs=210.9

Q ss_pred             HhhcccccccccccceEEEEEEeCCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEec
Q 002010          691 LESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEY  770 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  770 (982)
                      .++|+..+.||+|+||.||+|...++..||+|.+...  ......+.+|+.++++++||||+++++++. ++..++||||
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~   88 (279)
T 1qpc_A           12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG--SMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEY   88 (279)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT--SSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEEC
T ss_pred             HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCC--cccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEec
Confidence            3678999999999999999999888889999998543  334677899999999999999999999876 4568999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCc
Q 002010          771 MPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS  850 (982)
Q Consensus       771 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  850 (982)
                      +++++|.+++.......+++..+..++.|++.|++|||+.+   |+||||||+||++++++.+||+|||.+....... .
T Consensus        89 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~  164 (279)
T 1qpc_A           89 MENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE-Y  164 (279)
T ss_dssp             CTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSC-E
T ss_pred             CCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCcc-c
Confidence            99999999997433347999999999999999999999998   9999999999999999999999999998765332 2


Q ss_pred             ccccccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceee
Q 002010          851 ECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVV  929 (982)
Q Consensus       851 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  929 (982)
                      .......+++.|+|||++.+..++.++||||+|+++|||++ |+.||....... ....+.....               
T Consensus       165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-~~~~~~~~~~---------------  228 (279)
T 1qpc_A          165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE-VIQNLERGYR---------------  228 (279)
T ss_dssp             ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-HHHHHHTTCC---------------
T ss_pred             ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHH-HHHHHhcccC---------------
Confidence            22234556789999999998889999999999999999999 999997643322 2222211110               


Q ss_pred             cCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCC
Q 002010          930 DPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQ  974 (982)
Q Consensus       930 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~~  974 (982)
                          ...+...+..+.+++.+||+.||++|||++++++.|+++..
T Consensus       229 ----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  269 (279)
T 1qpc_A          229 ----MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT  269 (279)
T ss_dssp             ----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ----CCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHH
Confidence                01122344578999999999999999999999999876543

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=9.3e-39  Score=356.24  Aligned_cols=249  Identities=23%  Similarity=0.290  Sum_probs=205.3

Q ss_pred             HhhcccccccccccceEEEEEEeC-CCcEEEEEEeccCC--CCCchhhHHHHHHHHhcC-CCCcccceEeEEEcCCccEE
Q 002010          691 LESLKDENIIGKGGAGIVYRGSMP-DGIDVAIKRLVGRG--TGGNDHGFLAEIQTLGRI-RHRNIVRLLGYVSNRDTNLL  766 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~l  766 (982)
                      .++|+..+.||+|+||.||+|+.. +++.||+|++....  .......+..|..++..+ +||+|+++++++.+.+..|+
T Consensus        19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   98 (353)
T 2i0e_A           19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF   98 (353)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence            467999999999999999999764 47899999985432  234456788999999988 79999999999999999999


Q ss_pred             EEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccc
Q 002010          767 LYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQD  846 (982)
Q Consensus       767 v~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  846 (982)
                      ||||+++|+|.+++..  ...+++..+..++.||+.||+|||+.+   |+||||||+||+++.++.+||+|||+++....
T Consensus        99 v~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  173 (353)
T 2i0e_A           99 VMEYVNGGDLMYHIQQ--VGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIW  173 (353)
T ss_dssp             EEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             EEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCccccccc
Confidence            9999999999999973  357999999999999999999999998   99999999999999999999999999985432


Q ss_pred             cCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccc
Q 002010          847 AGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVL  926 (982)
Q Consensus       847 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  926 (982)
                      .  .......+||+.|+|||++.+..++.++||||+||++|||++|+.||....... ....+.....            
T Consensus       174 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~-~~~~i~~~~~------------  238 (353)
T 2i0e_A          174 D--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE-LFQSIMEHNV------------  238 (353)
T ss_dssp             T--TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHCCC------------
T ss_pred             C--CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHH-HHHHHHhCCC------------
Confidence            2  223445789999999999999999999999999999999999999997643322 2222221111            


Q ss_pred             eeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 002010          927 AVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPT-----MREVVH  967 (982)
Q Consensus       927 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt-----~~ell~  967 (982)
                              .+|...+..+.+++.+||+.||.+||+     ++|+++
T Consensus       239 --------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~  276 (353)
T 2i0e_A          239 --------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  276 (353)
T ss_dssp             --------CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred             --------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence                    122233457899999999999999995     577764

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=1.8e-38  Score=356.28  Aligned_cols=252  Identities=23%  Similarity=0.264  Sum_probs=197.2

Q ss_pred             HhhcccccccccccceEEEEEEeC-CCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEe
Q 002010          691 LESLKDENIIGKGGAGIVYRGSMP-DGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYE  769 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  769 (982)
                      .++|+..+.||+|+||.||+|+.. +++.||+|++....  .....+.+|+.++++++||||+++++++.+....++|||
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e   96 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA--AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIME   96 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST--TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc--cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEE
Confidence            367999999999999999999764 78999999985432  334568899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCC--EEEeccccchhcccc
Q 002010          770 YMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFE--AHVADFGLAKFLQDA  847 (982)
Q Consensus       770 ~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~--~kl~DfG~a~~~~~~  847 (982)
                      |+++|+|.+++..  ...+++..+..++.|++.|++|||+.+   |+||||||+||+++.++.  +||+|||+++.....
T Consensus        97 ~~~~~~L~~~l~~--~~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~  171 (361)
T 3uc3_A           97 YASGGELYERICN--AGRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH  171 (361)
T ss_dssp             CCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred             eCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCcccccccc
Confidence            9999999999963  457999999999999999999999998   999999999999987765  999999999754322


Q ss_pred             CCcccccccccccccccccccccCCCCcc-hhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccc
Q 002010          848 GASECMSSVAGSYGYIAPEYAYTLKVDEK-SDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVL  926 (982)
Q Consensus       848 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  926 (982)
                         .......||+.|+|||++.+..++.+ +||||+||++|+|++|+.||............+...........      
T Consensus       172 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~------  242 (361)
T 3uc3_A          172 ---SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIP------  242 (361)
T ss_dssp             ------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCC------
T ss_pred             ---CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCC------
Confidence               22345679999999999988887655 89999999999999999999876655555554444332111000      


Q ss_pred             eeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          927 AVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       927 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                               .....+..+.+++.+||+.||++|||++|+++
T Consensus       243 ---------~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~  274 (361)
T 3uc3_A          243 ---------DDIRISPECCHLISRIFVADPATRISIPEIKT  274 (361)
T ss_dssp             ---------TTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             ---------CcCCCCHHHHHHHHHHccCChhHCcCHHHHHh
Confidence                     00112346889999999999999999999987

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=1.3e-38  Score=346.82  Aligned_cols=257  Identities=24%  Similarity=0.364  Sum_probs=215.5

Q ss_pred             HhhcccccccccccceEEEEEEeC-CCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEe
Q 002010          691 LESLKDENIIGKGGAGIVYRGSMP-DGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYE  769 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  769 (982)
                      .++|+..+.||+|+||.||+|... ++..||+|.+..  .....+.+.+|+.++++++||||+++++++.++...++|||
T Consensus        12 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   89 (288)
T 3kfa_A           12 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE--DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE   89 (288)
T ss_dssp             GGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECS--CSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred             ccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence            467899999999999999999764 488999999843  33445678999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCC
Q 002010          770 YMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGA  849 (982)
Q Consensus       770 ~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  849 (982)
                      |+++++|.+++.......+++..+..++.|++.|++|||+.+   |+||||||+||+++.++.+||+|||.+...... .
T Consensus        90 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~-~  165 (288)
T 3kfa_A           90 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD-T  165 (288)
T ss_dssp             CCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSS-S
T ss_pred             cCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCC-c
Confidence            999999999998766678999999999999999999999998   999999999999999999999999999876533 2


Q ss_pred             cccccccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHhccCCCCCCccccccee
Q 002010          850 SECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAV  928 (982)
Q Consensus       850 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  928 (982)
                      ........+++.|+|||++.+..++.++||||+|+++|+|++ |..||...... .....+.....              
T Consensus       166 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~-~~~~~~~~~~~--------------  230 (288)
T 3kfa_A          166 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-QVYELLEKDYR--------------  230 (288)
T ss_dssp             SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG-GHHHHHHTTCC--------------
T ss_pred             cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHHhccCC--------------
Confidence            233344567889999999998999999999999999999999 99999765432 22332222111              


Q ss_pred             ecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 002010          929 VDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPP  973 (982)
Q Consensus       929 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~  973 (982)
                           ...+...+..+.+++.+||+.||.+|||++|+++.|+.+.
T Consensus       231 -----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~  270 (288)
T 3kfa_A          231 -----MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF  270 (288)
T ss_dssp             -----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -----CCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHH
Confidence                 1122334467899999999999999999999999987643

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.7e-39  Score=362.02  Aligned_cols=258  Identities=28%  Similarity=0.404  Sum_probs=197.7

Q ss_pred             hcccccccccccceEEEEEEeC--C--CcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEc-CCccEEE
Q 002010          693 SLKDENIIGKGGAGIVYRGSMP--D--GIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSN-RDTNLLL  767 (982)
Q Consensus       693 ~~~~~~~lg~G~~g~Vy~~~~~--~--~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv  767 (982)
                      .|+..+.||+|+||.||+|...  +  +..||+|.+...........+.+|+.++++++||||+++++++.. ++..++|
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv  169 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV  169 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence            4677789999999999999652  2  246899988654444556789999999999999999999998754 5678999


Q ss_pred             EeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhcccc
Q 002010          768 YEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDA  847 (982)
Q Consensus       768 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  847 (982)
                      |||+++|+|.+++.. ....+++..+..++.||++|++|||+.+   |+||||||+||+++.++.+||+|||+++.+...
T Consensus       170 ~e~~~~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~  245 (373)
T 3c1x_A          170 LPYMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDK  245 (373)
T ss_dssp             EECCTTCBHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred             EECCCCCCHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeecccccccccc
Confidence            999999999999974 3456899999999999999999999998   999999999999999999999999999876533


Q ss_pred             CCc--ccccccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHhccCCCCCCcccc
Q 002010          848 GAS--ECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAAS  924 (982)
Q Consensus       848 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  924 (982)
                      ...  .......+++.|+|||++.+..++.++||||+|+++|||++ |.+||........ ...+.....          
T Consensus       246 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~-~~~~~~~~~----------  314 (373)
T 3c1x_A          246 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI-TVYLLQGRR----------  314 (373)
T ss_dssp             ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCH-HHHHHTTCC----------
T ss_pred             ccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHH-HHHHHcCCC----------
Confidence            211  11234557789999999999999999999999999999999 7778876544332 222222111          


Q ss_pred             cceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCC
Q 002010          925 VLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQ  974 (982)
Q Consensus       925 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~~  974 (982)
                               ...+...+..+.+++.+||+.||++|||++|+++.|+++..
T Consensus       315 ---------~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~  355 (373)
T 3c1x_A          315 ---------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS  355 (373)
T ss_dssp             ---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence                     01122344578999999999999999999999999876543

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-38  Score=346.20  Aligned_cols=257  Identities=25%  Similarity=0.376  Sum_probs=209.1

Q ss_pred             hhccccc-ccccccceEEEEEEeC---CCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEE
Q 002010          692 ESLKDEN-IIGKGGAGIVYRGSMP---DGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLL  767 (982)
Q Consensus       692 ~~~~~~~-~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  767 (982)
                      ++|...+ .||+|+||.||+|...   ++..||+|++.........+.+.+|+.++++++||||+++++++ ..+..++|
T Consensus         9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv   87 (287)
T 1u59_A            9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV   87 (287)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred             HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence            4455555 8999999999999643   57889999996654444566789999999999999999999999 45668999


Q ss_pred             EeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhcccc
Q 002010          768 YEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDA  847 (982)
Q Consensus       768 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  847 (982)
                      |||+++++|.+++.. ....+++..+..++.|++.|++|||+.+   |+||||||+||+++.++.+||+|||++......
T Consensus        88 ~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~  163 (287)
T 1u59_A           88 MEMAGGGPLHKFLVG-KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGAD  163 (287)
T ss_dssp             EECCTTEEHHHHHTT-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred             EEeCCCCCHHHHHHh-CCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeeccC
Confidence            999999999999963 3467999999999999999999999998   999999999999999999999999999876533


Q ss_pred             CCc-ccccccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHhccCCCCCCccccc
Q 002010          848 GAS-ECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASV  925 (982)
Q Consensus       848 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  925 (982)
                      ... .......+|+.|+|||++.+..++.++||||+|+++|||++ |+.||...... .....+.....           
T Consensus       164 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-~~~~~i~~~~~-----------  231 (287)
T 1u59_A          164 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP-EVMAFIEQGKR-----------  231 (287)
T ss_dssp             SCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH-HHHHHHHTTCC-----------
T ss_pred             cceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH-HHHHHHhcCCc-----------
Confidence            221 12233456889999999998889999999999999999999 99999875433 22222222111           


Q ss_pred             ceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 002010          926 LAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPP  973 (982)
Q Consensus       926 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~  973 (982)
                              ...+...+..+.+++.+||+.||++||+++|+++.|+.+.
T Consensus       232 --------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~  271 (287)
T 1u59_A          232 --------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY  271 (287)
T ss_dssp             --------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             --------CCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence                    1223344568999999999999999999999999987653

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=1.8e-38  Score=360.02  Aligned_cols=251  Identities=23%  Similarity=0.295  Sum_probs=197.9

Q ss_pred             hhcccccccccccceEEEEEEeCCCcEEEEEEeccCCC-CCchhhHHHHHHHHhcCC--CCcccceEeEEEcCCccEEEE
Q 002010          692 ESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGT-GGNDHGFLAEIQTLGRIR--HRNIVRLLGYVSNRDTNLLLY  768 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~lv~  768 (982)
                      +.|++.+.||+|+||.||+|...+++.||||++..... ......+.+|+.++++++  ||||+++++++..++..++||
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~  135 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM  135 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence            35899999999999999999887899999999855432 233467899999999996  599999999999999999999


Q ss_pred             eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccC
Q 002010          769 EYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAG  848 (982)
Q Consensus       769 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  848 (982)
                      | +.+++|.+++..  ...+++.++..++.||+.||+|||+.+   |+||||||+||+++ ++.+||+|||+++.+....
T Consensus       136 E-~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~  208 (390)
T 2zmd_A          136 E-CGNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT  208 (390)
T ss_dssp             E-CCSEEHHHHHHH--CSSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC----
T ss_pred             e-cCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccCCC
Confidence            9 568899999974  357899999999999999999999988   99999999999995 5899999999998775443


Q ss_pred             Cccccccccccccccccccccc-----------CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCC
Q 002010          849 ASECMSSVAGSYGYIAPEYAYT-----------LKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVS  917 (982)
Q Consensus       849 ~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  917 (982)
                      .........||+.|+|||++.+           ..++.++||||+||++|||++|+.||....+.......+......  
T Consensus       209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~--  286 (390)
T 2zmd_A          209 TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE--  286 (390)
T ss_dssp             -----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSC--
T ss_pred             ccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCcccc--
Confidence            3333455689999999999865           368899999999999999999999997643322211111111100  


Q ss_pred             CCCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          918 QPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       918 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                                      ...+...+..+.+++.+||+.||++|||++|+++
T Consensus       287 ----------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~  320 (390)
T 2zmd_A          287 ----------------IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA  320 (390)
T ss_dssp             ----------------CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ----------------CCCCccchHHHHHHHHHHcccChhhCCCHHHHhh
Confidence                            0112222457889999999999999999999986

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=2.3e-38  Score=352.75  Aligned_cols=249  Identities=21%  Similarity=0.268  Sum_probs=203.1

Q ss_pred             hhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCC--CchhhHHHHHHHHhcC-CCCcccceEeEEEcCCccEEE
Q 002010          692 ESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTG--GNDHGFLAEIQTLGRI-RHRNIVRLLGYVSNRDTNLLL  767 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv  767 (982)
                      ++|+..+.||+|+||.||+|+. .+++.||+|++......  .....+.+|+.++.++ +||||+++++++.+++..++|
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv   88 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV   88 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence            5789999999999999999976 45889999999654322  2344678899999888 899999999999999999999


Q ss_pred             EeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhcccc
Q 002010          768 YEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDA  847 (982)
Q Consensus       768 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  847 (982)
                      |||+++|+|.+++..  ...+++..+..++.||+.|++|||+.+   |+||||||+||+++.++.+||+|||+++.....
T Consensus        89 ~e~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~  163 (345)
T 3a8x_A           89 IEYVNGGDLMFHMQR--QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP  163 (345)
T ss_dssp             ECCCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT
T ss_pred             EeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccccCC
Confidence            999999999999973  357999999999999999999999998   999999999999999999999999999854322


Q ss_pred             CCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCc--------hHHHHHHHhccCCCCC
Q 002010          848 GASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGV--------DIVRWVRKTTSEVSQP  919 (982)
Q Consensus       848 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~--------~~~~~~~~~~~~~~~~  919 (982)
                        ........||+.|+|||++.+..++.++||||+||++|||++|+.||.......        .....+....      
T Consensus       164 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~------  235 (345)
T 3a8x_A          164 --GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ------  235 (345)
T ss_dssp             --TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCC------
T ss_pred             --CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCC------
Confidence              223455689999999999999999999999999999999999999997532211        1111111100      


Q ss_pred             CcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCH------HHHHH
Q 002010          920 SDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTM------REVVH  967 (982)
Q Consensus       920 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~------~ell~  967 (982)
                                    ..+|...+..+.+++.+||+.||.+||++      +|+++
T Consensus       236 --------------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~  275 (345)
T 3a8x_A          236 --------------IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG  275 (345)
T ss_dssp             --------------CCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHT
T ss_pred             --------------CCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhc
Confidence                          01233344578999999999999999996      56654

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6e-39  Score=356.70  Aligned_cols=259  Identities=29%  Similarity=0.495  Sum_probs=203.8

Q ss_pred             hhcccccccccccceEEEEEEeCC-----CcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEE
Q 002010          692 ESLKDENIIGKGGAGIVYRGSMPD-----GIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLL  766 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  766 (982)
                      ++|+..+.||+|+||.||+|....     +..||+|.+...........+.+|+.++++++||||+++++++.+.+..++
T Consensus        44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  123 (333)
T 1mqb_A           44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI  123 (333)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence            567888999999999999996532     345999998655444445678899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccc
Q 002010          767 LYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQD  846 (982)
Q Consensus       767 v~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  846 (982)
                      ||||+++++|.+++.. ....+++..+..++.||+.|++|||+.+   |+||||||+||+++.++.+||+|||++.....
T Consensus       124 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~  199 (333)
T 1mqb_A          124 ITEYMENGALDKFLRE-KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED  199 (333)
T ss_dssp             EEECCTTEEHHHHHHH-TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred             EEeCCCCCcHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhhcc
Confidence            9999999999999974 3467999999999999999999999998   99999999999999999999999999987654


Q ss_pred             cCCc-ccccccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHhccCCCCCCcccc
Q 002010          847 AGAS-ECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAAS  924 (982)
Q Consensus       847 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  924 (982)
                      .... .......+++.|+|||++.+..++.++||||+|+++|||++ |+.||...... .....+.....          
T Consensus       200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~-~~~~~~~~~~~----------  268 (333)
T 1mqb_A          200 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH-EVMKAINDGFR----------  268 (333)
T ss_dssp             -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-HHHHHHHTTCC----------
T ss_pred             ccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH-HHHHHHHCCCc----------
Confidence            3211 11223346788999999999999999999999999999999 99999764332 22222221111          


Q ss_pred             cceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCC
Q 002010          925 VLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQ  974 (982)
Q Consensus       925 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~~  974 (982)
                               ...+...+..+.+++.+||+.||++||+++|+++.|+++..
T Consensus       269 ---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~  309 (333)
T 1mqb_A          269 ---------LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR  309 (333)
T ss_dssp             ---------CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             ---------CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence                     01122344578999999999999999999999999876543

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=2e-38  Score=366.31  Aligned_cols=247  Identities=26%  Similarity=0.363  Sum_probs=206.6

Q ss_pred             hhcccccccccccceEEEEEEe-CCCcEEEEEEeccCC--CCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEE
Q 002010          692 ESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRG--TGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLY  768 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  768 (982)
                      ++|+..+.||+|+||.||+|.. .+|+.||||++....  .......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~   95 (476)
T 2y94_A           16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM   95 (476)
T ss_dssp             TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            5789999999999999999976 479999999985432  2234567889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccC
Q 002010          769 EYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAG  848 (982)
Q Consensus       769 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  848 (982)
                      ||+++++|.+++.  +...+++..+..++.||+.|++|||+.+   |+||||||+||+++.++.+||+|||++...... 
T Consensus        96 E~~~gg~L~~~l~--~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~-  169 (476)
T 2y94_A           96 EYVSGGELFDYIC--KNGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-  169 (476)
T ss_dssp             ECCSSEEHHHHTT--SSSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCTT-
T ss_pred             eCCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhcccc-
Confidence            9999999999997  4567999999999999999999999988   999999999999999999999999999876532 


Q ss_pred             CcccccccccccccccccccccCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccce
Q 002010          849 ASECMSSVAGSYGYIAPEYAYTLKV-DEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLA  927 (982)
Q Consensus       849 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  927 (982)
                        .......||+.|+|||++.+..+ +.++||||+||++|||++|+.||...........+ .....             
T Consensus       170 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i-~~~~~-------------  233 (476)
T 2y94_A          170 --EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKI-CDGIF-------------  233 (476)
T ss_dssp             --CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHH-HTTCC-------------
T ss_pred             --ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHH-hcCCc-------------
Confidence              22345679999999999988776 68999999999999999999999764332222222 11110             


Q ss_pred             eecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          928 VVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       928 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                             ..+...+..+.+++.+||+.||++|||++|+++
T Consensus       234 -------~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~  266 (476)
T 2y94_A          234 -------YTPQYLNPSVISLLKHMLQVDPMKRATIKDIRE  266 (476)
T ss_dssp             -------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             -------CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence                   112223347889999999999999999999987

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.3e-38  Score=362.63  Aligned_cols=276  Identities=21%  Similarity=0.256  Sum_probs=216.9

Q ss_pred             hhcccccccccccceEEEEEEeC-CCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCC--ccEEEE
Q 002010          692 ESLKDENIIGKGGAGIVYRGSMP-DGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRD--TNLLLY  768 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~lv~  768 (982)
                      ++|+..+.||+|+||.||+|... +++.||||++...........+.+|+.++++++||||+++++++....  ..++||
T Consensus         9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~   88 (396)
T 4eut_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM   88 (396)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence            57899999999999999999764 589999999965544555677889999999999999999999998765  669999


Q ss_pred             eccCCCCHHHHhhcCCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEE----cCCCCEEEeccccchh
Q 002010          769 EYMPNGSLGEMLHGAKG-GHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILL----DSDFEAHVADFGLAKF  843 (982)
Q Consensus       769 e~~~~~sL~~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill----~~~~~~kl~DfG~a~~  843 (982)
                      ||+++++|.+++..... ..+++..++.++.||+.|++|||+.+   |+||||||+||++    +.++.+||+|||+++.
T Consensus        89 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~  165 (396)
T 4eut_A           89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE  165 (396)
T ss_dssp             CCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCEE
T ss_pred             ecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCceE
Confidence            99999999999975332 34999999999999999999999998   9999999999999    7778899999999987


Q ss_pred             ccccCCccccccccccccccccccccc--------CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccC
Q 002010          844 LQDAGASECMSSVAGSYGYIAPEYAYT--------LKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSE  915 (982)
Q Consensus       844 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  915 (982)
                      ....   .......||+.|+|||++.+        ..++.++||||+||++|||++|+.||...................
T Consensus       166 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~  242 (396)
T 4eut_A          166 LEDD---EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG  242 (396)
T ss_dssp             CCCG---GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHS
T ss_pred             ccCC---CccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcC
Confidence            6532   22345679999999998865        567889999999999999999999997654433333333222221


Q ss_pred             CCCCCcccccc------eeecCCC---CCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCC
Q 002010          916 VSQPSDAASVL------AVVDPRL---SGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQ  974 (982)
Q Consensus       916 ~~~~~~~~~~~------~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~~  974 (982)
                      .+... .....      -.+.+..   ...+...+..+.+++.+||+.||++|||++|+++.++.+..
T Consensus       243 ~p~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~  309 (396)
T 4eut_A          243 KPSGA-ISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH  309 (396)
T ss_dssp             CCTTC-CEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHT
T ss_pred             CCccc-chhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhh
Confidence            11100 00000      0111122   14557778889999999999999999999999998876554

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.5e-38  Score=346.39  Aligned_cols=259  Identities=28%  Similarity=0.401  Sum_probs=208.8

Q ss_pred             hcccccccccccceEEEEEEeC-C---CcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCcc-EEE
Q 002010          693 SLKDENIIGKGGAGIVYRGSMP-D---GIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTN-LLL  767 (982)
Q Consensus       693 ~~~~~~~lg~G~~g~Vy~~~~~-~---~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~-~lv  767 (982)
                      .|+..+.||+|+||.||+|... +   +..||+|.+.........+.+.+|+.++++++||||+++++++.+.+.. ++|
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  101 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL  101 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence            4667789999999999999642 2   2379999986544444556789999999999999999999999876665 999


Q ss_pred             EeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhcccc
Q 002010          768 YEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDA  847 (982)
Q Consensus       768 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  847 (982)
                      |||+.+++|.+++.. ....+++..+..++.|++.|++|||+.+   |+||||||+||+++.++.+||+|||+++...+.
T Consensus       102 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~  177 (298)
T 3pls_A          102 LPYMCHGDLLQFIRS-PQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILDR  177 (298)
T ss_dssp             ECCCTTCBHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTTG
T ss_pred             EecccCCCHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccCC
Confidence            999999999999974 3467899999999999999999999998   999999999999999999999999999866433


Q ss_pred             C--CcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCccccc
Q 002010          848 G--ASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASV  925 (982)
Q Consensus       848 ~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  925 (982)
                      .  .........+++.|+|||.+.+..++.++||||+|+++|+|++|..|+....+.......+......          
T Consensus       178 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~----------  247 (298)
T 3pls_A          178 EYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRL----------  247 (298)
T ss_dssp             GGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCC----------
T ss_pred             cccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCC----------
Confidence            2  1122334567889999999999999999999999999999999666654444444444444332211          


Q ss_pred             ceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCC
Q 002010          926 LAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQ  974 (982)
Q Consensus       926 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~~  974 (982)
                               ..+...+..+.+++.+||+.||.+|||++|+++.|+++..
T Consensus       248 ---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~  287 (298)
T 3pls_A          248 ---------PQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVS  287 (298)
T ss_dssp             ---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---------CCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence                     1122334578999999999999999999999999876543

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=2.1e-38  Score=348.64  Aligned_cols=271  Identities=23%  Similarity=0.263  Sum_probs=208.4

Q ss_pred             HHhhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCC----CCchhhHHHHHHHHhcCC---CCcccceEeEEEcC
Q 002010          690 VLESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGT----GGNDHGFLAEIQTLGRIR---HRNIVRLLGYVSNR  761 (982)
Q Consensus       690 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~  761 (982)
                      ..++|+..+.||+|+||+||+|.. .+++.||+|++.....    ......+.+|+.++++++   ||||+++++++...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            356899999999999999999975 5689999999854322    222346778888877775   99999999998775


Q ss_pred             C-----ccEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEe
Q 002010          762 D-----TNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVA  836 (982)
Q Consensus       762 ~-----~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~  836 (982)
                      .     ..++||||++ ++|.+++.......+++..+..++.||+.|++|||+.+   |+||||||+||+++.++.+||+
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~  162 (308)
T 3g33_A           87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLA  162 (308)
T ss_dssp             CSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEEC
T ss_pred             CCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEEe
Confidence            5     4789999996 69999998766666999999999999999999999998   9999999999999999999999


Q ss_pred             ccccchhccccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCC
Q 002010          837 DFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEV  916 (982)
Q Consensus       837 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  916 (982)
                      |||+++.....   .......||+.|+|||++.+..++.++||||+||++|||++|++||....................
T Consensus       163 Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~  239 (308)
T 3g33_A          163 DFGLARIYSYQ---MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPP  239 (308)
T ss_dssp             SCSCTTTSTTC---CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             eCccccccCCC---cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            99999876532   223456789999999999999999999999999999999999999987655444444444333221


Q ss_pred             CCCCcccc--cceeecCCCC----CCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          917 SQPSDAAS--VLAVVDPRLS----GYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       917 ~~~~~~~~--~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                      ........  ....+.+..+    ......+..+.+++.+||+.||++|||++|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  296 (308)
T 3g33_A          240 EDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ  296 (308)
T ss_dssp             TTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence            11110000  0000100000    112234567899999999999999999999986

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=1.4e-38  Score=348.28  Aligned_cols=260  Identities=28%  Similarity=0.412  Sum_probs=206.3

Q ss_pred             hhcccccccccccceEEEEEEeCC----CcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEE-cCCccEE
Q 002010          692 ESLKDENIIGKGGAGIVYRGSMPD----GIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVS-NRDTNLL  766 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-~~~~~~l  766 (982)
                      ..|+..+.||+|+||.||+|...+    ...||+|.+.........+.+.+|+.++++++||||+++++++. .+...++
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  104 (298)
T 3f66_A           25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV  104 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred             eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence            468888999999999999997532    33589998865444445567899999999999999999999864 4567899


Q ss_pred             EEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccc
Q 002010          767 LYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQD  846 (982)
Q Consensus       767 v~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  846 (982)
                      ||||+++++|.+++.. ....+++..+..++.|++.|++|||+.+   |+||||||+||+++.++.+||+|||+++....
T Consensus       105 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~  180 (298)
T 3f66_A          105 VLPYMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYD  180 (298)
T ss_dssp             EEECCTTCBHHHHHHC-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred             EEeCCCCCCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECcccccccccc
Confidence            9999999999999974 3467899999999999999999999998   99999999999999999999999999987653


Q ss_pred             cCC--cccccccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHhccCCCCCCccc
Q 002010          847 AGA--SECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAA  923 (982)
Q Consensus       847 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  923 (982)
                      ...  ........+|+.|+|||.+.+..++.++||||+|+++|||++ |.+||....... ....+.....         
T Consensus       181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~-~~~~~~~~~~---------  250 (298)
T 3f66_A          181 KEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-ITVYLLQGRR---------  250 (298)
T ss_dssp             GGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT-HHHHHHTTCC---------
T ss_pred             cchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH-HHHHHhcCCC---------
Confidence            321  122334567889999999999999999999999999999999 566665543333 2222222111         


Q ss_pred             ccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCCC
Q 002010          924 SVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQS  975 (982)
Q Consensus       924 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~~~  975 (982)
                                ...+...+..+.+++.+||+.||++|||++|+++.|+++...
T Consensus       251 ----------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~  292 (298)
T 3f66_A          251 ----------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST  292 (298)
T ss_dssp             ----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             ----------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence                      011222345789999999999999999999999999876543

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=1.3e-38  Score=361.25  Aligned_cols=253  Identities=22%  Similarity=0.243  Sum_probs=206.3

Q ss_pred             HhhcccccccccccceEEEEEEeC-CCcEEEEEEeccCC--CCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEE
Q 002010          691 LESLKDENIIGKGGAGIVYRGSMP-DGIDVAIKRLVGRG--TGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLL  767 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  767 (982)
                      .++|+..+.||+|+||.||+|+.. +++.||+|++....  .......+.+|+.+++.++||||+++++++.+++..|+|
T Consensus        68 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV  147 (410)
T 3v8s_A           68 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMV  147 (410)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence            467999999999999999999764 58899999985421  223345688999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhcccc
Q 002010          768 YEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDA  847 (982)
Q Consensus       768 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  847 (982)
                      |||+++|+|.+++..   ..+++..+..++.||+.|++|||+.+   |+||||||+||+++.++.+||+|||+|+.....
T Consensus       148 ~E~~~gg~L~~~l~~---~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~  221 (410)
T 3v8s_A          148 MEYMPGGDLVNLMSN---YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE  221 (410)
T ss_dssp             ECCCTTEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             EeCCCCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccceeEeeccC
Confidence            999999999999964   36899999999999999999999998   999999999999999999999999999876533


Q ss_pred             CCcccccccccccccccccccccCC----CCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCccc
Q 002010          848 GASECMSSVAGSYGYIAPEYAYTLK----VDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAA  923 (982)
Q Consensus       848 ~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  923 (982)
                      . .......+||+.|+|||++.+..    ++.++||||+||++|||++|+.||...........+...... ...+.   
T Consensus       222 ~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~-~~~p~---  296 (410)
T 3v8s_A          222 G-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNS-LTFPD---  296 (410)
T ss_dssp             S-EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH-CCCCT---
T ss_pred             C-cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhcccc-ccCCC---
Confidence            2 22334678999999999998665    889999999999999999999999865433333333222111 11110   


Q ss_pred             ccceeecCCCCCCChHhHHHHHHHHhhccCCCCCC--CCCHHHHHH
Q 002010          924 SVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSA--RPTMREVVH  967 (982)
Q Consensus       924 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--Rpt~~ell~  967 (982)
                                   ....+..+.+++.+||+.+|.+  ||+++||++
T Consensus       297 -------------~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~  329 (410)
T 3v8s_A          297 -------------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKR  329 (410)
T ss_dssp             -------------TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred             -------------cccccHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence                         0122347889999999999998  999999987

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=7.1e-39  Score=378.23  Aligned_cols=258  Identities=30%  Similarity=0.455  Sum_probs=213.5

Q ss_pred             hhcccccccccccceEEEEEEeCCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEecc
Q 002010          692 ESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYM  771 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  771 (982)
                      ++|+..+.||+|+||.||+|.+.++..||||++....  ...+.+.+|+.++++++||||+++++++.+ +..++||||+
T Consensus       267 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~  343 (535)
T 2h8h_A          267 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM  343 (535)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred             hhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC--CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehh
Confidence            5688889999999999999998888889999985432  345679999999999999999999999876 6789999999


Q ss_pred             CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCcc
Q 002010          772 PNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASE  851 (982)
Q Consensus       772 ~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~  851 (982)
                      ++|+|.+++.......+++.++..++.||+.||+|||+++   |+||||||+||++++++.+||+|||+++...... ..
T Consensus       344 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-~~  419 (535)
T 2h8h_A          344 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YT  419 (535)
T ss_dssp             TTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH-HH
T ss_pred             cCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCCc-ee
Confidence            9999999997544456899999999999999999999998   9999999999999999999999999998765321 11


Q ss_pred             cccccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceeec
Q 002010          852 CMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVD  930 (982)
Q Consensus       852 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  930 (982)
                      ......++..|+|||++.+..++.++|||||||++|||++ |+.||...... .....+.....                
T Consensus       420 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~-~~~~~i~~~~~----------------  482 (535)
T 2h8h_A          420 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-EVLDQVERGYR----------------  482 (535)
T ss_dssp             TTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH-HHHHHHHTTCC----------------
T ss_pred             cccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHHHcCCC----------------
Confidence            2233456789999999998899999999999999999999 99999764332 22222221111                


Q ss_pred             CCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCCCC
Q 002010          931 PRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQSA  976 (982)
Q Consensus       931 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~~~~  976 (982)
                         ...+..++..+.++|.+||+.||++|||+++|++.|+.+....
T Consensus       483 ---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~  525 (535)
T 2h8h_A          483 ---MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST  525 (535)
T ss_dssp             ---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCC
T ss_pred             ---CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhcc
Confidence               0123344567899999999999999999999999999886644

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=4.6e-38  Score=347.94  Aligned_cols=255  Identities=22%  Similarity=0.295  Sum_probs=209.0

Q ss_pred             HHHHhhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCCC-----chhhHHHHHHHHhcCCCCcccceEeEEEcC
Q 002010          688 EDVLESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGG-----NDHGFLAEIQTLGRIRHRNIVRLLGYVSNR  761 (982)
Q Consensus       688 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  761 (982)
                      ..+.+.|+..+.||+|+||.||+|.. .+|+.||+|.+.......     ....+.+|+.++++++||||+++++++.+.
T Consensus         8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   87 (321)
T 2a2a_A            8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENR   87 (321)
T ss_dssp             SCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             hhhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence            34567899999999999999999976 468999999986543322     356789999999999999999999999999


Q ss_pred             CccEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCC----CEEEec
Q 002010          762 DTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDF----EAHVAD  837 (982)
Q Consensus       762 ~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~----~~kl~D  837 (982)
                      ...++||||+++++|.+++.  +...+++..+..++.|++.|++|||+.+   |+||||||+||+++.++    .+||+|
T Consensus        88 ~~~~lv~e~~~~~~L~~~l~--~~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~D  162 (321)
T 2a2a_A           88 TDVVLILELVSGGELFDFLA--QKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLID  162 (321)
T ss_dssp             SEEEEEECCCCSCBHHHHHH--TCSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECC
T ss_pred             CEEEEEEEcCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEcc
Confidence            99999999999999999997  3467899999999999999999999998   99999999999999887    799999


Q ss_pred             cccchhccccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCC
Q 002010          838 FGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVS  917 (982)
Q Consensus       838 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  917 (982)
                      ||++......   .......||+.|+|||++.+..++.++||||+|+++|+|++|+.||........... +.....  .
T Consensus       163 fg~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~-i~~~~~--~  236 (321)
T 2a2a_A          163 FGLAHEIEDG---VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLAN-ITSVSY--D  236 (321)
T ss_dssp             CTTCEECCTT---CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHH-HHTTCC--C
T ss_pred             CccceecCcc---ccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHH-HHhccc--c
Confidence            9999876532   223456789999999999999999999999999999999999999976433222211 111110  0


Q ss_pred             CCCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          918 QPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       918 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                      .+              ...+...+..+.+++.+||+.||++|||++|+++
T Consensus       237 ~~--------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~  272 (321)
T 2a2a_A          237 FD--------------EEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR  272 (321)
T ss_dssp             CC--------------HHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred             cC--------------hhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            00              0001123356889999999999999999999987

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=8e-39  Score=352.89  Aligned_cols=265  Identities=24%  Similarity=0.355  Sum_probs=200.9

Q ss_pred             HhhcccccccccccceEEEEEEeC----CCcEEEEEEeccCCC-CCchhhHHHHHHHHhcCCCCcccceEeEEEcCCc--
Q 002010          691 LESLKDENIIGKGGAGIVYRGSMP----DGIDVAIKRLVGRGT-GGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDT--  763 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~--  763 (982)
                      .++|+..+.||+|+||.||+|...    ++..||+|++..... ....+.+.+|+.++++++||||+++++++.+...  
T Consensus        33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  112 (313)
T 3brb_A           33 RNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQG  112 (313)
T ss_dssp             GGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-----
T ss_pred             HHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccC
Confidence            367899999999999999999653    345899999854432 2234568899999999999999999999887553  


Q ss_pred             ---cEEEEeccCCCCHHHHhhc----CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEe
Q 002010          764 ---NLLLYEYMPNGSLGEMLHG----AKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVA  836 (982)
Q Consensus       764 ---~~lv~e~~~~~sL~~~l~~----~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~  836 (982)
                         .++||||+++++|.+++..    .....+++..++.++.|++.|++|||+.+   |+||||||+||+++.++.+||+
T Consensus       113 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kl~  189 (313)
T 3brb_A          113 IPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTVCVA  189 (313)
T ss_dssp             --CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSCEEEC
T ss_pred             CcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEEe
Confidence               4999999999999999853    23467999999999999999999999988   9999999999999999999999


Q ss_pred             ccccchhccccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHhccC
Q 002010          837 DFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSE  915 (982)
Q Consensus       837 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  915 (982)
                      |||++................+++.|+|||.+.+..++.++||||+|+++|||++ |..||........ ...+..... 
T Consensus       190 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~-~~~~~~~~~-  267 (313)
T 3brb_A          190 DFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEM-YDYLLHGHR-  267 (313)
T ss_dssp             SCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH-HHHHHTTCC-
T ss_pred             ecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHH-HHHHHcCCC-
Confidence            9999987654433333344567889999999999999999999999999999999 8899976543332 222221111 


Q ss_pred             CCCCCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCCCCCC
Q 002010          916 VSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQSAPS  978 (982)
Q Consensus       916 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~~~~~~  978 (982)
                                        ...+...+..+.+++.+||+.||.+|||++|+++.|+++.+..|+
T Consensus       268 ------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp~  312 (313)
T 3brb_A          268 ------------------LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLPD  312 (313)
T ss_dssp             ------------------CCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC--
T ss_pred             ------------------CCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCC
Confidence                              112233445789999999999999999999999999887665553

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=2.1e-38  Score=352.14  Aligned_cols=258  Identities=17%  Similarity=0.197  Sum_probs=208.0

Q ss_pred             hhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcC-CCCcccceEeEEEcCCccEEEEe
Q 002010          692 ESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRI-RHRNIVRLLGYVSNRDTNLLLYE  769 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e  769 (982)
                      ++|+..+.||+|+||.||+|.. .+++.||||++....   ....+.+|+.+++++ +||||+++++++...+..++|||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e   85 (330)
T 2izr_A            9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS---RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE   85 (330)
T ss_dssp             TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC---SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred             CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc---chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence            5788999999999999999975 678999999885432   234688999999999 99999999999999999999999


Q ss_pred             ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCC-----EEEeccccchhc
Q 002010          770 YMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFE-----AHVADFGLAKFL  844 (982)
Q Consensus       770 ~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~-----~kl~DfG~a~~~  844 (982)
                      |+ +++|.+++... ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.     +||+|||+++.+
T Consensus        86 ~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~  160 (330)
T 2izr_A           86 LL-GPSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY  160 (330)
T ss_dssp             CC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred             eC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence            99 99999999753 468999999999999999999999998   999999999999998887     999999999876


Q ss_pred             cccCCcc-----cccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhcc-CCCC
Q 002010          845 QDAGASE-----CMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTS-EVSQ  918 (982)
Q Consensus       845 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~-~~~~  918 (982)
                      .......     ......||+.|+|||++.+..++.++||||+||++|||++|+.||........ ......... ....
T Consensus       161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~-~~~~~~i~~~~~~~  239 (330)
T 2izr_A          161 IDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTL-KERYQKIGDTKRAT  239 (330)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSH-HHHHHHHHHHHHHS
T ss_pred             ecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccH-HHHHHHHHhhhccC
Confidence            5432211     22456799999999999999999999999999999999999999987543322 111111110 0000


Q ss_pred             CCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 002010          919 PSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANP  972 (982)
Q Consensus       919 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~  972 (982)
                      +             ........+ .+.+++.+||+.||.+||++++|++.|+++
T Consensus       240 ~-------------~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~  279 (330)
T 2izr_A          240 P-------------IEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDL  279 (330)
T ss_dssp             C-------------HHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred             C-------------HHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHH
Confidence            0             000011233 799999999999999999999999988643

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=7.5e-39  Score=348.86  Aligned_cols=253  Identities=20%  Similarity=0.333  Sum_probs=202.7

Q ss_pred             hhcccccccccccceEEEEEEeCC-C-------cEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCc
Q 002010          692 ESLKDENIIGKGGAGIVYRGSMPD-G-------IDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDT  763 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~~~-~-------~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  763 (982)
                      ++|+..+.||+|+||.||+|.... +       ..||+|++... .....+.+.+|+.++++++||||+++++++.+++.
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (289)
T 4fvq_A            8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA-HRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE   86 (289)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGG-GGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred             hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccc-cHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence            578899999999999999996532 3       47999988432 33455678999999999999999999999999999


Q ss_pred             cEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCC--------EEE
Q 002010          764 NLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFE--------AHV  835 (982)
Q Consensus       764 ~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~--------~kl  835 (982)
                      .++||||+++++|.+++... ...+++..+..++.|++.|++|||+.+   |+||||||+||+++.++.        +||
T Consensus        87 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~kl  162 (289)
T 4fvq_A           87 NILVQEFVKFGSLDTYLKKN-KNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKL  162 (289)
T ss_dssp             CEEEEECCTTCBHHHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEEE
T ss_pred             CEEEEECCCCCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceeee
Confidence            99999999999999999743 344899999999999999999999998   999999999999998887        999


Q ss_pred             eccccchhccccCCccccccccccccccccccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhcc
Q 002010          836 ADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTS  914 (982)
Q Consensus       836 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  914 (982)
                      +|||.+......      ....+++.|+|||++.+ ..++.++||||+|+++|||++|..|+....+.............
T Consensus       163 ~Dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~  236 (289)
T 4fvq_A          163 SDPGISITVLPK------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQ  236 (289)
T ss_dssp             CCCCSCTTTSCH------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCC
T ss_pred             ccCcccccccCc------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhccCC
Confidence            999999755321      23457889999999987 67999999999999999999965554433332222222221111


Q ss_pred             CCCCCCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCCCC
Q 002010          915 EVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQSA  976 (982)
Q Consensus       915 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~~~~  976 (982)
                         .                  +...+..+.+++.+||+.||++|||++|+++.|+++..+.
T Consensus       237 ---~------------------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~  277 (289)
T 4fvq_A          237 ---L------------------PAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPD  277 (289)
T ss_dssp             ---C------------------CCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC---
T ss_pred             ---C------------------CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence               0                  1111225789999999999999999999999999987754

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=9.8e-39  Score=358.58  Aligned_cols=246  Identities=23%  Similarity=0.257  Sum_probs=194.1

Q ss_pred             HhhcccccccccccceEEEEEEeC-CCcEEEEEEeccCCC--CCchhhHHHHHHH-HhcCCCCcccceEeEEEcCCccEE
Q 002010          691 LESLKDENIIGKGGAGIVYRGSMP-DGIDVAIKRLVGRGT--GGNDHGFLAEIQT-LGRIRHRNIVRLLGYVSNRDTNLL  766 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~-l~~l~h~niv~~~~~~~~~~~~~l  766 (982)
                      .++|+..+.||+|+||.||+|+.+ +++.||+|++.....  ......+.+|..+ ++.++||||+++++++.+.+..|+
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l  116 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF  116 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence            357899999999999999999764 588999999865432  2334456677776 567899999999999999999999


Q ss_pred             EEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccc
Q 002010          767 LYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQD  846 (982)
Q Consensus       767 v~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  846 (982)
                      ||||+++|+|.+++..  ...+++..+..++.||+.||+|||+.+   |+||||||+||+++.++.+||+|||+++....
T Consensus       117 v~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~~  191 (373)
T 2r5t_A          117 VLDYINGGELFYHLQR--ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIE  191 (373)
T ss_dssp             EEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGBC
T ss_pred             EEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCcccccccc
Confidence            9999999999999973  457899999999999999999999998   99999999999999999999999999986432


Q ss_pred             cCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccc
Q 002010          847 AGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVL  926 (982)
Q Consensus       847 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  926 (982)
                      .  .......+||+.|+|||++.+..++.++||||+||++|||++|..||...........+.....             
T Consensus       192 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~-------------  256 (373)
T 2r5t_A          192 H--NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPL-------------  256 (373)
T ss_dssp             C--CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCC-------------
T ss_pred             C--CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccc-------------
Confidence            2  2234567899999999999999999999999999999999999999976433222222221110             


Q ss_pred             eeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHH
Q 002010          927 AVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMRE  964 (982)
Q Consensus       927 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~e  964 (982)
                              .++...+..+.+++.+||+.||.+||++.+
T Consensus       257 --------~~~~~~~~~~~~li~~lL~~dp~~R~~~~~  286 (373)
T 2r5t_A          257 --------QLKPNITNSARHLLEGLLQKDRTKRLGAKD  286 (373)
T ss_dssp             --------CCCSSSCHHHHHHHHHHTCSSGGGSTTTTT
T ss_pred             --------CCCCCCCHHHHHHHHHHcccCHHhCCCCCC
Confidence                    112223347889999999999999999853

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=4.8e-38  Score=340.19  Aligned_cols=252  Identities=23%  Similarity=0.269  Sum_probs=206.2

Q ss_pred             HHHhhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEE
Q 002010          689 DVLESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLL  767 (982)
Q Consensus       689 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  767 (982)
                      ++.++|+..+.||+|+||.||+|.. .++..||+|++.... ....+.+.+|+.++++++||||+++++++.+....++|
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (277)
T 3f3z_A            6 DINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYF-VEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLV   84 (277)
T ss_dssp             CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGG-CSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhc-cchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEE
Confidence            4567899999999999999999975 457789999985443 34567889999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEE---cCCCCEEEeccccchhc
Q 002010          768 YEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILL---DSDFEAHVADFGLAKFL  844 (982)
Q Consensus       768 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill---~~~~~~kl~DfG~a~~~  844 (982)
                      |||+++++|.+++..  ...+++..+..++.|++.|++|||+.+   |+||||||+||++   +.++.+||+|||++..+
T Consensus        85 ~e~~~~~~L~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~  159 (277)
T 3f3z_A           85 MELCTGGELFERVVH--KRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF  159 (277)
T ss_dssp             EECCCSCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred             EeccCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceec
Confidence            999999999999873  456899999999999999999999998   9999999999999   78899999999999876


Q ss_pred             cccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccc
Q 002010          845 QDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAAS  924 (982)
Q Consensus       845 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  924 (982)
                      ...   .......||+.|+|||++.+. ++.++||||+|+++|||++|+.||...........+. .....  .+.    
T Consensus       160 ~~~---~~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~-~~~~~--~~~----  228 (277)
T 3f3z_A          160 KPG---KMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIR-EGTFT--FPE----  228 (277)
T ss_dssp             CTT---SCBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-HCCCC--CCH----
T ss_pred             cCc---cchhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHH-hCCCC--CCc----
Confidence            533   233456789999999988764 8999999999999999999999997654332222221 11110  000    


Q ss_pred             cceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          925 VLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       925 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                                ......+..+.+++.+||+.||++|||+.|+++
T Consensus       229 ----------~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  261 (277)
T 3f3z_A          229 ----------KDWLNVSPQAESLIRRLLTKSPKQRITSLQALE  261 (277)
T ss_dssp             ----------HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             ----------hhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                      000123457889999999999999999999985

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=3.3e-38  Score=368.66  Aligned_cols=253  Identities=24%  Similarity=0.306  Sum_probs=209.4

Q ss_pred             hhcccccccccccceEEEEEEe-CCCcEEEEEEeccCC--CCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEE
Q 002010          692 ESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRG--TGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLY  768 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  768 (982)
                      ++|+..+.||+|+||.||+|+. .+|+.||+|++....  .......+.+|+.++++++||||+++++++.+.+..++||
T Consensus       184 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm  263 (576)
T 2acx_A          184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVL  263 (576)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEE
Confidence            5688999999999999999976 469999999985432  2334566889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccC
Q 002010          769 EYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAG  848 (982)
Q Consensus       769 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  848 (982)
                      ||++||+|.+++.......+++..+..++.||+.||+|||+.+   |+||||||+||+++.++.+||+|||++..+... 
T Consensus       264 Ey~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~~~-  339 (576)
T 2acx_A          264 TLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEG-  339 (576)
T ss_dssp             CCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCTT-
T ss_pred             EcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceecccC-
Confidence            9999999999998655566999999999999999999999998   999999999999999999999999999876532 


Q ss_pred             CcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCccccccee
Q 002010          849 ASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAV  928 (982)
Q Consensus       849 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  928 (982)
                        .......||+.|+|||++.+..++.++||||+||++|||++|+.||....................            
T Consensus       340 --~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~------------  405 (576)
T 2acx_A          340 --QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVP------------  405 (576)
T ss_dssp             --CCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCC------------
T ss_pred             --ccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhccc------------
Confidence              223446899999999999999999999999999999999999999987543222222221111100            


Q ss_pred             ecCCCCCCChHhHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 002010          929 VDPRLSGYPLTGVIHLFKVAMMCVEDESSARP-----TMREVVH  967 (982)
Q Consensus       929 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~ell~  967 (982)
                           ..++...+..+.+++.+||+.||.+||     +++|+++
T Consensus       406 -----~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~  444 (576)
T 2acx_A          406 -----EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE  444 (576)
T ss_dssp             -----CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred             -----ccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence                 012223345789999999999999999     7888875

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.7e-38  Score=348.41  Aligned_cols=270  Identities=22%  Similarity=0.296  Sum_probs=201.8

Q ss_pred             HhhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCCC-chhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEE
Q 002010          691 LESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGG-NDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLY  768 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  768 (982)
                      .++|+..+.||+|+||.||+|.. .+|+.||+|++....... ..+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (311)
T 4agu_A            2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF   81 (311)
T ss_dssp             -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence            46799999999999999999976 458999999885443322 2456789999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccC
Q 002010          769 EYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAG  848 (982)
Q Consensus       769 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  848 (982)
                      ||+++++|.+++.  ....+++..+..++.|++.|++|||+.+   |+||||||+||+++.++.+||+|||.+...... 
T Consensus        82 e~~~~~~l~~~~~--~~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-  155 (311)
T 4agu_A           82 EYCDHTVLHELDR--YQRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGP-  155 (311)
T ss_dssp             ECCSEEHHHHHHH--TSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred             EeCCCchHHHHHh--hhcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCc-
Confidence            9999999999886  3467999999999999999999999998   999999999999999999999999999876532 


Q ss_pred             Cccccccccccccccccccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCC------Cc
Q 002010          849 ASECMSSVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQP------SD  921 (982)
Q Consensus       849 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~------~~  921 (982)
                       ........||+.|+|||++.+ ..++.++||||+|+++|+|++|+.||....................+..      ..
T Consensus       156 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (311)
T 4agu_A          156 -SDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQ  234 (311)
T ss_dssp             -----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCG
T ss_pred             -ccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccc
Confidence             222345678999999999876 6689999999999999999999999987544333333222211100000      00


Q ss_pred             ccccceeecCCCC-C---CChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          922 AASVLAVVDPRLS-G---YPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       922 ~~~~~~~~~~~~~-~---~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                      ........++... .   .....+..+.+++.+||+.||++|||++|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  284 (311)
T 4agu_A          235 YFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH  284 (311)
T ss_dssp             GGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred             ccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            0000000000000 0   01234456889999999999999999999986

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=1.6e-38  Score=352.66  Aligned_cols=260  Identities=24%  Similarity=0.380  Sum_probs=207.9

Q ss_pred             HhhcccccccccccceEEEEEEe------CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCcc
Q 002010          691 LESLKDENIIGKGGAGIVYRGSM------PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTN  764 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  764 (982)
                      .++|+..+.||+|+||.||+|..      .+++.||||++...........+.+|+.++++++||||+++++++......
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  108 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  108 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence            36799999999999999999973      357789999986554445566789999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHhhcCCC-----CCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcC---CCCEEEe
Q 002010          765 LLLYEYMPNGSLGEMLHGAKG-----GHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDS---DFEAHVA  836 (982)
Q Consensus       765 ~lv~e~~~~~sL~~~l~~~~~-----~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~---~~~~kl~  836 (982)
                      ++||||+++++|.+++.....     ..+++..++.++.|++.|++|||+.+   |+||||||+||+++.   +..+||+
T Consensus       109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl~  185 (327)
T 2yfx_A          109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG  185 (327)
T ss_dssp             EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEEC
Confidence            999999999999999975432     45899999999999999999999998   999999999999984   4569999


Q ss_pred             ccccchhccccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHhccC
Q 002010          837 DFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSE  915 (982)
Q Consensus       837 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  915 (982)
                      |||++................+++.|+|||++.+..++.++||||+|+++|||++ |..||..... ......+..... 
T Consensus       186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-~~~~~~~~~~~~-  263 (327)
T 2yfx_A          186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN-QEVLEFVTSGGR-  263 (327)
T ss_dssp             CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-HHHHHHHHTTCC-
T ss_pred             ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH-HHHHHHHhcCCC-
Confidence            9999987654433333445667899999999998899999999999999999998 9999976432 222222222111 


Q ss_pred             CCCCCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 002010          916 VSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPP  973 (982)
Q Consensus       916 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~  973 (982)
                                        ...+...+..+.+++.+||+.||.+|||++|+++.|+.+.
T Consensus       264 ------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~  303 (327)
T 2yfx_A          264 ------------------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT  303 (327)
T ss_dssp             ------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ------------------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence                              1112234457899999999999999999999999886543

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3.7e-38  Score=352.75  Aligned_cols=268  Identities=22%  Similarity=0.228  Sum_probs=208.5

Q ss_pred             HHHHHhhcccccccccccceEEEEEEe-CCCcEEEEEEeccC----CCCCchhhHHHHHHHHhcCCCCcccceEeEEEcC
Q 002010          687 AEDVLESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGR----GTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNR  761 (982)
Q Consensus       687 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  761 (982)
                      ..++.++|+..+.||+|+||.||+|.. .+++.||+|++...    ......+.+.+|+.++++++||||+++++++.+.
T Consensus        21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  100 (345)
T 3hko_A           21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE  100 (345)
T ss_dssp             HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence            456778999999999999999999965 56889999998543    1344567889999999999999999999999999


Q ss_pred             CccEEEEeccCCCCHHHHhhcCC--------------------------------------CCCCCHHHHHHHHHHHHHH
Q 002010          762 DTNLLLYEYMPNGSLGEMLHGAK--------------------------------------GGHLKWETRYRIALEAAKG  803 (982)
Q Consensus       762 ~~~~lv~e~~~~~sL~~~l~~~~--------------------------------------~~~l~~~~~~~i~~~i~~~  803 (982)
                      +..++||||+++|+|.+++....                                      ...+++..++.++.||+.|
T Consensus       101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~  180 (345)
T 3hko_A          101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA  180 (345)
T ss_dssp             SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred             CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence            99999999999999999985210                                      1123577888999999999


Q ss_pred             HHHHhhcCCCcEEecCCCCCcEEEcCCC--CEEEeccccchhccccCC--ccccccccccccccccccccc--CCCCcch
Q 002010          804 LCYLHHDCSPLIIHRDVKSNNILLDSDF--EAHVADFGLAKFLQDAGA--SECMSSVAGSYGYIAPEYAYT--LKVDEKS  877 (982)
Q Consensus       804 l~~LH~~~~~~ivHrDlkp~Nill~~~~--~~kl~DfG~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~--~~~~~~~  877 (982)
                      ++|||+.+   |+||||||+||+++.++  .+||+|||++..+.....  ........||+.|+|||++.+  ..++.++
T Consensus       181 l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~  257 (345)
T 3hko_A          181 LHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC  257 (345)
T ss_dssp             HHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred             HHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence            99999998   99999999999998776  899999999986643221  122345679999999999875  6789999


Q ss_pred             hhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCC
Q 002010          878 DVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESS  957 (982)
Q Consensus       878 DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~  957 (982)
                      ||||+|+++|||++|+.||.................. ...+                .....+..+.+++.+||+.||.
T Consensus       258 DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~----------------~~~~~~~~~~~li~~~l~~~p~  320 (345)
T 3hko_A          258 DAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLC-FENP----------------NYNVLSPLARDLLSNLLNRNVD  320 (345)
T ss_dssp             HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC-TTSG----------------GGGGSCHHHHHHHHHHSCSCTT
T ss_pred             HHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccc-cCCc----------------ccccCCHHHHHHHHHHcCCChh
Confidence            9999999999999999999865444333333222111 0000                0112345788999999999999


Q ss_pred             CCCCHHHHHH--HhcCCCC
Q 002010          958 ARPTMREVVH--MLANPPQ  974 (982)
Q Consensus       958 ~Rpt~~ell~--~L~~~~~  974 (982)
                      +|||++|+++  .++...+
T Consensus       321 ~Rps~~~~l~hp~~~~~~~  339 (345)
T 3hko_A          321 ERFDAMRALQHPWISQFSD  339 (345)
T ss_dssp             TSCCHHHHHHSHHHHTTSS
T ss_pred             HCCCHHHHhcChhhccChH
Confidence            9999999987  4555443

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=8.6e-39  Score=360.23  Aligned_cols=267  Identities=14%  Similarity=0.213  Sum_probs=204.3

Q ss_pred             HhhcccccccccccceEEEEEEeCC------CcEEEEEEeccCCCC----------CchhhHHHHHHHHhcCCCCcccce
Q 002010          691 LESLKDENIIGKGGAGIVYRGSMPD------GIDVAIKRLVGRGTG----------GNDHGFLAEIQTLGRIRHRNIVRL  754 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~----------~~~~~~~~E~~~l~~l~h~niv~~  754 (982)
                      .++|++.+.||+|+||.||+|....      ++.||||++......          .....+..|+..+..++||||+++
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~  113 (364)
T 3op5_A           34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY  113 (364)
T ss_dssp             CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred             CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence            3479999999999999999997644      478999998543210          011124456667778889999999


Q ss_pred             EeEEEcC----CccEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEc--
Q 002010          755 LGYVSNR----DTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLD--  828 (982)
Q Consensus       755 ~~~~~~~----~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~--  828 (982)
                      ++++...    ...++||||+ +++|.+++.. ....+++..+..++.||+.||+|||+.+   |+||||||+||+++  
T Consensus       114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~-~~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~~~  188 (364)
T 3op5_A          114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA-NAKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYK  188 (364)
T ss_dssp             EEEEEEEETTEEEEEEEEECE-EEEHHHHHHH-TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEESS
T ss_pred             EeeeeeccCCcceEEEEEeCC-CCCHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEecC
Confidence            9998765    4479999999 9999999974 3467999999999999999999999998   99999999999999  


Q ss_pred             CCCCEEEeccccchhccccCCcc-----cccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCc
Q 002010          829 SDFEAHVADFGLAKFLQDAGASE-----CMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGV  903 (982)
Q Consensus       829 ~~~~~kl~DfG~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~  903 (982)
                      .++.+||+|||+++.+.......     ......||+.|+|||++.+..++.++||||+||++|||++|+.||.......
T Consensus       189 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~  268 (364)
T 3op5_A          189 NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDP  268 (364)
T ss_dssp             CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH
T ss_pred             CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCH
Confidence            88999999999998765432111     1234559999999999999999999999999999999999999998644443


Q ss_pred             hHHHHHHHhccCCCCCCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 002010          904 DIVRWVRKTTSEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANP  972 (982)
Q Consensus       904 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~  972 (982)
                      ...........        ......+++.+.  +...+..+.+++..||+.||++||+++++++.|+.+
T Consensus       269 ~~~~~~~~~~~--------~~~~~~~~~~~~--~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~  327 (364)
T 3op5_A          269 KYVRDSKIRYR--------ENIASLMDKCFP--AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQG  327 (364)
T ss_dssp             HHHHHHHHHHH--------HCHHHHHHHHSC--TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHhh--------hhHHHHHHHhcc--cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Confidence            33333322211        011111111111  122345789999999999999999999999988654

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=2.5e-38  Score=346.40  Aligned_cols=260  Identities=18%  Similarity=0.244  Sum_probs=210.1

Q ss_pred             hhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcC-CCCcccceEeEEEcCCccEEEEe
Q 002010          692 ESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRI-RHRNIVRLLGYVSNRDTNLLLYE  769 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e  769 (982)
                      ++|+..+.||+|+||.||+|.. .+++.||+|++....   ....+.+|+.+++++ +|++++++++++.+....++|||
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e   86 (298)
T 1csn_A           10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS---DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   86 (298)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT---TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             cceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC---ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence            5799999999999999999974 679999999885432   334578999999999 79999999999999999999999


Q ss_pred             ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCC-----EEEeccccchhc
Q 002010          770 YMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFE-----AHVADFGLAKFL  844 (982)
Q Consensus       770 ~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~-----~kl~DfG~a~~~  844 (982)
                      |+ +++|.+++... ...+++..+..++.||+.|++|||+.+   |+||||||+||+++.++.     +||+|||++...
T Consensus        87 ~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~  161 (298)
T 1csn_A           87 LL-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY  161 (298)
T ss_dssp             CC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred             ec-CCCHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECcccccc
Confidence            99 99999999743 356999999999999999999999988   999999999999987776     999999999876


Q ss_pred             cccCCc-----ccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHH--HHHHHhccCCC
Q 002010          845 QDAGAS-----ECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIV--RWVRKTTSEVS  917 (982)
Q Consensus       845 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~--~~~~~~~~~~~  917 (982)
                      ......     .......||+.|+|||++.+..++.++||||+|+++|||++|+.||..........  ..+........
T Consensus       162 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  241 (298)
T 1csn_A          162 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP  241 (298)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC
T ss_pred             ccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCcc
Confidence            543221     22345679999999999999999999999999999999999999998754332211  11111111000


Q ss_pred             CCCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCC
Q 002010          918 QPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQ  974 (982)
Q Consensus       918 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~~  974 (982)
                                     ........+..+.+++.+||+.||++|||+++|++.|+++..
T Consensus       242 ---------------~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~  283 (298)
T 1csn_A          242 ---------------LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE  283 (298)
T ss_dssp             ---------------HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred             ---------------HHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHH
Confidence                           001112334578999999999999999999999999876543

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=1.6e-38  Score=351.15  Aligned_cols=267  Identities=23%  Similarity=0.286  Sum_probs=208.2

Q ss_pred             hhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEE----cCCccEE
Q 002010          692 ESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVS----NRDTNLL  766 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~----~~~~~~l  766 (982)
                      ++|+..+.||+|+||.||+|.. .+++.||+|++... .......+.+|+.++++++||||+++++++.    .....++
T Consensus        29 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l  107 (317)
T 2buj_A           29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH-EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL  107 (317)
T ss_dssp             EEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES-SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred             eEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC-CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence            5789999999999999999975 67999999988543 3344567889999999999999999999986    3446789


Q ss_pred             EEeccCCCCHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhc
Q 002010          767 LYEYMPNGSLGEMLHGA--KGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFL  844 (982)
Q Consensus       767 v~e~~~~~sL~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~  844 (982)
                      ||||+++++|.+++...  ....+++..++.++.|++.|++|||+.+   |+||||||+||+++.++.+||+|||.+...
T Consensus       108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~  184 (317)
T 2buj_A          108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQA  184 (317)
T ss_dssp             EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred             EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence            99999999999998742  3467999999999999999999999998   999999999999999999999999998754


Q ss_pred             cccCCc-------ccccccccccccccccccccCC---CCcchhhHHHHHHHHHHHhCCCCCCCCC-CCchHHHHHHHhc
Q 002010          845 QDAGAS-------ECMSSVAGSYGYIAPEYAYTLK---VDEKSDVYSFGVVLLELIAGKKPVGEFG-DGVDIVRWVRKTT  913 (982)
Q Consensus       845 ~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslG~il~elltg~~p~~~~~-~~~~~~~~~~~~~  913 (982)
                      ......       .......||+.|+|||++.+..   ++.++||||+|+++|||++|+.||.... .............
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~  264 (317)
T 2buj_A          185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQL  264 (317)
T ss_dssp             CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHCC-
T ss_pred             ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhccC
Confidence            321110       0112345799999999987554   7899999999999999999999996411 1111111111100


Q ss_pred             cCCCCCCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCCCCCCCCC
Q 002010          914 SEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQSAPSLIT  981 (982)
Q Consensus       914 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~~~~~~~~~  981 (982)
                      . .                  ..+...+..+.+++.+||+.||.+|||++|+++.|+.+..+.|...+
T Consensus       265 ~-~------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~~~~  313 (317)
T 2buj_A          265 S-I------------------PQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPGQHT  313 (317)
T ss_dssp             --C------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCCC---
T ss_pred             C-C------------------CccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCCCCCC
Confidence            0 0                  01123345789999999999999999999999999999998887654

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=100.00  E-value=5.4e-38  Score=367.71  Aligned_cols=348  Identities=20%  Similarity=0.138  Sum_probs=255.4

Q ss_pred             CCEEecccCcCcccCchhhcCCCccceeecccccCCCCCCccccCCCCCCEEEeeCCcccCcCchhhhcccchhhhhhcc
Q 002010          243 LQVLDMASCNISGEIPTSLSRLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQLFK  322 (982)
Q Consensus       243 L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~  322 (982)
                      -+.++.++++++ .+|..+.  ++++.|+|++|++++..+..|.++++|++|+|++|.+++..|..|.++++|++|+|++
T Consensus        13 ~~~v~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~   89 (477)
T 2id5_A           13 DRAVLCHRKRFV-AVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRS   89 (477)
T ss_dssp             TTEEECCSCCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCS
T ss_pred             CCEEEeCCCCcC-cCCCCCC--CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCC
Confidence            356888888887 5565553  5788888888888887788888888888888888888887788888888888888888


Q ss_pred             CCCCCCCCCcCCCCCCccEEEccCCCcccccCccccCCCcccEEEeccccccccCCccccCccccceeecccccccccCC
Q 002010          323 NNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFIGPIP  402 (982)
Q Consensus       323 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~l~~N~~~~~~~  402 (982)
                      |++++..+..|.++++|++|+|++|.+++..+..+..+++|+.|++++|.+++..+..|..+++|++|++++|.+.+..+
T Consensus        90 n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~  169 (477)
T 2id5_A           90 NRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPT  169 (477)
T ss_dssp             SCCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCH
T ss_pred             CcCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccCh
Confidence            88887666778888888888888888888778888888888888888888887777788888888888888888877777


Q ss_pred             ccccCCCCCCEEEccCCccCCCCCccccCCCccccccCCCccccccCCcccccCCccEEEeeccccCCCCchhccCCCCc
Q 002010          403 EELGQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLSGELPEKMSGASLNQLKVANNNITGKIPAAIGNLPSL  482 (982)
Q Consensus       403 ~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~L~~N~i~~~~p~~~~~l~~L  482 (982)
                      ..+..+++|+.|++++|.+.+..+..|..+++|+.|++++|.                       +.+.+|..+....+|
T Consensus       170 ~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~-----------------------~~~~~~~~~~~~~~L  226 (477)
T 2id5_A          170 EALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWP-----------------------YLDTMTPNCLYGLNL  226 (477)
T ss_dssp             HHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCT-----------------------TCCEECTTTTTTCCC
T ss_pred             hHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCc-----------------------cccccCcccccCccc
Confidence            777888888888888888876666666666655555555544                       444444444444566


Q ss_pred             ceeeeccccccCCCccccccccccceeeeeccccCCCCCcccccccCCCeeeCCCCcccCCCCcccccccccceEEcccc
Q 002010          483 NILSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYGKIPPGISKLIDLSILNLSRN  562 (982)
Q Consensus       483 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N  562 (982)
                      ++|++++|++++..+..+..+++|++|+|++|++++..+..|..+++|+.|+|++|++++..|..|.++++|+.|+|++|
T Consensus       227 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N  306 (477)
T 2id5_A          227 TSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGN  306 (477)
T ss_dssp             SEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSS
T ss_pred             cEEECcCCcccccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCC
Confidence            66666666666433345566666677777777776666666777777777777777777777777777777777777777


Q ss_pred             cccccCccccccccccceecccCCccccCCCCCccccccccccccCCcCcccCC
Q 002010          563 GITGSIPNEMRNMMSLTTLDLSYNNLIGNIPSGGQFLAFNETSFIGNPNLCLLR  616 (982)
Q Consensus       563 ~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~~~~~~~~~~~~~~n~~~c~~~  616 (982)
                      +|++..+..|..+++|+.|+|++|++++..+....+.......+.++...|..|
T Consensus       307 ~l~~~~~~~~~~l~~L~~L~l~~N~l~c~c~~~~~~~~~~~~~~~~~~~~C~~p  360 (477)
T 2id5_A          307 QLTTLEESVFHSVGNLETLILDSNPLACDCRLLWVFRRRWRLNFNRQQPTCATP  360 (477)
T ss_dssp             CCSCCCGGGBSCGGGCCEEECCSSCEECSGGGHHHHTTTTSSCCTTCCCBEEES
T ss_pred             cCceeCHhHcCCCcccCEEEccCCCccCccchHhHHhhhhccccCccCceeCCc
Confidence            777666667777778888888888777654422112223334566777777655

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=2.9e-38  Score=342.20  Aligned_cols=247  Identities=28%  Similarity=0.418  Sum_probs=201.9

Q ss_pred             HhhcccccccccccceEEEEEEe-CCCcEEEEEEeccCC--CCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEE
Q 002010          691 LESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRG--TGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLL  767 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  767 (982)
                      .++|+..+.||+|+||.||+|.. .++..||+|++....  .......+.+|+.++++++||||+++++++.+....++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   87 (279)
T 3fdn_A            8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI   87 (279)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence            36789999999999999999965 457899999984432  123356688999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhcccc
Q 002010          768 YEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDA  847 (982)
Q Consensus       768 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  847 (982)
                      |||+++++|.+++..  ...+++..+..++.|++.|++|||+.+   |+||||||+||+++.++.+||+|||++......
T Consensus        88 ~e~~~~~~l~~~l~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~  162 (279)
T 3fdn_A           88 LEYAPLGTVYRELQK--LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS  162 (279)
T ss_dssp             ECCCTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC---
T ss_pred             EecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCCcc
Confidence            999999999999973  357899999999999999999999988   999999999999999999999999998654322


Q ss_pred             CCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccce
Q 002010          848 GASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLA  927 (982)
Q Consensus       848 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  927 (982)
                          ......|++.|+|||++.+..++.++||||+|+++|+|++|+.||........ ...+.....             
T Consensus       163 ----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~-------------  224 (279)
T 3fdn_A          163 ----RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET-YKRISRVEF-------------  224 (279)
T ss_dssp             ---------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH-HHHHHHTCC-------------
T ss_pred             ----cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHH-HHHHHhCCC-------------
Confidence                22446789999999999999999999999999999999999999975432222 221111111             


Q ss_pred             eecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          928 VVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       928 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                             ..+...+..+.+++.+||+.||++|||++|+++
T Consensus       225 -------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~  257 (279)
T 3fdn_A          225 -------TFPDFVTEGARDLISRLLKHNPSQRPMLREVLE  257 (279)
T ss_dssp             -------CCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             -------CCCCcCCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence                   112223457889999999999999999999997

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=1.8e-38  Score=352.27  Aligned_cols=260  Identities=26%  Similarity=0.421  Sum_probs=206.7

Q ss_pred             hhcccccccccccceEEEEEEe-CCCcE--EEEEEeccCCCCCchhhHHHHHHHHhcC-CCCcccceEeEEEcCCccEEE
Q 002010          692 ESLKDENIIGKGGAGIVYRGSM-PDGID--VAIKRLVGRGTGGNDHGFLAEIQTLGRI-RHRNIVRLLGYVSNRDTNLLL  767 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~--vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv  767 (982)
                      ++|+..+.||+|+||.||+|+. .++..  ||+|.+...........+.+|+.+++++ +||||+++++++.+.+..++|
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv  104 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA  104 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence            6789999999999999999965 35654  4999986655555667899999999999 899999999999999999999


Q ss_pred             EeccCCCCHHHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCE
Q 002010          768 YEYMPNGSLGEMLHGAK--------------GGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEA  833 (982)
Q Consensus       768 ~e~~~~~sL~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~  833 (982)
                      |||+++++|.+++....              ...+++..++.++.||+.|++|||+.+   |+||||||+||+++.++.+
T Consensus       105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~  181 (327)
T 1fvr_A          105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA  181 (327)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred             EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence            99999999999997532              247999999999999999999999998   9999999999999999999


Q ss_pred             EEeccccchhccccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHh
Q 002010          834 HVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKT  912 (982)
Q Consensus       834 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~  912 (982)
                      ||+|||+++.....   .......+++.|+|||++.+..++.++||||+|+++|||++ |+.||......    ......
T Consensus       182 kL~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~----~~~~~~  254 (327)
T 1fvr_A          182 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA----ELYEKL  254 (327)
T ss_dssp             EECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH----HHHHHG
T ss_pred             EEcccCcCcccccc---ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHH----HHHHHh
Confidence            99999999743321   12233456789999999998889999999999999999998 99999764322    122111


Q ss_pred             ccCCCCCCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCCCCC
Q 002010          913 TSEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQSAP  977 (982)
Q Consensus       913 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~~~~~  977 (982)
                      ...                .....+...+..+.+++.+||+.||++|||++|+++.|+.+.....
T Consensus       255 ~~~----------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~  303 (327)
T 1fvr_A          255 PQG----------------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK  303 (327)
T ss_dssp             GGT----------------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred             hcC----------------CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhc
Confidence            110                0011223345678999999999999999999999999876554443

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=1.9e-38  Score=344.09  Aligned_cols=258  Identities=27%  Similarity=0.408  Sum_probs=206.4

Q ss_pred             HhhcccccccccccceEEEEEEeCC----CcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEE
Q 002010          691 LESLKDENIIGKGGAGIVYRGSMPD----GIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLL  766 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  766 (982)
                      .++|+..+.||+|+||.||+|...+    +..||+|.+.........+.+.+|+.++++++||||+++++++.+ +..++
T Consensus        11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~   89 (281)
T 3cc6_A           11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWI   89 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEE
T ss_pred             ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEE
Confidence            3678999999999999999996532    346999998655444456778999999999999999999998764 56789


Q ss_pred             EEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccc
Q 002010          767 LYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQD  846 (982)
Q Consensus       767 v~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  846 (982)
                      ||||+++++|.+++.. ....+++..+..++.|++.|++|||+.+   |+||||||+||+++.++.+||+|||.+.....
T Consensus        90 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  165 (281)
T 3cc6_A           90 IMELYPYGELGHYLER-NKNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYIED  165 (281)
T ss_dssp             EEECCTTCBHHHHHHH-HTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC--
T ss_pred             EEecCCCCCHHHHHHh-ccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCccccc
Confidence            9999999999999974 2356899999999999999999999998   99999999999999999999999999987654


Q ss_pred             cCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHhccCCCCCCccccc
Q 002010          847 AGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASV  925 (982)
Q Consensus       847 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  925 (982)
                      .. ........+++.|+|||++.+..++.++||||+|+++|||++ |+.||....... ....+..... .         
T Consensus       166 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~-~~~~~~~~~~-~---------  233 (281)
T 3cc6_A          166 ED-YYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD-VIGVLEKGDR-L---------  233 (281)
T ss_dssp             --------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG-HHHHHHHTCC-C---------
T ss_pred             cc-ccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH-HHHHHhcCCC-C---------
Confidence            32 122334557889999999998899999999999999999998 999997644332 2232222211 0         


Q ss_pred             ceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCC
Q 002010          926 LAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQ  974 (982)
Q Consensus       926 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~~  974 (982)
                               ..+...+..+.+++.+||+.||++|||++|+++.|+.+.+
T Consensus       234 ---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~  273 (281)
T 3cc6_A          234 ---------PKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQ  273 (281)
T ss_dssp             ---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---------CCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHH
Confidence                     1122234578999999999999999999999999976543

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=1.5e-38  Score=368.03  Aligned_cols=249  Identities=22%  Similarity=0.265  Sum_probs=197.2

Q ss_pred             HhhcccccccccccceEEEEEEe-CCCcEEEEEEeccC--CCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEE
Q 002010          691 LESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGR--GTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLL  767 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  767 (982)
                      .++|+..+.||+|+||.||+|.. .+++.||||++...  ........+.+|+.+++.++||||+++++++.+.+..++|
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv  226 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV  226 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence            35799999999999999999965 56899999998543  2334455678899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccc
Q 002010          768 YEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHH-DCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQD  846 (982)
Q Consensus       768 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  846 (982)
                      |||+++++|.+++..  ...+++..+..++.||+.||+|||+ .+   |+||||||+||+++.++.+||+|||+|+....
T Consensus       227 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  301 (446)
T 4ejn_A          227 MEYANGGELFFHLSR--ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIK  301 (446)
T ss_dssp             ECCCSSCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTCC
T ss_pred             EeeCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceeccC
Confidence            999999999999973  4579999999999999999999997 77   99999999999999999999999999986432


Q ss_pred             cCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccc
Q 002010          847 AGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVL  926 (982)
Q Consensus       847 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  926 (982)
                      .  ........||+.|+|||++.+..++.++||||+||++|||++|+.||...... .....+.....            
T Consensus       302 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-~~~~~i~~~~~------------  366 (446)
T 4ejn_A          302 D--GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-KLFELILMEEI------------  366 (446)
T ss_dssp             -------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHCCC------------
T ss_pred             C--CcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH-HHHHHHHhCCC------------
Confidence            2  22345578999999999999999999999999999999999999999764332 22222221111            


Q ss_pred             eeecCCCCCCChHhHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 002010          927 AVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARP-----TMREVVH  967 (982)
Q Consensus       927 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~ell~  967 (982)
                              .++...+..+.+++.+||+.||.+||     |++|+++
T Consensus       367 --------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~  404 (446)
T 4ejn_A          367 --------RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ  404 (446)
T ss_dssp             --------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             --------CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence                    11223345789999999999999999     9999986

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.4e-38  Score=352.41  Aligned_cols=268  Identities=19%  Similarity=0.268  Sum_probs=200.5

Q ss_pred             hhcccccccccccceEEEEEEeC-CCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEec
Q 002010          692 ESLKDENIIGKGGAGIVYRGSMP-DGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEY  770 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  770 (982)
                      ++|+..+.||+|+||.||+|... +++.||+|++...........+.+|+.++++++||||+++++++.+++..++||||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            57889999999999999999764 68999999986554444444566899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCc
Q 002010          771 MPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS  850 (982)
Q Consensus       771 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  850 (982)
                      ++ ++|.+++... ...+++..+..++.|++.|++|||+.+   |+||||||+||+++.++.+||+|||++......  .
T Consensus        82 ~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~--~  154 (324)
T 3mtl_A           82 LD-KDLKQYLDDC-GNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIP--T  154 (324)
T ss_dssp             CS-EEHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC------
T ss_pred             cc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCC--c
Confidence            96 5899988743 456899999999999999999999998   999999999999999999999999999865432  2


Q ss_pred             cccccccccccccccccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccc---
Q 002010          851 ECMSSVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVL---  926 (982)
Q Consensus       851 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---  926 (982)
                      .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||........................ .....   
T Consensus       155 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~-~~~~~~~~  233 (324)
T 3mtl_A          155 KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETW-PGILSNEE  233 (324)
T ss_dssp             --------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTS-TTGGGCHH
T ss_pred             cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhc-hhhhcchh
Confidence            22344578999999999876 56899999999999999999999999875444433333333322211111 00000   


Q ss_pred             --eeecCCCC-----CCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          927 --AVVDPRLS-----GYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       927 --~~~~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                        ....+...     ......+..+.+++.+||+.||++|||++|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  281 (324)
T 3mtl_A          234 FKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK  281 (324)
T ss_dssp             HHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence              00000100     111233457889999999999999999999987

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=3.4e-38  Score=350.11  Aligned_cols=270  Identities=17%  Similarity=0.214  Sum_probs=200.3

Q ss_pred             HHhhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCC-CCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEE
Q 002010          690 VLESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGT-GGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLL  767 (982)
Q Consensus       690 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  767 (982)
                      ..++|+..+.||+|+||+||+|.. .+++.||||++..... ......+.+|+.++++++||||+++++++.+++..++|
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  111 (329)
T 3gbz_A           32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI  111 (329)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred             chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence            457899999999999999999964 5789999999854432 22345677999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEc-----CCCCEEEeccccch
Q 002010          768 YEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLD-----SDFEAHVADFGLAK  842 (982)
Q Consensus       768 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~-----~~~~~kl~DfG~a~  842 (982)
                      |||++ ++|.+++..  ...+++..+..++.||+.|++|||+.+   |+||||||+||+++     +++.+||+|||+++
T Consensus       112 ~e~~~-~~L~~~~~~--~~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~  185 (329)
T 3gbz_A          112 FEYAE-NDLKKYMDK--NPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR  185 (329)
T ss_dssp             EECCS-EEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTHHH
T ss_pred             EecCC-CCHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCCcc
Confidence            99997 599999974  456999999999999999999999998   99999999999994     45569999999998


Q ss_pred             hccccCCcccccccccccccccccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCc
Q 002010          843 FLQDAGASECMSSVAGSYGYIAPEYAYTL-KVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSD  921 (982)
Q Consensus       843 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  921 (982)
                      .....  ........+|+.|+|||++.+. .++.++||||+||++|||++|+.||.........................
T Consensus       186 ~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  263 (329)
T 3gbz_A          186 AFGIP--IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWP  263 (329)
T ss_dssp             HHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred             ccCCc--ccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhh
Confidence            76532  2223456789999999998874 48999999999999999999999998755444444444433322111110


Q ss_pred             ccccceeecCCCCC---------CChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          922 AASVLAVVDPRLSG---------YPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       922 ~~~~~~~~~~~~~~---------~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                      .......+....+.         .+...+..+.+++.+||+.||++|||++|+++
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          264 GVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             TGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence            00000000111110         11123467889999999999999999999986

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=1e-38  Score=351.59  Aligned_cols=257  Identities=26%  Similarity=0.349  Sum_probs=196.8

Q ss_pred             HhhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCCC--chhhHHHHHHHHhcCCCCcccceEeEEEcCCcc---
Q 002010          691 LESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGG--NDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTN---  764 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~---  764 (982)
                      .++|+..+.||+|+||.||+|+. .+++.||||++.......  ....+.+|+.++++++||||+++++++......   
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~   90 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   90 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence            46799999999999999999975 678999999986543322  234688999999999999999999998776554   


Q ss_pred             -EEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchh
Q 002010          765 -LLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKF  843 (982)
Q Consensus       765 -~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~  843 (982)
                       ++||||+++++|.+++..  ...+++.++..++.|++.|++|||+.+   |+||||||+||+++.++.+||+|||+++.
T Consensus        91 ~~lv~e~~~g~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~  165 (311)
T 3ork_A           91 PYIVMEYVDGVTLRDIVHT--EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARA  165 (311)
T ss_dssp             EEEEEECCCEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC--
T ss_pred             cEEEEecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCccc
Confidence             999999999999999973  357999999999999999999999998   99999999999999999999999999987


Q ss_pred             ccccCC-cccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcc
Q 002010          844 LQDAGA-SECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDA  922 (982)
Q Consensus       844 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  922 (982)
                      +..... ........||+.|+|||++.+..++.++||||+|+++|||++|+.||..................   .+.  
T Consensus       166 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~---~~~--  240 (311)
T 3ork_A          166 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPI---PPS--  240 (311)
T ss_dssp             ----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCC---CHH--
T ss_pred             ccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCC---Ccc--
Confidence            654322 12233457899999999999999999999999999999999999999764332222222211111   000  


Q ss_pred             cccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHH-HHh
Q 002010          923 ASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVV-HML  969 (982)
Q Consensus       923 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell-~~L  969 (982)
                                  ......+..+.+++.+||+.||++||++.+++ +.+
T Consensus       241 ------------~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l  276 (311)
T 3ork_A          241 ------------ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADL  276 (311)
T ss_dssp             ------------HHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHH
T ss_pred             ------------cccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHH
Confidence                        01112345788999999999999999766654 444

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=3e-38  Score=347.29  Aligned_cols=265  Identities=20%  Similarity=0.224  Sum_probs=201.3

Q ss_pred             HHHhhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCCC--chhhHHHHHHHHhcCCCCcccceEeEEEcCCccE
Q 002010          689 DVLESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGG--NDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNL  765 (982)
Q Consensus       689 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  765 (982)
                      ...++|+..+.||+|+||.||+|.. .+++.||+|++.......  ....+.+|+.++++++||||+++++++..++..+
T Consensus        31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~  110 (309)
T 2h34_A           31 TQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLY  110 (309)
T ss_dssp             ---CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred             cEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEE
Confidence            3457899999999999999999976 468899999985443222  2367889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhcc
Q 002010          766 LLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQ  845 (982)
Q Consensus       766 lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~  845 (982)
                      +||||+++++|.+++..  ...+++..+..++.|++.|++|||+.+   |+||||||+||+++.++.+||+|||++....
T Consensus       111 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~  185 (309)
T 2h34_A          111 VDMRLINGVDLAAMLRR--QGPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATT  185 (309)
T ss_dssp             EEEECCCCEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred             EEEEecCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence            99999999999999973  357999999999999999999999998   9999999999999999999999999998765


Q ss_pred             ccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCccccc
Q 002010          846 DAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASV  925 (982)
Q Consensus       846 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  925 (982)
                      ... ........|++.|+|||++.+..++.++||||+|+++|||++|+.||...... .....+.....   .       
T Consensus       186 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~---~-------  253 (309)
T 2h34_A          186 DEK-LTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS-VMGAHINQAIP---R-------  253 (309)
T ss_dssp             ------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH-HHHHHHHSCCC---C-------
T ss_pred             ccc-cccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH-HHHHHhccCCC---C-------
Confidence            332 22234567899999999999999999999999999999999999999753221 11111111100   0       


Q ss_pred             ceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCC-CHHHHHHHhcCCCCCCC
Q 002010          926 LAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARP-TMREVVHMLANPPQSAP  977 (982)
Q Consensus       926 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-t~~ell~~L~~~~~~~~  977 (982)
                             ....+...+..+.+++.+||+.||++|| +++++++.|+...+...
T Consensus       254 -------~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~  299 (309)
T 2h34_A          254 -------PSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATAD  299 (309)
T ss_dssp             -------GGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC---
T ss_pred             -------ccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhc
Confidence                   0012223345788999999999999999 99999999988776554

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.8e-38  Score=360.42  Aligned_cols=255  Identities=22%  Similarity=0.194  Sum_probs=204.9

Q ss_pred             HhhcccccccccccceEEEEEEe-CCCcEEEEEEeccCC--CCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEE
Q 002010          691 LESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRG--TGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLL  767 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  767 (982)
                      .++|+..+.||+|+||.||+|+. .+++.||+|++.+..  .......+.+|+.++..++||||+++++++.+++..|+|
T Consensus        60 ~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV  139 (412)
T 2vd5_A           60 RDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLV  139 (412)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEE
T ss_pred             hhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEE
Confidence            46799999999999999999976 469999999985421  122344588999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhcccc
Q 002010          768 YEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDA  847 (982)
Q Consensus       768 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  847 (982)
                      |||+++|+|.+++... ...+++..+..++.||+.|++|||+.+   |+||||||+||+++.++++||+|||+++.....
T Consensus       140 mE~~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DFGla~~~~~~  215 (412)
T 2vd5_A          140 MEYYVGGDLLTLLSKF-GERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCLKLRAD  215 (412)
T ss_dssp             ECCCCSCBHHHHHHHH-SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             EcCCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeechhheeccCC
Confidence            9999999999999742 347999999999999999999999998   999999999999999999999999999876533


Q ss_pred             CCcccccccccccccccccccc-------cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCC
Q 002010          848 GASECMSSVAGSYGYIAPEYAY-------TLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPS  920 (982)
Q Consensus       848 ~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  920 (982)
                      . .......+||+.|+|||++.       ...++.++||||+||++|||++|+.||...........++..... ..   
T Consensus       216 ~-~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~-~~---  290 (412)
T 2vd5_A          216 G-TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEH-LS---  290 (412)
T ss_dssp             S-CEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH-CC---
T ss_pred             C-ccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC-cC---
Confidence            2 22234568999999999987       356899999999999999999999999765433333333221111 00   


Q ss_pred             cccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCC---CCHHHHHH
Q 002010          921 DAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSAR---PTMREVVH  967 (982)
Q Consensus       921 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R---pt~~ell~  967 (982)
                                  ++..+...+..+.+++.+||. +|.+|   |+++|+++
T Consensus       291 ------------~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~  327 (412)
T 2vd5_A          291 ------------LPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT  327 (412)
T ss_dssp             ------------CC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred             ------------CCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence                        011112234578999999999 99998   59999886

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=7.7e-39  Score=353.57  Aligned_cols=269  Identities=26%  Similarity=0.358  Sum_probs=207.6

Q ss_pred             cccccccccccceEEEEEEe-----CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcC--CccEE
Q 002010          694 LKDENIIGKGGAGIVYRGSM-----PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNR--DTNLL  766 (982)
Q Consensus       694 ~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~l  766 (982)
                      |+..+.||+|+||+||++.+     .+++.||||++...........+.+|+.++++++||||+++++++.+.  ...++
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l  112 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL  112 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence            48899999999999998854     268899999996554444556789999999999999999999999874  56789


Q ss_pred             EEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccc
Q 002010          767 LYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQD  846 (982)
Q Consensus       767 v~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  846 (982)
                      ||||+++++|.+++..   ..+++..++.++.|++.|++|||+.+   |+||||||+||+++.++.+||+|||++.....
T Consensus       113 v~e~~~~~~L~~~l~~---~~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~  186 (318)
T 3lxp_A          113 VMEYVPLGSLRDYLPR---HSIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE  186 (318)
T ss_dssp             EECCCTTCBHHHHGGG---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECCT
T ss_pred             EEecccCCcHHHHHhh---CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCccccccccc
Confidence            9999999999999964   34999999999999999999999998   99999999999999999999999999987654


Q ss_pred             cCCc-ccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCccccc
Q 002010          847 AGAS-ECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASV  925 (982)
Q Consensus       847 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  925 (982)
                      .... .......+++.|+|||++.+..++.++||||+|+++|||++|+.||......  ..........    .......
T Consensus       187 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~--~~~~~~~~~~----~~~~~~~  260 (318)
T 3lxp_A          187 GHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTK--FLELIGIAQG----QMTVLRL  260 (318)
T ss_dssp             TCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH--HHHHHCSCCH----HHHHHHH
T ss_pred             cccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchh--hhhhhccccc----chhHHHH
Confidence            3221 2233456788999999999989999999999999999999999998652110  0000000000    0000000


Q ss_pred             ceeecC-CCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCC
Q 002010          926 LAVVDP-RLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQ  974 (982)
Q Consensus       926 ~~~~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~~  974 (982)
                      ...++. .....+...+..+.+++.+||+.||++|||++|+++.|+++..
T Consensus       261 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~  310 (318)
T 3lxp_A          261 TELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHE  310 (318)
T ss_dssp             HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence            011111 1113344556789999999999999999999999999977644

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=4e-38  Score=354.67  Aligned_cols=248  Identities=21%  Similarity=0.255  Sum_probs=197.9

Q ss_pred             ccccccccccceEEEEEEe-CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEeccCC
Q 002010          695 KDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPN  773 (982)
Q Consensus       695 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  773 (982)
                      ...+.||+|+||.||+|.. .+|+.||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++||||+++
T Consensus        92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~  170 (373)
T 2x4f_A           92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTR-GMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDG  170 (373)
T ss_dssp             EEEEECC-----CEEEEEETTTCCEEEEEEEECC-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred             ecceEEecCcCEEEEEEEEcCCCcEEEEEEEccc-ccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCC
Confidence            3467899999999999965 56899999998543 223456789999999999999999999999999999999999999


Q ss_pred             CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEE--cCCCCEEEeccccchhccccCCcc
Q 002010          774 GSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILL--DSDFEAHVADFGLAKFLQDAGASE  851 (982)
Q Consensus       774 ~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill--~~~~~~kl~DfG~a~~~~~~~~~~  851 (982)
                      ++|.+++.. ....+++..+..++.||+.||+|||+.+   |+||||||+||++  +.++.+||+|||+++.+....   
T Consensus       171 ~~L~~~l~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~---  243 (373)
T 2x4f_A          171 GELFDRIID-ESYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE---  243 (373)
T ss_dssp             CEEHHHHHH-TGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC---
T ss_pred             CcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc---
Confidence            999998864 3356899999999999999999999998   9999999999999  567899999999998765332   


Q ss_pred             cccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceeecC
Q 002010          852 CMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDP  931 (982)
Q Consensus       852 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  931 (982)
                      ......||+.|+|||++.+..++.++||||+||++|||++|+.||....+......+.......   +          . 
T Consensus       244 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~---~----------~-  309 (373)
T 2x4f_A          244 KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDL---E----------D-  309 (373)
T ss_dssp             BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCS---C----------S-
T ss_pred             ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCC---C----------h-
Confidence            2334579999999999998899999999999999999999999997654433333332221110   0          0 


Q ss_pred             CCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          932 RLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       932 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                         ......+..+.+++.+||+.||.+|||++|+++
T Consensus       310 ---~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~  342 (373)
T 2x4f_A          310 ---EEFQDISEEAKEFISKLLIKEKSWRISASEALK  342 (373)
T ss_dssp             ---GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ---hhhccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence               001123457899999999999999999999987

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=7.5e-38  Score=340.00  Aligned_cols=252  Identities=21%  Similarity=0.308  Sum_probs=206.2

Q ss_pred             HhhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCC-CCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEE
Q 002010          691 LESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGT-GGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLY  768 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  768 (982)
                      .++|+..+.||+|+||.||+|.. .+++.||+|++..... ......+.+|+.++++++||||+++++++.++...++||
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   84 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   84 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence            46899999999999999999965 4689999999855432 233456889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCC---EEEeccccchhcc
Q 002010          769 EYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFE---AHVADFGLAKFLQ  845 (982)
Q Consensus       769 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~---~kl~DfG~a~~~~  845 (982)
                      ||+++++|.+++..  ...+++..+..++.|++.|++|||+.+   |+||||||+||+++.++.   +||+|||.+....
T Consensus        85 e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~  159 (284)
T 3kk8_A           85 DLVTGGELFEDIVA--REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN  159 (284)
T ss_dssp             CCCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred             ecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcc
Confidence            99999999998873  357999999999999999999999998   999999999999986655   9999999997665


Q ss_pred             ccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCccccc
Q 002010          846 DAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASV  925 (982)
Q Consensus       846 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  925 (982)
                      ..   .......|++.|+|||++.+..++.++||||+|+++|+|++|+.||....... ....+.......+.+      
T Consensus       160 ~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~------  229 (284)
T 3kk8_A          160 DS---EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR-LYAQIKAGAYDYPSP------  229 (284)
T ss_dssp             SS---CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHTCCCCCTT------
T ss_pred             cC---ccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhH-HHHHHHhccccCCch------
Confidence            32   22345678999999999999999999999999999999999999997643322 222222211111100      


Q ss_pred             ceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          926 LAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       926 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                                .....+..+.+++.+||+.||++|||++|+++
T Consensus       230 ----------~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (284)
T 3kk8_A          230 ----------EWDTVTPEAKSLIDSMLTVNPKKRITADQALK  261 (284)
T ss_dssp             ----------TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ----------hhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence                      11123456889999999999999999999987

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=8.9e-38  Score=342.82  Aligned_cols=248  Identities=28%  Similarity=0.375  Sum_probs=208.9

Q ss_pred             hhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEec
Q 002010          692 ESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEY  770 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  770 (982)
                      +.|+..+.||+|+||.||+|.. .+++.||+|++...........+.+|+.++++++||||+++++++.++...++||||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  101 (303)
T 3a7i_A           22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY  101 (303)
T ss_dssp             GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence            5688999999999999999965 568999999997665566678899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCc
Q 002010          771 MPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS  850 (982)
Q Consensus       771 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  850 (982)
                      +++++|.+++.   ...+++..+..++.|++.|++|||+.+   |+||||||+||+++.++.+||+|||.+.......  
T Consensus       102 ~~~~~L~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~--  173 (303)
T 3a7i_A          102 LGGGSALDLLE---PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--  173 (303)
T ss_dssp             CTTEEHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTB--
T ss_pred             CCCCcHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCccc--
Confidence            99999999995   357999999999999999999999998   9999999999999999999999999998765332  


Q ss_pred             ccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceeec
Q 002010          851 ECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVD  930 (982)
Q Consensus       851 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  930 (982)
                      .......|++.|+|||++.+..++.++||||+|+++|+|++|+.||...... .....+.....                
T Consensus       174 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~----------------  236 (303)
T 3a7i_A          174 IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPM-KVLFLIPKNNP----------------  236 (303)
T ss_dssp             CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-HHHHHHHHSCC----------------
T ss_pred             cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHH-HHHHHhhcCCC----------------
Confidence            2234567899999999999999999999999999999999999999764322 22222111110                


Q ss_pred             CCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          931 PRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       931 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                         ...+...+..+.+++.+||+.||++|||++|+++
T Consensus       237 ---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  270 (303)
T 3a7i_A          237 ---PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLK  270 (303)
T ss_dssp             ---CCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             ---CCCccccCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence               0112233457899999999999999999999986

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=5.2e-38  Score=349.37  Aligned_cols=251  Identities=21%  Similarity=0.292  Sum_probs=202.4

Q ss_pred             HHHhhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcC-CCCcccceEeEEEcCCccEE
Q 002010          689 DVLESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRI-RHRNIVRLLGYVSNRDTNLL  766 (982)
Q Consensus       689 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~l  766 (982)
                      .+.++|+..+.||+|+||.||+|.. .+++.||+|++.....     ...+|++++.++ +||||+++++++.+++..++
T Consensus        19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~l   93 (342)
T 2qr7_A           19 QFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYV   93 (342)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEE
T ss_pred             CccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEE
Confidence            3567899999999999999999965 4689999999854322     245788888888 79999999999999999999


Q ss_pred             EEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCC----CCEEEeccccch
Q 002010          767 LYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSD----FEAHVADFGLAK  842 (982)
Q Consensus       767 v~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~----~~~kl~DfG~a~  842 (982)
                      ||||+++|+|.+++.  +...+++..+..++.||+.|++|||+.+   |+||||||+||++.++    +.+||+|||++.
T Consensus        94 v~E~~~gg~L~~~i~--~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~  168 (342)
T 2qr7_A           94 VTELMKGGELLDKIL--RQKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAK  168 (342)
T ss_dssp             EECCCCSCBHHHHHH--TCTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCE
T ss_pred             EEeCCCCCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCcc
Confidence            999999999999997  4467999999999999999999999998   9999999999998543    359999999998


Q ss_pred             hccccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCC--chHHHHHHHhccCCCCCC
Q 002010          843 FLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDG--VDIVRWVRKTTSEVSQPS  920 (982)
Q Consensus       843 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~  920 (982)
                      ......  .......||+.|+|||++.+..++.++||||+||++|||++|..||....+.  ..+...+.......  + 
T Consensus       169 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~--~-  243 (342)
T 2qr7_A          169 QLRAEN--GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSL--S-  243 (342)
T ss_dssp             ECBCTT--CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCC--C-
T ss_pred             cCcCCC--CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCccc--C-
Confidence            765432  2234567899999999998888999999999999999999999999764322  12222222111100  0 


Q ss_pred             cccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          921 DAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       921 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                                   .......+..+.+++.+||+.||++|||++|+++
T Consensus       244 -------------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~  277 (342)
T 2qr7_A          244 -------------GGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR  277 (342)
T ss_dssp             -------------STTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             -------------ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence                         0112234457889999999999999999999886

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=5.8e-38  Score=348.54  Aligned_cols=244  Identities=23%  Similarity=0.341  Sum_probs=204.5

Q ss_pred             HHHhhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCCC-------chhhHHHHHHHHhcCCCCcccceEeEEEc
Q 002010          689 DVLESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGG-------NDHGFLAEIQTLGRIRHRNIVRLLGYVSN  760 (982)
Q Consensus       689 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~~~~~~~~  760 (982)
                      .+.++|+..+.||+|+||.||+|.. .+++.||||++.......       ....+.+|+.++++++||||+++++++.+
T Consensus        21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~  100 (335)
T 3dls_A           21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN  100 (335)
T ss_dssp             HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred             ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence            4668899999999999999999964 568999999986543211       33467789999999999999999999999


Q ss_pred             CCccEEEEeccCCC-CHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccc
Q 002010          761 RDTNLLLYEYMPNG-SLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFG  839 (982)
Q Consensus       761 ~~~~~lv~e~~~~~-sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG  839 (982)
                      .+..++||||+.+| +|.+++.  +...+++..+..++.||+.|++|||+.+   |+||||||+||+++.++.+||+|||
T Consensus       101 ~~~~~lv~e~~~~g~~l~~~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg  175 (335)
T 3dls_A          101 QGFFQLVMEKHGSGLDLFAFID--RHPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFG  175 (335)
T ss_dssp             SSEEEEEEECCTTSCBHHHHHH--TCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCT
T ss_pred             CCEEEEEEEeCCCCccHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeecc
Confidence            99999999999776 9999997  4457999999999999999999999998   9999999999999999999999999


Q ss_pred             cchhccccCCcccccccccccccccccccccCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCC
Q 002010          840 LAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKV-DEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQ  918 (982)
Q Consensus       840 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  918 (982)
                      ++......   .......||+.|+|||++.+..+ +.++||||+||++|||++|+.||......      .   ....  
T Consensus       176 ~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~---~~~~--  241 (335)
T 3dls_A          176 SAAYLERG---KLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET------V---EAAI--  241 (335)
T ss_dssp             TCEECCTT---CCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG------T---TTCC--
T ss_pred             cceECCCC---CceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH------H---hhcc--
Confidence            99876533   22344678999999999988876 78999999999999999999999652110      0   0000  


Q ss_pred             CCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          919 PSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       919 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                                      ..+...+..+.+++.+||+.||++|||++|+++
T Consensus       242 ----------------~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  274 (335)
T 3dls_A          242 ----------------HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVT  274 (335)
T ss_dssp             ----------------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ----------------CCCcccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                            011123457899999999999999999999998

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=3.1e-38  Score=352.85  Aligned_cols=269  Identities=17%  Similarity=0.198  Sum_probs=202.6

Q ss_pred             hhcccccccccccceEEEEEEeC----CCcEEEEEEeccCCCCC----------chhhHHHHHHHHhcCCCCcccceEeE
Q 002010          692 ESLKDENIIGKGGAGIVYRGSMP----DGIDVAIKRLVGRGTGG----------NDHGFLAEIQTLGRIRHRNIVRLLGY  757 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~----------~~~~~~~E~~~l~~l~h~niv~~~~~  757 (982)
                      ++|+..+.||+|+||.||+|...    ++..||+|+........          ....+.+|+..++.++||||++++++
T Consensus        37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~  116 (345)
T 2v62_A           37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS  116 (345)
T ss_dssp             CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred             ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence            57899999999999999999764    57889999885442210          12346678889999999999999999


Q ss_pred             EEc----CCccEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCC--
Q 002010          758 VSN----RDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDF--  831 (982)
Q Consensus       758 ~~~----~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~--  831 (982)
                      +..    ....++||||+ +++|.+++...  ..+++.+++.++.||+.|++|||+.+   |+||||||+||+++.++  
T Consensus       117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~  190 (345)
T 2v62_A          117 GLTEFKGRSYRFMVMERL-GIDLQKISGQN--GTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPD  190 (345)
T ss_dssp             EEEESSSCEEEEEEEECE-EEEHHHHCBGG--GBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSSTT
T ss_pred             cccccCCCcEEEEEEecc-CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCCCC
Confidence            887    67889999999 99999999743  38999999999999999999999998   99999999999999887  


Q ss_pred             CEEEeccccchhccccCCc-----ccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHH
Q 002010          832 EAHVADFGLAKFLQDAGAS-----ECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIV  906 (982)
Q Consensus       832 ~~kl~DfG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~  906 (982)
                      .+||+|||+++.+......     .......||+.|+|||++.+..++.++||||+||++|||++|+.||..........
T Consensus       191 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~  270 (345)
T 2v62_A          191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAV  270 (345)
T ss_dssp             SEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHH
T ss_pred             cEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHH
Confidence            9999999999876533211     11244579999999999999999999999999999999999999996533322222


Q ss_pred             HHHHHhccCCCCCCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCCCC
Q 002010          907 RWVRKTTSEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQSA  976 (982)
Q Consensus       907 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~~~~  976 (982)
                      .......... .+.   .....    .  .+...+..+.+++.+||+.||++|||+++|++.|+....+.
T Consensus       271 ~~~~~~~~~~-~~~---~~~~~----~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~  330 (345)
T 2v62_A          271 QTAKTNLLDE-LPQ---SVLKW----A--PSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGIPL  330 (345)
T ss_dssp             HHHHHHHHHT-TTH---HHHHH----S--CTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCCCC
T ss_pred             HHHHHhhccc-ccH---HHHhh----c--cccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCCcc
Confidence            2222111100 000   00000    0  00133457999999999999999999999999999876543

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=5.4e-38  Score=375.87  Aligned_cols=249  Identities=25%  Similarity=0.383  Sum_probs=202.1

Q ss_pred             ccccccceEEEEEEeC---CCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEeccCCCC
Q 002010          699 IIGKGGAGIVYRGSMP---DGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGS  775 (982)
Q Consensus       699 ~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~s  775 (982)
                      .||+|+||.||+|.+.   ++..||||+++........+.+.+|+.++++++|||||++++++.. +..++||||+++|+
T Consensus       343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~  421 (613)
T 2ozo_A          343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP  421 (613)
T ss_dssp             EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred             EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence            7999999999999653   4667999999765555567889999999999999999999999976 56899999999999


Q ss_pred             HHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCC-ccccc
Q 002010          776 LGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGA-SECMS  854 (982)
Q Consensus       776 L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~-~~~~~  854 (982)
                      |.+++.. ....+++..+..++.||+.||+|||+++   |+||||||+||+++.++.+||+|||+++.+..... .....
T Consensus       422 L~~~l~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~  497 (613)
T 2ozo_A          422 LHKFLVG-KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS  497 (613)
T ss_dssp             HHHHHTT-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC----------
T ss_pred             HHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeecc
Confidence            9999964 3467999999999999999999999998   99999999999999999999999999987653321 11122


Q ss_pred             ccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceeecCCC
Q 002010          855 SVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDPRL  933 (982)
Q Consensus       855 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  933 (982)
                      ...+++.|+|||++.+..++.++|||||||++|||++ |+.||...... +....+.....                   
T Consensus       498 ~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~-~~~~~i~~~~~-------------------  557 (613)
T 2ozo_A          498 AGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP-EVMAFIEQGKR-------------------  557 (613)
T ss_dssp             ----CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH-HHHHHHHTTCC-------------------
T ss_pred             CCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH-HHHHHHHcCCC-------------------
Confidence            3345689999999999999999999999999999998 99999875443 23333222111                   


Q ss_pred             CCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 002010          934 SGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANP  972 (982)
Q Consensus       934 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~  972 (982)
                      ...+..++..+.++|.+||+.||++|||+++|++.|+.+
T Consensus       558 ~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~  596 (613)
T 2ozo_A          558 MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC  596 (613)
T ss_dssp             CCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHH
T ss_pred             CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            122334556899999999999999999999999988653

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=4.2e-38  Score=340.84  Aligned_cols=250  Identities=25%  Similarity=0.390  Sum_probs=185.5

Q ss_pred             HhhcccccccccccceEEEEEEe-CCCcEEEEEEeccCC--CCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEE
Q 002010          691 LESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRG--TGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLL  767 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  767 (982)
                      .++|+..+.||+|+||.||+|.. .+++.||+|++....  .......+.+|+.++++++||||+++++++.+.+..++|
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV   89 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence            46799999999999999999975 579999999985432  223356788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhcccc
Q 002010          768 YEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDA  847 (982)
Q Consensus       768 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  847 (982)
                      |||+++++|.+++.. ....+++..+..++.|++.|++|||+.+   |+||||||+||+++.++.+||+|||.+......
T Consensus        90 ~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~  165 (278)
T 3cok_A           90 LEMCHNGEMNRYLKN-RVKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP  165 (278)
T ss_dssp             EECCTTEEHHHHHHT-CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred             EecCCCCcHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccCC
Confidence            999999999999974 3367899999999999999999999998   999999999999999999999999999866432


Q ss_pred             CCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccce
Q 002010          848 GASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLA  927 (982)
Q Consensus       848 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  927 (982)
                      .  .......|++.|+|||++.+..++.++||||+|+++|||++|+.||..........    ....             
T Consensus       166 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~----~~~~-------------  226 (278)
T 3cok_A          166 H--EKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLN----KVVL-------------  226 (278)
T ss_dssp             ----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC---------CCS-------------
T ss_pred             C--CcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHH----HHhh-------------
Confidence            1  12234578999999999999889999999999999999999999997643221110    0000             


Q ss_pred             eecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          928 VVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       928 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                         .. ...+...+..+.+++.+||+.||++|||++|+++
T Consensus       227 ---~~-~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          227 ---AD-YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD  262 (278)
T ss_dssp             ---SC-CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             ---cc-cCCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence               00 0122334457889999999999999999999987

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=4.6e-38  Score=347.96  Aligned_cols=254  Identities=19%  Similarity=0.252  Sum_probs=183.1

Q ss_pred             HHhhccc---ccccccccceEEEEEEe-CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCC-CCcccceEeEEEcCCcc
Q 002010          690 VLESLKD---ENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIR-HRNIVRLLGYVSNRDTN  764 (982)
Q Consensus       690 ~~~~~~~---~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~  764 (982)
                      +.++|+.   .+.||+|+||.||+|.. .+++.||||++..    .....+.+|+.+++++. ||||+++++++.++...
T Consensus         6 f~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~----~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~   81 (325)
T 3kn6_A            6 FYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISK----RMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHT   81 (325)
T ss_dssp             HHHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEG----GGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             chhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEECh----hhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEE
Confidence            3455554   37899999999999976 4689999999843    23566789999999997 99999999999999999


Q ss_pred             EEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCC---CEEEeccccc
Q 002010          765 LLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDF---EAHVADFGLA  841 (982)
Q Consensus       765 ~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~---~~kl~DfG~a  841 (982)
                      ++||||+++++|.+++..  ...+++.++..++.|++.|++|||+.+   |+||||||+||+++.++   .+||+|||++
T Consensus        82 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a  156 (325)
T 3kn6_A           82 FLVMELLNGGELFERIKK--KKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFA  156 (325)
T ss_dssp             EEEECCCCSCBHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTC
T ss_pred             EEEEEccCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccc
Confidence            999999999999999974  467999999999999999999999998   99999999999998765   8999999999


Q ss_pred             hhccccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCC---chHHHHHHHhccCCCC
Q 002010          842 KFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDG---VDIVRWVRKTTSEVSQ  918 (982)
Q Consensus       842 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~---~~~~~~~~~~~~~~~~  918 (982)
                      +.....  ........||+.|+|||++.+..++.++||||+||++|||++|+.||......   ................
T Consensus       157 ~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~  234 (325)
T 3kn6_A          157 RLKPPD--NQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFS  234 (325)
T ss_dssp             EECCC------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCC
T ss_pred             eecCCC--CCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCC
Confidence            865432  22234567899999999999999999999999999999999999999764321   1111222211110000


Q ss_pred             CCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          919 PSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       919 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                      ..             .......+..+.+++.+||+.||++|||++|+++
T Consensus       235 ~~-------------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  270 (325)
T 3kn6_A          235 FE-------------GEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY  270 (325)
T ss_dssp             CC-------------SHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred             CC-------------cccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence            00             0001123457899999999999999999999875

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=100.00  E-value=4.7e-37  Score=358.08  Aligned_cols=347  Identities=26%  Similarity=0.347  Sum_probs=194.6

Q ss_pred             cCCCccEEeccCccccCCCchhccccccccEEeecCcccccccCCCccccCcceEeeccCcccccchhhHHhhhhhHHHH
Q 002010          142 GMTELQVLDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLNGIGLNGTVPAFLSRLKNLREM  221 (982)
Q Consensus       142 ~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L  221 (982)
                      .+++|+.|++++|.++ .+| .+..+++|++|+|++|.+++..|  ++++++|++|++++|.+.+.              
T Consensus        44 ~l~~l~~L~l~~~~i~-~l~-~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--------------  105 (466)
T 1o6v_A           44 DLDQVTTLQADRLGIK-SID-GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADI--------------  105 (466)
T ss_dssp             HHHTCCEEECCSSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC--------------
T ss_pred             HhccccEEecCCCCCc-cCc-chhhhcCCCEEECCCCccCCchh--hhccccCCEEECCCCccccC--------------
Confidence            3566777777777776 344 36677777777777777764433  55555555555555444311              


Q ss_pred             hhcccccccccCCCCCCCCCCCCEEecccCcCcccCchhhcCCCccceeecccccCCCCCCccccCCCCCCEEEeeCCcc
Q 002010          222 YIGYFNTYTGGIPPGFGALTQLQVLDMASCNISGEIPTSLSRLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYL  301 (982)
Q Consensus       222 ~l~~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l  301 (982)
                                  ++ ++++++|++|++++|++++..+  +.++++|++|++++|++++. + .+..+++|++|+++ |.+
T Consensus       106 ------------~~-~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~-~-~~~~l~~L~~L~l~-~~~  167 (466)
T 1o6v_A          106 ------------TP-LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDI-S-ALSGLTSLQQLSFG-NQV  167 (466)
T ss_dssp             ------------GG-GTTCTTCCEEECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCC-G-GGTTCTTCSEEEEE-ESC
T ss_pred             ------------hh-hcCCCCCCEEECCCCCCCCChH--HcCCCCCCEEECCCCccCCC-h-hhccCCcccEeecC-Ccc
Confidence                        11 3444555555555555553322  45555555555555555532 2 24455555555554 222


Q ss_pred             cCcCchhhhcccchhhhhhccCCCCCCCCCcCCCCCCccEEEccCCCcccccCccccCCCcccEEEeccccccccCCccc
Q 002010          302 TGEIPESFAALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDL  381 (982)
Q Consensus       302 ~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~  381 (982)
                      .+..  .                        +..+++|++|++++|.++..  ..+..+++|+.|++++|.+++..|  +
T Consensus       168 ~~~~--~------------------------~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~  217 (466)
T 1o6v_A          168 TDLK--P------------------------LANLTTLERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDITP--L  217 (466)
T ss_dssp             CCCG--G------------------------GTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--G
T ss_pred             cCch--h------------------------hccCCCCCEEECcCCcCCCC--hhhccCCCCCEEEecCCccccccc--c
Confidence            2211  1                        34444444444444444421  124444444444444444443322  3


Q ss_pred             cCccccceeecccccccccCCccccCCCCCCEEEccCCccCCCCCccccCCCccccccCCCccccccCCcccccCCccEE
Q 002010          382 CKGGKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLSGELPEKMSGASLNQL  461 (982)
Q Consensus       382 ~~~~~L~~L~l~~N~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L  461 (982)
                      ..+++|++|++++|.+.+.  ..+..+++|++|++++|++++..+  +..+                       .+|+.|
T Consensus       218 ~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l-----------------------~~L~~L  270 (466)
T 1o6v_A          218 GILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGL-----------------------TKLTEL  270 (466)
T ss_dssp             GGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTC-----------------------TTCSEE
T ss_pred             cccCCCCEEECCCCCcccc--hhhhcCCCCCEEECCCCccccchh--hhcC-----------------------CCCCEE
Confidence            3344444444444444332  234555556666666665553322  3333                       345555


Q ss_pred             EeeccccCCCCchhccCCCCcceeeeccccccCCCccccccccccceeeeeccccCCCCCcccccccCCCeeeCCCCccc
Q 002010          462 KVANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLY  541 (982)
Q Consensus       462 ~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  541 (982)
                      ++++|++++..+  +..+++|+.|++++|++++..+  +..+++|++|++++|++++..|  +..+++|+.|++++|+++
T Consensus       271 ~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~  344 (466)
T 1o6v_A          271 KLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVS  344 (466)
T ss_dssp             ECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCC
T ss_pred             ECCCCccCcccc--ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh--hccCccCCEeECCCCccC
Confidence            555555554333  5667777777777777765433  5667777777777777776555  667777777777777777


Q ss_pred             CCCCcccccccccceEEcccccccccCccccccccccceecccCCccccC
Q 002010          542 GKIPPGISKLIDLSILNLSRNGITGSIPNEMRNMMSLTTLDLSYNNLIGN  591 (982)
Q Consensus       542 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~  591 (982)
                      +.  ..+.++++|+.|++++|++++..|  +..+++|+.|++++|++++.
T Consensus       345 ~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~~~~~  390 (466)
T 1o6v_A          345 DV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNA  390 (466)
T ss_dssp             CC--GGGTTCTTCCEEECCSSCCCBCGG--GTTCTTCCEEECCCEEEECC
T ss_pred             Cc--hhhccCCCCCEEeCCCCccCccch--hhcCCCCCEEeccCCcccCC
Confidence            54  457777777777777777776666  77777777777777777764

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=3.2e-38  Score=344.13  Aligned_cols=256  Identities=26%  Similarity=0.391  Sum_probs=204.4

Q ss_pred             hhccccc-ccccccceEEEEEEe---CCCcEEEEEEeccCCCCC-chhhHHHHHHHHhcCCCCcccceEeEEEcCCccEE
Q 002010          692 ESLKDEN-IIGKGGAGIVYRGSM---PDGIDVAIKRLVGRGTGG-NDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLL  766 (982)
Q Consensus       692 ~~~~~~~-~lg~G~~g~Vy~~~~---~~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  766 (982)
                      ++|+..+ .||+|+||.||+|..   .+++.||||++....... ..+.+.+|+.++++++||||+++++++ ..+..++
T Consensus        16 ~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~l   94 (291)
T 1xbb_A           16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWML   94 (291)
T ss_dssp             GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEE
T ss_pred             hhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEE
Confidence            4677777 999999999999943   346889999985543322 356789999999999999999999998 5677899


Q ss_pred             EEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccc
Q 002010          767 LYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQD  846 (982)
Q Consensus       767 v~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  846 (982)
                      ||||+++++|.+++..  ...+++..+..++.|++.|++|||+.+   |+||||||+||+++.++.+||+|||++.....
T Consensus        95 v~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  169 (291)
T 1xbb_A           95 VMEMAELGPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRA  169 (291)
T ss_dssp             EEECCTTEEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred             EEEeCCCCCHHHHHHh--CcCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcceeecc
Confidence            9999999999999974  456999999999999999999999998   99999999999999999999999999987654


Q ss_pred             cCCc-ccccccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHhccCCCCCCcccc
Q 002010          847 AGAS-ECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAAS  924 (982)
Q Consensus       847 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  924 (982)
                      .... .......+++.|+|||++.+..++.++||||+|+++|||++ |+.||..... ......+.....          
T Consensus       170 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-~~~~~~~~~~~~----------  238 (291)
T 1xbb_A          170 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG-SEVTAMLEKGER----------  238 (291)
T ss_dssp             TCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH-HHHHHHHHTTCC----------
T ss_pred             CCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH-HHHHHHHHcCCC----------
Confidence            3221 11223446788999999998889999999999999999999 9999976433 222222222111          


Q ss_pred             cceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 002010          925 VLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPP  973 (982)
Q Consensus       925 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~  973 (982)
                               ...+...+..+.+++.+||+.||++|||++|+++.|+++.
T Consensus       239 ---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~  278 (291)
T 1xbb_A          239 ---------MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY  278 (291)
T ss_dssp             ---------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             ---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence                     1123344567999999999999999999999999997643

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=1.7e-37  Score=353.00  Aligned_cols=250  Identities=23%  Similarity=0.265  Sum_probs=193.1

Q ss_pred             HHhhcccc-cccccccceEEEEEEe-CCCcEEEEEEeccCCCCCchhhHHHHHHHHhc-CCCCcccceEeEEEc----CC
Q 002010          690 VLESLKDE-NIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGR-IRHRNIVRLLGYVSN----RD  762 (982)
Q Consensus       690 ~~~~~~~~-~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~----~~  762 (982)
                      +.+.|... +.||+|+||+||+|.. .+++.||||++..      ...+.+|+.++.+ .+||||+++++++..    ..
T Consensus        59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~------~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~  132 (400)
T 1nxk_A           59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRK  132 (400)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred             ccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc------chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCc
Confidence            44567765 6899999999999965 4689999999842      2457788888744 489999999998865    56


Q ss_pred             ccEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcC---CCCEEEeccc
Q 002010          763 TNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDS---DFEAHVADFG  839 (982)
Q Consensus       763 ~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~---~~~~kl~DfG  839 (982)
                      ..++||||+++|+|.+++.......+++..+..++.||+.||+|||+.+   |+||||||+||+++.   ++.+||+|||
T Consensus       133 ~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG  209 (400)
T 1nxk_A          133 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFG  209 (400)
T ss_dssp             EEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred             EEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEecc
Confidence            6899999999999999998655567999999999999999999999998   999999999999997   7899999999


Q ss_pred             cchhccccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCc---hHHHHHHHhccCC
Q 002010          840 LAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGV---DIVRWVRKTTSEV  916 (982)
Q Consensus       840 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~---~~~~~~~~~~~~~  916 (982)
                      +++.....   .......||+.|+|||++.+..++.++||||+||++|||++|+.||.......   .....+.......
T Consensus       210 ~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~  286 (400)
T 1nxk_A          210 FAKETTSH---NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF  286 (400)
T ss_dssp             TCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCC
T ss_pred             cccccCCC---CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccC
Confidence            99865432   22345678999999999999999999999999999999999999997643321   1222222211111


Q ss_pred             CCCCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          917 SQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       917 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                      +.            +    .....+..+.+++.+||+.||++|||++|+++
T Consensus       287 ~~------------~----~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~  321 (400)
T 1nxk_A          287 PN------------P----EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  321 (400)
T ss_dssp             CT------------T----TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             CC------------c----ccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            00            0    01223457889999999999999999999987

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=100.00  E-value=4.1e-37  Score=358.58  Aligned_cols=327  Identities=24%  Similarity=0.308  Sum_probs=220.7

Q ss_pred             CCCCCCCEEecccCcCcccCchhhcCCCccceeecccccCCCCCCccccCCCCCCEEEeeCCcccCcCchhhhcccchhh
Q 002010          238 GALTQLQVLDMASCNISGEIPTSLSRLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTL  317 (982)
Q Consensus       238 ~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~  317 (982)
                      ..+++|++|++++|.+++..+  +.++++|++|++++|++++..+  +..+++|++|++++|.+++..+  +..+++|++
T Consensus        65 ~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~  138 (466)
T 1o6v_A           65 EYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP--LKNLTNLNR  138 (466)
T ss_dssp             GGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCSE
T ss_pred             hhhcCCCEEECCCCccCCchh--hhccccCCEEECCCCccccChh--hcCCCCCCEEECCCCCCCCChH--HcCCCCCCE
Confidence            334455555555555553332  5555555555555555554332  5555556666666665553322  555555555


Q ss_pred             hhhccCCCCCCCCCcCCCCCCccEEEccCCCcccccCccccCCCcccEEEeccccccccCCccccCccccceeecccccc
Q 002010          318 LQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFF  397 (982)
Q Consensus       318 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~l~~N~~  397 (982)
                      |++++|.+.+. + .+..+++|+.|+++ |.+.+..  .+..+++|+.|++++|.+++.  ..+..+++|++|++++|.+
T Consensus       139 L~l~~n~l~~~-~-~~~~l~~L~~L~l~-~~~~~~~--~~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l  211 (466)
T 1o6v_A          139 LELSSNTISDI-S-ALSGLTSLQQLSFG-NQVTDLK--PLANLTTLERLDISSNKVSDI--SVLAKLTNLESLIATNNQI  211 (466)
T ss_dssp             EEEEEEEECCC-G-GGTTCTTCSEEEEE-ESCCCCG--GGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCC
T ss_pred             EECCCCccCCC-h-hhccCCcccEeecC-CcccCch--hhccCCCCCEEECcCCcCCCC--hhhccCCCCCEEEecCCcc
Confidence            55555555532 2 35566666666664 3333222  266666666666666666532  2244445555555555554


Q ss_pred             cccCCccccCCCCCCEEEccCCccCCCCCccccCCCccccccCCCccccccCCcccccCCccEEEeeccccCCCCchhcc
Q 002010          398 IGPIPEELGQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLSGELPEKMSGASLNQLKVANNNITGKIPAAIG  477 (982)
Q Consensus       398 ~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~L~~N~i~~~~p~~~~  477 (982)
                      .+..|  ++.+++|++|++++|                        .+++. +.....++|+.|++++|++++..+  +.
T Consensus       212 ~~~~~--~~~l~~L~~L~l~~n------------------------~l~~~-~~l~~l~~L~~L~l~~n~l~~~~~--~~  262 (466)
T 1o6v_A          212 SDITP--LGILTNLDELSLNGN------------------------QLKDI-GTLASLTNLTDLDLANNQISNLAP--LS  262 (466)
T ss_dssp             CCCGG--GGGCTTCCEEECCSS------------------------CCCCC-GGGGGCTTCSEEECCSSCCCCCGG--GT
T ss_pred             ccccc--ccccCCCCEEECCCC------------------------Ccccc-hhhhcCCCCCEEECCCCccccchh--hh
Confidence            44333  344444555555544                        44432 222233578888888888886655  88


Q ss_pred             CCCCcceeeeccccccCCCccccccccccceeeeeccccCCCCCcccccccCCCeeeCCCCcccCCCCcccccccccceE
Q 002010          478 NLPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYGKIPPGISKLIDLSIL  557 (982)
Q Consensus       478 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L  557 (982)
                      .+++|++|++++|++++..+  +..+++|++|++++|++++..+  +..+++|+.|+|++|++++..|  +..+++|+.|
T Consensus       263 ~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L  336 (466)
T 1o6v_A          263 GLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRL  336 (466)
T ss_dssp             TCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEE
T ss_pred             cCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh--hccCccCCEe
Confidence            99999999999999996544  8899999999999999997655  8899999999999999997766  8899999999


Q ss_pred             EcccccccccCccccccccccceecccCCccccCCCCCccccccccccccCCcCcccC
Q 002010          558 NLSRNGITGSIPNEMRNMMSLTTLDLSYNNLIGNIPSGGQFLAFNETSFIGNPNLCLL  615 (982)
Q Consensus       558 ~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~~~~~~~~~~~~~~n~~~c~~  615 (982)
                      ++++|++++.  ..+..+++|+.|++++|++++.+| ...+..+....+.+|++...+
T Consensus       337 ~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~l~~n~~~~~p  391 (466)
T 1o6v_A          337 FFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP-LANLTRITQLGLNDQAWTNAP  391 (466)
T ss_dssp             ECCSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGG-GTTCTTCCEEECCCEEEECCC
T ss_pred             ECCCCccCCc--hhhccCCCCCEEeCCCCccCccch-hhcCCCCCEEeccCCcccCCc
Confidence            9999999975  479999999999999999999988 566778888888888877643

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-37  Score=347.27  Aligned_cols=267  Identities=25%  Similarity=0.357  Sum_probs=204.1

Q ss_pred             HHHHhhcccccccccccceEEEEEEeCCCcEEEEEEeccCCCCCchhhHHHHHHHHhcC--CCCcccceEeEEEcC----
Q 002010          688 EDVLESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRI--RHRNIVRLLGYVSNR----  761 (982)
Q Consensus       688 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~~~~~~~~~----  761 (982)
                      ..+.++|+..+.||+|+||.||+|+. .++.||||++...    ....+.+|.+++...  +||||+++++++...    
T Consensus        33 ~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~  107 (337)
T 3mdy_A           33 RTIAKQIQMVKQIGKGRYGEVWMGKW-RGEKVAVKVFFTT----EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSW  107 (337)
T ss_dssp             TTHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEEEGG----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGG
T ss_pred             cccccceEEEeEeecCCCeEEEEEEE-CCceEEEEEEecc----ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCC
Confidence            34567899999999999999999987 4899999998432    234455666666555  899999999998877    


Q ss_pred             CccEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhc--------CCCcEEecCCCCCcEEEcCCCCE
Q 002010          762 DTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHD--------CSPLIIHRDVKSNNILLDSDFEA  833 (982)
Q Consensus       762 ~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~--------~~~~ivHrDlkp~Nill~~~~~~  833 (982)
                      ...++||||+++|+|.++++.   ..+++..+..++.|++.|++|||+.        +   |+||||||+||+++.++.+
T Consensus       108 ~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~  181 (337)
T 3mdy_A          108 TQLYLITDYHENGSLYDYLKS---TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA---IAHRDLKSKNILVKKNGTC  181 (337)
T ss_dssp             CEEEEEECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC---EECSCCCGGGEEECTTSCE
T ss_pred             CceEEEEeccCCCcHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---EEecccchHHEEECCCCCE
Confidence            678999999999999999964   3699999999999999999999987        6   9999999999999999999


Q ss_pred             EEeccccchhccccCCcc--cccccccccccccccccccCCCCcc------hhhHHHHHHHHHHHhC----------CCC
Q 002010          834 HVADFGLAKFLQDAGASE--CMSSVAGSYGYIAPEYAYTLKVDEK------SDVYSFGVVLLELIAG----------KKP  895 (982)
Q Consensus       834 kl~DfG~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~------~DvwslG~il~elltg----------~~p  895 (982)
                      ||+|||++..+.......  ......||+.|+|||++.+..++.+      +||||+||++|||++|          +.|
T Consensus       182 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p  261 (337)
T 3mdy_A          182 CIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLP  261 (337)
T ss_dssp             EECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred             EEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccccccc
Confidence            999999997664332211  1234579999999999987766654      9999999999999999          666


Q ss_pred             CCCCCCCchHHHHHHHhccCCCCCCcccccceeecCCCC--CCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 002010          896 VGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDPRLS--GYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPP  973 (982)
Q Consensus       896 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~  973 (982)
                      |...................           ....+..+  ..+..++..+.+++.+||+.||++|||++|+++.|+.+.
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~  330 (337)
T 3mdy_A          262 YHDLVPSDPSYEDMREIVCI-----------KKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMS  330 (337)
T ss_dssp             TTTTSCSSCCHHHHHHHHTT-----------SCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HhhhcCCCCchhhhHHHHhh-----------hccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHH
Confidence            65532222111111111110           00111111  112366778999999999999999999999999998766


Q ss_pred             CCC
Q 002010          974 QSA  976 (982)
Q Consensus       974 ~~~  976 (982)
                      +..
T Consensus       331 ~~~  333 (337)
T 3mdy_A          331 ESQ  333 (337)
T ss_dssp             HTT
T ss_pred             hhc
Confidence            543

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=4.8e-38  Score=353.93  Aligned_cols=265  Identities=23%  Similarity=0.281  Sum_probs=205.3

Q ss_pred             HhhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCC-----CCcccceEeEEEcCCcc
Q 002010          691 LESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIR-----HRNIVRLLGYVSNRDTN  764 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~~~~~~~~~~~~  764 (982)
                      .++|++.+.||+|+||.||+|.. .+++.||||++..  .......+..|+.++++++     ||||+++++++...+..
T Consensus        34 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~--~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~  111 (360)
T 3llt_A           34 NNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN--IKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHM  111 (360)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS--CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEE
T ss_pred             cCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc--chhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCee
Confidence            46899999999999999999976 5689999999842  2233456778999999986     99999999999999999


Q ss_pred             EEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcC---------------
Q 002010          765 LLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDS---------------  829 (982)
Q Consensus       765 ~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~---------------  829 (982)
                      ++||||+ +++|.+++.......+++..+..++.||+.||+|||+.+   |+||||||+||+++.               
T Consensus       112 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~~~~~~~~~  187 (360)
T 3llt_A          112 CLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEKSLITVRRVTD  187 (360)
T ss_dssp             EEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTCCEEEEEEECTTT
T ss_pred             EEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEccccccccccchhcccc
Confidence            9999999 999999998766677999999999999999999999998   999999999999975               


Q ss_pred             ----------CCCEEEeccccchhccccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Q 002010          830 ----------DFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEF  899 (982)
Q Consensus       830 ----------~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~  899 (982)
                                ++.+||+|||++......     .....||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus       188 ~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~  262 (360)
T 3llt_A          188 GKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTH  262 (360)
T ss_dssp             CCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             cccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCC
Confidence                      789999999999864422     23567899999999999999999999999999999999999999865


Q ss_pred             CCCchHHHHHHHhccCCCCC-------Ccccccc-----eeecCCC--------------CCCChHhHHHHHHHHhhccC
Q 002010          900 GDGVDIVRWVRKTTSEVSQP-------SDAASVL-----AVVDPRL--------------SGYPLTGVIHLFKVAMMCVE  953 (982)
Q Consensus       900 ~~~~~~~~~~~~~~~~~~~~-------~~~~~~~-----~~~~~~~--------------~~~~~~~~~~l~~li~~cl~  953 (982)
                      ........ +.......+..       .......     ....+..              +..+......+.+++.+||+
T Consensus       263 ~~~~~~~~-~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~  341 (360)
T 3llt_A          263 EHMEHLAM-MESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQ  341 (360)
T ss_dssp             SHHHHHHH-HHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCC
T ss_pred             cHHHHHHH-HHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhc
Confidence            43332222 22221111100       0000000     0000000              00001112567899999999


Q ss_pred             CCCCCCCCHHHHHH
Q 002010          954 DESSARPTMREVVH  967 (982)
Q Consensus       954 ~dP~~Rpt~~ell~  967 (982)
                      .||++|||++|+++
T Consensus       342 ~dP~~Rpta~elL~  355 (360)
T 3llt_A          342 IDPTLRPSPAELLK  355 (360)
T ss_dssp             SSGGGSCCHHHHTT
T ss_pred             CChhhCCCHHHHhc
Confidence            99999999999875

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=2.1e-38  Score=351.68  Aligned_cols=273  Identities=26%  Similarity=0.324  Sum_probs=209.8

Q ss_pred             hhcccccccccccceEEEEEEe-----CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEc--CCcc
Q 002010          692 ESLKDENIIGKGGAGIVYRGSM-----PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSN--RDTN  764 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~  764 (982)
                      ++|+..+.||+|+||.||+|++     .+++.||+|++... .....+.+.+|+.++++++||||+++++++..  ....
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  101 (327)
T 3lxl_A           23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS-GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL  101 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred             hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC-CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence            5789999999999999999973     46889999998433 33344568999999999999999999998874  4568


Q ss_pred             EEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhc
Q 002010          765 LLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFL  844 (982)
Q Consensus       765 ~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~  844 (982)
                      ++||||+++++|.+++... ...+++..++.++.|++.|++|||+.+   |+||||||+||+++.++.+||+|||++...
T Consensus       102 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~  177 (327)
T 3lxl_A          102 RLVMEYLPSGCLRDFLQRH-RARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLL  177 (327)
T ss_dssp             EEEEECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred             EEEEeecCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccceec
Confidence            8999999999999999742 246899999999999999999999998   999999999999999999999999999876


Q ss_pred             cccCCc-ccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCccc
Q 002010          845 QDAGAS-ECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAA  923 (982)
Q Consensus       845 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  923 (982)
                      ...... .......+++.|+|||++.+..++.++||||+|+++|+|++|+.||.....     ............ ....
T Consensus       178 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~-----~~~~~~~~~~~~-~~~~  251 (327)
T 3lxl_A          178 PLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSA-----EFLRMMGCERDV-PALS  251 (327)
T ss_dssp             CTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHH-----HHHHHCC----C-CHHH
T ss_pred             ccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccc-----hhhhhccccccc-ccHH
Confidence            533221 123345678889999999998899999999999999999999999864211     011000000000 0000


Q ss_pred             ccceeecC-CCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCCC
Q 002010          924 SVLAVVDP-RLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQS  975 (982)
Q Consensus       924 ~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~~~  975 (982)
                      .....+.. .....+...+..+.+++.+||+.||++|||++|+++.|+.+...
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~  304 (327)
T 3lxl_A          252 RLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSG  304 (327)
T ss_dssp             HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC---
T ss_pred             HHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence            11111111 11233455667899999999999999999999999999887653

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=1.1e-37  Score=345.82  Aligned_cols=258  Identities=19%  Similarity=0.247  Sum_probs=207.6

Q ss_pred             HHHHHhhcccc-cccccccceEEEEEEe-CCCcEEEEEEeccCCC-CCchhhHHHHHHHHhcCC-CCcccceEeEEEcCC
Q 002010          687 AEDVLESLKDE-NIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGT-GGNDHGFLAEIQTLGRIR-HRNIVRLLGYVSNRD  762 (982)
Q Consensus       687 ~~~~~~~~~~~-~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~  762 (982)
                      .+.+.++|... +.||+|+||.||+|.. .+++.||+|++..... ......+.+|+.++.++. ||||+++++++.+.+
T Consensus        23 ~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~  102 (327)
T 3lm5_A           23 MENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTS  102 (327)
T ss_dssp             HHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred             HHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCC
Confidence            45667778877 8999999999999965 4689999999865432 234567889999999994 699999999999999


Q ss_pred             ccEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcC---CCCEEEeccc
Q 002010          763 TNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDS---DFEAHVADFG  839 (982)
Q Consensus       763 ~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~---~~~~kl~DfG  839 (982)
                      ..++||||+++++|.+++.......+++..+..++.|++.|++|||+.+   |+||||||+||+++.   ++.+||+|||
T Consensus       103 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~kL~Dfg  179 (327)
T 3lm5_A          103 EIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFG  179 (327)
T ss_dssp             EEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEEECCGG
T ss_pred             eEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEEEeeCc
Confidence            9999999999999999997656678999999999999999999999998   999999999999988   7899999999


Q ss_pred             cchhccccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCC
Q 002010          840 LAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQP  919 (982)
Q Consensus       840 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  919 (982)
                      +++.....   .......||+.|+|||++.+..++.++||||+|+++|||++|+.||.................. ..  
T Consensus       180 ~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~-~~--  253 (327)
T 3lm5_A          180 MSRKIGHA---CELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVD-YS--  253 (327)
T ss_dssp             GCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC-CC--
T ss_pred             cccccCCc---cccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccc-cC--
Confidence            99876532   2234467999999999999999999999999999999999999999765433222222211111 00  


Q ss_pred             CcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          920 SDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       920 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                                    .......+..+.+++.+||+.||++|||++|+++
T Consensus       254 --------------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~  287 (327)
T 3lm5_A          254 --------------EETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS  287 (327)
T ss_dssp             --------------TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             --------------chhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence                          0112234457889999999999999999999987

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=5.4e-38  Score=359.68  Aligned_cols=255  Identities=22%  Similarity=0.313  Sum_probs=197.6

Q ss_pred             HHHHhhcccccccccccceEEEEEEe-CCCcEEEEEEeccCC-------CCCchhhHHHHHHHHhcCCCCcccceEeEEE
Q 002010          688 EDVLESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRG-------TGGNDHGFLAEIQTLGRIRHRNIVRLLGYVS  759 (982)
Q Consensus       688 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~  759 (982)
                      ..+.++|+..+.||+|+||.||+|.. .+++.||+|++....       .......+.+|+.++++++||||+++++++.
T Consensus       131 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  210 (419)
T 3i6u_A          131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD  210 (419)
T ss_dssp             HHHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE
T ss_pred             hhhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence            45678899999999999999999965 568999999985432       1122345889999999999999999999986


Q ss_pred             cCCccEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCC---CCEEEe
Q 002010          760 NRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSD---FEAHVA  836 (982)
Q Consensus       760 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~---~~~kl~  836 (982)
                      . +..++||||+++++|.+++.  +...+++..+..++.|++.|++|||+.+   |+||||||+||+++.+   +.+||+
T Consensus       211 ~-~~~~lv~e~~~~g~L~~~l~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~  284 (419)
T 3i6u_A          211 A-EDYYIVLELMEGGELFDKVV--GNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKIT  284 (419)
T ss_dssp             S-SEEEEEEECCTTCBGGGGTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred             c-CceEEEEEcCCCCcHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEe
Confidence            4 55799999999999999986  4567999999999999999999999998   9999999999999754   459999


Q ss_pred             ccccchhccccCCccccccccccccccccccccc---CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhc
Q 002010          837 DFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYT---LKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTT  913 (982)
Q Consensus       837 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~  913 (982)
                      |||+++.....   .......||+.|+|||++.+   ..++.++||||+||++|+|++|+.||............+....
T Consensus       285 DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~  361 (419)
T 3i6u_A          285 DFGHSKILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGK  361 (419)
T ss_dssp             CSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTC
T ss_pred             ecccceecCCC---ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCC
Confidence            99999876532   22345679999999999863   5688899999999999999999999987555444444433222


Q ss_pred             cCCCCCCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          914 SEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       914 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                      ....                +......+..+.+++.+||+.||++|||++|+++
T Consensus       362 ~~~~----------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  399 (419)
T 3i6u_A          362 YNFI----------------PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR  399 (419)
T ss_dssp             CCCC----------------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CCCC----------------chhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence            1000                0001123457899999999999999999999986

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=1.2e-37  Score=363.58  Aligned_cols=254  Identities=24%  Similarity=0.317  Sum_probs=208.4

Q ss_pred             hhcccccccccccceEEEEEEe-CCCcEEEEEEeccCC--CCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEE
Q 002010          692 ESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRG--TGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLY  768 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  768 (982)
                      +.|+..+.||+|+||.||+|+. .+|+.||+|++....  .......+.+|+.++++++||||+++++++.+....|+||
T Consensus       185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm  264 (543)
T 3c4z_A          185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM  264 (543)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence            5788899999999999999976 469999999985432  2234567889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccc
Q 002010          769 EYMPNGSLGEMLHGAK--GGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQD  846 (982)
Q Consensus       769 e~~~~~sL~~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  846 (982)
                      ||++||+|.+++....  ...+++..+..++.||+.|++|||+.+   |+||||||+||+++.++.+||+|||+++.+..
T Consensus       265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~~  341 (543)
T 3c4z_A          265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKA  341 (543)
T ss_dssp             CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence            9999999999997533  457999999999999999999999998   99999999999999999999999999987653


Q ss_pred             cCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccc
Q 002010          847 AGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVL  926 (982)
Q Consensus       847 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  926 (982)
                      ..  .......||+.|+|||++.+..++.++||||+||++|||++|+.||...........+........          
T Consensus       342 ~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~----------  409 (543)
T 3c4z_A          342 GQ--TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQA----------  409 (543)
T ss_dssp             TC--CCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCC----------
T ss_pred             CC--cccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcc----------
Confidence            32  223446899999999999999999999999999999999999999987543322222222221100          


Q ss_pred             eeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCH-----HHHHH
Q 002010          927 AVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTM-----REVVH  967 (982)
Q Consensus       927 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~-----~ell~  967 (982)
                             ..++...+..+.+++.+||+.||++||++     +|+++
T Consensus       410 -------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~  448 (543)
T 3c4z_A          410 -------VTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT  448 (543)
T ss_dssp             -------CCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred             -------cCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence                   01223344578899999999999999965     66664

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=2e-38  Score=343.28  Aligned_cols=252  Identities=29%  Similarity=0.432  Sum_probs=200.8

Q ss_pred             HhhcccccccccccceEEEEEEeCCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcC-CccEEEEe
Q 002010          691 LESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNR-DTNLLLYE  769 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~lv~e  769 (982)
                      .++|+..+.||+|+||.||+|+. +|+.||+|++...   ...+.+.+|+.++++++||||+++++++.+. +..++|||
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e   95 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND---ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE   95 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC---C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred             hhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecch---hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEe
Confidence            46799999999999999999987 5889999988432   3456789999999999999999999987554 47899999


Q ss_pred             ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCC
Q 002010          770 YMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGA  849 (982)
Q Consensus       770 ~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  849 (982)
                      |+++++|.+++.......+++..+..++.|++.|++|||+.+   |+||||||+||+++.++.+||+|||++......  
T Consensus        96 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~--  170 (278)
T 1byg_A           96 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--  170 (278)
T ss_dssp             CCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred             cCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeecccccccccc--
Confidence            999999999997543334889999999999999999999998   999999999999999999999999999765432  


Q ss_pred             cccccccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHhccCCCCCCccccccee
Q 002010          850 SECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAV  928 (982)
Q Consensus       850 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  928 (982)
                         .....+++.|+|||++.+..++.++||||+|+++|||++ |+.||...... .....+.....              
T Consensus       171 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~-~~~~~~~~~~~--------------  232 (278)
T 1byg_A          171 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-DVVPRVEKGYK--------------  232 (278)
T ss_dssp             --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG-GHHHHHTTTCC--------------
T ss_pred             ---ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHHhcCCC--------------
Confidence               123456889999999998899999999999999999998 99999765332 22222211110              


Q ss_pred             ecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCC
Q 002010          929 VDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQ  974 (982)
Q Consensus       929 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~~  974 (982)
                           ...+...+..+.+++.+||+.||++|||++|+++.|+.+..
T Consensus       233 -----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~  273 (278)
T 1byg_A          233 -----MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT  273 (278)
T ss_dssp             -----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -----CCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHh
Confidence                 11223345678999999999999999999999999987643

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=4.8e-38  Score=357.40  Aligned_cols=272  Identities=22%  Similarity=0.317  Sum_probs=196.0

Q ss_pred             HHHhhcccccccccccceEEEEEEe-CCCcEEEEEEeccCC-CCCchhhHHHHHHHHhcCC-CCcccceEeEEEcCC--c
Q 002010          689 DVLESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRG-TGGNDHGFLAEIQTLGRIR-HRNIVRLLGYVSNRD--T  763 (982)
Q Consensus       689 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~--~  763 (982)
                      .+.++|+..+.||+|+||.||+|.. .+++.||||++.... .......+.+|+.+++++. ||||+++++++..++  .
T Consensus         6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~   85 (388)
T 3oz6_A            6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD   85 (388)
T ss_dssp             HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred             cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence            4668899999999999999999965 568999999985432 2233456789999999997 999999999997544  6


Q ss_pred             cEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchh
Q 002010          764 NLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKF  843 (982)
Q Consensus       764 ~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~  843 (982)
                      .|+||||++ ++|.+++..   ..+++..+..++.||+.|++|||+.+   |+||||||+||+++.++.+||+|||+|+.
T Consensus        86 ~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~  158 (388)
T 3oz6_A           86 VYLVFDYME-TDLHAVIRA---NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRS  158 (388)
T ss_dssp             EEEEEECCS-EEHHHHHHH---TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEecccC-cCHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCccccc
Confidence            799999996 689999864   47899999999999999999999998   99999999999999999999999999986


Q ss_pred             ccccC-------------------Cccccccccccccccccccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCc
Q 002010          844 LQDAG-------------------ASECMSSVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGV  903 (982)
Q Consensus       844 ~~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~  903 (982)
                      +....                   .........||+.|+|||++.+ ..++.++||||+||++|||++|++||.......
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~  238 (388)
T 3oz6_A          159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMN  238 (388)
T ss_dssp             SSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred             ccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            54211                   1122345689999999999876 678999999999999999999999998754433


Q ss_pred             hHHHHHHHhccCCCC-------CCcccccc---eee---cCCCCC-------------CChHhHHHHHHHHhhccCCCCC
Q 002010          904 DIVRWVRKTTSEVSQ-------PSDAASVL---AVV---DPRLSG-------------YPLTGVIHLFKVAMMCVEDESS  957 (982)
Q Consensus       904 ~~~~~~~~~~~~~~~-------~~~~~~~~---~~~---~~~~~~-------------~~~~~~~~l~~li~~cl~~dP~  957 (982)
                      .+..++.........       +.......   ...   ......             .+...+..+.+++.+||+.||+
T Consensus       239 ~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~  318 (388)
T 3oz6_A          239 QLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPN  318 (388)
T ss_dssp             HHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGG
T ss_pred             HHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcc
Confidence            333333222111000       00000000   000   000000             0113345788999999999999


Q ss_pred             CCCCHHHHHH
Q 002010          958 ARPTMREVVH  967 (982)
Q Consensus       958 ~Rpt~~ell~  967 (982)
                      +|||++|+++
T Consensus       319 ~R~t~~e~l~  328 (388)
T 3oz6_A          319 KRISANDALK  328 (388)
T ss_dssp             GSCCHHHHTT
T ss_pred             cCCCHHHHhC
Confidence            9999999987

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.1e-38  Score=352.14  Aligned_cols=254  Identities=24%  Similarity=0.261  Sum_probs=205.2

Q ss_pred             HhhcccccccccccceEEEEEEe----CCCcEEEEEEeccCC---CCCchhhHHHHHHHHhcC-CCCcccceEeEEEcCC
Q 002010          691 LESLKDENIIGKGGAGIVYRGSM----PDGIDVAIKRLVGRG---TGGNDHGFLAEIQTLGRI-RHRNIVRLLGYVSNRD  762 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~  762 (982)
                      .++|+..+.||+|+||.||+|+.    .+++.||||++....   .......+.+|+.+++++ +||||+++++++..+.
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  132 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  132 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence            36799999999999999999976    468999999985432   123345677899999999 6999999999999999


Q ss_pred             ccEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccch
Q 002010          763 TNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAK  842 (982)
Q Consensus       763 ~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~  842 (982)
                      ..++||||+++++|.+++..  ...+++..+..++.||+.||+|||+.+   |+||||||+||+++.++.+||+|||+++
T Consensus       133 ~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a~  207 (355)
T 1vzo_A          133 KLHLILDYINGGELFTHLSQ--RERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK  207 (355)
T ss_dssp             EEEEEECCCCSCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred             eEEEEeecCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence            99999999999999999974  357999999999999999999999998   9999999999999999999999999998


Q ss_pred             hccccCCccccccccccccccccccccc--CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCC
Q 002010          843 FLQDAGASECMSSVAGSYGYIAPEYAYT--LKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPS  920 (982)
Q Consensus       843 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  920 (982)
                      .+.... ........||+.|+|||++.+  ..++.++||||+||++|||++|+.||...........+........    
T Consensus       208 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~----  282 (355)
T 1vzo_A          208 EFVADE-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE----  282 (355)
T ss_dssp             ECCGGG-GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCC----
T ss_pred             ecccCC-CCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccC----
Confidence            654322 222345679999999999885  3478999999999999999999999976544333333332222110    


Q ss_pred             cccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 002010          921 DAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARP-----TMREVVH  967 (982)
Q Consensus       921 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~ell~  967 (982)
                                   ...+...+..+.+++.+||+.||.+||     |++|+++
T Consensus       283 -------------~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~  321 (355)
T 1vzo_A          283 -------------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  321 (355)
T ss_dssp             -------------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             -------------CCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHc
Confidence                         112233445788999999999999999     9999987

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=9e-38  Score=348.55  Aligned_cols=247  Identities=27%  Similarity=0.354  Sum_probs=201.2

Q ss_pred             HhhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCC--CchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEE
Q 002010          691 LESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTG--GNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLL  767 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  767 (982)
                      .+.|+..+.||+|+||.||+|.. .+++.||||++......  .....+.+|+.++++++||||+++++++..++..++|
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  132 (348)
T 1u5q_A           53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV  132 (348)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence            35688899999999999999975 57899999998544322  2235688999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhcccc
Q 002010          768 YEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDA  847 (982)
Q Consensus       768 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  847 (982)
                      |||++ |++.+++.. ....+++..+..++.|+++|++|||+.+   |+||||||+||+++.++.+||+|||++......
T Consensus       133 ~e~~~-g~l~~~l~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~  207 (348)
T 1u5q_A          133 MEYCL-GSASDLLEV-HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA  207 (348)
T ss_dssp             EECCS-EEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred             EecCC-CCHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCCC
Confidence            99996 688888753 2357999999999999999999999998   999999999999999999999999999765432


Q ss_pred             CCcccccccccccccccccccc---cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccc
Q 002010          848 GASECMSSVAGSYGYIAPEYAY---TLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAAS  924 (982)
Q Consensus       848 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  924 (982)
                            ....||+.|+|||++.   ...++.++||||+||++|||++|+.||..................          
T Consensus       208 ------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~----------  271 (348)
T 1u5q_A          208 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP----------  271 (348)
T ss_dssp             ------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC----------
T ss_pred             ------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC----------
Confidence                  3457899999999884   567899999999999999999999999764332222222111100          


Q ss_pred             cceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          925 VLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       925 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                             .  ..+...+..+.+++.+||+.||++|||++|+++
T Consensus       272 -------~--~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~  305 (348)
T 1u5q_A          272 -------A--LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  305 (348)
T ss_dssp             -------C--CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             -------C--CCCCCCCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence                   0  011123456889999999999999999999986

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=2.2e-37  Score=336.07  Aligned_cols=252  Identities=21%  Similarity=0.273  Sum_probs=203.3

Q ss_pred             HhhcccccccccccceEEEEEEeC-CCcEEEEEEeccCCCC-----CchhhHHHHHHHHhcCCCCcccceEeEEEcCCcc
Q 002010          691 LESLKDENIIGKGGAGIVYRGSMP-DGIDVAIKRLVGRGTG-----GNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTN  764 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  764 (982)
                      .++|+..+.||+|+||.||+|... +++.||+|.+......     ...+.+.+|+.++++++||||+++++++.++...
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   83 (283)
T 3bhy_A            4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV   83 (283)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence            467999999999999999999764 6899999998654322     2356789999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCC----CEEEecccc
Q 002010          765 LLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDF----EAHVADFGL  840 (982)
Q Consensus       765 ~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~----~~kl~DfG~  840 (982)
                      ++||||+++++|.+++..  ...+++..+..++.|++.|++|||+.+   |+||||||+||+++.++    .+||+|||.
T Consensus        84 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~  158 (283)
T 3bhy_A           84 VLILELVSGGELFDFLAE--KESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGI  158 (283)
T ss_dssp             EEEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred             EEEEeecCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEeccc
Confidence            999999999999999973  457899999999999999999999998   99999999999998877    899999999


Q ss_pred             chhccccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCC
Q 002010          841 AKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPS  920 (982)
Q Consensus       841 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  920 (982)
                      +.......   ......|++.|+|||++.+..++.++||||+|+++|+|++|+.||........ ...+.....  ..+ 
T Consensus       159 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~--~~~-  231 (283)
T 3bhy_A          159 AHKIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQET-LTNISAVNY--DFD-  231 (283)
T ss_dssp             CEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-HHHHHTTCC--CCC-
T ss_pred             ceeccCCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHH-HHHhHhccc--CCc-
Confidence            98664321   23345689999999999999999999999999999999999999976432221 111111110  000 


Q ss_pred             cccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          921 DAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       921 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                                   .......+..+.+++.+||+.||++|||++|+++
T Consensus       232 -------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  265 (283)
T 3bhy_A          232 -------------EEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE  265 (283)
T ss_dssp             -------------HHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             -------------chhcccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence                         0001123456889999999999999999999987

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=1.1e-37  Score=338.63  Aligned_cols=246  Identities=25%  Similarity=0.371  Sum_probs=204.7

Q ss_pred             hhcccccccccccceEEEEEEeC-CCcEEEEEEeccCC--CCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEE
Q 002010          692 ESLKDENIIGKGGAGIVYRGSMP-DGIDVAIKRLVGRG--TGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLY  768 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  768 (982)
                      ++|+..+.||+|+||.||+|... +++.||+|++....  .......+.+|+.++++++||||+++++++.+.+..++||
T Consensus        14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   93 (284)
T 2vgo_A           14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML   93 (284)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence            57899999999999999999764 57889999985432  2334567889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccC
Q 002010          769 EYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAG  848 (982)
Q Consensus       769 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  848 (982)
                      ||+++++|.+++..  ...+++..+..++.|++.|++|||+.+   |+||||||+||+++.++.+||+|||++...... 
T Consensus        94 e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~-  167 (284)
T 2vgo_A           94 EFAPRGELYKELQK--HGRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSL-  167 (284)
T ss_dssp             CCCTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSSS-
T ss_pred             EeCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCccc-
Confidence            99999999999974  357899999999999999999999988   999999999999999999999999998755422 


Q ss_pred             CcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCccccccee
Q 002010          849 ASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAV  928 (982)
Q Consensus       849 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  928 (982)
                         ......|++.|+|||++.+..++.++||||+|+++|+|++|+.||............. ...               
T Consensus       168 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~-~~~---------------  228 (284)
T 2vgo_A          168 ---RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIV-NVD---------------  228 (284)
T ss_dssp             ---CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH-TTC---------------
T ss_pred             ---ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHh-ccc---------------
Confidence               2234678999999999999999999999999999999999999997643222211111 100               


Q ss_pred             ecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          929 VDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       929 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                           ...+...+..+.+++.+||+.||++|||++|+++
T Consensus       229 -----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  262 (284)
T 2vgo_A          229 -----LKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVME  262 (284)
T ss_dssp             -----CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             -----cCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence                 0122233457889999999999999999999986

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=3.4e-37  Score=347.47  Aligned_cols=251  Identities=13%  Similarity=0.129  Sum_probs=205.2

Q ss_pred             hhcccccccccccceEEEEE------EeCCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCC---CCcccceEeEEEcCC
Q 002010          692 ESLKDENIIGKGGAGIVYRG------SMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIR---HRNIVRLLGYVSNRD  762 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~------~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~  762 (982)
                      ++|+..+.||+|+||+||+|      ...+++.||+|++..    ....++.+|+.++++++   |+||+++++++..++
T Consensus        65 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~----~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~  140 (365)
T 3e7e_A           65 KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKP----ANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQN  140 (365)
T ss_dssp             SEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESS----CCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSS
T ss_pred             EEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCC----CChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCC
Confidence            57889999999999999999      345689999999843    34567888888888886   999999999999999


Q ss_pred             ccEEEEeccCCCCHHHHhhcC---CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcC----------
Q 002010          763 TNLLLYEYMPNGSLGEMLHGA---KGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDS----------  829 (982)
Q Consensus       763 ~~~lv~e~~~~~sL~~~l~~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~----------  829 (982)
                      ..++||||+++|+|.+++...   ....+++..+..++.||+.||+|||+.+   |+||||||+||+++.          
T Consensus       141 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~~~  217 (365)
T 3e7e_A          141 GSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDEDD  217 (365)
T ss_dssp             CEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC-----
T ss_pred             CcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCcccccc
Confidence            999999999999999999642   3467999999999999999999999988   999999999999998          


Q ss_pred             -CCCEEEeccccchhccccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHH
Q 002010          830 -DFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRW  908 (982)
Q Consensus       830 -~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~  908 (982)
                       ++.+||+|||+|+.+.............||+.|+|||++.+..++.++||||+||++|||+||+.||.......     
T Consensus       218 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-----  292 (365)
T 3e7e_A          218 LSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE-----  292 (365)
T ss_dssp             -CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE-----
T ss_pred             ccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc-----
Confidence             89999999999976654434445566789999999999999999999999999999999999999986432210     


Q ss_pred             HHHhccCCCCCCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCC-CCHHHHHHHhcCCCC
Q 002010          909 VRKTTSEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSAR-PTMREVVHMLANPPQ  974 (982)
Q Consensus       909 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R-pt~~ell~~L~~~~~  974 (982)
                                        ...+..+...  .....+.+++..|++.+|.+| |+++++.+.|++..+
T Consensus       293 ------------------~~~~~~~~~~--~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~  339 (365)
T 3e7e_A          293 ------------------CKPEGLFRRL--PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQ  339 (365)
T ss_dssp             ------------------EEECSCCTTC--SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHH
T ss_pred             ------------------eeechhcccc--CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHH
Confidence                              0011111111  124467899999999999998 577888877765443

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=9.5e-38  Score=340.99  Aligned_cols=249  Identities=24%  Similarity=0.307  Sum_probs=206.2

Q ss_pred             HhhcccccccccccceEEEEEEeC-CCcEEEEEEeccCCCC--CchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEE
Q 002010          691 LESLKDENIIGKGGAGIVYRGSMP-DGIDVAIKRLVGRGTG--GNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLL  767 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  767 (982)
                      .++|+..+.||+|+||.||+|... +++.||+|.+......  ...+.+.+|+.++++++||||+++++++.+++..++|
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   93 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV   93 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence            357899999999999999999764 5889999998554322  2345688999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhcccc
Q 002010          768 YEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDA  847 (982)
Q Consensus       768 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  847 (982)
                      |||+++++|.+++..  ...+++.++..++.|++.|++|||+.+   |+||||||+||+++.++.+||+|||.+......
T Consensus        94 ~e~~~~~~L~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~  168 (294)
T 2rku_A           94 LELCRRRSLLELHKR--RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD  168 (294)
T ss_dssp             EECCTTCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred             EecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceecccC
Confidence            999999999999863  357899999999999999999999998   999999999999999999999999999876432


Q ss_pred             CCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccce
Q 002010          848 GASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLA  927 (982)
Q Consensus       848 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  927 (982)
                      .  .......|++.|+|||++.+..++.++||||+|+++|+|++|+.||..............   ...           
T Consensus       169 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~---~~~-----------  232 (294)
T 2rku_A          169 G--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKK---NEY-----------  232 (294)
T ss_dssp             T--CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT---TCC-----------
T ss_pred             c--cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhh---ccC-----------
Confidence            2  223446789999999999998999999999999999999999999976433222211111   100           


Q ss_pred             eecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          928 VVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       928 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                             ..+...+..+.+++.+||+.||++|||++|+++
T Consensus       233 -------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  265 (294)
T 2rku_A          233 -------SIPKHINPVAASLIQKMLQTDPTARPTINELLN  265 (294)
T ss_dssp             -------CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             -------CCccccCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence                   112233457889999999999999999999987

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=1e-37  Score=351.12  Aligned_cols=266  Identities=23%  Similarity=0.351  Sum_probs=205.4

Q ss_pred             hhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEec
Q 002010          692 ESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEY  770 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  770 (982)
                      ++|+..+.||+|+||.||+|.. .+++.||+|++...........+.+|+.++++++||||+++++++.+++..++||||
T Consensus        33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  112 (360)
T 3eqc_A           33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH  112 (360)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEEC
Confidence            5789999999999999999976 468999999986654444556789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhc-CCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCC
Q 002010          771 MPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHD-CSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGA  849 (982)
Q Consensus       771 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  849 (982)
                      +++++|.+++..  ...+++..+..++.|++.|++|||+. +   |+||||||+||+++.++.+||+|||++......  
T Consensus       113 ~~~~~L~~~l~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--  185 (360)
T 3eqc_A          113 MDGGSLDQVLKK--AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--  185 (360)
T ss_dssp             CTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--
T ss_pred             CCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCcccccc--
Confidence            999999999973  35789999999999999999999985 7   999999999999999999999999999866432  


Q ss_pred             cccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccC-----CCCCCcc--
Q 002010          850 SECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSE-----VSQPSDA--  922 (982)
Q Consensus       850 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~-----~~~~~~~--  922 (982)
                        ......||+.|+|||++.+..++.++||||+||++|||++|+.||....... ...........     .......  
T Consensus       186 --~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  262 (360)
T 3eqc_A          186 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKE-LELMFGCQVEGDAAETPPRPRTPGR  262 (360)
T ss_dssp             --C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHH-HHHHHC-------------------
T ss_pred             --cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHhcccccccCCCCCCCcccCCC
Confidence              2234578999999999999999999999999999999999999997643221 11111100000     0000000  


Q ss_pred             ----------------cccceeecCCCCCC-ChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          923 ----------------ASVLAVVDPRLSGY-PLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       923 ----------------~~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                                      .............. +...+..+.+++.+||+.||++|||++|+++
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  324 (360)
T 3eqc_A          263 PLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV  324 (360)
T ss_dssp             -----------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             cccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence                            00000000111111 1224567899999999999999999999986

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=1.8e-37  Score=341.35  Aligned_cols=247  Identities=23%  Similarity=0.261  Sum_probs=194.1

Q ss_pred             HHhhcccccccccccceEEEEEEeC-CCcEEEEEEeccCCCC-CchhhHHHHHHHHhcC-CCCcccceEeEEEcCCccEE
Q 002010          690 VLESLKDENIIGKGGAGIVYRGSMP-DGIDVAIKRLVGRGTG-GNDHGFLAEIQTLGRI-RHRNIVRLLGYVSNRDTNLL  766 (982)
Q Consensus       690 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~l  766 (982)
                      +.++|+..+.||+|+||+||+|... +++.||||++...... .....+..|+..+.++ +||||+++++++.+++..++
T Consensus        55 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~l  134 (311)
T 3p1a_A           55 FQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYL  134 (311)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             hhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEE
Confidence            4468999999999999999999764 7999999987543222 2233455666666555 89999999999999999999


Q ss_pred             EEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccc
Q 002010          767 LYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQD  846 (982)
Q Consensus       767 v~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  846 (982)
                      ||||+ +++|.+++... ...+++..+..++.||+.||+|||+.+   |+||||||+||+++.++.+||+|||++.....
T Consensus       135 v~e~~-~~~L~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~  209 (311)
T 3p1a_A          135 QTELC-GPSLQQHCEAW-GASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGT  209 (311)
T ss_dssp             EEECC-CCBHHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred             EEecc-CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence            99999 77999988643 357999999999999999999999998   99999999999999999999999999976643


Q ss_pred             cCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccc
Q 002010          847 AGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVL  926 (982)
Q Consensus       847 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  926 (982)
                      .   .......||+.|+|||++.+ .++.++||||+||++|||++|..|+...   .. ...+.....   .        
T Consensus       210 ~---~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~---~~-~~~~~~~~~---~--------  270 (311)
T 3p1a_A          210 A---GAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG---EG-WQQLRQGYL---P--------  270 (311)
T ss_dssp             --------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH---HH-HHHHTTTCC---C--------
T ss_pred             C---CCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc---cH-HHHHhccCC---C--------
Confidence            2   22344568999999998876 7999999999999999999997766431   11 111111000   0        


Q ss_pred             eeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          927 AVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       927 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                             ...+...+..+.+++.+||+.||++|||++|+++
T Consensus       271 -------~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  304 (311)
T 3p1a_A          271 -------PEFTAGLSSELRSVLVMMLEPDPKLRATAEALLA  304 (311)
T ss_dssp             -------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             -------cccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence                   0111223457899999999999999999999986

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=8.7e-38  Score=361.86  Aligned_cols=266  Identities=21%  Similarity=0.260  Sum_probs=198.4

Q ss_pred             HhhcccccccccccceEEEEEEe-CCCcEEEEEEeccCC-CCCchhhHHHHHHHHhcCCCCcccceEeEEEcCC------
Q 002010          691 LESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRG-TGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRD------  762 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------  762 (982)
                      .++|+..+.||+|+||+||+|.. .+++.||||++.... .....+.+.+|+.+++.++||||+++++++....      
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            46899999999999999999964 568999999985432 2233557889999999999999999999997654      


Q ss_pred             ccEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccch
Q 002010          763 TNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAK  842 (982)
Q Consensus       763 ~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~  842 (982)
                      ..|+||||+++ ++.+.+.    ..+++..+..++.||+.||+|||+.+   |+||||||+||+++.++.+||+|||+|+
T Consensus       141 ~~~lv~E~~~~-~l~~~~~----~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a~  212 (464)
T 3ttj_A          141 DVYLVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR  212 (464)
T ss_dssp             EEEEEEECCSE-EHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC-
T ss_pred             eEEEEEeCCCC-CHHHHHh----hcCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEeee
Confidence            45999999965 5767664    24899999999999999999999998   9999999999999999999999999998


Q ss_pred             hccccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCC--C
Q 002010          843 FLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQP--S  920 (982)
Q Consensus       843 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--~  920 (982)
                      .....   .......||+.|+|||++.+..|+.++||||+||++|||++|++||.+.........++.......+..  .
T Consensus       213 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~  289 (464)
T 3ttj_A          213 TAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK  289 (464)
T ss_dssp             ----C---CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTT
T ss_pred             ecCCC---cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence            76532   234557899999999999999999999999999999999999999987544333333333222211000  0


Q ss_pred             cccccceeec--CCC--------------CC---CChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          921 DAASVLAVVD--PRL--------------SG---YPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       921 ~~~~~~~~~~--~~~--------------~~---~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                      ........++  +..              +.   ........+.+|+.+||+.||++|||++|+++
T Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  355 (464)
T 3ttj_A          290 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  355 (464)
T ss_dssp             SCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             cchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            0000000000  000              00   01112567899999999999999999999987

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=4.4e-38  Score=345.26  Aligned_cols=263  Identities=28%  Similarity=0.413  Sum_probs=189.3

Q ss_pred             HhhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEe
Q 002010          691 LESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYE  769 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  769 (982)
                      .++|+..+.||+|+||.||+|.. .+++.||||++..........++.+|+.++++++||||+++++++..++..++|||
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   93 (303)
T 2vwi_A           14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMK   93 (303)
T ss_dssp             CCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEE
T ss_pred             hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEeh
Confidence            45789999999999999999965 46899999988555444556678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhc------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchh
Q 002010          770 YMPNGSLGEMLHG------AKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKF  843 (982)
Q Consensus       770 ~~~~~sL~~~l~~------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~  843 (982)
                      |+++++|.+++..      .....+++..+..++.||+.|++|||+.+   |+||||||+||+++.++.+||+|||.+..
T Consensus        94 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~  170 (303)
T 2vwi_A           94 LLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSAF  170 (303)
T ss_dssp             CCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHHHH
T ss_pred             hccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccchhe
Confidence            9999999999863      13456899999999999999999999998   99999999999999999999999999987


Q ss_pred             ccccCC---ccccccccccccccccccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCC
Q 002010          844 LQDAGA---SECMSSVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQP  919 (982)
Q Consensus       844 ~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  919 (982)
                      ......   ........||+.|+|||++.+ ..++.++||||+|+++|||++|+.||..................   ..
T Consensus       171 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~---~~  247 (303)
T 2vwi_A          171 LATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPP---SL  247 (303)
T ss_dssp             CC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCC---CT
T ss_pred             eccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCC---cc
Confidence            653321   112234578999999999875 56899999999999999999999999875443332222211111   00


Q ss_pred             CcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          920 SDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       920 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                      .  .   ...+   .......+..+.+++.+||+.||.+|||++|+++
T Consensus       248 ~--~---~~~~---~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  287 (303)
T 2vwi_A          248 E--T---GVQD---KEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR  287 (303)
T ss_dssp             T--C-----------CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             c--c---cccc---chhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence            0  0   0001   1122233457889999999999999999999987

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=3.2e-37  Score=338.74  Aligned_cols=259  Identities=23%  Similarity=0.301  Sum_probs=205.6

Q ss_pred             HHhhcccccccccccceEEEEEEe-CCCcEEEEEEeccCC---CCCchhhHHHHHHHHhcCCCCcccceEeEEE--cCCc
Q 002010          690 VLESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRG---TGGNDHGFLAEIQTLGRIRHRNIVRLLGYVS--NRDT  763 (982)
Q Consensus       690 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~--~~~~  763 (982)
                      +.++|+..+.||+|+||.||+|.. .+++.||+|++....   .......+.+|+.++++++||||+++++++.  +...
T Consensus         3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (305)
T 2wtk_C            3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK   82 (305)
T ss_dssp             --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred             cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence            457899999999999999999976 468899999985432   2344567899999999999999999999984  4457


Q ss_pred             cEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchh
Q 002010          764 NLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKF  843 (982)
Q Consensus       764 ~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~  843 (982)
                      .++||||++++ +.+++.......+++..+..++.||+.|++|||+.+   |+||||||+||+++.++.+||+|||.+..
T Consensus        83 ~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~  158 (305)
T 2wtk_C           83 MYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEA  158 (305)
T ss_dssp             EEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccccc
Confidence            89999999776 888887666778999999999999999999999998   99999999999999999999999999987


Q ss_pred             ccccCCcccccccccccccccccccccCC--CCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCc
Q 002010          844 LQDAGASECMSSVAGSYGYIAPEYAYTLK--VDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSD  921 (982)
Q Consensus       844 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  921 (982)
                      ..............|++.|+|||++.+..  ++.++||||+|+++|||++|+.||...... .....+.....       
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~i~~~~~-------  230 (305)
T 2wtk_C          159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIY-KLFENIGKGSY-------  230 (305)
T ss_dssp             CCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHCCC-------
T ss_pred             cCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHH-HHHHHHhcCCC-------
Confidence            65433334445567999999999987644  478999999999999999999999754221 22222211110       


Q ss_pred             ccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH--HhcCCC
Q 002010          922 AASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH--MLANPP  973 (982)
Q Consensus       922 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~--~L~~~~  973 (982)
                                   ..+...+..+.+++.+||+.||++|||++|+++  .+.+..
T Consensus       231 -------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~  271 (305)
T 2wtk_C          231 -------------AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKH  271 (305)
T ss_dssp             -------------CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCC
T ss_pred             -------------CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCC
Confidence                         112233457889999999999999999999997  444433

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.4e-37  Score=345.83  Aligned_cols=272  Identities=24%  Similarity=0.295  Sum_probs=204.6

Q ss_pred             HHHhhcccccccccccceEEEEEEeC-CCcEEEEEEeccCCCC----CchhhHHHHHHHHhcCCCCcccceEeEEEcCCc
Q 002010          689 DVLESLKDENIIGKGGAGIVYRGSMP-DGIDVAIKRLVGRGTG----GNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDT  763 (982)
Q Consensus       689 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  763 (982)
                      ...++|+..+.||+|+||.||+|... +|+.||+|++......    .....+.+|+.++++++||||+++++++.+.+.
T Consensus         7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (346)
T 1ua2_A            7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN   86 (346)
T ss_dssp             ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred             HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence            34578999999999999999999764 5899999998543221    223468899999999999999999999999999


Q ss_pred             cEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchh
Q 002010          764 NLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKF  843 (982)
Q Consensus       764 ~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~  843 (982)
                      .++||||+++ +|.+++.. ....+++..+..++.|++.|++|||+.+   |+||||||+||+++.++.+||+|||+++.
T Consensus        87 ~~lv~e~~~~-~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~  161 (346)
T 1ua2_A           87 ISLVFDFMET-DLEVIIKD-NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKS  161 (346)
T ss_dssp             CEEEEECCSE-EHHHHHTT-CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred             eEEEEEcCCC-CHHHHHHh-cCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEeccccee
Confidence            9999999975 89888863 3457889999999999999999999998   99999999999999999999999999987


Q ss_pred             ccccCCcccccccccccccccccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcc
Q 002010          844 LQDAGASECMSSVAGSYGYIAPEYAYTL-KVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDA  922 (982)
Q Consensus       844 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  922 (982)
                      +...  ........+|+.|+|||++.+. .++.++||||+||++|||++|.+||....+......+..............
T Consensus       162 ~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~  239 (346)
T 1ua2_A          162 FGSP--NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPD  239 (346)
T ss_dssp             TTSC--CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSS
T ss_pred             ccCC--cccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhh
Confidence            6533  2233456789999999998764 589999999999999999999999987654444444444333221111000


Q ss_pred             -cccce-eecCCCCCCC-----hHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          923 -ASVLA-VVDPRLSGYP-----LTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       923 -~~~~~-~~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                       ..... ......+..+     ...+..+.+++.+||+.||++|||++|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  291 (346)
T 1ua2_A          240 MCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  291 (346)
T ss_dssp             TTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             hccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhc
Confidence             00000 0001111111     234467999999999999999999999997

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=2.1e-37  Score=341.07  Aligned_cols=262  Identities=21%  Similarity=0.320  Sum_probs=199.1

Q ss_pred             HhhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCC--CCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEE
Q 002010          691 LESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGT--GGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLL  767 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  767 (982)
                      .++|+..+.||+|+||.||+|.. .+++.||+|++.....  ......+.+|+.++++++||||+++++++..++..++|
T Consensus        31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv  110 (310)
T 2wqm_A           31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV  110 (310)
T ss_dssp             GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence            46799999999999999999975 5799999999854322  22345688999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhcc
Q 002010          768 YEYMPNGSLGEMLHG--AKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQ  845 (982)
Q Consensus       768 ~e~~~~~sL~~~l~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~  845 (982)
                      |||+++++|.+++..  .....+++..++.++.|++.|++|||+.+   |+||||||+||+++.++.+||+|||++....
T Consensus       111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~  187 (310)
T 2wqm_A          111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFS  187 (310)
T ss_dssp             EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred             EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence            999999999999864  23467899999999999999999999998   9999999999999999999999999998765


Q ss_pred             ccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCccccc
Q 002010          846 DAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASV  925 (982)
Q Consensus       846 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  925 (982)
                      ...  .......|++.|+|||++.+..++.++||||+|+++|||++|+.||......  ..............+      
T Consensus       188 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~------  257 (310)
T 2wqm_A          188 SKT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN--LYSLCKKIEQCDYPP------  257 (310)
T ss_dssp             -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC--HHHHHHHHHTTCSCC------
T ss_pred             CCC--ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh--HHHHHHHhhcccCCC------
Confidence            321  2223457899999999999999999999999999999999999999753322  112221111100000      


Q ss_pred             ceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCC
Q 002010          926 LAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQ  974 (982)
Q Consensus       926 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~~  974 (982)
                               ..+...+..+.+++.+||+.||++|||++|+++.|+++..
T Consensus       258 ---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~  297 (310)
T 2wqm_A          258 ---------LPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHA  297 (310)
T ss_dssp             ---------CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---------CcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence                     0012234578999999999999999999999999977644

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=3.8e-38  Score=353.38  Aligned_cols=261  Identities=18%  Similarity=0.201  Sum_probs=206.5

Q ss_pred             hhcccccccccccceEEEEEEeC---------CCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccc---------
Q 002010          692 ESLKDENIIGKGGAGIVYRGSMP---------DGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVR---------  753 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~---------  753 (982)
                      ++|+..+.||+|+||.||+|...         +++.||+|++...      ..+.+|+.++++++||||++         
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~  115 (352)
T 2jii_A           42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD------GRLFNEQNFFQRAAKPLQVNKWKKLYSTP  115 (352)
T ss_dssp             CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT------STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred             CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc------chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence            57999999999999999999765         3789999998533      46889999999999999998         


Q ss_pred             ------eEeEEEc-CCccEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEE
Q 002010          754 ------LLGYVSN-RDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNIL  826 (982)
Q Consensus       754 ------~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nil  826 (982)
                            +++++.. +...++||||+ +++|.+++.......+++..+..++.||+.||+|||+.+   |+||||||+||+
T Consensus       116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIl  191 (352)
T 2jii_A          116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENIF  191 (352)
T ss_dssp             TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGEE
T ss_pred             ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEE
Confidence                  6677765 67789999999 999999998654578999999999999999999999998   999999999999


Q ss_pred             EcCCC--CEEEeccccchhccccCCc-----ccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Q 002010          827 LDSDF--EAHVADFGLAKFLQDAGAS-----ECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEF  899 (982)
Q Consensus       827 l~~~~--~~kl~DfG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~  899 (982)
                      ++.++  .+||+|||+++.+......     .......||+.|+|||++.+..++.++||||+|+++|||++|+.||...
T Consensus       192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  271 (352)
T 2jii_A          192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNC  271 (352)
T ss_dssp             EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred             EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence            99998  9999999999876543211     1123457999999999999999999999999999999999999999875


Q ss_pred             C-CCchHHHHHHHhccCCCCCCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 002010          900 G-DGVDIVRWVRKTTSEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPP  973 (982)
Q Consensus       900 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~  973 (982)
                      . ..................         ..++..  .....+..+.+++.+||+.||++|||++|+++.|+++.
T Consensus       272 ~~~~~~~~~~~~~~~~~~~~---------~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~  335 (352)
T 2jii_A          272 LPNTEDIMKQKQKFVDKPGP---------FVGPCG--HWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALL  335 (352)
T ss_dssp             TTCHHHHHHHHHHHHHSCCC---------EECTTS--CEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred             CcCHHHHHHHHHhccCChhh---------hhhhcc--ccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHH
Confidence            4 323333332222111100         000000  01122457899999999999999999999999987654

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=9.8e-38  Score=339.06  Aligned_cols=251  Identities=23%  Similarity=0.352  Sum_probs=207.2

Q ss_pred             HHHhhcccccccccccceEEEEEEeC-CCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEc-------
Q 002010          689 DVLESLKDENIIGKGGAGIVYRGSMP-DGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSN-------  760 (982)
Q Consensus       689 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-------  760 (982)
                      .+..+|+..+.||+|+||.||+|... +++.||+|++...     ...+.+|+.++++++||||+++++++..       
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   82 (284)
T 2a19_B            8 RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYN-----NEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPET   82 (284)
T ss_dssp             HHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECC-----SGGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---
T ss_pred             hhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHhCCCCCEEEEeeeEeccccCccc
Confidence            45578999999999999999999764 7999999998543     2457799999999999999999998754       


Q ss_pred             ---------CCccEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCC
Q 002010          761 ---------RDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDF  831 (982)
Q Consensus       761 ---------~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~  831 (982)
                               ....++||||+++++|.+++.......+++..+..++.|++.|++|||+.+   |+||||||+||+++.++
T Consensus        83 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~  159 (284)
T 2a19_B           83 SSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTK  159 (284)
T ss_dssp             ------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETT
T ss_pred             ccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCC
Confidence                     345789999999999999998655678999999999999999999999998   99999999999999999


Q ss_pred             CEEEeccccchhccccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHH
Q 002010          832 EAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRK  911 (982)
Q Consensus       832 ~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~  911 (982)
                      .+||+|||++.......   ......|++.|+|||++.+..++.++||||+|+++|||++|..|+...      ......
T Consensus       160 ~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~------~~~~~~  230 (284)
T 2a19_B          160 QVKIGDFGLVTSLKNDG---KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET------SKFFTD  230 (284)
T ss_dssp             EEEECCCTTCEESSCCS---CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH------HHHHHH
T ss_pred             CEEECcchhheeccccc---cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH------HHHHHH
Confidence            99999999998765332   233457899999999999999999999999999999999999887421      111111


Q ss_pred             hccCCCCCCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCCC
Q 002010          912 TTSEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQS  975 (982)
Q Consensus       912 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~~~  975 (982)
                      ....                .   .+...+..+.+++.+||+.||++|||++|+++.|+.+...
T Consensus       231 ~~~~----------------~---~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~  275 (284)
T 2a19_B          231 LRDG----------------I---ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS  275 (284)
T ss_dssp             HHTT----------------C---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred             hhcc----------------c---ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence            1110                0   1112234688999999999999999999999999776653

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=5e-37  Score=344.30  Aligned_cols=273  Identities=18%  Similarity=0.245  Sum_probs=206.4

Q ss_pred             HHhhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCC-CCchhhHHHHHHHHhcCCCCcccceEeEEEcC------
Q 002010          690 VLESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGT-GGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNR------  761 (982)
Q Consensus       690 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------  761 (982)
                      ..++|+..+.||+|+||.||+|.. .+|+.||+|++..... ......+.+|+.++++++||||+++++++...      
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   94 (351)
T 3mi9_A           15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR   94 (351)
T ss_dssp             BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC------
T ss_pred             cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeecccccccc
Confidence            357899999999999999999976 5789999998854433 33355788999999999999999999998773      


Q ss_pred             --CccEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccc
Q 002010          762 --DTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFG  839 (982)
Q Consensus       762 --~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG  839 (982)
                        +..++||||+++ ++.+.+.. ....+++.++..++.|++.|++|||+.+   |+||||||+||+++.++.+||+|||
T Consensus        95 ~~~~~~lv~e~~~~-~l~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg  169 (351)
T 3mi9_A           95 CKGSIYLVFDFCEH-DLAGLLSN-VLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG  169 (351)
T ss_dssp             --CEEEEEEECCSE-EHHHHHHC-TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred             CCceEEEEEeccCC-CHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccch
Confidence              457899999975 77777763 3357999999999999999999999998   9999999999999999999999999


Q ss_pred             cchhccccC--Cccccccccccccccccccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCC
Q 002010          840 LAKFLQDAG--ASECMSSVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEV  916 (982)
Q Consensus       840 ~a~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  916 (982)
                      +++.+....  .........||+.|+|||++.+ ..++.++||||+||++|||++|++||....................
T Consensus       170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~  249 (351)
T 3mi9_A          170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT  249 (351)
T ss_dssp             TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence            998765321  2223345678999999999876 4589999999999999999999999987544333333333222221


Q ss_pred             CCCCcccccceeecC---CCC-CCChH-------hHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          917 SQPSDAASVLAVVDP---RLS-GYPLT-------GVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       917 ~~~~~~~~~~~~~~~---~~~-~~~~~-------~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                      .............+.   ... .....       .+..+.+++.+||+.||++|||++|+++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  311 (351)
T 3mi9_A          250 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  311 (351)
T ss_dssp             TTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence            111110000000000   000 00100       1345889999999999999999999987

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=2.5e-37  Score=362.17  Aligned_cols=252  Identities=27%  Similarity=0.378  Sum_probs=208.5

Q ss_pred             HHhhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCC--CCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEE
Q 002010          690 VLESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGT--GGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLL  766 (982)
Q Consensus       690 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  766 (982)
                      +.++|+..+.||+|+||.||+|.. .+++.||||++.....  ......+.+|+.++++++||||+++++++.+....++
T Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  103 (484)
T 3nyv_A           24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL  103 (484)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            457899999999999999999976 4789999999855432  3456678999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEE---cCCCCEEEeccccchh
Q 002010          767 LYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILL---DSDFEAHVADFGLAKF  843 (982)
Q Consensus       767 v~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill---~~~~~~kl~DfG~a~~  843 (982)
                      ||||+++++|.+++.  ....+++..+..++.||+.|++|||+.+   |+||||||+||++   +.++.+||+|||++..
T Consensus       104 v~e~~~~~~L~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~  178 (484)
T 3nyv_A          104 VGEVYTGGELFDEII--SRKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTH  178 (484)
T ss_dssp             EECCCCSCBHHHHHH--TCSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred             EEecCCCCCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence            999999999999997  4467999999999999999999999998   9999999999999   5678999999999987


Q ss_pred             ccccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCccc
Q 002010          844 LQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAA  923 (982)
Q Consensus       844 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  923 (982)
                      +...   .......||+.|+|||++.+ .++.++||||+||++|+|++|.+||...... .....+.........+    
T Consensus       179 ~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~i~~~~~~~~~~----  249 (484)
T 3nyv_A          179 FEAS---KKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEY-DILKKVEKGKYTFELP----  249 (484)
T ss_dssp             BCCC---CSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHCCCCCCSG----
T ss_pred             cccc---cccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHH-HHHHHHHcCCCCCCCc----
Confidence            6543   22345679999999999876 6999999999999999999999999865332 2233332221111110    


Q ss_pred             ccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          924 SVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       924 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                                  .....+..+.+++.+||+.||.+|||++|+++
T Consensus       250 ------------~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  281 (484)
T 3nyv_A          250 ------------QWKKVSESAKDLIRKMLTYVPSMRISARDALD  281 (484)
T ss_dssp             ------------GGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ------------ccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence                        01223457889999999999999999999986

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=4.5e-37  Score=345.66  Aligned_cols=255  Identities=22%  Similarity=0.360  Sum_probs=206.0

Q ss_pred             HHHHhhcccccccccccceEEEEEEeC-CCcEEEEEEeccCCCCCc-------hhhHHHHHHHHhcC-CCCcccceEeEE
Q 002010          688 EDVLESLKDENIIGKGGAGIVYRGSMP-DGIDVAIKRLVGRGTGGN-------DHGFLAEIQTLGRI-RHRNIVRLLGYV  758 (982)
Q Consensus       688 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~-------~~~~~~E~~~l~~l-~h~niv~~~~~~  758 (982)
                      ..+.++|+..+.||+|+||.||+|... +|+.||||++........       .+.+.+|+.+++++ +||||+++++++
T Consensus        90 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~  169 (365)
T 2y7j_A           90 KEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY  169 (365)
T ss_dssp             HHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred             hhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEE
Confidence            455678999999999999999999764 799999999855432211       34578899999999 799999999999


Q ss_pred             EcCCccEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEecc
Q 002010          759 SNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADF  838 (982)
Q Consensus       759 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Df  838 (982)
                      ......++||||+++++|.+++..  ...+++..+..++.||+.|++|||+.+   |+||||||+||+++.++.+||+||
T Consensus       170 ~~~~~~~lv~e~~~g~~L~~~l~~--~~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ikl~Df  244 (365)
T 2y7j_A          170 ESSSFMFLVFDLMRKGELFDYLTE--KVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDF  244 (365)
T ss_dssp             EBSSEEEEEECCCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCC
T ss_pred             eeCCEEEEEEEeCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEEec
Confidence            999999999999999999999973  357999999999999999999999998   999999999999999999999999


Q ss_pred             ccchhccccCCccccccccccccccccccccc------CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHh
Q 002010          839 GLAKFLQDAGASECMSSVAGSYGYIAPEYAYT------LKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKT  912 (982)
Q Consensus       839 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~  912 (982)
                      |++..+...   .......||+.|+|||++.+      ..++.++||||+||++|||++|+.||...... .....+...
T Consensus       245 G~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~-~~~~~i~~~  320 (365)
T 2y7j_A          245 GFSCHLEPG---EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQI-LMLRMIMEG  320 (365)
T ss_dssp             TTCEECCTT---CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHT
T ss_pred             CcccccCCC---cccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHH-HHHHHHHhC
Confidence            999876533   22345679999999998863      35889999999999999999999999764322 222222221


Q ss_pred             ccCCCCCCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          913 TSEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       913 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                      ......+            .    ....+..+.+++.+||+.||++|||++|+++
T Consensus       321 ~~~~~~~------------~----~~~~~~~~~~li~~~L~~dP~~Rps~~ell~  359 (365)
T 2y7j_A          321 QYQFSSP------------E----WDDRSSTVKDLISRLLQVDPEARLTAEQALQ  359 (365)
T ss_dssp             CCCCCHH------------H----HSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CCCCCCc------------c----cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            1100000            0    0112346889999999999999999999986

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=1.1e-37  Score=347.00  Aligned_cols=249  Identities=24%  Similarity=0.301  Sum_probs=206.3

Q ss_pred             HhhcccccccccccceEEEEEEeC-CCcEEEEEEeccCCCC--CchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEE
Q 002010          691 LESLKDENIIGKGGAGIVYRGSMP-DGIDVAIKRLVGRGTG--GNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLL  767 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  767 (982)
                      .++|+..+.||+|+||.||+|... +++.||+|++......  .....+.+|+.++++++||||+++++++.+.+..++|
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  119 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV  119 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            357889999999999999999764 5889999998554322  2345688999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhcccc
Q 002010          768 YEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDA  847 (982)
Q Consensus       768 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  847 (982)
                      |||+++++|.+++..  ...+++.++..++.|++.|++|||+.+   |+||||||+||+++.++.+||+|||++......
T Consensus       120 ~e~~~~~~L~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  194 (335)
T 2owb_A          120 LELCRRRSLLELHKR--RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD  194 (335)
T ss_dssp             ECCCTTCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred             EecCCCCCHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceecccC
Confidence            999999999999873  357899999999999999999999998   999999999999999999999999999876432


Q ss_pred             CCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccce
Q 002010          848 GASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLA  927 (982)
Q Consensus       848 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  927 (982)
                      .  .......|++.|+|||++.+..++.++||||+|+++|||++|+.||............. ....             
T Consensus       195 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~-~~~~-------------  258 (335)
T 2owb_A          195 G--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIK-KNEY-------------  258 (335)
T ss_dssp             T--CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH-HTCC-------------
T ss_pred             c--ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHh-cCCC-------------
Confidence            2  22345678999999999999999999999999999999999999997643222222211 1110             


Q ss_pred             eecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          928 VVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       928 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                             ..+...+..+.+++.+||+.||++|||++|+++
T Consensus       259 -------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  291 (335)
T 2owb_A          259 -------SIPKHINPVAASLIQKMLQTDPTARPTINELLN  291 (335)
T ss_dssp             -------CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             -------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                   112223346889999999999999999999987

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=4.2e-38  Score=341.04  Aligned_cols=261  Identities=23%  Similarity=0.336  Sum_probs=206.0

Q ss_pred             HhhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCC-CCchhhHHHHHHHHhcCCCCcccceEeEEEc--CCccEE
Q 002010          691 LESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGT-GGNDHGFLAEIQTLGRIRHRNIVRLLGYVSN--RDTNLL  766 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~l  766 (982)
                      .++|+..+.||+|+||.||+|.. .+++.||+|.+..... ....+.+.+|+.++++++||||+++++++.+  ....++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            46799999999999999999976 4689999999865432 2344578899999999999999999998754  567899


Q ss_pred             EEeccCCCCHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHhhcC--CCcEEecCCCCCcEEEcCCCCEEEeccccch
Q 002010          767 LYEYMPNGSLGEMLHGA--KGGHLKWETRYRIALEAAKGLCYLHHDC--SPLIIHRDVKSNNILLDSDFEAHVADFGLAK  842 (982)
Q Consensus       767 v~e~~~~~sL~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~--~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~  842 (982)
                      ||||+++++|.+++...  ....+++..++.++.|++.|++|||+.+  ..+|+||||||+||+++.++.+||+|||.+.
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~  164 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR  164 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred             EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence            99999999999999742  2345999999999999999999999875  2349999999999999999999999999998


Q ss_pred             hccccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcc
Q 002010          843 FLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDA  922 (982)
Q Consensus       843 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  922 (982)
                      ......  .......|++.|+|||++.+..++.++||||+|+++|+|++|+.||..... ......+.....        
T Consensus       165 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-~~~~~~i~~~~~--------  233 (279)
T 2w5a_A          165 ILNHDT--SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ-KELAGKIREGKF--------  233 (279)
T ss_dssp             HC---C--HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHTCC--------
T ss_pred             eecccc--ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH-HHHHHHHhhccc--------
Confidence            765321  122345689999999999998999999999999999999999999976532 222222222111        


Q ss_pred             cccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 002010          923 ASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPP  973 (982)
Q Consensus       923 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~  973 (982)
                                 ...+...+..+.+++.+||+.||++|||++|+++.+..-.
T Consensus       234 -----------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~  273 (279)
T 2w5a_A          234 -----------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILE  273 (279)
T ss_dssp             -----------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCG
T ss_pred             -----------ccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhh
Confidence                       1122334457899999999999999999999998765443

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=1.6e-37  Score=338.26  Aligned_cols=246  Identities=20%  Similarity=0.282  Sum_probs=200.5

Q ss_pred             HHhhcccccccccccceEEEEEEeC-CCcEEEEEEeccCCC-CCchhhHHHHHHHHhcC-CCCcccceEeEEEcCCccEE
Q 002010          690 VLESLKDENIIGKGGAGIVYRGSMP-DGIDVAIKRLVGRGT-GGNDHGFLAEIQTLGRI-RHRNIVRLLGYVSNRDTNLL  766 (982)
Q Consensus       690 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~l  766 (982)
                      +.++|+..+.||+|+||.||+|... +++.||+|++..... ......+.+|+..+.++ +||||+++++++.+++..++
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l   88 (289)
T 1x8b_A            9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI   88 (289)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred             ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence            4578999999999999999999764 799999999865432 33456788999999999 99999999999999999999


Q ss_pred             EEeccCCCCHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCC--------------
Q 002010          767 LYEYMPNGSLGEMLHGAK--GGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSD--------------  830 (982)
Q Consensus       767 v~e~~~~~sL~~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~--------------  830 (982)
                      ||||+++++|.+++....  ...+++..+..++.||+.|++|||+.+   |+||||||+||+++.+              
T Consensus        89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~  165 (289)
T 1x8b_A           89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDD  165 (289)
T ss_dssp             EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC----------------
T ss_pred             EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCccccccccccc
Confidence            999999999999997432  257899999999999999999999998   9999999999999844              


Q ss_pred             -----CCEEEeccccchhccccCCcccccccccccccccccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCch
Q 002010          831 -----FEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTL-KVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVD  904 (982)
Q Consensus       831 -----~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~  904 (982)
                           ..+||+|||.+......      ....||+.|+|||++.+. .++.++||||+|+++|+|++|.+|+...   ..
T Consensus       166 ~~~~~~~~kl~Dfg~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~---~~  236 (289)
T 1x8b_A          166 WASNKVMFKIGDLGHVTRISSP------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG---DQ  236 (289)
T ss_dssp             ----CCCEEECCCTTCEETTCS------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS---HH
T ss_pred             ccCCceEEEEcccccccccCCc------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch---hH
Confidence                 47999999999866532      234589999999998765 5678999999999999999999876432   11


Q ss_pred             HHHHHHHhccCCCCCCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          905 IVRWVRKTTSEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       905 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                      .... ...                   ..+..+...+..+.+++.+||+.||++|||++|+++
T Consensus       237 ~~~~-~~~-------------------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  279 (289)
T 1x8b_A          237 WHEI-RQG-------------------RLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVK  279 (289)
T ss_dssp             HHHH-HTT-------------------CCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHH-HcC-------------------CCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence            1111 111                   111223334457899999999999999999999986

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=2.7e-37  Score=339.10  Aligned_cols=252  Identities=23%  Similarity=0.319  Sum_probs=204.7

Q ss_pred             HHHhhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEE
Q 002010          689 DVLESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLL  767 (982)
Q Consensus       689 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  767 (982)
                      .+.++|+..+.||+|+||.||+|.. .+|+.||+|++... .......+.+|+.++++++||||+++++++.+....++|
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (304)
T 2jam_A            6 NIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKS-PAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLV   84 (304)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC-------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             chhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecc-cccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEE
Confidence            3567899999999999999999976 46899999998543 223345688999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEE---cCCCCEEEeccccchhc
Q 002010          768 YEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILL---DSDFEAHVADFGLAKFL  844 (982)
Q Consensus       768 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill---~~~~~~kl~DfG~a~~~  844 (982)
                      |||+++++|.+++..  ...+++..+..++.|++.|++|||+.+   |+||||||+||++   +.++.+||+|||++...
T Consensus        85 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~  159 (304)
T 2jam_A           85 MQLVSGGELFDRILE--RGVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKME  159 (304)
T ss_dssp             ECCCCSCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCC
T ss_pred             EEcCCCccHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceec
Confidence            999999999999863  357899999999999999999999998   9999999999999   77899999999999754


Q ss_pred             cccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccc
Q 002010          845 QDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAAS  924 (982)
Q Consensus       845 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  924 (982)
                      ...    ......|++.|+|||++.+..++.++||||+|+++|||++|+.||...... .....+........       
T Consensus       160 ~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~i~~~~~~~~-------  227 (304)
T 2jam_A          160 QNG----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETES-KLFEKIKEGYYEFE-------  227 (304)
T ss_dssp             CCB----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH-HHHHHHHHCCCCCC-------
T ss_pred             CCC----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH-HHHHHHHcCCCCCC-------
Confidence            321    223456899999999999999999999999999999999999999764332 22222222111000       


Q ss_pred             cceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          925 VLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       925 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                               .......+..+.+++.+||+.||++|||++|+++
T Consensus       228 ---------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (304)
T 2jam_A          228 ---------SPFWDDISESAKDFICHLLEKDPNERYTCEKALS  261 (304)
T ss_dssp             ---------TTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             ---------ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence                     0112233457899999999999999999999986

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=3e-37  Score=336.25  Aligned_cols=250  Identities=27%  Similarity=0.432  Sum_probs=200.8

Q ss_pred             hhcccccccccccceEEEEEEe-CCCcEEEEEEeccCC-CCCchhhHHHHHHHHhcCCCCcccceEeEEEc----CCccE
Q 002010          692 ESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRG-TGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSN----RDTNL  765 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~  765 (982)
                      +.|+..+.||+|+||.||+|.. .++..||+|.+.... .....+.+.+|+.++++++||||+++++++..    ....+
T Consensus        26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  105 (290)
T 1t4h_A           26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV  105 (290)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred             eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence            4578888999999999999965 568899999985443 23345678899999999999999999998865    34579


Q ss_pred             EEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEc-CCCCEEEeccccchhc
Q 002010          766 LLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLD-SDFEAHVADFGLAKFL  844 (982)
Q Consensus       766 lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~-~~~~~kl~DfG~a~~~  844 (982)
                      +||||+++++|.+++..  ...+++..+..++.|++.|++|||+.+ .+|+||||||+||+++ .++.+||+|||++...
T Consensus       106 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~  182 (290)
T 1t4h_A          106 LVTELMTSGTLKTYLKR--FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK  182 (290)
T ss_dssp             EEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred             EEEEecCCCCHHHHHHH--ccCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCcccc
Confidence            99999999999999973  357899999999999999999999764 3499999999999997 7899999999999754


Q ss_pred             cccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccc
Q 002010          845 QDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAAS  924 (982)
Q Consensus       845 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  924 (982)
                      ...    ......|++.|+|||++.+ .++.++||||+|+++|+|++|+.||............+.......        
T Consensus       183 ~~~----~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~--------  249 (290)
T 1t4h_A          183 RAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPA--------  249 (290)
T ss_dssp             CTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCG--------
T ss_pred             ccc----ccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCcc--------
Confidence            422    2234578999999998764 589999999999999999999999987554443333322211100        


Q ss_pred             cceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          925 VLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       925 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                                ..+...+..+.+++.+||+.||++|||++|+++
T Consensus       250 ----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  282 (290)
T 1t4h_A          250 ----------SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             ----------GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ----------ccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence                      011122346899999999999999999999986

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=1.8e-37  Score=335.52  Aligned_cols=247  Identities=25%  Similarity=0.368  Sum_probs=197.0

Q ss_pred             hhcccccccccccceEEEEEEeC-CCcEEEEEEeccCC--CCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEE
Q 002010          692 ESLKDENIIGKGGAGIVYRGSMP-DGIDVAIKRLVGRG--TGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLY  768 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  768 (982)
                      ++|++.+.||+|+||.||+|... +++.||+|++....  .......+.+|+.++++++||||+++++++.+.+..++||
T Consensus        11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   90 (276)
T 2h6d_A           11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVM   90 (276)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEE
Confidence            57889999999999999999764 79999999985432  2344567889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccC
Q 002010          769 EYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAG  848 (982)
Q Consensus       769 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  848 (982)
                      ||+++++|.+++..  ...+++..+..++.|++.|++|||+.+   |+||||||+||+++.++.+||+|||.+...... 
T Consensus        91 e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~-  164 (276)
T 2h6d_A           91 EYVSGGELFDYICK--HGRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-  164 (276)
T ss_dssp             ECCCSCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC--
T ss_pred             eccCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCCC-
Confidence            99999999999973  356899999999999999999999998   999999999999999999999999999876532 


Q ss_pred             CcccccccccccccccccccccCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccce
Q 002010          849 ASECMSSVAGSYGYIAPEYAYTLKV-DEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLA  927 (982)
Q Consensus       849 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  927 (982)
                        .......+++.|+|||++.+..+ +.++||||+|+++|+|++|+.||...... .....+.....             
T Consensus       165 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~-------------  228 (276)
T 2h6d_A          165 --EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVP-TLFKKIRGGVF-------------  228 (276)
T ss_dssp             --------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHCCC-------------
T ss_pred             --cceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHH-HHHHHhhcCcc-------------
Confidence              22234578999999999988765 68999999999999999999999754221 22222211110             


Q ss_pred             eecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          928 VVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       928 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                             ..+...+..+.+++.+||+.||++|||++|+++
T Consensus       229 -------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~  261 (276)
T 2h6d_A          229 -------YIPEYLNRSVATLLMHMLQVDPLKRATIKDIRE  261 (276)
T ss_dssp             -------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -------cCchhcCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence                   112223457889999999999999999999987

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=3e-37  Score=340.77  Aligned_cols=250  Identities=22%  Similarity=0.332  Sum_probs=196.5

Q ss_pred             hhccc-ccccccccceEEEEEEe-CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcC-CCCcccceEeEEEcCCccEEEE
Q 002010          692 ESLKD-ENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRI-RHRNIVRLLGYVSNRDTNLLLY  768 (982)
Q Consensus       692 ~~~~~-~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~  768 (982)
                      +.|++ .+.||+|+||.||+|.. .+++.||||++... .......+.+|+.++.++ +||||+++++++.+++..++||
T Consensus        12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~   90 (316)
T 2ac3_A           12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQ-PGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF   90 (316)
T ss_dssp             TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECC-SSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeC-cchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence            56777 47899999999999975 57899999998543 344567789999999885 7999999999999999999999


Q ss_pred             eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCC---EEEeccccchhcc
Q 002010          769 EYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFE---AHVADFGLAKFLQ  845 (982)
Q Consensus       769 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~---~kl~DfG~a~~~~  845 (982)
                      ||+++++|.+++..  ...+++..+..++.||+.|++|||+.+   |+||||||+||+++.++.   +||+|||++....
T Consensus        91 e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~  165 (316)
T 2ac3_A           91 EKMRGGSILSHIHK--RRHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK  165 (316)
T ss_dssp             ECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred             EcCCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence            99999999999974  357899999999999999999999998   999999999999998766   9999999997654


Q ss_pred             ccCC-----ccccccccccccccccccccc-----CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCc------------
Q 002010          846 DAGA-----SECMSSVAGSYGYIAPEYAYT-----LKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGV------------  903 (982)
Q Consensus       846 ~~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~elltg~~p~~~~~~~~------------  903 (982)
                      ....     ........||+.|+|||++.+     ..++.++||||+||++|||++|+.||.......            
T Consensus       166 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  245 (316)
T 2ac3_A          166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPAC  245 (316)
T ss_dssp             ----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHH
T ss_pred             cCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhH
Confidence            2211     111234568999999999875     558899999999999999999999997643321            


Q ss_pred             --hHHHHHHHhccCCCCCCcccccceeecCCCCCCC----hHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          904 --DIVRWVRKTTSEVSQPSDAASVLAVVDPRLSGYP----LTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       904 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                        .....+.....                    ..+    ...+..+.+++.+||+.||++|||++|+++
T Consensus       246 ~~~~~~~i~~~~~--------------------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  295 (316)
T 2ac3_A          246 QNMLFESIQEGKY--------------------EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ  295 (316)
T ss_dssp             HHHHHHHHHHCCC--------------------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHHhccCc--------------------ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence              01111111000                    111    123457899999999999999999999998

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=2.1e-37  Score=337.58  Aligned_cols=252  Identities=24%  Similarity=0.344  Sum_probs=188.6

Q ss_pred             HhhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCCCchhh-HHHHHHHHhcCCCCcccceEeEEEcCCccEEEE
Q 002010          691 LESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHG-FLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLY  768 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~-~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  768 (982)
                      .++|+..+.||+|+||.||+|.. .+++.||+|++..........+ +.++...++.++||||+++++++.+++..++||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~   85 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM   85 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence            36799999999999999999975 5789999999855433333333 344455578889999999999999999999999


Q ss_pred             eccCCCCHHHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHHhhc-CCCcEEecCCCCCcEEEcCCCCEEEeccccchhcc
Q 002010          769 EYMPNGSLGEMLHG--AKGGHLKWETRYRIALEAAKGLCYLHHD-CSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQ  845 (982)
Q Consensus       769 e~~~~~sL~~~l~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~  845 (982)
                      ||++ ++|.+++..  .+...+++..+..++.|++.|++|||++ +   |+||||||+||+++.++.+||+|||++....
T Consensus        86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  161 (290)
T 3fme_A           86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYLV  161 (290)
T ss_dssp             ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred             ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence            9996 588887753  2456899999999999999999999998 8   9999999999999999999999999998765


Q ss_pred             ccCCccccccccccccccccccc----ccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCc
Q 002010          846 DAGASECMSSVAGSYGYIAPEYA----YTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSD  921 (982)
Q Consensus       846 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  921 (982)
                      ..   .......||+.|+|||++    .+..++.++||||+|+++|||++|+.||....................     
T Consensus       162 ~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-----  233 (290)
T 3fme_A          162 DD---VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQ-----  233 (290)
T ss_dssp             -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCC-----
T ss_pred             cc---ccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCC-----
Confidence            33   222345789999999996    566789999999999999999999999976443332222221111100     


Q ss_pred             ccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          922 AASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       922 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                                   ..+...+..+.+++.+||+.||++|||++|+++
T Consensus       234 -------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~  266 (290)
T 3fme_A          234 -------------LPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ  266 (290)
T ss_dssp             -------------CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             -------------cccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence                         011223457899999999999999999999986

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=3.6e-37  Score=360.70  Aligned_cols=254  Identities=26%  Similarity=0.342  Sum_probs=206.9

Q ss_pred             HHHHhhcccccccccccceEEEEEEe-CCCcEEEEEEeccCC-CCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccE
Q 002010          688 EDVLESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRG-TGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNL  765 (982)
Q Consensus       688 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  765 (982)
                      ..+.++|++.+.||+|+||+||+|.. .+++.||||++.... .......+.+|+.++++++||||+++++++.+....+
T Consensus        18 g~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~   97 (486)
T 3mwu_A           18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY   97 (486)
T ss_dssp             CHHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             CChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEE
Confidence            45678999999999999999999975 478999999985432 2345677899999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEc---CCCCEEEeccccch
Q 002010          766 LLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLD---SDFEAHVADFGLAK  842 (982)
Q Consensus       766 lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~---~~~~~kl~DfG~a~  842 (982)
                      +||||+++++|.+++..  ...+++..+..++.||+.|++|||+.+   |+||||||+||+++   .++.+||+|||+++
T Consensus        98 lv~e~~~~~~L~~~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~  172 (486)
T 3mwu_A           98 IVGELYTGGELFDEIIK--RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLST  172 (486)
T ss_dssp             EEECCCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTT
T ss_pred             EEEEcCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCe
Confidence            99999999999998863  357999999999999999999999998   99999999999995   45679999999998


Q ss_pred             hccccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcc
Q 002010          843 FLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDA  922 (982)
Q Consensus       843 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  922 (982)
                      .+...   .......||+.|+|||++.+ .++.++||||+||++|+|++|++||...... .....+.........+   
T Consensus       173 ~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~i~~~~~~~~~~---  244 (486)
T 3mwu_A          173 CFQQN---TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY-DILKRVETGKYAFDLP---  244 (486)
T ss_dssp             TBCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHTCCCSCSG---
T ss_pred             ECCCC---CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhCCCCCCCc---
Confidence            76532   23345679999999999876 5999999999999999999999999765332 2222222221111110   


Q ss_pred             cccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          923 ASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       923 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                                   .....+..+.+++.+||+.||.+|||++|+++
T Consensus       245 -------------~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~  276 (486)
T 3mwu_A          245 -------------QWRTISDDAKDLIRKMLTFHPSLRITATQCLE  276 (486)
T ss_dssp             -------------GGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             -------------ccCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence                         01123457889999999999999999999987

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=2.4e-37  Score=342.40  Aligned_cols=255  Identities=24%  Similarity=0.320  Sum_probs=202.3

Q ss_pred             HHHHhhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCC-------CCchhhHHHHHHHHhcCCCCcccceEeEEE
Q 002010          688 EDVLESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGT-------GGNDHGFLAEIQTLGRIRHRNIVRLLGYVS  759 (982)
Q Consensus       688 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~  759 (982)
                      ..+.++|+..+.||+|+||.||+|.. .+++.||||++.....       ......+.+|+.++++++||||+++++++.
T Consensus         6 ~~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   85 (322)
T 2ycf_A            6 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD   85 (322)
T ss_dssp             HHHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             hhhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEc
Confidence            44567899999999999999999965 4688999999854321       122346889999999999999999999987


Q ss_pred             cCCccEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCC---EEEe
Q 002010          760 NRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFE---AHVA  836 (982)
Q Consensus       760 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~---~kl~  836 (982)
                      .+. .++||||+++++|.+++.  ....+++..+..++.||+.|++|||+.+   |+||||||+||+++.++.   +||+
T Consensus        86 ~~~-~~lv~e~~~~~~L~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~  159 (322)
T 2ycf_A           86 AED-YYIVLELMEGGELFDKVV--GNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKIT  159 (322)
T ss_dssp             SSS-EEEEEECCTTEETHHHHS--TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEEC
T ss_pred             CCc-eEEEEecCCCCcHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEc
Confidence            655 899999999999999986  4568999999999999999999999998   999999999999987654   9999


Q ss_pred             ccccchhccccCCcccccccccccccccccccc---cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhc
Q 002010          837 DFGLAKFLQDAGASECMSSVAGSYGYIAPEYAY---TLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTT  913 (982)
Q Consensus       837 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~  913 (982)
                      |||++......   .......||+.|+|||++.   ...++.++||||+||++|+|++|..||............+....
T Consensus       160 Dfg~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  236 (322)
T 2ycf_A          160 DFGHSKILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGK  236 (322)
T ss_dssp             CCTTCEECCCC---HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTC
T ss_pred             cCccceecccc---cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCc
Confidence            99999865432   2223456899999999874   56789999999999999999999999987655444444433321


Q ss_pred             cCCCCCCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          914 SEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       914 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                      ....                +......+..+.+++.+||+.||++|||++|+++
T Consensus       237 ~~~~----------------~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          237 YNFI----------------PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             CCCC----------------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             cccC----------------chhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence            1000                0001123457899999999999999999999985

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=6.5e-37  Score=334.58  Aligned_cols=251  Identities=26%  Similarity=0.416  Sum_probs=200.0

Q ss_pred             hcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEecc
Q 002010          693 SLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYM  771 (982)
Q Consensus       693 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  771 (982)
                      .|.....||+|+||.||+|.. .+++.||+|.+... .....+.+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus        23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  101 (295)
T 2clq_A           23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPER-DSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV  101 (295)
T ss_dssp             TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECC-CC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCC-chHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence            455556899999999999975 56889999998544 3445567899999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcC-CCCEEEeccccchhccccCC
Q 002010          772 PNGSLGEMLHGAK-GGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDS-DFEAHVADFGLAKFLQDAGA  849 (982)
Q Consensus       772 ~~~sL~~~l~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~-~~~~kl~DfG~a~~~~~~~~  849 (982)
                      ++++|.+++.... ...+++..+..++.|++.|++|||+.+   |+||||||+||+++. ++.+||+|||.+....... 
T Consensus       102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~-  177 (295)
T 2clq_A          102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN-  177 (295)
T ss_dssp             SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred             CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCC-
Confidence            9999999997543 245678999999999999999999998   999999999999987 8999999999998664321 


Q ss_pred             cccccccccccccccccccccCC--CCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccce
Q 002010          850 SECMSSVAGSYGYIAPEYAYTLK--VDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLA  927 (982)
Q Consensus       850 ~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  927 (982)
                       .......|++.|+|||++.+..  ++.++||||+|+++|||++|+.||..................             
T Consensus       178 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~-------------  243 (295)
T 2clq_A          178 -PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKV-------------  243 (295)
T ss_dssp             ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCC-------------
T ss_pred             -CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccc-------------
Confidence             2234467899999999987643  889999999999999999999999764332221111111111             


Q ss_pred             eecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          928 VVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       928 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                           .+..+...+..+.+++.+||+.||++|||++|+++
T Consensus       244 -----~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  278 (295)
T 2clq_A          244 -----HPEIPESMSAEAKAFILKCFEPDPDKRACANDLLV  278 (295)
T ss_dssp             -----CCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred             -----cccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence                 11223344557899999999999999999999986

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=3.7e-37  Score=336.65  Aligned_cols=261  Identities=20%  Similarity=0.252  Sum_probs=203.6

Q ss_pred             HHhhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEE-EcCCccEEE
Q 002010          690 VLESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYV-SNRDTNLLL  767 (982)
Q Consensus       690 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-~~~~~~~lv  767 (982)
                      +.++|+..+.||+|+||.||+|.. .+++.||+|++....   ....+.+|+.++++++|++++..++++ ...+..++|
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv   83 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT---KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV   83 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc---cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence            346899999999999999999975 678999999864432   234578999999999988877777665 566778999


Q ss_pred             EeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEE---cCCCCEEEeccccchhc
Q 002010          768 YEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILL---DSDFEAHVADFGLAKFL  844 (982)
Q Consensus       768 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill---~~~~~~kl~DfG~a~~~  844 (982)
                      |||+ +++|.+++... ...+++..+..++.||+.|++|||+.+   |+||||||+||++   +.++.+||+|||+++..
T Consensus        84 ~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~  158 (296)
T 4hgt_A           84 MELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY  158 (296)
T ss_dssp             EECC-CCBHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred             EEcc-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence            9999 99999999742 356999999999999999999999998   9999999999999   78899999999999876


Q ss_pred             cccCCc-----ccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCc---hHHHHHHHhccCC
Q 002010          845 QDAGAS-----ECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGV---DIVRWVRKTTSEV  916 (982)
Q Consensus       845 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~---~~~~~~~~~~~~~  916 (982)
                      ......     .......||+.|+|||++.+..++.++||||+||++|||++|+.||.......   ............+
T Consensus       159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  238 (296)
T 4hgt_A          159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP  238 (296)
T ss_dssp             BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred             cCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch
Confidence            543221     12345678999999999999999999999999999999999999998744322   1112111111100


Q ss_pred             CCCCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCC
Q 002010          917 SQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQ  974 (982)
Q Consensus       917 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~~  974 (982)
                                      ........+..+.+++.+||+.||++|||++|+++.|+++..
T Consensus       239 ----------------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~  280 (296)
T 4hgt_A          239 ----------------IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH  280 (296)
T ss_dssp             ----------------HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHH
T ss_pred             ----------------hhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHH
Confidence                            000111224578999999999999999999999999876543

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=5.5e-37  Score=359.65  Aligned_cols=253  Identities=26%  Similarity=0.371  Sum_probs=202.3

Q ss_pred             HHHhhcccccccccccceEEEEEEe-CCCcEEEEEEeccCC-CCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEE
Q 002010          689 DVLESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRG-TGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLL  766 (982)
Q Consensus       689 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  766 (982)
                      .+.++|+..+.||+|+||+||+|.. .++..||+|++.... .......+.+|+.++++++||||+++++++.+....++
T Consensus        34 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  113 (494)
T 3lij_A           34 HLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYL  113 (494)
T ss_dssp             CHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             chhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence            4567899999999999999999976 468899999986543 23445678999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCC---CCEEEeccccchh
Q 002010          767 LYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSD---FEAHVADFGLAKF  843 (982)
Q Consensus       767 v~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~---~~~kl~DfG~a~~  843 (982)
                      ||||+++|+|.+++..  ...+++..+..++.||+.|++|||+.+   |+||||||+||+++..   +.+||+|||++..
T Consensus       114 v~e~~~~g~L~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~  188 (494)
T 3lij_A          114 VMECYKGGELFDEIIH--RMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAV  188 (494)
T ss_dssp             EEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred             EEecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence            9999999999998863  357999999999999999999999998   9999999999999764   5599999999987


Q ss_pred             ccccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCccc
Q 002010          844 LQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAA  923 (982)
Q Consensus       844 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  923 (982)
                      +...   .......||+.|+|||++. ..++.++||||+||++|+|++|.+||...... .....+.........+.   
T Consensus       189 ~~~~---~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~---  260 (494)
T 3lij_A          189 FENQ---KKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQ-EILRKVEKGKYTFDSPE---  260 (494)
T ss_dssp             CBTT---BCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHTCCCCCSGG---
T ss_pred             CCCC---ccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhCCCCCCchh---
Confidence            6532   2334567999999999876 46999999999999999999999999865433 22333322221111110   


Q ss_pred             ccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          924 SVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       924 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                                   ....+..+.+++.+||+.||.+|||++|+++
T Consensus       261 -------------~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  291 (494)
T 3lij_A          261 -------------WKNVSEGAKDLIKQMLQFDSQRRISAQQALE  291 (494)
T ss_dssp             -------------GTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             -------------cccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence                         0122346889999999999999999999875

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=2e-37  Score=347.27  Aligned_cols=267  Identities=20%  Similarity=0.295  Sum_probs=211.0

Q ss_pred             HhhcccccccccccceEEEEEEeCCCcEEEEEEeccCCCCCc----------------hhhHHHHHHHHhcCCCCcccce
Q 002010          691 LESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGN----------------DHGFLAEIQTLGRIRHRNIVRL  754 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~----------------~~~~~~E~~~l~~l~h~niv~~  754 (982)
                      .++|+..+.||+|+||.||+|.. +++.||+|++........                ...+.+|+.++++++||||+++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~  108 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC  108 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence            46799999999999999999988 999999999854322111                1778999999999999999999


Q ss_pred             EeEEEcCCccEEEEeccCCCCHHHH------hhcCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCcEEecCCCCCcEEE
Q 002010          755 LGYVSNRDTNLLLYEYMPNGSLGEM------LHGAKGGHLKWETRYRIALEAAKGLCYLHH-DCSPLIIHRDVKSNNILL  827 (982)
Q Consensus       755 ~~~~~~~~~~~lv~e~~~~~sL~~~------l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivHrDlkp~Nill  827 (982)
                      ++++.+.+..++||||+++++|.++      +.......+++..+..++.|++.|++|||+ .+   |+||||||+||++
T Consensus       109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil~  185 (348)
T 2pml_X          109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNILM  185 (348)
T ss_dssp             SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEEE
T ss_pred             EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEEE
Confidence            9999999999999999999999999      654446789999999999999999999998 87   9999999999999


Q ss_pred             cCCCCEEEeccccchhccccCCcccccccccccccccccccccC-CCCc-chhhHHHHHHHHHHHhCCCCCCCCCCCchH
Q 002010          828 DSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTL-KVDE-KSDVYSFGVVLLELIAGKKPVGEFGDGVDI  905 (982)
Q Consensus       828 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~DvwslG~il~elltg~~p~~~~~~~~~~  905 (982)
                      +.++.+||+|||.+......    ......|++.|+|||++.+. .++. ++||||+|+++|||++|+.||.........
T Consensus       186 ~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~  261 (348)
T 2pml_X          186 DKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVEL  261 (348)
T ss_dssp             CTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHH
T ss_pred             cCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHH
Confidence            99999999999999866432    33456789999999999877 6666 999999999999999999999876554444


Q ss_pred             HHHHHHhccCCCCCCcccccce-eecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          906 VRWVRKTTSEVSQPSDAASVLA-VVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       906 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                      ...+.......  +........ .............+..+.+++.+||+.||.+|||++|+++
T Consensus       262 ~~~i~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~  322 (348)
T 2pml_X          262 FNNIRTKNIEY--PLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK  322 (348)
T ss_dssp             HHHHTSCCCCC--CCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             HHHHhccCcCC--ccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            44433322111  111000000 0000001112345567899999999999999999999987

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-37  Score=350.01  Aligned_cols=272  Identities=22%  Similarity=0.305  Sum_probs=202.8

Q ss_pred             HhhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCC-CCchhhHHHHHHHHhcCCCCcccceEeEEEcCC------
Q 002010          691 LESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGT-GGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRD------  762 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------  762 (982)
                      .++|+..+.||+|+||.||+|.. .+|+.||||++..... ....+.+.+|+.++++++||||+++++++....      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            36789999999999999999965 5699999999854322 223456889999999999999999999997653      


Q ss_pred             ccEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccch
Q 002010          763 TNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAK  842 (982)
Q Consensus       763 ~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~  842 (982)
                      ..|+||||+ +++|.+++..   ..+++..+..++.||++|++|||+.+   |+||||||+||+++.++.+||+|||+++
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  176 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR  176 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             eEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeeccc
Confidence            459999999 8899999964   46899999999999999999999998   9999999999999999999999999998


Q ss_pred             hccccCCccccccccccccccccccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCC--
Q 002010          843 FLQDAGASECMSSVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQP--  919 (982)
Q Consensus       843 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--  919 (982)
                      ....     ......+|+.|+|||++.+ ..++.++||||+||++|||++|+.||........+..+...........  
T Consensus       177 ~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~  251 (367)
T 1cm8_A          177 QADS-----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ  251 (367)
T ss_dssp             ECCS-----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred             cccc-----ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence            6542     2345678999999999877 6799999999999999999999999986543333333332222111000  


Q ss_pred             ---C-cccc----cceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH--HhcCCCC
Q 002010          920 ---S-DAAS----VLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH--MLANPPQ  974 (982)
Q Consensus       920 ---~-~~~~----~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~--~L~~~~~  974 (982)
                         . ....    ........+.......+..+.+++.+||+.||++|||++|+++  .++....
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~  316 (367)
T 1cm8_A          252 RLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD  316 (367)
T ss_dssp             TCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC-
T ss_pred             HhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcC
Confidence               0 0000    0000011111223344567899999999999999999999998  4555443

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=3.5e-37  Score=344.39  Aligned_cols=265  Identities=25%  Similarity=0.370  Sum_probs=209.5

Q ss_pred             HHHHhhcccccccccccceEEEEEEeCCCcEEEEEEeccCCCCCchhhHHHHHHHHhc--CCCCcccceEeEEEcCC---
Q 002010          688 EDVLESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGR--IRHRNIVRLLGYVSNRD---  762 (982)
Q Consensus       688 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~~~~---  762 (982)
                      ..+.++|+..+.||+|+||.||+|.. +++.||||++..    .....+.+|++++..  ++||||+++++++....   
T Consensus        38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~----~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~  112 (342)
T 1b6c_B           38 RTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSS----REERSWFREAEIYQTVMLRHENILGFIAADNKDNGTW  112 (342)
T ss_dssp             HHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECG----GGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSC
T ss_pred             ccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCc----hhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcc
Confidence            44567899999999999999999987 689999999843    234567888888877  68999999999998876   


Q ss_pred             -ccEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHh--------hcCCCcEEecCCCCCcEEEcCCCCE
Q 002010          763 -TNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLH--------HDCSPLIIHRDVKSNNILLDSDFEA  833 (982)
Q Consensus       763 -~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH--------~~~~~~ivHrDlkp~Nill~~~~~~  833 (982)
                       ..++||||+++|+|.+++..   ..+++..++.++.|++.|++|||        +.+   |+||||||+||+++.++.+
T Consensus       113 ~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~~~~~  186 (342)
T 1b6c_B          113 TQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNGTC  186 (342)
T ss_dssp             CCEEEEECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECTTSCE
T ss_pred             ceeEEEEeecCCCcHHHHHhc---cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECCCCCE
Confidence             78999999999999999964   36899999999999999999999        777   9999999999999999999


Q ss_pred             EEeccccchhccccCCcc--cccccccccccccccccccC------CCCcchhhHHHHHHHHHHHhC----------CCC
Q 002010          834 HVADFGLAKFLQDAGASE--CMSSVAGSYGYIAPEYAYTL------KVDEKSDVYSFGVVLLELIAG----------KKP  895 (982)
Q Consensus       834 kl~DfG~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslG~il~elltg----------~~p  895 (982)
                      ||+|||++..........  ......||+.|+|||++.+.      .++.++||||+|+++|||++|          ..|
T Consensus       187 kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p  266 (342)
T 1b6c_B          187 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP  266 (342)
T ss_dssp             EECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred             EEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccC
Confidence            999999998765432211  23455799999999998765      344789999999999999999          778


Q ss_pred             CCCCCCCc-hHHHHHHHhccCCCCCCcccccceeecCCCCC--CChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 002010          896 VGEFGDGV-DIVRWVRKTTSEVSQPSDAASVLAVVDPRLSG--YPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANP  972 (982)
Q Consensus       896 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~  972 (982)
                      |....... ....+........            ..+.++.  .....+..+.+++.+||+.||++|||++||++.|+++
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i  334 (342)
T 1b6c_B          267 YYDLVPSDPSVEEMRKVVCEQK------------LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL  334 (342)
T ss_dssp             TTTTSCSSCCHHHHHHHHTTSC------------CCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             ccccCcCcccHHHHHHHHHHHH------------hCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence            86643222 1222222111100            1111111  1235667899999999999999999999999999876


Q ss_pred             CCC
Q 002010          973 PQS  975 (982)
Q Consensus       973 ~~~  975 (982)
                      .+.
T Consensus       335 ~~~  337 (342)
T 1b6c_B          335 SQQ  337 (342)
T ss_dssp             HHT
T ss_pred             HHH
Confidence            543

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=6e-37  Score=338.07  Aligned_cols=252  Identities=24%  Similarity=0.353  Sum_probs=201.6

Q ss_pred             HHHhhcccccccccccceEEEEEEeC-CCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEE
Q 002010          689 DVLESLKDENIIGKGGAGIVYRGSMP-DGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLL  767 (982)
Q Consensus       689 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  767 (982)
                      ...+.|+..+.||+|+||.||+|... +|+.||+|.+...   .....+.+|+.++++++||||+++++++......++|
T Consensus        26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  102 (314)
T 3com_A           26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE---SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIV  102 (314)
T ss_dssp             ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT---SCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch---HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEE
Confidence            34567999999999999999999764 5899999998543   3456789999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhcccc
Q 002010          768 YEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDA  847 (982)
Q Consensus       768 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  847 (982)
                      |||+++++|.+++.. ....+++..+..++.|++.|++|||+.+   |+||||||+||+++.++.+||+|||.+......
T Consensus       103 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~  178 (314)
T 3com_A          103 MEYCGAGSVSDIIRL-RNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT  178 (314)
T ss_dssp             EECCTTEEHHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred             eecCCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence            999999999999863 3467999999999999999999999998   999999999999999999999999999866532


Q ss_pred             CCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccce
Q 002010          848 GASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLA  927 (982)
Q Consensus       848 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  927 (982)
                        ........|++.|+|||++.+..++.++||||+|+++|+|++|+.||........... ......  .          
T Consensus       179 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-~~~~~~--~----------  243 (314)
T 3com_A          179 --MAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFM-IPTNPP--P----------  243 (314)
T ss_dssp             --BSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH-HHHSCC--C----------
T ss_pred             --ccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHH-HhcCCC--c----------
Confidence              1223446789999999999999999999999999999999999999976433222111 111110  0          


Q ss_pred             eecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          928 VVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       928 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                          . ...+...+..+.+++.+||+.||.+|||++|+++
T Consensus       244 ----~-~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~  278 (314)
T 3com_A          244 ----T-FRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ  278 (314)
T ss_dssp             ----C-CSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             ----c-cCCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence                0 0112233457899999999999999999999986

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=1e-37  Score=346.78  Aligned_cols=270  Identities=22%  Similarity=0.343  Sum_probs=204.1

Q ss_pred             HhhcccccccccccceEEEEEEeC-CCcEEEEEEeccCCCCC-chhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEE
Q 002010          691 LESLKDENIIGKGGAGIVYRGSMP-DGIDVAIKRLVGRGTGG-NDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLY  768 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  768 (982)
                      .++|+..+.||+|+||.||+|... +++.||+|++....... ..+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  103 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF  103 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence            468999999999999999999764 58999999985543322 2345779999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccC
Q 002010          769 EYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAG  848 (982)
Q Consensus       769 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  848 (982)
                      ||+++++|.++..  ....+++..+..++.|++.|++|||+.+   |+||||||+||+++.++.+||+|||++.......
T Consensus       104 e~~~~~~l~~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  178 (331)
T 4aaa_A          104 EFVDHTILDDLEL--FPNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG  178 (331)
T ss_dssp             ECCSEEHHHHHHH--STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred             ecCCcchHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCCc
Confidence            9999999998876  3457999999999999999999999998   9999999999999999999999999998765322


Q ss_pred             CcccccccccccccccccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCc----cc
Q 002010          849 ASECMSSVAGSYGYIAPEYAYTL-KVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSD----AA  923 (982)
Q Consensus       849 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~----~~  923 (982)
                        .......|++.|+|||++.+. .++.++||||+||++|+|++|+.||....+...............+....    ..
T Consensus       179 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (331)
T 4aaa_A          179 --EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNP  256 (331)
T ss_dssp             -------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCG
T ss_pred             --cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcc
Confidence              223456789999999998875 68999999999999999999999998765444443333322211000000    00


Q ss_pred             ccceeecCCCC------CCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          924 SVLAVVDPRLS------GYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       924 ~~~~~~~~~~~------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                      .......+...      ......+..+.+++.+||+.||++|||++|+++
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  306 (331)
T 4aaa_A          257 VFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH  306 (331)
T ss_dssp             GGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             ccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            00000001111      011234567999999999999999999999876

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=5.2e-37  Score=335.52  Aligned_cols=259  Identities=20%  Similarity=0.246  Sum_probs=206.0

Q ss_pred             HhhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEE-EcCCccEEEE
Q 002010          691 LESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYV-SNRDTNLLLY  768 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-~~~~~~~lv~  768 (982)
                      .++|+..+.||+|+||.||+|.. .+++.||+|++....   ....+.+|+.++++++|++++..++++ ......++||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT---KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS---SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc---chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence            36799999999999999999975 679999999885432   234688999999999998877766655 5567779999


Q ss_pred             eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEE---cCCCCEEEeccccchhcc
Q 002010          769 EYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILL---DSDFEAHVADFGLAKFLQ  845 (982)
Q Consensus       769 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill---~~~~~~kl~DfG~a~~~~  845 (982)
                      ||+ +++|.+++... ...+++..+..++.|++.|++|||+.+   |+||||||+||++   +.++.+||+|||++....
T Consensus        85 e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~  159 (296)
T 3uzp_A           85 ELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  159 (296)
T ss_dssp             ECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             Eec-CCCHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence            999 99999999743 357999999999999999999999998   9999999999999   478999999999998765


Q ss_pred             ccCCc-----ccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCC---chHHHHHHHhccCCC
Q 002010          846 DAGAS-----ECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDG---VDIVRWVRKTTSEVS  917 (982)
Q Consensus       846 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~---~~~~~~~~~~~~~~~  917 (982)
                      .....     .......||+.|+|||++.+..++.++||||+|+++|||++|+.||......   .............+ 
T Consensus       160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-  238 (296)
T 3uzp_A          160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP-  238 (296)
T ss_dssp             CTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC-
T ss_pred             ccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc-
Confidence            43221     1234567999999999999999999999999999999999999999874332   12222222111100 


Q ss_pred             CCCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 002010          918 QPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPP  973 (982)
Q Consensus       918 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~  973 (982)
                                     ....+...+..+.+++.+||+.||++|||++|+++.|+.+.
T Consensus       239 ---------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~  279 (296)
T 3uzp_A          239 ---------------IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF  279 (296)
T ss_dssp             ---------------HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHH
T ss_pred             ---------------hHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHH
Confidence                           00011223457899999999999999999999999997654

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=2.5e-37  Score=339.10  Aligned_cols=253  Identities=21%  Similarity=0.329  Sum_probs=201.3

Q ss_pred             HHhhcccccccccccceEEEEEEeC-CCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEE
Q 002010          690 VLESLKDENIIGKGGAGIVYRGSMP-DGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLY  768 (982)
Q Consensus       690 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  768 (982)
                      ..+.|++.+.||+|+||.||+|... +++.||+|++... .......+.+|+.++++++||||+++++++..++..++||
T Consensus        17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   95 (302)
T 2j7t_A           17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETK-SEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMI   95 (302)
T ss_dssp             GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEE
T ss_pred             CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCC-CHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEE
Confidence            3467999999999999999999764 5889999988443 4455678899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccC
Q 002010          769 EYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAG  848 (982)
Q Consensus       769 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  848 (982)
                      ||+++++|.+++.. ....+++..+..++.|++.|++|||+.+   |+||||||+||+++.++.+||+|||++...... 
T Consensus        96 e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-  170 (302)
T 2j7t_A           96 EFCPGGAVDAIMLE-LDRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT-  170 (302)
T ss_dssp             ECCTTEEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH-
T ss_pred             EeCCCCcHHHHHHh-hccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCcccccc-
Confidence            99999999999864 2356999999999999999999999998   999999999999999999999999998654321 


Q ss_pred             Cccccccccccccccccccc-----ccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCccc
Q 002010          849 ASECMSSVAGSYGYIAPEYA-----YTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAA  923 (982)
Q Consensus       849 ~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  923 (982)
                       ........|++.|+|||++     .+..++.++||||+|+++|+|++|+.||...................        
T Consensus       171 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--------  241 (302)
T 2j7t_A          171 -LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPT--------  241 (302)
T ss_dssp             -HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC--------
T ss_pred             -ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcc--------
Confidence             1112345789999999988     36678999999999999999999999998654332222222111110        


Q ss_pred             ccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          924 SVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       924 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                                ...+...+..+.+++.+||+.||++|||++|+++
T Consensus       242 ----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          242 ----------LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE  275 (302)
T ss_dssp             ----------CSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred             ----------cCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence                      0112334457899999999999999999999986

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=6.1e-38  Score=349.62  Aligned_cols=272  Identities=27%  Similarity=0.373  Sum_probs=195.9

Q ss_pred             HhhcccccccccccceEEEEEEeCCCcEEEEEEeccCCCCCchhhHHHHHHH--HhcCCCCcccceEeEEEc-----CCc
Q 002010          691 LESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQT--LGRIRHRNIVRLLGYVSN-----RDT  763 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~--l~~l~h~niv~~~~~~~~-----~~~  763 (982)
                      .++|+..+.||+|+||.||+|+. +++.||||++...    ....+..|.++  +..++||||+++++++..     ...
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~   86 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA----NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME   86 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGG----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeecc----chhhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence            36789999999999999999977 7899999998432    23344445444  445899999999986542     235


Q ss_pred             cEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhc---------CCCcEEecCCCCCcEEEcCCCCEE
Q 002010          764 NLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHD---------CSPLIIHRDVKSNNILLDSDFEAH  834 (982)
Q Consensus       764 ~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---------~~~~ivHrDlkp~Nill~~~~~~k  834 (982)
                      .++||||+++|+|.+++...   ..++..+..++.||+.||+|||+.         +   |+||||||+||+++.++.+|
T Consensus        87 ~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~k  160 (336)
T 3g2f_A           87 YLLVMEYYPNGSLXKYLSLH---TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTCV  160 (336)
T ss_dssp             EEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCEE
T ss_pred             EEEEEecCCCCcHHHHHhhc---ccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcEE
Confidence            68999999999999999643   458999999999999999999988         7   99999999999999999999


Q ss_pred             EeccccchhccccCC------ccccccccccccccccccccc-------CCCCcchhhHHHHHHHHHHHhCCCCCCCCCC
Q 002010          835 VADFGLAKFLQDAGA------SECMSSVAGSYGYIAPEYAYT-------LKVDEKSDVYSFGVVLLELIAGKKPVGEFGD  901 (982)
Q Consensus       835 l~DfG~a~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslG~il~elltg~~p~~~~~~  901 (982)
                      |+|||++..+.....      ........||+.|+|||++.+       ..++.++||||+||++|||++|..||.....
T Consensus       161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~  240 (336)
T 3g2f_A          161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES  240 (336)
T ss_dssp             ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred             EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence            999999987653211      122234579999999999886       4567899999999999999999777644222


Q ss_pred             CchHHHHHHHhccCCCCCCccc--ccceeecCCCC---CCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 002010          902 GVDIVRWVRKTTSEVSQPSDAA--SVLAVVDPRLS---GYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPP  973 (982)
Q Consensus       902 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~  973 (982)
                      ...............+......  .......+.++   ......+..+.+++.+||+.||++|||++|+++.|+++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll  317 (336)
T 3g2f_A          241 VPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELM  317 (336)
T ss_dssp             CCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred             hhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHH
Confidence            1111000000000000000000  00000111111   122346678999999999999999999999999887644

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=100.00  E-value=1e-36  Score=356.95  Aligned_cols=336  Identities=19%  Similarity=0.174  Sum_probs=292.7

Q ss_pred             cCCCCCCCCCCCCEEecccCcCcccCchhhcCCCccceeecccccCCCCCCccccCCCCCCEEEeeCCcccCcCchhhhc
Q 002010          232 GIPPGFGALTQLQVLDMASCNISGEIPTSLSRLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAA  311 (982)
Q Consensus       232 ~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~  311 (982)
                      .+|..+.  +++++|+|++|++++..+..|.++++|++|+|++|.+++..|..|.++++|++|+|++|++++..+..|..
T Consensus        25 ~ip~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~  102 (477)
T 2id5_A           25 AVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTG  102 (477)
T ss_dssp             SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCTTSSTT
T ss_pred             cCCCCCC--CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCccCcccccC
Confidence            5676554  68999999999999988999999999999999999999988999999999999999999999777778999


Q ss_pred             ccchhhhhhccCCCCCCCCCcCCCCCCccEEEccCCCcccccCccccCCCcccEEEeccccccccCCccccCccccceee
Q 002010          312 LKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDLCKGGKLKSLI  391 (982)
Q Consensus       312 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~  391 (982)
                      +++|++|+|++|++.+..|..|..+++|++|++++|.+++..+..+..+++|+.|++++|++++..+..+..+++|+.|+
T Consensus       103 l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~  182 (477)
T 2id5_A          103 LSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLR  182 (477)
T ss_dssp             CTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEE
T ss_pred             CCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEe
Confidence            99999999999999999999999999999999999999998899999999999999999999987777899999999999


Q ss_pred             cccccccccCCccccCCCCCCEEEccCCccCCCCCccccCCCccccccCCCccccccCCcccccCCccEEEeeccccCCC
Q 002010          392 LMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLSGELPEKMSGASLNQLKVANNNITGK  471 (982)
Q Consensus       392 l~~N~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~L~~N~i~~~  471 (982)
                      +++|.+.+..+..+..+++|++|++++|.+.+.+|......                       .+|+.|++++|++++.
T Consensus       183 l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~-----------------------~~L~~L~l~~n~l~~~  239 (477)
T 2id5_A          183 LRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYG-----------------------LNLTSLSITHCNLTAV  239 (477)
T ss_dssp             EESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTT-----------------------CCCSEEEEESSCCCSC
T ss_pred             CCCCcCcEeChhhcccCcccceeeCCCCccccccCcccccC-----------------------ccccEEECcCCccccc
Confidence            99999999999999999999999999998877766544332                       3677888888888866


Q ss_pred             CchhccCCCCcceeeeccccccCCCccccccccccceeeeeccccCCCCCcccccccCCCeeeCCCCcccCCCCcccccc
Q 002010          472 IPAAIGNLPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYGKIPPGISKL  551 (982)
Q Consensus       472 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l  551 (982)
                      .+..|..+++|+.|+|++|++++..+..+..+++|++|+|++|++++..|..|.++++|+.|+|++|+|++..+..|..+
T Consensus       240 ~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l  319 (477)
T 2id5_A          240 PYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSV  319 (477)
T ss_dssp             CHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCG
T ss_pred             CHHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCC
Confidence            66788999999999999999997777788899999999999999998889999999999999999999998777788999


Q ss_pred             cccceEEcccccccccCccccccccccceecccCCccccCCC
Q 002010          552 IDLSILNLSRNGITGSIPNEMRNMMSLTTLDLSYNNLIGNIP  593 (982)
Q Consensus       552 ~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip  593 (982)
                      ++|+.|+|++|.++...+. ..-...+..+++.++.....-|
T Consensus       320 ~~L~~L~l~~N~l~c~c~~-~~~~~~~~~~~~~~~~~~C~~p  360 (477)
T 2id5_A          320 GNLETLILDSNPLACDCRL-LWVFRRRWRLNFNRQQPTCATP  360 (477)
T ss_dssp             GGCCEEECCSSCEECSGGG-HHHHTTTTSSCCTTCCCBEEES
T ss_pred             cccCEEEccCCCccCccch-HhHHhhhhccccCccCceeCCc
Confidence            9999999999999853321 1112233445555655544444

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=8.6e-37  Score=338.78  Aligned_cols=270  Identities=21%  Similarity=0.266  Sum_probs=209.1

Q ss_pred             HhhcccccccccccceEEEEEEe--CCCcEEEEEEeccCCC-CCchhhHHHHHHHHhcC---CCCcccceEeEEE-----
Q 002010          691 LESLKDENIIGKGGAGIVYRGSM--PDGIDVAIKRLVGRGT-GGNDHGFLAEIQTLGRI---RHRNIVRLLGYVS-----  759 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~-----  759 (982)
                      .++|+..+.||+|+||.||+|..  .+++.||+|++..... ......+.+|+.+++.+   +||||+++++++.     
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~   89 (326)
T 1blx_A           10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   89 (326)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccC
Confidence            36799999999999999999976  4688999999854432 23344677888887776   8999999999987     


Q ss_pred             cCCccEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccc
Q 002010          760 NRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFG  839 (982)
Q Consensus       760 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG  839 (982)
                      .....++||||++ ++|.+++.......+++..+..++.|++.|++|||+.+   |+||||||+||+++.++.+||+|||
T Consensus        90 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~Dfg  165 (326)
T 1blx_A           90 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG  165 (326)
T ss_dssp             SEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSCC
T ss_pred             CCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEecCc
Confidence            5567899999997 69999998766667999999999999999999999998   9999999999999999999999999


Q ss_pred             cchhccccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCC
Q 002010          840 LAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQP  919 (982)
Q Consensus       840 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  919 (982)
                      ++......   .......|++.|+|||++.+..++.++||||+|+++|||++|+.||............+..........
T Consensus       166 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  242 (326)
T 1blx_A          166 LARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED  242 (326)
T ss_dssp             SCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred             ccccccCC---CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCccc
Confidence            99865432   223456789999999999999999999999999999999999999987544433333333222111000


Q ss_pred             --Cccc----ccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          920 --SDAA----SVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       920 --~~~~----~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                        ....    .................+..+.+++.+||+.||++|||++|+++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  296 (326)
T 1blx_A          243 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  296 (326)
T ss_dssp             SCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence              0000    00000001111233445667899999999999999999999995

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=2e-37  Score=343.68  Aligned_cols=272  Identities=25%  Similarity=0.342  Sum_probs=207.7

Q ss_pred             hhcccccccccccceEEEEEEe-----CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCC--cc
Q 002010          692 ESLKDENIIGKGGAGIVYRGSM-----PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRD--TN  764 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~  764 (982)
                      ++|+..+.||+|+||.||+|+.     .+++.||+|++.. ......+.+.+|+.++++++||||+++++++...+  ..
T Consensus        41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  119 (326)
T 2w1i_A           41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH-STEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL  119 (326)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESS-CCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred             HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEecc-CCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence            5688899999999999999973     4688999999854 33444567899999999999999999999886644  68


Q ss_pred             EEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhc
Q 002010          765 LLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFL  844 (982)
Q Consensus       765 ~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~  844 (982)
                      ++||||+++++|.+++... ...+++..+..++.|++.|++|||+.+   |+||||||+||+++.++.+||+|||++...
T Consensus       120 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~~  195 (326)
T 2w1i_A          120 KLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVL  195 (326)
T ss_dssp             EEEECCCTTCBHHHHHHHS-TTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEEEECCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhhc
Confidence            9999999999999999753 356899999999999999999999988   999999999999999999999999999876


Q ss_pred             cccCCc-ccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCccc
Q 002010          845 QDAGAS-ECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAA  923 (982)
Q Consensus       845 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  923 (982)
                      ...... .......++..|+|||++.+..++.++||||+|+++|||++|..|+....  ....+..   ...........
T Consensus       196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~--~~~~~~~---~~~~~~~~~~~  270 (326)
T 2w1i_A          196 PQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPP--AEFMRMI---GNDKQGQMIVF  270 (326)
T ss_dssp             CSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHH--HHHHHHH---CTTCCTHHHHH
T ss_pred             cccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCH--HHHHHhh---ccccchhhhHH
Confidence            543221 11233457778999999998889999999999999999999999986421  1111110   00000000000


Q ss_pred             ccceeecC-CCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 002010          924 SVLAVVDP-RLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPP  973 (982)
Q Consensus       924 ~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~  973 (982)
                      .+...+.. .....+...+..+.+++.+||+.||++|||++|+++.|+++.
T Consensus       271 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~  321 (326)
T 2w1i_A          271 HLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR  321 (326)
T ss_dssp             HHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            00000100 111223445568999999999999999999999999998654

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=4.8e-37  Score=348.39  Aligned_cols=266  Identities=22%  Similarity=0.248  Sum_probs=201.3

Q ss_pred             HHhhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcC-------
Q 002010          690 VLESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNR-------  761 (982)
Q Consensus       690 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-------  761 (982)
                      ..++|+..+.||+|+||.||+|.. .+|+.||||++.....     ...+|+.+++.++||||+++++++...       
T Consensus         5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~   79 (383)
T 3eb0_A            5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR-----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKP   79 (383)
T ss_dssp             -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT-----SCCHHHHHHTTCCCTTBCCEEEEEEEC-------
T ss_pred             ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc-----hHHHHHHHHHHcCCCCccchhheeeecCcccccc
Confidence            446899999999999999999965 6799999999854322     223799999999999999999998443       


Q ss_pred             -------------------------------CccEEEEeccCCCCHHHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHHh
Q 002010          762 -------------------------------DTNLLLYEYMPNGSLGEMLHG--AKGGHLKWETRYRIALEAAKGLCYLH  808 (982)
Q Consensus       762 -------------------------------~~~~lv~e~~~~~sL~~~l~~--~~~~~l~~~~~~~i~~~i~~~l~~LH  808 (982)
                                                     ...++||||++ ++|.+.+..  .....+++..+..++.||++|++|||
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH  158 (383)
T 3eb0_A           80 PQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH  158 (383)
T ss_dssp             ------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence                                           33789999997 587777653  24568999999999999999999999


Q ss_pred             hcCCCcEEecCCCCCcEEEc-CCCCEEEeccccchhccccCCcccccccccccccccccccccC-CCCcchhhHHHHHHH
Q 002010          809 HDCSPLIIHRDVKSNNILLD-SDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTL-KVDEKSDVYSFGVVL  886 (982)
Q Consensus       809 ~~~~~~ivHrDlkp~Nill~-~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il  886 (982)
                      +.+   |+||||||+||+++ .++.+||+|||+|+.+...   .......+|+.|+|||++.+. .++.++||||+||++
T Consensus       159 ~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il  232 (383)
T 3eb0_A          159 SLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPS---EPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF  232 (383)
T ss_dssp             TTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTT---SCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred             HCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCC---CCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHH
Confidence            988   99999999999997 6889999999999876533   223456789999999998765 489999999999999


Q ss_pred             HHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCc--ccccceeecCCCC------CCChHhHHHHHHHHhhccCCCCCC
Q 002010          887 LELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSD--AASVLAVVDPRLS------GYPLTGVIHLFKVAMMCVEDESSA  958 (982)
Q Consensus       887 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~------~~~~~~~~~l~~li~~cl~~dP~~  958 (982)
                      |||++|+.||......+....++............  ........-+...      ..+...+..+.+++.+||+.||++
T Consensus       233 ~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~  312 (383)
T 3eb0_A          233 GELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDL  312 (383)
T ss_dssp             HHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGG
T ss_pred             HHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhh
Confidence            99999999998765544444444433321100000  0000000000000      133445667899999999999999


Q ss_pred             CCCHHHHHH
Q 002010          959 RPTMREVVH  967 (982)
Q Consensus       959 Rpt~~ell~  967 (982)
                      |||++|+++
T Consensus       313 R~t~~e~l~  321 (383)
T 3eb0_A          313 RINPYEAMA  321 (383)
T ss_dssp             SCCHHHHHT
T ss_pred             CCCHHHHhc
Confidence            999999985

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=2.5e-37  Score=370.84  Aligned_cols=249  Identities=26%  Similarity=0.406  Sum_probs=199.9

Q ss_pred             cccccccceEEEEEEe---CCCcEEEEEEeccCCC-CCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEeccCC
Q 002010          698 NIIGKGGAGIVYRGSM---PDGIDVAIKRLVGRGT-GGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPN  773 (982)
Q Consensus       698 ~~lg~G~~g~Vy~~~~---~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  773 (982)
                      +.||+|+||.||+|.+   ..++.||||+++.... ....+++.+|+.++++++|||||++++++.. +..++||||+++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence            4799999999999954   3467899999865432 2335679999999999999999999999864 568899999999


Q ss_pred             CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCC-ccc
Q 002010          774 GSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGA-SEC  852 (982)
Q Consensus       774 ~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~-~~~  852 (982)
                      |+|.+++.  +...+++..+..++.||+.||+|||+++   |+||||||+||+++.++.+||+|||+++.+..... ...
T Consensus       454 g~L~~~l~--~~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  528 (635)
T 4fl3_A          454 GPLNKYLQ--QNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA  528 (635)
T ss_dssp             EEHHHHHH--HCTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------
T ss_pred             CCHHHHHh--hCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccccc
Confidence            99999997  3467999999999999999999999998   99999999999999999999999999987754322 222


Q ss_pred             ccccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceeecC
Q 002010          853 MSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDP  931 (982)
Q Consensus       853 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  931 (982)
                      .....+|+.|+|||++.+..++.++||||+||++|||++ |+.||...... .....+.....                 
T Consensus       529 ~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~-~~~~~i~~~~~-----------------  590 (635)
T 4fl3_A          529 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-EVTAMLEKGER-----------------  590 (635)
T ss_dssp             ------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-HHHHHHHTTCC-----------------
T ss_pred             ccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHHHcCCC-----------------
Confidence            333456789999999999999999999999999999998 99999765332 22222222111                 


Q ss_pred             CCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 002010          932 RLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANP  972 (982)
Q Consensus       932 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~  972 (982)
                        ...+..++..+.++|.+||+.||++|||+++|++.|+.+
T Consensus       591 --~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~  629 (635)
T 4fl3_A          591 --MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY  629 (635)
T ss_dssp             --CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             --CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence              122334556899999999999999999999999998754

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=7.1e-37  Score=351.30  Aligned_cols=265  Identities=22%  Similarity=0.243  Sum_probs=205.5

Q ss_pred             HhhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcC------CCCcccceEeEEEcCCc
Q 002010          691 LESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRI------RHRNIVRLLGYVSNRDT  763 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~~~~~~~~~~~  763 (982)
                      ..+|+..+.||+|+||.||+|.. .+++.||||++...  ......+.+|+.+++.+      +|+||+++++++.....
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~  173 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE--KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH  173 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTE
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc--cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCe
Confidence            45799999999999999999965 45899999998432  22335677788888777      57799999999999999


Q ss_pred             cEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCC--EEEeccccc
Q 002010          764 NLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFE--AHVADFGLA  841 (982)
Q Consensus       764 ~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~--~kl~DfG~a  841 (982)
                      .++||||+. ++|.+++.......+++..+..++.||+.||+|||+.+   |+||||||+||+++.++.  +||+|||++
T Consensus       174 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~a  249 (429)
T 3kvw_A          174 ICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSS  249 (429)
T ss_dssp             EEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred             EEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecccc
Confidence            999999995 69999998766677999999999999999999999998   999999999999999887  999999999


Q ss_pred             hhccccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCC---
Q 002010          842 KFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQ---  918 (982)
Q Consensus       842 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---  918 (982)
                      .....     ......||+.|+|||++.+..++.++||||+||++|||++|++||........+..++.........   
T Consensus       250 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~  324 (429)
T 3kvw_A          250 CYEHQ-----RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLD  324 (429)
T ss_dssp             EETTC-----CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred             eecCC-----cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHH
Confidence            75432     2334678999999999999999999999999999999999999998765444444333322211100   


Q ss_pred             --------------CCccccccee-----------------ecCCCC-----CCChHhHHHHHHHHhhccCCCCCCCCCH
Q 002010          919 --------------PSDAASVLAV-----------------VDPRLS-----GYPLTGVIHLFKVAMMCVEDESSARPTM  962 (982)
Q Consensus       919 --------------~~~~~~~~~~-----------------~~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~Rpt~  962 (982)
                                    +... .....                 ..+...     ..+......+.+|+.+||+.||++|||+
T Consensus       325 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta  403 (429)
T 3kvw_A          325 ASKRAKNFVSSKGYPRYC-TVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTP  403 (429)
T ss_dssp             TBTTHHHHBCTTSCBTTS-CEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCH
T ss_pred             hhhhhhhccCCCCCcccc-cccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCH
Confidence                          0000 00000                 000000     0111224568999999999999999999


Q ss_pred             HHHHH
Q 002010          963 REVVH  967 (982)
Q Consensus       963 ~ell~  967 (982)
                      +|+++
T Consensus       404 ~e~L~  408 (429)
T 3kvw_A          404 GQALR  408 (429)
T ss_dssp             HHHHT
T ss_pred             HHHhC
Confidence            99997

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=1.1e-36  Score=338.66  Aligned_cols=261  Identities=21%  Similarity=0.251  Sum_probs=202.2

Q ss_pred             hhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCC-CCcccceEeEEEc--CCccEEE
Q 002010          692 ESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIR-HRNIVRLLGYVSN--RDTNLLL  767 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~--~~~~~lv  767 (982)
                      ++|+..+.||+|+||.||+|.. .+++.||+|++..    ...+.+.+|+.++++++ ||||+++++++.+  ....++|
T Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~----~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv  111 (330)
T 3nsz_A           36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP----VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV  111 (330)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS----CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred             CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc----cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence            6799999999999999999964 6789999999842    34567899999999997 9999999999987  5667999


Q ss_pred             EeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCC-CEEEeccccchhccc
Q 002010          768 YEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDF-EAHVADFGLAKFLQD  846 (982)
Q Consensus       768 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~-~~kl~DfG~a~~~~~  846 (982)
                      |||+++++|.+++.     .+++..+..++.|++.|++|||+.+   |+||||||+||+++.++ .+||+|||+++....
T Consensus       112 ~e~~~~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~  183 (330)
T 3nsz_A          112 FEHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP  183 (330)
T ss_dssp             EECCCCCCHHHHGG-----GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred             EeccCchhHHHHHH-----hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence            99999999999985     4889999999999999999999998   99999999999999776 899999999986653


Q ss_pred             cCCccccccccccccccccccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCC---------
Q 002010          847 AGASECMSSVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEV---------  916 (982)
Q Consensus       847 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~---------  916 (982)
                      ..   ......+++.|+|||++.+ ..++.++||||+||++|||++|+.||.......+....+.......         
T Consensus       184 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  260 (330)
T 3nsz_A          184 GQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY  260 (330)
T ss_dssp             TC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHT
T ss_pred             CC---ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHh
Confidence            32   2345678999999999877 6689999999999999999999999965433322222211111100         


Q ss_pred             --CCCCcccccc-----eeecCCCC-CCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          917 --SQPSDAASVL-----AVVDPRLS-GYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       917 --~~~~~~~~~~-----~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                        ..........     ..++.... ..+...+..+.+++.+||+.||++|||++|+++
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~  319 (330)
T 3nsz_A          261 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  319 (330)
T ss_dssp             TCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             ccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence              0000000000     00000011 122334668999999999999999999999987

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=8.1e-37  Score=359.17  Aligned_cols=253  Identities=26%  Similarity=0.347  Sum_probs=202.9

Q ss_pred             HHHhhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCC------------CchhhHHHHHHHHhcCCCCcccceE
Q 002010          689 DVLESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTG------------GNDHGFLAEIQTLGRIRHRNIVRLL  755 (982)
Q Consensus       689 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------------~~~~~~~~E~~~l~~l~h~niv~~~  755 (982)
                      .+.++|++.+.||+|+||+||+|.. .+++.||+|++......            ...+.+.+|+.++++++||||++++
T Consensus        33 ~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~  112 (504)
T 3q5i_A           33 KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLF  112 (504)
T ss_dssp             CGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred             CcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence            3457899999999999999999975 45889999998654321            3356788999999999999999999


Q ss_pred             eEEEcCCccEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCC---C
Q 002010          756 GYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDF---E  832 (982)
Q Consensus       756 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~---~  832 (982)
                      +++.+....++||||+++|+|.+++..  ...+++..+..++.||+.|++|||+.+   |+||||||+||+++.++   .
T Consensus       113 ~~~~~~~~~~lv~e~~~gg~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~  187 (504)
T 3q5i_A          113 DVFEDKKYFYLVTEFYEGGELFEQIIN--RHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLN  187 (504)
T ss_dssp             EEEECSSEEEEEEECCTTCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSS
T ss_pred             EEEEcCCEEEEEEecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCcc
Confidence            999999999999999999999999873  357999999999999999999999998   99999999999998775   6


Q ss_pred             EEEeccccchhccccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHh
Q 002010          833 AHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKT  912 (982)
Q Consensus       833 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~  912 (982)
                      +||+|||++..+...   .......||+.|+|||++. ..++.++||||+||++|+|++|.+||...... .....+...
T Consensus       188 ~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~i~~~  262 (504)
T 3q5i_A          188 IKIVDFGLSSFFSKD---YKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ-DIIKKVEKG  262 (504)
T ss_dssp             EEECCCTTCEECCTT---SCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHC
T ss_pred             EEEEECCCCEEcCCC---CccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHcC
Confidence            999999999876532   2334567999999999887 46999999999999999999999999865332 222222221


Q ss_pred             ccCCCCCCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          913 TSEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       913 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                      ......+                .....+..+.+++.+||+.||.+|||++|+++
T Consensus       263 ~~~~~~~----------------~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~  301 (504)
T 3q5i_A          263 KYYFDFN----------------DWKNISDEAKELIKLMLTYDYNKRCTAEEALN  301 (504)
T ss_dssp             CCCCCHH----------------HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CCCCCcc----------------ccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            1100000                00122357899999999999999999999986

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=1.8e-37  Score=338.31  Aligned_cols=261  Identities=27%  Similarity=0.428  Sum_probs=198.6

Q ss_pred             hhcccccccccccceEEEEEEe--CCCc--EEEEEEeccCC--CCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccE
Q 002010          692 ESLKDENIIGKGGAGIVYRGSM--PDGI--DVAIKRLVGRG--TGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNL  765 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~--~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  765 (982)
                      ++|+..+.||+|+||.||+|.+  .+++  .||+|++....  .....+.+.+|+.++++++||||+++++++..+. .+
T Consensus        18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~   96 (291)
T 1u46_A           18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MK   96 (291)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CE
T ss_pred             hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ce
Confidence            5789999999999999999964  2333  68999885443  2234567889999999999999999999987654 89


Q ss_pred             EEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhcc
Q 002010          766 LLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQ  845 (982)
Q Consensus       766 lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~  845 (982)
                      +||||+++++|.+++... ...+++..+..++.|++.|++|||+.+   |+||||||+||+++.++.+||+|||++....
T Consensus        97 ~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~  172 (291)
T 1u46_A           97 MVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALP  172 (291)
T ss_dssp             EEEECCTTCBHHHHHHHH-GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred             eeEecccCCCHHHHHHhc-cCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEcccccccccc
Confidence            999999999999999742 356899999999999999999999998   9999999999999999999999999998765


Q ss_pred             ccCCc-ccccccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHhccCCCCCCccc
Q 002010          846 DAGAS-ECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAA  923 (982)
Q Consensus       846 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  923 (982)
                      ..... .......+++.|+|||++.+..++.++||||+|+++|||++ |+.||....... ....+.......       
T Consensus       173 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-~~~~~~~~~~~~-------  244 (291)
T 1u46_A          173 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ-ILHKIDKEGERL-------  244 (291)
T ss_dssp             C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-HHHHHHTSCCCC-------
T ss_pred             ccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHH-HHHHHHccCCCC-------
Confidence            43221 12234567888999999998889999999999999999999 999997653322 222221111110       


Q ss_pred             ccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCCCC
Q 002010          924 SVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQSA  976 (982)
Q Consensus       924 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~~~~  976 (982)
                                 ..+...+..+.+++.+||+.||++|||++++++.|+++.+..
T Consensus       245 -----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~  286 (291)
T 1u46_A          245 -----------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTD  286 (291)
T ss_dssp             -----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred             -----------CCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCccc
Confidence                       112234457899999999999999999999999998776543

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=5.8e-37  Score=356.46  Aligned_cols=195  Identities=25%  Similarity=0.354  Sum_probs=153.7

Q ss_pred             HhhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCC-CchhhHHHHHHHHhcCCCCcccceEeEEEcC-----Cc
Q 002010          691 LESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTG-GNDHGFLAEIQTLGRIRHRNIVRLLGYVSNR-----DT  763 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~  763 (982)
                      .++|+..+.||+|+||+||+|.. .+++.||||++...... ...+.+.+|+.++++++||||+++++++...     ..
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            36799999999999999999965 46899999998543222 2345788999999999999999999998443     46


Q ss_pred             cEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchh
Q 002010          764 NLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKF  843 (982)
Q Consensus       764 ~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~  843 (982)
                      .|+||||+ +++|.+++.  ....+++..+..++.||+.||+|||+.+   |+||||||+||+++.++.+||+|||+|+.
T Consensus       132 ~~lv~e~~-~~~L~~~~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~~  205 (458)
T 3rp9_A          132 LYVVLEIA-DSDFKKLFR--TPVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLART  205 (458)
T ss_dssp             EEEEECCC-SEEHHHHHH--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred             EEEEEecc-ccchhhhcc--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccchh
Confidence            79999998 579999997  4467999999999999999999999998   99999999999999999999999999987


Q ss_pred             ccccCC-------------------------ccccccccccccccccccc-ccCCCCcchhhHHHHHHHHHHHh
Q 002010          844 LQDAGA-------------------------SECMSSVAGSYGYIAPEYA-YTLKVDEKSDVYSFGVVLLELIA  891 (982)
Q Consensus       844 ~~~~~~-------------------------~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslG~il~ellt  891 (982)
                      ......                         .......+||+.|+|||++ .+..++.++||||+||++|||++
T Consensus       206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~ellt  279 (458)
T 3rp9_A          206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN  279 (458)
T ss_dssp             TTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHT
T ss_pred             ccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHH
Confidence            643211                         1223456789999999976 56679999999999999999999

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=1.1e-36  Score=350.60  Aligned_cols=201  Identities=26%  Similarity=0.343  Sum_probs=166.9

Q ss_pred             HhhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCC-CchhhHHHHHHHHhcCCCCcccceEeEEEcC-----Cc
Q 002010          691 LESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTG-GNDHGFLAEIQTLGRIRHRNIVRLLGYVSNR-----DT  763 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~  763 (982)
                      .++|+..+.||+|+||.||+|.. .+++.||||++...... ...+.+.+|+.++++++||||+++++++...     ..
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            46899999999999999999965 56889999998543222 2345788999999999999999999998766     56


Q ss_pred             cEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchh
Q 002010          764 NLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKF  843 (982)
Q Consensus       764 ~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~  843 (982)
                      .|+||||++ ++|.+++.  ....+++..+..++.||++||+|||+.+   |+||||||+||+++.++.+||+|||+|+.
T Consensus       105 ~~lv~e~~~-~~L~~~~~--~~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~~  178 (432)
T 3n9x_A          105 LYIVLEIAD-SDLKKLFK--TPIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLART  178 (432)
T ss_dssp             EEEEEECCS-EEHHHHHH--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEEecCC-cCHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCccc
Confidence            899999995 69999997  4467999999999999999999999998   99999999999999999999999999987


Q ss_pred             ccccCCc--------------------cccccccccccccccccc-ccCCCCcchhhHHHHHHHHHHHhCCCCCC
Q 002010          844 LQDAGAS--------------------ECMSSVAGSYGYIAPEYA-YTLKVDEKSDVYSFGVVLLELIAGKKPVG  897 (982)
Q Consensus       844 ~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslG~il~elltg~~p~~  897 (982)
                      .......                    ......+||+.|+|||++ ....++.++||||+||++|||++|..||.
T Consensus       179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~  253 (432)
T 3n9x_A          179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI  253 (432)
T ss_dssp             C-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred             ccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence            6533211                    224567899999999986 56679999999999999999998655543

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=4e-37  Score=371.68  Aligned_cols=249  Identities=23%  Similarity=0.280  Sum_probs=206.4

Q ss_pred             HhhcccccccccccceEEEEEEe-CCCcEEEEEEeccCC--CCCchhhHHHHHHHHhcC-CCCcccceEeEEEcCCccEE
Q 002010          691 LESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRG--TGGNDHGFLAEIQTLGRI-RHRNIVRLLGYVSNRDTNLL  766 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~l  766 (982)
                      .++|+..+.||+|+||.||+|+. .+++.||||++....  .......+..|..++..+ +||+|+++++++.+.+..|+
T Consensus       340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~l  419 (674)
T 3pfq_A          340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF  419 (674)
T ss_dssp             CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEE
T ss_pred             ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEE
Confidence            46789999999999999999975 468889999985432  234456688899999988 79999999999999999999


Q ss_pred             EEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccc
Q 002010          767 LYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQD  846 (982)
Q Consensus       767 v~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  846 (982)
                      ||||+++|+|.+++..  ...+++..+..++.||+.||+|||+.+   |+||||||+||+++.++.+||+|||+|+....
T Consensus       420 V~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~~~  494 (674)
T 3pfq_A          420 VMEYVNGGDLMYHIQQ--VGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIW  494 (674)
T ss_dssp             EEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEECCC
T ss_pred             EEeCcCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeecccc
Confidence            9999999999999973  357999999999999999999999998   99999999999999999999999999985432


Q ss_pred             cCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccc
Q 002010          847 AGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVL  926 (982)
Q Consensus       847 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  926 (982)
                      .  ........||+.|+|||++.+..|+.++||||+||++|||++|+.||......+....+. ....            
T Consensus       495 ~--~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~-~~~~------------  559 (674)
T 3pfq_A          495 D--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM-EHNV------------  559 (674)
T ss_dssp             T--TCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-SSCC------------
T ss_pred             C--CcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHH-hCCC------------
Confidence            2  223456789999999999999999999999999999999999999997643322222221 1110            


Q ss_pred             eeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCH-----HHHHH
Q 002010          927 AVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTM-----REVVH  967 (982)
Q Consensus       927 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~-----~ell~  967 (982)
                              .+|...+.++.+++.+||++||++||++     +||++
T Consensus       560 --------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~  597 (674)
T 3pfq_A          560 --------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  597 (674)
T ss_dssp             --------CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred             --------CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence                    1223344578999999999999999997     67764

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=9.6e-37  Score=343.50  Aligned_cols=269  Identities=19%  Similarity=0.270  Sum_probs=206.5

Q ss_pred             hhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcC-----CccE
Q 002010          692 ESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNR-----DTNL  765 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~  765 (982)
                      ++|+..+.||+|+||.||+|.. .+++.||||++...........+.+|+.++++++||||+++++++...     ...+
T Consensus        27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  106 (364)
T 3qyz_A           27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY  106 (364)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred             ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEE
Confidence            5799999999999999999965 468899999986544444456788999999999999999999998765     3579


Q ss_pred             EEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhcc
Q 002010          766 LLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQ  845 (982)
Q Consensus       766 lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~  845 (982)
                      +||||++ ++|.+++..   ..+++..+..++.|++.|++|||+.+   |+||||||+||+++.++.+||+|||++....
T Consensus       107 iv~e~~~-~~L~~~l~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~  179 (364)
T 3qyz_A          107 IVQDLME-TDLYKLLKT---QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVAD  179 (364)
T ss_dssp             EEEECCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEEcccC-cCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEecC
Confidence            9999996 599999863   46999999999999999999999998   9999999999999999999999999998765


Q ss_pred             ccCC-ccccccccccccccccccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcc-
Q 002010          846 DAGA-SECMSSVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDA-  922 (982)
Q Consensus       846 ~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-  922 (982)
                      .... ........||+.|+|||++.+ ..++.++||||+||++|||++|+.||...........+.............. 
T Consensus       180 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  259 (364)
T 3qyz_A          180 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI  259 (364)
T ss_dssp             GGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTC
T ss_pred             CCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHh
Confidence            3321 122345689999999998654 4589999999999999999999999987655544444443322211000000 


Q ss_pred             -----cc-cceeecCC-C--CCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          923 -----AS-VLAVVDPR-L--SGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       923 -----~~-~~~~~~~~-~--~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                           .. ......+. .  .......+..+.+++.+||+.||++|||++|+++
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  313 (364)
T 3qyz_A          260 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  313 (364)
T ss_dssp             CCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                 00 00000000 0  0111233457899999999999999999999987

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=5.5e-37  Score=346.12  Aligned_cols=266  Identities=22%  Similarity=0.262  Sum_probs=194.4

Q ss_pred             HhhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCC-CCchhhHHHHHHHHhcCCCCcccceEeEEEcCC------
Q 002010          691 LESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGT-GGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRD------  762 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------  762 (982)
                      .++|+..+.||+|+||.||+|.. .+++.||||++..... ......+.+|+.+++.++||||+++++++....      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            46799999999999999999965 5689999999864332 223456889999999999999999999997655      


Q ss_pred             ccEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccch
Q 002010          763 TNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAK  842 (982)
Q Consensus       763 ~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~  842 (982)
                      ..++||||++ ++|.+++.    ..+++..+..++.||+.|++|||+.+   |+||||||+||+++.++.+||+|||+++
T Consensus       104 ~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~  175 (371)
T 2xrw_A          104 DVYIVMELMD-ANLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR  175 (371)
T ss_dssp             EEEEEEECCS-EEHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC--
T ss_pred             ceEEEEEcCC-CCHHHHHh----hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeeccc
Confidence            6799999996 57888885    35899999999999999999999998   9999999999999999999999999998


Q ss_pred             hccccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCC-----
Q 002010          843 FLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVS-----  917 (982)
Q Consensus       843 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-----  917 (982)
                      .....   .......||+.|+|||++.+..++.++||||+||++|||++|+.||............+.......+     
T Consensus       176 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  252 (371)
T 2xrw_A          176 TAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK  252 (371)
T ss_dssp             -----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTT
T ss_pred             ccccc---cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence            65432   2234567899999999999999999999999999999999999999765433322222221111000     


Q ss_pred             -----------CCC-cccccceeecC-CCC---CCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          918 -----------QPS-DAASVLAVVDP-RLS---GYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       918 -----------~~~-~~~~~~~~~~~-~~~---~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                                 .+. ........+.. ..+   ..+...+..+.+++.+||+.||++|||++|+++
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  318 (371)
T 2xrw_A          253 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ  318 (371)
T ss_dssp             SCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             hhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence                       000 00000000000 000   111223567899999999999999999999987

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=9e-37  Score=338.59  Aligned_cols=252  Identities=26%  Similarity=0.394  Sum_probs=198.2

Q ss_pred             HHhhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcC-CCCcccceEeEEEc------C
Q 002010          690 VLESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRI-RHRNIVRLLGYVSN------R  761 (982)
Q Consensus       690 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~------~  761 (982)
                      ..++|+..+.||+|+||.||+|.. .+++.||+|++...  ......+.+|+.+++++ +||||+++++++..      .
T Consensus        22 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   99 (326)
T 2x7f_A           22 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT--GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD   99 (326)
T ss_dssp             CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--SSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCC
T ss_pred             CCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecC--cccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCcccc
Confidence            356799999999999999999976 57899999998543  33456788999999999 79999999999876      4


Q ss_pred             CccEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccc
Q 002010          762 DTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLA  841 (982)
Q Consensus       762 ~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a  841 (982)
                      ...++||||+++++|.+++.......+++..+..++.||+.|++|||+.+   |+||||||+||+++.++.+||+|||++
T Consensus       100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~  176 (326)
T 2x7f_A          100 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVS  176 (326)
T ss_dssp             CEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCTTT
T ss_pred             ceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEEEeeCcCc
Confidence            57899999999999999998665678999999999999999999999998   999999999999999999999999999


Q ss_pred             hhccccCCcccccccccccccccccccc-----cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCC
Q 002010          842 KFLQDAGASECMSSVAGSYGYIAPEYAY-----TLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEV  916 (982)
Q Consensus       842 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  916 (982)
                      ......  ........|++.|+|||++.     +..++.++||||+|+++|+|++|+.||............ .....  
T Consensus       177 ~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~-~~~~~--  251 (326)
T 2x7f_A          177 AQLDRT--VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI-PRNPA--  251 (326)
T ss_dssp             C---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH-HHSCC--
T ss_pred             eecCcC--ccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHh-hcCcc--
Confidence            866432  11233457899999999987     566899999999999999999999999764332222111 11110  


Q ss_pred             CCCCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          917 SQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       917 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                      +              .  ..+...+..+.+++.+||+.||++|||++|+++
T Consensus       252 ~--------------~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  286 (326)
T 2x7f_A          252 P--------------R--LKSKKWSKKFQSFIESCLVKNHSQRPATEQLMK  286 (326)
T ss_dssp             C--------------C--CSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             c--------------c--CCccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            0              0  011223457899999999999999999999987

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=1e-36  Score=336.08  Aligned_cols=251  Identities=22%  Similarity=0.290  Sum_probs=195.8

Q ss_pred             hhcccccccccccceEEEEEEeCCCcEEEEEEeccCCC-CCchhhHHHHHHHHhcCC--CCcccceEeEEEcCCccEEEE
Q 002010          692 ESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGT-GGNDHGFLAEIQTLGRIR--HRNIVRLLGYVSNRDTNLLLY  768 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~lv~  768 (982)
                      ++|+..+.||+|+||.||+|...+++.||+|++..... ......+.+|+.++++++  ||||+++++++..++..++||
T Consensus        28 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~  107 (313)
T 3cek_A           28 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM  107 (313)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEE
T ss_pred             ceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEE
Confidence            56899999999999999999888899999999854432 233467889999999997  599999999999999999999


Q ss_pred             eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccC
Q 002010          769 EYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAG  848 (982)
Q Consensus       769 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  848 (982)
                      | +.+++|.+++..  ...+++..+..++.|++.|++|||+.+   |+||||||+||++++ +.+||+|||++..+....
T Consensus       108 e-~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~  180 (313)
T 3cek_A          108 E-CGNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDT  180 (313)
T ss_dssp             C-CCSEEHHHHHHH--CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCSSSCC-----
T ss_pred             e-cCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeeccccccccCcc
Confidence            9 558899999974  357899999999999999999999998   999999999999964 899999999998765443


Q ss_pred             Cccccccccccccccccccccc-----------CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCC
Q 002010          849 ASECMSSVAGSYGYIAPEYAYT-----------LKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVS  917 (982)
Q Consensus       849 ~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  917 (982)
                      .........|++.|+|||++.+           ..++.++||||+|+++|||++|+.||...................  
T Consensus       181 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~--  258 (313)
T 3cek_A          181 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE--  258 (313)
T ss_dssp             ---------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSC--
T ss_pred             ccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhcccc--
Confidence            3333345678999999999875           468899999999999999999999997643322211111110000  


Q ss_pred             CCCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          918 QPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       918 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                                      ...+...+..+.+++.+||+.||++|||++|+++
T Consensus       259 ----------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  292 (313)
T 3cek_A          259 ----------------IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA  292 (313)
T ss_dssp             ----------------CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ----------------cCCcccchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence                            0122223457899999999999999999999987

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=7.2e-38  Score=354.34  Aligned_cols=242  Identities=13%  Similarity=0.109  Sum_probs=189.2

Q ss_pred             HhhcccccccccccceEEEEEEe-CCCcEEEEEEeccCC--CCCchhhHHHHHH---HHhcCCCCcccceE-------eE
Q 002010          691 LESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRG--TGGNDHGFLAEIQ---TLGRIRHRNIVRLL-------GY  757 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~---~l~~l~h~niv~~~-------~~  757 (982)
                      .++|+..+.||+|+||.||+|.. .+|+.||||++....  .....+.+.+|+.   ++++++|||||+++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            46788999999999999999975 569999999986432  3334567889994   55555899999998       66


Q ss_pred             EEcCCc-----------------cEEEEeccCCCCHHHHhhcCC-----CCCCCHHHHHHHHHHHHHHHHHHhhcCCCcE
Q 002010          758 VSNRDT-----------------NLLLYEYMPNGSLGEMLHGAK-----GGHLKWETRYRIALEAAKGLCYLHHDCSPLI  815 (982)
Q Consensus       758 ~~~~~~-----------------~~lv~e~~~~~sL~~~l~~~~-----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i  815 (982)
                      +.+++.                 .++||||+ +|+|.+++....     ...+++..+..++.||+.||+|||+.+   |
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i  227 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L  227 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence            665532                 78999999 689999997421     122335888899999999999999998   9


Q ss_pred             EecCCCCCcEEEcCCCCEEEeccccchhccccCCcccccccccccccccccccccC-----------CCCcchhhHHHHH
Q 002010          816 IHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTL-----------KVDEKSDVYSFGV  884 (982)
Q Consensus       816 vHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DvwslG~  884 (982)
                      +||||||+||+++.++.+||+|||+|+....     ......| +.|+|||++.+.           .++.++||||+||
T Consensus       228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~  301 (377)
T 3byv_A          228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL  301 (377)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred             ecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence            9999999999999999999999999985331     2344567 999999999887           8999999999999


Q ss_pred             HHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHH
Q 002010          885 VLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMRE  964 (982)
Q Consensus       885 il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~e  964 (982)
                      ++|||++|+.||............                    . +    .....+..+.+++.+||+.||++|||++|
T Consensus       302 il~elltg~~Pf~~~~~~~~~~~~--------------------~-~----~~~~~~~~~~~li~~~L~~dp~~Rpt~~e  356 (377)
T 3byv_A          302 VIYWIWCADLPITKDAALGGSEWI--------------------F-R----SCKNIPQPVRALLEGFLRYPKEDRLLPLQ  356 (377)
T ss_dssp             HHHHHHHSSCCC------CCSGGG--------------------G-S----SCCCCCHHHHHHHHHHTCSSGGGCCCHHH
T ss_pred             HHHHHHHCCCCCcccccccchhhh--------------------h-h----hccCCCHHHHHHHHHHcCCCchhCCCHHH
Confidence            999999999999653321110000                    0 0    01122357889999999999999999999


Q ss_pred             HHH
Q 002010          965 VVH  967 (982)
Q Consensus       965 ll~  967 (982)
                      +++
T Consensus       357 ~l~  359 (377)
T 3byv_A          357 AME  359 (377)
T ss_dssp             HHT
T ss_pred             Hhh
Confidence            986

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=7e-37  Score=338.37  Aligned_cols=260  Identities=24%  Similarity=0.340  Sum_probs=200.8

Q ss_pred             HhhcccccccccccceEEEEEEeCCCcEEEEEEeccCC-CCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEe
Q 002010          691 LESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRG-TGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYE  769 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  769 (982)
                      .++|+..+.||+|+||.||+|...+  .||+|++.... .....+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus        32 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e  109 (319)
T 2y4i_B           32 FEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITS  109 (319)
T ss_dssp             CSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECB
T ss_pred             HHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEee
Confidence            3678999999999999999998743  59999885443 23344567889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhcccc--
Q 002010          770 YMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDA--  847 (982)
Q Consensus       770 ~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--  847 (982)
                      |+++++|.+++.. ....+++..+..++.||+.|++|||+.+   |+||||||+||+++ ++.+||+|||++......  
T Consensus       110 ~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~  184 (319)
T 2y4i_B          110 LCKGRTLYSVVRD-AKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQA  184 (319)
T ss_dssp             CCCSEEHHHHTTS-SCCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC-------
T ss_pred             cccCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCccccccccc
Confidence            9999999999974 2357899999999999999999999998   99999999999998 679999999998765321  


Q ss_pred             -CCccccccccccccccccccccc---------CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCC
Q 002010          848 -GASECMSSVAGSYGYIAPEYAYT---------LKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVS  917 (982)
Q Consensus       848 -~~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  917 (982)
                       ..........|++.|+|||++.+         ..++.++||||+|+++|||++|+.||........ ...+....... 
T Consensus       185 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~~~~~~~~-  262 (319)
T 2y4i_B          185 GRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAI-IWQMGTGMKPN-  262 (319)
T ss_dssp             ---CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHH-HHHHHTTCCCC-
T ss_pred             cccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHhccCCCCC-
Confidence             11222334568999999999864         4578999999999999999999999976433222 11111111100 


Q ss_pred             CCCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCCCC
Q 002010          918 QPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQSA  976 (982)
Q Consensus       918 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~~~~  976 (982)
                                     .  .+...+..+.+++.+||+.||++|||++|+++.|+.+....
T Consensus       263 ---------------~--~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~  304 (319)
T 2y4i_B          263 ---------------L--SQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN  304 (319)
T ss_dssp             ---------------C--CCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred             ---------------C--CcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence                           0  00112236889999999999999999999999999987653

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=3.3e-37  Score=347.35  Aligned_cols=272  Identities=21%  Similarity=0.233  Sum_probs=200.3

Q ss_pred             HHHHhhcccccccccccceEEEEEEeCCCcEEEEEEeccCCCCCc----------hhhHHHHHHHHhcCCCCcccceEeE
Q 002010          688 EDVLESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGN----------DHGFLAEIQTLGRIRHRNIVRLLGY  757 (982)
Q Consensus       688 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~----------~~~~~~E~~~l~~l~h~niv~~~~~  757 (982)
                      ..+.++|+..+.||+|+||.||+|...+|+.||||++........          .+.+.+|+.++++++||||++++++
T Consensus        18 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~   97 (362)
T 3pg1_A           18 HAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDI   97 (362)
T ss_dssp             HHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEE
T ss_pred             HHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeee
Confidence            445678999999999999999999888899999999855433322          2678999999999999999999999


Q ss_pred             EEcC-----CccEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCC
Q 002010          758 VSNR-----DTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFE  832 (982)
Q Consensus       758 ~~~~-----~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~  832 (982)
                      +...     ...++||||++ |+|.+++.. ....+++..+..++.||+.|++|||+.+   |+||||||+||+++.++.
T Consensus        98 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~  172 (362)
T 3pg1_A           98 FVHFEEPAMHKLYLVTELMR-TDLAQVIHD-QRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILLADNND  172 (362)
T ss_dssp             EEECCTTTCCEEEEEEECCS-EEHHHHHHC-TTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCC
T ss_pred             EEeccCCCcceEEEEEccCC-CCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEEEcCCCC
Confidence            8543     35699999997 688888873 3457999999999999999999999998   999999999999999999


Q ss_pred             EEEeccccchhccccCCccccccccccccccccccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHH
Q 002010          833 AHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRK  911 (982)
Q Consensus       833 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~  911 (982)
                      +||+|||++......   .......+|+.|+|||++.+ ..++.++||||+||++|+|++|+.||............+..
T Consensus       173 ~kl~Dfg~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~  249 (362)
T 3pg1_A          173 ITICDFNLAREDTAD---ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEV  249 (362)
T ss_dssp             EEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred             EEEEecCcccccccc---cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence            999999999754432   22345678999999999876 67899999999999999999999999875443333333332


Q ss_pred             hccCCCCC---CcccccceeecCCC--------CCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          912 TTSEVSQP---SDAASVLAVVDPRL--------SGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       912 ~~~~~~~~---~~~~~~~~~~~~~~--------~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                      ........   .........+....        .......+..+.+++.+||+.||++|||++|+++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  316 (362)
T 3pg1_A          250 VGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR  316 (362)
T ss_dssp             HCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             cCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence            22110000   00000000000000        0112233456899999999999999999999987

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=1.1e-36  Score=346.15  Aligned_cols=270  Identities=22%  Similarity=0.269  Sum_probs=201.0

Q ss_pred             hhcccccccccccceEEEEEEeCCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCc------cE
Q 002010          692 ESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDT------NL  765 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~------~~  765 (982)
                      .+|+..+.||+|+||.||+|+...+..||+|++......     ..+|+.+++.++||||+++++++.....      .+
T Consensus        40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~-----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~  114 (394)
T 4e7w_A           40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF-----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN  114 (394)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS-----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred             ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch-----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence            468999999999999999998877777999988543221     2379999999999999999999865433      78


Q ss_pred             EEEeccCCCCHHHHhh-cCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEc-CCCCEEEeccccchh
Q 002010          766 LLYEYMPNGSLGEMLH-GAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLD-SDFEAHVADFGLAKF  843 (982)
Q Consensus       766 lv~e~~~~~sL~~~l~-~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~-~~~~~kl~DfG~a~~  843 (982)
                      +||||++++.+..... ......+++..+..++.||++||+|||+.+   |+||||||+||+++ .++.+||+|||+|+.
T Consensus       115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~  191 (394)
T 4e7w_A          115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKI  191 (394)
T ss_dssp             EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence            9999997654333322 123467999999999999999999999998   99999999999999 789999999999987


Q ss_pred             ccccCCcccccccccccccccccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCC--
Q 002010          844 LQDAGASECMSSVAGSYGYIAPEYAYTL-KVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPS--  920 (982)
Q Consensus       844 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--  920 (982)
                      .....   ......||+.|+|||++.+. .++.++||||+||++|||++|+.||...........++...........  
T Consensus       192 ~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~  268 (394)
T 4e7w_A          192 LIAGE---PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKT  268 (394)
T ss_dssp             CCTTC---CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred             ccCCC---CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            64332   23456789999999998765 5899999999999999999999999876544444444433222110000  


Q ss_pred             cccccceeecCCCC------CCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH--HhcCC
Q 002010          921 DAASVLAVVDPRLS------GYPLTGVIHLFKVAMMCVEDESSARPTMREVVH--MLANP  972 (982)
Q Consensus       921 ~~~~~~~~~~~~~~------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~--~L~~~  972 (982)
                      .........-+...      .++...+..+.+++.+||+.||.+|||++|+++  .++++
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  328 (394)
T 4e7w_A          269 MNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDEL  328 (394)
T ss_dssp             HCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTT
T ss_pred             hChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhh
Confidence            00000000000111      122334568999999999999999999999987  34444

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=5.6e-37  Score=369.21  Aligned_cols=256  Identities=25%  Similarity=0.376  Sum_probs=205.6

Q ss_pred             hhcccccccccccceEEEEEEeC----CCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEE
Q 002010          692 ESLKDENIIGKGGAGIVYRGSMP----DGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLL  767 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  767 (982)
                      ++|+..+.||+|+||.||+|...    .+..||+|.+.........+.+.+|+.++++++||||+++++++. ++..++|
T Consensus       390 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~lv  468 (656)
T 2j0j_A          390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII  468 (656)
T ss_dssp             GGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEE
T ss_pred             ccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEEE
Confidence            57889999999999999999753    246799998855444444567899999999999999999999885 5678999


Q ss_pred             EeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhcccc
Q 002010          768 YEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDA  847 (982)
Q Consensus       768 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  847 (982)
                      |||+++|+|.+++... ...+++..+..++.|++.|++|||+.+   |+||||||+||+++.++.+||+|||+++.....
T Consensus       469 ~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~~~~~~  544 (656)
T 2j0j_A          469 MELCTLGELRSFLQVR-KFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS  544 (656)
T ss_dssp             EECCTTCBHHHHHHHT-TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCCSCCC-
T ss_pred             EEcCCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCeecCCC
Confidence            9999999999999743 356899999999999999999999998   999999999999999999999999999876543


Q ss_pred             CCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHhccCCCCCCcccccc
Q 002010          848 GASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVL  926 (982)
Q Consensus       848 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  926 (982)
                      . ........+++.|+|||++.+..++.++||||+|+++|||++ |..||...... +....+.....            
T Consensus       545 ~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~-~~~~~i~~~~~------------  610 (656)
T 2j0j_A          545 T-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN-DVIGRIENGER------------  610 (656)
T ss_dssp             ----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-HHHHHHHHTCC------------
T ss_pred             c-ceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH-HHHHHHHcCCC------------
Confidence            2 222234456789999999998899999999999999999997 99999765332 22222222111            


Q ss_pred             eeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 002010          927 AVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPP  973 (982)
Q Consensus       927 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~  973 (982)
                             ...+...+..+.+++.+||+.||++|||++|+++.|+.+.
T Consensus       611 -------~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il  650 (656)
T 2j0j_A          611 -------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL  650 (656)
T ss_dssp             -------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -------CCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence                   1123344567899999999999999999999999987653

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=3.1e-36  Score=329.66  Aligned_cols=254  Identities=24%  Similarity=0.344  Sum_probs=205.1

Q ss_pred             HHHhhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCC--------CchhhHHHHHHHHhcCC-CCcccceEeEE
Q 002010          689 DVLESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTG--------GNDHGFLAEIQTLGRIR-HRNIVRLLGYV  758 (982)
Q Consensus       689 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--------~~~~~~~~E~~~l~~l~-h~niv~~~~~~  758 (982)
                      .+.++|+..+.||+|+||.||+|.. .+++.||||++......        ...+.+.+|+.+++++. ||||+++++++
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~   93 (298)
T 1phk_A           14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY   93 (298)
T ss_dssp             -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred             chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence            3457899999999999999999976 46899999998544321        11345788999999995 99999999999


Q ss_pred             EcCCccEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEecc
Q 002010          759 SNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADF  838 (982)
Q Consensus       759 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Df  838 (982)
                      ..+...++||||+++++|.+++..  ...+++..+..++.||+.|++|||+.+   |+||||||+||+++.++.+||+||
T Consensus        94 ~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~df  168 (298)
T 1phk_A           94 ETNTFFFLVFDLMKKGELFDYLTE--KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDF  168 (298)
T ss_dssp             ECSSEEEEEEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCC
T ss_pred             ccCCeEEEEEeccCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEecc
Confidence            999999999999999999999973  357999999999999999999999998   999999999999999999999999


Q ss_pred             ccchhccccCCcccccccccccccccccccc------cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHh
Q 002010          839 GLAKFLQDAGASECMSSVAGSYGYIAPEYAY------TLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKT  912 (982)
Q Consensus       839 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~  912 (982)
                      |.+......   .......+++.|+|||++.      ...++.++||||+|+++|||++|+.||....... ....+...
T Consensus       169 g~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~  244 (298)
T 1phk_A          169 GFSCQLDPG---EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML-MLRMIMSG  244 (298)
T ss_dssp             TTCEECCTT---CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHT
T ss_pred             cchhhcCCC---cccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHH-HHHHHhcC
Confidence            999876532   2234567899999999875      4568899999999999999999999997643322 22222221


Q ss_pred             ccCCCCCCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          913 TSEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       913 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                      ......                ......+..+.+++.+||+.||++|||++|+++
T Consensus       245 ~~~~~~----------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          245 NYQFGS----------------PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             CCCCCT----------------TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             CcccCc----------------ccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence            111000                011234457899999999999999999999986

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=1.7e-36  Score=350.85  Aligned_cols=261  Identities=18%  Similarity=0.276  Sum_probs=205.7

Q ss_pred             HhhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCC-CcccceEeEEEcCCccEEEE
Q 002010          691 LESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRH-RNIVRLLGYVSNRDTNLLLY  768 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~lv~  768 (982)
                      .++|++.+.||+|+||.||+|.. .+++.||||++....   ....+.+|+++++.++| +++..+..++...+..++||
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~---~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvm   82 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT---KHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVM   82 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTC---SSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccc---ccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEE
Confidence            36799999999999999999975 569999999874432   23457899999999987 55666666667788889999


Q ss_pred             eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEE---cCCCCEEEeccccchhcc
Q 002010          769 EYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILL---DSDFEAHVADFGLAKFLQ  845 (982)
Q Consensus       769 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill---~~~~~~kl~DfG~a~~~~  845 (982)
                      ||+ +++|.+++... ...+++..++.++.||+.||+|||+.+   |+||||||+||++   +.++.+||+|||+++.+.
T Consensus        83 e~~-g~sL~~ll~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~  157 (483)
T 3sv0_A           83 DLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR  157 (483)
T ss_dssp             ECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             ECC-CCCHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence            999 99999999742 457999999999999999999999998   9999999999999   588999999999998766


Q ss_pred             ccCCc-----ccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCC
Q 002010          846 DAGAS-----ECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPS  920 (982)
Q Consensus       846 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  920 (982)
                      .....     .......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+........    
T Consensus       158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~----  233 (483)
T 3sv0_A          158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV----  233 (483)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHH----
T ss_pred             CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccc----
Confidence            43221     122356799999999999999999999999999999999999999987554332222111111000    


Q ss_pred             cccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 002010          921 DAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANP  972 (982)
Q Consensus       921 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~  972 (982)
                               .......+...+.++.+++.+||+.||++||++++|++.|+.+
T Consensus       234 ---------~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l  276 (483)
T 3sv0_A          234 ---------ATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL  276 (483)
T ss_dssp             ---------HSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred             ---------cccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence                     0000001112345789999999999999999999999988664

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=3.8e-36  Score=326.97  Aligned_cols=255  Identities=25%  Similarity=0.338  Sum_probs=206.4

Q ss_pred             HHHHHhhcccccccccccceEEEEEEeC-CCcEEEEEEeccCC-CCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCcc
Q 002010          687 AEDVLESLKDENIIGKGGAGIVYRGSMP-DGIDVAIKRLVGRG-TGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTN  764 (982)
Q Consensus       687 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  764 (982)
                      ...+.++|++.+.||+|+||.||+|... +++.||+|++.... .......+.+|+.++++++||||+++++++.+....
T Consensus        17 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   96 (287)
T 2wei_A           17 QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSF   96 (287)
T ss_dssp             THHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             HHHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeE
Confidence            4556789999999999999999999764 68999999985443 334567789999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCC---CCEEEeccccc
Q 002010          765 LLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSD---FEAHVADFGLA  841 (982)
Q Consensus       765 ~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~---~~~kl~DfG~a  841 (982)
                      ++||||+++++|.+++..  ...+++..+..++.||+.|++|||+.+   |+||||||+||+++.+   +.+||+|||++
T Consensus        97 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~  171 (287)
T 2wei_A           97 YIVGELYTGGELFDEIIK--RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLS  171 (287)
T ss_dssp             EEEECCCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGG
T ss_pred             EEEEEccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcc
Confidence            999999999999998863  357899999999999999999999998   9999999999999764   47999999999


Q ss_pred             hhccccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCc
Q 002010          842 KFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSD  921 (982)
Q Consensus       842 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  921 (982)
                      .......   ......+++.|+|||++.+ .++.++||||+|+++|+|++|..||...... .....+.........+  
T Consensus       172 ~~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~--  244 (287)
T 2wei_A          172 TCFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY-DILKRVETGKYAFDLP--  244 (287)
T ss_dssp             GTBCCCS---SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHCCCCCCSG--
T ss_pred             eeecCCC---ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHH-HHHHHHHcCCCCCCch--
Confidence            8765321   2234568899999998876 4899999999999999999999999764332 2222222211100000  


Q ss_pred             ccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          922 AASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       922 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                                    .....+..+.+++.+||+.||++|||++|+++
T Consensus       245 --------------~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  276 (287)
T 2wei_A          245 --------------QWRTISDDAKDLIRKMLTFHPSLRITATQCLE  276 (287)
T ss_dssp             --------------GGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --------------hhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence                          00123357889999999999999999999987

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=2.1e-37  Score=347.96  Aligned_cols=265  Identities=21%  Similarity=0.300  Sum_probs=186.7

Q ss_pred             HhhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCC-CCchhhHHHHHHHHhcCCCCcccceEeEEEcC------C
Q 002010          691 LESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGT-GGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNR------D  762 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~  762 (982)
                      .++|+..+.||+|+||.||+|.. .+|+.||||++..... ......+.+|+.+++.++||||+++++++...      .
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence            36899999999999999999964 5689999999854322 22345788999999999999999999998654      5


Q ss_pred             ccEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccch
Q 002010          763 TNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAK  842 (982)
Q Consensus       763 ~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~  842 (982)
                      ..++|||++ +++|.+++..   ..+++..+..++.||++|++|||+.+   |+||||||+||+++.++.+||+|||+++
T Consensus       108 ~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a~  180 (367)
T 2fst_X          108 DVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR  180 (367)
T ss_dssp             CCEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC-----
T ss_pred             eEEEEeccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeeccccc
Confidence            579999999 7899998853   57999999999999999999999998   9999999999999999999999999998


Q ss_pred             hccccCCccccccccccccccccccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCC---
Q 002010          843 FLQDAGASECMSSVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQ---  918 (982)
Q Consensus       843 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---  918 (982)
                      .....     .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||...........+..........   
T Consensus       181 ~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~  255 (367)
T 2fst_X          181 HTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK  255 (367)
T ss_dssp             ---------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHT
T ss_pred             ccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            65422     345678999999999877 678999999999999999999999998654433333333322221000   


Q ss_pred             CCcccccceeec--CCCC-----CCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          919 PSDAASVLAVVD--PRLS-----GYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       919 ~~~~~~~~~~~~--~~~~-----~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                      ..........+.  +..+     ......+..+.+++.+||+.||++|||++|+++
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~  311 (367)
T 2fst_X          256 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  311 (367)
T ss_dssp             TCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence            000000000000  0000     111223456889999999999999999999987

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=1.2e-36  Score=341.50  Aligned_cols=275  Identities=21%  Similarity=0.272  Sum_probs=206.1

Q ss_pred             HhhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcC-----Ccc
Q 002010          691 LESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNR-----DTN  764 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~  764 (982)
                      .++|+..+.||+|+||.||+|.. .+|+.||||++...........+.+|+.++++++||||+++++++..+     ...
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   89 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV   89 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence            46799999999999999999976 468999999985443333455788999999999999999999987654     567


Q ss_pred             EEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhc
Q 002010          765 LLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFL  844 (982)
Q Consensus       765 ~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~  844 (982)
                      ++||||++ ++|.+++..   ..+++..+..++.|++.|++|||+.+   |+||||||+||+++.++.+||+|||++...
T Consensus        90 ~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~  162 (353)
T 2b9h_A           90 YIIQELMQ-TDLHRVIST---QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARII  162 (353)
T ss_dssp             EEEECCCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEeccC-ccHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEeccccccc
Confidence            99999996 699999864   46999999999999999999999998   999999999999999999999999999876


Q ss_pred             cccCCc--------cccccccccccccccccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccC
Q 002010          845 QDAGAS--------ECMSSVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSE  915 (982)
Q Consensus       845 ~~~~~~--------~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  915 (982)
                      ......        .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||...................
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  242 (353)
T 2b9h_A          163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTP  242 (353)
T ss_dssp             C----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             ccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Confidence            532111        11234578999999998764 678999999999999999999999998754333333333222221


Q ss_pred             CCCCCcccc-----cceeec--CCCC-----CCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH--HhcCCC
Q 002010          916 VSQPSDAAS-----VLAVVD--PRLS-----GYPLTGVIHLFKVAMMCVEDESSARPTMREVVH--MLANPP  973 (982)
Q Consensus       916 ~~~~~~~~~-----~~~~~~--~~~~-----~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~--~L~~~~  973 (982)
                      . .......     ....+.  +..+     ......+..+.+++.+||+.||++|||++|+++  .+....
T Consensus       243 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  313 (353)
T 2b9h_A          243 H-SDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYH  313 (353)
T ss_dssp             C-STTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred             c-hhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccC
Confidence            1 0000000     000000  0000     111234567889999999999999999999997  454443

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=2.1e-36  Score=337.49  Aligned_cols=265  Identities=20%  Similarity=0.283  Sum_probs=205.9

Q ss_pred             HhhcccccccccccceEEEEEEe--CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCc------ccceEeEEEcCC
Q 002010          691 LESLKDENIIGKGGAGIVYRGSM--PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRN------IVRLLGYVSNRD  762 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~~~~~~~~~~  762 (982)
                      .++|++.+.||+|+||.||+|..  .+++.||+|++...  ......+.+|+.+++.++|++      ++++++++...+
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~   90 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV--DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHG   90 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS--HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETT
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC--CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCC
Confidence            35799999999999999999965  46889999998432  233456788999999887654      999999999999


Q ss_pred             ccEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcC-------------
Q 002010          763 TNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDS-------------  829 (982)
Q Consensus       763 ~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~-------------  829 (982)
                      ..++||||+ +++|.+++.......+++..+..++.||+.|++|||+.+   |+||||||+||+++.             
T Consensus        91 ~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~  166 (339)
T 1z57_A           91 HICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKR  166 (339)
T ss_dssp             EEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----C
T ss_pred             cEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCcccc
Confidence            999999999 899999998666668999999999999999999999998   999999999999987             


Q ss_pred             ------CCCEEEeccccchhccccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCc
Q 002010          830 ------DFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGV  903 (982)
Q Consensus       830 ------~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~  903 (982)
                            ++.+||+|||.+......     .....||+.|+|||++.+..++.++||||+||++|||++|+.||.......
T Consensus       167 ~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~  241 (339)
T 1z57_A          167 DERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE  241 (339)
T ss_dssp             EEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHH
T ss_pred             ccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH
Confidence                  678999999999764322     234678999999999999999999999999999999999999998654333


Q ss_pred             hHHHHHHHhccCCCCCC-c---ccc------------------cceeecC--CCCCCChHhHHHHHHHHhhccCCCCCCC
Q 002010          904 DIVRWVRKTTSEVSQPS-D---AAS------------------VLAVVDP--RLSGYPLTGVIHLFKVAMMCVEDESSAR  959 (982)
Q Consensus       904 ~~~~~~~~~~~~~~~~~-~---~~~------------------~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~dP~~R  959 (982)
                      .... +.......+... .   ...                  ......+  .....+...+..+.+++.+||+.||++|
T Consensus       242 ~~~~-~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R  320 (339)
T 1z57_A          242 HLAM-MERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKR  320 (339)
T ss_dssp             HHHH-HHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred             HHHH-HHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccc
Confidence            2222 222211110000 0   000                  0000000  0012234556789999999999999999


Q ss_pred             CCHHHHHH
Q 002010          960 PTMREVVH  967 (982)
Q Consensus       960 pt~~ell~  967 (982)
                      ||++|+++
T Consensus       321 pt~~ell~  328 (339)
T 1z57_A          321 ITLREALK  328 (339)
T ss_dssp             CCHHHHTT
T ss_pred             cCHHHHhc
Confidence            99999985

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=2.3e-36  Score=346.33  Aligned_cols=264  Identities=25%  Similarity=0.285  Sum_probs=197.7

Q ss_pred             hhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcC------Ccc
Q 002010          692 ESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNR------DTN  764 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~~  764 (982)
                      .+|+..+.||+|+||.||+|.. .+++.||||++....     ....+|++++++++||||+++++++...      ...
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~  128 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL  128 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT-----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc-----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeE
Confidence            3688899999999999999976 468999999985432     2234799999999999999999988542      135


Q ss_pred             EEEEeccCCCCHHHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCC-CCEEEeccccc
Q 002010          765 LLLYEYMPNGSLGEMLHG--AKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSD-FEAHVADFGLA  841 (982)
Q Consensus       765 ~lv~e~~~~~sL~~~l~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~-~~~kl~DfG~a  841 (982)
                      ++||||+++ ++.+.+..  .....+++..+..++.||++||+|||+.+   |+||||||+||+++.+ +.+||+|||++
T Consensus       129 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a  204 (420)
T 1j1b_A          129 NLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSA  204 (420)
T ss_dssp             EEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             Eeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhh
Confidence            789999975 66666542  23467999999999999999999999988   9999999999999965 57899999999


Q ss_pred             hhccccCCcccccccccccccccccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCC
Q 002010          842 KFLQDAGASECMSSVAGSYGYIAPEYAYTL-KVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPS  920 (982)
Q Consensus       842 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  920 (982)
                      +.+....   ......||+.|+|||++.+. .++.++||||+||++|||++|+.||........+..++...........
T Consensus       205 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~  281 (420)
T 1j1b_A          205 KQLVRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI  281 (420)
T ss_dssp             EECCTTC---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred             hhcccCC---CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            8764322   23456789999999998765 7999999999999999999999999875544444444443222100000


Q ss_pred             --cccccceeecCCCCC------CChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          921 --DAASVLAVVDPRLSG------YPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       921 --~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                        .........-+....      ++...+..+.+|+.+||+.||++|||+.|+++
T Consensus       282 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~  336 (420)
T 1j1b_A          282 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  336 (420)
T ss_dssp             HHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence              000000000011111      22334567899999999999999999999986

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.3e-36  Score=347.50  Aligned_cols=268  Identities=19%  Similarity=0.276  Sum_probs=185.3

Q ss_pred             Hhhccc-ccccccccceEEEEEEeC---CCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEc--CCcc
Q 002010          691 LESLKD-ENIIGKGGAGIVYRGSMP---DGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSN--RDTN  764 (982)
Q Consensus       691 ~~~~~~-~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~  764 (982)
                      .+.|+. ++.||+|+||.||+|+..   +++.||+|++...   .....+.+|+.++++++||||+++++++..  +...
T Consensus        19 ~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~   95 (405)
T 3rgf_A           19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT---GISMSACREIALLRELKHPNVISLQKVFLSHADRKV   95 (405)
T ss_dssp             HHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSS---SCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEE
T ss_pred             hhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCC---CCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeE
Confidence            355665 568999999999999754   5789999998432   234568899999999999999999999854  6678


Q ss_pred             EEEEeccCCCCHHHHhhcC-------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEE----cCCCCE
Q 002010          765 LLLYEYMPNGSLGEMLHGA-------KGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILL----DSDFEA  833 (982)
Q Consensus       765 ~lv~e~~~~~sL~~~l~~~-------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill----~~~~~~  833 (982)
                      ++||||++ ++|.+++...       ....+++..++.++.||+.||+|||+.+   |+||||||+||++    +.++.+
T Consensus        96 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~  171 (405)
T 3rgf_A           96 WLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRV  171 (405)
T ss_dssp             EEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCE
T ss_pred             EEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcE
Confidence            99999996 5888877521       2235999999999999999999999998   9999999999999    677999


Q ss_pred             EEeccccchhccccC-CcccccccccccccccccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCC---------
Q 002010          834 HVADFGLAKFLQDAG-ASECMSSVAGSYGYIAPEYAYTL-KVDEKSDVYSFGVVLLELIAGKKPVGEFGDG---------  902 (982)
Q Consensus       834 kl~DfG~a~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~---------  902 (982)
                      ||+|||+|+.+.... .........||+.|+|||++.+. .++.++||||+||++|||++|++||......         
T Consensus       172 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~  251 (405)
T 3rgf_A          172 KIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHH  251 (405)
T ss_dssp             EECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCH
T ss_pred             EEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchH
Confidence            999999998765321 11233456789999999998874 5899999999999999999999999754331         


Q ss_pred             chHHHHHHHhccCCCCCCcccccce----------eecCCCCCC---------ChHhHHHHHHHHhhccCCCCCCCCCHH
Q 002010          903 VDIVRWVRKTTSEVSQPSDAASVLA----------VVDPRLSGY---------PLTGVIHLFKVAMMCVEDESSARPTMR  963 (982)
Q Consensus       903 ~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~---------~~~~~~~l~~li~~cl~~dP~~Rpt~~  963 (982)
                      ..+..++..... +...... ....          .........         .......+.+|+.+||+.||.+|||++
T Consensus       252 ~~l~~i~~~~g~-p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~  329 (405)
T 3rgf_A          252 DQLDRIFNVMGF-PADKDWE-DIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSE  329 (405)
T ss_dssp             HHHHHHHHHHCC-CCTTTCG-GGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHH
T ss_pred             HHHHHHHHhhCC-CChhhcc-hhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHH
Confidence            222222222221 1111100 0000          000000000         011134678999999999999999999


Q ss_pred             HHHH
Q 002010          964 EVVH  967 (982)
Q Consensus       964 ell~  967 (982)
                      |+++
T Consensus       330 e~L~  333 (405)
T 3rgf_A          330 QAMQ  333 (405)
T ss_dssp             HHHT
T ss_pred             HHhc
Confidence            9998

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=2.5e-36  Score=344.98  Aligned_cols=266  Identities=19%  Similarity=0.201  Sum_probs=203.6

Q ss_pred             HhhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCC--------CCcccceEeEEE--
Q 002010          691 LESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIR--------HRNIVRLLGYVS--  759 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~~~~~~~--  759 (982)
                      .++|++.+.||+|+||+||+|.. .+++.||||++...  ......+.+|+.++++++        ||||+++++++.  
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~  113 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA--EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKIS  113 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEE
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC--CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeec
Confidence            36799999999999999999965 56889999998432  233457889999999985        788999999987  


Q ss_pred             --cCCccEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhc-CCCcEEecCCCCCcEEEcCCC-----
Q 002010          760 --NRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHD-CSPLIIHRDVKSNNILLDSDF-----  831 (982)
Q Consensus       760 --~~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~ivHrDlkp~Nill~~~~-----  831 (982)
                        .....++||||+ ++++.+++.......+++..+..++.||+.||+|||++ +   |+||||||+||+++.++     
T Consensus       114 ~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~~  189 (397)
T 1wak_A          114 GVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIRR  189 (397)
T ss_dssp             ETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHHH
T ss_pred             CCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhhh
Confidence              556789999999 66777777655557899999999999999999999998 8   99999999999998775     


Q ss_pred             --------------------------------------------CEEEeccccchhccccCCcccccccccccccccccc
Q 002010          832 --------------------------------------------EAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEY  867 (982)
Q Consensus       832 --------------------------------------------~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~  867 (982)
                                                                  .+||+|||.+......     .....||+.|+|||+
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~  264 (397)
T 1wak_A          190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEV  264 (397)
T ss_dssp             HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHHH
T ss_pred             hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCChh
Confidence                                                        7999999999866432     344578999999999


Q ss_pred             cccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCc-----hHHHHHHHhccCCCC------------CCcccccceeec
Q 002010          868 AYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGV-----DIVRWVRKTTSEVSQ------------PSDAASVLAVVD  930 (982)
Q Consensus       868 ~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~-----~~~~~~~~~~~~~~~------------~~~~~~~~~~~~  930 (982)
                      +.+..++.++||||+||++|||++|+.||.......     .....+.......+.            ...........+
T Consensus       265 ~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~  344 (397)
T 1wak_A          265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITK  344 (397)
T ss_dssp             HHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCC
T ss_pred             hcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccc
Confidence            999999999999999999999999999997644321     111111111111000            000000000000


Q ss_pred             C----------CCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          931 P----------RLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       931 ~----------~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                      .          .....+...+..+.+++.+||+.||++|||++|+++
T Consensus       345 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  391 (397)
T 1wak_A          345 LKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR  391 (397)
T ss_dssp             CCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred             cCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence            0          001235667778999999999999999999999985

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=100.00  E-value=4.3e-36  Score=341.77  Aligned_cols=336  Identities=20%  Similarity=0.203  Sum_probs=266.2

Q ss_pred             CCCCCCEEecccCcCcccCchhhcCCCccceeecccccCCCCCCccccCCCCCCEEEeeCCcccCcCchhhhcccchhhh
Q 002010          239 ALTQLQVLDMASCNISGEIPTSLSRLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLL  318 (982)
Q Consensus       239 ~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L  318 (982)
                      .++++++|++++|.++...+..|..+++|++|++++|++++..+..|..+++|++|+|++|.+++..|..|..+++|++|
T Consensus        43 ~l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L  122 (390)
T 3o6n_A           43 TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVL  122 (390)
T ss_dssp             GGCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred             ccCCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEE
Confidence            46889999999999987666678999999999999999998777889999999999999999998888888999999999


Q ss_pred             hhccCCCCCCCCCcCCCCCCccEEEccCCCcccccCccccCCCcccEEEeccccccccCCccccCccccceeeccccccc
Q 002010          319 QLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFI  398 (982)
Q Consensus       319 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~l~~N~~~  398 (982)
                      ++++|+++...+..|..+++|++|++++|.+++..+..+..+++|++|++++|++++.   .+..+++|+.|++++|.+.
T Consensus       123 ~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~---~~~~l~~L~~L~l~~n~l~  199 (390)
T 3o6n_A          123 VLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLLS  199 (390)
T ss_dssp             ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBC---CGGGCTTCSEEECCSSCCS
T ss_pred             ECCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCcc---ccccccccceeeccccccc
Confidence            9999999866666678889999999999988877777888888888888888888743   2344455555555555543


Q ss_pred             ccCCccccCCCCCCEEEccCCccCCCCCccccCCCccccccCCCccccccCCcccccCCccEEEeeccccCCCCchhccC
Q 002010          399 GPIPEELGQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLSGELPEKMSGASLNQLKVANNNITGKIPAAIGN  478 (982)
Q Consensus       399 ~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~L~~N~i~~~~p~~~~~  478 (982)
                      +     +...++|++|++++|++                        .......  ..+|+.|++++|++++.  ..+..
T Consensus       200 ~-----~~~~~~L~~L~l~~n~l------------------------~~~~~~~--~~~L~~L~l~~n~l~~~--~~l~~  246 (390)
T 3o6n_A          200 T-----LAIPIAVEELDASHNSI------------------------NVVRGPV--NVELTILKLQHNNLTDT--AWLLN  246 (390)
T ss_dssp             E-----EECCSSCSEEECCSSCC------------------------CEEECCC--CSSCCEEECCSSCCCCC--GGGGG
T ss_pred             c-----cCCCCcceEEECCCCee------------------------eeccccc--cccccEEECCCCCCccc--HHHcC
Confidence            2     12223445555555544                        4332211  25788888888888854  57888


Q ss_pred             CCCcceeeeccccccCCCccccccccccceeeeeccccCCCCCcccccccCCCeeeCCCCcccCCCCcccccccccceEE
Q 002010          479 LPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYGKIPPGISKLIDLSILN  558 (982)
Q Consensus       479 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~  558 (982)
                      +++|++|++++|++++..|..+..+++|++|+|++|++++ +|..+..+++|+.|+|++|+++ .+|..+..+++|+.|+
T Consensus       247 l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~  324 (390)
T 3o6n_A          247 YPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLY  324 (390)
T ss_dssp             CTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEE
T ss_pred             CCCccEEECCCCcCCCcChhHccccccCCEEECCCCcCcc-cCcccCCCCCCCEEECCCCcce-ecCccccccCcCCEEE
Confidence            9999999999999998888889999999999999999984 5667788999999999999998 6788899999999999


Q ss_pred             cccccccccCccccccccccceecccCCccccCCCCCccccccccccccCCcCcccCC
Q 002010          559 LSRNGITGSIPNEMRNMMSLTTLDLSYNNLIGNIPSGGQFLAFNETSFIGNPNLCLLR  616 (982)
Q Consensus       559 Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~~~~~~~~~~~~~~n~~~c~~~  616 (982)
                      |++|+|++. |  +..+++|+.|++++|++++.... ..+..+....+.+++..|..+
T Consensus       325 L~~N~i~~~-~--~~~~~~L~~L~l~~N~~~~~~~~-~~~~~~~~~~~~~~~~~c~~~  378 (390)
T 3o6n_A          325 LDHNSIVTL-K--LSTHHTLKNLTLSHNDWDCNSLR-ALFRNVARPAVDDADQHCKID  378 (390)
T ss_dssp             CCSSCCCCC-C--CCTTCCCSEEECCSSCEEHHHHH-HHTTTCCTTTBCCCCSCCCTT
T ss_pred             CCCCcccee-C--chhhccCCEEEcCCCCccchhHH-HHHHHHHhhcccccCceeccc
Confidence            999999854 3  77889999999999999875322 234556666778888888754

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=2.7e-36  Score=330.96  Aligned_cols=253  Identities=25%  Similarity=0.408  Sum_probs=193.9

Q ss_pred             HHhhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEc--------
Q 002010          690 VLESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSN--------  760 (982)
Q Consensus       690 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--------  760 (982)
                      +.++|+..+.||+|+||.||+|.. .+++.||+|++...  ......+.+|+.++++++||||+++++++.+        
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   81 (303)
T 1zy4_A            4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT--EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPM   81 (303)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC--
T ss_pred             ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc--HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhh
Confidence            457899999999999999999975 57899999998432  2334678899999999999999999998765        


Q ss_pred             -----CCccEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEE
Q 002010          761 -----RDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHV  835 (982)
Q Consensus       761 -----~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl  835 (982)
                           ....++||||+++++|.+++.. ....+++..++.++.|++.|++|||+.+   |+||||||+||+++.++.+||
T Consensus        82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl  157 (303)
T 1zy4_A           82 TAVKKKSTLFIQMEYCENGTLYDLIHS-ENLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKI  157 (303)
T ss_dssp             ----CEEEEEEEEECCCSCBHHHHHHH-SCGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEE
T ss_pred             cccccCCceEEEEecCCCCCHHHhhhc-cccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEE
Confidence                 3567899999999999999974 3356788999999999999999999998   999999999999999999999


Q ss_pred             eccccchhccccC------------CcccccccccccccccccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCC
Q 002010          836 ADFGLAKFLQDAG------------ASECMSSVAGSYGYIAPEYAYTL-KVDEKSDVYSFGVVLLELIAGKKPVGEFGDG  902 (982)
Q Consensus       836 ~DfG~a~~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~  902 (982)
                      +|||++.......            .........|++.|+|||++.+. .++.++||||+|+++|||++   ||....+.
T Consensus       158 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~  234 (303)
T 1zy4_A          158 GDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMER  234 (303)
T ss_dssp             CCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHH
T ss_pred             eeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhH
Confidence            9999998654221            01223445789999999998864 68999999999999999998   55432111


Q ss_pred             chHHHHHHHhccCCCCCCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          903 VDIVRWVRKTTSEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       903 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                      ......+.....  .              ..+..+...+..+.+++.+||+.||.+|||++|+++
T Consensus       235 ~~~~~~~~~~~~--~--------------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  283 (303)
T 1zy4_A          235 VNILKKLRSVSI--E--------------FPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN  283 (303)
T ss_dssp             HHHHHHHHSTTC--C--------------CCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHhcccccc--c--------------cCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence            111221111110  0              001233445567899999999999999999999987

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=2.5e-36  Score=342.35  Aligned_cols=267  Identities=21%  Similarity=0.246  Sum_probs=203.9

Q ss_pred             HHhhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCC-CC-----cccceEeEEEcCC
Q 002010          690 VLESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIR-HR-----NIVRLLGYVSNRD  762 (982)
Q Consensus       690 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~~~~~~~~~~  762 (982)
                      +.++|+..+.||+|+||+||+|.. .+++.||||++...  ......+.+|+.+++.++ |+     +|+++++++...+
T Consensus        52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~  129 (382)
T 2vx3_A           52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK--KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN  129 (382)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS--HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETT
T ss_pred             eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc--HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCC
Confidence            457899999999999999999965 46889999998432  223455677888888774 44     5999999999999


Q ss_pred             ccEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhh--cCCCcEEecCCCCCcEEEc--CCCCEEEecc
Q 002010          763 TNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHH--DCSPLIIHRDVKSNNILLD--SDFEAHVADF  838 (982)
Q Consensus       763 ~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~--~~~~~ivHrDlkp~Nill~--~~~~~kl~Df  838 (982)
                      ..++||||++ ++|.+++.......+++..+..++.|++.|++|||.  .+   |+||||||+||+++  .++.+||+||
T Consensus       130 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~---ivHrDlkp~NIll~~~~~~~~kL~DF  205 (382)
T 2vx3_A          130 HLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELS---IIHCDLKPENILLCNPKRSAIKIVDF  205 (382)
T ss_dssp             EEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTC---EECCCCSGGGEEESSTTSCCEEECCC
T ss_pred             ceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCC---EEcCCCCcccEEEecCCCCcEEEEec
Confidence            9999999995 599999987666779999999999999999999994  45   99999999999995  4788999999


Q ss_pred             ccchhccccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCC
Q 002010          839 GLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQ  918 (982)
Q Consensus       839 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  918 (982)
                      |+++.....     .....||+.|+|||++.+..++.++||||+||++|||++|+.||...........++......+..
T Consensus       206 G~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~  280 (382)
T 2vx3_A          206 GSSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAH  280 (382)
T ss_dssp             TTCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHH
T ss_pred             cCceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence            999866422     345678999999999999999999999999999999999999998754444443333332211100


Q ss_pred             -----C----------Ccccccceeec-------CC---------------------CCCCChHhHHHHHHHHhhccCCC
Q 002010          919 -----P----------SDAASVLAVVD-------PR---------------------LSGYPLTGVIHLFKVAMMCVEDE  955 (982)
Q Consensus       919 -----~----------~~~~~~~~~~~-------~~---------------------~~~~~~~~~~~l~~li~~cl~~d  955 (982)
                           +          ..........+       +.                     ...........+.+|+.+||+.|
T Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~d  360 (382)
T 2vx3_A          281 ILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYD  360 (382)
T ss_dssp             HHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSC
T ss_pred             HHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCC
Confidence                 0          00000000000       00                     00112234457899999999999


Q ss_pred             CCCCCCHHHHHH
Q 002010          956 SSARPTMREVVH  967 (982)
Q Consensus       956 P~~Rpt~~ell~  967 (982)
                      |++|||++|+++
T Consensus       361 P~~Rpta~e~L~  372 (382)
T 2vx3_A          361 PKTRIQPYYALQ  372 (382)
T ss_dssp             TTTSCCHHHHTT
T ss_pred             hhhCCCHHHHhc
Confidence            999999999986

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=5.1e-36  Score=337.52  Aligned_cols=272  Identities=21%  Similarity=0.267  Sum_probs=195.2

Q ss_pred             HHHHHhhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCc--
Q 002010          687 AEDVLESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDT--  763 (982)
Q Consensus       687 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~--  763 (982)
                      .....++|+..+.||+|+||.||+|.. .+++.||||++...  ......+.+|+..+..++||||+++++++.....  
T Consensus        18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~   95 (360)
T 3e3p_A           18 SRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQD--PRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD   95 (360)
T ss_dssp             HHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECC--TTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred             chhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecC--ccccHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence            445678899999999999999999976 46899999988543  2334456788888899999999999999865433  


Q ss_pred             -----cEEEEeccCCCCHHHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHHh--hcCCCcEEecCCCCCcEEEcC-CCCE
Q 002010          764 -----NLLLYEYMPNGSLGEMLHG--AKGGHLKWETRYRIALEAAKGLCYLH--HDCSPLIIHRDVKSNNILLDS-DFEA  833 (982)
Q Consensus       764 -----~~lv~e~~~~~sL~~~l~~--~~~~~l~~~~~~~i~~~i~~~l~~LH--~~~~~~ivHrDlkp~Nill~~-~~~~  833 (982)
                           .++||||+++ ++.+.+..  .....+++..+..++.|++.|++|||  +.+   |+||||||+||+++. ++.+
T Consensus        96 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~  171 (360)
T 3e3p_A           96 RRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTL  171 (360)
T ss_dssp             TTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEE
T ss_pred             ccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcE
Confidence                 7899999976 55444332  34567899999999999999999999  887   999999999999997 8999


Q ss_pred             EEeccccchhccccCCcccccccccccccccccccccCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHh
Q 002010          834 HVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLK-VDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKT  912 (982)
Q Consensus       834 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~  912 (982)
                      ||+|||+++.+....   ......||+.|+|||++.+.. ++.++||||+||++|||++|+.||...........++...
T Consensus       172 kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~  248 (360)
T 3e3p_A          172 KLCDFGSAKKLSPSE---PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVL  248 (360)
T ss_dssp             EECCCTTCBCCCTTS---CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred             EEeeCCCceecCCCC---CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHc
Confidence            999999998765332   234567899999999987654 8999999999999999999999998765544444444332


Q ss_pred             ccCCCC------CCc-ccccc----eeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          913 TSEVSQ------PSD-AASVL----AVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       913 ~~~~~~------~~~-~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                      ......      +.. .....    ..+...+...+...+..+.+++.+||+.||++|||++|+++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  314 (360)
T 3e3p_A          249 GCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC  314 (360)
T ss_dssp             CCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence            221100      000 00000    00001111233345678999999999999999999999987

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=2.1e-36  Score=341.46  Aligned_cols=264  Identities=20%  Similarity=0.278  Sum_probs=200.4

Q ss_pred             HhhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCC-CchhhHHHHHHHHhcCCCCcccceEeEEEcCCcc----
Q 002010          691 LESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTG-GNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTN----  764 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~----  764 (982)
                      .++|+..+.||+|+||.||+|.. .+|+.||||++...... .....+.+|+.++++++||||+++++++...+..    
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            36789999999999999999965 56899999998543322 2245788999999999999999999999877655    


Q ss_pred             --EEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccch
Q 002010          765 --LLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAK  842 (982)
Q Consensus       765 --~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~  842 (982)
                        ++||||++ ++|.+++.    ..+++..+..++.|++.|++|||+.+   |+||||||+||+++.++.+||+|||+++
T Consensus       121 ~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a~  192 (371)
T 4exu_A          121 DFYLVMPFMQ-TDLQKIMG----MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLAR  192 (371)
T ss_dssp             CCEEEEECCC-EEHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC-
T ss_pred             eEEEEEcccc-ccHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCccc
Confidence              99999996 68888874    35999999999999999999999998   9999999999999999999999999998


Q ss_pred             hccccCCccccccccccccccccccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCC---
Q 002010          843 FLQDAGASECMSSVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQ---  918 (982)
Q Consensus       843 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---  918 (982)
                      .....     .....||+.|+|||++.+ ..++.++||||+||++|+|++|+.||......................   
T Consensus       193 ~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  267 (371)
T 4exu_A          193 HADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQ  267 (371)
T ss_dssp             ------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred             ccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHH
Confidence            65432     344678999999999887 679999999999999999999999998754444433333322221000   


Q ss_pred             CCccccc----ceeec---CCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          919 PSDAASV----LAVVD---PRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       919 ~~~~~~~----~~~~~---~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                      .......    .....   ..+.......+..+.+++.+||+.||++|||++|+++
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  323 (371)
T 4exu_A          268 KLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  323 (371)
T ss_dssp             TCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence            0000000    00000   0000112234567899999999999999999999987

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=1.5e-36  Score=342.86  Aligned_cols=253  Identities=12%  Similarity=0.055  Sum_probs=179.6

Q ss_pred             hhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCC--CchhhHHHHHHHHhcC--CCCcccceE-------eEEE
Q 002010          692 ESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTG--GNDHGFLAEIQTLGRI--RHRNIVRLL-------GYVS  759 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l--~h~niv~~~-------~~~~  759 (982)
                      ..|+..+.||+|+||.||+|.. .+++.||||++......  .....+.+|+.+++.+  +||||++++       +++.
T Consensus        62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~  141 (371)
T 3q60_A           62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA  141 (371)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred             eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence            4588999999999999999975 47899999999654322  2334566775444444  699988755       4444


Q ss_pred             cC-----------------CccEEEEeccCCCCHHHHhhcCCCCCCCHHHH------HHHHHHHHHHHHHHhhcCCCcEE
Q 002010          760 NR-----------------DTNLLLYEYMPNGSLGEMLHGAKGGHLKWETR------YRIALEAAKGLCYLHHDCSPLII  816 (982)
Q Consensus       760 ~~-----------------~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~------~~i~~~i~~~l~~LH~~~~~~iv  816 (982)
                      .+                 ...++||||++ ++|.+++... ...+.+..+      ..++.||+.||+|||+++   |+
T Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~---iv  216 (371)
T 3q60_A          142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL-DFVYVFRGDEGILALHILTAQLIRLAANLQSKG---LV  216 (371)
T ss_dssp             ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH-HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred             cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh-ccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---Cc
Confidence            33                 23799999998 8999999743 223444555      677899999999999998   99


Q ss_pred             ecCCCCCcEEEcCCCCEEEeccccchhccccCCccccccccccccccccccccc--CCCCcchhhHHHHHHHHHHHhCCC
Q 002010          817 HRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYT--LKVDEKSDVYSFGVVLLELIAGKK  894 (982)
Q Consensus       817 HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~elltg~~  894 (982)
                      ||||||+||+++.++.+||+|||+|+.....     .....+|+.|+|||++.+  ..++.++||||+||++|||++|+.
T Consensus       217 HrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~  291 (371)
T 3q60_A          217 HGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFL  291 (371)
T ss_dssp             ETTCSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSC
T ss_pred             cCcCCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCC
Confidence            9999999999999999999999999865421     124556799999999987  679999999999999999999999


Q ss_pred             CCCCCCCCchHHHHHHHhccCCCCCCcccccceeecCCCC-CCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          895 PVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDPRLS-GYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       895 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                      ||.........      ...       ............. ......+..+.+++.+||+.||++|||++|+++
T Consensus       292 Pf~~~~~~~~~------~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  352 (371)
T 3q60_A          292 PFGLVTPGIKG------SWK-------RPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME  352 (371)
T ss_dssp             STTBCCTTCTT------CCC-------BCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred             CCCCcCccccc------chh-------hhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            99764322100      000       0000000000110 112244568999999999999999999999875

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=2.8e-36  Score=334.65  Aligned_cols=253  Identities=27%  Similarity=0.387  Sum_probs=180.1

Q ss_pred             hhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCCCchhhHHHHHH-HHhcCCCCcccceEeEEEcCCccEEEEe
Q 002010          692 ESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQ-TLGRIRHRNIVRLLGYVSNRDTNLLLYE  769 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e  769 (982)
                      ++|+..+.||+|+||.||+|.. .+++.||||++...........+..|+. +++.++||||+++++++..++..++|||
T Consensus        22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e  101 (327)
T 3aln_A           22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICME  101 (327)
T ss_dssp             CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEe
Confidence            5788899999999999999976 4689999999965544344455666666 6777899999999999999999999999


Q ss_pred             ccCCCCHHHHhhc---CCCCCCCHHHHHHHHHHHHHHHHHHhhc-CCCcEEecCCCCCcEEEcCCCCEEEeccccchhcc
Q 002010          770 YMPNGSLGEMLHG---AKGGHLKWETRYRIALEAAKGLCYLHHD-CSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQ  845 (982)
Q Consensus       770 ~~~~~sL~~~l~~---~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~  845 (982)
                      |+++ +|.+++..   .....+++..+..++.|++.|++|||+. +   |+||||||+||+++.++.+||+|||+++...
T Consensus       102 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~  177 (327)
T 3aln_A          102 LMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQLV  177 (327)
T ss_dssp             CCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC--
T ss_pred             ecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceecc
Confidence            9975 88877752   2356799999999999999999999998 8   9999999999999999999999999998665


Q ss_pred             ccCCccccccccccccccccccc----ccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCc
Q 002010          846 DAGASECMSSVAGSYGYIAPEYA----YTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSD  921 (982)
Q Consensus       846 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  921 (982)
                      ...   ......||+.|+|||++    .+..++.++||||+|+++|||++|+.||........   .......       
T Consensus       178 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~~~~~-------  244 (327)
T 3aln_A          178 DSI---AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD---QLTQVVK-------  244 (327)
T ss_dssp             -------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC----------CCCCC-------
T ss_pred             ccc---ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH---HHHHHhc-------
Confidence            321   22334789999999998    456789999999999999999999999976432111   1100000       


Q ss_pred             ccccceeecCCCC-CCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          922 AASVLAVVDPRLS-GYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       922 ~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                            ...+.+. ......+..+.+++.+||+.||++|||++|+++
T Consensus       245 ------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  285 (327)
T 3aln_A          245 ------GDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK  285 (327)
T ss_dssp             ------SCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             ------CCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence                  0001111 112234567899999999999999999999976

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=5.6e-36  Score=335.92  Aligned_cols=263  Identities=20%  Similarity=0.279  Sum_probs=200.6

Q ss_pred             hhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCC-CchhhHHHHHHHHhcCCCCcccceEeEEEcCCc------
Q 002010          692 ESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTG-GNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDT------  763 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~------  763 (982)
                      ++|+..+.||+|+||.||+|.. .+|+.||||++...... .....+.+|+.++++++||||+++++++.....      
T Consensus        24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  103 (353)
T 3coi_A           24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD  103 (353)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred             ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence            5789999999999999999965 56899999998543322 224568899999999999999999999987654      


Q ss_pred             cEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchh
Q 002010          764 NLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKF  843 (982)
Q Consensus       764 ~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~  843 (982)
                      .++||||++ ++|.+++.    ..+++..+..++.||+.|++|||+.+   |+||||||+||+++.++.+||+|||+++.
T Consensus       104 ~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~  175 (353)
T 3coi_A          104 FYLVMPFMQ-TDLQKIMG----LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARH  175 (353)
T ss_dssp             CEEEEECCS-EEGGGTTT----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCTTC
T ss_pred             EEEEecccc-CCHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccccC
Confidence            499999996 68888774    35899999999999999999999998   99999999999999999999999999986


Q ss_pred             ccccCCccccccccccccccccccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCC---C
Q 002010          844 LQDAGASECMSSVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQ---P  919 (982)
Q Consensus       844 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~  919 (982)
                      ....     .....+|+.|+|||++.+ ..++.++||||+|+++|||++|+.||......................   .
T Consensus       176 ~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  250 (353)
T 3coi_A          176 ADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQK  250 (353)
T ss_dssp             -------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTT
T ss_pred             CCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence            5422     234578999999999876 678999999999999999999999998754333333333222111000   0


Q ss_pred             Ccc-------cccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          920 SDA-------ASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       920 ~~~-------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                      ...       ........+.+.......+..+.+++.+||+.||++|||++|+++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  305 (353)
T 3coi_A          251 LNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  305 (353)
T ss_dssp             CSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            000       000000111222333455678999999999999999999999986

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=6.2e-36  Score=332.65  Aligned_cols=251  Identities=21%  Similarity=0.244  Sum_probs=173.9

Q ss_pred             HHhhcccc-cccccccceEEEEEEeC-CCcEEEEEEeccCCCCCchhhHHHHH-HHHhcCCCCcccceEeEEEc----CC
Q 002010          690 VLESLKDE-NIIGKGGAGIVYRGSMP-DGIDVAIKRLVGRGTGGNDHGFLAEI-QTLGRIRHRNIVRLLGYVSN----RD  762 (982)
Q Consensus       690 ~~~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~-~~l~~l~h~niv~~~~~~~~----~~  762 (982)
                      +.++|++. +.||+|+||.||+|... +++.||+|++...     . ...+|+ ..++.++||||+++++++..    ..
T Consensus        26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~-~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~   99 (336)
T 3fhr_A           26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----P-KARQEVDHHWQASGGPHIVCILDVYENMHHGKR   99 (336)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-----H-HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred             ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-----H-HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCc
Confidence            45778884 46999999999999764 6999999998432     2 223333 33566799999999999876    44


Q ss_pred             ccEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcC---CCCEEEeccc
Q 002010          763 TNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDS---DFEAHVADFG  839 (982)
Q Consensus       763 ~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~---~~~~kl~DfG  839 (982)
                      ..++||||+++|+|.+++.......+++.+++.++.|++.|++|||+.+   |+||||||+||+++.   ++.+||+|||
T Consensus       100 ~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg  176 (336)
T 3fhr_A          100 CLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFG  176 (336)
T ss_dssp             EEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred             eEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEeccc
Confidence            5799999999999999998666668999999999999999999999998   999999999999976   4569999999


Q ss_pred             cchhccccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCC
Q 002010          840 LAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQP  919 (982)
Q Consensus       840 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  919 (982)
                      ++......    ......+|+.|+|||++.+..++.++||||+|+++|+|++|+.||...................    
T Consensus       177 ~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~----  248 (336)
T 3fhr_A          177 FAKETTQN----ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLG----  248 (336)
T ss_dssp             TCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-----------------------
T ss_pred             cceecccc----ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhcc----
Confidence            99765432    2334678999999999988889999999999999999999999997643322111110000000    


Q ss_pred             CcccccceeecCCCC-CCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          920 SDAASVLAVVDPRLS-GYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       920 ~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                                ....+ ......+..+.+++.+||+.||++|||++|+++
T Consensus       249 ----------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  287 (336)
T 3fhr_A          249 ----------QYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN  287 (336)
T ss_dssp             ------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             ----------ccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence                      00000 111234557899999999999999999999998

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=1.5e-36  Score=338.46  Aligned_cols=256  Identities=25%  Similarity=0.341  Sum_probs=184.6

Q ss_pred             hhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCC-CCcccceEeEEE--------cC
Q 002010          692 ESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIR-HRNIVRLLGYVS--------NR  761 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~--------~~  761 (982)
                      .+|+..+.||+|+||.||+|.. .+++.||+|++... .......+.+|+.++.++. ||||+++++++.        ..
T Consensus        28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~  106 (337)
T 3ll6_A           28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN-EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ  106 (337)
T ss_dssp             EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES-SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred             ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC-chHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence            4688999999999999999975 47899999988443 3334567889999999996 999999999984        23


Q ss_pred             CccEEEEeccCCCCHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEecccc
Q 002010          762 DTNLLLYEYMPNGSLGEMLHG-AKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGL  840 (982)
Q Consensus       762 ~~~~lv~e~~~~~sL~~~l~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~  840 (982)
                      ...++||||++ |+|.+++.. .....+++..++.++.||+.|++|||+.+ ++|+||||||+||+++.++.+||+|||+
T Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg~  184 (337)
T 3ll6_A          107 AEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFGS  184 (337)
T ss_dssp             EEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCCTT
T ss_pred             ceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecCcc
Confidence            34789999995 799998864 23457999999999999999999999764 3499999999999999999999999999


Q ss_pred             chhccccCCcc----------ccccccccccccccccc---ccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHH
Q 002010          841 AKFLQDAGASE----------CMSSVAGSYGYIAPEYA---YTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVR  907 (982)
Q Consensus       841 a~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~  907 (982)
                      +..........          ......||+.|+|||++   .+..++.++||||+|+++|||++|+.||......    .
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~----~  260 (337)
T 3ll6_A          185 ATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL----R  260 (337)
T ss_dssp             CBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----------
T ss_pred             ceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH----H
Confidence            98765332111          11245689999999998   5667899999999999999999999999753221    1


Q ss_pred             HHHHhccCCCCCCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 002010          908 WVRKTTSEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPP  973 (982)
Q Consensus       908 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~  973 (982)
                      ........                   ..+...+..+.+++.+||+.||++|||++|+++.|+.+.
T Consensus       261 ~~~~~~~~-------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~  307 (337)
T 3ll6_A          261 IVNGKYSI-------------------PPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIA  307 (337)
T ss_dssp             -----CCC-------------------CTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred             hhcCcccC-------------------CcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            11111110                   001111234789999999999999999999999987654

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=100.00  E-value=6.8e-36  Score=358.97  Aligned_cols=336  Identities=20%  Similarity=0.194  Sum_probs=274.1

Q ss_pred             CCCCCCEEecccCcCcccCchhhcCCCccceeecccccCCCCCCccccCCCCCCEEEeeCCcccCcCchhhhcccchhhh
Q 002010          239 ALTQLQVLDMASCNISGEIPTSLSRLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLL  318 (982)
Q Consensus       239 ~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L  318 (982)
                      .+++++.|++++|.++...+..|..+++|++|+|++|.+++..|..|+.+++|++|+|++|.+++..|..|+.+++|++|
T Consensus        49 ~l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L  128 (597)
T 3oja_B           49 TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVL  128 (597)
T ss_dssp             GGCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred             cCCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEE
Confidence            36789999999999997777778999999999999999998888899999999999999999998888888999999999


Q ss_pred             hhccCCCCCCCCCcCCCCCCccEEEccCCCcccccCccccCCCcccEEEeccccccccCCccccCccccceeeccccccc
Q 002010          319 QLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFI  398 (982)
Q Consensus       319 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~l~~N~~~  398 (982)
                      +|++|.+++..+..|+.+++|++|++++|.+++..|..++.+++|++|++++|.+++..   +..+++|+.|++++|.+.
T Consensus       129 ~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~---~~~l~~L~~L~l~~n~l~  205 (597)
T 3oja_B          129 VLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD---LSLIPSLFHANVSYNLLS  205 (597)
T ss_dssp             ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCC---GGGCTTCSEEECCSSCCS
T ss_pred             EeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCcC---hhhhhhhhhhhcccCccc
Confidence            99999999777777889999999999999998888888888888888888888887532   334455555555555544


Q ss_pred             ccCCccccCCCCCCEEEccCCccCCCCCccccCCCccccccCCCccccccCCcccccCCccEEEeeccccCCCCchhccC
Q 002010          399 GPIPEELGQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLSGELPEKMSGASLNQLKVANNNITGKIPAAIGN  478 (982)
Q Consensus       399 ~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~L~~N~i~~~~p~~~~~  478 (982)
                      +     +....+|+.|++++|.+                        ....+..  ..+|+.|+|++|++++  +..++.
T Consensus       206 ~-----l~~~~~L~~L~ls~n~l------------------------~~~~~~~--~~~L~~L~L~~n~l~~--~~~l~~  252 (597)
T 3oja_B          206 T-----LAIPIAVEELDASHNSI------------------------NVVRGPV--NVELTILKLQHNNLTD--TAWLLN  252 (597)
T ss_dssp             E-----EECCTTCSEEECCSSCC------------------------CEEECSC--CSCCCEEECCSSCCCC--CGGGGG
T ss_pred             c-----ccCCchhheeeccCCcc------------------------ccccccc--CCCCCEEECCCCCCCC--Chhhcc
Confidence            2     22233455555555544                        4332221  1468888888888886  367889


Q ss_pred             CCCcceeeeccccccCCCccccccccccceeeeeccccCCCCCcccccccCCCeeeCCCCcccCCCCcccccccccceEE
Q 002010          479 LPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYGKIPPGISKLIDLSILN  558 (982)
Q Consensus       479 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~  558 (982)
                      +++|+.|+|++|++++..|..+..+++|++|+|++|++++ +|..+..+++|+.|+|++|.++ .+|..+..+++|+.|+
T Consensus       253 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~  330 (597)
T 3oja_B          253 YPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLY  330 (597)
T ss_dssp             CTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEE
T ss_pred             CCCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCCC-CCcccccCCCCcEEECCCCCCC-ccCcccccCCCCCEEE
Confidence            9999999999999998889999999999999999999995 6777788999999999999998 6888899999999999


Q ss_pred             cccccccccCccccccccccceecccCCccccCCCCCccccccccccccCCcCcccCC
Q 002010          559 LSRNGITGSIPNEMRNMMSLTTLDLSYNNLIGNIPSGGQFLAFNETSFIGNPNLCLLR  616 (982)
Q Consensus       559 Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~~~~~~~~~~~~~~n~~~c~~~  616 (982)
                      |++|+|++. |  +..+++|+.|+|++|++++..+. ..+..+....+.+++..|+.+
T Consensus       331 L~~N~l~~~-~--~~~~~~L~~L~l~~N~~~~~~~~-~~~~~~~~~~~~~~~~~C~~~  384 (597)
T 3oja_B          331 LDHNSIVTL-K--LSTHHTLKNLTLSHNDWDCNSLR-ALFRNVARPAVDDADQHCKID  384 (597)
T ss_dssp             CCSSCCCCC-C--CCTTCCCSEEECCSSCEEHHHHH-HHTTTCCTTTBCCCCCCCCTT
T ss_pred             CCCCCCCCc-C--hhhcCCCCEEEeeCCCCCChhHH-HHHHHHhhhccccccccCCcc
Confidence            999999854 3  77889999999999999986432 235666677788999999864

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=6.9e-36  Score=330.51  Aligned_cols=273  Identities=21%  Similarity=0.293  Sum_probs=197.4

Q ss_pred             HhhcccccccccccceEEEEEEeC-CCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEE----------
Q 002010          691 LESLKDENIIGKGGAGIVYRGSMP-DGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVS----------  759 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~----------  759 (982)
                      .++|+..+.||+|+||.||+|... +++.||+|++... .....+.+.+|+.++++++||||+++++++.          
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   88 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT-DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDV   88 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC--
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC-ChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccc
Confidence            367899999999999999999764 4899999988533 3334567889999999999999999999874          


Q ss_pred             ----cCCccEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEc-CCCCEE
Q 002010          760 ----NRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLD-SDFEAH  834 (982)
Q Consensus       760 ----~~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~-~~~~~k  834 (982)
                          +....++||||++ |+|.+++.   ..++++..+..++.|++.|++|||+.+   |+||||||+||+++ +++.+|
T Consensus        89 ~~~~~~~~~~lv~e~~~-~~L~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k  161 (320)
T 2i6l_A           89 GSLTELNSVYIVQEYME-TDLANVLE---QGPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLK  161 (320)
T ss_dssp             --CCSCSEEEEEEECCS-EEHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEE
T ss_pred             ccccccCceeEEeeccC-CCHHHHhh---cCCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEE
Confidence                3456799999997 69999985   357899999999999999999999998   99999999999997 567999


Q ss_pred             EeccccchhccccC-Cccccccccccccccccccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHh
Q 002010          835 VADFGLAKFLQDAG-ASECMSSVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKT  912 (982)
Q Consensus       835 l~DfG~a~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~  912 (982)
                      |+|||+++...... .........++..|+|||++.+ ..++.++||||+|+++|||++|+.||................
T Consensus       162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~  241 (320)
T 2i6l_A          162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESI  241 (320)
T ss_dssp             ECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHS
T ss_pred             EccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence            99999998764321 1122334567889999998865 678999999999999999999999998654333322222221


Q ss_pred             ccCCCCCCccccc--------ce-eecCCC--CCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH--HhcCCC
Q 002010          913 TSEVSQPSDAASV--------LA-VVDPRL--SGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH--MLANPP  973 (982)
Q Consensus       913 ~~~~~~~~~~~~~--------~~-~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~--~L~~~~  973 (982)
                      .. ... ......        .. ...+..  .......+..+.+++.+||+.||++|||++|+++  .+....
T Consensus       242 ~~-~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  313 (320)
T 2i6l_A          242 PV-VHE-EDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYS  313 (320)
T ss_dssp             CC-CCH-HHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTC
T ss_pred             CC-Cch-hhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCccccccc
Confidence            11 000 000000        00 000000  0112234567899999999999999999999987  454433

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=2.7e-35  Score=330.84  Aligned_cols=266  Identities=21%  Similarity=0.255  Sum_probs=203.0

Q ss_pred             HhhcccccccccccceEEEEEEeC-CC-cEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCc------ccceEeEEEcCC
Q 002010          691 LESLKDENIIGKGGAGIVYRGSMP-DG-IDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRN------IVRLLGYVSNRD  762 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~-~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~~~~~~~~~~  762 (982)
                      .++|++.+.||+|+||.||+|... ++ +.||+|++...  ......+.+|+.++++++|++      ++.+++++...+
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~   95 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV--GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHG   95 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETT
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc--ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCC
Confidence            367999999999999999999753 34 68999998432  233456788999999997766      999999999999


Q ss_pred             ccEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEE---------------
Q 002010          763 TNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILL---------------  827 (982)
Q Consensus       763 ~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill---------------  827 (982)
                      ..++||||+ ++++.+++.......+++..+..++.||+.||+|||+.+   |+||||||+||++               
T Consensus        96 ~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~~  171 (355)
T 2eu9_A           96 HMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSC  171 (355)
T ss_dssp             EEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred             eEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccccccc
Confidence            999999999 677888887655568999999999999999999999988   9999999999999               


Q ss_pred             ----cCCCCEEEeccccchhccccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCc
Q 002010          828 ----DSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGV  903 (982)
Q Consensus       828 ----~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~  903 (982)
                          +.++.+||+|||++......     .....||+.|+|||++.+..++.++||||+||++|||++|+.||.......
T Consensus       172 ~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~  246 (355)
T 2eu9_A          172 EEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE  246 (355)
T ss_dssp             CEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred             cccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH
Confidence                56789999999999764322     234678999999999999999999999999999999999999998654333


Q ss_pred             hHHHHHHHhccCCCCCCc---ccc------------------cceeecC--CCCCCChHhHHHHHHHHhhccCCCCCCCC
Q 002010          904 DIVRWVRKTTSEVSQPSD---AAS------------------VLAVVDP--RLSGYPLTGVIHLFKVAMMCVEDESSARP  960 (982)
Q Consensus       904 ~~~~~~~~~~~~~~~~~~---~~~------------------~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~dP~~Rp  960 (982)
                      ............+.....   ...                  ......+  .........+..+.+++.+||+.||++||
T Consensus       247 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp  326 (355)
T 2eu9_A          247 HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRI  326 (355)
T ss_dssp             HHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred             HHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCc
Confidence            222222221111000000   000                  0000000  00012234456789999999999999999


Q ss_pred             CHHHHHH
Q 002010          961 TMREVVH  967 (982)
Q Consensus       961 t~~ell~  967 (982)
                      |++|+++
T Consensus       327 t~~e~l~  333 (355)
T 2eu9_A          327 TLAEALL  333 (355)
T ss_dssp             CHHHHTT
T ss_pred             CHHHHhc
Confidence            9999985

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=1.6e-35  Score=335.26  Aligned_cols=265  Identities=17%  Similarity=0.214  Sum_probs=202.0

Q ss_pred             hhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCC-----------CCcccceEeEEE
Q 002010          692 ESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIR-----------HRNIVRLLGYVS  759 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~~~~~~~  759 (982)
                      ++|+..+.||+|+||.||+|.. .+++.||||++..  .......+.+|+.++++++           ||||+++++++.
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~   96 (373)
T 1q8y_A           19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG--DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   96 (373)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS--CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecC--CccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence            5789999999999999999975 5789999999842  2223456788999998886           899999999987


Q ss_pred             cCC----ccEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhc-CCCcEEecCCCCCcEEEc------
Q 002010          760 NRD----TNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHD-CSPLIIHRDVKSNNILLD------  828 (982)
Q Consensus       760 ~~~----~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~ivHrDlkp~Nill~------  828 (982)
                      ..+    ..++||||+ +++|.+++.......+++..+..++.||+.||+|||++ +   |+||||||+||+++      
T Consensus        97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~~  172 (373)
T 1q8y_A           97 HKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPE  172 (373)
T ss_dssp             EEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTT
T ss_pred             ccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCCc
Confidence            654    679999999 89999999876667799999999999999999999997 8   99999999999994      


Q ss_pred             CCCCEEEeccccchhccccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCC------
Q 002010          829 SDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDG------  902 (982)
Q Consensus       829 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~------  902 (982)
                      ..+.+||+|||++......     .....||+.|+|||++.+..++.++||||+||++|||++|+.||......      
T Consensus       173 ~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~  247 (373)
T 1q8y_A          173 NLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD  247 (373)
T ss_dssp             TEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred             CcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChH
Confidence            4458999999999866432     23457899999999999999999999999999999999999999764321      


Q ss_pred             chHHHHHHHhccCCCCC-----------Ccccccceeec----------CCCCCCChHhHHHHHHHHhhccCCCCCCCCC
Q 002010          903 VDIVRWVRKTTSEVSQP-----------SDAASVLAVVD----------PRLSGYPLTGVIHLFKVAMMCVEDESSARPT  961 (982)
Q Consensus       903 ~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~----------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt  961 (982)
                      .............+...           ........+..          ......+...+..+.+++.+||+.||++|||
T Consensus       248 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt  327 (373)
T 1q8y_A          248 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD  327 (373)
T ss_dssp             HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred             HHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCC
Confidence            11222222111100000           00000000000          0011345677888999999999999999999


Q ss_pred             HHHHHH
Q 002010          962 MREVVH  967 (982)
Q Consensus       962 ~~ell~  967 (982)
                      ++|+++
T Consensus       328 ~~ell~  333 (373)
T 1q8y_A          328 AGGLVN  333 (373)
T ss_dssp             HHHHHT
T ss_pred             HHHHhh
Confidence            999998

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=100.00  E-value=1e-35  Score=327.17  Aligned_cols=260  Identities=29%  Similarity=0.493  Sum_probs=207.0

Q ss_pred             CCccEEEccCCCccc--ccCccccCCCcccEEEecc-ccccccCCccccCccccceeecccccccccCCccccCCCCCCE
Q 002010          337 PNLEVLQVWGNNFTF--ELPENLGRNGKLLILDVTS-NHLTGTIPRDLCKGGKLKSLILMQNFFIGPIPEELGQCKSLTK  413 (982)
Q Consensus       337 ~~L~~L~L~~N~l~~--~~~~~l~~l~~L~~L~L~~-N~l~~~~p~~~~~~~~L~~L~l~~N~~~~~~~~~l~~l~~L~~  413 (982)
                      .+++.|++++|.+++  .+|..+..+++|++|++++ |.+.+.+|..+.++++|++|++++|.+.+.+|..+.++++|++
T Consensus        50 ~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~  129 (313)
T 1ogq_A           50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT  129 (313)
T ss_dssp             CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCE
T ss_pred             ceEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCE
Confidence            356666666666666  5666666666666666663 6666666666666666666666666666666666666666666


Q ss_pred             EEccCCccCCCCCccccCCCccccccCCCccccccCCcccccCCccEEEeeccccCCCCchhccCCC-Ccceeeeccccc
Q 002010          414 IRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLSGELPEKMSGASLNQLKVANNNITGKIPAAIGNLP-SLNILSLQNNRL  492 (982)
Q Consensus       414 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~L~~N~i~~~~p~~~~~l~-~L~~L~L~~N~l  492 (982)
                      |++++|++++.+|..+..++                       +|++|++++|++++.+|..++.++ +|++|++++|++
T Consensus       130 L~Ls~N~l~~~~p~~~~~l~-----------------------~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l  186 (313)
T 1ogq_A          130 LDFSYNALSGTLPPSISSLP-----------------------NLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRL  186 (313)
T ss_dssp             EECCSSEEESCCCGGGGGCT-----------------------TCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEE
T ss_pred             EeCCCCccCCcCChHHhcCC-----------------------CCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCee
Confidence            66666666655555555554                       556666666666667778888887 899999999999


Q ss_pred             cCCCccccccccccceeeeeccccCCCCCcccccccCCCeeeCCCCcccCCCCcccccccccceEEcccccccccCcccc
Q 002010          493 EGEIPVESFNLKMITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYGKIPPGISKLIDLSILNLSRNGITGSIPNEM  572 (982)
Q Consensus       493 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l  572 (982)
                      ++.+|..+..++ |++|++++|++++.+|..|..+++|+.|+|++|.+++.+|. +..+++|++|+|++|+|++.+|..+
T Consensus       187 ~~~~~~~~~~l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l  264 (313)
T 1ogq_A          187 TGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGL  264 (313)
T ss_dssp             EEECCGGGGGCC-CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGG
T ss_pred             eccCChHHhCCc-ccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHH
Confidence            888888888887 99999999999988999999999999999999999877666 8899999999999999999999999


Q ss_pred             ccccccceecccCCccccCCCCCccccccccccccCCcCcccCCCCCCc
Q 002010          573 RNMMSLTTLDLSYNNLIGNIPSGGQFLAFNETSFIGNPNLCLLRNGTCQ  621 (982)
Q Consensus       573 ~~l~~L~~L~Ls~N~l~~~ip~~~~~~~~~~~~~~~n~~~c~~~~~~c~  621 (982)
                      ..+++|++|+|++|+++|.+|...++.++....+.|||++||.|.+.|.
T Consensus       265 ~~l~~L~~L~Ls~N~l~~~ip~~~~l~~L~~l~l~~N~~lc~~p~~~C~  313 (313)
T 1ogq_A          265 TQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPLPACT  313 (313)
T ss_dssp             GGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTTSSCCC
T ss_pred             hcCcCCCEEECcCCcccccCCCCccccccChHHhcCCCCccCCCCCCCC
Confidence            9999999999999999999999888999999999999999999888883

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=1.5e-35  Score=327.44  Aligned_cols=252  Identities=23%  Similarity=0.354  Sum_probs=182.5

Q ss_pred             HhhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCCCchhh-HHHHHHHHhcCCCCcccceEeEEEcCCccEEEE
Q 002010          691 LESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHG-FLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLY  768 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~-~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  768 (982)
                      .++|+..+.||+|+||.||+|.. .+++.||||++..........+ +.++..+++.++||||+++++++.+++..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~  103 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM  103 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence            46789999999999999999976 4689999999865443333333 344445677889999999999999999999999


Q ss_pred             eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhc-CCCcEEecCCCCCcEEEcCCCCEEEeccccchhcccc
Q 002010          769 EYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHD-CSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDA  847 (982)
Q Consensus       769 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  847 (982)
                      ||+ ++.+..+.. .....+++..+..++.|++.|++|||+. +   |+||||||+||+++.++.+||+|||++......
T Consensus       104 e~~-~~~~~~l~~-~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  178 (318)
T 2dyl_A          104 ELM-GTCAEKLKK-RMQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLVDD  178 (318)
T ss_dssp             CCC-SEEHHHHHH-HHTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred             ecc-CCcHHHHHH-HhccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhccCC
Confidence            999 555655554 2346799999999999999999999985 8   999999999999999999999999999766532


Q ss_pred             CCcccccccccccccccccccc-----cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcc
Q 002010          848 GASECMSSVAGSYGYIAPEYAY-----TLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDA  922 (982)
Q Consensus       848 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  922 (982)
                      .   ......+++.|+|||++.     ...++.++||||+|+++|||++|+.||............+.......      
T Consensus       179 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~------  249 (318)
T 2dyl_A          179 K---AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPL------  249 (318)
T ss_dssp             -----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCC------
T ss_pred             c---cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCC------
Confidence            2   223456899999999984     55688999999999999999999999986544333322222211100      


Q ss_pred             cccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          923 ASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       923 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                                .+ .....+..+.+++.+||+.||.+|||++|+++
T Consensus       250 ----------~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (318)
T 2dyl_A          250 ----------LP-GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE  283 (318)
T ss_dssp             ----------CC-SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             ----------CC-ccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence                      00 01123457889999999999999999999876

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=1.4e-35  Score=327.74  Aligned_cols=242  Identities=24%  Similarity=0.386  Sum_probs=199.6

Q ss_pred             HHhhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCCC-----chhhHHHHHHHHhcCC--CCcccceEeEEEcC
Q 002010          690 VLESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGG-----NDHGFLAEIQTLGRIR--HRNIVRLLGYVSNR  761 (982)
Q Consensus       690 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~  761 (982)
                      +.++|+..+.||+|+||.||+|.. .+++.||||++.......     ....+.+|+.++++++  ||||+++++++..+
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~  120 (320)
T 3a99_A           41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP  120 (320)
T ss_dssp             CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred             ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecC
Confidence            346799999999999999999964 578999999986543222     2345778999999996  59999999999999


Q ss_pred             CccEEEEeccCC-CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEc-CCCCEEEeccc
Q 002010          762 DTNLLLYEYMPN-GSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLD-SDFEAHVADFG  839 (982)
Q Consensus       762 ~~~~lv~e~~~~-~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~-~~~~~kl~DfG  839 (982)
                      +..++|||++.+ ++|.+++..  ...+++..+..++.||+.||+|||+.+   |+||||||+||+++ +++.+||+|||
T Consensus       121 ~~~~lv~e~~~~~~~L~~~l~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~Dfg  195 (320)
T 3a99_A          121 DSFVLILERPEPVQDLFDFITE--RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG  195 (320)
T ss_dssp             SEEEEEEECCSSEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCT
T ss_pred             CcEEEEEEcCCCCccHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEeeCc
Confidence            999999999976 899999973  457899999999999999999999998   99999999999999 78999999999


Q ss_pred             cchhccccCCcccccccccccccccccccccCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCC
Q 002010          840 LAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKV-DEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQ  918 (982)
Q Consensus       840 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  918 (982)
                      ++......    ......||+.|+|||++.+..+ +.++||||+|+++|||++|+.||....      .......     
T Consensus       196 ~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~~~~~-----  260 (320)
T 3a99_A          196 SGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQV-----  260 (320)
T ss_dssp             TCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCC-----
T ss_pred             cccccccc----cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------hhhcccc-----
Confidence            99876532    2234578999999999887765 688999999999999999999996421      1111100     


Q ss_pred             CCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          919 PSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       919 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                                      ..+...+..+.+++.+||+.||++|||++|+++
T Consensus       261 ----------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  293 (320)
T 3a99_A          261 ----------------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN  293 (320)
T ss_dssp             ----------------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ----------------cccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                            011223457889999999999999999999987

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=2.7e-36  Score=355.44  Aligned_cols=268  Identities=26%  Similarity=0.301  Sum_probs=201.0

Q ss_pred             HHHhhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEc------C
Q 002010          689 DVLESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSN------R  761 (982)
Q Consensus       689 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~------~  761 (982)
                      ...++|+..+.||+|+||.||+|.. .+|+.||||++...........+.+|+.++++++||||+++++++..      .
T Consensus        11 ~~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~   90 (676)
T 3qa8_A           11 QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPN   90 (676)
T ss_dssp             ------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTT
T ss_pred             CCCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCC
Confidence            3457899999999999999999965 56899999988654444455678999999999999999999998755      6


Q ss_pred             CccEEEEeccCCCCHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCC---EEEec
Q 002010          762 DTNLLLYEYMPNGSLGEMLHGAK-GGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFE---AHVAD  837 (982)
Q Consensus       762 ~~~~lv~e~~~~~sL~~~l~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~---~kl~D  837 (982)
                      +..++||||+++++|.+++.... ...+++..++.++.|++.|++|||+.+   |+||||||+||+++.++.   +||+|
T Consensus        91 ~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~D  167 (676)
T 3qa8_A           91 DLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIID  167 (676)
T ss_dssp             SSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECS
T ss_pred             CeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEcc
Confidence            67799999999999999998533 246899999999999999999999998   999999999999997765   99999


Q ss_pred             cccchhccccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCC
Q 002010          838 FGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVS  917 (982)
Q Consensus       838 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  917 (982)
                      ||.+......   .......||+.|+|||++.+..++.++||||+|+++|+|++|..||......   ..|.........
T Consensus       168 FG~a~~~~~~---~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~---~~~~~~i~~~~~  241 (676)
T 3qa8_A          168 LGYAKELDQG---ELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP---VQWHGKVREKSN  241 (676)
T ss_dssp             CCCCCBTTSC---CCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHH---HHSSTTCC----
T ss_pred             cccccccccc---cccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccch---hhhhhhhhcccc
Confidence            9999876533   2234567899999999999999999999999999999999999999753221   111111100000


Q ss_pred             C---CCcccccceeec---CCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHH
Q 002010          918 Q---PSDAASVLAVVD---PRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREV  965 (982)
Q Consensus       918 ~---~~~~~~~~~~~~---~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~el  965 (982)
                      .   ..........+.   +.........+..+.+++.+||+.||++|||++|+
T Consensus       242 ~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~el  295 (676)
T 3qa8_A          242 EHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQN  295 (676)
T ss_dssp             --CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTC
T ss_pred             hhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHH
Confidence            0   000000000011   11123556678899999999999999999999773

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=2.6e-35  Score=339.11  Aligned_cols=251  Identities=24%  Similarity=0.321  Sum_probs=188.5

Q ss_pred             hhcccccccccccceEEEEEEeCCCcEEEEEEeccCCCCCchhhHHHHHHHHhcC-CCCcccceEeEEEcCCccEEEEec
Q 002010          692 ESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRI-RHRNIVRLLGYVSNRDTNLLLYEY  770 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~  770 (982)
                      +.|...+.||+|+||+||.+...+|+.||||++...    ....+.+|+.+++++ +||||+++++++.+++..++||||
T Consensus        15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~----~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~   90 (434)
T 2rio_A           15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID----FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALEL   90 (434)
T ss_dssp             SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG----GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred             heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH----HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEec
Confidence            345667889999999998776678999999998432    245678999999876 899999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCC-----CCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCC-------------CC
Q 002010          771 MPNGSLGEMLHGAKGGH-----LKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSD-------------FE  832 (982)
Q Consensus       771 ~~~~sL~~~l~~~~~~~-----l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~-------------~~  832 (982)
                      ++ |+|.+++.......     .++..++.++.||+.||+|||+.+   |+||||||+||+++.+             +.
T Consensus        91 ~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~  166 (434)
T 2rio_A           91 CN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLR  166 (434)
T ss_dssp             CS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCE
T ss_pred             CC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceE
Confidence            95 69999997543211     123345789999999999999998   9999999999999754             48


Q ss_pred             EEEeccccchhccccCCc--cccccccccccccccccccc-------CCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCC
Q 002010          833 AHVADFGLAKFLQDAGAS--ECMSSVAGSYGYIAPEYAYT-------LKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDG  902 (982)
Q Consensus       833 ~kl~DfG~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~  902 (982)
                      +||+|||++..+......  .......||+.|+|||++.+       ..++.++||||+||++|||++ |..||......
T Consensus       167 ~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~  246 (434)
T 2rio_A          167 ILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR  246 (434)
T ss_dssp             EEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH
T ss_pred             EEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh
Confidence            999999999876543211  12234679999999999875       668999999999999999999 99999754322


Q ss_pred             chHHHHHHHhccCCCCCCcccccceeecCCCC-CCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          903 VDIVRWVRKTTSEVSQPSDAASVLAVVDPRLS-GYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       903 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                      .  ..+.......               +... ..+...+..+.+++.+||+.||.+|||++|+++
T Consensus       247 ~--~~i~~~~~~~---------------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          247 E--SNIIRGIFSL---------------DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             H--HHHHHTCCCC---------------CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             H--HHHhcCCCCc---------------ccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence            1  2222211110               0011 123456678999999999999999999999985

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.9e-35  Score=325.69  Aligned_cols=244  Identities=23%  Similarity=0.383  Sum_probs=192.1

Q ss_pred             HHHHhhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCC-----CchhhHHHHHHHHhcC----CCCcccceEeE
Q 002010          688 EDVLESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTG-----GNDHGFLAEIQTLGRI----RHRNIVRLLGY  757 (982)
Q Consensus       688 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l----~h~niv~~~~~  757 (982)
                      +.+.++|+..+.||+|+||.||+|.. .+++.||+|++......     .....+.+|+.++.++    +||||++++++
T Consensus        27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~  106 (312)
T 2iwi_A           27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW  106 (312)
T ss_dssp             ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred             hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence            44567899999999999999999965 56889999998544321     1233466799999888    89999999999


Q ss_pred             EEcCCccEEEEec-cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEc-CCCCEEE
Q 002010          758 VSNRDTNLLLYEY-MPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLD-SDFEAHV  835 (982)
Q Consensus       758 ~~~~~~~~lv~e~-~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~-~~~~~kl  835 (982)
                      +...+..++|||+ +++++|.+++..  ...+++..+..++.||+.|++|||+.+   |+||||||+||+++ .++.+||
T Consensus       107 ~~~~~~~~~v~e~~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl  181 (312)
T 2iwi_A          107 FETQEGFMLVLERPLPAQDLFDYITE--KGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKL  181 (312)
T ss_dssp             C-----CEEEEECCSSEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEEEE
T ss_pred             EecCCeEEEEEEecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeEEE
Confidence            9999999999999 789999999974  356999999999999999999999998   99999999999999 8899999


Q ss_pred             eccccchhccccCCcccccccccccccccccccccCCCC-cchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhcc
Q 002010          836 ADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVD-EKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTS  914 (982)
Q Consensus       836 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  914 (982)
                      +|||++......    ......|++.|+|||++.+..+. .++||||+|+++|||++|+.||....      ....... 
T Consensus       182 ~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~~~-  250 (312)
T 2iwi_A          182 IDFGSGALLHDE----PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEAEL-  250 (312)
T ss_dssp             CCCSSCEECCSS----CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHTCC-
T ss_pred             EEcchhhhcccC----cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------HHhhhcc-
Confidence            999999876532    23446689999999998877664 58999999999999999999996421      1111100 


Q ss_pred             CCCCCCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          915 EVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       915 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                                          ..+...+..+.+++.+||+.||++|||++|+++
T Consensus       251 --------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~  283 (312)
T 2iwi_A          251 --------------------HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILL  283 (312)
T ss_dssp             --------------------CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             --------------------CCcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                                112233457889999999999999999999998

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.6e-35  Score=339.49  Aligned_cols=248  Identities=24%  Similarity=0.301  Sum_probs=187.0

Q ss_pred             hcccccccccccceEEEEEEeCCCcEEEEEEeccCCCCCchhhHHHHHHHHhcC-CCCcccceEeEEEcCCccEEEEecc
Q 002010          693 SLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRI-RHRNIVRLLGYVSNRDTNLLLYEYM  771 (982)
Q Consensus       693 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~  771 (982)
                      +|+..+.||+|+||+||.....+++.||||++...    ....+.+|+.+++++ +|||||++++++.+....++||||+
T Consensus        25 ~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~----~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~  100 (432)
T 3p23_A           25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPE----CFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC  100 (432)
T ss_dssp             EEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTT----TEEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             EEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHH----HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECC
Confidence            57888899999999976655568999999998432    223466899999999 7999999999999999999999999


Q ss_pred             CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcC-----CCCEEEeccccchhccc
Q 002010          772 PNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDS-----DFEAHVADFGLAKFLQD  846 (982)
Q Consensus       772 ~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~-----~~~~kl~DfG~a~~~~~  846 (982)
                      + |+|.+++.... ....+..+..++.||+.|++|||+.+   |+||||||+||+++.     ...+||+|||+|+....
T Consensus       101 ~-g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~  175 (432)
T 3p23_A          101 A-ATLQEYVEQKD-FAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV  175 (432)
T ss_dssp             S-EEHHHHHHSSS-CCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC--
T ss_pred             C-CCHHHHHHhcC-CCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceeeccC
Confidence            5 69999997433 34455567789999999999999998   999999999999953     23688999999987653


Q ss_pred             cCC-cccccccccccccccccccc---cCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHhccCCCCCCc
Q 002010          847 AGA-SECMSSVAGSYGYIAPEYAY---TLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSD  921 (982)
Q Consensus       847 ~~~-~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  921 (982)
                      ... ........||+.|+|||++.   ...++.++||||+||++|||++ |..||......  ..........       
T Consensus       176 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~--~~~~~~~~~~-------  246 (432)
T 3p23_A          176 GRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR--QANILLGACS-------  246 (432)
T ss_dssp             ----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH--HHHHHTTCCC-------
T ss_pred             CCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH--HHHHHhccCC-------
Confidence            321 12334567999999999987   4567889999999999999999 99999653221  1111111000       


Q ss_pred             ccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          922 AASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       922 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                               ......+......+.+++.+||+.||.+|||++|+++
T Consensus       247 ---------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          247 ---------LDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             ---------CTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ---------ccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence                     0000112234556889999999999999999999984

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=100.00  E-value=4.3e-34  Score=325.23  Aligned_cols=311  Identities=20%  Similarity=0.211  Sum_probs=262.4

Q ss_pred             hhhhHHHHhhcccccccccCCCC-CCCCCCCCEEecccCcCcccCchhhcCCCccceeecccccCCCCCCccccCCCCCC
Q 002010          214 RLKNLREMYIGYFNTYTGGIPPG-FGALTQLQVLDMASCNISGEIPTSLSRLKLLHSLFLQMNKLTGHIPPQLSGLISLK  292 (982)
Q Consensus       214 ~l~~L~~L~l~~~n~~~~~~p~~-~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~  292 (982)
                      .+.+++.|++.. +.+ +.+|.. |..+++|++|++++|.+++..+..|..+++|++|+|++|++++..|..+..+++|+
T Consensus        43 ~l~~l~~l~l~~-~~l-~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~  120 (390)
T 3o6n_A           43 TLNNQKIVTFKN-STM-RKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLT  120 (390)
T ss_dssp             GGCCCSEEEEES-CEE-SEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCC
T ss_pred             ccCCceEEEecC-Cch-hhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCC
Confidence            367888888875 333 345554 78999999999999999988888999999999999999999998888899999999


Q ss_pred             EEEeeCCcccCcCchhhhcccchhhhhhccCCCCCCCCCcCCCCCCccEEEccCCCcccccCccccCCCcccEEEecccc
Q 002010          293 SLDLSLNYLTGEIPESFAALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNH  372 (982)
Q Consensus       293 ~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~  372 (982)
                      +|+|++|.++...+..|..+++|++|++++|++++..|..+..+++|++|++++|.+++.   .+..+++|+.|++++|.
T Consensus       121 ~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~---~~~~l~~L~~L~l~~n~  197 (390)
T 3o6n_A          121 VLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNL  197 (390)
T ss_dssp             EEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBC---CGGGCTTCSEEECCSSC
T ss_pred             EEECCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCcc---ccccccccceeeccccc
Confidence            999999999966666679999999999999999998899999999999999999999964   36778999999999999


Q ss_pred             ccccCCccccCccccceeecccccccccCCccccCCCCCCEEEccCCccCCCCCccccCCCccccccCCCccccccCCcc
Q 002010          373 LTGTIPRDLCKGGKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLSGELPEK  452 (982)
Q Consensus       373 l~~~~p~~~~~~~~L~~L~l~~N~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~  452 (982)
                      +++.     ....+|++|++++|.+......   ..++|+.|++++|++++.  ..+..+                    
T Consensus       198 l~~~-----~~~~~L~~L~l~~n~l~~~~~~---~~~~L~~L~l~~n~l~~~--~~l~~l--------------------  247 (390)
T 3o6n_A          198 LSTL-----AIPIAVEELDASHNSINVVRGP---VNVELTILKLQHNNLTDT--AWLLNY--------------------  247 (390)
T ss_dssp             CSEE-----ECCSSCSEEECCSSCCCEEECC---CCSSCCEEECCSSCCCCC--GGGGGC--------------------
T ss_pred             cccc-----CCCCcceEEECCCCeeeecccc---ccccccEEECCCCCCccc--HHHcCC--------------------
Confidence            9843     3446899999999998765332   347899999999988743  334433                    


Q ss_pred             cccCCccEEEeeccccCCCCchhccCCCCcceeeeccccccCCCccccccccccceeeeeccccCCCCCcccccccCCCe
Q 002010          453 MSGASLNQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIPYSISQCHSLTS  532 (982)
Q Consensus       453 ~~~~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~  532 (982)
                         ++|++|++++|++++..|..|..+++|++|+|++|++++ +|..+..+++|++|+|++|+++ .+|..+..+++|+.
T Consensus       248 ---~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~  322 (390)
T 3o6n_A          248 ---PGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLEN  322 (390)
T ss_dssp             ---TTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSE
T ss_pred             ---CCccEEECCCCcCCCcChhHccccccCCEEECCCCcCcc-cCcccCCCCCCCEEECCCCcce-ecCccccccCcCCE
Confidence               356667777777777778888899999999999999984 6777778899999999999998 56777889999999


Q ss_pred             eeCCCCcccCCCCcccccccccceEEccccccccc
Q 002010          533 VDLSRNSLYGKIPPGISKLIDLSILNLSRNGITGS  567 (982)
Q Consensus       533 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~  567 (982)
                      |+|++|.|++. |  +..+++|+.|+|++|+++..
T Consensus       323 L~L~~N~i~~~-~--~~~~~~L~~L~l~~N~~~~~  354 (390)
T 3o6n_A          323 LYLDHNSIVTL-K--LSTHHTLKNLTLSHNDWDCN  354 (390)
T ss_dssp             EECCSSCCCCC-C--CCTTCCCSEEECCSSCEEHH
T ss_pred             EECCCCcccee-C--chhhccCCEEEcCCCCccch
Confidence            99999999854 3  77889999999999999863

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=100.00  E-value=5.1e-34  Score=342.63  Aligned_cols=311  Identities=19%  Similarity=0.143  Sum_probs=161.0

Q ss_pred             ccccccEEEeccCCCCCCCChhhhhhcccceeeccCCccccccchhhhhcCCCccEEeccCccccCCCchhccccccccE
Q 002010           93 LLTKLVNLTISNVNLTGRLPSEMALLTSLKVFNISGNVFQGNFAGQIVRGMTELQVLDAYNNNFTGPLPVEIASLKSLRH  172 (982)
Q Consensus        93 ~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~  172 (982)
                      .+++++.|++++|.++...+..+..+++|++|+|++|.+.+. +...+..+++|++|+|++|.+++..|..|+++++|++
T Consensus        49 ~l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~-~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~  127 (597)
T 3oja_B           49 TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEI-DTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTV  127 (597)
T ss_dssp             GGCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEE-CTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCE
T ss_pred             cCCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCC-ChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCE
Confidence            356667777777776654444556666666666666666543 2234455666666666666666555555566666666


Q ss_pred             EeecCcccccccCCCccccCcceEeeccCcccccchhhHHhhhhhHHHHhhcccccccccCCCCCCCCCCCCEEecccCc
Q 002010          173 LSFGGNYFTGKIPQSYSEIQSLEYIGLNGIGLNGTVPAFLSRLKNLREMYIGYFNTYTGGIPPGFGALTQLQVLDMASCN  252 (982)
Q Consensus       173 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~l~~~n~~~~~~p~~~~~l~~L~~L~L~~n~  252 (982)
                      |+|++|.+++..+..|+++++|++|+|++|.+.+                         ..|..|+.+++|++|+|++|.
T Consensus       128 L~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~-------------------------~~~~~~~~l~~L~~L~L~~N~  182 (597)
T 3oja_B          128 LVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLER-------------------------IEDDTFQATTSLQNLQLSSNR  182 (597)
T ss_dssp             EECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCB-------------------------CCTTTTTTCTTCCEEECTTSC
T ss_pred             EEeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCC-------------------------CChhhhhcCCcCcEEECcCCC
Confidence            6666666654444444555555555555544332                         223334455555555555555


Q ss_pred             CcccCchhhcCCCccceeecccccCCCCCCccccCCCCCCEEEeeCCcccCcCchhhhcccchhhhhhccCCCCCCCCCc
Q 002010          253 ISGEIPTSLSRLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQLFKNNLRGPIPSF  332 (982)
Q Consensus       253 l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~  332 (982)
                      +++..   ++.+++|+.|++++|.+++     +....+|+.|++++|.++.. +..+  .++|+.|+|++|.+++     
T Consensus       183 l~~~~---~~~l~~L~~L~l~~n~l~~-----l~~~~~L~~L~ls~n~l~~~-~~~~--~~~L~~L~L~~n~l~~-----  246 (597)
T 3oja_B          183 LTHVD---LSLIPSLFHANVSYNLLST-----LAIPIAVEELDASHNSINVV-RGPV--NVELTILKLQHNNLTD-----  246 (597)
T ss_dssp             CSBCC---GGGCTTCSEEECCSSCCSE-----EECCTTCSEEECCSSCCCEE-ECSC--CSCCCEEECCSSCCCC-----
T ss_pred             CCCcC---hhhhhhhhhhhcccCcccc-----ccCCchhheeeccCCccccc-cccc--CCCCCEEECCCCCCCC-----
Confidence            55431   3344555555555555542     22334455555555555422 2111  1344444444444443     


Q ss_pred             CCCCCCccEEEccCCCcccccCccccCCCcccEEEeccccccccCCccccCccccceeecccccccccCCccccCCCCCC
Q 002010          333 LGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFIGPIPEELGQCKSLT  412 (982)
Q Consensus       333 ~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~l~~N~~~~~~~~~l~~l~~L~  412 (982)
                                           +..+..+++|+.|+|++|.+++..|..+..+++|+.|+|++|.+++ +|..+..+++|+
T Consensus       247 ---------------------~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~  304 (597)
T 3oja_B          247 ---------------------TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLK  304 (597)
T ss_dssp             ---------------------CGGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCE-EECSSSCCTTCC
T ss_pred             ---------------------ChhhccCCCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCCC-CCcccccCCCCc
Confidence                                 2334444444444444444444444444444444445554444443 233444455555


Q ss_pred             EEEccCCccCCCCCccccCCCccccccCCCccccccCCcccccCCccEEEeeccccCC
Q 002010          413 KIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLSGELPEKMSGASLNQLKVANNNITG  470 (982)
Q Consensus       413 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~L~~N~i~~  470 (982)
                      .|+|++|.++ .+|..+..+++|+.|++++|.+++....  ..++|+.|++++|.+.+
T Consensus       305 ~L~Ls~N~l~-~i~~~~~~l~~L~~L~L~~N~l~~~~~~--~~~~L~~L~l~~N~~~~  359 (597)
T 3oja_B          305 VLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLKLS--THHTLKNLTLSHNDWDC  359 (597)
T ss_dssp             EEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCCCCC--TTCCCSEEECCSSCEEH
T ss_pred             EEECCCCCCC-ccCcccccCCCCCEEECCCCCCCCcChh--hcCCCCEEEeeCCCCCC
Confidence            5555555555 4444555555555555555555543211  22466777777777664

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=100.00  E-value=1.4e-33  Score=315.92  Aligned_cols=308  Identities=27%  Similarity=0.314  Sum_probs=222.9

Q ss_pred             CCCCCCCCCEEecccCcCcccCchhhcCCCccceeecccccCCCCCCccccCCCCCCEEEeeCCcccCcCchhhhcccch
Q 002010          236 GFGALTQLQVLDMASCNISGEIPTSLSRLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNL  315 (982)
Q Consensus       236 ~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L  315 (982)
                      .+..+++|+.|++++|.+.. ++ .+..+++|++|++++|++++..+  +..+++|++|++++|.+++ ++ .+..+++|
T Consensus        39 ~~~~l~~L~~L~l~~~~i~~-~~-~~~~~~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~L~~n~i~~-~~-~~~~l~~L  112 (347)
T 4fmz_A           39 TQEELESITKLVVAGEKVAS-IQ-GIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITD-IS-ALQNLTNL  112 (347)
T ss_dssp             CHHHHTTCSEEECCSSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-CG-GGTTCTTC
T ss_pred             cchhcccccEEEEeCCcccc-ch-hhhhcCCccEEEccCCccccchh--hhcCCcCCEEEccCCcccC-ch-HHcCCCcC
Confidence            35577888999999988874 34 37888888888888888885433  8888888888888888885 33 57778888


Q ss_pred             hhhhhccCCCCCCCCCcCCCCCCccEEEccCCCcccccCccccCCCcccEEEeccccccccCCccccCccccceeecccc
Q 002010          316 TLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQN  395 (982)
Q Consensus       316 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~l~~N  395 (982)
                      ++|++++|.+.+..+  +..+++|+.|++++|.....++ .+..+++|++|++++|.+.+..+  +..+++|++|++++|
T Consensus       113 ~~L~l~~n~i~~~~~--~~~l~~L~~L~l~~n~~~~~~~-~~~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n  187 (347)
T 4fmz_A          113 RELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYN  187 (347)
T ss_dssp             SEEECTTSCCCCCGG--GTTCTTCCEEECTTCTTCCCCG-GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCSEEECTTS
T ss_pred             CEEECcCCcccCchh--hccCCceeEEECCCCCCccccc-chhhCCCCcEEEecCCCcCCchh--hccCCCCCEEEccCC
Confidence            888888888875433  7777888888888875553333 36677777777777777664322  445555555555555


Q ss_pred             cccccCCccccCCCCCCEEEccCCccCCCCCccccCCCccccccCCCccccccCCcccccCCccEEEeeccccCCCCchh
Q 002010          396 FFIGPIPEELGQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLSGELPEKMSGASLNQLKVANNNITGKIPAA  475 (982)
Q Consensus       396 ~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~L~~N~i~~~~p~~  475 (982)
                      .+.+..+  +..+++|+.|++++|.++                        +..+ .....+|++|++++|++++..+  
T Consensus       188 ~l~~~~~--~~~l~~L~~L~l~~n~l~------------------------~~~~-~~~~~~L~~L~l~~n~l~~~~~--  238 (347)
T 4fmz_A          188 QIEDISP--LASLTSLHYFTAYVNQIT------------------------DITP-VANMTRLNSLKIGNNKITDLSP--  238 (347)
T ss_dssp             CCCCCGG--GGGCTTCCEEECCSSCCC------------------------CCGG-GGGCTTCCEEECCSSCCCCCGG--
T ss_pred             ccccccc--ccCCCccceeecccCCCC------------------------CCch-hhcCCcCCEEEccCCccCCCcc--
Confidence            5443222  444555555555555444                        3322 2223567777777777775444  


Q ss_pred             ccCCCCcceeeeccccccCCCccccccccccceeeeeccccCCCCCcccccccCCCeeeCCCCcccCCCCcccccccccc
Q 002010          476 IGNLPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYGKIPPGISKLIDLS  555 (982)
Q Consensus       476 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~  555 (982)
                      +..+++|++|++++|++++ + ..+..+++|++|++++|++++.  ..+..+++|+.|++++|.+++..|..+..+++|+
T Consensus       239 ~~~l~~L~~L~l~~n~l~~-~-~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~  314 (347)
T 4fmz_A          239 LANLSQLTWLEIGTNQISD-I-NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLT  314 (347)
T ss_dssp             GTTCTTCCEEECCSSCCCC-C-GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCS
T ss_pred             hhcCCCCCEEECCCCccCC-C-hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccCC
Confidence            7888899999999998875 3 4577888999999999999864  4588899999999999999988888899999999


Q ss_pred             eEEcccccccccCccccccccccceecccCCccc
Q 002010          556 ILNLSRNGITGSIPNEMRNMMSLTTLDLSYNNLI  589 (982)
Q Consensus       556 ~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~  589 (982)
                      .|+|++|++++..|  +..+++|++|++++|+++
T Consensus       315 ~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~  346 (347)
T 4fmz_A          315 TLFLSQNHITDIRP--LASLSKMDSADFANQVIK  346 (347)
T ss_dssp             EEECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred             EEEccCCccccccC--hhhhhccceeehhhhccc
Confidence            99999999997666  888999999999999875

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=100.00  E-value=1.7e-34  Score=319.19  Aligned_cols=272  Identities=21%  Similarity=0.252  Sum_probs=169.2

Q ss_pred             cCchhHHHHHHHHHhcccCCCCCCCCCCCCC-CCCCCCCccceeeeCC---------CCCEEEEEeccCCccccCCcCcc
Q 002010           23 SCAYSDMDVLLKLKSSMIGPKGSGLKNWEPS-SSPSAHCSFSGVTCDQ---------DSRVVSLNVSFMPLFGSIPPEIG   92 (982)
Q Consensus        23 ~~~~~~~~~ll~~k~~~~~~~~~~~~~w~~~-~~~~~~C~w~gv~C~~---------~~~v~~l~l~~~~l~g~~~~~i~   92 (982)
                      ++..+|++||++||+++..++.+.+++|... ....++|.|.|+.|+.         .++|+.|+++++.+. .+|+.++
T Consensus        23 ~~~~~~~~aLl~~k~~~~~~~~~~~~~w~~~~~~~~~~~~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~-~lp~~l~  101 (328)
T 4fcg_A           23 TALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAF  101 (328)
T ss_dssp             CCCCCHHHHHHHHHHHHHHCCTTHHHHHHHHTTTCTTSCCSHHHHHHHHHHHHHHHTSTTCCEEEEESSCCS-SCCSCGG
T ss_pred             ccCchHHHHHHHHHHhccCCchhhhhhhcccccccccccccCCcchhhhHHHHhcccccceeEEEccCCCch-hcChhhh
Confidence            4667899999999999976655678899411 1245789999999952         257777777777766 6777777


Q ss_pred             ccccccEEEeccCCCCCCCChhhhhhcccceeeccCCccccccchhhhhcCCCccEEeccCccccCCCchhccc------
Q 002010           93 LLTKLVNLTISNVNLTGRLPSEMALLTSLKVFNISGNVFQGNFAGQIVRGMTELQVLDAYNNNFTGPLPVEIAS------  166 (982)
Q Consensus        93 ~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~------  166 (982)
                      .+++|++|+|++|+++ .+|..++.+++|++|+|++|.++ .+|. .+.++++|++|+|++|++.+.+|..++.      
T Consensus       102 ~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~-~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~  178 (328)
T 4fcg_A          102 RLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPA-SIASLNRLRELSIRACPELTELPEPLASTDASGE  178 (328)
T ss_dssp             GGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCG-GGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CCC
T ss_pred             hCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcH-HHhcCcCCCEEECCCCCCccccChhHhhccchhh
Confidence            7777777777777777 67777777777777777766665 3332 2455666666666665555555555443      


Q ss_pred             ---cccccEEeecCcccccccCCCccccCcceEeeccCcccccchhhHHhhhhhHHHHhhcccccccccCCCCCCCCCCC
Q 002010          167 ---LKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLNGIGLNGTVPAFLSRLKNLREMYIGYFNTYTGGIPPGFGALTQL  243 (982)
Q Consensus       167 ---l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~l~~~n~~~~~~p~~~~~l~~L  243 (982)
                         +++|++|+|++|+++ .+|..                                                 ++.+++|
T Consensus       179 ~~~l~~L~~L~L~~n~l~-~lp~~-------------------------------------------------l~~l~~L  208 (328)
T 4fcg_A          179 HQGLVNLQSLRLEWTGIR-SLPAS-------------------------------------------------IANLQNL  208 (328)
T ss_dssp             EEESTTCCEEEEEEECCC-CCCGG-------------------------------------------------GGGCTTC
T ss_pred             hccCCCCCEEECcCCCcC-cchHh-------------------------------------------------hcCCCCC
Confidence               444444444444444 33433                                                 4444555


Q ss_pred             CEEecccCcCcccCchhhcCCCccceeecccccCCCCCCccccCCCCCCEEEeeCCcccCcCchhhhcccchhhhhhccC
Q 002010          244 QVLDMASCNISGEIPTSLSRLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQLFKN  323 (982)
Q Consensus       244 ~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N  323 (982)
                      ++|+|++|++++ +|..++.+++|++|+|++|.+.+.+|..+..+++|++|+|++|.+.+.+|..+..+++|++|+|++|
T Consensus       209 ~~L~L~~N~l~~-l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n  287 (328)
T 4fcg_A          209 KSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGC  287 (328)
T ss_dssp             CEEEEESSCCCC-CCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTC
T ss_pred             CEEEccCCCCCc-CchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCC
Confidence            555555555553 3334555555555555555555555555555555555555555555555555555555566666655


Q ss_pred             CCCCCCCCcCCCCCCccEEEccCCCc
Q 002010          324 NLRGPIPSFLGDFPNLEVLQVWGNNF  349 (982)
Q Consensus       324 ~l~~~~p~~~~~l~~L~~L~L~~N~l  349 (982)
                      ++.+.+|..++++++|+.+++..|.+
T Consensus       288 ~~~~~iP~~l~~L~~L~~l~l~~~~~  313 (328)
T 4fcg_A          288 VNLSRLPSLIAQLPANCIILVPPHLQ  313 (328)
T ss_dssp             TTCCCCCGGGGGSCTTCEEECCGGGS
T ss_pred             CchhhccHHHhhccCceEEeCCHHHH
Confidence            55555565566666666665554443

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=1.1e-33  Score=309.34  Aligned_cols=230  Identities=22%  Similarity=0.249  Sum_probs=182.1

Q ss_pred             HHHHhhcccc-cccccccceEEEEEEe-CCCcEEEEEEeccCCCCCchhhHHHHHHHH-hcCCCCcccceEeEEEc----
Q 002010          688 EDVLESLKDE-NIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTL-GRIRHRNIVRLLGYVSN----  760 (982)
Q Consensus       688 ~~~~~~~~~~-~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~~~~~~~~----  760 (982)
                      ..+.++|... +.||+|+||.||+|.. .+++.||+|++..      ...+.+|+.++ +..+||||+++++++..    
T Consensus        13 ~~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~------~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~   86 (299)
T 3m2w_A           13 NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD------CPKARREVELHWRASQCPHIVRIVDVYENLYAG   86 (299)
T ss_dssp             SCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred             cccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc------cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCC
Confidence            3455677776 7899999999999965 5689999999842      34577899887 55589999999999876    


Q ss_pred             CCccEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcC---CCCEEEec
Q 002010          761 RDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDS---DFEAHVAD  837 (982)
Q Consensus       761 ~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~---~~~~kl~D  837 (982)
                      ....++||||+++++|.+++.......+++..+..++.|++.|++|||+.+   |+||||||+||+++.   ++.+||+|
T Consensus        87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~D  163 (299)
T 3m2w_A           87 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTD  163 (299)
T ss_dssp             EEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECC
T ss_pred             CceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEec
Confidence            667899999999999999998766678999999999999999999999998   999999999999998   78999999


Q ss_pred             cccchhccccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCC
Q 002010          838 FGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVS  917 (982)
Q Consensus       838 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  917 (982)
                      ||++....                        +..++.++||||+||++|||++|+.||........    ....     
T Consensus       164 fg~a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~----~~~~-----  210 (299)
T 3m2w_A          164 FGFAKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI----SPGM-----  210 (299)
T ss_dssp             CTTCEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-----------CCS-----
T ss_pred             cccccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh----hHHH-----
Confidence            99986432                        13467899999999999999999999975332110    0000     


Q ss_pred             CCCcccccceeecCCCCCCC----hHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          918 QPSDAASVLAVVDPRLSGYP----LTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       918 ~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                              ...+.......+    ...+..+.+++.+||+.||++|||++|+++
T Consensus       211 --------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~  256 (299)
T 3m2w_A          211 --------KTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  256 (299)
T ss_dssp             --------CCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             --------HHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence                    000000000111    234567899999999999999999999987

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=1.7e-34  Score=312.74  Aligned_cols=229  Identities=15%  Similarity=0.114  Sum_probs=183.2

Q ss_pred             hhcccccccccccceEEEEEEeC-CCcEEEEEEeccCCCCC--chhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEE
Q 002010          692 ESLKDENIIGKGGAGIVYRGSMP-DGIDVAIKRLVGRGTGG--NDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLY  768 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  768 (982)
                      ++|++.+.||+|+||.||+|... +++.||+|++.......  ....+.+|+.++.+++||||+++++++.+++..|+||
T Consensus        31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  110 (286)
T 3uqc_A           31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA  110 (286)
T ss_dssp             TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence            67999999999999999999764 48999999986543322  2367899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccC
Q 002010          769 EYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAG  848 (982)
Q Consensus       769 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  848 (982)
                      ||+++++|.+++..    .....++.+++.|++.|++|||+.+   |+||||||+||+++.++.+||+++|         
T Consensus       111 e~~~g~~L~~~l~~----~~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~---------  174 (286)
T 3uqc_A          111 EWIRGGSLQEVADT----SPSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA---------  174 (286)
T ss_dssp             ECCCEEEHHHHHTT----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC---------
T ss_pred             EecCCCCHHHHHhc----CCChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc---------
Confidence            99999999999952    2466678899999999999999998   9999999999999999999998543         


Q ss_pred             CcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCccccccee
Q 002010          849 ASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAV  928 (982)
Q Consensus       849 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  928 (982)
                                   |++|       ++.++||||+||++|||++|+.||............                 ...
T Consensus       175 -------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~-----------------~~~  217 (286)
T 3uqc_A          175 -------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA-----------------ERD  217 (286)
T ss_dssp             -------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC-----------------CBC
T ss_pred             -------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH-----------------HHH
Confidence                         3332       678999999999999999999999764322110000                 000


Q ss_pred             ecCCC---CCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCC
Q 002010          929 VDPRL---SGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQ  974 (982)
Q Consensus       929 ~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~~  974 (982)
                      .....   .......+..+.+++.+||+.||++| |++|+++.|+++..
T Consensus       218 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~  265 (286)
T 3uqc_A          218 TAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATA  265 (286)
T ss_dssp             TTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC
T ss_pred             hccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhc
Confidence            00000   01123345678999999999999999 99999999977544

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=100.00  E-value=4.6e-33  Score=311.59  Aligned_cols=308  Identities=22%  Similarity=0.306  Sum_probs=247.6

Q ss_pred             HHhhhhhHHHHhhcccccccccCCCCCCCCCCCCEEecccCcCcccCchhhcCCCccceeecccccCCCCCCccccCCCC
Q 002010          211 FLSRLKNLREMYIGYFNTYTGGIPPGFGALTQLQVLDMASCNISGEIPTSLSRLKLLHSLFLQMNKLTGHIPPQLSGLIS  290 (982)
Q Consensus       211 ~l~~l~~L~~L~l~~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~  290 (982)
                      .+..+++|++|++.++. +. .+| .+..+++|++|++++|++++..+  +..+++|++|++++|+++..  +.+..+++
T Consensus        39 ~~~~l~~L~~L~l~~~~-i~-~~~-~~~~~~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~L~~n~i~~~--~~~~~l~~  111 (347)
T 4fmz_A           39 TQEELESITKLVVAGEK-VA-SIQ-GIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITDI--SALQNLTN  111 (347)
T ss_dssp             CHHHHTTCSEEECCSSC-CC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC--GGGTTCTT
T ss_pred             cchhcccccEEEEeCCc-cc-cch-hhhhcCCccEEEccCCccccchh--hhcCCcCCEEEccCCcccCc--hHHcCCCc
Confidence            45688999999998643 32 343 48999999999999999996544  99999999999999999963  46999999


Q ss_pred             CCEEEeeCCcccCcCchhhhcccchhhhhhccCCCCCCCCCcCCCCCCccEEEccCCCcccccCccccCCCcccEEEecc
Q 002010          291 LKSLDLSLNYLTGEIPESFAALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTS  370 (982)
Q Consensus       291 L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~  370 (982)
                      |++|++++|.+++. +. +..+++|+.|++++|.....++ .+..+++|++|++++|.+....+  +..+++|+.|++++
T Consensus       112 L~~L~l~~n~i~~~-~~-~~~l~~L~~L~l~~n~~~~~~~-~~~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~  186 (347)
T 4fmz_A          112 LRELYLNEDNISDI-SP-LANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNY  186 (347)
T ss_dssp             CSEEECTTSCCCCC-GG-GTTCTTCCEEECTTCTTCCCCG-GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCSEEECTT
T ss_pred             CCEEECcCCcccCc-hh-hccCCceeEEECCCCCCccccc-chhhCCCCcEEEecCCCcCCchh--hccCCCCCEEEccC
Confidence            99999999999964 33 8899999999999997664444 48999999999999999986544  88999999999999


Q ss_pred             ccccccCCccccCccccceeecccccccccCCccccCCCCCCEEEccCCccCCCCCccccCCCccccccCCCccccccCC
Q 002010          371 NHLTGTIPRDLCKGGKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLSGELP  450 (982)
Q Consensus       371 N~l~~~~p~~~~~~~~L~~L~l~~N~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~  450 (982)
                      |.+++..+  +..+++|+.|++++|.+.+..+  +..+++|++|++++|++++..+  +..+++|++|++++        
T Consensus       187 n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~--------  252 (347)
T 4fmz_A          187 NQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGT--------  252 (347)
T ss_dssp             SCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCS--------
T ss_pred             Cccccccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCCcc--hhcCCCCCEEECCC--------
Confidence            99985443  8889999999999999987655  8899999999999999985433  55555555555555        


Q ss_pred             cccccCCccEEEeeccccCCCCchhccCCCCcceeeeccccccCCCccccccccccceeeeeccccCCCCCcccccccCC
Q 002010          451 EKMSGASLNQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIPYSISQCHSL  530 (982)
Q Consensus       451 ~~~~~~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L  530 (982)
                                     |++++.  ..+..+++|++|++++|++++.  ..+..+++|++|++++|++++..|..++.+++|
T Consensus       253 ---------------n~l~~~--~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L  313 (347)
T 4fmz_A          253 ---------------NQISDI--NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNL  313 (347)
T ss_dssp             ---------------SCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTC
T ss_pred             ---------------CccCCC--hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccC
Confidence                           444432  3467778888888888888743  346778888888888888887777888888888


Q ss_pred             CeeeCCCCcccCCCCcccccccccceEEccccccc
Q 002010          531 TSVDLSRNSLYGKIPPGISKLIDLSILNLSRNGIT  565 (982)
Q Consensus       531 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  565 (982)
                      +.|+|++|++++..|  +..+++|+.|++++|.|+
T Consensus       314 ~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~  346 (347)
T 4fmz_A          314 TTLFLSQNHITDIRP--LASLSKMDSADFANQVIK  346 (347)
T ss_dssp             SEEECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred             CEEEccCCccccccC--hhhhhccceeehhhhccc
Confidence            888888888886555  788888888888888875

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=6.1e-34  Score=346.65  Aligned_cols=237  Identities=23%  Similarity=0.304  Sum_probs=190.4

Q ss_pred             hhcccccccccccceEEEEEEeC--CCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCc-----c
Q 002010          692 ESLKDENIIGKGGAGIVYRGSMP--DGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDT-----N  764 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-----~  764 (982)
                      ++|++.+.||+|+||.||+|...  +++.||||++...........+.+|+.++.+++||||+++++++...+.     .
T Consensus        80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~  159 (681)
T 2pzi_A           80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG  159 (681)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence            67999999999999999999764  5899999988654444445678899999999999999999999987665     6


Q ss_pred             EEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhc
Q 002010          765 LLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFL  844 (982)
Q Consensus       765 ~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~  844 (982)
                      |+||||+++++|.+++..    .+++.++..++.||+.||+|||+++   |+||||||+||+++.+ .+||+|||+++..
T Consensus       160 ~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~~~  231 (681)
T 2pzi_A          160 YIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVSRI  231 (681)
T ss_dssp             EEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCEET
T ss_pred             EEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccchhc
Confidence            999999999999988752    7999999999999999999999998   9999999999999886 9999999999865


Q ss_pred             cccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccc
Q 002010          845 QDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAAS  924 (982)
Q Consensus       845 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  924 (982)
                      ...      ....||+.|+|||++.+. ++.++||||+||++|+|++|.+||.......            .  +.    
T Consensus       232 ~~~------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~------------~--~~----  286 (681)
T 2pzi_A          232 NSF------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDG------------L--PE----  286 (681)
T ss_dssp             TCC------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSS------------C--CT----
T ss_pred             ccC------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccccccc------------c--cc----
Confidence            432      446799999999988765 4899999999999999999998876411000            0  00    


Q ss_pred             cceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCC-HHHHHHHhc
Q 002010          925 VLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPT-MREVVHMLA  970 (982)
Q Consensus       925 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt-~~ell~~L~  970 (982)
                               ..........+.+++.+||+.||++||+ ++++.+.|.
T Consensus       287 ---------~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~  324 (681)
T 2pzi_A          287 ---------DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLT  324 (681)
T ss_dssp             ---------TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred             ---------cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHH
Confidence                     0000122346889999999999999995 555655553

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=3.9e-34  Score=327.01  Aligned_cols=241  Identities=13%  Similarity=0.110  Sum_probs=179.7

Q ss_pred             hhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCC--CCchhhHHHHHHHHhcCCC-Ccccc---------eE---
Q 002010          692 ESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGT--GGNDHGFLAEIQTLGRIRH-RNIVR---------LL---  755 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h-~niv~---------~~---  755 (982)
                      ..|+.++.||+|+||+||+|.+ .+|+.||||++.....  ....+.+.+|+.+++.++| ++...         ..   
T Consensus        78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  157 (413)
T 3dzo_A           78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV  157 (413)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred             eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence            4577888999999999999974 5699999999863332  2335678999999999976 22111         11   


Q ss_pred             ---------eEEEc-----CCccEEEEeccCCCCHHHHhh-----cCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEE
Q 002010          756 ---------GYVSN-----RDTNLLLYEYMPNGSLGEMLH-----GAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLII  816 (982)
Q Consensus       756 ---------~~~~~-----~~~~~lv~e~~~~~sL~~~l~-----~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iv  816 (982)
                               .++..     ....+++|+++ +++|.+++.     ......+++..+..++.||++||+|||+.+   |+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ii  233 (413)
T 3dzo_A          158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LV  233 (413)
T ss_dssp             ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred             ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cc
Confidence                     11111     12346677766 789999884     233456788899999999999999999998   99


Q ss_pred             ecCCCCCcEEEcCCCCEEEeccccchhccccCCccccccccccccccccccc----------ccCCCCcchhhHHHHHHH
Q 002010          817 HRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYA----------YTLKVDEKSDVYSFGVVL  886 (982)
Q Consensus       817 HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~DvwslG~il  886 (982)
                      ||||||+||+++.++.+||+|||+++.....     .....| +.|+|||++          .+..++.++||||+||++
T Consensus       234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil  307 (413)
T 3dzo_A          234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAI  307 (413)
T ss_dssp             CSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHH
T ss_pred             cCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHH
Confidence            9999999999999999999999998765432     344567 999999998          556688999999999999


Q ss_pred             HHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHH
Q 002010          887 LELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVV  966 (982)
Q Consensus       887 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell  966 (982)
                      |||++|+.||..........                    ..+. .    ....+..+.+++.+||+.||++|||+.|++
T Consensus       308 ~elltg~~Pf~~~~~~~~~~--------------------~~~~-~----~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l  362 (413)
T 3dzo_A          308 YWIWCADLPNTDDAALGGSE--------------------WIFR-S----CKNIPQPVRALLEGFLRYPKEDRLLPLQAM  362 (413)
T ss_dssp             HHHHHSSCCCCTTGGGSCSG--------------------GGGS-S----CCCCCHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred             HHHHHCCCCCCCcchhhhHH--------------------HHHh-h----cccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence            99999999997532211000                    0000 0    012235789999999999999999987764


Q ss_pred             H
Q 002010          967 H  967 (982)
Q Consensus       967 ~  967 (982)
                      +
T Consensus       363 ~  363 (413)
T 3dzo_A          363 E  363 (413)
T ss_dssp             T
T ss_pred             h
Confidence            3

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=100.00  E-value=2.1e-32  Score=303.97  Aligned_cols=288  Identities=19%  Similarity=0.231  Sum_probs=197.8

Q ss_pred             ccceeecccccCCCCCCccccCCCCCCEEEeeCCcccCcCchhhhcccchhhhhhccCCCCCCCCCcCCCCCCccEEEcc
Q 002010          266 LLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVW  345 (982)
Q Consensus       266 ~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~  345 (982)
                      +++.+++++|.++ .+|..+.  ++|+.|++++|.+++..|..|..+++|++|++++|++++..|..|+.+++|++|+++
T Consensus        34 ~l~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~  110 (332)
T 2ft3_A           34 HLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYIS  110 (332)
T ss_dssp             ETTEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECC
T ss_pred             cCCEEECCCCCcc-ccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECC
Confidence            4566666666665 3444332  455666666665554444555555555555555555555445555555555555555


Q ss_pred             CCCcccccCccccCCCcccEEEeccccccccCCccccCccccceeecccccccccCCccccCCCCCCEEEccCCccC--C
Q 002010          346 GNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLN--G  423 (982)
Q Consensus       346 ~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~l~~N~~~~~~~~~l~~l~~L~~L~Ls~N~l~--~  423 (982)
                      +|+++                         .+|..+.  ++|++|++++|.+.+..+..+.++++|++|++++|.++  +
T Consensus       111 ~n~l~-------------------------~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~  163 (332)
T 2ft3_A          111 KNHLV-------------------------EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSG  163 (332)
T ss_dssp             SSCCC-------------------------SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGG
T ss_pred             CCcCC-------------------------ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCC
Confidence            55554                         2333222  45555555555555544555666666666666666664  2


Q ss_pred             CCCccccCCCccccccCCCccccccCCcccccCCccEEEeeccccCCCCchhccCCCCcceeeeccccccCCCccccccc
Q 002010          424 TIPAGLFNLPLLNMMELDDNLLSGELPEKMSGASLNQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESFNL  503 (982)
Q Consensus       424 ~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l  503 (982)
                      ..|..+..+ +|+.|++++|.+++. |..+. .+|++|++++|++++..+..|..+++|+.|++++|++++..+..+..+
T Consensus       164 ~~~~~~~~l-~L~~L~l~~n~l~~l-~~~~~-~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l  240 (332)
T 2ft3_A          164 FEPGAFDGL-KLNYLRISEAKLTGI-PKDLP-ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFL  240 (332)
T ss_dssp             SCTTSSCSC-CCSCCBCCSSBCSSC-CSSSC-SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGC
T ss_pred             CCcccccCC-ccCEEECcCCCCCcc-Ccccc-CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCC
Confidence            455555555 666666666666653 32222 578888888888888888889999999999999999998777788899


Q ss_pred             cccceeeeeccccCCCCCcccccccCCCeeeCCCCcccCCCCcccccc------cccceEEccccccc--ccCccccccc
Q 002010          504 KMITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYGKIPPGISKL------IDLSILNLSRNGIT--GSIPNEMRNM  575 (982)
Q Consensus       504 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l------~~L~~L~Ls~N~l~--~~~p~~l~~l  575 (982)
                      ++|++|+|++|+++ .+|..+..+++|+.|++++|+|++..+..|...      ..|+.|++++|.+.  +..|..|..+
T Consensus       241 ~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l  319 (332)
T 2ft3_A          241 PTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCV  319 (332)
T ss_dssp             TTCCEEECCSSCCC-BCCTTGGGCTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSCGGGSCGGGGTTB
T ss_pred             CCCCEEECCCCcCe-ecChhhhcCccCCEEECCCCCCCccChhHccccccccccccccceEeecCcccccccCccccccc
Confidence            99999999999998 788889999999999999999997777777654      67899999999987  6788889999


Q ss_pred             cccceecccCCc
Q 002010          576 MSLTTLDLSYNN  587 (982)
Q Consensus       576 ~~L~~L~Ls~N~  587 (982)
                      ++|+.+++++|+
T Consensus       320 ~~L~~l~l~~n~  331 (332)
T 2ft3_A          320 TDRLAIQFGNYK  331 (332)
T ss_dssp             CCSTTEEC----
T ss_pred             chhhhhhccccc
Confidence            999999999885

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=100.00  E-value=4.3e-32  Score=301.30  Aligned_cols=290  Identities=23%  Similarity=0.244  Sum_probs=219.3

Q ss_pred             CccceeecccccCCCCCCccccCCCCCCEEEeeCCcccCcCchhhhcccchhhhhhccCCCCCCCCCcCCCCCCccEEEc
Q 002010          265 KLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQV  344 (982)
Q Consensus       265 ~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L  344 (982)
                      .+++.++++++.++ .+|..+.  ++|++|+|++|.+++..+..|..+++|++|+|++|++++..|..|+.+++|++|++
T Consensus        31 c~l~~l~~~~~~l~-~lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  107 (330)
T 1xku_A           31 CHLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYL  107 (330)
T ss_dssp             EETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEEC
T ss_pred             CCCeEEEecCCCcc-ccCccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEEC
Confidence            46788888888888 4565543  57888888888888777777888888888888888888777888888888888888


Q ss_pred             cCCCcccccCccccCCCcccEEEeccccccccCCccccCccccceeeccccccc--ccCCccccCCCCCCEEEccCCccC
Q 002010          345 WGNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFI--GPIPEELGQCKSLTKIRFSKNYLN  422 (982)
Q Consensus       345 ~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~l~~N~~~--~~~~~~l~~l~~L~~L~Ls~N~l~  422 (982)
                      ++|+++ .+|..+.  ++|+.|++++|++++..+..+..+++|+.|++++|.+.  +..+..+.++++|++|++++|+++
T Consensus       108 s~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~  184 (330)
T 1xku_A          108 SKNQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT  184 (330)
T ss_dssp             CSSCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC
T ss_pred             CCCcCC-ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCccc
Confidence            888877 3444433  56777777777776555555566666666666666653  244555555566666666655554


Q ss_pred             CCCCccccCCCccccccCCCccccccCCcccccCCccEEEeeccccCCCCchhccCCCCcceeeeccccccCCCcccccc
Q 002010          423 GTIPAGLFNLPLLNMMELDDNLLSGELPEKMSGASLNQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESFN  502 (982)
Q Consensus       423 ~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~  502 (982)
                       .+|..                        +. .+|++|++++|++++..|..|..+++|++|++++|++++..+..+..
T Consensus       185 -~l~~~------------------------~~-~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~  238 (330)
T 1xku_A          185 -TIPQG------------------------LP-PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLAN  238 (330)
T ss_dssp             -SCCSS------------------------CC-TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGG
T ss_pred             -cCCcc------------------------cc-ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccC
Confidence             22221                        11 57888888888888888888999999999999999998777778888


Q ss_pred             ccccceeeeeccccCCCCCcccccccCCCeeeCCCCcccCCCCcccccc------cccceEEcccccccc--cCcccccc
Q 002010          503 LKMITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYGKIPPGISKL------IDLSILNLSRNGITG--SIPNEMRN  574 (982)
Q Consensus       503 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l------~~L~~L~Ls~N~l~~--~~p~~l~~  574 (982)
                      +++|++|+|++|+++ .+|..+..+++|++|+|++|+|++..+..|+..      ..|+.|++++|.+..  ..|..|..
T Consensus       239 l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~  317 (330)
T 1xku_A          239 TPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRC  317 (330)
T ss_dssp             STTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTT
T ss_pred             CCCCCEEECCCCcCc-cCChhhccCCCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCcccccccCcccccc
Confidence            999999999999998 788889999999999999999997777777544      788999999999864  66788999


Q ss_pred             ccccceecccCCc
Q 002010          575 MMSLTTLDLSYNN  587 (982)
Q Consensus       575 l~~L~~L~Ls~N~  587 (982)
                      +.+++.++|++|+
T Consensus       318 ~~~l~~l~L~~N~  330 (330)
T 1xku_A          318 VYVRAAVQLGNYK  330 (330)
T ss_dssp             CCCGGGEEC----
T ss_pred             ccceeEEEecccC
Confidence            9999999999985

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=1.1e-33  Score=314.98  Aligned_cols=243  Identities=16%  Similarity=0.086  Sum_probs=184.4

Q ss_pred             HhhcccccccccccceEEEEEEeCCCcEEEEEEeccCCC-------CCchhhHHHHHHHHhcCC---------CCcccce
Q 002010          691 LESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGT-------GGNDHGFLAEIQTLGRIR---------HRNIVRL  754 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~E~~~l~~l~---------h~niv~~  754 (982)
                      .++|+..+.||+|+||+||+|+. +|+.||||++.....       ....+.+.+|+.++++++         ||||+++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            46799999999999999999987 789999999965532       223467889999998886         6666665


Q ss_pred             EeE-----------------EEc-------------CCccEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHH
Q 002010          755 LGY-----------------VSN-------------RDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGL  804 (982)
Q Consensus       755 ~~~-----------------~~~-------------~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l  804 (982)
                      .+.                 +.+             ....++||||+++|++.+.+.+   ..+++..+..++.||+.||
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~~aL  174 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLTASL  174 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHHHHH
Confidence            554                 332             6788999999999977666642   5689999999999999999


Q ss_pred             HHHh-hcCCCcEEecCCCCCcEEEcCCC--------------------CEEEeccccchhccccCCcccccccccccccc
Q 002010          805 CYLH-HDCSPLIIHRDVKSNNILLDSDF--------------------EAHVADFGLAKFLQDAGASECMSSVAGSYGYI  863 (982)
Q Consensus       805 ~~LH-~~~~~~ivHrDlkp~Nill~~~~--------------------~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~  863 (982)
                      +||| +.+   |+||||||+||+++.++                    .+||+|||+|+...+       ....||+.|+
T Consensus       175 ~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~~~gt~~y~  244 (336)
T 2vuw_A          175 AVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GIVVFCDVSM  244 (336)
T ss_dssp             HHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------TEEECCCCTT
T ss_pred             HHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------CcEEEeeccc
Confidence            9999 898   99999999999999887                    899999999987653       2347899999


Q ss_pred             cccccccCCCCcchhhHHHHHH-HHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceeecCCCCCCChHhHH
Q 002010          864 APEYAYTLKVDEKSDVYSFGVV-LLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDPRLSGYPLTGVI  942 (982)
Q Consensus       864 aPE~~~~~~~~~~~DvwslG~i-l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  942 (982)
                      |||++.+.. +.++||||++++ .+++++|..||............+.......             .......+...+.
T Consensus       245 aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~s~  310 (336)
T 2vuw_A          245 DEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFK-------------TKCNTPAMKQIKR  310 (336)
T ss_dssp             CSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCS-------------SCCCSHHHHHHHH
T ss_pred             ChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccC-------------cccchhhhhhcCH
Confidence            999998766 899999998777 7788889999843100000111111100000             0001112345677


Q ss_pred             HHHHHHhhccCCCCCCCCCHHHHH
Q 002010          943 HLFKVAMMCVEDESSARPTMREVV  966 (982)
Q Consensus       943 ~l~~li~~cl~~dP~~Rpt~~ell  966 (982)
                      ++.+|+.+||+.|     |++|++
T Consensus       311 ~~~dli~~~L~~d-----sa~e~l  329 (336)
T 2vuw_A          311 KIQEFHRTMLNFS-----SATDLL  329 (336)
T ss_dssp             HHHHHHHHGGGSS-----SHHHHH
T ss_pred             HHHHHHHHHhccC-----CHHHHH
Confidence            8999999999976     999988

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=99.98  E-value=8.9e-32  Score=298.90  Aligned_cols=289  Identities=21%  Similarity=0.270  Sum_probs=221.4

Q ss_pred             CCCCEEecccCcCcccCchhhcCCCccceeecccccCCCCCCccccCCCCCCEEEeeCCcccCcCchhhhcccchhhhhh
Q 002010          241 TQLQVLDMASCNISGEIPTSLSRLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQL  320 (982)
Q Consensus       241 ~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L  320 (982)
                      .+|+.++++++.++ .+|..+.  ++|++|++++|++++..+..|.++++|++|+|++|++++..|..|..+++|++|++
T Consensus        33 c~l~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  109 (332)
T 2ft3_A           33 CHLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYI  109 (332)
T ss_dssp             EETTEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEEC
T ss_pred             ccCCEEECCCCCcc-ccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEEC
Confidence            47999999999998 6676664  68999999999999888889999999999999999999888999999999999999


Q ss_pred             ccCCCCCCCCCcCCCCCCccEEEccCCCcccccCccccCCCcccEEEeccccccc--cCCccccCccccceeeccccccc
Q 002010          321 FKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTG--TIPRDLCKGGKLKSLILMQNFFI  398 (982)
Q Consensus       321 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~--~~p~~~~~~~~L~~L~l~~N~~~  398 (982)
                      ++|+++ .+|..+.  ++|++|++++|.++...+..+..+++|+.|++++|.++.  ..|..+..+ +|++|++++|.+.
T Consensus       110 ~~n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~  185 (332)
T 2ft3_A          110 SKNHLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLT  185 (332)
T ss_dssp             CSSCCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCS
T ss_pred             CCCcCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCC
Confidence            999999 5565554  789999999999997777778888999999999998863  555555555 6666666666655


Q ss_pred             ccCCccccCCCCCCEEEccCCccCCCCCccccCCCccccccCCCccccccCCcccccCCccEEEeeccccCCCCchhccC
Q 002010          399 GPIPEELGQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLSGELPEKMSGASLNQLKVANNNITGKIPAAIGN  478 (982)
Q Consensus       399 ~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~L~~N~i~~~~p~~~~~  478 (982)
                      + +|..+.  ++|++|++++|++++..+..+..+++                       |+.|++++|++++..+..+..
T Consensus       186 ~-l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~-----------------------L~~L~L~~N~l~~~~~~~~~~  239 (332)
T 2ft3_A          186 G-IPKDLP--ETLNELHLDHNKIQAIELEDLLRYSK-----------------------LYRLGLGHNQIRMIENGSLSF  239 (332)
T ss_dssp             S-CCSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTT-----------------------CSCCBCCSSCCCCCCTTGGGG
T ss_pred             c-cCcccc--CCCCEEECCCCcCCccCHHHhcCCCC-----------------------CCEEECCCCcCCcCChhHhhC
Confidence            4 333322  45556666666665554455555544                       555555555555556667777


Q ss_pred             CCCcceeeeccccccCCCccccccccccceeeeeccccCCCCCccccc------ccCCCeeeCCCCccc--CCCCccccc
Q 002010          479 LPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIPYSISQ------CHSLTSVDLSRNSLY--GKIPPGISK  550 (982)
Q Consensus       479 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~------l~~L~~L~Ls~N~l~--~~~p~~~~~  550 (982)
                      +++|++|++++|+++ .+|..+..+++|++|++++|+|++..+..|..      ...|+.|++++|.+.  +..|..|..
T Consensus       240 l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~  318 (332)
T 2ft3_A          240 LPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRC  318 (332)
T ss_dssp             CTTCCEEECCSSCCC-BCCTTGGGCTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSCGGGSCGGGGTT
T ss_pred             CCCCCEEECCCCcCe-ecChhhhcCccCCEEECCCCCCCccChhHccccccccccccccceEeecCcccccccCcccccc
Confidence            788888888888887 67777778888888888888888766666654      367889999999887  677788999


Q ss_pred             ccccceEEccccc
Q 002010          551 LIDLSILNLSRNG  563 (982)
Q Consensus       551 l~~L~~L~Ls~N~  563 (982)
                      +++|+.|+|++|+
T Consensus       319 l~~L~~l~l~~n~  331 (332)
T 2ft3_A          319 VTDRLAIQFGNYK  331 (332)
T ss_dssp             BCCSTTEEC----
T ss_pred             cchhhhhhccccc
Confidence            9999999998885

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=99.98  E-value=2e-31  Score=295.95  Aligned_cols=292  Identities=24%  Similarity=0.258  Sum_probs=236.0

Q ss_pred             CCCCCCEEecccCcCcccCchhhcCCCccceeecccccCCCCCCccccCCCCCCEEEeeCCcccCcCchhhhcccchhhh
Q 002010          239 ALTQLQVLDMASCNISGEIPTSLSRLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLL  318 (982)
Q Consensus       239 ~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L  318 (982)
                      ...+++.++++++.++ .+|..+.  ++|+.|++++|++++..+..|.++++|++|+|++|.+++..|..|..+++|++|
T Consensus        29 c~c~l~~l~~~~~~l~-~lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L  105 (330)
T 1xku_A           29 CQCHLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERL  105 (330)
T ss_dssp             CEEETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEE
T ss_pred             CcCCCeEEEecCCCcc-ccCccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEE
Confidence            3458999999999998 5666554  689999999999998888889999999999999999998889999999999999


Q ss_pred             hhccCCCCCCCCCcCCCCCCccEEEccCCCcccccCccccCCCcccEEEeccccccc--cCCccccCccccceeeccccc
Q 002010          319 QLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTG--TIPRDLCKGGKLKSLILMQNF  396 (982)
Q Consensus       319 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~--~~p~~~~~~~~L~~L~l~~N~  396 (982)
                      ++++|+++ .+|..+.  ++|++|++++|.++...+..+..+++|++|++++|.++.  ..+..+..+++|++|++++|.
T Consensus       106 ~Ls~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~  182 (330)
T 1xku_A          106 YLSKNQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTN  182 (330)
T ss_dssp             ECCSSCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSC
T ss_pred             ECCCCcCC-ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCc
Confidence            99999999 4565554  799999999999998888889999999999999999964  778889999999999999999


Q ss_pred             ccccCCccccCCCCCCEEEccCCccCCCCCccccCCCccccccCCCccccccCCcccccCCccEEEeeccccCCCCchhc
Q 002010          397 FIGPIPEELGQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLSGELPEKMSGASLNQLKVANNNITGKIPAAI  476 (982)
Q Consensus       397 ~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~L~~N~i~~~~p~~~  476 (982)
                      +.. +|..+.  ++|++|++++|++++..|..+..+++|+.|++++|.++                       +..+..+
T Consensus       183 l~~-l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~-----------------------~~~~~~~  236 (330)
T 1xku_A          183 ITT-IPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSIS-----------------------AVDNGSL  236 (330)
T ss_dssp             CCS-CCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCC-----------------------EECTTTG
T ss_pred             ccc-CCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCc-----------------------eeChhhc
Confidence            885 455443  79999999999999877777877766665555555554                       4444566


Q ss_pred             cCCCCcceeeeccccccCCCccccccccccceeeeeccccCCCCCccccc------ccCCCeeeCCCCcccC--CCCccc
Q 002010          477 GNLPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIPYSISQ------CHSLTSVDLSRNSLYG--KIPPGI  548 (982)
Q Consensus       477 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~------l~~L~~L~Ls~N~l~~--~~p~~~  548 (982)
                      ..+++|++|++++|+++ .+|..+..+++|++|++++|+|++..+..|..      ...|+.|++++|.+..  ..|..|
T Consensus       237 ~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~~~i~~~~f  315 (330)
T 1xku_A          237 ANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTF  315 (330)
T ss_dssp             GGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGG
T ss_pred             cCCCCCCEEECCCCcCc-cCChhhccCCCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCcccccccCcccc
Confidence            66777777777777776 66666777777777777777777666655543      3678889999998853  556788


Q ss_pred             ccccccceEEccccc
Q 002010          549 SKLIDLSILNLSRNG  563 (982)
Q Consensus       549 ~~l~~L~~L~Ls~N~  563 (982)
                      ..+.+|+.++|++|+
T Consensus       316 ~~~~~l~~l~L~~N~  330 (330)
T 1xku_A          316 RCVYVRAAVQLGNYK  330 (330)
T ss_dssp             TTCCCGGGEEC----
T ss_pred             ccccceeEEEecccC
Confidence            889999999999885

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=99.98  E-value=1.8e-35  Score=344.87  Aligned_cols=263  Identities=19%  Similarity=0.187  Sum_probs=177.5

Q ss_pred             cccccEEEeccCCCCCCCChh-hhhhcccceeeccCCccccc---cchhhhhcCCCccEEeccCccccCCCchhcc-ccc
Q 002010           94 LTKLVNLTISNVNLTGRLPSE-MALLTSLKVFNISGNVFQGN---FAGQIVRGMTELQVLDAYNNNFTGPLPVEIA-SLK  168 (982)
Q Consensus        94 l~~L~~L~l~~n~l~~~~p~~-l~~l~~L~~L~Ls~n~l~~~---~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~l~-~l~  168 (982)
                      +++|++|+|++|+++...... +..+++|++|+|++|.+.+.   ....++..+++|++|+|++|.+++..+..+. .++
T Consensus         2 ~~~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~   81 (461)
T 1z7x_W            2 SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQ   81 (461)
T ss_dssp             CEEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTC
T ss_pred             CccceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHh
Confidence            357889999999887654433 77888999999999988753   2234566788899999999888765555544 355


Q ss_pred             ----cccEEeecCccccc----ccCCCccccCcceEeeccCcccccchhhHHhhhhhHHHHhhcccccccccCCCCCCCC
Q 002010          169 ----SLRHLSFGGNYFTG----KIPQSYSEIQSLEYIGLNGIGLNGTVPAFLSRLKNLREMYIGYFNTYTGGIPPGFGAL  240 (982)
Q Consensus       169 ----~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~l~~~n~~~~~~p~~~~~l  240 (982)
                          +|++|+|++|+++.    .++..+..+++|++|++++|.+.+..+..+...                    .....
T Consensus        82 ~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~--------------------l~~~~  141 (461)
T 1z7x_W           82 TPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEG--------------------LLDPQ  141 (461)
T ss_dssp             STTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHH--------------------HTSTT
T ss_pred             hCCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHH--------------------HhcCC
Confidence                68889998888884    457778888888888888888765544443321                    02234


Q ss_pred             CCCCEEecccCcCcccC----chhhcCCCccceeecccccCCCCCCcccc-----CCCCCCEEEeeCCcccCc----Cch
Q 002010          241 TQLQVLDMASCNISGEI----PTSLSRLKLLHSLFLQMNKLTGHIPPQLS-----GLISLKSLDLSLNYLTGE----IPE  307 (982)
Q Consensus       241 ~~L~~L~L~~n~l~~~~----~~~l~~l~~L~~L~L~~N~l~~~~~~~l~-----~l~~L~~L~Ls~N~l~~~----~~~  307 (982)
                      ++|++|++++|++++..    +..+..+++|++|++++|.++...+..+.     ..++|++|++++|.+++.    ++.
T Consensus       142 ~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~  221 (461)
T 1z7x_W          142 CRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCG  221 (461)
T ss_dssp             CCCCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHH
T ss_pred             CcceEEECCCCCCCHHHHHHHHHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHH
Confidence            57888888888887643    45566678888888888887754444443     255788888888877753    355


Q ss_pred             hhhcccchhhhhhccCCCCCCC-----CCcCCCCCCccEEEccCCCcccc----cCccccCCCcccEEEecccccccc
Q 002010          308 SFAALKNLTLLQLFKNNLRGPI-----PSFLGDFPNLEVLQVWGNNFTFE----LPENLGRNGKLLILDVTSNHLTGT  376 (982)
Q Consensus       308 ~l~~l~~L~~L~L~~N~l~~~~-----p~~~~~l~~L~~L~L~~N~l~~~----~~~~l~~l~~L~~L~L~~N~l~~~  376 (982)
                      .+..+++|++|++++|.+++..     +..+..+++|++|++++|.++..    ++..+..+++|++|++++|.+++.
T Consensus       222 ~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~  299 (461)
T 1z7x_W          222 IVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDE  299 (461)
T ss_dssp             HHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHH
T ss_pred             HHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchH
Confidence            5666677777777777666432     22233466667777766666643    344455566666666666665543

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=99.97  E-value=1.6e-35  Score=345.50  Aligned_cols=363  Identities=20%  Similarity=0.183  Sum_probs=191.5

Q ss_pred             CCccEEeccCccccCCCchh-ccccccccEEeecCcccccc----cCCCccccCcceEeeccCcccccchhhHHhhhhhH
Q 002010          144 TELQVLDAYNNNFTGPLPVE-IASLKSLRHLSFGGNYFTGK----IPQSYSEIQSLEYIGLNGIGLNGTVPAFLSRLKNL  218 (982)
Q Consensus       144 ~~L~~L~Ls~n~l~~~~p~~-l~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L  218 (982)
                      ++|++|||++|+++...... +..+++|++|+|++|++++.    ++..+..+++|++|++++|.+.+..+..+...   
T Consensus         3 ~~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~---   79 (461)
T 1z7x_W            3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQG---   79 (461)
T ss_dssp             EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHT---
T ss_pred             ccceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHH---
Confidence            56888999998887544333 77888899999999988753    45566677888888888877765444333210   


Q ss_pred             HHHhhcccccccccCCCCCCC-CCCCCEEecccCcCcc----cCchhhcCCCccceeecccccCCCCCCcccc-----CC
Q 002010          219 REMYIGYFNTYTGGIPPGFGA-LTQLQVLDMASCNISG----EIPTSLSRLKLLHSLFLQMNKLTGHIPPQLS-----GL  288 (982)
Q Consensus       219 ~~L~l~~~n~~~~~~p~~~~~-l~~L~~L~L~~n~l~~----~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~-----~l  288 (982)
                                        +.. .++|++|+|++|+++.    .++..+..+++|++|++++|.+++..+..+.     ..
T Consensus        80 ------------------l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~  141 (461)
T 1z7x_W           80 ------------------LQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQ  141 (461)
T ss_dssp             ------------------TCSTTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTT
T ss_pred             ------------------HhhCCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCC
Confidence                              111 1267888888888774    4466777777788888877777654333322     24


Q ss_pred             CCCCEEEeeCCcccCcC----chhhhcccchhhhhhccCCCCCCCCCcCC-----CCCCccEEEccCCCcccc----cCc
Q 002010          289 ISLKSLDLSLNYLTGEI----PESFAALKNLTLLQLFKNNLRGPIPSFLG-----DFPNLEVLQVWGNNFTFE----LPE  355 (982)
Q Consensus       289 ~~L~~L~Ls~N~l~~~~----~~~l~~l~~L~~L~L~~N~l~~~~p~~~~-----~l~~L~~L~L~~N~l~~~----~~~  355 (982)
                      ++|++|+|++|++++..    +..+..+++|++|++++|.+++..+..+.     ..++|++|++++|.++..    ++.
T Consensus       142 ~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~  221 (461)
T 1z7x_W          142 CRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCG  221 (461)
T ss_dssp             CCCCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHH
T ss_pred             CcceEEECCCCCCCHHHHHHHHHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHH
Confidence            56777777777776533    33444455666666666655543222222     134555555555555532    233


Q ss_pred             cccCCCcccEEEeccccccccCCccccCccccceeecccccccccCCccccCCCCCCEEEccCCccCCC----CCccccC
Q 002010          356 NLGRNGKLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGT----IPAGLFN  431 (982)
Q Consensus       356 ~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~l~~N~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~----~p~~~~~  431 (982)
                      .+..+++|+.|++++|++++.....++                   +..+..+++|++|++++|++++.    ++..+..
T Consensus       222 ~l~~~~~L~~L~Ls~n~l~~~~~~~l~-------------------~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~  282 (461)
T 1z7x_W          222 IVASKASLRELALGSNKLGDVGMAELC-------------------PGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRA  282 (461)
T ss_dssp             HHHHCTTCCEEECCSSBCHHHHHHHHH-------------------HHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHH
T ss_pred             HHHhCCCccEEeccCCcCChHHHHHHH-------------------HHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhh
Confidence            444445555555555544432111000                   11122345555555555555432    3333334


Q ss_pred             CCccccccCCCccccccCCcccc------cCCccEEEeeccccCCC----CchhccCCCCcceeeeccccccCCCccccc
Q 002010          432 LPLLNMMELDDNLLSGELPEKMS------GASLNQLKVANNNITGK----IPAAIGNLPSLNILSLQNNRLEGEIPVESF  501 (982)
Q Consensus       432 l~~L~~L~L~~N~l~~~~~~~~~------~~~L~~L~L~~N~i~~~----~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~  501 (982)
                      +++|++|++++|.+++..+..+.      .++|++|++++|.+++.    ++..+..+++|++|++++|++++..+..+.
T Consensus       283 ~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~  362 (461)
T 1z7x_W          283 KESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELC  362 (461)
T ss_dssp             CTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHH
T ss_pred             CCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHH
Confidence            44444444444444322111111      02444555555554433    233444445555555555554433222222


Q ss_pred             cccccceeeeeccccCCCCCcccc-cccCCCeeeCCCCcccC----CCCcccccccccceEEcccccccc
Q 002010          502 NLKMITSINISDNNISGEIPYSIS-QCHSLTSVDLSRNSLYG----KIPPGISKLIDLSILNLSRNGITG  566 (982)
Q Consensus       502 ~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~  566 (982)
                      .                    .+. ..++|+.|+|++|.+++    .+|..+..+++|++|+|++|++++
T Consensus       363 ~--------------------~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~~  412 (461)
T 1z7x_W          363 Q--------------------GLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGD  412 (461)
T ss_dssp             H--------------------HHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCH
T ss_pred             H--------------------HHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCccEEECCCCCCCH
Confidence            1                    000 03455555555555553    445555555555555555555553

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=99.96  E-value=3.1e-32  Score=328.18  Aligned_cols=401  Identities=17%  Similarity=0.104  Sum_probs=205.2

Q ss_pred             ccccccEEEeccCCCCCCCChhhhhh--cccceeeccCCc-cccccchhhhhcCCCccEEeccCccccCC----Cchhcc
Q 002010           93 LLTKLVNLTISNVNLTGRLPSEMALL--TSLKVFNISGNV-FQGNFAGQIVRGMTELQVLDAYNNNFTGP----LPVEIA  165 (982)
Q Consensus        93 ~l~~L~~L~l~~n~l~~~~p~~l~~l--~~L~~L~Ls~n~-l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~----~p~~l~  165 (982)
                      .+++|++|+|++|.+++..+..+...  .+|++|+|++|. +.......+..++++|++|+|++|.+++.    ++..+.
T Consensus       110 ~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~  189 (592)
T 3ogk_B          110 NLRQLKSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQ  189 (592)
T ss_dssp             HCTTCCEEEEESCBCCHHHHHHHHHHHGGGCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHH
T ss_pred             hCCCCCeEEeeccEecHHHHHHHHHhccccCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHh
Confidence            45666666666666665555555553  336666666665 22111223334566666666666666554    333445


Q ss_pred             ccccccEEeecCcccc----cccCCCccccCcceEeeccCcccccchhhHHhhhhhHHHHhhccccccc--ccCCCCCCC
Q 002010          166 SLKSLRHLSFGGNYFT----GKIPQSYSEIQSLEYIGLNGIGLNGTVPAFLSRLKNLREMYIGYFNTYT--GGIPPGFGA  239 (982)
Q Consensus       166 ~l~~L~~L~L~~N~l~----~~~p~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~l~~~n~~~--~~~p~~~~~  239 (982)
                      .+++|++|+|++|.++    +.++..+.++++|++|++++|.+.+ ++..+.++++|++|.++.++...  +..+..+..
T Consensus       190 ~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~  268 (592)
T 3ogk_B          190 HNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVF  268 (592)
T ss_dssp             HCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCC
T ss_pred             cCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccccccccchHHHHHHhhc
Confidence            5666666666666665    2334444556666666666666654 45666666666666665422211  223344556


Q ss_pred             CCCCCEEecccCcCcccCchhhcCCCccceeecccccCCCCCC-ccccCCCCCCEEEeeCCcccCcCchhhhcccchhhh
Q 002010          240 LTQLQVLDMASCNISGEIPTSLSRLKLLHSLFLQMNKLTGHIP-PQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLL  318 (982)
Q Consensus       240 l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~-~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L  318 (982)
                      +++|+.|+++++... .+|..+..+++|++|+|++|.+++... ..+..+++|++|+++++...+.++..+..+++|++|
T Consensus       269 ~~~L~~L~l~~~~~~-~l~~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~~~~~l~~~~~~~~~L~~L  347 (592)
T 3ogk_B          269 PRKLCRLGLSYMGPN-EMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEVLAQYCKQLKRL  347 (592)
T ss_dssp             CTTCCEEEETTCCTT-TGGGGGGGGGGCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEEGGGHHHHHHHHHHHCTTCCEE
T ss_pred             cccccccCccccchh-HHHHHHhhcCCCcEEecCCCcCCHHHHHHHHHhCcCCCEEeccCccCHHHHHHHHHhCCCCCEE
Confidence            666666666654322 445555666666666666666543322 224556666666666322222223333445556666


Q ss_pred             hhc-----------cCCCCCCC-CCcCCCCCCccEEEccCCCcccccCccccC-CCcccEEEec----cccccccCCccc
Q 002010          319 QLF-----------KNNLRGPI-PSFLGDFPNLEVLQVWGNNFTFELPENLGR-NGKLLILDVT----SNHLTGTIPRDL  381 (982)
Q Consensus       319 ~L~-----------~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~-l~~L~~L~L~----~N~l~~~~p~~~  381 (982)
                      +++           .|.+++.. +..+..+++|++|+++.|.+++..+..++. +++|+.|+++    .|.+++..... 
T Consensus       348 ~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~-  426 (592)
T 3ogk_B          348 RIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDN-  426 (592)
T ss_dssp             EEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHH-
T ss_pred             EeecCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHH-
Confidence            665           23333221 111233455555555555555444444433 4555555553    34444320000 


Q ss_pred             cCccccceeecccccccccCCccccCCCCCCEEEccCCc--cCCCCCcccc-CCCccccccCCCcccccc-CCcccc-cC
Q 002010          382 CKGGKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNY--LNGTIPAGLF-NLPLLNMMELDDNLLSGE-LPEKMS-GA  456 (982)
Q Consensus       382 ~~~~~L~~L~l~~N~~~~~~~~~l~~l~~L~~L~Ls~N~--l~~~~p~~~~-~l~~L~~L~L~~N~l~~~-~~~~~~-~~  456 (982)
                                        .++..+.++++|++|++++|.  +++..+..+. .+++|++|++++|.+++. ++..+. .+
T Consensus       427 ------------------~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~  488 (592)
T 3ogk_B          427 ------------------GVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCP  488 (592)
T ss_dssp             ------------------HHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCT
T ss_pred             ------------------HHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCc
Confidence                              022223445555555554322  3333332222 244555555555555432 122212 25


Q ss_pred             CccEEEeeccccCCC-CchhccCCCCcceeeeccccccCCCcccc-ccccccceeeeecc
Q 002010          457 SLNQLKVANNNITGK-IPAAIGNLPSLNILSLQNNRLEGEIPVES-FNLKMITSINISDN  514 (982)
Q Consensus       457 ~L~~L~L~~N~i~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~L~Ls~N  514 (982)
                      +|++|++++|.+++. ++..+..+++|++|+|++|++++.....+ ..++.+....+..+
T Consensus       489 ~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~it~~~~~~l~~~~p~l~~~~~~~~  548 (592)
T 3ogk_B          489 NLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASMTGQDLMQMARPYWNIELIPSR  548 (592)
T ss_dssp             TCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBCCTTCTTGGGGCCTTEEEEEECCC
T ss_pred             ccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCcCCHHHHHHHHHhCCCcEEEEecCc
Confidence            677777777777644 33444567888888888888775422222 24555555555443

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=99.96  E-value=4.1e-30  Score=282.11  Aligned_cols=256  Identities=23%  Similarity=0.302  Sum_probs=166.6

Q ss_pred             CCCCCccceeeeCCCCCEEEEEeccCCccccCCcCccccccccEEEeccCCCCCCCChhhhhhcccceeeccCCcccccc
Q 002010           56 PSAHCSFSGVTCDQDSRVVSLNVSFMPLFGSIPPEIGLLTKLVNLTISNVNLTGRLPSEMALLTSLKVFNISGNVFQGNF  135 (982)
Q Consensus        56 ~~~~C~w~gv~C~~~~~v~~l~l~~~~l~g~~~~~i~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~  135 (982)
                      ..|.|.|.+|.|+..+            ...+|..+.  ++|++|+|++|+++...+..+..+++|++|+|++|.+....
T Consensus         3 ~~C~C~~~~l~c~~~~------------l~~ip~~~~--~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~   68 (306)
T 2z66_A            3 SRCSCSGTEIRCNSKG------------LTSVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKG   68 (306)
T ss_dssp             TTCEEETTEEECCSSC------------CSSCCSCCC--TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEE
T ss_pred             CCCeeCCCEEEcCCCC------------cccCCCCCC--CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCccc
Confidence            3566999999998643            224555443  68999999999998544455788999999999999886331


Q ss_pred             -chhhhhcCCCccEEeccCccccCCCchhccccccccEEeecCcccccccC-CCccccCcceEeeccCcccccchhhHHh
Q 002010          136 -AGQIVRGMTELQVLDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIP-QSYSEIQSLEYIGLNGIGLNGTVPAFLS  213 (982)
Q Consensus       136 -~~~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~n~i~~~~~~~l~  213 (982)
                       ....+.++++|++|+|++|.++ .+|..+..+++|++|++++|++++..+ ..+..+++|++|++++|.+.+       
T Consensus        69 ~~~~~~~~~~~L~~L~Ls~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~-------  140 (306)
T 2z66_A           69 CCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRV-------  140 (306)
T ss_dssp             EEEHHHHSCSCCCEEECCSCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEE-------
T ss_pred             CcccccccccccCEEECCCCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCc-------
Confidence             1233446888888888888887 467778888888888888888875554 456666666666666554432       


Q ss_pred             hhhhHHHHhhcccccccccCCCCCCCCCCCCEEecccCcCcc-cCchhhcCCCccceeecccccCCCCCCccccCCCCCC
Q 002010          214 RLKNLREMYIGYFNTYTGGIPPGFGALTQLQVLDMASCNISG-EIPTSLSRLKLLHSLFLQMNKLTGHIPPQLSGLISLK  292 (982)
Q Consensus       214 ~l~~L~~L~l~~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~-~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~  292 (982)
                                        ..+..++.+++|++|++++|.+++ ..|..+..+++|++|++++|++++..|..+..+++|+
T Consensus       141 ------------------~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~  202 (306)
T 2z66_A          141 ------------------AFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQ  202 (306)
T ss_dssp             ------------------CSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCC
T ss_pred             ------------------cchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCC
Confidence                              223345555666666666666654 3555566666666666666666655555566666666


Q ss_pred             EEEeeCCcccCcCchhhhcccchhhhhhccCCCCCCCCCcCCCCC-CccEEEccCCCccc
Q 002010          293 SLDLSLNYLTGEIPESFAALKNLTLLQLFKNNLRGPIPSFLGDFP-NLEVLQVWGNNFTF  351 (982)
Q Consensus       293 ~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~L~~N~l~~  351 (982)
                      +|+|++|++++..+..+..+++|++|++++|++++..|..+..++ +|++|++++|++++
T Consensus       203 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~  262 (306)
T 2z66_A          203 VLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFAC  262 (306)
T ss_dssp             EEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEEC
T ss_pred             EEECCCCccCccChhhccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeec
Confidence            666666666655454555555666666666666555555555553 55555555555553

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=99.96  E-value=5.1e-32  Score=326.35  Aligned_cols=408  Identities=14%  Similarity=0.038  Sum_probs=254.2

Q ss_pred             cchhhhhcCCCccEEeccCccc---cCCCchhcc------------ccccccEEeecCcccccccCCCcccc--CcceEe
Q 002010          135 FAGQIVRGMTELQVLDAYNNNF---TGPLPVEIA------------SLKSLRHLSFGGNYFTGKIPQSYSEI--QSLEYI  197 (982)
Q Consensus       135 ~~~~~~~~l~~L~~L~Ls~n~l---~~~~p~~l~------------~l~~L~~L~L~~N~l~~~~p~~~~~l--~~L~~L  197 (982)
                      .+..++..+++|++|+|+++..   .+.+|..++            .+++|++|+|++|.+++..+..++..  ++|++|
T Consensus        64 ~~~~~~~~~~~L~~L~L~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~L~~L  143 (592)
T 3ogk_B           64 TPDRLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLKSVHFRRMIVSDLDLDRLAKARADDLETL  143 (592)
T ss_dssp             CHHHHHHHCTTCSEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHHHHHHHGGGCCEE
T ss_pred             ChHHHHHhCCCCeEEEecCCcchhhcccccccccccchHHHHHHHhhCCCCCeEEeeccEecHHHHHHHHHhccccCcEE
Confidence            4567788899999999987532   123333332            67788888888888877777666663  448888


Q ss_pred             eccCcccccchhhHHhhhhhHHHHhhcccccccccCCCCCCCCCCCCEEecccCcCccc----CchhhcCCCccceeecc
Q 002010          198 GLNGIGLNGTVPAFLSRLKNLREMYIGYFNTYTGGIPPGFGALTQLQVLDMASCNISGE----IPTSLSRLKLLHSLFLQ  273 (982)
Q Consensus       198 ~L~~n~i~~~~~~~l~~l~~L~~L~l~~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~----~~~~l~~l~~L~~L~L~  273 (982)
                      +|++|.-  ..+..+.                     ..+.++++|++|+|++|.+++.    ++..+..+++|++|+++
T Consensus       144 ~L~~~~~--~~~~~l~---------------------~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~  200 (592)
T 3ogk_B          144 KLDKCSG--FTTDGLL---------------------SIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFY  200 (592)
T ss_dssp             EEESCEE--EEHHHHH---------------------HHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECT
T ss_pred             ECcCCCC--cCHHHHH---------------------HHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEee
Confidence            8877651  1111111                     1123467889999999988766    33456778899999999


Q ss_pred             cccCCCC----CCccccCCCCCCEEEeeCCcccCcCchhhhcccchhhhhhccCCCC---CCCCCcCCCCCCccEEEccC
Q 002010          274 MNKLTGH----IPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQLFKNNLR---GPIPSFLGDFPNLEVLQVWG  346 (982)
Q Consensus       274 ~N~l~~~----~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~---~~~p~~~~~l~~L~~L~L~~  346 (982)
                      +|++++.    ++..+..+++|++|++++|.+.+ ++..+..+++|+.|+++.+...   +..+..+..+++|+.|++++
T Consensus       201 ~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~  279 (592)
T 3ogk_B          201 MTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSY  279 (592)
T ss_dssp             TCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETT
T ss_pred             ccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccccccccchHHHHHHhhccccccccCccc
Confidence            9988733    34445678899999999998885 6788888899999998864333   23445677888999999888


Q ss_pred             CCcccccCccccCCCcccEEEeccccccccCC-ccccCccccceeecccccccccCCccccCCCCCCEEEccC-------
Q 002010          347 NNFTFELPENLGRNGKLLILDVTSNHLTGTIP-RDLCKGGKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSK-------  418 (982)
Q Consensus       347 N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p-~~~~~~~~L~~L~l~~N~~~~~~~~~l~~l~~L~~L~Ls~-------  418 (982)
                      +... .+|..+..+++|++|++++|.+++... ..+..+++|+.|+++++...+.++.....+++|++|++++       
T Consensus       280 ~~~~-~l~~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~~~~~l~~~~~~~~~L~~L~L~~g~~~~~~  358 (592)
T 3ogk_B          280 MGPN-EMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEVLAQYCKQLKRLRIERGADEQGM  358 (592)
T ss_dssp             CCTT-TGGGGGGGGGGCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEEGGGHHHHHHHHHHHCTTCCEEEEECCCCSSTT
T ss_pred             cchh-HHHHHHhhcCCCcEEecCCCcCCHHHHHHHHHhCcCCCEEeccCccCHHHHHHHHHhCCCCCEEEeecCcccccc
Confidence            6433 567777888899999999988765444 3356788888888884433334444556788888888883       


Q ss_pred             ----CccCCCCC-ccccCCCccccccCCCccccccCCcccc--cCCccEEEee----ccccCCC-----CchhccCCCCc
Q 002010          419 ----NYLNGTIP-AGLFNLPLLNMMELDDNLLSGELPEKMS--GASLNQLKVA----NNNITGK-----IPAAIGNLPSL  482 (982)
Q Consensus       419 ----N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~~~~~~--~~~L~~L~L~----~N~i~~~-----~p~~~~~l~~L  482 (982)
                          |.+++... .....+++|++|+++.|.+++..+..+.  .++|+.|+++    .|++++.     ++..+.++++|
T Consensus       359 ~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L  438 (592)
T 3ogk_B          359 EDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKL  438 (592)
T ss_dssp             SSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTC
T ss_pred             ccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCC
Confidence                55553211 1123355666666655555544333322  2456666664    4455542     23334455666


Q ss_pred             ceeeeccc--cccCCCcccccc-ccccceeeeeccccCC-CCCcccccccCCCeeeCCCCcccCCC-CcccccccccceE
Q 002010          483 NILSLQNN--RLEGEIPVESFN-LKMITSINISDNNISG-EIPYSISQCHSLTSVDLSRNSLYGKI-PPGISKLIDLSIL  557 (982)
Q Consensus       483 ~~L~L~~N--~l~~~~p~~~~~-l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L  557 (982)
                      +.|+++++  .+++..+..+.. +++|++|+|++|++++ .++..+.++++|+.|+|++|.+++.. +..+..+++|+.|
T Consensus       439 ~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L  518 (592)
T 3ogk_B          439 RRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYL  518 (592)
T ss_dssp             CEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEE
T ss_pred             CEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCee
Confidence            66666532  244333333322 5556666666666554 22333455556666666666654332 2333455566666


Q ss_pred             Eccccccccc
Q 002010          558 NLSRNGITGS  567 (982)
Q Consensus       558 ~Ls~N~l~~~  567 (982)
                      +|++|++++.
T Consensus       519 ~ls~n~it~~  528 (592)
T 3ogk_B          519 WVQGYRASMT  528 (592)
T ss_dssp             EEESCBCCTT
T ss_pred             ECcCCcCCHH
Confidence            6666665543

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=99.96  E-value=4e-29  Score=280.05  Aligned_cols=279  Identities=16%  Similarity=0.135  Sum_probs=179.7

Q ss_pred             CCCCCEEEeeCCcccCcCchhhhcccchhhhhhccCCCCCCCCCcCCCCCCccEEEccCCCcccccCccccCCCcccEEE
Q 002010          288 LISLKSLDLSLNYLTGEIPESFAALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILD  367 (982)
Q Consensus       288 l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~  367 (982)
                      ++.....++++|.++ .+|..+.  ++|++|++++|++++..+..|..+++|++|++++|.+++..+..+..+++|++|+
T Consensus        30 C~~~~~c~~~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  106 (353)
T 2z80_A           30 CDRNGICKGSSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLD  106 (353)
T ss_dssp             ECTTSEEECCSTTCS-SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEE
T ss_pred             CCCCeEeeCCCCCcc-ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEE
Confidence            344455677777777 4554443  3666677777776655555666666677776666666665556666666666666


Q ss_pred             eccccccccCCccccCccccceeecccccccccCC-ccccCCCCCCEEEccCCc-cCCCCCccccCCCccccccCCCccc
Q 002010          368 VTSNHLTGTIPRDLCKGGKLKSLILMQNFFIGPIP-EELGQCKSLTKIRFSKNY-LNGTIPAGLFNLPLLNMMELDDNLL  445 (982)
Q Consensus       368 L~~N~l~~~~p~~~~~~~~L~~L~l~~N~~~~~~~-~~l~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~L~~N~l  445 (982)
                      +++|++++..+..+..+++|++|++++|.+.+..+ ..+..+++|++|++++|. +++..+..+..+             
T Consensus       107 Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l-------------  173 (353)
T 2z80_A          107 LSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGL-------------  173 (353)
T ss_dssp             CCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTC-------------
T ss_pred             CCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCC-------------
Confidence            66666664333335555555555555555543333 345555555555555552 332223333333             


Q ss_pred             cccCCcccccCCccEEEeeccccCCCCchhccCCCCcceeeeccccccCCCccc-cccccccceeeeeccccCCCCCccc
Q 002010          446 SGELPEKMSGASLNQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVE-SFNLKMITSINISDNNISGEIPYSI  524 (982)
Q Consensus       446 ~~~~~~~~~~~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~-~~~l~~L~~L~Ls~N~l~~~~p~~~  524 (982)
                                .+|++|++++|++++..|..++.+++|++|++++|+++ .+|.. +..+++|++|++++|++++..+..+
T Consensus       174 ----------~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~-~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l  242 (353)
T 2z80_A          174 ----------TFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDTFHFSEL  242 (353)
T ss_dssp             ----------CEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCST-THHHHHHHHTTTEEEEEEESCBCTTCCCC--
T ss_pred             ----------CCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccc-cchhhhhhhcccccEEECCCCcccccccccc
Confidence                      45677777777777777777777888888888888876 34443 3357788888888888876555443


Q ss_pred             c---cccCCCeeeCCCCcccC----CCCcccccccccceEEcccccccccCccc-cccccccceecccCCccccCCCC
Q 002010          525 S---QCHSLTSVDLSRNSLYG----KIPPGISKLIDLSILNLSRNGITGSIPNE-MRNMMSLTTLDLSYNNLIGNIPS  594 (982)
Q Consensus       525 ~---~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~-l~~l~~L~~L~Ls~N~l~~~ip~  594 (982)
                      .   ....++.++|++|.+++    .+|..+..+++|+.|+|++|+|+ .+|.. |..+++|++|+|++|++++..|.
T Consensus       243 ~~~~~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~-~i~~~~~~~l~~L~~L~L~~N~~~~~~~~  319 (353)
T 2z80_A          243 STGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSCPR  319 (353)
T ss_dssp             ----CCCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCBCCCHHH
T ss_pred             ccccccchhhccccccccccCcchhhhHHHHhcccCCCEEECCCCCCC-ccCHHHHhcCCCCCEEEeeCCCccCcCCC
Confidence            3   35667777777777765    46777888889999999999998 45544 58889999999999999888764

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=99.95  E-value=4.6e-28  Score=279.90  Aligned_cols=252  Identities=23%  Similarity=0.326  Sum_probs=157.5

Q ss_pred             CCCc--cceeeeCCCCCEEEEEeccCCccccCCcCccccccccEEEeccCCCCCCCChhhhhhcccceeeccCCcccccc
Q 002010           58 AHCS--FSGVTCDQDSRVVSLNVSFMPLFGSIPPEIGLLTKLVNLTISNVNLTGRLPSEMALLTSLKVFNISGNVFQGNF  135 (982)
Q Consensus        58 ~~C~--w~gv~C~~~~~v~~l~l~~~~l~g~~~~~i~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~  135 (982)
                      |.|.  |..|.|...+            ...+|..+.  ++++.|+|++|++++..+..|.++++|++|+|++|.+.+ +
T Consensus        39 C~C~~~~~~v~c~~~~------------l~~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~-i  103 (440)
T 3zyj_A           39 CSCSNQFSKVICVRKN------------LREVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRT-I  103 (440)
T ss_dssp             SEECTTSCEEECCSCC------------CSSCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCE-E
T ss_pred             CEeCCCCCEEEeCCCC------------cCcCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCc-c
Confidence            4453  5677776432            235666554  678899999999998778888888888888888888864 3


Q ss_pred             chhhhhcCCCccEEeccCccccCCCchhccccccccEEeecCcccccccCCCccccCcceEeeccCcccccchhhHHhhh
Q 002010          136 AGQIVRGMTELQVLDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLNGIGLNGTVPAFLSRL  215 (982)
Q Consensus       136 ~~~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l  215 (982)
                      +...|.++++|++|+|++|++++..+..+..+++|++|+|++|++++..+..|..+++|++|++++|...          
T Consensus       104 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l----------  173 (440)
T 3zyj_A          104 EIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRL----------  173 (440)
T ss_dssp             CGGGGTTCSSCCEEECCSSCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTC----------
T ss_pred             ChhhccCCccCCEEECCCCcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCc----------
Confidence            4456677888888888888888666667788888888888888877666666666666666666653221          


Q ss_pred             hhHHHHhhcccccccccCCCCCCCCCCCCEEecccCcCcccCchhhcCCCccceeecccccCCCCCCccccCCCCCCEEE
Q 002010          216 KNLREMYIGYFNTYTGGIPPGFGALTQLQVLDMASCNISGEIPTSLSRLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLD  295 (982)
Q Consensus       216 ~~L~~L~l~~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~  295 (982)
                                    ....+..|.++++|++|+|++|+++ .+| .+..+++|++|+|++|++++..|..|.++++|+.|+
T Consensus       174 --------------~~i~~~~~~~l~~L~~L~L~~n~l~-~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  237 (440)
T 3zyj_A          174 --------------SYISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLW  237 (440)
T ss_dssp             --------------CEECTTTTTTCSSCCEEECTTSCCS-SCC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEE
T ss_pred             --------------ceeCcchhhcccccCeecCCCCcCc-ccc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEE
Confidence                          1112224556666666666666665 233 255555555555555555555555555555555555


Q ss_pred             eeCCcccCcCchhhhcccchhhhhhccCCCCCCCCCcCCCCCCccEEEccCCCcc
Q 002010          296 LSLNYLTGEIPESFAALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFT  350 (982)
Q Consensus       296 Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~  350 (982)
                      |++|++++..+..|..+++|+.|+|++|++++..+..|..+++|+.|+|++|++.
T Consensus       238 L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~  292 (440)
T 3zyj_A          238 MIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWN  292 (440)
T ss_dssp             CTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEE
T ss_pred             CCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCcc
Confidence            5555555544445555555555555555555444444444455555555444443

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=99.95  E-value=1.3e-28  Score=270.05  Aligned_cols=256  Identities=20%  Similarity=0.211  Sum_probs=151.1

Q ss_pred             hhhhhhccCCCCCCCCCcCCCCCCccEEEccCCCcccc--cCccccCCCcccEEEeccccccccCCccccCccccceeec
Q 002010          315 LTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFE--LPENLGRNGKLLILDVTSNHLTGTIPRDLCKGGKLKSLIL  392 (982)
Q Consensus       315 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~--~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~l  392 (982)
                      |++|++++|+++...+..|..+++|++|++++|.++..  .+..+..+++|++|++++|.++ .+|..+..+++|++|++
T Consensus        30 l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~-~l~~~~~~l~~L~~L~l  108 (306)
T 2z66_A           30 ATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDF  108 (306)
T ss_dssp             CCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECCSCSEE-EEEEEEETCTTCCEEEC
T ss_pred             CCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEECCCCccc-cChhhcCCCCCCCEEEC
Confidence            33333333333322222334444444444444444321  1333334444444444444444 23333444444444444


Q ss_pred             ccccccccCC-ccccCCCCCCEEEccCCccCCCCCccccCCCccccccCCCccccccCCcccccCCccEEEeeccccCC-
Q 002010          393 MQNFFIGPIP-EELGQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLSGELPEKMSGASLNQLKVANNNITG-  470 (982)
Q Consensus       393 ~~N~~~~~~~-~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~L~~N~i~~-  470 (982)
                      ++|.+.+..+ ..+..+++|++|++++|.+++..+..+..+++|++                       |++++|++++ 
T Consensus       109 ~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~-----------------------L~l~~n~l~~~  165 (306)
T 2z66_A          109 QHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEV-----------------------LKMAGNSFQEN  165 (306)
T ss_dssp             TTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCE-----------------------EECTTCEEGGG
T ss_pred             CCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCE-----------------------EECCCCccccc
Confidence            4444443333 34555555666666666555544444444444444                       4444444433 


Q ss_pred             CCchhccCCCCcceeeeccccccCCCccccccccccceeeeeccccCCCCCcccccccCCCeeeCCCCcccCCCCccccc
Q 002010          471 KIPAAIGNLPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYGKIPPGISK  550 (982)
Q Consensus       471 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~  550 (982)
                      ..|..+..+++|++|++++|++++..|..+..+++|++|+|++|++++..+..+..+++|+.|+|++|++++..|..+..
T Consensus       166 ~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~  245 (306)
T 2z66_A          166 FLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQH  245 (306)
T ss_dssp             EECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCC
T ss_pred             cchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccCHHHHHh
Confidence            35566677777777777777777666777777788888888888887766777888888888888888888888888888


Q ss_pred             cc-ccceEEcccccccccCc--cccccccccceecccCCccccCCCC
Q 002010          551 LI-DLSILNLSRNGITGSIP--NEMRNMMSLTTLDLSYNNLIGNIPS  594 (982)
Q Consensus       551 l~-~L~~L~Ls~N~l~~~~p--~~l~~l~~L~~L~Ls~N~l~~~ip~  594 (982)
                      ++ +|+.|+|++|.+++..+  .....+...+.+.+..|.+.+..|.
T Consensus       246 ~~~~L~~L~L~~N~~~~~c~~~~~~~~l~~~~~~~~~~~~~~C~~p~  292 (306)
T 2z66_A          246 FPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPS  292 (306)
T ss_dssp             CCTTCCEEECTTCCEECSGGGHHHHHHHHHTGGGBSCGGGCBEEESG
T ss_pred             hhccCCEEEccCCCeecccChHHHHHHHHhhhhhhccccccccCCch
Confidence            84 88888888888876432  1234455666677777777777764

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=99.95  E-value=5.4e-28  Score=267.06  Aligned_cols=234  Identities=17%  Similarity=0.218  Sum_probs=198.7

Q ss_pred             CCCccEEEccCCCcccccCccccCCCcccEEEeccccccccCCccccCccccceeecccccccccCCccccCCCCCCEEE
Q 002010          336 FPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFIGPIPEELGQCKSLTKIR  415 (982)
Q Consensus       336 l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~l~~N~~~~~~~~~l~~l~~L~~L~  415 (982)
                      .++++.|++++|.++ .+|..+..+++|++|+|++|.++ .+|..+..+++|++|++++|.+. .+|..++++++|++|+
T Consensus        80 ~~~l~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~  156 (328)
T 4fcg_A           80 QPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELS  156 (328)
T ss_dssp             STTCCEEEEESSCCS-SCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEE
T ss_pred             ccceeEEEccCCCch-hcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEE
Confidence            357888888888888 67777888888888888888888 77888888888888888888877 6677788888888888


Q ss_pred             ccCCccCCCCCccccCCCccccccCCCccccccCCccc-ccCCccEEEeeccccCCCCchhccCCCCcceeeeccccccC
Q 002010          416 FSKNYLNGTIPAGLFNLPLLNMMELDDNLLSGELPEKM-SGASLNQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLEG  494 (982)
Q Consensus       416 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~-~~~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~  494 (982)
                      +++|++.+.+|..+....           +    +..+ ...+|++|++++|+++ .+|..++.+++|++|+|++|++++
T Consensus       157 L~~n~~~~~~p~~~~~~~-----------~----~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~  220 (328)
T 4fcg_A          157 IRACPELTELPEPLASTD-----------A----SGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA  220 (328)
T ss_dssp             EEEETTCCCCCSCSEEEC----------------CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC
T ss_pred             CCCCCCccccChhHhhcc-----------c----hhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc
Confidence            888777777776655311           0    0111 1367999999999998 788889999999999999999994


Q ss_pred             CCccccccccccceeeeeccccCCCCCcccccccCCCeeeCCCCcccCCCCcccccccccceEEcccccccccCcccccc
Q 002010          495 EIPVESFNLKMITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYGKIPPGISKLIDLSILNLSRNGITGSIPNEMRN  574 (982)
Q Consensus       495 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~  574 (982)
                       +|..+..+++|++|+|++|++.+.+|..++.+++|+.|+|++|.+.+.+|..+.++++|+.|+|++|++.+.+|..+..
T Consensus       221 -l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~  299 (328)
T 4fcg_A          221 -LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQ  299 (328)
T ss_dssp             -CCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGG
T ss_pred             -CchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhh
Confidence             6778999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ccccceecccCCccc
Q 002010          575 MMSLTTLDLSYNNLI  589 (982)
Q Consensus       575 l~~L~~L~Ls~N~l~  589 (982)
                      +++|+.+++..|.+.
T Consensus       300 L~~L~~l~l~~~~~~  314 (328)
T 4fcg_A          300 LPANCIILVPPHLQA  314 (328)
T ss_dssp             SCTTCEEECCGGGSC
T ss_pred             ccCceEEeCCHHHHH
Confidence            999999999987664

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=99.95  E-value=1.9e-29  Score=277.23  Aligned_cols=255  Identities=21%  Similarity=0.176  Sum_probs=152.4

Q ss_pred             ccccccccEEEeccCCCCCCCChhhhhhcccceeeccCCccc-cccchhhh------hcCCCccEEeccCccccCCCchh
Q 002010           91 IGLLTKLVNLTISNVNLTGRLPSEMALLTSLKVFNISGNVFQ-GNFAGQIV------RGMTELQVLDAYNNNFTGPLPVE  163 (982)
Q Consensus        91 i~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~-~~~~~~~~------~~l~~L~~L~Ls~n~l~~~~p~~  163 (982)
                      .+..++|++|++++|++  .+|..+...  |++|+|++|.+. ..++....      .++++|++|+|++|++++.+|..
T Consensus        39 ~~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~  114 (312)
T 1wwl_A           39 YGGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPP  114 (312)
T ss_dssp             EEEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCC
T ss_pred             EccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHH
Confidence            34556777778888877  677766655  777777777774 33333221      14666666666666666666665


Q ss_pred             c--cccccccEEeecCcccccccCCCccccCcceEeeccCcccccchhhHHhhhhhHHHHhhcccccccccCCCCCCCCC
Q 002010          164 I--ASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLNGIGLNGTVPAFLSRLKNLREMYIGYFNTYTGGIPPGFGALT  241 (982)
Q Consensus       164 l--~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~l~~~n~~~~~~p~~~~~l~  241 (982)
                      +  +.+++|++|+|++|++++. |..++.+                        ..                    ..++
T Consensus       115 ~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l------------------------~~--------------------~~~~  149 (312)
T 1wwl_A          115 LLEATGPDLNILNLRNVSWATR-DAWLAEL------------------------QQ--------------------WLKP  149 (312)
T ss_dssp             SSSCCSCCCSEEEEESCBCSSS-SSHHHHH------------------------HT--------------------TCCT
T ss_pred             HHHhcCCCccEEEccCCCCcch-hHHHHHH------------------------HH--------------------hhcC
Confidence            4  5666666666666666644 4444333                        10                    0124


Q ss_pred             CCCEEecccCcCcccCchhhcCCCccceeecccccCCCC--CCccc--cCCCCCCEEEeeCCcccCc---Cchhhhcccc
Q 002010          242 QLQVLDMASCNISGEIPTSLSRLKLLHSLFLQMNKLTGH--IPPQL--SGLISLKSLDLSLNYLTGE---IPESFAALKN  314 (982)
Q Consensus       242 ~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~--~~~~l--~~l~~L~~L~Ls~N~l~~~---~~~~l~~l~~  314 (982)
                      +|++|+|++|++++..|..|+++++|++|++++|++.+.  .+..+  ..+++|++|+|++|++++.   ....+..+++
T Consensus       150 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~  229 (312)
T 1wwl_A          150 GLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQ  229 (312)
T ss_dssp             TCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCC
T ss_pred             CCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCC
Confidence            555566666666555555566666666666666665443  12222  5566666666666666521   1123345566


Q ss_pred             hhhhhhccCCCCCCCC-CcCCCCCCccEEEccCCCcccccCccccCCCcccEEEeccccccccCCccccCccccceeecc
Q 002010          315 LTLLQLFKNNLRGPIP-SFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDLCKGGKLKSLILM  393 (982)
Q Consensus       315 L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~l~  393 (982)
                      |++|++++|++++.+| ..+..+++|++|++++|.++ .+|..+.  ++|++|++++|++++. |. +..+++|++|+++
T Consensus       230 L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~  304 (312)
T 1wwl_A          230 LQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLK  304 (312)
T ss_dssp             CSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSSCC--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECT
T ss_pred             CCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhhcc--CCceEEECCCCCCCCC-hh-HhhCCCCCEEecc
Confidence            6666666666666553 34555667777777777776 4555554  6677777777777654 44 6677777777777


Q ss_pred             cccccc
Q 002010          394 QNFFIG  399 (982)
Q Consensus       394 ~N~~~~  399 (982)
                      +|.+++
T Consensus       305 ~N~l~~  310 (312)
T 1wwl_A          305 GNPFLD  310 (312)
T ss_dssp             TCTTTC
T ss_pred             CCCCCC
Confidence            777654

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=99.95  E-value=2.9e-28  Score=272.99  Aligned_cols=276  Identities=19%  Similarity=0.191  Sum_probs=197.8

Q ss_pred             CccEEeccCccccCCCchhccccccccEEeecCcccccccCCCccccCcceEeeccCcccccchhhHHhhhhhHHHHhhc
Q 002010          145 ELQVLDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLNGIGLNGTVPAFLSRLKNLREMYIG  224 (982)
Q Consensus       145 ~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~l~  224 (982)
                      .....++++|+++ .+|..+.  ++|++|+|++|++++..+..|+++++|++|++++|.+.+                  
T Consensus        32 ~~~~c~~~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~------------------   90 (353)
T 2z80_A           32 RNGICKGSSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINT------------------   90 (353)
T ss_dssp             TTSEEECCSTTCS-SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCE------------------
T ss_pred             CCeEeeCCCCCcc-ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCc------------------
Confidence            3344566666666 4565554  367777777777776555567777777777777665542                  


Q ss_pred             ccccccccCCCCCCCCCCCCEEecccCcCcccCchhhcCCCccceeecccccCCCCCC-ccccCCCCCCEEEeeCC-ccc
Q 002010          225 YFNTYTGGIPPGFGALTQLQVLDMASCNISGEIPTSLSRLKLLHSLFLQMNKLTGHIP-PQLSGLISLKSLDLSLN-YLT  302 (982)
Q Consensus       225 ~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~-~~l~~l~~L~~L~Ls~N-~l~  302 (982)
                             ..|..|+++++|++|++++|++++..+..|+++++|++|++++|++++..+ ..+..+++|++|++++| .++
T Consensus        91 -------~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~  163 (353)
T 2z80_A           91 -------IEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFT  163 (353)
T ss_dssp             -------ECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCC
T ss_pred             -------cCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCcccc
Confidence                   223456677788888888888886555568888888888888888885444 46788888888888888 466


Q ss_pred             CcCchhhhcccchhhhhhccCCCCCCCCCcCCCCCCccEEEccCCCcccccCccccCCCcccEEEeccccccccCCcccc
Q 002010          303 GEIPESFAALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDLC  382 (982)
Q Consensus       303 ~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~  382 (982)
                      +..+..|..+++|++|++++|++++..|..+..+++|++|++++|.++...+..+..+++|+.|++++|++++..+..+.
T Consensus       164 ~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~  243 (353)
T 2z80_A          164 KIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELS  243 (353)
T ss_dssp             EECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC---
T ss_pred             ccCHHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCccccccccccc
Confidence            66677788888888888888888888888888888888888888888754444455678888888888888876554443


Q ss_pred             ---Cccccceeecccccccc----cCCccccCCCCCCEEEccCCccCCCCCcc-ccCCCccccccCCCccccccC
Q 002010          383 ---KGGKLKSLILMQNFFIG----PIPEELGQCKSLTKIRFSKNYLNGTIPAG-LFNLPLLNMMELDDNLLSGEL  449 (982)
Q Consensus       383 ---~~~~L~~L~l~~N~~~~----~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~L~~N~l~~~~  449 (982)
                         ....++.++++++.+.+    .+|..+..+++|++|++++|+++ .+|.. |..+++|++|++++|.+.+..
T Consensus       244 ~~~~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~-~i~~~~~~~l~~L~~L~L~~N~~~~~~  317 (353)
T 2z80_A          244 TGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSC  317 (353)
T ss_dssp             ---CCCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCBCCCH
T ss_pred             cccccchhhccccccccccCcchhhhHHHHhcccCCCEEECCCCCCC-ccCHHHHhcCCCCCEEEeeCCCccCcC
Confidence               24556677777776654    35677888888888888888888 55555 467777777777777776544

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=99.95  E-value=6.5e-28  Score=279.65  Aligned_cols=253  Identities=23%  Similarity=0.285  Sum_probs=159.3

Q ss_pred             CCCCc--cceeeeCCCCCEEEEEeccCCccccCCcCccccccccEEEeccCCCCCCCChhhhhhcccceeeccCCccccc
Q 002010           57 SAHCS--FSGVTCDQDSRVVSLNVSFMPLFGSIPPEIGLLTKLVNLTISNVNLTGRLPSEMALLTSLKVFNISGNVFQGN  134 (982)
Q Consensus        57 ~~~C~--w~gv~C~~~~~v~~l~l~~~~l~g~~~~~i~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~  134 (982)
                      .|.|.  |..|.|...+            ...+|..+.  +++++|+|++|++++..|..|.++++|++|+|++|.+++.
T Consensus        49 ~C~C~~~~~~v~c~~~~------------l~~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~  114 (452)
T 3zyi_A           49 VCSCSNQFSKVVCTRRG------------LSEVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQI  114 (452)
T ss_dssp             TSEECSSSCEEECCSSC------------CSSCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEE
T ss_pred             CCEECCCCcEEEECCCC------------cCccCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCc
Confidence            34464  5677776432            224665544  6889999999999988888888888888888888888753


Q ss_pred             cchhhhhcCCCccEEeccCccccCCCchhccccccccEEeecCcccccccCCCccccCcceEeeccCcccccchhhHHhh
Q 002010          135 FAGQIVRGMTELQVLDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLNGIGLNGTVPAFLSR  214 (982)
Q Consensus       135 ~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~i~~~~~~~l~~  214 (982)
                       +...+.++++|++|+|++|++++..+..+..+++|++|+|++|++++..+..|.++++|++|++++|...         
T Consensus       115 -~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l---------  184 (452)
T 3zyi_A          115 -EVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKL---------  184 (452)
T ss_dssp             -CTTTTTTCTTCCEEECCSSCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTC---------
T ss_pred             -ChhhccCcccCCEEECCCCcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCc---------
Confidence             3455677888888888888888666666777888888888888877665666666666666666653221         


Q ss_pred             hhhHHHHhhcccccccccCCCCCCCCCCCCEEecccCcCcccCchhhcCCCccceeecccccCCCCCCccccCCCCCCEE
Q 002010          215 LKNLREMYIGYFNTYTGGIPPGFGALTQLQVLDMASCNISGEIPTSLSRLKLLHSLFLQMNKLTGHIPPQLSGLISLKSL  294 (982)
Q Consensus       215 l~~L~~L~l~~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L  294 (982)
                                     ....+..|.++++|++|+|++|++++. | .+..+++|++|+|++|++++..|..|.++++|+.|
T Consensus       185 ---------------~~i~~~~~~~l~~L~~L~L~~n~l~~~-~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L  247 (452)
T 3zyi_A          185 ---------------EYISEGAFEGLFNLKYLNLGMCNIKDM-P-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKL  247 (452)
T ss_dssp             ---------------CEECTTTTTTCTTCCEEECTTSCCSSC-C-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEE
T ss_pred             ---------------cccChhhccCCCCCCEEECCCCccccc-c-cccccccccEEECcCCcCcccCcccccCccCCCEE
Confidence                           111122355566666666666666533 2 35555555555555555555555555555555555


Q ss_pred             EeeCCcccCcCchhhhcccchhhhhhccCCCCCCCCCcCCCCCCccEEEccCCCcc
Q 002010          295 DLSLNYLTGEIPESFAALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFT  350 (982)
Q Consensus       295 ~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~  350 (982)
                      +|++|++++..+..|..+++|+.|+|++|++++..+..|..+++|+.|+|++|++.
T Consensus       248 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~  303 (452)
T 3zyi_A          248 WVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWN  303 (452)
T ss_dssp             ECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEE
T ss_pred             EeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccccCCCEEEccCCCcC
Confidence            55555555555555555555555555555555444444455555555555555443

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.95  E-value=1.1e-30  Score=304.48  Aligned_cols=237  Identities=18%  Similarity=0.159  Sum_probs=136.8

Q ss_pred             CCCCCccEEEccCCCcccccCccccCCCcccEEEeccccccccCCccccCccccceeecccccccccCCccccCCCCCCE
Q 002010          334 GDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFIGPIPEELGQCKSLTK  413 (982)
Q Consensus       334 ~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~l~~N~~~~~~~~~l~~l~~L~~  413 (982)
                      ..+++|+.|+|++|.+++..|..+..+++|++|+|++|.+++..|  +..+++|++|++++|.+.+..+     .++|++
T Consensus        31 ~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~-----~~~L~~  103 (487)
T 3oja_A           31 QSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLV-----GPSIET  103 (487)
T ss_dssp             TTGGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEE-----CTTCCE
T ss_pred             ccCCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCC-----CCCcCE
Confidence            345578888888888887777778888888888888888876554  6677777777777777664332     266777


Q ss_pred             EEccCCccCCCCCccccCCCccccccCCCccccccCCccccc-CCccEEEeeccccCCCCchhcc-CCCCcceeeecccc
Q 002010          414 IRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLSGELPEKMSG-ASLNQLKVANNNITGKIPAAIG-NLPSLNILSLQNNR  491 (982)
Q Consensus       414 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~-~~L~~L~L~~N~i~~~~p~~~~-~l~~L~~L~L~~N~  491 (982)
                      |++++|.+++..+..   +++|+.|++++|.+++..|..+.. ++|+.|+|++|++++.+|..+. .+++|+.|+|++|.
T Consensus       104 L~L~~N~l~~~~~~~---l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~  180 (487)
T 3oja_A          104 LHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNF  180 (487)
T ss_dssp             EECCSSCCCCEEECC---CSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSC
T ss_pred             EECcCCcCCCCCccc---cCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCc
Confidence            777777776544432   345555555555555554444332 4555555555555555554443 45555555555555


Q ss_pred             ccCCCccccccccccceeeeeccccCCCCCcccccccCCCeeeCCCCcccCCCCcccccccccceEEccccccc-ccCcc
Q 002010          492 LEGEIPVESFNLKMITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYGKIPPGISKLIDLSILNLSRNGIT-GSIPN  570 (982)
Q Consensus       492 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~  570 (982)
                      |++. | ....+++|++|+|++|+|++. |..+..+++|+.|+|++|.|++ +|..+..+++|+.|+|++|.++ +.+|.
T Consensus       181 l~~~-~-~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c~~~~~  256 (487)
T 3oja_A          181 IYDV-K-GQVVFAKLKTLDLSSNKLAFM-GPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRD  256 (487)
T ss_dssp             CCEE-E-CCCCCTTCCEEECCSSCCCEE-CGGGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCHHHHHH
T ss_pred             cccc-c-ccccCCCCCEEECCCCCCCCC-CHhHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcCcchHH
Confidence            5533 1 122355555555555555532 2235555555555555555552 4444555555555555555554 44444


Q ss_pred             ccccccccceeccc
Q 002010          571 EMRNMMSLTTLDLS  584 (982)
Q Consensus       571 ~l~~l~~L~~L~Ls  584 (982)
                      .+..++.|+.++++
T Consensus       257 ~~~~l~~L~~l~~~  270 (487)
T 3oja_A          257 FFSKNQRVQTVAKQ  270 (487)
T ss_dssp             HHTTCHHHHHHHHH
T ss_pred             HHHhCCCCcEEecc
Confidence            55555555555443

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=99.95  E-value=6.6e-29  Score=272.89  Aligned_cols=204  Identities=23%  Similarity=0.291  Sum_probs=130.5

Q ss_pred             CCcccEEEeccccccccCCccc--cCccccceeecccccccccCCccccCC-----CCCCEEEccCCccCCCCCccccCC
Q 002010          360 NGKLLILDVTSNHLTGTIPRDL--CKGGKLKSLILMQNFFIGPIPEELGQC-----KSLTKIRFSKNYLNGTIPAGLFNL  432 (982)
Q Consensus       360 l~~L~~L~L~~N~l~~~~p~~~--~~~~~L~~L~l~~N~~~~~~~~~l~~l-----~~L~~L~Ls~N~l~~~~p~~~~~l  432 (982)
                      +++|++|++++|++++.+|..+  ..+++|++|++++|.+.+. |..++.+     ++|++|++++|++++..|..+..+
T Consensus        94 l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l  172 (312)
T 1wwl_A           94 ISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVF  172 (312)
T ss_dssp             TSCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCC
T ss_pred             cCCccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccC
Confidence            4445555555555554444443  4445555555555555444 4444444     667777777777766555666666


Q ss_pred             CccccccCCCccccccCCcccccCCccEEEeeccccCCCCchhc--cCCCCcceeeeccccccC--CCc-cccccccccc
Q 002010          433 PLLNMMELDDNLLSGELPEKMSGASLNQLKVANNNITGKIPAAI--GNLPSLNILSLQNNRLEG--EIP-VESFNLKMIT  507 (982)
Q Consensus       433 ~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~L~~N~i~~~~p~~~--~~l~~L~~L~L~~N~l~~--~~p-~~~~~l~~L~  507 (982)
                      ++|++|++++|++.+.++                     .|..+  +.+++|++|+|++|++++  .++ ..+..+++|+
T Consensus       173 ~~L~~L~Ls~N~l~~~~~---------------------~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~  231 (312)
T 1wwl_A          173 PALSTLDLSDNPELGERG---------------------LISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQ  231 (312)
T ss_dssp             SSCCEEECCSCTTCHHHH---------------------HHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCS
T ss_pred             CCCCEEECCCCCcCcchH---------------------HHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCC
Confidence            655555555555432210                     12222  567777777777777762  122 2234567788


Q ss_pred             eeeeeccccCCCCC-cccccccCCCeeeCCCCcccCCCCcccccccccceEEcccccccccCccccccccccceecccCC
Q 002010          508 SINISDNNISGEIP-YSISQCHSLTSVDLSRNSLYGKIPPGISKLIDLSILNLSRNGITGSIPNEMRNMMSLTTLDLSYN  586 (982)
Q Consensus       508 ~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N  586 (982)
                      +|+|++|++++.+| ..+..+++|+.|+|++|+|+ .+|..+.  ++|+.|+|++|+|++. |. +..+++|++|+|++|
T Consensus       232 ~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N  306 (312)
T 1wwl_A          232 GLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGN  306 (312)
T ss_dssp             EEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSSCC--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTC
T ss_pred             EEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhhcc--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCC
Confidence            88888888877664 45566788888888888887 7777776  7888888888888865 55 888888999999998


Q ss_pred             cccc
Q 002010          587 NLIG  590 (982)
Q Consensus       587 ~l~~  590 (982)
                      ++++
T Consensus       307 ~l~~  310 (312)
T 1wwl_A          307 PFLD  310 (312)
T ss_dssp             TTTC
T ss_pred             CCCC
Confidence            8875

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=99.95  E-value=3.5e-27  Score=272.54  Aligned_cols=249  Identities=19%  Similarity=0.218  Sum_probs=170.3

Q ss_pred             hhhhhhccCCCCCCCCCcCCCCCCccEEEccCCCcccccCccccCCCcccEEEeccccccccCCccccCccccceeeccc
Q 002010          315 LTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQ  394 (982)
Q Consensus       315 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~l~~  394 (982)
                      .+.++.+++.++ .+|..+.  ++++.|+|++|+++...+..|..+++|++|+|++|++++..+..|.++++|++|+|++
T Consensus        45 ~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~  121 (440)
T 3zyj_A           45 FSKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFD  121 (440)
T ss_dssp             SCEEECCSCCCS-SCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCS
T ss_pred             CCEEEeCCCCcC-cCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCC
Confidence            344556666666 4554443  4566666666666665566666666666666666666655555555555555555555


Q ss_pred             ccccccCCccccCCCCCCEEEccCCccCCCCCccccCCCccccccCCCccccccCCcccccCCccEEEeec-cccCCCCc
Q 002010          395 NFFIGPIPEELGQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLSGELPEKMSGASLNQLKVAN-NNITGKIP  473 (982)
Q Consensus       395 N~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~L~~-N~i~~~~p  473 (982)
                      |.+++..+..|..+++|++|+|++|++++..+..|..++                       +|++|++++ |.+....+
T Consensus       122 n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~-----------------------~L~~L~l~~~~~l~~i~~  178 (440)
T 3zyj_A          122 NRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIP-----------------------SLRRLDLGELKRLSYISE  178 (440)
T ss_dssp             SCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCT-----------------------TCCEEECCCCTTCCEECT
T ss_pred             CcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCc-----------------------ccCEeCCCCCCCcceeCc
Confidence            555555555555555555555555555543333444444                       455555555 33333444


Q ss_pred             hhccCCCCcceeeeccccccCCCccccccccccceeeeeccccCCCCCcccccccCCCeeeCCCCcccCCCCcccccccc
Q 002010          474 AAIGNLPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYGKIPPGISKLID  553 (982)
Q Consensus       474 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~  553 (982)
                      ..|.++++|++|+|++|+++ .+| .+..+++|++|+|++|+|++..|..|.++++|+.|+|++|+|++..|..|.++++
T Consensus       179 ~~~~~l~~L~~L~L~~n~l~-~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~  256 (440)
T 3zyj_A          179 GAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQS  256 (440)
T ss_dssp             TTTTTCSSCCEEECTTSCCS-SCC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTT
T ss_pred             chhhcccccCeecCCCCcCc-ccc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCC
Confidence            56778888888888888887 455 4777888888888888888877888888888888888888888888888888888


Q ss_pred             cceEEcccccccccCccccccccccceecccCCccccC
Q 002010          554 LSILNLSRNGITGSIPNEMRNMMSLTTLDLSYNNLIGN  591 (982)
Q Consensus       554 L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~  591 (982)
                      |+.|+|++|+|++..+..|..+++|+.|+|++|++...
T Consensus       257 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~Cd  294 (440)
T 3zyj_A          257 LVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWNCN  294 (440)
T ss_dssp             CCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEECS
T ss_pred             CCEEECCCCCCCccChhHhccccCCCEEEcCCCCccCC
Confidence            88888888888877777788888888888888887654

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=99.95  E-value=1.1e-27  Score=259.69  Aligned_cols=251  Identities=18%  Similarity=0.153  Sum_probs=160.0

Q ss_pred             cEEEccCCCcccccCccccCCCcccEEEeccccccccCCccccCccccceeecccccccccCCccccCCCCCCEEEccCC
Q 002010          340 EVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKN  419 (982)
Q Consensus       340 ~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~l~~N~~~~~~~~~l~~l~~L~~L~Ls~N  419 (982)
                      +.++.+++.++. +|..+  .++|++|++++|.+++..+..|..+++|++|++++|.+.+..|..+..+++|++|++++|
T Consensus        14 ~~~~c~~~~l~~-ip~~~--~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n   90 (285)
T 1ozn_A           14 VTTSCPQQGLQA-VPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN   90 (285)
T ss_dssp             CEEECCSSCCSS-CCTTC--CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSC
T ss_pred             eEEEcCcCCccc-CCcCC--CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCC
Confidence            456666666663 34322  346666666666666555555666666666666666666655666666666666666666


Q ss_pred             c-cCCCCCccccCCCccccccCCCccccccCCcccccCCccEEEeeccccCCCCchhccCCCCcceeeeccccccCCCcc
Q 002010          420 Y-LNGTIPAGLFNLPLLNMMELDDNLLSGELPEKMSGASLNQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPV  498 (982)
Q Consensus       420 ~-l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~  498 (982)
                      + +++..|..+..++                       +|++|++++|++++..|..|..+++|++|++++|++++..+.
T Consensus        91 ~~l~~~~~~~~~~l~-----------------------~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~  147 (285)
T 1ozn_A           91 AQLRSVDPATFHGLG-----------------------RLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDD  147 (285)
T ss_dssp             TTCCCCCTTTTTTCT-----------------------TCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTT
T ss_pred             CCccccCHHHhcCCc-----------------------CCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHh
Confidence            5 5544455555554                       455555555555555566667777777777777777755555


Q ss_pred             ccccccccceeeeeccccCCCCCcccccccCCCeeeCCCCcccCCCCcccccccccceEEcccccccccCcccccccccc
Q 002010          499 ESFNLKMITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYGKIPPGISKLIDLSILNLSRNGITGSIPNEMRNMMSL  578 (982)
Q Consensus       499 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L  578 (982)
                      .+..+++|++|+|++|++++..+..|..+++|+.|+|++|.+++..|..|..+++|+.|+|++|++++..+..+..+++|
T Consensus       148 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L  227 (285)
T 1ozn_A          148 TFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRAL  227 (285)
T ss_dssp             TTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTC
T ss_pred             HhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCccc
Confidence            56677777777777777776555567777777777777777777777777777777777777777776666667777777


Q ss_pred             ceecccCCccccCCCCCccccccccccccCCcCcccCC
Q 002010          579 TTLDLSYNNLIGNIPSGGQFLAFNETSFIGNPNLCLLR  616 (982)
Q Consensus       579 ~~L~Ls~N~l~~~ip~~~~~~~~~~~~~~~n~~~c~~~  616 (982)
                      ++|++++|++.+..+....+..+.......|...|..|
T Consensus       228 ~~L~l~~N~~~c~~~~~~~~~~l~~~~~~~~~~~c~~p  265 (285)
T 1ozn_A          228 QYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCSLP  265 (285)
T ss_dssp             CEEECCSSCEECSGGGHHHHHHHHHCCSEECCCBEEES
T ss_pred             CEEeccCCCccCCCCcHHHHHHHHhcccccCccccCCc
Confidence            77777777777655532222223333344555555444

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=99.95  E-value=3.5e-27  Score=273.52  Aligned_cols=250  Identities=16%  Similarity=0.168  Sum_probs=176.1

Q ss_pred             hhhhhhccCCCCCCCCCcCCCCCCccEEEccCCCcccccCccccCCCcccEEEeccccccccCCccccCccccceeeccc
Q 002010          315 LTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQ  394 (982)
Q Consensus       315 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~l~~  394 (982)
                      ...++.+++.++ .+|..+.  ++|++|+|++|.+++..+..|..+++|++|+|++|++++..|..|.++++|++|+|++
T Consensus        56 ~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~  132 (452)
T 3zyi_A           56 FSKVVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFD  132 (452)
T ss_dssp             SCEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred             CcEEEECCCCcC-ccCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCC
Confidence            344566666666 4554433  4667777777777766666666677777777777776666666666666666666666


Q ss_pred             ccccccCCccccCCCCCCEEEccCCccCCCCCccccCCCccccccCCCccccccCCcccccCCccEEEeec-cccCCCCc
Q 002010          395 NFFIGPIPEELGQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLSGELPEKMSGASLNQLKVAN-NNITGKIP  473 (982)
Q Consensus       395 N~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~L~~-N~i~~~~p  473 (982)
                      |.+++..+..|..+++|++|+|++|++++..+..|..+++|                       ++|++++ |.+....+
T Consensus       133 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L-----------------------~~L~l~~~~~l~~i~~  189 (452)
T 3zyi_A          133 NWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSL-----------------------MRLDLGELKKLEYISE  189 (452)
T ss_dssp             SCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTC-----------------------CEEECCCCTTCCEECT
T ss_pred             CcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcc-----------------------cEEeCCCCCCccccCh
Confidence            66665555556666666666666666664444455555544                       4455554 33333344


Q ss_pred             hhccCCCCcceeeeccccccCCCccccccccccceeeeeccccCCCCCcccccccCCCeeeCCCCcccCCCCcccccccc
Q 002010          474 AAIGNLPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYGKIPPGISKLID  553 (982)
Q Consensus       474 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~  553 (982)
                      ..|.++++|++|+|++|++++ +| .+..+++|++|+|++|+|++..|..|.++++|+.|+|++|++++..|..|.++++
T Consensus       190 ~~~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~  267 (452)
T 3zyi_A          190 GAFEGLFNLKYLNLGMCNIKD-MP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLAS  267 (452)
T ss_dssp             TTTTTCTTCCEEECTTSCCSS-CC-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTT
T ss_pred             hhccCCCCCCEEECCCCcccc-cc-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCC
Confidence            467788888888888888874 44 4777888888888888888888888888888888888888888888888888888


Q ss_pred             cceEEcccccccccCccccccccccceecccCCccccCC
Q 002010          554 LSILNLSRNGITGSIPNEMRNMMSLTTLDLSYNNLIGNI  592 (982)
Q Consensus       554 L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~i  592 (982)
                      |+.|+|++|+|++..+..|..+++|+.|+|++|++....
T Consensus       268 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~CdC  306 (452)
T 3zyi_A          268 LVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWNCDC  306 (452)
T ss_dssp             CCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEECST
T ss_pred             CCEEECCCCcCCccChHHhccccCCCEEEccCCCcCCCC
Confidence            888888888888777777888888888888888876543

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=99.95  E-value=6.7e-27  Score=277.71  Aligned_cols=268  Identities=27%  Similarity=0.385  Sum_probs=156.9

Q ss_pred             CCCEEecccCcCcccCchhhcCCCccceeecccccCCCCCCccccCCCCCCEEEeeCCcccCcCchhhhcccchhhhhhc
Q 002010          242 QLQVLDMASCNISGEIPTSLSRLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQLF  321 (982)
Q Consensus       242 ~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~  321 (982)
                      +++.|++++|+++ .+|..+.  ++|++|+|++|+++ .+|.   .+++|++|+|++|+|++ +|.   .+++|++|+|+
T Consensus        41 ~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls  109 (622)
T 3g06_A           41 GNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLTS-LPV---LPPGLLELSIF  109 (622)
T ss_dssp             CCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC---CCTTCCEEEECSCCCSC-CCC---CCTTCCEEEEC
T ss_pred             CCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC---cCCCCCEEEcCCCcCCc-CCC---CCCCCCEEECc
Confidence            5778888888887 6666554  67888888888887 3444   45778888888888773 443   45677777777


Q ss_pred             cCCCCCCCCCcCCCCCCccEEEccCCCcccccCccccCCCcccEEEeccccccccCCccccCccccceeecccccccccC
Q 002010          322 KNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFIGPI  401 (982)
Q Consensus       322 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~l~~N~~~~~~  401 (982)
                      +|++++ +|.   .+++|+.|++++|+++. +|..   +++|++|++++|++++ +|.                      
T Consensus       110 ~N~l~~-l~~---~l~~L~~L~L~~N~l~~-lp~~---l~~L~~L~Ls~N~l~~-l~~----------------------  158 (622)
T 3g06_A          110 SNPLTH-LPA---LPSGLCKLWIFGNQLTS-LPVL---PPGLQELSVSDNQLAS-LPA----------------------  158 (622)
T ss_dssp             SCCCCC-CCC---CCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSC-CCC----------------------
T ss_pred             CCcCCC-CCC---CCCCcCEEECCCCCCCc-CCCC---CCCCCEEECcCCcCCC-cCC----------------------
Confidence            777764 333   45666777777776664 3332   2556666666665552 222                      


Q ss_pred             CccccCCCCCCEEEccCCccCCCCCccccCCCccccccCCCccccccCCcccccCCccEEEeeccccCCCCchhccCCCC
Q 002010          402 PEELGQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLSGELPEKMSGASLNQLKVANNNITGKIPAAIGNLPS  481 (982)
Q Consensus       402 ~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~L~~N~i~~~~p~~~~~l~~  481 (982)
                           .+.+|+.|++++|++++ +|   ..+++|+.|++++|.+++. |..  ..+|+.|++++|+++. +|.   .+++
T Consensus       159 -----~~~~L~~L~L~~N~l~~-l~---~~~~~L~~L~Ls~N~l~~l-~~~--~~~L~~L~L~~N~l~~-l~~---~~~~  222 (622)
T 3g06_A          159 -----LPSELCKLWAYNNQLTS-LP---MLPSGLQELSVSDNQLASL-PTL--PSELYKLWAYNNRLTS-LPA---LPSG  222 (622)
T ss_dssp             -----CCTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSCC-CCC--CTTCCEEECCSSCCSS-CCC---CCTT
T ss_pred             -----ccCCCCEEECCCCCCCC-Cc---ccCCCCcEEECCCCCCCCC-CCc--cchhhEEECcCCcccc-cCC---CCCC
Confidence                 12344455555555542 23   2233344444444444431 111  1355666666666652 332   2356


Q ss_pred             cceeeeccccccCCCccccccccccceeeeeccccCCCCCcccccccCCCeeeCCCCcccCCCCcccccccccceEEccc
Q 002010          482 LNILSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYGKIPPGISKLIDLSILNLSR  561 (982)
Q Consensus       482 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~  561 (982)
                      |+.|++++|+|++ +|   ..+++|++|+|++|+|+ .+|.   .+++|+.|+|++|+|+ .+|..|.++++|+.|+|++
T Consensus       223 L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~  293 (622)
T 3g06_A          223 LKELIVSGNRLTS-LP---VLPSELKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEG  293 (622)
T ss_dssp             CCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECCS
T ss_pred             CCEEEccCCccCc-CC---CCCCcCcEEECCCCCCC-cCCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEecC
Confidence            6666666666663 44   33456666666666666 3443   4566666666666666 5566666666666666666


Q ss_pred             ccccccCcccccccc
Q 002010          562 NGITGSIPNEMRNMM  576 (982)
Q Consensus       562 N~l~~~~p~~l~~l~  576 (982)
                      |++++.+|..+..++
T Consensus       294 N~l~~~~~~~l~~L~  308 (622)
T 3g06_A          294 NPLSERTLQALREIT  308 (622)
T ss_dssp             CCCCHHHHHHHHHHH
T ss_pred             CCCCCcCHHHHHhcc
Confidence            666666666555544

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=99.95  E-value=1.8e-27  Score=258.00  Aligned_cols=252  Identities=17%  Similarity=0.138  Sum_probs=133.5

Q ss_pred             CEEEeeCCcccCcCchhhhcccchhhhhhccCCCCCCCCCcCCCCCCccEEEccCCCcccccCccccCCCcccEEEeccc
Q 002010          292 KSLDLSLNYLTGEIPESFAALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSN  371 (982)
Q Consensus       292 ~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N  371 (982)
                      +.++.+++.++ .+|..+  .++|++|++++|.+++..+..|..+++|++|++++|.+++..|..+..+++|++|++++|
T Consensus        14 ~~~~c~~~~l~-~ip~~~--~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n   90 (285)
T 1ozn_A           14 VTTSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN   90 (285)
T ss_dssp             CEEECCSSCCS-SCCTTC--CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSC
T ss_pred             eEEEcCcCCcc-cCCcCC--CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCC
Confidence            45666666666 344332  245566666666665555555555556666666555555544555555555555555555


Q ss_pred             c-ccccCCccccCccccceeecccccccccCCccccCCCCCCEEEccCCccCCCCCccccCCCccccccCCCccccccCC
Q 002010          372 H-LTGTIPRDLCKGGKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLSGELP  450 (982)
Q Consensus       372 ~-l~~~~p~~~~~~~~L~~L~l~~N~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~  450 (982)
                      . ++                        ...|..+..+++|++|++++|++++..|..+..+++|++|++++|.++    
T Consensus        91 ~~l~------------------------~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~----  142 (285)
T 1ozn_A           91 AQLR------------------------SVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ----  142 (285)
T ss_dssp             TTCC------------------------CCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCC----
T ss_pred             CCcc------------------------ccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCccc----
Confidence            4 44                        333455555566666666666665544544544444433333333333    


Q ss_pred             cccccCCccEEEeeccccCCCCchhccCCCCcceeeeccccccCCCccccccccccceeeeeccccCCCCCcccccccCC
Q 002010          451 EKMSGASLNQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIPYSISQCHSL  530 (982)
Q Consensus       451 ~~~~~~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L  530 (982)
                                         +..+..|+.+++|++|++++|++++..+..+..+++|++|++++|++++..|..|..+++|
T Consensus       143 -------------------~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L  203 (285)
T 1ozn_A          143 -------------------ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRL  203 (285)
T ss_dssp             -------------------CCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTC
T ss_pred             -------------------ccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccc
Confidence                               2333334445555555555555553333345555555555555555555555556666666


Q ss_pred             CeeeCCCCcccCCCCcccccccccceEEcccccccccCccccccccccceecccCCccccCCCC
Q 002010          531 TSVDLSRNSLYGKIPPGISKLIDLSILNLSRNGITGSIPNEMRNMMSLTTLDLSYNNLIGNIPS  594 (982)
Q Consensus       531 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~  594 (982)
                      +.|+|++|.+++..+..+..+++|+.|+|++|.++...+. ..-...++.+..+.|.+.+..|.
T Consensus       204 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~-~~~~~~l~~~~~~~~~~~c~~p~  266 (285)
T 1ozn_A          204 MTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWAWLQKFRGSSSEVPCSLPQ  266 (285)
T ss_dssp             CEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGG-HHHHHHHHHCCSEECCCBEEESG
T ss_pred             cEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCCc-HHHHHHHHhcccccCccccCCch
Confidence            6666666666654445566666666666666666533221 11223344555566666666654

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=99.95  E-value=8.8e-29  Score=272.56  Aligned_cols=263  Identities=18%  Similarity=0.156  Sum_probs=165.2

Q ss_pred             EeeCCcccCcCchhhhcccchhhhhhccCCCCCCCCCcCCCCCCccEEEccCCCcccccCccccCCCcccEEEecccccc
Q 002010          295 DLSLNYLTGEIPESFAALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLT  374 (982)
Q Consensus       295 ~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~  374 (982)
                      +++.+.+.......+..+++|++|+|++|++++..|..|..+++|++|++++|.+++..+  +..+++|++|++++|+++
T Consensus        16 ~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n~l~   93 (317)
T 3o53_A           16 KVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQ   93 (317)
T ss_dssp             SCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCSSEEE
T ss_pred             eccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcCCccc
Confidence            344444433333333334444444444444444444444445555555555555543322  444455555555555544


Q ss_pred             ccCCccccCccccceeecccccccccCCccccCCCCCCEEEccCCccCCCCCccccCCCccccccCCCccccccCCcccc
Q 002010          375 GTIPRDLCKGGKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLSGELPEKMS  454 (982)
Q Consensus       375 ~~~p~~~~~~~~L~~L~l~~N~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~  454 (982)
                      +..     ..++|++|++++|.+.+..+..   +++|++|++++|++++..+..+..++                     
T Consensus        94 ~l~-----~~~~L~~L~l~~n~l~~~~~~~---~~~L~~L~l~~N~l~~~~~~~~~~l~---------------------  144 (317)
T 3o53_A           94 ELL-----VGPSIETLHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRS---------------------  144 (317)
T ss_dssp             EEE-----ECTTCCEEECCSSCCSEEEECC---CSSCEEEECCSSCCCSGGGBCTGGGS---------------------
T ss_pred             ccc-----CCCCcCEEECCCCccCCcCccc---cCCCCEEECCCCCCCCccchhhhccC---------------------
Confidence            211     1134444444444444333322   34566666666666544444444444                     


Q ss_pred             cCCccEEEeeccccCCCCchhc-cCCCCcceeeeccccccCCCccccccccccceeeeeccccCCCCCcccccccCCCee
Q 002010          455 GASLNQLKVANNNITGKIPAAI-GNLPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIPYSISQCHSLTSV  533 (982)
Q Consensus       455 ~~~L~~L~L~~N~i~~~~p~~~-~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L  533 (982)
                        +|++|++++|++++..+..+ ..+++|++|+|++|++++. |. ...+++|++|+|++|+|++ +|..+..+++|+.|
T Consensus       145 --~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~-~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L  219 (317)
T 3o53_A          145 --RVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KG-QVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWI  219 (317)
T ss_dssp             --SEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-EC-CCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEE
T ss_pred             --CCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccc-cc-ccccccCCEEECCCCcCCc-chhhhcccCcccEE
Confidence              45555555555555555555 3678888888888888744 32 3348889999999999985 45568999999999


Q ss_pred             eCCCCcccCCCCcccccccccceEEccccccc-ccCccccccccccceecccC-CccccCCCC
Q 002010          534 DLSRNSLYGKIPPGISKLIDLSILNLSRNGIT-GSIPNEMRNMMSLTTLDLSY-NNLIGNIPS  594 (982)
Q Consensus       534 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~l~~l~~L~~L~Ls~-N~l~~~ip~  594 (982)
                      +|++|+|+ .+|..+..+++|+.|+|++|+++ +.+|..+..+++|+.|++++ +.++|..|.
T Consensus       220 ~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~~~l~~~~~~  281 (317)
T 3o53_A          220 SLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEE  281 (317)
T ss_dssp             ECTTSCCC-EECTTCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHHHHHHHHSSSSC
T ss_pred             ECcCCccc-chhhHhhcCCCCCEEEccCCCccCcCHHHHHhccccceEEECCCchhccCCchh
Confidence            99999998 57888999999999999999999 78889999999999999994 567776664

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=99.94  E-value=8.6e-30  Score=307.04  Aligned_cols=460  Identities=16%  Similarity=0.129  Sum_probs=225.2

Q ss_pred             CCccceeeeCCCCCEEEEEeccCCccccCCc-CccccccccEEEeccCCCCC---CCC------------hhhhhhcccc
Q 002010           59 HCSFSGVTCDQDSRVVSLNVSFMPLFGSIPP-EIGLLTKLVNLTISNVNLTG---RLP------------SEMALLTSLK  122 (982)
Q Consensus        59 ~C~w~gv~C~~~~~v~~l~l~~~~l~g~~~~-~i~~l~~L~~L~l~~n~l~~---~~p------------~~l~~l~~L~  122 (982)
                      |++|.++...   ....+++...  .+..|. .+..+++|++|+++++....   ..|            .....+++|+
T Consensus        34 ck~W~~~~~~---~~~~l~~~~~--~~~~~~~~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~L~  108 (594)
T 2p1m_B           34 CKSWYEIERW---CRRKVFIGNC--YAVSPATVIRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLE  108 (594)
T ss_dssp             CHHHHHHHHH---HCCEEEESST--TSSCHHHHHHHCTTCCEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCC
T ss_pred             HHHHHHhhhh---hceEEeeccc--cccCHHHHHhhCCCceEEeccCCCchhhcccccccccchhhHHHHHHHHhCCCCC
Confidence            4589988321   1223444332  122222 24556778888888764221   111            1234566777


Q ss_pred             eeeccCCccccccchhhhhcCCCccEEeccCc-cccCC-CchhccccccccEEeecCcccccccCCCcc----ccCcceE
Q 002010          123 VFNISGNVFQGNFAGQIVRGMTELQVLDAYNN-NFTGP-LPVEIASLKSLRHLSFGGNYFTGKIPQSYS----EIQSLEY  196 (982)
Q Consensus       123 ~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n-~l~~~-~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~----~l~~L~~  196 (982)
                      +|+|++|.+.+..+..+...+++|++|+|++| .++.. ++..+.++++|++|+|++|.+++..+..+.    .+++|++
T Consensus       109 ~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~~  188 (594)
T 2p1m_B          109 EIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVS  188 (594)
T ss_dssp             EEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCCE
T ss_pred             eEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCcE
Confidence            77777777665555444445677777777776 44432 334444677777777777776655544443    3456666


Q ss_pred             eeccCcccccchhhHHhhhhhHHHHhhcccccccccCCCCCCCCCCCCEEecccC-cCcccCchhhcCCCccceeecccc
Q 002010          197 IGLNGIGLNGTVPAFLSRLKNLREMYIGYFNTYTGGIPPGFGALTQLQVLDMASC-NISGEIPTSLSRLKLLHSLFLQMN  275 (982)
Q Consensus       197 L~L~~n~i~~~~~~~l~~l~~L~~L~l~~~n~~~~~~p~~~~~l~~L~~L~L~~n-~l~~~~~~~l~~l~~L~~L~L~~N  275 (982)
                      |++++|. .......+..+                     +..+++|++|++++| .+.+ ++..+.++++|++|+++.+
T Consensus       189 L~l~~~~-~~~~~~~l~~l---------------------~~~~~~L~~L~L~~~~~~~~-l~~~~~~~~~L~~L~l~~~  245 (594)
T 2p1m_B          189 LNISCLA-SEVSFSALERL---------------------VTRCPNLKSLKLNRAVPLEK-LATLLQRAPQLEELGTGGY  245 (594)
T ss_dssp             EECTTCC-SCCCHHHHHHH---------------------HHHCTTCCEEECCTTSCHHH-HHHHHHHCTTCSEEECSBC
T ss_pred             EEecccC-CcCCHHHHHHH---------------------HHhCCCCcEEecCCCCcHHH-HHHHHhcCCcceEcccccc
Confidence            6666654 11111111111                     112456666666666 3333 5555666666666664333


Q ss_pred             -------cCCCCCCccccCCCCCCEE-EeeCCcccCcCchhhhcccchhhhhhccCCCCCCC-CCcCCCCCCccEEEccC
Q 002010          276 -------KLTGHIPPQLSGLISLKSL-DLSLNYLTGEIPESFAALKNLTLLQLFKNNLRGPI-PSFLGDFPNLEVLQVWG  346 (982)
Q Consensus       276 -------~l~~~~~~~l~~l~~L~~L-~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~L~~  346 (982)
                             .+.+ ++..+.++++|+.| .+.+... +.++..+..+++|++|+|++|.+++.. +..+..+++|+.|++++
T Consensus       246 ~~~~~~~~~~~-l~~~l~~~~~L~~Ls~~~~~~~-~~l~~~~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~  323 (594)
T 2p1m_B          246 TAEVRPDVYSG-LSVALSGCKELRCLSGFWDAVP-AYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLD  323 (594)
T ss_dssp             CCCCCHHHHHH-HHHHHHTCTTCCEEECCBTCCG-GGGGGGHHHHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEG
T ss_pred             cCccchhhHHH-HHHHHhcCCCcccccCCcccch-hhHHHHHHhhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcC
Confidence                   2222 22244455555555 2222211 122333333444444444444433211 11123344444444444


Q ss_pred             CCcccc-cCccccCCCcccEEEeccccccccCCccccCccccceeecccccccccCCcccc-CCCCCCEEEccCCccCCC
Q 002010          347 NNFTFE-LPENLGRNGKLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFIGPIPEELG-QCKSLTKIRFSKNYLNGT  424 (982)
Q Consensus       347 N~l~~~-~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~l~~N~~~~~~~~~l~-~l~~L~~L~Ls~N~l~~~  424 (982)
                      | ++.. ++.....+++|+.|+++++.-.|               ....+.+++.....+. .+++|++|+++.|.+++.
T Consensus       324 ~-~~~~~l~~l~~~~~~L~~L~L~~~~~~g---------------~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~  387 (594)
T 2p1m_B          324 Y-IEDAGLEVLASTCKDLRELRVFPSEPFV---------------MEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNA  387 (594)
T ss_dssp             G-GHHHHHHHHHHHCTTCCEEEEECSCTTC---------------SSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHH
T ss_pred             c-cCHHHHHHHHHhCCCCCEEEEecCcccc---------------cccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHH
Confidence            4 2211 11111123334444332210000               0011222221111121 244555555544444432


Q ss_pred             CCcccc-CCCccccccCCCccccccCCcccccCCccEEEee--c----cccCC-----CCchhccCCCCcceeeeccccc
Q 002010          425 IPAGLF-NLPLLNMMELDDNLLSGELPEKMSGASLNQLKVA--N----NNITG-----KIPAAIGNLPSLNILSLQNNRL  492 (982)
Q Consensus       425 ~p~~~~-~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~L~--~----N~i~~-----~~p~~~~~l~~L~~L~L~~N~l  492 (982)
                      .+..+. .++                       +|+.|+++  +    |++++     .++..+..+++|+.|++++ .+
T Consensus       388 ~~~~l~~~~~-----------------------~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l  443 (594)
T 2p1m_B          388 ALITIARNRP-----------------------NMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LL  443 (594)
T ss_dssp             HHHHHHHHCT-----------------------TCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SC
T ss_pred             HHHHHHhhCC-----------------------CcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-cc
Confidence            222221 122                       34444444  2    33331     1222355677777888766 55


Q ss_pred             cCCCcccccc-ccccceeeeeccccCCCCCccc-ccccCCCeeeCCCCcccCCCCc-ccccccccceEEcccccccccCc
Q 002010          493 EGEIPVESFN-LKMITSINISDNNISGEIPYSI-SQCHSLTSVDLSRNSLYGKIPP-GISKLIDLSILNLSRNGITGSIP  569 (982)
Q Consensus       493 ~~~~p~~~~~-l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p  569 (982)
                      ++..+..+.. +++|++|+|++|.+++..+..+ .++++|+.|+|++|.+++..+. .+..+++|+.|++++|+++..-.
T Consensus       444 ~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~~~~~  523 (594)
T 2p1m_B          444 TDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSVSFGAC  523 (594)
T ss_dssp             CHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSCCBHHHH
T ss_pred             cHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCCCHHHH
Confidence            5444444444 6778888888887765544444 5678888888888887654443 34557888888888888754433


Q ss_pred             ccc-ccccccceecccCCcc
Q 002010          570 NEM-RNMMSLTTLDLSYNNL  588 (982)
Q Consensus       570 ~~l-~~l~~L~~L~Ls~N~l  588 (982)
                      ..+ ..+++|+...+..+.-
T Consensus       524 ~~l~~~lp~l~i~~~~~~~~  543 (594)
T 2p1m_B          524 KLLGQKMPKLNVEVIDERGA  543 (594)
T ss_dssp             HHHHHHCTTEEEEEECSSSC
T ss_pred             HHHHHhCCCCEEEEecCCCc
Confidence            334 4567776666665543

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=99.94  E-value=2.5e-26  Score=272.77  Aligned_cols=269  Identities=25%  Similarity=0.343  Sum_probs=207.4

Q ss_pred             hhHHHHhhcccccccccCCCCCCCCCCCCEEecccCcCcccCchhhcCCCccceeecccccCCCCCCccccCCCCCCEEE
Q 002010          216 KNLREMYIGYFNTYTGGIPPGFGALTQLQVLDMASCNISGEIPTSLSRLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLD  295 (982)
Q Consensus       216 ~~L~~L~l~~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~  295 (982)
                      .+++.|+++. +.++ .+|..+.  ++|++|+|++|+|+ .+|.   .+++|++|+|++|++++ +|.   .+++|++|+
T Consensus        40 ~~l~~L~ls~-n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~  107 (622)
T 3g06_A           40 NGNAVLNVGE-SGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLTS-LPV---LPPGLLELS  107 (622)
T ss_dssp             HCCCEEECCS-SCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC---CCTTCCEEEECSCCCSC-CCC---CCTTCCEEE
T ss_pred             CCCcEEEecC-CCcC-ccChhhC--CCCcEEEecCCCCC-CCCC---cCCCCCEEEcCCCcCCc-CCC---CCCCCCEEE
Confidence            3578888885 3444 7787776  89999999999999 4555   57899999999999994 554   679999999


Q ss_pred             eeCCcccCcCchhhhcccchhhhhhccCCCCCCCCCcCCCCCCccEEEccCCCcccccCccccCCCcccEEEeccccccc
Q 002010          296 LSLNYLTGEIPESFAALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTG  375 (982)
Q Consensus       296 Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~  375 (982)
                      |++|.+++ +|.   .+++|+.|++++|++++ +|..   +++|++|++++|.+++ +|.   ...+|+.|++++|++++
T Consensus       108 Ls~N~l~~-l~~---~l~~L~~L~L~~N~l~~-lp~~---l~~L~~L~Ls~N~l~~-l~~---~~~~L~~L~L~~N~l~~  175 (622)
T 3g06_A          108 IFSNPLTH-LPA---LPSGLCKLWIFGNQLTS-LPVL---PPGLQELSVSDNQLAS-LPA---LPSELCKLWAYNNQLTS  175 (622)
T ss_dssp             ECSCCCCC-CCC---CCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC
T ss_pred             CcCCcCCC-CCC---CCCCcCEEECCCCCCCc-CCCC---CCCCCEEECcCCcCCC-cCC---ccCCCCEEECCCCCCCC
Confidence            99999995 444   56889999999999995 5553   4899999999999985 443   34678999999999984


Q ss_pred             cCCccccCccccceeecccccccccCCccccCCCCCCEEEccCCccCCCCCccccCCCccccccCCCccccccCCccccc
Q 002010          376 TIPRDLCKGGKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLSGELPEKMSG  455 (982)
Q Consensus       376 ~~p~~~~~~~~L~~L~l~~N~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~  455 (982)
                       +|   ..+++|+.|++++|.+++ +|..   +++|+.|++++|.++ .+|                        ..  .
T Consensus       176 -l~---~~~~~L~~L~Ls~N~l~~-l~~~---~~~L~~L~L~~N~l~-~l~------------------------~~--~  220 (622)
T 3g06_A          176 -LP---MLPSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLT-SLP------------------------AL--P  220 (622)
T ss_dssp             -CC---CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCS-SCC------------------------CC--C
T ss_pred             -Cc---ccCCCCcEEECCCCCCCC-CCCc---cchhhEEECcCCccc-ccC------------------------CC--C
Confidence             44   334556666666666553 2221   245555555555555 222                        11  1


Q ss_pred             CCccEEEeeccccCCCCchhccCCCCcceeeeccccccCCCccccccccccceeeeeccccCCCCCcccccccCCCeeeC
Q 002010          456 ASLNQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIPYSISQCHSLTSVDL  535 (982)
Q Consensus       456 ~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  535 (982)
                      .+|+.|++++|+|++ +|   ..+++|+.|++++|+|+ .+|.   .+++|++|+|++|+|+ .+|..|.++++|+.|+|
T Consensus       221 ~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L  291 (622)
T 3g06_A          221 SGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNL  291 (622)
T ss_dssp             TTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEEC
T ss_pred             CCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCC-cCCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEe
Confidence            467888888888875 44   45688999999999998 5665   6788999999999999 77889999999999999


Q ss_pred             CCCcccCCCCccccccc
Q 002010          536 SRNSLYGKIPPGISKLI  552 (982)
Q Consensus       536 s~N~l~~~~p~~~~~l~  552 (982)
                      ++|.+++.+|..+..++
T Consensus       292 ~~N~l~~~~~~~l~~L~  308 (622)
T 3g06_A          292 EGNPLSERTLQALREIT  308 (622)
T ss_dssp             CSCCCCHHHHHHHHHHH
T ss_pred             cCCCCCCcCHHHHHhcc
Confidence            99999999888887766

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=99.94  E-value=4.2e-30  Score=309.77  Aligned_cols=418  Identities=17%  Similarity=0.144  Sum_probs=256.8

Q ss_pred             CCEEEEEeccCCcccc---CCcC------------ccccccccEEEeccCCCCCCCChhhh-hhcccceeeccCC-cccc
Q 002010           71 SRVVSLNVSFMPLFGS---IPPE------------IGLLTKLVNLTISNVNLTGRLPSEMA-LLTSLKVFNISGN-VFQG  133 (982)
Q Consensus        71 ~~v~~l~l~~~~l~g~---~~~~------------i~~l~~L~~L~l~~n~l~~~~p~~l~-~l~~L~~L~Ls~n-~l~~  133 (982)
                      .++..+++.+......   .|..            ...+++|++|+|++|.+++..+..+. .+++|++|+|++| .+.+
T Consensus        66 ~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~  145 (594)
T 2p1m_B           66 PKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFST  145 (594)
T ss_dssp             TTCCEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEH
T ss_pred             CCceEEeccCCCchhhcccccccccchhhHHHHHHHHhCCCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCH
Confidence            4577888887653322   1211            24578999999999999988777776 7999999999999 5554


Q ss_pred             ccchhhhhcCCCccEEeccCccccCCCchhcc----ccccccEEeecCcc--cccc-cCCCccccCcceEeeccCccccc
Q 002010          134 NFAGQIVRGMTELQVLDAYNNNFTGPLPVEIA----SLKSLRHLSFGGNY--FTGK-IPQSYSEIQSLEYIGLNGIGLNG  206 (982)
Q Consensus       134 ~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~l~----~l~~L~~L~L~~N~--l~~~-~p~~~~~l~~L~~L~L~~n~i~~  206 (982)
                      .....+..++++|++|+|++|.+++..+..+.    .+++|++|+|++|.  ++.. ++..+..+++|++|++++|...+
T Consensus       146 ~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~~L~l~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~  225 (594)
T 2p1m_B          146 DGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLE  225 (594)
T ss_dssp             HHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCCEEECTTCCSCCCHHHHHHHHHHCTTCCEEECCTTSCHH
T ss_pred             HHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCcEEEecccCCcCCHHHHHHHHHhCCCCcEEecCCCCcHH
Confidence            44456667899999999999999877666655    66799999999997  3322 12223457999999999873222


Q ss_pred             chhhHHhhhhhHHHHhhcccccccccCCCCCCCCCCCCEEe-------cccCcCcccCchhhcCCCcccee-ecccccCC
Q 002010          207 TVPAFLSRLKNLREMYIGYFNTYTGGIPPGFGALTQLQVLD-------MASCNISGEIPTSLSRLKLLHSL-FLQMNKLT  278 (982)
Q Consensus       207 ~~~~~l~~l~~L~~L~l~~~n~~~~~~p~~~~~l~~L~~L~-------L~~n~l~~~~~~~l~~l~~L~~L-~L~~N~l~  278 (982)
                      .++..+.++                         ++|+.|+       +..+.+.+ ++..+.++++|+.| .+.+... 
T Consensus       226 ~l~~~~~~~-------------------------~~L~~L~l~~~~~~~~~~~~~~-l~~~l~~~~~L~~Ls~~~~~~~-  278 (594)
T 2p1m_B          226 KLATLLQRA-------------------------PQLEELGTGGYTAEVRPDVYSG-LSVALSGCKELRCLSGFWDAVP-  278 (594)
T ss_dssp             HHHHHHHHC-------------------------TTCSEEECSBCCCCCCHHHHHH-HHHHHHTCTTCCEEECCBTCCG-
T ss_pred             HHHHHHhcC-------------------------CcceEcccccccCccchhhHHH-HHHHHhcCCCcccccCCcccch-
Confidence            244444444                         4555555       44455554 44578999999999 4544333 


Q ss_pred             CCCCccccCCCCCCEEEeeCCcccCcCc-hhhhcccchhhhhhccCCCCCC-CCCcCCCCCCccEEEccC---------C
Q 002010          279 GHIPPQLSGLISLKSLDLSLNYLTGEIP-ESFAALKNLTLLQLFKNNLRGP-IPSFLGDFPNLEVLQVWG---------N  347 (982)
Q Consensus       279 ~~~~~~l~~l~~L~~L~Ls~N~l~~~~~-~~l~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~L~~---------N  347 (982)
                      +.++..+..+++|++|+|++|.+++... ..+..+++|+.|++++| +.+. ++.....+++|+.|++++         +
T Consensus       279 ~~l~~~~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~L~L~~~~~~g~~~~~  357 (594)
T 2p1m_B          279 AYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDLRELRVFPSEPFVMEPNV  357 (594)
T ss_dssp             GGGGGGHHHHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCCEEEEECSCTTCSSCSS
T ss_pred             hhHHHHHHhhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCCEEEEecCcccccccCC
Confidence            2445555578999999999999875433 33568899999999988 4422 222334588999999954         3


Q ss_pred             CcccccCcccc-CCCcccEEEeccccccccCCccccCccccceeecccccccccCCcccc-CCCCCCEEEcc--C----C
Q 002010          348 NFTFELPENLG-RNGKLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFIGPIPEELG-QCKSLTKIRFS--K----N  419 (982)
Q Consensus       348 ~l~~~~~~~l~-~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~l~~N~~~~~~~~~l~-~l~~L~~L~Ls--~----N  419 (982)
                      .++......+. .+++|+.|+++.|.+++..                        ...+. .+++|+.|+++  +    |
T Consensus       358 ~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~------------------------~~~l~~~~~~L~~L~L~~~~~~~~~  413 (594)
T 2p1m_B          358 ALTEQGLVSVSMGCPKLESVLYFCRQMTNAA------------------------LITIARNRPNMTRFRLCIIEPKAPD  413 (594)
T ss_dssp             CCCHHHHHHHHHHCTTCCEEEEEESCCCHHH------------------------HHHHHHHCTTCCEEEEEESSTTCCC
T ss_pred             CCCHHHHHHHHHhchhHHHHHHhcCCcCHHH------------------------HHHHHhhCCCcceeEeecccCCCcc
Confidence            44432222222 2455555555555555433                        33332 35566666666  2    2


Q ss_pred             ccCCCCC-----ccccCCCccccccCCCccccccCCcccccCCccEEEeeccccCCCCchhccC-CCCcceeeecccccc
Q 002010          420 YLNGTIP-----AGLFNLPLLNMMELDDNLLSGELPEKMSGASLNQLKVANNNITGKIPAAIGN-LPSLNILSLQNNRLE  493 (982)
Q Consensus       420 ~l~~~~p-----~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~L~~N~i~~~~p~~~~~-l~~L~~L~L~~N~l~  493 (982)
                      .+++...     ..+..+                       ++|+.|++++ ++++..+..+.. +++|+.|+|++|.++
T Consensus       414 ~l~~~~~~~~~~~l~~~~-----------------------~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~  469 (594)
T 2p1m_B          414 YLTLEPLDIGFGAIVEHC-----------------------KDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDS  469 (594)
T ss_dssp             TTTCCCTHHHHHHHHHHC-----------------------TTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSS
T ss_pred             cccCCchhhHHHHHHhhC-----------------------CCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCc
Confidence            3321100     001122                       2444455544 344333344443 566666666666665


Q ss_pred             CCCcccc-ccccccceeeeeccccCCCCCc-ccccccCCCeeeCCCCcccCCCCccc-ccccccceEEcccccc
Q 002010          494 GEIPVES-FNLKMITSINISDNNISGEIPY-SISQCHSLTSVDLSRNSLYGKIPPGI-SKLIDLSILNLSRNGI  564 (982)
Q Consensus       494 ~~~p~~~-~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~Ls~N~l  564 (982)
                      +..+..+ ..+++|++|+|++|.+++.... .+..+++|+.|++++|.++......+ ..+++|+...+..+.-
T Consensus       470 ~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~l~~~lp~l~i~~~~~~~~  543 (594)
T 2p1m_B          470 DLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSVSFGACKLLGQKMPKLNVEVIDERGA  543 (594)
T ss_dssp             HHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSCCBHHHHHHHHHHCTTEEEEEECSSSC
T ss_pred             HHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCCCHHHHHHHHHhCCCCEEEEecCCCc
Confidence            4333333 4466667777777766533332 23456777777777777643333333 4556666666665543

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=99.94  E-value=2.9e-28  Score=268.37  Aligned_cols=268  Identities=18%  Similarity=0.168  Sum_probs=163.0

Q ss_pred             CCCEEecccCcCcccCchhhcCCCccceeecccccCCCCCCccccCCCCCCEEEeeCCcccCcCchhhhcccchhhhhhc
Q 002010          242 QLQVLDMASCNISGEIPTSLSRLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQLF  321 (982)
Q Consensus       242 ~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~  321 (982)
                      +++.++++.+.+.......+..+++|++|+|++|++++..|..|..+++|++|+|++|.+++..+  +..+++|++|+++
T Consensus        11 ~l~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls   88 (317)
T 3o53_A           11 RYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLN   88 (317)
T ss_dssp             EEEEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECC
T ss_pred             ceeEeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECc
Confidence            35556666666665554555566667777777777776666666777777777777777765443  6666666666666


Q ss_pred             cCCCCCCCCCcCCCCCCccEEEccCCCcccccCccccCCCcccEEEeccccccccCCccccCccccceeecccccccccC
Q 002010          322 KNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFIGPI  401 (982)
Q Consensus       322 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~l~~N~~~~~~  401 (982)
                      +|++++..     ..++|++|++++|++++..+..   +++|++|++++|++++..+..+..+++|++|++++|.+.+..
T Consensus        89 ~n~l~~l~-----~~~~L~~L~l~~n~l~~~~~~~---~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~  160 (317)
T 3o53_A           89 NNYVQELL-----VGPSIETLHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVN  160 (317)
T ss_dssp             SSEEEEEE-----ECTTCCEEECCSSCCSEEEECC---CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEE
T ss_pred             CCcccccc-----CCCCcCEEECCCCccCCcCccc---cCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCccc
Confidence            66666422     2266777777777766544332   455666666666666555556666666666666666666555


Q ss_pred             Cccc-cCCCCCCEEEccCCccCCCCCccccCCCccccccCCCccccccCCcccccCCccEEEeeccccCCCCchhccCCC
Q 002010          402 PEEL-GQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLSGELPEKMSGASLNQLKVANNNITGKIPAAIGNLP  480 (982)
Q Consensus       402 ~~~l-~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~L~~N~i~~~~p~~~~~l~  480 (982)
                      +..+ ..+++|++|++++|++++. +. ...+                       .+|++|++++|++++. |..+..++
T Consensus       161 ~~~~~~~l~~L~~L~L~~N~l~~~-~~-~~~l-----------------------~~L~~L~Ls~N~l~~l-~~~~~~l~  214 (317)
T 3o53_A          161 FAELAASSDTLEHLNLQYNFIYDV-KG-QVVF-----------------------AKLKTLDLSSNKLAFM-GPEFQSAA  214 (317)
T ss_dssp             GGGGGGGTTTCCEEECTTSCCCEE-EC-CCCC-----------------------TTCCEEECCSSCCCEE-CGGGGGGT
T ss_pred             HHHHhhccCcCCEEECCCCcCccc-cc-cccc-----------------------ccCCEEECCCCcCCcc-hhhhcccC
Confidence            5554 3566666666666666532 11 1123                       3455555555555533 33366666


Q ss_pred             CcceeeeccccccCCCccccccccccceeeeeccccC-CCCCcccccccCCCeeeCC-CCcccCCCCc
Q 002010          481 SLNILSLQNNRLEGEIPVESFNLKMITSINISDNNIS-GEIPYSISQCHSLTSVDLS-RNSLYGKIPP  546 (982)
Q Consensus       481 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls-~N~l~~~~p~  546 (982)
                      +|+.|++++|+++ .+|..+..+++|+.|++++|.++ +.+|..+..+++|+.|+++ .+.++|..|.
T Consensus       215 ~L~~L~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~~~l~~~~~~  281 (317)
T 3o53_A          215 GVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEE  281 (317)
T ss_dssp             TCSEEECTTSCCC-EECTTCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHHHHHHHHSSSSC
T ss_pred             cccEEECcCCccc-chhhHhhcCCCCCEEEccCCCccCcCHHHHHhccccceEEECCCchhccCCchh
Confidence            6666666666666 45556666666666666666666 5566666666777777766 3345554444

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.93  E-value=8.6e-28  Score=283.71  Aligned_cols=186  Identities=19%  Similarity=0.123  Sum_probs=131.0

Q ss_pred             ccccccceEEEEE-EeCCCcEEEEEEeccCCCC---------CchhhHHHHHHHHhcC-CCCcccceEeEEEcCCccEEE
Q 002010          699 IIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTG---------GNDHGFLAEIQTLGRI-RHRNIVRLLGYVSNRDTNLLL  767 (982)
Q Consensus       699 ~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~---------~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv  767 (982)
                      ..+.|+.|.+..+ +.-.|+.||+|++......         ...+++.+|+++|+++ .|+||++++++++++...|||
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV  320 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV  320 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence            3566777777665 3346889999999654321         1234689999999999 799999999999999999999


Q ss_pred             EeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhcccc
Q 002010          768 YEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDA  847 (982)
Q Consensus       768 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  847 (982)
                      |||++|++|.+++.  +.++++..   +|+.||+.||+|+|++|   ||||||||+|||++++|.+||+|||+|+.....
T Consensus       321 MEyv~G~~L~d~i~--~~~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~  392 (569)
T 4azs_A          321 MEKLPGRLLSDMLA--AGEEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD  392 (569)
T ss_dssp             EECCCSEEHHHHHH--TTCCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred             EecCCCCcHHHHHH--hCCCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence            99999999999997  44567654   47899999999999999   999999999999999999999999999876533


Q ss_pred             CCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCC
Q 002010          848 GASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKP  895 (982)
Q Consensus       848 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p  895 (982)
                        .......+||+.|||||++.+ .+..++|+|++|++.+++.++..|
T Consensus       393 --~~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          393 --CSWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             ---CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred             --CccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence              223445789999999999876 467789999999998877655433

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.93  E-value=7e-27  Score=272.35  Aligned_cols=222  Identities=21%  Similarity=0.218  Sum_probs=188.4

Q ss_pred             CCCcccEEEeccccccccCCccccCccccceeecccccccccCCccccCCCCCCEEEccCCccCCCCCccccCCCccccc
Q 002010          359 RNGKLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMM  438 (982)
Q Consensus       359 ~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~l~~N~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L  438 (982)
                      .+++|+.|+|++|.+++..|..|..+++|++|+|++|.+++..|  ++.+++|++|+|++|.|++..     ..++|+.|
T Consensus        32 ~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~-----~~~~L~~L  104 (487)
T 3oja_A           32 SAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELL-----VGPSIETL  104 (487)
T ss_dssp             TGGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEE-----ECTTCCEE
T ss_pred             cCCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCC-----CCCCcCEE
Confidence            34589999999999998888889999999999999999987766  889999999999999998433     23789999


Q ss_pred             cCCCccccccCCcccccCCccEEEeeccccCCCCchhccCCCCcceeeeccccccCCCccccc-cccccceeeeeccccC
Q 002010          439 ELDDNLLSGELPEKMSGASLNQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESF-NLKMITSINISDNNIS  517 (982)
Q Consensus       439 ~L~~N~l~~~~~~~~~~~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~  517 (982)
                      ++++|.+++..+..+  ++|+.|+|++|++++..|..++.+++|++|+|++|++++.+|..+. .+++|++|+|++|.|+
T Consensus       105 ~L~~N~l~~~~~~~l--~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~  182 (487)
T 3oja_A          105 HAANNNISRVSCSRG--QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY  182 (487)
T ss_dssp             ECCSSCCCCEEECCC--SSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCC
T ss_pred             ECcCCcCCCCCcccc--CCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccc
Confidence            999999988776543  5799999999999988888899999999999999999988888776 7899999999999998


Q ss_pred             CCCCcccccccCCCeeeCCCCcccCCCCcccccccccceEEcccccccccCccccccccccceecccCCccc-cCCC
Q 002010          518 GEIPYSISQCHSLTSVDLSRNSLYGKIPPGISKLIDLSILNLSRNGITGSIPNEMRNMMSLTTLDLSYNNLI-GNIP  593 (982)
Q Consensus       518 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~-~~ip  593 (982)
                      +..+  +..+++|+.|+|++|.|++ +|..+..+++|+.|+|++|+|++ +|..+..+++|+.|++++|++. +.+|
T Consensus       183 ~~~~--~~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c~~~~  255 (487)
T 3oja_A          183 DVKG--QVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLR  255 (487)
T ss_dssp             EEEC--CCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCHHHHH
T ss_pred             cccc--cccCCCCCEEECCCCCCCC-CCHhHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcCcchH
Confidence            6633  3458999999999999986 45558899999999999999985 7777889999999999999987 4444

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=99.93  E-value=2.4e-25  Score=239.06  Aligned_cols=219  Identities=21%  Similarity=0.267  Sum_probs=170.4

Q ss_pred             CCCCccceeeeCCCCCEEEEEeccCCccccCCcCccccccccEEEeccCCCCCCCChhhhhhcccceeeccCCccccccc
Q 002010           57 SAHCSFSGVTCDQDSRVVSLNVSFMPLFGSIPPEIGLLTKLVNLTISNVNLTGRLPSEMALLTSLKVFNISGNVFQGNFA  136 (982)
Q Consensus        57 ~~~C~w~gv~C~~~~~v~~l~l~~~~l~g~~~~~i~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~~  136 (982)
                      .++|.|.|+.|+-.+.+..+++++.++. .+|..+.  +++++|+|++|++++..+..+..+++|++|+|++|.++ .++
T Consensus         2 ~~~C~~~~~~C~c~~~~~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~i~   77 (270)
T 2o6q_A            2 EALCKKDGGVCSCNNNKNSVDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLP   77 (270)
T ss_dssp             CCCBGGGTCSBEEETTTTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCS-CCC
T ss_pred             CccCCCCCCCCEeCCCCCEEEccCCCCC-ccCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccC-eeC
Confidence            3689999999975555667888888877 4777665  67899999999998777778888999999999998887 455


Q ss_pred             hhhhhcCCCccEEeccCccccCCCchhccccccccEEeecCcccccccCCCccccCcceEeeccCcccccchhhHHhhhh
Q 002010          137 GQIVRGMTELQVLDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLNGIGLNGTVPAFLSRLK  216 (982)
Q Consensus       137 ~~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~  216 (982)
                      ..++.++++|++|+|++|++++..+..+..+++|++|+|++|++++..+..|+.+++|++|++++|.+.+.         
T Consensus        78 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~---------  148 (270)
T 2o6q_A           78 AGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSL---------  148 (270)
T ss_dssp             TTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCC---------
T ss_pred             hhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCcc---------
Confidence            66677888888888888888876667778888888888888888877777778888888888877665422         


Q ss_pred             hHHHHhhcccccccccCCCCCCCCCCCCEEecccCcCcccCchhhcCCCccceeecccccCCCCCCccccCCCCCCEEEe
Q 002010          217 NLREMYIGYFNTYTGGIPPGFGALTQLQVLDMASCNISGEIPTSLSRLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDL  296 (982)
Q Consensus       217 ~L~~L~l~~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L  296 (982)
                                      .+..|+.+++|++|+|++|++++..+..|..+++|++|+|++|++++..+..+..+++|+.|+|
T Consensus       149 ----------------~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l  212 (270)
T 2o6q_A          149 ----------------PKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQL  212 (270)
T ss_dssp             ----------------CTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEEC
T ss_pred             ----------------CHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEe
Confidence                            1223666777888888888887766667777888888888888887666666777788888888


Q ss_pred             eCCcccCc
Q 002010          297 SLNYLTGE  304 (982)
Q Consensus       297 s~N~l~~~  304 (982)
                      ++|.+...
T Consensus       213 ~~N~~~c~  220 (270)
T 2o6q_A          213 QENPWDCT  220 (270)
T ss_dssp             CSSCBCCS
T ss_pred             cCCCeeCC
Confidence            88877643

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=99.92  E-value=7.6e-25  Score=236.17  Aligned_cols=210  Identities=20%  Similarity=0.175  Sum_probs=149.8

Q ss_pred             cccEEEeccccccccCCccccCccccceeecccccccccCCccccCCCCCCEEEccCCccCCCCCccccCCCccccccCC
Q 002010          362 KLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELD  441 (982)
Q Consensus       362 ~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~l~~N~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~  441 (982)
                      +|++|++++|++++..+..+.++++|++|++++|.+.+..+..+..+++|++|++++|++++..+..+..+         
T Consensus        29 ~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l---------   99 (276)
T 2z62_A           29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGL---------   99 (276)
T ss_dssp             TCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTC---------
T ss_pred             CccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCC---------
Confidence            45555555555554444455555555555555555554444455555555555555555544433444444         


Q ss_pred             CccccccCCcccccCCccEEEeeccccCCCCchhccCCCCcceeeeccccccCC-CccccccccccceeeeeccccCCCC
Q 002010          442 DNLLSGELPEKMSGASLNQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLEGE-IPVESFNLKMITSINISDNNISGEI  520 (982)
Q Consensus       442 ~N~l~~~~~~~~~~~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~  520 (982)
                                    .+|++|++++|++++..+..++.+++|++|++++|++++. +|..+..+++|++|+|++|++++..
T Consensus       100 --------------~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~  165 (276)
T 2z62_A          100 --------------SSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIY  165 (276)
T ss_dssp             --------------TTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEEC
T ss_pred             --------------ccccEEECCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCC
Confidence                          4566666666666666666788888999999999998763 5888888999999999999998877


Q ss_pred             CcccccccCCC----eeeCCCCcccCCCCcccccccccceEEcccccccccCccccccccccceecccCCccccCCCCC
Q 002010          521 PYSISQCHSLT----SVDLSRNSLYGKIPPGISKLIDLSILNLSRNGITGSIPNEMRNMMSLTTLDLSYNNLIGNIPSG  595 (982)
Q Consensus       521 p~~~~~l~~L~----~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~  595 (982)
                      +..+..+++|+    .|++++|.+++..+..+. ..+|+.|+|++|++++..+..+..+++|+.|+|++|++++..|..
T Consensus       166 ~~~~~~l~~L~~l~l~L~ls~n~l~~~~~~~~~-~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~l  243 (276)
T 2z62_A          166 CTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFK-EIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRI  243 (276)
T ss_dssp             GGGGHHHHTCTTCCEEEECCSSCCCEECTTSSC-SCCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCTTTT
T ss_pred             HHHhhhhhhccccceeeecCCCcccccCccccC-CCcccEEECCCCceeecCHhHhcccccccEEEccCCcccccCCch
Confidence            78888888887    899999999865555554 458999999999999777777899999999999999999888754

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=99.91  E-value=2.2e-24  Score=232.55  Aligned_cols=205  Identities=19%  Similarity=0.168  Sum_probs=111.9

Q ss_pred             ccceeecccccCCCCCCccccCCCCCCEEEeeCCcccCcCchhhhcccchhhhhhccCCCCCCCCCcCCCCCCccEEEcc
Q 002010          266 LLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVW  345 (982)
Q Consensus       266 ~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~  345 (982)
                      +|++|++++|++++..+..|.++++|++|++++|++++..+..|..+++|++|++++|++++..+..             
T Consensus        29 ~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~-------------   95 (276)
T 2z62_A           29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGA-------------   95 (276)
T ss_dssp             TCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTT-------------
T ss_pred             CccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhh-------------
Confidence            4555555555555444444555555555555555555444444444444444444444444444444             


Q ss_pred             CCCcccccCccccCCCcccEEEeccccccccCCccccCccccceeeccccccccc-CCccccCCCCCCEEEccCCccCCC
Q 002010          346 GNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFIGP-IPEELGQCKSLTKIRFSKNYLNGT  424 (982)
Q Consensus       346 ~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~l~~N~~~~~-~~~~l~~l~~L~~L~Ls~N~l~~~  424 (982)
                                 +..+++|++|++++|++++..+..+..+++|++|++++|.+.+. +|..++.+++|++|++++|++++.
T Consensus        96 -----------~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~  164 (276)
T 2z62_A           96 -----------FSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSI  164 (276)
T ss_dssp             -----------TTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEE
T ss_pred             -----------hcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcC
Confidence                       44444444444444444444333444555555555555555442 466666666777777777776655


Q ss_pred             CCccccCCCccc----cccCCCccccccCCcccccCCccEEEeeccccCCCCchhccCCCCcceeeeccccccC
Q 002010          425 IPAGLFNLPLLN----MMELDDNLLSGELPEKMSGASLNQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLEG  494 (982)
Q Consensus       425 ~p~~~~~l~~L~----~L~L~~N~l~~~~~~~~~~~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~  494 (982)
                      .+..+..++.|+    .|++++|.+++..+..+...+|+.|++++|++++..+..|..+++|+.|++++|++++
T Consensus       165 ~~~~~~~l~~L~~l~l~L~ls~n~l~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c  238 (276)
T 2z62_A          165 YCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDC  238 (276)
T ss_dssp             CGGGGHHHHTCTTCCEEEECCSSCCCEECTTSSCSCCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCC
T ss_pred             CHHHhhhhhhccccceeeecCCCcccccCccccCCCcccEEECCCCceeecCHhHhcccccccEEEccCCcccc
Confidence            555555555444    4555555555555544444556666666666665555556666666666666666653

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=99.91  E-value=9.6e-24  Score=228.51  Aligned_cols=203  Identities=21%  Similarity=0.204  Sum_probs=111.5

Q ss_pred             ccCccccceeecccccccccCCccccCCCCCCEEEccCCccCCCCCccccCCCccccccCCCccccccCCcccccCCccE
Q 002010          381 LCKGGKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLSGELPEKMSGASLNQ  460 (982)
Q Consensus       381 ~~~~~~L~~L~l~~N~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~  460 (982)
                      +.++++++++++++|.++. +|..+.  ++++.|+|++|++++..+..|..+++|++|++++|.+++..+. ....+|++
T Consensus         6 ~~~l~~l~~l~~~~~~l~~-ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~-~~l~~L~~   81 (290)
T 1p9a_G            6 VSKVASHLEVNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD-GTLPVLGT   81 (290)
T ss_dssp             EECSTTCCEEECTTSCCSS-CCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC-SCCTTCCE
T ss_pred             ccccCCccEEECCCCCCCc-CCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC-CCCCcCCE
Confidence            4455667777777777663 343332  5677777777777766666666666666666666666643332 22345555


Q ss_pred             EEeeccccCCCCchhccCCCCcceeeeccccccCCCccccccccccceeeeeccccCCCCCcccccccCCCeeeCCCCcc
Q 002010          461 LKVANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIPYSISQCHSLTSVDLSRNSL  540 (982)
Q Consensus       461 L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l  540 (982)
                      |++++|+++ .+|..+..+++|++|++++|++++..|..+..+++|++|+|++|+|++..+..|..+++|+.|+|++|+|
T Consensus        82 L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l  160 (290)
T 1p9a_G           82 LDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNL  160 (290)
T ss_dssp             EECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCC
T ss_pred             EECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcC
Confidence            555555555 3444555555555555555555544444455555555555555555544444455555555555555555


Q ss_pred             cCCCCcccccccccceEEcccccccccCccccccccccceecccCCccc
Q 002010          541 YGKIPPGISKLIDLSILNLSRNGITGSIPNEMRNMMSLTTLDLSYNNLI  589 (982)
Q Consensus       541 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~  589 (982)
                      ++..+..|..+++|+.|+|++|+|+ .+|..+..+.+|+.|+|++|++.
T Consensus       161 ~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~  208 (290)
T 1p9a_G          161 TELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL  208 (290)
T ss_dssp             SCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBC
T ss_pred             CccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCcc
Confidence            5433344455555555555555555 44444444455555555555443

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=99.91  E-value=2.6e-23  Score=223.13  Aligned_cols=205  Identities=21%  Similarity=0.195  Sum_probs=138.8

Q ss_pred             ccEEEeccccccccCCccccCccccceeecccccccccCCccccCCCCCCEEEccCCccCCCCCccccCCCccccccCCC
Q 002010          363 LLILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDD  442 (982)
Q Consensus       363 L~~L~L~~N~l~~~~p~~~~~~~~L~~L~l~~N~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~  442 (982)
                      .+.+++++|+++ .+|..+.  .++++|++++|.+.+..+..|.++++|++|++++|++++..+..|..++         
T Consensus        18 ~~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~---------   85 (270)
T 2o6q_A           18 KNSVDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELK---------   85 (270)
T ss_dssp             TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCT---------
T ss_pred             CCEEEccCCCCC-ccCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCC---------
Confidence            445555555555 3343332  3445555555555544444555555555555555555533333333343         


Q ss_pred             ccccccCCcccccCCccEEEeeccccCCCCchhccCCCCcceeeeccccccCCCccccccccccceeeeeccccCCCCCc
Q 002010          443 NLLSGELPEKMSGASLNQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIPY  522 (982)
Q Consensus       443 N~l~~~~~~~~~~~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~  522 (982)
                                    +|++|++++|++++..+..|..+++|++|++++|++++..+..+..+++|++|+|++|+|++..+.
T Consensus        86 --------------~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~  151 (270)
T 2o6q_A           86 --------------NLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKG  151 (270)
T ss_dssp             --------------TCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTT
T ss_pred             --------------CCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHh
Confidence                          455555555555555556677778888888888888766666677788888888888888866666


Q ss_pred             ccccccCCCeeeCCCCcccCCCCcccccccccceEEcccccccccCccccccccccceecccCCccccCCC
Q 002010          523 SISQCHSLTSVDLSRNSLYGKIPPGISKLIDLSILNLSRNGITGSIPNEMRNMMSLTTLDLSYNNLIGNIP  593 (982)
Q Consensus       523 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip  593 (982)
                      .|..+++|+.|+|++|++++..+..|.++++|+.|+|++|+|++..+..+..+++|+.|+|++|++....+
T Consensus       152 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~  222 (270)
T 2o6q_A          152 VFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCTCN  222 (270)
T ss_dssp             TTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCSSS
T ss_pred             HccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeCCCc
Confidence            68888888888888888887667778888888888888888887666678888888888888888876654

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.91  E-value=7.2e-25  Score=257.34  Aligned_cols=187  Identities=19%  Similarity=0.228  Sum_probs=147.4

Q ss_pred             ccccccccccceEEEEEEeCCCcEEEEEEeccCCCCCc-------hhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEE
Q 002010          695 KDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGN-------DHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLL  767 (982)
Q Consensus       695 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  767 (982)
                      ...+.||+|+||.||+|.. .++.+++|+.........       .+.+.+|++++++++||||+++..++...+..++|
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV  417 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM  417 (540)
T ss_dssp             ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred             CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence            4567899999999999955 678899998744322211       23478999999999999999766666677888999


Q ss_pred             EeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhcccc
Q 002010          768 YEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDA  847 (982)
Q Consensus       768 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  847 (982)
                      |||+++++|.+++..          +..++.|+++|++|||+++   |+||||||+||+++.  .+||+|||+|+.....
T Consensus       418 mE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~~  482 (540)
T 3en9_A          418 MSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNLD  482 (540)
T ss_dssp             EECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCCH
T ss_pred             EECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCCc
Confidence            999999999999963          5689999999999999998   999999999999998  9999999999877542


Q ss_pred             CCcc-----ccccccccccccccccccc--CCCCcchhhHHHHHHHHHHHhCCCCCC
Q 002010          848 GASE-----CMSSVAGSYGYIAPEYAYT--LKVDEKSDVYSFGVVLLELIAGKKPVG  897 (982)
Q Consensus       848 ~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~elltg~~p~~  897 (982)
                      ....     ......||+.|||||++..  ..|+..+|+|+..+-..+.+.++.+|.
T Consensus       483 ~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          483 EDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             HHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             cccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence            1111     1235679999999999986  668888999999999888888887774

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.91  E-value=4.9e-24  Score=229.04  Aligned_cols=224  Identities=15%  Similarity=0.140  Sum_probs=150.8

Q ss_pred             ccchhhhhhccCCCCCCCCCcCCCCCCccEEEccCCCcccccCccccCCCcccEEEeccccccccCCccccCccccceee
Q 002010          312 LKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDLCKGGKLKSLI  391 (982)
Q Consensus       312 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~  391 (982)
                      +.++..+++..+.+.+..  .+..+++|+.|++++|.++.  ...+..+++|++|++++|.+++.               
T Consensus        18 ~~~l~~l~l~~~~~~~~~--~~~~l~~L~~L~l~~~~i~~--~~~l~~l~~L~~L~l~~n~l~~~---------------   78 (272)
T 3rfs_A           18 FAETIKANLKKKSVTDAV--TQNELNSIDQIIANNSDIKS--VQGIQYLPNVRYLALGGNKLHDI---------------   78 (272)
T ss_dssp             HHHHHHHHHTCSCTTSEE--CHHHHTTCCEEECTTSCCCC--CTTGGGCTTCCEEECTTSCCCCC---------------
T ss_pred             HHHHHHHHhcCccccccc--ccccccceeeeeeCCCCccc--ccccccCCCCcEEECCCCCCCCc---------------
Confidence            456777888888777543  35567788888888888773  23466677777777777776631               


Q ss_pred             cccccccccCCccccCCCCCCEEEccCCccCCCCCccccCCCccccccCCCccccccCCcccccCCccEEEeeccccCCC
Q 002010          392 LMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLSGELPEKMSGASLNQLKVANNNITGK  471 (982)
Q Consensus       392 l~~N~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~L~~N~i~~~  471 (982)
                                 ..+..+++|++|++++|.+++..+..+..+++|++|+                       +++|++++.
T Consensus        79 -----------~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~-----------------------L~~n~l~~~  124 (272)
T 3rfs_A           79 -----------SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELV-----------------------LVENQLQSL  124 (272)
T ss_dssp             -----------GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEE-----------------------CTTSCCCCC
T ss_pred             -----------hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEE-----------------------CCCCcCCcc
Confidence                       2345556666666666666654444444444333333                       333333334


Q ss_pred             CchhccCCCCcceeeeccccccCCCccccccccccceeeeeccccCCCCCcccccccCCCeeeCCCCcccCCCCcccccc
Q 002010          472 IPAAIGNLPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYGKIPPGISKL  551 (982)
Q Consensus       472 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l  551 (982)
                      .+..|+.+++|++|++++|++++..+..+..+++|++|++++|++++..+..|+.+++|+.|+|++|++++..|..+..+
T Consensus       125 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l  204 (272)
T 3rfs_A          125 PDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRL  204 (272)
T ss_dssp             CTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTC
T ss_pred             CHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCC
Confidence            44456666677777777777765555556667777777777777776666667788888888888888887777777888


Q ss_pred             cccceEEcccccccccCccccccccccceecccCCccccCCCCC
Q 002010          552 IDLSILNLSRNGITGSIPNEMRNMMSLTTLDLSYNNLIGNIPSG  595 (982)
Q Consensus       552 ~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~  595 (982)
                      ++|+.|+|++|.+++.       +++|++|+++.|.++|.+|..
T Consensus       205 ~~L~~L~l~~N~~~~~-------~~~l~~l~~~~n~~~g~ip~~  241 (272)
T 3rfs_A          205 TSLQYIWLHDNPWDCT-------CPGIRYLSEWINKHSGVVRNS  241 (272)
T ss_dssp             TTCCEEECCSSCBCCC-------TTTTHHHHHHHHHTGGGBBCT
T ss_pred             cCCCEEEccCCCcccc-------CcHHHHHHHHHHhCCCcccCc
Confidence            8888888888887754       446888888888888888853

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.90  E-value=4.7e-24  Score=229.17  Aligned_cols=225  Identities=21%  Similarity=0.216  Sum_probs=108.3

Q ss_pred             cccceeeccCCccccccchhhhhcCCCccEEeccCccccCCCchhccccccccEEeecCcccccccCCCccccCcceEee
Q 002010          119 TSLKVFNISGNVFQGNFAGQIVRGMTELQVLDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIG  198 (982)
Q Consensus       119 ~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  198 (982)
                      ..+..++++.+.+.+...   ...+++|+.|++++|.++. + ..++.+++|++|+|++|++++.  ..++.        
T Consensus        19 ~~l~~l~l~~~~~~~~~~---~~~l~~L~~L~l~~~~i~~-~-~~l~~l~~L~~L~l~~n~l~~~--~~l~~--------   83 (272)
T 3rfs_A           19 AETIKANLKKKSVTDAVT---QNELNSIDQIIANNSDIKS-V-QGIQYLPNVRYLALGGNKLHDI--SALKE--------   83 (272)
T ss_dssp             HHHHHHHHTCSCTTSEEC---HHHHTTCCEEECTTSCCCC-C-TTGGGCTTCCEEECTTSCCCCC--GGGTT--------
T ss_pred             HHHHHHHhcCcccccccc---cccccceeeeeeCCCCccc-c-cccccCCCCcEEECCCCCCCCc--hhhcC--------
Confidence            344455555555543322   2345566666666666552 2 2456666666666666665531  13333        


Q ss_pred             ccCcccccchhhHHhhhhhHHHHhhcccccccccCCCCCCCCCCCCEEecccCcCcccCchhhcCCCccceeecccccCC
Q 002010          199 LNGIGLNGTVPAFLSRLKNLREMYIGYFNTYTGGIPPGFGALTQLQVLDMASCNISGEIPTSLSRLKLLHSLFLQMNKLT  278 (982)
Q Consensus       199 L~~n~i~~~~~~~l~~l~~L~~L~l~~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~  278 (982)
                                                               +++|++|++++|++++..+..|.++++|++|++++|+++
T Consensus        84 -----------------------------------------l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~  122 (272)
T 3rfs_A           84 -----------------------------------------LTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQ  122 (272)
T ss_dssp             -----------------------------------------CTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCC
T ss_pred             -----------------------------------------CCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCC
Confidence                                                     344444444444444444444444444444444444444


Q ss_pred             CCCCccccCCCCCCEEEeeCCcccCcCchhhhcccchhhhhhccCCCCCCCCCcCCCCCCccEEEccCCCcccccCcccc
Q 002010          279 GHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLG  358 (982)
Q Consensus       279 ~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~  358 (982)
                      +..+..+..+++|++|++++|++++..+..|..+++|++|++++|++++..+..++.+++|++|++++|++++..+..+.
T Consensus       123 ~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~  202 (272)
T 3rfs_A          123 SLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFD  202 (272)
T ss_dssp             CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTT
T ss_pred             ccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHh
Confidence            44444444445555555555555444444444444444455555544444444444455555555555555544444444


Q ss_pred             CCCcccEEEeccccccccCCccccCccccceeecccccccccCCcccc
Q 002010          359 RNGKLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFIGPIPEELG  406 (982)
Q Consensus       359 ~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~l~~N~~~~~~~~~l~  406 (982)
                      .+++|+.|++++|.+.+.       +++|+.|++..|.++|.+|.+++
T Consensus       203 ~l~~L~~L~l~~N~~~~~-------~~~l~~l~~~~n~~~g~ip~~~~  243 (272)
T 3rfs_A          203 RLTSLQYIWLHDNPWDCT-------CPGIRYLSEWINKHSGVVRNSAG  243 (272)
T ss_dssp             TCTTCCEEECCSSCBCCC-------TTTTHHHHHHHHHTGGGBBCTTS
T ss_pred             CCcCCCEEEccCCCcccc-------CcHHHHHHHHHHhCCCcccCccc
Confidence            445555555555544422       22344444444444444444443

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=99.90  E-value=1.1e-25  Score=250.43  Aligned_cols=268  Identities=15%  Similarity=0.180  Sum_probs=191.3

Q ss_pred             CCccceeeeCCCCCEEEEEeccCCccccCCcCcccc--ccccEEEeccCCCCCCCChhhhhhcccceeeccCCccccccc
Q 002010           59 HCSFSGVTCDQDSRVVSLNVSFMPLFGSIPPEIGLL--TKLVNLTISNVNLTGRLPSEMALLTSLKVFNISGNVFQGNFA  136 (982)
Q Consensus        59 ~C~w~gv~C~~~~~v~~l~l~~~~l~g~~~~~i~~l--~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~~  136 (982)
                      |.+|.++.|+. ..+..++++++.+.   |..++.+  ++++.|++++|.+++..+. +..+++|++|+|++|.+.+...
T Consensus        36 c~~W~~~~~~~-~~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~  110 (336)
T 2ast_B           36 CKRWYRLASDE-SLWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTL  110 (336)
T ss_dssp             CHHHHHHHTCS-TTSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHH
T ss_pred             HHHHHHHhcCc-hhheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHH
Confidence            55899999973 45778888887765   4456666  8899999999999887665 5678999999999998876534


Q ss_pred             hhhhhcCCCccEEeccCccccCCCchhccccccccEEeecCc-ccccc-cCCCccccCcceEeeccCc-ccccc-hhhHH
Q 002010          137 GQIVRGMTELQVLDAYNNNFTGPLPVEIASLKSLRHLSFGGN-YFTGK-IPQSYSEIQSLEYIGLNGI-GLNGT-VPAFL  212 (982)
Q Consensus       137 ~~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N-~l~~~-~p~~~~~l~~L~~L~L~~n-~i~~~-~~~~l  212 (982)
                      ...+..+++|++|+|++|++++..|..++.+++|++|+|++| .+++. ++..+..+++|++|++++| .+++. ++..+
T Consensus       111 ~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~  190 (336)
T 2ast_B          111 HGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAV  190 (336)
T ss_dssp             HHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHH
T ss_pred             HHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHH
Confidence            556788999999999999998888888999999999999999 67763 6667888999999999999 88764 56667


Q ss_pred             hhhh-hHHHHhhcccc-ccc-ccCCCCCCCCCCCCEEecccCc-CcccCchhhcCCCccceeeccccc-CCCCCCccccC
Q 002010          213 SRLK-NLREMYIGYFN-TYT-GGIPPGFGALTQLQVLDMASCN-ISGEIPTSLSRLKLLHSLFLQMNK-LTGHIPPQLSG  287 (982)
Q Consensus       213 ~~l~-~L~~L~l~~~n-~~~-~~~p~~~~~l~~L~~L~L~~n~-l~~~~~~~l~~l~~L~~L~L~~N~-l~~~~~~~l~~  287 (982)
                      ..++ +|++|+++++. .++ +.+|..+..+++|++|++++|. +++..+..+.++++|++|++++|. ++......+..
T Consensus       191 ~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~~l~~  270 (336)
T 2ast_B          191 AHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGE  270 (336)
T ss_dssp             HHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGG
T ss_pred             HhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCCCCCHHHHHHHhc
Confidence            7777 77777776653 233 4455556666777777777776 555566666677777777777764 22222224566


Q ss_pred             CCCCCEEEeeCCcccCcCchhhhcc-cchhhhhhccCCCCCCCCCcCCC
Q 002010          288 LISLKSLDLSLNYLTGEIPESFAAL-KNLTLLQLFKNNLRGPIPSFLGD  335 (982)
Q Consensus       288 l~~L~~L~Ls~N~l~~~~~~~l~~l-~~L~~L~L~~N~l~~~~p~~~~~  335 (982)
                      +++|+.|++++| ++.   ..+..+ ..++.|++++|++++..|..++.
T Consensus       271 ~~~L~~L~l~~~-i~~---~~~~~l~~~l~~L~l~~n~l~~~~~~~~~~  315 (336)
T 2ast_B          271 IPTLKTLQVFGI-VPD---GTLQLLKEALPHLQINCSHFTTIARPTIGN  315 (336)
T ss_dssp             CTTCCEEECTTS-SCT---TCHHHHHHHSTTSEESCCCSCCTTCSSCSS
T ss_pred             CCCCCEEeccCc-cCH---HHHHHHHhhCcceEEecccCccccCCcccc
Confidence            677777777766 332   223333 23555666666666666665543

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=99.90  E-value=6.5e-25  Score=246.41  Aligned_cols=259  Identities=15%  Similarity=0.184  Sum_probs=157.7

Q ss_pred             EEeccCCCCCCCChhhhhhcccceeeccCCccccccch---hhhhcCC-CccEEeccCccccCCCchhcccc-----ccc
Q 002010          100 LTISNVNLTGRLPSEMALLTSLKVFNISGNVFQGNFAG---QIVRGMT-ELQVLDAYNNNFTGPLPVEIASL-----KSL  170 (982)
Q Consensus       100 L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~~~---~~~~~l~-~L~~L~Ls~n~l~~~~p~~l~~l-----~~L  170 (982)
                      ++++.|+++|.+|..+...++|++|||++|.+.+..+.   +.+.+++ +|++|+|++|++++..+..++.+     ++|
T Consensus         3 ~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L   82 (362)
T 3goz_A            3 YKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANV   82 (362)
T ss_dssp             EECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTC
T ss_pred             cccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCc
Confidence            45666677766666666666677777777776543331   3445566 67777777777776666666665     677


Q ss_pred             cEEeecCcccccccCCCcccc-----CcceEeeccCcccccchhhHHhhhhhHHHHhhcccccccccCCCCCCCC-CCCC
Q 002010          171 RHLSFGGNYFTGKIPQSYSEI-----QSLEYIGLNGIGLNGTVPAFLSRLKNLREMYIGYFNTYTGGIPPGFGAL-TQLQ  244 (982)
Q Consensus       171 ~~L~L~~N~l~~~~p~~~~~l-----~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~l~~~n~~~~~~p~~~~~l-~~L~  244 (982)
                      ++|+|++|++++..+..++..     ++|++|++++|.+++..+..+...                     +..+ ++|+
T Consensus        83 ~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~---------------------l~~~~~~L~  141 (362)
T 3goz_A           83 TSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQA---------------------FSNLPASIT  141 (362)
T ss_dssp             CEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHH---------------------HTTSCTTCC
T ss_pred             cEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHH---------------------HHhCCCcee
Confidence            777777777776666544433     677777777777665555444321                     1222 4677


Q ss_pred             EEecccCcCcccCch----hhcCCC-ccceeecccccCCCCCCcccc----CC-CCCCEEEeeCCcccCc----Cchhhh
Q 002010          245 VLDMASCNISGEIPT----SLSRLK-LLHSLFLQMNKLTGHIPPQLS----GL-ISLKSLDLSLNYLTGE----IPESFA  310 (982)
Q Consensus       245 ~L~L~~n~l~~~~~~----~l~~l~-~L~~L~L~~N~l~~~~~~~l~----~l-~~L~~L~Ls~N~l~~~----~~~~l~  310 (982)
                      +|+|++|++++..+.    .+..++ +|++|+|++|++++..+..+.    .+ ++|++|+|++|.|++.    ++..+.
T Consensus       142 ~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~  221 (362)
T 3goz_A          142 SLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFS  221 (362)
T ss_dssp             EEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHH
T ss_pred             EEEccCCcCCHHHHHHHHHHHhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHh
Confidence            777777777653333    334444 677777777777665554333    33 4777777777777653    333444


Q ss_pred             c-ccchhhhhhccCCCCCCCC----CcCCCCCCccEEEccCCCcccc-------cCccccCCCcccEEEeccccccccCC
Q 002010          311 A-LKNLTLLQLFKNNLRGPIP----SFLGDFPNLEVLQVWGNNFTFE-------LPENLGRNGKLLILDVTSNHLTGTIP  378 (982)
Q Consensus       311 ~-l~~L~~L~L~~N~l~~~~p----~~~~~l~~L~~L~L~~N~l~~~-------~~~~l~~l~~L~~L~L~~N~l~~~~p  378 (982)
                      . .++|++|+|++|.+++..+    ..+..+++|+.|++++|.+...       ++..+..+++|+.||+++|++.+..+
T Consensus       222 ~~~~~L~~L~Ls~N~l~~~~~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~~~~  301 (362)
T 3goz_A          222 SIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHS  301 (362)
T ss_dssp             HSCTTCCEEECCSSCCCCCCHHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCGGGC
T ss_pred             cCCCCceEEECcCCCCCcHHHHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCCcch
Confidence            4 2467777777777665433    3345667777777777774322       23355666777777777777765544


Q ss_pred             c
Q 002010          379 R  379 (982)
Q Consensus       379 ~  379 (982)
                      .
T Consensus       302 ~  302 (362)
T 3goz_A          302 I  302 (362)
T ss_dssp             H
T ss_pred             H
Confidence            3

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=99.90  E-value=2.6e-23  Score=225.10  Aligned_cols=204  Identities=23%  Similarity=0.199  Sum_probs=149.3

Q ss_pred             CCCCCCccEEEccCCCcccccCccccCCCcccEEEeccccccccCCccccCccccceeecccccccccCCccccCCCCCC
Q 002010          333 LGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFIGPIPEELGQCKSLT  412 (982)
Q Consensus       333 ~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~l~~N~~~~~~~~~l~~l~~L~  412 (982)
                      +.++++++.+++++|.++. +|..+.  ++++.|++++|++++..+..+..+++|++|++++|.+++..+.  +.+++|+
T Consensus         6 ~~~l~~l~~l~~~~~~l~~-ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~--~~l~~L~   80 (290)
T 1p9a_G            6 VSKVASHLEVNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD--GTLPVLG   80 (290)
T ss_dssp             EECSTTCCEEECTTSCCSS-CCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC--SCCTTCC
T ss_pred             ccccCCccEEECCCCCCCc-CCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC--CCCCcCC
Confidence            4456666777777766663 343332  4566666666666655555555555555555555555543322  4455555


Q ss_pred             EEEccCCccCCCCCccccCCCccccccCCCccccccCCcccccCCccEEEeeccccCCCCchhccCCCCcceeeeccccc
Q 002010          413 KIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLSGELPEKMSGASLNQLKVANNNITGKIPAAIGNLPSLNILSLQNNRL  492 (982)
Q Consensus       413 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l  492 (982)
                      +|++++|+++ .+|..+..+                       .+|++|++++|+|++..|..|..+++|++|+|++|++
T Consensus        81 ~L~Ls~N~l~-~l~~~~~~l-----------------------~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l  136 (290)
T 1p9a_G           81 TLDLSHNQLQ-SLPLLGQTL-----------------------PALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNEL  136 (290)
T ss_dssp             EEECCSSCCS-SCCCCTTTC-----------------------TTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCC
T ss_pred             EEECCCCcCC-cCchhhccC-----------------------CCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCC
Confidence            5555555554 333333333                       5677777888888877778899999999999999999


Q ss_pred             cCCCccccccccccceeeeeccccCCCCCcccccccCCCeeeCCCCcccCCCCcccccccccceEEcccccccc
Q 002010          493 EGEIPVESFNLKMITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYGKIPPGISKLIDLSILNLSRNGITG  566 (982)
Q Consensus       493 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~  566 (982)
                      ++..+..+..+++|+.|+|++|+|++..+..|..+++|+.|+|++|+|+ .+|..+..+.+|+.|+|++|.+.-
T Consensus       137 ~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C  209 (290)
T 1p9a_G          137 KTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLC  209 (290)
T ss_dssp             CCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCC
T ss_pred             CccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCccC
Confidence            9776777789999999999999999777777899999999999999998 789899999999999999999873

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=99.89  E-value=2e-23  Score=229.05  Aligned_cols=227  Identities=19%  Similarity=0.184  Sum_probs=125.8

Q ss_pred             ccEEEeccCCCCCCCCh---hhhhhcccceeeccCCccccccchhhh-hcCCCccEEeccCccccCCCc----hhccccc
Q 002010           97 LVNLTISNVNLTGRLPS---EMALLTSLKVFNISGNVFQGNFAGQIV-RGMTELQVLDAYNNNFTGPLP----VEIASLK  168 (982)
Q Consensus        97 L~~L~l~~n~l~~~~p~---~l~~l~~L~~L~Ls~n~l~~~~~~~~~-~~l~~L~~L~Ls~n~l~~~~p----~~l~~l~  168 (982)
                      ++.|.+.++.++...-.   ....+++|++|+|++|.+.+..+..++ ..+++|++|+|++|++++..|    ..+..++
T Consensus        66 l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~  145 (310)
T 4glp_A           66 VRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKP  145 (310)
T ss_dssp             CCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCS
T ss_pred             eeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhcc
Confidence            55666665554421111   112334566666666666655554443 556666666666666665443    3334566


Q ss_pred             cccEEeecCcccccccCCCccccCcceEeeccCcccccchhhHHhhhhhHHHHhhcccccccccCCCCCCCCCCCCEEec
Q 002010          169 SLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLNGIGLNGTVPAFLSRLKNLREMYIGYFNTYTGGIPPGFGALTQLQVLDM  248 (982)
Q Consensus       169 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~l~~~n~~~~~~p~~~~~l~~L~~L~L  248 (982)
                      +|++|+|++|++++..|..|+.+++|++|+|++|.+.+...-                     ..+..++.+++|++|+|
T Consensus       146 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~---------------------~~~~~~~~l~~L~~L~L  204 (310)
T 4glp_A          146 GLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGL---------------------MAALCPHKFPAIQNLAL  204 (310)
T ss_dssp             CCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHH---------------------HTTSCTTSSCCCCSCBC
T ss_pred             CCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhh---------------------hHHHhhhcCCCCCEEEC
Confidence            666666666666665556666666666666666654311000                     00122355666777777


Q ss_pred             ccCcCcccCch----hhcCCCccceeecccccCCCCCCccccCC---CCCCEEEeeCCcccCcCchhhhcccchhhhhhc
Q 002010          249 ASCNISGEIPT----SLSRLKLLHSLFLQMNKLTGHIPPQLSGL---ISLKSLDLSLNYLTGEIPESFAALKNLTLLQLF  321 (982)
Q Consensus       249 ~~n~l~~~~~~----~l~~l~~L~~L~L~~N~l~~~~~~~l~~l---~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~  321 (982)
                      ++|+++. ++.    .++.+++|++|+|++|++++..|..+..+   ++|++|+|++|+|+ .+|..+.  ++|+.|+|+
T Consensus       205 s~N~l~~-l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls  280 (310)
T 4glp_A          205 RNTGMET-PTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLS  280 (310)
T ss_dssp             CSSCCCC-HHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECC
T ss_pred             CCCCCCc-hHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CCCCEEECC
Confidence            7777652 222    24566667777777777766656555554   46666666666666 4454443  566666666


Q ss_pred             cCCCCCCCCCcCCCCCCccEEEccCCCcc
Q 002010          322 KNNLRGPIPSFLGDFPNLEVLQVWGNNFT  350 (982)
Q Consensus       322 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~  350 (982)
                      +|++++. |. +..+++|+.|++++|+++
T Consensus       281 ~N~l~~~-~~-~~~l~~L~~L~L~~N~l~  307 (310)
T 4glp_A          281 SNRLNRA-PQ-PDELPEVDNLTLDGNPFL  307 (310)
T ss_dssp             SCCCCSC-CC-TTSCCCCSCEECSSTTTS
T ss_pred             CCcCCCC-ch-hhhCCCccEEECcCCCCC
Confidence            6666643 22 455566666666666554

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=99.89  E-value=8.1e-25  Score=245.65  Aligned_cols=255  Identities=19%  Similarity=0.199  Sum_probs=164.7

Q ss_pred             hhhccCCCCCCCCCcCCCCCCccEEEccCCCcccccC----ccccCCC-cccEEEeccccccccCCccccCc-----ccc
Q 002010          318 LQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELP----ENLGRNG-KLLILDVTSNHLTGTIPRDLCKG-----GKL  387 (982)
Q Consensus       318 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~----~~l~~l~-~L~~L~L~~N~l~~~~p~~~~~~-----~~L  387 (982)
                      +++++|.+++.+|..+...++|++|++++|.++...+    ..+..++ +|++|+|++|++++..+..++.+     ++|
T Consensus         3 ~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L   82 (362)
T 3goz_A            3 YKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANV   82 (362)
T ss_dssp             EECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTC
T ss_pred             cccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCc
Confidence            4567777777777766666667777777777776555    5566666 67777777777776666655554     666


Q ss_pred             ceeecccccccccCCccccC----C-CCCCEEEccCCccCCCCCccccCCCccccccCCCccccccCCcccc--cCCccE
Q 002010          388 KSLILMQNFFIGPIPEELGQ----C-KSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLSGELPEKMS--GASLNQ  460 (982)
Q Consensus       388 ~~L~l~~N~~~~~~~~~l~~----l-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~--~~~L~~  460 (982)
                      ++|++++|.+.+..+..+..    + ++|++|+|++|++++..+..+...                    +.  ..+|++
T Consensus        83 ~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~--------------------l~~~~~~L~~  142 (362)
T 3goz_A           83 TSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQA--------------------FSNLPASITS  142 (362)
T ss_dssp             CEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHH--------------------HTTSCTTCCE
T ss_pred             cEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHH--------------------HHhCCCceeE
Confidence            66666666666555543332    2 566666666666654333222110                    11  135666


Q ss_pred             EEeeccccCCCC----chhccCCC-CcceeeeccccccCCCccccccc-----cccceeeeeccccCCC----CCccccc
Q 002010          461 LKVANNNITGKI----PAAIGNLP-SLNILSLQNNRLEGEIPVESFNL-----KMITSINISDNNISGE----IPYSISQ  526 (982)
Q Consensus       461 L~L~~N~i~~~~----p~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l-----~~L~~L~Ls~N~l~~~----~p~~~~~  526 (982)
                      |+|++|++++..    +..+..++ +|++|+|++|++++..+..+...     ++|++|||++|+|++.    ++..+..
T Consensus       143 L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~  222 (362)
T 3goz_A          143 LNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSS  222 (362)
T ss_dssp             EECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHH
T ss_pred             EEccCCcCCHHHHHHHHHHHhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhc
Confidence            666666666433    33344554 78888888888876665544433     5788888888888753    4445544


Q ss_pred             -ccCCCeeeCCCCcccCCCC----cccccccccceEEccccccccc-------CccccccccccceecccCCccccCC
Q 002010          527 -CHSLTSVDLSRNSLYGKIP----PGISKLIDLSILNLSRNGITGS-------IPNEMRNMMSLTTLDLSYNNLIGNI  592 (982)
Q Consensus       527 -l~~L~~L~Ls~N~l~~~~p----~~~~~l~~L~~L~Ls~N~l~~~-------~p~~l~~l~~L~~L~Ls~N~l~~~i  592 (982)
                       .++|+.|+|++|.+++..+    ..+..+++|+.|+|++|.+.+.       ++..+..+++|+.||+++|++.+..
T Consensus       223 ~~~~L~~L~Ls~N~l~~~~~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~~~  300 (362)
T 3goz_A          223 IPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSH  300 (362)
T ss_dssp             SCTTCCEEECCSSCCCCCCHHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCGGG
T ss_pred             CCCCceEEECcCCCCCcHHHHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCCcc
Confidence             3588888888888876544    3346678888888888885533       3345677888999999999887653

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=99.88  E-value=3.2e-23  Score=227.40  Aligned_cols=227  Identities=21%  Similarity=0.230  Sum_probs=146.4

Q ss_pred             ccEEEccCCCcccccCc---cccCCCcccEEEeccccccccCCccc--cCccccceeecccccccccCC----ccccCCC
Q 002010          339 LEVLQVWGNNFTFELPE---NLGRNGKLLILDVTSNHLTGTIPRDL--CKGGKLKSLILMQNFFIGPIP----EELGQCK  409 (982)
Q Consensus       339 L~~L~L~~N~l~~~~~~---~l~~l~~L~~L~L~~N~l~~~~p~~~--~~~~~L~~L~l~~N~~~~~~~----~~l~~l~  409 (982)
                      ++.+.+.++.++.....   .+..+++|++|++++|.+++..|..+  ..+++|++|++++|.+.+..+    ..+..++
T Consensus        66 l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~  145 (310)
T 4glp_A           66 VRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKP  145 (310)
T ss_dssp             CCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCS
T ss_pred             eeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhcc
Confidence            45556655555421111   11123446677777777766666666  666667777777776665444    3345677


Q ss_pred             CCCEEEccCCccCCCCCccccCCCccccccCCCccccccCCcccccCCccEEEeeccccCCCCchhccCCCCcceeeecc
Q 002010          410 SLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLSGELPEKMSGASLNQLKVANNNITGKIPAAIGNLPSLNILSLQN  489 (982)
Q Consensus       410 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~  489 (982)
                      +|++|+|++|++++..|..+..+++|++|++++|++.+...                   -..+..++.+++|++|+|++
T Consensus       146 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-------------------~~~~~~~~~l~~L~~L~Ls~  206 (310)
T 4glp_A          146 GLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERG-------------------LMAALCPHKFPAIQNLALRN  206 (310)
T ss_dssp             CCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHH-------------------HHTTSCTTSSCCCCSCBCCS
T ss_pred             CCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchh-------------------hhHHHhhhcCCCCCEEECCC
Confidence            77777777777776666677666666666666665442100                   00112235667777777777


Q ss_pred             ccccCCCcc----ccccccccceeeeeccccCCCCCcccccc---cCCCeeeCCCCcccCCCCcccccccccceEEcccc
Q 002010          490 NRLEGEIPV----ESFNLKMITSINISDNNISGEIPYSISQC---HSLTSVDLSRNSLYGKIPPGISKLIDLSILNLSRN  562 (982)
Q Consensus       490 N~l~~~~p~----~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l---~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N  562 (982)
                      |+++ .++.    .+..+++|++|||++|+|++..|..+..+   ++|+.|+|++|+|+ .+|..+.  ++|+.|+|++|
T Consensus       207 N~l~-~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N  282 (310)
T 4glp_A          207 TGME-TPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSN  282 (310)
T ss_dssp             SCCC-CHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSC
T ss_pred             CCCC-chHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCC
Confidence            7775 2332    23566778888888888877767666666   58888888888887 6677664  68888888888


Q ss_pred             cccccCccccccccccceecccCCcccc
Q 002010          563 GITGSIPNEMRNMMSLTTLDLSYNNLIG  590 (982)
Q Consensus       563 ~l~~~~p~~l~~l~~L~~L~Ls~N~l~~  590 (982)
                      +|++. |. +..+++|+.|+|++|+++.
T Consensus       283 ~l~~~-~~-~~~l~~L~~L~L~~N~l~~  308 (310)
T 4glp_A          283 RLNRA-PQ-PDELPEVDNLTLDGNPFLV  308 (310)
T ss_dssp             CCCSC-CC-TTSCCCCSCEECSSTTTSC
T ss_pred             cCCCC-ch-hhhCCCccEEECcCCCCCC
Confidence            88853 43 6778888888888888763

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=99.88  E-value=5.7e-25  Score=249.45  Aligned_cols=249  Identities=18%  Similarity=0.211  Sum_probs=169.1

Q ss_pred             CCchhccccccccEEeecCcccccccC----CCccccCcceEeeccCcc---cccchhhHHhhhhhHHHHhhcccccccc
Q 002010          159 PLPVEIASLKSLRHLSFGGNYFTGKIP----QSYSEIQSLEYIGLNGIG---LNGTVPAFLSRLKNLREMYIGYFNTYTG  231 (982)
Q Consensus       159 ~~p~~l~~l~~L~~L~L~~N~l~~~~p----~~~~~l~~L~~L~L~~n~---i~~~~~~~l~~l~~L~~L~l~~~n~~~~  231 (982)
                      .++..+..+++|++|+|++|++++..+    ..+..+++|++|+|++|.   +.+.+|..+..+.               
T Consensus        23 ~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~---------------   87 (386)
T 2ca6_A           23 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLL---------------   87 (386)
T ss_dssp             TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHH---------------
T ss_pred             HHHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHH---------------
Confidence            455556666666666666666665433    235566666666666643   3344454443332               


Q ss_pred             cCCCCCCCCCCCCEEecccCcCcc----cCchhhcCCCccceeecccccCCCCCCccccC----C---------CCCCEE
Q 002010          232 GIPPGFGALTQLQVLDMASCNISG----EIPTSLSRLKLLHSLFLQMNKLTGHIPPQLSG----L---------ISLKSL  294 (982)
Q Consensus       232 ~~p~~~~~l~~L~~L~L~~n~l~~----~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~----l---------~~L~~L  294 (982)
                         ..+..+++|++|+|++|.+++    .+|..+..+++|++|+|++|.++...+..+..    +         ++|++|
T Consensus        88 ---~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L  164 (386)
T 2ca6_A           88 ---QALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSI  164 (386)
T ss_dssp             ---HHHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEE
T ss_pred             ---HHHhhCCcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEE
Confidence               234667889999999999987    46777888899999999999887544444333    3         789999


Q ss_pred             EeeCCccc-CcCc---hhhhcccchhhhhhccCCCCC-----CCCCcCCCCCCccEEEccCCCcc----cccCccccCCC
Q 002010          295 DLSLNYLT-GEIP---ESFAALKNLTLLQLFKNNLRG-----PIPSFLGDFPNLEVLQVWGNNFT----FELPENLGRNG  361 (982)
Q Consensus       295 ~Ls~N~l~-~~~~---~~l~~l~~L~~L~L~~N~l~~-----~~p~~~~~l~~L~~L~L~~N~l~----~~~~~~l~~l~  361 (982)
                      +|++|+++ +.++   ..+..+++|++|+|++|+++.     ..|..+..+++|++|+|++|.++    ..+|..+..++
T Consensus       165 ~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~  244 (386)
T 2ca6_A          165 ICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWP  244 (386)
T ss_dssp             ECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCT
T ss_pred             ECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCC
Confidence            99999887 3344   456677888888888888872     34446778888888888888885    45677777788


Q ss_pred             cccEEEecccccccc----CCcccc--Cccccceeecccccccc----cCCccc-cCCCCCCEEEccCCccCCCC
Q 002010          362 KLLILDVTSNHLTGT----IPRDLC--KGGKLKSLILMQNFFIG----PIPEEL-GQCKSLTKIRFSKNYLNGTI  425 (982)
Q Consensus       362 ~L~~L~L~~N~l~~~----~p~~~~--~~~~L~~L~l~~N~~~~----~~~~~l-~~l~~L~~L~Ls~N~l~~~~  425 (982)
                      +|+.|+|++|.+++.    ++..+.  .+++|+.|++++|.+.+    .+|..+ .++++|++|++++|++++..
T Consensus       245 ~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~  319 (386)
T 2ca6_A          245 NLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEED  319 (386)
T ss_dssp             TCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTS
T ss_pred             CcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcch
Confidence            888888888887765    344442  26667777777777666    355555 45677777777777766544

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=99.88  E-value=8e-23  Score=215.15  Aligned_cols=204  Identities=16%  Similarity=0.187  Sum_probs=114.7

Q ss_pred             ccCCcCccccccccEEEeccCCCCCCCChhhhhhcccceeeccCCc-cccccchhhhhcCCCccEEeccC-ccccCCCch
Q 002010           85 GSIPPEIGLLTKLVNLTISNVNLTGRLPSEMALLTSLKVFNISGNV-FQGNFAGQIVRGMTELQVLDAYN-NNFTGPLPV  162 (982)
Q Consensus        85 g~~~~~i~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~n~-l~~~~~~~~~~~l~~L~~L~Ls~-n~l~~~~p~  162 (982)
                      ..+|. +.  ++|++|++++|++++..+..+..+++|++|+|++|. ++ .++...|.++++|++|++++ |++++..+.
T Consensus        24 ~~ip~-~~--~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~-~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~   99 (239)
T 2xwt_C           24 QRIPS-LP--PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQ-QLESHSFYNLSKVTHIEIRNTRNLTYIDPD   99 (239)
T ss_dssp             SSCCC-CC--TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCC-EECTTTEESCTTCCEEEEEEETTCCEECTT
T ss_pred             cccCC-CC--CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcc-eeCHhHcCCCcCCcEEECCCCCCeeEcCHH
Confidence            34565 32  378888888888886655566666666666666665 43 23333444555555555555 555544444


Q ss_pred             hccccccccEEeecCcccccccCCCccccCcceEeeccCcccccchhhHHhhhhhHHHHhhcccccccccCCCCCCCCCC
Q 002010          163 EIASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLNGIGLNGTVPAFLSRLKNLREMYIGYFNTYTGGIPPGFGALTQ  242 (982)
Q Consensus       163 ~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~l~~~n~~~~~~p~~~~~l~~  242 (982)
                      .+.++++|++|++++|++++ +|.                                                  |+.+++
T Consensus       100 ~f~~l~~L~~L~l~~n~l~~-lp~--------------------------------------------------~~~l~~  128 (239)
T 2xwt_C          100 ALKELPLLKFLGIFNTGLKM-FPD--------------------------------------------------LTKVYS  128 (239)
T ss_dssp             SEECCTTCCEEEEEEECCCS-CCC--------------------------------------------------CTTCCB
T ss_pred             HhCCCCCCCEEeCCCCCCcc-ccc--------------------------------------------------cccccc
Confidence            45555555555555555442 222                                                  333444


Q ss_pred             CC---EEecccC-cCcccCchhhcCCCccc-eeecccccCCCCCCccccCCCCCCEEEeeCCc-ccCcCchhhhcc-cch
Q 002010          243 LQ---VLDMASC-NISGEIPTSLSRLKLLH-SLFLQMNKLTGHIPPQLSGLISLKSLDLSLNY-LTGEIPESFAAL-KNL  315 (982)
Q Consensus       243 L~---~L~L~~n-~l~~~~~~~l~~l~~L~-~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~-l~~~~~~~l~~l-~~L  315 (982)
                      |+   +|++++| ++++..+..|..+++|+ +|++++|+++...+..+.. ++|+.|+|++|+ +++..+..|..+ ++|
T Consensus       129 L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~~~~~-~~L~~L~L~~n~~l~~i~~~~~~~l~~~L  207 (239)
T 2xwt_C          129 TDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNG-TKLDAVYLNKNKYLTVIDKDAFGGVYSGP  207 (239)
T ss_dssp             CCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEECTTTTTT-CEEEEEECTTCTTCCEECTTTTTTCSBCC
T ss_pred             cccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcccCHhhcCC-CCCCEEEcCCCCCcccCCHHHhhccccCC
Confidence            44   6666666 66655555566666666 6666666666322223333 566666666663 665555556666 666


Q ss_pred             hhhhhccCCCCCCCCCcCCCCCCccEEEccCC
Q 002010          316 TLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGN  347 (982)
Q Consensus       316 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N  347 (982)
                      +.|++++|++++..+.   .+++|+.|+++++
T Consensus       208 ~~L~l~~N~l~~l~~~---~~~~L~~L~l~~~  236 (239)
T 2xwt_C          208 SLLDVSQTSVTALPSK---GLEHLKELIARNT  236 (239)
T ss_dssp             SEEECTTCCCCCCCCT---TCTTCSEEECTTC
T ss_pred             cEEECCCCccccCChh---HhccCceeeccCc
Confidence            6666666666633222   4556666666554

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=99.88  E-value=6.2e-25  Score=249.18  Aligned_cols=249  Identities=18%  Similarity=0.234  Sum_probs=171.9

Q ss_pred             CCCCcCCCCCCccEEEccCCCcccccC----ccccCCCcccEEEeccc---cccccCCccccCccccceeeccccccccc
Q 002010          328 PIPSFLGDFPNLEVLQVWGNNFTFELP----ENLGRNGKLLILDVTSN---HLTGTIPRDLCKGGKLKSLILMQNFFIGP  400 (982)
Q Consensus       328 ~~p~~~~~l~~L~~L~L~~N~l~~~~~----~~l~~l~~L~~L~L~~N---~l~~~~p~~~~~~~~L~~L~l~~N~~~~~  400 (982)
                      .++..+..+++|+.|+|++|.++...+    ..+..+++|++|+|++|   ++++.+|..+..                 
T Consensus        23 ~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~-----------------   85 (386)
T 2ca6_A           23 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRL-----------------   85 (386)
T ss_dssp             TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHH-----------------
T ss_pred             HHHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHH-----------------
Confidence            345556667777788888777775533    33556777777777774   344444443310                 


Q ss_pred             CCccccCCCCCCEEEccCCccCC----CCCccccCCCccccccCCCccccccCCccccc--------------CCccEEE
Q 002010          401 IPEELGQCKSLTKIRFSKNYLNG----TIPAGLFNLPLLNMMELDDNLLSGELPEKMSG--------------ASLNQLK  462 (982)
Q Consensus       401 ~~~~l~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~--------------~~L~~L~  462 (982)
                      +...+..+++|++|+|++|++++    .+|..+..+++|++|+|++|.++...+..+..              ++|++|+
T Consensus        86 l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~  165 (386)
T 2ca6_A           86 LLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSII  165 (386)
T ss_dssp             HHHHHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEE
T ss_pred             HHHHHhhCCcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEE
Confidence            00112444555555555555554    24444445555555555555554322222211              5788888


Q ss_pred             eeccccC-CCCc---hhccCCCCcceeeeccccccC-----CCccccccccccceeeeeccccC----CCCCcccccccC
Q 002010          463 VANNNIT-GKIP---AAIGNLPSLNILSLQNNRLEG-----EIPVESFNLKMITSINISDNNIS----GEIPYSISQCHS  529 (982)
Q Consensus       463 L~~N~i~-~~~p---~~~~~l~~L~~L~L~~N~l~~-----~~p~~~~~l~~L~~L~Ls~N~l~----~~~p~~~~~l~~  529 (982)
                      +++|+++ +.++   ..+..+++|++|+|++|+++.     ..|..+..+++|++|+|++|+|+    +.+|..+..+++
T Consensus       166 L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~  245 (386)
T 2ca6_A          166 CGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPN  245 (386)
T ss_dssp             CCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTT
T ss_pred             CCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCC
Confidence            8888887 4444   467788999999999999872     34447788999999999999996    567888999999


Q ss_pred             CCeeeCCCCcccCC----CCccc--ccccccceEEcccccccc----cCcccc-ccccccceecccCCccccCCC
Q 002010          530 LTSVDLSRNSLYGK----IPPGI--SKLIDLSILNLSRNGITG----SIPNEM-RNMMSLTTLDLSYNNLIGNIP  593 (982)
Q Consensus       530 L~~L~Ls~N~l~~~----~p~~~--~~l~~L~~L~Ls~N~l~~----~~p~~l-~~l~~L~~L~Ls~N~l~~~ip  593 (982)
                      |+.|+|++|.|++.    +|..+  +.+++|+.|+|++|+|++    .+|..+ .++++|++|+|++|++++..|
T Consensus       246 L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~~  320 (386)
T 2ca6_A          246 LRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDD  320 (386)
T ss_dssp             CCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTSH
T ss_pred             cCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcchh
Confidence            99999999999876    56666  348999999999999997    488877 668999999999999987664

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=99.88  E-value=2.3e-22  Score=224.46  Aligned_cols=246  Identities=17%  Similarity=0.124  Sum_probs=175.6

Q ss_pred             CCCccceeeeCCCCCEEEEEeccCCccccCCcCccccccccEEEeccCCCCCCCChhhhhhcccceeeccCCccccccch
Q 002010           58 AHCSFSGVTCDQDSRVVSLNVSFMPLFGSIPPEIGLLTKLVNLTISNVNLTGRLPSEMALLTSLKVFNISGNVFQGNFAG  137 (982)
Q Consensus        58 ~~C~w~gv~C~~~~~v~~l~l~~~~l~g~~~~~i~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~~~  137 (982)
                      |.|+|..|.|+..+ +           ..||..|  .+++++|+|++|+++...+..|.++++|++|+|++|.+.+.++.
T Consensus         7 C~C~~~~v~C~~~~-L-----------t~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~   72 (350)
T 4ay9_X            7 CHCSNRVFLCQESK-V-----------TEIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEA   72 (350)
T ss_dssp             SEEETTEEEEESTT-C-----------CSCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECT
T ss_pred             cEeeCCEEEecCCC-C-----------CccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccCh
Confidence            55889999997532 1           2567665  36899999999999955556789999999999999998888888


Q ss_pred             hhhhcCCCccE-EeccCccccCCCchhccccccccEEeecCcccccccCCCccccCcceEeeccCc-ccccchhhHHhhh
Q 002010          138 QIVRGMTELQV-LDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLNGI-GLNGTVPAFLSRL  215 (982)
Q Consensus       138 ~~~~~l~~L~~-L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n-~i~~~~~~~l~~l  215 (982)
                      .+|.++++|++ +.++.|+++...|..+..+++|++|++++|++++..+..+....++..|++.++ .+.          
T Consensus        73 ~~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~----------  142 (350)
T 4ay9_X           73 DVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIH----------  142 (350)
T ss_dssp             TSBCSCTTCCEEEEEEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCC----------
T ss_pred             hHhhcchhhhhhhcccCCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccc----------
Confidence            88888888775 666778998777888999999999999999998777777777777777777542 222          


Q ss_pred             hhHHHHhhcccccccccCCCCCCCCC-CCCEEecccCcCcccCchhhcCCCccceeeccc-ccCCCCCCccccCCCCCCE
Q 002010          216 KNLREMYIGYFNTYTGGIPPGFGALT-QLQVLDMASCNISGEIPTSLSRLKLLHSLFLQM-NKLTGHIPPQLSGLISLKS  293 (982)
Q Consensus       216 ~~L~~L~l~~~n~~~~~~p~~~~~l~-~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~-N~l~~~~~~~l~~l~~L~~  293 (982)
                                     ...+..|..+. .+++|+|++|+|+.. |.......+|++|++++ |.++...+..|.++++|++
T Consensus       143 ---------------~l~~~~f~~~~~~l~~L~L~~N~i~~i-~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~  206 (350)
T 4ay9_X          143 ---------------TIERNSFVGLSFESVILWLNKNGIQEI-HNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVI  206 (350)
T ss_dssp             ---------------EECTTSSTTSBSSCEEEECCSSCCCEE-CTTSSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSE
T ss_pred             ---------------cccccchhhcchhhhhhccccccccCC-ChhhccccchhHHhhccCCcccCCCHHHhccCcccch
Confidence                           11223344443 577888888888844 43444456788888864 5666444456777888888


Q ss_pred             EEeeCCcccCcCchhhhcccchhhhhhccCCCCCCCCCcCCCCCCccEEEccCC
Q 002010          294 LDLSLNYLTGEIPESFAALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGN  347 (982)
Q Consensus       294 L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N  347 (982)
                      |||++|+|+...+..|.++++|+.+++  ++++ .+| .+..+++|+.++++++
T Consensus       207 LdLs~N~l~~lp~~~~~~L~~L~~l~~--~~l~-~lP-~l~~l~~L~~l~l~~~  256 (350)
T 4ay9_X          207 LDISRTRIHSLPSYGLENLKKLRARST--YNLK-KLP-TLEKLVALMEASLTYP  256 (350)
T ss_dssp             EECTTSCCCCCCSSSCTTCCEEECTTC--TTCC-CCC-CTTTCCSCCEEECSCH
T ss_pred             hhcCCCCcCccChhhhccchHhhhccC--CCcC-cCC-CchhCcChhhCcCCCC
Confidence            888888888655556666666665554  3344 344 2566677777776544

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=99.87  E-value=5.3e-24  Score=236.79  Aligned_cols=234  Identities=18%  Similarity=0.176  Sum_probs=104.7

Q ss_pred             CCccEEeccCccccCCCchhccccccccEEeecCcccccc-cCCCccccCcceEeeccCcccccchhhHHhhhhhHHHHh
Q 002010          144 TELQVLDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGK-IPQSYSEIQSLEYIGLNGIGLNGTVPAFLSRLKNLREMY  222 (982)
Q Consensus       144 ~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~  222 (982)
                      +++++|++++|.+++..+. +..+++|++|+|++|.+++. +|..+..+++|++|++++|.+.+..+..+          
T Consensus        70 ~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l----------  138 (336)
T 2ast_B           70 QGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTL----------  138 (336)
T ss_dssp             TTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHH----------
T ss_pred             ccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHH----------
Confidence            4444444444444433332 33444455555555444433 44444444444555444444433333222          


Q ss_pred             hcccccccccCCCCCCCCCCCCEEecccC-cCccc-CchhhcCCCccceeecccc-cCCCC-CCccccCCC-CCCEEEee
Q 002010          223 IGYFNTYTGGIPPGFGALTQLQVLDMASC-NISGE-IPTSLSRLKLLHSLFLQMN-KLTGH-IPPQLSGLI-SLKSLDLS  297 (982)
Q Consensus       223 l~~~n~~~~~~p~~~~~l~~L~~L~L~~n-~l~~~-~~~~l~~l~~L~~L~L~~N-~l~~~-~~~~l~~l~-~L~~L~Ls  297 (982)
                                     +.+++|++|++++| .+++. ++..+..+++|++|++++| .+++. ++..+..++ +|++|+++
T Consensus       139 ---------------~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~  203 (336)
T 2ast_B          139 ---------------AKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLS  203 (336)
T ss_dssp             ---------------TTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECC
T ss_pred             ---------------hcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeC
Confidence                           22334444444444 33331 3333444444444444444 44432 233344444 45555555


Q ss_pred             CC--ccc-CcCchhhhcccchhhhhhccCC-CCCCCCCcCCCCCCccEEEccCCC-cccccCccccCCCcccEEEecccc
Q 002010          298 LN--YLT-GEIPESFAALKNLTLLQLFKNN-LRGPIPSFLGDFPNLEVLQVWGNN-FTFELPENLGRNGKLLILDVTSNH  372 (982)
Q Consensus       298 ~N--~l~-~~~~~~l~~l~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L~L~~N~-l~~~~~~~l~~l~~L~~L~L~~N~  372 (982)
                      +|  .++ +.++..+..+++|++|++++|. +++..+..+..+++|++|++++|. +.......+..+++|+.|++++| 
T Consensus       204 ~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~~l~~~~~L~~L~l~~~-  282 (336)
T 2ast_B          204 GYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI-  282 (336)
T ss_dssp             SCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-
T ss_pred             CCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCCCCCHHHHHHHhcCCCCCEEeccCc-
Confidence            44  222 2233444445555555555555 444444445555555555555553 22211223455555555555555 


Q ss_pred             ccccCCccccCc-cccceeecccccccccCCccccC
Q 002010          373 LTGTIPRDLCKG-GKLKSLILMQNFFIGPIPEELGQ  407 (982)
Q Consensus       373 l~~~~p~~~~~~-~~L~~L~l~~N~~~~~~~~~l~~  407 (982)
                      ++.   ..+..+ .++..|++++|.+++..|..+++
T Consensus       283 i~~---~~~~~l~~~l~~L~l~~n~l~~~~~~~~~~  315 (336)
T 2ast_B          283 VPD---GTLQLLKEALPHLQINCSHFTTIARPTIGN  315 (336)
T ss_dssp             SCT---TCHHHHHHHSTTSEESCCCSCCTTCSSCSS
T ss_pred             cCH---HHHHHHHhhCcceEEecccCccccCCcccc
Confidence            221   122222 23555556666666666665554

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.87  E-value=1.3e-21  Score=207.34  Aligned_cols=183  Identities=18%  Similarity=0.157  Sum_probs=132.0

Q ss_pred             ccceeecccccccccCCccccCCCCCCEEEccCCccCCCCCccccCCCccccccCCCccccccCCcccccCCccEEEeec
Q 002010          386 KLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLSGELPEKMSGASLNQLKVAN  465 (982)
Q Consensus       386 ~L~~L~l~~N~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~L~~  465 (982)
                      ..++++++++.+. .+|..+.  ++++.|+|++|.+++..+..|..++                       +|++|+|++
T Consensus        15 ~~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~-----------------------~L~~L~L~~   68 (251)
T 3m19_A           15 GKKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLT-----------------------KLTWLNLDY   68 (251)
T ss_dssp             GGTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCT-----------------------TCCEEECTT
T ss_pred             CCeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcc-----------------------cCCEEECCC
Confidence            3455666666555 2333332  3555666666666555444454444                       556666666


Q ss_pred             cccCCCCchhccCCCCcceeeeccccccCCCccccccccccceeeeeccccCCCCCcccccccCCCeeeCCCCcccCCCC
Q 002010          466 NNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYGKIP  545 (982)
Q Consensus       466 N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p  545 (982)
                      |+|++..+..|..+++|++|+|++|++++..+..+..+++|++|+|++|+|++..+..|..+++|+.|+|++|+|++..+
T Consensus        69 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~  148 (251)
T 3m19_A           69 NQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPA  148 (251)
T ss_dssp             SCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCT
T ss_pred             CcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCH
Confidence            66666666777788888888888888886666667788888888888888887667777888888888888888887666


Q ss_pred             cccccccccceEEcccccccccCccccccccccceecccCCccccCCCC
Q 002010          546 PGISKLIDLSILNLSRNGITGSIPNEMRNMMSLTTLDLSYNNLIGNIPS  594 (982)
Q Consensus       546 ~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~  594 (982)
                      ..|..+++|+.|+|++|+|++..+..+..+++|+.|+|++|++++..+.
T Consensus       149 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~  197 (251)
T 3m19_A          149 GAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCSRCE  197 (251)
T ss_dssp             TTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTTSTT
T ss_pred             HHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCCccc
Confidence            6788888888888888888877777888888888888888888876443

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=99.86  E-value=7.9e-22  Score=207.54  Aligned_cols=203  Identities=17%  Similarity=0.233  Sum_probs=164.1

Q ss_pred             cCCCCCCCCCCCCEEecccCcCcccCchhhcCCCccceeeccccc-CCCCCCccccCCCCCCEEEeeC-CcccCcCchhh
Q 002010          232 GIPPGFGALTQLQVLDMASCNISGEIPTSLSRLKLLHSLFLQMNK-LTGHIPPQLSGLISLKSLDLSL-NYLTGEIPESF  309 (982)
Q Consensus       232 ~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~-l~~~~~~~l~~l~~L~~L~Ls~-N~l~~~~~~~l  309 (982)
                      .+|. +.  ++|++|++++|++++..+..|.++++|++|++++|+ ++...+..|.++++|++|++++ |++++..+..|
T Consensus        25 ~ip~-~~--~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f  101 (239)
T 2xwt_C           25 RIPS-LP--PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDAL  101 (239)
T ss_dssp             SCCC-CC--TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSE
T ss_pred             ccCC-CC--CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHh
Confidence            4555 33  389999999999998777789999999999999997 8877677889999999999998 99997777888


Q ss_pred             hcccchhhhhhccCCCCCCCCCcCCCCCCcc---EEEccCC-CcccccCccccCCCccc-EEEeccccccccCCccccCc
Q 002010          310 AALKNLTLLQLFKNNLRGPIPSFLGDFPNLE---VLQVWGN-NFTFELPENLGRNGKLL-ILDVTSNHLTGTIPRDLCKG  384 (982)
Q Consensus       310 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~---~L~L~~N-~l~~~~~~~l~~l~~L~-~L~L~~N~l~~~~p~~~~~~  384 (982)
                      ..+++|++|++++|++++ +|. |..+++|+   +|++++| .++...+..|..+++|+ .|++++|+++ .+|......
T Consensus       102 ~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~-~i~~~~~~~  178 (239)
T 2xwt_C          102 KELPLLKFLGIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNG  178 (239)
T ss_dssp             ECCTTCCEEEEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCC-EECTTTTTT
T ss_pred             CCCCCCCEEeCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCc-ccCHhhcCC
Confidence            999999999999999986 665 88888888   9999999 88877777788899999 9999999998 555544444


Q ss_pred             cccceeeccccc-ccccCCccccCC-CCCCEEEccCCccCCCCCccccCCCccccccCCCc
Q 002010          385 GKLKSLILMQNF-FIGPIPEELGQC-KSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDN  443 (982)
Q Consensus       385 ~~L~~L~l~~N~-~~~~~~~~l~~l-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N  443 (982)
                      ++|++|++++|+ +.+..+..|..+ ++|++|++++|++++ +|..  .+++|+.|+++++
T Consensus       179 ~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~-l~~~--~~~~L~~L~l~~~  236 (239)
T 2xwt_C          179 TKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTA-LPSK--GLEHLKELIARNT  236 (239)
T ss_dssp             CEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCCC-CCCT--TCTTCSEEECTTC
T ss_pred             CCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCcccc-CChh--HhccCceeeccCc
Confidence            788888888884 887777788888 888888888888874 4433  4555666666554

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=99.86  E-value=8.2e-22  Score=215.55  Aligned_cols=126  Identities=29%  Similarity=0.450  Sum_probs=59.2

Q ss_pred             CCCCCCEEecccCcCcccCchhhcCCCccceeecccccCCCCCCccccCCCCCCEEEeeCCcccCcCchhhhcccchhhh
Q 002010          239 ALTQLQVLDMASCNISGEIPTSLSRLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLL  318 (982)
Q Consensus       239 ~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L  318 (982)
                      .+++|++|++++|++++. + .+..+++|++|++++|++++..+  +..+++|++|++++|.+++..+  +..+++|+.|
T Consensus       105 ~l~~L~~L~l~~n~l~~~-~-~l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L  178 (308)
T 1h6u_A          105 GLQSIKTLDLTSTQITDV-T-PLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTL  178 (308)
T ss_dssp             TCTTCCEEECTTSCCCCC-G-GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEE
T ss_pred             CCCCCCEEECCCCCCCCc-h-hhcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCChh--hcCCCCCCEE
Confidence            344444444444444432 1 14444445555555554443222  4444455555555555443222  4444555555


Q ss_pred             hhccCCCCCCCCCcCCCCCCccEEEccCCCcccccCccccCCCcccEEEecccccc
Q 002010          319 QLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLT  374 (982)
Q Consensus       319 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~  374 (982)
                      ++++|++++..+  +..+++|++|++++|++++..  .+..+++|+.|++++|+++
T Consensus       179 ~l~~n~l~~~~~--l~~l~~L~~L~L~~N~l~~~~--~l~~l~~L~~L~l~~N~i~  230 (308)
T 1h6u_A          179 KADDNKISDISP--LASLPNLIEVHLKNNQISDVS--PLANTSNLFIVTLTNQTIT  230 (308)
T ss_dssp             ECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBCG--GGTTCTTCCEEEEEEEEEE
T ss_pred             ECCCCccCcChh--hcCCCCCCEEEccCCccCccc--cccCCCCCCEEEccCCeee
Confidence            555555543322  444555555555555555332  2455555555555555554

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.86  E-value=1.9e-21  Score=206.26  Aligned_cols=178  Identities=21%  Similarity=0.206  Sum_probs=112.3

Q ss_pred             CCCEEecccCcCcccCchhhcCCCccceeecccccCCCCCCccccCCCCCCEEEeeCCcccCcCchhhhcccchhhhhhc
Q 002010          242 QLQVLDMASCNISGEIPTSLSRLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQLF  321 (982)
Q Consensus       242 ~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~  321 (982)
                      +.++++++++.++ .+|..+.  ++|+.|+|++|++++..+..|..+++|++|+|++|.+++..+..|..+++|++|+|+
T Consensus        15 ~~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~   91 (251)
T 3m19_A           15 GKKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLA   91 (251)
T ss_dssp             GGTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECT
T ss_pred             CCeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECC
Confidence            4566777777776 4554443  467777777777776666667777777777777777776666666667777777777


Q ss_pred             cCCCCCCCCCcCCCCCCccEEEccCCCcccccCccccCCCcccEEEeccccccccCCccccCccccceeecccccccccC
Q 002010          322 KNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFIGPI  401 (982)
Q Consensus       322 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~l~~N~~~~~~  401 (982)
                      +|++++..+..|..+++|++|++++|.+++..+..+..+++|++|+|++|++++..+..+..+++|++|++++|.+.+..
T Consensus        92 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~  171 (251)
T 3m19_A           92 NNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVP  171 (251)
T ss_dssp             TSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCC
T ss_pred             CCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccC
Confidence            77776666666666666666666666666555555566666666666666666444444555555555555555555544


Q ss_pred             CccccCCCCCCEEEccCCccC
Q 002010          402 PEELGQCKSLTKIRFSKNYLN  422 (982)
Q Consensus       402 ~~~l~~l~~L~~L~Ls~N~l~  422 (982)
                      +..+..+++|++|++++|+++
T Consensus       172 ~~~~~~l~~L~~L~l~~N~~~  192 (251)
T 3m19_A          172 HGAFDRLGKLQTITLFGNQFD  192 (251)
T ss_dssp             TTTTTTCTTCCEEECCSCCBC
T ss_pred             HHHHhCCCCCCEEEeeCCcee
Confidence            445555555555555555554

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=99.85  E-value=2.1e-21  Score=212.31  Aligned_cols=196  Identities=21%  Similarity=0.299  Sum_probs=131.8

Q ss_pred             ccCCCcccEEEeccccccccCCccccCccccceeecccccccccCCccccCCCCCCEEEccCCccCCCCCccccCCCccc
Q 002010          357 LGRNGKLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGTIPAGLFNLPLLN  436 (982)
Q Consensus       357 l~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~l~~N~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~  436 (982)
                      ...+++|+.|++++|.++. +| .+..+++|++|++++|.+.+..+  +..+++|++|++++|++++. + .+..+    
T Consensus        37 ~~~l~~L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~~-~-~~~~l----  106 (308)
T 1h6u_A           37 QADLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKNV-S-AIAGL----  106 (308)
T ss_dssp             HHHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSCC-G-GGTTC----
T ss_pred             HHHcCCcCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCCc-h-hhcCC----
Confidence            3445677777777777763 33 45566666666666666654433  56666666666666666532 1 34444    


Q ss_pred             cccCCCccccccCCcccccCCccEEEeeccccCCCCchhccCCCCcceeeeccccccCCCccccccccccceeeeecccc
Q 002010          437 MMELDDNLLSGELPEKMSGASLNQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNI  516 (982)
Q Consensus       437 ~L~L~~N~l~~~~~~~~~~~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l  516 (982)
                                         .+|++|++++|++++. + .+..+++|++|++++|++++..+  +..+++|++|++++|++
T Consensus       107 -------------------~~L~~L~l~~n~l~~~-~-~l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l  163 (308)
T 1h6u_A          107 -------------------QSIKTLDLTSTQITDV-T-PLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQV  163 (308)
T ss_dssp             -------------------TTCCEEECTTSCCCCC-G-GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCC
T ss_pred             -------------------CCCCEEECCCCCCCCc-h-hhcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcC
Confidence                               4566666666666643 2 26777888888888888775433  67778888888888888


Q ss_pred             CCCCCcccccccCCCeeeCCCCcccCCCCcccccccccceEEcccccccccCccccccccccceecccCCccccC
Q 002010          517 SGEIPYSISQCHSLTSVDLSRNSLYGKIPPGISKLIDLSILNLSRNGITGSIPNEMRNMMSLTTLDLSYNNLIGN  591 (982)
Q Consensus       517 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~  591 (982)
                      ++..+  +..+++|+.|+|++|++++..+  +..+++|+.|+|++|++++..|  +..+++|+.|+|++|++++.
T Consensus       164 ~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~l~~N~i~~~  232 (308)
T 1h6u_A          164 SDLTP--LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQ  232 (308)
T ss_dssp             CCCGG--GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEEEEEEECC
T ss_pred             CCChh--hcCCCCCCEEECCCCccCcChh--hcCCCCCCEEEccCCccCcccc--ccCCCCCCEEEccCCeeecC
Confidence            75433  7778888888888888875433  7788888888888888875543  77888888888888888763

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.85  E-value=4.6e-21  Score=196.97  Aligned_cols=134  Identities=20%  Similarity=0.268  Sum_probs=89.5

Q ss_pred             CCCCCccceeeeCCCCCEEEEEeccCCccccCCcCccccccccEEEeccCCCCCCCChhhhhhcccceeeccCCcccccc
Q 002010           56 PSAHCSFSGVTCDQDSRVVSLNVSFMPLFGSIPPEIGLLTKLVNLTISNVNLTGRLPSEMALLTSLKVFNISGNVFQGNF  135 (982)
Q Consensus        56 ~~~~C~w~gv~C~~~~~v~~l~l~~~~l~g~~~~~i~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~  135 (982)
                      ..|.|.|.+|.|+..+            ...+|..+  .++|++|++++|++++..+..+..+++|++|+|++|.+++ +
T Consensus         3 ~~C~C~~~~v~c~~~~------------l~~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~-~   67 (208)
T 2o6s_A            3 SRCSCSGTTVECYSQG------------RTSVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQS-L   67 (208)
T ss_dssp             TTCEEETTEEECCSSC------------CSSCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCC-C
T ss_pred             CCCEECCCEEEecCCC------------ccCCCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCc-c
Confidence            3467999999998643            12344433  4578889999998887666667778888888888887763 4


Q ss_pred             chhhhhcCCCccEEeccCccccCCCchhccccccccEEeecCcccccccCCCccccCcceEeeccCccc
Q 002010          136 AGQIVRGMTELQVLDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLNGIGL  204 (982)
Q Consensus       136 ~~~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~i  204 (982)
                      +...+.++++|++|++++|++++..+..++.+++|++|+|++|++++..+..|..+++|++|++++|.+
T Consensus        68 ~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l  136 (208)
T 2o6s_A           68 PNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQL  136 (208)
T ss_dssp             CTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred             ChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCcc
Confidence            445566677777777777777755555566777777777777776655444455555555555544433

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.84  E-value=1.7e-21  Score=209.38  Aligned_cols=145  Identities=14%  Similarity=0.074  Sum_probs=116.1

Q ss_pred             cccccccccccceEEEEEEeCCCcEEEEEEeccCCCCC-----------------chhhHHHHHHHHhcCCCCcccceEe
Q 002010          694 LKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGG-----------------NDHGFLAEIQTLGRIRHRNIVRLLG  756 (982)
Q Consensus       694 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~~E~~~l~~l~h~niv~~~~  756 (982)
                      |..++.||+|+||.||+|...+|+.||+|.+.......                 ....+.+|+.++++++  | +++++
T Consensus        92 ~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~  168 (282)
T 1zar_A           92 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPK  168 (282)
T ss_dssp             SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCC
T ss_pred             EEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCe
Confidence            45668999999999999988779999999985432110                 2346889999999998  5 66666


Q ss_pred             EEEcCCccEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEe
Q 002010          757 YVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVA  836 (982)
Q Consensus       757 ~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~  836 (982)
                      ++. .+..++||||+++++|.+ +..        .....++.|++.|++|||+.+   |+||||||+||+++ ++.+||+
T Consensus       169 ~~~-~~~~~lvmE~~~g~~L~~-l~~--------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl~-~~~vkl~  234 (282)
T 1zar_A          169 VYA-WEGNAVLMELIDAKELYR-VRV--------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVS-EEGIWII  234 (282)
T ss_dssp             EEE-EETTEEEEECCCCEEGGG-CCC--------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE-TTEEEEC
T ss_pred             EEe-ccceEEEEEecCCCcHHH-cch--------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEEE-CCcEEEE
Confidence            554 366799999999999998 531        234579999999999999998   99999999999999 9999999


Q ss_pred             ccccchhccccCCccccccccccccccccccccc
Q 002010          837 DFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYT  870 (982)
Q Consensus       837 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  870 (982)
                      |||+|+.               +..|+|||.+..
T Consensus       235 DFG~a~~---------------~~~~~a~e~l~r  253 (282)
T 1zar_A          235 DFPQSVE---------------VGEEGWREILER  253 (282)
T ss_dssp             CCTTCEE---------------TTSTTHHHHHHH
T ss_pred             ECCCCeE---------------CCCCCHHHHHHH
Confidence            9999863               234788997653

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=99.84  E-value=8.7e-21  Score=222.36  Aligned_cols=189  Identities=26%  Similarity=0.375  Sum_probs=109.5

Q ss_pred             CccEEEccCCCcccccCccccCCCcccEEEeccccccccCCccccCccccceeecccccccccCCccccCCCCCCEEEcc
Q 002010          338 NLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFIGPIPEELGQCKSLTKIRFS  417 (982)
Q Consensus       338 ~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~l~~N~~~~~~~~~l~~l~~L~~L~Ls  417 (982)
                      +|+.|++++|.+++ +|..+.  ++|++|+|++|+|+ .+|   ..                        +++|++|+++
T Consensus        60 ~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---~~------------------------l~~L~~L~Ls  108 (571)
T 3cvr_A           60 QFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---EL------------------------PASLEYLDAC  108 (571)
T ss_dssp             TCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---CC------------------------CTTCCEEECC
T ss_pred             CccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---cc------------------------cCCCCEEEcc
Confidence            56667776666664 444332  45666666666665 333   22                        3444444444


Q ss_pred             CCccCCCCCccccCCCccccccCCCccccccCCcccccCCccEEEeeccccCCCCchhccCCCCcceeeeccccccCCCc
Q 002010          418 KNYLNGTIPAGLFNLPLLNMMELDDNLLSGELPEKMSGASLNQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIP  497 (982)
Q Consensus       418 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p  497 (982)
                      +|+|++ +|. +..  +|+.|++++|.|++ +|.  ...+|+.|+|++|+|++ +|.   .+++|++|+|++|+|++ +|
T Consensus       109 ~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~--~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp  176 (571)
T 3cvr_A          109 DNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE--LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTF-LP  176 (571)
T ss_dssp             SSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC--CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CC
T ss_pred             CCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC--cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCC-cc
Confidence            444443 333 322  44444444444443 222  22456666666666664 333   45667777777777764 55


Q ss_pred             cccccccccceeeeeccccCCCCCcccccccCC-------CeeeCCCCcccCCCCcccccccccceEEcccccccccCcc
Q 002010          498 VESFNLKMITSINISDNNISGEIPYSISQCHSL-------TSVDLSRNSLYGKIPPGISKLIDLSILNLSRNGITGSIPN  570 (982)
Q Consensus       498 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L-------~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~  570 (982)
                      . +.  ++|++|+|++|+|+ .+|. |..  +|       +.|+|++|+|+ .+|..+..+++|+.|+|++|+|++.+|.
T Consensus       177 ~-l~--~~L~~L~Ls~N~L~-~lp~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~  248 (571)
T 3cvr_A          177 E-LP--ESLEALDVSTNLLE-SLPA-VPV--RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRE  248 (571)
T ss_dssp             C-CC--TTCCEEECCSSCCS-SCCC-CC----------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHH
T ss_pred             h-hh--CCCCEEECcCCCCC-chhh-HHH--hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCHH
Confidence            5 43  67777777777776 4554 443  55       77777777777 5677777777777777777777777777


Q ss_pred             ccccccc
Q 002010          571 EMRNMMS  577 (982)
Q Consensus       571 ~l~~l~~  577 (982)
                      .+..+..
T Consensus       249 ~l~~l~~  255 (571)
T 3cvr_A          249 SLSQQTA  255 (571)
T ss_dssp             HHHHHHH
T ss_pred             HHHHhhc
Confidence            7666544

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=99.84  E-value=1.2e-20  Score=210.62  Aligned_cols=122  Identities=18%  Similarity=0.198  Sum_probs=77.7

Q ss_pred             ceeecccccCCCCCCccccCCCCCCEEEeeCCcccCcCchhhhcccchhhhhhccCCCCCCCC-CcCCCCCCccE-EEcc
Q 002010          268 HSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQLFKNNLRGPIP-SFLGDFPNLEV-LQVW  345 (982)
Q Consensus       268 ~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~-L~L~  345 (982)
                      ++++.++++++ .+|..+.  +++++|+|++|+|+...+.+|.++++|++|+|++|++.+.+| ..|.++++|+. +.++
T Consensus        12 ~~v~C~~~~Lt-~iP~~l~--~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~   88 (350)
T 4ay9_X           12 RVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK   88 (350)
T ss_dssp             TEEEEESTTCC-SCCTTCC--TTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEE
T ss_pred             CEEEecCCCCC-ccCcCcC--CCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhccc
Confidence            45777777777 5565542  567788888888775555667777777777777777755444 45666666554 4555


Q ss_pred             CCCcccccCccccCCCcccEEEeccccccccCCccccCccccceeec
Q 002010          346 GNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDLCKGGKLKSLIL  392 (982)
Q Consensus       346 ~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~l  392 (982)
                      +|+++...|..|..+++|++|++++|++++..+..+....++..|++
T Consensus        89 ~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l  135 (350)
T 4ay9_X           89 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDI  135 (350)
T ss_dssp             ETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEE
T ss_pred             CCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhh
Confidence            66666666666666666666666666666444444444444444444

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=99.83  E-value=1.5e-20  Score=220.26  Aligned_cols=182  Identities=26%  Similarity=0.379  Sum_probs=152.4

Q ss_pred             ccceeecccccccccCCccccCCCCCCEEEccCCccCCCCCccccCCCccccccCCCccccccCCcccccCCccEEEeec
Q 002010          386 KLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLSGELPEKMSGASLNQLKVAN  465 (982)
Q Consensus       386 ~L~~L~l~~N~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~L~~  465 (982)
                      +++.|++++|.+++ +|..+  .++|++|+|++|+|+ .+|   ..+++|+.|++++|.|++ +|. +.. +|++|+|++
T Consensus        60 ~L~~L~Ls~n~L~~-lp~~l--~~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~-~L~~L~Ls~  129 (571)
T 3cvr_A           60 QFSELQLNRLNLSS-LPDNL--PPQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA-SLKHLDVDN  129 (571)
T ss_dssp             TCSEEECCSSCCSC-CCSCC--CTTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT-TCCEEECCS
T ss_pred             CccEEEeCCCCCCc-cCHhH--cCCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc-CCCEEECCC
Confidence            55566666666554 45444  268999999999999 677   457899999999999998 565 544 999999999


Q ss_pred             cccCCCCchhccCCCCcceeeeccccccCCCccccccccccceeeeeccccCCCCCcccccccCCCeeeCCCCcccCCCC
Q 002010          466 NNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYGKIP  545 (982)
Q Consensus       466 N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p  545 (982)
                      |+|++ +|.   .+++|+.|+|++|+|++ +|.   .+++|++|+|++|+|++ +|. |.  ++|+.|+|++|+|+ .+|
T Consensus       130 N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~-~lp  196 (571)
T 3cvr_A          130 NQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLE-SLP  196 (571)
T ss_dssp             SCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCS-SCC
T ss_pred             CcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCC-chh
Confidence            99997 555   68999999999999996 665   57899999999999997 666 66  99999999999999 777


Q ss_pred             ccccccccc-------ceEEcccccccccCccccccccccceecccCCccccCCCC
Q 002010          546 PGISKLIDL-------SILNLSRNGITGSIPNEMRNMMSLTTLDLSYNNLIGNIPS  594 (982)
Q Consensus       546 ~~~~~l~~L-------~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~  594 (982)
                      . |..  +|       +.|+|++|+|+ .+|..+..+++|+.|+|++|+|++.+|.
T Consensus       197 ~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~  248 (571)
T 3cvr_A          197 A-VPV--RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRE  248 (571)
T ss_dssp             C-CC----------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHH
T ss_pred             h-HHH--hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCHH
Confidence            7 665  78       99999999999 6888888899999999999999998885

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.82  E-value=7.3e-20  Score=187.99  Aligned_cols=114  Identities=18%  Similarity=0.147  Sum_probs=67.3

Q ss_pred             hhccCCCCcceeeeccccccCCCccccccccccceeeeeccccCCCCCcccccccCCCeeeCCCCcccCCCCcccccccc
Q 002010          474 AAIGNLPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYGKIPPGISKLID  553 (982)
Q Consensus       474 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~  553 (982)
                      ..|..+++|++|++++|++++..+..+..+++|++|+|++|+|++..+..|..+++|+.|+|++|++++..+..|..+++
T Consensus        70 ~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~  149 (208)
T 2o6s_A           70 GVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTS  149 (208)
T ss_dssp             TTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTT
T ss_pred             hhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCC
Confidence            34445555555555555555443334455555666666666665555555566666666666666666555555666666


Q ss_pred             cceEEcccccccccCccccccccccceecccCCccccCCCC
Q 002010          554 LSILNLSRNGITGSIPNEMRNMMSLTTLDLSYNNLIGNIPS  594 (982)
Q Consensus       554 L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~  594 (982)
                      |+.|+|++|.+.+       .+++|++|+++.|+++|.+|.
T Consensus       150 L~~L~l~~N~~~~-------~~~~l~~L~~~~n~~~g~ip~  183 (208)
T 2o6s_A          150 LQYIWLHDNPWDC-------TCPGIRYLSEWINKHSGVVRN  183 (208)
T ss_dssp             CCEEECCSCCBCC-------CTTTTHHHHHHHHHCTTTBBC
T ss_pred             ccEEEecCCCeec-------CCCCHHHHHHHHHhCCceeec
Confidence            6666666666553       234566666777777766664

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=99.81  E-value=9.6e-21  Score=230.62  Aligned_cols=241  Identities=15%  Similarity=0.145  Sum_probs=115.7

Q ss_pred             cCchhHHHHHHHHHhcccCCCCCCCCCCCCCCCCCCCCccceeeeCCCCCEEEEEeccCCccccCCcCccccccccEEEe
Q 002010           23 SCAYSDMDVLLKLKSSMIGPKGSGLKNWEPSSSPSAHCSFSGVTCDQDSRVVSLNVSFMPLFGSIPPEIGLLTKLVNLTI  102 (982)
Q Consensus        23 ~~~~~~~~~ll~~k~~~~~~~~~~~~~w~~~~~~~~~C~w~gv~C~~~~~v~~l~l~~~~l~g~~~~~i~~l~~L~~L~l  102 (982)
                      +....++++|+++......+.+..-.+|...  +...+.|.+++++. ++|+.++|.++++.. ++.     ..|+.++|
T Consensus       128 s~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~s~-~~~~~l~L~~n~~~~-~~~-----~~l~~l~L  198 (727)
T 4b8c_D          128 SLVDCTKQALMEMADTLTDSKTAKKQQPTGD--STPSGTATNSAVST-PLTPKIELFANGKDE-ANQ-----ALLQHKKL  198 (727)
T ss_dssp             ----CCCHHHHHHHHHHHHHHTTC--------------------------------------------------------
T ss_pred             hccccchhhhhhhhhhcccccCcccCCCcCC--CCccccCCCceecC-CccceEEeeCCCCCc-chh-----hHhhcCcc
Confidence            3557789999999998876655556677543  23467899998875 567777766554433 111     12233333


Q ss_pred             ccCCCCCCCChhhhhhcccceeeccCCccccccchhhhhcCCCccEEeccCccccCCCchhccccccccEEeecCccccc
Q 002010          103 SNVNLTGRLPSEMALLTSLKVFNISGNVFQGNFAGQIVRGMTELQVLDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTG  182 (982)
Q Consensus       103 ~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~  182 (982)
                      +.|.+.                                       .++++.|.+. ..|..+..+++|++|+|++|.+. 
T Consensus       199 s~~~i~---------------------------------------~~~~~~n~~~-~~~~~~~~l~~L~~L~Ls~n~l~-  237 (727)
T 4b8c_D          199 SQYSID---------------------------------------EDDDIENRMV-MPKDSKYDDQLWHALDLSNLQIF-  237 (727)
T ss_dssp             ---------------------------------------------------------------CCCCCCEEECTTSCCS-
T ss_pred             Cccccc---------------------------------------Ccccccccee-cChhhhccCCCCcEEECCCCCCC-
Confidence            333332                                       2233333333 33444444555555555555544 


Q ss_pred             ccCCCccccCcceEeeccCcccccchhhHHhhhhhHHHHhhcccccccccCCCCCCCCCCCCEEecccCcCcccCchhhc
Q 002010          183 KIPQSYSEIQSLEYIGLNGIGLNGTVPAFLSRLKNLREMYIGYFNTYTGGIPPGFGALTQLQVLDMASCNISGEIPTSLS  262 (982)
Q Consensus       183 ~~p~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~l~~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~  262 (982)
                      .+|..+..+++|++|+|++|.+.                          .+|..|+++++|++|+|++|+|+ .+|..|+
T Consensus       238 ~l~~~~~~l~~L~~L~Ls~N~l~--------------------------~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~  290 (727)
T 4b8c_D          238 NISANIFKYDFLTRLYLNGNSLT--------------------------ELPAEIKNLSNLRVLDLSHNRLT-SLPAELG  290 (727)
T ss_dssp             CCCGGGGGCCSCSCCBCTTSCCS--------------------------CCCGGGGGGTTCCEEECTTSCCS-SCCSSGG
T ss_pred             CCChhhcCCCCCCEEEeeCCcCc--------------------------ccChhhhCCCCCCEEeCcCCcCC-ccChhhc
Confidence            34444444444444444444332                          23445666778888888888888 6788888


Q ss_pred             CCCccceeecccccCCCCCCccccCCCCCCEEEeeCCcccCcCchhhhcccc-hhhhhhccCCCCCCCCCcCCCCCCccE
Q 002010          263 RLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKN-LTLLQLFKNNLRGPIPSFLGDFPNLEV  341 (982)
Q Consensus       263 ~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~-L~~L~L~~N~l~~~~p~~~~~l~~L~~  341 (982)
                      .+++|++|+|++|.|+ .+|..|+.+++|++|+|++|.|++.+|..+..+.. +..|+|++|.+++.+|..      |+.
T Consensus       291 ~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~------l~~  363 (727)
T 4b8c_D          291 SCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHE------RRF  363 (727)
T ss_dssp             GGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC---------
T ss_pred             CCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCccc------cce
Confidence            9999999999999997 67878999999999999999999988888876543 345889999999888864      456


Q ss_pred             EEccCC
Q 002010          342 LQVWGN  347 (982)
Q Consensus       342 L~L~~N  347 (982)
                      |+++.|
T Consensus       364 l~l~~n  369 (727)
T 4b8c_D          364 IEINTD  369 (727)
T ss_dssp             ------
T ss_pred             eEeecc
Confidence            666666

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.81  E-value=4.2e-20  Score=191.22  Aligned_cols=138  Identities=21%  Similarity=0.196  Sum_probs=121.0

Q ss_pred             CccEEEeeccccCCCCc-hhccCCCCcceeeeccccccCCCccccccccccceeeeeccccCCCCCcccccccCCCeeeC
Q 002010          457 SLNQLKVANNNITGKIP-AAIGNLPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIPYSISQCHSLTSVDL  535 (982)
Q Consensus       457 ~L~~L~L~~N~i~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  535 (982)
                      .+++|+|++|+|++..+ ..|..+++|++|+|++|+|++..+..+..+++|++|+|++|+|++..+..|..+++|++|+|
T Consensus        33 ~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  112 (220)
T 2v70_A           33 YTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLML  112 (220)
T ss_dssp             TCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEEC
T ss_pred             CCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEEC
Confidence            45677788888876644 45788999999999999998777778889999999999999999888888999999999999


Q ss_pred             CCCcccCCCCcccccccccceEEcccccccccCccccccccccceecccCCccccCCCC
Q 002010          536 SRNSLYGKIPPGISKLIDLSILNLSRNGITGSIPNEMRNMMSLTTLDLSYNNLIGNIPS  594 (982)
Q Consensus       536 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~  594 (982)
                      ++|+|++..|..|.++++|+.|+|++|+|++..|..|..+++|+.|+|++|++++..+.
T Consensus       113 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l  171 (220)
T 2v70_A          113 RSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCYL  171 (220)
T ss_dssp             TTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGGG
T ss_pred             CCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCch
Confidence            99999988899999999999999999999988899999999999999999999987663

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.80  E-value=1.3e-19  Score=187.59  Aligned_cols=137  Identities=19%  Similarity=0.244  Sum_probs=120.9

Q ss_pred             CCccEEEeeccccCCCCchhccCCCCcceeeeccccccCCCccccccccccceeeeeccccCCCCCcccccccCCCeeeC
Q 002010          456 ASLNQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIPYSISQCHSLTSVDL  535 (982)
Q Consensus       456 ~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  535 (982)
                      ..++.|++++|+|++..+..|..+++|++|+|++|++++..|..+..+++|++|+|++|+|++..+..|.++++|+.|+|
T Consensus        32 ~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L  111 (220)
T 2v9t_B           32 ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLL  111 (220)
T ss_dssp             TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEEC
Confidence            46788888888888777778889999999999999998887888999999999999999999776677889999999999


Q ss_pred             CCCcccCCCCcccccccccceEEcccccccccCccccccccccceecccCCccccCC
Q 002010          536 SRNSLYGKIPPGISKLIDLSILNLSRNGITGSIPNEMRNMMSLTTLDLSYNNLIGNI  592 (982)
Q Consensus       536 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~i  592 (982)
                      ++|+|++..|..|..+++|+.|+|++|+|++..+..|..+++|++|+|++|++....
T Consensus       112 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c  168 (220)
T 2v9t_B          112 NANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFICDC  168 (220)
T ss_dssp             CSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEECSG
T ss_pred             CCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCCCC
Confidence            999999888899999999999999999999888888999999999999999987653

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.79  E-value=6.4e-19  Score=183.58  Aligned_cols=110  Identities=25%  Similarity=0.299  Sum_probs=66.0

Q ss_pred             CCCCccceeeeCCCCCEEEEEeccCCccccCCcCccccccccEEEeccCCCCCCCChhhhhhcccceeeccCCccccccc
Q 002010           57 SAHCSFSGVTCDQDSRVVSLNVSFMPLFGSIPPEIGLLTKLVNLTISNVNLTGRLPSEMALLTSLKVFNISGNVFQGNFA  136 (982)
Q Consensus        57 ~~~C~w~gv~C~~~~~v~~l~l~~~~l~g~~~~~i~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~~  136 (982)
                      .+.|+|.+|.|+..+            .+.+|..+.  ++|++|+|++|++++..|..+..+++|++|+|++|.+. .++
T Consensus        16 ~~~Cs~~~v~c~~~~------------l~~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~-~i~   80 (229)
T 3e6j_A           16 QCSCSGTTVDCRSKR------------HASVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALP   80 (229)
T ss_dssp             TCEEETTEEECTTSC------------CSSCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCC
T ss_pred             CCEEeCCEeEccCCC------------cCccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCC-CcC
Confidence            568999999997543            345665544  77888888888888777777777777776666666663 233


Q ss_pred             hhhhhcCCCccEEeccCccccCCCchhccccccccEEeecCcccc
Q 002010          137 GQIVRGMTELQVLDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFT  181 (982)
Q Consensus       137 ~~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~  181 (982)
                      ...+.++++|++|+|++|+|++..+..+..+++|++|+|++|+|+
T Consensus        81 ~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~  125 (229)
T 3e6j_A           81 VGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT  125 (229)
T ss_dssp             TTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC
T ss_pred             hhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc
Confidence            334444444444444444444333333344444444444444433

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=99.79  E-value=3.1e-19  Score=211.71  Aligned_cols=189  Identities=24%  Similarity=0.332  Sum_probs=99.6

Q ss_pred             cceeeccCCccccccchhhhhcCCCccEEeccCccccCCCchhccccccccEEeecCcccccccCCCccccCcceEeecc
Q 002010          121 LKVFNISGNVFQGNFAGQIVRGMTELQVLDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLN  200 (982)
Q Consensus       121 L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~  200 (982)
                      +..++++.+.+.+..+   +..+++|+.|++++|.++. +| .++.+++|++|+|++|++++..|  ++.+++|+.|+|+
T Consensus        23 l~~l~l~~~~i~~~~~---~~~L~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls   95 (605)
T 1m9s_A           23 TIKDNLKKKSVTDAVT---QNELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLD   95 (605)
T ss_dssp             HHHHHTTCSCTTSEEC---HHHHTTCCCCBCTTCCCCC-CT-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECC
T ss_pred             HHHHhccCCCcccccc---hhcCCCCCEEECcCCCCCC-Ch-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECc
Confidence            3444444444443222   2334455555555555542 22 35555555555555555554333  5555555555555


Q ss_pred             CcccccchhhHHhhhhhHHHHhhcccccccccCCCCCCCCCCCCEEecccCcCcccCchhhcCCCccceeecccccCCCC
Q 002010          201 GIGLNGTVPAFLSRLKNLREMYIGYFNTYTGGIPPGFGALTQLQVLDMASCNISGEIPTSLSRLKLLHSLFLQMNKLTGH  280 (982)
Q Consensus       201 ~n~i~~~~~~~l~~l~~L~~L~l~~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~  280 (982)
                      +|.+.+                           ++.+..+++|+.|+|++|++++.  ..+..+++|+.|+|++|++++.
T Consensus        96 ~N~l~~---------------------------l~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l  146 (605)
T 1m9s_A           96 ENKIKD---------------------------LSSLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI  146 (605)
T ss_dssp             SSCCCC---------------------------CTTSTTCTTCCEEECTTSCCCCC--GGGGGCTTCSEEECCSSCCCCC
T ss_pred             CCCCCC---------------------------ChhhccCCCCCEEEecCCCCCCC--ccccCCCccCEEECCCCccCCc
Confidence            544431                           11345556666666666666542  3455666666666666666643


Q ss_pred             CCccccCCCCCCEEEeeCCcccCcCchhhhcccchhhhhhccCCCCCCCCCcCCCCCCccEEEccCCCccc
Q 002010          281 IPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTF  351 (982)
Q Consensus       281 ~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~  351 (982)
                        ..+..+++|+.|+|++|.|++..|  +..+++|+.|+|++|+|++.  ..+..+++|+.|+|++|++..
T Consensus       147 --~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i~~l--~~l~~l~~L~~L~L~~N~l~~  211 (605)
T 1m9s_A          147 --TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLN  211 (605)
T ss_dssp             --GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCBC--GGGTTCTTCSEEECCSEEEEC
T ss_pred             --hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEECcCCCCCCC--hHHccCCCCCEEEccCCcCcC
Confidence              445566666666666666664443  55555555555555555542  235555566666666555554

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=99.78  E-value=1.7e-21  Score=229.93  Aligned_cols=107  Identities=22%  Similarity=0.297  Sum_probs=53.5

Q ss_pred             cceeeeccccccCCCccccccccccceeeeeccccCCCCCcccccccCCCeeeCCCCcccCCCCcccccccccceEEccc
Q 002010          482 LNILSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYGKIPPGISKLIDLSILNLSR  561 (982)
Q Consensus       482 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~  561 (982)
                      |+.|+|++|+|++ +|. +..+++|+.|+|++|+|+ .+|..|+.+++|+.|+|++|+|++ +| .|+++++|+.|+|++
T Consensus       443 L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~  517 (567)
T 1dce_A          443 VRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCN  517 (567)
T ss_dssp             CSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCS
T ss_pred             ceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCC
Confidence            4445555555543 333 444555555555555554 444455555555555555555543 33 455555555555555


Q ss_pred             ccccccC-ccccccccccceecccCCccccCCC
Q 002010          562 NGITGSI-PNEMRNMMSLTTLDLSYNNLIGNIP  593 (982)
Q Consensus       562 N~l~~~~-p~~l~~l~~L~~L~Ls~N~l~~~ip  593 (982)
                      |+|++.+ |..+..+++|+.|+|++|++++.+|
T Consensus       518 N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~  550 (567)
T 1dce_A          518 NRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEG  550 (567)
T ss_dssp             SCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSS
T ss_pred             CCCCCCCCcHHHhcCCCCCEEEecCCcCCCCcc
Confidence            5555443 4555555555555555555555444

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=99.78  E-value=4.9e-19  Score=198.25  Aligned_cols=175  Identities=22%  Similarity=0.209  Sum_probs=83.8

Q ss_pred             CEEEccCCccCCCCCccccCCCccccccCCCccccccCCccc--ccCCccEEEeeccccCCCCchhccCCCCcceeeecc
Q 002010          412 TKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLSGELPEKM--SGASLNQLKVANNNITGKIPAAIGNLPSLNILSLQN  489 (982)
Q Consensus       412 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~--~~~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~  489 (982)
                      +.+++++|.++ .+|..+..  .++.|+|++|.|++..+..+  ...+|++|+|++|+|++..+..|.++++|++|+|++
T Consensus        21 ~~l~c~~~~l~-~iP~~~~~--~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~   97 (361)
T 2xot_A           21 NILSCSKQQLP-NVPQSLPS--YTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS   97 (361)
T ss_dssp             TEEECCSSCCS-SCCSSCCT--TCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred             CEEEeCCCCcC-ccCccCCC--CCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCC
Confidence            35556666555 34443321  23344444444443333333  123445555555555544444555555555555555


Q ss_pred             ccccCCCccccccccccceeeeeccccCCCCCcccccccCCCeeeCCCCcccCCCCccc---ccccccceEEcccccccc
Q 002010          490 NRLEGEIPVESFNLKMITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYGKIPPGI---SKLIDLSILNLSRNGITG  566 (982)
Q Consensus       490 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~---~~l~~L~~L~Ls~N~l~~  566 (982)
                      |+|++..+..+..+++|++|+|++|+|++..|..|.++++|+.|+|++|+|++..+..|   ..+++|+.|+|++|+|++
T Consensus        98 N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~  177 (361)
T 2xot_A           98 NHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKK  177 (361)
T ss_dssp             SCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCC
T ss_pred             CcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCc
Confidence            55554444445555555555555555554445555555555555555555553222223   345555555555555554


Q ss_pred             cCcccccccccc--ceecccCCccc
Q 002010          567 SIPNEMRNMMSL--TTLDLSYNNLI  589 (982)
Q Consensus       567 ~~p~~l~~l~~L--~~L~Ls~N~l~  589 (982)
                      ..+..+..++.+  +.|+|++|++.
T Consensus       178 l~~~~~~~l~~~~l~~l~l~~N~~~  202 (361)
T 2xot_A          178 LPLTDLQKLPAWVKNGLYLHNNPLE  202 (361)
T ss_dssp             CCHHHHHHSCHHHHTTEECCSSCEE
T ss_pred             cCHHHhhhccHhhcceEEecCCCcc
Confidence            443444444442  44444444443

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=99.77  E-value=3.1e-19  Score=193.25  Aligned_cols=190  Identities=24%  Similarity=0.335  Sum_probs=94.2

Q ss_pred             cccceeeccCCccccccchhhhhcCCCccEEeccCccccCCCchhccccccccEEeecCcccccccCCCccccCcceEee
Q 002010          119 TSLKVFNISGNVFQGNFAGQIVRGMTELQVLDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIG  198 (982)
Q Consensus       119 ~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  198 (982)
                      ..+..+++..+.+.+...   ...+++|++|++++|.++. +| .+..+++|++|+|++|++++..+  ++.+++|++|+
T Consensus        24 ~~~~~~~l~~~~~~~~~~---~~~l~~L~~L~l~~~~i~~-~~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~   96 (291)
T 1h6t_A           24 AETIKDNLKKKSVTDAVT---QNELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLF   96 (291)
T ss_dssp             HHHHHHHTTCSCTTSEEC---HHHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEE
T ss_pred             HHHHHHHhcCCCcccccc---hhhcCcccEEEccCCCccc-Ch-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEE
Confidence            334444555555443222   2345556666666666653 22 35666666666666666664333  55555555555


Q ss_pred             ccCcccccchhhHHhhhhhHHHHhhcccccccccCCCCCCCCCCCCEEecccCcCcccCchhhcCCCccceeecccccCC
Q 002010          199 LNGIGLNGTVPAFLSRLKNLREMYIGYFNTYTGGIPPGFGALTQLQVLDMASCNISGEIPTSLSRLKLLHSLFLQMNKLT  278 (982)
Q Consensus       199 L~~n~i~~~~~~~l~~l~~L~~L~l~~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~  278 (982)
                      +++|.+.+.                           +.++.+++|++|++++|++++.  ..+..+++|++|++++|+++
T Consensus        97 l~~n~l~~~---------------------------~~l~~l~~L~~L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~  147 (291)
T 1h6t_A           97 LDENKVKDL---------------------------SSLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKIT  147 (291)
T ss_dssp             CCSSCCCCG---------------------------GGGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCC
T ss_pred             CCCCcCCCC---------------------------hhhccCCCCCEEECCCCcCCCC--hhhcCCCCCCEEEccCCcCC
Confidence            555444310                           1134455555555555555532  24555555555555555555


Q ss_pred             CCCCccccCCCCCCEEEeeCCcccCcCchhhhcccchhhhhhccCCCCCCCCCcCCCCCCccEEEccCCCcc
Q 002010          279 GHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFT  350 (982)
Q Consensus       279 ~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~  350 (982)
                      +.  ..+..+++|++|++++|++++..+  +..+++|+.|++++|.+++. + .+..+++|+.|++++|+++
T Consensus       148 ~~--~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i~~l-~-~l~~l~~L~~L~l~~n~i~  213 (291)
T 1h6t_A          148 DI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISDL-R-ALAGLKNLDVLELFSQECL  213 (291)
T ss_dssp             CC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCBC-G-GGTTCTTCSEEEEEEEEEE
T ss_pred             cc--hhhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCcCCCC-h-hhccCCCCCEEECcCCccc
Confidence            33  345555555555555555553322  44444455555554444432 2 2444444444444444444

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=99.77  E-value=3.6e-19  Score=199.32  Aligned_cols=178  Identities=20%  Similarity=0.188  Sum_probs=151.0

Q ss_pred             ccccCCCccccccCCcccccCCccEEEeeccccCCCCchhcc-CCCCcceeeeccccccCCCccccccccccceeeeecc
Q 002010          436 NMMELDDNLLSGELPEKMSGASLNQLKVANNNITGKIPAAIG-NLPSLNILSLQNNRLEGEIPVESFNLKMITSINISDN  514 (982)
Q Consensus       436 ~~L~L~~N~l~~~~~~~~~~~~L~~L~L~~N~i~~~~p~~~~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N  514 (982)
                      +.+++++|.++.. |..+. ..++.|+|++|+|++..+..|. ++++|++|+|++|+|++..+..+..+++|++|+|++|
T Consensus        21 ~~l~c~~~~l~~i-P~~~~-~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N   98 (361)
T 2xot_A           21 NILSCSKQQLPNV-PQSLP-SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSN   98 (361)
T ss_dssp             TEEECCSSCCSSC-CSSCC-TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred             CEEEeCCCCcCcc-CccCC-CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCC
Confidence            5789999999864 44332 4689999999999988888888 9999999999999999877788999999999999999


Q ss_pred             ccCCCCCcccccccCCCeeeCCCCcccCCCCcccccccccceEEcccccccccCcccc---ccccccceecccCCccccC
Q 002010          515 NISGEIPYSISQCHSLTSVDLSRNSLYGKIPPGISKLIDLSILNLSRNGITGSIPNEM---RNMMSLTTLDLSYNNLIGN  591 (982)
Q Consensus       515 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l---~~l~~L~~L~Ls~N~l~~~  591 (982)
                      +|++..+..|..+++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++..+..|   ..+++|+.|||++|+|++.
T Consensus        99 ~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~l  178 (361)
T 2xot_A           99 HLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKL  178 (361)
T ss_dssp             CCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCCC
T ss_pred             cCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCcc
Confidence            9998888889999999999999999998889999999999999999999996555555   6799999999999999965


Q ss_pred             CCCC-ccccc--cccccccCCcCcccC
Q 002010          592 IPSG-GQFLA--FNETSFIGNPNLCLL  615 (982)
Q Consensus       592 ip~~-~~~~~--~~~~~~~~n~~~c~~  615 (982)
                      .+.. ..+..  +....+.|||+.|++
T Consensus       179 ~~~~~~~l~~~~l~~l~l~~N~~~C~C  205 (361)
T 2xot_A          179 PLTDLQKLPAWVKNGLYLHNNPLECDC  205 (361)
T ss_dssp             CHHHHHHSCHHHHTTEECCSSCEECCH
T ss_pred             CHHHhhhccHhhcceEEecCCCccCCc
Confidence            4321 11222  245678999999965

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.77  E-value=1.8e-18  Score=180.11  Aligned_cols=137  Identities=22%  Similarity=0.203  Sum_probs=123.0

Q ss_pred             CCccEEEeeccccCCCCchhccCCCCcceeeeccccccCCCccccccccccceeeeeccccCCCCCcccccccCCCeeeC
Q 002010          456 ASLNQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIPYSISQCHSLTSVDL  535 (982)
Q Consensus       456 ~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  535 (982)
                      .+|++|+|++|+|++..|..|..+++|++|+|++|+|++..+..+..+++|++|+|++|+|++..+..|..+++|+.|+|
T Consensus        40 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L  119 (229)
T 3e6j_A           40 TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFM  119 (229)
T ss_dssp             TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEec
Confidence            56888888888888888889999999999999999998655566788999999999999999877888899999999999


Q ss_pred             CCCcccCCCCcccccccccceEEcccccccccCccccccccccceecccCCccccCCC
Q 002010          536 SRNSLYGKIPPGISKLIDLSILNLSRNGITGSIPNEMRNMMSLTTLDLSYNNLIGNIP  593 (982)
Q Consensus       536 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip  593 (982)
                      ++|+|+ .+|..+..+++|+.|+|++|+|++..+..|..+++|+.|+|++|++.+..+
T Consensus       120 s~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~  176 (229)
T 3e6j_A          120 CCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCECR  176 (229)
T ss_dssp             CSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTTBG
T ss_pred             cCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCCcc
Confidence            999998 789999999999999999999997777889999999999999999998766

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=99.77  E-value=1.3e-18  Score=206.36  Aligned_cols=175  Identities=27%  Similarity=0.280  Sum_probs=124.9

Q ss_pred             CCCCCCCCEEecccCcCcccCchhhcCCCccceeecccccCCCCCCccccCCCCCCEEEeeCCcccCcCchhhhcccchh
Q 002010          237 FGALTQLQVLDMASCNISGEIPTSLSRLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLT  316 (982)
Q Consensus       237 ~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~  316 (982)
                      +..+++|+.|++++|.+... + .+..+++|+.|+|++|++++..+  +..+++|+.|+|++|.+++ +| .+..+++|+
T Consensus        39 ~~~L~~L~~L~l~~n~i~~l-~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~  112 (605)
T 1m9s_A           39 QNELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKD-LS-SLKDLKKLK  112 (605)
T ss_dssp             HHHHTTCCCCBCTTCCCCCC-T-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCC-CT-TSTTCTTCC
T ss_pred             hhcCCCCCEEECcCCCCCCC-h-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCCC-Ch-hhccCCCCC
Confidence            45677788888888887743 3 47778888888888888876544  7778888888888888874 33 577777777


Q ss_pred             hhhhccCCCCCCCCCcCCCCCCccEEEccCCCcccccCccccCCCcccEEEeccccccccCCccccCccccceeeccccc
Q 002010          317 LLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQNF  396 (982)
Q Consensus       317 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~l~~N~  396 (982)
                      .|+|++|++.+.  ..+..+++|+.|+|++|.+++.  ..+..+++|+.|+|++|++++..|  +..+++|+.|+|++|.
T Consensus       113 ~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~  186 (605)
T 1m9s_A          113 SLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNH  186 (605)
T ss_dssp             EEECTTSCCCCC--GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSC
T ss_pred             EEEecCCCCCCC--ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEECcCCC
Confidence            777777777753  3467777777777777777754  566777777777777777776555  6667777777777777


Q ss_pred             ccccCCccccCCCCCCEEEccCCccCCCC
Q 002010          397 FIGPIPEELGQCKSLTKIRFSKNYLNGTI  425 (982)
Q Consensus       397 ~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~  425 (982)
                      +.+.  ..+..+++|+.|+|++|++.+..
T Consensus       187 i~~l--~~l~~l~~L~~L~L~~N~l~~~p  213 (605)
T 1m9s_A          187 ISDL--RALAGLKNLDVLELFSQECLNKP  213 (605)
T ss_dssp             CCBC--GGGTTCTTCSEEECCSEEEECCC
T ss_pred             CCCC--hHHccCCCCCEEEccCCcCcCCc
Confidence            7653  34677777777777777776543

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=99.77  E-value=1.3e-18  Score=188.40  Aligned_cols=107  Identities=23%  Similarity=0.373  Sum_probs=58.4

Q ss_pred             ccCCCCcceeeeccccccCCCccccccccccceeeeeccccCCCCCcccccccCCCeeeCCCCcccCCCCcccccccccc
Q 002010          476 IGNLPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYGKIPPGISKLIDLS  555 (982)
Q Consensus       476 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~  555 (982)
                      +..+++|++|++++|++++.  ..+..+++|++|++++|++++.  ..++.+++|+.|+|++|++++..|  +..+++|+
T Consensus       108 l~~l~~L~~L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~  181 (291)
T 1h6t_A          108 LKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQ  181 (291)
T ss_dssp             GTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCC
T ss_pred             hccCCCCCEEECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh--hcCCCccC
Confidence            44555555555555555432  2344555555555555555533  345555666666666666654333  55566666


Q ss_pred             eEEcccccccccCccccccccccceecccCCcccc
Q 002010          556 ILNLSRNGITGSIPNEMRNMMSLTTLDLSYNNLIG  590 (982)
Q Consensus       556 ~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~  590 (982)
                      .|+|++|+|++ +| .+..+++|+.|++++|+++.
T Consensus       182 ~L~L~~N~i~~-l~-~l~~l~~L~~L~l~~n~i~~  214 (291)
T 1h6t_A          182 NLYLSKNHISD-LR-ALAGLKNLDVLELFSQECLN  214 (291)
T ss_dssp             EEECCSSCCCB-CG-GGTTCTTCSEEEEEEEEEEC
T ss_pred             EEECCCCcCCC-Ch-hhccCCCCCEEECcCCcccC
Confidence            66666666653 23 25556666666666666554

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.77  E-value=1.2e-18  Score=180.34  Aligned_cols=155  Identities=22%  Similarity=0.252  Sum_probs=137.7

Q ss_pred             cEEEeeccccCCCCchhccCCCCcceeeeccccccCCCccccccccccceeeeeccccCCCCCcccccccCCCeeeCCCC
Q 002010          459 NQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIPYSISQCHSLTSVDLSRN  538 (982)
Q Consensus       459 ~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N  538 (982)
                      +.+++++|+++ .+|..+.  ++|+.|++++|+|++..+..+..+++|++|+|++|+|++..|..|.++++|++|+|++|
T Consensus        14 ~~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N   90 (220)
T 2v9t_B           14 NIVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN   90 (220)
T ss_dssp             TEEECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSS
T ss_pred             CEEEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCC
Confidence            56888888888 4565543  68999999999999777778999999999999999999888999999999999999999


Q ss_pred             cccCCCCcccccccccceEEcccccccccCccccccccccceecccCCccccCCCC-CccccccccccccCCcCcccCC
Q 002010          539 SLYGKIPPGISKLIDLSILNLSRNGITGSIPNEMRNMMSLTTLDLSYNNLIGNIPS-GGQFLAFNETSFIGNPNLCLLR  616 (982)
Q Consensus       539 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~-~~~~~~~~~~~~~~n~~~c~~~  616 (982)
                      +|++..+..|.++++|+.|+|++|+|++..|..|..+++|++|+|++|++++..+. ...+.++....+.+||+.|++.
T Consensus        91 ~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~  169 (220)
T 2v9t_B           91 KITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFICDCH  169 (220)
T ss_dssp             CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEECSGG
T ss_pred             cCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCCCCc
Confidence            99976667789999999999999999999999999999999999999999988775 3346677888899999999654

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=99.76  E-value=7.8e-21  Score=224.16  Aligned_cols=204  Identities=19%  Similarity=0.204  Sum_probs=169.9

Q ss_pred             cCCCcccEEEeccccccccCCccccCccccceeeccccc-------------ccccCCccccCCCCCCEEE-ccCCccCC
Q 002010          358 GRNGKLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQNF-------------FIGPIPEELGQCKSLTKIR-FSKNYLNG  423 (982)
Q Consensus       358 ~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~l~~N~-------------~~~~~~~~l~~l~~L~~L~-Ls~N~l~~  423 (982)
                      ..++.|+.|+|++|+++ .+|..+..+++|+.|++++|.             +.+..|..++.+++|+.|+ ++.|.+  
T Consensus       346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~--  422 (567)
T 1dce_A          346 ATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYL--  422 (567)
T ss_dssp             STTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHH--
T ss_pred             ccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhccc--
Confidence            56778889999999997 788889999999999987775             4556666667777777776 566544  


Q ss_pred             CCCccccCCCccccccCCCccccccCCcccccCCccEEEeeccccCCCCchhccCCCCcceeeeccccccCCCccccccc
Q 002010          424 TIPAGLFNLPLLNMMELDDNLLSGELPEKMSGASLNQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESFNL  503 (982)
Q Consensus       424 ~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l  503 (982)
                               ..|..+.+++|.++...+     ..|+.|+|++|+|++ +|. |+.+++|+.|+|++|+|+ .+|..+..+
T Consensus       423 ---------~~L~~l~l~~n~i~~l~~-----~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l  485 (567)
T 1dce_A          423 ---------DDLRSKFLLENSVLKMEY-----ADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAAL  485 (567)
T ss_dssp             ---------HHHHHHHHHHHHHHHHHH-----TTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGC
T ss_pred             ---------chhhhhhhhcccccccCc-----cCceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcC
Confidence                     245566677777764332     359999999999996 566 999999999999999999 889999999


Q ss_pred             cccceeeeeccccCCCCCcccccccCCCeeeCCCCcccCCC-CcccccccccceEEcccccccccCccc---cccccccc
Q 002010          504 KMITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYGKI-PPGISKLIDLSILNLSRNGITGSIPNE---MRNMMSLT  579 (982)
Q Consensus       504 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p~~---l~~l~~L~  579 (982)
                      ++|++|+|++|+|++ +| .++.+++|+.|+|++|+|++.+ |..|+.+++|+.|+|++|+|++.+|..   +..+++|+
T Consensus       486 ~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~l~~~lp~L~  563 (567)
T 1dce_A          486 RCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVS  563 (567)
T ss_dssp             TTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCS
T ss_pred             CCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHHHHHHHHCcccC
Confidence            999999999999996 67 8999999999999999999887 999999999999999999999776632   34588999


Q ss_pred             eecc
Q 002010          580 TLDL  583 (982)
Q Consensus       580 ~L~L  583 (982)
                      .||+
T Consensus       564 ~L~l  567 (567)
T 1dce_A          564 SILT  567 (567)
T ss_dssp             EEEC
T ss_pred             ccCC
Confidence            8875

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.75  E-value=4.5e-18  Score=175.90  Aligned_cols=154  Identities=22%  Similarity=0.203  Sum_probs=121.4

Q ss_pred             EEEccCCccCCCCCccccCCCccccccCCCccccccCCc-ccc-cCCccEEEeeccccCCCCchhccCCCCcceeeeccc
Q 002010          413 KIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLSGELPE-KMS-GASLNQLKVANNNITGKIPAAIGNLPSLNILSLQNN  490 (982)
Q Consensus       413 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~-~~~-~~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N  490 (982)
                      .+++++|.++ .+|..+.  +.+++|++++|.+++..+. .+. ..+|+.|+|++|+|++..+..|.++++|++|+|++|
T Consensus        15 ~l~~s~n~l~-~iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N   91 (220)
T 2v70_A           15 TVDCSNQKLN-KIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSN   91 (220)
T ss_dssp             EEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred             EeEeCCCCcc-cCccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCC
Confidence            4555555554 3444332  2234555555555554332 222 257788888888888777788999999999999999


Q ss_pred             cccCCCccccccccccceeeeeccccCCCCCcccccccCCCeeeCCCCcccCCCCcccccccccceEEcccccccccCc
Q 002010          491 RLEGEIPVESFNLKMITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYGKIPPGISKLIDLSILNLSRNGITGSIP  569 (982)
Q Consensus       491 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p  569 (982)
                      ++++..+..+..+++|++|+|++|+|++..|..|..+++|+.|+|++|+|++..|..|..+++|+.|+|++|.++...+
T Consensus        92 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~  170 (220)
T 2v70_A           92 RLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCY  170 (220)
T ss_dssp             CCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGG
T ss_pred             ccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCc
Confidence            9998777788899999999999999998889999999999999999999998889999999999999999999986544

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.75  E-value=1.7e-18  Score=175.07  Aligned_cols=155  Identities=20%  Similarity=0.216  Sum_probs=112.7

Q ss_pred             cEEEeeccccCCCCchhccCCCCcceeeeccccccCCCcc-ccccccccceeeeeccccCCCCCcccccccCCCeeeCCC
Q 002010          459 NQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPV-ESFNLKMITSINISDNNISGEIPYSISQCHSLTSVDLSR  537 (982)
Q Consensus       459 ~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~  537 (982)
                      +.+++++|+++ .+|..+..  +|++|++++|++++..+. .+..+++|++|+|++|+|++..|..|.++++|+.|+|++
T Consensus        11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~   87 (192)
T 1w8a_A           11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE   87 (192)
T ss_dssp             TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred             CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence            56777777775 45554432  778888888888755443 367788888888888888877788888888888888888


Q ss_pred             CcccCCCCcccccccccceEEcccccccccCccccccccccceecccCCccccCCCCCccccccccccccCCcCcccCC
Q 002010          538 NSLYGKIPPGISKLIDLSILNLSRNGITGSIPNEMRNMMSLTTLDLSYNNLIGNIPSGGQFLAFNETSFIGNPNLCLLR  616 (982)
Q Consensus       538 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~~~~~~~~~~~~~~n~~~c~~~  616 (982)
                      |+|++..|..|.++++|+.|+|++|+|++.+|..+..+++|++|+|++|++++..+.......+....+.++...|+.|
T Consensus        88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~~~~~l~~~~~~~~~~~C~~P  166 (192)
T 1w8a_A           88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAP  166 (192)
T ss_dssp             CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBCSS
T ss_pred             CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcchHHHHHHHHcCCCCCCCCCCCC
Confidence            8888777777888888888888888888888888888888888888888888776632211223333455666667655

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=99.72  E-value=1.1e-18  Score=212.47  Aligned_cols=144  Identities=22%  Similarity=0.277  Sum_probs=75.9

Q ss_pred             cCCccccCCCCCCEEEccCCccCCCCCccccCCCccccccCCCccccccCCcccccCCccEEEeeccccCCCCchhccCC
Q 002010          400 PIPEELGQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLSGELPEKMSGASLNQLKVANNNITGKIPAAIGNL  479 (982)
Q Consensus       400 ~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~L~~N~i~~~~p~~~~~l  479 (982)
                      ..+..+..++.|+.|+|++|.+. .+|..++.+++|++|+|++|.|+                        .+|..|+++
T Consensus       215 ~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~------------------------~lp~~~~~l  269 (727)
T 4b8c_D          215 MPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT------------------------ELPAEIKNL  269 (727)
T ss_dssp             -------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS------------------------CCCGGGGGG
T ss_pred             cChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc------------------------ccChhhhCC
Confidence            44566666777777777777776 55655555555555555555444                        344445555


Q ss_pred             CCcceeeeccccccCCCccccccccccceeeeeccccCCCCCcccccccCCCeeeCCCCcccCCCCcccccccc-cceEE
Q 002010          480 PSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYGKIPPGISKLID-LSILN  558 (982)
Q Consensus       480 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~-L~~L~  558 (982)
                      ++|++|+|++|+|+ .+|..+..+++|++|+|++|.|+ .+|..|+.+++|+.|+|++|.|++.+|..+..+.. +..|+
T Consensus       270 ~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~  347 (727)
T 4b8c_D          270 SNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFY  347 (727)
T ss_dssp             TTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHH
T ss_pred             CCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHh
Confidence            55555555555555 44555555555555555555554 44555555555555555555555555555544321 12345


Q ss_pred             cccccccccCcc
Q 002010          559 LSRNGITGSIPN  570 (982)
Q Consensus       559 Ls~N~l~~~~p~  570 (982)
                      |++|.+++.+|.
T Consensus       348 l~~N~l~~~~p~  359 (727)
T 4b8c_D          348 LRDNRPEIPLPH  359 (727)
T ss_dssp             HHHCCCCCCCCC
T ss_pred             hccCcccCcCcc
Confidence            555555555554

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=99.72  E-value=3.6e-18  Score=181.84  Aligned_cols=167  Identities=16%  Similarity=0.210  Sum_probs=77.9

Q ss_pred             ccEEEeccccccccCCccccCccccceeecccccccccCCccccCCCCCCEEEccCCccCCCCCccccCCCccccccCCC
Q 002010          363 LLILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDD  442 (982)
Q Consensus       363 L~~L~L~~N~l~~~~p~~~~~~~~L~~L~l~~N~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~  442 (982)
                      +..+++++|.+++. + .+..+++|+.|++++|.+.. ++ .+..+++|++|++++|++++..+  +..+++|++|++++
T Consensus        21 l~~l~l~~~~i~~~-~-~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L~~   94 (263)
T 1xeu_A           21 AVKQNLGKQSVTDL-V-SQKELSGVQNFNGDNSNIQS-LA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSVNR   94 (263)
T ss_dssp             HHHHHHTCSCTTSE-E-CHHHHTTCSEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEECCS
T ss_pred             HHHHHhcCCCcccc-c-chhhcCcCcEEECcCCCccc-ch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEECCC
Confidence            33444444444322 1 23344444444444444432 22 34555555555555555553322  44455444444444


Q ss_pred             ccccccCCcccccCCccEEEeeccccCCCCchhccCCCCcceeeeccccccCCCccccccccccceeeeeccccCCCCCc
Q 002010          443 NLLSGELPEKMSGASLNQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIPY  522 (982)
Q Consensus       443 N~l~~~~~~~~~~~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~  522 (982)
                      |++++..+ ... .+|+.|++++|++++.                         + .+..+++|++|+|++|+|++. + 
T Consensus        95 N~l~~l~~-~~~-~~L~~L~L~~N~l~~~-------------------------~-~l~~l~~L~~L~Ls~N~i~~~-~-  144 (263)
T 1xeu_A           95 NRLKNLNG-IPS-ACLSRLFLDNNELRDT-------------------------D-SLIHLKNLEILSIRNNKLKSI-V-  144 (263)
T ss_dssp             SCCSCCTT-CCC-SSCCEEECCSSCCSBS-------------------------G-GGTTCTTCCEEECTTSCCCBC-G-
T ss_pred             CccCCcCc-ccc-CcccEEEccCCccCCC-------------------------h-hhcCcccccEEECCCCcCCCC-h-
Confidence            44443211 111 3444444444444432                         1 244444455555555555432 2 


Q ss_pred             ccccccCCCeeeCCCCcccCCCCcccccccccceEEccccccccc
Q 002010          523 SISQCHSLTSVDLSRNSLYGKIPPGISKLIDLSILNLSRNGITGS  567 (982)
Q Consensus       523 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~  567 (982)
                      .+..+++|+.|+|++|++++.  ..+..+++|+.|+|++|++++.
T Consensus       145 ~l~~l~~L~~L~L~~N~i~~~--~~l~~l~~L~~L~l~~N~~~~~  187 (263)
T 1xeu_A          145 MLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDLTGQKCVNE  187 (263)
T ss_dssp             GGGGCTTCCEEECTTSCCCBC--TTSTTCCCCCEEEEEEEEEECC
T ss_pred             HHccCCCCCEEECCCCcCcch--HHhccCCCCCEEeCCCCcccCC
Confidence            355555555555555555543  4455566666666666666543

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=99.71  E-value=1.2e-17  Score=169.63  Aligned_cols=155  Identities=21%  Similarity=0.265  Sum_probs=115.4

Q ss_pred             ccCCCCCCEEEccCCccCCCCCccccCCCccccccCCCccccccCCcccccCCccEEEeeccccCCCCchhccCCCCcce
Q 002010          405 LGQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLSGELPEKMSGASLNQLKVANNNITGKIPAAIGNLPSLNI  484 (982)
Q Consensus       405 l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~L~~N~i~~~~p~~~~~l~~L~~  484 (982)
                      .+.+++|++|++++|.++ .+| .+..++                       +|++|++++|.++.  +..+..+++|++
T Consensus        40 ~~~l~~L~~L~l~~n~i~-~l~-~l~~l~-----------------------~L~~L~l~~n~~~~--~~~l~~l~~L~~   92 (197)
T 4ezg_A           40 EAQMNSLTYITLANINVT-DLT-GIEYAH-----------------------NIKDLTINNIHATN--YNPISGLSNLER   92 (197)
T ss_dssp             HHHHHTCCEEEEESSCCS-CCT-TGGGCT-----------------------TCSEEEEESCCCSC--CGGGTTCTTCCE
T ss_pred             hhhcCCccEEeccCCCcc-ChH-HHhcCC-----------------------CCCEEEccCCCCCc--chhhhcCCCCCE
Confidence            356677888888888777 444 444444                       45666666665542  246778888888


Q ss_pred             eeeccccccCCCccccccccccceeeeeccccCCCCCcccccccCCCeeeCCCCc-ccCCCCcccccccccceEEccccc
Q 002010          485 LSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIPYSISQCHSLTSVDLSRNS-LYGKIPPGISKLIDLSILNLSRNG  563 (982)
Q Consensus       485 L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~Ls~N~  563 (982)
                      |++++|++++..|..+..+++|++|++++|++++..|..++.+++|+.|+|++|. ++ .+| .+..+++|+.|++++|+
T Consensus        93 L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~  170 (197)
T 4ezg_A           93 LRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFDG  170 (197)
T ss_dssp             EEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEECTTBC
T ss_pred             EEeECCccCcccChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEECCCCC
Confidence            8888888887777788888888888888888887778888888888888888887 54 555 68888888888888888


Q ss_pred             ccccCccccccccccceecccCCcccc
Q 002010          564 ITGSIPNEMRNMMSLTTLDLSYNNLIG  590 (982)
Q Consensus       564 l~~~~p~~l~~l~~L~~L~Ls~N~l~~  590 (982)
                      +++ ++ .+..+++|++|++++|++.+
T Consensus       171 i~~-~~-~l~~l~~L~~L~l~~N~i~~  195 (197)
T 4ezg_A          171 VHD-YR-GIEDFPKLNQLYAFSQTIGG  195 (197)
T ss_dssp             CCC-CT-TGGGCSSCCEEEECBC----
T ss_pred             CcC-hH-HhccCCCCCEEEeeCcccCC
Confidence            885 44 68888888999998888754

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=99.70  E-value=2.2e-18  Score=190.37  Aligned_cols=295  Identities=14%  Similarity=0.051  Sum_probs=155.1

Q ss_pred             cccCCcCccc--cccccEEEeccCCCCCCCChhhhh-hcccceeeccCCccccccchhhhhcCCCccEEeccCccccCCC
Q 002010           84 FGSIPPEIGL--LTKLVNLTISNVNLTGRLPSEMAL-LTSLKVFNISGNVFQGNFAGQIVRGMTELQVLDAYNNNFTGPL  160 (982)
Q Consensus        84 ~g~~~~~i~~--l~~L~~L~l~~n~l~~~~p~~l~~-l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~  160 (982)
                      .|.++..++.  +.+++.|.++++ +.+.-...+.. +++|++|||++|++......  ...++.++.+.+..|.+.   
T Consensus        12 ~g~l~~~l~~~~~~~l~~L~l~g~-i~~~~~~~l~~~l~~L~~LdLs~n~i~~~~~~--~~~~~~~~~~~~~~~~I~---   85 (329)
T 3sb4_A           12 PGTLISMMTEEEANSITHLTLTGK-LNAEDFRHLRDEFPSLKVLDISNAEIKMYSGK--AGTYPNGKFYIYMANFVP---   85 (329)
T ss_dssp             TTCGGGGSCHHHHHHCSEEEEEEE-ECHHHHHHHHHSCTTCCEEEEEEEEECCEEES--SSSSGGGCCEEECTTEEC---
T ss_pred             CCcHHhhccchhhCceeEEEEecc-ccHHHHHHHHHhhccCeEEecCcceeEEecCc--cccccccccccccccccC---
Confidence            4445555554  778888888864 22111123444 67799999999888710000  001122344444444332   


Q ss_pred             chhccc--------cccccEEeecCcccccccCCCccccCcceEeeccCcccccchhhHHhhhhhHHHHhhcccc---cc
Q 002010          161 PVEIAS--------LKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLNGIGLNGTVPAFLSRLKNLREMYIGYFN---TY  229 (982)
Q Consensus       161 p~~l~~--------l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~l~~~n---~~  229 (982)
                      +..|.+        +++|++|+|.+ .++...+.+|.++++|+.|++.+|.+....+.+|.++.++..+..+...   ..
T Consensus        86 ~~aF~~~~~~~~~g~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~  164 (329)
T 3sb4_A           86 AYAFSNVVNGVTKGKQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFK  164 (329)
T ss_dssp             TTTTEEEETTEEEECTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTS
T ss_pred             HHHhcccccccccccCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhcc
Confidence            233444        66666666665 5555555556666666666666665555555555555544444333211   01


Q ss_pred             cccCCCCCCCCCCCC-EEecccCcCcccCchhh----cCCCccceeecccccCCCCCCccc-cCCCCCCEEEeeCCcccC
Q 002010          230 TGGIPPGFGALTQLQ-VLDMASCNISGEIPTSL----SRLKLLHSLFLQMNKLTGHIPPQL-SGLISLKSLDLSLNYLTG  303 (982)
Q Consensus       230 ~~~~p~~~~~l~~L~-~L~L~~n~l~~~~~~~l----~~l~~L~~L~L~~N~l~~~~~~~l-~~l~~L~~L~Ls~N~l~~  303 (982)
                      ...-...|.++.+|+ .+.+....   .++..+    -...+++.+.+.++-.. .....+ ..+++|+.|+|++|+++.
T Consensus       165 ~~i~~~~f~~~~~L~~~i~~~~~~---~l~~~~~~~~~~~~~~~~l~~~~~l~~-~~~~~l~~~~~~L~~l~L~~n~i~~  240 (329)
T 3sb4_A          165 NRWEHFAFIEGEPLETTIQVGAMG---KLEDEIMKAGLQPRDINFLTIEGKLDN-ADFKLIRDYMPNLVSLDISKTNATT  240 (329)
T ss_dssp             TTTTTSCEEESCCCEEEEEECTTC---CHHHHHHHTTCCGGGCSEEEEEECCCH-HHHHHHHHHCTTCCEEECTTBCCCE
T ss_pred             ccccccccccccccceeEEecCCC---cHHHHHhhcccCccccceEEEeeeecH-HHHHHHHHhcCCCeEEECCCCCcce
Confidence            111122344455555 34443221   111111    12344455555443211 111111 125666666666666665


Q ss_pred             cCchhhhcccchhhhhhccCCCCCCCCCcCCCCCCcc-EEEccCCCcccccCccccCCCcccEEEeccccccccCCcccc
Q 002010          304 EIPESFAALKNLTLLQLFKNNLRGPIPSFLGDFPNLE-VLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDLC  382 (982)
Q Consensus       304 ~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~-~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~  382 (982)
                      ..+.+|.++++|+.|+|.+| ++.+.+.+|.++++|+ .+++.+ .++...+.+|..+.+|+.|+++.|+++...+..|.
T Consensus       241 I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~  318 (329)
T 3sb4_A          241 IPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFG  318 (329)
T ss_dssp             ECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTC
T ss_pred             ecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhc
Confidence            55556666666666666665 5555556666676776 777666 55555566677777777777777777666666677


Q ss_pred             Cccccceee
Q 002010          383 KGGKLKSLI  391 (982)
Q Consensus       383 ~~~~L~~L~  391 (982)
                      ++++|+.++
T Consensus       319 ~~~~L~~ly  327 (329)
T 3sb4_A          319 NGVPSKLIY  327 (329)
T ss_dssp             TTCCCCEEE
T ss_pred             CCcchhhhc
Confidence            777776665

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=99.70  E-value=2.2e-17  Score=167.65  Aligned_cols=156  Identities=17%  Similarity=0.243  Sum_probs=122.5

Q ss_pred             cccCccccceeecccccccccCCccccCCCCCCEEEccCCccCCCCCccccCCCccccccCCCccccccCCcccccCCcc
Q 002010          380 DLCKGGKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLSGELPEKMSGASLN  459 (982)
Q Consensus       380 ~~~~~~~L~~L~l~~N~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~  459 (982)
                      ....+++|++|++++|.+. .+| .+..+++|++|++++|.++  .+..+..++                       +|+
T Consensus        39 ~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~--~~~~l~~l~-----------------------~L~   91 (197)
T 4ezg_A           39 TEAQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT--NYNPISGLS-----------------------NLE   91 (197)
T ss_dssp             BHHHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS--CCGGGTTCT-----------------------TCC
T ss_pred             ChhhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC--cchhhhcCC-----------------------CCC
Confidence            3467889999999999998 455 6999999999999999765  223444443                       566


Q ss_pred             EEEeeccccCCCCchhccCCCCcceeeeccccccCCCccccccccccceeeeeccc-cCCCCCcccccccCCCeeeCCCC
Q 002010          460 QLKVANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNN-ISGEIPYSISQCHSLTSVDLSRN  538 (982)
Q Consensus       460 ~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~Ls~N  538 (982)
                      +|++++|++++..+..++.+++|++|++++|++++..|..+..+++|++|++++|+ ++ .+| .+..+++|+.|++++|
T Consensus        92 ~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n  169 (197)
T 4ezg_A           92 RLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFD  169 (197)
T ss_dssp             EEEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEECTTB
T ss_pred             EEEeECCccCcccChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEECCCC
Confidence            67777777776677778888888888888888887778888888888999999888 55 455 6888999999999999


Q ss_pred             cccCCCCcccccccccceEEcccccccc
Q 002010          539 SLYGKIPPGISKLIDLSILNLSRNGITG  566 (982)
Q Consensus       539 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~  566 (982)
                      ++++ ++ .+..+++|+.|++++|+|.+
T Consensus       170 ~i~~-~~-~l~~l~~L~~L~l~~N~i~~  195 (197)
T 4ezg_A          170 GVHD-YR-GIEDFPKLNQLYAFSQTIGG  195 (197)
T ss_dssp             CCCC-CT-TGGGCSSCCEEEECBC----
T ss_pred             CCcC-hH-HhccCCCCCEEEeeCcccCC
Confidence            9985 44 78899999999999998864

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=99.70  E-value=1.6e-17  Score=176.89  Aligned_cols=172  Identities=16%  Similarity=0.247  Sum_probs=136.0

Q ss_pred             CccccceeecccccccccCCccccCCCCCCEEEccCCccCCCCCccccCCCccccccCCCccccccCCcccccCCccEEE
Q 002010          383 KGGKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLSGELPEKMSGASLNQLK  462 (982)
Q Consensus       383 ~~~~L~~L~l~~N~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~  462 (982)
                      .+.++..+++++|.+.+..  .+..+++|++|++++|.++ .+| .+..+                       .+|++|+
T Consensus        17 ~l~~l~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~-~l~-~l~~l-----------------------~~L~~L~   69 (263)
T 1xeu_A           17 GLANAVKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQ-SLA-GMQFF-----------------------TNLKELH   69 (263)
T ss_dssp             HHHHHHHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCC-CCT-TGGGC-----------------------TTCCEEE
T ss_pred             HHHHHHHHHhcCCCccccc--chhhcCcCcEEECcCCCcc-cch-HHhhC-----------------------CCCCEEE
Confidence            3556677777777776443  4667777777777777776 333 33333                       4566677


Q ss_pred             eeccccCCCCchhccCCCCcceeeeccccccCCCccccccccccceeeeeccccCCCCCcccccccCCCeeeCCCCcccC
Q 002010          463 VANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYG  542 (982)
Q Consensus       463 L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~  542 (982)
                      +++|+|++..+  +..+++|++|++++|++++ +|....  ++|++|+|++|+|++. + .+..+++|+.|+|++|+|++
T Consensus        70 L~~N~i~~~~~--l~~l~~L~~L~L~~N~l~~-l~~~~~--~~L~~L~L~~N~l~~~-~-~l~~l~~L~~L~Ls~N~i~~  142 (263)
T 1xeu_A           70 LSHNQISDLSP--LKDLTKLEELSVNRNRLKN-LNGIPS--ACLSRLFLDNNELRDT-D-SLIHLKNLEILSIRNNKLKS  142 (263)
T ss_dssp             CCSSCCCCCGG--GTTCSSCCEEECCSSCCSC-CTTCCC--SSCCEEECCSSCCSBS-G-GGTTCTTCCEEECTTSCCCB
T ss_pred             CCCCccCCChh--hccCCCCCEEECCCCccCC-cCcccc--CcccEEEccCCccCCC-h-hhcCcccccEEECCCCcCCC
Confidence            77777775544  8899999999999999985 443333  9999999999999964 3 69999999999999999986


Q ss_pred             CCCcccccccccceEEcccccccccCccccccccccceecccCCccccCC
Q 002010          543 KIPPGISKLIDLSILNLSRNGITGSIPNEMRNMMSLTTLDLSYNNLIGNI  592 (982)
Q Consensus       543 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~i  592 (982)
                      . | .+..+++|+.|+|++|++++.  ..+..+++|+.|++++|++++..
T Consensus       143 ~-~-~l~~l~~L~~L~L~~N~i~~~--~~l~~l~~L~~L~l~~N~~~~~~  188 (263)
T 1xeu_A          143 I-V-MLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDLTGQKCVNEP  188 (263)
T ss_dssp             C-G-GGGGCTTCCEEECTTSCCCBC--TTSTTCCCCCEEEEEEEEEECCC
T ss_pred             C-h-HHccCCCCCEEECCCCcCcch--HHhccCCCCCEEeCCCCcccCCc
Confidence            4 4 699999999999999999976  67999999999999999998763

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.70  E-value=2.1e-17  Score=175.37  Aligned_cols=137  Identities=21%  Similarity=0.173  Sum_probs=106.3

Q ss_pred             cccccccccccceEEEEEEe-CCCcE--EEEEEeccCCCCC-----------------------chhhHHHHHHHHhcCC
Q 002010          694 LKDENIIGKGGAGIVYRGSM-PDGID--VAIKRLVGRGTGG-----------------------NDHGFLAEIQTLGRIR  747 (982)
Q Consensus       694 ~~~~~~lg~G~~g~Vy~~~~-~~~~~--vavK~~~~~~~~~-----------------------~~~~~~~E~~~l~~l~  747 (982)
                      |+..+.||+|+||.||+|.. .+|+.  ||||+++......                       ....+.+|+.++.++.
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            56778999999999999976 68888  9999874331110                       0125788999999998


Q ss_pred             CCcc--cceEeEEEcCCccEEEEeccCC-C----CHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHh-hcCCCcEEecC
Q 002010          748 HRNI--VRLLGYVSNRDTNLLLYEYMPN-G----SLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLH-HDCSPLIIHRD  819 (982)
Q Consensus       748 h~ni--v~~~~~~~~~~~~~lv~e~~~~-~----sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH-~~~~~~ivHrD  819 (982)
                      |+++  ..++++    ...++||||+.+ |    +|.++...     .++..+..++.|++.|++||| +.+   |+|||
T Consensus       129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~g---ivHrD  196 (258)
T 1zth_A          129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQEAE---LVHAD  196 (258)
T ss_dssp             HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHTSC---EECSS
T ss_pred             hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHHCC---EEeCC
Confidence            8764  334432    467999999942 3    77776532     234567789999999999999 888   99999


Q ss_pred             CCCCcEEEcCCCCEEEeccccchhc
Q 002010          820 VKSNNILLDSDFEAHVADFGLAKFL  844 (982)
Q Consensus       820 lkp~Nill~~~~~~kl~DfG~a~~~  844 (982)
                      |||+||+++.  .++|+|||+|...
T Consensus       197 lkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          197 LSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             CSTTSEEESS--SEEECCCTTCEET
T ss_pred             CCHHHEEEcC--cEEEEECcccccC
Confidence            9999999988  9999999999754

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.69  E-value=6.2e-17  Score=163.49  Aligned_cols=136  Identities=22%  Similarity=0.235  Sum_probs=110.6

Q ss_pred             CccEEEeeccccCCCCch-hccCCCCcceeeeccccccCCCccccccccccceeeeeccccCCCCCcccccccCCCeeeC
Q 002010          457 SLNQLKVANNNITGKIPA-AIGNLPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIPYSISQCHSLTSVDL  535 (982)
Q Consensus       457 ~L~~L~L~~N~i~~~~p~-~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  535 (982)
                      .+++|++++|+|++..+. .|+.+++|++|+|++|+|++..|..+..+++|++|+|++|+|++..|..|.++++|+.|+|
T Consensus        30 ~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  109 (192)
T 1w8a_A           30 HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNL  109 (192)
T ss_dssp             TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEEC
T ss_pred             CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCCcCCccCHHHhcCCCCCCEEEC
Confidence            677888888888866654 5889999999999999999888889999999999999999999888888999999999999


Q ss_pred             CCCcccCCCCcccccccccceEEcccccccccCcc-ccccccccceecccCCccccCCCC
Q 002010          536 SRNSLYGKIPPGISKLIDLSILNLSRNGITGSIPN-EMRNMMSLTTLDLSYNNLIGNIPS  594 (982)
Q Consensus       536 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~l~~l~~L~~L~Ls~N~l~~~ip~  594 (982)
                      ++|+|++.+|..|..+++|+.|+|++|.+++..+. ++.  ..++...+.++......|.
T Consensus       110 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~~~--~~l~~~~~~~~~~~C~~P~  167 (192)
T 1w8a_A          110 YDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFA--EWLRKKSLNGGAARCGAPS  167 (192)
T ss_dssp             CSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHH--HHHHHHCCSGGGCBBCSST
T ss_pred             CCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcchHHH--HHHHHcCCCCCCCCCCCCh
Confidence            99999999999999999999999999999976552 111  1233344555555554453

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=99.68  E-value=1.5e-17  Score=183.80  Aligned_cols=124  Identities=15%  Similarity=0.072  Sum_probs=90.4

Q ss_pred             CccEEEeeccccCCCCchhc-cCCCCcceeeeccccccCCCccccccccccceeeeeccccCCCCCcccccccCCC-eee
Q 002010          457 SLNQLKVANNNITGKIPAAI-GNLPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIPYSISQCHSLT-SVD  534 (982)
Q Consensus       457 ~L~~L~L~~N~i~~~~p~~~-~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~-~L~  534 (982)
                      .+..+.+.++-.. .....+ ..+++|+.|+|++|+++...+..|.++++|++|+|++| ++.+.+..|.++++|+ .|+
T Consensus       203 ~~~~l~~~~~l~~-~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~  280 (329)
T 3sb4_A          203 DINFLTIEGKLDN-ADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLE  280 (329)
T ss_dssp             GCSEEEEEECCCH-HHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEE
T ss_pred             ccceEEEeeeecH-HHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEE
Confidence            4455555544222 111222 23678888888888887555556778888888888887 7766677788888888 888


Q ss_pred             CCCCcccCCCCcccccccccceEEcccccccccCccccccccccceecc
Q 002010          535 LSRNSLYGKIPPGISKLIDLSILNLSRNGITGSIPNEMRNMMSLTTLDL  583 (982)
Q Consensus       535 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L  583 (982)
                      +.+ .++.+.+.+|.++++|+.|+|++|+++...+.+|.++++|+.++.
T Consensus       281 l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~ly~  328 (329)
T 3sb4_A          281 LPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLIYK  328 (329)
T ss_dssp             ECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEEEC
T ss_pred             Ecc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhhcc
Confidence            888 676566788888888888888888888777778888888888763

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.67  E-value=1.1e-16  Score=161.68  Aligned_cols=131  Identities=26%  Similarity=0.316  Sum_probs=111.2

Q ss_pred             cEEEeeccccCCCCchhccCCCCcceeeeccccccCCCccccccccccceeeeeccccCCCCCcccccccCCCeeeCCCC
Q 002010          459 NQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIPYSISQCHSLTSVDLSRN  538 (982)
Q Consensus       459 ~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N  538 (982)
                      +.+++++|+++ .+|..+.  ++|++|+|++|+|+ .+|..+..+++|++|+|++|+|++..+..|.++++|+.|+|++|
T Consensus        13 ~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N   88 (193)
T 2wfh_A           13 TVVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYN   88 (193)
T ss_dssp             TEEECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             CEEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCC
Confidence            56777888877 4555442  57889999999997 67788888999999999999999888888999999999999999


Q ss_pred             cccCCCCcccccccccceEEcccccccccCccccccccccceecccCCccccCCC
Q 002010          539 SLYGKIPPGISKLIDLSILNLSRNGITGSIPNEMRNMMSLTTLDLSYNNLIGNIP  593 (982)
Q Consensus       539 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip  593 (982)
                      +|++..|..|.++++|+.|+|++|+|++..+..|..+++|+.|+|++|++.+...
T Consensus        89 ~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~c~  143 (193)
T 2wfh_A           89 RLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCDCN  143 (193)
T ss_dssp             CCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECSGG
T ss_pred             ccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecCCc
Confidence            9998888889999999999999999997777788999999999999999886543

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.65  E-value=2.4e-16  Score=155.63  Aligned_cols=134  Identities=25%  Similarity=0.219  Sum_probs=116.7

Q ss_pred             CCccEEEeeccccC-CCCchhccCCCCcceeeeccccccCCCccccccccccceeeeeccccCCCCCcccccccCCCeee
Q 002010          456 ASLNQLKVANNNIT-GKIPAAIGNLPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIPYSISQCHSLTSVD  534 (982)
Q Consensus       456 ~~L~~L~L~~N~i~-~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~  534 (982)
                      ..|+.|++++|+++ +.+|..+..+++|++|++++|++++.  ..+..+++|++|+|++|++++.+|..+..+++|+.|+
T Consensus        24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  101 (168)
T 2ell_A           24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN  101 (168)
T ss_dssp             TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred             ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence            57888999999987 67888889999999999999999865  6788899999999999999987888888899999999


Q ss_pred             CCCCcccCCC-CcccccccccceEEcccccccccCc---cccccccccceecccCCccccC
Q 002010          535 LSRNSLYGKI-PPGISKLIDLSILNLSRNGITGSIP---NEMRNMMSLTTLDLSYNNLIGN  591 (982)
Q Consensus       535 Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p---~~l~~l~~L~~L~Ls~N~l~~~  591 (982)
                      |++|.+++.. +..+..+++|+.|+|++|++++..+   ..+..+++|++|++++|.+...
T Consensus       102 Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~  162 (168)
T 2ell_A          102 LSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQEA  162 (168)
T ss_dssp             CBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSCBC
T ss_pred             ccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChhhc
Confidence            9999998643 2789999999999999999996655   4789999999999999988743

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.63  E-value=7.8e-16  Score=153.30  Aligned_cols=134  Identities=22%  Similarity=0.205  Sum_probs=108.4

Q ss_pred             ccEEEeeccccCCCCchhccCCCCcceeeeccccccCCCccccccccccceeeeeccccCCCCCcccccccCCCeeeCCC
Q 002010          458 LNQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIPYSISQCHSLTSVDLSR  537 (982)
Q Consensus       458 L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~  537 (982)
                      .+.+++++|+++. +|..+  .++|+.|++++|++++..+..+..+++|++|++++|+|++..+..|..+++|+.|+|++
T Consensus         9 ~~~l~~~~~~l~~-~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~   85 (177)
T 2o6r_A            9 GTEIRCNSKGLTS-VPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHE   85 (177)
T ss_dssp             TTEEECCSSCCSS-CCTTC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             CCEEEecCCCCcc-CCCCC--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCC
Confidence            4567777777773 44333  36888888888888866666677888888888888888877777788899999999999


Q ss_pred             CcccCCCCcccccccccceEEcccccccccCccccccccccceecccCCccccCCCC
Q 002010          538 NSLYGKIPPGISKLIDLSILNLSRNGITGSIPNEMRNMMSLTTLDLSYNNLIGNIPS  594 (982)
Q Consensus       538 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~  594 (982)
                      |+|++..+..|..+++|+.|+|++|+|++..+..+..+++|++|+|++|++++..|.
T Consensus        86 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~  142 (177)
T 2o6r_A           86 NKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR  142 (177)
T ss_dssp             SCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHHH
T ss_pred             CCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCcc
Confidence            999877777788899999999999999876666678899999999999999887764

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.63  E-value=2.5e-16  Score=152.06  Aligned_cols=128  Identities=25%  Similarity=0.310  Sum_probs=113.4

Q ss_pred             CCccEEEeeccccC-CCCchhccCCCCcceeeeccccccCCCccccccccccceeeeeccccCCCCCcccccccCCCeee
Q 002010          456 ASLNQLKVANNNIT-GKIPAAIGNLPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIPYSISQCHSLTSVD  534 (982)
Q Consensus       456 ~~L~~L~L~~N~i~-~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~  534 (982)
                      .+++.|++++|+++ +.+|..+..+++|++|++++|++++.  ..+..+++|++|++++|++++.+|..+..+++|+.|+
T Consensus        17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~   94 (149)
T 2je0_A           17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN   94 (149)
T ss_dssp             GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred             ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence            57889999999998 78888889999999999999999865  6788899999999999999987888888899999999


Q ss_pred             CCCCcccCC-CCcccccccccceEEcccccccccCc---cccccccccceecccC
Q 002010          535 LSRNSLYGK-IPPGISKLIDLSILNLSRNGITGSIP---NEMRNMMSLTTLDLSY  585 (982)
Q Consensus       535 Ls~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p---~~l~~l~~L~~L~Ls~  585 (982)
                      +++|++++. .|..+..+++|+.|++++|++++..+   ..+..+++|++||+++
T Consensus        95 ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d  149 (149)
T 2je0_A           95 LSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD  149 (149)
T ss_dssp             CTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred             CCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence            999999864 34889999999999999999997666   5789999999999874

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.63  E-value=1e-15  Score=152.50  Aligned_cols=139  Identities=19%  Similarity=0.285  Sum_probs=118.9

Q ss_pred             CCCCCccceeeeCCCCCEEEEEeccCCccccCCcCccccccccEEEeccCCCCCCCChhhhhhcccceeeccCCcccccc
Q 002010           56 PSAHCSFSGVTCDQDSRVVSLNVSFMPLFGSIPPEIGLLTKLVNLTISNVNLTGRLPSEMALLTSLKVFNISGNVFQGNF  135 (982)
Q Consensus        56 ~~~~C~w~gv~C~~~~~v~~l~l~~~~l~g~~~~~i~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~  135 (982)
                      ..|.|+|.+|.|+..+            ...+|..+  .++|++|++++|++++..+..+..+++|++|+|++|.+++ +
T Consensus         3 ~~C~C~~~~l~~~~~~------------l~~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~-~   67 (177)
T 2o6r_A            3 SRCSCSGTEIRCNSKG------------LTSVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQS-L   67 (177)
T ss_dssp             TTCEEETTEEECCSSC------------CSSCCTTC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCC-C
T ss_pred             CCCEeCCCEEEecCCC------------CccCCCCC--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceE-e
Confidence            3467999999997543            12355433  3689999999999998777788999999999999999984 5


Q ss_pred             chhhhhcCCCccEEeccCccccCCCchhccccccccEEeecCcccccccCCCccccCcceEeeccCcccccchh
Q 002010          136 AGQIVRGMTELQVLDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLNGIGLNGTVP  209 (982)
Q Consensus       136 ~~~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~i~~~~~  209 (982)
                      +...+.++++|++|++++|++++..+..++.+++|++|+|++|++++..+..+..+++|++|++++|.+.+..|
T Consensus        68 ~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~  141 (177)
T 2o6r_A           68 PDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  141 (177)
T ss_dssp             CTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred             ChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence            55677899999999999999998777788999999999999999997777778999999999999999987665

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.61  E-value=1.6e-15  Score=152.94  Aligned_cols=130  Identities=22%  Similarity=0.269  Sum_probs=116.6

Q ss_pred             ceeeeccccccCCCccccccccccceeeeeccccCCCCCcccccccCCCeeeCCCCcccCCCCcccccccccceEEcccc
Q 002010          483 NILSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYGKIPPGISKLIDLSILNLSRN  562 (982)
Q Consensus       483 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N  562 (982)
                      +.+++++|+++ .+|..+.  ++|++|+|++|+|+ .+|..|..+++|+.|+|++|.|++..+..|.++++|++|+|++|
T Consensus        13 ~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N   88 (193)
T 2wfh_A           13 TVVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYN   88 (193)
T ss_dssp             TEEECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             CEEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCC
Confidence            68999999998 6787654  68999999999999 78899999999999999999999888889999999999999999


Q ss_pred             cccccCccccccccccceecccCCccccCCCC-CccccccccccccCCcCcccCC
Q 002010          563 GITGSIPNEMRNMMSLTTLDLSYNNLIGNIPS-GGQFLAFNETSFIGNPNLCLLR  616 (982)
Q Consensus       563 ~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~-~~~~~~~~~~~~~~n~~~c~~~  616 (982)
                      +|++..|..|..+++|++|+|++|++++..+. ...+..+....+.+|||.|++.
T Consensus        89 ~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~c~  143 (193)
T 2wfh_A           89 RLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCDCN  143 (193)
T ss_dssp             CCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECSGG
T ss_pred             ccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecCCc
Confidence            99998889999999999999999999976664 3346778888899999999764

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.60  E-value=1.4e-15  Score=149.96  Aligned_cols=133  Identities=24%  Similarity=0.186  Sum_probs=112.8

Q ss_pred             CCCCCEEecccCcCc-ccCchhhcCCCccceeecccccCCCCCCccccCCCCCCEEEeeCCcccCcCchhhhcccchhhh
Q 002010          240 LTQLQVLDMASCNIS-GEIPTSLSRLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLL  318 (982)
Q Consensus       240 l~~L~~L~L~~n~l~-~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L  318 (982)
                      .++|++|++++|+++ +.+|..+..+++|++|++++|++++.  ..+..+++|++|+|++|++++.+|..+..+++|++|
T Consensus        23 ~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L  100 (168)
T 2ell_A           23 PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHL  100 (168)
T ss_dssp             TTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEE
T ss_pred             cccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEE
Confidence            378999999999998 77888889999999999999999966  778899999999999999998788888889999999


Q ss_pred             hhccCCCCCCC-CCcCCCCCCccEEEccCCCcccccC---ccccCCCcccEEEecccccc
Q 002010          319 QLFKNNLRGPI-PSFLGDFPNLEVLQVWGNNFTFELP---ENLGRNGKLLILDVTSNHLT  374 (982)
Q Consensus       319 ~L~~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~~---~~l~~l~~L~~L~L~~N~l~  374 (982)
                      ++++|++++.. +..+..+++|++|++++|++++..+   ..+..+++|++|++++|.+.
T Consensus       101 ~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~  160 (168)
T 2ell_A          101 NLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ  160 (168)
T ss_dssp             ECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC
T ss_pred             eccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh
Confidence            99999998643 2678888888888888888886544   46777888888888888776

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.59  E-value=4.6e-16  Score=170.61  Aligned_cols=138  Identities=10%  Similarity=0.069  Sum_probs=98.6

Q ss_pred             cccccccccccceEEEEEEeCCCcEEEEEEeccCCCC-------------Cchhh--------HHHHHHHHhcCCCCccc
Q 002010          694 LKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTG-------------GNDHG--------FLAEIQTLGRIRHRNIV  752 (982)
Q Consensus       694 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-------------~~~~~--------~~~E~~~l~~l~h~niv  752 (982)
                      |++.+.||+|++|.||+|..++|+.||||+++.....             .....        ..+|...+.++.+..+.
T Consensus        97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~  176 (397)
T 4gyi_A           97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP  176 (397)
T ss_dssp             SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred             EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence            7888999999999999999889999999987432110             00111        12355555555333321


Q ss_pred             ceEeEEEcCCccEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCC-
Q 002010          753 RLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDF-  831 (982)
Q Consensus       753 ~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~-  831 (982)
                       +...+. ....++||||++|++|.++...        +....++.|++.++.+||+.|   ||||||||.|||+++++ 
T Consensus       177 -vp~p~~-~~~~~LVME~i~G~~L~~l~~~--------~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~~dgd  243 (397)
T 4gyi_A          177 -VPEPIA-QSRHTIVMSLVDALPMRQVSSV--------PDPASLYADLIALILRLAKHG---LIHGDFNEFNILIREEKD  243 (397)
T ss_dssp             -CCCEEE-EETTEEEEECCSCEEGGGCCCC--------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEEEEEC
T ss_pred             -CCeeee-ccCceEEEEecCCccHhhhccc--------HHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeCCCC
Confidence             111111 1345899999999888765421        234568899999999999998   99999999999998776 


Q ss_pred             ---------CEEEeccccchhc
Q 002010          832 ---------EAHVADFGLAKFL  844 (982)
Q Consensus       832 ---------~~kl~DfG~a~~~  844 (982)
                               .+.|+||+-+...
T Consensus       244 ~~d~~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          244 AEDPSSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             SSCTTSEEEEEEECCCTTCEET
T ss_pred             cccccccccceEEEEeCCcccC
Confidence                     3899999977643

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=99.57  E-value=4e-14  Score=159.49  Aligned_cols=264  Identities=9%  Similarity=0.039  Sum_probs=179.7

Q ss_pred             CCCCEEEeeCCcccCcCchhhhcccchhhhhhccCCCCCCCCCcCCCCCCccEEEccCCCcccccCccccCCCcccEEEe
Q 002010          289 ISLKSLDLSLNYLTGEIPESFAALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDV  368 (982)
Q Consensus       289 ~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L  368 (982)
                      ..++.+.+.+ .++.+...+|.+. +|+.+.+..| ++.+...+|.++ +|+.+.+.+ .++.....+|..+.+|+.+++
T Consensus       113 ~~l~~i~ip~-~i~~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~~-~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l  187 (401)
T 4fdw_A          113 KGYNEIILPN-SVKSIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFNS-TVQEIVFPS-TLEQLKEDIFYYCYNLKKADL  187 (401)
T ss_dssp             SSCSEEECCT-TCCEECTTTTTTC-CCSEEECCTT-CCEECTTTTTTC-CCCEEECCT-TCCEECSSTTTTCTTCCEEEC
T ss_pred             CCccEEEECC-ccCEehHhhcccC-CccEEEeCCC-ccEECHHhcCCC-CceEEEeCC-CccEehHHHhhCcccCCeeec
Confidence            5667777764 3554566677764 6888887666 665666677774 688888875 566566677777788888888


Q ss_pred             ccccccccCCccccCccccceeecccccccccCCccccCCCCCCEEEccCCccCCCCCccccCCCccccccCCCcccccc
Q 002010          369 TSNHLTGTIPRDLCKGGKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLSGE  448 (982)
Q Consensus       369 ~~N~l~~~~p~~~~~~~~L~~L~l~~N~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~  448 (982)
                      ++|+++......|. ..+|+.+.+.++ +......+|.+|++|+.+++..| +                        +..
T Consensus       188 ~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l------------------------~~I  240 (401)
T 4fdw_A          188 SKTKITKLPASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-V------------------------STI  240 (401)
T ss_dssp             TTSCCSEECTTTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-C------------------------CEE
T ss_pred             CCCcceEechhhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-c------------------------cCc
Confidence            77777744333443 466666666533 55555556666666666666543 2                        222


Q ss_pred             CCcccccCCccEEEeeccccCCCCchhccCCCCcceeeecccccc-----CCCccccccccccceeeeeccccCCCCCcc
Q 002010          449 LPEKMSGASLNQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLE-----GEIPVESFNLKMITSINISDNNISGEIPYS  523 (982)
Q Consensus       449 ~~~~~~~~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~-----~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~  523 (982)
                      ....|...+|+.+.+ .|.++...+.+|.++++|+.+++.+|.+.     ...+..|.++++|+.++|. |.++.+-...
T Consensus       241 ~~~aF~~~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~a  318 (401)
T 4fdw_A          241 GQEAFRESGITTVKL-PNGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGL  318 (401)
T ss_dssp             CTTTTTTCCCSEEEE-ETTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTT
T ss_pred             cccccccCCccEEEe-CCCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhh
Confidence            333444456777887 45566677788889999999999888764     2345567778888888888 4476566677


Q ss_pred             cccccCCCeeeCCCCcccCCCCcccccccccceEEcccccccccCcccccccc-ccceecccCCcc
Q 002010          524 ISQCHSLTSVDLSRNSLYGKIPPGISKLIDLSILNLSRNGITGSIPNEMRNMM-SLTTLDLSYNNL  588 (982)
Q Consensus       524 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~-~L~~L~Ls~N~l  588 (982)
                      |.+|++|+.++|..| ++..-+.+|.++ +|+.+++++|.+....+..|.+++ +++.|++..|.+
T Consensus       319 F~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~~  382 (401)
T 4fdw_A          319 LGGNRKVTQLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAESV  382 (401)
T ss_dssp             TTTCCSCCEEEECTT-CCEECTTSSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGGH
T ss_pred             hcCCCCccEEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHHH
Confidence            888888888888555 665666778888 888888888888766667777774 667777766654

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.55  E-value=2.2e-15  Score=145.36  Aligned_cols=128  Identities=23%  Similarity=0.177  Sum_probs=101.6

Q ss_pred             CCCCCEEecccCcCc-ccCchhhcCCCccceeecccccCCCCCCccccCCCCCCEEEeeCCcccCcCchhhhcccchhhh
Q 002010          240 LTQLQVLDMASCNIS-GEIPTSLSRLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLL  318 (982)
Q Consensus       240 l~~L~~L~L~~n~l~-~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L  318 (982)
                      .++|+.|++++|.++ +.+|..+..+++|++|++++|++++.  ..+..+++|++|++++|.+++.+|..+..+++|++|
T Consensus        16 ~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L   93 (149)
T 2je0_A           16 PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHL   93 (149)
T ss_dssp             GGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEE
T ss_pred             CccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEE
Confidence            478899999999998 77888888899999999999999866  678888999999999999987788877778888888


Q ss_pred             hhccCCCCCC-CCCcCCCCCCccEEEccCCCcccccC---ccccCCCcccEEEec
Q 002010          319 QLFKNNLRGP-IPSFLGDFPNLEVLQVWGNNFTFELP---ENLGRNGKLLILDVT  369 (982)
Q Consensus       319 ~L~~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~~---~~l~~l~~L~~L~L~  369 (982)
                      ++++|++++. .+..++.+++|++|++++|++++..+   ..+..+++|+.|+++
T Consensus        94 ~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~  148 (149)
T 2je0_A           94 NLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY  148 (149)
T ss_dssp             ECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred             ECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence            8888888763 34667777778888877777775544   356666667666654

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=99.55  E-value=3.9e-15  Score=148.05  Aligned_cols=133  Identities=17%  Similarity=0.165  Sum_probs=107.8

Q ss_pred             cccCCccEEEeeccccCCCCchhccCCCCcceeeeccccccCCCccccccccccceeeeeccccCCCCCcccccccCCCe
Q 002010          453 MSGASLNQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIPYSISQCHSLTS  532 (982)
Q Consensus       453 ~~~~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~  532 (982)
                      ....+|+.|++++|+++. +|......++|++|++++|++++.  ..+..+++|++|+|++|+|++..+..|..+++|+.
T Consensus        16 ~~~~~L~~L~l~~n~l~~-i~~~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~   92 (176)
T 1a9n_A           16 TNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTE   92 (176)
T ss_dssp             ECTTSCEEEECTTSCCCS-CCCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCE
T ss_pred             CCcCCceEEEeeCCCCch-hHHhhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCE
Confidence            344678888888888884 454333344899999999999864  57888999999999999999665566689999999


Q ss_pred             eeCCCCcccCCCCc--ccccccccceEEcccccccccCccc----cccccccceecccCCcccc
Q 002010          533 VDLSRNSLYGKIPP--GISKLIDLSILNLSRNGITGSIPNE----MRNMMSLTTLDLSYNNLIG  590 (982)
Q Consensus       533 L~Ls~N~l~~~~p~--~~~~l~~L~~L~Ls~N~l~~~~p~~----l~~l~~L~~L~Ls~N~l~~  590 (982)
                      |+|++|+|+ .+|.  .+..+++|+.|+|++|.++ .+|..    +..+++|++||+++|....
T Consensus        93 L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~~  154 (176)
T 1a9n_A           93 LILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLKE  154 (176)
T ss_dssp             EECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHHH
T ss_pred             EECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHHH
Confidence            999999996 5665  7899999999999999998 55654    8999999999999998764

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=99.54  E-value=1.1e-13  Score=156.04  Aligned_cols=241  Identities=14%  Similarity=0.102  Sum_probs=107.0

Q ss_pred             CCCEEecccCcCcccCchhhcCCCccceeecccccCCCCCCccccCCCCCCEEEeeCCcccCcCchhhhcccchhhhhhc
Q 002010          242 QLQVLDMASCNISGEIPTSLSRLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQLF  321 (982)
Q Consensus       242 ~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~  321 (982)
                      +|+.+.+..+ ++.....+|.+ .+|+++.+.. .++...+.+|.++++|+.+++++|.++.....+|. ..+|+.+.|.
T Consensus       136 ~L~~i~l~~~-i~~I~~~aF~~-~~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~~I~~~aF~-~~~L~~l~lp  211 (401)
T 4fdw_A          136 QIAKVVLNEG-LKSIGDMAFFN-STVQEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKITKLPASTFV-YAGIEEVLLP  211 (401)
T ss_dssp             CCSEEECCTT-CCEECTTTTTT-CCCCEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCSEECTTTTT-TCCCSEEECC
T ss_pred             CccEEEeCCC-ccEECHHhcCC-CCceEEEeCC-CccEehHHHhhCcccCCeeecCCCcceEechhhEe-ecccCEEEeC
Confidence            4555554433 43333344444 2355555543 34433344455555555555555554433333343 2444444444


Q ss_pred             cCCCCCCCCCcCCCCCCccEEEccCCCcccccCccccCCCcccEEEeccccccccCCccccCccccceeeccccccc---
Q 002010          322 KNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFI---  398 (982)
Q Consensus       322 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~l~~N~~~---  398 (982)
                      .+ ++.+....|.++++|+.+++..| ++.....+|.. .+|+.+++ .+.++......|..+.+|+.+.+.+|.+.   
T Consensus       212 ~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~  287 (401)
T 4fdw_A          212 VT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKL-PNGVTNIASRAFYYCPELAEVTTYGSTFNDDP  287 (401)
T ss_dssp             TT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEEESSCCCCCT
T ss_pred             Cc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEe-CCCccEEChhHhhCCCCCCEEEeCCccccCCc
Confidence            22 33334444444555555554432 23222333333 34444444 22233233333444444444444333322   


Q ss_pred             --ccCCccccCCCCCCEEEccCCccCCCCCccccCCCccccccCCCccccccCCcccccCCccEEEeeccccCCCCchhc
Q 002010          399 --GPIPEELGQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLSGELPEKMSGASLNQLKVANNNITGKIPAAI  476 (982)
Q Consensus       399 --~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~L~~N~i~~~~p~~~  476 (982)
                        ...+.+|.+|++|+.+++.+ .++......|.++                       .+|+.+.+..| ++...+.+|
T Consensus       288 ~~~I~~~aF~~c~~L~~l~l~~-~i~~I~~~aF~~c-----------------------~~L~~l~lp~~-l~~I~~~aF  342 (401)
T 4fdw_A          288 EAMIHPYCLEGCPKLARFEIPE-SIRILGQGLLGGN-----------------------RKVTQLTIPAN-VTQINFSAF  342 (401)
T ss_dssp             TCEECTTTTTTCTTCCEECCCT-TCCEECTTTTTTC-----------------------CSCCEEEECTT-CCEECTTSS
T ss_pred             ccEECHHHhhCCccCCeEEeCC-ceEEEhhhhhcCC-----------------------CCccEEEECcc-ccEEcHHhC
Confidence              23334444444444444442 2332222233333                       44555555332 444445566


Q ss_pred             cCCCCcceeeeccccccCCCccccccc-cccceeeeecccc
Q 002010          477 GNLPSLNILSLQNNRLEGEIPVESFNL-KMITSINISDNNI  516 (982)
Q Consensus       477 ~~l~~L~~L~L~~N~l~~~~p~~~~~l-~~L~~L~Ls~N~l  516 (982)
                      .++ +|+.+++++|.+....+..|..+ ..+..|.+..+.+
T Consensus       343 ~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~~  382 (401)
T 4fdw_A          343 NNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAESV  382 (401)
T ss_dssp             SSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGGH
T ss_pred             CCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHHH
Confidence            666 66666666666654444444444 2556666666554

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=99.52  E-value=3.6e-16  Score=158.84  Aligned_cols=127  Identities=22%  Similarity=0.256  Sum_probs=83.1

Q ss_pred             CCccEEEeeccccCCCCchhccCCCCcceeeeccccccCCCccccccccccceeeeeccccCCCCCcccccccCCCeeeC
Q 002010          456 ASLNQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIPYSISQCHSLTSVDL  535 (982)
Q Consensus       456 ~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  535 (982)
                      ..|++|++++|++++ +| .+..+++|++|++++|+++ .+|..+..+++|++|+|++|++++ +| .+..+++|+.|+|
T Consensus        48 ~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l  122 (198)
T 1ds9_A           48 KACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKLVNLRVLYM  122 (198)
T ss_dssp             TTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEE
T ss_pred             CCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcCCEEECcCCcCCc-CC-ccccCCCCCEEEC
Confidence            355666666666664 44 6666777777777777776 556666666777777777777764 34 5667777777777


Q ss_pred             CCCcccCCCC-cccccccccceEEcccccccccCccc----------cccccccceecccCCccc
Q 002010          536 SRNSLYGKIP-PGISKLIDLSILNLSRNGITGSIPNE----------MRNMMSLTTLDLSYNNLI  589 (982)
Q Consensus       536 s~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~----------l~~l~~L~~L~Ls~N~l~  589 (982)
                      ++|++++..+ ..+..+++|+.|++++|.+++.+|..          +..+++|+.||  +|+++
T Consensus       123 ~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~l~~L~~Ld--~~~i~  185 (198)
T 1ds9_A          123 SNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD--GMPVD  185 (198)
T ss_dssp             SEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHHHHHHCSSCSEEC--CGGGT
T ss_pred             CCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHHHHHhCCCcEEEC--CcccC
Confidence            7777764322 35677777777777777776655542          66777777776  55554

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.51  E-value=3.5e-14  Score=139.98  Aligned_cols=109  Identities=22%  Similarity=0.189  Sum_probs=77.6

Q ss_pred             cceeeeccccccCCCccccccccccceeeeeccccCCCCCcccccccCCCeeeCCCCcccCCCCcccccccccceEEccc
Q 002010          482 LNILSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYGKIPPGISKLIDLSILNLSR  561 (982)
Q Consensus       482 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~  561 (982)
                      .+.|++++|+++ .+|..+.  ++|++|+|++|+|++..|..|.++++|+.|+|++|+|++..|..|.++++|++|+|++
T Consensus        11 ~~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~   87 (170)
T 3g39_A           11 GTTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLND   87 (170)
T ss_dssp             TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             CCEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCC
Confidence            355666666665 4555442  6677777777777766677777777777777777777766666677777777777777


Q ss_pred             ccccccCccccccccccceecccCCccccCCC
Q 002010          562 NGITGSIPNEMRNMMSLTTLDLSYNNLIGNIP  593 (982)
Q Consensus       562 N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip  593 (982)
                      |+|++..+..|..+++|++|+|++|++++..+
T Consensus        88 N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~  119 (170)
T 3g39_A           88 NQLKSIPRGAFDNLKSLTHIWLLNNPWDCACS  119 (170)
T ss_dssp             SCCCCCCTTTTTTCTTCCEEECCSSCBCTTBG
T ss_pred             CccCEeCHHHhcCCCCCCEEEeCCCCCCCCch
Confidence            77776666667777778888888887776655

>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus}

Probab=99.48  E-value=4.5e-13  Score=151.64  Aligned_cols=310  Identities=15%  Similarity=0.101  Sum_probs=152.2

Q ss_pred             CCCCCCCCCEEecccCcCcccCchhhcCCCccceeecccccCCCCCCccccCCCCCCEEEeeCCcccCcCchhhhcccch
Q 002010          236 GFGALTQLQVLDMASCNISGEIPTSLSRLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNL  315 (982)
Q Consensus       236 ~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L  315 (982)
                      +|.++++|+.+.+.. .++.....+|.++++|+.+++..+ ++......|.++.+|+.+.+..+ +......+|.....+
T Consensus        66 AF~~c~~L~~i~lp~-~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~~i~~~aF~~~~~~  142 (394)
T 4fs7_A           66 AFQGCRKVTEIKIPS-TVREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LKSIGVEAFKGCDFK  142 (394)
T ss_dssp             TTTTCTTEEEEECCT-TCCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTTTTCCCS
T ss_pred             HhhCCCCceEEEeCC-CccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-eeeecceeeeccccc
Confidence            455555555555542 244344445555555555555433 33333344555555555444433 222333334333222


Q ss_pred             hhhhhccCCCCCCCCCcCCCCCCccEEEccCCCcccccCccccCCCcccEEEeccccccccCCccccCccccceeecccc
Q 002010          316 TLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQN  395 (982)
Q Consensus       316 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~l~~N  395 (982)
                      +....  +.+.......|.++.+|+.+.+.++. ..                        .....|..+.+|+.+.+..|
T Consensus       143 ~~~~~--~~~~~i~~~aF~~c~~L~~i~l~~~~-~~------------------------I~~~~F~~c~~L~~i~l~~~  195 (394)
T 4fs7_A          143 EITIP--EGVTVIGDEAFATCESLEYVSLPDSM-ET------------------------LHNGLFSGCGKLKSIKLPRN  195 (394)
T ss_dssp             EEECC--TTCCEECTTTTTTCTTCCEEECCTTC-CE------------------------ECTTTTTTCTTCCBCCCCTT
T ss_pred             ccccC--ccccccchhhhcccCCCcEEecCCcc-ce------------------------eccccccCCCCceEEEcCCC
Confidence            21111  11111223344444455555444332 21                        22333444444444444433


Q ss_pred             cccccCCccccCCCCCCEEEccCCccCCCCCccccCCCccccccCCCccccccCCcccc-cCCccEEEeeccccCCCCch
Q 002010          396 FFIGPIPEELGQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLSGELPEKMS-GASLNQLKVANNNITGKIPA  474 (982)
Q Consensus       396 ~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~-~~~L~~L~L~~N~i~~~~p~  474 (982)
                       +......+|.++..|+.+.+..+...  +.........|+.+.+..+. +......+. ...++.+.+..+... ....
T Consensus       196 -~~~I~~~~F~~~~~L~~i~~~~~~~~--i~~~~~~~~~l~~i~ip~~~-~~i~~~~f~~~~~l~~~~~~~~~~~-i~~~  270 (394)
T 4fs7_A          196 -LKIIRDYCFAECILLENMEFPNSLYY--LGDFALSKTGVKNIIIPDSF-TELGKSVFYGCTDLESISIQNNKLR-IGGS  270 (394)
T ss_dssp             -CCEECTTTTTTCTTCCBCCCCTTCCE--ECTTTTTTCCCCEEEECTTC-CEECSSTTTTCSSCCEEEECCTTCE-ECSC
T ss_pred             -ceEeCchhhccccccceeecCCCceE--eehhhcccCCCceEEECCCc-eecccccccccccceeEEcCCCcce-eecc
Confidence             23333444555555555544443321  12222223344444433221 111112222 245666666555433 4555


Q ss_pred             hccCCCCcceeeeccccccCCCccccccccccceeeeeccccCCCCCcccccccCCCeeeCCCCcccCCCCccccccccc
Q 002010          475 AIGNLPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYGKIPPGISKLIDL  554 (982)
Q Consensus       475 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L  554 (982)
                      .|..+..++.+....+.+.   ...+..+.+|+.+.+.++ ++.+-...|.++++|+.++|..+ ++..-..+|.++.+|
T Consensus       271 ~F~~~~~l~~~~~~~~~i~---~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L  345 (394)
T 4fs7_A          271 LFYNCSGLKKVIYGSVIVP---EKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSL  345 (394)
T ss_dssp             TTTTCTTCCEEEECSSEEC---TTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTC
T ss_pred             ccccccccceeccCceeec---cccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCC
Confidence            6666777777666665432   234556677777777654 55444566777777777777644 554445667777777


Q ss_pred             ceEEcccccccccCccccccccccceecccCC
Q 002010          555 SILNLSRNGITGSIPNEMRNMMSLTTLDLSYN  586 (982)
Q Consensus       555 ~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N  586 (982)
                      +.+++..| ++..-..+|.++.+|+.+++..|
T Consensus       346 ~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~~  376 (394)
T 4fs7_A          346 SNINFPLS-LRKIGANAFQGCINLKKVELPKR  376 (394)
T ss_dssp             CEECCCTT-CCEECTTTBTTCTTCCEEEEEGG
T ss_pred             CEEEECcc-ccEehHHHhhCCCCCCEEEECCC
Confidence            77777665 65555667777777777776543

>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus}

Probab=99.48  E-value=7.1e-13  Score=150.06  Aligned_cols=335  Identities=13%  Similarity=0.076  Sum_probs=234.0

Q ss_pred             cccchhhHHhhhhhHHHHhhcccccccccCCCCCCCCCCCCEEecccCcCcccCchhhcCCCccceeecccccCCCCCCc
Q 002010          204 LNGTVPAFLSRLKNLREMYIGYFNTYTGGIPPGFGALTQLQVLDMASCNISGEIPTSLSRLKLLHSLFLQMNKLTGHIPP  283 (982)
Q Consensus       204 i~~~~~~~l~~l~~L~~L~l~~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~  283 (982)
                      ++.....+|.++.+|+++.+.  +.++..-..+|.++++|+.+++..+ ++......|.++++|+.+.+..+ +......
T Consensus        59 VtsIg~~AF~~c~~L~~i~lp--~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~~i~~~  134 (394)
T 4fs7_A           59 VVSIGYAAFQGCRKVTEIKIP--STVREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LKSIGVE  134 (394)
T ss_dssp             EEEECTTTTTTCTTEEEEECC--TTCCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTT
T ss_pred             EeEhHHHHhhCCCCceEEEeC--CCccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-eeeecce
Confidence            344556789999999999886  3455444567999999999999765 66566778999999999888755 4445566


Q ss_pred             cccCCCCCCEEEeeCCcccCcCchhhhcccchhhhhhccCCCCCCCCCcCCCCCCccEEEccCCCcccccCccccCCCcc
Q 002010          284 QLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKL  363 (982)
Q Consensus       284 ~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L  363 (982)
                      +|.++..+.......  +......+|..+++|+.+.+.++. .......|.++.+|+.+.+..| ++.....++..+..|
T Consensus       135 aF~~~~~~~~~~~~~--~~~i~~~aF~~c~~L~~i~l~~~~-~~I~~~~F~~c~~L~~i~l~~~-~~~I~~~~F~~~~~L  210 (394)
T 4fs7_A          135 AFKGCDFKEITIPEG--VTVIGDEAFATCESLEYVSLPDSM-ETLHNGLFSGCGKLKSIKLPRN-LKIIRDYCFAECILL  210 (394)
T ss_dssp             TTTTCCCSEEECCTT--CCEECTTTTTTCTTCCEEECCTTC-CEECTTTTTTCTTCCBCCCCTT-CCEECTTTTTTCTTC
T ss_pred             eeecccccccccCcc--ccccchhhhcccCCCcEEecCCcc-ceeccccccCCCCceEEEcCCC-ceEeCchhhcccccc
Confidence            777765444333322  232455789999999999997654 4366778999999999999876 555566778888888


Q ss_pred             cEEEeccccccccCCccccCccccceeecccccccccCCccccCCCCCCEEEccCCccCCCCCccccCCCccccccCCCc
Q 002010          364 LILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDN  443 (982)
Q Consensus       364 ~~L~L~~N~l~~~~p~~~~~~~~L~~L~l~~N~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N  443 (982)
                      +.+.+..+...  +........+|+.+.+..+ +.......+..+..|+.+.+..+... .....|.....         
T Consensus       211 ~~i~~~~~~~~--i~~~~~~~~~l~~i~ip~~-~~~i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~---------  277 (394)
T 4fs7_A          211 ENMEFPNSLYY--LGDFALSKTGVKNIIIPDS-FTELGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCSG---------  277 (394)
T ss_dssp             CBCCCCTTCCE--ECTTTTTTCCCCEEEECTT-CCEECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTT---------
T ss_pred             ceeecCCCceE--eehhhcccCCCceEEECCC-ceecccccccccccceeEEcCCCcce-eeccccccccc---------
Confidence            88887766543  2333444567777777543 33344566777777887777766443 33334444443         


Q ss_pred             cccccCCcccccCCccEEEeeccccCCCCchhccCCCCcceeeeccccccCCCccccccccccceeeeeccccCCCCCcc
Q 002010          444 LLSGELPEKMSGASLNQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIPYS  523 (982)
Q Consensus       444 ~l~~~~~~~~~~~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~  523 (982)
                                    ++.+....+.+   ....|..+.+|+.+.+.++ ++..-...|.++.+|+.+++.++ ++.+-..+
T Consensus       278 --------------l~~~~~~~~~i---~~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~a  338 (394)
T 4fs7_A          278 --------------LKKVIYGSVIV---PEKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRS  338 (394)
T ss_dssp             --------------CCEEEECSSEE---CTTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTT
T ss_pred             --------------cceeccCceee---ccccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHh
Confidence                          34444433332   2346777788888888765 55344556777888888888754 66555778


Q ss_pred             cccccCCCeeeCCCCcccCCCCcccccccccceEEcccccccccCcccccccccccee
Q 002010          524 ISQCHSLTSVDLSRNSLYGKIPPGISKLIDLSILNLSRNGITGSIPNEMRNMMSLTTL  581 (982)
Q Consensus       524 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L  581 (982)
                      |.++++|+.+++..| ++..-..+|.++.+|+.+++..+ ++ .+..+|.++++|+.+
T Consensus       339 F~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~~-~~-~~~~~F~~c~~L~~I  393 (394)
T 4fs7_A          339 FRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELPKR-LE-QYRYDFEDTTKFKWI  393 (394)
T ss_dssp             TTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEGG-GG-GGGGGBCTTCEEEEE
T ss_pred             ccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEECCC-CE-EhhheecCCCCCcEE
Confidence            999999999999877 66566788999999999999765 44 456778888888765

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.47  E-value=9.2e-14  Score=137.43  Aligned_cols=108  Identities=21%  Similarity=0.204  Sum_probs=67.7

Q ss_pred             ceeeeccccccCCCccccccccccceeeeeccccCCCCCcccccccCCCeeeCCCCcccCCCCcccccccccceEEcccc
Q 002010          483 NILSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYGKIPPGISKLIDLSILNLSRN  562 (982)
Q Consensus       483 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N  562 (982)
                      +.+++++|+++ .+|..+.  ++|++|+|++|+|++..|..|.++++|+.|+|++|+|++..+..|.++++|+.|+|++|
T Consensus        15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N   91 (174)
T 2r9u_A           15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN   91 (174)
T ss_dssp             SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence            45555555554 4454443  56666666666666666666666666666666666666554455666667777777777


Q ss_pred             cccccCccccccccccceecccCCccccCCC
Q 002010          563 GITGSIPNEMRNMMSLTTLDLSYNNLIGNIP  593 (982)
Q Consensus       563 ~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip  593 (982)
                      +|++..+..|..+++|++|+|++|++....+
T Consensus        92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~c~~~  122 (174)
T 2r9u_A           92 HLKSIPRGAFDNLKSLTHIYLYNNPWDCECR  122 (174)
T ss_dssp             CCCCCCTTTTTTCTTCSEEECCSSCBCTTBG
T ss_pred             ccceeCHHHhccccCCCEEEeCCCCcccccc
Confidence            7765555556667777777777776665443

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=99.47  E-value=3.2e-14  Score=141.33  Aligned_cols=135  Identities=16%  Similarity=0.161  Sum_probs=102.3

Q ss_pred             cccCCCCCCEEEccCCccCCCCCccccCCCccccccCCCccccccCCcccccCCccEEEeeccccCCCCchhccCCCCcc
Q 002010          404 ELGQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLSGELPEKMSGASLNQLKVANNNITGKIPAAIGNLPSLN  483 (982)
Q Consensus       404 ~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~L~~N~i~~~~p~~~~~l~~L~  483 (982)
                      .+.++.+|+.|++++|+++. +|. +..+.                      ++|++|++++|+|++.  ..+..+++|+
T Consensus        14 ~~~~~~~L~~L~l~~n~l~~-i~~-~~~~~----------------------~~L~~L~Ls~N~l~~~--~~l~~l~~L~   67 (176)
T 1a9n_A           14 QYTNAVRDRELDLRGYKIPV-IEN-LGATL----------------------DQFDAIDFSDNEIRKL--DGFPLLRRLK   67 (176)
T ss_dssp             EEECTTSCEEEECTTSCCCS-CCC-GGGGT----------------------TCCSEEECCSSCCCEE--CCCCCCSSCC
T ss_pred             hcCCcCCceEEEeeCCCCch-hHH-hhhcC----------------------CCCCEEECCCCCCCcc--cccccCCCCC
Confidence            45667788888888887773 332 22221                      2566666666766654  5678888999


Q ss_pred             eeeeccccccCCCccccccccccceeeeeccccCCCCCc--ccccccCCCeeeCCCCcccCCCCcc----cccccccceE
Q 002010          484 ILSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIPY--SISQCHSLTSVDLSRNSLYGKIPPG----ISKLIDLSIL  557 (982)
Q Consensus       484 ~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~--~~~~l~~L~~L~Ls~N~l~~~~p~~----~~~l~~L~~L  557 (982)
                      +|++++|++++..+..+..+++|++|+|++|+|+ .+|.  .+..+++|+.|++++|.++ .+|..    +..+++|+.|
T Consensus        68 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~L  145 (176)
T 1a9n_A           68 TLLVNNNRICRIGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVL  145 (176)
T ss_dssp             EEECCSSCCCEECSCHHHHCTTCCEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEE
T ss_pred             EEECCCCcccccCcchhhcCCCCCEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCcccee
Confidence            9999999998544444578899999999999996 4565  7889999999999999998 56664    8999999999


Q ss_pred             Ecccccccc
Q 002010          558 NLSRNGITG  566 (982)
Q Consensus       558 ~Ls~N~l~~  566 (982)
                      |+++|.+..
T Consensus       146 d~~~n~~~~  154 (176)
T 1a9n_A          146 DFQKVKLKE  154 (176)
T ss_dssp             TTEECCHHH
T ss_pred             CCCcCCHHH
Confidence            999998874

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=99.47  E-value=7.7e-16  Score=156.37  Aligned_cols=155  Identities=19%  Similarity=0.213  Sum_probs=109.3

Q ss_pred             cCccccceeecccccccccCCc------cccCCCCCCEEEccCCccCCCCCccccCCCccccccCCCccccccCCccccc
Q 002010          382 CKGGKLKSLILMQNFFIGPIPE------ELGQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLSGELPEKMSG  455 (982)
Q Consensus       382 ~~~~~L~~L~l~~N~~~~~~~~------~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~  455 (982)
                      .....++.++++.+.+.+..|.      .+..+++|++|++++|++++ +| .+..+                       
T Consensus        15 ~~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l-----------------------   69 (198)
T 1ds9_A           15 EERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGM-----------------------   69 (198)
T ss_dssp             HHTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHH-----------------------
T ss_pred             HhcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccC-----------------------
Confidence            3445566666666666665554      55556666666666666553 33 33333                       


Q ss_pred             CCccEEEeeccccCCCCchhccCCCCcceeeeccccccCCCccccccccccceeeeeccccCCCCC-cccccccCCCeee
Q 002010          456 ASLNQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIP-YSISQCHSLTSVD  534 (982)
Q Consensus       456 ~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~  534 (982)
                      .+|++|++++|+++ .+|..+..+++|++|++++|++++ +| .+..+++|++|++++|++++..+ ..+..+++|+.|+
T Consensus        70 ~~L~~L~l~~n~l~-~l~~~~~~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~  146 (198)
T 1ds9_A           70 ENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLL  146 (198)
T ss_dssp             TTCCEEEEEEEEEC-SCSSHHHHHHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEE
T ss_pred             CCCCEEECCCCCcc-cccchhhcCCcCCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEE
Confidence            46777777777777 566677777888888888888875 45 57788888888888888885332 4678889999999


Q ss_pred             CCCCcccCCCCcc----------cccccccceEEcccccccc
Q 002010          535 LSRNSLYGKIPPG----------ISKLIDLSILNLSRNGITG  566 (982)
Q Consensus       535 Ls~N~l~~~~p~~----------~~~l~~L~~L~Ls~N~l~~  566 (982)
                      +++|.+++.+|..          +..+++|+.||  +|.++.
T Consensus       147 l~~N~l~~~~~~~~~~~~~~~~~~~~l~~L~~Ld--~~~i~~  186 (198)
T 1ds9_A          147 LAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD--GMPVDV  186 (198)
T ss_dssp             ECSCHHHHHHHTTTTHHHHHHHHHHHCSSCSEEC--CGGGTT
T ss_pred             ecCCccccccccccchHHHHHHHHHhCCCcEEEC--CcccCH
Confidence            9999998776653          78889999887  777763

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.42  E-value=3.5e-13  Score=132.79  Aligned_cols=109  Identities=17%  Similarity=0.201  Sum_probs=91.7

Q ss_pred             CccEEEeeccccCCCCchhccCCCCcceeeeccccccCCCccccccccccceeeeeccccCCCCCcccccccCCCeeeCC
Q 002010          457 SLNQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIPYSISQCHSLTSVDLS  536 (982)
Q Consensus       457 ~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls  536 (982)
                      +.+.+++++|+++. +|..+  .++|++|+|++|+|++..|..+..+++|++|+|++|+|++..+..|..+++|+.|+|+
T Consensus        10 ~~~~l~~s~n~l~~-ip~~~--~~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~   86 (170)
T 3g39_A           10 SGTTVDCSGKSLAS-VPTGI--PTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLN   86 (170)
T ss_dssp             ETTEEECTTSCCSS-CCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred             CCCEEEeCCCCcCc-cCccC--CCCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECC
Confidence            35678888888874 55544  3788899999999988778888889999999999999997777788999999999999


Q ss_pred             CCcccCCCCcccccccccceEEcccccccccC
Q 002010          537 RNSLYGKIPPGISKLIDLSILNLSRNGITGSI  568 (982)
Q Consensus       537 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~  568 (982)
                      +|+|++..+..|..+++|+.|+|++|.++...
T Consensus        87 ~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c  118 (170)
T 3g39_A           87 DNQLKSIPRGAFDNLKSLTHIWLLNNPWDCAC  118 (170)
T ss_dssp             SSCCCCCCTTTTTTCTTCCEEECCSSCBCTTB
T ss_pred             CCccCEeCHHHhcCCCCCCEEEeCCCCCCCCc
Confidence            99999777778999999999999999998543

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.42  E-value=3.5e-13  Score=133.23  Aligned_cols=106  Identities=20%  Similarity=0.187  Sum_probs=88.8

Q ss_pred             ccEEEeeccccCCCCchhccCCCCcceeeeccccccCCCccccccccccceeeeeccccCCCCCcccccccCCCeeeCCC
Q 002010          458 LNQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIPYSISQCHSLTSVDLSR  537 (982)
Q Consensus       458 L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~  537 (982)
                      -+.+++++|+++ .+|..+.  ++|++|+|++|+|++..|..+..+++|++|+|++|+|++..+..|.++++|+.|+|++
T Consensus        14 ~~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~   90 (174)
T 2r9u_A           14 QTLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLND   90 (174)
T ss_dssp             SSEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             CcEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCC
Confidence            357788888886 5565553  7888999999999887788888899999999999999977677788999999999999


Q ss_pred             CcccCCCCcccccccccceEEcccccccc
Q 002010          538 NSLYGKIPPGISKLIDLSILNLSRNGITG  566 (982)
Q Consensus       538 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~  566 (982)
                      |+|++..+..|..+++|+.|+|++|.+..
T Consensus        91 N~l~~l~~~~~~~l~~L~~L~L~~N~~~c  119 (174)
T 2r9u_A           91 NHLKSIPRGAFDNLKSLTHIYLYNNPWDC  119 (174)
T ss_dssp             SCCCCCCTTTTTTCTTCSEEECCSSCBCT
T ss_pred             CccceeCHHHhccccCCCEEEeCCCCccc
Confidence            99997666679999999999999999984

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=99.37  E-value=3.3e-14  Score=158.67  Aligned_cols=170  Identities=16%  Similarity=0.128  Sum_probs=89.9

Q ss_pred             ccccEEEeccCCCCCCCChhhhhh-----cccceeeccCCccccccchhhhhcCCCccEEeccCccccCCCchhcc----
Q 002010           95 TKLVNLTISNVNLTGRLPSEMALL-----TSLKVFNISGNVFQGNFAGQIVRGMTELQVLDAYNNNFTGPLPVEIA----  165 (982)
Q Consensus        95 ~~L~~L~l~~n~l~~~~p~~l~~l-----~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~l~----  165 (982)
                      +.|++|+|++|.++......+..+     .+|++|+|++|.+.+.....+...+++|++|+|++|+++......++    
T Consensus        72 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~  151 (372)
T 3un9_A           72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLL  151 (372)
T ss_dssp             TTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHH
T ss_pred             hhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHH
Confidence            456677777776665444444443     56666666666665443334444555666666666666544334432    


Q ss_pred             -ccccccEEeecCccccccc----CCCccccCcceEeeccCcccccchhhHHhhhhhHHHHhhcccccccccCCCCCCCC
Q 002010          166 -SLKSLRHLSFGGNYFTGKI----PQSYSEIQSLEYIGLNGIGLNGTVPAFLSRLKNLREMYIGYFNTYTGGIPPGFGAL  240 (982)
Q Consensus       166 -~l~~L~~L~L~~N~l~~~~----p~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~l~~~n~~~~~~p~~~~~l  240 (982)
                       ..++|++|+|++|.|+...    +..+..+++|++|+|++|.+++.....+.                     ..+...
T Consensus       152 ~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~---------------------~~L~~~  210 (372)
T 3un9_A          152 HDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLA---------------------AQLDRN  210 (372)
T ss_dssp             STTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHH---------------------HHGGGC
T ss_pred             hcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHH---------------------HHHhcC
Confidence             2355666666666665422    22334455666666666655433222211                     112334


Q ss_pred             CCCCEEecccCcCcccC----chhhcCCCccceeecccccCCCCCCccc
Q 002010          241 TQLQVLDMASCNISGEI----PTSLSRLKLLHSLFLQMNKLTGHIPPQL  285 (982)
Q Consensus       241 ~~L~~L~L~~n~l~~~~----~~~l~~l~~L~~L~L~~N~l~~~~~~~l  285 (982)
                      ++|++|+|++|.|++..    +..+...++|++|+|++|.|+......+
T Consensus       211 ~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~~g~~~L  259 (372)
T 3un9_A          211 RQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSEGRQVL  259 (372)
T ss_dssp             SCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCHHHHHHH
T ss_pred             CCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCHHHHHHH
Confidence            45666666666665432    2233445566666666666654433333

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=99.29  E-value=2e-13  Score=152.29  Aligned_cols=187  Identities=17%  Similarity=0.135  Sum_probs=86.8

Q ss_pred             CCccEEeccCccccCCCchhcccc-----ccccEEeecCcccccccCCCcc-ccCcceEeeccCcccccchhhHHhhhhh
Q 002010          144 TELQVLDAYNNNFTGPLPVEIASL-----KSLRHLSFGGNYFTGKIPQSYS-EIQSLEYIGLNGIGLNGTVPAFLSRLKN  217 (982)
Q Consensus       144 ~~L~~L~Ls~n~l~~~~p~~l~~l-----~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~L~~n~i~~~~~~~l~~l~~  217 (982)
                      +.|++|+|++|.++......+...     ++|++|+|++|.++......+. .+++|++|+|++|.++......+...- 
T Consensus        72 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L-  150 (372)
T 3un9_A           72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLL-  150 (372)
T ss_dssp             TTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHH-
T ss_pred             hhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHH-
Confidence            344555555555543333333222     4555555555555443333322 244555555555555543333332210 


Q ss_pred             HHHHhhcccccccccCCCCCCCCCCCCEEecccCcCccc----CchhhcCCCccceeecccccCCCCC----CccccCCC
Q 002010          218 LREMYIGYFNTYTGGIPPGFGALTQLQVLDMASCNISGE----IPTSLSRLKLLHSLFLQMNKLTGHI----PPQLSGLI  289 (982)
Q Consensus       218 L~~L~l~~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~----~~~~l~~l~~L~~L~L~~N~l~~~~----~~~l~~l~  289 (982)
                       +                  ...++|++|+|++|.|+..    ++..+..+++|++|+|++|.|+...    +..+...+
T Consensus       151 -~------------------~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~  211 (372)
T 3un9_A          151 -L------------------HDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNR  211 (372)
T ss_dssp             -H------------------STTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCS
T ss_pred             -H------------------hcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCC
Confidence             0                  1124566666666666532    2233355566666666666655322    33344555


Q ss_pred             CCCEEEeeCCcccCcC----chhhhcccchhhhhhccCCCCCCCCCcCCCC---C--CccEEE--ccCCCcc
Q 002010          290 SLKSLDLSLNYLTGEI----PESFAALKNLTLLQLFKNNLRGPIPSFLGDF---P--NLEVLQ--VWGNNFT  350 (982)
Q Consensus       290 ~L~~L~Ls~N~l~~~~----~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l---~--~L~~L~--L~~N~l~  350 (982)
                      +|++|+|++|.|+...    +..+...++|++|+|++|.|++.....+..+   .  .|+.+.  +..|.+.
T Consensus       212 ~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~~g~~~L~~~~~~~~~~L~~l~~ll~~~~~~  283 (372)
T 3un9_A          212 QLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSEGRQVLRDLGGAAEGGARVVVSLTEGTAVS  283 (372)
T ss_dssp             CCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCHHHHHHHHHCC------CEEECCCC----CH
T ss_pred             CcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCHHHHHHHHHHhcCCCccchhhHhhhcCCccC
Confidence            6666666666665422    2233344666666666666654332222211   1  266666  6666665

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=99.27  E-value=3.9e-12  Score=141.44  Aligned_cols=103  Identities=18%  Similarity=0.178  Sum_probs=68.4

Q ss_pred             EEEeecc-ccCCCCchhccCCCCcceeeecc-ccccCCCccccccccccceeeeeccccCCCCCcccccccCCCeeeCCC
Q 002010          460 QLKVANN-NITGKIPAAIGNLPSLNILSLQN-NRLEGEIPVESFNLKMITSINISDNNISGEIPYSISQCHSLTSVDLSR  537 (982)
Q Consensus       460 ~L~L~~N-~i~~~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~  537 (982)
                      .++++++ +++ .+|. +..+++|+.|+|++ |+|++..+..|..+++|++|+|++|+|++..|..|.++++|+.|+|++
T Consensus        12 ~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~   89 (347)
T 2ifg_A           12 GLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF   89 (347)
T ss_dssp             CEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred             EEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCC
Confidence            4566666 676 3555 77777777777775 777765556666777777777777777766666667777777777777


Q ss_pred             CcccCCCCcccccccccceEEccccccc
Q 002010          538 NSLYGKIPPGISKLIDLSILNLSRNGIT  565 (982)
Q Consensus       538 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  565 (982)
                      |+|++..+..|..+. |+.|+|++|.+.
T Consensus        90 N~l~~~~~~~~~~~~-L~~l~l~~N~~~  116 (347)
T 2ifg_A           90 NALESLSWKTVQGLS-LQELVLSGNPLH  116 (347)
T ss_dssp             SCCSCCCSTTTCSCC-CCEEECCSSCCC
T ss_pred             CccceeCHHHcccCC-ceEEEeeCCCcc
Confidence            777654444455444 667777766665

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=99.25  E-value=1.1e-11  Score=137.81  Aligned_cols=132  Identities=16%  Similarity=0.085  Sum_probs=93.5

Q ss_pred             ceeeeccc-cccCCCccccccccccceeeeec-cccCCCCCcccccccCCCeeeCCCCcccCCCCcccccccccceEEcc
Q 002010          483 NILSLQNN-RLEGEIPVESFNLKMITSINISD-NNISGEIPYSISQCHSLTSVDLSRNSLYGKIPPGISKLIDLSILNLS  560 (982)
Q Consensus       483 ~~L~L~~N-~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls  560 (982)
                      ..++.+++ +|+ .+|. +..+++|++|+|++ |+|++..+..|.++++|+.|+|++|+|++..|..|.+|++|+.|+|+
T Consensus        11 ~~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~   88 (347)
T 2ifg_A           11 SGLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS   88 (347)
T ss_dssp             SCEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred             CEEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCC
Confidence            34677777 787 4777 88888888888885 88887777788888888888888888888778888888888888888


Q ss_pred             cccccccCccccccccccceecccCCccccCCCCC--ccccccccccccCCcCcccCCC
Q 002010          561 RNGITGSIPNEMRNMMSLTTLDLSYNNLIGNIPSG--GQFLAFNETSFIGNPNLCLLRN  617 (982)
Q Consensus       561 ~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~--~~~~~~~~~~~~~n~~~c~~~~  617 (982)
                      +|+|++..+..|..+. |+.|+|++|+|.....-.  .+|.......+..+...|..++
T Consensus        89 ~N~l~~~~~~~~~~~~-L~~l~l~~N~~~c~c~l~~~~~~~~~~~~~l~~~~~~C~~~~  146 (347)
T 2ifg_A           89 FNALESLSWKTVQGLS-LQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQG  146 (347)
T ss_dssp             SSCCSCCCSTTTCSCC-CCEEECCSSCCCCCGGGHHHHHHHHTTCSSCGGGCCCCSSSS
T ss_pred             CCccceeCHHHcccCC-ceEEEeeCCCccCCCccHHHHHHHHhCcccccccCCCCCCCh
Confidence            8888866666666665 888888888887653311  1122222223344556665543

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=99.21  E-value=4.4e-10  Score=127.03  Aligned_cols=310  Identities=14%  Similarity=0.124  Sum_probs=185.9

Q ss_pred             chhhcCCC-ccceeecccccCCCCCCccccCCCCCCEEEeeCCc---ccCcCchhhhcccchhhhhhccCCCCCCCCCcC
Q 002010          258 PTSLSRLK-LLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNY---LTGEIPESFAALKNLTLLQLFKNNLRGPIPSFL  333 (982)
Q Consensus       258 ~~~l~~l~-~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~---l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~  333 (982)
                      ..+|.+.+ .|+++.+..+ ++.+...+|.++++|+.+.++.|.   ++.....+|..+.+|+.+.+..+ ++......|
T Consensus        56 ~~aF~~~~~~L~sI~iP~s-vt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~I~~~aF  133 (394)
T 4gt6_A           56 DRVFCNYKYVLTSVQIPDT-VTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTEIDSEAF  133 (394)
T ss_dssp             TTTTTTCCSCCCEEEECTT-CCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSEECTTTT
T ss_pred             HhhccCCCCcCEEEEECCC-eeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cceehhhhh
Confidence            34455543 3666666533 444455566666666666666553   44444566666677776666544 443555667


Q ss_pred             CCCCCccEEEccCCCcccccCccccCCCcccEEEeccccccccCCccccCccccceeecccccccccCCccccCCCCCCE
Q 002010          334 GDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFIGPIPEELGQCKSLTK  413 (982)
Q Consensus       334 ~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~l~~N~~~~~~~~~l~~l~~L~~  413 (982)
                      ..+.+|+.+.+..+ +.......|..+.+|+.+.+..+ ++......| ...+|+.+.+..+- ......++..+.+++.
T Consensus       134 ~~c~~L~~i~lp~~-~~~I~~~~F~~c~~L~~i~~~~~-~~~I~~~aF-~~~~l~~i~ip~~~-~~i~~~af~~c~~l~~  209 (394)
T 4gt6_A          134 HHCEELDTVTIPEG-VTSVADGMFSYCYSLHTVTLPDS-VTAIEERAF-TGTALTQIHIPAKV-TRIGTNAFSECFALST  209 (394)
T ss_dssp             TTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEECCTT-CCEECTTTT-TTCCCSEEEECTTC-CEECTTTTTTCTTCCE
T ss_pred             hhhcccccccccce-eeeecccceecccccccccccce-eeEeccccc-cccceeEEEECCcc-cccccchhhhccccce
Confidence            77777777777543 33344556667777777777654 332333333 33567777775543 3345566777888887


Q ss_pred             EEccCCccCCCCCccccCCCccccccCCCccccccCCcccccCCccEEEeeccccCCCCchhccCCCCcceeeecccccc
Q 002010          414 IRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLSGELPEKMSGASLNQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLE  493 (982)
Q Consensus       414 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~  493 (982)
                      .....+... .+...+..-......         ..........+..+.+. +.++.....+|.++.+|+.+.+.++..+
T Consensus       210 ~~~~~~~~~-~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~ip-~~v~~i~~~aF~~c~~L~~i~lp~~~~~  278 (394)
T 4gt6_A          210 ITSDSESYP-AIDNVLYEKSANGDY---------ALIRYPSQREDPAFKIP-NGVARIETHAFDSCAYLASVKMPDSVVS  278 (394)
T ss_dssp             EEECCSSSC-BSSSCEEEECTTSCE---------EEEECCTTCCCSEEECC-TTEEEECTTTTTTCSSCCEEECCTTCCE
T ss_pred             ecccccccc-cccceeecccccccc---------cccccccccccceEEcC-CcceEcccceeeecccccEEecccccce
Confidence            776665543 121111110000000         00000011223333332 2334345567888888888888766543


Q ss_pred             CCCccccccccccceeeeeccccCCCCCcccccccCCCeeeCCCCcccCCCCcccccccccceEEcccccccccCccccc
Q 002010          494 GEIPVESFNLKMITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYGKIPPGISKLIDLSILNLSRNGITGSIPNEMR  573 (982)
Q Consensus       494 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~  573 (982)
                       .....|.+++.|+.+.+. +.++......|.++.+|+.++|..+ ++.+-..+|.++.+|+.+.|..+ ++.+-..+|.
T Consensus       279 -I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~I~~~aF~  354 (394)
T 4gt6_A          279 -IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VTKIPESAFS  354 (394)
T ss_dssp             -ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CCBCCGGGGT
T ss_pred             -ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cCEEhHhHhh
Confidence             445567778888888886 4566556677888888998888765 55455677888888998888654 6656667888


Q ss_pred             cccccceecccCCcc
Q 002010          574 NMMSLTTLDLSYNNL  588 (982)
Q Consensus       574 ~l~~L~~L~Ls~N~l  588 (982)
                      ++++|+.+++.+|..
T Consensus       355 ~C~~L~~i~~~~~~~  369 (394)
T 4gt6_A          355 NCTALNNIEYSGSRS  369 (394)
T ss_dssp             TCTTCCEEEESSCHH
T ss_pred             CCCCCCEEEECCcee
Confidence            888998888887754

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=99.18  E-value=3.6e-10  Score=127.74  Aligned_cols=309  Identities=11%  Similarity=0.081  Sum_probs=149.9

Q ss_pred             CCEEecccCcCcccCchhhcCCCccceeeccccc---CCCCCCccccCCCCCCEEEeeCCcccCcCchhhhcccchhhhh
Q 002010          243 LQVLDMASCNISGEIPTSLSRLKLLHSLFLQMNK---LTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQ  319 (982)
Q Consensus       243 L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~---l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~  319 (982)
                      |+.+.+..+ ++.....+|.++++|+.+.+..|.   ++.....+|.++.+|+.+.+..+ ++.....+|..+.+|+.+.
T Consensus        66 L~sI~iP~s-vt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~I~~~aF~~c~~L~~i~  143 (394)
T 4gt6_A           66 LTSVQIPDT-VTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTEIDSEAFHHCEELDTVT  143 (394)
T ss_dssp             CCEEEECTT-CCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSEECTTTTTTCTTCCEEE
T ss_pred             CEEEEECCC-eeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cceehhhhhhhhccccccc
Confidence            555555432 443444455555555555555442   33333344555555555544433 2323344455555555555


Q ss_pred             hccCCCCCCCCCcCCCCCCccEEEccCCCcccccCccccCCCcccEEEeccccccccCCccccCccccceeecccccccc
Q 002010          320 LFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFIG  399 (982)
Q Consensus       320 L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~l~~N~~~~  399 (982)
                      +..+ +.......|..+.+|+.+.+..+ ++.....+|. ..+|+.+.+..+-.. .....|..+.++.......+....
T Consensus       144 lp~~-~~~I~~~~F~~c~~L~~i~~~~~-~~~I~~~aF~-~~~l~~i~ip~~~~~-i~~~af~~c~~l~~~~~~~~~~~~  219 (394)
T 4gt6_A          144 IPEG-VTSVADGMFSYCYSLHTVTLPDS-VTAIEERAFT-GTALTQIHIPAKVTR-IGTNAFSECFALSTITSDSESYPA  219 (394)
T ss_dssp             CCTT-CCEECTTTTTTCTTCCEEECCTT-CCEECTTTTT-TCCCSEEEECTTCCE-ECTTTTTTCTTCCEEEECCSSSCB
T ss_pred             ccce-eeeecccceecccccccccccce-eeEecccccc-ccceeEEEECCcccc-cccchhhhccccceeccccccccc
Confidence            5432 22233445555555555555443 2222223332 244555555443222 333444455555554444333221


Q ss_pred             cCCcccc-------------CCCCCCEEEccCCccCCCCCccccCCCccccccCCCccccccCCcccccCCccEEEeecc
Q 002010          400 PIPEELG-------------QCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLSGELPEKMSGASLNQLKVANN  466 (982)
Q Consensus       400 ~~~~~l~-------------~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~L~~N  466 (982)
                      .....+.             ....+..+.+..+ ++..-...|.+.                       ..|+.+.+..+
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~-v~~i~~~aF~~c-----------------------~~L~~i~lp~~  275 (394)
T 4gt6_A          220 IDNVLYEKSANGDYALIRYPSQREDPAFKIPNG-VARIETHAFDSC-----------------------AYLASVKMPDS  275 (394)
T ss_dssp             SSSCEEEECTTSCEEEEECCTTCCCSEEECCTT-EEEECTTTTTTC-----------------------SSCCEEECCTT
T ss_pred             ccceeecccccccccccccccccccceEEcCCc-ceEcccceeeec-----------------------ccccEEecccc
Confidence            1111111             1112222222111 110111122222                       34555555443


Q ss_pred             ccCCCCchhccCCCCcceeeeccccccCCCccccccccccceeeeeccccCCCCCcccccccCCCeeeCCCCcccCCCCc
Q 002010          467 NITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYGKIPP  546 (982)
Q Consensus       467 ~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~  546 (982)
                      ..+ .....|.++++|+.+.+. +.++......|.++.+|+.++|.++ ++.+-...|.++++|+.+.+..+ ++..-..
T Consensus       276 ~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~I~~~  351 (394)
T 4gt6_A          276 VVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VTKIPES  351 (394)
T ss_dssp             CCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CCBCCGG
T ss_pred             cce-ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cCEEhHh
Confidence            332 455667777777777775 3454344455667778888888754 55455677888888888888655 5545567


Q ss_pred             ccccccccceEEcccccccccCccccccccccceecccCCcc
Q 002010          547 GISKLIDLSILNLSRNGITGSIPNEMRNMMSLTTLDLSYNNL  588 (982)
Q Consensus       547 ~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l  588 (982)
                      +|.++.+|+.+++.+|....   .++....+|+.+.+..|.+
T Consensus       352 aF~~C~~L~~i~~~~~~~~~---~~~~~~~~L~~i~i~~~~~  390 (394)
T 4gt6_A          352 AFSNCTALNNIEYSGSRSQW---NAISTDSGLQNLPVAPGSI  390 (394)
T ss_dssp             GGTTCTTCCEEEESSCHHHH---HTCBCCCCC----------
T ss_pred             HhhCCCCCCEEEECCceeeh---hhhhccCCCCEEEeCCCCE
Confidence            78888888888888876542   4567777888887766644

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.18  E-value=8.1e-11  Score=125.08  Aligned_cols=145  Identities=14%  Similarity=0.089  Sum_probs=112.9

Q ss_pred             HHHhhcccccccccccceEEEEEEeCCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCC-CCcccceEeEEEcCCccEEE
Q 002010          689 DVLESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIR-HRNIVRLLGYVSNRDTNLLL  767 (982)
Q Consensus       689 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv  767 (982)
                      ...+.|+.....+.|+.+.||++.. .+..+++|+...... .....+.+|+.+++.+. +..+.++++++...+..|+|
T Consensus        11 ~~l~~~~~~~~~~g~s~~~v~~~~~-~~~~~vlK~~~~~~~-~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv   88 (263)
T 3tm0_A           11 KLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYK-GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL   88 (263)
T ss_dssp             HHHTTSEEEECCSCCSSSEEEEEEC-SSCEEEEEEECGGGT-TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred             HHhccceeEeeccCCCCCeEEEEEC-CCCcEEEEeCCcccC-CCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence            3456687777888899999999976 468999998854321 22346889999999884 67788899999888889999


Q ss_pred             EeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC------------------------------------
Q 002010          768 YEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDC------------------------------------  811 (982)
Q Consensus       768 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~------------------------------------  811 (982)
                      |||++|.++.+.+.       +......++.+++++++.||+..                                    
T Consensus        89 ~e~i~G~~l~~~~~-------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (263)
T 3tm0_A           89 MSEADGVLCSEEYE-------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED  161 (263)
T ss_dssp             EECCSSEEHHHHCC-------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTT
T ss_pred             EEecCCeehhhccC-------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccc
Confidence            99999999988642       11223467889999999999810                                    


Q ss_pred             --------------------CCcEEecCCCCCcEEEcCCCCEEEeccccch
Q 002010          812 --------------------SPLIIHRDVKSNNILLDSDFEAHVADFGLAK  842 (982)
Q Consensus       812 --------------------~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~  842 (982)
                                          ...++|+|++|.||+++++..+.|+||+.+.
T Consensus       162 ~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             CSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             ccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                                1338999999999999876666799999775

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.01  E-value=4.7e-10  Score=119.00  Aligned_cols=136  Identities=17%  Similarity=0.104  Sum_probs=100.1

Q ss_pred             hcccccccccccceEEEEEEeCCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCc--ccceEeEEEcCCccEEEEec
Q 002010          693 SLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRN--IVRLLGYVSNRDTNLLLYEY  770 (982)
Q Consensus       693 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~~~~~~~~~~~lv~e~  770 (982)
                      .+......+.|..+.||++...+|..+++|.....    ....+.+|+.+++.+.+.+  +.+++++...++..++||||
T Consensus        21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~----~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~   96 (264)
T 1nd4_A           21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG----ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGE   96 (264)
T ss_dssp             TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEEC
T ss_pred             CCceEecccCCCCceEEEEecCCCCeEEEEeCCcc----cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEe
Confidence            34443333466679999998777888999987432    2345788999998885434  55688888877788999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC---------------------------------------
Q 002010          771 MPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDC---------------------------------------  811 (982)
Q Consensus       771 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---------------------------------------  811 (982)
                      ++|.++.  ..     ..+   ...++.++++.++.||+..                                       
T Consensus        97 i~G~~l~--~~-----~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (264)
T 1nd4_A           97 VPGQDLL--SS-----HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLA  166 (264)
T ss_dssp             CSSEETT--TS-----CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCC
T ss_pred             cCCcccC--cC-----cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCcc
Confidence            9998884  22     111   2356778888888888642                                       


Q ss_pred             ----------------CCcEEecCCCCCcEEEcCCCCEEEeccccch
Q 002010          812 ----------------SPLIIHRDVKSNNILLDSDFEAHVADFGLAK  842 (982)
Q Consensus       812 ----------------~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~  842 (982)
                                      ...++|+|++|.||++++++.+.|+|||.+.
T Consensus       167 ~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          167 PAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             HHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence                            1129999999999999877667799999875

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=98.96  E-value=3.5e-10  Score=124.85  Aligned_cols=163  Identities=13%  Similarity=0.155  Sum_probs=92.5

Q ss_pred             hhhhcCCCccEEeccCccccCCCchhccccccccEEeecCcccccccCCCcc--ccCcceEeeccC--cccccc-hhhHH
Q 002010          138 QIVRGMTELQVLDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSYS--EIQSLEYIGLNG--IGLNGT-VPAFL  212 (982)
Q Consensus       138 ~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~l~~L~~L~L~~--n~i~~~-~~~~l  212 (982)
                      .++..+++|+.|+|++|.-. .++. + .+++|++|+|..|.++......++  .+++|++|+|+.  |...+. ....+
T Consensus       166 ~ll~~~P~L~~L~L~g~~~l-~l~~-~-~~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l  242 (362)
T 2ra8_A          166 PVLDAMPLLNNLKIKGTNNL-SIGK-K-PRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVF  242 (362)
T ss_dssp             HHHHTCTTCCEEEEECCBTC-BCCS-C-BCTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGT
T ss_pred             HHHhcCCCCcEEEEeCCCCc-eecc-c-cCCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHH
Confidence            44556666777777665211 2232 3 266777777777766554444443  567777777642  111111 00011


Q ss_pred             hhhhhHHHHhhcccccccccCCCCCCCCCCCCEEecccCcCcccCchhhc---CCCccceeecccccCCCCCC----ccc
Q 002010          213 SRLKNLREMYIGYFNTYTGGIPPGFGALTQLQVLDMASCNISGEIPTSLS---RLKLLHSLFLQMNKLTGHIP----PQL  285 (982)
Q Consensus       213 ~~l~~L~~L~l~~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~---~l~~L~~L~L~~N~l~~~~~----~~l  285 (982)
                      .      .+           +  ....+++|++|+|++|.+++..+..+.   .+++|++|+|+.|.+++..+    ..+
T Consensus       243 ~------~~-----------l--~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L  303 (362)
T 2ra8_A          243 R------PL-----------F--SKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHV  303 (362)
T ss_dssp             G------GG-----------S--CTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTH
T ss_pred             H------HH-----------H--hcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhc
Confidence            0      00           0  013467888888888888754444443   46788888888888876432    233


Q ss_pred             cCCCCCCEEEeeCCcccCcCchhhhc-ccchhhhhhccCC
Q 002010          286 SGLISLKSLDLSLNYLTGEIPESFAA-LKNLTLLQLFKNN  324 (982)
Q Consensus       286 ~~l~~L~~L~Ls~N~l~~~~~~~l~~-l~~L~~L~L~~N~  324 (982)
                      ..+++|+.|+|++|.|+...-..+.. +  ...++++.++
T Consensus       304 ~~l~~L~~L~L~~n~i~d~~~~~l~~al--g~~~~~~~~~  341 (362)
T 2ra8_A          304 DKIKHLKFINMKYNYLSDEMKKELQKSL--PMKIDVSDSQ  341 (362)
T ss_dssp             HHHTTCSEEECCSBBCCHHHHHHHHHHC--CSEEECCSBC
T ss_pred             ccCCcceEEECCCCcCCHHHHHHHHHHc--CCEEEecCCc
Confidence            45688888888888877544333433 2  2446777666

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=98.95  E-value=1.8e-09  Score=120.36  Aligned_cols=142  Identities=13%  Similarity=0.174  Sum_probs=105.4

Q ss_pred             ccccccccceEEEEEEeCCCcEEEEEEec--cCCCCCchhhHHHHHHHHhcCC--CCcccceEeEEEcC---CccEEEEe
Q 002010          697 ENIIGKGGAGIVYRGSMPDGIDVAIKRLV--GRGTGGNDHGFLAEIQTLGRIR--HRNIVRLLGYVSNR---DTNLLLYE  769 (982)
Q Consensus       697 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~--~~~~~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~---~~~~lv~e  769 (982)
                      .+.++.|.++.||++... +..+++|+..  ..........+.+|+.+++.+.  +..+.++++++.+.   +..|+|||
T Consensus        43 ~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme  121 (359)
T 3dxp_A           43 VEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIME  121 (359)
T ss_dssp             EEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred             EEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEE
Confidence            456899999999999874 4688888764  2222223456888999999986  45678888888766   34799999


Q ss_pred             ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC--------------------------------------
Q 002010          770 YMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDC--------------------------------------  811 (982)
Q Consensus       770 ~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--------------------------------------  811 (982)
                      |++|.++.+..    ...++..++..++.+++++++.||+..                                      
T Consensus       122 ~v~G~~l~~~~----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  197 (359)
T 3dxp_A          122 FVSGRVLWDQS----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAM  197 (359)
T ss_dssp             CCCCBCCCCTT----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHH
T ss_pred             ecCCeecCCCc----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHH
Confidence            99998775421    234678888899999999999999731                                      


Q ss_pred             -----------------CCcEEecCCCCCcEEEcCCCC--EEEeccccchh
Q 002010          812 -----------------SPLIIHRDVKSNNILLDSDFE--AHVADFGLAKF  843 (982)
Q Consensus       812 -----------------~~~ivHrDlkp~Nill~~~~~--~kl~DfG~a~~  843 (982)
                                       ...++|||+++.||+++.++.  +.++||+.+..
T Consensus       198 ~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          198 DSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                             245999999999999987753  68999998864

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=98.94  E-value=3.1e-10  Score=125.30  Aligned_cols=162  Identities=17%  Similarity=0.140  Sum_probs=108.4

Q ss_pred             CCchhccccccccEEeecCcccccccCCCccccCcceEeeccCcccccchhhHHhhhhhHHHHhhcccccccccCCCCCC
Q 002010          159 PLPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLNGIGLNGTVPAFLSRLKNLREMYIGYFNTYTGGIPPGFG  238 (982)
Q Consensus       159 ~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~l~~~n~~~~~~p~~~~  238 (982)
                      .++..+..+++|++|+|++|.-. .++. +. +++|++|++..|.+.......+.                       ..
T Consensus       163 ~L~~ll~~~P~L~~L~L~g~~~l-~l~~-~~-~~~L~~L~L~~~~l~~~~l~~l~-----------------------~~  216 (362)
T 2ra8_A          163 DLSPVLDAMPLLNNLKIKGTNNL-SIGK-KP-RPNLKSLEIISGGLPDSVVEDIL-----------------------GS  216 (362)
T ss_dssp             BCHHHHHTCTTCCEEEEECCBTC-BCCS-CB-CTTCSEEEEECSBCCHHHHHHHH-----------------------HS
T ss_pred             CHHHHHhcCCCCcEEEEeCCCCc-eecc-cc-CCCCcEEEEecCCCChHHHHHHH-----------------------Hc
Confidence            45667788999999999988311 2333 43 88999999998887643333322                       11


Q ss_pred             CCCCCCEEeccc--CcCccc-----Cchhh--cCCCccceeecccccCCCCCCcccc---CCCCCCEEEeeCCcccCcC-
Q 002010          239 ALTQLQVLDMAS--CNISGE-----IPTSL--SRLKLLHSLFLQMNKLTGHIPPQLS---GLISLKSLDLSLNYLTGEI-  305 (982)
Q Consensus       239 ~l~~L~~L~L~~--n~l~~~-----~~~~l--~~l~~L~~L~L~~N~l~~~~~~~l~---~l~~L~~L~Ls~N~l~~~~-  305 (982)
                      .+++|+.|+|+.  |...+.     +...+  ..+++|++|+|++|.+.+..+..+.   .+++|++|+|+.|.+++.. 
T Consensus       217 ~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~  296 (362)
T 2ra8_A          217 DLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGA  296 (362)
T ss_dssp             BCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHH
T ss_pred             cCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHH
Confidence            456777777753  221111     11122  3578999999999998854433333   4789999999999998643 


Q ss_pred             ---chhhhcccchhhhhhccCCCCCCCCCcCCC-CCCccEEEccCCC
Q 002010          306 ---PESFAALKNLTLLQLFKNNLRGPIPSFLGD-FPNLEVLQVWGNN  348 (982)
Q Consensus       306 ---~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~-l~~L~~L~L~~N~  348 (982)
                         +..+..+++|+.|+|++|.|+...-..+.. +  ...+++++++
T Consensus       297 ~~L~~~L~~l~~L~~L~L~~n~i~d~~~~~l~~al--g~~~~~~~~~  341 (362)
T 2ra8_A          297 RLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKSL--PMKIDVSDSQ  341 (362)
T ss_dssp             HHHHTTHHHHTTCSEEECCSBBCCHHHHHHHHHHC--CSEEECCSBC
T ss_pred             HHHHhhcccCCcceEEECCCCcCCHHHHHHHHHHc--CCEEEecCCc
Confidence               344466789999999999988543333332 2  3568888887

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=98.91  E-value=3.8e-08  Score=110.45  Aligned_cols=108  Identities=16%  Similarity=0.186  Sum_probs=51.8

Q ss_pred             hhccCCCCcceeeeccccccCCCccccccccccceeeeeccccCCCCCcccccccCCCeeeCCCCcccCCCCcccccccc
Q 002010          474 AAIGNLPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYGKIPPGISKLID  553 (982)
Q Consensus       474 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~  553 (982)
                      ..|.++..|+.+.+..+ ++..-...+.++..|+.+.+..+ ++......|.++++|+.+.+.++.++..-..+|.++.+
T Consensus       234 ~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~  311 (379)
T 4h09_A          234 GAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVK  311 (379)
T ss_dssp             TTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTT
T ss_pred             ccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceeccccccccccccccccccccccceehhhhhcCCCC
Confidence            34444444554444433 32222333444445555555332 33233344555555555555555555444455555555


Q ss_pred             cceEEcccccccccCccccccccccceeccc
Q 002010          554 LSILNLSRNGITGSIPNEMRNMMSLTTLDLS  584 (982)
Q Consensus       554 L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls  584 (982)
                      |+.+.|..+ ++.+-..+|.++.+|+.+.+.
T Consensus       312 L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip  341 (379)
T 4h09_A          312 LSSVTLPTA-LKTIQVYAFKNCKALSTISYP  341 (379)
T ss_dssp             CCEEECCTT-CCEECTTTTTTCTTCCCCCCC
T ss_pred             CCEEEcCcc-ccEEHHHHhhCCCCCCEEEEC
Confidence            555555433 443344455556666555543

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.90  E-value=4e-11  Score=125.32  Aligned_cols=147  Identities=17%  Similarity=0.170  Sum_probs=98.4

Q ss_pred             CCccceeeeCCCC-CEEEEEecc---CCccccCCc-CccccccccEEEeccCCCCCCCC-hhhhhhcccce--eeccCCc
Q 002010           59 HCSFSGVTCDQDS-RVVSLNVSF---MPLFGSIPP-EIGLLTKLVNLTISNVNLTGRLP-SEMALLTSLKV--FNISGNV  130 (982)
Q Consensus        59 ~C~w~gv~C~~~~-~v~~l~l~~---~~l~g~~~~-~i~~l~~L~~L~l~~n~l~~~~p-~~l~~l~~L~~--L~Ls~n~  130 (982)
                      -|+|.|+.|+..+ +|+.+-..+   ..+.|.+++ .+..++.  .|..++|..++.+. +.+...+.|+.  ++++.|.
T Consensus        77 l~~~~g~i~~~~~~ki~~~v~~~~~~~~~~~~l~~~~~~~Lk~--~l~~ryn~~~~~LdLs~l~~dp~L~~~~l~l~~N~  154 (267)
T 3rw6_A           77 LKAVNYKILDRENRRISIIINSSAPPHTILNELKPEQVEQLKL--IMSKRYDGSQQALDLKGLRSDPDLVAQNIDVVLNR  154 (267)
T ss_dssp             HHHTTSSCBCTTSCBCCCEEEECCCCHHHHTSCCHHHHHHHHH--HHHHTEETTTTEEECTTGGGCHHHHHTTCCCCTTS
T ss_pred             HHhcCcEEECCCCCEEEEEEecCCCcccccccCCHHHHHHHHH--HHHhccchhccccCHHHcCCCcchhhcCccccCCH
Confidence            3899999998654 554443333   234455553 2344443  23334444444433 23666677776  7788885


Q ss_pred             cccc--cchhhhhcCCCccEEeccCccccC--CCchhccccccccEEeecCcccccccCCCccccC--cceEeeccCccc
Q 002010          131 FQGN--FAGQIVRGMTELQVLDAYNNNFTG--PLPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQ--SLEYIGLNGIGL  204 (982)
Q Consensus       131 l~~~--~~~~~~~~l~~L~~L~Ls~n~l~~--~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~--~L~~L~L~~n~i  204 (982)
                      ....  ....+..++++|++|+|++|+|++  .+|..+..+++|+.|+|++|+|++.  ..+..++  +|++|+|++|.+
T Consensus       155 ~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl  232 (267)
T 3rw6_A          155 RSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSL  232 (267)
T ss_dssp             HHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTT
T ss_pred             HHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcC
Confidence            4311  112233579999999999999997  5667888999999999999999976  3344454  999999999999


Q ss_pred             ccchh
Q 002010          205 NGTVP  209 (982)
Q Consensus       205 ~~~~~  209 (982)
                      .+..|
T Consensus       233 ~~~~~  237 (267)
T 3rw6_A          233 CDTFR  237 (267)
T ss_dssp             GGGCS
T ss_pred             ccccC
Confidence            87654

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=98.82  E-value=8.1e-08  Score=107.77  Aligned_cols=303  Identities=12%  Similarity=0.057  Sum_probs=188.3

Q ss_pred             hhcCCCccceeecccccCCCCCCccccCCCCCCEEEeeCCcccCcCchhhhcccchhhhhhccCCCCCCCCCcCCCCCCc
Q 002010          260 SLSRLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQLFKNNLRGPIPSFLGDFPNL  339 (982)
Q Consensus       260 ~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L  339 (982)
                      ++....+|+++.+.. .++.+...+|.++.+|+.++|..+ ++.....+|.+. +|+.+.+..+ +.......|.. .+|
T Consensus        41 ~~~~~~~i~~v~ip~-~vt~Ig~~aF~~C~~L~~I~lp~~-v~~Ig~~aF~~c-~l~~i~~~~~-l~~I~~~aF~~-~~L  115 (379)
T 4h09_A           41 WYKDRDRISEVRVNS-GITSIGEANFNSCYNMTKVTVAST-VTSIGDGAFADT-KLQSYTGMER-VKKFGDYVFQG-TDL  115 (379)
T ss_dssp             TGGGGGGCSEEEECT-TEEEECTTTTTTCTTCCEEEECTT-CCEECTTTTTTC-CCCEEEECTT-CCEECTTTTTT-CCC
T ss_pred             ccccccCCEEEEeCC-CccChHHHHhhCCCCCCEEEeCCc-ceEechhhhcCC-CCceEECCce-eeEeccceecc-CCc
Confidence            466677899888874 466566778999999999999765 665667778776 5666666533 55344455655 478


Q ss_pred             cEEEccCCCcccccCccccCCCcccEEEeccccccccCCccccCccccceeecccccccc------------cCCccccC
Q 002010          340 EVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFIG------------PIPEELGQ  407 (982)
Q Consensus       340 ~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~l~~N~~~~------------~~~~~l~~  407 (982)
                      +.+.+..+- +......|.. .+|+.+.+..+ ++......|..+.+++...+..+....            .....+..
T Consensus       116 ~~i~lp~~~-~~i~~~~F~~-~~l~~~~~~~~-v~~i~~~~f~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (379)
T 4h09_A          116 DDFEFPGAT-TEIGNYIFYN-SSVKRIVIPKS-VTTIKDGIGYKAENLEKIEVSSNNKNYVAENYVLYNKNKTILESYPA  192 (379)
T ss_dssp             SEEECCTTC-CEECTTTTTT-CCCCEEEECTT-CCEECSCTTTTCTTCCEEEECTTCSSEEEETTEEEETTSSEEEECCT
T ss_pred             ccccCCCcc-cccccccccc-ceeeeeeccce-eeccccchhcccccccccccccccceeecccceecccccceeccccc
Confidence            888887653 3233334443 35666655543 333445566666777766665433211            11223344


Q ss_pred             CCCCCEEEccCCccCCCCCccccCCCccccccCCCccccccCCcccc-cCCccEEEeeccccCCCCchhccCCCCcceee
Q 002010          408 CKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLSGELPEKMS-GASLNQLKVANNNITGKIPAAIGNLPSLNILS  486 (982)
Q Consensus       408 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~-~~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~  486 (982)
                      +..+..+.+..+.-. .....+.....|+.+.+..+ +.......+. ...|+.+.+..+ ++.....+|.++.+|+.+.
T Consensus       193 ~~~~~~~~~~~~~~~-i~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~  269 (379)
T 4h09_A          193 AKTGTEFTIPSTVKT-VTAYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLN  269 (379)
T ss_dssp             TCCCSEEECCTTCCE-ECTTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEE
T ss_pred             cccccccccccceeE-Eeecccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcccc
Confidence            555555555443322 33445555666666666554 2222233333 356777777665 5556666777888888888


Q ss_pred             eccccccCCCccccccccccceeeeeccccCCCCCcccccccCCCeeeCCCCcccCCCCcccccccccceEEcccccccc
Q 002010          487 LQNNRLEGEIPVESFNLKMITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYGKIPPGISKLIDLSILNLSRNGITG  566 (982)
Q Consensus       487 L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~  566 (982)
                      +..+ ++......|.++.+|+.+++.++.++.+-...|.++.+|+.++|..+ ++.+-..+|.++.+|+.+.+..+ ++.
T Consensus       270 l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~~-v~~  346 (379)
T 4h09_A          270 FYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYPKS-ITL  346 (379)
T ss_dssp             ECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCCTT-CCE
T ss_pred             cccc-ceeccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECCc-cCE
Confidence            7654 44334455677788888888887777666677888888888888654 55455667888888888877654 554


Q ss_pred             cCcccccccc
Q 002010          567 SIPNEMRNMM  576 (982)
Q Consensus       567 ~~p~~l~~l~  576 (982)
                      +-..+|.++.
T Consensus       347 I~~~aF~~c~  356 (379)
T 4h09_A          347 IESGAFEGSS  356 (379)
T ss_dssp             ECTTTTTTSS
T ss_pred             EchhHhhCCC
Confidence            4455666553

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.75  E-value=3.1e-09  Score=115.41  Aligned_cols=186  Identities=21%  Similarity=0.213  Sum_probs=119.9

Q ss_pred             ccccccccceEEEEEEeCCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCC-CCc--ccceEeEEEcCC---ccEEEEec
Q 002010          697 ENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIR-HRN--IVRLLGYVSNRD---TNLLLYEY  770 (982)
Q Consensus       697 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~n--iv~~~~~~~~~~---~~~lv~e~  770 (982)
                      .+.++.|....||++.    ..+++|.....   .....+.+|+.+++.+. +..  +.+++.......   ..|+|||+
T Consensus        25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~---~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~   97 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----RDFIFKFPKHS---RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTK   97 (304)
T ss_dssp             CCEEEECSSEEEEEST----TSEEEEEESSH---HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEEC
T ss_pred             eEecCCCCcceEEEEC----CEEEEEecCCc---chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcc
Confidence            3468999999999874    46889975321   23456889999998873 322  334444433332   34889999


Q ss_pred             cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC---------------------------------------
Q 002010          771 MPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDC---------------------------------------  811 (982)
Q Consensus       771 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---------------------------------------  811 (982)
                      ++|.++.+...    ..++.+++..++.++++.++.||+..                                       
T Consensus        98 i~G~~l~~~~~----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  173 (304)
T 3sg8_A           98 IKGVPLTPLLL----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV  173 (304)
T ss_dssp             CCCEECCHHHH----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred             cCCeECCcccc----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence            99988865332    24677778888888888888888611                                       


Q ss_pred             ----------------CCcEEecCCCCCcEEEcC--CCCEEEeccccchhccccCCccccc-cc---cc---------cc
Q 002010          812 ----------------SPLIIHRDVKSNNILLDS--DFEAHVADFGLAKFLQDAGASECMS-SV---AG---------SY  860 (982)
Q Consensus       812 ----------------~~~ivHrDlkp~Nill~~--~~~~kl~DfG~a~~~~~~~~~~~~~-~~---~g---------t~  860 (982)
                                      ...++|+|++|.||++++  ...+.++||+.+..-... ..-... ..   .+         ..
T Consensus       174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~-~Dl~~~~~~~~~~~~~~~~~~l~~Y  252 (304)
T 3sg8_A          174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPD-NDFISLMEDDEEYGMEFVSKILNHY  252 (304)
T ss_dssp             HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTT-HHHHTTCCTTTSCCHHHHHHHHHHH
T ss_pred             HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChH-HHHHHHHhhccccCHHHHHHHHHHc
Confidence                            134899999999999998  456889999988643211 000000 00   00         00


Q ss_pred             cccc-ccccccCCCCcchhhHHHHHHHHHHHhCCCCC
Q 002010          861 GYIA-PEYAYTLKVDEKSDVYSFGVVLLELIAGKKPV  896 (982)
Q Consensus       861 ~y~a-PE~~~~~~~~~~~DvwslG~il~elltg~~p~  896 (982)
                      .... |+....  .....+.|+++.++|.+.+|+.+|
T Consensus       253 ~~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          253 KHKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             TCSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             CCCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHH
Confidence            1111 221111  122368999999999999998876

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.54  E-value=1.3e-08  Score=106.27  Aligned_cols=105  Identities=21%  Similarity=0.300  Sum_probs=60.4

Q ss_pred             ccCCCCcce--eeecccccc---CCCccccccccccceeeeeccccCC--CCCcccccccCCCeeeCCCCcccCCCCccc
Q 002010          476 IGNLPSLNI--LSLQNNRLE---GEIPVESFNLKMITSINISDNNISG--EIPYSISQCHSLTSVDLSRNSLYGKIPPGI  548 (982)
Q Consensus       476 ~~~l~~L~~--L~L~~N~l~---~~~p~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~  548 (982)
                      +...+.|+.  ++++.|+..   +.++....++++|++|+||+|+|++  .+|..+..+++|+.|+|++|+|++.  ..+
T Consensus       137 l~~dp~L~~~~l~l~~N~~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l  214 (267)
T 3rw6_A          137 LRSDPDLVAQNIDVVLNRRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--REL  214 (267)
T ss_dssp             GGGCHHHHHTTCCCCTTSHHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGG
T ss_pred             cCCCcchhhcCccccCCHHHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhh
Confidence            333444444  556666432   1111122346667777777777765  3345566677777777777777654  334


Q ss_pred             cccc--ccceEEcccccccccCcc-------ccccccccceec
Q 002010          549 SKLI--DLSILNLSRNGITGSIPN-------EMRNMMSLTTLD  582 (982)
Q Consensus       549 ~~l~--~L~~L~Ls~N~l~~~~p~-------~l~~l~~L~~L~  582 (982)
                      ..+.  +|++|+|++|.+++.+|.       .+..+++|+.||
T Consensus       215 ~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~~il~~~P~L~~LD  257 (267)
T 3rw6_A          215 DKIKGLKLEELWLDGNSLCDTFRDQSTYISAIRERFPKLLRLD  257 (267)
T ss_dssp             GGGTTSCCSEEECTTSTTGGGCSSHHHHHHHHHHHCTTCCEES
T ss_pred             hhcccCCcceEEccCCcCccccCcchhHHHHHHHHCcccCeEC
Confidence            4444  677777777777665542       355666776665

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=98.49  E-value=1.4e-08  Score=100.98  Aligned_cols=121  Identities=16%  Similarity=0.156  Sum_probs=92.4

Q ss_pred             CCcCccccccccEEEeccC-CCCCC----CChhhhhhcccceeeccCCcccccc---chhhhhcCCCccEEeccCccccC
Q 002010           87 IPPEIGLLTKLVNLTISNV-NLTGR----LPSEMALLTSLKVFNISGNVFQGNF---AGQIVRGMTELQVLDAYNNNFTG  158 (982)
Q Consensus        87 ~~~~i~~l~~L~~L~l~~n-~l~~~----~p~~l~~l~~L~~L~Ls~n~l~~~~---~~~~~~~l~~L~~L~Ls~n~l~~  158 (982)
                      +...+...+.|++|+|++| +++..    +...+...++|++|+|++|.+....   ..+.+...+.|++|+|++|.|+.
T Consensus        28 l~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~  107 (185)
T 1io0_A           28 LKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISG  107 (185)
T ss_dssp             HHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCH
T ss_pred             HHHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCH
Confidence            3344666788999999999 88754    3344556689999999999987532   23445567899999999999986


Q ss_pred             C----CchhccccccccEEee--cCcccccccC----CCccccCcceEeeccCcccccc
Q 002010          159 P----LPVEIASLKSLRHLSF--GGNYFTGKIP----QSYSEIQSLEYIGLNGIGLNGT  207 (982)
Q Consensus       159 ~----~p~~l~~l~~L~~L~L--~~N~l~~~~p----~~~~~l~~L~~L~L~~n~i~~~  207 (982)
                      .    +...+...++|++|+|  ++|.|+....    ..+...++|++|+|++|.++..
T Consensus       108 ~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~~~  166 (185)
T 1io0_A          108 SGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQGPR  166 (185)
T ss_dssp             HHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHHHH
T ss_pred             HHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCChH
Confidence            4    4566777889999999  8899987644    3445568999999999988743

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=98.47  E-value=4.6e-08  Score=97.30  Aligned_cols=124  Identities=13%  Similarity=0.128  Sum_probs=93.7

Q ss_pred             CChhhhhhcccceeeccCC-cccccc---chhhhhcCCCccEEeccCccccCC----CchhccccccccEEeecCccccc
Q 002010          111 LPSEMALLTSLKVFNISGN-VFQGNF---AGQIVRGMTELQVLDAYNNNFTGP----LPVEIASLKSLRHLSFGGNYFTG  182 (982)
Q Consensus       111 ~p~~l~~l~~L~~L~Ls~n-~l~~~~---~~~~~~~l~~L~~L~Ls~n~l~~~----~p~~l~~l~~L~~L~L~~N~l~~  182 (982)
                      +...+...++|++|+|++| .+....   ....+...++|++|+|++|+|+..    +...+...++|++|+|++|.|+.
T Consensus        28 l~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~  107 (185)
T 1io0_A           28 LKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISG  107 (185)
T ss_dssp             HHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCH
T ss_pred             HHHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCH
Confidence            3455677899999999999 886432   234456678999999999999854    34445566899999999999987


Q ss_pred             c----cCCCccccCcceEeec--cCcccccchhhHHhhhhhHHHHhhcccccccccCCCCCCCCCCCCEEecccCcCcc
Q 002010          183 K----IPQSYSEIQSLEYIGL--NGIGLNGTVPAFLSRLKNLREMYIGYFNTYTGGIPPGFGALTQLQVLDMASCNISG  255 (982)
Q Consensus       183 ~----~p~~~~~l~~L~~L~L--~~n~i~~~~~~~l~~l~~L~~L~l~~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~  255 (982)
                      .    +...+...++|++|+|  ++|.++......+...                     +...++|++|+|++|.+..
T Consensus       108 ~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~---------------------L~~n~~L~~L~L~~n~i~~  165 (185)
T 1io0_A          108 SGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANM---------------------LEKNTTLLKFGYHFTQQGP  165 (185)
T ss_dssp             HHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHH---------------------HHHCSSCCEEECCCSSHHH
T ss_pred             HHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHH---------------------HHhCCCcCEEeccCCCCCh
Confidence            5    3566777889999999  8899986655544432                     2234679999999998863

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.19  E-value=4.1e-06  Score=88.89  Aligned_cols=133  Identities=18%  Similarity=0.190  Sum_probs=94.7

Q ss_pred             cccccce-EEEEEEeC-CCcEEEEEEeccCCCCCchhhHHHHHHHHhcCC-CCcccceEeEEEcCCccEEEEeccCCCCH
Q 002010          700 IGKGGAG-IVYRGSMP-DGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIR-HRNIVRLLGYVSNRDTNLLLYEYMPNGSL  776 (982)
Q Consensus       700 lg~G~~g-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~~sL  776 (982)
                      +..|..+ .||+.... ++..+++|+...    .....+.+|...++.+. +--+-++++++.+++..++|||+++|.++
T Consensus        32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~----~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~  107 (272)
T 4gkh_A           32 DNVGQSGATIYRLYGKPNAPELFLKHGKG----SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA  107 (272)
T ss_dssp             EECSSSSCEEEEEECCTTCCCEEEEEEET----HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred             ccCCCcCCeEEEEEecCCCeEEEEEECCC----CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence            4455554 69988654 467899997632    23456788999988874 32366788888888899999999999888


Q ss_pred             HHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC---------------------------------------------
Q 002010          777 GEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDC---------------------------------------------  811 (982)
Q Consensus       777 ~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---------------------------------------------  811 (982)
                      .+.....      ......+..+++..++.||...                                             
T Consensus       108 ~~~~~~~------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  181 (272)
T 4gkh_A          108 FQVLEEY------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK  181 (272)
T ss_dssp             HHHHHHC------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHH
T ss_pred             cccccCC------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHH
Confidence            7765321      1223345566666666666421                                             


Q ss_pred             ----------CCcEEecCCCCCcEEEcCCCCEEEeccccch
Q 002010          812 ----------SPLIIHRDVKSNNILLDSDFEAHVADFGLAK  842 (982)
Q Consensus       812 ----------~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~  842 (982)
                                ...++|+|+++.||++++++.+-|+||+.+.
T Consensus       182 ~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~  222 (272)
T 4gkh_A          182 EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG  222 (272)
T ss_dssp             HHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence                      1237899999999999987777899999875

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.14  E-value=7.9e-06  Score=88.29  Aligned_cols=136  Identities=21%  Similarity=0.171  Sum_probs=94.2

Q ss_pred             ccccccccceEEEEEEeCCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCC---cccceEeEEE-cCCccEEEEeccC
Q 002010          697 ENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHR---NIVRLLGYVS-NRDTNLLLYEYMP  772 (982)
Q Consensus       697 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~~~~~~~-~~~~~~lv~e~~~  772 (982)
                      .+.++.|....||+.    +..+++|+..   .......+.+|+.+++.+.+.   .+.+++.+.. ..+..++||||++
T Consensus        24 v~~l~~G~~n~v~~v----g~~~VlR~~~---~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~   96 (306)
T 3tdw_A           24 VESLGEGFRNYAILV----NGDWVFRFPK---SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQ   96 (306)
T ss_dssp             EEEEEECSSEEEEEE----TTTEEEEEES---SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCC
T ss_pred             eeecCCCcceeEEEE----CCEEEEEecC---CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccC
Confidence            346788888999988    5678898742   122345688999999998642   3556666664 3455789999999


Q ss_pred             CCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC-----------------------------------------
Q 002010          773 NGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDC-----------------------------------------  811 (982)
Q Consensus       773 ~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-----------------------------------------  811 (982)
                      |.++.+...    ..++..+...++.++++.++.||+..                                         
T Consensus        97 G~~l~~~~~----~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l  172 (306)
T 3tdw_A           97 GQILGEDGM----AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL  172 (306)
T ss_dssp             SEECHHHHH----TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred             CeECchhhh----hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence            988876322    12345555556666666666655421                                         


Q ss_pred             ----------------CCcEEecCCCCCcEEEcC---CCC-EEEeccccchh
Q 002010          812 ----------------SPLIIHRDVKSNNILLDS---DFE-AHVADFGLAKF  843 (982)
Q Consensus       812 ----------------~~~ivHrDlkp~Nill~~---~~~-~kl~DfG~a~~  843 (982)
                                      ...++|+|++|.||+++.   ++. +.|+||+.+..
T Consensus       173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                            224799999999999987   455 48999998764

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.11  E-value=6.6e-06  Score=91.20  Aligned_cols=82  Identities=7%  Similarity=-0.032  Sum_probs=55.9

Q ss_pred             cccc-ccccceEEEEEEeC-------CCcEEEEEEeccCC--CCCchhhHHHHHHHHhcCC-C--CcccceEeEEEcC--
Q 002010          697 ENII-GKGGAGIVYRGSMP-------DGIDVAIKRLVGRG--TGGNDHGFLAEIQTLGRIR-H--RNIVRLLGYVSNR--  761 (982)
Q Consensus       697 ~~~l-g~G~~g~Vy~~~~~-------~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-h--~niv~~~~~~~~~--  761 (982)
                      .+.| +.|....+|+....       ++..+++|......  .......+.+|+.+++.+. +  -.+.+++.+..+.  
T Consensus        25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~  104 (357)
T 3ats_A           25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV  104 (357)
T ss_dssp             EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred             EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence            3467 88889999998654       26788998763321  0112346778999988884 2  3466778776554  


Q ss_pred             -CccEEEEeccCCCCHHH
Q 002010          762 -DTNLLLYEYMPNGSLGE  778 (982)
Q Consensus       762 -~~~~lv~e~~~~~sL~~  778 (982)
                       ...++||||++|.++.+
T Consensus       105 ~g~~~~v~e~l~G~~l~~  122 (357)
T 3ats_A          105 LGTPFFLMDYVEGVVPPD  122 (357)
T ss_dssp             TSSCEEEEECCCCBCCCB
T ss_pred             cCCceEEEEecCCCChhh
Confidence             35689999999876653

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.88  E-value=5.5e-05  Score=85.04  Aligned_cols=76  Identities=17%  Similarity=0.103  Sum_probs=49.8

Q ss_pred             ccccccccceEEEEEEeC-CCcEEEEEEeccCCC------CCchhhHHHHHHHHhcCCC--Cccc-ceEeEEEcCCccEE
Q 002010          697 ENIIGKGGAGIVYRGSMP-DGIDVAIKRLVGRGT------GGNDHGFLAEIQTLGRIRH--RNIV-RLLGYVSNRDTNLL  766 (982)
Q Consensus       697 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~~E~~~l~~l~h--~niv-~~~~~~~~~~~~~l  766 (982)
                      .+.+|.|..+.||++... +++.|++|.......      ......+..|+++++.+..  |..+ +++.+  +.+..++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            346899999999999653 468899998643221      1233456789888887732  4444 45543  3456789


Q ss_pred             EEeccCCC
Q 002010          767 LYEYMPNG  774 (982)
Q Consensus       767 v~e~~~~~  774 (982)
                      ||||+++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999764

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=97.84  E-value=9.1e-06  Score=78.47  Aligned_cols=84  Identities=13%  Similarity=0.091  Sum_probs=45.1

Q ss_pred             cccEEEeccCCCCCCCChhhhhhcccceeeccCCccccccchhhhhcCCCccEEeccCccccCCCchhcccc----cccc
Q 002010           96 KLVNLTISNVNLTGRLPSEMALLTSLKVFNISGNVFQGNFAGQIVRGMTELQVLDAYNNNFTGPLPVEIASL----KSLR  171 (982)
Q Consensus        96 ~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l----~~L~  171 (982)
                      +|++||++++.++...-..+..+++|++|+|++|.                        ++++..-..++.+    ++|+
T Consensus        62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~------------------------~ItD~gL~~L~~~~~~~~~L~  117 (176)
T 3e4g_A           62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCH------------------------YIEDGCLERLSQLENLQKSML  117 (176)
T ss_dssp             CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCT------------------------TCCHHHHHHHHTCHHHHHHCC
T ss_pred             eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCC------------------------ccCHHHHHHHHhcccccCCCC
Confidence            57777777777765554555555566666665553                        1332222333332    2455


Q ss_pred             EEeecCcc-cccccCCCccccCcceEeeccCcc
Q 002010          172 HLSFGGNY-FTGKIPQSYSEIQSLEYIGLNGIG  203 (982)
Q Consensus       172 ~L~L~~N~-l~~~~p~~~~~l~~L~~L~L~~n~  203 (982)
                      +|+|++|. ||+..-..+.++++|++|++++|.
T Consensus       118 ~L~Ls~C~~ITD~Gl~~L~~~~~L~~L~L~~c~  150 (176)
T 3e4g_A          118 EMEIISCGNVTDKGIIALHHFRNLKYLFLSDLP  150 (176)
T ss_dssp             EEEEESCTTCCHHHHHHGGGCTTCCEEEEESCT
T ss_pred             EEEcCCCCcCCHHHHHHHhcCCCCCEEECCCCC
Confidence            55555552 555444455555555555555553

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=97.77  E-value=4.7e-06  Score=80.45  Aligned_cols=87  Identities=18%  Similarity=0.219  Sum_probs=44.9

Q ss_pred             cccEEeecCcccccccCCCccccCcceEeeccCcc-cccchhhHHhhhhhHHHHhhcccccccccCCCCCCCCCCCCEEe
Q 002010          169 SLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLNGIG-LNGTVPAFLSRLKNLREMYIGYFNTYTGGIPPGFGALTQLQVLD  247 (982)
Q Consensus       169 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~-i~~~~~~~l~~l~~L~~L~l~~~n~~~~~~p~~~~~l~~L~~L~  247 (982)
                      +|++|||+++.|+...-..+..+++|++|+|++|. +++..-..++.+++.                     .++|++|+
T Consensus        62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~---------------------~~~L~~L~  120 (176)
T 3e4g_A           62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENL---------------------QKSMLEME  120 (176)
T ss_dssp             CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHH---------------------HHHCCEEE
T ss_pred             eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccc---------------------cCCCCEEE
Confidence            46666666666655555555566666666666653 443333333322100                     12455566


Q ss_pred             cccCc-CcccCchhhcCCCccceeeccccc
Q 002010          248 MASCN-ISGEIPTSLSRLKLLHSLFLQMNK  276 (982)
Q Consensus       248 L~~n~-l~~~~~~~l~~l~~L~~L~L~~N~  276 (982)
                      |++|. |++..-..+.++++|++|+|+++.
T Consensus       121 Ls~C~~ITD~Gl~~L~~~~~L~~L~L~~c~  150 (176)
T 3e4g_A          121 IISCGNVTDKGIIALHHFRNLKYLFLSDLP  150 (176)
T ss_dssp             EESCTTCCHHHHHHGGGCTTCCEEEEESCT
T ss_pred             cCCCCcCCHHHHHHHhcCCCCCEEECCCCC
Confidence            66553 554444445556666666666553

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.67  E-value=0.00013  Score=80.18  Aligned_cols=139  Identities=17%  Similarity=0.254  Sum_probs=78.5

Q ss_pred             cccccccceEEEEEEeCCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCC-----CCcccceE-e--EEEcCCccEEEEe
Q 002010          698 NIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIR-----HRNIVRLL-G--YVSNRDTNLLLYE  769 (982)
Q Consensus       698 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~~~-~--~~~~~~~~~lv~e  769 (982)
                      +.++.|..+.||++...+| .+++|+...     .......|+.+++.+.     .|.++... |  +....+..+++||
T Consensus        38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~-----~~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~  111 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTDSG-AVCLKRIHR-----PEKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD  111 (346)
T ss_dssp             EECC----CEEEEEEETTE-EEEEEEECS-----CHHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred             eeccccccCcEEEEEeCCC-CEEEEecCC-----CHHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence            3566677899999987554 589998743     1233445556555552     34443311 1  1234566789999


Q ss_pred             ccCCCCHH--------------HHhhc--CC---C-------CCCCHHHH------------------------------
Q 002010          770 YMPNGSLG--------------EMLHG--AK---G-------GHLKWETR------------------------------  793 (982)
Q Consensus       770 ~~~~~sL~--------------~~l~~--~~---~-------~~l~~~~~------------------------------  793 (982)
                      |++|.++.              ..+|.  ..   .       ....|...                              
T Consensus       112 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  191 (346)
T 2q83_A          112 WIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQE  191 (346)
T ss_dssp             CCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHH
T ss_pred             eecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHH
Confidence            99986542              11121  00   0       01122211                              


Q ss_pred             -HHHHHHHHHHHHHHhh--------c--CCCcEEecCCCCCcEEEcCCCCEEEeccccch
Q 002010          794 -YRIALEAAKGLCYLHH--------D--CSPLIIHRDVKSNNILLDSDFEAHVADFGLAK  842 (982)
Q Consensus       794 -~~i~~~i~~~l~~LH~--------~--~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~  842 (982)
                       ..+..++..++++|++        .  ....++|+|+++.||+++.++.+.++||+.+.
T Consensus       192 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          192 IDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             HHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence             1112234445666653        1  13459999999999999888899999999774

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.65  E-value=0.00025  Score=76.13  Aligned_cols=137  Identities=19%  Similarity=0.193  Sum_probs=91.3

Q ss_pred             ccccccccceEEEEEEeCCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCC---CCcccceEeEEEcCCccEEEEeccCC
Q 002010          697 ENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIR---HRNIVRLLGYVSNRDTNLLLYEYMPN  773 (982)
Q Consensus       697 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e~~~~  773 (982)
                      .+.++.|....+|+... ++..+++|+....    ....+..|+..++.+.   ...+.+++++....+..++||||+++
T Consensus        41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G  115 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLIND-EVQTVFVKINERS----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK  115 (312)
T ss_dssp             EEEECCSSSSEEEEEES-SSCEEEEEEEEGG----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred             eEEeCCccceeeeEEEE-CCCeEEEEeCCcc----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence            45689999999999986 5778999976432    3556888999988883   36688888888888889999999998


Q ss_pred             CCHH--------H---HhhcCCC-C-------------------CCCHHHHH---HHH----------------HHHHHH
Q 002010          774 GSLG--------E---MLHGAKG-G-------------------HLKWETRY---RIA----------------LEAAKG  803 (982)
Q Consensus       774 ~sL~--------~---~l~~~~~-~-------------------~l~~~~~~---~i~----------------~~i~~~  803 (982)
                      ..+.        +   .+|.... .                   .-+|....   ++.                ..++..
T Consensus       116 ~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~  195 (312)
T 3jr1_A          116 SKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQI  195 (312)
T ss_dssp             CCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHH
T ss_pred             CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHH
Confidence            7542        1   2232211 0                   12454321   111                111111


Q ss_pred             -HHHHhh-cCCCcEEecCCCCCcEEEcCCCCEEEeccc
Q 002010          804 -LCYLHH-DCSPLIIHRDVKSNNILLDSDFEAHVADFG  839 (982)
Q Consensus       804 -l~~LH~-~~~~~ivHrDlkp~Nill~~~~~~kl~DfG  839 (982)
                       ...|.. ...+.++|+|+.+.|++++.++ +.++|++
T Consensus       196 l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          196 VADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence             123321 1235599999999999999887 8899984

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.64  E-value=0.00022  Score=76.06  Aligned_cols=77  Identities=21%  Similarity=0.264  Sum_probs=55.1

Q ss_pred             cccccccccccceEEEEEEeCCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCC---CcccceEeEEEcCCccEEEEec
Q 002010          694 LKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRH---RNIVRLLGYVSNRDTNLLLYEY  770 (982)
Q Consensus       694 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~~~~~~~~~~~~~lv~e~  770 (982)
                      ....+.+|.|..+.||+.+..+|+.|++|+.... .......+.+|+..|+.+..   --+.+++++    +..++||||
T Consensus        17 v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~-~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~e~   91 (288)
T 3f7w_A           17 VAAVAERGHSHRWHLYRVELADGTPLFVKALPDD-APALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAMEW   91 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTSCEEEEEECCTT-CCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEEEC
T ss_pred             eEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCC-CcchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEEEe
Confidence            3445678999999999999999999999976433 33334567889999888742   224445543    245889999


Q ss_pred             cCCCC
Q 002010          771 MPNGS  775 (982)
Q Consensus       771 ~~~~s  775 (982)
                      ++++.
T Consensus        92 l~~~~   96 (288)
T 3f7w_A           92 VDERP   96 (288)
T ss_dssp             CCCCC
T ss_pred             ecccC
Confidence            98764

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.49  E-value=0.00061  Score=77.04  Aligned_cols=76  Identities=13%  Similarity=0.126  Sum_probs=47.0

Q ss_pred             CcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCcccccccc--cccccccccccccC---CCCcchhhHHHHHHHH
Q 002010          813 PLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVA--GSYGYIAPEYAYTL---KVDEKSDVYSFGVVLL  887 (982)
Q Consensus       813 ~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~---~~~~~~DvwslG~il~  887 (982)
                      ..++|+|++|.||+++.++ ++++||+.+..-... . . .....  -...|++|+.....   ......++......+|
T Consensus       232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~-~-D-la~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (420)
T 2pyw_A          232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMG-F-D-IGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTW  307 (420)
T ss_dssp             CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHH-H-H-HHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHH
T ss_pred             CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchH-H-H-HHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHH
Confidence            4499999999999998776 999999988643211 0 0 00001  12346666654321   1123455667788888


Q ss_pred             HHHhC
Q 002010          888 ELIAG  892 (982)
Q Consensus       888 elltg  892 (982)
                      +.+++
T Consensus       308 ~~y~~  312 (420)
T 2pyw_A          308 NLFNK  312 (420)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            87765

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=97.44  E-value=7.9e-05  Score=73.33  Aligned_cols=43  Identities=12%  Similarity=0.136  Sum_probs=20.9

Q ss_pred             hccccccccEEeecCcccccccCCCcc----ccCcceEeeccCcccc
Q 002010          163 EIASLKSLRHLSFGGNYFTGKIPQSYS----EIQSLEYIGLNGIGLN  205 (982)
Q Consensus       163 ~l~~l~~L~~L~L~~N~l~~~~p~~~~----~l~~L~~L~L~~n~i~  205 (982)
                      .+..-+.|++|+|++|+|+......++    .-+.|++|+|++|.|+
T Consensus        65 aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig  111 (197)
T 1pgv_A           65 AACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLT  111 (197)
T ss_dssp             HHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCC
T ss_pred             HHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCC
Confidence            334445566666666666544433332    2344444444444444

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=97.07  E-value=0.00012  Score=72.10  Aligned_cols=117  Identities=13%  Similarity=0.141  Sum_probs=74.3

Q ss_pred             cccccccEEeecCc-ccccc----cCCCccccCcceEeeccCcccccchhhHHhhhhhHHHHhhcccccccccCCCCCCC
Q 002010          165 ASLKSLRHLSFGGN-YFTGK----IPQSYSEIQSLEYIGLNGIGLNGTVPAFLSRLKNLREMYIGYFNTYTGGIPPGFGA  239 (982)
Q Consensus       165 ~~l~~L~~L~L~~N-~l~~~----~p~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~l~~~n~~~~~~p~~~~~  239 (982)
                      .+-+.|++|+|++| +|...    +.+.+..-+.|+.|+|++|.|+...-.++...                     +..
T Consensus        38 ~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~a---------------------L~~   96 (197)
T 1pgv_A           38 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIEL---------------------IET   96 (197)
T ss_dssp             TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHH---------------------HHH
T ss_pred             hcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHH---------------------Hhc
Confidence            34455666666664 55533    23345556788999999998886655555442                     222


Q ss_pred             CCCCCEEecccCcCcccCc----hhhcCCCccceeeccccc---CCCC----CCccccCCCCCCEEEeeCCccc
Q 002010          240 LTQLQVLDMASCNISGEIP----TSLSRLKLLHSLFLQMNK---LTGH----IPPQLSGLISLKSLDLSLNYLT  302 (982)
Q Consensus       240 l~~L~~L~L~~n~l~~~~~----~~l~~l~~L~~L~L~~N~---l~~~----~~~~l~~l~~L~~L~Ls~N~l~  302 (982)
                      -+.|+.|+|++|.|+....    ..+..-+.|++|+|++|.   +...    +...+..-++|+.|+++.|.+.
T Consensus        97 N~tL~~L~L~~N~Ig~~Ga~ala~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~~g  170 (197)
T 1pgv_A           97 SPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASME  170 (197)
T ss_dssp             CSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCHH
T ss_pred             CCccCeEecCCCcCCHHHHHHHHHHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCCcc
Confidence            3678899999999885433    345566778888887653   3321    2334445577888888877654

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.06  E-value=0.0017  Score=70.82  Aligned_cols=140  Identities=16%  Similarity=0.159  Sum_probs=72.1

Q ss_pred             cccccccceE-EEEEEeCCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCC--CcccceEeEEEcCCccEEEEeccCCC
Q 002010          698 NIIGKGGAGI-VYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRH--RNIVRLLGYVSNRDTNLLLYEYMPNG  774 (982)
Q Consensus       698 ~~lg~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~lv~e~~~~~  774 (982)
                      +.++.|+... +|+....++..+++|......    ...+..|+.+++.+..  -.+.+++.+.  .+..+++||++.+.
T Consensus        24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~----~~~~~~e~~~l~~L~~~g~~vP~v~~~d--~~~g~ll~e~l~~~   97 (333)
T 3csv_A           24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEE----GGDTQPFVDLAQYLRNLDISAPEIYAEE--HARGLLLIEDLGDA   97 (333)
T ss_dssp             CC--------CCEEEECTTCCEEEEEECCTTT----TCCSHHHHHHHHHHHHTTCBCCCEEEEE--TTTTEEEECCCCSC
T ss_pred             eECCCCCCCceEEEEEcCCCCeEEEEECCCCC----CccccHHHHHHHHHHhCCCCCCceeeec--CCCCEEEEeeCCCc
Confidence            3566665554 678766447778887653221    1234466777666632  2345566543  23347899999776


Q ss_pred             CHHHHhhcC---------------------CC---CCCCHHHHH-------HH-------------HHHHHHHHHHHh--
Q 002010          775 SLGEMLHGA---------------------KG---GHLKWETRY-------RI-------------ALEAAKGLCYLH--  808 (982)
Q Consensus       775 sL~~~l~~~---------------------~~---~~l~~~~~~-------~i-------------~~~i~~~l~~LH--  808 (982)
                      ++.+++...                     ..   ..++.....       .+             ...+...++.+.  
T Consensus        98 ~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~  177 (333)
T 3csv_A           98 LFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSA  177 (333)
T ss_dssp             BHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHH
T ss_pred             chHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHh
Confidence            665443211                     00   112221110       00             001111222221  


Q ss_pred             -hcCCCcEEecCCCCCcEEEcCC----CCEEEeccccchh
Q 002010          809 -HDCSPLIIHRDVKSNNILLDSD----FEAHVADFGLAKF  843 (982)
Q Consensus       809 -~~~~~~ivHrDlkp~Nill~~~----~~~kl~DfG~a~~  843 (982)
                       ......++|||+++.||+++.+    +.+.++||+.+..
T Consensus       178 ~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          178 QLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             HCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             cccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence             1113449999999999999875    6899999998864

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.04  E-value=0.0023  Score=68.63  Aligned_cols=71  Identities=13%  Similarity=0.103  Sum_probs=45.3

Q ss_pred             ccccccccceEEEEEEeCCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcc-cceEeEEEcCCccEEEEecc-CCC
Q 002010          697 ENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNI-VRLLGYVSNRDTNLLLYEYM-PNG  774 (982)
Q Consensus       697 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~-~~~  774 (982)
                      .+.++.|....+|++     ..+++|+.... . .......+|+.+++.+....+ .+++++  +.+..++++||+ +|.
T Consensus        23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~-~-~~~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~   93 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA-----GDLCLRIPGKG-T-EEYINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQ   93 (301)
T ss_dssp             CEEEESCSSEEEEEE-----TTEEEEEECC------CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCE
T ss_pred             eeEcCCcccccccee-----eeEEEECCCCC-c-cceeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCc
Confidence            567889999999998     56888876432 1 112234578888877743333 345543  444568899999 665


Q ss_pred             CH
Q 002010          775 SL  776 (982)
Q Consensus       775 sL  776 (982)
                      ++
T Consensus        94 ~l   95 (301)
T 3dxq_A           94 TM   95 (301)
T ss_dssp             EC
T ss_pred             cC
Confidence            44

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=96.91  E-value=0.0011  Score=60.97  Aligned_cols=55  Identities=27%  Similarity=0.372  Sum_probs=30.2

Q ss_pred             eeeCCCCccc-CCCCcccccccccceEEcccccccccCccccccccccceecccCCcc
Q 002010          532 SVDLSRNSLY-GKIPPGISKLIDLSILNLSRNGITGSIPNEMRNMMSLTTLDLSYNNL  588 (982)
Q Consensus       532 ~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l  588 (982)
                      .++.+++.|+ ..+|..+.  .+|+.|+|++|+|+...+..|..+++|+.|+|++|++
T Consensus        12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~   67 (130)
T 3rfe_A           12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPW   67 (130)
T ss_dssp             EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCC
T ss_pred             EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCe
Confidence            4555555554 23443322  2466666666666655555566666666666665544

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=96.61  E-value=0.011  Score=64.05  Aligned_cols=74  Identities=9%  Similarity=0.061  Sum_probs=47.9

Q ss_pred             ccccccceEEEEEEeCCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCC--cccceEeE-----EEcCCccEEEEecc
Q 002010          699 IIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHR--NIVRLLGY-----VSNRDTNLLLYEYM  771 (982)
Q Consensus       699 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~~~~~-----~~~~~~~~lv~e~~  771 (982)
                      .++ |....||++...+|+.+++|......  .....+..|..+++.+...  .+.+++..     ....+..+++|||+
T Consensus        33 ~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~--~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i  109 (328)
T 1zyl_A           33 PLN-SYENRVYQFQDEDRRRFVVKFYRPER--WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV  109 (328)
T ss_dssp             EEC-CSSSEEEEECCTTCCCEEEEEECTTT--SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred             eec-CcccceEEEEcCCCCEEEEEEcCCCC--CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence            466 78889999987778789999874321  2345667788887776321  13344432     12244557899999


Q ss_pred             CCCC
Q 002010          772 PNGS  775 (982)
Q Consensus       772 ~~~s  775 (982)
                      +|.+
T Consensus       110 ~G~~  113 (328)
T 1zyl_A          110 GGRQ  113 (328)
T ss_dssp             CCEE
T ss_pred             CCCC
Confidence            8754

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=96.61  E-value=0.0044  Score=69.91  Aligned_cols=72  Identities=19%  Similarity=0.318  Sum_probs=48.7

Q ss_pred             cccccccceEEEEEEeCC--------CcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcc-cceEeEEEcCCccEEEE
Q 002010          698 NIIGKGGAGIVYRGSMPD--------GIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNI-VRLLGYVSNRDTNLLLY  768 (982)
Q Consensus       698 ~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~  768 (982)
                      +.|+.|....||++..++        +..|++|+....   .....+.+|..+++.+...++ .++++.+.+    .+|+
T Consensus        79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~---~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~  151 (429)
T 1nw1_A           79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP---ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE  151 (429)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC---CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred             EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC---CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence            467888899999998653        578999876221   122456689999888853333 566665432    4899


Q ss_pred             eccCCCCH
Q 002010          769 EYMPNGSL  776 (982)
Q Consensus       769 e~~~~~sL  776 (982)
                      ||++|.++
T Consensus       152 e~l~G~~l  159 (429)
T 1nw1_A          152 EYIPSRPL  159 (429)
T ss_dssp             CCCCEEEC
T ss_pred             EEeCCccc
Confidence            99986443

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=96.58  E-value=0.012  Score=63.67  Aligned_cols=141  Identities=15%  Similarity=0.134  Sum_probs=76.9

Q ss_pred             cccccccceEEEEEEeCCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCC-----CCcccceE-e--EEEcCCccEEEEe
Q 002010          698 NIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIR-----HRNIVRLL-G--YVSNRDTNLLLYE  769 (982)
Q Consensus       698 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~~~-~--~~~~~~~~~lv~e  769 (982)
                      +.|+.|....+|+....+| .+++|.....   .....+..|+.+++.+.     .|.++... |  +....+..+++|+
T Consensus        28 ~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~---~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~  103 (322)
T 2ppq_A           28 KGIAEGVENSNFLLHTTKD-PLILTLYEKR---VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALIS  103 (322)
T ss_dssp             EEECC---EEEEEEEESSC-CEEEEEECC------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEE
T ss_pred             eccCCCcccceEEEEeCCc-cEEEEEeCCC---CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEE
Confidence            4577888899999987555 6889987442   12334556777776663     23333211 1  1122355689999


Q ss_pred             ccCCCCHHH--------------HhhcC----CCCC---C---CHHHHHH------------HHHHHHHHHHHHhhc---
Q 002010          770 YMPNGSLGE--------------MLHGA----KGGH---L---KWETRYR------------IALEAAKGLCYLHHD---  810 (982)
Q Consensus       770 ~~~~~sL~~--------------~l~~~----~~~~---l---~~~~~~~------------i~~~i~~~l~~LH~~---  810 (982)
                      |++|..+..              .+|..    ....   .   .|.....            +...+...++++++.   
T Consensus       104 ~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~  183 (322)
T 2ppq_A          104 FLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPK  183 (322)
T ss_dssp             CCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCC
T ss_pred             eCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcc
Confidence            998865321              11210    0000   1   1221100            001133444455421   


Q ss_pred             -CCCcEEecCCCCCcEEEcCCCCEEEeccccch
Q 002010          811 -CSPLIIHRDVKSNNILLDSDFEAHVADFGLAK  842 (982)
Q Consensus       811 -~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~  842 (982)
                       ....++|+|+++.||+++++..+.++||+.+.
T Consensus       184 ~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          184 DLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             SSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence             12348999999999999887666899998775

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=96.55  E-value=0.0065  Score=66.89  Aligned_cols=140  Identities=19%  Similarity=0.270  Sum_probs=83.1

Q ss_pred             cccccccceEEEEEEeC--------CCcEEEEEEeccCCCCCchhhHHHHHHHHhcCC-CCcccceEeEEEcCCccEEEE
Q 002010          698 NIIGKGGAGIVYRGSMP--------DGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIR-HRNIVRLLGYVSNRDTNLLLY  768 (982)
Q Consensus       698 ~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~  768 (982)
                      +.+..|-...+|++..+        +++.|++|+. .. .......+.+|..+++.+. +.-..++++.+.+    .+||
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~-g~-~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~  129 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLY-GA-ILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLE  129 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEEC-C----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEE
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEEC-CC-ccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEE
Confidence            35777888899999764        2478999875 22 1234556678999998884 3223556665543    3899


Q ss_pred             eccCCCCHHH-----------------HhhcCC---CCCCC--HHHHHHHHHHHHHH-------------------HHHH
Q 002010          769 EYMPNGSLGE-----------------MLHGAK---GGHLK--WETRYRIALEAAKG-------------------LCYL  807 (982)
Q Consensus       769 e~~~~~sL~~-----------------~l~~~~---~~~l~--~~~~~~i~~~i~~~-------------------l~~L  807 (982)
                      ||++|.++..                 .+|...   .....  +.++.++..++...                   +..|
T Consensus       130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L  209 (379)
T 3feg_A          130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL  209 (379)
T ss_dssp             ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred             EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence            9998865431                 112111   11222  45566666554321                   2222


Q ss_pred             ----hhcC-CCcEEecCCCCCcEEEcCC----CCEEEeccccchh
Q 002010          808 ----HHDC-SPLIIHRDVKSNNILLDSD----FEAHVADFGLAKF  843 (982)
Q Consensus       808 ----H~~~-~~~ivHrDlkp~Nill~~~----~~~kl~DfG~a~~  843 (982)
                          .... ...++|+|+.+.||+++.+    +.+.++||..+..
T Consensus       210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence                2211 2348899999999999876    7899999998863

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=96.50  E-value=0.0035  Score=57.49  Aligned_cols=56  Identities=18%  Similarity=0.226  Sum_probs=37.6

Q ss_pred             eeeeeccccC-CCCCcccccccCCCeeeCCCCcccCCCCcccccccccceEEccccccc
Q 002010          508 SINISDNNIS-GEIPYSISQCHSLTSVDLSRNSLYGKIPPGISKLIDLSILNLSRNGIT  565 (982)
Q Consensus       508 ~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  565 (982)
                      .++.+++.++ ..+|..+.  .+|+.|+|++|+|+...+..|..+++|+.|+|++|.+.
T Consensus        12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~   68 (130)
T 3rfe_A           12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR   68 (130)
T ss_dssp             EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred             EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence            5666666665 23444332  35778888888887655666777888888888888764

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.49  E-value=0.011  Score=64.27  Aligned_cols=31  Identities=16%  Similarity=0.373  Sum_probs=27.2

Q ss_pred             CcEEecCCCCCcEEEcCCCCEEEeccccchh
Q 002010          813 PLIIHRDVKSNNILLDSDFEAHVADFGLAKF  843 (982)
Q Consensus       813 ~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~  843 (982)
                      ..++|+|+.+.||++++++.+.++||+.+..
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            3489999999999999888899999987754

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.34  E-value=0.018  Score=65.26  Aligned_cols=73  Identities=18%  Similarity=0.129  Sum_probs=46.8

Q ss_pred             cccccccceEEEEEEeCC-CcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcc-cceEeEEEcCCccEEEEeccCCCC
Q 002010          698 NIIGKGGAGIVYRGSMPD-GIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNI-VRLLGYVSNRDTNLLLYEYMPNGS  775 (982)
Q Consensus       698 ~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~~s  775 (982)
                      +.|+.|-...+|++...+ +..+++|+.... .. ......+|..+++.+...++ .++++.+.    ...||||++|.+
T Consensus       114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~-~~-~~idR~~E~~vl~~L~~~gl~P~ll~~~~----~G~v~e~I~G~~  187 (458)
T 2qg7_A          114 QIINGGITNILIKVKDMSKQAKYLIRLYGPK-TD-EIINREREKKISCILYNKNIAKKIYVFFT----NGRIEEFMDGYA  187 (458)
T ss_dssp             EEECC--CEEEEEEEETTTTEEEEEEEECC--CC-SCSCHHHHHHHHHHHTTSSSBCCEEEEET----TEEEEECCCSEE
T ss_pred             EEcCCCeEeEEEEEEECCCCceEEEEECCCC-hh-hhcCHHHHHHHHHHHHhcCCCCCEEEEeC----CeEEEEeeCCcc
Confidence            468889899999998755 478888876322 21 12223588888888864444 46666652    246999998754


Q ss_pred             H
Q 002010          776 L  776 (982)
Q Consensus       776 L  776 (982)
                      +
T Consensus       188 l  188 (458)
T 2qg7_A          188 L  188 (458)
T ss_dssp             C
T ss_pred             C
Confidence            3

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.33  E-value=0.0078  Score=66.52  Aligned_cols=73  Identities=11%  Similarity=0.107  Sum_probs=43.5

Q ss_pred             cccccccceEEEEEEeCC---------CcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCc-ccceEeEEEcCCccEEE
Q 002010          698 NIIGKGGAGIVYRGSMPD---------GIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRN-IVRLLGYVSNRDTNLLL  767 (982)
Q Consensus       698 ~~lg~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~~~lv  767 (982)
                      +.++.|....+|++...+         +..+++|+.... . ........|..+++.+.... +.++++..    ..++|
T Consensus        39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~-~-~~~~~~~~E~~~l~~L~~~g~~P~~~~~~----~~~~v  112 (369)
T 3c5i_A           39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKH-V-DELYNTISEFEVYKTMSKYKIAPQLLNTF----NGGRI  112 (369)
T ss_dssp             EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTT-G-GGTSCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEE
T ss_pred             EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCC-c-cceecHHHHHHHHHHHHhcCCCCceEEec----CCcEE
Confidence            357888889999997644         268888875322 1 11123467888888774333 34666543    24789


Q ss_pred             EeccCCCCH
Q 002010          768 YEYMPNGSL  776 (982)
Q Consensus       768 ~e~~~~~sL  776 (982)
                      |||++|.++
T Consensus       113 ~e~i~G~~l  121 (369)
T 3c5i_A          113 EEWLYGDPL  121 (369)
T ss_dssp             EECCCSEEC
T ss_pred             EEEecCCcC
Confidence            999987543

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=96.05  E-value=0.044  Score=54.02  Aligned_cols=103  Identities=18%  Similarity=0.167  Sum_probs=67.8

Q ss_pred             CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCcccc
Q 002010          774 GSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECM  853 (982)
Q Consensus       774 ~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~  853 (982)
                      .+|.+++.. .+.+++++++|.++.|.+.++...-....+  ..+=+.|..|++..+|.|...+ +.+.           
T Consensus        33 vSL~eIL~~-~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~--~~~i~~~~~i~l~~dG~V~f~~-~~s~-----------   97 (229)
T 2yle_A           33 LSLEEILRL-YNQPINEEQAWAVCYQCCGSLRAAARRRQP--RHRVRSAAQIRVWRDGAVTLAP-AADD-----------   97 (229)
T ss_dssp             EEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHHTTCC--CCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred             ccHHHHHHH-cCCCcCHHHHHHHHHHHHHHHHhhhhcccC--CceecCCcceEEecCCceeccc-cccc-----------
Confidence            388998874 468999999999999999998776221111  1333457889999999988764 1111           


Q ss_pred             cccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCC
Q 002010          854 SSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKP  895 (982)
Q Consensus       854 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p  895 (982)
                         .....+.|||... ...+.+.=|||+|+++|..+--..|
T Consensus        98 ---~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~  135 (229)
T 2yle_A           98 ---AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK  135 (229)
T ss_dssp             ------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             ---ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence               1123466888753 3456888999999999999974444

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=94.75  E-value=0.099  Score=58.28  Aligned_cols=139  Identities=14%  Similarity=0.172  Sum_probs=82.8

Q ss_pred             cccccccceEEEEEEeCC--------CcEEEEEEeccCCCCCchhhHHHHHHHHhcCCC-CcccceEeEEEcCCccEEEE
Q 002010          698 NIIGKGGAGIVYRGSMPD--------GIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRH-RNIVRLLGYVSNRDTNLLLY  768 (982)
Q Consensus       698 ~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~lv~  768 (982)
                      +.+..|-...+|+....+        +..|++|+.. ... .......+|..+++.+.. .-..++++.+    ..+.||
T Consensus        76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g-~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~----~~~~I~  149 (424)
T 3mes_A           76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYG-KHV-GKFYDSKVELDVFRYLSNINIAPNIIADF----PEGRIE  149 (424)
T ss_dssp             EEECCCSSSEEEEEEECCC-----CCCSEEEEEECC-CCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEEE
T ss_pred             EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECC-CCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEc----CCCEEE
Confidence            357778889999997753        5789998753 222 222345688888888743 2234555533    247899


Q ss_pred             eccCCCCHHH--------------H---hhc--C---------CCCCCCHHHHHHHHHHHH-------------------
Q 002010          769 EYMPNGSLGE--------------M---LHG--A---------KGGHLKWETRYRIALEAA-------------------  801 (982)
Q Consensus       769 e~~~~~sL~~--------------~---l~~--~---------~~~~l~~~~~~~i~~~i~-------------------  801 (982)
                      ||++|.++..              .   +|.  .         ...+..+.++.++..++-                   
T Consensus       150 efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~  229 (424)
T 3mes_A          150 EFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKIL  229 (424)
T ss_dssp             ECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHH
T ss_pred             EEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHH
Confidence            9999865321              0   110  0         111112444444443321                   


Q ss_pred             HHHHHHh--------------------h-cCCCcEEecCCCCCcEEEcCCCCEEEeccccchh
Q 002010          802 KGLCYLH--------------------H-DCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKF  843 (982)
Q Consensus       802 ~~l~~LH--------------------~-~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~  843 (982)
                      ..+.+|.                    . .....++|+|+.+.||+ +.++.+.++||..|..
T Consensus       230 ~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~  291 (424)
T 3mes_A          230 EEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI  291 (424)
T ss_dssp             HHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             HHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence            1222222                    1 11234889999999999 7888999999998864

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=89.75  E-value=0.67  Score=51.38  Aligned_cols=29  Identities=28%  Similarity=0.510  Sum_probs=24.8

Q ss_pred             EEecCCCCCcEEE------cCCCCEEEeccccchh
Q 002010          815 IIHRDVKSNNILL------DSDFEAHVADFGLAKF  843 (982)
Q Consensus       815 ivHrDlkp~Nill------~~~~~~kl~DfG~a~~  843 (982)
                      ++|+|+.+.||++      +++..++++||..|..
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            5699999999999      4567899999998864

>2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A

Probab=84.88  E-value=0.63  Score=32.53  Aligned_cols=29  Identities=17%  Similarity=0.379  Sum_probs=12.2

Q ss_pred             eeehhhHHHHHHHHHHHHHhhhhhhhhhc
Q 002010          642 KIVITVIALLTFMLLVILTIYQLRKRRLQ  670 (982)
Q Consensus       642 ~ii~~~~~~~~~~~l~~l~~~~~r~~~~~  670 (982)
                      .++.++++++.++++.+..+++.|+|+++
T Consensus        13 ~Ia~~vVGvll~vi~~l~~~~~~RRR~~~   41 (44)
T 2jwa_A           13 SIISAVVGILLVVVLGVVFGILIKRRQQK   41 (44)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHHHHCSC
T ss_pred             chHHHHHHHHHHHHHHHHHHhheehhhhh
Confidence            34444444433333333334444444433

>2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens}

Probab=81.84  E-value=2.1  Score=30.03  Aligned_cols=28  Identities=18%  Similarity=0.381  Sum_probs=11.9

Q ss_pred             eeehhhHH-HHHHHHHHHHHhhhhhhhhh
Q 002010          642 KIVITVIA-LLTFMLLVILTIYQLRKRRL  669 (982)
Q Consensus       642 ~ii~~~~~-~~~~~~l~~l~~~~~r~~~~  669 (982)
                      .|..++++ ++++++++...+++.|+|++
T Consensus        12 ~IA~gVVgGv~~~~ii~~~~~~~~RRr~~   40 (44)
T 2ks1_B           12 SIATGMVGALLLLLVVALGIGLFMRRRHI   40 (44)
T ss_dssp             SSTHHHHHHHHHHHHHHHHHHHHHHTTTC
T ss_pred             eEEeehhHHHHHHHHHHHHHHHHhhhhHh
Confidence            34444444 33333333334444444443

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	982
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	2e-67
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	8e-64
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	6e-61
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	4e-60
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	7e-60
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	2e-59
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	1e-57
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	2e-57
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	2e-57
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	2e-57
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	5e-57
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	1e-56
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	2e-56
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	4e-56
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	1e-55
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	3e-55
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	5e-55
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	2e-54
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	3e-53
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	8e-53
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	2e-52
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	3e-52
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	5e-52
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	2e-51
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	5e-51
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	6e-51
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	9e-51
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	3e-50
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	6e-50
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	4e-48
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	4e-47
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	5e-47
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	2e-45
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	3e-44
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	4e-44
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	1e-42
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	3e-42
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	1e-41
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	5e-41
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	9e-41
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	2e-40
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	2e-40
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	3e-40
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	1e-39
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	4e-39
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	1e-38
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	3e-38
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	5e-38
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	5e-38
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	9e-38
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	2e-37
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	1e-35
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	2e-35
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	2e-35
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	8e-35
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	2e-33
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	3e-32
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	2e-31
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	3e-21
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	7e-18
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	9e-15
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	2e-30
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	8e-30
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	3e-29
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	6e-29
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	2e-27
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	2e-24
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	3e-24
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	2e-21
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	2e-19
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	1e-15
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	5e-24
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	6e-21
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	2e-20
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	2e-20
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	8e-19
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	2e-18
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	8e-04
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	4e-20
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	5e-19
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	3e-18
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	6e-17
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	3e-15
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	8e-13
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	2e-05
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	5e-13
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	5e-09
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	6e-07
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	1e-04
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	6e-04
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	0.001
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	9e-12
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	8e-11
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	2e-09
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	8e-06
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	3e-04
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	7e-10
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	5e-09
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	9e-09
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	8e-07
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	8e-07
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	9e-04
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	3e-08
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	9e-07
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	2e-05
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	5e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	4e-08
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	3e-07
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	5e-07
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	1e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	3e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	6e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	3e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	3e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	5e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	4e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	4e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	8e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.002
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.002
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.004
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	1e-07
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	3e-06
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	5e-06
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	3e-04
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	9e-04
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	0.002
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	3e-07
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	4e-07
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	3e-06
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	5e-06
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	6e-05
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	1e-04
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	0.002
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	4e-06
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	0.001
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	0.001
d2ifga3	156	c.10.2.7 (A:36-191) High affinity nerve growth fac	1e-05
d2ifga3	156	c.10.2.7 (A:36-191) High affinity nerve growth fac	2e-05
d1w8aa_	192	c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga	3e-05
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	3e-05
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	6e-05
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	4e-04
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	8e-04
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	3e-05
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	5e-05
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	7e-05
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	4e-04
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	7e-04
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	7e-04
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	0.001
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	0.002
d2omxa2	199	c.10.2.1 (A:37-235) Internalin B {Listeria monocyt	2e-04
d2omxa2	199	c.10.2.1 (A:37-235) Internalin B {Listeria monocyt	0.001
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	3e-04
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	4e-04

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  224 bits (573), Expect = 2e-67
 Identities = 79/290 (27%), Positives = 122/290 (42%), Gaps = 26/290 (8%)

Query: 692 ESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRL-VGRGTGGNDHGFLAEIQTLGRIRHRN 750
             +     IG G  G VY+G      DVA+K L V   T      F  E+  L + RH N
Sbjct: 8   GQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65

Query: 751 IVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHD 810
           I+  +GY +      ++ ++    SL   LH  +    +      IA + A+G+ YLH  
Sbjct: 66  ILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHIIET-KFEMIKLIDIARQTAQGMDYLHAK 123

Query: 811 CSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYT 870
               IIHRD+KSNNI L  D    + DFGLA        S     ++GS  ++APE    
Sbjct: 124 S---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 180

Query: 871 LK---VDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLA 927
                   +SDVY+FG+VL EL+ G+ P     +   I+  V +                
Sbjct: 181 QDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGR---------------G 225

Query: 928 VVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQSAP 977
            + P LS         + ++   C++ +   RP   +++  +    +S P
Sbjct: 226 YLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLP 275

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  214 bits (547), Expect = 8e-64
 Identities = 68/278 (24%), Positives = 120/278 (43%), Gaps = 26/278 (9%)

Query: 692 ESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNI 751
           E+LK    +G G  G V+ G       VA+K L  +    +   FLAE   + +++H+ +
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL--KQGSMSPDAFLAEANLMKQLQHQRL 70

Query: 752 VRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDC 811
           VRL   V+  +   ++ EYM NGSL + L    G  L       +A + A+G+ ++    
Sbjct: 71  VRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 129

Query: 812 SPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTL 871
               IHRD+++ NIL+       +ADFGLA+ ++D               + APE     
Sbjct: 130 ---YIHRDLRAANILVSDTLSCKIADFGLARLIED-NEYTAREGAKFPIKWTAPEAINYG 185

Query: 872 KVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDP 931
               KSDV+SFG++L E++   +         ++++ + +                    
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER---------------GYRMV 230

Query: 932 RLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHML 969
           R    P      L+++  +C ++    RPT   +  +L
Sbjct: 231 RPDNCPE----ELYQLMRLCWKERPEDRPTFDYLRSVL 264

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  207 bits (527), Expect = 6e-61
 Identities = 78/292 (26%), Positives = 124/292 (42%), Gaps = 31/292 (10%)

Query: 692 ESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNI 751
           ESL+ E  +G+G  G V+ G+      VAIK L  +    +   FL E Q + ++RH  +
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL--KPGTMSPEAFLQEAQVMKKLRHEKL 74

Query: 752 VRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDC 811
           V+L   VS  +   ++ EYM  GSL + L G  G +L+      +A + A G+ Y+    
Sbjct: 75  VQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN 133

Query: 812 SPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTL 871
               +HRD+++ NIL+  +    VADFGLA+ ++D               + APE A   
Sbjct: 134 ---YVHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIKWTAPEAALYG 189

Query: 872 KVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDP 931
           +   KSDV+SFG++L EL    +         +++  V +    +  P +          
Sbjct: 190 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY-RMPCPPECPE------- 241

Query: 932 RLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHML-----ANPPQSAPS 978
                       L  +   C   E   RPT   +   L     +  PQ  P 
Sbjct: 242 -----------SLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPG 282

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  205 bits (523), Expect = 4e-60
 Identities = 76/293 (25%), Positives = 129/293 (44%), Gaps = 30/293 (10%)

Query: 684 DFKAEDVLESLKDENIIGKGGAGIVYRGSMP----DGIDVAIKRLVGRGTGGNDHGFLAE 739
           +F  E  +  +K E +IG G  G V  G +       I VAIK L    T      FL+E
Sbjct: 18  EFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSE 77

Query: 740 IQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALE 799
              +G+  H N++ L G V+     +++ E+M NGSL +       G         +   
Sbjct: 78  ASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSL-DSFLRQNDGQFTVIQLVGMLRG 136

Query: 800 AAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGS 859
            A G+ YL        +HRD+ + NIL++S+    V+DFGL++FL+D  +    +S  G 
Sbjct: 137 IAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGG 193

Query: 860 YG---YIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEV 916
                + APE     K    SDV+S+G+V+ E+++  +         D++  + +     
Sbjct: 194 KIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQ----- 248

Query: 917 SQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHML 969
                        D RL   P+     L ++ + C + + + RP   ++V+ L
Sbjct: 249 -------------DYRLP-PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTL 287

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  203 bits (517), Expect = 7e-60
 Identities = 65/278 (23%), Positives = 120/278 (43%), Gaps = 26/278 (9%)

Query: 692 ESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNI 751
             L     IG G  G+V+ G   +   VAIK +  R    ++  F+ E + + ++ H  +
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI--REGAMSEEDFIEEAEVMMKLSHPKL 62

Query: 752 VRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDC 811
           V+L G    +    L++E+M +G L       + G    ET   + L+  +G+ YL   C
Sbjct: 63  VQLYGVCLEQAPICLVFEFMEHGCL-SDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC 121

Query: 812 SPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTL 871
              +IHRD+ + N L+  +    V+DFG+ +F+ D   +   +       + +PE     
Sbjct: 122 ---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFPVKWASPEVFSFS 177

Query: 872 KVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDP 931
           +   KSDV+SFGV++ E+ +  K   E     ++V  +                  +  P
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST-------------GFRLYKP 224

Query: 932 RLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHML 969
           RL+        H++++   C ++    RP    ++  L
Sbjct: 225 RLAS------THVYQIMNHCWKERPEDRPAFSRLLRQL 256

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  204 bits (519), Expect = 2e-59
 Identities = 58/214 (27%), Positives = 102/214 (47%), Gaps = 13/214 (6%)

Query: 683 LDFKAEDVLESLKDENIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHGFLAEIQ 741
           ++ K +D     +  + +G G  G+V++    P G+ +A K +         +  + E+Q
Sbjct: 1   MELKDDD----FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQ 56

Query: 742 TLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAA 801
            L       IV   G   +     +  E+M  GSL ++L   K G +  +   ++++   
Sbjct: 57  VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK--KAGRIPEQILGKVSIAVI 114

Query: 802 KGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYG 861
           KGL YL       I+HRDVK +NIL++S  E  + DFG++  L D       +S  G+  
Sbjct: 115 KGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGTRS 168

Query: 862 YIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
           Y++PE         +SD++S G+ L+E+  G+ P
Sbjct: 169 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  198 bits (503), Expect = 1e-57
 Identities = 65/306 (21%), Positives = 115/306 (37%), Gaps = 50/306 (16%)

Query: 692 ESLKDENIIGKGGAGIVYRGSMP------DGIDVAIKRLVGRGTGGNDHGFLAEIQTLGR 745
            +++    IG+G  G V++   P          VA+K L    +      F  E   +  
Sbjct: 13  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72

Query: 746 IRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKG-------------------- 785
             + NIV+LLG  +      LL+EYM  G L E L                         
Sbjct: 73  FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132

Query: 786 --GHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKF 843
               L    +  IA + A G+ YL        +HRD+ + N L+  +    +ADFGL++ 
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRN 189

Query: 844 LQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGV 903
           +  A   +   + A    ++ PE  +  +   +SDV+++GVVL E+ +            
Sbjct: 190 IYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE 249

Query: 904 DIVRWVRKTTSEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMR 963
           +++ +VR                   D  +   P    + L+ +  +C     + RP+  
Sbjct: 250 EVIYYVR-------------------DGNILACPENCPLELYNLMRLCWSKLPADRPSFC 290

Query: 964 EVVHML 969
            +  +L
Sbjct: 291 SIHRIL 296

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (500), Expect = 2e-57
 Identities = 74/280 (26%), Positives = 120/280 (42%), Gaps = 32/280 (11%)

Query: 691 LESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRN 750
           ++ LK    IGKG  G V  G    G  VA+K +    T      FLAE   + ++RH N
Sbjct: 6   MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDAT---AQAFLAEASVMTQLRHSN 61

Query: 751 IVRLLGYVSNRDTNL-LLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHH 809
           +V+LLG +      L ++ EYM  GSL + L       L  +   + +L+  + + YL  
Sbjct: 62  LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 121

Query: 810 DCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAY 869
           +     +HRD+ + N+L+  D  A V+DFGL K       S    +      + APE   
Sbjct: 122 NN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEA-----SSTQDTGKLPVKWTAPEALR 173

Query: 870 TLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVV 929
             K   KSDV+SFG++L E+ +  +         D+V  V K   ++  P          
Sbjct: 174 EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY-KMDAPDGCPP----- 227

Query: 930 DPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHML 969
                         +++V   C   +++ RP+  ++   L
Sbjct: 228 -------------AVYEVMKNCWHLDAAMRPSFLQLREQL 254

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (504), Expect = 2e-57
 Identities = 69/292 (23%), Positives = 114/292 (39%), Gaps = 26/292 (8%)

Query: 697 ENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLG 756
           +  IGKG  G V+RG    G +VA+K               AEI     +RH NI+  + 
Sbjct: 8   QESIGKGRFGEVWRGKW-RGEEVAVKIF--SSREERSWFREAEIYQTVMLRHENILGFIA 64

Query: 757 YVSNRDTNL----LLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDC- 811
             +  +       L+ +Y  +GSL + L+      +  E   ++AL  A GL +LH +  
Sbjct: 65  ADNKDNGTWTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIV 121

Query: 812 ----SPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAG--ASECMSSVAGSYGYIAP 865
                P I HRD+KS NIL+  +    +AD GLA     A        +   G+  Y+AP
Sbjct: 122 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 181

Query: 866 EYAYT------LKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQP 919
           E           +  +++D+Y+ G+V  E+       G   D       +  +   V + 
Sbjct: 182 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 241

Query: 920 SDAASVLAVVDPRLSGYPLT--GVIHLFKVAMMCVEDESSARPTMREVVHML 969
                    + P +     +   +  + K+   C     +AR T   +   L
Sbjct: 242 RKVV-CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 292

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (501), Expect = 2e-57
 Identities = 79/297 (26%), Positives = 132/297 (44%), Gaps = 29/297 (9%)

Query: 692 ESLKDENIIGKGGAGIVYRGSMPDG-----IDVAIKRLVGRGTGGNDHGFLAEIQTLGRI 746
             +  + +IG G  G VY+G +        + VAIK L    T      FL E   +G+ 
Sbjct: 7   SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66

Query: 747 RHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCY 806
            H NI+RL G +S     +++ EYM NG+L + L   K G         +    A G+ Y
Sbjct: 67  SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE-KDGEFSVLQLVGMLRGIAAGMKY 125

Query: 807 LHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQ-DAGASECMSSVAGSYGYIAP 865
           L +      +HRD+ + NIL++S+    V+DFGL++ L+ D  A+   S       + AP
Sbjct: 126 LANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAP 182

Query: 866 EYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASV 925
           E     K    SDV+SFG+V+ E++   +         ++++ +                
Sbjct: 183 EAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIND-------------- 228

Query: 926 LAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQSAPSLITL 982
                 RL   P+     ++++ M C + E + RP   ++V +L    ++  SL TL
Sbjct: 229 ----GFRLP-TPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLKTL 280

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (496), Expect = 5e-57
 Identities = 55/278 (19%), Positives = 113/278 (40%), Gaps = 26/278 (9%)

Query: 692 ESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNI 751
           + L     +G G  G+V  G      DVAIK +  +    ++  F+ E + +  + H  +
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMI--KEGSMSEDEFIEEAKVMMNLSHEKL 61

Query: 752 VRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDC 811
           V+L G  + +    ++ EYM NG L   L        + +    +  +  + + YL    
Sbjct: 62  VQLYGVCTKQRPIFIITEYMANGCLLNYLRE-MRHRFQTQQLLEMCKDVCEAMEYLESKQ 120

Query: 812 SPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTL 871
               +HRD+ + N L++      V+DFGL++++ D   +           +  PE     
Sbjct: 121 ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-SSVGSKFPVRWSPPEVLMYS 176

Query: 872 KVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDP 931
           K   KSD+++FGV++ E+ +  K   E     +    + +    + +P  A+        
Sbjct: 177 KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGL-RLYRPHLASE------- 228

Query: 932 RLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHML 969
                       ++ +   C  +++  RPT + ++  +
Sbjct: 229 -----------KVYTIMYSCWHEKADERPTFKILLSNI 255

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (495), Expect = 1e-56
 Identities = 65/296 (21%), Positives = 118/296 (39%), Gaps = 31/296 (10%)

Query: 681 QRLDFKAEDVLESLKDENIIGKGGAGIVYRG---SMPDGIDVAIKRLVGRGTGGNDHGFL 737
           ++L  K +++L     +  +G G  G V +G        IDVAIK L       +    +
Sbjct: 1   KKLFLKRDNLL---IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMM 57

Query: 738 AEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIA 797
            E Q + ++ +  IVRL+G        +L+ E    G L + L G K   +       + 
Sbjct: 58  REAQIMHQLDNPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVG-KREEIPVSNVAELL 115

Query: 798 LEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQ-DAGASECMSSV 856
            + + G+ YL        +HRD+ + N+LL +   A ++DFGL+K L  D       S+ 
Sbjct: 116 HQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAG 172

Query: 857 AGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEV 916
                + APE     K   +SDV+S+GV + E ++  +   +   G +++ ++ +    +
Sbjct: 173 KWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK-RM 231

Query: 917 SQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANP 972
             P +                      L+ +   C   +   RP    V   +   
Sbjct: 232 ECPPECPP------------------ELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (496), Expect = 2e-56
 Identities = 72/280 (25%), Positives = 118/280 (42%), Gaps = 30/280 (10%)

Query: 697 ENIIGKGGAGIVYRGSMPD----GIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIV 752
             +IG+G  G VY G++ D     I  A+K L      G    FL E   +    H N++
Sbjct: 32  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91

Query: 753 RLLGYVSNRDTNLLL-YEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDC 811
            LLG     + + L+   YM +G L       +  +   +      L+ AKG+ +L    
Sbjct: 92  SLLGICLRSEGSPLVVLPYMKHGDL-RNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK 150

Query: 812 SPLIIHRDVKSNNILLDSDFEAHVADFGLAKFL--QDAGASECMSSVAGSYGYIAPEYAY 869
               +HRD+ + N +LD  F   VADFGLA+ +  ++  +    +       ++A E   
Sbjct: 151 ---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 207

Query: 870 TLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVV 929
           T K   KSDV+SFGV+L EL+    P     +  DI  ++ +    + QP          
Sbjct: 208 TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR-RLLQPEYCPD----- 261

Query: 930 DPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHML 969
                         L++V + C   ++  RP+  E+V  +
Sbjct: 262 -------------PLYEVMLKCWHPKAEMRPSFSELVSRI 288

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (491), Expect = 4e-56
 Identities = 63/282 (22%), Positives = 112/282 (39%), Gaps = 30/282 (10%)

Query: 696 DENIIGKGGAGIVYRGSMPD---GIDVAIKRLVGRGTGGNDHG-FLAEIQTLGRIRHRNI 751
           ++  +G G  G V +G          VA+K L             LAE   + ++ +  I
Sbjct: 11  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70

Query: 752 VRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDC 811
           VR++G     ++ +L+ E    G L + L   +  H+K +    +  + + G+ YL    
Sbjct: 71  VRMIGICEA-ESWMLVMEMAELGPLNKYLQ--QNRHVKDKNIIELVHQVSMGMKYLEESN 127

Query: 812 SPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQ-DAGASECMSSVAGSYGYIAPEYAYT 870
               +HRD+ + N+LL +   A ++DFGL+K L+ D    +  +       + APE    
Sbjct: 128 ---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 184

Query: 871 LKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVD 930
            K   KSDV+SFGV++ E  +  +       G ++   + K                   
Sbjct: 185 YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK---------------GERM 229

Query: 931 PRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANP 972
              +G P      ++ +  +C   +   RP    V   L N 
Sbjct: 230 GCPAGCPR----EMYDLMNLCWTYDVENRPGFAAVELRLRNY 267

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (486), Expect = 1e-55
 Identities = 71/281 (25%), Positives = 116/281 (41%), Gaps = 33/281 (11%)

Query: 694 LKDENIIGKGGAGIVYRG-SMPDGIDVAIKRL-VGRGTGGNDHGFLAEIQTLGRIRHRNI 751
           LK +  IG+G    VY+G      ++VA   L   + T      F  E + L  ++H NI
Sbjct: 11  LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 70

Query: 752 VRLLGY----VSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYL 807
           VR        V  +   +L+ E M +G+L   L   +   +K +       +  KGL +L
Sbjct: 71  VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLK--RFKVMKIKVLRSWCRQILKGLQFL 128

Query: 808 HHDCSPLIIHRDVKSNNILLDS-DFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPE 866
           H    P IIHRD+K +NI +        + D GLA   +         +V G+  ++APE
Sbjct: 129 HTRTPP-IIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA----SFAKAVIGTPEFMAPE 183

Query: 867 YAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVL 926
             Y  K DE  DVY+FG+ +LE+   + P  E  +   I R V       S    A   +
Sbjct: 184 M-YEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEV 242

Query: 927 AVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH 967
                              ++   C+      R +++++++
Sbjct: 243 K------------------EIIEGCIRQNKDERYSIKDLLN 265

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  191 bits (485), Expect = 3e-55
 Identities = 64/291 (21%), Positives = 113/291 (38%), Gaps = 30/291 (10%)

Query: 680 FQRLDFKAEDVLESLKDENIIGKGGAGIVYRGSMPD-GIDVAIKRLVGRGTGGNDHGFLA 738
           + + + +  D    +  ++ +G G  G VY G      + VA+K L  +        FL 
Sbjct: 9   YDKWEMERTD----ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL--KEDTMEVEEFLK 62

Query: 739 EIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIAL 798
           E   +  I+H N+V+LLG  +      ++ E+M  G+L + L       +       +A 
Sbjct: 63  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 122

Query: 799 EAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAG 858
           + +  + YL        IHRD+ + N L+  +    VADFGL++ +         +    
Sbjct: 123 QISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKF 178

Query: 859 SYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQ 918
              + APE     K   KSDV++FGV+L E+           D   +   + K       
Sbjct: 179 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK------- 231

Query: 919 PSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHML 969
                      D R+   P      ++++   C +   S RP+  E+    
Sbjct: 232 -----------DYRME-RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF 270

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (487), Expect = 5e-55
 Identities = 64/315 (20%), Positives = 114/315 (36%), Gaps = 49/315 (15%)

Query: 684 DFKAEDVLESLKDENIIGKGGAGIVYRGSMPD------GIDVAIKRLVGRGTGGNDHGFL 737
           D K E   E+L+   ++G G  G V   +          I VA+K L  +         +
Sbjct: 29  DLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALM 88

Query: 738 AEIQTLGRI-RHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKG----------- 785
           +E++ + ++  H NIV LLG  +      L++EY   G L   L   +            
Sbjct: 89  SELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYEN 148

Query: 786 ----------GHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHV 835
                       L +E     A + AKG+ +L        +HRD+ + N+L+       +
Sbjct: 149 QKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKI 205

Query: 836 ADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
            DFGLA+ +          +      ++APE  +      KSDV+S+G++L E+ +    
Sbjct: 206 CDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN 265

Query: 896 VGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDE 955
                        + +   ++ QP  A                     ++ +   C   +
Sbjct: 266 PYPGIPVDANFYKLIQNGFKMDQPFYATE------------------EIYIIMQSCWAFD 307

Query: 956 SSARPTMREVVHMLA 970
           S  RP+   +   L 
Sbjct: 308 SRKRPSFPNLTSFLG 322

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (482), Expect = 2e-54
 Identities = 65/309 (21%), Positives = 111/309 (35%), Gaps = 44/309 (14%)

Query: 684 DFKAEDVLESLKDENIIGKGGAGIVYRGSM------PDGIDVAIKRLVGRGTGGNDHGFL 737
           D K E     L     +G G  G V   +          + VA+K L            +
Sbjct: 15  DHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALM 74

Query: 738 AEIQTLGRI-RHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGH--------- 787
           +E++ L  +  H NIV LLG  +     L++ EY   G L   L   +            
Sbjct: 75  SELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAI 134

Query: 788 -------LKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGL 840
                  L  E     + + AKG+ +L        IHRD+ + NILL       + DFGL
Sbjct: 135 MEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGL 191

Query: 841 AKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFG 900
           A+ +++        +      ++APE  +      +SDV+S+G+ L EL +         
Sbjct: 192 ARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM 251

Query: 901 DGVDIVRWVRKTTSEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARP 960
                   + K    +  P  A +                   ++ +   C + +   RP
Sbjct: 252 PVDSKFYKMIKEGFRMLSPEHAPA------------------EMYDIMKTCWDADPLKRP 293

Query: 961 TMREVVHML 969
           T +++V ++
Sbjct: 294 TFKQIVQLI 302

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (469), Expect = 3e-53
 Identities = 68/289 (23%), Positives = 112/289 (38%), Gaps = 34/289 (11%)

Query: 686 KAEDVLESLKDENIIGKGGAGIVYRG-SMPDGIDVAIKRL-VGRGTGGNDHGFLAEIQTL 743
           +AED  E L     IG G  G   +     DG  +  K L  G  T       ++E+  L
Sbjct: 2   RAED-YEVLY---TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLL 57

Query: 744 GRIRHRNIVRLLGYVSNRDTNLL--LYEYMPNGSLGEMLH--GAKGGHLKWETRYRIALE 799
             ++H NIVR    + +R    L  + EY   G L  ++     +  +L  E   R+  +
Sbjct: 58  RELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQ 117

Query: 800 AAKGLCYLH--HDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVA 857
               L   H   D    ++HRD+K  N+ LD      + DFGLA+ L     +    +  
Sbjct: 118 LTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH--DTSFAKAFV 175

Query: 858 GSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVS 917
           G+  Y++PE    +  +EKSD++S G +L EL A   P               K      
Sbjct: 176 GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPF----TAFSQKELAGK------ 225

Query: 918 QPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVV 966
                     + + +    P      L ++    +  +   RP++ E++
Sbjct: 226 ----------IREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEIL 264

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (470), Expect = 8e-53
 Identities = 68/310 (21%), Positives = 126/310 (40%), Gaps = 49/310 (15%)

Query: 678 TAFQRLDFKAEDVLESLKDENIIGKGGAGIVYRGSMPDG---IDVAIKRLVGRGTGGNDH 734
           T +  LD+        +K +++IG+G  G V +  +      +D AIKR+    +  +  
Sbjct: 2   TIYPVLDW------NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHR 55

Query: 735 GFLAEIQTLGRI-RHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHG----------- 782
            F  E++ L ++  H NI+ LLG   +R    L  EY P+G+L + L             
Sbjct: 56  DFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFA 115

Query: 783 ---AKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFG 839
              +    L  +     A + A+G+ YL        IHRD+ + NIL+  ++ A +ADFG
Sbjct: 116 IANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFG 172

Query: 840 LAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEF 899
           L++  +        +       ++A E          SDV+S+GV+L E+++        
Sbjct: 173 LSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG 229

Query: 900 GDGVDIVRWVRKTTSEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSAR 959
               ++   + +                    RL   PL     ++ +   C  ++   R
Sbjct: 230 MTCAELYEKLPQ------------------GYRLE-KPLNCDDEVYDLMRQCWREKPYER 270

Query: 960 PTMREVVHML 969
           P+  +++  L
Sbjct: 271 PSFAQILVSL 280

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (463), Expect = 2e-52
 Identities = 68/277 (24%), Positives = 106/277 (38%), Gaps = 30/277 (10%)

Query: 700 IGKGGAGIVYRGSMP----DGIDVAIKRLVGRGTGGND--HGFLAEIQTLGRIRHRNIVR 753
           +G G  G+V RG         + VA+K L        +    F+ E+  +  + HRN++R
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75

Query: 754 LLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSP 813
           L G V       ++ E  P GSL         GH    T  R A++ A+G+ YL      
Sbjct: 76  LYGVVLT-PPMKMVTELAPLGSL-LDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR-- 131

Query: 814 LIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSS-VAGSYGYIAPEYAYTLK 872
             IHRD+ + N+LL +     + DFGL + L        M       + + APE   T  
Sbjct: 132 -FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT 190

Query: 873 VDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDPR 932
               SD + FGV L E+    +      +G  I+  + K    + +P D           
Sbjct: 191 FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQ-------- 242

Query: 933 LSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHML 969
                      ++ V + C   +   RPT   +   L
Sbjct: 243 ----------DIYNVMVQCWAHKPEDRPTFVALRDFL 269

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (466), Expect = 3e-52
 Identities = 66/296 (22%), Positives = 114/296 (38%), Gaps = 34/296 (11%)

Query: 679 AFQRLDFKAEDVLESLKDENIIGKGGAGIVYRGSMPD-----GIDVAIKRLVGRGTGGND 733
           A  R+  K  +     K   ++G G  G VY+G          I VAIK L    +   +
Sbjct: 1   ALLRI-LKETE----FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN 55

Query: 734 HGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETR 793
              L E   +  + + ++ RLLG      T  L+ + MP G L +        ++  +  
Sbjct: 56  KEILDEAYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDY-VREHKDNIGSQYL 113

Query: 794 YRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECM 853
               ++ AKG+ YL       ++HRD+ + N+L+ +     + DFGLAK L         
Sbjct: 114 LNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 170

Query: 854 SSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTT 913
                   ++A E         +SDV+S+GV + EL+       +     +I   + K  
Sbjct: 171 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK-- 228

Query: 914 SEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHML 969
                             RL   P    I ++ + + C   ++ +RP  RE++   
Sbjct: 229 ----------------GERLP-QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEF 267

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (460), Expect = 5e-52
 Identities = 74/279 (26%), Positives = 110/279 (39%), Gaps = 33/279 (11%)

Query: 691 LESLKDENIIGKGGAGIVYRG-SMPDGIDVAIKRL--VGRGTGGNDHGFLAEIQTLGRIR 747
           LE  +    +GKG  G VY          +A+K L        G +H    E++    +R
Sbjct: 5   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 64

Query: 748 HRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYL 807
           H NI+RL GY  +     L+ EY P G++   L   K      +       E A  L Y 
Sbjct: 65  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ--KLSKFDEQRTATYITELANALSYC 122

Query: 808 HHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEY 867
           H   S  +IHRD+K  N+LL S  E  +ADFG +            +++ G+  Y+ PE 
Sbjct: 123 H---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS----SRRTTLCGTLDYLPPEM 175

Query: 868 AYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLA 927
                 DEK D++S GV+  E + GK P   F        + R +  E + P        
Sbjct: 176 IEGRMHDEKVDLWSLGVLCYEFLVGKPP---FEANTYQETYKRISRVEFTFPDFVTE--- 229

Query: 928 VVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVV 966
                              +    ++   S RP +REV+
Sbjct: 230 ---------------GARDLISRLLKHNPSQRPMLREVL 253

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  181 bits (460), Expect = 2e-51
 Identities = 72/306 (23%), Positives = 117/306 (38%), Gaps = 40/306 (13%)

Query: 685 FKAEDVLESLKDENIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGND--HGFLAEIQ 741
           F  +D  +   D   IG G  G VY    + +   VAIK++   G   N+     + E++
Sbjct: 8   FFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVR 67

Query: 742 TLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAA 801
            L ++RH N ++  G      T  L+ EY    +   +        L+      +   A 
Sbjct: 68  FLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEV--HKKPLQEVEIAAVTHGAL 125

Query: 802 KGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYG 861
           +GL YLH   S  +IHRDVK+ NILL       + DFG A  +         +S  G+  
Sbjct: 126 QGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ANSFVGTPY 176

Query: 862 YIAPEYAYTL---KVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQ 918
           ++APE    +   + D K DV+S G+  +EL   K P+    + +  +  + +  S   Q
Sbjct: 177 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-NAMSALYHIAQNESPALQ 235

Query: 919 PSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH----MLANPPQ 974
               +                           C++     RPT   ++     +   PP 
Sbjct: 236 SGHWSEYFR------------------NFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPT 277

Query: 975 SAPSLI 980
               LI
Sbjct: 278 VIMDLI 283

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (456), Expect = 5e-51
 Identities = 65/292 (22%), Positives = 111/292 (38%), Gaps = 36/292 (12%)

Query: 692 ESLKDENIIGKGGAGIVYRG------SMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGR 745
           E +     +G+G  G+VY G             VAIK +    +      FL E   +  
Sbjct: 20  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79

Query: 746 IRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGH--------LKWETRYRIA 797
               ++VRLLG VS     L++ E M  G L   L   +                  ++A
Sbjct: 80  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139

Query: 798 LEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVA 857
            E A G+ YL+ +     +HRD+ + N ++  DF   + DFG+ + + +           
Sbjct: 140 GEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196

Query: 858 GSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVS 917
               +++PE          SDV+SFGVVL E+    +   +      ++R+         
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF--------- 247

Query: 918 QPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHML 969
                     V++  L   P      LF++  MC +     RP+  E++  +
Sbjct: 248 ----------VMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 289

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (453), Expect = 6e-51
 Identities = 58/270 (21%), Positives = 103/270 (38%), Gaps = 25/270 (9%)

Query: 698 NIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLG 756
             +G+G  G V    +      VA+K +  +           EI     + H N+V+  G
Sbjct: 11  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 70

Query: 757 YVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLII 816
           +    +   L  EY   G L + +       +      R   +   G+ YLH      I 
Sbjct: 71  HRREGNIQYLFLEYCSGGELFDRIE--PDIGMPEPDAQRFFHQLMAGVVYLHGIG---IT 125

Query: 817 HRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVD-E 875
           HRD+K  N+LLD      ++DFGLA   +       ++ + G+  Y+APE     +   E
Sbjct: 126 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 185

Query: 876 KSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDPRLSG 935
             DV+S G+VL  ++AG+ P  +  D        ++  + ++           +D     
Sbjct: 186 PVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKK-------IDS---- 234

Query: 936 YPLTGVIHLFKVAMMCVEDESSARPTMREV 965
                      +    + +  SAR T+ ++
Sbjct: 235 -------APLALLHKILVENPSARITIPDI 257

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (453), Expect = 9e-51
 Identities = 66/288 (22%), Positives = 113/288 (39%), Gaps = 34/288 (11%)

Query: 684 DFKAEDVLESLKDENIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHGFLAEIQT 742
           D   ED  E +     +G G  G VY+  +    +  A K +  +     +  ++ EI  
Sbjct: 7   DLNPEDFWEIIG---ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELED-YMVEIDI 62

Query: 743 LGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAK 802
           L    H NIV+LL      +   +L E+   G++  ++       L       +  +   
Sbjct: 63  LASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVML-ELERPLTESQIQVVCKQTLD 121

Query: 803 GLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGY 862
            L YLH      IIHRD+K+ NIL   D +  +ADFG++         +   S  G+  +
Sbjct: 122 ALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--QRRDSFIGTPYW 176

Query: 863 IAPEYAYTL-----KVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVS 917
           +APE            D K+DV+S G+ L+E+   + P  E      +++  +     ++
Sbjct: 177 MAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLA 236

Query: 918 QPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREV 965
           QPS  +S                  +       C+E    AR T  ++
Sbjct: 237 QPSRWSS------------------NFKDFLKKCLEKNVDARWTTSQL 266

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (447), Expect = 3e-50
 Identities = 60/282 (21%), Positives = 110/282 (39%), Gaps = 29/282 (10%)

Query: 692 ESLKDENIIGKGGAGIVYRGSMPD----GIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIR 747
           E ++    IG+G  G V++G         + VAIK      +      FL E  T+ +  
Sbjct: 7   ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66

Query: 748 HRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYL 807
           H +IV+L+G ++  +   ++ E    G L       +   L   +    A + +  L YL
Sbjct: 67  HPHIVKLIGVITE-NPVWIIMELCTLGEL-RSFLQVRKYSLDLASLILYAYQLSTALAYL 124

Query: 808 HHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEY 867
                   +HRD+ + N+L+ S+    + DFGL+++++D       S       ++APE 
Sbjct: 125 ESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMED-STYYKASKGKLPIKWMAPES 180

Query: 868 AYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLA 927
               +    SDV+ FGV + E++       +     D++  +      +  P +      
Sbjct: 181 INFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN-GERLPMPPN------ 233

Query: 928 VVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHML 969
              P            L+ +   C   + S RP   E+   L
Sbjct: 234 -CPPT-----------LYSLMTKCWAYDPSRRPRFTELKAQL 263

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  178 bits (452), Expect = 6e-50
 Identities = 56/224 (25%), Positives = 99/224 (44%), Gaps = 11/224 (4%)

Query: 675 WKLTAFQRLDFKAEDVLESLKDENIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGND 733
           WK    Q ++ K + VL+       +G G  G+V+R      G + A K ++       +
Sbjct: 9   WKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKE 68

Query: 734 HGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETR 793
                EIQT+  +RH  +V L     + +  +++YE+M  G L E +   +   +  +  
Sbjct: 69  T-VRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVAD-EHNKMSEDEA 126

Query: 794 YRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHV--ADFGLAKFLQDAGASE 851
                +  KGLC++H +     +H D+K  NI+  +     +   DFGL   L      +
Sbjct: 127 VEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP---KQ 180

Query: 852 CMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
            +    G+  + APE A    V   +D++S GV+   L++G  P
Sbjct: 181 SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP 224

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (434), Expect = 4e-48
 Identities = 65/299 (21%), Positives = 120/299 (40%), Gaps = 32/299 (10%)

Query: 687 AEDVLESLKDENIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGR 745
             D  +       IG+G +G VY    +  G +VAI+++  +     +   + EI  +  
Sbjct: 15  VGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL-IINEILVMRE 73

Query: 746 IRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLC 805
            ++ NIV  L      D   ++ EY+  GSL +++       +       +  E  + L 
Sbjct: 74  NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALE 130

Query: 806 YLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAP 865
           +LH +    +IHRD+KS+NILL  D    + DFG    +         S++ G+  ++AP
Sbjct: 131 FLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKRSTMVGTPYWMAP 185

Query: 866 EYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASV 925
           E         K D++S G++ +E+I G+ P         +       T E+  P   +++
Sbjct: 186 EVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAI 245

Query: 926 LAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHM----LANPPQSAPSLI 980
                                    C++ +   R + +E++      +A P  S   LI
Sbjct: 246 FR------------------DFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLSSLTPLI 286

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (426), Expect = 4e-47
 Identities = 58/228 (25%), Positives = 89/228 (39%), Gaps = 11/228 (4%)

Query: 697 ENIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGND--HGFLAEIQTLGRIRHRNIVR 753
             I+G+G    V     +    + AIK L  R     +       E   + R+ H   V+
Sbjct: 13  GKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 72

Query: 754 LLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSP 813
           L     + +       Y  NG L + +   K G            E    L YLH     
Sbjct: 73  LYFTFQDDEKLYFGLSYAKNGELLKYIR--KIGSFDETCTRFYTAEIVSALEYLH---GK 127

Query: 814 LIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKV 873
            IIHRD+K  NILL+ D    + DFG AK L         +S  G+  Y++PE       
Sbjct: 128 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSA 187

Query: 874 DEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSD 921
            + SD+++ G ++ +L+AG  P   F  G + + + +    E   P  
Sbjct: 188 CKSSDLWALGCIIYQLVAGLPP---FRAGNEYLIFQKIIKLEYDFPEK 232

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (425), Expect = 5e-47
 Identities = 66/301 (21%), Positives = 120/301 (39%), Gaps = 45/301 (14%)

Query: 692 ESLKDENIIGKGGAGIVYRG--------SMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTL 743
           + L     +G+G  G V                  VA+K L    T  +    ++E++ +
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72

Query: 744 GRI-RHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKG--------------GHL 788
             I +H+NI+ LLG  +      ++ EY   G+L E L   +                 L
Sbjct: 73  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132

Query: 789 KWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAG 848
             +     A + A+G+ YL    S   IHRD+ + N+L+  D    +ADFGLA+ +    
Sbjct: 133 SSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189

Query: 849 ASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRW 908
             +  ++      ++APE  +      +SDV+SFGV+L E+              ++ + 
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 249

Query: 909 VRKTTSEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHM 968
           +++    + +PS+  +                   L+ +   C     S RPT +++V  
Sbjct: 250 LKEGH-RMDKPSNCTN------------------ELYMMMRDCWHAVPSQRPTFKQLVED 290

Query: 969 L 969
           L
Sbjct: 291 L 291

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (413), Expect = 2e-45
 Identities = 64/302 (21%), Positives = 104/302 (34%), Gaps = 43/302 (14%)

Query: 692 ESLKDENIIGKGGAGIVYRG------SMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGR 745
           + LK    +G+G  G V                VA+K L    T       ++E++ L  
Sbjct: 13  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72

Query: 746 IRHRNIVRLLGYVSNRDTN--LLLYEYMPNGSLGEMLHGAKG--------------GHLK 789
           I H   V  L     +     +++ E+   G+L   L   +                 L 
Sbjct: 73  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132

Query: 790 WETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGA 849
            E     + + AKG+ +L        IHRD+ + NILL       + DFGLA+ +     
Sbjct: 133 LEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189

Query: 850 SECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWV 909
                       ++APE  +      +SDV+SFGV+L E+ +            +     
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 249

Query: 910 RKTTSEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHML 969
            K  + +  P                        +++  + C   E S RPT  E+V  L
Sbjct: 250 LKEGTRMRAPDYTTP------------------EMYQTMLDCWHGEPSQRPTFSELVEHL 291

Query: 970 AN 971
            N
Sbjct: 292 GN 293

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  161 bits (409), Expect = 3e-44
 Identities = 49/226 (21%), Positives = 93/226 (41%), Gaps = 11/226 (4%)

Query: 673 KAWKLTAFQRLDFKAEDVLESLKDENIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGG 731
             WK    Q ++ K   V +       +G G  G+V+R      G     K +       
Sbjct: 10  DIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFI-NTPYPL 68

Query: 732 NDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWE 791
           + +    EI  + ++ H  ++ L     ++   +L+ E++  G L + +  A+   +   
Sbjct: 69  DKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIA-AEDYKMSEA 127

Query: 792 TRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHV--ADFGLAKFLQDAGA 849
                  +A +GL ++H      I+H D+K  NI+ ++   + V   DFGLA  L     
Sbjct: 128 EVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP--- 181

Query: 850 SECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
            E +     +  + APE      V   +D+++ GV+   L++G  P
Sbjct: 182 DEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSP 227

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  160 bits (405), Expect = 4e-44
 Identities = 56/214 (26%), Positives = 92/214 (42%), Gaps = 12/214 (5%)

Query: 686 KAEDVLESLKDENIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLG 744
           +AED+ +     +++G G    V           VAIK +  +   G +     EI  L 
Sbjct: 3   QAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLH 62

Query: 745 RIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGL 804
           +I+H NIV L     +     L+ + +  G L + +   + G        R+  +    +
Sbjct: 63  KIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIV--EKGFYTERDASRLIFQVLDAV 120

Query: 805 CYLHHDCSPLIIHRDVKSNNILL---DSDFEAHVADFGLAKFLQDAGASECMSSVAGSYG 861
            YLH      I+HRD+K  N+L    D D +  ++DFGL+K          +S+  G+ G
Sbjct: 121 KYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP---GSVLSTACGTPG 174

Query: 862 YIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
           Y+APE        +  D +S GV+   L+ G  P
Sbjct: 175 YVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 208

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  154 bits (391), Expect = 1e-42
 Identities = 71/282 (25%), Positives = 113/282 (40%), Gaps = 31/282 (10%)

Query: 697 ENIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDH--GFLAEIQTLGRIRHRNIVR 753
             I+G GG   V+    +    DVA+K L             F  E Q    + H  IV 
Sbjct: 12  GEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 71

Query: 754 LLGYVSNRDTNL----LLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHH 809
           +               ++ EY+   +L +++H    G +  +    +  +A + L + H 
Sbjct: 72  VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH--TEGPMTPKRAIEVIADACQALNFSHQ 129

Query: 810 DCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASEC-MSSVAGSYGYIAPEYA 868
           +    IIHRDVK  NI++ +     V DFG+A+ + D+G S    ++V G+  Y++PE A
Sbjct: 130 NG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 186

Query: 869 YTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAV 928
               VD +SDVYS G VL E++ G+ P   F     +    +    +   PS        
Sbjct: 187 RGDSVDARSDVYSLGCVLYEVLTGEPP---FTGDSPVSVAYQHVREDPIPPSA------- 236

Query: 929 VDPRLSGYPLTGVIHLFKVAMMCVEDESSARP-TMREVVHML 969
               LS         L  V +  +      R  T  E+   L
Sbjct: 237 RHEGLSA-------DLDAVVLKALAKNPENRYQTAAEMRADL 271

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (391), Expect = 3e-42
 Identities = 45/211 (21%), Positives = 88/211 (41%), Gaps = 12/211 (5%)

Query: 688 EDVLESLKDENIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRI 746
           +++ E       +G+G  GIV+R            K +  +  G +      EI  L   
Sbjct: 1   KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFV--KVKGTDQVLVKKEISILNIA 58

Query: 747 RHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCY 806
           RHRNI+ L     + +  ++++E++    + E ++      L          +  + L +
Sbjct: 59  RHRNILHLHESFESMEELVMIFEFISGLDIFERIN-TSAFELNEREIVSYVHQVCEALQF 117

Query: 807 LHHDCSPLIIHRDVKSNNILLDSDFEAHV--ADFGLAKFLQDAGASECMSSVAGSYGYIA 864
           LH   S  I H D++  NI+  +   + +   +FG A+ L+     +    +  +  Y A
Sbjct: 118 LH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP---GDNFRLLFTAPEYYA 171

Query: 865 PEYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
           PE      V   +D++S G ++  L++G  P
Sbjct: 172 PEVHQHDVVSTATDMWSLGTLVYVLLSGINP 202

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  153 bits (387), Expect = 1e-41
 Identities = 56/209 (26%), Positives = 91/209 (43%), Gaps = 16/209 (7%)

Query: 693 SLKD---ENIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGND--HGFLAEIQTLGRI 746
           SL+D      +G G  G V+   S  +G   A+K L                E   L  +
Sbjct: 2   SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV 61

Query: 747 RHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCY 806
            H  I+R+ G   +     ++ +Y+  G L  +L  ++         Y   +        
Sbjct: 62  THPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV-----CLA 116

Query: 807 LHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPE 866
           L +  S  II+RD+K  NILLD +    + DFG AK++ D        ++ G+  YIAPE
Sbjct: 117 LEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-----VTYTLCGTPDYIAPE 171

Query: 867 YAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
              T   ++  D +SFG+++ E++AG  P
Sbjct: 172 VVSTKPYNKSIDWWSFGILIYEMLAGYTP 200

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  150 bits (379), Expect = 5e-41
 Identities = 66/285 (23%), Positives = 108/285 (37%), Gaps = 41/285 (14%)

Query: 697 ENIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDH--------GFLAEIQTLGRIR 747
           + I+G+G + +V R    P   + A+K +   G G              L E+  L ++ 
Sbjct: 8   KEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVS 67

Query: 748 -HRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCY 806
            H NI++L           L+++ M  G L + L   +   L  +   +I     + +C 
Sbjct: 68  GHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT--EKVTLSEKETRKIMRALLEVICA 125

Query: 807 LHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPE 866
           LH      I+HRD+K  NILLD D    + DFG +  L      E +  V G+  Y+APE
Sbjct: 126 LHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDP---GEKLREVCGTPSYLAPE 179

Query: 867 YAYT------LKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPS 920
                         ++ D++S GV++  L+AG  P          +  +R   S   Q  
Sbjct: 180 IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF----WHRKQMLMLRMIMSGNYQFG 235

Query: 921 DAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREV 965
                     P    Y  T    +  +    +  +   R T  E 
Sbjct: 236 ---------SPEWDDYSDT----VKDLVSRFLVVQPQKRYTAEEA 267

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (380), Expect = 9e-41
 Identities = 64/255 (25%), Positives = 101/255 (39%), Gaps = 19/255 (7%)

Query: 691 LESLKDENIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGND--HGFLAEIQTLGR-I 746
           +E      ++GKG  G V+           AIK L       +D     + E + L    
Sbjct: 1   IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW 60

Query: 747 RHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCY 806
            H  +  +      ++    + EY+  G L   +                A E   GL +
Sbjct: 61  EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ--SCHKFDLSRATFYAAEIILGLQF 118

Query: 807 LHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPE 866
           LH      I++RD+K +NILLD D    +ADFG+ K      A    ++  G+  YIAPE
Sbjct: 119 LHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK--TNTFCGTPDYIAPE 173

Query: 867 YAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQ--PSDAAS 924
                K +   D +SFGV+L E++ G+ P     D  ++   +R       +    +A  
Sbjct: 174 ILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ-DEEELFHSIRMDNPFYPRWLEKEAKD 232

Query: 925 VLA---VVDP--RLS 934
           +L    V +P  RL 
Sbjct: 233 LLVKLFVREPEKRLG 247

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (376), Expect = 2e-40
 Identities = 66/297 (22%), Positives = 113/297 (38%), Gaps = 24/297 (8%)

Query: 698 NIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHG----FLAEIQTLGRIRHRNIV 752
           + +G+G    VY+         VAIK++          G     L EI+ L  + H NI+
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 753 RLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCS 812
            LL    ++    L++++M       ++       L         L   +GL YLH    
Sbjct: 64  GLLDAFGHKSNISLVFDFMETDLE--VIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW- 120

Query: 813 PLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLK 872
             I+HRD+K NN+LLD +    +ADFGLAK       +   +    +  Y APE  +  +
Sbjct: 121 --ILHRDLKPNNLLLDENGVLKLADFGLAKSFGS--PNRAYTHQVVTRWYRAPELLFGAR 176

Query: 873 V-DEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDP 931
           +     D+++ G +L EL+     +      +D +  + +T    ++             
Sbjct: 177 MYGVGVDMWAVGCILAELLLRVPFL-PGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV 235

Query: 932 RLSGYPLTGVIHLFKVA--------MMCVEDESSARPTMREVVHM--LANPPQSAPS 978
               +P   + H+F  A                 AR T  + + M   +N P   P 
Sbjct: 236 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPG 292

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  149 bits (376), Expect = 2e-40
 Identities = 54/283 (19%), Positives = 99/283 (34%), Gaps = 31/283 (10%)

Query: 700 IGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYV 758
           IG G  G +Y G  +  G +VAIK    +           E +    ++    +  + + 
Sbjct: 15  IGSGSFGDIYLGTDIAAGEEVAIKLECVKT---KHPQLHIESKIYKMMQGGVGIPTIRWC 71

Query: 759 -SNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIH 817
            +  D N+++ E +                   +T   +A +    + Y+H   S   IH
Sbjct: 72  GAEGDYNVMVMELLGPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIH---SKNFIH 126

Query: 818 RDVKSNNIL---LDSDFEAHVADFGLAKFLQDAGASECM-----SSVAGSYGYIAPEYAY 869
           RDVK +N L          ++ DFGLAK  +DA   + +      ++ G+  Y +     
Sbjct: 127 RDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHL 186

Query: 870 TLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVV 929
            ++   + D+ S G VL+    G  P           ++ R +  ++S P         +
Sbjct: 187 GIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP---------I 237

Query: 930 DPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANP 972
           +    GYP             C       +P    +  +  N 
Sbjct: 238 EVLCKGYP----SEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  148 bits (373), Expect = 3e-40
 Identities = 57/284 (20%), Positives = 112/284 (39%), Gaps = 15/284 (5%)

Query: 691 LESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRL-VGRGTGGNDHGFLAEIQTLGRIRHR 749
           +E       IG+G  G+VY+     G   A+K++ + +   G     + EI  L  ++H 
Sbjct: 1   MEKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHS 60

Query: 750 NIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHH 809
           NIV+L   +  +   +L++E++       +      G L+  T     L+   G+ Y H 
Sbjct: 61  NIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDV--CEGGLESVTAKSFLLQLLNGIAYCHD 118

Query: 810 DCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAY 869
                ++HRD+K  N+L++ + E  +ADFGLA+        +    +   +         
Sbjct: 119 RR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPV-RKYTHEIVTLWYRAPDVLMG 174

Query: 870 TLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVV 929
           + K     D++S G +  E++ G        +   ++R  R   +  S+     + L   
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234

Query: 930 DPRLSGYPLTGVIHLFKVA--------MMCVEDESSARPTMREV 965
           DP  + Y         K             ++ + + R T ++ 
Sbjct: 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (369), Expect = 1e-39
 Identities = 51/221 (23%), Positives = 91/221 (41%), Gaps = 18/221 (8%)

Query: 685 FKAEDVLESLKDENIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHG-----FLA 738
           F+ E+V +       +G G   +V +      G+  A K +  R T  +  G        
Sbjct: 3   FRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIER 62

Query: 739 EIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIAL 798
           E+  L  I+H N++ L     N+   +L+ E +  G L + L   +   L  E       
Sbjct: 63  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLA--EKESLTEEEATEFLK 120

Query: 799 EAAKGLCYLHHDCSPLIIHRDVKSNNILLDSD----FEAHVADFGLAKFLQDAGASECMS 854
           +   G   +++  S  I H D+K  NI+L           + DFGLA  +          
Sbjct: 121 QILNG---VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF---GNEFK 174

Query: 855 SVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
           ++ G+  ++APE      +  ++D++S GV+   L++G  P
Sbjct: 175 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 215

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (370), Expect = 4e-39
 Identities = 55/282 (19%), Positives = 107/282 (37%), Gaps = 17/282 (6%)

Query: 698 NIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLG 756
           + IG+G  G+V       + + VAIK++            L EI+ L R RH NI+ +  
Sbjct: 14  SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 73

Query: 757 YVSNRDTNLLLYEYMPNGSLG-EMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLI 815
            +       +   Y+    +G ++    K  HL  +       +  +GL Y+H   S  +
Sbjct: 74  IIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANV 130

Query: 816 IHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASEC-MSSVAGSYGYIAPEYAYTLKVD 874
           +HRD+K +N+LL++  +  + DFGLA+           ++    +  Y APE     K  
Sbjct: 131 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 190

Query: 875 -EKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVD--- 930
            +  D++S G +L E+++ +           +   +    S   +  +    L   +   
Sbjct: 191 TKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLL 250

Query: 931 --PRLSGYPLTGVIH-----LFKVAMMCVEDESSARPTMREV 965
             P  +  P   +          +    +      R  + + 
Sbjct: 251 SLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (362), Expect = 1e-38
 Identities = 54/302 (17%), Positives = 115/302 (38%), Gaps = 19/302 (6%)

Query: 691 LESLKDENIIGKGGAGIVYRG-SMPDGIDVAIKRL-VGRGTGGNDHGFLAEIQTLGRIRH 748
           +E+ +    IG+G  G+VY+  +   G  VA+K++ +   T G     + EI  L  + H
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 60

Query: 749 RNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLH 808
            NIV+LL  +   +   L++E++ +  L + +  +    +          +  +GL + H
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119

Query: 809 HDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPE-Y 867
                 ++HRD+K  N+L++++    +ADFGLA+           +    +  Y APE  
Sbjct: 120 SHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV--RTYTHEVVTLWYRAPEIL 174

Query: 868 AYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLA 927
                     D++S G +  E++  +       +   + R  R   +         + + 
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP 234

Query: 928 VVDPRLSGYPLTGVIHLFKVA--------MMCVEDESSARPTMREVVHM--LANPPQSAP 977
              P    +       +               +  + + R + +  +      +  +  P
Sbjct: 235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVP 294

Query: 978 SL 979
            L
Sbjct: 295 HL 296

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  144 bits (365), Expect = 3e-38
 Identities = 54/213 (25%), Positives = 85/213 (39%), Gaps = 19/213 (8%)

Query: 693 SLKD---ENIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHGFLA-----EIQTL 743
           ++ D     IIG+GG G VY       G   A+K L  +         LA      +  +
Sbjct: 2   TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLV 61

Query: 744 GRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKG 803
                  IV +       D    + + M  G L   L   + G          A E   G
Sbjct: 62  STGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS--QHGVFSEADMRFYAAEIILG 119

Query: 804 LCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYI 863
           L ++H+     +++RD+K  NILLD      ++D GLA         +   +  G++GY+
Sbjct: 120 LEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSK----KKPHASVGTHGYM 172

Query: 864 APEYAYT-LKVDEKSDVYSFGVVLLELIAGKKP 895
           APE     +  D  +D +S G +L +L+ G  P
Sbjct: 173 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 205

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  141 bits (357), Expect = 5e-38
 Identities = 48/283 (16%), Positives = 100/283 (35%), Gaps = 31/283 (10%)

Query: 700 IGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYV 758
           IG+G  G+++ G ++ +   VAIK    R    +      E +T   +     +  + Y 
Sbjct: 13  IGEGSFGVIFEGTNLLNNQQVAIKFEPRRS---DAPQLRDEYRTYKLLAGCTGIPNVYYF 69

Query: 759 SNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHR 818
                + +L   +  G   E L    G     +T    A +    +  +H      +++R
Sbjct: 70  GQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYR 125

Query: 819 DVKSNNILLDSDFEAH-----VADFGLAKFLQDAGASEC-----MSSVAGSYGYIAPEYA 868
           D+K +N L+      +     V DFG+ KF +D    +        +++G+  Y++    
Sbjct: 126 DIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTH 185

Query: 869 YTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAV 928
              +   + D+ + G V +  + G  P        +  ++ R    + S P         
Sbjct: 186 LGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP--------- 236

Query: 929 VDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLAN 971
           +    +G+P       +K           A P    +  + + 
Sbjct: 237 LRELCAGFP----EEFYKYMHYARNLAFDATPDYDYLQGLFSK 275

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (358), Expect = 5e-38
 Identities = 63/284 (22%), Positives = 105/284 (36%), Gaps = 22/284 (7%)

Query: 698 NIIGKGGAGIVYRG--SMPDGIDVAIKRL-VGRGTGGNDHGFLAEI---QTLGRIRHRNI 751
             IG+G  G V++       G  VA+KR+ V  G  G     + E+   + L    H N+
Sbjct: 13  AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72

Query: 752 VRLLGYVSNRDTNLLLYEYMPN----GSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYL 807
           VRL    +   T+      +        L   L       +  ET   +  +  +GL +L
Sbjct: 73  VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 132

Query: 808 HHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEY 867
           H      ++HRD+K  NIL+ S  +  +ADFGLA+          ++SV  +  Y APE 
Sbjct: 133 HSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSF---QMALTSVVVTLWYRAPEV 186

Query: 868 AYTLKVDEKSDVYSFGVVLLELIAGKKPV--GEFGDGVDIVRWVRKTTSEVSQPSDAASV 925
                     D++S G +  E+   K         D +  +  V     E   P D A  
Sbjct: 187 LLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALP 246

Query: 926 LAVVDPRLSGYPLTGVIHLFKVA----MMCVEDESSARPTMREV 965
                 + +      V  + ++     + C+    + R +    
Sbjct: 247 RQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (360), Expect = 9e-38
 Identities = 68/290 (23%), Positives = 108/290 (37%), Gaps = 27/290 (9%)

Query: 693 SLKDENIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNI 751
           S  D  +IG G  G+VY+      G  VAIK+++      +      E+Q + ++ H NI
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNI 75

Query: 752 VRLLGYVSNRDTN------LLLYEYMPNGSLGEMLHGAK-GGHLKWETRYRIALEAAKGL 804
           VRL  +  +           L+ +Y+P        H ++    L          +  + L
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135

Query: 805 CYLHHDCSPLIIHRDVKSNNILLDSDFEAH-VADFGLAKFLQDAGASECMSSVAGSYGYI 863
            Y+H   S  I HRD+K  N+LLD D     + DFG AK L        +S +   Y   
Sbjct: 136 AYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG--EPNVSYICSRYYRA 190

Query: 864 APEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRK--TTSEVSQPSD 921
                         DV+S G VL EL+ G+           +V  ++   T +       
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 250

Query: 922 AASVLAVVDPRLSGYPLTGVI------HLFKVAMMCVEDESSARPTMREV 965
             +      P++  +P T V           +    +E   +AR T  E 
Sbjct: 251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (352), Expect = 2e-37
 Identities = 63/277 (22%), Positives = 108/277 (38%), Gaps = 45/277 (16%)

Query: 699 IIGKGGAGIVYRG-SMPDGIDVAIKRL-----VGRGTGGNDHGFLAEIQTLGRIR--HRN 750
           ++G GG G VY G  + D + VAIK +        G   N      E+  L ++      
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70

Query: 751 IVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHD 810
           ++RLL +    D+ +L+ E              + G L+ E       +  + + + H+ 
Sbjct: 71  VIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSFFWQVLEAVRHCHNC 129

Query: 811 CSPLIIHRDVKSNNILLDSD-FEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEY-A 868
               ++HRD+K  NIL+D +  E  + DFG    L+D       +   G+  Y  PE+  
Sbjct: 130 G---VLHRDIKDENILIDLNRGELKLIDFGSGALLKD----TVYTDFDGTRVYSPPEWIR 182

Query: 869 YTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAV 928
           Y       + V+S G++L +++ G  P   F    +I+R        VS  S+   ++  
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCGDIP---FEHDEEIIRGQVFFRQRVS--SECQHLI-- 235

Query: 929 VDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREV 965
                                 C+    S RPT  E+
Sbjct: 236 --------------------RWCLALRPSDRPTFEEI 252

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (343), Expect = 1e-35
 Identities = 45/205 (21%), Positives = 80/205 (39%), Gaps = 15/205 (7%)

Query: 697 ENIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRI-RHRNIVRL 754
             ++G G  G V +  +       A+K L       +      E++   R  +  +IVR+
Sbjct: 17  SQVLGLGINGKVLQIFNKRTQEKFALKML------QDCPKARREVELHWRASQCPHIVRI 70

Query: 755 LGY----VSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHD 810
           +       + R   L++ E +  G L   +               I     + + YLH  
Sbjct: 71  VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH-- 128

Query: 811 CSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYT 870
            S  I HRDVK  N+L  S     +       F ++  +   +++   +  Y+APE    
Sbjct: 129 -SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGP 187

Query: 871 LKVDEKSDVYSFGVVLLELIAGKKP 895
            K D+  D++S GV++  L+ G  P
Sbjct: 188 EKYDKSCDMWSLGVIMYILLCGYPP 212

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (338), Expect = 2e-35
 Identities = 55/279 (19%), Positives = 101/279 (36%), Gaps = 17/279 (6%)

Query: 698 NIIGKGGAGIVYRG-SMPDGIDVAIKRL-VGRGTGGNDHGFLAEIQTLGRIRHRNIVRLL 755
             IG+G  G V++  +      VA+KR+ +     G     L EI  L  ++H+NIVRL 
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67

Query: 756 GYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLI 815
             + +     L++E+            +  G L  E       +  KGL + H      +
Sbjct: 68  DVLHSDKKLTLVFEFCDQDLK--KYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN---V 122

Query: 816 IHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDE 875
           +HRD+K  N+L++ + E  +A+FGLA+             V   +               
Sbjct: 123 LHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA-EVVTLWYRPPDVLFGAKLYST 181

Query: 876 KSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDPRLSG 935
             D++S G +  EL    +P+    D  D ++ + +     ++    +            
Sbjct: 182 SIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPM 241

Query: 936 YPLTGVIHLFKVAM---------MCVEDESSARPTMREV 965
           YP T  +      +           ++     R +  E 
Sbjct: 242 YPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (340), Expect = 2e-35
 Identities = 48/211 (22%), Positives = 87/211 (41%), Gaps = 18/211 (8%)

Query: 698 NIIGKGGAGIVYRG-SMPDGIDVAIKRL-VGRGTGGNDHGFLAEIQTLGRIRHRNIVRLL 755
             IG+G  G V++      G  VA+K++ +     G     L EI+ L  ++H N+V L+
Sbjct: 16  AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 75

Query: 756 G--------YVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYL 807
                    Y   + +  L++++  +   G + +      L    R    L     L  L
Sbjct: 76  EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML-----LNGL 130

Query: 808 HHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS--ECMSSVAGSYGYIAP 865
           ++     I+HRD+K+ N+L+  D    +ADFGLA+    A  S     ++   +  Y  P
Sbjct: 131 YYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPP 190

Query: 866 EYAYTLK-VDEKSDVYSFGVVLLELIAGKKP 895
           E     +      D++  G ++ E+      
Sbjct: 191 ELLLGERDYGPPIDLWGAGCIMAEMWTRSPI 221

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (336), Expect = 8e-35
 Identities = 63/260 (24%), Positives = 94/260 (36%), Gaps = 21/260 (8%)

Query: 693 SLKD---ENIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGND--HGFLAEIQTLGRI 746
           ++ D     ++GKG  G V        G   A+K L        D     + E + L   
Sbjct: 3   TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 62

Query: 747 RHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCY 806
           RH  +  L       D    + EY   G L   L   +      E       E    L  
Sbjct: 63  RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLS--RERVFTEERARFYGAEIVSAL-- 118

Query: 807 LHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPE 866
             +  S  +++RD+K  N++LD D    + DFGL K     GA+       G+  Y+APE
Sbjct: 119 -EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYLAPE 175

Query: 867 YAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQ--PSDAAS 924
                      D +  GVV+ E++ G+ P     D   +   +        +    +A S
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHERLFELILMEEIRFPRTLSPEAKS 234

Query: 925 VLA---VVDP--RLSGYPLT 939
           +LA     DP  RL G P  
Sbjct: 235 LLAGLLKKDPKQRLGGGPSD 254

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  130 bits (327), Expect = 2e-33
 Identities = 47/208 (22%), Positives = 81/208 (38%), Gaps = 13/208 (6%)

Query: 691 LESLKDENIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGND--HGFLAEIQTLGRIR 747
           L+       +G G  G V        G   A+K L  +           L E + L  + 
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99

Query: 748 HRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYL 807
              +V+L     +     ++ EY+  G +   L   + G          A +      YL
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR--RIGRFSEPHARFYAAQIVLTFEYL 157

Query: 808 HHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEY 867
           H      +I+RD+K  N+L+D      V DFG AK ++         ++ G+   +APE 
Sbjct: 158 HSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWTLCGTPEALAPEI 209

Query: 868 AYTLKVDEKSDVYSFGVVLLELIAGKKP 895
             +   ++  D ++ GV++ E+ AG  P
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (318), Expect = 3e-32
 Identities = 56/220 (25%), Positives = 90/220 (40%), Gaps = 13/220 (5%)

Query: 681 QRLDFKAEDVLESLKDENIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHG-FLA 738
           Q +   A +V    +D   +G G  G V        G  VAIK+L               
Sbjct: 7   QEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYR 66

Query: 739 EIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGA--KGGHLKWETRYRI 796
           E++ L  +RH N++ LL   +  +T     ++           G   K   L  +    +
Sbjct: 67  ELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFL 126

Query: 797 ALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSV 856
             +  KGL Y+H      IIHRD+K  N+ ++ D E  + DFGLA+          M+  
Sbjct: 127 VYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQA-----DSEMTGY 178

Query: 857 AGSYGYIAPEYAY-TLKVDEKSDVYSFGVVLLELIAGKKP 895
             +  Y APE     ++  +  D++S G ++ E+I GK  
Sbjct: 179 VVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTL 218

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score =  123 bits (309), Expect = 2e-31
 Identities = 84/316 (26%), Positives = 129/316 (40%), Gaps = 15/316 (4%)

Query: 24  CAYSDMDVLLKLKSSMIGPKGSGLKNWEPSSSPSAHCSFSGVTCDQDS---RVVSLNVSF 80
           C   D   LL++K  +  P  + L +W P++    + ++ GV CD D+   RV +L++S 
Sbjct: 3   CNPQDKQALLQIKKDLGNP--TTLSSWLPTTDCC-NRTWLGVLCDTDTQTYRVNNLDLSG 59

Query: 81  MPLFG--SIPPEIGLLTKLVNLTIS-NVNLTGRLPSEMALLTSLKVFNISGNVFQGNFAG 137
           + L     IP  +  L  L  L I    NL G +P  +A LT L    I+     G    
Sbjct: 60  LNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAI-P 118

Query: 138 QIVRGMTELQVLDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYI 197
             +  +  L  LD   N  +G LP  I+SL +L  ++F GN  +G IP SY     L   
Sbjct: 119 DFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTS 178

Query: 198 GLNGIGLNGTVPAFLSRLKNLREMYIGYFNTYTGGIPPGFGALTQLQVLDMASCNISGEI 257
               I  N           NL   ++        G         +       + N     
Sbjct: 179 --MTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFD 236

Query: 258 PTSLSRLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTL 317
              +   K L+ L L+ N++ G +P  L+ L  L SL++S N L GEIP+    L+   +
Sbjct: 237 LGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDV 295

Query: 318 LQLFKNNLR--GPIPS 331
                N      P+P+
Sbjct: 296 SAYANNKCLCGSPLPA 311

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 93.7 bits (231), Expect = 3e-21
 Identities = 65/263 (24%), Positives = 112/263 (42%), Gaps = 7/263 (2%)

Query: 356 NLGRNGKLLILDVTSNHLTG--TIPRDLCKGGKLKSLILMQN-FFIGPIPEELGQCKSLT 412
              +  ++  LD++  +L     IP  L     L  L +      +GPIP  + +   L 
Sbjct: 45  TDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLH 104

Query: 413 KIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLSGELPEKMSGASLNQLK-VANNNITGK 471
            +  +   ++G IP  L  +  L  ++   N LSG LP  +S            N I+G 
Sbjct: 105 YLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGA 164

Query: 472 IPAAIGNLPSLNI-LSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIPYSISQCHSL 530
           IP + G+   L   +++  NRL G+IP    NL +       +           S  ++ 
Sbjct: 165 IPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQ 224

Query: 531 TSVDLSRNSLYGKIPPGISKLIDLSILNLSRNGITGSIPNEMRNMMSLTTLDLSYNNLIG 590
                  +  +     G+SK +  + L+L  N I G++P  +  +  L +L++S+NNL G
Sbjct: 225 KIHLAKNSLAFDLGKVGLSKNL--NGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCG 282

Query: 591 NIPSGGQFLAFNETSFIGNPNLC 613
            IP GG    F+ +++  N  LC
Sbjct: 283 EIPQGGNLQRFDVSAYANNKCLC 305

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 83.6 bits (205), Expect = 7e-18
 Identities = 67/282 (23%), Positives = 102/282 (36%), Gaps = 26/282 (9%)

Query: 314 NLTLLQLFKNNLRG--PIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSN 371
            +  L L   NL    PIPS L + P L  L + G N                       
Sbjct: 51  RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINN---------------------- 88

Query: 372 HLTGTIPRDLCKGGKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGTIPAGLFN 431
            L G IP  + K  +L  L +      G IP+ L Q K+L  + FS N L+GT+P  + +
Sbjct: 89  -LVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISS 147

Query: 432 LPLLNMMELDDNLLSGELPEKMSGASLNQLKVANNNITGKIPAAIGNLPSLNILSLQNNR 491
           LP L  +  D N +SG +P+     S     +  +                      +  
Sbjct: 148 LPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRN 207

Query: 492 LEGEIPVESFNLKMITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYGKIPPGISKL 551
           +        F     T       N        +    +L  +DL  N +YG +P G+++L
Sbjct: 208 MLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQL 267

Query: 552 IDLSILNLSRNGITGSIPNEMRNMMSLTTLDLSYNNLIGNIP 593
             L  LN+S N + G IP +  N+        + N  +   P
Sbjct: 268 KFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCGSP 308

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 74.0 bits (180), Expect = 9e-15
 Identities = 65/269 (24%), Positives = 105/269 (39%), Gaps = 26/269 (9%)

Query: 233 IPPGFGALTQLQVLDMASC-NISGEIPTSLSRLKLLHSLFLQMNKLTGHIPPQLSGLISL 291
           IP     L  L  L +    N+ G IP ++++L  LH L++    ++G IP  LS + +L
Sbjct: 68  IPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTL 127

Query: 292 KSLDLSLNYLTGEIPESFAALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTF 351
            +LD S N L+G +P S ++L NL  +    N + G IP   G F  L        N   
Sbjct: 128 VTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNR-L 186

Query: 352 ELPENLGRNGKLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFIGPIPEELGQCKSL 411
                       L     S ++       L    K    I +    +     ++G  K+L
Sbjct: 187 TGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNL 246

Query: 412 TKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLSGELPEKMSGASLNQLKVANNNITGK 471
             +    N + GT+P GL  L  L+ + +  N L GE+P+                    
Sbjct: 247 NGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-------------------- 286

Query: 472 IPAAIGNLPSLNILSLQNNRLEGEIPVES 500
                GNL   ++ +  NN+     P+ +
Sbjct: 287 ----GGNLQRFDVSAYANNKCLCGSPLPA 311

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (302), Expect = 2e-30
 Identities = 65/262 (24%), Positives = 100/262 (38%), Gaps = 26/262 (9%)

Query: 698 NIIGKGGAGIVYRG----SMPDGIDVAIKRLVGRGTGGNDHG---FLAEIQTLGRIRHR- 749
            ++G G  G V+          G   A+K L                 E Q L  IR   
Sbjct: 30  KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 89

Query: 750 NIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHH 809
            +V L           L+ +Y+  G L   L        +  T + + +   + +  L H
Sbjct: 90  FLVTLHYAFQTETKLHLILDYINGGELFTHLS-----QRERFTEHEVQIYVGEIVLALEH 144

Query: 810 DCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAY 869
                II+RD+K  NILLDS+    + DFGL+K       +E      G+  Y+AP+   
Sbjct: 145 LHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADE-TERAYDFCGTIEYMAPDIVR 203

Query: 870 TLK--VDEKSDVYSFGVVLLELIAGKKP---VGEFGDGVDIVRWVRKTTSEVSQ--PSDA 922
                 D+  D +S GV++ EL+ G  P    GE     +I R + K+     Q   + A
Sbjct: 204 GGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALA 263

Query: 923 ASVLA---VVDP--RLSGYPLT 939
             ++    + DP  RL   P  
Sbjct: 264 KDLIQRLLMKDPKKRLGCGPRD 285

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  119 bits (298), Expect = 8e-30
 Identities = 51/219 (23%), Positives = 86/219 (39%), Gaps = 19/219 (8%)

Query: 698 NIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIR-HRNIVRLL 755
             +G+G    V+   ++ +   V +K L              EI+ L  +R   NI+ L 
Sbjct: 41  RKLGRGKYSEVFEAINITNNEKVVVKIL----KPVKKKKIKREIKILENLRGGPNIITLA 96

Query: 756 GYVSNRDTNL--LLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSP 813
             V +  +    L++E++ N    ++        L          E  K L Y H     
Sbjct: 97  DIVKDPVSRTPALVFEHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHSMG-- 149

Query: 814 LIIHRDVKSNNILLDSDF-EAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLK 872
            I+HRDVK +N+++D +  +  + D+GLA+F       E    VA  Y            
Sbjct: 150 -IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP--GQEYNVRVASRYFKGPELLVDYQM 206

Query: 873 VDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRK 911
            D   D++S G +L  +I  K+P     D  D +  + K
Sbjct: 207 YDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK 245

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (294), Expect = 3e-29
 Identities = 50/222 (22%), Positives = 97/222 (43%), Gaps = 17/222 (7%)

Query: 681 QRLDFKAEDVLESLKDENIIGKGGAGIVYRG-SMPDGIDVAIKRL-VGRGTGGNDHGFLA 738
           Q L+    +V E  ++ + +G G  G V        G+ VA+K+L     +  +      
Sbjct: 7   QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR 66

Query: 739 EIQTLGRIRHRNIVRLLGYVSNRDT-----NLLLYEYMPNGSLGEMLHGAKGGHLKWETR 793
           E++ L  ++H N++ LL   +   +     ++ L  ++       + +  K   L  +  
Sbjct: 67  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGAD---LNNIVKCQKLTDDHV 123

Query: 794 YRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECM 853
             +  +  +GL Y+H      IIHRD+K +N+ ++ D E  + DFGLA+   D    E  
Sbjct: 124 QFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMT 176

Query: 854 SSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
             VA  +          +  ++  D++S G ++ EL+ G+  
Sbjct: 177 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL 218

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (293), Expect = 6e-29
 Identities = 55/215 (25%), Positives = 88/215 (40%), Gaps = 19/215 (8%)

Query: 689 DVLESLKDENIIGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDH-GFLAEIQTLGRI 746
            VL+  ++   IG G  GIV          +VAIK+L               E+  +  +
Sbjct: 14  TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV 73

Query: 747 RHRNIVRLLGYVSNRDTN------LLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEA 800
            H+NI+ LL   + + T        L+ E M       +        L  E    +  + 
Sbjct: 74  NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM-----ELDHERMSYLLYQM 128

Query: 801 AKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSY 860
             G+ +LH      IIHRD+K +NI++ SD    + DFGLA+       S  M+    + 
Sbjct: 129 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVTR 182

Query: 861 GYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
            Y APE    +   E  D++S G ++ E++  K  
Sbjct: 183 YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKIL 217

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  113 bits (282), Expect = 2e-27
 Identities = 45/212 (21%), Positives = 79/212 (37%), Gaps = 20/212 (9%)

Query: 700 IGKGGAGIVYRG-SMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYV 758
           +G G    V+    M +   VA+K +  RG          EI+ L R+   +  +     
Sbjct: 21  LGWGHFSTVWLAKDMVNNTHVAMKIV--RGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 78

Query: 759 SNRDTNLLLY--EYMPNGSLGEM------------LHGAKGGHLKWETRYRIALEAAKGL 804
           +N    LL +     PNG    M            +   +   +      +I+ +   GL
Sbjct: 79  ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138

Query: 805 CYLHHDCSPLIIHRDVKSNNILLDS-DFEAHVADFGLAKFLQDAGASECMSSVAGSYGYI 863
            Y+H  C   IIH D+K  N+L++  D   ++    +A         E  ++   +  Y 
Sbjct: 139 DYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196

Query: 864 APEYAYTLKVDEKSDVYSFGVVLLELIAGKKP 895
           +PE          +D++S   ++ ELI G   
Sbjct: 197 SPEVLLGAPWGCGADIWSTACLIFELITGDFL 228

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  102 bits (254), Expect = 2e-24
 Identities = 70/289 (24%), Positives = 110/289 (38%), Gaps = 16/289 (5%)

Query: 280 HIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQLFKNNLRGPIPSFLGDFPNL 339
            +P  L        LDL  N +T      F  LKNL  L L  N +    P        L
Sbjct: 24  KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81

Query: 340 EVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFIG 399
           E L +  N    ELPE + +  + L +             +      +  L        G
Sbjct: 82  ERLYLSKNQLK-ELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSG 140

Query: 400 PIPEELGQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLSGELPEKMSG-ASL 458
                    K L+ IR +   +  TIP GL   P L  + LD N ++      + G  +L
Sbjct: 141 IENGAFQGMKKLSYIRIADTNIT-TIPQGLP--PSLTELHLDGNKITKVDAASLKGLNNL 197

Query: 459 NQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNISG 518
            +L ++ N+I+     ++ N P L  L L NN+L  ++P    + K I  + + +NNIS 
Sbjct: 198 AKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISA 256

Query: 519 ------EIPYSISQCHSLTSVDLSRNSL-YGKIPPG-ISKLIDLSILNL 559
                   P   ++  S + V L  N + Y +I P     +   + + L
Sbjct: 257 IGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQL 305

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  102 bits (254), Expect = 3e-24
 Identities = 61/287 (21%), Positives = 108/287 (37%), Gaps = 14/287 (4%)

Query: 233 IPPGFGALTQLQVLDMASCNISGEIPTSLSRLKLLHSLFLQMNKLTGHIPPQLSGLISLK 292
           +P          +LD+ +  I+         LK LH+L L  NK++   P   + L+ L+
Sbjct: 25  VPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLE 82

Query: 293 SLDLSLNYLTGEIPESFAALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFE 352
            L LS N L     +    L+ L + +     +R  + + L     +E L       +  
Sbjct: 83  RLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVE-LGTNPLKSSGI 141

Query: 353 LPENLGRNGKLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFIGPIPEELGQCKSLT 412
                    KL  + +   ++T TIP+ L     L  L L  N         L    +L 
Sbjct: 142 ENGAFQGMKKLSYIRIADTNIT-TIPQGLPP--SLTELHLDGNKITKVDAASLKGLNNLA 198

Query: 413 KIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLSGELPEKMSGASLNQLKVANNNITG-- 470
           K+  S N ++      L N P L  + L++N L            +  + + NNNI+   
Sbjct: 199 KLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNISAIG 258

Query: 471 ----KIPAAIGNLPSLNILSLQNNRLE-GEIPVESFN-LKMITSINI 511
                 P       S + +SL +N ++  EI   +F  + +  ++ +
Sbjct: 259 SNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQL 305

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 94.3 bits (233), Expect = 2e-21
 Identities = 42/237 (17%), Positives = 92/237 (38%), Gaps = 6/237 (2%)

Query: 352 ELPENLGRNGKLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFIGPIPEELGQCKSL 411
           ++P++L  +    +LD+ +N +T     D      L +LIL+ N      P        L
Sbjct: 24  KVPKDLPPD--TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81

Query: 412 TKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLSGELPEKMSGASLNQLKVANNNITGK 471
            ++  SKN L          L  L + E +   +   +   ++   + +L       +G 
Sbjct: 82  ERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGI 141

Query: 472 IPAAIGNLPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIPYSISQCHSLT 531
              A   +  L+ + + +  +     +       +T +++  N I+     S+   ++L 
Sbjct: 142 ENGAFQGMKKLSYIRIADTNIT---TIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLA 198

Query: 532 SVDLSRNSLYGKIPPGISKLIDLSILNLSRNGITGSIPNEMRNMMSLTTLDLSYNNL 588
            + LS NS+       ++    L  L+L+ N +   +P  + +   +  + L  NN+
Sbjct: 199 KLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNI 254

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 87.8 bits (216), Expect = 2e-19
 Identities = 60/291 (20%), Positives = 103/291 (35%), Gaps = 29/291 (9%)

Query: 144 TELQVLDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLNGIG 203
            +  +LD  NN  T     +  +LK+L  L    N  +   P +++ +  LE + L+   
Sbjct: 31  PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 90

Query: 204 LNGTVPAFLSRLKNLREMYIGYFNTYTGGIPPGFGALTQLQVLDMASCNI--SGEIPTSL 261
           L          L+ LR       N  T      F  L Q+ V+++ +  +  SG    + 
Sbjct: 91  LKELPEKMPKTLQELRVHE----NEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAF 146

Query: 262 SRLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQLF 321
             +K L  + +    +T  IP  L    SL  L L  N +T     S   L NL  L L 
Sbjct: 147 QGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLS 203

Query: 322 KNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDL 381
            N++       L + P+L  L +  N      P  L  +  + ++ + +N+++     D 
Sbjct: 204 FNSISAVDNGSLANTPHLRELHLNNNKLVKV-PGGLADHKYIQVVYLHNNNISAIGSNDF 262

Query: 382 CKGGKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLN-GTIPAGLFN 431
           C                   P    +  S + +    N +    I    F 
Sbjct: 263 C------------------PPGYNTKKASYSGVSLFSNPVQYWEIQPSTFR 295

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 76.6 bits (187), Expect = 1e-15
 Identities = 47/284 (16%), Positives = 90/284 (31%), Gaps = 23/284 (8%)

Query: 59  HCSFSGVTCDQ----------DSRVVSLNVSFMPLFGSIPPEIGLLTKLVNLTISNVNLT 108
            C    V C                  L++    +      +   L  L  L + N  ++
Sbjct: 9   QCHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS 68

Query: 109 GRLPSEMALLTSLKVFNISGNVFQGNFAGQIVRGMTELQVLDAYNNNFTGPLPVEIASLK 168
              P   A L  L+   +S N  +     ++ + + EL+V +         +   +  + 
Sbjct: 69  KISPGAFAPLVKLERLYLSKNQLK-ELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMI 127

Query: 169 SLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLNGIGLNGTVPAFLSRLKNLREMYIGYFNT 228
            +  L       +G    ++  ++ L YI +    +          L  L        N 
Sbjct: 128 VV-ELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPSLTELHLDG----NK 182

Query: 229 YTGGIPPGFGALTQLQVLDMASCNISGEIPTSLSRLKLLHSLFLQMNKLTGHIPPQLSGL 288
            T         L  L  L ++  +IS     SL+    L  L L  NKL   +P  L+  
Sbjct: 183 ITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADH 241

Query: 289 ISLKSLDLSLNYLTGEIPESFA------ALKNLTLLQLFKNNLR 326
             ++ + L  N ++      F          + + + LF N ++
Sbjct: 242 KYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score =  103 bits (256), Expect = 5e-24
 Identities = 68/382 (17%), Positives = 129/382 (33%), Gaps = 52/382 (13%)

Query: 239 ALTQLQVLDMASCNISGEIPTS-LSRLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLS 297
           AL +     +   N++  +  + L ++  L +  L +  + G     +  L +L  ++ S
Sbjct: 20  ALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDG-----VEYLNNLTQINFS 74

Query: 298 LNYLTGEIPESFAALKNLTLLQL------FKNNLRGPIPSFLGDFPNLEVLQVWGNNFTF 351
            N LT   P     L  L  + +          L            N ++  +       
Sbjct: 75  NNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLT 132

Query: 352 ELPENLGRNGKLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFIGPIPE-------E 404
            L      +  +  +   S   +        +   LK L  +       I          
Sbjct: 133 NLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISV 192

Query: 405 LGQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLSGELPEKMSGASLNQLKVA 464
           L +  +L  +  + N ++   P     L  L+ + L+ N L   +    S  +L  L +A
Sbjct: 193 LAKLTNLESLIATNNQISDITPL--GILTNLDELSLNGNQLKD-IGTLASLTNLTDLDLA 249

Query: 465 NNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESF--------------------NLK 504
           NN I+   P  +  L  L  L L  N++    P+                       NLK
Sbjct: 250 NNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLK 307

Query: 505 MITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYGKIPPGISKLIDLSILNLSRNGI 564
            +T + +  NNIS   P  +S    L  +  + N +       ++ L +++ L+   N I
Sbjct: 308 NLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQI 363

Query: 565 TGSIPNEMRNMMSLTTLDLSYN 586
           +   P  + N+  +T L L+  
Sbjct: 364 SDLTP--LANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 93.9 bits (232), Expect = 6e-21
 Identities = 66/385 (17%), Positives = 124/385 (32%), Gaps = 56/385 (14%)

Query: 248 MASCNISGEIPTS----LSRLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTG 303
           + S  I+ + P +     + L       L    +T  +    + L  + +L      +  
Sbjct: 1   LGSATITQDTPINQIFTDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS 58

Query: 304 EIPESFAALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKL 363
              +    L NLT +    N L    P  L +   L  + +  N      P     N   
Sbjct: 59  --IDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTG 114

Query: 364 LILDVTSNHLTGTIP---------------RDLCKGGKLKSLILMQNFFIGPIPEELGQC 408
           L L          +                 D+     L SL  +         + L   
Sbjct: 115 LTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANL 174

Query: 409 KSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLSGELPEKMSGASLNQLKVANNNI 468
            +L ++  S N ++         L  L  +   +N +S  +       +L++L +  N +
Sbjct: 175 TTLERLDISSNKVSDISVL--AKLTNLESLIATNNQISD-ITPLGILTNLDELSLNGNQL 231

Query: 469 TGKIPAAIGNLPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIP------- 521
                  + +L +L  L L NN++    P+    L  +T + +  N IS   P       
Sbjct: 232 KD--IGTLASLTNLTDLDLANNQISNLAPLS--GLTKLTELKLGANQISNISPLAGLTAL 287

Query: 522 -------------YSISQCHSLTSVDLSRNSLYGKIPPGISKLIDLSILNLSRNGITGSI 568
                          IS   +LT + L  N++    P  +S L  L  L  + N ++   
Sbjct: 288 TNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD-- 343

Query: 569 PNEMRNMMSLTTLDLSYNNLIGNIP 593
            + + N+ ++  L   +N +    P
Sbjct: 344 VSSLANLTNINWLSAGHNQISDLTP 368

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 92.4 bits (228), Expect = 2e-20
 Identities = 75/397 (18%), Positives = 132/397 (33%), Gaps = 34/397 (8%)

Query: 94  LTKLVNLTISNVNLTGRLPSEMALLTSLKVFNISGNVFQGNFAGQIVRGMTELQVLDAYN 153
           L + +   +   N+T  +      L  +          + +  G  V  +  L  ++  N
Sbjct: 21  LAEKMKTVLGKTNVTDTVSQTD--LDQVTTLQADRLGIK-SIDG--VEYLNNLTQINFSN 75

Query: 154 NNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLNGIGLNGTVPAFLS 213
           N  T   P  + +L  L  +    N      P +     +   +              ++
Sbjct: 76  NQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTL----------FNNQIT 123

Query: 214 RLKNLREMYIGYFNTYTGGIPPGFGALTQLQVLDMASCNISGEIPTSLSRLKLLHSLFLQ 273
            +  L+ +        +        AL+ L  L   S          L+ L  L  L + 
Sbjct: 124 DIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDIS 183

Query: 274 MNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQLFKNNLRGPIPSFL 333
            NK        L+ L +L+SL  + N ++   P       NL  L L  N L+      L
Sbjct: 184 SNK--VSDISVLAKLTNLESLIATNNQISDITPLGIL--TNLDELSLNGNQLKD--IGTL 237

Query: 334 GDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDLCKGGKLKSLILM 393
               NL  L +  N  +   P  L    KL  L + +N ++   P           L   
Sbjct: 238 ASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNEN 295

Query: 394 QNFFIGPIPEELGQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLSGELPEKM 453
           Q   I PI       K+LT +    N ++   P  + +L  L  +   +N +S  +    
Sbjct: 296 QLEDISPIS----NLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD-VSSLA 348

Query: 454 SGASLNQLKVANNNITGKIPAAIGNLPSLNILSLQNN 490
           +  ++N L   +N I+   P  + NL  +  L L + 
Sbjct: 349 NLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 92.4 bits (228), Expect = 2e-20
 Identities = 80/387 (20%), Positives = 131/387 (33%), Gaps = 35/387 (9%)

Query: 165 ASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLNGIGLNGTVPAFLSRLKNLREMYIG 224
            +L        G    T  + Q+  ++  +  +  + +G+       +  L NL ++   
Sbjct: 19  TALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFS 74

Query: 225 YFNTYTGGIPPGFGALTQLQVLDMASCNISGEIPTSLSRLKLLHSLFLQMNKLTGHIPP- 283
             N  T   P     LT+L  + M +  I+   P +        +LF         +   
Sbjct: 75  N-NQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNL 131

Query: 284 -----------QLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQLFKNN-LRGPIPS 331
                       +S + +L  L        G        L NLT L+    +  +    S
Sbjct: 132 TNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDIS 191

Query: 332 FLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDLCKGGKLKSLI 391
            L    NLE L    N  +   P  +  N  L  L +  N L       L     L  L 
Sbjct: 192 VLAKLTNLESLIATNNQISDITPLGILTN--LDELSLNGNQLKD--IGTLASLTNLTDLD 247

Query: 392 LMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLSGELPE 451
           L  N      P  L     LT+++   N ++   P  L  L  L  +EL++N L    P 
Sbjct: 248 LANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISPI 303

Query: 452 KMSGASLNQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESFNLKMITSINI 511
                +L  L +  NNI+   P  + +L  L  L   NN++         NL  I  ++ 
Sbjct: 304 SNLK-NLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSA 358

Query: 512 SDNNISGEIPYSISQCHSLTSVDLSRN 538
             N IS   P  ++    +T + L+  
Sbjct: 359 GHNQISDLTP--LANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 87.4 bits (215), Expect = 8e-19
 Identities = 78/373 (20%), Positives = 132/373 (35%), Gaps = 33/373 (8%)

Query: 143 MTELQVLDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLNGI 202
           + ++  L A          VE   L +L  ++F  N  T   P     +  L  I     
Sbjct: 43  LDQVTTLQADRLGIKSIDGVE--YLNNLTQINFSNNQLTDITP--LKNLTKLVDI----- 93

Query: 203 GLNGTVPAFLSRLKNLREMYIGYFNTYTGGIPPGFGALTQLQVLDMASCNISGEIPTSLS 262
                    ++  +      +      TG             + ++ + N       ++S
Sbjct: 94  --------LMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTIS 145

Query: 263 RLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDL-SLNYLTGEIPESFAALKNLTLLQLF 321
            +  L  L        G+    L  L +L +L+   ++          A L NL  L   
Sbjct: 146 DISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIAT 205

Query: 322 KNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDL 381
            N +    P  +    NL+ L + GN         L     L  LD+ +N ++   P  L
Sbjct: 206 NNQISDITPLGI--LTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--L 259

Query: 382 CKGGKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELD 441
               KL  L L  N      P  L    +LT +  ++N L    P    NL  L  + L 
Sbjct: 260 SGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISPI--SNLKNLTYLTLY 315

Query: 442 DNLLSGELPEKMSGASLNQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESF 501
            N +S  +    S   L +L  ANN ++    +++ NL ++N LS  +N++    P+   
Sbjct: 316 FNNISD-ISPVSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTPLA-- 370

Query: 502 NLKMITSINISDN 514
           NL  IT + ++D 
Sbjct: 371 NLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 85.8 bits (211), Expect = 2e-18
 Identities = 71/379 (18%), Positives = 123/379 (32%), Gaps = 33/379 (8%)

Query: 65  VTCDQDSRVVSLNVSFMPLFGSIPPEIGLLTKLVNLTISNVNLTGRLPSEMALLTSLKVF 124
           V+     +V +L    + +  SI   +  L  L  +  SN  LT   P  +  LT L   
Sbjct: 38  VSQTDLDQVTTLQADRLGI-KSIDG-VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDI 93

Query: 125 NISGNVFQGNFAGQIVRGMTELQVLDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKI 184
            ++ N          +  +T L + +    +      +   +   L   +         +
Sbjct: 94  LMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGL 153

Query: 185 PQSYSEIQSLEYIGLNGIGLNGTVPAFLSRLKNLREMYIGYFNTYTGGIPPGFGALTQLQ 244
                     +                L  L NL  +     ++           LT L+
Sbjct: 154 TSLQQLSFGNQVT-------------DLKPLANLTTLERLDISSNKVSDISVLAKLTNLE 200

Query: 245 VLDMASCNISGEIPTSLSRLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGE 304
            L   +  IS   P  +     L  L L  N+L       L+ L +L  LDL+ N ++  
Sbjct: 201 SLIATNNQISDITPLGIL--TNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNL 256

Query: 305 IPESFAALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLL 364
            P   + L  LT L+L  N +    P  L     L  L++  N      P +      L 
Sbjct: 257 AP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISPIS--NLKNLT 310

Query: 365 ILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGT 424
            L +  N+++   P  +    KL+ L    N         L    ++  +    N ++  
Sbjct: 311 YLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDL 366

Query: 425 IPAGLFNLPLLNMMELDDN 443
            P  L NL  +  + L+D 
Sbjct: 367 TP--LANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 40.4 bits (93), Expect = 8e-04
 Identities = 47/279 (16%), Positives = 93/279 (33%), Gaps = 28/279 (10%)

Query: 362 KLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYL 421
           + +   +   ++T T+ +      ++ +L   +   I  I + +    +LT+I FS N L
Sbjct: 23  EKMKTVLGKTNVTDTVSQTDLD--QVTTLQADRLG-IKSI-DGVEYLNNLTQINFSNNQL 78

Query: 422 NGTIPAGLFNLPLLNMMELDDNLLSGELPEKMSGASLNQLKVANNNITGKIPAAIGNLPS 481
               P  L NL  L  + +++N ++   P              N          + NL  
Sbjct: 79  TDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNR 136

Query: 482 LNILSLQNNRLEGEIPVESFNLKMITSINISDNNISG--------------EIPYSISQC 527
           L + S   + +     + S       +       ++                    +++ 
Sbjct: 137 LELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKL 196

Query: 528 HSLTSVDLSRNSLYGKIPPGISKLIDLSILNLSRNGITGSIPNEMRNMMSLTTLDLSYNN 587
            +L S+  + N +    P GI    +L  L+L+ N +       + ++ +LT LDL+ N 
Sbjct: 197 TNLESLIATNNQISDITPLGILT--NLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQ 252

Query: 588 LIGNIPSGG----QFLAFNETSFIGNPNLCLLRNGTCQS 622
           +    P  G      L            L  L   T   
Sbjct: 253 ISNLAPLSGLTKLTELKLGANQISNISPLAGLTALTNLE 291

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 87.1 bits (215), Expect = 4e-20
 Identities = 26/163 (15%), Positives = 55/163 (33%), Gaps = 18/163 (11%)

Query: 698 NIIGKGGAGIVYRGSMPDGIDVAIK---------RLVGRGTGGNDHGFLAEIQTLGRIRH 748
            ++G+G    V+        +  +K         + V       D  F        R   
Sbjct: 6   KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 749 RNIVRLLGYVSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLH 808
           R + +L G    +      Y +  N  L E++   +   ++ E    +     + +   +
Sbjct: 66  RALQKLQGLAVPKV-----YAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFY 120

Query: 809 HDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASE 851
           H     I+H D+   N+L+  +    + DF  +  + + G  E
Sbjct: 121 HRG---IVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGWRE 159

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 86.4 bits (212), Expect = 5e-19
 Identities = 59/263 (22%), Positives = 94/263 (35%), Gaps = 6/263 (2%)

Query: 233 IPPGFGALTQLQVLDMASCNISGEIPTSLSRLKLLHSLFLQMNKLTGHIPPQLSGLISLK 292
           +P G  A +Q   + +    IS     S    + L  L+L  N L        +GL  L+
Sbjct: 26  VPVGIPAASQ--RIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLE 83

Query: 293 SLDLSLNYLTGEI-PESFAALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTF 351
            LDLS N     + P +F  L  L  L L +  L+   P        L+ L +  N    
Sbjct: 84  QLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQA 143

Query: 352 ELPENLGRNGKLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFIGPIPEELGQCKSL 411
              +     G L  L +  N ++    R       L  L+L QN      P        L
Sbjct: 144 LPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRL 203

Query: 412 TKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLSGELPEKMSGASLNQLKVANNNITGK 471
             +    N L+      L  L  L  + L+DN    +   +   A L + + +++ +   
Sbjct: 204 MTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCS 263

Query: 472 IPAAIGNLPSLNILSLQNNRLEG 494
           +P     L   ++  L  N L+G
Sbjct: 264 LPQ---RLAGRDLKRLAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 84.1 bits (206), Expect = 3e-18
 Identities = 59/288 (20%), Positives = 93/288 (32%), Gaps = 30/288 (10%)

Query: 160 LPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLNGIGLNGTVPAFLSRLKNLR 219
           +PV I +  + + +   GN  +     S+   ++L  + L+   L     A  + L  L 
Sbjct: 26  VPVGIPA--ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLE 83

Query: 220 EMYIGYFNTYTGGIPPGFGALTQLQVLDMASCNISGEIPTSLSRLKLLHSLFLQMNKLTG 279
           ++ +          P  F  L +L  L +  C +    P     L  L  L+LQ N L  
Sbjct: 84  QLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQA 143

Query: 280 HIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQLFKNNLRGPIPSFLGDFPNL 339
                   L +L  L L  N ++     +F  L +L  L L +N +    P    D   L
Sbjct: 144 LPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRL 203

Query: 340 EVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFIG 399
             L ++ NN +    E L     L  L +  N                            
Sbjct: 204 MTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR--------------------- 242

Query: 400 PIPEELGQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLSG 447
                      L K R S + +  ++P  L    L     L  N L G
Sbjct: 243 ----ARPLWAWLQKFRGSSSEVPCSLPQRLAGRDLKR---LAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 80.2 bits (196), Expect = 6e-17
 Identities = 53/248 (21%), Positives = 88/248 (35%), Gaps = 4/248 (1%)

Query: 144 TELQVLDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLNGIG 203
              Q +  + N  +        + ++L  L    N        +++ +  LE + L+   
Sbjct: 32  AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91

Query: 204 LNGTV-PAFLSRLKNLREMYIGYFNTYTGGIPPGFGALTQLQVLDMASCNISGEIPTSLS 262
              +V PA    L  L  +++        G     G    LQ L +    +      +  
Sbjct: 92  QLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGL-AALQYLYLQDNALQALPDDTFR 150

Query: 263 RLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQLFK 322
            L  L  LFL  N+++        GL SL  L L  N +    P +F  L  L  L LF 
Sbjct: 151 DLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFA 210

Query: 323 NNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDLC 382
           NNL       L     L+ L++  N +  +          L     +S+ +  ++P+ L 
Sbjct: 211 NNLSALPTEALAPLRALQYLRLNDNPWVCD-CRARPLWAWLQKFRGSSSEVPCSLPQRL- 268

Query: 383 KGGKLKSL 390
            G  LK L
Sbjct: 269 AGRDLKRL 276

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 74.8 bits (182), Expect = 3e-15
 Identities = 46/263 (17%), Positives = 84/263 (31%), Gaps = 10/263 (3%)

Query: 352 ELPENLGRNGKLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFIGPIPEELGQCKSL 411
            +P  +        + +  N ++            L  L L  N               L
Sbjct: 25  AVPVGIPAA--SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82

Query: 412 TKIRFSKNYLNGTI-PAGLFNLPLLNMMELDDNLLSGELPEKMSG-ASLNQLKVANNNIT 469
            ++  S N    ++ PA    L  L+ + LD   L    P    G A+L  L + +N + 
Sbjct: 83  EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ 142

Query: 470 GKIPAAIGNLPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIPYSISQCHS 529
                   +L +L  L L  NR+          L  +  + +  N ++   P++      
Sbjct: 143 ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGR 202

Query: 530 LTSVDLSRNSLYGKIPPGISKLIDLSILNLSRNGITGSIPNEMRNMMS-LTTLDLSYNNL 588
           L ++ L  N+L       ++ L  L  L L+ N          R + + L     S + +
Sbjct: 203 LMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR--ARPLWAWLQKFRGSSSEV 260

Query: 589 IGNIPS---GGQFLAFNETSFIG 608
             ++P    G            G
Sbjct: 261 PCSLPQRLAGRDLKRLAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 67.9 bits (164), Expect = 8e-13
 Identities = 48/256 (18%), Positives = 85/256 (33%), Gaps = 5/256 (1%)

Query: 360 NGKLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKN 419
           N   +        L   +P  +      + + L  N            C++LT +    N
Sbjct: 10  NEPKVTTSCPQQGLQ-AVPVGIPAA--SQRIFLHGNRISHVPAASFRACRNLTILWLHSN 66

Query: 420 YLNGTIPAGLFNLPLLNMMELDDNLLSGELPEKMSG--ASLNQLKVANNNITGKIPAAIG 477
            L     A    L LL  ++L DN     +          L+ L +    +    P    
Sbjct: 67  VLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFR 126

Query: 478 NLPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIPYSISQCHSLTSVDLSR 537
            L +L  L LQ+N L+        +L  +T + +  N IS     +    HSL  + L +
Sbjct: 127 GLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQ 186

Query: 538 NSLYGKIPPGISKLIDLSILNLSRNGITGSIPNEMRNMMSLTTLDLSYNNLIGNIPSGGQ 597
           N +    P     L  L  L L  N ++      +  + +L  L L+ N  + +  +   
Sbjct: 187 NRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPL 246

Query: 598 FLAFNETSFIGNPNLC 613
           +    +     +   C
Sbjct: 247 WAWLQKFRGSSSEVPC 262

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.2 bits (105), Expect = 2e-05
 Identities = 30/158 (18%), Positives = 52/158 (32%), Gaps = 14/158 (8%)

Query: 465 NNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIPYSI 524
              +   +P  I    +   + L  NR+           + +T + +  N ++     + 
Sbjct: 20  QQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAF 76

Query: 525 SQCHSLTSVDLSRNSLYGKIPP-GISKLIDLSILNLSRNGITGSIPNEMRNMMSLTTLDL 583
           +    L  +DLS N+    + P     L  L  L+L R G+    P   R + +L  L L
Sbjct: 77  TGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYL 136

Query: 584 SYNNLIGNIPSGGQFLAFNETSFIGNPNLCLLRNGTCQ 621
             N L                +F    NL  L     +
Sbjct: 137 QDNALQALPDD----------TFRDLGNLTHLFLHGNR 164

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 69.5 bits (168), Expect = 5e-13
 Identities = 65/383 (16%), Positives = 112/383 (29%), Gaps = 38/383 (9%)

Query: 222 YIGYFNTYTGGIPPGFGALTQLQVLDMASCNISGEIPTSLSRLKLLHSLFLQMNKLTGHI 281
           Y   ++ +    PPG G   ++ V  +  C                H L L    L+  +
Sbjct: 6   YYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQ-----------AHELELNNLGLS-SL 53

Query: 282 PPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQLFKNNLRGPIPSFLGDFPNLEV 341
           P        L+SL  S N LT E+PE   +LK+L +       L    P       +   
Sbjct: 54  PELPP---HLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPPLLEYLGVSNNQ 109

Query: 342 LQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFIGPI 401
           L+           + +  +   L            I                      P 
Sbjct: 110 LEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIA------------AGNNQLEELPE 157

Query: 402 PEELGQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLSGELPEKMSGASLNQL 461
            + L    ++     S   L     +    +   N++E    L +      +   +    
Sbjct: 158 LQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYADNNLLK 217

Query: 462 KVANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIP 521
            + +   + +      N  +      Q+             L  +       N  S EI 
Sbjct: 218 TLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIR 277

Query: 522 YSISQCHSLTSVDLSRNSLYGKIPPGISKLIDLSILNLSRNGITGSIPNEMRNMMSLTTL 581
                  SL  +++S N L  ++P    +L     L  S N +   +P   +N   L  L
Sbjct: 278 SLCDLPPSLEELNVSNNKL-IELPALPPRL---ERLIASFNHLA-EVPELPQN---LKQL 329

Query: 582 DLSYNNL--IGNIPSGGQFLAFN 602
            + YN L    +IP   + L  N
Sbjct: 330 HVEYNPLREFPDIPESVEDLRMN 352

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 56.8 bits (135), Expect = 5e-09
 Identities = 21/97 (21%), Positives = 40/97 (41%), Gaps = 9/97 (9%)

Query: 221 MYIGYFNTYTGGIPPGFGALTQLQVLDMASCNISGEIPTSLSRLKLLHSLFLQMNKLTGH 280
             + Y N  +  I         L+ L++++  +  E+P    RL+    L    N L   
Sbjct: 264 PNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLE---RLIASFNHLA-E 318

Query: 281 IPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTL 317
           +P       +LK L +  N L  E P+   ++++L +
Sbjct: 319 VPELPQ---NLKQLHVEYNPLR-EFPDIPESVEDLRM 351

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 50.6 bits (119), Expect = 6e-07
 Identities = 22/94 (23%), Positives = 42/94 (44%), Gaps = 9/94 (9%)

Query: 465 NNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIPYSI 524
            N  + +I +     PSL  L++ NN+L  E+P     L+    +  S N+++ E+P   
Sbjct: 269 LNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLE---RLIASFNHLA-EVPELP 323

Query: 525 SQCHSLTSVDLSRNSLYGKIPPGISKLIDLSILN 558
               +L  + +  N L  + P     + DL + +
Sbjct: 324 Q---NLKQLHVEYNPLR-EFPDIPESVEDLRMNS 353

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 43.3 bits (100), Expect = 1e-04
 Identities = 18/89 (20%), Positives = 31/89 (34%), Gaps = 9/89 (10%)

Query: 131 FQGNFAGQIVRGMTELQVLDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSYSE 190
              N    +      L+ L+  NN     LP   A    L  L    N+   ++P     
Sbjct: 271 ASSNEIRSLCDLPPSLEELNVSNNKLIE-LP---ALPPRLERLIASFNHLA-EVP---EL 322

Query: 191 IQSLEYIGLNGIGLNGTVPAFLSRLKNLR 219
            Q+L+ + +    L    P     +++LR
Sbjct: 323 PQNLKQLHVEYNPLR-EFPDIPESVEDLR 350

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 41.0 bits (94), Expect = 6e-04
 Identities = 15/77 (19%), Positives = 28/77 (36%), Gaps = 10/77 (12%)

Query: 118 LTSLKVFNISGNVFQGNFAGQIVRGMTELQVLDAYNNNFTGPLPVEIASLKSLRHLSFGG 177
             SL+  N+S N        ++      L+ L A  N+    +P      ++L+ L    
Sbjct: 283 PPSLEELNVSNNKLI-----ELPALPPRLERLIASFNHLAE-VP---ELPQNLKQLHVEY 333

Query: 178 NYFTGKIPQSYSEIQSL 194
           N    + P     ++ L
Sbjct: 334 NPLR-EFPDIPESVEDL 349

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 40.2 bits (92), Expect = 0.001
 Identities = 15/67 (22%), Positives = 23/67 (34%), Gaps = 5/67 (7%)

Query: 554 LSILNLSRNGITGSIPNEMRNMMSLTTLDLSYNNLIGNIPSGGQFLAFNETSFIGNPNLC 613
              L L+  G++ S+P    +   L +L  S N+L   +P   Q L            L 
Sbjct: 40  AHELELNNLGLS-SLPELPPH---LESLVASCNSL-TELPELPQSLKSLLVDNNNLKALS 94

Query: 614 LLRNGTC 620
            L     
Sbjct: 95  DLPPLLE 101

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 64.7 bits (156), Expect = 9e-12
 Identities = 43/294 (14%), Positives = 90/294 (30%), Gaps = 37/294 (12%)

Query: 244 QVLDMASCNISGEIPTSLSRLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTG 303
           Q LD+   N+  ++   L    ++ +     + +   +    S    ++ +DLS + +  
Sbjct: 3   QTLDLTGKNLHPDVTGRLLSQGVI-AFRCPRSFMDQPLAEHFS-PFRVQHMDLSNSVIEV 60

Query: 304 E-IPESFAALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELP-------- 354
             +    +    L  L L    L  PI + L    NL  L + G +   E          
Sbjct: 61  STLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSC 120

Query: 355 ENLGRNGKLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFIGPIPEELGQCKSLTKI 414
             L         D T  H+   +        +L      +N     +   + +C +L  +
Sbjct: 121 SRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHL 180

Query: 415 RFSKNYL-NGTIPAGLFNLPLLNMMELDDNLLSGELPEKMSGASLNQLKVANNNITGKIP 473
             S + +         F L  L  + L                          +I  +  
Sbjct: 181 DLSDSVMLKNDCFQEFFQLNYLQHLSLSR----------------------CYDIIPETL 218

Query: 474 AAIGNLPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIPYSISQC 527
             +G +P+L  L +     +G + +    L     + I+ ++ +     +I   
Sbjct: 219 LELGEIPTLKTLQVFGIVPDGTLQLLKEALP---HLQINCSHFTTIARPTIGNK 269

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 61.7 bits (148), Expect = 8e-11
 Identities = 37/288 (12%), Positives = 81/288 (28%), Gaps = 19/288 (6%)

Query: 202 IGLNGTVPAFLSRLKNLREMYIGYFNTYTGGIPPGFGALTQLQVLDMASCNISGE-IPTS 260
           +      P    RL +   +      ++         +  ++Q +D+++  I    +   
Sbjct: 7   LTGKNLHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGI 66

Query: 261 LSRLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQL 320
           LS+   L +L L+  +L+  I   L+   +L  L+           E        +  +L
Sbjct: 67  LSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLN---LSGCSGFSEFALQTLLSSCSRL 123

Query: 321 FKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRD 380
            + NL                                      L     +   +      
Sbjct: 124 DELNLSWCFDFTEKHVQVAVAHVSETITQLN------------LSGYRKNLQKSDLSTLV 171

Query: 381 LCKGGKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSK-NYLNGTIPAGLFNLPLLNMME 439
                 +   +           +E  Q   L  +  S+   +       L  +P L  ++
Sbjct: 172 RRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQ 231

Query: 440 LDDNLLSGELPEKMSGASLNQLKVANNNITGKIPAAIGNLPSLNILSL 487
           +   +  G L       +L  L++  ++ T      IGN  +  I  +
Sbjct: 232 VFGIVPDGTLQLLKE--ALPHLQINCSHFTTIARPTIGNKKNQEIWGI 277

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 57.8 bits (138), Expect = 2e-09
 Identities = 34/276 (12%), Positives = 79/276 (28%), Gaps = 18/276 (6%)

Query: 292 KSLDLSLNYLTGEIPESFAALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTF 351
           ++LDL+   L  ++     +   +   +  ++ +  P+         ++ + +  +    
Sbjct: 3   QTLDLTGKNLHPDVTGRLLSQ-GVIAFRCPRSFMDQPLAEHFS-PFRVQHMDLSNSVIEV 60

Query: 352 E-LPENLGRNGKLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFIGPIPEELGQCKS 410
             L   L +  KL  L +    L+  I   L K   L  L L           +      
Sbjct: 61  STLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSC 120

Query: 411 LTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLSGELPEKMSGASLNQLKVANNNITG 470
                 + ++        +          +    LSG                 N   + 
Sbjct: 121 SRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRK--------------NLQKSD 166

Query: 471 KIPAAIGNLPSLNILSLQNNRLEGEIPVESFNLKMITSINISD-NNISGEIPYSISQCHS 529
                      +++    +  L+ +   E F L  +  +++S   +I  E    + +  +
Sbjct: 167 LSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPT 226

Query: 530 LTSVDLSRNSLYGKIPPGISKLIDLSILNLSRNGIT 565
           L ++ +      G +      L  L I       I 
Sbjct: 227 LKTLQVFGIVPDGTLQLLKEALPHLQINCSHFTTIA 262

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.3 bits (108), Expect = 8e-06
 Identities = 36/242 (14%), Positives = 78/242 (32%), Gaps = 20/242 (8%)

Query: 346 GNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFF-IGPIPEE 404
           G N   ++   L   G ++      + +   +  +     +++ + L  +   +  +   
Sbjct: 9   GKNLHPDVTGRLLSQG-VIAFRCPRSFMDQPLA-EHFSPFRVQHMDLSNSVIEVSTLHGI 66

Query: 405 LGQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLSGELPEKMSGASLNQLKVA 464
           L QC  L  +      L+  I   L     L  + L       E   +   +S ++L   
Sbjct: 67  LSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDEL 126

Query: 465 NNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIPYSI 524
           N +                        ++  +   S  +  +       N    ++   +
Sbjct: 127 NLSWCFDF---------------TEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLV 171

Query: 525 SQCHSLTSVDLSRNSLY-GKIPPGISKLIDLSILNLSR-NGITGSIPNEMRNMMSLTTLD 582
            +C +L  +DLS + +          +L  L  L+LSR   I      E+  + +L TL 
Sbjct: 172 RRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQ 231

Query: 583 LS 584
           + 
Sbjct: 232 VF 233

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.6 bits (96), Expect = 3e-04
 Identities = 26/240 (10%), Positives = 62/240 (25%), Gaps = 12/240 (5%)

Query: 56  PSAHCSFSGVTCDQDSRVVSLNVSFMPLFGSIPPEI-GLLTKLVNLTISNVNLTGRLPSE 114
           P +             RV  +++S   +  S    I    +KL NL++  + L+  + + 
Sbjct: 31  PRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNT 90

Query: 115 MALLTSLKVFNI--------SGNVFQGNFAGQIVRGMTELQVLDAYNNNFTGPLPVEIAS 166
           +A  ++L   N+               +   ++              +       V    
Sbjct: 91  LAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETI 150

Query: 167 LKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLNGIGLNGTVPAFLSRLKNLREMYIGYF 226
            +            +            +     + + L         +L  L+ + +   
Sbjct: 151 TQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRC 210

Query: 227 NTYTGGIPPGFGALTQLQVLDMASCNISGEIPTSLSRLKLLHSLFLQMNKLTGHIPPQLS 286
                      G +  L+ L +      G +      L     L +  +  T    P + 
Sbjct: 211 YDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALP---HLQINCSHFTTIARPTIG 267

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 58.6 bits (140), Expect = 7e-10
 Identities = 41/208 (19%), Positives = 69/208 (33%), Gaps = 8/208 (3%)

Query: 286 SGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVW 345
           S + S   ++     LT  +P      K+ T+L L +N L     + L  +  L  L + 
Sbjct: 7   SKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLD 63

Query: 346 GNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFIGPIPEEL 405
               T    +        L     S++   ++P        L  L +  N         L
Sbjct: 64  RAELTKLQVDGTLPV---LGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGAL 120

Query: 406 GQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLSGELPEKMSG-ASLNQLKVA 464
                L ++    N L    P  L   P L  + L +N L+      ++G  +L+ L + 
Sbjct: 121 RGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQ 180

Query: 465 NNNITGKIPAAIGNLPSLNILSLQNNRL 492
            N++   IP        L    L  N  
Sbjct: 181 ENSLY-TIPKGFFGSHLLPFAFLHGNPW 207

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 55.9 bits (133), Expect = 5e-09
 Identities = 31/184 (16%), Positives = 45/184 (24%), Gaps = 7/184 (3%)

Query: 144 TELQVLDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLNGIG 203
            +  +L    N         +     L  L+                  +L  +G   + 
Sbjct: 31  KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAEL-----TKLQVDGTLPVLGTLDLS 85

Query: 204 LNGTVPAFLSRLKNLREMYIGYFNTYTGGIPPGFGALTQLQVLDMASCNISGEIPTSLSR 263
            N      L          +         +P G               N    +P  L  
Sbjct: 86  HNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLT 145

Query: 264 LKLLHSL-FLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQLFK 322
                    L  N LT      L+GL +L +L L  N L   IP+ F     L    L  
Sbjct: 146 PTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHG 204

Query: 323 NNLR 326
           N   
Sbjct: 205 NPWL 208

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 55.5 bits (132), Expect = 9e-09
 Identities = 17/65 (26%), Positives = 29/65 (44%), Gaps = 3/65 (4%)

Query: 523 SISQCHSLTSVDLSRNSLYGKIPPGISKLIDLSILNLSRNGITGSIPNEMRNMMSLTTLD 582
            +S+  S   V+  + +L   +PP + K  D +IL+LS N +       +     LT L+
Sbjct: 5   EVSKVASHLEVNCDKRNLT-ALPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLN 61

Query: 583 LSYNN 587
           L    
Sbjct: 62  LDRAE 66

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 49.3 bits (116), Expect = 8e-07
 Identities = 37/191 (19%), Positives = 55/191 (28%), Gaps = 8/191 (4%)

Query: 233 IPPGFGALTQLQVLDMASCNISGEIPTSLSRLKLLHSLFLQ-MNKLTGHIPPQLSGLISL 291
           +PP         +L ++   +      +L     L  L L         +   L  L +L
Sbjct: 25  LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGTLPVLGTL 82

Query: 292 KSLDLSLNYLTGEIPESFAALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTF 351
                 L  L        A         +  N L       L     L+ L + GN    
Sbjct: 83  DLSHNQLQSLPLLGQTLPALTVL----DVSFNRLTSLPLGALRGLGELQELYLKGNELKT 138

Query: 352 ELPENLGRNGKLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFIGPIPEELGQCKSL 411
             P  L    KL  L + +N+LT      L     L +L+L +N     IP+       L
Sbjct: 139 LPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLL 197

Query: 412 TKIRFSKNYLN 422
                  N   
Sbjct: 198 PFAFLHGNPWL 208

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 49.3 bits (116), Expect = 8e-07
 Identities = 26/187 (13%), Positives = 47/187 (25%), Gaps = 47/187 (25%)

Query: 448 ELPEKMSGASLNQLKVANNNITGKIPAAIGNLPSLNILSLQNNR---------------- 491
            LP  +       L ++ N +     A +     L  L+L                    
Sbjct: 24  ALPPDL-PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGTLPVLGTL 82

Query: 492 -----------------------------LEGEIPVESFNLKMITSINISDNNISGEIPY 522
                                        L          L  +  + +  N +    P 
Sbjct: 83  DLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPG 142

Query: 523 SISQCHSLTSVDLSRNSLYGKIPPGISKLIDLSILNLSRNGITGSIPNEMRNMMSLTTLD 582
            ++    L  + L+ N+L       ++ L +L  L L  N +  +IP        L    
Sbjct: 143 LLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAF 201

Query: 583 LSYNNLI 589
           L  N  +
Sbjct: 202 LHGNPWL 208

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.1 bits (92), Expect = 9e-04
 Identities = 11/64 (17%), Positives = 26/64 (40%), Gaps = 3/64 (4%)

Query: 476 IGNLPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIPYSISQCHSLTSVDL 535
           +  + S   ++     L   +P +    K  T +++S+N +      ++     LT ++L
Sbjct: 6   VSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNL 62

Query: 536 SRNS 539
            R  
Sbjct: 63  DRAE 66

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 53.1 bits (126), Expect = 3e-08
 Identities = 38/226 (16%), Positives = 74/226 (32%), Gaps = 25/226 (11%)

Query: 305 IPESF--AALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGK 362
           I   F   AL N   +   K+N+   +     D   +  L  +G   T  + E +     
Sbjct: 9   INVIFPDPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TI-EGVQYLNN 64

Query: 363 LLILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLN 422
           L+ L++  N +T   P           L       +  I                 +   
Sbjct: 65  LIGLELKDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTP 124

Query: 423 GTIPAGLFNLPLLNMMELDDNLLSGELPEKM---------------SGASLNQLKVANNN 467
               + L  L L      + + L+G    +                + + L  LK  +N 
Sbjct: 125 LAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNK 184

Query: 468 ITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESFNLKMITSINISD 513
           I+   P  + +LP+L  + L+NN++    P+   N   +  + +++
Sbjct: 185 ISDISP--LASLPNLIEVHLKNNQISDVSPLA--NTSNLFIVTLTN 226

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 48.9 bits (115), Expect = 9e-07
 Identities = 34/217 (15%), Positives = 62/217 (28%), Gaps = 22/217 (10%)

Query: 94  LTKLVNLTISNVNLTGRLPSEMALLTSLKVFNISGNVFQGNFAGQIVRGMTELQVLDAYN 153
           L   + +     N+T  +      L  +   +  G        G  V+ +  L  L+  +
Sbjct: 18  LANAIKIAAGKSNVTDTVTQAD--LDGITTLSAFGTGVT-TIEG--VQYLNNLIGLELKD 72

Query: 154 NNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLNGIGLNGTVPAFLS 213
           N  T   P++  +  +   LS         I    S                    + L 
Sbjct: 73  NQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ 132

Query: 214 RL-------------KNLREMYIGYFNTYTGGIPPGFGALTQLQVLDMASCNISGEIPTS 260
            L               L  +                  L++L  L      IS   P  
Sbjct: 133 VLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP-- 190

Query: 261 LSRLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLS 297
           L+ L  L  + L+ N+++   P  L+   +L  + L+
Sbjct: 191 LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 44.6 bits (104), Expect = 2e-05
 Identities = 37/224 (16%), Positives = 72/224 (32%), Gaps = 19/224 (8%)

Query: 362 KLLILDVTSNHLTGTIP-RDLCKGGKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNY 420
             + +    +++T T+   DL     + +L            E +    +L  +    N 
Sbjct: 20  NAIKIAAGKSNVTDTVTQADL---DGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQ 74

Query: 421 LNGTIPAGLFNLPLLNMMELDDNLLSGELPEKMSGASLNQLKVANNNITGKIPAAIGNLP 480
           +    P    NL  +  +EL  N L          +       +         A + NL 
Sbjct: 75  ITDLAPLK--NLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ 132

Query: 481 SLNILSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIPYSISQCHSLTSVDLSRNSL 540
            L +   Q       I   S    +     +S  N        ++    LT++    N +
Sbjct: 133 VLYLDLNQ-------ITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKI 185

Query: 541 YGKIPPGISKLIDLSILNLSRNGITGSIPNEMRNMMSLTTLDLS 584
               P  ++ L +L  ++L  N I+   P  + N  +L  + L+
Sbjct: 186 SDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 40.4 bits (93), Expect = 5e-04
 Identities = 41/251 (16%), Positives = 69/251 (27%), Gaps = 41/251 (16%)

Query: 239 ALTQLQVLDMASCNISGEIPTSLSRLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSL 298
           AL     +     N++  +  + + L  + +L      +T  I   +  L +L  L+L  
Sbjct: 17  ALANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLELKD 72

Query: 299 NYLTGEIPESFAALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLG 358
           N +T   P             L K        + L +   +  LQ               
Sbjct: 73  NQITDLAPLK----------NLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDV 122

Query: 359 RNGKLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSK 418
                L            I       G      L            L     LT ++   
Sbjct: 123 TPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADD 182

Query: 419 NYLNGTIPAGLFNLPLLNMMELDDNLLSGELPEKMSGASLNQLKVANNNITGKIPAAIGN 478
           N ++   P  L +LP L  + L +N +S   P                         + N
Sbjct: 183 NKISDISP--LASLPNLIEVHLKNNQISDVSP-------------------------LAN 215

Query: 479 LPSLNILSLQN 489
             +L I++L N
Sbjct: 216 TSNLFIVTLTN 226

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 54.6 bits (129), Expect = 4e-08
 Identities = 18/90 (20%), Positives = 29/90 (32%), Gaps = 5/90 (5%)

Query: 243 LQVLDMASCNISGE-IPTSLSRLKLLHSLFLQMNKLTG----HIPPQLSGLISLKSLDLS 297
           +Q LD+    +S       L  L+    + L    LT      I   L    +L  L+L 
Sbjct: 4   IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63

Query: 298 LNYLTGEIPESFAALKNLTLLQLFKNNLRG 327
            N L                 ++ K +L+ 
Sbjct: 64  SNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 51.5 bits (121), Expect = 3e-07
 Identities = 18/109 (16%), Positives = 40/109 (36%), Gaps = 12/109 (11%)

Query: 481 SLNI--LSLQNNRLEGEIPVESF-NLKMITSINISDNNISGE----IPYSISQCHSLTSV 533
           SL+I  L +Q   L      E    L+    + + D  ++      I  ++    +L  +
Sbjct: 1   SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAEL 60

Query: 534 DLSRNSLYGKIPPGISKLID-----LSILNLSRNGITGSIPNEMRNMMS 577
           +L  N L       + + +      +  L+L    +TG+    + + + 
Sbjct: 61  NLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLR 109

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 50.7 bits (119), Expect = 5e-07
 Identities = 15/98 (15%), Positives = 28/98 (28%), Gaps = 13/98 (13%)

Query: 500 SFNLKMITSINISDNNISGE-IPYSISQCHSLTSVDLSRNSLYGK----IPPGISKLIDL 554
           S +++   S++I    +S       +        V L    L       I   +     L
Sbjct: 1   SLDIQ---SLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPAL 57

Query: 555 SILNLSRNGITGSIPNEM-----RNMMSLTTLDLSYNN 587
           + LNL  N +     + +          +  L L    
Sbjct: 58  AELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCC 95

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 49.6 bits (116), Expect = 1e-06
 Identities = 16/96 (16%), Positives = 35/96 (36%), Gaps = 15/96 (15%)

Query: 502 NLKMITSINISDNNISGE----IPYSISQCHSLTSVDLSRNSLYGKIPPGISKLID---- 553
              ++  + ++D ++S      +  ++   HSL  +DLS N L       + + +     
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426

Query: 554 -LSILNLSRNGITGSIPNEMRNMMSLTTLDLSYNNL 588
            L  L L     +  + +       L  L+    +L
Sbjct: 427 LLEQLVLYDIYWSEEMEDR------LQALEKDKPSL 456

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 49.2 bits (115), Expect = 2e-06
 Identities = 16/83 (19%), Positives = 27/83 (32%), Gaps = 6/83 (7%)

Query: 529 SLTSVDLSRNSLYGKIPPGI-SKLIDLSILNLSRNGITG----SIPNEMRNMMSLTTLDL 583
            + S+D+    L       +   L    ++ L   G+T      I + +R   +L  L+L
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 584 SYNNLIGNIPSG-GQFLAFNETS 605
             N L         Q L      
Sbjct: 63  RSNELGDVGVHCVLQGLQTPSCK 85

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.4 bits (113), Expect = 3e-06
 Identities = 19/115 (16%), Positives = 36/115 (31%), Gaps = 26/115 (22%)

Query: 289 ISLKSLDLSLNYLTGE-IPESFAALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGN 347
           + ++SLD+    L+     E    L+   +++L    L                      
Sbjct: 2   LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCK---------------- 45

Query: 348 NFTFELPENLGRNGKLLILDVTSNHLTGTIPRDLCKG-----GKLKSLILMQNFF 397
               ++   L  N  L  L++ SN L       + +G      K++ L L     
Sbjct: 46  ----DISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCL 96

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 47.3 bits (110), Expect = 6e-06
 Identities = 19/89 (21%), Positives = 31/89 (34%), Gaps = 13/89 (14%)

Query: 267 LHSLFLQMNKLTG----HIPPQLSGLISLKSLDLSLNYLTGEIPESFA-ALKN----LTL 317
           L  L+L    ++      +   L    SL+ LDLS N L          +++     L  
Sbjct: 371 LRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQ 430

Query: 318 LQLFKNNLRGPIPSFLGDF----PNLEVL 342
           L L+       +   L       P+L V+
Sbjct: 431 LVLYDIYWSEEMEDRLQALEKDKPSLRVI 459

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.4 bits (105), Expect = 3e-05
 Identities = 16/125 (12%), Positives = 35/125 (28%), Gaps = 15/125 (12%)

Query: 500 SFNLKMITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYGK----IPPGISKLIDLS 555
                 I++  + D  +             L  + L+   +       +   +     L 
Sbjct: 341 FLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLR 400

Query: 556 ILNLSRNGITGSIPNE-----MRNMMSLTTLDLSYNNLIGNIPSGGQFLAFNETSFIGNP 610
            L+LS N +  +   +      +    L  L L        +    Q L  +       P
Sbjct: 401 ELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEKD------KP 454

Query: 611 NLCLL 615
           +L ++
Sbjct: 455 SLRVI 459

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.0 bits (104), Expect = 3e-05
 Identities = 14/79 (17%), Positives = 29/79 (36%), Gaps = 9/79 (11%)

Query: 457 SLNQLKVANNNITGK----IPAAIGNLPSLNILSLQNNRLEGEIPVE-----SFNLKMIT 507
            L  L +A+ +++      + A +    SL  L L NN L     ++          ++ 
Sbjct: 370 VLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLE 429

Query: 508 SINISDNNISGEIPYSISQ 526
            + + D   S E+   +  
Sbjct: 430 QLVLYDIYWSEEMEDRLQA 448

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.6 bits (103), Expect = 5e-05
 Identities = 16/81 (19%), Positives = 29/81 (35%), Gaps = 9/81 (11%)

Query: 336 FPNLEVLQVWGNNFTFE----LPENLGRNGKLLILDVTSNHLTGTIPRDLCKG-----GK 386
              L VL +   + +      L   L  N  L  LD+++N L       L +        
Sbjct: 368 GSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCL 427

Query: 387 LKSLILMQNFFIGPIPEELGQ 407
           L+ L+L   ++   + + L  
Sbjct: 428 LEQLVLYDIYWSEEMEDRLQA 448

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.7 bits (98), Expect = 2e-04
 Identities = 8/93 (8%), Positives = 26/93 (27%), Gaps = 9/93 (9%)

Query: 120 SLKVFNISGNVFQGNFAGQIVRGMTELQVLDAYNNNFTG----PLPVEIASLKSLRHLSF 175
            ++  +I           +++  + + QV+   +   T      +   +    +L  L+ 
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 176 GGNYFTGKIPQSYSEI-----QSLEYIGLNGIG 203
             N           +        ++ + L    
Sbjct: 63  RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCC 95

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.9 bits (96), Expect = 4e-04
 Identities = 18/93 (19%), Positives = 28/93 (30%), Gaps = 14/93 (15%)

Query: 386 KLKSLILMQNFF----IGPIPEELGQCKSLTKIRFSKNYLNGTIPAGLF-----NLPLLN 436
            L+ L L            +   L    SL ++  S N L       L         LL 
Sbjct: 370 VLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLE 429

Query: 437 MMELDDNLLSGELPEKMSGASLNQLKVANNNIT 469
            + L D   S E+ +      L  L+    ++ 
Sbjct: 430 QLVLYDIYWSEEMED-----RLQALEKDKPSLR 457

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.5 bits (95), Expect = 4e-04
 Identities = 17/92 (18%), Positives = 40/92 (43%), Gaps = 12/92 (13%)

Query: 95  TKLVNLTISNVNLTGR----LPSEMALLTSLKVFNISGNVFQGNFAGQIVRGM----TEL 146
           + L  L +++ +++      L + +    SL+  ++S N        Q+V  +      L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428

Query: 147 QVLDAYNNNFTGPLPVEIASLK----SLRHLS 174
           + L  Y+  ++  +   + +L+    SLR +S
Sbjct: 429 EQLVLYDIYWSEEMEDRLQALEKDKPSLRVIS 460

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.7 bits (93), Expect = 8e-04
 Identities = 16/85 (18%), Positives = 28/85 (32%), Gaps = 9/85 (10%)

Query: 141 RGMTELQVLDAYNNNFTGPLPVEIAS----LKSLRHLSFGGNYFTGKIPQSYSEI----- 191
           +  + L+VL   + + +      +A+      SLR L    N           E      
Sbjct: 366 QPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPG 425

Query: 192 QSLEYIGLNGIGLNGTVPAFLSRLK 216
             LE + L  I  +  +   L  L+
Sbjct: 426 CLLEQLVLYDIYWSEEMEDRLQALE 450

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.6 bits (90), Expect = 0.002
 Identities = 16/102 (15%), Positives = 33/102 (32%), Gaps = 8/102 (7%)

Query: 435 LNMMELD--DNLLSGELPEKMSGA--SLNQLKVANNNITGK----IPAAIGNLPSLNILS 486
           L++  LD     LS     ++         +++ +  +T      I +A+   P+L  L+
Sbjct: 2   LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 61

Query: 487 LQNNRLEGEIPVESFNLKMITSINISDNNISGEIPYSISQCH 528
           L++N L               S  I   ++            
Sbjct: 62  LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGV 103

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.2 bits (89), Expect = 0.002
 Identities = 16/126 (12%), Positives = 37/126 (29%), Gaps = 26/126 (20%)

Query: 200 NGIGLNGTVPAFLSRLKNLREMYIGYFNTYTGG---IPPGFGALTQLQVLDMASCNISGE 256
              G+             LR +++   +        +     A   L+ LD+++  +   
Sbjct: 353 EDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDA 412

Query: 257 IPTSLSRLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALK--- 313
               L          ++                 L+ L L   Y + E+ +   AL+   
Sbjct: 413 GILQLVES-------VRQPGC------------LLEQLVLYDIYWSEEMEDRLQALEKDK 453

Query: 314 -NLTLL 318
            +L ++
Sbjct: 454 PSLRVI 459

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.4 bits (87), Expect = 0.004
 Identities = 11/78 (14%), Positives = 22/78 (28%), Gaps = 9/78 (11%)

Query: 313 KNLTLLQLFKNNLRG----PIPSFLGDFPNLEVLQVWGNNFTFELPENLGR-----NGKL 363
             L +L L   ++       + + L    +L  L +  N         L          L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428

Query: 364 LILDVTSNHLTGTIPRDL 381
             L +   + +  +   L
Sbjct: 429 EQLVLYDIYWSEEMEDRL 446

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 52.6 bits (124), Expect = 1e-07
 Identities = 38/327 (11%), Positives = 90/327 (27%), Gaps = 38/327 (11%)

Query: 290 SLKSLDLSLNYLTGE----IPESFAALKNLTLLQLFKNNLRGP----IPSFLGDFPNLEV 341
           S++   L L+ +T E    +        ++  + L  N +       +   +    +LE+
Sbjct: 4   SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEI 63

Query: 342 LQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFIGPI 401
            +           E       LL   +    L      D   G   +  ++       P+
Sbjct: 64  AEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPL 123

Query: 402 PEEL---GQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLSGELPEKMSGASL 458
                           + ++      +     N P L  +    N L     ++ +    
Sbjct: 124 EHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQ 183

Query: 459 NQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLE--------------GEIPVESFNLK 504
           +   +    +        G    L         L+                + +   +  
Sbjct: 184 SHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWP 243

Query: 505 MITSINISDNNISGEIPYSISQC------HSLTSVDLSRNSLYGKIPPGI-----SKLID 553
            +  + ++D  +S     ++           L ++ L  N +       +      K+ D
Sbjct: 244 NLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPD 303

Query: 554 LSILNLSRNGIT--GSIPNEMRNMMSL 578
           L  L L+ N  +    + +E+R + S 
Sbjct: 304 LLFLELNGNRFSEEDDVVDEIREVFST 330

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 48.0 bits (112), Expect = 3e-06
 Identities = 43/306 (14%), Positives = 92/306 (30%), Gaps = 32/306 (10%)

Query: 246 LDMASCNISGEIPTSLSRLKLLHSLFLQMNKLTG----HIPPQLSGLISLKSLDLSLNY- 300
           LD  +      +   L     +  + L  N +       +   ++    L+  + S  + 
Sbjct: 12  LDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFT 71

Query: 301 --LTGEIPESFAALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLG 358
             +  EIPE+   L    L     + +R    +F        +  +  +     L  +  
Sbjct: 72  GRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNN 131

Query: 359 RNGKLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFF----IGPIPEELGQCKSLTKI 414
             G      +        + +       L+S+I  +N      +    +     + L  +
Sbjct: 132 GLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTV 191

Query: 415 RFSKNYLNGTIPAGLFNLPLLNMMELDDNLL----------SGELPEKMSGASLNQLKVA 464
           +  +N +       L    L    EL    L          S       S  +L +L + 
Sbjct: 192 KMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLN 251

Query: 465 NNNITGKIPAAIGN------LPSLNILSLQNNRLEGEIPVE-----SFNLKMITSINISD 513
           +  ++ +  AA+ +         L  L LQ N +E +            +  +  + ++ 
Sbjct: 252 DCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNG 311

Query: 514 NNISGE 519
           N  S E
Sbjct: 312 NRFSEE 317

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 47.2 bits (110), Expect = 5e-06
 Identities = 39/310 (12%), Positives = 88/310 (28%), Gaps = 17/310 (5%)

Query: 199 LNGIGLNG--TVPAFLSRLKNLREMYIGYFNTYTGG---IPPGFGALTQLQVLDMASC-- 251
           L+ I      +V A L    +++E+ +      T     +     +   L++ + +    
Sbjct: 12  LDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFT 71

Query: 252 -NISGEIPTSLSRLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFA 310
             +  EIP +L  L        +++ +                  LS +     +     
Sbjct: 72  GRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNN 131

Query: 311 ALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTS 370
            L      ++ +      +     + P L  +    N       +   +  +   L  T 
Sbjct: 132 GLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTV 191

Query: 371 NHLTGTIPRDLCKGGKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGTIPAGLF 430
             +   I  +  +   L+ L   Q   +  + +        + +  +          GL 
Sbjct: 192 KMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLN 251

Query: 431 NLPLLNMMELDDNLLSGELPEKMSGASLNQLKVANNNITGKIPAAI-----GNLPSLNIL 485
           +     ++         +   K+    L  L++  N I       +       +P L  L
Sbjct: 252 D----CLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFL 307

Query: 486 SLQNNRLEGE 495
            L  NR   E
Sbjct: 308 ELNGNRFSEE 317

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 41.8 bits (96), Expect = 3e-04
 Identities = 15/93 (16%), Positives = 29/93 (31%), Gaps = 5/93 (5%)

Query: 500 SFNLKMITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYGK----IPPGISKLIDLS 555
           S   K +    I+  +    +   + +  S+  + LS N++  +    +   I+   DL 
Sbjct: 4   SIEGKSLKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLE 62

Query: 556 ILNLSRNGITGSIPNEMRNMMSLTTLDLSYNNL 588
           I   S              +  L    L    L
Sbjct: 63  IAEFSDIFTGRVKDEIPEALRLLLQALLKCPKL 95

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 40.2 bits (92), Expect = 9e-04
 Identities = 43/320 (13%), Positives = 91/320 (28%), Gaps = 37/320 (11%)

Query: 313 KNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFE----LPENLGRNGKLLILDV 368
           K+L L  +   + +  + + L +  +++ + + GN    E    L EN+     L I + 
Sbjct: 8   KSLKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEF 66

Query: 369 TSNHLTGTIPRDLCKGGKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGTIPAG 428
           +                ++K  I      +        +C  L  +R S N    T    
Sbjct: 67  SDIFTG-----------RVKDEIPEALRLLLQALL---KCPKLHTVRLSDNAFGPTAQEP 112

Query: 429 LFNLPLLNMMELDDNL-LSGELPEKMSGASLNQLKVANNNITGKIPAAIGNLPSLNILSL 487
           L +    +       L  +G  P+  +  +    ++A N      P     +   N L  
Sbjct: 113 LIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLEN 172

Query: 488 QNNRLEGEIPVESFNLKMITSINISDNNISGEIPYSISQCHSLT------SVDLSRNSLY 541
            + +   +       L  +  +         E        +           +   +   
Sbjct: 173 GSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGS 232

Query: 542 GKIPPGISKLIDLSILNLSRNGITGSIPNEMRNMM------SLTTLDLSYNNLIGNIPSG 595
             +   +    +L  L L+   ++      + +         L TL L YN +  +    
Sbjct: 233 SALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVR- 291

Query: 596 GQFLAFNETSFIGNPNLCLL 615
                         P+L  L
Sbjct: 292 ----TLKTVIDEKMPDLLFL 307

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 39.5 bits (90), Expect = 0.002
 Identities = 11/93 (11%), Positives = 27/93 (29%), Gaps = 8/93 (8%)

Query: 529 SLTSVDLSRNSL----YGKIPPGISKLIDLSILNLSRNGITG----SIPNEMRNMMSLTT 580
           S+    L  +++       +   + +   +  + LS N I       +   + +   L  
Sbjct: 4   SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEI 63

Query: 581 LDLSYNNLIGNIPSGGQFLAFNETSFIGNPNLC 613
            + S            + L     + +  P L 
Sbjct: 64  AEFSDIFTGRVKDEIPEALRLLLQALLKCPKLH 96

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 48.2 bits (114), Expect = 3e-07
 Identities = 22/108 (20%), Positives = 44/108 (40%), Gaps = 6/108 (5%)

Query: 484 ILSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYGK 543
           +L L +  L   +      L ++T +++S N +    P +++    L  +  S N    +
Sbjct: 2   VLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDN--ALE 56

Query: 544 IPPGISKLIDLSILNLSRNGITG-SIPNEMRNMMSLTTLDLSYNNLIG 590
              G++ L  L  L L  N +   +    + +   L  L+L  N+L  
Sbjct: 57  NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 47.8 bits (113), Expect = 4e-07
 Identities = 31/110 (28%), Positives = 48/110 (43%), Gaps = 6/110 (5%)

Query: 244 QVLDMASCNISGEIPTSLSRLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTG 303
           +VL +A  +++  +   L +L L+  L L  N+L    PP L+ L  L+ L    +    
Sbjct: 1   RVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRAL-PPALAALRCLEVLQA--SDNAL 55

Query: 304 EIPESFAALKNLTLLQLFKNNLRG-PIPSFLGDFPNLEVLQVWGNNFTFE 352
           E  +  A L  L  L L  N L+       L   P L +L + GN+   E
Sbjct: 56  ENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 45.1 bits (106), Expect = 3e-06
 Identities = 25/113 (22%), Positives = 45/113 (39%), Gaps = 7/113 (6%)

Query: 401 IPEELGQCKSLTKIRFSKNYLNGTIPA--GLFNLPLLNMMELDDNLLSGELPEKMSGASL 458
           +   L Q   +T +  S N L    PA   L  L +L   +         +    +   L
Sbjct: 12  VLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALE----NVDGVANLPRL 67

Query: 459 NQLKVANNNITG-KIPAAIGNLPSLNILSLQNNRLEGEIPVESFNLKMITSIN 510
            +L + NN +        + + P L +L+LQ N L  E  ++    +M+ S++
Sbjct: 68  QELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVS 120

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 44.7 bits (105), Expect = 5e-06
 Identities = 30/107 (28%), Positives = 45/107 (42%), Gaps = 6/107 (5%)

Query: 270 LFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQLFKNNLRGPI 329
           L L    LT  +   L  L+ +  LDLS N L    P + AAL+ L +LQ   N L    
Sbjct: 3   LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALENVD 59

Query: 330 PSFLGDFPNLEVLQVWGNNFT-FELPENLGRNGKLLILDVTSNHLTG 375
                + P L+ L +  N        + L    +L++L++  N L  
Sbjct: 60  GVA--NLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 41.2 bits (96), Expect = 6e-05
 Identities = 18/124 (14%), Positives = 43/124 (34%), Gaps = 5/124 (4%)

Query: 147 QVLDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLNGIGLNG 206
           +VL   + + T      +  L  + HL    N      P + + ++ LE +         
Sbjct: 1   RVLHLAHKDLTVL--CHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVL--QASDNAL 55

Query: 207 TVPAFLSRLKNLREMYIGYFNTYTGGIPPGFGALTQLQVLDMASCNISGEIPTSLSRLKL 266
                ++ L  L+E+ +               +  +L +L++   ++  E        ++
Sbjct: 56  ENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEM 115

Query: 267 LHSL 270
           L S+
Sbjct: 116 LPSV 119

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 40.5 bits (94), Expect = 1e-04
 Identities = 27/116 (23%), Positives = 44/116 (37%), Gaps = 8/116 (6%)

Query: 207 TVPAFLSRLKNLREMYIGYFNTYTGGIPPGFGALTQLQVLDMASCNISGEIPTSLSRLKL 266
           TV   L +L  +  + +   +     +PP   AL  L+VL     + + E    ++ L  
Sbjct: 11  TVLCHLEQLLLVTHLDLS--HNRLRALPPALAALRCLEVLQA--SDNALENVDGVANLPR 66

Query: 267 LHSLFLQMNKLTGHIPPQ-LSGLISLKSLDLSLNYLTGE---IPESFAALKNLTLL 318
           L  L L  N+L      Q L     L  L+L  N L  E          L +++ +
Sbjct: 67  LQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI 122

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 37.4 bits (86), Expect = 0.002
 Identities = 23/100 (23%), Positives = 42/100 (42%), Gaps = 3/100 (3%)

Query: 424 TIPAGLFNLPLLNMMELDDNLLSGELPEKMSGASLNQLKVANNNITGKIPAAIGNLPSLN 483
           T+   L  L L+  ++L  N L    P   +   L  L+   ++   +    + NLP L 
Sbjct: 11  TVLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQ--ASDNALENVDGVANLPRLQ 68

Query: 484 ILSLQNNRLEGEIPVESF-NLKMITSINISDNNISGEIPY 522
            L L NNRL+    ++   +   +  +N+  N++  E   
Sbjct: 69  ELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGI 108

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 46.5 bits (109), Expect = 4e-06
 Identities = 39/236 (16%), Positives = 78/236 (33%), Gaps = 36/236 (15%)

Query: 86  SIPPEIGLLTKLVNLTISNVNLTGRLPSEMALLTSLKVFNISGNVFQGNFAGQIVRGMTE 145
           ++P  I  +                      +  +LK  +++  V Q          +  
Sbjct: 9   TVPTPIKQIFSDDAF-------------AETIKDNLKKKSVTDAVTQNE--------LNS 47

Query: 146 LQVLDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLNGIGLN 205
           +  + A N++      ++   L ++  L   GN  T   P +           L  +G  
Sbjct: 48  IDQIIANNSDIKSVQGIQ--YLPNVTKLFLNGNKLTDIKPLA----------NLKNLGWL 95

Query: 206 GTVPAFLSRLKNLREMYIGYFNTYTGGIPPGFGALTQLQVLDMASCNISGEIPTSLSRLK 265
                 +  L +L+++      +           L  L  L+      +     ++    
Sbjct: 96  FLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQLESLYLGNNKITDITVLSRL 155

Query: 266 LLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQLF 321
                    +     I P L+GL  L++L LS N+++     + A LKNL +L+LF
Sbjct: 156 TKLDTLSLEDNQISDIVP-LAGLTKLQNLYLSKNHISD--LRALAGLKNLDVLELF 208

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 39.2 bits (90), Expect = 0.001
 Identities = 31/188 (16%), Positives = 59/188 (31%), Gaps = 48/188 (25%)

Query: 435 LNMMELDDNLLSGELPEKMSGASLNQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLEG 494
           L    + D +   EL       S++Q+   N++I       I  LP++  L L  N+L  
Sbjct: 31  LKKKSVTDAVTQNELN------SIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGNKLTD 82

Query: 495 EIPVESFNLKMITSIN------------------ISDNNISGEIPYSISQCHSLTSVDLS 536
             P+ +        ++                  +S  +        +     L S+ L 
Sbjct: 83  IKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQLESLYLG 142

Query: 537 RNSLYGKI--------------------PPGISKLIDLSILNLSRNGITGSIPNEMRNMM 576
            N +                           ++ L  L  L LS+N I+  +   +  + 
Sbjct: 143 NNKITDITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHIS-DLR-ALAGLK 200

Query: 577 SLTTLDLS 584
           +L  L+L 
Sbjct: 201 NLDVLELF 208

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 39.2 bits (90), Expect = 0.001
 Identities = 26/212 (12%), Positives = 67/212 (31%), Gaps = 19/212 (8%)

Query: 304 EIPESF--AALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNG 361
            I + F   A        L K ++   +     +  +++ +    ++      + +    
Sbjct: 13  PIKQIFSDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKS--VQGIQYLP 68

Query: 362 KLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYL 421
            +  L +  N LT            LK+L  +             +     K    ++  
Sbjct: 69  NVTKLFLNGNKLTDI-----KPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNG 123

Query: 422 NGTIPAGLFNLPLLNMMELDDNLLSGELPEKMSGASLNQLKVANNNITGKIPAAIGNLPS 481
              I   +    L ++   ++ +    +  +++      L+  +N I+  +P  +  L  
Sbjct: 124 ISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLE--DNQISDIVP--LAGLTK 179

Query: 482 LNILSLQNNRLEGEIPVESF-NLKMITSINIS 512
           L  L L  N +     + +   LK +  + + 
Sbjct: 180 LQNLYLSKNHISD---LRALAGLKNLDVLELF 208

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.4 bits (103), Expect = 1e-05
 Identities = 20/108 (18%), Positives = 41/108 (37%), Gaps = 2/108 (1%)

Query: 507 TSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYGKIPPGI-SKLIDLSILNLSRNGIT 565
           + +  + +    +  + +    +LT + +        +       L +L  L + ++G+ 
Sbjct: 11  SGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR 69

Query: 566 GSIPNEMRNMMSLTTLDLSYNNLIGNIPSGGQFLAFNETSFIGNPNLC 613
              P+       L+ L+LS+N L        Q L+  E    GNP  C
Sbjct: 70  FVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHC 117

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.6 bits (101), Expect = 2e-05
 Identities = 19/170 (11%), Positives = 51/170 (30%), Gaps = 25/170 (14%)

Query: 407 QCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLSGELPEKMSGASLNQLKVANN 466
                + +R +++         L     L  + +++                        
Sbjct: 6   CPHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQ----------------------Q 42

Query: 467 NITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIPYSISQ 526
           ++       +  L  L  L++  + L    P        ++ +N+S N +   + +   Q
Sbjct: 43  HLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQ 101

Query: 527 CHSLTSVDLSRNSLY-GKIPPGISKLIDLSILNLSRNGITGSIPNEMRNM 575
             SL  + LS N L+       + +  +  +  +    +       + +M
Sbjct: 102 GLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHM 151

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 44.0 bits (102), Expect = 3e-05
 Identities = 31/173 (17%), Positives = 58/173 (33%), Gaps = 8/173 (4%)

Query: 401 IPEELGQCKSLTKIRFSKNYLNGTIPAGLFNLP--LLNMMELDDNLLSGELPEKMSGASL 458
           IP ++      T++  + N L      GLF     L+ +    + L   E       + +
Sbjct: 23  IPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHI 80

Query: 459 NQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNISG 518
            +L++  N I          L  L  L+L +N++   +   SF      +     +N   
Sbjct: 81  QELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISC-VMPGSFEHLNSLTSLNLASNPFN 139

Query: 519 EIPYSISQCHSLTSVDLSRNSLYGKIPPGISKLIDLSILNLSRNGITGSIPNE 571
              +       L    L+  +     P    K+ D+ I +L  +    S  N 
Sbjct: 140 CNCHLAWFAEWLRKKSLNGGAARCGAPS---KVRDVQIKDLPHSEFKCSSENS 189

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.3 bits (101), Expect = 3e-05
 Identities = 29/148 (19%), Positives = 57/148 (38%), Gaps = 12/148 (8%)

Query: 458 LNQLKVANNNITGKIPAAIGNL--PSLNILSLQNNRLEGEIPVESFNLKMITSINISDNN 515
           LN+LK     +  ++   +      S   L L+  R + ++        +   +N   ++
Sbjct: 1   LNELK--PEQVE-QLKLIMSKRYDGSQQALDLKGLRSDPDL----VAQNIDVVLNRR-SS 52

Query: 516 ISGEIPYSISQCHSLTSVDLSRNSLYGK--IPPGISKLIDLSILNLSRNGITGSIPNEMR 573
           ++  +         L S++LS N LY    +   + K  +L ILNLS N +      +  
Sbjct: 53  MAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKI 112

Query: 574 NMMSLTTLDLSYNNLIGNIPSGGQFLAF 601
             + L  L L  N+L         +++ 
Sbjct: 113 KGLKLEELWLDGNSLSDTFRDQSTYISA 140

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.1 bits (98), Expect = 6e-05
 Identities = 25/125 (20%), Positives = 43/125 (34%), Gaps = 5/125 (4%)

Query: 256 EIPTSLSRLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNL 315
           ++   +S+        L +  L     P L        L+   +     +      +  L
Sbjct: 11  QLKLIMSKRYDGSQQALDLKGL--RSDPDLVAQNIDVVLNRRSSMAA-TLRIIEENIPEL 67

Query: 316 TLLQLFKNNLRG--PIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHL 373
             L L  N L     + S +   PNL++L + GN    E   +  +  KL  L +  N L
Sbjct: 68  LSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSL 127

Query: 374 TGTIP 378
           + T  
Sbjct: 128 SDTFR 132

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.8 bits (92), Expect = 4e-04
 Identities = 28/120 (23%), Positives = 38/120 (31%), Gaps = 10/120 (8%)

Query: 232 GIPPGFGALTQLQVLDMASCNISGEIPTSLSRLKLLHSLFLQMNKLTGH--IPPQLSGLI 289
              P   A     VL+  S   +  +      +  L SL L  N+L     +   +    
Sbjct: 33  RSDPDLVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAP 91

Query: 290 SLKSLDLSLNYLTGEIPESFAALKNLTLLQLFKNNLRGPIPSF-------LGDFPNLEVL 342
           +LK L+LS N L  E          L  L L  N+L                 FP L  L
Sbjct: 92  NLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRL 151

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.0 bits (90), Expect = 8e-04
 Identities = 23/125 (18%), Positives = 40/125 (32%), Gaps = 7/125 (5%)

Query: 242 QLQVLDMASCNISGEIPTSLSRLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYL 301
             Q LD+            L    +   L  + + +   +      +  L SL+LS N L
Sbjct: 23  SQQALDLKGLRS----DPDLVAQNIDVVLNRR-SSMAATLRIIEENIPELLSLNLSNNRL 77

Query: 302 TG--EIPESFAALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGR 359
               ++        NL +L L  N L+            LE L + GN+ +    +    
Sbjct: 78  YRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTY 137

Query: 360 NGKLL 364
              + 
Sbjct: 138 ISAIR 142

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.5 bits (103), Expect = 3e-05
 Identities = 36/231 (15%), Positives = 67/231 (29%), Gaps = 12/231 (5%)

Query: 268 HSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQLFKNNLRG 327
                Q +K+T  IP  L    +   L   L  L      +F+   +L  +++ +N++  
Sbjct: 11  RVFLCQESKVT-EIPSDLPR--NAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLE 67

Query: 328 PIPSFLGDFPNLEVLQVWG--NNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDLCKGG 385
            I + +               NN  +  PE       L  L +++  +            
Sbjct: 68  VIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSL 127

Query: 386 KLKSLILMQNFFIGPIPEELGQCKS-----LTKIRFSKNYLNGTIPAGLFNLPLLNMMEL 440
           +   L +  N  I  I        S     L   +     ++     G     L      
Sbjct: 128 QKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNN 187

Query: 441 DDNLLSGELPEKMSGASLNQLKVANNNITGKIPAAIGNLPSLNILSLQNNR 491
           +   L  ++    S      L ++   I       + NL  L   S  N +
Sbjct: 188 NLEELPNDVFHGAS--GPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.7 bits (101), Expect = 5e-05
 Identities = 10/72 (13%), Positives = 24/72 (33%), Gaps = 4/72 (5%)

Query: 521 PYSISQCHSLTSVDLSRNSLYGKIPPGISKLIDLSILNLSRNGITGSIPNEMRNMMSLTT 580
            + I  C S        + +  +IP  + +  +   L      +             L  
Sbjct: 2   HHRICHC-SNRVFLCQESKV-TEIPSDLPR--NAIELRFVLTKLRVIQKGAFSGFGDLEK 57

Query: 581 LDLSYNNLIGNI 592
           +++S N+++  I
Sbjct: 58  IEISQNDVLEVI 69

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.0 bits (99), Expect = 7e-05
 Identities = 14/74 (18%), Positives = 17/74 (22%), Gaps = 10/74 (13%)

Query: 267 LHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQLFKNNLR 326
                   N L         G      LD+S   +          LK L        NL+
Sbjct: 179 DELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST--YNLK 236

Query: 327 GPIPSFLGDFPNLE 340
                     P LE
Sbjct: 237 --------KLPTLE 242

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.7 bits (93), Expect = 4e-04
 Identities = 36/238 (15%), Positives = 62/238 (26%), Gaps = 13/238 (5%)

Query: 290 SLKSLDLSLNYLTGEIPESFAALKNLTLLQLFKNNLRGPIPSFLGDFPNLEV--LQVWGN 347
           S +      + +T EIP      +N   L+     LR         F +LE   +     
Sbjct: 9   SNRVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDV 65

Query: 348 NFTFELPENLGRNGKLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFIGPIPEELGQ 407
               E            I    +N+L    P        L+ L++               
Sbjct: 66  LEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIH 125

Query: 408 CKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELD---DNLLSGELPEKMSGASLNQLKVA 464
                 +    N    TI    F       + L    + +                    
Sbjct: 126 SLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSD 185

Query: 465 NNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESF-NLKMITSINISDNNISGEIP 521
           NNN+               IL +   R+   +P     NLK + + +    N+  ++P
Sbjct: 186 NNNLEELPNDVFHGASGPVILDISRTRIH-SLPSYGLENLKKLRARST--YNLK-KLP 239

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.3 bits (92), Expect = 7e-04
 Identities = 23/214 (10%), Positives = 45/214 (21%), Gaps = 6/214 (2%)

Query: 144 TELQVLDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLNGIG 203
                L               +    L  +    N     I           +       
Sbjct: 29  RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKA 88

Query: 204 LNGTVPAFLSRLKNLREMYIGYFNTYTGGIPPG---FGALTQLQVLDMASCNISGEIPTS 260
            N       +        Y+   NT    +P           L  +       + E  + 
Sbjct: 89  NNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSF 148

Query: 261 LSRLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQL 320
           +        L+L  N +        +G    +      N L     + F       +L +
Sbjct: 149 VGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDI 208

Query: 321 FKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELP 354
            +  +       L +   L     +      +LP
Sbjct: 209 SRTRIHSLPSYGLENLKKLRARSTYNLK---KLP 239

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.3 bits (92), Expect = 7e-04
 Identities = 34/230 (14%), Positives = 65/230 (28%), Gaps = 11/230 (4%)

Query: 346 GNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFIGPIPEEL 405
            +  T E+P +L RN   + L      L           G L+ + + QN  +  I  ++
Sbjct: 17  ESKVT-EIPSDLPRN--AIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADV 73

Query: 406 GQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLS-----GELPEKMSGASLNQ 460
                       +   N           L N+  L  +                   L  
Sbjct: 74  FSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLD 133

Query: 461 LKVANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNISGEI 520
           ++   N  T +  + +G      IL L  N ++          ++       +NN+    
Sbjct: 134 IQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELP 193

Query: 521 PYSISQCHSLTSVDLSRNSLYGKIPPGISKLIDLSILNLSRNGITGSIPN 570
                       +D+SR  ++     G+  L  L   +         +P 
Sbjct: 194 NDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNL---KKLPT 240

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.5 bits (90), Expect = 0.001
 Identities = 33/241 (13%), Positives = 58/241 (24%), Gaps = 16/241 (6%)

Query: 59  HCSFSGVTCDQDSRVVSLNVSFMPLFGSIPPEIGLLTKLVNLTISNVNLTGRLPSEMALL 118
           HCS     C +                 IP    L    + L      L        +  
Sbjct: 7   HCSNRVFLCQESK------------VTEIPS--DLPRNAIELRFVLTKLRVIQKGAFSGF 52

Query: 119 TSLKVFNISGNVFQGN-FAGQIVRGMTELQVLDAYNNNFTGPLPVEIASLKSLRHLSFGG 177
             L+   IS N       A          ++     NN     P    +L +L++L    
Sbjct: 53  GDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISN 112

Query: 178 NYFTGKIPQSYSEIQSLEYIGLNGIGLNGTVPAFLSRLKNLREMYIGYFNTYTGGIPPGF 237
                              + +       T+        +   + +         I    
Sbjct: 113 TGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCA 172

Query: 238 GALTQLQVLDMASCNISGEIPT-SLSRLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDL 296
              TQL  L+++  N   E+P            L +   ++       L  L  L++   
Sbjct: 173 FNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST 232

Query: 297 S 297
            
Sbjct: 233 Y 233

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.7 bits (88), Expect = 0.002
 Identities = 41/235 (17%), Positives = 71/235 (30%), Gaps = 11/235 (4%)

Query: 365 ILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGT 424
           +     + +T  IP DL +      L  +                 L KI  S+N +   
Sbjct: 12  VFLCQESKVT-EIPSDLPRN--AIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEV 68

Query: 425 IPAGLFNLPLLNMMELD---DNLLSGELPEKMSGASLNQLKVANNNITGKIPAAIGNLPS 481
           I A +F+             +NLL        +  +L  L ++N  I         +   
Sbjct: 69  IEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQ 128

Query: 482 LNILSLQNNRLEGEIPVESFNLKMIT--SINISDNNISGEIPYSISQCHSLTSVDLSRNS 539
             +L +Q+N     I   SF         + ++ N I      + +            N+
Sbjct: 129 KVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNN 188

Query: 540 LYGKIPPGISKLIDLSILNLSRNGITGSIPNEMRNMMSLTTLDLSYNNLIGNIPS 594
           L               IL++SR  I       + N+  L        NL   +P+
Sbjct: 189 LEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST--YNL-KKLPT 240

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 41.6 bits (96), Expect = 2e-04
 Identities = 34/196 (17%), Positives = 59/196 (30%), Gaps = 14/196 (7%)

Query: 310 AALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVT 369
            AL       L K N+   +     D   +  LQ         + + +     L  ++ +
Sbjct: 15  TALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK-SI-DGVEYLNNLTQINFS 70

Query: 370 SNHLTGTIPRDLCKGGKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGTIPAGL 429
           +N LT   P           +   Q   I P+                 +         L
Sbjct: 71  NNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNL 130

Query: 430 FNLPLLNMMELDDNLLSGELPEKMSGASLNQLKVANNNITGKIPAAIGNLPSLNILSLQN 489
             L L +    D               SL QL  ++N +T   P  + NL +L  L + +
Sbjct: 131 NRLELSSNTISDI-------SALSGLTSLQQLNFSSNQVTDLKP--LANLTTLERLDISS 181

Query: 490 NRLEGEIPVESF-NLK 504
           N++     +    NL+
Sbjct: 182 NKVSDISVLAKLTNLE 197

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 38.9 bits (89), Expect = 0.001
 Identities = 26/190 (13%), Positives = 54/190 (28%), Gaps = 20/190 (10%)

Query: 94  LTKLVNLTISNVNLTGRLPSEMALLTSLKVFNISGNVFQGNFAGQIVRGMTELQVLDAYN 153
           L + +   +   N+T  +      L  +          + +  G  V  +  L  ++  N
Sbjct: 17  LAEKMKTVLGKTNVTDTVSQTD--LDQVTTLQADRLGIK-SIDG--VEYLNNLTQINFSN 71

Query: 154 NNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLNGIGLNGTVPAFLS 213
           N  T   P++  +      ++         +    +      +               L+
Sbjct: 72  NQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLN 131

Query: 214 RLKNLREMYIGYFNTYTGGI-------------PPGFGALTQLQVLDMASCNISGEIPTS 260
           RL+                                    LT L+ LD++S  +S    + 
Sbjct: 132 RLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKPLANLTTLERLDISSNKVSD--ISV 189

Query: 261 LSRLKLLHSL 270
           L++L  L SL
Sbjct: 190 LAKLTNLESL 199

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.3 bits (93), Expect = 3e-04
 Identities = 23/129 (17%), Positives = 45/129 (34%), Gaps = 8/129 (6%)

Query: 491 RLEGEIPVES---FNLKMITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYGKIPPG 547
           +L  E+  ++    N      +++    I   I    +      ++D S N +      G
Sbjct: 2   KLTAELIEQAAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR--KLDG 58

Query: 548 ISKLIDLSILNLSRNGITGSIPNEMRNMMSLTTLDLSYNNL--IGNIPSGGQFLAFNETS 605
              L  L  L ++ N I        + +  LT L L+ N+L  +G++       +     
Sbjct: 59  FPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLC 118

Query: 606 FIGNPNLCL 614
            + NP    
Sbjct: 119 ILRNPVTNK 127

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.9 bits (92), Expect = 4e-04
 Identities = 22/151 (14%), Positives = 49/151 (32%), Gaps = 8/151 (5%)

Query: 438 MELDDNLLSGELPEKMSGASLNQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIP 497
           ++L   L+  +  +  +     +L +    I   I      L   + +   +N +  ++ 
Sbjct: 1   VKLTAELIE-QAAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLD 57

Query: 498 VESFNLKMITSINISDNNISGEIPYSISQCHSLTSVDLSRNSL----YGKIPPGISKLID 553
                L+ + ++ +++N I             LT + L+ NSL           +  L  
Sbjct: 58  GFP-LLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTY 116

Query: 554 LSILNLSRNGITGSIPNEMRNMMSLTTLDLS 584
           L IL              +  +  +  LD  
Sbjct: 117 LCILRNPVTNKKHYRLYVIYKVPQVRVLDFQ 147

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	982
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	99.98
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	99.96
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	99.96
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	99.93
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	99.93
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.91
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.91
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.88
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.88
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.84
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	99.83
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	99.81
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	99.79
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	99.76
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	99.76
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	99.75
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	99.74
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.72
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	99.72
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.7
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.7
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.67
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.66
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.64
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	99.57
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	99.55
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	99.52
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.49
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.49
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	99.49
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.47
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.41
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	99.27
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.27
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.27
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	99.26
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.64
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.39
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.39
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.01
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	97.72
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	97.55
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.52
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	97.12
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	96.88
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.35
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.04
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	95.03

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-49  Score=422.32  Aligned_cols=254  Identities=23%  Similarity=0.290  Sum_probs=210.0

Q ss_pred             HhhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEe
Q 002010          691 LESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYE  769 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  769 (982)
                      .++|++.+.||+|+||+||+|.. .+|+.||||++.........+.+.+|+.++++++|||||++++++.+++..|+|||
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE   83 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   83 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence            46799999999999999999975 56999999999665555556679999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCC
Q 002010          770 YMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGA  849 (982)
Q Consensus       770 ~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  849 (982)
                      |+++|+|.+++.  +...+++.++..++.||++|++|||+++   |+||||||+||++++++.+||+|||+|+.+.....
T Consensus        84 y~~gg~L~~~l~--~~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~  158 (271)
T d1nvra_          84 YCSGGELFDRIE--PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR  158 (271)
T ss_dssp             CCTTEEGGGGSB--TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred             ccCCCcHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCCc
Confidence            999999999996  4568999999999999999999999998   99999999999999999999999999998765444


Q ss_pred             cccccccccccccccccccccCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCccccccee
Q 002010          850 SECMSSVAGSYGYIAPEYAYTLKV-DEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAV  928 (982)
Q Consensus       850 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  928 (982)
                      .......+||+.|||||++.+..+ +.++||||+||++|||++|++||....+...............            
T Consensus       159 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~------------  226 (271)
T d1nvra_         159 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL------------  226 (271)
T ss_dssp             ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTS------------
T ss_pred             cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC------------
Confidence            444566789999999999988876 5789999999999999999999977554433333222211110            


Q ss_pred             ecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          929 VDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       929 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                            ......+..+.+++.+||+.||++|||++|+++
T Consensus       227 ------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         227 ------NPWKKIDSAPLALLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             ------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ------CccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence                  011223457889999999999999999999976

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-49  Score=424.97  Aligned_cols=264  Identities=30%  Similarity=0.437  Sum_probs=212.3

Q ss_pred             hhcccccccccccceEEEEEEeCCCcEEEEEEeccCC-CCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEec
Q 002010          692 ESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRG-TGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEY  770 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  770 (982)
                      ++|+..+.||+|+||+||+|+..  ..||||++.... .....+.|.+|+.++++++|||||++++++. ++..++||||
T Consensus         8 ~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~lv~Ey   84 (276)
T d1uwha_           8 GQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQW   84 (276)
T ss_dssp             TCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEEC
T ss_pred             ccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEEEEec
Confidence            57888999999999999999864  369999985443 3445578899999999999999999999875 4668999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCc
Q 002010          771 MPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS  850 (982)
Q Consensus       771 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  850 (982)
                      +++|+|.+++.. ....+++..+..++.||++||+|||+++   ||||||||+||+++.++.+||+|||+|+........
T Consensus        85 ~~~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~  160 (276)
T d1uwha_          85 CEGSSLYHHLHI-IETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS  160 (276)
T ss_dssp             CCEEEHHHHHHT-SCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC-------
T ss_pred             CCCCCHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccccCCc
Confidence            999999999974 3457999999999999999999999988   999999999999999999999999999877644444


Q ss_pred             cccccccccccccccccccc---CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccce
Q 002010          851 ECMSSVAGSYGYIAPEYAYT---LKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLA  927 (982)
Q Consensus       851 ~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  927 (982)
                      .......||+.|||||++.+   ..|+.++|||||||++|||+||+.||.+..........+.....             
T Consensus       161 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~-------------  227 (276)
T d1uwha_         161 HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYL-------------  227 (276)
T ss_dssp             -----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSC-------------
T ss_pred             ccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCC-------------
Confidence            44556789999999999864   35899999999999999999999999876554444444433222             


Q ss_pred             eecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCCCCC
Q 002010          928 VVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQSAP  977 (982)
Q Consensus       928 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~~~~~  977 (982)
                        .|.....+..++..+.+++.+||+.||++|||++||++.|+.+.+..|
T Consensus       228 --~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~P  275 (276)
T d1uwha_         228 --SPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLP  275 (276)
T ss_dssp             --CCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred             --CCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcCC
Confidence              112223344556789999999999999999999999999988776655

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-48  Score=412.45  Aligned_cols=255  Identities=25%  Similarity=0.443  Sum_probs=203.2

Q ss_pred             hhcccccccccccceEEEEEEeCCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEecc
Q 002010          692 ESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYM  771 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  771 (982)
                      ++|+..+.||+|+||+||+|++.+++.||||++..  .....+++.+|+.++++++|||||+++|++..++..++||||+
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~--~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~   82 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIRE--GAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM   82 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCS--SSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECC--CcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEec
Confidence            46888899999999999999988889999999854  3344578999999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCcc
Q 002010          772 PNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASE  851 (982)
Q Consensus       772 ~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~  851 (982)
                      ++|+|.+++.. ....++++.+..++.||++||+|+|+.+   |+||||||+||++++++.+||+|||+|+...+... .
T Consensus        83 ~~g~L~~~l~~-~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~-~  157 (263)
T d1sm2a_          83 EHGCLSDYLRT-QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-T  157 (263)
T ss_dssp             TTCBHHHHHHT-TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred             CCCcHHHHhhc-cccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCc-e
Confidence            99999999874 3467899999999999999999999988   99999999999999999999999999987754322 2


Q ss_pred             cccccccccccccccccccCCCCcchhhHHHHHHHHHHHhC-CCCCCCCCCCchHHHHHHHhccCCCCCCcccccceeec
Q 002010          852 CMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAG-KKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVD  930 (982)
Q Consensus       852 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  930 (982)
                      ......||+.|+|||++.+..|+.++|||||||++|||+|+ .+||.. .........+..... .              
T Consensus       158 ~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~-~~~~~~~~~i~~~~~-~--------------  221 (263)
T d1sm2a_         158 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN-RSNSEVVEDISTGFR-L--------------  221 (263)
T ss_dssp             -------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCS-CCHHHHHHHHHHTCC-C--------------
T ss_pred             eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCC-CCHHHHHHHHHhcCC-C--------------
Confidence            23346789999999999999999999999999999999995 555543 333334444333221 0              


Q ss_pred             CCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 002010          931 PRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPP  973 (982)
Q Consensus       931 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~  973 (982)
                          ..|..++.++.+++.+||+.||++|||++||++.|+++.
T Consensus       222 ----~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~  260 (263)
T d1sm2a_         222 ----YKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIA  260 (263)
T ss_dssp             ----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ----CCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence                122334457899999999999999999999999998764

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.1e-48  Score=416.44  Aligned_cols=261  Identities=24%  Similarity=0.325  Sum_probs=220.0

Q ss_pred             HhhcccccccccccceEEEEEEeC-CCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEe
Q 002010          691 LESLKDENIIGKGGAGIVYRGSMP-DGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYE  769 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  769 (982)
                      .++|+..+.||+|+||+||+|.+. +++.||||++...  ....+++.+|+.++++++|||||++++++.+++..++|||
T Consensus        16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E   93 (287)
T d1opja_          16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED--TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE   93 (287)
T ss_dssp             GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT--CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc--cchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEee
Confidence            357888999999999999999764 5889999998543  3456779999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCC
Q 002010          770 YMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGA  849 (982)
Q Consensus       770 ~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  849 (982)
                      |+++|+|.+++.......+++..+..++.||++||+|||+++   |+||||||+|||+++++.+||+|||+|+..... .
T Consensus        94 ~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~-~  169 (287)
T d1opja_          94 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD-T  169 (287)
T ss_dssp             CCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSS-S
T ss_pred             cccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecCCC-C
Confidence            999999999998777788999999999999999999999998   999999999999999999999999999877543 2


Q ss_pred             cccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceee
Q 002010          850 SECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVV  929 (982)
Q Consensus       850 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  929 (982)
                      ........|++.|+|||++.+..|+.++||||+||++|||++|..||....+.....+.+.....               
T Consensus       170 ~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~---------------  234 (287)
T d1opja_         170 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR---------------  234 (287)
T ss_dssp             SEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC---------------
T ss_pred             ceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCC---------------
Confidence            23334456889999999999999999999999999999999987776554444444443332211               


Q ss_pred             cCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCCCC
Q 002010          930 DPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQSA  976 (982)
Q Consensus       930 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~~~~  976 (982)
                          ...+...+..+.+++.+||+.||++|||++||++.|+.+.+..
T Consensus       235 ----~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~~  277 (287)
T d1opja_         235 ----MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES  277 (287)
T ss_dssp             ----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSSS
T ss_pred             ----CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhC
Confidence                1223344567999999999999999999999999998876643

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.3e-48  Score=413.72  Aligned_cols=249  Identities=24%  Similarity=0.350  Sum_probs=210.2

Q ss_pred             hhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEec
Q 002010          692 ESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEY  770 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  770 (982)
                      ++|+..+.||+|+||+||+|.. .+|+.||||++... .....+.+.+|+.++++++|||||++++++.+++..|+||||
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy   98 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQ-QQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGG-GCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecc-cChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEe
Confidence            5799999999999999999975 56999999998544 334456789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCc
Q 002010          771 MPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS  850 (982)
Q Consensus       771 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  850 (982)
                      +++|+|.+++..   ..+++.++..++.||+.||+|||+++   |+||||||+||+++.++.+||+|||+|+.+....  
T Consensus        99 ~~gg~L~~~~~~---~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~--  170 (293)
T d1yhwa1          99 LAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--  170 (293)
T ss_dssp             CTTCBHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT--
T ss_pred             cCCCcHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeecccc--
Confidence            999999998863   46999999999999999999999998   9999999999999999999999999998765432  


Q ss_pred             ccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceeec
Q 002010          851 ECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVD  930 (982)
Q Consensus       851 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  930 (982)
                      .......||+.|+|||++.+..|+.++||||+||++|||++|+.||....................              
T Consensus       171 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~--------------  236 (293)
T d1yhwa1         171 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPEL--------------  236 (293)
T ss_dssp             CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCC--------------
T ss_pred             ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCC--------------
Confidence            233556899999999999999999999999999999999999999976543333333322211111              


Q ss_pred             CCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          931 PRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       931 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                          ..+...+..+.+++.+||+.||++|||++|+++
T Consensus       237 ----~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  269 (293)
T d1yhwa1         237 ----QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (293)
T ss_dssp             ----SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             ----CCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                122334457899999999999999999999976

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-48  Score=411.52  Aligned_cols=255  Identities=26%  Similarity=0.413  Sum_probs=212.1

Q ss_pred             hhcccccccccccceEEEEEEeCCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEecc
Q 002010          692 ESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYM  771 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  771 (982)
                      ++|+..+.||+|+||+||+|..++++.||||++..  .....+.|.+|+.++++++|||||+++|++. ++..++||||+
T Consensus        13 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~-~~~~~iv~Ey~   89 (272)
T d1qpca_          13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQ--GSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYM   89 (272)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECT--TSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECC
T ss_pred             HHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEcc--CcCCHHHHHHHHHHHHhCCCCCEeEEEeeec-cCCeEEEEEeC
Confidence            57889999999999999999988889999999853  2345677999999999999999999999875 46679999999


Q ss_pred             CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCcc
Q 002010          772 PNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASE  851 (982)
Q Consensus       772 ~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~  851 (982)
                      ++|+|.+++......++++..+.+++.||++||+|||+++   |+||||||+||++++++.+||+|||+|+.+.+. ...
T Consensus        90 ~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~-~~~  165 (272)
T d1qpca_          90 ENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDN-EYT  165 (272)
T ss_dssp             TTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSS-CEE
T ss_pred             CCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCC-ccc
Confidence            9999999887555557999999999999999999999988   999999999999999999999999999877543 223


Q ss_pred             cccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceeecC
Q 002010          852 CMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDP  931 (982)
Q Consensus       852 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  931 (982)
                      ......||+.|||||++.+..++.++|||||||++|||+||..|+............+.....                 
T Consensus       166 ~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~-----------------  228 (272)
T d1qpca_         166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR-----------------  228 (272)
T ss_dssp             CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC-----------------
T ss_pred             cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCC-----------------
Confidence            334567899999999999999999999999999999999966665444343344343332211                 


Q ss_pred             CCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 002010          932 RLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANP  972 (982)
Q Consensus       932 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~  972 (982)
                        ...|...+..+.+++.+||+.||++|||++||++.|+.+
T Consensus       229 --~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~  267 (272)
T d1qpca_         229 --MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF  267 (272)
T ss_dssp             --CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --CCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhh
Confidence              112233455789999999999999999999999988753

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-48  Score=409.33  Aligned_cols=246  Identities=28%  Similarity=0.427  Sum_probs=207.8

Q ss_pred             hhcccccccccccceEEEEEEe-CCCcEEEEEEeccCC--CCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEE
Q 002010          692 ESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRG--TGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLY  768 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  768 (982)
                      ++|++.+.||+|+||+||+|+. .+++.||+|++....  .......+.+|+.++++++|||||++++++.+++..++||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            5789999999999999999976 468999999985432  2344667889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccC
Q 002010          769 EYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAG  848 (982)
Q Consensus       769 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  848 (982)
                      ||+++|+|.+++.  +...+++..+..++.||++|++|||+++   |+||||||+||+++.++.+||+|||+|...... 
T Consensus        86 Ey~~~g~L~~~l~--~~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~-  159 (263)
T d2j4za1          86 EYAPLGTVYRELQ--KLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-  159 (263)
T ss_dssp             ECCTTCBHHHHHH--HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC-
T ss_pred             eecCCCcHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCC-
Confidence            9999999999997  3457999999999999999999999998   999999999999999999999999999865432 


Q ss_pred             CcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCccccccee
Q 002010          849 ASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAV  928 (982)
Q Consensus       849 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  928 (982)
                         ......||+.|||||++.+..|+.++||||+||++|||++|+.||...... .....+.....              
T Consensus       160 ---~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~-~~~~~i~~~~~--------------  221 (263)
T d2j4za1         160 ---RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ-ETYKRISRVEF--------------  221 (263)
T ss_dssp             ---CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHHHHTTCC--------------
T ss_pred             ---cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHH-HHHHHHHcCCC--------------
Confidence               234567999999999999999999999999999999999999999754322 22222211110              


Q ss_pred             ecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          929 VDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       929 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                            ..|...+..+.+++.+||+.||++|||++|+++
T Consensus       222 ------~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         222 ------TFPDFVTEGARDLISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             ------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ------CCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence                  122234457889999999999999999999985

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.4e-48  Score=419.87  Aligned_cols=260  Identities=28%  Similarity=0.467  Sum_probs=204.5

Q ss_pred             HhhcccccccccccceEEEEEEeCC-C---cEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEE
Q 002010          691 LESLKDENIIGKGGAGIVYRGSMPD-G---IDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLL  766 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~---~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  766 (982)
                      .+.|+..+.||+|+||+||+|..+. +   ..||||++.........++|.+|+.++++++|||||+++|++.+++..++
T Consensus        25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~i  104 (299)
T d1jpaa_          25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMI  104 (299)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence            3568888999999999999997642 3   35899988655555556789999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccc
Q 002010          767 LYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQD  846 (982)
Q Consensus       767 v~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  846 (982)
                      ||||+++|+|.+++.. ....+++.++..++.||++||+|||+++   |+||||||+||+++.++++||+|||+|+.+.+
T Consensus       105 v~Ey~~~g~L~~~~~~-~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~  180 (299)
T d1jpaa_         105 ITEFMENGSLDSFLRQ-NDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED  180 (299)
T ss_dssp             EEECCTTEEHHHHHHT-TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             EEEecCCCcceeeecc-ccCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccC
Confidence            9999999999998873 3457999999999999999999999988   99999999999999999999999999987764


Q ss_pred             cCCccc---ccccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHhccCCCCCCcc
Q 002010          847 AGASEC---MSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDA  922 (982)
Q Consensus       847 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  922 (982)
                      ......   .....||+.|||||++.+..++.++|||||||++|||+| |++||.+... ......+.....        
T Consensus       181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~-~~~~~~i~~~~~--------  251 (299)
T d1jpaa_         181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN-QDVINAIEQDYR--------  251 (299)
T ss_dssp             ---------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-HHHHHHHHTTCC--------
T ss_pred             CCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH-HHHHHHHHcCCC--------
Confidence            322211   223457899999999999999999999999999999998 8999986543 233333322111        


Q ss_pred             cccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCC
Q 002010          923 ASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQ  974 (982)
Q Consensus       923 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~~  974 (982)
                                 ...+..++..+.+++.+||+.||++|||++||++.|+++.+
T Consensus       252 -----------~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~  292 (299)
T d1jpaa_         252 -----------LPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR  292 (299)
T ss_dssp             -----------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             -----------CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence                       11233455679999999999999999999999999987765

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-47  Score=420.89  Aligned_cols=258  Identities=24%  Similarity=0.416  Sum_probs=214.5

Q ss_pred             HhhcccccccccccceEEEEEEeCC------CcEEEEEEeccCCCCCchhhHHHHHHHHhcC-CCCcccceEeEEEcCCc
Q 002010          691 LESLKDENIIGKGGAGIVYRGSMPD------GIDVAIKRLVGRGTGGNDHGFLAEIQTLGRI-RHRNIVRLLGYVSNRDT  763 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~  763 (982)
                      .++|+..+.||+|+||+||+|+...      ...||+|.+...........+.+|+.++.++ +|||||++++++.+.+.
T Consensus        36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~  115 (325)
T d1rjba_          36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP  115 (325)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence            3678999999999999999997532      2369999987666666677899999999998 89999999999999999


Q ss_pred             cEEEEeccCCCCHHHHhhcCCC---------------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCC
Q 002010          764 NLLLYEYMPNGSLGEMLHGAKG---------------------GHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKS  822 (982)
Q Consensus       764 ~~lv~e~~~~~sL~~~l~~~~~---------------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp  822 (982)
                      .++||||+++|+|.++++..+.                     ..+++..+..++.||++||+|||+++   ||||||||
T Consensus       116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp  192 (325)
T d1rjba_         116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAA  192 (325)
T ss_dssp             CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSG
T ss_pred             EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCch
Confidence            9999999999999999975432                     35899999999999999999999988   99999999


Q ss_pred             CcEEEcCCCCEEEeccccchhccccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCC
Q 002010          823 NNILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGD  901 (982)
Q Consensus       823 ~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~  901 (982)
                      +||+++.++.+||+|||+|+...............||+.|||||++.+..|+.++|||||||++|||+| |++||.+...
T Consensus       193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~  272 (325)
T d1rjba_         193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV  272 (325)
T ss_dssp             GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred             hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH
Confidence            999999999999999999987765544444456678999999999999999999999999999999998 8999987666


Q ss_pred             CchHHHHHHHhccCCCCCCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 002010          902 GVDIVRWVRKTTSEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLA  970 (982)
Q Consensus       902 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~  970 (982)
                      ...+.+.+..... .                  ..|...+.++.+++.+||+.||++|||++||++.|.
T Consensus       273 ~~~~~~~~~~~~~-~------------------~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         273 DANFYKLIQNGFK-M------------------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             SHHHHHHHHTTCC-C------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHHHHHHhcCCC-C------------------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence            5555555443221 1                  123334567999999999999999999999999884

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-47  Score=411.11  Aligned_cols=251  Identities=24%  Similarity=0.338  Sum_probs=209.4

Q ss_pred             hhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEec
Q 002010          692 ESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEY  770 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  770 (982)
                      +.|++.+.||+|+||+||+|+. .+++.||||++... .....+.+.+|++++++++|||||++++++.+++..++||||
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy   90 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK-SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF   90 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-SSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEec
Confidence            4688899999999999999975 56899999998543 445567899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCc
Q 002010          771 MPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS  850 (982)
Q Consensus       771 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  850 (982)
                      +++|+|.+++.. ....+++.++..++.||+.||+|||+++   |+||||||+||+++.++.+||+|||+|......  .
T Consensus        91 ~~~g~L~~~~~~-~~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~--~  164 (288)
T d2jfla1          91 CAGGAVDAVMLE-LERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--I  164 (288)
T ss_dssp             CTTEEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHH--H
T ss_pred             CCCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCC--c
Confidence            999999999763 2357999999999999999999999998   999999999999999999999999999765432  1


Q ss_pred             ccccccccccccccccccc-----cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCccccc
Q 002010          851 ECMSSVAGSYGYIAPEYAY-----TLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASV  925 (982)
Q Consensus       851 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  925 (982)
                      .......||+.|||||++.     +..|+.++||||+||++|||+||+.||......+....+........         
T Consensus       165 ~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~---------  235 (288)
T d2jfla1         165 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTL---------  235 (288)
T ss_dssp             HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCC---------
T ss_pred             ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCC---------
Confidence            2234578999999999874     45689999999999999999999999987655444433332211111         


Q ss_pred             ceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          926 LAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       926 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                               ..+...+.++.+++.+||+.||++|||++|+++
T Consensus       236 ---------~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         236 ---------AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             ---------SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ---------CccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                     122334557899999999999999999999976

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-48  Score=414.84  Aligned_cols=249  Identities=24%  Similarity=0.317  Sum_probs=204.9

Q ss_pred             hhcccccccccccceEEEEEEe-CCCcEEEEEEeccCC--CCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEE
Q 002010          692 ESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRG--TGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLY  768 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  768 (982)
                      ++|++.+.||+|+||+||+|+. .+|+.||||++....  .....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            5799999999999999999976 569999999985432  2345567899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccC
Q 002010          769 EYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAG  848 (982)
Q Consensus       769 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  848 (982)
                      ||+++|+|.+++.  ..+.+++..+..++.|++.|++|||+.+   |+||||||+||++++++.+||+|||+|+.+....
T Consensus        88 Ey~~gg~L~~~~~--~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~  162 (288)
T d1uu3a_          88 SYAKNGELLKYIR--KIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPES  162 (288)
T ss_dssp             CCCTTEEHHHHHH--HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred             EccCCCCHHHhhh--ccCCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccCC
Confidence            9999999999987  4467999999999999999999999998   9999999999999999999999999998876544


Q ss_pred             CcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCccccccee
Q 002010          849 ASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAV  928 (982)
Q Consensus       849 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  928 (982)
                      .........||+.|||||++.+..|+.++||||+||++|||++|+.||....... ....+.....              
T Consensus       163 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~-~~~~i~~~~~--------------  227 (288)
T d1uu3a_         163 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL-IFQKIIKLEY--------------  227 (288)
T ss_dssp             -------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHTTCC--------------
T ss_pred             cccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHH-HHHHHHcCCC--------------
Confidence            4444556789999999999999999999999999999999999999997643222 2222111110              


Q ss_pred             ecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHH
Q 002010          929 VDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVV  966 (982)
Q Consensus       929 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell  966 (982)
                            .+|...+..+.+++.+||+.||++|||++|++
T Consensus       228 ------~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~  259 (288)
T d1uu3a_         228 ------DFPEKFFPKARDLVEKLLVLDATKRLGCEEME  259 (288)
T ss_dssp             ------CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGT
T ss_pred             ------CCCccCCHHHHHHHHHHccCCHhHCcCHHHHc
Confidence                  11223345788999999999999999999863

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-48  Score=410.14  Aligned_cols=254  Identities=24%  Similarity=0.371  Sum_probs=196.1

Q ss_pred             hhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCC-CCchhhHHHHHHHHhcCCCCcccceEeEEEc--CCccEEE
Q 002010          692 ESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGT-GGNDHGFLAEIQTLGRIRHRNIVRLLGYVSN--RDTNLLL  767 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv  767 (982)
                      ++|++.+.||+|+||+||+|+. .+|+.||+|.+..... +...+.+.+|++++++++|||||++++++.+  +...|+|
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence            5799999999999999999965 5689999999855432 2334568899999999999999999999865  4557899


Q ss_pred             EeccCCCCHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHhhcC--CCcEEecCCCCCcEEEcCCCCEEEeccccchh
Q 002010          768 YEYMPNGSLGEMLHGA--KGGHLKWETRYRIALEAAKGLCYLHHDC--SPLIIHRDVKSNNILLDSDFEAHVADFGLAKF  843 (982)
Q Consensus       768 ~e~~~~~sL~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~--~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~  843 (982)
                      |||+++|+|.+++.+.  ....+++..++.++.||+.||+|||+.+  ..+|+||||||+||+++.++.+||+|||+|+.
T Consensus        84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~  163 (269)
T d2java1          84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI  163 (269)
T ss_dssp             EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred             EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence            9999999999998642  3467999999999999999999999864  23599999999999999999999999999998


Q ss_pred             ccccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCccc
Q 002010          844 LQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAA  923 (982)
Q Consensus       844 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  923 (982)
                      +...  ........||+.|||||++.+..|+.++||||+||++|||+||+.||..... .+....+....          
T Consensus       164 ~~~~--~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~-~~~~~~i~~~~----------  230 (269)
T d2java1         164 LNHD--TSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ-KELAGKIREGK----------  230 (269)
T ss_dssp             C-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHHHHHTC----------
T ss_pred             cccC--CCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCH-HHHHHHHHcCC----------
Confidence            7643  2233457899999999999999999999999999999999999999976433 22222222211          


Q ss_pred             ccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          924 SVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       924 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                               ....+...+.++.+++.+||+.||.+|||++|+++
T Consensus       231 ---------~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         231 ---------FRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             ---------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ---------CCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence                     11122334457899999999999999999999975

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-47  Score=409.52  Aligned_cols=255  Identities=25%  Similarity=0.395  Sum_probs=209.8

Q ss_pred             hhcccccc-cccccceEEEEEEeC---CCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEE
Q 002010          692 ESLKDENI-IGKGGAGIVYRGSMP---DGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLL  767 (982)
Q Consensus       692 ~~~~~~~~-lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  767 (982)
                      ++|...+. ||+|+||+||+|.+.   ++..||||++.........++|.+|++++++++|||||+++|++.+ +..++|
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv   86 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV   86 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence            35666664 999999999999653   3567999999655555556789999999999999999999999875 567999


Q ss_pred             EeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhcccc
Q 002010          768 YEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDA  847 (982)
Q Consensus       768 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  847 (982)
                      |||+++|+|.+++.. ....+++..+..++.||++||+|||+++   |+||||||+||+++.++.+||+|||+|+.+...
T Consensus        87 mE~~~~g~L~~~l~~-~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~  162 (285)
T d1u59a_          87 MEMAGGGPLHKFLVG-KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGAD  162 (285)
T ss_dssp             EECCTTEEHHHHHTT-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred             EEeCCCCcHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhccccc
Confidence            999999999999863 3467999999999999999999999988   999999999999999999999999999877543


Q ss_pred             CCc-ccccccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHhccCCCCCCccccc
Q 002010          848 GAS-ECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASV  925 (982)
Q Consensus       848 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  925 (982)
                      ... .......||+.|+|||++.+..++.++|||||||++|||+| |+.||...... ++...+.....           
T Consensus       163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~-~~~~~i~~~~~-----------  230 (285)
T d1u59a_         163 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP-EVMAFIEQGKR-----------  230 (285)
T ss_dssp             SCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH-HHHHHHHTTCC-----------
T ss_pred             ccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH-HHHHHHHcCCC-----------
Confidence            222 22234568999999999999999999999999999999998 99999876543 33333322111           


Q ss_pred             ceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 002010          926 LAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLAN  971 (982)
Q Consensus       926 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~  971 (982)
                              ...|...+.++.+++.+||+.||++|||+.+|++.|+.
T Consensus       231 --------~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~  268 (285)
T d1u59a_         231 --------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA  268 (285)
T ss_dssp             --------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred             --------CCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence                    12334455689999999999999999999999998864

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-47  Score=401.07  Aligned_cols=254  Identities=22%  Similarity=0.397  Sum_probs=214.6

Q ss_pred             hhcccccccccccceEEEEEEeCCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEecc
Q 002010          692 ESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYM  771 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  771 (982)
                      ++|+..+.||+|+||+||+|+.++++.||||+++..  ....++|.+|+.++++++|||||+++|++.+++..++||||+
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~--~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~   81 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG--SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM   81 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESS--SSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred             HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcC--cCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEcc
Confidence            468888999999999999999988889999998543  334678999999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCcc
Q 002010          772 PNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGASE  851 (982)
Q Consensus       772 ~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~  851 (982)
                      ++|+|.+++.. ....+++..+.+++.|+++|++|||+.+   |+||||||+||++++++.+||+|||+|+.+.... ..
T Consensus        82 ~~g~l~~~~~~-~~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~-~~  156 (258)
T d1k2pa_          82 ANGCLLNYLRE-MRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-YT  156 (258)
T ss_dssp             TTEEHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS-CC
T ss_pred             CCCcHHHhhhc-cccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCC-ce
Confidence            99999999763 3467899999999999999999999988   9999999999999999999999999998765432 22


Q ss_pred             cccccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceeec
Q 002010          852 CMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVD  930 (982)
Q Consensus       852 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  930 (982)
                      ......||+.|+|||.+.+..++.++|||||||++|||+| |+.||......+ ....+..... .              
T Consensus       157 ~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~-~~~~i~~~~~-~--------------  220 (258)
T d1k2pa_         157 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE-TAEHIAQGLR-L--------------  220 (258)
T ss_dssp             CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH-HHHHHHTTCC-C--------------
T ss_pred             eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHH-HHHHHHhCCC-C--------------
Confidence            3345678999999999999999999999999999999998 899998765432 2332222111 1              


Q ss_pred             CCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 002010          931 PRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANP  972 (982)
Q Consensus       931 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~  972 (982)
                          ..|...+..+.+++.+||+.||++|||++|+++.|.++
T Consensus       221 ----~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di  258 (258)
T d1k2pa_         221 ----YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV  258 (258)
T ss_dssp             ----CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred             ----CCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence                12233446799999999999999999999999988654

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-47  Score=412.05  Aligned_cols=261  Identities=28%  Similarity=0.439  Sum_probs=207.0

Q ss_pred             hhcccccccccccceEEEEEEeCCC-----cEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEE
Q 002010          692 ESLKDENIIGKGGAGIVYRGSMPDG-----IDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLL  766 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  766 (982)
                      +.|+..++||+|+||+||+|.++..     ..||||++..........+|.+|+.++++++|||||+++|++.+.+..++
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~   86 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI   86 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence            4688889999999999999965432     46999998655555555678999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccc
Q 002010          767 LYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQD  846 (982)
Q Consensus       767 v~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  846 (982)
                      ||||++++++.+++.. ....+++.++..++.||+.|++|||+.+   |+||||||+||+++.++.+||+|||+|+.+..
T Consensus        87 v~e~~~~~~l~~~~~~-~~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~  162 (283)
T d1mqba_          87 ITEYMENGALDKFLRE-KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED  162 (283)
T ss_dssp             EEECCTTEEHHHHHHH-TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred             EEEecccCcchhhhhc-ccccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhcccC
Confidence            9999999999998764 3467999999999999999999999988   99999999999999999999999999987754


Q ss_pred             cCC-cccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCccccc
Q 002010          847 AGA-SECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASV  925 (982)
Q Consensus       847 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  925 (982)
                      ... ........||+.|||||++.+..++.++|||||||++|||++|..|+............+.....           
T Consensus       163 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~-----------  231 (283)
T d1mqba_         163 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFR-----------  231 (283)
T ss_dssp             -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC-----------
T ss_pred             CCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCC-----------
Confidence            322 22233456899999999999999999999999999999999976665544343444443332211           


Q ss_pred             ceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCCC
Q 002010          926 LAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQS  975 (982)
Q Consensus       926 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~~~  975 (982)
                              ...+...+..+.+++.+||+.||++|||++||++.|+++.+.
T Consensus       232 --------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~  273 (283)
T d1mqba_         232 --------LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA  273 (283)
T ss_dssp             --------CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             --------CCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence                    122334556799999999999999999999999999876554

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.2e-47  Score=413.14  Aligned_cols=254  Identities=24%  Similarity=0.325  Sum_probs=194.1

Q ss_pred             HHHhhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEE
Q 002010          689 DVLESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLL  767 (982)
Q Consensus       689 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  767 (982)
                      ++.+.|+..+.||+|+||+||+|+. .+++.||||++...........+.+|+.++++++|||||++++++.+++..|+|
T Consensus         6 di~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv   85 (307)
T d1a06a_           6 DIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLI   85 (307)
T ss_dssp             CGGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            4456799999999999999999976 468999999996655555556788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEc---CCCCEEEeccccchhc
Q 002010          768 YEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLD---SDFEAHVADFGLAKFL  844 (982)
Q Consensus       768 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~---~~~~~kl~DfG~a~~~  844 (982)
                      |||++||+|.+++.  +...+++.++..++.||+.|++|||+++   |+||||||+||++.   +++.+||+|||+|+..
T Consensus        86 mE~~~gg~L~~~l~--~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~  160 (307)
T d1a06a_          86 MQLVSGGELFDRIV--EKGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKME  160 (307)
T ss_dssp             ECCCCSCBHHHHHH--TCSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred             EeccCCCcHHHhhh--cccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEc
Confidence            99999999999997  4568999999999999999999999998   99999999999995   5789999999999876


Q ss_pred             cccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccc
Q 002010          845 QDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAAS  924 (982)
Q Consensus       845 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  924 (982)
                      ...   ......+||+.|||||++.+..|+.++||||+||++|||++|++||.+..... ....+.........      
T Consensus       161 ~~~---~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~-~~~~i~~~~~~~~~------  230 (307)
T d1a06a_         161 DPG---SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK-LFEQILKAEYEFDS------  230 (307)
T ss_dssp             ---------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHTTCCCCCT------
T ss_pred             cCC---CeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHH-HHHHHhccCCCCCC------
Confidence            532   23345689999999999999999999999999999999999999997643322 22222221111100      


Q ss_pred             cceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          925 VLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       925 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                                ..+...+..+.+++.+||+.||++|||++|+++
T Consensus       231 ----------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  263 (307)
T d1a06a_         231 ----------PYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ  263 (307)
T ss_dssp             ----------TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             ----------ccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence                      112233457899999999999999999999987

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.1e-47  Score=401.71  Aligned_cols=248  Identities=27%  Similarity=0.442  Sum_probs=200.1

Q ss_pred             cccccccccccceEEEEEEe-CCCcEEEEEEeccCC-CCCchhhHHHHHHHHhcCCCCcccceEeEEEc----CCccEEE
Q 002010          694 LKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRG-TGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSN----RDTNLLL  767 (982)
Q Consensus       694 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~lv  767 (982)
                      |+..+.||+|+||+||+|.. .+++.||+|++.... .....+.+.+|++++++++|||||++++++.+    +...++|
T Consensus        11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv   90 (270)
T d1t4ha_          11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV   90 (270)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence            35566899999999999975 468899999986543 33345578999999999999999999999865    3457899


Q ss_pred             EeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEc-CCCCEEEeccccchhccc
Q 002010          768 YEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLD-SDFEAHVADFGLAKFLQD  846 (982)
Q Consensus       768 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~-~~~~~kl~DfG~a~~~~~  846 (982)
                      |||+++|+|.+++.  +...+++..+..++.||++|++|||+++ ++|+||||||+||+++ +++.+||+|||+|+....
T Consensus        91 mE~~~~g~L~~~l~--~~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~  167 (270)
T d1t4ha_          91 TELMTSGTLKTYLK--RFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  167 (270)
T ss_dssp             EECCCSCBHHHHHH--HHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             EeCCCCCcHHHHHh--ccccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence            99999999999997  3467999999999999999999999864 4599999999999996 578999999999986442


Q ss_pred             cCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccc
Q 002010          847 AGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVL  926 (982)
Q Consensus       847 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  926 (982)
                          .......||+.|||||++.+ .++.++||||+||++|||++|+.||........+.+.+.......          
T Consensus       168 ----~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~----------  232 (270)
T d1t4ha_         168 ----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPA----------  232 (270)
T ss_dssp             ----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCG----------
T ss_pred             ----CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCc----------
Confidence                22345689999999998865 599999999999999999999999986554444433332211100          


Q ss_pred             eeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          927 AVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       927 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                              ..+...+.++.+++.+||+.||++|||++|+++
T Consensus       233 --------~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         233 --------SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             --------GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             --------ccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence                    111223346889999999999999999999975

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.4e-47  Score=404.52  Aligned_cols=260  Identities=29%  Similarity=0.408  Sum_probs=211.2

Q ss_pred             HhhcccccccccccceEEEEEEeCCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEec
Q 002010          691 LESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEY  770 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  770 (982)
                      .++|++++.||+|+||+||+|..+++++||||++...  ....+.|.+|+.++++++|||||+++|++. ++..++||||
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey   92 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG--TMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEY   92 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT--SSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECC
T ss_pred             HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc--cCCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEe
Confidence            3679999999999999999999888889999998433  344578999999999999999999999985 4568999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCc
Q 002010          771 MPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS  850 (982)
Q Consensus       771 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  850 (982)
                      +++|+|.+++.......+++.++..++.||+.|++|||+.+   |+||||||+||+++.++++||+|||+|+.+.+. ..
T Consensus        93 ~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~-~~  168 (285)
T d1fmka3          93 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDN-EY  168 (285)
T ss_dssp             CTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred             cCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCC-Cc
Confidence            99999999987655567999999999999999999999998   999999999999999999999999999876533 22


Q ss_pred             ccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceeec
Q 002010          851 ECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVD  930 (982)
Q Consensus       851 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  930 (982)
                      .......||+.|+|||++....++.++|||||||++|||++|..|+............+.....                
T Consensus       169 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~----------------  232 (285)
T d1fmka3         169 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR----------------  232 (285)
T ss_dssp             -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC----------------
T ss_pred             eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCC----------------
Confidence            3334567899999999999999999999999999999999977666554444444444433221                


Q ss_pred             CCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCCCC
Q 002010          931 PRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQSA  976 (982)
Q Consensus       931 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~~~~  976 (982)
                         ...+...+.++.+++.+||+.||++|||+++|++.|+......
T Consensus       233 ---~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~  275 (285)
T d1fmka3         233 ---MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST  275 (285)
T ss_dssp             ---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred             ---CCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence               1123344567899999999999999999999999998766543

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.8e-47  Score=413.73  Aligned_cols=268  Identities=23%  Similarity=0.358  Sum_probs=208.3

Q ss_pred             HhhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEe
Q 002010          691 LESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYE  769 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  769 (982)
                      .++|++.+.||+|+||+||+|.. .+|+.||+|++...........+.+|+.++++++|||||++++++.+++..++|||
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE   84 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   84 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            36799999999999999999975 56899999999765555556788999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccC
Q 002010          770 YMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHH-DCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAG  848 (982)
Q Consensus       770 ~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  848 (982)
                      |+++|+|.+++.+  ...+++..+..++.|++.|++|||+ ++   |+||||||+||+++.++++||+|||+|+.+.+. 
T Consensus        85 y~~gg~L~~~l~~--~~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~-  158 (322)
T d1s9ja_          85 HMDGGSLDQVLKK--AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-  158 (322)
T ss_dssp             CCTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-
T ss_pred             cCCCCcHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCCC-
Confidence            9999999999973  4579999999999999999999997 47   999999999999999999999999999977543 


Q ss_pred             CcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCC-CC---Cccc-
Q 002010          849 ASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVS-QP---SDAA-  923 (982)
Q Consensus       849 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~~---~~~~-  923 (982)
                         .....+||+.|||||++.+..|+.++||||+||++|||++|+.||..................... .+   .... 
T Consensus       159 ---~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (322)
T d1s9ja_         159 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR  235 (322)
T ss_dssp             ---TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------------------
T ss_pred             ---ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccc
Confidence               234568999999999999999999999999999999999999999764433221111110000000 00   0000 


Q ss_pred             -----------------ccceeecCCCCCCC-hHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          924 -----------------SVLAVVDPRLSGYP-LTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       924 -----------------~~~~~~~~~~~~~~-~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                                       ..........+..+ ...+.++.+++.+||+.||++|||++|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~  297 (322)
T d1s9ja_         236 PLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV  297 (322)
T ss_dssp             ----------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence                             00000000001111 123457889999999999999999999986

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-46  Score=401.91  Aligned_cols=248  Identities=26%  Similarity=0.410  Sum_probs=200.4

Q ss_pred             cccccccceEEEEEEeC---CCcEEEEEEeccCCC-CCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEeccCC
Q 002010          698 NIIGKGGAGIVYRGSMP---DGIDVAIKRLVGRGT-GGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEYMPN  773 (982)
Q Consensus       698 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  773 (982)
                      +.||+|+||+||+|.+.   .++.||||++..... ....+++.+|+.++++++|||||+++|++.. +..++||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence            46999999999999653   356899999854433 2334679999999999999999999999865 567899999999


Q ss_pred             CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCc-cc
Q 002010          774 GSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS-EC  852 (982)
Q Consensus       774 ~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~-~~  852 (982)
                      |+|.++++  +...+++..+..++.||+.||+|||+++   |+||||||+||+++.++.+|++|||+|+.+...... ..
T Consensus        92 g~L~~~l~--~~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~  166 (277)
T d1xbba_          92 GPLNKYLQ--QNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA  166 (277)
T ss_dssp             EEHHHHHH--HCTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC
T ss_pred             CcHHHHHh--hccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhcccccccccc
Confidence            99999997  4467999999999999999999999988   999999999999999999999999999876543222 22


Q ss_pred             ccccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceeecC
Q 002010          853 MSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVVDP  931 (982)
Q Consensus       853 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  931 (982)
                      .....||+.|||||++.+..++.++|||||||++|||+| |+.||.+.... .+...+....                  
T Consensus       167 ~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~-~~~~~i~~~~------------------  227 (277)
T d1xbba_         167 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-EVTAMLEKGE------------------  227 (277)
T ss_dssp             ----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-HHHHHHHTTC------------------
T ss_pred             ccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH-HHHHHHHcCC------------------
Confidence            334578999999999999999999999999999999998 89999865432 2333332211                  


Q ss_pred             CCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 002010          932 RLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLAN  971 (982)
Q Consensus       932 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~  971 (982)
                       ....|..++.++.+++.+||+.||++|||++||++.|+.
T Consensus       228 -~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~  266 (277)
T d1xbba_         228 -RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN  266 (277)
T ss_dssp             -CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             -CCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence             112233455689999999999999999999999988764

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2e-46  Score=405.66  Aligned_cols=247  Identities=25%  Similarity=0.325  Sum_probs=203.8

Q ss_pred             HhhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCC--CchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEE
Q 002010          691 LESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTG--GNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLL  767 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  767 (982)
                      .+.|+..+.||+|+||+||+|.. .+++.||||++......  ...+.+.+|+.++++++|||||++++++.+++..|+|
T Consensus        14 ~~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv   93 (309)
T d1u5ra_          14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV   93 (309)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEE
Confidence            35689999999999999999965 56889999998654332  2235688999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhcccc
Q 002010          768 YEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDA  847 (982)
Q Consensus       768 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  847 (982)
                      ||||++|++..++.  ...++++.++..++.||+.||+|||+++   |+||||||+||+++.++.+||+|||+|..... 
T Consensus        94 ~E~~~~g~l~~~~~--~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~-  167 (309)
T d1u5ra_          94 MEYCLGSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-  167 (309)
T ss_dssp             EECCSEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred             EEecCCCchHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCC-
Confidence            99999999987765  3467999999999999999999999998   99999999999999999999999999986543 


Q ss_pred             CCccccccccccccccccccccc---CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccc
Q 002010          848 GASECMSSVAGSYGYIAPEYAYT---LKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAAS  924 (982)
Q Consensus       848 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  924 (982)
                           .....||+.|||||++.+   ..|+.++||||+||++|||++|+.||........+..........         
T Consensus       168 -----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~---------  233 (309)
T d1u5ra_         168 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPA---------  233 (309)
T ss_dssp             -----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC---------
T ss_pred             -----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCC---------
Confidence                 234679999999999864   458999999999999999999999997654333222222211110         


Q ss_pred             cceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          925 VLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       925 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                                ..+...+..+.+++.+||+.||++|||++|+++
T Consensus       234 ----------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         234 ----------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             ----------CSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             ----------CCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence                      011123457899999999999999999999976

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5.4e-46  Score=403.02  Aligned_cols=259  Identities=25%  Similarity=0.418  Sum_probs=215.0

Q ss_pred             hhcccccccccccceEEEEEEeC------CCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccE
Q 002010          692 ESLKDENIIGKGGAGIVYRGSMP------DGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNL  765 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  765 (982)
                      ++|+..+.||+|+||+||+|+.+      +++.||||++.........++|.+|+.++++++||||+++++++.+....+
T Consensus        13 ~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~   92 (301)
T d1lufa_          13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMC   92 (301)
T ss_dssp             GGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCE
T ss_pred             HHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceE
Confidence            57899999999999999999753      357899999865555455677999999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHhhcCC----------------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCC
Q 002010          766 LLYEYMPNGSLGEMLHGAK----------------------GGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSN  823 (982)
Q Consensus       766 lv~e~~~~~sL~~~l~~~~----------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~  823 (982)
                      +||||+++|+|.++++...                      ...+++..+..++.|++.|++|||+.+   ||||||||+
T Consensus        93 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHrDlKp~  169 (301)
T d1lufa_          93 LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATR  169 (301)
T ss_dssp             EEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGG
T ss_pred             EEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEeeEEccc
Confidence            9999999999999996432                      235889999999999999999999988   999999999


Q ss_pred             cEEEcCCCCEEEeccccchhccccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCC-CCCCCCCCC
Q 002010          824 NILLDSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGK-KPVGEFGDG  902 (982)
Q Consensus       824 Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~-~p~~~~~~~  902 (982)
                      ||+++.++.+||+|||+|+.+.+...........|++.|+|||.+.+..|+.++|||||||++|||++|. +||.... .
T Consensus       170 NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~-~  248 (301)
T d1lufa_         170 NCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA-H  248 (301)
T ss_dssp             GEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC-H
T ss_pred             ceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCC-H
Confidence            9999999999999999998776554444455677899999999999999999999999999999999985 5676543 3


Q ss_pred             chHHHHHHHhccCCCCCCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 002010          903 VDIVRWVRKTTSEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPP  973 (982)
Q Consensus       903 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~  973 (982)
                      .+....+....                   ....+...+.++.+++.+||+.||++||||.||++.|+++.
T Consensus       249 ~e~~~~v~~~~-------------------~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~  300 (301)
T d1lufa_         249 EEVIYYVRDGN-------------------ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC  300 (301)
T ss_dssp             HHHHHHHHTTC-------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             HHHHHHHHcCC-------------------CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            33333333221                   11233444567899999999999999999999999998764

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.1e-46  Score=400.98  Aligned_cols=253  Identities=21%  Similarity=0.281  Sum_probs=208.4

Q ss_pred             HHhhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCC-----CchhhHHHHHHHHhcCCCCcccceEeEEEcCCc
Q 002010          690 VLESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTG-----GNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDT  763 (982)
Q Consensus       690 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  763 (982)
                      +.++|+..+.||+|+||+||+|+. .+|+.||||++......     ...+.+.+|+.++++++|||||++++++.+++.
T Consensus         8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~   87 (293)
T d1jksa_           8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD   87 (293)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             cccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence            446799999999999999999976 57999999998654322     235678999999999999999999999999999


Q ss_pred             cEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCC----CEEEeccc
Q 002010          764 NLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDF----EAHVADFG  839 (982)
Q Consensus       764 ~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~----~~kl~DfG  839 (982)
                      .|+||||+++|+|.+++..  ...+++..+..++.|++.|++|||+.+   |+||||||+||+++.++    .+|++|||
T Consensus        88 ~~iv~E~~~gg~L~~~i~~--~~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG  162 (293)
T d1jksa_          88 VILILELVAGGELFDFLAE--KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG  162 (293)
T ss_dssp             EEEEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEEEEcCCCccccchhcc--ccccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchh
Confidence            9999999999999999973  357999999999999999999999998   99999999999998776    49999999


Q ss_pred             cchhccccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCC
Q 002010          840 LAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQP  919 (982)
Q Consensus       840 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  919 (982)
                      +|......   .......||+.|+|||++.+..++.++||||+||++|||++|+.||......+....+ ........  
T Consensus       163 ~a~~~~~~---~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i-~~~~~~~~--  236 (293)
T d1jksa_         163 LAHKIDFG---NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV-SAVNYEFE--  236 (293)
T ss_dssp             TCEECTTS---CBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-HTTCCCCC--
T ss_pred             hhhhcCCC---ccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHH-HhcCCCCC--
Confidence            99876533   2334567899999999999999999999999999999999999999764332222222 11111000  


Q ss_pred             CcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          920 SDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       920 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                                    ...+...+..+.+++.+||+.||++|||++|+++
T Consensus       237 --------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         237 --------------DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             --------------HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             --------------chhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                          0011223456889999999999999999999986

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=8.7e-46  Score=407.54  Aligned_cols=255  Identities=23%  Similarity=0.350  Sum_probs=210.1

Q ss_pred             HHHHhhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEE
Q 002010          688 EDVLESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLL  766 (982)
Q Consensus       688 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  766 (982)
                      +.+.++|++.+.||+|+||.||+|.. .+|+.||||++... .....+.+.+|+.++++++|||||++++++.+++..|+
T Consensus        22 ~~il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i  100 (350)
T d1koaa2          22 DHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP-HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVM  100 (350)
T ss_dssp             SCGGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCC-SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEE
T ss_pred             CCCccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEccc-chhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            34567899999999999999999975 56999999998543 23345678899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcC--CCCEEEeccccchhc
Q 002010          767 LYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDS--DFEAHVADFGLAKFL  844 (982)
Q Consensus       767 v~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~--~~~~kl~DfG~a~~~  844 (982)
                      ||||+++|+|.+++.. +...+++..+..++.||+.||+|||+++   ||||||||+||+++.  ++.+||+|||+|+.+
T Consensus       101 vmE~~~gg~L~~~l~~-~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~  176 (350)
T d1koaa2         101 IYEFMSGGELFEKVAD-EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHL  176 (350)
T ss_dssp             EECCCCSCBHHHHHTC-TTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEEC
T ss_pred             EEEcCCCCCHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheec
Confidence            9999999999999863 3457999999999999999999999998   999999999999964  588999999999876


Q ss_pred             cccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccc
Q 002010          845 QDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAAS  924 (982)
Q Consensus       845 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  924 (982)
                      ...   .......||+.|||||++.+..|+.++||||+||++|||++|+.||......+.+.. +.........      
T Consensus       177 ~~~---~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~-i~~~~~~~~~------  246 (350)
T d1koaa2         177 DPK---QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRN-VKSCDWNMDD------  246 (350)
T ss_dssp             CTT---SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-HHHTCCCSCC------
T ss_pred             ccc---cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHH-HHhCCCCCCc------
Confidence            533   233457899999999999999999999999999999999999999976433322222 2221111000      


Q ss_pred             cceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          925 VLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       925 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                                ......+..+.+++.+||+.||++|||++|+++
T Consensus       247 ----------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  279 (350)
T d1koaa2         247 ----------SAFSGISEDGKDFIRKLLLADPNTRMTIHQALE  279 (350)
T ss_dssp             ----------GGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             ----------ccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                      011223457889999999999999999999987

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=2e-45  Score=404.91  Aligned_cols=254  Identities=19%  Similarity=0.251  Sum_probs=209.9

Q ss_pred             HHHhhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEE
Q 002010          689 DVLESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLL  767 (982)
Q Consensus       689 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  767 (982)
                      .+.+.|++.+.||+|+||.||+|.. .+|+.||||++.... ......+.+|+.++++++|||||++++++.+++..|+|
T Consensus        26 ~~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv  104 (352)
T d1koba_          26 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY-PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI  104 (352)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred             CcccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc-hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            4567899999999999999999965 579999999985432 23345688999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEc--CCCCEEEeccccchhcc
Q 002010          768 YEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLD--SDFEAHVADFGLAKFLQ  845 (982)
Q Consensus       768 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~--~~~~~kl~DfG~a~~~~  845 (982)
                      |||+++|+|.+++.. ...++++.++..++.||+.||+|||++|   |+||||||+|||++  .++.+||+|||+|..+.
T Consensus       105 mE~~~gg~L~~~~~~-~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~  180 (352)
T d1koba_         105 LEFLSGGELFDRIAA-EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLN  180 (352)
T ss_dssp             EECCCCCBHHHHTTC-TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred             EEcCCCChHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecC
Confidence            999999999998763 3457999999999999999999999998   99999999999997  57899999999998776


Q ss_pred             ccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCccccc
Q 002010          846 DAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASV  925 (982)
Q Consensus       846 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  925 (982)
                      ..   .......||+.|+|||++.+..|+.++||||+||++|||+||+.||........+ ..+.......+        
T Consensus       181 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~-~~i~~~~~~~~--------  248 (352)
T d1koba_         181 PD---EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETL-QNVKRCDWEFD--------  248 (352)
T ss_dssp             TT---SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH-HHHHHCCCCCC--------
T ss_pred             CC---CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHhCCCCCC--------
Confidence            43   2334567899999999999999999999999999999999999999764333222 22222111100        


Q ss_pred             ceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          926 LAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       926 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                              .......+..+.+|+.+||+.||.+|||++|+++
T Consensus       249 --------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  282 (352)
T d1koba_         249 --------EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE  282 (352)
T ss_dssp             --------SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             --------cccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                    0112233457889999999999999999999987

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-45  Score=400.45  Aligned_cols=248  Identities=23%  Similarity=0.264  Sum_probs=209.0

Q ss_pred             hhcccccccccccceEEEEEEe-CCCcEEEEEEeccCC--CCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEE
Q 002010          692 ESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRG--TGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLY  768 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  768 (982)
                      ++|++.+.||+|+||.||+|+. .+|+.||||++.+..  .......+.+|+.++++++||||+++++++.+++..|+||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~   84 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence            5799999999999999999975 579999999985432  2345667889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccC
Q 002010          769 EYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAG  848 (982)
Q Consensus       769 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  848 (982)
                      ||+++|+|.+++.  +...++++.++.++.||+.|++|||+++   |+||||||+||+++++|.+||+|||+|+..... 
T Consensus        85 ey~~gg~L~~~~~--~~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~-  158 (337)
T d1o6la_          85 EYANGGELFFHLS--RERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD-  158 (337)
T ss_dssp             ECCTTCBHHHHHH--HHSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT-
T ss_pred             eccCCCchhhhhh--cccCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccccC-
Confidence            9999999999997  4467999999999999999999999998   999999999999999999999999999865432 


Q ss_pred             CcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCccccccee
Q 002010          849 ASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAV  928 (982)
Q Consensus       849 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  928 (982)
                       .......+||+.|+|||++.+..|+.++||||+||++|||++|++||....... ..........              
T Consensus       159 -~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~-~~~~i~~~~~--------------  222 (337)
T d1o6la_         159 -GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER-LFELILMEEI--------------  222 (337)
T ss_dssp             -TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHCCC--------------
T ss_pred             -CcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHH-HHHHHhcCCC--------------
Confidence             233456789999999999999999999999999999999999999998653322 2222221111              


Q ss_pred             ecCCCCCCChHhHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 002010          929 VDPRLSGYPLTGVIHLFKVAMMCVEDESSARPT-----MREVVH  967 (982)
Q Consensus       929 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt-----~~ell~  967 (982)
                            .+|...+.++.+++.+||++||.+||+     ++|+++
T Consensus       223 ------~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         223 ------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             ------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             ------CCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence                  122233457889999999999999994     888876

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-45  Score=399.92  Aligned_cols=256  Identities=25%  Similarity=0.412  Sum_probs=205.3

Q ss_pred             hhcccccccccccceEEEEEEeC-CCc----EEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEE
Q 002010          692 ESLKDENIIGKGGAGIVYRGSMP-DGI----DVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLL  766 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  766 (982)
                      ++|+..+.||+|+||+||+|.+. +|+    +||+|++.........+++.+|+.++++++|||||+++|++.++ ..++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~   87 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   87 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence            35889999999999999999653 443    68999886666666778899999999999999999999999864 5678


Q ss_pred             EEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccc
Q 002010          767 LYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQD  846 (982)
Q Consensus       767 v~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  846 (982)
                      +|||+.+++|.+++.. ....+++..+.+++.||+.||+|||+++   |+||||||+||+++.++.+||+|||+|+.+..
T Consensus        88 v~e~~~~~~l~~~~~~-~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~  163 (317)
T d1xkka_          88 ITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  163 (317)
T ss_dssp             EEECCTTCBHHHHHHH-TSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred             EEEeccCCcccccccc-cccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceeccc
Confidence            8899999999998874 3567999999999999999999999988   99999999999999999999999999998765


Q ss_pred             cCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHhccCCCCCCccccc
Q 002010          847 AGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASV  925 (982)
Q Consensus       847 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  925 (982)
                      ...........||+.|+|||++.+..|+.++|||||||++|||+| |.+||..... ..+...+..... .         
T Consensus       164 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~-~~~~~~i~~~~~-~---------  232 (317)
T d1xkka_         164 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-SEISSILEKGER-L---------  232 (317)
T ss_dssp             TCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCG-GGHHHHHHHTCC-C---------
T ss_pred             ccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCH-HHHHHHHHcCCC-C---------
Confidence            444444445678999999999999999999999999999999999 7888876543 333444433221 1         


Q ss_pred             ceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 002010          926 LAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANP  972 (982)
Q Consensus       926 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~  972 (982)
                               ..|..++..+.+++.+||+.||++|||++|+++.|+.+
T Consensus       233 ---------~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~  270 (317)
T d1xkka_         233 ---------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM  270 (317)
T ss_dssp             ---------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---------CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence                     12334456789999999999999999999999887543

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-45  Score=394.99  Aligned_cols=256  Identities=24%  Similarity=0.377  Sum_probs=200.5

Q ss_pred             hhcccccccccccceEEEEEEeCC----CcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEE
Q 002010          692 ESLKDENIIGKGGAGIVYRGSMPD----GIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLL  767 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  767 (982)
                      ++|+..+.||+|+||+||+|.+..    +..||||.+...........+.+|+.++++++|||||+++|++. ++..++|
T Consensus         7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv   85 (273)
T d1mp8a_           7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII   85 (273)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred             HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEE
Confidence            579999999999999999997532    45689998855544445567999999999999999999999985 5678999


Q ss_pred             EeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhcccc
Q 002010          768 YEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDA  847 (982)
Q Consensus       768 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  847 (982)
                      |||+++|++.+++.. ....+++..+..++.||++|++|||+.+   |+||||||+||+++.++.+||+|||+|+.....
T Consensus        86 ~E~~~~g~l~~~~~~-~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~  161 (273)
T d1mp8a_          86 MELCTLGELRSFLQV-RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS  161 (273)
T ss_dssp             EECCTTEEHHHHHHH-TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC----------
T ss_pred             EEeccCCcHHhhhhc-cCCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheeccCC
Confidence            999999999998764 3467899999999999999999999998   999999999999999999999999999876543


Q ss_pred             CCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHhccCCCCCCcccccc
Q 002010          848 GASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVL  926 (982)
Q Consensus       848 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  926 (982)
                       .........||+.|+|||++.+..++.++|||||||++|||++ |.+||......+ ....+.....            
T Consensus       162 -~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~-~~~~i~~~~~------------  227 (273)
T d1mp8a_         162 -TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND-VIGRIENGER------------  227 (273)
T ss_dssp             ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-HHHHHHTTCC------------
T ss_pred             -cceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH-HHHHHHcCCC------------
Confidence             2223345678999999999999999999999999999999998 899997754433 3333322111            


Q ss_pred             eeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 002010          927 AVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPP  973 (982)
Q Consensus       927 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~  973 (982)
                             ...+...+..+.+++.+||+.||++|||++||++.|+.+.
T Consensus       228 -------~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~  267 (273)
T d1mp8a_         228 -------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL  267 (273)
T ss_dssp             -------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -------CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence                   1123344567999999999999999999999999987654

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-45  Score=400.22  Aligned_cols=261  Identities=27%  Similarity=0.382  Sum_probs=206.5

Q ss_pred             hhcccccccccccceEEEEEEeC------CCcEEEEEEeccCCCCCchhhHHHHHHHHhcC-CCCcccceEeEEEcC-Cc
Q 002010          692 ESLKDENIIGKGGAGIVYRGSMP------DGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRI-RHRNIVRLLGYVSNR-DT  763 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~-~~  763 (982)
                      ++|+..+.||+|+||.||+|...      +++.||||++.........+.+.+|..++.++ +|+||+++++++..+ ..
T Consensus        13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~   92 (299)
T d1ywna1          13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP   92 (299)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred             HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCe
Confidence            57899999999999999999642      34689999986555555566788888888887 689999999987664 46


Q ss_pred             cEEEEeccCCCCHHHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcC
Q 002010          764 NLLLYEYMPNGSLGEMLHGAK--------------GGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDS  829 (982)
Q Consensus       764 ~~lv~e~~~~~sL~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~  829 (982)
                      .++||||+++|+|.++++..+              ...+++.++..++.||++||+|||+++   ||||||||+||++++
T Consensus        93 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NILl~~  169 (299)
T d1ywna1          93 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSE  169 (299)
T ss_dssp             CEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECG
T ss_pred             EEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCccceeECC
Confidence            799999999999999997432              245889999999999999999999988   999999999999999


Q ss_pred             CCCEEEeccccchhccccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhC-CCCCCCCCCCchHHHH
Q 002010          830 DFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAG-KKPVGEFGDGVDIVRW  908 (982)
Q Consensus       830 ~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg-~~p~~~~~~~~~~~~~  908 (982)
                      ++++||+|||+|+...............||+.|||||++.+..++.++||||+||++|||+|| .+||........+...
T Consensus       170 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~  249 (299)
T d1ywna1         170 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR  249 (299)
T ss_dssp             GGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHH
T ss_pred             CCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence            999999999999877655444445567899999999999999999999999999999999996 5678766555555555


Q ss_pred             HHHhccCCCCCCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCC
Q 002010          909 VRKTTSEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQ  974 (982)
Q Consensus       909 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~~  974 (982)
                      +..... +                  ..+...+.++.+++.+||+.||++|||++|+++.|+.+.+
T Consensus       250 ~~~~~~-~------------------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq  296 (299)
T d1ywna1         250 LKEGTR-M------------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  296 (299)
T ss_dssp             HHHTCC-C------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HhcCCC-C------------------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence            443322 1                  1223344578999999999999999999999999987643

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-45  Score=389.25  Aligned_cols=250  Identities=29%  Similarity=0.433  Sum_probs=201.2

Q ss_pred             hhcccccccccccceEEEEEEeCCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEc-CCccEEEEec
Q 002010          692 ESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSN-RDTNLLLYEY  770 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~  770 (982)
                      ++|+..+.||+|+||.||+|+. .|.+||||+++.   ....+.+.+|++++++++|||||+++|++.+ ++..++||||
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~---~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey   82 (262)
T d1byga_           7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKN---DATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   82 (262)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCC---CC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             HHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECc---HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence            5688889999999999999998 678999999843   3345679999999999999999999999865 4568999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCc
Q 002010          771 MPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS  850 (982)
Q Consensus       771 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  850 (982)
                      +++|+|.+++.......+++..+.+++.||+.|++|||+.+   |+||||||+||+++.++.+|++|||+++.....   
T Consensus        83 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~---  156 (262)
T d1byga_          83 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---  156 (262)
T ss_dssp             CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred             cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCC---
Confidence            99999999997554456899999999999999999999988   999999999999999999999999999865432   


Q ss_pred             ccccccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceee
Q 002010          851 ECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVV  929 (982)
Q Consensus       851 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  929 (982)
                        .....+++.|+|||++.+..++.++|||||||++|||+| |++||... ...++...+....                
T Consensus       157 --~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~-~~~~~~~~i~~~~----------------  217 (262)
T d1byga_         157 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-PLKDVVPRVEKGY----------------  217 (262)
T ss_dssp             -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS-CGGGHHHHHTTTC----------------
T ss_pred             --CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCC-CHHHHHHHHHcCC----------------
Confidence              233567889999999999999999999999999999998 67777654 3334444432211                


Q ss_pred             cCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 002010          930 DPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPP  973 (982)
Q Consensus       930 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~  973 (982)
                         .+..+...+.++.+++.+||+.||.+||||+|+++.|++++
T Consensus       218 ---~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~  258 (262)
T d1byga_         218 ---KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK  258 (262)
T ss_dssp             ---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ---CCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence               11233344567899999999999999999999999997653

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=6e-45  Score=395.70  Aligned_cols=245  Identities=24%  Similarity=0.312  Sum_probs=206.9

Q ss_pred             hhcccccccccccceEEEEEEe-CCCcEEEEEEeccCC--CCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEE
Q 002010          692 ESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRG--TGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLY  768 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  768 (982)
                      ++|++.+.||+|+||+||+|+. .+|+.||||++....  .....+.+.+|+.++++++|||||++++++.+++..|+||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            5689999999999999999976 569999999985432  2345667899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccC
Q 002010          769 EYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAG  848 (982)
Q Consensus       769 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  848 (982)
                      ||++||++..++.  ....+++..+..++.||+.|++|||+++   |+||||||+||+++.++.+||+|||+|+..... 
T Consensus        84 E~~~gg~l~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~-  157 (316)
T d1fota_          84 DYIEGGELFSLLR--KSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-  157 (316)
T ss_dssp             CCCCSCBHHHHHH--HTSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC-
T ss_pred             eecCCcccccccc--ccccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccc-
Confidence            9999999999987  4467889999999999999999999988   999999999999999999999999999876532 


Q ss_pred             CcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCccccccee
Q 002010          849 ASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAV  928 (982)
Q Consensus       849 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  928 (982)
                          .....||+.|||||++.+..|+.++||||+||++|||++|+.||......+....+... ..              
T Consensus       158 ----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~-~~--------------  218 (316)
T d1fota_         158 ----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA-EL--------------  218 (316)
T ss_dssp             ----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHC-CC--------------
T ss_pred             ----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcC-CC--------------
Confidence                34578999999999999999999999999999999999999999764332222222211 11              


Q ss_pred             ecCCCCCCChHhHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 002010          929 VDPRLSGYPLTGVIHLFKVAMMCVEDESSARP-----TMREVVH  967 (982)
Q Consensus       929 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~ell~  967 (982)
                            ..|...+.++.+++.+||++||.+|+     |++|+++
T Consensus       219 ------~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~  256 (316)
T d1fota_         219 ------RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  256 (316)
T ss_dssp             ------CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             ------CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence                  11222335688999999999999996     8999875

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-45  Score=397.42  Aligned_cols=262  Identities=25%  Similarity=0.414  Sum_probs=209.0

Q ss_pred             hhcccccccccccceEEEEEEeC-CCc--EEEEEEeccCCCCCchhhHHHHHHHHhcC-CCCcccceEeEEEcCCccEEE
Q 002010          692 ESLKDENIIGKGGAGIVYRGSMP-DGI--DVAIKRLVGRGTGGNDHGFLAEIQTLGRI-RHRNIVRLLGYVSNRDTNLLL  767 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv  767 (982)
                      ++|+..+.||+|+||+||+|.+. ++.  .||||++.........+.+.+|++++.++ +|||||+++|++.+++..++|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence            67888999999999999999764 343  57888886555556677899999999998 799999999999999999999


Q ss_pred             EeccCCCCHHHHhhcC--------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCE
Q 002010          768 YEYMPNGSLGEMLHGA--------------KGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEA  833 (982)
Q Consensus       768 ~e~~~~~sL~~~l~~~--------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~  833 (982)
                      |||+++|+|.++++..              ....+++..+..++.||+.|+.|+|+.+   |+||||||+||+++.++.+
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~  166 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA  166 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred             EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence            9999999999999743              2367999999999999999999999988   9999999999999999999


Q ss_pred             EEeccccchhccccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCC-CCCCCCCCCchHHHHHHHh
Q 002010          834 HVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGK-KPVGEFGDGVDIVRWVRKT  912 (982)
Q Consensus       834 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~-~p~~~~~~~~~~~~~~~~~  912 (982)
                      ||+|||+|+.....   .......||..|+|||.+.+..++.++|||||||++|||++|. +||... ....+...+...
T Consensus       167 kl~DfG~a~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~-~~~~~~~~i~~~  242 (309)
T d1fvra_         167 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM-TCAELYEKLPQG  242 (309)
T ss_dssp             EECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC-CHHHHHHHGGGT
T ss_pred             EEcccccccccccc---ccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCC-CHHHHHHHHHhc
Confidence            99999999765432   1223456899999999999999999999999999999999975 466543 223333322211


Q ss_pred             ccCCCCCCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCCCCCCC
Q 002010          913 TSEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQSAPSL  979 (982)
Q Consensus       913 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~~~~~~~  979 (982)
                      .                   ....+...+..+.+++.+||+.||++||||+||++.|+++.+..++.
T Consensus       243 ~-------------------~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~~~  290 (309)
T d1fvra_         243 Y-------------------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTY  290 (309)
T ss_dssp             C-------------------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSCS
T ss_pred             C-------------------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCcCC
Confidence            1                   11223345568999999999999999999999999987766554443

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-45  Score=397.87  Aligned_cols=261  Identities=25%  Similarity=0.386  Sum_probs=213.1

Q ss_pred             HhhcccccccccccceEEEEEEeCC--------CcEEEEEEeccCCCCCchhhHHHHHHHHhcC-CCCcccceEeEEEcC
Q 002010          691 LESLKDENIIGKGGAGIVYRGSMPD--------GIDVAIKRLVGRGTGGNDHGFLAEIQTLGRI-RHRNIVRLLGYVSNR  761 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~  761 (982)
                      .++|+.++.||+|+||.||+|+...        +..||||++..........++.+|...+.++ +|||||++++++.++
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~   91 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   91 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence            3678999999999999999996422        3479999986655555567888999999888 799999999999999


Q ss_pred             CccEEEEeccCCCCHHHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEE
Q 002010          762 DTNLLLYEYMPNGSLGEMLHGAK--------------GGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILL  827 (982)
Q Consensus       762 ~~~~lv~e~~~~~sL~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill  827 (982)
                      +..++||||+++|+|.+++....              ...+++.++.+++.||+.||+|||+.+   ||||||||+||++
T Consensus        92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl  168 (299)
T d1fgka_          92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV  168 (299)
T ss_dssp             SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred             CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceee
Confidence            99999999999999999997543              246899999999999999999999998   9999999999999


Q ss_pred             cCCCCEEEeccccchhccccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHH
Q 002010          828 DSDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIV  906 (982)
Q Consensus       828 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~  906 (982)
                      +.++.+||+|||+++...............+++.|+|||.+.+..|+.++|||||||++|||++ |++||..... ....
T Consensus       169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~-~~~~  247 (299)
T d1fgka_         169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV-EELF  247 (299)
T ss_dssp             CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-HHHH
T ss_pred             cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH-HHHH
Confidence            9999999999999998876555555566789999999999999999999999999999999998 7888875433 2333


Q ss_pred             HHHHHhccCCCCCCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCC
Q 002010          907 RWVRKTTSEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQ  974 (982)
Q Consensus       907 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~~  974 (982)
                      ..+..... +                  ..+...+..+.+++.+||+.||++||||+||++.|+++.+
T Consensus       248 ~~i~~~~~-~------------------~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a  296 (299)
T d1fgka_         248 KLLKEGHR-M------------------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA  296 (299)
T ss_dssp             HHHHTTCC-C------------------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHcCCC-C------------------CCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence            33322111 1                  1222334578999999999999999999999999987643

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.4e-45  Score=395.28  Aligned_cols=261  Identities=24%  Similarity=0.391  Sum_probs=218.9

Q ss_pred             hhcccccccccccceEEEEEEe------CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcC-CCCcccceEeEEEcCCcc
Q 002010          692 ESLKDENIIGKGGAGIVYRGSM------PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRI-RHRNIVRLLGYVSNRDTN  764 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~  764 (982)
                      ++|+..+.||+|+||.||+|++      .+++.||||++..........++.+|+.+++++ +|||||+++|++.+++..
T Consensus        23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~  102 (311)
T d1t46a_          23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT  102 (311)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEE
Confidence            6788999999999999999964      346789999996655555566789999999999 699999999999999999


Q ss_pred             EEEEeccCCCCHHHHhhcCC----------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEc
Q 002010          765 LLLYEYMPNGSLGEMLHGAK----------------GGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLD  828 (982)
Q Consensus       765 ~lv~e~~~~~sL~~~l~~~~----------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~  828 (982)
                      ++||||+++|+|.++++...                ...+++..+.+++.||++|++|||+++   ||||||||+||+++
T Consensus       103 ~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~~  179 (311)
T d1t46a_         103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLT  179 (311)
T ss_dssp             EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEE
T ss_pred             EEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccccccccccc
Confidence            99999999999999997543                236899999999999999999999998   99999999999999


Q ss_pred             CCCCEEEeccccchhccccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHH
Q 002010          829 SDFEAHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVR  907 (982)
Q Consensus       829 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~  907 (982)
                      .++.+|++|||.++...............||+.|+|||++.+..++.++|||||||++|||+| |.+||........+.+
T Consensus       180 ~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~  259 (311)
T d1t46a_         180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK  259 (311)
T ss_dssp             TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHH
T ss_pred             ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            999999999999998765544455556789999999999999999999999999999999999 5666655555455555


Q ss_pred             HHHHhccCCCCCCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCC
Q 002010          908 WVRKTTSEVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQ  974 (982)
Q Consensus       908 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~~  974 (982)
                      ++......                   ..+...+..+.+++.+||+.||++||||+||+++|+++.+
T Consensus       260 ~i~~~~~~-------------------~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~  307 (311)
T d1t46a_         260 MIKEGFRM-------------------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS  307 (311)
T ss_dssp             HHHHTCCC-------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHhcCCCC-------------------CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhc
Confidence            55443221                   1122334578999999999999999999999999986543

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-44  Score=387.01  Aligned_cols=282  Identities=19%  Similarity=0.295  Sum_probs=218.7

Q ss_pred             hhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCC-CCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEe
Q 002010          692 ESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGT-GGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYE  769 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  769 (982)
                      ++|++.+.||+|+||+||+|.. .+|+.||||++..... +.....+.+|+.++++++|||||++++++.+++..|+|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            5799999999999999999965 6799999999854432 2345678999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCC
Q 002010          770 YMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGA  849 (982)
Q Consensus       770 ~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  849 (982)
                      |+.+ .+.+++.......+++..+..++.||+.||+|||+.+   ||||||||+||+++.++.+||+|||.|+.....  
T Consensus        82 ~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~--  155 (298)
T d1gz8a_          82 FLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP--  155 (298)
T ss_dssp             CCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC--
T ss_pred             ecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCC--
Confidence            9965 5566665556678999999999999999999999998   999999999999999999999999999876533  


Q ss_pred             cccccccccccccccccccccCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCccccccee
Q 002010          850 SECMSSVAGSYGYIAPEYAYTLK-VDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAV  928 (982)
Q Consensus       850 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  928 (982)
                      ........||+.|+|||++.... ++.++||||+||++|+|++|+.||................................
T Consensus       156 ~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  235 (298)
T d1gz8a_         156 VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD  235 (298)
T ss_dssp             SBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred             cccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccc
Confidence            23345568999999999877665 57899999999999999999999986544444444443333222111111100000


Q ss_pred             ecCCCCC--------CChHhHHHHHHHHhhccCCCCCCCCCHHHHHH--HhcCCCCCCCCC
Q 002010          929 VDPRLSG--------YPLTGVIHLFKVAMMCVEDESSARPTMREVVH--MLANPPQSAPSL  979 (982)
Q Consensus       929 ~~~~~~~--------~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~--~L~~~~~~~~~~  979 (982)
                      ..+..+.        ........+.+++.+||+.||++|||++|+++  .++++.++.|++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p~p~~  296 (298)
T d1gz8a_         236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL  296 (298)
T ss_dssp             CCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCCCCCC
T ss_pred             cccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCCCCCC
Confidence            1111110        01123357889999999999999999999999  589999888864

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.5e-45  Score=387.96  Aligned_cols=257  Identities=27%  Similarity=0.420  Sum_probs=198.7

Q ss_pred             hhcccccccccccceEEEEEEeC--C--CcEEEEEEeccCCC--CCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccE
Q 002010          692 ESLKDENIIGKGGAGIVYRGSMP--D--GIDVAIKRLVGRGT--GGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNL  765 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~~--~--~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  765 (982)
                      ++|+..+.||+|+||.||+|+..  +  ...||||++.....  ....++|.+|+.++++++|||||+++|++.+ +..+
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~   86 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK   86 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence            56888999999999999999642  2  34789998855432  2334679999999999999999999999965 5678


Q ss_pred             EEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhcc
Q 002010          766 LLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQ  845 (982)
Q Consensus       766 lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~  845 (982)
                      +||||+++|++.+++.. +...+++..+..++.||+.||+|||+++   |+||||||+||+++.++.+||+|||+++.+.
T Consensus        87 lv~e~~~~~~l~~~~~~-~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~~  162 (273)
T d1u46a_          87 MVTELAPLGSLLDRLRK-HQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALP  162 (273)
T ss_dssp             EEEECCTTCBHHHHHHH-HGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred             eeeeeecCcchhhhhhc-ccCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhcc
Confidence            99999999999998864 3457999999999999999999999988   9999999999999999999999999999775


Q ss_pred             ccCCcc-cccccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHhccCCCCCCccc
Q 002010          846 DAGASE-CMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIA-GKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAA  923 (982)
Q Consensus       846 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  923 (982)
                      ...... ......|+..|+|||++.+..++.++|||||||++|||+| |+.||......+ ....+......+       
T Consensus       163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~-~~~~i~~~~~~~-------  234 (273)
T d1u46a_         163 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ-ILHKIDKEGERL-------  234 (273)
T ss_dssp             C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-HHHHHHTSCCCC-------
T ss_pred             cCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHH-HHHHHHhCCCCC-------
Confidence            443222 2234567889999999999999999999999999999998 899997654332 333332222111       


Q ss_pred             ccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 002010          924 SVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANP  972 (982)
Q Consensus       924 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~  972 (982)
                                 ..+...+..+.+++.+||+.||++||||+||++.|++.
T Consensus       235 -----------~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         235 -----------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             -----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -----------CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence                       12223345789999999999999999999999998753

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-44  Score=388.31  Aligned_cols=255  Identities=28%  Similarity=0.418  Sum_probs=205.6

Q ss_pred             ccccccccceEEEEEEeCC----CcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEc-CCccEEEEecc
Q 002010          697 ENIIGKGGAGIVYRGSMPD----GIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSN-RDTNLLLYEYM  771 (982)
Q Consensus       697 ~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~  771 (982)
                      .++||+|+||+||+|.+.+    ...||||++..........+|.+|++++++++|||||+++|++.. +...++||||+
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            4689999999999997643    235899998655455556789999999999999999999999765 45789999999


Q ss_pred             CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCc-
Q 002010          772 PNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS-  850 (982)
Q Consensus       772 ~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~-  850 (982)
                      ++|+|.+++.. .....++..+.+++.|++.|+.|+|+.+   |+||||||+||++++++.+||+|||+++........ 
T Consensus       112 ~~g~l~~~~~~-~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~  187 (311)
T d1r0pa_         112 KHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS  187 (311)
T ss_dssp             TTCBHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCC
T ss_pred             ecCchhhhhcc-ccccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhcccccccc
Confidence            99999999874 4467788999999999999999999988   999999999999999999999999999876543222 


Q ss_pred             -ccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceee
Q 002010          851 -ECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVV  929 (982)
Q Consensus       851 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  929 (982)
                       .......||+.|+|||.+.+..++.++||||||+++|||+||+.||.......+....+..... +             
T Consensus       188 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~-~-------------  253 (311)
T d1r0pa_         188 VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR-L-------------  253 (311)
T ss_dssp             TTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCC-C-------------
T ss_pred             ceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC-C-------------
Confidence             2233457899999999999999999999999999999999988887664444444444433221 1             


Q ss_pred             cCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCC
Q 002010          930 DPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQ  974 (982)
Q Consensus       930 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~~  974 (982)
                           ..|..++..+.+++.+||+.||++|||+.||++.|+++..
T Consensus       254 -----~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~  293 (311)
T d1r0pa_         254 -----LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS  293 (311)
T ss_dssp             -----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -----CCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence                 1223344578999999999999999999999999876543

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=3.2e-44  Score=382.20  Aligned_cols=252  Identities=25%  Similarity=0.341  Sum_probs=206.7

Q ss_pred             HhhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCCCc--------hhhHHHHHHHHhcCC-CCcccceEeEEEc
Q 002010          691 LESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGN--------DHGFLAEIQTLGRIR-HRNIVRLLGYVSN  760 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~--------~~~~~~E~~~l~~l~-h~niv~~~~~~~~  760 (982)
                      .++|+..+.||+|+||+||+|+. .+|+.||||++........        .+.+.+|+.++++++ ||||+++++++.+
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~   81 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   81 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence            46899999999999999999975 5789999999865433221        235789999999997 9999999999999


Q ss_pred             CCccEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEecccc
Q 002010          761 RDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGL  840 (982)
Q Consensus       761 ~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~  840 (982)
                      ++..|+||||+++|+|.+++..  .+++++.++..++.||+.||+|||+++   |+||||||+||+++.++.+||+|||+
T Consensus        82 ~~~~~ivmE~~~~g~L~~~l~~--~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~  156 (277)
T d1phka_          82 NTFFFLVFDLMKKGELFDYLTE--KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGF  156 (277)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             CcceEEEEEcCCCchHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccchh
Confidence            9999999999999999999973  468999999999999999999999998   99999999999999999999999999


Q ss_pred             chhccccCCcccccccccccccccccccc------cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhcc
Q 002010          841 AKFLQDAGASECMSSVAGSYGYIAPEYAY------TLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTS  914 (982)
Q Consensus       841 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  914 (982)
                      ++.+...   .......||+.|+|||.+.      ...++.++||||+||++|||++|+.||........ ...+.....
T Consensus       157 a~~~~~~---~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~-~~~i~~~~~  232 (277)
T d1phka_         157 SCQLDPG---EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLM-LRMIMSGNY  232 (277)
T ss_dssp             CEECCTT---CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHTCC
T ss_pred             eeEccCC---CceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHH-HHHHHhCCC
Confidence            9876543   2234568999999999875      33578899999999999999999999986543222 222222111


Q ss_pred             CCCCCCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          915 EVSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       915 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                      ....                ......+.++.+++.+||+.||++|||++|+++
T Consensus       233 ~~~~----------------~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~  269 (277)
T d1phka_         233 QFGS----------------PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  269 (277)
T ss_dssp             CCCT----------------TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             CCCC----------------cccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            1110                111234457899999999999999999999875

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=1.5e-44  Score=387.05  Aligned_cols=260  Identities=26%  Similarity=0.334  Sum_probs=203.1

Q ss_pred             HhhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCCC--chhhHHHHHHHHhcCCCCcccceEeEEEcCCc----
Q 002010          691 LESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGG--NDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDT----  763 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~----  763 (982)
                      .++|++.+.||+|+||+||+|.. .+|+.||||++.......  ....+.+|+.++++++|||||++++++..++.    
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            36799999999999999999965 579999999996543322  34568999999999999999999999876543    


Q ss_pred             cEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchh
Q 002010          764 NLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKF  843 (982)
Q Consensus       764 ~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~  843 (982)
                      .|+||||++|++|.+++.  ..+.+++.++..++.||+.|++|||+.+   |+||||||+||+++.++.++++|||.+..
T Consensus        86 ~~lvmE~~~g~~L~~~~~--~~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~~  160 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVH--TEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARA  160 (277)
T ss_dssp             EEEEEECCCEEEHHHHHH--HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCEE
T ss_pred             EEEEEECCCCCEehhhhc--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhhh
Confidence            789999999999999987  3457999999999999999999999998   99999999999999999999999999876


Q ss_pred             cccc-CCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcc
Q 002010          844 LQDA-GASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDA  922 (982)
Q Consensus       844 ~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  922 (982)
                      .... ..........||+.|+|||++.+..++.++||||+||++|||+||++||......+.....+......   +   
T Consensus       161 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~---~---  234 (277)
T d1o6ya_         161 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIP---P---  234 (277)
T ss_dssp             CC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCC---G---
T ss_pred             hccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCC---C---
Confidence            5432 22233445689999999999999999999999999999999999999997643333222222221110   0   


Q ss_pred             cccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCC-CHHHHHHHhcCC
Q 002010          923 ASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARP-TMREVVHMLANP  972 (982)
Q Consensus       923 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-t~~ell~~L~~~  972 (982)
                                 .......+.++.+++.+||++||++|| |++|+++.|.++
T Consensus       235 -----------~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~  274 (277)
T d1o6ya_         235 -----------SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV  274 (277)
T ss_dssp             -----------GGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             -----------chhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence                       011223345789999999999999999 899999988654

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-44  Score=391.73  Aligned_cols=264  Identities=25%  Similarity=0.385  Sum_probs=218.3

Q ss_pred             HhhcccccccccccceEEEEEEeC------CCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCcc
Q 002010          691 LESLKDENIIGKGGAGIVYRGSMP------DGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTN  764 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  764 (982)
                      .++|+..+.||+|+||+||+|.+.      +++.||||++...........+.+|+.++++++|||||+++|++..++..
T Consensus        19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~   98 (308)
T d1p4oa_          19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT   98 (308)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence            468899999999999999999652      35789999986554444556789999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHhhcC--------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEe
Q 002010          765 LLLYEYMPNGSLGEMLHGA--------KGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVA  836 (982)
Q Consensus       765 ~lv~e~~~~~sL~~~l~~~--------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~  836 (982)
                      ++||||+++|+|.+++...        ....+++..+.+++.|+++||+|||+++   |+||||||+||++++++++||+
T Consensus        99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl~  175 (308)
T d1p4oa_          99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIG  175 (308)
T ss_dssp             EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEEC
T ss_pred             eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEEe
Confidence            9999999999999998632        2245789999999999999999999988   9999999999999999999999


Q ss_pred             ccccchhccccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhC-CCCCCCCCCCchHHHHHHHhccC
Q 002010          837 DFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAG-KKPVGEFGDGVDIVRWVRKTTSE  915 (982)
Q Consensus       837 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg-~~p~~~~~~~~~~~~~~~~~~~~  915 (982)
                      |||+|+...............||+.|+|||.+.+..++.++||||||+++|||+|| .+||...... .....+..    
T Consensus       176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~-~~~~~i~~----  250 (308)
T d1p4oa_         176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE-QVLRFVME----  250 (308)
T ss_dssp             CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH-HHHHHHHT----
T ss_pred             ecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHH-HHHHHHHh----
Confidence            99999877655444444556789999999999999999999999999999999998 4677654332 22222221    


Q ss_pred             CCCCCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCCCCC
Q 002010          916 VSQPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQSAP  977 (982)
Q Consensus       916 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~~~~~  977 (982)
                                     ......+...+..+.+++.+||+.||++|||++||++.|++..++..
T Consensus       251 ---------------~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~  297 (308)
T d1p4oa_         251 ---------------GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGF  297 (308)
T ss_dssp             ---------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTH
T ss_pred             ---------------CCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCC
Confidence                           11122333455689999999999999999999999999998877543

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.3e-44  Score=396.55  Aligned_cols=245  Identities=20%  Similarity=0.232  Sum_probs=206.7

Q ss_pred             hhcccccccccccceEEEEEEe-CCCcEEEEEEeccCC--CCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEE
Q 002010          692 ESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRG--TGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLY  768 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  768 (982)
                      ++|++.+.||+|+||.||+|+. .+|+.||||++....  .....+.+.+|+.++++++|||||++++++.+....++||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            6899999999999999999975 579999999985331  2344567899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccC
Q 002010          769 EYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAG  848 (982)
Q Consensus       769 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  848 (982)
                      ||+.+|+|.+++.  +...+++..+..++.||+.||+|||+++   ||||||||+|||++.++.+||+|||+|+.+... 
T Consensus       121 e~~~~g~l~~~l~--~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~-  194 (350)
T d1rdqe_         121 EYVAGGEMFSHLR--RIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-  194 (350)
T ss_dssp             ECCTTCBHHHHHH--HHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred             ccccccchhhhHh--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccc-
Confidence            9999999999997  3457999999999999999999999998   999999999999999999999999999876532 


Q ss_pred             CcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCccccccee
Q 002010          849 ASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAV  928 (982)
Q Consensus       849 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  928 (982)
                          .....||+.|||||++.+..|+.++||||+||++|||+||+.||...... .....+.....              
T Consensus       195 ----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~-~~~~~i~~~~~--------------  255 (350)
T d1rdqe_         195 ----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKIVSGKV--------------  255 (350)
T ss_dssp             ----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHCCC--------------
T ss_pred             ----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHH-HHHHHHhcCCC--------------
Confidence                34568999999999999999999999999999999999999999754322 22222211111              


Q ss_pred             ecCCCCCCChHhHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 002010          929 VDPRLSGYPLTGVIHLFKVAMMCVEDESSARP-----TMREVVH  967 (982)
Q Consensus       929 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~ell~  967 (982)
                            ..+...+.++.+++.+||+.||.+|+     |++|+++
T Consensus       256 ------~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         256 ------RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             ------CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             ------CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence                  11223345788999999999999994     8999986

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-44  Score=390.69  Aligned_cols=252  Identities=20%  Similarity=0.235  Sum_probs=206.6

Q ss_pred             HHhhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEE
Q 002010          690 VLESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLY  768 (982)
Q Consensus       690 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  768 (982)
                      +.++|++.+.||+|+||+||+|.. .+++.||||.+...  ......+.+|++++++++|||||++++++.+++..|+||
T Consensus         3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~--~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvm   80 (321)
T d1tkia_           3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK--GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIF   80 (321)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC--THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCC--cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence            467899999999999999999965 46889999998543  233456889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCC--CCEEEeccccchhccc
Q 002010          769 EYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSD--FEAHVADFGLAKFLQD  846 (982)
Q Consensus       769 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~--~~~kl~DfG~a~~~~~  846 (982)
                      |||+||+|.+++.. ....+++.++..++.||+.|++|||+.+   |+||||||+||+++.+  ..+||+|||+++....
T Consensus        81 E~~~gg~L~~~i~~-~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~  156 (321)
T d1tkia_          81 EFISGLDIFERINT-SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP  156 (321)
T ss_dssp             CCCCCCBHHHHHTS-SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred             ecCCCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhcccc
Confidence            99999999999963 2347999999999999999999999998   9999999999999854  5899999999986643


Q ss_pred             cCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccc
Q 002010          847 AGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVL  926 (982)
Q Consensus       847 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  926 (982)
                      .   .......+|+.|+|||...+..|+.++||||+||++|+|++|+.||...........+...... .  +.      
T Consensus       157 ~---~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~-~--~~------  224 (321)
T d1tkia_         157 G---DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYT-F--DE------  224 (321)
T ss_dssp             T---CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCC-C--CH------
T ss_pred             C---CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-C--Ch------
Confidence            2   2334567899999999999999999999999999999999999999765433322222221111 0  00      


Q ss_pred             eeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          927 AVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       927 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                              ......+.++.+++.+||+.||.+|||++|+++
T Consensus       225 --------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  257 (321)
T d1tkia_         225 --------EAFKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             --------HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             --------hhccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                    000112346889999999999999999999987

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=9.5e-44  Score=393.83  Aligned_cols=249  Identities=24%  Similarity=0.263  Sum_probs=201.0

Q ss_pred             hhcccccccccccceEEEEEEe-CCCcEEEEEEeccCC--CCCchhhHH---HHHHHHhcCCCCcccceEeEEEcCCccE
Q 002010          692 ESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRG--TGGNDHGFL---AEIQTLGRIRHRNIVRLLGYVSNRDTNL  765 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~---~E~~~l~~l~h~niv~~~~~~~~~~~~~  765 (982)
                      ++|++.+.||+|+||.||+|+. .+|+.||||++....  .......+.   +|+.+++.++|||||++++++.+++..|
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~   83 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS   83 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence            5789999999999999999975 469999999984321  112222333   4477778889999999999999999999


Q ss_pred             EEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhcc
Q 002010          766 LLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQ  845 (982)
Q Consensus       766 lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~  845 (982)
                      +||||+++|+|.+++.  +...+++..+..++.||+.||+|||+++   ||||||||+||+++.++.+||+|||+|+.+.
T Consensus        84 ivmE~~~gg~L~~~l~--~~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~~  158 (364)
T d1omwa3          84 FILDLMNGGDLHYHLS--QHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFS  158 (364)
T ss_dssp             EEECCCCSCBHHHHHH--HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEECS
T ss_pred             EEEEecCCCcHHHHHH--hcccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeecC
Confidence            9999999999999997  3467899999999999999999999998   9999999999999999999999999998765


Q ss_pred             ccCCccccccccccccccccccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccc
Q 002010          846 DAGASECMSSVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAAS  924 (982)
Q Consensus       846 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  924 (982)
                      ..    ......||+.|+|||++.+ ..|+.++||||+||++|||+||+.||....... ............        
T Consensus       159 ~~----~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~-~~~~~~~~~~~~--------  225 (364)
T d1omwa3         159 KK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-KHEIDRMTLTMA--------  225 (364)
T ss_dssp             SS----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSC-HHHHHHHSSSCC--------
T ss_pred             CC----cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhcccCC--------
Confidence            32    2345679999999999864 568999999999999999999999998654332 222222221110        


Q ss_pred             cceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 002010          925 VLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPT-----MREVVH  967 (982)
Q Consensus       925 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt-----~~ell~  967 (982)
                               ...+...+..+.+++.+||+.||++|||     ++|+++
T Consensus       226 ---------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         226 ---------VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             ---------CCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred             ---------CCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence                     1122234457899999999999999999     688875

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9e-44  Score=385.84  Aligned_cols=276  Identities=24%  Similarity=0.281  Sum_probs=208.3

Q ss_pred             cccccccccceEEEEEEe-CCCcEEEEEEeccCCCC----CchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEec
Q 002010          696 DENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTG----GNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEY  770 (982)
Q Consensus       696 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  770 (982)
                      ..++||+|+||+||+|.. .+|+.||||++......    .....+.+|+.++++++|||||++++++.+++..++||||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~   81 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF   81 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence            346899999999999976 46899999998544322    1235688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCc
Q 002010          771 MPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS  850 (982)
Q Consensus       771 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  850 (982)
                      ++++++..+..  ....+++..+..++.||+.||+|||+++   |+||||||+||+++.++.+||+|||+|+......  
T Consensus        82 ~~~~~~~~~~~--~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~--  154 (299)
T d1ua2a_          82 METDLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN--  154 (299)
T ss_dssp             CSEEHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC--
T ss_pred             hcchHHhhhhh--cccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCc--
Confidence            98887776664  4567899999999999999999999998   9999999999999999999999999998765432  


Q ss_pred             cccccccccccccccccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCc--ccccce
Q 002010          851 ECMSSVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSD--AASVLA  927 (982)
Q Consensus       851 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~  927 (982)
                      ......+||+.|+|||++.+ ..|+.++||||+||++|||++|++||....+.+.+..+.............  ......
T Consensus       155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~  234 (299)
T d1ua2a_         155 RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY  234 (299)
T ss_dssp             CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTC
T ss_pred             ccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchh
Confidence            22345679999999998865 458999999999999999999999998655444444444333221111100  000000


Q ss_pred             eecCCCCCCC-----hHhHHHHHHHHhhccCCCCCCCCCHHHHHH--HhcCCCCCCCC
Q 002010          928 VVDPRLSGYP-----LTGVIHLFKVAMMCVEDESSARPTMREVVH--MLANPPQSAPS  978 (982)
Q Consensus       928 ~~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~Rpt~~ell~--~L~~~~~~~~~  978 (982)
                      ......+..+     ......+.+|+.+||+.||++|||++|+++  .++....+.|.
T Consensus       235 ~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~p~~~  292 (299)
T d1ua2a_         235 VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPG  292 (299)
T ss_dssp             CCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCCCS
T ss_pred             hhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCCCCCC
Confidence            0001111111     233457899999999999999999999997  57666555443

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-44  Score=391.75  Aligned_cols=247  Identities=24%  Similarity=0.333  Sum_probs=204.4

Q ss_pred             hhcccccccccccceEEEEEEe-CCCcEEEEEEeccCC--CCCchhhHHHHHHHHh-cCCCCcccceEeEEEcCCccEEE
Q 002010          692 ESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRG--TGGNDHGFLAEIQTLG-RIRHRNIVRLLGYVSNRDTNLLL  767 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~-~l~h~niv~~~~~~~~~~~~~lv  767 (982)
                      ++|+..+.||+|+||+||+|.. .+++.||||++....  .......+..|..++. .++|||||++++++.+++..|+|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            5789999999999999999965 569999999985432  2344556777777765 68999999999999999999999


Q ss_pred             EeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhcccc
Q 002010          768 YEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDA  847 (982)
Q Consensus       768 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  847 (982)
                      |||+++|+|.+++.  ....+++.++..++.||+.|++|||+++   |+||||||+||++++++.+||+|||+|+.....
T Consensus        82 mEy~~~g~L~~~i~--~~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~  156 (320)
T d1xjda_          82 MEYLNGGDLMYHIQ--SCHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLG  156 (320)
T ss_dssp             EECCTTCBHHHHHH--HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred             EeecCCCcHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhcccc
Confidence            99999999999997  4467899999999999999999999998   999999999999999999999999999865432


Q ss_pred             CCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccce
Q 002010          848 GASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLA  927 (982)
Q Consensus       848 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  927 (982)
                        ........||+.|+|||++.+..|+.++||||+||++|||++|+.||.+.... .....+.....             
T Consensus       157 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~-~~~~~i~~~~~-------------  220 (320)
T d1xjda_         157 --DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE-ELFHSIRMDNP-------------  220 (320)
T ss_dssp             --TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHCCC-------------
T ss_pred             --cccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHH-HHHHHHHcCCC-------------
Confidence              23345578999999999999999999999999999999999999999764332 22222221111             


Q ss_pred             eecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHH-HHH
Q 002010          928 VVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMR-EVV  966 (982)
Q Consensus       928 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~-ell  966 (982)
                             ..|...+.++.+++.+||+.||++|||+. |++
T Consensus       221 -------~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~  253 (320)
T d1xjda_         221 -------FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR  253 (320)
T ss_dssp             -------CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             -------CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHH
Confidence                   12223345789999999999999999995 665

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.9e-44  Score=390.65  Aligned_cols=253  Identities=21%  Similarity=0.223  Sum_probs=201.2

Q ss_pred             HHHhhcccc-cccccccceEEEEEEe-CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcC-CCCcccceEeEEEc----C
Q 002010          689 DVLESLKDE-NIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRI-RHRNIVRLLGYVSN----R  761 (982)
Q Consensus       689 ~~~~~~~~~-~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~----~  761 (982)
                      .+.++|++. +.||+|+||+||+|.. .+++.||||++..      ...+.+|+.++.++ +|||||+++++|.+    +
T Consensus         8 ~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~------~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~   81 (335)
T d2ozaa1           8 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD------CPKARREVELHWRASQCPHIVRIVDVYENLYAGR   81 (335)
T ss_dssp             CGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred             CcccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC------cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCC
Confidence            345788876 5699999999999965 6799999999842      34677899987655 89999999999865    4


Q ss_pred             CccEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcC---CCCEEEecc
Q 002010          762 DTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDS---DFEAHVADF  838 (982)
Q Consensus       762 ~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~---~~~~kl~Df  838 (982)
                      ...|+|||||+||+|.+++.......+++.+++.++.||+.|++|||+.+   |+||||||+||+++.   ++.+||+||
T Consensus        82 ~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DF  158 (335)
T d2ozaa1          82 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDF  158 (335)
T ss_dssp             EEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCC
T ss_pred             CEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcC---Ccccccccccccccccccccccccccc
Confidence            56799999999999999998655678999999999999999999999998   999999999999985   567999999


Q ss_pred             ccchhccccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCC
Q 002010          839 GLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQ  918 (982)
Q Consensus       839 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  918 (982)
                      |+|+.....   .......||+.|||||++.+..|+.++||||+||++|+|+||++||.................. .  
T Consensus       159 G~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~-~--  232 (335)
T d2ozaa1         159 GFAKETTSH---NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM-G--  232 (335)
T ss_dssp             TTCEECCCC---CCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCS-C--
T ss_pred             ceeeeccCC---CccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhc-C--
Confidence            999876543   2335578999999999999999999999999999999999999999764332221111111000 0  


Q ss_pred             CCcccccceeecCCCC-CCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          919 PSDAASVLAVVDPRLS-GYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       919 ~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                                 +..++ ......+.++.+|+.+||+.||++|||++|+++
T Consensus       233 -----------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  271 (335)
T d2ozaa1         233 -----------QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  271 (335)
T ss_dssp             -----------SSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             -----------CCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence                       00011 011234567899999999999999999999987

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=5.4e-43  Score=377.28  Aligned_cols=269  Identities=22%  Similarity=0.307  Sum_probs=207.7

Q ss_pred             hhcccccccccccceEEEEEEeCCCcEEEEEEeccCC-CCCchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEec
Q 002010          692 ESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRG-TGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYEY  770 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  770 (982)
                      ++|+..+.||+|+||+||+|+.++|+.||||++.... .....+.+.+|+.++++++|||||++++++..++..+++||+
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence            5789999999999999999998899999999985443 233456789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCCc
Q 002010          771 MPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGAS  850 (982)
Q Consensus       771 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  850 (982)
                      +.++.+..+..  ....+++..+..++.||+.||+|||+.+   ||||||||+||+++.++.+|++|||.|.......  
T Consensus        82 ~~~~~~~~~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~--  154 (286)
T d1ob3a_          82 LDQDLKKLLDV--CEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPV--  154 (286)
T ss_dssp             CSEEHHHHHHT--STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred             ehhhhHHHHHh--hcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCc--
Confidence            98777666654  4578999999999999999999999988   9999999999999999999999999998765432  


Q ss_pred             ccccccccccccccccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCcccccceee
Q 002010          851 ECMSSVAGSYGYIAPEYAYTL-KVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAVV  929 (982)
Q Consensus       851 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  929 (982)
                      .......+++.|+|||.+.+. .++.++||||+||++|||++|+.||.+....+...+......................
T Consensus       155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  234 (286)
T d1ob3a_         155 RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY  234 (286)
T ss_dssp             -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred             cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhc
Confidence            223445789999999998754 4689999999999999999999999875544444444433332211111111100001


Q ss_pred             cCCCC--------CCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          930 DPRLS--------GYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       930 ~~~~~--------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                      +....        ......+..+.+++.+||+.||++|||++|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            11110        122334467889999999999999999999974

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-43  Score=380.27  Aligned_cols=265  Identities=27%  Similarity=0.361  Sum_probs=200.1

Q ss_pred             HhhcccccccccccceEEEEEEeCCCcEEEEEEeccCCCCCchhhHHH--HHHHHhcCCCCcccceEeEEEcCC----cc
Q 002010          691 LESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLA--EIQTLGRIRHRNIVRLLGYVSNRD----TN  764 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~--E~~~l~~l~h~niv~~~~~~~~~~----~~  764 (982)
                      .++|...+.||+|+||+||+|+. +|+.||||++...    ....+.+  |+..+.+++|||||++++++.+++    ..
T Consensus         2 ~~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~----~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~   76 (303)
T d1vjya_           2 ARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR----EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL   76 (303)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGG----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred             CcEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECcc----chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEE
Confidence            35688889999999999999987 7899999998432    2334444  455556789999999999987654    56


Q ss_pred             EEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC-----CCcEEecCCCCCcEEEcCCCCEEEeccc
Q 002010          765 LLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDC-----SPLIIHRDVKSNNILLDSDFEAHVADFG  839 (982)
Q Consensus       765 ~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-----~~~ivHrDlkp~Nill~~~~~~kl~DfG  839 (982)
                      ++||||+++|+|.+++++   .++++..+.+++.|++.|++|+|+..     .++|+||||||+||+++.++.+||+|||
T Consensus        77 ~lv~Ey~~~g~L~~~l~~---~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFG  153 (303)
T d1vjya_          77 WLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG  153 (303)
T ss_dssp             EEEEECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCT
T ss_pred             EEEEecccCCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecC
Confidence            899999999999999974   36899999999999999999999741     2349999999999999999999999999


Q ss_pred             cchhccccCCc--ccccccccccccccccccccCC------CCcchhhHHHHHHHHHHHhCCCCCCCCCCCchH------
Q 002010          840 LAKFLQDAGAS--ECMSSVAGSYGYIAPEYAYTLK------VDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDI------  905 (982)
Q Consensus       840 ~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwslG~il~elltg~~p~~~~~~~~~~------  905 (982)
                      +++........  .......||+.|+|||++.+..      ++.++|||||||++|||+||..||....+....      
T Consensus       154 l~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~  233 (303)
T d1vjya_         154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP  233 (303)
T ss_dssp             TCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSC
T ss_pred             ccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccc
Confidence            99877543221  1234578999999999987542      677999999999999999999887653322110      


Q ss_pred             ----HHHHHHhccCCCCCCcccccceeecCCCCC--CChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCC
Q 002010          906 ----VRWVRKTTSEVSQPSDAASVLAVVDPRLSG--YPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANPPQ  974 (982)
Q Consensus       906 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~~~  974 (982)
                          ........           .....+|.++.  .+.+.+..+.+++.+||+.||++|||+.||++.|+++.+
T Consensus       234 ~~~~~~~~~~~~-----------~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~  297 (303)
T d1vjya_         234 SDPSVEEMRKVV-----------CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ  297 (303)
T ss_dssp             SSCCHHHHHHHH-----------TTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ccchHHHHHHHH-----------hccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence                00000000           00112222221  123455679999999999999999999999999986543

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-43  Score=373.58  Aligned_cols=245  Identities=23%  Similarity=0.384  Sum_probs=199.8

Q ss_pred             hhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCC-----CchhhHHHHHHHHhcCC--CCcccceEeEEEcCCc
Q 002010          692 ESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTG-----GNDHGFLAEIQTLGRIR--HRNIVRLLGYVSNRDT  763 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~  763 (982)
                      ++|++.+.||+|+||+||+|.. .+|+.||||++......     ....++.+|+.++++++  |||||++++++.+++.
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~   83 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS   83 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence            5799999999999999999965 57999999998543221     12234678999999986  8999999999999999


Q ss_pred             cEEEEeccCC-CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCC-CCEEEeccccc
Q 002010          764 NLLLYEYMPN-GSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSD-FEAHVADFGLA  841 (982)
Q Consensus       764 ~~lv~e~~~~-~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~-~~~kl~DfG~a  841 (982)
                      .++||||+++ +++.+++.  +...++++++..++.||+.|++|||+.+   |+||||||+||+++.+ +.+||+|||+|
T Consensus        84 ~~lv~e~~~~~~~l~~~~~--~~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG~a  158 (273)
T d1xwsa_          84 FVLILERPEPVQDLFDFIT--ERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSG  158 (273)
T ss_dssp             EEEEEECCSSEEEHHHHHH--HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             EEEEEEeccCcchHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECccccc
Confidence            9999999976 58888886  3467999999999999999999999998   9999999999999854 79999999999


Q ss_pred             hhccccCCcccccccccccccccccccccCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCC
Q 002010          842 KFLQDAGASECMSSVAGSYGYIAPEYAYTLKV-DEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPS  920 (982)
Q Consensus       842 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  920 (982)
                      +.....    ......||+.|+|||++.+..+ +.++||||+||++|||++|+.||...   .   .......       
T Consensus       159 ~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~---~---~i~~~~~-------  221 (273)
T d1xwsa_         159 ALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD---E---EIIRGQV-------  221 (273)
T ss_dssp             EECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH---H---HHHHCCC-------
T ss_pred             eecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc---h---HHhhccc-------
Confidence            865432    2345789999999999987765 57799999999999999999999642   1   1111110       


Q ss_pred             cccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH--HhcCC
Q 002010          921 DAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH--MLANP  972 (982)
Q Consensus       921 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~--~L~~~  972 (982)
                                    ..+...+.++.+++.+||+.||++|||++|+++  .++.+
T Consensus       222 --------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~  261 (273)
T d1xwsa_         222 --------------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV  261 (273)
T ss_dssp             --------------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred             --------------CCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence                          011223357899999999999999999999987  45544

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-42  Score=375.44  Aligned_cols=274  Identities=20%  Similarity=0.251  Sum_probs=207.0

Q ss_pred             hhcccccccccccceEEEEEEe-CC-CcEEEEEEeccCC-CCCchhhHHHHHHHHhcC---CCCcccceEeEEEc-----
Q 002010          692 ESLKDENIIGKGGAGIVYRGSM-PD-GIDVAIKRLVGRG-TGGNDHGFLAEIQTLGRI---RHRNIVRLLGYVSN-----  760 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~-~~-~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~-----  760 (982)
                      ++|++.+.||+|+||+||+|+. ++ ++.||||++.... .......+.+|+.+++.+   +||||+++++++..     
T Consensus         7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~   86 (305)
T d1blxa_           7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   86 (305)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred             CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccccc
Confidence            6799999999999999999975 34 6679999985543 233344677888887766   79999999999853     


Q ss_pred             CCccEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEecccc
Q 002010          761 RDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGL  840 (982)
Q Consensus       761 ~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~  840 (982)
                      ....+++|||++++.+..... .....+++..+..++.|++.||+|||+++   ||||||||+|||++.++.+||+|||.
T Consensus        87 ~~~~~~~~e~~~~~~~~~~~~-~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~dfg~  162 (305)
T d1blxa_          87 ETKLTLVFEHVDQDLTTYLDK-VPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGL  162 (305)
T ss_dssp             EEEEEEEEECCSCBHHHHHHH-SCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred             CceEEEEEEeccCCchhhhhh-ccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecchhh
Confidence            345789999998876654443 45678999999999999999999999998   99999999999999999999999999


Q ss_pred             chhccccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCC-
Q 002010          841 AKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQP-  919 (982)
Q Consensus       841 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-  919 (982)
                      ++....   ........||+.|+|||++.+..|+.++||||+||++|||++|++||....+.+.+.............. 
T Consensus       163 ~~~~~~---~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  239 (305)
T d1blxa_         163 ARIYSF---QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW  239 (305)
T ss_dssp             CCCCCG---GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGS
T ss_pred             hhhhcc---cccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcc
Confidence            876543   2334567899999999999999999999999999999999999999987654444444443332211110 


Q ss_pred             -Ccccccceee----cCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH--HhcCC
Q 002010          920 -SDAASVLAVV----DPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH--MLANP  972 (982)
Q Consensus       920 -~~~~~~~~~~----~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~--~L~~~  972 (982)
                       .........+    ...........+..+.+|+.+||+.||++|||++|+++  .++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i  299 (305)
T d1blxa_         240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL  299 (305)
T ss_dssp             CTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred             cccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCc
Confidence             0000000000    01111223344567889999999999999999999986  34444

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=100.00  E-value=1e-41  Score=373.14  Aligned_cols=291  Identities=30%  Similarity=0.476  Sum_probs=215.8

Q ss_pred             CchhHHHHHHHHHhcccCCCCCCCCCCCCCCCCCCCC--ccceeeeCCC---CCEEEEEeccCCccc--cCCcCcccccc
Q 002010           24 CAYSDMDVLLKLKSSMIGPKGSGLKNWEPSSSPSAHC--SFSGVTCDQD---SRVVSLNVSFMPLFG--SIPPEIGLLTK   96 (982)
Q Consensus        24 ~~~~~~~~ll~~k~~~~~~~~~~~~~w~~~~~~~~~C--~w~gv~C~~~---~~v~~l~l~~~~l~g--~~~~~i~~l~~   96 (982)
                      |.++|++||++||+++.+|.  .+++|..+   +|||  .|.||+|+..   +||++|||+++++.|  .+|++|++|++
T Consensus         3 c~~~e~~aLl~~k~~~~~~~--~l~sW~~~---~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~   77 (313)
T d1ogqa_           3 CNPQDKQALLQIKKDLGNPT--TLSSWLPT---TDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPY   77 (313)
T ss_dssp             SCHHHHHHHHHHHHHTTCCG--GGTTCCTT---SCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTT
T ss_pred             CCHHHHHHHHHHHHHCCCCC--cCCCCCCC---CCCCCCcCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCChHHhcCcc
Confidence            99999999999999998774  59999753   4688  5999999864   389999999999988  68999999999


Q ss_pred             ccEEEecc-CCCCCCCChhhhhhcccceeeccCCccccccchhhhhcCCCccEEeccCccccCCCchhccccccccEEee
Q 002010           97 LVNLTISN-VNLTGRLPSEMALLTSLKVFNISGNVFQGNFAGQIVRGMTELQVLDAYNNNFTGPLPVEIASLKSLRHLSF  175 (982)
Q Consensus        97 L~~L~l~~-n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L  175 (982)
                      |++|+|++ |+++|.+|..+++|++|++|+|++|++.+..+ ..+..+..|+++++++|++.+.+|..++++++|+++++
T Consensus        78 L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~-~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l  156 (313)
T d1ogqa_          78 LNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIP-DFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITF  156 (313)
T ss_dssp             CSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECC-GGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEEC
T ss_pred             ccccccccccccccccccccccccccchhhhcccccccccc-ccccchhhhcccccccccccccCchhhccCcccceeec
Confidence            99999996 89999999999999999999999999987655 45678999999999999999999999999999999999


Q ss_pred             cCcccccccCCCccccCcc-eEeeccCcccccchhhHHhhhhhHHHHhhcccccccccCCCCCCCCCCCCEEecccCcCc
Q 002010          176 GGNYFTGKIPQSYSEIQSL-EYIGLNGIGLNGTVPAFLSRLKNLREMYIGYFNTYTGGIPPGFGALTQLQVLDMASCNIS  254 (982)
Q Consensus       176 ~~N~l~~~~p~~~~~l~~L-~~L~L~~n~i~~~~~~~l~~l~~L~~L~l~~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~  254 (982)
                      ++|.+++.+|..+..+..+ +.++++.|++.+..|..+..+..+ .+++.. +...+.+|..++.+++|+.|++++|.++
T Consensus       157 ~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~-~~~~~~~~~~~~~~~~l~~l~~~~~~l~  234 (313)
T d1ogqa_         157 DGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSR-NMLEGDASVLFGSDKNTQKIHLAKNSLA  234 (313)
T ss_dssp             CSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCS-SEEEECCGGGCCTTSCCSEEECCSSEEC
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccc-cccccc-cccccccccccccccccccccccccccc
Confidence            9999999999999998886 889999988887776666554332 233332 3334444444455555555555555554


Q ss_pred             ccCchhhcCCCccceeecccccCCCCCCccccCCCCCCEEEeeCCcccCcCchhhhcccchhhhhhccCC
Q 002010          255 GEIPTSLSRLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQLFKNN  324 (982)
Q Consensus       255 ~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~  324 (982)
                      +.+| .++.+++|+.|+|++|+++|.+|..|+++++|++|+|++|+|+|.+|. ++++++|+.+++++|+
T Consensus       235 ~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~-~~~L~~L~~l~l~~N~  302 (313)
T d1ogqa_         235 FDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNK  302 (313)
T ss_dssp             CBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC-STTGGGSCGGGTCSSS
T ss_pred             cccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCC-cccCCCCCHHHhCCCc
Confidence            4332 344445555555555555555555555555555555555555544442 3444445555554444

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-40  Score=365.31  Aligned_cols=272  Identities=18%  Similarity=0.242  Sum_probs=201.8

Q ss_pred             HhhcccccccccccceEEEEEEe-CCCcEEEEEEeccCC-CCCchhhHHHHHHHHhcCCCCcccceEeEEEc--------
Q 002010          691 LESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRG-TGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSN--------  760 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--------  760 (982)
                      .++|++.+.||+|+||+||+|.. .+|+.||||++.... .+.....+.+|+.++++++||||+++++++..        
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            57899999999999999999975 579999999985443 33455678899999999999999999998855        


Q ss_pred             CCccEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEecccc
Q 002010          761 RDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGL  840 (982)
Q Consensus       761 ~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~  840 (982)
                      +...++||||++++.+..+..  ....+++..++.++.||+.||+|||+.+   |+||||||+||+++.++.+|++|||+
T Consensus        89 ~~~~~iv~e~~~~~~~~~~~~--~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg~  163 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLLSN--VLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGL  163 (318)
T ss_dssp             --CEEEEEECCCEEHHHHHTC--TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTT
T ss_pred             CceEEEEEeccCCCccchhhh--cccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecce
Confidence            335789999998776665543  4567899999999999999999999998   99999999999999999999999999


Q ss_pred             chhccccCC--cccccccccccccccccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCC
Q 002010          841 AKFLQDAGA--SECMSSVAGSYGYIAPEYAYTL-KVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVS  917 (982)
Q Consensus       841 a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  917 (982)
                      +..+.....  ........||+.|+|||++.+. .++.++||||+||++|||++|+.||....+................
T Consensus       164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~  243 (318)
T d3blha1         164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP  243 (318)
T ss_dssp             CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred             eeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence            987653321  2223345799999999998765 6899999999999999999999999765443333333333322221


Q ss_pred             CCCcccc---cceeec-CCCCCCCh-------HhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          918 QPSDAAS---VLAVVD-PRLSGYPL-------TGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       918 ~~~~~~~---~~~~~~-~~~~~~~~-------~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                      .......   ...... ......+.       .....+.+|+.+||+.||++|||++|+++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~  304 (318)
T d3blha1         244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  304 (318)
T ss_dssp             TTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             hhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence            1110000   000000 00001111       11235678999999999999999999987

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-40  Score=357.00  Aligned_cols=274  Identities=21%  Similarity=0.262  Sum_probs=214.8

Q ss_pred             hhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCC-CchhhHHHHHHHHhcCCCCcccceEeEEEcCCccEEEEe
Q 002010          692 ESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTG-GNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRDTNLLLYE  769 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  769 (982)
                      ++|++.+.||+|+||+||+|+. .+++.||||+++..... .....+.+|+.+++.++||||+++++++.+....++|+|
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            5799999999999999999975 57899999998654433 345678999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccccCC
Q 002010          770 YMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQDAGA  849 (982)
Q Consensus       770 ~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  849 (982)
                      ++.++++..++.  ..+.+++..+..++.|++.||+|||+++   |+||||||+||+++.++.+|++|||.|+...... 
T Consensus        82 ~~~~~~l~~~~~--~~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~-  155 (292)
T d1unla_          82 FCDQDLKKYFDS--CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV-  155 (292)
T ss_dssp             CCSEEHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCC-
T ss_pred             eccccccccccc--cccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCC-
Confidence            999999988876  4568899999999999999999999998   9999999999999999999999999998765332 


Q ss_pred             cccccccccccccccccccccCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCccccccee
Q 002010          850 SECMSSVAGSYGYIAPEYAYTLK-VDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAASVLAV  928 (982)
Q Consensus       850 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  928 (982)
                       .......+++.|+|||.+.+.. ++.++||||+||++|||++|+.||....+..+....+............. .....
T Consensus       156 -~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~  233 (292)
T d1unla_         156 -RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWP-SMTKL  233 (292)
T ss_dssp             -SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCT-TGGGS
T ss_pred             -ccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhh-hhhhc
Confidence             2233456788999999887665 68999999999999999999999866555444444443333222111110 00000


Q ss_pred             e----------cCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH--HhcCCC
Q 002010          929 V----------DPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH--MLANPP  973 (982)
Q Consensus       929 ~----------~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~--~L~~~~  973 (982)
                      .          ..............+.+|+.+||+.||.+||||+|+++  .+.++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~  290 (292)
T d1unla_         234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC  290 (292)
T ss_dssp             TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCS
T ss_pred             ccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCCC
Confidence            0          01111233344567889999999999999999999986  455544

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.2e-41  Score=364.75  Aligned_cols=254  Identities=24%  Similarity=0.267  Sum_probs=207.8

Q ss_pred             HhhcccccccccccceEEEEEEe----CCCcEEEEEEeccCC---CCCchhhHHHHHHHHhcCCC-CcccceEeEEEcCC
Q 002010          691 LESLKDENIIGKGGAGIVYRGSM----PDGIDVAIKRLVGRG---TGGNDHGFLAEIQTLGRIRH-RNIVRLLGYVSNRD  762 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~  762 (982)
                      .++|+..+.||+|+||+||+|..    .+|+.||||.+....   .....+.+.+|+.++++++| |||+++++++.+..
T Consensus        23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~  102 (322)
T d1vzoa_          23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  102 (322)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence            36799999999999999999964    247899999985432   22345678899999999976 89999999999999


Q ss_pred             ccEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccch
Q 002010          763 TNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAK  842 (982)
Q Consensus       763 ~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~  842 (982)
                      ..++||||+++|+|.+++.  ....+++..+..++.||+.|++|+|+.+   |+||||||+||+++.++.+||+|||+|+
T Consensus       103 ~~~~v~e~~~~~~L~~~i~--~~~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~  177 (322)
T d1vzoa_         103 KLHLILDYINGGELFTHLS--QRERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK  177 (322)
T ss_dssp             EEEEEECCCCSCBHHHHHH--HHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred             ceeeeeecccccHHHHHHH--hcccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchh
Confidence            9999999999999999997  3456788999999999999999999998   9999999999999999999999999998


Q ss_pred             hccccCCcccccccccccccccccccccC--CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCC
Q 002010          843 FLQDAGASECMSSVAGSYGYIAPEYAYTL--KVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPS  920 (982)
Q Consensus       843 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  920 (982)
                      .+.... ........|++.|+|||.+.+.  .++.++||||+||++|||++|+.||.....................   
T Consensus       178 ~~~~~~-~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~---  253 (322)
T d1vzoa_         178 EFVADE-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP---  253 (322)
T ss_dssp             ECCGGG-GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCC---
T ss_pred             hhcccc-cccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCC---
Confidence            765432 2334457899999999998754  4788999999999999999999999876555544444443322111   


Q ss_pred             cccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 002010          921 DAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARP-----TMREVVH  967 (982)
Q Consensus       921 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~ell~  967 (982)
                                    ..+...+.++.+++.+||+.||++||     |++|+++
T Consensus       254 --------------~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         254 --------------PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             --------------CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             --------------CCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence                          12334456899999999999999999     5889886

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.6e-41  Score=370.29  Aligned_cols=269  Identities=20%  Similarity=0.258  Sum_probs=198.9

Q ss_pred             hhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcCC----ccEE
Q 002010          692 ESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRD----TNLL  766 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~l  766 (982)
                      ++|+..+.||+|+||+||+|.. .+|+.||||++.........+.+.+|+.++++++||||+++++++..+.    ..++
T Consensus         8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~   87 (345)
T d1pmea_           8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY   87 (345)
T ss_dssp             TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred             CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEE
Confidence            4699999999999999999964 6799999999865444444567889999999999999999999987654    2355


Q ss_pred             EEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchhccc
Q 002010          767 LYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKFLQD  846 (982)
Q Consensus       767 v~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  846 (982)
                      +++++.+|+|.+++..   .++++..+..++.|++.||+|||+++   ||||||||+||+++.++.+||+|||+|.....
T Consensus        88 l~~~~~~g~L~~~l~~---~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~  161 (345)
T d1pmea_          88 LVTHLMGADLYKLLKT---QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADP  161 (345)
T ss_dssp             EEEECCCEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred             EEEeecCCchhhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeeccC
Confidence            6667779999999963   36999999999999999999999998   99999999999999999999999999987654


Q ss_pred             cCC-cccccccccccccccccccc-cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCccc-
Q 002010          847 AGA-SECMSSVAGSYGYIAPEYAY-TLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSDAA-  923 (982)
Q Consensus       847 ~~~-~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  923 (982)
                      ... ........||+.|+|||++. +..++.++||||+||++|||++|+.||.................. +....... 
T Consensus       162 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~  240 (345)
T d1pmea_         162 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGS-PSQEDLNCI  240 (345)
T ss_dssp             GGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCS-CCHHHHHTC
T ss_pred             CCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccC-CChhhhhhh
Confidence            322 22235567999999999985 456789999999999999999999999764332222222211111 00000000 


Q ss_pred             ---ccce--eecCCCCCC-----ChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          924 ---SVLA--VVDPRLSGY-----PLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       924 ---~~~~--~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                         ....  ...+.....     ......++.+++.+||+.||++|||++|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~  294 (345)
T d1pmea_         241 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  294 (345)
T ss_dssp             CCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence               0000  000011111     1122346889999999999999999999997

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-40  Score=365.72  Aligned_cols=264  Identities=26%  Similarity=0.297  Sum_probs=195.9

Q ss_pred             hcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccceEeEEEcC------CccE
Q 002010          693 SLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVRLLGYVSNR------DTNL  765 (982)
Q Consensus       693 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~~~  765 (982)
                      +|+..++||+|+||+||+|+. .+|+.||||++.....     ...+|+.++++++||||+++++++...      ...+
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~   95 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN   95 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEE
Confidence            588889999999999999976 4699999999854322     234799999999999999999998543      2368


Q ss_pred             EEEeccCCCCHHHHhh-cCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCC-CEEEeccccchh
Q 002010          766 LLYEYMPNGSLGEMLH-GAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDF-EAHVADFGLAKF  843 (982)
Q Consensus       766 lv~e~~~~~sL~~~l~-~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~-~~kl~DfG~a~~  843 (982)
                      +||||++++.+..+.. ......+++.++..++.||+.||+|||+++   |+||||||+||+++.++ .+||+|||++..
T Consensus        96 lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~  172 (350)
T d1q5ka_          96 LVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ  172 (350)
T ss_dssp             EEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred             EEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhh
Confidence            9999997654333322 124567999999999999999999999988   99999999999999775 899999999987


Q ss_pred             ccccCCccccccccccccccccccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCC----
Q 002010          844 LQDAGASECMSSVAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQ----  918 (982)
Q Consensus       844 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~----  918 (982)
                      +...   .......|++.|+|||.+.+ ..++.++||||+||++|||++|++||......+.+..++.........    
T Consensus       173 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~  249 (350)
T d1q5ka_         173 LVRG---EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE  249 (350)
T ss_dssp             CCTT---SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred             ccCC---cccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhh
Confidence            6533   22345689999999998765 568999999999999999999999997655444343333322211000    


Q ss_pred             --CCcc-cccceeec-CCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          919 --PSDA-ASVLAVVD-PRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       919 --~~~~-~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                        +... ........ +.........+..+.+|+.+||+.||++|||++|+++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  302 (350)
T d1q5ka_         250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  302 (350)
T ss_dssp             HCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence              0000 00000000 0000112234557899999999999999999999985

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-40  Score=369.45  Aligned_cols=271  Identities=22%  Similarity=0.305  Sum_probs=200.7

Q ss_pred             HhhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCC-CchhhHHHHHHHHhcCCCCcccceEeEEEcCC------
Q 002010          691 LESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTG-GNDHGFLAEIQTLGRIRHRNIVRLLGYVSNRD------  762 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------  762 (982)
                      .++|++.+.||+|+||+||+|.. .+|+.||||++...... ...+.+.+|+.++++++|||||+++++|...+      
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            36799999999999999999975 56999999998543322 23456889999999999999999999997655      


Q ss_pred             ccEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccch
Q 002010          763 TNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAK  842 (982)
Q Consensus       763 ~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~  842 (982)
                      ..++||||+ +.+|..+.+   ...+++..+..++.||+.||+|||+++   |+||||||+||+++.++.+|++|||+|+
T Consensus        97 ~~~lv~e~~-~~~l~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a~  169 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLMK---HEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR  169 (346)
T ss_dssp             CCEEEEECC-SEEHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             eEEEEEecc-cccHHHHHH---hccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhccccccccccccccee
Confidence            469999999 668888775   357999999999999999999999998   9999999999999999999999999998


Q ss_pred             hccccCCcccccccccccccccccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCC---
Q 002010          843 FLQDAGASECMSSVAGSYGYIAPEYAYTL-KVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQ---  918 (982)
Q Consensus       843 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---  918 (982)
                      ....     ......||+.|+|||++.+. .++.++||||+||++|||++|++||...................+..   
T Consensus       170 ~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  244 (346)
T d1cm8a_         170 QADS-----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ  244 (346)
T ss_dssp             ECCS-----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred             ccCC-----ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHh
Confidence            6543     23457899999999998764 56899999999999999999999997654433333333222211100   


Q ss_pred             ---CCcccc----cceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH--HhcCCC
Q 002010          919 ---PSDAAS----VLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVH--MLANPP  973 (982)
Q Consensus       919 ---~~~~~~----~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~--~L~~~~  973 (982)
                         ......    ........+..........+.+|+.+||+.||++|||++|+++  .++++.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~  308 (346)
T d1cm8a_         245 RLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH  308 (346)
T ss_dssp             TCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             hhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence               000000    0000001111222334456889999999999999999999997  355543

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.5e-40  Score=358.75  Aligned_cols=260  Identities=20%  Similarity=0.241  Sum_probs=198.5

Q ss_pred             hhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcccc-eEeEEEcCCccEEEEe
Q 002010          692 ESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNIVR-LLGYVSNRDTNLLLYE  769 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-~~~~~~~~~~~~lv~e  769 (982)
                      ++|++.+.||+|+||.||+|.. .+|+.||||++....   ...++.+|++++++++|++++. +.+++.+.+..++|||
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~---~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme   83 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT---KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   83 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT---TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc---cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence            4699999999999999999965 568999999875432   2345789999999998776555 4555677788899999


Q ss_pred             ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcC---CCCEEEeccccchhccc
Q 002010          770 YMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDS---DFEAHVADFGLAKFLQD  846 (982)
Q Consensus       770 ~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~---~~~~kl~DfG~a~~~~~  846 (982)
                      |+ ++++.+.+.. ....+++..+..++.|++.|++|||+++   |+||||||+||+++.   +..+|++|||+|+.+.+
T Consensus        84 ~~-~~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~  158 (299)
T d1ckia_          84 LL-GPSLEDLFNF-CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD  158 (299)
T ss_dssp             CC-CCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred             Ec-CCchhhhhhh-ccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence            99 5667666643 4467999999999999999999999998   999999999999864   45799999999998764


Q ss_pred             cCC-----cccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCCCc
Q 002010          847 AGA-----SECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQPSD  921 (982)
Q Consensus       847 ~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  921 (982)
                      ...     ........||+.|||||++.+..++.++|||||||++|||+||+.||......................   
T Consensus       159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~---  235 (299)
T d1ckia_         159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST---  235 (299)
T ss_dssp             TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHS---
T ss_pred             cccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCC---
Confidence            322     223345679999999999999999999999999999999999999998754433322221111110000   


Q ss_pred             ccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 002010          922 AASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANP  972 (982)
Q Consensus       922 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~  972 (982)
                                ..+......+.++.+++.+||+.||++||+++++.+.|+.+
T Consensus       236 ----------~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~  276 (299)
T d1ckia_         236 ----------PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL  276 (299)
T ss_dssp             ----------CHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred             ----------ChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence                      00011223445789999999999999999999988877643

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=1.5e-39  Score=357.65  Aligned_cols=261  Identities=21%  Similarity=0.248  Sum_probs=200.1

Q ss_pred             hhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCC-CCcccceEeEEEcC--CccEEE
Q 002010          692 ESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIR-HRNIVRLLGYVSNR--DTNLLL  767 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~--~~~~lv  767 (982)
                      ++|++.+.||+|+||+||+|+. .+|+.||||++..    ...+.+.+|+.++++++ ||||+++++++...  ...++|
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~----~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v  110 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP----VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV  110 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS----SCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECH----HHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEE
Confidence            6799999999999999999975 5789999999843    33567889999999995 99999999998754  458899


Q ss_pred             EeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCC-CEEEeccccchhccc
Q 002010          768 YEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDF-EAHVADFGLAKFLQD  846 (982)
Q Consensus       768 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~-~~kl~DfG~a~~~~~  846 (982)
                      |||+++++|..+.     +.+++..+..++.||+.||+|||+++   |+||||||+|||++.++ .+||+|||+|+....
T Consensus       111 ~e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~  182 (328)
T d3bqca1         111 FEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP  182 (328)
T ss_dssp             EECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred             EeecCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccC
Confidence            9999999998764     36899999999999999999999998   99999999999998655 699999999987654


Q ss_pred             cCCcccccccccccccccccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCC--------C
Q 002010          847 AGASECMSSVAGSYGYIAPEYAYTL-KVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEV--------S  917 (982)
Q Consensus       847 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~--------~  917 (982)
                      .   .......+|+.|+|||.+.+. .++.++||||+||++|||++|+.||....+..+....+......+        .
T Consensus       183 ~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~  259 (328)
T d3bqca1         183 G---QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY  259 (328)
T ss_dssp             T---CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHT
T ss_pred             C---CcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhc
Confidence            3   233556789999999998765 479999999999999999999999987554433222221111000        0


Q ss_pred             CCCcccccceee--------cCCCC-CCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          918 QPSDAASVLAVV--------DPRLS-GYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       918 ~~~~~~~~~~~~--------~~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                      ............        ..... ........++.+|+.+||+.||++|||++|+++
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         260 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             TCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            000000000000        00001 112334467889999999999999999999986

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=6.7e-40  Score=353.15  Aligned_cols=258  Identities=18%  Similarity=0.240  Sum_probs=205.5

Q ss_pred             hhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCC-CcccceEeEEEcCCccEEEEe
Q 002010          692 ESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRH-RNIVRLLGYVSNRDTNLLLYE  769 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e  769 (982)
                      ++|++++.||+|+||+||+|+. .+|+.||||++....   ....+.+|++.++.++| +|++.+++++..+...++|||
T Consensus         5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~---~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme   81 (293)
T d1csna_           5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS---DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   81 (293)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT---TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc---CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence            5799999999999999999975 468999999874432   23457788999999865 899999999999999999999


Q ss_pred             ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcC-----CCCEEEeccccchhc
Q 002010          770 YMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDS-----DFEAHVADFGLAKFL  844 (982)
Q Consensus       770 ~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~-----~~~~kl~DfG~a~~~  844 (982)
                      |+ +++|.+++.. ....+++.++..++.|++.|++|||+.+   |+||||||+||+++.     ++.+||+|||+|+.+
T Consensus        82 ~~-~~~l~~~~~~-~~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~  156 (293)
T d1csna_          82 LL-GPSLEDLLDL-CGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY  156 (293)
T ss_dssp             CC-CCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred             ec-CCCHHHHHHh-hccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence            99 7899998864 3457999999999999999999999988   999999999999974     578999999999876


Q ss_pred             cccCC-----cccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHH--HHhccCCC
Q 002010          845 QDAGA-----SECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWV--RKTTSEVS  917 (982)
Q Consensus       845 ~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~--~~~~~~~~  917 (982)
                      .+...     ........||+.|||||++.+..++.++||||+||++|||+||+.||.............  ....... 
T Consensus       157 ~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~-  235 (293)
T d1csna_         157 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST-  235 (293)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS-
T ss_pred             ccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCC-
Confidence            54321     122345679999999999999999999999999999999999999998654433322211  1111100 


Q ss_pred             CCCcccccceeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 002010          918 QPSDAASVLAVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMREVVHMLANP  972 (982)
Q Consensus       918 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~~L~~~  972 (982)
                                    .........+.++.+++..|++.+|++||+++.+.+.|+++
T Consensus       236 --------------~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~  276 (293)
T d1csna_         236 --------------PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV  276 (293)
T ss_dssp             --------------CHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred             --------------ChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence                          00011123345789999999999999999999888877543

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-39  Score=359.60  Aligned_cols=265  Identities=20%  Similarity=0.238  Sum_probs=191.9

Q ss_pred             hhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCC-CchhhHHHHHHHHhcCCCCcccceEeEEEcC------Cc
Q 002010          692 ESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTG-GNDHGFLAEIQTLGRIRHRNIVRLLGYVSNR------DT  763 (982)
Q Consensus       692 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~  763 (982)
                      ++|++.+.||+|+||+||+|.. .+|+.||||++...... .....+.+|+.++++++|||||++++++...      ..
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            6799999999999999999975 46999999999654332 2344688999999999999999999998643      56


Q ss_pred             cEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchh
Q 002010          764 NLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKF  843 (982)
Q Consensus       764 ~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~  843 (982)
                      .|+||||+.++.+ +.+.    ..+++..++.++.||+.|++|||+.|   |+||||||+||+++.++.+|++|||+++.
T Consensus        97 ~~iv~Ey~~~~l~-~~~~----~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~~  168 (355)
T d2b1pa1          97 VYLVMELMDANLC-QVIQ----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART  168 (355)
T ss_dssp             EEEEEECCSEEHH-HHHT----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred             eEEEEeccchHHH-Hhhh----cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhhc
Confidence            7999999966544 4443    36899999999999999999999998   99999999999999999999999999886


Q ss_pred             ccccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCC-----
Q 002010          844 LQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQ-----  918 (982)
Q Consensus       844 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-----  918 (982)
                      ....   .......+|+.|+|||++.+..++.++||||+||++|||++|++||....+...............+.     
T Consensus       169 ~~~~---~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~  245 (355)
T d2b1pa1         169 AGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL  245 (355)
T ss_dssp             ---------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTS
T ss_pred             cccc---cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHh
Confidence            5432   33455678999999999999999999999999999999999999997654333222222222111000     


Q ss_pred             ------------CCcccccceee-cCCCC---CCChHhHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002010          919 ------------PSDAASVLAVV-DPRLS---GYPLTGVIHLFKVAMMCVEDESSARPTMREVVH  967 (982)
Q Consensus       919 ------------~~~~~~~~~~~-~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~  967 (982)
                                  ..........+ +....   ..+......+.+|+.+||+.||++||||+|+++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~  310 (355)
T d2b1pa1         246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  310 (355)
T ss_dssp             CHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence                        00000000000 00011   112334567899999999999999999999985

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-39  Score=360.04  Aligned_cols=274  Identities=20%  Similarity=0.278  Sum_probs=202.9

Q ss_pred             HhhcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCC-CchhhHHHHHHHHhcCCCCcccceEeEEEcC-----Cc
Q 002010          691 LESLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTG-GNDHGFLAEIQTLGRIRHRNIVRLLGYVSNR-----DT  763 (982)
Q Consensus       691 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~  763 (982)
                      .++|++.+.||+|+||+||+|+. .+|+.||||++...... ...+.+.+|+.++++++|||||++++++...     ..
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            36799999999999999999965 57999999998544322 2345688999999999999999999998643     34


Q ss_pred             cEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEeccccchh
Q 002010          764 NLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVADFGLAKF  843 (982)
Q Consensus       764 ~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~  843 (982)
                      .+++|||+.+|+|.+++.   ..++++.++..++.||+.||+|||+++   |+||||||+||+++.++.+|++|||.|..
T Consensus        97 ~~~i~~~~~gg~L~~~~~---~~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~~  170 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARH  170 (348)
T ss_dssp             CCEEEEECCSEEHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----C
T ss_pred             eEEEEEeecCCchhhhcc---cccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhcc
Confidence            567778888999999995   347999999999999999999999998   99999999999999999999999999976


Q ss_pred             ccccCCcccccccccccccccccccccCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHhccCCCCC---
Q 002010          844 LQDAGASECMSSVAGSYGYIAPEYAYTLK-VDEKSDVYSFGVVLLELIAGKKPVGEFGDGVDIVRWVRKTTSEVSQP---  919 (982)
Q Consensus       844 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---  919 (982)
                      ...     ......|++.|+|||...+.. ++.++||||+||++|+|++|++||...........+...........   
T Consensus       171 ~~~-----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~  245 (348)
T d2gfsa1         171 TDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK  245 (348)
T ss_dssp             CTG-----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred             cCc-----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhh
Confidence            542     234567899999999877654 68999999999999999999999976543333333332222110000   


Q ss_pred             Ccccccceeec--CCCCCC-----ChHhHHHHHHHHhhccCCCCCCCCCHHHHHH--HhcCCCCC
Q 002010          920 SDAASVLAVVD--PRLSGY-----PLTGVIHLFKVAMMCVEDESSARPTMREVVH--MLANPPQS  975 (982)
Q Consensus       920 ~~~~~~~~~~~--~~~~~~-----~~~~~~~l~~li~~cl~~dP~~Rpt~~ell~--~L~~~~~~  975 (982)
                      ...........  +.....     .......+.+|+.+||+.||.+|||++|+++  .+.+..++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~~  310 (348)
T d2gfsa1         246 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP  310 (348)
T ss_dssp             CCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCT
T ss_pred             ccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCCC
Confidence            00000000000  000111     1223456889999999999999999999998  56655443

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2.5e-34  Score=320.92  Aligned_cols=265  Identities=17%  Similarity=0.182  Sum_probs=190.8

Q ss_pred             hcccccccccccceEEEEEEe-CCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCC-----------CCcccceEeEEEc
Q 002010          693 SLKDENIIGKGGAGIVYRGSM-PDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIR-----------HRNIVRLLGYVSN  760 (982)
Q Consensus       693 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~~~~~~~~  760 (982)
                      +|++.+.||+|+||+||+|+. .+|+.||||++...  ....+.+.+|+.++++++           |+||+++++++..
T Consensus        14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~--~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~   91 (362)
T d1q8ya_          14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD--KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   91 (362)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc--ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence            599999999999999999975 57999999998432  223456778988888775           5789999998754


Q ss_pred             C--CccEEEEeccCCC-CHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCcEEecCCCCCcEEEcCCCC----
Q 002010          761 R--DTNLLLYEYMPNG-SLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHH-DCSPLIIHRDVKSNNILLDSDFE----  832 (982)
Q Consensus       761 ~--~~~~lv~e~~~~~-sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivHrDlkp~Nill~~~~~----  832 (982)
                      .  ...+++|+++..+ .............+++..+..++.||+.|++|||+ .+   |+||||||+||+++.++.    
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~  168 (362)
T d1q8ya_          92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENL  168 (362)
T ss_dssp             EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTE
T ss_pred             ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCccccc
Confidence            3  4455666665443 44444444566789999999999999999999997 76   999999999999986653    


Q ss_pred             --EEEeccccchhccccCCcccccccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCC------ch
Q 002010          833 --AHVADFGLAKFLQDAGASECMSSVAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGDG------VD  904 (982)
Q Consensus       833 --~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~------~~  904 (982)
                        ++++|||.|.....     ......||+.|+|||++....++.++||||+||++++|++|+.||......      ..
T Consensus       169 ~~~kl~dfg~s~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~  243 (362)
T d1q8ya_         169 IQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH  243 (362)
T ss_dssp             EEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred             ceeeEeeccccccccc-----ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHH
Confidence              99999999976542     234567999999999999999999999999999999999999999753221      11


Q ss_pred             HHHHHHHhccCCCC-----------------CCcccccc----eeecCCCCCCChHhHHHHHHHHhhccCCCCCCCCCHH
Q 002010          905 IVRWVRKTTSEVSQ-----------------PSDAASVL----AVVDPRLSGYPLTGVIHLFKVAMMCVEDESSARPTMR  963 (982)
Q Consensus       905 ~~~~~~~~~~~~~~-----------------~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~  963 (982)
                      ....+......+..                 ........    ....+.....+......+.+|+.+|++.||.+|||++
T Consensus       244 ~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~  323 (362)
T d1q8ya_         244 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG  323 (362)
T ss_dssp             HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred             HHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHH
Confidence            11111111110000                 00000000    0000001123456677899999999999999999999


Q ss_pred             HHHH
Q 002010          964 EVVH  967 (982)
Q Consensus       964 ell~  967 (982)
                      |+++
T Consensus       324 e~L~  327 (362)
T d1q8ya_         324 GLVN  327 (362)
T ss_dssp             HHHT
T ss_pred             HHhc
Confidence            9987

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=99.98  E-value=1.2e-32  Score=300.52  Aligned_cols=259  Identities=30%  Similarity=0.502  Sum_probs=194.4

Q ss_pred             CccEEEccCCCccc--ccCccccCCCcccEEEecc-ccccccCCccccCccccceeecccccccccCCccccCCCCCCEE
Q 002010          338 NLEVLQVWGNNFTF--ELPENLGRNGKLLILDVTS-NHLTGTIPRDLCKGGKLKSLILMQNFFIGPIPEELGQCKSLTKI  414 (982)
Q Consensus       338 ~L~~L~L~~N~l~~--~~~~~l~~l~~L~~L~L~~-N~l~~~~p~~~~~~~~L~~L~l~~N~~~~~~~~~l~~l~~L~~L  414 (982)
                      .++.|+|++|.+++  .+|..++++++|++|+|++ |+++|.+|..+.++++|++|+|++|++.+..+..+..+..|+++
T Consensus        51 ~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l  130 (313)
T d1ogqa_          51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL  130 (313)
T ss_dssp             CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEE
T ss_pred             EEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhccc
Confidence            45666666666655  3556666666666666654 56666666666666666666666666666666656666666666


Q ss_pred             EccCCccCCCCCccccCCCccccccCCCccccccCCcccccCCccEEEeeccccCCCCchhccCCCCc-ceeeecccccc
Q 002010          415 RFSKNYLNGTIPAGLFNLPLLNMMELDDNLLSGELPEKMSGASLNQLKVANNNITGKIPAAIGNLPSL-NILSLQNNRLE  493 (982)
Q Consensus       415 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~L~~N~i~~~~p~~~~~l~~L-~~L~L~~N~l~  493 (982)
                      ++++|.+.+.+|..+.+++                       .++.+++++|.+++.+|..+..+..+ +.+++++|+++
T Consensus       131 ~l~~N~~~~~~p~~l~~l~-----------------------~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~  187 (313)
T d1ogqa_         131 DFSYNALSGTLPPSISSLP-----------------------NLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLT  187 (313)
T ss_dssp             ECCSSEEESCCCGGGGGCT-----------------------TCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEE
T ss_pred             ccccccccccCchhhccCc-----------------------ccceeecccccccccccccccccccccccccccccccc
Confidence            6666666555555555554                       45556666666666677777777665 77888888888


Q ss_pred             CCCccccccccccceeeeeccccCCCCCcccccccCCCeeeCCCCcccCCCCcccccccccceEEcccccccccCccccc
Q 002010          494 GEIPVESFNLKMITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYGKIPPGISKLIDLSILNLSRNGITGSIPNEMR  573 (982)
Q Consensus       494 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~  573 (982)
                      +..|..+..+..+ .+++++|.+.+.+|..+..+++|+.|++++|.+++.+| .++.+++|+.|+|++|+|+|.+|.++.
T Consensus       188 ~~~~~~~~~l~~~-~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~  265 (313)
T d1ogqa_         188 GKIPPTFANLNLA-FVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLT  265 (313)
T ss_dssp             EECCGGGGGCCCS-EEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGG
T ss_pred             ccccccccccccc-cccccccccccccccccccccccccccccccccccccc-ccccccccccccCccCeecccCChHHh
Confidence            8777777666544 68888888888888888889999999999999987655 588889999999999999999999999


Q ss_pred             cccccceecccCCccccCCCCCccccccccccccCCcCcccCCCCCCc
Q 002010          574 NMMSLTTLDLSYNNLIGNIPSGGQFLAFNETSFIGNPNLCLLRNGTCQ  621 (982)
Q Consensus       574 ~l~~L~~L~Ls~N~l~~~ip~~~~~~~~~~~~~~~n~~~c~~~~~~c~  621 (982)
                      ++++|++|||++|+|+|.||....+.++...++.||+.+||.|.+.|.
T Consensus       266 ~L~~L~~L~Ls~N~l~g~iP~~~~L~~L~~l~l~~N~~l~g~plp~c~  313 (313)
T d1ogqa_         266 QLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPLPACT  313 (313)
T ss_dssp             GCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTTSSCCC
T ss_pred             CCCCCCEEECcCCcccccCCCcccCCCCCHHHhCCCccccCCCCCCCC
Confidence            999999999999999999998888889999999999999999998884

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.96  E-value=3.1e-28  Score=273.66  Aligned_cols=358  Identities=24%  Similarity=0.255  Sum_probs=210.3

Q ss_pred             EeccCccccCCCchhccccccccEEeecCcccccccCCCccccCcceEeeccCcccccchhhHHhhhhhHHHHhhccccc
Q 002010          149 LDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLNGIGLNGTVPAFLSRLKNLREMYIGYFNT  228 (982)
Q Consensus       149 L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~l~~~n~  228 (982)
                      ..++.+.+++.+.  ...+.+|++|++++|.|+..  +.+..+++|++|++++|.+++.                     
T Consensus        27 ~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~I~~l--~gl~~L~nL~~L~Ls~N~l~~l---------------------   81 (384)
T d2omza2          27 TVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDI---------------------   81 (384)
T ss_dssp             HHTTCSSTTSEEC--HHHHTTCCEEECCSSCCCCC--TTGGGCTTCCEEECCSSCCCCC---------------------
T ss_pred             HHhCCCCCCCccC--HHHhCCCCEEECCCCCCCCc--cccccCCCCCEEeCcCCcCCCC---------------------
Confidence            3566666665443  35677788888888877632  3455666666666666655421                     


Q ss_pred             ccccCCCCCCCCCCCCEEecccCcCcccCchhhcCCCccceeecccccCCCCCCccccCCCCCCEEEeeCCcccCcCchh
Q 002010          229 YTGGIPPGFGALTQLQVLDMASCNISGEIPTSLSRLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPES  308 (982)
Q Consensus       229 ~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~  308 (982)
                           | .++++++|++|++++|++++..  .++.+++|+.|++++|.+++..+  ......+..+....|.+....+..
T Consensus        82 -----~-~l~~L~~L~~L~L~~n~i~~i~--~l~~l~~L~~L~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~~~~~~  151 (384)
T d2omza2          82 -----T-PLKNLTKLVDILMNNNQIADIT--PLANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISALS  151 (384)
T ss_dssp             -----G-GGTTCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCCGGGT
T ss_pred             -----c-cccCCccccccccccccccccc--ccccccccccccccccccccccc--cccccccccccccccccccccccc
Confidence                 1 1455566666666666666432  25666666666666666664322  233445566666666555332222


Q ss_pred             hhcccchhhhhhccCCCCCCCCCcCCCCCCccEEEccCCCcccccCccccCCCcccEEEeccccccccCCccccCccccc
Q 002010          309 FAALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDLCKGGKLK  388 (982)
Q Consensus       309 l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~  388 (982)
                      .............     ......+.............|...  ....+..++++..+++++|.+++.            
T Consensus       152 ~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~~~~l~l~~n~i~~~------------  212 (384)
T d2omza2         152 GLTSLQQLSFGNQ-----VTDLKPLANLTTLERLDISSNKVS--DISVLAKLTNLESLIATNNQISDI------------  212 (384)
T ss_dssp             TCTTCSEEEEEES-----CCCCGGGTTCTTCCEEECCSSCCC--CCGGGGGCTTCSEEECCSSCCCCC------------
T ss_pred             ccccccccccccc-----cchhhhhccccccccccccccccc--cccccccccccceeeccCCccCCC------------
Confidence            1111111111100     011122333333444444444333  233344445555555555555433            


Q ss_pred             eeecccccccccCCccccCCCCCCEEEccCCccCCCCCccccCCCccccccCCCccccccCCcccccCCccEEEeecccc
Q 002010          389 SLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLSGELPEKMSGASLNQLKVANNNI  468 (982)
Q Consensus       389 ~L~l~~N~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~L~~N~i  468 (982)
                                  .|  +..+++|++|++++|+++. + ..+..+++|+.+++++|.+++..+ ....++|+.|++++|++
T Consensus       213 ------------~~--~~~~~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~l~~n~l~~~~~-~~~~~~L~~L~l~~~~l  275 (384)
T d2omza2         213 ------------TP--LGILTNLDELSLNGNQLKD-I-GTLASLTNLTDLDLANNQISNLAP-LSGLTKLTELKLGANQI  275 (384)
T ss_dssp             ------------GG--GGGCTTCCEEECCSSCCCC-C-GGGGGCTTCSEEECCSSCCCCCGG-GTTCTTCSEEECCSSCC
T ss_pred             ------------Cc--ccccCCCCEEECCCCCCCC-c-chhhcccccchhccccCccCCCCc-ccccccCCEeeccCccc
Confidence                        22  2334455555555555542 1 234445555555555555554322 22235677777777777


Q ss_pred             CCCCchhccCCCCcceeeeccccccCCCccccccccccceeeeeccccCCCCCcccccccCCCeeeCCCCcccCCCCccc
Q 002010          469 TGKIPAAIGNLPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYGKIPPGI  548 (982)
Q Consensus       469 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~  548 (982)
                      ++..  .+..++.++.+++++|++++  ...+..+++++.|++++|++++..+  +..+++|+.|+|++|+|++ ++ .+
T Consensus       276 ~~~~--~~~~~~~l~~l~~~~n~l~~--~~~~~~~~~l~~L~ls~n~l~~l~~--l~~l~~L~~L~L~~n~l~~-l~-~l  347 (384)
T d2omza2         276 SNIS--PLAGLTALTNLELNENQLED--ISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD-VS-SL  347 (384)
T ss_dssp             CCCG--GGTTCTTCSEEECCSSCCSC--CGGGGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCC-CG-GG
T ss_pred             CCCC--cccccccccccccccccccc--ccccchhcccCeEECCCCCCCCCcc--cccCCCCCEEECCCCCCCC-Ch-hH
Confidence            7543  36678888888888888874  3357778888888999888886543  7888899999999998874 44 58


Q ss_pred             ccccccceEEcccccccccCccccccccccceecccCCc
Q 002010          549 SKLIDLSILNLSRNGITGSIPNEMRNMMSLTTLDLSYNN  587 (982)
Q Consensus       549 ~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~  587 (982)
                      .++++|++|+|++|+|++.+|  +.++++|+.|+|++|.
T Consensus       348 ~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~Na  384 (384)
T d2omza2         348 ANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQA  384 (384)
T ss_dssp             GGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCEE
T ss_pred             cCCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCCc
Confidence            889999999999999987654  8888999999998873

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.96  E-value=5.6e-28  Score=271.58  Aligned_cols=357  Identities=22%  Similarity=0.278  Sum_probs=237.6

Q ss_pred             eccCCccccccchhhhhcCCCccEEeccCccccCCCchhccccccccEEeecCcccccccCCCccccCcceEeeccCccc
Q 002010          125 NISGNVFQGNFAGQIVRGMTELQVLDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLNGIGL  204 (982)
Q Consensus       125 ~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~i  204 (982)
                      +++.+.+.+.+..   +.+.+|++|++++|+++. + +.+..+++|++|+|++|+|++..|  ++++++|++|++++|.+
T Consensus        28 ~l~~~~~~~~~~~---~~l~~l~~L~l~~~~I~~-l-~gl~~L~nL~~L~Ls~N~l~~l~~--l~~L~~L~~L~L~~n~i  100 (384)
T d2omza2          28 VLGKTNVTDTVSQ---TDLDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQI  100 (384)
T ss_dssp             HTTCSSTTSEECH---HHHTTCCEEECCSSCCCC-C-TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCC
T ss_pred             HhCCCCCCCccCH---HHhCCCCEEECCCCCCCC-c-cccccCCCCCEEeCcCCcCCCCcc--ccCCccccccccccccc
Confidence            4444444443332   245566777777776663 3 356677777777777777775432  77777777777777766


Q ss_pred             ccchhhHHhhhhhHHHHhhcccccccccCCCCCCCCCCCCEEecccCcCcccCchhhcCCCccceeecccccCCCCCCcc
Q 002010          205 NGTVPAFLSRLKNLREMYIGYFNTYTGGIPPGFGALTQLQVLDMASCNISGEIPTSLSRLKLLHSLFLQMNKLTGHIPPQ  284 (982)
Q Consensus       205 ~~~~~~~l~~l~~L~~L~l~~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~  284 (982)
                      .+.                           ..++.+++|+.|++++|.+++..+  ......+..+....|.+....+..
T Consensus       101 ~~i---------------------------~~l~~l~~L~~L~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~~~~~~  151 (384)
T d2omza2         101 ADI---------------------------TPLANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISALS  151 (384)
T ss_dssp             CCC---------------------------GGGTTCTTCCEEECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCCGGGT
T ss_pred             ccc---------------------------cccccccccccccccccccccccc--cccccccccccccccccccccccc
Confidence            421                           125677899999999999986543  455677888888888887554433


Q ss_pred             ccCCCCCCEEEeeCCcccCcCchhhhcccchhhhhhccCCCCCCCCCcCCCCCCccEEEccCCCcccccCccccCCCccc
Q 002010          285 LSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLL  364 (982)
Q Consensus       285 l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~  364 (982)
                      ................+     ..+.............|...  ....+..+++++.+++++|.+++..|  +....+|+
T Consensus       152 ~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~  222 (384)
T d2omza2         152 GLTSLQQLSFGNQVTDL-----KPLANLTTLERLDISSNKVS--DISVLAKLTNLESLIATNNQISDITP--LGILTNLD  222 (384)
T ss_dssp             TCTTCSEEEEEESCCCC-----GGGTTCTTCCEEECCSSCCC--CCGGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCC
T ss_pred             ccccccccccccccchh-----hhhccccccccccccccccc--cccccccccccceeeccCCccCCCCc--ccccCCCC
Confidence            33333333332222222     23444444444455555543  34567788999999999999996544  46678899


Q ss_pred             EEEeccccccccCCccccCccccceeecccccccccCCccccCCCCCCEEEccCCccCCCCCccccCCCccccccCCCcc
Q 002010          365 ILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNL  444 (982)
Q Consensus       365 ~L~L~~N~l~~~~p~~~~~~~~L~~L~l~~N~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~  444 (982)
                      .|++++|+++. + ..+..+++|+.|++++|.+++..+  ++.+++|++|++++|++++..+  +..+            
T Consensus       223 ~L~l~~n~l~~-~-~~l~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~~~l~~~~~--~~~~------------  284 (384)
T d2omza2         223 ELSLNGNQLKD-I-GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGL------------  284 (384)
T ss_dssp             EEECCSSCCCC-C-GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTC------------
T ss_pred             EEECCCCCCCC-c-chhhcccccchhccccCccCCCCc--ccccccCCEeeccCcccCCCCc--cccc------------
Confidence            99999999874 2 345666677777777776665432  5566666666666666653221  2233            


Q ss_pred             ccccCCcccccCCccEEEeeccccCCCCchhccCCCCcceeeeccccccCCCccccccccccceeeeeccccCCCCCccc
Q 002010          445 LSGELPEKMSGASLNQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIPYSI  524 (982)
Q Consensus       445 l~~~~~~~~~~~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~  524 (982)
                                 ..++.+.+..|++++.  ..+..+++++.|++++|++++..  .+..+++|++|++++|+|++ ++ .+
T Consensus       285 -----------~~l~~l~~~~n~l~~~--~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~~-l~-~l  347 (384)
T d2omza2         285 -----------TALTNLELNENQLEDI--SPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKVSD-VS-SL  347 (384)
T ss_dssp             -----------TTCSEEECCSSCCSCC--GGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSSCCCC-CG-GG
T ss_pred             -----------cccccccccccccccc--cccchhcccCeEECCCCCCCCCc--ccccCCCCCEEECCCCCCCC-Ch-hH
Confidence                       4556666666666642  34677788888888888887543  36778888888888888874 34 58


Q ss_pred             ccccCCCeeeCCCCcccCCCCcccccccccceEEccccc
Q 002010          525 SQCHSLTSVDLSRNSLYGKIPPGISKLIDLSILNLSRNG  563 (982)
Q Consensus       525 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~  563 (982)
                      +++++|++|+|++|+|++..|  +.++++|+.|+|++|.
T Consensus       348 ~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~Na  384 (384)
T d2omza2         348 ANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQA  384 (384)
T ss_dssp             GGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCEE
T ss_pred             cCCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCCc
Confidence            888899999999999886554  8888999999998883

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.93  E-value=9.6e-26  Score=244.43  Aligned_cols=274  Identities=22%  Similarity=0.287  Sum_probs=178.6

Q ss_pred             CCCCCCccceeeeCCCCCEEEEEeccCCccccCCcCccccccccEEEeccCCCCCCCChhhhhhcccceeeccCCccccc
Q 002010           55 SPSAHCSFSGVTCDQDSRVVSLNVSFMPLFGSIPPEIGLLTKLVNLTISNVNLTGRLPSEMALLTSLKVFNISGNVFQGN  134 (982)
Q Consensus        55 ~~~~~C~w~gv~C~~~~~v~~l~l~~~~l~g~~~~~i~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~  134 (982)
                      |..|.|.|.+|.|+..+            ..++|+.+.  +++++|+|++|+++...+..|.++++|++|++++|.+.. 
T Consensus         5 p~~c~c~~~~~~C~~~~------------L~~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~-   69 (305)
T d1xkua_           5 PFRCQCHLRVVQCSDLG------------LEKVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISK-   69 (305)
T ss_dssp             CTTCEEETTEEECTTSC------------CCSCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCC-
T ss_pred             CCCCEecCCEEEecCCC------------CCccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccc-
Confidence            44566999999998643            235676653  678899999998885555578888888888888887764 


Q ss_pred             cchhhhhcCCCccEEeccCccccCCCchhccccccccEEeecCcccccccCCCccccCcceEeeccCcccccchhhHHhh
Q 002010          135 FAGQIVRGMTELQVLDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLNGIGLNGTVPAFLSR  214 (982)
Q Consensus       135 ~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~i~~~~~~~l~~  214 (982)
                      +++..|.++++|++|++++|+++ .+|..+  ...|+.|++++|.+.+..+..+.....++.++...|...         
T Consensus        70 i~~~~f~~l~~L~~L~l~~n~l~-~l~~~~--~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~---------  137 (305)
T d1xkua_          70 ISPGAFAPLVKLERLYLSKNQLK-ELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLK---------  137 (305)
T ss_dssp             BCTTTTTTCTTCCEEECCSSCCS-BCCSSC--CTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCC---------
T ss_pred             cchhhhhCCCccCEecccCCccC-cCccch--hhhhhhhhccccchhhhhhhhhhcccccccccccccccc---------
Confidence            34455667777777777777776 345433  246677777777776555555555555555555544322         


Q ss_pred             hhhHHHHhhcccccccccCCCCCCCCCCCCEEecccCcCcccCchhhcCCCccceeecccccCCCCCCccccCCCCCCEE
Q 002010          215 LKNLREMYIGYFNTYTGGIPPGFGALTQLQVLDMASCNISGEIPTSLSRLKLLHSLFLQMNKLTGHIPPQLSGLISLKSL  294 (982)
Q Consensus       215 l~~L~~L~l~~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L  294 (982)
                                    .....+..+..+++|+++++++|+++ .+|..+  .++|++|++++|..++..+..+..++.++.|
T Consensus       138 --------------~~~~~~~~~~~l~~L~~l~l~~n~l~-~l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L  200 (305)
T d1xkua_         138 --------------SSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKL  200 (305)
T ss_dssp             --------------GGGBCTTGGGGCTTCCEEECCSSCCC-SCCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEE
T ss_pred             --------------ccCCCccccccccccCccccccCCcc-ccCccc--CCccCEEECCCCcCCCCChhHhhcccccccc
Confidence                          12223345666677777777777776 334332  4667777777777777777777777777777


Q ss_pred             EeeCCcccCcCchhhhcccchhhhhhccCCCCCCCCCcCCCCCCccEEEccCCCcccccCccc------cCCCcccEEEe
Q 002010          295 DLSLNYLTGEIPESFAALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENL------GRNGKLLILDV  368 (982)
Q Consensus       295 ~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l------~~l~~L~~L~L  368 (982)
                      ++++|.+++..+..+..+++|++|+|++|+|+ .+|..|..+++|++|+|++|+|+......|      ..+.+|+.|++
T Consensus       201 ~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L  279 (305)
T d1xkua_         201 GLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSL  279 (305)
T ss_dssp             ECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEEC
T ss_pred             ccccccccccccccccccccceeeeccccccc-ccccccccccCCCEEECCCCccCccChhhccCcchhcccCCCCEEEC
Confidence            77777777666677777777777777777776 456667777777777777777764322222      23344555555


Q ss_pred             ccccc
Q 002010          369 TSNHL  373 (982)
Q Consensus       369 ~~N~l  373 (982)
                      ++|.+
T Consensus       280 ~~N~~  284 (305)
T d1xkua_         280 FSNPV  284 (305)
T ss_dssp             CSSSS
T ss_pred             CCCcC
Confidence            55544

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.93  E-value=2.4e-25  Score=241.21  Aligned_cols=222  Identities=25%  Similarity=0.278  Sum_probs=97.3

Q ss_pred             CCCEEEeeCCcccCcCchhhhcccchhhhhhccCCCCCCCCCcCCCCCCccEEEccCCCcccccCccccCCCcccEEEec
Q 002010          290 SLKSLDLSLNYLTGEIPESFAALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVT  369 (982)
Q Consensus       290 ~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~  369 (982)
                      ++++|+|++|+|+...+.+|.++++|++|++++|.+....|..|.++++|++|++++|+++. +|..+  ...+..|+++
T Consensus        32 ~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~n~l~~-l~~~~--~~~l~~L~~~  108 (305)
T d1xkua_          32 DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKE-LPEKM--PKTLQELRVH  108 (305)
T ss_dssp             TCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCSB-CCSSC--CTTCCEEECC
T ss_pred             CCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEecccCCccCc-Cccch--hhhhhhhhcc
Confidence            44445555554443333344444444444444444444444444445555555555554442 22211  1233444444


Q ss_pred             cccccccCCccccCccccceeeccccc--ccccCCccccCCCCCCEEEccCCccCCCCCccccCCCccccccCCCccccc
Q 002010          370 SNHLTGTIPRDLCKGGKLKSLILMQNF--FIGPIPEELGQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLSG  447 (982)
Q Consensus       370 ~N~l~~~~p~~~~~~~~L~~L~l~~N~--~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~  447 (982)
                      +|.+.+..+..+.....+..++...|.  .....+..+..+++|+.+++++|.++ .+|..+                  
T Consensus       109 ~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~-~l~~~~------------------  169 (305)
T d1xkua_         109 ENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL------------------  169 (305)
T ss_dssp             SSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-SCCSSC------------------
T ss_pred             ccchhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccCCcc-ccCccc------------------
Confidence            444443322223233333333333332  12223334455555555555555544 122111                  


Q ss_pred             cCCcccccCCccEEEeeccccCCCCchhccCCCCcceeeeccccccCCCccccccccccceeeeeccccCCCCCcccccc
Q 002010          448 ELPEKMSGASLNQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIPYSISQC  527 (982)
Q Consensus       448 ~~~~~~~~~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l  527 (982)
                             .++|+.|++++|.+++..+..|.+++.++.|++++|++++..+..+..+++|++|+|++|+|+ .+|..|..+
T Consensus       170 -------~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l  241 (305)
T d1xkua_         170 -------PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADH  241 (305)
T ss_dssp             -------CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTC
T ss_pred             -------CCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeeccccccc-ccccccccc
Confidence                   124455555555555555555555555555555555555443444444444444444444444 233344444


Q ss_pred             cCCCeeeCCCCccc
Q 002010          528 HSLTSVDLSRNSLY  541 (982)
Q Consensus       528 ~~L~~L~Ls~N~l~  541 (982)
                      ++|+.|+|++|+|+
T Consensus       242 ~~L~~L~Ls~N~i~  255 (305)
T d1xkua_         242 KYIQVVYLHNNNIS  255 (305)
T ss_dssp             SSCCEEECCSSCCC
T ss_pred             cCCCEEECCCCccC
Confidence            44444444444444

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.91  E-value=2.2e-25  Score=238.77  Aligned_cols=224  Identities=21%  Similarity=0.243  Sum_probs=153.3

Q ss_pred             eccCccccCCCchhccccccccEEeecCcccccccCCCccccCcceEeeccCcccccchhhHHhhhhhHHHHhhcccccc
Q 002010          150 DAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQSYSEIQSLEYIGLNGIGLNGTVPAFLSRLKNLREMYIGYFNTY  229 (982)
Q Consensus       150 ~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~l~~~n~~  229 (982)
                      +.++++++ .+|..+.  +++++|+|++|+|+...+.+|.++++|++|++++|.+....+..+..+..++++.....+.+
T Consensus        17 ~c~~~~L~-~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~   93 (284)
T d1ozna_          17 SCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQL   93 (284)
T ss_dssp             ECCSSCCS-SCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTC
T ss_pred             EcCCCCCC-ccCCCCC--CCCCEEECcCCcCCCCCHHHhhcccccccccccccccccccccccccccccccccccccccc
Confidence            34444444 3444333  34455555555555444445555555555555555555444444444444444444444445


Q ss_pred             cccCCCCCCCCCCCCEEecccCcCcccCchhhcCCCccceeecccccCCCCCCccccCCCCCCEEEeeCCcccCcCchhh
Q 002010          230 TGGIPPGFGALTQLQVLDMASCNISGEIPTSLSRLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESF  309 (982)
Q Consensus       230 ~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l  309 (982)
                      ....|..|.++++|++|++++|.+....+..+...++|+.+++++|++++..+..|..+++|+.|++++|++++..+.+|
T Consensus        94 ~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f  173 (284)
T d1ozna_          94 RSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAF  173 (284)
T ss_dssp             CCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTT
T ss_pred             ccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhh
Confidence            55556677888888888888888876666777778888888888888887666777778888888888888887777778


Q ss_pred             hcccchhhhhhccCCCCCCCCCcCCCCCCccEEEccCCCcccccCccccCCCcccEEEecccccccc
Q 002010          310 AALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGT  376 (982)
Q Consensus       310 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~  376 (982)
                      .++++|+++++++|++++..|..|..+++|++|++++|++.+..+..++.+.+|++|++++|.+...
T Consensus       174 ~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~  240 (284)
T d1ozna_         174 RGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCD  240 (284)
T ss_dssp             TTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECS
T ss_pred             ccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCC
Confidence            8888888888888888877788888888888888888888877777777788888888888877643

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.91  E-value=2e-24  Score=231.21  Aligned_cols=243  Identities=22%  Similarity=0.240  Sum_probs=180.5

Q ss_pred             cCCCCCCCCCCCCEEecccCcCcccCchhhcCCCccceeecccccCCCCCCccccCCCCCCEEEee-CCcccCcCchhhh
Q 002010          232 GIPPGFGALTQLQVLDMASCNISGEIPTSLSRLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLS-LNYLTGEIPESFA  310 (982)
Q Consensus       232 ~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls-~N~l~~~~~~~l~  310 (982)
                      .+|..+.  +++++|+|++|+|+...+..|.++++|++|++++|++....+..+..+..++.++.. .|.++...+..|.
T Consensus        25 ~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~  102 (284)
T d1ozna_          25 AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFH  102 (284)
T ss_dssp             SCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTT
T ss_pred             ccCCCCC--CCCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccccccccccchhhc
Confidence            3444433  467888888888886666778888888888888888887777777777888887664 5667766677788


Q ss_pred             cccchhhhhhccCCCCCCCCCcCCCCCCccEEEccCCCcccccCccccCCCcccEEEeccccccccCCccccCcccccee
Q 002010          311 ALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDLCKGGKLKSL  390 (982)
Q Consensus       311 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L  390 (982)
                      ++++|++|++++|.+....+..+....+|+.+++++|.++...+..|..+++|+.|++++|++++..+..|.++++|+++
T Consensus       103 ~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l  182 (284)
T d1ozna_         103 GLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRL  182 (284)
T ss_dssp             TCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEE
T ss_pred             ccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchh
Confidence            88888888888888877777777778888888888888887667777778888888888888887777778888888888


Q ss_pred             ecccccccccCCccccCCCCCCEEEccCCccCCCCCccccCCCccccccCCCccccccCCcccccCCccEEEeeccccCC
Q 002010          391 ILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLSGELPEKMSGASLNQLKVANNNITG  470 (982)
Q Consensus       391 ~l~~N~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~L~~N~i~~  470 (982)
                      ++++|++++..|..|..+++|++|++++|++.+..+..|..+++|++|++++|.+.+.-+..+....++.+....+++..
T Consensus       183 ~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~~~~l~~~l~~~~~~~~~~~C  262 (284)
T d1ozna_         183 LLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPC  262 (284)
T ss_dssp             ECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGHHHHHHHHHCCSEECCCBE
T ss_pred             hhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCccchHHHHHHHhCcCCCCceEe
Confidence            88888888888888888888888888888888777777778888888888888777543322222334444445555554


Q ss_pred             CCchhc
Q 002010          471 KIPAAI  476 (982)
Q Consensus       471 ~~p~~~  476 (982)
                      ..|..+
T Consensus       263 ~~p~~l  268 (284)
T d1ozna_         263 SLPQRL  268 (284)
T ss_dssp             EESGGG
T ss_pred             CCchHH
Confidence            444433

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.88  E-value=1.5e-22  Score=214.02  Aligned_cols=200  Identities=21%  Similarity=0.197  Sum_probs=130.3

Q ss_pred             ccccceeecccccccccCCccccCCCCCCEEEccCCccCCCCCccccCCCccccccCCCccccccCCcccccCCccEEEe
Q 002010          384 GGKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLSGELPEKMSGASLNQLKV  463 (982)
Q Consensus       384 ~~~L~~L~l~~N~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~L  463 (982)
                      ...+.+++.+++.++. +|..+.  +++++|+|++|+|++..+..|.++++|++|+|++|+|+.. +.....++|++|+|
T Consensus         9 ~~~~~~v~C~~~~L~~-iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l-~~~~~l~~L~~L~L   84 (266)
T d1p9ag_           9 VASHLEVNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKL-QVDGTLPVLGTLDL   84 (266)
T ss_dssp             STTCCEEECTTSCCSS-CCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEE-ECCSCCTTCCEEEC
T ss_pred             cCCCeEEEccCCCCCe-eCcCcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccccc-cccccccccccccc
Confidence            4456667777777774 565553  4678888888888765556777777777777777777643 32223356666777


Q ss_pred             eccccCCCCchhccCCCCcceeeeccccccCCCccccccccccceeeeeccccCCCCCcccccccCCCeeeCCCCcccCC
Q 002010          464 ANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYGK  543 (982)
Q Consensus       464 ~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~  543 (982)
                      ++|+++ ..+..+..+++|++|++++|++.+..+..+..+.++++|++++|.+++..+..+..++.|+.|++++|+|++.
T Consensus        85 s~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~  163 (266)
T d1p9ag_          85 SHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTEL  163 (266)
T ss_dssp             CSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCC
T ss_pred             cccccc-ccccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhccccccccccc
Confidence            766666 3455566666666666666666655555556666666666666666655555566666666666666666665


Q ss_pred             CCcccccccccceEEcccccccccCccccccccccceecccCCccc
Q 002010          544 IPPGISKLIDLSILNLSRNGITGSIPNEMRNMMSLTTLDLSYNNLI  589 (982)
Q Consensus       544 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~  589 (982)
                      .+..|..+++|++|+|++|+|+ .+|..+..+++|+.|+|++|++.
T Consensus       164 ~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~  208 (266)
T d1p9ag_         164 PAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL  208 (266)
T ss_dssp             CTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBC
T ss_pred             CccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCC
Confidence            5666666666666666666666 56666666666666666665544

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.88  E-value=1.6e-22  Score=213.65  Aligned_cols=199  Identities=23%  Similarity=0.224  Sum_probs=154.6

Q ss_pred             CcccEEEeccccccccCCccccCccccceeecccccccccCCccccCCCCCCEEEccCCccCCCCCccccCCCccccccC
Q 002010          361 GKLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMEL  440 (982)
Q Consensus       361 ~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~l~~N~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  440 (982)
                      ..+.++|.+++.++ .+|..+.  +++++|+|++|.|++..+..|.++++|++|+|++|+|+ .+| .+..+++|++|++
T Consensus        10 ~~~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~-~~~~l~~L~~L~L   84 (266)
T d1p9ag_          10 ASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQ-VDGTLPVLGTLDL   84 (266)
T ss_dssp             TTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEE-CCSCCTTCCEEEC
T ss_pred             CCCeEEEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccc-ccc-ccccccccccccc
Confidence            33444555555555 3444432  34566666666666555566666677777777777666 333 2456667777777


Q ss_pred             CCccccccCCcccccCCccEEEeeccccCCCCchhccCCCCcceeeeccccccCCCccccccccccceeeeeccccCCCC
Q 002010          441 DDNLLSGELPEKMSGASLNQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNISGEI  520 (982)
Q Consensus       441 ~~N~l~~~~~~~~~~~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~  520 (982)
                      ++|+++...+......+|+.|++++|.+.+..+..+..+.++++|++++|.+++..+..+..++.|+.|++++|+|++..
T Consensus        85 s~N~l~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~  164 (266)
T d1p9ag_          85 SHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELP  164 (266)
T ss_dssp             CSSCCSSCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCC
T ss_pred             ccccccccccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhcccccccccccC
Confidence            77777655444444478999999999999988999999999999999999999777777788999999999999999888


Q ss_pred             CcccccccCCCeeeCCCCcccCCCCcccccccccceEEccccccc
Q 002010          521 PYSISQCHSLTSVDLSRNSLYGKIPPGISKLIDLSILNLSRNGIT  565 (982)
Q Consensus       521 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  565 (982)
                      +..|..+++|++|+|++|+|+ .+|+.+..+++|+.|+|++|.+.
T Consensus       165 ~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~  208 (266)
T d1p9ag_         165 AGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL  208 (266)
T ss_dssp             TTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBC
T ss_pred             ccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCC
Confidence            889999999999999999999 89999999999999999999886

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.84  E-value=7.8e-22  Score=196.93  Aligned_cols=165  Identities=14%  Similarity=0.161  Sum_probs=119.7

Q ss_pred             ccccccccccceEEEEEEeCCCcEEEEEEeccCCCC----C-------------chhhHHHHHHHHhcCCCCcccceEeE
Q 002010          695 KDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTG----G-------------NDHGFLAEIQTLGRIRHRNIVRLLGY  757 (982)
Q Consensus       695 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----~-------------~~~~~~~E~~~l~~l~h~niv~~~~~  757 (982)
                      .+++.||+|+||+||+|...+|+.||||+++.....    .             ......+|...+.++.|+++++.+++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~   82 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW   82 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred             hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence            356789999999999998888999999987432110    0             01234568888999999999988865


Q ss_pred             EEcCCccEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcEEecCCCCCcEEEcCCCCEEEec
Q 002010          758 VSNRDTNLLLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLDSDFEAHVAD  837 (982)
Q Consensus       758 ~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~D  837 (982)
                      .    ..+++|||+++..+.+         ++...+..++.|++.|++|||+.+   |+||||||+||+++++ .++++|
T Consensus        83 ~----~~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~liD  145 (191)
T d1zara2          83 E----GNAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWIID  145 (191)
T ss_dssp             E----TTEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEECC
T ss_pred             c----CCEEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEEEEE
Confidence            3    3489999998765543         233445679999999999999998   9999999999999865 589999


Q ss_pred             cccchhccccCCccccccccccccccccc-----ccccCCCCcchhhHHHHHHH
Q 002010          838 FGLAKFLQDAGASECMSSVAGSYGYIAPE-----YAYTLKVDEKSDVYSFGVVL  886 (982)
Q Consensus       838 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE-----~~~~~~~~~~~DvwslG~il  886 (982)
                      ||.|.....+...          .|....     ....+.|+.++|+||+.--+
T Consensus       146 FG~a~~~~~~~~~----------~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         146 FPQSVEVGEEGWR----------EILERDVRNIITYFSRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             CTTCEETTSTTHH----------HHHHHHHHHHHHHHHHHHCCCCCHHHHHHHH
T ss_pred             CCCcccCCCCCcH----------HHHHHHHHHHHHHHcCCCCCcccHHHHHHHH
Confidence            9999765422111          111110     01235688899999975433

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=99.83  E-value=3.3e-19  Score=196.52  Aligned_cols=58  Identities=24%  Similarity=0.342  Sum_probs=30.4

Q ss_pred             cccceeeeeccccCCCCCcccccccCCCeeeCCCCcccCCCCcccccccccceEEcccccccccCcc
Q 002010          504 KMITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYGKIPPGISKLIDLSILNLSRNGITGSIPN  570 (982)
Q Consensus       504 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~  570 (982)
                      ++|++|+|++|+|+ .+|..   +++|+.|+|++|+|+ .+|..   +.+|+.|+|++|+|+ .+|.
T Consensus       284 ~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~L~~N~L~-~l~~~---~~~L~~L~L~~N~L~-~lp~  341 (353)
T d1jl5a_         284 PSLEELNVSNNKLI-ELPAL---PPRLERLIASFNHLA-EVPEL---PQNLKQLHVEYNPLR-EFPD  341 (353)
T ss_dssp             TTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-SCCC
T ss_pred             CCCCEEECCCCccC-ccccc---cCCCCEEECCCCcCC-ccccc---cCCCCEEECcCCcCC-CCCc
Confidence            44555555555555 33422   345556666666665 44432   345666666666665 4444

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=99.81  E-value=1.8e-18  Score=190.51  Aligned_cols=304  Identities=27%  Similarity=0.309  Sum_probs=209.9

Q ss_pred             CCCCEEecccCcCcccCchhhcCCCccceeecccccCCCCCCccccCCCCCCEEEeeCCcccCcCchhhhcccchhhhhh
Q 002010          241 TQLQVLDMASCNISGEIPTSLSRLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTLLQL  320 (982)
Q Consensus       241 ~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L  320 (982)
                      .++++|||++|+++ .+|+.   +++|++|+|++|+|+ .+|..   +.+|+.|++++|+++ .++. +  .+.|++|++
T Consensus        38 ~~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~l~~n~l~-~l~~-l--p~~L~~L~L  105 (353)
T d1jl5a_          38 RQAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPEL---PQSLKSLLVDNNNLK-ALSD-L--PPLLEYLGV  105 (353)
T ss_dssp             HTCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCC---CTTCCEEECCSSCCS-CCCS-C--CTTCCEEEC
T ss_pred             cCCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccc---hhhhhhhhhhhcccc-hhhh-h--ccccccccc
Confidence            35788999999888 56653   467888899999988 55654   357888899998887 3332 1  135888899


Q ss_pred             ccCCCCCCCCCcCCCCCCccEEEccCCCcccccCccccCCCcccEEEeccccccccCCccccCccccceeeccccccccc
Q 002010          321 FKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDLCKGGKLKSLILMQNFFIGP  400 (982)
Q Consensus       321 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~l~~N~~~~~  400 (982)
                      ++|.+. .+|. ++.+++|++|++++|.+... +.   ....+..+.+..+...  .+..+..++.++.+.+.+|.+...
T Consensus       106 ~~n~l~-~lp~-~~~l~~L~~L~l~~~~~~~~-~~---~~~~l~~l~~~~~~~~--~~~~l~~l~~l~~L~l~~n~~~~~  177 (353)
T d1jl5a_         106 SNNQLE-KLPE-LQNSSFLKIIDVDNNSLKKL-PD---LPPSLEFIAAGNNQLE--ELPELQNLPFLTAIYADNNSLKKL  177 (353)
T ss_dssp             CSSCCS-SCCC-CTTCTTCCEEECCSSCCSCC-CC---CCTTCCEEECCSSCCS--SCCCCTTCTTCCEEECCSSCCSSC
T ss_pred             cccccc-cccc-hhhhccceeecccccccccc-cc---ccccccchhhcccccc--ccccccccccceeccccccccccc
Confidence            999888 4554 57788899999988887743 22   2345666666666553  345566778888888888876532


Q ss_pred             CCccccCCCCCCEEEccCCccCCCCCccccCCCccccccCCCccccccCCcccccCCccEEEeeccccCCCCchhccCCC
Q 002010          401 IPEELGQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLSGELPEKMSGASLNQLKVANNNITGKIPAAIGNLP  480 (982)
Q Consensus       401 ~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~L~~N~i~~~~p~~~~~l~  480 (982)
                      ..    .....+.+..+++.+. .++ .+..++.|+.+++++|..... +..  ..++..+.+.+|.+... +.   ...
T Consensus       178 ~~----~~~~~~~l~~~~~~~~-~~~-~~~~l~~L~~l~l~~n~~~~~-~~~--~~~l~~~~~~~~~~~~~-~~---~~~  244 (353)
T d1jl5a_         178 PD----LPLSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLKTL-PDL--PPSLEALNVRDNYLTDL-PE---LPQ  244 (353)
T ss_dssp             CC----CCTTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCSSC-CSC--CTTCCEEECCSSCCSCC-CC---CCT
T ss_pred             cc----cccccccccccccccc-ccc-ccccccccccccccccccccc-ccc--ccccccccccccccccc-cc---ccc
Confidence            22    2234566777766665 333 356778888888888877643 221  24678888888888732 22   345


Q ss_pred             CcceeeeccccccCCCccccccccccceeeeeccccCCCCCcccccccCCCeeeCCCCcccCCCCcccccccccceEEcc
Q 002010          481 SLNILSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYGKIPPGISKLIDLSILNLS  560 (982)
Q Consensus       481 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls  560 (982)
                      .+...++..|.+.+. +.   -.......++..|.+.+.    ...+++|++|+|++|+|+ .+|..   +++|+.|+|+
T Consensus       245 ~l~~~~~~~~~~~~l-~~---l~~~~~~~~~~~~~~~~~----~~~~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~L~  312 (353)
T d1jl5a_         245 SLTFLDVSENIFSGL-SE---LPPNLYYLNASSNEIRSL----CDLPPSLEELNVSNNKLI-ELPAL---PPRLERLIAS  312 (353)
T ss_dssp             TCCEEECCSSCCSEE-SC---CCTTCCEEECCSSCCSEE----CCCCTTCCEEECCSSCCS-CCCCC---CTTCCEEECC
T ss_pred             ccccccccccccccc-cc---ccchhcccccccCccccc----cccCCCCCEEECCCCccC-ccccc---cCCCCEEECC
Confidence            666777777665521 10   113445677777777632    244689999999999998 67754   5789999999


Q ss_pred             cccccccCccccccccccceecccCCccccCCCC
Q 002010          561 RNGITGSIPNEMRNMMSLTTLDLSYNNLIGNIPS  594 (982)
Q Consensus       561 ~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~  594 (982)
                      +|+|+ .+|..   +++|++|+|++|+|+ .+|.
T Consensus       313 ~N~L~-~l~~~---~~~L~~L~L~~N~L~-~lp~  341 (353)
T d1jl5a_         313 FNHLA-EVPEL---PQNLKQLHVEYNPLR-EFPD  341 (353)
T ss_dssp             SSCCS-CCCCC---CTTCCEEECCSSCCS-SCCC
T ss_pred             CCcCC-ccccc---cCCCCEEECcCCcCC-CCCc
Confidence            99998 67753   568999999999998 4553

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.79  E-value=6.2e-22  Score=227.14  Aligned_cols=110  Identities=15%  Similarity=0.164  Sum_probs=52.3

Q ss_pred             cccEEEeccCCCCCCC-ChhhhhhcccceeeccCCccccccc---hhhhhcCCCccEEeccCccccCCCchhcc-----c
Q 002010           96 KLVNLTISNVNLTGRL-PSEMALLTSLKVFNISGNVFQGNFA---GQIVRGMTELQVLDAYNNNFTGPLPVEIA-----S  166 (982)
Q Consensus        96 ~L~~L~l~~n~l~~~~-p~~l~~l~~L~~L~Ls~n~l~~~~~---~~~~~~l~~L~~L~Ls~n~l~~~~p~~l~-----~  166 (982)
                      +|++||+++|++++.. ...+..+++|++|+|++|.++....   ..++..+++|++|||++|+|+......+.     .
T Consensus         3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~   82 (460)
T d1z7xw1           3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP   82 (460)
T ss_dssp             EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred             CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcC
Confidence            4666777777666432 2334556666666666665542211   22334555555566655555421111111     1


Q ss_pred             cccccEEeecCcccccc----cCCCccccCcceEeeccCcccc
Q 002010          167 LKSLRHLSFGGNYFTGK----IPQSYSEIQSLEYIGLNGIGLN  205 (982)
Q Consensus       167 l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~n~i~  205 (982)
                      ..+|++|+|++|++++.    ++..+..+++|++|++++|.++
T Consensus        83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~  125 (460)
T d1z7xw1          83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLG  125 (460)
T ss_dssp             TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCH
T ss_pred             CCCCCEEECCCCCccccccccccchhhccccccccccccccch
Confidence            12455555555555432    2223334444444444444443

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.76  E-value=2.9e-21  Score=221.41  Aligned_cols=114  Identities=18%  Similarity=0.230  Sum_probs=86.4

Q ss_pred             CEEEEEeccCCccccC-CcCccccccccEEEeccCCCCC----CCChhhhhhcccceeeccCCccccccchhhhh----c
Q 002010           72 RVVSLNVSFMPLFGSI-PPEIGLLTKLVNLTISNVNLTG----RLPSEMALLTSLKVFNISGNVFQGNFAGQIVR----G  142 (982)
Q Consensus        72 ~v~~l~l~~~~l~g~~-~~~i~~l~~L~~L~l~~n~l~~----~~p~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~----~  142 (982)
                      .+..||++++.+.+.- ..-++.+++++.|+|++|+++.    .+...+..+++|++|||++|.++......+..    .
T Consensus         3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~   82 (460)
T d1z7xw1           3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP   82 (460)
T ss_dssp             EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred             CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcC
Confidence            4788999999887632 3346678999999999999874    34456778899999999999986432222222    2


Q ss_pred             CCCccEEeccCccccCC----CchhccccccccEEeecCcccccccC
Q 002010          143 MTELQVLDAYNNNFTGP----LPVEIASLKSLRHLSFGGNYFTGKIP  185 (982)
Q Consensus       143 l~~L~~L~Ls~n~l~~~----~p~~l~~l~~L~~L~L~~N~l~~~~p  185 (982)
                      ..+|++|+|++|++++.    ++..+..+++|++|+|++|.++....
T Consensus        83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~~~  129 (460)
T d1z7xw1          83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGL  129 (460)
T ss_dssp             TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHH
T ss_pred             CCCCCEEECCCCCccccccccccchhhccccccccccccccchhhhh
Confidence            35799999999999854    45667889999999999999875443

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.76  E-value=1.8e-18  Score=179.72  Aligned_cols=224  Identities=16%  Similarity=0.129  Sum_probs=158.2

Q ss_pred             CCCccceeeeCCCCCEEEEEeccCCccccCCcCccccccccEEEeccCCCCCCCChhhhhhcccceeeccCCccccccch
Q 002010           58 AHCSFSGVTCDQDSRVVSLNVSFMPLFGSIPPEIGLLTKLVNLTISNVNLTGRLPSEMALLTSLKVFNISGNVFQGNFAG  137 (982)
Q Consensus        58 ~~C~w~gv~C~~~~~v~~l~l~~~~l~g~~~~~i~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~~~  137 (982)
                      |.|.+..|.|...           ++. .+|+.+.  +++++|+|++|+++...+..|.++++|++|+|++|.+...++.
T Consensus         6 C~C~~~~i~c~~~-----------~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~   71 (242)
T d1xwdc1           6 CHCSNRVFLCQES-----------KVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEA   71 (242)
T ss_dssp             EEECSSEEEEESC-----------SCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECS
T ss_pred             CCCcCCEEEEeCC-----------CCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeec
Confidence            3356666666532           222 5676553  5789999999999865556789999999999999998877777


Q ss_pred             hhhhcCCCccEEeccC-ccccCCCchhccccccccEEeecCcccccccCC-CccccCcceEeeccCcccccchhhHHhhh
Q 002010          138 QIVRGMTELQVLDAYN-NNFTGPLPVEIASLKSLRHLSFGGNYFTGKIPQ-SYSEIQSLEYIGLNGIGLNGTVPAFLSRL  215 (982)
Q Consensus       138 ~~~~~l~~L~~L~Ls~-n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~L~~n~i~~~~~~~l~~l  215 (982)
                      ..|.+++++++|++.. |++....+..+.++++|++|++++|+++...+. .+..++.++.+...++.+..         
T Consensus        72 ~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~---------  142 (242)
T d1xwdc1          72 DVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHT---------  142 (242)
T ss_dssp             SSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCE---------
T ss_pred             cccccccccccccccccccccccccccccccccccccccchhhhccccccccccccccccccccccccccc---------
Confidence            7888899999998764 678777788889999999999999988754332 34455666665555544431         


Q ss_pred             hhHHHHhhcccccccccCCCCCCCC-CCCCEEecccCcCcccCchhhcCCCccc-eeecccccCCCCCCccccCCCCCCE
Q 002010          216 KNLREMYIGYFNTYTGGIPPGFGAL-TQLQVLDMASCNISGEIPTSLSRLKLLH-SLFLQMNKLTGHIPPQLSGLISLKS  293 (982)
Q Consensus       216 ~~L~~L~l~~~n~~~~~~p~~~~~l-~~L~~L~L~~n~l~~~~~~~l~~l~~L~-~L~L~~N~l~~~~~~~l~~l~~L~~  293 (982)
                                      .-+..|.++ ..++.|++++|+++...+..+. ..+++ .+++++|+++...+..|.++++|++
T Consensus       143 ----------------i~~~~~~~~~~~l~~L~l~~n~l~~i~~~~~~-~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~  205 (242)
T d1xwdc1         143 ----------------IERNSFVGLSFESVILWLNKNGIQEIHNCAFN-GTQLDELNLSDNNNLEELPNDVFHGASGPVI  205 (242)
T ss_dssp             ----------------ECTTSSTTSBSSCEEEECCSSCCCEECTTTTT-TCCEEEEECTTCTTCCCCCTTTTTTSCCCSE
T ss_pred             ----------------ccccccccccccceeeeccccccccccccccc-chhhhccccccccccccccHHHhcCCCCCCE
Confidence                            112334444 3678888888888855544444 44444 4456778888555556788888888


Q ss_pred             EEeeCCcccCcCchhhhcccchhhhhhc
Q 002010          294 LDLSLNYLTGEIPESFAALKNLTLLQLF  321 (982)
Q Consensus       294 L~Ls~N~l~~~~~~~l~~l~~L~~L~L~  321 (982)
                      |+|++|+|+...+..|.++++|+.+++.
T Consensus       206 L~Ls~N~l~~l~~~~~~~l~~L~~l~~~  233 (242)
T d1xwdc1         206 LDISRTRIHSLPSYGLENLKKLRARSTY  233 (242)
T ss_dssp             EECTTSCCCCCCSSSCTTCCEEESSSEE
T ss_pred             EECCCCcCCccCHHHHcCCcccccCcCC
Confidence            8888888886656667788888777664

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.75  E-value=3.1e-18  Score=175.80  Aligned_cols=103  Identities=20%  Similarity=0.284  Sum_probs=63.0

Q ss_pred             cccchhhhhhccCCCCCCCCCcCCCCCCccEEEccCCCcccccCccccCCCcccEEEeccccccccCCccccCcccccee
Q 002010          311 ALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDLCKGGKLKSL  390 (982)
Q Consensus       311 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L  390 (982)
                      .+.++..++++.+++++.+  .+..+.+|+.|++.+|.++. + +.+..+++|++|++++|++++..|  +..+++++++
T Consensus        17 ~l~~~~~~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~~-l-~~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l   90 (227)
T d1h6ua2          17 ALANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTT-I-EGVQYLNNLIGLELKDNQITDLAP--LKNLTKITEL   90 (227)
T ss_dssp             HHHHHHHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEE
T ss_pred             HHHHHHHHHhCCCCcCCcC--CHHHcCCcCEEECCCCCCCc-c-hhHhcCCCCcEeecCCceeecccc--cccccccccc
Confidence            3456667788888887654  34567788888888888874 3 357777888888888887764322  4445555555


Q ss_pred             ecccccccccCCccccCCCCCCEEEccCCcc
Q 002010          391 ILMQNFFIGPIPEELGQCKSLTKIRFSKNYL  421 (982)
Q Consensus       391 ~l~~N~~~~~~~~~l~~l~~L~~L~Ls~N~l  421 (982)
                      ++++|.++..  ..+..+++|+.+++++|..
T Consensus        91 ~~~~n~~~~i--~~l~~l~~L~~l~l~~~~~  119 (227)
T d1h6ua2          91 ELSGNPLKNV--SAIAGLQSIKTLDLTSTQI  119 (227)
T ss_dssp             ECCSCCCSCC--GGGTTCTTCCEEECTTSCC
T ss_pred             cccccccccc--ccccccccccccccccccc
Confidence            5555544321  1344445555555554443

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.74  E-value=1.6e-18  Score=177.92  Aligned_cols=167  Identities=21%  Similarity=0.315  Sum_probs=99.8

Q ss_pred             ccCCCCCCEEEccCCccCCCCCccccCCCccccccCCCccccccCCcccccCCccEEEeeccccCCCCchhccCCCCcce
Q 002010          405 LGQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLSGELPEKMSGASLNQLKVANNNITGKIPAAIGNLPSLNI  484 (982)
Q Consensus       405 l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~L~~N~i~~~~p~~~~~l~~L~~  484 (982)
                      +..+++|++|++++|++++..|  +..++.++.+++++|.++. ++.......|+.+++++|.+.+.  ..+...+.++.
T Consensus        59 l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~~~-i~~l~~l~~L~~l~l~~~~~~~~--~~~~~~~~~~~  133 (227)
T d1h6ua2          59 VQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKN-VSAIAGLQSIKTLDLTSTQITDV--TPLAGLSNLQV  133 (227)
T ss_dssp             GGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSC-CGGGTTCTTCCEEECTTSCCCCC--GGGTTCTTCCE
T ss_pred             HhcCCCCcEeecCCceeecccc--ccccccccccccccccccc-ccccccccccccccccccccccc--chhccccchhh
Confidence            4444444444444444443221  4444444444444444432 22222334556666666655533  23455667777


Q ss_pred             eeeccccccCCCccccccccccceeeeeccccCCCCCcccccccCCCeeeCCCCcccCCCCcccccccccceEEcccccc
Q 002010          485 LSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYGKIPPGISKLIDLSILNLSRNGI  564 (982)
Q Consensus       485 L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l  564 (982)
                      +.++++.+...  ..+..+++|++|++++|++++..  .++++++|+.|+|++|++++ +| .++++++|++|+|++|+|
T Consensus       134 l~~~~~~~~~~--~~~~~~~~L~~L~l~~n~~~~~~--~l~~l~~L~~L~Ls~n~l~~-l~-~l~~l~~L~~L~Ls~N~l  207 (227)
T d1h6ua2         134 LYLDLNQITNI--SPLAGLTNLQYLSIGNAQVSDLT--PLANLSKLTTLKADDNKISD-IS-PLASLPNLIEVHLKNNQI  207 (227)
T ss_dssp             EECCSSCCCCC--GGGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECTTSCC
T ss_pred             hhchhhhhchh--hhhccccccccccccccccccch--hhcccccceecccCCCccCC-Ch-hhcCCCCCCEEECcCCcC
Confidence            77777776532  23556677777777777776432  36777888888888888774 33 377788888888888888


Q ss_pred             cccCccccccccccceeccc
Q 002010          565 TGSIPNEMRNMMSLTTLDLS  584 (982)
Q Consensus       565 ~~~~p~~l~~l~~L~~L~Ls  584 (982)
                      ++..|  +.++++|+.|+++
T Consensus       208 t~i~~--l~~l~~L~~L~ls  225 (227)
T d1h6ua2         208 SDVSP--LANTSNLFIVTLT  225 (227)
T ss_dssp             CBCGG--GTTCTTCCEEEEE
T ss_pred             CCCcc--cccCCCCCEEEee
Confidence            75332  7778888888876

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.72  E-value=8.1e-18  Score=167.53  Aligned_cols=158  Identities=20%  Similarity=0.190  Sum_probs=115.4

Q ss_pred             CCccEEEeeccccCC-CCchhccCCCCcceeeeccccccCCCccccccccccceeeeeccccCCCCCcccccccCCCeee
Q 002010          456 ASLNQLKVANNNITG-KIPAAIGNLPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIPYSISQCHSLTSVD  534 (982)
Q Consensus       456 ~~L~~L~L~~N~i~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~  534 (982)
                      ..+++|+|++|+|++ ..+..|.++++|+.|+|++|++.+..+..+..+++|++|+|++|+|++..|..|.++++|++|+
T Consensus        29 ~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~  108 (192)
T d1w8aa_          29 LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLN  108 (192)
T ss_dssp             TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEE
T ss_pred             CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccccccccCHHHHhCCCcccccc
Confidence            356777777777765 3456678888888888888888877777888888888888888888877778888888888888


Q ss_pred             CCCCcccCCCCcccccccccceEEcccccccccCccccccccccceecccCCccccCCCCCccccccccccccCCcCccc
Q 002010          535 LSRNSLYGKIPPGISKLIDLSILNLSRNGITGSIPNEMRNMMSLTTLDLSYNNLIGNIPSGGQFLAFNETSFIGNPNLCL  614 (982)
Q Consensus       535 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~~~~~~~~~~~~~~n~~~c~  614 (982)
                      |++|+|++..|..|..+++|++|+|++|.+....+. ..-...++.+.+..|.+++..|..  +....-.++..|...|.
T Consensus       109 L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~-~~~~~~l~~~~l~~~~~~c~~p~~--l~~~~l~~L~~n~l~C~  185 (192)
T d1w8aa_         109 LYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHL-AWFAEWLRKKSLNGGAARCGAPSK--VRDVQIKDLPHSEFKCS  185 (192)
T ss_dssp             CCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGG-HHHHHHHHHHCCSGGGCBBCSSTT--TTTSBGGGSCTTTCCCC
T ss_pred             cCCccccccCHHHhcCCcccccccccccccccccch-HHHhhhhhhhcccCCCeEeCCChh--hcCCEeeecCHhhCcCC
Confidence            888888877788888888888888888888743322 222334667778888887766643  22333334455655665


Q ss_pred             CC
Q 002010          615 LR  616 (982)
Q Consensus       615 ~~  616 (982)
                      .+
T Consensus       186 ~~  187 (192)
T d1w8aa_         186 SE  187 (192)
T ss_dssp             CC
T ss_pred             CC
Confidence            54

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.72  E-value=4.2e-18  Score=176.82  Aligned_cols=219  Identities=15%  Similarity=0.045  Sum_probs=107.4

Q ss_pred             ceeeccCCccccccchhhhhcCCCccEEeccCccccCCCchhccccccccEEeecCcccccccC-CCccccCcceEeecc
Q 002010          122 KVFNISGNVFQGNFAGQIVRGMTELQVLDAYNNNFTGPLPVEIASLKSLRHLSFGGNYFTGKIP-QSYSEIQSLEYIGLN  200 (982)
Q Consensus       122 ~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~  200 (982)
                      ++++.+++.++ .+|..++   +++++|+|++|+|+...+..|.++++|++|+|++|.+...++ ..|.++++++++.+.
T Consensus        11 ~~i~c~~~~l~-~iP~~l~---~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~   86 (242)
T d1xwdc1          11 RVFLCQESKVT-EIPSDLP---RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIE   86 (242)
T ss_dssp             SEEEEESCSCS-SCCSCSC---SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEE
T ss_pred             CEEEEeCCCCC-CcCCCCC---CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecccccccccccccccc
Confidence            34555554444 2332221   345555555555553333345555555555555555544332 344445555544433


Q ss_pred             CcccccchhhHHhhhhhHHHHhhcccccccccCCCCCCCCCCCCEEecccCcCcccCc-hhhcCCCccceeecccccCCC
Q 002010          201 GIGLNGTVPAFLSRLKNLREMYIGYFNTYTGGIPPGFGALTQLQVLDMASCNISGEIP-TSLSRLKLLHSLFLQMNKLTG  279 (982)
Q Consensus       201 ~n~i~~~~~~~l~~l~~L~~L~l~~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~-~~l~~l~~L~~L~L~~N~l~~  279 (982)
                      .                        ++.+....+..|.++++|++|++++|++....+ ..+..++.++.+..+++.+..
T Consensus        87 ~------------------------~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~  142 (242)
T d1xwdc1          87 K------------------------ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHT  142 (242)
T ss_dssp             C------------------------CTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCE
T ss_pred             c------------------------cccccccccccccccccccccccchhhhccccccccccccccccccccccccccc
Confidence            2                        223333334455666666666666666653322 123344455555555555554


Q ss_pred             CCCccccCCC-CCCEEEeeCCcccCcCchhhhcccchhhhhhccCCCCCCCCCcCCCCCCccEEEccCCCcccccCcccc
Q 002010          280 HIPPQLSGLI-SLKSLDLSLNYLTGEIPESFAALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLG  358 (982)
Q Consensus       280 ~~~~~l~~l~-~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~  358 (982)
                      ..+..+.+++ .++.|++++|+++...+..+.....++.+++++|+++...+..|.++++|++|++++|+++...+..|.
T Consensus       143 i~~~~~~~~~~~l~~L~l~~n~l~~i~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~  222 (242)
T d1xwdc1         143 IERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLE  222 (242)
T ss_dssp             ECTTSSTTSBSSCEEEECCSSCCCEECTTTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCT
T ss_pred             ccccccccccccceeeecccccccccccccccchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHc
Confidence            4444454443 556666666666644333333322233334555555544444455556666666666655543344444


Q ss_pred             CCCcccEEEe
Q 002010          359 RNGKLLILDV  368 (982)
Q Consensus       359 ~l~~L~~L~L  368 (982)
                      ++++|+++++
T Consensus       223 ~l~~L~~l~~  232 (242)
T d1xwdc1         223 NLKKLRARST  232 (242)
T ss_dssp             TCCEEESSSE
T ss_pred             CCcccccCcC
Confidence            4444444443

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.70  E-value=9.7e-18  Score=166.93  Aligned_cols=156  Identities=20%  Similarity=0.204  Sum_probs=130.9

Q ss_pred             ccEEEeeccccCCCCchhccCCCCcceeeeccccccCCC-ccccccccccceeeeeccccCCCCCcccccccCCCeeeCC
Q 002010          458 LNQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLEGEI-PVESFNLKMITSINISDNNISGEIPYSISQCHSLTSVDLS  536 (982)
Q Consensus       458 L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls  536 (982)
                      .+.++.++|+++ .+|..+.  +++++|+|++|+|++.+ +..|..+++|++|+|++|++.+..+..|..+++|++|+|+
T Consensus        10 ~~~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls   86 (192)
T d1w8aa_          10 GTTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLG   86 (192)
T ss_dssp             TTEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred             CCEEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeec
Confidence            457888888988 5666542  68999999999998645 5567889999999999999999999999999999999999


Q ss_pred             CCcccCCCCcccccccccceEEcccccccccCccccccccccceecccCCccccCCCCCccccccccccccCCcCcccCC
Q 002010          537 RNSLYGKIPPGISKLIDLSILNLSRNGITGSIPNEMRNMMSLTTLDLSYNNLIGNIPSGGQFLAFNETSFIGNPNLCLLR  616 (982)
Q Consensus       537 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~~~~~~~~~~~~~~n~~~c~~~  616 (982)
                      +|+|++..|..|.++++|++|+|++|+|++..|.+|..+++|++|+|++|++.+..+.......+......+|...|..|
T Consensus        87 ~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~~~~~~l~~~~l~~~~~~c~~p  166 (192)
T d1w8aa_          87 ENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAP  166 (192)
T ss_dssp             SCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBCSS
T ss_pred             cccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccchHHHhhhhhhhcccCCCeEeCCC
Confidence            99999888889999999999999999999988999999999999999999998765432212223444556676777665

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.70  E-value=1.9e-17  Score=167.33  Aligned_cols=100  Identities=34%  Similarity=0.447  Sum_probs=53.1

Q ss_pred             CCCCCCCEEecccCcCcccCchhhcCCCccceeecccccCCCCCCccccCCCCCCEEEeeCCcccCcCchhhhcccchhh
Q 002010          238 GALTQLQVLDMASCNISGEIPTSLSRLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNLTL  317 (982)
Q Consensus       238 ~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~  317 (982)
                      .++++|+.|++++|.+.. + ..+..++.|+.+++++|.+++.  ..+..+++|+++++++|++++. + .+.++++|+.
T Consensus       109 ~~l~~L~~L~l~~~~~~~-~-~~l~~l~~l~~l~~~~n~l~~~--~~~~~l~~L~~l~l~~n~l~~i-~-~l~~l~~L~~  182 (210)
T d1h6ta2         109 KDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDI-V-PLAGLTKLQN  182 (210)
T ss_dssp             TTCTTCCEEECTTSCCCC-C-GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCC-G-GGTTCTTCCE
T ss_pred             cccccccccccccccccc-c-cccccccccccccccccccccc--cccccccccccccccccccccc-c-cccCCCCCCE
Confidence            344555555555555542 1 2355555555555555555532  2344555566666666666532 2 2555566666


Q ss_pred             hhhccCCCCCCCCCcCCCCCCccEEEcc
Q 002010          318 LQLFKNNLRGPIPSFLGDFPNLEVLQVW  345 (982)
Q Consensus       318 L~L~~N~l~~~~p~~~~~l~~L~~L~L~  345 (982)
                      |+|++|++++ +| .+.++++|++|+|+
T Consensus       183 L~Ls~N~i~~-l~-~l~~l~~L~~L~Ls  208 (210)
T d1h6ta2         183 LYLSKNHISD-LR-ALAGLKNLDVLELF  208 (210)
T ss_dssp             EECCSSCCCB-CG-GGTTCTTCSEEEEE
T ss_pred             EECCCCCCCC-Ch-hhcCCCCCCEEEcc
Confidence            6666666653 23 35566666666654

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.67  E-value=9.3e-17  Score=162.12  Aligned_cols=164  Identities=23%  Similarity=0.323  Sum_probs=108.7

Q ss_pred             CCCCEEEccCCccCCCCCccccCCCccccccCCCccccccCCcccccCCccEEEeeccccCCCCchhccCCCCcceeeec
Q 002010          409 KSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLSGELPEKMSGASLNQLKVANNNITGKIPAAIGNLPSLNILSLQ  488 (982)
Q Consensus       409 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~  488 (982)
                      .+|++|++++|.++.. + ++..+++|++|++++|++++.. ......+|++|++++|+|++ +| .+..+++|+.|+++
T Consensus        46 ~~L~~L~l~~~~i~~l-~-~l~~l~~L~~L~L~~n~i~~l~-~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~l~  120 (210)
T d1h6ta2          46 NSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIK-PLANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLE  120 (210)
T ss_dssp             HTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCG-GGTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECT
T ss_pred             cCccEEECcCCCCCCc-h-hHhhCCCCCEEeCCCccccCcc-ccccCccccccccccccccc-cc-cccccccccccccc
Confidence            3444444444444421 1 2344444455555555444322 22223466777777777764 33 47778888888888


Q ss_pred             cccccCCCccccccccccceeeeeccccCCCCCcccccccCCCeeeCCCCcccCCCCcccccccccceEEcccccccccC
Q 002010          489 NNRLEGEIPVESFNLKMITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYGKIPPGISKLIDLSILNLSRNGITGSI  568 (982)
Q Consensus       489 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~  568 (982)
                      +|.+.. + ..+..++.++.+++++|.+++  +..+..+++|+.+++++|++++ ++ .+.++++|++|+|++|+|+. +
T Consensus       121 ~~~~~~-~-~~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~-i~-~l~~l~~L~~L~Ls~N~i~~-l  193 (210)
T d1h6ta2         121 HNGISD-I-NGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISD-IV-PLAGLTKLQNLYLSKNHISD-L  193 (210)
T ss_dssp             TSCCCC-C-GGGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCCB-C
T ss_pred             cccccc-c-ccccccccccccccccccccc--cccccccccccccccccccccc-cc-cccCCCCCCEEECCCCCCCC-C
Confidence            888763 2 356778888888888888874  3356778888888888888875 33 37888888899998888874 5


Q ss_pred             ccccccccccceecccC
Q 002010          569 PNEMRNMMSLTTLDLSY  585 (982)
Q Consensus       569 p~~l~~l~~L~~L~Ls~  585 (982)
                      | .+..+++|++|+|++
T Consensus       194 ~-~l~~l~~L~~L~Ls~  209 (210)
T d1h6ta2         194 R-ALAGLKNLDVLELFS  209 (210)
T ss_dssp             G-GGTTCTTCSEEEEEE
T ss_pred             h-hhcCCCCCCEEEccC
Confidence            5 588888888888874

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.66  E-value=4.7e-17  Score=162.88  Aligned_cols=115  Identities=28%  Similarity=0.402  Sum_probs=76.8

Q ss_pred             CccEEEeeccccCCCCchhccCCCCcceeeeccccccCCCccccccccccceeeeeccccCCCCCcccccccCCCeeeCC
Q 002010          457 SLNQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIPYSISQCHSLTSVDLS  536 (982)
Q Consensus       457 ~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls  536 (982)
                      +|++|++++|.+.. ++ .++++++|+.|++++|.+...  ..+..+++|+.|++++|++.. ++ .+..+++|+.|+++
T Consensus        85 ~L~~L~l~~n~~~~-~~-~l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~-~~-~l~~~~~L~~L~l~  158 (199)
T d2omxa2          85 KLVDILMNNNQIAD-IT-PLANLTNLTGLTLFNNQITDI--DPLKNLTNLNRLELSSNTISD-IS-ALSGLTSLQQLNFS  158 (199)
T ss_dssp             TCCEEECCSSCCCC-CG-GGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCC-CG-GGTTCTTCSEEECC
T ss_pred             cccccccccccccc-cc-ccccccccccccccccccccc--cccchhhhhHHhhhhhhhhcc-cc-cccccccccccccc
Confidence            45555555555543 22 366777777777777777632  235667777777777777763 33 46777888888888


Q ss_pred             CCcccCCCCcccccccccceEEcccccccccCcccccccccccee
Q 002010          537 RNSLYGKIPPGISKLIDLSILNLSRNGITGSIPNEMRNMMSLTTL  581 (982)
Q Consensus       537 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L  581 (982)
                      +|++++. + .++++++|+.|+|++|++++ ++ .+..+++|+.|
T Consensus       159 ~n~l~~l-~-~l~~l~~L~~L~ls~N~i~~-i~-~l~~L~~L~~L  199 (199)
T d2omxa2         159 SNQVTDL-K-PLANLTTLERLDISSNKVSD-IS-VLAKLTNLESL  199 (199)
T ss_dssp             SSCCCCC-G-GGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCSEE
T ss_pred             cccccCC-c-cccCCCCCCEEECCCCCCCC-Cc-cccCCCCCCcC
Confidence            8888743 2 37788888888888888874 33 46777777765

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.64  E-value=2.1e-16  Score=158.07  Aligned_cols=184  Identities=24%  Similarity=0.323  Sum_probs=121.3

Q ss_pred             cccchhhhhhccCCCCCCCCCcCCCCCCccEEEccCCCcccccCccccCCCcccEEEeccccccccCCccccCcccccee
Q 002010          311 ALKNLTLLQLFKNNLRGPIPSFLGDFPNLEVLQVWGNNFTFELPENLGRNGKLLILDVTSNHLTGTIPRDLCKGGKLKSL  390 (982)
Q Consensus       311 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L  390 (982)
                      .+.++..+.++.+.+++.++  ...++++++|++++|.++. + +.+..+++|++|++++|++++..|  +.++++|++|
T Consensus        16 ~l~~~i~~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~~-l-~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L   89 (199)
T d2omxa2          16 ALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDI   89 (199)
T ss_dssp             HHHHHHHHHTTCSSTTSEEC--HHHHTTCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEE
T ss_pred             HHHHHHHHHhCCCCCCCccC--HHHhcCCCEEECCCCCCCC-c-cccccCCCcCcCccccccccCccc--ccCCcccccc
Confidence            34566677888888886543  2457788889998888874 2 346777888888888888875332  6666777777


Q ss_pred             ecccccccccCCccccCCCCCCEEEccCCccCCCCCccccCCCccccccCCCccccccCCcccccCCccEEEeeccccCC
Q 002010          391 ILMQNFFIGPIPEELGQCKSLTKIRFSKNYLNGTIPAGLFNLPLLNMMELDDNLLSGELPEKMSGASLNQLKVANNNITG  470 (982)
Q Consensus       391 ~l~~N~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~L~~N~i~~  470 (982)
                      ++++|.+....  .+++++.|+.|++++|.+...  ..+..++                       +|+.|++++|++..
T Consensus        90 ~l~~n~~~~~~--~l~~l~~L~~L~l~~~~~~~~--~~~~~l~-----------------------~L~~L~l~~n~l~~  142 (199)
T d2omxa2          90 LMNNNQIADIT--PLANLTNLTGLTLFNNQITDI--DPLKNLT-----------------------NLNRLELSSNTISD  142 (199)
T ss_dssp             ECCSSCCCCCG--GGTTCTTCSEEECCSSCCCCC--GGGTTCT-----------------------TCSEEECCSSCCCC
T ss_pred             ccccccccccc--ccccccccccccccccccccc--cccchhh-----------------------hhHHhhhhhhhhcc
Confidence            77777655322  366667777777777666532  1233344                       45556666666553


Q ss_pred             CCchhccCCCCcceeeeccccccCCCccccccccccceeeeeccccCCCCCcccccccCCCee
Q 002010          471 KIPAAIGNLPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIPYSISQCHSLTSV  533 (982)
Q Consensus       471 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L  533 (982)
                       + +.+..+++|++|++++|++++. + .+.++++|++|++++|+|++ ++ .++++++|+.|
T Consensus       143 -~-~~l~~~~~L~~L~l~~n~l~~l-~-~l~~l~~L~~L~ls~N~i~~-i~-~l~~L~~L~~L  199 (199)
T d2omxa2         143 -I-SALSGLTSLQQLNFSSNQVTDL-K-PLANLTTLERLDISSNKVSD-IS-VLAKLTNLESL  199 (199)
T ss_dssp             -C-GGGTTCTTCSEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCSEE
T ss_pred             -c-ccccccccccccccccccccCC-c-cccCCCCCCEEECCCCCCCC-Cc-cccCCCCCCcC
Confidence             2 2466777777777777777643 2 36677788888888888774 33 46777777765

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.57  E-value=2.1e-16  Score=167.50  Aligned_cols=202  Identities=15%  Similarity=0.163  Sum_probs=100.6

Q ss_pred             ccEEEeccCCCCCCCChhhhhhcccceeeccCCccccccchhhhhcCCCccEEeccCccccCCCchhccccccccEEeec
Q 002010           97 LVNLTISNVNLTGRLPSEMALLTSLKVFNISGNVFQGNFAGQIVRGMTELQVLDAYNNNFTGPLPVEIASLKSLRHLSFG  176 (982)
Q Consensus        97 L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~  176 (982)
                      +..+.++...+...+. ......+|++|||+++.+.+.....++..+++|++|+|++|.+++..+..++.+++|++|+|+
T Consensus        25 ~~~lrl~~~~~~~~~~-~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls  103 (284)
T d2astb2          25 VIAFRCPRSFMDQPLA-EHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLS  103 (284)
T ss_dssp             CSEEECTTCEECSCCC-SCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECT
T ss_pred             ceEeeccccccccchh-hhccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCcccc
Confidence            3444444444332222 223445677777777776655555566677777777777777776667777777777777777


Q ss_pred             Cc-ccccccCC-CccccCcceEeeccCcc-cccc-hhhHHhhh-hhHHHHhhcccc-cccc-cCCCCCCCCCCCCEEecc
Q 002010          177 GN-YFTGKIPQ-SYSEIQSLEYIGLNGIG-LNGT-VPAFLSRL-KNLREMYIGYFN-TYTG-GIPPGFGALTQLQVLDMA  249 (982)
Q Consensus       177 ~N-~l~~~~p~-~~~~l~~L~~L~L~~n~-i~~~-~~~~l~~l-~~L~~L~l~~~n-~~~~-~~p~~~~~l~~L~~L~L~  249 (982)
                      +| .+++..-. ....+++|++|++++|. +++. +...+... ++|++|+++.+. .++. .+...+.++++|++|+++
T Consensus       104 ~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~  183 (284)
T d2astb2         104 GCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLS  183 (284)
T ss_dssp             TCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECT
T ss_pred             ccccccccccchhhHHHHhccccccccccccccccchhhhcccccccchhhhcccccccccccccccccccccccccccc
Confidence            74 45533222 23456777777777653 3321 12222222 334444443221 1111 111112334445555554


Q ss_pred             cC-cCcccCchhhcCCCccceeecccc-cCCCCCCccccCCCCCCEEEeeCC
Q 002010          250 SC-NISGEIPTSLSRLKLLHSLFLQMN-KLTGHIPPQLSGLISLKSLDLSLN  299 (982)
Q Consensus       250 ~n-~l~~~~~~~l~~l~~L~~L~L~~N-~l~~~~~~~l~~l~~L~~L~Ls~N  299 (982)
                      +| .+++.....+.++++|++|+|++| .+++.....++++++|++|+++++
T Consensus       184 ~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~  235 (284)
T d2astb2         184 DSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI  235 (284)
T ss_dssp             TCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred             cccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC
Confidence            43 244444444444555555555542 344333334444455555555444

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.55  E-value=2.2e-16  Score=167.42  Aligned_cols=221  Identities=21%  Similarity=0.282  Sum_probs=114.7

Q ss_pred             cEEEeccCCCCCCCChhhhhhc--ccceeeccCCccccccchhhhhcCCCccEEeccCccccCC-CchhccccccccEEe
Q 002010           98 VNLTISNVNLTGRLPSEMALLT--SLKVFNISGNVFQGNFAGQIVRGMTELQVLDAYNNNFTGP-LPVEIASLKSLRHLS  174 (982)
Q Consensus        98 ~~L~l~~n~l~~~~p~~l~~l~--~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~-~p~~l~~l~~L~~L~  174 (982)
                      ++|||+++.+.   |+.+..+.  .+..+.+++.........  .....+|++||++++.+++. ++..+.++++|++|+
T Consensus         3 ~~lDLs~~~l~---~~~l~~l~~~~~~~lrl~~~~~~~~~~~--~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~   77 (284)
T d2astb2           3 QTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE--HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLS   77 (284)
T ss_dssp             SEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS--CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEE
T ss_pred             CEEECCCCCCC---chHHHHHHhccceEeeccccccccchhh--hccCCCCCEEECCCCccCHHHHHHHHHhCCCccccc
Confidence            46788877765   33444332  244555555544322111  12345777777777777643 344456777777777


Q ss_pred             ecCcccccccCCCccccCcceEeeccCc-ccccchhhHHhhhhhHHHHhhcccccccccCCCCCCCCCCCCEEecccC-c
Q 002010          175 FGGNYFTGKIPQSYSEIQSLEYIGLNGI-GLNGTVPAFLSRLKNLREMYIGYFNTYTGGIPPGFGALTQLQVLDMASC-N  252 (982)
Q Consensus       175 L~~N~l~~~~p~~~~~l~~L~~L~L~~n-~i~~~~~~~l~~l~~L~~L~l~~~n~~~~~~p~~~~~l~~L~~L~L~~n-~  252 (982)
                      |++|.+++..+..++.+++|++|++++| .+++..-..+                        +.++++|++|++++| .
T Consensus        78 L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l------------------------~~~~~~L~~L~ls~c~~  133 (284)
T d2astb2          78 LEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTL------------------------LSSCSRLDELNLSWCFD  133 (284)
T ss_dssp             CTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHH------------------------HHHCTTCCEEECCCCTT
T ss_pred             ccccCCCcHHHHHHhcCCCCcCccccccccccccccchh------------------------hHHHHhccccccccccc
Confidence            7777777766777777777777777764 3332111111                        123456666666665 3


Q ss_pred             Cccc-CchhhcC-CCccceeecccc--cCCCC-CCccccCCCCCCEEEeeCC-cccCcCchhhhcccchhhhhhccC-CC
Q 002010          253 ISGE-IPTSLSR-LKLLHSLFLQMN--KLTGH-IPPQLSGLISLKSLDLSLN-YLTGEIPESFAALKNLTLLQLFKN-NL  325 (982)
Q Consensus       253 l~~~-~~~~l~~-l~~L~~L~L~~N--~l~~~-~~~~l~~l~~L~~L~Ls~N-~l~~~~~~~l~~l~~L~~L~L~~N-~l  325 (982)
                      ++.. +...+.. .++|+.|+++++  .++.. +...+..+++|++|++++| .+++.....+..+++|++|+|+++ .+
T Consensus       134 ~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i  213 (284)
T d2astb2         134 FTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDI  213 (284)
T ss_dssp             CCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTC
T ss_pred             cccccchhhhcccccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCC
Confidence            3321 1122222 245666666543  22211 1112234555666666554 344444444555555555555552 34


Q ss_pred             CCCCCCcCCCCCCccEEEccCC
Q 002010          326 RGPIPSFLGDFPNLEVLQVWGN  347 (982)
Q Consensus       326 ~~~~p~~~~~l~~L~~L~L~~N  347 (982)
                      ++.....++++++|+.|+++++
T Consensus       214 ~~~~l~~L~~~~~L~~L~l~~~  235 (284)
T d2astb2         214 IPETLLELGEIPTLKTLQVFGI  235 (284)
T ss_dssp             CGGGGGGGGGCTTCCEEECTTS
T ss_pred             ChHHHHHHhcCCCCCEEeeeCC
Confidence            4433344445555555555554

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.52  E-value=9.6e-16  Score=167.75  Aligned_cols=253  Identities=18%  Similarity=0.179  Sum_probs=153.8

Q ss_pred             CCChhhhhhcccceeeccCCccccccc---hhhhhcCCCccEEeccCccccCC----------CchhccccccccEEeec
Q 002010          110 RLPSEMALLTSLKVFNISGNVFQGNFA---GQIVRGMTELQVLDAYNNNFTGP----------LPVEIASLKSLRHLSFG  176 (982)
Q Consensus       110 ~~p~~l~~l~~L~~L~Ls~n~l~~~~~---~~~~~~l~~L~~L~Ls~n~l~~~----------~p~~l~~l~~L~~L~L~  176 (982)
                      .+...+.....|++|+|++|.+.....   .+.+...++|+.|+++++.+...          +...+...++|++|+|+
T Consensus        22 ~l~~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~  101 (344)
T d2ca6a1          22 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLS  101 (344)
T ss_dssp             TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECC
T ss_pred             HHHHHHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCccccccc
Confidence            345567777788888888887754322   23345667888888887654321          22334556789999999


Q ss_pred             Cccccccc----CCCccccCcceEeeccCcccccchhhHHhhhhhHHHHhhcccccccccCCCCCCCCCCCCEEecccCc
Q 002010          177 GNYFTGKI----PQSYSEIQSLEYIGLNGIGLNGTVPAFLSRLKNLREMYIGYFNTYTGGIPPGFGALTQLQVLDMASCN  252 (982)
Q Consensus       177 ~N~l~~~~----p~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~l~~~n~~~~~~p~~~~~l~~L~~L~L~~n~  252 (982)
                      +|.++...    ...+...++|++|++++|.+.......+..  .|..+....          .....+.|+.|++++|+
T Consensus       102 ~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~--~l~~~~~~~----------~~~~~~~L~~l~l~~n~  169 (344)
T d2ca6a1         102 DNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIAR--ALQELAVNK----------KAKNAPPLRSIICGRNR  169 (344)
T ss_dssp             SCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHH--HHHHHHHHH----------HHHTCCCCCEEECCSSC
T ss_pred             ccccccccccchhhhhcccccchheecccccccccccccccc--ccccccccc----------ccccCcccceeeccccc
Confidence            98887643    334456788999999988876544444432  233333221          11234678999999998


Q ss_pred             CcccC----chhhcCCCccceeecccccCCCC-----CCccccCCCCCCEEEeeCCcccCc----Cchhhhcccchhhhh
Q 002010          253 ISGEI----PTSLSRLKLLHSLFLQMNKLTGH-----IPPQLSGLISLKSLDLSLNYLTGE----IPESFAALKNLTLLQ  319 (982)
Q Consensus       253 l~~~~----~~~l~~l~~L~~L~L~~N~l~~~-----~~~~l~~l~~L~~L~Ls~N~l~~~----~~~~l~~l~~L~~L~  319 (982)
                      ++...    ...+...+.|++|+|++|+++..     +...+..+++|+.|+|++|.++..    +...+...++|++|+
T Consensus       170 i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~  249 (344)
T d2ca6a1         170 LENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELG  249 (344)
T ss_dssp             CTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEE
T ss_pred             ccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhh
Confidence            87432    33456778899999999988742     233466678888899988887643    223445566666667


Q ss_pred             hccCCCCCCCCCc----CC--CCCCccEEEccCCCccccc----Ccccc-CCCcccEEEecccccc
Q 002010          320 LFKNNLRGPIPSF----LG--DFPNLEVLQVWGNNFTFEL----PENLG-RNGKLLILDVTSNHLT  374 (982)
Q Consensus       320 L~~N~l~~~~p~~----~~--~l~~L~~L~L~~N~l~~~~----~~~l~-~l~~L~~L~L~~N~l~  374 (982)
                      |++|.|++.....    +.  ..+.|++|++++|+++...    ...+. +.++|+.|++++|++.
T Consensus       250 Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~  315 (344)
T d2ca6a1         250 LNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS  315 (344)
T ss_dssp             CTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSC
T ss_pred             hhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCC
Confidence            7766665432111    11  1245666666666665321    12221 3445555555555554

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.49  E-value=3.4e-14  Score=129.13  Aligned_cols=87  Identities=24%  Similarity=0.344  Sum_probs=39.3

Q ss_pred             cccccccceeeeeccccCCCCCcccccccCCCeeeCCCCcccCCCCcccccccccceEEcccccccccCc-ccccccccc
Q 002010          500 SFNLKMITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYGKIPPGISKLIDLSILNLSRNGITGSIP-NEMRNMMSL  578 (982)
Q Consensus       500 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~l~~l~~L  578 (982)
                      +..+++|++|++++|+|+ .+|..|+.+++|+.|++++|+|++ +| .++.+++|+.|++++|+|+.... ..+..+++|
T Consensus        16 l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~~~~L   92 (124)
T d1dcea3          16 LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRL   92 (124)
T ss_dssp             GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTC
T ss_pred             cccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCCccCCCCCchhhcCCCCC
Confidence            344444444444444444 233344444444444444444442 22 24444455555555555443221 334445555


Q ss_pred             ceecccCCccc
Q 002010          579 TTLDLSYNNLI  589 (982)
Q Consensus       579 ~~L~Ls~N~l~  589 (982)
                      ++|++++|+++
T Consensus        93 ~~L~l~~N~i~  103 (124)
T d1dcea3          93 VLLNLQGNSLC  103 (124)
T ss_dssp             CEEECTTSGGG
T ss_pred             CEEECCCCcCC
Confidence            55555555544

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.49  E-value=3.9e-14  Score=128.75  Aligned_cols=118  Identities=20%  Similarity=0.285  Sum_probs=98.4

Q ss_pred             cEEEeeccccCCCCchhccCCCCcceeeeccccccCCCccccccccccceeeeeccccCCCCCcccccccCCCeeeCCCC
Q 002010          459 NQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIPYSISQCHSLTSVDLSRN  538 (982)
Q Consensus       459 ~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N  538 (982)
                      +.|+|++|+|+ .++ .++.+++|++|++++|+|+ .+|..+..+++|++|++++|+|++ +| .+..+++|+.|++++|
T Consensus         1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N   75 (124)
T d1dcea3           1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNN   75 (124)
T ss_dssp             SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSS
T ss_pred             CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCC
Confidence            57999999999 444 4899999999999999998 678889999999999999999995 44 5899999999999999


Q ss_pred             cccCCC-CcccccccccceEEcccccccccC---cccccccccccee
Q 002010          539 SLYGKI-PPGISKLIDLSILNLSRNGITGSI---PNEMRNMMSLTTL  581 (982)
Q Consensus       539 ~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~---p~~l~~l~~L~~L  581 (982)
                      +|+... +..+..+++|+.|++++|+++...   ......+++|+.|
T Consensus        76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~~~~~~~~~l~~~lp~L~~L  122 (124)
T d1dcea3          76 RLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI  122 (124)
T ss_dssp             CCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEE
T ss_pred             ccCCCCCchhhcCCCCCCEEECCCCcCCcCccHHHHHHHHCcCcceE
Confidence            998544 257899999999999999998432   2233446666654

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.49  E-value=2.5e-15  Score=164.43  Aligned_cols=184  Identities=18%  Similarity=0.172  Sum_probs=98.2

Q ss_pred             CCCCCCEEecccCcCcccC----chhhcCCCccceeecccccCCCCCCcc-------------ccCCCCCCEEEeeCCcc
Q 002010          239 ALTQLQVLDMASCNISGEI----PTSLSRLKLLHSLFLQMNKLTGHIPPQ-------------LSGLISLKSLDLSLNYL  301 (982)
Q Consensus       239 ~l~~L~~L~L~~n~l~~~~----~~~l~~l~~L~~L~L~~N~l~~~~~~~-------------l~~l~~L~~L~Ls~N~l  301 (982)
                      ..++|+.|+|++|.++...    ...+...++|++|++++|.++......             ....+.|+.|++++|.+
T Consensus        91 ~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i  170 (344)
T d2ca6a1          91 KCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRL  170 (344)
T ss_dssp             TCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCC
T ss_pred             hCCCcccccccccccccccccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeecccccc
Confidence            3455666666666665432    223344556666666666554211100             12345677777777766


Q ss_pred             cCcC----chhhhcccchhhhhhccCCCCCC-----CCCcCCCCCCccEEEccCCCcccc----cCccccCCCcccEEEe
Q 002010          302 TGEI----PESFAALKNLTLLQLFKNNLRGP-----IPSFLGDFPNLEVLQVWGNNFTFE----LPENLGRNGKLLILDV  368 (982)
Q Consensus       302 ~~~~----~~~l~~l~~L~~L~L~~N~l~~~-----~p~~~~~l~~L~~L~L~~N~l~~~----~~~~l~~l~~L~~L~L  368 (982)
                      +...    ...+...+.|+.|+|++|.++..     +...+..+++|+.|++++|.++..    +...+..+++|++|++
T Consensus       171 ~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~L  250 (344)
T d2ca6a1         171 ENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGL  250 (344)
T ss_dssp             TGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEEC
T ss_pred             cccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhh
Confidence            5322    22344456666667766666531     233455667777777777776533    3344556677777777


Q ss_pred             ccccccccCCcccc------CccccceeecccccccccC----Ccccc-CCCCCCEEEccCCccC
Q 002010          369 TSNHLTGTIPRDLC------KGGKLKSLILMQNFFIGPI----PEELG-QCKSLTKIRFSKNYLN  422 (982)
Q Consensus       369 ~~N~l~~~~p~~~~------~~~~L~~L~l~~N~~~~~~----~~~l~-~l~~L~~L~Ls~N~l~  422 (982)
                      ++|.+++.....++      ....|++|++++|.+....    ...+. ++++|++|+|++|++.
T Consensus       251 s~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~  315 (344)
T d2ca6a1         251 NDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS  315 (344)
T ss_dssp             TTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSC
T ss_pred             hcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCC
Confidence            77777654333222      1234555666665554321    12221 3455666666666654

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.47  E-value=1.9e-14  Score=137.73  Aligned_cols=123  Identities=18%  Similarity=0.173  Sum_probs=87.1

Q ss_pred             CCccEEEeeccccCCCCchhccCCCCcceeeeccccccCCCccccccccccceeeeeccccCCCCCcccccccCCCeeeC
Q 002010          456 ASLNQLKVANNNITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIPYSISQCHSLTSVDL  535 (982)
Q Consensus       456 ~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  535 (982)
                      ..+++|+|++|+|+ .++..+..+++|+.|+|++|+|+ .++ .+..+++|++|++++|+|+...+..+..+++|+.|+|
T Consensus        18 ~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~L   94 (162)
T d1a9na_          18 VRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELIL   94 (162)
T ss_dssp             TSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEEC
T ss_pred             CcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCcccccccccccccee
Confidence            46777777777777 34566677778888888888877 333 4667778888888888887555555667788888888


Q ss_pred             CCCcccCCCC-cccccccccceEEcccccccccCc----cccccccccceec
Q 002010          536 SRNSLYGKIP-PGISKLIDLSILNLSRNGITGSIP----NEMRNMMSLTTLD  582 (982)
Q Consensus       536 s~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p----~~l~~l~~L~~L~  582 (982)
                      ++|+|+.... ..+..+++|+.|++++|.++. .|    ..+..+++|++||
T Consensus        95 ~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~-~~~~r~~~i~~lp~L~~LD  145 (162)
T d1a9na_          95 TNNSLVELGDLDPLASLKSLTYLCILRNPVTN-KKHYRLYVIYKVPQVRVLD  145 (162)
T ss_dssp             CSCCCCCGGGGGGGGGCTTCCEEECCSSGGGG-STTHHHHHHHHCTTCSEET
T ss_pred             ccccccccccccccccccccchhhcCCCcccc-ccchHHHHHHHCCCcCeeC
Confidence            8888763221 357777888888888888763 33    2467778888776

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.41  E-value=4.4e-14  Score=135.16  Aligned_cols=129  Identities=20%  Similarity=0.114  Sum_probs=88.6

Q ss_pred             CCCCCCCCCEEecccCcCcccCchhhcCCCccceeecccccCCCCCCccccCCCCCCEEEeeCCcccCcCchhhhcccch
Q 002010          236 GFGALTQLQVLDMASCNISGEIPTSLSRLKLLHSLFLQMNKLTGHIPPQLSGLISLKSLDLSLNYLTGEIPESFAALKNL  315 (982)
Q Consensus       236 ~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L  315 (982)
                      .+.+..+|++|+|++|+|+ .++..+..+++|+.|+|++|+|+..  +.+..+++|++|++++|+++...+..+..+++|
T Consensus        13 ~~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~~l--~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L   89 (162)
T d1a9na_          13 QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDL   89 (162)
T ss_dssp             EEECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred             hccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCCcc--CCcccCcchhhhhcccccccCCCcccccccccc
Confidence            3556677888888888887 4456667788888888888888743  347778888888888888886555556677788


Q ss_pred             hhhhhccCCCCCCCC-CcCCCCCCccEEEccCCCccccc---CccccCCCcccEEE
Q 002010          316 TLLQLFKNNLRGPIP-SFLGDFPNLEVLQVWGNNFTFEL---PENLGRNGKLLILD  367 (982)
Q Consensus       316 ~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~---~~~l~~l~~L~~L~  367 (982)
                      +.|++++|+|+.... ..+..+++|++|++++|+++...   +..+..+++|++||
T Consensus        90 ~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD  145 (162)
T d1a9na_          90 TELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLD  145 (162)
T ss_dssp             CEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEET
T ss_pred             ccceeccccccccccccccccccccchhhcCCCccccccchHHHHHHHCCCcCeeC
Confidence            888888887774321 35667777777777777776321   11344555555554

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.27  E-value=7.8e-14  Score=138.33  Aligned_cols=88  Identities=23%  Similarity=0.228  Sum_probs=41.3

Q ss_pred             ccCCCCcceeeeccccccCCCccccccccccceeeeeccccCCCCCcccccccCCCeeeCCCCcccCCCC-ccccccccc
Q 002010          476 IGNLPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYGKIP-PGISKLIDL  554 (982)
Q Consensus       476 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L  554 (982)
                      +..+++|++|+|++|+|+ .+|.....++.|++|++++|+|+. + ..+..+++|+.|+|++|+|+.... ..+..+++|
T Consensus        66 l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~-l-~~~~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L  142 (198)
T d1m9la_          66 LSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-L-SGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKL  142 (198)
T ss_dssp             HHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC-H-HHHHHHHHSSEEEESEEECCCHHHHHHHTTTTTC
T ss_pred             ccCCccccChhhcccccc-cccccccccccccccccccccccc-c-ccccccccccccccccchhccccccccccCCCcc
Confidence            444455555555555554 333333334445555555555542 1 124445555555555555542211 234555555


Q ss_pred             ceEEcccccccc
Q 002010          555 SILNLSRNGITG  566 (982)
Q Consensus       555 ~~L~Ls~N~l~~  566 (982)
                      +.|+|++|+++.
T Consensus       143 ~~L~L~~N~l~~  154 (198)
T d1m9la_         143 EDLLLAGNPLYN  154 (198)
T ss_dssp             SEEEECSSHHHH
T ss_pred             ceeecCCCcccc
Confidence            555555555543

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.27  E-value=6.9e-12  Score=118.74  Aligned_cols=92  Identities=21%  Similarity=0.135  Sum_probs=43.9

Q ss_pred             ccccccccccceeeeecc-ccCCCCCcccccccCCCeeeCCCCcccCCCCcccccccccceEEcccccccccCccccccc
Q 002010          497 PVESFNLKMITSINISDN-NISGEIPYSISQCHSLTSVDLSRNSLYGKIPPGISKLIDLSILNLSRNGITGSIPNEMRNM  575 (982)
Q Consensus       497 p~~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l  575 (982)
                      |..+..+++|++|++++| .|+...+..|.++++|+.|+|++|+|+...|..|..+++|++|+|++|+|+...+..|.. 
T Consensus        24 p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~-  102 (156)
T d2ifga3          24 LHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQG-  102 (156)
T ss_dssp             TTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCSCCCSTTTCS-
T ss_pred             cccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCCCCcccChhhhcc-
Confidence            333334444444444333 244333444555555555555555555444555555555555555555555322233322 


Q ss_pred             cccceecccCCccc
Q 002010          576 MSLTTLDLSYNNLI  589 (982)
Q Consensus       576 ~~L~~L~Ls~N~l~  589 (982)
                      .+|+.|+|++|++.
T Consensus       103 ~~l~~L~L~~Np~~  116 (156)
T d2ifga3         103 LSLQELVLSGNPLH  116 (156)
T ss_dssp             CCCCEEECCSSCCC
T ss_pred             ccccccccCCCccc
Confidence            24555555555553

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.27  E-value=4.8e-12  Score=119.85  Aligned_cols=112  Identities=19%  Similarity=0.199  Sum_probs=96.1

Q ss_pred             cccceeeeeccccCCCCCcccccccCCCeeeCCCC-cccCCCCcccccccccceEEcccccccccCccccccccccceec
Q 002010          504 KMITSINISDNNISGEIPYSISQCHSLTSVDLSRN-SLYGKIPPGISKLIDLSILNLSRNGITGSIPNEMRNMMSLTTLD  582 (982)
Q Consensus       504 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~  582 (982)
                      ...+.++.+++.+. ..|..+..+++|++|++++| .|+...+..|.++++|+.|+|++|+|++..|.+|..+++|++|+
T Consensus         8 ~~~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~   86 (156)
T d2ifga3           8 HGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLN   86 (156)
T ss_dssp             SSSSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEE
T ss_pred             CCCCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCccccccccccccccee
Confidence            44567888988888 67888999999999999876 58866678899999999999999999988899999999999999


Q ss_pred             ccCCccccCCCCCccccccccccccCCcCcccCC
Q 002010          583 LSYNNLIGNIPSGGQFLAFNETSFIGNPNLCLLR  616 (982)
Q Consensus       583 Ls~N~l~~~ip~~~~~~~~~~~~~~~n~~~c~~~  616 (982)
                      |++|+|+...+...+...+....+.|||+.|++.
T Consensus        87 Ls~N~l~~l~~~~~~~~~l~~L~L~~Np~~C~C~  120 (156)
T d2ifga3          87 LSFNALESLSWKTVQGLSLQELVLSGNPLHCSCA  120 (156)
T ss_dssp             CCSSCCSCCCSTTTCSCCCCEEECCSSCCCCCGG
T ss_pred             ccCCCCcccChhhhccccccccccCCCcccCCch
Confidence            9999999666655555577788899999999663

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.26  E-value=8.8e-14  Score=137.95  Aligned_cols=132  Identities=23%  Similarity=0.316  Sum_probs=108.2

Q ss_pred             ccEEEeecc--ccCCCCchhccCCCCcceeeeccccccCCCccccccccccceeeeeccccCCCCCcccccccCCCeeeC
Q 002010          458 LNQLKVANN--NITGKIPAAIGNLPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNISGEIPYSISQCHSLTSVDL  535 (982)
Q Consensus       458 L~~L~L~~N--~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  535 (982)
                      ++.+++.++  .+. .+|..+..+++|++|+|++|+|+ .++ .+..+++|++|+|++|+|+ .+|..+..++.|+.|++
T Consensus        25 ~~~~~l~~~~~~i~-~l~~sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l  100 (198)
T d1m9la_          25 AEKVELHGMIPPIE-KMDATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWI  100 (198)
T ss_dssp             CSCEECCBCCTTCC-CCHHHHHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEEC
T ss_pred             cceeeeecccCchh-hhhhHHhcccccceeECcccCCC-Ccc-cccCCccccChhhcccccc-ccccccccccccccccc
Confidence            344455443  243 56778999999999999999998 454 5889999999999999998 56766677789999999


Q ss_pred             CCCcccCCCCcccccccccceEEcccccccccCc-cccccccccceecccCCccccCCCCC
Q 002010          536 SRNSLYGKIPPGISKLIDLSILNLSRNGITGSIP-NEMRNMMSLTTLDLSYNNLIGNIPSG  595 (982)
Q Consensus       536 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~l~~l~~L~~L~Ls~N~l~~~ip~~  595 (982)
                      ++|+|+. + +.+..+++|+.|+|++|+|+.... ..+..+++|++|+|++|+++...+..
T Consensus       101 ~~N~i~~-l-~~~~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~  159 (198)
T d1m9la_         101 SYNQIAS-L-SGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKEN  159 (198)
T ss_dssp             SEEECCC-H-HHHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHCTT
T ss_pred             ccccccc-c-ccccccccccccccccchhccccccccccCCCccceeecCCCccccCcccc
Confidence            9999984 4 458999999999999999985432 56899999999999999998766543

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.64  E-value=1.6e-09  Score=102.96  Aligned_cols=108  Identities=19%  Similarity=0.167  Sum_probs=65.6

Q ss_pred             CCCCcceeeeccccccCCCccccccccccceeeeeccccCCCC--CcccccccCCCeeeCCCCcccCCCCcccccccccc
Q 002010          478 NLPSLNILSLQNNRLEGEIPVESFNLKMITSINISDNNISGEI--PYSISQCHSLTSVDLSRNSLYGKIPPGISKLIDLS  555 (982)
Q Consensus       478 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~--p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~  555 (982)
                      .+..+..++..+|... .++..+..+++|++|+||+|+|+...  +..+..+++|+.|||++|.|+...+-.+.....|+
T Consensus        40 ~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~  118 (162)
T d1koha1          40 AQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLE  118 (162)
T ss_dssp             TTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCS
T ss_pred             hccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccc
Confidence            3444444444444433 33333445677777777777776432  34466777888888888888743333344445678


Q ss_pred             eEEcccccccccCcc-------ccccccccceecccCCcc
Q 002010          556 ILNLSRNGITGSIPN-------EMRNMMSLTTLDLSYNNL  588 (982)
Q Consensus       556 ~L~Ls~N~l~~~~p~-------~l~~l~~L~~L~Ls~N~l  588 (982)
                      .|+|++|.++.....       .+..+|+|+.||  |+.+
T Consensus       119 ~L~L~~Npl~~~~~~~~~y~~~i~~~~P~L~~LD--g~~v  156 (162)
T d1koha1         119 ELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLD--GHEL  156 (162)
T ss_dssp             SCCCTTSTTSSSSSSHHHHHHHHHTTSTTCCEET--TEEC
T ss_pred             eeecCCCCcCcCcccchhHHHHHHHHCCCCCEEC--cCCC
Confidence            888888888755442       256678888776  5554

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.39  E-value=1.8e-08  Score=95.34  Aligned_cols=92  Identities=22%  Similarity=0.185  Sum_probs=65.7

Q ss_pred             CCchhccCCCCcceeeeccccccCCC--ccccccccccceeeeeccccCCCCCcccccccCCCeeeCCCCcccCCCCcc-
Q 002010          471 KIPAAIGNLPSLNILSLQNNRLEGEI--PVESFNLKMITSINISDNNISGEIPYSISQCHSLTSVDLSRNSLYGKIPPG-  547 (982)
Q Consensus       471 ~~p~~~~~l~~L~~L~L~~N~l~~~~--p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~-  547 (982)
                      .++..+..+++|++|+|++|+|+..-  +..+..+++|+.|+|++|+|+...+..+.+...|+.|+|++|.+.+..... 
T Consensus        56 ~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~  135 (162)
T d1koha1          56 TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQS  135 (162)
T ss_dssp             HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHH
T ss_pred             hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcCcCcccch
Confidence            44455567888888889999887532  344567888999999999988544434445567899999999998655432 


Q ss_pred             ------cccccccceEEcccccc
Q 002010          548 ------ISKLIDLSILNLSRNGI  564 (982)
Q Consensus       548 ------~~~l~~L~~L~Ls~N~l  564 (982)
                            +..+++|+.||  ++.+
T Consensus       136 ~y~~~i~~~~P~L~~LD--g~~v  156 (162)
T d1koha1         136 TYISAIRERFPKLLRLD--GHEL  156 (162)
T ss_dssp             HHHHHHHTTSTTCCEET--TEEC
T ss_pred             hHHHHHHHHCCCCCEEC--cCCC
Confidence                  56788888876  5554

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.39  E-value=6.2e-07  Score=92.21  Aligned_cols=147  Identities=14%  Similarity=0.099  Sum_probs=99.2

Q ss_pred             HHHHHhhcccccccccccceEEEEEEeCCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCC-CCcccceEeEEEcCCccE
Q 002010          687 AEDVLESLKDENIIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIR-HRNIVRLLGYVSNRDTNL  765 (982)
Q Consensus       687 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~  765 (982)
                      .....+.|+..+..+.++.+.||+... ++..+++|+.... .......+.+|...+..+. +--+.+++++...++..+
T Consensus         9 l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~-~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~   86 (263)
T d1j7la_           9 LKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSR-YKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN   86 (263)
T ss_dssp             HHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGG-GTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred             HHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCC-cccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence            344556677666555555679999875 6667888877433 3334446778888887763 333566778788888889


Q ss_pred             EEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC----------------------------------
Q 002010          766 LLYEYMPNGSLGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHDC----------------------------------  811 (982)
Q Consensus       766 lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~----------------------------------  811 (982)
                      +||++++|.++.+.....       .....++.++++.++.||+..                                  
T Consensus        87 lv~~~l~G~~~~~~~~~~-------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (263)
T d1j7la_          87 LLMSEADGVLCSEEYEDE-------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE  159 (263)
T ss_dssp             EEEECCSSEEHHHHTTTC-------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGS
T ss_pred             EEEEeccccccccccccc-------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccc
Confidence            999999998887654311       112224455555555555321                                  


Q ss_pred             ----------------------CCcEEecCCCCCcEEEcCCCCEEEeccccch
Q 002010          812 ----------------------SPLIIHRDVKSNNILLDSDFEAHVADFGLAK  842 (982)
Q Consensus       812 ----------------------~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~  842 (982)
                                            ...++|+|+.|.||++++++.+-++||+.+.
T Consensus       160 ~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             TTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             ccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                                  1227899999999999987667799999775

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.01  E-value=6.4e-06  Score=83.89  Aligned_cols=130  Identities=18%  Similarity=0.110  Sum_probs=84.8

Q ss_pred             ccccccc-eEEEEEEeCCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCC--CcccceEeEEEcCCccEEEEeccCCCC
Q 002010          699 IIGKGGA-GIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRH--RNIVRLLGYVSNRDTNLLLYEYMPNGS  775 (982)
Q Consensus       699 ~lg~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~lv~e~~~~~s  775 (982)
                      .+..|.. +.||+....++..+++|.....    ....+.+|+..++.+..  --+.+++++..+++..++|||+++|.+
T Consensus        17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~----~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~   92 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSG----ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQD   92 (255)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSC----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEE
T ss_pred             EcCCcccCCeEEEEEeCCCCEEEEEeCCcc----CHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccc
Confidence            3455553 6899998878888999976332    23346778888777632  335667888888888899999998866


Q ss_pred             HHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhc---------------------------------------------
Q 002010          776 LGEMLHGAKGGHLKWETRYRIALEAAKGLCYLHHD---------------------------------------------  810 (982)
Q Consensus       776 L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---------------------------------------------  810 (982)
                      +.+..       ....   ..+.++++.++.||+.                                             
T Consensus        93 ~~~~~-------~~~~---~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (255)
T d1nd4a_          93 LLSSH-------LAPA---EKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF  162 (255)
T ss_dssp             TTTSC-------CCHH---HHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred             ccccc-------ccHH---HHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHH
Confidence            53311       1111   1122233333333321                                             


Q ss_pred             ----------CCCcEEecCCCCCcEEEcCCCCEEEeccccch
Q 002010          811 ----------CSPLIIHRDVKSNNILLDSDFEAHVADFGLAK  842 (982)
Q Consensus       811 ----------~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~  842 (982)
                                ....++|+|+.|.||+++++..+-|+||+.+.
T Consensus       163 ~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~  204 (255)
T d1nd4a_         163 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  204 (255)
T ss_dssp             HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence                      01237999999999999987667899999774

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=97.72  E-value=1.4e-05  Score=75.32  Aligned_cols=19  Identities=11%  Similarity=0.235  Sum_probs=10.0

Q ss_pred             ccccccccEEeecCccccc
Q 002010          164 IASLKSLRHLSFGGNYFTG  182 (982)
Q Consensus       164 l~~l~~L~~L~L~~N~l~~  182 (982)
                      +...++|++|+|++|.++.
T Consensus        40 L~~n~~L~~L~Ls~n~l~~   58 (167)
T d1pgva_          40 ACNSKHIEKFSLANTAISD   58 (167)
T ss_dssp             HTTCSCCCEEECTTSCCBH
T ss_pred             HhhCCccceeeccccccch
Confidence            3444555555555555543

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=97.55  E-value=1.2e-05  Score=75.82  Aligned_cols=115  Identities=12%  Similarity=0.115  Sum_probs=69.5

Q ss_pred             ccccccEEeecCc-ccccc----cCCCccccCcceEeeccCcccccchhhHHhhhhhHHHHhhcccccccccCCCCCCCC
Q 002010          166 SLKSLRHLSFGGN-YFTGK----IPQSYSEIQSLEYIGLNGIGLNGTVPAFLSRLKNLREMYIGYFNTYTGGIPPGFGAL  240 (982)
Q Consensus       166 ~l~~L~~L~L~~N-~l~~~----~p~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~l~~~n~~~~~~p~~~~~l  240 (982)
                      +.++|++|+|+++ .++..    +-..+...+.|++|+|++|.++......+...                     +...
T Consensus        13 n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~---------------------L~~n   71 (167)
T d1pgva_          13 DDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIEL---------------------IETS   71 (167)
T ss_dssp             TCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHH---------------------HHHC
T ss_pred             CCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhh---------------------hhhc
Confidence            3456666666653 34432    22345566778888888888775444443322                     2233


Q ss_pred             CCCCEEecccCcCcccCc----hhhcCCCccceeecccccCCCC-------CCccccCCCCCCEEEeeCCcc
Q 002010          241 TQLQVLDMASCNISGEIP----TSLSRLKLLHSLFLQMNKLTGH-------IPPQLSGLISLKSLDLSLNYL  301 (982)
Q Consensus       241 ~~L~~L~L~~n~l~~~~~----~~l~~l~~L~~L~L~~N~l~~~-------~~~~l~~l~~L~~L~Ls~N~l  301 (982)
                      +.|+.|+|++|.++....    ..+...++|++|++++|++...       +...+...++|+.|+++.+..
T Consensus        72 ~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~~  143 (167)
T d1pgva_          72 PSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASM  143 (167)
T ss_dssp             SSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCH
T ss_pred             ccccceeeehhhcchHHHHHHHHHHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCCCc
Confidence            668888888888875432    3456667788888887765532       223344457788887766643

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.52  E-value=0.0002  Score=77.35  Aligned_cols=76  Identities=17%  Similarity=0.095  Sum_probs=48.6

Q ss_pred             cccccccceEEEEEEeCC-CcEEEEEEeccCC------CCCchhhHHHHHHHHhcCC-C-C-cccceEeEEEcCCccEEE
Q 002010          698 NIIGKGGAGIVYRGSMPD-GIDVAIKRLVGRG------TGGNDHGFLAEIQTLGRIR-H-R-NIVRLLGYVSNRDTNLLL  767 (982)
Q Consensus       698 ~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~------~~~~~~~~~~E~~~l~~l~-h-~-niv~~~~~~~~~~~~~lv  767 (982)
                      +.||.|....||++...+ ++.|+||...+..      -.....+...|.+.++.+. + | .+.+++.+  +++..++|
T Consensus        32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv  109 (392)
T d2pula1          32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV  109 (392)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred             EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence            358999999999997644 6789999764321      1123344567888877662 2 3 34455543  45677899


Q ss_pred             EeccCCCC
Q 002010          768 YEYMPNGS  775 (982)
Q Consensus       768 ~e~~~~~s  775 (982)
                      ||++++..
T Consensus       110 mE~L~~~~  117 (392)
T d2pula1         110 MEDLSHLK  117 (392)
T ss_dssp             ECCCTTSE
T ss_pred             EeccCCcc
Confidence            99997654

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=97.12  E-value=8.8e-05  Score=69.54  Aligned_cols=14  Identities=7%  Similarity=0.038  Sum_probs=7.3

Q ss_pred             CCCCCCEEEeeCCc
Q 002010          287 GLISLKSLDLSLNY  300 (982)
Q Consensus       287 ~l~~L~~L~Ls~N~  300 (982)
                      ..++|+.|+++.+.
T Consensus       130 ~n~~L~~L~l~~~~  143 (166)
T d1io0a_         130 KNTTLLKFGYHFTQ  143 (166)
T ss_dssp             HCSSCCEEECCCSS
T ss_pred             hCCCcCEEeCcCCC
Confidence            44555555555443

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=96.88  E-value=0.00015  Score=67.82  Aligned_cols=66  Identities=15%  Similarity=0.201  Sum_probs=32.3

Q ss_pred             hcCCCccEEeccCccccCC----CchhccccccccEEeecCcccccccC----CCccccCcceEeec--cCccccc
Q 002010          141 RGMTELQVLDAYNNNFTGP----LPVEIASLKSLRHLSFGGNYFTGKIP----QSYSEIQSLEYIGL--NGIGLNG  206 (982)
Q Consensus       141 ~~l~~L~~L~Ls~n~l~~~----~p~~l~~l~~L~~L~L~~N~l~~~~p----~~~~~l~~L~~L~L--~~n~i~~  206 (982)
                      ...++|++|+|++|.++..    +-..+...++|+.|++++|.++....    ..+...++|+.++|  ++|.++.
T Consensus        43 ~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~~  118 (166)
T d1io0a_          43 KTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGN  118 (166)
T ss_dssp             TTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCH
T ss_pred             hcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHHHHHHhCccccEEeeccCCCcCcH
Confidence            3455555566665555432    22223445566666666666553322    33445555654333  3444443

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.35  E-value=0.0077  Score=62.59  Aligned_cols=67  Identities=12%  Similarity=0.035  Sum_probs=44.4

Q ss_pred             eEEEEEEeCCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCCC-----CcccceE--eEEEcCCccEEEEeccCCC
Q 002010          706 GIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRH-----RNIVRLL--GYVSNRDTNLLLYEYMPNG  774 (982)
Q Consensus       706 g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-----~niv~~~--~~~~~~~~~~lv~e~~~~~  774 (982)
                      -.||+++..+|..|++|+.++.  .....++..|...+..+..     +..+..-  ..+...+..+.++++++|.
T Consensus        36 N~vy~v~~~dg~~~VlK~~rp~--~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~  109 (325)
T d1zyla1          36 NRVYQFQDEDRRRFVVKFYRPE--RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR  109 (325)
T ss_dssp             SEEEEECCTTCCCEEEEEECTT--TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred             ceeEEEEcCCCCEEEEEEeCCC--CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence            4899999889999999987433  2345667788888877742     1111111  1234456678899999764

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.04  E-value=0.0086  Score=64.11  Aligned_cols=72  Identities=19%  Similarity=0.282  Sum_probs=48.0

Q ss_pred             cccccccceEEEEEEeCCC--------cEEEEEEeccCCCCCchhhHHHHHHHHhcCCCCcc-cceEeEEEcCCccEEEE
Q 002010          698 NIIGKGGAGIVYRGSMPDG--------IDVAIKRLVGRGTGGNDHGFLAEIQTLGRIRHRNI-VRLLGYVSNRDTNLLLY  768 (982)
Q Consensus       698 ~~lg~G~~g~Vy~~~~~~~--------~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~  768 (982)
                      +.|+.|-.-.+|++..+++        +.|++++. ..  ........+|..+++.+.-.++ .++++++.    -+.|+
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~-g~--~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~----~g~I~  120 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVY-FN--PETESHLVAESVIFTLLSERHLGPKLYGIFS----GGRLE  120 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEE-CS--CCCHHHHHHHHHHHHHHHHTTSSSCEEEEET----TEEEE
T ss_pred             EEcCCccccceEEEEeCCCCccccCCCCcEEEEec-CC--cchhhHHHHHHHHHHHHHhCCCCCeEEEEcC----CceEE
Confidence            4678888899999976543        45666654 32  2234456789999888853344 46777654    27899


Q ss_pred             eccCCCCH
Q 002010          769 EYMPNGSL  776 (982)
Q Consensus       769 e~~~~~sL  776 (982)
                      ||++|.++
T Consensus       121 efi~g~~l  128 (395)
T d1nw1a_         121 EYIPSRPL  128 (395)
T ss_dssp             CCCCEEEC
T ss_pred             EEeccccC
Confidence            99987543

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=95.03  E-value=0.1  Score=53.27  Aligned_cols=152  Identities=11%  Similarity=0.017  Sum_probs=76.8

Q ss_pred             HHHHHhhccccc-----ccccccceEEEEEEeCCCcEEEEEEeccCCCCCchhhHHHHHHHHhcCC-----CCcccceEe
Q 002010          687 AEDVLESLKDEN-----IIGKGGAGIVYRGSMPDGIDVAIKRLVGRGTGGNDHGFLAEIQTLGRIR-----HRNIVRLLG  756 (982)
Q Consensus       687 ~~~~~~~~~~~~-----~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~~~~  756 (982)
                      .+.+..+|..++     .|..|.--+.|+.+..+| .+++|+.....   ...+...|+..+..+.     .|..+.-.+
T Consensus         8 l~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~---~~~~l~~~~~~l~~L~~~g~pvp~pi~~~~   83 (316)
T d2ppqa1           8 LRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV---EKNDLPFFLGLMQHLAAKGLSCPLPLPRKD   83 (316)
T ss_dssp             HHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC------CCHHHHHHHHHHHHHHTTCCCCCBCCBTT
T ss_pred             HHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCC---CHHHHHHHHHHHHhhhhccccccccceecC
Confidence            344555665543     345666678899987555 58999874322   2334455666666663     222222111


Q ss_pred             ---EEEcCCccEEEEeccCCCCHHH--------------Hhhc----CC---CCCCCH------------------HHHH
Q 002010          757 ---YVSNRDTNLLLYEYMPNGSLGE--------------MLHG----AK---GGHLKW------------------ETRY  794 (982)
Q Consensus       757 ---~~~~~~~~~lv~e~~~~~sL~~--------------~l~~----~~---~~~l~~------------------~~~~  794 (982)
                         +.......+.++.+..+.....              .++.    ..   ......                  ....
T Consensus        84 g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (316)
T d2ppqa1          84 GELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLR  163 (316)
T ss_dssp             CCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHH
T ss_pred             CCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHH
Confidence               1222345566777776542211              0000    00   000000                  0111


Q ss_pred             HHHHHHHHHHHHHhhc-CCCcEEecCCCCCcEEEcCCCCEEEeccccch
Q 002010          795 RIALEAAKGLCYLHHD-CSPLIIHRDVKSNNILLDSDFEAHVADFGLAK  842 (982)
Q Consensus       795 ~i~~~i~~~l~~LH~~-~~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~  842 (982)
                      ..+..+...+...+.. -..++||+|+.+.||+++.+...-++||+.+.
T Consensus       164 ~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         164 EEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             HHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence            2222222333332221 13459999999999999988777899999875